TSTP Solution File: MED011+1 by Metis---2.4
View Problem
- Process Solution
%------------------------------------------------------------------------------
% File : Metis---2.4
% Problem : MED011+1 : TPTP v8.1.0. Released v4.0.0.
% Transfm : none
% Format : tptp:raw
% Command : metis --show proof --show saturation %s
% Computer : n005.cluster.edu
% Model : x86_64 x86_64
% CPU : Intel(R) Xeon(R) CPU E5-2620 v4 2.10GHz
% Memory : 8042.1875MB
% OS : Linux 3.10.0-693.el7.x86_64
% CPULimit : 300s
% WCLimit : 600s
% DateTime : Sun Jul 17 21:54:10 EDT 2022
% Result : Satisfiable 207.76s 207.90s
% Output : Saturation 224.99s
% Verified :
% SZS Type : -
% Comments :
%------------------------------------------------------------------------------
%----WARNING: Could not form TPTP format derivation
%------------------------------------------------------------------------------
%----ORIGINAL SYSTEM OUTPUT
% 0.12/0.12 % Problem : MED011+1 : TPTP v8.1.0. Released v4.0.0.
% 0.12/0.13 % Command : metis --show proof --show saturation %s
% 0.12/0.34 % Computer : n005.cluster.edu
% 0.12/0.34 % Model : x86_64 x86_64
% 0.12/0.34 % CPU : Intel(R) Xeon(R) CPU E5-2620 v4 @ 2.10GHz
% 0.12/0.34 % Memory : 8042.1875MB
% 0.12/0.34 % OS : Linux 3.10.0-693.el7.x86_64
% 0.12/0.34 % CPULimit : 300
% 0.12/0.34 % WCLimit : 600
% 0.12/0.34 % DateTime : Tue Jul 5 01:52:37 EDT 2022
% 0.12/0.34 % CPUTime :
% 0.12/0.35 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% 207.76/207.90 % SZS status Satisfiable for /export/starexec/sandbox/benchmark/theBenchmark.p
% 207.76/207.90
% 207.76/207.90 SZS output start Saturation for /export/starexec/sandbox/benchmark/theBenchmark.p
% 207.76/207.90 |- rdf__type mesh__D003582sskos__Concept
% 207.76/207.90 |- mesh__recordAuthorizer mesh__D003582 sjn
% 207.76/207.90 |- mesh__dateEstablished mesh__D003582 1967-01-01
% 207.76/207.90 |- skos__annotation mesh__D003582
% 207.76/207.90 SPEC; avoid as coord: Manual 28.22.5; /methods: consider CYTOGENETIC ANALYSIS: Manual 28.22.5.2; CYTOGENETIC ABERRATIONS see CHROMOSOME ABERRATIONS is also available%A%
% 207.76/207.90 |- skos__related mesh__D003582smesh__D002869
% 207.76/207.90 |- skos__scopeNote mesh__D003582
% 207.76/207.90 A subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE.%A%
% 207.76/207.90 |- skos__related mesh__D003582smesh__D025063
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D003582 2005
% 207.76/207.90 |- mesh__recordOriginator mesh__D003582 NLM
% 207.76/207.90 |- mesh__recordMaintainer mesh__D003582 nns
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D003582 2003
% 207.76/207.90 |- skos__related mesh__D003582smesh__D020732
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D003582 2006
% 207.76/207.90 |- mesh__publicMeSHNote mesh__D003582 67
% 207.76/207.90 |- skos__hiddenLabel mesh__D003582 Cytogenetic
% 207.76/207.90 |- mesh__dateRevised mesh__D003582 2002-07-03
% 207.76/207.90 |- skos__related mesh__D003582smesh__D002874
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D003582 2004
% 207.76/207.90 |- mesh__dateCreated mesh__D003582 1999-01-01
% 207.76/207.90 |- skos__related mesh__D003582smesh__D007621
% 207.76/207.90 |- skos__broader mesh__D003582smesh__D005823
% 207.76/207.90 |- mesh__historyNote mesh__D003582 67
% 207.76/207.90 |- skos__historyNote mesh__D003582 Genetics, Medical %28%1966%29%
% 207.76/207.90 |- skos__prefLabel mesh__D003582 Cytogenetics
% 207.76/207.90 |- skos__hiddenLabel mesh__D011216 Practice Managements, Medical
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D011216 2000
% 207.76/207.90 |- skos__altLabel mesh__D011216 Medical Practice Management
% 207.76/207.90 |- skos__scopeNote mesh__D011216
% 207.76/207.90 The organization and operation of the business aspects of a physician%27%s practice.%A%
% 207.76/207.90 |- skos__historyNote mesh__D011216 Office Management %28%1966-1967%29%
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D011216 2005
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D011216 2001
% 207.76/207.90 |- skos__broader mesh__D011216smesh__D020399
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D011216 1999
% 207.76/207.90 |- mesh__historyNote mesh__D011216 68
% 207.76/207.90 |- mesh__recordOriginator mesh__D011216 NLM
% 207.76/207.90 |- skos__hiddenLabel mesh__D011216 Managements, Medical Practice
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D011216 2006
% 207.76/207.90 |- mesh__recordMaintainer mesh__D011216 JLS
% 207.76/207.90 |- mesh__dateRevised mesh__D011216 1998-06-10
% 207.76/207.90 |- skos__prefLabel mesh__D011216 Practice Management, Medical
% 207.76/207.90 |- skos__altLabel mesh__D011216 Management, Medical Practice
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D011216 2003
% 207.76/207.90 |- mesh__publicMeSHNote mesh__D011216 68
% 207.76/207.90 |- rdf__type mesh__D011216sskos__Concept
% 207.76/207.90 |- mesh__recordAuthorizer mesh__D011216 SJN
% 207.76/207.90 |- mesh__dateEstablished mesh__D011216 1968-01-01
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D011216 2002
% 207.76/207.90 |- mesh__dateCreated mesh__D011216 1999-01-01
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D011216 2004
% 207.76/207.90 |- skos__annotation mesh__D011216 DF: PRACTICE MANAGEMENT MED
% 207.76/207.90 |- skos__hiddenLabel mesh__D011216 Medical Practice Managements
% 207.76/207.90 |- skos__hiddenLabel mesh__D007973 Leukorrheas
% 207.76/207.90 |- mesh__dateCreated mesh__D007973 1999-01-01
% 207.76/207.90 |- skos__scopeNote mesh__D007973
% 207.76/207.90 A clear or white discharge from the VAGINA, consisting mainly of MUCUS.%A%
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D007973 2006
% 207.76/207.90 |- mesh__dateRevised mesh__D007973 2005-06-30
% 207.76/207.90 |- mesh__recordOriginator mesh__D007973 NLM
% 207.76/207.90 |- mesh__recordAuthorizer mesh__D007973 sjn
% 207.76/207.90 |- skos__prefLabel mesh__D007973 Leukorrhea
% 207.76/207.90 |- mesh__recordMaintainer mesh__D007973 lkt
% 207.76/207.90 |- skos__broader mesh__D007973smesh__D019522
% 207.76/207.90 |- rdf__type mesh__D007973sskos__Concept
% 207.76/207.90 |- skos__broader mesh__D029627smesh__D019685
% 207.76/207.90 |- skos__prefLabel mesh__D029627 Crassulaceae
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D029627 2006
% 207.76/207.90 |- mesh__publicMeSHNote mesh__D029627 2002
% 207.76/207.90 |- mesh__recordOriginator mesh__D029627 ssb
% 207.76/207.90 |- mesh__recordAuthorizer mesh__D029627 sjn
% 207.76/207.90 |- mesh__dateEstablished mesh__D029627 2002-01-01
% 207.76/207.90 |- skos__annotation mesh__D029627
% 207.76/207.90 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.76/207.90 |- mesh__dateCreated mesh__D029627 2001-07-25
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D029627 2003
% 207.76/207.90 |- mesh__historyNote mesh__D029627 2002
% 207.76/207.90 |- rdf__type mesh__D029627sskos__Concept
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D029627 2005
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D029627 2004
% 207.76/207.90 |- skos__scopeNote mesh__D029627
% 207.76/207.90 The stonecrop plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida that grow in warm, dry regions. The leaves are thick. The flower clusters are red, yellow, or white.%A%
% 207.76/207.90 |- mesh__recordMaintainer mesh__D029627 ssb
% 207.76/207.90 |- mesh__dateRevised mesh__D029627 2002-07-03
% 207.76/207.90 |- skos__hiddenLabel mesh__D007175 Impulsive Behaviors
% 207.76/207.90 |- skos__historyNote mesh__D007175 Behavior %28%1966-1967%29%
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D007175 2004
% 207.76/207.90 |- skos__annotation mesh__D007175 use Cat F3 qualif
% 207.76/207.90 |- skos__broader mesh__D007175smesh__D001519
% 207.76/207.90 |- mesh__recordOriginator mesh__D007175 NLM
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D007175 2003
% 207.76/207.90 |- skos__hiddenLabel mesh__D007175 Behaviors, Impulsive
% 207.76/207.90 |- mesh__recordMaintainer mesh__D007175 JLS
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D007175 2006
% 207.76/207.90 |- skos__prefLabel mesh__D007175 Impulsive Behavior
% 207.76/207.90 |- mesh__historyNote mesh__D007175 68
% 207.76/207.90 |- mesh__dateRevised mesh__D007175 2002-07-02
% 207.76/207.90 |- skos__scopeNote mesh__D007175
% 207.76/207.90 An act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus.%A%
% 207.76/207.90 |- rdf__type mesh__D007175sskos__Concept
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D007175 2005
% 207.76/207.90 |- mesh__recordAuthorizer mesh__D007175 sjn
% 207.76/207.90 |- mesh__dateCreated mesh__D007175 1999-01-01
% 207.76/207.90 |- skos__hiddenLabel mesh__D007175 Behavior, Impulsive
% 207.76/207.90 |- mesh__publicMeSHNote mesh__D007175 68
% 207.76/207.90 |- mesh__dateEstablished mesh__D007175 1968-01-01
% 207.76/207.90 |- skos__annotation mesh__D015607
% 207.76/207.90 do not use /util except by MeSH definition
% 207.76/207.90 |- skos__scopeNote mesh__D015607
% 207.76/207.90 Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.%A%
% 207.76/207.90 |- mesh__dateEstablished mesh__D015607 1990-01-01
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D015607 2006
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D015607 1999
% 207.76/207.90 |- skos__prefLabel mesh__D015607 Stents
% 207.76/207.90 |- mesh__publicMeSHNote mesh__D015607 90
% 207.76/207.90 |- mesh__dateCreated mesh__D015607 1989-04-13
% 207.76/207.90 |- skos__historyNote mesh__D015607 Catheters, Indwelling %28%1972-1989%29%
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D015607 2005
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D015607 1998
% 207.76/207.90 |- mesh__recordMaintainer mesh__D015607 PXP
% 207.76/207.90 |- skos__hiddenLabel mesh__D015607 Stent
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D015607 2002
% 207.76/207.90 |- rdf__type mesh__D015607sskos__Concept
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D015607 2004
% 207.76/207.90 |- skos__broader mesh__D015607smesh__D019736
% 207.76/207.90 |- skos__historyNote mesh__D015607 Splints %28%1966-1989%29%
% 207.76/207.90 |- mesh__historyNote mesh__D015607 90
% 207.76/207.90 |- mesh__recordOriginator mesh__D015607 AGS
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D015607 2001
% 207.76/207.90 |- skos__historyNote mesh__D015607 Implants, Artificial %28%1972-1989%29%
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D015607 2003
% 207.76/207.90 |- mesh__dateRevised mesh__D015607 1997-06-20
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D015607 2000
% 207.76/207.90 |- skos__historyNote mesh__D015607 Prosthesis %28%1966-1989%29%
% 207.76/207.90 |- mesh__recordAuthorizer mesh__D015607 SJN
% 207.76/207.90 |- skos__historyNote mesh__D003583 Adenine %28%1973-1974%29%
% 207.76/207.90 |- skos__historyNote mesh__D003583
% 207.76/207.90 Plant Growth Regulators %28%1973-1974%29%
% 207.76/207.90 |- mesh__dateRevised mesh__D003583 2005-06-30
% 207.76/207.90 |- rdf__type mesh__D003583sskos__Concept
% 207.76/207.90 |- mesh__dateCreated mesh__D003583 1974-11-11
% 207.76/207.90 |- skos__broader mesh__D003583smesh__D000225
% 207.76/207.90 |- mesh__recordMaintainer mesh__D003583 ssb
% 207.76/207.90 |- mesh__recordAuthorizer mesh__D003583 sjn
% 207.76/207.90 |- mesh__dateEstablished mesh__D003583 1991-01-01
% 207.76/207.90 |- skos__prefLabel mesh__D003583 Cytokinins
% 207.76/207.90 |- mesh__publicMeSHNote mesh__D003583
% 207.76/207.90 91; was see under PLANT GROWTH REGULATORS 1975-90
% 207.76/207.90 |- mesh__recordOriginator mesh__D003583 NLM
% 207.76/207.90 |- mesh__historyNote mesh__D003583
% 207.76/207.90 91%28%75%29%; was see under PLANT GROWTH REGULATORS 1975-90
% 207.76/207.90 |- skos__scopeNote mesh__D003583
% 207.76/207.90 Plant hormones that promote the separation of daughter cells after mitotic division of a parent cell. Frequently they are purine derivatives.%A%
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D003583 2006
% 207.76/207.90 |- mesh__recordAuthorizer mesh__D011217 sjn
% 207.76/207.90 |- skos__broader mesh__D011217smesh__D050198
% 207.76/207.90 |- mesh__publicMeSHNote mesh__D011217 74
% 207.76/207.90 |- mesh__dateRevised mesh__D011217 2005-06-30
% 207.76/207.90 |- skos__scopeNote mesh__D011217
% 207.76/207.90 A beta-adrenergic antagonist that has been used in the emergency treatment of cardiac arrhythmias.%A%
% 207.76/207.90 |- skos__hiddenLabel mesh__D011217 Practolol, Eralzdin
% 207.76/207.90 |- mesh__activeMeSHYear mesh__D011217 2006
% 207.76/207.90 |- skos__prefLabel mesh__D011217 Practolol
% 207.76/207.90 |- skos__broader mesh__D011217smesh__D000083
% 207.76/207.90 |- mesh__dateEstablished mesh__D011217 1974-01-01
% 207.76/207.90 |- rdf__type mesh__D011217sskos__Concept
% 207.76/207.90 |- skos__hiddenLabel mesh__D011217 ICI 50172
% 207.76/207.90 |- skos__hiddenLabel mesh__D011217 ICI50172
% 207.76/207.90 |- mesh__dateCreated mesh__D011217 1999-01-01
% 207.76/207.90 |- mesh__recordOriginator mesh__D011217 NLM
% 207.76/207.90 |- mesh__recordMaintainer mesh__D011217 ssb
% 207.76/207.90 |- mesh__historyNote mesh__D011217 74
% 207.76/207.90 |- skos__broader mesh__D011217smesh__D011412
% 207.76/207.90 |- mesh__dateRevised mesh__D016700 2005-06-30
% 207.76/207.90 |- skos__broader mesh__D016700smesh__D000813
% 207.76/207.90 |- skos__prefLabel mesh__D016700 Encainide
% 207.76/207.90 |- skos__historyNote mesh__D016700 Anilides %28%1966-1991%29%
% 207.76/207.90 |- skos__hiddenLabel mesh__D016700 MJ9067
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016700 2006
% 207.76/207.91 |- mesh__dateEstablished mesh__D016700 1992-01-01
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D016700 sjn
% 207.76/207.91 |- mesh__dateCreated mesh__D016700 1991-02-11
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D016700
% 207.76/207.91 92; ENCAINIDE was indexed under ANILIDES 1979-91
% 207.76/207.91 |- skos__hiddenLabel mesh__D016700 MJ 9067
% 207.76/207.91 |- skos__hiddenLabel mesh__D016700
% 207.76/207.91 Bristol Myers Squibb Brand of Encainide Hydrochloride
% 207.76/207.91 |- mesh__historyNote mesh__D016700 92; was ENCAINIDE %28%NM%29% 1979-91
% 207.76/207.91 |- skos__altLabel mesh__D016700
% 207.76/207.91 Bristol-Myers Squibb Brand of Encainide Hydrochloride
% 207.76/207.91 |- skos__altLabel mesh__D016700 Encainide Hydrochloride, %28%+-%29%-Isomer
% 207.76/207.91 |- rdf__type mesh__D016700sskos__Concept
% 207.76/207.91 |- skos__historyNote mesh__D016700 Anti-Arrhythmia Agents %28%1966-1991%29%
% 207.76/207.91 |- skos__scopeNote mesh__D016700
% 207.76/207.91 One of the ANTI-ARRHYTHMIA AGENTS, it blocks SODIUM CHANNELS and slows conduction within the His-Purkinje system and myocardium.%A%
% 207.76/207.91 |- mesh__onlineNote mesh__D016700
% 207.76/207.91 use ENCAINIDE %28%NM%29% to search ENCAINIDE 1980-91
% 207.76/207.91 |- mesh__recordOriginator mesh__D016700 RLS
% 207.76/207.91 |- mesh__recordMaintainer mesh__D016700 exl
% 207.76/207.91 |- skos__prefLabel mesh__D029628 Hydrangeaceae
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029628 2002
% 207.76/207.91 |- mesh__dateEstablished mesh__D029628 2002-01-01
% 207.76/207.91 |- skos__broader mesh__D029628smesh__D019685
% 207.76/207.91 |- skos__annotation mesh__D029628
% 207.76/207.91 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029628 2003
% 207.76/207.91 |- rdf__type mesh__D029628sskos__Concept
% 207.76/207.91 |- skos__scopeNote mesh__D029628
% 207.76/207.91 A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida.%A%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029628 2005
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029628 2004
% 207.76/207.91 |- mesh__dateCreated mesh__D029628 2001-07-25
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029628 2006
% 207.76/207.91 |- mesh__historyNote mesh__D029628 2002
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D029628 2002
% 207.76/207.91 |- skos__altLabel mesh__D007176 In Vitro %5B%Publication Type%5D%
% 207.76/207.91 |- skos__prefLabel mesh__D007176 In Vitro
% 207.76/207.91 |- skos__broader mesh__D007176smesh__D052182
% 207.76/207.91 |- mesh__historyNote mesh__D007176 1966
% 207.76/207.91 |- skos__altLabel mesh__D007176 In Vitro %5B%Pub Type%5D%
% 207.76/207.91 |- mesh__recordMaintainer mesh__D007176 jls
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007176 2006
% 207.76/207.91 |- skos__annotation mesh__D007176 CATALOG: do not use
% 207.76/207.91 |- mesh__recordOriginator mesh__D007176 NLM
% 207.76/207.91 |- rdf__type mesh__D007176sskos__Concept
% 207.76/207.91 |- mesh__dateRevised mesh__D007176 2005-06-30
% 207.76/207.91 |- mesh__dateCreated mesh__D007176 1999-01-01
% 207.76/207.91 |- skos__altLabel mesh__D007176 In Vitro %5B%PT%5D%
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D007176 sjn
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D015608 ags
% 207.76/207.91 |- skos__historyNote mesh__D015608 Vaccinia Virus %28%1967-1989%29%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015608 2006
% 207.76/207.91 |- mesh__historyNote mesh__D015608 90
% 207.76/207.91 |- skos__annotation mesh__D015608 infection = COWPOX: see note there
% 207.76/207.91 |- skos__altLabel mesh__D015608 Cow Pox Virus
% 207.76/207.91 |- skos__scopeNote mesh__D015608
% 207.76/207.91 A species of ORTHOPOXVIRUS that is the etiologic agent of COWPOX. It is closely related to but antigenically different from VACCINIA VIRUS.%A%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015608 2006A
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015608 2003
% 207.76/207.91 |- skos__prefLabel mesh__D015608 Cowpox virus
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015608 2002
% 207.76/207.91 |- rdf__type mesh__D015608sskos__Concept
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015608 2004
% 207.76/207.91 |- mesh__dateRevised mesh__D015608 2005-08-03
% 207.76/207.91 |- mesh__dateCreated mesh__D015608 1989-04-07
% 207.76/207.91 |- skos__hiddenLabel mesh__D015608 Cowpox viruses
% 207.76/207.91 |- skos__broader mesh__D015608smesh__D018155
% 207.76/207.91 |- mesh__recordMaintainer mesh__D015608 ags
% 207.76/207.91 |- mesh__recordOriginator mesh__D015608 PXP
% 207.76/207.91 |- mesh__dateEstablished mesh__D015608 1990-01-01
% 207.76/207.91 |- skos__hiddenLabel mesh__D015608 Cow Pox Viruses
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015608 2005
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D015608 90
% 207.76/207.91 |- mesh__dateRevised mesh__D040001 2003-07-09
% 207.76/207.91 |- rdf__type mesh__D040001sskos__Concept
% 207.76/207.91 |- skos__scopeNote mesh__D040001
% 207.76/207.91 Species of American house dust mite, in the family PYROGLYPHIDAE.%A%
% 207.76/207.91 |- skos__historyNote mesh__D040001 Mites %28%1968-2002%29%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D040001 2005
% 207.76/207.91 |- mesh__dateEstablished mesh__D040001 2003-01-01
% 207.76/207.91 |- skos__altLabel mesh__D040001 American House Dust Mite
% 207.76/207.91 |- skos__prefLabel mesh__D040001 Dermatophagoides farinae
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D040001 2006
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D040001 2004
% 207.76/207.91 |- skos__broader mesh__D040001smesh__D039981
% 207.76/207.91 |- mesh__dateCreated mesh__D040001 2002-07-02
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D040001 2003
% 207.76/207.91 |- skos__altLabel mesh__D040001 House Dust Mite, American
% 207.76/207.91 |- mesh__historyNote mesh__D040001 2003
% 207.76/207.91 |- mesh__dateRevised mesh__D012310 2004-07-07
% 207.76/207.91 |- mesh__dateCreated mesh__D012310 1999-01-01
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D012310 RISTOMYCIN was heading 1965-93
% 207.76/207.91 |- skos__broader mesh__D012310smesh__D006020
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D012310 2005
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D012310 sjn
% 207.76/207.91 |- mesh__recordOriginator mesh__D012310 NLM
% 207.76/207.91 |- skos__prefLabel mesh__D012310 Ristocetin
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D012310 2006
% 207.76/207.91 |- mesh__recordMaintainer mesh__D012310 ssb
% 207.76/207.91 |- mesh__onlineNote mesh__D012310
% 207.76/207.91 use RISTOCETIN to search RISTOMYCIN 1966-93 %28%as Prov 1966-72%29%%A%
% 207.76/207.91 |- rdf__type mesh__D012310sskos__Concept
% 207.76/207.91 |- mesh__historyNote mesh__D012310
% 207.76/207.91 RISTOMYCIN was heading 1965-93 %28%Prov 1965-72%29%
% 207.76/207.91 |- skos__scopeNote mesh__D012310
% 207.76/207.91 An antibiotic mixture of two components, A and B, obtained from Nocardia lurida %28%or the same substance produced by any other means%29%. It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.%A%
% 207.76/207.91 |- mesh__onlineNote mesh__D003584
% 207.76/207.91 use CYTOLOGICAL TECHNIQUES to search CYTOLOGICAL TECHNICS 1973-90%A%
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D003584
% 207.76/207.91 91; was CYTOLOGICAL TECHNICS 1973-90
% 207.76/207.91 |- skos__altLabel mesh__D003584 Technic, Cytological
% 207.76/207.91 |- rdf__type mesh__D003584sskos__Concept
% 207.76/207.91 |- mesh__dateEstablished mesh__D003584 1973-01-01
% 207.76/207.91 |- skos__hiddenLabel mesh__D003584 Cytologic Technic
% 207.76/207.91 |- skos__hiddenLabel mesh__D003584 Technics, Cytologic
% 207.76/207.91 |- skos__related mesh__D003584smesh__D003581
% 207.76/207.91 |- skos__broader mesh__D003584smesh__D019411
% 207.76/207.91 |- skos__altLabel mesh__D003584 Techniques, Cytological
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003584 2002
% 207.76/207.91 |- skos__prefLabel mesh__D003584 Cytological Techniques
% 207.76/207.91 |- mesh__dateCreated mesh__D003584 1999-01-01
% 207.76/207.91 |- skos__altLabel mesh__D003584 Cytologic Technics
% 207.76/207.91 |- mesh__dateRevised mesh__D003584 2000-06-22
% 207.76/207.91 |- skos__altLabel mesh__D003584 Technique, Cytological
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003584 2004
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003584 2001
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003584 2006
% 207.76/207.91 |- mesh__recordMaintainer mesh__D003584 kle
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D003584 sjn
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003584 2003
% 207.76/207.91 |- mesh__historyNote mesh__D003584 91; was CYTOLOGICAL TECHNICS 1973-90
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003584 2005
% 207.76/207.91 |- skos__hiddenLabel mesh__D003584 Technic, Cytologic
% 207.76/207.91 |- skos__altLabel mesh__D003584 Cytological Technique
% 207.76/207.91 |- skos__altLabel mesh__D003584 Cytological Technics
% 207.76/207.91 |- skos__altLabel mesh__D003584 Cytological Technic
% 207.76/207.91 |- skos__historyNote mesh__D003584 Cytology %28%1966-1972%29%
% 207.76/207.91 |- mesh__recordOriginator mesh__D003584 NLM
% 207.76/207.91 |- skos__altLabel mesh__D003584 Technics, Cytological
% 207.76/207.91 |- skos__annotation mesh__D003584 avoid: too general; usually NIM
% 207.76/207.91 |- mesh__recordMaintainer mesh__D011218 lkt
% 207.76/207.91 |- skos__historyNote mesh__D011218
% 207.76/207.91 Abnormalities, Multiple %28%1968-1976%29%
% 207.76/207.91 |- skos__hiddenLabel mesh__D011218 Syndrome, Royer
% 207.76/207.91 |- mesh__dateEstablished mesh__D011218 1977-01-01
% 207.76/207.91 |- skos__related mesh__D011218smesh__D008607
% 207.76/207.91 |- skos__hiddenLabel mesh__D011218 Syndrome, Labhart-Willi
% 207.76/207.91 |- rdf__type mesh__D011218sskos__Concept
% 207.76/207.91 |- skos__altLabel mesh__D011218 Labhart-Willi Syndrome
% 207.76/207.91 |- mesh__dateCreated mesh__D011218 1976-04-13
% 207.76/207.91 |- skos__hiddenLabel mesh__D011218 Labhart Willi Syndrome
% 207.76/207.91 |- skos__altLabel mesh__D011218 Labhart-Willi-Prader-Fanconi Syndrome
% 207.76/207.91 |- mesh__recordOriginator mesh__D011218 EC
% 207.76/207.91 |- skos__altLabel mesh__D011218 Royer%27%s Syndrome
% 207.76/207.91 |- skos__broader mesh__D011218smesh__D025063
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D011218 sjn
% 207.76/207.91 |- skos__scopeNote mesh__D011218
% 207.76/207.91 An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 %28%15q11-q13%29% or by inheritance of both of the pair of chromosomes 15 from the mother %28%UNIPARENTAL DISOMY%29% which are imprinted %28%GENETIC IMPRINTING%29% and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. %28%Menkes, Textbook of Child Neurology, 5th ed, p229%29%%A%
% 207.76/207.91 |- skos__historyNote mesh__D011218 Obesity %28%1966-1976%29%
% 207.76/207.91 |- mesh__dateRevised mesh__D011218 2005-06-30
% 207.76/207.91 |- skos__historyNote mesh__D011218
% 207.76/207.91 Carbohydrate Metabolism, Inborn Errors %28%1969-1976%29%
% 207.76/207.91 |- skos__historyNote mesh__D011218 Mental Retardation %28%1966-1976%29%
% 207.76/207.91 |- mesh__historyNote mesh__D011218 77
% 207.76/207.91 |- skos__broader mesh__D011218smesh__D008607
% 207.76/207.91 |- skos__hiddenLabel mesh__D011218 Royers Syndrome
% 207.76/207.91 |- skos__historyNote mesh__D011218 Hypogonadism %28%1966-1976%29%
% 207.76/207.91 |- skos__hiddenLabel mesh__D011218 Prader Willi Syndrome
% 207.76/207.91 |- skos__hiddenLabel mesh__D011218 Syndrome, Prader-Willi
% 207.76/207.91 |- skos__hiddenLabel mesh__D011218 Labhart Willi Prader Fanconi Syndrome
% 207.76/207.91 |- skos__prefLabel mesh__D011218 Prader-Willi Syndrome
% 207.76/207.91 |- skos__hiddenLabel mesh__D011218 Syndrome, Royer%27%s
% 207.76/207.91 |- skos__broader mesh__D011218smesh__D009765
% 207.76/207.91 |- skos__broader mesh__D011218smesh__D000015
% 207.76/207.91 |- skos__hiddenLabel mesh__D011218 Syndrome, Labhart-Willi-Prader-Fanconi
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D011218 77
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D011218 2006
% 207.76/207.91 |- mesh__recordOriginator mesh__D016701 TGC
% 207.76/207.91 |- skos__altLabel mesh__D016701 Guinea, Republic of
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016701 2001
% 207.76/207.91 |- skos__altLabel mesh__D016701 French Guinea
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016701 2006
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016701 2002
% 207.76/207.91 |- skos__altLabel mesh__D016701 Guinea, French
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D016701 SJN
% 207.76/207.91 |- rdf__type mesh__D016701sskos__Concept
% 207.76/207.91 |- mesh__onlineNote mesh__D016701
% 207.76/207.91 use AFRICA, WESTERN to search GUINEA %26% REPUBLIC OF GUINEA 1988-91; use GUINEA-BISSAU 1966-82%A%
% 207.76/207.91 |- mesh__recordMaintainer mesh__D016701 TGC
% 207.76/207.91 |- skos__annotation mesh__D016701
% 207.76/207.91 a republic in western Africa; X ref FRENCH GUINEA was its former name; do not confuse with GUINEA-BISSAU %28%formerly Portuguese Guinea%29% or EQUATORIAL GUINEA %28%formerly Spanish Guinea%29%; do not confuse with GUYANA in So. Amer.%A%
% 207.76/207.91 |- mesh__dateEstablished mesh__D016701 1992-01-01
% 207.76/207.91 |- skos__broader mesh__D016701smesh__D000354
% 207.76/207.91 |- mesh__dateRevised mesh__D016701 1997-06-20
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016701 2003
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016701 1998
% 207.76/207.91 |- skos__prefLabel mesh__D016701 Guinea
% 207.76/207.91 |- mesh__dateCreated mesh__D016701 1991-02-11
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016701 2004
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016701 1999
% 207.76/207.91 |- mesh__historyNote mesh__D016701
% 207.76/207.91 92; was REPUBLIC OF GUINEA see AFRICA, WESTERN 1988-91; was see GUINEA-BISSAU 1980-82; was heading 1966-79%A%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016701 2000
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D016701 2005
% 207.76/207.91 |- skos__historyNote mesh__D016701 Africa, Western %28%1966-1991%29%
% 207.76/207.91 |- skos__scopeNote mesh__D016701
% 207.76/207.91 A republic in western Africa, south of SENEGAL and MALI, east of GUINEA-BISSAU. Its capital is Conakry. Its coastal region was proclaimed a French protectorate in 1849, was established as a separate colony called French Guinea in 1893, and gained its independence in 1958. This Guinea gave its name to the coin originally made out of gold coming from there. Guinea is from a Tuareg word aginaw, meaning black people. %28%From Webster%27%s New Geographical Dictionary, 1988, p474 %26% Room, Brewer%27%s Dictionary of Names, 1992, p222%29%%A%
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D007975 sjn
% 207.76/207.91 |- skos__altLabel mesh__D007975 Leukotriene B
% 207.76/207.91 |- skos__altLabel mesh__D007975 5,12-HETE
% 207.76/207.91 |- skos__historyNote mesh__D007975 Arachidonic Acids %28%1967-1982%29%
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D007975
% 207.76/207.91 94; was LEUKOTRIENES B 1983-93; LEUKOTRIENE B4 was see LEUKOTRIENES B 1983-93%A%
% 207.76/207.91 |- skos__hiddenLabel mesh__D007975 Leukotriene B 4
% 207.76/207.91 |- skos__broader mesh__D007975smesh__D015289
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007975 2006
% 207.76/207.91 |- mesh__onlineNote mesh__D007975
% 207.76/207.91 use LEUKOTRIENE B4 to search LEUKOTRIENES B 1983-93
% 207.76/207.91 |- skos__hiddenLabel mesh__D007975 5,12 HETE
% 207.76/207.91 |- mesh__historyNote mesh__D007975
% 207.76/207.91 94; was LEUKOTRIENES B 1983-93; LEUKOTRIENE B4 was see LEUKOTRIENES B 1983-93%A%
% 207.76/207.91 |- skos__prefLabel mesh__D007975 Leukotriene B4
% 207.76/207.91 |- skos__altLabel mesh__D007975 LTB4
% 207.76/207.91 |- skos__altLabel mesh__D007975 Leukotriene B-4
% 207.76/207.91 |- mesh__recordMaintainer mesh__D007975 ssb
% 207.76/207.91 |- mesh__recordOriginator mesh__D007975 RLS
% 207.76/207.91 |- mesh__dateCreated mesh__D007975 1982-04-30
% 207.76/207.91 |- skos__hiddenLabel mesh__D007975 5,12 diHETE
% 207.76/207.91 |- mesh__dateEstablished mesh__D007975 1983-01-01
% 207.76/207.91 |- skos__annotation mesh__D007975
% 207.76/207.91 /biosyn /physiol permitted; DF: note short X ref
% 207.76/207.91 |- skos__hiddenLabel mesh__D007975 B-4, Leukotriene
% 207.76/207.91 |- rdf__type mesh__D007975sskos__Concept
% 207.76/207.91 |- skos__scopeNote mesh__D007975
% 207.76/207.91 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function %28%degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism%29%. %28%From Dictionary of Prostaglandins and Related Compounds, 1990%29%%A%
% 207.76/207.91 |- mesh__dateRevised mesh__D007975 2005-06-30
% 207.76/207.91 |- skos__annotation mesh__D029629
% 207.76/207.91 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029629 2003
% 207.76/207.91 |- mesh__dateCreated mesh__D029629 2001-07-25
% 207.76/207.91 |- rdf__type mesh__D029629sskos__Concept
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029629 2005
% 207.76/207.91 |- mesh__historyNote mesh__D029629 2002
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029629 2004
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029629 2002
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D029629 2006
% 207.76/207.91 |- skos__prefLabel mesh__D029629 Salicaceae
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D029629 2002
% 207.76/207.91 |- skos__scopeNote mesh__D029629
% 207.76/207.91 A plant family of the order Salicales, subclass Dilleniidae, class Magnoliopsida. The leaves are alternate and simple. Staminate %28%male%29% flowers consist of from one to many stamens. Pistillate %28%female%29% flowers consist of a one-chambered ovary with several to many ovules %28%potential silky seeds%29%.%A%
% 207.76/207.91 |- skos__broader mesh__D029629smesh__D019684
% 207.76/207.91 |- mesh__dateEstablished mesh__D029629 2002-01-01
% 207.76/207.91 |- skos__historyNote mesh__D007177 Hyponatremia %28%1966-1978%29%
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D007177 ags
% 207.76/207.91 |- skos__altLabel mesh__D007177
% 207.76/207.91 Antidiuretic Hormone, Inappropriate Secretion
% 207.76/207.91 |- skos__hiddenLabel mesh__D007177 Syndrome, Inappropriate ADH
% 207.76/207.91 |- rdf__type mesh__D007177sskos__Concept
% 207.76/207.91 |- mesh__recordOriginator mesh__D007177 VDK
% 207.76/207.91 |- skos__prefLabel mesh__D007177 Inappropriate ADH Syndrome
% 207.76/207.91 |- mesh__dateRevised mesh__D007177 2005-07-08
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D007177 1979
% 207.76/207.91 |- mesh__dateEstablished mesh__D007177 1979-01-01
% 207.76/207.91 |- mesh__recordMaintainer mesh__D007177 ags
% 207.76/207.91 |- skos__altLabel mesh__D007177
% 207.76/207.91 Syndrome of Inappropriate ADH %28%SIADH%29% Secretion
% 207.76/207.91 |- skos__altLabel mesh__D007177
% 207.76/207.91 Inappropriate Vasopressin Secretion Syndrome
% 207.76/207.91 |- skos__hiddenLabel mesh__D007177 Syndrome, Schwartz-Bartter
% 207.76/207.91 |- skos__scopeNote mesh__D007177
% 207.76/207.91 A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.%A%
% 207.76/207.91 |- skos__historyNote mesh__D007177 Vasopressins %28%1966-1978%29%
% 207.76/207.91 |- skos__altLabel mesh__D007177 Schwartz-Bartter Syndrome
% 207.76/207.91 |- mesh__historyNote mesh__D007177 1979
% 207.76/207.91 |- skos__hiddenLabel mesh__D007177 Schwartz Bartter Syndrome
% 207.76/207.91 |- skos__altLabel mesh__D007177 SIADH
% 207.76/207.91 |- skos__hiddenLabel mesh__D007177 ADH Syndrome, Inappropriate
% 207.76/207.91 |- skos__broader mesh__D007177smesh__D014883
% 207.76/207.91 |- skos__broader mesh__D007177smesh__D010900
% 207.76/207.91 |- mesh__dateCreated mesh__D007177 1977-12-06
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007177 2006
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007177 2006A
% 207.76/207.91 |- skos__annotation mesh__D015609 DF: ORGANOTECHNETIUM CPDS
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 2003
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 1996
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 2001
% 207.76/207.91 |- rdf__type mesh__D015609sskos__Concept
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 2004
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 1997
% 207.76/207.91 |- skos__hiddenLabel mesh__D015609 Compounds, Organotechnetium
% 207.76/207.91 |- skos__scopeNote mesh__D015609
% 207.76/207.91 Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents.%A%
% 207.76/207.91 |- mesh__historyNote mesh__D015609 90
% 207.76/207.91 |- mesh__recordOriginator mesh__D015609 RLS
% 207.76/207.91 |- skos__historyNote mesh__D015609 Technetium %28%1966-1989%29%
% 207.76/207.91 |- skos__historyNote mesh__D015609
% 207.76/207.91 Organometallic Compounds %28%1966-1989%29%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 2002
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 1994
% 207.76/207.91 |- skos__broader mesh__D015609smesh__D009942
% 207.76/207.91 |- mesh__dateEstablished mesh__D015609 1990-01-01
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 2005
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 1998
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D015609 PLS
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D015609 90
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 1995
% 207.76/207.91 |- mesh__dateCreated mesh__D015609 1989-05-15
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 2006
% 207.76/207.91 |- mesh__dateRevised mesh__D015609 1993-06-02
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 1999
% 207.76/207.91 |- skos__prefLabel mesh__D015609 Organotechnetium Compounds
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D015609 2000
% 207.76/207.91 |- mesh__recordMaintainer mesh__D015609 TAP
% 207.76/207.91 |- skos__prefLabel mesh__D040002 Dermatophagoides pteronyssinus
% 207.76/207.91 |- rdf__type mesh__D040002sskos__Concept
% 207.76/207.91 |- skos__altLabel mesh__D040002 European House Dust Mite
% 207.76/207.91 |- mesh__historyNote mesh__D040002 2003
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D040002 2005
% 207.76/207.91 |- skos__historyNote mesh__D040002 Mites %28%1966-2002%29%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D040002 2006
% 207.76/207.91 |- skos__scopeNote mesh__D040002
% 207.76/207.91 Species of European house dust mite, in the family PYROGLYPHIDAE. It is the most commonly found house dust mite.%A%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D040002 2004
% 207.76/207.91 |- skos__broader mesh__D040002smesh__D039981
% 207.76/207.91 |- mesh__dateEstablished mesh__D040002 2003-01-01
% 207.76/207.91 |- mesh__dateCreated mesh__D040002 2002-07-03
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D040002 2003
% 207.76/207.91 |- skos__altLabel mesh__D040002 House Dust Mite, European
% 207.76/207.91 |- mesh__dateRevised mesh__D040002 2003-07-09
% 207.76/207.91 |- mesh__dateCreated mesh__D003585 1999-01-01
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D003585 sjn
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003585 2004
% 207.76/207.91 |- skos__related mesh__D003585smesh__D002477
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003585 2006
% 207.76/207.91 |- mesh__recordOriginator mesh__D003585 NLM
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003585 2003
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003585 2005
% 207.76/207.91 |- skos__hiddenLabel mesh__D003585 Cytologies
% 207.76/207.91 |- skos__annotation mesh__D003585
% 207.76/207.91 SPEC only: prefer /cytol: Manual 19.7+, 19.8.20; SPEC qualif; DF: CYTOL%A%
% 207.76/207.91 |- mesh__dateRevised mesh__D003585 2001-07-25
% 207.76/207.91 |- skos__prefLabel mesh__D003585 Cytology
% 207.76/207.91 |- rdf__type mesh__D003585sskos__Concept
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D003585 2002
% 207.76/207.91 |- mesh__recordMaintainer mesh__D003585 jls
% 207.76/207.91 |- skos__broader mesh__D003585smesh__D000715
% 207.76/207.91 |- skos__historyNote mesh__D011219 Rauwolfia %28%1966-1971%29%
% 207.76/207.91 |- skos__hiddenLabel mesh__D011219 Neo Gilurytmal
% 207.76/207.91 |- skos__hiddenLabel mesh__D011219 NeoGilurytmal
% 207.76/207.91 |- skos__altLabel mesh__D011219 N-Propylajmaline
% 207.76/207.91 |- skos__prefLabel mesh__D011219 Prajmaline
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D011219 91; was see under AJMALINE 1980-90
% 207.76/207.91 |- mesh__dateEstablished mesh__D011219 1991-01-01
% 207.76/207.91 |- skos__hiddenLabel mesh__D011219 N Propylajmaline
% 207.76/207.91 |- skos__hiddenLabel mesh__D011219 Bitartrate, Prajmalium
% 207.76/207.91 |- mesh__recordMaintainer mesh__D011219 ssb
% 207.76/207.91 |- skos__scopeNote mesh__D011219
% 207.76/207.91 A derivative of the rauwolfia alkaloid AJMALINE. It is an anti-arrhythmia agent, but may cause liver damage.%A%
% 207.76/207.91 |- skos__altLabel mesh__D011219 Prajmalium
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D011219 2005
% 207.76/207.91 |- skos__historyNote mesh__D011219
% 207.76/207.91 Ajmaline %28%1971-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 207.76/207.91 |- skos__annotation mesh__D011219 /biosyn permitted if by plant
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D011219 sjn
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D011219 2006
% 207.76/207.91 |- mesh__historyNote mesh__D011219
% 207.76/207.91 91%28%80%29%; was see under AJMALINE 1980-90
% 207.76/207.91 |- mesh__dateCreated mesh__D011219 1979-03-02
% 207.76/207.91 |- mesh__recordOriginator mesh__D011219 SH
% 207.76/207.91 |- mesh__dateRevised mesh__D011219 2004-07-07
% 207.76/207.91 |- skos__broader mesh__D011219smesh__D000404
% 207.76/207.91 |- rdf__type mesh__D011219sskos__Concept
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D008270 2001
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D008270 2000
% 207.76/207.91 |- skos__altLabel mesh__D008270 Malagasy Republic
% 207.76/207.91 |- skos__annotation mesh__D008270
% 207.76/207.91 the largest of the Indian Ocean Islands; X ref MALAGASY REPUBLIC was its former name%A%
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D008270 SJN
% 207.76/207.91 |- skos__scopeNote mesh__D008270
% 207.76/207.91 One of the Indian Ocean Islands off the southeast coast of Africa. Its capital is Antananarivo. It was formerly called the Malagasy Republic. Discovered by the Portuguese in 1500, its history has been tied predominantly to the French, becoming a French protectorate in 1882, a French colony in 1896, and a territory within the French union in 1946. The Malagasy Republic was established in the French Community in 1958 but it achieved independence in 1960. Its name was changed to Madagascar in 1975. %28%From Webster%27%s New Geographical Dictionary, 1988, p714%29%%A%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D008270 2004
% 207.76/207.91 |- mesh__recordMaintainer mesh__D008270 TGC
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D008270 2006
% 207.76/207.91 |- mesh__dateCreated mesh__D008270 1999-01-01
% 207.76/207.91 |- mesh__historyNote mesh__D008270 80; was MALAGASY REPUBLIC 1964-79
% 207.76/207.91 |- mesh__recordOriginator mesh__D008270 NLM
% 207.76/207.91 |- skos__prefLabel mesh__D008270 Madagascar
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D008270 2003
% 207.76/207.91 |- mesh__onlineNote mesh__D008270
% 207.76/207.91 use MADAGASCAR to search MALAGASY REPUBLIC 1966-79
% 207.76/207.91 |- rdf__type mesh__D008270sskos__Concept
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D008270 2005
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D008270 1999
% 207.76/207.91 |- skos__broader mesh__D008270smesh__D007195
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D008270 2002
% 207.76/207.91 |- mesh__dateRevised mesh__D008270 1997-06-20
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D008270 1998
% 207.76/207.91 |- mesh__recordMaintainer mesh__D007976 KEV
% 207.76/207.91 |- mesh__dateCreated mesh__D007976 1974-11-19
% 207.76/207.91 |- skos__scopeNote mesh__D007976
% 207.76/207.91 A group of acylated oligopeptides produced by Actinomycetes that function as protease inhibitors. They have been known to inhibit to varying degrees trypsin, plasmin, KALLIKREINS, papain and the cathepsins.%A%
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D007976
% 207.76/207.91 91; was see under OLIGOPEPTIDES 1975-90
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007976 2001
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007976 2006
% 207.76/207.91 |- skos__annotation mesh__D007976 protease inhib
% 207.76/207.91 |- mesh__dateEstablished mesh__D007976 1991-01-01
% 207.76/207.91 |- mesh__recordAuthorizer mesh__D007976 sjn
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007976 2003
% 207.76/207.91 |- mesh__recordOriginator mesh__D007976 NLM
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007976 2000
% 207.76/207.91 |- skos__prefLabel mesh__D007976 Leupeptins
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007976 2005
% 207.76/207.91 |- skos__historyNote mesh__D007976 Oligopeptides %28%1973-1974%29%
% 207.76/207.91 |- rdf__type mesh__D007976sskos__Concept
% 207.76/207.91 |- mesh__historyNote mesh__D007976
% 207.76/207.91 91%28%75%29%; was see under OLIGOPEPTIDES 1975-90
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007976 2002
% 207.76/207.91 |- skos__broader mesh__D007976smesh__D009842
% 207.76/207.91 |- mesh__dateRevised mesh__D007976 1999-11-09
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007976 2004
% 207.76/207.91 |- skos__hiddenLabel mesh__D007178 Backcrossings
% 207.76/207.91 |- mesh__recordOriginator mesh__D007178 NLM
% 207.76/207.91 |- skos__prefLabel mesh__D007178 Inbreeding
% 207.76/207.91 |- mesh__dateCreated mesh__D007178 1999-01-01
% 207.76/207.91 |- skos__broader mesh__D007178smesh__D001947
% 207.76/207.91 |- skos__historyNote mesh__D007178 Genetics %28%1966-1967%29%
% 207.76/207.91 |- skos__hiddenLabel mesh__D007178 Self Fertilization
% 207.76/207.91 |- mesh__publicMeSHNote mesh__D007178 68
% 207.76/207.91 |- mesh__dateEstablished mesh__D007178 1968-01-01
% 207.76/207.91 |- skos__related mesh__D007178smesh__D003241
% 207.76/207.91 |- skos__scopeNote mesh__D007178
% 207.76/207.91 The mating of plants or non-human animals which are closely related genetically.%A%
% 207.76/207.91 |- mesh__activeMeSHYear mesh__D007178 2004
% 207.76/207.91 |- skos__related mesh__D007178smesh__D017849
% 207.76/207.92 |- mesh__recordMaintainer mesh__D007178 lkt
% 207.76/207.92 |- skos__hiddenLabel mesh__D007178 Mating, Sib
% 207.76/207.92 |- skos__annotation mesh__D007178
% 207.76/207.92 animal only: for humans use CONSANGUINITY; no qualif; restrict to inbreeding as a genetic concept or a technique: not a routine term for inbred animals %28% = ANIMALS, INBRED STRAINS or specific%29%%A%
% 207.76/207.92 |- mesh__historyNote mesh__D007178 68
% 207.76/207.92 |- mesh__dateRevised mesh__D007178 2002-07-02
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007178 2003
% 207.76/207.92 |- skos__hiddenLabel mesh__D007178 Sib Matings
% 207.76/207.92 |- skos__hiddenLabel mesh__D007178 Matings, Sib
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D007178 sjn
% 207.76/207.92 |- skos__hiddenLabel mesh__D007178 Half Sib Mating
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007178 2006
% 207.76/207.92 |- skos__hiddenLabel mesh__D007178 Half-Sib Matings
% 207.76/207.92 |- skos__historyNote mesh__D007178 Genetics, Population %28%1966-1967%29%
% 207.76/207.92 |- skos__hiddenLabel mesh__D007178 Self-Fertilizations
% 207.76/207.92 |- rdf__type mesh__D007178sskos__Concept
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007178 2005
% 207.76/207.92 |- skos__hiddenLabel mesh__D007178 Matings, Half-Sib
% 207.76/207.92 |- skos__hiddenLabel mesh__D007178 Mating, Half-Sib
% 207.76/207.92 |- mesh__recordMaintainer mesh__D012312 CCR
% 207.76/207.92 |- skos__scopeNote mesh__D012312
% 207.76/207.92 Adrenergic beta-agonist used to control premature labor.%A%
% 207.76/207.92 |- skos__hiddenLabel mesh__D012312 Pre Par
% 207.76/207.92 |- skos__altLabel mesh__D012312 Pre-Par
% 207.76/207.92 |- mesh__dateCreated mesh__D012312 1974-11-19
% 207.76/207.92 |- skos__prefLabel mesh__D012312 Ritodrine
% 207.76/207.92 |- mesh__historyNote mesh__D012312
% 207.76/207.92 86%28%75%29%; was see under PROPANOLAMINES 1975-85
% 207.76/207.92 |- skos__altLabel mesh__D012312 Janssen Brand of Ritodrine Hydrochloride
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D012312 2006
% 207.76/207.92 |- skos__altLabel mesh__D012312 Astra Brand of Ritodrine Hydrochloride
% 207.76/207.92 |- skos__historyNote mesh__D012312 Phenethylamines %28%1971-1974%29%
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D012312
% 207.76/207.92 86; was see under PROPANOLAMINES 1975-85
% 207.76/207.92 |- mesh__dateEstablished mesh__D012312 1986-01-01
% 207.76/207.92 |- skos__altLabel mesh__D012312 Solvay Brand of Ritodrine Hydrochloride
% 207.76/207.92 |- skos__hiddenLabel mesh__D012312 DU 21220
% 207.76/207.92 |- skos__broader mesh__D012312smesh__D010627
% 207.76/207.92 |- skos__hiddenLabel mesh__D012312 PrePar
% 207.76/207.92 |- skos__historyNote mesh__D012312 Phenols %28%1971-1974%29%
% 207.76/207.92 |- rdf__type mesh__D012312sskos__Concept
% 207.76/207.92 |- skos__hiddenLabel mesh__D012312 DU21220
% 207.76/207.92 |- mesh__dateRevised mesh__D012312 2005-06-30
% 207.76/207.92 |- skos__historyNote mesh__D012312 Propanolamines %28%1974%29%
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D012312 sjn
% 207.76/207.92 |- mesh__recordOriginator mesh__D012312 NLM
% 207.76/207.92 |- skos__hiddenLabel mesh__D012312 Hydrochloride, Ritodrine
% 207.76/207.92 |- skos__broader mesh__D012312smesh__D011412
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 1998
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D003586 PLS
% 207.76/207.92 |- mesh__onlineNote mesh__D003586
% 207.76/207.92 use CYTOMEGALOVIRUS INFECTIONS to search CYTOMEGALIC INCLUSION DISEASE 1966-93%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 2003
% 207.76/207.92 |- skos__hiddenLabel mesh__D003586 Cytomegalic Inclusion Diseases
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 2001
% 207.76/207.92 |- skos__altLabel mesh__D003586 Cytomegalic Inclusion Disease
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 1994
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 2005
% 207.76/207.92 |- skos__altLabel mesh__D003586 Salivary Gland Virus Disease
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D003586
% 207.76/207.92 94; was CYTOMEGALIC INCLUSION DISEASE 1963-93; CYTOMEGALOVIRUS INFECTIONS was see CYTOMEGALIC INCLUSION DISEASE 1992-93%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 2000
% 207.76/207.92 |- skos__altLabel mesh__D003586 Inclusion Disease
% 207.76/207.92 |- skos__altLabel mesh__D003586 Infections, Cytomegalovirus
% 207.76/207.92 |- mesh__dateRevised mesh__D003586 1993-06-04
% 207.76/207.92 |- rdf__type mesh__D003586sskos__Concept
% 207.76/207.92 |- mesh__recordOriginator mesh__D003586 NLM
% 207.76/207.92 |- skos__hiddenLabel mesh__D003586 Inclusion Diseases
% 207.76/207.92 |- skos__hiddenLabel mesh__D003586 Cytomegalovirus Infection
% 207.76/207.92 |- skos__prefLabel mesh__D003586 Cytomegalovirus Infections
% 207.76/207.92 |- skos__hiddenLabel mesh__D003586 Inclusion Diseases, Cytomegalic
% 207.76/207.92 |- mesh__recordMaintainer mesh__D003586 AGS
% 207.76/207.92 |- skos__broader mesh__D003586smesh__D006566
% 207.76/207.92 |- skos__hiddenLabel mesh__D003586 Disease, Cytomegalic Inclusion
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 1997
% 207.76/207.92 |- skos__scopeNote mesh__D003586
% 207.76/207.92 Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.%A%
% 207.76/207.92 |- mesh__historyNote mesh__D003586
% 207.76/207.92 94; was CYTOMEGALIC INCLUSION DISEASE 1963-93; CYTOMEGALOVIRUS INFECTIONS was see CYTOMEGALIC INCLUSION DISEASE 1992-93%A%
% 207.76/207.92 |- skos__hiddenLabel mesh__D003586 Inclusion Disease, Cytomegalic
% 207.76/207.92 |- mesh__dateCreated mesh__D003586 1999-01-01
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 1999
% 207.76/207.92 |- skos__annotation mesh__D003586
% 207.76/207.92 caused by a herpesvirus; GEN or unspecified; DF: note short X ref%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 2004
% 207.76/207.92 |- skos__hiddenLabel mesh__D003586 Infection, Cytomegalovirus
% 207.76/207.92 |- skos__hiddenLabel mesh__D003586 Diseases, Cytomegalic Inclusion
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 2002
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 1996
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 1995
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003586 2006
% 207.76/207.92 |- skos__broader mesh__D008271smesh__D009617
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 2004
% 207.76/207.92 |- skos__hiddenLabel mesh__D008271 Maduromycoses
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 2002
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 2003
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 2006
% 207.76/207.92 |- skos__hiddenLabel mesh__D008271 Mycetomas
% 207.76/207.92 |- skos__altLabel mesh__D008271 Madura Foot
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 2001
% 207.76/207.92 |- mesh__dateCreated mesh__D008271 1999-01-01
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 2005
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 1997
% 207.76/207.92 |- mesh__dateRevised mesh__D008271 1994-02-08
% 207.76/207.92 |- skos__broader mesh__D008271smesh__D003881
% 207.76/207.92 |- skos__annotation mesh__D008271
% 207.76/207.92 caused by various fungi or bacteria; coord with causative organism %28%IM%29% or precoord organism/dis %28%IM%29% if pertinent%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 2000
% 207.76/207.92 |- rdf__type mesh__D008271sskos__Concept
% 207.76/207.92 |- skos__altLabel mesh__D008271 Mycetoma
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 1996
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 1999
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D008271 PLS
% 207.76/207.92 |- skos__prefLabel mesh__D008271 Maduromycosis
% 207.76/207.92 |- skos__broader mesh__D008271smesh__D017192
% 207.76/207.92 |- skos__scopeNote mesh__D008271
% 207.76/207.92 A disease caused by various fungi %28%Madurella mycetomi%29% or actinomycetes %28%Nocardia brasiliensis%29%. It usually affects the foot, hand, and legs with tissues becoming necrosed and swollen after infection.%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 1995
% 207.76/207.92 |- mesh__recordMaintainer mesh__D008271 PXP
% 207.76/207.92 |- mesh__recordOriginator mesh__D008271 NLM
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008271 1998
% 207.76/207.92 |- skos__hiddenLabel mesh__D008271 Foot, Madura
% 207.76/207.92 |- mesh__dateCreated mesh__D016703 1991-02-11
% 207.76/207.92 |- skos__scopeNote mesh__D016703
% 207.76/207.92 A republic in central Africa, north of GABON and bounded on the west by the Atlantic Ocean. Its capital is Malabo. Equatorial Guinea was discovered by the Portuguese in 1491 and ceded to Spain in 1778. The country gained independence in 1968. Equatorial refers to its location near the equator in the broad region long known as Guinea %28%from the Tuareg aginaw, black people%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p375 %26% Room, Brewer%27%s Dictionary of Names, 1992, p173, 222%29%%A%
% 207.76/207.92 |- mesh__historyNote mesh__D016703 92; was see AFRICA, CENTRAL 1987-91
% 207.76/207.92 |- mesh__onlineNote mesh__D016703
% 207.76/207.92 use AFRICA, CENTRAL to search EQUATORIAL GUINEA 1987-91
% 207.76/207.92 |- skos__altLabel mesh__D016703 Guinea, Spanish
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D016703 2003
% 207.76/207.92 |- mesh__recordOriginator mesh__D016703 TGC
% 207.76/207.92 |- skos__historyNote mesh__D016703 Africa, Central %28%1966-1991%29%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D016703 2004
% 207.76/207.92 |- skos__prefLabel mesh__D016703 Equatorial Guinea
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D016703 2002
% 207.76/207.92 |- skos__annotation mesh__D016703
% 207.76/207.92 a republic in central Africa; formerly Spanish Guinea; do not confuse with GUINEA %28%formerly French Guinea%29% or GUINEA-BISSAU %28%formerly Portuguese Guinea%29%; in titles %26% translations spell R%C3%%AD%o Muni with accent%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D016703 2005
% 207.76/207.92 |- mesh__recordMaintainer mesh__D016703 jls
% 207.76/207.92 |- mesh__dateRevised mesh__D016703 2001-08-13
% 207.76/207.92 |- skos__altLabel mesh__D016703 Spanish Guinea
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D016703 sjn
% 207.76/207.92 |- mesh__dateEstablished mesh__D016703 1992-01-01
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D016703 2006
% 207.76/207.92 |- skos__broader mesh__D016703smesh__D000350
% 207.76/207.92 |- rdf__type mesh__D016703sskos__Concept
% 207.76/207.92 |- skos__scopeNote mesh__D007977
% 207.76/207.92 An opioid antagonist with properties similar to those of NALOXONE; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p683%29%%A%
% 207.76/207.92 |- mesh__dateCreated mesh__D007977 1999-01-01
% 207.76/207.92 |- mesh__dateEstablished mesh__D007977 1965-01-01
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007977 2002
% 207.76/207.92 |- rdf__type mesh__D007977sskos__Concept
% 207.76/207.92 |- mesh__recordMaintainer mesh__D007977 TWD
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007977 2001
% 207.76/207.92 |- skos__altLabel mesh__D007977 Naloxiphan
% 207.76/207.92 |- skos__broader mesh__D007977smesh__D009019
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D007977 sjn
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007977 2004
% 207.76/207.92 |- mesh__recordOriginator mesh__D007977 NLM
% 207.76/207.92 |- mesh__dateRevised mesh__D007977 2000-06-22
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007977 2006
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D007977
% 207.76/207.92 65; was see under NARCOTIC ANTAGONISTS 1963-64
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007977 2003
% 207.76/207.92 |- mesh__historyNote mesh__D007977
% 207.76/207.92 65; was see under NARCOTIC ANTAGONISTS 1963-64
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007977 2005
% 207.76/207.92 |- skos__prefLabel mesh__D007977 Levallorphan
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 1997
% 207.76/207.92 |- skos__prefLabel mesh__D007179 Incest
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 2000
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 2003
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D007179 PLS
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 1998
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 2001
% 207.76/207.92 |- skos__annotation mesh__D007179 /ethnol /psychol permitted
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 2004
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 1999
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 2002
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 2005
% 207.76/207.92 |- mesh__recordOriginator mesh__D007179 NLM
% 207.76/207.92 |- skos__scopeNote mesh__D007179
% 207.76/207.92 Sexual intercourse between persons so closely related that they are forbidden by law to marry.%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 1995
% 207.76/207.92 |- skos__historyNote mesh__D007179 Paraphilias %28%1966%29%
% 207.76/207.92 |- mesh__dateRevised mesh__D007179 1994-03-17
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 2006
% 207.76/207.92 |- mesh__dateEstablished mesh__D007179 1967-01-01
% 207.76/207.92 |- mesh__dateCreated mesh__D007179 1999-01-01
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D007179 67
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007179 1996
% 207.76/207.92 |- mesh__recordMaintainer mesh__D007179 PLS
% 207.76/207.92 |- skos__broader mesh__D007179smesh__D012940
% 207.76/207.92 |- mesh__historyNote mesh__D007179 67
% 207.76/207.92 |- rdf__type mesh__D007179sskos__Concept
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D012313 2003
% 207.76/207.92 |- skos__altLabel mesh__D012313 RNA, Non-Polyadenylated
% 207.76/207.92 |- skos__altLabel mesh__D012313 Gene Products, RNA
% 207.76/207.92 |- mesh__onlineNote mesh__D012313
% 207.76/207.92 use RNA %28%NM%29% to search RNA, NON-POLYADENYLATED 1981-94
% 207.76/207.92 |- skos__hiddenLabel mesh__D012313 RNA Gene Products
% 207.76/207.92 |- skos__altLabel mesh__D012313 Ribonucleic Acid
% 207.76/207.92 |- skos__hiddenLabel mesh__D012313 Acid, Ribonucleic
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D012313 2002
% 207.76/207.92 |- skos__annotation mesh__D012313
% 207.76/207.92 /immunol: consider also IMMUNE RNA MANIPULATION see IMMUNOTHERAPY, ACTIVE%A%
% 207.76/207.92 |- skos__broader mesh__D012313smesh__D009696
% 207.76/207.92 |- skos__hiddenLabel mesh__D012313 Non Polyadenylated RNA
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D012313 2001
% 207.76/207.92 |- mesh__historyNote mesh__D012313
% 207.76/207.92 RNA, NON-POLYADENYLATED was NON-POLYADENYLATED RNA %28%NM%29% 1981-94%A%
% 207.76/207.92 |- mesh__recordMaintainer mesh__D012313 nns
% 207.76/207.92 |- skos__scopeNote mesh__D012313
% 207.76/207.92 A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D012313 2006
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D012313 2000
% 207.76/207.92 |- rdf__type mesh__D012313sskos__Concept
% 207.76/207.92 |- mesh__dateCreated mesh__D012313 1999-01-01
% 207.76/207.92 |- mesh__dateRevised mesh__D012313 1999-11-03
% 207.76/207.92 |- skos__hiddenLabel mesh__D012313 RNA, Non Polyadenylated
% 207.76/207.92 |- mesh__recordOriginator mesh__D012313 NLM
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D012313 sjn
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D012313 2005
% 207.76/207.92 |- skos__related mesh__D012313smesh__D009562
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D012313
% 207.76/207.92 NON-POLYADENYLATED RNA was indexed under RNA, NEOPLASM 1981-94%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D012313 2004
% 207.76/207.92 |- skos__prefLabel mesh__D012313 RNA
% 207.76/207.92 |- skos__altLabel mesh__D012313 Non-Polyadenylated RNA
% 207.76/207.92 |- mesh__dateEstablished mesh__D036761 2003-01-01
% 207.76/207.92 |- skos__hiddenLabel mesh__D036761
% 207.76/207.92 Transrectal High Intensity Focused Ultrasound
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D036761 sjn
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D036761 2006
% 207.76/207.92 |- skos__historyNote mesh__D036761 Ultrasonic Therapy %28%1994-2002%29%
% 207.76/207.92 |- skos__annotation mesh__D036761 DF: TRANSRECTAL HIFU
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D036761 2003
% 207.76/207.92 |- skos__scopeNote mesh__D036761
% 207.76/207.92 Tissue ablation of the PROSTATE performed by ultrasound from a transducer placed in the RECTUM. The procedure is used to treat prostate cancer %28%PROSTATIC NEOPLASMS%29% and benign prostatic hypertrophy %28%PROSTATIC HYPERPLASIA%29%.%A%
% 207.76/207.92 |- skos__broader mesh__D036761smesh__D013521
% 207.76/207.92 |- mesh__recordOriginator mesh__D036761 ags
% 207.76/207.92 |- mesh__dateCreated mesh__D036761 2002-07-03
% 207.76/207.92 |- mesh__dateRevised mesh__D036761 2005-06-30
% 207.76/207.92 |- skos__prefLabel mesh__D036761
% 207.76/207.92 Ultrasound, High-Intensity Focused, Transrectal
% 207.76/207.92 |- skos__altLabel mesh__D036761
% 207.76/207.92 Transrectal High-Intensity Focused Ultrasound
% 207.76/207.92 |- rdf__type mesh__D036761sskos__Concept
% 207.76/207.92 |- mesh__recordMaintainer mesh__D036761 lkt
% 207.76/207.92 |- skos__broader mesh__D036761smesh__D014464
% 207.76/207.92 |- mesh__historyNote mesh__D036761 2003
% 207.76/207.92 |- skos__hiddenLabel mesh__D003587 Cytomegaloviruses
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D003587
% 207.76/207.92 94; was CYTOMEGALOVIRUSES 1966-93; SALIVARY GLAND VIRUSES was see under CYTOMEGALOVIRUSES 1966-78%A%
% 207.76/207.92 |- mesh__dateEstablished mesh__D003587 1966-01-01
% 207.76/207.92 |- skos__altLabel mesh__D003587 Herpesvirus 5 %28%beta%29%, Human
% 207.76/207.92 |- skos__altLabel mesh__D003587 HHV 5
% 207.76/207.92 |- skos__scopeNote mesh__D003587
% 207.76/207.92 A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.%A%
% 207.76/207.92 |- skos__altLabel mesh__D003587 Human Herpesvirus 5
% 207.76/207.92 |- skos__hiddenLabel mesh__D003587 Viruses, Salivary Gland
% 207.76/207.92 |- mesh__dateCreated mesh__D003587 1999-01-01
% 207.76/207.92 |- mesh__historyNote mesh__D003587
% 207.76/207.92 94; was CYTOMEGALOVIRUSES 1966-93; SALIVARY GLAND VIRUSES was see under CYTOMEGALOVIRUSES 1966-78%A%
% 207.76/207.92 |- rdf__type mesh__D003587sskos__Concept
% 207.76/207.92 |- skos__prefLabel mesh__D003587 Cytomegalovirus
% 207.76/207.92 |- skos__broader mesh__D003587smesh__D018141
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D003587 sjn
% 207.76/207.92 |- skos__annotation mesh__D003587
% 207.76/207.92 infection = CYTOMEGALOVIRUS INFECTIONS; DF: HHV 5
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003587 2003
% 207.76/207.92 |- mesh__onlineNote mesh__D003587
% 207.76/207.92 use CYTOMEGALOVIRUS to search CYTOMEGALOVIRUSES 1966-93 %26% SALIVARY GLAND VIRUSES 1966-78.%A%
% 207.76/207.92 |- skos__hiddenLabel mesh__D003587 Salivary Gland Virus
% 207.76/207.92 |- mesh__dateRevised mesh__D003587 2001-07-25
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003587 2005
% 207.76/207.92 |- skos__altLabel mesh__D003587 Salivary Gland Viruses
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003587 2004
% 207.76/207.92 |- skos__hiddenLabel mesh__D003587 Virus, Salivary Gland
% 207.76/207.92 |- mesh__recordOriginator mesh__D003587 NLM
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003587 2002
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003587 2006
% 207.76/207.92 |- mesh__recordMaintainer mesh__D003587 ags
% 207.76/207.92 |- skos__altLabel mesh__D008272 Sanofi Winthrop Brand of Mafenide Acetate
% 207.76/207.92 |- mesh__recordMaintainer mesh__D008272 CCR
% 207.76/207.92 |- skos__broader mesh__D008272smesh__D013449
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D008272 sjn
% 207.76/207.92 |- skos__altLabel mesh__D008272 4-Homosulfanilamide
% 207.76/207.92 |- mesh__historyNote mesh__D008272
% 207.76/207.92 91%28%75%29%; was see under SULFONAMIDES 1975-90
% 207.76/207.92 |- skos__altLabel mesh__D008272 Bensulfamide
% 207.76/207.92 |- mesh__recordOriginator mesh__D008272 NLM
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D008272 2006
% 207.76/207.92 |- mesh__dateCreated mesh__D008272 1974-11-11
% 207.76/207.92 |- skos__altLabel mesh__D008272 Sulfabenzamine
% 207.76/207.92 |- skos__hiddenLabel mesh__D008272 4 Homosulfanilamide
% 207.76/207.92 |- skos__scopeNote mesh__D008272
% 207.76/207.92 A sulfonamide that inhibits the enzyme carbonic anhydrase and is used as topical anti-infective, especially in burn therapy.%A%
% 207.76/207.92 |- skos__historyNote mesh__D008272 Tosyl Compounds %28%1973-1974%29%
% 207.76/207.92 |- skos__hiddenLabel mesh__D008272 Acetate, Mafenide
% 207.76/207.92 |- mesh__dateEstablished mesh__D008272 1991-01-01
% 207.76/207.92 |- rdf__type mesh__D008272sskos__Concept
% 207.76/207.92 |- skos__historyNote mesh__D008272 Sulfonamides %28%1970-1974%29%
% 207.76/207.92 |- skos__altLabel mesh__D008272 Maphenid
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D008272
% 207.76/207.92 91; was see under SULFONAMIDES 1975-90
% 207.76/207.92 |- skos__altLabel mesh__D008272 Bertek Brand of Mafenide Acetate
% 207.76/207.92 |- skos__prefLabel mesh__D008272 Mafenide
% 207.76/207.92 |- mesh__dateRevised mesh__D008272 2005-06-30
% 207.76/207.92 |- skos__historyNote mesh__D016704 Nerve Tissue Proteins %28%1966-1991%29%
% 207.76/207.92 |- mesh__dateEstablished mesh__D016704 1992-01-01
% 207.76/207.92 |- mesh__dateRevised mesh__D016704 2005-07-11
% 207.76/207.92 |- skos__prefLabel mesh__D016704 Synapsins
% 207.76/207.92 |- skos__broader mesh__D016704smesh__D009419
% 207.76/207.92 |- mesh__recordMaintainer mesh__D016704 ags
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D016704 ags
% 207.76/207.92 |- mesh__historyNote mesh__D016704
% 207.76/207.92 1992; use SYNAPSINS %28%NM%29% 1981-1991
% 207.76/207.92 |- skos__historyNote mesh__D016704 Phosphoproteins %28%1970-1991%29%
% 207.76/207.92 |- mesh__recordOriginator mesh__D016704 RLS
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D016704 1992
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D016704 2006
% 207.76/207.92 |- skos__broader mesh__D016704smesh__D010750
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D016704 2006A
% 207.76/207.92 |- mesh__dateCreated mesh__D016704 1991-07-12
% 207.76/207.92 |- rdf__type mesh__D016704sskos__Concept
% 207.76/207.92 |- skos__scopeNote mesh__D016704
% 207.76/207.92 A family of synaptic vesicle-associated proteins involved in the short-term regulation of NEUROTRANSMITTER release. Synapsin I, the predominant member of this family, links SYNAPTIC VESICLES to ACTIN FILAMENTS in the presynaptic nerve terminal. These interactions are modulated by the reversible PHOSPHORYLATION of synapsin I through various signal transduction pathways. The protein is also a substrate for cAMP- and CALCIUM-CALMODULIN DEPENDENT PROTEIN KINASES. It is believed that these functional properties are also shared by synapsin II.%A%
% 207.76/207.92 |- skos__historyNote mesh__D016704 Neuropeptides %28%1987-1991%29%
% 207.76/207.92 |- mesh__dateCreated mesh__D007978 1999-01-01
% 207.76/207.92 |- skos__prefLabel mesh__D007978 Levamisole
% 207.76/207.92 |- skos__altLabel mesh__D007978 L-Tetramisole
% 207.76/207.92 |- rdf__type mesh__D007978sskos__Concept
% 207.76/207.92 |- skos__scopeNote mesh__D007978
% 207.76/207.92 An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6%29%%A%
% 207.76/207.92 |- skos__altLabel mesh__D007978 Levotetramisole
% 207.76/207.92 |- skos__broader mesh__D007978smesh__D013844
% 207.76/207.92 |- mesh__recordMaintainer mesh__D007978 ssb
% 207.76/207.92 |- mesh__historyNote mesh__D007978 74
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D007978 74
% 207.76/207.92 |- mesh__dateEstablished mesh__D007978 1974-01-01
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D007978 2006
% 207.76/207.92 |- skos__hiddenLabel mesh__D007978 Hydrochloride, Levamisole
% 207.76/207.92 |- skos__altLabel mesh__D007978 Decaris
% 207.76/207.92 |- mesh__dateRevised mesh__D007978 2005-06-30
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D007978 sjn
% 207.76/207.92 |- mesh__recordOriginator mesh__D007978 NLM
% 207.76/207.92 |- skos__broader mesh__D007978smesh__D007093
% 207.76/207.92 |- mesh__dateRevised mesh__D004680 2001-07-25
% 207.76/207.92 |- skos__annotation mesh__D004680
% 207.76/207.92 do not confuse X ref MURINE ENCEPHALOMYELITIS VIRUS with THEILER%27%S MURINE ENCEPHALOMYELITIS VIRUS; infection: coord IM with CARDIOVIRUS INFECTIONS %28%IM%29%; DF: ENCEPH VIRUS MURINE%A%
% 207.76/207.92 |- mesh__historyNote mesh__D004680
% 207.76/207.92 2002 %28%1963%29%; for MOUSE ELBERFELD VIRUS use ENCEPHALOMYOCARDITIS VIRUS 1997-2001%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D004680 2005
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D004680 2003
% 207.76/207.92 |- skos__scopeNote mesh__D004680
% 207.76/207.92 A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, usually causing an inapparent intestinal infection in mice. A small number of mice may show signs of flaccid paralysis.%A%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D004680 2006
% 207.76/207.92 |- mesh__dateEstablished mesh__D004680 1991-01-01
% 207.76/207.92 |- mesh__dateCreated mesh__D004680 1999-01-01
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D004680 sjn
% 207.76/207.92 |- skos__altLabel mesh__D004680 Murine Encephalomyelitis Virus
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D004680 2004
% 207.76/207.92 |- skos__altLabel mesh__D004680 Mouse Elberfeld Virus
% 207.76/207.92 |- rdf__type mesh__D004680sskos__Concept
% 207.76/207.92 |- skos__altLabel mesh__D004680 Mouse Encephalomyelitis Virus
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D004680 2002
% 207.76/207.92 |- skos__altLabel mesh__D004680 Encephalomyelitis Virus, Murine
% 207.76/207.92 |- skos__broader mesh__D004680smesh__D004686
% 207.76/207.92 |- mesh__recordMaintainer mesh__D004680 ags
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D004680
% 207.76/207.92 2002; see ENCEPHALOMYELITIS VIRUS, MURINE 1991-2001, see ENTEROVIRUSES 1975-1990, see ENTEROVIRUS 1967-1974, see POLIOVIRUS 1963-1966; for MOUSE ELBERFELD VIRUS see ENCEPHALOMYOCARDITIS VIRUS 1997-2001%A%
% 207.76/207.92 |- mesh__recordOriginator mesh__D004680 NLM
% 207.76/207.92 |- skos__prefLabel mesh__D004680 Maus Elberfeld virus
% 207.76/207.92 |- skos__hiddenLabel mesh__D004680 Encephalomyelitis Virus, Mouse
% 207.76/207.92 |- skos__broader mesh__D005333Q000736smesh__D005333
% 207.76/207.92 |- mesh__preferredCombination mesh__D005333Q000736smesh__D016216
% 207.76/207.92 |- rdf__type mesh__D005333Q000736smesh__CompoundConcept
% 207.76/207.92 |- skos__scopeNote mesh__D012314
% 207.76/207.92 Analogs of RNA cap compounds which do not have a positive charge. These compounds inhibit the initiation of translation of both capped and uncapped messenger RNA.%A%
% 207.76/207.92 |- mesh__dateRevised mesh__D012314 2005-06-30
% 207.76/207.92 |- skos__annotation mesh__D012314 IM; /drug eff /ultrastruct permitted
% 207.76/207.92 |- mesh__recordMaintainer mesh__D012314 ags
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D012314 91; was see under RNA CAPS 1980-90
% 207.76/207.92 |- skos__hiddenLabel mesh__D012314 Analogs, RNA Cap
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D012314 2006
% 207.76/207.92 |- rdf__type mesh__D012314sskos__Concept
% 207.76/207.92 |- skos__hiddenLabel mesh__D012314 Analogues, RNA Cap
% 207.76/207.92 |- skos__broader mesh__D012314smesh__D012315
% 207.76/207.92 |- skos__altLabel mesh__D012314 RNA Cap Analogues
% 207.76/207.92 |- mesh__recordOriginator mesh__D012314 RLS
% 207.76/207.92 |- mesh__dateEstablished mesh__D012314 1991-01-01
% 207.76/207.92 |- skos__historyNote mesh__D012314 Guanine Nucleotides %28%1966-1979%29%
% 207.76/207.92 |- skos__historyNote mesh__D012314 RNA, Messenger %28%1966-1979%29%
% 207.76/207.92 |- mesh__dateCreated mesh__D012314 1979-05-25
% 207.76/207.92 |- skos__prefLabel mesh__D012314 RNA Cap Analogs
% 207.76/207.92 |- skos__historyNote mesh__D012314 Oligoribonucleotides %28%1976-1979%29%
% 207.76/207.92 |- skos__hiddenLabel mesh__D012314 Cap Analogues, RNA
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D012314 sjn
% 207.76/207.92 |- skos__historyNote mesh__D012314 Ribonucleotides %28%1971-1975%29%
% 207.76/207.92 |- skos__hiddenLabel mesh__D012314 Cap Analogs, RNA
% 207.76/207.92 |- mesh__historyNote mesh__D012314
% 207.76/207.92 91%28%80%29%; was see under RNA CAPS 1980-90
% 207.76/207.92 |- skos__broader mesh__D003588smesh__D003581
% 207.76/207.92 |- mesh__recordOriginator mesh__D003588 NLM
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003588 2002
% 207.76/207.92 |- skos__altLabel mesh__D003588 Viral Cytopathogenic Effect
% 207.76/207.92 |- skos__hiddenLabel mesh__D003588 Cytopathic Effects, Viral
% 207.76/207.92 |- mesh__dateCreated mesh__D003588 1999-01-01
% 207.76/207.92 |- rdf__type mesh__D003588sskos__Concept
% 207.76/207.92 |- mesh__publicMeSHNote mesh__D003588 68
% 207.76/207.92 |- skos__related mesh__D003588smesh__D010948
% 207.76/207.92 |- skos__hiddenLabel mesh__D003588 Viral Cytopathogenic Effects
% 207.76/207.92 |- skos__hiddenLabel mesh__D003588 Cytopathogenic Effects, Viral
% 207.76/207.92 |- skos__hiddenLabel mesh__D003588 Effect, Viral Cytopathic
% 207.76/207.92 |- mesh__recordMaintainer mesh__D003588 PXP
% 207.76/207.92 |- skos__hiddenLabel mesh__D003588 Effects, Viral Cytopathogenic
% 207.76/207.92 |- mesh__recordAuthorizer mesh__D003588 SJN
% 207.76/207.92 |- skos__broader mesh__D003588smesh__D018406
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003588 1998
% 207.76/207.92 |- skos__annotation mesh__D003588
% 207.76/207.92 NIM; do not confuse with CELL TRANSFORMATION, VIRAL: see note there; DF: CPE or CPE VIRAL%A%
% 207.76/207.92 |- skos__prefLabel mesh__D003588 Cytopathogenic Effect, Viral
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003588 2003
% 207.76/207.92 |- skos__altLabel mesh__D003588 Cytopathic Effect, Viral
% 207.76/207.92 |- mesh__dateRevised mesh__D003588 1997-06-20
% 207.76/207.92 |- skos__hiddenLabel mesh__D003588 Viral Cytopathic Effects
% 207.76/207.92 |- skos__hiddenLabel mesh__D003588 Effects, Viral Cytopathic
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003588 2000
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003588 2005
% 207.76/207.92 |- mesh__dateEstablished mesh__D003588 1968-01-01
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003588 1999
% 207.76/207.92 |- skos__hiddenLabel mesh__D003588 Effect, Viral Cytopathogenic
% 207.76/207.92 |- mesh__historyNote mesh__D003588 68%28%64%29%
% 207.76/207.92 |- mesh__activeMeSHYear mesh__D003588 2004
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D003588 2001
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D003588 2006
% 207.76/207.93 |- skos__scopeNote mesh__D003588
% 207.76/207.93 Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.%A%
% 207.76/207.93 |- skos__hiddenLabel mesh__D003588 Viral Cytopathic Effect
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008273 2006
% 207.76/207.93 |- skos__prefLabel mesh__D008273 Magic
% 207.76/207.93 |- skos__broader mesh__D008273smesh__D013483
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D008273 sjn
% 207.76/207.93 |- rdf__type mesh__D008273sskos__Concept
% 207.76/207.93 |- mesh__recordOriginator mesh__D008273 NLM
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008273 2002
% 207.76/207.93 |- skos__scopeNote mesh__D008273
% 207.76/207.93 Beliefs and practices concerned with producing desired results through supernatural forces or agents as with the manipulation of fetishes or rituals.%A%
% 207.76/207.93 |- skos__broader mesh__D008273smesh__D026443
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008273 2003
% 207.76/207.93 |- mesh__dateRevised mesh__D008273 2001-07-25
% 207.76/207.93 |- skos__annotation mesh__D008273 IM; consider also WITCHCRAFT
% 207.76/207.93 |- mesh__dateCreated mesh__D008273 1999-01-01
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008273 2005
% 207.76/207.93 |- skos__hiddenLabel mesh__D008273 Magics
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008273 2004
% 207.76/207.93 |- mesh__recordMaintainer mesh__D008273 ssb
% 207.76/207.93 |- mesh__recordOriginator mesh__D000290 NLM
% 207.76/207.93 |- skos__scopeNote mesh__D000290
% 207.76/207.93 Appendages of the UTERUS which include the FALLOPIAN TUBES, the OVARY, and the supporting ligaments of the uterus %28%BROAD LIGAMENT; ROUND LIGAMENT%29%.%A%
% 207.76/207.93 |- skos__annotation mesh__D000290
% 207.76/207.93 seen in titles more frequently in adjective form %22%adnexal%22%; inflammation = ADNEXITIS%A%
% 207.76/207.93 |- skos__prefLabel mesh__D000290 Adnexa Uteri
% 207.76/207.93 |- rdf__type mesh__D000290sskos__Concept
% 207.76/207.93 |- mesh__dateRevised mesh__D000290 2002-07-02
% 207.76/207.93 |- skos__hiddenLabel mesh__D000290 Appendages, Uterine
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D000290 sjn
% 207.76/207.93 |- skos__hiddenLabel mesh__D000290 Uterine Appendage
% 207.76/207.93 |- skos__broader mesh__D000290smesh__D005836
% 207.76/207.93 |- mesh__recordMaintainer mesh__D000290 lkt
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000290 2005
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000290 2003
% 207.76/207.93 |- skos__hiddenLabel mesh__D000290 Appendage, Uterine
% 207.76/207.93 |- skos__altLabel mesh__D000290 Uterine Appendages
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000290 2006
% 207.76/207.93 |- mesh__dateCreated mesh__D000290 1999-01-01
% 207.76/207.93 |- skos__related mesh__D000290smesh__D000291
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000290 2004
% 207.76/207.93 |- rdf__type mesh__D007979sskos__Concept
% 207.76/207.93 |- skos__annotation mesh__D007979
% 207.76/207.93 heart in left hemithorax; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 207.76/207.93 |- skos__hiddenLabel mesh__D007979 Levocardias
% 207.76/207.93 |- skos__scopeNote mesh__D007979
% 207.76/207.93 Location of heart in left hemithorax with apex pointing to the left, but with situs inversus of other viscera and defects of the heart, or corrected transposition of great vessels.%A%
% 207.76/207.93 |- mesh__dateRevised mesh__D007979 1999-11-03
% 207.76/207.93 |- skos__broader mesh__D007979smesh__D006330
% 207.76/207.93 |- skos__broader mesh__D007979smesh__D012857
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D007979 2002
% 207.76/207.93 |- mesh__recordMaintainer mesh__D007979 kle
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D007979 2004
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D007979
% 207.76/207.93 91; was see under HEART DEFECTS, CONGENITAL 1975-90
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D007979 2001
% 207.76/207.93 |- mesh__historyNote mesh__D007979
% 207.76/207.93 91%28%75%29%; was see under HEART DEFECTS, CONGENITAL 1975-90
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D007979 2006
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D007979 2003
% 207.76/207.93 |- mesh__dateEstablished mesh__D007979 1991-01-01
% 207.76/207.93 |- skos__prefLabel mesh__D007979 Levocardia
% 207.76/207.93 |- mesh__recordOriginator mesh__D007979 NLM
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D007979 sjn
% 207.76/207.93 |- mesh__dateCreated mesh__D007979 1974-12-12
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D007979 2000
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D007979 2005
% 207.76/207.93 |- mesh__recordOriginator mesh__D004681 NLM
% 207.76/207.93 |- skos__altLabel mesh__D004681 Autoimmune Encephalomyelitis, Experimental
% 207.76/207.93 |- skos__broader mesh__D004681smesh__D020278
% 207.76/207.93 |- skos__altLabel mesh__D004681 Experimental Allergic Encephalomyelitis
% 207.76/207.93 |- mesh__dateCreated mesh__D004681 1999-01-01
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004681 2006
% 207.76/207.93 |- mesh__dateEstablished mesh__D004681 1966-01-01
% 207.76/207.93 |- skos__hiddenLabel mesh__D004681
% 207.76/207.93 Encephalomyelitis, Autoimmune Experimental
% 207.76/207.93 |- skos__altLabel mesh__D004681 Experimental Autoimmune Encephalomyelitis
% 207.76/207.93 |- rdf__type mesh__D004681sskos__Concept
% 207.76/207.93 |- skos__annotation mesh__D004681
% 207.76/207.93 coordinate with specific demyelinating disease if pertinent; DF: ENCEPH ALLERGIC%A%
% 207.76/207.93 |- skos__altLabel mesh__D004681 Allergic Encephalomyelitis, Experimental
% 207.76/207.93 |- skos__hiddenLabel mesh__D004681 Encephalomyelitis, Experimental Allergic
% 207.76/207.93 |- mesh__dateRevised mesh__D004681 2004-07-07
% 207.76/207.93 |- skos__broader mesh__D004681smesh__D020721
% 207.76/207.93 |- skos__altLabel mesh__D004681 Autoimmune Experimental Encephalomyelitis
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D004681 sjn
% 207.76/207.93 |- mesh__historyNote mesh__D004681 2005 %28%1964%29%
% 207.76/207.93 |- skos__altLabel mesh__D004681 Allergic Encephalomyelitis
% 207.76/207.93 |- skos__altLabel mesh__D004681 Encephalomyelitis, Allergic
% 207.76/207.93 |- skos__altLabel mesh__D004681 Encephalomyelitis, Experimental Autoimmune
% 207.76/207.93 |- skos__scopeNote mesh__D004681
% 207.76/207.93 An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND%27%S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. %28%From Immunol Res 1998;17%28%1-2%29%:217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5%29%%A%
% 207.76/207.93 |- skos__prefLabel mesh__D004681
% 207.76/207.93 Encephalomyelitis, Autoimmune, Experimental
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D004681
% 207.76/207.93 2005; see ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE 2000-2004, see ENCEPHALOMYELITIS, ALLERGIC 1964-1999%A%
% 207.76/207.93 |- skos__hiddenLabel mesh__D004681
% 207.76/207.93 Experimental Encephalomyelitis, Autoimmune
% 207.76/207.93 |- mesh__recordMaintainer mesh__D004681 lkt
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004681 2005
% 207.76/207.93 |- rdf__type mesh__D012315sskos__Concept
% 207.76/207.93 |- skos__hiddenLabel mesh__D012315 Caps, RNA
% 207.76/207.93 |- skos__broader mesh__D012315smesh__D006150
% 207.76/207.93 |- skos__historyNote mesh__D012315
% 207.76/207.93 Guanosine Triphosphate %28%1972-1974%29%/analogs %26% derivatives %28%1975-1979%29%
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D012315 sjn
% 207.76/207.93 |- mesh__dateRevised mesh__D012315 2005-06-30
% 207.76/207.93 |- skos__historyNote mesh__D012315 Guanine Nucleotides %28%1966-1971%29%
% 207.76/207.93 |- skos__historyNote mesh__D012315 Oligoribonucleotides %28%1976-1979%29%
% 207.76/207.93 |- skos__broader mesh__D012315smesh__D012333
% 207.76/207.93 |- skos__altLabel mesh__D012315 5%27% Capped RNA
% 207.76/207.93 |- skos__prefLabel mesh__D012315 RNA Caps
% 207.76/207.93 |- skos__historyNote mesh__D012315 RNA, Messenger %28%1966-1979%29%
% 207.76/207.93 |- skos__scopeNote mesh__D012315
% 207.76/207.93 Nucleic acid structures found on the 5%27% end of eukaryotic cellular and viral messenger RNA and some heterogeneous nuclear RNAs. These structures, which are positively charged, protect the above specified RNAs at their termini against attack by phosphatases and other nucleases and promote mRNA function at the level of initiation of translation. Analogs of the RNA caps %28%RNA CAP ANALOGS%29%, which lack the positive charge, inhibit the initiation of protein synthesis.%A%
% 207.76/207.93 |- skos__annotation mesh__D012315 IM; /drug eff /ultrastruct permitted
% 207.76/207.93 |- skos__altLabel mesh__D012315 5%27% mRNA Cap Structure
% 207.76/207.93 |- skos__historyNote mesh__D012315 Ribonucleotides %28%1971-1975%29%
% 207.76/207.93 |- mesh__historyNote mesh__D012315 80
% 207.76/207.93 |- skos__hiddenLabel mesh__D012315 RNA, 5%27% Capped
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D012315 80
% 207.76/207.93 |- mesh__dateEstablished mesh__D012315 1980-01-01
% 207.76/207.93 |- mesh__recordOriginator mesh__D012315 RLS
% 207.76/207.93 |- mesh__dateCreated mesh__D012315 1979-05-23
% 207.76/207.93 |- mesh__recordMaintainer mesh__D012315 ags
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D012315 2006
% 207.76/207.93 |- mesh__dateRevised mesh__D017000 2005-06-30
% 207.76/207.93 |- mesh__dateCreated mesh__D017000 1991-05-30
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017000 2006
% 207.76/207.93 |- skos__broader mesh__D017000smesh__D002167
% 207.76/207.93 |- rdf__type mesh__D017000sskos__Concept
% 207.76/207.93 |- skos__historyNote mesh__D017000 Campylobacter %28%1983-1991%29%
% 207.76/207.93 |- mesh__historyNote mesh__D017000 92
% 207.76/207.93 |- skos__annotation mesh__D017000
% 207.76/207.93 in intestines of man, swine %26% poultry; infection: coord IM with CAMPYLOBACTER INFECTIONS %28%IM%29%%A%
% 207.76/207.93 |- skos__prefLabel mesh__D017000 Campylobacter coli
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D017000 sjn
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D017000 92
% 207.76/207.93 |- mesh__recordOriginator mesh__D017000 PXP
% 207.76/207.93 |- mesh__dateEstablished mesh__D017000 1992-01-01
% 207.76/207.93 |- mesh__recordMaintainer mesh__D017000 SYSTEM
% 207.76/207.93 |- skos__scopeNote mesh__D017000
% 207.76/207.93 A species of gram-negative, rod-shaped bacteria isolated from the intestinal tract of swine, poultry, and man. It may be pathogenic.%A%
% 207.76/207.93 |- mesh__dateRevised mesh__D003589 2005-06-30
% 207.76/207.93 |- skos__broader mesh__D003589smesh__D041964
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D003589 sjn
% 207.76/207.93 |- mesh__recordMaintainer mesh__D003589 SYSTEM
% 207.76/207.93 |- skos__scopeNote mesh__D003589
% 207.76/207.93 A genus of gram-negative gliding bacteria found in SOIL; HUMUS; and FRESHWATER and marine habitats.%A%
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D003589 2006
% 207.76/207.93 |- skos__annotation mesh__D003589
% 207.76/207.93 infection: coord IM with FLEXIBACTERACEAE INFECTIONS %28%IM%29%%A%
% 207.76/207.93 |- mesh__recordOriginator mesh__D003589 NLM
% 207.76/207.93 |- mesh__dateCreated mesh__D003589 1999-01-01
% 207.76/207.93 |- rdf__type mesh__D003589sskos__Concept
% 207.76/207.93 |- skos__prefLabel mesh__D003589 Cytophaga
% 207.76/207.93 |- rdf__type mesh__D008274sskos__Concept
% 207.76/207.93 |- skos__broader mesh__D008274smesh__D008673
% 207.76/207.93 |- mesh__dateRevised mesh__D008274 2001-07-25
% 207.76/207.93 |- mesh__recordMaintainer mesh__D008274 jmp
% 207.76/207.93 |- skos__annotation mesh__D008274
% 207.76/207.93 Mg-24; /physiol permitted; Mg-25, 26 = MAGNESIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Mg-20, 21, 23, 27, 28 = MAGNESIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 207.76/207.93 |- skos__prefLabel mesh__D008274 Magnesium
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008274 2003
% 207.76/207.93 |- mesh__dateCreated mesh__D008274 1999-01-01
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008274 2005
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008274 2004
% 207.76/207.93 |- skos__broader mesh__D008274smesh__D019565
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008274 2006
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D008274 sjn
% 207.76/207.93 |- skos__scopeNote mesh__D008274
% 207.76/207.93 A light, silvery, metallic element. It has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. Its salts are essential in nutrition, being required for the activity of many enzymes, especially those concerned with oxidative phosphorylation. It is a component of both intra- and extracellular fluids and is excreted in the urine and feces. Deficiency causes irritability of the nervous system with tetany, vasodilation, convulsions, tremors, depression, and psychotic behavior. %28%From Dorland, 27th ed%29%%A%
% 207.76/207.93 |- mesh__recordOriginator mesh__D008274 NLM
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008274 2002
% 207.76/207.93 |- skos__hiddenLabel mesh__D008274 Magnesium Level, Serum
% 207.76/207.93 |- skos__prefLabel mesh__D000291 Adnexal Diseases
% 207.76/207.93 |- skos__broader mesh__D000291smesh__D005831
% 207.76/207.93 |- mesh__recordOriginator mesh__D000291 NLM
% 207.76/207.93 |- skos__hiddenLabel mesh__D000291 Adnexal Disease
% 207.76/207.93 |- mesh__dateRevised mesh__D000291 2002-07-02
% 207.76/207.93 |- mesh__historyNote mesh__D000291 66
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000291 2005
% 207.76/207.93 |- skos__annotation mesh__D000291
% 207.76/207.93 inflamm dis = PELVIC INFLAMMATORY DISEASE
% 207.76/207.93 |- mesh__dateEstablished mesh__D000291 1966-01-01
% 207.76/207.93 |- skos__hiddenLabel mesh__D000291 Disease, Adnexal
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000291 2003
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D000291 sjn
% 207.76/207.93 |- skos__hiddenLabel mesh__D000291 Diseases, Adnexal
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000291 2006
% 207.76/207.93 |- mesh__dateCreated mesh__D000291 1999-01-01
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D000291 66
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000291 2004
% 207.76/207.93 |- mesh__recordMaintainer mesh__D000291 lkt
% 207.76/207.93 |- skos__scopeNote mesh__D000291
% 207.76/207.93 Diseases of the uterine appendages %28%ADNEXA UTERI%29% including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus %28%BROAD LIGAMENT; ROUND LIGAMENT%29%.%A%
% 207.76/207.93 |- rdf__type mesh__D000291sskos__Concept
% 207.76/207.93 |- skos__hiddenLabel mesh__D016706 Still Disease, Adult Onset
% 207.76/207.93 |- skos__altLabel mesh__D016706 Adult-Onset Still Disease
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016706 2000
% 207.76/207.93 |- mesh__historyNote mesh__D016706
% 207.76/207.93 92; STILL%27%S DISEASE was see ARTHRITIS, JUVENILE RHEUMATOID 1975-91%A%
% 207.76/207.93 |- skos__scopeNote mesh__D016706
% 207.76/207.93 Systemic-onset rheumatoid arthritis in adults. It differs from classical rheumatoid arthritis in that it is more often marked by acute febrile onset, and generalized lymphadenopathy and hepatosplenomegaly are more prominent.%A%
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016706 2003
% 207.76/207.93 |- mesh__dateEstablished mesh__D016706 1992-01-01
% 207.76/207.93 |- mesh__recordOriginator mesh__D016706 AGS
% 207.76/207.93 |- mesh__recordMaintainer mesh__D016706 kle
% 207.76/207.93 |- skos__altLabel mesh__D016706 Still Disease, Adult-Onset
% 207.76/207.93 |- skos__historyNote mesh__D016706
% 207.76/207.93 Arthritis, Juvenile Rheumatoid %28%1966-1991%29%
% 207.76/207.93 |- skos__hiddenLabel mesh__D016706 Adult-Onset Stills Disease
% 207.76/207.93 |- skos__hiddenLabel mesh__D016706 Adult Onset Still Disease
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D016706
% 207.76/207.93 92; STILL%27%S DISEASE was see ARTHRITIS, JUVENILE RHEUMATOID 1975-91%A%
% 207.76/207.93 |- skos__broader mesh__D016706smesh__D001172
% 207.76/207.93 |- mesh__onlineNote mesh__D016706
% 207.76/207.93 use ARTHRITIS, JUVENILE RHEMUMATOID to search STILL%27%S DISEASE 1975-91%A%
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D016706 sjn
% 207.76/207.93 |- skos__hiddenLabel mesh__D016706 Still%27%s Disease, Adult Onset
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016706 2006
% 207.76/207.93 |- skos__hiddenLabel mesh__D016706 Stills Disease, Adult-Onset
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016706 2002
% 207.76/207.93 |- skos__annotation mesh__D016706
% 207.76/207.93 a type of rheum arthritis; do not confuse with STILL%27%S DISEASE, JUVENILE-ONSET see ARTHRITIS, JUVENILE RHEUMATOID%A%
% 207.76/207.93 |- mesh__dateCreated mesh__D016706 1991-01-25
% 207.76/207.93 |- rdf__type mesh__D016706sskos__Concept
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016706 2005
% 207.76/207.93 |- skos__hiddenLabel mesh__D016706 Adult Onset Still%27%s Disease
% 207.76/207.93 |- skos__altLabel mesh__D016706 Adult-Onset Still%27%s Disease
% 207.76/207.93 |- mesh__dateRevised mesh__D016706 1999-11-03
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016706 2001
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016706 2004
% 207.76/207.93 |- skos__prefLabel mesh__D016706 Still%27%s Disease, Adult-Onset
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D004682 sjn
% 207.76/207.93 |- rdf__type mesh__D004682sskos__Concept
% 207.76/207.93 |- skos__altLabel mesh__D004682 Teschen Disease
% 207.76/207.93 |- mesh__dateEstablished mesh__D004682 1970-01-01
% 207.76/207.93 |- skos__historyNote mesh__D004682 Swine Diseases %28%1966-1969%29%
% 207.76/207.93 |- skos__altLabel mesh__D004682 Porcine Poliomyelitis
% 207.76/207.93 |- mesh__recordMaintainer mesh__D004682 ags
% 207.76/207.93 |- mesh__dateRevised mesh__D004682 2003-07-30
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D004682 70
% 207.76/207.93 |- skos__historyNote mesh__D004682 Enterovirus Infections %28%1966-1969%29%
% 207.76/207.93 |- skos__hiddenLabel mesh__D004682 Disease, Teschen
% 207.76/207.93 |- mesh__recordOriginator mesh__D004682 NLM
% 207.76/207.93 |- skos__altLabel mesh__D004682 Poliomyelitis, Porcine
% 207.76/207.93 |- skos__prefLabel mesh__D004682 Encephalomyelitis, Enzootic Porcine
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004682 2005
% 207.76/207.93 |- skos__annotation mesh__D004682
% 207.76/207.93 caused by an enterovirus; don%27%t forget also SWINE %28%NIM%29% %26% check tag ANIMALS; DF: note short X ref%A%
% 207.76/207.93 |- mesh__historyNote mesh__D004682 70
% 207.76/207.93 |- skos__hiddenLabel mesh__D004682 Disease, Talfan
% 207.76/207.93 |- skos__hiddenLabel mesh__D004682 Enzootic Porcine Encephalomyelitis
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004682 2006
% 207.76/207.93 |- skos__broader mesh__D004682smesh__D004769
% 207.76/207.93 |- mesh__dateCreated mesh__D004682 1999-01-01
% 207.76/207.93 |- skos__scopeNote mesh__D004682
% 207.76/207.93 A picornavirus infection producing symptoms similar to poliomyelitis in pigs.%A%
% 207.76/207.93 |- skos__hiddenLabel mesh__D004682 Porcine Encephalomyelitis, Enzootic
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004682 2004
% 207.76/207.93 |- skos__broader mesh__D004682smesh__D013553
% 207.76/207.93 |- skos__broader mesh__D009726Q000266smesh__D009726
% 207.76/207.93 |- mesh__preferredCombination mesh__D009726Q000266smesh__D006676
% 207.76/207.93 |- rdf__type mesh__D009726Q000266smesh__CompoundConcept
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D012316 2004
% 207.76/207.93 |- mesh__dateRevised mesh__D012316 2003-07-09
% 207.76/207.93 |- mesh__dateEstablished mesh__D012316 1968-01-01
% 207.76/207.93 |- skos__broader mesh__D012316smesh__D009713
% 207.76/207.93 |- mesh__recordOriginator mesh__D012316 NLM
% 207.76/207.93 |- skos__prefLabel mesh__D012316 RNA Nucleotidyltransferases
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D012316 sjn
% 207.76/207.93 |- mesh__recordMaintainer mesh__D012316 ssb
% 207.76/207.93 |- skos__hiddenLabel mesh__D012316 Nucleotidyltransferases, RNA
% 207.76/207.93 |- skos__scopeNote mesh__D012316
% 207.76/207.93 Enzymes that catalyze the template-directed incorporation of ribonucleotides into an RNA chain. EC 2.7.7.-.%A%
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D012316 2006
% 207.76/207.93 |- rdf__type mesh__D012316sskos__Concept
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D012316 68
% 207.76/207.93 |- mesh__historyNote mesh__D012316 68
% 207.76/207.93 |- mesh__dateCreated mesh__D012316 1999-01-01
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D012316 2005
% 207.76/207.93 |- skos__historyNote mesh__D012316
% 207.76/207.93 Nucleotidyltransferases %28%1966-1967%29%
% 207.76/207.93 |- skos__broader mesh__D014125Q000662smesh__D014125
% 207.76/207.93 |- mesh__preferredCombination mesh__D014125Q000662smesh__D014124Q000151
% 207.76/207.93 |- rdf__type mesh__D014125Q000662smesh__CompoundConcept
% 207.76/207.93 |- skos__prefLabel mesh__D017001 Tooth Demineralization
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D017001 SJN
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017001 2006
% 207.76/207.93 |- skos__altLabel mesh__D017001 Tooth Hypomineralization
% 207.76/207.93 |- skos__related mesh__D017001smesh__D003731
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017001 2001
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017001 2003
% 207.76/207.93 |- rdf__type mesh__D017001sskos__Concept
% 207.76/207.93 |- skos__scopeNote mesh__D017001
% 207.76/207.93 A tooth%27%s loss of minerals, such as calcium in hydroxyapatite from the tooth matrix, caused by acidic exposure. An example of the occurrence of demineralization is in the formation of dental caries.%A%
% 207.76/207.93 |- skos__altLabel mesh__D017001 Demineralization, Tooth
% 207.76/207.93 |- mesh__historyNote mesh__D017001 92
% 207.76/207.93 |- skos__annotation mesh__D017001
% 207.76/207.93 a tooth dis; white spots or white lesions do not go here: note WHITE SPOTS see DENTAL CARIES%A%
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017001 2004
% 207.76/207.93 |- mesh__dateCreated mesh__D017001 1991-05-30
% 207.76/207.93 |- skos__broader mesh__D017001smesh__D014076
% 207.76/207.93 |- skos__hiddenLabel mesh__D017001 Tooth Hypomineralizations
% 207.76/207.93 |- mesh__recordMaintainer mesh__D017001 TGC
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017001 2002
% 207.76/207.93 |- skos__altLabel mesh__D017001 Hypomineralization, Tooth
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017001 1998
% 207.76/207.93 |- mesh__recordOriginator mesh__D017001 MXR
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017001 1999
% 207.76/207.93 |- mesh__dateEstablished mesh__D017001 1992-01-01
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017001 2005
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D017001 2000
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D017001 92
% 207.76/207.93 |- mesh__dateRevised mesh__D017001 1997-06-20
% 207.76/207.93 |- skos__hiddenLabel mesh__D017001 Hypomineralizations, Tooth
% 207.76/207.93 |- mesh__dateRevised mesh__D008275 2003-07-09
% 207.76/207.93 |- mesh__recordOriginator mesh__D008275 NLM
% 207.76/207.93 |- skos__broader mesh__D008275smesh__D003677
% 207.76/207.93 |- skos__hiddenLabel mesh__D008275 Deficiencies, Magnesium
% 207.76/207.93 |- skos__prefLabel mesh__D008275 Magnesium Deficiency
% 207.76/207.93 |- mesh__recordMaintainer mesh__D008275 lkt
% 207.76/207.93 |- mesh__dateCreated mesh__D008275 1999-01-01
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008275 2004
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008275 2005
% 207.76/207.93 |- skos__hiddenLabel mesh__D008275 Magnesium Deficiencies
% 207.76/207.93 |- skos__scopeNote mesh__D008275
% 207.76/207.93 A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. %28%Harrison%27%s Principles of Internal Medicine, 12th ed, p1936%29%%A%
% 207.76/207.93 |- skos__altLabel mesh__D008275 Deficiency, Magnesium
% 207.76/207.93 |- skos__annotation mesh__D008275 DF: MAGNESIUM DEFIC
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D008275 2006
% 207.76/207.93 |- rdf__type mesh__D008275sskos__Concept
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D008275 sjn
% 207.76/207.93 |- skos__scopeNote mesh__D000292
% 207.76/207.93 A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus %28%ENDOMETRITIS%29%, the FALLOPIAN TUBES; %28%SALPINGITIS%29%; the ovaries %28%OOPHORITIS%29%, the supporting ligaments %28%PARAMETRITIS%29%, or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.%A%
% 207.76/207.93 |- skos__hiddenLabel mesh__D000292 Diseases, Inflammatory Pelvic
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D000292 ags
% 207.76/207.93 |- skos__hiddenLabel mesh__D000292 Pelvic Inflammatory Diseases
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000292 2005
% 207.76/207.93 |- skos__hiddenLabel mesh__D000292 Diseases, Pelvic Inflammatory
% 207.76/207.93 |- skos__altLabel mesh__D000292 Pelvic Disease, Inflammatory
% 207.76/207.93 |- rdf__type mesh__D000292sskos__Concept
% 207.76/207.93 |- skos__prefLabel mesh__D000292 Pelvic Inflammatory Disease
% 207.76/207.93 |- skos__hiddenLabel mesh__D000292 Inflammatory Pelvic Diseases
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D000292 2003; see ADNEXITIS 1963-2002
% 207.76/207.93 |- skos__broader mesh__D000292smesh__D034161
% 207.76/207.93 |- skos__hiddenLabel mesh__D000292 Pelvic Diseases, Inflammatory
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000292 2006A
% 207.76/207.93 |- mesh__dateRevised mesh__D000292 2005-07-13
% 207.76/207.93 |- mesh__dateCreated mesh__D000292 1999-01-01
% 207.76/207.93 |- mesh__recordOriginator mesh__D000292 NLM
% 207.76/207.93 |- skos__annotation mesh__D000292
% 207.76/207.93 female only: note category; %22%male adnexitis%22%: index under GENITAL DISEASES, MALE or PELVIC INFECTION%A%
% 207.76/207.93 |- skos__altLabel mesh__D000292 Inflammatory Pelvic Disease
% 207.76/207.93 |- mesh__recordMaintainer mesh__D000292 ags
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000292 2004
% 207.76/207.93 |- skos__hiddenLabel mesh__D000292 Disease, Inflammatory Pelvic
% 207.76/207.93 |- skos__hiddenLabel mesh__D000292 Inflammatory Diseases, Pelvic
% 207.76/207.93 |- skos__altLabel mesh__D000292 Inflammatory Disease, Pelvic
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000292 2006
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D000292 2003
% 207.76/207.93 |- skos__hiddenLabel mesh__D000292 Disease, Pelvic Inflammatory
% 207.76/207.93 |- mesh__historyNote mesh__D000292 2003 %28%1963%29%
% 207.76/207.93 |- skos__broader mesh__D000292smesh__D000291
% 207.76/207.93 |- skos__prefLabel mesh__D016707 Tissue Fixation
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016707 2002
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016707 2006
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016707 2001
% 207.76/207.93 |- mesh__recordMaintainer mesh__D016707 TAP
% 207.76/207.93 |- rdf__type mesh__D016707sskos__Concept
% 207.76/207.93 |- mesh__dateEstablished mesh__D016707 1992-01-01
% 207.76/207.93 |- mesh__dateRevised mesh__D016707 2000-06-22
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016707 2005
% 207.76/207.93 |- skos__broader mesh__D016707smesh__D014021
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016707 2004
% 207.76/207.93 |- mesh__recordOriginator mesh__D016707 MXR
% 207.76/207.93 |- mesh__historyNote mesh__D016707 92
% 207.76/207.93 |- mesh__dateCreated mesh__D016707 1991-06-21
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D016707 2003
% 207.76/207.93 |- skos__scopeNote mesh__D016707
% 207.76/207.93 The technique of using FIXATIVES in the preparation of cytologic, histologic, or pathologic specimens for the purpose of maintaining the existing form and structure of all the constituent elements.%A%
% 207.76/207.93 |- skos__related mesh__D016707smesh__D005404
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D016707 sjn
% 207.76/207.93 |- skos__altLabel mesh__D016707 Fixation, Tissue
% 207.76/207.93 |- mesh__publicMeSHNote mesh__D016707 92
% 207.76/207.93 |- skos__prefLabel mesh__D004683 Encephalomyelitis, Equine
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004683 2000
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004683 2001
% 207.76/207.93 |- mesh__recordAuthorizer mesh__D004683 sjn
% 207.76/207.93 |- skos__altLabel mesh__D004683 Infections, Equine Encephalomyelitis Virus
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004683 2005
% 207.76/207.93 |- skos__scopeNote mesh__D004683
% 207.76/207.93 A group of ALPHAVIRUS INFECTIONS which affect horses and man, transmitted via the bites of mosquitoes. Disorders in this category are endemic to regions of South America and North America. In humans, clinical manifestations vary with the type of infection, and range from a mild influenza-like syndrome to a fulminant encephalitis. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp8-10%29%%A%
% 207.76/207.93 |- skos__broader mesh__D004683smesh__D001102
% 207.76/207.93 |- mesh__dateRevised mesh__D004683 1999-11-03
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004683 2002
% 207.76/207.93 |- skos__broader mesh__D004683smesh__D004679
% 207.76/207.93 |- skos__altLabel mesh__D004683 Equine Encephalomyelitis Virus Infections
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004683 2003
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004683 2006
% 207.76/207.93 |- mesh__recordMaintainer mesh__D004683 KEV
% 207.76/207.93 |- mesh__dateCreated mesh__D004683 1999-01-01
% 207.76/207.93 |- skos__broader mesh__D004683smesh__D018792
% 207.76/207.93 |- skos__broader mesh__D004683smesh__D018354
% 207.76/207.93 |- mesh__recordOriginator mesh__D004683 NLM
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D004683 2004
% 207.76/207.93 |- skos__altLabel mesh__D004683 Equine Encephalitis
% 207.76/207.93 |- rdf__type mesh__D004683sskos__Concept
% 207.76/207.93 |- skos__altLabel mesh__D004683 Encephalitis, Equine
% 207.76/207.93 |- skos__altLabel mesh__D004683 Equine Encephalomyelitis Viral Infections
% 207.76/207.93 |- skos__annotation mesh__D004683
% 207.76/207.93 human %26% animal; if in horses, coord with HORSE DISEASES %28%IM%29% + HORSES %28%NIM%29% %26% use /vet; DF: ENCEPH EQUINE%A%
% 207.76/207.93 |- skos__hiddenLabel mesh__D004683 Equine Encephalomyelitis
% 207.76/207.93 |- skos__hiddenLabel mesh__D012317 Bacteriophage, RNA
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D012317 2002
% 207.76/207.93 |- mesh__dateRevised mesh__D012317 2001-07-25
% 207.76/207.93 |- skos__annotation mesh__D012317 coord with specific bacterium /virol
% 207.76/207.93 |- mesh__activeMeSHYear mesh__D012317 2004
% 207.76/207.93 |- mesh__historyNote mesh__D012317 80
% 207.76/207.93 |- skos__altLabel mesh__D012317 Bacteriophages, RNA
% 207.76/207.93 |- skos__prefLabel mesh__D012317 RNA Phages
% 207.76/207.93 |- skos__historyNote mesh__D012317 Coliphages %28%1966-1979%29%
% 207.76/207.93 |- skos__historyNote mesh__D012317 Bacteriophages %28%1966-1979%29%
% 207.76/207.93 |- mesh__recordOriginator mesh__D012317 AEP
% 207.76/207.93 |- skos__hiddenLabel mesh__D012317 RNA Phage
% 207.76/207.93 |- skos__scopeNote mesh__D012317
% 207.76/207.93 Bacteriophages whose genetic material is RNA, which is single-stranded in all except the Pseudomonas phage phi 6 %28%BACTERIOPHAGE PHI 6%29%. All RNA phages infect their host bacteria via the host%27%s surface pili. Some frequently encountered RNA phages are: BF23, F2, R17, fr, PhiCb5, PhiCb12r, PhiCb8r, PhiCb23r, 7s, PP7, Q beta phage, MS2 phage, and BACTERIOPHAGE PHI 6.%A%
% 207.76/207.93 |- mesh__dateEstablished mesh__D012317 1980-01-01
% 207.76/207.93 |- mesh__dateCreated mesh__D012317 1979-04-16
% 207.76/207.94 |- skos__hiddenLabel mesh__D012317 RNA Bacteriophage
% 207.76/207.94 |- skos__hiddenLabel mesh__D012317 Phage, RNA
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D012317 2005
% 207.76/207.94 |- mesh__recordMaintainer mesh__D012317 ags
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D012317 2006
% 207.76/207.94 |- rdf__type mesh__D012317sskos__Concept
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D012317 sjn
% 207.76/207.94 |- skos__altLabel mesh__D012317 Phages, RNA
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D012317 2003
% 207.76/207.94 |- skos__hiddenLabel mesh__D012317 RNA Bacteriophages
% 207.76/207.94 |- skos__broader mesh__D012317smesh__D001435
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D012317 80
% 207.76/207.94 |- skos__hiddenLabel mesh__D017800 Potyviruses
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 2001
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 2005
% 207.76/207.94 |- skos__broader mesh__D017800smesh__D009029
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 2000
% 207.76/207.94 |- skos__prefLabel mesh__D017800 Potyvirus
% 207.76/207.94 |- mesh__recordMaintainer mesh__D017800 AGS
% 207.76/207.94 |- skos__broader mesh__D017800smesh__D019176
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 1997
% 207.76/207.94 |- mesh__historyNote mesh__D017800 94
% 207.76/207.94 |- skos__hiddenLabel mesh__D017800 Potato Virus Ys
% 207.76/207.94 |- skos__historyNote mesh__D017800 Plant Viruses %28%1967-1993%29%
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 2004
% 207.76/207.94 |- mesh__dateCreated mesh__D017800 1993-06-04
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 2002
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 1999
% 207.76/207.94 |- mesh__recordOriginator mesh__D017800 AGS
% 207.76/207.94 |- mesh__dateEstablished mesh__D017800 1994-01-01
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 2003
% 207.76/207.94 |- skos__annotation mesh__D017800
% 207.76/207.94 a genus of mosaic viruses; from POTato virus Y %28%Y is one of a series, e.g., A, M, S, V, etc.%29%; coord IM with specific plant /virol %28%IM or NIM%29%%A%
% 207.76/207.94 |- mesh__dateRevised mesh__D017800 1996-06-10
% 207.76/207.94 |- skos__historyNote mesh__D017800 Mosaic Viruses %28%1973-1993%29%
% 207.76/207.94 |- skos__hiddenLabel mesh__D017800 Virus Ys, Potato
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 2006
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017800 1998
% 207.76/207.94 |- skos__hiddenLabel mesh__D017800 Ys, Potato Virus
% 207.76/207.94 |- rdf__type mesh__D017800sskos__Concept
% 207.76/207.94 |- skos__scopeNote mesh__D017800
% 207.76/207.94 A large genus of plant viruses of the family POTYVIRIDAE which infect mainly plants of the Solanaceae. Transmission is primarily by aphids in a non-persistent manner. The type species is potato virus Y.%A%
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D017800 PLS
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D017800 94
% 207.76/207.94 |- skos__scopeNote mesh__D050436
% 207.76/207.94 Nucleotide sequences of a gene that are involved in the regulation of GENETIC TRANSCRIPTION.%A%
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D050436
% 207.76/207.94 2006; see GENES, REGULATOR 1991-2005
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D050436 2006
% 207.76/207.94 |- skos__altLabel mesh__D050436 Elements, Transcriptional Regulatory
% 207.76/207.94 |- skos__altLabel mesh__D050436 Transcriptional Regulatory Elements
% 207.76/207.94 |- mesh__dateEstablished mesh__D050436 2006-01-01
% 207.76/207.94 |- rdf__type mesh__D050436sskos__Concept
% 207.76/207.94 |- mesh__recordOriginator mesh__D050436 nns
% 207.76/207.94 |- skos__prefLabel mesh__D050436 Regulatory Elements, Transcriptional
% 207.76/207.94 |- mesh__historyNote mesh__D050436 2006; use GENES, REGULATOR 1991-2005
% 207.76/207.94 |- skos__altLabel mesh__D050436 Transcriptional Regulatory Element
% 207.76/207.94 |- mesh__dateCreated mesh__D050436 2005-06-30
% 207.76/207.94 |- skos__broader mesh__D050436smesh__D040461
% 207.76/207.94 |- mesh__recordMaintainer mesh__D050436 nns
% 207.76/207.94 |- skos__altLabel mesh__D050436 Element, Transcriptional Regulatory
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D050436 sjn
% 207.76/207.94 |- skos__altLabel mesh__D050436 Regulatory Element, Transcriptional
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D008276
% 207.76/207.94 91; was see under MAGNESIUM 1977-90
% 207.76/207.94 |- rdf__type mesh__D008276sskos__Concept
% 207.76/207.94 |- skos__broader mesh__D008276smesh__D006878
% 207.76/207.94 |- skos__hiddenLabel mesh__D008276 Hydroxide, Magnesium
% 207.76/207.94 |- skos__broader mesh__D008276smesh__D017616
% 207.76/207.94 |- skos__prefLabel mesh__D008276 Magnesium Hydroxide
% 207.76/207.94 |- mesh__historyNote mesh__D008276
% 207.76/207.94 91%28%77%29%; was see under MAGNESIUM 1977-90
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008276 2004
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D008276 sjn
% 207.76/207.94 |- skos__altLabel mesh__D008276 Magnesium Hydrate
% 207.76/207.94 |- mesh__dateRevised mesh__D008276 2001-07-25
% 207.76/207.94 |- mesh__dateCreated mesh__D008276 1976-04-13
% 207.76/207.94 |- mesh__dateEstablished mesh__D008276 1991-01-01
% 207.76/207.94 |- skos__scopeNote mesh__D008276
% 207.76/207.94 An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects.%A%
% 207.76/207.94 |- skos__historyNote mesh__D008276 Hydroxides %28%1966-1976%29%
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008276 2003
% 207.76/207.94 |- skos__historyNote mesh__D008276 Magnesium %28%1966-1976%29%
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008276 2006
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008276 2002
% 207.76/207.94 |- mesh__recordOriginator mesh__D008276 RLS
% 207.76/207.94 |- skos__hiddenLabel mesh__D008276 Hydrate, Magnesium
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008276 2005
% 207.76/207.94 |- mesh__recordMaintainer mesh__D008276 jmp
% 207.76/207.94 |- mesh__recordMaintainer mesh__D000293 jrf
% 207.76/207.94 |- mesh__dateRevised mesh__D000293 2002-07-02
% 207.76/207.94 |- skos__hiddenLabel mesh__D000293 Female Adolescents
% 207.76/207.94 |- skos__related mesh__D000293smesh__D033242
% 207.76/207.94 |- rdf__type mesh__D000293sskos__Concept
% 207.76/207.94 |- skos__altLabel mesh__D000293 Adolescents
% 207.76/207.94 |- skos__hiddenLabel mesh__D000293 Adolescent, Female
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D000293 sjn
% 207.76/207.94 |- skos__hiddenLabel mesh__D000293 Female Adolescent
% 207.76/207.94 |- mesh__dateCreated mesh__D000293 1999-01-01
% 207.76/207.94 |- skos__scopeNote mesh__D000293 A person 13 to 18 years of age.
% 207.76/207.94 |- skos__annotation mesh__D000293
% 207.76/207.94 age 13-18 yr; IM as psychol %26% sociol entity; check tag ADOLESCENT for NIM; Manual 18.5.12, 34.9.5%A%
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D000293 2004
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D000293 2006
% 207.76/207.94 |- skos__hiddenLabel mesh__D000293 Teenager
% 207.76/207.94 |- skos__hiddenLabel mesh__D000293 Adolescent, Male
% 207.76/207.94 |- skos__prefLabel mesh__D000293 Adolescent
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D000293 2003
% 207.76/207.94 |- mesh__recordOriginator mesh__D000293 NLM
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D000293 2005
% 207.76/207.94 |- skos__broader mesh__D000293smesh__D009273
% 207.76/207.94 |- skos__hiddenLabel mesh__D000293 Youths
% 207.76/207.94 |- skos__altLabel mesh__D000293 Teenagers
% 207.76/207.94 |- skos__hiddenLabel mesh__D000293 Teen
% 207.76/207.94 |- skos__hiddenLabel mesh__D000293 Male Adolescents
% 207.76/207.94 |- skos__hiddenLabel mesh__D000293 Male Adolescent
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D016708 2006
% 207.76/207.94 |- mesh__dateRevised mesh__D016708 2005-06-30
% 207.76/207.94 |- skos__prefLabel mesh__D016708 Synaptophysin
% 207.76/207.94 |- skos__scopeNote mesh__D016708
% 207.76/207.94 A 38-kDa integral membrane glycoprotein of the presynaptic vesicles in neuron and neuroendocrine cells. It is expressed by a variety of normal and neoplastic neuroendocrine cells and is therefore used as an immunocytochemical marker for neuroendocrine differentiation in various tumors. In ALZHEIMER DISEASE and other dementing disorders, there is an important synapse loss due in part to a decrease of synaptophysin in the presynaptic vesicles.%A%
% 207.76/207.94 |- skos__broader mesh__D016708smesh__D014408
% 207.76/207.94 |- rdf__type mesh__D016708sskos__Concept
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D016708 sjn
% 207.76/207.94 |- skos__broader mesh__D016708smesh__D009419
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D016708
% 207.76/207.94 92; SYNAPTOPHYSIN was indexed under MEMBRANE PROTEINS 1985-91%A%
% 207.76/207.94 |- mesh__dateCreated mesh__D016708 1991-02-11
% 207.76/207.94 |- skos__altLabel mesh__D016708 P38 Membrane Protein, Synaptic Vesicle
% 207.76/207.94 |- mesh__recordOriginator mesh__D016708 RLS
% 207.76/207.94 |- mesh__onlineNote mesh__D016708
% 207.76/207.94 use SYNAPTOPHYSIN %28%NM%29% to search SYNAPTOPHYSIN 1985-91
% 207.76/207.94 |- skos__historyNote mesh__D016708 Nerve Tissue Proteins %28%1966-1991%29%
% 207.76/207.94 |- mesh__dateEstablished mesh__D016708 1992-01-01
% 207.76/207.94 |- mesh__recordMaintainer mesh__D016708 ssb
% 207.76/207.94 |- mesh__historyNote mesh__D016708
% 207.76/207.94 92; was SYNAPTOPHYSIN %28%NM%29% 1985-91
% 207.76/207.94 |- skos__historyNote mesh__D016708 Membrane Proteins %28%1977-1991%29%
% 207.76/207.94 |- skos__broader mesh__D016708smesh__D008562
% 207.76/207.94 |- skos__altLabel mesh__D016708 Protein P38, Synaptic Vesicle
% 207.76/207.94 |- skos__annotation mesh__D016708
% 207.76/207.94 /biosyn /drug eff /physiol /ultrastruct permitted
% 207.76/207.94 |- mesh__dateEstablished mesh__D041101 2003-01-01
% 207.76/207.94 |- skos__scopeNote mesh__D041101
% 207.76/207.94 A species of gram-negative bacteria in the genus NEORICKETTSIA, family ANAPLASMATACEAE, causing Sennetsu fever and found in the FAR EAST and SOUTHEAST ASIA.%A%
% 207.76/207.94 |- rdf__type mesh__D041101sskos__Concept
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D041101 2003
% 207.76/207.94 |- mesh__dateRevised mesh__D041101 2005-06-30
% 207.76/207.94 |- skos__prefLabel mesh__D041101 Neorickettsia sennetsu
% 207.76/207.94 |- skos__annotation mesh__D041101
% 207.76/207.94 infection: coord IM with ANAPLASMATACEAE INFECTIONS %28%IM%29%
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D041101 2006
% 207.76/207.94 |- mesh__dateCreated mesh__D041101 2002-07-03
% 207.76/207.94 |- mesh__recordOriginator mesh__D041101 ags
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D041101 sjn
% 207.76/207.94 |- skos__altLabel mesh__D041101 Ehrlichia sennetsu
% 207.76/207.94 |- skos__broader mesh__D041101smesh__D041102
% 207.76/207.94 |- skos__historyNote mesh__D041101 Ehrlichia %28%1985-2002%29%
% 207.76/207.94 |- mesh__historyNote mesh__D041101 2003
% 207.76/207.94 |- mesh__recordMaintainer mesh__D041101 SYSTEM
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D013410 2002
% 207.76/207.94 |- skos__prefLabel mesh__D013410 Sulfachlorpyridazine
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D013410 sjn
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D013410 2003
% 207.76/207.94 |- skos__broader mesh__D013410smesh__D013424
% 207.76/207.94 |- skos__historyNote mesh__D013410 Pyridazines %28%1974%29%
% 207.76/207.94 |- mesh__recordOriginator mesh__D013410 NLM
% 207.76/207.94 |- skos__altLabel mesh__D013410 Sulfachloropyridazine
% 207.76/207.94 |- mesh__dateRevised mesh__D013410 2000-06-22
% 207.76/207.94 |- skos__hiddenLabel mesh__D013410 Monosodium Salt Sulfachlorpyridazine
% 207.76/207.94 |- mesh__dateEstablished mesh__D013410 1991-01-01
% 207.76/207.94 |- mesh__historyNote mesh__D013410
% 207.76/207.94 91%28%75%29%; was see under SULFANILAMIDES 1975-90
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D013410 2004
% 207.76/207.94 |- skos__historyNote mesh__D013410 Sulfanilamides %28%1974%29%
% 207.76/207.94 |- rdf__type mesh__D013410sskos__Concept
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D013410
% 207.76/207.94 91; was see under SULFANILAMIDES 1975-90
% 207.76/207.94 |- mesh__dateCreated mesh__D013410 1974-11-19
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D013410 2005
% 207.76/207.94 |- skos__altLabel mesh__D013410 Sulphachlorpyridazine
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D013410 2001
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D013410 2006
% 207.76/207.94 |- mesh__recordMaintainer mesh__D013410 CCR
% 207.76/207.94 |- skos__scopeNote mesh__D013410
% 207.76/207.94 A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.%A%
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684
% 207.76/207.94 Encephalomyelitides, Hemorrhagic Necrotizing
% 207.76/207.94 |- skos__altLabel mesh__D004684 Encephalomyelitis, Necrotizing Hemorrhagic
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684
% 207.76/207.94 Hemorrhagic Leukoencephalitides, Subacute
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D004684 2006
% 207.76/207.94 |- rdf__type mesh__D004684sskos__Concept
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Leukoencephalitides, Acute Hemorrhagic
% 207.76/207.94 |- skos__altLabel mesh__D004684
% 207.76/207.94 Encephalomyelitis, Acute Necrotizing Hemorrhagic
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D004684 2003
% 207.76/207.94 |- skos__annotation mesh__D004684 DF: LEUKOENCEPH ACUTE HEMOR
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Subacute Hemorrhagic Leukoencephalitis
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Disease, Hurst%27%s
% 207.76/207.94 |- mesh__dateRevised mesh__D004684 1999-11-09
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Acute Necrotizing Encephalitis
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Encephalitides, Acute Necrotizing
% 207.76/207.94 |- skos__altLabel mesh__D004684 Hurst Disease
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D004684 2002
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Disease, Hurst
% 207.76/207.94 |- skos__altLabel mesh__D004684 Necrotizing Encephalomyelitis, Hemorrhagic
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Hemorrhagic Leukoencephalitides, Acute
% 207.76/207.94 |- skos__prefLabel mesh__D004684 Leukoencephalitis, Acute Hemorrhagic
% 207.76/207.94 |- skos__historyNote mesh__D004684 Encephalomyelitis %28%1966-1971%29%
% 207.76/207.94 |- mesh__historyNote mesh__D004684
% 207.76/207.94 1997; was ENCEPHALOMYELITIS, NECROTIZING HEMORRHAGIC 1991-1996 %28%see under ENCEPHALOMYELITIS 1972-1990%29%; HURST DISEASE was HURST%27%S DISEASE 1997%A%
% 207.76/207.94 |- skos__broader mesh__D004684smesh__D004679
% 207.76/207.94 |- skos__broader mesh__D004684smesh__D020278
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D004684 2004
% 207.76/207.94 |- skos__altLabel mesh__D004684 Encephalomyelitis, Hemorrhagic Necrotizing
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Hemorrhagic Leukoencephalitis, Acute
% 207.76/207.94 |- mesh__dateEstablished mesh__D004684 1991-01-01
% 207.76/207.94 |- skos__scopeNote mesh__D004684
% 207.76/207.94 A fulminant and often fatal demyelinating disease of the brain which primarily affects young adults and children. Clinical features include the rapid onset of weakness, SEIZURES, and COMA. It may follow a viral illness or MYCOPLASMA PNEUMONIAE infections but in most instances there is no precipitating event. Pathologic examination reveals marked perivascular demyelination and necrosis of white matter with microhemorrhages. %28%Adams et al., Principles of Neurology, 6th ed, pp924-5%29%%A%
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684
% 207.76/207.94 Necrotizing Hemorrhagic Encephalomyelitides
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Acute Hemorrhagic Leukoencephalitides
% 207.76/207.94 |- skos__altLabel mesh__D004684 Hemorrhagic Encephalomyelitis, Necrotizing
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Hemorrhagic Leukoencephalitis, Subacute
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Acute Hemorrhagic Leukoencephalitis
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684
% 207.76/207.94 Hemorrhagic Encephalomyelitides, Necrotizing
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D004684
% 207.76/207.94 1997; was ENCEPHALOMYELITIS, NECROTIZING HEMORRHAGIC 1991-1996 %28%see under ENCEPHALOMYELITIS 1972-1990%29%; HURST DISEASE was HURST%27%S DISEASE 1997%A%
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Hursts Disease
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Syndrome, Hurst
% 207.76/207.94 |- mesh__dateCreated mesh__D004684 1999-01-01
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684
% 207.76/207.94 Necrotizing Encephalomyelitides, Hemorrhagic
% 207.76/207.94 |- skos__altLabel mesh__D004684 Hurst Syndrome
% 207.76/207.94 |- mesh__recordMaintainer mesh__D004684 KEV
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D004684 2000
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Acute Necrotizing Encephalitides
% 207.76/207.94 |- skos__broader mesh__D004684smesh__D004660
% 207.76/207.94 |- skos__altLabel mesh__D004684 Leukoencephalitis Acuta Hemorrhagica
% 207.76/207.94 |- skos__broader mesh__D004684smesh__D020274
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Necrotizing Encephalitides, Acute
% 207.76/207.94 |- skos__altLabel mesh__D004684 Hemorrhagic Necrotizing Encephalomyelitis
% 207.76/207.94 |- skos__historyNote mesh__D004684 Demyelinating Diseases %28%1966-1971%29%
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Necrotizing Encephalitis, Acute
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D004684 2005
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684 Subacute Hemorrhagic Leukoencephalitides
% 207.76/207.94 |- mesh__recordOriginator mesh__D004684 NLM
% 207.76/207.94 |- skos__altLabel mesh__D004684 Hurst%27%s Disease
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D004684 sjn
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D004684 2001
% 207.76/207.94 |- skos__hiddenLabel mesh__D004684
% 207.76/207.94 Leukoencephalitides, Subacute Hemorrhagic
% 207.76/207.94 |- skos__scopeNote mesh__D012318
% 207.76/207.94 A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. The enzyme functions in the nucleolar structure and transcribes DNA into RNA. It has different requirements for cations and salts than RNA polymerase II and III and is not inhibited by alpha-amanitin. EC 2.7.7.6.%A%
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D012318 sjn
% 207.76/207.94 |- skos__altLabel mesh__D012318 RNA Polymerase A
% 207.76/207.94 |- skos__hiddenLabel mesh__D012318 Polymerase I, RNA
% 207.76/207.94 |- skos__historyNote mesh__D012318 RNA Polymerases %28%1973-1976%29%
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D012318 2005
% 207.76/207.94 |- skos__hiddenLabel mesh__D012318 DNA Dependent RNA Polymerase I
% 207.76/207.94 |- skos__altLabel mesh__D012318 DNA-Dependent RNA Polymerase I
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D012318
% 207.76/207.94 84; was see under RNA POLYMERASES 1977-83
% 207.76/207.94 |- mesh__historyNote mesh__D012318
% 207.76/207.94 84%28%77%29%; was see under RNA POLYMERASES 1977-83
% 207.76/207.94 |- skos__hiddenLabel mesh__D012318 A, RNA Polymerase
% 207.76/207.94 |- mesh__dateEstablished mesh__D012318 1984-01-01
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D012318 2006
% 207.76/207.94 |- skos__prefLabel mesh__D012318 RNA Polymerase I
% 207.76/207.94 |- rdf__type mesh__D012318sskos__Concept
% 207.76/207.94 |- skos__hiddenLabel mesh__D012318 Polymerase A, RNA
% 207.76/207.94 |- mesh__recordMaintainer mesh__D012318 ssb
% 207.76/207.94 |- skos__hiddenLabel mesh__D012318 I, RNA Polymerase
% 207.76/207.94 |- skos__broader mesh__D012318smesh__D012321
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D012318 2004
% 207.76/207.94 |- mesh__dateCreated mesh__D012318 1976-04-19
% 207.76/207.94 |- mesh__recordOriginator mesh__D012318 RLS
% 207.76/207.94 |- skos__historyNote mesh__D012318
% 207.76/207.94 RNA Nucleotidyltransferases %28%1968-1972%29%
% 207.76/207.94 |- mesh__dateRevised mesh__D012318 2003-07-09
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D017801 PLS
% 207.76/207.94 |- skos__hiddenLabel mesh__D017801 Viruses, Plum Pox
% 207.76/207.94 |- skos__hiddenLabel mesh__D017801 Pox Viruses, Plum
% 207.76/207.94 |- mesh__dateRevised mesh__D017801 1996-06-10
% 207.76/207.94 |- skos__hiddenLabel mesh__D017801 Pox Virus, Plum
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 2000
% 207.76/207.94 |- skos__historyNote mesh__D017801 Plant Viruses %28%1969-1993%29%
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 1997
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 2003
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D017801 94
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 2001
% 207.76/207.94 |- mesh__historyNote mesh__D017801 94
% 207.76/207.94 |- skos__scopeNote mesh__D017801
% 207.76/207.94 A species of the genus POTYVIRUS that affects many species of Prunus. It is transmitted by aphids and by infected rootstocks.%A%
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 1998
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 2004
% 207.76/207.94 |- skos__hiddenLabel mesh__D017801 Virus, Plum Pox
% 207.76/207.94 |- mesh__dateCreated mesh__D017801 1993-06-04
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 2002
% 207.76/207.94 |- skos__broader mesh__D017801smesh__D017800
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 1999
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 2005
% 207.76/207.94 |- mesh__recordMaintainer mesh__D017801 AGS
% 207.76/207.94 |- mesh__recordOriginator mesh__D017801 AGS
% 207.76/207.94 |- skos__annotation mesh__D017801 a species of Potyvirus, a mosaic virus
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017801 2006
% 207.76/207.94 |- rdf__type mesh__D017801sskos__Concept
% 207.76/207.94 |- mesh__dateEstablished mesh__D017801 1994-01-01
% 207.76/207.94 |- skos__hiddenLabel mesh__D017801 Plum Pox Viruses
% 207.76/207.94 |- skos__prefLabel mesh__D017801 Plum Pox Virus
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 Bovine toroviruses
% 207.76/207.94 |- mesh__dateRevised mesh__D017003 2001-07-25
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 torovirus, Bovine
% 207.76/207.94 |- mesh__dateCreated mesh__D017003 1991-05-30
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017003 2002
% 207.76/207.94 |- mesh__dateEstablished mesh__D017003 1992-01-01
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 toroviruses, Human
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 Equine toroviruses
% 207.76/207.94 |- mesh__recordOriginator mesh__D017003 AGS
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017003 2005
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 toroviruses, Bovine
% 207.76/207.94 |- skos__historyNote mesh__D017003 RNA Viruses %28%1984-1991%29%
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 torovirus, Human
% 207.76/207.94 |- skos__altLabel mesh__D017003 Toroviridae
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017003 2006
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 toroviruses, Equine
% 207.76/207.94 |- mesh__historyNote mesh__D017003
% 207.76/207.94 94; was TOROVIRIDAE 1992-93; TOROVIRUSES was see TOROVIRIDAE 1992-93%A%
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 toroviruses, Porcine
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D017003 sjn
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017003 2003
% 207.76/207.94 |- mesh__onlineNote mesh__D017003
% 207.76/207.94 use TOROVIRUS to search TOROVIRIDAE %26% TOROVIRUSES 1992-93%A%
% 207.76/207.94 |- skos__annotation mesh__D017003
% 207.76/207.94 infection = TOROVIRUS INFECTIONS %28%IM%29%
% 207.76/207.94 |- skos__altLabel mesh__D017003 Breda Virus
% 207.76/207.94 |- rdf__type mesh__D017003sskos__Concept
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 Human toroviruses
% 207.76/207.94 |- skos__scopeNote mesh__D017003
% 207.76/207.94 A genus of the family CORONAVIRIDAE characterized by enveloped, peplomer-bearing particles containing an elongated tubular nucleocapsid with helical symmetry. Toroviruses have been found in association with enteric infections in horses %28%Berne virus%29%, cattle %28%Breda virus%29%, swine, and humans. Transmission probably takes place via the fecal-oral route.%A%
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 Porcine toroviruses
% 207.76/207.94 |- skos__altLabel mesh__D017003 Berne Virus
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D017003 2004
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D017003
% 207.76/207.94 94; was TOROVIRIDAE 1992-93; TOROVIRUSES was see TOROVIRIDAE 1992-93%A%
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 torovirus, Equine
% 207.76/207.94 |- mesh__recordMaintainer mesh__D017003 ags
% 207.76/207.94 |- skos__broader mesh__D017003smesh__D003332
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 Toroviruses
% 207.76/207.94 |- skos__hiddenLabel mesh__D017003 torovirus, Porcine
% 207.76/207.94 |- skos__prefLabel mesh__D017003 Torovirus
% 207.76/207.94 |- mesh__recordOriginator mesh__D050437 nns
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D050437
% 207.76/207.94 2006; see GENES, STRUCTURAL 1988-2005
% 207.76/207.94 |- mesh__recordMaintainer mesh__D050437 ags
% 207.76/207.94 |- skos__hiddenLabel mesh__D050437 Gene, Developmental
% 207.76/207.94 |- skos__scopeNote mesh__D050437
% 207.76/207.94 Genes that determine the fate of a cell or CELLS in a region of the EMBRYO during EMBRYONIC DEVELOPMENT.%A%
% 207.76/207.94 |- skos__altLabel mesh__D050437 Developmental Genes
% 207.76/207.94 |- skos__related mesh__D050437smesh__D018507
% 207.76/207.94 |- mesh__dateEstablished mesh__D050437 2006-01-01
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D050437 2006A
% 207.76/207.94 |- mesh__dateRevised mesh__D050437 2005-11-09
% 207.76/207.94 |- skos__prefLabel mesh__D050437 Genes, Developmental
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D050437 2006
% 207.76/207.94 |- mesh__dateCreated mesh__D050437 2005-06-30
% 207.76/207.94 |- mesh__historyNote mesh__D050437 2006
% 207.76/207.94 |- skos__broader mesh__D050437smesh__D005796
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D050437 ags
% 207.76/207.94 |- skos__hiddenLabel mesh__D050437 Developmental Gene
% 207.76/207.94 |- rdf__type mesh__D050437sskos__Concept
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008277 2002
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008277 2004
% 207.76/207.94 |- skos__broader mesh__D008277smesh__D017616
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008277 2003
% 207.76/207.94 |- skos__scopeNote mesh__D008277
% 207.76/207.94 Magnesium oxide %28%MgO%29%. An inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. It is used as an antacid and mild laxative and has many nonmedicinal uses.%A%
% 207.76/207.94 |- skos__altLabel mesh__D008277 Magnesia
% 207.76/207.94 |- skos__broader mesh__D008277smesh__D010087
% 207.76/207.94 |- mesh__dateRevised mesh__D008277 1999-11-03
% 207.76/207.94 |- mesh__dateCreated mesh__D008277 1999-01-01
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008277 2001
% 207.76/207.94 |- mesh__recordMaintainer mesh__D008277 adp
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D008277 sjn
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008277 2006
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008277 2000
% 207.76/207.94 |- mesh__recordOriginator mesh__D008277 NLM
% 207.76/207.94 |- skos__annotation mesh__D008277 an antacid %26% cathartic
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D008277 2005
% 207.76/207.94 |- rdf__type mesh__D008277sskos__Concept
% 207.76/207.94 |- skos__prefLabel mesh__D008277 Magnesium Oxide
% 207.76/207.94 |- skos__hiddenLabel mesh__D008277 Oxide, Magnesium
% 207.76/207.94 |- mesh__recordOriginator mesh__D000294 EC
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D000294 2004
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D000294 2006
% 207.76/207.94 |- skos__hiddenLabel mesh__D000294 Behaviors, Adolescent
% 207.76/207.94 |- mesh__dateCreated mesh__D000294 1980-05-07
% 207.76/207.94 |- skos__annotation mesh__D000294 check also tag ADOLESCENCE
% 207.76/207.94 |- skos__related mesh__D000294smesh__D041923
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D000294 2005
% 207.76/207.94 |- mesh__historyNote mesh__D000294 81
% 207.76/207.94 |- skos__historyNote mesh__D000294 Adolescent Psychology %28%1967-1980%29%
% 207.76/207.94 |- mesh__publicMeSHNote mesh__D000294 81
% 207.76/207.94 |- mesh__dateRevised mesh__D000294 2003-07-09
% 207.76/207.94 |- skos__altLabel mesh__D000294 Behavior, Adolescent
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D000294 sjn
% 207.76/207.94 |- skos__broader mesh__D000294smesh__D001519
% 207.76/207.94 |- rdf__type mesh__D000294sskos__Concept
% 207.76/207.94 |- skos__scopeNote mesh__D000294
% 207.76/207.94 Any observable response or action of an adolescent.
% 207.76/207.94 |- mesh__dateEstablished mesh__D000294 1981-01-01
% 207.76/207.94 |- mesh__recordMaintainer mesh__D000294 lkt
% 207.76/207.94 |- skos__prefLabel mesh__D000294 Adolescent Behavior
% 207.76/207.94 |- skos__hiddenLabel mesh__D000294 Adolescent Behaviors
% 207.76/207.94 |- skos__broader mesh__D016709smesh__D008516
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D016709 2006
% 207.76/207.94 |- skos__related mesh__D016709smesh__D016710
% 207.76/207.94 |- skos__prefLabel mesh__D016709 Yin-Yang
% 207.76/207.94 |- rdf__type mesh__D016709sskos__Concept
% 207.76/207.94 |- skos__related mesh__D016709smesh__D019413
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D016709 2003
% 207.76/207.94 |- skos__hiddenLabel mesh__D016709 Yin Yang
% 207.76/207.94 |- mesh__activeMeSHYear mesh__D016709 2004
% 207.76/207.94 |- skos__scopeNote mesh__D016709
% 207.76/207.94 In Chinese philosophy and religion, two principles, one negative, dark, and feminine %28%yin%29% and one positive, bright, and masculine %28%yang%29%, from whose interaction all things are produced and all things are dissolved. As a concept the two polar elements referred originally to the shady and sunny sides of a valley or a hill but it developed into the relationship of any contrasting pair: those specified above %28%female-male, etc.%29% as well as cold-hot, wet-dry, weak-strong, etc. It is not a distinct system of thought by itself but permeates Chinese life and thought. A balance of yin and yang is essential to health. A deficiency of either principle can manifest as disease. %28%Encyclopedia Americana%29%%A%
% 207.76/207.94 |- skos__broader mesh__D016709smesh__D010684
% 207.76/207.94 |- mesh__historyNote mesh__D016709 92
% 207.76/207.94 |- skos__annotation mesh__D016709
% 207.76/207.94 yang exuberance syndrome can go here, defic syndromes: index YIN DEFICIENCY or YANG DEFICIENCY: see notes there%A%
% 207.76/207.94 |- mesh__recordAuthorizer mesh__D016709 sjn
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D016709 92
% 207.76/207.95 |- skos__historyNote mesh__D016709
% 207.76/207.95 Medicine, Chinese Traditional %28%1968-1991%29%
% 207.76/207.95 |- mesh__recordMaintainer mesh__D016709 ssb
% 207.76/207.95 |- mesh__dateCreated mesh__D016709 1991-02-11
% 207.76/207.95 |- mesh__recordOriginator mesh__D016709 TGC
% 207.76/207.95 |- mesh__dateEstablished mesh__D016709 1992-01-01
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D016709 2005
% 207.76/207.95 |- skos__related mesh__D016709smesh__D016711
% 207.76/207.95 |- mesh__dateRevised mesh__D016709 2002-07-03
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D041102 2006
% 207.76/207.95 |- mesh__dateEstablished mesh__D041102 2003-01-01
% 207.76/207.95 |- skos__scopeNote mesh__D041102
% 207.76/207.95 Genus of gram-negative, intracytoplasmic bacteria that are found primarily in VACUOLES of MONOCYTES in the BLOOD and MACROPHAGES of lymphoid or other tissues of DOGS; HORSES, and humans. %28%From Int. J. Syst. Evol. Microbiol. %28%2001%29% 51:2145-2165%29%%A%
% 207.76/207.95 |- skos__historyNote mesh__D041102 Rickettsiaceae %28%1969-2002%29%
% 207.76/207.95 |- mesh__dateRevised mesh__D041102 2005-06-30
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D041102 2003, 1963-1981
% 207.76/207.95 |- rdf__type mesh__D041102sskos__Concept
% 207.76/207.95 |- mesh__recordMaintainer mesh__D041102 SYSTEM
% 207.76/207.95 |- skos__broader mesh__D041102smesh__D000710
% 207.76/207.95 |- skos__annotation mesh__D041102
% 207.76/207.95 infection: coord IM with ANAPLASMATACEAE INFECTIONS %28%IM%29%
% 207.76/207.95 |- skos__prefLabel mesh__D041102 Neorickettsia
% 207.76/207.95 |- mesh__historyNote mesh__D041102 2003, 1963-1981
% 207.76/207.95 |- mesh__recordOriginator mesh__D041102 ags
% 207.76/207.95 |- mesh__dateCreated mesh__D041102 2002-07-03
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D041102 sjn
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013411 2003
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013411 2004
% 207.76/207.95 |- rdf__type mesh__D013411sskos__Concept
% 207.76/207.95 |- skos__scopeNote mesh__D013411
% 207.76/207.95 One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.%A%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013411 2005
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013411 2002
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013411 2006
% 207.76/207.95 |- skos__hiddenLabel mesh__D013411 Sulfadiazine, Zinc
% 207.76/207.95 |- mesh__recordMaintainer mesh__D013411 ssb
% 207.76/207.95 |- skos__altLabel mesh__D013411 Sulphadiazine
% 207.76/207.95 |- skos__prefLabel mesh__D013411 Sulfadiazine
% 207.76/207.95 |- mesh__dateCreated mesh__D013411 1999-01-01
% 207.76/207.95 |- skos__altLabel mesh__D013411 Sulfazine
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D013411 sjn
% 207.76/207.95 |- skos__broader mesh__D013411smesh__D013424
% 207.76/207.95 |- mesh__recordOriginator mesh__D013411 NLM
% 207.76/207.95 |- skos__annotation mesh__D013411
% 207.76/207.95 note: METHYLSULFADIAZINE see SULFAMERAZINE
% 207.76/207.95 |- mesh__dateRevised mesh__D013411 2001-07-25
% 207.76/207.95 |- mesh__dateEstablished mesh__D004685 1991-01-01
% 207.76/207.95 |- skos__prefLabel mesh__D004685 Encephalomyelitis, Venezuelan Equine
% 207.76/207.95 |- skos__altLabel mesh__D004685 Venezuelan Equine Encephalomyelitides
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D004685
% 207.76/207.95 1991; was see under ENCEPHALOMYELITIS, EQUINE 1976-1990
% 207.76/207.95 |- skos__scopeNote mesh__D004685
% 207.76/207.95 A form of arboviral encephalitis endemic to Central America and the northern latitudes of South America. The causative organism %28%ENCEPHALITIS VIRUS, VENEZUELAN EQUINE%29% is transmitted to humans and horses via the bite of several mosquito species. Human viral infection may be asymptomatic or remain restricted to a mild influenza-like illness. Encephalitis, usually not severe, occurs in a small percentage of cases and may rarely feature SEIZURES and COMA. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp9-10%29%%A%
% 207.76/207.95 |- mesh__recordOriginator mesh__D004685 FPG
% 207.76/207.95 |- skos__historyNote mesh__D004685
% 207.76/207.95 Encephalomyelitis, Equine %28%1966-1975%29%
% 207.76/207.95 |- skos__hiddenLabel mesh__D004685 Venezuelan Equine Encephalomyelitis
% 207.76/207.95 |- skos__hiddenLabel mesh__D004685 Equine Encephalomyelitis, Venezuelan
% 207.76/207.95 |- mesh__recordMaintainer mesh__D004685 sjn
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D004685 2006
% 207.76/207.95 |- mesh__dateCreated mesh__D004685 1975-07-25
% 207.76/207.95 |- skos__annotation mesh__D004685
% 207.76/207.95 human %26% animal; if in horses, coord with HORSE DISEASES %28%IM%29% + HORSES %28%NIM%29% %26% use /vet; DF: ENCEPH VENEZ EQUINE%A%
% 207.76/207.95 |- mesh__historyNote mesh__D004685
% 207.76/207.95 1991%28%1976%29%; was see under ENCEPHALOMYELITIS, EQUINE 1976-1990%A%
% 207.76/207.95 |- skos__altLabel mesh__D004685 Equine Encephalitis, Venezuelan
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D004685 2005
% 207.76/207.95 |- skos__altLabel mesh__D004685 Venezuelan Equine Encephalitis
% 207.76/207.95 |- skos__altLabel mesh__D004685 Encephalomyelitides, Venezuelan Equine
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D004685 sjn
% 207.76/207.95 |- mesh__dateRevised mesh__D004685 2004-07-13
% 207.76/207.95 |- skos__broader mesh__D004685smesh__D004683
% 207.76/207.95 |- rdf__type mesh__D004685sskos__Concept
% 207.76/207.95 |- skos__altLabel mesh__D004685 Equine Encephalomyelitides, Venezuelan
% 207.76/207.95 |- skos__altLabel mesh__D004685 Encephalitis, Venezuelan Equine
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D037061 2006A
% 207.76/207.95 |- skos__historyNote mesh__D037061 Pain %28%1967-2002%29%
% 207.76/207.95 |- mesh__historyNote mesh__D037061 2003
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D037061 2006
% 207.76/207.95 |- skos__broader mesh__D037061smesh__D010146
% 207.76/207.95 |- mesh__dateRevised mesh__D037061 2005-07-20
% 207.76/207.95 |- skos__broader mesh__D037061smesh__D007592
% 207.76/207.95 |- skos__broader mesh__D037061smesh__D005534
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D037061 2005
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D037061 ags
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D037061 2004
% 207.76/207.95 |- skos__scopeNote mesh__D037061
% 207.76/207.95 Pain in the region of the METATARSUS. It can include pain in the METATARSAL BONES; METATARSOPHALANGEAL JOINT; and/or intermetatarsal joints %28%TARSAL JOINTS%29%.%A%
% 207.76/207.95 |- skos__historyNote mesh__D037061 Metatarsus %28%1965-2002%29%
% 207.76/207.95 |- skos__prefLabel mesh__D037061 Metatarsalgia
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D037061 2003
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D037061 2003
% 207.76/207.95 |- rdf__type mesh__D037061sskos__Concept
% 207.76/207.95 |- mesh__dateCreated mesh__D037061 2002-07-03
% 207.76/207.95 |- mesh__recordOriginator mesh__D037061 ags
% 207.76/207.95 |- mesh__recordMaintainer mesh__D037061 ags
% 207.76/207.95 |- mesh__dateEstablished mesh__D037061 2003-01-01
% 207.76/207.95 |- skos__annotation mesh__D037061 coord with pertinent metatarsal term
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D012319
% 207.76/207.95 84; was see under RNA POLYMERASES 1977-83
% 207.76/207.95 |- mesh__recordOriginator mesh__D012319 RLS
% 207.76/207.95 |- mesh__dateCreated mesh__D012319 1976-04-19
% 207.76/207.95 |- mesh__recordMaintainer mesh__D012319 ssb
% 207.76/207.95 |- skos__historyNote mesh__D012319
% 207.76/207.95 RNA Nucleotidyltransferases %28%1968-1972%29%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D012319 2006
% 207.76/207.95 |- rdf__type mesh__D012319sskos__Concept
% 207.76/207.95 |- skos__prefLabel mesh__D012319 RNA Polymerase II
% 207.76/207.95 |- skos__hiddenLabel mesh__D012319 Polymerase B, RNA
% 207.76/207.95 |- skos__scopeNote mesh__D012319
% 207.76/207.95 A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.%A%
% 207.76/207.95 |- skos__hiddenLabel mesh__D012319 B, RNA Polymerase
% 207.76/207.95 |- skos__hiddenLabel mesh__D012319 DNA Dependent RNA Polymerase II
% 207.76/207.95 |- skos__hiddenLabel mesh__D012319 Polymerase II, RNA
% 207.76/207.95 |- skos__hiddenLabel mesh__D012319 II, RNA Polymerase
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D012319 sjn
% 207.76/207.95 |- skos__broader mesh__D012319smesh__D012321
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D012319 2004
% 207.76/207.95 |- mesh__dateRevised mesh__D012319 2003-07-09
% 207.76/207.95 |- skos__altLabel mesh__D012319 RNA Polymerase B
% 207.76/207.95 |- skos__altLabel mesh__D012319 DNA-Dependent RNA Polymerase II
% 207.76/207.95 |- mesh__dateEstablished mesh__D012319 1984-01-01
% 207.76/207.95 |- skos__historyNote mesh__D012319 RNA Polymerases %28%1973-1976%29%
% 207.76/207.95 |- mesh__historyNote mesh__D012319
% 207.76/207.95 84%28%77%29%; was see under RNA POLYMERASES 1977-83
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D012319 2005
% 207.76/207.95 |- skos__hiddenLabel mesh__D009370 Neoplasm Histological Types
% 207.76/207.95 |- mesh__historyNote mesh__D009370 98; use explode
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D009370 2006
% 207.76/207.95 |- skos__altLabel mesh__D009370 Neoplasms by Histological Type
% 207.76/207.95 |- mesh__dateEstablished mesh__D009370 1998-01-01
% 207.76/207.95 |- skos__annotation mesh__D009370
% 207.76/207.95 to collect neopl by histol type; not used for indexing; policy: Manual section 24; also TN Suppl: Tumor Key for human %26% corresponding vet tumors %28%does not contain exper tumors%29%; TN 135: correct use of tissue type terms; restricted use: Manual 24.2.2.5; DF: NEOPL HISTOL TYPE CATALOG: do not use%A%
% 207.76/207.95 |- skos__scopeNote mesh__D009370
% 207.76/207.95 A collective term for the various histological types of NEOPLASMS. It is more likely to be used by searchers than by indexers and catalogers.%A%
% 207.76/207.95 |- skos__broader mesh__D009370smesh__D009369
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D009370 2005
% 207.76/207.95 |- skos__altLabel mesh__D009370 Histological Type of Neoplasm
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D009370 sjn
% 207.76/207.95 |- skos__hiddenLabel mesh__D009370 Neoplasm Histological Type
% 207.76/207.95 |- mesh__recordOriginator mesh__D009370 NLM
% 207.76/207.95 |- mesh__recordMaintainer mesh__D009370 sjn
% 207.76/207.95 |- rdf__type mesh__D009370sskos__Concept
% 207.76/207.95 |- skos__hiddenLabel mesh__D009370 Neoplasms Histological Type
% 207.76/207.95 |- mesh__dateCreated mesh__D009370 1999-01-01
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D009370 98
% 207.76/207.95 |- skos__altLabel mesh__D009370 Histological Types of Neoplasms
% 207.76/207.95 |- skos__prefLabel mesh__D009370 Neoplasms by Histologic Type
% 207.76/207.95 |- mesh__dateRevised mesh__D009370 2004-07-13
% 207.76/207.95 |- skos__hiddenLabel mesh__D009370 Neoplasms Histological Types
% 207.76/207.95 |- skos__altLabel mesh__D023041 Tumor Xenograft Assay
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D023041 2006
% 207.76/207.95 |- mesh__dateRevised mesh__D023041 2004-08-03
% 207.76/207.95 |- skos__altLabel mesh__D023041 Xenograft Antitumor Assays
% 207.76/207.95 |- skos__broader mesh__D023041smesh__D009368
% 207.76/207.95 |- rdf__type mesh__D023041sskos__Concept
% 207.76/207.95 |- skos__scopeNote mesh__D023041
% 207.76/207.95 In vivo methods of screening investigative anticancer drugs, biologic response modifiers or radiotherapies. Human tumor tissue or cells are transplanted into mice or rats followed by tumor treatment regimens. A variety of outcomes are monitored to assess antitumor effectiveness.%A%
% 207.76/207.95 |- skos__hiddenLabel mesh__D023041 Xenograft Antitumor Assay
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D023041 jls
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D023041 2005
% 207.76/207.95 |- skos__hiddenLabel mesh__D023041 Antitumor Assays, Xenograft
% 207.76/207.95 |- skos__hiddenLabel mesh__D023041 Assays, Xenograft Antitumor
% 207.76/207.95 |- mesh__recordOriginator mesh__D023041 nns
% 207.76/207.95 |- skos__altLabel mesh__D023041 Antitumor Assays, Xenograft Model
% 207.76/207.95 |- mesh__recordMaintainer mesh__D023041 jls
% 207.76/207.95 |- skos__hiddenLabel mesh__D023041 Assay, Xenograft Antitumor
% 207.76/207.95 |- skos__broader mesh__D023041smesh__D004354
% 207.76/207.95 |- skos__hiddenLabel mesh__D023041 Antitumor Assay, Xenograft
% 207.76/207.95 |- mesh__dateEstablished mesh__D023041 2001-01-01
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D023041 2005A
% 207.76/207.95 |- skos__prefLabel mesh__D023041 Xenograft Model Antitumor Assays
% 207.76/207.95 |- mesh__historyNote mesh__D023041
% 207.76/207.95 2001; for TUMOR XENOGRAFT ASSAY use SUBRENAL CAPSULE ASSAY %28%1988-2000%29%%A%
% 207.76/207.95 |- mesh__dateCreated mesh__D023041 2000-06-21
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D023041
% 207.76/207.95 2001; for TUMOR XENOGRAFT ASSAY see SUBRENAL CAPSULE ASSAY %28%1988-2000%29%%A%
% 207.76/207.95 |- skos__altLabel mesh__D017004 Co-Dependency %28%Psychology%29%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017004 2005
% 207.76/207.95 |- skos__altLabel mesh__D017004 Co Dependency %28%Psychology%29%
% 207.76/207.95 |- skos__altLabel mesh__D017004 Co-Dependence %28%Psychology%29%
% 207.76/207.95 |- skos__historyNote mesh__D017004
% 207.76/207.95 Dependency %28%Psychology%29% %28%1987-1991%29%
% 207.76/207.95 |- mesh__recordOriginator mesh__D017004 MXR
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017004 2006
% 207.76/207.95 |- skos__hiddenLabel mesh__D017004 Dependence, Co %28%Psychology%29%
% 207.76/207.95 |- skos__scopeNote mesh__D017004
% 207.76/207.95 A relational pattern in which a person attempts to derive a sense of purpose through relationships with others.%A%
% 207.76/207.95 |- skos__hiddenLabel mesh__D017004 Dependency, Co %28%Psychology%29%
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D017004
% 207.76/207.95 1998; see CO-DEPENDENCY %28%PSYCHOLOGY%29% 1992-1997
% 207.76/207.95 |- mesh__dateEstablished mesh__D017004 1992-01-01
% 207.76/207.95 |- skos__hiddenLabel mesh__D017004 Codependencies %28%Psychology%29%
% 207.76/207.95 |- skos__hiddenLabel mesh__D017004 Dependences, Co %28%Psychology%29%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017004 2003
% 207.76/207.95 |- skos__hiddenLabel mesh__D017004 Co-Dependencies %28%Psychology%29%
% 207.76/207.95 |- skos__hiddenLabel mesh__D017004 Co Dependencies %28%Psychology%29%
% 207.76/207.95 |- skos__altLabel mesh__D017004 Codependence
% 207.76/207.95 |- rdf__type mesh__D017004sskos__Concept
% 207.76/207.95 |- skos__prefLabel mesh__D017004 Codependency %28%Psychology%29%
% 207.76/207.95 |- skos__hiddenLabel mesh__D017004 Co Dependences %28%Psychology%29%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017004 2004
% 207.76/207.95 |- skos__altLabel mesh__D017004 Co Dependence %28%Psychology%29%
% 207.76/207.95 |- mesh__recordMaintainer mesh__D017004 ags
% 207.76/207.95 |- skos__hiddenLabel mesh__D017004 Dependencies, Co %28%Psychology%29%
% 207.76/207.95 |- skos__broader mesh__D017004smesh__D001519
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D017004 sjn
% 207.76/207.95 |- mesh__dateRevised mesh__D017004 2002-07-03
% 207.76/207.95 |- mesh__historyNote mesh__D017004 1998%28%1992%29%
% 207.76/207.95 |- mesh__dateCreated mesh__D017004 1991-05-30
% 207.76/207.95 |- skos__hiddenLabel mesh__D017004 Co-Dependences %28%Psychology%29%
% 207.76/207.95 |- skos__annotation mesh__D017004
% 207.76/207.95 %22%dependency%22% is not restricted to substance dependence: can apply to family or workplace; DF: CODEPENDENCY%A%
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D050438
% 207.76/207.95 2006; see GENES, IMMUNOGLOBULIN 1987-2005
% 207.76/207.95 |- mesh__historyNote mesh__D050438
% 207.76/207.95 2006; use GENES, IMMUNOGLOBULIN 1987-2005
% 207.76/207.95 |- skos__altLabel mesh__D050438 Immunoglobulin VH Germ Line Genes
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D050438 2006
% 207.76/207.95 |- rdf__type mesh__D050438sskos__Concept
% 207.76/207.95 |- skos__scopeNote mesh__D050438
% 207.76/207.95 Genes and gene segments encoding the IMMUNOGLOBULIN HEAVY CHAINS. Gene segments of the heavy chain genes are symbolized V %28%variable%29%, D %28%diversity%29%, J %28%joining%29%, and C %28%constant%29%.%A%
% 207.76/207.95 |- skos__altLabel mesh__D050438 Immunoglobulin Heavy Chain Genes
% 207.76/207.95 |- mesh__recordOriginator mesh__D050438 nns
% 207.76/207.95 |- skos__prefLabel mesh__D050438 Genes, Immunoglobulin Heavy Chain
% 207.76/207.95 |- skos__related mesh__D050438smesh__D007129
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D050438 sjn
% 207.76/207.95 |- skos__broader mesh__D050438smesh__D005803
% 207.76/207.95 |- mesh__recordMaintainer mesh__D050438 nns
% 207.76/207.95 |- mesh__dateCreated mesh__D050438 2005-06-30
% 207.76/207.95 |- skos__related mesh__D050438smesh__D007143
% 207.76/207.95 |- mesh__dateEstablished mesh__D050438 2006-01-01
% 207.76/207.95 |- mesh__dateCreated mesh__D008278 1999-01-01
% 207.76/207.95 |- mesh__recordOriginator mesh__D008278 NLM
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D008278 2006
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D008278 2005
% 207.76/207.95 |- skos__prefLabel mesh__D008278 Magnesium Sulfate
% 207.76/207.95 |- rdf__type mesh__D008278sskos__Concept
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D008278 2002
% 207.76/207.95 |- skos__scopeNote mesh__D008278
% 207.76/207.95 A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. %28%From AMA Drug Evaluations Annual, 1992, p1083%29%%A%
% 207.76/207.95 |- skos__broader mesh__D008278smesh__D013431
% 207.76/207.95 |- mesh__recordMaintainer mesh__D008278 CCR
% 207.76/207.95 |- skos__broader mesh__D008278smesh__D017616
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D008278 2004
% 207.76/207.95 |- skos__hiddenLabel mesh__D008278 Heptahydrate Magnesium Sulfate
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D008278 sjn
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D008278 2003
% 207.76/207.95 |- skos__hiddenLabel mesh__D008278 Sulfate, Magnesium
% 207.76/207.95 |- mesh__dateRevised mesh__D008278 2001-07-25
% 207.76/207.95 |- mesh__dateCreated mesh__D000295 1979-05-29
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D000295 2006
% 207.76/207.95 |- mesh__dateRevised mesh__D000295 2002-07-03
% 207.76/207.95 |- mesh__historyNote mesh__D000295 80
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D000295 2003
% 207.76/207.95 |- skos__scopeNote mesh__D000295
% 207.76/207.95 A branch of medicine pertaining to the diagnosis and treatment of diseases occurring during the period beginning with puberty until the cessation of somatic growth.%A%
% 207.76/207.95 |- mesh__recordOriginator mesh__D000295 EC
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D000295 2005
% 207.76/207.95 |- skos__broader mesh__D000295smesh__D008511
% 207.76/207.95 |- skos__annotation mesh__D000295
% 207.76/207.95 SPEC; SPEC qualif; when permitted for %22%adolescent dis%22%: Manual 28.10.1; relation to ADOLESCENCE: Manual 28.10.1; DF: ADOLESCENT MED%A%
% 207.76/207.95 |- skos__prefLabel mesh__D000295 Adolescent Medicine
% 207.76/207.95 |- skos__altLabel mesh__D000295 Medicine, Adolescent
% 207.76/207.95 |- rdf__type mesh__D000295sskos__Concept
% 207.76/207.95 |- skos__historyNote mesh__D000295 Adolescence %28%1966-1979%29%
% 207.76/207.95 |- mesh__recordMaintainer mesh__D000295 sjn
% 207.76/207.95 |- mesh__dateEstablished mesh__D000295 1980-01-01
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D000295 sjn
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D000295 80
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D000295 2004
% 207.76/207.95 |- skos__annotation mesh__D041901
% 207.76/207.95 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.76/207.95 |- skos__prefLabel mesh__D041901 Stemonaceae
% 207.76/207.95 |- mesh__historyNote mesh__D041901 2004
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D041901 2006
% 207.76/207.95 |- rdf__type mesh__D041901sskos__Concept
% 207.76/207.95 |- mesh__dateCreated mesh__D041901 2003-07-09
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D041901 2004
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D041901 2004
% 207.76/207.95 |- skos__broader mesh__D041901smesh__D019684
% 207.76/207.95 |- skos__scopeNote mesh__D041901
% 207.76/207.95 A small plant family of the order Liliales, subclass Liliidae, class Liliopsida %28%monocotyledons%29%.%A%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D041901 2005
% 207.76/207.95 |- mesh__dateEstablished mesh__D041901 2004-01-01
% 207.76/207.95 |- skos__prefLabel mesh__D041103 Neorickettsia risticii
% 207.76/207.95 |- mesh__recordOriginator mesh__D041103 ags
% 207.76/207.95 |- mesh__dateCreated mesh__D041103 2002-07-03
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D041103 sjn
% 207.76/207.95 |- skos__broader mesh__D041103smesh__D041102
% 207.76/207.95 |- mesh__historyNote mesh__D041103 2003
% 207.76/207.95 |- mesh__dateEstablished mesh__D041103 2003-01-01
% 207.76/207.95 |- skos__historyNote mesh__D041103 Ehrlichia %28%1986-2002%29%
% 207.76/207.95 |- rdf__type mesh__D041103sskos__Concept
% 207.76/207.95 |- mesh__recordMaintainer mesh__D041103 SYSTEM
% 207.76/207.95 |- skos__scopeNote mesh__D041103
% 207.76/207.95 A species of gram-negative bacteria in the genus NEORICKETTSIA, family ANAPLASMATACEAE.%A%
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D041103 2003
% 207.76/207.95 |- skos__altLabel mesh__D041103 Ehrlichia risticii
% 207.76/207.95 |- mesh__dateRevised mesh__D041103 2005-06-30
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D041103 2006
% 207.76/207.95 |- skos__annotation mesh__D041103
% 207.76/207.95 infection: coord IM with ANAPLASMATACEAE INFECTIONS %28%IM%29%
% 207.76/207.95 |- rdf__type mesh__D013412sskos__Concept
% 207.76/207.95 |- mesh__recordOriginator mesh__D013412 NLM
% 207.76/207.95 |- skos__broader mesh__D013412smesh__D013424
% 207.76/207.95 |- mesh__dateRevised mesh__D013412 2000-06-22
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013412 2005
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013412 2006
% 207.76/207.95 |- mesh__recordMaintainer mesh__D013412 CCR
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013412 2001
% 207.76/207.95 |- mesh__dateCreated mesh__D013412 1999-01-01
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013412 2002
% 207.76/207.95 |- skos__altLabel mesh__D013412 Sulphadimethoxine
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013412 2003
% 207.76/207.95 |- skos__prefLabel mesh__D013412 Sulfadimethoxine
% 207.76/207.95 |- skos__scopeNote mesh__D013412
% 207.76/207.95 A sulfanilamide that is used as an anti-infective agent.%A%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D013412 2004
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D013412 sjn
% 207.76/207.95 |- skos__broader mesh__D019926Q000031smesh__D019926
% 207.76/207.95 |- mesh__preferredCombination mesh__D019926Q000031smesh__D016213
% 207.76/207.95 |- rdf__type mesh__D019926Q000031smesh__CompoundConcept
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D004686 2004
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D004686 2006
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D004686 sjn
% 207.76/207.95 |- skos__prefLabel mesh__D004686 Encephalomyocarditis virus
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D004686
% 207.76/207.95 94; was ENCEPHALOMYOCARDITIS VIRUSES 1965-93
% 207.76/207.95 |- skos__scopeNote mesh__D004686
% 207.76/207.95 The type species of CARDIOVIRUS causing encephalomyelitis and myocarditis in rodents, pigs, and monkeys. Infection in man has been reported with CNS involvement but without myocarditis.%A%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D004686 2003
% 207.76/207.95 |- mesh__recordMaintainer mesh__D004686 ags
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D004686 2005
% 207.76/207.95 |- skos__altLabel mesh__D004686 EMCV
% 207.76/207.95 |- rdf__type mesh__D004686sskos__Concept
% 207.76/207.95 |- skos__broader mesh__D004686smesh__D017943
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D004686 2002
% 207.76/207.95 |- mesh__recordOriginator mesh__D004686 NLM
% 207.76/207.95 |- skos__annotation mesh__D004686
% 207.76/207.95 infection: coord IM with CARDIOVIRUS INFECTIONS %28%IM%29%; DF: EMCV%A%
% 207.76/207.95 |- mesh__historyNote mesh__D004686
% 207.76/207.95 94; was ENCEPHALOMYOCARDITIS VIRUSES 1965-93
% 207.76/207.95 |- mesh__dateRevised mesh__D004686 2001-07-25
% 207.76/207.95 |- mesh__dateCreated mesh__D004686 1999-01-01
% 207.76/207.95 |- mesh__dateEstablished mesh__D004686 1965-01-01
% 207.76/207.95 |- mesh__onlineNote mesh__D004686
% 207.76/207.95 use ENCEPHALOMYOCARDITIS VIRUS to search ENCEPHALOMYOCARDITIS VIRUSES 1966-93%A%
% 207.76/207.95 |- mesh__recordOriginator mesh__D009371 NLM
% 207.76/207.95 |- skos__scopeNote mesh__D009371
% 207.76/207.95 A collective term for precoordinated organ/neoplasm headings locating neoplasms by organ, as BRAIN NEOPLASMS; DUODENAL NEOPLASMS; LIVER NEOPLASMS; etc.%A%
% 207.76/207.95 |- skos__annotation mesh__D009371
% 207.76/207.95 to collect neopl located by organ; not used for indexing; policy: Manual section 24; DF: NEOPL SITE CATALOG: do not use%A%
% 207.76/207.95 |- skos__altLabel mesh__D009371 Site, Neoplasm
% 207.76/207.95 |- skos__broader mesh__D009371smesh__D009369
% 207.76/207.95 |- skos__altLabel mesh__D009371 Neoplasms by Sites
% 207.76/207.95 |- skos__altLabel mesh__D009371 Sites, Neoplasm
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D009371 98
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D009371 2002
% 207.76/207.95 |- skos__hiddenLabel mesh__D009371 Neoplasm Sites
% 207.76/207.95 |- mesh__recordMaintainer mesh__D009371 mdb
% 207.76/207.95 |- rdf__type mesh__D009371sskos__Concept
% 207.76/207.95 |- mesh__dateEstablished mesh__D009371 1998-01-01
% 207.76/207.95 |- mesh__dateCreated mesh__D009371 1999-01-01
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D009371 2004
% 207.76/207.95 |- mesh__historyNote mesh__D009371 98; use explode
% 207.76/207.95 |- skos__prefLabel mesh__D009371 Neoplasms by Site
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D009371 2003
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D009371 2006
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D009371 sjn
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D009371 2005
% 207.76/207.95 |- skos__hiddenLabel mesh__D009371 Neoplasm Site
% 207.76/207.95 |- mesh__dateRevised mesh__D009371 2001-07-25
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D017005 92
% 207.76/207.95 |- skos__scopeNote mesh__D017005
% 207.76/207.95 Techniques used for removal of bonded orthodontic appliances, restorations, or fixed dentures from teeth.%A%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 1994
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 1993
% 207.76/207.95 |- mesh__recordMaintainer mesh__D017005 TAP
% 207.76/207.95 |- skos__historyNote mesh__D017005 Dental Bonding %28%1977-1991%29%
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 2002
% 207.76/207.95 |- skos__prefLabel mesh__D017005 Dental Debonding
% 207.76/207.95 |- skos__annotation mesh__D017005 DF: DENT DEBONDING
% 207.76/207.95 |- mesh__recordOriginator mesh__D017005 MXR
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 1999
% 207.76/207.95 |- mesh__dateCreated mesh__D017005 1991-05-30
% 207.76/207.95 |- mesh__dateEstablished mesh__D017005 1992-01-01
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 1998
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 1997
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 2006
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 2001
% 207.76/207.95 |- skos__altLabel mesh__D017005 Debonding, Dental
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 1996
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 2005
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 2004
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D017005 PLS
% 207.76/207.95 |- mesh__historyNote mesh__D017005 92
% 207.76/207.95 |- rdf__type mesh__D017005sskos__Concept
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 2000
% 207.76/207.95 |- mesh__dateRevised mesh__D017005 1992-05-14
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 2003
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D017005 1995
% 207.76/207.95 |- skos__broader mesh__D017005smesh__D003813
% 207.76/207.95 |- rdf__type mesh__D050439sskos__Concept
% 207.76/207.95 |- skos__altLabel mesh__D050439 Immunoglobulin Light Chain Genes
% 207.76/207.95 |- mesh__publicMeSHNote mesh__D050439
% 207.76/207.95 2006; see GENES, IMMUNOGLOBULIN 1988-2005
% 207.76/207.95 |- mesh__recordOriginator mesh__D050439 nns
% 207.76/207.95 |- mesh__dateEstablished mesh__D050439 2006-01-01
% 207.76/207.95 |- skos__related mesh__D050439smesh__D007131
% 207.76/207.95 |- mesh__historyNote mesh__D050439
% 207.76/207.95 2006; use GENES, IMMUNOGLOBULIN 1988-2005
% 207.76/207.95 |- skos__scopeNote mesh__D050439
% 207.76/207.95 Genes and gene segments encoding the IMMUNOGLOBULIN LIGHT CHAINS. Gene segments of the light chain genes are designated as V %28%variable%29%, J %28%joining%29%, and C %28%constant%29%.%A%
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D050439 sjn
% 207.76/207.95 |- skos__related mesh__D050439smesh__D007147
% 207.76/207.95 |- skos__prefLabel mesh__D050439 Genes, Immunoglobulin Light Chain
% 207.76/207.95 |- skos__broader mesh__D050439smesh__D005803
% 207.76/207.95 |- mesh__recordMaintainer mesh__D050439 nns
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D050439 2006
% 207.76/207.95 |- mesh__dateCreated mesh__D050439 2005-06-30
% 207.76/207.95 |- mesh__recordAuthorizer mesh__D047490 ags
% 207.76/207.95 |- mesh__historyNote mesh__D047490 2005
% 207.76/207.95 |- mesh__dateCreated mesh__D047490 2004-07-07
% 207.76/207.95 |- skos__scopeNote mesh__D047490
% 207.76/207.95 A nuclear transcription factor. Heterodimerization with PPAR-GAMMA is important in regulation of GLUCOSE metabolism and CELL GROWTH PROCESSES.%A%
% 207.76/207.95 |- skos__prefLabel mesh__D047490 Retinoid X Receptor alpha
% 207.76/207.95 |- skos__broader mesh__D047490smesh__D047488
% 207.76/207.95 |- rdf__type mesh__D047490sskos__Concept
% 207.76/207.95 |- mesh__activeMeSHYear mesh__D047490 2006A
% 207.76/207.95 |- skos__hiddenLabel mesh__D047490 Receptor, RXR alpha
% 207.76/207.95 |- mesh__recordMaintainer mesh__D047490 ags
% 207.76/207.95 |- skos__altLabel mesh__D047490 RXR alpha Receptor
% 207.76/207.95 |- skos__historyNote mesh__D047490
% 207.76/207.95 Receptors, Retinoic Acid %28%1993-2004%29%
% 207.76/207.96 |- mesh__dateRevised mesh__D047490 2005-07-12
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D047490 2005
% 207.76/207.96 |- mesh__recordOriginator mesh__D047490 ssb
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D047490 2005
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D047490 2006
% 207.76/207.96 |- mesh__dateEstablished mesh__D047490 2005-01-01
% 207.76/207.96 |- skos__broader mesh__D008279smesh__D003952
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Imagings, Chemical Shift
% 207.76/207.96 |- mesh__dateRevised mesh__D008279 2000-06-22
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D008279
% 207.76/207.96 1988; NMR TOMOGRAPHY %26% TOMOGRAPHY, NMR %26% TOMOGRAPHY, PROTON SPIN were see NUCLEAR MAGNETIC RESONANCE 1985-1987; for CHEMICAL SHIFT IMAGING see NUCLEAR MAGNETIC RESONANCE 1995-2000%A%
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D008279 sjn
% 207.76/207.96 |- skos__altLabel mesh__D008279 MR Tomography
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D008279 2005
% 207.76/207.96 |- skos__altLabel mesh__D008279 MRI, Functional
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D008279 2001
% 207.76/207.96 |- skos__prefLabel mesh__D008279 Magnetic Resonance Imaging
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 MRI Scan
% 207.76/207.96 |- skos__related mesh__D008279smesh__D019412
% 207.76/207.96 |- mesh__dateEstablished mesh__D008279 1988-01-01
% 207.76/207.96 |- skos__altLabel mesh__D008279 Tomography, MR
% 207.76/207.96 |- skos__altLabel mesh__D008279 Magnetic Resonance Imaging, Functional
% 207.76/207.96 |- skos__altLabel mesh__D008279 Proton Spin Tomography
% 207.76/207.96 |- skos__altLabel mesh__D008279 NMR Tomography
% 207.76/207.96 |- mesh__historyNote mesh__D008279
% 207.76/207.96 1988; for NMR TOMOGRAPHY %26% TOMOGRAPHY, NMR %26% TOMOGRAPHY, PROTON SPIN use MAGNETIC RESONANCE SPECTROSCOPY 1985-1987; for CHEMICAL SHIFT IMAGING use MAGNETIC RESONANCE SPECTROSCOPY 1995-2000%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D008279 2006
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Imaging, Magnetic Resonance
% 207.76/207.96 |- skos__altLabel mesh__D008279 Chemical Shift Imaging
% 207.76/207.96 |- skos__broader mesh__D008279smesh__D014054
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Functional MRI
% 207.76/207.96 |- skos__altLabel mesh__D008279 Zeugmatography
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Shift Imagings, Chemical
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Scan, MRI
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D008279 2002
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D008279 2003
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Chemical Shift Imagings
% 207.76/207.96 |- skos__historyNote mesh__D008279
% 207.76/207.96 Nuclear Magnetic Resonance %28%1966-1987%29%
% 207.76/207.96 |- rdf__type mesh__D008279sskos__Concept
% 207.76/207.96 |- mesh__dateCreated mesh__D008279 1987-05-08
% 207.76/207.96 |- skos__related mesh__D008279smesh__D009682
% 207.76/207.96 |- skos__altLabel mesh__D008279 NMR Imaging
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D008279 2004
% 207.76/207.96 |- skos__scopeNote mesh__D008279
% 207.76/207.96 Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.%A%
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 MRIs, Functional
% 207.76/207.96 |- skos__annotation mesh__D008279
% 207.76/207.96 GEN or unspecified; prefer specifics; do not confuse with MAGNETIC RESONANCE SPECTROSCOPY: check text; coord with disease, organ or tissue using pertinent qualifs; DF: MRI%A%
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Shift Imaging, Chemical
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Functional MRIs
% 207.76/207.96 |- mesh__recordMaintainer mesh__D008279 nns
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Scans, MRI
% 207.76/207.96 |- mesh__recordOriginator mesh__D008279 SCD
% 207.76/207.96 |- skos__hiddenLabel mesh__D008279 Imaging, NMR
% 207.76/207.96 |- skos__historyNote mesh__D000296 Child Psychiatry %28%1966%29%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000296 2006
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D000296 sjn
% 207.76/207.96 |- skos__hiddenLabel mesh__D000296 Psychiatry, Adolescent
% 207.76/207.96 |- mesh__dateCreated mesh__D000296 1999-01-01
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D000296 67
% 207.76/207.96 |- skos__annotation mesh__D000296
% 207.76/207.96 SPEC: SPEC qualif; not for mental disorders in adolescents %28% = MENTAL DISORDERS %28%IM%29% + ADOLESCENT %28%NIM%29% %29%: Manual 27.9%A%
% 207.76/207.96 |- rdf__type mesh__D000296sskos__Concept
% 207.76/207.96 |- mesh__dateRevised mesh__D000296 2002-07-03
% 207.76/207.96 |- skos__historyNote mesh__D000296 Psychiatry %28%1966%29%
% 207.76/207.96 |- skos__broader mesh__D000296smesh__D011570
% 207.76/207.96 |- mesh__dateEstablished mesh__D000296 1967-01-01
% 207.76/207.96 |- skos__historyNote mesh__D000296 Psychoanalysis %28%1966%29%
% 207.76/207.96 |- mesh__historyNote mesh__D000296 67
% 207.76/207.96 |- mesh__recordOriginator mesh__D000296 NLM
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000296 2003
% 207.76/207.96 |- skos__prefLabel mesh__D000296 Adolescent Psychiatry
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000296 2005
% 207.76/207.96 |- skos__scopeNote mesh__D000296
% 207.76/207.96 The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in individuals 13-18 years.%A%
% 207.76/207.96 |- mesh__recordMaintainer mesh__D000296 sjn
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000296 2004
% 207.76/207.96 |- mesh__dateCreated mesh__D041902 2003-07-09
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D041902 2004
% 207.76/207.96 |- mesh__dateEstablished mesh__D041902 2004-01-01
% 207.76/207.96 |- mesh__dateRevised mesh__D041902 2005-06-30
% 207.76/207.96 |- skos__broader mesh__D041902smesh__D020561
% 207.76/207.96 |- mesh__recordOriginator mesh__D041902 ags
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D041902 sjn
% 207.76/207.96 |- mesh__recordMaintainer mesh__D041902 SYSTEM
% 207.76/207.96 |- mesh__historyNote mesh__D041902 2004
% 207.76/207.96 |- skos__scopeNote mesh__D041902
% 207.76/207.96 A family in the order Rhodobacterales, class ALPHAPROTEOBACTERIA.%A%
% 207.76/207.96 |- skos__prefLabel mesh__D041902 Rhodobacteraceae
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D041902 2006
% 207.76/207.96 |- rdf__type mesh__D041902sskos__Concept
% 207.76/207.96 |- skos__broader mesh__D013413smesh__D013424
% 207.76/207.96 |- mesh__dateRevised mesh__D013413 2000-06-22
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013413 2004
% 207.76/207.96 |- skos__altLabel mesh__D013413 Sulformetoxine
% 207.76/207.96 |- skos__historyNote mesh__D013413 Sulfonamides %28%1971-1974%29%
% 207.76/207.96 |- mesh__historyNote mesh__D013413
% 207.76/207.96 91%28%75%29%; was see under SULFANILAMIDES 1975-90
% 207.76/207.96 |- skos__prefLabel mesh__D013413 Sulfadoxine
% 207.76/207.96 |- mesh__recordMaintainer mesh__D013413 CCR
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D013413
% 207.76/207.96 91; was see under SULFANILAMIDES 1975-90
% 207.76/207.96 |- skos__historyNote mesh__D013413 Pyrimidines %28%1971-1974%29%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013413 2005
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013413 2001
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013413 2006
% 207.76/207.96 |- skos__altLabel mesh__D013413 Sulforthomidine
% 207.76/207.96 |- skos__hiddenLabel mesh__D013413 Ro 4 4393
% 207.76/207.96 |- skos__scopeNote mesh__D013413
% 207.76/207.96 A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013413 2002
% 207.76/207.96 |- skos__altLabel mesh__D013413 Sulphormetoxin
% 207.76/207.96 |- skos__altLabel mesh__D013413 Sulphorthodimethoxine
% 207.76/207.96 |- skos__altLabel mesh__D013413 Sulformethoxine
% 207.76/207.96 |- skos__hiddenLabel mesh__D013413 Ro 44393
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013413 2003
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D013413 sjn
% 207.76/207.96 |- mesh__recordOriginator mesh__D013413 NLM
% 207.76/207.96 |- rdf__type mesh__D013413sskos__Concept
% 207.76/207.96 |- mesh__dateCreated mesh__D013413 1974-11-19
% 207.76/207.96 |- mesh__dateEstablished mesh__D013413 1991-01-01
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Multiple Enchondroses
% 207.76/207.96 |- skos__altLabel mesh__D004687 Ollier%27%s Disease
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Multiple Enchondroma
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 2006
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 2002
% 207.76/207.96 |- rdf__type mesh__D004687sskos__Concept
% 207.76/207.96 |- mesh__recordOriginator mesh__D004687 RC
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 2003
% 207.76/207.96 |- mesh__dateEstablished mesh__D004687 1991-01-01
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D004687 PLS
% 207.76/207.96 |- mesh__dateCreated mesh__D004687 1984-04-06
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 1998
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Multiple Enchondrosis
% 207.76/207.96 |- mesh__onlineNote mesh__D004687
% 207.76/207.96 to search OLLIER%27%S DISEASE use OSTEOCHONDRODYSPLASIAS 1966-84%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 2004
% 207.76/207.96 |- skos__annotation mesh__D004687
% 207.76/207.96 non-neoplastic; do not confuse X ref OLLIER%27%S DISEASE with Ollier%27%s disease as Ollier-Klippel-Trenaunay disease %28% = KLIPPEL-TRENAUNAY DISEASE%29%%A%
% 207.76/207.96 |- skos__scopeNote mesh__D004687
% 207.76/207.96 Benign growths of cartilage in the metaphyses of several bones.%A%
% 207.76/207.96 |- skos__broader mesh__D004687smesh__D010009
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Disease, Ollier%27%s
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Enchondromatoses
% 207.76/207.96 |- mesh__dateRevised mesh__D004687 1995-05-18
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 1999
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 1996
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Disease, Ollier
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Enchondromas, Multiple
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Multiple Enchondromas
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D004687
% 207.76/207.96 91; was see under OSTEOCHONDRODYSPLASIAS 1985-90; OLLIER%27%S DISEASE was see DYSCHONDROPLASIA 1963-84%A%
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Syndrome, Maffucci
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Olliers Disease
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 2000
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 1997
% 207.76/207.96 |- skos__altLabel mesh__D004687 Enchondrosis, Multiple
% 207.76/207.96 |- mesh__recordMaintainer mesh__D004687 TAP
% 207.76/207.96 |- skos__altLabel mesh__D004687 Enchondroma, Multiple
% 207.76/207.96 |- skos__prefLabel mesh__D004687 Enchondromatosis
% 207.76/207.96 |- skos__hiddenLabel mesh__D004687 Enchondroses, Multiple
% 207.76/207.96 |- skos__altLabel mesh__D004687 Ollier Disease
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 2005
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004687 2001
% 207.76/207.96 |- mesh__historyNote mesh__D004687
% 207.76/207.96 91%28%85%29%; was see under OSTEOCHONDRODYSPLASIAS 1985-90; OLLIER%27%S DISEASE was see DYSCHONDROPLASIA 1963-84%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 1998
% 207.76/207.96 |- skos__scopeNote mesh__D009372
% 207.76/207.96 Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue.%A%
% 207.76/207.96 |- skos__related mesh__D009372smesh__D012983
% 207.76/207.96 |- skos__hiddenLabel mesh__D009372 Connective Tissue Neoplasm
% 207.76/207.96 |- rdf__type mesh__D009372sskos__Concept
% 207.76/207.96 |- mesh__recordOriginator mesh__D009372 NLM
% 207.76/207.96 |- skos__hiddenLabel mesh__D009372 Neoplasm, Connective Tissue
% 207.76/207.96 |- mesh__dateCreated mesh__D009372 1999-01-01
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 2004
% 207.76/207.96 |- skos__prefLabel mesh__D009372 Neoplasms, Connective Tissue
% 207.76/207.96 |- skos__broader mesh__D009372smesh__D003240
% 207.76/207.96 |- mesh__dateRevised mesh__D009372 1995-06-08
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 2002
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 2003
% 207.76/207.96 |- skos__annotation mesh__D009372
% 207.76/207.96 neoplasms composed of connective tissue, NOT neoplasms located in connective tissue: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; DF: NEOPL CONNECTIVE TISSUE%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 2006
% 207.76/207.96 |- skos__altLabel mesh__D009372 Connective Tissue Neoplasms
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 1997
% 207.76/207.96 |- skos__broader mesh__D009372smesh__D018204
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 2001
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 2005
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D009372 PLS
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 1996
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 2000
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009372 1999
% 207.76/207.96 |- mesh__recordMaintainer mesh__D009372 KEV
% 207.76/207.96 |- skos__scopeNote mesh__D017006
% 207.76/207.96 The musculotendinous sheath formed by the supraspinatus, infraspinatus, subscapularis, and teres minor muscles. These help stabilize the head of the HUMERUS in the glenoid fossa and allow for rotation of the SHOULDER JOINT about its longitudinal axis.%A%
% 207.76/207.96 |- skos__related mesh__D017006smesh__D019534
% 207.76/207.96 |- skos__broader mesh__D017006smesh__D013711
% 207.76/207.96 |- skos__historyNote mesh__D017006 Shoulder Joint %28%1966-1991%29%
% 207.76/207.96 |- mesh__recordOriginator mesh__D017006 MXR
% 207.76/207.96 |- mesh__dateCreated mesh__D017006 1991-05-30
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017006 2006
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D017006 92
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017006 2002
% 207.76/207.96 |- skos__broader mesh__D017006smesh__D018482
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D017006 sjn
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017006 2004
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017006 2005
% 207.76/207.96 |- skos__prefLabel mesh__D017006 Rotator Cuff
% 207.76/207.96 |- skos__historyNote mesh__D017006
% 207.76/207.96 Tendons, Para-Articular %28%1972-1991%29%
% 207.76/207.96 |- mesh__recordMaintainer mesh__D017006 nns
% 207.76/207.96 |- mesh__dateRevised mesh__D017006 2001-07-25
% 207.76/207.96 |- mesh__historyNote mesh__D017006 92
% 207.76/207.96 |- rdf__type mesh__D017006sskos__Concept
% 207.76/207.96 |- mesh__dateEstablished mesh__D017006 1992-01-01
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017006 2003
% 207.76/207.96 |- skos__altLabel mesh__D017006 Cuff, Rotator
% 207.76/207.96 |- skos__broader mesh__D047491smesh__D047488
% 207.76/207.96 |- rdf__type mesh__D047491sskos__Concept
% 207.76/207.96 |- mesh__dateEstablished mesh__D047491 2005-01-01
% 207.76/207.96 |- mesh__historyNote mesh__D047491 2005
% 207.76/207.96 |- skos__altLabel mesh__D047491 RXR gamma Receptor
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D047491 2005
% 207.76/207.96 |- skos__hiddenLabel mesh__D047491 Receptor, RXR gamma
% 207.76/207.96 |- mesh__recordOriginator mesh__D047491 ssb
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D047491 2005
% 207.76/207.96 |- skos__prefLabel mesh__D047491 Retinoid X Receptor gamma
% 207.76/207.96 |- skos__scopeNote mesh__D047491
% 207.76/207.96 A nuclear transcription factor. Heterodimerization with PPAR ALPHA is important to metabolism of LIPIDS.%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D047491 2006
% 207.76/207.96 |- mesh__recordMaintainer mesh__D047491 ssb
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D047491 sjn
% 207.76/207.96 |- mesh__dateCreated mesh__D047491 2004-07-07
% 207.76/207.96 |- skos__historyNote mesh__D047491
% 207.76/207.96 Receptors, Retinoic Acid %28%1993-2004%29%
% 207.76/207.96 |- mesh__dateRevised mesh__D000297 1996-06-10
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D000297 PLS
% 207.76/207.96 |- mesh__dateCreated mesh__D000297 1999-01-01
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 2002
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D000297 67
% 207.76/207.96 |- skos__broader mesh__D000297smesh__D011584
% 207.76/207.96 |- rdf__type mesh__D000297sskos__Concept
% 207.76/207.96 |- mesh__recordMaintainer mesh__D000297 TAP
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 1998
% 207.76/207.96 |- skos__annotation mesh__D000297
% 207.76/207.96 SPEC but also the way a normal adolescent thinks %26% acts; when SPEC, SPEC qualif; Manual 27.11; DF: ADOLESCENT PSYCHOL%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 2003
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 1997
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 2000
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 2005
% 207.76/207.96 |- skos__altLabel mesh__D000297 Psychology, Adolescent
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 1999
% 207.76/207.96 |- skos__scopeNote mesh__D000297
% 207.76/207.96 Field of psychology concerned with the normal and abnormal behavior of adolescents. It includes mental processes as well as observable responses.%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 2004
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 2001
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D000297 2006
% 207.76/207.96 |- mesh__historyNote mesh__D000297 67
% 207.76/207.96 |- skos__prefLabel mesh__D000297 Adolescent Psychology
% 207.76/207.96 |- mesh__recordOriginator mesh__D000297 NLM
% 207.76/207.96 |- mesh__recordMaintainer mesh__D041903 SYSTEM
% 207.76/207.96 |- mesh__dateEstablished mesh__D041903 2004-01-01
% 207.76/207.96 |- mesh__dateRevised mesh__D041903 2005-06-30
% 207.76/207.96 |- skos__historyNote mesh__D041903 Rhodobacter %28%1996-2003%29%
% 207.76/207.96 |- skos__scopeNote mesh__D041903
% 207.76/207.96 A genus of facultatively or obligately anaerobic marine phototrophic bacteria, in the family RHODOBACTERACEAE.%A%
% 207.76/207.96 |- mesh__recordOriginator mesh__D041903 ags
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D041903 sjn
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D041903 2006
% 207.76/207.96 |- rdf__type mesh__D041903sskos__Concept
% 207.76/207.96 |- skos__broader mesh__D041903smesh__D041902
% 207.76/207.96 |- mesh__historyNote mesh__D041903 2004
% 207.76/207.96 |- skos__broader mesh__D041903smesh__D006090
% 207.76/207.96 |- skos__prefLabel mesh__D041903 Rhodovulum
% 207.76/207.96 |- mesh__dateCreated mesh__D041903 2003-07-09
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D041903 2004
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D005780 2001
% 207.76/207.96 |- mesh__dateRevised mesh__D005780 2000-06-22
% 207.76/207.96 |- skos__prefLabel mesh__D005780 Gelatin
% 207.76/207.96 |- skos__scopeNote mesh__D005780
% 207.76/207.96 A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories.%A%
% 207.76/207.96 |- mesh__dateCreated mesh__D005780 1999-01-01
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D005780 sjn
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D005780 2006
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D005780 2004
% 207.76/207.96 |- mesh__recordOriginator mesh__D005780 NLM
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D005780 2005
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D005780 2002
% 207.76/207.96 |- mesh__recordMaintainer mesh__D005780 adp
% 207.76/207.96 |- rdf__type mesh__D005780sskos__Concept
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D005780 2003
% 207.76/207.96 |- skos__broader mesh__D005780smesh__D012596
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013414 2004
% 207.76/207.96 |- mesh__historyNote mesh__D013414
% 207.76/207.96 91%28%63%29%; was see under GUANIDINES 1963-90
% 207.76/207.96 |- skos__prefLabel mesh__D013414 Sulfaguanidine
% 207.76/207.96 |- rdf__type mesh__D013414sskos__Concept
% 207.76/207.96 |- skos__broader mesh__D013414smesh__D013424
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013414 2003
% 207.76/207.96 |- mesh__dateRevised mesh__D013414 2000-06-22
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D013414 sjn
% 207.76/207.96 |- mesh__dateCreated mesh__D013414 1999-01-01
% 207.76/207.96 |- mesh__recordOriginator mesh__D013414 NLM
% 207.76/207.96 |- mesh__recordMaintainer mesh__D013414 CCR
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D013414
% 207.76/207.96 91; was see under GUANIDINES 1963-90
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013414 2002
% 207.76/207.96 |- skos__scopeNote mesh__D013414
% 207.76/207.96 A sulfanilamide antimicrobial agent that is used to treat enteric infections.%A%
% 207.76/207.96 |- mesh__dateEstablished mesh__D013414 1991-01-01
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013414 2001
% 207.76/207.96 |- skos__broader mesh__D013414smesh__D006146
% 207.76/207.96 |- skos__altLabel mesh__D013414 Sulphaguanidine
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013414 2006
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D013414 2005
% 207.76/207.96 |- mesh__historyNote mesh__D004688 69%28%63%29%
% 207.76/207.96 |- mesh__dateEstablished mesh__D004688 1969-01-01
% 207.76/207.96 |- rdf__type mesh__D004688sskos__Concept
% 207.76/207.96 |- mesh__recordOriginator mesh__D004688 NLM
% 207.76/207.96 |- mesh__dateCreated mesh__D004688 1999-01-01
% 207.76/207.96 |- skos__broader mesh__D004688smesh__D012817
% 207.76/207.96 |- mesh__dateRevised mesh__D004688 2002-07-03
% 207.76/207.96 |- skos__scopeNote mesh__D004688
% 207.76/207.96 Incontinence of feces not due to organic defect or illness.%A%
% 207.76/207.96 |- skos__prefLabel mesh__D004688 Encopresis
% 207.76/207.96 |- mesh__recordMaintainer mesh__D004688 JLS
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D004688 69
% 207.76/207.96 |- skos__broader mesh__D004688smesh__D019960
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004688 2003
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004688 2005
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D004688 sjn
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004688 2004
% 207.76/207.96 |- skos__broader mesh__D004688smesh__D001526
% 207.76/207.96 |- skos__annotation mesh__D004688
% 207.76/207.96 of psychol origin: differentiate from FECAL INCONTINENCE, of organic origin%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D004688 2006
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D023842 2003
% 207.76/207.96 |- mesh__historyNote mesh__D023842 2002
% 207.76/207.96 |- skos__prefLabel mesh__D023842 Rhinometry, Acoustic
% 207.76/207.96 |- skos__historyNote mesh__D023842 Acoustics %28%1991-2001%29%
% 207.76/207.96 |- skos__altLabel mesh__D023842 Acoustic Rhinometry
% 207.76/207.96 |- skos__broader mesh__D023842smesh__D003948
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D023842 2002
% 207.76/207.96 |- skos__historyNote mesh__D023842 Diagnosis %28%1989-2001%29%
% 207.76/207.96 |- skos__scopeNote mesh__D023842
% 207.76/207.96 Diagnostic measurement of the nose and its cavity through acoustic reflections. Used to measure nasal anatomical landmarks, nasal septal deviation, and nasal airway changes in response to allergen provocation tests %28%NASAL PROVOCATION TESTS%29%.%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D023842 2002
% 207.76/207.96 |- mesh__dateEstablished mesh__D023842 2002-01-01
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D023842 2006
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D023842 2004
% 207.76/207.96 |- rdf__type mesh__D023842sskos__Concept
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D023842 2005
% 207.76/207.96 |- mesh__dateCreated mesh__D023842 2001-07-25
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Embryonal Cancer
% 207.76/207.96 |- skos__altLabel mesh__D009373 Germ Cell and Embryonic Neoplasms
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Cancer, Germ Cell
% 207.76/207.96 |- skos__altLabel mesh__D009373 Embryonal Neoplasms
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Neoplasm, Embryonal
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Embryonal Cancers
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Tumor, Germ Cell
% 207.76/207.96 |- rdf__type mesh__D009373sskos__Concept
% 207.76/207.96 |- skos__altLabel mesh__D009373 Germ Cell Neoplasms
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Embryonal Neoplasm
% 207.76/207.96 |- skos__scopeNote mesh__D009373
% 207.76/207.96 Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.%A%
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Germ Cell Tumors
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Cancers, Embryonal
% 207.76/207.96 |- skos__broader mesh__D009373smesh__D009370
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Cancers, Germ Cell
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D009373 sjn
% 207.76/207.96 |- skos__annotation mesh__D009373
% 207.76/207.96 neoplasms composed of germ cells or embryonic tissue, NOT neoplasms located in germ cells or embryonic tissue; coordinate IM with precoordinated organ/neoplasm term %28%IM%29%; DF: NEOPL GERM CELL%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D009373 2006
% 207.76/207.96 |- mesh__recordMaintainer mesh__D009373 ags
% 207.76/207.96 |- skos__altLabel mesh__D009373 Germ Cell Tumor
% 207.76/207.96 |- mesh__recordOriginator mesh__D009373 NLM
% 207.76/207.96 |- mesh__dateRevised mesh__D009373 2005-06-30
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Germ Cell Cancers
% 207.76/207.96 |- skos__altLabel mesh__D009373 Germ Cell and Embryonal Neoplasms
% 207.76/207.96 |- skos__hiddenLabel mesh__D009373 Tumors, Germ Cell
% 207.76/207.96 |- skos__altLabel mesh__D009373 Neoplasms, Germ Cell and Embryonic
% 207.76/207.96 |- skos__prefLabel mesh__D009373 Neoplasms, Germ Cell and Embryonal
% 207.76/207.96 |- mesh__dateCreated mesh__D009373 1999-01-01
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D009373
% 207.76/207.96 1994; see NEOPLASMS, EMBRYONAL AND MIXED 1963-1993; for GERM CELL TUMOR see GERMINOMA 1994-2005%A%
% 207.76/207.96 |- mesh__historyNote mesh__D009373
% 207.76/207.96 1994 %28%1963%29%; for GERM CELL TUMOR use GERMINOMA 1994-2005
% 207.76/207.96 |- skos__altLabel mesh__D001390 Bayer Brand of Azlocillin
% 207.76/207.96 |- skos__hiddenLabel mesh__D001390 Bay e 6905
% 207.76/207.96 |- skos__broader mesh__D001390smesh__D000667
% 207.76/207.96 |- skos__historyNote mesh__D001390 Penicillins %28%1966-1984%29%
% 207.76/207.96 |- mesh__publicMeSHNote mesh__D001390 85
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D001390 2005
% 207.76/207.96 |- skos__prefLabel mesh__D001390 Azlocillin
% 207.76/207.96 |- mesh__dateEstablished mesh__D001390 1985-01-01
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D001390 2006
% 207.76/207.96 |- mesh__historyNote mesh__D001390 85
% 207.76/207.96 |- mesh__recordOriginator mesh__D001390 SH
% 207.76/207.96 |- mesh__recordAuthorizer mesh__D001390 sjn
% 207.76/207.96 |- skos__scopeNote mesh__D001390
% 207.76/207.96 A semisynthetic ampicillin-derived acylureido penicillin.%A%
% 207.76/207.96 |- mesh__recordMaintainer mesh__D001390 ssb
% 207.76/207.96 |- mesh__dateCreated mesh__D001390 1984-05-24
% 207.76/207.96 |- skos__hiddenLabel mesh__D001390 Azlocillin Bayer Brand
% 207.76/207.96 |- skos__hiddenLabel mesh__D001390 Baye 6905
% 207.76/207.96 |- rdf__type mesh__D001390sskos__Concept
% 207.76/207.96 |- skos__altLabel mesh__D001390 Bayer Brand of Azlocillin Sodium Salt
% 207.76/207.96 |- mesh__dateRevised mesh__D001390 2004-07-07
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017805 2005
% 207.76/207.96 |- mesh__recordOriginator mesh__D017805 TGC
% 207.76/207.96 |- skos__altLabel mesh__D017805 Widowed
% 207.76/207.96 |- skos__historyNote mesh__D017805 Marriage %28%1966-1967%29%
% 207.76/207.96 |- mesh__historyNote mesh__D017805
% 207.76/207.96 94; WIDOWERS %26% WIDOWS were WIDOWER %26% WIDOW see SINGLE PERSON 1983-93%A%
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017805 2001
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017805 1995
% 207.76/207.96 |- mesh__dateRevised mesh__D017805 1993-11-26
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017805 1996
% 207.76/207.96 |- mesh__recordMaintainer mesh__D017805 PLS
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017805 2006
% 207.76/207.96 |- skos__broader mesh__D017805smesh__D017533
% 207.76/207.96 |- skos__historyNote mesh__D017805 Single Person %28%1968-1993%29%
% 207.76/207.96 |- skos__hiddenLabel mesh__D017805 Widower
% 207.76/207.96 |- mesh__activeMeSHYear mesh__D017805 2002
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017805 1997
% 207.76/207.97 |- skos__scopeNote mesh__D017805
% 207.76/207.97 The state of having lost a marital partner by death.
% 207.76/207.97 |- mesh__dateEstablished mesh__D017805 1994-01-01
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017805 2003
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017805 1998
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D017805 PLS
% 207.76/207.97 |- mesh__onlineNote mesh__D017805
% 207.76/207.97 use SINGLE PERSON to search WIDOWER %26% WIDOW 1983-93
% 207.76/207.97 |- skos__prefLabel mesh__D017805 Widowhood
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017805 2004
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017805 1999
% 207.76/207.97 |- skos__hiddenLabel mesh__D017805 Widow
% 207.76/207.97 |- skos__annotation mesh__D017805
% 207.76/207.97 woman or man: note X refs; spousal bereavement: coord IM with BEREAVEMENT %28%IM%29%; coping behavior, coping strategy, coping style: coord IM with ADAPTATION, PSYCHOLOGICAL%A%
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D017805
% 207.76/207.97 94; WIDOWERS %26% WIDOWS were WIDOWER %26% WIDOW see SINGLE PERSON 1983-93%A%
% 207.76/207.97 |- mesh__dateCreated mesh__D017805 1993-02-16
% 207.76/207.97 |- skos__historyNote mesh__D017805 Death %28%1966-1967%29%
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017805 2000
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017805 1994
% 207.76/207.97 |- rdf__type mesh__D017805sskos__Concept
% 207.76/207.97 |- skos__broader mesh__D017007smesh__D003219
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017007 2004
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017007 2005
% 207.76/207.97 |- skos__broader mesh__D017007smesh__D014342
% 207.76/207.97 |- mesh__historyNote mesh__D017007 92
% 207.76/207.97 |- skos__related mesh__D017007smesh__D033002
% 207.76/207.97 |- rdf__type mesh__D017007sskos__Concept
% 207.76/207.97 |- skos__scopeNote mesh__D017007
% 207.76/207.97 A health professional%27%s obligation to breach patient CONFIDENTIALITY to warn third parties of the danger of their being assaulted or of contracting a serious infection.%A%
% 207.76/207.97 |- skos__hiddenLabel mesh__D017007 Warn, Duty to
% 207.76/207.97 |- mesh__dateCreated mesh__D017007 1991-07-26
% 207.76/207.97 |- mesh__recordMaintainer mesh__D017007 jls
% 207.76/207.97 |- skos__related mesh__D017007smesh__D019221
% 207.76/207.97 |- skos__hiddenLabel mesh__D017007 to Warn, Duty
% 207.76/207.97 |- skos__prefLabel mesh__D017007 Duty to Warn
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D017007 92
% 207.76/207.97 |- skos__historyNote mesh__D017007 Confidentiality %28%1976-1991%29%
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D017007 sjn
% 207.76/207.97 |- mesh__dateEstablished mesh__D017007 1992-01-01
% 207.76/207.97 |- skos__related mesh__D017007smesh__D003219
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017007 2006
% 207.76/207.97 |- mesh__recordOriginator mesh__D017007 MXR
% 207.76/207.97 |- mesh__dateRevised mesh__D017007 2003-07-09
% 207.76/207.97 |- skos__hiddenLabel mesh__D047492 PPAR, NUC1
% 207.76/207.97 |- skos__related mesh__D047492smesh__D020025
% 207.76/207.97 |- skos__historyNote mesh__D047492 Transcription Factors %28%1993-2004%29%
% 207.76/207.97 |- skos__hiddenLabel mesh__D047492
% 207.76/207.97 Peroxisome Proliferator Activated Receptors
% 207.76/207.97 |- skos__altLabel mesh__D047492 PPAR
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D047492 sjn
% 207.76/207.97 |- mesh__historyNote mesh__D047492 2005%28%1992%29%
% 207.76/207.97 |- skos__broader mesh__D047492smesh__D018160
% 207.76/207.97 |- mesh__recordOriginator mesh__D047492 ssb
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D047492 2006
% 207.76/207.97 |- mesh__dateRevised mesh__D047492 2005-06-30
% 207.76/207.97 |- mesh__dateEstablished mesh__D047492 2005-01-01
% 207.76/207.97 |- mesh__recordMaintainer mesh__D047492 SYSTEM
% 207.76/207.97 |- mesh__dateCreated mesh__D047492 2004-07-07
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D047492
% 207.76/207.97 2005; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%
% 207.76/207.97 |- skos__hiddenLabel mesh__D047492
% 207.76/207.97 Proliferator-Activated Receptors, Peroxisome
% 207.76/207.97 |- rdf__type mesh__D047492sskos__Concept
% 207.76/207.97 |- skos__prefLabel mesh__D047492
% 207.76/207.97 Peroxisome Proliferator-Activated Receptors
% 207.76/207.97 |- skos__annotation mesh__D047492 note specifics
% 207.76/207.97 |- skos__hiddenLabel mesh__D047492
% 207.76/207.97 Receptors, Peroxisome Proliferator-Activated
% 207.76/207.97 |- skos__scopeNote mesh__D047492
% 207.76/207.97 TRANSCRIPTION FACTORS that are activated by ligands and heterodimerize with RETINOID X RECEPTORS and bind to peroxisome proliferator response elements in the promoter regions of target genes.%A%
% 207.76/207.97 |- skos__broader mesh__D047492smesh__D014157
% 207.76/207.97 |- skos__annotation mesh__D000298
% 207.76/207.97 not for dis in adolescent in hosp for diag or ther: use only for hospitalized adolescents as a psychol, sociol or social entity; check also tag ADOLESCENT%A%
% 207.76/207.97 |- mesh__historyNote mesh__D000298 83
% 207.76/207.97 |- skos__hiddenLabel mesh__D000298 Hospitalized Adolescents
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D000298 2003
% 207.76/207.97 |- skos__hiddenLabel mesh__D000298 Adolescents, Hospitalized
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D000298 2005
% 207.76/207.97 |- skos__prefLabel mesh__D000298 Adolescent, Hospitalized
% 207.76/207.97 |- mesh__dateRevised mesh__D000298 2002-07-02
% 207.76/207.97 |- skos__historyNote mesh__D000298 Adolescence %28%1966-1982%29%
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D000298 2004
% 207.76/207.97 |- skos__hiddenLabel mesh__D000298 Hospitalized Adolescent
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D000298 2006
% 207.76/207.97 |- skos__scopeNote mesh__D000298
% 207.76/207.97 Adolescent hospitalized for short term care.
% 207.76/207.97 |- mesh__recordMaintainer mesh__D000298 jls
% 207.76/207.97 |- skos__related mesh__D000298smesh__D000299
% 207.76/207.97 |- skos__historyNote mesh__D000298 Hospitalization %28%1966-1982%29%
% 207.76/207.97 |- skos__broader mesh__D000298smesh__D010361
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D000298 sjn
% 207.76/207.97 |- mesh__recordOriginator mesh__D000298 EC
% 207.76/207.97 |- rdf__type mesh__D000298sskos__Concept
% 207.76/207.97 |- mesh__dateCreated mesh__D000298 1982-04-28
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D000298 83
% 207.76/207.97 |- mesh__dateEstablished mesh__D000298 1983-01-01
% 207.76/207.97 |- mesh__recordOriginator mesh__D041904 ags
% 207.76/207.97 |- mesh__historyNote mesh__D041904 2004
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D041904 2004
% 207.76/207.97 |- mesh__dateEstablished mesh__D041904 2004-01-01
% 207.76/207.97 |- skos__broader mesh__D041904smesh__D006090
% 207.76/207.97 |- mesh__recordMaintainer mesh__D041904 SYSTEM
% 207.76/207.97 |- skos__prefLabel mesh__D041904 Roseobacter
% 207.76/207.97 |- mesh__dateRevised mesh__D041904 2005-06-30
% 207.76/207.97 |- skos__broader mesh__D041904smesh__D041902
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D041904 2006
% 207.76/207.97 |- rdf__type mesh__D041904sskos__Concept
% 207.76/207.97 |- mesh__dateCreated mesh__D041904 2003-07-09
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D041904 sjn
% 207.76/207.97 |- skos__scopeNote mesh__D041904
% 207.76/207.97 A genus of obligately aerobic marine phototrophic and chemoorganotrophic bacteria, in the family RHODOBACTERACEAE.%A%
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D005781
% 207.76/207.97 78; was GELFOAM 1973-77, was GELFOAM see under HEMOSTATICS 1963-72%A%
% 207.76/207.97 |- mesh__recordOriginator mesh__D005781 NLM
% 207.76/207.97 |- mesh__dateCreated mesh__D005781 1999-01-01
% 207.76/207.97 |- skos__hiddenLabel mesh__D005781 Gelatin Sponges, Absorbable
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D005781 2005
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D005781 2003
% 207.76/207.97 |- skos__hiddenLabel mesh__D005781 Sponge, Absorbable Gelatin
% 207.76/207.97 |- mesh__dateRevised mesh__D005781 2001-07-25
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D005781 2006
% 207.76/207.97 |- mesh__onlineNote mesh__D005781
% 207.76/207.97 use GELATIN SPONGE, ABSORBABLE to search GELFOAM 1966-77 %28%as Prov 1966-72%29%%A%
% 207.76/207.97 |- mesh__historyNote mesh__D005781
% 207.76/207.97 78; was GELFOAM 1964-77 %28%Prov 1964-72%29%, was GELFOAM see under HEMOSTATICS 1963-72%A%
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D005781 2004
% 207.76/207.97 |- skos__broader mesh__D005781smesh__D015503
% 207.76/207.97 |- mesh__recordMaintainer mesh__D005781 ssb
% 207.76/207.97 |- skos__hiddenLabel mesh__D005781 Absorbable Gelatin Sponges
% 207.76/207.97 |- skos__hiddenLabel mesh__D005781 Absorbable Gelatin Sponge
% 207.76/207.97 |- skos__prefLabel mesh__D005781 Gelatin Sponge, Absorbable
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D005781 2002
% 207.76/207.97 |- skos__scopeNote mesh__D005781
% 207.76/207.97 Sterile, gelatin-base surgical sponge applied topically as an adjunct to hemostasis when the control of bleeding by conventional procedures is ineffective to reduce capillary ooze or is impractical. %28%From AMA Drug Evaluations Annual, 1994, p797%29%%A%
% 207.76/207.97 |- rdf__type mesh__D005781sskos__Concept
% 207.76/207.97 |- skos__hiddenLabel mesh__D005781 Sponges, Absorbable Gelatin
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D005781 sjn
% 207.76/207.97 |- mesh__dateEstablished mesh__D005781 1973-01-01
% 207.76/207.97 |- skos__annotation mesh__D005781 D25-26 qualif
% 207.76/207.97 |- skos__historyNote mesh__D013415 Pyrazines %28%1971-1974%29%
% 207.76/207.97 |- mesh__dateEstablished mesh__D013415 1991-01-01
% 207.76/207.97 |- skos__altLabel mesh__D013415 Longum
% 207.76/207.97 |- skos__altLabel mesh__D013415 Pharmacia Brand of Sulfalene
% 207.76/207.97 |- skos__historyNote mesh__D013415 Sulfonamides %28%1971-1974%29%
% 207.76/207.97 |- skos__altLabel mesh__D013415 Sulfamethopyrazine
% 207.76/207.97 |- skos__broader mesh__D013415smesh__D013424
% 207.76/207.97 |- skos__altLabel mesh__D013415 Sulphametopyrazine
% 207.76/207.97 |- skos__altLabel mesh__D013415 Sulfametopyrazine
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D013415
% 207.76/207.97 91; was see under SULFANILAMIDES 1975-90
% 207.76/207.97 |- mesh__dateRevised mesh__D013415 2005-06-30
% 207.76/207.97 |- mesh__recordMaintainer mesh__D013415 CCR
% 207.76/207.97 |- mesh__recordOriginator mesh__D013415 NLM
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D013415 sjn
% 207.76/207.97 |- skos__altLabel mesh__D013415 Sulphalene
% 207.76/207.97 |- skos__altLabel mesh__D013415 Sulfapyrazinmethoxine
% 207.76/207.97 |- mesh__historyNote mesh__D013415
% 207.76/207.97 91%28%75%29%; was see under SULFANILAMIDES 1975-90
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D013415 2006
% 207.76/207.97 |- mesh__dateCreated mesh__D013415 1974-11-19
% 207.76/207.97 |- skos__scopeNote mesh__D013415
% 207.76/207.97 Long-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria.%A%
% 207.76/207.97 |- skos__prefLabel mesh__D013415 Sulfalene
% 207.76/207.97 |- skos__altLabel mesh__D013415 Sulfamethoxypyrazine
% 207.76/207.97 |- rdf__type mesh__D013415sskos__Concept
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D018100 sjn
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D018100 2006
% 207.76/207.97 |- skos__broader mesh__D018100smesh__D011968
% 207.76/207.97 |- mesh__dateRevised mesh__D018100 2005-06-30
% 207.76/207.97 |- rdf__type mesh__D018100sskos__Concept
% 207.76/207.97 |- skos__altLabel mesh__D018100 Histamine H3 Receptors
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D018100
% 207.76/207.97 94; HISTAMINE H3 RECEPTOR was indexed under RECEPTORS, HISTAMINE 1983-93%A%
% 207.76/207.97 |- skos__scopeNote mesh__D018100
% 207.76/207.97 A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H3 receptors were first recognized as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems. %28%From Biochem Soc Trans 1992 Feb;20%28%1%29%:122-5%29%%A%
% 207.76/207.97 |- skos__hiddenLabel mesh__D018100 H3 Receptors, Histamine
% 207.76/207.97 |- skos__prefLabel mesh__D018100 Receptors, Histamine H3
% 207.76/207.97 |- skos__hiddenLabel mesh__D018100 Receptor, Histamine H3
% 207.76/207.97 |- skos__altLabel mesh__D018100 H3 Receptors
% 207.76/207.97 |- skos__hiddenLabel mesh__D018100 H3 Receptor, Histamine
% 207.76/207.97 |- mesh__historyNote mesh__D018100
% 207.76/207.97 94; was HISTAMINE H3 RECEPTOR %28%NM%29% 1983-93
% 207.76/207.97 |- skos__historyNote mesh__D018100 Receptors, Histamine %28%1983-1993%29%
% 207.76/207.97 |- mesh__onlineNote mesh__D018100
% 207.76/207.97 use RECEPTORS, HISTAMINE H3 %28%NM%29% to search HISTAMINE H3 RECEPTOR 1983-93%A%
% 207.76/207.97 |- skos__hiddenLabel mesh__D018100 Receptors, H3
% 207.76/207.97 |- mesh__dateCreated mesh__D018100 1993-06-16
% 207.76/207.97 |- mesh__recordOriginator mesh__D018100 RAZ
% 207.76/207.97 |- mesh__dateEstablished mesh__D018100 1994-01-01
% 207.76/207.97 |- skos__altLabel mesh__D018100 Histamine H3 Receptor
% 207.76/207.97 |- skos__annotation mesh__D018100 DF: RECEPT H3
% 207.76/207.97 |- mesh__recordMaintainer mesh__D018100 jmp
% 207.76/207.97 |- rdf__type mesh__D009374sskos__Concept
% 207.76/207.97 |- skos__hiddenLabel mesh__D009374 Experimental Neoplasm
% 207.76/207.97 |- skos__annotation mesh__D009374
% 207.76/207.97 IM general only; not a routine coordinate for specific neoplasms in experimental animals; policy: Manual 24.5+; /chem ind: Manual 24.5.6+; spontaneous: Manual 24.5.5; DF: NEOPL EXPER%A%
% 207.76/207.97 |- skos__altLabel mesh__D009374 Experimental Neoplasms
% 207.76/207.97 |- mesh__dateRevised mesh__D009374 2004-07-13
% 207.76/207.97 |- skos__hiddenLabel mesh__D009374 Neoplasm, Experimental
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D009374 2005
% 207.76/207.97 |- skos__broader mesh__D009374smesh__D004195
% 207.76/207.97 |- skos__related mesh__D009374smesh__D014412
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D009374 2006
% 207.76/207.97 |- skos__scopeNote mesh__D009374
% 207.76/207.97 Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.%A%
% 207.76/207.97 |- mesh__recordMaintainer mesh__D009374 sjn
% 207.76/207.97 |- skos__related mesh__D009374smesh__D009368
% 207.76/207.97 |- skos__prefLabel mesh__D009374 Neoplasms, Experimental
% 207.76/207.97 |- mesh__dateCreated mesh__D009374 1999-01-01
% 207.76/207.97 |- skos__broader mesh__D009374smesh__D009369
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D009374 sjn
% 207.76/207.97 |- mesh__recordOriginator mesh__D009374 NLM
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 2006
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 2000
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 1994
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 2004
% 207.76/207.97 |- skos__broader mesh__D001391smesh__D009930
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D001391 PLS
% 207.76/207.97 |- mesh__recordMaintainer mesh__D001391 TGC
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 1995
% 207.76/207.97 |- mesh__dateRevised mesh__D001391 1992-05-07
% 207.76/207.97 |- rdf__type mesh__D001391sskos__Concept
% 207.76/207.97 |- mesh__recordOriginator mesh__D001391 NLM
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 2001
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 1993
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 1998
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 2002
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 1996
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 1999
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 1997
% 207.76/207.97 |- skos__prefLabel mesh__D001391 Azo Compounds
% 207.76/207.97 |- mesh__dateCreated mesh__D001391 1999-01-01
% 207.76/207.97 |- skos__hiddenLabel mesh__D001391 Compounds, Azo
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 2005
% 207.76/207.97 |- skos__annotation mesh__D001391
% 207.76/207.97 do not confuse with AZA COMPOUNDS; DF: AZO CPDS
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D001391 2003
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D017806 94
% 207.76/207.97 |- skos__historyNote mesh__D017806 Plant Viruses %28%1966-1993%29%
% 207.76/207.97 |- rdf__type mesh__D017806sskos__Concept
% 207.76/207.97 |- mesh__dateCreated mesh__D017806 1993-06-04
% 207.76/207.97 |- mesh__recordOriginator mesh__D017806 AGS
% 207.76/207.97 |- mesh__dateEstablished mesh__D017806 1994-01-01
% 207.76/207.97 |- skos__scopeNote mesh__D017806
% 207.76/207.97 A genus of plant viruses, in the family TYMOVIRIDAE, possessing a narrow host range that includes CRUCIFERAE. Transmission occurs by BEETLES and mechanical inoculation.%A%
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D017806 sjn
% 207.76/207.97 |- skos__broader mesh__D017806smesh__D046830
% 207.76/207.97 |- mesh__recordMaintainer mesh__D017806 ags
% 207.76/207.97 |- skos__broader mesh__D017806smesh__D009029
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017806 2006
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017806 2005
% 207.76/207.97 |- skos__prefLabel mesh__D017806 Tymovirus
% 207.76/207.97 |- mesh__dateRevised mesh__D017806 2004-07-07
% 207.76/207.97 |- mesh__historyNote mesh__D017806 94
% 207.76/207.97 |- skos__hiddenLabel mesh__D017806 Tymoviruses
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017008 2003
% 207.76/207.97 |- skos__broader mesh__D017008smesh__D003142
% 207.76/207.97 |- skos__altLabel mesh__D017008 Arbitration
% 207.76/207.97 |- skos__broader mesh__D017008smesh__D003657
% 207.76/207.97 |- skos__broader mesh__D017008smesh__D010559
% 207.76/207.97 |- skos__prefLabel mesh__D017008 Negotiating
% 207.76/207.97 |- mesh__recordMaintainer mesh__D017008 jls
% 207.76/207.97 |- skos__altLabel mesh__D017008 Negotiation
% 207.76/207.97 |- skos__broader mesh__D017008smesh__D007398
% 207.76/207.97 |- skos__related mesh__D017008smesh__D003098
% 207.76/207.97 |- skos__annotation mesh__D017008
% 207.76/207.97 not restricted to labor unions: used also for interpersonal communications, personnel management, business transactions, etc.%A%
% 207.76/207.97 |- skos__altLabel mesh__D017008 Mediation
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017008 2006
% 207.76/207.97 |- mesh__recordOriginator mesh__D017008 MXR
% 207.76/207.97 |- mesh__dateCreated mesh__D017008 1991-05-30
% 207.76/207.97 |- mesh__dateRevised mesh__D017008 2002-07-02
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017008 2004
% 207.76/207.97 |- skos__hiddenLabel mesh__D017008 Negotiations
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D017008 92
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D017008 2005
% 207.76/207.97 |- skos__scopeNote mesh__D017008
% 207.76/207.97 The process of bargaining in order to arrive at an agreement or compromise on a matter of importance to the parties involved. It also applies to the hearing and determination of a case by a third party chosen by the parties in controversy, as well as the interposing of a third party to reconcile the parties in controversy.%A%
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D017008 sjn
% 207.76/207.97 |- mesh__historyNote mesh__D017008 92
% 207.76/207.97 |- rdf__type mesh__D017008sskos__Concept
% 207.76/207.97 |- mesh__dateEstablished mesh__D017008 1992-01-01
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D047493 2005
% 207.76/207.97 |- skos__scopeNote mesh__D047493
% 207.76/207.97 A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR GAMMA is important to metabolism of LIPIDS. It is the target of FIBRATES to control HYPERLIPIDEMIA.%A%
% 207.76/207.97 |- skos__broader mesh__D047493smesh__D047492
% 207.76/207.97 |- mesh__recordOriginator mesh__D047493 ssb
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D047493 2006
% 207.76/207.97 |- skos__altLabel mesh__D047493 PPARalpha
% 207.76/207.97 |- skos__prefLabel mesh__D047493 PPAR alpha
% 207.76/207.97 |- mesh__dateCreated mesh__D047493 2004-07-07
% 207.76/207.97 |- mesh__recordMaintainer mesh__D047493 ssb
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D047493 sjn
% 207.76/207.97 |- rdf__type mesh__D047493sskos__Concept
% 207.76/207.97 |- mesh__historyNote mesh__D047493 2005%28%1992%29%
% 207.76/207.97 |- skos__hiddenLabel mesh__D047493
% 207.76/207.97 Peroxisome Proliferator Activated Receptor alpha
% 207.76/207.97 |- mesh__dateEstablished mesh__D047493 2005-01-01
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D047493
% 207.76/207.97 2005; PPAR ALPHA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%
% 207.76/207.97 |- skos__historyNote mesh__D047493 Transcription Factors %28%1993-2004%29%
% 207.76/207.97 |- skos__altLabel mesh__D047493
% 207.76/207.97 Peroxisome Proliferator-Activated Receptor alpha
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D000299 2005
% 207.76/207.97 |- skos__scopeNote mesh__D000299
% 207.76/207.97 An adolescent who is receiving long-term in-patient services or who resides in an institutional setting.%A%
% 207.76/207.97 |- skos__historyNote mesh__D000299 Adolescence %28%1966-1982%29%
% 207.76/207.97 |- skos__hiddenLabel mesh__D000299 Institutionalized Adolescents
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D000299 83
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D000299 2004
% 207.76/207.97 |- mesh__dateEstablished mesh__D000299 1983-01-01
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D000299 2006
% 207.76/207.97 |- skos__prefLabel mesh__D000299 Adolescent, Institutionalized
% 207.76/207.97 |- skos__annotation mesh__D000299 check also tag ADOLESCENT
% 207.76/207.97 |- mesh__dateRevised mesh__D000299 2002-07-02
% 207.76/207.97 |- skos__broader mesh__D000299smesh__D010361
% 207.76/207.97 |- skos__altLabel mesh__D000299 Institutionalized Adolescent
% 207.76/207.97 |- skos__hiddenLabel mesh__D000299 Adolescents, Institutionalized
% 207.76/207.97 |- rdf__type mesh__D000299sskos__Concept
% 207.76/207.97 |- mesh__dateCreated mesh__D000299 1982-04-28
% 207.76/207.97 |- mesh__recordMaintainer mesh__D000299 jls
% 207.76/207.97 |- mesh__historyNote mesh__D000299 83
% 207.76/207.97 |- skos__historyNote mesh__D000299 Residential Facilities %28%1968-1982%29%
% 207.76/207.97 |- skos__historyNote mesh__D000299 Institutionalization %28%1979-1982%29%
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D000299 2003
% 207.76/207.97 |- mesh__recordOriginator mesh__D000299 EC
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D000299 sjn
% 207.76/207.97 |- skos__hiddenLabel mesh__D041905 Cells, Erythroid
% 207.76/207.97 |- skos__hiddenLabel mesh__D041905 Cell, Erythroid
% 207.76/207.97 |- skos__prefLabel mesh__D041905 Erythroid Cells
% 207.76/207.97 |- mesh__historyNote mesh__D041905 2004
% 207.76/207.97 |- mesh__dateEstablished mesh__D041905 2004-01-01
% 207.76/207.97 |- skos__broader mesh__D041905smesh__D002477
% 207.76/207.97 |- skos__scopeNote mesh__D041905
% 207.76/207.97 The series of cells in the red blood cell lineage at various stages of differentiation.%A%
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D041905 2006
% 207.76/207.97 |- skos__hiddenLabel mesh__D041905 Erythroid Cell
% 207.76/207.97 |- mesh__dateCreated mesh__D041905 2003-07-09
% 207.76/207.97 |- rdf__type mesh__D041905sskos__Concept
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D041905 2004
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D041905 2005
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D041905 2004
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D005782 2005
% 207.76/207.97 |- skos__scopeNote mesh__D005782
% 207.76/207.97 Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.%A%
% 207.76/207.97 |- mesh__recordMaintainer mesh__D005782 jls
% 207.76/207.97 |- mesh__recordOriginator mesh__D005782 NLM
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D005782 2006
% 207.76/207.97 |- mesh__dateRevised mesh__D005782 2004-07-27
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D005782 2004
% 207.76/207.97 |- skos__annotation mesh__D005782
% 207.76/207.97 IM for general only, qualif permitted; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%%A%
% 207.76/207.97 |- skos__broader mesh__D005782smesh__D003102
% 207.76/207.97 |- rdf__type mesh__D005782sskos__Concept
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D005782 2005A
% 207.76/207.97 |- skos__prefLabel mesh__D005782 Gels
% 207.76/207.97 |- mesh__dateCreated mesh__D005782 1999-01-01
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D005782 jls
% 207.76/207.97 |- skos__scopeNote mesh__D013416
% 207.76/207.97 A sulfanilamide that is used as an antibacterial agent.%A%
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D013416 2006
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D013416 2001
% 207.76/207.97 |- skos__prefLabel mesh__D013416 Sulfamerazine
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D013416 2005
% 207.76/207.97 |- skos__altLabel mesh__D013416 Methylsulfadiazine
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D013416 2004
% 207.76/207.97 |- rdf__type mesh__D013416sskos__Concept
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D013416 2003
% 207.76/207.97 |- mesh__dateCreated mesh__D013416 1999-01-01
% 207.76/207.97 |- mesh__recordMaintainer mesh__D013416 CCR
% 207.76/207.97 |- skos__broader mesh__D013416smesh__D013424
% 207.76/207.97 |- mesh__dateRevised mesh__D013416 2000-06-22
% 207.76/207.97 |- mesh__recordOriginator mesh__D013416 NLM
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D013416 sjn
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D013416 2002
% 207.76/207.97 |- skos__broader mesh__D018101smesh__D008810
% 207.76/207.97 |- rdf__type mesh__D018101sskos__Concept
% 207.76/207.97 |- mesh__dateEstablished mesh__D018101 1994-01-01
% 207.76/207.97 |- skos__altLabel mesh__D018101 Mouse, Inbred mdx
% 207.76/207.97 |- skos__related mesh__D018101smesh__D009136
% 207.76/207.97 |- skos__hiddenLabel mesh__D018101 Inbred mdx Mice
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D018101 sjn
% 207.76/207.97 |- skos__altLabel mesh__D018101 Mouse, mdx
% 207.76/207.97 |- mesh__dateCreated mesh__D018101 1993-06-03
% 207.76/207.97 |- skos__scopeNote mesh__D018101
% 207.76/207.97 A strain of mice arising from a spontaneous MUTATION %28%mdx%29% in inbred C57BL mice. This mutation is X chromosome-linked and produces viable homozygous animals that lack the muscle protein DYSTROPHIN, have high serum levels of muscle ENZYMES, and possess histological lesions similar to human MUSCULAR DYSTROPHY. The histological features, linkage, and map position of mdx make these mice a worthy animal model of DUCHENNE MUSCULAR DYSTROPHY.%A%
% 207.76/207.97 |- skos__historyNote mesh__D018101 Mice, Mutant Strains %28%1984-1993%29%
% 207.76/207.97 |- skos__hiddenLabel mesh__D018101 mdx Mouse
% 207.76/207.97 |- skos__hiddenLabel mesh__D018101 mdx Mice, Inbred
% 207.76/207.97 |- mesh__dateRevised mesh__D018101 2005-06-30
% 207.76/207.97 |- mesh__historyNote mesh__D018101 94
% 207.76/207.97 |- skos__hiddenLabel mesh__D018101 mdx Mouse, Inbred
% 207.76/207.97 |- skos__hiddenLabel mesh__D018101 mdx Mice
% 207.76/207.97 |- mesh__publicMeSHNote mesh__D018101 94
% 207.76/207.97 |- skos__historyNote mesh__D018101 Mice, Inbred C57BL %28%1984-1993%29%
% 207.76/207.97 |- skos__altLabel mesh__D018101 Mice, mdx
% 207.76/207.97 |- mesh__recordOriginator mesh__D018101 PXP
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D018101 2006
% 207.76/207.97 |- skos__hiddenLabel mesh__D018101 Inbred mdx Mouse
% 207.76/207.97 |- skos__broader mesh__D018101smesh__D008817
% 207.76/207.97 |- mesh__recordMaintainer mesh__D018101 ags
% 207.76/207.97 |- skos__prefLabel mesh__D018101 Mice, Inbred mdx
% 207.76/207.97 |- skos__annotation mesh__D018101
% 207.76/207.97 NIM with no qualifiers when experimental animal; check the tag MICE%A%
% 207.76/207.97 |- skos__hiddenLabel mesh__D009375 Glandular Epithelial Neoplasms
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D009375 1997
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D009375 1998
% 207.76/207.97 |- skos__broader mesh__D009375smesh__D009370
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D009375 2002
% 207.76/207.97 |- mesh__historyNote mesh__D009375
% 207.76/207.97 94; was NEOPLASMS, GLANDULAR EPITHELIAL 1963-93
% 207.76/207.97 |- skos__hiddenLabel mesh__D009375 Neoplasm, Glandular Epithelial
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D009375 1999
% 207.76/207.97 |- mesh__recordMaintainer mesh__D009375 KEV
% 207.76/207.97 |- mesh__recordOriginator mesh__D009375 NLM
% 207.76/207.97 |- mesh__dateCreated mesh__D009375 1999-01-01
% 207.76/207.97 |- skos__hiddenLabel mesh__D009375 Neoplasm, Epithelial
% 207.76/207.97 |- skos__annotation mesh__D009375
% 207.76/207.97 neoplasms composed of glandular %26% epithelial tissue, NOT neoplasms located in various glands or epithelium: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 207.76/207.97 |- skos__prefLabel mesh__D009375 Neoplasms, Glandular and Epithelial
% 207.76/207.97 |- skos__hiddenLabel mesh__D009375 Neoplasm, Glandular
% 207.76/207.97 |- mesh__recordAuthorizer mesh__D009375 PLS
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D009375 2000
% 207.76/207.97 |- skos__hiddenLabel mesh__D009375 Epithelial Neoplasm
% 207.76/207.97 |- skos__altLabel mesh__D009375 Neoplasms, Glandular
% 207.76/207.97 |- skos__altLabel mesh__D009375 Glandular and Epithelial Neoplasms
% 207.76/207.97 |- skos__hiddenLabel mesh__D009375 Epithelial Neoplasm, Glandular
% 207.76/207.97 |- skos__scopeNote mesh__D009375
% 207.76/207.97 Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.%A%
% 207.76/207.97 |- mesh__activeMeSHYear mesh__D009375 2003
% 207.76/207.97 |- skos__hiddenLabel mesh__D009375 Glandular Neoplasm
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D009375
% 207.76/207.98 94; was NEOPLASMS, GLANDULAR EPITHELIAL 1963-93
% 207.76/207.98 |- mesh__onlineNote mesh__D009375
% 207.76/207.98 use NEOPLASMS, GLANDULAR AND EPITHELIAL to search NEOPLASMS, GLANDULAR EPITHELIAL 1966-93%A%
% 207.76/207.98 |- rdf__type mesh__D009375sskos__Concept
% 207.76/207.98 |- skos__altLabel mesh__D009375 Neoplasms, Glandular Epithelial
% 207.76/207.98 |- skos__hiddenLabel mesh__D009375 Epithelial Neoplasms, Glandular
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D009375 2001
% 207.76/207.98 |- skos__altLabel mesh__D009375 Epithelial Neoplasms
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D009375 2004
% 207.76/207.98 |- skos__hiddenLabel mesh__D009375 Glandular Epithelial Neoplasm
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D009375 2005
% 207.76/207.98 |- mesh__dateRevised mesh__D009375 1995-06-08
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D009375 1996
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D009375 2006
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 1995
% 207.76/207.98 |- mesh__dateRevised mesh__D001392 1992-05-07
% 207.76/207.98 |- rdf__type mesh__D001392sskos__Concept
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 1993
% 207.76/207.98 |- skos__prefLabel mesh__D001392 Azocines
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 1998
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 2000
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 1996
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 1999
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D001392 PLS
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 1997
% 207.76/207.98 |- mesh__recordOriginator mesh__D001392 NLM
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 2001
% 207.76/207.98 |- mesh__dateCreated mesh__D001392 1999-01-01
% 207.76/207.98 |- mesh__historyNote mesh__D001392 66%28%64%29%
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 2005
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D001392 66
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 2002
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 2003
% 207.76/207.98 |- skos__broader mesh__D001392smesh__D006573
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 2006
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 1994
% 207.76/207.98 |- mesh__dateEstablished mesh__D001392 1966-01-01
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001392 2004
% 207.76/207.98 |- mesh__recordMaintainer mesh__D001392 TAP
% 207.76/207.98 |- skos__broader mesh__D017009smesh__D011364
% 207.76/207.98 |- skos__scopeNote mesh__D017009
% 207.76/207.98 The quality or state of being independent and self-directing, especially in making decisions, enabling professionals to exercise judgment as they see fit during the performance of their jobs.%A%
% 207.76/207.98 |- mesh__dateRevised mesh__D017009 2001-07-25
% 207.76/207.98 |- skos__hiddenLabel mesh__D017009 Professional Self Regulation
% 207.76/207.98 |- skos__hiddenLabel mesh__D017009 Regulation, Professional Self
% 207.76/207.98 |- mesh__dateEstablished mesh__D017009 1992-01-01
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D017009 92
% 207.76/207.98 |- mesh__recordMaintainer mesh__D017009 tjk
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D017009 sjn
% 207.76/207.98 |- mesh__recordOriginator mesh__D017009 MXR
% 207.76/207.98 |- mesh__dateCreated mesh__D017009 1991-07-26
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D017009 2005
% 207.76/207.98 |- skos__prefLabel mesh__D017009 Professional Autonomy
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D017009 2006
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D017009 2003
% 207.76/207.98 |- skos__hiddenLabel mesh__D017009 Autonomy, Professional
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D017009 2004
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D017009 2002
% 207.76/207.98 |- skos__related mesh__D017009smesh__D026684
% 207.76/207.98 |- mesh__historyNote mesh__D017009 92
% 207.76/207.98 |- rdf__type mesh__D017009sskos__Concept
% 207.76/207.98 |- skos__hiddenLabel mesh__D047494
% 207.76/207.98 Peroxisome Proliferator Activated Receptor delta
% 207.76/207.98 |- skos__altLabel mesh__D047494
% 207.76/207.98 Peroxisome Proliferator-Activated Receptor delta
% 207.76/207.98 |- mesh__dateCreated mesh__D047494 2004-07-07
% 207.76/207.98 |- skos__scopeNote mesh__D047494
% 207.76/207.98 A nuclear transcription factor. It is activated by PROSTACYCLIN.%A%
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D047494 2006
% 207.76/207.98 |- skos__broader mesh__D047494smesh__D047492
% 207.76/207.98 |- mesh__recordMaintainer mesh__D047494 ssb
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D047494 2005
% 207.76/207.98 |- skos__altLabel mesh__D047494 PPARD protein
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D047494
% 207.76/207.98 2005; PPAR DELTA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%
% 207.76/207.98 |- mesh__dateEstablished mesh__D047494 2005-01-01
% 207.76/207.98 |- mesh__recordOriginator mesh__D047494 ssb
% 207.76/207.98 |- rdf__type mesh__D047494sskos__Concept
% 207.76/207.98 |- skos__altLabel mesh__D047494 PPARdelta
% 207.76/207.98 |- skos__prefLabel mesh__D047494 PPAR delta
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D047494 sjn
% 207.76/207.98 |- mesh__historyNote mesh__D047494 2005%28%1992%29%
% 207.76/207.98 |- skos__historyNote mesh__D047494 Transcription Factors %28%1993-2004%29%
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D005783 2004
% 207.76/207.98 |- skos__altLabel mesh__D005783 Man%27%s Role
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Woman%27%s Roles
% 207.76/207.98 |- skos__broader mesh__D005783smesh__D007062
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Roles, Woman%27%s
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Role, Women%27%s
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Role, Sex
% 207.76/207.98 |- mesh__dateRevised mesh__D005783 2005-07-29
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Role, Men%27%s
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Gender Identities
% 207.76/207.98 |- skos__prefLabel mesh__D005783 Gender Identity
% 207.76/207.98 |- skos__historyNote mesh__D005783
% 207.76/207.98 Identification %28%Psychology%29% %28%1968-1975%29%
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Role, Woman%27%s
% 207.76/207.98 |- rdf__type mesh__D005783sskos__Concept
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D005783
% 207.76/207.98 1991; see IDENTIFICATION %28%PSYCHOLOGY%29% 1976-1990; for GENDER see SEX 1991-2003%A%
% 207.76/207.98 |- mesh__dateEstablished mesh__D005783 1991-01-01
% 207.76/207.98 |- skos__altLabel mesh__D005783 Gender Role
% 207.76/207.98 |- skos__historyNote mesh__D005783 Sex %28%1968-1975%29%
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Sex Roles
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D005783 ags
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Roles, Gender
% 207.76/207.98 |- mesh__recordMaintainer mesh__D005783 ags
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Roles, Sex
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D005783 2005
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Roles, Men%27%s
% 207.76/207.98 |- mesh__historyNote mesh__D005783
% 207.76/207.98 1991%28%1975%29%; for GENDER use SEX 1991-2003
% 207.76/207.98 |- skos__broader mesh__D005783smesh__D011606
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Roles, Women%27%s
% 207.76/207.98 |- mesh__dateCreated mesh__D005783 1975-07-21
% 207.76/207.98 |- skos__altLabel mesh__D005783 Women%27%s Role
% 207.76/207.98 |- skos__annotation mesh__D005783
% 207.76/207.98 psychological; do not confuse with SEX CHARACTERISTICS %28%physiological%29%; do not confuse with SEXUAL ORIENTATION see SEX BEHAVIOR: gender identity is knowing that one is male or female; sexual orientation is preferring heterosexual or homosexual behavior; no qualif%A%
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D005783 2006A
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Women%27%s Roles
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Identity, Gender
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D005783 2006
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Role, Man%27%s
% 207.76/207.98 |- skos__hiddenLabel mesh__D005783 Gender Roles
% 207.76/207.98 |- mesh__recordOriginator mesh__D005783 EC
% 207.76/207.98 |- skos__scopeNote mesh__D005783
% 207.76/207.98 A person%27%s concept of self as being male and masculine or female and feminine, or ambivalent, based in part on physical characteristics, parental responses, and psychological and social pressures. It is the internal experience of gender role.%A%
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D013417 sjn
% 207.76/207.98 |- skos__historyNote mesh__D013417 Sulfanilamides %28%1973-1974%29%
% 207.76/207.98 |- mesh__recordOriginator mesh__D013417 NLM
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013417 2005
% 207.76/207.98 |- mesh__historyNote mesh__D013417
% 207.76/207.98 91%28%75%29%; was see under SULFANILAMIDES 1975-90
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013417 2002
% 207.76/207.98 |- skos__scopeNote mesh__D013417
% 207.76/207.98 Long acting sulfonamide used in leprosy, urinary, and respiratory tract infections.%A%
% 207.76/207.98 |- mesh__dateCreated mesh__D013417 1974-12-12
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013417 2004
% 207.76/207.98 |- skos__altLabel mesh__D013417 Sulfametoxydiazine
% 207.76/207.98 |- rdf__type mesh__D013417sskos__Concept
% 207.76/207.98 |- skos__altLabel mesh__D013417 Sulphamethoxydiazine
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013417 2001
% 207.76/207.98 |- skos__historyNote mesh__D013417 Pyrimidines %28%1970-1974%29%
% 207.76/207.98 |- skos__altLabel mesh__D013417 Sulfametin
% 207.76/207.98 |- skos__altLabel mesh__D013417 Sulfametorinum
% 207.76/207.98 |- skos__altLabel mesh__D013417 Sulfamethoxydiazine
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013417 2003
% 207.76/207.98 |- skos__altLabel mesh__D013417 Sulfamethoxydine
% 207.76/207.98 |- mesh__dateRevised mesh__D013417 2000-06-22
% 207.76/207.98 |- skos__altLabel mesh__D013417 Sulfametoxidine
% 207.76/207.98 |- mesh__dateEstablished mesh__D013417 1991-01-01
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D013417
% 207.76/207.98 91; was see under SULFANILAMIDES 1975-90
% 207.76/207.98 |- mesh__recordMaintainer mesh__D013417 CCR
% 207.76/207.98 |- skos__prefLabel mesh__D013417 Sulfameter
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013417 2006
% 207.76/207.98 |- skos__broader mesh__D013417smesh__D013424
% 207.76/207.98 |- skos__scopeNote mesh__D018900
% 207.76/207.98 The most common of the microsatellite tandem repeats %28%MICROSATELLITE REPEATS%29% dispersed in the euchromatic arms of chromosomes. They consist of two nucleotides repeated in tandem; guanine and thymine, %28%GT%29%n, is the most frequently seen.%A%
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D018900 96
% 207.76/207.98 |- mesh__historyNote mesh__D018900 96
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D018900 sjn
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D018900 2006
% 207.76/207.98 |- rdf__type mesh__D018900sskos__Concept
% 207.76/207.98 |- skos__broader mesh__D018900smesh__D018895
% 207.76/207.98 |- mesh__recordMaintainer mesh__D018900 nns
% 207.76/207.98 |- mesh__dateEstablished mesh__D018900 1996-01-01
% 207.76/207.98 |- skos__historyNote mesh__D018900
% 207.76/207.98 Repetitive Sequences, Nucleic Acid %28%1989-1995%29%
% 207.76/207.98 |- skos__prefLabel mesh__D018900 Dinucleotide Repeats
% 207.76/207.98 |- mesh__recordOriginator mesh__D018900 AGS
% 207.76/207.98 |- mesh__dateCreated mesh__D018900 1995-06-08
% 207.76/207.98 |- skos__hiddenLabel mesh__D018900 Dinucleotide Repeat
% 207.76/207.98 |- mesh__dateRevised mesh__D018900 2005-06-30
% 207.76/207.98 |- rdf__type mesh__D018102sskos__Concept
% 207.76/207.98 |- skos__historyNote mesh__D018102
% 207.76/207.98 Receptors, Cell Surface %28%1982-1984%29%
% 207.76/207.98 |- skos__scopeNote mesh__D018102
% 207.76/207.98 A class of cell surface leukotriene receptors with a preference for leukotriene B4. Leukotriene B4 receptor activation influences chemotaxis, chemokinesis, adherence, enzyme release, oxidative bursts, and degranulation in polymorphonuclear leukocytes. There are at least two subtypes of these receptors. Some actions are mediated through the inositol phosphate and diacylglycerol second messenger systems.%A%
% 207.76/207.98 |- skos__annotation mesh__D018102 DF: RECEPT LEUKOTRIENE B4
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D018102 2004
% 207.76/207.98 |- mesh__onlineNote mesh__D018102
% 207.76/207.98 use RECEPTORS, LEUKOTRIENE B4 %28%NM%29% to search LEUKOTRIENE B4 RECEPTOR 1982-93%A%
% 207.76/207.98 |- skos__hiddenLabel mesh__D018102 Receptor, LTB4
% 207.76/207.98 |- mesh__dateEstablished mesh__D018102 1994-01-01
% 207.76/207.98 |- mesh__historyNote mesh__D018102
% 207.76/207.98 94; was LEUKOTRIENE B4 RECEPTOR %28%NM%29% 1982-93
% 207.76/207.98 |- mesh__recordOriginator mesh__D018102 RAZ
% 207.76/207.98 |- mesh__dateCreated mesh__D018102 1993-06-16
% 207.76/207.98 |- skos__altLabel mesh__D018102 LTB4 Receptors
% 207.76/207.98 |- mesh__dateRevised mesh__D018102 2003-07-09
% 207.76/207.98 |- mesh__recordMaintainer mesh__D018102 jmp
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D018102 2005
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D018102 sjn
% 207.76/207.98 |- skos__hiddenLabel mesh__D018102 Receptors, LTB4
% 207.76/207.98 |- skos__altLabel mesh__D018102 Leukotriene B4 Receptor
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D018102 2006
% 207.76/207.98 |- skos__broader mesh__D018102smesh__D018077
% 207.76/207.98 |- skos__prefLabel mesh__D018102 Receptors, Leukotriene B4
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D018102
% 207.76/207.98 94; LEUKOTRIENE B4 RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1985-93, RECEPTORS, ENDOGENOUS SUBSTANCES 1982-84 %26% RECEPTORS, HORMONE 1982%A%
% 207.76/207.98 |- skos__altLabel mesh__D018102 LTB4 Receptor
% 207.76/207.98 |- skos__hiddenLabel mesh__D018102 Receptor, Leukotriene B4
% 207.76/207.98 |- skos__altLabel mesh__D018102 Leukotriene B4 Receptors
% 207.76/207.98 |- skos__historyNote mesh__D018102 Receptors, Immunologic %28%1985-1993%29%
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D051536 2006
% 207.76/207.98 |- skos__annotation mesh__D051536 general; prefer specifics
% 207.76/207.98 |- rdf__type mesh__D051536sskos__Concept
% 207.76/207.98 |- mesh__historyNote mesh__D051536 2006
% 207.76/207.98 |- mesh__dateEstablished mesh__D051536 2006-01-01
% 207.76/207.98 |- skos__broader mesh__D051536smesh__D014157
% 207.76/207.98 |- skos__prefLabel mesh__D051536 Hepatocyte Nuclear Factors
% 207.76/207.98 |- mesh__dateCreated mesh__D051536 2005-06-30
% 207.76/207.98 |- skos__broader mesh__D051536smesh__D004268
% 207.76/207.98 |- skos__scopeNote mesh__D051536
% 207.76/207.98 Hepatocyte nuclear factors are a family of evolutionarily conserved transcription factors that are preferentially expressed in HEPATOCYTES. They play important roles in liver-specific transcription and are critical for CELL DIFFERENTIATION and METABOLISM.%A%
% 207.76/207.98 |- skos__broader mesh__D051536smesh__D009687
% 207.76/207.98 |- mesh__recordOriginator mesh__D051536 DRC
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D051536 2006
% 207.76/207.98 |- mesh__recordMaintainer mesh__D051536 DRC
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D051536 sjn
% 207.76/207.98 |- skos__hiddenLabel mesh__D009376 Neoplasms, Hormone Dependent
% 207.76/207.98 |- skos__broader mesh__D009376smesh__D009369
% 207.76/207.98 |- mesh__dateEstablished mesh__D009376 1979-01-01
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D009376 sjn
% 207.76/207.98 |- skos__prefLabel mesh__D009376 Neoplasms, Hormone-Dependent
% 207.76/207.98 |- skos__hiddenLabel mesh__D009376 Hormone Dependent Neoplasms
% 207.76/207.98 |- mesh__dateRevised mesh__D009376 2004-07-07
% 207.76/207.98 |- rdf__type mesh__D009376sskos__Concept
% 207.76/207.98 |- mesh__recordOriginator mesh__D009376 VDK
% 207.76/207.98 |- skos__hiddenLabel mesh__D009376 Neoplasm, Hormone-Dependent
% 207.76/207.98 |- mesh__historyNote mesh__D009376 79
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D009376 2005
% 207.76/207.98 |- skos__altLabel mesh__D009376 Hormone-Dependent Neoplasms
% 207.76/207.98 |- skos__hiddenLabel mesh__D009376 Hormone-Dependent Neoplasm
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D009376 2006
% 207.76/207.98 |- skos__scopeNote mesh__D009376
% 207.76/207.98 Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.%A%
% 207.76/207.98 |- mesh__recordMaintainer mesh__D009376 wdj
% 207.76/207.98 |- skos__related mesh__D009376smesh__D018931
% 207.76/207.98 |- mesh__dateCreated mesh__D009376 1978-05-19
% 207.76/207.98 |- skos__annotation mesh__D009376
% 207.76/207.98 /blood supply /chem /secret /ultrastruct permitted; /drug ther: consider also ANTINEOPLASTIC AGENTS, HORMONAL; coord IM with precoord organ/neopl term %28%IM%29% + histol type %28%IM%29% + specific hormone %28%IM%29%%A%
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D009376 79
% 207.76/207.98 |- skos__broader mesh__D005167Q000172smesh__D005167
% 207.76/207.98 |- mesh__preferredCombination mesh__D005167Q000172smesh__D005168
% 207.76/207.98 |- rdf__type mesh__D005167Q000172smesh__CompoundConcept
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D001393 2006
% 207.76/207.98 |- skos__broader mesh__D001393smesh__D006573
% 207.76/207.98 |- mesh__recordMaintainer mesh__D001393 ssb
% 207.76/207.98 |- skos__scopeNote mesh__D001393
% 207.76/207.98 Five membered rings containing a NITROGEN atom.
% 207.76/207.98 |- mesh__dateCreated mesh__D001393 1999-01-01
% 207.76/207.98 |- rdf__type mesh__D001393sskos__Concept
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D001393 sjn
% 207.76/207.98 |- mesh__dateRevised mesh__D001393 2005-06-30
% 207.76/207.98 |- skos__prefLabel mesh__D001393 Azoles
% 207.76/207.98 |- mesh__recordOriginator mesh__D001393 NLM
% 207.76/207.98 |- mesh__recordOriginator mesh__D042201 ags
% 207.76/207.98 |- mesh__recordMaintainer mesh__D042201 ags
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D042201 2004
% 207.76/207.98 |- skos__scopeNote mesh__D042201
% 207.76/207.98 A genus of microaerophilic, gram-negative bacteria that forms crystals of the mineral magnetite.%A%
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D042201 2006
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D042201 sjn
% 207.76/207.98 |- rdf__type mesh__D042201sskos__Concept
% 207.76/207.98 |- mesh__historyNote mesh__D042201 2004
% 207.76/207.98 |- skos__broader mesh__D042201smesh__D012244
% 207.76/207.98 |- mesh__dateEstablished mesh__D042201 2004-01-01
% 207.76/207.98 |- skos__prefLabel mesh__D042201 Magnetospirillum
% 207.76/207.98 |- mesh__dateCreated mesh__D042201 2003-07-09
% 207.76/207.98 |- mesh__dateRevised mesh__D042201 2005-06-30
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D047495 ags
% 207.76/207.98 |- skos__altLabel mesh__D047495
% 207.76/207.98 Peroxisome Proliferator-Activated Receptor gamma
% 207.76/207.98 |- mesh__historyNote mesh__D047495 2005%28%1992%29%
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D047495 2006
% 207.76/207.98 |- mesh__recordMaintainer mesh__D047495 ags
% 207.76/207.98 |- skos__scopeNote mesh__D047495
% 207.76/207.98 A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR ALPHA is important in regulation of GLUCOSE metabolism and CELL GROWTH PROCESSES. It is a target of THIAZOLIDINEDIONES for control of DIABETES MELLITUS.%A%
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D047495 2005
% 207.76/207.98 |- skos__altLabel mesh__D047495 PPARgamma
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D047495
% 207.76/207.98 2005; PPAR GAMMA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%
% 207.76/207.98 |- skos__hiddenLabel mesh__D047495
% 207.76/207.98 Peroxisome Proliferator Activated Receptor gamma
% 207.76/207.98 |- mesh__dateRevised mesh__D047495 2005-07-13
% 207.76/207.98 |- mesh__recordOriginator mesh__D047495 ssb
% 207.76/207.98 |- rdf__type mesh__D047495sskos__Concept
% 207.76/207.98 |- skos__altLabel mesh__D047495 Thiazolidinedione Receptor
% 207.76/207.98 |- skos__broader mesh__D047495smesh__D047492
% 207.76/207.98 |- skos__historyNote mesh__D047495 Transcription Factors %28%1993-2004%29%
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D047495 2006B
% 207.76/207.98 |- mesh__dateCreated mesh__D047495 2004-07-07
% 207.76/207.98 |- skos__prefLabel mesh__D047495 PPAR gamma
% 207.76/207.98 |- skos__hiddenLabel mesh__D047495 Receptor, Thiazolidinedione
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D047495 2006A
% 207.76/207.98 |- mesh__dateEstablished mesh__D047495 2005-01-01
% 207.76/207.98 |- skos__scopeNote mesh__D014510
% 207.76/207.98 An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5.%A%
% 207.76/207.98 |- mesh__dateCreated mesh__D014510 1999-01-01
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D014510 sjn
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D014510 2005
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D014510 2006
% 207.76/207.98 |- skos__hiddenLabel mesh__D014510 Amidohydrolase, Urea
% 207.76/207.98 |- mesh__recordOriginator mesh__D014510 NLM
% 207.76/207.98 |- skos__altLabel mesh__D014510 Urea Amidohydrolase
% 207.76/207.98 |- mesh__dateRevised mesh__D014510 2003-07-09
% 207.76/207.98 |- skos__prefLabel mesh__D014510 Urease
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D014510 2004
% 207.76/207.98 |- mesh__recordMaintainer mesh__D014510 ssb
% 207.76/207.98 |- skos__broader mesh__D014510smesh__D000581
% 207.76/207.98 |- rdf__type mesh__D014510sskos__Concept
% 207.76/207.98 |- skos__broader mesh__D001205Q000172smesh__D001205
% 207.76/207.98 |- mesh__preferredCombination mesh__D001205Q000172smesh__D001206
% 207.76/207.98 |- rdf__type mesh__D001205Q000172smesh__CompoundConcept
% 207.76/207.98 |- rdf__type mesh__D005784sskos__Concept
% 207.76/207.98 |- skos__annotation mesh__D005784
% 207.76/207.98 for physiol process only; for technique use NUCLEIC ACID AMPLIFICATION TECHNIQUES or specifics%A%
% 207.76/207.98 |- skos__historyNote mesh__D005784 Plasmids %28%1975-1979%29%
% 207.76/207.98 |- skos__scopeNote mesh__D005784
% 207.76/207.98 A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication.%A%
% 207.76/207.98 |- skos__broader mesh__D005784smesh__D009154
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D005784 2005
% 207.76/207.98 |- mesh__recordMaintainer mesh__D005784 NDW
% 207.76/207.98 |- skos__historyNote mesh__D005784 Genes, Structural %28%1968-1979%29%
% 207.76/207.98 |- skos__broader mesh__D005784smesh__D016296
% 207.76/207.98 |- mesh__dateCreated mesh__D005784 1979-04-17
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D005784 80
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D005784 2003
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D005784 2006
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D005784 sjn
% 207.76/207.98 |- mesh__recordOriginator mesh__D005784 AEP
% 207.76/207.98 |- skos__historyNote mesh__D005784 Genes %28%1966-1967%29%
% 207.76/207.98 |- skos__related mesh__D005784smesh__D018628
% 207.76/207.98 |- skos__broader mesh__D005784smesh__D005786
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D005784 2004
% 207.76/207.98 |- mesh__dateEstablished mesh__D005784 1980-01-01
% 207.76/207.98 |- skos__hiddenLabel mesh__D005784 Amplification, Gene
% 207.76/207.98 |- skos__prefLabel mesh__D005784 Gene Amplification
% 207.76/207.98 |- skos__historyNote mesh__D005784
% 207.76/207.98 Nucleic Acid Hybridization %28%1971-1979%29%
% 207.76/207.98 |- mesh__historyNote mesh__D005784 80
% 207.76/207.98 |- mesh__dateRevised mesh__D005784 2002-07-02
% 207.76/207.98 |- mesh__dateCreated mesh__D013418 1999-01-01
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013418 2003
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013418 2002
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013418 2004
% 207.76/207.98 |- skos__prefLabel mesh__D013418 Sulfamethazine
% 207.76/207.98 |- mesh__recordMaintainer mesh__D013418 jmp
% 207.76/207.98 |- rdf__type mesh__D013418sskos__Concept
% 207.76/207.98 |- skos__broader mesh__D013418smesh__D013424
% 207.76/207.98 |- skos__altLabel mesh__D013418 Sulphamezathine
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D013418 sjn
% 207.76/207.98 |- mesh__recordOriginator mesh__D013418 NLM
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013418 2000
% 207.76/207.98 |- skos__altLabel mesh__D013418 Sulfadimidine
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013418 2005
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013418 2001
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D013418 2006
% 207.76/207.98 |- skos__altLabel mesh__D013418 Sulfadimezine
% 207.76/207.98 |- mesh__dateRevised mesh__D013418 1999-11-03
% 207.76/207.98 |- skos__scopeNote mesh__D013418
% 207.76/207.98 A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.%A%
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Dysfunctions, General Peroxisomal
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Dysfunctions, Single Peroxisomal
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Acidemias, Hyperpipecolic
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Peroxisomal Dysfunctions, Multiple
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Single Peroxisomal Dysfunctions
% 207.76/207.98 |- rdf__type mesh__D018901sskos__Concept
% 207.76/207.98 |- skos__prefLabel mesh__D018901 Peroxisomal Disorders
% 207.76/207.98 |- skos__scopeNote mesh__D018901
% 207.76/207.98 A heterogeneous group of inherited metabolic disorders marked by absent or dysfunctional PEROXISOMES. Peroxisomal enzymatic abnormalities may be single or multiple. Biosynthetic peroxisomal pathways are compromised, including the ability to synthesize ether lipids and to oxidize long-chain fatty acid precursors. Diseases in this category include ZELLWEGER SYNDROME; infantile Refsum disease; rhizomelic chondrodysplasia %28%CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC%29%; hyperpipecolic acidemia; neonatal adrenoleukodystrophy; and ADRENOLEUKODYSTROPHY %28%X-linked%29%. Neurologic dysfunction is a prominent feature of most peroxisomal disorders.%A%
% 207.76/207.98 |- mesh__dateEstablished mesh__D018901 1996-01-01
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Single Peroxisomal Dysfunction
% 207.76/207.98 |- skos__broader mesh__D018901smesh__D020739
% 207.76/207.98 |- skos__altLabel mesh__D018901 Refsum%27%s Disease, Infantile
% 207.76/207.98 |- skos__broader mesh__D018901smesh__D008052
% 207.76/207.98 |- mesh__recordMaintainer mesh__D018901 nns
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Hyperpipecolic Acidemias
% 207.76/207.98 |- skos__annotation mesh__D018901
% 207.76/207.98 GEN or unspecified; prefer specifics; do not confuse X ref REFSUM DISEASE, INFANTILE with REFSUM DISEASE, a hered peripheral neuropathy; do not confuse X ref ADRENOLEUKODYSTROPHY, NEONATAL with ADRENOLEUKODYSTROPHY; do not use /in inf%A%
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Peroxisomal Dysfunctions, General
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Refsums Disease, Infantile
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D018901 2005
% 207.76/207.98 |- mesh__dateRevised mesh__D018901 2001-07-25
% 207.76/207.98 |- mesh__recordAuthorizer mesh__D018901 sjn
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Multiple Peroxisomal Dysfunctions
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 General Peroxisomal Dysfunctions
% 207.76/207.98 |- skos__altLabel mesh__D018901 Infantile Refsum Disease
% 207.76/207.98 |- mesh__recordOriginator mesh__D018901 AGS
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D018901 2006
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Dysfunction, Single Peroxisomal
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Neonatal Adrenoleukodystrophy
% 207.76/207.98 |- skos__historyNote mesh__D018901
% 207.76/207.98 Metabolism, Inborn Errors %28%1988-1995%29%
% 207.76/207.98 |- skos__altLabel mesh__D018901 Infantile Refsum%27%s Disease
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Peroxisomal Disorder
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Dysfunction, General Peroxisomal
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D018901 2002
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Neonatal Adrenoleukodystrophies
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Dysfunctions, Multiple Peroxisomal
% 207.76/207.98 |- mesh__dateCreated mesh__D018901 1994-12-27
% 207.76/207.98 |- mesh__activeMeSHYear mesh__D018901 2003
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Multiple Peroxisomal Dysfunction
% 207.76/207.98 |- mesh__historyNote mesh__D018901 96
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Infantile Refsums Disease
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Acidemia, Hyperpipecolic
% 207.76/207.98 |- mesh__publicMeSHNote mesh__D018901 96
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Dysfunction, Multiple Peroxisomal
% 207.76/207.98 |- skos__historyNote mesh__D018901
% 207.76/207.98 Lipid Metabolism, Inborn Errors %28%1988-1995%29%
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Adrenoleukodystrophies, Neonatal
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 Peroxisomal Dysfunctions, Single
% 207.76/207.98 |- skos__hiddenLabel mesh__D018901 General Peroxisomal Dysfunction
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018901 2004
% 207.76/207.99 |- skos__historyNote mesh__D018103 Paramyxoviridae %28%1983-1993%29%
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018103 2004
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D018103
% 207.76/207.99 94; MORBILLI VIRUS was see MEASLES VIRUS 1975-93
% 207.76/207.99 |- skos__scopeNote mesh__D018103
% 207.76/207.99 A genus of the family PARAMYXOVIRIDAE %28%subfamily PARAMYXOVIRINAE%29% where the virions of most members have hemagglutinin but not neuraminidase activity. All members produce both cytoplasmic and intranuclear inclusion bodies. MEASLES VIRUS is the type species.%A%
% 207.76/207.99 |- mesh__onlineNote mesh__D018103
% 207.76/207.99 use MEASLES VIRUS to search MORBILLI VIRUS 1975-93
% 207.76/207.99 |- mesh__recordOriginator mesh__D018103 AGS
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018103 2005
% 207.76/207.99 |- skos__historyNote mesh__D018103 specific Morbillivirus %28%1979-1993%29%
% 207.76/207.99 |- skos__altLabel mesh__D018103 Morbilli Virus
% 207.76/207.99 |- mesh__dateEstablished mesh__D018103 1994-01-01
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018103 2002
% 207.76/207.99 |- mesh__dateRevised mesh__D018103 2001-08-03
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018103 2006
% 207.76/207.99 |- skos__hiddenLabel mesh__D018103 Morbilliviruses
% 207.76/207.99 |- mesh__historyNote mesh__D018103
% 207.76/207.99 94; MORBILLI VIRUS was see MEASLES VIRUS 1975-93
% 207.76/207.99 |- skos__annotation mesh__D018103
% 207.76/207.99 %22%morbilli virus%22% sometimes refers to the genus Morbillivirus %26% sometimes to MEASLES VIRUS: check text; infection = MORBILLIVIRUS INFECTIONS%A%
% 207.76/207.99 |- mesh__recordMaintainer mesh__D018103 sjn
% 207.76/207.99 |- skos__broader mesh__D018103smesh__D018098
% 207.76/207.99 |- mesh__dateCreated mesh__D018103 1993-06-04
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018103 2003
% 207.76/207.99 |- skos__prefLabel mesh__D018103 Morbillivirus
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D018103 sjn
% 207.76/207.99 |- rdf__type mesh__D018103sskos__Concept
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D010120 sjn
% 207.76/207.99 |- skos__altLabel mesh__D010120 Oxytocic Drugs
% 207.76/207.99 |- rdf__type mesh__D010120sskos__Concept
% 207.76/207.99 |- mesh__recordOriginator mesh__D010120 NLM
% 207.76/207.99 |- skos__hiddenLabel mesh__D010120 Drugs, Oxytocic
% 207.76/207.99 |- mesh__dateCreated mesh__D010120 1999-01-01
% 207.76/207.99 |- skos__hiddenLabel mesh__D010120 Agents, Oxytocic
% 207.76/207.99 |- skos__broader mesh__D010120smesh__D012102
% 207.76/207.99 |- skos__annotation mesh__D010120
% 207.76/207.99 no qualif for oxytocics when used to induce labor
% 207.76/207.99 |- skos__hiddenLabel mesh__D010120 Stimulants, Uterine
% 207.76/207.99 |- skos__scopeNote mesh__D010120
% 207.76/207.99 Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions %28%ABORTIFACIENTS%29%. Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. %28%From AMA Drug Evaluations, 1994, p1157%29%%A%
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D010120 2006
% 207.76/207.99 |- skos__altLabel mesh__D010120 Uterine Stimulants
% 207.76/207.99 |- skos__altLabel mesh__D010120 Oxytocic Agents
% 207.76/207.99 |- mesh__dateRevised mesh__D010120 2005-06-30
% 207.76/207.99 |- mesh__recordMaintainer mesh__D010120 ssb
% 207.76/207.99 |- skos__prefLabel mesh__D010120 Oxytocics
% 207.76/207.99 |- skos__altLabel mesh__D051537 Hepatic Nuclear Factor 1
% 207.76/207.99 |- mesh__recordMaintainer mesh__D051537 DRC
% 207.76/207.99 |- skos__prefLabel mesh__D051537 Hepatocyte Nuclear Factor 1
% 207.76/207.99 |- mesh__recordOriginator mesh__D051537 DRC
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D051537 2006
% 207.76/207.99 |- skos__scopeNote mesh__D051537
% 207.76/207.99 A transcription factor that regulates the expression of a large set of hepatic proteins including SERUM ALBUMIN; beta-fibrinogen; and ALPHA 1-ANTITRYPSIN. It is composed of hetero- or homo-dimers of HEPATOCYTE NUCLEAR FACTOR 1-ALPHA and HEPATOCYTE NUCLEAR FACTOR 1-BETA.%A%
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D051537 sjn
% 207.76/207.99 |- mesh__dateEstablished mesh__D051537 2006-01-01
% 207.76/207.99 |- skos__altLabel mesh__D051537 HNF-1 Protein
% 207.76/207.99 |- mesh__dateCreated mesh__D051537 2005-07-06
% 207.76/207.99 |- skos__hiddenLabel mesh__D051537 HNF 1 Protein
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D051537
% 207.76/207.99 2006; HEPATOCYTE NUCLEAR FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A%
% 207.76/207.99 |- skos__broader mesh__D051537smesh__D051536
% 207.76/207.99 |- rdf__type mesh__D051537sskos__Concept
% 207.76/207.99 |- skos__altLabel mesh__D051537 HNF1 Transcription Factor
% 207.76/207.99 |- mesh__historyNote mesh__D051537 2006%28%1989%29%
% 207.76/207.99 |- skos__hiddenLabel mesh__D051537 Transcription Factor, HNF1
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Adenopathy, Multiple Endocrine
% 207.76/207.99 |- skos__prefLabel mesh__D009377 Multiple Endocrine Neoplasia
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Multiple Endocrine Adenomatoses
% 207.76/207.99 |- skos__altLabel mesh__D009377 Neoplasms, Multiple Endocrine
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Endocrine Adenopathy, Multiple
% 207.76/207.99 |- skos__scopeNote mesh__D009377
% 207.76/207.99 A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively.%A%
% 207.76/207.99 |- mesh__dateEstablished mesh__D009377 1965-01-01
% 207.76/207.99 |- skos__broader mesh__D009377smesh__D009378
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D009377
% 207.76/207.99 95; was NEOPLASMS, MULTIPLE ENDOCRINE 1983-94; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82%A%
% 207.76/207.99 |- skos__altLabel mesh__D009377 Multiple Endocrine Neoplasia Syndromes
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Endocrine Adenopathies, Multiple
% 207.76/207.99 |- rdf__type mesh__D009377sskos__Concept
% 207.76/207.99 |- mesh__recordMaintainer mesh__D009377 lkt
% 207.76/207.99 |- skos__altLabel mesh__D009377 Endocrine Neoplasia, Multiple
% 207.76/207.99 |- skos__broader mesh__D009377smesh__D009386
% 207.76/207.99 |- skos__altLabel mesh__D009377 Multiple Endocrine Neoplasms
% 207.76/207.99 |- mesh__recordOriginator mesh__D009377 NLM
% 207.76/207.99 |- skos__altLabel mesh__D009377 Multiple Endocrine Adenopathy
% 207.76/207.99 |- skos__annotation mesh__D009377
% 207.76/207.99 general or unspecified; prefer specifics; coordinate IM with specific endocrine/neoplasm pre-coordinates %28%IM%29% + specific histological type %28%IM%29% if pertinent; DF MULTIPLE ENDOCRINE NEOPL%A%
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Endocrine Adenomatosis, Familial
% 207.76/207.99 |- mesh__dateRevised mesh__D009377 2005-06-30
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D009377 sjn
% 207.76/207.99 |- mesh__dateCreated mesh__D009377 1999-01-01
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Multiple Endocrine Adenopathies
% 207.76/207.99 |- skos__altLabel mesh__D009377 Neoplasia, Multiple Endocrine
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Familial Endocrine Adenomatosis
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Endocrine Adenomatoses, Multiple
% 207.76/207.99 |- skos__altLabel mesh__D009377 Adenomatosis, Familial Endocrine
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Familial Endocrine Adenomatoses
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Adenomatoses, Multiple Endocrine
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Endocrine Neoplasms, Multiple
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D009377 2006
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Endocrine Adenomatosis, Multiple
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Multiple Endocrine Adenomatosis
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Endocrine Adenomatoses, Familial
% 207.76/207.99 |- mesh__onlineNote mesh__D009377
% 207.76/207.99 use MULTIPLE ENDOCRINE NEOPLASIA to search NEOPLASMS, MULTIPLE ENDOCRINE 1983-94 %26% ADENOMATOSIS, FAMILIAL ENDOCRINE 1966-82%A%
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Adenomatoses, Familial Endocrine
% 207.76/207.99 |- skos__altLabel mesh__D009377 Adenomatosis, Multiple Endocrine
% 207.76/207.99 |- skos__hiddenLabel mesh__D009377 Adenopathies, Multiple Endocrine
% 207.76/207.99 |- mesh__historyNote mesh__D009377
% 207.76/207.99 95; was NEOPLASMS, MULTIPLE ENDOCRINE 1983-94; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82 %28%Prov 1964%29%%A%
% 207.76/207.99 |- skos__broader mesh__D009377smesh__D004701
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 2005
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 2000
% 207.76/207.99 |- mesh__recordOriginator mesh__D001394 NLM
% 207.76/207.99 |- skos__broader mesh__D001394smesh__D001266
% 207.76/207.99 |- mesh__dateCreated mesh__D001394 1999-01-01
% 207.76/207.99 |- rdf__type mesh__D001394sskos__Concept
% 207.76/207.99 |- mesh__dateRevised mesh__D001394 1995-02-17
% 207.76/207.99 |- skos__prefLabel mesh__D001394 Azores
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 1997
% 207.76/207.99 |- skos__scopeNote mesh__D001394
% 207.76/207.99 A group of nine islands and several islets belonging to Portugal in the north Atlantic Ocean off the coast of Portugal. The islands are named after the acores, the Portuguese for goshawks, living there in abundance. %28%Webster%27%s New Geographical Dictionary, 1988, p102 %26% Room, Brewer%27%s Dictionary of Names, 1992, p42%29%%A%
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 1999
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 1996
% 207.76/207.99 |- skos__annotation mesh__D001394
% 207.76/207.99 a group of 9 Atlantic islands off the coast of Portugal
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 1998
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 2002
% 207.76/207.99 |- mesh__recordMaintainer mesh__D001394 TGC
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D001394 PLS
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 2004
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 2001
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 2006
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D001394 2003
% 207.76/207.99 |- mesh__recordOriginator mesh__D017809 TGC
% 207.76/207.99 |- skos__prefLabel mesh__D017809 Fatal Outcome
% 207.76/207.99 |- mesh__dateRevised mesh__D017809 2004-07-07
% 207.76/207.99 |- mesh__historyNote mesh__D017809 94
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D017809 sjn
% 207.76/207.99 |- skos__hiddenLabel mesh__D017809 Outcomes, Fatal
% 207.76/207.99 |- mesh__recordMaintainer mesh__D017809 lkt
% 207.76/207.99 |- skos__hiddenLabel mesh__D017809 Fatal Outcomes
% 207.76/207.99 |- skos__broader mesh__D017809smesh__D009026
% 207.76/207.99 |- skos__scopeNote mesh__D017809
% 207.76/207.99 Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.%A%
% 207.76/207.99 |- rdf__type mesh__D017809sskos__Concept
% 207.76/207.99 |- skos__related mesh__D017809smesh__D003643
% 207.76/207.99 |- skos__hiddenLabel mesh__D017809 Outcome, Fatal
% 207.76/207.99 |- skos__historyNote mesh__D017809 specific disease %28%1966-1993%29%
% 207.76/207.99 |- mesh__dateCreated mesh__D017809 1993-05-28
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D017809 2006
% 207.76/207.99 |- skos__annotation mesh__D017809
% 207.76/207.99 never IM; used only for individual fatalities: do not confuse with MORTALITY or /mortal, both epidemiological %26% statistical concepts, or with DEATH, a physiological process; do not use for animal toxicity studies %28% = /toxicity%29%; coordinate with specific disease or procedure with no qualifiers %28%IM%29%; index CASE REPORTS %5B%Publication Type%5D%%A%
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D017809 2005
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D017809 94
% 207.76/207.99 |- skos__historyNote mesh__D017809 specific procedure %28%1966-1993%29%
% 207.76/207.99 |- mesh__dateEstablished mesh__D017809 1994-01-01
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 2001
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 2006
% 207.76/207.99 |- mesh__recordMaintainer mesh__D014511 RAZ
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 2002
% 207.76/207.99 |- skos__hiddenLabel mesh__D014511 Azotemias
% 207.76/207.99 |- skos__prefLabel mesh__D014511 Uremia
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 1996
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D014511 PLS
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 1997
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 2003
% 207.76/207.99 |- skos__annotation mesh__D014511
% 207.76/207.99 azotemia in foreign lit means often UREMIA %26% often BLOOD UREA NITROGEN%A%
% 207.76/207.99 |- mesh__recordOriginator mesh__D014511 NLM
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 1998
% 207.76/207.99 |- skos__broader mesh__D014511smesh__D007674
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 2004
% 207.76/207.99 |- rdf__type mesh__D014511sskos__Concept
% 207.76/207.99 |- mesh__dateRevised mesh__D014511 1995-06-09
% 207.76/207.99 |- mesh__dateCreated mesh__D014511 1999-01-01
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 1999
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 2000
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D014511 2005
% 207.76/207.99 |- skos__hiddenLabel mesh__D014511 Uremias
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D005785 sjn
% 207.76/207.99 |- skos__hiddenLabel mesh__D005785 Polar Recombinations
% 207.76/207.99 |- skos__historyNote mesh__D005785 Mutation %28%1966-1979%29%
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D005785 80
% 207.76/207.99 |- skos__hiddenLabel mesh__D005785 Gene Conversions
% 207.76/207.99 |- skos__hiddenLabel mesh__D005785 Recombinations, Polar
% 207.76/207.99 |- skos__hiddenLabel mesh__D005785 Conversions, Gene
% 207.76/207.99 |- mesh__recordOriginator mesh__D005785 AEP
% 207.76/207.99 |- skos__hiddenLabel mesh__D005785 Recombination, Polar
% 207.76/207.99 |- skos__historyNote mesh__D005785 Recombination, Genetic %28%1968-1979%29%
% 207.76/207.99 |- skos__hiddenLabel mesh__D005785 Polarons
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D005785 2004
% 207.76/207.99 |- mesh__dateRevised mesh__D005785 2002-07-03
% 207.76/207.99 |- mesh__recordMaintainer mesh__D005785 KEV
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D005785 2006
% 207.76/207.99 |- mesh__dateCreated mesh__D005785 1979-05-23
% 207.76/207.99 |- mesh__historyNote mesh__D005785 80
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D005785 2003
% 207.76/207.99 |- skos__scopeNote mesh__D005785
% 207.76/207.99 The asymmetrical segregation of genes during replication which leads to the production of non-reciprocal recombinant strands and the apparent conversion of one allele into another. Thus, e.g., the meiotic products of an Aa individual may be AAAa or aaaA instead of AAaa, i.e., the A allele has been converted into the a allele or vice versa.%A%
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D005785 2005
% 207.76/207.99 |- rdf__type mesh__D005785sskos__Concept
% 207.76/207.99 |- skos__hiddenLabel mesh__D005785 Conversion, Gene
% 207.76/207.99 |- mesh__dateEstablished mesh__D005785 1980-01-01
% 207.76/207.99 |- skos__broader mesh__D005785smesh__D011995
% 207.76/207.99 |- skos__prefLabel mesh__D005785 Gene Conversion
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D038161 2004
% 207.76/207.99 |- mesh__dateCreated mesh__D038161 2002-07-03
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D038161 2003
% 207.76/207.99 |- mesh__dateEstablished mesh__D038161 2003-01-01
% 207.76/207.99 |- skos__broader mesh__D038161smesh__D013177
% 207.76/207.99 |- skos__prefLabel mesh__D038161 Snow Sports
% 207.76/207.99 |- rdf__type mesh__D038161sskos__Concept
% 207.76/207.99 |- skos__scopeNote mesh__D038161 Sports activities in the snow.
% 207.76/207.99 |- skos__historyNote mesh__D038161 Skiing %28%1963-2002%29%
% 207.76/207.99 |- skos__hiddenLabel mesh__D038161 Sports, Snow
% 207.76/207.99 |- skos__hiddenLabel mesh__D038161 Sport, Snow
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D038161 2006
% 207.76/207.99 |- skos__annotation mesh__D038161
% 207.76/207.99 /inj: coord with specific injury %28%IM%29%
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D038161 2003
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D038161 2005
% 207.76/207.99 |- mesh__historyNote mesh__D038161 2003
% 207.76/207.99 |- skos__hiddenLabel mesh__D038161 Snow Sport
% 207.76/207.99 |- rdf__type mesh__D013419sskos__Concept
% 207.76/207.99 |- skos__altLabel mesh__D013419 Wyeth Brand of Sulfamethizole
% 207.76/207.99 |- skos__prefLabel mesh__D013419 Sulfamethizole
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D013419
% 207.76/207.99 91; was see under SULFATHIAZOLES 1963-90
% 207.76/207.99 |- skos__altLabel mesh__D013419 Sulphamethizole
% 207.76/207.99 |- skos__altLabel mesh__D013419 Urgo Brand of Sulfamethizole
% 207.76/207.99 |- mesh__historyNote mesh__D013419
% 207.76/207.99 91%28%63%29%; was see under SULFATHIAZOLES 1963-90
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D013419 sjn
% 207.76/207.99 |- mesh__dateRevised mesh__D013419 2005-06-30
% 207.76/207.99 |- mesh__recordMaintainer mesh__D013419 CCR
% 207.76/207.99 |- mesh__recordOriginator mesh__D013419 NLM
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D013419 2006
% 207.76/207.99 |- skos__altLabel mesh__D013419 FNA Brand of Sulfamethizole
% 207.76/207.99 |- mesh__dateCreated mesh__D013419 1999-01-01
% 207.76/207.99 |- skos__broader mesh__D013419smesh__D013432
% 207.76/207.99 |- skos__scopeNote mesh__D013419 A sulfathiazole antibacterial agent.
% 207.76/207.99 |- skos__hiddenLabel mesh__D013419 FNA, Sulfamethizol
% 207.76/207.99 |- mesh__dateEstablished mesh__D013419 1991-01-01
% 207.76/207.99 |- skos__scopeNote mesh__D024141
% 207.76/207.99 A non-fibrillar collagen found in the structure of BASEMENT MEMBRANE. Collagen type IV molecules assemble to form a sheet-like network which is involved in maintaining the structural integrity of basement membranes. The predominant form of the protein is comprised of two alpha1%28%IV%29% subunits and one alpha2%28%IV%29% subunit, however, at least six different alpha subunits can be incorporated into the heterotrimer.%A%
% 207.76/207.99 |- skos__altLabel mesh__D024141 Type IV Collagen
% 207.76/207.99 |- skos__annotation mesh__D024141
% 207.76/207.99 precursors: coord IM with PROCOLLAGEN %28%IM%29%
% 207.76/207.99 |- skos__historyNote mesh__D024141 Collagen %28%1978-2001%29%
% 207.76/207.99 |- mesh__historyNote mesh__D024141
% 207.76/207.99 2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE IV use PROCOLLAGEN 1982-2001; for 7S COLLAGEN use COLLAGEN 1982-2001%A%
% 207.76/207.99 |- skos__altLabel mesh__D024141 Collagen Type IV, alpha2 Chain
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D024141
% 207.76/207.99 2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE IV see PROCOLLAGEN 1982-2001; for 7S COLLAGEN see COLLAGEN 1982-2001%A%
% 207.76/207.99 |- skos__hiddenLabel mesh__D024141 Collagen, Type IV
% 207.76/207.99 |- skos__hiddenLabel mesh__D024141 Collagen, 7S
% 207.76/207.99 |- skos__prefLabel mesh__D024141 Collagen Type IV
% 207.76/207.99 |- mesh__dateRevised mesh__D024141 2004-07-07
% 207.76/207.99 |- mesh__dateCreated mesh__D024141 2001-07-25
% 207.76/207.99 |- mesh__dateEstablished mesh__D024141 2002-01-01
% 207.76/207.99 |- skos__altLabel mesh__D024141 Type IV %28%Basement Membrane%29% Collagen
% 207.76/207.99 |- skos__altLabel mesh__D024141 alpha1%28%IV%29% collagen
% 207.76/207.99 |- rdf__type mesh__D024141sskos__Concept
% 207.76/207.99 |- skos__broader mesh__D024141smesh__D024041
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D024141 2006
% 207.76/207.99 |- skos__hiddenLabel mesh__D024141 Procollagen, Type IV
% 207.76/207.99 |- skos__altLabel mesh__D024141 Collagen alpha1%28%IV%29%
% 207.76/207.99 |- mesh__recordOriginator mesh__D024141 jmp
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D024141 sjn
% 207.76/207.99 |- skos__altLabel mesh__D024141 Type IV Procollagen
% 207.76/207.99 |- skos__altLabel mesh__D024141 Collagen Type IV, alpha1 Chain
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D024141 2005
% 207.76/207.99 |- mesh__recordMaintainer mesh__D024141 jmp
% 207.76/207.99 |- skos__historyNote mesh__D018902
% 207.76/207.99 Chondrodysplasia Punctata %28%1971-1995%29%
% 207.76/207.99 |- skos__annotation mesh__D018902
% 207.76/207.99 a form of osteochondrodysplasia with stippled epiphyses; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018902 2006
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D018902 96
% 207.76/207.99 |- skos__scopeNote mesh__D018902
% 207.76/207.99 An autosomal recessive form of CHONDRODYSPLASIA PUNCTATA characterized by defective plasmalogen biosynthesis and impaired peroxisomes. Patients have shortened proximal limbs and severely disturbed endochondral bone formation. The metabolic defects associated with the impaired peroxisomes are present only in the rhizomelic form of chondrodysplasia punctata. %28%From Scriver et al, Metabolic Basis of Inherited Disease, 6th ed, p1497%29%%A%
% 207.76/207.99 |- mesh__recordMaintainer mesh__D018902 jls
% 207.76/207.99 |- skos__broader mesh__D018902smesh__D002806
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D018902 sjn
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018902 2005
% 207.76/207.99 |- skos__altLabel mesh__D018902 Rhizomelic Chondrodysplasia Punctata
% 207.76/207.99 |- mesh__dateRevised mesh__D018902 2004-07-19
% 207.76/207.99 |- skos__hiddenLabel mesh__D018902 Punctata, Rhizomelic Chondrodysplasia
% 207.76/207.99 |- mesh__dateEstablished mesh__D018902 1996-01-01
% 207.76/207.99 |- mesh__dateCreated mesh__D018902 1994-12-27
% 207.76/207.99 |- skos__broader mesh__D018902smesh__D018901
% 207.76/207.99 |- skos__prefLabel mesh__D018902 Chondrodysplasia Punctata, Rhizomelic
% 207.76/207.99 |- mesh__historyNote mesh__D018902 96
% 207.76/207.99 |- mesh__recordOriginator mesh__D018902 AGS
% 207.76/207.99 |- rdf__type mesh__D018902sskos__Concept
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018104 2005
% 207.76/207.99 |- skos__hiddenLabel mesh__D018104 Seal Distemper Viruses
% 207.76/207.99 |- skos__historyNote mesh__D018104 Paramyxoviridae %28%1989-1993%29%
% 207.76/207.99 |- skos__hiddenLabel mesh__D018104 Distemper Viruses, Seal
% 207.76/207.99 |- skos__hiddenLabel mesh__D018104 Distemper Virus, Seal
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018104 2006
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D018104 sjn
% 207.76/207.99 |- skos__hiddenLabel mesh__D018104 Phocid Distemper Virus
% 207.76/207.99 |- mesh__dateCreated mesh__D018104 1993-06-03
% 207.76/207.99 |- mesh__recordMaintainer mesh__D018104 ags
% 207.76/207.99 |- skos__hiddenLabel mesh__D018104 Phocine Distemper Viruses
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018104 2003
% 207.76/207.99 |- mesh__dateRevised mesh__D018104 2001-07-25
% 207.76/207.99 |- rdf__type mesh__D018104sskos__Concept
% 207.76/207.99 |- skos__scopeNote mesh__D018104
% 207.76/207.99 A species of MORBILLIVIRUS causing distemper in seals.
% 207.76/207.99 |- skos__hiddenLabel mesh__D018104 Distemper Viruses, Phocine
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018104 2004
% 207.76/207.99 |- skos__altLabel mesh__D018104 Distemper Virus, Phocid
% 207.76/207.99 |- skos__altLabel mesh__D018104 Phocine distemper virus
% 207.76/207.99 |- skos__broader mesh__D018104smesh__D018103
% 207.76/207.99 |- mesh__dateEstablished mesh__D018104 1994-01-01
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D018104 94
% 207.76/207.99 |- mesh__recordOriginator mesh__D018104 AGS
% 207.76/207.99 |- mesh__historyNote mesh__D018104 94
% 207.76/207.99 |- skos__annotation mesh__D018104
% 207.76/207.99 infection: coord IM with DISTEMPER %28%IM%29%; DISTEMPER VIRUS, CANINE is also available%A%
% 207.76/207.99 |- skos__prefLabel mesh__D018104 Distemper Virus, Phocine
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D018104 2002
% 207.76/207.99 |- skos__hiddenLabel mesh__D018104 Distemper Viruses, Phocid
% 207.76/207.99 |- skos__hiddenLabel mesh__D018104 Phocid Distemper Viruses
% 207.76/207.99 |- skos__altLabel mesh__D018104 Seal Distemper Virus
% 207.76/207.99 |- skos__broader mesh__D010121smesh__D010909
% 207.76/207.99 |- skos__altLabel mesh__D010121 Ocytocin
% 207.76/207.99 |- mesh__dateRevised mesh__D010121 2005-06-30
% 207.76/207.99 |- mesh__recordMaintainer mesh__D010121 ssb
% 207.76/207.99 |- mesh__dateCreated mesh__D010121 1999-01-01
% 207.76/207.99 |- mesh__onlineNote mesh__D010121
% 207.76/207.99 use OXYTOCIN to search ALPHA-HYPOPHAMINE 1977-93 %26% ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, %26% 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN 1983-93%A%
% 207.76/207.99 |- skos__broader mesh__D010121smesh__D014667
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D010121 sjn
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D010121
% 207.76/207.99 ALPHA-HYPOPHAMINE was see OXYTOCIN 1977-93; ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, %26% 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN were see OXYTOCIN 1983-93%A%
% 207.76/207.99 |- skos__prefLabel mesh__D010121 Oxytocin
% 207.76/207.99 |- mesh__recordOriginator mesh__D010121 NLM
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D010121 2006
% 207.76/207.99 |- skos__scopeNote mesh__D010121
% 207.76/207.99 A nonapeptide posterior pituitary hormone that causes UTERINE CONTRACTIONS and stimulates MILK EJECTION.%A%
% 207.76/207.99 |- skos__related mesh__D010121smesh__D018045
% 207.76/207.99 |- mesh__historyNote mesh__D010121
% 207.76/207.99 ALPHA-HYPOPHAMINE was see OXYTOCIN 1977-93; ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, %26% 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN were see OXYTOCIN 1983-93%A%
% 207.76/207.99 |- rdf__type mesh__D010121sskos__Concept
% 207.76/207.99 |- skos__altLabel mesh__D051538 Liver-Specific Transcription Factor LF-B1
% 207.76/207.99 |- mesh__recordOriginator mesh__D051538 DRC
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D051538 2006
% 207.76/207.99 |- mesh__dateCreated mesh__D051538 2005-06-30
% 207.76/207.99 |- skos__prefLabel mesh__D051538 Hepatocyte Nuclear Factor 1-alpha
% 207.76/207.99 |- skos__hiddenLabel mesh__D051538 Hepatocyte Nuclear Factor 1 alpha
% 207.76/207.99 |- mesh__recordMaintainer mesh__D051538 DRC
% 207.76/207.99 |- skos__hiddenLabel mesh__D051538
% 207.76/207.99 Liver Specific Transcription Factor LF B1
% 207.76/207.99 |- skos__broader mesh__D051538smesh__D051537
% 207.76/207.99 |- skos__hiddenLabel mesh__D051538 HNF 1alpha
% 207.76/207.99 |- skos__altLabel mesh__D051538 HNF-1alpha
% 207.76/207.99 |- rdf__type mesh__D051538sskos__Concept
% 207.76/207.99 |- skos__scopeNote mesh__D051538
% 207.76/207.99 Hepatocyte nuclear factor 1-alpha is a transcription factor found in the LIVER; PANCREAS; and KIDNEY that regulates HOMEOSTASIS of GLUCOSE.%A%
% 207.76/207.99 |- mesh__recordAuthorizer mesh__D051538 sjn
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D051538
% 207.76/207.99 2006; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A%
% 207.76/207.99 |- skos__altLabel mesh__D051538 LFB1 Transcription Factor
% 207.76/207.99 |- skos__altLabel mesh__D051538 Hepatocyte Nuclear Factor 1alpha
% 207.76/207.99 |- mesh__dateEstablished mesh__D051538 2006-01-01
% 207.76/207.99 |- mesh__historyNote mesh__D051538 2006%28%1989%29%
% 207.76/207.99 |- skos__altLabel mesh__D051538 Albumin Proximal Factor
% 207.76/207.99 |- skos__scopeNote mesh__D009378
% 207.76/207.99 Two or more abnormal growths of tissue occurring simultaneously. The neoplasms are histologically different and may be found in the same or different sites.%A%
% 207.76/207.99 |- skos__altLabel mesh__D009378 Synchronous Multiple Primary Neoplasms
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D009378 1999
% 207.76/207.99 |- mesh__recordOriginator mesh__D009378 NLM
% 207.76/207.99 |- skos__hiddenLabel mesh__D009378 Synchronous Neoplasm
% 207.76/207.99 |- skos__related mesh__D009378smesh__D016609
% 207.76/207.99 |- skos__hiddenLabel mesh__D009378 Multiple Primary Neoplasm
% 207.76/207.99 |- skos__hiddenLabel mesh__D009378 Primary Neoplasms, Multiple
% 207.76/207.99 |- skos__hiddenLabel mesh__D009378 Primary Neoplasm, Multiple
% 207.76/207.99 |- skos__altLabel mesh__D009378 Synchronous Neoplasms
% 207.76/207.99 |- mesh__dateCreated mesh__D009378 1999-01-01
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D009378 1998
% 207.76/207.99 |- mesh__publicMeSHNote mesh__D009378 65
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D009378 2002
% 207.76/207.99 |- skos__altLabel mesh__D009378 Multiple Primary Neoplasms
% 207.76/207.99 |- mesh__activeMeSHYear mesh__D009378 2004
% 207.76/207.99 |- mesh__dateRevised mesh__D009378 1996-06-10
% 207.76/207.99 |- rdf__type mesh__D009378sskos__Concept
% 207.76/208.00 |- skos__altLabel mesh__D009378 Neoplasms, Synchronous
% 207.76/208.00 |- mesh__recordMaintainer mesh__D009378 TGC
% 207.76/208.00 |- mesh__dateEstablished mesh__D009378 1965-01-01
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009378 2003
% 207.76/208.00 |- skos__altLabel mesh__D009378 Neoplasms, Synchronous Multiple Primary
% 207.76/208.00 |- skos__prefLabel mesh__D009378 Neoplasms, Multiple Primary
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009378 1997
% 207.76/208.00 |- skos__annotation mesh__D009378
% 207.76/208.00 2 or more neopl, histologically different, at same or different sites occurring simultaneously: do not confuse with NEOPLASMS, SECOND PRIMARY %28%a neopl following an earlier neopl but not its metastasis%29%; coord with each specific histol type %28%IM%29% %26% each precoord organ/neopl term %28%IM%29%; do not use /compl with specific multiple neopl terms to show multiplicity; differentiate from NEOPLASM METASTASIS %26% NEOPLASM RECURRENCE, LOCAL: Manual 24.4.1.5, 24.4.1.6; MULTIPLE ENDOCRINE NEOPLASIA %26% its specifics are also available; DF: NEOPL MULTIPLE PRIMARY%A%
% 207.76/208.00 |- skos__altLabel mesh__D009378 Multiple Primary Neoplasms, Synchronous
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009378 2001
% 207.76/208.00 |- mesh__historyNote mesh__D009378 65
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009378 2006
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D009378 PLS
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009378 2000
% 207.76/208.00 |- skos__hiddenLabel mesh__D009378 Neoplasm, Synchronous
% 207.76/208.00 |- skos__hiddenLabel mesh__D009378 Neoplasm, Multiple Primary
% 207.76/208.00 |- skos__broader mesh__D009378smesh__D009369
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009378 2005
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D001395 sjn
% 207.76/208.00 |- skos__scopeNote mesh__D001395
% 207.76/208.00 A genus of gram-negative, aerobic bacteria found in soil and water. Its organisms occur singly, in pairs or irregular clumps, and sometimes in chains of varying lengths.%A%
% 207.76/208.00 |- skos__broader mesh__D001395smesh__D001396
% 207.76/208.00 |- mesh__dateRevised mesh__D001395 2005-06-30
% 207.76/208.00 |- skos__prefLabel mesh__D001395 Azotobacter
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D001395 2006
% 207.76/208.00 |- mesh__recordOriginator mesh__D001395 NLM
% 207.76/208.00 |- mesh__recordMaintainer mesh__D001395 SYSTEM
% 207.76/208.00 |- skos__annotation mesh__D001395 in soil %26% water
% 207.76/208.00 |- rdf__type mesh__D001395sskos__Concept
% 207.76/208.00 |- mesh__dateCreated mesh__D001395 1999-01-01
% 207.76/208.00 |- mesh__recordOriginator mesh__D006080 NLM
% 207.76/208.00 |- skos__related mesh__D006080smesh__D010063
% 207.76/208.00 |- mesh__dateCreated mesh__D006080 1999-01-01
% 207.76/208.00 |- mesh__historyNote mesh__D006080 99
% 207.76/208.00 |- mesh__dateRevised mesh__D006080 2005-06-30
% 207.76/208.00 |- skos__altLabel mesh__D006080 Ovarian Follicles
% 207.76/208.00 |- skos__hiddenLabel mesh__D006080 Atretic Follicles
% 207.76/208.00 |- mesh__recordMaintainer mesh__D006080 lkt
% 207.76/208.00 |- skos__hiddenLabel mesh__D006080 Graafian Follicles
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D006080 2006
% 207.76/208.00 |- skos__hiddenLabel mesh__D006080 Follicle, Ovarian
% 207.76/208.00 |- skos__annotation mesh__D006080
% 207.76/208.00 /cytol: consider also THECA CELLS; GRANULOSA CELLS; for follicular development use /physiol, not /growth%A%
% 207.76/208.00 |- skos__broader mesh__D006080smesh__D010053
% 207.76/208.00 |- skos__related mesh__D006080smesh__D006107
% 207.76/208.00 |- rdf__type mesh__D006080sskos__Concept
% 207.76/208.00 |- skos__scopeNote mesh__D006080
% 207.76/208.00 An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment %28%FOLLICULAR FLUID%29%. The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS.%A%
% 207.76/208.00 |- skos__hiddenLabel mesh__D006080 Follicles, Graafian
% 207.76/208.00 |- skos__hiddenLabel mesh__D006080 Follicle, Graafian
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D006080 99; see GRAAFIAN FOLLICLE 1966-98
% 207.76/208.00 |- skos__hiddenLabel mesh__D006080 Follicles, Atretic
% 207.76/208.00 |- skos__hiddenLabel mesh__D006080 Follicle, Atretic
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D006080 sjn
% 207.76/208.00 |- skos__related mesh__D006080smesh__D013799
% 207.76/208.00 |- skos__prefLabel mesh__D006080 Ovarian Follicle
% 207.76/208.00 |- skos__hiddenLabel mesh__D006080 Follicles, Ovarian
% 207.76/208.00 |- mesh__recordOriginator mesh__D014512 NLM
% 207.76/208.00 |- mesh__dateRevised mesh__D014512 2003-07-09
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D014512 2004
% 207.76/208.00 |- rdf__type mesh__D014512sskos__Concept
% 207.76/208.00 |- mesh__dateCreated mesh__D014512 1999-01-01
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D014512 2005
% 207.76/208.00 |- mesh__recordMaintainer mesh__D014512 ssb
% 207.76/208.00 |- skos__broader mesh__D014512smesh__D006867
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D014512 2006
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D014512 sjn
% 207.76/208.00 |- skos__prefLabel mesh__D014512 Ureohydrolases
% 207.76/208.00 |- skos__related mesh__D005786smesh__D002454
% 207.76/208.00 |- skos__related mesh__D005786smesh__D002868
% 207.76/208.00 |- skos__prefLabel mesh__D005786 Gene Expression Regulation
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D005786 2004
% 207.76/208.00 |- mesh__dateEstablished mesh__D005786 1981-01-01
% 207.76/208.00 |- mesh__dateRevised mesh__D005786 2002-07-02
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D005786 sjn
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D005786 2006
% 207.76/208.00 |- skos__scopeNote mesh__D005786
% 207.76/208.00 Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action at the level of transcription or translation. These processes include gene activation and genetic induction.%A%
% 207.76/208.00 |- skos__historyNote mesh__D005786 Translation, Genetic %28%1973-1980%29%
% 207.76/208.00 |- skos__altLabel mesh__D005786 Gene Action Regulation
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D005786 2003
% 207.76/208.00 |- skos__historyNote mesh__D005786 Transcription, Genetic %28%1973-1980%29%
% 207.76/208.00 |- skos__altLabel mesh__D005786 Regulation, Gene Action
% 207.76/208.00 |- mesh__dateCreated mesh__D005786 1980-04-02
% 207.76/208.00 |- skos__historyNote mesh__D005786 Genes %28%1966-1980%29%
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D005786 2005
% 207.76/208.00 |- mesh__recordOriginator mesh__D005786 AEP
% 207.76/208.00 |- skos__altLabel mesh__D005786 Expression Regulation, Gene
% 207.76/208.00 |- rdf__type mesh__D005786sskos__Concept
% 207.76/208.00 |- skos__related mesh__D005786smesh__D014157
% 207.76/208.00 |- skos__annotation mesh__D005786
% 207.76/208.00 GEN or unspecified; prefer specifics; DF: GENE EXPRESSION REG%A%
% 207.76/208.00 |- mesh__recordMaintainer mesh__D005786 NDW
% 207.76/208.00 |- skos__related mesh__D005786smesh__D015534
% 207.76/208.00 |- skos__altLabel mesh__D005786 Regulation of Gene Expression
% 207.76/208.00 |- skos__altLabel mesh__D005786 Genetic Induction
% 207.76/208.00 |- skos__hiddenLabel mesh__D005786 Activation, Gene
% 207.76/208.00 |- skos__historyNote mesh__D005786 Genes, Regulator %28%1973-1980%29%
% 207.76/208.00 |- skos__altLabel mesh__D005786 Regulation, Gene Expression
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D005786 81
% 207.76/208.00 |- skos__broader mesh__D005786smesh__D039361
% 207.76/208.00 |- mesh__historyNote mesh__D005786 81
% 207.76/208.00 |- mesh__recordOriginator mesh__D024142 jmp
% 207.76/208.00 |- skos__annotation mesh__D024142
% 207.76/208.00 precursors: coord IM with PROCOLLAGEN %28%IM%29%
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D024142 sjn
% 207.76/208.00 |- skos__historyNote mesh__D024142 Collagen %28%1985-2001%29%
% 207.76/208.00 |- skos__scopeNote mesh__D024142
% 207.76/208.00 A non-fibrillar collagen that forms a network of MICROFIBRILS within the EXTRACELLULAR MATRIX of CONNECTIVE TISSUE. The alpha subunits of collagen type VI assemble into antiparallel, overlapping dimers which then align to form tetramers.%A%
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D024142 2002; see COLLAGEN 1990-2001
% 207.76/208.00 |- skos__altLabel mesh__D024142 Collagen Type-VI, alpha2 Chain
% 207.76/208.00 |- skos__hiddenLabel mesh__D024142 Procollagen, Type VI
% 207.76/208.00 |- skos__altLabel mesh__D024142 Type VI %28%Intima%29% Collagen
% 207.76/208.00 |- mesh__dateRevised mesh__D024142 2004-07-07
% 207.76/208.00 |- mesh__dateEstablished mesh__D024142 2002-01-01
% 207.76/208.00 |- rdf__type mesh__D024142sskos__Concept
% 207.76/208.00 |- skos__altLabel mesh__D024142 Collagen alpha3%28%VI%29%
% 207.76/208.00 |- skos__altLabel mesh__D024142 Collagen alpha1%28%VI%29%
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D024142 2006
% 207.76/208.00 |- skos__altLabel mesh__D024142 Collagen Type VI, alpha3 Chain
% 207.76/208.00 |- skos__altLabel mesh__D024142 Type VI Procollagen
% 207.76/208.00 |- skos__hiddenLabel mesh__D024142 Collagen, Type VI
% 207.76/208.00 |- skos__hiddenLabel mesh__D024142 Collagen Type VI, alpha2 Chain
% 207.76/208.00 |- skos__altLabel mesh__D024142 Collagen alpha2%28%VI%29%
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D024142 2005
% 207.76/208.00 |- skos__prefLabel mesh__D024142 Collagen Type VI
% 207.76/208.00 |- skos__altLabel mesh__D024142 Type VI Collagen
% 207.76/208.00 |- mesh__recordMaintainer mesh__D024142 jmp
% 207.76/208.00 |- skos__altLabel mesh__D024142 Intima Collagen
% 207.76/208.00 |- mesh__dateCreated mesh__D024142 2001-07-25
% 207.76/208.00 |- skos__altLabel mesh__D024142 Collagen Type VI, alpha1 Chain
% 207.76/208.00 |- skos__hiddenLabel mesh__D024142 Collagen, Intima
% 207.76/208.00 |- skos__broader mesh__D024142smesh__D024041
% 207.76/208.00 |- mesh__historyNote mesh__D024142 2002; use COLLAGEN 1990-2001
% 207.76/208.00 |- skos__altLabel mesh__D018903
% 207.76/208.00 Keratectomy, Phototherapeutic, Excimer Laser
% 207.76/208.00 |- skos__prefLabel mesh__D018903
% 207.76/208.00 Keratectomy, Photorefractive, Excimer Laser
% 207.76/208.00 |- skos__scopeNote mesh__D018903
% 207.76/208.00 A type of refractive surgery of the CORNEA to correct MYOPIA and ASTIGMATISM. An excimer laser is used directly on the surface of the EYE to remove the CORNEAL EPITHELIUM in order to reshape the anterior curvature of the cornea.%A%
% 207.76/208.00 |- skos__historyNote mesh__D018903 Cornea/surgery %28%1983-1995%29%
% 207.76/208.00 |- skos__annotation mesh__D018903 DF: PRK
% 207.76/208.00 |- skos__altLabel mesh__D018903 Keratectomy, Excimer Laser Photorefractive
% 207.76/208.00 |- mesh__dateRevised mesh__D018903 2004-07-07
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D018903 2006
% 207.76/208.00 |- skos__altLabel mesh__D018903 Photorefractive Keratectomy, Excimer Laser
% 207.76/208.00 |- mesh__recordMaintainer mesh__D018903 lkt
% 207.76/208.00 |- skos__historyNote mesh__D018903 Laser Surgery %28%1987-1995%29%
% 207.76/208.00 |- skos__altLabel mesh__D018903 Keratectomy, Excimer Laser
% 207.76/208.00 |- skos__broader mesh__D018903smesh__D048988
% 207.76/208.00 |- skos__hiddenLabel mesh__D018903 Excimer Laser Keratectomies
% 207.76/208.00 |- mesh__dateCreated mesh__D018903 1995-06-08
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D018903 96
% 207.76/208.00 |- skos__broader mesh__D018903smesh__D013508
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D018903 sjn
% 207.76/208.00 |- mesh__recordOriginator mesh__D018903 TGC
% 207.76/208.00 |- mesh__dateEstablished mesh__D018903 1996-01-01
% 207.76/208.00 |- mesh__historyNote mesh__D018903 96
% 207.76/208.00 |- rdf__type mesh__D018903sskos__Concept
% 207.76/208.00 |- skos__hiddenLabel mesh__D018903 Excimer Laser Keratectomy
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D018903 2005
% 207.76/208.00 |- mesh__recordOriginator mesh__D010920 NLM
% 207.76/208.00 |- skos__related mesh__D010920smesh__D021041
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D010920 2004
% 207.76/208.00 |- skos__hiddenLabel mesh__D010920 Placentomes
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D010920 2005
% 207.76/208.00 |- mesh__dateRevised mesh__D010920 2002-07-03
% 207.76/208.00 |- skos__broader mesh__D010920smesh__D004628
% 207.76/208.00 |- skos__scopeNote mesh__D010920
% 207.76/208.00 A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion %28%CHORIONIC VILLI%29% derived from TROPHOBLASTS and a maternal portion %28%DECIDUA%29% derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones %28%PLACENTAL HORMONES%29%.%A%
% 207.76/208.00 |- skos__altLabel mesh__D010920 Placentome
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D010920 2006
% 207.76/208.00 |- skos__related mesh__D010920smesh__D008431
% 207.76/208.00 |- skos__altLabel mesh__D010920 Placentoma, Normal
% 207.76/208.00 |- mesh__dateCreated mesh__D010920 1999-01-01
% 207.76/208.00 |- skos__hiddenLabel mesh__D010920 Placentomas, Normal
% 207.76/208.00 |- mesh__recordMaintainer mesh__D010920 lkt
% 207.76/208.00 |- skos__prefLabel mesh__D010920 Placenta
% 207.76/208.00 |- rdf__type mesh__D010920sskos__Concept
% 207.76/208.00 |- skos__hiddenLabel mesh__D010920 Normal Placentoma
% 207.76/208.00 |- skos__hiddenLabel mesh__D010920 Placentas
% 207.76/208.00 |- skos__hiddenLabel mesh__D010920 Normal Placentomas
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D010920 2003
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D010920 sjn
% 207.76/208.00 |- skos__annotation mesh__D010920
% 207.76/208.00 mammals only; check the tags FEMALE %26% PREGNANCY; /blood supply: consider PLACENTAL CIRCULATION; placental serum or placental blood = PLACENTA + BLOOD%A%
% 207.76/208.00 |- skos__historyNote mesh__D018105 DNA, Circular %28%1973-1993%29%
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D018105 2006
% 207.76/208.00 |- mesh__dateRevised mesh__D018105 2000-06-22
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D018105 2002
% 207.76/208.00 |- skos__altLabel mesh__D018105 kDNA Maxicircles
% 207.76/208.00 |- mesh__historyNote mesh__D018105
% 207.76/208.00 94; was KINETOPLAST DNA %28%NM%29% 1987-93; KINETOPLAST DNA MAXICIRCLES was NM 1987-93; KINETOPLAST DNA MINICIRCLES was NM 1980-93%A%
% 207.76/208.00 |- skos__annotation mesh__D018105
% 207.76/208.00 protozoan DNA; from Kinetoplastida, an order of flagellate protozoa; coord IM with specific protozoon %28%IM%29%; /drug eff /ultrastruct permitted%A%
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D018105 2003
% 207.76/208.00 |- skos__broader mesh__D018105smesh__D004272
% 207.76/208.00 |- rdf__type mesh__D018105sskos__Concept
% 207.76/208.00 |- skos__broader mesh__D018105smesh__D016054
% 207.76/208.00 |- skos__scopeNote mesh__D018105
% 207.76/208.00 DNA of kinetoplasts which are specialized MITOCHONDRIA of trypanosomes and related parasitic protozoa within the order KINETOPLASTIDA. Kinetoplast DNA consists of a complex network of numerous catenated rings of two classes; the first being a large number of small DNA duplex rings, called minicircles, approximately 2000 base pairs in length, and the second being several dozen much larger rings, called maxicircles, approximately 37 kb in length.%A%
% 207.76/208.00 |- mesh__recordMaintainer mesh__D018105 nns
% 207.76/208.00 |- skos__altLabel mesh__D018105 kDNA Minicircles
% 207.76/208.00 |- skos__historyNote mesh__D018105 DNA, Protozoan %28%1991-1993%29%
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D018105 2004
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D018105 sjn
% 207.76/208.00 |- mesh__dateCreated mesh__D018105 1993-06-03
% 207.76/208.00 |- skos__hiddenLabel mesh__D018105 Maxicircles, Kinetoplast DNA
% 207.76/208.00 |- skos__hiddenLabel mesh__D018105 DNA Minicircles, Kinetoplast
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D018105 2001
% 207.76/208.00 |- mesh__onlineNote mesh__D018105
% 207.76/208.00 use DNA, KINETOPLAST %28%NM%29% to search KINETOPLAST DNA %26% KINETOPLAST DNA MAXICIRCLES 1987-93 %26% KINETOPLAST DNA MINICIRCLES 1980-93%A%
% 207.76/208.00 |- skos__hiddenLabel mesh__D018105 Minicircles, kDNA
% 207.76/208.00 |- skos__prefLabel mesh__D018105 DNA, Kinetoplast
% 207.76/208.00 |- mesh__recordOriginator mesh__D018105 PXP
% 207.76/208.00 |- skos__hiddenLabel mesh__D018105 Minicircles, Kinetoplast DNA
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D018105 2005
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D018105
% 207.76/208.00 94; KINETOPLAST DNA was indexed under DNA, CIRCULAR 1987-93; KINETOPLAST DNA MAXICIRCLES was indexed under DNA, CIRCULAR 1987-93; KINETOPLAST DNA MINICIRCLES was indexed under DNA, CIRCULAR 1980-93%A%
% 207.76/208.00 |- skos__historyNote mesh__D018105 DNA %28%1969-1973%29%
% 207.76/208.00 |- skos__altLabel mesh__D018105 kDNA
% 207.76/208.00 |- skos__hiddenLabel mesh__D018105 Maxicircles, kDNA
% 207.76/208.00 |- skos__hiddenLabel mesh__D018105 DNA Maxicircles, Kinetoplast
% 207.76/208.00 |- mesh__dateEstablished mesh__D018105 1994-01-01
% 207.76/208.00 |- skos__altLabel mesh__D018105 Kinetoplast DNA
% 207.76/208.00 |- skos__altLabel mesh__D010122 Cystyl Aminopeptidase
% 207.76/208.00 |- skos__broader mesh__D010122smesh__D045727
% 207.76/208.00 |- skos__altLabel mesh__D010122 Cystidyl Aminopeptidase
% 207.76/208.00 |- rdf__type mesh__D010122sskos__Concept
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D010122 2004
% 207.76/208.00 |- skos__altLabel mesh__D010122 Cystinaminopeptidase
% 207.76/208.00 |- skos__altLabel mesh__D010122 Oxytocinase
% 207.76/208.00 |- mesh__recordMaintainer mesh__D010122 jmp
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D010122
% 207.76/208.00 2000; see OXYTOCINASE 1991-1999; see AMINOPEPTIDASES 1973-1990%A%
% 207.76/208.00 |- skos__altLabel mesh__D010122 Vasopressinase
% 207.76/208.00 |- skos__scopeNote mesh__D010122
% 207.76/208.00 A zinc-containing sialoglycoprotein that is used to study aminopeptidase activity in the pathogenesis of hypertension. EC 3.4.11.3.%A%
% 207.76/208.00 |- mesh__dateEstablished mesh__D010122 1991-01-01
% 207.76/208.00 |- skos__altLabel mesh__D010122 Cystine Arylamidase
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D010122 sjn
% 207.76/208.00 |- skos__altLabel mesh__D010122 Cystine Aminopeptidase
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D010122 2006
% 207.76/208.00 |- mesh__recordOriginator mesh__D010122 NLM
% 207.76/208.00 |- skos__broader mesh__D010122smesh__D000626
% 207.76/208.00 |- skos__prefLabel mesh__D010122 Cystinyl Aminopeptidase
% 207.76/208.00 |- mesh__historyNote mesh__D010122 2000%28%1973%29%
% 207.76/208.00 |- mesh__dateRevised mesh__D010122 2003-07-09
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D010122 2005
% 207.76/208.00 |- mesh__dateCreated mesh__D010122 1999-01-01
% 207.76/208.00 |- skos__hiddenLabel mesh__D051539
% 207.76/208.00 Liver Specific Transcription Factor LF B3
% 207.76/208.00 |- mesh__dateCreated mesh__D051539 2005-07-06
% 207.76/208.00 |- skos__scopeNote mesh__D051539
% 207.76/208.00 A hepatocyte nuclear factor that is closely related to HEPATOCYTE NUCLEAR FACTOR 1-ALPHA but is only weakly expressed in the LIVER. Mutations in hepatocyte nuclear factor 1-beta are associated with renal CYSTS and MATURITY-ONSET DIABETES MELLITUS type 5.%A%
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D051539
% 207.76/208.00 2006; HEPATOCYTE NUCLEAR FACTOR 1-BETA was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%
% 207.76/208.00 |- skos__altLabel mesh__D051539 HNF-1beta
% 207.76/208.00 |- skos__altLabel mesh__D051539 Liver Specific Transcription Factor LF-B3
% 207.76/208.00 |- mesh__dateEstablished mesh__D051539 2006-01-01
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D051539 2006
% 207.76/208.00 |- mesh__recordMaintainer mesh__D051539 DRC
% 207.76/208.00 |- skos__hiddenLabel mesh__D051539 Hepatocyte Nuclear Factor 1beta
% 207.76/208.00 |- skos__hiddenLabel mesh__D051539 HNF 1beta
% 207.76/208.00 |- skos__hiddenLabel mesh__D051539 Hepatocyte Nuclear Factor 1 beta
% 207.76/208.00 |- skos__altLabel mesh__D051539 Variant Hepatic Nuclear Factor 1
% 207.76/208.00 |- rdf__type mesh__D051539sskos__Concept
% 207.76/208.00 |- skos__prefLabel mesh__D051539 Hepatocyte Nuclear Factor 1-beta
% 207.76/208.00 |- skos__broader mesh__D051539smesh__D051537
% 207.76/208.00 |- mesh__recordOriginator mesh__D051539 DRC
% 207.76/208.00 |- skos__altLabel mesh__D051539 Hepatocyte Nuclear Factor-1beta
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D051539 sjn
% 207.76/208.00 |- mesh__historyNote mesh__D051539 2006%28%1991%29%
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 2004
% 207.76/208.00 |- skos__prefLabel mesh__D009379 Neoplasms, Muscle Tissue
% 207.76/208.00 |- skos__altLabel mesh__D009379 Muscle Tissue Neoplasms
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 2001
% 207.76/208.00 |- skos__hiddenLabel mesh__D009379 Neoplasm, Muscle Tissue
% 207.76/208.00 |- mesh__dateRevised mesh__D009379 1995-06-08
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D009379 MYOBLASTOMA was heading 1963-93
% 207.76/208.00 |- rdf__type mesh__D009379sskos__Concept
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 2003
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D009379 PLS
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 1997
% 207.76/208.00 |- skos__broader mesh__D009379smesh__D018204
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 2000
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 2006
% 207.76/208.00 |- skos__hiddenLabel mesh__D009379 Myoblastomas
% 207.76/208.00 |- mesh__recordMaintainer mesh__D009379 KEV
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 1996
% 207.76/208.00 |- mesh__recordOriginator mesh__D009379 NLM
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 2005
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 1999
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 2002
% 207.76/208.00 |- mesh__historyNote mesh__D009379 MYOBLASTOMA was heading 1963-93
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D009379 1998
% 207.76/208.00 |- skos__annotation mesh__D009379
% 207.76/208.00 neoplasms composed of muscle tissue, NOT neoplasms located in muscles: TN 135; /blood supply /chem /secret /second /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5; DF: NEOPL MUSCLE TISSUE%A%
% 207.76/208.00 |- skos__scopeNote mesh__D009379
% 207.76/208.00 Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles.%A%
% 207.76/208.00 |- skos__hiddenLabel mesh__D009379 Myofibroblastomas
% 207.76/208.00 |- mesh__dateCreated mesh__D009379 1999-01-01
% 207.76/208.00 |- mesh__onlineNote mesh__D009379
% 207.76/208.00 use NEOPLASMS, MUSCLE TISSUE to search MYOBLASTOMA 1966-93%A%
% 207.76/208.00 |- skos__hiddenLabel mesh__D009379 Muscle Tissue Neoplasm
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D001396
% 207.76/208.00 75; AZOMONAS was heading 1976-81; AZOMONAS AGILIS was see under AZOMONAS 1976-81, was AZOTOBACTER AGILIS see under AZOTOBACTER 1975%A%
% 207.76/208.00 |- skos__prefLabel mesh__D001396 Azotobacteraceae
% 207.76/208.00 |- mesh__historyNote mesh__D001396
% 207.76/208.00 75; AZOMONAS was heading 1976-81; AZOMONAS AGILIS was see under AZOMONAS 1976-81, was AZOTOBACTER AGILIS see under AZOTOBACTER 1975, was AZOTOBACTER AGILIS 1972-74 %28%Prov%29%%A%
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D001396 2006
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D001396 sjn
% 207.76/208.00 |- skos__historyNote mesh__D001396 Bacteria %28%1966-1974%29%
% 207.76/208.00 |- mesh__recordMaintainer mesh__D001396 SYSTEM
% 207.76/208.00 |- mesh__onlineNote mesh__D001396
% 207.76/208.00 use AZOTOBACTERACEAE to search AZOMONAS 1976-81 %26% AZOMONAS AGILIS 1972-81 %28%as Prov 1972-74%29%%A%
% 207.76/208.00 |- mesh__dateRevised mesh__D001396 2005-06-30
% 207.76/208.00 |- skos__broader mesh__D001396smesh__D016946
% 207.76/208.00 |- rdf__type mesh__D001396sskos__Concept
% 207.76/208.00 |- mesh__dateCreated mesh__D001396 1999-01-01
% 207.76/208.00 |- skos__broader mesh__D001396smesh__D011548
% 207.76/208.00 |- skos__scopeNote mesh__D001396
% 207.76/208.00 A subfamily of motile, gram-negative bacteria found in SOIL and WATER and capable of fixing atmospheric nitrogen.%A%
% 207.76/208.00 |- mesh__recordOriginator mesh__D001396 NLM
% 207.76/208.00 |- mesh__dateEstablished mesh__D001396 1975-01-01
% 207.76/208.00 |- skos__annotation mesh__D001396 in soil %26% water
% 207.76/208.00 |- skos__related mesh__D014513smesh__D014547
% 207.76/208.00 |- mesh__recordMaintainer mesh__D014513 jls
% 207.76/208.00 |- skos__broader mesh__D014513smesh__D014551
% 207.76/208.00 |- mesh__dateRevised mesh__D014513 2001-08-13
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D014513 2003
% 207.76/208.00 |- rdf__type mesh__D014513sskos__Concept
% 207.76/208.00 |- mesh__dateCreated mesh__D014513 1999-01-01
% 207.76/208.00 |- skos__prefLabel mesh__D014513 Ureter
% 207.76/208.00 |- skos__related mesh__D014513smesh__D018666
% 207.76/208.00 |- skos__hiddenLabel mesh__D014513 Ureters
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D014513 2004
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D014513 sjn
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D014513 2002
% 207.76/208.00 |- skos__related mesh__D014513smesh__D014519
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D014513 2005
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D014513 2006
% 207.76/208.00 |- mesh__recordOriginator mesh__D014513 NLM
% 207.76/208.00 |- skos__scopeNote mesh__D014513
% 207.76/208.00 One of a pair of thick-walled tubes that transports urine from the KIDNEY PELVIS to the BLADDER.%A%
% 207.76/208.00 |- skos__annotation mesh__D014513
% 207.76/208.00 do not confuse with URETHRA, espec in Romance lang: uret%C3%%A8%re %28%French%29%, ur%C3%%A9%ter %28%Span%29%, uretere %28%Ital%29% = URETER, while ur%C3%%A8%tre %28%French%29%, uretra %28%Span%29%, uretra %28%Ital%29% = URETHRA; /surg: consider URETEROSTOMY %26% URINARY DIVERSION %28%TN 189: probably do not index under URETER%29%; ureteral catheterization: coord NIM with URINARY CATHETERIZATION %28%IM%29%%A%
% 207.76/208.00 |- mesh__dateCreated mesh__D038961 2002-07-02
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D038961 2005
% 207.76/208.00 |- skos__prefLabel mesh__D038961 O-Acetyl-ADP-Ribose
% 207.76/208.00 |- skos__hiddenLabel mesh__D038961 O Acetyl Adenosine Diphosphate Ribose
% 207.76/208.00 |- rdf__type mesh__D038961sskos__Concept
% 207.76/208.00 |- skos__scopeNote mesh__D038961
% 207.76/208.00 An acetyl ester of ADENOSINE DIPHOSPHATE RIBOSE formed during NAD-dependent deacetylation of proteins by SIRTUINS. The acetate group resides on the ribose ring where nicotinamide was cleaved from NAD during the reaction. Several isomers of O-acetyl-ADP-ribose have been isolated from the reaction.%A%
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D038961 sjn
% 207.76/208.00 |- mesh__historyNote mesh__D038961
% 207.76/208.00 2003; use O-ACETYL-ADP-RIBOSE %28%NM%29% 2001-2002
% 207.76/208.00 |- skos__altLabel mesh__D038961 O-Acetyl-Adenosine-Diphosphate-Ribose
% 207.76/208.00 |- skos__altLabel mesh__D038961 Adenosine-Diphosphate-Ribose, O-Acetyl-
% 207.76/208.00 |- skos__hiddenLabel mesh__D038961 Adenosine Diphosphate Ribose, O Acetyl
% 207.76/208.00 |- mesh__recordOriginator mesh__D038961 nns
% 207.76/208.00 |- mesh__recordMaintainer mesh__D038961 ssb
% 207.76/208.00 |- mesh__dateRevised mesh__D038961 2004-07-07
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D038961
% 207.76/208.00 2003; O-ACETYL-ADP-RIBOSE was indexed under ADENOSINE DIPHOSPHATE RIBOSE 2001-2002%A%
% 207.76/208.00 |- skos__altLabel mesh__D038961 AADPR
% 207.76/208.00 |- skos__broader mesh__D038961smesh__D000246
% 207.76/208.00 |- skos__hiddenLabel mesh__D038961 O-Acetyl- Adenosine-Diphosphate-Ribose
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D038961 2006
% 207.76/208.00 |- mesh__dateEstablished mesh__D038961 2003-01-01
% 207.76/208.00 |- skos__hiddenLabel mesh__D038961 O Acetyl ADP Ribose
% 207.76/208.00 |- skos__scopeNote mesh__D005787
% 207.76/208.00 The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION.%A%
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D005787 2003
% 207.76/208.00 |- mesh__dateEstablished mesh__D005787 1968-01-01
% 207.76/208.00 |- mesh__activeMeSHYear mesh__D005787 2005
% 207.76/208.00 |- skos__hiddenLabel mesh__D005787 Frequencies, Allele
% 207.76/208.00 |- rdf__type mesh__D005787sskos__Concept
% 207.76/208.00 |- mesh__publicMeSHNote mesh__D005787
% 207.76/208.00 1968; for GENETIC EQUILIBRIUM see GENETICS, POPULATION 1998-2002%A%
% 207.76/208.00 |- mesh__recordMaintainer mesh__D005787 nns
% 207.76/208.00 |- skos__historyNote mesh__D005787 Genetics %28%1966-1967%29%
% 207.76/208.00 |- skos__hiddenLabel mesh__D005787 Frequency, Allele
% 207.76/208.00 |- mesh__recordOriginator mesh__D005787 NLM
% 207.76/208.00 |- skos__hiddenLabel mesh__D005787 Frequency, Gene
% 207.76/208.00 |- mesh__dateCreated mesh__D005787 1999-01-01
% 207.76/208.00 |- skos__historyNote mesh__D005787 Genetics, Population %28%1966-1967%29%
% 207.76/208.00 |- skos__prefLabel mesh__D005787 Gene Frequency
% 207.76/208.00 |- skos__hiddenLabel mesh__D005787 Allele Frequencies
% 207.76/208.00 |- skos__altLabel mesh__D005787 Equilibrium, Genetic
% 207.76/208.00 |- mesh__dateRevised mesh__D005787 2002-07-02
% 207.76/208.00 |- mesh__historyNote mesh__D005787
% 207.76/208.00 1968; for GENETIC EQUILIBRIUM use GENETICS, POPULATION 1998-2002%A%
% 207.76/208.00 |- mesh__recordAuthorizer mesh__D005787 sjn
% 207.76/208.00 |- skos__hiddenLabel mesh__D005787 Gene Frequencies
% 207.76/208.00 |- skos__hiddenLabel mesh__D005787 Frequencies, Gene
% 207.76/208.01 |- skos__broader mesh__D005787smesh__D040341
% 207.76/208.01 |- skos__historyNote mesh__D005787 Genes %28%1966-1967%29%
% 207.76/208.01 |- skos__altLabel mesh__D005787 Allele Frequency
% 207.76/208.01 |- mesh__activeMeSHYear mesh__D005787 2004
% 207.76/208.01 |- mesh__activeMeSHYear mesh__D005787 2006
% 207.76/208.01 |- skos__prefLabel mesh__D024941 Starch Phosphorylase
% 207.76/208.01 |- mesh__recordMaintainer mesh__D024941 ssb
% 207.76/208.01 |- mesh__recordOriginator mesh__D024941 lkt
% 207.76/208.01 |- skos__broader mesh__D024941smesh__D006005
% 207.76/208.01 |- mesh__dateRevised mesh__D024941 2003-07-09
% 207.76/208.01 |- skos__historyNote mesh__D024941 Glucosyltransferases %28%1964-1972%29%
% 207.76/208.01 |- mesh__activeMeSHYear mesh__D024941 2004
% 207.76/208.01 |- skos__historyNote mesh__D024941 Phosphorylases %28%1973-2001%29%
% 207.76/208.01 |- mesh__dateEstablished mesh__D024941 2002-01-01
% 207.76/208.01 |- skos__altLabel mesh__D024941 Amylophosphorylase
% 207.76/208.01 |- skos__hiddenLabel mesh__D024941 Phosphorylase, Starch
% 207.76/208.01 |- mesh__historyNote mesh__D024941 2002
% 207.76/208.01 |- skos__scopeNote mesh__D024941
% 207.76/208.01 An enzyme of the PHOSPHORYLASES family that catalyzes the degradation of starch, a mixture of unbranched AMYLOSE and branched AMYLOPECTIN compounds. This phosphorylase from plants is the counterpart of GLYCOGEN PHOSPHORYLASE in animals that catalyzes the reaction of inorganic phosphate on the terminal alpha-1,4-glycosidic bond at the non-reducing end of glucans resulting in the release of glucose-1-phosphate.%A%
% 207.76/208.01 |- mesh__dateCreated mesh__D024941 2001-07-25
% 207.76/208.01 |- skos__hiddenLabel mesh__D024941 Phosphorylase a, Starch
% 207.76/208.01 |- mesh__activeMeSHYear mesh__D024941 2005
% 207.76/208.01 |- mesh__publicMeSHNote mesh__D024941 2002
% 207.76/208.01 |- skos__hiddenLabel mesh__D024941 Phosphorylase b, Starch
% 207.76/208.01 |- rdf__type mesh__D024941sskos__Concept
% 207.76/208.01 |- mesh__activeMeSHYear mesh__D024941 2006
% 207.76/208.01 |- mesh__recordAuthorizer mesh__D024941 sjn
% 207.76/208.01 |- mesh__dateRevised mesh__D024143 2004-07-07
% 207.76/208.01 |- rdf__type mesh__D024143sskos__Concept
% 207.76/208.01 |- skos__broader mesh__D024143smesh__D024041
% 207.76/208.01 |- mesh__activeMeSHYear mesh__D024143 2006
% 207.76/208.01 |- skos__prefLabel mesh__D024143 Collagen Type VII
% 207.76/208.01 |- mesh__dateEstablished mesh__D024143 2002-01-01
% 207.76/208.01 |- skos__historyNote mesh__D024143 Collagen %28%1990-2001%29%
% 207.76/208.01 |- mesh__dateCreated mesh__D024143 2001-07-25
% 207.76/208.01 |- mesh__activeMeSHYear mesh__D024143 2005
% 207.76/208.01 |- skos__hiddenLabel mesh__D024143 Procollagen, Type VII
% 207.76/208.01 |- mesh__historyNote mesh__D024143 2002; use COLLAGEN 1990-2001
% 207.76/208.01 |- mesh__recordOriginator mesh__D024143 jmp
% 207.76/208.01 |- mesh__recordAuthorizer mesh__D024143 sjn
% 207.76/208.01 |- mesh__recordMaintainer mesh__D024143 jmp
% 207.76/208.01 |- skos__altLabel mesh__D024143 Type VII Collagen
% 207.76/208.01 |- skos__scopeNote mesh__D024143
% 207.76/208.01 A non-fibrillar collagen involved in anchoring the epidermal BASEMENT MEMBRANE to underlying tissue. It is a homotrimer comprised of C-terminal and N-terminal globular domains connected by a central triple-helical region.%A%
% 207.76/208.01 |- skos__altLabel mesh__D024143 Collagen alpha1%28%VII%29%
% 207.76/208.01 |- skos__annotation mesh__D024143
% 207.76/208.01 precursors: coord IM with PROCOLLAGEN %28%IM%29%
% 207.76/208.01 |- skos__altLabel mesh__D024143 Collagen Type VII, alpha1 Chain
% 207.76/208.01 |- mesh__publicMeSHNote mesh__D024143 2002; see COLLAGEN 1990-2001
% 207.76/208.01 |- skos__hiddenLabel mesh__D024143 Type VII, Procollagen
% 207.76/208.01 |- skos__altLabel mesh__D024143 Type VII Procollagen
% 207.76/208.01 |- skos__hiddenLabel mesh__D024143 Collagen, Type VII
% 207.76/208.01 |- mesh__dateCreated mesh__D010921 1999-01-01
% 207.76/208.01 |- skos__broader mesh__D010921smesh__D007744
% 207.76/208.01 |- mesh__dateRevised mesh__D010921 2005-06-30
% 207.76/208.01 |- skos__scopeNote mesh__D010921
% 207.76/208.01 Abnormal placentation in which all or parts of the PLACENTA are attached directly to the MYOMETRIUM due to a complete or partial absence of DECIDUA. It is associated with POSTPARTUM HEMORRHAGE because of the failure of placental separation.%A%
% 207.76/208.01 |- mesh__recordAuthorizer mesh__D010921 sjn
% 207.76/208.01 |- rdf__type mesh__D010921sskos__Concept
% 207.76/208.01 |- skos__annotation mesh__D010921 check the tags FEMALE %26% PREGNANCY
% 207.76/208.01 |- mesh__recordOriginator mesh__D010921 NLM
% 207.76/208.01 |- skos__broader mesh__D010921smesh__D010922
% 207.76/208.01 |- skos__hiddenLabel mesh__D010921 Accreta, Placenta
% 207.76/208.01 |- mesh__recordMaintainer mesh__D010921 lkt
% 207.76/208.01 |- skos__hiddenLabel mesh__D010921 Percreta, Placenta
% 207.76/208.01 |- mesh__activeMeSHYear mesh__D010921 2006
% 207.76/208.01 |- skos__prefLabel mesh__D010921 Placenta Accreta
% 207.76/208.01 |- skos__hiddenLabel mesh__D010921 Increta, Placenta
% 207.76/208.01 |- skos__scopeNote mesh__D018106
% 207.76/208.01 T-cell differentiation antigens that serve as the receptors for the B7 antigen %28%ANTIGENS, CD80%29% which modulates T-cell lymphokine production.%A%
% 207.76/208.01 |- skos__historyNote mesh__D018106 Antigens, CD %28%1990-1993%29%
% 207.76/208.01 |- skos__historyNote mesh__D018106
% 207.76/208.01 Antigens, Differentiation, T-Lymphocyte %28%1986-1993%29%
% 207.76/208.01 |- mesh__dateEstablished mesh__D018106 1994-01-01
% 207.76/208.01 |- mesh__historyNote mesh__D018106
% 207.76/208.01 94; was CD28 ANTIGEN %28%NM%29% 1986-93
% 207.76/208.01 |- skos__related mesh__D018106smesh__D018122
% 207.76/208.01 |- mesh__activeMeSHYear mesh__D018106 2006
% 207.76/208.01 |- skos__broader mesh__D018106smesh__D000945
% 207.76/208.01 |- mesh__dateCreated mesh__D018106 1993-06-21
% 207.76/208.01 |- skos__annotation mesh__D018106 T-lymphocyte differentiation antigens
% 207.76/208.01 |- skos__altLabel mesh__D018106 CD28 Antigen
% 207.76/208.01 |- rdf__type mesh__D018106sskos__Concept
% 207.76/208.01 |- mesh__recordMaintainer mesh__D018106 ssb
% 207.76/208.01 |- skos__altLabel mesh__D018106 CD28 Antigens
% 207.76/208.01 |- skos__prefLabel mesh__D018106 Antigens, CD28
% 207.76/208.01 |- mesh__recordOriginator mesh__D018106 AGS
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D018106 sjn
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D018106
% 207.86/208.01 94; CD28 ANTIGEN was indexed under ANTIGENS, CD 1990-93 %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1986-93%A%
% 207.86/208.01 |- skos__broader mesh__D018106smesh__D011948
% 207.86/208.01 |- mesh__onlineNote mesh__D018106
% 207.86/208.01 use ANTIGENS, CD28 %28%NM%29% to search CD28 ANTIGEN 1986-93
% 207.86/208.01 |- skos__hiddenLabel mesh__D018106 Antigen, CD28
% 207.86/208.01 |- skos__broader mesh__D018106smesh__D015703
% 207.86/208.01 |- mesh__dateRevised mesh__D018106 2005-06-30
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010123 2001
% 207.86/208.01 |- skos__hiddenLabel mesh__D010123 Aspiculariases
% 207.86/208.01 |- skos__hiddenLabel mesh__D010123 Oxyuriases
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010123 2003
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D010123
% 207.86/208.01 ASPICULARIASIS was see NEMATODE INFECTIONS 1986-92; was heading 1968-85%A%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010123 2000
% 207.86/208.01 |- mesh__dateRevised mesh__D010123 1997-06-20
% 207.86/208.01 |- mesh__recordMaintainer mesh__D010123 TGC
% 207.86/208.01 |- skos__annotation mesh__D010123
% 207.86/208.01 nematode infect caused by genera of the superfamily OXYUROIDEA; infect by Oxyuris species goes here but note X ref OXYURIS VERMICULARIS INFECTION see ENTEROBIASIS%A%
% 207.86/208.01 |- skos__prefLabel mesh__D010123 Oxyuriasis
% 207.86/208.01 |- skos__broader mesh__D010123smesh__D017194
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010123 2006
% 207.86/208.01 |- skos__scopeNote mesh__D010123
% 207.86/208.01 Infection with nematodes of the superfamily OXYUROIDEA.%A%
% 207.86/208.01 |- mesh__historyNote mesh__D010123
% 207.86/208.01 ASPICULARIASIS was see NEMATODE INFECTIONS 1986-92; was heading 1968-85%A%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010123 1999
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010123 2005
% 207.86/208.01 |- mesh__dateCreated mesh__D010123 1999-01-01
% 207.86/208.01 |- mesh__onlineNote mesh__D010123
% 207.86/208.01 use NEMATODE INFECTIONS to search ASPICULARIASIS 1968-92
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010123 2002
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D010123 SJN
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010123 1998
% 207.86/208.01 |- rdf__type mesh__D010123sskos__Concept
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010123 2004
% 207.86/208.01 |- mesh__recordOriginator mesh__D010123 NLM
% 207.86/208.01 |- skos__annotation mesh__D001397 a carcinogen
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 2005
% 207.86/208.01 |- mesh__recordMaintainer mesh__D001397 JRT
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 2004
% 207.86/208.01 |- mesh__recordOriginator mesh__D001397 NLM
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 2002
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 2006
% 207.86/208.01 |- skos__scopeNote mesh__D001397
% 207.86/208.01 A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas.%A%
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D001397 PLS
% 207.86/208.01 |- skos__broader mesh__D001397smesh__D001391
% 207.86/208.01 |- mesh__dateEstablished mesh__D001397 1991-01-01
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 1996
% 207.86/208.01 |- mesh__dateCreated mesh__D001397 1974-11-11
% 207.86/208.01 |- skos__prefLabel mesh__D001397 Azoxymethane
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 2000
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 1998
% 207.86/208.01 |- rdf__type mesh__D001397sskos__Concept
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 1997
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D001397
% 207.86/208.01 91; was see under AZO COMPOUNDS 1975-90
% 207.86/208.01 |- skos__historyNote mesh__D001397 Nitrogen Oxides %28%1973-1974%29%
% 207.86/208.01 |- skos__historyNote mesh__D001397 Azo Compounds %28%1973-1975%29%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 2001
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 1999
% 207.86/208.01 |- mesh__dateRevised mesh__D001397 1995-06-08
% 207.86/208.01 |- mesh__historyNote mesh__D001397
% 207.86/208.01 91%28%75%29%; was see under AZO COMPOUNDS 1975-90
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D001397 2003
% 207.86/208.01 |- mesh__historyNote mesh__D006880 75
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 1999
% 207.86/208.01 |- rdf__type mesh__D006880sskos__Concept
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 1997
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 2002
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 1998
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D006880 75
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 1996
% 207.86/208.01 |- mesh__recordOriginator mesh__D006880 NLM
% 207.86/208.01 |- skos__broader mesh__D006880smesh__D002264
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 2006
% 207.86/208.01 |- skos__historyNote mesh__D006880 Fatty Acids %28%1966-1974%29%
% 207.86/208.01 |- mesh__dateRevised mesh__D006880 1992-05-19
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 2004
% 207.86/208.01 |- skos__prefLabel mesh__D006880 Hydroxy Acids
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D006880 PLS
% 207.86/208.01 |- mesh__recordMaintainer mesh__D006880 TGC
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 2005
% 207.86/208.01 |- skos__historyNote mesh__D006880 Carboxylic Acids %28%1971-1974%29%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 2001
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 1995
% 207.86/208.01 |- mesh__dateEstablished mesh__D006880 1975-09-01
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 2003
% 207.86/208.01 |- skos__hiddenLabel mesh__D006880 Acids, Hydroxy
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 1993
% 207.86/208.01 |- skos__scopeNote mesh__D006880
% 207.86/208.01 Organic compounds containing both the hydroxyl and carboxyl radicals.%A%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 2000
% 207.86/208.01 |- mesh__dateCreated mesh__D006880 1999-01-01
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006880 1994
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D020551 2002
% 207.86/208.01 |- skos__prefLabel mesh__D020551 Pulse Therapy, Drug
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D020551 2000
% 207.86/208.01 |- skos__scopeNote mesh__D020551
% 207.86/208.01 Administration of high doses of pharmaceuticals over short periods of time.%A%
% 207.86/208.01 |- skos__altLabel mesh__D020551 Pulse Drug Therapy
% 207.86/208.01 |- skos__annotation mesh__D020551
% 207.86/208.01 coord NIM with drug /admin %28%IM%29%; DF: PULSE THER DRUG
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D020551 2006
% 207.86/208.01 |- skos__broader mesh__D020551smesh__D004334
% 207.86/208.01 |- rdf__type mesh__D020551sskos__Concept
% 207.86/208.01 |- skos__hiddenLabel mesh__D020551 Pulse Therapies, Drug
% 207.86/208.01 |- mesh__historyNote mesh__D020551 2000
% 207.86/208.01 |- skos__hiddenLabel mesh__D020551 Pulse Drug Therapies
% 207.86/208.01 |- skos__hiddenLabel mesh__D020551 Drug Therapies, Pulse
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D020551 2004
% 207.86/208.01 |- skos__historyNote mesh__D020551
% 207.86/208.01 Drug Administration Schedule %28%1978-1999%29%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D020551 2005
% 207.86/208.01 |- skos__hiddenLabel mesh__D020551 Drug Pulse Therapies
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D020551 2001
% 207.86/208.01 |- skos__hiddenLabel mesh__D020551 Drug Therapy, Pulse
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D020551 2003
% 207.86/208.01 |- skos__hiddenLabel mesh__D020551 Therapy, Drug Pulse
% 207.86/208.01 |- skos__hiddenLabel mesh__D020551 Therapies, Pulse Drug
% 207.86/208.01 |- skos__altLabel mesh__D020551 Drug Pulse Therapy
% 207.86/208.01 |- mesh__dateCreated mesh__D020551 1999-11-05
% 207.86/208.01 |- skos__hiddenLabel mesh__D020551 Therapies, Drug Pulse
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D020551 2000
% 207.86/208.01 |- skos__hiddenLabel mesh__D020551 Therapy, Pulse Drug
% 207.86/208.01 |- mesh__dateEstablished mesh__D020551 2000-01-01
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 1993
% 207.86/208.01 |- skos__annotation mesh__D006082
% 207.86/208.01 to prevent graft rejection of normal or tumor tissue; do not coord with IMMUNOTHERAPY; DF: GRAFT ENHANCEMENT%A%
% 207.86/208.01 |- skos__historyNote mesh__D006082
% 207.86/208.01 Transplantation, Homologous %28%1966-1979%29%
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Graft Enhancements, Immunologic
% 207.86/208.01 |- rdf__type mesh__D006082sskos__Concept
% 207.86/208.01 |- skos__altLabel mesh__D006082 Immunologic Graft Enhancement
% 207.86/208.01 |- mesh__recordOriginator mesh__D006082 AEP
% 207.86/208.01 |- mesh__recordMaintainer mesh__D006082 TAP
% 207.86/208.01 |- skos__prefLabel mesh__D006082 Graft Enhancement, Immunologic
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Immunologic Graft Enhancements
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 1998
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D006082 80
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Graft Enhancements
% 207.86/208.01 |- mesh__dateCreated mesh__D006082 1979-05-29
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 1997
% 207.86/208.01 |- mesh__dateRevised mesh__D006082 1992-05-15
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Immunological Graft Enhancements
% 207.86/208.01 |- skos__scopeNote mesh__D006082
% 207.86/208.01 The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft%27%s surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.%A%
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D006082 PLS
% 207.86/208.01 |- skos__historyNote mesh__D006082
% 207.86/208.01 Transplantation Immunology %28%1966-1979%29%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 2001
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Enhancement, Graft
% 207.86/208.01 |- skos__altLabel mesh__D006082 Immunologic Enhancement of Grafts
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 1996
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 2006
% 207.86/208.01 |- skos__altLabel mesh__D006082 Enhancement, Immunologic Graft
% 207.86/208.01 |- skos__broader mesh__D006082smesh__D007165
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 2000
% 207.86/208.01 |- skos__historyNote mesh__D006082 Graft Survival %28%1977-1979%29%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 2005
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 2004
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Enhancement, Immunological Graft
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 1995
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Enhancements, Immunologic Graft
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Enhancements, Graft
% 207.86/208.01 |- mesh__dateEstablished mesh__D006082 1980-01-01
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Immunological Graft Enhancement
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Graft Enhancements, Immunological
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 2003
% 207.86/208.01 |- skos__hiddenLabel mesh__D006082 Enhancements, Immunological Graft
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 1999
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 1994
% 207.86/208.01 |- skos__altLabel mesh__D006082 Graft Enhancement, Immunological
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D006082 2002
% 207.86/208.01 |- mesh__historyNote mesh__D006082 80
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D014514 2003
% 207.86/208.01 |- mesh__onlineNote mesh__D014514
% 207.86/208.01 to search for chem composition of ureteral calculi, use URETERAL CALCULI/anal 1987-90 %26% URETERAL CALCULI/metab 1966-86%A%
% 207.86/208.01 |- rdf__type mesh__D014514sskos__Concept
% 207.86/208.01 |- skos__hiddenLabel mesh__D014514 Ureteral Calculus
% 207.86/208.01 |- mesh__recordOriginator mesh__D014514 NLM
% 207.86/208.01 |- mesh__dateCreated mesh__D014514 1999-01-01
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D014514 2004
% 207.86/208.01 |- mesh__recordMaintainer mesh__D014514 ags
% 207.86/208.01 |- mesh__dateRevised mesh__D014514 2001-07-25
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D014514 2005
% 207.86/208.01 |- skos__prefLabel mesh__D014514 Ureteral Calculi
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D014514 2006
% 207.86/208.01 |- skos__scopeNote mesh__D014514
% 207.86/208.01 Calculi of the ureter, usually the result of the passage of one originating in the kidney. It occurs usually in mid-life, rarely in children; and is more frequent in males than females. %28%From CMIT, 5th ed%29%%A%
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D014514 sjn
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D014514 2002
% 207.86/208.01 |- skos__broader mesh__D014514smesh__D014545
% 207.86/208.01 |- skos__broader mesh__D014514smesh__D014515
% 207.86/208.01 |- skos__annotation mesh__D014514
% 207.86/208.01 chem composition of caclculi use /chem; /ultrastruct permitted%A%
% 207.86/208.01 |- skos__altLabel mesh__D014514 Ureterolithiasis
% 207.86/208.01 |- skos__hiddenLabel mesh__D014514 Calculi, Ureteral
% 207.86/208.01 |- skos__hiddenLabel mesh__D014514 Calculus, Ureteral
% 207.86/208.01 |- mesh__recordOriginator mesh__D005788 AEP
% 207.86/208.01 |- skos__related mesh__D005788smesh__D018703
% 207.86/208.01 |- mesh__dateRevised mesh__D005788 2002-07-03
% 207.86/208.01 |- skos__historyNote mesh__D005788 Genetics, Population %28%1966-1977%29%
% 207.86/208.01 |- skos__hiddenLabel mesh__D005788 Gene Pools
% 207.86/208.01 |- mesh__dateCreated mesh__D005788 1977-03-02
% 207.86/208.01 |- mesh__recordMaintainer mesh__D005788 PXP
% 207.86/208.01 |- skos__annotation mesh__D005788 not for micro-organisms; no qualif
% 207.86/208.01 |- skos__hiddenLabel mesh__D005788 Pool, Gene
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D005788
% 207.86/208.01 91; was see under GENETICS, POPULATION 1978-90
% 207.86/208.01 |- mesh__historyNote mesh__D005788
% 207.86/208.01 91%28%78%29%; was see under GENETICS, POPULATION 1978-90
% 207.86/208.01 |- skos__prefLabel mesh__D005788 Gene Pool
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D005788 2004
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D005788 2006
% 207.86/208.01 |- skos__scopeNote mesh__D005788
% 207.86/208.01 The total genetic information possessed by the reproductive members of a POPULATION of sexually reproducing organisms.%A%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D005788 2003
% 207.86/208.01 |- mesh__dateEstablished mesh__D005788 1991-01-01
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D005788 sjn
% 207.86/208.01 |- skos__historyNote mesh__D005788 Gene Frequency %28%1968-1977%29%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D005788 2005
% 207.86/208.01 |- skos__broader mesh__D005788smesh__D040341
% 207.86/208.01 |- skos__hiddenLabel mesh__D005788 Pools, Gene
% 207.86/208.01 |- rdf__type mesh__D005788sskos__Concept
% 207.86/208.01 |- skos__broader mesh__D030181smesh__D020218
% 207.86/208.01 |- mesh__recordOriginator mesh__D030181 nns
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D030181 2006
% 207.86/208.01 |- mesh__dateEstablished mesh__D030181 2002-01-01
% 207.86/208.01 |- mesh__dateCreated mesh__D030181 2001-07-25
% 207.86/208.01 |- mesh__historyNote mesh__D030181
% 207.86/208.01 2002; was VITAMIN D-BINDING PROTEIN 1992-2001
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D030181
% 207.86/208.01 2002; 2002; see VITAMIN D-BINDING PROTEIN 1992-2001
% 207.86/208.01 |- mesh__recordMaintainer mesh__D030181 nns
% 207.86/208.01 |- mesh__dateRevised mesh__D030181 2005-06-30
% 207.86/208.01 |- skos__altLabel mesh__D030181 Response Element, Vitamin D
% 207.86/208.01 |- skos__scopeNote mesh__D030181
% 207.86/208.01 A DNA sequence that is found in the promoter region of vitamin D regulated genes. Vitamin D receptor %28%RECEPTOR, CALCITRIOL%29% binds to and regulates the activity of genes containing this element.%A%
% 207.86/208.01 |- skos__historyNote mesh__D030181 Receptors, Calcitriol %28%1989-2001%29%
% 207.86/208.01 |- skos__historyNote mesh__D030181 Vitamin D %28%1989-2001%29%
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D030181 sjn
% 207.86/208.01 |- rdf__type mesh__D030181sskos__Concept
% 207.86/208.01 |- skos__prefLabel mesh__D030181 Vitamin D Response Element
% 207.86/208.01 |- skos__broader mesh__D002490smesh__D009420
% 207.86/208.01 |- skos__hiddenLabel mesh__D002490 Systems, Central Nervous
% 207.86/208.01 |- mesh__dateRevised mesh__D002490 2004-07-07
% 207.86/208.01 |- skos__hiddenLabel mesh__D002490 Central Nervous Systems
% 207.86/208.01 |- mesh__recordOriginator mesh__D002490 NLM
% 207.86/208.01 |- skos__hiddenLabel mesh__D002490 Nervous Systems, Central
% 207.86/208.01 |- rdf__type mesh__D002490sskos__Concept
% 207.86/208.01 |- mesh__recordMaintainer mesh__D002490 ags
% 207.86/208.01 |- mesh__onlineNote mesh__D002490
% 207.86/208.01 pre-explosion = CENTRAL NERVOUS SYSTEM %28%PX%29%
% 207.86/208.01 |- mesh__dateCreated mesh__D002490 1999-01-01
% 207.86/208.01 |- skos__scopeNote mesh__D002490
% 207.86/208.01 The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.%A%
% 207.86/208.01 |- skos__annotation mesh__D002490
% 207.86/208.01 text must discuss both brain %26% spinal cord; prefer BRAIN or SPINAL CORD; neural tube: index CENTRAL NERVOUS SYSTEM /embryol; %22%CNS effects%22% or %22%central effects%22% of drugs in texts usually means BRAIN /drug eff, not CNS /drug eff; /drug eff: consider terms in D14 %26% D15%A%
% 207.86/208.01 |- skos__prefLabel mesh__D002490 Central Nervous System
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D002490 2005
% 207.86/208.01 |- skos__hiddenLabel mesh__D002490 Nervous System, Central
% 207.86/208.01 |- skos__hiddenLabel mesh__D002490 System, Central Nervous
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D002490 sjn
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D002490 2006
% 207.86/208.01 |- skos__annotation mesh__D010922
% 207.86/208.01 check the tags FEMALE %26% PREGNANCY; FETAL MALNUTRITION is available%A%
% 207.86/208.01 |- skos__historyNote mesh__D010922 Placenta %28%1966-1968%29%
% 207.86/208.01 |- rdf__type mesh__D010922sskos__Concept
% 207.86/208.01 |- skos__altLabel mesh__D010922 Placental Diseases
% 207.86/208.01 |- skos__hiddenLabel mesh__D010922 Disorder, Placenta
% 207.86/208.01 |- mesh__historyNote mesh__D010922
% 207.86/208.01 80; was PLACENTA DISORDERS 1969-79 %28%Prov 1969-72%29%
% 207.86/208.01 |- skos__hiddenLabel mesh__D010922 Disease, Placenta
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D010922 80; was PLACENTA DISORDERS 1973-79
% 207.86/208.01 |- skos__hiddenLabel mesh__D010922 Placenta Disorder
% 207.86/208.01 |- mesh__dateRevised mesh__D010922 2005-06-30
% 207.86/208.01 |- skos__prefLabel mesh__D010922 Placenta Diseases
% 207.86/208.01 |- skos__historyNote mesh__D010922
% 207.86/208.01 Pregnancy Complications %28%1966-1968%29%
% 207.86/208.01 |- skos__hiddenLabel mesh__D010922 Disease, Placental
% 207.86/208.01 |- skos__broader mesh__D010922smesh__D011248
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D010922 sjn
% 207.86/208.01 |- skos__scopeNote mesh__D010922
% 207.86/208.01 Pathological processes or abnormal functions of the PLACENTA.%A%
% 207.86/208.01 |- mesh__recordOriginator mesh__D010922 NLM
% 207.86/208.01 |- skos__hiddenLabel mesh__D010922 Diseases, Placenta
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010922 2006
% 207.86/208.01 |- skos__altLabel mesh__D010922 Placenta Disorders
% 207.86/208.01 |- mesh__dateCreated mesh__D010922 1999-01-01
% 207.86/208.01 |- mesh__onlineNote mesh__D010922
% 207.86/208.01 use PLACENTA DISEASES to search PLACENTA DISORDERS 1969-79 %28%as Prov 1969-72%29%%A%
% 207.86/208.01 |- mesh__recordMaintainer mesh__D010922 lkt
% 207.86/208.01 |- mesh__dateEstablished mesh__D010922 1973-01-01
% 207.86/208.01 |- skos__hiddenLabel mesh__D010922 Diseases, Placental
% 207.86/208.01 |- skos__hiddenLabel mesh__D010922 Placental Disease
% 207.86/208.01 |- skos__hiddenLabel mesh__D010922 Placenta Disease
% 207.86/208.01 |- skos__hiddenLabel mesh__D010922 Disorders, Placenta
% 207.86/208.01 |- skos__historyNote mesh__D018107 Rinderpest Virus %28%1971-1993%29%
% 207.86/208.01 |- mesh__recordMaintainer mesh__D018107 ags
% 207.86/208.01 |- mesh__recordAuthorizer mesh__D018107 sjn
% 207.86/208.01 |- mesh__dateCreated mesh__D018107 1993-06-30
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D018107 2002
% 207.86/208.01 |- skos__hiddenLabel mesh__D018107 Peste des petits ruminants virus
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D018107 2004
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D018107 2005
% 207.86/208.01 |- rdf__type mesh__D018107sskos__Concept
% 207.86/208.01 |- mesh__dateEstablished mesh__D018107 1994-01-01
% 207.86/208.01 |- skos__annotation mesh__D018107
% 207.86/208.01 for foreign titles, do not translate the disease %22%peste des petits ruminants%22%; infection = PESTE-DES-PETITS-RUMINANTS%A%
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D018107 2003
% 207.86/208.01 |- skos__prefLabel mesh__D018107 Peste-des-petits-ruminants virus
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D018107 94
% 207.86/208.01 |- mesh__historyNote mesh__D018107 94
% 207.86/208.01 |- skos__scopeNote mesh__D018107
% 207.86/208.01 A species of MORBILLIVIRUS causing a severe, often fatal enteritis and pneumonia %28%PESTE-DES-PETITS-RUMINANTS%29% in sheep and goats.%A%
% 207.86/208.01 |- skos__broader mesh__D018107smesh__D018103
% 207.86/208.01 |- mesh__dateRevised mesh__D018107 2001-07-25
% 207.86/208.01 |- mesh__recordOriginator mesh__D018107 AGS
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D018107 2006
% 207.86/208.01 |- mesh__publicMeSHNote mesh__D010124
% 207.86/208.01 SYPHACIA was see under OXYUROIDEA 1963-85
% 207.86/208.01 |- mesh__activeMeSHYear mesh__D010124 2004
% 207.86/208.02 |- mesh__onlineNote mesh__D010124
% 207.86/208.02 use OXYUROIDEA to search SYPHACIA 1966-85
% 207.86/208.02 |- mesh__recordMaintainer mesh__D010124 ags
% 207.86/208.02 |- mesh__historyNote mesh__D010124
% 207.86/208.02 SYPHACIA was see under OXYUROIDEA 1963-85
% 207.86/208.02 |- skos__scopeNote mesh__D010124
% 207.86/208.02 A superfamily of parasitic nematodes consisting of several genera. ENTEROBIUS, which occurs in humans, and Oxyuris, which occurs in horses, are two of the most common. Other genera are: Skrjabinema, Passalurus, Dermatoxys, and Probstmayria.%A%
% 207.86/208.02 |- skos__annotation mesh__D010124
% 207.86/208.02 a superfamily of nematodes; infection: coord IM with OXYURIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 207.86/208.02 |- skos__prefLabel mesh__D010124 Oxyuroidea
% 207.86/208.02 |- mesh__dateCreated mesh__D010124 1999-01-01
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D010124 2006
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D010124 sjn
% 207.86/208.02 |- skos__broader mesh__D010124smesh__D017167
% 207.86/208.02 |- mesh__recordOriginator mesh__D010124 NLM
% 207.86/208.02 |- rdf__type mesh__D010124sskos__Concept
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D010124 2005
% 207.86/208.02 |- mesh__dateRevised mesh__D010124 2003-07-09
% 207.86/208.02 |- skos__broader mesh__D001152Q000506smesh__D001152
% 207.86/208.02 |- mesh__preferredCombination mesh__D001152Q000506smesh__D020261
% 207.86/208.02 |- rdf__type mesh__D001152Q000506smesh__CompoundConcept
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D001398 2006
% 207.86/208.02 |- skos__hiddenLabel mesh__D001398 SQ 26,776
% 207.86/208.02 |- mesh__recordOriginator mesh__D001398 SH
% 207.86/208.02 |- skos__altLabel mesh__D001398 Azthreonam
% 207.86/208.02 |- skos__altLabel mesh__D001398 Squibb Brand of Aztreonam
% 207.86/208.02 |- skos__historyNote mesh__D001398 Antibiotics %28%1966-1982%29%
% 207.86/208.02 |- mesh__dateEstablished mesh__D001398 1986-01-01
% 207.86/208.02 |- skos__hiddenLabel mesh__D001398 Aztreonam Esteve Brand
% 207.86/208.02 |- skos__altLabel mesh__D001398 Az-threonam
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D001398 86
% 207.86/208.02 |- skos__historyNote mesh__D001398 Antibiotics, Lactam %28%1983-1985%29%
% 207.86/208.02 |- mesh__dateCreated mesh__D001398 1985-06-14
% 207.86/208.02 |- skos__altLabel mesh__D001398 Esteve Brand of Aztreonam
% 207.86/208.02 |- mesh__recordMaintainer mesh__D001398 ssb
% 207.86/208.02 |- mesh__dateRevised mesh__D001398 2004-07-07
% 207.86/208.02 |- skos__altLabel mesh__D001398 Bristol-Myers Squibb Brand of Aztreonam
% 207.86/208.02 |- rdf__type mesh__D001398sskos__Concept
% 207.86/208.02 |- skos__hiddenLabel mesh__D001398 Az threonam
% 207.86/208.02 |- skos__broader mesh__D001398smesh__D008997
% 207.86/208.02 |- skos__scopeNote mesh__D001398
% 207.86/208.02 A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.%A%
% 207.86/208.02 |- skos__prefLabel mesh__D001398 Aztreonam
% 207.86/208.02 |- skos__hiddenLabel mesh__D001398 SQ26,776
% 207.86/208.02 |- skos__hiddenLabel mesh__D001398 Aztreonam Squibb Brand
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D001398 2005
% 207.86/208.02 |- skos__altLabel mesh__D001398 Sanofi Winthrop Brand of Aztreonam
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D001398 sjn
% 207.86/208.02 |- skos__hiddenLabel mesh__D001398 Bristol Myers Squibb Brand of Aztreonam
% 207.86/208.02 |- mesh__historyNote mesh__D001398 86
% 207.86/208.02 |- skos__annotation mesh__D001398
% 207.86/208.02 do not use /biosyn unless by living matter
% 207.86/208.02 |- skos__broader mesh__D006881smesh__D015073
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006881 2000
% 207.86/208.02 |- mesh__dateEstablished mesh__D006881 1991-01-01
% 207.86/208.02 |- mesh__recordMaintainer mesh__D006881 adp
% 207.86/208.02 |- skos__historyNote mesh__D006881 Hydroxamic Acids %28%1966-1974%29%
% 207.86/208.02 |- skos__prefLabel mesh__D006881 Hydroxyacetylaminofluorene
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006881 2006
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006881 2004
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D006881 sjn
% 207.86/208.02 |- skos__historyNote mesh__D006881 Fluorenes %28%1966-1974%29%
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006881 2005
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006881 2002
% 207.86/208.02 |- skos__altLabel mesh__D006881 N-Hydroxy-2-acetamidofluorene
% 207.86/208.02 |- skos__scopeNote mesh__D006881
% 207.86/208.02 A N-hydroxylated derivative of 2-ACETYLAMINOFLUORENE that has demonstrated carcinogenic action.%A%
% 207.86/208.02 |- mesh__historyNote mesh__D006881
% 207.86/208.02 91%28%75%29%; was see under 2-ACETYLAMINOFLUORENE 1980-90; was see under FLUORENES 1975-79%A%
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006881 2003
% 207.86/208.02 |- mesh__recordOriginator mesh__D006881 NLM
% 207.86/208.02 |- skos__hiddenLabel mesh__D006881 N Hydroxy 2 acetamidofluorene
% 207.86/208.02 |- mesh__dateCreated mesh__D006881 1974-11-11
% 207.86/208.02 |- rdf__type mesh__D006881sskos__Concept
% 207.86/208.02 |- mesh__dateRevised mesh__D006881 1999-11-03
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006881 2001
% 207.86/208.02 |- skos__altLabel mesh__D006881 Hydroxyfluorenylacetamide
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D006881
% 207.86/208.02 91; was see under 2-ACETYLAMINOFLUORENE 1980-90; was see under FLUORENES 1975-79%A%
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Assay, Comet
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D020552 2000
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D020552 2002
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552
% 207.86/208.02 Alkaline Single Cell Gel Electrophoresis Assay
% 207.86/208.02 |- skos__broader mesh__D020552smesh__D009152
% 207.86/208.02 |- skos__prefLabel mesh__D020552 Comet Assay
% 207.86/208.02 |- skos__historyNote mesh__D020552 Mutagenicity Tests %28%1992-1999%29%
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Assays, Comet
% 207.86/208.02 |- rdf__type mesh__D020552sskos__Concept
% 207.86/208.02 |- skos__scopeNote mesh__D020552
% 207.86/208.02 A genotoxicological technique for measuring DNA damage in an individual cell using single-cell gel electrophoresis. Cell DNA fragments assume a %22%comet with tail%22% formation on electrophoresis and are detected with an image analysis system. Alkaline assay conditions facilitate sensitive detection of single-strand damage.%A%
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Single-Cell Gel Electrophoreses
% 207.86/208.02 |- mesh__historyNote mesh__D020552 2000
% 207.86/208.02 |- skos__altLabel mesh__D020552 Gel Electrophoresis, Single-Cell
% 207.86/208.02 |- mesh__dateCreated mesh__D020552 1999-11-03
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Gel Electrophoresis, Single Cell
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Comet Assays, Alkaline
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Comet Assay, Alkaline
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Assay, Alkaline Comet
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D020552 2006
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D020552 2001
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D020552 2004
% 207.86/208.02 |- skos__historyNote mesh__D020552
% 207.86/208.02 Electrophoresis, Agar Gel %28%1990-1999%29%
% 207.86/208.02 |- skos__broader mesh__D020552smesh__D004587
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Comet Assays
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D020552 2005
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Single-Cell Gel Electrophoresis
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D020552 2000
% 207.86/208.02 |- skos__historyNote mesh__D020552 Electrophoresis %28%1990-1999%29%
% 207.86/208.02 |- skos__altLabel mesh__D020552
% 207.86/208.02 Alkaline Single-Cell Gel Electrophoresis Assay
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D020552 2003
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Assays, Alkaline Comet
% 207.86/208.02 |- skos__related mesh__D020552smesh__D004249
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Gel Electrophoreses, Single-Cell
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Alkaline Comet Assays
% 207.86/208.02 |- mesh__dateEstablished mesh__D020552 2000-01-01
% 207.86/208.02 |- skos__altLabel mesh__D020552 Electrophoresis, Gel, Single-Cell
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Electrophoresis, Single-Cell Gel
% 207.86/208.02 |- skos__hiddenLabel mesh__D020552 Electrophoreses, Single-Cell Gel
% 207.86/208.02 |- skos__hiddenLabel mesh__D006083 Graft Restenoses, Vascular
% 207.86/208.02 |- skos__altLabel mesh__D006083 Graft Restenosis, Vascular
% 207.86/208.02 |- mesh__recordMaintainer mesh__D006083 KEV
% 207.86/208.02 |- skos__hiddenLabel mesh__D006083 Restenosis, Vascular Graft
% 207.86/208.02 |- mesh__dateRevised mesh__D006083 1999-11-03
% 207.86/208.02 |- skos__altLabel mesh__D006083 Vascular Graft Occlusion
% 207.86/208.02 |- mesh__recordOriginator mesh__D006083 VDK
% 207.86/208.02 |- skos__hiddenLabel mesh__D006083 Occlusion, Vascular Graft
% 207.86/208.02 |- mesh__historyNote mesh__D006083 85
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006083 2002
% 207.86/208.02 |- skos__related mesh__D006083smesh__D014654
% 207.86/208.02 |- rdf__type mesh__D006083sskos__Concept
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D006083 85
% 207.86/208.02 |- skos__broader mesh__D006083smesh__D011183
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006083 2003
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D006083 sjn
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006083 2000
% 207.86/208.02 |- mesh__dateEstablished mesh__D006083 1985-01-01
% 207.86/208.02 |- skos__scopeNote mesh__D006083
% 207.86/208.02 Obstruction of flow in biological or prosthetic vascular grafts.%A%
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006083 2005
% 207.86/208.02 |- skos__altLabel mesh__D006083 Vascular Graft Restenosis
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006083 2004
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006083 2001
% 207.86/208.02 |- mesh__dateCreated mesh__D006083 1984-05-29
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006083 2006
% 207.86/208.02 |- skos__prefLabel mesh__D006083 Graft Occlusion, Vascular
% 207.86/208.02 |- mesh__recordMaintainer mesh__D014515 jls
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014515 2005
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D014515 sjn
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014515 2004
% 207.86/208.02 |- rdf__type mesh__D014515sskos__Concept
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D014515 66
% 207.86/208.02 |- skos__hiddenLabel mesh__D014515 Disease, Ureteral
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014515 2003
% 207.86/208.02 |- mesh__dateRevised mesh__D014515 2001-08-13
% 207.86/208.02 |- mesh__recordOriginator mesh__D014515 NLM
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014515 2002
% 207.86/208.02 |- skos__prefLabel mesh__D014515 Ureteral Diseases
% 207.86/208.02 |- skos__broader mesh__D014515smesh__D014570
% 207.86/208.02 |- skos__hiddenLabel mesh__D014515 Diseases, Ureteral
% 207.86/208.02 |- mesh__dateEstablished mesh__D014515 1966-01-01
% 207.86/208.02 |- mesh__historyNote mesh__D014515 66
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014515 2006
% 207.86/208.02 |- skos__annotation mesh__D014515
% 207.86/208.02 do not confuse with URETHRAL DISEASES, espec in Romance lang: ur%C3%%A9%t%C3%%A9%ral %28%French%29%, ureteral %28%Span%29%, ureterale %28%Ital%29% = %22%ureteral%22%, while ur%C3%%A9%tral %28%French%29%, uretral %28%Span%29%, uretrale %28%Ital%29% = %22%urethral%22%%A%
% 207.86/208.02 |- mesh__dateCreated mesh__D014515 1999-01-01
% 207.86/208.02 |- skos__hiddenLabel mesh__D014515 Ureteral Disease
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 1997
% 207.86/208.02 |- skos__broader mesh__D019200smesh__D012328
% 207.86/208.02 |- rdf__type mesh__D019200sskos__Concept
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 2006
% 207.86/208.02 |- skos__scopeNote mesh__D019200
% 207.86/208.02 A family of RNA viruses with one genus: ASTROVIRUS. They cause gastroenteritis in humans and also infect other vertebrates.%A%
% 207.86/208.02 |- skos__annotation mesh__D019200
% 207.86/208.02 a family of RNA viruses; infection = ASTROVIRIDAE INFECTIONS%A%
% 207.86/208.02 |- mesh__dateEstablished mesh__D019200 1997-01-01
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 2005
% 207.86/208.02 |- mesh__dateCreated mesh__D019200 1996-06-10
% 207.86/208.02 |- mesh__historyNote mesh__D019200 97
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 2002
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 2004
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 1999
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 2001
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D019200 97
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 2003
% 207.86/208.02 |- skos__prefLabel mesh__D019200 Astroviridae
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 1998
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019200 2000
% 207.86/208.02 |- skos__altLabel mesh__D005789 Geneology and Heraldry
% 207.86/208.02 |- mesh__recordMaintainer mesh__D005789 jls
% 207.86/208.02 |- mesh__dateRevised mesh__D005789 2004-07-07
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D005789 sjn
% 207.86/208.02 |- skos__altLabel mesh__D005789 Heraldry and Geneology
% 207.86/208.02 |- skos__altLabel mesh__D005789 Heraldry and Genealogy
% 207.86/208.02 |- skos__prefLabel mesh__D005789 Genealogy and Heraldry
% 207.86/208.02 |- skos__altLabel mesh__D005789 Genealogy
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D005789 2005
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D005789 2006
% 207.86/208.02 |- skos__annotation mesh__D005789
% 207.86/208.02 IM; no qualif; do not confuse with GENEALOGICAL TREE see PEDIGREE; DF: GENEALOGY%A%
% 207.86/208.02 |- mesh__dateCreated mesh__D005789 1999-01-01
% 207.86/208.02 |- skos__hiddenLabel mesh__D005789 Geneologies
% 207.86/208.02 |- skos__altLabel mesh__D005789 Genealogies
% 207.86/208.02 |- mesh__recordOriginator mesh__D005789 NLM
% 207.86/208.02 |- skos__related mesh__D005789smesh__D004616
% 207.86/208.02 |- skos__broader mesh__D005789smesh__D006664
% 207.86/208.02 |- rdf__type mesh__D005789sskos__Concept
% 207.86/208.02 |- skos__annotation mesh__D002491
% 207.86/208.02 GEN or unspecified; prefer specific groups or specific drugs; consider also CENTRAL NERVOUS SYSTEM /drug eff %26% BRAIN /drug eff; DF: CNS AGENTS%A%
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D002491 sjn
% 207.86/208.02 |- mesh__historyNote mesh__D002491 79; was NON MESH before 1979
% 207.86/208.02 |- mesh__dateRevised mesh__D002491 2005-08-15
% 207.86/208.02 |- skos__broader mesh__D002491smesh__D045506
% 207.86/208.02 |- mesh__onlineNote mesh__D002491
% 207.86/208.02 consider also CENTRAL NERVOUS SYSTEM /DE %26% BRAIN /DE
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D002491 79
% 207.86/208.02 |- rdf__type mesh__D002491sskos__Concept
% 207.86/208.02 |- mesh__recordMaintainer mesh__D002491 sjn
% 207.86/208.02 |- mesh__dateEstablished mesh__D002491 1979-01-01
% 207.86/208.02 |- mesh__dateCreated mesh__D002491 1999-01-01
% 207.86/208.02 |- skos__altLabel mesh__D002491 Central Nervous System Drugs
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D002491 2006A
% 207.86/208.02 |- mesh__recordOriginator mesh__D002491 NLM
% 207.86/208.02 |- skos__prefLabel mesh__D002491 Central Nervous System Agents
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D002491 2006
% 207.86/208.02 |- skos__scopeNote mesh__D002491
% 207.86/208.02 A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into %22%specific%22% agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and %22%nonspecific%22% agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. %28%From Gilman AG, et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p252%29%%A%
% 207.86/208.02 |- mesh__historyNote mesh__D018906 96
% 207.86/208.02 |- rdf__type mesh__D018906sskos__Concept
% 207.86/208.02 |- mesh__dateCreated mesh__D018906 1995-05-26
% 207.86/208.02 |- skos__altLabel mesh__D018906 Alkylating Antineoplastic Drugs
% 207.86/208.02 |- skos__altLabel mesh__D018906 Antineoplastic Drugs, Alkylating
% 207.86/208.02 |- skos__historyNote mesh__D018906 Antineoplastic Agents %28%1966-1995%29%
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D018906 2006
% 207.86/208.02 |- mesh__dateRevised mesh__D018906 2005-06-30
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D018906 96
% 207.86/208.02 |- mesh__dateEstablished mesh__D018906 1996-01-01
% 207.86/208.02 |- skos__altLabel mesh__D018906 Antineoplastic Alkylating Agents
% 207.86/208.02 |- skos__altLabel mesh__D018906 Alkylating Antineoplastics
% 207.86/208.02 |- mesh__recordMaintainer mesh__D018906 ssb
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D018906 sjn
% 207.86/208.02 |- skos__historyNote mesh__D018906 Alkylating Agents %28%1966-1995%29%
% 207.86/208.02 |- skos__prefLabel mesh__D018906 Antineoplastic Agents, Alkylating
% 207.86/208.02 |- skos__altLabel mesh__D018906 Alkylating Antineoplastic Agents
% 207.86/208.02 |- skos__altLabel mesh__D018906 Alkylating Agents, Antineoplastic
% 207.86/208.02 |- skos__altLabel mesh__D018906 Antineoplastics, Alkylating
% 207.86/208.02 |- skos__scopeNote mesh__D018906
% 207.86/208.02 A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. %28%From AMA, Drug Evaluations Annual, 1994, p2026%29%%A%
% 207.86/208.02 |- skos__broader mesh__D018906smesh__D000477
% 207.86/208.02 |- skos__altLabel mesh__D018906 Alkylating Drugs, Antineoplastic
% 207.86/208.02 |- skos__hiddenLabel mesh__D018906 Antineoplastic Alkylating Drugs
% 207.86/208.02 |- skos__broader mesh__D018906smesh__D000970
% 207.86/208.02 |- mesh__recordOriginator mesh__D018906 JRT
% 207.86/208.02 |- skos__hiddenLabel mesh__D018906 Drugs, Antineoplastic Alkylating
% 207.86/208.02 |- mesh__recordOriginator mesh__D010923 NLM
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D010923
% 207.86/208.02 2006; see PLACENTA PRAEVIA 1963-2005
% 207.86/208.02 |- mesh__dateCreated mesh__D010923 1999-01-01
% 207.86/208.02 |- skos__prefLabel mesh__D010923 Placenta Previa
% 207.86/208.02 |- rdf__type mesh__D010923sskos__Concept
% 207.86/208.02 |- skos__scopeNote mesh__D010923
% 207.86/208.02 Abnormal placentation in which the PLACENTA implants in the lower segment of the UTERUS %28%the zone of dilation%29% and may cover part or all of the opening of the CERVIX. It is often associated with serious antepartum bleeding and PREMATURE LABOR.%A%
% 207.86/208.02 |- mesh__historyNote mesh__D010923 2006 %28%1963%29%
% 207.86/208.02 |- mesh__recordMaintainer mesh__D010923 lkt
% 207.86/208.02 |- skos__broader mesh__D010923smesh__D007744
% 207.86/208.02 |- skos__annotation mesh__D010923 check the tags FEMALE %26% PREGNANCY
% 207.86/208.02 |- skos__broader mesh__D010923smesh__D010922
% 207.86/208.02 |- mesh__dateRevised mesh__D010923 2005-06-30
% 207.86/208.02 |- skos__altLabel mesh__D010923 Placenta Praevia
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D010923 2006
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D010923 sjn
% 207.86/208.02 |- skos__annotation mesh__D018108 infection = RESPIROVIRUS INFECTIONS
% 207.86/208.02 |- mesh__dateRevised mesh__D018108 2003-07-09
% 207.86/208.02 |- skos__historyNote mesh__D018108 Paramyxoviridae %28%1967-1993%29%
% 207.86/208.02 |- skos__scopeNote mesh__D018108
% 207.86/208.02 A genus of the family PARAMYXOVIRIDAE %28%subfamily PARAMYXOVIRINAE%29% where all the virions have both HEMAGGLUTININ and NEURAMINIDASE activities and encode a non-structural C protein. SENDAI VIRUS is the type species.%A%
% 207.86/208.02 |- mesh__recordOriginator mesh__D018108 AGS
% 207.86/208.02 |- mesh__historyNote mesh__D018108 2002 %28%1994%29%
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D018108 sjn
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D018108 2002; see PARAMYXOVIRUS 1994-2001
% 207.86/208.02 |- skos__broader mesh__D018108smesh__D018098
% 207.86/208.02 |- mesh__dateEstablished mesh__D018108 1994-01-01
% 207.86/208.02 |- skos__prefLabel mesh__D018108 Respirovirus
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D018108 2006
% 207.86/208.02 |- skos__hiddenLabel mesh__D018108 Respiroviruses
% 207.86/208.02 |- mesh__recordMaintainer mesh__D018108 ags
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D018108 2004
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D018108 2005
% 207.86/208.02 |- rdf__type mesh__D018108sskos__Concept
% 207.86/208.02 |- mesh__dateCreated mesh__D018108 1993-06-04
% 207.86/208.02 |- mesh__recordMaintainer mesh__D010125 ags
% 207.86/208.02 |- skos__prefLabel mesh__D010125 Ostreidae
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D010125 sjn
% 207.86/208.02 |- mesh__dateRevised mesh__D010125 2005-06-30
% 207.86/208.02 |- mesh__historyNote mesh__D010125 2006
% 207.86/208.02 |- skos__annotation mesh__D010125
% 207.86/208.02 as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%; note entry term OYSTERS: oysters unspecified go here; OYSTERS, TRUE is also available%A%
% 207.86/208.02 |- skos__historyNote mesh__D010125 Mollusca %28%1966-1971%29%
% 207.86/208.02 |- mesh__recordOriginator mesh__D010125 NLM
% 207.86/208.02 |- skos__scopeNote mesh__D010125
% 207.86/208.02 A family of marine mollusks in the class BIVALVIA, commonly known as oysters. They have a rough irregular shell closed by a single adductor muscle.%A%
% 207.86/208.02 |- mesh__dateCreated mesh__D010125 1999-01-01
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D010125 2006
% 207.86/208.02 |- rdf__type mesh__D010125sskos__Concept
% 207.86/208.02 |- skos__broader mesh__D010125smesh__D049872
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D010125 2006; see OYSTERS 1972-2006
% 207.86/208.02 |- mesh__dateEstablished mesh__D010125 1972-01-01
% 207.86/208.02 |- skos__altLabel mesh__D010125 Oysters
% 207.86/208.02 |- rdf__type mesh__D001399sskos__Concept
% 207.86/208.02 |- mesh__dateEstablished mesh__D001399 1991-01-01
% 207.86/208.02 |- skos__historyNote mesh__D001399 Phenothiazines %28%1969-1975%29%
% 207.86/208.02 |- skos__hiddenLabel mesh__D001399 Stain, Giemsa
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D001399 sjn
% 207.86/208.02 |- mesh__dateCreated mesh__D001399 1975-07-18
% 207.86/208.02 |- skos__historyNote mesh__D001399 Staining %28%1966-1975%29%
% 207.86/208.02 |- mesh__historyNote mesh__D001399
% 207.86/208.02 91%28%76%29%; was see under PHENOTHIAZINES 1976-90
% 207.86/208.02 |- skos__historyNote mesh__D001399 Imines %28%1974-1975%29%
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D001399
% 207.86/208.02 91; was see under PHENOTHIAZINES 1976-90
% 207.86/208.02 |- mesh__dateRevised mesh__D001399 2005-06-30
% 207.86/208.02 |- skos__scopeNote mesh__D001399
% 207.86/208.02 PHENOTHIAZINES with an amino group at the 3-position that are green crystals or powder. They are used as biological stains.%A%
% 207.86/208.02 |- skos__hiddenLabel mesh__D001399 Giemsa 11
% 207.86/208.02 |- mesh__recordOriginator mesh__D001399 RLS
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D001399 2006
% 207.86/208.02 |- skos__broader mesh__D001399smesh__D010640
% 207.86/208.02 |- mesh__recordMaintainer mesh__D001399 ssb
% 207.86/208.02 |- skos__historyNote mesh__D001399 Dimethylamines %28%1974-1975%29%
% 207.86/208.02 |- skos__hiddenLabel mesh__D001399 Stains, Azure
% 207.86/208.02 |- skos__prefLabel mesh__D001399 Azure Stains
% 207.86/208.02 |- mesh__recordOriginator mesh__D006882 NLM
% 207.86/208.02 |- rdf__type mesh__D006882sskos__Concept
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D006882 75; was HYDROXYAPATITE 1967-74
% 207.86/208.02 |- mesh__dateRevised mesh__D006882 2004-07-13
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006882 2006
% 207.86/208.02 |- skos__prefLabel mesh__D006882 Hydroxyapatites
% 207.86/208.02 |- mesh__dateCreated mesh__D006882 1999-01-01
% 207.86/208.02 |- mesh__recordMaintainer mesh__D006882 sjn
% 207.86/208.02 |- mesh__dateEstablished mesh__D006882 1967-01-01
% 207.86/208.02 |- mesh__historyNote mesh__D006882
% 207.86/208.02 75; was HYDROXYAPATITE 1964-74 %28%Prov 1964-66%29%
% 207.86/208.02 |- skos__broader mesh__D006882smesh__D001031
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D006882 sjn
% 207.86/208.02 |- skos__scopeNote mesh__D006882
% 207.86/208.02 A group of compounds with the general formula M10%28%PO4%29%6%28%OH%29%2, where M is barium, strontium, or calcium. The compounds are the principal mineral in phosphorite deposits, biological tissue, human bones, and teeth. They are also used as an anticaking agent and polymer catalysts. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%
% 207.86/208.02 |- mesh__onlineNote mesh__D006882
% 207.86/208.02 use HYDROXYAPATITES to search HYDROXYAPATITE 1964-74 %28%as Prov 1966%29%%A%
% 207.86/208.02 |- skos__annotation mesh__D006882
% 207.86/208.02 in phosphorite deposits %26% biol tissue
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006882 2005
% 207.86/208.02 |- rdf__type mesh__D006084sskos__Concept
% 207.86/208.02 |- mesh__dateEstablished mesh__D006084 1973-01-01
% 207.86/208.02 |- mesh__recordMaintainer mesh__D006084 ags
% 207.86/208.02 |- skos__hiddenLabel mesh__D006084 Rejection, Transplantation
% 207.86/208.02 |- skos__hiddenLabel mesh__D006084 Transplant Rejections
% 207.86/208.02 |- skos__altLabel mesh__D006084 Transplantation Rejection
% 207.86/208.02 |- mesh__dateRevised mesh__D006084 2005-06-30
% 207.86/208.02 |- skos__altLabel mesh__D006084 Transplant Rejection
% 207.86/208.02 |- skos__altLabel mesh__D006084 Rejection, Transplant
% 207.86/208.02 |- skos__annotation mesh__D006084
% 207.86/208.02 may be used with transplanted neoplasms
% 207.86/208.02 |- mesh__recordOriginator mesh__D006084 NLM
% 207.86/208.02 |- skos__hiddenLabel mesh__D006084 Rejections, Transplantation
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D006084 73
% 207.86/208.02 |- skos__hiddenLabel mesh__D006084 Rejection, Graft
% 207.86/208.02 |- skos__historyNote mesh__D006084
% 207.86/208.02 Transplantation Immunology %28%1966-1970%29%
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D006084 2006
% 207.86/208.02 |- skos__hiddenLabel mesh__D006084 Graft Rejections
% 207.86/208.02 |- skos__broader mesh__D006084smesh__D006789
% 207.86/208.02 |- skos__hiddenLabel mesh__D006084 Transplantation Rejections
% 207.86/208.02 |- skos__hiddenLabel mesh__D006084 Rejections, Graft
% 207.86/208.02 |- skos__scopeNote mesh__D006084
% 207.86/208.02 An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.%A%
% 207.86/208.02 |- skos__related mesh__D006084smesh__D051799
% 207.86/208.02 |- skos__prefLabel mesh__D006084 Graft Rejection
% 207.86/208.02 |- mesh__historyNote mesh__D006084 73%28%71%29%
% 207.86/208.02 |- skos__hiddenLabel mesh__D006084 Rejections, Transplant
% 207.86/208.02 |- mesh__dateCreated mesh__D006084 1999-01-01
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D006084 sjn
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014516 2004
% 207.86/208.02 |- rdf__type mesh__D014516sskos__Concept
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Ureter Neoplasm
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014516 2000
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Neoplasm, Ureter
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Cancer, Ureter
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014516 2003
% 207.86/208.02 |- mesh__recordMaintainer mesh__D014516 nns
% 207.86/208.02 |- skos__altLabel mesh__D014516 Ureter Cancer
% 207.86/208.02 |- mesh__recordAuthorizer mesh__D014516 sjn
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Ureteral Cancers
% 207.86/208.02 |- skos__altLabel mesh__D014516 Ureter Neoplasms
% 207.86/208.02 |- skos__altLabel mesh__D014516 Neoplasms, Ureteral
% 207.86/208.02 |- skos__prefLabel mesh__D014516 Ureteral Neoplasms
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Ureter Cancers
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Cancers, Ureter
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Neoplasms, Ureter
% 207.86/208.02 |- mesh__recordOriginator mesh__D014516 NLM
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014516 2006
% 207.86/208.02 |- skos__annotation mesh__D014516
% 207.86/208.02 do not confuse with URETHRAL NEOPLASMS, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES; coord IM with histol type of neopl %28%IM%29%%A%
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Cancers, Ureteral
% 207.86/208.02 |- mesh__dateCreated mesh__D014516 1999-01-01
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014516 2002
% 207.86/208.02 |- skos__scopeNote mesh__D014516
% 207.86/208.02 Cancer or tumors of the URETER. Hematuria, which occurs in 75%25% of patients with ureteral carcinoma, is the most common presenting symptom. The most common site for the occurrence of a ureteral tumor is in the lower third of the URETER, with a lesser incidence higher up.%A%
% 207.86/208.02 |- skos__altLabel mesh__D014516 Cancer of the Ureter
% 207.86/208.02 |- skos__broader mesh__D014516smesh__D014571
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014516 2005
% 207.86/208.02 |- skos__broader mesh__D014516smesh__D014515
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Ureteral Neoplasm
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Neoplasm, Ureteral
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D014516 2001
% 207.86/208.02 |- mesh__dateRevised mesh__D014516 1999-11-03
% 207.86/208.02 |- skos__hiddenLabel mesh__D014516 Cancer, Ureteral
% 207.86/208.02 |- skos__altLabel mesh__D014516 Ureteral Cancer
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019201 2002
% 207.86/208.02 |- skos__annotation mesh__D019201
% 207.86/208.02 a genus of the family Birnaviridae; infection: coord IM with BIRNAVIRIDAE INFECTIONS %28%IM%29%%A%
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019201 2005
% 207.86/208.02 |- mesh__historyNote mesh__D019201 97
% 207.86/208.02 |- mesh__activeMeSHYear mesh__D019201 2001
% 207.86/208.02 |- mesh__publicMeSHNote mesh__D019201 97
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019201 2004
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019201 1999
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019201 2000
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019201 2003
% 207.86/208.03 |- skos__scopeNote mesh__D019201
% 207.86/208.03 A genus of RNA viruses in the family BIRNAVIRIDAE infecting fish, mollusks, and crustaceans. It is transmitted both vertically and horizontally with no known vectors. The natural hosts are salmonids and the type species is INFECTIOUS PANCREATIC NECROSIS VIRUS.%A%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019201 1998
% 207.86/208.03 |- skos__broader mesh__D019201smesh__D018059
% 207.86/208.03 |- skos__prefLabel mesh__D019201 Aquabirnavirus
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019201 1997
% 207.86/208.03 |- skos__hiddenLabel mesh__D019201 Aquabirnaviruses
% 207.86/208.03 |- mesh__dateEstablished mesh__D019201 1997-01-01
% 207.86/208.03 |- rdf__type mesh__D019201sskos__Concept
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019201 2006
% 207.86/208.03 |- mesh__dateCreated mesh__D019201 1996-06-10
% 207.86/208.03 |- skos__related mesh__D030981smesh__D010015
% 207.86/208.03 |- skos__altLabel mesh__D030981 Acroosteolysis Syndrome
% 207.86/208.03 |- skos__historyNote mesh__D030981 Osteolysis %28%1966-2002%29%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D030981 2003
% 207.86/208.03 |- skos__broader mesh__D030981smesh__D010014
% 207.86/208.03 |- skos__historyNote mesh__D030981 Osteolysis, Essential %28%1972-2002%29%
% 207.86/208.03 |- skos__altLabel mesh__D030981 Acro-Osteolysis Syndromes
% 207.86/208.03 |- mesh__historyNote mesh__D030981 2003
% 207.86/208.03 |- skos__broader mesh__D030981smesh__D001848
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D030981 2005
% 207.86/208.03 |- skos__hiddenLabel mesh__D030981 Acro Osteolysis
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D030981 2004
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D030981 2006
% 207.86/208.03 |- skos__hiddenLabel mesh__D030981 Acro-Osteolysis Syndrome
% 207.86/208.03 |- rdf__type mesh__D030981sskos__Concept
% 207.86/208.03 |- mesh__dateEstablished mesh__D030981 2003-01-01
% 207.86/208.03 |- skos__scopeNote mesh__D030981
% 207.86/208.03 A condition with congenital and acquired forms causing recurrent ulcers in the fingers and toes. The congenital form exhibits autosomal dominant inheritance; the acquired form is found in workers who handle VINYL CHLORIDE. When acro-osteolysis is accompanied by generalized OSTEOPOROSIS and skull deformations, it is called HAJDU-CHENEY SYNDROME.%A%
% 207.86/208.03 |- skos__altLabel mesh__D030981 Acroosteolysis
% 207.86/208.03 |- skos__prefLabel mesh__D030981 Acro-Osteolysis
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D030981 2003
% 207.86/208.03 |- mesh__dateCreated mesh__D030981 2002-07-02
% 207.86/208.03 |- skos__altLabel mesh__D002492 CNS Depressants
% 207.86/208.03 |- mesh__dateEstablished mesh__D002492 1979-01-01
% 207.86/208.03 |- mesh__dateCreated mesh__D002492 1999-01-01
% 207.86/208.03 |- skos__prefLabel mesh__D002492 Central Nervous System Depressants
% 207.86/208.03 |- mesh__onlineNote mesh__D002492
% 207.86/208.03 consider also CENTRAL NERVOUS SYSTEM /DE + DEPRESSION, CHEMICAL or BRAIN /DE + DEPRESSION, CHEMICAL%A%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D002492 2006
% 207.86/208.03 |- skos__scopeNote mesh__D002492
% 207.86/208.03 A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents %28%antipsychotics and antianxiety agents%29%.%A%
% 207.86/208.03 |- skos__annotation mesh__D002492
% 207.86/208.03 GEN or unspecified; prefer specific groups or specific drugs; consider also CENTRAL NERVOUS SYSTEM /drug eff or BRAIN /drug eff; DF: CNS DEPRESS%A%
% 207.86/208.03 |- mesh__dateRevised mesh__D002492 2005-06-30
% 207.86/208.03 |- skos__broader mesh__D002492smesh__D002491
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D002492 sjn
% 207.86/208.03 |- mesh__recordMaintainer mesh__D002492 ssb
% 207.86/208.03 |- skos__hiddenLabel mesh__D002492 Depressants, CNS
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D002492 79
% 207.86/208.03 |- skos__broader mesh__D002492smesh__D045505
% 207.86/208.03 |- mesh__historyNote mesh__D002492 79; was NON MESH before 1979
% 207.86/208.03 |- rdf__type mesh__D002492sskos__Concept
% 207.86/208.03 |- mesh__recordOriginator mesh__D002492 NLM
% 207.86/208.03 |- skos__hiddenLabel mesh__D018907 Law 93-579, Public
% 207.86/208.03 |- skos__annotation mesh__D018907
% 207.86/208.03 a civil right to freedom from intrusion in one%27%s private affairs; note X ref, a Federal statute; privacy of patient data or records: index under CONFIDENTIALITY%A%
% 207.86/208.03 |- skos__scopeNote mesh__D018907
% 207.86/208.03 The state of being free from intrusion or disturbance in one%27%s private life or affairs. %28%Random House Unabridged Dictionary, 2d ed, 1993%29%%A%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018907 2003
% 207.86/208.03 |- skos__prefLabel mesh__D018907 Privacy
% 207.86/208.03 |- skos__hiddenLabel mesh__D018907 PL93 579
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018907 2002
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D018907 SJN
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D018907
% 207.86/208.03 96; PRIVACY ACT was see CIVIL RIGHTS 1980-95
% 207.86/208.03 |- mesh__dateCreated mesh__D018907 1994-12-27
% 207.86/208.03 |- rdf__type mesh__D018907sskos__Concept
% 207.86/208.03 |- skos__hiddenLabel mesh__D018907 Act, Privacy
% 207.86/208.03 |- mesh__recordMaintainer mesh__D018907 JLS
% 207.86/208.03 |- skos__related mesh__D018907smesh__D003219
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018907 2001
% 207.86/208.03 |- skos__broader mesh__D018907smesh__D002961
% 207.86/208.03 |- skos__hiddenLabel mesh__D018907 Public Law 93 579
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018907 2006
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018907 2000
% 207.86/208.03 |- mesh__recordOriginator mesh__D018907 TGC
% 207.86/208.03 |- mesh__historyNote mesh__D018907
% 207.86/208.03 96; PRIVACY ACT was see CIVIL RIGHTS 1980-95
% 207.86/208.03 |- skos__related mesh__D018907smesh__D012650
% 207.86/208.03 |- mesh__dateRevised mesh__D018907 1998-06-10
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018907 1999
% 207.86/208.03 |- skos__hiddenLabel mesh__D018907 PL 93 579
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018907 2005
% 207.86/208.03 |- skos__altLabel mesh__D018907 PL 93-579
% 207.86/208.03 |- mesh__dateEstablished mesh__D018907 1996-01-01
% 207.86/208.03 |- mesh__onlineNote mesh__D018907
% 207.86/208.03 use CIVIL RIGHTS to search PRIVACY 1980-95
% 207.86/208.03 |- skos__related mesh__D018907smesh__D010550
% 207.86/208.03 |- skos__altLabel mesh__D018907 PL93-579
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018907 2004
% 207.86/208.03 |- skos__annotation mesh__D010924
% 207.86/208.03 extracts of placenta or placental fractions; do not confuse with chemical substances %22%extracted%22% from the placenta, as %22%peptides extracted from the mouse placenta%22% %28% = PEPTIDES /anal + PLACENTA /chem%29%%A%
% 207.86/208.03 |- mesh__dateCreated mesh__D010924 1999-01-01
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D010924 sjn
% 207.86/208.03 |- rdf__type mesh__D010924sskos__Concept
% 207.86/208.03 |- mesh__recordOriginator mesh__D010924 NLM
% 207.86/208.03 |- skos__hiddenLabel mesh__D010924 Extracts, Placental
% 207.86/208.03 |- skos__broader mesh__D010924smesh__D014020
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010924 2006
% 207.86/208.03 |- skos__scopeNote mesh__D010924
% 207.86/208.03 Extracts prepared from placental tissue; they may contain specific but uncharacterized factors or proteins with specific activities.%A%
% 207.86/208.03 |- skos__prefLabel mesh__D010924 Placental Extracts
% 207.86/208.03 |- mesh__recordMaintainer mesh__D010924 ssb
% 207.86/208.03 |- mesh__dateRevised mesh__D010924 2005-06-30
% 207.86/208.03 |- skos__altLabel mesh__D018109 Paramyxoviruses, Avian
% 207.86/208.03 |- skos__hiddenLabel mesh__D018109 Avulaviruses
% 207.86/208.03 |- skos__hiddenLabel mesh__D018109 Avian Paramyxovirus
% 207.86/208.03 |- mesh__dateCreated mesh__D018109 1993-06-04
% 207.86/208.03 |- skos__altLabel mesh__D018109 Avian Paramyxoviruses
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018109 2006
% 207.86/208.03 |- mesh__historyNote mesh__D018109 2004 %28%1994%29%
% 207.86/208.03 |- skos__hiddenLabel mesh__D018109 Paramyxovirus, Avian
% 207.86/208.03 |- mesh__recordOriginator mesh__D018109 AGS
% 207.86/208.03 |- skos__scopeNote mesh__D018109
% 207.86/208.03 A genus in the subfamily PARAMYXOVIRINAE, family PARAMYXOVIRIDAE, causing disease in domestic fowl. There are many species, the most well-known being avian paramyxovirus 1 %28%NEWCASTLE DISEASE VIRUS%29%.%A%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018109 2004
% 207.86/208.03 |- mesh__recordMaintainer mesh__D018109 ags
% 207.86/208.03 |- skos__prefLabel mesh__D018109 Avulavirus
% 207.86/208.03 |- skos__historyNote mesh__D018109 Paramyxoviridae %28%1975-1993%29%
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D018109 sjn
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018109 2005
% 207.86/208.03 |- skos__broader mesh__D018109smesh__D018098
% 207.86/208.03 |- rdf__type mesh__D018109sskos__Concept
% 207.86/208.03 |- mesh__dateEstablished mesh__D018109 1994-01-01
% 207.86/208.03 |- skos__annotation mesh__D018109
% 207.86/208.03 infection: coord IM with AVULAVIRUS INFECTIONS %28%IM%29%
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D018109
% 207.86/208.03 2004; see PARAMYXOVIRUSES, AVIAN 1994-2003
% 207.86/208.03 |- mesh__dateRevised mesh__D018109 2003-07-09
% 207.86/208.03 |- skos__scopeNote mesh__D010126
% 207.86/208.03 An unstable triatomic form of oxygen, O3, that exists in the atmosphere in varying proportions. It is produced continuously in the outer layers of the atmosphere by the action of solar UV-radiation on the oxygen of the air.%A%
% 207.86/208.03 |- skos__broader mesh__D010126smesh__D010100
% 207.86/208.03 |- mesh__dateCreated mesh__D010126 1999-01-01
% 207.86/208.03 |- skos__prefLabel mesh__D010126 Ozone
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010126 2006
% 207.86/208.03 |- rdf__type mesh__D010126sskos__Concept
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010126 2005
% 207.86/208.03 |- mesh__dateRevised mesh__D010126 2003-07-09
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D010126 sjn
% 207.86/208.03 |- mesh__recordOriginator mesh__D010126 NLM
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010126 2004
% 207.86/208.03 |- mesh__recordMaintainer mesh__D010126 ssb
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D006883 2006
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D006883 2004
% 207.86/208.03 |- mesh__recordOriginator mesh__D006883 NLM
% 207.86/208.03 |- skos__scopeNote mesh__D006883
% 207.86/208.03 Benzoic acid substituted by one or more hydroxy groups in any position on the benzene ring.%A%
% 207.86/208.03 |- mesh__recordMaintainer mesh__D006883 ADP
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D006883 2000
% 207.86/208.03 |- skos__hiddenLabel mesh__D006883 Acids, Hydroxybenzoic
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D006883 2001
% 207.86/208.03 |- skos__broader mesh__D006883smesh__D020185
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D006883 1999
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D006883 SJN
% 207.86/208.03 |- skos__historyNote mesh__D006883 Phenols %28%1966-1974%29%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D006883 2002
% 207.86/208.03 |- mesh__historyNote mesh__D006883 75
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D006883
% 207.86/208.03 75; VANILLIC ACID was see under BENZOATES 1968-74
% 207.86/208.03 |- mesh__dateCreated mesh__D006883 1974-11-19
% 207.86/208.03 |- mesh__dateEstablished mesh__D006883 1975-09-01
% 207.86/208.03 |- skos__broader mesh__D006883smesh__D010636
% 207.86/208.03 |- skos__broader mesh__D006883smesh__D006880
% 207.86/208.03 |- skos__prefLabel mesh__D006883 Hydroxybenzoic Acids
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D006883 2005
% 207.86/208.03 |- mesh__dateRevised mesh__D006883 1998-06-10
% 207.86/208.03 |- rdf__type mesh__D006883sskos__Concept
% 207.86/208.03 |- skos__historyNote mesh__D006883 Benzoates %28%1966-1974%29%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D006883 2003
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D020554 sjn
% 207.86/208.03 |- skos__hiddenLabel mesh__D020554 Injection, Intracytoplasmic Sperm
% 207.86/208.03 |- skos__broader mesh__D020554smesh__D005307
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D020554 2005
% 207.86/208.03 |- rdf__type mesh__D020554sskos__Concept
% 207.86/208.03 |- mesh__dateEstablished mesh__D020554 2000-01-01
% 207.86/208.03 |- mesh__recordOriginator mesh__D020554 ndw
% 207.86/208.03 |- skos__related mesh__D020554smesh__D007248
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D020554 2003
% 207.86/208.03 |- mesh__dateCreated mesh__D020554 1999-11-03
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D020554 2000
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D020554 2006
% 207.86/208.03 |- skos__hiddenLabel mesh__D020554 Injections, Intracytoplasmic Sperm
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D020554 2002
% 207.86/208.03 |- mesh__dateRevised mesh__D020554 2001-07-25
% 207.86/208.03 |- skos__historyNote mesh__D020554 Microinjections %28%1994-1999%29%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D020554 2004
% 207.86/208.03 |- skos__hiddenLabel mesh__D020554 Sperm Injection, Intracytoplasmic
% 207.86/208.03 |- skos__hiddenLabel mesh__D020554 Intracytoplasmic Sperm Injection
% 207.86/208.03 |- mesh__recordMaintainer mesh__D020554 lkt
% 207.86/208.03 |- skos__altLabel mesh__D020554 ICSI
% 207.86/208.03 |- skos__historyNote mesh__D020554 Fertilization in Vitro %28%1994-1999%29%
% 207.86/208.03 |- mesh__historyNote mesh__D020554 2000
% 207.86/208.03 |- skos__prefLabel mesh__D020554 Sperm Injections, Intracytoplasmic
% 207.86/208.03 |- skos__scopeNote mesh__D020554
% 207.86/208.03 An assisted fertilization technique consisting of the microinjection of a single viable sperm into an extracted ovum. It is used principally to overcome low sperm count, low sperm motility, inability of sperm to penetrate the egg, or other conditions related to male infertility %28%INFERTILITY, MALE%29%.%A%
% 207.86/208.03 |- skos__altLabel mesh__D020554 Intracytoplasmic Sperm Injections
% 207.86/208.03 |- skos__altLabel mesh__D020554 Injections, Sperm, Intracytoplasmic
% 207.86/208.03 |- skos__hiddenLabel mesh__D006085 Graft Survivals
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D006085 77
% 207.86/208.03 |- skos__historyNote mesh__D006085
% 207.86/208.03 Transplantation Immunology %28%1966-1972%29%
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D006085 sjn
% 207.86/208.03 |- skos__prefLabel mesh__D006085 Graft Survival
% 207.86/208.03 |- mesh__dateRevised mesh__D006085 2005-06-30
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D006085 2006
% 207.86/208.03 |- skos__annotation mesh__D006085
% 207.86/208.03 may be used with transplanted neoplasms
% 207.86/208.03 |- mesh__historyNote mesh__D006085 77
% 207.86/208.03 |- mesh__dateEstablished mesh__D006085 1977-01-01
% 207.86/208.03 |- skos__broader mesh__D006085smesh__D006789
% 207.86/208.03 |- skos__historyNote mesh__D006085 Graft Rejection %28%1971-1976%29%
% 207.86/208.03 |- rdf__type mesh__D006085sskos__Concept
% 207.86/208.03 |- skos__hiddenLabel mesh__D006085 Survivals, Graft
% 207.86/208.03 |- mesh__recordMaintainer mesh__D006085 ags
% 207.86/208.03 |- skos__hiddenLabel mesh__D006085 Survival, Graft
% 207.86/208.03 |- skos__scopeNote mesh__D006085
% 207.86/208.03 The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.%A%
% 207.86/208.03 |- skos__related mesh__D006085smesh__D023001
% 207.86/208.03 |- mesh__recordOriginator mesh__D006085 MM
% 207.86/208.03 |- mesh__dateCreated mesh__D006085 1976-05-19
% 207.86/208.03 |- skos__related mesh__D006085smesh__D051799
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 1993
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 1998
% 207.86/208.03 |- skos__annotation mesh__D014517
% 207.86/208.03 do not confuse with URETHRAL OBSTRUCTION, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES%A%
% 207.86/208.03 |- mesh__recordOriginator mesh__D014517 NLM
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D014517 NLM
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 2002
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 1997
% 207.86/208.03 |- skos__hiddenLabel mesh__D014517 Ureteral Obstructions
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 1992
% 207.86/208.03 |- skos__prefLabel mesh__D014517 Ureteral Obstruction
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 2006
% 207.86/208.03 |- skos__broader mesh__D014517smesh__D014515
% 207.86/208.03 |- mesh__dateCreated mesh__D014517 1999-01-01
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 2001
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 1996
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 2000
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 2005
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 1991
% 207.86/208.03 |- skos__hiddenLabel mesh__D014517 Obstructions, Ureteral
% 207.86/208.03 |- mesh__recordMaintainer mesh__D014517 PLS
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 2004
% 207.86/208.03 |- rdf__type mesh__D014517sskos__Concept
% 207.86/208.03 |- skos__hiddenLabel mesh__D014517 Obstruction, Ureteral
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 1995
% 207.86/208.03 |- mesh__dateRevised mesh__D014517 1990-05-29
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 2003
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 1999
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D014517 1994
% 207.86/208.03 |- skos__hiddenLabel mesh__D019202 Avibirnaviruses
% 207.86/208.03 |- mesh__historyNote mesh__D019202 97
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 1999
% 207.86/208.03 |- mesh__dateCreated mesh__D019202 1996-06-10
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 2004
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 2002
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 1998
% 207.86/208.03 |- skos__broader mesh__D019202smesh__D018059
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 2003
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 2001
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D019202 97
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 1997
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 2000
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 2006
% 207.86/208.03 |- skos__scopeNote mesh__D019202
% 207.86/208.03 A genus of RNA viruses in the family BIRNAVIRIDAE infecting birds. It is transmitted horizontally with no known vectors. The type species is INFECTIOUS BURSAL DISEASE VIRUS.%A%
% 207.86/208.03 |- rdf__type mesh__D019202sskos__Concept
% 207.86/208.03 |- skos__annotation mesh__D019202
% 207.86/208.03 a genus of the family Birnaviridae; infection: coord IM with BIRNAVIRIDAE INFECTIONS %28%IM%29%%A%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D019202 2005
% 207.86/208.03 |- mesh__dateEstablished mesh__D019202 1997-01-01
% 207.86/208.03 |- skos__prefLabel mesh__D019202 Avibirnavirus
% 207.86/208.03 |- skos__hiddenLabel mesh__D002493 CNS Disease
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D002493 2003
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D002493 2006
% 207.86/208.03 |- mesh__recordOriginator mesh__D002493 NLM
% 207.86/208.03 |- mesh__dateRevised mesh__D002493 1999-11-03
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D002493 2004
% 207.86/208.03 |- skos__altLabel mesh__D002493 CNS Diseases
% 207.86/208.03 |- mesh__onlineNote mesh__D002493
% 207.86/208.03 pre-explosion = CENTRAL NERVOUS SYSTEM DISEASES %28%PX%29%
% 207.86/208.03 |- skos__prefLabel mesh__D002493 Central Nervous System Diseases
% 207.86/208.03 |- skos__scopeNote mesh__D002493
% 207.86/208.03 Diseases of any component of the brain %28%including the cerebral hemispheres, diencephalon, brain stem, and cerebellum%29% or the spinal cord.%A%
% 207.86/208.03 |- skos__annotation mesh__D002493 GEN: prefer specifics; DF: CNS DIS
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D002493 2000
% 207.86/208.03 |- skos__broader mesh__D002493smesh__D009422
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D002493 2001
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D002493 sjn
% 207.86/208.03 |- skos__altLabel mesh__D002493 Central Nervous System Disorders
% 207.86/208.03 |- rdf__type mesh__D002493sskos__Concept
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D002493 2005
% 207.86/208.03 |- mesh__dateCreated mesh__D002493 1999-01-01
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D002493 2002
% 207.86/208.03 |- mesh__recordMaintainer mesh__D002493 KEV
% 207.86/208.03 |- skos__annotation mesh__D018908
% 207.86/208.03 GEN or unspecified as a clin state or clin manifest: specific musc or neuromusc dis of which this is a manifest are also available; do not confuse %22%myasthenia%22% %28%my-, muscle + asthenia, weakness%29% in foreign titles with %22%muscle weakness%22%: it is more likely to refer to MYASTHENIA GRAVIS; do not confuse with MUSCLE HYPOTONIA or MUSCLE FATIGUE%A%
% 207.86/208.03 |- mesh__dateEstablished mesh__D018908 1996-01-01
% 207.86/208.03 |- mesh__historyNote mesh__D018908 96
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D018908 sjn
% 207.86/208.03 |- mesh__dateCreated mesh__D018908 1994-12-27
% 207.86/208.03 |- rdf__type mesh__D018908sskos__Concept
% 207.86/208.03 |- skos__broader mesh__D018908smesh__D009135
% 207.86/208.03 |- mesh__dateRevised mesh__D018908 1999-11-03
% 207.86/208.03 |- skos__scopeNote mesh__D018908
% 207.86/208.03 A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. %28%From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251%29%%A%
% 207.86/208.03 |- skos__hiddenLabel mesh__D018908 Weaknesses, Muscle
% 207.86/208.03 |- skos__hiddenLabel mesh__D018908 Muscle Weaknesses
% 207.86/208.03 |- skos__prefLabel mesh__D018908 Muscle Weakness
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018908 2006
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018908 2002
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D018908 96
% 207.86/208.03 |- skos__hiddenLabel mesh__D018908 Weakness, Muscular
% 207.86/208.03 |- skos__related mesh__D018908smesh__D001247
% 207.86/208.03 |- skos__broader mesh__D018908smesh__D020879
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018908 2005
% 207.86/208.03 |- skos__hiddenLabel mesh__D018908 Muscular Weaknesses
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018908 2001
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018908 2004
% 207.86/208.03 |- skos__hiddenLabel mesh__D018908 Weaknesses, Muscular
% 207.86/208.03 |- skos__altLabel mesh__D018908 Muscular Weakness
% 207.86/208.03 |- mesh__recordMaintainer mesh__D018908 KEV
% 207.86/208.03 |- skos__broader mesh__D018908smesh__D010335
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018908 2000
% 207.86/208.03 |- mesh__recordOriginator mesh__D018908 TGC
% 207.86/208.03 |- skos__historyNote mesh__D018908 Muscular Diseases %28%1966-1995%29%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D018908 2003
% 207.86/208.03 |- skos__hiddenLabel mesh__D018908 Weakness, Muscle
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010925 2000
% 207.86/208.03 |- skos__scopeNote mesh__D010925
% 207.86/208.03 Methods used for the assessment of placental function.
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D010925 SJN
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Tests, Fetoplacental Function
% 207.86/208.03 |- skos__historyNote mesh__D010925
% 207.86/208.03 Fetal Diseases/diagnosis %28%1966-1974%29%
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010925 2003
% 207.86/208.03 |- skos__historyNote mesh__D010925 Placenta %28%1966-1974%29%
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Tests, Placental Function
% 207.86/208.03 |- mesh__dateRevised mesh__D010925 1997-06-20
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010925 1999
% 207.86/208.03 |- skos__altLabel mesh__D010925 Fetoplacental Function Tests
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010925 2006
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Function Test, Placental
% 207.86/208.03 |- skos__historyNote mesh__D010925 Placenta Diseases %28%1969-1974%29%
% 207.86/208.03 |- mesh__dateCreated mesh__D010925 1974-11-19
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010925 2002
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010925 1998
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Test, Fetoplacental Function
% 207.86/208.03 |- mesh__dateEstablished mesh__D010925 1975-09-01
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010925 2005
% 207.86/208.03 |- skos__prefLabel mesh__D010925 Placental Function Tests
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Fetoplacental Function Test
% 207.86/208.03 |- mesh__recordMaintainer mesh__D010925 PXP
% 207.86/208.03 |- skos__annotation mesh__D010925 NIM
% 207.86/208.03 |- skos__broader mesh__D010925smesh__D003944
% 207.86/208.03 |- mesh__recordOriginator mesh__D010925 NLM
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Test, Placental Function
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D010925 75
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Function Tests, Placental
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Function Test, Fetoplacental
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010925 2001
% 207.86/208.03 |- rdf__type mesh__D010925sskos__Concept
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Function Tests, Fetoplacental
% 207.86/208.03 |- mesh__historyNote mesh__D010925 75
% 207.86/208.03 |- skos__hiddenLabel mesh__D010925 Placental Function Test
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010925 2004
% 207.86/208.03 |- skos__broader mesh__D029630smesh__D019684
% 207.86/208.03 |- skos__scopeNote mesh__D029630
% 207.86/208.03 A plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are parasites that form connections %28%haustoria%29% to their hosts to obtain water and nutrients. The one-seeded fruit may be surrounded by a brightly colored nut-like structure.%A%
% 207.86/208.03 |- skos__altLabel mesh__D029630 Toadflax, Bastard
% 207.86/208.03 |- mesh__dateCreated mesh__D029630 2001-07-25
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D029630 2002
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D029630 sjn
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D029630 2005
% 207.86/208.03 |- skos__prefLabel mesh__D029630 Santalaceae
% 207.86/208.03 |- mesh__historyNote mesh__D029630 2002
% 207.86/208.03 |- mesh__recordOriginator mesh__D029630 ssb
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D029630 2003
% 207.86/208.03 |- rdf__type mesh__D029630sskos__Concept
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D029630 2006
% 207.86/208.03 |- skos__annotation mesh__D029630
% 207.86/208.03 X ref Toadflax, Bastard: Toadflax see LINARIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.03 |- mesh__dateEstablished mesh__D029630 2002-01-01
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D029630 2004
% 207.86/208.03 |- mesh__recordMaintainer mesh__D029630 ssb
% 207.86/208.03 |- mesh__dateRevised mesh__D029630 2002-07-03
% 207.86/208.03 |- skos__annotation mesh__D010127
% 207.86/208.03 IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D010127
% 207.86/208.03 91; was see under BLOOD GROUPS 1976-90
% 207.86/208.03 |- skos__hiddenLabel mesh__D010127 Blood-Group Systems, P
% 207.86/208.03 |- mesh__dateCreated mesh__D010127 1975-07-25
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D010127 2006
% 207.86/208.03 |- skos__scopeNote mesh__D010127
% 207.86/208.03 A blood group related to the ABO, Lewis and I systems. At least five different erythrocyte antigens are possible, some very rare, others almost universal. Multiple alleles are involved in this blood group.%A%
% 207.86/208.03 |- mesh__dateEstablished mesh__D010127 1991-01-01
% 207.86/208.03 |- skos__hiddenLabel mesh__D010127 System, P Blood-Group
% 207.86/208.03 |- rdf__type mesh__D010127sskos__Concept
% 207.86/208.03 |- skos__hiddenLabel mesh__D010127 P Blood-Group Systems
% 207.86/208.03 |- mesh__historyNote mesh__D010127
% 207.86/208.03 91%28%76%29%; was see under BLOOD GROUPS 1976-90
% 207.86/208.03 |- skos__historyNote mesh__D010127 Blood Groups %28%1966-1975%29%
% 207.86/208.03 |- skos__hiddenLabel mesh__D010127 Systems, P Blood-Group
% 207.86/208.03 |- skos__hiddenLabel mesh__D010127 Blood-Group System, P
% 207.86/208.03 |- mesh__recordOriginator mesh__D010127 SH
% 207.86/208.03 |- skos__prefLabel mesh__D010127 P Blood-Group System
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D010127 sjn
% 207.86/208.03 |- mesh__dateRevised mesh__D010127 2005-06-30
% 207.86/208.03 |- mesh__recordMaintainer mesh__D010127 ssb
% 207.86/208.03 |- skos__broader mesh__D010127smesh__D001789
% 207.86/208.03 |- skos__hiddenLabel mesh__D010127 P Blood Group System
% 207.86/208.03 |- mesh__publicMeSHNote mesh__D015610 90
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D015610 2005
% 207.86/208.03 |- skos__historyNote mesh__D015610
% 207.86/208.03 Microbial Sensitivity Tests %28%1972-1989%29%
% 207.86/208.03 |- mesh__recordAuthorizer mesh__D015610 jls
% 207.86/208.03 |- mesh__dateEstablished mesh__D015610 1990-01-01
% 207.86/208.03 |- skos__hiddenLabel mesh__D015610 Serum Bactericidal Tests
% 207.86/208.03 |- skos__scopeNote mesh__D015610
% 207.86/208.03 Method of measuring the bactericidal activity contained in a patient%27%s serum as a result of antimicrobial therapy. It is used to monitor the therapy in BACTERIAL ENDOCARDITIS; OSTEOMYELITIS and other serious bacterial infections. As commonly performed, the test is a variation of the broth dilution test. This test needs to be distinguished from testing of the naturally occurring BLOOD BACTERICIDAL ACTIVITY.%A%
% 207.86/208.03 |- skos__hiddenLabel mesh__D015610 Tests, Serum Bactericidal
% 207.86/208.03 |- skos__hiddenLabel mesh__D015610 Test, Serum Bactericidal
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D015610 2005A
% 207.86/208.03 |- skos__hiddenLabel mesh__D015610 Test, Schlichter
% 207.86/208.03 |- rdf__type mesh__D015610sskos__Concept
% 207.86/208.03 |- mesh__activeMeSHYear mesh__D015610 2004
% 207.86/208.04 |- skos__hiddenLabel mesh__D015610 Bactericidal Tests, Serum
% 207.86/208.04 |- skos__annotation mesh__D015610
% 207.86/208.04 do not confuse with BLOOD BACTERICIDAL ACTIVITY, the natural bactericidal property of blood %28%Cat G%29%; MIC %28%Minimum Inhibitory Concentration%29% goes here if with regard to blood levels of drug or under MICROBIAL SENSITIVITY TESTS if on eff of drug on microorganism%A%
% 207.86/208.04 |- mesh__recordMaintainer mesh__D015610 jls
% 207.86/208.04 |- mesh__historyNote mesh__D015610 90
% 207.86/208.04 |- skos__prefLabel mesh__D015610 Serum Bactericidal Test
% 207.86/208.04 |- mesh__dateCreated mesh__D015610 1989-04-07
% 207.86/208.04 |- skos__broader mesh__D015610smesh__D008826
% 207.86/208.04 |- skos__historyNote mesh__D015610
% 207.86/208.04 Blood Bactericidal Activity %28%1972-1989%29%
% 207.86/208.04 |- skos__related mesh__D015610smesh__D001770
% 207.86/208.04 |- skos__hiddenLabel mesh__D015610 Bactericidal Test, Serum
% 207.86/208.04 |- skos__altLabel mesh__D015610 Schlichter Test
% 207.86/208.04 |- mesh__recordOriginator mesh__D015610 AGS
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D015610 2006
% 207.86/208.04 |- mesh__dateRevised mesh__D015610 2004-08-02
% 207.86/208.04 |- skos__prefLabel mesh__D006884 Hydroxybutyrate Dehydrogenase
% 207.86/208.04 |- mesh__historyNote mesh__D006884 65
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D006884 65
% 207.86/208.04 |- skos__hiddenLabel mesh__D006884 Dehydrogenase, D-3-Hydroxybutyrate
% 207.86/208.04 |- skos__hiddenLabel mesh__D006884 3 Hydroxybutyrate Dehydrogenase
% 207.86/208.04 |- skos__hiddenLabel mesh__D006884 D 3 Hydroxybutyrate Dehydrogenase
% 207.86/208.04 |- rdf__type mesh__D006884sskos__Concept
% 207.86/208.04 |- skos__hiddenLabel mesh__D006884 Dehydrogenase, 3-Hydroxybutyrate
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006884 2005
% 207.86/208.04 |- skos__altLabel mesh__D006884 3-Hydroxybutyrate Dehydrogenase
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D006884 sjn
% 207.86/208.04 |- skos__hiddenLabel mesh__D006884 D beta Hydroxybutyrate Dehydrogenase
% 207.86/208.04 |- mesh__recordMaintainer mesh__D006884 ssb
% 207.86/208.04 |- mesh__recordOriginator mesh__D006884 NLM
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006884 2006
% 207.86/208.04 |- mesh__dateRevised mesh__D006884 2003-07-09
% 207.86/208.04 |- skos__hiddenLabel mesh__D006884 Dehydrogenase, D-beta-Hydroxybutyrate
% 207.86/208.04 |- mesh__dateEstablished mesh__D006884 1965-01-01
% 207.86/208.04 |- mesh__dateCreated mesh__D006884 1999-01-01
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006884 2004
% 207.86/208.04 |- skos__hiddenLabel mesh__D006884 Dehydrogenase, Hydroxybutyrate
% 207.86/208.04 |- skos__altLabel mesh__D006884 D-beta-Hydroxybutyrate Dehydrogenase
% 207.86/208.04 |- skos__altLabel mesh__D006884 D-3-Hydroxybutyrate Dehydrogenase
% 207.86/208.04 |- skos__broader mesh__D006884smesh__D000429
% 207.86/208.04 |- skos__hiddenLabel mesh__D020555 Signaling Regulators, G-Protein
% 207.86/208.04 |- skos__altLabel mesh__D020555 Regulating Factors, G-Protein
% 207.86/208.04 |- skos__hiddenLabel mesh__D020555 Regulators, GTP-Binding Protein
% 207.86/208.04 |- mesh__dateRevised mesh__D020555 2005-06-30
% 207.86/208.04 |- skos__altLabel mesh__D020555 G-Protein Signaling Regulators
% 207.86/208.04 |- skos__hiddenLabel mesh__D020555 G Protein Signaling Regulators
% 207.86/208.04 |- mesh__recordOriginator mesh__D020555 jmp
% 207.86/208.04 |- skos__hiddenLabel mesh__D020555 Regulating Factors, GTP Binding Protein
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D020555 2006
% 207.86/208.04 |- skos__hiddenLabel mesh__D020555 Regulators, G Protein Signaling
% 207.86/208.04 |- skos__scopeNote mesh__D020555
% 207.86/208.04 Proteins that regulate the signaling activity of GTP-BINDING PROTEINS. They are divided into three categories depending upon whether they stimulate GTPase activity %28%GTPASE-ACTIVATING PROTEINS%29%, inhibit release of GDP; %28%GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS%29%; or exchange GTP for GDP; %28%GUANINE NUCLEOTIDE EXCHANGE FACTORS%29%.%A%
% 207.86/208.04 |- skos__altLabel mesh__D020555 Regulating Factors, GTP-Binding Protein
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D020555 sjn
% 207.86/208.04 |- skos__annotation mesh__D020555
% 207.86/208.04 Do not confuse with RGS proteins; DF: GTP BINDING PROTEIN REG%A%
% 207.86/208.04 |- skos__hiddenLabel mesh__D020555 G Protein Regulating Factors
% 207.86/208.04 |- mesh__dateCreated mesh__D020555 1999-11-03
% 207.86/208.04 |- skos__altLabel mesh__D020555 G-Protein Regulating Factors
% 207.86/208.04 |- mesh__recordMaintainer mesh__D020555 SYSTEM
% 207.86/208.04 |- skos__broader mesh__D020555smesh__D011506
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D020555 2000
% 207.86/208.04 |- mesh__historyNote mesh__D020555 2000
% 207.86/208.04 |- skos__historyNote mesh__D020555 Proteins %28%1978-1999%29%
% 207.86/208.04 |- skos__altLabel mesh__D020555 Regulators, G-Protein Signaling
% 207.86/208.04 |- skos__broader mesh__D020555smesh__D047908
% 207.86/208.04 |- rdf__type mesh__D020555sskos__Concept
% 207.86/208.04 |- skos__prefLabel mesh__D020555 GTP-Binding Protein Regulators
% 207.86/208.04 |- mesh__dateEstablished mesh__D020555 2000-01-01
% 207.86/208.04 |- skos__historyNote mesh__D020555 G-Proteins %28%1988-1999%29%
% 207.86/208.04 |- skos__hiddenLabel mesh__D020555 GTP Binding Protein Regulators
% 207.86/208.04 |- skos__hiddenLabel mesh__D006086 Disease, Graft-vs-Host
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 2006
% 207.86/208.04 |- mesh__historyNote mesh__D006086
% 207.86/208.04 84; was HOMOLOGOUS WASTING DISEASE 1964-83 %28%Prov 1964-66%29%%A%
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 1994
% 207.86/208.04 |- skos__altLabel mesh__D006086 Graft-Versus-Host Disease
% 207.86/208.04 |- mesh__dateRevised mesh__D006086 1993-05-28
% 207.86/208.04 |- skos__hiddenLabel mesh__D006086 Disease, Graft-Versus-Host
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 2003
% 207.86/208.04 |- skos__broader mesh__D006086smesh__D007154
% 207.86/208.04 |- skos__altLabel mesh__D006086 Homologous Wasting Disease
% 207.86/208.04 |- mesh__recordMaintainer mesh__D006086 TGC
% 207.86/208.04 |- skos__altLabel mesh__D006086 Graft-vs-Host Disease
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 2002
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 1998
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 1995
% 207.86/208.04 |- skos__hiddenLabel mesh__D006086 Disease, Homologous Wasting
% 207.86/208.04 |- skos__prefLabel mesh__D006086 Graft vs Host Disease
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 2004
% 207.86/208.04 |- skos__hiddenLabel mesh__D006086 Diseases, Graft-vs-Host
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D006086 PLS
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 1999
% 207.86/208.04 |- mesh__dateEstablished mesh__D006086 1967-01-01
% 207.86/208.04 |- skos__hiddenLabel mesh__D006086 Graft-Versus-Host Diseases
% 207.86/208.04 |- skos__hiddenLabel mesh__D006086 Disease, Runt
% 207.86/208.04 |- mesh__onlineNote mesh__D006086
% 207.86/208.04 use GRAFT VS HOST DISEASE to search HOMOLOGOUS WASTING DISEASE 1966-83 %28%as Prov 1966%29%%A%
% 207.86/208.04 |- skos__hiddenLabel mesh__D006086 Diseases, Graft-Versus-Host
% 207.86/208.04 |- skos__scopeNote mesh__D006086
% 207.86/208.04 The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.%A%
% 207.86/208.04 |- rdf__type mesh__D006086sskos__Concept
% 207.86/208.04 |- skos__annotation mesh__D006086
% 207.86/208.04 do not confuse with GRAFT VS HOST REACTION %28%Cat G%29%; DF: note short X ref%A%
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 2000
% 207.86/208.04 |- mesh__dateCreated mesh__D006086 1999-01-01
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 1996
% 207.86/208.04 |- skos__altLabel mesh__D006086 Runt Disease
% 207.86/208.04 |- skos__hiddenLabel mesh__D006086 Graft Versus Host Disease
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 2005
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D006086
% 207.86/208.04 84; was HOMOLOGOUS WASTING DISEASE 1967-83
% 207.86/208.04 |- mesh__recordOriginator mesh__D006086 NLM
% 207.86/208.04 |- skos__hiddenLabel mesh__D006086 Graft-vs-Host Diseases
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 1997
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006086 2001
% 207.86/208.04 |- skos__prefLabel mesh__D014518 Ureterocele
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 2006
% 207.86/208.04 |- mesh__dateCreated mesh__D014518 1999-01-01
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 1996
% 207.86/208.04 |- mesh__dateRevised mesh__D014518 1993-06-03
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D014518 68
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 2005
% 207.86/208.04 |- mesh__recordOriginator mesh__D014518 NLM
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 2002
% 207.86/208.04 |- mesh__historyNote mesh__D014518 68%28%63%29%
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 2004
% 207.86/208.04 |- rdf__type mesh__D014518sskos__Concept
% 207.86/208.04 |- skos__broader mesh__D014518smesh__D014515
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 1995
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 2001
% 207.86/208.04 |- skos__annotation mesh__D014518 cystic dilat of ureter
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 2003
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 2000
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 1999
% 207.86/208.04 |- mesh__recordMaintainer mesh__D014518 TAP
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D014518 PLS
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 1994
% 207.86/208.04 |- skos__hiddenLabel mesh__D014518 Ureteroceles
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 1998
% 207.86/208.04 |- mesh__dateEstablished mesh__D014518 1968-01-01
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014518 1997
% 207.86/208.04 |- skos__scopeNote mesh__D014518
% 207.86/208.04 Cystic dilatation of the ureter with ballooning of the ureteral orifice into the lumen of the bladder.%A%
% 207.86/208.04 |- mesh__historyNote mesh__D019203 97
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 1999
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 2004
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 2002
% 207.86/208.04 |- skos__broader mesh__D019203smesh__D018059
% 207.86/208.04 |- skos__scopeNote mesh__D019203
% 207.86/208.04 A genus of RNA viruses of the family BIRNAVIRIDAE infecting fruitflies. Transmission is horizontal and there are no known vectors. Drosophila melanogaster is the natural host and the type species is Drosophila X virus.%A%
% 207.86/208.04 |- skos__annotation mesh__D019203
% 207.86/208.04 a genus of the family Birnaviridae; infection: coord IM with BIRNAVIRIDAE INFECTIONS %28%IM%29%%A%
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 2005
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 1997
% 207.86/208.04 |- mesh__dateEstablished mesh__D019203 1997-01-01
% 207.86/208.04 |- mesh__dateCreated mesh__D019203 1996-06-10
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 2000
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 2006
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 2001
% 207.86/208.04 |- skos__hiddenLabel mesh__D019203 Entomobirnaviruses
% 207.86/208.04 |- rdf__type mesh__D019203sskos__Concept
% 207.86/208.04 |- skos__prefLabel mesh__D019203 Entomobirnavirus
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 1998
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D019203 97
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D019203 2003
% 207.86/208.04 |- mesh__recordOriginator mesh__D011220 NLM
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D011220 2001
% 207.86/208.04 |- skos__altLabel mesh__D011220 Pyridine Aldoxime Methyl Compounds
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D011220 2006
% 207.86/208.04 |- skos__broader mesh__D011220smesh__D010091
% 207.86/208.04 |- skos__hiddenLabel mesh__D011220 Compounds, Pralidoxime
% 207.86/208.04 |- mesh__dateRevised mesh__D011220 2000-06-22
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D011220 2002
% 207.86/208.04 |- skos__altLabel mesh__D011220 2-PAM Compounds
% 207.86/208.04 |- mesh__historyNote mesh__D011220 65%28%63%29%
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D011220 sjn
% 207.86/208.04 |- skos__hiddenLabel mesh__D011220 2 PAM Compounds
% 207.86/208.04 |- mesh__dateCreated mesh__D011220 1999-01-01
% 207.86/208.04 |- skos__annotation mesh__D011220 DF: PRALIDOXIME CPDS
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D011220 2003
% 207.86/208.04 |- rdf__type mesh__D011220sskos__Concept
% 207.86/208.04 |- skos__hiddenLabel mesh__D011220 Compounds, 2-PAM
% 207.86/208.04 |- mesh__recordMaintainer mesh__D011220 CCR
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D011220 2004
% 207.86/208.04 |- skos__prefLabel mesh__D011220 Pralidoxime Compounds
% 207.86/208.04 |- skos__scopeNote mesh__D011220
% 207.86/208.04 Various salts of a quaternary ammonium oxime that reconstitute inactivated acetylcholinesterase, especially at the neuromuscular junction, and may cause neuromuscular blockade. They are used as antidotes to organophosphorus poisoning as chlorides, iodides, methanesulfonates %28%mesylates%29%, or other salts.%A%
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D011220 2005
% 207.86/208.04 |- mesh__dateEstablished mesh__D011220 1965-01-01
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D011220 65
% 207.86/208.04 |- skos__broader mesh__D002494smesh__D002493
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D002494 sjn
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D002494 2000
% 207.86/208.04 |- mesh__historyNote mesh__D002494 1998; use explode 1971-1997
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D002494 1998
% 207.86/208.04 |- mesh__dateEstablished mesh__D002494 1998-01-01
% 207.86/208.04 |- mesh__recordMaintainer mesh__D002494 KEV
% 207.86/208.04 |- skos__historyNote mesh__D002494
% 207.86/208.04 Central Nervous System Diseases %28%1967-1997%29%
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D002494 2004
% 207.86/208.04 |- skos__historyNote mesh__D002494 Infection %28%1967-1997%29%
% 207.86/208.04 |- skos__prefLabel mesh__D002494 Central Nervous System Infections
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D002494 2006
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D002494 2003
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D002494 2005
% 207.86/208.04 |- mesh__dateCreated mesh__D002494 1999-01-01
% 207.86/208.04 |- skos__scopeNote mesh__D002494
% 207.86/208.04 Pathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process.%A%
% 207.86/208.04 |- mesh__recordOriginator mesh__D002494 NLM
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D002494 2002
% 207.86/208.04 |- skos__annotation mesh__D002494
% 207.86/208.04 GEN or unspecified; prefer specifics; coord IM with specific site/dis term %28%IM%29% if pertinent; DF: CNS INFECT%A%
% 207.86/208.04 |- skos__altLabel mesh__D002494 Infections, Central Nervous System
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D002494 2001
% 207.86/208.04 |- skos__altLabel mesh__D002494 Central Nervous System Infection
% 207.86/208.04 |- skos__broader mesh__D002494smesh__D001423
% 207.86/208.04 |- rdf__type mesh__D002494sskos__Concept
% 207.86/208.04 |- mesh__dateRevised mesh__D002494 1999-11-04
% 207.86/208.04 |- skos__hiddenLabel mesh__D018909 Homology Domains, src
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D018909 2006
% 207.86/208.04 |- mesh__recordOriginator mesh__D018909 AGS
% 207.86/208.04 |- skos__historyNote mesh__D018909 Amino Acid Sequence %28%1989-1995%29%
% 207.86/208.04 |- skos__hiddenLabel mesh__D018909 SH2 Domains
% 207.86/208.04 |- mesh__dateRevised mesh__D018909 2004-07-07
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D018909 2005
% 207.86/208.04 |- skos__broader mesh__D018909smesh__D017434
% 207.86/208.04 |- skos__hiddenLabel mesh__D018909 src Homology Domain
% 207.86/208.04 |- mesh__dateEstablished mesh__D018909 1996-01-01
% 207.86/208.04 |- skos__altLabel mesh__D018909 SH Domains
% 207.86/208.04 |- skos__hiddenLabel mesh__D018909 SH Domain
% 207.86/208.04 |- skos__altLabel mesh__D018909 src Homology Region 2 Domain
% 207.86/208.04 |- skos__prefLabel mesh__D018909 src Homology Domains
% 207.86/208.04 |- skos__historyNote mesh__D018909
% 207.86/208.04 Sequence Homology, Amino Acid %28%1993-1995%29%
% 207.86/208.04 |- mesh__dateCreated mesh__D018909 1995-01-06
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D018909 sjn
% 207.86/208.04 |- mesh__recordMaintainer mesh__D018909 nns
% 207.86/208.04 |- skos__hiddenLabel mesh__D018909 SH1 Domains
% 207.86/208.04 |- skos__scopeNote mesh__D018909
% 207.86/208.04 Regions of sequence similarity in the src family of cytoplasmic tyrosine kinases. The SH1 domain is a catalytic domain. SH2 and SH3 domains are protein-binding domains. SH2 usually binds phosphotyrosine-containing proteins and SH3 interacts with cytoskeletal proteins.%A%
% 207.86/208.04 |- mesh__historyNote mesh__D018909 96
% 207.86/208.04 |- rdf__type mesh__D018909sskos__Concept
% 207.86/208.04 |- skos__hiddenLabel mesh__D018909 Homology Domain, src
% 207.86/208.04 |- skos__hiddenLabel mesh__D018909 SH3 Domains
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D018909 96
% 207.86/208.04 |- skos__broader mesh__D010926smesh__D036361
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D010926 2006
% 207.86/208.04 |- mesh__recordMaintainer mesh__D010926 lkt
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D010926 2005
% 207.86/208.04 |- mesh__dateCreated mesh__D010926 1999-01-01
% 207.86/208.04 |- rdf__type mesh__D010926sskos__Concept
% 207.86/208.04 |- skos__broader mesh__D010926smesh__D006728
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D010926 2004
% 207.86/208.04 |- skos__prefLabel mesh__D010926 Placental Hormones
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D010926 sjn
% 207.86/208.04 |- mesh__recordOriginator mesh__D010926 NLM
% 207.86/208.04 |- mesh__dateRevised mesh__D010926 2002-07-03
% 207.86/208.04 |- skos__scopeNote mesh__D010926
% 207.86/208.04 Hormones produced by the placenta include CHORIONIC GONADOTROPIN, and PLACENTAL LACTOGEN as well as steroids %28%ESTROGENS; PROGESTERONE%29%, and neuropeptide hormones similar to those found in the hypothalamus %28%HYPOTHALAMIC HORMONES%29%.%A%
% 207.86/208.04 |- skos__hiddenLabel mesh__D010926 Hormones, Placental
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D010926 2003
% 207.86/208.04 |- mesh__recordMaintainer mesh__D029631 ssb
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D029631 2002
% 207.86/208.04 |- skos__prefLabel mesh__D029631 Sapindaceae
% 207.86/208.04 |- skos__broader mesh__D029631smesh__D019684
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D029631 2005
% 207.86/208.04 |- skos__annotation mesh__D029631
% 207.86/208.04 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.04 |- mesh__recordOriginator mesh__D029631 ssb
% 207.86/208.04 |- mesh__dateCreated mesh__D029631 2001-07-25
% 207.86/208.04 |- rdf__type mesh__D029631sskos__Concept
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D029631 2006
% 207.86/208.04 |- skos__scopeNote mesh__D029631
% 207.86/208.04 The soapberry plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Some members contain SAPONINS.%A%
% 207.86/208.04 |- mesh__dateEstablished mesh__D029631 2002-01-01
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D029631 sjn
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D029631 2004
% 207.86/208.04 |- mesh__dateRevised mesh__D029631 2003-07-09
% 207.86/208.04 |- mesh__historyNote mesh__D029631 2002
% 207.86/208.04 |- skos__hiddenLabel mesh__D043302 Products, Cultured Milk
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D043302 2006
% 207.86/208.04 |- skos__hiddenLabel mesh__D043302 Milk Product, Cultured
% 207.86/208.04 |- skos__altLabel mesh__D043302 Milk Products, Cultured
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D043302 2004
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D043302
% 207.86/208.04 2004; for BUTTERMILK and KEFIR see MILK 1998-2003
% 207.86/208.04 |- skos__scopeNote mesh__D043302
% 207.86/208.04 Milk modified with controlled FERMENTATION. This should not be confused with KAFFIR LIME or with KAFFIR CORN.%A%
% 207.86/208.04 |- skos__hiddenLabel mesh__D043302 Milk Products, Fermented
% 207.86/208.04 |- skos__hiddenLabel mesh__D043302 Fermented Milk Product
% 207.86/208.04 |- skos__prefLabel mesh__D043302 Cultured Milk Products
% 207.86/208.04 |- skos__historyNote mesh__D043302 Milk %28%1963-2003%29%
% 207.86/208.04 |- mesh__dateCreated mesh__D043302 2003-07-09
% 207.86/208.04 |- skos__hiddenLabel mesh__D043302 Milk Product, Fermented
% 207.86/208.04 |- mesh__historyNote mesh__D043302
% 207.86/208.04 2004; for BUTTERMILK and KEFIR use MILK 1998-2003
% 207.86/208.04 |- mesh__recordOriginator mesh__D043302 ssb
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D043302 sjn
% 207.86/208.04 |- mesh__dateEstablished mesh__D043302 2004-01-01
% 207.86/208.04 |- skos__altLabel mesh__D043302 Fermented Milk Products
% 207.86/208.04 |- skos__hiddenLabel mesh__D043302 Cultured Milk Product
% 207.86/208.04 |- mesh__recordMaintainer mesh__D043302 ssb
% 207.86/208.04 |- skos__broader mesh__D043302smesh__D008892
% 207.86/208.04 |- skos__hiddenLabel mesh__D043302 Product, Fermented Milk
% 207.86/208.04 |- skos__hiddenLabel mesh__D043302 Product, Cultured Milk
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D043302 2005
% 207.86/208.04 |- skos__hiddenLabel mesh__D043302 Products, Fermented Milk
% 207.86/208.04 |- rdf__type mesh__D043302sskos__Concept
% 207.86/208.04 |- rdf__type mesh__D010128sskos__Concept
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D010128 NLM
% 207.86/208.04 |- skos__hiddenLabel mesh__D010128 para Aminoazobenzene
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D010128
% 207.86/208.04 91; was see under AZO COMPOUNDS 1976-90
% 207.86/208.04 |- mesh__historyNote mesh__D010128
% 207.86/208.04 91%28%76%29%; was see under AZO COMPOUNDS 1976-90
% 207.86/208.04 |- skos__prefLabel mesh__D010128 p-Aminoazobenzene
% 207.86/208.04 |- skos__hiddenLabel mesh__D010128 p Aminoazobenzene
% 207.86/208.04 |- mesh__recordOriginator mesh__D010128 RLS
% 207.86/208.04 |- skos__historyNote mesh__D010128 Azo Compounds %28%1969-1975%29%
% 207.86/208.04 |- skos__altLabel mesh__D010128 para-Aminoazobenzene
% 207.86/208.04 |- skos__scopeNote mesh__D010128
% 207.86/208.04 Used in the form of its salts as a dye and as an intermediate in manufacture of Acid Yellow, diazo dyes, and indulines.%A%
% 207.86/208.04 |- mesh__dateCreated mesh__D010128 1975-07-23
% 207.86/208.04 |- skos__annotation mesh__D010128 D25-26 qualif
% 207.86/208.04 |- mesh__dateRevised mesh__D010128 2005-07-06
% 207.86/208.04 |- skos__historyNote mesh__D010128 Aniline Compounds %28%1973-1975%29%
% 207.86/208.04 |- skos__broader mesh__D010128smesh__D001391
% 207.86/208.04 |- mesh__recordMaintainer mesh__D010128 NLM
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D010128 2006
% 207.86/208.04 |- mesh__dateEstablished mesh__D010128 1991-01-01
% 207.86/208.04 |- mesh__recordOriginator mesh__D015611 PXP
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D015611 sjn
% 207.86/208.04 |- mesh__historyNote mesh__D015611 90
% 207.86/208.04 |- skos__altLabel mesh__D015611 DHBV
% 207.86/208.04 |- skos__historyNote mesh__D015611 Hepatitis B Virus %28%1981-1989%29%
% 207.86/208.04 |- skos__prefLabel mesh__D015611 Hepatitis B Virus, Duck
% 207.86/208.04 |- mesh__recordMaintainer mesh__D015611 sjn
% 207.86/208.04 |- skos__altLabel mesh__D015611 Duck hepatitis B virus
% 207.86/208.04 |- skos__altLabel mesh__D015611 Hepatitis B Viruses, Duck
% 207.86/208.04 |- rdf__type mesh__D015611sskos__Concept
% 207.86/208.04 |- mesh__dateRevised mesh__D015611 2004-07-13
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D015611 2005
% 207.86/208.04 |- skos__annotation mesh__D015611
% 207.86/208.04 do not confuse with HEPATITIS VIRUS, DUCK, an enterovirus; infection: coord IM with HEPADNAVIRIDAE INFECTIONS %28%IM%29% + HEPATITIS, VIRAL, ANIMAL %28%IM%29%%A%
% 207.86/208.04 |- skos__altLabel mesh__D015611 Duck Hepatitis B Viruses
% 207.86/208.04 |- skos__broader mesh__D015611smesh__D017917
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D015611 90
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D015611 2006
% 207.86/208.04 |- skos__scopeNote mesh__D015611
% 207.86/208.04 A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks.%A%
% 207.86/208.04 |- mesh__dateCreated mesh__D015611 1989-04-07
% 207.86/208.04 |- mesh__dateEstablished mesh__D015611 1990-01-01
% 207.86/208.04 |- rdf__type mesh__D006885sskos__Concept
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006885 2005
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006885 2006
% 207.86/208.04 |- mesh__dateRevised mesh__D006885 2003-07-09
% 207.86/208.04 |- mesh__dateCreated mesh__D006885 1999-01-01
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006885 2004
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D006885 sjn
% 207.86/208.04 |- skos__broader mesh__D006885smesh__D020155
% 207.86/208.04 |- mesh__recordMaintainer mesh__D006885 ssb
% 207.86/208.04 |- mesh__recordOriginator mesh__D006885 NLM
% 207.86/208.04 |- skos__scopeNote mesh__D006885
% 207.86/208.04 Salts and esters of hydroxybutyric acid.
% 207.86/208.04 |- skos__prefLabel mesh__D006885 Hydroxybutyrates
% 207.86/208.04 |- mesh__historyNote mesh__D020556 2000
% 207.86/208.04 |- skos__broader mesh__D020556smesh__D007109
% 207.86/208.04 |- skos__prefLabel mesh__D020556 Neutrophil Infiltration
% 207.86/208.04 |- mesh__dateCreated mesh__D020556 1999-11-04
% 207.86/208.04 |- skos__scopeNote mesh__D020556
% 207.86/208.04 The diffusion or accumulation of neutrophils in tissues or cells in response to a wide variety of substances released at the sites of inflammatory reactions.%A%
% 207.86/208.04 |- skos__related mesh__D020556smesh__D017254
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D020556 2000
% 207.86/208.04 |- rdf__type mesh__D020556sskos__Concept
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D020556 2005
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D020556 2003
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D020556 2006
% 207.86/208.04 |- mesh__dateEstablished mesh__D020556 2000-01-01
% 207.86/208.04 |- skos__hiddenLabel mesh__D020556 Recruitment, Neutrophil
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D020556 2001
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D020556 2004
% 207.86/208.04 |- skos__related mesh__D020556smesh__D002634
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D020556 2000
% 207.86/208.04 |- skos__altLabel mesh__D020556 Neutrophil Recruitment
% 207.86/208.04 |- skos__hiddenLabel mesh__D020556 Infiltration, Neutrophil
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D020556 2002
% 207.86/208.04 |- skos__historyNote mesh__D020556 Neutrophils %28%1969-1999%29%
% 207.86/208.04 |- mesh__recordOriginator mesh__D006087 NLM
% 207.86/208.04 |- mesh__dateEstablished mesh__D006087 1970-01-01
% 207.86/208.04 |- skos__historyNote mesh__D006087 Graft vs Host Disease %28%1966-1969%29%
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 1998
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 2003
% 207.86/208.04 |- skos__scopeNote mesh__D006087
% 207.86/208.04 An immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE.%A%
% 207.86/208.04 |- mesh__dateRevised mesh__D006087 1996-06-10
% 207.86/208.04 |- skos__historyNote mesh__D006087
% 207.86/208.04 Transplantation Immunology %28%1966-1969%29%
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 2001
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 2006
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 2000
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 1997
% 207.86/208.04 |- skos__related mesh__D006087smesh__D006086
% 207.86/208.04 |- skos__prefLabel mesh__D006087 Graft vs Host Reaction
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 2005
% 207.86/208.04 |- mesh__historyNote mesh__D006087 70
% 207.86/208.04 |- skos__annotation mesh__D006087
% 207.86/208.04 do not confuse with HOST VS GRAFT REACTION nor with GRAFT VS HOST DISEASE%A%
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D006087 70
% 207.86/208.04 |- rdf__type mesh__D006087sskos__Concept
% 207.86/208.04 |- skos__broader mesh__D006087smesh__D014181
% 207.86/208.04 |- mesh__recordAuthorizer mesh__D006087 PLS
% 207.86/208.04 |- mesh__dateCreated mesh__D006087 1999-01-01
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 2002
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 1999
% 207.86/208.04 |- mesh__recordMaintainer mesh__D006087 TGC
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D006087 2004
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014519 2006
% 207.86/208.04 |- skos__annotation mesh__D014519
% 207.86/208.04 do not use /util except by MeSH definition
% 207.86/208.04 |- mesh__dateEstablished mesh__D014519 1988-01-01
% 207.86/208.04 |- mesh__publicMeSHNote mesh__D014519 88
% 207.86/208.04 |- mesh__dateCreated mesh__D014519 1987-03-20
% 207.86/208.04 |- mesh__activeMeSHYear mesh__D014519 2003
% 207.86/208.04 |- skos__scopeNote mesh__D014519
% 207.86/208.04 Surgical formation of an opening in the ureter for external drainage of the urine; cutaneous route utilizes a ureteral orifice emerging through the skin.%A%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D014519 2002
% 207.86/208.05 |- skos__broader mesh__D014519smesh__D010030
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D014519 2004
% 207.86/208.05 |- mesh__historyNote mesh__D014519 88
% 207.86/208.05 |- rdf__type mesh__D014519sskos__Concept
% 207.86/208.05 |- skos__historyNote mesh__D014519 Ureter/surgery %28%1966-1987%29%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D014519 1998
% 207.86/208.05 |- mesh__recordMaintainer mesh__D014519 PXP
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D014519 SJN
% 207.86/208.05 |- mesh__recordOriginator mesh__D014519 SCD
% 207.86/208.05 |- skos__hiddenLabel mesh__D014519 Ureterostomies
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D014519 1999
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D014519 2000
% 207.86/208.05 |- skos__historyNote mesh__D014519 Urinary Diversion %28%1966-1987%29%
% 207.86/208.05 |- skos__prefLabel mesh__D014519 Ureterostomy
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D014519 2005
% 207.86/208.05 |- mesh__dateRevised mesh__D014519 1997-06-20
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D014519 2001
% 207.86/208.05 |- skos__broader mesh__D014519smesh__D014547
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025241 2005
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025241 2002
% 207.86/208.05 |- skos__prefLabel mesh__D025241 Spondylarthritis
% 207.86/208.05 |- mesh__dateCreated mesh__D025241 2001-07-25
% 207.86/208.05 |- skos__related mesh__D025241smesh__D013167
% 207.86/208.05 |- skos__annotation mesh__D025241
% 207.86/208.05 coord IM with specific vertebrae %28%IM%29%
% 207.86/208.05 |- skos__broader mesh__D025241smesh__D013122
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025241 2003
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025241 2006
% 207.86/208.05 |- skos__historyNote mesh__D025241
% 207.86/208.05 Spondylitis, Ankylosing %28%1966-2001%29%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025241 2004
% 207.86/208.05 |- mesh__dateEstablished mesh__D025241 2002-01-01
% 207.86/208.05 |- skos__broader mesh__D025241smesh__D001168
% 207.86/208.05 |- skos__hiddenLabel mesh__D025241 Spondylarthritides
% 207.86/208.05 |- skos__scopeNote mesh__D025241
% 207.86/208.05 Arthritis of the spine, specifically involving the intervertebral articulations.%A%
% 207.86/208.05 |- mesh__historyNote mesh__D025241 2002
% 207.86/208.05 |- rdf__type mesh__D025241sskos__Concept
% 207.86/208.05 |- skos__altLabel mesh__D025241 Spinal Arthritis
% 207.86/208.05 |- skos__altLabel mesh__D025241 Arthritis, Spinal
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D025241 2002
% 207.86/208.05 |- skos__hiddenLabel mesh__D025241 Spinal Arthritides
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 Proteins, GTP-Regulatory
% 207.86/208.05 |- skos__altLabel mesh__D019204 GTP-Regulatory Proteins
% 207.86/208.05 |- skos__scopeNote mesh__D019204
% 207.86/208.05 Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-.%A%
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 GTP Binding Protein
% 207.86/208.05 |- skos__altLabel mesh__D019204 Guanine Nucleotide Regulatory Proteins
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 G Protein
% 207.86/208.05 |- skos__altLabel mesh__D019204 GTP-Regulatory Protein
% 207.86/208.05 |- skos__altLabel mesh__D019204 G-Proteins
% 207.86/208.05 |- skos__altLabel mesh__D019204 G-Protein
% 207.86/208.05 |- skos__broader mesh__D019204smesh__D020558
% 207.86/208.05 |- mesh__recordOriginator mesh__D019204 TPW
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D019204
% 207.86/208.05 1997; see G-PROTEINS 1985-1996; for G-PROTEINS see G-PROTEINS 1992-1999; for GUANINE NUCLEOTIDE REGULATORY PROTEINS see G-PROTEINS 1992-1996; for GTP-REGULATORY PROTEINS see G-PROTEINS 1985-1996%A%
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 Proteins, GTP-Binding
% 207.86/208.05 |- skos__prefLabel mesh__D019204 GTP-Binding Proteins
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 Protein, GTP-Binding
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 G Proteins
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 GTP Regulatory Proteins
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D019204 2006
% 207.86/208.05 |- skos__broader mesh__D019204smesh__D002352
% 207.86/208.05 |- mesh__dateRevised mesh__D019204 2005-06-30
% 207.86/208.05 |- skos__altLabel mesh__D019204 GTP-Binding Protein
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 Protein, GTP-Regulatory
% 207.86/208.05 |- rdf__type mesh__D019204sskos__Concept
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D019204 sjn
% 207.86/208.05 |- skos__annotation mesh__D019204
% 207.86/208.05 GEN or unspecified; prefer specifics; GTP stands for Guanosine TriPhosphate%A%
% 207.86/208.05 |- mesh__recordMaintainer mesh__D019204 SYSTEM
% 207.86/208.05 |- mesh__dateEstablished mesh__D019204 1997-01-01
% 207.86/208.05 |- mesh__historyNote mesh__D019204 1997%28%1985%29%
% 207.86/208.05 |- mesh__dateCreated mesh__D019204 1996-06-10
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 GTP Regulatory Protein
% 207.86/208.05 |- skos__hiddenLabel mesh__D019204 GTP Binding Proteins
% 207.86/208.05 |- skos__altLabel mesh__D019204 Guanine Nucleotide Coupling Protein
% 207.86/208.05 |- skos__annotation mesh__D011221
% 207.86/208.05 a rare earth metal; Pr-141; Pr-134-140, 142-148 = PRASEODYMIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 207.86/208.05 |- mesh__dateCreated mesh__D011221 1999-01-01
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D011221 2003
% 207.86/208.05 |- rdf__type mesh__D011221sskos__Concept
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D011221 2004
% 207.86/208.05 |- mesh__recordOriginator mesh__D011221 NLM
% 207.86/208.05 |- mesh__dateRevised mesh__D011221 2001-07-25
% 207.86/208.05 |- mesh__recordMaintainer mesh__D011221 jmp
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D011221 2005
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D011221 2002
% 207.86/208.05 |- skos__broader mesh__D011221smesh__D028581
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D011221 2006
% 207.86/208.05 |- skos__scopeNote mesh__D011221
% 207.86/208.05 Praseodymium. An element of the rare earth family of metals. It has the atomic symbol Pr, atomic number 59, and atomic weight 140.91.%A%
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D011221 sjn
% 207.86/208.05 |- skos__prefLabel mesh__D011221 Praseodymium
% 207.86/208.05 |- mesh__recordMaintainer mesh__D002495 KEV
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 2004
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 2001
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 2006
% 207.86/208.05 |- skos__scopeNote mesh__D002495
% 207.86/208.05 Hospital department responsible for receiving, storing, and distributing medical and surgical supplies and equipment.%A%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 2003
% 207.86/208.05 |- mesh__onlineNote mesh__D002495
% 207.86/208.05 use CENTRAL SUPPLY, HOSPITAL to search HOSPITAL CENTRAL SUPPLY 1968-77%A%
% 207.86/208.05 |- skos__altLabel mesh__D002495 Supplies, Hospital Central
% 207.86/208.05 |- skos__altLabel mesh__D002495 Supply, Hospital Central
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 2005
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 2000
% 207.86/208.05 |- mesh__dateRevised mesh__D002495 1996-06-10
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D002495
% 207.86/208.05 78; was HOSPITAL CENTRAL SUPPLY 1968-77
% 207.86/208.05 |- mesh__dateCreated mesh__D002495 1999-01-01
% 207.86/208.05 |- skos__prefLabel mesh__D002495 Central Supply, Hospital
% 207.86/208.05 |- skos__broader mesh__D002495smesh__D006748
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 1997
% 207.86/208.05 |- skos__annotation mesh__D002495
% 207.86/208.05 do not confuse with CENTRALIZED HOSPITAL SERVICES
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D002495 PLS
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 1999
% 207.86/208.05 |- skos__hiddenLabel mesh__D002495 Central Supplies, Hospital
% 207.86/208.05 |- mesh__historyNote mesh__D002495
% 207.86/208.05 78; was HOSPITAL CENTRAL SUPPLY 1968-77
% 207.86/208.05 |- rdf__type mesh__D002495sskos__Concept
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 1998
% 207.86/208.05 |- mesh__dateEstablished mesh__D002495 1968-01-01
% 207.86/208.05 |- skos__altLabel mesh__D002495 Hospital Central Supply
% 207.86/208.05 |- mesh__recordOriginator mesh__D002495 NLM
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D002495 2002
% 207.86/208.05 |- skos__altLabel mesh__D002495 Hospital Central Supplies
% 207.86/208.05 |- rdf__type mesh__D043303sskos__Concept
% 207.86/208.05 |- skos__altLabel mesh__D043303 Paraoxonase
% 207.86/208.05 |- skos__broader mesh__D043303smesh__D044345
% 207.86/208.05 |- skos__altLabel mesh__D043303 Organophosphorus Acid Anhydrase
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D043303
% 207.86/208.05 2004; ARYLDIALKYLPHOSPHATASE was indexed under ESTERASES 1994-2003; PHOSPHORIC MONOESTER HYRDOLASES 1990-1993; PHOSPHOMONOESTERASES 1982-1989%A%
% 207.86/208.05 |- skos__altLabel mesh__D043303 Arylalkylphosphatase
% 207.86/208.05 |- skos__historyNote mesh__D043303 Esterases %28%1980-2003%29%
% 207.86/208.05 |- skos__altLabel mesh__D043303 Homocysteine Thiolactone Hydrolase
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Phosphatase, Aryl-dialkyl
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D043303 2005
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Paraoxonase 1
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Anhydrase, OPA
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Anhydrolase, Organophosphorus Acid
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Aryl dialkyl Phosphatase
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Thiolactone Hydrolase, Homocysteine
% 207.86/208.05 |- skos__scopeNote mesh__D043303
% 207.86/208.05 An enzyme which catalyzes the hydrolysis of an aryl-dialkyl phosphate to form dialkyl phosphate and an aryl alcohol. It can hydrolyze a broad spectrum of organophosphate substrates and a number of aromatic carboxylic acid esters. It may also mediate an enzymatic protection of LOW DENSITY LIPOPROTEINS against oxidative modification and the consequent series of events leading to ATHEROMA formation. The enzyme was previously regarded to be identical with Arylesterase %28%EC 3.1.1.2%29%.%A%
% 207.86/208.05 |- skos__altLabel mesh__D043303 Organophosphorus Acid Hydrolase
% 207.86/208.05 |- mesh__recordMaintainer mesh__D043303 jmp
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Paraoxonase 2
% 207.86/208.05 |- skos__prefLabel mesh__D043303 Aryldialkylphosphatase
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D043303 sjn
% 207.86/208.05 |- skos__altLabel mesh__D043303 OPH Enzyme
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Anhydrase, Organophosphorus Acid
% 207.86/208.05 |- skos__annotation mesh__D043303
% 207.86/208.05 X refs PARAOXONASE-1 and PARAOXONASE-2 see SCR for organism specific terms%A%
% 207.86/208.05 |- mesh__historyNote mesh__D043303
% 207.86/208.05 2004; use ARYLDIALKYLPHOSPHATASE %28%NM%29% 1980 - 2003
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Hydrolase, Homocysteine Thiolactone
% 207.86/208.05 |- skos__altLabel mesh__D043303 Aryl-dialkyl Phosphatase
% 207.86/208.05 |- skos__altLabel mesh__D043303 Organophosphorus Hydrolase
% 207.86/208.05 |- skos__altLabel mesh__D043303 Organophosphorus Acid Anhydrolase
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Enzyme, OPH
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Acid Anhydrase, Organophosphorus
% 207.86/208.05 |- mesh__dateEstablished mesh__D043303 2004-01-01
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D043303 2004
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Hydrolase, Organophosphorus
% 207.86/208.05 |- mesh__recordOriginator mesh__D043303 AKE
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Acid Anhydrolase, Organophosphorus
% 207.86/208.05 |- mesh__dateCreated mesh__D043303 2003-07-09
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Hydrolase, Organophosphorus Acid
% 207.86/208.05 |- skos__altLabel mesh__D043303 OPA Anhydrase
% 207.86/208.05 |- skos__hiddenLabel mesh__D043303 Acid Hydrolase, Organophosphorus
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D043303 2006
% 207.86/208.05 |- skos__scopeNote mesh__D010927
% 207.86/208.05 Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.%A%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D010927 2006
% 207.86/208.05 |- mesh__historyNote mesh__D010927
% 207.86/208.05 91%28%75%29%; was see under PLACENTA DISEASES 1980-90; was see under PLACENTA DISORDERS 1975-79%A%
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D010927 sjn
% 207.86/208.05 |- mesh__recordOriginator mesh__D010927 NLM
% 207.86/208.05 |- skos__annotation mesh__D010927 check the tags FEMALE %26% PREGNANCY
% 207.86/208.05 |- skos__prefLabel mesh__D010927 Placental Insufficiency
% 207.86/208.05 |- mesh__dateCreated mesh__D010927 1974-11-11
% 207.86/208.05 |- mesh__dateEstablished mesh__D010927 1991-01-01
% 207.86/208.05 |- skos__broader mesh__D010927smesh__D010922
% 207.86/208.05 |- rdf__type mesh__D010927sskos__Concept
% 207.86/208.05 |- mesh__recordMaintainer mesh__D010927 lkt
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D010927
% 207.86/208.05 91; was see under PLACENTA DISEASES 1980-90; was see under PLACENTA DISORDERS 1975-79%A%
% 207.86/208.05 |- skos__hiddenLabel mesh__D010927 Insufficiency, Placental
% 207.86/208.05 |- mesh__dateRevised mesh__D010927 2005-06-30
% 207.86/208.05 |- skos__prefLabel mesh__D029632 Sapotaceae
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D029632 sjn
% 207.86/208.05 |- rdf__type mesh__D029632sskos__Concept
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D029632 2006
% 207.86/208.05 |- skos__annotation mesh__D029632
% 207.86/208.05 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.05 |- mesh__recordOriginator mesh__D029632 ssb
% 207.86/208.05 |- mesh__historyNote mesh__D029632 2002
% 207.86/208.05 |- skos__broader mesh__D029632smesh__D019684
% 207.86/208.05 |- mesh__dateEstablished mesh__D029632 2002-01-01
% 207.86/208.05 |- mesh__recordMaintainer mesh__D029632 ssb
% 207.86/208.05 |- mesh__dateRevised mesh__D029632 2005-06-30
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D029632 2002
% 207.86/208.05 |- skos__scopeNote mesh__D029632
% 207.86/208.05 A plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida that are tropical trees which have elongate latex cells. Several members bear sweet edible fruits and produce triterpenoid saponins.%A%
% 207.86/208.05 |- mesh__dateCreated mesh__D029632 2001-07-25
% 207.86/208.05 |- skos__hiddenLabel mesh__D010129 para-Aminobenzoate, Magnesium
% 207.86/208.05 |- skos__scopeNote mesh__D010129
% 207.86/208.05 A member of the VITAMIN B COMPLEX. It used to be a common sunscreening agent until found to also be a sensitizer. The potassium salt is used therapeutically in fibrotic skin disorders.%A%
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D010129
% 207.86/208.05 90; was P-AMINOBENZOIC ACID see under AMINOBENZOIC ACIDS 1977-89; was PARA-AMINOBENZOIC ACID see under AMINOBENZOIC ACID 1965-76; was PARA-AMINOBENZOIC ACID 1963-64%A%
% 207.86/208.05 |- skos__annotation mesh__D010129
% 207.86/208.05 deficiency: coordinate 4-AMINOBENZOIC ACID /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%%A%
% 207.86/208.05 |- mesh__onlineNote mesh__D010129
% 207.86/208.05 use 4-AMINOBENZOIC ACID to search P-AMINOBENZOIC ACID 1977-89; search AMINOBENZOIC ACIDS 1966-76%A%
% 207.86/208.05 |- skos__prefLabel mesh__D010129 4-Aminobenzoic Acid
% 207.86/208.05 |- skos__hiddenLabel mesh__D010129 p Aminobenzoic Acid
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D010129 sjn
% 207.86/208.05 |- mesh__dateRevised mesh__D010129 2005-06-30
% 207.86/208.05 |- mesh__dateCreated mesh__D010129 1976-05-19
% 207.86/208.05 |- mesh__recordMaintainer mesh__D010129 ssb
% 207.86/208.05 |- skos__historyNote mesh__D010129 Aminobenzoic Acids %28%1966-1976%29%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D010129 2006
% 207.86/208.05 |- skos__broader mesh__D010129smesh__D000610
% 207.86/208.05 |- skos__altLabel mesh__D010129 para-Aminobenzoic Acid
% 207.86/208.05 |- skos__altLabel mesh__D010129 Aminobenzoic Acid
% 207.86/208.05 |- mesh__recordOriginator mesh__D010129 RLS
% 207.86/208.05 |- rdf__type mesh__D010129sskos__Concept
% 207.86/208.05 |- mesh__historyNote mesh__D010129
% 207.86/208.05 90%28%77%29%; was P-AMINOBENZOIC ACID see under AMINOBENZOIC ACIDS 1977-89; was PARA-AMINOBENZOIC ACID see under AMINOBENZOIC ACID 1965-76; was PARA-AMINOBENZOIC ACID 1963-64%A%
% 207.86/208.05 |- mesh__dateEstablished mesh__D010129 1990-01-01
% 207.86/208.05 |- skos__hiddenLabel mesh__D010129 4 Aminobenzoic Acid
% 207.86/208.05 |- skos__hiddenLabel mesh__D010129 para Aminobenzoic Acid
% 207.86/208.05 |- skos__altLabel mesh__D010129 PABA
% 207.86/208.05 |- skos__altLabel mesh__D010129 p-Aminobenzoic Acid
% 207.86/208.05 |- skos__hiddenLabel mesh__D007180 Incisors
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D007180 sjn
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D007180 2004
% 207.86/208.05 |- mesh__recordMaintainer mesh__D007180 lkt
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D007180 2006
% 207.86/208.05 |- rdf__type mesh__D007180sskos__Concept
% 207.86/208.05 |- skos__scopeNote mesh__D007180
% 207.86/208.05 Any of the eight frontal teeth %28%four maxillary and four mandibular%29% having a sharp incisal edge for cutting food and a single root, which occurs in man both as a deciduous and a permanent tooth. %28%Jablonski, Dictionary of Dentistry, 1992, p820%29%%A%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D007180 2005
% 207.86/208.05 |- skos__broader mesh__D007180smesh__D014070
% 207.86/208.05 |- mesh__recordOriginator mesh__D007180 NLM
% 207.86/208.05 |- mesh__dateRevised mesh__D007180 2003-07-09
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D007180 65
% 207.86/208.05 |- mesh__dateCreated mesh__D007180 1999-01-01
% 207.86/208.05 |- skos__prefLabel mesh__D007180 Incisor
% 207.86/208.05 |- mesh__historyNote mesh__D007180 65
% 207.86/208.05 |- mesh__dateEstablished mesh__D007180 1965-01-01
% 207.86/208.05 |- skos__annotation mesh__D007180
% 207.86/208.05 one of the 8 front teeth; NIM when merely locational; %22%incisive papilla%22%, a projection on the palate posterior to the central incisors: index under PALATE %26% do not add INCISOR%A%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1990
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1995
% 207.86/208.05 |- mesh__dateCreated mesh__D015612 1989-04-07
% 207.86/208.05 |- skos__annotation mesh__D015612
% 207.86/208.05 %22%use of ultrasound to increase percutaneous adsorption of drugs%22%; do not use /util except by MeSH definition%A%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 2003
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1991
% 207.86/208.05 |- skos__scopeNote mesh__D015612
% 207.86/208.05 Use of ultrasound to increase the percutaneous adsorption of drugs.%A%
% 207.86/208.05 |- rdf__type mesh__D015612sskos__Concept
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 2004
% 207.86/208.05 |- mesh__historyNote mesh__D015612 90
% 207.86/208.05 |- skos__broader mesh__D015612smesh__D014465
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1996
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 2000
% 207.86/208.05 |- skos__hiddenLabel mesh__D015612 Phonophoreses
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 2005
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1992
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1997
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 2001
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D015612 90
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 2006
% 207.86/208.05 |- skos__broader mesh__D015612smesh__D004333
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1993
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1998
% 207.86/208.05 |- skos__prefLabel mesh__D015612 Phonophoresis
% 207.86/208.05 |- mesh__dateEstablished mesh__D015612 1990-01-01
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 2002
% 207.86/208.05 |- skos__historyNote mesh__D015612 Ultrasonics %28%1966-1989%29%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1994
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D015612 1999
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D006886 sjn
% 207.86/208.05 |- skos__altLabel mesh__D006886 Oxychlorochin
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D006886 2001
% 207.86/208.05 |- mesh__recordOriginator mesh__D006886 NLM
% 207.86/208.05 |- mesh__dateRevised mesh__D006886 2000-06-22
% 207.86/208.05 |- mesh__dateCreated mesh__D006886 1999-01-01
% 207.86/208.05 |- rdf__type mesh__D006886sskos__Concept
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D006886 2004
% 207.86/208.05 |- mesh__recordMaintainer mesh__D006886 TWD
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D006886 2006
% 207.86/208.05 |- skos__broader mesh__D006886smesh__D002738
% 207.86/208.05 |- skos__altLabel mesh__D006886 Oxychloroquine
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D006886 2003
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D006886 2005
% 207.86/208.05 |- skos__altLabel mesh__D006886 Hydroxychlorochin
% 207.86/208.05 |- skos__scopeNote mesh__D006886
% 207.86/208.05 A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p970%29%%A%
% 207.86/208.05 |- skos__prefLabel mesh__D006886 Hydroxychloroquine
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D006886 2002
% 207.86/208.05 |- skos__altLabel mesh__D006886 Hydroxychloroquine Sulfate %28%1:1%29% Salt
% 207.86/208.05 |- skos__related mesh__D020557smesh__D011613
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D020557 2000
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D020557 2002
% 207.86/208.05 |- rdf__type mesh__D020557sskos__Concept
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D020557 2005
% 207.86/208.05 |- skos__prefLabel mesh__D020557 Neurolinguistic Programming
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D020557 2003
% 207.86/208.05 |- skos__scopeNote mesh__D020557
% 207.86/208.05 A set of models of how communication impacts and is impacted by subjective experience. Techniques are generated from these models by sequencing of various aspects of the models in order to change someone%27%s internal representations. Neurolinguistic programming is concerned with the patterns or programming created by the interactions among the brain, language, and the body, that produce both effective and ineffective behavior.%A%
% 207.86/208.05 |- skos__hiddenLabel mesh__D020557 Programming, Neuro-linguistic
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D020557 2006
% 207.86/208.05 |- mesh__dateEstablished mesh__D020557 2000-01-01
% 207.86/208.05 |- skos__hiddenLabel mesh__D020557 Programming, Neurolinguistic
% 207.86/208.05 |- skos__broader mesh__D020557smesh__D008959
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D020557 2004
% 207.86/208.05 |- skos__broader mesh__D020557smesh__D007858
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D020557 2000
% 207.86/208.05 |- mesh__dateCreated mesh__D020557 1999-11-03
% 207.86/208.05 |- skos__broader mesh__D020557smesh__D011578
% 207.86/208.05 |- skos__broader mesh__D020557smesh__D008960
% 207.86/208.05 |- mesh__historyNote mesh__D020557 2000
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D020557 2001
% 207.86/208.05 |- skos__altLabel mesh__D020557 Neuro-linguistic Programming
% 207.86/208.05 |- mesh__dateEstablished mesh__D039262 2003-01-01
% 207.86/208.05 |- skos__prefLabel mesh__D039262 Eriocaulaceae
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D039262 2006
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D039262 2003
% 207.86/208.05 |- skos__annotation mesh__D039262
% 207.86/208.05 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D039262 2005
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D039262 2004
% 207.86/208.05 |- mesh__historyNote mesh__D039262 2003
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D039262 2003
% 207.86/208.05 |- mesh__dateCreated mesh__D039262 2002-07-03
% 207.86/208.05 |- rdf__type mesh__D039262sskos__Concept
% 207.86/208.05 |- skos__broader mesh__D039262smesh__D019684
% 207.86/208.05 |- skos__scopeNote mesh__D039262
% 207.86/208.05 A plant family of the order Commelinales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29%.%A%
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D006088 2006
% 207.86/208.05 |- skos__prefLabel mesh__D006088 Gram-Negative Aerobic Bacteria
% 207.86/208.05 |- mesh__historyNote mesh__D006088
% 207.86/208.05 76; ACHROMATIACEAE was heading 1975-96; ACHROMATIUM, LEPTOTHRIX, %26% SPHAEROTILUS were headings 1963-96; ACHROMOBACTERIACEAE was heading 1975-91 %28%was see under GRAM-NEGATIVE AEROBIC BACTERIA 1976-90%29%%A%
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D006088 sjn
% 207.86/208.05 |- mesh__onlineNote mesh__D006088
% 207.86/208.05 use GRAM-NEGATIVE AEROBIC BACTERIA to search ACHROMATIACEAE 1975-96; ACHROMATIUM, LEPTOTHRIX, %26% SPHAEROTILUS 1966-96, %26% ACHROMOBACTERIACEAE 1975-91%A%
% 207.86/208.05 |- skos__altLabel mesh__D006088 Gram Negative Aerobic Bacteria
% 207.86/208.05 |- skos__broader mesh__D006088smesh__D006090
% 207.86/208.05 |- mesh__dateRevised mesh__D006088 2005-06-30
% 207.86/208.05 |- rdf__type mesh__D006088sskos__Concept
% 207.86/208.05 |- mesh__dateEstablished mesh__D006088 1976-01-01
% 207.86/208.05 |- skos__annotation mesh__D006088
% 207.86/208.05 GEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative aerobic bact; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM NEG AEROBIC BACT%A%
% 207.86/208.05 |- mesh__dateCreated mesh__D006088 1975-07-25
% 207.86/208.05 |- skos__scopeNote mesh__D006088
% 207.86/208.05 A large group of aerobic bacteria which show up as pink %28%negative%29% when treated by the gram-staining method. This is because the cell walls of gram-negative bacteria are low in peptidoglycan and thus have low affinity for violet stain and high affinity for the pink dye safranine.%A%
% 207.86/208.05 |- mesh__recordMaintainer mesh__D006088 SYSTEM
% 207.86/208.05 |- skos__historyNote mesh__D006088 Bacteria %28%1966-1975%29%
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D006088
% 207.86/208.05 76; ACHROMATIACEAE was heading 1975-96; ACHROMATIUM, LEPTOTHRIX, %26% SPHAEROTILUS were headings 1963-96; ACHROMOBACTERIACEAE was heading 1975-91 %28%see under GRAM-NEGATIVE AEROBIC BACTERIA 1976-90%29%%A%
% 207.86/208.05 |- mesh__recordOriginator mesh__D006088 JW
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025242 2002
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D025242 sjn
% 207.86/208.05 |- skos__scopeNote mesh__D025242
% 207.86/208.05 Heterogeneous group of arthritic diseases sharing clinical and radiologic features and presence of the HLA-B27 ANTIGEN.%A%
% 207.86/208.05 |- rdf__type mesh__D025242sskos__Concept
% 207.86/208.05 |- skos__historyNote mesh__D025242
% 207.86/208.05 Spondylitis, Ankylosing %28%1977-2001%29%
% 207.86/208.05 |- skos__historyNote mesh__D025242 Spinal Diseases %28%1977-2001%29%
% 207.86/208.05 |- mesh__historyNote mesh__D025242 2002
% 207.86/208.05 |- skos__annotation mesh__D025242
% 207.86/208.05 coord IM with specific vertebrae %28%IM%29%
% 207.86/208.05 |- mesh__recordOriginator mesh__D025242 ags
% 207.86/208.05 |- mesh__recordMaintainer mesh__D025242 jls
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025242 2004
% 207.86/208.05 |- mesh__dateCreated mesh__D025242 2001-08-03
% 207.86/208.05 |- mesh__dateEstablished mesh__D025242 2002-01-01
% 207.86/208.05 |- skos__altLabel mesh__D025242 Spondylarthropathy
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025242 2006
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D025242 2002
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025242 2003
% 207.86/208.05 |- skos__prefLabel mesh__D025242 Spondylarthropathies
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D025242 2005
% 207.86/208.05 |- skos__broader mesh__D025242smesh__D025241
% 207.86/208.05 |- mesh__historyNote mesh__D019205
% 207.86/208.05 2003%28%1997%29%; for STIMULATORY GTP-BINDING PROTEIN, ALPHA SUBUNIT use G-PROTEIN, GS FAMILY %28%NM%29% 1996-2003%A%
% 207.86/208.05 |- mesh__recordAuthorizer mesh__D019205 sjn
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 Stimulatory G-Proteins, Gs
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 Gs alpha GTP Binding Protein Subunits
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 G-Proteins, Gs Stimulatory
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 Stimulatory Gs G-Protein
% 207.86/208.05 |- mesh__dateEstablished mesh__D019205 1997-01-01
% 207.86/208.05 |- skos__altLabel mesh__D019205
% 207.86/208.05 Stimulatory GTP-Binding Protein, alpha Subunit
% 207.86/208.05 |- skos__altLabel mesh__D019205 G-Protein, Stimulatory Gs
% 207.86/208.05 |- skos__altLabel mesh__D019205 Gs, Stimulatory G-Protein
% 207.86/208.05 |- skos__broader mesh__D019205smesh__D044385
% 207.86/208.05 |- skos__altLabel mesh__D019205 Ns Protein, Regulatory
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205
% 207.86/208.05 Stimulatory GTP Binding Protein, alpha Subunit
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 Gs, Stimulatory G Protein
% 207.86/208.05 |- skos__altLabel mesh__D019205 alpha-Gs
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 G Protein, Gs alpha Family
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D019205
% 207.86/208.05 2003; see G-PROTEIN, STIMULATORY GS 1997-2003; STIMULATORY GTP-BINDNG PROTEIN, ALPHA SUBUNIT was indexed under G-PROTEIN, STIMULATORY GS 1997-2003 %26% under G-PROTEINS 1996%A%
% 207.86/208.05 |- skos__altLabel mesh__D019205 G%28%s%29%alpha
% 207.86/208.05 |- skos__altLabel mesh__D019205 Gs alpha GTP-Binding Protein Subunits
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D019205 2006
% 207.86/208.05 |- mesh__recordMaintainer mesh__D019205 jmp
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 Stimulatory G-Protein Gs
% 207.86/208.05 |- skos__scopeNote mesh__D019205
% 207.86/208.05 A family of heterotrimeric GTP-binding protein alpha subunits that activate ADENYLATE CYCLASE.%A%
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 alpha Gs
% 207.86/208.05 |- skos__altLabel mesh__D019205 Gs Stimulatory G-Proteins
% 207.86/208.05 |- mesh__dateCreated mesh__D019205 1996-06-10
% 207.86/208.05 |- skos__annotation mesh__D019205 DF: G PROTEIN STIM GS
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 GTP Binding Protein alpha Subunits, Gs
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 Gs G-Protein, Stimulatory
% 207.86/208.05 |- rdf__type mesh__D019205sskos__Concept
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 G Protein, Stimulatory Gs
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 Gs Stimulatory G Proteins
% 207.86/208.05 |- mesh__dateRevised mesh__D019205 2004-07-07
% 207.86/208.05 |- skos__prefLabel mesh__D019205 GTP-Binding Protein alpha Subunits, Gs
% 207.86/208.05 |- mesh__activeMeSHYear mesh__D019205 2005
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 Regulatory Ns Protein
% 207.86/208.05 |- skos__altLabel mesh__D019205 G-Protein, Gs alpha Family
% 207.86/208.05 |- skos__historyNote mesh__D019205 G-Proteins %28%1985-1996%29%
% 207.86/208.05 |- skos__hiddenLabel mesh__D019205 G-Protein Gs, Stimulatory
% 207.86/208.05 |- mesh__recordOriginator mesh__D019205 TPW
% 207.86/208.05 |- skos__altLabel mesh__D019205 G%28%s%29%, alpha Subunit
% 207.86/208.05 |- mesh__publicMeSHNote mesh__D011222 73
% 207.86/208.06 |- rdf__type mesh__D011222sskos__Concept
% 207.86/208.06 |- skos__altLabel mesh__D011222 Demetrin
% 207.86/208.06 |- skos__scopeNote mesh__D011222
% 207.86/208.06 A benzodiazepine that is used in the treatment of ANXIETY DISORDERS.%A%
% 207.86/208.06 |- skos__altLabel mesh__D011222 Mono Demetrin
% 207.86/208.06 |- skos__historyNote mesh__D011222 Benzazepines %28%1968-1971%29%
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D011222 2006
% 207.86/208.06 |- skos__altLabel mesh__D011222 Warner-Lambert Brand of Prazepam
% 207.86/208.06 |- skos__historyNote mesh__D011222
% 207.86/208.06 Muscle Relaxants, Central %28%1970-1971%29%
% 207.86/208.06 |- skos__altLabel mesh__D011222 Pfizer Brand of Prazepam
% 207.86/208.06 |- skos__altLabel mesh__D011222 Parke Davis Brand of Prazepam
% 207.86/208.06 |- mesh__recordOriginator mesh__D011222 NLM
% 207.86/208.06 |- skos__prefLabel mesh__D011222 Prazepam
% 207.86/208.06 |- mesh__recordMaintainer mesh__D011222 lkw
% 207.86/208.06 |- mesh__dateEstablished mesh__D011222 1973-01-01
% 207.86/208.06 |- mesh__historyNote mesh__D011222 73%28%72%29%
% 207.86/208.06 |- mesh__dateCreated mesh__D011222 1999-01-01
% 207.86/208.06 |- skos__broader mesh__D011222smesh__D001570
% 207.86/208.06 |- mesh__dateRevised mesh__D011222 2005-06-30
% 207.86/208.06 |- skos__altLabel mesh__D011222 United Drug Brand of Prazepam
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D011222 sjn
% 207.86/208.06 |- skos__broader mesh__D012067Q000523smesh__D012067
% 207.86/208.06 |- mesh__preferredCombination mesh__D012067Q000523smesh__D012069
% 207.86/208.06 |- rdf__type mesh__D012067Q000523smesh__CompoundConcept
% 207.86/208.06 |- skos__altLabel mesh__D049690 Ancient History of Medicine
% 207.86/208.06 |- skos__scopeNote mesh__D049690
% 207.86/208.06 The period of history before 500 of the common era.
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D049690 2005
% 207.86/208.06 |- skos__hiddenLabel mesh__D049690 Ancient History Medicines
% 207.86/208.06 |- skos__hiddenLabel mesh__D049690 Ancient Histories %28%Medicine%29%
% 207.86/208.06 |- skos__broader mesh__D049690smesh__D006664
% 207.86/208.06 |- skos__altLabel mesh__D049690 Medicine, Ancient History
% 207.86/208.06 |- skos__altLabel mesh__D049690 Ancient History %28%Medicine%29%
% 207.86/208.06 |- skos__hiddenLabel mesh__D049690 Ancient History Medicine
% 207.86/208.06 |- skos__hiddenLabel mesh__D049690 Medicines, Ancient History
% 207.86/208.06 |- skos__hiddenLabel mesh__D049690 History, Ancient %28%Medicine%29%
% 207.86/208.06 |- skos__historyNote mesh__D049690
% 207.86/208.06 History of Medicine, Ancient %28%1966-2004%29%
% 207.86/208.06 |- skos__hiddenLabel mesh__D049690 Medicine Ancient History
% 207.86/208.06 |- mesh__historyNote mesh__D049690 2005
% 207.86/208.06 |- skos__hiddenLabel mesh__D049690 History Medicine, Ancient
% 207.86/208.06 |- mesh__dateEstablished mesh__D049690 2005-01-01
% 207.86/208.06 |- skos__prefLabel mesh__D049690 History, Ancient
% 207.86/208.06 |- mesh__recordMaintainer mesh__D049690 jls
% 207.86/208.06 |- mesh__dateCreated mesh__D049690 2004-07-07
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D049690
% 207.86/208.06 2005; see HISTORY OF MEDICINE, ANCIENT 1966-2004
% 207.86/208.06 |- mesh__recordOriginator mesh__D049690 jls
% 207.86/208.06 |- skos__altLabel mesh__D049690 Ancient History
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D049690 2006
% 207.86/208.06 |- skos__hiddenLabel mesh__D049690 History Medicines, Ancient
% 207.86/208.06 |- skos__hiddenLabel mesh__D049690 Histories, Ancient %28%Medicine%29%
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D049690 sjn
% 207.86/208.06 |- rdf__type mesh__D049690sskos__Concept
% 207.86/208.06 |- skos__annotation mesh__D049690
% 207.86/208.06 before 500 AD; IM general only; NIM as check tag; note ANCIENT LANDS in Category Z%A%
% 207.86/208.06 |- skos__hiddenLabel mesh__D002496 Central Venous Pressures
% 207.86/208.06 |- mesh__dateCreated mesh__D002496 1999-01-01
% 207.86/208.06 |- skos__altLabel mesh__D002496 Venous Pressure, Central
% 207.86/208.06 |- mesh__dateRevised mesh__D002496 2003-07-09
% 207.86/208.06 |- skos__historyNote mesh__D002496 Veins %28%1966-1969%29%
% 207.86/208.06 |- mesh__recordMaintainer mesh__D002496 nns
% 207.86/208.06 |- mesh__recordOriginator mesh__D002496 NLM
% 207.86/208.06 |- skos__historyNote mesh__D002496 Blood Pressure %28%1966-1969%29%
% 207.86/208.06 |- rdf__type mesh__D002496sskos__Concept
% 207.86/208.06 |- mesh__historyNote mesh__D002496 70
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D002496 70
% 207.86/208.06 |- mesh__dateEstablished mesh__D002496 1970-01-01
% 207.86/208.06 |- skos__hiddenLabel mesh__D002496 Venous Pressures, Central
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D002496 2004
% 207.86/208.06 |- skos__scopeNote mesh__D002496
% 207.86/208.06 The blood pressure in the central large VEINS of the body. It is distinguished from peripheral venous pressure which occurs in an extremity.%A%
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D002496 sjn
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D002496 2006
% 207.86/208.06 |- skos__prefLabel mesh__D002496 Central Venous Pressure
% 207.86/208.06 |- skos__broader mesh__D002496smesh__D014690
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D002496 2005
% 207.86/208.06 |- skos__hiddenLabel mesh__D002496 Pressures, Central Venous
% 207.86/208.06 |- skos__hiddenLabel mesh__D002496 Pressure, Central Venous
% 207.86/208.06 |- skos__related mesh__D010928smesh__D011986
% 207.86/208.06 |- skos__hiddenLabel mesh__D010928 Human Chorionic Somatomammotropin
% 207.86/208.06 |- skos__hiddenLabel mesh__D010928 Lactogen, Placental
% 207.86/208.06 |- mesh__dateEstablished mesh__D010928 1972-01-01
% 207.86/208.06 |- skos__altLabel mesh__D010928 Placental Luteotropin
% 207.86/208.06 |- mesh__dateRevised mesh__D010928 2004-07-07
% 207.86/208.06 |- skos__altLabel mesh__D010928 PAPP-D
% 207.86/208.06 |- mesh__historyNote mesh__D010928 72%28%68%29%
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D010928 72
% 207.86/208.06 |- skos__hiddenLabel mesh__D010928 Luteotropin, Placental
% 207.86/208.06 |- skos__altLabel mesh__D010928 Somatomammotropin, Chorionic
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D010928 sjn
% 207.86/208.06 |- skos__scopeNote mesh__D010928
% 207.86/208.06 A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist.%A%
% 207.86/208.06 |- rdf__type mesh__D010928sskos__Concept
% 207.86/208.06 |- mesh__recordOriginator mesh__D010928 NLM
% 207.86/208.06 |- skos__hiddenLabel mesh__D010928 Placental Lactogen, Human
% 207.86/208.06 |- skos__broader mesh__D010928smesh__D011257
% 207.86/208.06 |- skos__hiddenLabel mesh__D010928 Chorionic Somatomammotropin
% 207.86/208.06 |- skos__hiddenLabel mesh__D010928 Pregnancy Associated Plasma Protein D
% 207.86/208.06 |- skos__altLabel mesh__D010928 Choriomammotropin
% 207.86/208.06 |- skos__historyNote mesh__D010928 Placental Hormones %28%1966-1967%29%
% 207.86/208.06 |- skos__broader mesh__D010928smesh__D010926
% 207.86/208.06 |- skos__hiddenLabel mesh__D010928 Placental Mammotropic Hormone
% 207.86/208.06 |- skos__altLabel mesh__D010928 Lactogen Hormone, Placental
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D010928 2005
% 207.86/208.06 |- skos__altLabel mesh__D010928 HPL %28%Human Placental Lactogen%29%
% 207.86/208.06 |- skos__altLabel mesh__D010928 Choriomammotrophin
% 207.86/208.06 |- skos__altLabel mesh__D010928 Chorionic Somatomammotropin, Human
% 207.86/208.06 |- skos__prefLabel mesh__D010928 Placental Lactogen
% 207.86/208.06 |- skos__altLabel mesh__D010928 Pregnancy-Associated Plasma Protein D
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D010928 2006
% 207.86/208.06 |- mesh__dateCreated mesh__D010928 1999-01-01
% 207.86/208.06 |- skos__altLabel mesh__D010928
% 207.86/208.06 HCS %28%Human Chorionic Somatomammotropin%29%
% 207.86/208.06 |- mesh__recordMaintainer mesh__D010928 lkt
% 207.86/208.06 |- skos__altLabel mesh__D010928 Mammotropic Hormone, Placental
% 207.86/208.06 |- mesh__dateCreated mesh__D029633 2001-07-25
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D029633 2004
% 207.86/208.06 |- mesh__dateEstablished mesh__D029633 2002-01-01
% 207.86/208.06 |- skos__prefLabel mesh__D029633 Schisandraceae
% 207.86/208.06 |- mesh__historyNote mesh__D029633 2002
% 207.86/208.06 |- skos__annotation mesh__D029633
% 207.86/208.06 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D029633 2002
% 207.86/208.06 |- skos__broader mesh__D029633smesh__D019684
% 207.86/208.06 |- skos__scopeNote mesh__D029633
% 207.86/208.06 A plant family of the order Illiciales, subclass Magnoliidae, class Magnoliopsida.%A%
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D029633 2005
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D029633 2002
% 207.86/208.06 |- rdf__type mesh__D029633sskos__Concept
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D029633 2003
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D029633 2006
% 207.86/208.06 |- skos__hiddenLabel mesh__D007181 Inclusion Body, Viral
% 207.86/208.06 |- skos__altLabel mesh__D007181 Negri Bodies
% 207.86/208.06 |- mesh__dateRevised mesh__D007181 2005-06-30
% 207.86/208.06 |- skos__annotation mesh__D007181
% 207.86/208.06 A11 qualif except /cytol; /genet permitted; coord IM with specific virus %28%IM%29%%A%
% 207.86/208.06 |- skos__hiddenLabel mesh__D007181 Bodies, Viral Inclusion
% 207.86/208.06 |- mesh__dateCreated mesh__D007181 1999-01-01
% 207.86/208.06 |- skos__broader mesh__D007181smesh__D018406
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D007181 sjn
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D007181 66
% 207.86/208.06 |- skos__scopeNote mesh__D007181
% 207.86/208.06 An area showing altered staining behavior in the nucleus or cytoplasm of a virus-infected cell. Some inclusion bodies represent %22%virus factories%22% in which viral nucleic acid or protein is being synthesized; others are merely artifacts of fixation and staining. One example, Negri bodies, are found in the cytoplasm or processes of nerve cells in animals that have died from rabies.%A%
% 207.86/208.06 |- mesh__historyNote mesh__D007181 66
% 207.86/208.06 |- skos__prefLabel mesh__D007181 Inclusion Bodies, Viral
% 207.86/208.06 |- mesh__recordMaintainer mesh__D007181 nns
% 207.86/208.06 |- skos__broader mesh__D007181smesh__D002479
% 207.86/208.06 |- skos__altLabel mesh__D007181 Viral Inclusion Bodies
% 207.86/208.06 |- skos__hiddenLabel mesh__D007181 Viral Inclusion Body
% 207.86/208.06 |- mesh__dateEstablished mesh__D007181 1966-01-01
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D007181 2006
% 207.86/208.06 |- skos__hiddenLabel mesh__D007181 Body, Negri
% 207.86/208.06 |- mesh__recordOriginator mesh__D007181 NLM
% 207.86/208.06 |- rdf__type mesh__D007181sskos__Concept
% 207.86/208.06 |- skos__hiddenLabel mesh__D007181 Body, Viral Inclusion
% 207.86/208.06 |- skos__hiddenLabel mesh__D007181 Bodies, Negri
% 207.86/208.06 |- skos__hiddenLabel mesh__D015613 Hepadnavirus
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D015613 sjn
% 207.86/208.06 |- skos__broader mesh__D015613smesh__D004267
% 207.86/208.06 |- mesh__dateCreated mesh__D015613 1989-04-07
% 207.86/208.06 |- rdf__type mesh__D015613sskos__Concept
% 207.86/208.06 |- mesh__historyNote mesh__D015613 90
% 207.86/208.06 |- skos__altLabel mesh__D015613 Hepadnaviruses
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D015613 90
% 207.86/208.06 |- skos__historyNote mesh__D015613 Hepatitis B Virus %28%1982-1989%29%
% 207.86/208.06 |- mesh__dateRevised mesh__D015613 2004-07-13
% 207.86/208.06 |- mesh__dateEstablished mesh__D015613 1990-01-01
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D015613 2005
% 207.86/208.06 |- mesh__recordMaintainer mesh__D015613 sjn
% 207.86/208.06 |- skos__prefLabel mesh__D015613 Hepadnaviridae
% 207.86/208.06 |- mesh__recordOriginator mesh__D015613 PXP
% 207.86/208.06 |- skos__scopeNote mesh__D015613
% 207.86/208.06 A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus %28%HEPATITIS B VIRUS, DUCK%29%, heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis B virus %28%HEPATITIS B VIRUS, WOODCHUCK%29%.%A%
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D015613 2006
% 207.86/208.06 |- skos__broader mesh__D015613smesh__D006518
% 207.86/208.06 |- skos__annotation mesh__D015613
% 207.86/208.06 a family of hepatitis viruses; from HEPAtotropic DNA viruses; infection = HEPADNAVIRIDAE INFECTIONS%A%
% 207.86/208.06 |- mesh__recordMaintainer mesh__D006887 ssb
% 207.86/208.06 |- mesh__dateRevised mesh__D006887 2005-06-30
% 207.86/208.06 |- skos__altLabel mesh__D006887 Hydroxycholecalciferol
% 207.86/208.06 |- skos__broader mesh__D006887smesh__D002762
% 207.86/208.06 |- mesh__dateEstablished mesh__D006887 1973-01-01
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D006887 sjn
% 207.86/208.06 |- mesh__dateCreated mesh__D006887 1999-01-01
% 207.86/208.06 |- rdf__type mesh__D006887sskos__Concept
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D006887 2006
% 207.86/208.06 |- mesh__recordOriginator mesh__D006887 NLM
% 207.86/208.06 |- mesh__historyNote mesh__D006887
% 207.86/208.06 75; was HYDROXYCHOLECALCIFEROL 1972-74 %28%Prov 1972%29%
% 207.86/208.06 |- skos__scopeNote mesh__D006887
% 207.86/208.06 Hydroxy analogs of vitamin D 3; %28%CHOLECALCIFEROL%29%; including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3.%A%
% 207.86/208.06 |- skos__altLabel mesh__D006887 Hydroxyvitamins D
% 207.86/208.06 |- skos__hiddenLabel mesh__D006887 D, Hydroxyvitamins
% 207.86/208.06 |- skos__prefLabel mesh__D006887 Hydroxycholecalciferols
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D006887
% 207.86/208.06 75; was HYDROXYCHOLECALCIFEROL 1973-74
% 207.86/208.06 |- skos__annotation mesh__D006887
% 207.86/208.06 deficiency: coordinate HYDROXYCHOLECALCIFEROLS /defic %28%IM%29% with VITAMIN D DEFICIENCY %28%IM%29%%A%
% 207.86/208.06 |- mesh__onlineNote mesh__D006887
% 207.86/208.06 use HYDROXYCHOLECALCIFEROLS to search HYDROXYCHOLECALCIFEROL 1972-74 %28%as Prov 1972%29%%A%
% 207.86/208.06 |- skos__broader mesh__D020558smesh__D017766
% 207.86/208.06 |- skos__altLabel mesh__D020558 GTP Phosphohydrolase
% 207.86/208.06 |- skos__scopeNote mesh__D020558
% 207.86/208.06 Enzymes that hydrolyze GTP to GDP. EC 3.6.1.-.
% 207.86/208.06 |- skos__prefLabel mesh__D020558 GTP Phosphohydrolases
% 207.86/208.06 |- mesh__historyNote mesh__D020558
% 207.86/208.06 2000; for GTP PHOSPHOHYDROLASE use GTP PHOSPHOHYDROLASES 1975-1999%A%
% 207.86/208.06 |- skos__hiddenLabel mesh__D020558 Phosphohydrolases, GTP
% 207.86/208.06 |- skos__hiddenLabel mesh__D020558 Phosphohydrolase, GTP
% 207.86/208.06 |- skos__altLabel mesh__D020558 Guanosine Triphosphate Phosphohydrolases
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D020558
% 207.86/208.06 2000; for GUANOSINE TRIPHOSPHATE PHOSPHOHYDROLASES, GTP PHOSPHOHYDROLASE AND GUANOSINETRIPHOSPHATASES see GTP PHOSPHOHYDROLASE %28%1975-1999%29%; for GTPASE see GTP PHOSPHOHYDROLASE %28%1977-1999%29%%A%
% 207.86/208.06 |- skos__annotation mesh__D020558
% 207.86/208.06 GTP PHOSPHOHYDROLASE ACTIVATORS is available
% 207.86/208.06 |- skos__altLabel mesh__D020558 GTPases
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D020558 2004
% 207.86/208.06 |- rdf__type mesh__D020558sskos__Concept
% 207.86/208.06 |- skos__altLabel mesh__D020558 GTPase
% 207.86/208.06 |- mesh__dateRevised mesh__D020558 2003-07-09
% 207.86/208.06 |- mesh__dateEstablished mesh__D020558 2000-01-01
% 207.86/208.06 |- skos__hiddenLabel mesh__D020558
% 207.86/208.06 Phosphohydrolases, Guanosine Triphosphate
% 207.86/208.06 |- skos__altLabel mesh__D020558 Guanosinetriphosphatases
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D020558 2006
% 207.86/208.06 |- mesh__dateCreated mesh__D020558 1999-11-03
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D020558 2005
% 207.86/208.06 |- skos__hiddenLabel mesh__D020558
% 207.86/208.06 Triphosphate Phosphohydrolases, Guanosine
% 207.86/208.06 |- skos__broader mesh__D006089smesh__D006090
% 207.86/208.06 |- skos__prefLabel mesh__D006089 Gram-Negative Anaerobic Bacteria
% 207.86/208.06 |- mesh__recordOriginator mesh__D006089 JW
% 207.86/208.06 |- skos__scopeNote mesh__D006089
% 207.86/208.06 A large group of anaerobic bacteria which show up as pink %28%negative%29% when treated by the Gram-staining method.%A%
% 207.86/208.06 |- rdf__type mesh__D006089sskos__Concept
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D006089 76
% 207.86/208.06 |- mesh__historyNote mesh__D006089 76
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D006089 sjn
% 207.86/208.06 |- mesh__dateCreated mesh__D006089 1975-07-25
% 207.86/208.06 |- mesh__dateRevised mesh__D006089 2005-06-30
% 207.86/208.06 |- mesh__recordMaintainer mesh__D006089 SYSTEM
% 207.86/208.06 |- skos__historyNote mesh__D006089 Bacteria %28%1966-1975%29%
% 207.86/208.06 |- skos__altLabel mesh__D006089 Gram Negative Anaerobic Bacteria
% 207.86/208.06 |- mesh__dateEstablished mesh__D006089 1976-01-01
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D006089 2006
% 207.86/208.06 |- skos__annotation mesh__D006089
% 207.86/208.06 GEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative anaerobic bact; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM NEG ANAEROBIC BACT%A%
% 207.86/208.06 |- skos__hiddenLabel mesh__D025243 ATPases, Bacterial Proton-Translocating
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D025243
% 207.86/208.06 2002; for E COLI COUPLING FACTOR see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1993-2001, H%28%+%29%-TRANSPORTING ATPASE 1984-1992 %26% ADENOSINE TRIPHOSPHATASE F1 1983%A%
% 207.86/208.06 |- skos__annotation mesh__D025243 coord with specific bacterium /enzymol
% 207.86/208.06 |- skos__hiddenLabel mesh__D025243 F1F0-ATPase, E coli
% 207.86/208.06 |- skos__altLabel mesh__D025243 E coli F1F0-ATPase
% 207.86/208.06 |- skos__hiddenLabel mesh__D025243 Proton-Translocating ATPases, Bacterial
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D025243 2004
% 207.86/208.06 |- skos__altLabel mesh__D025243 E coli Coupling Factor
% 207.86/208.06 |- skos__altLabel mesh__D025243 Bacterial F%28%1%29%F%28%0%29% ATPases
% 207.86/208.06 |- skos__scopeNote mesh__D025243
% 207.86/208.06 Membrane-bound proton-translocating ATPases that serve two important physiological functions in bacteria. One function is to generate ADENOSINE TRIPHOSPHATE by utilizing the energy provided by an electrochemical gradient of protons across the cellular membrane. A second function is to counteract a loss of the transmembrane ion gradient by pumping protons at the expense of adenosine triphosphate hydrolysis.%A%
% 207.86/208.06 |- mesh__dateEstablished mesh__D025243 2002-01-01
% 207.86/208.06 |- skos__hiddenLabel mesh__D025243 Bacterial Proton Translocating ATPases
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D025243 2006
% 207.86/208.06 |- skos__historyNote mesh__D025243
% 207.86/208.06 Proton-Translocating ATPases %28%1983-2001%29%
% 207.86/208.06 |- skos__hiddenLabel mesh__D025243
% 207.86/208.06 Escherichia coli Proton Translocating ATPase
% 207.86/208.06 |- skos__hiddenLabel mesh__D025243 E Coli Proton Translocating ATPase
% 207.86/208.06 |- mesh__dateCreated mesh__D025243 2001-07-25
% 207.86/208.06 |- skos__prefLabel mesh__D025243 Bacterial Proton-Translocating ATPases
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D025243 2005
% 207.86/208.06 |- mesh__dateRevised mesh__D025243 2003-07-09
% 207.86/208.06 |- skos__broader mesh__D025243smesh__D006180
% 207.86/208.06 |- skos__altLabel mesh__D025243 E Coli Proton-Translocating ATPase
% 207.86/208.06 |- skos__hiddenLabel mesh__D025243 E coli F1F0 ATPase
% 207.86/208.06 |- mesh__historyNote mesh__D025243
% 207.86/208.06 2002; for E COLI COUPLING FACTOR use PROTON TRANSLOCATING ATPASES 1983-2001%A%
% 207.86/208.06 |- rdf__type mesh__D025243sskos__Concept
% 207.86/208.06 |- skos__altLabel mesh__D019206 G%28%o%29% Protein
% 207.86/208.06 |- skos__altLabel mesh__D019206 Gi alpha Subunit
% 207.86/208.06 |- skos__altLabel mesh__D019206 Gi-Alpha Protein
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D019206 sjn
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 G Protein, Go1 Subunit
% 207.86/208.06 |- skos__altLabel mesh__D019206 G-Protein, Gi Subunit
% 207.86/208.06 |- skos__annotation mesh__D019206 DF: G PROTEIN INHIB GI
% 207.86/208.06 |- skos__broader mesh__D019206smesh__D044385
% 207.86/208.06 |- mesh__dateEstablished mesh__D019206 1997-01-01
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 alpha Subunit, Gi
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Gi Go G Proteins
% 207.86/208.06 |- skos__altLabel mesh__D019206 G-Protein, Inhibitory Go
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Go1 Subunit G-Protein
% 207.86/208.06 |- mesh__recordMaintainer mesh__D019206 DRC
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 G Protein, Inhibitory Gi
% 207.86/208.06 |- skos__altLabel mesh__D019206 G-Protein, Go1 Subunit
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Inhibitory Gi G-Protein
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Subunit G-Protein, Go1
% 207.86/208.06 |- skos__altLabel mesh__D019206 G-Protein, Go Subunit
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, GoC
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 G Protein, Gi Go alpha Family
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Inhibitory G-Protein Gi
% 207.86/208.06 |- skos__altLabel mesh__D019206 Gi-Go G-Proteins
% 207.86/208.06 |- skos__altLabel mesh__D019206 Go Alpha Subunit
% 207.86/208.06 |- skos__altLabel mesh__D019206 Gi, Inhibitory G-Protein
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D019206 2006
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, Go
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Inhibitory Go G-Protein
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D019206
% 207.86/208.06 2004; see G-PROTEIN, INHBITORY GI 1997-2003; GUANINE NUCLEOTIDE-BINDING PROTEIN GO was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003 %26% GTP-BINDING PROTEINS 1991-1999%A%
% 207.86/208.06 |- skos__altLabel mesh__D019206 G-Protein, Gi-Go Subunits
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, Go1
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 G Protein, Inhibitory Go
% 207.86/208.06 |- rdf__type mesh__D019206sskos__Concept
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Gi-Go Subunits G-Protein
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Guanine Nucleotide Binding Protein Go
% 207.86/208.06 |- mesh__dateCreated mesh__D019206 1996-06-10
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Gi Subunit G-Protein
% 207.86/208.06 |- skos__altLabel mesh__D019206 G Protein Go
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Subunits G-Protein, Gi-Go
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Gi Alpha Protein
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Go G-Protein, Inhibitory
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Alpha Subunit, Go
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Gi G-Protein, Inhibitory
% 207.86/208.06 |- skos__altLabel mesh__D019206 G%28%o1%29%alpha
% 207.86/208.06 |- skos__historyNote mesh__D019206 G-Proteins %28%1985-1996%29%
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Gi, Inhibitory G Protein
% 207.86/208.06 |- mesh__historyNote mesh__D019206
% 207.86/208.06 2004%28%1997%29%; for GUANINE NUCLEOTIDE-BINDING PROTEIN GO use GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO %28%NM%29% 1997-2003%A%
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, Gi
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 G Protein, Gi Go Subunits
% 207.86/208.06 |- skos__altLabel mesh__D019206 G Protein Subunit alphaoA
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 G Protein, Go Subunit
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Subunit G-Protein, Gi
% 207.86/208.06 |- skos__altLabel mesh__D019206 Ni Protein
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, GoA
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Subunit, Gi alpha
% 207.86/208.06 |- skos__altLabel mesh__D019206 G-Protein, Inhibitory Gi
% 207.86/208.06 |- mesh__dateRevised mesh__D019206 2005-06-30
% 207.86/208.06 |- skos__scopeNote mesh__D019206
% 207.86/208.06 A family of heterotrimeric GTP-binding protein alpha subunits that were originally identified by their ability to inhibit ADENYLATE CYCLASE. Members of this family can couple to beta and gamma G-protein subunits that activate POTASSIUM CHANNELS. The Gi-Go part of the name is also spelled Gi/Go.%A%
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Subunit G-Protein, Go
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206
% 207.86/208.06 GTP Binding Protein alpha Subunits, Gi Go
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Subunit, Go Alpha
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 G-Proteins, Gi-Go
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 G Protein, Gi Subunit
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Go, G Protein
% 207.86/208.06 |- skos__prefLabel mesh__D019206 GTP-Binding Protein alpha Subunits, Gi-Go
% 207.86/208.06 |- skos__altLabel mesh__D019206 G-Protein, Gi-Go alpha Family
% 207.86/208.06 |- skos__altLabel mesh__D019206 G Protein Subunit alphaoC
% 207.86/208.06 |- skos__hiddenLabel mesh__D019206 Go Subunit G-Protein
% 207.86/208.06 |- mesh__recordOriginator mesh__D019206 TPW
% 207.86/208.06 |- skos__altLabel mesh__D019206 Guanine Nucleotide-Binding Protein Go
% 207.86/208.06 |- skos__historyNote mesh__D011223 Pyrazines %28%1966-1979%29%
% 207.86/208.06 |- skos__altLabel mesh__D011223 Merck Brand of Praziquantel
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D011223 86; see ISOQUINOLINES 1980-85
% 207.86/208.06 |- mesh__dateEstablished mesh__D011223 1986-01-01
% 207.86/208.06 |- mesh__recordOriginator mesh__D011223 SH
% 207.86/208.06 |- skos__altLabel mesh__D011223 Cysticide
% 207.86/208.06 |- rdf__type mesh__D011223sskos__Concept
% 207.86/208.06 |- mesh__dateRevised mesh__D011223 2005-06-30
% 207.86/208.06 |- skos__altLabel mesh__D011223 Bayer Brand of Praziquantel
% 207.86/208.06 |- skos__altLabel mesh__D011223 Prasiquantel
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D011223 sjn
% 207.86/208.06 |- skos__scopeNote mesh__D011223
% 207.86/208.06 An anthelmintic used in most schistosome and many cestode infestations.%A%
% 207.86/208.06 |- skos__hiddenLabel mesh__D011223 8440, EMBAY
% 207.86/208.06 |- skos__historyNote mesh__D011223 Isoquinolines %28%1969-1979%29%
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D011223 2006
% 207.86/208.06 |- mesh__historyNote mesh__D011223 86%28%80%29%
% 207.86/208.06 |- skos__broader mesh__D011223smesh__D007546
% 207.86/208.06 |- skos__prefLabel mesh__D011223 Praziquantel
% 207.86/208.06 |- skos__altLabel mesh__D011223 Cisticid
% 207.86/208.06 |- mesh__recordMaintainer mesh__D011223 lkw
% 207.86/208.06 |- skos__historyNote mesh__D011223 Quinolines %28%1966-1968%29%
% 207.86/208.06 |- mesh__dateCreated mesh__D011223 1979-05-30
% 207.86/208.06 |- skos__prefLabel mesh__D049691 History, Medieval
% 207.86/208.06 |- skos__hiddenLabel mesh__D049691 Histories, Medieval %28%Medicine%29%
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D049691 sjn
% 207.86/208.06 |- skos__altLabel mesh__D049691 Medieval History %28%Medicine%29%
% 207.86/208.06 |- mesh__dateCreated mesh__D049691 2004-07-07
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D049691
% 207.86/208.06 2005; see HISTORY OF MEDICINE, MEDIEVAL 1995-2004; for HISTORY OF MEDICINE, MEDIEVAL see HISTORY OF MEDICINE, MEDIEVAL 1966-2004%A%
% 207.86/208.06 |- mesh__historyNote mesh__D049691 2005
% 207.86/208.06 |- mesh__recordOriginator mesh__D049691 jls
% 207.86/208.06 |- skos__annotation mesh__D049691 IM general only; NIM as check tag
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D049691 2006
% 207.86/208.06 |- mesh__dateEstablished mesh__D049691 2005-01-01
% 207.86/208.06 |- skos__altLabel mesh__D049691 Medieval History
% 207.86/208.06 |- skos__hiddenLabel mesh__D049691 Medieval History Medicine
% 207.86/208.06 |- skos__altLabel mesh__D049691 Medicine, Medieval History
% 207.86/208.06 |- rdf__type mesh__D049691sskos__Concept
% 207.86/208.06 |- skos__hiddenLabel mesh__D049691 Medieval Histories %28%Medicine%29%
% 207.86/208.06 |- skos__hiddenLabel mesh__D049691 History, Medieval %28%Medicine%29%
% 207.86/208.06 |- mesh__recordMaintainer mesh__D049691 jls
% 207.86/208.06 |- skos__scopeNote mesh__D049691
% 207.86/208.06 The period of history from the year 500 through 1450 of the common era.%A%
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D049691 2005
% 207.86/208.06 |- skos__broader mesh__D049691smesh__D006664
% 207.86/208.06 |- skos__hiddenLabel mesh__D049691 History Medicine, Medieval
% 207.86/208.06 |- skos__altLabel mesh__D049691 Renaissance Medicine
% 207.86/208.06 |- skos__broader mesh__D004912Q000637smesh__D004912
% 207.86/208.06 |- mesh__preferredCombination mesh__D004912Q000637smesh__D017707
% 207.86/208.06 |- rdf__type mesh__D004912Q000637smesh__CompoundConcept
% 207.86/208.06 |- mesh__dateEstablished mesh__D002497 1991-01-01
% 207.86/208.06 |- mesh__recordAuthorizer mesh__D002497 PLS
% 207.86/208.06 |- mesh__recordOriginator mesh__D002497 EC
% 207.86/208.06 |- mesh__publicMeSHNote mesh__D002497
% 207.86/208.06 91; was see under HOSPITAL ADMINISTRATION Aug 1977-90
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D002497 1996
% 207.86/208.06 |- rdf__type mesh__D002497sskos__Concept
% 207.86/208.06 |- skos__hiddenLabel mesh__D002497 Centralized Service, Hospital
% 207.86/208.06 |- skos__hiddenLabel mesh__D002497 Service, Centralized Hospital
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D002497 1998
% 207.86/208.06 |- skos__hiddenLabel mesh__D002497 Hospital Service, Centralized
% 207.86/208.06 |- mesh__dateCreated mesh__D002497 1977-05-19
% 207.86/208.06 |- skos__altLabel mesh__D002497 Hospital Services, Centralized
% 207.86/208.06 |- skos__broader mesh__D002497smesh__D006739
% 207.86/208.06 |- mesh__dateRevised mesh__D002497 1995-05-22
% 207.86/208.06 |- mesh__recordMaintainer mesh__D002497 KEV
% 207.86/208.06 |- skos__hiddenLabel mesh__D002497 Hospital Centralized Services
% 207.86/208.06 |- skos__hiddenLabel mesh__D002497 Centralized Hospital Service
% 207.86/208.06 |- skos__altLabel mesh__D002497 Centralized Services, Hospital
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D002497 2004
% 207.86/208.06 |- skos__scopeNote mesh__D002497
% 207.86/208.06 The coordination of services in one area of a facility to improve efficiency.%A%
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D002497 2002
% 207.86/208.06 |- skos__altLabel mesh__D002497 Services, Centralized Hospital
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D002497 2006
% 207.86/208.06 |- skos__hiddenLabel mesh__D002497 Services, Hospital Centralized
% 207.86/208.06 |- skos__hiddenLabel mesh__D002497 Hospital Centralized Service
% 207.86/208.06 |- mesh__activeMeSHYear mesh__D002497 2003
% 207.86/208.07 |- skos__prefLabel mesh__D002497 Centralized Hospital Services
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D002497 2001
% 207.86/208.07 |- mesh__historyNote mesh__D002497
% 207.86/208.07 91%28%Aug 77%29%; was see under HOSPITAL ADMINISTRATION 1977-90%A%
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D002497 2005
% 207.86/208.07 |- skos__annotation mesh__D002497
% 207.86/208.07 do not confuse with CENTRAL SUPPLY, HOSPITAL; DF: CENTRALIZED HOSP SERV%A%
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D002497 1997
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D002497 2000
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D002497 1999
% 207.86/208.07 |- skos__hiddenLabel mesh__D002497 Service, Hospital Centralized
% 207.86/208.07 |- skos__hiddenLabel mesh__D010929 Placental Development, Hemochorial
% 207.86/208.07 |- rdf__type mesh__D010929sskos__Concept
% 207.86/208.07 |- mesh__recordMaintainer mesh__D010929 lkt
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D010929 2005
% 207.86/208.07 |- skos__historyNote mesh__D010929 Placenta %28%1966-1974%29%
% 207.86/208.07 |- skos__altLabel mesh__D010929 Placental Development
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D010929 2006
% 207.86/208.07 |- mesh__onlineNote mesh__D010929 76; was see under PLACENTA 1975
% 207.86/208.07 |- skos__scopeNote mesh__D010929
% 207.86/208.07 The development of the PLACENTA, a highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products between mother and FETUS. The process begins at FERTILIZATION, through the development of CYTOTROPHOBLASTS and SYNCYTIOTROPHOBLASTS, the formation of CHORIONIC VILLI, to the progressive increase in BLOOD VESSELS to support the growing fetus.%A%
% 207.86/208.07 |- skos__annotation mesh__D010929 check the tags FEMALE %26% PREGNANCY
% 207.86/208.07 |- skos__prefLabel mesh__D010929 Placentation
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D010929 sjn
% 207.86/208.07 |- mesh__historyNote mesh__D010929
% 207.86/208.07 76%28%75%29%; was see under PLACENTA 1975
% 207.86/208.07 |- mesh__dateRevised mesh__D010929 2004-07-07
% 207.86/208.07 |- skos__broader mesh__D010929smesh__D011247
% 207.86/208.07 |- mesh__dateCreated mesh__D010929 1974-11-11
% 207.86/208.07 |- mesh__recordOriginator mesh__D010929 NLM
% 207.86/208.07 |- mesh__dateEstablished mesh__D010929 1976-01-01
% 207.86/208.07 |- skos__hiddenLabel mesh__D010929 Placentation, Hemochorial
% 207.86/208.07 |- skos__altLabel mesh__D010929 Hemochorial Placental Development
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007980 2006
% 207.86/208.07 |- mesh__onlineNote mesh__D007980 search DOPA 1972-74
% 207.86/208.07 |- skos__related mesh__D007980smesh__D004298
% 207.86/208.07 |- skos__altLabel mesh__D007980 Medphano Brand of Levodopa
% 207.86/208.07 |- skos__altLabel mesh__D007980 3-Hydroxy-L-tyrosine
% 207.86/208.07 |- mesh__dateCreated mesh__D007980 1999-01-01
% 207.86/208.07 |- skos__hiddenLabel mesh__D007980 3 Hydroxy L tyrosine
% 207.86/208.07 |- skos__hiddenLabel mesh__D007980 L Dopa
% 207.86/208.07 |- skos__altLabel mesh__D007980 L-3,4-Dihydroxyphenylalanine
% 207.86/208.07 |- mesh__dateRevised mesh__D007980 2005-06-30
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D007980 sjn
% 207.86/208.07 |- mesh__recordOriginator mesh__D007980 NLM
% 207.86/208.07 |- skos__hiddenLabel mesh__D007980 L 3,4 Dihydroxyphenylalanine
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D007980 75; was see DOPA 1972-74
% 207.86/208.07 |- skos__altLabel mesh__D007980 Roberts Brand of Levodopa
% 207.86/208.07 |- skos__altLabel mesh__D007980 L-Dopa
% 207.86/208.07 |- rdf__type mesh__D007980sskos__Concept
% 207.86/208.07 |- skos__scopeNote mesh__D007980
% 207.86/208.07 The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.%A%
% 207.86/208.07 |- skos__prefLabel mesh__D007980 Levodopa
% 207.86/208.07 |- mesh__recordMaintainer mesh__D007980 ssb
% 207.86/208.07 |- skos__altLabel mesh__D007980 Roche Brand of Levodopa
% 207.86/208.07 |- mesh__historyNote mesh__D007980 75; was see DOPA 1972-74
% 207.86/208.07 |- mesh__dateEstablished mesh__D007980 1975-01-01
% 207.86/208.07 |- skos__broader mesh__D007980smesh__D004295
% 207.86/208.07 |- skos__historyNote mesh__D007980 Dopa %28%1966-1974%29%
% 207.86/208.07 |- skos__scopeNote mesh__D007182
% 207.86/208.07 Revenues or receipts accruing from business enterprise, labor, or invested capital.%A%
% 207.86/208.07 |- skos__hiddenLabel mesh__D007182 Incomes
% 207.86/208.07 |- skos__annotation mesh__D007182
% 207.86/208.07 includes income from salaries, annuities, stocks, etc.; does not include fees charged by a professional %28% = FEES AND CHARGES%29%%A%
% 207.86/208.07 |- skos__prefLabel mesh__D007182 Income
% 207.86/208.07 |- skos__broader mesh__D007182smesh__D012959
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D007182 68
% 207.86/208.07 |- mesh__dateEstablished mesh__D007182 1968-01-01
% 207.86/208.07 |- mesh__recordOriginator mesh__D007182 NLM
% 207.86/208.07 |- mesh__recordMaintainer mesh__D007182 kle
% 207.86/208.07 |- mesh__dateCreated mesh__D007182 1999-01-01
% 207.86/208.07 |- skos__hiddenLabel mesh__D007182 Program, Income Generation
% 207.86/208.07 |- skos__hiddenLabel mesh__D007182 Income Generation Program
% 207.86/208.07 |- skos__hiddenLabel mesh__D007182 Distributions, Income
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007182 2004
% 207.86/208.07 |- mesh__dateRevised mesh__D007182 1999-11-03
% 207.86/208.07 |- skos__hiddenLabel mesh__D007182 Distribution, Income
% 207.86/208.07 |- mesh__historyNote mesh__D007182 68
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007182 2002
% 207.86/208.07 |- skos__related mesh__D007182smesh__D012456
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007182 2003
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007182 2006
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D007182 sjn
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007182 2001
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007182 2005
% 207.86/208.07 |- skos__hiddenLabel mesh__D007182 Income Distributions
% 207.86/208.07 |- rdf__type mesh__D007182sskos__Concept
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007182 2000
% 207.86/208.07 |- skos__hiddenLabel mesh__D007182 Programs, Income Generation
% 207.86/208.07 |- skos__historyNote mesh__D007182 Social Conditions %28%1966-1967%29%
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D015614 PLS
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 1997
% 207.86/208.07 |- skos__broader mesh__D015614smesh__D012158
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 2002
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 2005
% 207.86/208.07 |- mesh__recordMaintainer mesh__D015614 TGC
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D015614 90
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 1998
% 207.86/208.07 |- mesh__dateCreated mesh__D015614 1989-06-20
% 207.86/208.07 |- skos__scopeNote mesh__D015614
% 207.86/208.07 General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS CELL; and HISTIOCYTIC DISORDERS, MALIGNANT.%A%
% 207.86/208.07 |- skos__annotation mesh__D015614
% 207.86/208.07 %22%abnormal appearance of histiocytes in the blood%22% %28%usually in tissue%29%; GEN or unspecified only; prefer specifics; do not confuse with HISTIOCYTOSIS X see HISTIOCYTOSIS, LANGERHANS-CELL%A%
% 207.86/208.07 |- mesh__recordOriginator mesh__D015614 AGS
% 207.86/208.07 |- mesh__dateEstablished mesh__D015614 1990-01-01
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 2006
% 207.86/208.07 |- skos__hiddenLabel mesh__D015614 Histiocytoses
% 207.86/208.07 |- mesh__historyNote mesh__D015614 90
% 207.86/208.07 |- skos__prefLabel mesh__D015614 Histiocytosis
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 1999
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 1994
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 2000
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 2003
% 207.86/208.07 |- rdf__type mesh__D015614sskos__Concept
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 1995
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 1996
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 2001
% 207.86/208.07 |- mesh__dateRevised mesh__D015614 1993-06-02
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015614 2004
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D006888 2006
% 207.86/208.07 |- skos__broader mesh__D006888smesh__D002784
% 207.86/208.07 |- mesh__historyNote mesh__D006888
% 207.86/208.07 78; was HYDROXYCHOLESTEROL see under CHOLESTEROL 1973-77
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D006888 2005
% 207.86/208.07 |- mesh__dateRevised mesh__D006888 2003-07-09
% 207.86/208.07 |- skos__prefLabel mesh__D006888 Hydroxycholesterols
% 207.86/208.07 |- mesh__recordMaintainer mesh__D006888 ssb
% 207.86/208.07 |- skos__historyNote mesh__D006888 Cholesterol %28%1966-1977%29%
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D006888 sjn
% 207.86/208.07 |- mesh__onlineNote mesh__D006888
% 207.86/208.07 use HYDROXYCHOLESTEROLS to search HYDROXYCHOLESTEROL 1975-77; use CHOLESTEROL 1973-74%A%
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D006888
% 207.86/208.07 78; was HYDROXYCHOLESTEROL see under CHOLESTEROL 1973-77
% 207.86/208.07 |- mesh__recordOriginator mesh__D006888 NLM
% 207.86/208.07 |- rdf__type mesh__D006888sskos__Concept
% 207.86/208.07 |- mesh__dateCreated mesh__D006888 1999-01-01
% 207.86/208.07 |- mesh__dateEstablished mesh__D006888 1978-01-01
% 207.86/208.07 |- skos__scopeNote mesh__D006888
% 207.86/208.07 Cholesterol which is substituted by a hydroxy group in any position.%A%
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D006888 2004
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 G-Proteins, Small
% 207.86/208.07 |- skos__broader mesh__D020559smesh__D047908
% 207.86/208.07 |- mesh__dateCreated mesh__D020559 1999-11-03
% 207.86/208.07 |- skos__broader mesh__D020559smesh__D019204
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 GTP Binding Proteins, Monomeric
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 Monomeric G Proteins
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 GTPases, Small
% 207.86/208.07 |- skos__altLabel mesh__D020559 G-Proteins, Monomeric
% 207.86/208.07 |- mesh__historyNote mesh__D020559 2000
% 207.86/208.07 |- skos__altLabel mesh__D020559 GTP-Binding Proteins, Monomeric
% 207.86/208.07 |- skos__altLabel mesh__D020559 ras-Related G-Proteins
% 207.86/208.07 |- mesh__dateRevised mesh__D020559 2005-06-30
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 Monomeric GTP Binding Proteins
% 207.86/208.07 |- skos__historyNote mesh__D020559
% 207.86/208.07 Heterotrimeric GTP-Binding Proteins %28%1985-1996%29%
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D020559 sjn
% 207.86/208.07 |- rdf__type mesh__D020559sskos__Concept
% 207.86/208.07 |- mesh__dateEstablished mesh__D020559 2000-01-01
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 GTPases, ras-Related
% 207.86/208.07 |- skos__scopeNote mesh__D020559
% 207.86/208.07 A class of monomeric, low molecular weight %28%20-25 kDa%29% GTP-binding proteins that regulate a variety of intracellular processes. The GTP bound form of the protein is active and limited by its inherent GTPase activity, which is controlled by an array of GTPase activators, GDP dissociation inhibitors, and guanine nucleotide exchange factors. This enzyme was formerly listed as EC 3.6.1.47%A%
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 ras Related G Proteins
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 ras Related GTPases
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D020559 2006
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 Proteins, ras-Related GTP-Binding
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 GTP-Binding Proteins, ras-Related
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 G-Proteins, ras-Related
% 207.86/208.07 |- skos__altLabel mesh__D020559 ras-Related GTP-Binding Proteins
% 207.86/208.07 |- skos__altLabel mesh__D020559 Monomeric G-Proteins
% 207.86/208.07 |- mesh__recordMaintainer mesh__D020559 jmp
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D020559 2000
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 G Proteins, Monomeric
% 207.86/208.07 |- skos__altLabel mesh__D020559 Small GTPases
% 207.86/208.07 |- mesh__recordOriginator mesh__D020559 jmp
% 207.86/208.07 |- skos__prefLabel mesh__D020559 Monomeric GTP-Binding Proteins
% 207.86/208.07 |- skos__historyNote mesh__D020559 GTP-Binding Proteins %28%1997-1999%29%
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 Small G Proteins
% 207.86/208.07 |- skos__hiddenLabel mesh__D020559 ras Related GTP Binding Proteins
% 207.86/208.07 |- skos__altLabel mesh__D020559 Small G-Proteins
% 207.86/208.07 |- mesh__historyNote mesh__D031281 2003
% 207.86/208.07 |- rdf__type mesh__D031281sskos__Concept
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D031281 2004
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D031281 2003
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D031281 2005
% 207.86/208.07 |- skos__broader mesh__D031281smesh__D031263
% 207.86/208.07 |- skos__altLabel mesh__D031281 Sea Buckthorn
% 207.86/208.07 |- skos__prefLabel mesh__D031281 Hippophae
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D031281 2006
% 207.86/208.07 |- mesh__dateCreated mesh__D031281 2002-07-02
% 207.86/208.07 |- mesh__dateEstablished mesh__D031281 2003-01-01
% 207.86/208.07 |- skos__altLabel mesh__D031281 Fructus Hippophae
% 207.86/208.07 |- skos__altLabel mesh__D031281 Buckthorn, Sea
% 207.86/208.07 |- skos__scopeNote mesh__D031281
% 207.86/208.07 A plant genus of the family ELAEAGNACEAE. Linoleic %28%18:2n-6%29% and alpha-linolenic acids %28%18:3n-3%29% comprised about 70%25% of seed oil fatty acids. This is unrelated to %27%artificial sea buckthorn oil%27%.%A%
% 207.86/208.07 |- skos__annotation mesh__D031281
% 207.86/208.07 unrelated to %22%artificial sea buckthorn oil%22%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D031281 2003
% 207.86/208.07 |- skos__altLabel mesh__D019207 3M Brand of Betacarotene
% 207.86/208.07 |- skos__broader mesh__D019207smesh__D002338
% 207.86/208.07 |- skos__hiddenLabel mesh__D019207 Betacarotene Merck Brand
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D019207
% 207.86/208.07 97; BETA-CAROTENE was indexed under CAROTENE 1980-96
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D019207 2006
% 207.86/208.07 |- skos__hiddenLabel mesh__D019207 Betacarotene Hermal Brand
% 207.86/208.07 |- rdf__type mesh__D019207sskos__Concept
% 207.86/208.07 |- skos__hiddenLabel mesh__D019207 Betacarotene Solgar Brand
% 207.86/208.07 |- skos__scopeNote mesh__D019207
% 207.86/208.07 A carotenoid that is a precursor of VITAMIN A. It is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria %28%PORPHYRIA, ERYTHROPOIETIC%29%. %28%From Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Engewood, CO, 1995.%29%%A%
% 207.86/208.07 |- skos__altLabel mesh__D019207 beta-Carotene
% 207.86/208.07 |- mesh__historyNote mesh__D019207
% 207.86/208.07 97; was BETA-CAROTENE %28%NM%29% 1980-96
% 207.86/208.07 |- skos__prefLabel mesh__D019207 beta Carotene
% 207.86/208.07 |- skos__altLabel mesh__D019207 Merck Brand of Betacarotene
% 207.86/208.07 |- skos__hiddenLabel mesh__D019207 MaxCaro
% 207.86/208.07 |- skos__altLabel mesh__D019207 Hermal Brand of Betacarotene
% 207.86/208.07 |- skos__hiddenLabel mesh__D019207 Betacarotene 3M Brand
% 207.86/208.07 |- skos__hiddenLabel mesh__D019207 Max Caro
% 207.86/208.07 |- skos__altLabel mesh__D019207 Marlyn Brand of Betacarotene
% 207.86/208.07 |- skos__historyNote mesh__D019207 Carotene %28%1980-1996%29%
% 207.86/208.07 |- mesh__recordMaintainer mesh__D019207 ssb
% 207.86/208.07 |- mesh__recordOriginator mesh__D019207 TPW
% 207.86/208.07 |- mesh__dateRevised mesh__D019207 2005-06-30
% 207.86/208.07 |- skos__altLabel mesh__D019207 Solgar Brand of Betacarotene
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D019207 sjn
% 207.86/208.07 |- skos__altLabel mesh__D019207 Roche Brand of Betacarotene
% 207.86/208.07 |- mesh__onlineNote mesh__D019207
% 207.86/208.07 use BETA CAROTENE %28%NM%29% to search BETA-CAROTENE 1980-96
% 207.86/208.07 |- skos__altLabel mesh__D019207 Betacarotene
% 207.86/208.07 |- mesh__dateEstablished mesh__D019207 1997-01-01
% 207.86/208.07 |- skos__hiddenLabel mesh__D019207 Betacarotene Marlyn Brand
% 207.86/208.07 |- mesh__dateCreated mesh__D019207 1996-06-10
% 207.86/208.07 |- skos__hiddenLabel mesh__D019207 Carotene, beta
% 207.86/208.07 |- skos__hiddenLabel mesh__D019207 Betacarotene Roche Brand
% 207.86/208.07 |- mesh__recordOriginator mesh__D011224 SH
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D011224 2005
% 207.86/208.07 |- mesh__dateEstablished mesh__D011224 1986-01-01
% 207.86/208.07 |- skos__historyNote mesh__D011224 Piperazines %28%1974-1976%29%
% 207.86/208.07 |- mesh__dateCreated mesh__D011224 1976-04-13
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D011224
% 207.86/208.07 86; was see under QUINAZOLINES 1977-85
% 207.86/208.07 |- rdf__type mesh__D011224sskos__Concept
% 207.86/208.07 |- skos__broader mesh__D011224smesh__D011799
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D011224 2004
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D011224 sjn
% 207.86/208.07 |- skos__scopeNote mesh__D011224
% 207.86/208.07 A selective adrenergic alpha-1 antagonist used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud%27%s syndrome, prostatic hypertrophy, and urinary retention.%A%
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D011224 2003
% 207.86/208.07 |- mesh__recordMaintainer mesh__D011224 TWD
% 207.86/208.07 |- skos__altLabel mesh__D011224 Furazosin
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D011224 2002
% 207.86/208.07 |- skos__prefLabel mesh__D011224 Prazosin
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D011224 2001
% 207.86/208.07 |- mesh__historyNote mesh__D011224
% 207.86/208.07 86%28%77%29%; was see under QUINAZOLINES 1977-85
% 207.86/208.07 |- skos__historyNote mesh__D011224 Quinazolines %28%1974-1976%29%
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D011224 2006
% 207.86/208.07 |- mesh__dateRevised mesh__D011224 2000-06-22
% 207.86/208.07 |- mesh__historyNote mesh__D049692 2005
% 207.86/208.07 |- mesh__recordMaintainer mesh__D049692 jls
% 207.86/208.07 |- skos__hiddenLabel mesh__D049692 Modern Histories, Early %28%Medicine%29%
% 207.86/208.07 |- mesh__dateCreated mesh__D049692 2004-07-07
% 207.86/208.07 |- skos__hiddenLabel mesh__D049692 Early Modern Histories %28%Medicine%29%
% 207.86/208.07 |- skos__altLabel mesh__D049692 Early Modern History of Medicine
% 207.86/208.07 |- skos__prefLabel mesh__D049692 History, Early Modern 1451-1600
% 207.86/208.07 |- skos__scopeNote mesh__D049692
% 207.86/208.07 The period of history from 1451 through 1600 of the common era.%A%
% 207.86/208.07 |- mesh__recordOriginator mesh__D049692 jls
% 207.86/208.07 |- skos__hiddenLabel mesh__D049692 Modern History, Early %28%Medicine%29%
% 207.86/208.07 |- skos__annotation mesh__D049692 not used for indexing
% 207.86/208.07 |- skos__hiddenLabel mesh__D049692 Modern Medicine, Early
% 207.86/208.07 |- skos__hiddenLabel mesh__D049692 History, Early Modern 1451 1600
% 207.86/208.07 |- skos__hiddenLabel mesh__D049692 Modern History, Early
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D049692 2005
% 207.86/208.07 |- skos__hiddenLabel mesh__D049692 History, Early Modern %28%Medicine%29%
% 207.86/208.07 |- skos__altLabel mesh__D049692 Early Modern History
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D049692 sjn
% 207.86/208.07 |- skos__altLabel mesh__D049692 History, Early Modern
% 207.86/208.07 |- skos__hiddenLabel mesh__D049692 Histories, Early Modern %28%Medicine%29%
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D049692 2006
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D049692
% 207.86/208.07 2005; for HISTORY OF MEDICINE, EARLY MODERN see HISTORY OF MEDICINE, EARLY MODERN 1995-2004%A%
% 207.86/208.07 |- rdf__type mesh__D049692sskos__Concept
% 207.86/208.07 |- skos__altLabel mesh__D049692 Early Modern History %28%Medicine%29%
% 207.86/208.07 |- mesh__dateEstablished mesh__D049692 2005-01-01
% 207.86/208.07 |- skos__broader mesh__D049692smesh__D006664
% 207.86/208.07 |- skos__altLabel mesh__D049692 Medicine, Early Modern
% 207.86/208.07 |- skos__annotation mesh__D002498
% 207.86/208.07 as a lab technique %26% to simulate gravitational eff in space; NIM%A%
% 207.86/208.07 |- skos__related mesh__D002498smesh__D018471
% 207.86/208.07 |- skos__scopeNote mesh__D002498
% 207.86/208.07 Process of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. %28%From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 207.86/208.07 |- rdf__type mesh__D002498sskos__Concept
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D002498 sjn
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D002498 2005
% 207.86/208.07 |- mesh__recordMaintainer mesh__D002498 sjn
% 207.86/208.07 |- mesh__dateCreated mesh__D002498 1999-01-01
% 207.86/208.07 |- mesh__dateRevised mesh__D002498 2004-07-13
% 207.86/208.07 |- skos__related mesh__D002498smesh__D018470
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D002498 2006
% 207.86/208.07 |- skos__broader mesh__D002498smesh__D008919
% 207.86/208.07 |- skos__prefLabel mesh__D002498 Centrifugation
% 207.86/208.07 |- skos__related mesh__D002498smesh__D014461
% 207.86/208.07 |- mesh__recordOriginator mesh__D002498 NLM
% 207.86/208.07 |- skos__hiddenLabel mesh__D007981 LevoDromoran
% 207.86/208.07 |- mesh__dateRevised mesh__D007981 2004-07-07
% 207.86/208.07 |- rdf__type mesh__D007981sskos__Concept
% 207.86/208.07 |- skos__hiddenLabel mesh__D007981 L Dromoran
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D007981
% 207.86/208.07 65; was LEVORPHAN see under MORPHINE 1963-64
% 207.86/208.07 |- skos__hiddenLabel mesh__D007981 Levo Dromoran
% 207.86/208.07 |- skos__hiddenLabel mesh__D007981 Tartrate, Levorphanol
% 207.86/208.07 |- skos__prefLabel mesh__D007981 Levorphanol
% 207.86/208.07 |- skos__altLabel mesh__D007981 Levodroman
% 207.86/208.07 |- skos__scopeNote mesh__D007981
% 207.86/208.07 A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection.%A%
% 207.86/208.07 |- skos__altLabel mesh__D007981 ICN Brand of Levorphanol Tartrate
% 207.86/208.07 |- skos__broader mesh__D007981smesh__D009019
% 207.86/208.07 |- skos__altLabel mesh__D007981 Levorphan
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007981 2006
% 207.86/208.07 |- skos__hiddenLabel mesh__D007981 3 Hydroxy N methylmorphinan
% 207.86/208.07 |- mesh__historyNote mesh__D007981
% 207.86/208.07 65; was LEVORPHAN see under MORPHINE 1963-64
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D007981 sjn
% 207.86/208.07 |- mesh__recordOriginator mesh__D007981 NLM
% 207.86/208.07 |- mesh__dateEstablished mesh__D007981 1965-01-01
% 207.86/208.07 |- mesh__dateCreated mesh__D007981 1999-01-01
% 207.86/208.07 |- mesh__recordMaintainer mesh__D007981 CCR
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007981 2005
% 207.86/208.07 |- mesh__dateRevised mesh__D007183 1999-11-03
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D007183 sjn
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007183 2001
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007183 2003
% 207.86/208.07 |- skos__prefLabel mesh__D007183 Income Tax
% 207.86/208.07 |- skos__hiddenLabel mesh__D007183 Tax, Income
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007183 2005
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007183 2004
% 207.86/208.07 |- skos__scopeNote mesh__D007183
% 207.86/208.07 Tax on the net income of an individual, organization, or business.%A%
% 207.86/208.07 |- skos__hiddenLabel mesh__D007183 Taxes, Income
% 207.86/208.07 |- mesh__recordOriginator mesh__D007183 NLM
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007183 2002
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007183 2006
% 207.86/208.07 |- mesh__recordMaintainer mesh__D007183 kle
% 207.86/208.07 |- skos__annotation mesh__D007183 IM; specify geog
% 207.86/208.07 |- skos__altLabel mesh__D007183 Income Taxes
% 207.86/208.07 |- mesh__dateCreated mesh__D007183 1999-01-01
% 207.86/208.07 |- rdf__type mesh__D007183sskos__Concept
% 207.86/208.07 |- skos__broader mesh__D007183smesh__D013660
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D007183 2000
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015615 2005
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D015615 90
% 207.86/208.07 |- skos__broader mesh__D015615smesh__D015619
% 207.86/208.07 |- skos__broader mesh__D015615smesh__D008171
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015615 2001
% 207.86/208.07 |- mesh__dateEstablished mesh__D015615 1990-01-01
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015615 2006
% 207.86/208.07 |- skos__prefLabel mesh__D015615
% 207.86/208.07 Cystic Adenomatoid Malformation of Lung, Congenital
% 207.86/208.07 |- mesh__recordMaintainer mesh__D015615 kle
% 207.86/208.07 |- skos__historyNote mesh__D015615 Lung/abnormalities %28%1966-1989%29%
% 207.86/208.07 |- skos__annotation mesh__D015615
% 207.86/208.07 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: CCAM%A%
% 207.86/208.07 |- mesh__recordOriginator mesh__D015615 PXP
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015615 2002
% 207.86/208.07 |- rdf__type mesh__D015615sskos__Concept
% 207.86/208.07 |- skos__altLabel mesh__D015615
% 207.86/208.07 Lung Malformation, Cystic Adenomatoid, Congenital
% 207.86/208.07 |- mesh__dateCreated mesh__D015615 1989-04-07
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015615 2003
% 207.86/208.07 |- skos__scopeNote mesh__D015615
% 207.86/208.07 A developmental anomaly that usually becomes apparent in the neonatal period with progressive respiratory distress. This malformation is a focal pulmonary dysplasia characterized by a multicystic mass of terminal bronchiolar structures. CCAM is classified into 3 separate types %28%I, II, III%29% depending on cyst size.%A%
% 207.86/208.07 |- mesh__historyNote mesh__D015615 90
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D015615 sjn
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015615 2004
% 207.86/208.07 |- skos__altLabel mesh__D015615
% 207.86/208.07 Congenital Cystic Adenomatoid Malformation of Lung
% 207.86/208.07 |- mesh__dateRevised mesh__D015615 1999-11-03
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D015615 2000
% 207.86/208.07 |- skos__altLabel mesh__D015615 Cystic Adenomatoid Malformation of Lung
% 207.86/208.07 |- skos__altLabel mesh__D015615
% 207.86/208.07 Lung Malformation, Congenital Cystic Adenomatoid
% 207.86/208.07 |- mesh__recordOriginator mesh__D006889 NLM
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D006889 2005
% 207.86/208.07 |- skos__historyNote mesh__D006889 Glucocorticoids %28%1967-1971%29%
% 207.86/208.07 |- mesh__dateRevised mesh__D006889 2003-07-09
% 207.86/208.07 |- skos__historyNote mesh__D006889 Mineralocorticoids %28%1967-1971%29%
% 207.86/208.07 |- mesh__historyNote mesh__D006889 73%28%72%29%
% 207.86/208.07 |- skos__scopeNote mesh__D006889
% 207.86/208.07 A group of corticosteroids carrying hydroxy groups, usually in the 11- or 17-positions. They comprise the bulk of the corticosteroids used systemically. As they are relatively insoluble in water, salts of various esterified forms are often used for injections or solutions.%A%
% 207.86/208.07 |- skos__historyNote mesh__D006889
% 207.86/208.07 Adrenal Cortex Hormones %28%1966-1971%29%
% 207.86/208.07 |- mesh__recordMaintainer mesh__D006889 ssb
% 207.86/208.07 |- mesh__dateEstablished mesh__D006889 1973-01-01
% 207.86/208.07 |- mesh__dateCreated mesh__D006889 1999-01-01
% 207.86/208.07 |- rdf__type mesh__D006889sskos__Concept
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D006889 2004
% 207.86/208.07 |- mesh__recordAuthorizer mesh__D006889 sjn
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D006889 2006
% 207.86/208.07 |- skos__broader mesh__D006889smesh__D000305
% 207.86/208.07 |- skos__prefLabel mesh__D006889 Hydroxycorticosteroids
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D006889 73
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D031282 2003
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D031282 2005
% 207.86/208.07 |- mesh__historyNote mesh__D031282 2003
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D031282 2006
% 207.86/208.07 |- mesh__dateCreated mesh__D031282 2002-07-03
% 207.86/208.07 |- skos__annotation mesh__D031282
% 207.86/208.07 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.07 |- skos__scopeNote mesh__D031282
% 207.86/208.07 A plant genus of the family ERICACEAE. The common name of %22%wintergreen%22% is also used for PYROLA and %22%snowberry%22% is also used for SYMPHORICARPOS.%A%
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D031282 2003
% 207.86/208.07 |- skos__prefLabel mesh__D031282 Gaultheria
% 207.86/208.07 |- mesh__dateEstablished mesh__D031282 2003-01-01
% 207.86/208.07 |- rdf__type mesh__D031282sskos__Concept
% 207.86/208.07 |- skos__broader mesh__D031282smesh__D029791
% 207.86/208.07 |- mesh__activeMeSHYear mesh__D031282 2004
% 207.86/208.07 |- rdf__type mesh__D019208sskos__Concept
% 207.86/208.07 |- mesh__publicMeSHNote mesh__D019208
% 207.86/208.07 97; BRAIN-DERIVED NEUROTROPHIC FACTOR was indexed under NERVE TISSUE PROTEINS 1986-96%A%
% 207.86/208.07 |- skos__hiddenLabel mesh__D019208 Factor, Brain-Derived Neurotrophic
% 207.86/208.07 |- mesh__historyNote mesh__D019208
% 207.86/208.07 97; was BRAIN-DERIVED NEUROTROPHIC FACTOR 1986-96
% 207.86/208.07 |- mesh__dateEstablished mesh__D019208 1997-01-01
% 207.86/208.07 |- mesh__dateCreated mesh__D019208 1996-06-10
% 207.86/208.07 |- skos__annotation mesh__D019208
% 207.86/208.07 a nerve growth factor; DF: note short X ref
% 207.86/208.07 |- skos__broader mesh__D019208smesh__D009414
% 207.86/208.07 |- mesh__onlineNote mesh__D019208
% 207.86/208.07 use BRAIN-DERIVED NEUROTROPHIC FACTOR %28%NM%29% to search BRAIN-DERIVED NEUROTROPHIC FACTOR 1986-96%A%
% 207.86/208.07 |- mesh__recordMaintainer mesh__D019208 ssb
% 207.86/208.08 |- mesh__recordOriginator mesh__D019208 TPW
% 207.86/208.08 |- skos__scopeNote mesh__D019208
% 207.86/208.08 A member of the nerve growth factor family of trophic factors. In the brain BDNF has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. %28%From Kendrew, The Encyclopedia of Molecular Biology, 1994%29%%A%
% 207.86/208.08 |- skos__hiddenLabel mesh__D019208 Brain Derived Neurotrophic Factor
% 207.86/208.08 |- mesh__dateRevised mesh__D019208 2005-06-30
% 207.86/208.08 |- skos__prefLabel mesh__D019208 Brain-Derived Neurotrophic Factor
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D019208 sjn
% 207.86/208.08 |- skos__hiddenLabel mesh__D019208 Neurotrophic Factor, Brain-Derived
% 207.86/208.08 |- skos__historyNote mesh__D019208 Nerve Tissue Proteins %28%1986-1996%29%
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D019208 2006
% 207.86/208.08 |- skos__altLabel mesh__D019208 BDNF
% 207.86/208.08 |- skos__broader mesh__D011225smesh__D046110
% 207.86/208.08 |- skos__altLabel mesh__D011225 EPH Complex
% 207.86/208.08 |- mesh__recordOriginator mesh__D011225 NLM
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Proteinuria Edema Hypertension Gestosis
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 EPH Toxemia
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Gestosis, Proteinuria-Edema-Hypertension
% 207.86/208.08 |- mesh__recordMaintainer mesh__D011225 lkt
% 207.86/208.08 |- skos__historyNote mesh__D011225 Pregnancy Toxemias %28%1966-1974%29%
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D011225
% 207.86/208.08 1979; see PREGNANCY TOXEMIAS 1963-1978; for PREGNANCY TOXEMIAS see PREGNANCY TOXEMIAS 1963-2004; for EDEMA-PROTEINURIA-HYPERTENSION GESTOSIS see GESTOSIS, EPH 1989-2004%A%
% 207.86/208.08 |- skos__altLabel mesh__D011225 Preeclampsia
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Toxemia, EPH
% 207.86/208.08 |- skos__altLabel mesh__D011225 Proteinuria-Edema-Hypertension Gestosis
% 207.86/208.08 |- mesh__dateCreated mesh__D011225 1999-01-01
% 207.86/208.08 |- skos__altLabel mesh__D011225 Edema-Proteinuria-Hypertension Gestosis
% 207.86/208.08 |- skos__altLabel mesh__D011225 Pregnancy Toxemias
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D011225 sjn
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Edema Proteinuria Hypertension Gestosis
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Hypertension Edema Proteinuria Gestosis
% 207.86/208.08 |- skos__altLabel mesh__D011225 Hypertension-Edema-Proteinuria Gestosis
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Toxemias, EPH
% 207.86/208.08 |- skos__related mesh__D011225smesh__D014115
% 207.86/208.08 |- skos__altLabel mesh__D011225 EPH Gestosis
% 207.86/208.08 |- mesh__dateRevised mesh__D011225 2005-06-30
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Pregnancy Toxemia
% 207.86/208.08 |- mesh__historyNote mesh__D011225 1979%28%1963%29%
% 207.86/208.08 |- skos__prefLabel mesh__D011225 Pre-Eclampsia
% 207.86/208.08 |- skos__altLabel mesh__D011225 Toxemias, Pregnancy
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011225 2006
% 207.86/208.08 |- mesh__dateEstablished mesh__D011225 1979-01-01
% 207.86/208.08 |- rdf__type mesh__D011225sskos__Concept
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Pre Eclampsia
% 207.86/208.08 |- skos__scopeNote mesh__D011225
% 207.86/208.08 A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.%A%
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Toxemia, Pregnancy
% 207.86/208.08 |- skos__altLabel mesh__D011225 EPH Toxemias
% 207.86/208.08 |- skos__annotation mesh__D011225 check tags FEMALE %26% PREGNANCY
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Gestosis, Hypertension-Edema-Proteinuria
% 207.86/208.08 |- skos__altLabel mesh__D011225 Gestosis, EPH
% 207.86/208.08 |- skos__hiddenLabel mesh__D011225 Gestosis, Edema-Proteinuria-Hypertension
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D002499 2003
% 207.86/208.08 |- mesh__recordOriginator mesh__D002499 NLM
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D002499 2005
% 207.86/208.08 |- skos__broader mesh__D002499smesh__D014461
% 207.86/208.08 |- mesh__dateCreated mesh__D002499 1999-01-01
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D002499 2004
% 207.86/208.08 |- skos__hiddenLabel mesh__D002499 Density Gradient Centrifugations
% 207.86/208.08 |- skos__hiddenLabel mesh__D002499 Density Gradient Centrifugation
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D002499 2006
% 207.86/208.08 |- mesh__historyNote mesh__D002499 68%28%66%29%
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D002499 sjn
% 207.86/208.08 |- mesh__dateEstablished mesh__D002499 1968-01-01
% 207.86/208.08 |- skos__hiddenLabel mesh__D002499 Centrifugations, Density Gradient
% 207.86/208.08 |- skos__scopeNote mesh__D002499
% 207.86/208.08 Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 207.86/208.08 |- skos__annotation mesh__D002499
% 207.86/208.08 a type of ultracentrif; NIM; index sucrose density gradient centrif here but ignore SUCROSE%A%
% 207.86/208.08 |- skos__hiddenLabel mesh__D002499 Gradient Centrifugation, Density
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D002499 68
% 207.86/208.08 |- skos__prefLabel mesh__D002499 Centrifugation, Density Gradient
% 207.86/208.08 |- mesh__dateRevised mesh__D002499 2002-07-03
% 207.86/208.08 |- mesh__recordMaintainer mesh__D002499 lkt
% 207.86/208.08 |- rdf__type mesh__D002499sskos__Concept
% 207.86/208.08 |- skos__hiddenLabel mesh__D002499 Gradient Centrifugations, Density
% 207.86/208.08 |- rdf__type mesh__D007982sskos__Concept
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 2001
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 1998
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 1997
% 207.86/208.08 |- mesh__recordMaintainer mesh__D007982 KEV
% 207.86/208.08 |- skos__broader mesh__D007982smesh__D007651
% 207.86/208.08 |- mesh__dateRevised mesh__D007982 1995-05-18
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D007982 PLS
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 1996
% 207.86/208.08 |- skos__scopeNote mesh__D007982
% 207.86/208.08 Keto acids that are derivatives of 4-oxopentanoic acids %28%levulinic acid%29%.%A%
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 2000
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 2006
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 2005
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 2004
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D007982 75; was LEVULINIC ACID 1963-74
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 2002
% 207.86/208.08 |- mesh__onlineNote mesh__D007982
% 207.86/208.08 use LEVULINIC ACIDS to search LEVULINIC ACID 1966-74
% 207.86/208.08 |- mesh__dateCreated mesh__D007982 1999-01-01
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 2003
% 207.86/208.08 |- mesh__historyNote mesh__D007982 75; was LEVULINIC ACID 1963-74
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007982 1999
% 207.86/208.08 |- skos__hiddenLabel mesh__D007982 Acids, Levulinic
% 207.86/208.08 |- skos__prefLabel mesh__D007982 Levulinic Acids
% 207.86/208.08 |- mesh__recordOriginator mesh__D007982 NLM
% 207.86/208.08 |- skos__altLabel mesh__D007184 Bloch-Sulzberger Syndrome
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007184 2005
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007184 2004
% 207.86/208.08 |- skos__prefLabel mesh__D007184 Incontinentia Pigmenti
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D007184
% 207.86/208.08 91; was see under PIGMENTATION DISORDERS 1987-90
% 207.86/208.08 |- skos__annotation mesh__D007184
% 207.86/208.08 multiple skin %26% other abnorm; do not confuse with INCONTINENTIA PIGMENTI ACHROMIANS see PIGMENTATION DISORDERS%A%
% 207.86/208.08 |- mesh__dateCreated mesh__D007184 1986-04-03
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D007184 sjn
% 207.86/208.08 |- skos__scopeNote mesh__D007184
% 207.86/208.08 A genodermatosis occurring mostly in females and characterized by skin changes in three phases - vesiculobullous, verrucous papillomatous, and macular melanodermic. Hyperpigmentation is bizarre and irregular. Sixty percent of patients have abnormalities of eyes, teeth, central nervous system, and skin appendages.%A%
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007184 2006
% 207.86/208.08 |- mesh__dateEstablished mesh__D007184 1991-01-01
% 207.86/208.08 |- mesh__historyNote mesh__D007184
% 207.86/208.08 91%28%87%29%; was see under PIGMENTATION DISORDERS 1987-90
% 207.86/208.08 |- mesh__recordMaintainer mesh__D007184 nns
% 207.86/208.08 |- skos__broader mesh__D007184smesh__D012873
% 207.86/208.08 |- skos__hiddenLabel mesh__D007184 Syndrome, Bloch-Sulzberger
% 207.86/208.08 |- skos__hiddenLabel mesh__D007184 Bloch Sulzberger Syndrome
% 207.86/208.08 |- rdf__type mesh__D007184sskos__Concept
% 207.86/208.08 |- mesh__dateRevised mesh__D007184 2001-07-25
% 207.86/208.08 |- skos__broader mesh__D007184smesh__D000015
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007184 2002
% 207.86/208.08 |- skos__historyNote mesh__D007184 Pigmentation Disorders %28%1966-1986%29%
% 207.86/208.08 |- skos__broader mesh__D007184smesh__D010859
% 207.86/208.08 |- mesh__recordOriginator mesh__D007184 RC
% 207.86/208.08 |- skos__broader mesh__D007184smesh__D012868
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007184 2003
% 207.86/208.08 |- skos__hiddenLabel mesh__D015616 Non-Langerhans-Cell Histiocytosis
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D015616 sjn
% 207.86/208.08 |- skos__hiddenLabel mesh__D015616 Reticulohistiocytomas
% 207.86/208.08 |- skos__broader mesh__D015616smesh__D015614
% 207.86/208.08 |- mesh__dateEstablished mesh__D015616 1990-01-01
% 207.86/208.08 |- skos__scopeNote mesh__D015616
% 207.86/208.08 Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma; JUVENILE XANTHOGRANULOMA; xanthoma disseminatum; as well as the lipid storage diseases %28%SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES%29%.%A%
% 207.86/208.08 |- mesh__dateCreated mesh__D015616 1989-04-07
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D015616 90
% 207.86/208.08 |- mesh__recordOriginator mesh__D015616 AGS
% 207.86/208.08 |- skos__annotation mesh__D015616
% 207.86/208.08 general or unspecified; prefer specifics
% 207.86/208.08 |- skos__prefLabel mesh__D015616 Histiocytosis, Non-Langerhans-Cell
% 207.86/208.08 |- skos__historyNote mesh__D015616 Reticuloendotheliosis %28%1966-1989%29%
% 207.86/208.08 |- mesh__dateRevised mesh__D015616 2005-06-30
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D015616 2006
% 207.86/208.08 |- mesh__historyNote mesh__D015616 90
% 207.86/208.08 |- skos__hiddenLabel mesh__D015616 Histiocytosis, Non Langerhans Cell
% 207.86/208.08 |- skos__hiddenLabel mesh__D015616 Disseminatum, Xanthoma
% 207.86/208.08 |- rdf__type mesh__D015616sskos__Concept
% 207.86/208.08 |- mesh__recordMaintainer mesh__D015616 ags
% 207.86/208.08 |- mesh__dateEstablished mesh__D031283 2003-01-01
% 207.86/208.08 |- skos__altLabel mesh__D031283 Du-zhong
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D031283 2003
% 207.86/208.08 |- skos__broader mesh__D031283smesh__D019684
% 207.86/208.08 |- rdf__type mesh__D031283sskos__Concept
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D031283 2004
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D031283 2003
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D031283 2005
% 207.86/208.08 |- mesh__historyNote mesh__D031283 2003
% 207.86/208.08 |- skos__scopeNote mesh__D031283
% 207.86/208.08 A plant family of the order Eucommiales, subclass Hamamelidae, class Magnoliopsida %28%some botanists have classified this in the order Hamamelidales or Urticales%29%. Eucomia is an elmlike tree of central and eastern China. Leaves are alternate; deciduous flowers are solitary and unisexual and lack petals and sepals. The male flowers have 6 to 10 stamens and female flowers have one ovary of two carpels, one of which aborts during development so the fruit %28%a dry, winged structure%29% contains only one seed. The latex is a source of RUBBER. Tochu tea is an aqueous extract of Eucommia ulmoides leaves and a popular beverage in Japan. %28%Mutat Res 1997 Jan 15;388%28%1%29%:7-20%29%.%A%
% 207.86/208.08 |- mesh__dateCreated mesh__D031283 2002-07-03
% 207.86/208.08 |- skos__prefLabel mesh__D031283 Eucommiaceae
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D031283 2006
% 207.86/208.08 |- skos__annotation mesh__D031283
% 207.86/208.08 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.08 |- skos__scopeNote mesh__D003592
% 207.86/208.08 A method for the study of certain organic compounds within cells, in situ, by measuring the light intensities of the selectively stained areas of cytoplasm. The compounds studied and their locations in the cells are made to fluoresce and are observed under a microscope.%A%
% 207.86/208.08 |- rdf__type mesh__D003592sskos__Concept
% 207.86/208.08 |- skos__historyNote mesh__D003592 Flow Cytometry %28%1982-1985%29%
% 207.86/208.08 |- skos__hiddenLabel mesh__D003592 Microfluorometries
% 207.86/208.08 |- skos__broader mesh__D003592smesh__D003584
% 207.86/208.08 |- mesh__recordMaintainer mesh__D003592 ssb
% 207.86/208.08 |- skos__hiddenLabel mesh__D003592 Cytophotometries
% 207.86/208.08 |- skos__broader mesh__D003592smesh__D005470
% 207.86/208.08 |- skos__altLabel mesh__D003592 Microfluorometry
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D003592 86
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D003592 2005
% 207.86/208.08 |- skos__historyNote mesh__D003592 Photometry %28%1966-1985%29%
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D003592 2006
% 207.86/208.08 |- mesh__recordOriginator mesh__D003592 SH
% 207.86/208.08 |- mesh__dateCreated mesh__D003592 1985-02-28
% 207.86/208.08 |- mesh__dateRevised mesh__D003592 2004-07-07
% 207.86/208.08 |- skos__prefLabel mesh__D003592 Cytophotometry
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D003592 sjn
% 207.86/208.08 |- mesh__dateEstablished mesh__D003592 1986-01-01
% 207.86/208.08 |- mesh__historyNote mesh__D003592 86
% 207.86/208.08 |- mesh__historyNote mesh__D019209 97; was TROPONIN C %28%NM%29% 1975-96
% 207.86/208.08 |- mesh__dateRevised mesh__D019209 2005-06-30
% 207.86/208.08 |- skos__historyNote mesh__D019209 Troponin %28%1980-1996%29%
% 207.86/208.08 |- skos__broader mesh__D019209smesh__D002135
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D019209 sjn
% 207.86/208.08 |- mesh__recordMaintainer mesh__D019209 DRC
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D019209
% 207.86/208.08 97; TROPONIN C was indexed under TROPONIN 1980-96 %26% MUSCLE PROTEINS 1975-79%A%
% 207.86/208.08 |- mesh__onlineNote mesh__D019209
% 207.86/208.08 use TROPONIN C %28%NM%29% to search TROPONIN C 1980-96
% 207.86/208.08 |- skos__scopeNote mesh__D019209
% 207.86/208.08 One of the three polypeptide chains that make up the TROPONIN complex of skeletal muscle. It is a calcium-binding protein.%A%
% 207.86/208.08 |- skos__altLabel mesh__D019209 Troponin-C
% 207.86/208.08 |- mesh__dateEstablished mesh__D019209 1997-01-01
% 207.86/208.08 |- skos__broader mesh__D019209smesh__D014336
% 207.86/208.08 |- skos__annotation mesh__D019209
% 207.86/208.08 TROPONIN I %26% TROPONIN T are also available
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D019209 2006
% 207.86/208.08 |- mesh__dateCreated mesh__D019209 1996-06-10
% 207.86/208.08 |- rdf__type mesh__D019209sskos__Concept
% 207.86/208.08 |- skos__prefLabel mesh__D019209 Troponin C
% 207.86/208.08 |- mesh__recordOriginator mesh__D019209 TPW
% 207.86/208.08 |- skos__historyNote mesh__D019209 Muscle Proteins %28%1975-1979%29%
% 207.86/208.08 |- mesh__recordMaintainer mesh__D011226 ags
% 207.86/208.08 |- skos__historyNote mesh__D011226 Arrhythmia %28%1966-1985%29%
% 207.86/208.08 |- mesh__recordOriginator mesh__D011226 VDK
% 207.86/208.08 |- skos__historyNote mesh__D011226 Tachycardia %28%1966-1985%29%
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011226 2002
% 207.86/208.08 |- skos__hiddenLabel mesh__D011226 Pre-Excitation Syndrome
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D011226 86
% 207.86/208.08 |- skos__hiddenLabel mesh__D011226 Pre Excitation Syndromes
% 207.86/208.08 |- mesh__dateRevised mesh__D011226 2005-07-27
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011226 2006
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011226 2001
% 207.86/208.08 |- skos__hiddenLabel mesh__D011226 Syndromes, Pre-Excitation
% 207.86/208.08 |- skos__broader mesh__D011226smesh__D001145
% 207.86/208.08 |- skos__scopeNote mesh__D011226
% 207.86/208.08 Conditions characterized by activation of the whole or some part of the ventricle by the atrial impulse earlier than would be expected if the impulse reached the ventricle by way of the normal specific conduction system only.%A%
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011226 2005
% 207.86/208.08 |- mesh__dateEstablished mesh__D011226 1986-01-01
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011226 2000
% 207.86/208.08 |- skos__historyNote mesh__D011226
% 207.86/208.08 Heart Conduction System %28%1966-1985%29%
% 207.86/208.08 |- rdf__type mesh__D011226sskos__Concept
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011226 2004
% 207.86/208.08 |- mesh__historyNote mesh__D011226 86
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011226 2006A
% 207.86/208.08 |- skos__annotation mesh__D011226
% 207.86/208.08 GEN: prefer specifics; long QT = LONG QT SYNDROME; normal PR-long QRS = PRE-EXCITATION, MAHAIM-TYPE; short PR-normal QRS = LOWN-GANONG-LEVINE SYNDROME; short PR, long QRS = WOLFF-PARKINSON-WHITE SYNDROME%A%
% 207.86/208.08 |- mesh__dateCreated mesh__D011226 1985-03-20
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011226 2003
% 207.86/208.08 |- skos__hiddenLabel mesh__D011226 Syndrome, Pre-Excitation
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D011226 ags
% 207.86/208.08 |- skos__prefLabel mesh__D011226 Pre-Excitation Syndromes
% 207.86/208.08 |- skos__broader mesh__D005174Q000172smesh__D005174
% 207.86/208.08 |- mesh__preferredCombination mesh__D005174Q000172smesh__D005175
% 207.86/208.08 |- rdf__type mesh__D005174Q000172smesh__CompoundConcept
% 207.86/208.08 |- rdf__type mesh__D007983sskos__Concept
% 207.86/208.08 |- skos__hiddenLabel mesh__D007983 Blood-Group System, Lewis
% 207.86/208.08 |- mesh__dateEstablished mesh__D007983 1974-01-01
% 207.86/208.08 |- skos__hiddenLabel mesh__D007983 Antigens, Le
% 207.86/208.08 |- skos__annotation mesh__D007983
% 207.86/208.08 IM; coord with disease /blood, not /immunol nor /genet; TN 230%A%
% 207.86/208.08 |- mesh__dateCreated mesh__D007983 1999-01-01
% 207.86/208.08 |- mesh__recordMaintainer mesh__D007983 ssb
% 207.86/208.08 |- skos__altLabel mesh__D007983 Le Antigens
% 207.86/208.08 |- mesh__historyNote mesh__D007983 74%28%63%29%
% 207.86/208.08 |- mesh__dateRevised mesh__D007983 2005-06-30
% 207.86/208.08 |- mesh__recordOriginator mesh__D007983 NLM
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D007983 sjn
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007983 2006
% 207.86/208.08 |- skos__scopeNote mesh__D007983
% 207.86/208.08 A group of dominantly and independently inherited antigens associated with the ABO blood factors. They are glycolipids present in plasma and secretions that may adhere to the erythrocytes. The phenotype Le%28%b%29% is the result of the interaction of the Le gene Le%28%a%29% with the genes for the ABO blood groups.%A%
% 207.86/208.08 |- skos__altLabel mesh__D007983 Le%28%a%29% Blood Group System
% 207.86/208.08 |- skos__prefLabel mesh__D007983 Lewis Blood-Group System
% 207.86/208.08 |- skos__hiddenLabel mesh__D007983 Le Antigen
% 207.86/208.08 |- skos__hiddenLabel mesh__D007983 System, Lewis Blood-Group
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D007983 74
% 207.86/208.08 |- skos__broader mesh__D007983smesh__D001789
% 207.86/208.08 |- skos__altLabel mesh__D007983 Lewis System
% 207.86/208.08 |- skos__hiddenLabel mesh__D007983 Antigen, Le
% 207.86/208.08 |- skos__hiddenLabel mesh__D007983 Lewis Blood Group System
% 207.86/208.08 |- skos__hiddenLabel mesh__D007983 System, Lewis
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D007185 SJN
% 207.86/208.08 |- mesh__historyNote mesh__D007185 73
% 207.86/208.08 |- skos__annotation mesh__D007185
% 207.86/208.08 for eggs, microbial cultures, cell cultures, etc.; INCUBATORS, INFANT is also available%A%
% 207.86/208.08 |- mesh__recordOriginator mesh__D007185 NLM
% 207.86/208.08 |- mesh__dateEstablished mesh__D007185 1973-01-01
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007185 2002
% 207.86/208.08 |- skos__hiddenLabel mesh__D007185 Incubator
% 207.86/208.08 |- rdf__type mesh__D007185sskos__Concept
% 207.86/208.08 |- mesh__dateCreated mesh__D007185 1999-01-01
% 207.86/208.08 |- skos__scopeNote mesh__D007185
% 207.86/208.08 Insulated enclosures in which temperature, humidity, and other environmental conditions can be regulated at levels optimal for growth, hatching, reproduction, or metabolic reactions.%A%
% 207.86/208.08 |- skos__related mesh__D007185smesh__D004780
% 207.86/208.08 |- skos__prefLabel mesh__D007185 Incubators
% 207.86/208.08 |- mesh__dateRevised mesh__D007185 1997-06-20
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007185 1998
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D007185 73
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007185 2000
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007185 2003
% 207.86/208.08 |- mesh__recordMaintainer mesh__D007185 PXP
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007185 1999
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007185 2001
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007185 2005
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007185 2004
% 207.86/208.08 |- skos__related mesh__D007185smesh__D008021
% 207.86/208.08 |- skos__broader mesh__D007185smesh__D004864
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007185 2006
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D031284 2003
% 207.86/208.08 |- mesh__dateEstablished mesh__D031284 2003-01-01
% 207.86/208.08 |- rdf__type mesh__D031284sskos__Concept
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D031284 2004
% 207.86/208.08 |- mesh__dateCreated mesh__D031284 2002-07-02
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D031284 2003
% 207.86/208.08 |- skos__prefLabel mesh__D031284 Aleurites
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D031284 2005
% 207.86/208.08 |- skos__altLabel mesh__D031284 Tung
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D031284 2006
% 207.86/208.08 |- skos__broader mesh__D031284smesh__D019665
% 207.86/208.08 |- skos__annotation mesh__D031284
% 207.86/208.08 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.08 |- mesh__historyNote mesh__D031284 2003
% 207.86/208.08 |- skos__scopeNote mesh__D031284
% 207.86/208.08 A plant genus of the family EUPHORBIACEAE that is the source of tung oil and a phorbol diester %28%PHORBOL ESTERS%29%.%A%
% 207.86/208.08 |- skos__hiddenLabel mesh__D003593 Protoplasms
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D003593 2005
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D003593 2006
% 207.86/208.08 |- mesh__historyNote mesh__D003593
% 207.86/208.08 65%28%64%29%; PROTOPLASM was heading 1963-64
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D003593 sjn
% 207.86/208.08 |- skos__scopeNote mesh__D003593
% 207.86/208.08 The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. %28%Glick, Glossary of Biochemistry and Molecular Biology, 1990%29%%A%
% 207.86/208.08 |- skos__broader mesh__D003593smesh__D042541
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D003593 2004
% 207.86/208.08 |- mesh__dateCreated mesh__D003593 1999-01-01
% 207.86/208.08 |- skos__prefLabel mesh__D003593 Cytoplasm
% 207.86/208.08 |- mesh__dateEstablished mesh__D003593 1965-01-01
% 207.86/208.08 |- mesh__dateRevised mesh__D003593 2003-07-09
% 207.86/208.08 |- mesh__recordOriginator mesh__D003593 NLM
% 207.86/208.08 |- rdf__type mesh__D003593sskos__Concept
% 207.86/208.08 |- mesh__recordMaintainer mesh__D003593 nns
% 207.86/208.08 |- skos__annotation mesh__D003593
% 207.86/208.08 A 11 qualif except /cytol; /genet permitted
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D003593 65; PROTOPLASM was heading 1963-64
% 207.86/208.08 |- skos__hiddenLabel mesh__D003593 Cytoplasms
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D011227 sjn
% 207.86/208.08 |- mesh__dateEstablished mesh__D011227 1991-01-01
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011227 2006
% 207.86/208.08 |- mesh__recordMaintainer mesh__D011227 PLS
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011227 2005
% 207.86/208.08 |- mesh__recordOriginator mesh__D011227 VDK
% 207.86/208.08 |- skos__hiddenLabel mesh__D011227 Mahaim Type Preexcitation
% 207.86/208.08 |- rdf__type mesh__D011227sskos__Concept
% 207.86/208.08 |- mesh__onlineNote mesh__D011227
% 207.86/208.08 use PRE-EXCITATION, MAHAIM-TYPE to search PRE-EXCITATION, MAHAIM TYPE 1986-91%A%
% 207.86/208.08 |- skos__hiddenLabel mesh__D011227 Pre Excitation, Mahaim Type
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011227 2002
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011227 2004
% 207.86/208.08 |- skos__prefLabel mesh__D011227 Pre-Excitation, Mahaim-Type
% 207.86/208.08 |- skos__broader mesh__D011227smesh__D011226
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011227 2001
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011227 2003
% 207.86/208.08 |- mesh__historyNote mesh__D011227
% 207.86/208.08 92; was PRE-EXCITATION, MAHAIM TYPE 1986-91 %28%see under PRE-EXCITATION SYNDROMES 1986-90%29%%A%
% 207.86/208.08 |- skos__hiddenLabel mesh__D011227 Preexcitation, Mahaim-Type
% 207.86/208.08 |- skos__altLabel mesh__D011227 Mahaim-Type Pre-Excitation
% 207.86/208.08 |- skos__annotation mesh__D011227
% 207.86/208.08 normal PR interval %26% long QRS interval with delta wave; SHORT PR NORMAL QRS COMPLEX SYNDROME see LOWN-GANONG-LEVINE SYNDROME is available%A%
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D011227 2000
% 207.86/208.08 |- mesh__dateRevised mesh__D011227 1999-11-03
% 207.86/208.08 |- skos__scopeNote mesh__D011227
% 207.86/208.08 A form of pre-excitation characterized by a normal PR interval and a long QRS interval with a delta wave.%A%
% 207.86/208.08 |- mesh__dateCreated mesh__D011227 1985-03-20
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D011227
% 207.86/208.08 92; was PRE-EXCITATION, MAHAIM TYPE 1986-91 %28%see under PRE-EXCITATION SYNDROMES 1986-90%29%%A%
% 207.86/208.08 |- skos__hiddenLabel mesh__D011227 Mahaim Type Pre Excitation
% 207.86/208.08 |- skos__altLabel mesh__D011227 Mahaim-Type Preexcitation
% 207.86/208.08 |- skos__altLabel mesh__D016710 Yinxu
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D016710 2005
% 207.86/208.08 |- skos__altLabel mesh__D016710 Yin Xu
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D016710 sjn
% 207.86/208.08 |- mesh__dateCreated mesh__D016710 1991-02-11
% 207.86/208.08 |- mesh__dateRevised mesh__D016710 2002-07-03
% 207.86/208.08 |- mesh__dateEstablished mesh__D016710 1992-01-01
% 207.86/208.08 |- rdf__type mesh__D016710sskos__Concept
% 207.86/208.08 |- mesh__historyNote mesh__D016710 92
% 207.86/208.08 |- skos__hiddenLabel mesh__D016710 Xu, Yin
% 207.86/208.08 |- skos__prefLabel mesh__D016710 Yin Deficiency
% 207.86/208.08 |- mesh__publicMeSHNote mesh__D016710 92
% 207.86/208.08 |- mesh__recordMaintainer mesh__D016710 ssb
% 207.86/208.08 |- skos__altLabel mesh__D016710 Deficiency, Yin
% 207.86/208.08 |- skos__hiddenLabel mesh__D016710 Yin Deficiencies
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D016710 2004
% 207.86/208.08 |- mesh__recordOriginator mesh__D016710 TGC
% 207.86/208.08 |- skos__altLabel mesh__D016710 Yin Hsu
% 207.86/208.08 |- skos__hiddenLabel mesh__D016710 Hsu, Yin
% 207.86/208.08 |- skos__historyNote mesh__D016710
% 207.86/208.08 Medicine, Chinese Traditional %28%1983-1991%29%
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D016710 2003
% 207.86/208.08 |- skos__broader mesh__D016710smesh__D010335
% 207.86/208.08 |- skos__scopeNote mesh__D016710
% 207.86/208.08 In the YIN-YANG system of philosophy and medicine, an insufficiency of body fluid %28%called yinxu%29%, manifesting often as irritability, thirst, constipation, etc. %28%The Pinyin Chinese-English Dictionary, 1979%29%.%A%
% 207.86/208.08 |- skos__related mesh__D016710smesh__D019413
% 207.86/208.08 |- skos__related mesh__D016710smesh__D016709
% 207.86/208.08 |- skos__annotation mesh__D016710
% 207.86/208.08 coord IM with clin manifest %28%IM%29% or precoord organ/dis term %28%IM%29%; DF: YIN DEFIC%A%
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D016710 2006
% 207.86/208.08 |- mesh__dateCreated mesh__D007984 1999-01-01
% 207.86/208.08 |- skos__annotation mesh__D007984
% 207.86/208.08 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with TESTICULAR NEOPLASMS %28%IM%29% in male or OVARIAN NEOPLASMS %28%IM%29% if in female%A%
% 207.86/208.08 |- skos__prefLabel mesh__D007984 Leydig Cell Tumor
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007984 2006
% 207.86/208.08 |- mesh__dateRevised mesh__D007984 2004-07-07
% 207.86/208.08 |- skos__hiddenLabel mesh__D007984 Tumor, Leydig Cell
% 207.86/208.08 |- skos__altLabel mesh__D007984 Interstitial Cell Tumor
% 207.86/208.08 |- mesh__recordOriginator mesh__D007984 NLM
% 207.86/208.08 |- skos__hiddenLabel mesh__D007984 Tumor, Interstitial Cell
% 207.86/208.08 |- mesh__recordAuthorizer mesh__D007984 sjn
% 207.86/208.08 |- skos__hiddenLabel mesh__D007984 Tumors, Interstitial Cell
% 207.86/208.08 |- skos__broader mesh__D007984smesh__D018310
% 207.86/208.08 |- skos__hiddenLabel mesh__D007984 Interstitial Cell Tumors
% 207.86/208.08 |- rdf__type mesh__D007984sskos__Concept
% 207.86/208.08 |- skos__scopeNote mesh__D007984
% 207.86/208.08 Gonadal interstitial or stromal cell neoplasm composed of only LEYDIG CELLS. These tumors may produce one or more of the steroid hormones such as ANDROGENS; ESTROGENS; and CORTICOSTEROIDS. Clinical symptoms include testicular swelling, GYNECOMASTIA, sexual precocity in children, or virilization %28%VIRILISM%29% in females.%A%
% 207.86/208.08 |- mesh__recordMaintainer mesh__D007984 lkt
% 207.86/208.08 |- mesh__activeMeSHYear mesh__D007984 2005
% 207.86/208.08 |- mesh__dateCreated mesh__D007186 1999-01-01
% 207.86/208.08 |- rdf__type mesh__D007186sskos__Concept
% 207.86/208.08 |- skos__hiddenLabel mesh__D007186 Radiant Warmer, Infant
% 207.86/208.08 |- skos__hiddenLabel mesh__D007186 Infant Radiant Warmer
% 207.86/208.08 |- skos__hiddenLabel mesh__D007186 Infant Incubator
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007186 2002
% 207.86/208.09 |- mesh__recordOriginator mesh__D007186 NLM
% 207.86/208.09 |- skos__prefLabel mesh__D007186 Incubators, Infant
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007186 2003
% 207.86/208.09 |- mesh__dateEstablished mesh__D007186 1974-01-01
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007186 2004
% 207.86/208.09 |- skos__broader mesh__D007186smesh__D004865
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007186 2005
% 207.86/208.09 |- skos__scopeNote mesh__D007186
% 207.86/208.09 Electrically powered devices that are intended to assist in the maintenance of the thermal balance of infants, principally by controlling the air temperature and humidity in an enclosure. %28%from UMDNS, 1999%29%%A%
% 207.86/208.09 |- skos__hiddenLabel mesh__D007186 Infant Incubators
% 207.86/208.09 |- skos__hiddenLabel mesh__D007186 Incubator, Infant
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007186 2000
% 207.86/208.09 |- skos__hiddenLabel mesh__D007186 Warmers, Infant Radiant
% 207.86/208.09 |- skos__altLabel mesh__D007186 Radiant Warmers, Infant
% 207.86/208.09 |- skos__hiddenLabel mesh__D007186 Warmer, Infant Radiant
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007186 2006
% 207.86/208.09 |- mesh__recordMaintainer mesh__D007186 KEV
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D007186 74
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D007186 sjn
% 207.86/208.09 |- mesh__dateRevised mesh__D007186 1999-11-09
% 207.86/208.09 |- skos__broader mesh__D007186smesh__D007185
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007186 2001
% 207.86/208.09 |- mesh__historyNote mesh__D007186 74
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 2000
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 2005
% 207.86/208.09 |- skos__broader mesh__D015618smesh__D015616
% 207.86/208.09 |- skos__hiddenLabel mesh__D015618 Disease, Rosai-Dorfman
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 1998
% 207.86/208.09 |- skos__hiddenLabel mesh__D015618 Syndrome, Destombes-Rosai-Dorfman
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 2004
% 207.86/208.09 |- skos__annotation mesh__D015618
% 207.86/208.09 a non-Langerhans cell histiocytosis; sinus refers to the lymphatic sinuses%A%
% 207.86/208.09 |- rdf__type mesh__D015618sskos__Concept
% 207.86/208.09 |- skos__hiddenLabel mesh__D015618 Rosai Dorfman Disease
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 1997
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 2003
% 207.86/208.09 |- mesh__recordMaintainer mesh__D015618 TGC
% 207.86/208.09 |- skos__altLabel mesh__D015618 Destombes-Rosai-Dorfman Syndrome
% 207.86/208.09 |- skos__altLabel mesh__D015618 Rosai-Dorfman Disease
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 1996
% 207.86/208.09 |- skos__hiddenLabel mesh__D015618 Sinus Histiocytosis
% 207.86/208.09 |- skos__hiddenLabel mesh__D015618 Histiocytoses, Sinus
% 207.86/208.09 |- mesh__dateCreated mesh__D015618 1989-04-07
% 207.86/208.09 |- skos__hiddenLabel mesh__D015618 Sinus Histiocytoses
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 2002
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 1995
% 207.86/208.09 |- skos__prefLabel mesh__D015618 Histiocytosis, Sinus
% 207.86/208.09 |- skos__historyNote mesh__D015618 Reticuloendotheliosis %28%1966-1989%29%
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D015618 PLS
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 2006
% 207.86/208.09 |- mesh__dateEstablished mesh__D015618 1990-01-01
% 207.86/208.09 |- skos__scopeNote mesh__D015618
% 207.86/208.09 Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy.%A%
% 207.86/208.09 |- mesh__historyNote mesh__D015618 90
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 2001
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 1999
% 207.86/208.09 |- skos__historyNote mesh__D015618 Lymphatic Diseases %28%1966-1989%29%
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D015618 90
% 207.86/208.09 |- mesh__recordOriginator mesh__D015618 AGS
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015618 1994
% 207.86/208.09 |- mesh__dateRevised mesh__D015618 1993-06-02
% 207.86/208.09 |- skos__hiddenLabel mesh__D015618 Destombes Rosai Dorfman Syndrome
% 207.86/208.09 |- skos__broader mesh__D012320smesh__D012321
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D012320 sjn
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D012320 2004
% 207.86/208.09 |- skos__historyNote mesh__D012320 RNA Polymerases %28%1973-1976%29%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D012320 2005
% 207.86/208.09 |- skos__hiddenLabel mesh__D012320 DNA Dependent RNA Polymerase III
% 207.86/208.09 |- skos__hiddenLabel mesh__D012320 Polymerase III, RNA
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D012320 2006
% 207.86/208.09 |- mesh__recordMaintainer mesh__D012320 ssb
% 207.86/208.09 |- mesh__dateCreated mesh__D012320 1976-04-19
% 207.86/208.09 |- skos__prefLabel mesh__D012320 RNA Polymerase III
% 207.86/208.09 |- skos__hiddenLabel mesh__D012320 III, RNA Polymerase
% 207.86/208.09 |- skos__scopeNote mesh__D012320
% 207.86/208.09 A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II. EC 2.7.7.6.%A%
% 207.86/208.09 |- skos__hiddenLabel mesh__D012320 Polymerase C, RNA
% 207.86/208.09 |- mesh__historyNote mesh__D012320
% 207.86/208.09 91%28%77%29%; was see under RNA POLYMERASES 1977-90
% 207.86/208.09 |- skos__altLabel mesh__D012320 RNA Polymerase C
% 207.86/208.09 |- mesh__dateRevised mesh__D012320 2003-07-09
% 207.86/208.09 |- mesh__dateEstablished mesh__D012320 1991-01-01
% 207.86/208.09 |- skos__altLabel mesh__D012320 DNA-Dependent RNA Polymerase III
% 207.86/208.09 |- rdf__type mesh__D012320sskos__Concept
% 207.86/208.09 |- skos__historyNote mesh__D012320
% 207.86/208.09 RNA Nucleotidyltransferases %28%1968-1972%29%
% 207.86/208.09 |- mesh__recordOriginator mesh__D012320 RLS
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D012320
% 207.86/208.09 91; was see under RNA POLYMERASES 1977-90
% 207.86/208.09 |- skos__hiddenLabel mesh__D012320 C, RNA Polymerase
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D031285 2005
% 207.86/208.09 |- skos__annotation mesh__D031285
% 207.86/208.09 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D031285 2004
% 207.86/208.09 |- skos__scopeNote mesh__D031285
% 207.86/208.09 A plant genus of the family EUPHORBIACEAE. The trees contain hippomanin A %28%TANNINS%29% and the latex is a skin irritant.%A%
% 207.86/208.09 |- skos__broader mesh__D031285smesh__D019665
% 207.86/208.09 |- skos__altLabel mesh__D031285 Manchincel
% 207.86/208.09 |- rdf__type mesh__D031285sskos__Concept
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D031285 2003
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D031285 2003
% 207.86/208.09 |- mesh__dateEstablished mesh__D031285 2003-01-01
% 207.86/208.09 |- mesh__historyNote mesh__D031285 2003
% 207.86/208.09 |- mesh__dateCreated mesh__D031285 2002-07-03
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D031285 2006
% 207.86/208.09 |- skos__altLabel mesh__D031285 Manchineel
% 207.86/208.09 |- skos__prefLabel mesh__D031285 Hippomane
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D003594 2006
% 207.86/208.09 |- skos__broader mesh__D003594smesh__D022162
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D003594 2004
% 207.86/208.09 |- mesh__dateCreated mesh__D003594 1999-01-01
% 207.86/208.09 |- mesh__dateRevised mesh__D003594 2003-07-09
% 207.86/208.09 |- skos__annotation mesh__D003594
% 207.86/208.09 ZYMOGEN GRANULES see SECRETORY VESICLES is also available%A%
% 207.86/208.09 |- rdf__type mesh__D003594sskos__Concept
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D003594 sjn
% 207.86/208.09 |- skos__hiddenLabel mesh__D003594 Cytoplasmic Granule
% 207.86/208.09 |- mesh__historyNote mesh__D003594 65%28%64%29%
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D003594 65
% 207.86/208.09 |- skos__broader mesh__D003594smesh__D022083
% 207.86/208.09 |- mesh__dateEstablished mesh__D003594 1965-01-01
% 207.86/208.09 |- skos__hiddenLabel mesh__D003594 Granules, Cytoplasmic
% 207.86/208.09 |- skos__prefLabel mesh__D003594 Cytoplasmic Granules
% 207.86/208.09 |- skos__hiddenLabel mesh__D003594 Granule, Cytoplasmic
% 207.86/208.09 |- mesh__recordOriginator mesh__D003594 NLM
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D003594 2005
% 207.86/208.09 |- skos__scopeNote mesh__D003594
% 207.86/208.09 Condensed areas of cellular material that may be bounded by a membrane.%A%
% 207.86/208.09 |- mesh__recordMaintainer mesh__D003594 nns
% 207.86/208.09 |- skos__hiddenLabel mesh__D044402 Receptor, 5-HT2A
% 207.86/208.09 |- mesh__dateEstablished mesh__D044402 2004-01-01
% 207.86/208.09 |- skos__hiddenLabel mesh__D044402 2A Receptors, Serotonin
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D044402 2006
% 207.86/208.09 |- rdf__type mesh__D044402sskos__Concept
% 207.86/208.09 |- skos__broader mesh__D044402smesh__D044348
% 207.86/208.09 |- skos__scopeNote mesh__D044402
% 207.86/208.09 A serotonin receptor subtype found widely distributed in peripheral tissues where it mediates the contractile responses of variety of tissues that contain SMOOTH MUSCLE. Selective 5-HT2A receptor antagonists include KETANSERIN. The 5-HT2A subtype is also located in BASAL GANGLIA and CEREBRAL CORTEX of the BRAIN where it mediates the effects of HALLUCINOGENS such as LSD.%A%
% 207.86/208.09 |- skos__altLabel mesh__D044402 Serotonin 2A Receptors
% 207.86/208.09 |- skos__altLabel mesh__D044402 5-HT%28%2A%29% Receptor
% 207.86/208.09 |- mesh__recordOriginator mesh__D044402 jmp
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D044402 sjn
% 207.86/208.09 |- skos__altLabel mesh__D044402 Receptor, Serotonin 2A
% 207.86/208.09 |- skos__historyNote mesh__D044402 Receptors, Serotonin %28%1994-2003%29%
% 207.86/208.09 |- skos__hiddenLabel mesh__D044402 Receptors, Serotonin 2A
% 207.86/208.09 |- mesh__dateCreated mesh__D044402 2003-07-09
% 207.86/208.09 |- mesh__dateRevised mesh__D044402 2005-06-30
% 207.86/208.09 |- mesh__recordMaintainer mesh__D044402 DRC
% 207.86/208.09 |- skos__altLabel mesh__D044402 5-HT2A Receptor
% 207.86/208.09 |- mesh__historyNote mesh__D044402
% 207.86/208.09 2004; use RECEPTOR, SEROTONIN, 5-HT2A %28%NM%29% 1994-2003
% 207.86/208.09 |- skos__hiddenLabel mesh__D044402 5 HT2A Receptor
% 207.86/208.09 |- skos__altLabel mesh__D044402 Serotonin 2A Receptor
% 207.86/208.09 |- skos__prefLabel mesh__D044402 Receptor, Serotonin, 5-HT2A
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D044402
% 207.86/208.09 2004; SEROTONIN 2A RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT2A%29% was indexed under RECEPTORS, SEROTONIN 1994-2003%A%
% 207.86/208.09 |- skos__hiddenLabel mesh__D044402 2A Receptor, Serotonin
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 2006
% 207.86/208.09 |- mesh__recordOriginator mesh__D011228 NLM
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D011228 PLS
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 1996
% 207.86/208.09 |- mesh__historyNote mesh__D011228
% 207.86/208.09 84%28%75%29%; was see under SERUM ALBUMIN 1975-83
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 2003
% 207.86/208.09 |- skos__historyNote mesh__D011228 Protein Precursors %28%1973-1974%29%
% 207.86/208.09 |- skos__scopeNote mesh__D011228
% 207.86/208.09 A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease.%A%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 1997
% 207.86/208.09 |- mesh__recordMaintainer mesh__D011228 KEV
% 207.86/208.09 |- rdf__type mesh__D011228sskos__Concept
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 2002
% 207.86/208.09 |- skos__broader mesh__D011228smesh__D012709
% 207.86/208.09 |- skos__altLabel mesh__D011228 Transthyretin
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 2004
% 207.86/208.09 |- skos__annotation mesh__D011228 /biosyn /drug eff /physiol permitted
% 207.86/208.09 |- mesh__dateRevised mesh__D011228 1995-05-22
% 207.86/208.09 |- skos__altLabel mesh__D011228 Proalbumin
% 207.86/208.09 |- skos__prefLabel mesh__D011228 Prealbumin
% 207.86/208.09 |- mesh__dateEstablished mesh__D011228 1984-01-01
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 2000
% 207.86/208.09 |- mesh__dateCreated mesh__D011228 1974-11-19
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D011228
% 207.86/208.09 84; was see under SERUM ALBUMIN 1975-83
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 1998
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 2005
% 207.86/208.09 |- skos__historyNote mesh__D011228 Serum Albumin %28%1972-1974%29%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 2001
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D011228 1999
% 207.86/208.09 |- skos__prefLabel mesh__D016711 Yang Deficiency
% 207.86/208.09 |- skos__scopeNote mesh__D016711
% 207.86/208.09 In the YIN-YANG system of philosophy and medicine, a lack of vital energy %28%called yangxu in Chinese%29%. It manifests itself in various systemic and organic diseases. %28%The Pinyin Chinese-English Dictionary, 1979%29%%A%
% 207.86/208.09 |- skos__altLabel mesh__D016711 Yangxu
% 207.86/208.09 |- skos__broader mesh__D016711smesh__D010335
% 207.86/208.09 |- skos__related mesh__D016711smesh__D016709
% 207.86/208.09 |- skos__altLabel mesh__D016711 Yang Hsu
% 207.86/208.09 |- rdf__type mesh__D016711sskos__Concept
% 207.86/208.09 |- mesh__historyNote mesh__D016711 92
% 207.86/208.09 |- skos__hiddenLabel mesh__D016711 Xu, Yang
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D016711 2004
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D016711 sjn
% 207.86/208.09 |- skos__hiddenLabel mesh__D016711 Hsu, Yang
% 207.86/208.09 |- mesh__dateCreated mesh__D016711 1991-02-11
% 207.86/208.09 |- mesh__dateRevised mesh__D016711 2002-07-03
% 207.86/208.09 |- skos__annotation mesh__D016711
% 207.86/208.09 coord IM with clin manifest %28%IM%29% or precoord organ/dis term %28%IM%29%; DF: YANG DEFIC%A%
% 207.86/208.09 |- mesh__dateEstablished mesh__D016711 1992-01-01
% 207.86/208.09 |- skos__historyNote mesh__D016711
% 207.86/208.09 Medicine, Chinese Traditional %28%1983-1991%29%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D016711 2003
% 207.86/208.09 |- skos__related mesh__D016711smesh__D019413
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D016711 92
% 207.86/208.09 |- mesh__recordMaintainer mesh__D016711 ssb
% 207.86/208.09 |- skos__altLabel mesh__D016711 Yang Xu
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D016711 2006
% 207.86/208.09 |- mesh__recordOriginator mesh__D016711 TGC
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D016711 2005
% 207.86/208.09 |- skos__altLabel mesh__D016711 Deficiency, Yang
% 207.86/208.09 |- skos__broader mesh__D019793Q000031smesh__D019793
% 207.86/208.09 |- mesh__preferredCombination mesh__D019793Q000031smesh__D005452
% 207.86/208.09 |- rdf__type mesh__D019793Q000031smesh__CompoundConcept
% 207.86/208.09 |- skos__broader mesh__D007985smesh__D002477
% 207.86/208.09 |- mesh__dateEstablished mesh__D007985 1968-01-01
% 207.86/208.09 |- mesh__recordMaintainer mesh__D007985 ags
% 207.86/208.09 |- skos__hiddenLabel mesh__D007985 Testicular Interstitial Cell
% 207.86/208.09 |- mesh__historyNote mesh__D007985 68%28%64%29%
% 207.86/208.09 |- skos__scopeNote mesh__D007985
% 207.86/208.09 Steroid-producing cells in the interstitial tissue of the TESTIS. They are under the regulation of PITUITARY HORMONES; LUTEINIZING HORMONE; or interstitial cell-stimulating hormone. TESTOSTERONE is the major androgen %28%ANDROGENS%29% produced.%A%
% 207.86/208.09 |- skos__broader mesh__D007985smesh__D013737
% 207.86/208.09 |- skos__hiddenLabel mesh__D007985 Interstitial Cell, Testicular
% 207.86/208.09 |- rdf__type mesh__D007985sskos__Concept
% 207.86/208.09 |- skos__hiddenLabel mesh__D007985 Cells, Testicular Interstitial
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007985 2005
% 207.86/208.09 |- skos__hiddenLabel mesh__D007985 Cells, Leydig
% 207.86/208.09 |- skos__hiddenLabel mesh__D007985 Cell, Testicular Interstitial
% 207.86/208.09 |- skos__altLabel mesh__D007985 Interstitial Cells, Testicular
% 207.86/208.09 |- mesh__dateCreated mesh__D007985 1999-01-01
% 207.86/208.09 |- skos__annotation mesh__D007985
% 207.86/208.09 do not confuse X ref interstitial cells here with interstitial cells of connective tissue %28% = CONNECTIVE TISSUE CELLS%29%%A%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007985 2006A
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007985 2003
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007985 2006
% 207.86/208.09 |- mesh__dateRevised mesh__D007985 2005-07-27
% 207.86/208.09 |- skos__altLabel mesh__D007985 Testicular Interstitial Cells
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D007985 68
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D007985 ags
% 207.86/208.09 |- skos__prefLabel mesh__D007985 Leydig Cells
% 207.86/208.09 |- mesh__recordOriginator mesh__D007985 NLM
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007985 2004
% 207.86/208.09 |- skos__prefLabel mesh__D007187 Incunabula
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1994
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 2002
% 207.86/208.09 |- mesh__recordMaintainer mesh__D007187 sjn
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 2005
% 207.86/208.09 |- rdf__type mesh__D007187sskos__Concept
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D007187 sjn
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1997
% 207.86/208.09 |- skos__broader mesh__D007187smesh__D001877
% 207.86/208.09 |- mesh__dateCreated mesh__D007187 1999-01-01
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1993
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1990
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1996
% 207.86/208.09 |- skos__annotation mesh__D007187 before 1501; IM; no qualif
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 2004
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 2001
% 207.86/208.09 |- mesh__dateRevised mesh__D007187 2002-10-24
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1992
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 2000
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1999
% 207.86/208.09 |- mesh__recordOriginator mesh__D007187 NLM
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 2003
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 2003A
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1995
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1998
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 1991
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D007187 2006
% 207.86/208.09 |- skos__historyNote mesh__D015619
% 207.86/208.09 Respiratory System/abnormalities %28%1966-1997%29%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015619 2001
% 207.86/208.09 |- mesh__historyNote mesh__D015619 98; use explode 1990-97
% 207.86/208.09 |- skos__altLabel mesh__D015619 Abnormalities, Respiratory System
% 207.86/208.09 |- mesh__dateRevised mesh__D015619 1999-11-03
% 207.86/208.09 |- mesh__dateEstablished mesh__D015619 1998-01-01
% 207.86/208.09 |- skos__annotation mesh__D015619
% 207.86/208.09 for congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ /abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: RESPIRATORY SYSTEM ABNORM%A%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015619 2003
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015619 2000
% 207.86/208.09 |- skos__hiddenLabel mesh__D015619 Respiratory System Abnormality
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D015619 98
% 207.86/208.09 |- skos__broader mesh__D015619smesh__D012140
% 207.86/208.09 |- skos__prefLabel mesh__D015619 Respiratory System Abnormalities
% 207.86/208.09 |- skos__hiddenLabel mesh__D015619 System Abnormality, Respiratory
% 207.86/208.09 |- skos__scopeNote mesh__D015619
% 207.86/208.09 Congenital structural abnormalities of the respiratory system.%A%
% 207.86/208.09 |- skos__hiddenLabel mesh__D015619 Abnormality, Respiratory System
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015619 2006
% 207.86/208.09 |- skos__hiddenLabel mesh__D015619 System Abnormalities, Respiratory
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015619 2005
% 207.86/208.09 |- mesh__recordMaintainer mesh__D015619 kle
% 207.86/208.09 |- mesh__recordOriginator mesh__D015619 PXP
% 207.86/208.09 |- mesh__dateCreated mesh__D015619 1989-04-07
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D015619 sjn
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015619 2002
% 207.86/208.09 |- skos__broader mesh__D015619smesh__D000013
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D015619 2004
% 207.86/208.09 |- rdf__type mesh__D015619sskos__Concept
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D026341 2002
% 207.86/208.09 |- skos__altLabel mesh__D026341 Transcription Factor MCM1
% 207.86/208.09 |- mesh__historyNote mesh__D026341
% 207.86/208.09 2002; use MCM1 PROTEIN %28%NM%29% 1992-2001
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D026341 2005
% 207.86/208.09 |- skos__prefLabel mesh__D026341 MCM1 Protein
% 207.86/208.09 |- skos__historyNote mesh__D026341 Transcription Factors %28%1993-2001%29%
% 207.86/208.09 |- skos__historyNote mesh__D026341 DNA-Binding Proteins %28%1993-2001%29%
% 207.86/208.09 |- skos__altLabel mesh__D026341 Minichromosome Maintenance 1 Protein
% 207.86/208.09 |- skos__hiddenLabel mesh__D026341 MCM 1 Protein
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D026341 2003
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D026341
% 207.86/208.09 2002; MCM1 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001 %26% FUNGAL PROTEINS 1992%A%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D026341 2006
% 207.86/208.09 |- skos__broader mesh__D026341smesh__D029701
% 207.86/208.09 |- skos__broader mesh__D026341smesh__D026161
% 207.86/208.09 |- mesh__dateCreated mesh__D026341 2001-07-25
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D026341 2004
% 207.86/208.09 |- skos__scopeNote mesh__D026341
% 207.86/208.09 A sequence-specific DNA-binding protein that plays an essential role as a global regulator of yeast cell cycle control. It contains a MADS-box domain within the N-terminal 56 amino acids. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A%
% 207.86/208.09 |- skos__altLabel mesh__D026341 MCM-1 Protein
% 207.86/208.09 |- skos__historyNote mesh__D026341 Fungal Proteins %28%1992%29%
% 207.86/208.09 |- mesh__dateEstablished mesh__D026341 2002-01-01
% 207.86/208.09 |- rdf__type mesh__D026341sskos__Concept
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 Polymerases, RNA
% 207.86/208.09 |- skos__historyNote mesh__D012321
% 207.86/208.09 RNA Nucleotidyltransferases %28%1968-1972%29%
% 207.86/208.09 |- skos__altLabel mesh__D012321 Transcriptases
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D012321 2005
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 Polymerases, DNA-Dependent RNA
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D012321 2006
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D012321 sjn
% 207.86/208.09 |- mesh__recordOriginator mesh__D012321 NLM
% 207.86/208.09 |- mesh__dateEstablished mesh__D012321 1973-01-01
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 Polymerases, DNA-Directed RNA
% 207.86/208.09 |- mesh__historyNote mesh__D012321 2003%28%1973%29%
% 207.86/208.09 |- skos__prefLabel mesh__D012321 DNA-Directed RNA Polymerases
% 207.86/208.09 |- skos__altLabel mesh__D012321 RNA Polymerases
% 207.86/208.09 |- skos__altLabel mesh__D012321 RNA Polymerase
% 207.86/208.09 |- skos__altLabel mesh__D012321 DNA-Dependent RNA Polymerases
% 207.86/208.09 |- skos__scopeNote mesh__D012321
% 207.86/208.09 Enzymes that catalyze DNA template-directed extension of the 3%27%-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. %28%From Enzyme Nomenclature, 1992%29%.%A%
% 207.86/208.09 |- skos__altLabel mesh__D012321 DNA-Directed RNA Polymerase
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 Polymerase, DNA-Directed RNA
% 207.86/208.09 |- mesh__dateRevised mesh__D012321 2003-07-09
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 DNA Directed RNA Polymerases
% 207.86/208.09 |- skos__broader mesh__D012321smesh__D012316
% 207.86/208.09 |- rdf__type mesh__D012321sskos__Concept
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D012321
% 207.86/208.09 2003; see DNA-DIRECTED RNA POLYMERASE 1998-2002, see RNA POLYMERASES 1977-1997, see RNA POLYMERASE 1973-1976%A%
% 207.86/208.09 |- mesh__recordMaintainer mesh__D012321 ssb
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 Polymerase, RNA
% 207.86/208.09 |- skos__annotation mesh__D012321
% 207.86/208.09 GEN or unspecified; prefer specifics RNA POLYMERASE I, etc.%A%
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 RNA Polymerases, DNA-Dependent
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 RNA Polymerases, DNA-Directed
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 DNA Directed RNA Polymerase
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D012321 2004
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 DNA Dependent RNA Polymerases
% 207.86/208.09 |- skos__hiddenLabel mesh__D012321 RNA Polymerase, DNA-Directed
% 207.86/208.09 |- mesh__dateCreated mesh__D012321 1999-01-01
% 207.86/208.09 |- skos__annotation mesh__D031286
% 207.86/208.09 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.09 |- mesh__dateCreated mesh__D031286 2002-07-03
% 207.86/208.09 |- skos__scopeNote mesh__D031286
% 207.86/208.09 A plant genus of the family EUPHORBIACEAE. Members contain jatrophone and other diterpenes.%A%
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D031286 2004
% 207.86/208.09 |- skos__broader mesh__D031286smesh__D019665
% 207.86/208.09 |- skos__altLabel mesh__D031286 Nettlespurge
% 207.86/208.09 |- skos__prefLabel mesh__D031286 Jatropha
% 207.86/208.09 |- rdf__type mesh__D031286sskos__Concept
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D031286 2003
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D031286 2003
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D031286 2006
% 207.86/208.09 |- skos__altLabel mesh__D031286 Spurge, Nettle
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D031286 2005
% 207.86/208.09 |- mesh__dateEstablished mesh__D031286 2003-01-01
% 207.86/208.09 |- mesh__historyNote mesh__D031286 2003
% 207.86/208.09 |- skos__hiddenLabel mesh__D050440 Subunits, Ig
% 207.86/208.09 |- mesh__recordAuthorizer mesh__D050440 ags
% 207.86/208.09 |- rdf__type mesh__D050440sskos__Concept
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D050440 2006A
% 207.86/208.09 |- skos__altLabel mesh__D050440 Immunoglobulin Polypeptide Chains
% 207.86/208.09 |- mesh__recordMaintainer mesh__D050440 ags
% 207.86/208.09 |- skos__scopeNote mesh__D050440
% 207.86/208.09 The PROTEIN SUBUNITS of the multimeric IMMUNOGLOBULIN proteins, such as IGA; IGD; IGE; IGG; and IGM. Included are the heavy and light chains which contain the specific ANTIGEN binding domains, as well as the accessory proteins that are part of the the secreted forms of IGM and IGA; %28%SECRETORY IGA%29%.%A%
% 207.86/208.09 |- mesh__recordOriginator mesh__D050440 nns
% 207.86/208.09 |- mesh__dateEstablished mesh__D050440 2006-01-01
% 207.86/208.09 |- skos__altLabel mesh__D050440 Ig Subunits
% 207.86/208.09 |- skos__broader mesh__D050440smesh__D007136
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D050440 2006
% 207.86/208.09 |- skos__altLabel mesh__D050440 Ig Polypeptide Chains
% 207.86/208.09 |- skos__hiddenLabel mesh__D050440 Subunit, Ig
% 207.86/208.09 |- mesh__dateRevised mesh__D050440 2005-07-18
% 207.86/208.09 |- skos__altLabel mesh__D050440 Immunoglobulin Chains
% 207.86/208.09 |- mesh__historyNote mesh__D050440 2006
% 207.86/208.09 |- skos__prefLabel mesh__D050440 Immunoglobulin Subunits
% 207.86/208.09 |- mesh__dateCreated mesh__D050440 2005-06-30
% 207.86/208.09 |- skos__altLabel mesh__D050440 Ig Subunit
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D050440 2006
% 207.86/208.09 |- skos__hiddenLabel mesh__D003595 Streamings, Protoplasmic
% 207.86/208.09 |- mesh__dateCreated mesh__D003595 1999-01-01
% 207.86/208.09 |- skos__hiddenLabel mesh__D003595 Streaming, Protoplasmic
% 207.86/208.09 |- mesh__recordOriginator mesh__D003595 NLM
% 207.86/208.09 |- mesh__publicMeSHNote mesh__D003595 70
% 207.86/208.09 |- mesh__activeMeSHYear mesh__D003595 2006
% 207.86/208.09 |- mesh__historyNote mesh__D003595 70%28%67%29%
% 207.86/208.09 |- skos__hiddenLabel mesh__D003595 Streamings, Cytoplasmic
% 207.86/208.09 |- skos__broader mesh__D003595smesh__D001692
% 207.86/208.10 |- skos__broader mesh__D003595smesh__D002468
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003595 2005
% 207.86/208.10 |- skos__historyNote mesh__D003595 Cytoplasm %28%1966%29%
% 207.86/208.10 |- skos__hiddenLabel mesh__D003595 Cytoplasmic Streamings
% 207.86/208.10 |- skos__prefLabel mesh__D003595 Cytoplasmic Streaming
% 207.86/208.10 |- skos__hiddenLabel mesh__D003595 Streaming, Cytoplasmic
% 207.86/208.10 |- mesh__recordMaintainer mesh__D003595 nns
% 207.86/208.10 |- skos__annotation mesh__D003595
% 207.86/208.10 permitted for micro-organisms also; do not confuse with CYTOKINESIS or CELL MOVEMENT%A%
% 207.86/208.10 |- mesh__dateRevised mesh__D003595 2004-07-07
% 207.86/208.10 |- skos__hiddenLabel mesh__D003595 Protoplasmic Streamings
% 207.86/208.10 |- skos__scopeNote mesh__D003595
% 207.86/208.10 The movement of CYTOPLASM within a CELL. It serves as an internal transport system for moving essential substances throughout the cell, and in single-celled organisms, such as the AMOEBA, it is responsible for the movement %28%CELL MOVEMENT%29% of the entire cell.%A%
% 207.86/208.10 |- rdf__type mesh__D003595sskos__Concept
% 207.86/208.10 |- mesh__dateEstablished mesh__D003595 1970-01-01
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D003595 sjn
% 207.86/208.10 |- skos__altLabel mesh__D044403 Receptor, Serotonin 2B
% 207.86/208.10 |- skos__prefLabel mesh__D044403 Receptor, Serotonin, 5-HT2B
% 207.86/208.10 |- mesh__historyNote mesh__D044403
% 207.86/208.10 2004; use RECEPTOR, SEROTONIN, 5-HT2B %28%NM%29% 1994-2003
% 207.86/208.10 |- skos__scopeNote mesh__D044403
% 207.86/208.10 A serotonin receptor subtype found in the BRAIN; HEART; LUNGS; PLACENTA and DIGESTIVE SYSTEM organs. A number of functions have been attributed to the action of the 5-HT2B receptor including the development of cardiac myocytes %28%MYOCYTES, CARDIAC%29% and the contraction of SMOOTH MUSCLE.%A%
% 207.86/208.10 |- mesh__dateRevised mesh__D044403 2005-06-30
% 207.86/208.10 |- skos__hiddenLabel mesh__D044403 5 Hydroxytryptamine 2B Receptor
% 207.86/208.10 |- skos__altLabel mesh__D044403 Serotonin 2B Receptor
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D044403 2006
% 207.86/208.10 |- skos__historyNote mesh__D044403 Receptors, Serotonin %28%1994-2003%29%
% 207.86/208.10 |- rdf__type mesh__D044403sskos__Concept
% 207.86/208.10 |- skos__hiddenLabel mesh__D044403 Receptor, 5-Hydroxytryptamine 2B
% 207.86/208.10 |- skos__hiddenLabel mesh__D044403 Receptor, 5-HT2B
% 207.86/208.10 |- skos__altLabel mesh__D044403 5-Hydroxytryptamine 2B Receptor
% 207.86/208.10 |- mesh__recordMaintainer mesh__D044403 jmp
% 207.86/208.10 |- mesh__dateEstablished mesh__D044403 2004-01-01
% 207.86/208.10 |- skos__hiddenLabel mesh__D044403 2B Receptor, 5-Hydroxytryptamine
% 207.86/208.10 |- mesh__dateCreated mesh__D044403 2003-07-09
% 207.86/208.10 |- skos__altLabel mesh__D044403 5-HT2B Receptor
% 207.86/208.10 |- skos__broader mesh__D044403smesh__D044348
% 207.86/208.10 |- skos__hiddenLabel mesh__D044403 5 HT2B Receptor
% 207.86/208.10 |- skos__altLabel mesh__D044403 %28%5-HT%29%2B Receptors
% 207.86/208.10 |- skos__hiddenLabel mesh__D044403 2B Receptor, Serotonin
% 207.86/208.10 |- skos__hiddenLabel mesh__D044403 2B Receptors, Serotonin
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D044403
% 207.86/208.10 2004; SEROTONIN 2B RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT2B%29% was indexed under RECEPTORS, SEROTONIN 1994-2003%A%
% 207.86/208.10 |- mesh__recordOriginator mesh__D044403 jmp
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D044403 sjn
% 207.86/208.10 |- skos__hiddenLabel mesh__D044403 Receptors, Serotonin 2B
% 207.86/208.10 |- skos__altLabel mesh__D044403 Serotonin 2B Receptors
% 207.86/208.10 |- mesh__recordMaintainer mesh__D011229 PLS
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 1997
% 207.86/208.10 |- rdf__type mesh__D011229sskos__Concept
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 2001
% 207.86/208.10 |- skos__prefLabel mesh__D011229 Preanesthetic Medication
% 207.86/208.10 |- mesh__dateCreated mesh__D011229 1999-01-01
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 2004
% 207.86/208.10 |- skos__hiddenLabel mesh__D011229 Medication, Preanesthetic
% 207.86/208.10 |- mesh__recordOriginator mesh__D011229 NLM
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D011229 PLS
% 207.86/208.10 |- skos__hiddenLabel mesh__D011229 Preanesthetic Medications
% 207.86/208.10 |- skos__annotation mesh__D011229
% 207.86/208.10 do not use /util except by MeSH definition
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 1994
% 207.86/208.10 |- skos__broader mesh__D011229smesh__D000760
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 2002
% 207.86/208.10 |- mesh__dateRevised mesh__D011229 1993-05-03
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 1998
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 1995
% 207.86/208.10 |- skos__hiddenLabel mesh__D011229 Medications, Preanesthetic
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 2005
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 1999
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 2006
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 2000
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 1996
% 207.86/208.10 |- skos__broader mesh__D011229smesh__D011300
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D011229 2003
% 207.86/208.10 |- mesh__dateRevised mesh__D008280 2005-06-30
% 207.86/208.10 |- skos__hiddenLabel mesh__D008280 Magnetometries
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008280 2006
% 207.86/208.10 |- skos__broader mesh__D008280smesh__D010825
% 207.86/208.10 |- skos__annotation mesh__D008280
% 207.86/208.10 TRANSCRANIAL MAGNETIC STIMULATION and ELECTROMAGNETICS are also available%A%
% 207.86/208.10 |- rdf__type mesh__D008280sskos__Concept
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D008280 sjn
% 207.86/208.10 |- mesh__dateCreated mesh__D008280 1999-01-01
% 207.86/208.10 |- skos__prefLabel mesh__D008280 Magnetics
% 207.86/208.10 |- skos__scopeNote mesh__D008280
% 207.86/208.10 The study of magnetic phenomena and magnetic fields. Magnetism produced by electric currents is ELECTROMAGNETICS.%A%
% 207.86/208.10 |- skos__hiddenLabel mesh__D008280 Magnetic
% 207.86/208.10 |- mesh__recordMaintainer mesh__D008280 ssb
% 207.86/208.10 |- mesh__recordOriginator mesh__D008280 NLM
% 207.86/208.10 |- skos__historyNote mesh__D016712 Fatty Acids %28%1966-1991%29%
% 207.86/208.10 |- mesh__dateRevised mesh__D016712 2003-07-09
% 207.86/208.10 |- skos__annotation mesh__D016712
% 207.86/208.10 do not use /biosyn unless by living matter
% 207.86/208.10 |- rdf__type mesh__D016712sskos__Concept
% 207.86/208.10 |- mesh__dateCreated mesh__D016712 1991-07-12
% 207.86/208.10 |- skos__hiddenLabel mesh__D016712 BRL 4910A
% 207.86/208.10 |- skos__hiddenLabel mesh__D016712 14C-Labeled Mupirocin
% 207.86/208.10 |- mesh__recordOriginator mesh__D016712 RLS
% 207.86/208.10 |- skos__historyNote mesh__D016712 Antibiotics %28%1966-1991%29%
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D016712 2004
% 207.86/208.10 |- skos__scopeNote mesh__D016712
% 207.86/208.10 A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.%A%
% 207.86/208.10 |- skos__prefLabel mesh__D016712 Mupirocin
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D016712 2005
% 207.86/208.10 |- skos__altLabel mesh__D016712 Pseudomonic Acid A
% 207.86/208.10 |- mesh__recordMaintainer mesh__D016712 ssb
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D016712 2006
% 207.86/208.10 |- skos__broader mesh__D016712smesh__D005227
% 207.86/208.10 |- skos__hiddenLabel mesh__D016712 BRL4910A
% 207.86/208.10 |- skos__hiddenLabel mesh__D016712 Acid, Pseudomonic
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D016712 sjn
% 207.86/208.10 |- mesh__dateEstablished mesh__D016712 1992-01-01
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D016712
% 207.86/208.10 92; PSEUDOMONIC ACID was indexed under ANTIBIOTICS 1977-91%A%
% 207.86/208.10 |- mesh__historyNote mesh__D016712
% 207.86/208.10 92; was PSEUDOMONIC ACID %28%NM%29% 1977-91
% 207.86/208.10 |- mesh__onlineNote mesh__D016712
% 207.86/208.10 use MUPIROCIN %28%NM%29% to search PSEUDOMONIC ACID %28%NM%29% 1980-91%A%
% 207.86/208.10 |- skos__hiddenLabel mesh__D016712 Mupirocin, 14C Labeled
% 207.86/208.10 |- skos__altLabel mesh__D016712 Pseudomonic Acid
% 207.86/208.10 |- skos__altLabel mesh__D007986 Luteoziman
% 207.86/208.10 |- skos__hiddenLabel mesh__D007986 Interstitial Cell Stimulating Hormone
% 207.86/208.10 |- skos__hiddenLabel mesh__D007986 Hormone, Luteinizing
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D007986 sjn
% 207.86/208.10 |- skos__annotation mesh__D007986
% 207.86/208.10 do not confuse X ref LUTROPIN with LUTEOTROPIN see PLACENTAL LACTOGEN; for alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; LUTEINIZING HORMONE, BETA SUBUNIT is also available%A%
% 207.86/208.10 |- mesh__dateRevised mesh__D007986 2002-07-03
% 207.86/208.10 |- rdf__type mesh__D007986sskos__Concept
% 207.86/208.10 |- mesh__recordOriginator mesh__D007986 NLM
% 207.86/208.10 |- skos__altLabel mesh__D007986 Interstitial Cell-Stimulating Hormone
% 207.86/208.10 |- skos__altLabel mesh__D007986 Lutropin
% 207.86/208.10 |- skos__broader mesh__D007986smesh__D006065
% 207.86/208.10 |- skos__altLabel mesh__D007986
% 207.86/208.10 ICSH %28%Interstitial Cell Stimulating Hormone%29%
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007986 2005
% 207.86/208.10 |- mesh__dateCreated mesh__D007986 1999-01-01
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007986 2006
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007986 2003
% 207.86/208.10 |- skos__altLabel mesh__D007986 LH %28%Luteinizing Hormone%29%
% 207.86/208.10 |- skos__prefLabel mesh__D007986 Luteinizing Hormone
% 207.86/208.10 |- skos__hiddenLabel mesh__D007986 Hormone, Interstitial Cell-Stimulating
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007986 2004
% 207.86/208.10 |- mesh__historyNote mesh__D007986 2003 %28%1968%29%; use ICSH 1963-1967
% 207.86/208.10 |- skos__related mesh__D007986smesh__D011974
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D007986
% 207.86/208.10 2003 %28%1968%29%; see ICSH 1963-1967
% 207.86/208.10 |- mesh__recordMaintainer mesh__D007986 sjn
% 207.86/208.10 |- mesh__dateEstablished mesh__D007986 1968-01-01
% 207.86/208.10 |- skos__scopeNote mesh__D007986
% 207.86/208.10 A major gonadotropin secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones %28%TSH, LH and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A%
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007188 2005
% 207.86/208.10 |- rdf__type mesh__D007188sskos__Concept
% 207.86/208.10 |- skos__broader mesh__D007188smesh__D004429
% 207.86/208.10 |- mesh__dateEstablished mesh__D007188 1991-01-01
% 207.86/208.10 |- mesh__dateCreated mesh__D007188 1999-01-01
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D007188
% 207.86/208.10 91; was see under EAR OSSICLES 1975-90
% 207.86/208.10 |- mesh__onlineNote mesh__D007188 search EAR OSSICLES 1966-74
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007188 2002
% 207.86/208.10 |- skos__scopeNote mesh__D007188
% 207.86/208.10 One of three ossicles of the middle ear. It conducts sound vibrations from the MALLEUS to the STAPES.%A%
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007188 2004
% 207.86/208.10 |- skos__prefLabel mesh__D007188 Incus
% 207.86/208.10 |- mesh__dateRevised mesh__D007188 1999-11-03
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D007188 sjn
% 207.86/208.10 |- mesh__recordMaintainer mesh__D007188 KEV
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007188 2003
% 207.86/208.10 |- mesh__historyNote mesh__D007188
% 207.86/208.10 91%28%75%29%; was see under EAR OSSICLES 1975-90
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007188 2001
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007188 2006
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007188 2000
% 207.86/208.10 |- mesh__recordOriginator mesh__D007188 NLM
% 207.86/208.10 |- skos__historyNote mesh__D026342 Transcription Factors %28%1993-2001%29%
% 207.86/208.10 |- skos__scopeNote mesh__D026342
% 207.86/208.10 A plant homeotic protein involved in the development of stamens and carpels of Arabidopsis thaliana. It is a DNA-binding protein that contains the MADS-box domain. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A%
% 207.86/208.10 |- skos__altLabel mesh__D026342 AGAMOUS 1 Protein
% 207.86/208.10 |- mesh__recordMaintainer mesh__D026342 SYSTEM
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D026342 2006
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D026342 sjn
% 207.86/208.10 |- mesh__dateRevised mesh__D026342 2005-06-30
% 207.86/208.10 |- skos__annotation mesh__D026342
% 207.86/208.10 AGAMOUS-LIKE PROTEINS see MADS DOMAIN PROTEINS is also available%A%
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D026342
% 207.86/208.10 2002; AGAMOUS PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001%A%
% 207.86/208.10 |- skos__historyNote mesh__D026342 DNA-Binding Proteins %28%1993-2001%29%
% 207.86/208.10 |- mesh__historyNote mesh__D026342
% 207.86/208.10 2002; use AGAMOUS PROTEIN %28%NM%29% 1993-2001
% 207.86/208.10 |- mesh__recordOriginator mesh__D026342 jmp
% 207.86/208.10 |- mesh__dateEstablished mesh__D026342 2002-01-01
% 207.86/208.10 |- rdf__type mesh__D026342sskos__Concept
% 207.86/208.10 |- skos__broader mesh__D026342smesh__D029681
% 207.86/208.10 |- skos__prefLabel mesh__D026342 AGAMOUS Protein, Arabidopsis
% 207.86/208.10 |- skos__broader mesh__D026342smesh__D026161
% 207.86/208.10 |- mesh__dateCreated mesh__D026342 2001-07-25
% 207.86/208.10 |- skos__hiddenLabel mesh__D026342 Arabidopsis AGAMOUS Protein
% 207.86/208.10 |- skos__historyNote mesh__D012322
% 207.86/208.10 Nucleic Acid Precursors %28%1975-1987%29%
% 207.86/208.10 |- rdf__type mesh__D012322sskos__Concept
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Pre rRNA
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Precursor, mRNA
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Transcript, Primary RNA
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 RNA Transcript, Primary
% 207.86/208.10 |- mesh__dateRevised mesh__D012322 2002-07-03
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D012322 sjn
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D012322 88
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Pre snRNA
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Pre tRNA
% 207.86/208.10 |- skos__historyNote mesh__D012322 Nucleic Acids %28%1966-1974%29%
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D012322 2006
% 207.86/208.10 |- skos__prefLabel mesh__D012322 RNA Precursors
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Precursor, RNA
% 207.86/208.10 |- skos__altLabel mesh__D012322 tRNA Precursor
% 207.86/208.10 |- skos__annotation mesh__D012322 coord with specific RNA
% 207.86/208.10 |- skos__altLabel mesh__D012322 snRNA Precursor
% 207.86/208.10 |- mesh__dateEstablished mesh__D012322 1988-01-01
% 207.86/208.10 |- skos__broader mesh__D012322smesh__D009694
% 207.86/208.10 |- skos__scopeNote mesh__D012322
% 207.86/208.10 RNA transcripts of the DNA that are in some unfinished stage of post-transcriptional processing %28%RNA PROCESSING, POST-TRANSCRIPTIONAL%29% required for function. RNA precursors may undergo several steps of RNA SPLICING during which the phosphodiester bonds at exon-intron boundaries are cleaved and the introns are excised. Consequently a new bond is formed between the ends of the exons. Resulting mature RNAs can then be used; for example, mature mRNA %28%RNA, MESSENGER%29% is used as a template for protein production.%A%
% 207.86/208.10 |- skos__altLabel mesh__D012322 Primary Transcript, RNA
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Precursors, RNA
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D012322 2005
% 207.86/208.10 |- mesh__recordMaintainer mesh__D012322 nns
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Pre mRNA
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Precursor, snRNA
% 207.86/208.10 |- skos__altLabel mesh__D012322 Pre-snRNA
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Precursor, rRNA
% 207.86/208.10 |- mesh__historyNote mesh__D012322 88
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Precursor, tRNA
% 207.86/208.10 |- skos__broader mesh__D012322smesh__D012313
% 207.86/208.10 |- skos__altLabel mesh__D012322 rRNA Precursor
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 RNA Primary Transcript
% 207.86/208.10 |- mesh__recordOriginator mesh__D012322 RLS
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 Transcript, RNA Primary
% 207.86/208.10 |- mesh__dateCreated mesh__D012322 1987-05-05
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D012322 2004
% 207.86/208.10 |- skos__altLabel mesh__D012322 Precursor RNA
% 207.86/208.10 |- skos__altLabel mesh__D012322 Pre-rRNA
% 207.86/208.10 |- skos__altLabel mesh__D012322 Pre-tRNA
% 207.86/208.10 |- skos__altLabel mesh__D012322 mRNA Precursor
% 207.86/208.10 |- skos__hiddenLabel mesh__D012322 RNA, Precursor
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D012322 2003
% 207.86/208.10 |- skos__altLabel mesh__D012322 Pre-mRNA
% 207.86/208.10 |- skos__scopeNote mesh__D031287
% 207.86/208.10 A plant genus of the family EUPHORBIACEAE that contains bukittinggine and PHORBOL ESTERS.%A%
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D031287 2003
% 207.86/208.10 |- mesh__dateEstablished mesh__D031287 2003-01-01
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D031287 2006
% 207.86/208.10 |- mesh__historyNote mesh__D031287 2003
% 207.86/208.10 |- mesh__dateCreated mesh__D031287 2002-07-03
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D031287 2005
% 207.86/208.10 |- skos__altLabel mesh__D031287 Tallow Tree, Chinese
% 207.86/208.10 |- skos__annotation mesh__D031287
% 207.86/208.10 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D031287 2004
% 207.86/208.10 |- skos__broader mesh__D031287smesh__D019665
% 207.86/208.10 |- rdf__type mesh__D031287sskos__Concept
% 207.86/208.10 |- skos__prefLabel mesh__D031287 Sapium
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D031287 2003
% 207.86/208.10 |- mesh__recordOriginator mesh__D050441 nns
% 207.86/208.10 |- mesh__historyNote mesh__D050441 2006
% 207.86/208.10 |- mesh__dateCreated mesh__D050441 2005-06-30
% 207.86/208.10 |- skos__prefLabel mesh__D050441 VDJ Exons
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D050441 sjn
% 207.86/208.10 |- skos__scopeNote mesh__D050441
% 207.86/208.10 Exons that are created in vivo during LYMPHOCYTE maturation from the V, D, and J gene segments of immunoglobulin superfamily genes %28%e.g., the IMMUNOGLOBULIN HEAVY CHAIN GENES, or the T-CELL RECEPTOR BETA GENES or T-CELL RECEPTOR GAMMA GENES %29% by the VDJ RECOMBINASE system.%A%
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D050441 2006
% 207.86/208.10 |- skos__related mesh__D050441smesh__D045567
% 207.86/208.10 |- mesh__dateEstablished mesh__D050441 2006-01-01
% 207.86/208.10 |- skos__related mesh__D050441smesh__D019672
% 207.86/208.10 |- skos__hiddenLabel mesh__D050441 Exon, VDJ
% 207.86/208.10 |- skos__hiddenLabel mesh__D050441 Exons, VDJ
% 207.86/208.10 |- skos__related mesh__D050441smesh__D050438
% 207.86/208.10 |- skos__broader mesh__D050441smesh__D005091
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D050441 2006
% 207.86/208.10 |- rdf__type mesh__D050441sskos__Concept
% 207.86/208.10 |- mesh__recordMaintainer mesh__D050441 nns
% 207.86/208.10 |- skos__altLabel mesh__D050441 VDJ Exon
% 207.86/208.10 |- skos__scopeNote mesh__D003596
% 207.86/208.10 A pyrimidine base that is a fundamental unit of nucleic acids.%A%
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003596 2006
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003596 1998
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D003596 SJN
% 207.86/208.10 |- skos__prefLabel mesh__D003596 Cytosine
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003596 2003
% 207.86/208.10 |- skos__broader mesh__D003596smesh__D011744
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003596 2005
% 207.86/208.10 |- mesh__dateRevised mesh__D003596 1997-06-20
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003596 2000
% 207.86/208.10 |- mesh__recordOriginator mesh__D003596 NLM
% 207.86/208.10 |- skos__annotation mesh__D003596 /biosyn /physiol permitted
% 207.86/208.10 |- mesh__recordMaintainer mesh__D003596 TGC
% 207.86/208.10 |- rdf__type mesh__D003596sskos__Concept
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003596 2002
% 207.86/208.10 |- mesh__dateCreated mesh__D003596 1999-01-01
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003596 1999
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003596 2004
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D003596 2001
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D044404 2006
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Pathogenicity Islet
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islets, Genomic
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islet, Genomic
% 207.86/208.10 |- rdf__type mesh__D044404sskos__Concept
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islands, Pathogenicity
% 207.86/208.10 |- skos__scopeNote mesh__D044404
% 207.86/208.10 Distinct units in some bacterial, bacteriophage or plasmid GENOMES that are types of MOBILE GENETIC ELEMENTS. Encoded in them are a variety of fitness conferring genes, such as VIRULENCE FACTORS %28%in %22%pathogenicity islands or islets%22%%29%, ANTIBIOTIC RESISTANCE genes, or genes required for SYMBIOSIS %28%in %22%symbiosis islands or islets%22%%29%. They range in size from 10 - 500 kilobases, and their GC CONTENT and CODON usage differ from the rest of the genome. They typically contain an INTEGRASE gene, although in some cases this gene has been deleted resulting in %22%anchored genomic islands%22%.%A%
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Island, Anchored Genomic
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islets, Pathogenicity
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D044404 sjn
% 207.86/208.10 |- skos__broader mesh__D044404smesh__D020071
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islets, Symbiosis
% 207.86/208.10 |- skos__prefLabel mesh__D044404 Genomic Islands
% 207.86/208.10 |- mesh__dateRevised mesh__D044404 2005-06-30
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Symbiosis Islet
% 207.86/208.10 |- mesh__recordMaintainer mesh__D044404 nns
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Genomic Islands, Anchored
% 207.86/208.10 |- mesh__dateCreated mesh__D044404 2003-07-09
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islands, Genomic
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Island, Genomic
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Island, Symbiosis
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islands, Anchored Genomic
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Pathogenicity Island
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islet, Symbiosis
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islet, Pathogenicity
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D044404 2004
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Islands, Symbiosis
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Anchored Genomic Island
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Genomic Island
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Genomic Island, Anchored
% 207.86/208.10 |- mesh__dateEstablished mesh__D044404 2004-01-01
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Genomic Islet
% 207.86/208.10 |- mesh__historyNote mesh__D044404 2004
% 207.86/208.10 |- mesh__recordOriginator mesh__D044404 nns
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Symbiosis Island
% 207.86/208.10 |- skos__hiddenLabel mesh__D044404 Island, Pathogenicity
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008281 1999
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008281 2006
% 207.86/208.10 |- rdf__type mesh__D008281sskos__Concept
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008281 2003
% 207.86/208.10 |- mesh__recordOriginator mesh__D008281 NLM
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008281 1998
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008281 2005
% 207.86/208.10 |- mesh__dateCreated mesh__D008281 1999-01-01
% 207.86/208.10 |- mesh__dateRevised mesh__D008281 1997-06-20
% 207.86/208.10 |- skos__broader mesh__D008281smesh__D009511
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008281 2002
% 207.86/208.10 |- mesh__recordMaintainer mesh__D008281 PXP
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D008281 SJN
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008281 2001
% 207.86/208.10 |- skos__prefLabel mesh__D008281 Maine
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008281 2004
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D008281 2000
% 207.86/208.10 |- skos__historyNote mesh__D016713
% 207.86/208.10 Histamine H2 Receptor Blockaders %28%1977-1991%29%
% 207.86/208.10 |- rdf__type mesh__D016713sskos__Concept
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D016713
% 207.86/208.10 92; RITANSERIN was indexed under PIPERIDINES 1985-91
% 207.86/208.10 |- skos__prefLabel mesh__D016713 Ritanserin
% 207.86/208.10 |- mesh__dateRevised mesh__D016713 2003-07-09
% 207.86/208.10 |- skos__altLabel mesh__D016713
% 207.86/208.10 6-%28%2-%28%4-%28%Bis%28%4-fluorophenyl%29%methylene%29%-1-piperidinyl%29%ethyl%29%-7-methyl-5H-thiazolo%28%3,2-a%29%pyrimidin-5-one
% 207.86/208.10 |- skos__broader mesh__D016713smesh__D010880
% 207.86/208.10 |- skos__broader mesh__D016713smesh__D011744
% 207.86/208.10 |- mesh__historyNote mesh__D016713 92; was RITANSERIN %28%NM%29% 1985-91
% 207.86/208.10 |- mesh__recordOriginator mesh__D016713 RLS
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D016713 2004
% 207.86/208.10 |- skos__hiddenLabel mesh__D016713 R 55667
% 207.86/208.10 |- skos__historyNote mesh__D016713 Piperidines %28%1966-1991%29%
% 207.86/208.10 |- mesh__recordMaintainer mesh__D016713 ssb
% 207.86/208.10 |- mesh__recordAuthorizer mesh__D016713 sjn
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D016713 2005
% 207.86/208.10 |- skos__scopeNote mesh__D016713
% 207.86/208.10 A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.%A%
% 207.86/208.10 |- skos__hiddenLabel mesh__D016713 R55667
% 207.86/208.10 |- mesh__dateCreated mesh__D016713 1991-02-11
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D016713 2006
% 207.86/208.10 |- mesh__dateEstablished mesh__D016713 1992-01-01
% 207.86/208.10 |- mesh__onlineNote mesh__D016713
% 207.86/208.10 use RITANSERIN %28%NM%29% to search RITANSERIN 1985-91
% 207.86/208.10 |- skos__altLabel mesh__D007987 LHRH
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 Acetate, Gonadorelin
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 Hormone, Gonadotropin-Releasing
% 207.86/208.10 |- skos__altLabel mesh__D007987 LHFSHRH
% 207.86/208.10 |- skos__broader mesh__D007987smesh__D009842
% 207.86/208.10 |- mesh__dateCreated mesh__D007987 1999-01-01
% 207.86/208.10 |- skos__altLabel mesh__D007987 LH-RH
% 207.86/208.10 |- skos__related mesh__D007987smesh__D011966
% 207.86/208.10 |- rdf__type mesh__D007987sskos__Concept
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 Hydrochloride, Gonadorelin
% 207.86/208.10 |- mesh__publicMeSHNote mesh__D007987
% 207.86/208.10 91; was LH-FSH RELEASING HORMONE 1974-90; GONADOTROPIN- RELEASING HORMONE was see PITUITARY HORMONE RELEASING HORMONES 1977-90%A%
% 207.86/208.10 |- mesh__onlineNote mesh__D007987
% 207.86/208.10 use GONADORELIN to search LH-FSH RELEASING HORMONE 1974-90; use PITUITARY HORMONE RELEASING HORMONES to search GONADOTROPIN-RELEASING HORMONE 1977-90%A%
% 207.86/208.10 |- skos__altLabel mesh__D007987 GnRH
% 207.86/208.10 |- mesh__recordMaintainer mesh__D007987 ssb
% 207.86/208.10 |- skos__altLabel mesh__D007987 Luteinizing Hormone-Releasing Hormone
% 207.86/208.10 |- skos__altLabel mesh__D007987 FSH-Releasing Hormone
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 Releasing Hormone, LH-FSH
% 207.86/208.10 |- skos__altLabel mesh__D007987 Gonadotropin-Releasing Hormone
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 Releasing Hormone, LHFSH
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 LH Releasing Hormone
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 Hormone, Luteinizing Hormone-Releasing
% 207.86/208.10 |- mesh__dateEstablished mesh__D007987 1974-01-01
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 Gonadotropin Releasing Hormone
% 207.86/208.10 |- skos__broader mesh__D007987smesh__D010906
% 207.86/208.10 |- skos__altLabel mesh__D007987 LH-FSH Releasing Hormone
% 207.86/208.10 |- mesh__dateRevised mesh__D007987 2005-06-30
% 207.86/208.10 |- mesh__historyNote mesh__D007987
% 207.86/208.10 91; was LH-FSH RELEASING HORMONE 1974-90; GONADOTROPIN- RELEASING HORMONE was see PITUITARY HORMONE RELEASING HORMONES 1977-90%A%
% 207.86/208.10 |- mesh__recordOriginator mesh__D007987 NLM
% 207.86/208.10 |- skos__broader mesh__D007987smesh__D009479
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 Hormone, FSH-Releasing
% 207.86/208.10 |- mesh__activeMeSHYear mesh__D007987 2006
% 207.86/208.10 |- skos__altLabel mesh__D007987 Gonadoliberin
% 207.86/208.10 |- skos__hiddenLabel mesh__D007987 FSH Releasing Hormone
% 207.86/208.10 |- skos__prefLabel mesh__D007987 Gonadorelin
% 207.86/208.10 |- skos__altLabel mesh__D007987 LHFSH Releasing Hormone
% 207.86/208.11 |- skos__altLabel mesh__D007987 Gn-RH
% 207.86/208.11 |- mesh__recordAuthorizer mesh__D007987 sjn
% 207.86/208.11 |- skos__hiddenLabel mesh__D007987 LH FSH Releasing Hormone
% 207.86/208.11 |- skos__hiddenLabel mesh__D007987 Hormone, LH-Releasing
% 207.86/208.11 |- skos__hiddenLabel mesh__D007987 Hormone, LH-FSH Releasing
% 207.86/208.11 |- skos__altLabel mesh__D007987 LFRH
% 207.86/208.11 |- skos__altLabel mesh__D007987 Luliberin
% 207.86/208.11 |- skos__scopeNote mesh__D007987
% 207.86/208.11 A decapeptide hormone released by the hypothalamus. It stimulates the synthesis and secretion of both FOLLICLE STIMULATING HORMONE and luteinizing hormone %28%LH%29% from the pituitary gland.%A%
% 207.86/208.11 |- skos__altLabel mesh__D007987 LH-Releasing Hormone
% 207.86/208.11 |- skos__hiddenLabel mesh__D007987 Hormone, LHFSH Releasing
% 207.86/208.11 |- mesh__recordMaintainer mesh__D007189 ssb
% 207.86/208.11 |- mesh__recordOriginator mesh__D007189 NLM
% 207.86/208.11 |- mesh__onlineNote mesh__D007189 search INDENES 1966-74
% 207.86/208.11 |- skos__prefLabel mesh__D007189 Indans
% 207.86/208.11 |- mesh__publicMeSHNote mesh__D007189
% 207.86/208.11 91,63-67; was see under INDENES 1975-90; was heading 1963-67%A%
% 207.86/208.11 |- mesh__activeMeSHYear mesh__D007189 2006
% 207.86/208.11 |- mesh__dateRevised mesh__D007189 2003-07-09
% 207.86/208.11 |- mesh__activeMeSHYear mesh__D007189 2005
% 207.86/208.11 |- rdf__type mesh__D007189sskos__Concept
% 207.86/208.11 |- skos__scopeNote mesh__D007189
% 207.86/208.11 Aryl CYCLOPENTANES that are a reduced %28%protonated%29% form of INDENES.%A%
% 207.86/208.11 |- mesh__dateCreated mesh__D007189 1999-01-01
% 207.86/208.11 |- mesh__historyNote mesh__D007189
% 207.86/208.11 91%28%75%29%63-67; was see under INDENES 1975-90; was heading 1963-67%A%
% 207.86/208.11 |- mesh__recordAuthorizer mesh__D007189 sjn
% 207.86/208.11 |- skos__broader mesh__D007189smesh__D007192
% 207.86/208.11 |- mesh__dateEstablished mesh__D007189 1991-01-01
% 207.86/208.11 |- mesh__activeMeSHYear mesh__D007189 2004
% 207.86/208.11 |- rdf__type mesh__D012323sskos__Concept
% 207.86/208.11 |- skos__annotation mesh__D012323
% 207.86/208.11 coord IM with specific RNA /metab %28%IM%29%; DF: RNA PROC POST TRANSCRIPTIONAL%A%
% 207.86/208.11 |- skos__altLabel mesh__D012323 Posttranscriptional RNA Processing
% 207.86/208.11 |- mesh__historyNote mesh__D012323 83
% 207.86/208.11 |- skos__broader mesh__D012323smesh__D005786
% 207.86/208.11 |- skos__historyNote mesh__D012323 RNA, Messenger %28%1966-1982%29%
% 207.86/208.11 |- skos__altLabel mesh__D012323 RNA Processing, Posttranscriptional
% 207.86/208.11 |- mesh__dateEstablished mesh__D012323 1983-01-01
% 207.86/208.11 |- mesh__recordMaintainer mesh__D012323 nns
% 207.86/208.11 |- mesh__dateRevised mesh__D012323 2004-07-07
% 207.86/208.11 |- skos__hiddenLabel mesh__D012323 Post Transcriptional RNA Modification
% 207.86/208.11 |- skos__scopeNote mesh__D012323
% 207.86/208.11 Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein.%A%
% 207.86/208.11 |- mesh__recordOriginator mesh__D012323 AEP
% 207.86/208.11 |- mesh__publicMeSHNote mesh__D012323 83
% 207.86/208.11 |- skos__historyNote mesh__D012323 Transcription, Genetic %28%1973-1982%29%
% 207.86/208.11 |- skos__hiddenLabel mesh__D012323 RNA Modifications, Post-Transcriptional
% 207.86/208.11 |- mesh__activeMeSHYear mesh__D012323 2005
% 207.86/208.11 |- mesh__dateCreated mesh__D012323 1982-04-23
% 207.86/208.11 |- skos__altLabel mesh__D012323 Post-Transcriptional RNA Modification
% 207.86/208.11 |- skos__broader mesh__D012323smesh__D008660
% 207.86/208.11 |- skos__hiddenLabel mesh__D012323 Modification, Post-Transcriptional RNA
% 207.86/208.11 |- skos__hiddenLabel mesh__D012323 Modifications, Post-Transcriptional RNA
% 207.86/208.11 |- skos__historyNote mesh__D012323
% 207.86/208.11 Nucleic Acid Precursors %28%1975-1982%29%
% 207.86/208.11 |- mesh__activeMeSHYear mesh__D012323 2006
% 207.86/208.11 |- skos__hiddenLabel mesh__D012323 Processing, Posttranscriptional RNA
% 207.86/208.11 |- skos__altLabel mesh__D012323 RNA Processing, Post Transcriptional
% 207.86/208.11 |- skos__prefLabel mesh__D012323 RNA Processing, Post-Transcriptional
% 207.86/208.11 |- skos__hiddenLabel mesh__D012323 Post Transcriptional RNA Processing
% 207.86/208.11 |- skos__altLabel mesh__D012323 Post-Transcriptional RNA Processing
% 207.86/208.11 |- mesh__recordAuthorizer mesh__D012323 sjn
% 207.86/208.11 |- skos__hiddenLabel mesh__D012323 RNA Modification, Post-Transcriptional
% 207.86/208.11 |- skos__hiddenLabel mesh__D012323 Post-Transcriptional RNA Modifications
% 207.86/208.11 |- skos__altLabel mesh__D031288 Pea, Partridge
% 207.86/208.11 |- mesh__publicMeSHNote mesh__D031288 2003
% 207.86/208.11 |- mesh__recordAuthorizer mesh__D031288 ags
% 207.86/208.11 |- mesh__dateEstablished mesh__D031288 2003-01-01
% 207.86/208.11 |- mesh__recordOriginator mesh__D031288 ssb
% 207.86/208.11 |- skos__broader mesh__D031288smesh__D007887
% 207.86/208.11 |- mesh__dateRevised mesh__D031288 2005-07-29
% 207.86/208.11 |- skos__altLabel mesh__D031288 Pea, Sensitive
% 207.86/208.11 |- mesh__activeMeSHYear mesh__D031288 2006
% 207.86/208.11 |- mesh__historyNote mesh__D031288 2003
% 207.86/208.11 |- mesh__dateCreated mesh__D031288 2002-07-03
% 207.86/208.11 |- skos__scopeNote mesh__D031288
% 207.86/208.11 A plant genus of the family FABACEAE. Some species were reclassified from CASSIA and Senna.%A%
% 207.86/208.11 |- mesh__recordMaintainer mesh__D031288 ags
% 207.86/208.11 |- mesh__activeMeSHYear mesh__D031288 2005
% 207.86/208.11 |- skos__annotation mesh__D031288
% 207.86/208.11 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.86/208.11 |- rdf__type mesh__D031288sskos__Concept
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D031288 2004
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D031288 2006A
% 207.97/208.11 |- skos__altLabel mesh__D031288 Partridgepea
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D031288 2003
% 207.97/208.11 |- skos__prefLabel mesh__D031288 Chamaecrista
% 207.97/208.11 |- skos__hiddenLabel mesh__D003597 Nucleotides, Cytosine
% 207.97/208.11 |- skos__broader mesh__D003597smesh__D011742
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 2002
% 207.97/208.11 |- rdf__type mesh__D003597sskos__Concept
% 207.97/208.11 |- skos__annotation mesh__D003597 /biosyn /physiol permitted
% 207.97/208.11 |- mesh__dateRevised mesh__D003597 1992-05-11
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D003597 PLS
% 207.97/208.11 |- mesh__recordMaintainer mesh__D003597 TGC
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 2001
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 1997
% 207.97/208.11 |- mesh__dateCreated mesh__D003597 1999-01-01
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 1999
% 207.97/208.11 |- skos__hiddenLabel mesh__D003597 Phosphates, Cytidine
% 207.97/208.11 |- skos__broader mesh__D003597smesh__D012265
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 2004
% 207.97/208.11 |- skos__altLabel mesh__D003597 Cytidine Phosphates
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 1993
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 2006
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 2000
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 1996
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 1995
% 207.97/208.11 |- skos__prefLabel mesh__D003597 Cytosine Nucleotides
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 1998
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 2003
% 207.97/208.11 |- mesh__recordOriginator mesh__D003597 NLM
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 1994
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003597 2005
% 207.97/208.11 |- mesh__dateEstablished mesh__D044405 2004-01-01
% 207.97/208.11 |- skos__hiddenLabel mesh__D044405 Receptor, Serotonin 2C
% 207.97/208.11 |- mesh__historyNote mesh__D044405
% 207.97/208.11 2004; use RECEPTOR, SEROTONIN, 5-HT2C %28%NM%29% 1994-2003
% 207.97/208.11 |- skos__altLabel mesh__D044405 Serotonin 2C Receptor
% 207.97/208.11 |- mesh__dateCreated mesh__D044405 2003-07-09
% 207.97/208.11 |- mesh__recordMaintainer mesh__D044405 jmp
% 207.97/208.11 |- skos__prefLabel mesh__D044405 Receptor, Serotonin, 5-HT2C
% 207.97/208.11 |- skos__broader mesh__D044405smesh__D044348
% 207.97/208.11 |- mesh__publicMeSHNote mesh__D044405
% 207.97/208.11 2004; SEROTONIN 2C RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HTC%29% was indexed under RECEPTORS, SEROTONIN 1994-2003%A%
% 207.97/208.11 |- skos__hiddenLabel mesh__D044405 5 HT2C Receptor
% 207.97/208.11 |- skos__hiddenLabel mesh__D044405 Receptor, 5-HT2C
% 207.97/208.11 |- skos__altLabel mesh__D044405 Receptor, 5-Hydroxytryptamine Type 2C
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D044405 sjn
% 207.97/208.11 |- skos__scopeNote mesh__D044405
% 207.97/208.11 A serotonin receptor subtype found primarily in the CENTRAL NERVOUS SYSTEM and the CHOROID PLEXUS. This receptor subtype is believed to mediate the anorectic action of SEROTONIN, while selective antagonists of the 5-HT2C receptor appear to induce ANXIETY. Several isoforms of this receptor subtype exist, due to adenine deaminase editing of the receptor mRNA.%A%
% 207.97/208.11 |- skos__hiddenLabel mesh__D044405 5 Hydroxytryptamine Type 2C Receptors
% 207.97/208.11 |- skos__altLabel mesh__D044405 5-HT2C Receptor
% 207.97/208.11 |- mesh__recordOriginator mesh__D044405 jmp
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D044405 2006
% 207.97/208.11 |- skos__altLabel mesh__D044405 5-HT%28%2C%29% Receptor
% 207.97/208.11 |- rdf__type mesh__D044405sskos__Concept
% 207.97/208.11 |- skos__historyNote mesh__D044405 Receptors, Serotonin %28%1994-2003%29%
% 207.97/208.11 |- mesh__dateRevised mesh__D044405 2005-06-30
% 207.97/208.11 |- skos__hiddenLabel mesh__D044405 5 Hydroxytryptamine Type 2C Receptor
% 207.97/208.11 |- skos__altLabel mesh__D044405 5-Hydroxytryptamine Type 2C Receptor
% 207.97/208.11 |- skos__altLabel mesh__D044405 5-Hydroxytryptamine Type 2C Receptors
% 207.97/208.11 |- skos__hiddenLabel mesh__D044405 2C Receptor, Serotonin
% 207.97/208.11 |- skos__hiddenLabel mesh__D044405 Receptor, 5 Hydroxytryptamine Type 2C
% 207.97/208.11 |- skos__hiddenLabel mesh__D008282 Mainstreamings %28%Education%29%
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 1994
% 207.97/208.11 |- skos__broader mesh__D008282smesh__D004519
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 2002
% 207.97/208.11 |- mesh__dateRevised mesh__D008282 1992-05-14
% 207.97/208.11 |- mesh__dateEstablished mesh__D008282 1987-01-01
% 207.97/208.11 |- mesh__dateCreated mesh__D008282 1986-04-15
% 207.97/208.11 |- skos__scopeNote mesh__D008282
% 207.97/208.11 Most frequently refers to the integration of a physically or mentally disabled child into the regular class of normal peers and provision of the appropriately determined educational program.%A%
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 2001
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 2004
% 207.97/208.11 |- skos__historyNote mesh__D008282
% 207.97/208.11 Education, Special/trends %28%1968-1986%29%
% 207.97/208.11 |- skos__annotation mesh__D008282 DF: MAINSTREAMING
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 2000
% 207.97/208.11 |- mesh__recordMaintainer mesh__D008282 TGC
% 207.97/208.11 |- mesh__historyNote mesh__D008282 87
% 207.97/208.11 |- skos__broader mesh__D008282smesh__D003479
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 2003
% 207.97/208.11 |- mesh__recordOriginator mesh__D008282 EC
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 2006
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 1997
% 207.97/208.11 |- mesh__publicMeSHNote mesh__D008282 87
% 207.97/208.11 |- skos__hiddenLabel mesh__D008282 Mainstreamings
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 1993
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 2005
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 1996
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 1999
% 207.97/208.11 |- rdf__type mesh__D008282sskos__Concept
% 207.97/208.11 |- skos__prefLabel mesh__D008282 Mainstreaming %28%Education%29%
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D008282 PLS
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 1995
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008282 1998
% 207.97/208.11 |- skos__altLabel mesh__D008282 Mainstreaming
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 1997
% 207.97/208.11 |- mesh__dateCreated mesh__D007988 1999-01-01
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 1999
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D007988 PLS
% 207.97/208.11 |- rdf__type mesh__D007988sskos__Concept
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 1996
% 207.97/208.11 |- skos__annotation mesh__D007988 a republic in western Africa
% 207.97/208.11 |- skos__scopeNote mesh__D007988
% 207.97/208.11 A republic in western Africa, south of GUINEA and east of COTE D%27%IVOIRE. Its capital is Monrovia, named for the U.S. President James Monroe. Liberia was projected as a settlement of freed American slaves by the American Colonization Society in 1817 and hence named from the Latin liber, free. In 1847 it was established as the Free and Independent Republic of Liberia. Liberia is the only black African state never to have been subjected to colonial rule. %28%From Webster%27%s New Geographical Dictionary, 1988, p668 %26% Room, Brewer%27%s Dictionary of Names, 1992, p307%29%%A%
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 2002
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 1998
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 2004
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 2001
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 2006
% 207.97/208.11 |- mesh__recordOriginator mesh__D007988 NLM
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 2003
% 207.97/208.11 |- mesh__dateRevised mesh__D007988 1995-02-21
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 2000
% 207.97/208.11 |- skos__prefLabel mesh__D007988 Liberia
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007988 2005
% 207.97/208.11 |- skos__broader mesh__D007988smesh__D000354
% 207.97/208.11 |- mesh__recordMaintainer mesh__D007988 TGC
% 207.97/208.11 |- skos__annotation mesh__D032381
% 207.97/208.11 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.11 |- skos__scopeNote mesh__D032381
% 207.97/208.11 A plant genus of the family TILIACEAE. Members contain cycloartane saponins and CARDENOLIDES.%A%
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D032381 2006
% 207.97/208.11 |- skos__prefLabel mesh__D032381 Corchorus
% 207.97/208.11 |- skos__broader mesh__D032381smesh__D029646
% 207.97/208.11 |- mesh__dateCreated mesh__D032381 2002-07-03
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D032381 2005
% 207.97/208.11 |- mesh__publicMeSHNote mesh__D032381 2003
% 207.97/208.11 |- rdf__type mesh__D032381sskos__Concept
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D032381 2004
% 207.97/208.11 |- mesh__dateEstablished mesh__D032381 2003-01-01
% 207.97/208.11 |- mesh__historyNote mesh__D032381 2003
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D032381 2003
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D004690 2006
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D004690 2004
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D004690 sjn
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D004690 2005
% 207.97/208.11 |- rdf__type mesh__D004690sskos__Concept
% 207.97/208.11 |- skos__scopeNote mesh__D004690
% 207.97/208.11 Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. %28%From The ALA Glossary of Library and Information Science, 1983%29%%A%
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D004690 2001
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D004690 2003
% 207.97/208.11 |- mesh__dateCreated mesh__D004690 1999-01-01
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D004690 2000
% 207.97/208.11 |- skos__hiddenLabel mesh__D004690 Encyclopedia
% 207.97/208.11 |- skos__prefLabel mesh__D004690 Encyclopedias
% 207.97/208.11 |- mesh__dateRevised mesh__D004690 1999-11-03
% 207.97/208.11 |- skos__annotation mesh__D004690
% 207.97/208.11 do not confuse with Publication Type ENCYCLOPEDIAS; no qualif%A%
% 207.97/208.11 |- skos__broader mesh__D004690smesh__D012013
% 207.97/208.11 |- mesh__recordMaintainer mesh__D004690 kle
% 207.97/208.11 |- mesh__recordOriginator mesh__D004690 NLM
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D004690 2002
% 207.97/208.11 |- mesh__dateEstablished mesh__D012324 1991-01-01
% 207.97/208.11 |- mesh__dateRevised mesh__D012324 2003-07-09
% 207.97/208.11 |- skos__hiddenLabel mesh__D012324 Replicase, RNA
% 207.97/208.11 |- mesh__recordMaintainer mesh__D012324 ssb
% 207.97/208.11 |- mesh__dateCreated mesh__D012324 1974-11-19
% 207.97/208.11 |- skos__historyNote mesh__D012324
% 207.97/208.11 RNA Nucleotidyltransferases %28%1969-1974%29%
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D012324 2004
% 207.97/208.11 |- skos__hiddenLabel mesh__D012324 RNA Dependent RNA Polymerase
% 207.97/208.11 |- skos__prefLabel mesh__D012324 RNA Replicase
% 207.97/208.11 |- mesh__historyNote mesh__D012324
% 207.97/208.11 91%28%75%29%; was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90%A%
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D012324 2005
% 207.97/208.11 |- mesh__publicMeSHNote mesh__D012324
% 207.97/208.11 91; was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90
% 207.97/208.11 |- skos__altLabel mesh__D012324 RNA-Dependent RNA Polymerase
% 207.97/208.11 |- skos__hiddenLabel mesh__D012324 RNA Polymerase, RNA-Directed
% 207.97/208.11 |- mesh__recordOriginator mesh__D012324 NLM
% 207.97/208.11 |- skos__hiddenLabel mesh__D012324 RNA Polymerase, RNA-Dependent
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D012324 sjn
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D012324 2006
% 207.97/208.11 |- skos__hiddenLabel mesh__D012324 RNA Directed RNA Polymerase
% 207.97/208.11 |- skos__scopeNote mesh__D012324
% 207.97/208.11 An enzyme that catalyses RNA-template-directed extension of the 3%27%- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. %28%Enzyme Nomenclature, 1992, p293%29%%A%
% 207.97/208.11 |- skos__altLabel mesh__D012324 RNA-Directed RNA Polymerase
% 207.97/208.11 |- rdf__type mesh__D012324sskos__Concept
% 207.97/208.11 |- skos__broader mesh__D012324smesh__D012316
% 207.97/208.11 |- skos__altLabel mesh__D031289 Albizia
% 207.97/208.11 |- skos__broader mesh__D031289smesh__D007887
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D031289 2006
% 207.97/208.11 |- mesh__dateCreated mesh__D031289 2002-07-02
% 207.97/208.11 |- skos__prefLabel mesh__D031289 Albizzia
% 207.97/208.11 |- mesh__dateEstablished mesh__D031289 2003-01-01
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D031289 2005
% 207.97/208.11 |- skos__annotation mesh__D031289
% 207.97/208.11 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.11 |- skos__altLabel mesh__D031289 Silktree
% 207.97/208.11 |- skos__scopeNote mesh__D031289
% 207.97/208.11 A plant genus of the family FABACEAE that contains julibroside %28%triterpenoid saponins%29%.%A%
% 207.97/208.11 |- rdf__type mesh__D031289sskos__Concept
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D031289 2004
% 207.97/208.11 |- mesh__historyNote mesh__D031289 2003
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D031289 2003
% 207.97/208.11 |- mesh__publicMeSHNote mesh__D031289 2003
% 207.97/208.11 |- rdf__type mesh__D003598sskos__Concept
% 207.97/208.11 |- mesh__dateCreated mesh__D003598 1984-06-11
% 207.97/208.11 |- skos__historyNote mesh__D003598 Cytoplasm %28%1966-1979%29%
% 207.97/208.11 |- mesh__recordOriginator mesh__D003598 RLS
% 207.97/208.11 |- mesh__dateEstablished mesh__D003598 1985-01-01
% 207.97/208.11 |- skos__broader mesh__D003598smesh__D011506
% 207.97/208.11 |- skos__annotation mesh__D003598
% 207.97/208.11 /biosyn /drug eff /physiol permitted; do not use /analogs%A%
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D003598 2006
% 207.97/208.11 |- skos__prefLabel mesh__D003598 Cytoskeletal Proteins
% 207.97/208.11 |- mesh__dateRevised mesh__D003598 2005-06-30
% 207.97/208.11 |- skos__scopeNote mesh__D003598
% 207.97/208.11 Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible.%A%
% 207.97/208.11 |- mesh__publicMeSHNote mesh__D003598 85
% 207.97/208.11 |- mesh__historyNote mesh__D003598 85
% 207.97/208.11 |- skos__hiddenLabel mesh__D003598 Proteins, Cytoskeletal
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D003598 sjn
% 207.97/208.11 |- skos__historyNote mesh__D003598 Cytoskeleton %28%1977-1984%29%
% 207.97/208.11 |- mesh__recordMaintainer mesh__D003598 SYSTEM
% 207.97/208.11 |- skos__historyNote mesh__D003598
% 207.97/208.11 Proteins or specific proteins %28%1966-1984%29%
% 207.97/208.11 |- skos__prefLabel mesh__D044406 Receptors, Serotonin, 5-HT3
% 207.97/208.11 |- mesh__recordMaintainer mesh__D044406 jmp
% 207.97/208.11 |- skos__altLabel mesh__D044406 5-HT3B Receptor
% 207.97/208.11 |- skos__broader mesh__D044406smesh__D011985
% 207.97/208.11 |- skos__hiddenLabel mesh__D044406 Receptor, 5-HT3A
% 207.97/208.11 |- mesh__historyNote mesh__D044406
% 207.97/208.11 2004; use RECEPTORS, SEROTONIN, 5-HT3 %28%NM%29% 1995-2003
% 207.97/208.11 |- skos__hiddenLabel mesh__D044406 5 HT3A Receptor
% 207.97/208.11 |- mesh__dateEstablished mesh__D044406 2004-01-01
% 207.97/208.11 |- skos__altLabel mesh__D044406 5-Hydroxytryptamine-3 Receptor
% 207.97/208.11 |- skos__scopeNote mesh__D044406
% 207.97/208.11 A subclass of serotonin receptors that form cation channels and mediate signal transduction by depolarizing the cell membrane. The cation channels are formed from 5 receptor subunits. When stimulated the receptors and allow the selective passage of SODIUM; POTASSIUM; and CALCIUM.%A%
% 207.97/208.11 |- mesh__publicMeSHNote mesh__D044406
% 207.97/208.11 2004; SEROTONIN 3 RECEPTOR %28%now RECEPTORS, SEROTONIN, 5-HT3%29% was indexed under RECEPTORS, SEROTONIN 1995-2003%A%
% 207.97/208.11 |- skos__hiddenLabel mesh__D044406 Receptors, Serotonin 3
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D044406 2006
% 207.97/208.11 |- rdf__type mesh__D044406sskos__Concept
% 207.97/208.11 |- skos__hiddenLabel mesh__D044406 5 HT3 Receptor
% 207.97/208.11 |- skos__altLabel mesh__D044406 Receptor, Serotonin 3
% 207.97/208.11 |- skos__hiddenLabel mesh__D044406 Receptor, 5-Hydroxytryptamine-3
% 207.97/208.11 |- skos__altLabel mesh__D044406 5-HT3A Receptor
% 207.97/208.11 |- skos__hiddenLabel mesh__D044406 Receptor, 5-HT3
% 207.97/208.11 |- skos__altLabel mesh__D044406 5-HT3 Receptor
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D044406 sjn
% 207.97/208.11 |- skos__hiddenLabel mesh__D044406 5 Hydroxytryptamine 3 Receptor
% 207.97/208.11 |- skos__altLabel mesh__D044406 Serotonin 3 Receptor
% 207.97/208.11 |- mesh__recordOriginator mesh__D044406 jmp
% 207.97/208.11 |- skos__historyNote mesh__D044406 Receptors, Serotonin %28%1995-2003%29%
% 207.97/208.11 |- skos__altLabel mesh__D044406 Serotonin 3 Receptors
% 207.97/208.11 |- mesh__dateRevised mesh__D044406 2005-06-30
% 207.97/208.11 |- mesh__dateCreated mesh__D044406 2003-07-09
% 207.97/208.11 |- skos__hiddenLabel mesh__D044406 Receptor, 5-HT3B
% 207.97/208.11 |- skos__hiddenLabel mesh__D044406 5 HT3B Receptor
% 207.97/208.11 |- skos__annotation mesh__D008283
% 207.97/208.11 %22%upkeep of property or equipment%22%; NIM
% 207.97/208.11 |- mesh__dateEstablished mesh__D008283 1973-01-01
% 207.97/208.11 |- mesh__publicMeSHNote mesh__D008283 73
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D008283 sjn
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008283 2004
% 207.97/208.11 |- skos__hiddenLabel mesh__D008283 Maintenances
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008283 2002
% 207.97/208.11 |- mesh__recordMaintainer mesh__D008283 TGC
% 207.97/208.11 |- skos__scopeNote mesh__D008283 The upkeep of property or equipment.
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008283 2003
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008283 2006
% 207.97/208.11 |- skos__prefLabel mesh__D008283 Maintenance
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008283 2001
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008283 2005
% 207.97/208.11 |- mesh__dateRevised mesh__D008283 1999-11-05
% 207.97/208.11 |- mesh__historyNote mesh__D008283 73
% 207.97/208.11 |- rdf__type mesh__D008283sskos__Concept
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D008283 2000
% 207.97/208.11 |- skos__broader mesh__D008283smesh__D005159
% 207.97/208.11 |- mesh__dateCreated mesh__D008283 1999-01-01
% 207.97/208.11 |- mesh__recordOriginator mesh__D008283 NLM
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D016715 2002
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D016715 2005
% 207.97/208.11 |- skos__historyNote mesh__D016715 Neurofibromatosis 1 %28%1979-1990%29%
% 207.97/208.11 |- skos__broader mesh__D016715smesh__D009378
% 207.97/208.11 |- mesh__recordAuthorizer mesh__D016715 sjn
% 207.97/208.11 |- mesh__dateCreated mesh__D016715 1991-06-21
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D016715 2006
% 207.97/208.11 |- mesh__dateEstablished mesh__D016715 1992-01-01
% 207.97/208.11 |- skos__prefLabel mesh__D016715 Proteus Syndrome
% 207.97/208.11 |- mesh__dateRevised mesh__D016715 1999-11-03
% 207.97/208.11 |- skos__broader mesh__D016715smesh__D000015
% 207.97/208.11 |- rdf__type mesh__D016715sskos__Concept
% 207.97/208.11 |- mesh__recordMaintainer mesh__D016715 kle
% 207.97/208.11 |- mesh__recordOriginator mesh__D016715 AGS
% 207.97/208.11 |- skos__historyNote mesh__D016715
% 207.97/208.11 Abnormalities, Multiple %28%1979-1991%29%
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D016715 2000
% 207.97/208.11 |- skos__broader mesh__D016715smesh__D017880
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D016715 2003
% 207.97/208.11 |- skos__broader mesh__D016715smesh__D006222
% 207.97/208.11 |- mesh__historyNote mesh__D016715 92
% 207.97/208.11 |- mesh__publicMeSHNote mesh__D016715 92
% 207.97/208.11 |- skos__scopeNote mesh__D016715
% 207.97/208.11 Hamartoneoplastic malformation syndrome of uncertain etiology characterized by partial gigantism of the hands and/or feet, asymmetry of the limbs, plantar hyperplasia, hemangiomas, lipomas, lymphangiomas, epidermal nevi, macrocephaly, cranial hyperostoses, and long-bone overgrowth. Joseph Merrick, the so-called %22%elephant man%22%, apparently suffered from Proteus syndrome and not neurofibromatosis, a disorder with similar characteristics.%A%
% 207.97/208.11 |- skos__broader mesh__D016715smesh__D001848
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D016715 2001
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D016715 2004
% 207.97/208.11 |- skos__historyNote mesh__D016715
% 207.97/208.11 Neoplasms, Multiple Primary %28%1986-1991%29%
% 207.97/208.11 |- skos__annotation mesh__D016715
% 207.97/208.11 hamartomas %26% multiple abnorm; %22%Proteus%22% refers to the sea god in Greek mythol who could assume many forms; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 207.97/208.11 |- skos__altLabel mesh__D016715 Elephant Man Disease
% 207.97/208.11 |- mesh__dateRevised mesh__D007989 1992-03-25
% 207.97/208.11 |- mesh__historyNote mesh__D007989 68
% 207.97/208.11 |- mesh__recordOriginator mesh__D007989 NLM
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007989 1994
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007989 2004
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007989 2000
% 207.97/208.11 |- mesh__activeMeSHYear mesh__D007989 2006
% 207.97/208.11 |- mesh__recordMaintainer mesh__D007989 PLS
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 2003
% 207.97/208.12 |- skos__scopeNote mesh__D007989
% 207.97/208.12 The psychic drive or energy associated with sexual instinct in the broad sense %28%pleasure and love-object seeking%29%. It may also connote the psychic energy associated with instincts in general that motivate behavior.%A%
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 2005
% 207.97/208.12 |- skos__prefLabel mesh__D007989 Libido
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D007989 PLS
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 1997
% 207.97/208.12 |- skos__hiddenLabel mesh__D007989 Libido, Increased
% 207.97/208.12 |- skos__hiddenLabel mesh__D007989 Libido, Decreased
% 207.97/208.12 |- mesh__dateCreated mesh__D007989 1999-01-01
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 2002
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 1999
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D007989 68
% 207.97/208.12 |- skos__broader mesh__D007989smesh__D011574
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 1993
% 207.97/208.12 |- rdf__type mesh__D007989sskos__Concept
% 207.97/208.12 |- mesh__dateEstablished mesh__D007989 1968-01-01
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 1996
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 1995
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 2001
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D007989 1998
% 207.97/208.12 |- skos__annotation mesh__D032382
% 207.97/208.12 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.12 |- mesh__dateEstablished mesh__D032382 2003-01-01
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032382 2006
% 207.97/208.12 |- skos__broader mesh__D032382smesh__D029646
% 207.97/208.12 |- mesh__historyNote mesh__D032382 2003
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D032382 2003
% 207.97/208.12 |- rdf__type mesh__D032382sskos__Concept
% 207.97/208.12 |- skos__prefLabel mesh__D032382 Grewia
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032382 2003
% 207.97/208.12 |- mesh__dateCreated mesh__D032382 2002-07-03
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032382 2004
% 207.97/208.12 |- skos__altLabel mesh__D032382 Dhaman Tree
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032382 2005
% 207.97/208.12 |- skos__scopeNote mesh__D032382
% 207.97/208.12 A plant genus of the family TILIACEAE. Members contain lupeol and betulin TRITERPENES.%A%
% 207.97/208.12 |- rdf__type mesh__D004691sskos__Concept
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004691 2005
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D004691 67
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004691 2002
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004691 2003
% 207.97/208.12 |- mesh__dateRevised mesh__D004691 1997-06-20
% 207.97/208.12 |- mesh__dateCreated mesh__D004691 1999-01-01
% 207.97/208.12 |- skos__annotation mesh__D004691
% 207.97/208.12 do not use /util except by MeSH definition
% 207.97/208.12 |- skos__broader mesh__D004691smesh__D014656
% 207.97/208.12 |- mesh__dateEstablished mesh__D004691 1967-01-01
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004691 2001
% 207.97/208.12 |- mesh__recordMaintainer mesh__D004691 PXP
% 207.97/208.12 |- skos__related mesh__D004691smesh__D017073
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004691 2000
% 207.97/208.12 |- skos__prefLabel mesh__D004691 Endarterectomy
% 207.97/208.12 |- skos__hiddenLabel mesh__D004691 Endarterectomies
% 207.97/208.12 |- skos__related mesh__D004691smesh__D017130
% 207.97/208.12 |- skos__scopeNote mesh__D004691
% 207.97/208.12 Surgical excision, performed under general anesthesia, of the atheromatous tunica intima of an artery. When reconstruction of an artery is performed as an endovascular procedure through a catheter, it is called ATHERECTOMY.%A%
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004691 1999
% 207.97/208.12 |- skos__hiddenLabel mesh__D004691 Thromboendarterectomies
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004691 2006
% 207.97/208.12 |- mesh__historyNote mesh__D004691 67%28%65%29%
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D004691 SJN
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004691 2004
% 207.97/208.12 |- mesh__recordOriginator mesh__D004691 NLM
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004691 1998
% 207.97/208.12 |- mesh__dateRevised mesh__D017010 1992-05-18
% 207.97/208.12 |- skos__hiddenLabel mesh__D017010 Reminder System
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 2006
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 1998
% 207.97/208.12 |- skos__scopeNote mesh__D017010
% 207.97/208.12 Systems used to prompt or aid the memory. The systems can be computerized reminders, color coding, telephone calls, or devices such as letters and postcards.%A%
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 1997
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 2005
% 207.97/208.12 |- skos__prefLabel mesh__D017010 Reminder Systems
% 207.97/208.12 |- rdf__type mesh__D017010sskos__Concept
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 2002
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D017010 92
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 2004
% 207.97/208.12 |- mesh__historyNote mesh__D017010 92
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 1996
% 207.97/208.12 |- mesh__recordMaintainer mesh__D017010 TAP
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 1995
% 207.97/208.12 |- skos__broader mesh__D017010smesh__D003142
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 2001
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D017010 PLS
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 2003
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 2000
% 207.97/208.12 |- mesh__dateEstablished mesh__D017010 1992-01-01
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 1994
% 207.97/208.12 |- mesh__recordOriginator mesh__D017010 MXR
% 207.97/208.12 |- mesh__dateCreated mesh__D017010 1991-05-30
% 207.97/208.12 |- skos__broader mesh__D017010smesh__D007256
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 1993
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017010 1999
% 207.97/208.12 |- skos__hiddenLabel mesh__D017010 System, Reminder
% 207.97/208.12 |- skos__hiddenLabel mesh__D017010 Systems, Reminder
% 207.97/208.12 |- mesh__dateRevised mesh__D003599 2003-07-09
% 207.97/208.12 |- mesh__historyNote mesh__D003599
% 207.97/208.12 86; was CYTOPLASMIC FILAMENTS 1980-85; was MICROFILAMENTS see under CYTOPLASM 1977-79%A%
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Filament, Cytoskeletal
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D003599 sjn
% 207.97/208.12 |- mesh__onlineNote mesh__D003599
% 207.97/208.12 use CYTOSKELETON to search CYTOPLASMIC FILAMENTS 1977-85
% 207.97/208.12 |- skos__broader mesh__D003599smesh__D022083
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Cytoplasmic Filament
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Filaments, Cytoplasmic
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D003599 2005
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Filaments, Cytoskeletal
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D003599 2004
% 207.97/208.12 |- mesh__dateCreated mesh__D003599 1976-05-19
% 207.97/208.12 |- skos__historyNote mesh__D003599 Cellular Inclusions %28%1970-1976%29%
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D003599 2006
% 207.97/208.12 |- mesh__recordMaintainer mesh__D003599 nns
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Lattice, Microtrabecular
% 207.97/208.12 |- skos__historyNote mesh__D003599 Organoids %28%1966-1976%29%
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Filament, Cytoplasmic
% 207.97/208.12 |- mesh__dateEstablished mesh__D003599 1980-01-01
% 207.97/208.12 |- skos__annotation mesh__D003599
% 207.97/208.12 A 11 qualif except /cytol; /genet permitted
% 207.97/208.12 |- skos__historyNote mesh__D003599 Cytoplasm %28%1966-1976%29%
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D003599
% 207.97/208.12 86; was CYTOPLASMIC FILAMENTS 1980-85; was MICROFILAMENTS see under CYTOPLASM 1977-79%A%
% 207.97/208.12 |- skos__scopeNote mesh__D003599
% 207.97/208.12 The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm.%A%
% 207.97/208.12 |- mesh__recordOriginator mesh__D003599 VDK
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Microtrabecular Lattices
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Lattices, Microtrabecular
% 207.97/208.12 |- skos__related mesh__D003599smesh__D003598
% 207.97/208.12 |- skos__prefLabel mesh__D003599 Cytoskeleton
% 207.97/208.12 |- rdf__type mesh__D003599sskos__Concept
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Cytoskeletons
% 207.97/208.12 |- skos__hiddenLabel mesh__D003599 Cytoskeletal Filament
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D008284 PLS
% 207.97/208.12 |- mesh__recordMaintainer mesh__D008284 TGC
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 2005
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 1996
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 2004
% 207.97/208.12 |- mesh__recordOriginator mesh__D008284 NLM
% 207.97/208.12 |- skos__prefLabel mesh__D008284 Maintenance and Engineering, Hospital
% 207.97/208.12 |- mesh__historyNote mesh__D008284
% 207.97/208.12 80; was MAINTENANCE, HOSPITAL 1978-79; was HOSPITAL MAINTENANCE 1963-77%A%
% 207.97/208.12 |- skos__broader mesh__D008284smesh__D006748
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 2002
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 1998
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 2006
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 1997
% 207.97/208.12 |- mesh__dateCreated mesh__D008284 1999-01-01
% 207.97/208.12 |- skos__altLabel mesh__D008284 Engineering, Hospital
% 207.97/208.12 |- skos__altLabel mesh__D008284 Hospital Landscaping
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 1994
% 207.97/208.12 |- skos__annotation mesh__D008284
% 207.97/208.12 DF: MAINTENANCE HOSP or MAINTENANCE HOSPITAL
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 1993
% 207.97/208.12 |- skos__altLabel mesh__D008284 Groundskeeping, Hospital
% 207.97/208.12 |- rdf__type mesh__D008284sskos__Concept
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 1999
% 207.97/208.12 |- mesh__onlineNote mesh__D008284
% 207.97/208.12 use MAINTENANCE AND ENGINEERING, HOSPITAL to search MAINTENANCE, HOSPITAL 1978-79 %26% HOSPITAL MAINTENANCE 1966-77%A%
% 207.97/208.12 |- skos__scopeNote mesh__D008284
% 207.97/208.12 Hospital department whose primary function is the upkeep and supervision of the buildings and grounds and the maintenance of hospital physical plant and equipment which requires engineering expertise.%A%
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 2000
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 1995
% 207.97/208.12 |- skos__altLabel mesh__D008284 Hospital Maintenance and Engineering
% 207.97/208.12 |- mesh__dateRevised mesh__D008284 1992-05-14
% 207.97/208.12 |- skos__broader mesh__D008284smesh__D008283
% 207.97/208.12 |- skos__altLabel mesh__D008284 Maintenance, Hospital
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 2001
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D008284
% 207.97/208.12 80; was MAINTENANCE, HOSPITAL 1978-79; was HOSPITAL MAINTENANCE 1963-77%A%
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008284 2003
% 207.97/208.12 |- skos__scopeNote mesh__D016716
% 207.97/208.12 A CELL LINE derived from a PHEOCHROMOCYTOMA of the rat ADRENAL MEDULLA. PC12 cells stop dividing and undergo terminal differentiation when treated with NERVE GROWTH FACTOR, making the line a useful model system for NERVE CELL differentiation.%A%
% 207.97/208.12 |- skos__altLabel mesh__D016716 Pheochromocytoma Cell Line
% 207.97/208.12 |- skos__broader mesh__D016716smesh__D045744
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016716 2006
% 207.97/208.12 |- skos__hiddenLabel mesh__D016716 Cell Lines, Pheochromocytoma
% 207.97/208.12 |- rdf__type mesh__D016716sskos__Concept
% 207.97/208.12 |- skos__historyNote mesh__D016716 Cell Line %28%1976-1991%29%
% 207.97/208.12 |- skos__historyNote mesh__D016716 Tumor Cells, Cultured %28%1987-1991%29%
% 207.97/208.12 |- skos__hiddenLabel mesh__D016716 Cell Line, Pheochromocytoma
% 207.97/208.12 |- skos__historyNote mesh__D016716 Clone Cells %28%1977-1987%29%
% 207.97/208.12 |- skos__hiddenLabel mesh__D016716 Pheochromocytoma Cell Lines
% 207.97/208.12 |- mesh__dateRevised mesh__D016716 2003-07-09
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D016716 sjn
% 207.97/208.12 |- mesh__dateEstablished mesh__D016716 1992-01-01
% 207.97/208.12 |- mesh__historyNote mesh__D016716 92
% 207.97/208.12 |- skos__annotation mesh__D016716
% 207.97/208.12 PC stands for PheochromoCytoma; almost always NIM with no subheadings; check ANIMAL; %26% RATS; do not routinely add PHEOCHROMOCYTOMA or ADRENAL GLAND NEOPLASMS%A%
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016716 2004
% 207.97/208.12 |- skos__prefLabel mesh__D016716 PC12 Cells
% 207.97/208.12 |- mesh__dateCreated mesh__D016716 1991-02-11
% 207.97/208.12 |- mesh__recordOriginator mesh__D016716 AGS
% 207.97/208.12 |- mesh__recordMaintainer mesh__D016716 nns
% 207.97/208.12 |- skos__broader mesh__D016716smesh__D019439
% 207.97/208.12 |- skos__hiddenLabel mesh__D016716 PC12 Cell
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016716 2005
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D016716 92
% 207.97/208.12 |- skos__scopeNote mesh__D032383
% 207.97/208.12 Striated muscle cells found in the heart. They are derived from cardiac myoblasts %28%MYOBLASTS, CARDIAC%29%.%A%
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Cells, Heart Muscle
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Cells, Cardiac Muscle
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Muscle Cell, Heart
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Cardiac Myocytes
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Heart Muscle Cells
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Myocyte, Cardiac
% 207.97/208.12 |- mesh__dateEstablished mesh__D032383 2003-01-01
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Cell, Heart Muscle
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D032383 2003
% 207.97/208.12 |- rdf__type mesh__D032383sskos__Concept
% 207.97/208.12 |- skos__altLabel mesh__D032383 Muscle Cells, Cardiac
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032383 2003
% 207.97/208.12 |- skos__related mesh__D032383smesh__D009210
% 207.97/208.12 |- mesh__historyNote mesh__D032383 2003
% 207.97/208.12 |- skos__altLabel mesh__D032383 Muscle Cells, Heart
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Heart Muscle Cell
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032383 2004
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Muscle Cell, Cardiac
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Cardiac Muscle Cell
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Cell, Cardiac Muscle
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032383 2005
% 207.97/208.12 |- skos__historyNote mesh__D032383 Myocardium/cytology %28%1968-2002%29%
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Cardiac Myocyte
% 207.97/208.12 |- skos__hiddenLabel mesh__D032383 Cardiac Muscle Cells
% 207.97/208.12 |- skos__broader mesh__D032383smesh__D032342
% 207.97/208.12 |- skos__related mesh__D032383smesh__D032386
% 207.97/208.12 |- skos__prefLabel mesh__D032383 Myocytes, Cardiac
% 207.97/208.12 |- mesh__dateCreated mesh__D032383 2002-07-03
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032383 2006
% 207.97/208.12 |- rdf__type mesh__D004692sskos__Concept
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 2002
% 207.97/208.12 |- skos__scopeNote mesh__D004692
% 207.97/208.12 Inflammation of the tunica intima of an artery. %28%Dorland, 27th ed%29%%A%
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 1994
% 207.97/208.12 |- mesh__recordOriginator mesh__D004692 NLM
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 1995
% 207.97/208.12 |- skos__hiddenLabel mesh__D004692 Endarteritides
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 1998
% 207.97/208.12 |- skos__annotation mesh__D004692 inflamm of the intima of an artery
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 2000
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 2005
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 1996
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 2003
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 1999
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 2006
% 207.97/208.12 |- mesh__dateCreated mesh__D004692 1999-01-01
% 207.97/208.12 |- skos__prefLabel mesh__D004692 Endarteritis
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 1997
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 2004
% 207.97/208.12 |- mesh__recordMaintainer mesh__D004692 TAP
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004692 2001
% 207.97/208.12 |- mesh__dateRevised mesh__D004692 1993-06-02
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D004692 PLS
% 207.97/208.12 |- skos__broader mesh__D004692smesh__D001167
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D012326 2005
% 207.97/208.12 |- skos__historyNote mesh__D012326 Base Sequence %28%1976-1981%29%
% 207.97/208.12 |- skos__historyNote mesh__D012326 RNA, Messenger %28%1976-1981%29%
% 207.97/208.12 |- skos__hiddenLabel mesh__D012326 RNA Splicings
% 207.97/208.12 |- skos__scopeNote mesh__D012326
% 207.97/208.12 The ultimate exclusion of nonsense sequences or intervening sequences %28%introns%29% before the final RNA transcript is sent to the cytoplasm.%A%
% 207.97/208.12 |- mesh__dateEstablished mesh__D012326 1982-01-01
% 207.97/208.12 |- mesh__recordMaintainer mesh__D012326 nns
% 207.97/208.12 |- mesh__historyNote mesh__D012326 82
% 207.97/208.12 |- skos__annotation mesh__D012326
% 207.97/208.12 note category: a physiol process taking place within the cell nucleus; do not confuse with DNA, RECOMBINANT; CLONING, MOLECULAR or GENETIC INTERVENTION%A%
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D012326 82
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D012326 sjn
% 207.97/208.12 |- skos__related mesh__D012326smesh__D012322
% 207.97/208.12 |- skos__related mesh__D012326smesh__D017381
% 207.97/208.12 |- skos__historyNote mesh__D012326
% 207.97/208.12 Nucleic Acid Precursors %28%1976-1981%29%
% 207.97/208.12 |- mesh__dateRevised mesh__D012326 2004-07-07
% 207.97/208.12 |- skos__prefLabel mesh__D012326 RNA Splicing
% 207.97/208.12 |- skos__altLabel mesh__D012326 Splicing, RNA
% 207.97/208.12 |- skos__hiddenLabel mesh__D012326 Splicings, RNA
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D012326 2006
% 207.97/208.12 |- mesh__recordOriginator mesh__D012326 AEP
% 207.97/208.12 |- skos__broader mesh__D012326smesh__D012323
% 207.97/208.12 |- rdf__type mesh__D012326sskos__Concept
% 207.97/208.12 |- mesh__dateCreated mesh__D012326 1981-05-20
% 207.97/208.12 |- skos__historyNote mesh__D012326 Transcription, Genetic %28%1976-1981%29%
% 207.97/208.12 |- mesh__historyNote mesh__D017011 92
% 207.97/208.12 |- skos__annotation mesh__D017011
% 207.97/208.12 pathogenic for swine; infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; DF: STREP SUIS%A%
% 207.97/208.12 |- mesh__dateRevised mesh__D017011 2005-06-30
% 207.97/208.12 |- mesh__recordOriginator mesh__D017011 PXP
% 207.97/208.12 |- mesh__recordMaintainer mesh__D017011 SYSTEM
% 207.97/208.12 |- skos__broader mesh__D017011smesh__D013291
% 207.97/208.12 |- skos__prefLabel mesh__D017011 Streptococcus suis
% 207.97/208.12 |- mesh__dateCreated mesh__D017011 1991-05-30
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D017011 2006
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D017011 sjn
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D017011 92
% 207.97/208.12 |- skos__historyNote mesh__D017011 Streptococcus %28%1966-1991%29%
% 207.97/208.12 |- skos__scopeNote mesh__D017011
% 207.97/208.12 A species of STREPTOCOCCUS isolated from pigs. It is a pathogen of swine but rarely occurs in humans.%A%
% 207.97/208.12 |- mesh__dateEstablished mesh__D017011 1992-01-01
% 207.97/208.12 |- rdf__type mesh__D017011sskos__Concept
% 207.97/208.12 |- skos__broader mesh__D016718Q000031smesh__D016718
% 207.97/208.12 |- mesh__preferredCombination mesh__D016718Q000031smesh__D001095
% 207.97/208.12 |- rdf__type mesh__D016718Q000031smesh__CompoundConcept
% 207.97/208.12 |- skos__altLabel mesh__D008285 Histocompatibility Complex
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008285 2006A
% 207.97/208.12 |- mesh__recordMaintainer mesh__D008285 ags
% 207.97/208.12 |- mesh__historyNote mesh__D008285 79
% 207.97/208.12 |- skos__broader mesh__D008285smesh__D007125
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D008285 2006
% 207.97/208.12 |- skos__annotation mesh__D008285 DF: MHC
% 207.97/208.12 |- mesh__recordOriginator mesh__D008285 AEP
% 207.97/208.12 |- skos__hiddenLabel mesh__D008285 Complices, Major Histocompatibility
% 207.97/208.12 |- skos__broader mesh__D008285smesh__D005796
% 207.97/208.12 |- rdf__type mesh__D008285sskos__Concept
% 207.97/208.12 |- skos__hiddenLabel mesh__D008285 Complices, Histocompatibility
% 207.97/208.12 |- skos__hiddenLabel mesh__D008285 Complex, Histocompatibility
% 207.97/208.12 |- skos__related mesh__D008285smesh__D005805
% 207.97/208.12 |- mesh__dateRevised mesh__D008285 2005-07-18
% 207.97/208.12 |- skos__scopeNote mesh__D008285
% 207.97/208.12 The genetic region which contains the loci of genes which determine the structure of the serologically defined %28%SD%29% and lymphocyte-defined %28%LD%29% TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement.%A%
% 207.97/208.12 |- skos__hiddenLabel mesh__D008285 Histocompatibility Complices, Major
% 207.97/208.12 |- skos__hiddenLabel mesh__D008285 Histocompatibility Complices
% 207.97/208.12 |- skos__historyNote mesh__D008285 HLA Antigens %28%1975-1978%29%
% 207.97/208.12 |- mesh__dateCreated mesh__D008285 1978-03-20
% 207.97/208.12 |- skos__historyNote mesh__D008285
% 207.97/208.12 Histocompatibility Antigens %28%1973-1978%29%
% 207.97/208.12 |- skos__hiddenLabel mesh__D008285 Complex, Major Histocompatibility
% 207.97/208.12 |- skos__hiddenLabel mesh__D008285 Histocompatibility Complex, Major
% 207.97/208.12 |- mesh__dateEstablished mesh__D008285 1979-01-01
% 207.97/208.12 |- skos__prefLabel mesh__D008285 Major Histocompatibility Complex
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D008285 ags
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D008285 79
% 207.97/208.12 |- skos__hiddenLabel mesh__D008285 Major Histocompatibility Complices
% 207.97/208.12 |- skos__altLabel mesh__D016717 Endoscopic Sphincterotomy
% 207.97/208.12 |- mesh__dateCreated mesh__D016717 1991-02-11
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016717 2001
% 207.97/208.12 |- mesh__dateRevised mesh__D016717 1999-11-03
% 207.97/208.12 |- skos__historyNote mesh__D016717
% 207.97/208.12 Sphincterotomy, Transhepatic %28%1986-1991%29%
% 207.97/208.12 |- skos__historyNote mesh__D016717
% 207.97/208.12 Oddi%27%s Sphincter/surgery %28%1974-1991%29%
% 207.97/208.12 |- skos__altLabel mesh__D016717 Endoscopic Papillotomy
% 207.97/208.12 |- skos__broader mesh__D016717smesh__D001662
% 207.97/208.12 |- skos__hiddenLabel mesh__D016717 Sphincterotomies, Endoscopic
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016717 2006
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016717 2000
% 207.97/208.12 |- skos__hiddenLabel mesh__D016717 Papillotomies, Endoscopic
% 207.97/208.12 |- skos__prefLabel mesh__D016717 Sphincterotomy, Endoscopic
% 207.97/208.12 |- skos__historyNote mesh__D016717
% 207.97/208.12 Vater%27%s Ampulla/surgery %28%1974-1991%29%
% 207.97/208.12 |- skos__hiddenLabel mesh__D016717 Endoscopic Sphincterotomies
% 207.97/208.12 |- skos__altLabel mesh__D016717 Papillotomy, Endoscopic
% 207.97/208.12 |- skos__historyNote mesh__D016717 Endoscopy %28%1974-1991%29%
% 207.97/208.12 |- skos__annotation mesh__D016717
% 207.97/208.12 refers to Oddi%27%s sphincter or Vater%27%s ampulla only; coord with disease /surg, not /diag; /instrum is probably DUODENOSCOPES%A%
% 207.97/208.12 |- rdf__type mesh__D016717sskos__Concept
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016717 2005
% 207.97/208.12 |- mesh__dateEstablished mesh__D016717 1992-01-01
% 207.97/208.12 |- mesh__recordMaintainer mesh__D016717 nns
% 207.97/208.12 |- mesh__recordOriginator mesh__D016717 AGS
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016717 2004
% 207.97/208.12 |- skos__related mesh__D016717smesh__D002760
% 207.97/208.12 |- mesh__historyNote mesh__D016717 92
% 207.97/208.12 |- skos__scopeNote mesh__D016717
% 207.97/208.12 Incision of Oddi%27%s sphincter or Vater%27%s ampulla performed by inserting a sphincterotome through an endoscope %28%DUODENOSCOPE%29% often following retrograde cholangiography %28%CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE%29%. Endoscopic treatment by sphincterotomy is the preferred method of treatment for patients with retained or recurrent bile duct stones post-cholecystectomy, and for poor-surgical-risk patients that have the gallbladder still present.%A%
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D016717 sjn
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016717 2003
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D016717 92
% 207.97/208.12 |- skos__hiddenLabel mesh__D016717 Endoscopic Papillotomies
% 207.97/208.12 |- skos__broader mesh__D016717smesh__D016099
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D016717 2002
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032384 2003
% 207.97/208.12 |- skos__altLabel mesh__D032384 Linden
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032384 2004
% 207.97/208.12 |- skos__scopeNote mesh__D032384
% 207.97/208.12 A plant genus of the family TILIACEAE. Some species in this genus are called Limetree which is nearly the same as the common name for lime %28%CITRUS AURANTIIFOLIA%29%. Some people are allergic to the POLLEN.%A%
% 207.97/208.12 |- skos__altLabel mesh__D032384 Basswood
% 207.97/208.12 |- skos__annotation mesh__D032384
% 207.97/208.12 Lime citrus fruit see CITRUS AURANTIIFOLIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032384 2005
% 207.97/208.12 |- mesh__dateEstablished mesh__D032384 2003-01-01
% 207.97/208.12 |- skos__prefLabel mesh__D032384 Tilia
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D032384 2006
% 207.97/208.12 |- skos__broader mesh__D032384smesh__D029646
% 207.97/208.12 |- mesh__dateCreated mesh__D032384 2002-07-02
% 207.97/208.12 |- mesh__historyNote mesh__D032384 2003
% 207.97/208.12 |- mesh__publicMeSHNote mesh__D032384 2003
% 207.97/208.12 |- rdf__type mesh__D032384sskos__Concept
% 207.97/208.12 |- skos__altLabel mesh__D004693 Endo-1,3-beta-Glucanase
% 207.97/208.12 |- mesh__recordAuthorizer mesh__D004693 sjn
% 207.97/208.12 |- skos__prefLabel mesh__D004693 Glucan Endo-1,3-beta-D-Glucosidase
% 207.97/208.12 |- mesh__dateCreated mesh__D004693 1974-11-19
% 207.97/208.12 |- skos__annotation mesh__D004693 DF: ENDO GLUCANASE
% 207.97/208.12 |- skos__historyNote mesh__D004693 Glycoside Hydrolases %28%1969-1974%29%
% 207.97/208.12 |- skos__hiddenLabel mesh__D004693 Glucan Endo 1,3 beta D Glucosidase
% 207.97/208.12 |- skos__hiddenLabel mesh__D004693 Endo 1,3 beta Glucanase
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004693 2005
% 207.97/208.12 |- skos__hiddenLabel mesh__D004693 Oligo 1,3 Glucosidase
% 207.97/208.12 |- mesh__historyNote mesh__D004693
% 207.97/208.12 97; was ENDO-1,3-BETA-GLUCANASE 1975-96 %28%see under GLYCOSIDE HYDROLASES 1975-90%29%%A%
% 207.97/208.12 |- skos__altLabel mesh__D004693 Oligo-1,3-Glucosidase
% 207.97/208.12 |- skos__hiddenLabel mesh__D004693 Endo-1,3-beta-D-Glucosidase, Glucan
% 207.97/208.12 |- mesh__recordOriginator mesh__D004693 NLM
% 207.97/208.12 |- mesh__activeMeSHYear mesh__D004693 2006
% 207.97/208.12 |- skos__historyNote mesh__D004693 Polysaccharides %28%1969-1974%29%
% 207.97/208.13 |- skos__scopeNote mesh__D004693
% 207.97/208.13 An endocellulase with specificity for the hydrolysis of 1,3-beta-D-glucosidic linkages in 1,3-beta-D-glucans including laminarin, paramylon, and pachyman.%A%
% 207.97/208.13 |- mesh__recordMaintainer mesh__D004693 jmp
% 207.97/208.13 |- skos__broader mesh__D004693smesh__D044602
% 207.97/208.13 |- mesh__dateEstablished mesh__D004693 1991-01-01
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D004693
% 207.97/208.13 97; was ENDO-1,3-BETA-GLUCANASE 1975-96 %28%see under GLYCOSIDE HYDROLASES 1975-90%29%%A%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004693 2004
% 207.97/208.13 |- mesh__dateRevised mesh__D004693 2003-07-09
% 207.97/208.13 |- rdf__type mesh__D004693sskos__Concept
% 207.97/208.13 |- skos__altLabel mesh__D004693 Zymolase
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012327 1999
% 207.97/208.13 |- skos__altLabel mesh__D012327 Infections, RNA Virus
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D012327 SJN
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012327 1998
% 207.97/208.13 |- skos__prefLabel mesh__D012327 RNA Virus Infections
% 207.97/208.13 |- skos__hiddenLabel mesh__D012327 RNA Virus Infection
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012327 2002
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D012327 98
% 207.97/208.13 |- skos__broader mesh__D012327smesh__D014777
% 207.97/208.13 |- skos__historyNote mesh__D012327 RNA Viruses %28%1975-1997%29%
% 207.97/208.13 |- skos__hiddenLabel mesh__D012327 Virus Infections, RNA
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012327 2006
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012327 2001
% 207.97/208.13 |- mesh__historyNote mesh__D012327 98; use explode 1975-97
% 207.97/208.13 |- rdf__type mesh__D012327sskos__Concept
% 207.97/208.13 |- mesh__dateCreated mesh__D012327 1999-01-01
% 207.97/208.13 |- mesh__dateRevised mesh__D012327 1997-06-20
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012327 2005
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012327 2000
% 207.97/208.13 |- mesh__dateEstablished mesh__D012327 1998-01-01
% 207.97/208.13 |- mesh__recordOriginator mesh__D012327 NLM
% 207.97/208.13 |- skos__hiddenLabel mesh__D012327 Virus Infection, RNA
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012327 2004
% 207.97/208.13 |- skos__historyNote mesh__D012327 Virus Diseases %28%1975-1997%29%
% 207.97/208.13 |- skos__hiddenLabel mesh__D012327 Infection, RNA Virus
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012327 2003
% 207.97/208.13 |- skos__annotation mesh__D012327
% 207.97/208.13 GEN or unspecified; prefer specifics; DF: RNA VIRUS INFECT%A%
% 207.97/208.13 |- mesh__recordMaintainer mesh__D012327 TGC
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D017012 92
% 207.97/208.13 |- skos__scopeNote mesh__D017012
% 207.97/208.13 An order of anaerobic, coccoid to rod-shaped methanogens, in the kingdom EURYARCHAEOTA. They are nonmotile, do not catabolize carbohydrates, proteinaceous material, or organic compounds other than formate or carbon monoxide, and are widely distributed in nature.%A%
% 207.97/208.13 |- mesh__recordOriginator mesh__D017012 PXP
% 207.97/208.13 |- mesh__dateEstablished mesh__D017012 1992-01-01
% 207.97/208.13 |- mesh__recordMaintainer mesh__D017012 SYSTEM
% 207.97/208.13 |- skos__broader mesh__D017012smesh__D019605
% 207.97/208.13 |- mesh__dateCreated mesh__D017012 1991-05-30
% 207.97/208.13 |- skos__prefLabel mesh__D017012 Methanobacteriales
% 207.97/208.13 |- mesh__dateRevised mesh__D017012 2005-06-30
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D017012 2006
% 207.97/208.13 |- rdf__type mesh__D017012sskos__Concept
% 207.97/208.13 |- mesh__historyNote mesh__D017012 92
% 207.97/208.13 |- skos__annotation mesh__D017012
% 207.97/208.13 an order of methanogens found throughout nature
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D017012 sjn
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D008286
% 207.97/208.13 65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64%A%
% 207.97/208.13 |- skos__scopeNote mesh__D008286
% 207.97/208.13 General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.%A%
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D008286 sjn
% 207.97/208.13 |- skos__broader mesh__D008286smesh__D007410
% 207.97/208.13 |- skos__hiddenLabel mesh__D008286 Syndrome, Malabsorption
% 207.97/208.13 |- skos__broader mesh__D008286smesh__D008659
% 207.97/208.13 |- skos__hiddenLabel mesh__D008286 Syndromes, Malabsorption
% 207.97/208.13 |- mesh__recordMaintainer mesh__D008286 lkt
% 207.97/208.13 |- skos__hiddenLabel mesh__D008286 Malabsorption Syndrome
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008286 2004
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008286 2005
% 207.97/208.13 |- mesh__historyNote mesh__D008286
% 207.97/208.13 65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64%A%
% 207.97/208.13 |- mesh__dateEstablished mesh__D008286 1965-01-01
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008286 2006
% 207.97/208.13 |- mesh__dateCreated mesh__D008286 1999-01-01
% 207.97/208.13 |- mesh__dateRevised mesh__D008286 2003-07-09
% 207.97/208.13 |- mesh__recordOriginator mesh__D008286 NLM
% 207.97/208.13 |- skos__prefLabel mesh__D008286 Malabsorption Syndromes
% 207.97/208.13 |- rdf__type mesh__D008286sskos__Concept
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D016718 sjn
% 207.97/208.13 |- skos__historyNote mesh__D016718 Arachidonic Acids %28%1975-1991%29%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016718 2006
% 207.97/208.13 |- skos__altLabel mesh__D016718
% 207.97/208.13 %28%all-Z%29%-5,8,11,14-Eicosatetraenoic acid
% 207.97/208.13 |- mesh__recordMaintainer mesh__D016718 sjn
% 207.97/208.13 |- mesh__dateCreated mesh__D016718 1991-02-08
% 207.97/208.13 |- skos__broader mesh__D016718smesh__D001095
% 207.97/208.13 |- skos__hiddenLabel mesh__D016718 Arachidonate, Sodium
% 207.97/208.13 |- rdf__type mesh__D016718sskos__Concept
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016718 2005
% 207.97/208.13 |- skos__prefLabel mesh__D016718 Arachidonic Acid
% 207.97/208.13 |- skos__annotation mesh__D016718 do not confuse with ARACHIDONIC ACIDS
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D016718
% 207.97/208.13 92; ARACHIDONIC ACID was indexed under ARACHIDONIC ACIDS 1981-91%A%
% 207.97/208.13 |- mesh__historyNote mesh__D016718
% 207.97/208.13 92; was ARACHIDONIC ACID %28%NM%29% 1981-91
% 207.97/208.13 |- skos__altLabel mesh__D016718 Vitamin F
% 207.97/208.13 |- skos__altLabel mesh__D016718 Sodium Arachidonate
% 207.97/208.13 |- mesh__recordOriginator mesh__D016718 RLS
% 207.97/208.13 |- mesh__onlineNote mesh__D016718
% 207.97/208.13 use ARACHIDONIC ACID %28%NM%29% to search ARACHIDONIC ACID 1977-91%A%
% 207.97/208.13 |- skos__scopeNote mesh__D016718
% 207.97/208.13 An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes.%A%
% 207.97/208.13 |- mesh__dateEstablished mesh__D016718 1992-01-01
% 207.97/208.13 |- mesh__dateRevised mesh__D016718 2004-07-13
% 207.97/208.13 |- skos__prefLabel mesh__D013420 Sulfamethoxazole
% 207.97/208.13 |- mesh__dateCreated mesh__D013420 1999-01-01
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013420 2004
% 207.97/208.13 |- mesh__recordMaintainer mesh__D013420 jmp
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D013420 sjn
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013420 2002
% 207.97/208.13 |- skos__broader mesh__D013420smesh__D013424
% 207.97/208.13 |- rdf__type mesh__D013420sskos__Concept
% 207.97/208.13 |- mesh__recordOriginator mesh__D013420 NLM
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013420 2003
% 207.97/208.13 |- skos__altLabel mesh__D013420 Sulfamethylisoxazole
% 207.97/208.13 |- mesh__dateEstablished mesh__D013420 1968-01-01
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013420 2006
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D013420 68
% 207.97/208.13 |- skos__annotation mesh__D013420 a sulfanilamide anti-infective
% 207.97/208.13 |- skos__altLabel mesh__D013420 Sulfisomezole
% 207.97/208.13 |- skos__scopeNote mesh__D013420
% 207.97/208.13 A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p208%29%%A%
% 207.97/208.13 |- skos__altLabel mesh__D013420 Sulphamethoxazole
% 207.97/208.13 |- mesh__dateRevised mesh__D013420 2001-07-25
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013420 2005
% 207.97/208.13 |- mesh__historyNote mesh__D013420 68%28%63%29%
% 207.97/208.13 |- mesh__historyNote mesh__D032385 2003
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D032385 2005
% 207.97/208.13 |- skos__annotation mesh__D032385
% 207.97/208.13 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D032385 2006
% 207.97/208.13 |- skos__prefLabel mesh__D032385 Triumfetta
% 207.97/208.13 |- skos__broader mesh__D032385smesh__D029646
% 207.97/208.13 |- skos__scopeNote mesh__D032385
% 207.97/208.13 A plant genus of the family TILIACEAE. The common name of burweed is also used for AMSINCKIA. Triumfetta semitriloba is considered a noxious weed.%A%
% 207.97/208.13 |- mesh__dateCreated mesh__D032385 2002-07-03
% 207.97/208.13 |- mesh__dateEstablished mesh__D032385 2003-01-01
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D032385 2003
% 207.97/208.13 |- rdf__type mesh__D032385sskos__Concept
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D032385 2003
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D032385 2004
% 207.97/208.13 |- skos__broader mesh__D005530Q000151smesh__D005530
% 207.97/208.13 |- mesh__preferredCombination mesh__D005530Q000151smesh__D005532
% 207.97/208.13 |- rdf__type mesh__D005530Q000151smesh__CompoundConcept
% 207.97/208.13 |- skos__hiddenLabel mesh__D004694 Ostium Primum, Persistent
% 207.97/208.13 |- skos__hiddenLabel mesh__D004694 Endocardial Cushion Defect
% 207.97/208.13 |- skos__annotation mesh__D004694
% 207.97/208.13 a heart septal defect; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 207.97/208.13 |- skos__hiddenLabel mesh__D004694 Cushion Defect, Endocardial
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004694 2003
% 207.97/208.13 |- skos__historyNote mesh__D004694
% 207.97/208.13 Heart Defects, Congenital %28%1966-1982%29%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004694 2006
% 207.97/208.13 |- skos__hiddenLabel mesh__D004694 Cushion Defects, Endocardial
% 207.97/208.13 |- skos__prefLabel mesh__D004694 Endocardial Cushion Defects
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004694 2000
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004694 2004
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004694 2001
% 207.97/208.13 |- skos__broader mesh__D004694smesh__D006343
% 207.97/208.13 |- mesh__dateEstablished mesh__D004694 1991-01-01
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D004694 sjn
% 207.97/208.13 |- rdf__type mesh__D004694sskos__Concept
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004694 2002
% 207.97/208.13 |- mesh__dateRevised mesh__D004694 1999-11-03
% 207.97/208.13 |- skos__hiddenLabel mesh__D004694 Primum, Persistent Ostium
% 207.97/208.13 |- mesh__recordOriginator mesh__D004694 AEP
% 207.97/208.13 |- mesh__recordMaintainer mesh__D004694 kle
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D004694
% 207.97/208.13 91; was see under HEART SEPTAL DEFECTS 1983-90
% 207.97/208.13 |- skos__scopeNote mesh__D004694
% 207.97/208.13 A spectrum of septal defects associated with persistence of the embryonic atrioventricular canal due to incomplete growth and fusion of the endocardial cushion.%A%
% 207.97/208.13 |- skos__hiddenLabel mesh__D004694 Defect, Endocardial Cushion
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004694 2005
% 207.97/208.13 |- mesh__dateCreated mesh__D004694 1982-04-23
% 207.97/208.13 |- mesh__historyNote mesh__D004694
% 207.97/208.13 91%28%83%29%; was see under HEART SEPTAL DEFECTS 1983-90
% 207.97/208.13 |- skos__hiddenLabel mesh__D004694 Defects, Endocardial Cushion
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D045502 2004
% 207.97/208.13 |- mesh__recordOriginator mesh__D045502 ags
% 207.97/208.13 |- skos__prefLabel mesh__D045502 Helicobacter mustelae
% 207.97/208.13 |- skos__annotation mesh__D045502
% 207.97/208.13 infection: coord IM with HELICOBACTER INFECTIONS %28%IM%29%
% 207.97/208.13 |- skos__broader mesh__D045502smesh__D016998
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D045502 sjn
% 207.97/208.13 |- rdf__type mesh__D045502sskos__Concept
% 207.97/208.13 |- mesh__dateRevised mesh__D045502 2005-06-30
% 207.97/208.13 |- skos__historyNote mesh__D045502 Helicobacter %28%1992-2003%29%
% 207.97/208.13 |- mesh__dateEstablished mesh__D045502 2004-01-01
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D045502 2006
% 207.97/208.13 |- mesh__historyNote mesh__D045502 2004
% 207.97/208.13 |- mesh__dateCreated mesh__D045502 2003-07-09
% 207.97/208.13 |- skos__scopeNote mesh__D045502
% 207.97/208.13 A species of HELICOBACTER commonly associated with STOMACH DISEASES in FERRETS.%A%
% 207.97/208.13 |- mesh__recordMaintainer mesh__D045502 SYSTEM
% 207.97/208.13 |- skos__hiddenLabel mesh__D012328 Virus, RNA
% 207.97/208.13 |- skos__prefLabel mesh__D012328 RNA Viruses
% 207.97/208.13 |- skos__broader mesh__D012328smesh__D014780
% 207.97/208.13 |- skos__hiddenLabel mesh__D012328 Viruses, RNA
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012328 2006
% 207.97/208.13 |- skos__scopeNote mesh__D012328
% 207.97/208.13 Viruses whose genetic material is RNA.
% 207.97/208.13 |- mesh__dateCreated mesh__D012328 1999-01-01
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D012328 SJN
% 207.97/208.13 |- rdf__type mesh__D012328sskos__Concept
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012328 2005
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012328 2002
% 207.97/208.13 |- mesh__historyNote mesh__D012328
% 207.97/208.13 66; RNA RODENT VIRUSES was heading 1975-93
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D012328
% 207.97/208.13 66; RNA RODENT VIRUSES was heading 1975-93
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012328 2004
% 207.97/208.13 |- skos__hiddenLabel mesh__D012328 RNA Rodent Virus
% 207.97/208.13 |- skos__annotation mesh__D012328
% 207.97/208.13 avoid: too general; prefer specifics; infection = RNA VIRUS INFECTIONS%A%
% 207.97/208.13 |- mesh__onlineNote mesh__D012328
% 207.97/208.13 use RNA VIRUSES to search RNA RODENT VIRUSES 1975-93
% 207.97/208.13 |- skos__broader mesh__D012328smesh__D014712
% 207.97/208.13 |- skos__hiddenLabel mesh__D012328 Viruses, RNA Rodent
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012328 2001
% 207.97/208.13 |- mesh__dateRevised mesh__D012328 1997-06-20
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012328 2003
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012328 1999
% 207.97/208.13 |- mesh__recordMaintainer mesh__D012328 TGC
% 207.97/208.13 |- mesh__dateEstablished mesh__D012328 1966-01-01
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012328 2000
% 207.97/208.13 |- skos__hiddenLabel mesh__D012328 Rodent Viruses, RNA
% 207.97/208.13 |- skos__hiddenLabel mesh__D012328 Virus, RNA Rodent
% 207.97/208.13 |- skos__hiddenLabel mesh__D012328 RNA Virus
% 207.97/208.13 |- mesh__recordOriginator mesh__D012328 NLM
% 207.97/208.13 |- skos__hiddenLabel mesh__D012328 Rodent Virus, RNA
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012328 1998
% 207.97/208.13 |- skos__prefLabel mesh__D017013 Methanobacteriaceae
% 207.97/208.13 |- mesh__dateEstablished mesh__D017013 1992-01-01
% 207.97/208.13 |- skos__broader mesh__D017013smesh__D017012
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D017013 92
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D017013 sjn
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D017013 2006
% 207.97/208.13 |- mesh__recordMaintainer mesh__D017013 SYSTEM
% 207.97/208.13 |- mesh__recordOriginator mesh__D017013 PXP
% 207.97/208.13 |- mesh__historyNote mesh__D017013 92
% 207.97/208.13 |- rdf__type mesh__D017013sskos__Concept
% 207.97/208.13 |- skos__scopeNote mesh__D017013
% 207.97/208.13 A family of anaerobic, coccoid to rod-shaped METHANOBACTERIALES. Cell membranes are composed mainly of polyisoprenoid hydrocarbons ether-linked to glycerol. Its organisms are found in anaerobic habitats throughout nature.%A%
% 207.97/208.13 |- mesh__dateCreated mesh__D017013 1991-05-30
% 207.97/208.13 |- mesh__dateRevised mesh__D017013 2005-06-30
% 207.97/208.13 |- mesh__recordOriginator mesh__D008287 NLM
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008287 2002
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008287 2003
% 207.97/208.13 |- mesh__dateEstablished mesh__D008287 1973-01-01
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D008287 73
% 207.97/208.13 |- mesh__recordMaintainer mesh__D008287 KEV
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D008287 sjn
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008287 2004
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008287 2005
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008287 2000
% 207.97/208.13 |- skos__hiddenLabel mesh__D008287 Malacoplakias
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008287 2006
% 207.97/208.13 |- mesh__dateCreated mesh__D008287 1999-01-01
% 207.97/208.13 |- skos__prefLabel mesh__D008287 Malacoplakia
% 207.97/208.13 |- mesh__historyNote mesh__D008287 73%28%65%29%
% 207.97/208.13 |- mesh__dateRevised mesh__D008287 1999-11-03
% 207.97/208.13 |- skos__broader mesh__D008287smesh__D010335
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D008287 2001
% 207.97/208.13 |- rdf__type mesh__D008287sskos__Concept
% 207.97/208.13 |- skos__scopeNote mesh__D008287
% 207.97/208.13 The formation of soft patches on the mucous membrane of a hollow organ, such as the urogenital tract or digestive tract.%A%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016719 2004
% 207.97/208.13 |- mesh__recordMaintainer mesh__D016719 TPW
% 207.97/208.13 |- skos__altLabel mesh__D016719 Radiolabelled Immunoscintigraphy
% 207.97/208.13 |- mesh__dateRevised mesh__D016719 1997-06-20
% 207.97/208.13 |- mesh__recordOriginator mesh__D016719 AGS
% 207.97/208.13 |- skos__altLabel mesh__D016719 Immunoscintigraphy, Radiolabeled
% 207.97/208.13 |- mesh__historyNote mesh__D016719 92
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016719 1999
% 207.97/208.13 |- skos__annotation mesh__D016719
% 207.97/208.13 uses radiolabeled antibodies for diag imaging; do not use /util except by MeSH definition; coord IM or NIM with dis /radionuclide %28%IM%29%, not /diag, not /radiogr %26% not /immunol, + specific radioisotope /diag use %28%IM or NIM%29%%A%
% 207.97/208.13 |- skos__altLabel mesh__D016719 Immunoscintigraphy, Radiolabelled
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016719 2003
% 207.97/208.13 |- skos__broader mesh__D016719smesh__D007158
% 207.97/208.13 |- skos__hiddenLabel mesh__D016719 Radiolabeled Immunoscintigraphies
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016719 1998
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D016719 92
% 207.97/208.13 |- skos__historyNote mesh__D016719
% 207.97/208.13 Antibodies, Monoclonal/diagnostic use %28%1980-1991%29%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016719 2002
% 207.97/208.13 |- skos__broader mesh__D016719smesh__D011877
% 207.97/208.13 |- skos__hiddenLabel mesh__D016719 Radioimmunoscintigraphies
% 207.97/208.13 |- skos__altLabel mesh__D016719 Radioimmunoimaging
% 207.97/208.13 |- skos__altLabel mesh__D016719 Radiolabeled Immunoscintigraphy
% 207.97/208.13 |- mesh__dateCreated mesh__D016719 1991-02-11
% 207.97/208.13 |- skos__hiddenLabel mesh__D016719 Immunoscintigraphies, Radiolabeled
% 207.97/208.13 |- skos__historyNote mesh__D016719 Radionuclide Imaging %28%1980-1991%29%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016719 2006
% 207.97/208.13 |- skos__prefLabel mesh__D016719 Radioimmunodetection
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016719 2001
% 207.97/208.13 |- skos__hiddenLabel mesh__D016719 Radioimmunoimagings
% 207.97/208.13 |- skos__scopeNote mesh__D016719
% 207.97/208.13 Use of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera.%A%
% 207.97/208.13 |- rdf__type mesh__D016719sskos__Concept
% 207.97/208.13 |- skos__historyNote mesh__D016719 Antibodies, Neoplasm %28%1980-1986%29%
% 207.97/208.13 |- skos__hiddenLabel mesh__D016719 Radiolabelled Immunoscintigraphies
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016719 2000
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D016719 2005
% 207.97/208.13 |- mesh__dateEstablished mesh__D016719 1992-01-01
% 207.97/208.13 |- skos__hiddenLabel mesh__D016719 Radioimmunodetections
% 207.97/208.13 |- skos__hiddenLabel mesh__D016719 Immunoscintigraphies, Radiolabelled
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D016719 SJN
% 207.97/208.13 |- skos__altLabel mesh__D016719 Radioimmunoscintigraphy
% 207.97/208.13 |- mesh__dateEstablished mesh__D027441 2002-01-01
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D027441 2006
% 207.97/208.13 |- mesh__dateCreated mesh__D027441 2001-07-25
% 207.97/208.13 |- skos__scopeNote mesh__D027441
% 207.97/208.13 A plant genus in the LAURACEAE family. The tree bark has been used medicinally.%A%
% 207.97/208.13 |- mesh__historyNote mesh__D027441 2002; use LAURACEAE 1996-2001
% 207.97/208.13 |- skos__prefLabel mesh__D027441 Sassafras
% 207.97/208.13 |- rdf__type mesh__D027441sskos__Concept
% 207.97/208.13 |- mesh__recordOriginator mesh__D027441 ssb
% 207.97/208.13 |- mesh__recordMaintainer mesh__D027441 ssb
% 207.97/208.13 |- skos__annotation mesh__D027441
% 207.97/208.13 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D027441 2002; see LAURACEAE 1996-2001
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D027441 sjn
% 207.97/208.13 |- skos__broader mesh__D027441smesh__D019770
% 207.97/208.13 |- mesh__dateRevised mesh__D027441 2004-07-07
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D027441 2005
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013421 2003
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013421 2001
% 207.97/208.13 |- mesh__dateRevised mesh__D013421 2000-06-22
% 207.97/208.13 |- mesh__recordMaintainer mesh__D013421 CCR
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013421 2004
% 207.97/208.13 |- skos__prefLabel mesh__D013421 Sulfamethoxypyridazine
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013421 2002
% 207.97/208.13 |- skos__altLabel mesh__D013421 Sulphamethoxypyridazine
% 207.97/208.13 |- rdf__type mesh__D013421sskos__Concept
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013421 2005
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D013421 2006
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D013421 sjn
% 207.97/208.13 |- skos__broader mesh__D013421smesh__D013424
% 207.97/208.13 |- mesh__recordOriginator mesh__D013421 NLM
% 207.97/208.13 |- mesh__dateCreated mesh__D013421 1999-01-01
% 207.97/208.13 |- skos__altLabel mesh__D013421 Sulfapyridazine
% 207.97/208.13 |- skos__scopeNote mesh__D013421 A sulfanilamide antibacterial agent.
% 207.97/208.13 |- mesh__historyNote mesh__D032386 2003
% 207.97/208.13 |- skos__related mesh__D032386smesh__D032383
% 207.97/208.13 |- mesh__dateEstablished mesh__D032386 2003-01-01
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D032386 2003
% 207.97/208.13 |- skos__hiddenLabel mesh__D032386 Cardiac Myoblast
% 207.97/208.13 |- skos__historyNote mesh__D032386 Myocardium %28%1969-2002%29%
% 207.97/208.13 |- skos__hiddenLabel mesh__D032386 Cardiac Myoblasts
% 207.97/208.13 |- mesh__dateCreated mesh__D032386 2002-07-03
% 207.97/208.13 |- skos__prefLabel mesh__D032386 Myoblasts, Cardiac
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D032386 2006
% 207.97/208.13 |- skos__scopeNote mesh__D032386
% 207.97/208.13 Precursor cells destined to differentiate into cardiac myocytes %28%MYOCYTES, CARDIAC%29%.%A%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D032386 2005
% 207.97/208.13 |- skos__broader mesh__D032386smesh__D032446
% 207.97/208.13 |- skos__hiddenLabel mesh__D032386 Myoblast, Cardiac
% 207.97/208.13 |- rdf__type mesh__D032386sskos__Concept
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D032386 2004
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D032386 2003
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D051540 sjn
% 207.97/208.13 |- rdf__type mesh__D051540sskos__Concept
% 207.97/208.13 |- skos__broader mesh__D051540smesh__D014157
% 207.97/208.13 |- skos__hiddenLabel mesh__D051540 Transcription Factors, Winged-Helix
% 207.97/208.13 |- mesh__dateEstablished mesh__D051540 2006-01-01
% 207.97/208.13 |- mesh__historyNote mesh__D051540 2006
% 207.97/208.13 |- skos__prefLabel mesh__D051540 Winged-Helix Transcription Factors
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D051540 2006
% 207.97/208.13 |- mesh__recordMaintainer mesh__D051540 DRC
% 207.97/208.13 |- skos__broader mesh__D051540smesh__D004268
% 207.97/208.13 |- mesh__dateCreated mesh__D051540 2005-06-30
% 207.97/208.13 |- skos__scopeNote mesh__D051540
% 207.97/208.13 A subfamily of HELIX-TURN-HELIX DNA-binding proteins that contain a variable length loop adjacent to the HTH motif. The loop connects two anti-parallel strands and forms a wing when bound to DNA.%A%
% 207.97/208.13 |- mesh__recordOriginator mesh__D051540 DRC
% 207.97/208.13 |- skos__hiddenLabel mesh__D051540 Winged Helix Transcription Factors
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D051540 2006
% 207.97/208.13 |- mesh__dateCreated mesh__D004695 1999-01-01
% 207.97/208.13 |- skos__hiddenLabel mesh__D004695 Fibroelastosis, Endocardial
% 207.97/208.13 |- mesh__recordOriginator mesh__D004695 NLM
% 207.97/208.13 |- mesh__dateRevised mesh__D004695 2005-07-15
% 207.97/208.13 |- rdf__type mesh__D004695sskos__Concept
% 207.97/208.13 |- skos__hiddenLabel mesh__D004695 Endocardial Fibroelastoses
% 207.97/208.13 |- skos__hiddenLabel mesh__D004695 Fibroelastoses, Endocardial
% 207.97/208.13 |- skos__scopeNote mesh__D004695
% 207.97/208.13 A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function %28%CARDIOMYOPATHY, RESTRICTIVE%29%. It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies %28%HEART DEFECTS,CONGENITAL;%29% INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.%A%
% 207.97/208.13 |- mesh__recordMaintainer mesh__D004695 ags
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004695 2006A
% 207.97/208.13 |- skos__broader mesh__D004695smesh__D009202
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004695 2005
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D004695 ags
% 207.97/208.13 |- skos__prefLabel mesh__D004695 Endocardial Fibroelastosis
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D004695 2006
% 207.97/208.13 |- skos__broader mesh__D045503smesh__D001473
% 207.97/208.13 |- rdf__type mesh__D045503sskos__Concept
% 207.97/208.13 |- skos__historyNote mesh__D045503 Bartonella %28%1966-2003%29%
% 207.97/208.13 |- skos__annotation mesh__D045503
% 207.97/208.13 infection: coord IM with BARTONELLA INFECTIONS %28%IM%29%
% 207.97/208.13 |- mesh__recordOriginator mesh__D045503 ags
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D045503 2006
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D045503 sjn
% 207.97/208.13 |- skos__scopeNote mesh__D045503
% 207.97/208.13 The type species of the genus BARTONELLA, a gram-negative bacteria found in humans. It is found in the mountain valleys of Peru, Ecuador, and Southwest Columbia where the sandfly %28%see PHLEBOTOMUS%29% vector is present. It causes OROYA FEVER and VERRUGA PERUANA.%A%
% 207.97/208.13 |- mesh__dateRevised mesh__D045503 2005-06-30
% 207.97/208.13 |- mesh__dateCreated mesh__D045503 2003-07-09
% 207.97/208.13 |- mesh__dateEstablished mesh__D045503 2004-01-01
% 207.97/208.13 |- skos__prefLabel mesh__D045503 Bartonella bacilliformis
% 207.97/208.13 |- mesh__recordMaintainer mesh__D045503 SYSTEM
% 207.97/208.13 |- mesh__publicMeSHNote mesh__D045503 2004
% 207.97/208.13 |- mesh__historyNote mesh__D045503 2004
% 207.97/208.13 |- mesh__recordMaintainer mesh__D012329 JRT
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012329 2005
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012329 1997
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012329 2001
% 207.97/208.13 |- skos__scopeNote mesh__D012329
% 207.97/208.13 Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis.%A%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012329 2006
% 207.97/208.13 |- rdf__type mesh__D012329sskos__Concept
% 207.97/208.13 |- mesh__recordOriginator mesh__D012329 NLM
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012329 2003
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012329 2002
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012329 2004
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012329 1998
% 207.97/208.13 |- mesh__dateRevised mesh__D012329 1995-03-20
% 207.97/208.13 |- mesh__recordAuthorizer mesh__D012329 PLS
% 207.97/208.13 |- skos__broader mesh__D012329smesh__D012313
% 207.97/208.13 |- skos__annotation mesh__D012329
% 207.97/208.13 IM; coord with specific bacterium %28%IM%29%; /drug eff /ultrastruct permitted; DF: RNA BACT%A%
% 207.97/208.13 |- mesh__activeMeSHYear mesh__D012329 1999
% 207.97/208.14 |- skos__prefLabel mesh__D012329 RNA, Bacterial
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D012329 2000
% 207.97/208.14 |- mesh__dateCreated mesh__D012329 1999-01-01
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D012329 1996
% 207.97/208.14 |- skos__altLabel mesh__D012329 Bacterial RNA
% 207.97/208.14 |- skos__altLabel mesh__D009380 Nerve Tissue Neoplasms
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 2001
% 207.97/208.14 |- rdf__type mesh__D009380sskos__Concept
% 207.97/208.14 |- skos__hiddenLabel mesh__D009380 Nervous Tissue Neoplasm
% 207.97/208.14 |- skos__prefLabel mesh__D009380 Neoplasms, Nerve Tissue
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 2002
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D009380 PLS
% 207.97/208.14 |- skos__scopeNote mesh__D009380
% 207.97/208.14 Neoplasms composed of nerve tissue. This concept does not refer to neoplasms located in the nervous system or its component nerves.%A%
% 207.97/208.14 |- skos__annotation mesh__D009380
% 207.97/208.14 neoplasms composed of nerve tissue, NOT neoplasms located in the nervous system or nerves %28% = NERVOUS SYSTEM NEOPLASMS%29%: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 2005
% 207.97/208.14 |- mesh__recordMaintainer mesh__D009380 KEV
% 207.97/208.14 |- mesh__recordOriginator mesh__D009380 NLM
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 1998
% 207.97/208.14 |- skos__broader mesh__D009380smesh__D009370
% 207.97/208.14 |- skos__altLabel mesh__D009380 Nervous Tissue Neoplasms
% 207.97/208.14 |- skos__altLabel mesh__D009380 Neoplasms, Nervous Tissue
% 207.97/208.14 |- mesh__dateCreated mesh__D009380 1999-01-01
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 2006
% 207.97/208.14 |- mesh__historyNote mesh__D009380
% 207.97/208.14 94; was NEOPLASMS, NERVOUS TISSUE 1963-93
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 2003
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 1999
% 207.97/208.14 |- mesh__dateRevised mesh__D009380 1995-06-08
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 1996
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 2004
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D009380
% 207.97/208.14 94; was NEOPLASMS, NERVOUS TISSUE 1963-93
% 207.97/208.14 |- skos__hiddenLabel mesh__D009380 Neoplasm, Nerve Tissue
% 207.97/208.14 |- mesh__onlineNote mesh__D009380
% 207.97/208.14 use NEOPLASMS, NERVE TISSUE to search NEOPLASMS, NERVOUS TISSUE 1966-93%A%
% 207.97/208.14 |- skos__hiddenLabel mesh__D009380 Neoplasm, Nervous Tissue
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 1997
% 207.97/208.14 |- skos__hiddenLabel mesh__D009380 Nerve Tissue Neoplasm
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009380 2000
% 207.97/208.14 |- mesh__dateCreated mesh__D017812 1993-02-16
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D017812 2004
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Water Moccasins
% 207.97/208.14 |- skos__broader mesh__D017812smesh__D012911
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Water Snakes
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Snakes, King
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Snakes, Garter
% 207.97/208.14 |- skos__altLabel mesh__D017812 Garter Snake
% 207.97/208.14 |- skos__prefLabel mesh__D017812 Colubridae
% 207.97/208.14 |- skos__altLabel mesh__D017812 Natrix
% 207.97/208.14 |- mesh__recordOriginator mesh__D017812 TGC
% 207.97/208.14 |- skos__annotation mesh__D017812
% 207.97/208.14 the largest family of snakes; its venom: coord IM with SNAKE VENOMS %28%IM%29%%A%
% 207.97/208.14 |- mesh__dateEstablished mesh__D017812 1994-01-01
% 207.97/208.14 |- mesh__recordMaintainer mesh__D017812 ags
% 207.97/208.14 |- rdf__type mesh__D017812sskos__Concept
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 King Snakes
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D017812 2006
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Snake, Garter
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D017812 sjn
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Snakes, Water
% 207.97/208.14 |- skos__scopeNote mesh__D017812
% 207.97/208.14 The largest family of snakes, comprising five subfamilies: Colubrinae, Natricinae, Homalopsinae, Lycodontinae, and Xenodontinae. They show a great diversity of eating habits, some eating almost anything, others having a specialized diet. They can be oviparous, ovoviviparous, or viviparous. The majority of North American snakes are colubrines. Among the colubrids are king snakes, water moccasins, water snakes, and garter snakes. Some genera are poisonous. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp321-29%29%%A%
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Mocassins, Water
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D017812 2005
% 207.97/208.14 |- skos__historyNote mesh__D017812 Snakes %28%1968-1993%29%
% 207.97/208.14 |- skos__altLabel mesh__D017812 King Snake
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Water Mocassins
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Moccasins, Water
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Moccasin, Water
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Garter Snakes
% 207.97/208.14 |- mesh__historyNote mesh__D017812 94
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D017812 94
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Snake, King
% 207.97/208.14 |- mesh__dateRevised mesh__D017812 2003-07-09
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Mocassin, Water
% 207.97/208.14 |- skos__hiddenLabel mesh__D017812 Snake, Water
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D017014 2006A
% 207.97/208.14 |- skos__prefLabel mesh__D017014 Methanobacterium
% 207.97/208.14 |- skos__scopeNote mesh__D017014
% 207.97/208.14 A genus of anaerobic, rod-shaped METHANOBACTERIACEAE. Its organisms are nonmotile and use ammonia as the sole source of nitrogen. These methanogens are found in aquatic sediments, soil, sewage, and the gastrointestinal tract of animals.%A%
% 207.97/208.14 |- mesh__dateRevised mesh__D017014 2005-07-20
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D017014 2006
% 207.97/208.14 |- skos__historyNote mesh__D017014 Methanogens %28%1979-1991%29%
% 207.97/208.14 |- mesh__recordOriginator mesh__D017014 PXP
% 207.97/208.14 |- mesh__dateEstablished mesh__D017014 1992-01-01
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D017014 2006B
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D017014 92
% 207.97/208.14 |- mesh__historyNote mesh__D017014 92
% 207.97/208.14 |- mesh__recordMaintainer mesh__D017014 ags
% 207.97/208.14 |- rdf__type mesh__D017014sskos__Concept
% 207.97/208.14 |- mesh__dateCreated mesh__D017014 1991-05-30
% 207.97/208.14 |- skos__historyNote mesh__D017014 Bacteria %28%1968-1978%29%
% 207.97/208.14 |- skos__annotation mesh__D017014
% 207.97/208.14 a genus of methanogens found throughout nature %26% in gastrointestinal tract of animals: do not confuse with plural see ref METHANOBACTERIA see EURYARCHAEOTA; DF: METHANOBACT%A%
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D017014 ags
% 207.97/208.14 |- skos__broader mesh__D017014smesh__D017013
% 207.97/208.14 |- skos__altLabel mesh__D008288 Marsh Fever
% 207.97/208.14 |- skos__scopeNote mesh__D008288
% 207.97/208.14 A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.%A%
% 207.97/208.14 |- skos__hiddenLabel mesh__D008288 Fever, Remittent
% 207.97/208.14 |- skos__hiddenLabel mesh__D008288 Fever, Marsh
% 207.97/208.14 |- mesh__dateRevised mesh__D008288 2005-06-30
% 207.97/208.14 |- skos__prefLabel mesh__D008288 Malaria
% 207.97/208.14 |- skos__altLabel mesh__D008288 Paludism
% 207.97/208.14 |- skos__altLabel mesh__D008288 Remittent Fever
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D008288
% 207.97/208.14 MALARIA CONTROL was heading 1963-66
% 207.97/208.14 |- skos__altLabel mesh__D008288 Plasmodium Infections
% 207.97/208.14 |- mesh__recordOriginator mesh__D008288 NLM
% 207.97/208.14 |- skos__broader mesh__D008288smesh__D003048
% 207.97/208.14 |- skos__related mesh__D008288smesh__D000962
% 207.97/208.14 |- skos__altLabel mesh__D008288 Infections, Plasmodium
% 207.97/208.14 |- skos__hiddenLabel mesh__D008288 Plasmodium Infection
% 207.97/208.14 |- mesh__historyNote mesh__D008288 MALARIA CONTROL was heading 1963-66
% 207.97/208.14 |- skos__hiddenLabel mesh__D008288 Infection, Plasmodium
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D008288 sjn
% 207.97/208.14 |- mesh__recordMaintainer mesh__D008288 ags
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D008288 2006
% 207.97/208.14 |- mesh__onlineNote mesh__D008288
% 207.97/208.14 use MALARIA to search MALARIA CONTROL 1966
% 207.97/208.14 |- mesh__dateCreated mesh__D008288 1999-01-01
% 207.97/208.14 |- skos__annotation mesh__D008288
% 207.97/208.14 GEN or unspecified; specify Plasmodium species IM if possible but note P. falciparum malaria = MALARIA, FALCIPARUM; P. vivax malaria = MALARIA, VIVAX; tertian malaria = MALARIA, VIVAX, quartan malaria: coord IM with PLASMODIUM MALARIAE %28%IM%29%; malariotherapy = HYPERTHERMIA, INDUCED: do not confuse with MALARIA /ther; /drug ther: consider also ANTIMALARIALS%A%
% 207.97/208.14 |- rdf__type mesh__D008288sskos__Concept
% 207.97/208.14 |- skos__annotation mesh__D027442
% 207.97/208.14 do not confuse X ref BAY LAUREL with BAY LAUREL, CALIFORNIA see UMBELLULARIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.14 |- mesh__recordMaintainer mesh__D027442 ssb
% 207.97/208.14 |- skos__historyNote mesh__D027442 Lauraceae %28%1998-2001%29%
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D027442 sjn
% 207.97/208.14 |- mesh__recordOriginator mesh__D027442 ssb
% 207.97/208.14 |- mesh__historyNote mesh__D027442 2002; use LAURACEAE 1998-2001
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D027442 2005
% 207.97/208.14 |- mesh__dateCreated mesh__D027442 2001-07-25
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D027442 2003
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D027442 2006
% 207.97/208.14 |- skos__prefLabel mesh__D027442 Laurus
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D027442 2002; see LAURACEAE 1998-2001
% 207.97/208.14 |- skos__scopeNote mesh__D027442
% 207.97/208.14 A plant genus in the LAURACEAE family. Laurus nobilis L. leaves are known for use in SPICES, having a similar flavor as UMBELLULARIA.%A%
% 207.97/208.14 |- skos__altLabel mesh__D027442 Bay Laurel
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D027442 2004
% 207.97/208.14 |- mesh__dateEstablished mesh__D027442 2002-01-01
% 207.97/208.14 |- mesh__dateRevised mesh__D027442 2002-07-02
% 207.97/208.14 |- skos__broader mesh__D027442smesh__D019770
% 207.97/208.14 |- rdf__type mesh__D027442sskos__Concept
% 207.97/208.14 |- mesh__dateEstablished mesh__D013422 1991-01-01
% 207.97/208.14 |- skos__scopeNote mesh__D013422
% 207.97/208.14 Long acting sulfonamide antibacterial agent.
% 207.97/208.14 |- mesh__historyNote mesh__D013422
% 207.97/208.14 91%28%75%29%; was see under SULFANILAMIDES 1975-90
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013422 2004
% 207.97/208.14 |- rdf__type mesh__D013422sskos__Concept
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D013422
% 207.97/208.14 91; was see under SULFANILAMIDES 1975-90
% 207.97/208.14 |- mesh__dateCreated mesh__D013422 1974-11-19
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013422 2005
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013422 2001
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013422 2006
% 207.97/208.14 |- mesh__recordMaintainer mesh__D013422 CCR
% 207.97/208.14 |- skos__historyNote mesh__D013422 Pyrimidines %28%1972-1974%29%
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013422 2002
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D013422 sjn
% 207.97/208.14 |- skos__prefLabel mesh__D013422 Sulfamonomethoxine
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013422 2003
% 207.97/208.14 |- skos__broader mesh__D013422smesh__D013424
% 207.97/208.14 |- mesh__recordOriginator mesh__D013422 NLM
% 207.97/208.14 |- skos__historyNote mesh__D013422 Sulfonamides %28%1969-1974%29%
% 207.97/208.14 |- mesh__dateRevised mesh__D013422 2000-06-22
% 207.97/208.14 |- skos__prefLabel mesh__D032387 Tropaeolaceae
% 207.97/208.14 |- skos__broader mesh__D032387smesh__D019684
% 207.97/208.14 |- mesh__historyNote mesh__D032387 2003
% 207.97/208.14 |- skos__annotation mesh__D032387
% 207.97/208.14 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.14 |- mesh__dateEstablished mesh__D032387 2003-01-01
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D032387 2006
% 207.97/208.14 |- mesh__dateCreated mesh__D032387 2002-07-03
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D032387 2005
% 207.97/208.14 |- rdf__type mesh__D032387sskos__Concept
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D032387 2003
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D032387 2004
% 207.97/208.14 |- skos__scopeNote mesh__D032387
% 207.97/208.14 A plant family of the order Geraniales, subclass Rosidae, class Magnoliopsida.%A%
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D032387 2003
% 207.97/208.14 |- skos__hiddenLabel mesh__D051541
% 207.97/208.14 Hepatocyte Enriched Transcription Factor HNF 3A
% 207.97/208.14 |- skos__hiddenLabel mesh__D051541 HNF 3alpha Protein
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D051541
% 207.97/208.14 2006; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%
% 207.97/208.14 |- mesh__dateCreated mesh__D051541 2005-06-30
% 207.97/208.14 |- skos__altLabel mesh__D051541
% 207.97/208.14 Hepatocyte-Enriched Transcription Factor HNF-3A
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D051541 2006
% 207.97/208.14 |- skos__altLabel mesh__D051541 HNF-3A Transcription Factor
% 207.97/208.14 |- skos__hiddenLabel mesh__D051541 Hepatocyte Nuclear Factor 3 alpha
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D051541 sjn
% 207.97/208.14 |- mesh__recordOriginator mesh__D051541 DRC
% 207.97/208.14 |- mesh__dateEstablished mesh__D051541 2006-01-01
% 207.97/208.14 |- skos__hiddenLabel mesh__D051541 HNF 3A Transcription Factor
% 207.97/208.14 |- skos__broader mesh__D051541smesh__D051858
% 207.97/208.14 |- rdf__type mesh__D051541sskos__Concept
% 207.97/208.14 |- skos__altLabel mesh__D051541 HNF-3alpha Protein
% 207.97/208.14 |- skos__altLabel mesh__D051541 Forkhead Box A1 Protein
% 207.97/208.14 |- skos__scopeNote mesh__D051541
% 207.97/208.14 A forkhead transcription factor that is an essential activator of GLUCAGON gene expression.%A%
% 207.97/208.14 |- mesh__recordMaintainer mesh__D051541 DRC
% 207.97/208.14 |- skos__altLabel mesh__D051541 Hepatocyte Nuclear Factor 3alpha
% 207.97/208.14 |- mesh__historyNote mesh__D051541 2006%28%1990%29%
% 207.97/208.14 |- skos__broader mesh__D051541smesh__D051536
% 207.97/208.14 |- skos__prefLabel mesh__D051541 Hepatocyte Nuclear Factor 3-alpha
% 207.97/208.14 |- skos__hiddenLabel mesh__D051541 Transcription Factor, HNF-3A
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 2000
% 207.97/208.14 |- mesh__dateRevised mesh__D004696 1993-06-02
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 2004
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 1997
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 2006
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 1999
% 207.97/208.14 |- mesh__recordMaintainer mesh__D004696 PLS
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 2003
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 1996
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 1995
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 2005
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 1998
% 207.97/208.14 |- skos__prefLabel mesh__D004696 Endocarditis
% 207.97/208.14 |- mesh__recordOriginator mesh__D004696 NLM
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 1994
% 207.97/208.14 |- skos__broader mesh__D004696smesh__D006331
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 2002
% 207.97/208.14 |- rdf__type mesh__D004696sskos__Concept
% 207.97/208.14 |- skos__hiddenLabel mesh__D004696 Endocarditides
% 207.97/208.14 |- skos__scopeNote mesh__D004696
% 207.97/208.14 Exudative and proliferative inflammatory alterations of the endocardium, characterized by the presence of vegetations on the surface of the endocardium or in the endocardium itself, and most commonly involving a heart valve, but sometimes affecting the inner lining of the cardiac chambers or the endocardium elsewhere. It may occur as a primary disorder or as a complication of or in association with another disease. %28%Dorland, 27th ed%29%%A%
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004696 2001
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D004696 PLS
% 207.97/208.14 |- skos__annotation mesh__D004696
% 207.97/208.14 inflamm of endocardium but read MeSH definition; rheumatic endocarditis: index under RHEUMATIC HEART DISEASE %28%IM%29% + ENDOCARDITIS %28%IM%29%%A%
% 207.97/208.14 |- mesh__dateCreated mesh__D004696 1999-01-01
% 207.97/208.14 |- skos__annotation mesh__D045504 not used for indexing or cataloging
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D045504 2005
% 207.97/208.14 |- rdf__type mesh__D045504sskos__Concept
% 207.97/208.14 |- mesh__dateEstablished mesh__D045504 2004-01-01
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D045504 2006
% 207.97/208.14 |- mesh__historyNote mesh__D045504 2004
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D045504 2004
% 207.97/208.14 |- skos__related mesh__D045504smesh__D011506
% 207.97/208.14 |- mesh__dateCreated mesh__D045504 2003-07-09
% 207.97/208.14 |- skos__prefLabel mesh__D045504 Molecular Mechanisms of Action
% 207.97/208.14 |- skos__related mesh__D045504smesh__D007155
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D045504 2004
% 207.97/208.14 |- skos__broader mesh__D045504smesh__D020228
% 207.97/208.14 |- skos__scopeNote mesh__D045504
% 207.97/208.14 Activities at the molecular level of exogenous compounds affecting normal biochemical pathways, including the actions of PROTEINS; CELL SURFACE RECEPTORS; NEUROTRANSMITTERS; and inhibitors.%A%
% 207.97/208.14 |- skos__related mesh__D045504smesh__D004798
% 207.97/208.14 |- skos__hiddenLabel mesh__D009381 Neoplasm, Radiation-Induced
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009381 2003
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009381 2002
% 207.97/208.14 |- skos__broader mesh__D009381smesh__D009369
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009381 2005
% 207.97/208.14 |- skos__hiddenLabel mesh__D009381 Radiation-Induced Cancers
% 207.97/208.14 |- skos__hiddenLabel mesh__D009381 Radiation Induced Neoplasms
% 207.97/208.14 |- skos__prefLabel mesh__D009381 Neoplasms, Radiation-Induced
% 207.97/208.14 |- skos__annotation mesh__D009381
% 207.97/208.14 IM; coord with specific histol type %28%IM%29% + organ/neopl term %28%IM%29%; Manual 24.4.3.2+; DF: NEOPL RAD IND%A%
% 207.97/208.14 |- skos__related mesh__D009381smesh__D007953
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009381 2001
% 207.97/208.14 |- skos__hiddenLabel mesh__D009381 Cancers, Radiation-Induced
% 207.97/208.14 |- skos__altLabel mesh__D009381 Cancer, Radiation-Induced
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009381 2000
% 207.97/208.14 |- mesh__dateCreated mesh__D009381 1999-01-01
% 207.97/208.14 |- rdf__type mesh__D009381sskos__Concept
% 207.97/208.14 |- skos__hiddenLabel mesh__D009381 Radiation Induced Cancer
% 207.97/208.14 |- mesh__dateRevised mesh__D009381 1999-11-03
% 207.97/208.14 |- skos__hiddenLabel mesh__D009381 Neoplasms, Radiation Induced
% 207.97/208.14 |- skos__altLabel mesh__D009381 Radiation-Induced Neoplasms
% 207.97/208.14 |- mesh__recordMaintainer mesh__D009381 nns
% 207.97/208.14 |- skos__scopeNote mesh__D009381
% 207.97/208.14 Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.%A%
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D009381 sjn
% 207.97/208.14 |- skos__hiddenLabel mesh__D009381 Cancer, Radiation Induced
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009381 2004
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D009381 2006
% 207.97/208.14 |- skos__related mesh__D009381smesh__D016609
% 207.97/208.14 |- skos__broader mesh__D009381smesh__D011832
% 207.97/208.14 |- mesh__recordOriginator mesh__D009381 NLM
% 207.97/208.14 |- skos__hiddenLabel mesh__D009381 Radiation-Induced Neoplasm
% 207.97/208.14 |- skos__prefLabel mesh__D017015 Methanococcales
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D017015 sjn
% 207.97/208.14 |- mesh__recordMaintainer mesh__D017015 SYSTEM
% 207.97/208.14 |- mesh__historyNote mesh__D017015 92
% 207.97/208.14 |- mesh__recordOriginator mesh__D017015 PXP
% 207.97/208.14 |- rdf__type mesh__D017015sskos__Concept
% 207.97/208.14 |- skos__scopeNote mesh__D017015
% 207.97/208.14 An order of anaerobic methanogens in the kingdom EURYARCHAEOTA. They are pseudosarcina, coccoid or sheathed rod-shaped and catabolize methyl groups. The cell wall is composed of protein. The order includes one family, METHANOCOCCACEAE. %28%From Bergey%27%s Manual of Systemic Bacteriology, 1989%29%%A%
% 207.97/208.14 |- mesh__dateRevised mesh__D017015 2005-06-30
% 207.97/208.14 |- mesh__dateCreated mesh__D017015 1991-05-30
% 207.97/208.14 |- skos__broader mesh__D017015smesh__D019605
% 207.97/208.14 |- mesh__dateEstablished mesh__D017015 1992-01-01
% 207.97/208.14 |- skos__annotation mesh__D017015 an order of methanogens
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D017015 2006
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D017015 92
% 207.97/208.14 |- skos__broader mesh__D011942Q000037smesh__D011942
% 207.97/208.14 |- mesh__preferredCombination mesh__D011942Q000037smesh__D000317
% 207.97/208.14 |- rdf__type mesh__D011942Q000037smesh__CompoundConcept
% 207.97/208.14 |- skos__annotation mesh__D008289
% 207.97/208.14 coord with BIRDS %28%NIM%29% or specific bird or fowl %28%IM%29%
% 207.97/208.14 |- skos__broader mesh__D008289smesh__D008288
% 207.97/208.14 |- skos__hiddenLabel mesh__D008289 Avian Malaria
% 207.97/208.14 |- mesh__recordMaintainer mesh__D008289 sjn
% 207.97/208.14 |- skos__prefLabel mesh__D008289 Malaria, Avian
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D008289 2006
% 207.97/208.14 |- mesh__recordOriginator mesh__D008289 NLM
% 207.97/208.14 |- mesh__dateRevised mesh__D008289 2004-07-13
% 207.97/208.14 |- mesh__dateCreated mesh__D008289 1999-01-01
% 207.97/208.14 |- rdf__type mesh__D008289sskos__Concept
% 207.97/208.14 |- skos__broader mesh__D008289smesh__D001715
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D008289 2005
% 207.97/208.14 |- skos__scopeNote mesh__D008289
% 207.97/208.14 Any of a group of infections of fowl caused by protozoa of the genera PLASMODIUM, Leucocytozoon, and Haemoproteus. The life cycles of these parasites and the disease produced bears strong resemblance to those observed in human malaria.%A%
% 207.97/208.14 |- skos__hiddenLabel mesh__D008289 Malarias, Avian
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D008289 sjn
% 207.97/208.14 |- skos__hiddenLabel mesh__D008289 Avian Malarias
% 207.97/208.14 |- mesh__recordOriginator mesh__D027443 ssb
% 207.97/208.14 |- skos__annotation mesh__D027443
% 207.97/208.14 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.14 |- mesh__historyNote mesh__D027443 2002
% 207.97/208.14 |- skos__scopeNote mesh__D027443
% 207.97/208.14 A plant genus in the LAURACEAE family. Lindera benzoin is a source of a balsamic resin called benzoin which is up to 1/3 BENZOIC ACID. This should not be confused with the chemical BENZOIN or the plant STYRAX BENZOIDES.%A%
% 207.97/208.14 |- skos__broader mesh__D027443smesh__D019770
% 207.97/208.14 |- skos__prefLabel mesh__D027443 Lindera
% 207.97/208.14 |- mesh__recordMaintainer mesh__D027443 ssb
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D027443 2005
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D027443 sjn
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D027443 2003
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D027443 2006
% 207.97/208.14 |- skos__altLabel mesh__D027443 Wild Allspice
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D027443 2004
% 207.97/208.14 |- mesh__dateEstablished mesh__D027443 2002-01-01
% 207.97/208.14 |- mesh__dateRevised mesh__D027443 2002-07-03
% 207.97/208.14 |- rdf__type mesh__D027443sskos__Concept
% 207.97/208.14 |- mesh__dateCreated mesh__D027443 2001-07-25
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D027443 2002
% 207.97/208.14 |- skos__related mesh__D027443smesh__D019817
% 207.97/208.14 |- skos__altLabel mesh__D027443 Spicebush
% 207.97/208.14 |- mesh__dateCreated mesh__D013423 1999-01-01
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D013423 sjn
% 207.97/208.14 |- skos__broader mesh__D013423smesh__D013424
% 207.97/208.14 |- mesh__recordOriginator mesh__D013423 NLM
% 207.97/208.14 |- skos__scopeNote mesh__D013423 A sulfanilamide antibacterial agent.
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013423 2003
% 207.97/208.14 |- skos__altLabel mesh__D013423 Sulphamoxole
% 207.97/208.14 |- mesh__recordMaintainer mesh__D013423 CCR
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013423 2004
% 207.97/208.14 |- rdf__type mesh__D013423sskos__Concept
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013423 2001
% 207.97/208.14 |- mesh__dateRevised mesh__D013423 2000-06-22
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013423 2005
% 207.97/208.14 |- skos__prefLabel mesh__D013423 Sulfamoxole
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013423 2002
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D013423 2006
% 207.97/208.14 |- skos__scopeNote mesh__D032388
% 207.97/208.14 A plant genus of the family TROPAEOLACEAE. The common nasturtium is a plant that grows 2.4-3.6 m %28%8-12 feet%29% tall and has funnel-shaped flowers that are commonly yellow-orange with red spots or stripes and have a long spur that contains sweet nectar. Some species in this genus are called watercress which is also a common name for RORIPPA and NASTURTIUM.%A%
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D032388 jls
% 207.97/208.14 |- skos__broader mesh__D032388smesh__D032387
% 207.97/208.14 |- skos__altLabel mesh__D032388 Cress, Indian
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D032388 2005A
% 207.97/208.14 |- mesh__dateRevised mesh__D032388 2004-08-02
% 207.97/208.14 |- mesh__historyNote mesh__D032388 2003
% 207.97/208.14 |- mesh__dateEstablished mesh__D032388 2003-01-01
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D032388 2006
% 207.97/208.14 |- mesh__recordMaintainer mesh__D032388 jls
% 207.97/208.14 |- mesh__dateCreated mesh__D032388 2002-07-03
% 207.97/208.14 |- mesh__recordOriginator mesh__D032388 ssb
% 207.97/208.14 |- rdf__type mesh__D032388sskos__Concept
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D032388 2005
% 207.97/208.14 |- skos__altLabel mesh__D032388 Nasturtium, Garden
% 207.97/208.14 |- skos__annotation mesh__D032388
% 207.97/208.14 X ref NASTURTIUM, GARDEN: the genus NASTURTIUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D032388 2004
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D032388 2003
% 207.97/208.14 |- skos__prefLabel mesh__D032388 Tropaeolum
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D032388 2003
% 207.97/208.14 |- mesh__recordMaintainer mesh__D051542 DRC
% 207.97/208.14 |- mesh__publicMeSHNote mesh__D051542
% 207.97/208.14 2006; HEPATOCYTE NUCLEAR FACTOR 3-BETA was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%
% 207.97/208.14 |- skos__hiddenLabel mesh__D051542 HNF 3beta Protein
% 207.97/208.14 |- mesh__recordOriginator mesh__D051542 DRC
% 207.97/208.14 |- skos__hiddenLabel mesh__D051542 Hepatocyte Nuclear Factor 3 beta
% 207.97/208.14 |- mesh__dateCreated mesh__D051542 2005-06-30
% 207.97/208.14 |- skos__altLabel mesh__D051542 Forkhead Box A2 Protein
% 207.97/208.14 |- skos__prefLabel mesh__D051542 Hepatocyte Nuclear Factor 3-beta
% 207.97/208.14 |- skos__broader mesh__D051542smesh__D051858
% 207.97/208.14 |- rdf__type mesh__D051542sskos__Concept
% 207.97/208.14 |- skos__altLabel mesh__D051542 HNF-3beta Protein
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D051542 sjn
% 207.97/208.14 |- skos__altLabel mesh__D051542 Hepatocyte Nuclear Factor 3beta
% 207.97/208.14 |- mesh__dateEstablished mesh__D051542 2006-01-01
% 207.97/208.14 |- skos__broader mesh__D051542smesh__D051536
% 207.97/208.14 |- mesh__historyNote mesh__D051542 2006%28%1991%29%
% 207.97/208.14 |- skos__scopeNote mesh__D051542
% 207.97/208.14 A forkhead transcription factor that regulates expression of metabolic GENES and is involved in EMBRYONIC DEVELOPMENT. Mutations in HNF-3beta have been associated with PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY.%A%
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D051542 2006
% 207.97/208.14 |- mesh__recordAuthorizer mesh__D004697 PLS
% 207.97/208.14 |- mesh__dateRevised mesh__D004697 1991-06-27
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 1993
% 207.97/208.14 |- skos__altLabel mesh__D004697 Endocarditides, Bacterial
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 2003
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 1996
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 1995
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 2000
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 2005
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 1998
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 1992
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 1994
% 207.97/208.14 |- rdf__type mesh__D004697sskos__Concept
% 207.97/208.14 |- mesh__recordMaintainer mesh__D004697 TGC
% 207.97/208.14 |- skos__broader mesh__D004697smesh__D001424
% 207.97/208.14 |- skos__altLabel mesh__D004697 Bacterial Endocarditides
% 207.97/208.14 |- skos__related mesh__D004697smesh__D000785
% 207.97/208.14 |- mesh__recordOriginator mesh__D004697 NLM
% 207.97/208.14 |- mesh__dateCreated mesh__D004697 1999-01-01
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 2002
% 207.97/208.14 |- skos__annotation mesh__D004697
% 207.97/208.14 coord with specific bacterium /infections heading %28%IM%29% if pertinent; DF: ENDOCARDITIS BACT%A%
% 207.97/208.14 |- skos__altLabel mesh__D004697 Bacterial Endocarditis
% 207.97/208.14 |- skos__prefLabel mesh__D004697 Endocarditis, Bacterial
% 207.97/208.14 |- mesh__activeMeSHYear mesh__D004697 2004
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004697 1997
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004697 2001
% 207.97/208.15 |- skos__broader mesh__D004697smesh__D004696
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004697 2006
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004697 1999
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D045505 2006
% 207.97/208.15 |- skos__scopeNote mesh__D045505
% 207.97/208.15 Activities which affect organs and systemic functions without regard to a particular disease.%A%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D045505 2004
% 207.97/208.15 |- skos__prefLabel mesh__D045505 Physiological Effects of Drugs
% 207.97/208.15 |- skos__annotation mesh__D045505 not used for indexing or cataloging
% 207.97/208.15 |- skos__altLabel mesh__D045505 Drug Effects on Physiology
% 207.97/208.15 |- mesh__dateEstablished mesh__D045505 2004-01-01
% 207.97/208.15 |- mesh__dateCreated mesh__D045505 2003-07-09
% 207.97/208.15 |- mesh__historyNote mesh__D045505 2004
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D045505 2004
% 207.97/208.15 |- skos__hiddenLabel mesh__D045505 Effects, Drug Physiological
% 207.97/208.15 |- skos__hiddenLabel mesh__D045505 Physiological Effects, Drug
% 207.97/208.15 |- skos__altLabel mesh__D045505 Drug Physiological Effects
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D045505 2005
% 207.97/208.15 |- rdf__type mesh__D045505sskos__Concept
% 207.97/208.15 |- skos__broader mesh__D045505smesh__D020228
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D009382 87
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D009382 sjn
% 207.97/208.15 |- mesh__dateRevised mesh__D009382 2000-06-22
% 207.97/208.15 |- skos__annotation mesh__D009382
% 207.97/208.15 IM; do not use /second; coord IM with organ/neopl term with /second %28%IM%29% + histol type /second %28%IM%29%; Manual 24.4.1.8%A%
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Tumors, Unknown Primary
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Primary Tumors, Unknown
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Unknown Primary Tumor
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Occult Primary Neoplasm
% 207.97/208.15 |- skos__scopeNote mesh__D009382
% 207.97/208.15 Metastases in which the tissue of origin is unknown.
% 207.97/208.15 |- skos__altLabel mesh__D009382 Unknown Primary Neoplasm Metastasis
% 207.97/208.15 |- mesh__dateEstablished mesh__D009382 1987-01-01
% 207.97/208.15 |- mesh__recordOriginator mesh__D009382 VDK
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Unknown Primary Neoplasm
% 207.97/208.15 |- mesh__dateCreated mesh__D009382 1986-04-18
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Primary Neoplasms, Unknown
% 207.97/208.15 |- rdf__type mesh__D009382sskos__Concept
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009382 2002
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009382 2004
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Primary Tumor, Unknown
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Tumor, Unknown Primary
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009382 2001
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Neoplasm, Unknown Primary
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009382 2003
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009382 2006
% 207.97/208.15 |- skos__prefLabel mesh__D009382 Neoplasms, Unknown Primary
% 207.97/208.15 |- mesh__historyNote mesh__D009382 87
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Neoplasm, Occult Primary
% 207.97/208.15 |- skos__altLabel mesh__D009382 Occult Primary Neoplasms
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009382 2005
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Primary Neoplasm, Unknown
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Primary Neoplasm, Occult
% 207.97/208.15 |- skos__broader mesh__D009382smesh__D009362
% 207.97/208.15 |- skos__altLabel mesh__D009382 Unknown Primary Neoplasms
% 207.97/208.15 |- skos__altLabel mesh__D009382 Neoplasms, Occult Primary
% 207.97/208.15 |- mesh__recordMaintainer mesh__D009382 KEV
% 207.97/208.15 |- skos__hiddenLabel mesh__D009382 Primary Neoplasms, Occult
% 207.97/208.15 |- mesh__recordOriginator mesh__D017016 PXP
% 207.97/208.15 |- rdf__type mesh__D017016sskos__Concept
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D017016 92
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D017016 sjn
% 207.97/208.15 |- mesh__dateCreated mesh__D017016 1991-05-30
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D017016 2006
% 207.97/208.15 |- skos__broader mesh__D017016smesh__D017015
% 207.97/208.15 |- mesh__dateRevised mesh__D017016 2005-06-30
% 207.97/208.15 |- skos__prefLabel mesh__D017016 Methanococcaceae
% 207.97/208.15 |- mesh__dateEstablished mesh__D017016 1992-01-01
% 207.97/208.15 |- skos__scopeNote mesh__D017016
% 207.97/208.15 A family of anaerobic METHANOCOCCALES whose organisms are motile by means of flagella. These methanogens use carbon dioxide as an electron acceptor.%A%
% 207.97/208.15 |- mesh__recordMaintainer mesh__D017016 SYSTEM
% 207.97/208.15 |- mesh__historyNote mesh__D017016 92
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D033481 2004
% 207.97/208.15 |- mesh__dateEstablished mesh__D033481 2003-01-01
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D033481 2003
% 207.97/208.15 |- skos__prefLabel mesh__D033481 Chromosomes, Mammalian
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D033481 2006
% 207.97/208.15 |- skos__historyNote mesh__D033481 Chromosomes %28%1965-2002%29%
% 207.97/208.15 |- skos__hiddenLabel mesh__D033481 Mammalian Chromosomes
% 207.97/208.15 |- skos__scopeNote mesh__D033481
% 207.97/208.15 Complex nucleoprotein structures which contain the genomic DNA and are part of the CELL NUCLEUS of MAMMALS.%A%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D033481 2005
% 207.97/208.15 |- skos__hiddenLabel mesh__D033481 Mammalian Chromosome
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D033481 2003
% 207.97/208.15 |- mesh__dateCreated mesh__D033481 2002-07-03
% 207.97/208.15 |- skos__hiddenLabel mesh__D033481 Chromosome, Mammalian
% 207.97/208.15 |- skos__broader mesh__D033481smesh__D002875
% 207.97/208.15 |- mesh__historyNote mesh__D033481 2003
% 207.97/208.15 |- rdf__type mesh__D033481sskos__Concept
% 207.97/208.15 |- mesh__recordOriginator mesh__D005790 NLM
% 207.97/208.15 |- mesh__dateEstablished mesh__D005790 1991-01-01
% 207.97/208.15 |- mesh__onlineNote mesh__D005790
% 207.97/208.15 search STRESS %26% ADAPTATION, PHYSIOLOGICAL 1966-74
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005790 2006
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005790 2002
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005790 2004
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D005790 sjn
% 207.97/208.15 |- mesh__dateCreated mesh__D005790 1999-01-01
% 207.97/208.15 |- rdf__type mesh__D005790sskos__Concept
% 207.97/208.15 |- skos__hiddenLabel mesh__D005790 Adaptation Syndromes, General
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005790 2005
% 207.97/208.15 |- skos__hiddenLabel mesh__D005790 General Adaptation Syndromes
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005790 2003
% 207.97/208.15 |- skos__prefLabel mesh__D005790 General Adaptation Syndrome
% 207.97/208.15 |- skos__scopeNote mesh__D005790
% 207.97/208.15 The sum of all nonspecific systemic reactions of the body to long-continued exposure to systemic stress.%A%
% 207.97/208.15 |- mesh__historyNote mesh__D005790
% 207.97/208.15 91%28%75%29%; was see under STRESS 1975-90; was see under STRESS %26% ADAPTATION, PHYSIOLOGICAL 1963-74%A%
% 207.97/208.15 |- skos__hiddenLabel mesh__D005790 Adaptation Syndrome, General
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005790 2001
% 207.97/208.15 |- skos__broader mesh__D005790smesh__D012920
% 207.97/208.15 |- skos__hiddenLabel mesh__D005790 Syndromes, General Adaptation
% 207.97/208.15 |- skos__annotation mesh__D005790
% 207.97/208.15 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005790 2000
% 207.97/208.15 |- mesh__dateRevised mesh__D005790 1999-11-08
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D005790
% 207.97/208.15 91; was see under STRESS 1975-90; was see under STRESS %26% ADAPTATION, PHYSIOLOGICAL 1963-74%A%
% 207.97/208.15 |- skos__hiddenLabel mesh__D005790 Syndrome, General Adaptation
% 207.97/208.15 |- mesh__recordMaintainer mesh__D005790 KEV
% 207.97/208.15 |- skos__broader mesh__D027444smesh__D019770
% 207.97/208.15 |- rdf__type mesh__D027444sskos__Concept
% 207.97/208.15 |- skos__prefLabel mesh__D027444 Ocotea
% 207.97/208.15 |- mesh__dateRevised mesh__D027444 2002-07-03
% 207.97/208.15 |- mesh__recordMaintainer mesh__D027444 ssb
% 207.97/208.15 |- skos__annotation mesh__D027444
% 207.97/208.15 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.15 |- skos__scopeNote mesh__D027444
% 207.97/208.15 A plant genus in the LAURACEAE family. The common name of stinkwood is also used for Zieria %28%RUTACEAE%29%.%A%
% 207.97/208.15 |- mesh__historyNote mesh__D027444 2002
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D027444 2002
% 207.97/208.15 |- mesh__recordOriginator mesh__D027444 ssb
% 207.97/208.15 |- mesh__dateEstablished mesh__D027444 2002-01-01
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D027444 2004
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D027444 sjn
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D027444 2006
% 207.97/208.15 |- mesh__dateCreated mesh__D027444 2001-07-25
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D027444 2003
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D027444 2005
% 207.97/208.15 |- mesh__dateCreated mesh__D013424 1999-01-01
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 2006
% 207.97/208.15 |- mesh__recordOriginator mesh__D013424 NLM
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 1996
% 207.97/208.15 |- skos__annotation mesh__D013424
% 207.97/208.15 anti-infectives; GEN; prefer specific sulfanilamide anti-infective%A%
% 207.97/208.15 |- skos__prefLabel mesh__D013424 Sulfanilamides
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 1997
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D013424 PLS
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 2000
% 207.97/208.15 |- mesh__onlineNote mesh__D013424
% 207.97/208.15 use SULFANILAMIDES to search SULFANILAMIDE 1966-74
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 2003
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D013424 75; was SULFANILAMIDE 1963-74
% 207.97/208.15 |- mesh__recordMaintainer mesh__D013424 JRT
% 207.97/208.15 |- rdf__type mesh__D013424sskos__Concept
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 1998
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 2001
% 207.97/208.15 |- mesh__historyNote mesh__D013424 75; was SULFANILAMIDE 1963-74
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 2004
% 207.97/208.15 |- mesh__dateRevised mesh__D013424 1995-06-08
% 207.97/208.15 |- skos__broader mesh__D013424smesh__D013449
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 1999
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 2002
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013424 2005
% 207.97/208.15 |- skos__scopeNote mesh__D032389
% 207.97/208.15 Non-striated, elongated, spindle-shaped cells found lining the digestive tract, uterus, and blood vessels. They are derived from specialized myoblasts %28%MYOBLASTS, SMOOTH MUSCLE%29%.%A%
% 207.97/208.15 |- skos__hiddenLabel mesh__D032389 Smooth Muscle Cell
% 207.97/208.15 |- skos__prefLabel mesh__D032389 Myocytes, Smooth Muscle
% 207.97/208.15 |- skos__hiddenLabel mesh__D032389 Cell, Smooth Muscle
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D032389 2006
% 207.97/208.15 |- skos__hiddenLabel mesh__D032389 Myocyte, Smooth Muscle
% 207.97/208.15 |- skos__historyNote mesh__D032389
% 207.97/208.15 Muscle, Smooth/cytology %28%1964-2002%29%
% 207.97/208.15 |- skos__related mesh__D032389smesh__D032390
% 207.97/208.15 |- rdf__type mesh__D032389sskos__Concept
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D032389 2005
% 207.97/208.15 |- skos__hiddenLabel mesh__D032389 Cells, Smooth Muscle
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D032389 2004
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D032389 2003
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D032389 2003
% 207.97/208.15 |- mesh__dateEstablished mesh__D032389 2003-01-01
% 207.97/208.15 |- skos__broader mesh__D032389smesh__D032342
% 207.97/208.15 |- mesh__historyNote mesh__D032389 2003
% 207.97/208.15 |- skos__altLabel mesh__D032389 Smooth Muscle Cells
% 207.97/208.15 |- skos__hiddenLabel mesh__D032389 Smooth Muscle Myocytes
% 207.97/208.15 |- skos__hiddenLabel mesh__D032389 Smooth Muscle Myocyte
% 207.97/208.15 |- mesh__dateCreated mesh__D032389 2002-07-03
% 207.97/208.15 |- skos__prefLabel mesh__D051543 Hepatocyte Nuclear Factor 3-gamma
% 207.97/208.15 |- skos__altLabel mesh__D051543 HNF-3gamma Protein
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D051543 2006
% 207.97/208.15 |- mesh__dateEstablished mesh__D051543 2006-01-01
% 207.97/208.15 |- skos__broader mesh__D051543smesh__D051858
% 207.97/208.15 |- mesh__recordMaintainer mesh__D051543 DRC
% 207.97/208.15 |- skos__altLabel mesh__D051543 Forkhead Box A3 Protein
% 207.97/208.15 |- mesh__historyNote mesh__D051543 2006%28%1991%29%
% 207.97/208.15 |- skos__hiddenLabel mesh__D051543 HNF 3gamma Protein
% 207.97/208.15 |- skos__scopeNote mesh__D051543
% 207.97/208.15 A winged-helix transcription factor that regulates GENE expression in metabolic tissues. It plays a role in HOMEOSTASIS of GLUCOSE and controls expression of GLUT2 PROTEIN.%A%
% 207.97/208.15 |- skos__hiddenLabel mesh__D051543 Hepatocyte Nuclear Factor 3 gamma
% 207.97/208.15 |- mesh__recordOriginator mesh__D051543 DRC
% 207.97/208.15 |- mesh__dateCreated mesh__D051543 2005-06-30
% 207.97/208.15 |- rdf__type mesh__D051543sskos__Concept
% 207.97/208.15 |- skos__broader mesh__D051543smesh__D051536
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D051543
% 207.97/208.15 2006; HEPATOCYTE NUCLEAR FACTOR 3-GAMMA was indexed under DNA-BINDING PROTINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%
% 207.97/208.15 |- skos__altLabel mesh__D051543 Hepatocyte Nuclear Factor 3gamma
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D051543 sjn
% 207.97/208.15 |- mesh__dateRevised mesh__D004698 1991-06-12
% 207.97/208.15 |- mesh__recordOriginator mesh__D004698 NLM
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 2002
% 207.97/208.15 |- skos__altLabel mesh__D004698 Bacterial Endocarditides, Subacute
% 207.97/208.15 |- skos__altLabel mesh__D004698 Bacterial Endocarditis, Subacute
% 207.97/208.15 |- mesh__dateCreated mesh__D004698 1999-01-01
% 207.97/208.15 |- skos__broader mesh__D004698smesh__D013290
% 207.97/208.15 |- skos__altLabel mesh__D004698 Subacute Bacterial Endocarditides
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 2001
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D004698 PLS
% 207.97/208.15 |- skos__prefLabel mesh__D004698 Endocarditis, Subacute Bacterial
% 207.97/208.15 |- skos__annotation mesh__D004698
% 207.97/208.15 coord with specific bacterium /infections heading %28%IM%29%; DF: ENDOCARDITIS SUBACUTE BACT%A%
% 207.97/208.15 |- skos__altLabel mesh__D004698 Subacute Bacterial Endocarditis
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 2004
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 1997
% 207.97/208.15 |- mesh__recordMaintainer mesh__D004698 PXP
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 2000
% 207.97/208.15 |- skos__broader mesh__D004698smesh__D004697
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 2006
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 1999
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 1993
% 207.97/208.15 |- skos__scopeNote mesh__D004698
% 207.97/208.15 Infection of the endocardium caused by species of STREPTOCOCCUS. This condition does not produce metastatic foci and if untreated may take up to a year to be fatal.%A%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 2003
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 1996
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 1995
% 207.97/208.15 |- skos__altLabel mesh__D004698 Endocarditides, Subacute Bacterial
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 2005
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 1998
% 207.97/208.15 |- skos__altLabel mesh__D004698 Endocarditis Lenta
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 1992
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D004698 1994
% 207.97/208.15 |- rdf__type mesh__D004698sskos__Concept
% 207.97/208.15 |- mesh__dateCreated mesh__D045506 2003-07-09
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D045506 2004
% 207.97/208.15 |- skos__broader mesh__D045506smesh__D020228
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D045506 2005
% 207.97/208.15 |- rdf__type mesh__D045506sskos__Concept
% 207.97/208.15 |- skos__hiddenLabel mesh__D045506 Uses, Therapeutic
% 207.97/208.15 |- skos__scopeNote mesh__D045506
% 207.97/208.15 Uses of chemicals which affect the course of conditions, diseases, syndromes or pathology to benefit the health of an individual.%A%
% 207.97/208.15 |- mesh__dateEstablished mesh__D045506 2004-01-01
% 207.97/208.15 |- skos__annotation mesh__D045506 not used for indexing or cataloging
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D045506 2006
% 207.97/208.15 |- skos__prefLabel mesh__D045506 Therapeutic Uses
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D045506 2004
% 207.97/208.15 |- mesh__historyNote mesh__D045506 2004
% 207.97/208.15 |- rdf__type mesh__D009383sskos__Concept
% 207.97/208.15 |- skos__altLabel mesh__D009383 Blood Vessel Tumors
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 2004
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D009383 PLS
% 207.97/208.15 |- skos__scopeNote mesh__D009383
% 207.97/208.15 Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels.%A%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 2000
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 2003
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 2006
% 207.97/208.15 |- skos__hiddenLabel mesh__D009383 Tumors, Blood Vessel
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 1997
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 2005
% 207.97/208.15 |- mesh__recordMaintainer mesh__D009383 TGC
% 207.97/208.15 |- skos__altLabel mesh__D009383 Vascular Tissue Neoplasms
% 207.97/208.15 |- skos__hiddenLabel mesh__D009383 Blood Vessel Tumor
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 1999
% 207.97/208.15 |- skos__annotation mesh__D009383
% 207.97/208.15 neoplasms composed of vascular tissue, NOT neoplasms located in vascular tissue %28% = VASCULAR NEOPLASMS%29%: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5%A%
% 207.97/208.15 |- skos__hiddenLabel mesh__D009383 Neoplasm, Vascular Tissue
% 207.97/208.15 |- mesh__recordOriginator mesh__D009383 NLM
% 207.97/208.15 |- skos__prefLabel mesh__D009383 Neoplasms, Vascular Tissue
% 207.97/208.15 |- skos__hiddenLabel mesh__D009383 Vascular Tissue Neoplasm
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 1998
% 207.97/208.15 |- mesh__dateRevised mesh__D009383 1996-06-10
% 207.97/208.15 |- skos__broader mesh__D009383smesh__D009370
% 207.97/208.15 |- skos__hiddenLabel mesh__D009383 Tumor, Blood Vessel
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 2002
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D009383 2001
% 207.97/208.15 |- mesh__dateCreated mesh__D009383 1999-01-01
% 207.97/208.15 |- skos__related mesh__D017815smesh__D004546
% 207.97/208.15 |- skos__altLabel mesh__D017815 Dendroaspis
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D017815 2005
% 207.97/208.15 |- skos__hiddenLabel mesh__D017815 Coral Snakes
% 207.97/208.15 |- skos__annotation mesh__D017815 a family of very venomous snakes
% 207.97/208.15 |- skos__historyNote mesh__D017815 Snakes %28%1966-1993%29%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D017815 2006
% 207.97/208.15 |- skos__hiddenLabel mesh__D017815 Snakes, Coral
% 207.97/208.15 |- skos__hiddenLabel mesh__D017815 Snake, Coral
% 207.97/208.15 |- skos__hiddenLabel mesh__D017815 Mambas
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D017815 94
% 207.97/208.15 |- mesh__historyNote mesh__D017815 94
% 207.97/208.15 |- skos__prefLabel mesh__D017815 Elapidae
% 207.97/208.15 |- skos__scopeNote mesh__D017815
% 207.97/208.15 A family of extremely venomous snakes, comprising coral snakes, cobras, mambas, kraits, and sea snakes. They are widely distributed, being found in the southern United States, South America, Africa, southern Asia, Australia, and the Pacific Islands. The elapids include three subfamilies: Elapinae, Hydrophiinae, and Lauticaudinae. Like the viperids, they have venom fangs in the front part of the upper jaw. The mambas of Africa are the most dangerous of all snakes by virtue of their size, speed, and highly toxic venom. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p329-33%29%%A%
% 207.97/208.15 |- mesh__dateEstablished mesh__D017815 1994-01-01
% 207.97/208.15 |- mesh__recordOriginator mesh__D017815 TGC
% 207.97/208.15 |- mesh__dateCreated mesh__D017815 1993-02-16
% 207.97/208.15 |- mesh__dateRevised mesh__D017815 2003-07-09
% 207.97/208.15 |- skos__broader mesh__D017815smesh__D012911
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D017815 2004
% 207.97/208.15 |- mesh__recordMaintainer mesh__D017815 ags
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D017815 sjn
% 207.97/208.15 |- rdf__type mesh__D017815sskos__Concept
% 207.97/208.15 |- skos__altLabel mesh__D017815 Coral Snake
% 207.97/208.15 |- mesh__dateRevised mesh__D017017 2005-06-30
% 207.97/208.15 |- skos__broader mesh__D017017smesh__D017016
% 207.97/208.15 |- mesh__recordOriginator mesh__D017017 PXP
% 207.97/208.15 |- mesh__historyNote mesh__D017017 92
% 207.97/208.15 |- rdf__type mesh__D017017sskos__Concept
% 207.97/208.15 |- mesh__recordMaintainer mesh__D017017 SYSTEM
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D017017 92
% 207.97/208.15 |- skos__prefLabel mesh__D017017 Methanococcus
% 207.97/208.15 |- skos__historyNote mesh__D017017 Bacteria %28%1977-1978%29%
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D017017 sjn
% 207.97/208.15 |- skos__annotation mesh__D017017
% 207.97/208.15 a genus of methanogens found in aquatic environments %26% in animal intestine%A%
% 207.97/208.15 |- mesh__dateCreated mesh__D017017 1991-05-30
% 207.97/208.15 |- skos__scopeNote mesh__D017017
% 207.97/208.15 A genus of anaerobic coccoid METHANOCOCCACEAE whose organisms are motile by means of polar tufts of flagella. These methanogens are found in salt marshes, marine and estuarine sediments, and the intestinal tract of animals.%A%
% 207.97/208.15 |- mesh__dateEstablished mesh__D017017 1992-01-01
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D017017 2006
% 207.97/208.15 |- skos__historyNote mesh__D017017 Methanogens %28%1979-1991%29%
% 207.97/208.15 |- rdf__type mesh__D005791sskos__Concept
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005791 2005
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005791 2001
% 207.97/208.15 |- skos__hiddenLabel mesh__D005791 Care, Patient
% 207.97/208.15 |- mesh__dateEstablished mesh__D005791 1998-01-01
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005791 2003
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005791 2000
% 207.97/208.15 |- skos__historyNote mesh__D005791 Nursing Care %28%1966-1997%29%
% 207.97/208.15 |- skos__annotation mesh__D005791
% 207.97/208.15 by professional %26% non-professional; GEN or unspecified; prefer specifics; not a synonym for NURSING CARE: nursing care is only one type of patient care%A%
% 207.97/208.15 |- mesh__recordOriginator mesh__D005791 NLM
% 207.97/208.15 |- mesh__dateRevised mesh__D005791 1999-11-03
% 207.97/208.15 |- skos__historyNote mesh__D005791 Patient Care Planning %28%1993-1997%29%
% 207.97/208.15 |- skos__prefLabel mesh__D005791 Patient Care
% 207.97/208.15 |- mesh__historyNote mesh__D005791 98; use explode 1975-97
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005791 2002
% 207.97/208.15 |- skos__broader mesh__D005791smesh__D013812
% 207.97/208.15 |- skos__scopeNote mesh__D005791
% 207.97/208.15 The services rendered by members of the health profession and non-professionals under their supervision for the benefit of the patient. %28%From Dorland, 28th ed, p269%29%%A%
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D005791 sjn
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005791 2006
% 207.97/208.15 |- mesh__recordMaintainer mesh__D005791 kle
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D005791 98
% 207.97/208.15 |- skos__broader mesh__D005791smesh__D006296
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D005791 2004
% 207.97/208.15 |- mesh__dateCreated mesh__D005791 1999-01-01
% 207.97/208.15 |- skos__historyNote mesh__D013425 Benzenesulfonates %28%1974%29%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013425 2002
% 207.97/208.15 |- skos__broader mesh__D013425smesh__D017739
% 207.97/208.15 |- skos__historyNote mesh__D013425 Amines %28%1974%29%
% 207.97/208.15 |- skos__scopeNote mesh__D013425
% 207.97/208.15 Aminobenzenesulfonic acids. Organic acids that are used in the manufacture of dyes and organic chemicals and as reagents.%A%
% 207.97/208.15 |- skos__altLabel mesh__D013425 Anilinesulfonic Acids
% 207.97/208.15 |- mesh__historyNote mesh__D013425
% 207.97/208.15 91%28%83%29%; was see under BENZENESULFONATES 1983-90; was SULFANILIC ACID see under BENZENESULFONATES 1975-82%A%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013425 2003
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D013425 sjn
% 207.97/208.15 |- skos__broader mesh__D013425smesh__D001555
% 207.97/208.15 |- mesh__recordOriginator mesh__D013425 NLM
% 207.97/208.15 |- rdf__type mesh__D013425sskos__Concept
% 207.97/208.15 |- skos__hiddenLabel mesh__D013425 Acids, Sulfanilic
% 207.97/208.15 |- mesh__dateEstablished mesh__D013425 1991-01-01
% 207.97/208.15 |- mesh__dateCreated mesh__D013425 1974-11-19
% 207.97/208.15 |- skos__prefLabel mesh__D013425 Sulfanilic Acids
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013425 2004
% 207.97/208.15 |- skos__related mesh__D013425smesh__D007202
% 207.97/208.15 |- skos__altLabel mesh__D013425 Aminobenzenesulfonic Acids
% 207.97/208.15 |- mesh__recordMaintainer mesh__D013425 CCR
% 207.97/208.15 |- mesh__dateRevised mesh__D013425 2000-06-21
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013425 2005
% 207.97/208.15 |- skos__hiddenLabel mesh__D013425 Acids, Anilinesulfonic
% 207.97/208.15 |- skos__hiddenLabel mesh__D013425 Acids, Aminobenzenesulfonic
% 207.97/208.15 |- mesh__onlineNote mesh__D013425
% 207.97/208.15 use SULFANILIC ACIDS to search SULFANILIC ACID 1975-82
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D013425
% 207.97/208.15 91; was see under BENZENESULFONATES 1983-90; was SULFANILIC ACID see under BENZENESULFONATES 1975-82%A%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013425 2001
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D013425 2006
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 2002
% 207.97/208.15 |- mesh__historyNote mesh__D018110
% 207.97/208.15 94; was LIPOPROTEIN RECEPTOR %28%NM%29% 1981-93
% 207.97/208.15 |- skos__hiddenLabel mesh__D018110 Lipoproteins Receptors
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 2006
% 207.97/208.15 |- skos__annotation mesh__D018110
% 207.97/208.15 GEN; RECEPTORS, LDL is available; DF: RECEPT LIPOPROTEIN
% 207.97/208.15 |- skos__broader mesh__D018110smesh__D011956
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 1999
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 2001
% 207.97/208.15 |- mesh__onlineNote mesh__D018110
% 207.97/208.15 use RECEPTORS, LIPOPROTEIN %28%NM%29% to search LIPOPROTEIN RECEPTOR 1981-93%A%
% 207.97/208.15 |- mesh__dateRevised mesh__D018110 1995-06-08
% 207.97/208.15 |- rdf__type mesh__D018110sskos__Concept
% 207.97/208.15 |- mesh__publicMeSHNote mesh__D018110
% 207.97/208.15 94; LIPOPROTEIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93%A%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 2000
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 2005
% 207.97/208.15 |- skos__altLabel mesh__D018110 Lipoprotein Receptor
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 1998
% 207.97/208.15 |- mesh__dateCreated mesh__D018110 1993-06-21
% 207.97/208.15 |- skos__altLabel mesh__D018110 Receptors, Lipoproteins
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 2004
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 1997
% 207.97/208.15 |- mesh__recordAuthorizer mesh__D018110 PLS
% 207.97/208.15 |- skos__hiddenLabel mesh__D018110 Receptor, Lipoprotein
% 207.97/208.15 |- skos__historyNote mesh__D018110
% 207.97/208.15 Receptors, Cell Surface %28%1981-1993%29%
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 2003
% 207.97/208.15 |- skos__prefLabel mesh__D018110 Receptors, Lipoprotein
% 207.97/208.15 |- skos__historyNote mesh__D018110 Lipoproteins %28%1981-1993%29%
% 207.97/208.15 |- mesh__recordMaintainer mesh__D018110 KEV
% 207.97/208.15 |- mesh__recordOriginator mesh__D018110 RAZ
% 207.97/208.15 |- mesh__activeMeSHYear mesh__D018110 1996
% 207.97/208.15 |- skos__altLabel mesh__D018110 Lipoprotein Receptors
% 207.97/208.15 |- mesh__dateEstablished mesh__D018110 1994-01-01
% 207.97/208.15 |- skos__scopeNote mesh__D018110
% 207.97/208.15 Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognize the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis.%A%
% 207.97/208.15 |- skos__altLabel mesh__D051544 Erythromycin N-Demethylase
% 207.97/208.15 |- skos__hiddenLabel mesh__D051544 Cytochrome P 450 CYP3A
% 207.97/208.16 |- skos__altLabel mesh__D051544 Cytochrome P-450IIIA
% 207.97/208.16 |- mesh__recordMaintainer mesh__D051544 AKE
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D051544 sjn
% 207.97/208.16 |- mesh__recordOriginator mesh__D051544 AKE
% 207.97/208.16 |- skos__hiddenLabel mesh__D051544 Erythromycin N Demethylase
% 207.97/208.16 |- skos__hiddenLabel mesh__D051544 Cytochrome P 450IIIA
% 207.97/208.16 |- skos__hiddenLabel mesh__D051544 P-450IIIA, Cytochrome
% 207.97/208.16 |- skos__broader mesh__D051544smesh__D010089
% 207.97/208.16 |- skos__scopeNote mesh__D051544
% 207.97/208.16 A cytochrome P-450 monooxygenase that is involved in an NADPH-dependent electron transport pathway by oxidizing a variety of structurally unrelated compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN.%A%
% 207.97/208.16 |- skos__hiddenLabel mesh__D051544 N-Demethylase, Erythromycin
% 207.97/208.16 |- rdf__type mesh__D051544sskos__Concept
% 207.97/208.16 |- skos__hiddenLabel mesh__D051544 P450 3A, Cytochrome
% 207.97/208.16 |- mesh__dateEstablished mesh__D051544 2006-01-01
% 207.97/208.16 |- skos__prefLabel mesh__D051544 Cytochrome P-450 CYP3A
% 207.97/208.16 |- mesh__historyNote mesh__D051544 2006%28%1980%29%
% 207.97/208.16 |- skos__hiddenLabel mesh__D051544 P-450 CYP3A, Cytochrome
% 207.97/208.16 |- mesh__dateCreated mesh__D051544 2005-06-30
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D051544
% 207.97/208.16 2006; CYTOCHROME P-450 CYP3A was indexed under ARYL HYDROCARBON HYDROXYLASES %26% OXIDOREDUCTASES, N-DEMETHYLATING 1980-2005%A%
% 207.97/208.16 |- skos__broader mesh__D051544smesh__D001189
% 207.97/208.16 |- skos__altLabel mesh__D051544 Cytochrome P450 3A
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D051544 2006
% 207.97/208.16 |- skos__altLabel mesh__D051544 CYP3A
% 207.97/208.16 |- skos__hiddenLabel mesh__D004699 Endocardiums
% 207.97/208.16 |- mesh__dateCreated mesh__D004699 1999-01-01
% 207.97/208.16 |- skos__broader mesh__D004699smesh__D006321
% 207.97/208.16 |- skos__annotation mesh__D004699
% 207.97/208.16 inflammation = ENDOCARDITIS %26% its specifics
% 207.97/208.16 |- mesh__recordOriginator mesh__D004699 NLM
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 2004
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 1997
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 2002
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 2006
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 1999
% 207.97/208.16 |- mesh__dateRevised mesh__D004699 1992-05-15
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 1993
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 2003
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 1996
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 1995
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 2001
% 207.97/208.16 |- skos__scopeNote mesh__D004699
% 207.97/208.16 The innermost layer of the heart, comprised of endothelial cells.%A%
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 2005
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D004699 PLS
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 1998
% 207.97/208.16 |- rdf__type mesh__D004699sskos__Concept
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 1994
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D004699 2000
% 207.97/208.16 |- mesh__recordMaintainer mesh__D004699 TAP
% 207.97/208.16 |- skos__prefLabel mesh__D004699 Endocardium
% 207.97/208.16 |- skos__historyNote mesh__D009384 Hormones, Ectopic %28%1968-1972%29%
% 207.97/208.16 |- skos__prefLabel mesh__D009384 Paraneoplastic Endocrine Syndromes
% 207.97/208.16 |- skos__related mesh__D009384smesh__D000182
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009384 2006
% 207.97/208.16 |- mesh__dateRevised mesh__D009384 2004-07-07
% 207.97/208.16 |- mesh__dateEstablished mesh__D009384 1973-01-01
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009384 2005
% 207.97/208.16 |- skos__broader mesh__D009384smesh__D010257
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D009384
% 207.97/208.16 2005; see NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1973-2004
% 207.97/208.16 |- mesh__historyNote mesh__D009384 2005 %28%1973%29%
% 207.97/208.16 |- skos__hiddenLabel mesh__D009384 Endocrine Syndrome, Paraneoplastic
% 207.97/208.16 |- skos__scopeNote mesh__D009384
% 207.97/208.16 Syndromes resulting from inappropriate production of HORMONES or hormone-like materials by NEOPLASMS in non-endocrine tissues or not by the usual ENDOCRINE GLANDS. Such hormone outputs are called ectopic hormone %28%HORMONES, ECTOPIC%29% secretion.%A%
% 207.97/208.16 |- skos__altLabel mesh__D009384 Ectopic Hormone Syndromes
% 207.97/208.16 |- mesh__recordMaintainer mesh__D009384 lkt
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D009384 sjn
% 207.97/208.16 |- skos__related mesh__D009384smesh__D006729
% 207.97/208.16 |- skos__hiddenLabel mesh__D009384 Syndrome, Ectopic Hormone
% 207.97/208.16 |- skos__hiddenLabel mesh__D009384 Paraneoplastic Endocrine Syndrome
% 207.97/208.16 |- rdf__type mesh__D009384sskos__Concept
% 207.97/208.16 |- mesh__recordOriginator mesh__D009384 NLM
% 207.97/208.16 |- mesh__dateCreated mesh__D009384 1999-01-01
% 207.97/208.16 |- skos__hiddenLabel mesh__D009384 Syndromes, Ectopic Hormone
% 207.97/208.16 |- skos__annotation mesh__D009384
% 207.97/208.16 coordinate IM with pre-coordinated organ/neoplasm term with /secret %28%IM%29% + histological type of neoplasm /secret %28%IM%29% + specific hormone /secret %28%IM%29%; but ACTH SYNDROME, ECTOPIC is also available%A%
% 207.97/208.16 |- skos__broader mesh__D009384smesh__D004701
% 207.97/208.16 |- skos__hiddenLabel mesh__D009384 Ectopic Hormone Syndrome
% 207.97/208.16 |- skos__hiddenLabel mesh__D009384 Syndrome, Paraneoplastic Endocrine
% 207.97/208.16 |- skos__hiddenLabel mesh__D009384 Syndromes, Paraneoplastic Endocrine
% 207.97/208.16 |- mesh__recordOriginator mesh__D017018 PXP
% 207.97/208.16 |- mesh__historyNote mesh__D017018 92
% 207.97/208.16 |- rdf__type mesh__D017018sskos__Concept
% 207.97/208.16 |- mesh__dateEstablished mesh__D017018 1992-01-01
% 207.97/208.16 |- mesh__recordMaintainer mesh__D017018 SYSTEM
% 207.97/208.16 |- mesh__dateRevised mesh__D017018 2005-06-30
% 207.97/208.16 |- skos__scopeNote mesh__D017018
% 207.97/208.16 An order of anaerobic, highly specialized methanogens, in the kingdom EURYARCHAEOTA. Its organisms are nonmotile or motile, with cells occurring as coccoid bodies, pseudosarcina, or rods. Families include METHANOMICROBIACEAE, Methanocorpusculaceae, and Methanospirillaceae.%A%
% 207.97/208.16 |- skos__broader mesh__D017018smesh__D019605
% 207.97/208.16 |- mesh__dateCreated mesh__D017018 1991-05-30
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D017018 2006
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D017018 92
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D017018 sjn
% 207.97/208.16 |- skos__prefLabel mesh__D017018 Methanomicrobiales
% 207.97/208.16 |- skos__broader mesh__D005792smesh__D003813
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 1999
% 207.97/208.16 |- mesh__dateEstablished mesh__D005792 1967-01-01
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D005792 PLS
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 1997
% 207.97/208.16 |- mesh__historyNote mesh__D005792 67
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 1998
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 2001
% 207.97/208.16 |- skos__historyNote mesh__D005792 Dentistry %28%1966%29%
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 1996
% 207.97/208.16 |- skos__scopeNote mesh__D005792
% 207.97/208.16 Nonspecialized dental practice which is concerned with providing primary and continuing dental care.%A%
% 207.97/208.16 |- skos__prefLabel mesh__D005792 General Practice, Dental
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 2000
% 207.97/208.16 |- mesh__dateRevised mesh__D005792 1990-05-29
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D005792 67
% 207.97/208.16 |- skos__altLabel mesh__D005792 Practice, Dental General
% 207.97/208.16 |- skos__altLabel mesh__D005792 Dental General Practice
% 207.97/208.16 |- skos__altLabel mesh__D005792 General Practices, Dental
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 2006
% 207.97/208.16 |- mesh__recordOriginator mesh__D005792 NLM
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 2004
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 1995
% 207.97/208.16 |- skos__annotation mesh__D005792
% 207.97/208.16 SPEC: SPEC qualif; %22%extraction in general practice in dentistry%22% is GENERAL PRACTICE, DENTAL %28%NIM%29% if indexed there at all; DF: GENERAL PRACTICE DENT%A%
% 207.97/208.16 |- skos__altLabel mesh__D005792 Practices, Dental General
% 207.97/208.16 |- skos__altLabel mesh__D005792 Dental General Practices
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 1993
% 207.97/208.16 |- mesh__dateCreated mesh__D005792 1999-01-01
% 207.97/208.16 |- mesh__recordMaintainer mesh__D005792 TAP
% 207.97/208.16 |- rdf__type mesh__D005792sskos__Concept
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 2005
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 2002
% 207.97/208.16 |- skos__historyNote mesh__D005792 Family Practice %28%1966%29%
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 1991
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 2003
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 1994
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005792 1992
% 207.97/208.16 |- skos__altLabel mesh__D013426 Sulphaphenazole
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013426 2001
% 207.97/208.16 |- skos__altLabel mesh__D013426 Phenylsulfapyrazole
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013426 2006
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013426 2005
% 207.97/208.16 |- skos__altLabel mesh__D013426 Sulfaphenylpyrazol
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013426 2004
% 207.97/208.16 |- skos__broader mesh__D013426smesh__D013424
% 207.97/208.16 |- rdf__type mesh__D013426sskos__Concept
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013426 2003
% 207.97/208.16 |- skos__scopeNote mesh__D013426 A sulfonilamide anti-infective agent.
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D013426 sjn
% 207.97/208.16 |- mesh__dateCreated mesh__D013426 1999-01-01
% 207.97/208.16 |- mesh__dateRevised mesh__D013426 2000-06-22
% 207.97/208.16 |- mesh__recordOriginator mesh__D013426 NLM
% 207.97/208.16 |- mesh__recordMaintainer mesh__D013426 CCR
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013426 2002
% 207.97/208.16 |- skos__prefLabel mesh__D013426 Sulfaphenazole
% 207.97/208.16 |- skos__historyNote mesh__D018111 Paramyxoviridae %28%1985-1993%29%
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D018111 sjn
% 207.97/208.16 |- rdf__type mesh__D018111sskos__Concept
% 207.97/208.16 |- skos__scopeNote mesh__D018111
% 207.97/208.16 A genus of the family PARAMYXOVIRIDAE %28%subfamily PNEUMOVIRINAE%29% where the human and bovine virions have neither hemagglutinin nor neuraminidase activity. RESPIRATORY SYNCYTIAL VIRUS, HUMAN is the type species.%A%
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D018111 2005
% 207.97/208.16 |- skos__annotation mesh__D018111 infection = PNEUMOVIRUS INFECTIONS
% 207.97/208.16 |- mesh__recordOriginator mesh__D018111 AGS
% 207.97/208.16 |- mesh__dateEstablished mesh__D018111 1994-01-01
% 207.97/208.16 |- mesh__dateCreated mesh__D018111 1993-06-04
% 207.97/208.16 |- mesh__recordMaintainer mesh__D018111 sjn
% 207.97/208.16 |- mesh__historyNote mesh__D018111 94
% 207.97/208.16 |- skos__prefLabel mesh__D018111 Pneumovirus
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D018111 94
% 207.97/208.16 |- skos__broader mesh__D018111smesh__D018099
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D018111 2006
% 207.97/208.16 |- mesh__dateRevised mesh__D018111 2004-07-13
% 207.97/208.16 |- skos__altLabel mesh__D051545 Cyclooxygenase-1
% 207.97/208.16 |- rdf__type mesh__D051545sskos__Concept
% 207.97/208.16 |- mesh__historyNote mesh__D051545 2006%28%1996%29%
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D051545
% 207.97/208.16 2006; CYCLOOXYGENASE 1 was indexed under ISOENZYMES, %26% PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1996-2005%A%
% 207.97/208.16 |- skos__hiddenLabel mesh__D051545 Cyclo Oxygenase I
% 207.97/208.16 |- skos__hiddenLabel mesh__D051545 Prostaglandin Synthase, COX-1
% 207.97/208.16 |- mesh__dateCreated mesh__D051545 2005-06-30
% 207.97/208.16 |- skos__altLabel mesh__D051545 Cyclo-Oxygenase I
% 207.97/208.16 |- skos__hiddenLabel mesh__D051545 Prostaglandin H Synthase 1
% 207.97/208.16 |- mesh__recordOriginator mesh__D051545 AKE
% 207.97/208.16 |- skos__broader mesh__D051545smesh__D011451
% 207.97/208.16 |- skos__altLabel mesh__D051545 Prostaglandin H Synthase-1
% 207.97/208.16 |- skos__hiddenLabel mesh__D051545 COX 1 Prostaglandin Synthase
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D051545 sjn
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D051545 2006
% 207.97/208.16 |- skos__prefLabel mesh__D051545 Cyclooxygenase 1
% 207.97/208.16 |- mesh__dateEstablished mesh__D051545 2006-01-01
% 207.97/208.16 |- mesh__recordMaintainer mesh__D051545 AKE
% 207.97/208.16 |- skos__scopeNote mesh__D051545
% 207.97/208.16 A constitutively-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes.%A%
% 207.97/208.16 |- skos__altLabel mesh__D051545 COX-1 Prostaglandin Synthase
% 207.97/208.16 |- skos__hiddenLabel mesh__D051545 Synthase, COX-1 Prostaglandin
% 207.97/208.16 |- mesh__recordMaintainer mesh__D009385 TGC
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D009385 sjn
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009385 2002
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009385 2006
% 207.97/208.16 |- mesh__dateRevised mesh__D009385 2000-06-22
% 207.97/208.16 |- skos__scopeNote mesh__D009385
% 207.97/208.16 The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.%A%
% 207.97/208.16 |- skos__prefLabel mesh__D009385 Neoplastic Processes
% 207.97/208.16 |- mesh__dateCreated mesh__D009385 1981-05-19
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D009385 98
% 207.97/208.16 |- mesh__recordOriginator mesh__D009385 VDK
% 207.97/208.16 |- mesh__dateEstablished mesh__D009385 1998-01-01
% 207.97/208.16 |- skos__broader mesh__D009385smesh__D009369
% 207.97/208.16 |- skos__annotation mesh__D009385
% 207.97/208.16 GEN or unspecified; prefer specifics; for neopl process in general, coord NIM when precoord organ/neopl %28%with /pathol%29% or histol type %28%with /pathol%29% is IM; DF: NEOPL PROCESSES%A%
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009385 2001
% 207.97/208.16 |- mesh__historyNote mesh__D009385 98; use explode 1982-97
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009385 2003
% 207.97/208.16 |- skos__altLabel mesh__D009385 Processes, Neoplastic
% 207.97/208.16 |- rdf__type mesh__D009385sskos__Concept
% 207.97/208.16 |- skos__broader mesh__D009385smesh__D010335
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009385 2005
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009385 2004
% 207.97/208.16 |- skos__historyNote mesh__D009385
% 207.97/208.16 specific neoplastic process %28%1966-1997%29%
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D017817 94
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D017817 2003
% 207.97/208.16 |- mesh__dateEstablished mesh__D017817 1994-01-01
% 207.97/208.16 |- skos__altLabel mesh__D017817 Nasal Washings
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D017817 2004
% 207.97/208.16 |- skos__historyNote mesh__D017817 Irrigation %28%1971-1993%29%
% 207.97/208.16 |- skos__broader mesh__D017817smesh__D001826
% 207.97/208.16 |- rdf__type mesh__D017817sskos__Concept
% 207.97/208.16 |- skos__hiddenLabel mesh__D017817 Nasal Washing
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D017817 2000
% 207.97/208.16 |- skos__prefLabel mesh__D017817 Nasal Lavage Fluid
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D017817 sjn
% 207.97/208.16 |- skos__hiddenLabel mesh__D017817 Nasal Lavage Fluids
% 207.97/208.16 |- skos__hiddenLabel mesh__D017817 Washing, Nasal
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D017817 2005
% 207.97/208.16 |- mesh__recordOriginator mesh__D017817 JLS
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D017817 2001
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D017817 2006
% 207.97/208.16 |- skos__hiddenLabel mesh__D017817 Lavage Fluid, Nasal
% 207.97/208.16 |- skos__scopeNote mesh__D017817
% 207.97/208.16 Fluid obtained by irrigation or washout of the nasal cavity and NASAL MUCOSA. The resulting fluid is used in cytologic and immunologic assays of the nasal mucosa such as with the NASAL PROVOCATION TEST in the diagnosis of nasal hypersensitivity.%A%
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D017817 2002
% 207.97/208.16 |- mesh__dateCreated mesh__D017817 1993-06-04
% 207.97/208.16 |- mesh__recordMaintainer mesh__D017817 KEV
% 207.97/208.16 |- skos__hiddenLabel mesh__D017817 Fluid, Nasal Lavage
% 207.97/208.16 |- mesh__dateRevised mesh__D017817 1999-11-09
% 207.97/208.16 |- mesh__historyNote mesh__D017817 94
% 207.97/208.16 |- mesh__recordMaintainer mesh__D017019 SYSTEM
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D017019 92
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D017019 sjn
% 207.97/208.16 |- mesh__dateEstablished mesh__D017019 1992-01-01
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D017019 2006
% 207.97/208.16 |- mesh__dateCreated mesh__D017019 1991-05-30
% 207.97/208.16 |- skos__broader mesh__D017019smesh__D019640
% 207.97/208.16 |- skos__annotation mesh__D017019
% 207.97/208.16 a family of methanogens %22%found in any anaerobic environment%22%%A%
% 207.97/208.16 |- skos__scopeNote mesh__D017019
% 207.97/208.16 A family of anaerobic METHANOSARCINALES whose cells are mesophilic or thermophilic and appear as irregular spheroid bodies or sheathed rods. These methanogens are found in any anaerobic environment including aquatic sediments, anaerobic sewage digesters and gastrointestinal tracts. There are four genera: METHANOSARCINA, Methanolobus, Methanothrix, and Methanococcoides.%A%
% 207.97/208.16 |- mesh__historyNote mesh__D017019 92
% 207.97/208.16 |- rdf__type mesh__D017019sskos__Concept
% 207.97/208.16 |- mesh__dateRevised mesh__D017019 2005-06-30
% 207.97/208.16 |- mesh__recordOriginator mesh__D017019 PXP
% 207.97/208.16 |- skos__prefLabel mesh__D017019 Methanosarcinaceae
% 207.97/208.16 |- skos__hiddenLabel mesh__D005793 Generalizations %28%Psychology%29%
% 207.97/208.16 |- mesh__recordOriginator mesh__D005793 NLM
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D005793
% 207.97/208.16 65; was GENERALIZATION LEARNING 1963-64
% 207.97/208.16 |- skos__altLabel mesh__D005793 Generalization
% 207.97/208.16 |- skos__annotation mesh__D005793 DF: GENERALIZATION
% 207.97/208.16 |- mesh__recordMaintainer mesh__D005793 TAP
% 207.97/208.16 |- mesh__historyNote mesh__D005793
% 207.97/208.16 65; was GENERALIZATION LEARNING 1963-64
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D005793 PLS
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 1997
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 2005
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 1994
% 207.97/208.16 |- mesh__dateCreated mesh__D005793 1999-01-01
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 2000
% 207.97/208.16 |- skos__broader mesh__D005793smesh__D007858
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 2006
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 2003
% 207.97/208.16 |- mesh__dateRevised mesh__D005793 1992-05-15
% 207.97/208.16 |- mesh__dateEstablished mesh__D005793 1965-01-01
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 2001
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 1995
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 2004
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 1998
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 1993
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 2002
% 207.97/208.16 |- skos__scopeNote mesh__D005793
% 207.97/208.16 The phenomenon of an organism%27%s responding to all situations similar to one in which it has been conditioned.%A%
% 207.97/208.16 |- skos__hiddenLabel mesh__D005793 Generalizations
% 207.97/208.16 |- skos__prefLabel mesh__D005793 Generalization %28%Psychology%29%
% 207.97/208.16 |- rdf__type mesh__D005793sskos__Concept
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 1996
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D005793 1999
% 207.97/208.16 |- mesh__historyNote mesh__D013427
% 207.97/208.16 91%28%75%29%; was see under SULFANILAMIDES 1975-90
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013427 2002
% 207.97/208.16 |- skos__altLabel mesh__D013427 Sulphapyridin
% 207.97/208.16 |- mesh__dateCreated mesh__D013427 1974-11-19
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013427 2005
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013427 2001
% 207.97/208.16 |- skos__scopeNote mesh__D013427
% 207.97/208.16 Antibacterial, potentially toxic, used to treat certain skin diseases.%A%
% 207.97/208.16 |- skos__historyNote mesh__D013427 Pyridines %28%1974%29%
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013427 2004
% 207.97/208.16 |- rdf__type mesh__D013427sskos__Concept
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013427 2003
% 207.97/208.16 |- mesh__dateRevised mesh__D013427 2000-06-22
% 207.97/208.16 |- skos__altLabel mesh__D013427 Sulphapyridine
% 207.97/208.16 |- mesh__dateEstablished mesh__D013427 1991-01-01
% 207.97/208.16 |- skos__broader mesh__D013427smesh__D013424
% 207.97/208.16 |- skos__prefLabel mesh__D013427 Sulfapyridine
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D013427
% 207.97/208.16 91; was see under SULFANILAMIDES 1975-90
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D013427 sjn
% 207.97/208.16 |- skos__historyNote mesh__D013427 Sulfanilamides %28%1974%29%
% 207.97/208.16 |- mesh__recordOriginator mesh__D013427 NLM
% 207.97/208.16 |- mesh__recordMaintainer mesh__D013427 CCR
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D013427 2006
% 207.97/208.16 |- skos__hiddenLabel mesh__D018910 Games, Video
% 207.97/208.16 |- mesh__dateCreated mesh__D018910 1994-12-27
% 207.97/208.16 |- skos__annotation mesh__D018910 /adv eff /psychol permitted
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D018910 sjn
% 207.97/208.16 |- skos__hiddenLabel mesh__D018910 Game, Video
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D018910 2006
% 207.97/208.16 |- mesh__recordMaintainer mesh__D018910 jls
% 207.97/208.16 |- rdf__type mesh__D018910sskos__Concept
% 207.97/208.16 |- skos__broader mesh__D018910smesh__D010988
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D018910 2005
% 207.97/208.16 |- mesh__dateEstablished mesh__D018910 1996-01-01
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D018910
% 207.97/208.16 96; was see PLAY AND PLAYTHINGS 1984-95
% 207.97/208.16 |- mesh__recordOriginator mesh__D018910 AGS
% 207.97/208.16 |- mesh__onlineNote mesh__D018910
% 207.97/208.16 use PLAY AND PLAYTHINGS to search VIDEO GAMES 1984-95
% 207.97/208.16 |- skos__prefLabel mesh__D018910 Video Games
% 207.97/208.16 |- mesh__dateRevised mesh__D018910 2004-07-07
% 207.97/208.16 |- mesh__historyNote mesh__D018910
% 207.97/208.16 96; was see PLAY AND PLAYTHINGS 1984-95
% 207.97/208.16 |- skos__broader mesh__D018910smesh__D012984
% 207.97/208.16 |- skos__historyNote mesh__D018910 Play and Playthings %28%1983-1995%29%
% 207.97/208.16 |- skos__scopeNote mesh__D018910
% 207.97/208.16 A form of interactive entertainment in which the player controls electronically generated images that appear on a video display screen. This includes video games played in the home on special machines or home computers, and those played in arcades. %28%McGraw Hill Encyclopedia of Science %26% Technology, 7th ed, v19, p223%29%%A%
% 207.97/208.16 |- skos__hiddenLabel mesh__D018910 Video Game
% 207.97/208.16 |- skos__historyNote mesh__D018112
% 207.97/208.16 Respiratory Syncytial Viruses %28%1968-1993%29%
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D018112 2003
% 207.97/208.16 |- mesh__historyNote mesh__D018112 94
% 207.97/208.16 |- skos__broader mesh__D018112smesh__D012136
% 207.97/208.16 |- skos__annotation mesh__D018112
% 207.97/208.16 infection: coord IM with RESPIRATORY SYNCYTIAL VIRUS INFECTIONS %28%IM%29%%A%
% 207.97/208.16 |- skos__altLabel mesh__D018112 Bovine respiratory syncytial virus
% 207.97/208.16 |- mesh__dateRevised mesh__D018112 2001-07-25
% 207.97/208.16 |- mesh__dateEstablished mesh__D018112 1994-01-01
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D018112 sjn
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D018112 2006
% 207.97/208.16 |- mesh__recordOriginator mesh__D018112 AGS
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D018112 2002
% 207.97/208.16 |- skos__scopeNote mesh__D018112
% 207.97/208.16 A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress.%A%
% 207.97/208.16 |- mesh__recordMaintainer mesh__D018112 ags
% 207.97/208.16 |- mesh__dateCreated mesh__D018112 1993-06-04
% 207.97/208.16 |- rdf__type mesh__D018112sskos__Concept
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D018112 2005
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D018112 2004
% 207.97/208.16 |- skos__prefLabel mesh__D018112 Respiratory Syncytial Virus, Bovine
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D018112 94
% 207.97/208.16 |- skos__hiddenLabel mesh__D051546 Prostaglandin H Synthase 2
% 207.97/208.16 |- skos__hiddenLabel mesh__D051546 Cyclo Oxygenase II
% 207.97/208.16 |- skos__altLabel mesh__D051546 Prostaglandin H Synthase-2
% 207.97/208.16 |- skos__altLabel mesh__D051546 Cyclo-Oxygenase II
% 207.97/208.16 |- mesh__historyNote mesh__D051546 2006%28%1996%29%
% 207.97/208.16 |- skos__broader mesh__D051546smesh__D011451
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D051546
% 207.97/208.16 2006; CYCLOOXYGENASE 2 was indexed under ISOENZYMES, under PEROXIDASES %26% PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1996-2005%A%
% 207.97/208.16 |- skos__altLabel mesh__D051546 PGHS-2
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D051546 2006
% 207.97/208.16 |- skos__scopeNote mesh__D051546
% 207.97/208.16 An inducibly-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes and INFLAMMATION. It is the target of COX2 INHIBITORS.%A%
% 207.97/208.16 |- mesh__dateCreated mesh__D051546 2005-06-30
% 207.97/208.16 |- skos__prefLabel mesh__D051546 Cyclooxygenase 2
% 207.97/208.16 |- skos__altLabel mesh__D051546 Cyclooxygenase-2
% 207.97/208.16 |- skos__hiddenLabel mesh__D051546 Prostaglandin Synthase, COX-2
% 207.97/208.16 |- mesh__recordMaintainer mesh__D051546 AKE
% 207.97/208.16 |- skos__hiddenLabel mesh__D051546 COX 2 Prostaglandin Synthase
% 207.97/208.16 |- mesh__recordOriginator mesh__D051546 AKE
% 207.97/208.16 |- skos__altLabel mesh__D051546 PTGS2
% 207.97/208.16 |- skos__altLabel mesh__D051546 COX-2 Prostaglandin Synthase
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D051546 sjn
% 207.97/208.16 |- rdf__type mesh__D051546sskos__Concept
% 207.97/208.16 |- mesh__dateEstablished mesh__D051546 2006-01-01
% 207.97/208.16 |- skos__hiddenLabel mesh__D051546 Synthase, COX-2 Prostaglandin
% 207.97/208.16 |- skos__broader mesh__D009386smesh__D030342
% 207.97/208.16 |- mesh__recordAuthorizer mesh__D009386 sjn
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009386 2002
% 207.97/208.16 |- skos__broader mesh__D009386smesh__D009369
% 207.97/208.16 |- skos__hiddenLabel mesh__D009386 Syndrome, Hereditary Cancer
% 207.97/208.16 |- skos__prefLabel mesh__D009386 Neoplastic Syndromes, Hereditary
% 207.97/208.16 |- mesh__dateCreated mesh__D009386 1986-06-23
% 207.97/208.16 |- skos__hiddenLabel mesh__D009386 Syndrome, Hereditary Neoplastic
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009386 2003
% 207.97/208.16 |- rdf__type mesh__D009386sskos__Concept
% 207.97/208.16 |- mesh__historyNote mesh__D009386 87
% 207.97/208.16 |- mesh__dateEstablished mesh__D009386 1987-01-01
% 207.97/208.16 |- mesh__recordOriginator mesh__D009386 VDK
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009386 2004
% 207.97/208.16 |- skos__hiddenLabel mesh__D009386 Syndromes, Hereditary Cancer
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009386 2005
% 207.97/208.16 |- skos__hiddenLabel mesh__D009386 Hereditary Cancer Syndrome
% 207.97/208.16 |- skos__altLabel mesh__D009386 Hereditary Neoplastic Syndromes
% 207.97/208.16 |- skos__altLabel mesh__D009386 Hereditary Cancer Syndromes
% 207.97/208.16 |- skos__scopeNote mesh__D009386
% 207.97/208.16 The condition of a pattern of malignancies within a family, but not every individual%27%s necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the tumors may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance.%A%
% 207.97/208.16 |- skos__hiddenLabel mesh__D009386 Syndromes, Hereditary Neoplastic
% 207.97/208.16 |- mesh__activeMeSHYear mesh__D009386 2006
% 207.97/208.16 |- mesh__publicMeSHNote mesh__D009386 87
% 207.97/208.16 |- mesh__recordMaintainer mesh__D009386 nns
% 207.97/208.16 |- skos__hiddenLabel mesh__D009386 Cancer Syndrome, Hereditary
% 207.97/208.16 |- mesh__dateRevised mesh__D009386 2001-07-25
% 207.97/208.16 |- skos__hiddenLabel mesh__D009386 Hereditary Neoplastic Syndrome
% 207.97/208.16 |- skos__hiddenLabel mesh__D009386 Neoplastic Syndrome, Hereditary
% 207.97/208.16 |- skos__altLabel mesh__D009386 Cancer Syndromes, Hereditary
% 207.97/208.16 |- skos__annotation mesh__D009386
% 207.97/208.16 do not use /blood supply /chem /second /secret /ultrastruct; coord IM with specific hereditary organ/neopl term %28%IM%29% or specific hereditary histol type %28%IM%29%%A%
% 207.97/208.17 |- mesh__recordOriginator mesh__D014520 NLM
% 207.97/208.17 |- skos__altLabel mesh__D014520 Ethyl Carbamate
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D014520 2004
% 207.97/208.17 |- mesh__recordMaintainer mesh__D014520 adp
% 207.97/208.17 |- rdf__type mesh__D014520sskos__Concept
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D014520 2001
% 207.97/208.17 |- skos__altLabel mesh__D014520 Urethan
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D014520 2003
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D014520 2000
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D014520 2006
% 207.97/208.17 |- skos__broader mesh__D014520smesh__D002219
% 207.97/208.17 |- skos__prefLabel mesh__D014520 Urethane
% 207.97/208.17 |- skos__annotation mesh__D014520 POLYURETHANES is available
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D014520 sjn
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D014520 2005
% 207.97/208.17 |- skos__scopeNote mesh__D014520
% 207.97/208.17 Antineoplastic agent that is also used as a veterinary anesthetic. It has also been used as an intermediate in organic synthesis. Urethane is suspected to be a carcinogen.%A%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D014520 2002
% 207.97/208.17 |- mesh__dateRevised mesh__D014520 1999-11-03
% 207.97/208.17 |- mesh__dateCreated mesh__D014520 1999-01-01
% 207.97/208.17 |- skos__hiddenLabel mesh__D014520 Carbamate, Ethyl
% 207.97/208.17 |- skos__hiddenLabel mesh__D000500 Allylestrenol Organon Brand
% 207.97/208.17 |- mesh__dateEstablished mesh__D000500 1991-01-01
% 207.97/208.17 |- skos__historyNote mesh__D000500 Estranes %28%1970-1974%29%
% 207.97/208.17 |- mesh__dateRevised mesh__D000500 2003-07-09
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D000500 sjn
% 207.97/208.17 |- skos__scopeNote mesh__D000500
% 207.97/208.17 A synthetic steroid with progestational activity.
% 207.97/208.17 |- skos__historyNote mesh__D000500 Hydroxysteroids %28%1973-1974%29%
% 207.97/208.17 |- skos__prefLabel mesh__D000500 Allylestrenol
% 207.97/208.17 |- rdf__type mesh__D000500sskos__Concept
% 207.97/208.17 |- skos__broader mesh__D000500smesh__D004963
% 207.97/208.17 |- skos__altLabel mesh__D000500 Allyloestrenol
% 207.97/208.17 |- mesh__recordMaintainer mesh__D000500 lkt
% 207.97/208.17 |- skos__altLabel mesh__D000500 Gestanin
% 207.97/208.17 |- skos__altLabel mesh__D000500 Organon Brand of Allylestrenol
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D000500 2006
% 207.97/208.17 |- mesh__dateCreated mesh__D000500 1974-11-11
% 207.97/208.17 |- mesh__recordOriginator mesh__D000500 NLM
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D000500 2004
% 207.97/208.17 |- mesh__historyNote mesh__D000500
% 207.97/208.17 91%28%75%29%; was see under ESTRENES 1975-90
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D000500 2005
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D000500 91; was see under ESTRENES 1975-90
% 207.97/208.17 |- skos__historyNote mesh__D000500 Allyl Compounds %28%1973-1974%29%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 2002
% 207.97/208.17 |- skos__hiddenLabel mesh__D005794 Response Generalization
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 2005
% 207.97/208.17 |- skos__broader mesh__D005794smesh__D005793
% 207.97/208.17 |- mesh__dateEstablished mesh__D005794 1969-01-01
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 1994
% 207.97/208.17 |- mesh__dateCreated mesh__D005794 1999-01-01
% 207.97/208.17 |- mesh__recordOriginator mesh__D005794 NLM
% 207.97/208.17 |- mesh__recordMaintainer mesh__D005794 TAP
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 2003
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D005794 PLS
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 2006
% 207.97/208.17 |- skos__hiddenLabel mesh__D005794 Response Generalizations
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D005794 69
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 1995
% 207.97/208.17 |- skos__scopeNote mesh__D005794
% 207.97/208.17 The principle that after an organism learns to respond in a particular manner to a stimulus, that stimulus is effective in eliciting similar responses.%A%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 2004
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 1998
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 1993
% 207.97/208.17 |- rdf__type mesh__D005794sskos__Concept
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 2000
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 1996
% 207.97/208.17 |- mesh__dateRevised mesh__D005794 1992-05-15
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 1999
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 2001
% 207.97/208.17 |- skos__hiddenLabel mesh__D005794 Generalizations, Response
% 207.97/208.17 |- skos__prefLabel mesh__D005794 Generalization, Response
% 207.97/208.17 |- mesh__historyNote mesh__D005794 69%28%65%29%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005794 1997
% 207.97/208.17 |- rdf__type mesh__D013428sskos__Concept
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D013428
% 207.97/208.17 91; was see under SULFANILAMIDES 1975-90
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D013428 2003
% 207.97/208.17 |- mesh__recordMaintainer mesh__D013428 CCR
% 207.97/208.17 |- skos__broader mesh__D013428smesh__D013424
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D013428 sjn
% 207.97/208.17 |- mesh__dateRevised mesh__D013428 2000-06-22
% 207.97/208.17 |- mesh__dateCreated mesh__D013428 1974-11-19
% 207.97/208.17 |- mesh__recordOriginator mesh__D013428 NLM
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D013428 2002
% 207.97/208.17 |- mesh__dateEstablished mesh__D013428 1991-01-01
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D013428 2006
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D013428 2001
% 207.97/208.17 |- skos__altLabel mesh__D013428 Sulfachinoxalin
% 207.97/208.17 |- skos__historyNote mesh__D013428 Sulfanilamides %28%1974%29%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D013428 2005
% 207.97/208.17 |- skos__altLabel mesh__D013428 Sulfabenzpyrazine
% 207.97/208.17 |- mesh__historyNote mesh__D013428
% 207.97/208.17 91%28%75%29%; was see under SULFANILAMIDES 1975-90
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D013428 2004
% 207.97/208.17 |- skos__prefLabel mesh__D013428 Sulfaquinoxaline
% 207.97/208.17 |- skos__scopeNote mesh__D013428
% 207.97/208.17 An antiprotozoal agent used to combat coccidial infections of swine, cattle, fowl, and other veterinary animals. Also used in controlling outbreaks of fowl typhoid and fowl cholera and in treatment of infectious enteritis.%A%
% 207.97/208.17 |- skos__historyNote mesh__D013428 Quinoxalines %28%1974%29%
% 207.97/208.17 |- skos__hiddenLabel mesh__D018911 Repeat, Triplet
% 207.97/208.17 |- mesh__historyNote mesh__D018911 96
% 207.97/208.17 |- skos__hiddenLabel mesh__D018911 Repeats, Trinucleotide
% 207.97/208.17 |- mesh__dateRevised mesh__D018911 2005-06-30
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018911 2006
% 207.97/208.17 |- skos__hiddenLabel mesh__D018911 Triplet Repeat
% 207.97/208.17 |- rdf__type mesh__D018911sskos__Concept
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D018911 96
% 207.97/208.17 |- skos__historyNote mesh__D018911
% 207.97/208.17 Repetitive Sequences, Nucleic Acid %28%1989-1995%29%
% 207.97/208.17 |- skos__broader mesh__D018911smesh__D018895
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D018911 sjn
% 207.97/208.17 |- skos__hiddenLabel mesh__D018911 Repeats, Triplet
% 207.97/208.17 |- skos__hiddenLabel mesh__D018911 Trinucleotide Repeat
% 207.97/208.17 |- skos__altLabel mesh__D018911 Triplet Repeats
% 207.97/208.17 |- skos__prefLabel mesh__D018911 Trinucleotide Repeats
% 207.97/208.17 |- mesh__recordMaintainer mesh__D018911 nns
% 207.97/208.17 |- mesh__dateCreated mesh__D018911 1995-06-08
% 207.97/208.17 |- mesh__dateEstablished mesh__D018911 1996-01-01
% 207.97/208.17 |- skos__hiddenLabel mesh__D018911 Repeat, Trinucleotide
% 207.97/208.17 |- skos__scopeNote mesh__D018911
% 207.97/208.17 Microsatellite repeats consisting of three nucleotides dispersed in the euchromatic arms of chromosomes.%A%
% 207.97/208.17 |- mesh__recordOriginator mesh__D018911 AGS
% 207.97/208.17 |- skos__broader mesh__D018113smesh__D012136
% 207.97/208.17 |- skos__scopeNote mesh__D018113
% 207.97/208.17 The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.%A%
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D018113 94
% 207.97/208.17 |- skos__historyNote mesh__D018113
% 207.97/208.17 Respiratory Syncytial Viruses %28%1966-1993%29%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018113 2006
% 207.97/208.17 |- mesh__dateRevised mesh__D018113 2001-07-25
% 207.97/208.17 |- skos__annotation mesh__D018113
% 207.97/208.17 infection: coord IM with RESPIRATORY SYNCYTIAL VIRUS INFECTIONS %28%IM%29%%A%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018113 2005
% 207.97/208.17 |- mesh__recordMaintainer mesh__D018113 ags
% 207.97/208.17 |- mesh__dateEstablished mesh__D018113 1994-01-01
% 207.97/208.17 |- rdf__type mesh__D018113sskos__Concept
% 207.97/208.17 |- skos__altLabel mesh__D018113 Human respiratory syncytial virus
% 207.97/208.17 |- mesh__recordOriginator mesh__D018113 AGS
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018113 2004
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D018113 sjn
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018113 2002
% 207.97/208.17 |- skos__prefLabel mesh__D018113 Respiratory Syncytial Virus, Human
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018113 2003
% 207.97/208.17 |- mesh__historyNote mesh__D018113 94
% 207.97/208.17 |- mesh__dateCreated mesh__D018113 1993-06-04
% 207.97/208.17 |- skos__hiddenLabel mesh__D010130 Sodium, Aminohippurate
% 207.97/208.17 |- skos__hiddenLabel mesh__D010130 p Aminohippurate
% 207.97/208.17 |- skos__hiddenLabel mesh__D010130 Para-Aminohippurate, Sodium
% 207.97/208.17 |- skos__prefLabel mesh__D010130 p-Aminohippuric Acid
% 207.97/208.17 |- mesh__dateCreated mesh__D010130 1976-05-19
% 207.97/208.17 |- skos__altLabel mesh__D010130 para-Aminohippuric Acid
% 207.97/208.17 |- skos__historyNote mesh__D010130 Aminohippuric Acids %28%1966-1976%29%
% 207.97/208.17 |- mesh__dateEstablished mesh__D010130 1991-01-01
% 207.97/208.17 |- rdf__type mesh__D010130sskos__Concept
% 207.97/208.17 |- skos__hiddenLabel mesh__D010130 p Aminohippuric Acid
% 207.97/208.17 |- skos__broader mesh__D010130smesh__D000618
% 207.97/208.17 |- skos__altLabel mesh__D010130 Sodium Para-Aminohippurate
% 207.97/208.17 |- mesh__recordOriginator mesh__D010130 RLS
% 207.97/208.17 |- mesh__onlineNote mesh__D010130
% 207.97/208.17 use P-AMINOHIPPURIC ACID to search PARA-AMINOHIPPURIC ACID 1975-76; use AMINOHIPPURIC ACIDS 1966-74%A%
% 207.97/208.17 |- mesh__historyNote mesh__D010130
% 207.97/208.17 91%28%77%29%; was see under AMINOHIPPURIC ACIDS 1977-90; was PARA-AMINOHIPPURIC ACID see under AMINOHIPPURIC ACID 1965-76; was PARA-AMINOHIPPURIC ACID 1963-64%A%
% 207.97/208.17 |- mesh__recordMaintainer mesh__D010130 CCR
% 207.97/208.17 |- skos__hiddenLabel mesh__D010130 para Aminohippuric Acid
% 207.97/208.17 |- skos__hiddenLabel mesh__D010130 Sodium Para Aminohippurate
% 207.97/208.17 |- skos__altLabel mesh__D010130 Aminohippuric Acid
% 207.97/208.17 |- skos__hiddenLabel mesh__D010130 4 Aminohippuric Acid
% 207.97/208.17 |- mesh__dateRevised mesh__D010130 2005-06-30
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D010130 2006
% 207.97/208.17 |- skos__altLabel mesh__D010130 4-Aminohippuric Acid
% 207.97/208.17 |- skos__scopeNote mesh__D010130
% 207.97/208.17 The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow %28%ERPF%29% and excretory capacity.%A%
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D010130 sjn
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D010130
% 207.97/208.17 91; was see under AMINOHIPPURIC ACIDS 1977-90; was PARA-AMINOHIPPURIC ACID see under AMINOHIPPURIC ACID 1965-76; was PARA-AMINOHIPPURIC ACID 1963-64%A%
% 207.97/208.17 |- skos__historyNote mesh__D051547
% 207.97/208.17 Heme Oxygenase %28%Decyclizing%29% %28%1997-2005%29%
% 207.97/208.17 |- skos__broader mesh__D051547smesh__D006419
% 207.97/208.17 |- mesh__recordOriginator mesh__D051547 AKE
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D051547 sjn
% 207.97/208.17 |- skos__altLabel mesh__D051547 Hemeoxygenase 1
% 207.97/208.17 |- mesh__historyNote mesh__D051547 2006%28%1997%29%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D051547 2006
% 207.97/208.17 |- skos__hiddenLabel mesh__D051547 Oxygenase-1, Heme
% 207.97/208.17 |- skos__hiddenLabel mesh__D051547 Heme Oxygenase 1
% 207.97/208.17 |- mesh__recordMaintainer mesh__D051547 AKE
% 207.97/208.17 |- mesh__dateEstablished mesh__D051547 2006-01-01
% 207.97/208.17 |- skos__prefLabel mesh__D051547 Heme Oxygenase-1
% 207.97/208.17 |- skos__scopeNote mesh__D051547
% 207.97/208.17 A ubiquitous stress-responsive enzyme that catalyzes the oxidative cleavage of HEME to yield IRON; CARBON MONOXIDE; and BILIVERDIN.%A%
% 207.97/208.17 |- mesh__dateCreated mesh__D051547 2005-06-30
% 207.97/208.17 |- rdf__type mesh__D051547sskos__Concept
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D051547
% 207.97/208.17 2006; HEME OXYGENASE-1 was indexed under HEME OXYGENASE %28%DECYCLIZING%29% 1997-200%A%
% 207.97/208.17 |- skos__historyNote mesh__D009387 Polymers %28%1971-1974%29%
% 207.97/208.17 |- skos__altLabel mesh__D009387 Chloroprene Polymer
% 207.97/208.17 |- skos__historyNote mesh__D009387 Hydrocarbons, Chlorinated %28%1974%29%
% 207.97/208.17 |- mesh__dateRevised mesh__D009387 2004-07-07
% 207.97/208.17 |- rdf__type mesh__D009387sskos__Concept
% 207.97/208.17 |- skos__prefLabel mesh__D009387 Neoprene
% 207.97/208.17 |- skos__broader mesh__D009387smesh__D011090
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D009387 2005
% 207.97/208.17 |- mesh__recordMaintainer mesh__D009387 jmp
% 207.97/208.17 |- skos__hiddenLabel mesh__D009387 Polychloroprenes
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D009387 2006
% 207.97/208.17 |- skos__altLabel mesh__D009387 Polychloroprene
% 207.97/208.17 |- mesh__dateCreated mesh__D009387 1974-11-19
% 207.97/208.17 |- skos__altLabel mesh__D009387 Duprene
% 207.97/208.17 |- skos__scopeNote mesh__D009387
% 207.97/208.17 An oil-resistant synthetic rubber made by the polymerization of chloroprene.%A%
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D009387 sjn
% 207.97/208.17 |- mesh__historyNote mesh__D009387
% 207.97/208.17 91%28%75%29%; was see under POLYENES 1975-90
% 207.97/208.17 |- mesh__recordOriginator mesh__D009387 NLM
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D009387 91; was see under POLYENES 1975-90
% 207.97/208.17 |- skos__historyNote mesh__D009387 Butadienes %28%1971-1974%29%
% 207.97/208.17 |- mesh__dateEstablished mesh__D009387 1991-01-01
% 207.97/208.17 |- skos__hiddenLabel mesh__D009387 Chloroprene Polymers
% 207.97/208.17 |- skos__broader mesh__D009387smesh__D012408
% 207.97/208.17 |- mesh__dateEstablished mesh__D017819 1994-01-01
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D017819 2004
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D017819 sjn
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D017819 94
% 207.97/208.17 |- skos__altLabel mesh__D017819 European Adder
% 207.97/208.17 |- skos__scopeNote mesh__D017819
% 207.97/208.17 A family of snakes comprising three subfamilies: Azemiopinae %28%the mountain viper, the sole member of this subfamily%29%, Viperinae %28%true vipers%29%, and Crotalinae %28%pit vipers%29%. They are widespread throughout the world, being found in the United States, Central and South America, Europe, Asia and Africa. Their venoms act on the blood %28%hemotoxic%29% as compared to the venom of elapids which act on the nervous system %28%neurotoxic%29%. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp333-36%29%%A%
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Vipers, European
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Gaboon Vipers
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Vipers, True
% 207.97/208.17 |- rdf__type mesh__D017819sskos__Concept
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Crotalid
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Asps
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Adder, European
% 207.97/208.17 |- mesh__dateCreated mesh__D017819 1993-05-07
% 207.97/208.17 |- skos__prefLabel mesh__D017819 Viperidae
% 207.97/208.17 |- skos__historyNote mesh__D017819 Snakes %28%1968-1993%29%
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Bushmasters
% 207.97/208.17 |- skos__broader mesh__D017819smesh__D012911
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Viper, European
% 207.97/208.17 |- skos__annotation mesh__D017819
% 207.97/208.17 mountain viper, true vipers %26% pit vipers
% 207.97/208.17 |- mesh__dateRevised mesh__D017819 2003-07-09
% 207.97/208.17 |- mesh__recordOriginator mesh__D017819 TGC
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Adders, European
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Viper, True
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D017819 2006
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 European Vipers
% 207.97/208.17 |- skos__related mesh__D017819smesh__D014757
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 True Viper
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Vipers, Gaboon
% 207.97/208.17 |- skos__altLabel mesh__D017819 True Vipers
% 207.97/208.17 |- mesh__recordMaintainer mesh__D017819 ags
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 European Adders
% 207.97/208.17 |- skos__hiddenLabel mesh__D017819 Viper, Gaboon
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D017819 2005
% 207.97/208.17 |- mesh__historyNote mesh__D017819 94
% 207.97/208.17 |- skos__scopeNote mesh__D014521
% 207.97/208.17 A tube that transports URINE from the BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM.%A%
% 207.97/208.17 |- skos__hiddenLabel mesh__D014521 Urethras
% 207.97/208.17 |- skos__broader mesh__D014521smesh__D010413
% 207.97/208.17 |- rdf__type mesh__D014521sskos__Concept
% 207.97/208.17 |- mesh__recordMaintainer mesh__D014521 lkt
% 207.97/208.17 |- mesh__recordOriginator mesh__D014521 NLM
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D014521 2006
% 207.97/208.17 |- mesh__dateRevised mesh__D014521 2005-06-30
% 207.97/208.17 |- skos__prefLabel mesh__D014521 Urethra
% 207.97/208.17 |- mesh__dateCreated mesh__D014521 1999-01-01
% 207.97/208.17 |- skos__broader mesh__D014521smesh__D014551
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D014521 sjn
% 207.97/208.17 |- skos__annotation mesh__D014521
% 207.97/208.17 do not confuse with URETER, especially in Romance language: see note on URETER; inflammation = URETHRITIS%A%
% 207.97/208.17 |- mesh__recordOriginator mesh__D000501 RLS
% 207.97/208.17 |- skos__scopeNote mesh__D000501
% 207.97/208.17 An inhibitor of glutamate decarboxylase and an antagonist of GAMMA-AMINOBUTYRIC ACID. It is used to induce convulsions in experimental animals.%A%
% 207.97/208.17 |- skos__historyNote mesh__D000501
% 207.97/208.17 Glycine %28%1966-1974%29% /antagonists %26% inhibitors %28%1975-1979%29%
% 207.97/208.17 |- skos__altLabel mesh__D000501 2-Amino-4-Pentenoic Acid
% 207.97/208.17 |- rdf__type mesh__D000501sskos__Concept
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D000501 91; was see under GLYCINE 1980-90
% 207.97/208.17 |- skos__historyNote mesh__D000501 Analeptics %28%1966-1974%29%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D000501 2002
% 207.97/208.17 |- skos__historyNote mesh__D000501 Allyl Compounds %28%1971-1975%29%
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D000501 sjn
% 207.97/208.17 |- skos__historyNote mesh__D000501 Convulsants %28%1974-1979%29%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D000501 2006
% 207.97/208.17 |- mesh__historyNote mesh__D000501
% 207.97/208.17 91%28%80%29%; was see under GLYCINE 1980-90
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D000501 2004
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D000501 2005
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D000501 2003
% 207.97/208.17 |- mesh__dateRevised mesh__D000501 2001-08-03
% 207.97/208.17 |- mesh__dateCreated mesh__D000501 1979-05-23
% 207.97/208.17 |- mesh__recordMaintainer mesh__D000501 sjn
% 207.97/208.17 |- skos__broader mesh__D000501smesh__D000498
% 207.97/208.17 |- mesh__dateEstablished mesh__D000501 1991-01-01
% 207.97/208.17 |- skos__broader mesh__D000501smesh__D005998
% 207.97/208.17 |- skos__prefLabel mesh__D000501 Allylglycine
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D005795 69
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 1995
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 2000
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 2004
% 207.97/208.17 |- mesh__dateRevised mesh__D005795 1992-05-15
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 1998
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 2001
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 1993
% 207.97/208.17 |- skos__scopeNote mesh__D005795
% 207.97/208.17 The tendency to react to stimuli that are different from, but somewhat similar to, the stimulus used as a conditioned stimulus.%A%
% 207.97/208.17 |- rdf__type mesh__D005795sskos__Concept
% 207.97/208.17 |- mesh__historyNote mesh__D005795 69%28%65%29%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 1996
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 1999
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 2002
% 207.97/208.17 |- skos__hiddenLabel mesh__D005795 Stimulus Generalization
% 207.97/208.17 |- skos__hiddenLabel mesh__D005795 Generalizations, Stimulus
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 1997
% 207.97/208.17 |- skos__prefLabel mesh__D005795 Generalization, Stimulus
% 207.97/208.17 |- mesh__recordOriginator mesh__D005795 NLM
% 207.97/208.17 |- mesh__recordMaintainer mesh__D005795 TAP
% 207.97/208.17 |- skos__broader mesh__D005795smesh__D005793
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D005795 PLS
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 2005
% 207.97/208.17 |- mesh__dateEstablished mesh__D005795 1969-01-01
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 1994
% 207.97/208.17 |- mesh__dateCreated mesh__D005795 1999-01-01
% 207.97/208.17 |- skos__hiddenLabel mesh__D005795 Stimulus Generalizations
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 2003
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D005795 2006
% 207.97/208.17 |- mesh__recordMaintainer mesh__D013429 ssb
% 207.97/208.17 |- skos__prefLabel mesh__D013429 Sulfatases
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D013429 2006
% 207.97/208.17 |- mesh__dateRevised mesh__D013429 2003-07-09
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D013429 sjn
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D013429 2005
% 207.97/208.17 |- mesh__recordOriginator mesh__D013429 NLM
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D013429 2004
% 207.97/208.17 |- rdf__type mesh__D013429sskos__Concept
% 207.97/208.17 |- mesh__dateCreated mesh__D013429 1999-01-01
% 207.97/208.17 |- skos__broader mesh__D013429smesh__D004950
% 207.97/208.17 |- skos__hiddenLabel mesh__D018912 Palestinian
% 207.97/208.17 |- skos__scopeNote mesh__D018912
% 207.97/208.17 Members of a Semitic people inhabiting the Arabian peninsula or other countries of the Middle East and North Africa. The term may be used with reference to ancient, medieval, or modern ethnic or cultural groups. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018912 2004A
% 207.97/208.17 |- skos__broader mesh__D018912smesh__D005006
% 207.97/208.17 |- skos__hiddenLabel mesh__D018912 Bedouin
% 207.97/208.17 |- skos__annotation mesh__D018912 specify geog if relevant
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018912 2004
% 207.97/208.17 |- skos__related mesh__D018912smesh__D007514
% 207.97/208.17 |- mesh__dateRevised mesh__D018912 2003-10-30
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D018912 jls
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D018912 96
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018912 2004B
% 207.97/208.17 |- mesh__historyNote mesh__D018912 96
% 207.97/208.17 |- mesh__dateCreated mesh__D018912 1995-01-06
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018912 2006
% 207.97/208.17 |- mesh__recordMaintainer mesh__D018912 jls
% 207.97/208.17 |- mesh__recordOriginator mesh__D018912 TGC
% 207.97/208.17 |- rdf__type mesh__D018912sskos__Concept
% 207.97/208.17 |- skos__hiddenLabel mesh__D018912 Arab
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018912 2005
% 207.97/208.17 |- mesh__dateEstablished mesh__D018912 1996-01-01
% 207.97/208.17 |- skos__prefLabel mesh__D018912 Arabs
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018114 2005
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D018114 sjn
% 207.97/208.17 |- skos__hiddenLabel mesh__D018114 lyssavirus, Australian bat
% 207.97/208.17 |- skos__hiddenLabel mesh__D018114 Lyssaviruses
% 207.97/208.17 |- mesh__recordMaintainer mesh__D018114 ags
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018114 2006
% 207.97/208.17 |- mesh__dateRevised mesh__D018114 2001-07-25
% 207.97/208.17 |- skos__hiddenLabel mesh__D018114 lyssaviruses, Australian bat
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018114 2003
% 207.97/208.17 |- skos__broader mesh__D018114smesh__D012209
% 207.97/208.17 |- rdf__type mesh__D018114sskos__Concept
% 207.97/208.17 |- skos__annotation mesh__D018114
% 207.97/208.17 infection: coord IM with RHABDOVIRIDAE INFECTIONS %28%IM%29%
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D018114 94
% 207.97/208.17 |- skos__scopeNote mesh__D018114
% 207.97/208.17 A genus of the family RHABDOVIRIDAE that includes RABIES VIRUS and other rabies-like viruses.%A%
% 207.97/208.17 |- skos__historyNote mesh__D018114 Rhabdoviridae %28%1978-1993%29%
% 207.97/208.17 |- skos__prefLabel mesh__D018114 Lyssavirus
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018114 2004
% 207.97/208.17 |- mesh__recordOriginator mesh__D018114 AGS
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D018114 2002
% 207.97/208.17 |- mesh__dateEstablished mesh__D018114 1994-01-01
% 207.97/208.17 |- mesh__historyNote mesh__D018114 94
% 207.97/208.17 |- skos__hiddenLabel mesh__D018114 Australian bat lyssaviruses
% 207.97/208.17 |- mesh__dateCreated mesh__D018114 1993-06-04
% 207.97/208.17 |- mesh__dateEstablished mesh__D010131 1991-01-01
% 207.97/208.17 |- skos__hiddenLabel mesh__D010131 p Aminosalicylic Acid Monolithium Salt
% 207.97/208.17 |- skos__hiddenLabel mesh__D010131 p Aminosalicylic Acid Monosodium Salt
% 207.97/208.17 |- skos__prefLabel mesh__D010131 p-Aminosalicylic Acid
% 207.97/208.17 |- rdf__type mesh__D010131sskos__Concept
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D010131 2003
% 207.97/208.17 |- skos__altLabel mesh__D010131 4-Aminosalicylic Acid
% 207.97/208.17 |- mesh__recordAuthorizer mesh__D010131 sjn
% 207.97/208.17 |- skos__historyNote mesh__D010131 Aminosalicylic Acids %28%1966-1976%29%
% 207.97/208.17 |- skos__hiddenLabel mesh__D010131 Alumino 4 Aminosalicylic Acid
% 207.97/208.17 |- mesh__onlineNote mesh__D010131
% 207.97/208.17 use P-AMINOSALICYLIC ACID to search PARA-AMINOSALICYLIC ACID 1975-76; use AMINOSALICYLIC ACIDS to search PARA-AMINOSALICYLIC ACID 1966-74 %26% PAS 1966-67%A%
% 207.97/208.17 |- skos__annotation mesh__D010131 AMINOSALICYLIC ACIDS is also available
% 207.97/208.17 |- skos__altLabel mesh__D010131 para-Aminosalicylic Acid
% 207.97/208.17 |- skos__broader mesh__D010131smesh__D000636
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D010131 2004
% 207.97/208.17 |- mesh__dateCreated mesh__D010131 1976-05-19
% 207.97/208.17 |- skos__hiddenLabel mesh__D010131 4 Aminosalicylic Acid
% 207.97/208.17 |- mesh__historyNote mesh__D010131
% 207.97/208.17 91%28%77%29%; was see under AMINOSALICYLIC ACIDS 1977-90; was PARA-AMINOSALICYLIC ACID see under AMINOSALICYLIC ACID 1963-76; PAS was see under AMINOSALICYLIC ACID 1963-67%A%
% 207.97/208.17 |- skos__hiddenLabel mesh__D010131 para Aminosalicylic Acid
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D010131 2005
% 207.97/208.17 |- skos__hiddenLabel mesh__D010131 p Aminosalicylic Acid Monopotassium Salt
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D010131 2001
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D010131 2006
% 207.97/208.17 |- mesh__dateRevised mesh__D010131 2000-06-21
% 207.97/208.17 |- mesh__recordOriginator mesh__D010131 RLS
% 207.97/208.17 |- mesh__publicMeSHNote mesh__D010131
% 207.97/208.17 91; was see under AMINOSALICYLIC ACIDS 1977-90; was PARA-AMINOSALICYLIC ACID see under AMINOSALICYLIC ACID 1963-76; PAS was see under AMINOSALICYCLIC ACID 1963-67%A%
% 207.97/208.17 |- mesh__activeMeSHYear mesh__D010131 2002
% 207.97/208.17 |- skos__hiddenLabel mesh__D010131 p Aminosalicylic Acid
% 207.97/208.17 |- mesh__recordMaintainer mesh__D010131 CCR
% 207.97/208.18 |- skos__scopeNote mesh__D010131
% 207.97/208.18 An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid.%A%
% 207.97/208.18 |- skos__altLabel mesh__D010131 PAS
% 207.97/208.18 |- mesh__dateCreated mesh__D051548 2005-06-30
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D051548
% 207.97/208.18 2006; HISTONE ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1981-2005, HISTONES 1973-1980%A%
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D051548 2006
% 207.97/208.18 |- mesh__historyNote mesh__D051548
% 207.97/208.18 2006%28%1980%29% use HISTONES 1973-1979
% 207.97/208.18 |- mesh__recordMaintainer mesh__D051548 AKE
% 207.97/208.18 |- skos__hiddenLabel mesh__D051548 Acetyltransferase, Histone
% 207.97/208.18 |- skos__broader mesh__D051548smesh__D000123
% 207.97/208.18 |- skos__hiddenLabel mesh__D051548 Acetyltransferases, Histone
% 207.97/208.18 |- mesh__recordOriginator mesh__D051548 AKE
% 207.97/208.18 |- skos__hiddenLabel mesh__D051548 Acetylase, Histone
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D051548 sjn
% 207.97/208.18 |- skos__prefLabel mesh__D051548 Histone Acetyltransferases
% 207.97/208.18 |- skos__altLabel mesh__D051548 Histone Acetyltransferase
% 207.97/208.18 |- mesh__dateEstablished mesh__D051548 2006-01-01
% 207.97/208.18 |- rdf__type mesh__D051548sskos__Concept
% 207.97/208.18 |- skos__scopeNote mesh__D051548
% 207.97/208.18 Enzymes that catalyze acyl group transfer from ACETYL-CoA to HISTONES forming CoA and acetyl-histones.%A%
% 207.97/208.18 |- skos__altLabel mesh__D051548 Histone Acetylase
% 207.97/208.18 |- skos__hiddenLabel mesh__D009388 Bromide, Neostigmine
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D009388 2006
% 207.97/208.18 |- skos__altLabel mesh__D009388 Prozerin
% 207.97/208.18 |- skos__broader mesh__D009388smesh__D000644
% 207.97/208.18 |- skos__broader mesh__D009388smesh__D050338
% 207.97/208.18 |- skos__prefLabel mesh__D009388 Neostigmine
% 207.97/208.18 |- skos__hiddenLabel mesh__D009388 Methylsulfate, Neostigmine
% 207.97/208.18 |- mesh__dateCreated mesh__D009388 1999-01-01
% 207.97/208.18 |- skos__altLabel mesh__D009388 Synstigmin
% 207.97/208.18 |- skos__scopeNote mesh__D009388
% 207.97/208.18 A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.%A%
% 207.97/208.18 |- skos__altLabel mesh__D009388 Prostigmin
% 207.97/208.18 |- mesh__recordMaintainer mesh__D009388 ssb
% 207.97/208.18 |- skos__altLabel mesh__D009388 Proserine
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D009388 sjn
% 207.97/208.18 |- mesh__dateRevised mesh__D009388 2005-06-30
% 207.97/208.18 |- rdf__type mesh__D009388sskos__Concept
% 207.97/208.18 |- mesh__recordOriginator mesh__D009388 NLM
% 207.97/208.18 |- mesh__dateRevised mesh__D006090 2005-06-30
% 207.97/208.18 |- skos__altLabel mesh__D006090 Gram Negative Bacteria
% 207.97/208.18 |- mesh__historyNote mesh__D006090 84,73-75
% 207.97/208.18 |- mesh__recordMaintainer mesh__D006090 SYSTEM
% 207.97/208.18 |- mesh__dateEstablished mesh__D006090 1984-01-01
% 207.97/208.18 |- skos__annotation mesh__D006090
% 207.97/208.18 GEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative bact; infection = GRAM-NEGATIVE BACTERIAL INFECTIONS; DF: GRAM NEG BACT%A%
% 207.97/208.18 |- mesh__recordOriginator mesh__D006090 RC
% 207.97/208.18 |- skos__broader mesh__D006090smesh__D001419
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D006090 84,73-75
% 207.97/208.18 |- mesh__dateCreated mesh__D006090 1983-06-03
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D006090 2006
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D006090 sjn
% 207.97/208.18 |- skos__prefLabel mesh__D006090 Gram-Negative Bacteria
% 207.97/208.18 |- skos__scopeNote mesh__D006090
% 207.97/208.18 Bacteria which lose crystal violet stain but are stained pink when treated by Gram%27%s method.%A%
% 207.97/208.18 |- mesh__onlineNote mesh__D006090 search BACTERIA 1973-75
% 207.97/208.18 |- rdf__type mesh__D006090sskos__Concept
% 207.97/208.18 |- skos__historyNote mesh__D006090 Bacteria %28%1966-1983%29%
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 2004
% 207.97/208.18 |- rdf__type mesh__D014522sskos__Concept
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 1996
% 207.97/208.18 |- mesh__dateRevised mesh__D014522 1990-05-29
% 207.97/208.18 |- skos__hiddenLabel mesh__D014522 Disease, Urethral
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 2002
% 207.97/208.18 |- skos__prefLabel mesh__D014522 Urethral Diseases
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 2005
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 1992
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 1997
% 207.97/208.18 |- mesh__dateEstablished mesh__D014522 1966-01-01
% 207.97/208.18 |- skos__annotation mesh__D014522
% 207.97/208.18 do not confuse with URETERAL DISEASES, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES; inflamm dis = URETHRITIS%A%
% 207.97/208.18 |- skos__hiddenLabel mesh__D014522 Diseases, Urethral
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 2006
% 207.97/208.18 |- mesh__dateCreated mesh__D014522 1999-01-01
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 1993
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 1998
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 1991
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 1994
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D014522 66
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 1999
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D014522 NLM
% 207.97/208.18 |- skos__broader mesh__D014522smesh__D014570
% 207.97/208.18 |- mesh__recordOriginator mesh__D014522 NLM
% 207.97/208.18 |- mesh__recordMaintainer mesh__D014522 PLS
% 207.97/208.18 |- mesh__historyNote mesh__D014522 66
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 1995
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 2000
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 2003
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014522 2001
% 207.97/208.18 |- skos__hiddenLabel mesh__D014522 Urethral Disease
% 207.97/208.18 |- skos__scopeNote mesh__D000502
% 207.97/208.18 An allylic compound that acts as a suicide inactivator of CYTOCHROME P450 by covalently binding to its heme moiety or surrounding protein.%A%
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000502 2006
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000502 1999
% 207.97/208.18 |- skos__hiddenLabel mesh__D000502 2 Isopropyl 4 Pentenamide
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000502 2001
% 207.97/208.18 |- mesh__historyNote mesh__D000502
% 207.97/208.18 91%28%73%29%; was see under ACETAMIDES 1973-90
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000502 2004
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000502 2005
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000502 2000
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D000502
% 207.97/208.18 91; was see under ACETAMIDES 1973-90
% 207.97/208.18 |- mesh__recordOriginator mesh__D000502 NLM
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000502 2003
% 207.97/208.18 |- mesh__dateRevised mesh__D000502 1998-06-10
% 207.97/208.18 |- skos__broader mesh__D000502smesh__D000498
% 207.97/208.18 |- skos__prefLabel mesh__D000502 Allylisopropylacetamide
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D000502 SJN
% 207.97/208.18 |- mesh__dateEstablished mesh__D000502 1991-01-01
% 207.97/208.18 |- mesh__dateCreated mesh__D000502 1999-01-01
% 207.97/208.18 |- mesh__recordMaintainer mesh__D000502 ADP
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000502 2002
% 207.97/208.18 |- rdf__type mesh__D000502sskos__Concept
% 207.97/208.18 |- skos__broader mesh__D000502smesh__D000081
% 207.97/208.18 |- skos__altLabel mesh__D000502 2-Isopropyl-4-Pentenamide
% 207.97/208.18 |- skos__hiddenLabel mesh__D005796 Material, Genetic
% 207.97/208.18 |- skos__related mesh__D005796smesh__D016678
% 207.97/208.18 |- rdf__type mesh__D005796sskos__Concept
% 207.97/208.18 |- mesh__recordMaintainer mesh__D005796 ags
% 207.97/208.18 |- mesh__dateEstablished mesh__D005796 1965-01-01
% 207.97/208.18 |- skos__prefLabel mesh__D005796 Genes
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D005796 2006A
% 207.97/208.18 |- skos__hiddenLabel mesh__D005796 Materials, Genetic
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D005796
% 207.97/208.18 1965; see CHROMOSOMES 1963-1964; for CISTRON see GENES, STRUCTURAL 1980-2005%A%
% 207.97/208.18 |- skos__annotation mesh__D005796
% 207.97/208.18 locus = CHROMOSOME MAPPING; restorer genes: index under SUPPRESSION, GENETIC and probably PLANT INFERTILITY; repressor genes = GENES, REGULATOR but also consider REPRESSOR PROTEINS; lac gene = LAC OPERON but consider also LAC FACTORS or LAC REPRESSORS %28%see note on REPRESSOR PROTEINS%29%; split genes = EXONS or INTRONS%A%
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D005796 ags
% 207.97/208.18 |- skos__hiddenLabel mesh__D005796 Cistrons
% 207.97/208.18 |- mesh__historyNote mesh__D005796
% 207.97/208.18 1965; %28%1963%29%; for CISTRON use GENES, STRUCTURAL 1980-2005%A%
% 207.97/208.18 |- skos__altLabel mesh__D005796 Gene
% 207.97/208.18 |- mesh__dateCreated mesh__D005796 1999-01-01
% 207.97/208.18 |- skos__hiddenLabel mesh__D005796 Genetic Material
% 207.97/208.18 |- skos__related mesh__D005796smesh__D015698
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D005796 2006
% 207.97/208.18 |- mesh__dateRevised mesh__D005796 2005-07-27
% 207.97/208.18 |- skos__related mesh__D005796smesh__D001483
% 207.97/208.18 |- mesh__recordOriginator mesh__D005796 NLM
% 207.97/208.18 |- skos__scopeNote mesh__D005796
% 207.97/208.18 Specific sequences of nucleotides along a molecule of DNA %28%or, in the case of some viruses, RNA%29% which represent functional units of HEREDITY. Most eukaryotic genes contain a set of coding regions %28%EXONS%29% that are spliced together in the transcript, after removal of intervening sequence %28%INTRONS%29% and are therefore labeled split genes.%A%
% 207.97/208.18 |- skos__broader mesh__D005796smesh__D040481
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 2002
% 207.97/208.18 |- skos__scopeNote mesh__D018913
% 207.97/208.18 A late-appearing component of the event-related potential. P stands for positive voltage potential and 300 represents 300 millisecond poststimulus. Its amplitude increases with unpredictable, unlikely, or highly significant stimuli and thereby constitutes an index of mental activity. %28%From Campbell, Psychiatric Dictionary, 6th ed%29%%A%
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 2005
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 1998
% 207.97/208.18 |- mesh__dateCreated mesh__D018913 1994-12-27
% 207.97/208.18 |- skos__historyNote mesh__D018913
% 207.97/208.18 specific Evoked Potentials %28%1980-1995%29%
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 2001
% 207.97/208.18 |- skos__hiddenLabel mesh__D018913 Event Related Potentials, P300
% 207.97/208.18 |- skos__hiddenLabel mesh__D018913 P300 Event Related Potentials
% 207.97/208.18 |- skos__altLabel mesh__D018913 Evoked Potentials, P300 Component
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 2004
% 207.97/208.18 |- skos__hiddenLabel mesh__D018913 P300 Event-Related Potential
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D018913 96
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 1997
% 207.97/208.18 |- mesh__historyNote mesh__D018913 96
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 2000
% 207.97/208.18 |- skos__prefLabel mesh__D018913 Event-Related Potentials, P300
% 207.97/208.18 |- skos__altLabel mesh__D018913 P300 Component
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 2003
% 207.97/208.18 |- rdf__type mesh__D018913sskos__Concept
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 1996
% 207.97/208.18 |- skos__hiddenLabel mesh__D018913 P300 Components
% 207.97/208.18 |- skos__altLabel mesh__D018913 P300 Event-Related Potentials
% 207.97/208.18 |- skos__annotation mesh__D018913
% 207.97/208.18 an evoked potential; DF: P300 COMPONENT
% 207.97/208.18 |- skos__broader mesh__D018913smesh__D005071
% 207.97/208.18 |- skos__hiddenLabel mesh__D018913 Event-Related Potential, P300
% 207.97/208.18 |- skos__historyNote mesh__D018913 Evoked Potentials %28%1975-1995%29%
% 207.97/208.18 |- mesh__dateEstablished mesh__D018913 1996-01-01
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 2006
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018913 1999
% 207.97/208.18 |- mesh__dateRevised mesh__D010930 2002-07-03
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D010930 2006
% 207.97/208.18 |- mesh__recordMaintainer mesh__D010930 sjn
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Plague, Meningeal
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D010930 2005
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Plagues, Pulmonic
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Meningeal Plagues
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Plague, Pneumonic
% 207.97/208.18 |- skos__prefLabel mesh__D010930 Plague
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Pulmonic Plagues
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Plagues, Pneumonic
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Plague, Pulmonic
% 207.97/208.18 |- rdf__type mesh__D010930sskos__Concept
% 207.97/208.18 |- mesh__dateCreated mesh__D010930 1999-01-01
% 207.97/208.18 |- skos__annotation mesh__D010930
% 207.97/208.18 Pasteurella pestis or Yersinia pestis infection only; swine plague = HEMORRHAGIC SEPTICEMIA /vet %28%IM%29% + SWINE DISEASES %28%IM%29% but do not confuse with African swine plague %28% = AFRICAN SWINE FEVER%29%%A%
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Plagues, Meningeal
% 207.97/208.18 |- skos__broader mesh__D010930smesh__D015009
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D010930 2004
% 207.97/208.18 |- skos__scopeNote mesh__D010930
% 207.97/208.18 An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form.%A%
% 207.97/208.18 |- mesh__recordOriginator mesh__D010930 NLM
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D010930 sjn
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Pneumonic Plagues
% 207.97/208.18 |- skos__hiddenLabel mesh__D010930 Plague, Bubonic
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D010930 2003
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018115 2002
% 207.97/208.18 |- mesh__dateEstablished mesh__D018115 1994-01-01
% 207.97/208.18 |- skos__historyNote mesh__D018115 Rhabdoviridae %28%1977-1993%29%
% 207.97/208.18 |- mesh__recordMaintainer mesh__D018115 ags
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018115 2006
% 207.97/208.18 |- mesh__dateCreated mesh__D018115 1993-06-04
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018115 2003
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D018115 sjn
% 207.97/208.18 |- rdf__type mesh__D018115sskos__Concept
% 207.97/208.18 |- skos__historyNote mesh__D018115 RNA Viruses %28%1969-1978%29%
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018115 2004
% 207.97/208.18 |- mesh__dateRevised mesh__D018115 2001-07-25
% 207.97/208.18 |- skos__annotation mesh__D018115
% 207.97/208.18 infection = EPHEMERAL FEVER: see note there
% 207.97/208.18 |- skos__scopeNote mesh__D018115
% 207.97/208.18 The type species of EPHEMEROVIRUS causing disease in cattle. Transmission is by hematophagous arthropods and the virus has been isolated from both culicoides and mosquitoes.%A%
% 207.97/208.18 |- skos__prefLabel mesh__D018115 Ephemeral Fever Virus, Bovine
% 207.97/208.18 |- mesh__historyNote mesh__D018115 94
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D018115 94
% 207.97/208.18 |- skos__broader mesh__D018115smesh__D019235
% 207.97/208.18 |- skos__altLabel mesh__D018115 Bovine ephemeral fever virus
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018115 2005
% 207.97/208.18 |- mesh__recordOriginator mesh__D018115 AGS
% 207.97/208.18 |- skos__hiddenLabel mesh__D010132 p Azobenzenearsonate
% 207.97/208.18 |- skos__scopeNote mesh__D010132
% 207.97/208.18 A hapten capable of eliciting both antibody formation and delayed hypersensitivity when bound to aromatic amino acids, polypeptides or proteins. It is used as an immunologic research tool.%A%
% 207.97/208.18 |- skos__historyNote mesh__D010132 Azo Compounds %28%1972-1975%29%
% 207.97/208.18 |- skos__altLabel mesh__D010132 para-Azobenzenearsonate
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D010132 2006
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D010132
% 207.97/208.18 91; was see under AZO COMPOUNDS 1976-90
% 207.97/208.18 |- skos__hiddenLabel mesh__D010132 para Azobenzenearsonate
% 207.97/208.18 |- skos__broader mesh__D010132smesh__D001391
% 207.97/208.18 |- mesh__dateRevised mesh__D010132 2005-06-30
% 207.97/208.18 |- mesh__recordMaintainer mesh__D010132 ssb
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D010132 sjn
% 207.97/208.18 |- mesh__historyNote mesh__D010132
% 207.97/208.18 91%28%76%29%; was see under AZO COMPOUNDS 1976-90
% 207.97/208.18 |- skos__broader mesh__D010132smesh__D001152
% 207.97/208.18 |- rdf__type mesh__D010132sskos__Concept
% 207.97/208.18 |- mesh__recordOriginator mesh__D010132 SH
% 207.97/208.18 |- mesh__dateEstablished mesh__D010132 1991-01-01
% 207.97/208.18 |- skos__prefLabel mesh__D010132 p-Azobenzenearsonate
% 207.97/208.18 |- skos__historyNote mesh__D010132 Arsenicals %28%1972-1975%29%
% 207.97/208.18 |- skos__broader mesh__D010132smesh__D006241
% 207.97/208.18 |- mesh__dateCreated mesh__D010132 1975-07-18
% 207.97/208.18 |- skos__scopeNote mesh__D051549
% 207.97/208.18 A glutathione transferase that catalyzes the conjugation of electrophilic substrates to GLUTATHIONE. This enzyme has been shown to provide cellular protection against redox-mediated damage by FREE RADICALS.%A%
% 207.97/208.18 |- skos__hiddenLabel mesh__D051549 GST Class phi
% 207.97/208.18 |- skos__broader mesh__D051549smesh__D005982
% 207.97/208.18 |- rdf__type mesh__D051549sskos__Concept
% 207.97/208.18 |- skos__hiddenLabel mesh__D051549 Glutathione D-Transferase, GSTP1
% 207.97/208.18 |- skos__hiddenLabel mesh__D051549 Glutathione S Transferase pi
% 207.97/208.18 |- mesh__dateCreated mesh__D051549 2005-06-30
% 207.97/208.18 |- skos__altLabel mesh__D051549 GST Class-phi
% 207.97/208.18 |- skos__hiddenLabel mesh__D051549 Class-phi, GST
% 207.97/208.18 |- skos__hiddenLabel mesh__D051549 D-Transferase, GSTP1 Glutathione
% 207.97/208.18 |- mesh__recordOriginator mesh__D051549 AKE
% 207.97/208.18 |- skos__hiddenLabel mesh__D051549 Transferase P1-1, Glutathione
% 207.97/208.18 |- skos__hiddenLabel mesh__D051549 GSTP1 Glutathione D Transferase
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D051549
% 207.97/208.18 2006; GLUTATHIONE S-TRANSFERASE PI was indexed under GLUTATHIONE TRANSFERASE %26% ISOENZYMES 1997-2005%A%
% 207.97/208.18 |- skos__altLabel mesh__D051549 GSTP1 Glutathione D-Transferase
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D051549 2006
% 207.97/208.18 |- mesh__historyNote mesh__D051549 2006%28%1997%29%
% 207.97/208.18 |- skos__prefLabel mesh__D051549 Glutathione S-Transferase pi
% 207.97/208.18 |- mesh__recordMaintainer mesh__D051549 AKE
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D051549 sjn
% 207.97/208.18 |- mesh__dateEstablished mesh__D051549 2006-01-01
% 207.97/208.18 |- skos__hiddenLabel mesh__D051549 Glutathione Transferase P1 1
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D009389 2004
% 207.97/208.18 |- mesh__onlineNote mesh__D009389
% 207.97/208.18 use NEOVASCULARIZATION, PATHOLOGIC to search NEOVASCULARIZATION %26% ANGIOGENESIS 1980-95%A%
% 207.97/208.18 |- skos__altLabel mesh__D009389 Angiogenesis, Pathological
% 207.97/208.18 |- mesh__historyNote mesh__D009389
% 207.97/208.18 96; was NEOVASCULARIZATION 1980-95; ANGIOGENESIS, PATHOLOGIC was ANGIOGENESIS 1980-85; was in Cat G 1980-82%A%
% 207.97/208.18 |- rdf__type mesh__D009389sskos__Concept
% 207.97/208.18 |- skos__altLabel mesh__D009389 Pathologic Angiogenesis
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D009389 sjn
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D009389 2003
% 207.97/208.18 |- skos__altLabel mesh__D009389 Pathologic Neovascularization
% 207.97/208.18 |- skos__related mesh__D009389smesh__D018919
% 207.97/208.18 |- skos__scopeNote mesh__D009389
% 207.97/208.18 A pathologic process consisting in proliferation of blood vessels in abnormal tissues or in abnormal positions.%A%
% 207.97/208.18 |- skos__hiddenLabel mesh__D009389 Pathological Angiogenesis
% 207.97/208.18 |- skos__prefLabel mesh__D009389 Neovascularization, Pathologic
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D009389 2006
% 207.97/208.18 |- mesh__recordMaintainer mesh__D009389 nns
% 207.97/208.18 |- mesh__dateEstablished mesh__D009389 1980-01-01
% 207.97/208.18 |- mesh__dateRevised mesh__D009389 2002-07-02
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D009389 2005
% 207.97/208.18 |- skos__altLabel mesh__D009389 Angiogenesis, Pathologic
% 207.97/208.18 |- mesh__recordOriginator mesh__D009389 VDK
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D009389
% 207.97/208.18 96; was NEOVASCULARIZATION 1980-95; ANGIOGENESIS, PATHOLOGIC was ANGIOGENESIS 1980-85%A%
% 207.97/208.18 |- mesh__dateCreated mesh__D009389 1979-04-23
% 207.97/208.18 |- skos__altLabel mesh__D009389 Neovascularization, Pathological
% 207.97/208.18 |- skos__annotation mesh__D009389
% 207.97/208.18 note category: a pathol process; do not confuse with NEOVASCULARIZATION, PHYSIOLOGIC, a physiol phenomenon; coord IM or NIM with organ /blood supply %28%IM%29%; DF: NEOVASC PATHOL%A%
% 207.97/208.18 |- skos__hiddenLabel mesh__D009389 Pathological Neovascularization
% 207.97/208.18 |- skos__broader mesh__D009389smesh__D008679
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D020560 sjn
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D020560 2000
% 207.97/208.18 |- skos__altLabel mesh__D020560 Purple Bacteria
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D020560 2006
% 207.97/208.18 |- mesh__historyNote mesh__D020560 2000
% 207.97/208.18 |- rdf__type mesh__D020560sskos__Concept
% 207.97/208.18 |- skos__altLabel mesh__D020560 Bacteria, Purple
% 207.97/208.18 |- mesh__recordOriginator mesh__D020560 ndw
% 207.97/208.18 |- skos__annotation mesh__D020560 DF: PROTEOBACT
% 207.97/208.18 |- mesh__dateEstablished mesh__D020560 2000-01-01
% 207.97/208.18 |- skos__broader mesh__D020560smesh__D001419
% 207.97/208.18 |- mesh__dateRevised mesh__D020560 2005-06-30
% 207.97/208.18 |- mesh__recordMaintainer mesh__D020560 SYSTEM
% 207.97/208.18 |- mesh__dateCreated mesh__D020560 1999-11-03
% 207.97/208.18 |- skos__prefLabel mesh__D020560 Proteobacteria
% 207.97/208.18 |- skos__scopeNote mesh__D020560
% 207.97/208.18 A phylum of bacteria consisting of the purple bacteria and their relatives which form a branch of the eubacterial tree. This group of predominantly gram-negative bacteria is classified based on homology of equivalent nucleotide sequences of 16S ribosomal RNA or by hybridization of ribosomal RNA or DNA with 16S and 23S ribosomal RNA.%A%
% 207.97/208.18 |- skos__historyNote mesh__D006091 Bacteria %28%1966-1972%29%
% 207.97/208.18 |- skos__annotation mesh__D006091
% 207.97/208.18 GEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative chemolithotrophic bact; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: note short X ref%A%
% 207.97/208.18 |- mesh__dateCreated mesh__D006091 1975-07-25
% 207.97/208.18 |- mesh__recordOriginator mesh__D006091 JW
% 207.97/208.18 |- mesh__dateRevised mesh__D006091 2005-06-30
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D006091 2006
% 207.97/208.18 |- mesh__dateEstablished mesh__D006091 1976-01-01
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D006091
% 207.97/208.18 76; THIOBACTERIACEAE was heading 1975-91 %28%see under GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA 1976-90%29%%A%
% 207.97/208.18 |- skos__broader mesh__D006091smesh__D006088
% 207.97/208.18 |- skos__scopeNote mesh__D006091
% 207.97/208.18 A large group of bacteria including those which oxidize ammonia or nitrite, metabolize sulfur and sulfur compounds, or deposit iron and/or manganese oxides.%A%
% 207.97/208.18 |- mesh__onlineNote mesh__D006091
% 207.97/208.18 use GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA to search THIOBACTERIACEAE 1975-91%A%
% 207.97/208.18 |- skos__prefLabel mesh__D006091 Gram-Negative Chemolithotrophic Bacteria
% 207.97/208.18 |- rdf__type mesh__D006091sskos__Concept
% 207.97/208.18 |- skos__historyNote mesh__D006091 Schizomycetes %28%1973-1974%29%
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D006091 sjn
% 207.97/208.18 |- mesh__recordMaintainer mesh__D006091 SYSTEM
% 207.97/208.18 |- mesh__historyNote mesh__D006091
% 207.97/208.18 76; THIOBACTERIACEAE was heading 1975-91 %28%see under GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA 1976-90%29%%A%
% 207.97/208.18 |- skos__altLabel mesh__D006091 Gram Negative Chemolithotrophic Bacteria
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014523 2005
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Urethra Cancers
% 207.97/208.18 |- skos__altLabel mesh__D014523 Urethral Cancer
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Cancer, Urethra
% 207.97/208.18 |- skos__annotation mesh__D014523
% 207.97/208.18 do not confuse with URETERAL NEOPLASMS, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES; coord IM with histol type of neopl %28%IM%29%%A%
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Neoplasm, Urethra
% 207.97/208.18 |- skos__altLabel mesh__D014523 Neoplasms, Urethral
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014523 2001
% 207.97/208.18 |- mesh__dateCreated mesh__D014523 1999-01-01
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014523 2006
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Urethral Neoplasm
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014523 2002
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Neoplasms, Urethra
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Neoplasm, Urethral
% 207.97/208.18 |- skos__altLabel mesh__D014523 Urethra Cancer
% 207.97/208.18 |- skos__broader mesh__D014523smesh__D014571
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Urethral Cancers
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D014523 sjn
% 207.97/208.18 |- skos__altLabel mesh__D014523 Urethra Neoplasms
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014523 2003
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Urethra Neoplasm
% 207.97/208.18 |- skos__broader mesh__D014523smesh__D014522
% 207.97/208.18 |- skos__scopeNote mesh__D014523
% 207.97/208.18 Cancer or tumors of the URETHRA. This condition is relatively uncommon and is the only cancer of the urinary system that has a higher incidence rate in females than males. Squamous cell carcinoma is the most frequent histologic type.%A%
% 207.97/208.18 |- skos__altLabel mesh__D014523 Cancer of the Urethra
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014523 2004
% 207.97/208.18 |- mesh__recordOriginator mesh__D014523 NLM
% 207.97/208.18 |- mesh__recordMaintainer mesh__D014523 nns
% 207.97/208.18 |- rdf__type mesh__D014523sskos__Concept
% 207.97/208.18 |- mesh__dateRevised mesh__D014523 1999-11-03
% 207.97/208.18 |- skos__prefLabel mesh__D014523 Urethral Neoplasms
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Cancers, Urethral
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Cancers, Urethra
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D014523 2000
% 207.97/208.18 |- skos__hiddenLabel mesh__D014523 Cancer, Urethral
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 2005
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 1998
% 207.97/208.18 |- skos__prefLabel mesh__D000503 Almanacs
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 2003
% 207.97/208.18 |- skos__hiddenLabel mesh__D000503 Almanac
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 2001
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D000503 PLS
% 207.97/208.18 |- mesh__dateCreated mesh__D000503 1999-01-01
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 2000
% 207.97/208.18 |- rdf__type mesh__D000503sskos__Concept
% 207.97/208.18 |- skos__annotation mesh__D000503
% 207.97/208.18 for med almanacs, do not coord with MEDICINE; do not confuse with Publication Type ALMANACS%A%
% 207.97/208.18 |- mesh__recordOriginator mesh__D000503 NLM
% 207.97/208.18 |- skos__scopeNote mesh__D000503
% 207.97/208.18 Publications, usually annual, containing a calendar for the coming year, the times of such events and phenomena as anniversaries, sunrises, sunsets, phases of the moon, tides, meteorological, and other statistical information and related topics. Almanacs are also annual reference books of useful and interesting facts relating to countries of the world, sports, entertainment, population groups, etc. %28%Random House Unabridged Dictionary, 2d ed%29%%A%
% 207.97/208.18 |- mesh__recordMaintainer mesh__D000503 TGC
% 207.97/208.18 |- skos__broader mesh__D000503smesh__D012013
% 207.97/208.18 |- mesh__dateRevised mesh__D000503 1996-06-10
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 2006
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 1999
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 2002
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 2004
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D000503 1997
% 207.97/208.18 |- skos__annotation mesh__D005797
% 207.97/208.18 araC stands for %22%arabinose C%22% where C is 3d of a sequence araA, araB, etc.%A%
% 207.97/208.18 |- skos__historyNote mesh__D005797 Genes, Regulator %28%1971-1987%29%
% 207.97/208.18 |- rdf__type mesh__D005797sskos__Concept
% 207.97/208.18 |- skos__altLabel mesh__D005797 araC Genes
% 207.97/208.18 |- mesh__recordMaintainer mesh__D005797 nns
% 207.97/208.18 |- skos__prefLabel mesh__D005797 Genes, araC
% 207.97/208.18 |- skos__historyNote mesh__D005797 Arabinose %28%1971-1987%29%
% 207.97/208.18 |- skos__broader mesh__D005797smesh__D005809
% 207.97/208.18 |- mesh__recordAuthorizer mesh__D005797 sjn
% 207.97/208.18 |- skos__altLabel mesh__D005797 Locus, araC Regulator
% 207.97/208.18 |- mesh__historyNote mesh__D005797
% 207.97/208.18 91%28%88%29%; was see under GENES, REGULATOR 1988-90
% 207.97/208.18 |- skos__altLabel mesh__D005797 araC Regulator Locus
% 207.97/208.18 |- skos__hiddenLabel mesh__D005797 araC Gene
% 207.97/208.18 |- mesh__dateCreated mesh__D005797 1987-05-09
% 207.97/208.18 |- mesh__dateRevised mesh__D005797 2005-06-30
% 207.97/208.18 |- mesh__recordOriginator mesh__D005797 SCD
% 207.97/208.18 |- skos__scopeNote mesh__D005797
% 207.97/208.18 Regulatory genes which encode a cyclic AMP receptor protein required for L-arabinose utilization in E. coli. It is an example of positive control or regulation of gene expression in the bacterial operon.%A%
% 207.97/208.18 |- mesh__dateEstablished mesh__D005797 1991-01-01
% 207.97/208.18 |- skos__historyNote mesh__D005797 Operon %28%1971-1987%29%
% 207.97/208.18 |- skos__hiddenLabel mesh__D005797 Gene, araC
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D005797 2006
% 207.97/208.18 |- mesh__publicMeSHNote mesh__D005797
% 207.97/208.18 91; was see under GENES, REGULATOR 1988-90
% 207.97/208.18 |- mesh__dateCreated mesh__D018914 1995-01-06
% 207.97/208.18 |- skos__altLabel mesh__D018914 Immobilized Cells
% 207.97/208.18 |- mesh__dateEstablished mesh__D018914 1996-01-01
% 207.97/208.18 |- skos__scopeNote mesh__D018914
% 207.97/208.18 Microbial, plant, or animal cells which are immobilized by attachment to solid structures, usually a column matrix. A common use of immobilized cells is in biotechnology for the bioconversion of a substrate to a particular product. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%
% 207.97/208.18 |- skos__prefLabel mesh__D018914 Cells, Immobilized
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018914 2002
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018914 2004
% 207.97/208.18 |- mesh__activeMeSHYear mesh__D018914 1997
% 207.97/208.18 |- mesh__historyNote mesh__D018914 96
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018914 2003
% 207.97/208.19 |- rdf__type mesh__D018914sskos__Concept
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018914 1996
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018914 2001
% 207.97/208.19 |- skos__broader mesh__D018914smesh__D002477
% 207.97/208.19 |- skos__hiddenLabel mesh__D018914 Cell, Immobilized
% 207.97/208.19 |- skos__hiddenLabel mesh__D018914 Immobilized Cell
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018914 2006
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D018914 96
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018914 2000
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018914 1999
% 207.97/208.19 |- skos__annotation mesh__D018914
% 207.97/208.19 NIM; specify cell if relevant, probably NIM; A 11 qualif
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018914 2005
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018914 1998
% 207.97/208.19 |- mesh__dateRevised mesh__D010931 2005-06-30
% 207.97/208.19 |- skos__scopeNote mesh__D010931
% 207.97/208.19 A suspension of killed Yersinia pestis used for immunizing people in enzootic plague areas.%A%
% 207.97/208.19 |- skos__prefLabel mesh__D010931 Plague Vaccine
% 207.97/208.19 |- mesh__dateCreated mesh__D010931 1999-01-01
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D010931 sjn
% 207.97/208.19 |- mesh__recordOriginator mesh__D010931 NLM
% 207.97/208.19 |- mesh__recordMaintainer mesh__D010931 ssb
% 207.97/208.19 |- rdf__type mesh__D010931sskos__Concept
% 207.97/208.19 |- skos__hiddenLabel mesh__D010931 Vaccine, Plague
% 207.97/208.19 |- skos__broader mesh__D010931smesh__D001428
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010931 2006
% 207.97/208.19 |- rdf__type mesh__D018116sskos__Concept
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018116 2004
% 207.97/208.19 |- skos__broader mesh__D018116smesh__D012209
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D018116 94
% 207.97/208.19 |- mesh__dateEstablished mesh__D018116 1994-01-01
% 207.97/208.19 |- skos__hiddenLabel mesh__D018116 Vesiculoviruses
% 207.97/208.19 |- mesh__recordOriginator mesh__D018116 AGS
% 207.97/208.19 |- mesh__historyNote mesh__D018116 94
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018116 2002
% 207.97/208.19 |- skos__historyNote mesh__D018116 Rhabdoviridae %28%1979-1993%29%
% 207.97/208.19 |- skos__scopeNote mesh__D018116
% 207.97/208.19 A genus of the family RHABDOVIRIDAE that infects a wide range of vertebrates and invertebrates. The type species is VESICULAR STOMATITIS-INDIANA VIRUS.%A%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018116 2005
% 207.97/208.19 |- mesh__dateCreated mesh__D018116 1993-06-04
% 207.97/208.19 |- skos__prefLabel mesh__D018116 Vesiculovirus
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018116 2006
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D018116 sjn
% 207.97/208.19 |- mesh__recordMaintainer mesh__D018116 ags
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018116 2003
% 207.97/208.19 |- mesh__dateRevised mesh__D018116 2001-07-25
% 207.97/208.19 |- skos__annotation mesh__D018116
% 207.97/208.19 infection: coord IM with RHABDOVIRIDAE INFECTIONS %28%IM%29%
% 207.97/208.19 |- skos__hiddenLabel mesh__D010133 Ly 123362
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010133 2006
% 207.97/208.19 |- skos__broader mesh__D010133smesh__D000662
% 207.97/208.19 |- skos__altLabel mesh__D010133 p-Chloramphetamine
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D010133
% 207.97/208.19 91; was see under AMPHETAMINES 1975-90
% 207.97/208.19 |- skos__hiddenLabel mesh__D010133 p Chloramphetamine
% 207.97/208.19 |- skos__historyNote mesh__D010133 Amphetamine %28%1966-1974%29%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010133 2001
% 207.97/208.19 |- skos__historyNote mesh__D010133 Chlorine %28%1966-1974%29%
% 207.97/208.19 |- mesh__recordMaintainer mesh__D010133 CCR
% 207.97/208.19 |- skos__prefLabel mesh__D010133 p-Chloroamphetamine
% 207.97/208.19 |- skos__hiddenLabel mesh__D010133 LY121860
% 207.97/208.19 |- skos__hiddenLabel mesh__D010133 p Chloroamphetamine
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010133 2002
% 207.97/208.19 |- rdf__type mesh__D010133sskos__Concept
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010133 2003
% 207.97/208.19 |- mesh__dateCreated mesh__D010133 1974-11-19
% 207.97/208.19 |- mesh__historyNote mesh__D010133
% 207.97/208.19 91%28%75%29%; was see under AMPHETAMINES 1975-90
% 207.97/208.19 |- skos__hiddenLabel mesh__D010133 LY 121860
% 207.97/208.19 |- mesh__dateEstablished mesh__D010133 1991-01-01
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010133 2004
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D010133 sjn
% 207.97/208.19 |- skos__hiddenLabel mesh__D010133 para Chloroamphetamine
% 207.97/208.19 |- skos__scopeNote mesh__D010133
% 207.97/208.19 Chlorinated analog of AMPHETAMINE. Potent neurotoxin that causes release and eventually depletion of serotonin in the CNS. It is used as a research tool.%A%
% 207.97/208.19 |- skos__hiddenLabel mesh__D010133 Ly123362
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010133 2005
% 207.97/208.19 |- skos__altLabel mesh__D010133 para-Chloroamphetamine
% 207.97/208.19 |- skos__altLabel mesh__D010133 Parachloroamphetamine
% 207.97/208.19 |- mesh__recordOriginator mesh__D010133 NLM
% 207.97/208.19 |- mesh__dateRevised mesh__D010133 2000-06-22
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D034581 2003
% 207.97/208.19 |- mesh__dateCreated mesh__D034581 2002-07-02
% 207.97/208.19 |- mesh__dateEstablished mesh__D034581 2003-01-01
% 207.97/208.19 |- skos__hiddenLabel mesh__D034581 Bighorn Sheep
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D034581 2004
% 207.97/208.19 |- skos__altLabel mesh__D034581 Ovis canadensis
% 207.97/208.19 |- rdf__type mesh__D034581sskos__Concept
% 207.97/208.19 |- skos__broader mesh__D034581smesh__D012756
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D034581 2006
% 207.97/208.19 |- skos__scopeNote mesh__D034581
% 207.97/208.19 A species of sheep, Ovis canadensis, characterized by massive brown horns. There are at least four subspecies and they are all endangered or threatened.%A%
% 207.97/208.19 |- skos__historyNote mesh__D034581 Sheep %28%1965-2002%29%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D034581 2005
% 207.97/208.19 |- mesh__dateRevised mesh__D034581 2003-07-09
% 207.97/208.19 |- skos__prefLabel mesh__D034581 Sheep, Bighorn
% 207.97/208.19 |- mesh__historyNote mesh__D034581 2003
% 207.97/208.19 |- mesh__dateRevised mesh__D020561 2005-06-30
% 207.97/208.19 |- mesh__recordMaintainer mesh__D020561 SYSTEM
% 207.97/208.19 |- skos__scopeNote mesh__D020561
% 207.97/208.19 A class in the phylum PROTEOBACTERIA comprised mostly of two major phenotypes: purple non-sulfur bacteria and aerobic bacteriochlorophyll-containing bacteria.%A%
% 207.97/208.19 |- mesh__recordOriginator mesh__D020561 ndw
% 207.97/208.19 |- skos__broader mesh__D020561smesh__D020560
% 207.97/208.19 |- mesh__dateCreated mesh__D020561 1999-11-03
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D020561 2006
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D020561 sjn
% 207.97/208.19 |- skos__annotation mesh__D020561 DF: ALPHAPROTEOBACT
% 207.97/208.19 |- rdf__type mesh__D020561sskos__Concept
% 207.97/208.19 |- skos__altLabel mesh__D020561 alpha Proteobacteria
% 207.97/208.19 |- mesh__dateEstablished mesh__D020561 2000-01-01
% 207.97/208.19 |- skos__prefLabel mesh__D020561 Alphaproteobacteria
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D020561
% 207.97/208.19 2004; see ALPHA PROTEOBACTERIA 2000-2003
% 207.97/208.19 |- mesh__historyNote mesh__D020561 2004 %28%2000%29%
% 207.97/208.19 |- skos__altLabel mesh__D020561 Proteobacteria alpha
% 207.97/208.19 |- mesh__historyNote mesh__D006092
% 207.97/208.19 92; was GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS %28%NON MESH%29% 1976-91%A%
% 207.97/208.19 |- skos__altLabel mesh__D006092 Gram Negative Facultatively Anaerobic Rods
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D006092 sjn
% 207.97/208.19 |- rdf__type mesh__D006092sskos__Concept
% 207.97/208.19 |- skos__scopeNote mesh__D006092
% 207.97/208.19 A large group of facultatively anaerobic, rod-shaped bacteria that show up as pink %28%negative%29% when treated by the gram-staining method.%A%
% 207.97/208.19 |- skos__historyNote mesh__D006092 Gram-Negative Bacteria %28%1973-1975%29%
% 207.97/208.19 |- skos__broader mesh__D006092smesh__D006090
% 207.97/208.19 |- mesh__dateEstablished mesh__D006092 1992-01-01
% 207.97/208.19 |- mesh__recordOriginator mesh__D006092 JW
% 207.97/208.19 |- mesh__dateRevised mesh__D006092 2005-06-30
% 207.97/208.19 |- mesh__recordMaintainer mesh__D006092 SYSTEM
% 207.97/208.19 |- mesh__dateCreated mesh__D006092 1975-07-25
% 207.97/208.19 |- skos__annotation mesh__D006092
% 207.97/208.19 GEN: avoid; prefer specifics; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 207.97/208.19 |- skos__historyNote mesh__D006092 Bacteria %28%1966-1972%29%
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D006092 92
% 207.97/208.19 |- skos__prefLabel mesh__D006092 Gram-Negative Facultatively Anaerobic Rods
% 207.97/208.19 |- skos__historyNote mesh__D006092
% 207.97/208.19 Gram-Negative Anaerobic Bacteria %28%1976-1991%29%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D006092 2006
% 207.97/208.19 |- skos__annotation mesh__D014524
% 207.97/208.19 do not confuse with URETERAL OBSTRUCTION, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES; URETHRAL STRICTURE is also available%A%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 2001
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 1998
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 2005
% 207.97/208.19 |- skos__historyNote mesh__D014524 Urethral Diseases %28%1966-1978%29%
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D014524 PLS
% 207.97/208.19 |- mesh__dateRevised mesh__D014524 1996-06-10
% 207.97/208.19 |- mesh__recordOriginator mesh__D014524 SMH
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 2002
% 207.97/208.19 |- skos__hiddenLabel mesh__D014524 Urethral Obstructions
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 2006
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 1999
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D014524 79
% 207.97/208.19 |- skos__hiddenLabel mesh__D014524 Obstruction, Urethral
% 207.97/208.19 |- skos__historyNote mesh__D014524 Urethral Stricture %28%1966-1978%29%
% 207.97/208.19 |- mesh__dateCreated mesh__D014524 1977-11-23
% 207.97/208.19 |- mesh__historyNote mesh__D014524 79
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 2003
% 207.97/208.19 |- mesh__dateEstablished mesh__D014524 1979-01-01
% 207.97/208.19 |- skos__scopeNote mesh__D014524
% 207.97/208.19 Obstruction anywhere along the urethra.
% 207.97/208.19 |- rdf__type mesh__D014524sskos__Concept
% 207.97/208.19 |- skos__hiddenLabel mesh__D014524 Obstructions, Urethral
% 207.97/208.19 |- skos__broader mesh__D014524smesh__D014522
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 2000
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 2004
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014524 1997
% 207.97/208.19 |- skos__prefLabel mesh__D014524 Urethral Obstruction
% 207.97/208.19 |- mesh__recordMaintainer mesh__D014524 TGC
% 207.97/208.19 |- mesh__recordOriginator mesh__D000504 NLM
% 207.97/208.19 |- mesh__dateCreated mesh__D000504 1999-01-01
% 207.97/208.19 |- skos__broader mesh__D000504smesh__D019684
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D000504
% 207.97/208.19 91,63-77; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77%A%
% 207.97/208.19 |- mesh__historyNote mesh__D000504
% 207.97/208.19 91%28%78%29%63; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77; was in Cat B %26% D 1963-77%A%
% 207.97/208.19 |- skos__scopeNote mesh__D000504
% 207.97/208.19 A plant genus of the family Aloeaceae, order Liliales %28%or Asphodelaceae, Asparagales in APG system%29% which is used medicinally. It contains anthraquinone glycosides such as aloin-emodin or aloe-emodin %28%EMODIN%29%.%A%
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D000504 sjn
% 207.97/208.19 |- rdf__type mesh__D000504sskos__Concept
% 207.97/208.19 |- mesh__dateRevised mesh__D000504 2002-07-02
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D000504 2005
% 207.97/208.19 |- skos__prefLabel mesh__D000504 Aloe
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D000504 2003
% 207.97/208.19 |- mesh__recordMaintainer mesh__D000504 ssb
% 207.97/208.19 |- mesh__dateEstablished mesh__D000504 1964-01-01
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D000504 2006
% 207.97/208.19 |- skos__annotation mesh__D000504
% 207.97/208.19 for HESPERALOE see AGAVACEAE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D000504 2004
% 207.97/208.19 |- rdf__type mesh__D005798sskos__Concept
% 207.97/208.19 |- skos__scopeNote mesh__D005798
% 207.97/208.19 The functional hereditary units of BACTERIA.
% 207.97/208.19 |- skos__altLabel mesh__D005798 Gene, Bacterial
% 207.97/208.19 |- skos__prefLabel mesh__D005798 Genes, Bacterial
% 207.97/208.19 |- mesh__dateEstablished mesh__D005798 1982-01-01
% 207.97/208.19 |- skos__annotation mesh__D005798
% 207.97/208.19 coordinate IM with specific bacterium /genet %28%IM%29%; DF: GENES BACT%A%
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D005798 82
% 207.97/208.19 |- mesh__dateCreated mesh__D005798 1981-02-23
% 207.97/208.19 |- skos__broader mesh__D005798smesh__D016680
% 207.97/208.19 |- mesh__historyNote mesh__D005798 82
% 207.97/208.19 |- skos__historyNote mesh__D005798 Genes %28%1966-1981%29%
% 207.97/208.19 |- mesh__recordMaintainer mesh__D005798 nns
% 207.97/208.19 |- skos__altLabel mesh__D005798 Bacterial Genes
% 207.97/208.19 |- skos__altLabel mesh__D005798 Bacterial Gene
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D005798 sjn
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D005798 2006
% 207.97/208.19 |- skos__related mesh__D005798smesh__D016680
% 207.97/208.19 |- skos__historyNote mesh__D005798 specific bacterium/GE %28%1978-1981%29%
% 207.97/208.19 |- skos__broader mesh__D005798smesh__D005796
% 207.97/208.19 |- mesh__recordOriginator mesh__D005798 AEP
% 207.97/208.19 |- mesh__dateRevised mesh__D005798 2005-06-30
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 2001
% 207.97/208.19 |- mesh__recordMaintainer mesh__D018915 TGC
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 2003
% 207.97/208.19 |- skos__hiddenLabel mesh__D018915 Root Canal Preparations
% 207.97/208.19 |- skos__scopeNote mesh__D018915
% 207.97/208.19 Preparatory activities in ROOT CANAL THERAPY by partial or complete extirpation of diseased pulp, cleaning and sterilization of the empty canal, enlarging and shaping the canal to receive the sealing material. The cavity may be prepared by mechanical, sonic, chemical, or other means. %28%From Dorland, 28th ed, p1700%29%%A%
% 207.97/208.19 |- mesh__dateCreated mesh__D018915 1995-06-08
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D018915 96
% 207.97/208.19 |- mesh__dateRevised mesh__D018915 1996-06-10
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 2002
% 207.97/208.19 |- mesh__recordOriginator mesh__D018915 TGC
% 207.97/208.19 |- skos__historyNote mesh__D018915 Root Canal Therapy %28%1966-1995%29%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 2004
% 207.97/208.19 |- skos__hiddenLabel mesh__D018915 Preparation, Root Canal
% 207.97/208.19 |- mesh__dateEstablished mesh__D018915 1996-01-01
% 207.97/208.19 |- skos__annotation mesh__D018915
% 207.97/208.19 preparatory activities leading to treatment of pulp dis %28% = ROOT CANAL THERAPY%29%; do not use /util except by MeSH definition; /instrum: reamers %26% broaches go here%A%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 1997
% 207.97/208.19 |- mesh__historyNote mesh__D018915 96
% 207.97/208.19 |- skos__broader mesh__D018915smesh__D019246
% 207.97/208.19 |- skos__hiddenLabel mesh__D018915 Canal Preparation, Root
% 207.97/208.19 |- rdf__type mesh__D018915sskos__Concept
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 2005
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D018915 PLS
% 207.97/208.19 |- skos__broader mesh__D018915smesh__D012390
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 1998
% 207.97/208.19 |- skos__hiddenLabel mesh__D018915 Preparations, Root Canal
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 2006
% 207.97/208.19 |- skos__hiddenLabel mesh__D018915 Canal Preparations, Root
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 1999
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018915 2000
% 207.97/208.19 |- skos__prefLabel mesh__D018915 Root Canal Preparation
% 207.97/208.19 |- mesh__onlineNote mesh__D010932 search TURBELLARIA 1966-74
% 207.97/208.19 |- mesh__dateRevised mesh__D010932 2003-07-09
% 207.97/208.19 |- mesh__dateEstablished mesh__D010932 1991-01-01
% 207.97/208.19 |- skos__broader mesh__D010932smesh__D014419
% 207.97/208.19 |- rdf__type mesh__D010932sskos__Concept
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D010932 sjn
% 207.97/208.19 |- skos__annotation mesh__D010932
% 207.97/208.19 non-parasitic flatworms used in regeneration experiments
% 207.97/208.19 |- mesh__recordOriginator mesh__D010932 NLM
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010932 2004
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010932 2005
% 207.97/208.19 |- mesh__recordMaintainer mesh__D010932 ags
% 207.97/208.19 |- mesh__historyNote mesh__D010932
% 207.97/208.19 91%28%75%29%; was see under TURBELLARIA 1975-90
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010932 2006
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D010932
% 207.97/208.19 91; was see under TURBELLARIA 1975-90
% 207.97/208.19 |- mesh__dateCreated mesh__D010932 1999-01-01
% 207.97/208.19 |- skos__prefLabel mesh__D010932 Planarians
% 207.97/208.19 |- skos__scopeNote mesh__D010932
% 207.97/208.19 Nonparasitic free-living flatworms of the class Turbellaria. The most common genera are Dugesia, formerly Planaria, which lives in water, and Bipalium, which lives on land. Geoplana occurs in South America and California.%A%
% 207.97/208.19 |- skos__scopeNote mesh__D018117
% 207.97/208.19 A genus of the family ORTHOMYXOVIRIDAE comprising tick-borne viruses occasionally infecting humans. Dhori and Thogoto viruses were formerly thought to be members of BUNYAVIRIDAE. Thogoto virus is the type species.%A%
% 207.97/208.19 |- skos__annotation mesh__D018117
% 207.97/208.19 infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in animals%A%
% 207.97/208.19 |- skos__historyNote mesh__D018117 Orthomyxoviridae %28%1987-1993%29%
% 207.97/208.19 |- skos__altLabel mesh__D018117 Influenza Viruses Type D
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018117 2006A
% 207.97/208.19 |- skos__altLabel mesh__D018117 Influenzavirus D
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D018117 ags
% 207.97/208.19 |- skos__hiddenLabel mesh__D018117 Thogoto-Like Virus
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018117 2005
% 207.97/208.19 |- mesh__dateEstablished mesh__D018117 1994-01-01
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018117 2006
% 207.97/208.19 |- skos__altLabel mesh__D018117 Thogoto-Like Viruses
% 207.97/208.19 |- skos__broader mesh__D018117smesh__D009975
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D018117
% 207.97/208.19 2002; see THOGOTO-LIKE VIRUSES 1997-2001, see ORTHOMYXOVIRUSES TYPE D 1994-1996%A%
% 207.97/208.19 |- skos__altLabel mesh__D018117 Orthomyxoviruses Type D
% 207.97/208.19 |- mesh__recordOriginator mesh__D018117 AGS
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018117 2002
% 207.97/208.19 |- skos__hiddenLabel mesh__D018117 Thogotoviruses
% 207.97/208.19 |- skos__historyNote mesh__D018117 Bunyaviridae %28%1985-1989%29%
% 207.97/208.19 |- mesh__recordMaintainer mesh__D018117 ags
% 207.97/208.19 |- mesh__dateRevised mesh__D018117 2005-11-10
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018117 2003
% 207.97/208.19 |- mesh__dateCreated mesh__D018117 1993-06-04
% 207.97/208.19 |- rdf__type mesh__D018117sskos__Concept
% 207.97/208.19 |- mesh__historyNote mesh__D018117 2002 %28%1994%29%
% 207.97/208.19 |- skos__hiddenLabel mesh__D018117 Thogoto Like Viruses
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D018117 2004
% 207.97/208.19 |- skos__historyNote mesh__D018117 Arboviruses %28%1970-1987%29%
% 207.97/208.19 |- skos__prefLabel mesh__D018117 Thogotovirus
% 207.97/208.19 |- mesh__historyNote mesh__D010134 93%28%71%29%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010134 2002
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D010134 sjn
% 207.97/208.19 |- mesh__dateEstablished mesh__D010134 1973-01-01
% 207.97/208.19 |- skos__broader mesh__D010134smesh__D010649
% 207.97/208.19 |- skos__hiddenLabel mesh__D010134 Hydrochloride, Fenclonine
% 207.97/208.19 |- skos__prefLabel mesh__D010134 Fenclonine
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010134 2006
% 207.97/208.19 |- skos__hiddenLabel mesh__D010134 Hydrobromide, Fenclonine
% 207.97/208.19 |- mesh__recordOriginator mesh__D010134 NLM
% 207.97/208.19 |- skos__scopeNote mesh__D010134
% 207.97/208.19 A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin %28%5-HYDROXYTRYPTAMINE%29%. Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.%A%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010134 2005
% 207.97/208.19 |- mesh__dateCreated mesh__D010134 1999-01-01
% 207.97/208.19 |- skos__historyNote mesh__D010134 Phenylalanine %28%1966-1970%29%
% 207.97/208.19 |- skos__altLabel mesh__D010134 para-Chlorophenylalanine
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010134 2004
% 207.97/208.19 |- skos__hiddenLabel mesh__D010134 para Chlorophenylalanine
% 207.97/208.19 |- skos__altLabel mesh__D010134 Fenclonin
% 207.97/208.19 |- rdf__type mesh__D010134sskos__Concept
% 207.97/208.19 |- skos__altLabel mesh__D010134 DL-3-%28%4-Chlorophenyl%29%alanine
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D010134
% 207.97/208.19 93; see P-CHLOROPHENYLALANINE 1973-92; for FENCLONINE see P-CHLOROPHENYLALANINE 1978-92%A%
% 207.97/208.19 |- skos__altLabel mesh__D010134 p-Chlorophenylalanine
% 207.97/208.19 |- mesh__recordMaintainer mesh__D010134 nns
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D010134 2003
% 207.97/208.19 |- mesh__dateRevised mesh__D010134 2001-07-25
% 207.97/208.19 |- rdf__type mesh__D034582sskos__Concept
% 207.97/208.19 |- mesh__runningHead mesh__D034582 A17 - ANATOMY-INTEGUMENTARY SYSTEM
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D034582 2003
% 207.97/208.19 |- skos__hiddenLabel mesh__D034582 Integumentary Systems
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D034582 2006
% 207.97/208.19 |- skos__hiddenLabel mesh__D034582 Systems, Integumentary
% 207.97/208.19 |- mesh__historyNote mesh__D034582 2003
% 207.97/208.19 |- skos__hiddenLabel mesh__D034582 System, Integumentary
% 207.97/208.19 |- skos__prefLabel mesh__D034582 Integumentary System
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D034582 2005
% 207.97/208.19 |- mesh__dateEstablished mesh__D034582 2003-01-01
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D034582 2003
% 207.97/208.19 |- mesh__dateCreated mesh__D034582 2002-07-03
% 207.97/208.19 |- skos__scopeNote mesh__D034582
% 207.97/208.19 The outer covering of the body composed of the SKIN and the skin appendages, which are the HAIR, the NAILS; and the SEBACEOUS GLANDS and the SWEAT GLANDS and their ducts.%A%
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D034582 2004
% 207.97/208.19 |- mesh__historyNote mesh__D020562 2004 %28%2000%29%
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D020562
% 207.97/208.19 2004; see BETA PROTEOBACTERIA 2000-2003
% 207.97/208.19 |- mesh__recordOriginator mesh__D020562 ndw
% 207.97/208.19 |- skos__prefLabel mesh__D020562 Betaproteobacteria
% 207.97/208.19 |- skos__broader mesh__D020562smesh__D020560
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D020562 2006
% 207.97/208.19 |- mesh__dateRevised mesh__D020562 2005-06-30
% 207.97/208.19 |- rdf__type mesh__D020562sskos__Concept
% 207.97/208.19 |- skos__scopeNote mesh__D020562
% 207.97/208.19 A class in the phylum PROTEOBACTERIA comprised of chemoheterotrophs and chemoautotrophs which derive nutrients from decomposition of organic material.%A%
% 207.97/208.19 |- mesh__dateEstablished mesh__D020562 2000-01-01
% 207.97/208.19 |- mesh__dateCreated mesh__D020562 1999-11-03
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D020562 sjn
% 207.97/208.19 |- skos__altLabel mesh__D020562 beta Proteobacteria
% 207.97/208.19 |- skos__altLabel mesh__D020562 Proteobacteria beta
% 207.97/208.19 |- skos__annotation mesh__D020562 DF: BETAPROTEOBACT
% 207.97/208.19 |- mesh__recordMaintainer mesh__D020562 SYSTEM
% 207.97/208.19 |- rdf__type mesh__D006093sskos__Concept
% 207.97/208.19 |- mesh__onlineNote mesh__D006093 indexed under BACTERIA 1976-83
% 207.97/208.19 |- skos__scopeNote mesh__D006093
% 207.97/208.19 A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common.%A%
% 207.97/208.19 |- skos__broader mesh__D006093smesh__D016987
% 207.97/208.19 |- skos__altLabel mesh__D006093 Gram-Positive Non-Spore-Forming Rods
% 207.97/208.19 |- mesh__dateEstablished mesh__D006093 1990-01-01
% 207.97/208.19 |- skos__annotation mesh__D006093
% 207.97/208.19 GEN: avoid; prefer specifics; do not use as a routine coord for a gram-positive asporogenous bact; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 207.97/208.19 |- mesh__recordMaintainer mesh__D006093 SYSTEM
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D006093 sjn
% 207.97/208.19 |- mesh__dateCreated mesh__D006093 1975-07-25
% 207.97/208.19 |- mesh__publicMeSHNote mesh__D006093 90
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D006093 2006
% 207.97/208.19 |- mesh__dateRevised mesh__D006093 2005-06-30
% 207.97/208.19 |- skos__altLabel mesh__D006093 Gram Positive Non Spore Forming Rods
% 207.97/208.19 |- skos__altLabel mesh__D006093 Gram Positive Asporogenous Rods
% 207.97/208.19 |- mesh__historyNote mesh__D006093 90; was NON MESH before 1990
% 207.97/208.19 |- mesh__recordOriginator mesh__D006093 JW
% 207.97/208.19 |- skos__prefLabel mesh__D006093 Gram-Positive Asporogenous Rods
% 207.97/208.19 |- skos__prefLabel mesh__D014525 Urethral Stricture
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 1994
% 207.97/208.19 |- mesh__recordOriginator mesh__D014525 NLM
% 207.97/208.19 |- skos__hiddenLabel mesh__D014525 Urethral Stenoses
% 207.97/208.19 |- skos__hiddenLabel mesh__D014525 Stenoses, Urethral
% 207.97/208.19 |- skos__hiddenLabel mesh__D014525 Strictures, Urethral
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 2000
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 1995
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 1996
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 2003
% 207.97/208.19 |- rdf__type mesh__D014525sskos__Concept
% 207.97/208.19 |- skos__altLabel mesh__D014525 Urethral Stenosis
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 2001
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 1997
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 2004
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D014525 PLS
% 207.97/208.19 |- skos__broader mesh__D014525smesh__D014524
% 207.97/208.19 |- mesh__dateCreated mesh__D014525 1999-01-01
% 207.97/208.19 |- skos__hiddenLabel mesh__D014525 Urethral Strictures
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 2002
% 207.97/208.19 |- mesh__dateRevised mesh__D014525 1992-05-22
% 207.97/208.19 |- skos__hiddenLabel mesh__D014525 Stricture, Urethral
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 1998
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 2005
% 207.97/208.19 |- mesh__recordMaintainer mesh__D014525 TGC
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 1993
% 207.97/208.19 |- skos__hiddenLabel mesh__D014525 Stenosis, Urethral
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 1999
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D014525 2006
% 207.97/208.19 |- skos__annotation mesh__D014525
% 207.97/208.19 do not confuse with URETHRAL OBSTRUCTION
% 207.97/208.19 |- skos__altLabel mesh__D000505 Male Pattern Baldness
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D000505 2002
% 207.97/208.19 |- mesh__recordOriginator mesh__D000505 NLM
% 207.97/208.19 |- skos__broader mesh__D000505smesh__D007039
% 207.97/208.19 |- skos__scopeNote mesh__D000505
% 207.97/208.19 Absence of hair from areas where it is normally present.%A%
% 207.97/208.19 |- skos__altLabel mesh__D000505 Baldness
% 207.97/208.19 |- rdf__type mesh__D000505sskos__Concept
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D000505 2005
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D000505 2003
% 207.97/208.19 |- mesh__recordAuthorizer mesh__D000505 sjn
% 207.97/208.19 |- skos__broader mesh__D000505smesh__D020763
% 207.97/208.19 |- skos__hiddenLabel mesh__D000505 Baldness, Male Pattern
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D000505 2006
% 207.97/208.19 |- skos__prefLabel mesh__D000505 Alopecia
% 207.97/208.19 |- skos__altLabel mesh__D000505 Alopecia, Male Pattern
% 207.97/208.19 |- mesh__activeMeSHYear mesh__D000505 2004
% 207.97/208.19 |- skos__hiddenLabel mesh__D000505 Male Pattern Alopecia
% 207.97/208.19 |- skos__altLabel mesh__D000505 Alopecia, Androgenetic
% 207.97/208.19 |- mesh__dateRevised mesh__D000505 2001-07-25
% 207.97/208.19 |- mesh__dateCreated mesh__D000505 1999-01-01
% 207.97/208.19 |- mesh__recordMaintainer mesh__D000505 lkt
% 207.97/208.19 |- skos__historyNote mesh__D019210 Muscle Proteins %28%1975-1978%29%
% 207.97/208.20 |- mesh__dateEstablished mesh__D019210 1997-01-01
% 207.97/208.20 |- skos__historyNote mesh__D019210 Troponin %28%1979-1996%29%
% 207.97/208.20 |- mesh__dateRevised mesh__D019210 2005-06-30
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D019210 sjn
% 207.97/208.20 |- mesh__dateCreated mesh__D019210 1996-06-10
% 207.97/208.20 |- skos__scopeNote mesh__D019210
% 207.97/208.20 One of the three polypeptide chains that make up the TROPONIN complex. It inhibits F-actin-myosin interactions.%A%
% 207.97/208.20 |- mesh__onlineNote mesh__D019210
% 207.97/208.20 use TROPONIN I %28%NM%29% to search TROPONIN I 1980-96
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D019210
% 207.97/208.20 97; TROPONIN I was indexed under TROPONIN 1979-96 %26% MUSCLE PROTEINS 1975-78%A%
% 207.97/208.20 |- mesh__recordOriginator mesh__D019210 TPW
% 207.97/208.20 |- mesh__recordMaintainer mesh__D019210 DRC
% 207.97/208.20 |- skos__annotation mesh__D019210
% 207.97/208.20 a muscle protein; /biosyn /physiol permitted; TROPONIN C %26% TROPONIN T are also available%A%
% 207.97/208.20 |- mesh__historyNote mesh__D019210 97; was TROPONIN I %28%NM%29% 1975-96
% 207.97/208.20 |- skos__broader mesh__D019210smesh__D014336
% 207.97/208.20 |- skos__prefLabel mesh__D019210 Troponin I
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D019210 2006
% 207.97/208.20 |- skos__altLabel mesh__D019210 Troponin-I
% 207.97/208.20 |- rdf__type mesh__D019210sskos__Concept
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D005799 sjn
% 207.97/208.20 |- skos__scopeNote mesh__D005799
% 207.97/208.20 Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state.%A%
% 207.97/208.20 |- skos__historyNote mesh__D005799 Genes %28%1966-1967%29%
% 207.97/208.20 |- mesh__historyNote mesh__D005799 68
% 207.97/208.20 |- skos__hiddenLabel mesh__D005799 Dominant Genetic Condition
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D005799 2006
% 207.97/208.20 |- mesh__dateRevised mesh__D005799 2005-06-30
% 207.97/208.20 |- skos__hiddenLabel mesh__D005799 Genetic Condition, Dominant
% 207.97/208.20 |- skos__broader mesh__D005799smesh__D005796
% 207.97/208.20 |- skos__hiddenLabel mesh__D005799 Gene, Dominant
% 207.97/208.20 |- skos__prefLabel mesh__D005799 Genes, Dominant
% 207.97/208.20 |- mesh__dateEstablished mesh__D005799 1968-01-01
% 207.97/208.20 |- skos__hiddenLabel mesh__D005799 Dominant Genes
% 207.97/208.20 |- skos__broader mesh__D005799smesh__D040582
% 207.97/208.20 |- rdf__type mesh__D005799sskos__Concept
% 207.97/208.20 |- mesh__recordMaintainer mesh__D005799 nns
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D005799 68
% 207.97/208.20 |- skos__hiddenLabel mesh__D005799 Condition, Dominant Genetic
% 207.97/208.20 |- mesh__recordOriginator mesh__D005799 NLM
% 207.97/208.20 |- mesh__dateCreated mesh__D005799 1999-01-01
% 207.97/208.20 |- skos__hiddenLabel mesh__D005799 Dominant Gene
% 207.97/208.20 |- skos__altLabel mesh__D005799 Dominant Genetic Conditions
% 207.97/208.20 |- skos__altLabel mesh__D005799 Conditions, Dominant Genetic
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018916 2004
% 207.97/208.20 |- skos__hiddenLabel mesh__D018916 Barrier, Aqueous-Blood
% 207.97/208.20 |- mesh__historyNote mesh__D018916 96
% 207.97/208.20 |- rdf__type mesh__D018916sskos__Concept
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018916 2005
% 207.97/208.20 |- mesh__dateRevised mesh__D018916 2003-07-09
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D018916 96
% 207.97/208.20 |- skos__broader mesh__D018916smesh__D002319
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D018916 sjn
% 207.97/208.20 |- mesh__recordOriginator mesh__D018916 TGC
% 207.97/208.20 |- skos__historyNote mesh__D018916 Aqueous Humor %28%1966-1995%29%
% 207.97/208.20 |- mesh__recordMaintainer mesh__D018916 nns
% 207.97/208.20 |- skos__hiddenLabel mesh__D018916 Barrier, Blood-Aqueous
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018916 2006
% 207.97/208.20 |- mesh__dateEstablished mesh__D018916 1996-01-01
% 207.97/208.20 |- skos__hiddenLabel mesh__D018916 Blood-Aqueous Barriers
% 207.97/208.20 |- skos__hiddenLabel mesh__D018916 Blood Aqueous Barrier
% 207.97/208.20 |- skos__hiddenLabel mesh__D018916 Barriers, Aqueous-Blood
% 207.97/208.20 |- skos__scopeNote mesh__D018916
% 207.97/208.20 The selectively permeable barrier, in the EYE, formed by the nonpigmented layer of the EPITHELIUM of the CILIARY BODY, and the ENDOTHELIUM of the BLOOD VESSELS of the IRIS. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.%A%
% 207.97/208.20 |- skos__related mesh__D018916smesh__D002199
% 207.97/208.20 |- skos__hiddenLabel mesh__D018916 Barriers, Blood-Aqueous
% 207.97/208.20 |- skos__annotation mesh__D018916
% 207.97/208.20 coord IM with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%%A%
% 207.97/208.20 |- skos__hiddenLabel mesh__D018916 Aqueous-Blood Barriers
% 207.97/208.20 |- mesh__dateCreated mesh__D018916 1995-01-06
% 207.97/208.20 |- skos__altLabel mesh__D018916 Aqueous-Blood Barrier
% 207.97/208.20 |- skos__prefLabel mesh__D018916 Blood-Aqueous Barrier
% 207.97/208.20 |- skos__broader mesh__D018916smesh__D014602
% 207.97/208.20 |- skos__hiddenLabel mesh__D018916 Aqueous Blood Barrier
% 207.97/208.20 |- skos__broader mesh__D010933smesh__D007448
% 207.97/208.20 |- skos__scopeNote mesh__D010933
% 207.97/208.20 Community of tiny aquatic organisms, both PLANTS and ANIMALS, that are either free-floating or suspended in the water, with little or no power of locomotion. They are divided into PHYTOPLANKTON and ZOOPLANKTON.%A%
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D010933 ags
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D010933 2006A
% 207.97/208.20 |- skos__annotation mesh__D010933
% 207.97/208.20 coord with specific organism; PHYTOPLANKTON and ZOOPLANKTON are also available; non-phototrophic bacterioplankton: index PLANKTON + BACTERIA or specific; phototrophic bacterioplankton: index PHYTOPLANKTON + BACTERIA or specific%A%
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D010933 2006
% 207.97/208.20 |- skos__broader mesh__D010933smesh__D010944
% 207.97/208.20 |- mesh__recordMaintainer mesh__D010933 ags
% 207.97/208.20 |- mesh__dateRevised mesh__D010933 2005-07-27
% 207.97/208.20 |- mesh__dateCreated mesh__D010933 1999-01-01
% 207.97/208.20 |- skos__related mesh__D010933smesh__D005068
% 207.97/208.20 |- rdf__type mesh__D010933sskos__Concept
% 207.97/208.20 |- mesh__recordOriginator mesh__D010933 NLM
% 207.97/208.20 |- skos__prefLabel mesh__D010933 Plankton
% 207.97/208.20 |- rdf__type mesh__D018118sskos__Concept
% 207.97/208.20 |- skos__broader mesh__D018118smesh__D007473
% 207.97/208.20 |- skos__historyNote mesh__D018118 Chlorides %28%1979-1993%29%
% 207.97/208.20 |- skos__prefLabel mesh__D018118 Chloride Channels
% 207.97/208.20 |- skos__scopeNote mesh__D018118
% 207.97/208.20 Cell membrane glycoproteins selective for chloride ions.%A%
% 207.97/208.20 |- mesh__historyNote mesh__D018118
% 207.97/208.20 94; was CHLORIDE CHANNELS %28%NM%29% 1988-93
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D018118
% 207.97/208.20 94; CHLORIDE CHANNELS was indexed under MEMBRANE PROTEINS 1988-93%A%
% 207.97/208.20 |- skos__hiddenLabel mesh__D018118 Channel, Chloride
% 207.97/208.20 |- skos__altLabel mesh__D018118 Chloride Ion Channels
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D018118 sjn
% 207.97/208.20 |- mesh__onlineNote mesh__D018118
% 207.97/208.20 use CHLORIDE CHANNELS %28%NM%29% to search CHLORIDE CHANNELS 1988-93%A%
% 207.97/208.20 |- mesh__recordOriginator mesh__D018118 TPW
% 207.97/208.20 |- skos__historyNote mesh__D018118 Membrane Proteins %28%1988-1993%29%
% 207.97/208.20 |- skos__altLabel mesh__D018118 Chloride Channel
% 207.97/208.20 |- mesh__dateRevised mesh__D018118 2005-06-30
% 207.97/208.20 |- skos__hiddenLabel mesh__D018118 Channels, Chloride Ion
% 207.97/208.20 |- skos__altLabel mesh__D018118 Ion Channel, Chloride
% 207.97/208.20 |- skos__annotation mesh__D018118
% 207.97/208.20 /biosyn /drug eff /physiol /rad eff /ultrastruct permitted; DF: CL CHANNELS%A%
% 207.97/208.20 |- skos__hiddenLabel mesh__D018118 Chloride Ion Channel
% 207.97/208.20 |- mesh__dateEstablished mesh__D018118 1994-01-01
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018118 2006
% 207.97/208.20 |- skos__hiddenLabel mesh__D018118 Channel, Chloride Ion
% 207.97/208.20 |- mesh__dateCreated mesh__D018118 1993-06-04
% 207.97/208.20 |- mesh__recordMaintainer mesh__D018118 SYSTEM
% 207.97/208.20 |- skos__historyNote mesh__D018118 Ion Channels %28%1979-1993%29%
% 207.97/208.20 |- skos__altLabel mesh__D018118 Ion Channels, Chloride
% 207.97/208.20 |- skos__hiddenLabel mesh__D018118 Channels, Chloride
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D010135 sjn
% 207.97/208.20 |- mesh__dateRevised mesh__D010135 2001-07-25
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D010135 2002
% 207.97/208.20 |- skos__hiddenLabel mesh__D010135 para Fluorophenylalanine
% 207.97/208.20 |- skos__scopeNote mesh__D010135 3-%28%p-Fluorophenyl%29%-alanine.
% 207.97/208.20 |- mesh__recordOriginator mesh__D010135 NLM
% 207.97/208.20 |- skos__broader mesh__D010135smesh__D010649
% 207.97/208.20 |- skos__prefLabel mesh__D010135 p-Fluorophenylalanine
% 207.97/208.20 |- mesh__historyNote mesh__D010135
% 207.97/208.20 91%28%75%29%; was see under PHENYLALANINE 1975-90
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D010135 2006
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D010135 2005
% 207.97/208.20 |- rdf__type mesh__D010135sskos__Concept
% 207.97/208.20 |- skos__altLabel mesh__D010135 p Fluorophenylalanine
% 207.97/208.20 |- skos__historyNote mesh__D010135 Fluorine %28%1972-1974%29%
% 207.97/208.20 |- skos__hiddenLabel mesh__D010135 Fluorophenylalanine, p
% 207.97/208.20 |- skos__hiddenLabel mesh__D010135 4 Fluorophenylalanine
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D010135 2004
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D010135
% 207.97/208.20 91; was see under PHENYLALANINE 1975-90
% 207.97/208.20 |- skos__historyNote mesh__D010135 Phenylalanine %28%1972-1974%29%
% 207.97/208.20 |- mesh__recordMaintainer mesh__D010135 nns
% 207.97/208.20 |- skos__altLabel mesh__D010135 para-Fluorophenylalanine
% 207.97/208.20 |- mesh__dateCreated mesh__D010135 1974-11-19
% 207.97/208.20 |- mesh__dateEstablished mesh__D010135 1991-01-01
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D010135 2003
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 2004
% 207.97/208.20 |- mesh__dateRevised mesh__D006892 1994-05-24
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D006892 PLS
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D006892 82; was HYDROXYDOPAMINE 1973-81
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 2005
% 207.97/208.20 |- skos__prefLabel mesh__D006892 Hydroxydopamines
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 1995
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 2001
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 2003
% 207.97/208.20 |- skos__historyNote mesh__D006892 Phenethylamines %28%1966-1972%29%
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 2000
% 207.97/208.20 |- mesh__dateCreated mesh__D006892 1999-01-01
% 207.97/208.20 |- mesh__onlineNote mesh__D006892
% 207.97/208.20 use HYDROXYDOPAMINES to search HYDROXYDOPAMINE 1973-81
% 207.97/208.20 |- skos__broader mesh__D006892smesh__D004298
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 1999
% 207.97/208.20 |- mesh__recordMaintainer mesh__D006892 RAZ
% 207.97/208.20 |- mesh__historyNote mesh__D006892 82; was HYDROXYDOPAMINE 1973-81
% 207.97/208.20 |- skos__scopeNote mesh__D006892
% 207.97/208.20 Dopamines with a hydroxy group substituted in one or more positions.%A%
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 1997
% 207.97/208.20 |- rdf__type mesh__D006892sskos__Concept
% 207.97/208.20 |- skos__historyNote mesh__D006892 Dopamine %28%1966-1972%29%
% 207.97/208.20 |- mesh__dateEstablished mesh__D006892 1973-01-01
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 2002
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 1998
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 1996
% 207.97/208.20 |- mesh__recordOriginator mesh__D006892 NLM
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006892 2006
% 207.97/208.20 |- mesh__recordMaintainer mesh__D020563 SYSTEM
% 207.97/208.20 |- mesh__historyNote mesh__D020563 2004 %28%2000%29%
% 207.97/208.20 |- skos__altLabel mesh__D020563 Proteobacteria gamma
% 207.97/208.20 |- mesh__recordOriginator mesh__D020563 ndw
% 207.97/208.20 |- rdf__type mesh__D020563sskos__Concept
% 207.97/208.20 |- skos__broader mesh__D020563smesh__D020560
% 207.97/208.20 |- mesh__dateRevised mesh__D020563 2005-06-30
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D020563
% 207.97/208.20 2004; use GAMMA PROTEOBACTERIA 2000-2003
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D020563 2006
% 207.97/208.20 |- skos__prefLabel mesh__D020563 Gammaproteobacteria
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D020563 sjn
% 207.97/208.20 |- mesh__dateEstablished mesh__D020563 2000-01-01
% 207.97/208.20 |- skos__altLabel mesh__D020563 gamma Proteobacteria
% 207.97/208.20 |- mesh__dateCreated mesh__D020563 1999-11-03
% 207.97/208.20 |- skos__annotation mesh__D020563 DF: GAMMAPROTEOBACT
% 207.97/208.20 |- skos__scopeNote mesh__D020563
% 207.97/208.20 A group of the proteobacteria comprised of facultatively anaerobic and fermentative gram-negative bacteria.%A%
% 207.97/208.20 |- mesh__recordOriginator mesh__D006094 RC
% 207.97/208.20 |- mesh__dateRevised mesh__D006094 2005-06-30
% 207.97/208.20 |- rdf__type mesh__D006094sskos__Concept
% 207.97/208.20 |- skos__historyNote mesh__D006094 Bacteria %28%1966-1983%29%
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D006094 84,73-75
% 207.97/208.20 |- skos__altLabel mesh__D006094 Gram Positive Bacteria
% 207.97/208.20 |- skos__broader mesh__D006094smesh__D001419
% 207.97/208.20 |- skos__scopeNote mesh__D006094
% 207.97/208.20 Bacteria which retain the crystal violet stain when treated by Gram%27%s method.%A%
% 207.97/208.20 |- skos__annotation mesh__D006094
% 207.97/208.20 GEN: avoid; prefer specifics; do not use as a routine coord for a gram-positive bact; infection = GRAM-POSITIVE BACTERIAL INFECTIONS; DF: GRAM POS BACT%A%
% 207.97/208.20 |- mesh__onlineNote mesh__D006094 search BACTERIA 1973-75
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D006094 2006
% 207.97/208.20 |- mesh__dateCreated mesh__D006094 1983-06-03
% 207.97/208.20 |- skos__prefLabel mesh__D006094 Gram-Positive Bacteria
% 207.97/208.20 |- mesh__recordMaintainer mesh__D006094 SYSTEM
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D006094 sjn
% 207.97/208.20 |- mesh__dateEstablished mesh__D006094 1984-01-01
% 207.97/208.20 |- mesh__historyNote mesh__D006094 84,73-75
% 207.97/208.20 |- mesh__recordMaintainer mesh__D014526 TAP
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 1995
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 1996
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 2003
% 207.97/208.20 |- skos__scopeNote mesh__D014526
% 207.97/208.20 Inflammation of the urethra. %28%Dorland, 27th ed%29%
% 207.97/208.20 |- rdf__type mesh__D014526sskos__Concept
% 207.97/208.20 |- skos__broader mesh__D014526smesh__D014522
% 207.97/208.20 |- mesh__dateRevised mesh__D014526 1993-06-03
% 207.97/208.20 |- mesh__recordOriginator mesh__D014526 NLM
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 1997
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 2004
% 207.97/208.20 |- mesh__dateCreated mesh__D014526 1999-01-01
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 2000
% 207.97/208.20 |- skos__hiddenLabel mesh__D014526 Urethritides
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 1998
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 2005
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 2001
% 207.97/208.20 |- skos__prefLabel mesh__D014526 Urethritis
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 1999
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 2006
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D014526 PLS
% 207.97/208.20 |- skos__annotation mesh__D014526 inflamm of the urethra
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 1994
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D014526 2002
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D000506 sjn
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D000506 2005
% 207.97/208.20 |- skos__annotation mesh__D000506 baldness in defined areas
% 207.97/208.20 |- mesh__recordMaintainer mesh__D000506 lkt
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D000506 2003
% 207.97/208.20 |- mesh__dateRevised mesh__D000506 2001-07-25
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D000506 2006
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D000506 2004
% 207.97/208.20 |- mesh__dateCreated mesh__D000506 1999-01-01
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D000506 2002
% 207.97/208.20 |- mesh__recordOriginator mesh__D000506 NLM
% 207.97/208.20 |- skos__scopeNote mesh__D000506
% 207.97/208.20 A microscopically inflammatory, usually reversible, patchy hair loss occurring in sharply defined areas and usually involving the beard or scalp. %28%Dorland, 27th ed%29%%A%
% 207.97/208.20 |- skos__broader mesh__D000506smesh__D000505
% 207.97/208.20 |- rdf__type mesh__D000506sskos__Concept
% 207.97/208.20 |- skos__prefLabel mesh__D000506 Alopecia Areata
% 207.97/208.20 |- skos__hiddenLabel mesh__D019211 Guinea pig cytomegaloviruses
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D019211 2006
% 207.97/208.20 |- skos__prefLabel mesh__D019211 Roseolovirus
% 207.97/208.20 |- rdf__type mesh__D019211sskos__Concept
% 207.97/208.20 |- mesh__recordMaintainer mesh__D019211 sjn
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D019211 97
% 207.97/208.20 |- mesh__recordOriginator mesh__D019211 AGS
% 207.97/208.20 |- skos__annotation mesh__D019211 infection = ROSEOLOVIRUS INFECTIONS
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D019211 2005
% 207.97/208.20 |- mesh__historyNote mesh__D019211 97
% 207.97/208.20 |- skos__broader mesh__D019211smesh__D018141
% 207.97/208.20 |- skos__hiddenLabel mesh__D019211 cytomegalovirus, Guinea pig
% 207.97/208.20 |- skos__hiddenLabel mesh__D019211 cytomegaloviruses, Guinea pig
% 207.97/208.20 |- mesh__dateRevised mesh__D019211 2004-07-13
% 207.97/208.20 |- skos__hiddenLabel mesh__D019211 Roseoloviruses
% 207.97/208.20 |- skos__hiddenLabel mesh__D019211 herpesvirus 2, Caviid
% 207.97/208.20 |- skos__altLabel mesh__D019211 Guinea pig cytomegalovirus
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D019211 sjn
% 207.97/208.20 |- skos__scopeNote mesh__D019211
% 207.97/208.20 A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, whose viruses have been isolated from lymphocytes. HERPESVIRUS 6, HUMAN is the type species.%A%
% 207.97/208.20 |- mesh__dateEstablished mesh__D019211 1997-01-01
% 207.97/208.20 |- mesh__dateCreated mesh__D019211 1996-06-10
% 207.97/208.20 |- skos__hiddenLabel mesh__D046608 Synkineses
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D046608 sjn
% 207.97/208.20 |- mesh__historyNote mesh__D046608 2005
% 207.97/208.20 |- skos__broader mesh__D046608smesh__D020820
% 207.97/208.20 |- mesh__recordMaintainer mesh__D046608 ags
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D046608 2005
% 207.97/208.20 |- rdf__type mesh__D046608sskos__Concept
% 207.97/208.20 |- skos__prefLabel mesh__D046608 Synkinesis
% 207.97/208.20 |- skos__historyNote mesh__D046608
% 207.97/208.20 Neurologic Manifestations %28%1966-2004%29%
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D046608 2006
% 207.97/208.20 |- skos__scopeNote mesh__D046608
% 207.97/208.20 An involuntary movement accompanying a volitional movement. It often refers to facial movements that accompany FACIAL PARALYSIS.%A%
% 207.97/208.20 |- mesh__dateEstablished mesh__D046608 2005-01-01
% 207.97/208.20 |- mesh__dateCreated mesh__D046608 2004-07-07
% 207.97/208.20 |- mesh__recordOriginator mesh__D046608 ags
% 207.97/208.20 |- mesh__publicMeSHNote mesh__D046608 2005
% 207.97/208.20 |- skos__hiddenLabel mesh__D018917 Ischemic Optic Neuropathies
% 207.97/208.20 |- mesh__recordMaintainer mesh__D018917 ags
% 207.97/208.20 |- mesh__dateCreated mesh__D018917 1995-01-06
% 207.97/208.20 |- skos__altLabel mesh__D018917 Optic Neuropathy, Anterior Ischemic
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018917 2006
% 207.97/208.20 |- skos__scopeNote mesh__D018917
% 207.97/208.20 Ischemic injury to the optic nerve which usually affects the optic disk %28%optic neuropathy, anterior ischemic%29% and less frequently the retrobulbar portion of the nerve %28%optic neuropathy, posterior ischemic%29%. The injury results from occlusion of arterial blood supply which may result from TEMPORAL ARTERITIS; ATHEROSCLEROSIS; COLLAGEN DISEASES; EMBOLISM; DIABETES MELLITUS; and other conditions. The disease primarily occurs in the sixth decade or later and presents with the sudden onset of painless and usually severe monocular visual loss. Anterior ischemic optic neuropathy also features optic disk edema with microhemorrhages. The optic disk appears normal in posterior ischemic optic neuropathy. %28%Glaser, Neuro-Ophthalmology, 2nd ed, p135%29%%A%
% 207.97/208.20 |- mesh__recordAuthorizer mesh__D018917 ags
% 207.97/208.20 |- skos__historyNote mesh__D018917 Optic Nerve Diseases %28%1976-1995%29%
% 207.97/208.20 |- mesh__dateRevised mesh__D018917 2005-07-13
% 207.97/208.20 |- skos__altLabel mesh__D018917 Optic Neuropathy, Posterior Ischemic
% 207.97/208.20 |- skos__hiddenLabel mesh__D018917 Nerve Ischemias, Optic
% 207.97/208.20 |- skos__hiddenLabel mesh__D018917 Optic Neuropathies, Ischemic
% 207.97/208.20 |- skos__hiddenLabel mesh__D018917 Neuropathies, Ischemic Optic
% 207.97/208.20 |- skos__altLabel mesh__D018917 Ischemic Optic Neuropathy
% 207.97/208.20 |- skos__broader mesh__D018917smesh__D009901
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018917 2000
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018917 2003
% 207.97/208.20 |- skos__hiddenLabel mesh__D018917 Ischemia, Optic Nerve
% 207.97/208.20 |- skos__prefLabel mesh__D018917 Optic Neuropathy, Ischemic
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018917 2006A
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018917 2001
% 207.97/208.20 |- mesh__activeMeSHYear mesh__D018917 2004
% 207.97/208.20 |- skos__hiddenLabel mesh__D018917 Ischemias, Optic Nerve
% 207.97/208.20 |- mesh__dateEstablished mesh__D018917 1996-01-01
% 207.97/208.20 |- skos__hiddenLabel mesh__D018917 Nerve Ischemia, Optic
% 208.06/208.20 |- mesh__publicMeSHNote mesh__D018917 96
% 208.06/208.20 |- skos__hiddenLabel mesh__D018917 Neuropathy, Ischemic Optic
% 208.06/208.20 |- mesh__historyNote mesh__D018917 96
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D018917 2002
% 208.06/208.20 |- mesh__recordOriginator mesh__D018917 TGC
% 208.06/208.20 |- rdf__type mesh__D018917sskos__Concept
% 208.06/208.20 |- skos__historyNote mesh__D018917 Optic Nerve %28%1966-1975%29%
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D018917 2005
% 208.06/208.20 |- skos__hiddenLabel mesh__D018917 Optic Nerve Ischemias
% 208.06/208.20 |- skos__broader mesh__D018917smesh__D007511
% 208.06/208.20 |- skos__altLabel mesh__D018917 Optic Nerve Ischemia
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 1999
% 208.06/208.20 |- skos__scopeNote mesh__D010934
% 208.06/208.20 Procedures, strategies, and theories of planning.
% 208.06/208.20 |- mesh__dateEstablished mesh__D010934 1980-01-01
% 208.06/208.20 |- skos__related mesh__D010934smesh__D006285
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Techniques, Planning
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 2000
% 208.06/208.20 |- skos__altLabel mesh__D010934 Methodology, Planning
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 2006
% 208.06/208.20 |- mesh__dateCreated mesh__D010934 1979-06-01
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 1998
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Theory, Planning
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Planning Methodologies
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 1997
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Methodologies, Planning
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 2005
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 2004
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Planning Theory
% 208.06/208.20 |- mesh__dateRevised mesh__D010934 1995-05-23
% 208.06/208.20 |- skos__altLabel mesh__D010934 Planning Technic
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 1996
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 2002
% 208.06/208.20 |- skos__annotation mesh__D010934 NIM; no qualif
% 208.06/208.20 |- mesh__recordAuthorizer mesh__D010934 PLS
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Planning Technique
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 2003
% 208.06/208.20 |- rdf__type mesh__D010934sskos__Concept
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Planning Technics
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Technic, Planning
% 208.06/208.20 |- mesh__historyNote mesh__D010934 91; was PLANNING TECHNICS 1980-90
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Technics, Planning
% 208.06/208.20 |- mesh__recordOriginator mesh__D010934 EC
% 208.06/208.20 |- skos__prefLabel mesh__D010934 Planning Techniques
% 208.06/208.20 |- mesh__onlineNote mesh__D010934
% 208.06/208.20 use PLANNING TECHNIQUES to search PLANNING TECHNICS 1980-90%A%
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Technique, Planning
% 208.06/208.20 |- skos__broader mesh__D010934smesh__D009934
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010934 2001
% 208.06/208.20 |- skos__related mesh__D010934smesh__D012939
% 208.06/208.20 |- skos__hiddenLabel mesh__D010934 Theories, Planning
% 208.06/208.20 |- skos__altLabel mesh__D010934 Planning Methodology
% 208.06/208.20 |- mesh__recordMaintainer mesh__D010934 KEV
% 208.06/208.20 |- mesh__publicMeSHNote mesh__D010934 91; was PLANNING TECHNICS 1980-90
% 208.06/208.20 |- mesh__onlineNote mesh__D018119
% 208.06/208.20 use STAVUDINE %28%NM%29% to search STAVUDINE 1987-93
% 208.06/208.20 |- mesh__publicMeSHNote mesh__D018119
% 208.06/208.20 94; STAVUDINE was indexed under DIDEOXYNUCLEOSIDES 1988-93 %26% THYMIDINE/*ANALOGS %26% DERIVATIVES 1987-88%A%
% 208.06/208.20 |- skos__prefLabel mesh__D018119 Stavudine
% 208.06/208.20 |- skos__altLabel mesh__D018119
% 208.06/208.20 2%27%,3%27%-Didehydro-2%27%,3%27%-dideoxythmidine
% 208.06/208.20 |- skos__broader mesh__D018119smesh__D015224
% 208.06/208.20 |- skos__historyNote mesh__D018119 Dideoxynucleosides %28%1989-1993%29%
% 208.06/208.20 |- skos__altLabel mesh__D018119 Bristol-Myers Squibb Brand of Stavudine
% 208.06/208.20 |- skos__scopeNote mesh__D018119
% 208.06/208.20 A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.%A%
% 208.06/208.20 |- mesh__historyNote mesh__D018119 94; was STAVUDINE %28%NM%29% 1987-93
% 208.06/208.20 |- skos__hiddenLabel mesh__D018119 BMY27857
% 208.06/208.20 |- mesh__recordMaintainer mesh__D018119 CCR
% 208.06/208.20 |- skos__annotation mesh__D018119 DF: note short X ref
% 208.06/208.20 |- skos__altLabel mesh__D018119 D4T
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D018119 2006
% 208.06/208.20 |- mesh__recordAuthorizer mesh__D018119 sjn
% 208.06/208.20 |- skos__altLabel mesh__D018119 2%27%,3%27%-Didehydro-3%27%-deoxythymidine
% 208.06/208.20 |- mesh__recordOriginator mesh__D018119 TPW
% 208.06/208.20 |- skos__hiddenLabel mesh__D018119
% 208.06/208.20 2%27%,3%27% Didehydro 3%27% deoxythymidine
% 208.06/208.20 |- skos__historyNote mesh__D018119
% 208.06/208.20 Thymidine/analogs %26% derivatives %28%1987-1988%29%
% 208.06/208.20 |- mesh__dateRevised mesh__D018119 2005-06-30
% 208.06/208.20 |- skos__hiddenLabel mesh__D018119 BMY 27857
% 208.06/208.20 |- rdf__type mesh__D018119sskos__Concept
% 208.06/208.20 |- mesh__dateEstablished mesh__D018119 1994-01-01
% 208.06/208.20 |- skos__altLabel mesh__D018119 Bristol-Myers Brand of Stavudine
% 208.06/208.20 |- skos__broader mesh__D018119smesh__D013936
% 208.06/208.20 |- mesh__dateCreated mesh__D018119 1993-06-04
% 208.06/208.20 |- mesh__publicMeSHNote mesh__D010136
% 208.06/208.20 91; was see under AMPHETAMINES 1975-90
% 208.06/208.20 |- skos__altLabel mesh__D010136 Oxyamphetamine
% 208.06/208.20 |- mesh__dateRevised mesh__D010136 2004-07-07
% 208.06/208.20 |- mesh__dateCreated mesh__D010136 1974-11-19
% 208.06/208.20 |- skos__broader mesh__D010136smesh__D000662
% 208.06/208.20 |- mesh__historyNote mesh__D010136
% 208.06/208.20 91%28%75%29%; was see under AMPHETAMINES 1975-90
% 208.06/208.20 |- mesh__activeMeSHYear mesh__D010136 2006
% 208.06/208.20 |- mesh__recordAuthorizer mesh__D010136 sjn
% 208.06/208.20 |- skos__altLabel mesh__D010136 Hydroxyamphetamin
% 208.06/208.20 |- skos__historyNote mesh__D010136 Amphetamine %28%1973-1974%29%
% 208.06/208.20 |- mesh__recordOriginator mesh__D010136 NLM
% 208.06/208.21 |- skos__scopeNote mesh__D010136
% 208.06/208.21 Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.%A%
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010136 2005
% 208.06/208.21 |- rdf__type mesh__D010136sskos__Concept
% 208.06/208.21 |- skos__altLabel mesh__D010136 Hydroxyamfetamine
% 208.06/208.21 |- skos__altLabel mesh__D010136 Norpholedrin
% 208.06/208.21 |- skos__hiddenLabel mesh__D010136 para Hydroxyamphetamine
% 208.06/208.21 |- skos__altLabel mesh__D010136 Hydroxyamphetamine
% 208.06/208.21 |- skos__altLabel mesh__D010136 Hydroxyphenylisopropylamine
% 208.06/208.21 |- skos__prefLabel mesh__D010136 p-Hydroxyamphetamine
% 208.06/208.21 |- mesh__dateEstablished mesh__D010136 1991-01-01
% 208.06/208.21 |- mesh__recordMaintainer mesh__D010136 ssb
% 208.06/208.21 |- skos__hiddenLabel mesh__D010136 p Hydroxyamphetamine
% 208.06/208.21 |- skos__historyNote mesh__D010136 Phenols %28%1968-1974%29%
% 208.06/208.21 |- skos__hiddenLabel mesh__D010136 Hydrobromide, Hydroxyamphetamine
% 208.06/208.21 |- skos__altLabel mesh__D010136 para-Hydroxyamphetamine
% 208.06/208.21 |- skos__historyNote mesh__D006893 Arachidonic Acids %28%1967-1984%29%
% 208.06/208.21 |- skos__altLabel mesh__D006893 HETE
% 208.06/208.21 |- skos__scopeNote mesh__D006893
% 208.06/208.21 Eicosatetraenoic acids substituted in any position by one or more hydroxy groups. They are important intermediates in a series of biosynthetic processes leading from arachidonic acid to a number of biologically active compounds such as prostaglandins, thromboxanes, and leukotrienes.%A%
% 208.06/208.21 |- skos__prefLabel mesh__D006893 Hydroxyeicosatetraenoic Acids
% 208.06/208.21 |- mesh__recordOriginator mesh__D006893 RLS
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D006893 85
% 208.06/208.21 |- skos__broader mesh__D006893smesh__D001095
% 208.06/208.21 |- mesh__dateCreated mesh__D006893 1984-05-30
% 208.06/208.21 |- mesh__recordMaintainer mesh__D006893 ssb
% 208.06/208.21 |- rdf__type mesh__D006893sskos__Concept
% 208.06/208.21 |- mesh__historyNote mesh__D006893 85
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006893 2006
% 208.06/208.21 |- mesh__dateRevised mesh__D006893 2003-07-09
% 208.06/208.21 |- skos__hiddenLabel mesh__D006893 Acids, Hydroxyeicosatetraenoic
% 208.06/208.21 |- mesh__dateEstablished mesh__D006893 1985-01-01
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006893 2005
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006893 2004
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D006893 sjn
% 208.06/208.21 |- skos__historyNote mesh__D006893 Fatty Acids, Essential %28%1966%29%
% 208.06/208.21 |- mesh__recordOriginator mesh__D020564 ndw
% 208.06/208.21 |- skos__altLabel mesh__D020564 delta Proteobacteria
% 208.06/208.21 |- mesh__dateEstablished mesh__D020564 2000-01-01
% 208.06/208.21 |- mesh__historyNote mesh__D020564 2004 %28%2000%29%
% 208.06/208.21 |- skos__annotation mesh__D020564 DF: DELTAPROTEOBACT
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D020564
% 208.06/208.21 2004; see delta Proteobacteria 2000-2003
% 208.06/208.21 |- mesh__dateRevised mesh__D020564 2005-06-30
% 208.06/208.21 |- skos__altLabel mesh__D020564 Proteobacteria delta
% 208.06/208.21 |- mesh__dateCreated mesh__D020564 1999-11-03
% 208.06/208.21 |- rdf__type mesh__D020564sskos__Concept
% 208.06/208.21 |- skos__broader mesh__D020564smesh__D020560
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D020564 sjn
% 208.06/208.21 |- mesh__recordMaintainer mesh__D020564 SYSTEM
% 208.06/208.21 |- skos__prefLabel mesh__D020564 Deltaproteobacteria
% 208.06/208.21 |- skos__scopeNote mesh__D020564
% 208.06/208.21 A group of PROTEOBACTERIA represented by morphologically diverse, anaerobic sulfidogens. Some members of this group are considered bacterial predators, having bacteriolytic properties.%A%
% 208.06/208.21 |- skos__historyNote mesh__D020564
% 208.06/208.21 Gram-negative Anaerobic Bacteria %28%1995-1999%29%
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D020564 2006
% 208.06/208.21 |- skos__historyNote mesh__D006095 Bacteria %28%1966-1983%29%
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D006095 sjn
% 208.06/208.21 |- mesh__historyNote mesh__D006095
% 208.06/208.21 92; was GRAM-POSITIVE COCCI %28%NON MESH%29% 1976-91
% 208.06/208.21 |- mesh__dateRevised mesh__D006095 2005-06-30
% 208.06/208.21 |- skos__scopeNote mesh__D006095
% 208.06/208.21 Coccus-shaped bacteria that retain the crystal violet stain when treated by Gram%27%s method.%A%
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006095 2006
% 208.06/208.21 |- skos__historyNote mesh__D006095 Gram-Positive Bacteria %28%1973-1991%29%
% 208.06/208.21 |- mesh__recordOriginator mesh__D006095 JW
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D006095 92
% 208.06/208.21 |- skos__altLabel mesh__D006095 Gram Positive Cocci
% 208.06/208.21 |- mesh__recordMaintainer mesh__D006095 SYSTEM
% 208.06/208.21 |- skos__prefLabel mesh__D006095 Gram-Positive Cocci
% 208.06/208.21 |- skos__broader mesh__D006095smesh__D006094
% 208.06/208.21 |- rdf__type mesh__D006095sskos__Concept
% 208.06/208.21 |- skos__annotation mesh__D006095
% 208.06/208.21 gram-positive bacteria; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM POS COCCI%A%
% 208.06/208.21 |- mesh__dateCreated mesh__D006095 1975-07-25
% 208.06/208.21 |- mesh__dateEstablished mesh__D006095 1992-01-01
% 208.06/208.21 |- mesh__recordMaintainer mesh__D014527 jmp
% 208.06/208.21 |- skos__broader mesh__D014527smesh__D014970
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D014527 2005
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Urate, Sodium Acid
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Monohydrate, Sodium Urate
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Urate, Potassium
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Acid Urate, Sodium
% 208.06/208.21 |- mesh__dateCreated mesh__D014527 1999-01-01
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D014527 2004
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Acid, Uric
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Acid Urate, Ammonium
% 208.06/208.21 |- rdf__type mesh__D014527sskos__Concept
% 208.06/208.21 |- skos__altLabel mesh__D014527 Trioxopurine
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D014527 sjn
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Urate, Sodium
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D014527 2003
% 208.06/208.21 |- skos__altLabel mesh__D014527 Sodium Acid Urate
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Urate, Monosodium
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Urate, Ammonium Acid
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Monohydrate, Monosodium Urate
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Urate Monohydrate, Sodium
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D014527 2002
% 208.06/208.21 |- mesh__recordOriginator mesh__D014527 NLM
% 208.06/208.21 |- mesh__dateRevised mesh__D014527 2001-07-25
% 208.06/208.21 |- skos__altLabel mesh__D014527 2,6,8-Trihydroxypurine
% 208.06/208.21 |- skos__altLabel mesh__D014527 Monosodium Urate
% 208.06/208.21 |- skos__altLabel mesh__D014527 Monosodium Urate Monohydrate
% 208.06/208.21 |- skos__hiddenLabel mesh__D014527 Urate Monohydrate, Monosodium
% 208.06/208.21 |- skos__altLabel mesh__D014527 Sodium Urate
% 208.06/208.21 |- skos__altLabel mesh__D014527 Sodium Acid Urate Monohydrate
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D014527 2006
% 208.06/208.21 |- skos__prefLabel mesh__D014527 Uric Acid
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D000507 2003
% 208.06/208.21 |- skos__broader mesh__D000507smesh__D000505
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D000507 2006
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D000507
% 208.06/208.21 93; was ALOPECIA MUCINOSA 1965-92 %28%see under ALOPECIA 1965-90%29%%A%
% 208.06/208.21 |- skos__hiddenLabel mesh__D000507 Follicular Mucinosis
% 208.06/208.21 |- mesh__onlineNote mesh__D000507
% 208.06/208.21 use MUCINOSIS, FOLLICULAR to search ALOPECIA MUCINOSA 1966-92%A%
% 208.06/208.21 |- skos__hiddenLabel mesh__D000507 Follicular Mucinoses
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D000507 2004
% 208.06/208.21 |- skos__broader mesh__D000507smesh__D012625
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D000507 sjn
% 208.06/208.21 |- mesh__dateEstablished mesh__D000507 1991-01-01
% 208.06/208.21 |- skos__hiddenLabel mesh__D000507 Mucinoses, Follicular
% 208.06/208.21 |- mesh__dateRevised mesh__D000507 2001-07-25
% 208.06/208.21 |- skos__altLabel mesh__D000507 Alopecia Mucinosa
% 208.06/208.21 |- mesh__dateCreated mesh__D000507 1999-01-01
% 208.06/208.21 |- mesh__recordMaintainer mesh__D000507 lkt
% 208.06/208.21 |- skos__broader mesh__D000507smesh__D017520
% 208.06/208.21 |- mesh__historyNote mesh__D000507
% 208.06/208.21 93; was ALOPECIA MUCINOSA 1965-92 %28%see under ALOPECIA 1965-90%29%%A%
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D000507 2002
% 208.06/208.21 |- skos__scopeNote mesh__D000507
% 208.06/208.21 A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary %28%idiopathic%29% or secondary to mycosis fungoides or reticulosis.%A%
% 208.06/208.21 |- rdf__type mesh__D000507sskos__Concept
% 208.06/208.21 |- mesh__recordOriginator mesh__D000507 NLM
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D000507 2005
% 208.06/208.21 |- skos__annotation mesh__D000507 a sebaceous gland dis
% 208.06/208.21 |- skos__prefLabel mesh__D000507 Mucinosis, Follicular
% 208.06/208.21 |- mesh__recordOriginator mesh__D019212 JLS
% 208.06/208.21 |- mesh__dateCreated mesh__D019212 1996-06-13
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D019212 2005
% 208.06/208.21 |- mesh__dateEstablished mesh__D019212 1997-01-01
% 208.06/208.21 |- mesh__historyNote mesh__D019212 97
% 208.06/208.21 |- mesh__recordMaintainer mesh__D019212 ags
% 208.06/208.21 |- mesh__dateRevised mesh__D019212 2004-07-07
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D019212 97
% 208.06/208.21 |- skos__broader mesh__D019212smesh__D001296
% 208.06/208.21 |- skos__altLabel mesh__D019212 Multimedium
% 208.06/208.21 |- skos__prefLabel mesh__D019212 Multimedia
% 208.06/208.21 |- skos__scopeNote mesh__D019212
% 208.06/208.21 Materials, frequently computer applications, that combine some or all of text, sound, graphics, animation, and video into integrated packages. %28%Thesaurus of ERIC Descriptors, 1994%29%%A%
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D019212 2006
% 208.06/208.21 |- rdf__type mesh__D019212sskos__Concept
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D019212 sjn
% 208.06/208.21 |- skos__historyNote mesh__D019212
% 208.06/208.21 Computer-Assisted Instruction %28%1993-1996%29%
% 208.06/208.21 |- skos__annotation mesh__D019212
% 208.06/208.21 restrict to a combination of audiovisual aids: do not use for a multiplicity of media such as newspapers, radio, TV%A%
% 208.06/208.21 |- skos__broader mesh__D046609smesh__D009862
% 208.06/208.21 |- skos__hiddenLabel mesh__D046609 Library, Digital
% 208.06/208.21 |- skos__hiddenLabel mesh__D046609 Virtual Library
% 208.06/208.21 |- mesh__historyNote mesh__D046609 2005
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D046609 2005
% 208.06/208.21 |- skos__broader mesh__D046609smesh__D007990
% 208.06/208.21 |- mesh__recordOriginator mesh__D046609 ags
% 208.06/208.21 |- skos__hiddenLabel mesh__D046609 Virtual Libraries
% 208.06/208.21 |- skos__scopeNote mesh__D046609
% 208.06/208.21 Libraries in which a major proportion of the resources are available in machine-readable format, rather than on paper or MICROFORM.%A%
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D046609 sjn
% 208.06/208.21 |- mesh__dateCreated mesh__D046609 2004-07-07
% 208.06/208.21 |- rdf__type mesh__D046609sskos__Concept
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D046609 2006
% 208.06/208.21 |- mesh__dateEstablished mesh__D046609 2005-01-01
% 208.06/208.21 |- skos__hiddenLabel mesh__D046609 Digital Library
% 208.06/208.21 |- mesh__recordMaintainer mesh__D046609 ags
% 208.06/208.21 |- skos__hiddenLabel mesh__D046609 Library, Virtual
% 208.06/208.21 |- skos__prefLabel mesh__D046609 Libraries, Digital
% 208.06/208.21 |- skos__altLabel mesh__D046609 Digital Libraries
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D046609 2005
% 208.06/208.21 |- mesh__recordOriginator mesh__D018918 TGC
% 208.06/208.21 |- skos__historyNote mesh__D018918 Cataract Extraction %28%1970-1995%29%
% 208.06/208.21 |- mesh__dateCreated mesh__D018918 1995-01-06
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D018918 2003
% 208.06/208.21 |- skos__hiddenLabel mesh__D018918 Phacoemulsifications
% 208.06/208.21 |- mesh__recordMaintainer mesh__D018918 PXP
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D018918 2004
% 208.06/208.21 |- skos__annotation mesh__D018918
% 208.06/208.21 a type of cataract extraction; do not use /util except by MeSH definition%A%
% 208.06/208.21 |- skos__prefLabel mesh__D018918 Phacoemulsification
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D018918 2000
% 208.06/208.21 |- mesh__historyNote mesh__D018918 96
% 208.06/208.21 |- rdf__type mesh__D018918sskos__Concept
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D018918 2005
% 208.06/208.21 |- skos__broader mesh__D018918smesh__D002387
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D018918 1998
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D018918 SJN
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D018918 2001
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D018918 2006
% 208.06/208.21 |- skos__scopeNote mesh__D018918
% 208.06/208.21 A procedure for removal of the crystalline lens in cataract surgery in which an anterior capsulectomy is performed by means of a needle inserted through a small incision at the temporal limbus, allowing the lens contents to fall through the dilated pupil into the anterior chamber where they are broken up by the use of ultrasound and aspirated out of the eye through the incision. The small incision allows the surgeon to use very few or even no stitches to close the tiny wound. There is usually no need for hospitalization and patients may resume most activities within days. %28%Cline, et al., Dictionary of Visual Science, 4th ed %26% In Focus 1993;1%28%1%29%:1%29%%A%
% 208.06/208.21 |- mesh__dateEstablished mesh__D018918 1996-01-01
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D018918 1999
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D018918 96
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D018918 2002
% 208.06/208.21 |- mesh__dateRevised mesh__D018918 1997-06-20
% 208.06/208.21 |- skos__hiddenLabel mesh__D010935 Diseases, Plant
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010935 2004
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010935 2003
% 208.06/208.21 |- skos__broader mesh__D010935smesh__D018521
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010935 2002
% 208.06/208.21 |- mesh__dateEstablished mesh__D010935 1968-01-01
% 208.06/208.21 |- skos__hiddenLabel mesh__D010935 Disease, Plant
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010935 2006
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010935 1999
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D010935 68
% 208.06/208.21 |- skos__scopeNote mesh__D010935 Diseases of plants.
% 208.06/208.21 |- mesh__dateRevised mesh__D010935 1998-06-10
% 208.06/208.21 |- mesh__recordOriginator mesh__D010935 NLM
% 208.06/208.21 |- skos__hiddenLabel mesh__D010935 Plant Disease
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010935 2005
% 208.06/208.21 |- skos__prefLabel mesh__D010935 Plant Diseases
% 208.06/208.21 |- skos__annotation mesh__D010935
% 208.06/208.21 coord with specific causative organism if pertinent but not with infection term%A%
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010935 2001
% 208.06/208.21 |- mesh__historyNote mesh__D010935 68
% 208.06/208.21 |- mesh__dateCreated mesh__D010935 1999-01-01
% 208.06/208.21 |- skos__historyNote mesh__D010935 Plants %28%1966-1967%29%
% 208.06/208.21 |- mesh__recordMaintainer mesh__D010935 JLS
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010935 2000
% 208.06/208.21 |- rdf__type mesh__D010935sskos__Concept
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D010935 SJN
% 208.06/208.21 |- skos__prefLabel mesh__D010137 p-Hydroxynorephedrine
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D010137
% 208.06/208.21 91; was see under PHENYLPROPANOLAMINE 1975-90
% 208.06/208.21 |- skos__broader mesh__D010137smesh__D010665
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010137 2004
% 208.06/208.21 |- skos__hiddenLabel mesh__D010137 para Hydroxynorephedrine
% 208.06/208.21 |- skos__altLabel mesh__D010137 p Hydroxynorephedrine
% 208.06/208.21 |- mesh__dateCreated mesh__D010137 1974-11-19
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010137 2003
% 208.06/208.21 |- skos__historyNote mesh__D010137 Phenols %28%1972-1974%29%
% 208.06/208.21 |- skos__altLabel mesh__D010137 para-Hydroxynorephedrine
% 208.06/208.21 |- skos__hiddenLabel mesh__D010137 Hydroxynorephedrine, p
% 208.06/208.21 |- mesh__dateEstablished mesh__D010137 1991-01-01
% 208.06/208.21 |- skos__historyNote mesh__D010137 Phenylpropanolamine %28%1972-1974%29%
% 208.06/208.21 |- mesh__recordMaintainer mesh__D010137 CCR
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D010137 sjn
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010137 2002
% 208.06/208.21 |- mesh__recordOriginator mesh__D010137 NLM
% 208.06/208.21 |- mesh__dateRevised mesh__D010137 2000-06-22
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010137 2006
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010137 2001
% 208.06/208.21 |- skos__scopeNote mesh__D010137
% 208.06/208.21 Parahydroxy analog of phenylpropanolamine with properties as a sympathomimetic.%A%
% 208.06/208.21 |- mesh__historyNote mesh__D010137
% 208.06/208.21 91%28%75%29%; was see under PHENYLPROPANOLAMINE 1975-90
% 208.06/208.21 |- rdf__type mesh__D010137sskos__Concept
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D010137 2005
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 1996
% 208.06/208.21 |- mesh__dateEstablished mesh__D015620 1990-01-01
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 2000
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 2005
% 208.06/208.21 |- skos__prefLabel mesh__D015620 Histiocytic Disorders, Malignant
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 1999
% 208.06/208.21 |- mesh__dateRevised mesh__D015620 1995-06-08
% 208.06/208.21 |- skos__hiddenLabel mesh__D015620 Histiocytic Disorder, Malignant
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 1998
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D015620 PLS
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 2002
% 208.06/208.21 |- skos__hiddenLabel mesh__D015620 Disorder, Malignant Histiocytic
% 208.06/208.21 |- skos__annotation mesh__D015620
% 208.06/208.21 GEN or unspecified; prefer specifics; do not use /blood supply /chem /second /secret /ultrastruct; do not confuse with HISTIOCYTOSIS, MALIGNANT%A%
% 208.06/208.21 |- skos__hiddenLabel mesh__D015620 Malignant Histiocytic Disorder
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 2004
% 208.06/208.21 |- rdf__type mesh__D015620sskos__Concept
% 208.06/208.21 |- mesh__historyNote mesh__D015620 90
% 208.06/208.21 |- mesh__recordOriginator mesh__D015620 AGS
% 208.06/208.21 |- skos__hiddenLabel mesh__D015620 Disorders, Malignant Histiocytic
% 208.06/208.21 |- skos__broader mesh__D015620smesh__D015614
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 2003
% 208.06/208.21 |- skos__broader mesh__D015620smesh__D009370
% 208.06/208.21 |- skos__hiddenLabel mesh__D015620 Malignant Histiocytic Disorders
% 208.06/208.21 |- mesh__recordMaintainer mesh__D015620 KEV
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 2001
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 1997
% 208.06/208.21 |- mesh__dateCreated mesh__D015620 1989-06-20
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D015620 90
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D015620 2006
% 208.06/208.21 |- skos__scopeNote mesh__D015620
% 208.06/208.21 Distinctive neoplastic disorders of histiocytes. Included are acute monocytic leukemias, malignant histiocytosis %28%HISTIOCYTOSIS, MALIGNANT%29%, and true histiocytic lymphomas.%A%
% 208.06/208.21 |- skos__prefLabel mesh__D001600 Berberine Alkaloids
% 208.06/208.21 |- mesh__dateEstablished mesh__D001600 1969-01-01
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D001600 2005
% 208.06/208.21 |- mesh__historyNote mesh__D001600 2001%28%1969%29%
% 208.06/208.21 |- skos__broader mesh__D001600smesh__D006576
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D001600 2002
% 208.06/208.21 |- skos__broader mesh__D001600smesh__D000470
% 208.06/208.21 |- mesh__recordOriginator mesh__D001600 NLM
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D001600 2006
% 208.06/208.21 |- skos__scopeNote mesh__D001600
% 208.06/208.21 A group of related plant alkaloids that contain the BERBERINE heterocyclic ring structure.%A%
% 208.06/208.21 |- skos__historyNote mesh__D001600 Alkaloids %28%1966-1968%29%
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D001600 2003
% 208.06/208.21 |- skos__hiddenLabel mesh__D001600 Alkaloids, Berberine
% 208.06/208.21 |- mesh__recordMaintainer mesh__D001600 jmp
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D001600 2001; see BERBINES 1969-2000
% 208.06/208.21 |- rdf__type mesh__D001600sskos__Concept
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D001600 sjn
% 208.06/208.21 |- skos__altLabel mesh__D001600 Berbines
% 208.06/208.21 |- mesh__dateRevised mesh__D001600 2000-06-21
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D001600 2004
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D001600 2001
% 208.06/208.21 |- mesh__dateCreated mesh__D001600 1999-01-01
% 208.06/208.21 |- mesh__recordMaintainer mesh__D006894 lkt
% 208.06/208.21 |- mesh__dateEstablished mesh__D006894 1991-01-01
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D006894 91; was see under ESTRONE 1977-90
% 208.06/208.21 |- skos__scopeNote mesh__D006894
% 208.06/208.21 Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.%A%
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D006894 sjn
% 208.06/208.21 |- skos__historyNote mesh__D006894 Hydroxysteroids %28%1972-1975%29%
% 208.06/208.21 |- mesh__historyNote mesh__D006894
% 208.06/208.21 91%28%77%29%; was see under ESTRONE 1977-90
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006894 2005
% 208.06/208.21 |- rdf__type mesh__D006894sskos__Concept
% 208.06/208.21 |- skos__historyNote mesh__D006894 Estrone %28%1972-1976%29%
% 208.06/208.21 |- skos__broader mesh__D006894smesh__D002393
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006894 2006
% 208.06/208.21 |- skos__broader mesh__D006894smesh__D004970
% 208.06/208.21 |- mesh__dateRevised mesh__D006894 2003-07-09
% 208.06/208.21 |- mesh__dateCreated mesh__D006894 1976-04-27
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006894 2004
% 208.06/208.21 |- mesh__recordOriginator mesh__D006894 RLS
% 208.06/208.21 |- skos__prefLabel mesh__D006894 Hydroxyestrones
% 208.06/208.21 |- mesh__dateCreated mesh__D020565 1999-11-03
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D020565 sjn
% 208.06/208.21 |- mesh__dateEstablished mesh__D020565 2000-01-01
% 208.06/208.21 |- skos__prefLabel mesh__D020565 Epsilonproteobacteria
% 208.06/208.21 |- skos__scopeNote mesh__D020565
% 208.06/208.21 A group of proteobacteria consisting of chemoorganotrophs usually associated with the DIGESTIVE SYSTEM of humans and animals.%A%
% 208.06/208.21 |- skos__altLabel mesh__D020565 epsilon Proteobacteria
% 208.06/208.21 |- rdf__type mesh__D020565sskos__Concept
% 208.06/208.21 |- skos__broader mesh__D020565smesh__D020560
% 208.06/208.21 |- mesh__recordMaintainer mesh__D020565 SYSTEM
% 208.06/208.21 |- skos__altLabel mesh__D020565 Proteobacteria epsilon
% 208.06/208.21 |- mesh__historyNote mesh__D020565 2004 %28%2000%29%
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D020565 2006
% 208.06/208.21 |- mesh__recordOriginator mesh__D020565 ndw
% 208.06/208.21 |- skos__annotation mesh__D020565 DF: EPSILONPROTEOBACT
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D020565
% 208.06/208.21 2004; see episilon Proteobacteria 2000-2004
% 208.06/208.21 |- skos__historyNote mesh__D020565
% 208.06/208.21 Bacteria/classification %28%1994-1999%29%
% 208.06/208.21 |- mesh__dateRevised mesh__D020565 2005-06-30
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006096 2006
% 208.06/208.21 |- skos__altLabel mesh__D006096 Gramicidins
% 208.06/208.21 |- mesh__dateEstablished mesh__D006096 1974-01-01
% 208.06/208.21 |- skos__hiddenLabel mesh__D006096 Gramicidin, Linear
% 208.06/208.21 |- skos__broader mesh__D006096smesh__D014449
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D006096
% 208.06/208.21 96; was GRAMICIDINS 1963-95 %28%see under TYROTHRICIN 1963-73%29%%A%
% 208.06/208.21 |- mesh__dateCreated mesh__D006096 1999-01-01
% 208.06/208.21 |- rdf__type mesh__D006096sskos__Concept
% 208.06/208.21 |- mesh__historyNote mesh__D006096
% 208.06/208.21 96; was GRAMICIDINS 1963-95 %28%see under TYROTHRICIN 1963-73%29%%A%
% 208.06/208.21 |- skos__prefLabel mesh__D006096 Gramicidin
% 208.06/208.21 |- skos__altLabel mesh__D006096 Gramicidin Dubos
% 208.06/208.21 |- mesh__recordMaintainer mesh__D006096 ags
% 208.06/208.21 |- skos__altLabel mesh__D006096 Gramicidin D
% 208.06/208.21 |- mesh__onlineNote mesh__D006096 search TYROTHRICIN 1966-73
% 208.06/208.21 |- mesh__recordOriginator mesh__D006096 NLM
% 208.06/208.21 |- mesh__dateRevised mesh__D006096 2005-07-22
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006096 2005
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D006096 ags
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006096 2004
% 208.06/208.21 |- skos__scopeNote mesh__D006096
% 208.06/208.21 A group of peptide antibiotics from BACILLUS brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidins A, B, D are linear. Gramicidin is one of the two principal components of TYROTHRICIN which is used topically for gram-positive organisms. It is toxic to blood, liver, kidneys, meninges, and the olfactory apparatus.%A%
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D006096 2006A
% 208.06/208.21 |- skos__scopeNote mesh__D014528
% 208.06/208.21 Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma.%A%
% 208.06/208.21 |- mesh__dateCreated mesh__D014528 1999-01-01
% 208.06/208.21 |- rdf__type mesh__D014528sskos__Concept
% 208.06/208.21 |- skos__broader mesh__D014528smesh__D006074
% 208.06/208.21 |- mesh__recordMaintainer mesh__D014528 ssb
% 208.06/208.21 |- mesh__dateRevised mesh__D014528 2005-06-30
% 208.06/208.21 |- skos__prefLabel mesh__D014528 Uricosuric Agents
% 208.06/208.21 |- mesh__historyNote mesh__D014528 64
% 208.06/208.21 |- mesh__dateEstablished mesh__D014528 1964-01-01
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D014528 sjn
% 208.06/208.21 |- skos__hiddenLabel mesh__D014528 Agents, Uricosuric
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D014528 64
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D014528 2006
% 208.06/208.21 |- mesh__recordOriginator mesh__D014528 NLM
% 208.06/208.21 |- skos__broader mesh__D014528smesh__D012076
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D019213 2003
% 208.06/208.21 |- skos__hiddenLabel mesh__D019213 Rubulaviruses
% 208.06/208.21 |- skos__prefLabel mesh__D019213 Rubulavirus
% 208.06/208.21 |- mesh__dateEstablished mesh__D019213 1997-01-01
% 208.06/208.21 |- mesh__historyNote mesh__D019213 1997
% 208.06/208.21 |- mesh__recordAuthorizer mesh__D019213 sjn
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D019213 2006
% 208.06/208.21 |- mesh__dateCreated mesh__D019213 1996-06-10
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D019213 2002
% 208.06/208.21 |- rdf__type mesh__D019213sskos__Concept
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D019213 2005
% 208.06/208.21 |- mesh__dateRevised mesh__D019213 2001-07-25
% 208.06/208.21 |- mesh__recordOriginator mesh__D019213 AGS
% 208.06/208.21 |- skos__broader mesh__D019213smesh__D018098
% 208.06/208.21 |- mesh__activeMeSHYear mesh__D019213 2004
% 208.06/208.21 |- mesh__publicMeSHNote mesh__D019213 1997
% 208.06/208.21 |- skos__scopeNote mesh__D019213
% 208.06/208.21 A genus of the family PARAMYXOVIRIDAE %28%subfamily PARAMYXOVIRINAE%29% where all the species have hemagglutinin and neuraminidase activities but lack a C protein. MUMPS VIRUS is the type species.%A%
% 208.06/208.21 |- skos__annotation mesh__D019213
% 208.06/208.21 do not confuse with RUBELLA VIRUS, a rubivirus; infection = RUBULAVIRUS INFECTIONS%A%
% 208.06/208.21 |- mesh__recordMaintainer mesh__D019213 ags
% 208.06/208.21 |- skos__scopeNote mesh__D000508
% 208.06/208.21 A genus of the subfamily ALOUATTINAE, family CEBIDAE, composed of six species. They are A. belzebul %28%black and red howler%29%, A. caraya %28%black howler%29%, A. fusca %28%brown howler%29%, A. palliata %28%mantled howler%29%, A. seniculus %28%red howler%29%, and A. villosa %28%also known as A. pigra; Guatemalan howler%29%. They inhabit the forests of Central and South America. Howlers travel in groups and define their territories by howling accompanied by vigorously shaking and breaking branches.%A%
% 208.06/208.21 |- mesh__recordMaintainer mesh__D000508 ags
% 208.06/208.21 |- rdf__type mesh__D000508sskos__Concept
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D000508
% 208.06/208.22 91; was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80%A%
% 208.06/208.22 |- mesh__onlineNote mesh__D000508
% 208.06/208.22 use ALOUATTA to search HOWLER MONKEYS 1975-80
% 208.06/208.22 |- mesh__recordOriginator mesh__D000508 NLM
% 208.06/208.22 |- skos__altLabel mesh__D000508 Howler Monkeys
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D000508 2006
% 208.06/208.22 |- skos__hiddenLabel mesh__D000508 Alouattas
% 208.06/208.22 |- skos__hiddenLabel mesh__D000508 Monkeys, Howler
% 208.06/208.22 |- skos__altLabel mesh__D000508 Monkey, Howler
% 208.06/208.22 |- skos__prefLabel mesh__D000508 Alouatta
% 208.06/208.22 |- mesh__dateCreated mesh__D000508 1974-11-11
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D000508 sjn
% 208.06/208.22 |- mesh__dateEstablished mesh__D000508 1991-01-01
% 208.06/208.22 |- skos__broader mesh__D000508smesh__D016661
% 208.06/208.22 |- skos__hiddenLabel mesh__D000508 Howler Monkey
% 208.06/208.22 |- skos__annotation mesh__D000508
% 208.06/208.22 New World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%
% 208.06/208.22 |- mesh__dateRevised mesh__D000508 2005-06-30
% 208.06/208.22 |- mesh__historyNote mesh__D000508
% 208.06/208.22 91%28%81%29%; was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80%A%
% 208.06/208.22 |- skos__hiddenLabel mesh__D011230 Conditions, Precancerous
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 2000
% 208.06/208.22 |- rdf__type mesh__D011230sskos__Concept
% 208.06/208.22 |- skos__hiddenLabel mesh__D011230 Precancerous Condition
% 208.06/208.22 |- skos__altLabel mesh__D011230 Preneoplastic Conditions
% 208.06/208.22 |- mesh__dateEstablished mesh__D011230 1968-01-01
% 208.06/208.22 |- skos__scopeNote mesh__D011230
% 208.06/208.22 Pathological processes that tend eventually to become malignant. %28%From Dorland, 27th ed%29%%A%
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 1997
% 208.06/208.22 |- skos__hiddenLabel mesh__D011230 Condition, Precancerous
% 208.06/208.22 |- mesh__dateCreated mesh__D011230 1999-01-01
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 2004
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 2002
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 1996
% 208.06/208.22 |- mesh__historyNote mesh__D011230 68
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 2003
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 1999
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D011230 68
% 208.06/208.22 |- skos__prefLabel mesh__D011230 Precancerous Conditions
% 208.06/208.22 |- skos__altLabel mesh__D011230 Conditions, Preneoplastic
% 208.06/208.22 |- mesh__recordMaintainer mesh__D011230 KEV
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 2006
% 208.06/208.22 |- mesh__dateRevised mesh__D011230 1995-05-24
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 1998
% 208.06/208.22 |- skos__annotation mesh__D011230
% 208.06/208.22 IM; do not use /compl for develop into cancer: use /pathol; coord IM with organ/neopl term %28%IM%29%; Manual 24.4.1.13%A%
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 2001
% 208.06/208.22 |- skos__broader mesh__D011230smesh__D009369
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011230 2005
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D011230 PLS
% 208.06/208.22 |- skos__altLabel mesh__D011230 Preneoplastic Condition
% 208.06/208.22 |- mesh__recordOriginator mesh__D011230 NLM
% 208.06/208.22 |- skos__broader mesh__D014803Q000172smesh__D014803
% 208.06/208.22 |- mesh__preferredCombination mesh__D014803Q000172smesh__D014804
% 208.06/208.22 |- rdf__type mesh__D014803Q000172smesh__CompoundConcept
% 208.06/208.22 |- mesh__recordMaintainer mesh__D018919 lkt
% 208.06/208.22 |- skos__altLabel mesh__D018919 Angiogenesis, Physiologic
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D018919 2006
% 208.06/208.22 |- mesh__recordOriginator mesh__D018919 TGC
% 208.06/208.22 |- skos__altLabel mesh__D018919 Physiologic Angiogenesis
% 208.06/208.22 |- skos__hiddenLabel mesh__D018919 Physiological Neovascularization
% 208.06/208.22 |- skos__annotation mesh__D018919
% 208.06/208.22 do not confuse with NEOVASCULARIZATION, PATHOLOGIC; coord IM or NIM with organ /blood supply %28%IM%29%; do not confuse with COLLATERAL CIRCULATION: physiol neovasc is formation of new blood vessels in tissue, collat circ is circ through secondary channels after obstruct of principal vessel supplying a part; DF: NEOVASC PHYSIOL%A%
% 208.06/208.22 |- mesh__dateRevised mesh__D018919 2004-07-07
% 208.06/208.22 |- skos__altLabel mesh__D018919 Angiogenesis, Physiological
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D018919 2005
% 208.06/208.22 |- skos__altLabel mesh__D018919 Physiologic Neovascularization
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D018919 sjn
% 208.06/208.22 |- mesh__dateEstablished mesh__D018919 1996-01-01
% 208.06/208.22 |- skos__related mesh__D018919smesh__D003097
% 208.06/208.22 |- skos__prefLabel mesh__D018919 Neovascularization, Physiologic
% 208.06/208.22 |- mesh__dateCreated mesh__D018919 1995-01-06
% 208.06/208.22 |- skos__broader mesh__D018919smesh__D045125
% 208.06/208.22 |- skos__altLabel mesh__D018919 Neovascularization, Physiological
% 208.06/208.22 |- skos__scopeNote mesh__D018919
% 208.06/208.22 The development of new BLOOD VESSELS in restoration of BLOOD CIRCULATION during the healing process.%A%
% 208.06/208.22 |- skos__related mesh__D018919smesh__D009389
% 208.06/208.22 |- mesh__historyNote mesh__D018919 96
% 208.06/208.22 |- skos__hiddenLabel mesh__D018919 Physiological Angiogenesis
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D018919 96
% 208.06/208.22 |- rdf__type mesh__D018919sskos__Concept
% 208.06/208.22 |- skos__hiddenLabel mesh__D010936 Extracts, Plant
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010936 2006
% 208.06/208.22 |- mesh__dateEstablished mesh__D010936 1976-01-01
% 208.06/208.22 |- skos__broader mesh__D010936smesh__D028321
% 208.06/208.22 |- skos__annotation mesh__D010936
% 208.06/208.22 IM GEN only; NIM when specific plant term is IM; /ther use: coord with disease /drug ther, not /ther; extracts of medicinal plants in Chinese med = PLANT EXTRACTS, CHINESE see DRUGS, CHINESE HERBAL: TN J%A%
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D010936 76; was see under PLANTS 1975
% 208.06/208.22 |- mesh__recordMaintainer mesh__D010936 ssb
% 208.06/208.22 |- skos__prefLabel mesh__D010936 Plant Extracts
% 208.06/208.22 |- mesh__dateRevised mesh__D010936 2005-06-30
% 208.06/208.22 |- mesh__dateCreated mesh__D010936 1999-01-01
% 208.06/208.22 |- skos__related mesh__D010936smesh__D008517
% 208.06/208.22 |- skos__broader mesh__D010936smesh__D004364
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D010936 sjn
% 208.06/208.22 |- mesh__recordOriginator mesh__D010936 NLM
% 208.06/208.22 |- rdf__type mesh__D010936sskos__Concept
% 208.06/208.22 |- skos__historyNote mesh__D010936 Plants %28%1966%29%
% 208.06/208.22 |- mesh__historyNote mesh__D010936
% 208.06/208.22 76%28%67%29%; was see under PLANTS 1975
% 208.06/208.22 |- skos__scopeNote mesh__D010936
% 208.06/208.22 Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard.%A%
% 208.06/208.22 |- skos__prefLabel mesh__D029641 Simaroubaceae
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D029641 2006
% 208.06/208.22 |- skos__broader mesh__D029641smesh__D019684
% 208.06/208.22 |- rdf__type mesh__D029641sskos__Concept
% 208.06/208.22 |- skos__scopeNote mesh__D029641
% 208.06/208.22 A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are alternate and compound. Most have small flowers, bitter bark, and fleshy fruits that are sometimes winged. Members contain QUASSINS.%A%
% 208.06/208.22 |- skos__annotation mesh__D029641
% 208.06/208.22 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.22 |- mesh__recordMaintainer mesh__D029641 ssb
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D029641 2005
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D029641 2004
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D029641 sjn
% 208.06/208.22 |- mesh__dateRevised mesh__D029641 2003-07-09
% 208.06/208.22 |- mesh__recordOriginator mesh__D029641 ssb
% 208.06/208.22 |- mesh__dateCreated mesh__D029641 2001-07-25
% 208.06/208.22 |- mesh__historyNote mesh__D029641 2002
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D029641 2002
% 208.06/208.22 |- mesh__dateEstablished mesh__D029641 2002-01-01
% 208.06/208.22 |- skos__hiddenLabel mesh__D010138 Cardiac Pacemakers, Artificial
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010138 2001
% 208.06/208.22 |- skos__hiddenLabel mesh__D010138 Pacemakers, Artificial Cardiac
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010138 2003
% 208.06/208.22 |- skos__broader mesh__D010138smesh__D001187
% 208.06/208.22 |- skos__hiddenLabel mesh__D010138 Artificial Cardiac Pacemaker
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010138 2000
% 208.06/208.22 |- mesh__dateRevised mesh__D010138 1997-06-20
% 208.06/208.22 |- skos__scopeNote mesh__D010138
% 208.06/208.22 A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary %28%external%29% or permanent %28%internal or internal-external%29%.%A%
% 208.06/208.22 |- skos__hiddenLabel mesh__D010138 Artificial Pacemakers
% 208.06/208.22 |- skos__hiddenLabel mesh__D010138 Artificial Pacemaker
% 208.06/208.22 |- skos__hiddenLabel mesh__D010138 Artificial Cardiac Pacemakers
% 208.06/208.22 |- skos__prefLabel mesh__D010138 Pacemaker, Artificial
% 208.06/208.22 |- mesh__dateCreated mesh__D010138 1999-01-01
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010138 1999
% 208.06/208.22 |- skos__hiddenLabel mesh__D010138 Pacemaker, Artificial Cardiac
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010138 2006
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010138 1998
% 208.06/208.22 |- rdf__type mesh__D010138sskos__Concept
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010138 2005
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D010138 SJN
% 208.06/208.22 |- skos__altLabel mesh__D010138 Cardiac Pacemaker, Artificial
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010138 2002
% 208.06/208.22 |- skos__annotation mesh__D010138
% 208.06/208.22 may be temporary %28%external%29% or permanent %28%internal or internal-external%29%; coord dis with /ther, not /surg for treatment with pacemaker%A%
% 208.06/208.22 |- mesh__recordOriginator mesh__D010138 NLM
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010138 2004
% 208.06/208.22 |- skos__hiddenLabel mesh__D010138 Pacemakers, Artificial
% 208.06/208.22 |- mesh__recordMaintainer mesh__D010138 PXP
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 2002
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D001601 PLS
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D001601 88
% 208.06/208.22 |- mesh__dateRevised mesh__D001601 1991-06-20
% 208.06/208.22 |- skos__annotation mesh__D001601 human %26% animal; no qualif
% 208.06/208.22 |- skos__hiddenLabel mesh__D001601 Bereavements
% 208.06/208.22 |- mesh__dateEstablished mesh__D001601 1988-01-01
% 208.06/208.22 |- mesh__recordMaintainer mesh__D001601 TGC
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 1995
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 1993
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 2001
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 1999
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 1994
% 208.06/208.22 |- skos__scopeNote mesh__D001601
% 208.06/208.22 Refers to the whole process of grieving and mourning and is associated with a deep sense of loss and sadness.%A%
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 1997
% 208.06/208.22 |- skos__related mesh__D001601smesh__D006117
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 1992
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 2006
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 2000
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 1998
% 208.06/208.22 |- mesh__dateCreated mesh__D001601 1987-03-14
% 208.06/208.22 |- skos__historyNote mesh__D001601 Grief %28%1968-1987%29%
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 2004
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 1996
% 208.06/208.22 |- rdf__type mesh__D001601sskos__Concept
% 208.06/208.22 |- skos__prefLabel mesh__D001601 Bereavement
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 2005
% 208.06/208.22 |- mesh__recordOriginator mesh__D001601 EC
% 208.06/208.22 |- skos__broader mesh__D001601smesh__D004644
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D001601 2003
% 208.06/208.22 |- mesh__historyNote mesh__D001601 88
% 208.06/208.22 |- skos__historyNote mesh__D006895 Alcohol, Ethyl %28%1971-1974%29%
% 208.06/208.22 |- skos__altLabel mesh__D006895 Fresenius Brand of Pentastarch
% 208.06/208.22 |- skos__broader mesh__D006895smesh__D013213
% 208.06/208.22 |- mesh__dateCreated mesh__D006895 1974-11-19
% 208.06/208.22 |- skos__altLabel mesh__D006895 Hydroxyethyl Starch
% 208.06/208.22 |- rdf__type mesh__D006895sskos__Concept
% 208.06/208.22 |- mesh__recordMaintainer mesh__D006895 lkw
% 208.06/208.22 |- skos__historyNote mesh__D006895 Starch %28%1971-1974%29%
% 208.06/208.22 |- mesh__historyNote mesh__D006895
% 208.06/208.22 96; was HYDROXYETHYL STARCH 1975-95 %28%see under STARCH 1975-90%29%%A%
% 208.06/208.22 |- skos__altLabel mesh__D006895 Pentastarch
% 208.06/208.22 |- mesh__dateRevised mesh__D006895 2005-06-30
% 208.06/208.22 |- skos__hiddenLabel mesh__D006895 Starch, Hydroxyethyl
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D006895
% 208.06/208.22 96; was HYDROXYETHYL STARCH 1975-95 %28%see under STARCH 1975-90%29%%A%
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D006895 2006
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D006895 sjn
% 208.06/208.22 |- mesh__recordOriginator mesh__D006895 NLM
% 208.06/208.22 |- skos__altLabel mesh__D006895 Braun Brand of Pentastarch
% 208.06/208.22 |- skos__prefLabel mesh__D006895 Hetastarch
% 208.06/208.22 |- skos__scopeNote mesh__D006895
% 208.06/208.22 A derivative of STARCH used as a plasma substitute in the treatment of hemorrhage.%A%
% 208.06/208.22 |- mesh__dateEstablished mesh__D006895 1991-01-01
% 208.06/208.22 |- skos__altLabel mesh__D006895 Bristol-Myers Squibb Brand of Pentastarch
% 208.06/208.22 |- skos__altLabel mesh__D006895
% 208.06/208.22 Rh%C3%%B4%ne-Poulenc Rorer Brand of Pentastarch
% 208.06/208.22 |- skos__broader mesh__D020566smesh__D000938
% 208.06/208.22 |- skos__hiddenLabel mesh__D020566 Dendritic Cell, Follicular
% 208.06/208.22 |- skos__scopeNote mesh__D020566
% 208.06/208.22 Cells with extensive dendritic processes found in the B-cell areas %28%primary follicles and germinal centers%29% of lymphoid tissue. They are unrelated to the DENDRITIC CELLS associated with T-cells. Follicular dendritic cells have Fc receptors %28%RECEPTORS, FC%29% and C3b receptors %28%RECEPTORS, COMPLEMENT 3B%29%, but unlike other dendritic cells, they do not process or present antigen in a way that allows recognition by T-cells. Instead, they hold antigen in the form of immune complexes on their surfaces for long periods and can present antigen to B-cells during an immune response. %28%From Herbert et al., Dictionary of Immunology, 4th ed%29%%A%
% 208.06/208.22 |- mesh__recordOriginator mesh__D020566 ags
% 208.06/208.22 |- skos__hiddenLabel mesh__D020566 Follicular Dendritic Cell
% 208.06/208.22 |- skos__broader mesh__D020566smesh__D018858
% 208.06/208.22 |- mesh__dateRevised mesh__D020566 2003-07-09
% 208.06/208.22 |- skos__altLabel mesh__D020566 Follicular Dendritic Cells
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D020566
% 208.06/208.22 2000; see DENDRITIC CELLS 1987-1999
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D020566 sjn
% 208.06/208.22 |- skos__historyNote mesh__D020566 Lymph Nodes %28%1980-1986%29%
% 208.06/208.22 |- skos__prefLabel mesh__D020566 Dendritic Cells, Follicular
% 208.06/208.22 |- mesh__historyNote mesh__D020566 2000; use DENDRITIC CELLS 1987-1999
% 208.06/208.22 |- mesh__dateEstablished mesh__D020566 2000-01-01
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D020566 2005
% 208.06/208.22 |- skos__annotation mesh__D020566 DENDRITIC CELLS is also available
% 208.06/208.22 |- mesh__dateCreated mesh__D020566 1999-11-03
% 208.06/208.22 |- rdf__type mesh__D020566sskos__Concept
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D020566 2006
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D020566 2004
% 208.06/208.22 |- skos__historyNote mesh__D020566 Dendritic Cells %28%1987-1999%29%
% 208.06/208.22 |- mesh__recordMaintainer mesh__D020566 jmp
% 208.06/208.22 |- mesh__recordMaintainer mesh__D006097 KEV
% 208.06/208.22 |- mesh__dateCreated mesh__D006097 1999-01-01
% 208.06/208.22 |- skos__hiddenLabel mesh__D006097 Tissue, Granulation
% 208.06/208.22 |- rdf__type mesh__D006097sskos__Concept
% 208.06/208.22 |- mesh__dateRevised mesh__D006097 2002-07-03
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D006097 2003
% 208.06/208.22 |- skos__broader mesh__D006097smesh__D003238
% 208.06/208.22 |- skos__prefLabel mesh__D006097 Granulation Tissue
% 208.06/208.22 |- skos__hiddenLabel mesh__D006097 Tissues, Granulation
% 208.06/208.22 |- skos__hiddenLabel mesh__D006097 Granulation Tissues
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D006097 sjn
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D006097 2004
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D006097 2005
% 208.06/208.22 |- skos__scopeNote mesh__D006097
% 208.06/208.22 A vascular connective tissue formed on the surface of a healing wound, ulcer, or inflamed tissue. It consists of new capillaries and an infiltrate containing lymphoid cells, macrophages, and plasma cells.%A%
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D006097 2006
% 208.06/208.22 |- mesh__recordOriginator mesh__D006097 NLM
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 1991
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D014529 NLM
% 208.06/208.22 |- skos__broader mesh__D014529smesh__D011741
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 1995
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 2002
% 208.06/208.22 |- skos__altLabel mesh__D014529 Allo-Uridine
% 208.06/208.22 |- mesh__recordOriginator mesh__D014529 NLM
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 1999
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 2006
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 1994
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 2001
% 208.06/208.22 |- skos__broader mesh__D014529smesh__D012263
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 1993
% 208.06/208.22 |- skos__prefLabel mesh__D014529 Uridine
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D014529
% 208.06/208.22 66; was see under NUCLEOSIDES 1963-65; ARABINOFURANOSYLURACIL was see under PYRIMIDINE NUCLEOSIDES 1976-77%A%
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 2000
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 1998
% 208.06/208.22 |- mesh__dateEstablished mesh__D014529 1966-01-01
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 2005
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 1997
% 208.06/208.22 |- mesh__recordMaintainer mesh__D014529 PLS
% 208.06/208.22 |- mesh__dateCreated mesh__D014529 1999-01-01
% 208.06/208.22 |- skos__annotation mesh__D014529 /biosyn /physiol permitted
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 2004
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 1992
% 208.06/208.22 |- skos__hiddenLabel mesh__D014529 Allo Uridine
% 208.06/208.22 |- rdf__type mesh__D014529sskos__Concept
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 1996
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D014529 2003
% 208.06/208.22 |- mesh__dateRevised mesh__D014529 1990-05-30
% 208.06/208.22 |- mesh__historyNote mesh__D014529
% 208.06/208.22 66%28%64%29%; was see under NUCLEOSIDES 1963-65
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 1997
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 2000
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 2006
% 208.06/208.22 |- skos__broader mesh__D019214smesh__D005882
% 208.06/208.22 |- skos__hiddenLabel mesh__D019214 Overgrowth, Gingival
% 208.06/208.22 |- rdf__type mesh__D019214sskos__Concept
% 208.06/208.22 |- skos__historyNote mesh__D019214 Gingival Hypertrophy %28%1992-1996%29%
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 2005
% 208.06/208.22 |- skos__hiddenLabel mesh__D019214 Gingival Overgrowths
% 208.06/208.22 |- mesh__dateEstablished mesh__D019214 1997-01-01
% 208.06/208.22 |- skos__hiddenLabel mesh__D019214 Overgrowths, Gingival
% 208.06/208.22 |- mesh__historyNote mesh__D019214 97
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 1999
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 2004
% 208.06/208.22 |- skos__annotation mesh__D019214
% 208.06/208.22 GEN or unspecified; prefer GINGIVAL HYPERTROPHY or GINGIVAL HYPERPLASIA%A%
% 208.06/208.22 |- mesh__dateCreated mesh__D019214 1996-06-10
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 2002
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 1998
% 208.06/208.22 |- skos__prefLabel mesh__D019214 Gingival Overgrowth
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 2003
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D019214 2001
% 208.06/208.22 |- skos__scopeNote mesh__D019214
% 208.06/208.22 Excessive growth of the gingiva either by an increase in the size of the constituent cells %28%GINGIVAL HYPERTROPHY%29% or by an increase in their number %28%GINGIVAL HYPERPLASIA%29%. %28%From Jablonski%27%s Dictionary of Dentistry, 1992, p574%29%%A%
% 208.06/208.22 |- skos__historyNote mesh__D019214 Gingival Hyperplasia %28%1978-1996%29%
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D019214 97
% 208.06/208.22 |- skos__scopeNote mesh__D000509
% 208.06/208.22 The first alpha-globulins to appear in mammalian sera during development of the embryo and the dominant serum proteins in early embryonic life. They reappear in the adult serum during certain pathologic states, primarily hepatocellular carcinoma. They may also be elevated in the amniotic fluid and maternal serum during pregnancy in ANENCEPHALY.%A%
% 208.06/208.22 |- mesh__dateEstablished mesh__D000509 1977-01-01
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D000509 2006
% 208.06/208.22 |- skos__hiddenLabel mesh__D000509 alpha Fetoprotein
% 208.06/208.22 |- mesh__dateRevised mesh__D000509 2005-06-30
% 208.06/208.22 |- mesh__onlineNote mesh__D000509
% 208.06/208.22 use ALPHA-FETOPROTEINS to search ALPHA FETOPROTEINS 1975-95%A%
% 208.06/208.22 |- mesh__historyNote mesh__D000509
% 208.06/208.22 96; was ALPHA FETOPROTEINS 1975-95 %28%see under FETAL GLOBULINS 1975-76%29%%A%
% 208.06/208.22 |- skos__annotation mesh__D000509 /biosyn /physiol permitted
% 208.06/208.22 |- skos__altLabel mesh__D000509 Fetuin
% 208.06/208.22 |- skos__prefLabel mesh__D000509 alpha-Fetoproteins
% 208.06/208.22 |- skos__broader mesh__D000509smesh__D014408
% 208.06/208.22 |- skos__historyNote mesh__D000509 Fetal Proteins %28%1970-1974%29%
% 208.06/208.22 |- mesh__dateCreated mesh__D000509 1974-11-11
% 208.06/208.22 |- skos__altLabel mesh__D000509 alpha-Fetoprotein
% 208.06/208.22 |- mesh__recordOriginator mesh__D000509 NLM
% 208.06/208.22 |- skos__hiddenLabel mesh__D000509 alpha Fetoproteins
% 208.06/208.22 |- skos__altLabel mesh__D000509 AFP
% 208.06/208.22 |- skos__altLabel mesh__D000509 Fetuins
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D000509
% 208.06/208.22 96; was ALPHA FETOPROTEINS 1975-95 %28%see under FETAL GLOBULINS 1975-76%29%%A%
% 208.06/208.22 |- skos__broader mesh__D000509smesh__D005326
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D000509 sjn
% 208.06/208.22 |- rdf__type mesh__D000509sskos__Concept
% 208.06/208.22 |- skos__related mesh__D000509smesh__D000757
% 208.06/208.22 |- mesh__recordMaintainer mesh__D000509 ssb
% 208.06/208.22 |- skos__broader mesh__D011231smesh__D004493
% 208.06/208.22 |- skos__hiddenLabel mesh__D011231 Preceptorships
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011231 2000
% 208.06/208.22 |- mesh__historyNote mesh__D011231 75
% 208.06/208.22 |- skos__historyNote mesh__D011231 Education, Dental %28%1966-1974%29%
% 208.06/208.22 |- rdf__type mesh__D011231sskos__Concept
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011231 2003
% 208.06/208.22 |- skos__prefLabel mesh__D011231 Preceptorship
% 208.06/208.22 |- mesh__dateRevised mesh__D011231 1999-11-03
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011231 2001
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011231 2004
% 208.06/208.22 |- mesh__recordOriginator mesh__D011231 NLM
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011231 2002
% 208.06/208.22 |- skos__historyNote mesh__D011231 Education, Medical %28%1966-1974%29%
% 208.06/208.22 |- mesh__dateEstablished mesh__D011231 1975-09-01
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011231 2005
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D011231 sjn
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D011231 2006
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D011231 75
% 208.06/208.22 |- mesh__recordMaintainer mesh__D011231 jls
% 208.06/208.22 |- mesh__dateCreated mesh__D011231 1974-11-11
% 208.06/208.22 |- skos__scopeNote mesh__D011231
% 208.06/208.22 Practical experience in medical and health-related services that occurs as part of an educational program wherein the professionally-trained student works outside the academic environment under the supervision of an established professional in the particular field.%A%
% 208.06/208.22 |- skos__hiddenLabel mesh__D010937 Hormones, Plant
% 208.06/208.22 |- mesh__recordOriginator mesh__D010937 NLM
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D010937 sjn
% 208.06/208.22 |- skos__altLabel mesh__D010937 Plant Hormones
% 208.06/208.22 |- mesh__dateCreated mesh__D010937 1999-01-01
% 208.06/208.22 |- skos__annotation mesh__D010937 DF: PLANT GROWTH REG
% 208.06/208.22 |- skos__scopeNote mesh__D010937
% 208.06/208.22 Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins.%A%
% 208.06/208.22 |- skos__altLabel mesh__D010937 Regulators, Plant Growth
% 208.06/208.22 |- rdf__type mesh__D010937sskos__Concept
% 208.06/208.22 |- skos__prefLabel mesh__D010937 Plant Growth Regulators
% 208.06/208.22 |- skos__broader mesh__D010937smesh__D006133
% 208.06/208.22 |- skos__altLabel mesh__D010937 Growth Regulators, Plant
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010937 2006
% 208.06/208.22 |- mesh__recordMaintainer mesh__D010937 ssb
% 208.06/208.22 |- skos__altLabel mesh__D010937 Phytohormones
% 208.06/208.22 |- mesh__dateRevised mesh__D010937 2005-06-30
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D029642 2005
% 208.06/208.22 |- mesh__historyNote mesh__D029642 2002
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D029642 2003
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D029642 2006
% 208.06/208.22 |- rdf__type mesh__D029642sskos__Concept
% 208.06/208.22 |- mesh__dateEstablished mesh__D029642 2002-01-01
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D029642 2004
% 208.06/208.22 |- skos__broader mesh__D029642smesh__D019684
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D029642 2002
% 208.06/208.22 |- skos__scopeNote mesh__D029642
% 208.06/208.22 A plant family of the order Liliales, subclass Liliidae, class Liliopsida %28%monocotyledon%29%.%A%
% 208.06/208.22 |- skos__prefLabel mesh__D029642 Smilacaceae
% 208.06/208.22 |- skos__annotation mesh__D029642
% 208.06/208.22 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.22 |- mesh__dateCreated mesh__D029642 2001-07-25
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D029642 2002
% 208.06/208.22 |- mesh__dateCreated mesh__D010139 1999-01-01
% 208.06/208.22 |- mesh__recordAuthorizer mesh__D010139 sjn
% 208.06/208.22 |- skos__annotation mesh__D010139
% 208.06/208.22 includes MELANESIA; MICRONESIA %26% POLYNESIA: see notes under each %26% indentions in trees%A%
% 208.06/208.22 |- mesh__recordOriginator mesh__D010139 NLM
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010139 2005
% 208.06/208.22 |- skos__prefLabel mesh__D010139 Pacific Islands
% 208.06/208.22 |- skos__broader mesh__D010139smesh__D005842
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010139 2006
% 208.06/208.22 |- skos__broader mesh__D010139smesh__D044362
% 208.06/208.22 |- rdf__type mesh__D010139sskos__Concept
% 208.06/208.22 |- mesh__dateRevised mesh__D010139 2003-07-09
% 208.06/208.22 |- mesh__onlineNote mesh__D010139
% 208.06/208.22 use PACIFIC ISLANDS to search SOUTH PACIFIC ISLANDS 1967-77%A%
% 208.06/208.22 |- mesh__recordMaintainer mesh__D010139 jls
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D010139 2004
% 208.06/208.22 |- skos__scopeNote mesh__D010139
% 208.06/208.22 The islands of the Pacific Ocean divided into MICRONESIA; MELANESIA; and POLYNESIA %28%including NEW ZEALAND%29%. The collective name Oceania includes the aforenamed islands, adding AUSTRALIA; NEW ZEALAND; and the Malay Archipelago %28%INDONESIA%29%. %28%Webster%27%s New Geographical Dictionary, 1988, p910, 880%29%%A%
% 208.06/208.22 |- mesh__historyNote mesh__D010139 78; was SOUTH PACIFIC ISLANDS 1967-77
% 208.06/208.22 |- skos__broader mesh__D007190smesh__D007211
% 208.06/208.22 |- skos__historyNote mesh__D007190 Diuretics, Sulfamyl %28%1974%29%
% 208.06/208.22 |- skos__hiddenLabel mesh__D007190 SE1520
% 208.06/208.22 |- skos__altLabel mesh__D007190 Metindamide
% 208.06/208.22 |- skos__hiddenLabel mesh__D007190 S 1520
% 208.06/208.22 |- skos__scopeNote mesh__D007190
% 208.06/208.22 A benzamide-sulfonamide-indole. It is called a thiazide-like diuretic but structure is different enough %28%lacking the thiazo-ring%29% so it is not clear that the mechanism is comparable.%A%
% 208.06/208.22 |- skos__historyNote mesh__D007190 Indoles %28%1974%29%
% 208.06/208.22 |- skos__historyNote mesh__D007190 Benzamides %28%1974%29%
% 208.06/208.22 |- skos__hiddenLabel mesh__D007190 S1520
% 208.06/208.22 |- mesh__recordOriginator mesh__D007190 NLM
% 208.06/208.22 |- mesh__recordMaintainer mesh__D007190 ssb
% 208.06/208.22 |- mesh__publicMeSHNote mesh__D007190
% 208.06/208.22 91; was see under DIURETICS, SULFAMYL 1975-90
% 208.06/208.22 |- mesh__dateCreated mesh__D007190 1974-11-19
% 208.06/208.22 |- mesh__activeMeSHYear mesh__D007190 2006
% 208.06/208.22 |- skos__hiddenLabel mesh__D007190 SE 1520
% 208.06/208.23 |- mesh__historyNote mesh__D007190
% 208.06/208.23 91%28%75%29%; was see under DIURETICS, SULFAMYL 1975-90
% 208.06/208.23 |- mesh__dateRevised mesh__D007190 2005-06-30
% 208.06/208.23 |- mesh__dateEstablished mesh__D007190 1991-01-01
% 208.06/208.23 |- rdf__type mesh__D007190sskos__Concept
% 208.06/208.23 |- skos__prefLabel mesh__D007190 Indapamide
% 208.06/208.23 |- skos__altLabel mesh__D007190 SE-1520
% 208.06/208.23 |- skos__broader mesh__D007190smesh__D013449
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D007190 sjn
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D015622 2004
% 208.06/208.23 |- rdf__type mesh__D015622sskos__Concept
% 208.06/208.23 |- skos__historyNote mesh__D015622 Epithelium %28%1966-1989%29%
% 208.06/208.23 |- mesh__historyNote mesh__D015622 90
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D015622 sjn
% 208.06/208.23 |- skos__prefLabel mesh__D015622 Epithelioid Cells
% 208.06/208.23 |- mesh__dateCreated mesh__D015622 1989-03-29
% 208.06/208.23 |- skos__related mesh__D015622smesh__D015726
% 208.06/208.23 |- mesh__recordOriginator mesh__D015622 AGS
% 208.06/208.23 |- skos__annotation mesh__D015622
% 208.06/208.23 a type of macrophage; A 11 qualif; do not confuse with EPITHELIAL CELLS%A%
% 208.06/208.23 |- skos__historyNote mesh__D015622 Macrophages %28%1966-1989%29%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D015622 2006
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D015622 90
% 208.06/208.23 |- skos__hiddenLabel mesh__D015622 Cell, Epithelioid
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D015622 2005
% 208.06/208.23 |- skos__broader mesh__D015622smesh__D008264
% 208.06/208.23 |- mesh__dateRevised mesh__D015622 2003-07-09
% 208.06/208.23 |- skos__hiddenLabel mesh__D015622 Epithelioid Cell
% 208.06/208.23 |- mesh__dateEstablished mesh__D015622 1990-01-01
% 208.06/208.23 |- mesh__recordMaintainer mesh__D015622 nns
% 208.06/208.23 |- skos__scopeNote mesh__D015622
% 208.06/208.23 Characteristic cells of granulomatous hypersensitivity. They appear as large, flattened cells with increased endoplasmic reticulum. They are believed to be activated macrophages that have differentiated as a result of prolonged antigenic stimulation. Further differentiation or fusion of epithelioid cells is thought to produce multinucleated giant cells %28%GIANT CELLS%29%.%A%
% 208.06/208.23 |- skos__hiddenLabel mesh__D015622 Cells, Epithelioid
% 208.06/208.23 |- mesh__dateCreated mesh__D001602 1999-01-01
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D001602 sjn
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D001602 2006
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D001602 2004
% 208.06/208.23 |- rdf__type mesh__D001602sskos__Concept
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D001602 2005
% 208.06/208.23 |- skos__broader mesh__D001602smesh__D013832
% 208.06/208.23 |- mesh__dateRevised mesh__D001602 2003-07-09
% 208.06/208.23 |- skos__annotation mesh__D001602 caused by THIAMINE DEFICIENCY
% 208.06/208.23 |- mesh__recordMaintainer mesh__D001602 lkt
% 208.06/208.23 |- skos__prefLabel mesh__D001602 Beriberi
% 208.06/208.23 |- mesh__recordOriginator mesh__D001602 NLM
% 208.06/208.23 |- skos__scopeNote mesh__D001602
% 208.06/208.23 A disease caused by a deficiency of thiamine %28%vitamin B1%29% and characterized by polyneuritis, cardiac pathology, and edema. The epidemic form is found primarily in areas in which white %28%polished%29% rice is the staple food, as in Japan, China, the Philippines, India, and other countries of southeast Asia. %28%Dorland, 27th ed%29%%A%
% 208.06/208.23 |- skos__prefLabel mesh__D006896 Hydroxyethylrutoside
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006896 2006
% 208.06/208.23 |- mesh__recordMaintainer mesh__D006896 ssb
% 208.06/208.23 |- mesh__recordOriginator mesh__D006896 NLM
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D006896 91; was see under RUTIN 1975-90
% 208.06/208.23 |- skos__historyNote mesh__D006896 Rutin %28%1972-1974%29%
% 208.06/208.23 |- skos__hiddenLabel mesh__D006896 beta Hydroxyethylrutoside
% 208.06/208.23 |- skos__hiddenLabel mesh__D006896 0 beta Hydroxyethylrutoside
% 208.06/208.23 |- mesh__dateCreated mesh__D006896 1974-11-19
% 208.06/208.23 |- skos__altLabel mesh__D006896 beta-Hydroxyethylrutoside
% 208.06/208.23 |- mesh__dateEstablished mesh__D006896 1991-01-01
% 208.06/208.23 |- skos__scopeNote mesh__D006896
% 208.06/208.23 Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders.%A%
% 208.06/208.23 |- mesh__historyNote mesh__D006896
% 208.06/208.23 91%28%75%29%; was see under RUTIN 1975-90
% 208.06/208.23 |- mesh__dateRevised mesh__D006896 2005-06-30
% 208.06/208.23 |- skos__historyNote mesh__D006896 Alcohol, Ethyl %28%1972-1974%29%
% 208.06/208.23 |- rdf__type mesh__D006896sskos__Concept
% 208.06/208.23 |- skos__altLabel mesh__D006896 0-beta-Hydroxyethylrutoside
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D006896 sjn
% 208.06/208.23 |- skos__broader mesh__D006896smesh__D012431
% 208.06/208.23 |- skos__broader mesh__D020567smesh__D001835
% 208.06/208.23 |- skos__broader mesh__D020567smesh__D047109
% 208.06/208.23 |- mesh__historyNote mesh__D020567 2000
% 208.06/208.23 |- skos__scopeNote mesh__D020567
% 208.06/208.23 The weight of the FETUS in utero. It is usually estimated by various formulas based on measurements made during PRENATAL ULTRASONOGRAPHY.%A%
% 208.06/208.23 |- skos__historyNote mesh__D020567 Body Weight %28%1965-1999%29%
% 208.06/208.23 |- skos__related mesh__D020567smesh__D001724
% 208.06/208.23 |- skos__hiddenLabel mesh__D020567 Fetal Body Weights
% 208.06/208.23 |- mesh__recordMaintainer mesh__D020567 lkt
% 208.06/208.23 |- skos__hiddenLabel mesh__D020567 Body Weights, Fetal
% 208.06/208.23 |- mesh__dateEstablished mesh__D020567 2000-01-01
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D020567 2005
% 208.06/208.23 |- skos__altLabel mesh__D020567 Body Weight, Fetal
% 208.06/208.23 |- rdf__type mesh__D020567sskos__Concept
% 208.06/208.23 |- skos__hiddenLabel mesh__D020567 Weights, Fetal
% 208.06/208.23 |- mesh__recordOriginator mesh__D020567 ags
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D020567 2006
% 208.06/208.23 |- skos__prefLabel mesh__D020567 Fetal Weight
% 208.06/208.23 |- skos__hiddenLabel mesh__D020567 Fetal Weights
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D020567 sjn
% 208.06/208.23 |- skos__hiddenLabel mesh__D020567 Fetal Body Weight
% 208.06/208.23 |- skos__hiddenLabel mesh__D020567 Weight, Fetal
% 208.06/208.23 |- skos__historyNote mesh__D020567 Fetus %28%1965-1999%29%
% 208.06/208.23 |- mesh__dateCreated mesh__D020567 1999-11-03
% 208.06/208.23 |- mesh__dateRevised mesh__D020567 2004-07-07
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D020567 2000
% 208.06/208.23 |- skos__annotation mesh__D020567 mammalian only
% 208.06/208.23 |- skos__scopeNote mesh__D006098
% 208.06/208.23 Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS.%A%
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D006098 sjn
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006098 2006
% 208.06/208.23 |- skos__prefLabel mesh__D006098 Granulocytes
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006098 2005
% 208.06/208.23 |- mesh__recordOriginator mesh__D006098 NLM
% 208.06/208.23 |- mesh__onlineNote mesh__D006098 search LEUKOCYTES 1968-74
% 208.06/208.23 |- skos__broader mesh__D006098smesh__D007962
% 208.06/208.23 |- skos__broader mesh__D006098smesh__D001854
% 208.06/208.23 |- rdf__type mesh__D006098sskos__Concept
% 208.06/208.23 |- mesh__dateCreated mesh__D006098 1999-01-01
% 208.06/208.23 |- mesh__dateRevised mesh__D006098 2003-07-09
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006098 2004
% 208.06/208.23 |- mesh__recordMaintainer mesh__D006098 nns
% 208.06/208.23 |- mesh__historyNote mesh__D006098
% 208.06/208.23 79%28%75%29%; was see under LEUKOCYTES 1968-78
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D006098
% 208.06/208.23 79; was see under LEUKOCYTES 1968-78
% 208.06/208.23 |- skos__hiddenLabel mesh__D006098 Granulocyte
% 208.06/208.23 |- mesh__dateEstablished mesh__D006098 1979-01-01
% 208.06/208.23 |- skos__historyNote mesh__D006098 Leukocytes %28%1966-1974%29%
% 208.06/208.23 |- skos__broader mesh__D006098smesh__D022423
% 208.06/208.23 |- skos__altLabel mesh__D019215 Historical Biography
% 208.06/208.23 |- mesh__dateRevised mesh__D019215 2005-07-22
% 208.06/208.23 |- mesh__dateEstablished mesh__D019215 1997-01-01
% 208.06/208.23 |- skos__related mesh__D019215smesh__D020493
% 208.06/208.23 |- skos__annotation mesh__D019215
% 208.06/208.23 publication type only; check appropriate century tags; add also HISTORICAL ARTICLE %5B%Publication Type%5D%; Manual 32.16+, 32.17+; obituaries go here; biography as a subject is indexed under the main heading BIOGRAPHY; CATALOG: use for individual and collective biographies. For autobiographies, use PERSONAL NARRATIVES %5B%PUBLICATION TYPE%5D%.%A%
% 208.06/208.23 |- mesh__historyNote mesh__D019215
% 208.06/208.23 1997; CURRENT BIOG-OBIT was Publication Type 1991-1996, was Citation Type 1966-1990; HISTORICAL BIOGRAPHY was Publication Type 1991-1996, was Citation Type 1966-1990%A%
% 208.06/208.23 |- skos__related mesh__D019215smesh__D020467
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019215 2006
% 208.06/208.23 |- rdf__type mesh__D019215sskos__Concept
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D019215 ags
% 208.06/208.23 |- mesh__recordOriginator mesh__D019215 TGC
% 208.06/208.23 |- skos__broader mesh__D019215smesh__D052181
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019215 2006A
% 208.06/208.23 |- skos__historyNote mesh__D019215
% 208.06/208.23 Historical Biography %5B%Publication Type%5D% %28%1966-1996%29%
% 208.06/208.23 |- mesh__recordMaintainer mesh__D019215 ags
% 208.06/208.23 |- skos__scopeNote mesh__D019215
% 208.06/208.23 Works consisting of an account of the events, works, and achievements, personal and professional, during a person%27%s life. It includes articles on the activities and accomplishments of living persons as well as the presentation of an obituary.%A%
% 208.06/208.23 |- skos__prefLabel mesh__D019215 Biography %5B%Publication Type%5D%
% 208.06/208.23 |- skos__altLabel mesh__D019215 Current Biog-Obit
% 208.06/208.23 |- mesh__dateCreated mesh__D019215 1996-06-21
% 208.06/208.23 |- skos__historyNote mesh__D019215
% 208.06/208.23 Current Biog-Obit %5B%Publication Type%5D% %28%1966-1996%29%
% 208.06/208.23 |- skos__broader mesh__D019215smesh__D052180
% 208.06/208.23 |- skos__broader mesh__D019215smesh__D016456
% 208.06/208.23 |- skos__altLabel mesh__D019215 Biography %28%PT%29%
% 208.06/208.23 |- rdf__type mesh__D011232sskos__Concept
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D011232 66
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 2003
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1992
% 208.06/208.23 |- mesh__dateEstablished mesh__D011232 1966-01-01
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1997
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D011232 PLS
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 2004
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1998
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1993
% 208.06/208.23 |- skos__annotation mesh__D011232 NIM; no qualif
% 208.06/208.23 |- mesh__historyNote mesh__D011232 66%28%64%29%
% 208.06/208.23 |- skos__prefLabel mesh__D011232 Precipitation
% 208.06/208.23 |- skos__broader mesh__D011232smesh__D002627
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 2000
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 2005
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1994
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1999
% 208.06/208.23 |- mesh__recordMaintainer mesh__D011232 TGC
% 208.06/208.23 |- skos__hiddenLabel mesh__D011232 Precipitations
% 208.06/208.23 |- mesh__dateRevised mesh__D011232 1989-05-16
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 2001
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1990
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 2006
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1995
% 208.06/208.23 |- mesh__recordOriginator mesh__D011232 NLM
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 2002
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1991
% 208.06/208.23 |- mesh__dateCreated mesh__D011232 1999-01-01
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011232 1996
% 208.06/208.23 |- skos__historyNote mesh__D010938 Oils %28%1966-1986%29%
% 208.06/208.23 |- mesh__dateCreated mesh__D010938 1986-06-03
% 208.06/208.23 |- mesh__dateRevised mesh__D010938 2005-06-30
% 208.06/208.23 |- mesh__recordMaintainer mesh__D010938 DRC
% 208.06/208.23 |- rdf__type mesh__D010938sskos__Concept
% 208.06/208.23 |- skos__altLabel mesh__D010938 Vegetable Oils
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D010938 sjn
% 208.06/208.23 |- mesh__recordOriginator mesh__D010938 RLS
% 208.06/208.23 |- skos__annotation mesh__D010938
% 208.06/208.23 D25-26 qualif; coord IM with specific plant source of oil %28%IM or NIM%29% but not PLANTS; %22%yusho poisoning%22%: see note on RICE%A%
% 208.06/208.23 |- mesh__dateEstablished mesh__D010938 1987-01-01
% 208.06/208.23 |- mesh__historyNote mesh__D010938 87
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D010938 87; SESAME OIL was heading 1963-86
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010938 2006
% 208.06/208.23 |- skos__broader mesh__D010938smesh__D009821
% 208.06/208.23 |- skos__altLabel mesh__D010938 Oils, Plant
% 208.06/208.23 |- skos__broader mesh__D010938smesh__D028321
% 208.06/208.23 |- skos__scopeNote mesh__D010938
% 208.06/208.23 Oils derived from plants or plant products.
% 208.06/208.23 |- skos__prefLabel mesh__D010938 Plant Oils
% 208.06/208.23 |- mesh__dateCreated mesh__D029643 2001-07-25
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D029643 2006
% 208.06/208.23 |- rdf__type mesh__D029643sskos__Concept
% 208.06/208.23 |- mesh__dateEstablished mesh__D029643 2002-01-01
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D029643 sjn
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D029643 2004
% 208.06/208.23 |- skos__scopeNote mesh__D029643
% 208.06/208.23 A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida. The leaves of Sterculiaceae are alternate and simple or palmately compound. Flowers have three to five sepals and five or no petals.%A%
% 208.06/208.23 |- mesh__historyNote mesh__D029643 2002
% 208.06/208.23 |- mesh__dateRevised mesh__D029643 2003-07-09
% 208.06/208.23 |- mesh__recordMaintainer mesh__D029643 ssb
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D029643 2002
% 208.06/208.23 |- skos__broader mesh__D029643smesh__D019684
% 208.06/208.23 |- skos__prefLabel mesh__D029643 Sterculiaceae
% 208.06/208.23 |- skos__annotation mesh__D029643
% 208.06/208.23 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D029643 2005
% 208.06/208.23 |- mesh__recordOriginator mesh__D029643 ssb
% 208.06/208.23 |- mesh__historyNote mesh__D007191
% 208.06/208.23 91%28%71%29%; was see under PYRAZOLES 1971-90
% 208.06/208.23 |- rdf__type mesh__D007191sskos__Concept
% 208.06/208.23 |- mesh__dateRevised mesh__D007191 2005-06-30
% 208.06/208.23 |- mesh__dateEstablished mesh__D007191 1991-01-01
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D007191 sjn
% 208.06/208.23 |- mesh__dateCreated mesh__D007191 1999-01-01
% 208.06/208.23 |- mesh__recordMaintainer mesh__D007191 ssb
% 208.06/208.23 |- skos__historyNote mesh__D007191 Pyrazoles %28%1966-1970%29%
% 208.06/208.23 |- mesh__recordOriginator mesh__D007191 NLM
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D007191
% 208.06/208.23 91; was see under PYRAZOLES 1971-90
% 208.06/208.23 |- skos__broader mesh__D007191smesh__D006574
% 208.06/208.23 |- skos__prefLabel mesh__D007191 Indazoles
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D007191 2006
% 208.06/208.23 |- skos__broader mesh__D007191smesh__D011720
% 208.06/208.23 |- rdf__type mesh__D015623sskos__Concept
% 208.06/208.23 |- skos__scopeNote mesh__D015623
% 208.06/208.23 An approach to nutrition based on whole cereal grains, beans, cooked vegetables and the Chinese YIN-YANG principle. It advocates a diet consisting of organic and locally grown foods, seasonal vegetables, complex carbohydrates, and fewer fats, sugars, and chemically processed foods.%A%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D015623 2005
% 208.06/208.23 |- skos__prefLabel mesh__D015623 Diet, Macrobiotic
% 208.06/208.23 |- skos__hiddenLabel mesh__D015623 Macrobiotic Diet
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D015623 90
% 208.06/208.23 |- mesh__recordOriginator mesh__D015623 AGS
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D015623 2006
% 208.06/208.23 |- mesh__dateRevised mesh__D015623 2002-07-03
% 208.06/208.23 |- mesh__dateCreated mesh__D015623 1989-04-07
% 208.06/208.23 |- skos__broader mesh__D015623smesh__D014676
% 208.06/208.23 |- mesh__dateEstablished mesh__D015623 1990-01-01
% 208.06/208.23 |- mesh__recordMaintainer mesh__D015623 TAP
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D015623 sjn
% 208.06/208.23 |- mesh__historyNote mesh__D015623 90
% 208.06/208.23 |- skos__hiddenLabel mesh__D015623 Macrobiotic Diets
% 208.06/208.23 |- skos__hiddenLabel mesh__D015623 Diets, Macrobiotic
% 208.06/208.23 |- skos__annotation mesh__D015623 coord with specific disease /diet ther
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D015623 2003
% 208.06/208.23 |- skos__historyNote mesh__D015623 Diet Fads %28%1966-1989%29%
% 208.06/208.23 |- skos__historyNote mesh__D015623 Diet %28%1986-1989%29%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D015623 2004
% 208.06/208.23 |- skos__broader mesh__D001603smesh__D008671
% 208.06/208.23 |- mesh__dateRevised mesh__D001603 2005-06-30
% 208.06/208.23 |- mesh__recordMaintainer mesh__D001603 jmp
% 208.06/208.23 |- rdf__type mesh__D001603sskos__Concept
% 208.06/208.23 |- mesh__recordOriginator mesh__D001603 NLM
% 208.06/208.23 |- skos__broader mesh__D001603smesh__D019216
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D001603 sjn
% 208.06/208.23 |- mesh__dateCreated mesh__D001603 1999-01-01
% 208.06/208.23 |- skos__annotation mesh__D001603 man-made radioactive element; IM
% 208.06/208.23 |- skos__scopeNote mesh__D001603
% 208.06/208.23 Berkelium. A man-made radioactive actinide with atomic symbol Bk, atomic number 97, and atomic weight 247. Its valence can be +3 or +4. Twelve isotopes have been produced with mass numbers 240-251.%A%
% 208.06/208.23 |- skos__prefLabel mesh__D001603 Berkelium
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D001603 2006
% 208.06/208.23 |- skos__hiddenLabel mesh__D006897 Acid, 5-Hydroxyindolamine Acetic
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 2004
% 208.06/208.23 |- mesh__dateCreated mesh__D006897 1999-01-01
% 208.06/208.23 |- mesh__dateEstablished mesh__D006897 1966-01-01
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D006897 PLS
% 208.06/208.23 |- skos__hiddenLabel mesh__D006897 Acetic Acid, 5-Hydroxyindolamine
% 208.06/208.23 |- skos__altLabel mesh__D006897 5-Hydroxyindolamine Acetic Acid
% 208.06/208.23 |- skos__hiddenLabel mesh__D006897 5 Hydroxyindolamine Acetic Acid
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D006897 66
% 208.06/208.23 |- mesh__dateRevised mesh__D006897 1995-05-31
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 1998
% 208.06/208.23 |- mesh__recordOriginator mesh__D006897 NLM
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 2000
% 208.06/208.23 |- skos__hiddenLabel mesh__D006897 5 Hydroxy 3 Indoleacetic Acid
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 1999
% 208.06/208.23 |- mesh__recordMaintainer mesh__D006897 TPW
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 1996
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 2001
% 208.06/208.23 |- skos__altLabel mesh__D006897 5-HIAA
% 208.06/208.23 |- rdf__type mesh__D006897sskos__Concept
% 208.06/208.23 |- mesh__historyNote mesh__D006897 66%28%64%29%
% 208.06/208.23 |- skos__annotation mesh__D006897 DF: HIAA
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 1997
% 208.06/208.23 |- skos__hiddenLabel mesh__D006897 Acid, 5-Hydroxy-3-Indoleacetic
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 2005
% 208.06/208.23 |- skos__prefLabel mesh__D006897 Hydroxyindoleacetic Acid
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 2002
% 208.06/208.23 |- skos__broader mesh__D006897smesh__D007210
% 208.06/208.23 |- skos__hiddenLabel mesh__D006897 Acid, Hydroxyindoleacetic
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 2006
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006897 2003
% 208.06/208.23 |- skos__altLabel mesh__D006897 5-Hydroxy-3-Indoleacetic Acid
% 208.06/208.23 |- rdf__type mesh__D031290sskos__Concept
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D031290 2004
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D031290 2003
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D031290 2003
% 208.06/208.23 |- mesh__dateCreated mesh__D031290 2002-07-02
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D031290 2006
% 208.06/208.23 |- mesh__dateEstablished mesh__D031290 2003-01-01
% 208.06/208.23 |- mesh__historyNote mesh__D031290 2003
% 208.06/208.23 |- skos__annotation mesh__D031290
% 208.06/208.23 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.23 |- skos__broader mesh__D031290smesh__D007887
% 208.06/208.23 |- skos__prefLabel mesh__D031290 Butea
% 208.06/208.23 |- skos__scopeNote mesh__D031290
% 208.06/208.23 A plant genus of the family FABACEAE that contains butrin and isobutrin.%A%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D031290 2005
% 208.06/208.23 |- skos__scopeNote mesh__D006099
% 208.06/208.23 A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.%A%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006099 2005
% 208.06/208.23 |- skos__related mesh__D006099smesh__D014375
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D006099 sjn
% 208.06/208.23 |- rdf__type mesh__D006099sskos__Concept
% 208.06/208.23 |- mesh__dateCreated mesh__D006099 1999-01-01
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006099 2002
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006099 2004
% 208.06/208.23 |- mesh__recordOriginator mesh__D006099 NLM
% 208.06/208.23 |- skos__annotation mesh__D006099
% 208.06/208.23 GEN: prefer specifics; coord IM with organ/dis %28%IM%29%; malignant of nose = GRANULOMA, LETHAL MIDLINE; central giant cell granuloma %26% giant cell granuloma = GRANULOMA, GIANT CELL; granulomatous dis or granulomatous dis of childhood = GRANULOMATOUS DISEASE, CHRONIC; cholesterol granuloma = GRANULOMA, FOREIGN BODY %28%IM%29% + CHOLESTEROL %28%IM%29%; talc granuloma = GRANULOMA, FOREIGN BODY /etiol %28%not/chem ind%29% + TALC /adv eff; xanthogranuloma = XANTHOMATOSIS %28%IM%29% + GRANULOMA %28%IM%29% but XANTHOGRANULOMA, JUVENILE is available%A%
% 208.06/208.23 |- skos__altLabel mesh__D006099 Granulomas
% 208.06/208.23 |- skos__prefLabel mesh__D006099 Granuloma
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006099 2003
% 208.06/208.23 |- mesh__recordMaintainer mesh__D006099 KEV
% 208.06/208.23 |- skos__broader mesh__D006099smesh__D010335
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006099 2001
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006099 2006
% 208.06/208.23 |- mesh__dateRevised mesh__D006099 1999-11-03
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D006099 2000
% 208.06/208.23 |- skos__broader mesh__D006099smesh__D008232
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019216 2006
% 208.06/208.23 |- mesh__dateCreated mesh__D019216 1996-06-20
% 208.06/208.23 |- mesh__dateRevised mesh__D019216 1997-06-20
% 208.06/208.23 |- skos__broader mesh__D019216smesh__D004602
% 208.06/208.23 |- rdf__type mesh__D019216sskos__Concept
% 208.06/208.23 |- mesh__recordOriginator mesh__D019216 JLS
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019216 1998
% 208.06/208.23 |- skos__historyNote mesh__D019216 Metals or specifics %28%1966-1996%29%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019216 2003
% 208.06/208.23 |- mesh__dateEstablished mesh__D019216 1997-01-01
% 208.06/208.23 |- skos__broader mesh__D019216smesh__D008670
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019216 2000
% 208.06/208.23 |- skos__scopeNote mesh__D019216
% 208.06/208.23 Metals with high specific gravity, typically larger than 5. They have complex spectra, form colored salts and double salts, have a low electrode potential, are mainly amphoteric, yield weak bases and weak acids, and are oxidizing or reducing agents %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%
% 208.06/208.23 |- mesh__historyNote mesh__D019216 97
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019216 1999
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D019216 SJN
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019216 2004
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019216 2001
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D019216 97
% 208.06/208.23 |- skos__prefLabel mesh__D019216 Metals, Heavy
% 208.06/208.23 |- mesh__recordMaintainer mesh__D019216 TGC
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019216 2005
% 208.06/208.23 |- skos__altLabel mesh__D019216 Heavy Metals
% 208.06/208.23 |- mesh__onlineNote mesh__D019216
% 208.06/208.23 pre-explosion - METALS, HEAVY %28%PX%29%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D019216 2002
% 208.06/208.23 |- skos__annotation mesh__D019216 GEN: prefer specifics
% 208.06/208.23 |- mesh__recordOriginator mesh__D011233 NLM
% 208.06/208.23 |- skos__broader mesh__D011233smesh__D047468
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011233 2006
% 208.06/208.23 |- skos__prefLabel mesh__D011233 Precipitin Tests
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D011233 sjn
% 208.06/208.23 |- skos__hiddenLabel mesh__D011233 Test, Precipitin
% 208.06/208.23 |- mesh__dateCreated mesh__D011233 1999-01-01
% 208.06/208.23 |- skos__hiddenLabel mesh__D011233 Tests, Precipitin
% 208.06/208.23 |- mesh__recordMaintainer mesh__D011233 nns
% 208.06/208.23 |- rdf__type mesh__D011233sskos__Concept
% 208.06/208.23 |- skos__broader mesh__D011233smesh__D012698
% 208.06/208.23 |- skos__hiddenLabel mesh__D011233 Precipitin Test
% 208.06/208.23 |- mesh__dateRevised mesh__D011233 2004-07-07
% 208.06/208.23 |- skos__scopeNote mesh__D011233
% 208.06/208.23 Serologic tests in which a positive reaction manifested by visible precipitation occurs when a soluble ANTIGEN reacts with its ANTIBODIES.%A%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D011233 2005
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D035681 2006
% 208.06/208.23 |- skos__annotation mesh__D035681
% 208.06/208.23 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D035681 2005
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D035681 2003
% 208.06/208.23 |- mesh__dateEstablished mesh__D035681 2003-01-01
% 208.06/208.23 |- skos__prefLabel mesh__D035681 Adiantum
% 208.06/208.23 |- mesh__dateCreated mesh__D035681 2002-07-02
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D035681 2004
% 208.06/208.23 |- skos__broader mesh__D035681smesh__D029625
% 208.06/208.23 |- rdf__type mesh__D035681sskos__Concept
% 208.06/208.23 |- skos__scopeNote mesh__D035681
% 208.06/208.23 A plant genus of the family Pteridaceae. Members contain TRITERPENES. Some species in this genus are called maidenhair fern which is also a common name occasionally used for Lygodium %28%FERNS%29% and POLYPODIUM.%A%
% 208.06/208.23 |- mesh__historyNote mesh__D035681 2003
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D035681 2003
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D029644 2002
% 208.06/208.23 |- skos__annotation mesh__D029644
% 208.06/208.23 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.23 |- mesh__publicMeSHNote mesh__D029644 2002
% 208.06/208.23 |- skos__prefLabel mesh__D029644 Styracaceae
% 208.06/208.23 |- mesh__dateCreated mesh__D029644 2001-07-25
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D029644 2005
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D029644 2003
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D029644 2006
% 208.06/208.23 |- rdf__type mesh__D029644sskos__Concept
% 208.06/208.23 |- mesh__historyNote mesh__D029644 2002
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D029644 2004
% 208.06/208.23 |- skos__broader mesh__D029644smesh__D019684
% 208.06/208.23 |- skos__scopeNote mesh__D029644
% 208.06/208.23 A plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida.%A%
% 208.06/208.23 |- mesh__dateEstablished mesh__D029644 2002-01-01
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010939 2003
% 208.06/208.23 |- mesh__recordMaintainer mesh__D010939 TGC
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010939 2002
% 208.06/208.23 |- skos__prefLabel mesh__D010939 Plant Poisoning
% 208.06/208.23 |- skos__altLabel mesh__D010939 Poisoning, Plant
% 208.06/208.23 |- rdf__type mesh__D010939sskos__Concept
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010939 2004
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010939 2005
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010939 1998
% 208.06/208.23 |- skos__broader mesh__D010939smesh__D011041
% 208.06/208.23 |- skos__annotation mesh__D010939
% 208.06/208.23 human %26% animal; coord IM with specific plant %28%IM%29% + specific dis /etiol %28%IM%29%; do not coord with food plants in Cat J: index under specific Cat J2 food plant /pois %28%IM%29%, as FRUIT /pois or GARLIC /pois but not also here; Jamaican vomiting sickness: index PLANT POISONING + HYPOGLYCINS /pois%A%
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010939 2006
% 208.06/208.23 |- mesh__dateCreated mesh__D010939 1999-01-01
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010939 1999
% 208.06/208.23 |- skos__scopeNote mesh__D010939
% 208.06/208.23 Poisoning by the ingestion of plants or its leaves, berries, roots or stalks. The manifestations in both humans and animals vary in severity from mild to life threatening. In animals, especially domestic animals, it is usually the result of ingesting moldy or fermented forage.%A%
% 208.06/208.23 |- skos__hiddenLabel mesh__D010939 Poisonings, Plant
% 208.06/208.23 |- mesh__recordOriginator mesh__D010939 NLM
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010939 2000
% 208.06/208.23 |- mesh__recordAuthorizer mesh__D010939 SJN
% 208.06/208.23 |- mesh__activeMeSHYear mesh__D010939 2001
% 208.06/208.24 |- mesh__dateRevised mesh__D010939 1997-06-20
% 208.06/208.24 |- skos__hiddenLabel mesh__D010939 Plant Poisonings
% 208.06/208.24 |- skos__prefLabel mesh__D007990 Libraries
% 208.06/208.24 |- rdf__type mesh__D007990sskos__Concept
% 208.06/208.24 |- skos__scopeNote mesh__D007990
% 208.06/208.24 Collections of organized information for study and reference.%A%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007990 2001
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D007990 sjn
% 208.06/208.24 |- mesh__recordOriginator mesh__D007990 NLM
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007990 2005
% 208.06/208.24 |- skos__broader mesh__D007990smesh__D007253
% 208.06/208.24 |- skos__annotation mesh__D007990 IM; specify geog or other site
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007990 2006
% 208.06/208.24 |- mesh__dateCreated mesh__D007990 1999-01-01
% 208.06/208.24 |- mesh__recordMaintainer mesh__D007990 kle
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007990 2002
% 208.06/208.24 |- skos__hiddenLabel mesh__D007990 Library
% 208.06/208.24 |- mesh__dateRevised mesh__D007990 1999-11-03
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007990 2003
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007990 2004
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007990 2000
% 208.06/208.24 |- skos__hiddenLabel mesh__D021661 Organization, Management Service
% 208.06/208.24 |- mesh__dateCreated mesh__D021661 2000-06-22
% 208.06/208.24 |- skos__hiddenLabel mesh__D021661 Management Service Organization
% 208.06/208.24 |- rdf__type mesh__D021661sskos__Concept
% 208.06/208.24 |- skos__broader mesh__D021661smesh__D011364
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D021661 2006
% 208.06/208.24 |- mesh__recordMaintainer mesh__D021661 jls
% 208.06/208.24 |- mesh__dateRevised mesh__D021661 2004-07-28
% 208.06/208.24 |- mesh__dateEstablished mesh__D021661 2001-01-01
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D021661 jls
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D021661 2002
% 208.06/208.24 |- skos__hiddenLabel mesh__D021661 Service Organizations, Management
% 208.06/208.24 |- skos__scopeNote mesh__D021661
% 208.06/208.24 Voluntarily-formed groups of healthcare professionals who join for common management services and other benefits such as collective bargaining agreements with reimbursement agents. The physical assets of a practice are controlled by the MSO which also provides billing, collections, and similar services. The practitioner retains control of patient records and management of patient care.%A%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D021661 2003
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D021661 2005A
% 208.06/208.24 |- mesh__recordOriginator mesh__D021661 jls
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D021661 2004
% 208.06/208.24 |- skos__altLabel mesh__D021661 Organizations, Management Service
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D021661 2005B
% 208.06/208.24 |- skos__prefLabel mesh__D021661 Management Service Organizations
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D021661 2001
% 208.06/208.24 |- skos__hiddenLabel mesh__D021661 Service Organization, Management
% 208.06/208.24 |- mesh__historyNote mesh__D021661
% 208.06/208.24 2001; use HOSPITAL-PHYSICIAN JOINT VENTURES 1996-2000
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D021661 2005
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 1997
% 208.06/208.24 |- skos__annotation mesh__D007192 aromatic hydrocarbons
% 208.06/208.24 |- mesh__dateEstablished mesh__D007192 1968-01-01
% 208.06/208.24 |- mesh__dateCreated mesh__D007192 1999-01-01
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 2002
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 1999
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D007192 68
% 208.06/208.24 |- mesh__dateRevised mesh__D007192 1993-06-03
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 1996
% 208.06/208.24 |- mesh__recordMaintainer mesh__D007192 PLS
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 2001
% 208.06/208.24 |- skos__prefLabel mesh__D007192 Indenes
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 1998
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 2004
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 1995
% 208.06/208.24 |- mesh__historyNote mesh__D007192 68
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 2000
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 2006
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D007192 PLS
% 208.06/208.24 |- skos__scopeNote mesh__D007192
% 208.06/208.24 A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.%A%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 2003
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 1994
% 208.06/208.24 |- rdf__type mesh__D007192sskos__Concept
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007192 2005
% 208.06/208.24 |- skos__broader mesh__D007192smesh__D011084
% 208.06/208.24 |- mesh__recordOriginator mesh__D007192 NLM
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Eaton-Lambert Myopathic-Myasthenic Syndromes
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Eaton-Lambert Myopathic-Myasthenic Syndrome
% 208.06/208.24 |- skos__altLabel mesh__D015624
% 208.06/208.24 Myopathic-Myasthenic Syndrome of Lambert-Eaton
% 208.06/208.24 |- skos__broader mesh__D015624smesh__D020511
% 208.06/208.24 |- skos__historyNote mesh__D015624 Muscular Diseases %28%1967-1988%29%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015624 2004
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Lambert-Eaton Myopathic-Myasthenic Syndromes
% 208.06/208.24 |- skos__historyNote mesh__D015624 Myasthenia Gravis %28%1980-1989%29%
% 208.06/208.24 |- mesh__recordMaintainer mesh__D015624 KEV
% 208.06/208.24 |- skos__altLabel mesh__D015624 Eaton-Lambert Myasthenic Syndrome
% 208.06/208.24 |- skos__broader mesh__D015624smesh__D020274
% 208.06/208.24 |- skos__altLabel mesh__D015624 Myasthenic Syndrome, Lambert-Eaton
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D015624 1990
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015624 2003
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Eaton Lambert Myasthenic Syndrome
% 208.06/208.24 |- mesh__dateCreated mesh__D015624 1989-04-07
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Syndrome, Eaton-Lambert
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015624 2002
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Myasthenic Myopathic Syndrome of Eaton Lambert
% 208.06/208.24 |- skos__broader mesh__D015624smesh__D001327
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Myasthenic Syndrome, Lambert Eaton
% 208.06/208.24 |- skos__broader mesh__D015624smesh__D020361
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Eaton-Lambert Myasthenic-Myopathic Syndrome
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Myasthenic Syndrome, Eaton-Lambert
% 208.06/208.24 |- mesh__historyNote mesh__D015624 1990
% 208.06/208.24 |- skos__historyNote mesh__D015624 Neuromuscular Diseases %28%1980-1989%29%
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Lambert-Eaton Myasthenic-Myopathic Syndromes
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Lambert-Eaton Myopathic-Myasthenic Syndrome
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Syndrome, Lambert-Eaton Myasthenic
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D015624 sjn
% 208.06/208.24 |- skos__altLabel mesh__D015624 Eaton-Lambert Syndrome
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Eaton Lambert Syndrome
% 208.06/208.24 |- mesh__dateEstablished mesh__D015624 1990-01-01
% 208.06/208.24 |- mesh__dateRevised mesh__D015624 1999-11-03
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015624 2001
% 208.06/208.24 |- skos__altLabel mesh__D015624
% 208.06/208.24 Myasthenic-Myopathic Syndrome of Eaton-Lambert
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015624 2006
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Lambert Eaton Syndrome
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015624 2000
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Lambert-Eaton Myasthenic-Myopathic Syndrome
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Syndrome, Lambert-Eaton
% 208.06/208.24 |- skos__prefLabel mesh__D015624 Lambert-Eaton Myasthenic Syndrome
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Myopathic Myasthenic Syndrome of Eaton Lambert
% 208.06/208.24 |- skos__scopeNote mesh__D015624
% 208.06/208.24 An autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle, lower extremities, trunk, and shoulder girdle. There is relative sparing of extraocular and bulbar muscles. CARCINOMA, SMALL CELL of the lung is a frequently associated condition, although other malignancies and autoimmune diseases may be associated. Muscular weakness results from impaired impulse transmission at the NEUROMUSCULAR JUNCTION. Presynaptic calcium channel dysfunction leads to a reduced amount of acetylcholine being released in response to stimulation of the nerve. %28%From Adams et al., Principles of Neurology, 6th ed, pp 1471%29%%A%
% 208.06/208.24 |- rdf__type mesh__D015624sskos__Concept
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015624 2005
% 208.06/208.24 |- skos__altLabel mesh__D015624 Lambert-Eaton Syndrome
% 208.06/208.24 |- skos__altLabel mesh__D015624
% 208.06/208.24 Myasthenic-Myopathic Syndrome of Lambert-Eaton
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Syndrome, Eaton-Lambert Myasthenic
% 208.06/208.24 |- skos__altLabel mesh__D015624
% 208.06/208.24 Myopathic-Myasthenic Syndrome of Eaton-Lambert
% 208.06/208.24 |- mesh__recordOriginator mesh__D015624 PXP
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624
% 208.06/208.24 Myasthenic Myopathic Syndrome of Lambert Eaton
% 208.06/208.24 |- skos__hiddenLabel mesh__D015624 Lambert Eaton Myasthenic Syndrome
% 208.06/208.24 |- skos__historyNote mesh__D015624 Neuromuscular Junction %28%1980-1986%29%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 2005
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 2003
% 208.06/208.24 |- skos__broader mesh__D001604smesh__D002947
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 2001
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 2000
% 208.06/208.24 |- mesh__dateRevised mesh__D001604 1989-07-13
% 208.06/208.24 |- mesh__recordMaintainer mesh__D001604 PLS
% 208.06/208.24 |- mesh__dateCreated mesh__D001604 1999-01-01
% 208.06/208.24 |- skos__prefLabel mesh__D001604 Berlin
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1995
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1991
% 208.06/208.24 |- mesh__recordOriginator mesh__D001604 NLM
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1993
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1999
% 208.06/208.24 |- skos__annotation mesh__D001604
% 208.06/208.24 includes East or West Berlin; for historical or modern Berlin%A%
% 208.06/208.24 |- skos__broader mesh__D001604smesh__D005858
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1994
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1997
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 2006
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 2002
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1992
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D001604 PLS
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1998
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 2004
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1996
% 208.06/208.24 |- rdf__type mesh__D001604sskos__Concept
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001604 1990
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D006898 2004
% 208.06/208.24 |- skos__prefLabel mesh__D006898 Hydroxylamines
% 208.06/208.24 |- mesh__dateRevised mesh__D006898 1997-06-20
% 208.06/208.24 |- mesh__dateCreated mesh__D006898 1999-01-01
% 208.06/208.24 |- skos__broader mesh__D006898smesh__D000588
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D006898 2006
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D006898 2003
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D006898 2005
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D006898 2002
% 208.06/208.24 |- mesh__recordMaintainer mesh__D006898 ADP
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D006898 SJN
% 208.06/208.24 |- skos__scopeNote mesh__D006898
% 208.06/208.24 Organic compounds that contain the %28%-NH2OH%29% radical.
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D006898 2001
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D006898 1999
% 208.06/208.24 |- mesh__recordOriginator mesh__D006898 NLM
% 208.06/208.24 |- rdf__type mesh__D006898sskos__Concept
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D006898 2000
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D006898 1998
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 Proteins, c-rel
% 208.06/208.24 |- mesh__dateEstablished mesh__D020569 2000-01-01
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 rel Proto Oncogene Product p68
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 Protein, c-rel
% 208.06/208.24 |- mesh__dateCreated mesh__D020569 1999-11-08
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 c-rel, Proto-Oncogene Proteins
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 Proto Oncogene Proteins c rel
% 208.06/208.24 |- skos__altLabel mesh__D020569 Proto-Oncogene Proteins rel
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 Proto Oncogene Proteins rel
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 Proto-Oncogene Proteins, rel
% 208.06/208.24 |- skos__altLabel mesh__D020569 p68 c-rel
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 rel Proto Oncogene Proteins
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D020569 sjn
% 208.06/208.24 |- skos__altLabel mesh__D020569 p68%28%c-rel%29%
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 c-rel, Proto-Oncogene Protein
% 208.06/208.24 |- skos__scopeNote mesh__D020569
% 208.06/208.24 Cellular DNA-binding proteins encoded by the rel gene %28%GENES, REL%29%. They are expressed predominately in hematopoietic cells and may play a role in lymphocyte differentiation. Rel frequently combines with other related proteins %28%NF-KAPPA B, I-kappa B, relA%29% to form heterodimers that regulate transcription. Rearrangement or overexpression of c-rel can cause tumorigenesis.%A%
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 c-rel, p68
% 208.06/208.24 |- skos__historyNote mesh__D020569
% 208.06/208.24 Proto-Oncogene Proteins %28%1988-1999%29%
% 208.06/208.24 |- mesh__historyNote mesh__D020569
% 208.06/208.24 2000; use PROTO-ONCOGENE PROTEINS C-REL %28%NM%29% 1988-1999
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 Proto Oncogene Products c rel
% 208.06/208.24 |- skos__broader mesh__D020569smesh__D014157
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D020569 2006
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 p68 c rel
% 208.06/208.24 |- skos__altLabel mesh__D020569 rel Proto-Oncogene Proteins
% 208.06/208.24 |- skos__altLabel mesh__D020569 c-rel Protein
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 c rel Protein
% 208.06/208.24 |- skos__prefLabel mesh__D020569 Proto-Oncogene Proteins c-rel
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 c-rel, Proto-Oncogene Products
% 208.06/208.24 |- mesh__dateRevised mesh__D020569 2005-06-30
% 208.06/208.24 |- skos__related mesh__D020569smesh__D020573
% 208.06/208.24 |- skos__related mesh__D020569smesh__D020672
% 208.06/208.24 |- mesh__recordOriginator mesh__D020569 ags
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 Proto Oncogene Protein c rel
% 208.06/208.24 |- mesh__recordMaintainer mesh__D020569 DRC
% 208.06/208.24 |- skos__broader mesh__D020569smesh__D004268
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D020569
% 208.06/208.24 2000; PROTO-ONCOGENE PROTEIN C-REL was indexed under PROTO-ONCOGENE PROTEINS 1988-1999%A%
% 208.06/208.24 |- skos__altLabel mesh__D020569 Proto-Oncogene Protein c-rel
% 208.06/208.24 |- skos__altLabel mesh__D020569 rel Proto-Oncogene Product p68
% 208.06/208.24 |- skos__broader mesh__D020569smesh__D009687
% 208.06/208.24 |- skos__broader mesh__D020569smesh__D011518
% 208.06/208.24 |- skos__hiddenLabel mesh__D020569 c rel Proteins
% 208.06/208.24 |- skos__altLabel mesh__D020569 c-rel Proteins
% 208.06/208.24 |- skos__altLabel mesh__D020569 Proto-Oncogene Products c-rel
% 208.06/208.24 |- rdf__type mesh__D020569sskos__Concept
% 208.06/208.24 |- mesh__dateCreated mesh__D031291 2002-07-03
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D031291 2006
% 208.06/208.24 |- skos__annotation mesh__D031291
% 208.06/208.24 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.24 |- skos__broader mesh__D031291smesh__D007887
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D031291 2005
% 208.06/208.24 |- mesh__dateEstablished mesh__D031291 2003-01-01
% 208.06/208.24 |- rdf__type mesh__D031291sskos__Concept
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D031291 2004
% 208.06/208.24 |- skos__prefLabel mesh__D031291 Castanospermum
% 208.06/208.24 |- skos__scopeNote mesh__D031291
% 208.06/208.24 A plant genus of the family FABACEAE that contains castanospermines, swainsonine, and triterpenoid saponins.%A%
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D031291 2003
% 208.06/208.24 |- mesh__historyNote mesh__D031291 2003
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D031291 2003
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 2004
% 208.06/208.24 |- skos__historyNote mesh__D019217 Tooth Abrasion %28%1966-1996%29%
% 208.06/208.24 |- skos__broader mesh__D019217smesh__D014076
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 2002
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 1997
% 208.06/208.24 |- mesh__onlineNote mesh__D019217
% 208.06/208.24 use TOOTH ABRASION to search DENTAL ATTRITION 1976-96
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 2005
% 208.06/208.24 |- mesh__dateEstablished mesh__D019217 1997-01-01
% 208.06/208.24 |- skos__annotation mesh__D019217
% 208.06/208.24 result of tooth-to-tooth contact as in mastication: do not confuse with TOOTH EROSION %28%result of chem action without bact action%29% or TOOTH ABRASION %28%loss of substance from friction like bruxism%29%: read MeSH definitions%A%
% 208.06/208.24 |- skos__scopeNote mesh__D019217
% 208.06/208.24 The wearing away of a tooth as a result of tooth-to-tooth contact, as in mastication, occurring only on the occlusal, incisal, and proximal surfaces. It is chiefly associated with aging. It is differentiated from TOOTH ABRASION %28%the pathologic wearing away of the tooth substance by friction, as brushing, bruxism, clenching, and other mechanical causes%29% and from TOOTH EROSION %28%the loss of substance caused by chemical action without bacterial action%29%. %28%Jablonski, Dictionary of Dentistry, 1992, p86%29%%A%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 2006
% 208.06/208.24 |- mesh__dateCreated mesh__D019217 1996-06-10
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 2000
% 208.06/208.24 |- rdf__type mesh__D019217sskos__Concept
% 208.06/208.24 |- skos__altLabel mesh__D019217 Dental Attrition
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D019217
% 208.06/208.24 97; DENTAL ATTRITION was see TOOTH ABRASION 1976-96
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 1998
% 208.06/208.24 |- skos__altLabel mesh__D019217 Attrition, Dental
% 208.06/208.24 |- skos__prefLabel mesh__D019217 Tooth Attrition
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 2003
% 208.06/208.24 |- skos__hiddenLabel mesh__D019217 Attrition, Tooth
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 2001
% 208.06/208.24 |- mesh__historyNote mesh__D019217
% 208.06/208.24 97; DENTAL ATTRITION was see TOOTH ABRASION 1976-96
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D019217 1999
% 208.06/208.24 |- skos__hiddenLabel mesh__D011234 Precipitates, Immune
% 208.06/208.24 |- mesh__dateCreated mesh__D011234 1999-01-01
% 208.06/208.24 |- mesh__recordOriginator mesh__D011234 NLM
% 208.06/208.24 |- skos__prefLabel mesh__D011234 Precipitins
% 208.06/208.24 |- rdf__type mesh__D011234sskos__Concept
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D011234 sjn
% 208.06/208.24 |- mesh__dateRevised mesh__D011234 2005-06-30
% 208.06/208.24 |- skos__scopeNote mesh__D011234
% 208.06/208.24 Antibodies which elicit IMMUNOPRECIPITATION when combined with antigen.%A%
% 208.06/208.24 |- skos__broader mesh__D011234smesh__D000906
% 208.06/208.24 |- mesh__recordMaintainer mesh__D011234 ssb
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D011234 2006
% 208.06/208.24 |- mesh__dateCreated mesh__D035682 2002-07-03
% 208.06/208.24 |- skos__prefLabel mesh__D035682 Gnetophyta
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D035682 2003; see GYMNOSPERMS 1998-2002
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D035682 2004
% 208.06/208.24 |- rdf__type mesh__D035682sskos__Concept
% 208.06/208.24 |- skos__broader mesh__D035682smesh__D019681
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D035682 2003
% 208.06/208.24 |- mesh__dateEstablished mesh__D035682 2003-01-01
% 208.06/208.24 |- mesh__historyNote mesh__D035682 2003; use GYMNOSPERMS 1998-2002
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D035682 2006
% 208.06/208.24 |- skos__historyNote mesh__D035682 Gymnosperms %28%1998-2002%29%
% 208.06/208.24 |- skos__annotation mesh__D035682
% 208.06/208.24 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.24 |- skos__scopeNote mesh__D035682
% 208.06/208.24 A plant division of seed plants containing only a few members.%A%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D035682 2005
% 208.06/208.24 |- skos__broader mesh__D007991smesh__D007990
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007991 2003
% 208.06/208.24 |- mesh__dateRevised mesh__D007991 1999-11-03
% 208.06/208.24 |- rdf__type mesh__D007991sskos__Concept
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007991 2002
% 208.06/208.24 |- skos__altLabel mesh__D007991 Dental Libraries
% 208.06/208.24 |- mesh__historyNote mesh__D007991 65
% 208.06/208.24 |- skos__altLabel mesh__D007991 Dental Library
% 208.06/208.24 |- mesh__recordOriginator mesh__D007991 NLM
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D007991 sjn
% 208.06/208.24 |- skos__altLabel mesh__D007991 Library, Dental
% 208.06/208.24 |- skos__prefLabel mesh__D007991 Libraries, Dental
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007991 2006
% 208.06/208.24 |- skos__annotation mesh__D007991
% 208.06/208.24 IM; specify geog or other site; DF: LIBRARIES DENT
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007991 2004
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007991 2001
% 208.06/208.24 |- mesh__dateCreated mesh__D007991 1999-01-01
% 208.06/208.24 |- mesh__dateEstablished mesh__D007991 1965-01-01
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007991 2005
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007991 2000
% 208.06/208.24 |- mesh__recordMaintainer mesh__D007991 kle
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D007991 65
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D029645 2002
% 208.06/208.24 |- skos__broader mesh__D029645smesh__D019684
% 208.06/208.24 |- mesh__recordMaintainer mesh__D029645 ssb
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D029645 2005
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D029645 2006
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D029645 2003
% 208.06/208.24 |- rdf__type mesh__D029645sskos__Concept
% 208.06/208.24 |- mesh__recordOriginator mesh__D029645 ssb
% 208.06/208.24 |- skos__annotation mesh__D029645
% 208.06/208.24 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.24 |- mesh__dateCreated mesh__D029645 2001-07-25
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D029645 2004
% 208.06/208.24 |- mesh__dateRevised mesh__D029645 2002-07-02
% 208.06/208.24 |- skos__prefLabel mesh__D029645 Thymelaeaceae
% 208.06/208.24 |- mesh__dateEstablished mesh__D029645 2002-01-01
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D029645 sjn
% 208.06/208.24 |- skos__scopeNote mesh__D029645
% 208.06/208.24 A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mainly trees and shrubs. Many members contain mucilage and COUMARINS.%A%
% 208.06/208.24 |- mesh__historyNote mesh__D029645 2002
% 208.06/208.24 |- skos__altLabel mesh__D007193 Association, Individual Practice
% 208.06/208.24 |- skos__hiddenLabel mesh__D007193
% 208.06/208.24 IPAs %28%Independent Practice Association%29%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 1996
% 208.06/208.24 |- skos__altLabel mesh__D007193 Individual Practice Associations
% 208.06/208.24 |- skos__altLabel mesh__D007193 IPA %28%Individual Practice Association%29%
% 208.06/208.24 |- skos__altLabel mesh__D007193 Practice Association, Individual
% 208.06/208.24 |- skos__prefLabel mesh__D007193 Independent Practice Associations
% 208.06/208.24 |- mesh__dateRevised mesh__D007193 1994-05-12
% 208.06/208.24 |- skos__scopeNote mesh__D007193
% 208.06/208.24 A partnership, corporation, association, or other legal entity that enters into an arrangement for the provision of services with persons who are licensed to practice medicine, osteopathy, and dentistry, and with other care personnel. Under an IPA arrangement, licensed professional persons provide services through the entity in accordance with a mutually accepted compensation arrangement, while retaining their private practices. Services under the IPA are marketed through a prepaid health plan. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A%
% 208.06/208.24 |- rdf__type mesh__D007193sskos__Concept
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 2001
% 208.06/208.24 |- skos__hiddenLabel mesh__D007193 Practice Associations, Individual
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 2005
% 208.06/208.24 |- mesh__dateCreated mesh__D007193 1987-05-02
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 1997
% 208.06/208.24 |- skos__hiddenLabel mesh__D007193 Independent Practice Association
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 2002
% 208.06/208.24 |- skos__broader mesh__D007193smesh__D011331
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 2006
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 2003
% 208.06/208.24 |- mesh__historyNote mesh__D007193
% 208.06/208.24 92; was INDEPENDENT PRACTICE ASSOCIATION 1988-91 %28%see under PRIVATE PRACTICE 1988-90%29%%A%
% 208.06/208.24 |- skos__hiddenLabel mesh__D007193
% 208.06/208.24 IPAs %28%Individual Practice Association%29%
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D007193 PLS
% 208.06/208.24 |- mesh__recordOriginator mesh__D007193 EC
% 208.06/208.24 |- skos__altLabel mesh__D007193 Practice Association, Independent
% 208.06/208.24 |- skos__altLabel mesh__D007193 Association, Independent Practice
% 208.06/208.24 |- skos__hiddenLabel mesh__D007193 Individual Practice Association
% 208.06/208.24 |- mesh__onlineNote mesh__D007193
% 208.06/208.24 use INDEPENDENT PRACTICE ASSOCIATIONS to search INDEPENDENT PRACTICE ASSOCIATION 1988-91%A%
% 208.06/208.24 |- skos__annotation mesh__D007193 DF: IPA
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 2004
% 208.06/208.24 |- skos__broader mesh__D007193smesh__D006123
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 1998
% 208.06/208.24 |- skos__altLabel mesh__D007193
% 208.06/208.24 IPA %28%Independent Practice Association%29%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 1995
% 208.06/208.24 |- skos__hiddenLabel mesh__D007193 Associations, Independent Practice
% 208.06/208.24 |- mesh__dateEstablished mesh__D007193 1991-01-01
% 208.06/208.24 |- skos__broader mesh__D007193smesh__D008329
% 208.06/208.24 |- skos__hiddenLabel mesh__D007193 Associations, Individual Practice
% 208.06/208.24 |- skos__hiddenLabel mesh__D007193 Practice Associations, Independent
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 2000
% 208.06/208.24 |- mesh__recordMaintainer mesh__D007193 PLS
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D007193
% 208.06/208.24 92; was INDEPENDENT PRACTICE ASSOCIATION 1988-91 %28%see under PRIVATE PRACTICE 1988-90%29%%A%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D007193 1999
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015625 2001
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015625 2005
% 208.06/208.24 |- mesh__dateEstablished mesh__D015625 1990-01-01
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015625 1998
% 208.06/208.24 |- skos__hiddenLabel mesh__D015625 Expander, Tissue
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015625 2002
% 208.06/208.24 |- skos__broader mesh__D015625smesh__D013523
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015625 2006
% 208.06/208.24 |- skos__hiddenLabel mesh__D015625 Expanders, Tissue
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015625 1999
% 208.06/208.24 |- mesh__dateRevised mesh__D015625 1997-06-20
% 208.06/208.24 |- mesh__recordOriginator mesh__D015625 AGS
% 208.06/208.24 |- skos__broader mesh__D015625smesh__D019736
% 208.06/208.24 |- mesh__recordMaintainer mesh__D015625 PXP
% 208.06/208.24 |- skos__hiddenLabel mesh__D015625 Tissue Expander
% 208.06/208.24 |- skos__historyNote mesh__D015625 Implants, Artificial %28%1983-1989%29%
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015625 2003
% 208.06/208.24 |- mesh__dateCreated mesh__D015625 1989-04-07
% 208.06/208.24 |- mesh__recordAuthorizer mesh__D015625 SJN
% 208.06/208.24 |- skos__scopeNote mesh__D015625
% 208.06/208.24 Inflatable reservoirs, usually made of silicone, which are implanted subcutaneously in order to generate tissue needed for surgical reconstruction. After implantation, the reservoir is inflated over several weeks by percutaneous injection of fluid. Once the tissue has grown, the expander is surgically removed and the expanded skin is used to cover the area being reconstructed.%A%
% 208.06/208.24 |- rdf__type mesh__D015625sskos__Concept
% 208.06/208.24 |- mesh__historyNote mesh__D015625 90
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015625 2000
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D015625 2004
% 208.06/208.24 |- mesh__publicMeSHNote mesh__D015625 90
% 208.06/208.24 |- skos__prefLabel mesh__D015625 Tissue Expanders
% 208.06/208.24 |- skos__annotation mesh__D015625
% 208.06/208.24 do not use /util except by MeSH definition
% 208.06/208.24 |- skos__scopeNote mesh__D001605
% 208.06/208.24 A British colony in the western North Atlantic Ocean about 640 miles east southeast of Cape Hatteras, North Carolina. It comprises a group of about 300 islands of which only about 20 are inhabited. It is called also the Bermuda Islands or the Bermudas. It was named for the Spanish explorer Juan Bermudez who visited the islands in 1515. %28%From Webster%27%s New Geographical Dictionary, 1988, p140 %26% Room, Brewer%27%s Dictionary of Names, 1992, p61%29%%A%
% 208.06/208.24 |- mesh__dateCreated mesh__D001605 1999-01-01
% 208.06/208.24 |- skos__annotation mesh__D001605 a British colony in the North Atlantic
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001605 2000
% 208.06/208.24 |- mesh__recordMaintainer mesh__D001605 TGC
% 208.06/208.24 |- skos__prefLabel mesh__D001605 Bermuda
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001605 1998
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001605 1996
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001605 2005
% 208.06/208.24 |- mesh__activeMeSHYear mesh__D001605 1999
% 208.06/208.24 |- skos__broader mesh__D001605smesh__D001266
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001605 2001
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001605 2003
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001605 1997
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001605 2006
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001605 2002
% 208.06/208.25 |- mesh__dateRevised mesh__D001605 1995-02-17
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D001605 PLS
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001605 2004
% 208.06/208.25 |- mesh__recordOriginator mesh__D001605 NLM
% 208.06/208.25 |- rdf__type mesh__D001605sskos__Concept
% 208.06/208.25 |- mesh__recordOriginator mesh__D006899 NLM
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D006899 2005
% 208.06/208.25 |- skos__annotation mesh__D006899 do not confuse with HYDRO-LYASES
% 208.06/208.25 |- skos__altLabel mesh__D006899 Monooxygenases
% 208.06/208.25 |- skos__prefLabel mesh__D006899 Mixed Function Oxygenases
% 208.06/208.25 |- skos__hiddenLabel mesh__D006899 Oxygenases, Mixed Function
% 208.06/208.25 |- skos__hiddenLabel mesh__D006899 Oxidases, Mixed Function
% 208.06/208.25 |- mesh__historyNote mesh__D006899 2003 %28%1966%29%
% 208.06/208.25 |- skos__broader mesh__D006899smesh__D010105
% 208.06/208.25 |- mesh__recordMaintainer mesh__D006899 ssb
% 208.06/208.25 |- skos__scopeNote mesh__D006899
% 208.06/208.25 Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate %28%COENZYMES%29% required in the mixed-function oxidation.%A%
% 208.06/208.25 |- skos__altLabel mesh__D006899 Hydroxylases
% 208.06/208.25 |- skos__altLabel mesh__D006899 Mixed Function Oxidases
% 208.06/208.25 |- rdf__type mesh__D006899sskos__Concept
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D006899 sjn
% 208.06/208.25 |- mesh__dateRevised mesh__D006899 2004-07-07
% 208.06/208.25 |- mesh__dateCreated mesh__D006899 1999-01-01
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D006899 2003 %28%1966%29%
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D006899 2006
% 208.06/208.25 |- skos__prefLabel mesh__D031292 Clitoria
% 208.06/208.25 |- skos__annotation mesh__D031292
% 208.06/208.25 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.25 |- skos__broader mesh__D031292smesh__D007887
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D031292 2005
% 208.06/208.25 |- mesh__historyNote mesh__D031292 2003
% 208.06/208.25 |- mesh__dateCreated mesh__D031292 2002-07-03
% 208.06/208.25 |- rdf__type mesh__D031292sskos__Concept
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D031292 2004
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D031292 2003
% 208.06/208.25 |- skos__scopeNote mesh__D031292
% 208.06/208.25 A plant genus of the family FABACEAE that contains ternatins %28%anthocyanins%29% and preternatins, antifungal proteins, stigmast-4-ene-3,6-dione, and clitoriacetal %28%ROTENONE%29%.%A%
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D031292 2003
% 208.06/208.25 |- mesh__dateEstablished mesh__D031292 2003-01-01
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D031292 2006
% 208.06/208.25 |- skos__annotation mesh__D019218
% 208.06/208.25 infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%
% 208.06/208.25 |- mesh__dateRevised mesh__D019218 2004-07-27
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019218 2005A
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D019218 97
% 208.06/208.25 |- skos__broader mesh__D019218smesh__D019219
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019218 2005
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D019218 jls
% 208.06/208.25 |- skos__altLabel mesh__D019218 Parvovirus, Simian
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019218 2006
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019218 2002
% 208.06/208.25 |- rdf__type mesh__D019218sskos__Concept
% 208.06/208.25 |- skos__prefLabel mesh__D019218 Erythrovirus
% 208.06/208.25 |- mesh__dateEstablished mesh__D019218 1997-01-01
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019218 2003
% 208.06/208.25 |- mesh__historyNote mesh__D019218 97
% 208.06/208.25 |- mesh__recordOriginator mesh__D019218 AGS
% 208.06/208.25 |- skos__hiddenLabel mesh__D019218 Erythroviruses
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019218 2004
% 208.06/208.25 |- mesh__dateCreated mesh__D019218 1996-06-10
% 208.06/208.25 |- mesh__recordMaintainer mesh__D019218 jls
% 208.06/208.25 |- skos__scopeNote mesh__D019218
% 208.06/208.25 A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, and containing the type species PARVOVIRUS B19, HUMAN.%A%
% 208.06/208.25 |- mesh__recordMaintainer mesh__D011235 TAP
% 208.06/208.25 |- mesh__recordOriginator mesh__D011235 NLM
% 208.06/208.25 |- skos__annotation mesh__D011235 animal only
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D011235 2006
% 208.06/208.25 |- skos__broader mesh__D011235smesh__D001070
% 208.06/208.25 |- skos__prefLabel mesh__D011235 Predatory Behavior
% 208.06/208.25 |- skos__scopeNote mesh__D011235
% 208.06/208.25 Instinctual behavior pattern in which food is obtained by killing and consuming other species.%A%
% 208.06/208.25 |- rdf__type mesh__D011235sskos__Concept
% 208.06/208.25 |- skos__broader mesh__D011235smesh__D003259
% 208.06/208.25 |- skos__hiddenLabel mesh__D011235 Predatory Behaviors
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D011235 sjn
% 208.06/208.25 |- mesh__historyNote mesh__D011235
% 208.06/208.25 91%28%75%29%; was see under APPETITIVE BEHAVIOR 1975-90
% 208.06/208.25 |- skos__hiddenLabel mesh__D011235 Behavior, Predatory
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D011235 2003
% 208.06/208.25 |- mesh__dateEstablished mesh__D011235 1991-01-01
% 208.06/208.25 |- skos__hiddenLabel mesh__D011235 Behaviors, Predatory
% 208.06/208.25 |- mesh__dateCreated mesh__D011235 1974-12-12
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D011235 2004
% 208.06/208.25 |- mesh__dateRevised mesh__D011235 2002-07-02
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D011235 2005
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D011235
% 208.06/208.25 91; was see under APPETITIVE BEHAVIOR 1975-90
% 208.06/208.25 |- skos__historyNote mesh__D035683 RNA, Untranslated %28%2001-2002%29%
% 208.06/208.25 |- skos__altLabel mesh__D035683 Micro RNA
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D035683 2004
% 208.06/208.25 |- mesh__historyNote mesh__D035683
% 208.06/208.25 2003; use MICRORNAS %28%NM%29% 2001-2002
% 208.06/208.25 |- skos__altLabel mesh__D035683 miRNA
% 208.06/208.25 |- rdf__type mesh__D035683sskos__Concept
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D035683 2003
% 208.06/208.25 |- mesh__dateCreated mesh__D035683 2002-07-03
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D035683 2006
% 208.06/208.25 |- skos__scopeNote mesh__D035683
% 208.06/208.25 Small regulatory, ANTISENSE RNAs, 21-25 nucleotides in length that repress the translation %28%TRANSLATION, GENETIC%29% of homologous target RNA. The process by which they are generated is related to the process that produces small interfering RNAs %28%RNA, SMALL INTERFERING%29%. The small temporal RNAs %28%stRNAs%29%, let-7 and lin-4, from C. elegans are a class of miRNAs%A%
% 208.06/208.25 |- skos__prefLabel mesh__D035683 MicroRNAs
% 208.06/208.25 |- skos__altLabel mesh__D035683 miRNAs
% 208.06/208.25 |- skos__hiddenLabel mesh__D035683 Temporal RNA, Small
% 208.06/208.25 |- skos__altLabel mesh__D035683 Small Temporal RNA
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D035683 2005
% 208.06/208.25 |- skos__historyNote mesh__D035683 RNA, Antisense %28%2001-2002%29%
% 208.06/208.25 |- skos__broader mesh__D035683smesh__D022661
% 208.06/208.25 |- skos__hiddenLabel mesh__D035683 RNA, Micro
% 208.06/208.25 |- skos__altLabel mesh__D035683 stRNA
% 208.06/208.25 |- skos__broader mesh__D035683smesh__D016372
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D035683
% 208.06/208.25 2003; MICRORNAS was indexed under RNA, UNTRANSLATED and RNA, ANTISENSE 2001-2002%A%
% 208.06/208.25 |- mesh__dateEstablished mesh__D035683 2003-01-01
% 208.06/208.25 |- skos__altLabel mesh__D035683 MicroRNA
% 208.06/208.25 |- skos__related mesh__D035683smesh__D034741
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007992 2001
% 208.06/208.25 |- rdf__type mesh__D007992sskos__Concept
% 208.06/208.25 |- skos__broader mesh__D007992smesh__D006739
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007992 2000
% 208.06/208.25 |- mesh__recordMaintainer mesh__D007992 kle
% 208.06/208.25 |- skos__scopeNote mesh__D007992
% 208.06/208.25 Information centers primarily serving the needs of hospital medical staff and sometimes also providing patient education and other services.%A%
% 208.06/208.25 |- skos__annotation mesh__D007992
% 208.06/208.25 IM; specify geog or other site; DF: LIBRARIES HOSP
% 208.06/208.25 |- skos__broader mesh__D007992smesh__D007990
% 208.06/208.25 |- mesh__dateRevised mesh__D007992 1999-11-03
% 208.06/208.25 |- skos__altLabel mesh__D007992 Library, Hospital
% 208.06/208.25 |- skos__altLabel mesh__D007992 Hospital Library
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007992 2006
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007992 2002
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007992 2004
% 208.06/208.25 |- mesh__dateCreated mesh__D007992 1999-01-01
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007992 2005
% 208.06/208.25 |- skos__altLabel mesh__D007992 Hospital Libraries
% 208.06/208.25 |- skos__prefLabel mesh__D007992 Libraries, Hospital
% 208.06/208.25 |- mesh__recordOriginator mesh__D007992 NLM
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D007992 sjn
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007992 2003
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029646 2002
% 208.06/208.25 |- skos__prefLabel mesh__D029646 Tiliaceae
% 208.06/208.25 |- mesh__historyNote mesh__D029646 2002
% 208.06/208.25 |- skos__annotation mesh__D029646
% 208.06/208.25 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.25 |- skos__broader mesh__D029646smesh__D019684
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029646 2004
% 208.06/208.25 |- mesh__dateCreated mesh__D029646 2001-07-25
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029646 2006
% 208.06/208.25 |- mesh__dateEstablished mesh__D029646 2002-01-01
% 208.06/208.25 |- rdf__type mesh__D029646sskos__Concept
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D029646 2002
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029646 2003
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029646 2005
% 208.06/208.25 |- skos__scopeNote mesh__D029646
% 208.06/208.25 A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida.%A%
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1998
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 2002
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 2003
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 2006
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1990
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1994
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 2001
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 2005
% 208.06/208.25 |- skos__annotation mesh__D007194
% 208.06/208.25 Indians are of CAUCASOID RACE unless otherwise specified
% 208.06/208.25 |- skos__broader mesh__D007194smesh__D001211
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 2000
% 208.06/208.25 |- rdf__type mesh__D007194sskos__Concept
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D007194 PLS
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1989
% 208.06/208.25 |- mesh__recordOriginator mesh__D007194 NLM
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1997
% 208.06/208.25 |- mesh__dateCreated mesh__D007194 1999-01-01
% 208.06/208.25 |- mesh__recordMaintainer mesh__D007194 PLS
% 208.06/208.25 |- skos__prefLabel mesh__D007194 India
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1993
% 208.06/208.25 |- mesh__dateRevised mesh__D007194 1991-11-14
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1996
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1999
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 2004
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1991
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1992
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007194 1995
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D015626 SJN
% 208.06/208.25 |- skos__historyNote mesh__D015626 Surgical Flaps %28%1983-1989%29%
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D015626 2000
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D015626 2003
% 208.06/208.25 |- rdf__type mesh__D015626sskos__Concept
% 208.06/208.25 |- skos__prefLabel mesh__D015626 Tissue Expansion
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D015626 2001
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D015626 2004
% 208.06/208.25 |- skos__broader mesh__D015626smesh__D019651
% 208.06/208.25 |- skos__annotation mesh__D015626
% 208.06/208.25 do not use /util except by MeSH definition
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D015626 2002
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D015626 2005
% 208.06/208.25 |- skos__hiddenLabel mesh__D015626 Expansions, Tissue
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D015626 90
% 208.06/208.25 |- skos__hiddenLabel mesh__D015626 Expansion, Tissue
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D015626 1998
% 208.06/208.25 |- mesh__dateRevised mesh__D015626 1997-06-20
% 208.06/208.25 |- skos__hiddenLabel mesh__D015626 Tissue Expansions
% 208.06/208.25 |- skos__historyNote mesh__D015626 Surgery, Plastic %28%1980-1989%29%
% 208.06/208.25 |- mesh__recordOriginator mesh__D015626 AGS
% 208.06/208.25 |- mesh__dateCreated mesh__D015626 1989-04-07
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D015626 2006
% 208.06/208.25 |- mesh__recordMaintainer mesh__D015626 PXP
% 208.06/208.25 |- mesh__historyNote mesh__D015626 90
% 208.06/208.25 |- mesh__dateEstablished mesh__D015626 1990-01-01
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D015626 1999
% 208.06/208.25 |- skos__scopeNote mesh__D015626
% 208.06/208.25 Process whereby tissue adjacent to a soft tissue defect is expanded by means of a subcutaneously implanted reservoir. The procedure is used in reconstructive surgery for injuries caused by trauma, burns, or ablative surgery.%A%
% 208.06/208.25 |- skos__broader mesh__D016226Q000737smesh__D016226
% 208.06/208.25 |- mesh__preferredCombination mesh__D016226Q000737smesh__D010758Q000737
% 208.06/208.25 |- rdf__type mesh__D016226Q000737smesh__CompoundConcept
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001606 2002
% 208.06/208.25 |- skos__historyNote mesh__D001606
% 208.06/208.25 Blood Platelet Disorders %28%1967-1985%29%
% 208.06/208.25 |- mesh__dateCreated mesh__D001606 1985-03-11
% 208.06/208.25 |- mesh__recordOriginator mesh__D001606 VDK
% 208.06/208.25 |- skos__hiddenLabel mesh__D001606 Bernard Soulier Syndrome
% 208.06/208.25 |- mesh__dateRevised mesh__D001606 2001-07-25
% 208.06/208.25 |- skos__broader mesh__D001606smesh__D025861
% 208.06/208.25 |- mesh__historyNote mesh__D001606
% 208.06/208.25 91%28%86%29%; was see under BLOOD PLATELET DISORDERS 1986-90
% 208.06/208.25 |- skos__scopeNote mesh__D001606
% 208.06/208.25 A familial coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, and impaired prothrombin consumption.%A%
% 208.06/208.25 |- skos__prefLabel mesh__D001606 Bernard-Soulier Syndrome
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D001606
% 208.06/208.25 91; was see under BLOOD PLATELET DISORDERS 1986-90
% 208.06/208.25 |- skos__altLabel mesh__D001606 Giant Platelet Syndrome
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D001606 sjn
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001606 2005
% 208.06/208.25 |- mesh__recordMaintainer mesh__D001606 nns
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001606 2003
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001606 2006
% 208.06/208.25 |- skos__broader mesh__D001606smesh__D006474
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001606 2004
% 208.06/208.25 |- skos__hiddenLabel mesh__D001606 Syndrome, Giant Platelet
% 208.06/208.25 |- rdf__type mesh__D001606sskos__Concept
% 208.06/208.25 |- skos__broader mesh__D001606smesh__D001791
% 208.06/208.25 |- mesh__dateEstablished mesh__D001606 1991-01-01
% 208.06/208.25 |- skos__annotation mesh__D001606 a familial blood platelet disord
% 208.06/208.25 |- skos__hiddenLabel mesh__D001606 Syndrome, Bernard-Soulier
% 208.06/208.25 |- skos__scopeNote mesh__D031293
% 208.06/208.25 A plant genus of the family FABACEAE that is the source of guar gum.%A%
% 208.06/208.25 |- skos__annotation mesh__D031293
% 208.06/208.25 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.25 |- mesh__dateEstablished mesh__D031293 2003-01-01
% 208.06/208.25 |- skos__prefLabel mesh__D031293 Cyamopsis
% 208.06/208.25 |- mesh__recordMaintainer mesh__D031293 ssb
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D031293 sjn
% 208.06/208.25 |- mesh__dateRevised mesh__D031293 2003-07-09
% 208.06/208.25 |- mesh__historyNote mesh__D031293 2003
% 208.06/208.25 |- rdf__type mesh__D031293sskos__Concept
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D031293 2004
% 208.06/208.25 |- mesh__dateCreated mesh__D031293 2002-07-03
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D031293 2003
% 208.06/208.25 |- skos__broader mesh__D031293smesh__D007887
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D031293 2005
% 208.06/208.25 |- skos__altLabel mesh__D031293 Guar
% 208.06/208.25 |- skos__altLabel mesh__D031293 Cyamposis
% 208.06/208.25 |- mesh__recordOriginator mesh__D031293 ssb
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D031293 2006
% 208.06/208.25 |- skos__broader mesh__D047708smesh__D009372
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D047708 2005; see LEIOMYOMA 1994-2004
% 208.06/208.25 |- mesh__recordMaintainer mesh__D047708 ags
% 208.06/208.25 |- mesh__historyNote mesh__D047708 2005; use LEIOMYOMA 1994-2004
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D047708 2005
% 208.06/208.25 |- mesh__dateEstablished mesh__D047708 2005-01-01
% 208.06/208.25 |- skos__scopeNote mesh__D047708
% 208.06/208.25 A benign tumor that consists chiefly of fibrous CONNECTIVE TISSUE, with variable numbers of MUSCLE CELLS forming portions of the neoplasm %28%From Stedman%27%s, 27th ed%29%.%A%
% 208.06/208.25 |- skos__hiddenLabel mesh__D047708 Myofibromas
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D047708 sjn
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D047708 2006
% 208.06/208.25 |- mesh__dateCreated mesh__D047708 2004-07-07
% 208.06/208.25 |- skos__prefLabel mesh__D047708 Myofibroma
% 208.06/208.25 |- mesh__recordOriginator mesh__D047708 ags
% 208.06/208.25 |- rdf__type mesh__D047708sskos__Concept
% 208.06/208.25 |- skos__annotation mesh__D047708
% 208.06/208.25 coordinate IM with organ/neoplasm term %28%IM%29%
% 208.06/208.25 |- skos__historyNote mesh__D047708 Leiomyoma %28%1963-2004%29%
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019219 2003
% 208.06/208.25 |- skos__annotation mesh__D019219
% 208.06/208.25 a subfamily of the family Parvoviridae; infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%%A%
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D019219 sjn
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019219 2002
% 208.06/208.25 |- skos__broader mesh__D019219smesh__D010321
% 208.06/208.25 |- mesh__dateEstablished mesh__D019219 1997-01-01
% 208.06/208.25 |- mesh__dateCreated mesh__D019219 1996-06-10
% 208.06/208.25 |- mesh__recordOriginator mesh__D019219 AGS
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D019219 97
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019219 2006
% 208.06/208.25 |- skos__prefLabel mesh__D019219 Parvovirinae
% 208.06/208.25 |- mesh__dateRevised mesh__D019219 2001-07-25
% 208.06/208.25 |- skos__scopeNote mesh__D019219
% 208.06/208.25 A subfamily of DNA vertebrate viruses, in the family PARVOVIRIDAE. There are three genera: PARVOVIRUS; ERYTHROVIRUS; and DEPENDOVIRUS.%A%
% 208.06/208.25 |- rdf__type mesh__D019219sskos__Concept
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019219 2004
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D019219 2005
% 208.06/208.25 |- mesh__recordMaintainer mesh__D019219 mdb
% 208.06/208.25 |- mesh__historyNote mesh__D019219 97
% 208.06/208.25 |- skos__related mesh__D011236smesh__D006943
% 208.06/208.25 |- mesh__dateRevised mesh__D011236 2004-07-07
% 208.06/208.25 |- mesh__recordMaintainer mesh__D011236 lkt
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D011236 2006
% 208.06/208.25 |- mesh__recordOriginator mesh__D011236 NLM
% 208.06/208.25 |- skos__annotation mesh__D011236
% 208.06/208.25 do not use /compl for development into diabetes mellitus; coordinate IM with specific type of diabetes mellitus %28%IM%29% if pertinent%A%
% 208.06/208.25 |- skos__broader mesh__D011236smesh__D003920
% 208.06/208.25 |- rdf__type mesh__D011236sskos__Concept
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D011236 2005
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D011236 68
% 208.06/208.25 |- skos__altLabel mesh__D011236 Prediabetes
% 208.06/208.25 |- skos__scopeNote mesh__D011236
% 208.06/208.25 The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes %28%DIABETES MELLITUS, TYPE 2%29%.%A%
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D011236 sjn
% 208.06/208.25 |- mesh__historyNote mesh__D011236 68%28%65%29%
% 208.06/208.25 |- skos__hiddenLabel mesh__D011236 State, Prediabetic
% 208.06/208.25 |- mesh__dateEstablished mesh__D011236 1968-01-01
% 208.06/208.25 |- mesh__dateCreated mesh__D011236 1999-01-01
% 208.06/208.25 |- skos__hiddenLabel mesh__D011236 States, Prediabetic
% 208.06/208.25 |- skos__hiddenLabel mesh__D011236 Prediabetic States
% 208.06/208.25 |- skos__prefLabel mesh__D011236 Prediabetic State
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D035684 2003
% 208.06/208.25 |- mesh__dateEstablished mesh__D035684 2003-01-01
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D035684 2006
% 208.06/208.25 |- skos__scopeNote mesh__D035684
% 208.06/208.25 A plant genus of the family Gnetaceae, order Gnetales class Gnetopsida, division GNETOPHYTA. Members contain STILBENES and benzylisoquinoline alkaloids.%A%
% 208.06/208.25 |- skos__annotation mesh__D035684
% 208.06/208.25 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D035684 2005
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D035684 2003
% 208.06/208.25 |- skos__broader mesh__D035684smesh__D035682
% 208.06/208.25 |- skos__prefLabel mesh__D035684 Gnetum
% 208.06/208.25 |- mesh__dateCreated mesh__D035684 2002-07-03
% 208.06/208.25 |- mesh__historyNote mesh__D035684 2003
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D035684 2004
% 208.06/208.25 |- rdf__type mesh__D035684sskos__Concept
% 208.06/208.25 |- skos__hiddenLabel mesh__D007993 Science Library, Health
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007993 2006
% 208.06/208.25 |- skos__altLabel mesh__D007993 Library, Medical
% 208.06/208.25 |- mesh__recordOriginator mesh__D007993 NLM
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007993 2005
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D007993 sjn
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007993 2004
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007993 2001
% 208.06/208.25 |- mesh__dateCreated mesh__D007993 1999-01-01
% 208.06/208.25 |- skos__broader mesh__D007993smesh__D007990
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007993 2003
% 208.06/208.25 |- skos__hiddenLabel mesh__D007993 Library, Health Science
% 208.06/208.25 |- mesh__recordMaintainer mesh__D007993 kle
% 208.06/208.25 |- mesh__dateRevised mesh__D007993 1999-11-03
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007993 2000
% 208.06/208.25 |- skos__hiddenLabel mesh__D007993 Health Science Libraries
% 208.06/208.25 |- skos__annotation mesh__D007993
% 208.06/208.25 private %26% public libraries; includes private collections of books; IM; specify geog or other site; DF: LIBRARIES MED%A%
% 208.06/208.25 |- skos__hiddenLabel mesh__D007993 Science Libraries, Health
% 208.06/208.25 |- rdf__type mesh__D007993sskos__Concept
% 208.06/208.25 |- skos__altLabel mesh__D007993 Medical Libraries
% 208.06/208.25 |- skos__altLabel mesh__D007993 Medical Library
% 208.06/208.25 |- skos__prefLabel mesh__D007993 Libraries, Medical
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007993 2002
% 208.06/208.25 |- skos__hiddenLabel mesh__D007993 Health Science Library
% 208.06/208.25 |- skos__scopeNote mesh__D029647
% 208.06/208.25 A plant genus of the family Turneraceae, order Violales, subclass Dilleniidae, class Magnoliopsida.%A%
% 208.06/208.25 |- skos__annotation mesh__D029647
% 208.06/208.25 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029647 2002
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029647 2004
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029647 2006
% 208.06/208.25 |- mesh__dateEstablished mesh__D029647 2002-01-01
% 208.06/208.25 |- rdf__type mesh__D029647sskos__Concept
% 208.06/208.25 |- mesh__historyNote mesh__D029647 2002
% 208.06/208.25 |- mesh__publicMeSHNote mesh__D029647 2002
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029647 2003
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D029647 2005
% 208.06/208.25 |- skos__broader mesh__D029647smesh__D019684
% 208.06/208.25 |- skos__prefLabel mesh__D029647 Turnera
% 208.06/208.25 |- mesh__dateCreated mesh__D029647 2001-07-25
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 2002
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 2006
% 208.06/208.25 |- mesh__recordMaintainer mesh__D007195 TGC
% 208.06/208.25 |- skos__scopeNote mesh__D007195
% 208.06/208.25 Numerous islands in the Indian Ocean situated east of Madagascar, north to the Arabian Sea and east to Sri Lanka. Included are COMOROS %28%republic%29%, MADAGASCAR %28%republic%29%, Maldives %28%republic%29%, MAURITIUS %28%parliamentary democracy%29%, Pemba %28%administered by Tanzania%29%, REUNION %28%a department of France%29%, and SEYCHELLES %28%republic%29%.%A%
% 208.06/208.25 |- mesh__dateCreated mesh__D007195 1999-01-01
% 208.06/208.25 |- rdf__type mesh__D007195sskos__Concept
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 2000
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D007195 PLS
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 1996
% 208.06/208.25 |- mesh__dateRevised mesh__D007195 1995-02-17
% 208.06/208.25 |- skos__broader mesh__D007195smesh__D005842
% 208.06/208.25 |- skos__prefLabel mesh__D007195 Indian Ocean Islands
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 2001
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 1998
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 1997
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 2003
% 208.06/208.25 |- skos__annotation mesh__D007195
% 208.06/208.25 in addition to indentions here, includes Maldives, Pemba %26% Cocos %28%Keeling%29% Islands%A%
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 1999
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 2005
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D007195 2004
% 208.06/208.25 |- mesh__recordOriginator mesh__D007195 NLM
% 208.06/208.25 |- skos__broader mesh__D005224Q000737smesh__D005224
% 208.06/208.25 |- rdf__type mesh__D005224Q000737smesh__CompoundConcept
% 208.06/208.25 |- skos__hiddenLabel mesh__D001607 Beryllioses
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001607 1999
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001607 2000
% 208.06/208.25 |- skos__historyNote mesh__D001607 Lung Diseases %28%1966-1978%29%
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001607 2003
% 208.06/208.25 |- skos__prefLabel mesh__D001607 Berylliosis
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001607 2006
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001607 2001
% 208.06/208.25 |- skos__broader mesh__D001607smesh__D011009
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001607 1997
% 208.06/208.25 |- mesh__recordOriginator mesh__D001607 VDK
% 208.06/208.25 |- mesh__dateRevised mesh__D001607 1993-03-03
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001607 2004
% 208.06/208.25 |- mesh__recordMaintainer mesh__D001607 PLS
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001607 2002
% 208.06/208.25 |- skos__historyNote mesh__D001607 Pneumoconiosis %28%1966-1978%29%
% 208.06/208.25 |- rdf__type mesh__D001607sskos__Concept
% 208.06/208.25 |- mesh__recordAuthorizer mesh__D001607 PLS
% 208.06/208.25 |- mesh__dateCreated mesh__D001607 1978-05-19
% 208.06/208.25 |- mesh__activeMeSHYear mesh__D001607 1994
% 208.06/208.25 |- skos__scopeNote mesh__D001607
% 208.06/208.25 A lung disease caused by exposure to metallic beryllium or its soluble salts.%A%
% 208.06/208.25 |- mesh__historyNote mesh__D001607 79
% 208.06/208.26 |- mesh__dateEstablished mesh__D001607 1979-01-01
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D001607 79
% 208.06/208.26 |- skos__annotation mesh__D001607
% 208.06/208.26 pneumoconiosis from beryllium; do not coord with OCCUPATIONAL DISEASES%A%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001607 1998
% 208.06/208.26 |- skos__altLabel mesh__D001607 Beryllium Disease
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001607 1995
% 208.06/208.26 |- skos__hiddenLabel mesh__D001607 Disease, Beryllium
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001607 2005
% 208.06/208.26 |- skos__historyNote mesh__D001607 Occupational Diseases %28%1966-1978%29%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001607 1996
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D031294 2003
% 208.06/208.26 |- mesh__dateEstablished mesh__D031294 2003-01-01
% 208.06/208.26 |- skos__prefLabel mesh__D031294 Dolichos
% 208.06/208.26 |- rdf__type mesh__D031294sskos__Concept
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D031294 2004
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D031294 2003
% 208.06/208.26 |- skos__broader mesh__D031294smesh__D007887
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D031294 2005
% 208.06/208.26 |- skos__scopeNote mesh__D031294
% 208.06/208.26 A plant genus of the family FABACEAE that contains LECTINS. Many members have been reclassified into other genera of the FABACEAE family.%A%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D031294 2006
% 208.06/208.26 |- mesh__historyNote mesh__D031294 2003
% 208.06/208.26 |- mesh__dateCreated mesh__D031294 2002-07-03
% 208.06/208.26 |- skos__annotation mesh__D031294
% 208.06/208.26 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.26 |- skos__prefLabel mesh__D047709 Hirudo medicinalis
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D047709 2005
% 208.06/208.26 |- mesh__historyNote mesh__D047709 2005; use LEECHES 2002-2004
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D047709 2005; see LEECHES 2002-2004
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D047709 2006
% 208.06/208.26 |- mesh__dateCreated mesh__D047709 2004-07-07
% 208.06/208.26 |- skos__broader mesh__D047709smesh__D007865
% 208.06/208.26 |- rdf__type mesh__D047709sskos__Concept
% 208.06/208.26 |- mesh__dateEstablished mesh__D047709 2005-01-01
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D047709 sjn
% 208.06/208.26 |- skos__scopeNote mesh__D047709
% 208.06/208.26 A species of European freshwater LEECHES used for BLOODLETTING in ancient times and also for LEECHING in modern times.%A%
% 208.06/208.26 |- mesh__recordOriginator mesh__D047709 ags
% 208.06/208.26 |- skos__historyNote mesh__D047709 Leeches %28%1965-2004%29%
% 208.06/208.26 |- mesh__recordMaintainer mesh__D047709 ags
% 208.06/208.26 |- skos__broader mesh__D011237smesh__D012680
% 208.06/208.26 |- skos__prefLabel mesh__D011237 Predictive Value of Tests
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D011237 2006
% 208.06/208.26 |- skos__scopeNote mesh__D011237
% 208.06/208.26 In screening and diagnostic tests, the probability that a person with a positive test is a true positive %28%i.e., has the disease%29%, is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.%A%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D011237 2002
% 208.06/208.26 |- rdf__type mesh__D011237sskos__Concept
% 208.06/208.26 |- mesh__dateRevised mesh__D011237 2001-07-25
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D011237 2005
% 208.06/208.26 |- skos__related mesh__D011237smesh__D005188
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D011237 2004
% 208.06/208.26 |- mesh__dateCreated mesh__D011237 1986-03-25
% 208.06/208.26 |- mesh__recordOriginator mesh__D011237 EC
% 208.06/208.26 |- skos__related mesh__D011237smesh__D005189
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D011237 87
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D011237 2003
% 208.06/208.26 |- skos__annotation mesh__D011237
% 208.06/208.26 IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%
% 208.06/208.26 |- mesh__historyNote mesh__D011237 87
% 208.06/208.26 |- mesh__dateEstablished mesh__D011237 1987-01-01
% 208.06/208.26 |- skos__broader mesh__D011237smesh__D011336
% 208.06/208.26 |- mesh__recordMaintainer mesh__D011237 ags
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D011237 sjn
% 208.06/208.26 |- skos__scopeNote mesh__D016720
% 208.06/208.26 Infections with species in the genus PNEUMOCYSTIS, a fungus causing interstitial plasma cell pneumonia %28%PNEUMONIA, PNEUMOCYSTIS%29% and other infections in humans and other MAMMALS. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally.%A%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D016720 2006
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D016720 sjn
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D016720
% 208.06/208.26 2004; see PNEUMOCYSTIS CARINII INFECTIONS 1992-2003
% 208.06/208.26 |- mesh__historyNote mesh__D016720 2004 %28%1992%29%
% 208.06/208.26 |- mesh__dateCreated mesh__D016720 1991-02-11
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D016720 2005
% 208.06/208.26 |- skos__historyNote mesh__D016720 Mycoses %28%1989-1991%29%
% 208.06/208.26 |- skos__hiddenLabel mesh__D016720 Infection, Pneumocystis
% 208.06/208.26 |- mesh__dateEstablished mesh__D016720 1992-01-01
% 208.06/208.26 |- mesh__dateRevised mesh__D016720 2003-07-09
% 208.06/208.26 |- rdf__type mesh__D016720sskos__Concept
% 208.06/208.26 |- skos__hiddenLabel mesh__D016720 Pneumocystis carinii Infection
% 208.06/208.26 |- skos__annotation mesh__D016720
% 208.06/208.26 coord IM with precoord organ/dis term %28%IM%29% but consider more commonly PNEUMONIA, PNEUMOCYSTIS%A%
% 208.06/208.26 |- skos__hiddenLabel mesh__D016720 Infections, Pneumocystis
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D016720 2004
% 208.06/208.26 |- skos__historyNote mesh__D016720
% 208.06/208.26 Pneumonia, Pneumocystis carinii %28%1966-1991%29%
% 208.06/208.26 |- mesh__recordMaintainer mesh__D016720 ags
% 208.06/208.26 |- mesh__recordOriginator mesh__D016720 AGS
% 208.06/208.26 |- skos__broader mesh__D016720smesh__D009181
% 208.06/208.26 |- skos__historyNote mesh__D016720 Protozoan Infections %28%1985-1988%29%
% 208.06/208.26 |- skos__hiddenLabel mesh__D016720 Pneumocystis Infection
% 208.06/208.26 |- skos__prefLabel mesh__D016720 Pneumocystis Infections
% 208.06/208.26 |- skos__altLabel mesh__D016720 Pneumocystis carinii Infections
% 208.06/208.26 |- mesh__historyNote mesh__D035685 2003
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D035685 2005
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D035685 2006
% 208.06/208.26 |- skos__annotation mesh__D035685
% 208.06/208.26 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.26 |- mesh__dateEstablished mesh__D035685 2003-01-01
% 208.06/208.26 |- mesh__dateCreated mesh__D035685 2002-07-02
% 208.06/208.26 |- skos__scopeNote mesh__D035685
% 208.06/208.26 A plant genus of the family ACANTHACEAE. Members contain andrographolide and other DITERPENES and androechin, a CHALCONE.%A%
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D035685 2003
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D035685 2003
% 208.06/208.26 |- skos__broader mesh__D035685smesh__D027901
% 208.06/208.26 |- skos__prefLabel mesh__D035685 Andrographis
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D035685 2004
% 208.06/208.26 |- rdf__type mesh__D035685sskos__Concept
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D002700 2003
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D002700 sjn
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D002700 2004
% 208.06/208.26 |- rdf__type mesh__D002700sskos__Concept
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D002700 2002
% 208.06/208.26 |- mesh__recordMaintainer mesh__D002700 CCR
% 208.06/208.26 |- mesh__dateCreated mesh__D002700 1999-01-01
% 208.06/208.26 |- skos__prefLabel mesh__D002700 Chloramines
% 208.06/208.26 |- skos__broader mesh__D002700smesh__D013449
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D002700 2005
% 208.06/208.26 |- mesh__dateRevised mesh__D002700 2000-06-22
% 208.06/208.26 |- skos__altLabel mesh__D002700 Chloroamines
% 208.06/208.26 |- mesh__recordOriginator mesh__D002700 NLM
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D002700 2006
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D002700 2001
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007994 2005
% 208.06/208.26 |- mesh__dateEstablished mesh__D007994 1967-01-01
% 208.06/208.26 |- skos__annotation mesh__D007994
% 208.06/208.26 IM; specify geog or other site; DF: LIBRARIES NURS
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007994 2004
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007994 2002
% 208.06/208.26 |- mesh__dateCreated mesh__D007994 1999-01-01
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007994 2003
% 208.06/208.26 |- skos__hiddenLabel mesh__D007994 Nursing Library
% 208.06/208.26 |- mesh__recordOriginator mesh__D007994 NLM
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D007994 sjn
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007994 2001
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D007994 67
% 208.06/208.26 |- rdf__type mesh__D007994sskos__Concept
% 208.06/208.26 |- skos__broader mesh__D007994smesh__D007990
% 208.06/208.26 |- skos__prefLabel mesh__D007994 Libraries, Nursing
% 208.06/208.26 |- skos__hiddenLabel mesh__D007994 Library, Nursing
% 208.06/208.26 |- mesh__dateRevised mesh__D007994 1999-11-03
% 208.06/208.26 |- mesh__recordMaintainer mesh__D007994 kle
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007994 2000
% 208.06/208.26 |- mesh__historyNote mesh__D007994 67%28%65%29%
% 208.06/208.26 |- skos__altLabel mesh__D007994 Nursing Libraries
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007994 2006
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D029648 2006
% 208.06/208.26 |- rdf__type mesh__D029648sskos__Concept
% 208.06/208.26 |- skos__scopeNote mesh__D029648
% 208.06/208.26 A plant family of the order Lamiales, subclass Asteridae, class Magnoliopsida. The leaves are opposite or whorled. The flowers are aggregated in spikes, clusters, or racemes.%A%
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D029648 2002
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D029648 2003
% 208.06/208.26 |- mesh__dateCreated mesh__D029648 2001-07-25
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D029648 2005
% 208.06/208.26 |- mesh__dateEstablished mesh__D029648 2002-01-01
% 208.06/208.26 |- skos__prefLabel mesh__D029648 Verbenaceae
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D029648 2002
% 208.06/208.26 |- skos__annotation mesh__D029648
% 208.06/208.26 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.26 |- skos__broader mesh__D029648smesh__D019684
% 208.06/208.26 |- mesh__historyNote mesh__D029648 2002
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D029648 2004
% 208.06/208.26 |- mesh__dateCreated mesh__D007196 1999-01-01
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D007196 SJN
% 208.06/208.26 |- rdf__type mesh__D007196sskos__Concept
% 208.06/208.26 |- mesh__recordOriginator mesh__D007196 NLM
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007196 2002
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007196 1998
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007196 2003
% 208.06/208.26 |- mesh__dateRevised mesh__D007196 1997-06-20
% 208.06/208.26 |- skos__broader mesh__D007196smesh__D006114
% 208.06/208.26 |- skos__broader mesh__D007196smesh__D015146
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007196 2000
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007196 1999
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007196 2005
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007196 2004
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007196 2001
% 208.06/208.26 |- mesh__recordMaintainer mesh__D007196 PXP
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007196 2006
% 208.06/208.26 |- skos__prefLabel mesh__D007196 Indiana
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D040021 2006
% 208.06/208.26 |- skos__historyNote mesh__D040021 Mites %28%1965-2002%29%
% 208.06/208.26 |- mesh__historyNote mesh__D040021 2003
% 208.06/208.26 |- skos__prefLabel mesh__D040021 Sarcoptidae
% 208.06/208.26 |- skos__scopeNote mesh__D040021
% 208.06/208.26 Family of MITES, in the superfamily Sarcoptoidea, order Astigmata. They are slow moving, obligate PARASITES that infect MAMMALS and BIRDS. The species SARCOPTIDAE SCABIEI causes SCABIES.%A%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D040021 2004
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D040021 2005
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D040021 2003
% 208.06/208.26 |- mesh__dateCreated mesh__D040021 2002-07-03
% 208.06/208.26 |- skos__annotation mesh__D040021
% 208.06/208.26 infestation: coord IM with MITE INFESTATIONS %28%IM%29%
% 208.06/208.26 |- skos__broader mesh__D040021smesh__D008925
% 208.06/208.26 |- mesh__dateRevised mesh__D040021 2003-07-09
% 208.06/208.26 |- mesh__dateEstablished mesh__D040021 2003-01-01
% 208.06/208.26 |- rdf__type mesh__D040021sskos__Concept
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D001608 sjn
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001608 2004
% 208.06/208.26 |- mesh__recordMaintainer mesh__D001608 jmp
% 208.06/208.26 |- rdf__type mesh__D001608sskos__Concept
% 208.06/208.26 |- skos__broader mesh__D001608smesh__D008673
% 208.06/208.26 |- mesh__dateCreated mesh__D001608 1999-01-01
% 208.06/208.26 |- skos__broader mesh__D001608smesh__D019565
% 208.06/208.26 |- skos__scopeNote mesh__D001608
% 208.06/208.26 Beryllium. An element with the atomic symbol Be, atomic number 4, and atomic weight 9.01218. Short exposure to this element can lead to a type of poisoning known as BERYLLIOSIS.%A%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001608 2002
% 208.06/208.26 |- mesh__dateRevised mesh__D001608 2001-07-25
% 208.06/208.26 |- skos__annotation mesh__D001608
% 208.06/208.26 Be-9; Be-6-8, 10, 11 = BERYLLIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%; /adv eff /tox permitted but /pois = BERYLLIOSIS%A%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001608 2005
% 208.06/208.26 |- mesh__recordOriginator mesh__D001608 NLM
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001608 2003
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001608 2006
% 208.06/208.26 |- skos__prefLabel mesh__D001608 Beryllium
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 2003
% 208.06/208.26 |- skos__hiddenLabel mesh__D012330 RNA, Double Stranded
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 1995
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 1998
% 208.06/208.26 |- skos__prefLabel mesh__D012330 RNA, Double-Stranded
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 2000
% 208.06/208.26 |- skos__altLabel mesh__D012330 Double-Stranded RNA
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 2006
% 208.06/208.26 |- skos__historyNote mesh__D012330 RNA %28%1966-1979%29%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 1994
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D012330 80
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 2005
% 208.06/208.26 |- mesh__dateEstablished mesh__D012330 1980-01-01
% 208.06/208.26 |- mesh__historyNote mesh__D012330 80
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D012330 PLS
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 2002
% 208.06/208.26 |- rdf__type mesh__D012330sskos__Concept
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 1997
% 208.06/208.26 |- mesh__recordOriginator mesh__D012330 RLS
% 208.06/208.26 |- skos__scopeNote mesh__D012330
% 208.06/208.26 RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms.%A%
% 208.06/208.26 |- mesh__dateCreated mesh__D012330 1979-05-25
% 208.06/208.26 |- skos__hiddenLabel mesh__D012330 Double Stranded RNA
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 1996
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 1993
% 208.06/208.26 |- mesh__dateRevised mesh__D012330 1992-05-20
% 208.06/208.26 |- skos__broader mesh__D012330smesh__D012313
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 2004
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 2001
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D012330 1999
% 208.06/208.26 |- skos__annotation mesh__D012330
% 208.06/208.26 IM; /drug eff /ultrastruct permitted; DF: DSRNA
% 208.06/208.26 |- mesh__recordMaintainer mesh__D012330 TGC
% 208.06/208.26 |- skos__broader mesh__D031295smesh__D007887
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D031295 2003
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D031295 2005
% 208.06/208.26 |- mesh__historyNote mesh__D031295 2003
% 208.06/208.26 |- mesh__dateCreated mesh__D031295 2002-07-03
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D031295 2006
% 208.06/208.26 |- skos__annotation mesh__D031295
% 208.06/208.26 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.26 |- mesh__dateEstablished mesh__D031295 2003-01-01
% 208.06/208.26 |- skos__scopeNote mesh__D031295
% 208.06/208.26 A plant genus of the family FABACEAE. Members contain Griffonia simplicifolia agglutin-I and griffonin.%A%
% 208.06/208.26 |- skos__prefLabel mesh__D031295 Griffonia
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D031295 2003
% 208.06/208.26 |- rdf__type mesh__D031295sskos__Concept
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D031295 2004
% 208.06/208.26 |- mesh__historyNote mesh__D011238
% 208.06/208.26 91%28%80%29%; was see under CHLORAMBUCIL 1980-90
% 208.06/208.26 |- skos__broader mesh__D011238smesh__D002699
% 208.06/208.26 |- skos__altLabel mesh__D011238 Sterecyt
% 208.06/208.26 |- skos__prefLabel mesh__D011238 Prednimustine
% 208.06/208.26 |- mesh__recordMaintainer mesh__D011238 lkw
% 208.06/208.26 |- skos__historyNote mesh__D011238
% 208.06/208.26 Chlorambucil %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 208.06/208.26 |- mesh__dateCreated mesh__D011238 1979-05-30
% 208.06/208.26 |- skos__hiddenLabel mesh__D011238 Leo1031
% 208.06/208.26 |- skos__historyNote mesh__D011238
% 208.06/208.26 Prednisolone %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 208.06/208.26 |- skos__hiddenLabel mesh__D011238 NSC134087
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D011238 sjn
% 208.06/208.26 |- skos__broader mesh__D011238smesh__D011239
% 208.06/208.26 |- mesh__dateEstablished mesh__D011238 1991-01-01
% 208.06/208.26 |- skos__scopeNote mesh__D011238
% 208.06/208.26 Ester of CHLORAMBUCIL and PREDNISOLONE used as a combination alkylating agent and synthetic steroid to treat various leukemias and other neoplasms. It causes gastrointestinal and bone marrow toxicity.%A%
% 208.06/208.26 |- skos__hiddenLabel mesh__D011238 NSC 134087
% 208.06/208.26 |- skos__hiddenLabel mesh__D011238 Leo 1031
% 208.06/208.26 |- mesh__dateRevised mesh__D011238 2005-06-30
% 208.06/208.26 |- skos__altLabel mesh__D011238 St%C3%%A9%r%C3%%A9%ocyt
% 208.06/208.26 |- mesh__recordOriginator mesh__D011238 SH
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D011238 2006
% 208.06/208.26 |- rdf__type mesh__D011238sskos__Concept
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D011238
% 208.06/208.26 91; was see under CHLORAMBUCIL 1980-90
% 208.06/208.26 |- skos__altLabel mesh__D011238 Pharmacia Brand of Prednimustine
% 208.06/208.26 |- skos__historyNote mesh__D016721 Retroviridae %28%1966-1987%29%
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D016721 2005
% 208.06/208.26 |- skos__hiddenLabel mesh__D016721 Leukemia Virus, Radiation
% 208.06/208.26 |- mesh__dateCreated mesh__D016721 1991-06-21
% 208.06/208.26 |- skos__altLabel mesh__D016721 RadLV
% 208.06/208.26 |- skos__prefLabel mesh__D016721 Radiation Leukemia Virus
% 208.06/208.26 |- mesh__historyNote mesh__D016721 92
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D016721 sjn
% 208.06/208.26 |- skos__broader mesh__D016721smesh__D009052
% 208.06/208.26 |- rdf__type mesh__D016721sskos__Concept
% 208.06/208.26 |- skos__scopeNote mesh__D016721
% 208.06/208.26 A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% isolated from radiation-induced lymphomas in C57BL mice. It is leukemogenic, thymotrophic, can be transmitted vertically, and replicates only in vivo.%A%
% 208.06/208.26 |- mesh__dateRevised mesh__D016721 2002-07-03
% 208.06/208.26 |- skos__hiddenLabel mesh__D016721 Radiation Leukemia Viruses
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D016721 2004
% 208.06/208.26 |- mesh__recordMaintainer mesh__D016721 ags
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D016721 92
% 208.06/208.26 |- mesh__dateEstablished mesh__D016721 1992-01-01
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D016721 2003
% 208.06/208.26 |- skos__historyNote mesh__D016721 Mouse Leukemia Viruses %28%1966-1991%29%
% 208.06/208.26 |- skos__hiddenLabel mesh__D016721 Leukemia Viruses, Radiation
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D016721 2006
% 208.06/208.26 |- skos__annotation mesh__D016721
% 208.06/208.26 infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29% or LEUKEMIA %28%IM%29% %28%for spontaneous leukemia%29%%A%
% 208.06/208.26 |- mesh__recordOriginator mesh__D016721 AGS
% 208.06/208.26 |- skos__prefLabel mesh__D002701 Chloramphenicol
% 208.06/208.26 |- rdf__type mesh__D002701sskos__Concept
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D002701 2004
% 208.06/208.26 |- mesh__recordOriginator mesh__D002701 NLM
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D002701 NLM
% 208.06/208.26 |- mesh__dateRevised mesh__D002701 2003-07-30
% 208.06/208.26 |- skos__altLabel mesh__D002701 Cloranfenicol
% 208.06/208.26 |- mesh__dateCreated mesh__D002701 1999-01-01
% 208.06/208.26 |- skos__altLabel mesh__D002701 Kloramfenikol
% 208.06/208.26 |- mesh__recordMaintainer mesh__D002701 SYSTEM
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D002701 2005
% 208.06/208.26 |- skos__scopeNote mesh__D002701
% 208.06/208.26 An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. %28%From Martindale, The Extra Pharmacopoeia, 29th ed, p106%29%%A%
% 208.06/208.26 |- skos__annotation mesh__D002701 an antibiotic
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D002701 2006
% 208.06/208.26 |- skos__broader mesh__D002701smesh__D009578
% 208.06/208.26 |- skos__broader mesh__D002701smesh__D011409
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1992
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 2004
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1995
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1990
% 208.06/208.26 |- skos__hiddenLabel mesh__D007995 Administrations, Library
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 2002
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1998
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1993
% 208.06/208.26 |- skos__scopeNote mesh__D007995
% 208.06/208.26 Planning, organizing, staffing, direction, and control of libraries.%A%
% 208.06/208.26 |- skos__prefLabel mesh__D007995 Library Administration
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1991
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1996
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1999
% 208.06/208.26 |- skos__broader mesh__D007995smesh__D007998
% 208.06/208.26 |- skos__annotation mesh__D007995 SPEC: SPEC qualif
% 208.06/208.26 |- rdf__type mesh__D007995sskos__Concept
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1997
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 2005
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D007995 PLS
% 208.06/208.26 |- skos__altLabel mesh__D007995 Administration, Library
% 208.06/208.26 |- mesh__dateCreated mesh__D007995 1999-01-01
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 2000
% 208.06/208.26 |- mesh__recordOriginator mesh__D007995 NLM
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 2003
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 1994
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 2006
% 208.06/208.26 |- mesh__recordMaintainer mesh__D007995 PLS
% 208.06/208.26 |- mesh__dateRevised mesh__D007995 1989-06-26
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007995 2001
% 208.06/208.26 |- skos__hiddenLabel mesh__D007995 Library Administrations
% 208.06/208.26 |- rdf__type mesh__D029649sskos__Concept
% 208.06/208.26 |- skos__broader mesh__D029649smesh__D019684
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D029649 2004
% 208.06/208.26 |- skos__scopeNote mesh__D029649
% 208.06/208.26 A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.%A%
% 208.06/208.26 |- mesh__historyNote mesh__D029649 2002
% 208.06/208.26 |- mesh__dateEstablished mesh__D029649 2002-01-01
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D029649 2006
% 208.06/208.26 |- mesh__dateCreated mesh__D029649 2001-07-25
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D029649 2002
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D029649 2005
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D029649 sjn
% 208.06/208.26 |- mesh__recordMaintainer mesh__D029649 ssb
% 208.06/208.26 |- skos__prefLabel mesh__D029649 Violaceae
% 208.06/208.26 |- skos__annotation mesh__D029649
% 208.06/208.26 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.26 |- mesh__dateRevised mesh__D029649 2003-07-09
% 208.06/208.26 |- mesh__recordOriginator mesh__D029649 ssb
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 Central American Indians
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 Central American Indian
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007197 2004A
% 208.06/208.26 |- skos__historyNote mesh__D007197
% 208.06/208.26 Indians, South American %28%1966-1977%29%
% 208.06/208.26 |- skos__prefLabel mesh__D007197 Indians, Central American
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007197 2004
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007197 2005
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 American Indian, Central
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 American Indians, Central
% 208.06/208.26 |- mesh__dateEstablished mesh__D007197 1978-01-01
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 Central American Amerinds
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 Amerind, Central American
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007197 2006
% 208.06/208.26 |- mesh__dateRevised mesh__D007197 2003-10-30
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 Indian, Central American
% 208.06/208.26 |- mesh__recordAuthorizer mesh__D007197 jls
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D007197 2004B
% 208.06/208.26 |- mesh__recordOriginator mesh__D007197 EC
% 208.06/208.26 |- skos__broader mesh__D007197smesh__D044467
% 208.06/208.26 |- mesh__recordMaintainer mesh__D007197 jls
% 208.06/208.26 |- skos__scopeNote mesh__D007197
% 208.06/208.26 Individual members of Central American ethnic groups with ancient historic ancestral origins in Asia. Mexican Indians are not included.%A%
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 American Amerind, Central
% 208.06/208.26 |- skos__annotation mesh__D007197
% 208.06/208.26 specify geog if possible; not for Indians of Mexico %28% = INDIANS, NORTH AMERICAN + MEXICO%29%%A%
% 208.06/208.26 |- skos__altLabel mesh__D007197 Amerinds, Central American
% 208.06/208.26 |- rdf__type mesh__D007197sskos__Concept
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 American Amerinds, Central
% 208.06/208.26 |- skos__hiddenLabel mesh__D007197 Central American Amerind
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D007197 78
% 208.06/208.26 |- mesh__dateCreated mesh__D007197 1977-05-13
% 208.06/208.26 |- mesh__historyNote mesh__D007197 78
% 208.06/208.26 |- skos__hiddenLabel mesh__D001609 Beta Globulin
% 208.06/208.26 |- skos__altLabel mesh__D001609 Beta-Globulin
% 208.06/208.26 |- mesh__activeMeSHYear mesh__D001609 2006
% 208.06/208.26 |- mesh__recordOriginator mesh__D001609 NLM
% 208.06/208.26 |- mesh__publicMeSHNote mesh__D001609 75; was BETA GLOBULIN 1965-74
% 208.06/208.26 |- skos__hiddenLabel mesh__D001609 Beta Globulins
% 208.06/208.26 |- mesh__historyNote mesh__D001609
% 208.06/208.26 75; was BETA GLOBULIN 1963-74 %28%Prov 1963-64%29%
% 208.06/208.26 |- rdf__type mesh__D001609sskos__Concept
% 208.06/208.26 |- skos__annotation mesh__D001609
% 208.06/208.26 GEN or unspecified; prefer specifics; do not confuse with beta 2 A-globulin or beta 2 M-globulin %28% = BETA 2-MICROGLOBULIN%29%%A%
% 208.06/208.26 |- mesh__dateRevised mesh__D001609 2005-07-01
% 208.06/208.27 |- mesh__dateCreated mesh__D001609 1999-01-01
% 208.06/208.27 |- mesh__recordMaintainer mesh__D001609 sjn
% 208.06/208.27 |- skos__broader mesh__D001609smesh__D012712
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D001609 sjn
% 208.06/208.27 |- mesh__dateEstablished mesh__D001609 1965-01-01
% 208.06/208.27 |- skos__prefLabel mesh__D001609 Beta-Globulins
% 208.06/208.27 |- skos__scopeNote mesh__D001609
% 208.06/208.27 Serum proteins with an electrophoretic mobility that falls between ALPHA-GLOBULINS and GAMMA-GLOBULINS.%A%
% 208.06/208.27 |- mesh__onlineNote mesh__D001609
% 208.06/208.27 use BETA-GLOBULINS to search BETA GLOBULIN 1966-74
% 208.06/208.27 |- skos__scopeNote mesh__D012331
% 208.06/208.27 Ribonucleic acid in fungi having regulatory and catalytic roles as well as involvement in protein synthesis.%A%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 2001
% 208.06/208.27 |- mesh__dateRevised mesh__D012331 1995-06-08
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 2005
% 208.06/208.27 |- mesh__dateEstablished mesh__D012331 1980-01-01
% 208.06/208.27 |- mesh__historyNote mesh__D012331 80
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 2000
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 1997
% 208.06/208.27 |- skos__historyNote mesh__D012331 RNA %28%1966-1979%29%
% 208.06/208.27 |- rdf__type mesh__D012331sskos__Concept
% 208.06/208.27 |- mesh__dateCreated mesh__D012331 1979-05-25
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D012331 80
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 1996
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 2004
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D012331 PLS
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 2002
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 1999
% 208.06/208.27 |- skos__prefLabel mesh__D012331 RNA, Fungal
% 208.06/208.27 |- skos__annotation mesh__D012331
% 208.06/208.27 IM; coord with specific fungus %28%IM%29%; /drug eff /ultrastruct permitted%A%
% 208.06/208.27 |- skos__altLabel mesh__D012331 Fungal RNA
% 208.06/208.27 |- mesh__recordMaintainer mesh__D012331 KEV
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 2003
% 208.06/208.27 |- mesh__recordOriginator mesh__D012331 RLS
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 1998
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012331 2006
% 208.06/208.27 |- skos__broader mesh__D012331smesh__D012313
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D031296 2006
% 208.06/208.27 |- skos__altLabel mesh__D031296 Cytisus laburnum
% 208.06/208.27 |- skos__scopeNote mesh__D031296
% 208.06/208.27 A plant genus of the family FABACEAE named after the drooping clusters of flowers.%A%
% 208.06/208.27 |- skos__annotation mesh__D031296
% 208.06/208.27 INDIAN LABURNUM see CASSIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.27 |- mesh__historyNote mesh__D031296 2003
% 208.06/208.27 |- mesh__dateCreated mesh__D031296 2002-07-03
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D031296 2003
% 208.06/208.27 |- skos__altLabel mesh__D031296 Golden Chain
% 208.06/208.27 |- mesh__dateEstablished mesh__D031296 2003-01-01
% 208.06/208.27 |- rdf__type mesh__D031296sskos__Concept
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D031296 2004
% 208.06/208.27 |- skos__broader mesh__D031296smesh__D007887
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D031296 2003
% 208.06/208.27 |- skos__prefLabel mesh__D031296 Laburnum
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D031296 2005
% 208.06/208.27 |- mesh__dateCreated mesh__D011239 1999-01-01
% 208.06/208.27 |- mesh__historyNote mesh__D011239
% 208.06/208.27 /therapeutic use was PREDNISOLONE, THERAPEUTIC 1965
% 208.06/208.27 |- skos__prefLabel mesh__D011239 Prednisolone
% 208.06/208.27 |- mesh__recordOriginator mesh__D011239 NLM
% 208.06/208.27 |- mesh__dateRevised mesh__D011239 2003-07-09
% 208.06/208.27 |- skos__hiddenLabel mesh__D011239 Di Adreson F
% 208.06/208.27 |- skos__broader mesh__D011239smesh__D011246
% 208.06/208.27 |- skos__hiddenLabel mesh__D011239 DiAdresonF
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D011239 sjn
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D011239 2006
% 208.06/208.27 |- mesh__recordMaintainer mesh__D011239 ssb
% 208.06/208.27 |- rdf__type mesh__D011239sskos__Concept
% 208.06/208.27 |- skos__scopeNote mesh__D011239
% 208.06/208.27 A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.%A%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D011239 2005
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D011239
% 208.06/208.27 /therapeutic use was PREDNISOLONE, THERAPEUTIC 1965
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D011239 2004
% 208.06/208.27 |- skos__broader mesh__D008290smesh__D003904
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D008290 2006A
% 208.06/208.27 |- mesh__dateCreated mesh__D008290 1999-01-01
% 208.06/208.27 |- skos__scopeNote mesh__D008290
% 208.06/208.27 A mitosporic fungal genus that causes a variety of skin disorders. Malassezia furfur %28%Pityrosporum orbiculare%29% causes TINEA VERSICOLOR.%A%
% 208.06/208.27 |- mesh__recordMaintainer mesh__D008290 ags
% 208.06/208.27 |- skos__altLabel mesh__D008290 Pityrosporum
% 208.06/208.27 |- skos__prefLabel mesh__D008290 Malassezia
% 208.06/208.27 |- skos__altLabel mesh__D008290 Pityrosporum orbiculare
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D008290 2006
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D008290 ags
% 208.06/208.27 |- rdf__type mesh__D008290sskos__Concept
% 208.06/208.27 |- skos__annotation mesh__D008290
% 208.06/208.27 infection: coord IM with DERMATOMYCOSES %28%IM%29% or TINEA VERSICOLOR %28%IM%29%%A%
% 208.06/208.27 |- mesh__recordOriginator mesh__D008290 NLM
% 208.06/208.27 |- skos__broader mesh__D008290smesh__D015003
% 208.06/208.27 |- mesh__dateRevised mesh__D008290 2005-08-03
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D016722 SJN
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016722 2004
% 208.06/208.27 |- skos__annotation mesh__D016722
% 208.06/208.27 cermet stands for %22%CERamic%22% %26% %22%METal%22%; D25-26 qualif
% 208.06/208.27 |- skos__historyNote mesh__D016722 Dental Alloys %28%1988-1991%29%
% 208.06/208.27 |- mesh__dateRevised mesh__D016722 1997-06-20
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016722 2001
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016722 1999
% 208.06/208.27 |- skos__broader mesh__D016722smesh__D005899
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016722 2003
% 208.06/208.27 |- skos__prefLabel mesh__D016722 Cermet Cements
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016722 2000
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016722 1998
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016722 2006
% 208.06/208.27 |- skos__hiddenLabel mesh__D016722 Cements, Cermet
% 208.06/208.27 |- skos__hiddenLabel mesh__D016722 KetacSilver
% 208.06/208.27 |- skos__historyNote mesh__D016722 Glass Ionomer Cements %28%1985-1991%29%
% 208.06/208.27 |- skos__altLabel mesh__D016722 Cermet
% 208.06/208.27 |- mesh__recordMaintainer mesh__D016722 ADP
% 208.06/208.27 |- skos__scopeNote mesh__D016722
% 208.06/208.27 Fluoride-releasing restorative materials made by the sintering of metal %28%usually silver%29% particles to glass ionomer powder. Glass ionomers are fluoride-releasing cements that are not very durable. Sintering of the metal particles is a means of improving those physical properties that will make the glass ionomer cement more durable.%A%
% 208.06/208.27 |- mesh__recordOriginator mesh__D016722 MXR
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016722 2005
% 208.06/208.27 |- skos__hiddenLabel mesh__D016722 Ketac Silver
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016722 2002
% 208.06/208.27 |- mesh__dateEstablished mesh__D016722 1992-01-01
% 208.06/208.27 |- mesh__dateCreated mesh__D016722 1991-04-29
% 208.06/208.27 |- mesh__historyNote mesh__D016722 92
% 208.06/208.27 |- skos__historyNote mesh__D016722 Dental Cements %28%1988-1991%29%
% 208.06/208.27 |- rdf__type mesh__D016722sskos__Concept
% 208.06/208.27 |- skos__historyNote mesh__D016722 Silver %28%1988-1991%29%
% 208.06/208.27 |- skos__broader mesh__D016722smesh__D016876
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D016722 92
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D002702 2004
% 208.06/208.27 |- skos__scopeNote mesh__D002702
% 208.06/208.27 Nonsusceptibility of bacteria to the action of CHLORAMPHENICOL, a potent inhibitor of protein synthesis in the 50S ribosomal subunit where amino acids are added to nascent bacterial polypeptides.%A%
% 208.06/208.27 |- mesh__recordMaintainer mesh__D002702 ssb
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D002702 2005
% 208.06/208.27 |- skos__historyNote mesh__D002702
% 208.06/208.27 Drug Resistance, Microbial %28%1966-1987%29%
% 208.06/208.27 |- rdf__type mesh__D002702sskos__Concept
% 208.06/208.27 |- skos__historyNote mesh__D002702 Chloramphenicol %28%1966-1987%29%
% 208.06/208.27 |- skos__hiddenLabel mesh__D002702 Chloramphenicol Resistances
% 208.06/208.27 |- mesh__recordOriginator mesh__D002702 SCD
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D002702 1988
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D002702 sjn
% 208.06/208.27 |- skos__broader mesh__D002702smesh__D024881
% 208.06/208.27 |- mesh__dateCreated mesh__D002702 1987-05-09
% 208.06/208.27 |- skos__prefLabel mesh__D002702 Chloramphenicol Resistance
% 208.06/208.27 |- mesh__historyNote mesh__D002702 1988
% 208.06/208.27 |- mesh__dateEstablished mesh__D002702 1988-01-01
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D002702 2006
% 208.06/208.27 |- mesh__dateRevised mesh__D002702 2003-07-09
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007996 2000
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D007996 sjn
% 208.06/208.27 |- skos__annotation mesh__D007996
% 208.06/208.27 med libr assoc: do not coord with MEDICINE; DF: LIBRARY ASSOC%A%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007996 2001
% 208.06/208.27 |- skos__broader mesh__D007996smesh__D007998
% 208.06/208.27 |- mesh__recordMaintainer mesh__D007996 kle
% 208.06/208.27 |- rdf__type mesh__D007996sskos__Concept
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007996 2002
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007996 2005
% 208.06/208.27 |- skos__altLabel mesh__D007996 Associations, Library
% 208.06/208.27 |- mesh__dateRevised mesh__D007996 1999-11-03
% 208.06/208.27 |- mesh__dateCreated mesh__D007996 1999-01-01
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007996 2003
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007996 2006
% 208.06/208.27 |- skos__hiddenLabel mesh__D007996 Association, Library
% 208.06/208.27 |- skos__hiddenLabel mesh__D007996 Library Association
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007996 2004
% 208.06/208.27 |- skos__prefLabel mesh__D007996 Library Associations
% 208.06/208.27 |- mesh__recordOriginator mesh__D007996 NLM
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 American Indians, North
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007198 2004
% 208.06/208.27 |- skos__altLabel mesh__D007198 Amerinds, North American
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007198 2005
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 Amerind, North American
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 North American Amerind
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 American, Native
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 Indian, North American
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007198 2006
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 Americans, Native
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007198 2004A
% 208.06/208.27 |- mesh__dateCreated mesh__D007198 1999-01-01
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 North American Indian
% 208.06/208.27 |- rdf__type mesh__D007198sskos__Concept
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 Indians, American
% 208.06/208.27 |- skos__related mesh__D007198smesh__D016549
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 North American Amerinds
% 208.06/208.27 |- mesh__dateRevised mesh__D007198 2003-10-30
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 North American Indians
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D007198 jls
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 American Indian
% 208.06/208.27 |- skos__prefLabel mesh__D007198 Indians, North American
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007198 2004B
% 208.06/208.27 |- mesh__recordOriginator mesh__D007198 NLM
% 208.06/208.27 |- skos__broader mesh__D007198smesh__D044467
% 208.06/208.27 |- skos__annotation mesh__D007198
% 208.06/208.27 specify geog if possible; in titles capitalize both Native and American%A%
% 208.06/208.27 |- mesh__recordMaintainer mesh__D007198 jls
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 Native American
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 Indian, American
% 208.06/208.27 |- skos__scopeNote mesh__D007198
% 208.06/208.27 Individual members of North American ethnic groups with ancient historic ancestral origins in Asia.%A%
% 208.06/208.27 |- skos__hiddenLabel mesh__D007198 American Indian, North
% 208.06/208.27 |- skos__scopeNote mesh__D040821
% 208.06/208.27 The fundamental dispositions and traits of humans. %28%Merriam-Webster%27%s Collegiate Dictionary, 10th ed%29%%A%
% 208.06/208.27 |- skos__altLabel mesh__D040821 Human Nature
% 208.06/208.27 |- skos__related mesh__D040821smesh__D010551
% 208.06/208.27 |- mesh__dateEstablished mesh__D040821 2003-01-01
% 208.06/208.27 |- skos__hiddenLabel mesh__D040821 Nature, Human
% 208.06/208.27 |- skos__hiddenLabel mesh__D040821 Characteristic, Human
% 208.06/208.27 |- skos__hiddenLabel mesh__D040821 Characteristics, Human
% 208.06/208.27 |- rdf__type mesh__D040821sskos__Concept
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D040821 2006
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D040821 2003
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D040821 2005
% 208.06/208.27 |- skos__hiddenLabel mesh__D040821 Human Characteristic
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D040821 2004
% 208.06/208.27 |- skos__related mesh__D040821smesh__D028723
% 208.06/208.27 |- skos__broader mesh__D040821smesh__D001520
% 208.06/208.27 |- skos__prefLabel mesh__D040821 Human Characteristics
% 208.06/208.27 |- mesh__historyNote mesh__D040821 2003
% 208.06/208.27 |- mesh__dateCreated mesh__D040821 2002-07-03
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D040821 2003
% 208.06/208.27 |- mesh__historyNote mesh__D012332 79
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 1996
% 208.06/208.27 |- skos__annotation mesh__D012332
% 208.06/208.27 IM; /drug eff /ultrastruct permitted; DF: HNRNA
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 2000
% 208.06/208.27 |- mesh__dateEstablished mesh__D012332 1979-01-01
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 1997
% 208.06/208.27 |- mesh__dateRevised mesh__D012332 1992-05-20
% 208.06/208.27 |- rdf__type mesh__D012332sskos__Concept
% 208.06/208.27 |- mesh__dateCreated mesh__D012332 1978-03-15
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 2003
% 208.06/208.27 |- mesh__recordOriginator mesh__D012332 RLS
% 208.06/208.27 |- skos__broader mesh__D012332smesh__D015138
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 2001
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 1998
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 1993
% 208.06/208.27 |- mesh__recordMaintainer mesh__D012332 TGC
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 2004
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 2002
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 1994
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D012332 PLS
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 1999
% 208.06/208.27 |- skos__scopeNote mesh__D012332
% 208.06/208.27 Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesized and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnRNA hybridizes with nuclear DNA rather than with mRNA.%A%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 2005
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 1995
% 208.06/208.27 |- skos__prefLabel mesh__D012332 RNA, Heterogeneous Nuclear
% 208.06/208.27 |- skos__historyNote mesh__D012332 RNA %28%1966-1978%29%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012332 2006
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D012332 79
% 208.06/208.27 |- skos__hiddenLabel mesh__D012332 Nuclear RNA, Heterogeneous
% 208.06/208.27 |- skos__altLabel mesh__D012332 Heterogeneous Nuclear RNA
% 208.06/208.27 |- skos__scopeNote mesh__D031297
% 208.06/208.27 A plant genus of the family FABACEAE that is a source of SPARTEINE, lupanine and other lupin alkaloids.%A%
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D031297 2003
% 208.06/208.27 |- mesh__dateEstablished mesh__D031297 2003-01-01
% 208.06/208.27 |- skos__altLabel mesh__D031297 Lupine
% 208.06/208.27 |- skos__broader mesh__D031297smesh__D007887
% 208.06/208.27 |- mesh__historyNote mesh__D031297 2003
% 208.06/208.27 |- mesh__dateCreated mesh__D031297 2002-07-03
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D031297 2006
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D031297 2005
% 208.06/208.27 |- skos__annotation mesh__D031297
% 208.06/208.27 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.27 |- skos__prefLabel mesh__D031297 Lupinus
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D031297 2004
% 208.06/208.27 |- rdf__type mesh__D031297sskos__Concept
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D031297 2003
% 208.06/208.27 |- skos__hiddenLabel mesh__D008291 Dehydrogenase, NAD-Malate
% 208.06/208.27 |- mesh__recordOriginator mesh__D008291 NLM
% 208.06/208.27 |- mesh__dateCreated mesh__D008291 1999-01-01
% 208.06/208.27 |- skos__prefLabel mesh__D008291 Malate Dehydrogenase
% 208.06/208.27 |- mesh__dateRevised mesh__D008291 2003-07-09
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D008291
% 208.06/208.27 MALIC ENZYME was see MALATE DEHYDROGENASE 1983-93
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D008291 2005
% 208.06/208.27 |- skos__hiddenLabel mesh__D008291 NAD Malate Dehydrogenase
% 208.06/208.27 |- skos__scopeNote mesh__D008291
% 208.06/208.27 An enzyme that catalyzes the conversion of %28%S%29%-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37.%A%
% 208.06/208.27 |- skos__altLabel mesh__D008291 Malic Dehydrogenase
% 208.06/208.27 |- mesh__recordMaintainer mesh__D008291 ssb
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D008291 sjn
% 208.06/208.27 |- mesh__onlineNote mesh__D008291
% 208.06/208.27 use MALATE DEHYDROGENASE to search MALIC ENZYME 1983-93
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D008291 2006
% 208.06/208.27 |- skos__hiddenLabel mesh__D008291 Dehydrogenase, Malic
% 208.06/208.27 |- rdf__type mesh__D008291sskos__Concept
% 208.06/208.27 |- mesh__historyNote mesh__D008291
% 208.06/208.27 MALIC ENZYME was see MALATE DEHYDROGENASE 1983-93
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D008291 2004
% 208.06/208.27 |- skos__hiddenLabel mesh__D008291 Dehydrogenase, Malate
% 208.06/208.27 |- skos__broader mesh__D008291smesh__D000429
% 208.06/208.27 |- skos__altLabel mesh__D008291 NAD-Malate Dehydrogenase
% 208.06/208.27 |- mesh__dateEstablished mesh__D016723 1992-01-01
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D016723 92
% 208.06/208.27 |- skos__scopeNote mesh__D016723
% 208.06/208.27 The continuous turnover of bone matrix and mineral that involves first, an increase in resorption %28%osteoclastic activity%29% and later, reactive bone formation %28%osteoblastic activity%29%. The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone remodeling%27%s two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS.%A%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016723 2006
% 208.06/208.27 |- skos__prefLabel mesh__D016723 Bone Remodeling
% 208.06/208.27 |- skos__hiddenLabel mesh__D016723 Remodeling, Bone
% 208.06/208.27 |- skos__historyNote mesh__D016723 Bone Regeneration %28%1967-1991%29%
% 208.06/208.27 |- skos__annotation mesh__D016723
% 208.06/208.27 note category: an aspect of bone physiol
% 208.06/208.27 |- mesh__recordOriginator mesh__D016723 MXR
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016723 2005
% 208.06/208.27 |- mesh__recordMaintainer mesh__D016723 nns
% 208.06/208.27 |- skos__broader mesh__D016723smesh__D043702
% 208.06/208.27 |- skos__broader mesh__D016723smesh__D012038
% 208.06/208.27 |- mesh__dateCreated mesh__D016723 1991-04-29
% 208.06/208.27 |- mesh__historyNote mesh__D016723 92
% 208.06/208.27 |- skos__historyNote mesh__D016723 Bone Resorption %28%1967-1991%29%
% 208.06/208.27 |- mesh__dateRevised mesh__D016723 2003-07-09
% 208.06/208.27 |- rdf__type mesh__D016723sskos__Concept
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D016723 2004
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D016723 sjn
% 208.06/208.27 |- skos__historyNote mesh__D016723 Bone Development %28%1967-1991%29%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D002703 2003
% 208.06/208.27 |- skos__altLabel mesh__D002703 Tetrachloro-1,4-benzoquinone
% 208.06/208.27 |- rdf__type mesh__D002703sskos__Concept
% 208.06/208.27 |- mesh__recordOriginator mesh__D002703 RLS
% 208.06/208.27 |- skos__broader mesh__D002703smesh__D016227
% 208.06/208.27 |- mesh__dateEstablished mesh__D002703 1991-01-01
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D002703 91; was see under QUINONES 1976-90
% 208.06/208.27 |- skos__prefLabel mesh__D002703 Chloranil
% 208.06/208.27 |- mesh__dateRevised mesh__D002703 2000-06-22
% 208.06/208.27 |- mesh__recordMaintainer mesh__D002703 CCR
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D002703 2002
% 208.06/208.27 |- skos__scopeNote mesh__D002703
% 208.06/208.27 A quinone fungicide used for treatment of seeds and foliage.%A%
% 208.06/208.27 |- skos__altLabel mesh__D002703 2,3,5,6-Tetrachloro-1,4-benzoquinone
% 208.06/208.27 |- skos__historyNote mesh__D002703 Chlorine %28%1974-1975%29%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D002703 2006
% 208.06/208.27 |- mesh__dateCreated mesh__D002703 1975-07-18
% 208.06/208.27 |- mesh__historyNote mesh__D002703
% 208.06/208.27 91%28%76%29%; was see under QUINONES 1976-90
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D002703 2004
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D002703 sjn
% 208.06/208.27 |- skos__hiddenLabel mesh__D002703 Tetrachloro 1,4 benzoquinone
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D002703 2005
% 208.06/208.27 |- skos__historyNote mesh__D002703 Quinones %28%1968-1975%29%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D002703 2001
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007997 2005
% 208.06/208.27 |- skos__hiddenLabel mesh__D007997 School, Library
% 208.06/208.27 |- mesh__dateCreated mesh__D007997 1999-01-01
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007997 2006
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007997 2003
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007997 2000
% 208.06/208.27 |- skos__hiddenLabel mesh__D007997 Library School
% 208.06/208.27 |- skos__altLabel mesh__D007997 Schools, Library
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007997 2004
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D007997 sjn
% 208.06/208.27 |- mesh__recordOriginator mesh__D007997 NLM
% 208.06/208.27 |- skos__annotation mesh__D007997 specify geog if pertinent
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007997 2001
% 208.06/208.27 |- skos__scopeNote mesh__D007997
% 208.06/208.27 Educational institutions for individuals specializing in the field of library science or information.%A%
% 208.06/208.27 |- skos__prefLabel mesh__D007997 Library Schools
% 208.06/208.27 |- mesh__recordMaintainer mesh__D007997 kle
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007997 2002
% 208.06/208.27 |- mesh__dateRevised mesh__D007997 1999-11-03
% 208.06/208.27 |- skos__broader mesh__D007997smesh__D012574
% 208.06/208.27 |- skos__broader mesh__D007997smesh__D007998
% 208.06/208.27 |- rdf__type mesh__D007997sskos__Concept
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D032390 2004
% 208.06/208.27 |- skos__related mesh__D032390smesh__D032389
% 208.06/208.27 |- skos__prefLabel mesh__D032390 Myoblasts, Smooth Muscle
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D032390 2003
% 208.06/208.27 |- skos__scopeNote mesh__D032390
% 208.06/208.27 Precursor cells destined to differentiate into smooth muscle myocytes %28%MYOCYTES, SMOOTH MUSCLE%29%.%A%
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D032390 2006
% 208.06/208.27 |- skos__broader mesh__D032390smesh__D032446
% 208.06/208.27 |- skos__altLabel mesh__D032390 Smooth Muscle Myoblasts
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D032390 2005
% 208.06/208.27 |- mesh__historyNote mesh__D032390 2003
% 208.06/208.27 |- skos__hiddenLabel mesh__D032390 Myoblast, Smooth Muscle
% 208.06/208.27 |- skos__hiddenLabel mesh__D032390 Smooth Muscle Myoblast
% 208.06/208.27 |- rdf__type mesh__D032390sskos__Concept
% 208.06/208.27 |- mesh__dateEstablished mesh__D032390 2003-01-01
% 208.06/208.27 |- mesh__publicMeSHNote mesh__D032390 2003
% 208.06/208.27 |- mesh__dateCreated mesh__D032390 2002-07-03
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 South American Indian
% 208.06/208.27 |- mesh__recordMaintainer mesh__D007199 jls
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007199 2004
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007199 2004A
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 South American Amerinds
% 208.06/208.27 |- mesh__recordOriginator mesh__D007199 NLM
% 208.06/208.27 |- skos__broader mesh__D007199smesh__D044467
% 208.06/208.27 |- skos__annotation mesh__D007199
% 208.06/208.27 specify geog if possible; in titles capitalize both Native and American%A%
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 Amerind, South American
% 208.06/208.27 |- mesh__recordAuthorizer mesh__D007199 jls
% 208.06/208.27 |- skos__scopeNote mesh__D007199
% 208.06/208.27 Individual members of South American ethnic groups with historic ancestral origins in Asia.%A%
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 Indian, South American
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 American Amerind, South
% 208.06/208.27 |- skos__prefLabel mesh__D007199 Indians, South American
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007199 2006
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007199 2005A
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007199 2004B
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D007199 2005
% 208.06/208.27 |- mesh__dateRevised mesh__D007199 2004-07-28
% 208.06/208.27 |- skos__altLabel mesh__D007199 Amerinds, South American
% 208.06/208.27 |- rdf__type mesh__D007199sskos__Concept
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 American Amerinds, South
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 American Indians, South
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 South American Amerind
% 208.06/208.27 |- mesh__dateCreated mesh__D007199 1999-01-01
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 American Indian, South
% 208.06/208.27 |- skos__hiddenLabel mesh__D007199 South American Indians
% 208.06/208.27 |- skos__annotation mesh__D012333
% 208.06/208.27 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.06/208.27 |- mesh__historyNote mesh__D012333
% 208.06/208.27 65%28%64%29%; MRNA, NON-POLYADENYLATED was NON-POLYADENYLATED MRNA %28%NM%29% 1981-94; MRNA, POLYADENYLATED was POLYADENYLATED MRNA %28%NM%29% 1980-94; POLY%28%A%29%+ RNA was SY to POLY%28%A%29% RNA %28%NM%29% 1980-94%A%
% 208.06/208.27 |- rdf__type mesh__D012333sskos__Concept
% 208.06/208.27 |- skos__scopeNote mesh__D012333
% 208.06/208.27 RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3%27% end, referred to as the poly%28%A%29% tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.%A%
% 208.06/208.27 |- mesh__onlineNote mesh__D012333
% 208.06/208.27 use RNA, MESSENGER %28%NM%29% to search MRNA, NON-POLYADENYLATED 1981-94, MRNA, POLYADENYLATED 1980-94, %26% POLY%28%A%29%+ RNA 1980-94%A%
% 208.06/208.27 |- skos__altLabel mesh__D012333 RNA, Messenger, Polyadenylated
% 208.06/208.27 |- mesh__recordMaintainer mesh__D012333 ags
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012333 2003
% 208.06/208.27 |- skos__hiddenLabel mesh__D012333 mRNA, Non Polyadenylated
% 208.06/208.27 |- skos__hiddenLabel mesh__D012333 Polyadenylated RNA
% 208.06/208.27 |- skos__hiddenLabel mesh__D012333 Polyadenylated Messenger RNA
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012333 2004
% 208.06/208.27 |- mesh__dateCreated mesh__D012333 1999-01-01
% 208.06/208.27 |- skos__broader mesh__D012333smesh__D012313
% 208.06/208.27 |- skos__altLabel mesh__D012333 Polyadenylated mRNA
% 208.06/208.27 |- skos__altLabel mesh__D012333 Poly%28%A%29%+ mRNA
% 208.06/208.27 |- skos__altLabel mesh__D012333 Messenger RNA
% 208.06/208.27 |- mesh__dateRevised mesh__D012333 2002-07-03
% 208.06/208.27 |- mesh__activeMeSHYear mesh__D012333 2005
% 208.06/208.27 |- mesh__dateEstablished mesh__D012333 1965-01-01
% 208.06/208.28 |- skos__hiddenLabel mesh__D012333 RNA, Polyadenylated Messenger
% 208.06/208.28 |- skos__altLabel mesh__D012333 mRNA
% 208.06/208.28 |- skos__altLabel mesh__D012333 Poly%28%A%29%+ RNA
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012333 2006
% 208.06/208.28 |- skos__altLabel mesh__D012333 Poly%28%A%29% RNA
% 208.06/208.28 |- skos__hiddenLabel mesh__D012333 Non Polyadenylated mRNA
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D012333 sjn
% 208.06/208.28 |- skos__altLabel mesh__D012333 Non-Polyadenylated mRNA
% 208.06/208.28 |- mesh__recordOriginator mesh__D012333 NLM
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D012333
% 208.06/208.28 65; NON-POLYADENYLATED MRNA was indexed under RNA, MESSENGER 1981-94; POLYADENYLATED MRNA %26% POLY%28%A%29% RNA were indexed under POLY A %26% RNA, MESSENGER 1980-94%A%
% 208.06/208.28 |- skos__altLabel mesh__D012333 Messenger RNA, Polyadenylated
% 208.06/208.28 |- skos__prefLabel mesh__D012333 RNA, Messenger
% 208.06/208.28 |- skos__broader mesh__D031298smesh__D007887
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D031298 2006
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D031298 2005
% 208.06/208.28 |- mesh__dateEstablished mesh__D031298 2003-01-01
% 208.06/208.28 |- mesh__dateCreated mesh__D031298 2002-07-03
% 208.06/208.28 |- mesh__historyNote mesh__D031298 2003
% 208.06/208.28 |- skos__annotation mesh__D031298
% 208.06/208.28 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.28 |- skos__scopeNote mesh__D031298
% 208.06/208.28 A plant genus of the family FABACEAE that contains kukulkanin, a CHALCONE.%A%
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D031298 2004
% 208.06/208.28 |- skos__prefLabel mesh__D031298 Mimosa
% 208.06/208.28 |- rdf__type mesh__D031298sskos__Concept
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D031298 2003
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D031298 2003
% 208.06/208.28 |- skos__altLabel mesh__D036781 Pilins
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D036781
% 208.06/208.28 2003; PILIN %28%now FIMBRIAE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1977-2002; PROPILIN %28%now FIMBRIAE PROTEINS%29% was indexed under BACTERIAL OUTER MEMBRANE PROTEINS %26% PROTEIN PRECURSORS 1989-2002%A%
% 208.06/208.28 |- skos__altLabel mesh__D036781 Propilin
% 208.06/208.28 |- skos__altLabel mesh__D036781 Pilin
% 208.06/208.28 |- mesh__dateCreated mesh__D036781 2002-07-03
% 208.06/208.28 |- rdf__type mesh__D036781sskos__Concept
% 208.06/208.28 |- skos__related mesh__D036781smesh__D018933
% 208.06/208.28 |- skos__hiddenLabel mesh__D036781 Precusors, Fimbriae Protein
% 208.06/208.28 |- mesh__recordOriginator mesh__D036781 jmp
% 208.06/208.28 |- skos__altLabel mesh__D036781 Pre-Pilin
% 208.06/208.28 |- mesh__historyNote mesh__D036781
% 208.06/208.28 2003; use FIMBRIAE PROTEINS %28%NM%29% 1977-2002
% 208.06/208.28 |- skos__annotation mesh__D036781
% 208.06/208.28 Coordinate with PILI, SEX if involved in BACTERIAL CONJUGATION, otherwise coordinate with FIMBRIAE, BACTERIAL%A%
% 208.06/208.28 |- skos__hiddenLabel mesh__D036781 Precursors, Pilin
% 208.06/208.28 |- skos__altLabel mesh__D036781 Pilin Precursors
% 208.06/208.28 |- skos__scopeNote mesh__D036781
% 208.06/208.28 Proteins that are structural components of bacterial fimbriae %28%FIMBRIAE, BACTERIAL%29% or sex pili %28%PILI, SEX%29%.%A%
% 208.06/208.28 |- skos__related mesh__D036781smesh__D010861
% 208.06/208.28 |- skos__prefLabel mesh__D036781 Fimbriae Proteins
% 208.06/208.28 |- skos__altLabel mesh__D036781 Pili Structural Proteins
% 208.06/208.28 |- mesh__dateRevised mesh__D036781 2005-06-30
% 208.06/208.28 |- mesh__recordMaintainer mesh__D036781 SYSTEM
% 208.06/208.28 |- mesh__dateEstablished mesh__D036781 2003-01-01
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D036781 2006
% 208.06/208.28 |- skos__hiddenLabel mesh__D036781 Pre Pilin
% 208.06/208.28 |- skos__hiddenLabel mesh__D036781 Protein Precusors, Fimbriae
% 208.06/208.28 |- skos__broader mesh__D036781smesh__D001425
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D036781 sjn
% 208.06/208.28 |- skos__altLabel mesh__D022761 Horizontal Gene Transfer
% 208.06/208.28 |- skos__prefLabel mesh__D022761 Gene Transfer, Horizontal
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D022761 2005
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D022761 2001
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D022761 jls
% 208.06/208.28 |- mesh__dateEstablished mesh__D022761 2001-01-01
% 208.06/208.28 |- skos__hiddenLabel mesh__D022761 Lateral Gene Transfers
% 208.06/208.28 |- skos__hiddenLabel mesh__D022761 Interspecific Recombination
% 208.06/208.28 |- skos__broader mesh__D022761smesh__D011995
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D022761 2006
% 208.06/208.28 |- mesh__recordOriginator mesh__D022761 nns
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D022761 2005B
% 208.06/208.28 |- skos__altLabel mesh__D022761 Lateral Gene Transfer
% 208.06/208.28 |- skos__annotation mesh__D022761
% 208.06/208.28 note category: do not confuse with GENE TRANSFER TECHNIQUES%A%
% 208.06/208.28 |- mesh__recordMaintainer mesh__D022761 jls
% 208.06/208.28 |- skos__altLabel mesh__D022761 Recombination, Interspecific
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D022761 2005C
% 208.06/208.28 |- rdf__type mesh__D022761sskos__Concept
% 208.06/208.28 |- skos__altLabel mesh__D022761 Gene Transfer, Lateral
% 208.06/208.28 |- mesh__historyNote mesh__D022761 2001
% 208.06/208.28 |- skos__hiddenLabel mesh__D022761 Gene Transfers, Lateral
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D022761 2004
% 208.06/208.28 |- skos__scopeNote mesh__D022761
% 208.06/208.28 The naturally occurring transmission of genetic information between organisms, related or unrelated, circumventing parent-to-offspring transmission. Horizontal gene transfer may occur via a variety of naturally occurring processes such as GENETIC CONJUGATION; GENETIC TRANSDUCTION; and TRANSFECTION. It may result in a change of the recipient organism%27%s genetic composition %28%TRANSFORMATION, GENETIC%29%.%A%
% 208.06/208.28 |- skos__hiddenLabel mesh__D022761 Interspecies Recombination
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D022761 2005A
% 208.06/208.28 |- mesh__dateRevised mesh__D022761 2004-07-27
% 208.06/208.28 |- mesh__dateCreated mesh__D022761 2000-07-06
% 208.06/208.28 |- mesh__dateCreated mesh__D008292 1976-04-16
% 208.06/208.28 |- skos__prefLabel mesh__D008292 Malate Synthase
% 208.06/208.28 |- skos__altLabel mesh__D008292 Malate Condensing Enzyme
% 208.06/208.28 |- mesh__recordMaintainer mesh__D008292 jmp
% 208.06/208.28 |- skos__hiddenLabel mesh__D008292 Transacetylase, Glyoxylate
% 208.06/208.28 |- skos__hiddenLabel mesh__D008292 Synthase, Malate
% 208.06/208.28 |- mesh__recordOriginator mesh__D008292 RLS
% 208.06/208.28 |- mesh__dateEstablished mesh__D008292 1991-01-01
% 208.06/208.28 |- mesh__dateRevised mesh__D008292 2005-06-30
% 208.06/208.28 |- skos__historyNote mesh__D008292 Malates %28%1973-1976%29%
% 208.06/208.28 |- skos__broader mesh__D008292smesh__D000217
% 208.06/208.28 |- skos__historyNote mesh__D008292 Ketoacid-Lyases %28%1973-1976%29%
% 208.06/208.28 |- skos__altLabel mesh__D008292 Glyoxylate Transacetylase
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008292 2006
% 208.06/208.28 |- skos__hiddenLabel mesh__D008292 Condensing Enzyme, Malate
% 208.06/208.28 |- skos__hiddenLabel mesh__D008292 Enzyme, Malate Condensing
% 208.06/208.28 |- skos__scopeNote mesh__D008292
% 208.06/208.28 An important enzyme in the glyoxylic acid cycle which reversibly catalyzes the synthesis of L-malate from acetyl-CoA and glyoxylate. This enzyme was formerly listed as EC 4.1.3.2.%A%
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D008292 sjn
% 208.06/208.28 |- rdf__type mesh__D008292sskos__Concept
% 208.06/208.28 |- skos__altLabel mesh__D008292 Malate Synthetase
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D008292
% 208.06/208.28 91; was see under KETOACID-LYASES 1977-90
% 208.06/208.28 |- skos__hiddenLabel mesh__D008292 Synthetase, Malate
% 208.06/208.28 |- mesh__historyNote mesh__D008292
% 208.06/208.28 91%28%77%29%; was see under KETOACID-LYASES 1977-90
% 208.06/208.28 |- skos__hiddenLabel mesh__D016724 Thoracic Empyema
% 208.06/208.28 |- mesh__recordMaintainer mesh__D016724 PLS
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 2003
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 1998
% 208.06/208.28 |- mesh__onlineNote mesh__D016724
% 208.06/208.28 use EMPYEMA to search EMPYEMA, PLEURAL %26% PYOTHORAX 1984-91%A%
% 208.06/208.28 |- mesh__dateRevised mesh__D016724 1994-05-27
% 208.06/208.28 |- mesh__dateEstablished mesh__D016724 1992-01-01
% 208.06/208.28 |- skos__altLabel mesh__D016724 Pyothorax
% 208.06/208.28 |- skos__broader mesh__D016724smesh__D012141
% 208.06/208.28 |- skos__hiddenLabel mesh__D016724 Thoracic Empyemas
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 2001
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 1995
% 208.06/208.28 |- mesh__recordOriginator mesh__D016724 TGC
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 2006
% 208.06/208.28 |- skos__broader mesh__D016724smesh__D010995
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D016724
% 208.06/208.28 92; was see EMPYEMA 1984-91; PYOTHORAX was see EMPYEMA 1984-91%A%
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D016724 PLS
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 2000
% 208.06/208.28 |- skos__annotation mesh__D016724 if tuberculous = EMPYEMA, TUBERCULOUS
% 208.06/208.28 |- skos__historyNote mesh__D016724 Empyema %28%1966-1991%29%
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 1997
% 208.06/208.28 |- skos__hiddenLabel mesh__D016724 Empyemas, Thoracic
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 2005
% 208.06/208.28 |- skos__hiddenLabel mesh__D016724 Pleural Empyema
% 208.06/208.28 |- rdf__type mesh__D016724sskos__Concept
% 208.06/208.28 |- skos__scopeNote mesh__D016724
% 208.06/208.28 Suppurative inflammation of the pleural space.
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 1996
% 208.06/208.28 |- mesh__historyNote mesh__D016724
% 208.06/208.28 92; was see EMPYEMA 1984-91; PYOTHORAX was see EMPYEMA 1984-91%A%
% 208.06/208.28 |- skos__altLabel mesh__D016724 Empyema, Thoracic
% 208.06/208.28 |- skos__hiddenLabel mesh__D016724 Empyemas, Pleural
% 208.06/208.28 |- skos__broader mesh__D016724smesh__D004653
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 2002
% 208.06/208.28 |- skos__prefLabel mesh__D016724 Empyema, Pleural
% 208.06/208.28 |- skos__hiddenLabel mesh__D016724 Pleural Empyemas
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 2004
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D016724 1999
% 208.06/208.28 |- mesh__dateCreated mesh__D016724 1991-02-11
% 208.06/208.28 |- mesh__recordOriginator mesh__D002704 NLM
% 208.06/208.28 |- mesh__dateCreated mesh__D002704 1999-01-01
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 1995
% 208.06/208.28 |- skos__broader mesh__D002704smesh__D017606
% 208.06/208.28 |- skos__broader mesh__D002704smesh__D000838
% 208.06/208.28 |- mesh__recordMaintainer mesh__D002704 TPW
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 2006
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 1999
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 2004
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 2001
% 208.06/208.28 |- mesh__dateEstablished mesh__D002704 1973-01-01
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 1994
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 1997
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 2000
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 2005
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 1998
% 208.06/208.28 |- mesh__dateRevised mesh__D002704 1993-06-04
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 2003
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 1996
% 208.06/208.28 |- skos__historyNote mesh__D002704 Chlorine %28%1966-1970%29%
% 208.06/208.28 |- rdf__type mesh__D002704sskos__Concept
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D002704 PLS
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D002704 73
% 208.06/208.28 |- skos__scopeNote mesh__D002704
% 208.06/208.28 Inorganic salts of chloric acid that contain the ClO3- ion.%A%
% 208.06/208.28 |- skos__prefLabel mesh__D002704 Chlorates
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D002704 2002
% 208.06/208.28 |- mesh__historyNote mesh__D002704 73%28%71%29%
% 208.06/208.28 |- skos__broader mesh__D019817Q000031smesh__D019817
% 208.06/208.28 |- mesh__preferredCombination mesh__D019817Q000031smesh__D020185
% 208.06/208.28 |- rdf__type mesh__D019817Q000031smesh__CompoundConcept
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 2006
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 1991
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 2003
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 1994
% 208.06/208.28 |- mesh__dateRevised mesh__D007998 1990-05-07
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 2004
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 1992
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 1995
% 208.06/208.28 |- skos__hiddenLabel mesh__D007998 Sciences, Library
% 208.06/208.28 |- skos__hiddenLabel mesh__D007998 Library Sciences
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 1993
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 1998
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D007998 PLS
% 208.06/208.28 |- skos__annotation mesh__D007998
% 208.06/208.28 SPEC: SPEC qualif; med librarianship: do not coord with MEDICINE%A%
% 208.06/208.28 |- mesh__recordMaintainer mesh__D007998 PLS
% 208.06/208.28 |- skos__broader mesh__D007998smesh__D007254
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 2000
% 208.06/208.28 |- skos__prefLabel mesh__D007998 Library Science
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 1999
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 1996
% 208.06/208.28 |- mesh__recordOriginator mesh__D007998 NLM
% 208.06/208.28 |- rdf__type mesh__D007998sskos__Concept
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 2001
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 1997
% 208.06/208.28 |- skos__hiddenLabel mesh__D007998 Science, Library
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 2005
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007998 2002
% 208.06/208.28 |- mesh__dateCreated mesh__D007998 1999-01-01
% 208.06/208.28 |- skos__scopeNote mesh__D007998
% 208.06/208.28 Study of the principles and practices of library administration and services.%A%
% 208.06/208.28 |- skos__prefLabel mesh__D048008 TNF Receptor-Associated Factor 3
% 208.06/208.28 |- skos__hiddenLabel mesh__D048008 LAP 1 Protein
% 208.06/208.28 |- skos__hiddenLabel mesh__D048008 CD40 Receptor Associated Factor 1
% 208.06/208.28 |- mesh__dateCreated mesh__D048008 2004-07-07
% 208.06/208.28 |- skos__scopeNote mesh__D048008
% 208.06/208.28 A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signaling and activation of MITOGEN-ACTIVATED PROTEIN KINASES.%A%
% 208.06/208.28 |- mesh__recordOriginator mesh__D048008 jmp
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D048008 sjn
% 208.06/208.28 |- mesh__historyNote mesh__D048008 2005%28%1995%29%
% 208.06/208.28 |- skos__historyNote mesh__D048008 Proteins %28%1995-2004%29%
% 208.06/208.28 |- skos__altLabel mesh__D048008 TRAF-3
% 208.06/208.28 |- skos__broader mesh__D048008smesh__D047988
% 208.06/208.28 |- skos__altLabel mesh__D048008 CRAF1 Protein
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D048008
% 208.06/208.28 2005; TNF RECEPTOR-ASSOCIATED FACTOR 3 was indexed under PROTEINS 1995-2004%A%
% 208.06/208.28 |- skos__altLabel mesh__D048008 CD40bp Protein
% 208.06/208.28 |- skos__altLabel mesh__D048008 LAP-1 Protein
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D048008 2005
% 208.06/208.28 |- skos__hiddenLabel mesh__D048008 TNF Receptor Associated Factor 3
% 208.06/208.28 |- skos__altLabel mesh__D048008 CD40 Receptor-Associated Factor 1
% 208.06/208.28 |- mesh__dateEstablished mesh__D048008 2005-01-01
% 208.06/208.28 |- mesh__recordMaintainer mesh__D048008 jmp
% 208.06/208.28 |- rdf__type mesh__D048008sskos__Concept
% 208.06/208.28 |- skos__altLabel mesh__D048008 TRAF3
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D048008 2006
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 2004
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 2001
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 1999
% 208.06/208.28 |- mesh__dateCreated mesh__D012334 1999-01-01
% 208.06/208.28 |- mesh__recordMaintainer mesh__D012334 TGC
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 2005
% 208.06/208.28 |- skos__prefLabel mesh__D012334 RNA, Neoplasm
% 208.06/208.28 |- mesh__recordOriginator mesh__D012334 NLM
% 208.06/208.28 |- skos__annotation mesh__D012334
% 208.06/208.28 IM; /drug eff /ultrastruct permitted; coord with required neopl term%28%s%29% %28%IM%29%; Manual 24.4.4.2; DF: RNA NEOPL%A%
% 208.06/208.28 |- skos__altLabel mesh__D012334 Neoplasm RNA
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D012334 PLS
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 2002
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 2006
% 208.06/208.28 |- mesh__dateRevised mesh__D012334 1995-03-20
% 208.06/208.28 |- skos__scopeNote mesh__D012334 RNA present in neoplastic tissue.
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 1996
% 208.06/208.28 |- rdf__type mesh__D012334sskos__Concept
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 1997
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 2003
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 1998
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012334 2000
% 208.06/208.28 |- skos__broader mesh__D012334smesh__D012313
% 208.06/208.28 |- skos__prefLabel mesh__D031299 Mucuna
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D031299 2003
% 208.06/208.28 |- mesh__dateCreated mesh__D031299 2002-07-02
% 208.06/208.28 |- skos__altLabel mesh__D031299 Bean, Velvet
% 208.06/208.28 |- skos__broader mesh__D031299smesh__D007887
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D031299 2006
% 208.06/208.28 |- skos__annotation mesh__D031299
% 208.06/208.28 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D031299 2005
% 208.06/208.28 |- mesh__dateEstablished mesh__D031299 2003-01-01
% 208.06/208.28 |- mesh__historyNote mesh__D031299 2003
% 208.06/208.28 |- skos__scopeNote mesh__D031299
% 208.06/208.28 A plant genus of the family FABACEAE that is the source of mucuna gum.%A%
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D031299 2004
% 208.06/208.28 |- skos__altLabel mesh__D031299 Cowitch
% 208.06/208.28 |- rdf__type mesh__D031299sskos__Concept
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D031299 2003
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D022762 2006
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 C-EBP, Nuclear Protein
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 CAAT Enhancer Binding Proteins
% 208.06/208.28 |- skos__altLabel mesh__D022762 Nuclear Protein C-EBP
% 208.06/208.28 |- skos__altLabel mesh__D022762 C-EBP Proteins
% 208.06/208.28 |- skos__altLabel mesh__D022762 CAAT-Enhancer Binding Protein
% 208.06/208.28 |- skos__altLabel mesh__D022762 C-EBP Protein
% 208.06/208.28 |- skos__altLabel mesh__D022762 CCAAT-Enhancer-Binding Protein
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 CCAAT Enhancer Binding Proteins
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 C EBP Nuclear Protein
% 208.06/208.28 |- skos__scopeNote mesh__D022762
% 208.06/208.28 A class of proteins that were originally identified by their ability to bind the DNA sequence CCAAT. The typical CCAAT-enhancer binding protein forms dimers and consists of an activation domain, a DNA-binding basic region, and a leucine-rich dimerization domain %28%LEUCINE ZIPPERS%29%. CCAAT-BINDING FACTOR is structurally distinct type of CCAAT-enhancer binding protein consisting of a trimer of three different subunits.%A%
% 208.06/208.28 |- skos__historyNote mesh__D022762 DNA-Binding Proteins %28%1991-2000%29%
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 C EBP Proteins
% 208.06/208.28 |- skos__historyNote mesh__D022762 Nuclear Proteins %28%1991-2000%29%
% 208.06/208.28 |- rdf__type mesh__D022762sskos__Concept
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 Nuclear Protein, C-EBP
% 208.06/208.28 |- skos__altLabel mesh__D022762 CAAT-Enhancer-Binding Proteins
% 208.06/208.28 |- skos__altLabel mesh__D022762
% 208.06/208.28 CCAAT Sequence-Specific DNA-Binding Proteins
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 Binding Protein, CAAT-Enhancer
% 208.06/208.28 |- skos__broader mesh__D022762smesh__D009687
% 208.06/208.28 |- mesh__dateRevised mesh__D022762 2005-06-30
% 208.06/208.28 |- mesh__dateCreated mesh__D022762 2000-06-21
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D022762
% 208.06/208.28 2001; C-EBP NUCLEAR PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS 1989-2000; CCAAT SEQUENCE-SPECIFIC DNA-BINDING PROTEINS was indexed under DNA-BINDING PROTEINS 1988-2000%A%
% 208.06/208.28 |- skos__broader mesh__D022762smesh__D050976
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 C EBP Protein
% 208.06/208.28 |- mesh__recordMaintainer mesh__D022762 DRC
% 208.06/208.28 |- mesh__historyNote mesh__D022762
% 208.06/208.28 2001; for C-EBP NUCLEAR PROTEIN use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1989-2000; for CCAAT SEQUENCE-SPECIFIC DNA-BINDING PROTEINS use CCAAT-ENHANCER BINDING PROTEINS 1988-2000%A%
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762
% 208.06/208.28 CCAAT Sequence Specific DNA Binding Proteins
% 208.06/208.28 |- mesh__recordOriginator mesh__D022762 jmp
% 208.06/208.28 |- skos__altLabel mesh__D022762 C-EBP Nuclear Protein
% 208.06/208.28 |- skos__annotation mesh__D022762 GEN: prefer specifics
% 208.06/208.28 |- skos__prefLabel mesh__D022762 CCAAT-Enhancer-Binding Proteins
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 CAAT Enhancer Binding Protein
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 Nuclear Protein C EBP
% 208.06/208.28 |- mesh__dateEstablished mesh__D022762 2001-01-01
% 208.06/208.28 |- skos__hiddenLabel mesh__D022762 CCAAT Enhancer Binding Protein
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D022762 sjn
% 208.06/208.28 |- skos__prefLabel mesh__D008293 Malates
% 208.06/208.28 |- skos__broader mesh__D008293smesh__D006880
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 2002
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 2004
% 208.06/208.28 |- mesh__dateRevised mesh__D008293 1992-05-18
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 2001
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 2003
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 2006
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 1997
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 2000
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 2005
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 1996
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 1993
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 1999
% 208.06/208.28 |- rdf__type mesh__D008293sskos__Concept
% 208.06/208.28 |- mesh__recordOriginator mesh__D008293 NLM
% 208.06/208.28 |- skos__broader mesh__D008293smesh__D003998
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 1995
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 1998
% 208.06/208.28 |- mesh__dateCreated mesh__D008293 1999-01-01
% 208.06/208.28 |- skos__annotation mesh__D008293 do not confuse with MALEATES
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D008293 PLS
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D008293 1994
% 208.06/208.28 |- mesh__recordMaintainer mesh__D008293 TAP
% 208.06/208.28 |- skos__broader mesh__D001769Q000737smesh__D001769
% 208.06/208.28 |- mesh__preferredCombination mesh__D001769Q000737smesh__D001774
% 208.06/208.28 |- rdf__type mesh__D001769Q000737smesh__CompoundConcept
% 208.06/208.28 |- mesh__historyNote mesh__D007999 76; was NON MESH before 1976
% 208.06/208.28 |- skos__broader mesh__D007999smesh__D007255
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007999 2000
% 208.06/208.28 |- skos__annotation mesh__D007999 IM; DF: LIBRARY SERV
% 208.06/208.28 |- skos__altLabel mesh__D007999 Services, Library
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007999 2004
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007999 2006
% 208.06/208.28 |- mesh__dateEstablished mesh__D007999 1976-01-01
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007999 2003
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007999 2005
% 208.06/208.28 |- skos__hiddenLabel mesh__D007999 Service, Library
% 208.06/208.28 |- mesh__dateRevised mesh__D007999 1999-11-03
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007999 2002
% 208.06/208.28 |- mesh__recordMaintainer mesh__D007999 kle
% 208.06/208.28 |- skos__broader mesh__D007999smesh__D007998
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D007999 2001
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D007999 76
% 208.06/208.28 |- skos__hiddenLabel mesh__D007999 Library Service
% 208.06/208.28 |- skos__prefLabel mesh__D007999 Library Services
% 208.06/208.28 |- rdf__type mesh__D007999sskos__Concept
% 208.06/208.28 |- skos__scopeNote mesh__D007999
% 208.06/208.28 Services offered to the library user. They include reference and circulation.%A%
% 208.06/208.28 |- mesh__recordOriginator mesh__D007999 SMH
% 208.06/208.28 |- mesh__dateCreated mesh__D007999 1975-07-25
% 208.06/208.28 |- skos__historyNote mesh__D007999
% 208.06/208.28 specific library or library science heading %28%1966-1975%29%
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D007999 sjn
% 208.06/208.28 |- skos__broader mesh__D002802Q000037smesh__D002802
% 208.06/208.28 |- mesh__preferredCombination mesh__D002802Q000037smesh__D002800
% 208.06/208.28 |- rdf__type mesh__D002802Q000037smesh__CompoundConcept
% 208.06/208.28 |- mesh__dateRevised mesh__D048009 2005-06-30
% 208.06/208.28 |- mesh__recordOriginator mesh__D048009 ags
% 208.06/208.28 |- rdf__type mesh__D048009sskos__Concept
% 208.06/208.28 |- skos__prefLabel mesh__D048009 Clostridium symbiosum
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D048009 2006
% 208.06/208.28 |- skos__historyNote mesh__D048009 Clostridium %28%1985-2004%29%
% 208.06/208.28 |- mesh__recordMaintainer mesh__D048009 SYSTEM
% 208.06/208.28 |- skos__scopeNote mesh__D048009
% 208.06/208.28 A species of gram-positive bacteria in the family Clostridiaceae. Its GLUTAMATE DEHYDROGENASE is commonly used in research.%A%
% 208.06/208.28 |- mesh__recordAuthorizer mesh__D048009 sjn
% 208.06/208.28 |- skos__broader mesh__D048009smesh__D003013
% 208.06/208.28 |- mesh__publicMeSHNote mesh__D048009 2005
% 208.06/208.28 |- mesh__dateCreated mesh__D048009 2004-07-07
% 208.06/208.28 |- mesh__historyNote mesh__D048009 2005
% 208.06/208.28 |- mesh__dateEstablished mesh__D048009 2005-01-01
% 208.06/208.28 |- mesh__activeMeSHYear mesh__D012335 2001
% 208.15/208.28 |- skos__annotation mesh__D012335
% 208.15/208.28 IM; /drug eff /ultrastruct permitted; RRNA OPERON is also available%A%
% 208.15/208.28 |- mesh__activeMeSHYear mesh__D012335 1999
% 208.15/208.28 |- mesh__recordOriginator mesh__D012335 NLM
% 208.15/208.28 |- mesh__activeMeSHYear mesh__D012335 2004
% 208.15/208.28 |- mesh__recordAuthorizer mesh__D012335 PLS
% 208.15/208.28 |- mesh__recordMaintainer mesh__D012335 KEV
% 208.15/208.28 |- mesh__dateEstablished mesh__D012335 1972-01-01
% 208.15/208.28 |- skos__scopeNote mesh__D012335
% 208.15/208.28 The most abundant form of RNA. Together with proteins, it forms the ribosomes, playing a structural role and also a role in ribosomal binding of mRNA and tRNAs. Individual chains are conventionally designated by their sedimentation coefficients. In eukaryotes, four large chains exist, synthesized in the nucleolus and constituting about 50%25% of the ribosome. %28%Dorland, 28th ed%29%%A%
% 208.15/208.28 |- mesh__activeMeSHYear mesh__D012335 2002
% 208.15/208.28 |- mesh__historyNote mesh__D012335 72%28%71%29%
% 208.15/208.28 |- mesh__activeMeSHYear mesh__D012335 2005
% 208.15/208.28 |- skos__altLabel mesh__D012335 Ribosomal RNA
% 208.15/208.28 |- mesh__dateRevised mesh__D012335 1995-06-08
% 208.15/208.28 |- mesh__activeMeSHYear mesh__D012335 1996
% 208.15/208.28 |- skos__historyNote mesh__D012335 Ribosomes %28%1966-1970%29%
% 208.15/208.28 |- mesh__activeMeSHYear mesh__D012335 2006
% 208.15/208.28 |- skos__prefLabel mesh__D012335 RNA, Ribosomal
% 208.15/208.28 |- skos__hiddenLabel mesh__D012335 RNA, 15S
% 208.15/208.28 |- mesh__activeMeSHYear mesh__D012335 1997
% 208.15/208.28 |- rdf__type mesh__D012335sskos__Concept
% 208.15/208.28 |- mesh__activeMeSHYear mesh__D012335 2000
% 208.15/208.28 |- mesh__activeMeSHYear mesh__D012335 1998
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D012335 72
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012335 2003
% 208.15/208.29 |- skos__historyNote mesh__D012335 RNA %28%1966-1970%29%
% 208.15/208.29 |- skos__broader mesh__D012335smesh__D012313
% 208.15/208.29 |- mesh__dateCreated mesh__D012335 1999-01-01
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D017020 sjn
% 208.15/208.29 |- mesh__dateEstablished mesh__D017020 1992-01-01
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D017020 2006
% 208.15/208.29 |- mesh__recordOriginator mesh__D017020 PXP
% 208.15/208.29 |- skos__broader mesh__D017020smesh__D017019
% 208.15/208.29 |- mesh__dateRevised mesh__D017020 2005-06-30
% 208.15/208.29 |- skos__historyNote mesh__D017020 Sarcina %28%1966-1974%29%
% 208.15/208.29 |- rdf__type mesh__D017020sskos__Concept
% 208.15/208.29 |- skos__historyNote mesh__D017020 Methanogens %28%1979-1991%29%
% 208.15/208.29 |- mesh__dateCreated mesh__D017020 1991-05-30
% 208.15/208.29 |- skos__historyNote mesh__D017020 Bacteria %28%1973-1978%29%
% 208.15/208.29 |- mesh__historyNote mesh__D017020 92
% 208.15/208.29 |- skos__annotation mesh__D017020
% 208.15/208.29 a genus of methanogens found in aquatic environments
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D017020 92
% 208.15/208.29 |- skos__scopeNote mesh__D017020
% 208.15/208.29 A genus of anaerobic, irregular spheroid-shaped METHANOSARCINALES whose organisms are nonmotile. Endospores are not formed. These archaea derive energy via formation of methane from acetate, methanol, mono-, di-, and trimethylamine, and possibly, carbon monoxide. Organisms are isolated from freshwater and marine environments.%A%
% 208.15/208.29 |- skos__prefLabel mesh__D017020 Methanosarcina
% 208.15/208.29 |- mesh__recordMaintainer mesh__D017020 SYSTEM
% 208.15/208.29 |- rdf__type mesh__D003000sskos__Concept
% 208.15/208.29 |- mesh__recordOriginator mesh__D003000 NLM
% 208.15/208.29 |- skos__historyNote mesh__D003000
% 208.15/208.29 Antihypertensive Agents %28%1966-1971%29%
% 208.15/208.29 |- mesh__historyNote mesh__D003000 73%28%72%29%
% 208.15/208.29 |- skos__altLabel mesh__D003000 Clofelin
% 208.15/208.29 |- skos__hiddenLabel mesh__D003000 ST 155
% 208.15/208.29 |- skos__hiddenLabel mesh__D003000 Monohydrobromide, Clonidine
% 208.15/208.29 |- mesh__dateCreated mesh__D003000 1999-01-01
% 208.15/208.29 |- skos__altLabel mesh__D003000 Catapressan
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D003000 sjn
% 208.15/208.29 |- skos__hiddenLabel mesh__D003000 Monohydrochloride, Clonidine
% 208.15/208.29 |- skos__altLabel mesh__D003000 Clopheline
% 208.15/208.29 |- skos__hiddenLabel mesh__D003000 ST155
% 208.15/208.29 |- skos__hiddenLabel mesh__D003000 Hydrochloride, Clonidine
% 208.15/208.29 |- skos__hiddenLabel mesh__D003000 M5041T
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D003000 2006
% 208.15/208.29 |- mesh__recordMaintainer mesh__D003000 ssb
% 208.15/208.29 |- mesh__dateRevised mesh__D003000 2005-06-30
% 208.15/208.29 |- skos__hiddenLabel mesh__D003000 Dihydrochloride, Clonidine
% 208.15/208.29 |- skos__prefLabel mesh__D003000 Clonidine
% 208.15/208.29 |- skos__altLabel mesh__D003000 Klofenil
% 208.15/208.29 |- skos__altLabel mesh__D003000 Clofenil
% 208.15/208.29 |- skos__broader mesh__D003000smesh__D048288
% 208.15/208.29 |- skos__historyNote mesh__D003000 Imidazoles %28%1966-1971%29%
% 208.15/208.29 |- skos__altLabel mesh__D003000 Catapresan
% 208.15/208.29 |- skos__scopeNote mesh__D003000
% 208.15/208.29 An alpha-2 adrenergic agonist that crosses the blood-brain barrier. Clonidine acts centrally by reducing sympathetic tone, resulting in a fall in diastolic and systolic blood pressure and a reduction in heart rate. It also acts peripherally, and this peripheral activity may be responsible for the transient increase in blood pressure seen during rapid intravenous administration. %28%From Martindale, the Extra Pharmacopoeia, 30th ed, p350%29%%A%
% 208.15/208.29 |- skos__hiddenLabel mesh__D003000 M 5041T
% 208.15/208.29 |- mesh__dateEstablished mesh__D003000 1973-01-01
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D003000 73
% 208.15/208.29 |- skos__altLabel mesh__D022763 C-EBP alpha
% 208.15/208.29 |- skos__historyNote mesh__D022763 DNA-Binding Proteins %28%1990-2000%29%
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D022763 2006
% 208.15/208.29 |- rdf__type mesh__D022763sskos__Concept
% 208.15/208.29 |- skos__broader mesh__D022763smesh__D022762
% 208.15/208.29 |- skos__scopeNote mesh__D022763
% 208.15/208.29 A CCAAT-enhancer-binding protein found in LIVER; ADIPOSE TISSUE; INTESTINES; LUNG; ADRENAL GLANDS; PLACENTA; OVARY and peripheral blood mononuclear cells %28%LEUKOCYTES, MONONUCLEAR%29%. Experiments with knock-out mice have demonstrated that CCAAT-enhancer binding protein-alpha is essential for the functioning and differentiation of HEPATOCYTES and ADIPOCYTES.%A%
% 208.15/208.29 |- mesh__historyNote mesh__D022763
% 208.15/208.29 2001; C-EBPALPHA use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1996-2000%A%
% 208.15/208.29 |- mesh__dateCreated mesh__D022763 2000-06-21
% 208.15/208.29 |- skos__hiddenLabel mesh__D022763 CCAAT Enhancer Binding Protein alpha
% 208.15/208.29 |- skos__historyNote mesh__D022763 Nuclear Proteins %28%1990-2000%29%
% 208.15/208.29 |- skos__hiddenLabel mesh__D022763 C EBPalpha
% 208.15/208.29 |- mesh__dateRevised mesh__D022763 2005-06-30
% 208.15/208.29 |- mesh__dateEstablished mesh__D022763 2001-01-01
% 208.15/208.29 |- mesh__recordOriginator mesh__D022763 jmp
% 208.15/208.29 |- mesh__recordMaintainer mesh__D022763 DRC
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D022763 sjn
% 208.15/208.29 |- skos__altLabel mesh__D022763 C-EBPalpha
% 208.15/208.29 |- skos__prefLabel mesh__D022763 CCAAT-Enhancer-Binding Protein-alpha
% 208.15/208.29 |- skos__hiddenLabel mesh__D022763 C EBP alpha
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D022763
% 208.15/208.29 2001; C-EBPALPHA was indexed under NUCLEAR PROTEINS %26% DNA-BINDING PROTEINS 1996-2000%A%
% 208.15/208.29 |- skos__altLabel mesh__D008294 Carbafos
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008294 2006
% 208.15/208.29 |- skos__historyNote mesh__D008294 Phosphoric Acids %28%1968-1971%29%
% 208.15/208.29 |- skos__altLabel mesh__D008294 Karbofos
% 208.15/208.29 |- mesh__dateEstablished mesh__D008294 1972-01-01
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D008294 72
% 208.15/208.29 |- skos__altLabel mesh__D008294 Carbophos
% 208.15/208.29 |- mesh__recordOriginator mesh__D008294 NLM
% 208.15/208.29 |- mesh__recordMaintainer mesh__D008294 ssb
% 208.15/208.29 |- skos__historyNote mesh__D008294 Thiomalates %28%1966-1971%29%
% 208.15/208.29 |- rdf__type mesh__D008294sskos__Concept
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D008294 sjn
% 208.15/208.29 |- skos__prefLabel mesh__D008294 Malathion
% 208.15/208.29 |- mesh__dateCreated mesh__D008294 1999-01-01
% 208.15/208.29 |- skos__scopeNote mesh__D008294
% 208.15/208.29 A wide spectrum aliphatic organophosphate insecticide widely used for both domestic and commercial agricultural purposes.%A%
% 208.15/208.29 |- skos__broader mesh__D008294smesh__D009946
% 208.15/208.29 |- skos__historyNote mesh__D008294 Phosphates %28%1966-1971%29%
% 208.15/208.29 |- mesh__historyNote mesh__D008294 72
% 208.15/208.29 |- skos__altLabel mesh__D008294 Carbofos
% 208.15/208.29 |- mesh__dateRevised mesh__D008294 2005-06-30
% 208.15/208.29 |- skos__altLabel mesh__D016726 Pseudotumor, Inflammatory, Pulmonary
% 208.15/208.29 |- skos__hiddenLabel mesh__D016726 Pseudotumors, Inflammatory Pulmonary
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016726 2004
% 208.15/208.29 |- skos__hiddenLabel mesh__D016726 Inflammatory Pseudotumors, Pulmonary
% 208.15/208.29 |- skos__hiddenLabel mesh__D016726 Lung Inflammatory Pseudotumor
% 208.15/208.29 |- skos__altLabel mesh__D016726 Pulmonary Granuloma, Plasma Cell
% 208.15/208.29 |- skos__hiddenLabel mesh__D016726 Pseudotumors, Pulmonary Inflammatory
% 208.15/208.29 |- rdf__type mesh__D016726sskos__Concept
% 208.15/208.29 |- skos__altLabel mesh__D016726 Plasma Cell Granuloma, Pulmonary
% 208.15/208.29 |- skos__altLabel mesh__D016726 Pulmonary Inflammatory Pseudotumor
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016726 2003
% 208.15/208.29 |- skos__altLabel mesh__D016726 Pulmonary Pseudotumor, Inflammatory
% 208.15/208.29 |- mesh__recordMaintainer mesh__D016726 jls
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D016726 sjn
% 208.15/208.29 |- mesh__dateRevised mesh__D016726 1999-11-08
% 208.15/208.29 |- skos__altLabel mesh__D016726 Inflammatory Pseudotumor, Pulmonary
% 208.15/208.29 |- mesh__dateEstablished mesh__D016726 1992-01-01
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016726 2002
% 208.15/208.29 |- skos__scopeNote mesh__D016726
% 208.15/208.29 A pseudotumor of the lung composed of inflammatory cells and showing complete maturity of fibroblastic components with a striking lack of mitosis. It is also called postinflammatory pseudotumor and pseudoneoplastic pneumonitis. %28%Surg Gynecol Obstet 1983 Jan;156%28%1%29%:89-96%29%%A%
% 208.15/208.29 |- skos__hiddenLabel mesh__D016726 Pseudotumor, Inflammatory Pulmonary
% 208.15/208.29 |- skos__altLabel mesh__D016726 Pseudotumor, Pulmonary Inflammatory
% 208.15/208.29 |- skos__altLabel mesh__D016726 Inflammatory Pseudotumor of Lung
% 208.15/208.29 |- skos__hiddenLabel mesh__D016726 Lung Inflammatory Pseudotumors
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016726 2001
% 208.15/208.29 |- mesh__historyNote mesh__D016726 92
% 208.15/208.29 |- skos__broader mesh__D016726smesh__D008171
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016726 2006
% 208.15/208.29 |- mesh__recordOriginator mesh__D016726 TGC
% 208.15/208.29 |- skos__hiddenLabel mesh__D016726 Pulmonary Inflammatory Pseudotumors
% 208.15/208.29 |- skos__historyNote mesh__D016726 Lung Diseases %28%1966-1991%29%
% 208.15/208.29 |- skos__hiddenLabel mesh__D016726 Inflammatory Pulmonary Pseudotumors
% 208.15/208.29 |- skos__altLabel mesh__D016726 Pulmonary Plasma Cell Granuloma
% 208.15/208.29 |- skos__hiddenLabel mesh__D016726 Pulmonary Pseudotumors, Inflammatory
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016726 2000
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016726 2005
% 208.15/208.29 |- skos__prefLabel mesh__D016726 Granuloma, Plasma Cell, Pulmonary
% 208.15/208.29 |- mesh__dateCreated mesh__D016726 1991-02-11
% 208.15/208.29 |- skos__annotation mesh__D016726
% 208.15/208.29 non-neoplastic; DF: GRANULOMA PLASMA CELL PULM
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D016726 92
% 208.15/208.29 |- skos__broader mesh__D016726smesh__D006104
% 208.15/208.29 |- skos__altLabel mesh__D016726 Inflammatory Pulmonary Pseudotumor
% 208.15/208.29 |- skos__hiddenLabel mesh__D002706 gamma Chlordane
% 208.15/208.29 |- skos__broader mesh__D002706smesh__D006843
% 208.15/208.29 |- skos__prefLabel mesh__D002706 Chlordan
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D002706 2006
% 208.15/208.29 |- mesh__dateRevised mesh__D002706 2004-07-07
% 208.15/208.29 |- rdf__type mesh__D002706sskos__Concept
% 208.15/208.29 |- skos__altLabel mesh__D002706 gamma-Chlordane
% 208.15/208.29 |- mesh__dateCreated mesh__D002706 1999-01-01
% 208.15/208.29 |- skos__scopeNote mesh__D002706
% 208.15/208.29 A highly poisonous organochlorine insecticide. The EPA has cancelled registrations of pesticides containing this compound with the exception of its use through subsurface ground insertion for termite control and the dipping of roots or tops of non-food plants. %28%From Merck Index, 11th ed%29%%A%
% 208.15/208.29 |- mesh__recordOriginator mesh__D002706 NLM
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D002706 sjn
% 208.15/208.29 |- mesh__recordMaintainer mesh__D002706 ssb
% 208.15/208.29 |- skos__altLabel mesh__D002706 Chlordane
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D002706 2005
% 208.15/208.29 |- skos__annotation mesh__D002706 TN 111 for eff on insects
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 2000
% 208.15/208.29 |- skos__altLabel mesh__D012336 16S Ribosomal RNA
% 208.15/208.29 |- skos__annotation mesh__D012336
% 208.15/208.29 IM; /drug eff /ultrastruct permitted; DF: 16S RRNA
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 2005
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D012336
% 208.15/208.29 91; was see under RNA, RIBOSOMAL 1988-90
% 208.15/208.29 |- mesh__recordOriginator mesh__D012336 RLS
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 1996
% 208.15/208.29 |- skos__prefLabel mesh__D012336 RNA, Ribosomal, 16S
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 2001
% 208.15/208.29 |- skos__hiddenLabel mesh__D012336 RNA, 16S Ribosomal
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 2006
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D012336 PLS
% 208.15/208.29 |- skos__broader mesh__D012336smesh__D012335
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 1997
% 208.15/208.29 |- rdf__type mesh__D012336sskos__Concept
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 2002
% 208.15/208.29 |- mesh__dateRevised mesh__D012336 1995-05-22
% 208.15/208.29 |- skos__scopeNote mesh__D012336
% 208.15/208.29 Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis.%A%
% 208.15/208.29 |- mesh__dateEstablished mesh__D012336 1991-01-01
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 1998
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 2003
% 208.15/208.29 |- skos__historyNote mesh__D012336 RNA %28%1966-1970%29%
% 208.15/208.29 |- mesh__dateCreated mesh__D012336 1987-05-09
% 208.15/208.29 |- skos__hiddenLabel mesh__D012336 Ribosomal RNA, 16S
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 1999
% 208.15/208.29 |- skos__historyNote mesh__D012336 RNA, Ribosomal %28%1971-1987%29%
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012336 2004
% 208.15/208.29 |- mesh__recordMaintainer mesh__D012336 KEV
% 208.15/208.29 |- mesh__historyNote mesh__D012336
% 208.15/208.29 91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90
% 208.15/208.29 |- mesh__dateEstablished mesh__D017021 1992-01-01
% 208.15/208.29 |- skos__prefLabel mesh__D017021 Methanosarcina barkeri
% 208.15/208.29 |- mesh__recordOriginator mesh__D017021 PXP
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D017021 sjn
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D017021 2006
% 208.15/208.29 |- mesh__dateCreated mesh__D017021 1991-05-30
% 208.15/208.29 |- skos__scopeNote mesh__D017021
% 208.15/208.29 A species of halophilic archaea whose organisms are nonmotile. Habitats include freshwater and marine mud, animal-waste lagoons, and the rumens of ungulates.%A%
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D017021 92
% 208.15/208.29 |- skos__broader mesh__D017021smesh__D017020
% 208.15/208.29 |- rdf__type mesh__D017021sskos__Concept
% 208.15/208.29 |- skos__historyNote mesh__D017021 Methanogens %28%1979-1991%29%
% 208.15/208.29 |- mesh__dateRevised mesh__D017021 2005-06-30
% 208.15/208.29 |- skos__annotation mesh__D017021
% 208.15/208.29 a gram-pos methanogen found in mud %26% ungulate rumens
% 208.15/208.29 |- mesh__recordMaintainer mesh__D017021 SYSTEM
% 208.15/208.29 |- skos__historyNote mesh__D017021 Sarcina %28%1966-1968%29%
% 208.15/208.29 |- mesh__historyNote mesh__D017021 92
% 208.15/208.29 |- mesh__dateEstablished mesh__D003001 1980-01-01
% 208.15/208.29 |- skos__scopeNote mesh__D003001
% 208.15/208.29 The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.%A%
% 208.15/208.29 |- mesh__recordMaintainer mesh__D003001 nns
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D003001 2001
% 208.15/208.29 |- skos__historyNote mesh__D003001 DNA, Recombinant %28%1977-1979%29%
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D003001 2005
% 208.15/208.29 |- skos__related mesh__D003001smesh__D011993
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D003001 2002
% 208.15/208.29 |- mesh__dateRevised mesh__D003001 2000-06-22
% 208.15/208.29 |- mesh__recordOriginator mesh__D003001 AEP
% 208.15/208.29 |- skos__related mesh__D003001smesh__D005818
% 208.15/208.29 |- mesh__historyNote mesh__D003001 80
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D003001 2003
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D003001 80
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D003001 2006
% 208.15/208.29 |- skos__historyNote mesh__D003001 DNA %28%1966-1976%29%
% 208.15/208.29 |- skos__altLabel mesh__D003001 Molecular Cloning
% 208.15/208.29 |- skos__broader mesh__D003001smesh__D005821
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D003001 2004
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D003001 sjn
% 208.15/208.29 |- rdf__type mesh__D003001sskos__Concept
% 208.15/208.29 |- mesh__dateCreated mesh__D003001 1978-12-21
% 208.15/208.29 |- skos__related mesh__D003001smesh__D019976
% 208.15/208.29 |- skos__annotation mesh__D003001
% 208.15/208.29 differentiate from CLONE CELLS and CLONING, ORGANISM; %22%clonal analysis%22%: index under CLONE CELLS; DF: CLONING MOL or MOL CLONING%A%
% 208.15/208.29 |- skos__historyNote mesh__D003001 Plasmids %28%1975-1979%29%
% 208.15/208.29 |- skos__related mesh__D003001smesh__D004274
% 208.15/208.29 |- skos__prefLabel mesh__D003001 Cloning, Molecular
% 208.15/208.29 |- skos__broader mesh__D013339Q000193smesh__D013339
% 208.15/208.29 |- mesh__preferredCombination mesh__D013339Q000193smesh__D004512
% 208.15/208.29 |- rdf__type mesh__D013339Q000193smesh__CompoundConcept
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008295 2005
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008295 1999
% 208.15/208.29 |- rdf__type mesh__D008295sskos__Concept
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008295 2000
% 208.15/208.29 |- skos__annotation mesh__D008295
% 208.15/208.29 a republic in southern Africa; X ref NYASALAND was its former name%A%
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008295 1998
% 208.15/208.29 |- mesh__dateCreated mesh__D008295 1999-01-01
% 208.15/208.29 |- mesh__recordOriginator mesh__D008295 NLM
% 208.15/208.29 |- skos__scopeNote mesh__D008295
% 208.15/208.29 A republic in southern Africa east of ZAMBIA. Its capital is Lilongwe. It was formerly called Nyasaland. This region was visited by Livingstone in 1859. It became a British protectorate in 1891, part of the Federation of Rhodesia and Nyasaland in 1953, and independent in 1964. It takes its name from the Malavi people whose name means flames, possibly referring to the reflection of the rising sun on Lake Malawi. Its former name Nyasaland is from the Malawi word for lake. %28%Webster%27%s New Geographical Dictionary, 1988, p715 %26% Room, Brewer%27%s Dictionary of Names, 1992, p326, 386%29%%A%
% 208.15/208.29 |- skos__broader mesh__D008295smesh__D000353
% 208.15/208.29 |- skos__altLabel mesh__D008295 Nyasaland
% 208.15/208.29 |- mesh__dateRevised mesh__D008295 1997-06-20
% 208.15/208.29 |- skos__prefLabel mesh__D008295 Malawi
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008295 2004
% 208.15/208.29 |- mesh__recordMaintainer mesh__D008295 TGC
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008295 2002
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008295 2003
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008295 2006
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D008295 SJN
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D008295 2001
% 208.15/208.29 |- mesh__dateRevised mesh__D016727 1999-11-03
% 208.15/208.29 |- skos__altLabel mesh__D016727 Orbital Granuloma, Plasma Cell
% 208.15/208.29 |- skos__broader mesh__D016727smesh__D006104
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D016727 sjn
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016727 2004
% 208.15/208.29 |- skos__altLabel mesh__D016727 Myositis, Orbital
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016727 2002
% 208.15/208.29 |- mesh__recordMaintainer mesh__D016727 KEV
% 208.15/208.29 |- skos__hiddenLabel mesh__D016727 Orbit Inflammatory Pseudotumors
% 208.15/208.29 |- rdf__type mesh__D016727sskos__Concept
% 208.15/208.29 |- skos__historyNote mesh__D016727 Orbit %28%1966-1980%29%
% 208.15/208.29 |- skos__hiddenLabel mesh__D016727 Pseudotumors, Orbital Inflammatory
% 208.15/208.29 |- skos__hiddenLabel mesh__D016727 Orbital Inflammatory Pseudotumors
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016727 2003
% 208.15/208.29 |- skos__altLabel mesh__D016727 Inflammatory Pseudotumor of Orbit
% 208.15/208.29 |- mesh__dateEstablished mesh__D016727 1992-01-01
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016727 2001
% 208.15/208.29 |- skos__scopeNote mesh__D016727
% 208.15/208.29 A chronic neoplasm-like inflammatory reaction, usually affecting the orbital tissues of both eyes, also known as orbital myositis.%A%
% 208.15/208.29 |- skos__hiddenLabel mesh__D016727 Inflammatory Pseudotumors, Orbital
% 208.15/208.29 |- mesh__recordOriginator mesh__D016727 TGC
% 208.15/208.29 |- skos__annotation mesh__D016727 non-neoplastic
% 208.15/208.29 |- skos__altLabel mesh__D016727 Orbital Myositis
% 208.15/208.29 |- skos__altLabel mesh__D016727 Pseudotumor, Inflammatory, Orbital
% 208.15/208.29 |- skos__altLabel mesh__D016727 Pseudotumor, Orbital Inflammatory
% 208.15/208.29 |- skos__hiddenLabel mesh__D016727 Orbital Myositides
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016727 2000
% 208.15/208.29 |- skos__altLabel mesh__D016727 Plasma Cell Granuloma, Orbital
% 208.15/208.29 |- mesh__dateCreated mesh__D016727 1991-02-11
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D016727 92
% 208.15/208.29 |- skos__hiddenLabel mesh__D016727 Orbit Inflammatory Pseudotumor
% 208.15/208.29 |- mesh__historyNote mesh__D016727 92
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016727 2006
% 208.15/208.29 |- skos__historyNote mesh__D016727 Orbital Diseases %28%1981-1991%29%
% 208.15/208.29 |- skos__altLabel mesh__D016727 Orbital Inflammatory Pseudotumor
% 208.15/208.29 |- skos__altLabel mesh__D016727 Inflammatory Pseudotumor, Orbital
% 208.15/208.29 |- skos__hiddenLabel mesh__D016727 Myositides, Orbital
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D016727 2005
% 208.15/208.29 |- skos__historyNote mesh__D016727 Granuloma %28%1966-1991%29%
% 208.15/208.29 |- skos__broader mesh__D016727smesh__D009916
% 208.15/208.29 |- skos__prefLabel mesh__D016727 Granuloma, Plasma Cell, Orbital
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D002707 sjn
% 208.15/208.29 |- mesh__dateRevised mesh__D002707 2004-07-19
% 208.15/208.29 |- skos__hiddenLabel mesh__D002707 Monohydrochloride, Chlordiazepoxide
% 208.15/208.29 |- rdf__type mesh__D002707sskos__Concept
% 208.15/208.29 |- skos__scopeNote mesh__D002707
% 208.15/208.29 An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.%A%
% 208.15/208.29 |- mesh__dateCreated mesh__D002707 1999-01-01
% 208.15/208.29 |- skos__altLabel mesh__D002707 Methaminodiazepoxide
% 208.15/208.29 |- skos__hiddenLabel mesh__D002707 Hydrobromide, Chlordiazepoxide
% 208.15/208.29 |- skos__altLabel mesh__D002707
% 208.15/208.29 7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D002707 2005
% 208.15/208.29 |- skos__hiddenLabel mesh__D002707 Perchlorate, Chlordiazepoxide
% 208.15/208.29 |- skos__hiddenLabel mesh__D002707 Hydrochloride, Chlordiazepoxide
% 208.15/208.29 |- mesh__recordMaintainer mesh__D002707 jls
% 208.15/208.29 |- skos__altLabel mesh__D002707 Chlordiazepoxide Monohydrochloride
% 208.15/208.29 |- skos__hiddenLabel mesh__D002707
% 208.15/208.29 7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D002707 2006
% 208.15/208.29 |- mesh__recordOriginator mesh__D002707 NLM
% 208.15/208.29 |- skos__broader mesh__D002707smesh__D001569
% 208.15/208.29 |- skos__prefLabel mesh__D002707 Chlordiazepoxide
% 208.15/208.29 |- mesh__historyNote mesh__D048809 2005%28%1978%29%
% 208.15/208.29 |- skos__hiddenLabel mesh__D048809
% 208.15/208.29 alpha D N Acetyl Galactosaminyloligosaccharidase
% 208.15/208.29 |- skos__altLabel mesh__D048809 N-Acetyl-alpha-D-Galactosaminidase
% 208.15/208.29 |- skos__historyNote mesh__D048809 Hexosaminidases %28%1978-2004%29%
% 208.15/208.29 |- skos__hiddenLabel mesh__D048809 alpha N Acetyl D galactosaminidase
% 208.15/208.29 |- mesh__recordOriginator mesh__D048809 jmp
% 208.15/208.29 |- skos__hiddenLabel mesh__D048809
% 208.15/208.29 alpha D N Acetylgalactosaminyloligosaccharidase
% 208.15/208.29 |- skos__altLabel mesh__D048809 endo-alpha-N-Acetylgalactosaminidase
% 208.15/208.29 |- skos__altLabel mesh__D048809
% 208.15/208.29 alpha-D-N-Acetyl-Galactosaminyloligosaccharidase
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D048809 2005
% 208.15/208.29 |- skos__prefLabel mesh__D048809 alpha-N-Acetylgalactosaminidase
% 208.15/208.29 |- mesh__dateCreated mesh__D048809 2004-07-07
% 208.15/208.29 |- skos__hiddenLabel mesh__D048809 alpha Galactosidase B
% 208.15/208.29 |- skos__hiddenLabel mesh__D048809 endo alpha N Acetylgalactosaminidase
% 208.15/208.29 |- mesh__recordMaintainer mesh__D048809 jmp
% 208.15/208.29 |- skos__altLabel mesh__D048809 alpha-N-Acetyl-D-galactosaminidase
% 208.15/208.29 |- mesh__dateEstablished mesh__D048809 2005-01-01
% 208.15/208.29 |- skos__altLabel mesh__D048809
% 208.15/208.29 alpha-D-N-Acetylgalactosaminyloligosaccharidase
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D048809 2006
% 208.15/208.29 |- skos__hiddenLabel mesh__D048809 N Acetyl alpha D Galactosaminidase
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D048809
% 208.15/208.29 2005; ALPHA-N-ACETYL-D-GALATOSAMINIDASE was indexed under GALATOSAMINIDASE 1982-2004 %26% ACETYLGALACTOSAMINE 1978-1981%A%
% 208.15/208.29 |- skos__scopeNote mesh__D048809
% 208.15/208.29 A hexosaminidase with specificity for terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-alpha-D-galactosaminides.%A%
% 208.15/208.29 |- skos__hiddenLabel mesh__D048809 endo N Acetyl alpha D Galactosamidase
% 208.15/208.29 |- skos__altLabel mesh__D048809 alpha-Galactosidase B
% 208.15/208.29 |- skos__hiddenLabel mesh__D048809 alpha N Acetylgalactosaminidase
% 208.15/208.29 |- skos__broader mesh__D048809smesh__D006596
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D048809 sjn
% 208.15/208.29 |- rdf__type mesh__D048809sskos__Concept
% 208.15/208.29 |- skos__altLabel mesh__D048809 endo-N-Acetyl-alpha-D-Galactosamidase
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 2003
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 1999
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 2002
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 1998
% 208.15/208.29 |- mesh__historyNote mesh__D012337
% 208.15/208.29 91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90
% 208.15/208.29 |- skos__hiddenLabel mesh__D012337 Ribosomal RNA, 18S
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D012337 PLS
% 208.15/208.29 |- mesh__dateCreated mesh__D012337 1987-05-07
% 208.15/208.29 |- mesh__recordMaintainer mesh__D012337 KEV
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 2001
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 1997
% 208.15/208.29 |- skos__hiddenLabel mesh__D012337 RNA, 18S Ribosomal
% 208.15/208.29 |- mesh__recordOriginator mesh__D012337 RLS
% 208.15/208.29 |- mesh__dateRevised mesh__D012337 1995-05-22
% 208.15/208.29 |- skos__broader mesh__D012337smesh__D012335
% 208.15/208.29 |- skos__historyNote mesh__D012337 RNA %28%1966-1970%29%
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 2006
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 2000
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 1996
% 208.15/208.29 |- rdf__type mesh__D012337sskos__Concept
% 208.15/208.29 |- skos__historyNote mesh__D012337 RNA, Ribosomal %28%1971-1987%29%
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 2005
% 208.15/208.29 |- skos__prefLabel mesh__D012337 RNA, Ribosomal, 18S
% 208.15/208.29 |- skos__annotation mesh__D012337
% 208.15/208.29 IM; /drug eff /ultrastruct permitted; DF: 18S RRNA
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D012337 2004
% 208.15/208.29 |- skos__scopeNote mesh__D012337
% 208.15/208.29 Constituent of the 40S subunit of eukaryotic ribosomes. 18S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.%A%
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D012337
% 208.15/208.29 91; was see under RNA, RIBOSOMAL 1988-90
% 208.15/208.29 |- mesh__dateEstablished mesh__D012337 1991-01-01
% 208.15/208.29 |- skos__altLabel mesh__D012337 18S Ribosomal RNA
% 208.15/208.29 |- mesh__recordMaintainer mesh__D050456 ags
% 208.15/208.29 |- mesh__publicMeSHNote mesh__D050456 2006
% 208.15/208.29 |- skos__broader mesh__D050456smesh__D004197
% 208.15/208.29 |- mesh__recordOriginator mesh__D050456 ags
% 208.15/208.29 |- mesh__historyNote mesh__D050456 2006
% 208.15/208.29 |- mesh__dateCreated mesh__D050456 2005-06-30
% 208.15/208.29 |- mesh__recordAuthorizer mesh__D050456 sjn
% 208.15/208.29 |- skos__scopeNote mesh__D050456
% 208.15/208.29 Inanimate objects that carry pathogenic microorganisms and thus can serve as the source of infection. Microorganisms typically survive on fomites for minutes or hours. Common fomites include CLOTHING, tissue paper, hairbrushes, and COOKING AND EATING UTENSILS.%A%
% 208.15/208.29 |- skos__hiddenLabel mesh__D050456 Fomite
% 208.15/208.29 |- skos__related mesh__D050456smesh__D004866
% 208.15/208.29 |- skos__related mesh__D050456smesh__D018562
% 208.15/208.29 |- skos__prefLabel mesh__D050456 Fomites
% 208.15/208.29 |- mesh__activeMeSHYear mesh__D050456 2006
% 208.15/208.30 |- mesh__dateEstablished mesh__D050456 2006-01-01
% 208.15/208.30 |- rdf__type mesh__D050456sskos__Concept
% 208.15/208.30 |- skos__hiddenLabel mesh__D017022 Analyses, Flow Injection
% 208.15/208.30 |- mesh__recordOriginator mesh__D017022 MXR
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 1995
% 208.15/208.30 |- skos__hiddenLabel mesh__D017022 Flow Injection Analyses
% 208.15/208.30 |- skos__hiddenLabel mesh__D017022 Injection Analysis, Flow
% 208.15/208.30 |- mesh__dateEstablished mesh__D017022 1992-01-01
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 2006
% 208.15/208.30 |- skos__broader mesh__D017022smesh__D002623
% 208.15/208.30 |- mesh__dateCreated mesh__D017022 1991-05-30
% 208.15/208.30 |- skos__prefLabel mesh__D017022 Flow Injection Analysis
% 208.15/208.30 |- mesh__recordMaintainer mesh__D017022 TGC
% 208.15/208.30 |- skos__annotation mesh__D017022
% 208.15/208.30 an anal chem technique; NIM; DF: FLOW INJECT ANAL
% 208.15/208.30 |- skos__scopeNote mesh__D017022
% 208.15/208.30 The analysis of a chemical substance by inserting a sample into a carrier stream of reagent using a sample injection valve that propels the sample downstream where mixing occurs in a coiled tube, then passes into a flow-through detector and a recorder or other data handling device.%A%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 1999
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 2005
% 208.15/208.30 |- rdf__type mesh__D017022sskos__Concept
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 2002
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D017022 PLS
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 2004
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 1998
% 208.15/208.30 |- skos__hiddenLabel mesh__D017022 Injection Analyses, Flow
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 2001
% 208.15/208.30 |- skos__altLabel mesh__D017022 Analysis, Flow Injection
% 208.15/208.30 |- mesh__historyNote mesh__D017022 92
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 1997
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 2003
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 2000
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D017022 92
% 208.15/208.30 |- mesh__dateRevised mesh__D017022 1994-05-12
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017022 1996
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 1996
% 208.15/208.30 |- skos__altLabel mesh__D003800 Technician, Dental
% 208.15/208.30 |- mesh__historyNote mesh__D003800 65
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 1993
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 2002
% 208.15/208.30 |- mesh__dateEstablished mesh__D003800 1965-01-01
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 1997
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 2005
% 208.15/208.30 |- skos__broader mesh__D003800smesh__D003727
% 208.15/208.30 |- skos__altLabel mesh__D003800 Technicians, Dental
% 208.15/208.30 |- mesh__dateRevised mesh__D003800 1992-05-14
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 2006
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 2000
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 2003
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 1994
% 208.15/208.30 |- mesh__dateCreated mesh__D003800 1999-01-01
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D003800 65
% 208.15/208.30 |- mesh__recordMaintainer mesh__D003800 TAP
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D003800 PLS
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 1998
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 2001
% 208.15/208.30 |- skos__annotation mesh__D003800
% 208.15/208.30 executes dentists%27% prescripts for mechanical fabrication of dental appliances; DF: DENT TECHNICIANS%A%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 1995
% 208.15/208.30 |- rdf__type mesh__D003800sskos__Concept
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 2004
% 208.15/208.30 |- mesh__recordOriginator mesh__D003800 NLM
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003800 1999
% 208.15/208.30 |- skos__prefLabel mesh__D003800 Dental Technicians
% 208.15/208.30 |- skos__scopeNote mesh__D003800
% 208.15/208.30 Individuals responsible for fabrication of dental appliances.%A%
% 208.15/208.30 |- skos__altLabel mesh__D003800 Dental Technician
% 208.15/208.30 |- skos__broader mesh__D014810Q000172smesh__D014810
% 208.15/208.30 |- mesh__preferredCombination mesh__D014810Q000172smesh__D014811
% 208.15/208.30 |- rdf__type mesh__D014810Q000172smesh__CompoundConcept
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D003002 sjn
% 208.15/208.30 |- rdf__type mesh__D003002sskos__Concept
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003002 2002
% 208.15/208.30 |- skos__broader mesh__D003002smesh__D009539
% 208.15/208.30 |- mesh__dateCreated mesh__D003002 1974-11-19
% 208.15/208.30 |- skos__historyNote mesh__D003002 Toluidines %28%1973-1974%29%
% 208.15/208.30 |- skos__hiddenLabel mesh__D003002 CBA 93626
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003002 2001
% 208.15/208.30 |- mesh__recordMaintainer mesh__D003002 TWD
% 208.15/208.30 |- skos__scopeNote mesh__D003002 Anti-inflammatory analgesic.
% 208.15/208.30 |- mesh__dateEstablished mesh__D003002 1991-01-01
% 208.15/208.30 |- mesh__dateRevised mesh__D003002 2000-06-22
% 208.15/208.30 |- skos__hiddenLabel mesh__D003002 Sch10304
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003002 2004
% 208.15/208.30 |- mesh__recordOriginator mesh__D003002 NLM
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003002 2006
% 208.15/208.30 |- skos__hiddenLabel mesh__D003002 CBA93626
% 208.15/208.30 |- skos__hiddenLabel mesh__D003002 Sch 10304
% 208.15/208.30 |- skos__prefLabel mesh__D003002 Clonixin
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003002 2003
% 208.15/208.30 |- mesh__historyNote mesh__D003002
% 208.15/208.30 91%28%75%29%; was see under NICOTINIC ACIDS 1975-90
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D003002
% 208.15/208.30 91; was see under NICOTINIC ACIDS 1975-90
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003002 2005
% 208.15/208.30 |- skos__historyNote mesh__D003002 Nicotinic Acids %28%1971-1974%29%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008296 1999
% 208.15/208.30 |- rdf__type mesh__D008296sskos__Concept
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008296 2000
% 208.15/208.30 |- skos__prefLabel mesh__D008296 Malaysia
% 208.15/208.30 |- skos__annotation mesh__D008296
% 208.15/208.30 a monarchy in southeast Asia; note X refs but Malay Archipelago = INDONESIA; Malaysians are of MONGOLOID RACE unless otherwise specified%A%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008296 2001
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008296 2003
% 208.15/208.30 |- skos__altLabel mesh__D008296 Federation of Malaya
% 208.15/208.30 |- skos__scopeNote mesh__D008296
% 208.15/208.30 A parliamentary democracy with a constitutional monarch in southeast Asia, consisting of 11 states %28%West Malaysia%29% on the Malay Peninsula and two states %28%East Malaysia%29% on the island of BORNEO. It is also called the Federation of Malaysia. Its capital is Kuala Lumpur. Before 1963 it was the Union of Malaya. It reorganized in 1948 as the Federation of Malaya, becoming independent from British Malaya in 1957 and becoming Malaysia in 1963 as a federation of Malaya, Sabah, Sarawak, and Singapore %28%which seceded in 1965%29%. The form Malay- probably derives from the Tamil malay, mountain, with reference to its geography. %28%From Webster%27%s New Geographical Dictionary, 1988, p715 %26% Room, Brewer%27%s Dictionary of Names, 1992, p329%29%%A%
% 208.15/208.30 |- skos__altLabel mesh__D008296 Malay Federation
% 208.15/208.30 |- mesh__recordMaintainer mesh__D008296 TGC
% 208.15/208.30 |- mesh__dateRevised mesh__D008296 1997-06-20
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008296 2005
% 208.15/208.30 |- skos__altLabel mesh__D008296 Malaya
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008296 2004
% 208.15/208.30 |- mesh__recordOriginator mesh__D008296 NLM
% 208.15/208.30 |- skos__altLabel mesh__D008296 Malaya Federation
% 208.15/208.30 |- skos__broader mesh__D008296smesh__D001210
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008296 2002
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008296 1998
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008296 2006
% 208.15/208.30 |- mesh__dateCreated mesh__D008296 1999-01-01
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D008296 SJN
% 208.15/208.30 |- mesh__historyNote mesh__D016728 92
% 208.15/208.30 |- skos__hiddenLabel mesh__D016728 Behavior, Self-Injurious
% 208.15/208.30 |- mesh__dateRevised mesh__D016728 2003-07-09
% 208.15/208.30 |- skos__altLabel mesh__D016728 Deliberate Self-Harm
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D016728 2004
% 208.15/208.30 |- skos__scopeNote mesh__D016728
% 208.15/208.30 Behavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation.%A%
% 208.15/208.30 |- skos__hiddenLabel mesh__D016728 Self Injurious Behavior
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D016728 2005
% 208.15/208.30 |- skos__hiddenLabel mesh__D016728 Behavior, Self-Destructive
% 208.15/208.30 |- skos__hiddenLabel mesh__D016728 Self Destructive Behavior
% 208.15/208.30 |- mesh__recordOriginator mesh__D016728 MXR
% 208.15/208.30 |- mesh__dateCreated mesh__D016728 1991-04-29
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D016728 92
% 208.15/208.30 |- skos__broader mesh__D016728smesh__D001526
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D016728 2006
% 208.15/208.30 |- skos__annotation mesh__D016728
% 208.15/208.30 SELF MUTILATION is also available; DF: SELF INJ BEHAVIOR
% 208.15/208.30 |- rdf__type mesh__D016728sskos__Concept
% 208.15/208.30 |- mesh__recordMaintainer mesh__D016728 ssb
% 208.15/208.30 |- skos__prefLabel mesh__D016728 Self-Injurious Behavior
% 208.15/208.30 |- skos__hiddenLabel mesh__D016728 Self-Harm, Deliberate
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D016728 sjn
% 208.15/208.30 |- skos__historyNote mesh__D016728 Self Mutilation %28%1968-1991%29%
% 208.15/208.30 |- skos__hiddenLabel mesh__D016728 Deliberate Self Harm
% 208.15/208.30 |- mesh__dateEstablished mesh__D016728 1992-01-01
% 208.15/208.30 |- mesh__dateEstablished mesh__D041121 2003-01-01
% 208.15/208.30 |- mesh__dateRevised mesh__D041121 2005-06-30
% 208.15/208.30 |- skos__historyNote mesh__D041121 Klebsiella %28%1970-2002%29%
% 208.15/208.30 |- skos__annotation mesh__D041121
% 208.15/208.30 infection: coord IM with KLEBSIELLA INFECTIONS %28%IM%29%
% 208.15/208.30 |- skos__scopeNote mesh__D041121
% 208.15/208.30 A species of gram-negative bacteria causing URINARY TRACT INFECTIONS and SEPTICEMIA.%A%
% 208.15/208.30 |- mesh__dateCreated mesh__D041121 2002-07-03
% 208.15/208.30 |- rdf__type mesh__D041121sskos__Concept
% 208.15/208.30 |- skos__prefLabel mesh__D041121 Klebsiella oxytoca
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D041121 2003
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D041121 2006
% 208.15/208.30 |- mesh__historyNote mesh__D041121 2003
% 208.15/208.30 |- mesh__recordOriginator mesh__D041121 ags
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D041121 sjn
% 208.15/208.30 |- skos__broader mesh__D041121smesh__D007709
% 208.15/208.30 |- mesh__recordMaintainer mesh__D041121 SYSTEM
% 208.15/208.30 |- mesh__dateEstablished mesh__D002708 1974-01-01
% 208.15/208.30 |- mesh__dateCreated mesh__D002708 1999-01-01
% 208.15/208.30 |- skos__broader mesh__D002708smesh__D000460
% 208.15/208.30 |- skos__annotation mesh__D002708 a unicellular green alga
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D002708 74
% 208.15/208.30 |- mesh__recordMaintainer mesh__D002708 SYSTEM
% 208.15/208.30 |- mesh__recordOriginator mesh__D002708 NLM
% 208.15/208.30 |- skos__prefLabel mesh__D002708 Chlorella
% 208.15/208.30 |- mesh__historyNote mesh__D002708 74%28%72%29%
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D002708 sjn
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D002708 2006
% 208.15/208.30 |- mesh__dateRevised mesh__D002708 2005-06-30
% 208.15/208.30 |- skos__historyNote mesh__D002708 Algae, Green %28%1970-1971%29%
% 208.15/208.30 |- rdf__type mesh__D002708sskos__Concept
% 208.15/208.30 |- skos__scopeNote mesh__D002708
% 208.15/208.30 Nonmotile unicellular green algae potentially valuable as a source of high-grade protein and B-complex vitamins.%A%
% 208.15/208.30 |- skos__hiddenLabel mesh__D002708 Chlorellas
% 208.15/208.30 |- skos__altLabel mesh__D013430 Sulfurylase
% 208.15/208.30 |- skos__scopeNote mesh__D013430
% 208.15/208.30 An enzyme that catalyzes the activation of sulfate ions by ATP to form adenosine-5%27%-phosphosulfate and pyrophosphate. This reaction constitutes the first enzymatic step in sulfate utilization following the uptake of sulfate. EC 2.7.7.4.%A%
% 208.15/208.30 |- skos__historyNote mesh__D013430 Transferases %28%1966-1967%29%
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D013430 sjn
% 208.15/208.30 |- skos__hiddenLabel mesh__D013430 Adenylyltransferase, Sulfate
% 208.15/208.30 |- skos__hiddenLabel mesh__D013430 Sulfurylase, ATP
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D013430 2004
% 208.15/208.30 |- skos__historyNote mesh__D013430
% 208.15/208.30 Nucleotidyltransferases %28%1966-1978%29%
% 208.15/208.30 |- skos__broader mesh__D013430smesh__D009713
% 208.15/208.30 |- mesh__recordMaintainer mesh__D013430 ssb
% 208.15/208.30 |- rdf__type mesh__D013430sskos__Concept
% 208.15/208.30 |- mesh__dateRevised mesh__D013430 2003-07-09
% 208.15/208.30 |- skos__historyNote mesh__D013430 Sulfates %28%1966-1978%29%
% 208.15/208.30 |- mesh__historyNote mesh__D013430
% 208.15/208.30 91%28%79%29%; was see under NUCLEOTIDYLTRANSFERASES 1979-90
% 208.15/208.30 |- mesh__dateCreated mesh__D013430 1978-03-16
% 208.15/208.30 |- skos__historyNote mesh__D013430 Adenosine Triphosphate %28%1966-1978%29%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D013430 2006
% 208.15/208.30 |- mesh__recordOriginator mesh__D013430 RLS
% 208.15/208.30 |- mesh__dateEstablished mesh__D013430 1991-01-01
% 208.15/208.30 |- skos__altLabel mesh__D013430 ATP Sulfurylase
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D013430 2005
% 208.15/208.30 |- skos__prefLabel mesh__D013430 Sulfate Adenylyltransferase
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D013430
% 208.15/208.30 91; was see under NUCLEOTIDYLTRANSFERASES 1979-90
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 1998
% 208.15/208.30 |- skos__annotation mesh__D012338
% 208.15/208.30 IM; /drug eff /ultrastruct permitted; DF: 23S RRNA
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 1993
% 208.15/208.30 |- skos__hiddenLabel mesh__D012338 Ribosomal RNA, 23S
% 208.15/208.30 |- skos__hiddenLabel mesh__D012338 RNA, 23S Ribosomal
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 1997
% 208.15/208.30 |- mesh__dateRevised mesh__D012338 1992-05-20
% 208.15/208.30 |- skos__historyNote mesh__D012338 RNA %28%1966-1970%29%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 2006
% 208.15/208.30 |- skos__altLabel mesh__D012338 23S Ribosomal RNA
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 1996
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 2002
% 208.15/208.30 |- skos__prefLabel mesh__D012338 RNA, Ribosomal, 23S
% 208.15/208.30 |- rdf__type mesh__D012338sskos__Concept
% 208.15/208.30 |- mesh__historyNote mesh__D012338
% 208.15/208.30 91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90
% 208.15/208.30 |- skos__historyNote mesh__D012338 RNA, Ribosomal %28%1971-1987%29%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 2005
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D012338 PLS
% 208.15/208.30 |- mesh__dateCreated mesh__D012338 1987-05-07
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 2001
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 2004
% 208.15/208.30 |- mesh__recordMaintainer mesh__D012338 TGC
% 208.15/208.30 |- skos__broader mesh__D012338smesh__D012335
% 208.15/208.30 |- mesh__recordOriginator mesh__D012338 RLS
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 2000
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 1995
% 208.15/208.30 |- mesh__dateEstablished mesh__D012338 1991-01-01
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D012338
% 208.15/208.30 91; was see under RNA, RIBOSOMAL 1988-90
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 2003
% 208.15/208.30 |- skos__scopeNote mesh__D012338
% 208.15/208.30 Constituent of 50S subunit of prokaryotic ribosomes containing about 3200 nucleotides. 23S rRNA is involved in the initiation of polypeptide synthesis.%A%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 1999
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D012338 1994
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D017821 sjn
% 208.15/208.30 |- mesh__dateEstablished mesh__D017821 1994-01-01
% 208.15/208.30 |- skos__historyNote mesh__D017821 Snakes %28%1966-1993%29%
% 208.15/208.30 |- mesh__dateRevised mesh__D017821 2003-07-09
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017821 2004
% 208.15/208.30 |- mesh__dateCreated mesh__D017821 1993-02-16
% 208.15/208.30 |- skos__hiddenLabel mesh__D017821 Anacondas
% 208.15/208.30 |- skos__scopeNote mesh__D017821
% 208.15/208.30 A family of snakes comprising the boas, anacondas, and pythons. They occupy a variety of habitats through the tropics and subtropics and are arboreal, aquatic or fossorial %28%burrowing%29%. Some are oviparous, others ovoviviparous. Contrary to popular opinion, they do not crush the bones of their victims: their coils exert enough pressure to stop a prey%27%s breathing, thus suffocating it. There are five subfamilies: Boinae, Bolyerinae, Erycinae, Pythoninae, and Tropidophiinae. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p315-320%29%%A%
% 208.15/208.30 |- mesh__recordMaintainer mesh__D017821 ags
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D017821 94
% 208.15/208.30 |- skos__hiddenLabel mesh__D017821 Boas
% 208.15/208.30 |- rdf__type mesh__D017821sskos__Concept
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017821 2006
% 208.15/208.30 |- skos__hiddenLabel mesh__D017821 Pythons
% 208.15/208.30 |- skos__broader mesh__D017821smesh__D012911
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017821 2005
% 208.15/208.30 |- skos__prefLabel mesh__D017821 Boidae
% 208.15/208.30 |- skos__annotation mesh__D017821 a family of snakes; note X refs
% 208.15/208.30 |- mesh__historyNote mesh__D017821 94
% 208.15/208.30 |- mesh__recordOriginator mesh__D017821 TGC
% 208.15/208.30 |- mesh__recordOriginator mesh__D017023 AGS
% 208.15/208.30 |- mesh__dateRevised mesh__D017023 1997-06-20
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017023 1999
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017023 2005
% 208.15/208.30 |- rdf__type mesh__D017023sskos__Concept
% 208.15/208.30 |- mesh__dateCreated mesh__D017023 1991-05-30
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017023 2001
% 208.15/208.30 |- skos__broader mesh__D017023smesh__D000792
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017023 2004
% 208.15/208.30 |- skos__scopeNote mesh__D017023
% 208.15/208.30 Radiography of the vascular system of the heart muscle after injection of a contrast medium.%A%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017023 2000
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D017023 92
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017023 1998
% 208.15/208.30 |- skos__hiddenLabel mesh__D017023 Angiographies, Coronary
% 208.15/208.30 |- skos__broader mesh__D017023smesh__D006334
% 208.15/208.30 |- skos__historyNote mesh__D017023
% 208.15/208.30 Coronary Vessels/radiography %28%1966-1991%29%
% 208.15/208.30 |- mesh__historyNote mesh__D017023 92
% 208.15/208.30 |- skos__annotation mesh__D017023
% 208.15/208.30 /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CORONARY ANGIOGR%A%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017023 2003
% 208.15/208.30 |- skos__hiddenLabel mesh__D017023 Coronary Angiographies
% 208.15/208.30 |- mesh__dateEstablished mesh__D017023 1992-01-01
% 208.15/208.30 |- skos__historyNote mesh__D017023 Angiography %28%1966-1991%29%
% 208.15/208.30 |- skos__altLabel mesh__D017023 Angiography, Coronary
% 208.15/208.30 |- skos__prefLabel mesh__D017023 Coronary Angiography
% 208.15/208.30 |- mesh__recordMaintainer mesh__D017023 PXP
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D017023 SJN
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017023 2006
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D017023 2002
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D003801 PLS
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 2006
% 208.15/208.30 |- skos__altLabel mesh__D003801 Veneers, Dental
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 2001
% 208.15/208.30 |- skos__historyNote mesh__D003801 Crowns %28%1966-1983%29%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 2003
% 208.15/208.30 |- mesh__dateRevised mesh__D003801 1996-06-10
% 208.15/208.30 |- skos__altLabel mesh__D003801 Laminate, Dental
% 208.15/208.30 |- mesh__dateCreated mesh__D003801 1983-02-09
% 208.15/208.30 |- skos__historyNote mesh__D003801 Dental Prosthesis %28%1966-1969%29%
% 208.15/208.30 |- mesh__recordOriginator mesh__D003801 RC
% 208.15/208.30 |- skos__altLabel mesh__D003801 Dental Veneer
% 208.15/208.30 |- skos__altLabel mesh__D003801 Laminates, Dental
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 1998
% 208.15/208.30 |- skos__altLabel mesh__D003801 Dental Laminate
% 208.15/208.30 |- rdf__type mesh__D003801sskos__Concept
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 2004
% 208.15/208.30 |- mesh__historyNote mesh__D003801 84
% 208.15/208.30 |- skos__historyNote mesh__D003801
% 208.15/208.30 Dental Prosthesis Design %28%1970-1983%29%
% 208.15/208.30 |- mesh__recordMaintainer mesh__D003801 TGC
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 1999
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 2002
% 208.15/208.30 |- skos__altLabel mesh__D003801 Dental Laminates
% 208.15/208.30 |- skos__broader mesh__D003801smesh__D017266
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D003801 84
% 208.15/208.30 |- skos__broader mesh__D003801smesh__D003793
% 208.15/208.30 |- skos__altLabel mesh__D003801 Veneer, Dental
% 208.15/208.30 |- skos__scopeNote mesh__D003801
% 208.15/208.30 The use of a layer of tooth-colored material, usually porcelain or acrylic resin, applied to the surface of natural teeth, crowns, or pontics by fusion, cementation, or mechanical retention.%A%
% 208.15/208.30 |- mesh__dateEstablished mesh__D003801 1984-01-01
% 208.15/208.30 |- skos__annotation mesh__D003801
% 208.15/208.30 IM; coord with specific material %28%IM%29% if pertinent; DF: DENT VENEERS%A%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 1997
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 2005
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003801 2000
% 208.15/208.30 |- skos__prefLabel mesh__D003801 Dental Veneers
% 208.15/208.30 |- skos__historyNote mesh__D003801 Dental Porcelain %28%1966-1983%29%
% 208.15/208.30 |- skos__broader mesh__D007501Q000172smesh__D007501
% 208.15/208.30 |- rdf__type mesh__D007501Q000172smesh__CompoundConcept
% 208.15/208.30 |- mesh__recordMaintainer mesh__D003003 TGC
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 2002
% 208.15/208.30 |- mesh__dateRevised mesh__D003003 1996-06-10
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 1997
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 2004
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D003003 PLS
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 2001
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 1999
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 2006
% 208.15/208.30 |- skos__annotation mesh__D003003
% 208.15/208.30 trematode infect caused by CLONORCHIS SINENSIS; OPISTHORCHIS SINENSIS infection = CLONORCHIASIS, not OPISTHORCHIASIS which is Opisthorchis infect by Opisthorchis species other than O. sinensis%A%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 2003
% 208.15/208.30 |- skos__broader mesh__D003003smesh__D014201
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 2005
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 2000
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D003003 1998
% 208.15/208.30 |- skos__hiddenLabel mesh__D003003 Clonorchiases
% 208.15/208.30 |- mesh__dateCreated mesh__D003003 1999-01-01
% 208.15/208.30 |- rdf__type mesh__D003003sskos__Concept
% 208.15/208.30 |- skos__scopeNote mesh__D003003
% 208.15/208.30 Infection of the biliary passages with CLONORCHIS SINENSIS, also called Opisthorchis sinensis. It may lead to inflammation of the biliary tract, proliferation of biliary epithelium, progressive portal fibrosis, and sometimes bile duct carcinoma. Extension to the liver may lead to fatty changes and cirrhosis. %28%From Dorland, 27th ed%29%%A%
% 208.15/208.30 |- mesh__recordOriginator mesh__D003003 NLM
% 208.15/208.30 |- skos__prefLabel mesh__D003003 Clonorchiasis
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D008297 sjn
% 208.15/208.30 |- skos__altLabel mesh__D008297 Males
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D008297 2006
% 208.15/208.30 |- mesh__dateCreated mesh__D008297 1999-01-01
% 208.15/208.30 |- mesh__recordMaintainer mesh__D008297 ags
% 208.15/208.30 |- mesh__dateRevised mesh__D008297 2005-06-30
% 208.15/208.30 |- mesh__historyNote mesh__D008297 1966; for MALES use MEN 1979-2005
% 208.15/208.30 |- skos__prefLabel mesh__D008297 Male
% 208.15/208.30 |- skos__annotation mesh__D008297
% 208.15/208.30 check tag only for male organs, diseases, physiol processes, genetics, etc.; do not confuse with MEN as a social, cultural, political, economic force; Manual 18.9+, 35.6.2 CATALOG: do not use: for indexers only%A%
% 208.15/208.30 |- mesh__recordOriginator mesh__D008297 NLM
% 208.15/208.30 |- mesh__dateCreated mesh__D016729 1991-05-30
% 208.15/208.30 |- rdf__type mesh__D016729sskos__Concept
% 208.15/208.30 |- skos__hiddenLabel mesh__D016729 A 43818
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D016729 2004
% 208.15/208.30 |- skos__altLabel mesh__D016729 Leuprorelin
% 208.15/208.30 |- mesh__historyNote mesh__D016729 92; was LEUPROLIDE %28%NM%29% 1975-91
% 208.15/208.30 |- mesh__recordMaintainer mesh__D016729 WXM
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D016729 2003
% 208.15/208.30 |- mesh__recordAuthorizer mesh__D016729 sjn
% 208.15/208.30 |- mesh__dateRevised mesh__D016729 2001-07-25
% 208.15/208.30 |- skos__broader mesh__D016729smesh__D007987
% 208.15/208.30 |- skos__hiddenLabel mesh__D016729 TAP 144
% 208.15/208.30 |- skos__historyNote mesh__D016729
% 208.15/208.30 Gonadorelin/analogs %26% derivatives %28%1980-1991%29%
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D016729 2002
% 208.15/208.30 |- skos__hiddenLabel mesh__D016729 TAP144
% 208.15/208.30 |- mesh__recordOriginator mesh__D016729 PXP
% 208.15/208.30 |- skos__hiddenLabel mesh__D016729 Monoacetate, Leuprolide
% 208.15/208.30 |- skos__scopeNote mesh__D016729
% 208.15/208.30 A potent and long acting analog of naturally occurring gonadotropin-releasing hormone %28%GONADORELIN%29%. Its action is similar to gonadorelin, which regulates the synthesis and release of pituitary gonadotropins.%A%
% 208.15/208.30 |- skos__hiddenLabel mesh__D016729 A43818
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D016729
% 208.15/208.30 92; LEUPROLIDE was indexed under PEPTIDES 1975-76 %26% GONADORELIN/analogs %26% derivatives 1977-91%A%
% 208.15/208.30 |- mesh__onlineNote mesh__D016729
% 208.15/208.30 use LEUPROLIDE %28%NM%29% to search LEUPROLIDE 1980-91
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D016729 2006
% 208.15/208.30 |- skos__hiddenLabel mesh__D016729 Acetate, Leuprolide
% 208.15/208.30 |- skos__historyNote mesh__D016729 Antineoplastic Agents %28%1984-1991%29%
% 208.15/208.30 |- skos__prefLabel mesh__D016729 Leuprolide
% 208.15/208.30 |- mesh__dateEstablished mesh__D016729 1992-01-01
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D016729 2005
% 208.15/208.30 |- skos__broader mesh__D041122smesh__D010961
% 208.15/208.30 |- mesh__dateEstablished mesh__D041122 2003-01-01
% 208.15/208.30 |- skos__prefLabel mesh__D041122 Plasmodium ovale
% 208.15/208.30 |- rdf__type mesh__D041122sskos__Concept
% 208.15/208.30 |- skos__historyNote mesh__D041122 Plasmodium %28%1966-2002%29%
% 208.15/208.30 |- mesh__dateRevised mesh__D041122 2003-07-09
% 208.15/208.30 |- mesh__dateCreated mesh__D041122 2002-07-03
% 208.15/208.30 |- skos__scopeNote mesh__D041122
% 208.15/208.30 A species of protozoan parasite causing MALARIA. It is the rarest of the four species of PLASMODIUM infecting humans, but is common in West African countries and neighboring areas.%A%
% 208.15/208.30 |- mesh__publicMeSHNote mesh__D041122 2003
% 208.15/208.30 |- skos__annotation mesh__D041122
% 208.15/208.30 infection: coord IM with MALARIA %28%IM%29%; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%
% 208.15/208.30 |- mesh__historyNote mesh__D041122 2003
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D041122 2006
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D041122 2004
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D041122 2005
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D002709 2005
% 208.15/208.30 |- skos__altLabel mesh__D002709 Clofenvinfos
% 208.15/208.30 |- mesh__activeMeSHYear mesh__D002709 2006
% 208.15/208.30 |- skos__historyNote mesh__D002709 Vinyl Compounds %28%1971-1974%29%
% 208.15/208.30 |- skos__historyNote mesh__D002709 Insecticides %28%1966-1972%29%
% 208.15/208.30 |- skos__scopeNote mesh__D002709
% 208.15/208.30 An organophosphorus cholinesterase inhibitor that is used as an insecticide and an acaricide.%A%
% 208.15/208.30 |- mesh__historyNote mesh__D002709
% 208.15/208.30 91%28%80%29%; was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90%A%
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D002709
% 208.15/208.31 91; was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90
% 208.15/208.31 |- mesh__dateRevised mesh__D002709 2004-07-08
% 208.15/208.31 |- mesh__dateCreated mesh__D002709 1979-05-23
% 208.15/208.31 |- skos__annotation mesh__D002709 TN 111 for eff on insects
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D002709 sjn
% 208.15/208.31 |- rdf__type mesh__D002709sskos__Concept
% 208.15/208.31 |- mesh__recordOriginator mesh__D002709 RLS
% 208.15/208.31 |- mesh__recordMaintainer mesh__D002709 ssb
% 208.15/208.31 |- mesh__dateEstablished mesh__D002709 1991-01-01
% 208.15/208.31 |- skos__historyNote mesh__D002709 Phosphoric Acids %28%1966-1970%29%
% 208.15/208.31 |- skos__altLabel mesh__D002709 Chlorphenvinphos
% 208.15/208.31 |- skos__prefLabel mesh__D002709 Chlorfenvinphos
% 208.15/208.31 |- skos__historyNote mesh__D002709
% 208.15/208.31 Organophosphorus Compounds %28%1971-1979%29%
% 208.15/208.31 |- skos__broader mesh__D002709smesh__D009943
% 208.15/208.31 |- skos__historyNote mesh__D002709
% 208.15/208.31 Insecticides, Organophosphate %28%1973-1979%29%
% 208.15/208.31 |- skos__altLabel mesh__D013431 Inorganic Sulfates
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 2001
% 208.15/208.31 |- rdf__type mesh__D013431sskos__Concept
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 1996
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 2003
% 208.15/208.31 |- skos__prefLabel mesh__D013431 Sulfates
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D013431 PLS
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 2000
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 1999
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 2006
% 208.15/208.31 |- mesh__dateRevised mesh__D013431 1993-06-04
% 208.15/208.31 |- skos__scopeNote mesh__D013431 Inorganic salts of sulfuric acid.
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 1995
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 1998
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 2005
% 208.15/208.31 |- skos__altLabel mesh__D013431 Sulfates, Inorganic
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 2002
% 208.15/208.31 |- mesh__recordMaintainer mesh__D013431 TPW
% 208.15/208.31 |- skos__broader mesh__D013431smesh__D013464
% 208.15/208.31 |- mesh__recordOriginator mesh__D013431 NLM
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 1994
% 208.15/208.31 |- skos__broader mesh__D013431smesh__D000838
% 208.15/208.31 |- mesh__dateCreated mesh__D013431 1999-01-01
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 1997
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013431 2004
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550 Essential Modifier, NF-kappaB
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550 NF kappaB Essential Modifier
% 208.15/208.31 |- skos__altLabel mesh__D051550 IKK 2 Kinase
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550
% 208.15/208.31 I Kappa B alpha Associated Protein Kinase
% 208.15/208.31 |- skos__altLabel mesh__D051550 IkappaB Kinase
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D051550 2006
% 208.15/208.31 |- skos__scopeNote mesh__D051550
% 208.15/208.31 A protein serine-threonine kinase that catalyzes the PHOSPHORYLATION of I KAPPA B PROTEINS. This enzyme also activates the transcription factor NF-KAPPA B and is composed of alpha and beta catalytic subunits, which are protein kinases and gamma, a regulatory subunit.%A%
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550 Kinase epsilon, IkappaB
% 208.15/208.31 |- skos__prefLabel mesh__D051550 I-kappa B Kinase
% 208.15/208.31 |- mesh__historyNote mesh__D051550 2006%28%1997%29%
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D051550
% 208.15/208.31 2006; I-KAPPA B KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1997-2005%A%
% 208.15/208.31 |- skos__altLabel mesh__D051550 I kappa B Kinase
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550 Kinase alpha, IkappaB
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550 B Kinase, I-kappa
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550 Kinase beta, IkappaB
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550 NK kappa B Activating Kinase NAK
% 208.15/208.31 |- skos__altLabel mesh__D051550 CHUK Kinase
% 208.15/208.31 |- skos__broader mesh__D051550smesh__D017346
% 208.15/208.31 |- skos__altLabel mesh__D051550 IKK epsilon
% 208.15/208.31 |- skos__altLabel mesh__D051550 NK-kappa B-Activating Kinase NAK
% 208.15/208.31 |- mesh__recordOriginator mesh__D051550 AKE
% 208.15/208.31 |- mesh__dateCreated mesh__D051550 2005-06-30
% 208.15/208.31 |- skos__altLabel mesh__D051550 NF-kappaB Essential Modifier
% 208.15/208.31 |- skos__altLabel mesh__D051550 IkappaBalpha Kinase
% 208.15/208.31 |- skos__altLabel mesh__D051550 IKBKB
% 208.15/208.31 |- skos__altLabel mesh__D051550 IKK gamma
% 208.15/208.31 |- skos__altLabel mesh__D051550
% 208.15/208.31 Conserved Helix-Loop-Helix Ubiquitous Kinase
% 208.15/208.31 |- skos__altLabel mesh__D051550 IKKepsilon
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550 Kinase, I-kappa B
% 208.15/208.31 |- rdf__type mesh__D051550sskos__Concept
% 208.15/208.31 |- skos__altLabel mesh__D051550 IKK beta
% 208.15/208.31 |- skos__altLabel mesh__D051550 IKK alpha
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D051550 sjn
% 208.15/208.31 |- mesh__recordMaintainer mesh__D051550 AKE
% 208.15/208.31 |- skos__altLabel mesh__D051550 IKK 1 Kinase
% 208.15/208.31 |- skos__broader mesh__D051550smesh__D036341
% 208.15/208.31 |- mesh__dateEstablished mesh__D051550 2006-01-01
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550
% 208.15/208.31 Conserved Helix Loop Helix Ubiquitous Kinase
% 208.15/208.31 |- skos__hiddenLabel mesh__D051550 Kinase, IkappaB
% 208.15/208.31 |- skos__altLabel mesh__D051550 I Kappa B alpha-Associated Protein Kinase
% 208.15/208.31 |- skos__related mesh__D051550smesh__D020672
% 208.15/208.31 |- skos__broader mesh__D051550smesh__D047908
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D037081 2003
% 208.15/208.31 |- mesh__dateCreated mesh__D037081 2002-07-03
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D037081 2003
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D037081 2004
% 208.15/208.31 |- skos__hiddenLabel mesh__D037081 Dysfunction, Tibialis Posterior
% 208.15/208.31 |- skos__historyNote mesh__D037081 Flatfoot %28%1991-2002%29%
% 208.15/208.31 |- rdf__type mesh__D037081sskos__Concept
% 208.15/208.31 |- skos__altLabel mesh__D037081 Tibialis Posterior Dysfunction
% 208.15/208.31 |- skos__historyNote mesh__D037081 Tendons %28%1989-2002%29%
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D037081 2005
% 208.15/208.31 |- mesh__historyNote mesh__D037081 2003
% 208.15/208.31 |- skos__scopeNote mesh__D037081
% 208.15/208.31 A condition characterized by a broad range of progressive disorders ranging from TENOSYNOVITIS to tendon rupture with or without hindfoot collapse to a fixed, rigid, FLATFOOT deformity. Pathologic changes can involve associated tendons, ligaments, joint structures of the ANKLE, hindfoot, and midfoot. Posterior tibial tendon dysfunction is the most common cause of acquired flatfoot deformity in adults.%A%
% 208.15/208.31 |- skos__broader mesh__D037081smesh__D005534
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D037081 2006
% 208.15/208.31 |- skos__historyNote mesh__D037081 Muscular Diseases %28%1989-2002%29%
% 208.15/208.31 |- skos__altLabel mesh__D037081 Tibial Tendon Dysfunction, Posterior
% 208.15/208.31 |- skos__related mesh__D037081smesh__D005413
% 208.15/208.31 |- mesh__dateEstablished mesh__D037081 2003-01-01
% 208.15/208.31 |- skos__prefLabel mesh__D037081 Posterior Tibial Tendon Dysfunction
% 208.15/208.31 |- rdf__type mesh__D012339sskos__Concept
% 208.15/208.31 |- skos__broader mesh__D012339smesh__D012335
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 2000
% 208.15/208.31 |- mesh__dateRevised mesh__D012339 1995-05-22
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 2005
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 2004
% 208.15/208.31 |- skos__historyNote mesh__D012339 RNA, Ribosomal %28%1971-1987%29%
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D012339
% 208.15/208.31 91; was see under RNA, RIBOSOMAL 1988-90
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 1999
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 2003
% 208.15/208.31 |- skos__altLabel mesh__D012339 28S Ribosomal RNA
% 208.15/208.31 |- mesh__dateEstablished mesh__D012339 1991-01-01
% 208.15/208.31 |- skos__hiddenLabel mesh__D012339 Ribosomal RNA, 28S
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 1998
% 208.15/208.31 |- skos__prefLabel mesh__D012339 RNA, Ribosomal, 28S
% 208.15/208.31 |- skos__scopeNote mesh__D012339
% 208.15/208.31 Constituent of the 60S subunit of eukaryotic ribosomes. 28S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.%A%
% 208.15/208.31 |- skos__hiddenLabel mesh__D012339 RNA, 28S Ribosomal
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 2002
% 208.15/208.31 |- mesh__recordMaintainer mesh__D012339 KEV
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 1997
% 208.15/208.31 |- mesh__historyNote mesh__D012339
% 208.15/208.31 91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90
% 208.15/208.31 |- skos__annotation mesh__D012339
% 208.15/208.31 IM; /drug eff /ultrastruct permitted; DF: 28S RRNA
% 208.15/208.31 |- mesh__dateCreated mesh__D012339 1987-05-09
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D012339 PLS
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 2006
% 208.15/208.31 |- mesh__recordOriginator mesh__D012339 RLS
% 208.15/208.31 |- skos__historyNote mesh__D012339 RNA %28%1966-1970%29%
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 2001
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D012339 1996
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 2001
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 2002
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D009390 PLS
% 208.15/208.31 |- rdf__type mesh__D009390sskos__Concept
% 208.15/208.31 |- mesh__recordOriginator mesh__D009390 NLM
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 1994
% 208.15/208.31 |- mesh__recordMaintainer mesh__D009390 PLS
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 2005
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 1998
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 1995
% 208.15/208.31 |- mesh__dateCreated mesh__D009390 1999-01-01
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 2006
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 2003
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 1999
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 1996
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 2000
% 208.15/208.31 |- skos__prefLabel mesh__D009390 Nepal
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 2004
% 208.15/208.31 |- skos__broader mesh__D009390smesh__D001211
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009390 1997
% 208.15/208.31 |- mesh__dateRevised mesh__D009390 1993-06-03
% 208.15/208.31 |- skos__altLabel mesh__D023061 Gene Position
% 208.15/208.31 |- skos__hiddenLabel mesh__D023061 Order, Gene
% 208.15/208.31 |- mesh__dateCreated mesh__D023061 2000-06-21
% 208.15/208.31 |- skos__hiddenLabel mesh__D023061 Arrangement, Gene
% 208.15/208.31 |- skos__hiddenLabel mesh__D023061 Position, Gene
% 208.15/208.31 |- skos__related mesh__D023061smesh__D008040
% 208.15/208.31 |- skos__prefLabel mesh__D023061 Gene Order
% 208.15/208.31 |- skos__hiddenLabel mesh__D023061 Gene Positions
% 208.15/208.31 |- skos__hiddenLabel mesh__D023061 Gene Arrangements
% 208.15/208.31 |- mesh__dateRevised mesh__D023061 2002-07-02
% 208.15/208.31 |- skos__hiddenLabel mesh__D023061 Arrangements, Gene
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D023061 2005
% 208.15/208.31 |- skos__scopeNote mesh__D023061
% 208.15/208.31 The sequential location of genes on a chromosome.
% 208.15/208.31 |- skos__broader mesh__D023061smesh__D040341
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D023061 2003
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D023061 2006
% 208.15/208.31 |- mesh__dateEstablished mesh__D023061 2001-01-01
% 208.15/208.31 |- mesh__historyNote mesh__D023061 2001
% 208.15/208.31 |- rdf__type mesh__D023061sskos__Concept
% 208.15/208.31 |- skos__historyNote mesh__D023061 Chromosome Mapping %28%1965-2000%29%
% 208.15/208.31 |- skos__altLabel mesh__D023061 Gene Arrangement
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D023061 2001
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D023061 2004
% 208.15/208.31 |- skos__hiddenLabel mesh__D023061 Positions, Gene
% 208.15/208.31 |- skos__scopeNote mesh__D017024
% 208.15/208.31 Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.%A%
% 208.15/208.31 |- skos__altLabel mesh__D017024 Adjuvant Drug Therapy
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 2004
% 208.15/208.31 |- skos__broader mesh__D017024smesh__D003131
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 2002
% 208.15/208.31 |- mesh__historyNote mesh__D017024 92
% 208.15/208.31 |- skos__altLabel mesh__D017024 Drug Therapy, Adjuvant
% 208.15/208.31 |- mesh__recordOriginator mesh__D017024 AGS
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 2003
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D017024 PLS
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 2001
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 1997
% 208.15/208.31 |- skos__annotation mesh__D017024
% 208.15/208.31 almost never IM; coordinate with dis /drug ther + specific drug or drugs /ther use + other form of ther to which this is adjuvant; Manual 24.4.2.2.1; DF: CHEMOTHER ADJUVANT%A%
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D017024 92
% 208.15/208.31 |- skos__broader mesh__D017024smesh__D004358
% 208.15/208.31 |- skos__historyNote mesh__D017024
% 208.15/208.31 Drug Therapy, Combination %28%1974-1983%29%
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 1996
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 1995
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 2000
% 208.15/208.31 |- mesh__dateEstablished mesh__D017024 1992-01-01
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 2006
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 1994
% 208.15/208.31 |- skos__hiddenLabel mesh__D017024 Adjuvant Chemotherapy
% 208.15/208.31 |- skos__historyNote mesh__D017024
% 208.15/208.31 specific drug/therapeutic use %28%1966-1991%29%
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 2005
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 1999
% 208.15/208.31 |- mesh__dateRevised mesh__D017024 1993-06-29
% 208.15/208.31 |- skos__historyNote mesh__D017024
% 208.15/208.31 Combined Modality Therapy %28%1984-1991%29%
% 208.15/208.31 |- skos__prefLabel mesh__D017024 Chemotherapy, Adjuvant
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017024 1998
% 208.15/208.31 |- mesh__dateCreated mesh__D017024 1991-05-30
% 208.15/208.31 |- mesh__recordMaintainer mesh__D017024 TGC
% 208.15/208.31 |- rdf__type mesh__D017024sskos__Concept
% 208.15/208.31 |- skos__prefLabel mesh__D003802 Dentifrices
% 208.15/208.31 |- skos__altLabel mesh__D003802 Polishes, Dental
% 208.15/208.31 |- skos__annotation mesh__D003802 D25-26 qualif
% 208.15/208.31 |- rdf__type mesh__D003802sskos__Concept
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D003802 2004
% 208.15/208.31 |- skos__broader mesh__D003802smesh__D003358
% 208.15/208.31 |- mesh__recordOriginator mesh__D003802 NLM
% 208.15/208.31 |- skos__scopeNote mesh__D003802
% 208.15/208.31 Any preparations used for cleansing teeth; they usually contain an abrasive, detergent, binder and flavoring agent and may exist in the form of liquid, paste or powder; may also contain medicaments and caries preventives.%A%
% 208.15/208.31 |- mesh__dateRevised mesh__D003802 2003-07-09
% 208.15/208.31 |- mesh__recordMaintainer mesh__D003802 ssb
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D003802 2005
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D003802 sjn
% 208.15/208.31 |- skos__related mesh__D003802smesh__D009067
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D003802 2006
% 208.15/208.31 |- mesh__dateCreated mesh__D003802 1999-01-01
% 208.15/208.31 |- skos__broader mesh__D003802smesh__D001697
% 208.15/208.31 |- skos__broader mesh__D001285Q000031smesh__D001285
% 208.15/208.31 |- mesh__preferredCombination mesh__D001285Q000031smesh__D001286
% 208.15/208.31 |- rdf__type mesh__D001285Q000031smesh__CompoundConcept
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D003004 2004
% 208.15/208.31 |- mesh__historyNote mesh__D003004
% 208.15/208.31 72; was see under OPISTHORCHIS 1963-71
% 208.15/208.31 |- mesh__dateEstablished mesh__D003004 1972-01-01
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D003004 2006
% 208.15/208.31 |- skos__scopeNote mesh__D003004
% 208.15/208.31 A species of trematode flukes of the family Opisthorchidae. Many authorities consider this genus belonging to Opisthorchis. It is common in China and other Asiatic countries. Snails and fish are the intermediate hosts.%A%
% 208.15/208.31 |- skos__broader mesh__D003004smesh__D009890
% 208.15/208.31 |- skos__prefLabel mesh__D003004 Clonorchis sinensis
% 208.15/208.31 |- skos__altLabel mesh__D003004 Opisthorchis sinensis
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D003004
% 208.15/208.31 72; was see under OPISTHORCHIS 1963-71
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D003004 2005
% 208.15/208.31 |- mesh__recordOriginator mesh__D003004 NLM
% 208.15/208.31 |- mesh__dateCreated mesh__D003004 1999-01-01
% 208.15/208.31 |- rdf__type mesh__D003004sskos__Concept
% 208.15/208.31 |- mesh__onlineNote mesh__D003004 search OPISTHORCHIS 1966-71
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D003004 sjn
% 208.15/208.31 |- skos__historyNote mesh__D003004 Opisthorchis %28%1966-1971%29%
% 208.15/208.31 |- skos__annotation mesh__D003004
% 208.15/208.31 infection = CLONORCHIASIS; note X ref: OPISTHORCHIS SINENSIS infection = CLONORCHIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 208.15/208.31 |- mesh__dateRevised mesh__D003004 2003-07-09
% 208.15/208.31 |- mesh__recordMaintainer mesh__D003004 ags
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 2004
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 2005
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 1996
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D008298 PLS
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 2006
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 1997
% 208.15/208.31 |- mesh__dateCreated mesh__D008298 1999-01-01
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 1998
% 208.15/208.31 |- skos__broader mesh__D008298smesh__D003998
% 208.15/208.31 |- mesh__recordOriginator mesh__D008298 NLM
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 2002
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 1994
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 1993
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 1999
% 208.15/208.31 |- skos__prefLabel mesh__D008298 Maleates
% 208.15/208.31 |- rdf__type mesh__D008298sskos__Concept
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 1995
% 208.15/208.31 |- mesh__recordMaintainer mesh__D008298 TAP
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 2000
% 208.15/208.31 |- mesh__dateRevised mesh__D008298 1992-05-18
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 2003
% 208.15/208.31 |- skos__annotation mesh__D008298 do not confuse with MALATES
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D008298 2001
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D041921 2006
% 208.15/208.31 |- mesh__historyNote mesh__D041921 2004
% 208.15/208.31 |- skos__prefLabel mesh__D041921 Hyphomicrobiaceae
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D041921 2004
% 208.15/208.31 |- mesh__dateCreated mesh__D041921 2003-07-09
% 208.15/208.31 |- skos__broader mesh__D041921smesh__D020561
% 208.15/208.31 |- mesh__dateRevised mesh__D041921 2005-06-30
% 208.15/208.31 |- skos__scopeNote mesh__D041921
% 208.15/208.31 A family in the order Rhizobiales, class ALPHAPROTEOBACTERIA comprised of many genera of budding or appendaged bacteria.%A%
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D041921 sjn
% 208.15/208.31 |- mesh__dateEstablished mesh__D041921 2004-01-01
% 208.15/208.31 |- mesh__recordOriginator mesh__D041921 ags
% 208.15/208.31 |- rdf__type mesh__D041921sskos__Concept
% 208.15/208.31 |- mesh__recordMaintainer mesh__D041921 SYSTEM
% 208.15/208.31 |- skos__broader mesh__D013432smesh__D013844
% 208.15/208.31 |- mesh__recordMaintainer mesh__D013432 ssb
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D013432 2006
% 208.15/208.31 |- mesh__dateRevised mesh__D013432 2005-06-30
% 208.15/208.31 |- skos__prefLabel mesh__D013432 Sulfathiazoles
% 208.15/208.31 |- mesh__dateCreated mesh__D013432 1999-01-01
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D013432 sjn
% 208.15/208.31 |- mesh__recordOriginator mesh__D013432 NLM
% 208.15/208.31 |- skos__annotation mesh__D013432 sulfanilamide anti-infectives
% 208.15/208.31 |- rdf__type mesh__D013432sskos__Concept
% 208.15/208.31 |- skos__broader mesh__D013432smesh__D013424
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D009391
% 208.15/208.31 81; was TURBIDIMETRY see under PHOTOMETRY 1975-80; was TURBIDIMETRY see under DENSITOMETRY 1969-74%A%
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009391 2005
% 208.15/208.31 |- mesh__dateRevised mesh__D009391 2002-07-03
% 208.15/208.31 |- mesh__dateCreated mesh__D009391 1999-01-01
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009391 2006
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009391 2003
% 208.15/208.31 |- mesh__onlineNote mesh__D009391
% 208.15/208.31 use NEPHELOMETRY AND TURBIDIMETRY to search TURBIDIMETRY 1975-80; use DENSITOMETRY 1969-74%A%
% 208.15/208.31 |- mesh__dateEstablished mesh__D009391 1981-01-01
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D009391 2004
% 208.15/208.31 |- skos__annotation mesh__D009391 NIM; DF: NEPHELOMETRY
% 208.15/208.31 |- skos__broader mesh__D009391smesh__D010783
% 208.15/208.31 |- skos__hiddenLabel mesh__D009391 Turbidimetry and Nephelometry
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D009391 sjn
% 208.15/208.31 |- mesh__historyNote mesh__D009391
% 208.15/208.31 81; was TURBIDIMETRY see under PHOTOMETRY 1975-80; was TURBIDIMETRY see under DENSITOMETRY 1969-74%A%
% 208.15/208.31 |- skos__scopeNote mesh__D009391
% 208.15/208.31 Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam.%A%
% 208.15/208.31 |- mesh__recordOriginator mesh__D009391 NLM
% 208.15/208.31 |- skos__prefLabel mesh__D009391 Nephelometry and Turbidimetry
% 208.15/208.31 |- mesh__recordMaintainer mesh__D009391 lkt
% 208.15/208.31 |- rdf__type mesh__D009391sskos__Concept
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 IL 8A Receptors
% 208.15/208.31 |- skos__altLabel mesh__D023062 CXC Chemokine Receptor 1
% 208.15/208.31 |- mesh__recordAuthorizer mesh__D023062 sjn
% 208.15/208.31 |- skos__altLabel mesh__D023062 IL-8A Receptors
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 Receptor, Interleukin 8A
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 IL 8Ralpha
% 208.15/208.31 |- skos__altLabel mesh__D023062 IL-8A Receptor
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 Receptor, IL-8A
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 Receptor, NAP-1
% 208.15/208.31 |- skos__altLabel mesh__D023062 CXCR1 Protein
% 208.15/208.31 |- mesh__dateEstablished mesh__D023062 2001-01-01
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 Receptor, Interleukin 8
% 208.15/208.31 |- mesh__dateCreated mesh__D023062 2000-06-23
% 208.15/208.31 |- mesh__recordOriginator mesh__D023062 ags
% 208.15/208.31 |- skos__historyNote mesh__D023062 Antigens, CD %28%1993-2000%29%
% 208.15/208.31 |- skos__altLabel mesh__D023062 Interleukin 8A Receptor
% 208.15/208.31 |- skos__historyNote mesh__D023062 Receptors, Immunologic %28%1989-1993%29%
% 208.15/208.31 |- mesh__historyNote mesh__D023062
% 208.15/208.31 2001; use RECEPTORS, INTERLEUKIN-8A %28%NM%29% to search INTERLEUKIN 8 RECEPTOR 1989-2000%A%
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 Receptors, MDNCF
% 208.15/208.31 |- rdf__type mesh__D023062sskos__Concept
% 208.15/208.31 |- skos__broader mesh__D023062smesh__D018123
% 208.15/208.31 |- skos__annotation mesh__D023062 DF: IL8RA
% 208.15/208.31 |- skos__historyNote mesh__D023062 Receptors, Interleukin %28%1994-2000%29%
% 208.15/208.31 |- skos__altLabel mesh__D023062 IL8RA
% 208.15/208.31 |- skos__altLabel mesh__D023062 Receptors, CXCR1
% 208.15/208.31 |- skos__altLabel mesh__D023062 IL-8Ralpha
% 208.15/208.31 |- skos__altLabel mesh__D023062 CXCR1 Receptor
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 Receptors, Interleukin 8A
% 208.15/208.31 |- mesh__recordMaintainer mesh__D023062 ssb
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 IL 8A Receptor
% 208.15/208.31 |- skos__broader mesh__D023062smesh__D043562
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 Receptor, CXCR1
% 208.15/208.31 |- skos__altLabel mesh__D023062 IL-8RA
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 Interleukin 8A Receptors
% 208.15/208.31 |- skos__altLabel mesh__D023062 Antigens, CDw128a
% 208.15/208.31 |- skos__scopeNote mesh__D023062
% 208.15/208.31 High-affinity receptors for INTERLEUKIN-8 present on neutrophils, monocytes, and basophils.%A%
% 208.15/208.31 |- skos__altLabel mesh__D023062 MDNCF Receptors
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 Receptors, IL-8A
% 208.15/208.31 |- skos__prefLabel mesh__D023062 Receptors, Interleukin-8A
% 208.15/208.31 |- skos__broader mesh__D023062smesh__D015703
% 208.15/208.31 |- skos__altLabel mesh__D023062 Interleukin-8A Receptors
% 208.15/208.31 |- skos__altLabel mesh__D023062 CDw128a Antigens
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D023062
% 208.15/208.31 2001; INTERLEUKIN 8 RECEPTOR was indexed under RECEPTORS, INTERLEUKIN 1994-2000, ANTIGENS, CD 1989-2000, %26% RECEPTORS, IMMUNOLOGIC 1989-1993%A%
% 208.15/208.31 |- skos__hiddenLabel mesh__D023062 NAP 1 Receptor
% 208.15/208.31 |- skos__broader mesh__D023062smesh__D019707
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D023062 2006
% 208.15/208.31 |- skos__altLabel mesh__D023062 Interleukin 8 Receptor Type A
% 208.15/208.31 |- mesh__dateRevised mesh__D023062 2005-06-30
% 208.15/208.31 |- skos__altLabel mesh__D023062 CXCR1 Receptors
% 208.15/208.31 |- skos__altLabel mesh__D023062 NAP-1 Receptor
% 208.15/208.31 |- skos__altLabel mesh__D023062 Interleukin 8 Receptor
% 208.15/208.31 |- rdf__type mesh__D017823sskos__Concept
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 2000
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 2006
% 208.15/208.31 |- mesh__publicMeSHNote mesh__D017823 94
% 208.15/208.31 |- skos__broader mesh__D017823smesh__D010510
% 208.15/208.31 |- skos__hiddenLabel mesh__D017823 Defect, Furcation
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 2005
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 1997
% 208.15/208.31 |- skos__prefLabel mesh__D017823 Furcation Defects
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 2002
% 208.15/208.31 |- mesh__historyNote mesh__D017823 94
% 208.15/208.31 |- mesh__dateCreated mesh__D017823 1993-06-04
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 1996
% 208.15/208.31 |- skos__hiddenLabel mesh__D017823 Defects, Furcation
% 208.15/208.31 |- mesh__dateEstablished mesh__D017823 1994-01-01
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 1999
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 2004
% 208.15/208.31 |- skos__annotation mesh__D017823 a periodontal dis
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 1995
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 2001
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 1998
% 208.15/208.31 |- skos__historyNote mesh__D017823 Tooth Root %28%1966-1993%29%
% 208.15/208.31 |- skos__scopeNote mesh__D017823
% 208.15/208.31 Conditions in which a bifurcation or trifurcation of the molar tooth root becomes denuded as a result of periodontal disease. It may be followed by tooth mobility, temperature sensitivity, pain, and alveolar bone resorption.%A%
% 208.15/208.31 |- skos__hiddenLabel mesh__D017823 Furcation Defect
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 2003
% 208.15/208.31 |- mesh__activeMeSHYear mesh__D017823 1994
% 208.15/208.32 |- skos__hiddenLabel mesh__D003803 Cyst, Dentigerous
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 2006
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 2000
% 208.15/208.32 |- mesh__dateRevised mesh__D003803 1990-06-05
% 208.15/208.32 |- skos__hiddenLabel mesh__D003803 Dentigerous Cysts
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 2004
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D003803 PLS
% 208.15/208.32 |- skos__annotation mesh__D003803
% 208.15/208.32 non-neoplastic; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/dis term %28%IM%29%%A%
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 2005
% 208.15/208.32 |- mesh__dateCreated mesh__D003803 1999-01-01
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 2003
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 1995
% 208.15/208.32 |- rdf__type mesh__D003803sskos__Concept
% 208.15/208.32 |- skos__prefLabel mesh__D003803 Dentigerous Cyst
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 1993
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 2002
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 1999
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 1994
% 208.15/208.32 |- mesh__recordMaintainer mesh__D003803 TAP
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 1997
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 1992
% 208.15/208.32 |- skos__hiddenLabel mesh__D003803 Cysts, Dentigerous
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 1998
% 208.15/208.32 |- skos__scopeNote mesh__D003803
% 208.15/208.32 Most common follicular odontogenic cyst. Occurs in relation to a partially erupted or unerupted tooth with at least the crown of the tooth to which the cyst is attached protruding into the cystic cavity. May give rise to an ameloblastoma and, in rare instances, undergo malignant transformation.%A%
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 1991
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 1996
% 208.15/208.32 |- skos__broader mesh__D003803smesh__D009807
% 208.15/208.32 |- mesh__recordOriginator mesh__D003803 NLM
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003803 2001
% 208.15/208.32 |- mesh__dateEstablished mesh__D003005 1974-01-01
% 208.15/208.32 |- mesh__dateRevised mesh__D003005 2005-06-30
% 208.15/208.32 |- mesh__dateCreated mesh__D003005 1999-01-01
% 208.15/208.32 |- rdf__type mesh__D003005sskos__Concept
% 208.15/208.32 |- mesh__historyNote mesh__D003005 74%28%64%29%
% 208.15/208.32 |- skos__scopeNote mesh__D003005
% 208.15/208.32 A sulfamoylbenzamide piperidine. It is considered a thiazide-like diuretic.%A%
% 208.15/208.32 |- skos__broader mesh__D003005smesh__D010880
% 208.15/208.32 |- mesh__recordOriginator mesh__D003005 NLM
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D003005 74
% 208.15/208.32 |- skos__prefLabel mesh__D003005 Clopamide
% 208.15/208.32 |- mesh__recordMaintainer mesh__D003005 ssb
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D003005 sjn
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003005 2006
% 208.15/208.32 |- skos__broader mesh__D003005smesh__D013449
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D008299 2006
% 208.15/208.32 |- skos__broader mesh__D008299smesh__D005663
% 208.15/208.32 |- skos__broader mesh__D008299smesh__D000812
% 208.15/208.32 |- skos__hiddenLabel mesh__D008299 2,5 Furandiones
% 208.15/208.32 |- mesh__recordOriginator mesh__D008299 RLS
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D008299 2001
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D008299
% 208.15/208.32 91; was see under FURANS 1979-90; was MALEIC ANHYDRIDE see under FURANS 1977-78%A%
% 208.15/208.32 |- mesh__onlineNote mesh__D008299
% 208.15/208.32 use MALEIC ANHYDRIDES to search MALEIC ANHYDRIDE 1977-78
% 208.15/208.32 |- rdf__type mesh__D008299sskos__Concept
% 208.15/208.32 |- skos__scopeNote mesh__D008299
% 208.15/208.32 Used in copolymerization reactions, in the Diels-Alder%28%diene%29%synthesis, in the preparation of resins, pharmaceuticals and agricultural chemicals. It is a powerful irritant and causes burns.%A%
% 208.15/208.32 |- skos__historyNote mesh__D008299 Furans %28%1966-1976%29%
% 208.15/208.32 |- skos__prefLabel mesh__D008299 Maleic Anhydrides
% 208.15/208.32 |- skos__historyNote mesh__D008299 Anhydrides %28%1966-1976%29%
% 208.15/208.32 |- mesh__dateCreated mesh__D008299 1976-05-19
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D008299 2002
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D008299 2003
% 208.15/208.32 |- mesh__dateEstablished mesh__D008299 1991-01-01
% 208.15/208.32 |- mesh__historyNote mesh__D008299
% 208.15/208.32 91%28%79%29%; was see under FURANS 1979-90; was MALEIC ANHYDRIDE see under FURANS 1977-78%A%
% 208.15/208.32 |- skos__historyNote mesh__D008299 Maleates %28%1966-1976%29%
% 208.15/208.32 |- skos__hiddenLabel mesh__D008299 Anhydride, Maleic
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D008299 sjn
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D008299 2004
% 208.15/208.32 |- mesh__dateRevised mesh__D008299 2000-06-21
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D008299 2005
% 208.15/208.32 |- mesh__recordMaintainer mesh__D008299 TWD
% 208.15/208.32 |- skos__altLabel mesh__D008299 2,5-Furandiones
% 208.15/208.32 |- skos__hiddenLabel mesh__D008299 Anhydrides, Maleic
% 208.15/208.32 |- mesh__recordMaintainer mesh__D013433 ssb
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013433 2006
% 208.15/208.32 |- skos__scopeNote mesh__D013433
% 208.15/208.32 GLYCOSPHINGOLIPIDS with a sulfate group esterified to one of the sugar groups.%A%
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D013433 sjn
% 208.15/208.32 |- mesh__recordOriginator mesh__D013433 NLM
% 208.15/208.32 |- mesh__dateRevised mesh__D013433 2004-07-07
% 208.15/208.32 |- skos__historyNote mesh__D013433 Cerebrosides %28%1966-1970%29%
% 208.15/208.32 |- mesh__dateCreated mesh__D013433 1999-01-01
% 208.15/208.32 |- mesh__dateEstablished mesh__D013433 1973-01-01
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D013433 99; see SULFATIDES 1971-98
% 208.15/208.32 |- mesh__historyNote mesh__D013433 99%28%71%29%
% 208.15/208.32 |- skos__altLabel mesh__D013433 Sulfatides
% 208.15/208.32 |- skos__altLabel mesh__D013433 Sulfatoglycosphingolipids
% 208.15/208.32 |- skos__broader mesh__D013433smesh__D020384
% 208.15/208.32 |- rdf__type mesh__D013433sskos__Concept
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013433 2005
% 208.15/208.32 |- skos__prefLabel mesh__D013433 Sulfoglycosphingolipids
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D037881 2003; see FETUS 1978-2002
% 208.15/208.32 |- skos__historyNote mesh__D037881 Fetus %28%1968-2002%29%
% 208.15/208.32 |- mesh__historyNote mesh__D037881 2003; use FETUS 1978-2002
% 208.15/208.32 |- skos__hiddenLabel mesh__D037881 Fetuses, Aborted
% 208.15/208.32 |- rdf__type mesh__D037881sskos__Concept
% 208.15/208.32 |- skos__hiddenLabel mesh__D037881 Aborted Embryos
% 208.15/208.32 |- skos__altLabel mesh__D037881 Aborted Fetuses
% 208.15/208.32 |- skos__related mesh__D037881smesh__D000022
% 208.15/208.32 |- mesh__dateCreated mesh__D037881 2002-07-02
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D037881 2003
% 208.15/208.32 |- skos__prefLabel mesh__D037881 Aborted Fetus
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D037881 2005
% 208.15/208.32 |- mesh__dateEstablished mesh__D037881 2003-01-01
% 208.15/208.32 |- skos__altLabel mesh__D037881 Fetus, Aborted
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D037881 2004
% 208.15/208.32 |- skos__altLabel mesh__D037881 Aborted Embryo
% 208.15/208.32 |- skos__broader mesh__D037881smesh__D005333
% 208.15/208.32 |- skos__related mesh__D037881smesh__D000028
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D037881 2006
% 208.15/208.32 |- skos__scopeNote mesh__D037881
% 208.15/208.32 A mammalian fetus expelled by INDUCED ABORTION or SPONTANEOUS ABORTION.%A%
% 208.15/208.32 |- skos__hiddenLabel mesh__D037881 Embryo, Aborted
% 208.15/208.32 |- skos__hiddenLabel mesh__D037881 Embryos, Aborted
% 208.15/208.32 |- skos__hiddenLabel mesh__D051552 beta Adrenergic Receptor Kinase
% 208.15/208.32 |- skos__altLabel mesh__D051552 beta-AR Kinase
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D051552 2006
% 208.15/208.32 |- skos__broader mesh__D051552smesh__D017868
% 208.15/208.32 |- mesh__dateCreated mesh__D051552 2005-06-30
% 208.15/208.32 |- mesh__recordMaintainer mesh__D051552 ags
% 208.15/208.32 |- skos__hiddenLabel mesh__D051552 beta AR Kinase
% 208.15/208.32 |- skos__prefLabel mesh__D051552 beta-Adrenergic Receptor Kinase
% 208.15/208.32 |- mesh__recordOriginator mesh__D051552 AKE
% 208.15/208.32 |- rdf__type mesh__D051552sskos__Concept
% 208.15/208.32 |- mesh__dateRevised mesh__D051552 2005-07-14
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D051552
% 208.15/208.32 2006; BETA-ADRENERGIC RECEPTOR KINASE was indexed PROTEIN KINASES 1987-1993, %26% CYCLIC AMP-DEPENDENT PROTEIN KINASES 1992-2005%A%
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D051552 2006A
% 208.15/208.32 |- skos__hiddenLabel mesh__D051552 Receptor Kinase, beta-Adrenergic
% 208.15/208.32 |- mesh__dateEstablished mesh__D051552 2006-01-01
% 208.15/208.32 |- mesh__historyNote mesh__D051552 2006
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D051552 ags
% 208.15/208.32 |- skos__scopeNote mesh__D051552
% 208.15/208.32 A cyclic-AMP protein kinase that mediates agonist-dependent PHOSPHORYLATION and desensitization of G-PROTEIN-COUPLED RECEPTORS.%A%
% 208.15/208.32 |- skos__prefLabel mesh__D023861 Photography, Dental
% 208.15/208.32 |- mesh__dateCreated mesh__D023861 2001-07-25
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D023861 2006
% 208.15/208.32 |- skos__scopeNote mesh__D023861
% 208.15/208.32 Photographic techniques used in ORTHODONTICS; DENTAL ESTHETICS; and PATIENT EDUCATION.%A%
% 208.15/208.32 |- skos__hiddenLabel mesh__D023861 Intraoral Photographies
% 208.15/208.32 |- skos__broader mesh__D023861smesh__D003945
% 208.15/208.32 |- skos__historyNote mesh__D023861 Photography %28%1969-1999%29%
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D023861
% 208.15/208.32 2002; for PHOTOGRAPHY, INTRAORAL see PHOTOGRAPHY, INTRAORAL %28%2000-2001%29%%A%
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D023861 sjn
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D023861 2004
% 208.15/208.32 |- rdf__type mesh__D023861sskos__Concept
% 208.15/208.32 |- skos__hiddenLabel mesh__D023861 Photographies, Intraoral
% 208.15/208.32 |- skos__broader mesh__D023861smesh__D010781
% 208.15/208.32 |- mesh__dateRevised mesh__D023861 2003-07-09
% 208.15/208.32 |- skos__altLabel mesh__D023861 Intraoral Photography
% 208.15/208.32 |- skos__hiddenLabel mesh__D023861 Orthodontic Photography
% 208.15/208.32 |- skos__hiddenLabel mesh__D023861 Dental Photography
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D023861 2005
% 208.15/208.32 |- mesh__recordOriginator mesh__D023861 lkt
% 208.15/208.32 |- mesh__historyNote mesh__D023861 2002
% 208.15/208.32 |- mesh__recordMaintainer mesh__D023861 lkt
% 208.15/208.32 |- mesh__dateEstablished mesh__D023861 2002-01-01
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D009392 SJN
% 208.15/208.32 |- skos__prefLabel mesh__D009392 Nephrectomy
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009392 1998
% 208.15/208.32 |- mesh__recordOriginator mesh__D009392 NLM
% 208.15/208.32 |- skos__scopeNote mesh__D009392
% 208.15/208.32 Excision of a kidney. %28%Dorland, 28th ed%29%
% 208.15/208.32 |- mesh__dateCreated mesh__D009392 1999-01-01
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009392 2006
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009392 2003
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009392 1999
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009392 2004
% 208.15/208.32 |- mesh__recordMaintainer mesh__D009392 PXP
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009392 2000
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009392 2001
% 208.15/208.32 |- skos__hiddenLabel mesh__D009392 Nephrectomies
% 208.15/208.32 |- mesh__dateRevised mesh__D009392 1997-06-20
% 208.15/208.32 |- skos__broader mesh__D009392smesh__D013520
% 208.15/208.32 |- rdf__type mesh__D009392sskos__Concept
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009392 2002
% 208.15/208.32 |- skos__annotation mesh__D009392
% 208.15/208.32 do not use /util except by MeSH definition
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009392 2005
% 208.15/208.32 |- skos__altLabel mesh__D023063 Interleukin-8 Receptors Type B
% 208.15/208.32 |- skos__altLabel mesh__D023063 Interleukin-8 Receptors B
% 208.15/208.32 |- mesh__historyNote mesh__D023063
% 208.15/208.32 2001; use RECEPTORS, INTERLEUKIN-8B %28%NM%29% to search INTERLEUKIN-8 RECEPTOR TYPE B 1994-2000%A%
% 208.15/208.32 |- skos__hiddenLabel mesh__D023063 Receptor, Interleukin-8B
% 208.15/208.32 |- skos__altLabel mesh__D023063 CDw128b Antigens
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D023063 2005
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D023063 sjn
% 208.15/208.32 |- skos__prefLabel mesh__D023063 Receptors, Interleukin-8B
% 208.15/208.32 |- mesh__dateEstablished mesh__D023063 2001-01-01
% 208.15/208.32 |- skos__hiddenLabel mesh__D023063 Interleukin 8 Receptors Type B
% 208.15/208.32 |- skos__hiddenLabel mesh__D023063 Interleukin 8 Receptors B
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D023063
% 208.15/208.32 2001; INTERLEUKIN-8 RECEPTOR TYPE B was indexed under RECEPTORS, CHEMOKINE 1998-2000 %26% RECEPTORS, INTERLEUKIN 1994-2000%A%
% 208.15/208.32 |- skos__altLabel mesh__D023063 IL8RB
% 208.15/208.32 |- mesh__dateCreated mesh__D023063 2000-06-23
% 208.15/208.32 |- skos__hiddenLabel mesh__D023063 IL 8Rbeta
% 208.15/208.32 |- mesh__recordOriginator mesh__D023063 ags
% 208.15/208.32 |- skos__altLabel mesh__D023063 Receptors, CXCR2
% 208.15/208.32 |- skos__historyNote mesh__D023063 Receptors, Interleukin %28%1994-2000%29%
% 208.15/208.32 |- rdf__type mesh__D023063sskos__Concept
% 208.15/208.32 |- mesh__recordMaintainer mesh__D023063 jmp
% 208.15/208.32 |- skos__altLabel mesh__D023063 Interleukin-8 Receptor Type B
% 208.15/208.32 |- skos__altLabel mesh__D023063 Interleukin-8B Receptor
% 208.15/208.32 |- skos__broader mesh__D023063smesh__D018123
% 208.15/208.32 |- skos__hiddenLabel mesh__D023063 Interleukin 8B Receptor
% 208.15/208.32 |- skos__hiddenLabel mesh__D023063 IL 8RB
% 208.15/208.32 |- skos__altLabel mesh__D023063 IL-8Rbeta
% 208.15/208.32 |- skos__broader mesh__D023063smesh__D043562
% 208.15/208.32 |- skos__altLabel mesh__D023063 Antigens, CDw128b
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D023063 2004
% 208.15/208.32 |- skos__altLabel mesh__D023063 Interleukin-8B Receptors
% 208.15/208.32 |- skos__historyNote mesh__D023063 Receptors, Chemokine %28%1997-2000%29%
% 208.15/208.32 |- skos__altLabel mesh__D023063 CXCR2 Protein
% 208.15/208.32 |- skos__hiddenLabel mesh__D023063 Receptors, Interleukin 8B
% 208.15/208.32 |- skos__altLabel mesh__D023063 CXC Chemokine Receptor 2
% 208.15/208.32 |- skos__annotation mesh__D023063 DF: IL8RB
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D023063 2006
% 208.15/208.32 |- skos__hiddenLabel mesh__D023063 Interleukin 8B Receptors
% 208.15/208.32 |- skos__altLabel mesh__D023063 CXCR2 Receptors
% 208.15/208.32 |- mesh__dateRevised mesh__D023063 2003-07-09
% 208.15/208.32 |- skos__altLabel mesh__D023063 IL-8RB
% 208.15/208.32 |- skos__scopeNote mesh__D023063
% 208.15/208.32 Low-affinity receptors for INTERLEUKIN-8 present on neutrophils, monocytes, basophils, and T-cells. These receptors also bind GRO and NAP-2.%A%
% 208.15/208.32 |- skos__hiddenLabel mesh__D023063 Interleukin 8 Receptor Type B
% 208.15/208.32 |- skos__hiddenLabel mesh__D017824 Bone Cyst, Aneurysmal
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 1994
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D017824 94
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 1997
% 208.15/208.32 |- mesh__dateCreated mesh__D017824 1993-06-03
% 208.15/208.32 |- skos__annotation mesh__D017824
% 208.15/208.32 non-neoplastic; nothing to do with %22%aneurysm%22%: see MeSH definition; /blood supply /chem /secret /ultrastruct permitted; coord IM with precord organ/diseases term %28%IM%29% %28%but not BONE DISEASES%29%%A%
% 208.15/208.32 |- skos__hiddenLabel mesh__D017824 Aneurysmal Bone Cysts
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 2006
% 208.15/208.32 |- skos__broader mesh__D017824smesh__D001845
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 1996
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 2002
% 208.15/208.32 |- skos__hiddenLabel mesh__D017824 Cysts, Aneurysmal Bone
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 2005
% 208.15/208.32 |- skos__prefLabel mesh__D017824 Bone Cysts, Aneurysmal
% 208.15/208.32 |- mesh__historyNote mesh__D017824 94
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 1999
% 208.15/208.32 |- mesh__dateEstablished mesh__D017824 1994-01-01
% 208.15/208.32 |- skos__hiddenLabel mesh__D017824 Aneurysmal Bone Cyst
% 208.15/208.32 |- skos__scopeNote mesh__D017824
% 208.15/208.32 Solitary lesions of bone that typically cause a bulging of the overlying cortex bearing some resemblance to the saccular protrusion of the aortic wall in aortic aneurysm, hence the name. %28%Dorland, 27th ed%29%%A%
% 208.15/208.32 |- skos__hiddenLabel mesh__D017824 Cyst, Aneurysmal Bone
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 2001
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 1998
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 2004
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 2000
% 208.15/208.32 |- rdf__type mesh__D017824sskos__Concept
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 1995
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017824 2003
% 208.15/208.32 |- mesh__recordMaintainer mesh__D017026 TWD
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017026 2005
% 208.15/208.32 |- mesh__dateRevised mesh__D017026 2000-06-22
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017026 2002
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D017026
% 208.15/208.32 92; SWAINSONINE was indexed under ALKALOIDS 1981-91
% 208.15/208.32 |- mesh__recordOriginator mesh__D017026 AGS
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017026 2006
% 208.15/208.32 |- mesh__dateCreated mesh__D017026 1991-07-12
% 208.15/208.32 |- skos__prefLabel mesh__D017026 Swainsonine
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017026 2003
% 208.15/208.32 |- mesh__onlineNote mesh__D017026
% 208.15/208.32 use SWAINSONINE %28%NM%29% to search SWAINSONINE 1981-91
% 208.15/208.32 |- skos__historyNote mesh__D017026 Alkaloids %28%1980-1991%29%
% 208.15/208.32 |- mesh__historyNote mesh__D017026
% 208.15/208.32 92; was SWAINSONINE %28%NM%29% 1981-91
% 208.15/208.32 |- rdf__type mesh__D017026sskos__Concept
% 208.15/208.32 |- skos__broader mesh__D017026smesh__D000470
% 208.15/208.32 |- skos__scopeNote mesh__D017026
% 208.15/208.32 An indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity.%A%
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017026 2004
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017026 2001
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D017026 sjn
% 208.15/208.32 |- mesh__dateEstablished mesh__D017026 1992-01-01
% 208.15/208.32 |- mesh__recordOriginator mesh__D003804 NLM
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003804 2005
% 208.15/208.32 |- mesh__dateCreated mesh__D003804 1999-01-01
% 208.15/208.32 |- skos__related mesh__D003804smesh__D003810
% 208.15/208.32 |- rdf__type mesh__D003804sskos__Concept
% 208.15/208.32 |- skos__prefLabel mesh__D003804 Dentin
% 208.15/208.32 |- mesh__dateRevised mesh__D003804 2003-07-09
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D003804 sjn
% 208.15/208.32 |- skos__scopeNote mesh__D003804
% 208.15/208.32 The hard portion of the tooth surrounding the pulp, covered by enamel on the crown and cementum on the root, which is harder and denser than bone but softer than enamel, and is thus readily abraded when left unprotected. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%
% 208.15/208.32 |- skos__annotation mesh__D003804
% 208.15/208.32 /embryol: consider also DENTINOGENESIS; reparative dentin = DENTIN, SECONDARY; dentin bridge = DENTIN, SECONDARY%A%
% 208.15/208.32 |- skos__broader mesh__D003804smesh__D019589
% 208.15/208.32 |- skos__related mesh__D003804smesh__D009804
% 208.15/208.32 |- skos__altLabel mesh__D003804 Dentine
% 208.15/208.32 |- skos__hiddenLabel mesh__D003804 Dentines
% 208.15/208.32 |- skos__hiddenLabel mesh__D003804 Dentins
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003804 2006
% 208.15/208.32 |- mesh__recordMaintainer mesh__D003804 lkt
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003804 2004
% 208.15/208.32 |- skos__hiddenLabel mesh__D003006 alpha Clopenthixol
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D003006 sjn
% 208.15/208.32 |- rdf__type mesh__D003006sskos__Concept
% 208.15/208.32 |- mesh__dateEstablished mesh__D003006 1991-01-01
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D003006
% 208.15/208.32 91; was see under THIOXANTHENES 1975-90; was see under TRANQUILIZING AGENTS 1967-74%A%
% 208.15/208.32 |- skos__prefLabel mesh__D003006 Clopenthixol
% 208.15/208.32 |- mesh__recordMaintainer mesh__D003006 jmp
% 208.15/208.32 |- skos__broader mesh__D003006smesh__D013892
% 208.15/208.32 |- skos__altLabel mesh__D003006 alpha-Clopenthixol
% 208.15/208.32 |- mesh__dateRevised mesh__D003006 2005-06-30
% 208.15/208.32 |- mesh__dateCreated mesh__D003006 1999-01-01
% 208.15/208.32 |- skos__scopeNote mesh__D003006
% 208.15/208.32 A thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors.%A%
% 208.15/208.32 |- mesh__historyNote mesh__D003006
% 208.15/208.32 91%28%63%29%; was see under THIOXANTHENES 1975-90; was see under TRANQUILIZING AGENTS 1967-74%A%
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D003006 2006
% 208.15/208.32 |- mesh__recordOriginator mesh__D003006 NLM
% 208.15/208.32 |- mesh__recordMaintainer mesh__D041923 lkt
% 208.15/208.32 |- skos__prefLabel mesh__D041923 Adolescent Development
% 208.15/208.32 |- mesh__recordOriginator mesh__D041923 lkt
% 208.15/208.32 |- mesh__dateRevised mesh__D041923 2004-07-07
% 208.15/208.32 |- mesh__dateEstablished mesh__D041923 2004-01-01
% 208.15/208.32 |- skos__related mesh__D041923smesh__D000294
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D041923 sjn
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D041923 2006
% 208.15/208.32 |- rdf__type mesh__D041923sskos__Concept
% 208.15/208.32 |- skos__historyNote mesh__D041923 Adolescence %28%1965-2003%29%
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D041923 2005
% 208.15/208.32 |- mesh__dateCreated mesh__D041923 2003-07-09
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D041923 2004
% 208.15/208.32 |- mesh__historyNote mesh__D041923 2004
% 208.15/208.32 |- skos__hiddenLabel mesh__D041923 Development, Adolescent
% 208.15/208.32 |- skos__scopeNote mesh__D041923
% 208.15/208.32 The continuous sequential physiological and psychological changes during ADOLESCENCE, approximately between the age of 13 and 18.%A%
% 208.15/208.32 |- skos__broader mesh__D041923smesh__D006803
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D049108 2005
% 208.15/208.32 |- mesh__historyNote mesh__D049108 2005
% 208.15/208.32 |- mesh__dateCreated mesh__D049108 2004-07-07
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D049108 2006
% 208.15/208.32 |- skos__hiddenLabel mesh__D049108 Growth, Cell Size
% 208.15/208.32 |- mesh__recordMaintainer mesh__D049108 nns
% 208.15/208.32 |- skos__prefLabel mesh__D049108 Cell Enlargement
% 208.15/208.32 |- skos__hiddenLabel mesh__D049108 Size Growth, Cell
% 208.15/208.32 |- skos__hiddenLabel mesh__D049108 Growths, Cell Size
% 208.15/208.32 |- skos__altLabel mesh__D049108 Cell Size Growth
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D049108 sjn
% 208.15/208.32 |- skos__broader mesh__D049108smesh__D048708
% 208.15/208.32 |- skos__altLabel mesh__D049108 Cell Growth in Size
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D049108 2005
% 208.15/208.32 |- skos__scopeNote mesh__D049108
% 208.15/208.32 Growth processes that result in an increase in CELL SIZE.%A%
% 208.15/208.32 |- mesh__dateEstablished mesh__D049108 2005-01-01
% 208.15/208.32 |- skos__hiddenLabel mesh__D049108 Enlargement, Cell
% 208.15/208.32 |- mesh__recordOriginator mesh__D049108 nns
% 208.15/208.32 |- skos__related mesh__D049108smesh__D006984
% 208.15/208.32 |- rdf__type mesh__D049108sskos__Concept
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 2002
% 208.15/208.32 |- skos__broader mesh__D013434smesh__D013456
% 208.15/208.32 |- mesh__dateCreated mesh__D013434 1999-01-01
% 208.15/208.32 |- mesh__recordMaintainer mesh__D013434 TPW
% 208.15/208.32 |- skos__scopeNote mesh__D013434
% 208.15/208.32 Oxy acids of sulfur with the general formula RSOH, where R is an alkyl or aryl group such as CH3. They are often encountered as esters and halides. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 2003
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 1996
% 208.15/208.32 |- mesh__recordOriginator mesh__D013434 NLM
% 208.15/208.32 |- mesh__historyNote mesh__D013434 68
% 208.15/208.32 |- mesh__dateEstablished mesh__D013434 1968-01-01
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 1997
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 2004
% 208.15/208.32 |- skos__prefLabel mesh__D013434 Sulfenic Acids
% 208.15/208.32 |- rdf__type mesh__D013434sskos__Concept
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D013434 PLS
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 2000
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 1998
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 2005
% 208.15/208.32 |- skos__hiddenLabel mesh__D013434 Acids, Sulfenic
% 208.15/208.32 |- mesh__dateRevised mesh__D013434 1993-06-04
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 1994
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 2001
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 1999
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 2006
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D013434 68
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D013434 1995
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 2000
% 208.15/208.32 |- skos__hiddenLabel mesh__D009393 Nephritides
% 208.15/208.32 |- mesh__recordAuthorizer mesh__D009393 PLS
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 2004
% 208.15/208.32 |- skos__prefLabel mesh__D009393 Nephritis
% 208.15/208.32 |- skos__broader mesh__D009393smesh__D007674
% 208.15/208.32 |- mesh__dateCreated mesh__D009393 1999-01-01
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 2003
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 2006
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 2005
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 1997
% 208.15/208.32 |- mesh__recordOriginator mesh__D009393 NLM
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 1996
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 2002
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 1999
% 208.15/208.32 |- skos__scopeNote mesh__D009393
% 208.15/208.32 Inflammation of the kidney. It is a focal or diffuse proliferative or destructive process which may involve the glomerulus, tubule, or interstitial renal tissue. %28%Dorland, 27th ed%29%%A%
% 208.15/208.32 |- skos__annotation mesh__D009393
% 208.15/208.32 inflamm of kidney; familial: consider also NEPHRITIS, HEREDITARY%A%
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 2001
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 1995
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 1998
% 208.15/208.32 |- mesh__dateRevised mesh__D009393 1993-06-02
% 208.15/208.32 |- mesh__recordMaintainer mesh__D009393 TAP
% 208.15/208.32 |- rdf__type mesh__D009393sskos__Concept
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D009393 1994
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017825 2006
% 208.15/208.32 |- skos__altLabel mesh__D017825 Canavan-van Bogaert-Bertrand Disease
% 208.15/208.32 |- skos__annotation mesh__D017825
% 208.15/208.32 do not confuse X ref CANAVAN-VAN BOGAERT-BERTRAND SYNDROME with VAN BOGAERT%27%S LEUKOENCEPHALITIS see SUBACUTE SCLEROSING PANENCEPHALITIS; DF: CANAVAN DIS%A%
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017825 2002
% 208.15/208.32 |- skos__prefLabel mesh__D017825 Canavan Disease
% 208.15/208.32 |- mesh__publicMeSHNote mesh__D017825 94
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017825 2003
% 208.15/208.32 |- skos__altLabel mesh__D017825 Neonatal Canavan Disease
% 208.15/208.32 |- mesh__historyNote mesh__D017825 94
% 208.15/208.32 |- skos__altLabel mesh__D017825 Canavan Disease, Type I
% 208.15/208.32 |- skos__hiddenLabel mesh__D017825 Aspartoacylase Deficiency Disease
% 208.15/208.32 |- skos__altLabel mesh__D017825 Deficiency Disease, Aspartoacylase
% 208.15/208.32 |- skos__altLabel mesh__D017825 Spongy Degeneration of Infancy
% 208.15/208.32 |- skos__altLabel mesh__D017825 Infantile Canavan Disease
% 208.15/208.32 |- mesh__activeMeSHYear mesh__D017825 2004
% 208.15/208.33 |- skos__altLabel mesh__D017825 Leukodystrophy, Spongiform
% 208.15/208.33 |- skos__altLabel mesh__D017825 Type III Canavan Disease
% 208.15/208.33 |- skos__hiddenLabel mesh__D017825 Bogaert-Bertrand Disease, Canavan-van
% 208.15/208.33 |- skos__altLabel mesh__D017825 Sporadic Form of Canavan Disease
% 208.15/208.33 |- skos__hiddenLabel mesh__D017825 Spongiform Leukodystrophies
% 208.15/208.33 |- mesh__recordMaintainer mesh__D017825 ags
% 208.15/208.33 |- skos__hiddenLabel mesh__D017825 Aspartoacylase Deficiency Diseases
% 208.15/208.33 |- skos__hiddenLabel mesh__D017825 Diseases, Aspartoacylase Deficiency
% 208.15/208.33 |- skos__altLabel mesh__D017825 Spongy Disease of Central Nervous System
% 208.15/208.33 |- skos__scopeNote mesh__D017825
% 208.15/208.33 A rare neurodegenerative condition of infancy or childhood characterized by white matter vacuolization and demeylination that gives rise to a spongy appearance. Aspartoacylase deficiency leads to an accumulation of N-acetylaspartate in astrocytes. Inheritance may be autosomal recessive or the illness may occur sporadically. This illness occurs more frequently in individuals of Ashkenazic Jewish descent. The neonatal form features the onset of hypotonia and lethargy at birth, rapidly progressing to coma and death. The infantile form features developmental delay, DYSKINESIAS, hypotonia, spasticity, blindness, and megalencephaly. The juvenile form is characterized by ATAXIA; OPTIC ATROPHY; and DEMENTIA. %28%From Adams et al., Principles of Neurology, 6th ed, p944; Am J Med Genet 1988 Feb;29%28%2%29%:463-71%29%%A%
% 208.15/208.33 |- mesh__recordOriginator mesh__D017825 TGC
% 208.15/208.33 |- mesh__dateRevised mesh__D017825 2005-07-11
% 208.15/208.33 |- mesh__dateEstablished mesh__D017825 1994-01-01
% 208.15/208.33 |- skos__hiddenLabel mesh__D017825 Leukodystrophies, Spongiform
% 208.15/208.33 |- skos__altLabel mesh__D017825 Familial Form of Canavan Disease
% 208.15/208.33 |- skos__hiddenLabel mesh__D017825 Spongiform Leukodystrophy
% 208.15/208.33 |- skos__hiddenLabel mesh__D017825 Deficiency Diseases, Aspartoacylase
% 208.15/208.33 |- skos__broader mesh__D017825smesh__D020271
% 208.15/208.33 |- skos__altLabel mesh__D017825 Canavan Disease, Type III
% 208.15/208.33 |- skos__altLabel mesh__D017825 Juvenile Canavan Disease
% 208.15/208.33 |- skos__altLabel mesh__D017825 Type I Canavan Disease
% 208.15/208.33 |- skos__hiddenLabel mesh__D017825 Disease, Aspartoacylase Deficiency
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017825 2006A
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D017825 ags
% 208.15/208.33 |- skos__historyNote mesh__D017825 Demyelinating Diseases %28%1967-1993%29%
% 208.15/208.33 |- skos__altLabel mesh__D017825 Type II Canavan Disease
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017825 2005
% 208.15/208.33 |- rdf__type mesh__D017825sskos__Concept
% 208.15/208.33 |- skos__historyNote mesh__D017825
% 208.15/208.33 Cerebral Sclerosis, Diffuse %28%1981-1993%29%
% 208.15/208.33 |- mesh__dateCreated mesh__D017825 1993-02-16
% 208.15/208.33 |- skos__altLabel mesh__D017825 Spongy Disease of White Matter
% 208.15/208.33 |- skos__broader mesh__D017825smesh__D020279
% 208.15/208.33 |- skos__hiddenLabel mesh__D017825 Canavan van Bogaert Bertrand Disease
% 208.15/208.33 |- skos__altLabel mesh__D017825 Canavan Disease, Type II
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017027 2006
% 208.15/208.33 |- skos__prefLabel mesh__D017027 Protein-Tyrosine-Phosphatase
% 208.15/208.33 |- mesh__dateRevised mesh__D017027 2003-07-09
% 208.15/208.33 |- skos__broader mesh__D017027smesh__D010749
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Phosphoprotein Phosphatase, Tyrosyl
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Phosphatase, Phosphotyrosyl Histone
% 208.15/208.33 |- mesh__dateEstablished mesh__D017027 1992-01-01
% 208.15/208.33 |- skos__annotation mesh__D017027 DF: note short X ref
% 208.15/208.33 |- mesh__onlineNote mesh__D017027
% 208.15/208.33 use PROTEIN-TYROSINE-PHOSPHATASE %28%NM%29% to search PROTEIN-TYROSINE PHOSPHATASE 1985-91%A%
% 208.15/208.33 |- skos__altLabel mesh__D017027 Tyrosyl Phosphoprotein Phosphatase
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Phosphatase, Phosphotyrosine
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D017027 sjn
% 208.15/208.33 |- rdf__type mesh__D017027sskos__Concept
% 208.15/208.33 |- skos__scopeNote mesh__D017027
% 208.15/208.33 An enzyme group that specifically dephosphorylates phosphotyrosyl residues in selected proteins. Together with PROTEIN-TYROSINE KINASE, it regulates tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis. EC 3.1.3.48.%A%
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Phosphatase, Phosphotyrosyl Protein
% 208.15/208.33 |- mesh__recordMaintainer mesh__D017027 ssb
% 208.15/208.33 |- skos__altLabel mesh__D017027 Protein-Tyrosine Phosphatase
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017027 2004
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Protein Phosphatase, Phosphotyrosyl
% 208.15/208.33 |- skos__altLabel mesh__D017027 Tyrosine Phosphatase
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Protein Tyrosine Phosphatase
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Phosphatase, Tyrosyl Phosphoprotein
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Phosphatase, Protein-Tyrosine
% 208.15/208.33 |- skos__altLabel mesh__D017027 Phosphotyrosine Phosphatase
% 208.15/208.33 |- skos__altLabel mesh__D017027 Phosphotyrosyl Protein Phosphatase
% 208.15/208.33 |- skos__altLabel mesh__D017027 PTPase
% 208.15/208.33 |- skos__historyNote mesh__D017027
% 208.15/208.33 Phosphoprotein Phosphatases %28%1985-1991%29%
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017027 2005
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Phosphatase, Tyrosine
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D017027
% 208.15/208.33 92; PROTEIN-TYROSINE PHOSPHATASE was indexed under PHOSPHOPROTEIN PHOSPHATASES 1985-91%A%
% 208.15/208.33 |- mesh__historyNote mesh__D017027
% 208.15/208.33 92; was PROTEIN-TYROSINE PHOSPHATASE %28%NM%29% 1985-91
% 208.15/208.33 |- mesh__recordOriginator mesh__D017027 PLS
% 208.15/208.33 |- skos__hiddenLabel mesh__D017027 Histone Phosphatase, Phosphotyrosyl
% 208.15/208.33 |- mesh__dateCreated mesh__D017027 1991-05-30
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003805 2002
% 208.15/208.33 |- mesh__historyNote mesh__D003805 65
% 208.15/208.33 |- skos__hiddenLabel mesh__D003805 Dysplasias, Dentin
% 208.15/208.33 |- mesh__recordMaintainer mesh__D003805 kle
% 208.15/208.33 |- skos__hiddenLabel mesh__D003805 Dentin Dysplasias
% 208.15/208.33 |- mesh__recordOriginator mesh__D003805 NLM
% 208.15/208.33 |- mesh__dateRevised mesh__D003805 1999-11-03
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003805 2006
% 208.15/208.33 |- skos__broader mesh__D003805smesh__D014071
% 208.15/208.33 |- skos__scopeNote mesh__D003805
% 208.15/208.33 An apparently hereditary disorder of dentin formation, marked by a normal appearance of coronal dentin associated with pulpal obliteration, faulty root formation, and a tendency for peripheral lesions without obvious cause. %28%From Dorland, 27th ed%29%%A%
% 208.15/208.33 |- skos__hiddenLabel mesh__D003805 Dysplasia, Dentin
% 208.15/208.33 |- skos__prefLabel mesh__D003805 Dentin Dysplasia
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003805 2001
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003805 2004
% 208.15/208.33 |- mesh__dateEstablished mesh__D003805 1965-01-01
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003805 2000
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D003805 sjn
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003805 2005
% 208.15/208.33 |- mesh__dateCreated mesh__D003805 1999-01-01
% 208.15/208.33 |- rdf__type mesh__D003805sskos__Concept
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003805 2003
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D003805 65
% 208.15/208.33 |- skos__annotation mesh__D003805
% 208.15/208.33 a tooth abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 2006
% 208.15/208.33 |- mesh__dateEstablished mesh__D003007 1991-01-01
% 208.15/208.33 |- rdf__type mesh__D003007sskos__Concept
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 2000
% 208.15/208.33 |- mesh__historyNote mesh__D003007
% 208.15/208.33 91%28%75%29%; was see under PYRIDINES 1975-90
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 2001
% 208.15/208.33 |- skos__broader mesh__D003007smesh__D011725
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 1996
% 208.15/208.33 |- skos__annotation mesh__D003007 a coccidiostat
% 208.15/208.33 |- skos__altLabel mesh__D003007 3,5-Dichloro-2,6-dimethyl-4-pyridinol
% 208.15/208.33 |- mesh__recordMaintainer mesh__D003007 JRT
% 208.15/208.33 |- mesh__dateRevised mesh__D003007 1995-06-08
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 2003
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 1998
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 1997
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D003007
% 208.15/208.33 91; was see under PYRIDINES 1975-90
% 208.15/208.33 |- skos__altLabel mesh__D003007 Meticlorpindol
% 208.15/208.33 |- mesh__recordOriginator mesh__D003007 NLM
% 208.15/208.33 |- skos__scopeNote mesh__D003007
% 208.15/208.33 A very effective anticoccidial agent used in poultry.
% 208.15/208.33 |- skos__prefLabel mesh__D003007 Clopidol
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 2005
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 2002
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 1999
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003007 2004
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D003007 PLS
% 208.15/208.33 |- skos__historyNote mesh__D003007 Pyridines %28%1973-1974%29%
% 208.15/208.33 |- mesh__dateCreated mesh__D003007 1974-11-19
% 208.15/208.33 |- skos__altLabel mesh__D003007 Clopindol
% 208.15/208.33 |- skos__hiddenLabel mesh__D049109 Multiplication, Cell
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D049109 2006
% 208.15/208.33 |- skos__hiddenLabel mesh__D049109 Proliferation, Cell
% 208.15/208.33 |- skos__hiddenLabel mesh__D049109 Growth, Cell Number
% 208.15/208.33 |- mesh__historyNote mesh__D049109 2005
% 208.15/208.33 |- skos__altLabel mesh__D049109 Cell Number Growth
% 208.15/208.33 |- skos__altLabel mesh__D049109 Cell Multiplication
% 208.15/208.33 |- skos__hiddenLabel mesh__D049109 Number Growth, Cell
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D049109 2005
% 208.15/208.33 |- skos__historyNote mesh__D049109 Cell Division %28%1966-2004%29%
% 208.15/208.33 |- skos__related mesh__D049109smesh__D006965
% 208.15/208.33 |- mesh__recordMaintainer mesh__D049109 nns
% 208.15/208.33 |- mesh__recordOriginator mesh__D049109 nns
% 208.15/208.33 |- skos__altLabel mesh__D049109 Cellular Proliferation
% 208.15/208.33 |- skos__prefLabel mesh__D049109 Cell Proliferation
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D049109 sjn
% 208.15/208.33 |- skos__broader mesh__D049109smesh__D048708
% 208.15/208.33 |- rdf__type mesh__D049109sskos__Concept
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D049109 2005
% 208.15/208.33 |- skos__hiddenLabel mesh__D049109 Proliferation, Cellular
% 208.15/208.33 |- mesh__dateCreated mesh__D049109 2004-07-07
% 208.15/208.33 |- skos__altLabel mesh__D049109 Cell Growth in Number
% 208.15/208.33 |- skos__scopeNote mesh__D049109
% 208.15/208.33 All of the processes involved in increasing in CELL NUMBER. These processes include more than CELL DIVISION which is part of the CELL CYCLE.%A%
% 208.15/208.33 |- mesh__dateEstablished mesh__D049109 2005-01-01
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 2006
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 1995
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 1996
% 208.15/208.33 |- mesh__recordOriginator mesh__D013435 NLM
% 208.15/208.33 |- skos__prefLabel mesh__D013435 Sulfhemoglobin
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 2003
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 1997
% 208.15/208.33 |- mesh__dateRevised mesh__D013435 1992-05-18
% 208.15/208.33 |- rdf__type mesh__D013435sskos__Concept
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 2000
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D013435 PLS
% 208.15/208.33 |- mesh__historyNote mesh__D013435 65%28%63%29%
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 2004
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 1998
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D013435 65
% 208.15/208.33 |- mesh__recordMaintainer mesh__D013435 TAP
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 1993
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 2001
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 2005
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 1999
% 208.15/208.33 |- mesh__dateEstablished mesh__D013435 1965-01-01
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 1994
% 208.15/208.33 |- mesh__dateCreated mesh__D013435 1999-01-01
% 208.15/208.33 |- skos__broader mesh__D013435smesh__D006454
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013435 2002
% 208.15/208.33 |- mesh__dateRevised mesh__D018120 2005-06-30
% 208.15/208.33 |- skos__altLabel mesh__D018120 Merck Brand 2 of Finasteride
% 208.15/208.33 |- skos__historyNote mesh__D018120 Androstenes %28%1988-1993%29%
% 208.15/208.33 |- mesh__recordMaintainer mesh__D018120 CCR
% 208.15/208.33 |- skos__altLabel mesh__D018120 Lipha Brand of Finasteride
% 208.15/208.33 |- skos__altLabel mesh__D018120 Cahill May Roberts Brand of Finasteride
% 208.15/208.33 |- skos__altLabel mesh__D018120
% 208.15/208.33 Merck Sharp %26% Dhome Brand 2 of Finasteride
% 208.15/208.33 |- mesh__recordOriginator mesh__D018120 TPW
% 208.15/208.33 |- skos__altLabel mesh__D018120 MSD Brand of Finasteride
% 208.15/208.33 |- skos__scopeNote mesh__D018120
% 208.15/208.33 An orally active TESTOSTERONE 5-ALPHA-REDUCTASE inhibitor. It is used as a surgical alternative for treatment of benign prostatic hyperplasia.%A%
% 208.15/208.33 |- skos__altLabel mesh__D018120 Merck Brand 1 of Finasteride
% 208.15/208.33 |- skos__broader mesh__D018120smesh__D000736
% 208.15/208.33 |- skos__altLabel mesh__D018120 Frosst Iberica Brand of Finasteride
% 208.15/208.33 |- skos__hiddenLabel mesh__D018120 MK906
% 208.15/208.33 |- skos__hiddenLabel mesh__D018120 Chibro Proscar
% 208.15/208.33 |- skos__prefLabel mesh__D018120 Finasteride
% 208.15/208.33 |- skos__broader mesh__D018120smesh__D001378
% 208.15/208.33 |- skos__hiddenLabel mesh__D018120 MK 906
% 208.15/208.33 |- skos__altLabel mesh__D018120 Merck Frosst Brand 1 of Finasteride
% 208.15/208.33 |- mesh__dateCreated mesh__D018120 1993-06-18
% 208.15/208.33 |- mesh__dateEstablished mesh__D018120 1994-01-01
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D018120 2006
% 208.15/208.33 |- skos__altLabel mesh__D018120 MSD Chibropharm Brand of Finasteride
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D018120 sjn
% 208.15/208.33 |- skos__historyNote mesh__D018120 Azasteroids %28%1988-1993%29%
% 208.15/208.33 |- skos__altLabel mesh__D018120 Merck Frosst Brand 2 of Finasteride
% 208.15/208.33 |- mesh__onlineNote mesh__D018120
% 208.15/208.33 use FINASTERIDE %28%NM%29% to search FINASTERIDE 1988-93
% 208.15/208.33 |- skos__altLabel mesh__D018120
% 208.15/208.33 Merck Sharp %26% Dohme Brand 1 of Finasteride
% 208.15/208.33 |- rdf__type mesh__D018120sskos__Concept
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D018120
% 208.15/208.33 94; FINASTERIDE was indexed under ANDROSTENES %26% AZASTEROIDS 1988-93%A%
% 208.15/208.33 |- skos__altLabel mesh__D018120 Propeshia
% 208.15/208.33 |- mesh__historyNote mesh__D018120
% 208.15/208.33 94; was FINASTERIDE %28%NM%29% 1988-93
% 208.15/208.33 |- skos__annotation mesh__D004100
% 208.15/208.33 deficiency: coordinate DIHYDROXYCHOLECALCIFEROLS /defic %28%IM%29% with VITAMIN D DEFICIENCY %28%IM%29%%A%
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D004100 sjn
% 208.15/208.33 |- mesh__dateEstablished mesh__D004100 1983-01-01
% 208.15/208.33 |- mesh__historyNote mesh__D004100
% 208.15/208.33 83%28%73%29%; was see under HYDROXYCHOLECALCIFEROLS 1975-82
% 208.15/208.33 |- skos__altLabel mesh__D004100 Dihydroxyvitamins D
% 208.15/208.33 |- skos__scopeNote mesh__D004100
% 208.15/208.33 Cholecalciferols substituted with two hydroxy groups in any position.%A%
% 208.15/208.33 |- mesh__dateRevised mesh__D004100 2005-06-30
% 208.15/208.33 |- skos__broader mesh__D004100smesh__D006887
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D004100
% 208.15/208.33 83; was see under HYDROXYCHOLECALCIFEROLS 1975-82
% 208.15/208.33 |- rdf__type mesh__D004100sskos__Concept
% 208.15/208.33 |- mesh__recordOriginator mesh__D004100 NLM
% 208.15/208.33 |- mesh__dateCreated mesh__D004100 1999-01-01
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D004100 2006
% 208.15/208.33 |- skos__prefLabel mesh__D004100 Dihydroxycholecalciferols
% 208.15/208.33 |- mesh__recordMaintainer mesh__D004100 ssb
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D009394
% 208.15/208.33 77; was ALPORT%27%S SYNDROME 1970-76
% 208.15/208.33 |- skos__hiddenLabel mesh__D009394 Hereditary Nephritides
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D009394 2006
% 208.15/208.33 |- skos__altLabel mesh__D009394 Nephritis, Familial
% 208.15/208.33 |- skos__prefLabel mesh__D009394 Nephritis, Hereditary
% 208.15/208.33 |- skos__broader mesh__D009394smesh__D009393
% 208.15/208.33 |- skos__hiddenLabel mesh__D009394 Nephritides, Hereditary
% 208.15/208.33 |- mesh__onlineNote mesh__D009394
% 208.15/208.33 use NEPHRITIS, HEREDITARY to search ALPORT%27%S SYNDROME 1966-76 %28%as Prov 1966-69%29%%A%
% 208.15/208.33 |- skos__scopeNote mesh__D009394
% 208.15/208.33 A group of inherited conditions characterized initially by HEMATURIA and slowly progressing to RENAL INSUFFICIENCY. The most common form is the Alport syndrome %28%hereditary nephritis with HEARING LOSS%29% which is caused by mutations in genes for TYPE IV COLLAGEN and defective GLOMERULAR BASEMENT MEMBRANE.%A%
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D009394 sjn
% 208.15/208.33 |- mesh__dateRevised mesh__D009394 2005-06-30
% 208.15/208.33 |- skos__hiddenLabel mesh__D009394 Syndrome, X-Linked Alport
% 208.15/208.33 |- skos__hiddenLabel mesh__D009394 Familial Nephritis
% 208.15/208.33 |- skos__altLabel mesh__D009394 Alport%27%s Syndrome
% 208.15/208.33 |- skos__broader mesh__D009394smesh__D014564
% 208.15/208.33 |- skos__hiddenLabel mesh__D009394 Familial Nephritides
% 208.15/208.33 |- rdf__type mesh__D009394sskos__Concept
% 208.15/208.33 |- mesh__recordOriginator mesh__D009394 NLM
% 208.15/208.33 |- mesh__dateEstablished mesh__D009394 1970-01-01
% 208.15/208.33 |- skos__hiddenLabel mesh__D009394 Hereditary Nephritis
% 208.15/208.33 |- skos__hiddenLabel mesh__D009394 Nephritides, Familial
% 208.15/208.33 |- mesh__recordMaintainer mesh__D009394 lkt
% 208.15/208.33 |- mesh__historyNote mesh__D009394
% 208.15/208.33 77; was ALPORT%27%S SYNDROME 1964-76 %28%Prov 1964-69%29%
% 208.15/208.33 |- skos__hiddenLabel mesh__D009394 X-Linked Alport Syndrome
% 208.15/208.33 |- skos__hiddenLabel mesh__D009394 Alport Syndrome, X Linked
% 208.15/208.33 |- mesh__dateCreated mesh__D009394 1999-01-01
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017028 2003
% 208.15/208.33 |- mesh__recordOriginator mesh__D017028 TGC
% 208.15/208.33 |- skos__hiddenLabel mesh__D017028 Caregiver, Family
% 208.15/208.33 |- rdf__type mesh__D017028sskos__Concept
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017028 2004
% 208.15/208.33 |- mesh__historyNote mesh__D017028 92
% 208.15/208.33 |- skos__hiddenLabel mesh__D017028 Caregiver, Spouse
% 208.15/208.33 |- skos__hiddenLabel mesh__D017028 Caregivers, Family
% 208.15/208.33 |- mesh__dateEstablished mesh__D017028 1992-01-01
% 208.15/208.33 |- skos__prefLabel mesh__D017028 Caregivers
% 208.15/208.33 |- skos__hiddenLabel mesh__D017028 Spouse Caregiver
% 208.15/208.33 |- skos__scopeNote mesh__D017028
% 208.15/208.33 Persons who provide care to those who need supervision or assistance in illness or disability. They may provide the care in the home, in a hospital, or in an institution. Although caregivers include trained medical, nursing, and other health personnel, the concept also refers to parents, spouses, or other family members, friends, members of the clergy, teachers, social workers, fellow patients, etc.%A%
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D017028 sjn
% 208.15/208.33 |- skos__hiddenLabel mesh__D017028 Caregiver
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D017028 92
% 208.15/208.33 |- mesh__dateRevised mesh__D017028 2001-07-25
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017028 2005
% 208.15/208.33 |- skos__annotation mesh__D017028
% 208.15/208.33 GEN or unspecified: prefer specific caregiver as NURSES; PHYSICIANS; etc.; IM; coord with specific field if pertinent %28%IM%29%: %22%the teacher as caregiver%22% = CAREGIVERS %28%IM%29% + TEACHING %28%IM%29%%A%
% 208.15/208.33 |- skos__hiddenLabel mesh__D017028 Caregivers, Spouse
% 208.15/208.33 |- skos__hiddenLabel mesh__D017028 Care Giver
% 208.15/208.33 |- skos__hiddenLabel mesh__D017028 Family Caregiver
% 208.15/208.33 |- mesh__dateCreated mesh__D017028 1991-05-30
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017028 2006
% 208.15/208.33 |- skos__broader mesh__D017028smesh__D009272
% 208.15/208.33 |- mesh__recordMaintainer mesh__D017028 mdb
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D017028 2002
% 208.15/208.33 |- skos__broader mesh__D017028smesh__D006282
% 208.15/208.33 |- skos__altLabel mesh__D017028 Care Givers
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D003806 PLS
% 208.15/208.33 |- skos__broader mesh__D003806smesh__D014088
% 208.15/208.33 |- mesh__dateEstablished mesh__D003806 1991-01-01
% 208.15/208.33 |- skos__scopeNote mesh__D003806
% 208.15/208.33 The property of dentin that permits passage of light, heat, cold, and chemical substances. It does not include penetration by microorganisms.%A%
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D003806
% 208.15/208.33 91; was see under TOOTH PERMEABILITY 1975-90
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 2006
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 2002
% 208.15/208.33 |- mesh__historyNote mesh__D003806
% 208.15/208.33 91%28%75%29%; was see under TOOTH PERMEABILITY 1975-90
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 2004
% 208.15/208.33 |- skos__hiddenLabel mesh__D003806 Dentin Permeabilities
% 208.15/208.33 |- mesh__recordMaintainer mesh__D003806 TGC
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 2005
% 208.15/208.33 |- mesh__dateCreated mesh__D003806 1999-01-01
% 208.15/208.33 |- mesh__dateRevised mesh__D003806 1996-06-13
% 208.15/208.33 |- rdf__type mesh__D003806sskos__Concept
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 2003
% 208.15/208.33 |- mesh__recordOriginator mesh__D003806 NLM
% 208.15/208.33 |- skos__hiddenLabel mesh__D003806 Permeabilities, Dentin
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 1999
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 2001
% 208.15/208.33 |- skos__hiddenLabel mesh__D003806 Permeability, Dentin
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 1997
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 2000
% 208.15/208.33 |- skos__annotation mesh__D003806
% 208.15/208.33 IM; coord with permeating substance %28%IM%29% if relevant
% 208.15/208.33 |- mesh__onlineNote mesh__D003806 search TOOTH PERMEABILITY 1966-74
% 208.15/208.33 |- skos__prefLabel mesh__D003806 Dentin Permeability
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003806 1998
% 208.15/208.33 |- skos__hiddenLabel mesh__D003008 Sodium, Cloprostenol
% 208.15/208.33 |- skos__prefLabel mesh__D003008 Cloprostenol
% 208.15/208.33 |- skos__historyNote mesh__D003008 Prostaglandins F %28%1975-1977%29%
% 208.15/208.33 |- mesh__recordOriginator mesh__D003008 RLS
% 208.15/208.33 |- skos__scopeNote mesh__D003008
% 208.15/208.33 A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle.%A%
% 208.15/208.33 |- skos__hiddenLabel mesh__D003008 ICI80,966
% 208.15/208.33 |- skos__historyNote mesh__D003008 Prostaglandins F, Synthetic %28%1978%29%
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D003008 sjn
% 208.15/208.33 |- skos__hiddenLabel mesh__D003008 ICI 80,966
% 208.15/208.33 |- skos__altLabel mesh__D003008 Cloprostenol Monosodium Salt
% 208.15/208.33 |- mesh__dateCreated mesh__D003008 1977-12-09
% 208.15/208.33 |- mesh__historyNote mesh__D003008
% 208.15/208.33 91%28%79%29%; was see under PROSTAGLANDINS F, SYNTHETIC 1979-90%A%
% 208.15/208.33 |- mesh__dateRevised mesh__D003008 2005-06-30
% 208.15/208.33 |- mesh__recordMaintainer mesh__D003008 ssb
% 208.15/208.33 |- skos__broader mesh__D003008smesh__D011461
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D003008 2006
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D003008
% 208.15/208.33 91; was see under PROSTAGLANDINS F, SYNTHETIC 1979-90
% 208.15/208.33 |- rdf__type mesh__D003008sskos__Concept
% 208.15/208.33 |- mesh__dateEstablished mesh__D003008 1991-01-01
% 208.15/208.33 |- skos__hiddenLabel mesh__D003008 Monosodium Salt, Cloprostenol
% 208.15/208.33 |- skos__hiddenLabel mesh__D003008 Salt, Cloprostenol Monosodium
% 208.15/208.33 |- mesh__dateEstablished mesh__D013436 1965-01-01
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D013436 65
% 208.15/208.33 |- mesh__recordMaintainer mesh__D013436 TGC
% 208.15/208.33 |- rdf__type mesh__D013436sskos__Concept
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 2001
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 2004
% 208.15/208.33 |- mesh__historyNote mesh__D013436 65
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 1998
% 208.15/208.33 |- mesh__dateRevised mesh__D013436 1993-06-03
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 2002
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 2005
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 1999
% 208.15/208.33 |- skos__prefLabel mesh__D013436 Sulfhemoglobinemia
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 1994
% 208.15/208.33 |- mesh__dateCreated mesh__D013436 1999-01-01
% 208.15/208.33 |- skos__annotation mesh__D013436
% 208.15/208.33 sulfmethemoglobin %28%see Dorland%29% in the blood
% 208.15/208.33 |- mesh__recordOriginator mesh__D013436 NLM
% 208.15/208.33 |- skos__hiddenLabel mesh__D013436 Sulfhemoglobinemias
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 2006
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 1995
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 1996
% 208.15/208.33 |- skos__scopeNote mesh__D013436
% 208.15/208.33 A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. %28%Stedman, 25th ed%29%%A%
% 208.15/208.33 |- skos__broader mesh__D013436smesh__D006402
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D013436 PLS
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 2000
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 2003
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D013436 1997
% 208.15/208.33 |- skos__broader mesh__D018121smesh__D011971
% 208.15/208.33 |- mesh__dateCreated mesh__D018121 1993-06-21
% 208.15/208.33 |- skos__altLabel mesh__D018121 Receptors, Cytokines
% 208.15/208.33 |- skos__scopeNote mesh__D018121
% 208.15/208.33 Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behavior of cells.%A%
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D018121 2005
% 208.15/208.33 |- skos__altLabel mesh__D018121 Cytokine Receptor
% 208.15/208.33 |- skos__prefLabel mesh__D018121 Receptors, Cytokine
% 208.15/208.33 |- mesh__recordMaintainer mesh__D018121 jmp
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D018121 2006
% 208.15/208.33 |- skos__hiddenLabel mesh__D018121 Cytokines Receptors
% 208.15/208.33 |- skos__historyNote mesh__D018121 Receptors, Immunologic %28%1980-1993%29%
% 208.15/208.33 |- mesh__recordOriginator mesh__D018121 RAZ
% 208.15/208.33 |- rdf__type mesh__D018121sskos__Concept
% 208.15/208.33 |- skos__annotation mesh__D018121 DF: RECEPT CYTOKINE
% 208.15/208.33 |- skos__hiddenLabel mesh__D018121 Receptor, Cytokine
% 208.15/208.33 |- mesh__dateEstablished mesh__D018121 1994-01-01
% 208.15/208.33 |- skos__altLabel mesh__D018121 Cytokine Receptors
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D018121 2004
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D018121 sjn
% 208.15/208.33 |- mesh__historyNote mesh__D018121 94
% 208.15/208.33 |- mesh__dateRevised mesh__D018121 2003-07-09
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D018121 94
% 208.15/208.33 |- skos__broader mesh__D004101smesh__D001580
% 208.15/208.33 |- mesh__recordOriginator mesh__D004101 RLS
% 208.15/208.33 |- mesh__dateRevised mesh__D004101 1999-11-03
% 208.15/208.33 |- skos__prefLabel mesh__D004101 Dihydroxydihydrobenzopyrenes
% 208.15/208.33 |- mesh__dateCreated mesh__D004101 1986-04-09
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D004101 2005
% 208.15/208.33 |- rdf__type mesh__D004101sskos__Concept
% 208.15/208.33 |- mesh__publicMeSHNote mesh__D004101 87
% 208.15/208.33 |- mesh__recordMaintainer mesh__D004101 adp
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D004101 2003
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D004101 2006
% 208.15/208.33 |- skos__scopeNote mesh__D004101
% 208.15/208.33 Benzopyrenes saturated in any two adjacent positions and substituted with two hydroxyl groups in any position. The majority of these compounds have carcinogenic or mutagenic activity.%A%
% 208.15/208.33 |- skos__altLabel mesh__D004101 Dihydrodiolbenzopyrenes
% 208.15/208.33 |- skos__hiddenLabel mesh__D004101 Dihydrodiols, Benzopyrene
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D004101 2000
% 208.15/208.33 |- mesh__recordAuthorizer mesh__D004101 sjn
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D004101 2004
% 208.15/208.33 |- skos__hiddenLabel mesh__D004101 Diols, Dihydrobenzopyrene
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D004101 2001
% 208.15/208.33 |- skos__altLabel mesh__D004101 Dihydrobenzopyrene Diols
% 208.15/208.33 |- mesh__historyNote mesh__D004101 87
% 208.15/208.33 |- skos__altLabel mesh__D004101 Benzopyrene Dihydrodiols
% 208.15/208.33 |- skos__annotation mesh__D004101 carcinogens; D25-26 qualif; DF: DDBPS
% 208.15/208.33 |- mesh__dateEstablished mesh__D004101 1987-01-01
% 208.15/208.33 |- mesh__activeMeSHYear mesh__D004101 2002
% 208.15/208.33 |- skos__historyNote mesh__D004101 Benzopyrenes %28%1966-1986%29%
% 208.15/208.34 |- skos__hiddenLabel mesh__D009395 Nephritides, Tubulointerstitial
% 208.15/208.34 |- skos__prefLabel mesh__D009395 Nephritis, Interstitial
% 208.15/208.34 |- mesh__recordMaintainer mesh__D009395 KEV
% 208.15/208.34 |- mesh__dateEstablished mesh__D009395 1964-01-01
% 208.15/208.34 |- mesh__recordOriginator mesh__D009395 NLM
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D009395 2002
% 208.15/208.34 |- rdf__type mesh__D009395sskos__Concept
% 208.15/208.34 |- mesh__dateRevised mesh__D009395 1999-11-03
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D009395 2001
% 208.15/208.34 |- skos__broader mesh__D009395smesh__D009393
% 208.15/208.34 |- skos__scopeNote mesh__D009395
% 208.15/208.34 Diffuse or local inflammation and edema of the interstitial tissue of the kidney, including the tubules.%A%
% 208.15/208.34 |- skos__altLabel mesh__D009395 Interstitial Nephritis
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D009395 2004
% 208.15/208.34 |- mesh__dateCreated mesh__D009395 1999-01-01
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D009395 2000
% 208.15/208.34 |- mesh__historyNote mesh__D009395 64
% 208.15/208.34 |- skos__hiddenLabel mesh__D009395 Tubulointerstitial Nephritides
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D009395 2003
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D009395 64
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D009395 2006
% 208.15/208.34 |- skos__altLabel mesh__D009395 Tubulointerstitial Nephritis
% 208.15/208.34 |- skos__hiddenLabel mesh__D009395 Interstitial Nephritides
% 208.15/208.34 |- skos__hiddenLabel mesh__D009395 Nephritides, Interstitial
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D009395 sjn
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D009395 2005
% 208.15/208.34 |- skos__altLabel mesh__D017827 Joseph Disease
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease Type I
% 208.15/208.34 |- mesh__historyNote mesh__D017827
% 208.15/208.34 94; was see SPINOCEREBELLAR DEGENERATION 1987-93
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Disease, Joseph Azorean
% 208.15/208.34 |- skos__scopeNote mesh__D017827
% 208.15/208.34 A dominantly-inherited ATAXIA first described in people of Azorean and Portuguese descent, and subsequently identified in Brazil, Japan, China, and Australia. This disorder is classified as one of the SPINOCEREBELLAR ATAXIAS %28%Type 3%29% and has been associated with a mutation of the MJD1 gene on chromosome 14. Clinical features include progressive ataxia, DYSARTHRIA, postural instability, nystagmus, eyelid retraction, and facial FASCICULATIONS. DYSTONIA is prominent in younger patients %28%referred to as Type I Machado-Joseph Disease%29%. Type II features ataxia and ocular signs; Type III features MUSCULAR ATROPHY and a sensorimotor neuropathy; and Type IV features extrapyramidal signs combined with a sensorimotor neuropathy. %28%From Clin Neurosci 1995;3%28%1%29%:17-22; Ann Neurol 1998 Mar;43%28%3%29%:288-96%29%%A%
% 208.15/208.34 |- mesh__onlineNote mesh__D017827
% 208.15/208.34 use SPINOCEREBELLAR DEGENERATION to search MACHADO-JOSEPH DISEASE 1987-93%A%
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease Type II
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Type III Machado Joseph Disease
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Type II Machado Joseph Disease
% 208.15/208.34 |- skos__altLabel mesh__D017827 Type 3 Spinocerebellar Ataxia
% 208.15/208.34 |- skos__altLabel mesh__D017827 Joseph Azorean Disease
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Diseases, Azorean %28%Machado-Joseph%29%
% 208.15/208.34 |- skos__altLabel mesh__D017827 Azorean Disease
% 208.15/208.34 |- skos__altLabel mesh__D017827 Nervous System Azorean Disease
% 208.15/208.34 |- skos__altLabel mesh__D017827 Azorean Disease %28%Machado-Joseph%29%
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease Type III
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Disease, Azorean %28%Machado-Joseph%29%
% 208.15/208.34 |- mesh__recordMaintainer mesh__D017827 nns
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Disease, Machado-Joseph Azorean
% 208.15/208.34 |- skos__broader mesh__D017827smesh__D020754
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D017827
% 208.15/208.34 94; was see SPINOCEREBELLAR DEGENERATION 1987-93
% 208.15/208.34 |- skos__historyNote mesh__D017827
% 208.15/208.34 Spinocerebellar Degeneration %28%1986-1993%29%
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Type IV Machado Joseph Disease
% 208.15/208.34 |- skos__altLabel mesh__D017827 Type I Machado-Joseph Disease
% 208.15/208.34 |- skos__historyNote mesh__D017827 Cerebellar Ataxia %28%1980-1986%29%
% 208.15/208.34 |- mesh__dateRevised mesh__D017827 2005-06-30
% 208.15/208.34 |- skos__altLabel mesh__D017827
% 208.15/208.34 Striatonigral Degeneration, Autosomal Dominant
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Azorean Diseases %28%Machado-Joseph%29%
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Disease, Joseph
% 208.15/208.34 |- skos__altLabel mesh__D017827 Azorean Disease, Nervous System
% 208.15/208.34 |- mesh__recordOriginator mesh__D017827 TGC
% 208.15/208.34 |- rdf__type mesh__D017827sskos__Concept
% 208.15/208.34 |- skos__altLabel mesh__D017827
% 208.15/208.34 Autosomal Dominant Striatonigral Degeneration
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease
% 208.15/208.34 |- mesh__dateCreated mesh__D017827 1993-02-16
% 208.15/208.34 |- skos__altLabel mesh__D017827 Type III Machado-Joseph Disease
% 208.15/208.34 |- skos__prefLabel mesh__D017827 Machado-Joseph Disease
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Type I Machado Joseph Disease
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Spinocerebellar Ataxia 3
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease Type IV
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Azorean Disease %28%Machado Joseph%29%
% 208.15/208.34 |- skos__altLabel mesh__D017827 Spinocerebellar Ataxia Type 3
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D017827 sjn
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017827 2006
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Disease, Machado-Joseph
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Disease, Azorean
% 208.15/208.34 |- skos__altLabel mesh__D017827 Spinocerebellar Ataxia-3
% 208.15/208.34 |- mesh__dateEstablished mesh__D017827 1994-01-01
% 208.15/208.34 |- skos__altLabel mesh__D017827 Type II Machado-Joseph Disease
% 208.15/208.34 |- skos__hiddenLabel mesh__D017827 Machado Joseph Azorean Disease
% 208.15/208.34 |- skos__altLabel mesh__D017827 Type IV Machado-Joseph Disease
% 208.15/208.34 |- skos__altLabel mesh__D017827 Machado-Joseph Azorean Disease
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017029 2006
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017029 2001
% 208.15/208.34 |- skos__altLabel mesh__D017029 Disorder, Complex Partial Seizures
% 208.15/208.34 |- skos__altLabel mesh__D017029 Symptomatic Partial Complex Epilepsy
% 208.15/208.34 |- mesh__dateCreated mesh__D017029 1991-05-30
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017029 2004
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017029 2005
% 208.15/208.34 |- skos__altLabel mesh__D017029 Complex Partial Epilepsy
% 208.15/208.34 |- skos__altLabel mesh__D017029 Epilepsy, Cryptogenic, Partial Complex
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017029 2000
% 208.15/208.34 |- skos__historyNote mesh__D017029
% 208.15/208.34 Epilepsy, Temporal Lobe %28%1979-1991%29%
% 208.15/208.34 |- mesh__dateEstablished mesh__D017029 1992-01-01
% 208.15/208.34 |- skos__altLabel mesh__D017029 Complex Partial Seizure Disorder
% 208.15/208.34 |- rdf__type mesh__D017029sskos__Concept
% 208.15/208.34 |- skos__altLabel mesh__D017029 Partial Complex Epilepsy, Cryptogenic
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D017029
% 208.15/208.34 1992; see EPILEPSY, TEMPORAL LOBE 1977-1991; for EPILEPSY, PSYCHIC EQUIVALENT see EPILEPSY, TEMPORAL LOBE 1975-1991; for EPILEPSY, PSYCHOMOTOR see EPILEPSY, TEMPORAL LOBE 1964-1991%A%
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017029 2003
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D017029 ags
% 208.15/208.34 |- skos__altLabel mesh__D017029 Seizure Disorder, Complex Partial
% 208.15/208.34 |- mesh__dateRevised mesh__D017029 1999-12-09
% 208.15/208.34 |- skos__altLabel mesh__D017029 Partial Complex Epilepsy, Symptomatic
% 208.15/208.34 |- mesh__historyNote mesh__D017029
% 208.15/208.34 1992; use EPILEPSY, TEMPORAL LOBE 1977-1991; for EPILEPSY, PSYCHIC EQUIVALENT use EPILEPSY, TEMPORAL LOBE 1975-1991; for EPILEPSY, PSYCHOMOTOR use EPILEPSY, TEMPORAL LOBE 1964-1991%A%
% 208.15/208.34 |- skos__annotation mesh__D017029
% 208.15/208.34 do not confuse with EPILEPSY, SIMPLE PARTIAL see EPILEPSIES, PARTIAL%A%
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017029 2002
% 208.15/208.34 |- skos__hiddenLabel mesh__D017029 Psychomotor Epilepsy
% 208.15/208.34 |- skos__prefLabel mesh__D017029 Epilepsy, Complex Partial
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017029 2000A
% 208.15/208.34 |- skos__hiddenLabel mesh__D017029 Partial Epilepsy, Complex
% 208.15/208.34 |- skos__hiddenLabel mesh__D017029 Psychic Equivalent Epilepsy
% 208.15/208.34 |- skos__scopeNote mesh__D017029
% 208.15/208.34 A disorder characterized by recurrent partial seizures marked by impairment of cognition. During the seizure the individual may experience a wide variety of psychic phenomenon including formed hallucinations, illusions, deja vu, intense emotional feelings, confusion, and spatial disorientation. Focal motor activity, sensory alterations and AUTOMATISM may also occur. Complex partial seizures often originate from foci in one or both temporal lobes. The etiology may be idiopathic %28%cryptogenic partial complex epilepsy%29% or occur as a secondary manifestation of a focal cortical lesion %28%symptomatic partial complex epilepsy%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp317-8%29%%A%
% 208.15/208.34 |- skos__broader mesh__D017029smesh__D004828
% 208.15/208.34 |- skos__altLabel mesh__D017029 Epilepsy, Psychomotor
% 208.15/208.34 |- skos__altLabel mesh__D017029 Epilepsy, Psychic Equivalent
% 208.15/208.34 |- mesh__recordOriginator mesh__D017029 MXR
% 208.15/208.34 |- mesh__recordMaintainer mesh__D017029 ags
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003807 2005
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D003807 65
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003807 2001
% 208.15/208.34 |- mesh__recordOriginator mesh__D003807 NLM
% 208.15/208.34 |- skos__hiddenLabel mesh__D003807 Hypersensitivity, Dentin
% 208.15/208.34 |- skos__broader mesh__D003807smesh__D014076
% 208.15/208.34 |- skos__hiddenLabel mesh__D003807 Dentin Hypersensitivities
% 208.15/208.34 |- mesh__dateCreated mesh__D003807 1999-01-01
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003807 2003
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003807 2006
% 208.15/208.34 |- mesh__recordMaintainer mesh__D003807 TGC
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003807 2002
% 208.15/208.34 |- skos__hiddenLabel mesh__D003807 Sensitivities, Dentin
% 208.15/208.34 |- skos__hiddenLabel mesh__D003807 Sensitivity, Dentin
% 208.15/208.34 |- mesh__dateEstablished mesh__D003807 1965-01-01
% 208.15/208.34 |- skos__altLabel mesh__D003807 Dentin Hypersensitivity
% 208.15/208.34 |- skos__annotation mesh__D003807 note category
% 208.15/208.34 |- skos__hiddenLabel mesh__D003807 Hypersensitivities, Dentin
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003807 2004
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003807 1998
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D003807 SJN
% 208.15/208.34 |- rdf__type mesh__D003807sskos__Concept
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003807 1999
% 208.15/208.34 |- skos__prefLabel mesh__D003807 Dentin Sensitivity
% 208.15/208.34 |- mesh__historyNote mesh__D003807 65
% 208.15/208.34 |- skos__hiddenLabel mesh__D003807 Dentin Sensitivities
% 208.15/208.34 |- mesh__dateRevised mesh__D003807 1997-06-20
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003807 2000
% 208.15/208.34 |- mesh__dateCreated mesh__D003009 1974-11-11
% 208.15/208.34 |- skos__hiddenLabel mesh__D003009 Chlorazepate, Dipotassium
% 208.15/208.34 |- skos__broader mesh__D003009smesh__D001569
% 208.15/208.34 |- skos__scopeNote mesh__D003009
% 208.15/208.34 A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions.%A%
% 208.15/208.34 |- skos__altLabel mesh__D003009 Dipotassium Chlorazepate
% 208.15/208.34 |- mesh__recordMaintainer mesh__D003009 ssb
% 208.15/208.34 |- skos__hiddenLabel mesh__D003009 Monopotassium, Clorazepate
% 208.15/208.34 |- skos__historyNote mesh__D003009 Benzazepines %28%1971-1974%29%
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003009 2005
% 208.15/208.34 |- mesh__dateRevised mesh__D003009 2003-07-09
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003009 2004
% 208.15/208.34 |- skos__historyNote mesh__D003009 Carboxylic Acids %28%1971-1974%29%
% 208.15/208.34 |- mesh__historyNote mesh__D003009
% 208.15/208.34 91%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90%A%
% 208.15/208.34 |- mesh__recordOriginator mesh__D003009 NLM
% 208.15/208.34 |- skos__prefLabel mesh__D003009 Clorazepate Dipotassium
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003009 2006
% 208.15/208.34 |- rdf__type mesh__D003009sskos__Concept
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D003009
% 208.15/208.34 91; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D003009 sjn
% 208.15/208.34 |- mesh__dateEstablished mesh__D003009 1991-01-01
% 208.15/208.34 |- skos__hiddenLabel mesh__D003009 Dipotassium, Clorazepate
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D013437 2004
% 208.15/208.34 |- mesh__dateEstablished mesh__D013437 1991-01-01
% 208.15/208.34 |- skos__broader mesh__D013437smesh__D008190
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D013437 2005
% 208.15/208.34 |- mesh__dateRevised mesh__D013437 2003-07-09
% 208.15/208.34 |- mesh__historyNote mesh__D013437 98%28%75%29%
% 208.15/208.34 |- skos__hiddenLabel mesh__D013437 Carbon Sulfur Lyases
% 208.15/208.34 |- mesh__dateCreated mesh__D013437 1999-01-01
% 208.15/208.34 |- skos__altLabel mesh__D013437 Sulfhydrases
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D013437 2006
% 208.15/208.34 |- skos__hiddenLabel mesh__D013437 Lyases, Carbon-Sulfur
% 208.15/208.34 |- mesh__recordMaintainer mesh__D013437 ssb
% 208.15/208.34 |- skos__annotation mesh__D013437 DF: C S LYASES
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D013437
% 208.15/208.34 98; see SULFHYDRASES 1991-97, see LYASES 1975-90
% 208.15/208.34 |- mesh__recordOriginator mesh__D013437 NLM
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D013437 sjn
% 208.15/208.34 |- skos__prefLabel mesh__D013437 Carbon-Sulfur Lyases
% 208.15/208.34 |- skos__scopeNote mesh__D013437
% 208.15/208.34 Enzymes that catalyze the cleavage of a carbon-sulfur bond by means other than hydrolysis or oxidation. EC 4.4.%A%
% 208.15/208.34 |- rdf__type mesh__D013437sskos__Concept
% 208.15/208.34 |- skos__annotation mesh__D018920
% 208.15/208.34 NIM; specify cell or tissue %26% infecting organism if relevant, probably NIM%A%
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D018920 sjn
% 208.15/208.34 |- skos__altLabel mesh__D018920 Co-culture
% 208.15/208.34 |- mesh__dateRevised mesh__D018920 2004-07-13
% 208.15/208.34 |- mesh__historyNote mesh__D018920 2005 %28%1996%29%
% 208.15/208.34 |- skos__historyNote mesh__D018920 Cells, Cultured %28%1979-1995%29%
% 208.15/208.34 |- skos__hiddenLabel mesh__D018920 Cocultivations
% 208.15/208.34 |- skos__prefLabel mesh__D018920 Coculture Techniques
% 208.15/208.34 |- skos__altLabel mesh__D018920 Cocultivation
% 208.15/208.34 |- mesh__recordOriginator mesh__D018920 AGS
% 208.15/208.34 |- skos__hiddenLabel mesh__D018920 Co culture
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D018920 2005; see COCULTURE 1996-2004
% 208.15/208.34 |- skos__related mesh__D018920smesh__D002478
% 208.15/208.34 |- skos__broader mesh__D018920smesh__D046508
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D018920 2005
% 208.15/208.34 |- skos__historyNote mesh__D018920 Tissue Culture %28%1974-1995%29%
% 208.15/208.34 |- mesh__dateCreated mesh__D018920 1995-01-06
% 208.15/208.34 |- rdf__type mesh__D018920sskos__Concept
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D018920 2006
% 208.15/208.34 |- skos__related mesh__D018920smesh__D014407
% 208.15/208.34 |- skos__hiddenLabel mesh__D018920 Coculture Technique
% 208.15/208.34 |- skos__hiddenLabel mesh__D018920 Co-cultures
% 208.15/208.34 |- skos__altLabel mesh__D018920 Coculture
% 208.15/208.34 |- skos__hiddenLabel mesh__D018920 Cocultures
% 208.15/208.34 |- mesh__dateEstablished mesh__D018920 1996-01-01
% 208.15/208.34 |- skos__scopeNote mesh__D018920
% 208.15/208.34 A technique of culturing mixed cell types in vitro to allow their synergistic or antagonistic interactions, such as on CELL DIFFERENTIATION or APOPTOSIS. Coculture can be of different types of cells, tissues, or organs from normal or disease states.%A%
% 208.15/208.34 |- mesh__recordMaintainer mesh__D018920 sjn
% 208.15/208.34 |- skos__prefLabel mesh__D018122 Antigens, CD80
% 208.15/208.34 |- skos__scopeNote mesh__D018122
% 208.15/208.34 The natural ligand for the T-cell antigen CD28; %28%ANTIGENS, CD28%29%; mediating T- and B-cell adhesion. CD80 is expressed on activated B-cells and gamma-interferon-stimulated monocytes. The binding of CD80 to CD28 and CTLA-4 provides a co-stimulatory signal to T-cells and leads to greatly upregulated lymphokine production.%A%
% 208.15/208.34 |- skos__altLabel mesh__D018122 Antigen, B7-1
% 208.15/208.34 |- skos__altLabel mesh__D018122 B7-1 Costimulatory Molecule
% 208.15/208.34 |- skos__altLabel mesh__D018122 B-Cell Activation Antigen
% 208.15/208.34 |- skos__broader mesh__D018122smesh__D015703
% 208.15/208.34 |- skos__altLabel mesh__D018122 CD80 Antigens
% 208.15/208.34 |- mesh__onlineNote mesh__D018122
% 208.15/208.34 use ANTIGENS, CD80 %28%NM%29% to search B7-1 PROTEIN 1994-95 %26% B CELL ACTIVATION ANTIGEN B7 1991-93%A%
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D018122 sjn
% 208.15/208.34 |- skos__altLabel mesh__D018122 B7 Antigen
% 208.15/208.34 |- skos__altLabel mesh__D018122 CD80 Antigen
% 208.15/208.34 |- mesh__recordOriginator mesh__D018122 AGS
% 208.15/208.34 |- skos__hiddenLabel mesh__D018122 B7 1 Costimulatory Molecule
% 208.15/208.34 |- mesh__dateEstablished mesh__D018122 1994-01-01
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D018122
% 208.15/208.34 96; was B-CELL ACTIVATION ANTIGEN 1994-95; B7-1 PROTEIN was indexed under B-CELL ACTIVATION ANTIGEN 1994-95; B CELL ACTIVATION ANTIGEN B7 was indexed under ANTIGENS, SURFACE 1991-93%A%
% 208.15/208.34 |- mesh__dateRevised mesh__D018122 2005-06-30
% 208.15/208.34 |- skos__historyNote mesh__D018122 Antigens, Surface %28%1991-1993%29%
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D018122 2006
% 208.15/208.34 |- mesh__dateCreated mesh__D018122 1993-06-04
% 208.15/208.34 |- skos__hiddenLabel mesh__D018122 B7 1 Antigen
% 208.15/208.34 |- skos__hiddenLabel mesh__D018122 B Cell Activation Antigen
% 208.15/208.34 |- mesh__historyNote mesh__D018122
% 208.15/208.34 96; was B-CELL ACTIVATION ANTIGEN 1994-95; was B CELL ACTIVATION ANTIGEN B7 %28%NM%29% 1991-93; B7-1 COSTIMULATORY MOLECULE was B7-1 PROTEIN %28%NM%29% 1994-95%A%
% 208.15/208.34 |- mesh__recordMaintainer mesh__D018122 ssb
% 208.15/208.34 |- rdf__type mesh__D018122sskos__Concept
% 208.15/208.34 |- skos__hiddenLabel mesh__D018122 Costimulatory Molecule, B7-1
% 208.15/208.34 |- skos__hiddenLabel mesh__D018122 Antigen, B7 1
% 208.15/208.34 |- skos__altLabel mesh__D018122 B7-1 Antigen
% 208.15/208.34 |- mesh__recordMaintainer mesh__D004900 nns
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D004900
% 208.15/208.34 84; was see under ERYTHROCYTES 1975-83
% 208.15/208.34 |- skos__scopeNote mesh__D004900
% 208.15/208.34 Immature, nucleated ERYTHROCYTES occupying the stage of ERYTHROPOIESIS that follows formation of ERYTHROID PROGENITOR CELLS and precedes formation of RETICULOCYTES. Popularly called normoblasts.%A%
% 208.15/208.34 |- skos__hiddenLabel mesh__D004900 Erythrocyte, Nucleated
% 208.15/208.34 |- skos__hiddenLabel mesh__D004900 Erythroblast
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004900 2005
% 208.15/208.34 |- skos__hiddenLabel mesh__D004900 Normoblast
% 208.15/208.34 |- mesh__dateCreated mesh__D004900 1974-11-11
% 208.15/208.34 |- mesh__recordOriginator mesh__D004900 NLM
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004900 2006
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D004900 sjn
% 208.15/208.34 |- skos__altLabel mesh__D004900 Erythrocytes, Nucleated
% 208.15/208.34 |- skos__hiddenLabel mesh__D004900 Nucleated Erythrocytes
% 208.15/208.34 |- skos__hiddenLabel mesh__D004900 Proerythroblast
% 208.15/208.34 |- skos__prefLabel mesh__D004900 Erythroblasts
% 208.15/208.34 |- skos__historyNote mesh__D004900 Erythrocytes %28%1966-1974%29%
% 208.15/208.34 |- rdf__type mesh__D004900sskos__Concept
% 208.15/208.34 |- skos__broader mesh__D004900smesh__D015672
% 208.15/208.34 |- skos__hiddenLabel mesh__D004900 Pronormoblast
% 208.15/208.34 |- mesh__historyNote mesh__D004900
% 208.15/208.34 84%28%75%29%; was see under ERYTHROCYTES 1975-83
% 208.15/208.34 |- skos__hiddenLabel mesh__D004900 Nucleated Erythrocyte
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004900 2004
% 208.15/208.34 |- skos__altLabel mesh__D004900 Normoblasts
% 208.15/208.34 |- skos__altLabel mesh__D004900 Pronormoblasts
% 208.15/208.34 |- mesh__dateRevised mesh__D004900 2003-07-09
% 208.15/208.34 |- mesh__dateEstablished mesh__D004900 1984-01-01
% 208.15/208.34 |- skos__hiddenLabel mesh__D051556 Hyperbilirubinemia, Neonatal Direct
% 208.15/208.34 |- mesh__recordMaintainer mesh__D051556 lkt
% 208.15/208.34 |- skos__scopeNote mesh__D051556
% 208.15/208.34 Accumulation of BILIRUBIN, a breakdown product of HEME PROTEINS, in the BLOOD during the first weeks of life. This may lead to NEONATAL JAUNDICE. The excess bilirubin may exist in the unconjugated %28%indirect%29% or the conjugated %28%direct%29% form. The condition may be self-limiting %28%PHYSIOLOGICAL NEONATAL JAUNDICE%29% or pathological with toxic levels of bilirubin.%A%
% 208.15/208.34 |- mesh__historyNote mesh__D051556
% 208.15/208.34 2006; use JAUNDICE, NEONATAL 1976-2005
% 208.15/208.34 |- skos__annotation mesh__D051556 check the tag, INFANT, NEWBORN
% 208.15/208.34 |- skos__broader mesh__D051556smesh__D006932
% 208.15/208.34 |- mesh__dateCreated mesh__D051556 2005-06-30
% 208.15/208.34 |- skos__broader mesh__D051556smesh__D007232
% 208.15/208.34 |- skos__related mesh__D051556smesh__D007567
% 208.15/208.34 |- skos__hiddenLabel mesh__D051556 Hyperbilirubinemia, Neonatal Indirect
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D051556 2006
% 208.15/208.34 |- skos__hiddenLabel mesh__D051556 Neonatal Indirect Hyperbilirubinemia
% 208.15/208.34 |- skos__hiddenLabel mesh__D051556 Neonatal Direct Hyperbilirubinemia
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D051556
% 208.15/208.34 2006; see JAUNDICE, NEONATAL 1976-2005
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D051556 sjn
% 208.15/208.34 |- skos__prefLabel mesh__D051556 Hyperbilirubinemia, Neonatal
% 208.15/208.34 |- mesh__recordOriginator mesh__D051556 lkt
% 208.15/208.34 |- mesh__dateEstablished mesh__D051556 2006-01-01
% 208.15/208.34 |- skos__altLabel mesh__D051556 Neonatal Hyperbilirubinemia
% 208.15/208.34 |- rdf__type mesh__D051556sskos__Concept
% 208.15/208.34 |- skos__historyNote mesh__D051556 Jaundice, Neonatal %28%1965-2005%29%
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 2002
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 1998
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 2003
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 2006
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 1996
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 1999
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D004102 78
% 208.15/208.34 |- skos__historyNote mesh__D004102 Tryptamines %28%1966-1977%29%
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 2004
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 1997
% 208.15/208.34 |- skos__broader mesh__D004102smesh__D014363
% 208.15/208.34 |- mesh__dateRevised mesh__D004102 1994-05-24
% 208.15/208.34 |- mesh__recordMaintainer mesh__D004102 TPW
% 208.15/208.34 |- mesh__dateEstablished mesh__D004102 1978-01-01
% 208.15/208.34 |- skos__scopeNote mesh__D004102
% 208.15/208.34 Tryptamine substituted with two hydroxyl groups in any position. Some are cytotoxic serotonin analogs that are preferentially taken up by serotonergic neurons and then destroy those neurons.%A%
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 2000
% 208.15/208.34 |- mesh__recordOriginator mesh__D004102 SH
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 2001
% 208.15/208.34 |- mesh__historyNote mesh__D004102 78
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D004102 PLS
% 208.15/208.34 |- mesh__dateCreated mesh__D004102 1977-04-22
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 1995
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D004102 2005
% 208.15/208.34 |- skos__prefLabel mesh__D004102 Dihydroxytryptamines
% 208.15/208.34 |- rdf__type mesh__D004102sskos__Concept
% 208.15/208.34 |- skos__hiddenLabel mesh__D009396 Wilm Tumor
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D009396 sjn
% 208.15/208.34 |- skos__hiddenLabel mesh__D009396 Wilm%27%s Tumor
% 208.15/208.34 |- mesh__dateRevised mesh__D009396 2005-06-30
% 208.15/208.34 |- rdf__type mesh__D009396sskos__Concept
% 208.15/208.34 |- skos__broader mesh__D009396smesh__D018193
% 208.15/208.34 |- skos__annotation mesh__D009396
% 208.15/208.34 coordinate IM with KIDNEY NEOPLASMS %28%IM%29%; /genet: consider also GENES, WILMS TUMOR%A%
% 208.15/208.34 |- mesh__recordMaintainer mesh__D009396 lkt
% 208.15/208.34 |- mesh__recordOriginator mesh__D009396 NLM
% 208.15/208.34 |- mesh__dateCreated mesh__D009396 1999-01-01
% 208.15/208.34 |- skos__hiddenLabel mesh__D009396 Tumor, Wilms
% 208.15/208.34 |- skos__hiddenLabel mesh__D009396 Nephroblastomas
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D009396 2006
% 208.15/208.34 |- skos__related mesh__D009396smesh__D016162
% 208.15/208.34 |- skos__altLabel mesh__D009396 Wilms%27% Tumor
% 208.15/208.34 |- skos__related mesh__D009396smesh__D025721
% 208.15/208.34 |- mesh__historyNote mesh__D009396 2006 %28%1963%29%
% 208.15/208.34 |- skos__altLabel mesh__D009396 Nephroblastoma
% 208.15/208.34 |- skos__broader mesh__D009396smesh__D009386
% 208.15/208.34 |- skos__broader mesh__D009396smesh__D007680
% 208.15/208.34 |- skos__hiddenLabel mesh__D009396 Tumor, Wilms%27%
% 208.15/208.34 |- skos__prefLabel mesh__D009396 Wilms Tumor
% 208.15/208.34 |- skos__scopeNote mesh__D009396
% 208.15/208.34 A malignant kidney tumor, caused by the uncontrolled multiplication of renal stem %28%blastemal%29%, stromal %28%STROMAL CELLS%29%, and epithelial %28%EPITHELIAL CELLS%29% elements. However, not all three are present in every case. Several genes or chromosomal areas have been associated with Wilms tumor which is usually found in childhood as a firm lump in a child%27%s side or ABDOMEN.%A%
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D009396
% 208.15/208.34 2006; see NEPHROBLASTOMA 1994-2005, WILMS%27% TUMOR 1991-1993, see NEPHROBLASTOMA 1963-1990%A%
% 208.15/208.34 |- skos__altLabel mesh__D017828 Gr%C3%%BC%nenthal Brand of Rifabutin
% 208.15/208.34 |- rdf__type mesh__D017828sskos__Concept
% 208.15/208.34 |- mesh__dateCreated mesh__D017828 1993-06-04
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D017828
% 208.15/208.34 94; RIFABUTINE was indexed under RIFAMYCINS 1981-93
% 208.15/208.34 |- skos__prefLabel mesh__D017828 Rifabutin
% 208.15/208.34 |- mesh__recordOriginator mesh__D017828 TPW
% 208.15/208.34 |- skos__historyNote mesh__D017828 Rifamycins %28%1981-1993%29%
% 208.15/208.34 |- skos__broader mesh__D017828smesh__D012294
% 208.15/208.34 |- mesh__onlineNote mesh__D017828
% 208.15/208.34 use RIFABUTIN %28%NM%29% to search RIFABUTINE 1981-93
% 208.15/208.34 |- skos__altLabel mesh__D017828 Pharmacia Brand of Rifabutin
% 208.15/208.34 |- skos__hiddenLabel mesh__D017828 LM427
% 208.15/208.34 |- skos__scopeNote mesh__D017828
% 208.15/208.34 A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.%A%
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D017828 2006
% 208.15/208.34 |- skos__hiddenLabel mesh__D017828 LM 427
% 208.15/208.34 |- skos__altLabel mesh__D017828 Ansatipine
% 208.15/208.34 |- mesh__dateEstablished mesh__D017828 1994-01-01
% 208.15/208.34 |- mesh__dateRevised mesh__D017828 2005-06-30
% 208.15/208.34 |- mesh__recordMaintainer mesh__D017828 CCR
% 208.15/208.34 |- mesh__historyNote mesh__D017828 94; was RIFABUTINE %28%NM%29% 1981-93
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D017828 sjn
% 208.15/208.34 |- skos__altLabel mesh__D017828 Kenfarma Brand of Rifabutin
% 208.15/208.34 |- skos__altLabel mesh__D017828 Ansamycin
% 208.15/208.34 |- skos__altLabel mesh__D017828 Rifabutine
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 2003
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 2006
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 1994
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 2000
% 208.15/208.34 |- skos__hiddenLabel mesh__D003808 Dentin Solubilities
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 2004
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D003808 65
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 2001
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 1998
% 208.15/208.34 |- mesh__recordOriginator mesh__D003808 NLM
% 208.15/208.34 |- mesh__recordAuthorizer mesh__D003808 PLS
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 1995
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 1996
% 208.15/208.34 |- rdf__type mesh__D003808sskos__Concept
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 1999
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 2002
% 208.15/208.34 |- mesh__historyNote mesh__D003808 65
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 1993
% 208.15/208.34 |- skos__hiddenLabel mesh__D003808 Solubilities, Dentin
% 208.15/208.34 |- mesh__dateEstablished mesh__D003808 1965-01-01
% 208.15/208.34 |- skos__broader mesh__D003808smesh__D009063
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 1997
% 208.15/208.34 |- skos__prefLabel mesh__D003808 Dentin Solubility
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D003808 2005
% 208.15/208.34 |- mesh__dateRevised mesh__D003808 1992-05-14
% 208.15/208.34 |- mesh__recordMaintainer mesh__D003808 TAP
% 208.15/208.34 |- skos__hiddenLabel mesh__D003808 Solubility, Dentin
% 208.15/208.34 |- mesh__dateCreated mesh__D003808 1999-01-01
% 208.15/208.34 |- skos__scopeNote mesh__D014530
% 208.15/208.34 A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety.%A%
% 208.15/208.34 |- mesh__dateRevised mesh__D014530 1999-11-08
% 208.15/208.34 |- skos__broader mesh__D014530smesh__D014500
% 208.15/208.34 |- mesh__dateEstablished mesh__D014530 1991-01-01
% 208.15/208.34 |- mesh__recordMaintainer mesh__D014530 adp
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D014530 2001
% 208.15/208.34 |- mesh__publicMeSHNote mesh__D014530
% 208.15/208.34 91; was see under URACIL NUCLEOTIDES 1978-90
% 208.15/208.34 |- mesh__historyNote mesh__D014530
% 208.15/208.34 91%28%78%29%; was see under URACIL NUCLEOTIDES 1978-90
% 208.15/208.34 |- mesh__activeMeSHYear mesh__D014530 2004
% 208.15/208.35 |- skos__prefLabel mesh__D014530 Uridine Diphosphate
% 208.15/208.35 |- skos__historyNote mesh__D014530 Uracil Nucleotides %28%1966-1977%29%
% 208.15/208.35 |- mesh__recordOriginator mesh__D014530 RLS
% 208.15/208.35 |- rdf__type mesh__D014530sskos__Concept
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D014530 2000
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D014530 2003
% 208.15/208.35 |- skos__hiddenLabel mesh__D014530 Diphosphate, Uridine
% 208.15/208.35 |- mesh__dateCreated mesh__D014530 1977-04-22
% 208.15/208.35 |- skos__altLabel mesh__D014530 Uridine Pyrophosphate
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D014530 2006
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D014530 sjn
% 208.15/208.35 |- skos__altLabel mesh__D014530 UDP
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D014530 2002
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D014530 2005
% 208.15/208.35 |- skos__hiddenLabel mesh__D014530 Pyrophosphate, Uridine
% 208.15/208.35 |- skos__hiddenLabel mesh__D000510 Alpha Globulins
% 208.15/208.35 |- mesh__historyNote mesh__D000510
% 208.15/208.35 75; was ALPHA GLOBULIN 1964-74 %28%Prov 1964%29%
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D000510 sjn
% 208.15/208.35 |- mesh__onlineNote mesh__D000510
% 208.15/208.35 use ALPHA-GLOBULINS to search ALPHA GLOBULIN 1966-74
% 208.15/208.35 |- mesh__dateRevised mesh__D000510 2000-06-21
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000510 2006
% 208.15/208.35 |- skos__prefLabel mesh__D000510 Alpha-Globulins
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000510 2001
% 208.15/208.35 |- skos__altLabel mesh__D000510 Alpha-Globulin
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000510 2003
% 208.15/208.35 |- skos__broader mesh__D000510smesh__D012712
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000510 2004
% 208.15/208.35 |- skos__scopeNote mesh__D000510
% 208.15/208.35 Serum proteins that have the most rapid migration during ELECTROPHORESIS. This subgroup of globulins is divided into faster and slower alpha%28%1%29%- and alpha%28%2%29%-globulins.%A%
% 208.15/208.35 |- mesh__dateCreated mesh__D000510 1999-01-01
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000510 2002
% 208.15/208.35 |- mesh__recordOriginator mesh__D000510 NLM
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D000510 75; was ALPHA GLOBULIN 1965-74
% 208.15/208.35 |- skos__hiddenLabel mesh__D000510 Alpha Globulin
% 208.15/208.35 |- mesh__dateEstablished mesh__D000510 1965-01-01
% 208.15/208.35 |- rdf__type mesh__D000510sskos__Concept
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000510 2005
% 208.15/208.35 |- mesh__recordMaintainer mesh__D000510 adp
% 208.15/208.35 |- skos__annotation mesh__D000510 GEN or unspecified; prefer specifics
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 2004
% 208.15/208.35 |- skos__annotation mesh__D013438
% 208.15/208.35 do not confuse with SULFHYDRYL REAGENTS; /physiol permitted with only endogenous SH cpds; DF: SULFHYDRYL CPDS%A%
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D013438 PLS
% 208.15/208.35 |- rdf__type mesh__D013438sskos__Concept
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 2003
% 208.15/208.35 |- mesh__recordOriginator mesh__D013438 NLM
% 208.15/208.35 |- mesh__dateCreated mesh__D013438 1999-01-01
% 208.15/208.35 |- skos__broader mesh__D013438smesh__D013457
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 2002
% 208.15/208.35 |- skos__prefLabel mesh__D013438 Sulfhydryl Compounds
% 208.15/208.35 |- skos__hiddenLabel mesh__D013438 Compounds, Sulfhydryl
% 208.15/208.35 |- skos__hiddenLabel mesh__D013438 Compounds, Mercapto
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 1999
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 2001
% 208.15/208.35 |- mesh__recordMaintainer mesh__D013438 PXP
% 208.15/208.35 |- skos__altLabel mesh__D013438 Mercaptans
% 208.15/208.35 |- skos__scopeNote mesh__D013438 Compounds containing the -SH radical.
% 208.15/208.35 |- skos__altLabel mesh__D013438 Mercapto Compounds
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 1998
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 2006
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 2000
% 208.15/208.35 |- skos__altLabel mesh__D013438 Thiols
% 208.15/208.35 |- mesh__dateRevised mesh__D013438 1995-05-31
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 1997
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 2005
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D013438 1996
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D018921 96
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 2002
% 208.15/208.35 |- mesh__dateEstablished mesh__D018921 1996-01-01
% 208.15/208.35 |- skos__prefLabel mesh__D018921 Leukostasis
% 208.15/208.35 |- skos__hiddenLabel mesh__D018921 Syndrome, Leukostasis
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 2003
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 2005
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 2004
% 208.15/208.35 |- mesh__historyNote mesh__D018921 96
% 208.15/208.35 |- rdf__type mesh__D018921sskos__Concept
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 2006
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 2000
% 208.15/208.35 |- skos__altLabel mesh__D018921 Leukostasis Syndrome
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 1996
% 208.15/208.35 |- skos__annotation mesh__D018921
% 208.15/208.35 note category: abnorm intravasc leukocyte aggreg
% 208.15/208.35 |- skos__hiddenLabel mesh__D018921 Syndromes, Leukostasis
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 2001
% 208.15/208.35 |- skos__broader mesh__D018921smesh__D007960
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 1998
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 1997
% 208.15/208.35 |- skos__hiddenLabel mesh__D018921 Leukostasis Syndromes
% 208.15/208.35 |- mesh__dateCreated mesh__D018921 1995-01-06
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018921 1999
% 208.15/208.35 |- skos__scopeNote mesh__D018921
% 208.15/208.35 Abnormal intravascular leukocyte aggregation and clumping often seen in leukemia patients. The brain and lungs are the two most commonly affected organs. This acute syndrome requires aggressive cytoreductive modalities including chemotherapy and/or leukophoresis. It is differentiated from LEUKEMIC INFILTRATION which is a neoplastic process where leukemic cells invade organs.%A%
% 208.15/208.35 |- skos__hiddenLabel mesh__D018921 Leukostases
% 208.15/208.35 |- skos__altLabel mesh__D018123 Interleukin Receptors
% 208.15/208.35 |- mesh__historyNote mesh__D018123 94
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D018123 94
% 208.15/208.35 |- skos__scopeNote mesh__D018123
% 208.15/208.35 Cell surface proteins that bind interleukins and trigger intracellular changes influencing the behavior of cells.%A%
% 208.15/208.35 |- mesh__recordMaintainer mesh__D018123 jmp
% 208.15/208.35 |- mesh__dateCreated mesh__D018123 1993-06-21
% 208.15/208.35 |- mesh__dateRevised mesh__D018123 2003-07-09
% 208.15/208.35 |- skos__hiddenLabel mesh__D018123 Interleukins Receptors
% 208.15/208.35 |- skos__hiddenLabel mesh__D018123 Receptor, Interleukin
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018123 2006
% 208.15/208.35 |- mesh__recordOriginator mesh__D018123 RAZ
% 208.15/208.35 |- skos__historyNote mesh__D018123 Receptors, Immunologic %28%1980-1993%29%
% 208.15/208.35 |- skos__broader mesh__D018123smesh__D018121
% 208.15/208.35 |- skos__altLabel mesh__D018123 Interleukin Receptor
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D018123 sjn
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018123 2005
% 208.15/208.35 |- rdf__type mesh__D018123sskos__Concept
% 208.15/208.35 |- mesh__dateEstablished mesh__D018123 1994-01-01
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D018123 2004
% 208.15/208.35 |- skos__annotation mesh__D018123
% 208.15/208.35 GEN; prefer specific; DF: RECEPT INTERLEUKIN
% 208.15/208.35 |- skos__prefLabel mesh__D018123 Receptors, Interleukin
% 208.15/208.35 |- skos__altLabel mesh__D018123 Receptors, Interleukins
% 208.15/208.35 |- mesh__recordOriginator mesh__D010140 RC
% 208.15/208.35 |- rdf__type mesh__D010140sskos__Concept
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 1994
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 2004
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 2001
% 208.15/208.35 |- skos__prefLabel mesh__D010140 Pacific Ocean
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 2003
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 1997
% 208.15/208.35 |- mesh__dateEstablished mesh__D010140 1987-01-01
% 208.15/208.35 |- mesh__dateCreated mesh__D010140 1986-04-02
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 2000
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 2006
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 1993
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 1996
% 208.15/208.35 |- mesh__historyNote mesh__D010140 87
% 208.15/208.35 |- skos__broader mesh__D010140smesh__D009792
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 2005
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 1999
% 208.15/208.35 |- mesh__recordMaintainer mesh__D010140 TGC
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 2002
% 208.15/208.35 |- mesh__dateRevised mesh__D010140 1992-05-15
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D010140 PLS
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 1995
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D010140 1998
% 208.15/208.35 |- skos__annotation mesh__D010140 no qualif
% 208.15/208.35 |- mesh__dateCreated mesh__D004901 1974-11-11
% 208.15/208.35 |- skos__altLabel mesh__D004901 Monkey, Red
% 208.15/208.35 |- skos__altLabel mesh__D004901 Patas Monkey
% 208.15/208.35 |- mesh__dateRevised mesh__D004901 2005-06-30
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D004901 2006
% 208.15/208.35 |- skos__scopeNote mesh__D004901
% 208.15/208.35 A species of the genus ERYTHROCEBUS, subfamily CERCOPITHECINAE, family CERCOPITHECIDAE. It inhabits the flat open arid country of Africa. It is also known as the patas monkey or the red monkey.%A%
% 208.15/208.35 |- skos__hiddenLabel mesh__D004901 patas, Erythrocebus
% 208.15/208.35 |- rdf__type mesh__D004901sskos__Concept
% 208.15/208.35 |- mesh__onlineNote mesh__D004901
% 208.15/208.35 use ERYTHROCEBUS PATAS to search PATAS MONKEYS 1975-80
% 208.15/208.35 |- mesh__dateEstablished mesh__D004901 1991-01-01
% 208.15/208.35 |- mesh__recordOriginator mesh__D004901 NLM
% 208.15/208.35 |- mesh__recordMaintainer mesh__D004901 ags
% 208.15/208.35 |- skos__prefLabel mesh__D004901 Erythrocebus patas
% 208.15/208.35 |- skos__altLabel mesh__D004901 Monkey, Patas
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D004901 sjn
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D004901
% 208.15/208.35 91; was see under CERCOPITHECIDAE 1981-90; was PATAS MONKEYS see under MONKEYS 1975-80%A%
% 208.15/208.35 |- mesh__historyNote mesh__D004901
% 208.15/208.35 91%28%81%29%; was see under CERCOPITHECIDAE 1981-90; was PATAS MONKEYS see under MONKEYS 1975-80%A%
% 208.15/208.35 |- skos__altLabel mesh__D004901 Red Monkey
% 208.15/208.35 |- skos__hiddenLabel mesh__D004901 Patas Monkeys
% 208.15/208.35 |- skos__annotation mesh__D004901
% 208.15/208.35 Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%
% 208.15/208.35 |- skos__broader mesh__D004901smesh__D016669
% 208.15/208.35 |- skos__hiddenLabel mesh__D004901 Red Monkeys
% 208.15/208.35 |- skos__hiddenLabel mesh__D004901 Monkeys, Red
% 208.15/208.35 |- skos__hiddenLabel mesh__D004901 Monkeys, Patas
% 208.15/208.35 |- skos__broader mesh__D051557smesh__D051536
% 208.15/208.35 |- skos__hiddenLabel mesh__D051557 Hepatocyte Nuclear Factor 4 beta
% 208.15/208.35 |- skos__hiddenLabel mesh__D051557 Transcription Factor, HNF4
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D051557 2006
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D051557 2006B
% 208.15/208.35 |- mesh__dateEstablished mesh__D051557 2006-01-01
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D051557
% 208.15/208.35 2006; HEPATOCYTE NUCLEAR FACTOR 4 was indexed under DNA-BINDING PROTEINS, PHOSPHOPROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%
% 208.15/208.35 |- skos__hiddenLabel mesh__D051557
% 208.15/208.35 Hepatocyte Nuclear Factor Forkhead Homolog 4
% 208.15/208.35 |- skos__hiddenLabel mesh__D051557 Hepatocyte Nuclear Factor 4 alpha
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D051557 ags
% 208.15/208.35 |- skos__scopeNote mesh__D051557
% 208.15/208.35 A subfamily of nuclear receptors that regulate GENETIC TRANSCRIPTION of a diverse group of GENES involved in the synthesis of BLOOD COAGULATION FACTORS; and in GLUCOSE; CHOLESTEROL; and FATTY ACIDS metabolism.%A%
% 208.15/208.35 |- skos__broader mesh__D051557smesh__D018160
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D051557 2006A
% 208.15/208.35 |- mesh__recordOriginator mesh__D051557 DRC
% 208.15/208.35 |- rdf__type mesh__D051557sskos__Concept
% 208.15/208.35 |- mesh__recordMaintainer mesh__D051557 ags
% 208.15/208.35 |- skos__altLabel mesh__D051557
% 208.15/208.35 Hepatocyte Nuclear Factor-Forkhead Homolog 4
% 208.15/208.35 |- mesh__dateCreated mesh__D051557 2005-06-30
% 208.15/208.35 |- skos__hiddenLabel mesh__D051557 Hepatocyte Nuclear Factor 4 gamma
% 208.15/208.35 |- mesh__historyNote mesh__D051557 2006 %28%1991%29%
% 208.15/208.35 |- mesh__dateRevised mesh__D051557 2005-08-03
% 208.15/208.35 |- skos__prefLabel mesh__D051557 Hepatocyte Nuclear Factor 4
% 208.15/208.35 |- skos__altLabel mesh__D051557 HNF4 Transcription Factor
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D004103 sjn
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D004103
% 208.15/208.35 91; was DIIODOHYDROXYQUIN 1963-91 %28%see under HYDROXYQUINOLINES 1983-90%29%%A%
% 208.15/208.35 |- rdf__type mesh__D004103sskos__Concept
% 208.15/208.35 |- mesh__dateCreated mesh__D004103 1999-01-01
% 208.15/208.35 |- skos__scopeNote mesh__D004103
% 208.15/208.35 One of the halogenated 8-quinolinols widely used as an intestinal antiseptic, especially as an antiamebic agent. It is also used topically in other infections and may cause CNS and eye damage. It is known by very many similar trade names world-wide.%A%
% 208.15/208.35 |- skos__altLabel mesh__D004103 Summers Brand of Iodoquinol
% 208.15/208.35 |- skos__altLabel mesh__D004103 Searle Brand of Iodoquinol
% 208.15/208.35 |- skos__altLabel mesh__D004103 Diiodohydroxyquin
% 208.15/208.35 |- mesh__dateRevised mesh__D004103 2005-06-30
% 208.15/208.35 |- skos__altLabel mesh__D004103 CMC Brand of Iodoquinol
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D004103 2006
% 208.15/208.35 |- skos__altLabel mesh__D004103 Diodoxyquinoline
% 208.15/208.35 |- mesh__recordMaintainer mesh__D004103 exl
% 208.15/208.35 |- skos__altLabel mesh__D004103 Diiodohydroxyquinoline
% 208.15/208.35 |- skos__altLabel mesh__D004103 Diba Brand of Iodoquinol
% 208.15/208.35 |- skos__altLabel mesh__D004103 Glenwood Brand of Iodoquinol
% 208.15/208.35 |- mesh__dateEstablished mesh__D004103 1963-01-01
% 208.15/208.35 |- skos__altLabel mesh__D004103 Serral Brand of Iodoquinol
% 208.15/208.35 |- mesh__recordOriginator mesh__D004103 NLM
% 208.15/208.35 |- skos__prefLabel mesh__D004103 Iodoquinol
% 208.15/208.35 |- mesh__onlineNote mesh__D004103
% 208.15/208.35 use IODOQUINOL to search DIIODOHYDROXYQUIN 1966-90
% 208.15/208.35 |- mesh__historyNote mesh__D004103
% 208.15/208.35 91%28%83%29%63; was DIIODOHYDROXYQUIN 1963-91 %28%see under HYDROXYQUINOLINES 1983-90%29%%A%
% 208.15/208.35 |- skos__broader mesh__D004103smesh__D015125
% 208.15/208.35 |- skos__altLabel mesh__D004103 Diodoquin
% 208.15/208.35 |- skos__broader mesh__D018821Q000172smesh__D018821
% 208.15/208.35 |- mesh__preferredCombination mesh__D018821Q000172smesh__D018370
% 208.15/208.35 |- rdf__type mesh__D018821Q000172smesh__CompoundConcept
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 2001
% 208.15/208.35 |- rdf__type mesh__D009397sskos__Concept
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 2003
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 2004
% 208.15/208.35 |- skos__broader mesh__D009397smesh__D007674
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 2005
% 208.15/208.35 |- mesh__recordMaintainer mesh__D009397 TGC
% 208.15/208.35 |- skos__scopeNote mesh__D009397
% 208.15/208.35 A condition characterized by precipitation of calcium phosphate in the tubules of the kidney, with resultant renal insufficiency. %28%Dorland, 27th ed%29%%A%
% 208.15/208.35 |- skos__annotation mesh__D009397
% 208.15/208.35 calcium phosphate deposition in kidney tubules
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 2006
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 2002
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 1996
% 208.15/208.35 |- skos__prefLabel mesh__D009397 Nephrocalcinosis
% 208.15/208.35 |- skos__hiddenLabel mesh__D009397 Nephrocalcinoses
% 208.15/208.35 |- mesh__dateRevised mesh__D009397 1993-06-02
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 1997
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 1998
% 208.15/208.35 |- mesh__recordOriginator mesh__D009397 NLM
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 2000
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 1994
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 1999
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D009397 PLS
% 208.15/208.35 |- skos__broader mesh__D009397smesh__D002114
% 208.15/208.35 |- mesh__dateCreated mesh__D009397 1999-01-01
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D009397 1995
% 208.15/208.35 |- mesh__recordMaintainer mesh__D017829 ssb
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D017829 2006
% 208.15/208.35 |- skos__hiddenLabel mesh__D017829 BRL 43694A
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D017829
% 208.15/208.35 94; GRANISETRON was indexed under INDAZOLES 1988-93
% 208.15/208.35 |- skos__prefLabel mesh__D017829 Granisetron
% 208.15/208.35 |- skos__hiddenLabel mesh__D017829 BRL43694
% 208.15/208.35 |- mesh__dateCreated mesh__D017829 1993-06-04
% 208.15/208.35 |- mesh__historyNote mesh__D017829
% 208.15/208.35 94; was GRANISETRON %28%NM%29% 1988-93
% 208.15/208.35 |- mesh__recordOriginator mesh__D017829 TPW
% 208.15/208.35 |- skos__hiddenLabel mesh__D017829 BRL 43694
% 208.15/208.35 |- skos__hiddenLabel mesh__D017829 Monohydrochloride, Granisetron
% 208.15/208.35 |- skos__hiddenLabel mesh__D017829 BRL43694A
% 208.15/208.35 |- skos__scopeNote mesh__D017829
% 208.15/208.35 A serotonin receptor %28%5HT-3 selective%29% antagonist that has been used as an antiemetic for cancer chemotherapy patients.%A%
% 208.15/208.35 |- skos__altLabel mesh__D017829
% 208.15/208.35 1-Methyl-N-%28%endo-9-Methyl-9-Azabicyclo%28%3.3.1%29%non-3-yl%29%-1H-Indazole-3-Carboxamide
% 208.15/208.35 |- skos__broader mesh__D017829smesh__D007191
% 208.15/208.35 |- mesh__dateRevised mesh__D017829 2005-06-30
% 208.15/208.35 |- mesh__dateEstablished mesh__D017829 1994-01-01
% 208.15/208.35 |- skos__hiddenLabel mesh__D017829 Hydrochloride, Granisetron
% 208.15/208.35 |- mesh__onlineNote mesh__D017829
% 208.15/208.35 use GRANISETRON %28%NM%29% to search GRANISETRON 1988-93
% 208.15/208.35 |- skos__altLabel mesh__D017829 BRL-43694
% 208.15/208.35 |- skos__altLabel mesh__D017829 Granisetron Monohydrochloride
% 208.15/208.35 |- rdf__type mesh__D017829sskos__Concept
% 208.15/208.35 |- skos__historyNote mesh__D017829 Indazoles %28%1988-1993%29%
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D017829 sjn
% 208.15/208.35 |- mesh__dateRevised mesh__D003809 2003-07-09
% 208.15/208.35 |- rdf__type mesh__D003809sskos__Concept
% 208.15/208.35 |- skos__altLabel mesh__D003809 Secondary Dentin
% 208.15/208.35 |- mesh__historyNote mesh__D003809 65
% 208.15/208.35 |- skos__hiddenLabel mesh__D003809 Secondary Dentins
% 208.15/208.35 |- mesh__recordMaintainer mesh__D003809 lkt
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D003809 2005
% 208.15/208.35 |- skos__broader mesh__D003809smesh__D003804
% 208.15/208.35 |- mesh__dateCreated mesh__D003809 1999-01-01
% 208.15/208.35 |- skos__scopeNote mesh__D003809
% 208.15/208.35 Dentin formed by normal pulp after completion of root end formation.%A%
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D003809 2006
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D003809 65
% 208.15/208.35 |- mesh__recordOriginator mesh__D003809 NLM
% 208.15/208.35 |- mesh__dateEstablished mesh__D003809 1965-01-01
% 208.15/208.35 |- skos__prefLabel mesh__D003809 Dentin, Secondary
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D003809 2004
% 208.15/208.35 |- skos__broader mesh__D003809smesh__D003788
% 208.15/208.35 |- skos__hiddenLabel mesh__D003809 Dentins, Secondary
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D003809 sjn
% 208.15/208.35 |- skos__scopeNote mesh__D014531
% 208.15/208.35 A nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism. Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose.%A%
% 208.15/208.35 |- skos__hiddenLabel mesh__D014531 Galactose, Uridine Diphosphate
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D014531
% 208.15/208.35 91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.15/208.35 |- skos__altLabel mesh__D014531 UDPGal
% 208.15/208.35 |- mesh__recordOriginator mesh__D014531 NLM
% 208.15/208.35 |- rdf__type mesh__D014531sskos__Concept
% 208.15/208.35 |- mesh__recordMaintainer mesh__D014531 ssb
% 208.15/208.35 |- skos__hiddenLabel mesh__D014531 Pyrophosphogalactose, Uridine
% 208.15/208.35 |- skos__hiddenLabel mesh__D014531 Galactose, UDP
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D014531 2006
% 208.15/208.35 |- skos__hiddenLabel mesh__D014531 Diphosphate Galactose, Uridine
% 208.15/208.35 |- mesh__dateCreated mesh__D014531 1974-11-19
% 208.15/208.35 |- skos__altLabel mesh__D014531 Uridine Diphosphogalactose
% 208.15/208.35 |- skos__historyNote mesh__D014531
% 208.15/208.35 Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.15/208.35 |- skos__hiddenLabel mesh__D014531 Diphosphogalactose, Uridine
% 208.15/208.35 |- skos__altLabel mesh__D014531 UDP Galactose
% 208.15/208.35 |- skos__altLabel mesh__D014531 Uridine Pyrophosphogalactose
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D014531 2005
% 208.15/208.35 |- mesh__dateRevised mesh__D014531 2004-07-07
% 208.15/208.35 |- skos__broader mesh__D014531smesh__D014539
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D014531 sjn
% 208.15/208.35 |- skos__prefLabel mesh__D014531 Uridine Diphosphate Galactose
% 208.15/208.35 |- mesh__historyNote mesh__D014531
% 208.15/208.35 91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.15/208.35 |- mesh__dateEstablished mesh__D014531 1991-01-01
% 208.15/208.35 |- skos__historyNote mesh__D014531 Galactose %28%1973-1974%29%
% 208.15/208.35 |- skos__historyNote mesh__D000511 Macroglobulins %28%1973-1975%29%
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D000511 PLS
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha Macrofetoproteins
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 2-Macroglobulins, Slow
% 208.15/208.35 |- skos__altLabel mesh__D000511 alpha 2-Acute Phase Globulin
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 1996
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 Slow alpha 2 Globulin
% 208.15/208.35 |- skos__altLabel mesh__D000511 alpha 2-Glucoprotein
% 208.15/208.35 |- mesh__onlineNote mesh__D000511
% 208.15/208.35 use ALPHA-MACROGLOBULINS to search ALPHA MACROGLOBULINS 1976-95%A%
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 2006
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 2 Glucoproteins
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 2001
% 208.15/208.35 |- mesh__dateEstablished mesh__D000511 1976-01-01
% 208.15/208.35 |- skos__altLabel mesh__D000511 alpha-Macrofetoproteins
% 208.15/208.35 |- mesh__dateRevised mesh__D000511 1995-03-16
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 1999
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 2005
% 208.15/208.35 |- mesh__dateCreated mesh__D000511 1975-07-18
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 1-Protein, Acute-Phase
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 2000
% 208.15/208.35 |- skos__broader mesh__D000511smesh__D008259
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 Acute Phase alpha 1 Protein
% 208.15/208.35 |- mesh__historyNote mesh__D000511 96; was ALPHA MACROGLOBULINS 1976-95
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha2 Macroglobulin
% 208.15/208.35 |- skos__broader mesh__D000511smesh__D000209
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 1998
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 RNP, 45S
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 1 Acute Phase Globulin
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D000511
% 208.15/208.35 96; was ALPHA MACROGLOBULINS 1976-95
% 208.15/208.35 |- skos__historyNote mesh__D000511 alpha Globulins %28%1974-1975%29%
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 2 Acute Phase Globulin
% 208.15/208.35 |- skos__altLabel mesh__D000511 Acute-Phase alpha 1-Protein
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 1 Acute Phase Protein
% 208.15/208.35 |- mesh__recordOriginator mesh__D000511 RLS
% 208.15/208.35 |- skos__altLabel mesh__D000511 alpha2-Macroglobulin
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 2004
% 208.15/208.35 |- mesh__recordMaintainer mesh__D000511 PLS
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha Macroglobulins
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 2 Acute Phase Globulins
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 2-Globulin, Slow
% 208.15/208.35 |- skos__altLabel mesh__D000511 Slow alpha 2-Globulin
% 208.15/208.35 |- skos__broader mesh__D000511smesh__D000510
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 2002
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 2 Macroglobulin
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 Slow alpha 2 Macroglobulins
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 1997
% 208.15/208.35 |- skos__scopeNote mesh__D000511
% 208.15/208.35 Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters.%A%
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 1 Macroglobulin
% 208.15/208.35 |- skos__altLabel mesh__D000511 45S RNP
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D000511 2003
% 208.15/208.35 |- rdf__type mesh__D000511sskos__Concept
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha 2 Glucoprotein
% 208.15/208.35 |- skos__prefLabel mesh__D000511 alpha-Macroglobulins
% 208.15/208.35 |- skos__hiddenLabel mesh__D000511 alpha Macrofetoprotein
% 208.15/208.35 |- skos__altLabel mesh__D000511 alpha 2-Macroglobulin
% 208.15/208.35 |- skos__altLabel mesh__D038181 NADH-Flavin Oxidoreductase
% 208.15/208.35 |- skos__hiddenLabel mesh__D038181 Reductase, Flavin Mononucleotide
% 208.15/208.35 |- skos__hiddenLabel mesh__D038181 Oxidoreductase, FMN
% 208.15/208.35 |- skos__hiddenLabel mesh__D038181 Reductase, FMN
% 208.15/208.35 |- mesh__dateEstablished mesh__D038181 2003-01-01
% 208.15/208.35 |- skos__altLabel mesh__D038181 FMN Oxidoreductase
% 208.15/208.35 |- mesh__activeMeSHYear mesh__D038181 2006
% 208.15/208.35 |- skos__hiddenLabel mesh__D038181 NADPH Flavin Reductase
% 208.15/208.35 |- mesh__dateCreated mesh__D038181 2002-07-03
% 208.15/208.35 |- mesh__recordAuthorizer mesh__D038181 sjn
% 208.15/208.35 |- skos__altLabel mesh__D038181 NADH-FMN Oxidoreductase
% 208.15/208.35 |- skos__hiddenLabel mesh__D038181 NADH FMN Oxidoreductase
% 208.15/208.35 |- skos__hiddenLabel mesh__D038181 Reductase, NADPH-Flavin
% 208.15/208.35 |- skos__hiddenLabel mesh__D038181 Mononucleotide Reductase, Flavin
% 208.15/208.35 |- skos__altLabel mesh__D038181 Flavin Mononucleotide Reductase
% 208.15/208.35 |- mesh__historyNote mesh__D038181 2006%28%1975%29%
% 208.15/208.35 |- mesh__dateRevised mesh__D038181 2005-06-30
% 208.15/208.35 |- skos__altLabel mesh__D038181 NAD%28%P%29%H Dehydrogenase %28%FMN%29%
% 208.15/208.35 |- skos__prefLabel mesh__D038181 FMN Reductase
% 208.15/208.35 |- skos__altLabel mesh__D038181 NAD%28%P%29%H-Flavin Oxidoreductase
% 208.15/208.35 |- skos__historyNote mesh__D038181
% 208.15/208.35 NADH, NADPH Oxidoreductases %28%1981-2002%29%
% 208.15/208.35 |- skos__hiddenLabel mesh__D038181 Oxidoreductase, NADH-Flavin
% 208.15/208.35 |- skos__altLabel mesh__D038181 NAD%28%P%29%H-FMN Oxidoreductase
% 208.15/208.35 |- mesh__recordMaintainer mesh__D038181 AKE
% 208.15/208.35 |- mesh__recordOriginator mesh__D038181 jmp
% 208.15/208.35 |- skos__broader mesh__D038181smesh__D000587
% 208.15/208.35 |- skos__historyNote mesh__D038181 Flavin Mononucleotide %28%1975-1980%29%
% 208.15/208.35 |- skos__scopeNote mesh__D038181
% 208.15/208.35 An enzyme that utilizes NADH or NADPH to reduce FLAVINS. It is involved in a number of biological processes that require reduced flavin for their functions such as bacterial bioluminescence. Formerly listed as EC 1.6.8.1%A%
% 208.15/208.35 |- skos__hiddenLabel mesh__D038181 Oxidoreductase, NADH-FMN
% 208.15/208.35 |- mesh__publicMeSHNote mesh__D038181
% 208.15/208.35 2006; see FLAVIN MONONUCLEOTIDE REDUCTASE 2003-2005; FLAVIN MONONUCLEOTIDE REDUCTASE%28%now FMN REDUCTASE%29% was indexed under NADH, NADPH OXIDOREDUCTASES 1981-2002 %26% under FMN 1975-1980%A%
% 208.15/208.36 |- rdf__type mesh__D038181sskos__Concept
% 208.15/208.36 |- skos__altLabel mesh__D038181 NADPH-Flavin Reductase
% 208.15/208.36 |- skos__hiddenLabel mesh__D013439 Inhibitors, Sulfhydryl Compound
% 208.15/208.36 |- skos__hiddenLabel mesh__D013439 Reagents, Sulfhydryl
% 208.15/208.36 |- skos__hiddenLabel mesh__D013439 Compound Antagonists, Sulfhydryl
% 208.15/208.36 |- skos__hiddenLabel mesh__D013439 SH Reagents
% 208.15/208.36 |- skos__hiddenLabel mesh__D013439 Reagents, Thiol
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D013439
% 208.15/208.36 99; for SULFHYDRYL COMPOUND ANTAGONISTS see SULFHYDRYL COMPOUNDS ANTAGONISTS 1978-98; for SULFHYDRYL COMPOUND INHIBITORS see SULFHYDRYL COMPOUNDS INHIBITORS 1978-98%A%
% 208.15/208.36 |- mesh__historyNote mesh__D013439 99%28%72%29%
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D013439 sjn
% 208.15/208.36 |- skos__broader mesh__D013439smesh__D007202
% 208.15/208.36 |- skos__related mesh__D013439smesh__D004791
% 208.15/208.36 |- skos__hiddenLabel mesh__D013439 Antagonists, Sulfhydryl Compounds
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D013439 2006
% 208.15/208.36 |- mesh__recordOriginator mesh__D013439 NLM
% 208.15/208.36 |- skos__altLabel mesh__D013439 Sulfhydryl Compound Inhibitors
% 208.15/208.36 |- skos__prefLabel mesh__D013439 Sulfhydryl Reagents
% 208.15/208.36 |- mesh__dateEstablished mesh__D013439 1972-01-01
% 208.15/208.36 |- mesh__dateRevised mesh__D013439 2003-07-09
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D013439 2005
% 208.15/208.36 |- skos__altLabel mesh__D013439 SH-Reagents
% 208.15/208.36 |- skos__historyNote mesh__D013439
% 208.15/208.36 Sulfhydryl Compounds/antagonists %26% inhibitors %28%1968-1970%29%
% 208.15/208.36 |- skos__altLabel mesh__D013439 Sulfhydryl Compounds Antagonists
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D013439 2004
% 208.15/208.36 |- rdf__type mesh__D013439sskos__Concept
% 208.15/208.36 |- skos__hiddenLabel mesh__D013439 Compound Inhibitors, Sulfhydryl
% 208.15/208.36 |- mesh__recordMaintainer mesh__D013439 ssb
% 208.15/208.36 |- skos__scopeNote mesh__D013439
% 208.15/208.36 Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling.%A%
% 208.15/208.36 |- skos__hiddenLabel mesh__D013439 Antagonists, Sulfhydryl Compound
% 208.15/208.36 |- skos__hiddenLabel mesh__D013439 Inhibitors, Sulfhydryl Compounds
% 208.15/208.36 |- mesh__dateCreated mesh__D013439 1999-01-01
% 208.15/208.36 |- skos__altLabel mesh__D013439 Thiol Reagents
% 208.15/208.36 |- skos__annotation mesh__D013439
% 208.15/208.36 do not confuse with SULFHYDRYL COMPOUNDS
% 208.15/208.36 |- skos__hiddenLabel mesh__D024161 Collagen Type XI, alpha2 Chain
% 208.15/208.36 |- mesh__dateRevised mesh__D024161 2004-07-07
% 208.15/208.36 |- skos__altLabel mesh__D024161 Collagen alpha3%28%XI%29%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D024161 2005
% 208.15/208.36 |- skos__prefLabel mesh__D024161 Collagen Type XI
% 208.15/208.36 |- mesh__recordOriginator mesh__D024161 jmp
% 208.15/208.36 |- rdf__type mesh__D024161sskos__Concept
% 208.15/208.36 |- skos__altLabel mesh__D024161 Type XI Collagen
% 208.15/208.36 |- skos__hiddenLabel mesh__D024161 Collagen, Type XI
% 208.15/208.36 |- skos__hiddenLabel mesh__D024161 Collagen Type XI, alpha1 Chain
% 208.15/208.36 |- mesh__dateEstablished mesh__D024161 2002-01-01
% 208.15/208.36 |- skos__hiddenLabel mesh__D024161 Collagen Type XI, alpha3 Chain
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D024161 2006
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D024161 2002; see COLLAGEN 1992-2001
% 208.15/208.36 |- mesh__recordMaintainer mesh__D024161 jmp
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D024161 sjn
% 208.15/208.36 |- skos__altLabel mesh__D024161 Collagen Type-XI, alpha3 Chain
% 208.15/208.36 |- skos__altLabel mesh__D024161 Collagen Type-XI, alpha1 Chain
% 208.15/208.36 |- mesh__historyNote mesh__D024161 2002; use COLLAGEN 1992-2001
% 208.15/208.36 |- skos__hiddenLabel mesh__D024161 Procollagen, Type XI
% 208.15/208.36 |- skos__altLabel mesh__D024161 Type XI Procollagen
% 208.15/208.36 |- skos__altLabel mesh__D024161 Collagen alpha1%28%XI%29%
% 208.15/208.36 |- mesh__dateCreated mesh__D024161 2001-07-25
% 208.15/208.36 |- skos__historyNote mesh__D024161 Collagen %28%1992-2001%29%
% 208.15/208.36 |- skos__scopeNote mesh__D024161
% 208.15/208.36 A fibrillar collagen found primarily in interstitial CARTILAGE. Collagen type XI is heterotrimer containing alpha1%28%XI%29%, alpha2%28%XI%29% and alpha3%28%XI%29% subunits.%A%
% 208.15/208.36 |- skos__broader mesh__D024161smesh__D024022
% 208.15/208.36 |- skos__altLabel mesh__D024161 Collagen Type-XI, alpha2 Chain
% 208.15/208.36 |- skos__annotation mesh__D024161
% 208.15/208.36 precursors: coord IM with PROCOLLAGEN %28%IM%29%
% 208.15/208.36 |- skos__altLabel mesh__D024161 Collagen alpha2%28%XI%29%
% 208.15/208.36 |- skos__prefLabel mesh__D018922 HL-60 Cells
% 208.15/208.36 |- mesh__dateEstablished mesh__D018922 1996-01-01
% 208.15/208.36 |- mesh__recordMaintainer mesh__D018922 sjn
% 208.15/208.36 |- skos__broader mesh__D018922smesh__D045744
% 208.15/208.36 |- mesh__recordOriginator mesh__D018922 AGS
% 208.15/208.36 |- skos__historyNote mesh__D018922 Cell Line %28%1979-1995%29%
% 208.15/208.36 |- skos__broader mesh__D018922smesh__D042381
% 208.15/208.36 |- mesh__dateCreated mesh__D018922 1995-06-08
% 208.15/208.36 |- skos__historyNote mesh__D018922 Tumor Cells, Cultured %28%1987-1995%29%
% 208.15/208.36 |- skos__hiddenLabel mesh__D018922 Cell, HL60
% 208.15/208.36 |- skos__altLabel mesh__D018922 HL60 Cells
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D018922 96
% 208.15/208.36 |- skos__scopeNote mesh__D018922
% 208.15/208.36 A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. %28%From Hay et al., American Type Culture Collection, 7th ed, pp127-8%29%%A%
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D018922 sjn
% 208.15/208.36 |- skos__hiddenLabel mesh__D018922 Cells, HL60
% 208.15/208.36 |- rdf__type mesh__D018922sskos__Concept
% 208.15/208.36 |- mesh__historyNote mesh__D018922 96
% 208.15/208.36 |- skos__hiddenLabel mesh__D018922 HL-60 Cell
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018922 2006
% 208.15/208.36 |- skos__hiddenLabel mesh__D018922 HL 60 Cells
% 208.15/208.36 |- mesh__dateRevised mesh__D018922 2005-07-01
% 208.15/208.36 |- skos__hiddenLabel mesh__D018922 HL60 Cell
% 208.15/208.36 |- skos__annotation mesh__D018922
% 208.15/208.36 almost always NIM with no subheadings; check HUMAN; do not routinely add LEUKEMIA, PROMYELOCYTIC, ACUTE%A%
% 208.15/208.36 |- skos__altLabel mesh__D018124 TNF Receptors
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D018124 sjn
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018124 2005
% 208.15/208.36 |- skos__altLabel mesh__D018124 Receptors, TNF
% 208.15/208.36 |- rdf__type mesh__D018124sskos__Concept
% 208.15/208.36 |- skos__altLabel mesh__D018124 Receptors, Cachectin
% 208.15/208.36 |- skos__historyNote mesh__D018124
% 208.15/208.36 Receptors, Cell Surface %28%1985-1993%29%
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D018124
% 208.15/208.36 94; TUMOR NECROSIS FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93%A%
% 208.15/208.36 |- skos__prefLabel mesh__D018124 Receptors, Tumor Necrosis Factor
% 208.15/208.36 |- skos__altLabel mesh__D018124 Cachectin Receptors
% 208.15/208.36 |- mesh__onlineNote mesh__D018124
% 208.15/208.36 use RECEPTORS, TUMOR NECROSIS FACTOR %28%NM%29% to search TUMOR NECROSIS FACTOR RECEPTOR 1985-93%A%
% 208.15/208.36 |- mesh__dateCreated mesh__D018124 1993-06-21
% 208.15/208.36 |- skos__annotation mesh__D018124 general; prefer specifics
% 208.15/208.36 |- skos__altLabel mesh__D018124 Tumor Necrosis Factor Receptors
% 208.15/208.36 |- skos__broader mesh__D018124smesh__D018121
% 208.15/208.36 |- mesh__historyNote mesh__D018124
% 208.15/208.36 94; was TUMOR NECROSIS FACTOR RECEPTOR %28%NM%29% 1985-93
% 208.15/208.36 |- skos__altLabel mesh__D018124 TNF Receptor
% 208.15/208.36 |- skos__scopeNote mesh__D018124
% 208.15/208.36 Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells.%A%
% 208.15/208.36 |- mesh__recordOriginator mesh__D018124 RAZ
% 208.15/208.36 |- skos__hiddenLabel mesh__D018124 Receptor, TNF
% 208.15/208.36 |- skos__altLabel mesh__D018124 Tumor Necrosis Factor Receptor
% 208.15/208.36 |- mesh__dateRevised mesh__D018124 2004-07-07
% 208.15/208.36 |- mesh__dateEstablished mesh__D018124 1994-01-01
% 208.15/208.36 |- mesh__recordMaintainer mesh__D018124 jmp
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018124 2006
% 208.15/208.36 |- mesh__onlineNote mesh__D010141
% 208.15/208.36 search MECHANORECEPTORS 1972-74 %26% NERVE ENDINGS 1966-71
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 2002
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D010141 PLS
% 208.15/208.36 |- mesh__recordOriginator mesh__D010141 NLM
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 2003
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D010141
% 208.15/208.36 91; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71%A%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 1997
% 208.15/208.36 |- skos__hiddenLabel mesh__D010141 Corpuscles, Pacinian
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 2006
% 208.15/208.36 |- mesh__dateCreated mesh__D010141 1999-01-01
% 208.15/208.36 |- mesh__dateRevised mesh__D010141 1993-06-30
% 208.15/208.36 |- mesh__recordMaintainer mesh__D010141 RAZ
% 208.15/208.36 |- mesh__dateEstablished mesh__D010141 1991-01-01
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 1996
% 208.15/208.36 |- skos__broader mesh__D010141smesh__D008465
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 2001
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 2005
% 208.15/208.36 |- skos__annotation mesh__D010141 mechanoreceptors
% 208.15/208.36 |- skos__prefLabel mesh__D010141 Pacinian Corpuscles
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 1999
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 1995
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 2000
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 1998
% 208.15/208.36 |- mesh__historyNote mesh__D010141
% 208.15/208.36 91%28%75%29%; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71%A%
% 208.15/208.36 |- rdf__type mesh__D010141sskos__Concept
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 1994
% 208.15/208.36 |- skos__scopeNote mesh__D010141
% 208.15/208.36 Rapidly adapting mechanoreceptors found in subcutaneous tissue beneath both hairy and glabrous skin. Pacinian corpuscles contain an afferent nerve fiber surrounded by a capsule with multiple concentric layers. They have large receptive fields and are most sensitive to high-frequency stimuli, such as vibration.%A%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010141 2004
% 208.15/208.36 |- skos__prefLabel mesh__D004902 Erythrocruorins
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 1996
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 1993
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 2004
% 208.15/208.36 |- mesh__recordMaintainer mesh__D004902 TAP
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D004902
% 208.15/208.36 91; was see under HEMOGLOBINS 1977-90
% 208.15/208.36 |- mesh__dateEstablished mesh__D004902 1991-01-01
% 208.15/208.36 |- skos__annotation mesh__D004902
% 208.15/208.36 in plasma of various annelids %26% mollusks
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 2002
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 1997
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D004902 PLS
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 2005
% 208.15/208.36 |- mesh__historyNote mesh__D004902
% 208.15/208.36 91%28%77%29%; was see under HEMOGLOBINS 1977-90
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 2000
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 1994
% 208.15/208.36 |- skos__broader mesh__D004902smesh__D006454
% 208.15/208.36 |- mesh__dateCreated mesh__D004902 1976-04-27
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 1998
% 208.15/208.36 |- skos__scopeNote mesh__D004902
% 208.15/208.36 High molecular weight %28%1,500,000 to 3,000,000%29% hemoglobins found in the plasma of many polychete and oligochete annelid worms and various mollusks. They bind one mole of oxygen per heme and function as oxygen carriers.%A%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 2006
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 2001
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 1995
% 208.15/208.36 |- mesh__dateRevised mesh__D004902 1992-05-19
% 208.15/208.36 |- mesh__recordOriginator mesh__D004902 RLS
% 208.15/208.36 |- skos__historyNote mesh__D004902 Hemeproteins %28%1973-1976%29%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 2003
% 208.15/208.36 |- rdf__type mesh__D004902sskos__Concept
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004902 1999
% 208.15/208.36 |- skos__hiddenLabel mesh__D051558 Transcription Factors, Onecut
% 208.15/208.36 |- mesh__recordOriginator mesh__D051558 DRC
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D051558 2006
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D051558 sjn
% 208.15/208.36 |- mesh__dateEstablished mesh__D051558 2006-01-01
% 208.15/208.36 |- rdf__type mesh__D051558sskos__Concept
% 208.15/208.36 |- skos__scopeNote mesh__D051558
% 208.15/208.36 A family of transcription factors that contain a single cut domain and a divergent homeodomain. They regulate gene networks by controlling the expression of other transcription factors and they play an important role in CELL DIFFERENTIATION and METABOLISM.%A%
% 208.15/208.36 |- mesh__recordMaintainer mesh__D051558 DRC
% 208.15/208.36 |- skos__broader mesh__D051558smesh__D018398
% 208.15/208.36 |- skos__altLabel mesh__D051558 Onecut Homeodomain Proteins
% 208.15/208.36 |- mesh__historyNote mesh__D051558 2006
% 208.15/208.36 |- skos__prefLabel mesh__D051558 Onecut Transcription Factors
% 208.15/208.36 |- skos__broader mesh__D051558smesh__D014157
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D051558 2006
% 208.15/208.36 |- mesh__dateCreated mesh__D051558 2005-06-30
% 208.15/208.36 |- skos__hiddenLabel mesh__D051558 Homeodomain Proteins, Onecut
% 208.15/208.36 |- skos__prefLabel mesh__D004104 Diiodothyronines
% 208.15/208.36 |- mesh__historyNote mesh__D004104
% 208.15/208.36 91%28%79%29%; was see under THYRONINES 1979-90
% 208.15/208.36 |- skos__broader mesh__D004104smesh__D013970
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D004104 2006
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D004104 sjn
% 208.15/208.36 |- mesh__dateEstablished mesh__D004104 1991-01-01
% 208.15/208.36 |- mesh__dateCreated mesh__D004104 1978-05-16
% 208.15/208.36 |- mesh__dateRevised mesh__D004104 2005-06-30
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D004104
% 208.15/208.36 91; was see under THYRONINES 1979-90
% 208.15/208.36 |- mesh__recordMaintainer mesh__D004104 SYSTEM
% 208.15/208.36 |- mesh__recordOriginator mesh__D004104 RLS
% 208.15/208.36 |- skos__historyNote mesh__D004104 Thyronines %28%1966-1978%29%
% 208.15/208.36 |- skos__scopeNote mesh__D004104
% 208.15/208.36 These metabolites of THYROXINE are formed by the deiodination of T3 or reverse T3.%A%
% 208.15/208.36 |- rdf__type mesh__D004104sskos__Concept
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 2000
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D009398 80
% 208.15/208.36 |- skos__broader mesh__D009398smesh__D007388
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D009398 PLS
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 2004
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 2005
% 208.15/208.36 |- mesh__recordOriginator mesh__D009398 EC
% 208.15/208.36 |- mesh__dateEstablished mesh__D009398 1980-01-01
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 2001
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 2006
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 1996
% 208.15/208.36 |- skos__prefLabel mesh__D009398 Nephrology
% 208.15/208.36 |- skos__scopeNote mesh__D009398
% 208.15/208.36 A subspecialty of internal medicine concerned with the anatomy, physiology, and pathology of the kidney.%A%
% 208.15/208.36 |- skos__related mesh__D009398smesh__D007674
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 1997
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 1998
% 208.15/208.36 |- skos__annotation mesh__D009398 SPEC; SPEC qualif; DF: NEPHROL
% 208.15/208.36 |- mesh__recordMaintainer mesh__D009398 JLS
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 1994
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 1999
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 2002
% 208.15/208.36 |- mesh__dateCreated mesh__D009398 1979-05-29
% 208.15/208.36 |- skos__historyNote mesh__D009398 Kidney Diseases %28%1966-1979%29%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 1995
% 208.15/208.36 |- mesh__historyNote mesh__D009398 80
% 208.15/208.36 |- rdf__type mesh__D009398sskos__Concept
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D009398 2003
% 208.15/208.36 |- mesh__dateRevised mesh__D009398 1993-06-04
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D014532 2006
% 208.15/208.36 |- skos__prefLabel mesh__D014532 Uridine Diphosphate Glucose
% 208.15/208.36 |- skos__broader mesh__D014532smesh__D014539
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D014532 sjn
% 208.15/208.36 |- skos__hiddenLabel mesh__D014532 Diphosphoglucose, Uridine
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D014532 2005
% 208.15/208.36 |- mesh__historyNote mesh__D014532
% 208.15/208.36 91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.15/208.36 |- mesh__dateRevised mesh__D014532 2004-07-07
% 208.15/208.36 |- skos__historyNote mesh__D014532
% 208.15/208.36 Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.15/208.36 |- mesh__recordOriginator mesh__D014532 NLM
% 208.15/208.36 |- mesh__recordMaintainer mesh__D014532 ssb
% 208.15/208.36 |- skos__hiddenLabel mesh__D014532 Glucose, UDP
% 208.15/208.36 |- mesh__dateEstablished mesh__D014532 1991-01-01
% 208.15/208.36 |- mesh__dateCreated mesh__D014532 1974-11-19
% 208.15/208.36 |- skos__hiddenLabel mesh__D014532 Diphosphate Glucose, Uridine
% 208.15/208.36 |- skos__altLabel mesh__D014532 UDPG
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D014532
% 208.15/208.36 91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.15/208.36 |- skos__hiddenLabel mesh__D014532 Glucose, Uridine Diphosphate
% 208.15/208.36 |- skos__altLabel mesh__D014532 Uridine Diphosphoglucose
% 208.15/208.36 |- rdf__type mesh__D014532sskos__Concept
% 208.15/208.36 |- skos__altLabel mesh__D014532 UDP Glucose
% 208.15/208.36 |- skos__historyNote mesh__D014532 Glucose %28%1973-1974%29%
% 208.15/208.36 |- skos__scopeNote mesh__D014532
% 208.15/208.36 A key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids.%A%
% 208.15/208.36 |- skos__broader mesh__D000512smesh__D009686
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D000512 2001
% 208.15/208.36 |- skos__altLabel mesh__D000512 Radiation, Alpha
% 208.15/208.36 |- skos__scopeNote mesh__D000512
% 208.15/208.36 Positively charged particles composed of two protons and two neutrons, i.e., helium nuclei, emitted during disintegration of very heavy isotopes; a beam of alpha particles or an alpha ray has very strong ionizing power, but weak penetrability.%A%
% 208.15/208.36 |- skos__hiddenLabel mesh__D000512 Particles, Alpha
% 208.15/208.36 |- skos__altLabel mesh__D000512 Alpha Radiation
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D000512 2006
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D000512 2000
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D000512 1999
% 208.15/208.36 |- skos__hiddenLabel mesh__D000512 Alpha Radiations
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D000512 2004
% 208.15/208.36 |- mesh__recordMaintainer mesh__D000512 TPW
% 208.15/208.36 |- mesh__historyNote mesh__D000512 66
% 208.15/208.36 |- mesh__recordOriginator mesh__D000512 NLM
% 208.15/208.36 |- mesh__dateRevised mesh__D000512 1997-06-20
% 208.15/208.36 |- skos__hiddenLabel mesh__D000512 Alpha Ray
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D000512 2005
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D000512 1998
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D000512 2003
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D000512 SJN
% 208.15/208.36 |- skos__annotation mesh__D000512
% 208.15/208.36 ionizing; radiation policy: see Manual index under RADIATION %26% entries following%A%
% 208.15/208.36 |- skos__hiddenLabel mesh__D000512 Ray, Alpha
% 208.15/208.36 |- skos__broader mesh__D000512smesh__D011839
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D000512 66
% 208.15/208.36 |- skos__hiddenLabel mesh__D000512 Particle, Alpha
% 208.15/208.36 |- skos__hiddenLabel mesh__D000512 Alpha Particle
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D000512 2002
% 208.15/208.36 |- skos__hiddenLabel mesh__D000512 Radiations, Alpha
% 208.15/208.36 |- mesh__dateEstablished mesh__D000512 1966-01-01
% 208.15/208.36 |- skos__prefLabel mesh__D000512 Alpha Particles
% 208.15/208.36 |- mesh__dateCreated mesh__D000512 1999-01-01
% 208.15/208.36 |- skos__hiddenLabel mesh__D000512 Rays, Alpha
% 208.15/208.36 |- rdf__type mesh__D000512sskos__Concept
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D024162 2003
% 208.15/208.36 |- mesh__dateEstablished mesh__D024162 2002-01-01
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D024162 2006
% 208.15/208.36 |- skos__altLabel mesh__D024162 Surgery, Second-Look
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D024162 2004
% 208.15/208.36 |- skos__broader mesh__D024162smesh__D013514
% 208.15/208.36 |- skos__scopeNote mesh__D024162
% 208.15/208.36 A followup operation to examine the outcome of the previous surgery and other treatments, such as chemotherapy or radiation therapy.%A%
% 208.15/208.36 |- skos__prefLabel mesh__D024162 Second-Look Surgery
% 208.15/208.36 |- mesh__historyNote mesh__D024162 2002
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D024162 2002
% 208.15/208.36 |- skos__historyNote mesh__D024162 Reoperation %28%1983-2001%29%
% 208.15/208.36 |- skos__hiddenLabel mesh__D024162 Second Look Surgery
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D024162 2002
% 208.15/208.36 |- skos__related mesh__D024162smesh__D012086
% 208.15/208.36 |- skos__hiddenLabel mesh__D024162 Surgery, Second Look
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D024162 2005
% 208.15/208.36 |- rdf__type mesh__D024162sskos__Concept
% 208.15/208.36 |- mesh__dateCreated mesh__D024162 2001-07-25
% 208.15/208.36 |- skos__hiddenLabel mesh__D018923 Syndrome, Persian Gulf
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018923 2002
% 208.15/208.36 |- skos__prefLabel mesh__D018923 Persian Gulf Syndrome
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018923 2004
% 208.15/208.36 |- skos__broader mesh__D018923smesh__D009784
% 208.15/208.36 |- skos__altLabel mesh__D018923 Gulf War Syndrome
% 208.15/208.36 |- mesh__dateEstablished mesh__D018923 1996-01-01
% 208.15/208.36 |- skos__annotation mesh__D018923
% 208.15/208.36 coord IM with specific dis or manifest %28%IM%29%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018923 2003
% 208.15/208.36 |- mesh__dateCreated mesh__D018923 1994-12-27
% 208.15/208.36 |- rdf__type mesh__D018923sskos__Concept
% 208.15/208.36 |- skos__scopeNote mesh__D018923
% 208.15/208.36 Unexplained symptoms reported by veterans of the Persian Gulf War with Iraq in 1991. The symptoms reported include fatigue, skin rash, muscle and joint pain, headaches, loss of memory, shortness of breath, gastrointestinal and respiratory symptoms, and extreme sensitivity to commonly occurring chemicals. %28%Nature 1994 May 5;369%28%6475%29%:8%29%%A%
% 208.15/208.36 |- mesh__historyNote mesh__D018923 96
% 208.15/208.36 |- skos__hiddenLabel mesh__D018923 Syndrome, Gulf War
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018923 2001
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018923 2006
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D018923 96
% 208.15/208.36 |- mesh__dateRevised mesh__D018923 1999-11-03
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018923 2000
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018923 2005
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D018923 sjn
% 208.15/208.36 |- mesh__recordOriginator mesh__D018923 TGC
% 208.15/208.36 |- mesh__recordMaintainer mesh__D018923 MCC
% 208.15/208.36 |- skos__scopeNote mesh__D010940
% 208.15/208.36 Proteins found in plants %28%flowers, herbs, shrubs, trees, etc.%29%. The concept does not include proteins found in vegetables for which VEGETABLE PROTEINS is available.%A%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010940 2006
% 208.15/208.36 |- skos__annotation mesh__D010940
% 208.15/208.36 dietary plant proteins: coord IM with specific plant %28%IM%29% + specific protein %28%IM%29% + DIETARY PROTEINS %28%IM%29% but note that VEGETABLE PROTEINS is available %28%see note there%29%; nutritive value of plant proteins: coord IM with specific protein %28%IM%29% + NUTRITIVE VALUE %28%NIM%29% but not also DIETARY PROTEINS%A%
% 208.15/208.36 |- skos__related mesh__D010940smesh__D010944
% 208.15/208.36 |- rdf__type mesh__D010940sskos__Concept
% 208.15/208.36 |- mesh__dateRevised mesh__D010940 2005-06-30
% 208.15/208.36 |- mesh__dateCreated mesh__D010940 1999-01-01
% 208.15/208.36 |- skos__prefLabel mesh__D010940 Plant Proteins
% 208.15/208.36 |- mesh__recordMaintainer mesh__D010940 SYSTEM
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D010940 sjn
% 208.15/208.36 |- mesh__recordOriginator mesh__D010940 NLM
% 208.15/208.36 |- skos__broader mesh__D010940smesh__D011506
% 208.15/208.36 |- skos__hiddenLabel mesh__D010940 Proteins, Plant
% 208.15/208.36 |- skos__altLabel mesh__D018125 Transforming Growth Factor beta Receptor
% 208.15/208.36 |- skos__altLabel mesh__D018125 Receptors, TGF-beta
% 208.15/208.36 |- mesh__recordOriginator mesh__D018125 RAZ
% 208.15/208.36 |- skos__hiddenLabel mesh__D018125 TGF beta Receptors
% 208.15/208.36 |- mesh__dateEstablished mesh__D018125 1994-01-01
% 208.15/208.36 |- rdf__type mesh__D018125sskos__Concept
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018125 2004
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D018125 sjn
% 208.15/208.36 |- mesh__onlineNote mesh__D018125
% 208.15/208.36 use RECEPTORS, TRANSFORMING GROWTH FACTOR BETA %28%NM%29% to search TRANSFORMING GROWTH FACTOR RECEPTOR, BETA 1986-93%A%
% 208.15/208.36 |- skos__hiddenLabel mesh__D018125 Receptors, TGF beta
% 208.15/208.36 |- skos__historyNote mesh__D018125
% 208.15/208.36 Receptors, Cell Surface %28%1986-1993%29%
% 208.15/208.36 |- skos__hiddenLabel mesh__D018125 Receptor, TGF-beta
% 208.15/208.36 |- skos__scopeNote mesh__D018125
% 208.15/208.36 Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action.%A%
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D018125
% 208.15/208.36 94; TRANSFORMING GROWTH FACTOR RECEPTOR, BETA 1986-93 was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1986-93%A%
% 208.15/208.36 |- skos__hiddenLabel mesh__D018125 TGF beta Receptor
% 208.15/208.36 |- skos__broader mesh__D018125smesh__D017978
% 208.15/208.36 |- skos__altLabel mesh__D018125 Transforming Growth Factor beta Receptors
% 208.15/208.36 |- mesh__dateRevised mesh__D018125 2003-07-09
% 208.15/208.36 |- skos__annotation mesh__D018125 DF: RECEPT TGF BETA
% 208.15/208.36 |- mesh__dateCreated mesh__D018125 1993-06-21
% 208.15/208.36 |- mesh__recordMaintainer mesh__D018125 jmp
% 208.15/208.36 |- mesh__historyNote mesh__D018125
% 208.15/208.36 94; was TRANSFORMING GROWTH FACTOR RECEPTOR, BETA %28%NM%29% 1986-93%A%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018125 2006
% 208.15/208.36 |- skos__prefLabel mesh__D018125 Receptors, Transforming Growth Factor beta
% 208.15/208.36 |- skos__broader mesh__D018125smesh__D018121
% 208.15/208.36 |- skos__altLabel mesh__D018125 TGF-beta Receptor
% 208.15/208.36 |- skos__altLabel mesh__D018125 TGF-beta Receptors
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D018125 2005
% 208.15/208.36 |- mesh__historyNote mesh__D010142
% 208.15/208.36 91%28%75%29%; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%A%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010142 2002
% 208.15/208.36 |- mesh__dateRevised mesh__D010142 1998-06-10
% 208.15/208.36 |- skos__historyNote mesh__D010142
% 208.15/208.36 Antibiotics, Antineoplastic %28%1972-1974%29%
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010142 2005
% 208.15/208.36 |- skos__prefLabel mesh__D010142 Pactamycin
% 208.15/208.36 |- skos__broader mesh__D010142smesh__D006883
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010142 2006
% 208.15/208.36 |- skos__scopeNote mesh__D010142
% 208.15/208.36 Antibiotic produced by Streptomyces pactum used as an antineoplastic agent. It is also used as a tool in biochemistry because it inhibits certain steps in protein synthesis.%A%
% 208.15/208.36 |- mesh__dateCreated mesh__D010142 1974-11-19
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010142 1999
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D010142
% 208.15/208.36 91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90
% 208.15/208.36 |- mesh__recordOriginator mesh__D010142 NLM
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010142 2000
% 208.15/208.36 |- mesh__dateEstablished mesh__D010142 1991-01-01
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010142 2003
% 208.15/208.36 |- rdf__type mesh__D010142sskos__Concept
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010142 2001
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D010142 SJN
% 208.15/208.36 |- mesh__recordMaintainer mesh__D010142 ADP
% 208.15/208.36 |- mesh__activeMeSHYear mesh__D010142 2004
% 208.15/208.36 |- mesh__publicMeSHNote mesh__D004903
% 208.15/208.36 1976; for ERYTHROCYTE AGGREGATION, INTRAVASCULAR see ERYTHROCYTE AGGREGATION, INTRAVASCULAR 1964-2003; for INTRAVASCULAR AGGLUTINATION see ERYTHROCYTE AGGREGATION, INTRAVASCULAR 1976-2003%A%
% 208.15/208.36 |- mesh__recordAuthorizer mesh__D004903 sjn
% 208.15/208.36 |- skos__hiddenLabel mesh__D004903 Erythrocyte Rouleaux Formations
% 208.15/208.36 |- mesh__dateRevised mesh__D004903 2003-07-09
% 208.15/208.36 |- skos__related mesh__D004903smesh__D018056
% 208.15/208.36 |- skos__hiddenLabel mesh__D004903 Erythrocyte Rouleaux Formation
% 208.15/208.36 |- skos__hiddenLabel mesh__D004903 Aggregation, Erythrocyte
% 208.15/208.36 |- skos__altLabel mesh__D004903 Intravascular Agglutination
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Rouleaux Formations, Erythrocyte
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004903 2005
% 208.15/208.37 |- skos__broader mesh__D004903smesh__D045123
% 208.15/208.37 |- skos__scopeNote mesh__D004903
% 208.15/208.37 The formation of clumps of RED BLOOD CELLS under low or non-flow conditions, resulting from the attraction forces between the red blood cells. The cells adhere to each other in rouleaux aggregates. Slight mechanical force, such as occurs in the circulation, is enough to disperse these aggregates. Stronger or weaker than normal aggregation may result from a variety of effects in the ERYTHROCYTE MEMBRANE or in BLOOD PLASMA. The degree of aggregation is affected by ERYTHROCYTE DEFORMABILITY, erythrocyte membrane sialylation, masking of negative surface charge by plasma proteins, etc. BLOOD VISCOSITY and the ERYTHROCYTE SEDIMENTATION RATE are affected by the amount of erythrocyte aggregation and are parameters used to measure the aggregation.%A%
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Aggregations, Intravascular Erythrocyte
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Agglutinations, Intravascular
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Erythrocyte Aggregations, Intravascular
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Intravascular Agglutinations
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004903 2006
% 208.15/208.37 |- skos__altLabel mesh__D004903 Intravascular Erythrocyte Aggregation
% 208.15/208.37 |- skos__historyNote mesh__D004903 Erythrocytes %28%1966-1975%29%
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Erythrocyte Aggregations
% 208.15/208.37 |- mesh__dateCreated mesh__D004903 1975-07-25
% 208.15/208.37 |- rdf__type mesh__D004903sskos__Concept
% 208.15/208.37 |- mesh__recordMaintainer mesh__D004903 nns
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Formations, Erythrocyte Rouleaux
% 208.15/208.37 |- mesh__recordOriginator mesh__D004903 SMB
% 208.15/208.37 |- skos__broader mesh__D004903smesh__D006403
% 208.15/208.37 |- skos__annotation mesh__D004903
% 208.15/208.37 coord with disease /blood, not disease /physiopathol; do not confuse with DISSEMINATED INTRAVASCULAR COAGULATION; DF: ERYTHROCYTE AGGREGATION INTRAVASC%A%
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Formation, Erythrocyte Rouleaux
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Aggregations, Erythrocyte
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Aggregation, Intravascular Erythrocyte
% 208.15/208.37 |- mesh__dateEstablished mesh__D004903 1976-01-01
% 208.15/208.37 |- mesh__historyNote mesh__D004903 1976
% 208.15/208.37 |- skos__prefLabel mesh__D004903 Erythrocyte Aggregation
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004903 2004
% 208.15/208.37 |- skos__hiddenLabel mesh__D004903 Intravascular Erythrocyte Aggregations
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D051559
% 208.15/208.37 2006; HEPATOCYTE NUCLEAR FACTOR 6 was indexed under TRANS-ACTIVATORS %26% HOMEODOMAIN PROTEINS 1996-2005%A%
% 208.15/208.37 |- skos__hiddenLabel mesh__D051559 Hepatocyte Nuclear Factor 6 Alpha
% 208.15/208.37 |- skos__broader mesh__D051559smesh__D051536
% 208.15/208.37 |- mesh__dateCreated mesh__D051559 2005-06-30
% 208.15/208.37 |- skos__altLabel mesh__D051559 HNF6alpha Transcription Factor
% 208.15/208.37 |- skos__broader mesh__D051559smesh__D051558
% 208.15/208.37 |- skos__scopeNote mesh__D051559
% 208.15/208.37 A onecut transcription factor that regulates expression of GENES involved in EMBRYONIC DEVELOPMENT of the PANCREAS and LIVER.%A%
% 208.15/208.37 |- rdf__type mesh__D051559sskos__Concept
% 208.15/208.37 |- skos__hiddenLabel mesh__D051559 Transcription Factor, HNF6
% 208.15/208.37 |- skos__hiddenLabel mesh__D051559 Transcription Factor, HNF6beta
% 208.15/208.37 |- mesh__recordMaintainer mesh__D051559 DRC
% 208.15/208.37 |- skos__altLabel mesh__D051559 HNF6 Transcription Factor
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D051559 sjn
% 208.15/208.37 |- mesh__historyNote mesh__D051559 2006%28%1996%29%
% 208.15/208.37 |- skos__prefLabel mesh__D051559 Hepatocyte Nuclear Factor 6
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D051559 2006
% 208.15/208.37 |- skos__hiddenLabel mesh__D051559 Transcription Factor, HNF6alpha
% 208.15/208.37 |- skos__hiddenLabel mesh__D051559 Hepatocyte Nuclear Factor 6 Beta
% 208.15/208.37 |- skos__altLabel mesh__D051559 HNF6beta Transcription Factor
% 208.15/208.37 |- mesh__recordOriginator mesh__D051559 DRC
% 208.15/208.37 |- mesh__dateEstablished mesh__D051559 2006-01-01
% 208.15/208.37 |- skos__scopeNote mesh__D004105
% 208.15/208.37 A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones %28%THYROXINE and TRIIODOTHYRONINE%29%.%A%
% 208.15/208.37 |- mesh__recordMaintainer mesh__D004105 nns
% 208.15/208.37 |- skos__broader mesh__D004105smesh__D013963
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004105 2002
% 208.15/208.37 |- mesh__recordOriginator mesh__D004105 NLM
% 208.15/208.37 |- skos__broader mesh__D004105smesh__D014443
% 208.15/208.37 |- rdf__type mesh__D004105sskos__Concept
% 208.15/208.37 |- mesh__dateCreated mesh__D004105 1999-01-01
% 208.15/208.37 |- skos__altLabel mesh__D004105 Iodogorgoic Acid
% 208.15/208.37 |- skos__hiddenLabel mesh__D004105 Acid, Iodogorgoic
% 208.15/208.37 |- skos__related mesh__D004105smesh__D011988
% 208.15/208.37 |- mesh__dateRevised mesh__D004105 2001-07-25
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D004105 sjn
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004105 2004
% 208.15/208.37 |- skos__prefLabel mesh__D004105 Diiodotyrosine
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004105 2006
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004105 2003
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004105 2005
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 1992
% 208.15/208.37 |- mesh__dateRevised mesh__D009399 1991-01-07
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D009399 79; was see under KIDNEY 1975-78
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 2002
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 1997
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 1998
% 208.15/208.37 |- skos__historyNote mesh__D009399 Kidney %28%1966-1972%29%
% 208.15/208.37 |- skos__hiddenLabel mesh__D009399 Nephron
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 1993
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 1994
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 1999
% 208.15/208.37 |- skos__prefLabel mesh__D009399 Nephrons
% 208.15/208.37 |- mesh__recordOriginator mesh__D009399 NLM
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 2000
% 208.15/208.37 |- mesh__dateCreated mesh__D009399 1999-01-01
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 1995
% 208.15/208.37 |- mesh__dateEstablished mesh__D009399 1979-01-01
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D009399 PLS
% 208.15/208.37 |- rdf__type mesh__D009399sskos__Concept
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 2003
% 208.15/208.37 |- mesh__historyNote mesh__D009399
% 208.15/208.37 79%28%73%29%; was see under KIDNEY 1975-78
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 2001
% 208.15/208.37 |- skos__broader mesh__D009399smesh__D007668
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 2004
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 2005
% 208.15/208.37 |- skos__scopeNote mesh__D009399
% 208.15/208.37 The functional units of the kidney, consisting of the glomerulus and the attached tubule.%A%
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 2006
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D009399 1996
% 208.15/208.37 |- mesh__recordMaintainer mesh__D009399 TGC
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Proto-Oncogenes, c-myb
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 v-myb Gene
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 c myb Genes
% 208.15/208.37 |- skos__altLabel mesh__D020570 myb Genes
% 208.15/208.37 |- skos__prefLabel mesh__D020570 Genes, myb
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Oncogenes, v-myb
% 208.15/208.37 |- skos__broader mesh__D020570smesh__D011519
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Oncogene, v-myb
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Proto-Oncogene, c-myb
% 208.15/208.37 |- skos__altLabel mesh__D020570 myb Oncogene
% 208.15/208.37 |- mesh__dateCreated mesh__D020570 1999-11-03
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 v myb Oncogenes
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Gene, c-myb
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 c myb Proto Oncogenes
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 myb Oncogenes
% 208.15/208.37 |- skos__historyNote mesh__D020570 Genes, Viral %28%1983-1999%29%
% 208.15/208.37 |- mesh__dateRevised mesh__D020570 2005-06-30
% 208.15/208.37 |- skos__altLabel mesh__D020570 v-myb Oncogenes
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Oncogenes, myb
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Genes, c-myb
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Gene, myb
% 208.15/208.37 |- mesh__recordMaintainer mesh__D020570 nns
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D020570 sjn
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 c-myb Gene
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 myb Gene
% 208.15/208.37 |- skos__altLabel mesh__D020570 c-myb Proto-Oncogenes
% 208.15/208.37 |- skos__historyNote mesh__D020570 Oncogenes %28%1983-1999%29%
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 v-myb Oncogene
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D020570 2006
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 v myb Genes
% 208.15/208.37 |- skos__scopeNote mesh__D020570
% 208.15/208.37 Retrovirus-associated DNA sequences %28%v-myb%29% originally isolated from the avian myeloblastosis and E26 leukemia viruses. The proto-oncogene c-myb codes for a nuclear protein involved in transcriptional regulation and appears to be essential for hematopoietic cell proliferation. The human myb gene is located at 6q22-23 on the short arm of chromosome 6. This is the point of break in translocations involved in T-cell acute lymphatic leukemia and in some ovarian cancers and melanomas. %28%From Ibelgaufts, Dictionary of Cytokines, 1995%29%.%A%
% 208.15/208.37 |- mesh__historyNote mesh__D020570 2000; use ONCOGENES 1985-1999
% 208.15/208.37 |- rdf__type mesh__D020570sskos__Concept
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Gene, v-myb
% 208.15/208.37 |- mesh__dateEstablished mesh__D020570 2000-01-01
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Oncogene, myb
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 c-myb Proto-Oncogene
% 208.15/208.37 |- skos__hiddenLabel mesh__D020570 Genes, v-myb
% 208.15/208.37 |- mesh__recordOriginator mesh__D020570 ags
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D020570 2000; use ONCOGENES 1985-1999
% 208.15/208.37 |- skos__scopeNote mesh__D014533
% 208.15/208.37 An enzyme that catalyzes the oxidation of UDPglucose to UDPglucuronate in the presence of NAD+. EC 1.1.1.22.%A%
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D014533 2005
% 208.15/208.37 |- skos__historyNote mesh__D014533 Glucose %28%1973-1974%29%
% 208.15/208.37 |- skos__historyNote mesh__D014533
% 208.15/208.37 Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.15/208.37 |- mesh__dateRevised mesh__D014533 2003-07-09
% 208.15/208.37 |- skos__annotation mesh__D014533 DF: note short X ref
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D014533
% 208.15/208.37 91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77%A%
% 208.15/208.37 |- skos__hiddenLabel mesh__D014533 Dehydrogenase, UDP Glucose
% 208.15/208.37 |- skos__broader mesh__D014533smesh__D002237
% 208.15/208.37 |- skos__altLabel mesh__D014533 UDPG Dehydrogenase
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D014533 sjn
% 208.15/208.37 |- mesh__dateEstablished mesh__D014533 1991-01-01
% 208.15/208.37 |- mesh__historyNote mesh__D014533
% 208.15/208.37 91%28%75%29%; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77%A%
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D014533 2004
% 208.15/208.37 |- skos__prefLabel mesh__D014533 Uridine Diphosphate Glucose Dehydrogenase
% 208.15/208.37 |- rdf__type mesh__D014533sskos__Concept
% 208.15/208.37 |- skos__altLabel mesh__D014533 UDP Glucose Dehydrogenase
% 208.15/208.37 |- mesh__recordOriginator mesh__D014533 NLM
% 208.15/208.37 |- skos__historyNote mesh__D014533
% 208.15/208.37 Alcohol Oxidoreductases %28%1973-1974%29%
% 208.15/208.37 |- skos__hiddenLabel mesh__D014533 Glucose Dehydrogenase, UDP
% 208.15/208.37 |- skos__hiddenLabel mesh__D014533 Dehydrogenase, UDPG
% 208.15/208.37 |- mesh__recordMaintainer mesh__D014533 ssb
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D014533 2006
% 208.15/208.37 |- mesh__dateCreated mesh__D014533 1974-11-19
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D000513 2006
% 208.15/208.37 |- skos__prefLabel mesh__D000513 Alpha Rhythm
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D000513 2004
% 208.15/208.37 |- skos__hiddenLabel mesh__D000513 Alpha Rhythms
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D000513 2005
% 208.15/208.37 |- skos__hiddenLabel mesh__D000513 Alpha Rhythm Electroencephalography
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D000513 2001
% 208.15/208.37 |- mesh__dateRevised mesh__D000513 1999-11-03
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D000513 2003
% 208.15/208.37 |- mesh__recordMaintainer mesh__D000513 KEV
% 208.15/208.37 |- skos__scopeNote mesh__D000513
% 208.15/208.37 One of four types of brain waves characterized by a relatively high voltage or amplitude and a frequency of 8-13 Hz. They constitute the majority of waves recorded by EEG registering the activity of the parietal and occipital lobes when the individual is awake, but relaxed with the eyes closed.%A%
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D000513 2000
% 208.15/208.37 |- skos__annotation mesh__D000513 in EEG
% 208.15/208.37 |- skos__hiddenLabel mesh__D000513 Encephalography, Alpha Rhythm
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D000513 74
% 208.15/208.37 |- mesh__recordOriginator mesh__D000513 NLM
% 208.15/208.37 |- mesh__dateEstablished mesh__D000513 1974-01-01
% 208.15/208.37 |- skos__historyNote mesh__D000513 Electroencephalography %28%1966-1971%29%
% 208.15/208.37 |- mesh__dateCreated mesh__D000513 1999-01-01
% 208.15/208.37 |- rdf__type mesh__D000513sskos__Concept
% 208.15/208.37 |- skos__hiddenLabel mesh__D000513 Rhythm, Alpha
% 208.15/208.37 |- skos__hiddenLabel mesh__D000513 Rhythms, Alpha
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D000513 2002
% 208.15/208.37 |- mesh__historyNote mesh__D000513 74%28%72%29%
% 208.15/208.37 |- skos__altLabel mesh__D000513 Alpha Rhythm Encephalography
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D000513 sjn
% 208.15/208.37 |- skos__broader mesh__D000513smesh__D004569
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D038981 sjn
% 208.15/208.37 |- skos__altLabel mesh__D038981 Collagen Receptor
% 208.15/208.37 |- skos__broader mesh__D038981smesh__D011956
% 208.15/208.37 |- mesh__historyNote mesh__D038981
% 208.15/208.37 2003; use RECEPTORS, COLLAGEN %28%NM%29% 1983-2002
% 208.15/208.37 |- mesh__recordOriginator mesh__D038981 MDJ
% 208.15/208.37 |- skos__scopeNote mesh__D038981
% 208.15/208.37 Collagen receptors are cell surface receptors that modulate signal transduction between cells and the EXTRACELLULAR MATRIX. They are found in many cell types and are involved in the maintenance and regulation of cell shape and behavior, including PLATELET ACTIVATION and aggregation, through many different signaling pathways and differences in their affinities for collagen isoforms. Collagen receptors include discoidin domain receptors, INTEGRINS, and glycoprotein VI.%A%
% 208.15/208.37 |- mesh__dateRevised mesh__D038981 2005-06-30
% 208.15/208.37 |- mesh__dateEstablished mesh__D038981 2003-01-01
% 208.15/208.37 |- skos__altLabel mesh__D038981 Collagen Receptors
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D038981 2006
% 208.15/208.37 |- skos__historyNote mesh__D038981 Integrins %28%1983-2002%29%
% 208.15/208.37 |- skos__hiddenLabel mesh__D038981 Receptor, Collagen
% 208.15/208.37 |- rdf__type mesh__D038981sskos__Concept
% 208.15/208.37 |- mesh__recordMaintainer mesh__D038981 jmp
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D038981
% 208.15/208.37 2003; COLLAGEN RECEPTOR was indexed under INTEGRINS 1983-2002%A%
% 208.15/208.37 |- mesh__dateCreated mesh__D038981 2002-07-03
% 208.15/208.37 |- skos__prefLabel mesh__D038981 Receptors, Collagen
% 208.15/208.37 |- skos__historyNote mesh__D018924 Vascular Resistance %28%1967-1995%29%
% 208.15/208.37 |- skos__prefLabel mesh__D018924 Vascular Capacitance
% 208.15/208.37 |- mesh__dateEstablished mesh__D018924 1996-01-01
% 208.15/208.37 |- skos__scopeNote mesh__D018924
% 208.15/208.37 The measure of a BLOOD VESSEL%27%s ability to increase the volume of BLOOD it holds without a large increase in BLOOD PRESSURE. The vascular capacitance is equal to the change in volume divided by the change in pressure.%A%
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018924 2004
% 208.15/208.37 |- skos__broader mesh__D018924smesh__D045472
% 208.15/208.37 |- rdf__type mesh__D018924sskos__Concept
% 208.15/208.37 |- skos__hiddenLabel mesh__D018924 Capacitance, Vascular
% 208.15/208.37 |- mesh__historyNote mesh__D018924 96
% 208.15/208.37 |- mesh__dateCreated mesh__D018924 1995-02-22
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D018924 96
% 208.15/208.37 |- mesh__dateRevised mesh__D018924 2003-07-09
% 208.15/208.37 |- skos__related mesh__D018924smesh__D014655
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018924 2006
% 208.15/208.37 |- skos__annotation mesh__D018924
% 208.15/208.37 do not confuse with VASCULAR RESISTANCE, opposition to blood flow in a vasc bed%A%
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018924 2005
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010941 2002
% 208.15/208.37 |- skos__altLabel mesh__D010941 Crown Gall
% 208.15/208.37 |- mesh__recordOriginator mesh__D010941 NLM
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010941 2001
% 208.15/208.37 |- rdf__type mesh__D010941sskos__Concept
% 208.15/208.37 |- mesh__dateCreated mesh__D010941 1999-01-01
% 208.15/208.37 |- skos__prefLabel mesh__D010941 Plant Tumors
% 208.15/208.37 |- skos__broader mesh__D010941smesh__D010935
% 208.15/208.37 |- skos__hiddenLabel mesh__D010941 Tumor, Plant
% 208.15/208.37 |- skos__hiddenLabel mesh__D010941 Plant Tumor
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010941 2000
% 208.15/208.37 |- mesh__recordMaintainer mesh__D010941 JLS
% 208.15/208.37 |- skos__altLabel mesh__D010941 Plant Galls
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D010941 SJN
% 208.15/208.37 |- skos__scopeNote mesh__D010941
% 208.15/208.37 A localized proliferation of plant tissue forming a swelling or outgrowth, commonly with a characteristic shape and unlike any organ of the normal plant. Plant tumors or galls usually form in response to the action of a pathogen or a pest. %28%Holliday, P., A Dictionary of Plant Pathology, 1989, p330%29%%A%
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010941 2004
% 208.15/208.37 |- skos__hiddenLabel mesh__D010941 Galls, Crown
% 208.15/208.37 |- skos__hiddenLabel mesh__D010941 Gall, Plant
% 208.15/208.37 |- mesh__dateRevised mesh__D010941 1997-06-20
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010941 2003
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010941 2006
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010941 1999
% 208.15/208.37 |- skos__hiddenLabel mesh__D010941 Tumors, Plant
% 208.15/208.37 |- skos__hiddenLabel mesh__D010941 Plant Gall
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010941 2005
% 208.15/208.37 |- skos__hiddenLabel mesh__D010941 Gall, Crown
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010941 1998
% 208.15/208.37 |- skos__hiddenLabel mesh__D010941 Crown Galls
% 208.15/208.37 |- skos__altLabel mesh__D010941 Galls, Plant
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018126 2003
% 208.15/208.37 |- skos__altLabel mesh__D018126 Odontogenic Dysplasia
% 208.15/208.37 |- skos__hiddenLabel mesh__D018126 Odontodysplasias
% 208.15/208.37 |- rdf__type mesh__D018126sskos__Concept
% 208.15/208.37 |- skos__hiddenLabel mesh__D018126 Tooth, Ghost
% 208.15/208.37 |- skos__hiddenLabel mesh__D018126 Teeth, Ghost
% 208.15/208.37 |- skos__prefLabel mesh__D018126 Odontodysplasia
% 208.15/208.37 |- mesh__historyNote mesh__D018126
% 208.15/208.37 94; ODONTOGENESIS IMPERFECTA was heading 1965-93
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018126 2004
% 208.15/208.37 |- skos__altLabel mesh__D018126 Ghost Teeth
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018126 2002
% 208.15/208.37 |- mesh__dateEstablished mesh__D018126 1994-01-01
% 208.15/208.37 |- skos__broader mesh__D018126smesh__D014071
% 208.15/208.37 |- skos__hiddenLabel mesh__D018126 Odontogenic Dysplasias
% 208.15/208.37 |- mesh__recordOriginator mesh__D018126 TGC
% 208.15/208.37 |- skos__scopeNote mesh__D018126
% 208.15/208.37 A localized arrested tooth development which appears to involve most commonly the anterior teeth, usually on one side of the midline, most often the maxillary central and lateral incisors. Roentgenographically, the teeth have a ghostlike appearance. Calcification and bits of prismatic enamel may be found in the pulp and the enamel is thin and absent in part. %28%Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A%
% 208.15/208.37 |- skos__hiddenLabel mesh__D018126 Dysplasia, Odontogenic
% 208.15/208.37 |- mesh__recordMaintainer mesh__D018126 kle
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018126 2005
% 208.15/208.37 |- skos__annotation mesh__D018126
% 208.15/208.37 an abnorm of tooth develop; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D018126 sjn
% 208.15/208.37 |- mesh__dateCreated mesh__D018126 1993-06-03
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018126 2000
% 208.15/208.37 |- mesh__onlineNote mesh__D018126
% 208.15/208.37 use ODONTODYSPLASIA to search ODONTOGENESIS IMPERFECTA 1966-93%A%
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018126 2006
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D018126 2001
% 208.15/208.37 |- skos__altLabel mesh__D018126 Ghost Tooth
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D018126
% 208.15/208.37 94; ODONTOGENESIS IMPERFECTA was heading 1965-93
% 208.15/208.37 |- skos__hiddenLabel mesh__D018126 Dysplasias, Odontogenic
% 208.15/208.37 |- mesh__dateRevised mesh__D018126 1999-11-03
% 208.15/208.37 |- skos__scopeNote mesh__D010143
% 208.15/208.37 A mitosporic fungal genus occasionally causing human diseases such as pulmonary infections, mycotic keratitis, endocarditis, and opportunistic infections. Its teleomorph is Byssochlamys.%A%
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D010143 2006
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D010143 91; see HYPHOMYCETES 1986-90
% 208.15/208.37 |- mesh__recordOriginator mesh__D010143 RC
% 208.15/208.37 |- mesh__historyNote mesh__D010143 91%28%86%29%
% 208.15/208.37 |- skos__broader mesh__D010143smesh__D003904
% 208.15/208.37 |- mesh__recordMaintainer mesh__D010143 SYSTEM
% 208.15/208.37 |- skos__prefLabel mesh__D010143 Paecilomyces
% 208.15/208.37 |- mesh__dateRevised mesh__D010143 2005-06-30
% 208.15/208.37 |- mesh__dateEstablished mesh__D010143 1991-01-01
% 208.15/208.37 |- rdf__type mesh__D010143sskos__Concept
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D010143 sjn
% 208.15/208.37 |- mesh__dateCreated mesh__D010143 1985-02-12
% 208.15/208.37 |- skos__annotation mesh__D010143
% 208.15/208.37 infection: coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%
% 208.15/208.37 |- skos__historyNote mesh__D010143 Hyphomycetes %28%1966-1985%29%
% 208.15/208.37 |- mesh__dateEstablished mesh__D004106 1976-01-01
% 208.15/208.37 |- skos__broader mesh__D004106smesh__D008919
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 1994
% 208.15/208.37 |- skos__scopeNote mesh__D004106 The act of dilating.
% 208.15/208.37 |- rdf__type mesh__D004106sskos__Concept
% 208.15/208.37 |- mesh__historyNote mesh__D004106
% 208.15/208.37 76%28%68%29%; was in Cat C %26% E 1968-75 %28%Prov 1968-74%29%; was see under PATHOLOGY 1975%A%
% 208.15/208.37 |- mesh__dateCreated mesh__D004106 1999-01-01
% 208.15/208.37 |- mesh__dateRevised mesh__D004106 1992-05-14
% 208.15/208.37 |- skos__related mesh__D004106smesh__D001451
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 2004
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D004106 76; was see under PATHOLOGY 1975
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 2002
% 208.15/208.37 |- mesh__recordOriginator mesh__D004106 NLM
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 2006
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 1997
% 208.15/208.37 |- skos__hiddenLabel mesh__D004106 Dilatations
% 208.15/208.37 |- skos__prefLabel mesh__D004106 Dilatation
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 2003
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 1999
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 2001
% 208.15/208.37 |- mesh__recordMaintainer mesh__D004106 TAP
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 1993
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 2005
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D004106 PLS
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 1996
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 1995
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 1998
% 208.15/208.37 |- skos__annotation mesh__D004106 note category
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D004106 2000
% 208.15/208.37 |- rdf__type mesh__D020571sskos__Concept
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 sis Oncogenes
% 208.15/208.37 |- skos__altLabel mesh__D020571 sis Oncogene
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Gene, c-sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 v sis Oncogenes
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Genes, v-sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 v-sis Gene
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D020571 2000; see ONCOGENES 1988-1999
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 c-sis Gene
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Gene, v-sis
% 208.15/208.37 |- mesh__historyNote mesh__D020571 2000; use ONCOGENES 1988-1999
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 c sis Proto Oncogenes
% 208.15/208.37 |- skos__broader mesh__D020571smesh__D011519
% 208.15/208.37 |- skos__altLabel mesh__D020571 Genes, PDGFB
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Proto-Oncogenes, c-sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 c sis Genes
% 208.15/208.37 |- skos__related mesh__D020571smesh__D020574
% 208.15/208.37 |- mesh__dateRevised mesh__D020571 2005-06-30
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 sis Gene
% 208.15/208.37 |- skos__altLabel mesh__D020571 c-sis Proto-Oncogenes
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 v-sis Oncogene
% 208.15/208.37 |- mesh__recordAuthorizer mesh__D020571 sjn
% 208.15/208.37 |- skos__altLabel mesh__D020571 sis Genes
% 208.15/208.37 |- skos__historyNote mesh__D020571 Oncogenes %28%1983-1999%29%
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Oncogenes, v-sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Genes, c-sis
% 208.15/208.37 |- skos__scopeNote mesh__D020571
% 208.15/208.37 Retrovirus-associated DNA sequences %28%v-sis%29% originally isolated from the simian sarcoma virus %28%SSV%29%. The proto-oncogene c-sis codes for a growth factor which is the B chain of PLATELET-DERIVED GROWTH FACTOR. v-sis or overexpression of c-sis causes tumorigenesis. The human sis gene is located at 22q12.3-13.1 on the long arm of chromosome 22.%A%
% 208.15/208.37 |- mesh__dateCreated mesh__D020571 1999-11-03
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Proto-Oncogene, c-sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Gene, sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 v sis Genes
% 208.15/208.37 |- skos__related mesh__D020571smesh__D020575
% 208.15/208.37 |- skos__prefLabel mesh__D020571 Genes, sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 PDGFB Genes
% 208.15/208.37 |- mesh__recordMaintainer mesh__D020571 nns
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 c-sis Proto-Oncogene
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Oncogene, v-sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Oncogenes, sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Gene, PDGFB
% 208.15/208.37 |- mesh__recordOriginator mesh__D020571 ags
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D020571 2006
% 208.15/208.37 |- mesh__dateEstablished mesh__D020571 2000-01-01
% 208.15/208.37 |- skos__altLabel mesh__D020571 v-sis Oncogenes
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 Oncogene, sis
% 208.15/208.37 |- skos__hiddenLabel mesh__D020571 PDGFB Gene
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 Epimerase, UDP Galactose
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 4-Epimerase, UDPglucose
% 208.15/208.37 |- skos__historyNote mesh__D014534
% 208.15/208.37 Carbohydrate Isomerases %28%1973-1974%29%
% 208.15/208.37 |- skos__historyNote mesh__D014534 Glucose %28%1973-1974%29%
% 208.15/208.37 |- mesh__recordOriginator mesh__D014534 NLM
% 208.15/208.37 |- mesh__dateRevised mesh__D014534 2003-07-09
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 UDP Glucose 4 Epimerase
% 208.15/208.37 |- mesh__publicMeSHNote mesh__D014534
% 208.15/208.37 98; see URIDINE DIPHOSPHATE GLUCOSE EPIMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90; UDPGALACTOSE 4-EPIMERASE %26% UPD-GALACTOSE 4-EPIMERASE were indexed under CARBOHYDRATE ISOMERASES 1977-96, GALACTOSE 1977-82, and UDPGLUCOSE 4-EPIMERASE 1977-98,%A%
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 UDPglucose 4 Epimerase
% 208.15/208.37 |- skos__altLabel mesh__D014534 UDP-Glucose 4-Epimerase
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 4-Epimerase, UDP-Galactose
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 UDP Galactose 4 Epimerase
% 208.15/208.37 |- skos__altLabel mesh__D014534 UDP Galactose Epimerase
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 Epimerase, UDP Glucose
% 208.15/208.37 |- skos__broader mesh__D014534smesh__D002238
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D014534 2004
% 208.15/208.37 |- skos__historyNote mesh__D014534 Galactose %28%1973-1974%29%
% 208.15/208.37 |- skos__altLabel mesh__D014534 UDP-Galactose 4-Epimerase
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 Galactose Epimerase, UDP
% 208.15/208.37 |- rdf__type mesh__D014534sskos__Concept
% 208.15/208.37 |- skos__related mesh__D014534smesh__D005693
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 Glucose Epimerase, UDP
% 208.15/208.37 |- skos__hiddenLabel mesh__D014534 UDPgalactose 4 Epimerase
% 208.15/208.37 |- skos__altLabel mesh__D014534 Uridine Diphosphate Glucose Epimerase
% 208.15/208.37 |- mesh__activeMeSHYear mesh__D014534 2005
% 208.15/208.37 |- skos__prefLabel mesh__D014534 UDPglucose 4-Epimerase
% 208.15/208.38 |- skos__scopeNote mesh__D014534
% 208.15/208.38 A necessary enzyme in the metabolism of galactose. It reversibly catalyzes the conversion of UDPglucose to UDPgalactose. NAD+ is an essential component for enzymatic activity. EC 5.1.3.2.%A%
% 208.15/208.38 |- mesh__dateCreated mesh__D014534 1974-11-11
% 208.15/208.38 |- skos__altLabel mesh__D014534 UDPgalactose 4-Epimerase
% 208.15/208.38 |- mesh__recordAuthorizer mesh__D014534 sjn
% 208.15/208.38 |- mesh__activeMeSHYear mesh__D014534 2006
% 208.15/208.38 |- mesh__recordMaintainer mesh__D014534 ssb
% 208.15/208.38 |- skos__hiddenLabel mesh__D014534 4-Epimerase, UDPgalactose
% 208.15/208.38 |- mesh__dateEstablished mesh__D014534 1991-01-01
% 208.15/208.38 |- skos__historyNote mesh__D014534
% 208.15/208.38 Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.15/208.38 |- skos__hiddenLabel mesh__D014534 4-Epimerase, UDP-Glucose
% 208.15/208.38 |- skos__altLabel mesh__D014534 UDP Glucose Epimerase
% 208.15/208.38 |- mesh__historyNote mesh__D014534
% 208.15/208.38 98%28%75%29%; for UDPGALACTOSE 4-EPIMERASE use GALACTOSE EPIMERASE %28%NM%29% 1977-98; for UDP-GALACTOSE 4-EPIPMERASE use GALACTOSE EPIMERASE %28%NM%29% 1977-98%A%
% 208.15/208.38 |- mesh__publicMeSHNote mesh__D000514 87
% 208.15/208.38 |- mesh__dateCreated mesh__D000514 1986-04-14
% 208.15/208.38 |- mesh__historyNote mesh__D000514 87
% 208.15/208.38 |- skos__scopeNote mesh__D000514
% 208.15/208.38 Glycoprotein found in alpha%28%1%29%-globulin region in human serum. It inhibits chymotrypsin-like proteinases in vivo and has cytotoxic killer-cell activity in vitro. The protein also has a role as an acute-phase protein and is active in the control of immunologic and inflammatory processes, and as a tumor marker. It is a member of the serpin superfamily.%A%
% 208.15/208.38 |- skos__broader mesh__D000514smesh__D006023
% 208.15/208.38 |- skos__historyNote mesh__D000514
% 208.15/208.38 Chymotrypsin/antagonists %26% inhibitors %28%1968-1986%29%
% 208.15/208.38 |- skos__prefLabel mesh__D000514 alpha 1-Antichymotrypsin
% 208.15/208.38 |- skos__broader mesh__D000514smesh__D000510
% 208.15/208.38 |- rdf__type mesh__D000514sskos__Concept
% 208.15/208.38 |- skos__historyNote mesh__D000514 Glycoproteins %28%1966-1986%29%
% 208.15/208.38 |- mesh__recordAuthorizer mesh__D000514 sjn
% 208.15/208.38 |- skos__hiddenLabel mesh__D000514 gp68, Glycoprotein
% 208.15/208.38 |- mesh__dateEstablished mesh__D000514 1987-01-01
% 208.15/208.38 |- mesh__dateRevised mesh__D000514 2004-07-13
% 208.15/208.38 |- mesh__recordMaintainer mesh__D000514 sjn
% 208.15/208.38 |- skos__altLabel mesh__D000514 alpha%28%1%29%-Antichymotrypsin
% 208.15/208.38 |- mesh__activeMeSHYear mesh__D000514 2006
% 208.15/208.38 |- skos__broader mesh__D000514smesh__D015843
% 208.15/208.38 |- skos__annotation mesh__D000514
% 208.15/208.38 a serpin %26% acute phase protein; /biosyn /physiol permitted%A%
% 208.15/208.38 |- skos__broader mesh__D000514smesh__D000209
% 208.15/208.38 |- skos__historyNote mesh__D000514 Protease Inhibitors %28%1979-1986%29%
% 208.15/208.38 |- mesh__recordOriginator mesh__D000514 RLS
% 208.15/208.38 |- mesh__activeMeSHYear mesh__D000514 2005
% 208.15/208.38 |- skos__hiddenLabel mesh__D000514 1-Antichymotrypsin, alpha
% 208.15/208.38 |- skos__hiddenLabel mesh__D000514 alpha 1 Antichymotrypsin
% 208.15/208.38 |- mesh__activeMeSHYear mesh__D038982 2006
% 208.15/208.38 |- mesh__publicMeSHNote mesh__D038982
% 208.15/208.38 2003; INTEGRIN ALPHA2BETA1 was indexed under INTEGRINS 1994-2002%A%
% 208.15/208.38 |- skos__altLabel mesh__D038982 alpha2beta1Integrin
% 208.15/208.38 |- skos__broader mesh__D038982smesh__D038981
% 208.15/208.38 |- skos__hiddenLabel mesh__D038982 Late Antigen-2, Very
% 208.15/208.38 |- skos__altLabel mesh__D038982 CD49b-CD29
% 208.15/208.38 |- skos__hiddenLabel mesh__D038982 VLA 2
% 208.15/208.38 |- skos__altLabel mesh__D038982
% 208.15/208.38 Platelet Membrane Glycoprotein Heterodimer Ia-IIa
% 208.15/208.38 |- skos__broader mesh__D038982smesh__D017469
% 208.15/208.38 |- skos__prefLabel mesh__D038982 Integrin alpha2beta1
% 208.15/208.38 |- rdf__type mesh__D038982sskos__Concept
% 208.15/208.38 |- skos__altLabel mesh__D038982 Very Late Antigen-2
% 208.15/208.38 |- skos__broader mesh__D038982smesh__D017474
% 208.15/208.38 |- skos__historyNote mesh__D038982 Integrins %28%1994-2002%29%
% 208.15/208.38 |- mesh__recordAuthorizer mesh__D038982 sjn
% 208.15/208.38 |- skos__hiddenLabel mesh__D038982 CD49b CD29
% 208.15/208.38 |- mesh__dateCreated mesh__D038982 2002-07-02
% 208.15/208.38 |- mesh__dateEstablished mesh__D038982 2003-01-01
% 208.15/208.38 |- skos__hiddenLabel mesh__D038982
% 208.15/208.38 Platelet Membrane Glycoprotein Heterodimer Ia IIa
% 208.15/208.38 |- mesh__historyNote mesh__D038982
% 208.15/208.38 2003; for VLA-2 use COLLAGEN RECEPTORS %28%NM%29% 1991-2002; for PLATELET MEMBRANE GLYCOPROTEIN HETERODIMER IA-IIA use COLLAGEN RECEPTORS %28%NM%29% 1992-2000; for INTEGRIN ALPHA2BETA1 %26% CD49B-CD29 use COLLAGEN RECEPTORS %28%NM%29% 1994-2002; for ALPHA2BETA1INTEGRIN use COLLAGEN RECEPTORS %28%NM%29% 2001-2002%A%
% 208.15/208.38 |- mesh__recordMaintainer mesh__D038982 jmp
% 208.15/208.38 |- skos__scopeNote mesh__D038982
% 208.15/208.38 An integrin found on fibroblasts, platelets, endothelial and epithelial cells, and lymphocytes where it functions as a receptor for COLLAGEN and LAMININ. Although originally referred to as the collagen receptor, it is one of several receptors for collagen. Ligand binding to integrin alpha2beta1 triggers a cascade of intracellular signaling, including activation of p38 MAP kinase.%A%
% 208.15/208.38 |- skos__hiddenLabel mesh__D038982 alpha2beta1, Integrin
% 208.15/208.38 |- skos__broader mesh__D038982smesh__D016029
% 208.15/208.38 |- skos__altLabel mesh__D038982 VLA-2
% 208.15/208.38 |- mesh__recordOriginator mesh__D038982 MDJ
% 208.15/208.38 |- mesh__dateRevised mesh__D038982 2005-06-30
% 208.15/208.38 |- skos__hiddenLabel mesh__D038982 Glycoprotein Ia IIa
% 208.15/208.38 |- skos__broader mesh__D038982smesh__D010980
% 208.15/208.38 |- skos__hiddenLabel mesh__D038982 Very Late Antigen 2
% 208.15/208.38 |- skos__historyNote mesh__D038982 Collagen Receptors %28%1991-2002%29%
% 208.15/208.38 |- skos__altLabel mesh__D038982 Glycoprotein Ia-IIa
% 208.15/208.38 |- rdf__type mesh__D018925sskos__Concept
% 208.15/208.38 |- mesh__recordAuthorizer mesh__D018925 sjn
% 208.15/208.38 |- mesh__historyNote mesh__D018925 96
% 208.15/208.38 |- skos__broader mesh__D018925smesh__D002630
% 208.15/208.38 |- skos__annotation mesh__D018925
% 208.15/208.38 a class of cytokines that attract %26% activate leukocytes; chemokines stands for CHEMOtactic cytoKINES; GEN or unspecified; prefer specifics%A%
% 208.15/208.38 |- skos__prefLabel mesh__D018925 Chemokines
% 208.15/208.38 |- mesh__activeMeSHYear mesh__D018925 2006
% 208.15/208.38 |- mesh__dateEstablished mesh__D018925 1996-01-01
% 208.15/208.38 |- mesh__recordMaintainer mesh__D018925 ssb
% 208.15/208.38 |- skos__altLabel mesh__D018925 Intercrines
% 208.15/208.38 |- skos__altLabel mesh__D018925 Chemotactic Cytokines
% 208.15/208.38 |- skos__historyNote mesh__D018925 Cytokines %28%1992-1995%29%
% 208.15/208.38 |- skos__historyNote mesh__D018925 Chemotactic Factors %28%1992-1995%29%
% 208.15/208.38 |- skos__altLabel mesh__D018925 Cytokines, Chemotactic
% 208.15/208.38 |- mesh__recordOriginator mesh__D018925 AGS
% 208.15/208.38 |- skos__broader mesh__D018925smesh__D016207
% 208.15/208.38 |- skos__related mesh__D018925smesh__D002634
% 208.15/208.38 |- skos__broader mesh__D018925smesh__D018836
% 208.15/208.38 |- mesh__dateCreated mesh__D018925 1995-02-17
% 208.15/208.38 |- mesh__dateRevised mesh__D018925 2005-06-30
% 208.15/208.38 |- skos__scopeNote mesh__D018925
% 208.15/208.38 Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; %28%CHEMOKINES, C%29%; CC; %28%CHEMOKINES, CC%29%; and CXC; %28%CHEMOKINES, CXC%29%; according to variations in a shared cysteine motif.%A%
% 208.15/208.38 |- mesh__publicMeSHNote mesh__D018925 96
% 208.15/208.38 |- rdf__type mesh__D010942sskos__Concept
% 208.24/208.38 |- mesh__historyNote mesh__D010942
% 208.24/208.38 PHYTOPHAGINEAE was see under PLANT VIRUSES 1963-78
% 208.24/208.38 |- skos__hiddenLabel mesh__D010942 Virus, Plant
% 208.24/208.38 |- mesh__dateRevised mesh__D010942 1995-03-13
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 2002
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 2004
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 1997
% 208.24/208.38 |- skos__altLabel mesh__D010942 Phytophagineae
% 208.24/208.38 |- mesh__recordAuthorizer mesh__D010942 PLS
% 208.24/208.38 |- skos__annotation mesh__D010942
% 208.24/208.38 GEN or unspecified; prefer specifics; coord IM with specific plant /virol %28%IM or NIM%29%%A%
% 208.24/208.38 |- skos__hiddenLabel mesh__D010942 Viruses, Plant
% 208.24/208.38 |- skos__prefLabel mesh__D010942 Plant Viruses
% 208.24/208.38 |- skos__hiddenLabel mesh__D010942 Plant Virus
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 2001
% 208.24/208.38 |- mesh__recordOriginator mesh__D010942 NLM
% 208.24/208.38 |- mesh__recordMaintainer mesh__D010942 TGC
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D010942
% 208.24/208.38 PHYTOPHAGINEAE was see under PLANT VIRUSES 1963-78
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 2006
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 2003
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 1999
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 1996
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 2000
% 208.24/208.38 |- skos__scopeNote mesh__D010942
% 208.24/208.38 Viruses parasitic on plants higher than bacteria.
% 208.24/208.38 |- skos__broader mesh__D010942smesh__D014780
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 2005
% 208.24/208.38 |- mesh__onlineNote mesh__D010942
% 208.24/208.38 use PLANT VIRUSES to search PHYTOPHAGINEAE 1966-78
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010942 1998
% 208.24/208.38 |- mesh__dateCreated mesh__D010942 1999-01-01
% 208.24/208.38 |- skos__historyNote mesh__D018127 Antigens, CD %28%1989-1993%29%
% 208.24/208.38 |- skos__broader mesh__D018127smesh__D018124
% 208.24/208.38 |- skos__broader mesh__D018127smesh__D000945
% 208.24/208.38 |- skos__hiddenLabel mesh__D018127 Antigen, T-Cell Activation
% 208.24/208.38 |- mesh__dateRevised mesh__D018127 2005-06-30
% 208.24/208.38 |- skos__hiddenLabel mesh__D018127 Activation Antigen, T-Cell
% 208.24/208.38 |- skos__altLabel mesh__D018127 Antigen, CD27
% 208.24/208.38 |- skos__hiddenLabel mesh__D018127 Receptor, TNFRSF7
% 208.24/208.38 |- mesh__recordOriginator mesh__D018127 AGS
% 208.24/208.38 |- skos__altLabel mesh__D018127 T-Cell Activation Antigen
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D018127
% 208.24/208.38 94; CD27 ANTIGEN was indexed under ANTIGENS, CD %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989-93; T-CELL ACTIVATION ANTIGEN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1983-93%A%
% 208.24/208.38 |- skos__hiddenLabel mesh__D018127 T Cell Activation Antigen
% 208.24/208.38 |- mesh__dateEstablished mesh__D018127 1994-01-01
% 208.24/208.38 |- skos__prefLabel mesh__D018127 Antigens, CD27
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D018127 2006
% 208.24/208.38 |- mesh__historyNote mesh__D018127
% 208.24/208.38 94; was CD27 ANTIGEN %28%NM%29% 1989-93; T-CELL ACTIVATION ANTIGEN was T CELL ACTIVATION ANTIGEN %28%NM%29% 1983-93%A%
% 208.24/208.38 |- skos__historyNote mesh__D018127
% 208.24/208.38 Antigens, Differentiation, T-Lymphocyte %28%1989-1993%29%
% 208.24/208.38 |- skos__broader mesh__D018127smesh__D015703
% 208.24/208.38 |- mesh__dateCreated mesh__D018127 1993-06-04
% 208.24/208.38 |- skos__hiddenLabel mesh__D018127 CD27 Antigen
% 208.24/208.38 |- skos__altLabel mesh__D018127 TNFRSF7 Receptor
% 208.24/208.38 |- mesh__onlineNote mesh__D018127
% 208.24/208.38 use ANTIGENS, CD27 %28%NM%29% to search CD27 ANTIGEN 1989-93 and T CELL ACTIVATION ANTIGEN 1983-93%A%
% 208.24/208.38 |- mesh__recordAuthorizer mesh__D018127 sjn
% 208.24/208.38 |- skos__altLabel mesh__D018127
% 208.24/208.38 Tumor Necrosis Factor Receptor Superfamily, Member 7
% 208.24/208.38 |- mesh__recordMaintainer mesh__D018127 ssb
% 208.24/208.38 |- skos__scopeNote mesh__D018127
% 208.24/208.38 A member of the tumor necrosis factor receptor superfamily found on most T-LYMPHOCYTES. Activation of T-cells by the receptor increases CD27 surface expression and T cell expansion.%A%
% 208.24/208.38 |- rdf__type mesh__D018127sskos__Concept
% 208.24/208.38 |- skos__altLabel mesh__D018127 CD27 Antigens
% 208.24/208.38 |- skos__broader mesh__D018100Q000819smesh__D018100
% 208.24/208.38 |- mesh__preferredCombination mesh__D018100Q000819smesh__D017442
% 208.24/208.38 |- rdf__type mesh__D018100Q000819smesh__CompoundConcept
% 208.24/208.38 |- skos__altLabel mesh__D010144 Mammary Paget%27%s Disease
% 208.24/208.38 |- skos__prefLabel mesh__D010144 Paget%27%s Disease, Mammary
% 208.24/208.38 |- skos__hiddenLabel mesh__D010144 Pagets Disease, Mammary
% 208.24/208.38 |- mesh__recordOriginator mesh__D010144 NLM
% 208.24/208.38 |- skos__altLabel mesh__D010144 Mammary Paget Disease
% 208.24/208.38 |- rdf__type mesh__D010144sskos__Concept
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 2003
% 208.24/208.38 |- skos__scopeNote mesh__D010144
% 208.24/208.38 An intraductal carcinoma of the breast extending to involve the nipple and areola, characterized clinically by eczema-like inflammatory skin changes and histologically by infiltration of the dermis by malignant cells %28%Paget%27%s cells%29%. %28%Dorland, 27th ed%29%%A%
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 2000
% 208.24/208.38 |- mesh__dateCreated mesh__D010144 1999-01-01
% 208.24/208.38 |- skos__altLabel mesh__D010144 Paget Disease, Mammary
% 208.24/208.38 |- mesh__historyNote mesh__D010144
% 208.24/208.38 94; was PAGET%27%S DISEASE OF BREAST 1975-93 %28%see under CARCINOMA, DUCTAL 1975-90%29%%A%
% 208.24/208.38 |- skos__hiddenLabel mesh__D010144 Disease, Mammary Paget%27%s
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 2004
% 208.24/208.38 |- mesh__dateEstablished mesh__D010144 1991-01-01
% 208.24/208.38 |- skos__altLabel mesh__D010144 Paget Disease of Breast
% 208.24/208.38 |- skos__annotation mesh__D010144
% 208.24/208.38 neoplastic; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BREAST NEOPLASMS %28%IM%29%%A%
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 1996
% 208.24/208.38 |- mesh__dateRevised mesh__D010144 1995-06-08
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 2001
% 208.24/208.38 |- mesh__onlineNote mesh__D010144
% 208.24/208.38 use PAGET%27%S DISEASE, MAMMARY to search PAGET%27%S DISEASE OF BREAST 1975-93; search CARCINOMA, INTRADUCTAL, NONINFILTRATING 1966-74%A%
% 208.24/208.38 |- skos__altLabel mesh__D010144 Paget%27%s Disease of Breast
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 2005
% 208.24/208.38 |- mesh__recordMaintainer mesh__D010144 KEV
% 208.24/208.38 |- skos__hiddenLabel mesh__D010144 Pagets Disease, Breast
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 1997
% 208.24/208.38 |- skos__hiddenLabel mesh__D010144 Mammary Pagets Disease
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 2002
% 208.24/208.38 |- mesh__recordAuthorizer mesh__D010144 PLS
% 208.24/208.38 |- skos__hiddenLabel mesh__D010144 Paget Disease, Breast
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 2006
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 1998
% 208.24/208.38 |- skos__hiddenLabel mesh__D010144 Disease, Mammary Paget
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D010144
% 208.24/208.38 94; was PAGET%27%S DISEASE OF BREAST 1975-93 %28%see under CARCINOMA, DUCTAL 1975-90%29%%A%
% 208.24/208.38 |- skos__broader mesh__D010144smesh__D002285
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D010144 1999
% 208.24/208.38 |- mesh__recordMaintainer mesh__D004905 nns
% 208.24/208.38 |- mesh__dateEstablished mesh__D004905 1967-01-01
% 208.24/208.38 |- skos__broader mesh__D004905smesh__D045123
% 208.24/208.38 |- skos__annotation mesh__D004905
% 208.24/208.38 coord with disease /blood, not /physiopathol
% 208.24/208.38 |- mesh__historyNote mesh__D004905 67%28%65%29%
% 208.24/208.38 |- skos__prefLabel mesh__D004905 Erythrocyte Aging
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004905 2006
% 208.24/208.38 |- mesh__recordOriginator mesh__D004905 NLM
% 208.24/208.38 |- skos__hiddenLabel mesh__D004905 Survival, Erythrocyte
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004905 2004
% 208.24/208.38 |- rdf__type mesh__D004905sskos__Concept
% 208.24/208.38 |- mesh__dateCreated mesh__D004905 1999-01-01
% 208.24/208.38 |- skos__scopeNote mesh__D004905
% 208.24/208.38 The senescence of RED BLOOD CELLS. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.%A%
% 208.24/208.38 |- mesh__recordAuthorizer mesh__D004905 sjn
% 208.24/208.38 |- skos__hiddenLabel mesh__D004905 Aging, Erythrocyte
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004905 2005
% 208.24/208.38 |- skos__broader mesh__D004905smesh__D016922
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D004905 67
% 208.24/208.38 |- mesh__dateRevised mesh__D004905 2003-07-09
% 208.24/208.38 |- skos__altLabel mesh__D004107 Dilatation %26% Curettage
% 208.24/208.38 |- skos__prefLabel mesh__D004107 Dilatation and Curettage
% 208.24/208.38 |- rdf__type mesh__D004107sskos__Concept
% 208.24/208.38 |- skos__broader mesh__D004107smesh__D013509
% 208.24/208.38 |- skos__scopeNote mesh__D004107
% 208.24/208.38 Dilatation of the cervix uteri followed by a scraping of the endometrium with a curette.%A%
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D004107 75
% 208.24/208.38 |- mesh__historyNote mesh__D004107 75
% 208.24/208.38 |- mesh__recordOriginator mesh__D004107 NLM
% 208.24/208.38 |- mesh__recordMaintainer mesh__D004107 PXP
% 208.24/208.38 |- mesh__dateRevised mesh__D004107 1997-06-20
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004107 2002
% 208.24/208.38 |- mesh__dateCreated mesh__D004107 1974-11-19
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004107 2004
% 208.24/208.38 |- mesh__recordAuthorizer mesh__D004107 SJN
% 208.24/208.38 |- skos__broader mesh__D004107smesh__D003475
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004107 2001
% 208.24/208.38 |- skos__altLabel mesh__D004107 Curettage and Dilatation
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004107 1999
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004107 2003
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004107 2006
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004107 2000
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004107 1998
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D004107 2005
% 208.24/208.38 |- skos__historyNote mesh__D004107 Curettage %28%1966-1974%29%
% 208.24/208.38 |- skos__altLabel mesh__D004107 D%26%C
% 208.24/208.38 |- skos__annotation mesh__D004107
% 208.24/208.38 do not use /util except by MeSH definition; DF: D %26% C
% 208.24/208.38 |- mesh__dateEstablished mesh__D004107 1975-09-01
% 208.24/208.38 |- skos__altLabel mesh__D020572 v-rel Proteins
% 208.24/208.38 |- skos__broader mesh__D020572smesh__D015682
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 Oncogene Products v rel
% 208.24/208.38 |- skos__altLabel mesh__D020572 Oncogene Protein rel
% 208.24/208.38 |- mesh__dateEstablished mesh__D020572 2000-01-01
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 rel, Oncogene Proteins
% 208.24/208.38 |- skos__historyNote mesh__D020572
% 208.24/208.38 Retroviridae Proteins, Oncogenic %28%1990-1999%29%
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 Oncogene Proteins, rel
% 208.24/208.38 |- mesh__recordOriginator mesh__D020572 ags
% 208.24/208.38 |- mesh__historyNote mesh__D020572
% 208.24/208.38 2000; use ONCOGENE PROTEINS V-REL %28%NM%29% 1988-1999
% 208.24/208.38 |- mesh__dateRevised mesh__D020572 2005-06-30
% 208.24/208.38 |- mesh__recordMaintainer mesh__D020572 SYSTEM
% 208.24/208.38 |- skos__historyNote mesh__D020572
% 208.24/208.38 Oncogene Proteins, Viral %28%1986-1987%29%
% 208.24/208.38 |- skos__altLabel mesh__D020572 rel Oncogene Proteins
% 208.24/208.38 |- mesh__dateCreated mesh__D020572 1999-11-03
% 208.24/208.38 |- skos__prefLabel mesh__D020572 Oncogene Proteins v-rel
% 208.24/208.38 |- skos__scopeNote mesh__D020572
% 208.24/208.38 Transforming proteins coded by rel oncogenes. The v-rel protein competes with rel-related proteins and probably transforms cells by acting as a dominant negative version of c-rel. This results in the induction of a broad range of leukemias and lymphomas.%A%
% 208.24/208.38 |- mesh__recordAuthorizer mesh__D020572 sjn
% 208.24/208.38 |- skos__altLabel mesh__D020572 Oncogene Products v-rel
% 208.24/208.38 |- skos__related mesh__D020572smesh__D020573
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D020572
% 208.24/208.38 2000; ONCOGENE PROTEIN REL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999 %26% RETROVIRIDAE PROTEINS 1988-1989%A%
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 Proteins, v-rel
% 208.24/208.38 |- skos__altLabel mesh__D020572 v-rel Protein
% 208.24/208.38 |- skos__altLabel mesh__D020572 Oncogene Proteins rel
% 208.24/208.38 |- skos__altLabel mesh__D020572 pp59%28%v-rel%29%
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 v-rel, Oncogene Proteins
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D020572 2006
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 v rel Protein
% 208.24/208.38 |- skos__altLabel mesh__D020572 Oncogene Protein pp59%28%v-rel%29%
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 v rel Proteins
% 208.24/208.38 |- rdf__type mesh__D020572sskos__Concept
% 208.24/208.38 |- skos__historyNote mesh__D020572 Retroviridae Proteins %28%1988-1989%29%
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 rel, Oncogene Protein
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 Protein, v-rel
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 v-rel, Oncogene Products
% 208.24/208.38 |- skos__hiddenLabel mesh__D020572 Oncogene Proteins v rel
% 208.24/208.38 |- skos__hiddenLabel mesh__D014535 Acid, Uridine Diphosphoglucuronic
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D014535 2006
% 208.24/208.38 |- mesh__dateCreated mesh__D014535 1974-11-19
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D014535
% 208.24/208.38 91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.24/208.38 |- skos__hiddenLabel mesh__D014535 Acid, UDP Glucuronic
% 208.24/208.38 |- skos__altLabel mesh__D014535 UDPGA
% 208.24/208.38 |- rdf__type mesh__D014535sskos__Concept
% 208.24/208.38 |- skos__hiddenLabel mesh__D014535 Diphosphoglucuronic Acid, Uridine
% 208.24/208.38 |- skos__historyNote mesh__D014535 Glucuronates %28%1973-1974%29%
% 208.24/208.38 |- skos__altLabel mesh__D014535 Uridine Diphosphoglucuronic Acid
% 208.24/208.38 |- skos__related mesh__D014535smesh__D020719
% 208.24/208.38 |- skos__hiddenLabel mesh__D014535 Glucuronic Acid, UDP
% 208.24/208.38 |- skos__prefLabel mesh__D014535 Uridine Diphosphate Glucuronic Acid
% 208.24/208.38 |- mesh__recordAuthorizer mesh__D014535 sjn
% 208.24/208.38 |- skos__altLabel mesh__D014535 UDP Glucuronic Acid
% 208.24/208.38 |- mesh__recordMaintainer mesh__D014535 ssb
% 208.24/208.38 |- mesh__historyNote mesh__D014535
% 208.24/208.38 91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.24/208.38 |- skos__historyNote mesh__D014535
% 208.24/208.38 Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.24/208.38 |- mesh__dateRevised mesh__D014535 2004-07-07
% 208.24/208.38 |- mesh__dateEstablished mesh__D014535 1991-01-01
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D014535 2005
% 208.24/208.38 |- skos__scopeNote mesh__D014535
% 208.24/208.38 A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones.%A%
% 208.24/208.38 |- skos__broader mesh__D014535smesh__D014539
% 208.24/208.38 |- mesh__recordOriginator mesh__D014535 NLM
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 alpha 1 Proteinase Inhibitor
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 1-Antiproteinase, alpha
% 208.24/208.38 |- rdf__type mesh__D000515sskos__Concept
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D000515 74
% 208.24/208.38 |- mesh__recordOriginator mesh__D000515 NLM
% 208.24/208.38 |- skos__altLabel mesh__D000515 alpha 1-Proteinase Inhibitor
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 Antiprotease, alpha 1
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 alpha 1 Proteinase Inhibitor S
% 208.24/208.38 |- skos__scopeNote mesh__D000515
% 208.24/208.38 Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Commonly referred to as alpha 1-proteinase inhibitor %28%A1PI%29%, it exists in over 30 different biochemical variant forms known collectively as the Pi %28%protease inhibitor%29% system. Hereditary A1PI deficiency is associated with PULMONARY EMPHYSEMA.%A%
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 Trypsin Inhibitor, alpha 1 Antitrypsin
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 Inhibitor, alpha 1-Protease
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D000515 2006
% 208.24/208.38 |- skos__prefLabel mesh__D000515 alpha 1-Antitrypsin
% 208.24/208.38 |- skos__related mesh__D000515smesh__D019896
% 208.24/208.38 |- skos__broader mesh__D000515smesh__D015843
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 Inhibitor, alpha 1-Proteinase
% 208.24/208.38 |- skos__altLabel mesh__D000515 A1PI
% 208.24/208.38 |- skos__broader mesh__D000515smesh__D000510
% 208.24/208.38 |- mesh__historyNote mesh__D000515 74
% 208.24/208.38 |- mesh__recordAuthorizer mesh__D000515 sjn
% 208.24/208.38 |- mesh__dateRevised mesh__D000515 2004-07-07
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D000515 2005
% 208.24/208.38 |- skos__altLabel mesh__D000515 alpha 1-Antiproteinase
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 alpha 1 Antiproteinase
% 208.24/208.38 |- skos__broader mesh__D000515smesh__D000209
% 208.24/208.38 |- skos__altLabel mesh__D000515 alpha 1-Protease Inhibitor
% 208.24/208.38 |- skos__altLabel mesh__D000515 alpha 1 Antiprotease
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 alpha 1 Proteinase Inhibitor F
% 208.24/208.38 |- mesh__recordMaintainer mesh__D000515 jmp
% 208.24/208.38 |- mesh__dateEstablished mesh__D000515 1974-01-01
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 alpha 1 Protease Inhibitor
% 208.24/208.38 |- mesh__dateCreated mesh__D000515 1999-01-01
% 208.24/208.38 |- skos__altLabel mesh__D000515 Trypsin Inhibitor, alpha 1-Antitrypsin
% 208.24/208.38 |- skos__hiddenLabel mesh__D000515 alpha 1 Antitrypsin
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 2002
% 208.24/208.38 |- skos__altLabel mesh__D019220 HESW
% 208.24/208.38 |- skos__hiddenLabel mesh__D019220 Shock Wave, High-Energy
% 208.24/208.38 |- mesh__dateEstablished mesh__D019220 1997-01-01
% 208.24/208.38 |- skos__related mesh__D019220smesh__D008096
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 1998
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 2003
% 208.24/208.38 |- skos__hiddenLabel mesh__D019220 Shock Waves, High Energy
% 208.24/208.38 |- skos__annotation mesh__D019220
% 208.24/208.38 a form of non-ionizing radiation; DF: note short X ref
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 1999
% 208.24/208.38 |- skos__hiddenLabel mesh__D019220 High-Energy Shock Wave
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 2004
% 208.24/208.38 |- skos__hiddenLabel mesh__D019220 Wave, High-Energy Shock
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 2000
% 208.24/208.38 |- mesh__historyNote mesh__D019220 97
% 208.24/208.38 |- skos__historyNote mesh__D019220 Lithotripsy %28%1993-1996%29%
% 208.24/208.38 |- skos__scopeNote mesh__D019220
% 208.24/208.38 Compression waves of large amplitude, across which density, pressure, and particle velocity change drastically. %28%From McGraw Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D019220 97
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 2005
% 208.24/208.38 |- skos__broader mesh__D019220smesh__D011840
% 208.24/208.38 |- skos__altLabel mesh__D019220 High Energy Shock Waves
% 208.24/208.38 |- skos__hiddenLabel mesh__D019220 Waves, High-Energy Shock
% 208.24/208.38 |- skos__altLabel mesh__D019220 Shock Waves, High-Energy
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 2001
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 2006
% 208.24/208.38 |- mesh__dateCreated mesh__D019220 1996-06-13
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D019220 1997
% 208.24/208.38 |- skos__prefLabel mesh__D019220 High-Energy Shock Waves
% 208.24/208.38 |- rdf__type mesh__D019220sskos__Concept
% 208.24/208.38 |- mesh__recordMaintainer mesh__D038983 ssb
% 208.24/208.38 |- mesh__publicMeSHNote mesh__D038983
% 208.24/208.38 2003; GALACTOLIPIDS was indexed under GLYCOLIPIDS 1976-2002%A%
% 208.24/208.38 |- rdf__type mesh__D038983sskos__Concept
% 208.24/208.38 |- mesh__historyNote mesh__D038983
% 208.24/208.38 2003; use GALACTOLIPIDS %28%NM%29% 1976-2002
% 208.24/208.38 |- skos__scopeNote mesh__D038983
% 208.24/208.38 A group of GLYCOLIPIDS in which the sugar group is GALACTOSE. They are distinguished from GLYCOSPHINGOLIPIDS in lacking nitrogen. They constitute the majority of MEMBRANE LIPIDS in PLANTS.%A%
% 208.24/208.38 |- mesh__dateRevised mesh__D038983 2004-07-07
% 208.24/208.38 |- skos__prefLabel mesh__D038983 Galactolipids
% 208.24/208.38 |- mesh__dateCreated mesh__D038983 2002-07-03
% 208.24/208.38 |- mesh__recordOriginator mesh__D038983 ssb
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D038983 2005
% 208.24/208.38 |- mesh__recordAuthorizer mesh__D038983 sjn
% 208.24/208.38 |- skos__historyNote mesh__D038983 Glycolipids %28%1976-2002%29%
% 208.24/208.38 |- mesh__dateEstablished mesh__D038983 2003-01-01
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D038983 2006
% 208.24/208.38 |- skos__broader mesh__D038983smesh__D006017
% 208.24/208.38 |- mesh__dateCreated mesh__D005200 1974-11-19
% 208.24/208.38 |- mesh__activeMeSHYear mesh__D005200 2006
% 208.24/208.38 |- skos__historyNote mesh__D005200 Thiazoles %28%1970-1974%29%
% 208.24/208.39 |- mesh__publicMeSHNote mesh__D005200
% 208.24/208.39 91; was see under THIAZOLES 1975-90
% 208.24/208.39 |- skos__historyNote mesh__D005200 Nitrofurans %28%1972-1974%29%
% 208.24/208.39 |- skos__prefLabel mesh__D005200 FANFT
% 208.24/208.39 |- skos__annotation mesh__D005200 D25-26 qualif
% 208.24/208.39 |- mesh__recordMaintainer mesh__D005200 ssb
% 208.24/208.39 |- skos__scopeNote mesh__D005200
% 208.24/208.39 A potent nitrofuran derivative tumor initiator. It causes bladder tumors in all animals studied and is mutagenic to many bacteria.%A%
% 208.24/208.39 |- skos__broader mesh__D005200smesh__D009581
% 208.24/208.39 |- skos__historyNote mesh__D005200 Formamides %28%1972-1974%29%
% 208.24/208.39 |- mesh__dateEstablished mesh__D005200 1991-01-01
% 208.24/208.39 |- mesh__recordOriginator mesh__D005200 NLM
% 208.24/208.39 |- rdf__type mesh__D005200sskos__Concept
% 208.24/208.39 |- skos__altLabel mesh__D005200
% 208.24/208.39 N-4-%28%5-Nitro-2-furyl%29%-2-thiazolylformamide
% 208.24/208.39 |- mesh__recordAuthorizer mesh__D005200 sjn
% 208.24/208.39 |- mesh__dateRevised mesh__D005200 2005-06-30
% 208.24/208.39 |- mesh__historyNote mesh__D005200
% 208.24/208.39 91%28%75%29%; was see under THIAZOLES 1975-90
% 208.24/208.39 |- skos__broader mesh__D005200smesh__D013844
% 208.24/208.39 |- skos__broader mesh__D005492Q000037smesh__D005492
% 208.24/208.39 |- mesh__preferredCombination mesh__D005492Q000037smesh__D005493
% 208.24/208.39 |- rdf__type mesh__D005492Q000037smesh__CompoundConcept
% 208.24/208.39 |- skos__hiddenLabel mesh__D018926 Anti Allergics
% 208.24/208.39 |- mesh__dateRevised mesh__D018926 2005-06-30
% 208.24/208.39 |- mesh__recordOriginator mesh__D018926 JRT
% 208.24/208.39 |- skos__historyNote mesh__D018926
% 208.24/208.39 Histamine H1 Antagonists %28%1966-1995%29%
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D018926 2006
% 208.24/208.39 |- mesh__publicMeSHNote mesh__D018926 96
% 208.24/208.39 |- skos__altLabel mesh__D018926 Antiallergic Agents
% 208.24/208.39 |- skos__related mesh__D018926smesh__D006634
% 208.24/208.39 |- mesh__recordAuthorizer mesh__D018926 sjn
% 208.24/208.39 |- skos__hiddenLabel mesh__D018926 Anti Allergic Agents
% 208.24/208.39 |- skos__altLabel mesh__D018926 Antiallergics
% 208.24/208.39 |- skos__hiddenLabel mesh__D018926 Agents, Antiallergic
% 208.24/208.39 |- skos__altLabel mesh__D018926 Antiallergic Drugs
% 208.24/208.39 |- skos__annotation mesh__D018926
% 208.24/208.39 consider also HYPERSENSITIVITY /drug ther
% 208.24/208.39 |- skos__hiddenLabel mesh__D018926 Agents, Antiallergy
% 208.24/208.39 |- skos__hiddenLabel mesh__D018926 Drugs, Anti-Allergy
% 208.24/208.39 |- skos__hiddenLabel mesh__D018926 Anti Allergy Drugs
% 208.24/208.39 |- skos__altLabel mesh__D018926 Antiallergy Agents
% 208.24/208.39 |- skos__hiddenLabel mesh__D018926 Agents, Anti-Allergic
% 208.24/208.39 |- skos__altLabel mesh__D018926 Anti-Allergy Drugs
% 208.24/208.39 |- mesh__recordMaintainer mesh__D018926 ssb
% 208.24/208.39 |- mesh__dateEstablished mesh__D018926 1996-01-01
% 208.24/208.39 |- skos__altLabel mesh__D018926 Anti-Allergics
% 208.24/208.39 |- skos__prefLabel mesh__D018926 Anti-Allergic Agents
% 208.24/208.39 |- skos__scopeNote mesh__D018926
% 208.24/208.39 Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. %28%From AMA Drug Evaluations Annual, 1994, p475%29%%A%
% 208.24/208.39 |- skos__hiddenLabel mesh__D018926 Drugs, Antiallergic
% 208.24/208.39 |- mesh__dateCreated mesh__D018926 1995-05-26
% 208.24/208.39 |- rdf__type mesh__D018926sskos__Concept
% 208.24/208.39 |- mesh__historyNote mesh__D018926 96
% 208.24/208.39 |- skos__broader mesh__D018926smesh__D045506
% 208.24/208.39 |- mesh__recordOriginator mesh__D010943 SH
% 208.24/208.39 |- mesh__historyNote mesh__D010943
% 208.24/208.39 91%28%78%29%; was see under PLANTS, MEDICINAL 1978-90; was see PSYLLIUM 1963-77 %28%Cat B %26% D heading%29%%A%
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010943 2003
% 208.24/208.39 |- skos__historyNote mesh__D010943 Psyllium %28%1966-1977%29%
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010943 2004
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010943 2005
% 208.24/208.39 |- skos__annotation mesh__D010943
% 208.24/208.39 Xref PLANTAIN: for the banana-like fruit or green plantain flour use MUSA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010943 2006
% 208.24/208.39 |- mesh__onlineNote mesh__D010943
% 208.24/208.39 search PSYLLIUM 1966-77 %28%as Cat B %26% D heading%29%
% 208.24/208.39 |- mesh__recordAuthorizer mesh__D010943 sjn
% 208.24/208.39 |- skos__broader mesh__D010943smesh__D019684
% 208.24/208.39 |- skos__scopeNote mesh__D010943
% 208.24/208.39 A plant genus of the family Plantaginaceae, order Plantaginales, subclass Asteridae, class Magnoliopsida. The small plants usually have a dense tuft of basal leaves and long, leafless stalks bearing a terminal spike of small flowers. The seeds, known as PSYLLIUM, swell in water and are used as laxatives. The leaves have been used medicinally.%A%
% 208.24/208.39 |- skos__altLabel mesh__D010943 Plantain
% 208.24/208.39 |- mesh__publicMeSHNote mesh__D010943
% 208.24/208.39 91; was see under PLANTS, MEDICINAL 1978-90; was see PSYLLIUM 1963-77 %28%Cat B %26% D heading%29%%A%
% 208.24/208.39 |- mesh__dateEstablished mesh__D010943 1991-01-01
% 208.24/208.39 |- mesh__dateCreated mesh__D010943 1977-03-29
% 208.24/208.39 |- mesh__recordMaintainer mesh__D010943 ssb
% 208.24/208.39 |- mesh__dateRevised mesh__D010943 2002-07-03
% 208.24/208.39 |- skos__prefLabel mesh__D010943 Plantago
% 208.24/208.39 |- rdf__type mesh__D010943sskos__Concept
% 208.24/208.39 |- skos__related mesh__D010943smesh__D011620
% 208.24/208.39 |- skos__prefLabel mesh__D010145 Paget%27%s Disease, Extramammary
% 208.24/208.39 |- skos__broader mesh__D010145smesh__D000230
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Paget Disease, Extra Mammary
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Disease, Extra-Mammary Paget
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 2005
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 1997
% 208.24/208.39 |- skos__altLabel mesh__D010145 Extra-Mammary Paget%27%s Disease
% 208.24/208.39 |- skos__scopeNote mesh__D010145
% 208.24/208.39 A rare cutaneous neoplasm that occurs in the elderly. It develops more frequently in women and predominantly involves apocrine gland-bearing areas, especially the vulva, scrotum, and perianal areas. The lesions develop as erythematous scaly patches that progress to crusted, pruritic, erythematous plaques. The clinical differential diagnosis includes squamous cell carcinoma in situ and superficial fungal infection. It is generally thought to be an adenocarcinoma of the epidermis, from which it extends into the contiguous epithelium of hair follicles and eccrine sweat ducts. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1478%29%%A%
% 208.24/208.39 |- skos__annotation mesh__D010145
% 208.24/208.39 neoplastic; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Extra-Mammary Pagets Disease
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Extra Mammary Paget%27%s Disease
% 208.24/208.39 |- skos__altLabel mesh__D010145 Paget%27%s Disease, Extra-Mammary
% 208.24/208.39 |- mesh__onlineNote mesh__D010145
% 208.24/208.39 use PAGET%27%S DISEASE, EXTAMAMMARY to search PAGET%27%S DISEASE, EXTRA-MAMMARY 1966-93%A%
% 208.24/208.39 |- skos__broader mesh__D010145smesh__D018299
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Extramammary Pagets Disease
% 208.24/208.39 |- mesh__recordMaintainer mesh__D010145 KEV
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Disease, Extramammary Paget
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 2004
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 1996
% 208.24/208.39 |- mesh__dateCreated mesh__D010145 1999-01-01
% 208.24/208.39 |- mesh__historyNote mesh__D010145
% 208.24/208.39 94; was PAGET%27%S DISEASE, EXTRA-MAMMARY 1963-93
% 208.24/208.39 |- skos__altLabel mesh__D010145 Paget Disease, Extra-Mammary
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 2002
% 208.24/208.39 |- skos__altLabel mesh__D010145 Paget Disease, Extramammary
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 2003
% 208.24/208.39 |- rdf__type mesh__D010145sskos__Concept
% 208.24/208.39 |- mesh__dateRevised mesh__D010145 1995-06-08
% 208.24/208.39 |- skos__altLabel mesh__D010145 Extramammary Paget Disease
% 208.24/208.39 |- skos__altLabel mesh__D010145 Extra-Mammary Paget Disease
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Disease, Extra-Mammary Paget%27%s
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 1999
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Pagets Disease, Extra-Mammary
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 2001
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Paget%27%s Disease, Extra Mammary
% 208.24/208.39 |- mesh__recordOriginator mesh__D010145 NLM
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Pagets Disease, Extramammary
% 208.24/208.39 |- mesh__recordAuthorizer mesh__D010145 PLS
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Extra Mammary Paget Disease
% 208.24/208.39 |- mesh__publicMeSHNote mesh__D010145
% 208.24/208.39 94; was PAGET%27%S DISEASE, EXTRA-MAMMARY 1963-93
% 208.24/208.39 |- skos__hiddenLabel mesh__D010145 Disease, Extramammary Paget%27%s
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 2006
% 208.24/208.39 |- skos__altLabel mesh__D010145 Extramammary Paget%27%s Disease
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 1998
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D010145 2000
% 208.24/208.39 |- mesh__recordOriginator mesh__D004906 NLM
% 208.24/208.39 |- skos__altLabel mesh__D004906 Blood Cell Count, Red
% 208.24/208.39 |- skos__hiddenLabel mesh__D004906 Count, Erythrocyte
% 208.24/208.39 |- skos__scopeNote mesh__D004906
% 208.24/208.39 The number of RED BLOOD CELLS per unit volume in a sample of venous BLOOD.%A%
% 208.24/208.39 |- mesh__recordAuthorizer mesh__D004906 sjn
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D004906 2006
% 208.24/208.39 |- mesh__recordMaintainer mesh__D004906 nns
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D004906 2004
% 208.24/208.39 |- rdf__type mesh__D004906sskos__Concept
% 208.24/208.39 |- mesh__dateCreated mesh__D004906 1999-01-01
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D004906 2005
% 208.24/208.39 |- skos__altLabel mesh__D004906 Red Blood Cell Count
% 208.24/208.39 |- skos__altLabel mesh__D004906 Erythrocyte Number
% 208.24/208.39 |- skos__annotation mesh__D004906
% 208.24/208.39 usually NIM; coord with disease /blood, not /physiopathol%A%
% 208.24/208.39 |- mesh__dateRevised mesh__D004906 2003-07-09
% 208.24/208.39 |- skos__prefLabel mesh__D004906 Erythrocyte Count
% 208.24/208.39 |- skos__hiddenLabel mesh__D004906 Counts, Erythrocyte
% 208.24/208.39 |- skos__hiddenLabel mesh__D004906 Erythrocyte Counts
% 208.24/208.39 |- skos__broader mesh__D004906smesh__D001772
% 208.24/208.39 |- skos__hiddenLabel mesh__D004906 Erythrocyte Numbers
% 208.24/208.39 |- skos__scopeNote mesh__D004108
% 208.24/208.39 The condition of an anatomical structure%27%s being dilated beyond normal dimensions.%A%
% 208.24/208.39 |- mesh__publicMeSHNote mesh__D004108
% 208.24/208.39 76; was included in DILATATION see under PATHOLOGY 1975
% 208.24/208.39 |- mesh__activeMeSHYear mesh__D004108 2001
% 208.25/208.39 |- mesh__dateEstablished mesh__D004108 1976-01-01
% 208.25/208.39 |- mesh__dateCreated mesh__D004108 1975-07-25
% 208.25/208.39 |- mesh__recordAuthorizer mesh__D004108 sjn
% 208.25/208.39 |- rdf__type mesh__D004108sskos__Concept
% 208.25/208.39 |- skos__altLabel mesh__D004108 Ectasia
% 208.25/208.39 |- mesh__historyNote mesh__D004108
% 208.25/208.39 76; was included in DILATATION 1968-75 %28%Prov 1968-74, Cat C %26% E heading 1968-75%29%%A%
% 208.25/208.39 |- skos__annotation mesh__D004108 never IM; DF: DILATATION PATHOL
% 208.25/208.39 |- skos__hiddenLabel mesh__D004108 Pathological Dilatations
% 208.25/208.39 |- skos__prefLabel mesh__D004108 Dilatation, Pathologic
% 208.25/208.39 |- skos__historyNote mesh__D004108 Dilatation %28%1968-1975%29%
% 208.25/208.39 |- skos__altLabel mesh__D004108 Pathologic Dilatation
% 208.25/208.39 |- skos__altLabel mesh__D004108 Pathologic Dilatations
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D004108 2003
% 208.25/208.39 |- skos__altLabel mesh__D004108 Dilatations, Pathological
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D004108 2002
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D004108 2005
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D004108 2004
% 208.25/208.39 |- mesh__dateRevised mesh__D004108 1999-11-08
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D004108 2006
% 208.25/208.39 |- skos__altLabel mesh__D004108 Dilatations, Pathologic
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D004108 2000
% 208.25/208.39 |- mesh__recordOriginator mesh__D004108 SMH
% 208.25/208.39 |- skos__hiddenLabel mesh__D004108 Pathological Dilatation
% 208.25/208.39 |- skos__broader mesh__D004108smesh__D020763
% 208.25/208.39 |- mesh__recordMaintainer mesh__D004108 KEV
% 208.25/208.39 |- mesh__onlineNote mesh__D004108
% 208.25/208.39 search DILATATION 1968-75 %28%as Prov 1968-74, as Cat C %26% E heading 1968-75%29%%A%
% 208.25/208.39 |- skos__altLabel mesh__D004108 Dilatation, Pathological
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Genes, c-rel
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 c-rel Proto-Oncogene
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Gene, c-rel
% 208.25/208.39 |- skos__altLabel mesh__D020573 rel Oncogene
% 208.25/208.39 |- skos__broader mesh__D020573smesh__D011519
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 c rel Proto Oncogenes
% 208.25/208.39 |- mesh__dateCreated mesh__D020573 1999-11-03
% 208.25/208.39 |- skos__related mesh__D020573smesh__D020572
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Proto-Oncogene, c-rel
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 rel Gene
% 208.25/208.39 |- mesh__dateRevised mesh__D020573 2005-06-30
% 208.25/208.39 |- skos__altLabel mesh__D020573 c-rel Proto-Oncogenes
% 208.25/208.39 |- skos__related mesh__D020573smesh__D020569
% 208.25/208.39 |- skos__altLabel mesh__D020573 v-rel Oncogenes
% 208.25/208.39 |- mesh__dateEstablished mesh__D020573 2000-01-01
% 208.25/208.39 |- mesh__recordAuthorizer mesh__D020573 sjn
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D020573 2006
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 rel Oncogenes
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Gene, rel
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 v rel Oncogenes
% 208.25/208.39 |- skos__altLabel mesh__D020573 rel Genes
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 c-rel Gene
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Oncogenes, rel
% 208.25/208.39 |- skos__scopeNote mesh__D020573
% 208.25/208.39 Family of retrovirus-associated DNA sequences %28%v-rel%29% originally isolated from an avian reticuloendotheliosis virus strain. The proto-oncogene rel %28%c-rel%29% codes for a subcellular %28%nuclear and cytoplasmic%29% transcription factor that has a role in lymphocyte differentiation. Translocation or overexpression of c-rel or competition from v-rel causes oncogenesis. The human rel gene is located at 2p12-13 on the short arm of chromosome 2.%A%
% 208.25/208.39 |- rdf__type mesh__D020573sskos__Concept
% 208.25/208.39 |- skos__prefLabel mesh__D020573 Genes, rel
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Gene, v-rel
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Oncogenes, v-rel
% 208.25/208.39 |- mesh__publicMeSHNote mesh__D020573 2000; see ONCOGENES 1988-1999
% 208.25/208.39 |- mesh__recordOriginator mesh__D020573 ags
% 208.25/208.39 |- mesh__historyNote mesh__D020573 2000; use ONCOGENES 1988-1999
% 208.25/208.39 |- mesh__recordMaintainer mesh__D020573 nns
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 v-rel Oncogene
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 c rel Genes
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Proto-Oncogenes, c-rel
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Genes, v-rel
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Oncogene, rel
% 208.25/208.39 |- skos__historyNote mesh__D020573 Genes, Viral %28%1983-1999%29%
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 v-rel Gene
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 Oncogene, v-rel
% 208.25/208.39 |- skos__hiddenLabel mesh__D020573 v rel Genes
% 208.25/208.39 |- skos__historyNote mesh__D020573 Oncogenes %28%1983-1999%29%
% 208.25/208.39 |- skos__hiddenLabel mesh__D014536
% 208.25/208.39 Diphosphate N-Acetylgalactosamine, Uridine
% 208.25/208.39 |- skos__scopeNote mesh__D014536
% 208.25/208.39 A nucleoside diphosphate sugar which serves as a source of N-acetylgalactosamine for glycoproteins, sulfatides and cerebrosides.%A%
% 208.25/208.39 |- mesh__recordOriginator mesh__D014536 NLM
% 208.25/208.39 |- skos__hiddenLabel mesh__D014536 Acetylgalactosamine, UDP
% 208.25/208.39 |- skos__broader mesh__D014536smesh__D014539
% 208.25/208.39 |- mesh__dateCreated mesh__D014536 1974-11-19
% 208.25/208.39 |- rdf__type mesh__D014536sskos__Concept
% 208.25/208.39 |- skos__altLabel mesh__D014536 Uridine Diphosphate N Acetylgalactosamine
% 208.25/208.39 |- skos__historyNote mesh__D014536
% 208.25/208.39 Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.25/208.39 |- skos__altLabel mesh__D014536 UDP Acetylgalactosamine
% 208.25/208.39 |- mesh__dateRevised mesh__D014536 2004-07-07
% 208.25/208.39 |- mesh__dateEstablished mesh__D014536 1991-01-01
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D014536 2005
% 208.25/208.39 |- skos__hiddenLabel mesh__D014536
% 208.25/208.39 N-Acetylgalactosamine, Uridine Diphosphate
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D014536 2006
% 208.25/208.39 |- skos__prefLabel mesh__D014536 Uridine Diphosphate N-Acetylgalactosamine
% 208.25/208.39 |- mesh__recordAuthorizer mesh__D014536 sjn
% 208.25/208.39 |- mesh__historyNote mesh__D014536
% 208.25/208.39 91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.25/208.39 |- mesh__recordMaintainer mesh__D014536 ssb
% 208.25/208.39 |- mesh__publicMeSHNote mesh__D014536
% 208.25/208.39 91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.25/208.39 |- skos__historyNote mesh__D014536 Galactosamine %28%1973-1974%29%
% 208.25/208.39 |- rdf__type mesh__D000516sskos__Concept
% 208.25/208.39 |- skos__hiddenLabel mesh__D000516 alpha Amylase 2
% 208.25/208.39 |- mesh__publicMeSHNote mesh__D000516 84; was see under AMYLASES 1978-83
% 208.25/208.39 |- skos__broader mesh__D000516smesh__D000681
% 208.25/208.39 |- skos__hiddenLabel mesh__D000516 alpha 1,4 D Glucanglucanohydrolase
% 208.25/208.39 |- mesh__dateCreated mesh__D000516 1977-04-15
% 208.25/208.39 |- mesh__dateRevised mesh__D000516 2005-06-30
% 208.25/208.39 |- skos__hiddenLabel mesh__D000516 TakaAmylase A
% 208.25/208.39 |- skos__altLabel mesh__D000516 Sanofi Synthelabo Brand of alpha-Amylase
% 208.25/208.39 |- mesh__recordMaintainer mesh__D000516 lkw
% 208.25/208.39 |- skos__scopeNote mesh__D000516
% 208.25/208.39 An enzyme that catalyzes the endohydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides containing 3 or more 1,4-alpha-linked D-glucose units. EC 3.2.1.1.%A%
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D000516 2006
% 208.25/208.39 |- skos__historyNote mesh__D000516 Amylases %28%1966-1977%29%
% 208.25/208.39 |- skos__altLabel mesh__D000516 Bayer Brand of alpha-Amylase
% 208.25/208.39 |- skos__hiddenLabel mesh__D000516 Alpha Amylase Bayer
% 208.25/208.39 |- mesh__recordOriginator mesh__D000516 RLS
% 208.25/208.39 |- mesh__dateEstablished mesh__D000516 1984-01-01
% 208.25/208.39 |- mesh__historyNote mesh__D000516
% 208.25/208.39 84%28%78%29%; was see under AMYLASES 1978-83
% 208.25/208.39 |- skos__altLabel mesh__D000516 Leurquin Brand of alpha-Amylase
% 208.25/208.39 |- skos__hiddenLabel mesh__D000516 alpha Amylase
% 208.25/208.39 |- skos__prefLabel mesh__D000516 alpha-Amylase
% 208.25/208.39 |- skos__hiddenLabel mesh__D000516 AlphaAmylase Bayer
% 208.25/208.39 |- skos__altLabel mesh__D000516 alpha-1,4-D-Glucanglucanohydrolase
% 208.25/208.39 |- skos__hiddenLabel mesh__D000516 Taka Amylase A
% 208.25/208.39 |- mesh__recordAuthorizer mesh__D000516 sjn
% 208.25/208.39 |- skos__hiddenLabel mesh__D019221 Reporting, Abuse
% 208.25/208.39 |- mesh__recordMaintainer mesh__D019221 jls
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D019221 2004
% 208.25/208.39 |- skos__broader mesh__D019221smesh__D037141
% 208.25/208.39 |- mesh__publicMeSHNote mesh__D019221 97
% 208.25/208.39 |- mesh__recordOriginator mesh__D019221 JLS
% 208.25/208.39 |- mesh__historyNote mesh__D019221 97
% 208.25/208.39 |- skos__related mesh__D019221smesh__D018563
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D019221 2003A
% 208.25/208.39 |- mesh__dateEstablished mesh__D019221 1997-01-01
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D019221 2005
% 208.25/208.39 |- skos__related mesh__D019221smesh__D035622
% 208.25/208.39 |- skos__broader mesh__D019221smesh__D030881
% 208.25/208.39 |- mesh__dateRevised mesh__D019221 2002-10-31
% 208.25/208.39 |- skos__historyNote mesh__D019221
% 208.25/208.39 Elder Abuse/legislation %26% jurisprudence %28%1984-1996%29%
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D019221 2006
% 208.25/208.39 |- mesh__recordAuthorizer mesh__D019221 jls
% 208.25/208.39 |- rdf__type mesh__D019221sskos__Concept
% 208.25/208.39 |- skos__prefLabel mesh__D019221 Mandatory Reporting
% 208.25/208.39 |- mesh__dateCreated mesh__D019221 1996-06-10
% 208.25/208.39 |- skos__hiddenLabel mesh__D019221 Reporting, Mandatory
% 208.25/208.39 |- skos__historyNote mesh__D019221
% 208.25/208.39 Child Abuse/legislation %26% jurisprudence %28%1966-1996%29%
% 208.25/208.39 |- skos__scopeNote mesh__D019221
% 208.25/208.39 A legal requirement that designated types of information acquired by professionals or institutions in the course of their work be reported to appropriate authorities.%A%
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D019221 2003
% 208.25/208.39 |- skos__broader mesh__D019221smesh__D007603
% 208.25/208.39 |- skos__hiddenLabel mesh__D005201 Daydream
% 208.25/208.39 |- mesh__publicMeSHNote mesh__D005201 68
% 208.25/208.39 |- skos__altLabel mesh__D005201 Daydreams
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 2004
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 1997
% 208.25/208.39 |- mesh__recordAuthorizer mesh__D005201 PLS
% 208.25/208.39 |- mesh__dateEstablished mesh__D005201 1968-01-01
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 2000
% 208.25/208.39 |- mesh__historyNote mesh__D005201
% 208.25/208.39 68; DAY DREAMS was see under FANTASY 1968-78
% 208.25/208.39 |- mesh__recordMaintainer mesh__D005201 PLS
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 2001
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 1994
% 208.25/208.39 |- skos__broader mesh__D005201smesh__D003674
% 208.25/208.39 |- mesh__onlineNote mesh__D005201
% 208.25/208.39 use FANTASY to search DAY DREAMS 1968-78
% 208.25/208.39 |- skos__annotation mesh__D005201 no qualif
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 1992
% 208.25/208.39 |- rdf__type mesh__D005201sskos__Concept
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 2002
% 208.25/208.39 |- skos__prefLabel mesh__D005201 Fantasy
% 208.25/208.39 |- mesh__dateCreated mesh__D005201 1999-01-01
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 1995
% 208.25/208.39 |- skos__broader mesh__D005201smesh__D007092
% 208.25/208.39 |- skos__historyNote mesh__D005201 Imagination %28%1966-1967%29%
% 208.25/208.39 |- skos__scopeNote mesh__D005201
% 208.25/208.39 An imagined sequence of events or mental images, e.g., daydreams.%A%
% 208.25/208.39 |- skos__hiddenLabel mesh__D005201 Dream, Day
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 2005
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 1998
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 1993
% 208.25/208.39 |- skos__hiddenLabel mesh__D005201 Dreams, Day
% 208.25/208.39 |- skos__hiddenLabel mesh__D005201 Fantasies
% 208.25/208.39 |- skos__hiddenLabel mesh__D005201 Day Dream
% 208.25/208.39 |- mesh__dateRevised mesh__D005201 1991-06-11
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 2006
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 2003
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 1996
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D005201 1999
% 208.25/208.39 |- mesh__recordOriginator mesh__D005201 NLM
% 208.25/208.39 |- skos__hiddenLabel mesh__D018927 Anti Asthmatics
% 208.25/208.39 |- skos__altLabel mesh__D018927 Antiasthmatic Drugs
% 208.25/208.39 |- skos__prefLabel mesh__D018927 Anti-Asthmatic Agents
% 208.25/208.39 |- mesh__recordOriginator mesh__D018927 JRT
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D018927 2006
% 208.25/208.39 |- skos__scopeNote mesh__D018927 Drugs that are used to treat asthma.
% 208.25/208.39 |- skos__annotation mesh__D018927 consider also ASTHMA /drug ther
% 208.25/208.39 |- skos__hiddenLabel mesh__D018927 Anti Asthmatic Agents
% 208.25/208.39 |- skos__broader mesh__D018927smesh__D019141
% 208.25/208.39 |- skos__altLabel mesh__D018927 Antiasthmatics
% 208.25/208.39 |- skos__altLabel mesh__D018927 Antiasthmatic Agents
% 208.25/208.39 |- skos__altLabel mesh__D018927 Anti-Asthmatics
% 208.25/208.39 |- mesh__dateRevised mesh__D018927 2005-06-30
% 208.25/208.39 |- skos__historyNote mesh__D018927 Asthma/drug therapy %28%1966-1995%29%
% 208.25/208.39 |- mesh__publicMeSHNote mesh__D018927 96
% 208.25/208.39 |- mesh__recordMaintainer mesh__D018927 ssb
% 208.25/208.39 |- mesh__recordAuthorizer mesh__D018927 sjn
% 208.25/208.39 |- mesh__dateCreated mesh__D018927 1995-05-26
% 208.25/208.39 |- rdf__type mesh__D018927sskos__Concept
% 208.25/208.39 |- mesh__dateEstablished mesh__D018927 1996-01-01
% 208.25/208.39 |- skos__hiddenLabel mesh__D018927 Drugs, Antiasthmatic
% 208.25/208.39 |- mesh__historyNote mesh__D018927 96
% 208.25/208.39 |- skos__hiddenLabel mesh__D018927 Agents, Antiasthmatic
% 208.25/208.39 |- skos__hiddenLabel mesh__D018927 Drugs, Anti-Asthmatic
% 208.25/208.39 |- skos__hiddenLabel mesh__D018927 Anti Asthmatic Drugs
% 208.25/208.39 |- skos__hiddenLabel mesh__D018927 Agents, Anti-Asthmatic
% 208.25/208.39 |- skos__altLabel mesh__D018927 Anti-Asthmatic Drugs
% 208.25/208.39 |- mesh__runningHead mesh__D010944 B6 - ORGANISMS-PLANTS
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D010944 2004
% 208.25/208.39 |- mesh__publicMeSHNote mesh__D010944 PYRETHRUM was heading 1963-85
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D010944 2005
% 208.25/208.39 |- skos__annotation mesh__D010944
% 208.25/208.39 GEN only: prefer specific groups or specific plants; plants or %22%plant tissue%22%: Manual 31.10; /anat: consider also PLANT COMPONENTS; /embryol: consider also SEEDS; policy 22.30, 36.25; plants used in therapy = PHYTOTHERAPY: Manual 26.29%A%
% 208.25/208.39 |- skos__related mesh__D010944smesh__D010940
% 208.25/208.39 |- mesh__onlineNote mesh__D010944 use PLANTS to search PYRETHRUM 1966-85
% 208.25/208.39 |- skos__related mesh__D010944smesh__D012639
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D010944 2006
% 208.25/208.39 |- mesh__recordAuthorizer mesh__D010944 jls
% 208.25/208.39 |- skos__related mesh__D010944smesh__D011058
% 208.25/208.39 |- mesh__dateCreated mesh__D010944 1999-01-01
% 208.25/208.39 |- mesh__recordMaintainer mesh__D010944 jls
% 208.25/208.39 |- skos__prefLabel mesh__D010944 Plants
% 208.25/208.39 |- skos__related mesh__D010944smesh__D006540
% 208.25/208.39 |- mesh__dateRevised mesh__D010944 2004-07-30
% 208.25/208.39 |- skos__scopeNote mesh__D010944
% 208.25/208.39 Multicellular, eukaryotic life forms of the kingdom Plantae. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions %28%MERISTEMS%29%; cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alteration of haploid and diploid generations.%A%
% 208.25/208.39 |- rdf__type mesh__D010944sskos__Concept
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D010944 2005A
% 208.25/208.39 |- mesh__activeMeSHYear mesh__D010944 2003
% 208.25/208.39 |- mesh__recordOriginator mesh__D010944 NLM
% 208.25/208.39 |- mesh__historyNote mesh__D010944 PYRETHRUM was heading 1963-85
% 208.25/208.39 |- skos__hiddenLabel mesh__D018129 Phosphates, Phosphatidyl Inositol
% 208.25/208.39 |- mesh__publicMeSHNote mesh__D018129
% 208.25/208.39 94; POLYPHOSPHOINOSITIDES was indexed under PHOSPHOINOSITIDES 1983-93 %26% POLYMERS 1978-82; PHOSPHATIDYLINOSITOL PHOSPHATES was see PHOSPHOINOSITIDES 1977-93%A%
% 208.25/208.39 |- skos__altLabel mesh__D018129 Polyphosphoinositide
% 208.25/208.39 |- skos__hiddenLabel mesh__D018129 Phosphates, Phosphatidylinositol
% 208.25/208.39 |- mesh__dateCreated mesh__D018129 1993-06-04
% 208.25/208.39 |- mesh__recordOriginator mesh__D018129 TPW
% 208.25/208.39 |- rdf__type mesh__D018129sskos__Concept
% 208.25/208.40 |- skos__scopeNote mesh__D018129
% 208.25/208.40 Phosphatidylinositols in which one or more alcohol group of the inositol has been substituted with a phosphate group.%A%
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D018129 sjn
% 208.25/208.40 |- skos__altLabel mesh__D018129 Polyphosphoinositides
% 208.25/208.40 |- mesh__dateRevised mesh__D018129 2004-07-07
% 208.25/208.40 |- skos__historyNote mesh__D018129 Phosphatidylinositols %28%1977-1993%29%
% 208.25/208.40 |- skos__prefLabel mesh__D018129 Phosphatidylinositol Phosphates
% 208.25/208.40 |- mesh__historyNote mesh__D018129
% 208.25/208.40 94; was POLYPHOSPHOINOSITIDES %28%NM%29% 1978-93; PHOSPHATIDYLINOSITOL PHOSPHATES was see PHOSPHOINOSITIDES 1977-93%A%
% 208.25/208.40 |- skos__altLabel mesh__D018129 Phosphatidyl Inositol Phosphates
% 208.25/208.40 |- skos__historyNote mesh__D018129 Polymers %28%1978-1982%29%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D018129 2005
% 208.25/208.40 |- skos__hiddenLabel mesh__D018129 Inositol Phosphates, Phosphatidyl
% 208.25/208.40 |- skos__broader mesh__D018129smesh__D010716
% 208.25/208.40 |- mesh__onlineNote mesh__D018129
% 208.25/208.40 use PHOSPHATIDYLINOSITOL PHOSPHATES %28%NM%29% to search POLYPHOSPHOINOSITIDES 1980-93; use PHOSPHATIDYLINOSITOLS to search PHOSPHATIDYLINOSITOL PHOSPHATES 1977-93%A%
% 208.25/208.40 |- mesh__recordMaintainer mesh__D018129 jmp
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D018129 2006
% 208.25/208.40 |- mesh__dateEstablished mesh__D018129 1994-01-01
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010146 2006
% 208.25/208.40 |- skos__related mesh__D010146smesh__D000700
% 208.25/208.40 |- skos__related mesh__D010146smesh__D000698
% 208.25/208.40 |- skos__broader mesh__D010146smesh__D012677
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Pains, Splitting
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D010146 sjn
% 208.25/208.40 |- mesh__dateRevised mesh__D010146 1999-11-03
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Crushing Pain
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010146 2005
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Aches
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Physical Suffering
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Radiating Pain
% 208.25/208.40 |- skos__related mesh__D010146smesh__D000699
% 208.25/208.40 |- mesh__recordMaintainer mesh__D010146 KEV
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Splitting Pains
% 208.25/208.40 |- mesh__dateCreated mesh__D010146 1999-01-01
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Migratory Pain
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010146 2004
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Pains, Radiating
% 208.25/208.40 |- skos__annotation mesh__D010146
% 208.25/208.40 IM, GEN only; prefer precoord locational pain terms, like ABDOMINAL PAIN, CHEST PAIN, etc.; /diag: consider also PAIN MEASUREMENT but PAIN /diag is probably PAIN /etiol; /ther: consider also PALLIATIVE CARE %28% = pain relief without cure%29%; /physiopathol: PAIN THRESHOLD is also available; chronic pain = PAIN %28%IM%29% + CHRONIC DISEASE %28%NIM%29%: do not equate with PAIN, INTRACTABLE; congen absence of pain = PAIN INSENSITIVITY, CONGENITAL; excessive sensitivity to pain = HYPERALGESIA; policy: Manual 23.17+%A%
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Physical Sufferings
% 208.25/208.40 |- skos__broader mesh__D010146smesh__D012816
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Splitting Pain
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010146 2002
% 208.25/208.40 |- rdf__type mesh__D010146sskos__Concept
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010146 2003
% 208.25/208.40 |- skos__broader mesh__D010146smesh__D009461
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Sufferings, Physical
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Pains, Crushing
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Pains, Migratory
% 208.25/208.40 |- mesh__recordOriginator mesh__D010146 NLM
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010146 2001
% 208.25/208.40 |- skos__scopeNote mesh__D010146
% 208.25/208.40 An unpleasant sensation induced by noxious stimuli and generally received by specialized nerve endings.%A%
% 208.25/208.40 |- skos__related mesh__D010146smesh__D010166
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Migratory Pains
% 208.25/208.40 |- skos__prefLabel mesh__D010146 Pain
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Crushing Pains
% 208.25/208.40 |- skos__related mesh__D010146smesh__D006930
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Burning Pains
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010146 2000
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Burning Pain
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Radiating Pains
% 208.25/208.40 |- skos__hiddenLabel mesh__D010146 Pains, Burning
% 208.25/208.40 |- skos__historyNote mesh__D004907 Erythrocytes, Abnormal %28%1968-1984%29%
% 208.25/208.40 |- skos__annotation mesh__D004907
% 208.25/208.40 note category: do not confuse with ERYTHROCYTES, ABNORMAL: deformability is a normal desirable characteristic of erythrocytes; coord with disease /blood, not /physiopathol%A%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D004907 2005
% 208.25/208.40 |- skos__hiddenLabel mesh__D004907 Deformability, Erythrocyte
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D004907 2004
% 208.25/208.40 |- rdf__type mesh__D004907sskos__Concept
% 208.25/208.40 |- mesh__dateCreated mesh__D004907 1984-05-30
% 208.25/208.40 |- mesh__dateRevised mesh__D004907 2003-07-09
% 208.25/208.40 |- mesh__historyNote mesh__D004907 85
% 208.25/208.40 |- skos__historyNote mesh__D004907 Erythrocytes %28%1966-1984%29%
% 208.25/208.40 |- mesh__recordMaintainer mesh__D004907 nns
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D004907 sjn
% 208.25/208.40 |- skos__prefLabel mesh__D004907 Erythrocyte Deformability
% 208.25/208.40 |- mesh__recordOriginator mesh__D004907 VDK
% 208.25/208.40 |- skos__broader mesh__D004907smesh__D045122
% 208.25/208.40 |- skos__scopeNote mesh__D004907
% 208.25/208.40 Ability of ERYTHROCYTES to change shape as they pass through narrow spaces, such as the microvasculature.%A%
% 208.25/208.40 |- mesh__publicMeSHNote mesh__D004907 85
% 208.25/208.40 |- skos__hiddenLabel mesh__D004907 Filterability, Erythrocyte
% 208.25/208.40 |- mesh__dateEstablished mesh__D004907 1985-01-01
% 208.25/208.40 |- skos__altLabel mesh__D004907 Erythrocyte Filterability
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D004907 2006
% 208.25/208.40 |- skos__related mesh__D004907smesh__D018056
% 208.25/208.40 |- skos__hiddenLabel mesh__D004109 4898, Asta C
% 208.25/208.40 |- mesh__recordMaintainer mesh__D004109 TWD
% 208.25/208.40 |- mesh__historyNote mesh__D004109
% 208.25/208.40 91%28%75%29%; was see under AZEPINES 1975-90
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D004109 2003
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D004109 2001
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D004109 sjn
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D004109 2005
% 208.25/208.40 |- skos__prefLabel mesh__D004109 Dilazep
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D004109 2004
% 208.25/208.40 |- mesh__publicMeSHNote mesh__D004109 91; was see under AZEPINES 1975-90
% 208.25/208.40 |- skos__historyNote mesh__D004109 Benzoates %28%1972-1974%29%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D004109 2006
% 208.25/208.40 |- mesh__dateRevised mesh__D004109 2000-06-21
% 208.25/208.40 |- skos__altLabel mesh__D004109 Biopropazepan Trimethoxybenzoate
% 208.25/208.40 |- skos__scopeNote mesh__D004109
% 208.25/208.40 Coronary vasodilator with some antiarrhythmic activity.%A%
% 208.25/208.40 |- skos__hiddenLabel mesh__D004109 C 4898, Asta
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D004109 2002
% 208.25/208.40 |- mesh__dateCreated mesh__D004109 1974-11-27
% 208.25/208.40 |- skos__broader mesh__D004109smesh__D001381
% 208.25/208.40 |- skos__hiddenLabel mesh__D004109 Trimethoxybenzoate, Biopropazepan
% 208.25/208.40 |- rdf__type mesh__D004109sskos__Concept
% 208.25/208.40 |- skos__historyNote mesh__D004109 Azepines %28%1972-1974%29%
% 208.25/208.40 |- mesh__dateEstablished mesh__D004109 1991-01-01
% 208.25/208.40 |- mesh__recordOriginator mesh__D004109 NLM
% 208.25/208.40 |- skos__altLabel mesh__D020574 c-sis Proteins
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D020574 2006
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 sis Proto Oncogene Proteins
% 208.25/208.40 |- skos__scopeNote mesh__D020574
% 208.25/208.40 Cellular DNA-binding proteins encoded by the sis gene %28%GENES, SIS%29%. c-sis proteins make up the B chain of PLATELET-DERIVED GROWTH FACTOR. Overexpression of c-sis causes tumorigenesis.%A%
% 208.25/208.40 |- mesh__recordMaintainer mesh__D020574 DRC
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 Proto Oncogene Protein sis
% 208.25/208.40 |- skos__prefLabel mesh__D020574 Proto-Oncogene Proteins c-sis
% 208.25/208.40 |- skos__altLabel mesh__D020574 Proto-Oncogene Proteins sis
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 sis, Proto-Oncogene Protein
% 208.25/208.40 |- skos__broader mesh__D020574smesh__D010982
% 208.25/208.40 |- mesh__dateEstablished mesh__D020574 2000-01-01
% 208.25/208.40 |- skos__altLabel mesh__D020574 Platelet-Derived Growth Factor B
% 208.25/208.40 |- skos__altLabel mesh__D020574 PDGFB
% 208.25/208.40 |- skos__historyNote mesh__D020574
% 208.25/208.40 Platelet-Derived Growth Factor %28%1990-1999%29%
% 208.25/208.40 |- mesh__historyNote mesh__D020574
% 208.25/208.40 2000; use PROTO-ONCOGENE PROTEINS C-SIS %28%NM%29% 1987-1999
% 208.25/208.40 |- skos__related mesh__D020574smesh__D020571
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 Platelet Derived Growth Factor B
% 208.25/208.40 |- skos__historyNote mesh__D020574
% 208.25/208.40 Proto-Oncogene Proteins %28%1987-1999%29%
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 Proto Oncogene Proteins c sis
% 208.25/208.40 |- skos__broader mesh__D020574smesh__D004268
% 208.25/208.40 |- skos__altLabel mesh__D020574 Proto-Oncogene Protein sis
% 208.25/208.40 |- skos__broader mesh__D020574smesh__D011518
% 208.25/208.40 |- mesh__recordOriginator mesh__D020574 ags
% 208.25/208.40 |- skos__altLabel mesh__D020574 sis Proto-Oncogene Proteins
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 c sis Proteins
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 Proto-Oncogene Proteins, sis
% 208.25/208.40 |- mesh__dateRevised mesh__D020574 2005-06-30
% 208.25/208.40 |- skos__altLabel mesh__D020574 Proto-Oncogene Products c-sis
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D020574 sjn
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 sis, Proto-Oncogene Proteins
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 Proto Oncogene Proteins sis
% 208.25/208.40 |- skos__hiddenLabel mesh__D020574 Proto Oncogene Products c sis
% 208.25/208.40 |- mesh__publicMeSHNote mesh__D020574
% 208.25/208.40 2000; PROTO-ONCOGENE PROTEIN SIS was indexed under PROTO-ONCOGENE PROTEINS 1987-1999 %26% PLATELET-DERIVED GROWTH FACTOR 1990-1999%A%
% 208.25/208.40 |- mesh__dateCreated mesh__D020574 1999-11-03
% 208.25/208.40 |- rdf__type mesh__D020574sskos__Concept
% 208.25/208.40 |- skos__broader mesh__D007717Q000293smesh__D007717
% 208.25/208.40 |- mesh__preferredCombination mesh__D007717Q000293smesh__D007718
% 208.25/208.40 |- rdf__type mesh__D007717Q000293smesh__CompoundConcept
% 208.25/208.40 |- skos__historyNote mesh__D014537 Uridine Diphosphate Sugars %28%1974%29%
% 208.25/208.40 |- skos__altLabel mesh__D014537 Uridine Pyrophosphoacetylglucosamine
% 208.25/208.40 |- skos__hiddenLabel mesh__D014537 N-Acetylglucosamine, Uridine Diphosphate
% 208.25/208.40 |- skos__altLabel mesh__D014537 Uridine Diphospho-N-Acetylglucosamine
% 208.25/208.40 |- skos__hiddenLabel mesh__D014537 Acetylglucosamine, UDP
% 208.25/208.40 |- skos__scopeNote mesh__D014537
% 208.25/208.40 Serves as the biological precursor of insect chitin, of muramic acid in bacterial cell walls, and of sialic acids in mammalian glycoproteins.%A%
% 208.25/208.40 |- mesh__dateRevised mesh__D014537 2004-07-07
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D014537 2005
% 208.25/208.40 |- skos__historyNote mesh__D014537 Glucosamine %28%1974%29%
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D014537 sjn
% 208.25/208.40 |- mesh__recordMaintainer mesh__D014537 ssb
% 208.25/208.40 |- mesh__historyNote mesh__D014537
% 208.25/208.40 91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.25/208.40 |- skos__altLabel mesh__D014537 Uridine Diphosphate N Acetylglucosamine
% 208.25/208.40 |- mesh__dateEstablished mesh__D014537 1991-01-01
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D014537 2006
% 208.25/208.40 |- mesh__dateCreated mesh__D014537 1974-11-19
% 208.25/208.40 |- skos__hiddenLabel mesh__D014537 Diphospho-N-Acetylglucosamine, Uridine
% 208.25/208.40 |- mesh__recordOriginator mesh__D014537 NLM
% 208.25/208.40 |- skos__broader mesh__D014537smesh__D014539
% 208.25/208.40 |- mesh__publicMeSHNote mesh__D014537
% 208.25/208.40 91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.25/208.40 |- skos__hiddenLabel mesh__D014537 Diphosphate N-Acetylglucosamine, Uridine
% 208.25/208.40 |- skos__altLabel mesh__D014537 UDPGNAc
% 208.25/208.40 |- skos__prefLabel mesh__D014537 Uridine Diphosphate N-Acetylglucosamine
% 208.25/208.40 |- skos__hiddenLabel mesh__D014537 Uridine Diphospho N Acetylglucosamine
% 208.25/208.40 |- skos__altLabel mesh__D014537 UDP Acetylglucosamine
% 208.25/208.40 |- skos__hiddenLabel mesh__D014537 Pyrophosphoacetylglucosamine, Uridine
% 208.25/208.40 |- rdf__type mesh__D014537sskos__Concept
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D000517 2005
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D000517 2003
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D000517 sjn
% 208.25/208.40 |- mesh__dateEstablished mesh__D000517 1991-01-01
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D000517 2006
% 208.25/208.40 |- skos__altLabel mesh__D000517 alpha-Chlorhydrin
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D000517 2004
% 208.25/208.40 |- skos__broader mesh__D000517smesh__D011409
% 208.25/208.40 |- skos__historyNote mesh__D000517 Chlorine %28%1972-1974%29%
% 208.25/208.40 |- skos__hiddenLabel mesh__D000517 U 5897
% 208.25/208.40 |- skos__prefLabel mesh__D000517 alpha-Chlorohydrin
% 208.25/208.40 |- skos__altLabel mesh__D000517 3-Chloropropanediol
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D000517 2001
% 208.25/208.40 |- mesh__historyNote mesh__D000517
% 208.25/208.40 91%28%75%29%; was see under CHLOROHYDRINS 1975-90
% 208.25/208.40 |- skos__altLabel mesh__D000517 Glycerol alpha-Monochlorohydrin
% 208.25/208.40 |- mesh__publicMeSHNote mesh__D000517
% 208.25/208.40 91; was see under CHLOROHYDRINS 1975-90
% 208.25/208.40 |- mesh__recordMaintainer mesh__D000517 CCR
% 208.25/208.40 |- skos__historyNote mesh__D000517 Propanediols %28%1969-1974%29%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D000517 2002
% 208.25/208.40 |- skos__hiddenLabel mesh__D000517 3 Chloropropanediol
% 208.25/208.40 |- skos__hiddenLabel mesh__D000517 3 Chloro 1,2 propanediol
% 208.25/208.40 |- skos__hiddenLabel mesh__D000517 alpha Chlorohydrin
% 208.25/208.40 |- skos__hiddenLabel mesh__D000517 Glycerol alpha Monochlorohydrin
% 208.25/208.40 |- mesh__recordOriginator mesh__D000517 NLM
% 208.25/208.40 |- mesh__dateRevised mesh__D000517 2000-06-21
% 208.25/208.40 |- mesh__dateCreated mesh__D000517 1974-11-14
% 208.25/208.40 |- skos__hiddenLabel mesh__D000517 U5897
% 208.25/208.40 |- skos__hiddenLabel mesh__D000517 alpha Chlorhydrin
% 208.25/208.40 |- rdf__type mesh__D000517sskos__Concept
% 208.25/208.40 |- skos__hiddenLabel mesh__D000517 alpha-Monochlorohydrin, Glycerol
% 208.25/208.40 |- skos__altLabel mesh__D000517 3-Chloro-1,2-propanediol
% 208.25/208.40 |- skos__broader mesh__D000517smesh__D002728
% 208.25/208.40 |- skos__scopeNote mesh__D000517
% 208.25/208.40 A chlorinated propanediol compound that has shown anti-fertility activity in males and has been used as a chemosterilant in rodents.%A%
% 208.25/208.40 |- skos__broader mesh__D019222smesh__D008606
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222
% 208.25/208.40 Mind Body Relationship %28%Non Physiology%29%
% 208.25/208.40 |- mesh__historyNote mesh__D019222 97
% 208.25/208.40 |- mesh__dateRevised mesh__D019222 2001-07-25
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222 Relations, Mind-Body %28%Metaphysics%29%
% 208.25/208.40 |- skos__related mesh__D019222smesh__D011603
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222 Relation, Mind-Body %28%Metaphysics%29%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D019222 2005
% 208.25/208.40 |- skos__altLabel mesh__D019222
% 208.25/208.40 Mind-Body Relationship %28%Non-Physiology%29%
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222 Mind-Body Relation %28%Metaphysics%29%
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222
% 208.25/208.40 Mind Body Relations %28%Non Physiology%29%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D019222 2006
% 208.25/208.40 |- mesh__publicMeSHNote mesh__D019222 97
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222
% 208.25/208.40 Relations, Mind-Body %28%Non-Physiology%29%
% 208.25/208.40 |- skos__prefLabel mesh__D019222 Mind-Body Relations %28%Metaphysics%29%
% 208.25/208.40 |- rdf__type mesh__D019222sskos__Concept
% 208.25/208.40 |- mesh__recordOriginator mesh__D019222 TGC
% 208.25/208.40 |- mesh__dateEstablished mesh__D019222 1997-01-01
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222
% 208.25/208.40 Relationship, Mind-Body %28%Non-Physiology%29%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D019222 2002
% 208.25/208.40 |- skos__scopeNote mesh__D019222
% 208.25/208.40 The relation between the mind and the body in a religious, social, spiritual, behavioral, and metaphysical context. This concept is significant in the field of alternative medicine. It differs from the relationship between physiologic processes and behavior where the emphasis is on the body%27%s physiology %28% = PSYCHOPHYSIOLOGY%29%.%A%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D019222 2003
% 208.25/208.40 |- mesh__recordMaintainer mesh__D019222 ssb
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222
% 208.25/208.40 Relationships, Mind-Body %28%Non-Physiology%29%
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D019222 sjn
% 208.25/208.40 |- mesh__dateCreated mesh__D019222 1996-06-10
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222
% 208.25/208.40 Mind-Body Relation %28%Non-Physiology%29%
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222 Mind Body Relations %28%Metaphysics%29%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D019222 2004
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222
% 208.25/208.40 Relation, Mind-Body %28%Non-Physiology%29%
% 208.25/208.40 |- skos__annotation mesh__D019222
% 208.25/208.40 important in alternative med; do not confuse with MIND-BODY RELATIONS %28%PHYSIOLOGY%29% see PSYCHOPHYSIOLOGY where emphasis is on physiol; DF: MIND BODY RELAT METAPHYSICS%A%
% 208.25/208.40 |- skos__hiddenLabel mesh__D019222
% 208.25/208.40 Mind-Body Relationships %28%Non-Physiology%29%
% 208.25/208.40 |- skos__broader mesh__D019222smesh__D026441
% 208.25/208.40 |- skos__altLabel mesh__D019222 Mind-Body Relations %28%Non-Physiology%29%
% 208.25/208.40 |- skos__broader mesh__D005202smesh__D001208
% 208.25/208.40 |- skos__annotation mesh__D005202
% 208.25/208.40 a geog area of east %26% southeast Asia; prefer specific countries%A%
% 208.25/208.40 |- mesh__dateEstablished mesh__D005202 1963-01-01
% 208.25/208.40 |- rdf__type mesh__D005202sskos__Concept
% 208.25/208.40 |- skos__altLabel mesh__D005202 Eastern Asia
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D005202 2005
% 208.25/208.40 |- mesh__dateRevised mesh__D005202 2001-07-25
% 208.25/208.40 |- mesh__recordOriginator mesh__D005202 CAB
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D005202 sjn
% 208.25/208.40 |- skos__prefLabel mesh__D005202 Far East
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D005202 2003
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D005202 2006
% 208.25/208.40 |- skos__altLabel mesh__D005202 East Asia
% 208.25/208.40 |- mesh__recordMaintainer mesh__D005202 mdb
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D005202 2004
% 208.25/208.40 |- mesh__dateCreated mesh__D005202 1975-06-19
% 208.25/208.40 |- skos__scopeNote mesh__D005202
% 208.25/208.40 A geographic area of east and southeast Asia encompassing CHINA; HONG KONG; JAPAN; KOREA; MACAO; MONGOLIA; and TAIWAN.%A%
% 208.25/208.40 |- mesh__historyNote mesh__D005202 67
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D005202 2002
% 208.25/208.40 |- mesh__dateRevised mesh__D018928 2001-08-03
% 208.25/208.40 |- mesh__dateCreated mesh__D018928 1995-02-17
% 208.25/208.40 |- mesh__dateEstablished mesh__D018928 1996-01-01
% 208.25/208.40 |- mesh__recordOriginator mesh__D018928 AGS
% 208.25/208.40 |- skos__hiddenLabel mesh__D018928 Mucosal Immune Responses
% 208.25/208.40 |- mesh__recordMaintainer mesh__D018928 sjn
% 208.25/208.40 |- skos__hiddenLabel mesh__D018928 Mucosal Immune Response
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D018928 2003
% 208.25/208.40 |- skos__related mesh__D018928smesh__D007071
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D018928 2004
% 208.25/208.40 |- rdf__type mesh__D018928sskos__Concept
% 208.25/208.40 |- skos__historyNote mesh__D018928
% 208.25/208.40 Mucous Membrane/immunology %28%1970-1995%29%
% 208.25/208.40 |- skos__scopeNote mesh__D018928
% 208.25/208.40 Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA %28%IMMUNOGLOBULIN A, SECRETORY%29% that serves to protect these ports of entry into the body.%A%
% 208.25/208.40 |- skos__hiddenLabel mesh__D018928 Immune Responses, Mucosal
% 208.25/208.40 |- mesh__historyNote mesh__D018928 96
% 208.25/208.40 |- skos__prefLabel mesh__D018928 Immunity, Mucosal
% 208.25/208.40 |- skos__broader mesh__D018928smesh__D007109
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D018928 2005
% 208.25/208.40 |- skos__annotation mesh__D018928
% 208.25/208.40 IM general only, NIM with specific disease /immunol %28%IM%29%
% 208.25/208.40 |- mesh__publicMeSHNote mesh__D018928 96
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D018928 sjn
% 208.25/208.40 |- skos__historyNote mesh__D018928
% 208.25/208.40 Intestinal Mucosa/immunology %28%1976-1995%29%
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D018928 2002
% 208.25/208.40 |- skos__altLabel mesh__D018928 Mucosal Immunity
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D018928 2006
% 208.25/208.40 |- mesh__dateCreated mesh__D010945 1999-01-01
% 208.25/208.40 |- skos__altLabel mesh__D010945 Food Plants
% 208.25/208.40 |- skos__scopeNote mesh__D010945
% 208.25/208.40 An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES.%A%
% 208.25/208.40 |- mesh__recordMaintainer mesh__D010945 sjn
% 208.25/208.40 |- skos__annotation mesh__D010945
% 208.25/208.40 as plants %26% food; prefer FRUIT %28%J%29% or VEGETABLES %28%J%29% if ascertainable; specify geog if pertinent; use qualif available to PLANTS with discretion%A%
% 208.25/208.40 |- mesh__dateRevised mesh__D010945 2004-07-13
% 208.25/208.40 |- skos__prefLabel mesh__D010945 Plants, Edible
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D010945 sjn
% 208.25/208.40 |- rdf__type mesh__D010945sskos__Concept
% 208.25/208.40 |- mesh__recordOriginator mesh__D010945 NLM
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010945 2005
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010945 2006
% 208.25/208.40 |- skos__broader mesh__D010945smesh__D010944
% 208.25/208.40 |- mesh__dateEstablished mesh__D029650 2002-01-01
% 208.25/208.40 |- skos__historyNote mesh__D029650 Enterovirus %28%1965-2001%29%
% 208.25/208.40 |- skos__annotation mesh__D029650
% 208.25/208.40 infection: coord IM with ENTEROVIRUS INFECTIONS %28%IM%29%
% 208.25/208.40 |- mesh__publicMeSHNote mesh__D029650 2002
% 208.25/208.40 |- mesh__recordOriginator mesh__D029650 ags
% 208.25/208.40 |- skos__altLabel mesh__D029650 Bovine enterovirus
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D029650 sjn
% 208.25/208.40 |- mesh__dateCreated mesh__D029650 2001-07-25
% 208.25/208.40 |- skos__broader mesh__D029650smesh__D004770
% 208.25/208.40 |- rdf__type mesh__D029650sskos__Concept
% 208.25/208.40 |- skos__hiddenLabel mesh__D029650 Enteroviruses, Bovine
% 208.25/208.40 |- mesh__recordMaintainer mesh__D029650 ags
% 208.25/208.40 |- mesh__historyNote mesh__D029650 2002
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D029650 2006
% 208.25/208.40 |- skos__prefLabel mesh__D029650 Enterovirus, Bovine
% 208.25/208.40 |- skos__scopeNote mesh__D029650
% 208.25/208.40 A species in the family ENTEROVIRUS infecting cattle.
% 208.25/208.40 |- skos__hiddenLabel mesh__D029650 Bovine Enteroviruses
% 208.25/208.40 |- mesh__dateRevised mesh__D029650 2005-06-30
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Measurements, Pain
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Scale, Analogue Pain
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Analogue Pain Scales
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Tests, Tourniquet Pain
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Tests, Analgesia
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Scale, Visual Analog
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010147 1998
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Test, Tourniquet Pain
% 208.25/208.40 |- mesh__dateEstablished mesh__D010147 1987-01-01
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Analogue Scale, Visual
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010147 2004
% 208.25/208.40 |- rdf__type mesh__D010147sskos__Concept
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Scales, Analog
% 208.25/208.40 |- mesh__recordMaintainer mesh__D010147 PXP
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Visual Analogue Scales
% 208.25/208.40 |- skos__altLabel mesh__D010147 Visual Analogue Pain Scale
% 208.25/208.40 |- mesh__recordOriginator mesh__D010147 SH
% 208.25/208.40 |- skos__altLabel mesh__D010147 Nociception Tests
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Test, Analgesia
% 208.25/208.40 |- skos__broader mesh__D010147smesh__D009460
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Visual Analog Scales
% 208.25/208.40 |- skos__altLabel mesh__D010147 Analgesia Tests
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Scale, McGill Pain
% 208.25/208.40 |- mesh__publicMeSHNote mesh__D010147 87
% 208.25/208.40 |- mesh__recordAuthorizer mesh__D010147 SJN
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Scale, Analogue
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Assessments, Pain
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010147 1999
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Scale, Analog Pain
% 208.25/208.40 |- mesh__dateRevised mesh__D010147 1997-06-20
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Measurement, Pain
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Measurements
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Test, Tourniquet
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Test, Nociception
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Formalin Tests
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010147 2005
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Analog Pain Scales
% 208.25/208.40 |- mesh__dateCreated mesh__D010147 1986-03-25
% 208.25/208.40 |- skos__altLabel mesh__D010147 Visual Analog Pain Scale
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Assessments
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Scale, McGill
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Scales, Analogue Pain
% 208.25/208.40 |- skos__altLabel mesh__D010147 McGill Pain Scale
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Scales, Analog Pain
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Analgesia Test
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010147 2000
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Questionnaire, McGill
% 208.25/208.40 |- mesh__historyNote mesh__D010147 87
% 208.25/208.40 |- mesh__activeMeSHYear mesh__D010147 2006
% 208.25/208.40 |- skos__altLabel mesh__D010147 Assessment, Pain
% 208.25/208.40 |- skos__altLabel mesh__D010147 Pain Assessment
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Questionnaire, McGill Pain
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Tourniquet Pain Tests
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Scales, Visual Analog
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Tests, Tourniquet
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Scale, Visual Analogue
% 208.25/208.40 |- skos__historyNote mesh__D010147 Pain %28%1966-1986%29%
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Scale, Analog
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Pain Scales, Analogue
% 208.25/208.40 |- skos__hiddenLabel mesh__D010147 Scales, Visual Analogue
% 208.25/208.40 |- skos__annotation mesh__D010147 /drug eff /rad eff permitted
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D010147 2001
% 208.25/208.41 |- skos__related mesh__D010147smesh__D017288
% 208.25/208.41 |- skos__scopeNote mesh__D010147
% 208.25/208.41 Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies.%A%
% 208.25/208.41 |- skos__prefLabel mesh__D010147 Pain Measurement
% 208.25/208.41 |- skos__hiddenLabel mesh__D010147 Tests, Nociception
% 208.25/208.41 |- skos__hiddenLabel mesh__D010147 Nociception Test
% 208.25/208.41 |- skos__hiddenLabel mesh__D010147 Test, Formalin
% 208.25/208.41 |- skos__related mesh__D010147smesh__D012684
% 208.25/208.41 |- skos__hiddenLabel mesh__D010147 Analogue Scales, Visual
% 208.25/208.41 |- skos__hiddenLabel mesh__D010147 Tests, Formalin
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D010147 2003
% 208.25/208.41 |- skos__altLabel mesh__D010147 Analog Pain Scale
% 208.25/208.41 |- skos__altLabel mesh__D010147 Visual Analogue Scale
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D010147 2002
% 208.25/208.41 |- mesh__recordMaintainer mesh__D004908 TGC
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D004908 2004
% 208.25/208.41 |- rdf__type mesh__D004908sskos__Concept
% 208.25/208.41 |- mesh__dateEstablished mesh__D004908 1991-01-01
% 208.25/208.41 |- skos__hiddenLabel mesh__D004908 Inclusion, Erythrocyte
% 208.25/208.41 |- mesh__dateCreated mesh__D004908 1975-02-04
% 208.25/208.41 |- skos__hiddenLabel mesh__D004908 Howell Jolly Bodies
% 208.25/208.41 |- skos__scopeNote mesh__D004908
% 208.25/208.41 Pathologic inclusions occurring in erythrocytes.
% 208.25/208.41 |- skos__hiddenLabel mesh__D004908 Bodies, Howell-Jolly
% 208.25/208.41 |- skos__prefLabel mesh__D004908 Erythrocyte Inclusions
% 208.25/208.41 |- skos__hiddenLabel mesh__D004908 Inclusions, Erythrocyte
% 208.25/208.41 |- skos__annotation mesh__D004908 A 11 qualif except /cytol
% 208.25/208.41 |- mesh__onlineNote mesh__D004908 search ERYTHROCYTES, ABNORMAL 1968-74
% 208.25/208.41 |- skos__broader mesh__D004908smesh__D002479
% 208.25/208.41 |- mesh__recordOriginator mesh__D004908 NLM
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D004908 2005
% 208.25/208.41 |- skos__broader mesh__D004908smesh__D004913
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D004908 2001
% 208.25/208.41 |- mesh__publicMeSHNote mesh__D004908
% 208.25/208.41 91; was see under ERYTHROCYTES, ABNORMAL 1975-90
% 208.25/208.41 |- mesh__historyNote mesh__D004908
% 208.25/208.41 91%28%75%29%; was see under ERYTHROCYTES, ABNORMAL 1975-90
% 208.25/208.41 |- mesh__dateRevised mesh__D004908 2000-06-22
% 208.25/208.41 |- skos__hiddenLabel mesh__D004908 Erythrocyte Inclusion
% 208.25/208.41 |- mesh__recordAuthorizer mesh__D004908 sjn
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D004908 2003
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D004908 2006
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D004908 2002
% 208.25/208.41 |- rdf__type mesh__D001610sskos__Concept
% 208.25/208.41 |- skos__hiddenLabel mesh__D001610 Cathode Ray
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D001610 2006
% 208.25/208.41 |- skos__historyNote mesh__D001610 Elementary Particles %28%1970-1984%29%
% 208.25/208.41 |- skos__altLabel mesh__D001610 Beta Radiation
% 208.25/208.41 |- skos__hiddenLabel mesh__D001610 Beta Particle
% 208.25/208.41 |- mesh__recordOriginator mesh__D001610 SH
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D001610 1997
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D001610 2005
% 208.25/208.41 |- skos__annotation mesh__D001610 NIM
% 208.25/208.41 |- skos__altLabel mesh__D001610 Beta Particles
% 208.25/208.41 |- skos__broader mesh__D001610smesh__D009686
% 208.25/208.41 |- mesh__recordAuthorizer mesh__D001610 PLS
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D001610 2001
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D001610 1996
% 208.25/208.41 |- skos__hiddenLabel mesh__D001610 Beta Ray
% 208.25/208.41 |- mesh__dateRevised mesh__D001610 1994-06-30
% 208.25/208.41 |- skos__hiddenLabel mesh__D001610 Radiations, Beta
% 208.25/208.41 |- mesh__onlineNote mesh__D001610
% 208.25/208.41 use BETA RAYS to search CATHODE RAYS 1976-84, RADIATION 1966-75%A%
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D001610 2000
% 208.25/208.41 |- skos__hiddenLabel mesh__D001610 Rays, Beta
% 208.25/208.41 |- mesh__dateCreated mesh__D001610 1984-02-24
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D001610 1999
% 208.25/208.41 |- mesh__activeMeSHYear mesh__D001610 2004
% 208.25/208.41 |- skos__hiddenLabel mesh__D001610 Ray, Cathode
% 208.25/208.41 |- skos__historyNote mesh__D001610 Radiation %28%1966-1984%29%
% 208.25/208.41 |- skos__broader mesh__D001610smesh__D011839
% 208.25/208.41 |- mesh__historyNote mesh__D001610
% 208.25/208.41 85; CATHODE RAYS was see under RADIATION, IONIZING 1976-84, was see under RADIATION 1963-75%A%
% 208.25/208.41 |- mesh__dateEstablished mesh__D001610 1985-01-01
% 208.25/208.41 |- skos__hiddenLabel mesh__D001610 Beta Radiations
% 208.25/208.41 |- skos__hiddenLabel mesh__D001610 Particle, Beta
% 208.26/208.41 |- skos__hiddenLabel mesh__D001610 Rays, Cathode
% 208.26/208.41 |- skos__prefLabel mesh__D001610 Beta Rays
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D001610 1995
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D001610 1998
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D001610 2003
% 208.26/208.41 |- skos__altLabel mesh__D001610 Radiation, Beta
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D001610
% 208.26/208.41 85; CATHODE RAYS was see under RADIATION, IONIZING 1976-84, was see under RADIATION 1963-75%A%
% 208.26/208.41 |- mesh__recordMaintainer mesh__D001610 TGC
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D001610 2002
% 208.26/208.41 |- skos__hiddenLabel mesh__D001610 Ray, Beta
% 208.26/208.41 |- skos__hiddenLabel mesh__D001610 Particles, Beta
% 208.26/208.41 |- skos__scopeNote mesh__D001610
% 208.26/208.41 A stream of positive or negative electrons ejected with high energy from a disintegrating atomic nucleus; most biomedically used isotopes emit negative particles %28%electrons or negatrons, rather than positrons%29%. Cathode rays are low-energy negative electrons produced in cathode ray tubes, also called television tubes or oscilloscopes.%A%
% 208.26/208.41 |- skos__historyNote mesh__D001610 Electrons %28%1966-1984%29%
% 208.26/208.41 |- skos__hiddenLabel mesh__D020575 Oncogene Proteins v sis
% 208.26/208.41 |- mesh__dateEstablished mesh__D020575 2000-01-01
% 208.26/208.41 |- skos__altLabel mesh__D020575 Oncogene Products v-sis
% 208.26/208.41 |- skos__prefLabel mesh__D020575 Oncogene Proteins v-sis
% 208.26/208.41 |- mesh__dateCreated mesh__D020575 1999-11-03
% 208.26/208.41 |- skos__scopeNote mesh__D020575
% 208.26/208.41 Transforming proteins coded by sis oncogenes. Transformation of cells by v-sis is related to its interaction with the PDGF receptor and also its ability to alter other transcription factors.%A%
% 208.26/208.41 |- skos__related mesh__D020575smesh__D020571
% 208.26/208.41 |- skos__hiddenLabel mesh__D020575 v-sis, Oncogene Products
% 208.26/208.41 |- skos__altLabel mesh__D020575 v-sis Proteins
% 208.26/208.41 |- skos__historyNote mesh__D020575 Viral Proteins %28%1983-1985%29%
% 208.26/208.41 |- skos__hiddenLabel mesh__D020575 Proteins, v-sis
% 208.26/208.41 |- skos__hiddenLabel mesh__D020575 v-sis, Oncogene Proteins
% 208.26/208.41 |- skos__altLabel mesh__D020575 p28%28%v-sis%29%
% 208.26/208.41 |- mesh__historyNote mesh__D020575
% 208.26/208.41 2000; use ONCOGENE PROTEINS V-SIS %28%NM%29% 1983-1999
% 208.26/208.41 |- skos__broader mesh__D020575smesh__D015682
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D020575
% 208.26/208.41 2000; ONCOGENE PROTEINS SIS was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999; RETROVIRIDAE PROTEINS 1986-1989; %26% VIRAL PROTEINS 1983-1985%A%
% 208.26/208.41 |- skos__hiddenLabel mesh__D020575 v sis Proteins
% 208.26/208.41 |- skos__hiddenLabel mesh__D020575 Oncogene Products v sis
% 208.26/208.41 |- mesh__recordMaintainer mesh__D020575 SYSTEM
% 208.26/208.41 |- rdf__type mesh__D020575sskos__Concept
% 208.26/208.41 |- skos__historyNote mesh__D020575
% 208.26/208.41 Retroviridae Proteins, Oncogenic %28%1990-1999%29%
% 208.26/208.41 |- skos__historyNote mesh__D020575 Retroviridae Proteins %28%1986-1989%29%
% 208.26/208.41 |- skos__altLabel mesh__D020575 sis Oncogene Proteins
% 208.26/208.41 |- mesh__recordOriginator mesh__D020575 ags
% 208.26/208.41 |- skos__altLabel mesh__D020575 Oncogene Proteins sis
% 208.26/208.41 |- skos__altLabel mesh__D020575 Oncogene Protein p28%28%v-sis%29%
% 208.26/208.41 |- skos__hiddenLabel mesh__D020575 Oncogene Proteins, sis
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D020575 2006
% 208.26/208.41 |- mesh__dateRevised mesh__D020575 2005-06-30
% 208.26/208.41 |- skos__hiddenLabel mesh__D020575 sis, Oncogene Proteins
% 208.26/208.41 |- mesh__recordAuthorizer mesh__D020575 sjn
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D014538 2005
% 208.26/208.41 |- skos__altLabel mesh__D014538 Uridine Diphosphate N Acetylmuramic Acid
% 208.26/208.41 |- skos__historyNote mesh__D014538
% 208.26/208.41 Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.26/208.41 |- mesh__dateEstablished mesh__D014538 1991-01-01
% 208.26/208.41 |- skos__historyNote mesh__D014538 Muramic Acid %28%1973-1974%29%
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D014538 2006
% 208.26/208.41 |- skos__altLabel mesh__D014538 UDP Acetylmuramic Acid
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D014538
% 208.26/208.41 91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.26/208.41 |- skos__prefLabel mesh__D014538 Uridine Diphosphate N-Acetylmuramic Acid
% 208.26/208.41 |- mesh__recordAuthorizer mesh__D014538 sjn
% 208.26/208.41 |- mesh__recordMaintainer mesh__D014538 ssb
% 208.26/208.41 |- mesh__historyNote mesh__D014538
% 208.26/208.41 91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.26/208.41 |- mesh__dateCreated mesh__D014538 1974-11-19
% 208.26/208.41 |- rdf__type mesh__D014538sskos__Concept
% 208.26/208.41 |- skos__hiddenLabel mesh__D014538 Acetylmuramic Acid, UDP
% 208.26/208.41 |- skos__scopeNote mesh__D014538
% 208.26/208.41 A nucleoside diphosphate sugar which is formed from UDP-N-acetylglucosamine and phosphoenolpyruvate. It serves as the building block upon which peptidoglycan is formed.%A%
% 208.26/208.41 |- skos__hiddenLabel mesh__D014538 Acid, UDP Acetylmuramic
% 208.26/208.41 |- mesh__recordOriginator mesh__D014538 NLM
% 208.26/208.41 |- skos__broader mesh__D014538smesh__D014539
% 208.26/208.41 |- mesh__dateRevised mesh__D014538 2004-07-07
% 208.26/208.41 |- mesh__onlineNote mesh__D000518
% 208.26/208.41 use EFLORNITHINE to search ALPHA-DIFLUOROMETHYLORNITHINE 1987-90%A%
% 208.26/208.41 |- skos__hiddenLabel mesh__D000518 MDL71,782 A
% 208.26/208.41 |- skos__hiddenLabel mesh__D000518 alpha Difluoromethylornithine
% 208.26/208.41 |- mesh__historyNote mesh__D000518
% 208.26/208.41 91; was ALPHA-DIFLUOROMETHYLORNITHINE 1987-90
% 208.26/208.41 |- skos__hiddenLabel mesh__D000518 DL alpha Difluoromethylornithine
% 208.26/208.41 |- skos__hiddenLabel mesh__D000518 Ornithine, alpha-Difluoromethyl
% 208.26/208.41 |- mesh__recordMaintainer mesh__D000518 exl
% 208.26/208.41 |- skos__altLabel mesh__D000518 alpha-Difluoromethylornithine
% 208.26/208.41 |- skos__historyNote mesh__D000518
% 208.26/208.41 Ornithine/analogs %26% derivatives %28%1975-1986%29%
% 208.26/208.41 |- skos__altLabel mesh__D000518
% 208.26/208.41 Women First Brand of Eflornithine Hydrochloride
% 208.26/208.41 |- mesh__dateCreated mesh__D000518 1986-06-03
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D000518
% 208.26/208.41 91; was ALPHA-DIFLUOROMETHYLORNITHINE 1987-90
% 208.26/208.41 |- skos__hiddenLabel mesh__D000518 MDL 71,782 A
% 208.26/208.41 |- skos__hiddenLabel mesh__D000518 alpha Difluoromethyl Ornithine
% 208.26/208.41 |- skos__hiddenLabel mesh__D000518
% 208.26/208.41 Monohydrochloride, Monohydrate Eflornithine
% 208.26/208.41 |- rdf__type mesh__D000518sskos__Concept
% 208.26/208.41 |- skos__hiddenLabel mesh__D000518 Hydrochloride, Eflornithine
% 208.26/208.41 |- skos__annotation mesh__D000518 DF:DFMO
% 208.26/208.41 |- mesh__recordAuthorizer mesh__D000518 sjn
% 208.26/208.41 |- skos__historyNote mesh__D000518 Ornithine %28%1966-1974%29%
% 208.26/208.41 |- mesh__dateEstablished mesh__D000518 1987-01-01
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D000518 2006
% 208.26/208.41 |- skos__scopeNote mesh__D000518
% 208.26/208.41 An inhibitor of ornithine decarboxylase, the rate limiting enzyme of the polyamine biosynthetic pathway.%A%
% 208.26/208.41 |- skos__altLabel mesh__D000518 alpha-Difluoromethyl Ornithine
% 208.26/208.41 |- skos__altLabel mesh__D000518 Eflornithine Monohydrochloride, Monohydrate
% 208.26/208.41 |- skos__altLabel mesh__D000518 DL-alpha-Difluoromethylornithine
% 208.26/208.41 |- mesh__dateRevised mesh__D000518 2005-06-30
% 208.26/208.41 |- skos__broader mesh__D000518smesh__D009952
% 208.26/208.41 |- mesh__recordOriginator mesh__D000518 RLS
% 208.26/208.41 |- skos__hiddenLabel mesh__D000518 71782, RMI
% 208.26/208.41 |- skos__prefLabel mesh__D000518 Eflornithine
% 208.26/208.41 |- skos__annotation mesh__D019223
% 208.26/208.41 coord IM with specific arthropod /virol or insect /virol %28%IM%29%; do not confuse X ref INFECTIOUS HYPODERMAL AND HEMATOPOIETIC NECROSIS VIRUS see DENSOVIRINAE with INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS%A%
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D019223 2003
% 208.26/208.41 |- mesh__recordAuthorizer mesh__D019223 sjn
% 208.26/208.41 |- skos__broader mesh__D019223smesh__D010321
% 208.26/208.41 |- mesh__dateEstablished mesh__D019223 1997-01-01
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D019223 2002
% 208.26/208.41 |- mesh__dateCreated mesh__D019223 1996-06-10
% 208.26/208.41 |- skos__hiddenLabel mesh__D019223 densovirus, Aedes aegypti
% 208.26/208.41 |- skos__scopeNote mesh__D019223
% 208.26/208.41 A subfamily of DNA arthropod viruses, in the family PARVOVIRIDAE. The host range includes members of Dictyoptera, DIPTERA, LEPIDOPTERA, Odonata, and ORTHOPTERA. There are three genera: DENSOVIRUS, Iteravirus, and Brevidensovirus. Densovirus-like viruses also infect and multiply in crabs and shrimp.%A%
% 208.26/208.41 |- skos__altLabel mesh__D019223 IHHNV
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D019223 2006
% 208.26/208.41 |- skos__prefLabel mesh__D019223 Densovirinae
% 208.26/208.41 |- skos__hiddenLabel mesh__D019223 Brevidensoviruses
% 208.26/208.41 |- rdf__type mesh__D019223sskos__Concept
% 208.26/208.41 |- mesh__dateRevised mesh__D019223 2001-07-25
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D019223 97
% 208.26/208.41 |- mesh__recordOriginator mesh__D019223 AGS
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D019223 2005
% 208.26/208.41 |- skos__hiddenLabel mesh__D019223 Contraviruses
% 208.26/208.41 |- mesh__historyNote mesh__D019223 97
% 208.26/208.41 |- skos__hiddenLabel mesh__D019223 Iteraviruses
% 208.26/208.41 |- skos__hiddenLabel mesh__D019223 Aedes aegypti densoviruses
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D019223 2004
% 208.26/208.41 |- mesh__recordMaintainer mesh__D019223 ags
% 208.26/208.41 |- skos__broader mesh__D019223smesh__D007304
% 208.26/208.41 |- skos__altLabel mesh__D019223 Contravirus
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 2005
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 2002
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 1998
% 208.26/208.41 |- skos__annotation mesh__D005203
% 208.26/208.41 caused by bacteria Micropolyspora %26% Thermoactinomyces %28%see MICROMONOSPORACEAE%29%%A%
% 208.26/208.41 |- mesh__recordMaintainer mesh__D005203 TGC
% 208.26/208.41 |- mesh__dateEstablished mesh__D005203 1965-01-01
% 208.26/208.41 |- skos__hiddenLabel mesh__D005203 Lung, Farmer%27%s
% 208.26/208.41 |- skos__broader mesh__D005203smesh__D000382
% 208.26/208.41 |- skos__hiddenLabel mesh__D005203 Farmer%27%s Lungs
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 2006
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D005203 65
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 1999
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 2003
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 1996
% 208.26/208.41 |- mesh__historyNote mesh__D005203 65%28%63%29%
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 2004
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 1997
% 208.26/208.41 |- skos__prefLabel mesh__D005203 Farmer%27%s Lung
% 208.26/208.41 |- skos__hiddenLabel mesh__D005203 Farmer Lung
% 208.26/208.41 |- skos__hiddenLabel mesh__D005203 Lungs, Farmer%27%s
% 208.26/208.41 |- mesh__recordOriginator mesh__D005203 NLM
% 208.26/208.41 |- skos__hiddenLabel mesh__D005203 Farmers Lung
% 208.26/208.41 |- mesh__dateRevised mesh__D005203 1994-04-16
% 208.26/208.41 |- mesh__recordAuthorizer mesh__D005203 PLS
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 2000
% 208.26/208.41 |- skos__broader mesh__D005203smesh__D000542
% 208.26/208.41 |- rdf__type mesh__D005203sskos__Concept
% 208.26/208.41 |- skos__scopeNote mesh__D005203
% 208.26/208.41 Systemic and pulmonary reactions resulting from inhalation of dust from moldy hay, threshing dust, or moldy straw, by persons who have become hypersensitive to antigens in the dust. It is most often associated with inhalation of spores of Micromonospora faeni or Thermoactinomyces vulgaris. %28%From Dorland, 27th ed%29%%A%
% 208.26/208.41 |- mesh__dateCreated mesh__D005203 1999-01-01
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 1995
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D005203 2001
% 208.26/208.41 |- skos__hiddenLabel mesh__D018929 Cell Cultures, Primary
% 208.26/208.41 |- skos__hiddenLabel mesh__D018929 Cell Culture, Primary
% 208.26/208.41 |- skos__scopeNote mesh__D018929
% 208.26/208.41 A technique for maintaining or growing CELLS in vitro. Cultures of dispersed cells derived directly from fresh TISSUES are called primary cell cultures. Cultures may also derive from established CELL LINE usually stored frozen.%A%
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D018929 2005; see CELL CULTURE 1996-2004
% 208.26/208.41 |- skos__hiddenLabel mesh__D018929 Culture Technique, Cell
% 208.26/208.41 |- rdf__type mesh__D018929sskos__Concept
% 208.26/208.41 |- skos__historyNote mesh__D018929 Tissue Culture %28%1966-1995%29%
% 208.26/208.41 |- mesh__recordAuthorizer mesh__D018929 sjn
% 208.26/208.41 |- skos__hiddenLabel mesh__D018929 Primary Cell Cultures
% 208.26/208.41 |- mesh__dateEstablished mesh__D018929 1996-01-01
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D018929 2005
% 208.26/208.41 |- mesh__dateRevised mesh__D018929 2004-07-07
% 208.26/208.41 |- mesh__dateCreated mesh__D018929 1995-01-06
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D018929 2006
% 208.26/208.41 |- mesh__recordOriginator mesh__D018929 AGS
% 208.26/208.41 |- mesh__historyNote mesh__D018929 2005 %28%1996%29%
% 208.26/208.41 |- skos__altLabel mesh__D018929 Cell Culture
% 208.26/208.41 |- skos__annotation mesh__D018929
% 208.26/208.41 note category: do not confuse with CELLS, CULTURED %28%Cat A%29%; NIM%A%
% 208.26/208.41 |- skos__related mesh__D018929smesh__D002478
% 208.26/208.41 |- skos__hiddenLabel mesh__D018929 Cell Culture Technique
% 208.26/208.41 |- skos__hiddenLabel mesh__D018929 Cell Cultures
% 208.26/208.41 |- skos__hiddenLabel mesh__D018929 Culture Techniques, Cell
% 208.26/208.41 |- mesh__recordMaintainer mesh__D018929 lkt
% 208.26/208.41 |- skos__prefLabel mesh__D018929 Cell Culture Techniques
% 208.26/208.41 |- skos__broader mesh__D018929smesh__D046508
% 208.26/208.41 |- mesh__historyNote mesh__D010946
% 208.26/208.41 AESCULUS, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX %26% TAMARIND were headings 1963-85; ADONIS, ASPIDIUM %26% OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85%A%
% 208.26/208.41 |- skos__related mesh__D010946smesh__D008517
% 208.26/208.41 |- skos__related mesh__D010946smesh__D010936
% 208.26/208.41 |- skos__altLabel mesh__D010946 Herbs, Medicinal
% 208.26/208.41 |- skos__broader mesh__D010946smesh__D010944
% 208.26/208.41 |- rdf__type mesh__D010946sskos__Concept
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010946 2003
% 208.26/208.41 |- skos__prefLabel mesh__D010946 Plants, Medicinal
% 208.26/208.41 |- skos__altLabel mesh__D010946 Medicinal Plants
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010946 2005
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010946 2004
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D010946
% 208.26/208.41 AESCULUS, ARECA, CASTANEA, CHELIDONIUM, CHENOPODIUM, COCA, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, ERYTHRINA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, PAPAVER, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX, TAMARIND %26% VALERIAN were headings 1963-85; ADONIS, ASPIDIUM %26% OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85; ALOE %26% RHUBARB were headings 1963-77; PLANTAGO was see PSYLLIUM 1963-77%A%
% 208.26/208.41 |- mesh__recordAuthorizer mesh__D010946 sjn
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010946 2006
% 208.26/208.41 |- mesh__recordOriginator mesh__D010946 NLM
% 208.26/208.41 |- mesh__dateRevised mesh__D010946 2002-07-03
% 208.26/208.41 |- mesh__onlineNote mesh__D010946
% 208.26/208.41 use PLANTS, MEDICINAL to search AESCULUS, ASPIDIUM, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX %26% TAMARIND 1966-85%A%
% 208.26/208.41 |- mesh__recordMaintainer mesh__D010946 ssb
% 208.26/208.41 |- mesh__dateCreated mesh__D010946 1999-01-01
% 208.26/208.41 |- skos__scopeNote mesh__D010946
% 208.26/208.41 Plants whose roots, leaves, seeds, bark, or other constituent possess therapeutic, tonic, purgative, or other pharmacologic activity when administered to higher animals.%A%
% 208.26/208.41 |- skos__annotation mesh__D010946 IM GEN only; spec geog if pertinent;
% 208.26/208.41 |- mesh__historyNote mesh__D043322
% 208.26/208.41 2004; use LACTASE %28%NM%29% 1990-2003
% 208.26/208.41 |- mesh__dateCreated mesh__D043322 2003-07-09
% 208.26/208.41 |- mesh__dateEstablished mesh__D043322 2004-01-01
% 208.26/208.41 |- skos__prefLabel mesh__D043322 Lactase
% 208.26/208.41 |- skos__scopeNote mesh__D043322
% 208.26/208.41 An enzyme which catalyzes the hydrolysis of LACTOSE to D-GALACTOSE and D-GLUCOSE. Defects in the enzyme cause LACTOSE INTOLERANCE.%A%
% 208.26/208.41 |- skos__related mesh__D043322smesh__D007787
% 208.26/208.41 |- skos__hiddenLabel mesh__D043322 Galactohydrolase, Lactose
% 208.26/208.41 |- skos__altLabel mesh__D043322 Lactose Galactohydrolase
% 208.26/208.41 |- skos__historyNote mesh__D043322 beta-Galactosidase %28%1990-2003%29%
% 208.26/208.41 |- skos__broader mesh__D043322smesh__D001616
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D043322
% 208.26/208.41 2004; LACTASE was indexed under BETA-GALACTOSIDASE 1990-2003%A%
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D043322 2006
% 208.26/208.41 |- rdf__type mesh__D043322sskos__Concept
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D043322 2004
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D043322 2005
% 208.26/208.41 |- skos__scopeNote mesh__D010148
% 208.26/208.41 Persistent pain that is refractory to some or all forms of treatment.%A%
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010148 2004
% 208.26/208.41 |- skos__annotation mesh__D010148
% 208.26/208.41 IM; usually chronic so do not coord with CHRONIC DISEASE but chronic pain = PAIN %28%IM%29% + CHRONIC DISEASE %28%NIM%29%%A%
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010148 2000
% 208.26/208.41 |- mesh__recordAuthorizer mesh__D010148 ags
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010148 2003
% 208.26/208.41 |- mesh__historyNote mesh__D010148 1974
% 208.26/208.41 |- mesh__recordMaintainer mesh__D010148 ags
% 208.26/208.41 |- skos__hiddenLabel mesh__D010148 Pains, Intractable
% 208.26/208.41 |- skos__prefLabel mesh__D010148 Pain, Intractable
% 208.26/208.41 |- skos__hiddenLabel mesh__D010148 Pain, Refractory
% 208.26/208.41 |- skos__altLabel mesh__D010148 Refractory Pain
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010148 2000A
% 208.26/208.41 |- mesh__dateEstablished mesh__D010148 1974-01-01
% 208.26/208.41 |- mesh__dateCreated mesh__D010148 1999-01-01
% 208.26/208.41 |- skos__hiddenLabel mesh__D010148 Pains, Refractory
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010148 2006
% 208.26/208.41 |- mesh__dateRevised mesh__D010148 1999-12-08
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010148 2002
% 208.26/208.41 |- mesh__recordOriginator mesh__D010148 NLM
% 208.26/208.41 |- mesh__publicMeSHNote mesh__D010148 1974
% 208.26/208.41 |- skos__hiddenLabel mesh__D010148 Refractory Pains
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010148 2005
% 208.26/208.41 |- rdf__type mesh__D010148sskos__Concept
% 208.26/208.41 |- skos__hiddenLabel mesh__D010148 Intractable Pains
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D010148 2001
% 208.26/208.41 |- skos__hiddenLabel mesh__D010148 Intractable Pain
% 208.26/208.41 |- skos__broader mesh__D010148smesh__D010146
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D004909 2006
% 208.26/208.41 |- skos__hiddenLabel mesh__D004909 Erythrocyte Size Determinations
% 208.26/208.41 |- skos__altLabel mesh__D004909 Mean Cell Volume
% 208.26/208.41 |- skos__hiddenLabel mesh__D004909 Determinations, Erythrocyte Size
% 208.26/208.41 |- skos__broader mesh__D004909smesh__D045122
% 208.26/208.41 |- mesh__dateCreated mesh__D004909 1978-12-19
% 208.26/208.41 |- skos__hiddenLabel mesh__D004909 Diameter, Erythrocyte
% 208.26/208.41 |- skos__historyNote mesh__D004909 Erythrocyte Volume %28%1978-1979%29%
% 208.26/208.41 |- mesh__recordMaintainer mesh__D004909 nns
% 208.26/208.41 |- mesh__historyNote mesh__D004909 80
% 208.26/208.41 |- skos__hiddenLabel mesh__D004909 Indexes, Red Cell
% 208.26/208.41 |- skos__annotation mesh__D004909
% 208.26/208.41 coord with disease /blood, not /physiopathol
% 208.26/208.41 |- mesh__activeMeSHYear mesh__D004909 2005
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Volumes, Mean Corpuscular
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Size Determination, Erythrocyte
% 208.27/208.41 |- mesh__recordAuthorizer mesh__D004909 sjn
% 208.27/208.41 |- rdf__type mesh__D004909sskos__Concept
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Mean Cell Volumes
% 208.27/208.41 |- skos__historyNote mesh__D004909 Erythrocyte Count %28%1966-1979%29%
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Corpuscular Volumes, Mean
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Erythrocyte Diameters
% 208.27/208.41 |- skos__altLabel mesh__D004909 Red Cell Index
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Size Determinations, Erythrocyte
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Volume, Mean Corpuscular
% 208.27/208.41 |- mesh__dateRevised mesh__D004909 2003-07-25
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Cell Volumes, Mean
% 208.27/208.41 |- skos__broader mesh__D004909smesh__D006403
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Mean Corpuscular Hemoglobins
% 208.27/208.41 |- skos__altLabel mesh__D004909 Mean Cell Hemoglobin Concentration
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Index, Red Cell
% 208.27/208.41 |- skos__historyNote mesh__D004909 Erythrocytes %28%1966-1979%29%
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Indices, Red Cell
% 208.27/208.41 |- skos__altLabel mesh__D004909 Erythrocyte Hemoglobin, Mean Cell
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Hemoglobin, Mean Corpuscular
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Mean Corpuscular Volumes
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Index, Erythrocyte
% 208.27/208.41 |- skos__altLabel mesh__D004909 Hemoglobin, Erythrocyte, Mean Cell
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Volume, Mean Cell
% 208.27/208.41 |- skos__altLabel mesh__D004909 Erythrocyte Indexes
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Determination, Erythrocyte Size
% 208.27/208.41 |- mesh__publicMeSHNote mesh__D004909 80
% 208.27/208.41 |- mesh__dateEstablished mesh__D004909 1980-01-01
% 208.27/208.41 |- skos__scopeNote mesh__D004909
% 208.27/208.41 ERYTHROCYTE size and HEMOGLOBIN content or concentration, usually derived from ERYTHROCYTE COUNT; BLOOD hemoglobin concentration; and HEMATOCRIT. The indices include the mean corpuscular volume %28%MCV%29%, the mean corpuscular hemoglobin %28%MCH%29%, and the mean corpuscular hemoglobin concentration %28%MCHC%29%.%A%
% 208.27/208.41 |- mesh__activeMeSHYear mesh__D004909 2004
% 208.27/208.41 |- mesh__recordOriginator mesh__D004909 SMH
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Diameters, Erythrocyte
% 208.27/208.41 |- skos__historyNote mesh__D004909 Hematocrit %28%1966-1979%29%
% 208.27/208.41 |- skos__altLabel mesh__D004909 Erythrocyte Index
% 208.27/208.41 |- skos__altLabel mesh__D004909 Red Cell Indexes
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Hemoglobins, Mean Corpuscular
% 208.27/208.41 |- skos__altLabel mesh__D004909 Red Cell Indices
% 208.27/208.41 |- skos__historyNote mesh__D004909 Erythrocytes, Abnormal %28%1968-1979%29%
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Volumes, Mean Cell
% 208.27/208.41 |- skos__hiddenLabel mesh__D004909 Indices, Erythrocyte
% 208.27/208.41 |- skos__altLabel mesh__D004909 Erythrocyte Volume, Mean Cell
% 208.27/208.42 |- skos__prefLabel mesh__D004909 Erythrocyte Indices
% 208.27/208.42 |- skos__hiddenLabel mesh__D004909 Indexes, Erythrocyte
% 208.27/208.42 |- skos__historyNote mesh__D004909 Hemoglobins %28%1966-1979%29%
% 208.27/208.42 |- skos__hiddenLabel mesh__D004909 Thickness, Erythrocyte
% 208.27/208.42 |- mesh__dateCreated mesh__D001611 1974-12-12
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D001611 2006
% 208.27/208.42 |- skos__prefLabel mesh__D001611 Beta Rhythm
% 208.27/208.42 |- skos__hiddenLabel mesh__D001611 Beta Rhythms
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D001611 2001
% 208.27/208.42 |- rdf__type mesh__D001611sskos__Concept
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D001611 2003
% 208.27/208.42 |- skos__scopeNote mesh__D001611
% 208.27/208.42 Brain waves with frequency greater than 13 Hz seen on EEG during wakefulness.%A%
% 208.27/208.42 |- skos__annotation mesh__D001611 /drug eff /rad eff permitted
% 208.27/208.42 |- mesh__dateRevised mesh__D001611 1999-11-03
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D001611 2004
% 208.27/208.42 |- skos__altLabel mesh__D001611 Electroencephalography, Beta Rhythm
% 208.27/208.42 |- skos__hiddenLabel mesh__D001611 Rhythms, Beta
% 208.27/208.42 |- mesh__historyNote mesh__D001611
% 208.27/208.42 91%28%75%29%; was see under ELECTROENCEPHALOGRAPHY 1975-90
% 208.27/208.42 |- skos__hiddenLabel mesh__D001611 Rhythm, Beta
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D001611 2002
% 208.27/208.42 |- mesh__dateEstablished mesh__D001611 1991-01-01
% 208.27/208.42 |- mesh__recordOriginator mesh__D001611 NLM
% 208.27/208.42 |- mesh__recordMaintainer mesh__D001611 KEV
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D001611
% 208.27/208.42 91; was see under ELECTROENCEPHALOGRAPHY 1975-90
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D001611 2005
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D001611 2000
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D001611 sjn
% 208.27/208.42 |- skos__broader mesh__D001611smesh__D004569
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D020576 2000
% 208.27/208.42 |- skos__scopeNote mesh__D020576
% 208.27/208.42 A genus of gram-negative, rod-shaped to ellipsoidal bacteria occurring singly or in pairs and found in flowers, soil, honey bees, fruits, cider, beer, wine, and vinegar. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.27/208.42 |- skos__prefLabel mesh__D020576 Gluconobacter
% 208.27/208.42 |- mesh__dateRevised mesh__D020576 2005-06-30
% 208.27/208.42 |- skos__broader mesh__D020576smesh__D016947
% 208.27/208.42 |- mesh__dateCreated mesh__D020576 1999-11-03
% 208.27/208.42 |- rdf__type mesh__D020576sskos__Concept
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D020576 sjn
% 208.27/208.42 |- skos__annotation mesh__D020576
% 208.27/208.42 do not confuse X ref GLUCONOBACTER SUBOXYDANS with GLUCONOBACTER OXYDANS%A%
% 208.27/208.42 |- mesh__historyNote mesh__D020576 2000
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D020576 2006
% 208.27/208.42 |- mesh__recordOriginator mesh__D020576 ndw
% 208.27/208.42 |- mesh__recordMaintainer mesh__D020576 ags
% 208.27/208.42 |- mesh__dateEstablished mesh__D020576 2000-01-01
% 208.27/208.42 |- mesh__dateEstablished mesh__D039281 2003-01-01
% 208.27/208.42 |- mesh__dateCreated mesh__D039281 2002-07-02
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D039281 2003
% 208.27/208.42 |- rdf__type mesh__D039281sskos__Concept
% 208.27/208.42 |- skos__scopeNote mesh__D039281
% 208.27/208.42 A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida.%A%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D039281 2004
% 208.27/208.42 |- skos__prefLabel mesh__D039281 Nyctaginaceae
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D039281 2005
% 208.27/208.42 |- skos__annotation mesh__D039281
% 208.27/208.42 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.27/208.42 |- skos__broader mesh__D039281smesh__D019684
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D039281 2003
% 208.27/208.42 |- skos__altLabel mesh__D039281 Boerhaavia
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D039281 2006
% 208.27/208.42 |- mesh__historyNote mesh__D039281 2003
% 208.27/208.42 |- skos__altLabel mesh__D014539 UDP Sugars
% 208.27/208.42 |- skos__hiddenLabel mesh__D014539 Sugars, UDP
% 208.27/208.42 |- mesh__recordOriginator mesh__D014539 NLM
% 208.27/208.42 |- mesh__historyNote mesh__D014539 73
% 208.27/208.42 |- mesh__dateRevised mesh__D014539 2004-07-07
% 208.27/208.42 |- mesh__dateEstablished mesh__D014539 1973-01-01
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D014539 73
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D014539 2006
% 208.27/208.42 |- mesh__recordMaintainer mesh__D014539 ssb
% 208.27/208.42 |- skos__broader mesh__D014539smesh__D009702
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D014539 2005
% 208.27/208.42 |- mesh__dateCreated mesh__D014539 1999-01-01
% 208.27/208.42 |- skos__historyNote mesh__D014539 specific carbohydrate %28%1966-1972%29%
% 208.27/208.42 |- skos__broader mesh__D014539smesh__D014530
% 208.27/208.42 |- skos__hiddenLabel mesh__D014539 Sugars, Uridine Diphosphate
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D014539 sjn
% 208.27/208.42 |- rdf__type mesh__D014539sskos__Concept
% 208.27/208.42 |- skos__prefLabel mesh__D014539 Uridine Diphosphate Sugars
% 208.27/208.42 |- skos__hiddenLabel mesh__D014539 Diphosphate Sugars, Uridine
% 208.27/208.42 |- skos__historyNote mesh__D014539 Uracil Nucleotides %28%1966-1972%29%
% 208.27/208.42 |- skos__altLabel mesh__D025261 Mitochondrial F%28%1%29%F%28%0%29% ATPase
% 208.27/208.42 |- skos__hiddenLabel mesh__D025261
% 208.27/208.42 Mitochondrial Proton Translocating ATPases
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D025261 2006
% 208.27/208.42 |- skos__scopeNote mesh__D025261
% 208.27/208.42 Proton-translocating ATPases responsible for ADENOSINE TRIPHOSPHATE synthesis in the MITOCHONDRIA. They derive energy from the respiratory chain-driven reactions that develop high concentrations of protons within the intermembranous space of the mitochondria.%A%
% 208.27/208.42 |- mesh__dateRevised mesh__D025261 2003-07-09
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D025261 2004
% 208.27/208.42 |- mesh__dateCreated mesh__D025261 2001-07-25
% 208.27/208.42 |- skos__prefLabel mesh__D025261 Mitochondrial Proton-Translocating ATPases
% 208.27/208.42 |- skos__hiddenLabel mesh__D025261
% 208.27/208.42 ATPases, Mitochondrial Proton-Translocating
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D025261 2005
% 208.27/208.42 |- rdf__type mesh__D025261sskos__Concept
% 208.27/208.42 |- skos__hiddenLabel mesh__D025261 ATP Synthases, Mitochondrial
% 208.27/208.42 |- skos__altLabel mesh__D025261 Mitochondrial ATP Synthase
% 208.27/208.42 |- mesh__dateEstablished mesh__D025261 2002-01-01
% 208.27/208.42 |- skos__broader mesh__D025261smesh__D006180
% 208.27/208.42 |- mesh__historyNote mesh__D025261 2002
% 208.27/208.42 |- skos__historyNote mesh__D025261
% 208.27/208.42 Proton-Translocating ATPases %28%1979-2001%29%
% 208.27/208.42 |- skos__hiddenLabel mesh__D025261
% 208.27/208.42 Proton-Translocating ATPases, Mitochondrial
% 208.27/208.42 |- skos__hiddenLabel mesh__D025261 ATP Synthase, Mitochondrial
% 208.27/208.42 |- skos__altLabel mesh__D025261 Mitochondrial ATP Synthases
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D025261 2002
% 208.27/208.42 |- skos__hiddenLabel mesh__D019224 Joint Disks, Temporomandibular
% 208.27/208.42 |- skos__broader mesh__D019224smesh__D013704
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 1997
% 208.27/208.42 |- skos__hiddenLabel mesh__D019224 Disk, Temporomandibular Articular
% 208.27/208.42 |- skos__scopeNote mesh__D019224
% 208.27/208.42 A plate of fibrous tissue that divides the temporomandibular joint into an upper and lower cavity. The disk is attached to the articular capsule and moves forward with the condyle in free opening and protrusion. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p92%29%%A%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 2006
% 208.27/208.42 |- skos__hiddenLabel mesh__D019224 Disks, Temporomandibular Joint
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 2005
% 208.27/208.42 |- rdf__type mesh__D019224sskos__Concept
% 208.27/208.42 |- mesh__dateEstablished mesh__D019224 1997-01-01
% 208.27/208.42 |- skos__hiddenLabel mesh__D019224 Articular Disks, Temporomandibular
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 2002
% 208.27/208.42 |- mesh__dateCreated mesh__D019224 1996-06-10
% 208.27/208.42 |- skos__hiddenLabel mesh__D019224 Temporomandibular Articular Disks
% 208.27/208.42 |- mesh__historyNote mesh__D019224 97
% 208.27/208.42 |- skos__annotation mesh__D019224
% 208.27/208.42 disk displacement: coord IM with DISLOCATIONS %28%IM%29%; DF: TMJ DISK%A%
% 208.27/208.42 |- skos__hiddenLabel mesh__D019224 Temporomandibular Articular Disk
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 2004
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 2001
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 1999
% 208.27/208.42 |- skos__altLabel mesh__D019224 Articular Disk, Temporomandibular
% 208.27/208.42 |- skos__hiddenLabel mesh__D019224 Temporomandibular Joint Disks
% 208.27/208.42 |- skos__historyNote mesh__D019224
% 208.27/208.42 Temporomandibular Joint %28%1966-1996%29%
% 208.27/208.42 |- skos__hiddenLabel mesh__D019224 Disks, Temporomandibular Articular
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 2003
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 1998
% 208.27/208.42 |- skos__prefLabel mesh__D019224 Temporomandibular Joint Disk
% 208.27/208.42 |- skos__altLabel mesh__D019224 Disk, Temporomandibular Joint
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D019224 97
% 208.27/208.42 |- skos__hiddenLabel mesh__D019224 Joint Disk, Temporomandibular
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D019224 2000
% 208.27/208.42 |- mesh__dateRevised mesh__D000519 2003-07-09
% 208.27/208.42 |- mesh__recordOriginator mesh__D000519 RLS
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D000519
% 208.27/208.42 94; was ALPHA-GALACTOSIDASES 1978-93 %28%see under GALACTOSIDASES 1978-90%29%; MELIBIASES was see ALPHA-GALACTOSIDASE 1978-93; MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74%A%
% 208.27/208.42 |- mesh__recordMaintainer mesh__D000519 ssb
% 208.27/208.42 |- skos__hiddenLabel mesh__D000519 alpha Galactosidase A
% 208.27/208.42 |- skos__altLabel mesh__D000519 alpha-Galactosidases
% 208.27/208.42 |- skos__historyNote mesh__D000519 Galactosidases %28%1966-1978%29%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D000519 2005
% 208.27/208.42 |- rdf__type mesh__D000519sskos__Concept
% 208.27/208.42 |- skos__broader mesh__D000519smesh__D005696
% 208.27/208.42 |- skos__hiddenLabel mesh__D000519 alpha Galactosidases
% 208.27/208.42 |- skos__scopeNote mesh__D000519
% 208.27/208.42 An enzyme that catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids. EC 3.2.1.22.%A%
% 208.27/208.42 |- mesh__dateCreated mesh__D000519 1977-04-15
% 208.27/208.42 |- skos__altLabel mesh__D000519 alpha-Galactosidase A
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D000519 2006
% 208.27/208.42 |- mesh__onlineNote mesh__D000519
% 208.27/208.42 use ALPHA-GALACTOSIDASE to search ALPHA-GALACTOSIDASES %26% MELIBIASES 1978-93; use GALACTOSIDASES to search MELIBIASE 1966-78%A%
% 208.27/208.42 |- mesh__historyNote mesh__D000519
% 208.27/208.42 94; was ALPHA-GALACTOSIDASES 1978-93 %28%see under GALACTOSIDASES 1978-90%29%; MELIBIASES was see ALPHA-GALACTOSIDASES 1978-93; MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74%A%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D000519 2004
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D000519 sjn
% 208.27/208.42 |- mesh__dateEstablished mesh__D000519 1991-01-01
% 208.27/208.42 |- skos__hiddenLabel mesh__D000519 alpha Galactosidase
% 208.27/208.42 |- skos__altLabel mesh__D000519 Melibiase
% 208.27/208.42 |- skos__prefLabel mesh__D000519 alpha-Galactosidase
% 208.27/208.42 |- skos__altLabel mesh__D011241 Lichtenstein Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 delta-Cortisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 GALENpharma Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 acis Brand of Prednisone
% 208.27/208.42 |- mesh__dateCreated mesh__D011241 1999-01-01
% 208.27/208.42 |- skos__altLabel mesh__D011241 Trommsdorff Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 Merck Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 Hoechst Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 mibe Brand of Prednisone
% 208.27/208.42 |- skos__prefLabel mesh__D011241 Prednisone
% 208.27/208.42 |- mesh__recordOriginator mesh__D011241 NLM
% 208.27/208.42 |- skos__altLabel mesh__D011241 Diba Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 ICN Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 Dehydrocortisone
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D011241 2006
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D011241
% 208.27/208.42 /adverse effects /poisoning /toxicity were PREDNISONE TOXICOLOGY 1963-65; /therapeutic use was PREDNISONE, THERAPEUTIC 1965%A%
% 208.27/208.42 |- skos__altLabel mesh__D011241 Seatrace Brand of Prednisone
% 208.27/208.42 |- skos__scopeNote mesh__D011241
% 208.27/208.42 A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.%A%
% 208.27/208.42 |- skos__altLabel mesh__D011241 Panafcort
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D011241 sjn
% 208.27/208.42 |- skos__altLabel mesh__D011241 Aventis Brand of Prednisone
% 208.27/208.42 |- mesh__historyNote mesh__D011241
% 208.27/208.42 /adv eff-pois-tox was PREDNISONE TOXICOLOGY 1963-65; /ther use was PREDNISONE, THERAPEUTIC 1965%A%
% 208.27/208.42 |- skos__altLabel mesh__D011241 Schering-Plough Brand of Prednisone
% 208.27/208.42 |- skos__annotation mesh__D011241
% 208.27/208.42 do not confuse trade name Decortin %28%Merck%29% with DESOXYCORTICOSTERONE tradename Decortin %28%Schieffelin%29%%A%
% 208.27/208.42 |- skos__altLabel mesh__D011241 Decortin Brand of Prednisone
% 208.27/208.42 |- mesh__dateRevised mesh__D011241 2005-06-30
% 208.27/208.42 |- skos__altLabel mesh__D011241 Pharmacia Brand of Prednisone
% 208.27/208.42 |- skos__broader mesh__D011241smesh__D011244
% 208.27/208.42 |- skos__altLabel mesh__D011241 Hexal Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 Ferring Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 Merz Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 Fawns %26% McAllan Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 Encorton
% 208.27/208.42 |- skos__altLabel mesh__D011241 Halsey Drug Brand of Prednisone
% 208.27/208.42 |- skos__altLabel mesh__D011241 Apotex Brand of Prednisone
% 208.27/208.42 |- mesh__recordMaintainer mesh__D011241 lkw
% 208.27/208.42 |- rdf__type mesh__D011241sskos__Concept
% 208.27/208.42 |- skos__altLabel mesh__D011241 Solvay Brand of Prednisone
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D005204 68
% 208.27/208.42 |- skos__broader mesh__D005204smesh__D012717
% 208.27/208.42 |- skos__scopeNote mesh__D005204
% 208.27/208.42 A colorless liquid extracted from oils of plants such as citronella, neroli, cyclamen, and tuberose. It is an intermediate step in the biological synthesis of cholesterol from mevalonic acid in vertebrates. It has a delicate odor and is used in perfumery. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%
% 208.27/208.42 |- skos__broader mesh__D005204smesh__D005233
% 208.27/208.42 |- mesh__dateEstablished mesh__D005204 1968-01-01
% 208.27/208.42 |- rdf__type mesh__D005204sskos__Concept
% 208.27/208.42 |- mesh__historyNote mesh__D005204
% 208.27/208.42 68; was FARNESYL COMPOUNDS 1965-67 %28%Prov%29%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005204 2004
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005204 2006
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005204 2005A
% 208.27/208.42 |- mesh__dateRevised mesh__D005204 2004-07-27
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005204 2005
% 208.27/208.42 |- mesh__recordMaintainer mesh__D005204 jls
% 208.27/208.42 |- mesh__onlineNote mesh__D005204
% 208.27/208.42 use FARNESOL to search FARNESYL COMPOUNDS 1966-67 %28%as Prov%29%%A%
% 208.27/208.42 |- mesh__dateCreated mesh__D005204 1999-01-01
% 208.27/208.42 |- skos__prefLabel mesh__D005204 Farnesol
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D005204 jls
% 208.27/208.42 |- mesh__recordOriginator mesh__D005204 NLM
% 208.27/208.42 |- skos__broader mesh__D010947smesh__D010944
% 208.27/208.42 |- skos__altLabel mesh__D010947 Plants, Poisonous
% 208.27/208.42 |- skos__annotation mesh__D010947 IM general only
% 208.27/208.42 |- mesh__dateCreated mesh__D010947 1975-07-23
% 208.27/208.42 |- skos__related mesh__D010947smesh__D010939
% 208.27/208.42 |- mesh__historyNote mesh__D010947 1976; was NON MESH before 1976;
% 208.27/208.42 |- mesh__recordOriginator mesh__D010947 JW
% 208.27/208.42 |- rdf__type mesh__D010947sskos__Concept
% 208.27/208.42 |- skos__prefLabel mesh__D010947 Plants, Toxic
% 208.27/208.42 |- mesh__dateEstablished mesh__D010947 1976-01-01
% 208.27/208.42 |- skos__scopeNote mesh__D010947
% 208.27/208.42 Plants or plant parts which are harmful to man or other animals.%A%
% 208.27/208.42 |- mesh__recordMaintainer mesh__D010947 ssb
% 208.27/208.42 |- mesh__dateRevised mesh__D010947 2005-06-30
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010947 2006
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D010947 1976
% 208.27/208.42 |- skos__historyNote mesh__D010947 Plants %28%1966-1975%29%
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D010947 sjn
% 208.27/208.42 |- skos__altLabel mesh__D043323 Neutral alpha-Mannosidase
% 208.27/208.42 |- mesh__dateCreated mesh__D043323 2003-07-09
% 208.27/208.42 |- skos__prefLabel mesh__D043323 alpha-Mannosidase
% 208.27/208.42 |- skos__hiddenLabel mesh__D043323 Neutral alpha Mannosidase
% 208.27/208.42 |- skos__hiddenLabel mesh__D043323 alpha D Mannoside Mannohydrolase
% 208.27/208.42 |- skos__annotation mesh__D043323
% 208.27/208.42 /DEFIC: consider also ALPHA-MANNOSIDOSIS
% 208.27/208.42 |- skos__altLabel mesh__D043323 LAMAN
% 208.27/208.42 |- skos__altLabel mesh__D043323 alpha Mannosidase B
% 208.27/208.42 |- skos__hiddenLabel mesh__D043323 alpha D Mannosidase
% 208.27/208.42 |- skos__broader mesh__D043323smesh__D008361
% 208.27/208.42 |- mesh__dateEstablished mesh__D043323 2004-01-01
% 208.27/208.42 |- skos__hiddenLabel mesh__D043323 alpha-Mannosidase, Neutral
% 208.27/208.42 |- mesh__historyNote mesh__D043323
% 208.27/208.42 2004; use ALPHA-MANNOSIDASE %28%NM%29% 1980-2003
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D043323 2006
% 208.27/208.42 |- rdf__type mesh__D043323sskos__Concept
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D043323 2004
% 208.27/208.42 |- skos__hiddenLabel mesh__D043323 Mannosidase B, alpha
% 208.27/208.42 |- skos__altLabel mesh__D043323 alpha-D-Mannoside Mannohydrolase
% 208.27/208.42 |- skos__hiddenLabel mesh__D043323 alpha Mannosidase
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D043323 2005
% 208.27/208.42 |- skos__scopeNote mesh__D043323
% 208.27/208.42 An enzyme that catalyzes the HYDROLYSIS of terminal, non-reducing alpha-D-mannose residues in alpha-D-mannosides. The enzyme plays a role in the processing of newly formed N-glycans and in degradation of mature GLYCOPROTEINS. There are multiple isoforms of alpha-mannosidase, each having its own specific cellular location and pH optimum. Defects in the lysosomal form of the enzyme results in a buildup of mannoside intermediate metabolites and the disease ALPHA-MANNOSIDOSIS.%A%
% 208.27/208.42 |- skos__hiddenLabel mesh__D043323 alpha-Mannosidase, Lysosomal
% 208.27/208.42 |- skos__hiddenLabel mesh__D043323 Mannohydrolase, alpha-D-Mannoside
% 208.27/208.42 |- skos__historyNote mesh__D043323 Mannosidases %28%1980-2003%29%
% 208.27/208.42 |- skos__altLabel mesh__D043323 alpha-D-Mannosidase
% 208.27/208.42 |- skos__related mesh__D043323smesh__D008363
% 208.27/208.42 |- skos__hiddenLabel mesh__D043323 Lysosomal alpha Mannosidase
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D043323
% 208.27/208.42 2004; ALPHA-MANNOSIDASE was indexed under MANNOSIDASES 1980-2003%A%
% 208.27/208.42 |- skos__hiddenLabel mesh__D010149 Postoperative Pains
% 208.27/208.42 |- mesh__historyNote mesh__D010149 74
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D010149 sjn
% 208.27/208.42 |- mesh__dateRevised mesh__D010149 1999-11-03
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010149 2002
% 208.27/208.42 |- skos__scopeNote mesh__D010149 Pain during the period after surgery.
% 208.27/208.42 |- mesh__recordOriginator mesh__D010149 NLM
% 208.27/208.42 |- skos__annotation mesh__D010149 DF: PAIN POSTOP or POSTOP PAIN
% 208.27/208.42 |- mesh__recordMaintainer mesh__D010149 KEV
% 208.27/208.42 |- mesh__dateCreated mesh__D010149 1999-01-01
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010149 2006
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010149 2001
% 208.27/208.42 |- skos__broader mesh__D010149smesh__D010146
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010149 2005
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010149 2000
% 208.27/208.42 |- rdf__type mesh__D010149sskos__Concept
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010149 2004
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D010149 74
% 208.27/208.42 |- skos__broader mesh__D010149smesh__D011183
% 208.27/208.42 |- skos__altLabel mesh__D010149 Postoperative Pain
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010149 2003
% 208.27/208.42 |- mesh__dateEstablished mesh__D010149 1974-01-01
% 208.27/208.42 |- skos__prefLabel mesh__D010149 Pain, Postoperative
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D015632 sjn
% 208.27/208.42 |- mesh__dateRevised mesh__D015632 2005-06-30
% 208.27/208.42 |- mesh__recordMaintainer mesh__D015632 ssb
% 208.27/208.42 |- skos__altLabel mesh__D015632
% 208.27/208.42 N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
% 208.27/208.42 |- skos__altLabel mesh__D015632 MPTP
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D015632 90
% 208.27/208.42 |- mesh__historyNote mesh__D015632 90
% 208.27/208.42 |- skos__historyNote mesh__D015632 Pyridines %28%1966-1989%29%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D015632 2006
% 208.27/208.42 |- mesh__recordOriginator mesh__D015632 RLS
% 208.27/208.42 |- mesh__dateEstablished mesh__D015632 1990-01-01
% 208.27/208.42 |- mesh__dateCreated mesh__D015632 1989-05-25
% 208.27/208.42 |- skos__prefLabel mesh__D015632
% 208.27/208.42 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
% 208.27/208.42 |- skos__scopeNote mesh__D015632
% 208.27/208.42 A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.%A%
% 208.27/208.42 |- skos__broader mesh__D015632smesh__D011725
% 208.27/208.42 |- rdf__type mesh__D015632sskos__Concept
% 208.27/208.42 |- rdf__type mesh__D020577sskos__Concept
% 208.27/208.42 |- mesh__recordMaintainer mesh__D020577 SYSTEM
% 208.27/208.42 |- mesh__historyNote mesh__D020577 2000
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D020577 2000
% 208.27/208.42 |- skos__scopeNote mesh__D020577
% 208.27/208.42 A genus of bacteria comprised of a heterogenous group of gram-negative small rods and coccoid forms associated with arthropods. %28%From Bergey%27%s Manual of Systematic Bacteriology, vol 1, 1984%29%%A%
% 208.27/208.42 |- skos__historyNote mesh__D020577 Rickettsiaceae %28%1976-1999%29%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D020577 2006
% 208.27/208.42 |- mesh__recordOriginator mesh__D020577 ndw
% 208.27/208.42 |- mesh__dateRevised mesh__D020577 2005-06-30
% 208.27/208.42 |- skos__prefLabel mesh__D020577 Wolbachia
% 208.27/208.42 |- mesh__dateCreated mesh__D020577 1999-11-03
% 208.27/208.42 |- skos__broader mesh__D020577smesh__D012287
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D020577 sjn
% 208.27/208.42 |- mesh__dateEstablished mesh__D020577 2000-01-01
% 208.27/208.42 |- mesh__dateCreated mesh__D039282 2002-07-03
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D039282 2003
% 208.27/208.42 |- rdf__type mesh__D039282sskos__Concept
% 208.27/208.42 |- mesh__historyNote mesh__D039282 2003
% 208.27/208.42 |- mesh__dateEstablished mesh__D039282 2003-01-01
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D039282 2004
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D039282 2005
% 208.27/208.42 |- skos__scopeNote mesh__D039282
% 208.27/208.42 A plant genus of the family NYCTAGINACEAE. Members contain Mirabilis antiviral protein %28%a ribosome-inactivating protein%29%.%A%
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D039282 2003
% 208.27/208.42 |- skos__broader mesh__D039282smesh__D039281
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D039282 2006
% 208.27/208.42 |- skos__annotation mesh__D039282
% 208.27/208.42 do not confuse with PROTEUS MIRABILIS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.27/208.42 |- skos__prefLabel mesh__D039282 Mirabilis
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D025262 2005
% 208.27/208.42 |- skos__hiddenLabel mesh__D025262 Lysosomal Proton Translocating ATPases
% 208.27/208.42 |- skos__altLabel mesh__D025262 Vacuolar F%28%1%29%F%28%0%29% ATPases
% 208.27/208.42 |- mesh__recordMaintainer mesh__D025262 ssb
% 208.27/208.42 |- skos__altLabel mesh__D025262 Lysosomal Proton-Translocating ATPases
% 208.27/208.42 |- skos__historyNote mesh__D025262
% 208.27/208.42 Proton-Translocating ATPases %28%1984-2001%29%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D025262 2006
% 208.27/208.42 |- mesh__recordOriginator mesh__D025262 jmp
% 208.27/208.42 |- mesh__dateRevised mesh__D025262 2003-07-09
% 208.27/208.42 |- skos__scopeNote mesh__D025262
% 208.27/208.42 Proton-translocating ATPases that are involved in acidification of a variety of intracellular compartments.%A%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D025262 2004
% 208.27/208.42 |- skos__altLabel mesh__D025262 Lysosomal F%28%1%29%F%28%0%29% ATPase
% 208.27/208.42 |- mesh__dateCreated mesh__D025262 2001-07-25
% 208.27/208.42 |- skos__altLabel mesh__D025262 Vacuolar F%28%1%29%F%28%0%29% ATPase
% 208.27/208.42 |- skos__hiddenLabel mesh__D025262 ATPases, Lysosomal Proton-Translocating
% 208.27/208.42 |- rdf__type mesh__D025262sskos__Concept
% 208.27/208.42 |- skos__prefLabel mesh__D025262 Vacuolar Proton-Translocating ATPases
% 208.27/208.42 |- skos__hiddenLabel mesh__D025262 Proton-Translocating ATPases, Lysosomal
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D025262 sjn
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D025262 2002
% 208.27/208.42 |- mesh__historyNote mesh__D025262 2002
% 208.27/208.42 |- mesh__dateEstablished mesh__D025262 2002-01-01
% 208.27/208.42 |- skos__broader mesh__D025262smesh__D006180
% 208.27/208.42 |- rdf__type mesh__D005205sskos__Concept
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1989
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 2002
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 2004
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1997
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1991
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 2001
% 208.27/208.42 |- skos__prefLabel mesh__D005205 Fascia
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 2006
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1999
% 208.27/208.42 |- skos__hiddenLabel mesh__D005205 Fascias
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1993
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 2003
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1996
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1995
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1990
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 2000
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 2005
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1998
% 208.27/208.42 |- mesh__dateCreated mesh__D005205 1999-01-01
% 208.27/208.42 |- skos__broader mesh__D005205smesh__D009141
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1992
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D005205 1994
% 208.27/208.42 |- skos__scopeNote mesh__D010948
% 208.27/208.42 Method for measuring viral infectivity and multiplication in cultured cells. Clear lysed areas or plaques develop as the viral particles are released from the infected cells during incubation. With some viruses, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain viral antigens which can be measured by immunofluorescence.%A%
% 208.27/208.42 |- mesh__dateEstablished mesh__D010948 1973-01-01
% 208.27/208.42 |- mesh__dateCreated mesh__D010948 1999-01-01
% 208.27/208.42 |- mesh__publicMeSHNote mesh__D010948 73
% 208.27/208.42 |- mesh__recordAuthorizer mesh__D010948 sjn
% 208.27/208.42 |- mesh__recordOriginator mesh__D010948 NLM
% 208.27/208.42 |- rdf__type mesh__D010948sskos__Concept
% 208.27/208.42 |- skos__historyNote mesh__D010948 Virus Cultivation %28%1966-1972%29%
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010948 2004
% 208.27/208.42 |- mesh__activeMeSHYear mesh__D010948 2001
% 208.27/208.43 |- skos__broader mesh__D010948smesh__D014776
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D010948 2003
% 208.27/208.43 |- mesh__dateRevised mesh__D010948 2000-06-21
% 208.27/208.43 |- mesh__recordMaintainer mesh__D010948 TAP
% 208.27/208.43 |- skos__hiddenLabel mesh__D010948 Assay, Plaque
% 208.27/208.43 |- mesh__historyNote mesh__D010948 73
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D010948 2006
% 208.27/208.43 |- skos__prefLabel mesh__D010948 Plaque Assay
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D010948 2005
% 208.27/208.43 |- skos__hiddenLabel mesh__D010948 Plaque Assays
% 208.27/208.43 |- skos__annotation mesh__D010948
% 208.27/208.43 for viruses; coord IM or NIM with specific virus /growth %28%IM%29%; do not confuse with HEMOLYTIC PLAQUE TECHNIQUE in immunol%A%
% 208.27/208.43 |- skos__hiddenLabel mesh__D010948 Assays, Plaque
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D010948 2002
% 208.27/208.43 |- skos__prefLabel mesh__D043324 beta-Fructofuranosidase
% 208.27/208.43 |- skos__hiddenLabel mesh__D043324 beta Fructofuranosidase
% 208.27/208.43 |- mesh__historyNote mesh__D043324
% 208.27/208.43 2004; use BETA-FRUCTOFURANOSIDASE %28%NM%29% 1980-2003
% 208.27/208.43 |- skos__altLabel mesh__D043324 beta-Fructosidase
% 208.27/208.43 |- mesh__recordMaintainer mesh__D043324 AKE
% 208.27/208.43 |- rdf__type mesh__D043324sskos__Concept
% 208.27/208.43 |- skos__historyNote mesh__D043324 Glycoside Hydrolases %28%1983-2003%29%
% 208.27/208.43 |- skos__historyNote mesh__D043324 Fructose %28%1979-1981%29%
% 208.27/208.43 |- skos__scopeNote mesh__D043324
% 208.27/208.43 A glycoside hydrolase found primarily in PLANTS and YEASTS. It has specificity for beta-D-fructofuranosides such as SUCROSE.%A%
% 208.27/208.43 |- skos__hiddenLabel mesh__D043324 beta Fructosidase
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D043324 2006
% 208.27/208.43 |- skos__altLabel mesh__D043324 beta-D-Fructofuranosidase
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D043324 2004
% 208.27/208.43 |- skos__hiddenLabel mesh__D043324 Hydrolase, Sucrose 6-Phosphate
% 208.27/208.43 |- skos__altLabel mesh__D043324 Saccharase
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D043324 2005
% 208.27/208.43 |- skos__altLabel mesh__D043324 Sucrose 6-Phosphate Hydrolase
% 208.27/208.43 |- skos__hiddenLabel mesh__D043324 Sucrose 6 Phosphate Hydrolase
% 208.27/208.43 |- mesh__recordOriginator mesh__D043324 AKE
% 208.27/208.43 |- skos__hiddenLabel mesh__D043324 beta D Fructofuranosidase
% 208.27/208.43 |- mesh__dateCreated mesh__D043324 2003-07-09
% 208.27/208.43 |- skos__historyNote mesh__D043324 Sucrase %28%1979-2003%29%
% 208.27/208.43 |- skos__hiddenLabel mesh__D043324 6-Phosphate Hydrolase, Sucrose
% 208.27/208.43 |- mesh__dateEstablished mesh__D043324 2004-01-01
% 208.27/208.43 |- skos__broader mesh__D043324smesh__D006026
% 208.27/208.43 |- skos__altLabel mesh__D043324 Invertase
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D043324 sjn
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D043324
% 208.27/208.43 2004; BETA-FRUCTOFURANOSIDASE was indexed under GLYCOSIDE HYDROLASES 1983-2003, under SUCRASE 1979-1982, %26% under FRUCTOSE 1979-1981%A%
% 208.27/208.43 |- skos__hiddenLabel mesh__D043324 Invertase, Acid
% 208.27/208.43 |- skos__altLabel mesh__D043324 Acid Invertase
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D015633 2006
% 208.27/208.43 |- mesh__recordMaintainer mesh__D015633 nns
% 208.27/208.43 |- skos__annotation mesh__D015633 DF: EVLW
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D015633 90
% 208.27/208.43 |- skos__hiddenLabel mesh__D015633 Water, Extravascular Lung
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D015633 2005
% 208.27/208.43 |- mesh__dateEstablished mesh__D015633 1990-01-01
% 208.27/208.43 |- skos__historyNote mesh__D015633 Body Water %28%1972-1989%29%
% 208.27/208.43 |- skos__historyNote mesh__D015633 Extracellular Space %28%1978-1989%29%
% 208.27/208.43 |- mesh__dateRevised mesh__D015633 2003-07-09
% 208.27/208.43 |- skos__scopeNote mesh__D015633
% 208.27/208.43 Water present within the lungs; its volume is roughly equal to, or a little less than, the intracellular blood volume of the lungs. Accumulations of extravascular lung water result in pulmonary edema.%A%
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D015633 sjn
% 208.27/208.43 |- skos__prefLabel mesh__D015633 Extravascular Lung Water
% 208.27/208.43 |- skos__altLabel mesh__D015633 Lung Water, Extra Vascular
% 208.27/208.43 |- mesh__historyNote mesh__D015633 90
% 208.27/208.43 |- skos__altLabel mesh__D015633 Extra Vascular Lung Water
% 208.27/208.43 |- skos__altLabel mesh__D015633 Lung Water, Extravascular
% 208.27/208.43 |- rdf__type mesh__D015633sskos__Concept
% 208.27/208.43 |- mesh__dateCreated mesh__D015633 1989-04-07
% 208.27/208.43 |- skos__broader mesh__D015633smesh__D045604
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D015633 2004
% 208.27/208.43 |- skos__historyNote mesh__D015633 Lung %28%1969-1989%29%
% 208.27/208.43 |- skos__broader mesh__D015633smesh__D008168
% 208.27/208.43 |- mesh__recordOriginator mesh__D015633 PXP
% 208.27/208.43 |- mesh__historyNote mesh__D001613
% 208.27/208.43 91%28%75%29%; was BETA 2 MICROGLOBULIN 1984-90; was see under BETA GLOBULINS 1975-83%A%
% 208.27/208.43 |- mesh__onlineNote mesh__D001613
% 208.27/208.43 use BETA 2-MICROGLOBULIN tosearch BETA 2 MICROGLOBULIN 1984-90%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D001613 2006
% 208.27/208.43 |- skos__hiddenLabel mesh__D001613 2-Microglobulin, beta
% 208.27/208.43 |- mesh__recordMaintainer mesh__D001613 jmp
% 208.27/208.43 |- rdf__type mesh__D001613sskos__Concept
% 208.27/208.43 |- skos__scopeNote mesh__D001613
% 208.27/208.43 An 11-kDa protein associated with the outer membrane of many cells including lymphocytes. It is the small subunit of the MHC class I molecule. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinemia, renal failure, or kidney transplants.%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D001613 2005
% 208.27/208.43 |- mesh__recordOriginator mesh__D001613 NLM
% 208.27/208.43 |- skos__annotation mesh__D001613 /biosyn /physiol /blood permitted
% 208.27/208.43 |- skos__prefLabel mesh__D001613 beta 2-Microglobulin
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D001613
% 208.27/208.43 91; was BETA 2 MICROGLOBULIN 1984-90; was see under BETA GLOBULINS 1975-83%A%
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D001613 sjn
% 208.27/208.43 |- mesh__dateCreated mesh__D001613 1974-11-19
% 208.27/208.43 |- skos__hiddenLabel mesh__D001613 beta 2 Microglobulin
% 208.27/208.43 |- mesh__dateEstablished mesh__D001613 1984-01-01
% 208.27/208.43 |- skos__broader mesh__D001613smesh__D001609
% 208.27/208.43 |- skos__altLabel mesh__D001613 Thymotaxin
% 208.27/208.43 |- mesh__dateRevised mesh__D001613 2004-07-07
% 208.27/208.43 |- skos__historyNote mesh__D001613 Beta Globulins %28%1973-1974%29%
% 208.27/208.43 |- mesh__dateEstablished mesh__D020578 2000-01-01
% 208.27/208.43 |- skos__prefLabel mesh__D020578 Sphingomonas
% 208.27/208.43 |- rdf__type mesh__D020578sskos__Concept
% 208.27/208.43 |- mesh__recordOriginator mesh__D020578 ndw
% 208.27/208.43 |- mesh__dateCreated mesh__D020578 1999-11-03
% 208.27/208.43 |- skos__scopeNote mesh__D020578
% 208.27/208.43 A genus of gram-negative, aerobic, rod-shaped bacteria characterized by an outer membrane that contains glycosphingolipids but lacks lipopolysaccharide. They have the ability to degrade a broad range of substituted aromatic compounds.%A%
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D020578 2000
% 208.27/208.43 |- skos__broader mesh__D020578smesh__D042301
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D020578 2006
% 208.27/208.43 |- mesh__recordMaintainer mesh__D020578 SYSTEM
% 208.27/208.43 |- skos__broader mesh__D020578smesh__D016946
% 208.27/208.43 |- mesh__historyNote mesh__D020578 2000
% 208.27/208.43 |- skos__annotation mesh__D020578
% 208.27/208.43 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 208.27/208.43 |- mesh__dateRevised mesh__D020578 2005-06-30
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D020578 sjn
% 208.27/208.43 |- mesh__historyNote mesh__D019226 97
% 208.27/208.43 |- skos__related mesh__D019226smesh__D009625
% 208.27/208.43 |- skos__hiddenLabel mesh__D019226 Mouth Ulcers
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D019226 2004
% 208.27/208.43 |- skos__annotation mesh__D019226
% 208.27/208.43 coord IM with cause %28%IM%29% if pertinent; not a synonym for STOMATITIS, APHTHOUS%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D019226 2002
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D019226 ags
% 208.27/208.43 |- skos__hiddenLabel mesh__D019226 Ulcers, Oral
% 208.27/208.43 |- mesh__dateCreated mesh__D019226 1996-06-10
% 208.27/208.43 |- skos__historyNote mesh__D019226 Ulcer %28%1966-1996%29%
% 208.27/208.43 |- skos__hiddenLabel mesh__D019226 Ulcers, Mouth
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D019226 2003
% 208.27/208.43 |- mesh__recordMaintainer mesh__D019226 ags
% 208.27/208.43 |- skos__scopeNote mesh__D019226
% 208.27/208.43 A loss of mucous substance of the mouth showing local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue. It is the result of a variety of causes, e.g., denture irritation, aphthous stomatitis %28%STOMATITIS, APHTHOUS%29%; NOMA; necrotizing gingivitis %28%GINGIVITIS, NECROTIZING ULCERATIVE%29%; TOOTHBRUSHING; and various irritants. %28%From Jablonski, Dictionary of Dentistry, 1992, p842%29%%A%
% 208.27/208.43 |- skos__historyNote mesh__D019226 Mouth Diseases %28%1966-1996%29%
% 208.27/208.43 |- skos__historyNote mesh__D019226 Stomatitis %28%1966-1996%29%
% 208.27/208.43 |- mesh__recordOriginator mesh__D019226 TGC
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D019226 97
% 208.27/208.43 |- skos__related mesh__D019226smesh__D005892
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D019226 2006A
% 208.27/208.43 |- mesh__dateRevised mesh__D019226 2005-07-15
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D019226 2006
% 208.27/208.43 |- skos__broader mesh__D019226smesh__D009059
% 208.27/208.43 |- skos__related mesh__D019226smesh__D013281
% 208.27/208.43 |- skos__hiddenLabel mesh__D019226 Ulcer, Mouth
% 208.27/208.43 |- rdf__type mesh__D019226sskos__Concept
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D019226 2005
% 208.27/208.43 |- skos__historyNote mesh__D019226 Stomatitis, Aphthous %28%1966-1996%29%
% 208.27/208.43 |- skos__prefLabel mesh__D019226 Oral Ulcer
% 208.27/208.43 |- mesh__dateEstablished mesh__D019226 1997-01-01
% 208.27/208.43 |- skos__hiddenLabel mesh__D019226 Oral Ulcers
% 208.27/208.43 |- skos__altLabel mesh__D019226 Mouth Ulcer
% 208.27/208.43 |- skos__hiddenLabel mesh__D019226 Ulcer, Oral
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011243 2005
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D011243 sjn
% 208.27/208.43 |- skos__hiddenLabel mesh__D011243 Organization, Preferred Provider
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011243 2006
% 208.27/208.43 |- mesh__recordMaintainer mesh__D011243 kle
% 208.27/208.43 |- skos__prefLabel mesh__D011243 Preferred Provider Organizations
% 208.27/208.43 |- skos__altLabel mesh__D011243 Organizations, Preferred Provider
% 208.27/208.43 |- skos__broader mesh__D011243smesh__D008329
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011243 2000
% 208.27/208.43 |- mesh__dateEstablished mesh__D011243 1991-01-01
% 208.27/208.43 |- rdf__type mesh__D011243sskos__Concept
% 208.27/208.43 |- skos__scopeNote mesh__D011243
% 208.27/208.43 Arrangements negotiated between a third-party payer %28%often a self-insured company or union trust fund%29% and a group of health-care providers %28%hospitals and physicians%29% who furnish services at lower than usual fees, and, in return, receive prompt payment and an expectation of an increased volume of patients.%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011243 2003
% 208.27/208.43 |- mesh__dateCreated mesh__D011243 1984-04-13
% 208.27/208.43 |- mesh__onlineNote mesh__D011243
% 208.27/208.43 use INSURANCE, HEALTH to search PREFERRED PROVIDER ORGANIZATIONS 1984%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011243 2001
% 208.27/208.43 |- mesh__dateRevised mesh__D011243 1999-11-03
% 208.27/208.43 |- skos__historyNote mesh__D011243 Insurance, Health %28%1966-1984%29%
% 208.27/208.43 |- mesh__recordOriginator mesh__D011243 EC
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D011243
% 208.27/208.43 91; was see under MANAGED CARE PROGRAMS 1990; was see under INSURANCE, HEALTH 1985-89; was see INSURANCE, HEALTH 1984%A%
% 208.27/208.43 |- mesh__historyNote mesh__D011243
% 208.27/208.43 91%28%85%29%; was see under MANAGED CARE PROGRAMS 1990; was see under INSURANCE, HEALTH 1985-89; was see INSURANCE, HEALTH 1984%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011243 2004
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011243 2002
% 208.27/208.43 |- skos__annotation mesh__D011243 specify geog if possible; DF: PPO
% 208.27/208.43 |- skos__altLabel mesh__D011243 Preferred Provider Organization
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 1993
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 2003
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 1996
% 208.27/208.43 |- mesh__dateEstablished mesh__D005206 1991-01-01
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 1995
% 208.27/208.43 |- skos__broader mesh__D005206smesh__D005205
% 208.27/208.43 |- skos__historyNote mesh__D005206 Thigh %28%1966-1971%29%
% 208.27/208.43 |- mesh__dateRevised mesh__D005206 1990-04-13
% 208.27/208.43 |- skos__hiddenLabel mesh__D005206 Latas, Fascia
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 2005
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 1998
% 208.27/208.43 |- mesh__dateCreated mesh__D005206 1999-01-01
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 1992
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 1994
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D005206 PLS
% 208.27/208.43 |- skos__hiddenLabel mesh__D005206 Lata, Fascia
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 2002
% 208.27/208.43 |- mesh__historyNote mesh__D005206
% 208.27/208.43 91%28%72%29%; was see under FASCIA 1972-90
% 208.27/208.43 |- mesh__recordOriginator mesh__D005206 NLM
% 208.27/208.43 |- rdf__type mesh__D005206sskos__Concept
% 208.27/208.43 |- mesh__recordMaintainer mesh__D005206 NLM
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 1991
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 2001
% 208.27/208.43 |- skos__historyNote mesh__D005206 Fascia %28%1966-1971%29%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 2004
% 208.27/208.43 |- skos__prefLabel mesh__D005206 Fascia Lata
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 1997
% 208.27/208.43 |- skos__hiddenLabel mesh__D005206 Fascia Latas
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 2000
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 2006
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D005206 91; was see under FASCIA 1972-90
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005206 1999
% 208.27/208.43 |- skos__hiddenLabel mesh__D010949 Plasmas
% 208.27/208.43 |- skos__hiddenLabel mesh__D010949 Plasmas, Fresh Frozen
% 208.27/208.43 |- skos__hiddenLabel mesh__D010949 Plasma, Fresh Frozen
% 208.27/208.43 |- skos__hiddenLabel mesh__D010949 Plasmas, Blood
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D010949 2006
% 208.27/208.43 |- mesh__dateRevised mesh__D010949 2003-07-09
% 208.27/208.43 |- skos__hiddenLabel mesh__D010949 Plasma, Blood
% 208.27/208.43 |- skos__hiddenLabel mesh__D010949 Frozen Plasmas, Fresh
% 208.27/208.43 |- skos__hiddenLabel mesh__D010949 Fresh Frozen Plasmas
% 208.27/208.43 |- skos__altLabel mesh__D010949 Blood Plasma
% 208.27/208.43 |- skos__annotation mesh__D010949
% 208.27/208.43 restrict to plasma for transfusions or plasma when compared with serum or blood cells or whole blood; substances in plasma = /blood, not PLASMA; policy: Manual 21.47, 25.14.5; for X ref FRESH FROZEN PLASMA do not coord with FREEZING nor BLOOD PRESERVATION%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D010949 2005
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D010949 sjn
% 208.27/208.43 |- mesh__recordOriginator mesh__D010949 NLM
% 208.27/208.43 |- skos__hiddenLabel mesh__D010949 Blood Plasmas
% 208.27/208.43 |- mesh__dateCreated mesh__D010949 1999-01-01
% 208.27/208.43 |- skos__scopeNote mesh__D010949
% 208.27/208.43 The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION.%A%
% 208.27/208.43 |- skos__related mesh__D010949smesh__D044967
% 208.27/208.43 |- skos__hiddenLabel mesh__D010949 Frozen Plasma, Fresh
% 208.27/208.43 |- mesh__recordMaintainer mesh__D010949 lkt
% 208.27/208.43 |- skos__prefLabel mesh__D010949 Plasma
% 208.27/208.43 |- rdf__type mesh__D010949sskos__Concept
% 208.27/208.43 |- skos__broader mesh__D010949smesh__D045604
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D010949 2004
% 208.27/208.43 |- skos__broader mesh__D010949smesh__D001769
% 208.27/208.43 |- rdf__type mesh__D043325sskos__Concept
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D043325 2006
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D043325 sjn
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D043325 2004
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D043325 2005
% 208.27/208.43 |- skos__hiddenLabel mesh__D043325 Endo-1,3-beta-Xylosidase, Xylan
% 208.27/208.43 |- skos__scopeNote mesh__D043325
% 208.27/208.43 A xylosidase that catalyses the random hydrolysis of 1,3-beta-D-xylosidic linkages in 1,3-beta-D-xylans.%A%
% 208.27/208.43 |- skos__hiddenLabel mesh__D043325 Endo 1,3 beta Xylanase
% 208.27/208.43 |- skos__broader mesh__D043325smesh__D014995
% 208.27/208.43 |- mesh__dateCreated mesh__D043325 2003-07-09
% 208.27/208.43 |- skos__historyNote mesh__D043325 Xylans %28%1979-1982%29%
% 208.27/208.43 |- skos__historyNote mesh__D043325 Glycoside Hydrolases %28%1975-1994%29%
% 208.27/208.43 |- skos__historyNote mesh__D043325 Xylosidases %28%1995-2003%29%
% 208.27/208.43 |- mesh__recordOriginator mesh__D043325 AKE
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D043325
% 208.27/208.43 2004; XYLAN ENDO-1,3-BETA-XYLOSIDASE was indexed under XYLOSIDASES 1995-2003, under GYCOSIDE HYDROLASES 1975-1994, under XYLANS 1979-1982 %26% under XYLOSE 1975-1979%A%
% 208.27/208.43 |- mesh__historyNote mesh__D043325
% 208.27/208.43 2004; use XYLAN ENDO-1,3-BETA-XYLOSIDASE %28%NM%29% 1980-2003
% 208.27/208.43 |- skos__historyNote mesh__D043325 Xylose %28%1975-1979%29%
% 208.27/208.43 |- skos__prefLabel mesh__D043325 Xylan Endo-1,3-beta-Xylosidase
% 208.27/208.43 |- skos__related mesh__D043325smesh__D014990
% 208.27/208.43 |- skos__hiddenLabel mesh__D043325 Xylan Endo 1,3 beta Xylosidase
% 208.27/208.43 |- skos__altLabel mesh__D043325 Endo-1,3-beta-Xylanase
% 208.27/208.43 |- mesh__recordMaintainer mesh__D043325 AKE
% 208.27/208.43 |- mesh__dateEstablished mesh__D043325 2004-01-01
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D048010 2005
% 208.27/208.43 |- mesh__recordMaintainer mesh__D048010 SYSTEM
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D048010 sjn
% 208.27/208.43 |- mesh__dateEstablished mesh__D048010 2005-01-01
% 208.27/208.43 |- skos__historyNote mesh__D048010 Clostridium %28%1963-2004%29%
% 208.27/208.43 |- mesh__dateRevised mesh__D048010 2005-06-30
% 208.27/208.43 |- skos__prefLabel mesh__D048010 Clostridium tertium
% 208.27/208.43 |- skos__annotation mesh__D048010
% 208.27/208.43 infection: coordinate IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%
% 208.27/208.43 |- mesh__historyNote mesh__D048010 2005
% 208.27/208.43 |- skos__broader mesh__D048010smesh__D003013
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D048010 2006
% 208.27/208.43 |- mesh__dateCreated mesh__D048010 2004-07-07
% 208.27/208.43 |- mesh__recordOriginator mesh__D048010 ags
% 208.27/208.43 |- rdf__type mesh__D048010sskos__Concept
% 208.27/208.43 |- skos__scopeNote mesh__D048010
% 208.27/208.43 A species of gram-positive bacteria in the family Clostridiaceae, causing BACTEREMIA in humans and ANIMALS.%A%
% 208.27/208.43 |- skos__scopeNote mesh__D001614
% 208.27/208.43 An enzyme that catalyzes the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. EC 3.2.1.2.%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D001614 2005
% 208.27/208.43 |- mesh__dateRevised mesh__D001614 2003-07-09
% 208.27/208.43 |- mesh__recordMaintainer mesh__D001614 ssb
% 208.27/208.43 |- mesh__recordOriginator mesh__D001614 RLS
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D001614 91; was see under AMYLASES 1978-90
% 208.27/208.43 |- skos__prefLabel mesh__D001614 beta-Amylase
% 208.27/208.43 |- mesh__dateEstablished mesh__D001614 1991-01-01
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D001614 sjn
% 208.27/208.43 |- mesh__dateCreated mesh__D001614 1977-04-15
% 208.27/208.43 |- mesh__historyNote mesh__D001614
% 208.27/208.43 91%28%78%29%; was see under AMYLASES 1978-90
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D001614 2006
% 208.27/208.43 |- skos__broader mesh__D001614smesh__D000681
% 208.27/208.43 |- skos__historyNote mesh__D001614 Amylases %28%1966-1977%29%
% 208.27/208.43 |- rdf__type mesh__D001614sskos__Concept
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D001614 2004
% 208.27/208.43 |- skos__hiddenLabel mesh__D001614 beta Amylase
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D020579 2006
% 208.27/208.43 |- mesh__dateRevised mesh__D020579 2005-06-30
% 208.27/208.43 |- skos__prefLabel mesh__D020579 Sinorhizobium
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D020579 sjn
% 208.27/208.43 |- skos__scopeNote mesh__D020579
% 208.27/208.43 A genus of gram-negative, aerobic, nonsporeforming rods which usually contain granules of poly-beta-hydroxybutyrate. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.27/208.43 |- mesh__dateCreated mesh__D020579 1999-11-03
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D020579 2000
% 208.27/208.43 |- mesh__recordMaintainer mesh__D020579 SYSTEM
% 208.27/208.43 |- skos__broader mesh__D020579smesh__D012230
% 208.27/208.43 |- mesh__historyNote mesh__D020579 2000
% 208.27/208.43 |- mesh__dateEstablished mesh__D020579 2000-01-01
% 208.27/208.43 |- rdf__type mesh__D020579sskos__Concept
% 208.27/208.43 |- mesh__recordOriginator mesh__D020579 ndw
% 208.27/208.43 |- skos__broader mesh__D019227smesh__D014092
% 208.27/208.43 |- skos__scopeNote mesh__D019227
% 208.27/208.43 The tip or terminal end of the root of a tooth. %28%Jablonski, Dictionary of Dentistry, 1992, p62%29%%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D019227 2004
% 208.27/208.43 |- mesh__historyNote mesh__D019227
% 208.27/208.43 97; was see TOOTH ROOT 1975-96; was see under TOOTH ROOT 1969-74%A%
% 208.27/208.43 |- skos__hiddenLabel mesh__D019227 Foramen, Apical
% 208.27/208.43 |- mesh__onlineNote mesh__D019227
% 208.27/208.43 use TOOTH ROOT to search TOOTH APEX 1969-96
% 208.27/208.43 |- skos__hiddenLabel mesh__D019227 Apex, Tooth
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D019227 sjn
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D019227 2005
% 208.27/208.43 |- mesh__dateEstablished mesh__D019227 1997-01-01
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D019227
% 208.27/208.43 97; was see TOOTH ROOT 1975-96; was see under TOOTH ROOT 1969-74%A%
% 208.27/208.43 |- skos__altLabel mesh__D019227 Tooth Apices
% 208.27/208.43 |- skos__prefLabel mesh__D019227 Tooth Apex
% 208.27/208.43 |- mesh__dateCreated mesh__D019227 1996-06-10
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D019227 2006
% 208.27/208.43 |- mesh__dateRevised mesh__D019227 2003-07-09
% 208.27/208.43 |- skos__hiddenLabel mesh__D019227 Apices, Tooth
% 208.27/208.43 |- skos__annotation mesh__D019227
% 208.27/208.43 dis: coord IM with TOOTH DISEASES %28%IM%29%; /surg: consider also APICOECTOMY; apical foramen goes here%A%
% 208.27/208.43 |- mesh__recordMaintainer mesh__D019227 lkt
% 208.27/208.43 |- rdf__type mesh__D019227sskos__Concept
% 208.27/208.43 |- mesh__recordOriginator mesh__D019227 TGC
% 208.27/208.43 |- skos__related mesh__D019227smesh__D001047
% 208.27/208.43 |- skos__historyNote mesh__D019227 Tooth Root %28%1975-1996%29%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 2001
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 2006
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 1995
% 208.27/208.43 |- mesh__recordOriginator mesh__D011244 NLM
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 2002
% 208.27/208.43 |- mesh__dateEstablished mesh__D011244 1974-01-01
% 208.27/208.43 |- mesh__dateCreated mesh__D011244 1999-01-01
% 208.27/208.43 |- mesh__historyNote mesh__D011244 74
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 1996
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D011244 74
% 208.27/208.43 |- skos__scopeNote mesh__D011244
% 208.27/208.43 Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains.%A%
% 208.27/208.43 |- rdf__type mesh__D011244sskos__Concept
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 2003
% 208.27/208.43 |- mesh__dateRevised mesh__D011244 1993-06-03
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 1997
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D011244 PLS
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 2004
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 1998
% 208.27/208.43 |- skos__broader mesh__D011244smesh__D011245
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 2000
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 2005
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 1994
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D011244 1999
% 208.27/208.43 |- skos__prefLabel mesh__D011244 Pregnadienediols
% 208.27/208.43 |- mesh__recordMaintainer mesh__D011244 PLS
% 208.27/208.43 |- skos__altLabel mesh__D011244 Dihydroxypregnadienes
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005207 2001
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Muscle Fasciculations, Skeletal
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Muscular Fasciculation
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005207 2005
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Neural Fasciculations
% 208.27/208.43 |- skos__altLabel mesh__D005207 Fasciculation, Muscular
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D005207
% 208.27/208.43 1987; see NEUROLOGIC MANIFESTATIONS 1982-86, see MOVEMENT DISORDERS 1979-81%A%
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005207 2002
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Benign Fasciculations
% 208.27/208.43 |- mesh__historyNote mesh__D005207 1987%28%1979%29%
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Skeletal Muscle Fasciculation
% 208.27/208.43 |- skos__prefLabel mesh__D005207 Fasciculation
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005207 2006
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Muscular Fasciculations
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005207 2003
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Benign Fasciculation
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005207 2000A
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D005207 ags
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Skeletal Muscle Fasciculations
% 208.27/208.43 |- skos__annotation mesh__D005207
% 208.27/208.43 note category: do not confuse with axonal fasciculation %28%index under AXONS /physiol%29%%A%
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Fasciculations
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Fasciculations, Muscular
% 208.27/208.43 |- mesh__dateCreated mesh__D005207 1978-05-22
% 208.27/208.43 |- rdf__type mesh__D005207sskos__Concept
% 208.27/208.43 |- skos__broader mesh__D005207smesh__D020879
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Fasciculations, Benign
% 208.27/208.43 |- mesh__dateRevised mesh__D005207 1999-12-03
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Tongue Fasciculation
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005207 2004
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Muscle Fasciculation, Skeletal
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Tongue Fasciculations
% 208.27/208.43 |- skos__scopeNote mesh__D005207
% 208.27/208.43 Involuntary contraction of the muscle fibers innervated by a motor unit. Fasciculations can often by visualized and take the form of a muscle twitch or dimpling under the skin, but usually do not generate sufficient force to move a limb. They may represent a benign condition or occur as a manifestation of MOTOR NEURON DISEASE or PERIPHERAL NERVOUS SYSTEM DISEASES. %28%Adams et al., Principles of Neurology, 6th ed, p1294%29%%A%
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Fasciculations, Tongue
% 208.27/208.43 |- mesh__recordOriginator mesh__D005207 RC
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D005207 2000
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Fasciculations, Skeletal Muscle
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Neural Fasciculation
% 208.27/208.43 |- skos__altLabel mesh__D005207 Fasciculation, Neural
% 208.27/208.43 |- mesh__dateEstablished mesh__D005207 1987-01-01
% 208.27/208.43 |- mesh__recordMaintainer mesh__D005207 ags
% 208.27/208.43 |- skos__hiddenLabel mesh__D005207 Fasciculations, Neural
% 208.27/208.43 |- rdf__type mesh__D043326sskos__Concept
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D043326 2005A
% 208.27/208.43 |- mesh__dateRevised mesh__D043326 2004-07-27
% 208.27/208.43 |- mesh__activeMeSHYear mesh__D043326 2004
% 208.27/208.43 |- mesh__publicMeSHNote mesh__D043326
% 208.27/208.43 2004; GLUCAN 1,3-BETA-GLUCOSIDASE was indexed under BETA-GLUCOSIDASE 1979-2003%A%
% 208.27/208.43 |- skos__hiddenLabel mesh__D043326 1,3-beta-Glucosidase, Glucan
% 208.27/208.43 |- mesh__recordAuthorizer mesh__D043326 jls
% 208.27/208.43 |- skos__historyNote mesh__D043326 beta-Glucosidase %28%1979-2003%29%
% 208.27/208.43 |- mesh__recordOriginator mesh__D043326 AKE
% 208.27/208.43 |- skos__hiddenLabel mesh__D043326 Beta 1,3 Glucanase Type II
% 208.27/208.43 |- skos__hiddenLabel mesh__D043326 beta-D-Glucosidase, Exo-1,3
% 208.27/208.43 |- skos__scopeNote mesh__D043326
% 208.27/208.43 An exocellulase with specificity for 1,3-beta-D-glucasidic linkages. It catalyzes hydrolysis of beta-D-glucose units from the non-reducing ends of 1,3-beta-D-glucans, releasing GLUCOSE.%A%
% 208.27/208.44 |- skos__hiddenLabel mesh__D043326 Glucan 1,3 beta Glucosidase
% 208.27/208.44 |- skos__hiddenLabel mesh__D043326 1,3 beta Glucanase
% 208.27/208.44 |- skos__broader mesh__D043326smesh__D044602
% 208.27/208.44 |- mesh__dateCreated mesh__D043326 2003-07-09
% 208.27/208.44 |- mesh__dateEstablished mesh__D043326 2004-01-01
% 208.27/208.44 |- mesh__historyNote mesh__D043326
% 208.27/208.44 2004; use GLUCAN 1,3-BETA-GLUCOSIDASE %28%NM%29% 1979-2003
% 208.27/208.44 |- mesh__recordMaintainer mesh__D043326 jls
% 208.27/208.44 |- skos__hiddenLabel mesh__D043326 Exo 1,3 beta D Glucosidase
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D043326 2005
% 208.27/208.44 |- skos__prefLabel mesh__D043326 Glucan 1,3-beta-Glucosidase
% 208.27/208.44 |- skos__altLabel mesh__D043326 1,3-beta-Glucanase
% 208.27/208.44 |- skos__altLabel mesh__D043326 Exo-1,3 beta-D-Glucosidase
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D043326 2006
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015635 2000
% 208.27/208.44 |- mesh__dateCreated mesh__D015635 1989-06-19
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015635 1999
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015635 2005
% 208.27/208.44 |- rdf__type mesh__D015635sskos__Concept
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015635 1998
% 208.27/208.44 |- skos__broader mesh__D015635smesh__D011875
% 208.27/208.44 |- skos__historyNote mesh__D015635
% 208.27/208.44 Heart/radionuclide imaging %28%1977-1989%29%
% 208.27/208.44 |- skos__historyNote mesh__D015635
% 208.27/208.44 Heart Ventricle/radionuclide imaging %28%1977-1989%29%
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015635 2002
% 208.27/208.44 |- mesh__historyNote mesh__D015635 90
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015635 2004
% 208.27/208.44 |- skos__annotation mesh__D015635
% 208.27/208.44 %22%ventriculo-%22% refers to the heart, not the cerebral ventricles; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: RADIONUCLIDE VENTRICULOGR%A%
% 208.27/208.44 |- mesh__dateRevised mesh__D015635 1997-06-20
% 208.27/208.44 |- mesh__recordMaintainer mesh__D015635 PXP
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015635 2003
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D015635 90
% 208.27/208.44 |- skos__scopeNote mesh__D015635
% 208.27/208.44 Imaging of a ventricle of the heart after the injection of a radioactive contrast medium. The technique is less invasive than cardiac catheterization and is used to assess ventricular function.%A%
% 208.27/208.44 |- mesh__recordOriginator mesh__D015635 AGS
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D015635 SJN
% 208.27/208.44 |- skos__broader mesh__D015635smesh__D006334
% 208.27/208.44 |- mesh__dateEstablished mesh__D015635 1990-01-01
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015635 2001
% 208.27/208.44 |- skos__prefLabel mesh__D015635 Radionuclide Ventriculography
% 208.27/208.44 |- skos__altLabel mesh__D015635 Ventriculography, Radionuclide
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015635 2006
% 208.27/208.44 |- mesh__dateEstablished mesh__D001615 1988-01-01
% 208.27/208.44 |- skos__altLabel mesh__D001615 Lipotropin C Fragment
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 Endorphin, C-Fragment
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D001615 sjn
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 C Fragment Endorphin
% 208.27/208.44 |- skos__broader mesh__D001615smesh__D004723
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 C Fragment, beta-Lipotropin
% 208.27/208.44 |- skos__altLabel mesh__D001615 beta-LPH %28%61-91%29%
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 beta Endorphin
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 beta Lipotropin C Fragment
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 Fragment, beta-Lipotropin C
% 208.27/208.44 |- skos__altLabel mesh__D001615 Lipotropin Fragment C
% 208.27/208.44 |- mesh__dateCreated mesh__D001615 1987-05-04
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 Fragment, Lipotropin C
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D001615 2006
% 208.27/208.44 |- skos__scopeNote mesh__D001615
% 208.27/208.44 A peptide consisting of amino acid sequence 61-91 of the endogenous pituitary hormone BETA-LIPOTROPIN. The first four amino acids show a common tetrapeptide sequence with METHIONINE- and LEUCINE ENKEPHALIN. The compound shows opiate-like activity. Injection of beta-endorphin induces a profound analgesia of the whole body for several hours. This action is reversed after administration of naloxone.%A%
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 Lipotropin 61 91
% 208.27/208.44 |- mesh__dateRevised mesh__D001615 2005-06-30
% 208.27/208.44 |- rdf__type mesh__D001615sskos__Concept
% 208.27/208.44 |- mesh__recordOriginator mesh__D001615 RLS
% 208.27/208.44 |- skos__prefLabel mesh__D001615 beta-Endorphin
% 208.27/208.44 |- mesh__recordMaintainer mesh__D001615 ssb
% 208.27/208.44 |- skos__altLabel mesh__D001615 beta-Lipotropin C Fragment
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 C Fragment, Lipotropin
% 208.27/208.44 |- skos__altLabel mesh__D001615 Lipotropin 61-91
% 208.27/208.44 |- skos__historyNote mesh__D001615 Endorphins %28%1978-1987%29%
% 208.27/208.44 |- skos__altLabel mesh__D001615 C-Fragment Endorphin
% 208.27/208.44 |- skos__historyNote mesh__D001615 Peptides %28%1966-1977%29%
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D001615 88
% 208.27/208.44 |- mesh__historyNote mesh__D001615 88
% 208.27/208.44 |- skos__hiddenLabel mesh__D001615 Fragment C, Lipotropin
% 208.27/208.44 |- skos__altLabel mesh__D001615 Endorphin, beta
% 208.27/208.44 |- skos__hiddenLabel mesh__D006300 Misuses, Health Services
% 208.27/208.44 |- skos__scopeNote mesh__D006300
% 208.27/208.44 Excessive or unnecessary utilization of health services by patients or physicians.%A%
% 208.27/208.44 |- skos__prefLabel mesh__D006300 Health Services Misuse
% 208.27/208.44 |- rdf__type mesh__D006300sskos__Concept
% 208.27/208.44 |- mesh__recordMaintainer mesh__D006300 KEV
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 2001
% 208.27/208.44 |- skos__altLabel mesh__D006300 Misuse, Health Services
% 208.27/208.44 |- skos__altLabel mesh__D006300 Misuse of Health Services
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D006300 PLS
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 1999
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 2000
% 208.27/208.44 |- mesh__dateCreated mesh__D006300 1977-05-12
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 1998
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 1997
% 208.27/208.44 |- skos__hiddenLabel mesh__D006300 Health Services Abuses
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 2006
% 208.27/208.44 |- mesh__historyNote mesh__D006300
% 208.27/208.44 91%28%Aug 77%29%; was see under HEALTH SERVICES 1977-90
% 208.27/208.44 |- skos__altLabel mesh__D006300 Overutilization of Health Services
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 1996
% 208.27/208.44 |- skos__broader mesh__D006300smesh__D006296
% 208.27/208.44 |- mesh__dateEstablished mesh__D006300 1991-01-01
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 2005
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 2004
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 2002
% 208.27/208.44 |- skos__hiddenLabel mesh__D006300 Health Services Misuses
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D006300
% 208.27/208.44 91; was see under HEALTH SERVICES Aug 1977-90
% 208.27/208.44 |- skos__broader mesh__D006300smesh__D001294
% 208.27/208.44 |- skos__annotation mesh__D006300
% 208.27/208.44 misuse, overuse or abuse by patient or physician; DF: HEALTH SERV MISUSE%A%
% 208.27/208.44 |- skos__hiddenLabel mesh__D006300 Overutilization, Health Services
% 208.27/208.44 |- skos__hiddenLabel mesh__D006300 Health Services Abuse
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006300 2003
% 208.27/208.44 |- mesh__dateRevised mesh__D006300 1995-05-22
% 208.27/208.44 |- mesh__recordOriginator mesh__D006300 EC
% 208.27/208.44 |- mesh__recordOriginator mesh__D019228 TGC
% 208.27/208.44 |- mesh__recordMaintainer mesh__D019228 lkt
% 208.27/208.44 |- skos__hiddenLabel mesh__D019228 Crowns, Tooth
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D019228 97
% 208.27/208.44 |- skos__prefLabel mesh__D019228 Tooth Crown
% 208.27/208.44 |- skos__hiddenLabel mesh__D019228 Crown, Tooth
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D019228 2005
% 208.27/208.44 |- skos__hiddenLabel mesh__D019228 Tooth Crowns
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D019228 2006
% 208.27/208.44 |- mesh__dateRevised mesh__D019228 2003-07-09
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D019228 sjn
% 208.27/208.44 |- skos__annotation mesh__D019228
% 208.27/208.44 anatomical crown: do not confuse with CROWNS or its X ref DENTAL CROWNS %28%Cat E6%29%, prosthetic restorations; coord IM with specific tooth %28%IM%29% if pertinent%A%
% 208.27/208.44 |- rdf__type mesh__D019228sskos__Concept
% 208.27/208.44 |- mesh__dateEstablished mesh__D019228 1997-01-01
% 208.27/208.44 |- skos__historyNote mesh__D019228 specific tooth %28%1966-1996%29%
% 208.27/208.44 |- skos__scopeNote mesh__D019228
% 208.27/208.44 The upper part of the tooth, which joins the lower part of the tooth %28%TOOTH ROOT%29% at the cervix %28%TOOTH CERVIX%29% at a line called the cementoenamel junction. The entire surface of the crown is covered with enamel which is thicker at the extremity and becomes progressively thinner toward the cervix. %28%From Jablonski, Dictionary of Dentistry, 1992, p216%29%%A%
% 208.27/208.44 |- skos__historyNote mesh__D019228 Tooth %28%1966-1996%29%
% 208.27/208.44 |- mesh__dateCreated mesh__D019228 1996-06-10
% 208.27/208.44 |- mesh__historyNote mesh__D019228 97
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D019228 2004
% 208.27/208.44 |- skos__broader mesh__D019228smesh__D019589
% 208.27/208.44 |- skos__prefLabel mesh__D011245 Pregnadienes
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 1996
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D011245 PLS
% 208.27/208.44 |- rdf__type mesh__D011245sskos__Concept
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 2003
% 208.27/208.44 |- mesh__recordMaintainer mesh__D011245 PLS
% 208.27/208.44 |- mesh__historyNote mesh__D011245 73
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 1997
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 2000
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 2004
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 1998
% 208.27/208.44 |- skos__broader mesh__D011245smesh__D011278
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 2001
% 208.27/208.44 |- skos__scopeNote mesh__D011245
% 208.27/208.44 Pregnane derivatives containing two double bonds anywhere within the ring structures.%A%
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 2005
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 1994
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 1999
% 208.27/208.44 |- mesh__recordOriginator mesh__D011245 NLM
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 2002
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 2006
% 208.27/208.44 |- skos__historyNote mesh__D011245 Pregnanes %28%1966-1972%29%
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011245 1995
% 208.27/208.44 |- mesh__dateEstablished mesh__D011245 1973-01-01
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D011245 73
% 208.27/208.44 |- mesh__dateCreated mesh__D011245 1999-01-01
% 208.27/208.44 |- mesh__dateRevised mesh__D011245 1993-06-03
% 208.27/208.44 |- skos__historyNote mesh__D005208 Necrosis %28%1966-1980%29%
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D005208 2005
% 208.27/208.44 |- skos__historyNote mesh__D005208 Eosinophils %28%1966-1980%29%
% 208.27/208.44 |- mesh__dateCreated mesh__D005208 1980-04-09
% 208.27/208.44 |- skos__historyNote mesh__D005208 Fascia %28%1966-1980%29%
% 208.27/208.44 |- skos__historyNote mesh__D005208 Eosinophilia %28%1966-1980%29%
% 208.27/208.44 |- rdf__type mesh__D005208sskos__Concept
% 208.27/208.44 |- skos__prefLabel mesh__D005208 Fasciitis
% 208.27/208.44 |- mesh__recordOriginator mesh__D005208 RC
% 208.27/208.44 |- skos__historyNote mesh__D005208 Inflammation %28%1966-1980%29%
% 208.27/208.44 |- mesh__dateRevised mesh__D005208 2004-07-07
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D005208 sjn
% 208.27/208.44 |- mesh__historyNote mesh__D005208 81
% 208.27/208.44 |- skos__scopeNote mesh__D005208
% 208.27/208.44 Inflammation of the fascia. There are three major types: 1, Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma and considered by some a variant of scleroderma; 2, Necrotizing fasciitis %28%FASCIITIS, NECROTIZING%29%, a serious fulminating infection %28%usually by a beta hemolytic streptococcus%29% causing extensive necrosis of superficial fascia; 3, Nodular/Pseudosarcomatous /Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm; it is not malignant but is sometimes mistaken for fibrosarcoma.%A%
% 208.27/208.44 |- skos__hiddenLabel mesh__D005208 Fasciitides
% 208.27/208.44 |- skos__hiddenLabel mesh__D005208 Fascitides
% 208.27/208.44 |- skos__annotation mesh__D005208
% 208.27/208.44 see MeSH definition for major types; eosinophilic fasciitis: coord IM with EOSINOPHILIA %28%IM%29%; FASCIITIS, NECROTIZING is available%A%
% 208.27/208.44 |- skos__broader mesh__D005208smesh__D009140
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D005208 81
% 208.27/208.44 |- mesh__dateEstablished mesh__D005208 1981-01-01
% 208.27/208.44 |- skos__altLabel mesh__D005208 Fascitis
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D005208 2006
% 208.27/208.44 |- mesh__recordMaintainer mesh__D005208 wdj
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015636 2000
% 208.27/208.44 |- skos__broader mesh__D015636smesh__D017616
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015636 1999
% 208.27/208.44 |- mesh__historyNote mesh__D015636 90
% 208.27/208.44 |- skos__annotation mesh__D015636 used as a source of magnesium ions
% 208.27/208.44 |- rdf__type mesh__D015636sskos__Concept
% 208.27/208.44 |- skos__historyNote mesh__D015636 Magnesium %28%1966-1989%29%
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015636 2001
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015636 2003
% 208.27/208.44 |- mesh__dateCreated mesh__D015636 1989-05-25
% 208.27/208.44 |- skos__broader mesh__D015636smesh__D002712
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015636 2002
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D015636 90
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015636 2004
% 208.27/208.44 |- mesh__recordMaintainer mesh__D015636 TPW
% 208.27/208.44 |- mesh__recordOriginator mesh__D015636 RLS
% 208.27/208.44 |- skos__prefLabel mesh__D015636 Magnesium Chloride
% 208.27/208.44 |- mesh__dateEstablished mesh__D015636 1990-01-01
% 208.27/208.44 |- skos__altLabel mesh__D015636 MgCl2
% 208.27/208.44 |- mesh__dateRevised mesh__D015636 1997-06-20
% 208.27/208.44 |- skos__scopeNote mesh__D015636
% 208.27/208.44 Magnesium chloride. An inorganic compound consisting of one magnesium and two chloride ions. The compound is used in medicine as a source of magnesium ions, which are essential for many cellular activities. It has also been used as a cathartic and in alloys.%A%
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015636 2005
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D015636 SJN
% 208.27/208.44 |- skos__hiddenLabel mesh__D015636 Chloride, Magnesium
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015636 1998
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015636 2006
% 208.27/208.44 |- mesh__dateCreated mesh__D048012 2004-07-07
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D048012 2006
% 208.27/208.44 |- mesh__dateRevised mesh__D048012 2005-06-30
% 208.27/208.44 |- skos__broader mesh__D048012smesh__D003013
% 208.27/208.44 |- mesh__historyNote mesh__D048012 2005
% 208.27/208.44 |- rdf__type mesh__D048012sskos__Concept
% 208.27/208.44 |- mesh__recordOriginator mesh__D048012 ags
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D048012 2005
% 208.27/208.44 |- skos__scopeNote mesh__D048012
% 208.27/208.44 A species of gram-positive bacteria in the family Clostridiaceae. Its glutamate mutase is commonly used in research.%A%
% 208.27/208.44 |- mesh__dateEstablished mesh__D048012 2005-01-01
% 208.27/208.44 |- mesh__recordMaintainer mesh__D048012 SYSTEM
% 208.27/208.44 |- skos__historyNote mesh__D048012 Clostridium %28%1965-2004%29%
% 208.27/208.44 |- skos__prefLabel mesh__D048012 Clostridium tetanomorphum
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D048012 sjn
% 208.27/208.44 |- skos__broader mesh__D001554Q000031smesh__D001554
% 208.27/208.44 |- mesh__preferredCombination mesh__D001554Q000031smesh__D001555
% 208.27/208.44 |- rdf__type mesh__D001554Q000031smesh__CompoundConcept
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D001616 ags
% 208.27/208.44 |- skos__annotation mesh__D001616
% 208.27/208.44 /defic: consider also LACTOSE INTOLERANCE and GANGLIOSIDOSIS GM1%A%
% 208.27/208.44 |- mesh__dateCreated mesh__D001616 1977-04-15
% 208.27/208.44 |- mesh__dateEstablished mesh__D001616 1991-01-01
% 208.27/208.44 |- skos__altLabel mesh__D001616 Sunrise Brand of beta-Galactosidase
% 208.27/208.44 |- mesh__onlineNote mesh__D001616
% 208.27/208.44 use BETA-GALACTOSIDASE to search BETA-GALACTOSIDASES 1978-91%A%
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 beta Galactosidase A3
% 208.27/208.44 |- skos__altLabel mesh__D001616 McNeil Brand of beta-Galactosidase
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 beta Galactosidases
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D001616 2006
% 208.27/208.44 |- rdf__type mesh__D001616sskos__Concept
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 Tanta Brand of beta Galactosidase
% 208.27/208.44 |- skos__historyNote mesh__D001616 Galactosidases %28%1966-1977%29%
% 208.27/208.44 |- mesh__dateRevised mesh__D001616 2005-07-14
% 208.27/208.44 |- skos__prefLabel mesh__D001616 beta-Galactosidase
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 beta Galactosidase
% 208.27/208.44 |- skos__altLabel mesh__D001616 Rivex Brand of beta-Galactosidase
% 208.27/208.44 |- skos__broader mesh__D001616smesh__D005696
% 208.27/208.44 |- mesh__historyNote mesh__D001616
% 208.27/208.44 92; was BETA-GALACTOSIDASES 1978-91 %28%see under GALACTOSIDASES 1978-90%29%%A%
% 208.27/208.44 |- mesh__recordMaintainer mesh__D001616 ags
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 Protein, lac Z
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 Rivex Brand of beta Galactosidase
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 beta Galactosidase A2
% 208.27/208.44 |- mesh__recordOriginator mesh__D001616 RLS
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 beta Galactosidase A1
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 Thompson Brand of beta Galactosidase
% 208.27/208.44 |- skos__altLabel mesh__D001616 Thompson Brand of beta-Galactosidase
% 208.27/208.44 |- skos__altLabel mesh__D001616 lac Z Protein
% 208.27/208.44 |- skos__altLabel mesh__D001616 beta-D-Galactosidase
% 208.27/208.44 |- skos__related mesh__D001616smesh__D016537
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 beta D Galactosidase
% 208.27/208.44 |- skos__altLabel mesh__D001616 beta-Galactosidases
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D001616 2006A
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D001616
% 208.27/208.44 92; was BETA-GALACTOSIDASES 1978-91 %28%see under GALACTOSIDASES 1978-90%29%%A%
% 208.27/208.44 |- skos__scopeNote mesh__D001616
% 208.27/208.44 A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS GM1.%A%
% 208.27/208.44 |- skos__hiddenLabel mesh__D001616 Sunrise Brand of beta Galactosidase
% 208.27/208.44 |- skos__altLabel mesh__D001616 Tanta Brand of beta-Galactosidase
% 208.27/208.44 |- skos__altLabel mesh__D001616 Lactases
% 208.27/208.44 |- mesh__dateRevised mesh__D006301 1999-11-03
% 208.27/208.44 |- mesh__recordMaintainer mesh__D006301 kle
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D006301 sjn
% 208.27/208.44 |- mesh__dateEstablished mesh__D006301 1991-01-01
% 208.27/208.44 |- rdf__type mesh__D006301sskos__Concept
% 208.27/208.44 |- mesh__recordOriginator mesh__D006301 EC
% 208.27/208.44 |- skos__broader mesh__D006301smesh__D003695
% 208.27/208.44 |- skos__prefLabel mesh__D006301 Health Services Needs and Demand
% 208.27/208.44 |- skos__hiddenLabel mesh__D006301 Health Services Need
% 208.27/208.44 |- mesh__historyNote mesh__D006301
% 208.27/208.44 91%28%Aug 77%29%; was see under HEALTH SERVICES RESEARCH 1980-90; was see under HEALTH PLANNING 1979; was see under HEALTH AND WELFARE PLANNING 1977-78%A%
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006301 2005
% 208.27/208.44 |- skos__altLabel mesh__D006301 Needs and Demand, Health Services
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D006301
% 208.27/208.44 91; was see under HEALTH SERVICES RESEARCH 1980-90; was see under HEALTH PLANNING 1979; was see under HEALTH AND WELFARE PLANNING Aug 1977-78%A%
% 208.27/208.44 |- skos__scopeNote mesh__D006301
% 208.27/208.44 Health services required by a population or community as well as the health services that the population or community is able and willing to pay for.%A%
% 208.27/208.44 |- skos__hiddenLabel mesh__D006301 Need, Health Services
% 208.27/208.44 |- mesh__dateCreated mesh__D006301 1977-05-12
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006301 2000
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006301 2003
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006301 2006
% 208.27/208.44 |- skos__hiddenLabel mesh__D006301 Population, Target
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006301 2001
% 208.27/208.44 |- skos__annotation mesh__D006301 specify geog; DF: HEALTH SERV NEEDS
% 208.27/208.44 |- skos__hiddenLabel mesh__D006301 Target Populations
% 208.27/208.44 |- skos__hiddenLabel mesh__D006301 Needs, Health Services
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006301 2004
% 208.27/208.44 |- skos__hiddenLabel mesh__D006301 Populations, Target
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D006301 2002
% 208.27/208.44 |- skos__broader mesh__D006301smesh__D006302
% 208.27/208.44 |- skos__broader mesh__D006321Q000736smesh__D006321
% 208.27/208.44 |- mesh__preferredCombination mesh__D006321Q000736smesh__D004452
% 208.27/208.44 |- rdf__type mesh__D006321Q000736smesh__CompoundConcept
% 208.27/208.44 |- skos__hiddenLabel mesh__D019229 Permanent Dentition
% 208.27/208.44 |- skos__altLabel mesh__D019229 Dentition, Adult
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D019229 2006
% 208.27/208.44 |- skos__altLabel mesh__D019229 Dentition, Secondary
% 208.27/208.44 |- mesh__dateRevised mesh__D019229 2003-07-09
% 208.27/208.44 |- skos__prefLabel mesh__D019229 Dentition, Permanent
% 208.27/208.44 |- mesh__dateCreated mesh__D019229 1996-06-10
% 208.27/208.44 |- skos__scopeNote mesh__D019229
% 208.27/208.44 The 32 teeth of adulthood that either replace or are added to the complement of deciduous teeth. %28%Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A%
% 208.27/208.44 |- skos__historyNote mesh__D019229 Dentition %28%1966-1996%29%
% 208.27/208.44 |- rdf__type mesh__D019229sskos__Concept
% 208.27/208.44 |- skos__hiddenLabel mesh__D019229 Adult Dentition
% 208.27/208.44 |- mesh__recordMaintainer mesh__D019229 lkt
% 208.27/208.44 |- mesh__recordOriginator mesh__D019229 JLS
% 208.27/208.44 |- mesh__historyNote mesh__D019229 97
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D019229 2004
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D019229 97
% 208.27/208.44 |- skos__annotation mesh__D019229 see note at DENTITION; no qualif
% 208.27/208.44 |- skos__hiddenLabel mesh__D019229 Secondary Dentition
% 208.27/208.44 |- mesh__dateEstablished mesh__D019229 1997-01-01
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D019229 2005
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D019229 sjn
% 208.27/208.44 |- skos__broader mesh__D019229smesh__D003817
% 208.27/208.44 |- rdf__type mesh__D011246sskos__Concept
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 1997
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 2000
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 2003
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 1998
% 208.27/208.44 |- skos__scopeNote mesh__D011246
% 208.27/208.44 Doubly unsaturated pregnane derivatives substituted with three hydroxy groups anywhere within the ring structure or side chains.%A%
% 208.27/208.44 |- mesh__recordMaintainer mesh__D011246 PLS
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 2001
% 208.27/208.44 |- mesh__dateEstablished mesh__D011246 1974-01-01
% 208.27/208.44 |- mesh__recordOriginator mesh__D011246 NLM
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 2004
% 208.27/208.44 |- skos__broader mesh__D011246smesh__D011245
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 1999
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 2002
% 208.27/208.44 |- skos__prefLabel mesh__D011246 Pregnadienetriols
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 2005
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 1994
% 208.27/208.44 |- mesh__dateCreated mesh__D011246 1999-01-01
% 208.27/208.44 |- mesh__publicMeSHNote mesh__D011246 74
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 2006
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 1995
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D011246 1996
% 208.27/208.44 |- mesh__dateRevised mesh__D011246 1993-06-03
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D011246 PLS
% 208.27/208.44 |- mesh__historyNote mesh__D011246 74
% 208.27/208.44 |- skos__altLabel mesh__D011246 Trihydroxypregnadienes
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D005209 sjn
% 208.27/208.44 |- skos__prefLabel mesh__D005209 Fasciola
% 208.27/208.44 |- rdf__type mesh__D005209sskos__Concept
% 208.27/208.44 |- skos__broader mesh__D005209smesh__D005212
% 208.27/208.44 |- mesh__dateRevised mesh__D005209 2003-07-09
% 208.27/208.44 |- mesh__dateCreated mesh__D005209 1999-01-01
% 208.27/208.44 |- mesh__recordMaintainer mesh__D005209 ags
% 208.27/208.44 |- skos__scopeNote mesh__D005209
% 208.27/208.44 A genus of trematode liver flukes of the family Fasciolidae. Two species of this genus are F. hepatica and F. gigantica. The parasites are found in the liver and gallbladder and associated ducts in mammals and occasionally man. F. gigantica occurs rarely in man.%A%
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D005209 2005
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D005209 2004
% 208.27/208.44 |- skos__annotation mesh__D005209
% 208.27/208.44 infection = FASCIOLIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D005209 2006
% 208.27/208.44 |- mesh__recordOriginator mesh__D005209 NLM
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Blood-Pool Scintigraphy, Gated
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Blood-Pool Scintigraphies
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015637 2002
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Gated Blood-Pool Imagings
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Gated Radionuclide Angiographies
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015637 1999
% 208.27/208.44 |- skos__altLabel mesh__D015637 Blood-Pool Scintigraphy
% 208.27/208.44 |- mesh__dateEstablished mesh__D015637 1990-01-01
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Scintigraphy, Blood-Pool
% 208.27/208.44 |- skos__annotation mesh__D015637
% 208.27/208.44 a type of radionuclide ventriculography usually for the left heart: for the right heart VENTRICULOGRAPHY, FIRST-PASS is usually preferred; /drug eff /rad eff permitted; do not use /util except by MeSH definition%A%
% 208.27/208.44 |- mesh__dateRevised mesh__D015637 1997-06-20
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637
% 208.27/208.44 Radionuclide Ventriculography, Equilibrium
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Gated Radionuclide Angiography
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015637 2001
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Radionuclide Angiographies, Gated
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015637 2006
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Gated Blood Pool Imaging
% 208.27/208.44 |- skos__altLabel mesh__D015637 Equilibrium Radionuclide Angiocardiography
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015637 1998
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Gated Radionuclide Ventriculography
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Angiographies, Equilibrium Radionuclide
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637
% 208.27/208.44 Ventriculographies, Equilibrium Radionuclide
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Scintigraphy, Gated Blood-Pool
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015637 2000
% 208.27/208.44 |- mesh__recordAuthorizer mesh__D015637 SJN
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Equilibrium Scintigraphy
% 208.27/208.44 |- skos__prefLabel mesh__D015637 Gated Blood-Pool Imaging
% 208.27/208.44 |- mesh__dateCreated mesh__D015637 1989-05-02
% 208.27/208.44 |- mesh__recordMaintainer mesh__D015637 PXP
% 208.27/208.44 |- rdf__type mesh__D015637sskos__Concept
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637
% 208.27/208.44 Angiocardiography, Equilibrium Radionuclide
% 208.27/208.44 |- mesh__activeMeSHYear mesh__D015637 2005
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Radionuclide Ventriculographies, Gated
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Angiographies, Gated Radionuclide
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Gated Blood Pool Scintigraphy
% 208.27/208.44 |- skos__altLabel mesh__D015637 Gated Equilibrium Blood-Pool Scintigraphy
% 208.27/208.44 |- skos__altLabel mesh__D015637 Gated Equilibrium Blood Pool Scintigraphy
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Gated Radionuclide Ventriculographies
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637
% 208.27/208.44 Angiocardiographies, Equilibrium Radionuclide
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Scintigraphies, Blood-Pool
% 208.27/208.44 |- mesh__recordOriginator mesh__D015637 AGS
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637
% 208.27/208.44 Radionuclide Ventriculographies, Equilibrium
% 208.27/208.44 |- skos__hiddenLabel mesh__D015637 Ventriculographies, Gated Radionuclide
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D015637 90
% 208.27/208.45 |- skos__altLabel mesh__D015637 Equilibrium Radionuclide Angiography
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Imaging, Gated Blood-Pool
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637
% 208.27/208.45 Radionuclide Angiocardiographies, Equilibrium
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Gated Blood-Pool Scintigraphies
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Blood-Pool Scintigraphies, Gated
% 208.27/208.45 |- skos__altLabel mesh__D015637 Radionuclide Ventriculography, Gated
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Angiography, Equilibrium Radionuclide
% 208.27/208.45 |- skos__altLabel mesh__D015637 Ventriculography, Gated Radionuclide
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Imagings, Gated Blood-Pool
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D015637 2004
% 208.27/208.45 |- mesh__historyNote mesh__D015637 90
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Scintigraphies, Gated Blood-Pool
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Scintigraphies, Equilibrium
% 208.27/208.45 |- skos__altLabel mesh__D015637 Equilibrium Radionuclide Ventriculography
% 208.27/208.45 |- skos__altLabel mesh__D015637 Gated Blood-Pool Scintigraphy
% 208.27/208.45 |- skos__altLabel mesh__D015637 Scintigraphy, Equilibrium
% 208.27/208.45 |- skos__altLabel mesh__D015637 Radionuclide Angiography, Gated
% 208.27/208.45 |- skos__altLabel mesh__D015637 Ventriculography, Equilibrium Radionuclide
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Equilibrium Scintigraphies
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Radionuclide Angiography, Equilibrium
% 208.27/208.45 |- skos__scopeNote mesh__D015637
% 208.27/208.45 Radionuclide ventriculography where scintigraphic data is acquired during repeated cardiac cycles at specific times in the cycle, using an electrocardiographic synchronizer or gating device. Analysis of right ventricular function is difficult with this technique; that is best evaluated by first-pass ventriculography %28%VENTRICULOGRAPHY, FIRST-PASS%29%.%A%
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Blood-Pool Imaging, Gated
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Radionuclide Angiographies, Equilibrium
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D015637 2003
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637
% 208.27/208.45 Equilibrium Radionuclide Ventriculographies
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Equilibrium Radionuclide Angiographies
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Blood-Pool Imagings, Gated
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637
% 208.27/208.45 Equilibrium Radionuclide Angiocardiographies
% 208.27/208.45 |- skos__broader mesh__D015637smesh__D015635
% 208.27/208.45 |- skos__altLabel mesh__D015637 Angiography, Gated Radionuclide
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637
% 208.27/208.45 Radionuclide Angiocardiography, Equilibrium
% 208.27/208.45 |- skos__hiddenLabel mesh__D015637 Blood Pool Scintigraphy
% 208.27/208.45 |- skos__scopeNote mesh__D048013
% 208.27/208.45 A species of gram-positive, thermophilic, cellulolytic bacteria in the family Clostridaceae. It degrades and ferments CELLOBIOSE and CELLULOSE to ETHANOL in the CELLULOSOME.%A%
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D048013 sjn
% 208.27/208.45 |- skos__historyNote mesh__D048013 Clostridium %28%1968-2004%29%
% 208.27/208.45 |- rdf__type mesh__D048013sskos__Concept
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D048013 2005
% 208.27/208.45 |- mesh__dateRevised mesh__D048013 2005-06-30
% 208.27/208.45 |- skos__prefLabel mesh__D048013 Clostridium thermocellum
% 208.27/208.45 |- mesh__recordMaintainer mesh__D048013 SYSTEM
% 208.27/208.45 |- mesh__historyNote mesh__D048013 2005
% 208.27/208.45 |- mesh__recordOriginator mesh__D048013 ags
% 208.27/208.45 |- mesh__dateEstablished mesh__D048013 2005-01-01
% 208.27/208.45 |- skos__broader mesh__D048013smesh__D003013
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D048013 2006
% 208.27/208.45 |- mesh__dateCreated mesh__D048013 2004-07-07
% 208.27/208.45 |- skos__altLabel mesh__D001617 Cellobiases
% 208.27/208.45 |- skos__altLabel mesh__D001617 Amygdalase
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D001617 2005
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D001617 2006
% 208.27/208.45 |- rdf__type mesh__D001617sskos__Concept
% 208.27/208.45 |- mesh__recordOriginator mesh__D001617 RLS
% 208.27/208.45 |- mesh__recordMaintainer mesh__D001617 jmp
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D001617 2004
% 208.27/208.45 |- skos__hiddenLabel mesh__D001617 beta-D-Glucosidase, Emulsion
% 208.27/208.45 |- skos__altLabel mesh__D001617 Cellobiase
% 208.27/208.45 |- skos__historyNote mesh__D001617 Glucosidases %28%1966-1977%29%
% 208.27/208.45 |- skos__altLabel mesh__D001617 Gentiobiase
% 208.27/208.45 |- mesh__dateEstablished mesh__D001617 1991-01-01
% 208.27/208.45 |- skos__hiddenLabel mesh__D001617 beta Glucosidase
% 208.27/208.45 |- mesh__dateRevised mesh__D001617 2003-07-09
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D001617 sjn
% 208.27/208.45 |- mesh__dateCreated mesh__D001617 1977-04-15
% 208.27/208.45 |- skos__scopeNote mesh__D001617
% 208.27/208.45 An exocellulase with specificity for a variety of beta-D-glycoside substrates. It catalyzes the hydrolysis of terminal non-reducing residues in beta-D-glucosides with release of GLUCOSE.%A%
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D001617
% 208.27/208.45 92; was BETA-GLUCOSIDASES 1978-91 %28%see under GLUCOSIDASES 1978-90%29%%A%
% 208.27/208.45 |- mesh__historyNote mesh__D001617
% 208.27/208.45 92; was BETA-GLUCOSIDASES 1978-91 %28%see under GLUCOSIDASES 1978-90%29%%A%
% 208.27/208.45 |- skos__hiddenLabel mesh__D001617 Emulsion beta D Glucosidase
% 208.27/208.45 |- skos__prefLabel mesh__D001617 beta-Glucosidase
% 208.27/208.45 |- mesh__onlineNote mesh__D001617
% 208.27/208.45 use BETA-GLUCOSIDASE to search BETA-GLUCOSIDASES 1978-91
% 208.27/208.45 |- skos__broader mesh__D001617smesh__D044602
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006302 2002
% 208.27/208.45 |- skos__altLabel mesh__D006302 Health Care Research
% 208.27/208.45 |- skos__altLabel mesh__D006302 Medical Care Research
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006302 2005
% 208.27/208.45 |- mesh__recordMaintainer mesh__D006302 jls
% 208.27/208.45 |- skos__hiddenLabel mesh__D006302 Health Services Evaluations
% 208.27/208.45 |- skos__prefLabel mesh__D006302 Health Services Research
% 208.27/208.45 |- skos__hiddenLabel mesh__D006302 Research, Healthcare
% 208.27/208.45 |- skos__hiddenLabel mesh__D006302 Research, Health Care
% 208.27/208.45 |- skos__altLabel mesh__D006302 Research, Health Services
% 208.27/208.45 |- skos__broader mesh__D006302smesh__D017530
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D006302 sjn
% 208.27/208.45 |- skos__hiddenLabel mesh__D006302 Evaluations, Health Services
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006302 2003
% 208.27/208.45 |- skos__broader mesh__D006302smesh__D006285
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006302 2006
% 208.27/208.45 |- mesh__recordOriginator mesh__D006302 EC
% 208.27/208.45 |- skos__historyNote mesh__D006302 Research %28%1966-1979%29%
% 208.27/208.45 |- skos__historyNote mesh__D006302 Health Services %28%1974-1979%29%
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006302 2004
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D006302 80
% 208.27/208.45 |- skos__hiddenLabel mesh__D006302 Research, Action
% 208.27/208.45 |- skos__annotation mesh__D006302 IM; DF: HEALTH SERV RESEARCH
% 208.27/208.45 |- skos__altLabel mesh__D006302 Health Services Evaluation
% 208.27/208.45 |- mesh__historyNote mesh__D006302 80
% 208.27/208.45 |- skos__altLabel mesh__D006302 Healthcare Research
% 208.27/208.45 |- mesh__dateEstablished mesh__D006302 1980-01-01
% 208.27/208.45 |- skos__hiddenLabel mesh__D006302 Evaluation, Health Services
% 208.27/208.45 |- mesh__dateCreated mesh__D006302 1979-06-01
% 208.27/208.45 |- skos__altLabel mesh__D006302 Research, Medical Care
% 208.27/208.45 |- rdf__type mesh__D006302sskos__Concept
% 208.27/208.45 |- skos__scopeNote mesh__D006302
% 208.27/208.45 The integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome. %28%From Last, Dictionary of Epidemiology, 2d ed%29%%A%
% 208.27/208.45 |- mesh__dateRevised mesh__D006302 2001-07-25
% 208.27/208.45 |- skos__broader mesh__D006321Q000737smesh__D006321
% 208.27/208.45 |- mesh__preferredCombination mesh__D006321Q000737smesh__D009206Q000737
% 208.27/208.45 |- rdf__type mesh__D006321Q000737smesh__CompoundConcept
% 208.27/208.45 |- skos__altLabel mesh__D011247 Gestation
% 208.27/208.45 |- mesh__recordMaintainer mesh__D011247 ags
% 208.27/208.45 |- skos__related mesh__D011247smesh__D011295
% 208.27/208.45 |- mesh__historyNote mesh__D011247 1963
% 208.27/208.45 |- skos__scopeNote mesh__D011247
% 208.27/208.45 The status during which female mammals carry their developing young %28%EMBRYOS or FETUSES%29% in utero before birth, beginning from FERTILIZATION to BIRTH.%A%
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D011247 1963
% 208.27/208.45 |- skos__prefLabel mesh__D011247 Pregnancy
% 208.27/208.45 |- skos__hiddenLabel mesh__D011247 Pregnancies
% 208.27/208.45 |- mesh__dateCreated mesh__D011247 1999-01-01
% 208.27/208.45 |- mesh__dateRevised mesh__D011247 2005-07-22
% 208.27/208.45 |- skos__broader mesh__D011247smesh__D012098
% 208.27/208.45 |- mesh__recordOriginator mesh__D011247 NLM
% 208.27/208.45 |- skos__related mesh__D011247smesh__D008098
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D011247 2006
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D011247 ags
% 208.27/208.45 |- skos__related mesh__D011247smesh__D033261
% 208.27/208.45 |- skos__annotation mesh__D011247
% 208.27/208.45 IM for articles on normal pregn, NIM as check tag; policy: Manual 18.4+, 28.16+; in children or adolescents, see note under PREGNANCY IN ADOLESCENCE; check tag FEMALE also; molar pregn = HYDATIDIFORM MOLE; surrogate pregnancy = SURROGATE MOTHERS; heterotopic pregnancy: see note under PREGNANCY, ECTOPIC; for %22%pregnancy%22% in non-placental organisms: use OVIPARITY; OVOVIVIPARITY; or VIVIPARITY, NON-MAMMALIAN; DF: PREGN%A%
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D011247 2006A
% 208.27/208.45 |- skos__related mesh__D011247smesh__D011555
% 208.27/208.45 |- rdf__type mesh__D011247sskos__Concept
% 208.27/208.45 |- skos__related mesh__D011247smesh__D037841
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Program Description
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D016730 sjn
% 208.27/208.45 |- rdf__type mesh__D016730sskos__Concept
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Field Reports
% 208.27/208.45 |- mesh__dateRevised mesh__D016730 2003-07-25
% 208.27/208.45 |- skos__scopeNote mesh__D016730
% 208.27/208.45 The process of formulating, improving, and expanding educational, managerial, or service-oriented work plans %28%excluding computer program development%29%.%A%
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Development, Program
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Report, Progress
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Description, Program
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D016730 2005
% 208.27/208.45 |- mesh__recordMaintainer mesh__D016730 sjn
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D016730 92
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D016730 2004
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Progress Reports
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Reports, Field
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Report, Field
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D016730 2006
% 208.27/208.45 |- skos__annotation mesh__D016730
% 208.27/208.45 coord IM with specific subject %28%IM%29%; not for computer programs%A%
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Reports, Progress
% 208.27/208.45 |- mesh__recordOriginator mesh__D016730 MXR
% 208.27/208.45 |- skos__broader mesh__D016730smesh__D009934
% 208.27/208.45 |- mesh__dateCreated mesh__D016730 1991-04-29
% 208.27/208.45 |- mesh__dateEstablished mesh__D016730 1992-01-01
% 208.27/208.45 |- skos__prefLabel mesh__D016730 Program Development
% 208.27/208.45 |- skos__hiddenLabel mesh__D016730 Descriptions, Program
% 208.27/208.45 |- mesh__historyNote mesh__D016730 92
% 208.27/208.45 |- mesh__dateCreated mesh__D030401 2001-07-25
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Cytochrome Oxidase Deficiencies
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D030401 2006
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Oxidase Deficiency, Cytochrome
% 208.27/208.45 |- mesh__dateEstablished mesh__D030401 2002-01-01
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Cytochrome c Oxidase Deficiency
% 208.27/208.45 |- mesh__recordOriginator mesh__D030401 nns
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D030401 2002
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Deficiency, Cytochrome c Oxidase
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Cytochrome-c Oxidase Deficiencies
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Deficiencies, Cytochrome-c Oxidase
% 208.27/208.45 |- mesh__dateRevised mesh__D030401 2003-07-25
% 208.27/208.45 |- rdf__type mesh__D030401sskos__Concept
% 208.27/208.45 |- skos__scopeNote mesh__D030401
% 208.27/208.45 A disease that results from a congenital defect in ELECTRON TRANSPORT COMPLEX IV. Defects in ELECTRON TRANSPORT COMPLEX IV can be caused by mutations in the SURF1, SCO2, COX10, or SCO1 genes. ELECTRON TRANSPORT COMPLEX IV deficiency caused by mutation in SURF1 manifests itself as LEIGH DISEASE; that caused by mutation in SCO2 as fatal infantile cardioencephalomyopathy; that caused by mutation in COX10 as tubulopathy and leukodystrophy; and that caused by mutation in SCO1 as early-onset hepatic failure and neurologic disorder. %28%from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM%23%220110, May 17, 2001%29%%A%
% 208.27/208.45 |- skos__historyNote mesh__D030401 Leigh Disease %28%1997-2001%29%
% 208.27/208.45 |- mesh__recordMaintainer mesh__D030401 sjn
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Deficiency, Cytochrome Oxidase
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D030401 sjn
% 208.27/208.45 |- skos__historyNote mesh__D030401
% 208.27/208.45 Cytochrome-c Oxidase/deficiency %28%1976-2001%29%
% 208.27/208.45 |- skos__broader mesh__D030401smesh__D008661
% 208.27/208.45 |- skos__altLabel mesh__D030401 Deficiency, Cytochrome-c Oxidase
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Deficiencies, Cytochrome Oxidase
% 208.27/208.45 |- skos__related mesh__D030401smesh__D003576
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Oxidase Deficiencies, Cytochrome-c
% 208.27/208.45 |- skos__altLabel mesh__D030401 Cytochrome Oxidase Deficiency
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D030401 2004
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Oxidase Deficiencies, Cytochrome
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D030401 2005
% 208.27/208.45 |- skos__broader mesh__D030401smesh__D028361
% 208.27/208.45 |- skos__hiddenLabel mesh__D030401 Oxidase Deficiency, Cytochrome-c
% 208.27/208.45 |- skos__prefLabel mesh__D030401 Cytochrome-c Oxidase Deficiency
% 208.27/208.45 |- mesh__historyNote mesh__D030401 2002
% 208.27/208.45 |- skos__historyNote mesh__D002710 Chlorobenzenes %28%1974%29%
% 208.27/208.45 |- mesh__dateCreated mesh__D002710 1974-11-11
% 208.27/208.45 |- skos__hiddenLabel mesh__D002710 MK412A
% 208.27/208.45 |- skos__hiddenLabel mesh__D002710 Acetate, Chlorhexidine
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D002710 2003
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D002710 2002
% 208.27/208.45 |- mesh__historyNote mesh__D002710
% 208.27/208.45 80%28%75%29%; was see under BIGUANIDES 1975-79
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D002710 2004
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D002710
% 208.27/208.45 80; was see under BIGUANIDES 1975-79
% 208.27/208.45 |- skos__hiddenLabel mesh__D002710 MK 412A
% 208.27/208.45 |- rdf__type mesh__D002710sskos__Concept
% 208.27/208.45 |- skos__hiddenLabel mesh__D002710 Hydrochloride, Chlorhexidine
% 208.27/208.45 |- mesh__dateRevised mesh__D002710 2001-07-25
% 208.27/208.45 |- skos__scopeNote mesh__D002710
% 208.27/208.45 A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.%A%
% 208.27/208.45 |- skos__prefLabel mesh__D002710 Chlorhexidine
% 208.27/208.45 |- mesh__dateEstablished mesh__D002710 1980-01-01
% 208.27/208.45 |- skos__hiddenLabel mesh__D002710 A, Sebidin
% 208.27/208.45 |- skos__historyNote mesh__D002710 Biguanides %28%1968-1974%29%
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D002710 2005
% 208.27/208.45 |- mesh__recordOriginator mesh__D002710 NLM
% 208.27/208.45 |- mesh__recordMaintainer mesh__D002710 ssb
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D002710 sjn
% 208.27/208.45 |- skos__broader mesh__D002710smesh__D001645
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D002710 2006
% 208.27/208.45 |- mesh__recordMaintainer mesh__D015638 ssb
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D015638 90
% 208.27/208.45 |- skos__broader mesh__D015638smesh__D003572
% 208.27/208.45 |- mesh__dateEstablished mesh__D015638 1990-01-01
% 208.27/208.45 |- skos__scopeNote mesh__D015638
% 208.27/208.45 A fungal metabolite that blocks cytoplasmic cleavage by blocking formation of contractile microfilament structures resulting in multinucleated cell formation, reversible inhibition of cell movement, and the induction of cellular extrusion. Additional reported effects include the inhibition of actin polymerization, DNA synthesis, sperm motility, glucose transport, thyroid secretion, and growth hormone release.%A%
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D015638 2006
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D015638 sjn
% 208.27/208.45 |- mesh__historyNote mesh__D015638 90
% 208.27/208.45 |- skos__prefLabel mesh__D015638 Cytochalasin D
% 208.27/208.45 |- rdf__type mesh__D015638sskos__Concept
% 208.27/208.45 |- mesh__dateRevised mesh__D015638 2005-06-30
% 208.27/208.45 |- skos__historyNote mesh__D015638 Cytochalasins %28%1973-1989%29%
% 208.27/208.45 |- mesh__dateCreated mesh__D015638 1989-05-15
% 208.27/208.45 |- mesh__recordOriginator mesh__D015638 RLS
% 208.27/208.45 |- mesh__recordOriginator mesh__D048014 ags
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D048014 2006
% 208.27/208.45 |- skos__broader mesh__D048014smesh__D003013
% 208.27/208.45 |- mesh__dateEstablished mesh__D048014 2005-01-01
% 208.27/208.45 |- rdf__type mesh__D048014sskos__Concept
% 208.27/208.45 |- skos__historyNote mesh__D048014 Clostridium %28%1969-2004%29%
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D048014 sjn
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D048014 2005
% 208.27/208.45 |- mesh__historyNote mesh__D048014 2005
% 208.27/208.45 |- mesh__dateCreated mesh__D048014 2004-07-07
% 208.27/208.45 |- mesh__recordMaintainer mesh__D048014 SYSTEM
% 208.27/208.45 |- skos__prefLabel mesh__D048014 Clostridium tyrobutyricum
% 208.27/208.45 |- skos__scopeNote mesh__D048014
% 208.27/208.45 A species of gram-positive bacteria in the family Clostridiaceae responsible for spoilage of some CHEESE via FERMENTATION of BUTYRIC ACID.%A%
% 208.27/208.45 |- mesh__dateRevised mesh__D048014 2005-06-30
% 208.27/208.45 |- skos__hiddenLabel mesh__D001618 beta Lactamase
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D001618 2006
% 208.27/208.45 |- mesh__recordMaintainer mesh__D001618 ssb
% 208.27/208.45 |- rdf__type mesh__D001618sskos__Concept
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D001618 2004
% 208.27/208.45 |- mesh__dateRevised mesh__D001618 2003-07-09
% 208.27/208.45 |- mesh__recordOriginator mesh__D001618 RLS
% 208.27/208.45 |- skos__altLabel mesh__D001618 beta-Lactamase
% 208.27/208.45 |- skos__broader mesh__D001618smesh__D000581
% 208.27/208.45 |- mesh__dateEstablished mesh__D001618 1979-01-01
% 208.27/208.45 |- skos__scopeNote mesh__D001618
% 208.27/208.45 Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. EC 3.5.2.6.%A%
% 208.27/208.45 |- skos__historyNote mesh__D001618 Amidohydrolases %28%1966-1978%29%
% 208.27/208.45 |- skos__historyNote mesh__D001618 Cephalosporinase %28%1975-1978%29%
% 208.27/208.45 |- skos__historyNote mesh__D001618 Penicillinase %28%1966-1978%29%
% 208.27/208.45 |- mesh__historyNote mesh__D001618 79
% 208.27/208.45 |- skos__prefLabel mesh__D001618 beta-Lactamases
% 208.27/208.45 |- skos__hiddenLabel mesh__D001618 beta Lactamases
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D001618 79
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D001618 2005
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D001618 sjn
% 208.27/208.45 |- mesh__dateCreated mesh__D001618 1978-05-16
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 2000
% 208.27/208.45 |- mesh__dateEstablished mesh__D012340 1991-01-01
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 1999
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 2003
% 208.27/208.45 |- mesh__recordMaintainer mesh__D012340 KEV
% 208.27/208.45 |- skos__hiddenLabel mesh__D012340 Ribosomal RNA, 5.8S
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 1998
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 2006
% 208.27/208.45 |- skos__historyNote mesh__D012340 RNA %28%1966-1970%29%
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 2002
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 2005
% 208.27/208.45 |- mesh__dateRevised mesh__D012340 1995-05-22
% 208.27/208.45 |- skos__altLabel mesh__D012340 5.8S Ribosomal RNA
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D012340 PLS
% 208.27/208.45 |- rdf__type mesh__D012340sskos__Concept
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D012340
% 208.27/208.45 91; was see under RNA, RIBOSOMAL 1988-90
% 208.27/208.45 |- mesh__recordOriginator mesh__D012340 RLS
% 208.27/208.45 |- skos__scopeNote mesh__D012340
% 208.27/208.45 Constituent of the 60S subunit of eukaryotic ribosomes. 5.8S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.%A%
% 208.27/208.45 |- skos__hiddenLabel mesh__D012340 RNA, 5.8S Ribosomal
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 1997
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 2001
% 208.27/208.45 |- skos__annotation mesh__D012340
% 208.27/208.45 IM; /drug eff /ultrastruct permitted; DF: 58S RRNA
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 2004
% 208.27/208.45 |- mesh__historyNote mesh__D012340
% 208.27/208.45 91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D012340 1996
% 208.27/208.45 |- mesh__dateCreated mesh__D012340 1987-05-07
% 208.27/208.45 |- skos__prefLabel mesh__D012340 RNA, Ribosomal, 5.8S
% 208.27/208.45 |- skos__broader mesh__D012340smesh__D012335
% 208.27/208.45 |- skos__historyNote mesh__D012340 RNA, Ribosomal %28%1971-1987%29%
% 208.27/208.45 |- skos__hiddenLabel mesh__D006303 Service, Health Indigenous
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006303 2000
% 208.27/208.45 |- skos__hiddenLabel mesh__D006303 Services, Health Indigenous
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006303 2004
% 208.27/208.45 |- mesh__dateEstablished mesh__D006303 1981-01-01
% 208.27/208.45 |- skos__hiddenLabel mesh__D006303 Health Indigenous Services
% 208.27/208.45 |- skos__scopeNote mesh__D006303
% 208.27/208.45 Health care provided to specific cultural or tribal peoples which incorporates local customs, beliefs, and taboos.%A%
% 208.27/208.45 |- skos__prefLabel mesh__D006303 Health Services, Indigenous
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006303 2001
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D006303
% 208.27/208.45 81; was see under HEALTH SERVICES 1977-80
% 208.27/208.45 |- mesh__historyNote mesh__D006303
% 208.27/208.45 81%28%Aug 77%29%; was see under HEALTH SERVICES Aug 1977-80
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006303 2002
% 208.27/208.45 |- skos__annotation mesh__D006303
% 208.27/208.45 %22%health care provided to specific cultural or tribal peoples which incorporates local customs, beliefs %26% taboos%22%; specify ethnic group %28%IM%29% + geog; DF: HEALTH SERV INDIGENOUS%A%
% 208.27/208.45 |- mesh__dateRevised mesh__D006303 1999-11-03
% 208.27/208.45 |- skos__hiddenLabel mesh__D006303 Indigenous Health Service
% 208.27/208.45 |- skos__hiddenLabel mesh__D006303 Service, Indigenous Health
% 208.27/208.45 |- rdf__type mesh__D006303sskos__Concept
% 208.27/208.45 |- mesh__recordOriginator mesh__D006303 EC
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D006303 sjn
% 208.27/208.45 |- mesh__recordMaintainer mesh__D006303 kle
% 208.27/208.45 |- skos__broader mesh__D006303smesh__D006296
% 208.27/208.45 |- skos__altLabel mesh__D006303 Services, Indigenous Health
% 208.27/208.45 |- skos__altLabel mesh__D006303 Indigenous Services, Health
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006303 2005
% 208.27/208.45 |- skos__hiddenLabel mesh__D006303 Health Service, Indigenous
% 208.27/208.45 |- mesh__dateCreated mesh__D006303 1977-05-12
% 208.27/208.45 |- skos__hiddenLabel mesh__D006303 Indigenous Service, Health
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006303 2006
% 208.27/208.45 |- skos__altLabel mesh__D006303 Indigenous Health Services
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D006303 2003
% 208.27/208.45 |- skos__hiddenLabel mesh__D006303 Health Indigenous Service
% 208.27/208.45 |- skos__prefLabel mesh__D044422 Receptors, Serotonin, 5-HT4
% 208.27/208.45 |- skos__hiddenLabel mesh__D044422 5 HT4 Receptor
% 208.27/208.45 |- skos__hiddenLabel mesh__D044422 Receptor, 5-HT4L
% 208.27/208.45 |- skos__hiddenLabel mesh__D044422 5 HT4L Receptor
% 208.27/208.45 |- skos__altLabel mesh__D044422 Serotonin 4 Receptors
% 208.27/208.45 |- skos__hiddenLabel mesh__D044422 5 HT4S Receptor
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D044422 sjn
% 208.27/208.45 |- skos__hiddenLabel mesh__D044422 5 Hydroxytryptamine 4 Receptor
% 208.27/208.45 |- mesh__recordOriginator mesh__D044422 jmp
% 208.27/208.45 |- mesh__dateCreated mesh__D044422 2003-07-09
% 208.27/208.45 |- mesh__dateRevised mesh__D044422 2005-06-30
% 208.27/208.45 |- skos__altLabel mesh__D044422 Receptor, Serotonin 4
% 208.27/208.45 |- skos__broader mesh__D044422smesh__D011985
% 208.27/208.45 |- skos__historyNote mesh__D044422 Receptors, Serotonin %28%1995-2003%29%
% 208.27/208.45 |- mesh__recordMaintainer mesh__D044422 jmp
% 208.27/208.45 |- skos__altLabel mesh__D044422 Serotonin 4 Receptor
% 208.27/208.45 |- skos__altLabel mesh__D044422 5-HT4 Receptor
% 208.27/208.45 |- mesh__historyNote mesh__D044422
% 208.27/208.45 2004; use RECEPTORS, SEROTININ, 5HT4 %28%NM%29% 1995-2003
% 208.27/208.45 |- skos__hiddenLabel mesh__D044422 Receptor, 5-HT4S
% 208.27/208.45 |- mesh__dateEstablished mesh__D044422 2004-01-01
% 208.27/208.45 |- skos__hiddenLabel mesh__D044422 Receptor, 5-HT4
% 208.27/208.45 |- rdf__type mesh__D044422sskos__Concept
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D044422 2006
% 208.27/208.45 |- skos__hiddenLabel mesh__D044422 Receptor, 5-Hydroxytryptamine-4
% 208.27/208.45 |- skos__hiddenLabel mesh__D044422 Receptors, Serotonin 4
% 208.27/208.45 |- skos__altLabel mesh__D044422 5-HT4L Receptor
% 208.27/208.45 |- skos__altLabel mesh__D044422 5-Hydroxytryptamine-4 Receptor
% 208.27/208.45 |- skos__scopeNote mesh__D044422
% 208.27/208.45 A subtype of G-protein-coupled SEROTONIN receptors that preferentially couple to GS STIMULATORY G-PROTEINS resulting in increased intracellular CYCLIC AMP. Several isoforms of the receptor exist due to ALTERNATIVE SPLICING of its mRNA.%A%
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D044422
% 208.27/208.45 2004; SEROTONIN 4 RECEPTOR %28%now RECEPTORS, SEROTININ, 5HT4%29% was indexed under RECEPTORS, SEROTONIN 1995-2003%A%
% 208.27/208.45 |- skos__altLabel mesh__D044422 5-HT4S Receptor
% 208.27/208.45 |- rdf__type mesh__D011248sskos__Concept
% 208.27/208.45 |- skos__annotation mesh__D011248
% 208.27/208.45 coord IM with dis %28%IM%29%; /surg: consider also OBSTETRIC SURGICAL PROCEDURES; do not use for heterotopic pregn: see note at PREGNANCY, ECTOPIC; check tags FEMALE %26% PREGNANCY; Manual 18.4.7; DF: PREGN COMPL%A%
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D011248 sjn
% 208.27/208.45 |- skos__scopeNote mesh__D011248
% 208.27/208.45 Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.%A%
% 208.27/208.45 |- mesh__dateCreated mesh__D011248 1999-01-01
% 208.27/208.45 |- skos__prefLabel mesh__D011248 Pregnancy Complications
% 208.27/208.45 |- mesh__dateRevised mesh__D011248 2005-06-30
% 208.27/208.45 |- skos__altLabel mesh__D011248 Complications, Pregnancy
% 208.27/208.45 |- mesh__recordMaintainer mesh__D011248 lkt
% 208.27/208.45 |- skos__related mesh__D011248smesh__D011273
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D011248 2006
% 208.27/208.45 |- skos__hiddenLabel mesh__D011248 Pregnancy Complication
% 208.27/208.45 |- skos__broader mesh__D011248smesh__D005261
% 208.27/208.45 |- mesh__recordOriginator mesh__D011248 NLM
% 208.27/208.45 |- skos__hiddenLabel mesh__D011248 Complication, Pregnancy
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D016731 2005
% 208.27/208.45 |- skos__scopeNote mesh__D016731
% 208.27/208.45 Contagious infection with human B19 Parvovirus most commonly seen in school age children and characterized by fever, headache, and rashes of the face, trunk, and extremities. It is often confused with rubella.%A%
% 208.27/208.45 |- mesh__recordAuthorizer mesh__D016731 sjn
% 208.27/208.45 |- skos__historyNote mesh__D016731
% 208.27/208.45 Skin Diseases, Infectious %28%1972-1991%29%
% 208.27/208.45 |- mesh__activeMeSHYear mesh__D016731 2006
% 208.27/208.45 |- skos__historyNote mesh__D016731 Virus Diseases %28%1966-1982%29%
% 208.27/208.45 |- skos__historyNote mesh__D016731 Parvovirus Infections %28%1986-1991%29%
% 208.27/208.45 |- mesh__recordOriginator mesh__D016731 AGS
% 208.27/208.45 |- skos__prefLabel mesh__D016731 Erythema Infectiosum
% 208.27/208.45 |- mesh__publicMeSHNote mesh__D016731 92
% 208.27/208.45 |- mesh__recordMaintainer mesh__D016731 sjn
% 208.27/208.45 |- mesh__dateCreated mesh__D016731 1991-04-29
% 208.27/208.45 |- mesh__dateRevised mesh__D016731 2004-07-13
% 208.27/208.45 |- mesh__historyNote mesh__D016731 92
% 208.27/208.45 |- skos__annotation mesh__D016731
% 208.27/208.45 caused by Parvovirus B19 but do not index under PARVOVIRUS B19, HUMAN unless particularly discussed%A%
% 208.27/208.45 |- skos__broader mesh__D016731smesh__D004890
% 208.27/208.45 |- skos__broader mesh__D016731smesh__D017193
% 208.27/208.45 |- rdf__type mesh__D016731sskos__Concept
% 208.27/208.45 |- skos__broader mesh__D016731smesh__D010322
% 208.27/208.45 |- skos__altLabel mesh__D016731 Fifth Disease
% 208.27/208.45 |- mesh__dateEstablished mesh__D016731 1992-01-01
% 208.27/208.45 |- mesh__recordMaintainer mesh__D002711 ssb
% 208.27/208.45 |- mesh__dateEstablished mesh__D002711 1991-01-01
% 208.27/208.45 |- skos__broader mesh__D002711smesh__D010544
% 208.27/208.46 |- mesh__dateRevised mesh__D002711 2003-07-09
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002711 2004
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D002711 sjn
% 208.27/208.46 |- rdf__type mesh__D002711sskos__Concept
% 208.27/208.46 |- skos__prefLabel mesh__D002711 Chloride Peroxidase
% 208.27/208.46 |- mesh__recordOriginator mesh__D002711 RLS
% 208.27/208.46 |- mesh__dateCreated mesh__D002711 1975-07-23
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002711 2005
% 208.27/208.46 |- skos__altLabel mesh__D002711 Chloroperoxidase
% 208.27/208.46 |- skos__historyNote mesh__D002711 Chlorine %28%1973-1975%29%
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D002711
% 208.27/208.46 91; was see under PEROXIDASES 1976-90
% 208.27/208.46 |- skos__hiddenLabel mesh__D002711 Peroxidase, Chloride
% 208.27/208.46 |- skos__historyNote mesh__D002711 Peroxidases %28%1973-1975%29%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002711 2006
% 208.27/208.46 |- mesh__historyNote mesh__D002711
% 208.27/208.46 91%28%76%29%; was see under PEROXIDASES 1976-90
% 208.27/208.46 |- skos__scopeNote mesh__D002711
% 208.27/208.46 An enzyme that catalyzes the chlorination of a range of organic molecules, forming stable carbon-chloride bonds. EC 1.11.1.10.%A%
% 208.27/208.46 |- skos__broader mesh__D026361smesh__D009603
% 208.27/208.46 |- skos__altLabel mesh__D026361 Nitrogen Species, Reactive
% 208.27/208.46 |- skos__broader mesh__D026361smesh__D017672
% 208.27/208.46 |- mesh__dateEstablished mesh__D026361 2002-01-01
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026361 2002
% 208.27/208.46 |- mesh__recordMaintainer mesh__D026361 ags
% 208.27/208.46 |- skos__scopeNote mesh__D026361
% 208.27/208.46 Nitrogenous products of NITRIC OXIDE synthases, ranging from NITRIC OXIDE to NITRATES. These reactive nitrogen intermediates also include the inorganic PEROXYNITROUS ACID and the organic S-NITROSOTHIOLS.%A%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026361 2006
% 208.27/208.46 |- mesh__recordOriginator mesh__D026361 lkt
% 208.27/208.46 |- skos__historyNote mesh__D026361 Nitrogen Oxides %28%1976-2001%29%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026361 2004
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D026361 ags
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D026361 2002
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026361 2005
% 208.27/208.46 |- mesh__dateRevised mesh__D026361 2005-07-21
% 208.27/208.46 |- skos__historyNote mesh__D026361 Nitroso Compounds %28%1992-2001%29%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026361 2003
% 208.27/208.46 |- rdf__type mesh__D026361sskos__Concept
% 208.27/208.46 |- skos__hiddenLabel mesh__D026361 Species, Reactive Nitrogen
% 208.27/208.46 |- mesh__dateCreated mesh__D026361 2001-07-25
% 208.27/208.46 |- skos__prefLabel mesh__D026361 Reactive Nitrogen Species
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026361 2006A
% 208.27/208.46 |- mesh__historyNote mesh__D026361 2002
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D048015
% 208.27/208.46 2005; TNF RECEPTOR-ASSOCIATED FACTOR 5 was indexed under PROTEINS 1999-2004, under CARRIER PROTEINS 1996-1998%A%
% 208.27/208.46 |- skos__historyNote mesh__D048015 Proteins %28%1999-2004%29%
% 208.27/208.46 |- rdf__type mesh__D048015sskos__Concept
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D048015 2005
% 208.27/208.46 |- mesh__dateRevised mesh__D048015 2005-07-12
% 208.27/208.46 |- mesh__dateCreated mesh__D048015 2004-07-07
% 208.27/208.46 |- skos__historyNote mesh__D048015 Carrier Proteins %28%1996-1998%29%
% 208.27/208.46 |- mesh__recordMaintainer mesh__D048015 ags
% 208.27/208.46 |- skos__altLabel mesh__D048015 TRAF5
% 208.27/208.46 |- mesh__dateEstablished mesh__D048015 2005-01-01
% 208.27/208.46 |- mesh__recordOriginator mesh__D048015 jmp
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D048015 ags
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D048015 2006A
% 208.27/208.46 |- skos__prefLabel mesh__D048015 TNF Receptor-Associated Factor 5
% 208.27/208.46 |- mesh__historyNote mesh__D048015 2005%28%1996%29%
% 208.27/208.46 |- skos__broader mesh__D048015smesh__D047988
% 208.27/208.46 |- skos__hiddenLabel mesh__D048015 TNF Receptor Associated Factor 5
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D048015 2006
% 208.27/208.46 |- skos__scopeNote mesh__D048015
% 208.27/208.46 A signal transducing tumor necrosis factor receptor associated factor that mediates signaling from CD27 ANTIGENS; CD40 ANTIGENS; and the lymphotoxin beta-specific receptor. It is involved in regulation of NF-KAPPA B signalling.%A%
% 208.27/208.46 |- skos__altLabel mesh__D001619 Hex A
% 208.27/208.46 |- mesh__recordMaintainer mesh__D001619 ags
% 208.27/208.46 |- mesh__dateRevised mesh__D001619 2005-07-15
% 208.27/208.46 |- skos__related mesh__D001619smesh__D013661
% 208.27/208.46 |- skos__altLabel mesh__D001619 beta-N-Acetylhexosaminidase A
% 208.27/208.46 |- skos__hiddenLabel mesh__D001619 beta N Acetyl hexosaminidase
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D001619 87
% 208.27/208.46 |- skos__historyNote mesh__D001619 Glycoside Hydrolases %28%1966-1970%29%
% 208.27/208.46 |- mesh__historyNote mesh__D001619 87
% 208.27/208.46 |- skos__hiddenLabel mesh__D001619 beta N Acetylhexosaminidase
% 208.27/208.46 |- skos__hiddenLabel mesh__D001619 beta Hexosaminidase
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D001619 2005
% 208.27/208.46 |- mesh__dateEstablished mesh__D001619 1987-01-01
% 208.27/208.46 |- skos__prefLabel mesh__D001619 beta-N-Acetylhexosaminidase
% 208.27/208.46 |- mesh__dateCreated mesh__D001619 1986-06-02
% 208.27/208.46 |- skos__hiddenLabel mesh__D001619 N Acetyl beta D hexosaminidase
% 208.27/208.46 |- skos__altLabel mesh__D001619 beta-N-Acetyl-hexosaminidase
% 208.27/208.46 |- skos__altLabel mesh__D001619 Hex B
% 208.27/208.46 |- skos__historyNote mesh__D001619 Hexosaminidases %28%1971-1986%29%
% 208.27/208.46 |- skos__hiddenLabel mesh__D001619 beta N Acetyl D hexosaminidase
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D001619 2006
% 208.27/208.46 |- skos__altLabel mesh__D001619 beta-N-Acetyl-D-hexosaminidase
% 208.27/208.46 |- mesh__recordOriginator mesh__D001619 RLS
% 208.27/208.46 |- skos__scopeNote mesh__D001619
% 208.27/208.46 An enzyme hydrolyzing terminal non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Hexosaminidase A cleaves GM2, GA2, globosides, and hexosamine oligosaccharides. Hexosaminidase B cleaves all the above substrates except GM2. Deficiency of Hexosaminidase A causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease.%A%
% 208.27/208.46 |- skos__broader mesh__D001619smesh__D006596
% 208.27/208.46 |- skos__altLabel mesh__D001619 beta-Hexosaminidase
% 208.27/208.46 |- skos__hiddenLabel mesh__D001619 beta N Acetylhexosaminidase A
% 208.27/208.46 |- skos__related mesh__D001619smesh__D012497
% 208.27/208.46 |- rdf__type mesh__D001619sskos__Concept
% 208.27/208.46 |- skos__altLabel mesh__D001619 N-Acetyl-beta-D-hexosaminidase
% 208.27/208.46 |- skos__annotation mesh__D001619
% 208.27/208.46 do not confuse with ACETYLGLUCOSAMINIDASE; /defic: consider also TAY SACHS DISEASE and SANDHOFF DISEASE; coord with ISOENZYMES if discussed%A%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D001619 2006A
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D001619 ags
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 1998
% 208.27/208.46 |- mesh__dateCreated mesh__D012341 1987-05-09
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 2006
% 208.27/208.46 |- mesh__historyNote mesh__D012341
% 208.27/208.46 91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90
% 208.27/208.46 |- skos__historyNote mesh__D012341 RNA %28%1966-1970%29%
% 208.27/208.46 |- skos__altLabel mesh__D012341 5S Ribosomal RNA
% 208.27/208.46 |- skos__broader mesh__D012341smesh__D012335
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 2005
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 2000
% 208.27/208.46 |- rdf__type mesh__D012341sskos__Concept
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D012341
% 208.27/208.46 91; was see under RNA, RIBOSOMAL 1988-90
% 208.27/208.46 |- skos__prefLabel mesh__D012341 RNA, Ribosomal, 5S
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 1997
% 208.27/208.46 |- skos__scopeNote mesh__D012341
% 208.27/208.46 Constituent of the 50S subunit of prokaryotic ribosomes containing about 120 nucleotides and 34 proteins. It is also a constituent of the 60S subunit of eukaryotic ribosomes. 5S rRNA is involved in initiation of polypeptide synthesis.%A%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 2002
% 208.27/208.46 |- skos__hiddenLabel mesh__D012341 RNA, 5S Ribosomal
% 208.27/208.46 |- mesh__dateRevised mesh__D012341 1995-05-22
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 1996
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D012341 PLS
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 2004
% 208.27/208.46 |- skos__hiddenLabel mesh__D012341 Ribosomal RNA, 5S
% 208.27/208.46 |- mesh__recordOriginator mesh__D012341 RLS
% 208.27/208.46 |- skos__historyNote mesh__D012341 RNA, Ribosomal %28%1971-1987%29%
% 208.27/208.46 |- mesh__dateEstablished mesh__D012341 1991-01-01
% 208.27/208.46 |- skos__annotation mesh__D012341
% 208.27/208.46 IM; /drug eff /ultrastruct permitted; DF: 5S RRNA
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 1999
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 2003
% 208.27/208.46 |- mesh__recordMaintainer mesh__D012341 KEV
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012341 2001
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D006304 PLS
% 208.27/208.46 |- skos__historyNote mesh__D006304 Health Surveys %28%1966-1979%29%
% 208.27/208.46 |- skos__historyNote mesh__D006304
% 208.27/208.46 Health Status Indicators %28%1975-1979%29%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 1995
% 208.27/208.46 |- skos__prefLabel mesh__D006304 Health Status
% 208.27/208.46 |- skos__broader mesh__D006304smesh__D003710
% 208.27/208.46 |- mesh__historyNote mesh__D006304
% 208.27/208.46 90%28%80%29%; was see under HEALTH 1980-89
% 208.27/208.46 |- mesh__dateEstablished mesh__D006304 1990-01-01
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 2000
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 1998
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 1993
% 208.27/208.46 |- mesh__dateCreated mesh__D006304 1979-06-01
% 208.27/208.46 |- rdf__type mesh__D006304sskos__Concept
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D006304 90; was see under HEALTH 1980-89
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 2001
% 208.27/208.46 |- mesh__dateRevised mesh__D006304 1992-05-20
% 208.27/208.46 |- skos__scopeNote mesh__D006304
% 208.27/208.46 The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures.%A%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 1999
% 208.27/208.46 |- skos__historyNote mesh__D006304 Health %28%1966-1979%29%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 1996
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 2005
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 2002
% 208.27/208.46 |- skos__hiddenLabel mesh__D006304 Health Level
% 208.27/208.46 |- skos__hiddenLabel mesh__D006304 Status, Health
% 208.27/208.46 |- skos__hiddenLabel mesh__D006304 Health Levels
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 1997
% 208.27/208.46 |- skos__altLabel mesh__D006304 Level of Health
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 2006
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 2003
% 208.27/208.46 |- mesh__recordOriginator mesh__D006304 EC
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 2004
% 208.27/208.46 |- skos__annotation mesh__D006304 no qualif
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006304 1994
% 208.27/208.46 |- mesh__recordMaintainer mesh__D006304 PLS
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D044423 2006
% 208.27/208.46 |- skos__scopeNote mesh__D044423
% 208.27/208.46 Large, robust forms of brown algae %28%PHAEOPHYCEAE%29% in the order Laminariales. They are a major component of the lower intertidal and sublittoral zones on rocky coasts in temperate and polar waters. Kelp, a kind of SEAWEED, usually refers to species in the genera LAMINARIA or MACROCYSTIS, but the term may also be used for species in FUCUS or Nereocystis.%A%
% 208.27/208.46 |- skos__broader mesh__D044423smesh__D012624
% 208.27/208.46 |- skos__historyNote mesh__D044423 Algae %28%1965-2003%29%
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D044423 2004; see SEAWEED 2000-2003
% 208.27/208.46 |- skos__hiddenLabel mesh__D044423 Kelps
% 208.27/208.46 |- mesh__dateCreated mesh__D044423 2003-07-09
% 208.27/208.46 |- mesh__historyNote mesh__D044423 2004; use SEAWEED 2000-2003
% 208.27/208.46 |- mesh__recordMaintainer mesh__D044423 SYSTEM
% 208.27/208.46 |- mesh__dateEstablished mesh__D044423 2004-01-01
% 208.27/208.46 |- skos__historyNote mesh__D044423 Seaweed %28%1971-2003%29%
% 208.27/208.46 |- mesh__recordOriginator mesh__D044423 ags
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D044423 sjn
% 208.27/208.46 |- skos__broader mesh__D044423smesh__D000459
% 208.27/208.46 |- mesh__dateRevised mesh__D044423 2005-06-30
% 208.27/208.46 |- skos__prefLabel mesh__D044423 Kelp
% 208.27/208.46 |- skos__annotation mesh__D044423 coord with specific alga if pertinent
% 208.27/208.46 |- rdf__type mesh__D044423sskos__Concept
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D011249 64
% 208.27/208.46 |- skos__annotation mesh__D011249
% 208.27/208.46 coordinate IM with specific cardiovascular disease %28%IM%29%; check the tags FEMALE %26% PREGNANCY; hemorrhage during pregnancy goes here, not PREGNANCY COMPLICATIONS, HEMATOLOGIC; Manual 18.4.7; DF: PREGN COMPL CARDIOVASC%A%
% 208.27/208.46 |- mesh__recordOriginator mesh__D011249 NLM
% 208.27/208.46 |- mesh__dateCreated mesh__D011249 1999-01-01
% 208.27/208.46 |- skos__altLabel mesh__D011249 Cardiovascular Pregnancy Complications
% 208.27/208.46 |- skos__prefLabel mesh__D011249 Pregnancy Complications, Cardiovascular
% 208.27/208.46 |- skos__hiddenLabel mesh__D011249 Cardiovascular Pregnancy Complication
% 208.27/208.46 |- skos__hiddenLabel mesh__D011249 Pregnancy Complication, Cardiovascular
% 208.27/208.46 |- skos__scopeNote mesh__D011249
% 208.27/208.46 The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.%A%
% 208.27/208.46 |- skos__hiddenLabel mesh__D011249 Complication, Cardiovascular Pregnancy
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D011249 sjn
% 208.27/208.46 |- mesh__dateEstablished mesh__D011249 1964-01-01
% 208.27/208.46 |- skos__altLabel mesh__D011249 Complications, Cardiovascular Pregnancy
% 208.27/208.46 |- skos__altLabel mesh__D011249 Pregnancy, Cardiovascular Complications
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D011249 2006
% 208.27/208.46 |- skos__broader mesh__D011249smesh__D011248
% 208.27/208.46 |- mesh__dateRevised mesh__D011249 2005-06-30
% 208.27/208.46 |- mesh__historyNote mesh__D011249 64
% 208.27/208.46 |- skos__hiddenLabel mesh__D011249
% 208.27/208.46 Pregnancies, Cardiovascular Complications
% 208.27/208.46 |- rdf__type mesh__D011249sskos__Concept
% 208.27/208.46 |- skos__broader mesh__D011249smesh__D002318
% 208.27/208.46 |- mesh__recordMaintainer mesh__D011249 lkt
% 208.27/208.46 |- skos__related mesh__D016732smesh__D016731
% 208.27/208.46 |- rdf__type mesh__D016732sskos__Concept
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016732 2004
% 208.27/208.46 |- skos__scopeNote mesh__D016732
% 208.27/208.46 The type species of ERYTHROVIRUS and the etiological agent of ERYTHEMA INFECTIOSUM, a disease most commonly seen in school-age children.%A%
% 208.27/208.46 |- mesh__recordOriginator mesh__D016732 AGS
% 208.27/208.46 |- mesh__recordMaintainer mesh__D016732 ags
% 208.27/208.46 |- skos__prefLabel mesh__D016732 Parvovirus B19, Human
% 208.27/208.46 |- skos__broader mesh__D016732smesh__D019218
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016732 2003
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016732 2006
% 208.27/208.46 |- mesh__dateRevised mesh__D016732 2001-07-25
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D016732 sjn
% 208.27/208.46 |- skos__historyNote mesh__D016732 Parvoviridae %28%1981-1991%29%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016732 2002
% 208.27/208.46 |- skos__hiddenLabel mesh__D016732 B19 viruses
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016732 2005
% 208.27/208.46 |- skos__altLabel mesh__D016732 Human Parvovirus B19
% 208.27/208.46 |- skos__annotation mesh__D016732
% 208.27/208.46 infection = probably ERYTHEMA INFECTIOSUM but if not so specified, coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%%A%
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D016732 92
% 208.27/208.46 |- skos__altLabel mesh__D016732 B19 virus
% 208.27/208.46 |- mesh__dateCreated mesh__D016732 1991-04-29
% 208.27/208.46 |- mesh__dateEstablished mesh__D016732 1992-01-01
% 208.27/208.46 |- mesh__historyNote mesh__D016732 92
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 1994
% 208.27/208.46 |- skos__prefLabel mesh__D002712 Chlorides
% 208.27/208.46 |- mesh__dateCreated mesh__D002712 1999-01-01
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 2005
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 2000
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 1998
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 1995
% 208.27/208.46 |- mesh__recordMaintainer mesh__D002712 TPW
% 208.27/208.46 |- mesh__dateRevised mesh__D002712 1993-06-04
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 2006
% 208.27/208.46 |- mesh__recordOriginator mesh__D002712 NLM
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 2001
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D002712 PLS
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 1999
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 2003
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 1996
% 208.27/208.46 |- skos__broader mesh__D002712smesh__D006851
% 208.27/208.46 |- skos__scopeNote mesh__D002712
% 208.27/208.46 Inorganic compounds derived from hydrochloric acid that contain the Cl- ion.%A%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 2004
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 1997
% 208.27/208.46 |- rdf__type mesh__D002712sskos__Concept
% 208.27/208.46 |- skos__hiddenLabel mesh__D002712 Ion Level, Chloride
% 208.27/208.46 |- skos__annotation mesh__D002712
% 208.27/208.46 only for inorganic cpds or chloride ion; /physiol permitted%A%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D002712 2002
% 208.27/208.46 |- skos__hiddenLabel mesh__D002712 Level, Chloride Ion
% 208.27/208.46 |- skos__broader mesh__D002712smesh__D000838
% 208.27/208.46 |- mesh__dateCreated mesh__D026362 2001-07-25
% 208.27/208.46 |- skos__altLabel mesh__D026362 p67-SRF
% 208.27/208.46 |- mesh__recordMaintainer mesh__D026362 jmp
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D026362 sjn
% 208.27/208.46 |- skos__hiddenLabel mesh__D026362 c fos Serum Response Factor
% 208.27/208.46 |- skos__historyNote mesh__D026362 Nuclear Proteins %28%1988-2001%29%
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D026362
% 208.27/208.46 2002; SERUM RESPONSE FACTOR was indexed under NUCLEAR PROTEINS 1988-2001 %26% DNA-BINDING PROTEINS 1992-2001%A%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026362 2006
% 208.27/208.46 |- skos__scopeNote mesh__D026362
% 208.27/208.46 A MADS domain-containing transcription factor that binds to the SERUM RESPONSE ELEMENT in the promoter-enhancer region of many genes. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A%
% 208.27/208.46 |- skos__altLabel mesh__D026362 Serum Response Factor, p67
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026362 2004
% 208.27/208.46 |- skos__historyNote mesh__D026362 DNA-Binding Proteins %28%1992-2001%29%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026362 2005
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026362 2002
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D026362 2003
% 208.27/208.46 |- mesh__historyNote mesh__D026362
% 208.27/208.46 2002; use SERUM RESPONSE FACTOR %28%NM%29% 1988-2001
% 208.27/208.46 |- rdf__type mesh__D026362sskos__Concept
% 208.27/208.46 |- mesh__recordOriginator mesh__D026362 jmp
% 208.27/208.46 |- skos__broader mesh__D026362smesh__D026161
% 208.27/208.46 |- skos__altLabel mesh__D026362 c-fos Serum Response Factor
% 208.27/208.46 |- skos__hiddenLabel mesh__D026362 Response Factor, Serum
% 208.27/208.46 |- skos__altLabel mesh__D026362 Transcription Factor SRF
% 208.27/208.46 |- mesh__dateEstablished mesh__D026362 2002-01-01
% 208.27/208.46 |- skos__prefLabel mesh__D026362 Serum Response Factor
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D048016 sjn
% 208.27/208.46 |- skos__historyNote mesh__D048016 Sea Cucumbers %28%1989-2004%29%
% 208.27/208.46 |- mesh__historyNote mesh__D048016 2005
% 208.27/208.46 |- skos__broader mesh__D048016smesh__D012616
% 208.27/208.46 |- mesh__recordMaintainer mesh__D048016 ags
% 208.27/208.46 |- skos__prefLabel mesh__D048016 Cucumaria
% 208.27/208.46 |- skos__scopeNote mesh__D048016
% 208.27/208.46 A genus of large SEA CUCUMBERS possessing the primitive radial configuration of podia in all five ambulacral areas.%A%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D048016 2006
% 208.27/208.46 |- mesh__recordOriginator mesh__D048016 ags
% 208.27/208.46 |- rdf__type mesh__D048016sskos__Concept
% 208.27/208.46 |- mesh__dateEstablished mesh__D048016 2005-01-01
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D048016 2005
% 208.27/208.46 |- skos__historyNote mesh__D048016 Echinodermata %28%1970-1988%29%
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D048016 2005
% 208.27/208.46 |- mesh__dateCreated mesh__D048016 2004-07-07
% 208.27/208.46 |- mesh__recordOriginator mesh__D012342 RLS
% 208.27/208.46 |- skos__altLabel mesh__D012342 snRNA
% 208.27/208.46 |- mesh__dateRevised mesh__D012342 2000-06-22
% 208.27/208.46 |- skos__altLabel mesh__D012342 Small Molecular Weight RNA
% 208.27/208.46 |- skos__broader mesh__D012342smesh__D015138
% 208.27/208.46 |- skos__historyNote mesh__D012342 RNA, Messenger %28%1966-1985%29%
% 208.27/208.46 |- skos__hiddenLabel mesh__D012342 RNA, Chromatin-Associated
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012342 2004
% 208.27/208.46 |- mesh__recordMaintainer mesh__D012342 nns
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D012342 86
% 208.27/208.46 |- skos__annotation mesh__D012342 DF: SNRNA
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012342 2001
% 208.27/208.46 |- mesh__dateCreated mesh__D012342 1985-04-25
% 208.27/208.46 |- mesh__historyNote mesh__D012342 86
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D012342 sjn
% 208.27/208.46 |- mesh__dateEstablished mesh__D012342 1986-01-01
% 208.27/208.46 |- skos__altLabel mesh__D012342 Small Nuclear RNA
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012342 2003
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012342 2006
% 208.27/208.46 |- skos__historyNote mesh__D012342 RNA %28%1966-1985%29%
% 208.27/208.46 |- skos__prefLabel mesh__D012342 RNA, Small Nuclear
% 208.27/208.46 |- skos__broader mesh__D012342smesh__D022661
% 208.27/208.46 |- skos__altLabel mesh__D012342 Low Molecular Weight Nuclear RNA
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012342 2005
% 208.27/208.46 |- skos__hiddenLabel mesh__D012342 Chromatin Associated RNA
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D012342 2002
% 208.27/208.46 |- rdf__type mesh__D012342sskos__Concept
% 208.27/208.46 |- skos__scopeNote mesh__D012342
% 208.27/208.46 Short chains of RNA %28%100-300 nucleotides long%29% that are abundant in the nucleus and usually complexed with proteins in snRNPs %28%RIBONUCLEOPROTEINS, SMALL NUCLEAR%29%. Many function in the processing of messenger RNA precursors. Others, the snoRNAs %28%RNA, SMALL NUCLEOLAR%29%, are involved with the processing of ribosomal RNA precursors.%A%
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Indicators, Health Status
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Appraisals, Health Risk
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006305 2003
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Indicator, Health Status
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Indices, Health Status
% 208.27/208.46 |- mesh__dateRevised mesh__D006305 1999-11-03
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006305 2005
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D006305 sjn
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Indexes, Health Status
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Appraisal, Health Risk
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Health Status Indicator
% 208.27/208.46 |- mesh__dateEstablished mesh__D006305 1990-01-01
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006305 2002
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Risk Appraisal, Health
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D006305
% 208.27/208.46 90; was see under HEALTH SURVEYS 1975-89
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Health Risk Appraisals
% 208.27/208.46 |- mesh__dateCreated mesh__D006305 1974-11-11
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Index, Health Status
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006305 2001
% 208.27/208.46 |- rdf__type mesh__D006305sskos__Concept
% 208.27/208.46 |- skos__broader mesh__D006305smesh__D006306
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Health Status Indices
% 208.27/208.46 |- skos__altLabel mesh__D006305 Health Status Indexes
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006305 2000
% 208.27/208.46 |- mesh__historyNote mesh__D006305
% 208.27/208.46 90%28%75%29%; was see under HEALTH SURVEYS 1975-89
% 208.27/208.46 |- skos__altLabel mesh__D006305 Health Status Index
% 208.27/208.46 |- mesh__recordOriginator mesh__D006305 NLM
% 208.27/208.46 |- mesh__recordMaintainer mesh__D006305 kle
% 208.27/208.46 |- skos__scopeNote mesh__D006305
% 208.27/208.46 The measurement of the health status for a given population using a variety of indices, including morbidity, mortality, and available health resources.%A%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006305 2004
% 208.27/208.46 |- skos__prefLabel mesh__D006305 Health Status Indicators
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D006305 2006
% 208.27/208.46 |- skos__annotation mesh__D006305 no qualif
% 208.27/208.46 |- skos__hiddenLabel mesh__D006305 Risk Appraisals, Health
% 208.27/208.46 |- mesh__dateRevised mesh__D044424 2005-06-30
% 208.27/208.46 |- skos__scopeNote mesh__D044424
% 208.27/208.46 A genus of primitive ALGAE in the family Cyanophoraceae, class Glaucocystophyceae. They contain pigmented prokaryotic endosymbionts called cyanelles, which have characteristics of both CYANOBACTERIA and CHLOROPLASTS.%A%
% 208.27/208.46 |- mesh__dateCreated mesh__D044424 2003-07-09
% 208.27/208.46 |- mesh__recordMaintainer mesh__D044424 SYSTEM
% 208.27/208.46 |- skos__broader mesh__D044424smesh__D000456
% 208.27/208.46 |- skos__hiddenLabel mesh__D044424 paradoxa, Cyanophora
% 208.27/208.46 |- mesh__historyNote mesh__D044424 2004; use ALGAE 1998-2003
% 208.27/208.46 |- skos__hiddenLabel mesh__D044424 paradoxas, Cyanophora
% 208.27/208.46 |- skos__annotation mesh__D044424
% 208.27/208.46 do not confuse CYANOPHORA with the group CYANOBACTERIA
% 208.27/208.46 |- skos__hiddenLabel mesh__D044424 Cyanophora paradoxas
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D044424 2004; see ALGAE 1998-2003
% 208.27/208.46 |- mesh__dateEstablished mesh__D044424 2004-01-01
% 208.27/208.46 |- skos__historyNote mesh__D044424 Cyanobacteria %28%1980-1988%29%
% 208.27/208.46 |- skos__hiddenLabel mesh__D044424 Cyanophoras
% 208.27/208.46 |- rdf__type mesh__D044424sskos__Concept
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D044424 2006
% 208.27/208.46 |- mesh__recordOriginator mesh__D044424 ags
% 208.27/208.46 |- skos__prefLabel mesh__D044424 Cyanophora
% 208.27/208.46 |- skos__historyNote mesh__D044424 Algae %28%1989-2003%29%
% 208.27/208.46 |- mesh__recordAuthorizer mesh__D044424 sjn
% 208.27/208.46 |- skos__broader mesh__D016733smesh__D003748
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016733 1999
% 208.27/208.46 |- mesh__dateRevised mesh__D016733 1992-04-21
% 208.27/208.46 |- mesh__publicMeSHNote mesh__D016733 92
% 208.27/208.46 |- skos__historyNote mesh__D016733
% 208.27/208.46 Dentistry, Operative/instrumentation %28%1977-1991%29%
% 208.27/208.46 |- mesh__dateEstablished mesh__D016733 1992-01-01
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016733 2003
% 208.27/208.46 |- skos__historyNote mesh__D016733 Dental Materials %28%1966-1977%29%
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016733 1995
% 208.27/208.46 |- skos__hiddenLabel mesh__D016733 Rubber Dam
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016733 2001
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016733 1998
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016733 2006
% 208.27/208.46 |- mesh__recordOriginator mesh__D016733 MXR
% 208.27/208.46 |- skos__scopeNote mesh__D016733
% 208.27/208.46 Sheets of latex rubber punched and placed over the teeth during dental procedures to isolate the field of operation from the rest of the oral cavity %28%Jablonski; Illustrated Dictionary of Dentistry, 1982%29%. Rubber dams are useful in preventing the swallowing of instruments or restorations during dental work.%A%
% 208.27/208.46 |- mesh__recordMaintainer mesh__D016733 NLM
% 208.27/208.46 |- skos__hiddenLabel mesh__D016733 Dam, Rubber
% 208.27/208.46 |- mesh__activeMeSHYear mesh__D016733 1994
% 208.27/208.46 |- skos__hiddenLabel mesh__D016733 Dams, Rubber
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D016733 PLS
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016733 2000
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016733 2005
% 208.27/208.47 |- skos__prefLabel mesh__D016733 Rubber Dams
% 208.27/208.47 |- skos__altLabel mesh__D016733 Rubberdam
% 208.27/208.47 |- mesh__dateCreated mesh__D016733 1991-04-29
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016733 1997
% 208.27/208.47 |- mesh__historyNote mesh__D016733 92
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016733 2002
% 208.27/208.47 |- rdf__type mesh__D016733sskos__Concept
% 208.27/208.47 |- skos__annotation mesh__D016733
% 208.27/208.47 to isolate operative field during dent proced; do not use /util except by MeSH definition%A%
% 208.27/208.47 |- skos__hiddenLabel mesh__D016733 Rubberdams
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016733 1993
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016733 1996
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016733 2004
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002713 2002
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002713 2003A
% 208.27/208.47 |- skos__prefLabel mesh__D002713 Chlorine
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002713 2006
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002713 2003B
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002713 2003
% 208.27/208.47 |- skos__annotation mesh__D002713
% 208.27/208.47 Cl-35; Cl-37 = CHLORINE %28%IM%29% + ISOTOPES %28%NIM%29%; Cl-34, 36, 38-40 = CHLORINE %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002713 2004
% 208.27/208.47 |- rdf__type mesh__D002713sskos__Concept
% 208.27/208.47 |- mesh__recordOriginator mesh__D002713 NLM
% 208.27/208.47 |- mesh__dateRevised mesh__D002713 2003-03-21
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002713 2001
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D002713 ags
% 208.27/208.47 |- skos__broader mesh__D002713smesh__D005740
% 208.27/208.47 |- skos__broader mesh__D002713smesh__D006219
% 208.27/208.47 |- mesh__dateCreated mesh__D002713 1999-01-01
% 208.27/208.47 |- mesh__recordMaintainer mesh__D002713 ags
% 208.27/208.47 |- skos__scopeNote mesh__D002713
% 208.27/208.47 A greenish-yellow, diatomic gas that is a member of the halogen family of elements. It has the atomic symbol Cl, atomic number 17, and atomic weight 70.906. It is a powerful irritant that can cause fatal pulmonary edema. Chlorine is used in manufacturing, as a reagent in synthetic chemistry, for water purification, and in the production of chlorinated lime, which is used in fabric bleaching.%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002713 2005
% 208.27/208.47 |- mesh__dateEstablished mesh__D012343 1972-01-01
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012343 2004
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012343 2002
% 208.27/208.47 |- skos__altLabel mesh__D012343 Transfer RNA, Suppressor
% 208.27/208.47 |- mesh__dateRevised mesh__D012343 2001-07-25
% 208.27/208.47 |- skos__hiddenLabel mesh__D012343 RNA, Suppressor Transfer
% 208.27/208.47 |- skos__altLabel mesh__D012343 tRNA
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012343 2003
% 208.27/208.47 |- mesh__onlineNote mesh__D012343
% 208.27/208.47 use RNA, TRANSFER to search RNA, SOLUBLE 1966-71
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012343 2006
% 208.27/208.47 |- skos__altLabel mesh__D012343 Suppressor Transfer RNA
% 208.27/208.47 |- mesh__recordMaintainer mesh__D012343 nns
% 208.27/208.47 |- skos__scopeNote mesh__D012343
% 208.27/208.47 The small RNA molecules, 73-80 nucleotides long, that function during translation %28%TRANSLATION, GENETIC%29% to align AMINO ACIDS at the RIBOSOMES in a sequence determined by the mRNA %28%RNA, MESSENGER%29%. There are about 30 different transfer RNAs. Each recognizes a specific CODON set on the mRNA through its own ANTICODON and as aminoacyl tRNAs %28%RNA, TRANSFER, AMINO ACYL%29%, each carries a specific amino acid to the ribosome to add to the elongating peptide chains.%A%
% 208.27/208.47 |- skos__broader mesh__D012343smesh__D012313
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012343 2005
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D012343 sjn
% 208.27/208.47 |- mesh__dateCreated mesh__D012343 1999-01-01
% 208.27/208.47 |- skos__annotation mesh__D012343
% 208.27/208.47 GEN; prefer specifics; for suppressor transfer RNA coord with GENES, SUPPRESSOR or SUPPRESSION, GENETIC%A%
% 208.27/208.47 |- rdf__type mesh__D012343sskos__Concept
% 208.27/208.47 |- skos__altLabel mesh__D012343 Transfer RNA
% 208.27/208.47 |- skos__prefLabel mesh__D012343 RNA, Transfer
% 208.27/208.47 |- mesh__recordOriginator mesh__D012343 NLM
% 208.27/208.47 |- mesh__historyNote mesh__D012343 72; was RNA, SOLUBLE 1965-71
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D012343 72; was RNA, SOLUBLE 1965-71
% 208.27/208.47 |- mesh__recordOriginator mesh__D006306 NLM
% 208.27/208.47 |- skos__hiddenLabel mesh__D006306 Survey, Health
% 208.27/208.47 |- skos__broader mesh__D006306smesh__D003625
% 208.27/208.47 |- skos__hiddenLabel mesh__D006306 Surveys, Health
% 208.27/208.47 |- skos__annotation mesh__D006306
% 208.27/208.47 do not confuse with HEALTH CARE SURVEYS: health surveys are on health statist, health care surveys are on health services provided; no qualif; TN 97: misuse of %22%surveys%22%; specify geog if pertinent%A%
% 208.27/208.47 |- rdf__type mesh__D006306sskos__Concept
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D006306 sjn
% 208.27/208.47 |- mesh__onlineNote mesh__D006306
% 208.27/208.47 use HEALTH SURVEYS to search SANITARY SURVEYS 1966
% 208.27/208.47 |- skos__prefLabel mesh__D006306 Health Surveys
% 208.27/208.47 |- mesh__dateRevised mesh__D006306 2004-07-13
% 208.27/208.47 |- mesh__recordMaintainer mesh__D006306 sjn
% 208.27/208.47 |- skos__hiddenLabel mesh__D006306 Survey, Abortion
% 208.27/208.47 |- mesh__dateCreated mesh__D006306 1999-01-01
% 208.27/208.47 |- skos__scopeNote mesh__D006306
% 208.27/208.47 A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area.%A%
% 208.27/208.47 |- skos__hiddenLabel mesh__D006306 Surveys, Abortion
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D006306
% 208.27/208.47 SANITARY SURVEYS was heading 1963-66
% 208.27/208.47 |- skos__hiddenLabel mesh__D006306 Health Survey
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006306 2006
% 208.27/208.47 |- skos__hiddenLabel mesh__D006306 Abortion Survey
% 208.27/208.47 |- mesh__historyNote mesh__D006306 SANITARY SURVEYS was heading 1963-66
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006306 2005
% 208.27/208.47 |- mesh__recordOriginator mesh__D016734 MXR
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016734 2005
% 208.27/208.47 |- skos__hiddenLabel mesh__D016734 Clasp, Denture
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016734 2002
% 208.27/208.47 |- skos__altLabel mesh__D016734 Clasps, Dental
% 208.27/208.47 |- mesh__dateCreated mesh__D016734 1991-04-29
% 208.27/208.47 |- skos__historyNote mesh__D016734
% 208.27/208.47 Denture, Partial, Removable %28%1966-1991%29%
% 208.27/208.47 |- mesh__dateEstablished mesh__D016734 1992-01-01
% 208.27/208.47 |- mesh__historyNote mesh__D016734 92
% 208.27/208.47 |- skos__annotation mesh__D016734
% 208.27/208.47 for any prosthesis; do not confuse X ref DENTURE CLASPS with DENTURE PRECISION ATTACHMENT, a special type of precision device for use with partial dentures; do not use for orthodontic clasps; DF: DENT CLASPS%A%
% 208.27/208.47 |- rdf__type mesh__D016734sskos__Concept
% 208.27/208.47 |- skos__altLabel mesh__D016734 Dental Clasp
% 208.27/208.47 |- skos__altLabel mesh__D016734 Denture Clasps
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D016734 92
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D016734 SJN
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016734 2004
% 208.27/208.47 |- skos__prefLabel mesh__D016734 Dental Clasps
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016734 2001
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016734 1999
% 208.27/208.47 |- mesh__dateRevised mesh__D016734 1997-06-20
% 208.27/208.47 |- skos__scopeNote mesh__D016734
% 208.27/208.47 Metal devices for fastening together two or more parts of dental prostheses for stabilizing or retaining them by attachment to abutment teeth. For a precision attachment for a partial denture DENTURE PRECISION ATTACHMENT is available.%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016734 2003
% 208.27/208.47 |- skos__altLabel mesh__D016734 Clasp, Dental
% 208.27/208.47 |- mesh__recordMaintainer mesh__D016734 PXP
% 208.27/208.47 |- skos__hiddenLabel mesh__D016734 Denture Clasp
% 208.27/208.47 |- skos__broader mesh__D016734smesh__D017266
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016734 2000
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016734 1998
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016734 2006
% 208.27/208.47 |- skos__hiddenLabel mesh__D016734 Clasps, Denture
% 208.27/208.47 |- skos__hiddenLabel mesh__D002714 Chloride, Chlorisondamine
% 208.27/208.47 |- mesh__recordOriginator mesh__D002714 NLM
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D002714 sjn
% 208.27/208.47 |- mesh__dateRevised mesh__D002714 2005-06-30
% 208.27/208.47 |- mesh__dateCreated mesh__D002714 1999-01-01
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002714 2006
% 208.27/208.47 |- skos__broader mesh__D002714smesh__D007211
% 208.27/208.47 |- mesh__recordMaintainer mesh__D002714 ssb
% 208.27/208.47 |- skos__prefLabel mesh__D002714 Chlorisondamine
% 208.27/208.47 |- skos__altLabel mesh__D002714 Chlorisondamine Dichloride
% 208.27/208.47 |- rdf__type mesh__D002714sskos__Concept
% 208.27/208.47 |- skos__scopeNote mesh__D002714
% 208.27/208.47 A nicotinic antagonist used primarily as a ganglionic blocker in animal research. It has been used as an antihypertensive agent but has been supplanted by more specific drugs in most clinical applications.%A%
% 208.27/208.47 |- skos__hiddenLabel mesh__D002714 Dichloride, Chlorisondamine
% 208.27/208.47 |- skos__broader mesh__D002714smesh__D050337
% 208.27/208.47 |- skos__broader mesh__D002714smesh__D000644
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 1998
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 2004
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 2002
% 208.27/208.47 |- skos__hiddenLabel mesh__D012344 tRNA, Alanine-Specific
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 1999
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 2005
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D012344 PLS
% 208.27/208.47 |- mesh__dateRevised mesh__D012344 1996-06-10
% 208.27/208.47 |- skos__altLabel mesh__D012344 Transfer RNA, Ala
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 2006
% 208.27/208.47 |- skos__prefLabel mesh__D012344 RNA, Transfer, Ala
% 208.27/208.47 |- skos__broader mesh__D012344smesh__D012345
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D012344
% 208.27/208.47 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.27/208.47 |- skos__hiddenLabel mesh__D012344 Alanine Specific tRNA
% 208.27/208.47 |- skos__altLabel mesh__D012344 tRNA%28%Ala%29%
% 208.27/208.47 |- skos__hiddenLabel mesh__D012344 RNA, Ala Transfer
% 208.27/208.47 |- skos__hiddenLabel mesh__D012344 Ala Transfer RNA
% 208.27/208.47 |- rdf__type mesh__D012344sskos__Concept
% 208.27/208.47 |- skos__historyNote mesh__D012344 RNA, Transfer %28%1966-1987%29%
% 208.27/208.47 |- skos__scopeNote mesh__D012344
% 208.27/208.47 A transfer RNA which is specific for carrying alanine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.27/208.47 |- skos__historyNote mesh__D012344 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.47 |- mesh__dateCreated mesh__D012344 1987-05-07
% 208.27/208.47 |- skos__annotation mesh__D012344
% 208.27/208.47 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.27/208.47 |- mesh__recordOriginator mesh__D012344 RLS
% 208.27/208.47 |- skos__altLabel mesh__D012344 tRNAAla
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 2000
% 208.27/208.47 |- mesh__dateEstablished mesh__D012344 1991-01-01
% 208.27/208.47 |- mesh__historyNote mesh__D012344
% 208.27/208.47 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.27/208.47 |- skos__altLabel mesh__D012344 Alanine-Specific tRNA
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 1997
% 208.27/208.47 |- mesh__recordMaintainer mesh__D012344 TGC
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 2003
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012344 2001
% 208.27/208.47 |- skos__broader mesh__D014466Q000627smesh__D014466
% 208.27/208.47 |- mesh__preferredCombination mesh__D014466Q000627smesh__D014467
% 208.27/208.47 |- rdf__type mesh__D014466Q000627smesh__CompoundConcept
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006307 2005
% 208.27/208.47 |- skos__historyNote mesh__D006307 Health Planning %28%1968-1977%29%
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D006307 sjn
% 208.27/208.47 |- rdf__type mesh__D006307sskos__Concept
% 208.27/208.47 |- skos__prefLabel mesh__D006307 Health Systems Agencies
% 208.27/208.47 |- mesh__recordOriginator mesh__D006307 EC
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D006307 78
% 208.27/208.47 |- skos__hiddenLabel mesh__D006307 Health Systems Agency
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006307 2002
% 208.27/208.47 |- mesh__dateRevised mesh__D006307 1999-11-03
% 208.27/208.47 |- mesh__dateCreated mesh__D006307 1977-05-05
% 208.27/208.47 |- skos__annotation mesh__D006307
% 208.27/208.47 Public Law 93-641; specify geog %26% add UNITED STATES also
% 208.27/208.47 |- skos__hiddenLabel mesh__D006307 Systems Agency, Health
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006307 2001
% 208.27/208.47 |- skos__hiddenLabel mesh__D006307 Agencies, Health Systems
% 208.27/208.47 |- mesh__historyNote mesh__D006307 78
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006307 2004
% 208.27/208.47 |- skos__hiddenLabel mesh__D006307 Systems Agencies, Health
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006307 2000
% 208.27/208.47 |- mesh__dateEstablished mesh__D006307 1978-01-01
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006307 2003
% 208.27/208.47 |- skos__scopeNote mesh__D006307
% 208.27/208.47 Health planning and resources development agencies which function in each health service area of the United States %28%PL 93-641%29%.%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006307 2006
% 208.27/208.47 |- skos__broader mesh__D006307smesh__D013220
% 208.27/208.47 |- skos__hiddenLabel mesh__D006307 Agency, Health Systems
% 208.27/208.47 |- mesh__recordMaintainer mesh__D006307 kle
% 208.27/208.47 |- skos__broader mesh__D007074Q000172smesh__D007074
% 208.27/208.47 |- mesh__preferredCombination mesh__D007074Q000172smesh__D017099
% 208.27/208.47 |- rdf__type mesh__D007074Q000172smesh__CompoundConcept
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016735 2006
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016735 2002
% 208.27/208.47 |- skos__scopeNote mesh__D016735
% 208.27/208.47 A phenomenon in which symptoms of a disease are fabricated by an individual other than the patient causing unnecessary, and often painful, physical examinations and treatments. This syndrome is considered a form of CHILD ABUSE, since another individual, usually a parent, is the source of the fabrication of symptoms and presents the child for medical care.%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016735 2005
% 208.27/208.47 |- skos__historyNote mesh__D016735 Munchausen Syndrome %28%1977-1991%29%
% 208.27/208.47 |- rdf__type mesh__D016735sskos__Concept
% 208.27/208.47 |- mesh__dateCreated mesh__D016735 1991-04-29
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D016735 SJN
% 208.27/208.47 |- mesh__dateEstablished mesh__D016735 1992-01-01
% 208.27/208.47 |- mesh__historyNote mesh__D016735 92
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016735 2001
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D016735 92
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016735 2004
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016735 1999
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016735 2000
% 208.27/208.47 |- mesh__dateRevised mesh__D016735 1997-06-24
% 208.27/208.47 |- skos__broader mesh__D016735smesh__D002649
% 208.27/208.47 |- mesh__recordMaintainer mesh__D016735 TGC
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016735 2003
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016735 1998
% 208.27/208.47 |- skos__prefLabel mesh__D016735 Munchausen Syndrome by Proxy
% 208.27/208.47 |- mesh__recordOriginator mesh__D016735 MXR
% 208.27/208.47 |- skos__annotation mesh__D016735
% 208.27/208.47 dis symptoms fabricated by person other than patient, usually a parent for a child%A%
% 208.27/208.47 |- mesh__dateCreated mesh__D002715 1999-01-01
% 208.27/208.47 |- skos__broader mesh__D002715smesh__D013258
% 208.27/208.47 |- skos__hiddenLabel mesh__D002715 Acetate, Chlormadinon
% 208.27/208.47 |- skos__scopeNote mesh__D002715
% 208.27/208.47 An orally active synthetic progestational hormone used often in combinations as an oral contraceptive.%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002715 2006
% 208.27/208.47 |- mesh__recordOriginator mesh__D002715 NLM
% 208.27/208.47 |- skos__hiddenLabel mesh__D002715 Neo Eunomin
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002715 2004
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D002715 sjn
% 208.27/208.47 |- mesh__dateRevised mesh__D002715 2003-07-09
% 208.27/208.47 |- mesh__dateEstablished mesh__D002715 1966-01-01
% 208.27/208.47 |- skos__altLabel mesh__D002715 Chlormadinon Acetate
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D002715 2005
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D002715 96; was CHLORMADINONE 1966-1995
% 208.27/208.47 |- skos__hiddenLabel mesh__D002715 Acetate, Chlormadinone
% 208.27/208.47 |- skos__hiddenLabel mesh__D002715 NeoEunomin
% 208.27/208.47 |- mesh__recordMaintainer mesh__D002715 lkt
% 208.27/208.47 |- rdf__type mesh__D002715sskos__Concept
% 208.27/208.47 |- skos__prefLabel mesh__D002715 Chlormadinone Acetate
% 208.27/208.47 |- skos__broader mesh__D002715smesh__D011245
% 208.27/208.47 |- mesh__historyNote mesh__D002715
% 208.27/208.47 96; was CHLORMADINONE 1964-1995 %28%Prov 1964-65%29%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D007400 2003
% 208.27/208.47 |- mesh__dateEstablished mesh__D007400 1965-01-01
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D007400 65
% 208.27/208.47 |- mesh__dateRevised mesh__D007400 2002-10-31
% 208.27/208.47 |- mesh__dateCreated mesh__D007400 1999-01-01
% 208.27/208.47 |- rdf__type mesh__D007400sskos__Concept
% 208.27/208.47 |- skos__broader mesh__D007400smesh__D007398
% 208.27/208.47 |- skos__scopeNote mesh__D007400
% 208.27/208.47 The reciprocal interaction of two or more professional individuals.%A%
% 208.27/208.47 |- skos__altLabel mesh__D007400 Medical Etiquette
% 208.27/208.47 |- skos__related mesh__D007400smesh__D033183
% 208.27/208.47 |- skos__prefLabel mesh__D007400 Interprofessional Relations
% 208.27/208.47 |- mesh__recordOriginator mesh__D007400 NLM
% 208.27/208.47 |- skos__hiddenLabel mesh__D007400 Relations, Interprofessional
% 208.27/208.47 |- mesh__recordMaintainer mesh__D007400 jls
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D007400 2006
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D007400 jls
% 208.27/208.47 |- mesh__historyNote mesh__D007400 65
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D007400 2005
% 208.27/208.47 |- skos__annotation mesh__D007400
% 208.27/208.47 coord IM with med or other spec %28%IM%29% if pertinent; INTERDISCIPLINARY COMMUNICATION is also available%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D007400 2004
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D007400 2003A
% 208.27/208.47 |- skos__altLabel mesh__D012345 Amino Acid-Specific tRNA
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 2000
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 1999
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 2005
% 208.27/208.47 |- mesh__dateEstablished mesh__D012345 1988-01-01
% 208.27/208.47 |- skos__hiddenLabel mesh__D012345 Transfer RNA, Amino Acid Specific
% 208.27/208.47 |- skos__historyNote mesh__D012345 RNA, Transfer %28%1972-1987%29%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 2001
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 2006
% 208.27/208.47 |- skos__hiddenLabel mesh__D012345 Acid, tRNA-Amino
% 208.27/208.47 |- skos__scopeNote mesh__D012345
% 208.27/208.47 A group of transfer RNAs which are specific for carrying each one of the 20 amino acids to the ribosome in preparation for protein synthesis.%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 2002
% 208.27/208.47 |- mesh__historyNote mesh__D012345 88
% 208.27/208.47 |- skos__hiddenLabel mesh__D012345 Amino Acid Specific Transfer RNA
% 208.27/208.47 |- skos__hiddenLabel mesh__D012345 Amino Acid Specific tRNA
% 208.27/208.47 |- skos__altLabel mesh__D012345 tRNA-Amino Acid
% 208.27/208.47 |- skos__altLabel mesh__D012345 Amino Acid-Specific Transfer RNA
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D012345 PLS
% 208.27/208.47 |- rdf__type mesh__D012345sskos__Concept
% 208.27/208.47 |- mesh__dateCreated mesh__D012345 1987-05-05
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D012345 88
% 208.27/208.47 |- skos__prefLabel mesh__D012345 RNA, Transfer, Amino Acid-Specific
% 208.27/208.47 |- mesh__dateRevised mesh__D012345 1996-06-10
% 208.27/208.47 |- skos__broader mesh__D012345smesh__D012343
% 208.27/208.47 |- skos__historyNote mesh__D012345 Amino Acids %28%1966-1987%29%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 1997
% 208.27/208.47 |- mesh__recordMaintainer mesh__D012345 TGC
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 2003
% 208.27/208.47 |- skos__annotation mesh__D012345
% 208.27/208.47 GEN or unspecified; prefer available tRNA terms naming the specific amino acids; /drug eff /ultrastruct permitted; DF: TRNA AA SPECIFIC%A%
% 208.27/208.47 |- skos__hiddenLabel mesh__D012345 tRNA Amino Acid
% 208.27/208.47 |- skos__altLabel mesh__D012345 Transfer RNA, Amino Acid-Specific
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 1998
% 208.27/208.47 |- skos__hiddenLabel mesh__D012345 tRNA, Amino Acid-Specific
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D012345 2004
% 208.27/208.47 |- skos__hiddenLabel mesh__D012345 Acid-Specific tRNA, Amino
% 208.27/208.47 |- skos__altLabel mesh__D012345 RNA, Transfer, Amino Acid Specific
% 208.27/208.47 |- skos__historyNote mesh__D012345 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.47 |- skos__altLabel mesh__D012345 tRNA %28%Amino Acid%29%
% 208.27/208.47 |- mesh__recordOriginator mesh__D012345 RLS
% 208.27/208.47 |- skos__broader mesh__D000418Q000652smesh__D000418
% 208.27/208.47 |- mesh__preferredCombination mesh__D000418Q000652smesh__D000419
% 208.27/208.47 |- rdf__type mesh__D000418Q000652smesh__CompoundConcept
% 208.27/208.47 |- mesh__dateCreated mesh__D006308 1979-06-01
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D006308
% 208.27/208.47 91; was see under REGIONAL HEALTH PLANNING 1981-90; was see under STATE HEALTH PLANS 1980%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006308 2001
% 208.27/208.47 |- skos__broader mesh__D006308smesh__D012040
% 208.27/208.47 |- mesh__historyNote mesh__D006308
% 208.27/208.47 91%28%80%29%; was see under REGIONAL HEALTH PLANNING 1981-90; was see under STATE HEALTH PLANS 1980%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006308 2000
% 208.27/208.47 |- skos__prefLabel mesh__D006308 Health Systems Plans
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006308 2004
% 208.27/208.47 |- mesh__recordMaintainer mesh__D006308 kle
% 208.27/208.47 |- mesh__dateEstablished mesh__D006308 1991-01-01
% 208.27/208.47 |- skos__scopeNote mesh__D006308
% 208.27/208.47 Statements of goals for the delivery of health services pertaining to the Health Systems Agency service area, established under PL 93-641, and consistent with national guidelines for health planning.%A%
% 208.27/208.47 |- skos__hiddenLabel mesh__D006308 Health Systems Plan
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006308 2003
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006308 2006
% 208.27/208.47 |- mesh__recordOriginator mesh__D006308 EC
% 208.27/208.47 |- skos__hiddenLabel mesh__D006308 Plans, Health Systems
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D006308 sjn
% 208.27/208.47 |- mesh__dateRevised mesh__D006308 1999-11-03
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006308 2005
% 208.27/208.47 |- skos__annotation mesh__D006308
% 208.27/208.47 Public Law 93-641; specify geog %26% add UNITED STATES also
% 208.27/208.47 |- skos__hiddenLabel mesh__D006308 Plan, Health Systems
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D006308 2002
% 208.27/208.47 |- rdf__type mesh__D006308sskos__Concept
% 208.27/208.47 |- skos__historyNote mesh__D003010 Propylamines %28%1970-1974%29%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D003010 2002
% 208.27/208.47 |- skos__historyNote mesh__D003010 Phenyl Ethers %28%1974%29%
% 208.27/208.47 |- mesh__recordOriginator mesh__D003010 NLM
% 208.27/208.47 |- mesh__dateEstablished mesh__D003010 1991-01-01
% 208.27/208.47 |- rdf__type mesh__D003010sskos__Concept
% 208.27/208.47 |- skos__altLabel mesh__D003010 Clorgilin
% 208.27/208.47 |- skos__altLabel mesh__D003010 Chlorgyline
% 208.27/208.47 |- mesh__historyNote mesh__D003010
% 208.27/208.47 91%28%75%29%; was see under PROPYLAMINES 1975-90
% 208.27/208.47 |- skos__broader mesh__D003010smesh__D011437
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D003010 sjn
% 208.27/208.47 |- skos__altLabel mesh__D003010 Clorgiline
% 208.27/208.47 |- mesh__dateRevised mesh__D003010 2000-06-22
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D003010 2005
% 208.27/208.47 |- skos__historyNote mesh__D003010 Alkynes %28%1972-1974%29%
% 208.27/208.47 |- mesh__dateCreated mesh__D003010 1974-11-19
% 208.27/208.47 |- skos__prefLabel mesh__D003010 Clorgyline
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D003010 2003
% 208.27/208.47 |- skos__scopeNote mesh__D003010
% 208.27/208.47 An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D003010 2006
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D003010 2001
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D003010
% 208.27/208.47 91; was see under PROPYLAMINES 1975-90
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D003010 2004
% 208.27/208.47 |- mesh__recordMaintainer mesh__D003010 CCR
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D049910 2006
% 208.27/208.47 |- mesh__recordOriginator mesh__D049910 ags
% 208.27/208.47 |- skos__broader mesh__D049910smesh__D049897
% 208.27/208.47 |- skos__historyNote mesh__D049910 Mollusca %28%1965-2005%29%
% 208.27/208.47 |- rdf__type mesh__D049910sskos__Concept
% 208.27/208.47 |- mesh__dateEstablished mesh__D049910 2006-01-01
% 208.27/208.47 |- mesh__recordMaintainer mesh__D049910 ags
% 208.27/208.47 |- skos__prefLabel mesh__D049910 Pecten
% 208.27/208.47 |- mesh__historyNote mesh__D049910 2006
% 208.27/208.47 |- mesh__dateCreated mesh__D049910 2005-06-30
% 208.27/208.47 |- skos__scopeNote mesh__D049910
% 208.27/208.47 A genus of scallops in the family PECTINIDAE, class BIVALVIA. The shell is usually radially ribbed.%A%
% 208.27/208.47 |- mesh__recordAuthorizer mesh__D049910 sjn
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D049910 2006
% 208.27/208.47 |- skos__annotation mesh__D049910
% 208.27/208.47 as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016736 2004
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016736 1998
% 208.27/208.47 |- skos__hiddenLabel mesh__D016736 Anti Phospholipid Syndrome
% 208.27/208.47 |- mesh__recordOriginator mesh__D016736 TGC
% 208.27/208.47 |- skos__scopeNote mesh__D016736
% 208.27/208.47 The presence of antibodies directed against phospholipids %28%ANTIBODIES, ANTIPHOSPHOLIPID%29%. The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies %28%ANTIBODIES, ANTICARDIOLIPIN%29%. Present also are high levels of lupus anticoagulant %28%LUPUS COAGULATION INHIBITOR%29%.%A%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016736 1995
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016736 2000
% 208.27/208.47 |- skos__altLabel mesh__D016736 Antiphospholipid Antibody Syndrome
% 208.27/208.47 |- skos__hiddenLabel mesh__D016736 Syndrome, Antiphospholipid
% 208.27/208.47 |- mesh__historyNote mesh__D016736
% 208.27/208.47 92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992%A%
% 208.27/208.47 |- mesh__publicMeSHNote mesh__D016736
% 208.27/208.47 92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992%A%
% 208.27/208.47 |- skos__historyNote mesh__D016736
% 208.27/208.47 Phospholipids/immunology %28%1977-1991%29%
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016736 1993
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016736 1999
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016736 2001
% 208.27/208.47 |- skos__prefLabel mesh__D016736 Antiphospholipid Syndrome
% 208.27/208.47 |- mesh__activeMeSHYear mesh__D016736 2005
% 208.27/208.47 |- skos__hiddenLabel mesh__D016736 Antiphospholipid Antibody Syndromes
% 208.27/208.47 |- skos__hiddenLabel mesh__D016736 Antibody Syndrome, Antiphospholipid
% 208.27/208.48 |- mesh__dateCreated mesh__D016736 1991-04-29
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016736 1996
% 208.27/208.48 |- skos__hiddenLabel mesh__D016736 Syndrome, Anti-Phospholipid
% 208.27/208.48 |- mesh__dateEstablished mesh__D016736 1992-01-01
% 208.27/208.48 |- skos__altLabel mesh__D016736 Anti-Phospholipid Antibody Syndrome
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016736 2006
% 208.27/208.48 |- skos__altLabel mesh__D016736 Anti-Phospholipid Syndrome
% 208.27/208.48 |- mesh__onlineNote mesh__D016736
% 208.27/208.48 use ANTIPHOSPHOLIPID SYNDROME to search PHOSPHOLIPID ANTIBODY SYNDROME 1992%A%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016736 1997
% 208.27/208.48 |- skos__hiddenLabel mesh__D016736 Syndrome, Antiphospholipid Antibody
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016736 2002
% 208.27/208.48 |- mesh__dateRevised mesh__D016736 1992-05-07
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D016736 PLS
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016736 2003
% 208.27/208.48 |- skos__hiddenLabel mesh__D016736 Syndrome, Anti-Phospholipid Antibody
% 208.27/208.48 |- skos__hiddenLabel mesh__D016736 Antibody Syndrome, Anti-Phospholipid
% 208.27/208.48 |- rdf__type mesh__D016736sskos__Concept
% 208.27/208.48 |- skos__hiddenLabel mesh__D016736 Anti Phospholipid Antibody Syndrome
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016736 1994
% 208.27/208.48 |- skos__annotation mesh__D016736 an autoimmune dis, not a metab dis
% 208.27/208.48 |- mesh__recordMaintainer mesh__D016736 AGS
% 208.27/208.48 |- skos__broader mesh__D016736smesh__D001327
% 208.27/208.48 |- mesh__historyNote mesh__D002716
% 208.27/208.48 91%28%72%29%; was see under AMMONIUM COMPOUNDS 1972-90
% 208.27/208.48 |- rdf__type mesh__D002716sskos__Concept
% 208.27/208.48 |- mesh__recordMaintainer mesh__D002716 ssb
% 208.27/208.48 |- skos__historyNote mesh__D002716
% 208.27/208.48 Plant Growth Regulators %28%1966-1971%29%
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D002716
% 208.27/208.48 91; was see under AMMONIUM COMPOUNDS 1972-90
% 208.27/208.48 |- skos__broader mesh__D002716smesh__D050337
% 208.27/208.48 |- skos__broader mesh__D002716smesh__D000644
% 208.27/208.48 |- mesh__recordOriginator mesh__D002716 NLM
% 208.27/208.48 |- mesh__dateEstablished mesh__D002716 1991-01-01
% 208.27/208.48 |- mesh__dateCreated mesh__D002716 1999-01-01
% 208.27/208.48 |- skos__historyNote mesh__D002716 Ammonium Compounds %28%1966-1971%29%
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D002716 sjn
% 208.27/208.48 |- skos__prefLabel mesh__D002716 Chlormequat
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D002716 2006
% 208.27/208.48 |- mesh__dateRevised mesh__D002716 2005-06-30
% 208.27/208.48 |- skos__hiddenLabel mesh__D002716 Chloride, Chlorocholine
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1989
% 208.27/208.48 |- mesh__historyNote mesh__D007401
% 208.27/208.48 89%28%75%29%; was see under ADRENAL GLANDS 1969-88
% 208.27/208.48 |- skos__hiddenLabel mesh__D007401 Interrenal Glands
% 208.27/208.48 |- skos__hiddenLabel mesh__D007401 Glands, Interrenal
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 2001
% 208.27/208.48 |- mesh__dateRevised mesh__D007401 1988-06-11
% 208.27/208.48 |- skos__scopeNote mesh__D007401
% 208.27/208.48 Structures in fishes homologous to the cortical tissue of the mammalian adrenal gland; they are in close proximity to or imbedded in the kidney.%A%
% 208.27/208.48 |- skos__broader mesh__D007401smesh__D000825
% 208.27/208.48 |- skos__hiddenLabel mesh__D007401 Gland, Interrenal
% 208.27/208.48 |- skos__annotation mesh__D007401 also called interrenal body; in fish
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1995
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D007401 MED
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 2000
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1994
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1993
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D007401
% 208.27/208.48 89; was see under ADRENAL GLANDS 1969-88
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1991
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 2006
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1992
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1999
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 2005
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 2004
% 208.27/208.48 |- mesh__recordMaintainer mesh__D007401 FES
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 2002
% 208.27/208.48 |- mesh__recordOriginator mesh__D007401 NLM
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1998
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1997
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 2003
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1990
% 208.27/208.48 |- rdf__type mesh__D007401sskos__Concept
% 208.27/208.48 |- mesh__dateCreated mesh__D007401 1999-01-01
% 208.27/208.48 |- mesh__dateEstablished mesh__D007401 1989-01-01
% 208.27/208.48 |- skos__prefLabel mesh__D007401 Interrenal Gland
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007401 1996
% 208.27/208.48 |- skos__hiddenLabel mesh__D012346 Acyl tRNA, Amino
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 2001
% 208.27/208.48 |- mesh__recordOriginator mesh__D012346 RLS
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 2005
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D012346 88; was AMINO ACYL T RNA 1978-87
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 2002
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D012346 PLS
% 208.27/208.48 |- skos__altLabel mesh__D012346 Transfer RNA, Amino Acyl
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 2006
% 208.27/208.48 |- rdf__type mesh__D012346sskos__Concept
% 208.27/208.48 |- skos__historyNote mesh__D012346 Amino Acids %28%1966-1977%29%
% 208.27/208.48 |- mesh__dateRevised mesh__D012346 1996-06-10
% 208.27/208.48 |- skos__altLabel mesh__D012346 Amino Acyl T RNA
% 208.27/208.48 |- skos__scopeNote mesh__D012346
% 208.27/208.48 Intermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase. They are key compounds in the genetic translation process.%A%
% 208.27/208.48 |- mesh__onlineNote mesh__D012346
% 208.27/208.48 use RNA, TRANSFER, AMINO ACYL to search AMINO ACYL T RNA 1978-87%A%
% 208.27/208.48 |- skos__hiddenLabel mesh__D012346 tRNA Amino Acyl
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 1997
% 208.27/208.48 |- mesh__historyNote mesh__D012346 88; was AMINO ACYL T RNA 1978-87
% 208.27/208.48 |- skos__hiddenLabel mesh__D012346 Acyl, tRNA-Amino
% 208.27/208.48 |- mesh__dateEstablished mesh__D012346 1978-01-01
% 208.27/208.48 |- skos__altLabel mesh__D012346 Amino Acyl tRNA
% 208.27/208.48 |- skos__broader mesh__D012346smesh__D000596
% 208.27/208.48 |- skos__annotation mesh__D012346
% 208.27/208.48 IM; /drug eff /ultrastruct permitted; DF: TRNA AMINO ACYL%A%
% 208.27/208.48 |- skos__hiddenLabel mesh__D012346 tRNA, Amino Acyl
% 208.27/208.48 |- skos__altLabel mesh__D012346 tRNA-Amino Acyl
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 2003
% 208.27/208.48 |- skos__broader mesh__D012346smesh__D012343
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 1998
% 208.27/208.48 |- skos__historyNote mesh__D012346 RNA, Transfer %28%1966-1977%29%
% 208.27/208.48 |- mesh__dateCreated mesh__D012346 1977-05-20
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 2000
% 208.27/208.48 |- skos__prefLabel mesh__D012346 RNA, Transfer, Amino Acyl
% 208.27/208.48 |- mesh__recordMaintainer mesh__D012346 TGC
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 2004
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012346 1999
% 208.27/208.48 |- skos__related mesh__D006309smesh__D000161
% 208.27/208.48 |- skos__related mesh__D006309smesh__D001844
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D006309 2002
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D006309 2004
% 208.27/208.48 |- skos__hiddenLabel mesh__D006309 Hearings
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D006309 2001
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D006309 2003
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D006309 2006
% 208.27/208.48 |- skos__annotation mesh__D006309
% 208.27/208.48 differentiate from AUDITORY PERCEPTION: aud percept takes place in the brain, hearing takes place in the ear: TN 98; PSYCHOACOUSTICS is also available; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is available%A%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D006309 2000
% 208.27/208.48 |- mesh__recordOriginator mesh__D006309 NLM
% 208.27/208.48 |- skos__related mesh__D006309smesh__D001307
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D006309 2005
% 208.27/208.48 |- mesh__considerAlso mesh__D006309
% 208.27/208.48 consider also terms at ACOUSTIC and AUDIO-
% 208.27/208.48 |- skos__scopeNote mesh__D006309 The sensation of sound.
% 208.27/208.48 |- mesh__recordMaintainer mesh__D006309 kle
% 208.27/208.48 |- rdf__type mesh__D006309sskos__Concept
% 208.27/208.48 |- skos__broader mesh__D006309smesh__D012677
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D006309 sjn
% 208.27/208.48 |- mesh__dateRevised mesh__D006309 1999-11-03
% 208.27/208.48 |- skos__prefLabel mesh__D006309 Hearing
% 208.27/208.48 |- mesh__dateCreated mesh__D006309 1999-01-01
% 208.27/208.48 |- mesh__dateRevised mesh__D003011 2003-07-09
% 208.27/208.48 |- skos__hiddenLabel mesh__D003011 Volume, Closing
% 208.27/208.48 |- skos__annotation mesh__D003011 NIM
% 208.27/208.48 |- mesh__recordMaintainer mesh__D003011 nns
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D003011
% 208.27/208.48 91; was see under LUNG VOLUME MEASUREMENTS 1978-90
% 208.27/208.48 |- skos__hiddenLabel mesh__D003011 Volumes, Closing
% 208.27/208.48 |- skos__broader mesh__D003011smesh__D014109
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D003011 2005
% 208.27/208.48 |- skos__historyNote mesh__D003011
% 208.27/208.48 Lung Volume Measurements %28%1975-1977%29%
% 208.27/208.48 |- mesh__historyNote mesh__D003011
% 208.27/208.48 91%28%78%29%; was see under LUNG VOLUME MEASUREMENTS 1978-90
% 208.27/208.48 |- skos__prefLabel mesh__D003011 Closing Volume
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D003011 2006
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D003011 sjn
% 208.27/208.48 |- skos__historyNote mesh__D003011
% 208.27/208.48 Respiratory Function Tests %28%1966-1974%29%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D003011 2004
% 208.27/208.48 |- mesh__dateEstablished mesh__D003011 1991-01-01
% 208.27/208.48 |- rdf__type mesh__D003011sskos__Concept
% 208.27/208.48 |- skos__scopeNote mesh__D003011
% 208.27/208.48 The lung volume at which the dependent lung zones cease to ventilate presumably as a result of airway closure.%A%
% 208.27/208.48 |- mesh__recordOriginator mesh__D003011 VDK
% 208.27/208.48 |- skos__hiddenLabel mesh__D003011 Closing Volumes
% 208.27/208.48 |- mesh__dateCreated mesh__D003011 1977-04-27
% 208.27/208.48 |- mesh__recordOriginator mesh__D049911 ags
% 208.27/208.48 |- skos__scopeNote mesh__D049911
% 208.27/208.48 A genus of pearl oysters in the family Pteriidae, class BIVALVIA. Both cultured and natural pearls are obtained from species in the genus. They are distinct from the distantly related, edible true oysters of the family OSTREIDAE.%A%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D049911 2006
% 208.27/208.48 |- rdf__type mesh__D049911sskos__Concept
% 208.27/208.48 |- skos__altLabel mesh__D049911 Pearl Oyster
% 208.27/208.48 |- mesh__dateEstablished mesh__D049911 2006-01-01
% 208.27/208.48 |- mesh__recordMaintainer mesh__D049911 ags
% 208.27/208.48 |- mesh__historyNote mesh__D049911 2006
% 208.27/208.48 |- skos__prefLabel mesh__D049911 Pinctada
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D049911 2006A
% 208.27/208.48 |- mesh__dateRevised mesh__D049911 2005-07-08
% 208.27/208.48 |- skos__historyNote mesh__D049911 Ostreidae %28%1969-2005%29%
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D049911 2006
% 208.27/208.48 |- skos__altLabel mesh__D049911 Oysters, Pearl
% 208.27/208.48 |- skos__broader mesh__D049911smesh__D049872
% 208.27/208.48 |- mesh__dateCreated mesh__D049911 2005-06-30
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D049911 ags
% 208.27/208.48 |- skos__related mesh__D016737smesh__D019449
% 208.27/208.48 |- mesh__dateRevised mesh__D016737 2002-07-03
% 208.27/208.48 |- rdf__type mesh__D016737sskos__Concept
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016737 2003
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D016737 92
% 208.27/208.48 |- skos__broader mesh__D016737smesh__D003082
% 208.27/208.48 |- mesh__historyNote mesh__D016737 92
% 208.27/208.48 |- skos__hiddenLabel mesh__D016737 Restorative Proctocolectomy
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016737 2004
% 208.27/208.48 |- mesh__recordMaintainer mesh__D016737 ags
% 208.27/208.48 |- skos__hiddenLabel mesh__D016737 Proctocolectomies, Restorative
% 208.27/208.48 |- mesh__recordOriginator mesh__D016737 MXR
% 208.27/208.48 |- skos__scopeNote mesh__D016737
% 208.27/208.48 A surgical procedure involving the excision of the COLON and RECTUM and the formation of an ILEOANAL RESERVOIR %28%pouch%29%. In patients with intestinal diseases, such as ulcerative colitis, this procedure avoids the need for an OSTOMY by allowing for transanal defecation.%A%
% 208.27/208.48 |- skos__historyNote mesh__D016737 Colectomy %28%1981-1991%29%
% 208.27/208.48 |- skos__hiddenLabel mesh__D016737 Restorative Coloproctectomy
% 208.27/208.48 |- skos__prefLabel mesh__D016737 Proctocolectomy, Restorative
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D016737 sjn
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016737 2005
% 208.27/208.48 |- mesh__dateCreated mesh__D016737 1991-04-29
% 208.27/208.48 |- skos__altLabel mesh__D016737 Coloproctectomy, Restorative
% 208.27/208.48 |- skos__related mesh__D016737smesh__D039021
% 208.27/208.48 |- skos__hiddenLabel mesh__D016737 Restorative Proctocolectomies
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D016737 2006
% 208.27/208.48 |- skos__hiddenLabel mesh__D016737 Coloproctectomies, Restorative
% 208.27/208.48 |- mesh__dateEstablished mesh__D016737 1992-01-01
% 208.27/208.48 |- skos__hiddenLabel mesh__D016737 Restorative Coloproctectomies
% 208.27/208.48 |- skos__scopeNote mesh__D002717
% 208.27/208.48 A mercurial compound that has been used as a diuretic but is now superseded by more potent and less toxic drugs. The radiolabeled form has been used as a diagnostic and research tool.%A%
% 208.27/208.48 |- skos__hiddenLabel mesh__D002717 3 Chloromercuri 2 methoxypropylurea
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D002717 2001
% 208.27/208.48 |- skos__altLabel mesh__D002717 3-Chloromercuri-2-methoxypropylurea
% 208.27/208.48 |- skos__altLabel mesh__D002717 Promeran
% 208.27/208.48 |- skos__altLabel mesh__D002717 Chlormeroprin
% 208.27/208.48 |- mesh__recordMaintainer mesh__D002717 CCR
% 208.27/208.48 |- mesh__dateCreated mesh__D002717 1999-01-01
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D002717 2006
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D002717 2002
% 208.27/208.48 |- mesh__dateRevised mesh__D002717 2000-06-22
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D002717 2004
% 208.27/208.48 |- mesh__dateEstablished mesh__D002717 1966-01-01
% 208.27/208.48 |- mesh__historyNote mesh__D002717
% 208.27/208.48 66%28%64%29%; was see under DIURETICS, MERCURIAL 1963-65
% 208.27/208.48 |- skos__broader mesh__D002717smesh__D000479
% 208.27/208.48 |- mesh__recordOriginator mesh__D002717 NLM
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D002717 2005
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D002717 2003
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D002717 sjn
% 208.27/208.48 |- skos__prefLabel mesh__D002717 Chlormerodrin
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D002717
% 208.27/208.48 66; was see under DIURETICS, MERCURIAL 1963-65
% 208.27/208.48 |- rdf__type mesh__D002717sskos__Concept
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 1994
% 208.27/208.48 |- skos__broader mesh__D007402smesh__D003872
% 208.27/208.48 |- mesh__recordOriginator mesh__D007402 NLM
% 208.27/208.48 |- skos__broader mesh__D007402smesh__D017443
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 2005
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 1995
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 1998
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 2000
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 1993
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 2003
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D007402 PLS
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 2006
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 2001
% 208.27/208.48 |- mesh__dateCreated mesh__D007402 1999-01-01
% 208.27/208.48 |- skos__prefLabel mesh__D007402 Intertrigo
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 1996
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 1999
% 208.27/208.48 |- mesh__dateRevised mesh__D007402 1992-05-20
% 208.27/208.48 |- mesh__recordMaintainer mesh__D007402 PLS
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 2004
% 208.27/208.48 |- skos__annotation mesh__D007402 a dermatitis of skin folds
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 2002
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D007402 1997
% 208.27/208.48 |- skos__scopeNote mesh__D007402
% 208.27/208.48 A superficial dermatitis occurring on skin surfaces in contact with each other, such as the axillae, neck creases, intergluteal fold, between the toes, etc. Obesity is a predisposing factor. The condition is caused by moisture and friction and is characterized by erythema, maceration, burning, and exudation.%A%
% 208.27/208.48 |- rdf__type mesh__D007402sskos__Concept
% 208.27/208.48 |- rdf__type mesh__D012347sskos__Concept
% 208.27/208.48 |- skos__scopeNote mesh__D012347
% 208.27/208.48 A transfer RNA which is specific for carrying arginine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.27/208.48 |- skos__annotation mesh__D012347
% 208.27/208.48 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.27/208.48 |- skos__altLabel mesh__D012347 Transfer RNA, Arg
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 1997
% 208.27/208.48 |- skos__historyNote mesh__D012347 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.48 |- skos__historyNote mesh__D012347 RNA, Transfer %28%1966-1987%29%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 2000
% 208.27/208.48 |- mesh__dateEstablished mesh__D012347 1991-01-01
% 208.27/208.48 |- mesh__recordOriginator mesh__D012347 RLS
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 2003
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 1998
% 208.27/208.48 |- mesh__historyNote mesh__D012347
% 208.27/208.48 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 2001
% 208.27/208.48 |- skos__hiddenLabel mesh__D012347 tRNA, Arginine-Specific
% 208.27/208.48 |- skos__altLabel mesh__D012347 tRNA%28%Arg%29%
% 208.27/208.48 |- mesh__dateCreated mesh__D012347 1987-05-06
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 2004
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 1999
% 208.27/208.48 |- skos__hiddenLabel mesh__D012347 Arginine Specific tRNA
% 208.27/208.48 |- skos__altLabel mesh__D012347 tRNAArg
% 208.27/208.48 |- mesh__recordMaintainer mesh__D012347 TGC
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 2002
% 208.27/208.48 |- skos__prefLabel mesh__D012347 RNA, Transfer, Arg
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D012347 PLS
% 208.27/208.48 |- skos__hiddenLabel mesh__D012347 Arg Transfer RNA
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 2005
% 208.27/208.48 |- mesh__dateRevised mesh__D012347 1996-06-10
% 208.27/208.48 |- skos__hiddenLabel mesh__D012347 RNA, Arg Transfer
% 208.27/208.48 |- skos__altLabel mesh__D012347 Arginine-Specific tRNA
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D012347
% 208.27/208.48 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.27/208.48 |- skos__broader mesh__D012347smesh__D012345
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D012347 2006
% 208.27/208.48 |- skos__annotation mesh__D017830 D25-26 qualif
% 208.27/208.48 |- skos__altLabel mesh__D017830 Octylphenoxy Polyethoxyethanol
% 208.27/208.48 |- skos__historyNote mesh__D017830 Polyethylene Glycols %28%1974-1993%29%
% 208.27/208.48 |- skos__hiddenLabel mesh__D017830 Triton X 45
% 208.27/208.48 |- mesh__dateEstablished mesh__D017830 1994-01-01
% 208.27/208.48 |- mesh__recordOriginator mesh__D017830 TPW
% 208.27/208.48 |- mesh__dateCreated mesh__D017830 1993-07-12
% 208.27/208.48 |- skos__prefLabel mesh__D017830 Octoxynol
% 208.27/208.48 |- skos__hiddenLabel mesh__D017830 Octoxynol 9
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D017830 2005
% 208.27/208.48 |- mesh__onlineNote mesh__D017830
% 208.27/208.48 use OCTOXYNOL %28%NM%29% to search OCTOXYNOL 1980-93
% 208.27/208.48 |- mesh__dateRevised mesh__D017830 2004-07-07
% 208.27/208.48 |- skos__hiddenLabel mesh__D017830 Triton X100
% 208.27/208.48 |- skos__broader mesh__D017830smesh__D011092
% 208.27/208.48 |- skos__scopeNote mesh__D017830
% 208.27/208.48 Nonionic surfactant mixtures varying in the number of repeating ethoxy %28%oxy-1,2-ethanediyl%29% groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Octoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide.%A%
% 208.27/208.48 |- skos__altLabel mesh__D017830 Octoxinol
% 208.27/208.48 |- rdf__type mesh__D017830sskos__Concept
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D017830 2006
% 208.27/208.48 |- skos__hiddenLabel mesh__D017830 Triton X 305
% 208.27/208.48 |- skos__historyNote mesh__D017830 Phenyl Ethers %28%1975-1976%29%
% 208.27/208.48 |- skos__altLabel mesh__D017830 Octylphenoxypolyethoxyethanols
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D017830 sjn
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D017830
% 208.27/208.48 94; OCTOXYNOL was indexed under POLYETHYLENE GLYCOLS 1983-94 %26% 1974-79, TRITONS 1979-82 %26% PHENYL ETHERS 1975-76%A%
% 208.27/208.48 |- mesh__historyNote mesh__D017830 94; was OCTOXYNOL %28%NM%29% 1974-93
% 208.27/208.48 |- skos__hiddenLabel mesh__D017830 Polyethoxyethanol, Octylphenoxy
% 208.27/208.48 |- skos__hiddenLabel mesh__D017830 Triton X45
% 208.27/208.48 |- skos__altLabel mesh__D017830 Octoxinols
% 208.27/208.48 |- skos__altLabel mesh__D017830 Octoxynols
% 208.27/208.48 |- mesh__recordMaintainer mesh__D017830 jmp
% 208.27/208.48 |- skos__hiddenLabel mesh__D017830 Triton X 100
% 208.27/208.48 |- skos__hiddenLabel mesh__D017830 Triton X305
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D031501 2003
% 208.27/208.48 |- skos__altLabel mesh__D031501 Fagara horrida
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D031501 2003
% 208.27/208.48 |- skos__scopeNote mesh__D031501
% 208.27/208.48 A plant genus of the family FABACEAE that contains gleditsiosides %28%triterpenoid SAPONINS%29%.%A%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D031501 2004
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D031501 2005
% 208.27/208.48 |- mesh__dateCreated mesh__D031501 2002-07-03
% 208.27/208.48 |- skos__broader mesh__D031501smesh__D007887
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D031501 2006
% 208.27/208.48 |- mesh__dateEstablished mesh__D031501 2003-01-01
% 208.27/208.48 |- skos__prefLabel mesh__D031501 Gleditsia
% 208.27/208.48 |- skos__annotation mesh__D031501
% 208.27/208.48 X ref FAGARA HORRIDA: FAGARA, unspecified index RUTACEAE; for other species check plant taxonomy reference: Manual 22.37; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.27/208.48 |- mesh__historyNote mesh__D031501 2003
% 208.27/208.48 |- rdf__type mesh__D031501sskos__Concept
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D003810 sjn
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D003810 2006
% 208.27/208.48 |- mesh__historyNote mesh__D003810 65
% 208.27/208.48 |- skos__annotation mesh__D003810
% 208.27/208.48 formation of primary dentin; formation of secondary dentin = DENTIN, SECONDARY /growth; AMELOGENESIS, formation of dent enamel, is also available%A%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D003810 2005
% 208.27/208.48 |- mesh__recordMaintainer mesh__D003810 lkt
% 208.27/208.48 |- skos__broader mesh__D003810smesh__D009805
% 208.27/208.48 |- rdf__type mesh__D003810sskos__Concept
% 208.27/208.48 |- mesh__dateCreated mesh__D003810 1999-01-01
% 208.27/208.48 |- mesh__dateRevised mesh__D003810 2004-07-07
% 208.27/208.48 |- mesh__recordOriginator mesh__D003810 NLM
% 208.27/208.48 |- skos__scopeNote mesh__D003810
% 208.27/208.48 The formation of dentin. Dentin first appears in the layer between the ameloblasts and odontoblasts and becomes calcified immediately. Formation progresses from the tip of the papilla over its slope to form a calcified cap becoming thicker by the apposition of new layers pulpward. A layer of uncalcified dentin intervenes between the calcified tissue and the odontoblast and its processes. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%
% 208.27/208.48 |- skos__prefLabel mesh__D003810 Dentinogenesis
% 208.27/208.48 |- mesh__dateEstablished mesh__D003810 1965-01-01
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D003810 65
% 208.27/208.48 |- skos__hiddenLabel mesh__D003810 Dentinogeneses
% 208.27/208.48 |- skos__prefLabel mesh__D003012 Microbial Collagenase
% 208.27/208.48 |- mesh__historyNote mesh__D003012
% 208.27/208.48 94; was CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93; was CLOSTRIDIOPEPTIDASE A 1963-90%A%
% 208.27/208.48 |- skos__hiddenLabel mesh__D003012 Collagenase, Clostridium histolyticum
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D003012 2006
% 208.27/208.48 |- skos__altLabel mesh__D003012 Clostridium histolyticum Collagenase
% 208.27/208.48 |- skos__broader mesh__D003012smesh__D017364
% 208.27/208.48 |- skos__altLabel mesh__D003012 Collalysine
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D003012
% 208.27/208.48 94; was CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93; was CLOSTRIDIOPEPTIDASE A 1963-90%A%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D003012 2004
% 208.27/208.48 |- mesh__onlineNote mesh__D003012
% 208.27/208.48 use MICROBIAL COLLAGENASE to search CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93 %26% CLOSTRIDIOPEPTIDASE A 1966-90%A%
% 208.27/208.48 |- rdf__type mesh__D003012sskos__Concept
% 208.27/208.48 |- skos__hiddenLabel mesh__D003012 Peptidase, Collagenase-Like
% 208.27/208.48 |- skos__altLabel mesh__D003012 Clostridiopeptidase A
% 208.27/208.48 |- skos__altLabel mesh__D003012 Nucleolysin
% 208.27/208.48 |- mesh__recordOriginator mesh__D003012 NLM
% 208.27/208.48 |- skos__hiddenLabel mesh__D003012 Collagenase Like Peptidase
% 208.27/208.48 |- skos__altLabel mesh__D003012 Collagenase, Microbial
% 208.27/208.48 |- mesh__dateRevised mesh__D003012 2003-07-09
% 208.27/208.48 |- mesh__recordMaintainer mesh__D003012 jmp
% 208.27/208.48 |- mesh__dateEstablished mesh__D003012 1966-01-01
% 208.27/208.48 |- mesh__dateCreated mesh__D003012 1999-01-01
% 208.27/208.48 |- skos__scopeNote mesh__D003012
% 208.27/208.48 A metalloproteinase which degrades helical regions of native collagen to small fragments. Preferred cleavage is -Gly in the sequence -Pro-Xaa-Gly-Pro-. Six forms %28%or 2 classes%29% have been isolated from Clostridium histolyticum that are immunologically cross-reactive but possess different sequences and different specificities. Other variants have been isolated from Bacillus cereus, Empedobacter collagenolyticum, Pseudomonas marinoglutinosa, and species of Vibrio and Streptomyces. EC 3.4.24.3.%A%
% 208.27/208.48 |- skos__annotation mesh__D003012
% 208.27/208.48 coord IM with specific bacterium /enzymol %28%IM or NIM%29% if pertinent%A%
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D003012 2005
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D003012 sjn
% 208.27/208.48 |- skos__broader mesh__D049912smesh__D000236
% 208.27/208.48 |- mesh__historyNote mesh__D049912 2006
% 208.27/208.48 |- mesh__recordAuthorizer mesh__D049912 sjn
% 208.27/208.48 |- mesh__dateEstablished mesh__D049912 2006-01-01
% 208.27/208.48 |- mesh__activeMeSHYear mesh__D049912 2006
% 208.27/208.48 |- skos__altLabel mesh__D049912 Somatotroph Adenoma
% 208.27/208.48 |- rdf__type mesh__D049912sskos__Concept
% 208.27/208.48 |- skos__scopeNote mesh__D049912
% 208.27/208.48 A pituitary tumor that secretes GROWTH HORMONE. In humans, excess HUMAN GROWTH HORMONE leads to ACROMEGALY.%A%
% 208.27/208.48 |- skos__hiddenLabel mesh__D049912 Adenoma, Somatotroph
% 208.27/208.48 |- skos__hiddenLabel mesh__D049912 Adenomas, Somatotroph
% 208.27/208.48 |- mesh__recordOriginator mesh__D049912 lkt
% 208.27/208.48 |- mesh__dateCreated mesh__D049912 2005-06-30
% 208.27/208.48 |- skos__prefLabel mesh__D049912 Growth Hormone-Secreting Pituitary Adenoma
% 208.27/208.48 |- skos__hiddenLabel mesh__D049912 Pituitary Adenoma, GH Secreting
% 208.27/208.48 |- skos__annotation mesh__D049912 coordinate IM with ADENOMA %28%IM%29%
% 208.27/208.48 |- skos__hiddenLabel mesh__D049912 GH Secreting Pituitary Adenoma
% 208.27/208.48 |- skos__hiddenLabel mesh__D049912
% 208.27/208.48 Pituitary Growth Hormone Secreting Adenoma
% 208.27/208.48 |- skos__hiddenLabel mesh__D049912 GH-Secreting Pituitary Adenomas
% 208.27/208.48 |- mesh__recordMaintainer mesh__D049912 lkt
% 208.27/208.48 |- skos__hiddenLabel mesh__D049912 Somatotroph Adenomas
% 208.27/208.48 |- skos__historyNote mesh__D049912 Pituitary Neoplasms %28%1981-2005%29%
% 208.27/208.48 |- skos__broader mesh__D049912smesh__D010911
% 208.27/208.48 |- skos__altLabel mesh__D049912 GH-Secreting Pituitary Adenoma
% 208.27/208.48 |- mesh__publicMeSHNote mesh__D049912 2006
% 208.27/208.48 |- skos__hiddenLabel mesh__D049912 Pituitary Adenomas, GH-Secreting
% 208.27/208.48 |- skos__altLabel mesh__D049912 Pituitary Adenoma, GH-Secreting
% 208.27/208.48 |- skos__altLabel mesh__D049912 Pituitary Growth Hormone-Secreting Adenoma
% 208.27/208.48 |- skos__broader mesh__D016738smesh__D000015
% 208.27/208.48 |- skos__scopeNote mesh__D016738
% 208.27/208.48 An autosomal dominant MUTATION involving CHROMOSOME 20. It is characterized by the almost normal LIVER that has few or no intrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC%29%. Other extrahepatic malformations include those in the heart, the eyes, the vertebral column, and the facies. Major clinical features include JAUNDICE, and congenital heart disease with peripheral PULMONARY STENOSIS.%A%
% 208.27/208.49 |- skos__historyNote mesh__D016738
% 208.27/208.49 Bile Ducts, Intrahepatic/abnormalities %28%1980-1991%29%
% 208.27/208.49 |- skos__altLabel mesh__D016738 Dysplasia, Arteriohepatic
% 208.27/208.49 |- skos__historyNote mesh__D016738
% 208.27/208.49 Abnormalities, Multiple %28%1981-1991%29%
% 208.27/208.49 |- skos__hiddenLabel mesh__D016738 Syndrome, Alagille
% 208.27/208.49 |- mesh__dateEstablished mesh__D016738 1992-01-01
% 208.27/208.49 |- mesh__historyNote mesh__D016738 92
% 208.27/208.49 |- mesh__dateRevised mesh__D016738 2003-07-09
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D016738 2004
% 208.27/208.49 |- skos__hiddenLabel mesh__D016738 Arteriohepatic Dysplasias
% 208.27/208.49 |- mesh__recordMaintainer mesh__D016738 lkt
% 208.27/208.49 |- skos__hiddenLabel mesh__D016738 Alagille Watson Syndrome
% 208.27/208.49 |- mesh__recordOriginator mesh__D016738 TGC
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D016738 92
% 208.27/208.49 |- skos__altLabel mesh__D016738
% 208.27/208.49 Cholestasis with Peripheral Pulmonary Stenosis
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D016738 2005
% 208.27/208.49 |- skos__hiddenLabel mesh__D016738 Syndrome, Alagille-Watson
% 208.27/208.49 |- skos__altLabel mesh__D016738 Alagille-Watson Syndrome
% 208.27/208.49 |- skos__altLabel mesh__D016738 Arteriohepatic Dysplasia
% 208.27/208.49 |- mesh__dateCreated mesh__D016738 1991-04-29
% 208.27/208.49 |- skos__historyNote mesh__D016738
% 208.27/208.49 Pulmonary Artery/abnormalities %28%1988-1991%29%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D016738 2006
% 208.27/208.49 |- skos__broader mesh__D016738smesh__D006330
% 208.27/208.49 |- skos__altLabel mesh__D016738 Hepatic Ductular Hypoplasia, Syndromatic
% 208.27/208.49 |- skos__historyNote mesh__D016738
% 208.27/208.49 Cholestasis, Intrahepatic %28%1979-1991%29%
% 208.27/208.49 |- skos__broader mesh__D016738smesh__D002780
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D016738 sjn
% 208.27/208.49 |- rdf__type mesh__D016738sskos__Concept
% 208.27/208.49 |- skos__prefLabel mesh__D016738 Alagille Syndrome
% 208.27/208.49 |- skos__hiddenLabel mesh__D016738 Dysplasias, Arteriohepatic
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 2004
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 1997
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 1994
% 208.27/208.49 |- mesh__recordOriginator mesh__D013440 NLM
% 208.27/208.49 |- skos__scopeNote mesh__D013440
% 208.27/208.49 Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties.%A%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 2006
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 1999
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D013440 PLS
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 2000
% 208.27/208.49 |- skos__broader mesh__D013440smesh__D013457
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 2001
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 1995
% 208.27/208.49 |- skos__broader mesh__D013440smesh__D000838
% 208.27/208.49 |- skos__broader mesh__D013440smesh__D006862
% 208.27/208.49 |- skos__prefLabel mesh__D013440 Sulfides
% 208.27/208.49 |- skos__hiddenLabel mesh__D013440 Ethers, Sulfur
% 208.27/208.49 |- mesh__dateRevised mesh__D013440 1993-06-03
% 208.27/208.49 |- mesh__recordMaintainer mesh__D013440 TPW
% 208.27/208.49 |- mesh__dateCreated mesh__D013440 1999-01-01
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 2002
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 1996
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 2003
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 1998
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013440 2005
% 208.27/208.49 |- rdf__type mesh__D013440sskos__Concept
% 208.27/208.49 |- mesh__dateRevised mesh__D007403 2005-06-30
% 208.27/208.49 |- skos__hiddenLabel mesh__D007403 Discs, Intervertebral
% 208.27/208.49 |- skos__hiddenLabel mesh__D007403 Intervertebral Discs
% 208.27/208.49 |- skos__altLabel mesh__D007403 Disc, Intervertebral
% 208.27/208.49 |- skos__annotation mesh__D007403
% 208.27/208.49 coord IM with specific vertebrae %28%IM%29%; diseases: probably DISCITIS or INTERVERTEBRAL DISK DISPLACEMENT but if not, index as INTERVERTEBRAL DISK %28%IM%29% + SPINAL DISEASES %28%IM%29%; chemonucleolysis = INTERVERTEBRAL DISK CHEMOLYSIS%A%
% 208.27/208.49 |- mesh__recordMaintainer mesh__D007403 ags
% 208.27/208.49 |- skos__hiddenLabel mesh__D007403 Disks, Intervertebral
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D007403 2006
% 208.27/208.49 |- skos__broader mesh__D007403smesh__D051445
% 208.27/208.49 |- mesh__dateCreated mesh__D007403 1999-01-01
% 208.27/208.49 |- mesh__recordOriginator mesh__D007403 NLM
% 208.27/208.49 |- skos__hiddenLabel mesh__D007403 Intervertebral Disc
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D007403 sjn
% 208.27/208.49 |- skos__hiddenLabel mesh__D007403 Intervertebral Disks
% 208.27/208.49 |- skos__related mesh__D007403smesh__D017586
% 208.27/208.49 |- skos__altLabel mesh__D007403 Disk, Intervertebral
% 208.27/208.49 |- rdf__type mesh__D007403sskos__Concept
% 208.27/208.49 |- skos__broader mesh__D007403smesh__D013131
% 208.27/208.49 |- skos__prefLabel mesh__D007403 Intervertebral Disk
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D045522 2006
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D045522 sjn
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D045522
% 208.27/208.49 2004; RECOMBINASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1986-2003; RESOLVASE was indexed under TRANSPOSASES 1997-2003, under DNA NUCLEOTIDYLTRANSFERASES 1992-1997 %26% under NUCLEOTIDYLTRANSFERASES 1981-1995%A%
% 208.27/208.49 |- mesh__dateEstablished mesh__D045522 2004-01-01
% 208.27/208.49 |- skos__altLabel mesh__D045522 Resolvase
% 208.27/208.49 |- mesh__recordMaintainer mesh__D045522 jmp
% 208.27/208.49 |- skos__broader mesh__D045522smesh__D004798
% 208.27/208.49 |- mesh__dateCreated mesh__D045522 2003-07-25
% 208.27/208.49 |- skos__prefLabel mesh__D045522 Recombinases
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D045522 2004
% 208.27/208.49 |- skos__altLabel mesh__D045522 Recombinase
% 208.27/208.49 |- mesh__recordOriginator mesh__D045522 jmp
% 208.27/208.49 |- skos__scopeNote mesh__D045522
% 208.27/208.49 A broad category of enzymes that are involved in the process of GENETIC RECOMBINATION.%A%
% 208.27/208.49 |- skos__historyNote mesh__D045522
% 208.27/208.49 DNA Nucleotidyltransferases %28%1986-2003%29%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D045522 2005
% 208.27/208.49 |- rdf__type mesh__D045522sskos__Concept
% 208.27/208.49 |- mesh__historyNote mesh__D045522
% 208.27/208.49 2004; use RECOMBINASES %28%NM%29% 1986-2003; for RESOLVASE use RECOMBINASES %28%NM%29% 1981-2003%A%
% 208.27/208.49 |- skos__altLabel mesh__D012348 tRNAAsn
% 208.27/208.49 |- mesh__dateRevised mesh__D012348 1996-06-10
% 208.27/208.49 |- skos__scopeNote mesh__D012348
% 208.27/208.49 A transfer RNA which is specific for carrying asparagine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.27/208.49 |- skos__historyNote mesh__D012348 RNA, Transfer %28%1966-1987%29%
% 208.27/208.49 |- mesh__dateEstablished mesh__D012348 1991-01-01
% 208.27/208.49 |- skos__hiddenLabel mesh__D012348 RNA, Asn Transfer
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 2003
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 1998
% 208.27/208.49 |- skos__hiddenLabel mesh__D012348 Asn Transfer RNA
% 208.27/208.49 |- skos__hiddenLabel mesh__D012348 tRNA, Asparagine-Specific
% 208.27/208.49 |- skos__altLabel mesh__D012348 Asparagine-Specific tRNA
% 208.27/208.49 |- skos__altLabel mesh__D012348 Transfer RNA, Asn
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 2004
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 1999
% 208.27/208.49 |- skos__historyNote mesh__D012348 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.49 |- mesh__recordMaintainer mesh__D012348 TGC
% 208.27/208.49 |- mesh__dateCreated mesh__D012348 1987-05-07
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 2000
% 208.27/208.49 |- mesh__recordOriginator mesh__D012348 RLS
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 2005
% 208.27/208.49 |- skos__altLabel mesh__D012348 tRNA%28%Asn%29%
% 208.27/208.49 |- mesh__historyNote mesh__D012348
% 208.27/208.49 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.27/208.49 |- skos__broader mesh__D012348smesh__D012345
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 2001
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D012348
% 208.27/208.49 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.27/208.49 |- rdf__type mesh__D012348sskos__Concept
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 2006
% 208.27/208.49 |- skos__prefLabel mesh__D012348 RNA, Transfer, Asn
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 2002
% 208.27/208.49 |- skos__annotation mesh__D012348
% 208.27/208.49 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.27/208.49 |- skos__hiddenLabel mesh__D012348 Asparagine Specific tRNA
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D012348 PLS
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D012348 1997
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Dual Diagnosis %28%Psychiatry%29%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 2000
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 1994
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D017831 94
% 208.27/208.49 |- skos__historyNote mesh__D017831
% 208.27/208.49 specific substance abuse disorder/diagnosis %28%1989-1993%29%
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Dual Psychiatric Diagnoses
% 208.27/208.49 |- skos__annotation mesh__D017831
% 208.27/208.49 restrict to substance abuse with ment disord; IM GEN only; coord NIM with specific addiction %28%IM%29% + specific ment disord %28%IM%29%; DF: DUAL DIAG%A%
% 208.27/208.49 |- skos__prefLabel mesh__D017831 Diagnosis, Dual %28%Psychiatry%29%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 2006
% 208.27/208.49 |- skos__altLabel mesh__D017831 Psychiatric Diagnosis, Dual
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 1998
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Dual Diagnoses %28%Psychiatry%29%
% 208.27/208.49 |- skos__altLabel mesh__D017831 Dual Diagnosis, Psychiatric
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Diagnosis, Psychiatric Dual
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 1997
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 2005
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Diagnoses, Psychiatric Dual
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 2004
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Dual Psychiatric Diagnosis
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Diagnoses, Dual
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 2002
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Diagnosis, Dual
% 208.27/208.49 |- skos__altLabel mesh__D017831 Psychiatric Dual Diagnosis
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Psychiatric Diagnoses, Dual
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 1996
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 2003
% 208.27/208.49 |- skos__altLabel mesh__D017831 Dual Diagnosis
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Psychiatric Dual Diagnoses
% 208.27/208.49 |- skos__broader mesh__D017831smesh__D003933
% 208.27/208.49 |- rdf__type mesh__D017831sskos__Concept
% 208.27/208.49 |- mesh__dateCreated mesh__D017831 1993-02-16
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Diagnosis, Dual Psychiatric
% 208.27/208.49 |- mesh__historyNote mesh__D017831 94
% 208.27/208.49 |- mesh__dateEstablished mesh__D017831 1994-01-01
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Diagnoses, Dual Psychiatric
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 2001
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 1995
% 208.27/208.49 |- skos__scopeNote mesh__D017831
% 208.27/208.49 The co-existence of a substance abuse disorder with a psychiatric disorder. The diagnostic principle is based on the fact that it has been found often that chemically dependent patients also have psychiatric problems of various degrees of severity.%A%
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Dual Diagnoses, Psychiatric
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Dual Diagnoses
% 208.27/208.49 |- skos__historyNote mesh__D017831
% 208.27/208.49 specific mental disorder/diagnosis %28%1989-1993%29%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017831 1999
% 208.27/208.49 |- skos__hiddenLabel mesh__D017831 Diagnoses, Dual %28%Psychiatry%29%
% 208.27/208.49 |- skos__historyNote mesh__D017033 Algae %28%1966-1969%29%
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D017033 92
% 208.27/208.49 |- rdf__type mesh__D017033sskos__Concept
% 208.27/208.49 |- skos__historyNote mesh__D017033 Cyanobacteria %28%1970-1991%29%
% 208.27/208.49 |- mesh__dateRevised mesh__D017033 2005-06-30
% 208.27/208.49 |- mesh__recordMaintainer mesh__D017033 SYSTEM
% 208.27/208.49 |- mesh__historyNote mesh__D017033 92
% 208.27/208.49 |- skos__broader mesh__D017033smesh__D000458
% 208.27/208.49 |- skos__scopeNote mesh__D017033
% 208.27/208.49 A genus of CYANOBACTERIA consisting of trichomes that are untapered with conspicuous constrictions at cross-walls. A firm individual sheath is absent, but a soft covering is often present. Many species are known worldwide as major components of freshwater PLANKTON and also of many saline lakes. The species ANABAENA FLOS-AQUAE is responsible for acute poisonings of various animals.%A%
% 208.27/208.49 |- mesh__dateEstablished mesh__D017033 1992-01-01
% 208.27/208.49 |- skos__prefLabel mesh__D017033 Anabaena
% 208.27/208.49 |- skos__annotation mesh__D017033
% 208.27/208.49 general or unspecified; prefer specifics
% 208.27/208.49 |- mesh__recordOriginator mesh__D017033 PXP
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D017033 sjn
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D017033 2006
% 208.27/208.49 |- mesh__dateCreated mesh__D017033 1991-05-30
% 208.27/208.49 |- skos__hiddenLabel mesh__D003811 Imperfectas, Dentinogenesis
% 208.27/208.49 |- mesh__recordOriginator mesh__D003811 NLM
% 208.27/208.49 |- skos__broader mesh__D003811smesh__D014071
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D003811 2006
% 208.27/208.49 |- mesh__recordMaintainer mesh__D003811 kle
% 208.27/208.49 |- skos__hiddenLabel mesh__D003811 Opalescent Dentin, Hereditary
% 208.27/208.49 |- mesh__dateCreated mesh__D003811 1999-01-01
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D003811 2003
% 208.27/208.49 |- mesh__dateRevised mesh__D003811 1999-11-03
% 208.27/208.49 |- skos__prefLabel mesh__D003811 Dentinogenesis Imperfecta
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D003811 sjn
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D003811 2002
% 208.27/208.49 |- skos__hiddenLabel mesh__D003811 Imperfecta, Dentinogenesis
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D003811 2004
% 208.27/208.49 |- skos__hiddenLabel mesh__D003811 Dentins, Hereditary Opalescent
% 208.27/208.49 |- rdf__type mesh__D003811sskos__Concept
% 208.27/208.49 |- skos__hiddenLabel mesh__D003811 Hereditary Opalescent Dentins
% 208.27/208.49 |- skos__hiddenLabel mesh__D003811 Opalescent Dentins, Hereditary
% 208.27/208.49 |- skos__hiddenLabel mesh__D003811 Dentin, Hereditary Opalescent
% 208.27/208.49 |- skos__annotation mesh__D003811
% 208.27/208.49 a dentin abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D003811 2000
% 208.27/208.49 |- mesh__historyNote mesh__D003811 65
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D003811 65
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D003811 2005
% 208.27/208.49 |- skos__scopeNote mesh__D003811
% 208.27/208.49 An autosomal dominant disorder of tooth development characterized by opalescent dentin resulting in discoloration of the teeth, ranging from dusky blue to brownish. The dentin is poorly formed with an abnormally low mineral content; the pulp canal is obliterated, but the enamel is normal. The teeth usually wear down rapidly, leaving short, brown stumps. %28%Dorland, 27th ed%29%%A%
% 208.27/208.49 |- skos__hiddenLabel mesh__D003811 Dentinogenesis Imperfectas
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D003811 2001
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D003013 sjn
% 208.27/208.49 |- skos__broader mesh__D003013smesh__D016937
% 208.27/208.49 |- skos__scopeNote mesh__D003013
% 208.27/208.49 A genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.%A%
% 208.27/208.49 |- rdf__type mesh__D003013sskos__Concept
% 208.27/208.49 |- mesh__dateRevised mesh__D003013 2005-06-30
% 208.27/208.49 |- mesh__recordMaintainer mesh__D003013 SYSTEM
% 208.27/208.49 |- mesh__dateCreated mesh__D003013 1999-01-01
% 208.27/208.49 |- skos__prefLabel mesh__D003013 Clostridium
% 208.27/208.49 |- mesh__recordOriginator mesh__D003013 NLM
% 208.27/208.49 |- skos__annotation mesh__D003013
% 208.27/208.49 GEN or unspecified; prefer specifics; infection = CLOSTRIDIUM INFECTIONS or its specifics%A%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D003013 2006
% 208.27/208.49 |- skos__altLabel mesh__D049913 Pituitary Corticotropin-Secreting Adenoma
% 208.27/208.49 |- skos__altLabel mesh__D049913 Pituitary Adenoma, ACTH-Secreting
% 208.27/208.49 |- skos__altLabel mesh__D049913 ACTH-Producing Pituitary Adenoma
% 208.27/208.49 |- skos__historyNote mesh__D049913 Pituitary Neoplasms %28%1981-2005%29%
% 208.27/208.49 |- skos__broader mesh__D049913smesh__D010911
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 ACTH Secreting Pituitary Adenoma
% 208.27/208.49 |- mesh__recordOriginator mesh__D049913 lkt
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 ACTH Producing Pituitary Adenoma
% 208.27/208.49 |- skos__broader mesh__D049913smesh__D000236
% 208.27/208.49 |- skos__scopeNote mesh__D049913
% 208.27/208.49 A pituitary adenoma which secretes ADRENOCORTICOTROPIN, leading to CUSHING DISEASE.%A%
% 208.27/208.49 |- mesh__historyNote mesh__D049913 2006
% 208.27/208.49 |- skos__annotation mesh__D049913 coordinate IM with ADENOMA %28%IM%29%
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D049913 sjn
% 208.27/208.49 |- mesh__dateEstablished mesh__D049913 2006-01-01
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913
% 208.27/208.49 Corticotropin-Secreting Adenoma, Pituitary
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 Pituitary Adenomas, ACTH-Producing
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 Pituitary Adenomas, ACTH-Secreting
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913
% 208.27/208.49 Pituitary Corticotropin Secreting Adenoma
% 208.27/208.49 |- mesh__dateCreated mesh__D049913 2005-06-30
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 Corticotroph Adenomas
% 208.27/208.49 |- skos__altLabel mesh__D049913 Corticotroph Adenoma
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 Adenoma, Corticotroph
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D049913 2006
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913
% 208.27/208.49 Pituitary Corticotropin-Secreting Adenomas
% 208.27/208.49 |- skos__prefLabel mesh__D049913 ACTH-Secreting Pituitary Adenoma
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 Pituitary Adenoma, ACTH Secreting
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913
% 208.27/208.49 Corticotropin-Secreting Adenomas, Pituitary
% 208.27/208.49 |- mesh__recordMaintainer mesh__D049913 lkt
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 Pituitary Adenoma, ACTH-Producing
% 208.27/208.49 |- rdf__type mesh__D049913sskos__Concept
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 Adenomas, Corticotroph
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 ACTH-Secreting Pituitary Adenomas
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D049913 2006
% 208.27/208.49 |- skos__hiddenLabel mesh__D049913 ACTH-Producing Pituitary Adenomas
% 208.27/208.49 |- skos__annotation mesh__D016739 use Cat F3 qualif
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D016739 2005
% 208.27/208.49 |- mesh__recordMaintainer mesh__D016739 JLS
% 208.27/208.49 |- mesh__dateRevised mesh__D016739 2002-07-02
% 208.27/208.49 |- mesh__recordOriginator mesh__D016739 MXR
% 208.27/208.49 |- mesh__dateCreated mesh__D016739 1991-04-29
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D016739 sjn
% 208.27/208.49 |- skos__historyNote mesh__D016739 Behavior %28%1974-1991%29%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D016739 2006
% 208.27/208.49 |- mesh__dateEstablished mesh__D016739 1992-01-01
% 208.27/208.49 |- skos__prefLabel mesh__D016739 Behavior, Addictive
% 208.27/208.49 |- skos__scopeNote mesh__D016739
% 208.27/208.49 The observable, measurable, and often pathological activity of an organism that portrays its inability to overcome a habit resulting in an insatiable craving for a substance or for performing certain acts. The addictive behavior includes the emotional and physical overdependence on the object of habit in increasing amount or frequency.%A%
% 208.27/208.49 |- skos__broader mesh__D016739smesh__D003192
% 208.27/208.49 |- skos__historyNote mesh__D016739 Substance Abuse %28%1980-1991%29%
% 208.27/208.49 |- rdf__type mesh__D016739sskos__Concept
% 208.27/208.49 |- skos__altLabel mesh__D016739 Addictive Behavior
% 208.27/208.49 |- skos__related mesh__D016739smesh__D019966
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D016739 2003
% 208.27/208.49 |- skos__historyNote mesh__D016739 Substance Dependence %28%1974-1991%29%
% 208.27/208.49 |- skos__hiddenLabel mesh__D016739 Addictive Behaviors
% 208.27/208.49 |- mesh__historyNote mesh__D016739 92
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D016739 2004
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D016739 92
% 208.27/208.49 |- skos__hiddenLabel mesh__D016739 Behaviors, Addictive
% 208.27/208.49 |- mesh__dateRevised mesh__D027461 2004-07-07
% 208.27/208.49 |- skos__annotation mesh__D027461
% 208.27/208.49 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.27/208.49 |- rdf__type mesh__D027461sskos__Concept
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D027461 2005
% 208.27/208.49 |- skos__broader mesh__D027461smesh__D019663
% 208.27/208.49 |- mesh__historyNote mesh__D027461 2002; use CHENOPODIACEAE 1998-2001
% 208.27/208.49 |- mesh__dateEstablished mesh__D027461 2002-01-01
% 208.27/208.49 |- mesh__dateCreated mesh__D027461 2001-07-25
% 208.27/208.49 |- skos__prefLabel mesh__D027461 Beta vulgaris
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D027461 sjn
% 208.27/208.49 |- mesh__recordOriginator mesh__D027461 ssb
% 208.27/208.49 |- mesh__recordMaintainer mesh__D027461 ssb
% 208.27/208.49 |- skos__historyNote mesh__D027461 Chenopodiaceae %28%1998-2001%29%
% 208.27/208.49 |- skos__scopeNote mesh__D027461
% 208.27/208.49 A species of the Beta genus. Cultivars are used as a source of beets %28%root%29% or chard %28%leaves%29%.%A%
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D027461 2006
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D027461 2002; see CHENOPODIACEAE 1998-2001
% 208.27/208.49 |- skos__historyNote mesh__D002719
% 208.27/208.49 Hypnotics and Sedatives %28%1966-1967%29%
% 208.27/208.49 |- skos__broader mesh__D002719smesh__D013844
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D002719
% 208.27/208.49 68; CHLORETHIAZOLE was see CHLORMETHAZOLE 1975-95
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D002719 2006
% 208.27/208.49 |- skos__historyNote mesh__D002719 Thiazoles %28%1966-1967%29%
% 208.27/208.49 |- skos__prefLabel mesh__D002719 Chlormethiazole
% 208.27/208.49 |- mesh__recordOriginator mesh__D002719 NLM
% 208.27/208.49 |- skos__altLabel mesh__D002719 Clomethiazole
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D002719 sjn
% 208.27/208.49 |- mesh__historyNote mesh__D002719
% 208.27/208.49 68; CHLORETHIAZOLE was see CHLORMETHAZOLE 1975-95
% 208.27/208.49 |- mesh__dateRevised mesh__D002719 2005-06-30
% 208.27/208.49 |- mesh__recordMaintainer mesh__D002719 ssb
% 208.27/208.49 |- mesh__dateEstablished mesh__D002719 1968-01-01
% 208.27/208.49 |- rdf__type mesh__D002719sskos__Concept
% 208.27/208.49 |- skos__scopeNote mesh__D002719
% 208.27/208.49 A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors.%A%
% 208.27/208.49 |- mesh__dateCreated mesh__D002719 1999-01-01
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 1997
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 2004
% 208.27/208.49 |- mesh__dateEstablished mesh__D013441 1965-01-01
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D013441 PLS
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 2000
% 208.27/208.49 |- rdf__type mesh__D013441sskos__Concept
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 1996
% 208.27/208.49 |- skos__prefLabel mesh__D013441 Sulfinic Acids
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 2003
% 208.27/208.49 |- mesh__dateRevised mesh__D013441 1993-06-04
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D013441 65
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 1999
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 2006
% 208.27/208.49 |- skos__annotation mesh__D013441 do not confuse with SULFONIC ACIDS
% 208.27/208.49 |- mesh__recordOriginator mesh__D013441 NLM
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 2002
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 1995
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 1998
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 2005
% 208.27/208.49 |- skos__scopeNote mesh__D013441
% 208.27/208.49 Any of the monobasic inorganic or organic acids of sulfur with the general formula RSO%28%OH%29%. %28%From McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 208.27/208.49 |- mesh__historyNote mesh__D013441 65
% 208.27/208.49 |- mesh__recordMaintainer mesh__D013441 TPW
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 1994
% 208.27/208.49 |- skos__hiddenLabel mesh__D013441 Acids, Sulfinic
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D013441 2001
% 208.27/208.49 |- skos__broader mesh__D013441smesh__D013456
% 208.27/208.49 |- mesh__dateCreated mesh__D013441 1999-01-01
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Intervertebral Disk Chemolyses
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Chemonucleolyses
% 208.27/208.49 |- mesh__recordMaintainer mesh__D007404 lkt
% 208.27/208.49 |- skos__altLabel mesh__D007404 Chemonucleolysis
% 208.27/208.49 |- skos__broader mesh__D007404smesh__D019637
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Nucleolyses, Intervertebral Disk
% 208.27/208.49 |- rdf__type mesh__D007404sskos__Concept
% 208.27/208.49 |- skos__historyNote mesh__D007404
% 208.27/208.49 Intervertebral Disk Displacement %28%1966-1986%29%
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Disk Chemolyses, Intervertebral
% 208.27/208.49 |- skos__historyNote mesh__D007404 Chymopapain %28%1975-1986%29%
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Disk Chemolysis, Intervertebral
% 208.27/208.49 |- skos__altLabel mesh__D007404 Discolysis
% 208.27/208.49 |- skos__prefLabel mesh__D007404 Intervertebral Disk Chemolysis
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Intervertebral Disk Nucleolyses
% 208.27/208.49 |- skos__annotation mesh__D007404
% 208.27/208.49 coordinate IM with specific substance /ther use %28%usually CHYMOPAPAIN%29% if particularly discussed%A%
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D007404 87
% 208.27/208.49 |- skos__related mesh__D007404smesh__D002917
% 208.27/208.49 |- skos__scopeNote mesh__D007404
% 208.27/208.49 The dissolving of the nucleus pulposus, the semi-gelatinous tissue of a displaced INTERVERTEBRAL DISK. It is usually achieved by the direct injection of a proteolytic enzyme, especially CHYMOPAPAIN, into the herniated disk.%A%
% 208.27/208.49 |- mesh__dateRevised mesh__D007404 2005-06-30
% 208.27/208.49 |- mesh__recordOriginator mesh__D007404 SH
% 208.27/208.49 |- mesh__dateCreated mesh__D007404 1986-06-20
% 208.27/208.49 |- skos__altLabel mesh__D007404 Chemolysis, Intervertebral Disk
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Intervertebral Disk Nucleolysis
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Discolyses
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D007404 2006
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D007404 sjn
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Chemolyses, Intervertebral Disk
% 208.27/208.49 |- skos__altLabel mesh__D007404 Nucleolysis, Intervertebral Disk
% 208.27/208.49 |- mesh__dateEstablished mesh__D007404 1987-01-01
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Disk Nucleolyses, Intervertebral
% 208.27/208.49 |- mesh__historyNote mesh__D007404 87
% 208.27/208.49 |- skos__hiddenLabel mesh__D007404 Disk Nucleolysis, Intervertebral
% 208.27/208.49 |- mesh__recordMaintainer mesh__D051560 DRC
% 208.27/208.49 |- skos__altLabel mesh__D051560 c-bcl-6 Proto-Oncogene Proteins
% 208.27/208.49 |- skos__hiddenLabel mesh__D051560 Proto-Oncogene Proteins, c-bcl-6
% 208.27/208.49 |- skos__hiddenLabel mesh__D051560 Proto Oncogene Proteins c bcl 6
% 208.27/208.49 |- mesh__dateEstablished mesh__D051560 2006-01-01
% 208.27/208.49 |- skos__hiddenLabel mesh__D051560 c bcl 6 Protein
% 208.27/208.49 |- skos__hiddenLabel mesh__D051560 Proto Oncogene Protein c bcl 6
% 208.27/208.49 |- mesh__historyNote mesh__D051560 2006%28%1993%29%
% 208.27/208.49 |- mesh__recordAuthorizer mesh__D051560 sjn
% 208.27/208.49 |- skos__scopeNote mesh__D051560
% 208.27/208.49 A DNA-binding protein that represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA.%A%
% 208.27/208.49 |- skos__hiddenLabel mesh__D051560 B Cell Lymphoma 6 Protein
% 208.27/208.49 |- skos__altLabel mesh__D051560 B-Cell Lymphoma 6 Protein
% 208.27/208.49 |- mesh__publicMeSHNote mesh__D051560
% 208.27/208.49 2006; PROTO-ONCOGENE PROTEIN C-BCL-6 was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A%
% 208.27/208.49 |- skos__altLabel mesh__D051560 bcl-6 Proto-Oncogene Proteins
% 208.27/208.49 |- skos__hiddenLabel mesh__D051560 Proto-Oncogene Proteins, bcl-6
% 208.27/208.49 |- rdf__type mesh__D051560sskos__Concept
% 208.27/208.49 |- skos__broader mesh__D051560smesh__D014157
% 208.27/208.49 |- skos__hiddenLabel mesh__D051560 bcl 6 Proto Oncogene Proteins
% 208.27/208.49 |- skos__altLabel mesh__D051560 Zinc Finger Protein 51
% 208.27/208.49 |- mesh__recordOriginator mesh__D051560 DRC
% 208.27/208.49 |- mesh__dateCreated mesh__D051560 2005-06-30
% 208.27/208.49 |- skos__altLabel mesh__D051560 c-bcl-6 Protein
% 208.27/208.49 |- mesh__activeMeSHYear mesh__D051560 2006
% 208.27/208.49 |- skos__broader mesh__D051560smesh__D011518
% 208.27/208.50 |- skos__broader mesh__D051560smesh__D004268
% 208.27/208.50 |- skos__hiddenLabel mesh__D051560 c-bcl-6, Proto-Oncogene Proteins
% 208.27/208.50 |- skos__hiddenLabel mesh__D051560 c bcl 6 Proto Oncogene Proteins
% 208.27/208.50 |- skos__hiddenLabel mesh__D051560 bcl-6, Proto-Oncogene Protein
% 208.27/208.50 |- skos__hiddenLabel mesh__D051560 Proto Oncogene Protein bcl 6
% 208.27/208.50 |- skos__altLabel mesh__D051560 Proto-Oncogene Protein c-bcl-6
% 208.27/208.50 |- skos__prefLabel mesh__D051560 Proto-Oncogene Proteins c-bcl-6
% 208.27/208.50 |- skos__altLabel mesh__D051560 Proto-Oncogene Protein bcl-6
% 208.27/208.50 |- rdf__type mesh__D012349sskos__Concept
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 2006
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 2000
% 208.27/208.50 |- skos__hiddenLabel mesh__D012349 RNA, Asp Transfer
% 208.27/208.50 |- skos__broader mesh__D012349smesh__D012345
% 208.27/208.50 |- skos__historyNote mesh__D012349 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.50 |- skos__altLabel mesh__D012349 tRNA%28%Asp%29%
% 208.27/208.50 |- skos__scopeNote mesh__D012349
% 208.27/208.50 A transfer RNA which is specific for carrying aspartic acid to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 2005
% 208.27/208.50 |- skos__prefLabel mesh__D012349 RNA, Transfer, Asp
% 208.27/208.50 |- mesh__dateRevised mesh__D012349 1996-06-10
% 208.27/208.50 |- skos__altLabel mesh__D012349 Transfer RNA, Asp
% 208.27/208.50 |- skos__altLabel mesh__D012349 tRNAAsp
% 208.27/208.50 |- mesh__recordMaintainer mesh__D012349 TGC
% 208.27/208.50 |- skos__annotation mesh__D012349
% 208.27/208.50 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 2004
% 208.27/208.50 |- skos__hiddenLabel mesh__D012349 Acid-Specific tRNA, Aspartic
% 208.27/208.50 |- mesh__historyNote mesh__D012349
% 208.27/208.50 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.27/208.50 |- skos__hiddenLabel mesh__D012349 Aspartic Acid Specific tRNA
% 208.27/208.50 |- mesh__dateEstablished mesh__D012349 1991-01-01
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 2003
% 208.27/208.50 |- mesh__publicMeSHNote mesh__D012349
% 208.27/208.50 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.27/208.50 |- skos__altLabel mesh__D012349 Aspartic Acid-Specific tRNA
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 1999
% 208.27/208.50 |- skos__historyNote mesh__D012349 RNA, Transfer %28%1966-1987%29%
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 2002
% 208.27/208.50 |- skos__hiddenLabel mesh__D012349 tRNA, Aspartic Acid-Specific
% 208.27/208.50 |- skos__hiddenLabel mesh__D012349 Asp Transfer RNA
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 1998
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 2001
% 208.27/208.50 |- mesh__recordOriginator mesh__D012349 RLS
% 208.27/208.50 |- mesh__dateCreated mesh__D012349 1987-05-07
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D012349 1997
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D012349 PLS
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017034 2001
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017034 2003
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Opercular Epilepsy
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Epilepsies, Orbito-Frontal
% 208.27/208.50 |- skos__altLabel mesh__D017034 Benign Frontal Childhood Epilepsy
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Epilepsies, Cingulate
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Orbito-Frontal Epilepsies
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Opercular Epilepsies
% 208.27/208.50 |- skos__altLabel mesh__D017034 Epilepsy, Benign Frontal, Childhood
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017034 2002
% 208.27/208.50 |- skos__historyNote mesh__D017034 Epilepsy %28%1966-1988%29%
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017034 2004
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Supplementary Motor Epilepsies
% 208.27/208.50 |- mesh__dateRevised mesh__D017034 1999-12-09
% 208.27/208.50 |- skos__altLabel mesh__D017034 Frontal Lobe Epilepsy
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017034 2000A
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Frontal Lobe Epilepsies
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D017034 ags
% 208.27/208.50 |- rdf__type mesh__D017034sskos__Concept
% 208.27/208.50 |- mesh__recordMaintainer mesh__D017034 ags
% 208.27/208.50 |- mesh__recordOriginator mesh__D017034 MXR
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Cingulate Epilepsy
% 208.27/208.50 |- skos__historyNote mesh__D017034
% 208.27/208.50 Epilepsy, Temporal Lobe %28%1966-1991%29%
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Cingulate Epilepsies
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017034 2005
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Fronto-Polar Epilepsy, Anterior
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Supplementary Motor Epilepsy
% 208.27/208.50 |- mesh__dateEstablished mesh__D017034 1992-01-01
% 208.27/208.50 |- mesh__historyNote mesh__D017034 1992
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Epilepsies, Anterior Fronto-Polar
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Orbito-Frontal Epilepsy
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Anterior Fronto-Polar Epilepsies
% 208.27/208.50 |- mesh__dateCreated mesh__D017034 1991-05-30
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Motor Epilepsies, Supplementary
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017034 2006
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Epilepsy, Orbito Frontal
% 208.27/208.50 |- skos__altLabel mesh__D017034 Childhood Benign Frontal Epilepsy
% 208.27/208.50 |- skos__prefLabel mesh__D017034 Epilepsy, Frontal Lobe
% 208.27/208.50 |- skos__scopeNote mesh__D017034
% 208.27/208.50 A localization-related %28%focal%29% form of epilepsy characterized by seizures which arise in the frontal lobe. A variety of clinical syndromes exist depending on the exact location of the seizure focus. Simple or complex motor movements may occur, and most commonly involve the face and upper extremities. Seizures in the anterior frontal regions may be associated with head and eye turning, typically away from the side of origin of the seizure. Frontal lobe seizures may be idiopathic %28%cryptogenic%29% or caused by an identifiable disease process such as traumatic injuries, neoplasms, or other macroscopic or microscopic lesions of the frontal lobes %28%symptomatic frontal lobe seizures%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp318-9%29%%A%
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Anterior Fronto-Polar Epilepsy
% 208.27/208.50 |- mesh__publicMeSHNote mesh__D017034 1992
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017034 2000
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Fronto-Polar Epilepsies, Anterior
% 208.27/208.50 |- skos__broader mesh__D017034smesh__D004828
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Epilepsy, Anterior Fronto Polar
% 208.27/208.50 |- skos__hiddenLabel mesh__D017034 Epilepsies, Supplementary Motor
% 208.27/208.50 |- skos__historyNote mesh__D017034 Epilepsy, Partial %28%1980-1991%29%
% 208.27/208.50 |- mesh__dateCreated mesh__D003812 1999-01-01
% 208.27/208.50 |- skos__hiddenLabel mesh__D003812 Dentist Patient Relationship
% 208.27/208.50 |- mesh__publicMeSHNote mesh__D003812 65
% 208.27/208.50 |- skos__annotation mesh__D003812 DF: DENTIST PATIENT RELAT
% 208.27/208.50 |- mesh__dateRevised mesh__D003812 2005-06-30
% 208.27/208.50 |- mesh__recordOriginator mesh__D003812 NLM
% 208.27/208.50 |- rdf__type mesh__D003812sskos__Concept
% 208.27/208.50 |- mesh__recordMaintainer mesh__D003812 ssb
% 208.27/208.50 |- skos__hiddenLabel mesh__D003812 Relation, Dentist-Patient
% 208.27/208.50 |- skos__altLabel mesh__D003812 Dentist-Patient Relationship
% 208.27/208.50 |- skos__hiddenLabel mesh__D003812 Relationship, Dentist-Patient
% 208.27/208.50 |- mesh__historyNote mesh__D003812 65
% 208.27/208.50 |- skos__hiddenLabel mesh__D003812 Dentist Patient Relations
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D003812 sjn
% 208.27/208.50 |- skos__broader mesh__D003812smesh__D011369
% 208.27/208.50 |- mesh__dateEstablished mesh__D003812 1965-01-01
% 208.27/208.50 |- skos__scopeNote mesh__D003812
% 208.27/208.50 The psychological relations between the dentist and patient.%A%
% 208.27/208.50 |- skos__prefLabel mesh__D003812 Dentist-Patient Relations
% 208.27/208.50 |- skos__hiddenLabel mesh__D003812 Dentist-Patient Relation
% 208.27/208.50 |- skos__hiddenLabel mesh__D003812 Relationships, Dentist-Patient
% 208.27/208.50 |- skos__hiddenLabel mesh__D003812 Relations, Dentist-Patient
% 208.27/208.50 |- skos__hiddenLabel mesh__D003812 Dentist-Patient Relationships
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D003812 2006
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D003014 2006
% 208.27/208.50 |- skos__related mesh__D003014smesh__D001905
% 208.27/208.50 |- mesh__recordOriginator mesh__D003014 NLM
% 208.27/208.50 |- skos__prefLabel mesh__D003014 Clostridium botulinum
% 208.27/208.50 |- skos__broader mesh__D003014smesh__D003013
% 208.27/208.50 |- mesh__dateCreated mesh__D003014 1999-01-01
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D003014 sjn
% 208.27/208.50 |- mesh__recordMaintainer mesh__D003014 SYSTEM
% 208.27/208.50 |- rdf__type mesh__D003014sskos__Concept
% 208.27/208.50 |- mesh__dateRevised mesh__D003014 2005-06-30
% 208.27/208.50 |- skos__annotation mesh__D003014
% 208.27/208.50 note specific types; infection = BOTULISM
% 208.27/208.50 |- skos__scopeNote mesh__D003014
% 208.27/208.50 A species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes %28%sometimes called antigenic types, or strains%29% exist, each producing a different botulinum toxin %28%BOTULINUM TOXINS%29%. The organism and its spores are widely distributed in nature.%A%
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 DNA Repair-Deficiencies
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 DNA Repair-Deficiency Disorder
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 Disorder, DNA Repair-Deficiency
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 Syndromes, Chromosome Instability
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 Repair, Defic DNA
% 208.27/208.50 |- skos__broader mesh__D049914smesh__D008659
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 Disorders, DNA Repair-Deficiency
% 208.27/208.50 |- skos__related mesh__D049914smesh__D045643
% 208.27/208.50 |- skos__annotation mesh__D049914 general; prefer specifics
% 208.27/208.50 |- mesh__publicMeSHNote mesh__D049914 2006
% 208.27/208.50 |- mesh__recordMaintainer mesh__D049914 nns
% 208.27/208.50 |- skos__scopeNote mesh__D049914
% 208.27/208.50 Disorders resulting from defective DNA REPAIR processes or the associated cellular responses to DNA DAMAGE.%A%
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 DNA Repair Deficiency Disorders
% 208.27/208.50 |- mesh__recordOriginator mesh__D049914 nns
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 Syndrome, Chromosome Instability
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 Chromosome Instability Syndrome
% 208.27/208.50 |- skos__altLabel mesh__D049914 Defic DNA Repair
% 208.27/208.50 |- skos__historyNote mesh__D049914 DNA Repair %28%1977-2005%29%
% 208.27/208.50 |- mesh__dateEstablished mesh__D049914 2006-01-01
% 208.27/208.50 |- skos__related mesh__D049914smesh__D018816
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D049914 2006
% 208.27/208.50 |- rdf__type mesh__D049914sskos__Concept
% 208.27/208.50 |- mesh__historyNote mesh__D049914 2006
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 DNA Repairs, Defic
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D049914 sjn
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 DNA Repair Deficiency
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 Defic DNA Repairs
% 208.27/208.50 |- mesh__dateCreated mesh__D049914 2005-06-30
% 208.27/208.50 |- skos__prefLabel mesh__D049914 DNA Repair-Deficiency Disorders
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 Repairs, Defic DNA
% 208.27/208.50 |- skos__hiddenLabel mesh__D049914 DNA Repair, Defic
% 208.27/208.50 |- skos__scopeNote mesh__D027462
% 208.27/208.50 A plant genus in the CHENOPODIACEAE family.
% 208.27/208.50 |- mesh__dateEstablished mesh__D027462 2002-01-01
% 208.27/208.50 |- mesh__recordMaintainer mesh__D027462 ssb
% 208.27/208.50 |- mesh__historyNote mesh__D027462
% 208.27/208.50 2002; for GOOSEFOOT use CHENOPODIACEAE 1998-2001
% 208.27/208.50 |- mesh__publicMeSHNote mesh__D027462
% 208.27/208.50 2002; for GOOSEFOOT see CHENOPODIACEAE 1998-2001
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D027462 2002
% 208.27/208.50 |- mesh__recordOriginator mesh__D027462 ssb
% 208.27/208.50 |- skos__broader mesh__D027462smesh__D019663
% 208.27/208.50 |- skos__prefLabel mesh__D027462 Chenopodium
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D027462 2006
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D027462 2004
% 208.27/208.50 |- skos__annotation mesh__D027462
% 208.27/208.50 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.27/208.50 |- mesh__dateCreated mesh__D027462 2001-07-25
% 208.27/208.50 |- rdf__type mesh__D027462sskos__Concept
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D027462 2005
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D027462 sjn
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D027462 2003
% 208.27/208.50 |- skos__hiddenLabel mesh__D013442 Nu Sulfinpyrazone
% 208.27/208.50 |- skos__hiddenLabel mesh__D013442 Apo Sulfinpyrazone
% 208.27/208.50 |- skos__hiddenLabel mesh__D013442 Nu Pharm Brand of Sulfinpyrazone
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D013442 2006
% 208.27/208.50 |- skos__altLabel mesh__D013442 Sulfoxyphenylpyrazolidin
% 208.27/208.50 |- mesh__historyNote mesh__D013442 65%28%64%29%
% 208.27/208.50 |- skos__altLabel mesh__D013442 Apotex Brand of Sulfinpyrazone
% 208.27/208.50 |- skos__altLabel mesh__D013442 Sulphinpyrazone
% 208.27/208.50 |- mesh__dateEstablished mesh__D013442 1965-01-01
% 208.27/208.50 |- skos__altLabel mesh__D013442 Nu-Pharm Brand of Sulfinpyrazone
% 208.27/208.50 |- skos__altLabel mesh__D013442 Anturan
% 208.27/208.50 |- skos__prefLabel mesh__D013442 Sulfinpyrazone
% 208.27/208.50 |- skos__scopeNote mesh__D013442
% 208.27/208.50 A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.%A%
% 208.27/208.50 |- skos__altLabel mesh__D013442 Novartis Brand of Sulfinpyrazone
% 208.27/208.50 |- mesh__dateRevised mesh__D013442 2005-06-30
% 208.27/208.50 |- skos__broader mesh__D013442smesh__D010653
% 208.27/208.50 |- mesh__publicMeSHNote mesh__D013442 65
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D013442 sjn
% 208.27/208.50 |- skos__annotation mesh__D013442 a uricosuric
% 208.27/208.50 |- mesh__recordOriginator mesh__D013442 NLM
% 208.27/208.50 |- mesh__dateCreated mesh__D013442 1999-01-01
% 208.27/208.50 |- mesh__recordMaintainer mesh__D013442 ssb
% 208.27/208.50 |- rdf__type mesh__D013442sskos__Concept
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 2000
% 208.27/208.50 |- skos__related mesh__D007405smesh__D012585
% 208.27/208.50 |- mesh__recordMaintainer mesh__D007405 RAZ
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disk, Slipped
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 1997
% 208.27/208.50 |- mesh__dateRevised mesh__D007405 1995-06-09
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Discs, Herniated
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Displacements, Intervertebral Disk
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disk, Prolapsed
% 208.27/208.50 |- skos__altLabel mesh__D007405 Slipped Disk
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Intervertebral Disc Displacements
% 208.27/208.50 |- skos__altLabel mesh__D007405 Herniated Disc
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Slipped Disks
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Herniated Disk
% 208.27/208.50 |- skos__broader mesh__D007405smesh__D013122
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Intervertebral Disk Displacements
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disc, Herniated
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 1996
% 208.27/208.50 |- skos__related mesh__D007405smesh__D007404
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 2004
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 1999
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disk Displacements, Intervertebral
% 208.27/208.50 |- mesh__recordOriginator mesh__D007405 NLM
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Displacement, Intervertebral Disk
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Prolapsed Disks
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disk Displacement, Intervertebral
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Herniated Discs
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disks, Slipped
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Displacement, Intervertebral Disc
% 208.27/208.50 |- skos__altLabel mesh__D007405 Prolapsed Disk
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 2002
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 2003
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 1998
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D007405 PLS
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Prolapses, Disk
% 208.27/208.50 |- mesh__dateCreated mesh__D007405 1999-01-01
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 2006
% 208.27/208.50 |- skos__altLabel mesh__D007405 Intervertebral Disc Displacement
% 208.27/208.50 |- skos__altLabel mesh__D007405 Disk Prolapse
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disc Displacement, Intervertebral
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disks, Herniated
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Prolapse, Disk
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 2001
% 208.27/208.50 |- skos__scopeNote mesh__D007405
% 208.27/208.50 An intervertebral disk in which the nucleus pulposus has protruded through surrounding fibrocartilage. This occurs most frequently in the lower lumbar region.%A%
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disc Displacements, Intervertebral
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disks, Prolapsed
% 208.27/208.50 |- skos__annotation mesh__D007405
% 208.27/208.50 = herniation or prolapse; coord IM with specific vertebrae %28%IM%29%; ther by chemonucleolysis = INTERVERTEBRAL DISK CHEMOLYSIS: see note there%A%
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D007405 2005
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Herniated Disks
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Disk Prolapses
% 208.27/208.50 |- skos__hiddenLabel mesh__D007405 Displacements, Intervertebral Disc
% 208.27/208.50 |- skos__prefLabel mesh__D007405 Intervertebral Disk Displacement
% 208.27/208.50 |- rdf__type mesh__D007405sskos__Concept
% 208.27/208.50 |- skos__altLabel mesh__D051561
% 208.27/208.50 Complement 3 Convertase, Alternative Pathway
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D051561 sjn
% 208.27/208.50 |- skos__scopeNote mesh__D051561
% 208.27/208.50 A serine protease that is the complex of COMPLEMENT C3B and COMPLEMENT FACTOR BB. It cleaves multiple COMPLEMENT C3 into COMPLEMENT C3A %28%anaphylatoxin%29% and COMPLEMENT C3B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY.%A%
% 208.27/208.50 |- mesh__dateEstablished mesh__D051561 2006-01-01
% 208.27/208.50 |- skos__altLabel mesh__D051561 C3 Convertase %28%C3bBb%29%
% 208.27/208.50 |- mesh__recordOriginator mesh__D051561 lkt
% 208.27/208.50 |- mesh__recordMaintainer mesh__D051561 lkt
% 208.27/208.50 |- skos__altLabel mesh__D051561 Alternative Pathway C3 Convertase
% 208.27/208.50 |- skos__altLabel mesh__D051561 C3 Convertase, Alternative Pathway
% 208.27/208.50 |- mesh__historyNote mesh__D051561
% 208.27/208.50 2006 %28%1989%29%; for CVFBB use COMPLEMENT FACTOR B 1985-2005
% 208.27/208.50 |- rdf__type mesh__D051561sskos__Concept
% 208.27/208.50 |- skos__prefLabel mesh__D051561
% 208.27/208.50 Complement C3 Convertase, Alternative Pathway
% 208.27/208.50 |- skos__historyNote mesh__D051561 Esterases %28%1976-2005%29%
% 208.27/208.50 |- mesh__publicMeSHNote mesh__D051561
% 208.27/208.50 2006; was indexed under COMPLEMENT 3B 1989-2005; for CVFBB see COMPLEMENT FACTOR B 1985-2005%A%
% 208.27/208.50 |- skos__altLabel mesh__D051561
% 208.27/208.50 Complement 3b-Associated Factor B-fragment Bb
% 208.27/208.50 |- skos__historyNote mesh__D051561 Complement C3 %28%1976-2005%29%
% 208.27/208.50 |- skos__altLabel mesh__D051561 CVFBb
% 208.27/208.50 |- skos__hiddenLabel mesh__D051561
% 208.27/208.50 Complement 3b Associated Factor B fragment Bb
% 208.27/208.50 |- mesh__dateCreated mesh__D051561 2005-06-30
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D051561 2006
% 208.27/208.50 |- skos__broader mesh__D051561smesh__D050578
% 208.27/208.50 |- mesh__recordOriginator mesh__D045524 jmp
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D045524 2006
% 208.27/208.50 |- mesh__dateEstablished mesh__D045524 2004-01-01
% 208.27/208.50 |- mesh__historyNote mesh__D045524
% 208.27/208.50 2004; use PHYCOBILISOMES %28%NM%29% 1980-2003; use PROTEINS 1978-1979%A%
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D045524 2005
% 208.27/208.50 |- mesh__dateCreated mesh__D045524 2003-07-09
% 208.27/208.50 |- skos__prefLabel mesh__D045524 Phycobilisomes
% 208.27/208.50 |- skos__related mesh__D045524smesh__D045342
% 208.27/208.50 |- mesh__recordMaintainer mesh__D045524 ags
% 208.27/208.50 |- mesh__publicMeSHNote mesh__D045524
% 208.27/208.50 2004; PHYCOBILISOMES was indexed under PROTEINS 1978-2003%A%
% 208.27/208.50 |- mesh__recordAuthorizer mesh__D045524 sjn
% 208.27/208.50 |- skos__broader mesh__D045524smesh__D021961
% 208.27/208.50 |- skos__scopeNote mesh__D045524
% 208.27/208.50 Light energy harvesting structures attached to the THYLAKOID MEMBRANES of CYANOBACTERIA and red algae %28%ALGAE, RED%29%. These multiprotein complexes contain pigments %28%PHYCOBILIPROTEINS%29% that transfer light energy to chlorophyll a.%A%
% 208.27/208.50 |- rdf__type mesh__D045524sskos__Concept
% 208.27/208.50 |- skos__historyNote mesh__D045524 Proteins %28%1978-2003%29%
% 208.27/208.50 |- skos__broader mesh__D045524smesh__D045342
% 208.27/208.50 |- skos__hiddenLabel mesh__D045524 Phycobilisome
% 208.27/208.50 |- mesh__dateRevised mesh__D045524 2004-07-07
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017833 2003
% 208.27/208.50 |- skos__hiddenLabel mesh__D017833 Afferents, Visceral
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017833 1994
% 208.27/208.50 |- mesh__activeMeSHYear mesh__D017833 2006
% 208.27/208.50 |- rdf__type mesh__D017833sskos__Concept
% 208.36/208.50 |- skos__hiddenLabel mesh__D017833 Visceral Afferent
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 2002
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 2005
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 1997
% 208.36/208.50 |- skos__scopeNote mesh__D017833
% 208.36/208.50 The sensory fibers innervating the viscera.
% 208.36/208.50 |- skos__historyNote mesh__D017833 Viscera/innervation %28%1986-1993%29%
% 208.36/208.50 |- skos__hiddenLabel mesh__D017833 Afferent, Visceral
% 208.36/208.50 |- mesh__historyNote mesh__D017833 94
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 1996
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 2001
% 208.36/208.50 |- mesh__dateEstablished mesh__D017833 1994-01-01
% 208.36/208.50 |- mesh__dateCreated mesh__D017833 1993-06-21
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 1999
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 2004
% 208.36/208.50 |- skos__prefLabel mesh__D017833 Visceral Afferents
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 1995
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 2000
% 208.36/208.50 |- skos__broader mesh__D017833smesh__D000344
% 208.36/208.50 |- mesh__publicMeSHNote mesh__D017833 94
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017833 1998
% 208.36/208.50 |- skos__altLabel mesh__D017035 Linson Pharma Brand of Pravastatin Sodium
% 208.36/208.50 |- skos__prefLabel mesh__D017035 Pravastatin
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 RMS 431
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 Lin Pravastatin
% 208.36/208.50 |- mesh__recordAuthorizer mesh__D017035 sjn
% 208.36/208.50 |- skos__altLabel mesh__D017035 Eptastatin
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 RMS431
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 Sodium Salt, Pravastatin
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 Apo Pravastatin
% 208.36/208.50 |- skos__altLabel mesh__D017035 Mevalotin
% 208.36/208.50 |- skos__altLabel mesh__D017035 Nu-Pharma Brand of Pravastatin Sodium
% 208.36/208.50 |- skos__altLabel mesh__D017035 Selektine
% 208.36/208.50 |- skos__altLabel mesh__D017035 Pravacol
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 CS514
% 208.36/208.50 |- skos__altLabel mesh__D017035 Apotex Brand of Pravastatin Sodium
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 Nu Pravastatin
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 SQ 31,000
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 Pravastatin tert Octylamine Salt
% 208.36/208.50 |- skos__broader mesh__D017035smesh__D009281
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 SQ31000
% 208.36/208.50 |- rdf__type mesh__D017035sskos__Concept
% 208.36/208.50 |- mesh__dateEstablished mesh__D017035 1992-01-01
% 208.36/208.50 |- skos__altLabel mesh__D017035 Esteve Brand of Pravastatin Sodium
% 208.36/208.50 |- mesh__publicMeSHNote mesh__D017035
% 208.36/208.50 92; PRAVASTATIN was indexed under NAPHTHALENES %26% HEPTANOIC ACIDS 1986-91%A%
% 208.36/208.50 |- skos__altLabel mesh__D017035 Juste Brand of Pravastatin Sodium
% 208.36/208.50 |- skos__altLabel mesh__D017035 SQ-31,000
% 208.36/208.50 |- mesh__recordMaintainer mesh__D017035 lkw
% 208.36/208.50 |- skos__scopeNote mesh__D017035
% 208.36/208.50 An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase %28%HYDROXYMETHYLGLUTARYL COA REDUCTASES%29%.%A%
% 208.36/208.50 |- mesh__dateRevised mesh__D017035 2005-06-30
% 208.36/208.50 |- skos__altLabel mesh__D017035 Pravasin
% 208.36/208.50 |- skos__altLabel mesh__D017035 Sankyo Brand of Pravastatin Sodium
% 208.36/208.50 |- skos__altLabel mesh__D017035 Elisor
% 208.36/208.50 |- skos__altLabel mesh__D017035 Pravastatin Sodium Salt
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D017035 2006
% 208.36/208.50 |- skos__altLabel mesh__D017035
% 208.36/208.50 Bristol-Myers Squibb Brand of Pravastatin Sodium
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 SQ31,000
% 208.36/208.50 |- skos__altLabel mesh__D017035 Lipostat
% 208.36/208.50 |- mesh__historyNote mesh__D017035
% 208.36/208.50 92; was PRAVASTATIN %28%NM%29% 1986-91
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 CS 514
% 208.36/208.50 |- mesh__dateCreated mesh__D017035 1991-07-12
% 208.36/208.50 |- mesh__recordOriginator mesh__D017035 PLS
% 208.36/208.50 |- skos__altLabel mesh__D017035 Aventis Brand of Pravastatin Sodium
% 208.36/208.50 |- mesh__onlineNote mesh__D017035
% 208.36/208.50 use PRAVASTATIN %28%NM%29% to search PRAVASTATIN 1986-91
% 208.36/208.50 |- skos__hiddenLabel mesh__D017035 SQ 31000
% 208.36/208.50 |- skos__altLabel mesh__D017035 Squibb Brand of Pravastatin Sodium
% 208.36/208.50 |- skos__related mesh__D003813smesh__D007879
% 208.36/208.50 |- mesh__recordAuthorizer mesh__D003813 sjn
% 208.36/208.50 |- mesh__onlineNote mesh__D003813 pre-explosion = DENTISTRY %28%PX%29%
% 208.36/208.50 |- skos__annotation mesh__D003813
% 208.36/208.50 specialty; /instrum = DENTAL INSTRUMENTS; DENTAL EQUIPMENT or other specifics; /legislation %26% jurisprudence = LEGISLATION, DENTAL or DENTISTRY %28%IM%29% + JURISPRUDENCE %28%IM%29% or FORENSIC DENTISTRY; /man permissible but consider also DENTISTS /supply; veterinary dentistry = DENTISTRY /vet %28%IM%29% + VETERINARY MEDICINE %28%IM%29%%A%
% 208.36/208.50 |- skos__related mesh__D003813smesh__D004468
% 208.36/208.50 |- skos__related mesh__D003813smesh__D003748
% 208.36/208.50 |- mesh__historyNote mesh__D003813
% 208.36/208.50 AVIATION DENTISTRY was heading 1965-79
% 208.36/208.50 |- skos__related mesh__D003813smesh__D019242
% 208.36/208.50 |- skos__related mesh__D003813smesh__D006665
% 208.36/208.50 |- skos__related mesh__D003813smesh__D004497
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D003813 2005
% 208.36/208.50 |- mesh__recordMaintainer mesh__D003813 jls
% 208.36/208.50 |- skos__related mesh__D003813smesh__D003762
% 208.36/208.50 |- skos__prefLabel mesh__D003813 Dentistry
% 208.36/208.50 |- mesh__dateRevised mesh__D003813 2003-07-14
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D003813 2006
% 208.36/208.50 |- mesh__publicMeSHNote mesh__D003813
% 208.36/208.50 AVIATION DENTISTRY was heading 1965-79
% 208.36/208.50 |- mesh__dateCreated mesh__D003813 1999-01-01
% 208.36/208.50 |- mesh__recordOriginator mesh__D003813 NLM
% 208.36/208.50 |- mesh__runningHead mesh__D003813 E6 - PROCEDURES AND TECHNIQUES-DENTAL
% 208.36/208.50 |- skos__scopeNote mesh__D003813
% 208.36/208.50 The profession concerned with the teeth, oral cavity, and associated structures, and the diagnosis and treatment of their diseases including prevention and the restoration of defective and missing tissue.%A%
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D003813 2004
% 208.36/208.50 |- rdf__type mesh__D003813sskos__Concept
% 208.36/208.50 |- skos__broader mesh__D003015smesh__D016908
% 208.36/208.50 |- skos__hiddenLabel mesh__D003015 Clostridium Infection
% 208.36/208.50 |- mesh__activeMeSHYear mesh__D003015 2005
% 208.36/208.50 |- mesh__dateEstablished mesh__D003015 1968-01-01
% 208.36/208.50 |- mesh__dateCreated mesh__D003015 1999-01-01
% 208.36/208.51 |- skos__scopeNote mesh__D003015
% 208.36/208.51 Infections with bacteria of the genus CLOSTRIDIUM.
% 208.36/208.51 |- rdf__type mesh__D003015sskos__Concept
% 208.36/208.51 |- skos__historyNote mesh__D003015 Clostridium %28%1966-1967%29%
% 208.36/208.51 |- mesh__recordOriginator mesh__D003015 NLM
% 208.36/208.51 |- skos__prefLabel mesh__D003015 Clostridium Infections
% 208.36/208.51 |- mesh__historyNote mesh__D003015
% 208.36/208.51 68; HEMOGLOBINURIA, BACILLARY was heading 1968-81
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D003015
% 208.36/208.51 68; HEMOGLOBINURIA, BACILLARY was heading 1968-81
% 208.36/208.51 |- skos__hiddenLabel mesh__D003015 Infection, Clostridium
% 208.36/208.51 |- skos__annotation mesh__D003015
% 208.36/208.51 gram-pos bact infect; GEN: prefer specifics
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D003015 sjn
% 208.36/208.51 |- mesh__recordMaintainer mesh__D003015 ags
% 208.36/208.51 |- mesh__onlineNote mesh__D003015
% 208.36/208.51 use CLOSTRIDIUM INFECTIONS /VE to search HEMOGLOBINURIA, BACILLARY 1968-81%A%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003015 2004
% 208.36/208.51 |- mesh__dateRevised mesh__D003015 2003-07-09
% 208.36/208.51 |- skos__altLabel mesh__D003015 Infections, Clostridium
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003015 2006
% 208.36/208.51 |- skos__prefLabel mesh__D049915 Ipomoea nil
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D049915 2006
% 208.36/208.51 |- mesh__recordOriginator mesh__D049915 ssb
% 208.36/208.51 |- mesh__dateCreated mesh__D049915 2005-06-30
% 208.36/208.51 |- skos__historyNote mesh__D049915 Ipomoea %28%2001-2005%29%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D049915 2006
% 208.36/208.51 |- mesh__recordMaintainer mesh__D049915 ssb
% 208.36/208.51 |- rdf__type mesh__D049915sskos__Concept
% 208.36/208.51 |- skos__annotation mesh__D049915
% 208.36/208.51 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.51 |- skos__scopeNote mesh__D049915
% 208.36/208.51 A plant species of the genus IPOMOEA, family CONVOLVULACEAE. An abundance of spontaneous mutants makes it useful in study of PLANT DNA and GENETICS.%A%
% 208.36/208.51 |- skos__broader mesh__D049915smesh__D027741
% 208.36/208.51 |- mesh__dateEstablished mesh__D049915 2006-01-01
% 208.36/208.51 |- skos__altLabel mesh__D049915 Japanese Morning Glory
% 208.36/208.51 |- mesh__historyNote mesh__D049915 2006
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D049915 sjn
% 208.36/208.51 |- skos__altLabel mesh__D049915 Pharbitis nil
% 208.36/208.51 |- skos__scopeNote mesh__D027463
% 208.36/208.51 A plant species in the CHENOPODIUM genus known for edible greens.%A%
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D027463 sjn
% 208.36/208.51 |- mesh__recordOriginator mesh__D027463 ssb
% 208.36/208.51 |- skos__historyNote mesh__D027463 Chenopodiaceae %28%1998-2001%29%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027463 2006
% 208.36/208.51 |- skos__annotation mesh__D027463
% 208.36/208.51 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.51 |- mesh__recordMaintainer mesh__D027463 ssb
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027463 2005
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027463 2004
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027463 2002
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D027463 2002
% 208.36/208.51 |- rdf__type mesh__D027463sskos__Concept
% 208.36/208.51 |- skos__altLabel mesh__D027463 Lamb%27%s Quarters
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027463 2003
% 208.36/208.51 |- skos__broader mesh__D027463smesh__D027462
% 208.36/208.51 |- skos__prefLabel mesh__D027463 Chenopodium album
% 208.36/208.51 |- skos__altLabel mesh__D027463 Lambsquarters
% 208.36/208.51 |- mesh__dateCreated mesh__D027463 2001-07-25
% 208.36/208.51 |- mesh__historyNote mesh__D027463 2002
% 208.36/208.51 |- mesh__dateEstablished mesh__D027463 2002-01-01
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D013443 sjn
% 208.36/208.51 |- skos__altLabel mesh__D013443 Optima Brand of Sulfisomidine
% 208.36/208.51 |- mesh__recordOriginator mesh__D013443 NLM
% 208.36/208.51 |- skos__broader mesh__D013443smesh__D013424
% 208.36/208.51 |- skos__prefLabel mesh__D013443 Sulfisomidine
% 208.36/208.51 |- skos__hiddenLabel mesh__D013443 Augensalbe, Aristamid
% 208.36/208.51 |- skos__hiddenLabel mesh__D013443 Sodium, Sulfisomidine
% 208.36/208.51 |- mesh__dateCreated mesh__D013443 1999-01-01
% 208.36/208.51 |- mesh__recordMaintainer mesh__D013443 CCR
% 208.36/208.51 |- rdf__type mesh__D013443sskos__Concept
% 208.36/208.51 |- skos__scopeNote mesh__D013443 A sulfanilamide antibacterial agent.
% 208.36/208.51 |- skos__altLabel mesh__D013443 Optima Brand of Sulfisomidine Sodium
% 208.36/208.51 |- skos__altLabel mesh__D013443 Sulphasomidine
% 208.36/208.51 |- skos__altLabel mesh__D013443 Sulfaisodimidine
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D013443 2006
% 208.36/208.51 |- skos__hiddenLabel mesh__D013443 Augentropfen, Aristamid
% 208.36/208.51 |- mesh__dateRevised mesh__D013443 2005-06-30
% 208.36/208.51 |- skos__altLabel mesh__D007406 Psychological Interview
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 2005
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 1993
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 1996
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 1995
% 208.36/208.51 |- skos__hiddenLabel mesh__D007406 Psychologic Interviews
% 208.36/208.51 |- mesh__dateRevised mesh__D007406 1992-05-14
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 1998
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 2002
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D007406 PLS
% 208.36/208.51 |- skos__scopeNote mesh__D007406
% 208.36/208.51 A directed conversation aimed at eliciting information for psychiatric diagnosis, evaluation, treatment planning, etc. The interview may be conducted by a social worker or psychologist.%A%
% 208.36/208.51 |- skos__altLabel mesh__D007406 Interview, Psychologic
% 208.36/208.51 |- rdf__type mesh__D007406sskos__Concept
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 1994
% 208.36/208.51 |- mesh__recordOriginator mesh__D007406 NLM
% 208.36/208.51 |- skos__prefLabel mesh__D007406 Interview, Psychological
% 208.36/208.51 |- mesh__dateEstablished mesh__D007406 1968-01-01
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 2001
% 208.36/208.51 |- mesh__dateCreated mesh__D007406 1999-01-01
% 208.36/208.51 |- mesh__recordMaintainer mesh__D007406 TAP
% 208.36/208.51 |- skos__broader mesh__D007406smesh__D011580
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 2000
% 208.36/208.51 |- mesh__historyNote mesh__D007406 68%28%65%29%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 2004
% 208.36/208.51 |- skos__hiddenLabel mesh__D007406 Psychologic Interview
% 208.36/208.51 |- skos__hiddenLabel mesh__D007406 Interviews, Psychologic
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 2006
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 1997
% 208.36/208.51 |- skos__altLabel mesh__D007406 Psychological Interviews
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 2003
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D007406 68
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007406 1999
% 208.36/208.51 |- skos__altLabel mesh__D007406 Interviews, Psychological
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 Proto-Oncogene Proteins, bcr
% 208.36/208.51 |- mesh__dateCreated mesh__D051562 2005-06-30
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 c bcr Proto Oncogene Proteins
% 208.36/208.51 |- skos__altLabel mesh__D051562 Breakpoint Cluster Region Protein
% 208.36/208.51 |- mesh__recordMaintainer mesh__D051562 DRC
% 208.36/208.51 |- rdf__type mesh__D051562sskos__Concept
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 Proteins, c-bcr
% 208.36/208.51 |- skos__altLabel mesh__D051562 c-bcr Proto-Oncogene Proteins
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D051562 sjn
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 c-bcr, Proto-Oncogene Proteins
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D051562
% 208.36/208.51 2006; PROTO-ONCOGENE PROTEIN C-BCR was indexed under PROTEIN-TYROSINE KINASE %26% PROTO-ONCOGENE PROTEINS 1988-2005%A%
% 208.36/208.51 |- mesh__dateEstablished mesh__D051562 2006-01-01
% 208.36/208.51 |- mesh__historyNote mesh__D051562 2006%28%1988%29%
% 208.36/208.51 |- mesh__recordOriginator mesh__D051562 DRC
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 Proto Oncogene Protein c bcr
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 Proto Oncogene Proteins c bcr
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 Proto Oncogene Protein bcr
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 c bcr Proteins
% 208.36/208.51 |- skos__prefLabel mesh__D051562 Proto-Oncogene Proteins c-bcr
% 208.36/208.51 |- skos__altLabel mesh__D051562 Proto-Oncogene Protein bcr
% 208.36/208.51 |- skos__broader mesh__D051562smesh__D011518
% 208.36/208.51 |- skos__altLabel mesh__D051562 c-bcr Proteins
% 208.36/208.51 |- skos__scopeNote mesh__D051562
% 208.36/208.51 Proto-oncogene protein bcr is a serine-threonine kinase that functions as a negative regulator of CELL PROLIFERATION and NEOPLASTIC CELL TRANSFORMATION. It is commonly fused with cellular abl protein to form BCR-ABL FUSION PROTEINS in PHILADELPHIA CHROMOSOME positive LEUKEMIA patients.%A%
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 Proto-Oncogene Proteins, c-bcr
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D051562 2006
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 bcr Proto Oncogene Proteins
% 208.36/208.51 |- skos__altLabel mesh__D051562 bcr Proto-Oncogene Proteins
% 208.36/208.51 |- skos__altLabel mesh__D051562 Proto-Oncogene Protein c-bcr
% 208.36/208.51 |- skos__hiddenLabel mesh__D051562 c-bcr, Proto-Oncogene Protein
% 208.36/208.51 |- skos__broader mesh__D051562smesh__D017346
% 208.36/208.51 |- skos__altLabel mesh__D017036 Kojewnikow Syndrome
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Syndrome, Kojewnikow%27%s
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Epilepsy, Kojewnikov%27%s
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Kojevnikov Epilepsy
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017036 2002
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017036 2003
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Syndrome, Kojewnikow
% 208.36/208.51 |- skos__broader mesh__D017036smesh__D013226
% 208.36/208.51 |- mesh__recordMaintainer mesh__D017036 ags
% 208.36/208.51 |- skos__altLabel mesh__D017036 Kozhevnikow Syndrome, Progressive Variant
% 208.36/208.51 |- mesh__recordOriginator mesh__D017036 MXR
% 208.36/208.51 |- skos__altLabel mesh__D017036
% 208.36/208.51 Epilepsia Partialis Continua, Chronic Progressive
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Epilepsies, Kojevnikov%27%s
% 208.36/208.51 |- skos__historyNote mesh__D017036
% 208.36/208.51 Epilepsy, Temporal Lobe %28%1966-1991%29%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017036 2004
% 208.36/208.51 |- mesh__dateRevised mesh__D017036 1999-12-09
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017036 2000A
% 208.36/208.51 |- mesh__historyNote mesh__D017036 1992
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Syndrome, Kozhevnikov
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D017036 ags
% 208.36/208.51 |- mesh__dateCreated mesh__D017036 1991-05-30
% 208.36/208.51 |- rdf__type mesh__D017036sskos__Concept
% 208.36/208.51 |- skos__altLabel mesh__D017036 Kojewnikov%27%s Epilepsy
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017036 2005
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Kojevnikov%27%s Epilepsies
% 208.36/208.51 |- mesh__dateEstablished mesh__D017036 1992-01-01
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017036 2000B
% 208.36/208.51 |- skos__altLabel mesh__D017036 Kojevnikov%27%s Epilepsy
% 208.36/208.51 |- skos__altLabel mesh__D017036 Kojewnikow%27%s Syndrome
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017036 2000
% 208.36/208.51 |- skos__historyNote mesh__D017036 Epilepsy %28%1966-1991%29%
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Kojewnikov Epilepsy
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017036 2006
% 208.36/208.51 |- skos__scopeNote mesh__D017036
% 208.36/208.51 A variant of epilepsy characterized by continuous focal jerking of a body part over a period of hours, days, or even years without spreading to other body regions. Contractions may be aggravated by movement and are reduced, but not abolished during sleep. ELECTROENCEPHALOGRAPHY demonstrates epileptiform %28%spike and wave%29% discharges over the hemisphere opposite to the affected limb in most instances. The repetitive movements may originate from the CEREBRAL CORTEX or from subcortical structures %28%e.g., BRAIN STEM; BASAL GANGLIA%29%. This condition is associated with Russian Spring and Summer encephalitis %28%see ENCEPHALITIS, TICK BORNE%29%; Rasmussen syndrome %28%see ENCEPHALITIS%29%; MULTIPLE SCLEROSIS; DIABETES MELLITUS; BRAIN NEOPLASMS; and CEREBROVASCULAR DISORDERS. %28%From Brain, 1996 April;119%28%pt2%29%:393-407; Epilepsia 1993;34;Suppl 1:S29-S36; and Adams et al., Principles of Neurology, 6th ed, p319%29%%A%
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Epilepsy, Kojevnikov%27%s
% 208.36/208.51 |- skos__altLabel mesh__D017036 Kozhevnikov%27%s Syndrome
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D017036 1992
% 208.36/208.51 |- skos__altLabel mesh__D017036 Progressive Variant of Kozhevnikow Syndrome
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017036 2001
% 208.36/208.51 |- skos__altLabel mesh__D017036 Kozhevnikov Syndrome
% 208.36/208.51 |- skos__historyNote mesh__D017036 Epilepsy, Partial %28%1977-1991%29%
% 208.36/208.51 |- skos__prefLabel mesh__D017036 Epilepsia Partialis Continua
% 208.36/208.51 |- skos__hiddenLabel mesh__D017036 Syndrome, Kozhevnikov%27%s
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 1996
% 208.36/208.51 |- mesh__dateEstablished mesh__D003814 1965-01-01
% 208.36/208.51 |- skos__annotation mesh__D003814
% 208.36/208.51 SPEC; SPEC qualif; to restore tooth function %28%filling, inlay, etc.%29%; do not confuse with SURGERY, ORAL %28%surg ther of dis, inj or defects of soft tissues of mouth or of jaws%29%; DF: DENT OPERATIVE%A%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 2005
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 1997
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 2002
% 208.36/208.51 |- mesh__dateRevised mesh__D003814 1995-03-13
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 2006
% 208.36/208.51 |- mesh__historyNote mesh__D003814 65; was in Cat E only 1972-79
% 208.36/208.51 |- mesh__dateCreated mesh__D003814 1999-01-01
% 208.36/208.51 |- skos__altLabel mesh__D003814 Operative Dentistry
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 2003
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 2000
% 208.36/208.51 |- skos__prefLabel mesh__D003814 Dentistry, Operative
% 208.36/208.51 |- skos__broader mesh__D003814smesh__D003813
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 2004
% 208.36/208.51 |- rdf__type mesh__D003814sskos__Concept
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 1998
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D003814 PLS
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D003814 65
% 208.36/208.51 |- skos__scopeNote mesh__D003814
% 208.36/208.51 That phase of clinical dentistry concerned with the restoration of parts of existing teeth that are defective through disease, trauma, or abnormal development, to the state of normal function, health, and esthetics, including preventive, diagnostic, biological, mechanical, and therapeutic techniques, as well as material and instrument science and application. %28%Jablonski%27%s Dictionary of Dentistry, 2d ed, p237%29%%A%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 2001
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003814 1999
% 208.36/208.51 |- mesh__recordMaintainer mesh__D003814 TGC
% 208.36/208.51 |- mesh__recordOriginator mesh__D003814 NLM
% 208.36/208.51 |- mesh__recordMaintainer mesh__D003016 SYSTEM
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D003016 sjn
% 208.36/208.51 |- skos__annotation mesh__D003016
% 208.36/208.51 infection = GAS GANGRENE if in text; otherwise coord IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%
% 208.36/208.51 |- skos__altLabel mesh__D003016 Clostridium welchii
% 208.36/208.51 |- mesh__dateRevised mesh__D003016 2005-06-30
% 208.36/208.51 |- skos__scopeNote mesh__D003016
% 208.36/208.51 The most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins.%A%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003016 2006
% 208.36/208.51 |- skos__broader mesh__D003016smesh__D003013
% 208.36/208.51 |- mesh__recordOriginator mesh__D003016 NLM
% 208.36/208.51 |- skos__prefLabel mesh__D003016 Clostridium perfringens
% 208.36/208.51 |- mesh__dateCreated mesh__D003016 1999-01-01
% 208.36/208.51 |- rdf__type mesh__D003016sskos__Concept
% 208.36/208.51 |- skos__broader mesh__D049916smesh__D008974
% 208.36/208.51 |- mesh__historyNote mesh__D049916 2006
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D049916 sjn
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D049916 2006
% 208.36/208.51 |- mesh__dateEstablished mesh__D049916 2006-01-01
% 208.36/208.51 |- skos__historyNote mesh__D049916 Mollusca %28%1967-2005%29%
% 208.36/208.51 |- skos__prefLabel mesh__D049916 Polyplacophora
% 208.36/208.51 |- mesh__dateCreated mesh__D049916 2005-06-30
% 208.36/208.51 |- skos__scopeNote mesh__D049916
% 208.36/208.51 A class in the phylum MOLLUSCA comprised of flattened, elongated marine mollusks, commonly called chitons. They are unique in that they possess seven or eight separate shell plates.%A%
% 208.36/208.51 |- skos__altLabel mesh__D049916 Chitons
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D049916 2006
% 208.36/208.51 |- rdf__type mesh__D049916sskos__Concept
% 208.36/208.51 |- mesh__recordOriginator mesh__D049916 ags
% 208.36/208.51 |- mesh__recordMaintainer mesh__D049916 ags
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027464 2005
% 208.36/208.51 |- skos__prefLabel mesh__D027464 Chenopodium ambrosioides
% 208.36/208.51 |- skos__scopeNote mesh__D027464
% 208.36/208.51 A plant species of the genus Chenopodium known for toxicity to intestinal worms and other simple organisms.%A%
% 208.36/208.51 |- skos__broader mesh__D027464smesh__D027462
% 208.36/208.51 |- skos__altLabel mesh__D027464 Epazote
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027464 2003
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027464 2006
% 208.36/208.51 |- mesh__historyNote mesh__D027464 2002
% 208.36/208.51 |- mesh__dateEstablished mesh__D027464 2002-01-01
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027464 2004
% 208.36/208.51 |- skos__annotation mesh__D027464
% 208.36/208.51 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D027464 2002
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D027464 2002
% 208.36/208.51 |- rdf__type mesh__D027464sskos__Concept
% 208.36/208.51 |- skos__altLabel mesh__D027464 Wormseed
% 208.36/208.51 |- mesh__dateCreated mesh__D027464 2001-07-25
% 208.36/208.51 |- skos__hiddenLabel mesh__D013444 TL azole
% 208.36/208.51 |- skos__scopeNote mesh__D013444
% 208.36/208.51 A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.%A%
% 208.36/208.51 |- mesh__dateRevised mesh__D013444 2005-06-30
% 208.36/208.51 |- mesh__dateCreated mesh__D013444 1999-01-01
% 208.36/208.51 |- skos__altLabel mesh__D013444 Sulfadimethyloxazole
% 208.36/208.51 |- skos__hiddenLabel mesh__D013444 Ammonium Salt Sulfisoxazole
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D013444 sjn
% 208.36/208.51 |- skos__hiddenLabel mesh__D013444 Monolithium Salt Sulfisoxazole
% 208.36/208.51 |- skos__hiddenLabel mesh__D013444 V Sul
% 208.36/208.51 |- skos__hiddenLabel mesh__D013444 Diolamine, Sulfisoxazole
% 208.36/208.51 |- mesh__recordOriginator mesh__D013444 NLM
% 208.36/208.51 |- skos__altLabel mesh__D013444 Zenith Brand of Sulfisoxazole
% 208.36/208.51 |- skos__broader mesh__D013444smesh__D013424
% 208.36/208.51 |- rdf__type mesh__D013444sskos__Concept
% 208.36/208.51 |- skos__hiddenLabel mesh__D013444 Monosodium Salt Sulfisoxazole
% 208.36/208.51 |- skos__altLabel mesh__D013444 Sulfasoxizole
% 208.36/208.51 |- skos__altLabel mesh__D013444 Sulfafurazole
% 208.36/208.51 |- skos__altLabel mesh__D013444 Vangard Brand of Sulfisoxazole
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D013444 2006
% 208.36/208.51 |- mesh__recordMaintainer mesh__D013444 CCR
% 208.36/208.51 |- skos__prefLabel mesh__D013444 Sulfisoxazole
% 208.36/208.51 |- skos__altLabel mesh__D013444 FNA Brand of Sulfisoxazole
% 208.36/208.51 |- skos__hiddenLabel mesh__D013444 Triammonium Salt Sulfisoxazole
% 208.36/208.51 |- mesh__historyNote mesh__D007407 80
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007407 2006
% 208.36/208.51 |- mesh__dateRevised mesh__D007407 2001-07-25
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007407 2002
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007407 2005
% 208.36/208.51 |- rdf__type mesh__D007407sskos__Concept
% 208.36/208.51 |- skos__scopeNote mesh__D007407
% 208.36/208.51 Conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes school admission or job interviews.%A%
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D007407 80
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D007407 sjn
% 208.36/208.51 |- mesh__dateCreated mesh__D007407 1979-05-30
% 208.36/208.51 |- skos__hiddenLabel mesh__D007407 Interview, Group
% 208.36/208.51 |- skos__hiddenLabel mesh__D007407 Interviews, Group
% 208.36/208.51 |- skos__broader mesh__D007407smesh__D003625
% 208.36/208.51 |- skos__prefLabel mesh__D007407 Interviews
% 208.36/208.51 |- skos__hiddenLabel mesh__D007407 Telephone Interview
% 208.36/208.51 |- skos__hiddenLabel mesh__D007407 Group Interview
% 208.36/208.51 |- skos__hiddenLabel mesh__D007407 Interviewer
% 208.36/208.51 |- mesh__recordOriginator mesh__D007407 SMH
% 208.36/208.51 |- skos__hiddenLabel mesh__D007407 Interview, Telephone
% 208.36/208.51 |- mesh__dateEstablished mesh__D007407 1980-01-01
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007407 2004
% 208.36/208.51 |- mesh__recordMaintainer mesh__D007407 lkt
% 208.36/208.51 |- skos__annotation mesh__D007407
% 208.36/208.51 for articles on how to conduct interviews, their value, behavior of participants, etc.: do not confuse with Publication Type INTERVIEW %28%Manual 17.64+%29%%A%
% 208.36/208.51 |- skos__hiddenLabel mesh__D007407 Telephone Interviews
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D007407 2003
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D017835
% 208.36/208.51 94; NEDOCROMIL was indexed under QUINOLINONES 1989-93 %26% QUINOLINES 1984-88%A%
% 208.36/208.51 |- skos__scopeNote mesh__D017835
% 208.36/208.51 A pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with ASTHMA, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets.%A%
% 208.36/208.51 |- skos__altLabel mesh__D017835 Nedocromil, Disodium Salt
% 208.36/208.51 |- skos__altLabel mesh__D017835 ASTA Medica Brand of Nedocromil Sodium
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017835 2006
% 208.36/208.51 |- mesh__onlineNote mesh__D017835
% 208.36/208.51 use NEDOCROMIL %28%NM%29% to search NEDOCROMIL 1984-93
% 208.36/208.51 |- mesh__recordMaintainer mesh__D017835 lkw
% 208.36/208.51 |- skos__altLabel mesh__D017835
% 208.36/208.51 Rh%C3%%B4%ne-Poulenc Rorer Brand of Nedocromil Sodium
% 208.36/208.51 |- skos__historyNote mesh__D017835 Quinolines %28%1984-1988%29%
% 208.36/208.51 |- mesh__historyNote mesh__D017835 94; was NEDOCROMIL %28%NM%29% 1984-93
% 208.36/208.51 |- mesh__recordOriginator mesh__D017835 TPW
% 208.36/208.51 |- mesh__dateRevised mesh__D017835 2005-06-30
% 208.36/208.51 |- mesh__dateCreated mesh__D017835 1993-06-04
% 208.36/208.51 |- skos__hiddenLabel mesh__D017835 FPL59002
% 208.36/208.51 |- skos__altLabel mesh__D017835 Tilavist
% 208.36/208.51 |- skos__hiddenLabel mesh__D017835 Sodium, Nedocromil
% 208.36/208.51 |- skos__altLabel mesh__D017835 Tilad
% 208.36/208.51 |- skos__altLabel mesh__D017835 Allergan Brand of Nedocromil Sodium
% 208.36/208.51 |- skos__altLabel mesh__D017835 Aventis Brand of Nedocromil Sodium
% 208.36/208.51 |- skos__altLabel mesh__D017835 Aventis Behring Brand of Nedocromil Sodium
% 208.36/208.51 |- skos__hiddenLabel mesh__D017835 FPL 59002
% 208.36/208.51 |- skos__altLabel mesh__D017835 Tilaire
% 208.36/208.51 |- skos__altLabel mesh__D017835 Lesvi Brand of Nedocromil Sodium
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D017835 sjn
% 208.36/208.51 |- skos__altLabel mesh__D017835 Fisons Brand of Nedocromil Sodium
% 208.36/208.51 |- skos__altLabel mesh__D017835 Vita Brand of Nedocromil Sodium
% 208.36/208.51 |- skos__altLabel mesh__D017835 Rapitil
% 208.36/208.51 |- rdf__type mesh__D017835sskos__Concept
% 208.36/208.51 |- skos__altLabel mesh__D017835 Irtan
% 208.36/208.51 |- skos__altLabel mesh__D017835 Nedocromil, Calcium Salt %28%1:1%29%
% 208.36/208.51 |- skos__prefLabel mesh__D017835 Nedocromil
% 208.36/208.51 |- skos__historyNote mesh__D017835 Quinolones %28%1989-1993%29%
% 208.36/208.51 |- mesh__dateEstablished mesh__D017835 1994-01-01
% 208.36/208.51 |- skos__broader mesh__D017835smesh__D042462
% 208.36/208.51 |- skos__altLabel mesh__D017835
% 208.36/208.51 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano%28%3,2-g%29%quinoline-2,8-dicarboxylic acid
% 208.36/208.51 |- skos__hiddenLabel mesh__D017835 Calcium, Nedocromil
% 208.36/208.51 |- skos__altLabel mesh__D017835 Pantheon Brand of Nedocromil Sodium
% 208.36/208.51 |- mesh__onlineNote mesh__D017037
% 208.36/208.51 use DINITROGENASE REDUCTASE %28%NM%29% to search AZOFERREDOXIN %28%NM%29% 1985-91%A%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017037 2006
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D017037
% 208.36/208.51 92; AZOFERREDOXIN %28%NM%29% was indexed under FERREDOXINS 1985-91; AZOFERREDOXIN was see under FERREDOXINS 1977-85%A%
% 208.36/208.51 |- mesh__dateRevised mesh__D017037 2003-07-09
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D017037 sjn
% 208.36/208.51 |- mesh__dateEstablished mesh__D017037 1992-01-01
% 208.36/208.51 |- mesh__recordMaintainer mesh__D017037 ssb
% 208.36/208.51 |- skos__broader mesh__D017037smesh__D009591
% 208.36/208.51 |- rdf__type mesh__D017037sskos__Concept
% 208.36/208.51 |- skos__prefLabel mesh__D017037 Dinitrogenase Reductase
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017037 2004
% 208.36/208.51 |- skos__hiddenLabel mesh__D017037 Reductase, Dinitrogenase
% 208.36/208.51 |- skos__historyNote mesh__D017037 Ferredoxins %28%1977-1991%29%
% 208.36/208.51 |- mesh__recordOriginator mesh__D017037 AGS
% 208.36/208.51 |- mesh__dateCreated mesh__D017037 1991-07-12
% 208.36/208.51 |- mesh__historyNote mesh__D017037
% 208.36/208.51 92; was AZOFERREDOXIN %28%NM%29% 1985-91; AZOFERREDOXIN was see under FERREDOXINS 1977-85%A%
% 208.36/208.51 |- skos__scopeNote mesh__D017037
% 208.36/208.51 A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE along with molybdoferredoxin and is active in nitrogen fixation.%A%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D017037 2005
% 208.36/208.51 |- skos__altLabel mesh__D017037 Azoferredoxin
% 208.36/208.51 |- skos__annotation mesh__D017037 from bacteria
% 208.36/208.51 |- skos__prefLabel mesh__D003815 Dentists
% 208.36/208.51 |- skos__broader mesh__D003815smesh__D006282
% 208.36/208.51 |- skos__scopeNote mesh__D003815
% 208.36/208.51 Individuals licensed to practice dentistry.
% 208.36/208.51 |- mesh__recordOriginator mesh__D003815 NLM
% 208.36/208.51 |- mesh__recordMaintainer mesh__D003815 kle
% 208.36/208.51 |- mesh__historyNote mesh__D003815 65
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003815 2001
% 208.36/208.51 |- mesh__dateRevised mesh__D003815 1999-11-03
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003815 2006
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003815 2000
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D003815 sjn
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003815 2004
% 208.36/208.51 |- mesh__dateEstablished mesh__D003815 1965-01-01
% 208.36/208.51 |- skos__hiddenLabel mesh__D003815 Dentist
% 208.36/208.51 |- mesh__publicMeSHNote mesh__D003815 65
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003815 2005
% 208.36/208.51 |- mesh__dateCreated mesh__D003815 1999-01-01
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003815 2003
% 208.36/208.51 |- rdf__type mesh__D003815sskos__Concept
% 208.36/208.51 |- skos__annotation mesh__D003815 /educ = EDUCATION, DENTAL or specific
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003815 2002
% 208.36/208.51 |- skos__annotation mesh__D003017 infection = TETANUS
% 208.36/208.51 |- mesh__recordAuthorizer mesh__D003017 sjn
% 208.36/208.51 |- skos__scopeNote mesh__D003017
% 208.36/208.51 The cause of TETANUS in humans and domestic animals. It is a common inhabitant of human and horse intestines as well as soil. Two components make up its potent exotoxin activity, a neurotoxin and a hemolytic toxin.%A%
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D003017 2006
% 208.36/208.51 |- skos__broader mesh__D003017smesh__D003013
% 208.36/208.51 |- mesh__dateRevised mesh__D003017 2005-06-30
% 208.36/208.51 |- mesh__dateCreated mesh__D003017 1999-01-01
% 208.36/208.51 |- rdf__type mesh__D003017sskos__Concept
% 208.36/208.51 |- skos__prefLabel mesh__D003017 Clostridium tetani
% 208.36/208.51 |- mesh__recordMaintainer mesh__D003017 SYSTEM
% 208.36/208.51 |- skos__related mesh__D003017smesh__D013744
% 208.36/208.51 |- mesh__recordOriginator mesh__D003017 NLM
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D008500 1994
% 208.36/208.51 |- mesh__activeMeSHYear mesh__D008500 1993
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D008500
% 208.36/208.52 91; was see under HOSPITAL DEPARTMENTS Aug 1977-90
% 208.36/208.52 |- skos__hiddenLabel mesh__D008500 Departments, Medical Records
% 208.36/208.52 |- skos__prefLabel mesh__D008500 Medical Records Department, Hospital
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 1999
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 2006
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 2002
% 208.36/208.52 |- mesh__dateCreated mesh__D008500 1977-05-19
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 2005
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 1998
% 208.36/208.52 |- mesh__dateEstablished mesh__D008500 1991-01-01
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 1997
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 2004
% 208.36/208.52 |- skos__hiddenLabel mesh__D008500 Department, Medical Records
% 208.36/208.52 |- skos__scopeNote mesh__D008500
% 208.36/208.52 Hospital department responsible for the creating, care, storage and retrieval of medical records. It also provides statistical information for the medical and administrative staff.%A%
% 208.36/208.52 |- skos__altLabel mesh__D008500 Medical Records Department
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 2003
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 1996
% 208.36/208.52 |- mesh__dateRevised mesh__D008500 1992-05-14
% 208.36/208.52 |- rdf__type mesh__D008500sskos__Concept
% 208.36/208.52 |- skos__hiddenLabel mesh__D008500 Records Department, Medical
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 2001
% 208.36/208.52 |- skos__hiddenLabel mesh__D008500 Records Departments, Medical
% 208.36/208.52 |- skos__broader mesh__D008500smesh__D006748
% 208.36/208.52 |- mesh__historyNote mesh__D008500
% 208.36/208.52 91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90
% 208.36/208.52 |- skos__annotation mesh__D008500 DF: MED REC DEP
% 208.36/208.52 |- mesh__recordOriginator mesh__D008500 EC
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 1995
% 208.36/208.52 |- mesh__recordMaintainer mesh__D008500 TGC
% 208.36/208.52 |- skos__altLabel mesh__D008500 Hospital Medical Records Department
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008500 2000
% 208.36/208.52 |- skos__hiddenLabel mesh__D008500 Medical Records Departments
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D008500 PLS
% 208.36/208.52 |- mesh__recordOriginator mesh__D049917 ssb
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D049917 2006
% 208.36/208.52 |- skos__scopeNote mesh__D049917
% 208.36/208.52 A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. It is sometimes called the teasel family.%A%
% 208.36/208.52 |- skos__annotation mesh__D049917
% 208.36/208.52 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.52 |- skos__prefLabel mesh__D049917 Dipsacaceae
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D049917 2006
% 208.36/208.52 |- mesh__historyNote mesh__D049917 2006
% 208.36/208.52 |- rdf__type mesh__D049917sskos__Concept
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D049917 sjn
% 208.36/208.52 |- skos__broader mesh__D049917smesh__D019684
% 208.36/208.52 |- mesh__dateEstablished mesh__D049917 2006-01-01
% 208.36/208.52 |- mesh__recordMaintainer mesh__D049917 ssb
% 208.36/208.52 |- skos__altLabel mesh__D049917 Teasel
% 208.36/208.52 |- mesh__dateCreated mesh__D049917 2005-06-30
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D027465 2006
% 208.36/208.52 |- mesh__dateCreated mesh__D027465 2001-07-25
% 208.36/208.52 |- mesh__dateEstablished mesh__D027465 2002-01-01
% 208.36/208.52 |- skos__scopeNote mesh__D027465
% 208.36/208.52 A species of the Chenopodium genus which is the source of edible seed called quinoa. It contains makisterone A and other STEROIDS, some having ECDYSTEROID activity on insects.%A%
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D027465 2002
% 208.36/208.52 |- mesh__recordOriginator mesh__D027465 ssb
% 208.36/208.52 |- rdf__type mesh__D027465sskos__Concept
% 208.36/208.52 |- skos__broader mesh__D027465smesh__D027462
% 208.36/208.52 |- mesh__dateRevised mesh__D027465 2005-06-30
% 208.36/208.52 |- mesh__historyNote mesh__D027465 2002
% 208.36/208.52 |- mesh__recordMaintainer mesh__D027465 ssb
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D027465 sjn
% 208.36/208.52 |- skos__prefLabel mesh__D027465 Chenopodium quinoa
% 208.36/208.52 |- skos__annotation mesh__D027465
% 208.36/208.52 coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.52 |- rdf__type mesh__D007408sskos__Concept
% 208.36/208.52 |- mesh__recordMaintainer mesh__D007408 lkt
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D007408 65
% 208.36/208.52 |- skos__broader mesh__D007408smesh__D000042
% 208.36/208.52 |- mesh__dateCreated mesh__D007408 1999-01-01
% 208.36/208.52 |- skos__altLabel mesh__D007408 Absorption, Intestinal
% 208.36/208.52 |- mesh__dateRevised mesh__D007408 2005-06-30
% 208.36/208.52 |- mesh__recordOriginator mesh__D007408 NLM
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D007408 sjn
% 208.36/208.52 |- mesh__dateEstablished mesh__D007408 1965-01-01
% 208.36/208.52 |- skos__broader mesh__D007408smesh__D004068
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D007408 2006
% 208.36/208.52 |- mesh__historyNote mesh__D007408 65
% 208.36/208.52 |- skos__prefLabel mesh__D007408 Intestinal Absorption
% 208.36/208.52 |- skos__scopeNote mesh__D007408
% 208.36/208.52 Uptake of substances through the lining of the INTESTINES.%A%
% 208.36/208.52 |- skos__related mesh__D007408smesh__D008286
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 2000
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 2003
% 208.36/208.52 |- skos__scopeNote mesh__D018130
% 208.36/208.52 Diamond. A crystalline form of carbon that occurs as hard, colorless or tinted isomeric crystals. It is used as a precious stone, for cutting glass, and as bearings for delicate mechanisms. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 1996
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 2001
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 2004
% 208.36/208.52 |- skos__historyNote mesh__D018130 Carbon %28%1980-1993%29%
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D018130
% 208.36/208.52 94; DIAMOND was indexed under CARBON 1980-93
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 1997
% 208.36/208.52 |- skos__broader mesh__D018130smesh__D002244
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 2002
% 208.36/208.52 |- mesh__dateCreated mesh__D018130 1993-06-04
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 2005
% 208.36/208.52 |- skos__annotation mesh__D018130 a form of carbon
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 1998
% 208.36/208.52 |- mesh__historyNote mesh__D018130 94; was DIAMOND %28%NM%29% 1980-93
% 208.36/208.52 |- mesh__dateEstablished mesh__D018130 1994-01-01
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 2006
% 208.36/208.52 |- skos__prefLabel mesh__D018130 Diamond
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 1994
% 208.36/208.52 |- rdf__type mesh__D018130sskos__Concept
% 208.36/208.52 |- skos__altLabel mesh__D018130 Diamonds
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 1999
% 208.36/208.52 |- mesh__onlineNote mesh__D018130
% 208.36/208.52 use DIAMOND %28%NM%29% to search DIAMOND 1980-93
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D018130 1995
% 208.36/208.52 |- mesh__recordMaintainer mesh__D004110 ssb
% 208.36/208.52 |- mesh__dateRevised mesh__D004110 2001-07-25
% 208.36/208.52 |- mesh__recordOriginator mesh__D004110 SH
% 208.36/208.52 |- mesh__dateCreated mesh__D004110 1974-11-19
% 208.36/208.52 |- rdf__type mesh__D004110sskos__Concept
% 208.36/208.52 |- skos__hiddenLabel mesh__D004110 CRD401
% 208.36/208.52 |- skos__hiddenLabel mesh__D004110 Malate, Diltiazem
% 208.36/208.52 |- skos__historyNote mesh__D004110 Benzazepines %28%1971-1974%29%
% 208.36/208.52 |- skos__scopeNote mesh__D004110
% 208.36/208.52 A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions. It is also teratogenic.%A%
% 208.36/208.52 |- mesh__dateEstablished mesh__D004110 1987-01-01
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D004110 2006
% 208.36/208.52 |- skos__broader mesh__D004110smesh__D001552
% 208.36/208.52 |- skos__historyNote mesh__D004110 Anisoles %28%1973-1974%29%
% 208.36/208.52 |- skos__hiddenLabel mesh__D004110 Hydrochloride, Diltiazem
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D004110 2005
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D004110 2004
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D004110 2002
% 208.36/208.52 |- skos__historyNote mesh__D004110 Dimethylamines %28%1973-1974%29%
% 208.36/208.52 |- mesh__historyNote mesh__D004110
% 208.36/208.52 87%28%79%29%; was see under BENZAZEPINES 1979-86; was CRD 401 see under BENZAZEPINES 1975-78%A%
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D004110 2003
% 208.36/208.52 |- mesh__onlineNote mesh__D004110
% 208.36/208.52 use DILTIAZEM to search CRD 401 1975-78
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D004110
% 208.36/208.52 87; was see under BENZAZEPINES 1979-86; was CRD 401 see under BENZAZEPINES 1975-78%A%
% 208.36/208.52 |- skos__hiddenLabel mesh__D004110 CRD 401
% 208.36/208.52 |- skos__prefLabel mesh__D004110 Diltiazem
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D004110 sjn
% 208.36/208.52 |- skos__scopeNote mesh__D017836
% 208.36/208.52 A genus of venomous snakes of the subfamily Crotalinae. Twelve species of this genus are found in North and Central America and Asia. Agkistrodon contortrix is the copperhead, A. piscivorus, the cottonmouth. The former is named for its russet or orange-brown color, the latter for the white interior of its mouth. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336; Moore, Poisonous Snakes of the World, 1980, p75%29%%A%
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D017836 sjn
% 208.36/208.52 |- mesh__dateEstablished mesh__D017836 1994-01-01
% 208.36/208.52 |- mesh__dateCreated mesh__D017836 1993-02-16
% 208.36/208.52 |- skos__altLabel mesh__D017836 Ancistrodon
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D017836 2004
% 208.36/208.52 |- skos__historyNote mesh__D017836 Snakes %28%1966-1993%29%
% 208.36/208.52 |- mesh__dateRevised mesh__D017836 2003-07-09
% 208.36/208.52 |- rdf__type mesh__D017836sskos__Concept
% 208.36/208.52 |- skos__hiddenLabel mesh__D017836 Copperheads
% 208.36/208.52 |- mesh__recordMaintainer mesh__D017836 ags
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D017836 94
% 208.36/208.52 |- skos__annotation mesh__D017836
% 208.36/208.52 a genus of vipers; note X refs; its venom: coord IM with CROTALID VENOMS %28%IM%29%%A%
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D017836 2006
% 208.36/208.52 |- skos__prefLabel mesh__D017836 Agkistrodon
% 208.36/208.52 |- skos__broader mesh__D017836smesh__D017819
% 208.36/208.52 |- skos__hiddenLabel mesh__D017836 Cottonmouths
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D017836 2005
% 208.36/208.52 |- mesh__historyNote mesh__D017836 94
% 208.36/208.52 |- mesh__recordOriginator mesh__D017836 TGC
% 208.36/208.52 |- mesh__historyNote mesh__D017038
% 208.36/208.52 1992 %28%1979%29%; for ENDOGLUCOSAMINIDASE F use GLUCOSAMINIDASE 1987-2004; for ENDOGLUCOSAMINIDASE H use GLUCOSAMINIDASE 1983-2004; for ENDOGLYCOSIDASE D use GLUCOSAMINIDASE 1980-2004%A%
% 208.36/208.52 |- skos__altLabel mesh__D017038 Peptide N-Glycosidase F
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endo D Endoglucosaminidase
% 208.36/208.52 |- skos__broader mesh__D017038smesh__D006596
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038 Endo beta Acetylglucosaminidase
% 208.36/208.52 |- rdf__type mesh__D017038sskos__Concept
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038 Endo beta N Acetylglucosaminidase H
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038 Endo N Acetyl beta d glucosaminidase
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endoglycosidase D
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endo-N-Acetyl-beta-d-glucosaminidase
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endo F Endoglucosaminidase
% 208.36/208.52 |- skos__scopeNote mesh__D017038
% 208.36/208.52 A group of related enzymes responsible for the endohydrolysis of the di-N-acetylchitobiosyl unit in high-mannose-content glycopeptides and GLYCOPROTEINS.%A%
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D017038 sjn
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038 Endo beta N Acetylglucosaminidase D
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endoglucosaminidase H
% 208.36/208.52 |- mesh__dateEstablished mesh__D017038 1992-01-01
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endoglycosidase F
% 208.36/208.52 |- mesh__dateRevised mesh__D017038 2004-07-07
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038
% 208.36/208.52 Endo-beta-N-Acetylglucosaminidase, Mannosyl-Glycoprotein
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D017038
% 208.36/208.52 1992; for ENDOGLUCOSAMINIDASE F use GLUCOSAMINIDASE 1987-2004, for ENDOGLUCOSAMINIDASE H use GLUCOSAMINIDASE 1983-2004; for ENDOGLYCOSIDASE D use GLUCOSAMINIDASE 1980-2004; ENDO-BETA-ACETYLGLUCOSAMINIDASE was indexed under ACETYLGLUCOSAMINIDASE 1986-1991 %26% under GLYCOSIDE HYDROLASES 1979-1985; ENDOGLYCOSIDASE F was indexed under GLYCOSIDE HYDROLASES 1983-1991; ENDOHEXOSAMINIDASE H was indexed under HEXOSAMINIDASES 1982-1992%A%
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038
% 208.36/208.52 beta-N-Acetylglucosaminidase, Di-N-Acetylchitobiosyl
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endoglucosaminidase F
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endo H Endoglucosaminidase
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D017038 2005
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endoglucosaminidase D
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038 Peptide N Glycosidase F
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038 Endo beta N Acetylglucosaminidase F
% 208.36/208.52 |- skos__prefLabel mesh__D017038
% 208.36/208.52 Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endo-beta-Acetylglucosaminidase
% 208.36/208.52 |- skos__historyNote mesh__D017038 Glycoside Hydrolases %28%1979-1985%29%
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038
% 208.36/208.52 Mannosyl Glycoprotein Endo beta N Acetylglucosaminidase
% 208.36/208.52 |- mesh__recordOriginator mesh__D017038 AGS
% 208.36/208.52 |- skos__altLabel mesh__D017038
% 208.36/208.52 Di-N-Acetylchitobiosyl beta-N-Acetylglucosaminidase
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D017038 2006
% 208.36/208.52 |- skos__historyNote mesh__D017038 Acetylglucosaminidase %28%1986-1991%29%
% 208.36/208.52 |- mesh__dateCreated mesh__D017038 1991-07-12
% 208.36/208.52 |- skos__altLabel mesh__D017038 Endoglucosidase H
% 208.36/208.52 |- skos__hiddenLabel mesh__D017038
% 208.36/208.52 Di N Acetylchitobiosyl beta N Acetylglucosaminidase
% 208.36/208.52 |- mesh__recordMaintainer mesh__D017038 jmp
% 208.36/208.52 |- skos__prefLabel mesh__D003816 Dentists, Women
% 208.36/208.52 |- mesh__historyNote mesh__D003816 65
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003816 2002
% 208.36/208.52 |- skos__annotation mesh__D003816
% 208.36/208.52 /educ = EDUCATION, DENTAL or specific; Manual 34.11.3
% 208.36/208.52 |- skos__altLabel mesh__D003816 Woman Dentist
% 208.36/208.52 |- skos__hiddenLabel mesh__D003816 Dentist, Woman
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003816 2006
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003816 2004
% 208.36/208.52 |- mesh__recordOriginator mesh__D003816 NLM
% 208.36/208.52 |- mesh__recordMaintainer mesh__D003816 kle
% 208.36/208.52 |- skos__scopeNote mesh__D003816 Female dentists.
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003816 2005
% 208.36/208.52 |- mesh__dateCreated mesh__D003816 1999-01-01
% 208.36/208.52 |- skos__broader mesh__D003816smesh__D014930
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003816 2001
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003816 2003
% 208.36/208.52 |- rdf__type mesh__D003816sskos__Concept
% 208.36/208.52 |- mesh__dateRevised mesh__D003816 1999-11-03
% 208.36/208.52 |- skos__hiddenLabel mesh__D003816 Woman Dentists
% 208.36/208.52 |- skos__broader mesh__D003816smesh__D003815
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003816 2000
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D003816 sjn
% 208.36/208.52 |- skos__hiddenLabel mesh__D003816 Women Dentists
% 208.36/208.52 |- mesh__dateEstablished mesh__D003816 1965-01-01
% 208.36/208.52 |- skos__hiddenLabel mesh__D003816 Dentists, Woman
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D003816 65
% 208.36/208.52 |- skos__hiddenLabel mesh__D003018 Retraction, Clot
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D003018 sjn
% 208.36/208.52 |- skos__prefLabel mesh__D003018 Clot Retraction
% 208.36/208.52 |- skos__broader mesh__D003018smesh__D015539
% 208.36/208.52 |- mesh__historyNote mesh__D003018 73%28%64%29%
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003018 2004
% 208.36/208.52 |- mesh__dateRevised mesh__D003018 2003-07-09
% 208.36/208.52 |- skos__scopeNote mesh__D003018
% 208.36/208.52 Retraction of a clot resulting from contraction of PLATELET pseudopods attached to FIBRIN strands. The retraction is dependent on the contractile protein thrombosthenin. Clot retraction is used as a measure of platelet function.%A%
% 208.36/208.52 |- skos__hiddenLabel mesh__D003018 Clot Retractions
% 208.36/208.52 |- mesh__dateCreated mesh__D003018 1999-01-01
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D003018 73
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003018 2006
% 208.36/208.52 |- skos__broader mesh__D003018smesh__D010979
% 208.36/208.52 |- rdf__type mesh__D003018sskos__Concept
% 208.36/208.52 |- mesh__dateEstablished mesh__D003018 1973-01-01
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003018 2005
% 208.36/208.52 |- skos__hiddenLabel mesh__D003018 Retractions, Clot
% 208.36/208.52 |- mesh__recordOriginator mesh__D003018 NLM
% 208.36/208.52 |- mesh__recordMaintainer mesh__D003018 nns
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008501 2005
% 208.36/208.52 |- skos__altLabel mesh__D008501 Records, Problem-Oriented Medical
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008501 2004
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D008501
% 208.36/208.52 91; was see under MEDICAL RECORDS 1975-90; was MEDICAL RECORDS, PROBLEM ORIENTED 1975-89%A%
% 208.36/208.52 |- skos__hiddenLabel mesh__D008501 Problem Oriented Medical Records
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008501 2001
% 208.36/208.52 |- skos__scopeNote mesh__D008501
% 208.36/208.52 A system of record keeping in which a list of the patient%27%s problems is made and all history, physical findings, laboratory data, etc. pertinent to each problem are placed under that heading.%A%
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008501 2003
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D008501 sjn
% 208.36/208.52 |- mesh__dateEstablished mesh__D008501 1991-01-01
% 208.36/208.52 |- skos__altLabel mesh__D008501 Record, Problem-Oriented Medical
% 208.36/208.52 |- rdf__type mesh__D008501sskos__Concept
% 208.36/208.52 |- skos__altLabel mesh__D008501 Problem-Oriented Medical Records
% 208.36/208.52 |- skos__altLabel mesh__D008501 Medical Record, Problem-Oriented
% 208.36/208.52 |- skos__hiddenLabel mesh__D008501 Records, Problem Oriented Medical
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008501 2000
% 208.36/208.52 |- skos__broader mesh__D008501smesh__D008499
% 208.36/208.52 |- skos__hiddenLabel mesh__D008501 Record, Problem Oriented Medical
% 208.36/208.52 |- skos__altLabel mesh__D008501 Medical Records, Problem Oriented
% 208.36/208.52 |- mesh__onlineNote mesh__D008501
% 208.36/208.52 use MEDICAL RECORDS, PROBLEM-ORIENTED to search MEDICAL RECORDS, PROBLEM ORIENTED 1975-89%A%
% 208.36/208.52 |- mesh__recordMaintainer mesh__D008501 jls
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008501 2002
% 208.36/208.52 |- mesh__recordOriginator mesh__D008501 NLM
% 208.36/208.52 |- mesh__dateRevised mesh__D008501 1999-11-03
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D008501 2006
% 208.36/208.52 |- skos__prefLabel mesh__D008501 Medical Records, Problem-Oriented
% 208.36/208.52 |- skos__annotation mesh__D008501 DF: POMR
% 208.36/208.52 |- mesh__historyNote mesh__D008501
% 208.36/208.52 91%28%89%29%; was see under MEDICAL RECORDS 1975-90; was MEDICAL RECORDS, PROBLEM ORIENTED 1975-89%A%
% 208.36/208.52 |- skos__hiddenLabel mesh__D008501 Problem-Oriented Medical Record
% 208.36/208.52 |- mesh__dateCreated mesh__D008501 1974-11-11
% 208.36/208.52 |- skos__hiddenLabel mesh__D008501 Medical Record, Problem Oriented
% 208.36/208.52 |- skos__prefLabel mesh__D049918 Salacia
% 208.36/208.52 |- rdf__type mesh__D049918sskos__Concept
% 208.36/208.52 |- mesh__dateCreated mesh__D049918 2005-06-30
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D049918 2006
% 208.36/208.52 |- skos__broader mesh__D049918smesh__D029753
% 208.36/208.52 |- mesh__dateEstablished mesh__D049918 2006-01-01
% 208.36/208.52 |- mesh__historyNote mesh__D049918 2006
% 208.36/208.52 |- mesh__recordOriginator mesh__D049918 ssb
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D049918 sjn
% 208.36/208.52 |- skos__annotation mesh__D049918
% 208.36/208.52 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.52 |- skos__scopeNote mesh__D049918
% 208.36/208.52 A plant genus of the family CELASTRACEAE. Members contain friedelane-type TRITERPENES and SESQUITERPENES, EUDESMANE.%A%
% 208.36/208.52 |- mesh__recordMaintainer mesh__D049918 ssb
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D049918 2006
% 208.36/208.52 |- rdf__type mesh__D027466sskos__Concept
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D027466 2002
% 208.36/208.52 |- skos__prefLabel mesh__D027466 Atriplex
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D027466 2005
% 208.36/208.52 |- mesh__dateCreated mesh__D027466 2001-07-25
% 208.36/208.52 |- skos__broader mesh__D027466smesh__D019663
% 208.36/208.52 |- skos__altLabel mesh__D027466 Saltbush
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D027466 2003
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D027466 2006
% 208.36/208.52 |- skos__scopeNote mesh__D027466
% 208.36/208.52 A plant genus in the CHENOPODIACEAE family.
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D027466 2004
% 208.36/208.52 |- skos__annotation mesh__D027466
% 208.36/208.52 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.52 |- mesh__historyNote mesh__D027466 2002
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D027466 2002
% 208.36/208.52 |- mesh__dateEstablished mesh__D027466 2002-01-01
% 208.36/208.52 |- skos__broader mesh__D007409smesh__D004065
% 208.36/208.52 |- skos__altLabel mesh__D007409 Atresia, Intestinal
% 208.36/208.52 |- skos__scopeNote mesh__D007409
% 208.36/208.52 Congenital obliteration of the lumen of the intestine, with the ILEUM involved in 50%25% of the cases and the JEJUNUM and DUODENUM following in frequency. It is the most frequent cause of INTESTINAL OBSTRUCTION in NEWBORNS. %28%From Stedman, 25th ed%29%%A%
% 208.36/208.52 |- mesh__recordMaintainer mesh__D007409 lkt
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D007409 2004
% 208.36/208.52 |- skos__annotation mesh__D007409
% 208.36/208.52 coord IM with specific intestine /abnorm except for duodenum: index duodenal atresia as DUODENAL OBSTRUCTION /congen %28%IM%29% + INTESTINAL ATRESIA %28%IM%29%%A%
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D007409 2006
% 208.36/208.52 |- rdf__type mesh__D007409sskos__Concept
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D007409 2005
% 208.36/208.52 |- mesh__recordOriginator mesh__D007409 NLM
% 208.36/208.52 |- skos__prefLabel mesh__D007409 Intestinal Atresia
% 208.36/208.52 |- mesh__dateRevised mesh__D007409 2003-07-09
% 208.36/208.52 |- mesh__dateCreated mesh__D007409 1999-01-01
% 208.36/208.52 |- skos__broader mesh__D007409smesh__D007410
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D007409 sjn
% 208.36/208.52 |- mesh__dateCreated mesh__D004111 1999-01-01
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Lichtenstein, Dimen
% 208.36/208.52 |- skos__altLabel mesh__D004111 Uriach Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Republic Drug Brand of Dimenhydrinate
% 208.36/208.52 |- mesh__recordOriginator mesh__D004111 NLM
% 208.36/208.52 |- skos__altLabel mesh__D004111 Hyrex Brand of Dimenhydrinate
% 208.36/208.52 |- skos__broader mesh__D004111smesh__D004155
% 208.36/208.52 |- skos__altLabel mesh__D004111 RubiePharm Brand of Dimenhydrinate
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Vertigo Vomex
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Motion Aid
% 208.36/208.52 |- skos__altLabel mesh__D004111 Whitehall-Much Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Del Brand of Dimenhydrinate
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Reisetabletten ratiopharm
% 208.36/208.52 |- skos__altLabel mesh__D004111 Lichtenstein Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Apotex Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Brothier Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Carter Horner Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Stada Brand of Dimenhydrinate
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D004111 2006
% 208.36/208.52 |- skos__altLabel mesh__D004111 Gr%C3%%BC%nwalder Brand of Dimenhydrinate
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 L%C3%%BC%nopharm, Reisetabletten
% 208.36/208.52 |- skos__altLabel mesh__D004111 Vomex A
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Calm X
% 208.36/208.52 |- skos__scopeNote mesh__D004111
% 208.36/208.52 A drug combination that contains DIPHENHYDRAMINE and THEOPHYLLINE. It is used for treating vertigo, motion sickness, and nausea associated with pregnancy. It is not effective in the treatment of nausea associated with cancer chemotherapy.%A%
% 208.36/208.52 |- skos__altLabel mesh__D004111 Vangard Brand of Dimenhydrinate
% 208.36/208.52 |- mesh__recordMaintainer mesh__D004111 exl
% 208.36/208.52 |- skos__prefLabel mesh__D004111 Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Roberts Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Yamanouchi Brand of Dimenhydrinate
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Apo Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Diphenhydramine Theoclate
% 208.36/208.52 |- skos__altLabel mesh__D004111 ratiopharm Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Vortech Brand of Dimenhydrinate
% 208.36/208.52 |- rdf__type mesh__D004111sskos__Concept
% 208.36/208.52 |- skos__altLabel mesh__D004111 Farmalider Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Jones Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Pasadena Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Pharmacia Brand of Dimenhydrinate
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Theoclate, Diphenhydramine
% 208.36/208.52 |- skos__altLabel mesh__D004111 Cinfa Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Alra Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Torrens Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Heumann Brand of Dimenhydrinate
% 208.36/208.52 |- mesh__dateRevised mesh__D004111 2005-06-30
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Stada, Reisetabletten
% 208.36/208.52 |- skos__altLabel mesh__D004111 Hexal Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Wallace Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Hermes Brand of Dimenhydrinate
% 208.36/208.52 |- skos__broader mesh__D004111smesh__D013806
% 208.36/208.52 |- skos__altLabel mesh__D004111 Rayere Brand of Dimenhydrinate
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D004111 sjn
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Heumann, Dimen
% 208.36/208.52 |- skos__altLabel mesh__D004111 Seatrace Brand of Dimenhydrinate
% 208.36/208.52 |- skos__hiddenLabel mesh__D004111 Whitehall Much Brand of Dimenhydrinate
% 208.36/208.52 |- skos__altLabel mesh__D004111 Lunopharm Brand of Dimenhydrinate
% 208.36/208.52 |- skos__scopeNote mesh__D017837
% 208.36/208.52 A genus of poisonous snakes of the VIPERIDAE family. About 50 species are known and all are found in tropical America and southern South America. Bothrops atrox is the fer-de-lance and B. jararaca is the jararaca. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336%29%%A%
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D017837 2004
% 208.36/208.52 |- skos__historyNote mesh__D017837 Snakes %28%1966-1993%29%
% 208.36/208.52 |- mesh__dateRevised mesh__D017837 2003-07-09
% 208.36/208.52 |- mesh__recordOriginator mesh__D017837 TGC
% 208.36/208.52 |- skos__hiddenLabel mesh__D017837 Fer de Lance
% 208.36/208.52 |- skos__altLabel mesh__D017837 Jararaca
% 208.36/208.52 |- rdf__type mesh__D017837sskos__Concept
% 208.36/208.52 |- mesh__recordAuthorizer mesh__D017837 sjn
% 208.36/208.52 |- skos__prefLabel mesh__D017837 Bothrops
% 208.36/208.52 |- mesh__dateEstablished mesh__D017837 1994-01-01
% 208.36/208.52 |- mesh__recordMaintainer mesh__D017837 ags
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D017837 2006
% 208.36/208.52 |- skos__annotation mesh__D017837
% 208.36/208.52 a genus of vipers; its venom: coord IM with CROTALID VENOMS %28%IM%29%%A%
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D017837 2005
% 208.36/208.52 |- skos__hiddenLabel mesh__D017837 Fer-de-Lances
% 208.36/208.52 |- mesh__publicMeSHNote mesh__D017837 94
% 208.36/208.52 |- mesh__historyNote mesh__D017837 94
% 208.36/208.52 |- skos__broader mesh__D017837smesh__D017819
% 208.36/208.52 |- mesh__dateCreated mesh__D017837 1993-02-16
% 208.36/208.52 |- skos__scopeNote mesh__D003817
% 208.36/208.52 The teeth collectively in the dental arch. Dentition ordinarily refers to the natural teeth in position in their alveoli. Dentition referring to the deciduous teeth is DENTITION, PRIMARY; to the permanent teeth, DENTITION, PERMANENT. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%
% 208.36/208.52 |- mesh__recordMaintainer mesh__D003817 ags
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003817 2004
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003817 2005
% 208.36/208.52 |- mesh__dateRevised mesh__D003817 2005-07-13
% 208.36/208.52 |- mesh__dateCreated mesh__D003817 1999-01-01
% 208.36/208.52 |- skos__broader mesh__D003817smesh__D009055
% 208.36/208.52 |- skos__annotation mesh__D003817
% 208.36/208.52 GEN or unspecified; prefer DENTITION, PRIMARY; DENTITION, PERMANENT; or DENTITION, MIXED; differentiate from TOOTH%A%
% 208.36/208.52 |- mesh__activeMeSHYear mesh__D003817 2006A
% 208.36/208.52 |- rdf__type mesh__D003817sskos__Concept
% 208.36/208.52 |- skos__hiddenLabel mesh__D003817 Dentitions
% 208.36/208.52 |- mesh__recordOriginator mesh__D003817 NLM
% 208.36/208.52 |- skos__prefLabel mesh__D003817 Dentition
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D003817 ags
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D003817 2006
% 208.36/208.53 |- rdf__type mesh__D008502sskos__Concept
% 208.36/208.53 |- mesh__recordMaintainer mesh__D008502 TAP
% 208.36/208.53 |- skos__scopeNote mesh__D008502
% 208.36/208.53 Individuals responsible for various duties pertaining to the medical office routine.%A%
% 208.36/208.53 |- skos__altLabel mesh__D008502 Medical Secretary
% 208.36/208.53 |- mesh__dateRevised mesh__D008502 1992-05-14
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 2001
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 1995
% 208.36/208.53 |- skos__altLabel mesh__D008502 Secretary, Medical
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 1994
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 1993
% 208.36/208.53 |- skos__prefLabel mesh__D008502 Medical Secretaries
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 2000
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D008502 PLS
% 208.36/208.53 |- skos__broader mesh__D008502smesh__D000488
% 208.36/208.53 |- mesh__dateCreated mesh__D008502 1999-01-01
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 1999
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 2006
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 1998
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 2005
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 1997
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 2004
% 208.36/208.53 |- skos__altLabel mesh__D008502 Secretaries, Medical
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 2002
% 208.36/208.53 |- mesh__recordOriginator mesh__D008502 NLM
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 1996
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008502 2003
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D049919 sjn
% 208.36/208.53 |- skos__altLabel mesh__D049919 Fleabane
% 208.36/208.53 |- skos__prefLabel mesh__D049919 Erigeron
% 208.36/208.53 |- skos__historyNote mesh__D049919 Asteraceae %28%2001-2005%29%
% 208.36/208.53 |- mesh__dateCreated mesh__D049919 2005-06-30
% 208.36/208.53 |- mesh__recordMaintainer mesh__D049919 ssb
% 208.36/208.53 |- skos__broader mesh__D049919smesh__D019659
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D049919 2006
% 208.36/208.53 |- mesh__recordOriginator mesh__D049919 ssb
% 208.36/208.53 |- skos__annotation mesh__D049919
% 208.36/208.53 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.53 |- skos__scopeNote mesh__D049919
% 208.36/208.53 A plant genus of the family ASTERACEAE that is similar to CONYZA. Members contain SESQUITERPENES.%A%
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D049919 2006
% 208.36/208.53 |- rdf__type mesh__D049919sskos__Concept
% 208.36/208.53 |- mesh__historyNote mesh__D049919 2006
% 208.36/208.53 |- mesh__dateEstablished mesh__D049919 2006-01-01
% 208.36/208.53 |- mesh__historyNote mesh__D027467 2002
% 208.36/208.53 |- mesh__dateCreated mesh__D027467 2001-08-03
% 208.36/208.53 |- skos__altLabel mesh__D027467 Burningbush %28%Bassia%29%
% 208.36/208.53 |- skos__prefLabel mesh__D027467 Bassia scoparia
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D027467 sjn
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027467 2005
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027467 2002
% 208.36/208.53 |- skos__altLabel mesh__D027467 Summer cypress
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027467 2006
% 208.36/208.53 |- mesh__recordMaintainer mesh__D027467 jls
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027467 2003
% 208.36/208.53 |- skos__altLabel mesh__D027467 Fireweed
% 208.36/208.53 |- skos__altLabel mesh__D027467 Kochia scoparia
% 208.36/208.53 |- skos__altLabel mesh__D027467 Firebrush
% 208.36/208.53 |- skos__annotation mesh__D027467
% 208.36/208.53 do not confuse X ref BURNINGBUSH %28%BASSIA%29% with BURNINGBUSH %28%EUONYMUS%29% see EUONYMUS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027467 2004
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D027467 2002
% 208.36/208.53 |- mesh__dateEstablished mesh__D027467 2002-01-01
% 208.36/208.53 |- rdf__type mesh__D027467sskos__Concept
% 208.36/208.53 |- skos__broader mesh__D027467smesh__D019663
% 208.36/208.53 |- mesh__recordOriginator mesh__D027467 ssb
% 208.36/208.53 |- skos__scopeNote mesh__D027467
% 208.36/208.53 A plant species of the family CHENOPODIACEAE. It is a source of furonaphthoquinones. The common name of burning bush is also used with the unrelated EUONYMUS sieboldianus.%A%
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D013447 PLS
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 2000
% 208.36/208.53 |- rdf__type mesh__D013447sskos__Concept
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 2004
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 1998
% 208.36/208.53 |- skos__prefLabel mesh__D013447 Sulfites
% 208.36/208.53 |- skos__broader mesh__D013447smesh__D013457
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 2001
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 2005
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 1999
% 208.36/208.53 |- skos__broader mesh__D013447smesh__D000838
% 208.36/208.53 |- mesh__dateRevised mesh__D013447 1993-06-03
% 208.36/208.53 |- mesh__dateCreated mesh__D013447 1999-01-01
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 1994
% 208.36/208.53 |- skos__altLabel mesh__D013447 Sulfites, Inorganic
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 2002
% 208.36/208.53 |- skos__scopeNote mesh__D013447 Inorganic salts of sulfurous acid.
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 2006
% 208.36/208.53 |- mesh__recordMaintainer mesh__D013447 TPW
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 1995
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 1996
% 208.36/208.53 |- mesh__recordOriginator mesh__D013447 NLM
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 2003
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013447 1997
% 208.36/208.53 |- skos__altLabel mesh__D013447 Inorganic Sulfites
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D032601 2006
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D032601 2003
% 208.36/208.53 |- skos__scopeNote mesh__D032601
% 208.36/208.53 A plant genus of the family BRASSICACEAE. Some members contain CARDIAC GLYCOSIDES.%A%
% 208.36/208.53 |- rdf__type mesh__D032601sskos__Concept
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D032601 2005
% 208.36/208.53 |- mesh__dateCreated mesh__D032601 2002-07-03
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D032601 2003
% 208.36/208.53 |- mesh__historyNote mesh__D032601 2003
% 208.36/208.53 |- skos__annotation mesh__D032601
% 208.36/208.53 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.53 |- mesh__dateEstablished mesh__D032601 2003-01-01
% 208.36/208.53 |- skos__altLabel mesh__D032601 Wallflower
% 208.36/208.53 |- skos__broader mesh__D032601smesh__D019607
% 208.36/208.53 |- skos__prefLabel mesh__D032601 Erysimum
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D032601 2004
% 208.36/208.53 |- mesh__dateCreated mesh__D018132 1993-06-04
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D018132 2006
% 208.36/208.53 |- mesh__recordMaintainer mesh__D018132 sjn
% 208.36/208.53 |- mesh__recordOriginator mesh__D018132 AGS
% 208.36/208.53 |- mesh__historyNote mesh__D018132 94; was see RUBELLA VIRUS 1981-93
% 208.36/208.53 |- mesh__dateEstablished mesh__D018132 1994-01-01
% 208.36/208.53 |- rdf__type mesh__D018132sskos__Concept
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D018132 sjn
% 208.36/208.53 |- skos__hiddenLabel mesh__D018132 Rubiviruses
% 208.36/208.53 |- mesh__dateRevised mesh__D018132 2001-08-03
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D018132 94; was see RUBELLA VIRUS 1981-93
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D018132 2003
% 208.36/208.53 |- mesh__onlineNote mesh__D018132
% 208.36/208.53 use RUBELLA VIRUS to search RUBIVIRUS 1981-93
% 208.36/208.53 |- skos__broader mesh__D018132smesh__D014035
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D018132 2004
% 208.36/208.53 |- skos__annotation mesh__D018132
% 208.36/208.53 a genus of the family Togaviridae; from Latin rub-, red, with reference to the type species RUBELLA VIRUS %28%Latin rubella, reddish, a disease showing a generalized reddish rash%29%; infection = RUBIVIRUS INFECTIONS%A%
% 208.36/208.53 |- skos__prefLabel mesh__D018132 Rubivirus
% 208.36/208.53 |- skos__scopeNote mesh__D018132
% 208.36/208.53 A genus of the family TOGAVIRIDAE containing only one recognized species, RUBELLA VIRUS. Transmission is primarily by aerosolization.%A%
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D018132 2005
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D018132 2002
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Red Cell Ghosts
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Cytoskeleton, Erythrocyte
% 208.36/208.53 |- skos__altLabel mesh__D004910 Erythrocyte Ghost
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D004910 2006
% 208.36/208.53 |- mesh__recordMaintainer mesh__D004910 lkt
% 208.36/208.53 |- mesh__dateEstablished mesh__D004910 1984-01-01
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Erythrocyte Membranes
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Membranes, Erythrocyte
% 208.36/208.53 |- skos__broader mesh__D004910smesh__D002462
% 208.36/208.53 |- rdf__type mesh__D004910sskos__Concept
% 208.36/208.53 |- skos__prefLabel mesh__D004910 Erythrocyte Membrane
% 208.36/208.53 |- mesh__recordOriginator mesh__D004910 VDK
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Ghost, Erythrocyte
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D004910 sjn
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Ghost, Red Cell
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Cytoskeletons, Erythrocyte
% 208.36/208.53 |- mesh__dateCreated mesh__D004910 1976-05-19
% 208.36/208.53 |- skos__broader mesh__D004910smesh__D004912
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Ghosts, Erythrocyte
% 208.36/208.53 |- skos__altLabel mesh__D004910 Erythrocyte Cytoskeleton
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Erythrocyte Cytoskeletons
% 208.36/208.53 |- skos__scopeNote mesh__D004910
% 208.36/208.53 The semi-permeable outer structure of a red blood cell. It is known as a red cell %27%ghost%27% after HEMOLYSIS.%A%
% 208.36/208.53 |- skos__historyNote mesh__D004910 Erythrocytes %28%1966-1976%29%
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Membrane, Erythrocyte
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Erythrocyte Ghosts
% 208.36/208.53 |- mesh__historyNote mesh__D004910
% 208.36/208.53 84%28%77%29%; was see under ERYTHROCYTES 1977-83
% 208.36/208.53 |- mesh__dateRevised mesh__D004910 2005-06-30
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D004910
% 208.36/208.53 84; was see under ERYTHROCYTES 1977-83
% 208.36/208.53 |- skos__hiddenLabel mesh__D004910 Ghosts, Red Cell
% 208.36/208.53 |- skos__broader mesh__D051566smesh__D050578
% 208.36/208.53 |- skos__altLabel mesh__D051566 Alternative Pathway C5 Convertase
% 208.36/208.53 |- skos__prefLabel mesh__D051566
% 208.36/208.53 Complement C5 Convertase, Alternative Pathway
% 208.36/208.53 |- skos__historyNote mesh__D051566 Complement C5 %28%1976-2005%29%
% 208.36/208.53 |- skos__historyNote mesh__D051566
% 208.36/208.53 Complement Activating Enzymes %28%1978-2005%29%
% 208.36/208.53 |- mesh__dateCreated mesh__D051566 2005-06-30
% 208.36/208.53 |- mesh__recordOriginator mesh__D051566 lkt
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D051566 2006
% 208.36/208.53 |- rdf__type mesh__D051566sskos__Concept
% 208.36/208.53 |- skos__altLabel mesh__D051566 C5 Convertase %28%C3bBb3b%29%
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D051566 sjn
% 208.36/208.53 |- mesh__dateEstablished mesh__D051566 2006-01-01
% 208.36/208.53 |- mesh__recordMaintainer mesh__D051566 lkt
% 208.36/208.53 |- skos__altLabel mesh__D051566 C5 Convertase, Alternative Pathway
% 208.36/208.53 |- skos__scopeNote mesh__D051566
% 208.36/208.53 A serine protease that cleaves multiple COMPLEMENT C5 into COMPLEMENT C5A %28%anaphylatoxin%29% and COMPLEMENT C5B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. It is the complex of ALTERNATIVE PATHWAY C3 CONVERTASE %28%C3bBb%29% with an additional COMPLEMENT C3B, or C3bBb3b.%A%
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D051566 2006
% 208.36/208.53 |- mesh__historyNote mesh__D051566 2006
% 208.36/208.53 |- skos__hiddenLabel mesh__D004112 Anti-Lewisite, British
% 208.36/208.53 |- skos__scopeNote mesh__D004112
% 208.36/208.53 An anti-gas warfare agent that is effective against Lewisite %28%dichloro%28%2-chlorovinyl%29%arsine%29% and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.%A%
% 208.36/208.53 |- mesh__recordMaintainer mesh__D004112 exl
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D004112 2006
% 208.36/208.53 |- mesh__recordOriginator mesh__D004112 NLM
% 208.36/208.53 |- mesh__dateCreated mesh__D004112 1999-01-01
% 208.36/208.53 |- skos__altLabel mesh__D004112 2,3-Dithiopropan-1-o1
% 208.36/208.53 |- skos__altLabel mesh__D004112 2,3-Dimercaptopropanol
% 208.36/208.53 |- skos__annotation mesh__D004112 a chelating agent; D25-26 qualif
% 208.36/208.53 |- skos__hiddenLabel mesh__D004112 Cadmium 2,3 Dimercaptopropanol
% 208.36/208.53 |- skos__altLabel mesh__D004112 British Anti-Lewisite
% 208.36/208.53 |- skos__hiddenLabel mesh__D004112 2,3 Dithiopropan 1 o1
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D004112 sjn
% 208.36/208.53 |- skos__hiddenLabel mesh__D004112 British Anti Lewisite Agent
% 208.36/208.53 |- skos__altLabel mesh__D004112 British Anti-Lewisite Agent
% 208.36/208.53 |- skos__hiddenLabel mesh__D004112 2,3-Dimercaptopropanol, Cadmium
% 208.36/208.53 |- skos__prefLabel mesh__D004112 Dimercaprol
% 208.36/208.53 |- skos__altLabel mesh__D004112 Taylor Brand of Dimercaprol
% 208.36/208.53 |- skos__hiddenLabel mesh__D004112 2,3 Dimercaptopropanol
% 208.36/208.53 |- mesh__dateRevised mesh__D004112 2005-06-30
% 208.36/208.53 |- skos__broader mesh__D004112smesh__D013438
% 208.36/208.53 |- skos__hiddenLabel mesh__D004112 British Anti Lewisite
% 208.36/208.53 |- skos__hiddenLabel mesh__D004112 Anti-Lewisite Agent, British
% 208.36/208.53 |- skos__altLabel mesh__D004112 Knoll Brand of Dimercaprol
% 208.36/208.53 |- rdf__type mesh__D004112sskos__Concept
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D017838 2004
% 208.36/208.53 |- mesh__dateRevised mesh__D017838 2003-07-09
% 208.36/208.53 |- mesh__recordMaintainer mesh__D017838 ags
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D017838 94
% 208.36/208.53 |- rdf__type mesh__D017838sskos__Concept
% 208.36/208.53 |- skos__scopeNote mesh__D017838
% 208.36/208.53 A genus of poisonous snakes of the subfamily Elapinae of the family ELAPIDAE. They comprise the kraits. Twelve species are recognized and all inhabit southeast Asia. They are considered extremely dangerous. %28%Moore: Poisonous Snakes of the World, 1980, p120%29%%A%
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D017838 2005
% 208.36/208.53 |- skos__altLabel mesh__D017838 Krait
% 208.36/208.53 |- skos__hiddenLabel mesh__D017838 Kraits
% 208.36/208.53 |- skos__historyNote mesh__D017838 Snakes %28%1966-1993%29%
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D017838 2006
% 208.36/208.53 |- skos__related mesh__D017838smesh__D002038
% 208.36/208.53 |- mesh__dateEstablished mesh__D017838 1994-01-01
% 208.36/208.53 |- mesh__recordOriginator mesh__D017838 TGC
% 208.36/208.53 |- skos__broader mesh__D017838smesh__D017815
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D017838 sjn
% 208.36/208.53 |- skos__prefLabel mesh__D017838 Bungarus
% 208.36/208.53 |- mesh__historyNote mesh__D017838 94
% 208.36/208.53 |- skos__annotation mesh__D017838 a genus of poisonous snakes
% 208.36/208.53 |- mesh__dateCreated mesh__D017838 1993-02-16
% 208.36/208.53 |- skos__annotation mesh__D003818
% 208.36/208.53 some deciduous teeth, some permanent; see note at DENTITION; no qualif%A%
% 208.36/208.53 |- mesh__dateCreated mesh__D003818 1999-01-01
% 208.36/208.53 |- mesh__recordOriginator mesh__D003818 NLM
% 208.36/208.53 |- mesh__dateRevised mesh__D003818 2003-07-09
% 208.36/208.53 |- skos__scopeNote mesh__D003818
% 208.36/208.53 The complement of teeth in the jaws after the eruption of some of the permanent teeth but before all the deciduous teeth are absent. %28%Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A%
% 208.36/208.53 |- skos__related mesh__D003818smesh__D012690
% 208.36/208.53 |- rdf__type mesh__D003818sskos__Concept
% 208.36/208.53 |- skos__hiddenLabel mesh__D003818 Mixed Dentition
% 208.36/208.53 |- skos__hiddenLabel mesh__D003818 Transitional Dentition
% 208.36/208.53 |- skos__hiddenLabel mesh__D003818 Dentitions, Mixed
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D003818 sjn
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D003818 73
% 208.36/208.53 |- skos__prefLabel mesh__D003818 Dentition, Mixed
% 208.36/208.53 |- skos__hiddenLabel mesh__D003818 Mixed Dentitions
% 208.36/208.53 |- skos__hiddenLabel mesh__D003818 Transitional Dentitions
% 208.36/208.53 |- skos__historyNote mesh__D003818 Dentition %28%1966-1970%29%
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D003818 2006
% 208.36/208.53 |- mesh__dateEstablished mesh__D003818 1973-01-01
% 208.36/208.53 |- mesh__recordMaintainer mesh__D003818 lkt
% 208.36/208.53 |- skos__hiddenLabel mesh__D003818 Dentitions, Transitional
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D003818 2005
% 208.36/208.53 |- skos__altLabel mesh__D003818 Dentition, Transitional
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D003818 2004
% 208.36/208.53 |- skos__broader mesh__D003818smesh__D003817
% 208.36/208.53 |- mesh__historyNote mesh__D003818 73%28%71%29%
% 208.36/208.53 |- skos__scopeNote mesh__D014540
% 208.36/208.53 The decarboxylation product of UDPglucuronic acid, which is used for formation of the xylosides of seryl hydroxyl groups in mucoprotein synthesis. Also forms plant xylans.%A%
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D014540 2006
% 208.36/208.53 |- mesh__dateRevised mesh__D014540 2004-07-07
% 208.36/208.53 |- mesh__recordMaintainer mesh__D014540 ssb
% 208.36/208.53 |- mesh__historyNote mesh__D014540
% 208.36/208.53 91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.36/208.53 |- skos__hiddenLabel mesh__D014540 Diphosphate Xylose, Uridine
% 208.36/208.53 |- mesh__dateEstablished mesh__D014540 1991-01-01
% 208.36/208.53 |- skos__broader mesh__D014540smesh__D014539
% 208.36/208.53 |- skos__hiddenLabel mesh__D014540 Xylose, UDP
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D014540 sjn
% 208.36/208.53 |- skos__hiddenLabel mesh__D014540 Xylose, Uridine Diphosphate
% 208.36/208.53 |- skos__historyNote mesh__D014540 Xylose %28%1973-1974%29%
% 208.36/208.53 |- mesh__dateCreated mesh__D014540 1974-11-19
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D014540
% 208.36/208.53 91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90
% 208.36/208.53 |- skos__historyNote mesh__D014540
% 208.36/208.53 Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.36/208.53 |- mesh__recordOriginator mesh__D014540 NLM
% 208.36/208.53 |- skos__prefLabel mesh__D014540 Uridine Diphosphate Xylose
% 208.36/208.53 |- rdf__type mesh__D014540sskos__Concept
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D014540 2005
% 208.36/208.53 |- skos__altLabel mesh__D014540 UDP Xylose
% 208.36/208.53 |- rdf__type mesh__D008503sskos__Concept
% 208.36/208.53 |- skos__altLabel mesh__D008503 Staffs, Medical
% 208.36/208.53 |- skos__broader mesh__D008503smesh__D006282
% 208.36/208.53 |- mesh__dateCreated mesh__D008503 1999-01-01
% 208.36/208.53 |- skos__prefLabel mesh__D008503 Medical Staff
% 208.36/208.53 |- mesh__historyNote mesh__D008503 73
% 208.36/208.53 |- skos__annotation mesh__D008503
% 208.36/208.53 other than in hosp; in hosp = MEDICAL STAFF, HOSPITAL; coord IM with med milieu %28%IM%29%%A%
% 208.36/208.53 |- skos__altLabel mesh__D008503 Staff, Medical
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D008503 73
% 208.36/208.53 |- mesh__recordMaintainer mesh__D008503 KEV
% 208.36/208.53 |- mesh__recordOriginator mesh__D008503 NLM
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 1998
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 2005
% 208.36/208.53 |- skos__altLabel mesh__D008503 Medical Staffs
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 2000
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D008503 PLS
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 1999
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 2006
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 1996
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 2003
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 2001
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 1997
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 2004
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D008503 2002
% 208.36/208.53 |- mesh__dateEstablished mesh__D008503 1973-01-01
% 208.36/208.53 |- skos__scopeNote mesh__D008503
% 208.36/208.53 Professional medical personnel who provide care to patients in an organized facility, institution or agency.%A%
% 208.36/208.53 |- mesh__dateRevised mesh__D008503 1995-05-23
% 208.36/208.53 |- skos__broader mesh__D000520smesh__D005959
% 208.36/208.53 |- skos__hiddenLabel mesh__D000520 Maltase Glucoamylase
% 208.36/208.53 |- mesh__dateCreated mesh__D000520 1977-04-15
% 208.36/208.53 |- skos__hiddenLabel mesh__D000520 alpha-Glucosidase, Neutral
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D000520 2004
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D000520 sjn
% 208.36/208.53 |- skos__hiddenLabel mesh__D000520 Neutral alpha Glucosidase
% 208.36/208.53 |- mesh__dateEstablished mesh__D000520 1987-01-01
% 208.36/208.53 |- skos__annotation mesh__D000520
% 208.36/208.53 defic/: consider also GLYCOGEN STORAGE DISEASE TYPE II
% 208.36/208.53 |- mesh__recordOriginator mesh__D000520 RLS
% 208.36/208.53 |- mesh__recordMaintainer mesh__D000520 ssb
% 208.36/208.53 |- skos__altLabel mesh__D000520 Maltases
% 208.36/208.53 |- skos__historyNote mesh__D000520 Glucosidases %28%1966-1977%29%
% 208.36/208.53 |- skos__prefLabel mesh__D000520 alpha-Glucosidases
% 208.36/208.53 |- skos__altLabel mesh__D000520 Maltase-Glucoamylase
% 208.36/208.53 |- mesh__historyNote mesh__D000520
% 208.36/208.53 87%28%78%29%; was see under GLUCOSIDASES 1978-86
% 208.36/208.53 |- skos__hiddenLabel mesh__D000520 alpha Glucosidases
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D000520 2005
% 208.36/208.53 |- mesh__dateRevised mesh__D000520 2003-07-09
% 208.36/208.53 |- skos__related mesh__D000520smesh__D006009
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D000520 2006
% 208.36/208.53 |- rdf__type mesh__D000520sskos__Concept
% 208.36/208.53 |- skos__scopeNote mesh__D000520
% 208.36/208.53 Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II. EC 3.2.1.20.%A%
% 208.36/208.53 |- skos__hiddenLabel mesh__D000520 Maltase, Neutral
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D000520
% 208.36/208.53 87; was see under GLUCOSIDASES 1978-86
% 208.36/208.53 |- rdf__type mesh__D027468sskos__Concept
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027468 2002
% 208.36/208.53 |- skos__broader mesh__D027468smesh__D019659
% 208.36/208.53 |- skos__annotation mesh__D027468
% 208.36/208.53 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.53 |- skos__scopeNote mesh__D027468
% 208.36/208.53 A plant genus in the ASTERACEAE family.
% 208.36/208.53 |- skos__prefLabel mesh__D027468 Crepis
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D027468
% 208.36/208.53 2002; see ASTERACEAE 1998-2001, see HERBS 1995-1997
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027468 2004
% 208.36/208.53 |- mesh__dateEstablished mesh__D027468 2002-01-01
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027468 2006
% 208.36/208.53 |- mesh__dateCreated mesh__D027468 2001-07-25
% 208.36/208.53 |- skos__altLabel mesh__D027468 Hawk%27%s Beard
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027468 2003
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D027468 2005
% 208.36/208.53 |- mesh__historyNote mesh__D027468
% 208.36/208.53 2002; use ASTERACEAE 1998-2001, use HERBS 1995-1997
% 208.36/208.53 |- mesh__dateCreated mesh__D013448 1999-01-01
% 208.36/208.53 |- skos__hiddenLabel mesh__D013448 Disodium, Sulfobromophthalein
% 208.36/208.53 |- mesh__recordOriginator mesh__D013448 NLM
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D013448 2006
% 208.36/208.53 |- skos__broader mesh__D013448smesh__D010635
% 208.36/208.53 |- skos__annotation mesh__D013448
% 208.36/208.53 usually /diag use in LIVER FUNCTION TESTS
% 208.36/208.53 |- skos__altLabel mesh__D013448 Sulfobromophthalein Disodium
% 208.36/208.53 |- skos__scopeNote mesh__D013448
% 208.36/208.53 A phenolphthalein that is used as a diagnostic aid in hepatic function determination.%A%
% 208.36/208.53 |- skos__altLabel mesh__D013448 Bromosulfophthalein
% 208.36/208.53 |- mesh__recordMaintainer mesh__D013448 NLM
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D013448 NLM
% 208.36/208.53 |- skos__hiddenLabel mesh__D013448 Sodium, Sulfobromophthalein
% 208.36/208.53 |- mesh__dateRevised mesh__D013448 2005-07-06
% 208.36/208.53 |- rdf__type mesh__D013448sskos__Concept
% 208.36/208.53 |- skos__prefLabel mesh__D013448 Sulfobromophthalein
% 208.36/208.53 |- skos__altLabel mesh__D013448 Bromosulphthalein
% 208.36/208.53 |- skos__altLabel mesh__D018931 Antineoplastic Hormonal Agents
% 208.36/208.53 |- mesh__recordAuthorizer mesh__D018931 sjn
% 208.36/208.53 |- skos__altLabel mesh__D018931 Hormonal Antineoplastics
% 208.36/208.53 |- skos__hiddenLabel mesh__D018931 Hormonal Drugs, Antineoplastic
% 208.36/208.53 |- skos__hiddenLabel mesh__D018931 Agents, Antineoplastic Hormonal
% 208.36/208.53 |- skos__altLabel mesh__D018931 Antineoplastics, Hormonal
% 208.36/208.53 |- mesh__recordOriginator mesh__D018931 JRT
% 208.36/208.53 |- mesh__dateEstablished mesh__D018931 1996-01-01
% 208.36/208.53 |- skos__scopeNote mesh__D018931
% 208.36/208.53 Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. %28%From AMA Drug Evaluations Annual 1994, p2079%29%%A%
% 208.36/208.53 |- skos__altLabel mesh__D018931 Hormonal Antineoplastic Drugs
% 208.36/208.53 |- skos__broader mesh__D018931smesh__D000970
% 208.36/208.53 |- skos__hiddenLabel mesh__D018931 Drugs, Antineoplastic Hormonal
% 208.36/208.53 |- skos__altLabel mesh__D018931 Antineoplastic Drugs, Hormonal
% 208.36/208.53 |- mesh__dateCreated mesh__D018931 1995-05-26
% 208.36/208.53 |- skos__altLabel mesh__D018931 Hormonal Agents, Antineoplastic
% 208.36/208.53 |- rdf__type mesh__D018931sskos__Concept
% 208.36/208.53 |- mesh__historyNote mesh__D018931 96
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D018931 2006
% 208.36/208.53 |- skos__altLabel mesh__D018931 Hormonal Antineoplastic Agents
% 208.36/208.53 |- skos__prefLabel mesh__D018931 Antineoplastic Agents, Hormonal
% 208.36/208.53 |- mesh__dateRevised mesh__D018931 2005-06-30
% 208.36/208.53 |- skos__annotation mesh__D018931
% 208.36/208.53 consider also NEOPLASMS, HORMONE-DEPENDENT /drug ther
% 208.36/208.53 |- skos__historyNote mesh__D018931 Antineoplastic Agents %28%1966-1995%29%
% 208.36/208.53 |- mesh__recordMaintainer mesh__D018931 ssb
% 208.36/208.53 |- skos__altLabel mesh__D018931 Antineoplastic Hormonal Drugs
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D018931 96
% 208.36/208.53 |- mesh__historyNote mesh__D032602 2003
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D032602 2006
% 208.36/208.53 |- skos__altLabel mesh__D032602 Peashrub
% 208.36/208.53 |- skos__scopeNote mesh__D032602
% 208.36/208.53 A plant genus of the family FABACEAE. Members contain STILBENES.%A%
% 208.36/208.53 |- skos__prefLabel mesh__D032602 Caragana
% 208.36/208.53 |- rdf__type mesh__D032602sskos__Concept
% 208.36/208.53 |- mesh__publicMeSHNote mesh__D032602 2003
% 208.36/208.53 |- skos__annotation mesh__D032602
% 208.36/208.53 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.53 |- skos__broader mesh__D032602smesh__D007887
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D032602 2003
% 208.36/208.53 |- mesh__dateCreated mesh__D032602 2002-07-03
% 208.36/208.53 |- mesh__dateEstablished mesh__D032602 2003-01-01
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D032602 2004
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D032602 2005
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D010150 2001
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D010150 1994
% 208.36/208.53 |- rdf__type mesh__D010150sskos__Concept
% 208.36/208.53 |- skos__hiddenLabel mesh__D010150 Paints
% 208.36/208.53 |- mesh__recordMaintainer mesh__D010150 sjn
% 208.36/208.53 |- mesh__activeMeSHYear mesh__D010150 2004
% 208.36/208.54 |- skos__broader mesh__D010150smesh__D008420
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 2000
% 208.36/208.54 |- mesh__onlineNote mesh__D010150 use PAINT to search VARNISH 1966-78
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 2003
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 1997
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 2003A
% 208.36/208.54 |- mesh__dateCreated mesh__D010150 1999-01-01
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 2006
% 208.36/208.54 |- mesh__historyNote mesh__D010150 VARNISH was see under PAINT 1963-78
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 1996
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 1993
% 208.36/208.54 |- skos__prefLabel mesh__D010150 Paint
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 2002
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D010150 sjn
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 2005
% 208.36/208.54 |- mesh__dateRevised mesh__D010150 2002-10-23
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 1999
% 208.36/208.54 |- mesh__recordOriginator mesh__D010150 NLM
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 1995
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010150 1998
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D004911 2005
% 208.36/208.54 |- rdf__type mesh__D004911sskos__Concept
% 208.36/208.54 |- skos__hiddenLabel mesh__D004911 Mass, Red Cell
% 208.36/208.54 |- skos__related mesh__D004911smesh__D006400
% 208.36/208.54 |- skos__hiddenLabel mesh__D004911 Volume, Erythrocyte
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D004911 2004
% 208.36/208.54 |- skos__broader mesh__D004911smesh__D001810
% 208.36/208.54 |- skos__historyNote mesh__D004911 Erythrocytes %28%1966-1977%29%
% 208.36/208.54 |- mesh__recordMaintainer mesh__D004911 nns
% 208.36/208.54 |- mesh__recordOriginator mesh__D004911 VDK
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D004911 sjn
% 208.36/208.54 |- mesh__dateRevised mesh__D004911 2003-07-09
% 208.36/208.54 |- skos__hiddenLabel mesh__D004911 Erythrocyte Volumes
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D004911 78
% 208.36/208.54 |- mesh__dateEstablished mesh__D004911 1978-01-01
% 208.36/208.54 |- mesh__dateCreated mesh__D004911 1977-04-27
% 208.36/208.54 |- skos__annotation mesh__D004911
% 208.36/208.54 restrict to total amt of circulating erythrocytes: do not use for size of individual erythrocytes %28%use ERYTHROCYTES /cytol%29%; ERYTHROCYTE VOLUME, PACKED %26% ERYTHROCYTE INDICES are also available; coord with disease /blood, not /physiopathol%A%
% 208.36/208.54 |- skos__hiddenLabel mesh__D004911 Volumes, Erythrocyte
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D004911 2006
% 208.36/208.54 |- skos__scopeNote mesh__D004911
% 208.36/208.54 Volume of circulating ERYTHROCYTES . It is usually measured by RADIOISOTOPE DILUTION TECHNIQUE.%A%
% 208.36/208.54 |- skos__hiddenLabel mesh__D004911 Masses, Red Cell
% 208.36/208.54 |- skos__hiddenLabel mesh__D004911 Red Cell Masses
% 208.36/208.54 |- mesh__historyNote mesh__D004911 78
% 208.36/208.54 |- skos__prefLabel mesh__D004911 Erythrocyte Volume
% 208.36/208.54 |- skos__scopeNote mesh__D051567
% 208.36/208.54 Proto-oncogene proteins that are guanine nucleotide exchange factors for RHO GTPASES. They also function as signal transducing adaptor proteins.%A%
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 Proto Oncogene Protein c vav
% 208.36/208.54 |- skos__altLabel mesh__D051567 Proto-Oncogene Protein vav1
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 Proto Oncogene Protein vav
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 Proteins c-vav, Proto-Oncogene
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 vav, Proto-Oncogene Protein
% 208.36/208.54 |- skos__altLabel mesh__D051567 Proto-Oncogene Protein vav
% 208.36/208.54 |- skos__broader mesh__D051567smesh__D020662
% 208.36/208.54 |- skos__altLabel mesh__D051567 vav Proto-Oncogene Protein
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D051567 2006
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 c-vav, Proto-Oncogene Protein
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 c vav Protein
% 208.36/208.54 |- mesh__dateEstablished mesh__D051567 2006-01-01
% 208.36/208.54 |- skos__prefLabel mesh__D051567 Proto-Oncogene Proteins c-vav
% 208.36/208.54 |- mesh__recordMaintainer mesh__D051567 DRC
% 208.36/208.54 |- skos__altLabel mesh__D051567 Proto-Oncogene Protein c-vav
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 Proto-Oncogene Protein, vav
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 c-vav, Proto-Oncogene Proteins
% 208.36/208.54 |- mesh__historyNote mesh__D051567 2006%28%1991%29%
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 Proto Oncogene Protein vav1
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D051567
% 208.36/208.54 2006; PROTO-ONCOGENE PROTEIN C-VAV was indexed under PROTO-ONCOGENE PROTEINS %26% CELL CYCLE PROTEINS 2004-2005, %26% under ONCOGENE PROTEINS 1991-2004%A%
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 vav Proto Oncogene Protein
% 208.36/208.54 |- skos__altLabel mesh__D051567 c-vav Protein
% 208.36/208.54 |- skos__broader mesh__D051567smesh__D048868
% 208.36/208.54 |- mesh__recordOriginator mesh__D051567 DRC
% 208.36/208.54 |- rdf__type mesh__D051567sskos__Concept
% 208.36/208.54 |- mesh__dateCreated mesh__D051567 2005-06-30
% 208.36/208.54 |- skos__broader mesh__D051567smesh__D011518
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 vav Guanine Nucleotide Exchange Factor
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 Proto Oncogene Proteins c vav
% 208.36/208.54 |- skos__hiddenLabel mesh__D051567 vav1, Proto-Oncogene Protein
% 208.36/208.54 |- skos__altLabel mesh__D051567 vav Guanine-Nucleotide Exchange Factor
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D051567 sjn
% 208.36/208.54 |- skos__broader mesh__D019855Q000031smesh__D019855
% 208.36/208.54 |- mesh__preferredCombination mesh__D019855Q000031smesh__D005026
% 208.36/208.54 |- rdf__type mesh__D019855Q000031smesh__CompoundConcept
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 Tin Salt Succimer
% 208.36/208.54 |- skos__altLabel mesh__D004113 SERB Brand of Succimer
% 208.36/208.54 |- skos__altLabel mesh__D004113 Sanofi Brand of Succimer
% 208.36/208.54 |- skos__prefLabel mesh__D004113 Succimer
% 208.36/208.54 |- mesh__dateRevised mesh__D004113 2005-06-30
% 208.36/208.54 |- skos__broader mesh__D004113smesh__D013438
% 208.36/208.54 |- mesh__historyNote mesh__D004113
% 208.36/208.54 94; was DIMERCAPTOSUCCINIC ACID 1979-93 %28%see under SULFHYDRYL COMPOUNDS 1979-90%29%; SUCCIMER was see DIMERCAPTOSUCCINIC ACID 1979-93%A%
% 208.36/208.54 |- skos__historyNote mesh__D004113 Succinates %28%1966-1978%29%
% 208.36/208.54 |- skos__altLabel mesh__D004113 2,3-Dimercaptosuccinic Acid
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 meso Dimercaptosuccinic Acid
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D004113
% 208.36/208.54 94; was DIMERCAPTOSUCCINIC ACID 1979-93 %28%see under SULFHYDRYL COMPOUNDS 1979-90%29%; SUCCIMER was see DIMERCAPTOSUCCINIC ACID 1979-93%A%
% 208.36/208.54 |- skos__altLabel mesh__D004113 DMSA
% 208.36/208.54 |- mesh__dateCreated mesh__D004113 1978-02-07
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 Ro17977
% 208.36/208.54 |- skos__broader mesh__D004113smesh__D019822
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 Monosodium Salt Succimer
% 208.36/208.54 |- mesh__recordOriginator mesh__D004113 SH
% 208.36/208.54 |- skos__annotation mesh__D004113 D25-26 qualif
% 208.36/208.54 |- rdf__type mesh__D004113sskos__Concept
% 208.36/208.54 |- skos__historyNote mesh__D004113 Sulfhydryl Compounds %28%1966-1978%29%
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 Dimercaptosuccinate, Tin
% 208.36/208.54 |- mesh__recordMaintainer mesh__D004113 CCR
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 2,3 Dimercaptosuccinic Acid
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 Rhenium Salt Succimer
% 208.36/208.54 |- mesh__dateEstablished mesh__D004113 1991-01-01
% 208.36/208.54 |- skos__altLabel mesh__D004113 Tin Dimercaptosuccinate
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 Disodium Salt Succimer
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 Dipotassium Salt Succimer
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D004113 2006
% 208.36/208.54 |- skos__scopeNote mesh__D004113
% 208.36/208.54 A mercaptodicarboxylic acid used as an antidote to heavy metal poisoning because it forms strong chelates with them.%A%
% 208.36/208.54 |- mesh__onlineNote mesh__D004113
% 208.36/208.54 use SUCCIMER to search DIMERCAPTOSUCCINIC ACID 1979-93
% 208.36/208.54 |- skos__altLabel mesh__D004113 meso-Dimercaptosuccinic Acid
% 208.36/208.54 |- skos__hiddenLabel mesh__D004113 Ro 1 7977
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D004113 sjn
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D017839 2005
% 208.36/208.54 |- skos__broader mesh__D017839smesh__D017819
% 208.36/208.54 |- skos__altLabel mesh__D017839 Rattlesnake
% 208.36/208.54 |- skos__historyNote mesh__D017839 Snakes %28%1966-1993%29%
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D017839 2006
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D017839 94
% 208.36/208.54 |- skos__annotation mesh__D017839
% 208.36/208.54 a genus of pit vipers; note X ref; its venom: coord IM with CROTALID VENOMS %28%IM%29%%A%
% 208.36/208.54 |- skos__hiddenLabel mesh__D017839 Rattlesnakes
% 208.36/208.54 |- mesh__historyNote mesh__D017839 94
% 208.36/208.54 |- mesh__recordOriginator mesh__D017839 TGC
% 208.36/208.54 |- mesh__dateEstablished mesh__D017839 1994-01-01
% 208.36/208.54 |- mesh__dateCreated mesh__D017839 1993-02-16
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D017839 2004
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D017839 sjn
% 208.36/208.54 |- mesh__dateRevised mesh__D017839 2003-07-09
% 208.36/208.54 |- skos__scopeNote mesh__D017839
% 208.36/208.54 A genus of snakes of the family VIPERIDAE, one of the pit vipers, so-called from the pit hollowing out the maxillary bone, opening between the eye and the nostril. They are distinctively American serpents. Most of the 25 recognized species are found in the southwestern United States and northern Mexico. Several species are found as far north as Canada and east of the Mississippi, including southern Appalachia. They are named for the jointed rattle %28%Greek krotalon%29% at the tip of their tail. %28%Goin, Goin, and Zug: Introduction to Herpetology, 3d ed; Moore: Poisonous Snakes of the World, 1980, p335%29%%A%
% 208.36/208.54 |- skos__prefLabel mesh__D017839 Crotalus
% 208.36/208.54 |- mesh__recordMaintainer mesh__D017839 ags
% 208.36/208.54 |- rdf__type mesh__D017839sskos__Concept
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D028561 2005
% 208.36/208.54 |- mesh__historyNote mesh__D028561 2002
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D028561 2003
% 208.36/208.54 |- mesh__dateCreated mesh__D028561 2001-07-25
% 208.36/208.54 |- skos__annotation mesh__D028561 GEN or unspecified; prefer specifics
% 208.36/208.54 |- skos__hiddenLabel mesh__D028561 Elements, Transition
% 208.36/208.54 |- skos__broader mesh__D028561smesh__D004602
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D028561 2002
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D028561 2002
% 208.36/208.54 |- mesh__dateEstablished mesh__D028561 2002-01-01
% 208.36/208.54 |- skos__scopeNote mesh__D028561
% 208.36/208.54 Elements with partially filled d orbitals. They constitute groups 3-12 of the periodic table of elements.%A%
% 208.36/208.54 |- skos__prefLabel mesh__D028561 Transition Elements
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D028561 2006
% 208.36/208.54 |- rdf__type mesh__D028561sskos__Concept
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D028561 2004
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D003819 SJN
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D003819 1998
% 208.36/208.54 |- skos__scopeNote mesh__D003819
% 208.36/208.54 The part of a denture that overlies the soft tissue and supports the supplied teeth and is supported in turn by abutment teeth or the residual alveolar ridge. It is usually made of resins or metal or their combination.%A%
% 208.36/208.54 |- skos__hiddenLabel mesh__D003819 Denture Base
% 208.36/208.54 |- skos__prefLabel mesh__D003819 Denture Bases
% 208.36/208.54 |- rdf__type mesh__D003819sskos__Concept
% 208.36/208.54 |- mesh__recordMaintainer mesh__D003819 PXP
% 208.36/208.54 |- skos__annotation mesh__D003819
% 208.36/208.54 coord IM with specific denture term %28%IM or NIM%29%
% 208.36/208.54 |- mesh__historyNote mesh__D003819 65
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D003819 1999
% 208.36/208.54 |- skos__hiddenLabel mesh__D003819 Base, Denture
% 208.36/208.54 |- skos__hiddenLabel mesh__D003819 Bases, Denture
% 208.36/208.54 |- mesh__dateRevised mesh__D003819 1997-06-20
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D003819 2000
% 208.36/208.54 |- skos__broader mesh__D003819smesh__D003778
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D003819 2005
% 208.36/208.54 |- mesh__recordOriginator mesh__D003819 NLM
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D003819 2001
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D003819 65
% 208.36/208.54 |- mesh__dateCreated mesh__D003819 1999-01-01
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D003819 2003
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D003819 2006
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D003819 2002
% 208.36/208.54 |- mesh__dateEstablished mesh__D003819 1965-01-01
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D003819 2004
% 208.36/208.54 |- skos__hiddenLabel mesh__D014541 Kinase, Uridine
% 208.36/208.54 |- mesh__dateCreated mesh__D014541 1974-11-11
% 208.36/208.54 |- mesh__dateEstablished mesh__D014541 1991-01-01
% 208.36/208.54 |- skos__scopeNote mesh__D014541
% 208.36/208.54 An enzyme that catalyzes the phosphorylation of uridine and cytidine to uridine 5%27%-phosphate and cytidine 5%27%-phosphate, respectively. ATP, dUTP, dGTP, and dATP are effective phosphate donors. EC 2.7.1.48.%A%
% 208.36/208.54 |- mesh__historyNote mesh__D014541
% 208.36/208.54 91%28%75%29%; was see under PHOSPHOTRANSFERASES, ATP 1975-90
% 208.36/208.54 |- mesh__recordMaintainer mesh__D014541 ssb
% 208.36/208.54 |- mesh__dateRevised mesh__D014541 2003-07-09
% 208.36/208.54 |- skos__altLabel mesh__D014541 Cytidine Kinase
% 208.36/208.54 |- skos__historyNote mesh__D014541 Uridine %28%1974%29%
% 208.36/208.54 |- skos__hiddenLabel mesh__D014541 Kinase, Uridine-Cytidine
% 208.36/208.54 |- rdf__type mesh__D014541sskos__Concept
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014541 2005
% 208.36/208.54 |- skos__hiddenLabel mesh__D014541 Kinase, Cytidine
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D014541 sjn
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014541 2004
% 208.36/208.54 |- skos__prefLabel mesh__D014541 Uridine Kinase
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D014541
% 208.36/208.54 91; was see under PHOSPHOTRANSFERASES, ATP 1975-90
% 208.36/208.54 |- skos__altLabel mesh__D014541 Uridine-Cytidine Kinase
% 208.36/208.54 |- skos__historyNote mesh__D014541 Phosphotransferases, ATP %28%1974%29%
% 208.36/208.54 |- skos__broader mesh__D014541smesh__D017853
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014541 2006
% 208.36/208.54 |- skos__hiddenLabel mesh__D014541 Uridine Cytidine Kinase
% 208.36/208.54 |- mesh__recordOriginator mesh__D014541 NLM
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 1995
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 2002
% 208.36/208.54 |- mesh__historyNote mesh__D008504
% 208.36/208.54 91%28%Aug 77%29%; was see under MEDICAL STAFF, HOSPITAL 1977-90%A%
% 208.36/208.54 |- skos__altLabel mesh__D008504 Staff Privileges, Medical
% 208.36/208.54 |- mesh__dateEstablished mesh__D008504 1991-01-01
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 1998
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 2005
% 208.36/208.54 |- skos__hiddenLabel mesh__D008504 Privileges, Medical Staff
% 208.36/208.54 |- skos__historyNote mesh__D008504
% 208.36/208.54 Medical Staff, Hospital %28%1966-Jul 1977%29%
% 208.36/208.54 |- skos__hiddenLabel mesh__D008504 Privilege, Medical Staff
% 208.36/208.54 |- mesh__dateRevised mesh__D008504 1994-04-19
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 2006
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 1999
% 208.36/208.54 |- skos__prefLabel mesh__D008504 Medical Staff Privileges
% 208.36/208.54 |- mesh__dateCreated mesh__D008504 1977-05-11
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 1996
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 2003
% 208.36/208.54 |- skos__annotation mesh__D008504 DF: MED STAFF PRIVILEGES
% 208.36/208.54 |- mesh__recordMaintainer mesh__D008504 JLS
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 1997
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 2004
% 208.36/208.54 |- skos__historyNote mesh__D008504
% 208.36/208.54 Hospital Administration %28%1966-Jul 1977%29%
% 208.36/208.54 |- mesh__recordOriginator mesh__D008504 EC
% 208.36/208.54 |- skos__hiddenLabel mesh__D008504 Staff Privilege, Medical
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D008504
% 208.36/208.54 91; was see under MEDICAL STAFF, HOSPITAL Aug 1977-90
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 2000
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D008504 PLS
% 208.36/208.54 |- rdf__type mesh__D008504sskos__Concept
% 208.36/208.54 |- skos__scopeNote mesh__D008504
% 208.36/208.54 Those rights or activities which are specific to members of the institution%27%s medical staff, including the right to admit private patients.%A%
% 208.36/208.54 |- skos__hiddenLabel mesh__D008504 Medical Staff Privilege
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D008504 2001
% 208.36/208.54 |- skos__broader mesh__D008504smesh__D018578
% 208.36/208.54 |- mesh__dateEstablished mesh__D000521 1988-01-01
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D000521 2006
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D000521 1988
% 208.36/208.54 |- skos__prefLabel mesh__D000521 alpha-MSH
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D000521 sjn
% 208.36/208.54 |- skos__historyNote mesh__D000521 MSH %28%1966-1987%29%
% 208.36/208.54 |- mesh__recordMaintainer mesh__D000521 ssb
% 208.36/208.54 |- mesh__dateRevised mesh__D000521 2005-06-30
% 208.36/208.54 |- skos__scopeNote mesh__D000521
% 208.36/208.54 A 13-amino acid peptide derived from the ANTERIOR PITUITARY GLAND in man and from the pars intermedia in lower vertebrates. Its amino acid sequence is identical to the first 13 amino acids of ACTH. It influences the formation of deposition of MELANIN in the body.%A%
% 208.36/208.54 |- skos__hiddenLabel mesh__D000521 alpha MSH
% 208.36/208.54 |- mesh__recordOriginator mesh__D000521 RLS
% 208.36/208.54 |- skos__altLabel mesh__D000521 MSH, alpha
% 208.36/208.54 |- mesh__historyNote mesh__D000521 1988
% 208.36/208.54 |- skos__altLabel mesh__D000521 alpha-Melanocyte-Stimulating Hormone
% 208.36/208.54 |- skos__hiddenLabel mesh__D000521 alpha Melanotropin
% 208.36/208.54 |- rdf__type mesh__D000521sskos__Concept
% 208.36/208.54 |- skos__hiddenLabel mesh__D000521 alpha Melanocyte Stimulating Hormone
% 208.36/208.54 |- skos__hiddenLabel mesh__D000521 Melanocortin 1
% 208.36/208.54 |- skos__broader mesh__D000521smesh__D009074
% 208.36/208.54 |- skos__altLabel mesh__D000521 alpha-Melanotropin
% 208.36/208.54 |- mesh__dateCreated mesh__D000521 1987-05-05
% 208.36/208.54 |- skos__broader mesh__D000521smesh__D000324
% 208.36/208.54 |- skos__altLabel mesh__D000521 Melanocortin-1
% 208.36/208.54 |- mesh__onlineNote mesh__D013449
% 208.36/208.54 use SULFONAMIDES to search SULFONAMIDE MIXTURES 1966-79
% 208.36/208.54 |- skos__broader mesh__D013449smesh__D013450
% 208.36/208.54 |- mesh__recordMaintainer mesh__D013449 ssb
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D013449 sjn
% 208.36/208.54 |- mesh__recordOriginator mesh__D013449 NLM
% 208.36/208.54 |- mesh__dateRevised mesh__D013449 2005-06-30
% 208.36/208.54 |- mesh__historyNote mesh__D013449
% 208.36/208.54 SULFONAMIDE MIXTURES was heading 1963-79
% 208.36/208.54 |- rdf__type mesh__D013449sskos__Concept
% 208.36/208.54 |- skos__prefLabel mesh__D013449 Sulfonamides
% 208.36/208.54 |- skos__scopeNote mesh__D013449
% 208.36/208.54 A group of compounds that contain the structure SO2NH2. Members of this group, also known as sulfa drugs, are derivatives of sulfanilamide, which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. They have been largely supplanted by more effective and less toxic antibiotics. %28%From Dorland, 28th ed%29%%A%
% 208.36/208.54 |- skos__broader mesh__D013449smesh__D000577
% 208.36/208.54 |- skos__hiddenLabel mesh__D013449 Mixtures, Sulfonamide
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D013449
% 208.36/208.54 SULFONAMIDE MIXTURES was heading 1963-79
% 208.36/208.54 |- mesh__dateCreated mesh__D013449 1999-01-01
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D013449 2006
% 208.36/208.54 |- skos__hiddenLabel mesh__D018932 Chemoattractant Protein-1, Monocyte
% 208.36/208.54 |- skos__scopeNote mesh__D018932
% 208.36/208.54 A chemokine that is a chemoattractant for human MONOCYTES and may also cause cellular activation of specific functions related to host defense. It is produced by LEUKOCYTES of both monocyte and lymphocyte lineage and by FIBROBLASTS during tissue injury.%A%
% 208.36/208.54 |- mesh__dateCreated mesh__D018932 1995-02-21
% 208.36/208.54 |- mesh__dateRevised mesh__D018932 2005-06-30
% 208.36/208.54 |- skos__altLabel mesh__D018932 CCL2
% 208.36/208.54 |- rdf__type mesh__D018932sskos__Concept
% 208.36/208.54 |- skos__hiddenLabel mesh__D018932 Chemotactic Protein-1, Monocyte
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D018932 2006
% 208.36/208.54 |- mesh__recordMaintainer mesh__D018932 ssb
% 208.36/208.54 |- skos__prefLabel mesh__D018932 Monocyte Chemoattractant Protein-1
% 208.36/208.54 |- mesh__dateEstablished mesh__D018932 1996-01-01
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D018932 sjn
% 208.36/208.54 |- mesh__historyNote mesh__D018932
% 208.36/208.54 96; was MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR %28%NM%29% 1989-95%A%
% 208.36/208.54 |- mesh__recordOriginator mesh__D018932 AGS
% 208.36/208.54 |- skos__hiddenLabel mesh__D018932 Monocyte Chemoattractant Protein 1
% 208.36/208.54 |- skos__altLabel mesh__D018932 Monocyte Chemotactic and Activating Factor
% 208.36/208.54 |- skos__broader mesh__D018932smesh__D018945
% 208.36/208.54 |- skos__hiddenLabel mesh__D018932 Monocyte Chemotactic Protein 1
% 208.36/208.54 |- skos__historyNote mesh__D018932 Chemotactic Factors %28%1989-1995%29%
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D018932
% 208.36/208.54 96; MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR was indexed under CHEMOTACTIC FACTORS 1991-95 %26% GLYCOPROTEINS 1988-90%A%
% 208.36/208.54 |- skos__historyNote mesh__D018932 Glycoproteins %28%1988-1990%29%
% 208.36/208.54 |- skos__altLabel mesh__D018932 Monocyte Chemotactic Protein-1
% 208.36/208.54 |- mesh__dateCreated mesh__D032603 2002-07-03
% 208.36/208.54 |- rdf__type mesh__D032603sskos__Concept
% 208.36/208.54 |- mesh__dateEstablished mesh__D032603 2003-01-01
% 208.36/208.54 |- skos__prefLabel mesh__D032603 Scopolia
% 208.36/208.54 |- mesh__historyNote mesh__D032603 2003
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D032603 2003
% 208.36/208.54 |- skos__annotation mesh__D032603
% 208.36/208.54 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.54 |- skos__broader mesh__D032603smesh__D019657
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D032603 2003
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D032603 2004
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D032603 2005
% 208.36/208.54 |- skos__scopeNote mesh__D032603
% 208.36/208.54 A plant genus of the family SOLANACEAE after which the compound SCOPOLAMINE got its name.%A%
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D032603 2006
% 208.36/208.54 |- mesh__recordMaintainer mesh__D010151 TAP
% 208.36/208.54 |- mesh__recordOriginator mesh__D010151 NLM
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 2004
% 208.36/208.54 |- mesh__historyNote mesh__D010151
% 208.36/208.54 91%28%75%29%; was see under ART 1975-90
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 2003
% 208.36/208.54 |- mesh__dateEstablished mesh__D010151 1991-01-01
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 1997
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 2001
% 208.36/208.54 |- skos__hiddenLabel mesh__D010151 Painting
% 208.36/208.54 |- mesh__dateCreated mesh__D010151 1999-01-01
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 2006
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D010151 91; was see under ART 1975-90
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 1996
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 1993
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 2005
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 2000
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 1999
% 208.36/208.54 |- skos__prefLabel mesh__D010151 Paintings
% 208.36/208.54 |- mesh__onlineNote mesh__D010151 search ART 1966-74
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 1995
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 1998
% 208.36/208.54 |- skos__broader mesh__D010151smesh__D001154
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 2002
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D010151 1994
% 208.36/208.54 |- mesh__dateRevised mesh__D010151 1992-05-15
% 208.36/208.54 |- rdf__type mesh__D010151sskos__Concept
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D010151 PLS
% 208.36/208.54 |- rdf__type mesh__D004912sskos__Concept
% 208.36/208.54 |- skos__altLabel mesh__D004912 Red Blood Cells
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D004912 2004
% 208.36/208.54 |- skos__altLabel mesh__D004912 Blood Cells, Red
% 208.36/208.54 |- skos__hiddenLabel mesh__D004912 Erythrocyte
% 208.36/208.54 |- skos__hiddenLabel mesh__D004912 Red Blood Cell
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D004912 2005
% 208.36/208.54 |- mesh__dateRevised mesh__D004912 2003-07-25
% 208.36/208.54 |- skos__prefLabel mesh__D004912 Erythrocytes
% 208.36/208.54 |- mesh__recordOriginator mesh__D004912 NLM
% 208.36/208.54 |- skos__broader mesh__D004912smesh__D001773
% 208.36/208.54 |- skos__scopeNote mesh__D004912
% 208.36/208.54 Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.%A%
% 208.36/208.54 |- skos__hiddenLabel mesh__D004912 Blood Cell, Red
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D004912 2006
% 208.36/208.54 |- mesh__dateCreated mesh__D004912 1999-01-01
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D004912 sjn
% 208.36/208.54 |- skos__broader mesh__D004912smesh__D041905
% 208.36/208.54 |- mesh__recordMaintainer mesh__D004912 sjn
% 208.36/208.54 |- skos__annotation mesh__D004912
% 208.36/208.54 vertebrates only; for invertebrates index under HEMOCYTES; /cytol: consider also ERYTHROCYTE INDICES; do not equate /pathol with ERYTHROCYTES, ABNORMAL; nucleated erythrocytes in circulating blood = ERYTHROCYTES /pathol; ERYTHROCYTE DEFORMABILITY is available; erythrocyte antibodies: index BLOOD GROUP ANTIGENS /immunol + ISOANTIBODIES %26% do not index under ERYTHROCYTES%A%
% 208.36/208.54 |- mesh__dateCreated mesh__D004114 1974-11-19
% 208.36/208.54 |- skos__broader mesh__D004114smesh__D010080
% 208.36/208.54 |- skos__altLabel mesh__D004114 5,5-Dimethyl-2,4-oxazolidinedione
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D004114 sjn
% 208.36/208.54 |- skos__altLabel mesh__D004114 Dimethyloxazolidinedione
% 208.36/208.54 |- rdf__type mesh__D004114sskos__Concept
% 208.36/208.54 |- mesh__recordOriginator mesh__D004114 SH
% 208.36/208.54 |- skos__prefLabel mesh__D004114 Dimethadione
% 208.36/208.54 |- mesh__dateRevised mesh__D004114 2005-06-30
% 208.36/208.54 |- skos__historyNote mesh__D004114 Oxazoles %28%1970-1974%29%
% 208.36/208.54 |- skos__altLabel mesh__D004114 5,5-Dimethyloxazolidine-2,4-dione
% 208.36/208.54 |- mesh__dateEstablished mesh__D004114 1991-01-01
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D004114 91; was see under OXAZOLES 1975-90
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D004114 2006
% 208.36/208.54 |- skos__scopeNote mesh__D004114
% 208.36/208.54 An anticonvulsant that is the active metabolite of TRIMETHADIONE.%A%
% 208.36/208.54 |- mesh__historyNote mesh__D004114
% 208.36/208.54 91%28%75%29%; was see under OXAZOLES 1975-90
% 208.36/208.54 |- mesh__recordMaintainer mesh__D004114 ssb
% 208.36/208.54 |- skos__broader mesh__D008511Q000191smesh__D008511
% 208.36/208.54 |- mesh__preferredCombination mesh__D008511Q000191smesh__D004470
% 208.36/208.54 |- rdf__type mesh__D008511Q000191smesh__CompoundConcept
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014542 2003
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014542 1997
% 208.36/208.54 |- skos__altLabel mesh__D014542 Uridine 5%27%-Monophosphate
% 208.36/208.54 |- skos__altLabel mesh__D014542 Uridylic Acids
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014542 2006
% 208.36/208.54 |- skos__historyNote mesh__D014542 Uracil Nucleotides %28%1966-1974%29%
% 208.36/208.54 |- skos__prefLabel mesh__D014542 Uridine Monophosphate
% 208.36/208.54 |- mesh__recordMaintainer mesh__D014542 TAP
% 208.36/208.54 |- mesh__publicMeSHNote mesh__D014542
% 208.36/208.54 91; was see under URACIL NUCLEOTIDES 1978-90; was URIDYLIC ACIDS see under URACIL NUCLEOTIDES 1963-77%A%
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014542 2002
% 208.36/208.54 |- mesh__recordAuthorizer mesh__D014542 PLS
% 208.36/208.54 |- mesh__dateRevised mesh__D014542 1995-05-18
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014542 1996
% 208.36/208.54 |- skos__altLabel mesh__D014542 UMP
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014542 2005
% 208.36/208.54 |- skos__scopeNote mesh__D014542
% 208.36/208.54 5%27%-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2%27%, 3%27% or 5%27% position.%A%
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014542 1999
% 208.36/208.54 |- skos__hiddenLabel mesh__D014542 Monophosphate, Uridine
% 208.36/208.54 |- mesh__recordOriginator mesh__D014542 NLM
% 208.36/208.54 |- mesh__dateCreated mesh__D014542 1999-01-01
% 208.36/208.54 |- skos__altLabel mesh__D014542 Uridylic Acid
% 208.36/208.54 |- mesh__activeMeSHYear mesh__D014542 1998
% 208.36/208.54 |- skos__hiddenLabel mesh__D014542 Uridine 5%27% Monophosphate
% 208.36/208.54 |- skos__hiddenLabel mesh__D014542 Acids, Uridylic
% 208.36/208.54 |- mesh__dateEstablished mesh__D014542 1991-01-01
% 208.36/208.55 |- skos__broader mesh__D014542smesh__D014500
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D014542 2001
% 208.36/208.55 |- mesh__historyNote mesh__D014542
% 208.36/208.55 91%28%78%29%; was see under URACIL NUCLEOTIDES 1978-90; was URIDYLIC ACIDS see under URACIL NUCLEOTIDES 1963-77%A%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D014542 2004
% 208.36/208.55 |- mesh__onlineNote mesh__D014542
% 208.36/208.55 to search URIDYLIC ACIDS use URIDINE MONOPHOSPHATE 1975-77 %26% URACIL NUCLEOTIDES 1966-74%A%
% 208.36/208.55 |- skos__hiddenLabel mesh__D014542 5%27%-Monophosphate, Uridine
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D014542 2000
% 208.36/208.55 |- skos__hiddenLabel mesh__D014542 Acid, Uridylic
% 208.36/208.55 |- rdf__type mesh__D014542sskos__Concept
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008505 2006
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008505 2003
% 208.36/208.55 |- skos__hiddenLabel mesh__D008505 Staff, Hospital Medical
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008505 2000
% 208.36/208.55 |- mesh__dateRevised mesh__D008505 1997-06-20
% 208.36/208.55 |- skos__altLabel mesh__D008505 Hospital Medical Staff
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008505 2004
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008505 2001
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D008505 SJN
% 208.36/208.55 |- skos__altLabel mesh__D008505 Hospital Attending Physician
% 208.36/208.55 |- skos__hiddenLabel mesh__D008505 Registrar, Hospital
% 208.36/208.55 |- skos__broader mesh__D008505smesh__D008503
% 208.36/208.55 |- skos__altLabel mesh__D008505 Attending Physician, Hospital
% 208.36/208.55 |- skos__hiddenLabel mesh__D008505 Hospital Registrars
% 208.36/208.55 |- skos__hiddenLabel mesh__D008505 Staffs, Hospital Medical
% 208.36/208.55 |- skos__altLabel mesh__D008505 Hospital Attending Physicians
% 208.36/208.55 |- rdf__type mesh__D008505sskos__Concept
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008505 2002
% 208.36/208.55 |- skos__annotation mesh__D008505
% 208.36/208.55 hosp only: non-hosp med staff = MEDICAL STAFF; X ref REGISTRARS, HOSPITAL refers to British hosp; DF: MED STAFF HOSP%A%
% 208.36/208.55 |- mesh__dateCreated mesh__D008505 1999-01-01
% 208.36/208.55 |- skos__hiddenLabel mesh__D008505 Junior Physician
% 208.36/208.55 |- skos__hiddenLabel mesh__D008505 Junior Physicians
% 208.36/208.55 |- mesh__historyNote mesh__D008505
% 208.36/208.55 78; was HOSPITAL MEDICAL STAFF 1963-77
% 208.36/208.55 |- skos__scopeNote mesh__D008505
% 208.36/208.55 Professional medical personnel approved to provide care to patients in a hospital.%A%
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D008505
% 208.36/208.55 78; was HOSPITAL MEDICAL STAFF 1963-77
% 208.36/208.55 |- skos__altLabel mesh__D008505 Hospital Medical Staffs
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008505 2005
% 208.36/208.55 |- mesh__recordMaintainer mesh__D008505 TGC
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008505 1998
% 208.36/208.55 |- skos__prefLabel mesh__D008505 Medical Staff, Hospital
% 208.36/208.55 |- skos__broader mesh__D008505smesh__D010564
% 208.36/208.55 |- skos__hiddenLabel mesh__D008505 Physician, Junior
% 208.36/208.55 |- mesh__onlineNote mesh__D008505
% 208.36/208.55 use MEDICAL STAFF, HOSPITAL to search HOSPITAL MEDICAL STAFF 1966-77%A%
% 208.36/208.55 |- mesh__recordOriginator mesh__D008505 NLM
% 208.36/208.55 |- skos__altLabel mesh__D008505 Medical Staffs, Hospital
% 208.36/208.55 |- skos__hiddenLabel mesh__D008505 Hospital Registrar
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008505 1999
% 208.36/208.55 |- skos__prefLabel mesh__D000522 Alphaprodine
% 208.36/208.55 |- mesh__dateCreated mesh__D000522 1999-01-01
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D000522 2002
% 208.36/208.55 |- mesh__recordOriginator mesh__D000522 NLM
% 208.36/208.55 |- skos__hiddenLabel mesh__D000522 Hydrochloride, Alphaprodine
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D000522 65
% 208.36/208.55 |- mesh__dateEstablished mesh__D000522 1965-01-01
% 208.36/208.55 |- mesh__recordMaintainer mesh__D000522 TWD
% 208.36/208.55 |- mesh__historyNote mesh__D000522 65%28%64%29%
% 208.36/208.55 |- rdf__type mesh__D000522sskos__Concept
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D000522 2005
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D000522 sjn
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D000522 2006
% 208.36/208.55 |- mesh__dateRevised mesh__D000522 2000-06-21
% 208.36/208.55 |- skos__scopeNote mesh__D000522
% 208.36/208.55 An opioid analgesic chemically related to and with an action resembling that of MEPERIDINE, but more rapid in onset and of shorter duration. It has been used in obstetrics, as pre-operative medication, for minor surgical procedures, and for dental procedures. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1067%29%%A%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D000522 2001
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D000522 2003
% 208.36/208.55 |- skos__broader mesh__D000522smesh__D010880
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D000522 2004
% 208.36/208.55 |- rdf__type mesh__D018933sskos__Concept
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018933 2006
% 208.36/208.55 |- skos__historyNote mesh__D018933 Fimbriae, Bacterial %28%1980-1994%29%
% 208.36/208.55 |- mesh__historyNote mesh__D018933 95
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D018933 95
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018933 2001
% 208.36/208.55 |- mesh__recordMaintainer mesh__D018933 PLS
% 208.36/208.55 |- mesh__dateEstablished mesh__D018933 1995-01-01
% 208.36/208.55 |- skos__related mesh__D018933smesh__D003227
% 208.36/208.55 |- mesh__dateCreated mesh__D018933 1994-10-25
% 208.36/208.55 |- skos__broader mesh__D018933smesh__D022081
% 208.36/208.55 |- skos__hiddenLabel mesh__D018933 Pilus, Conjugative
% 208.36/208.55 |- skos__altLabel mesh__D018933 Pili, Conjugative
% 208.36/208.55 |- skos__altLabel mesh__D018933 Sex Pili
% 208.36/208.55 |- skos__altLabel mesh__D018933 Conjugative Pili
% 208.36/208.55 |- mesh__dateRevised mesh__D018933 2000-06-22
% 208.36/208.55 |- skos__scopeNote mesh__D018933
% 208.36/208.55 Filamentous or elongated proteinaceous structures which extend from the cell surface in gram-negative bacteria that contain certain types of conjugative plasmid. These pili are the organs associated with genetic transfer and have essential roles in conjugation. Normally, only one or a few pili occur on a given donor cell. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p675%29% This preferred use of %22%pili%22% refers to the sexual appendage, to be distinguished from bacterial fimbriae %28%FIMBRIAE, BACTERIAL%29%, also known as common pili, which are usually concerned with adhesion.%A%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018933 2002
% 208.36/208.55 |- skos__prefLabel mesh__D018933 Pili, Sex
% 208.36/208.55 |- skos__hiddenLabel mesh__D018933 Pilus, Sex
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D018933 sjn
% 208.36/208.55 |- mesh__recordOriginator mesh__D018933 PLS
% 208.36/208.55 |- skos__hiddenLabel mesh__D018933 Conjugative Pilus
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018933 2003
% 208.36/208.55 |- skos__historyNote mesh__D018933
% 208.36/208.55 specific bacteria/ultrastructure %28%1975-1979%29%
% 208.36/208.55 |- skos__annotation mesh__D018933
% 208.36/208.55 note X refs: do not confuse with COMMON PILI see FIMBRIAE, BACTERIAL; coord IM with specific bacterium %28%IM%29%; A 11 qualif except /cytol; /genet permitted%A%
% 208.36/208.55 |- skos__historyNote mesh__D018933
% 208.36/208.55 specific bacteria/cytology %28%1969-1974%29%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018933 2005
% 208.36/208.55 |- skos__altLabel mesh__D018933 Sex Pilus
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018933 2004
% 208.36/208.55 |- rdf__type mesh__D010950sskos__Concept
% 208.36/208.55 |- skos__hiddenLabel mesh__D010950 Cell, Plasma
% 208.36/208.55 |- skos__broader mesh__D010950smesh__D001402
% 208.36/208.55 |- mesh__recordMaintainer mesh__D010950 jmp
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010950 2005
% 208.36/208.55 |- mesh__dateCreated mesh__D010950 1999-01-01
% 208.36/208.55 |- skos__hiddenLabel mesh__D010950 Plasma Cell
% 208.36/208.55 |- skos__altLabel mesh__D010950 Plasmacytes
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010950 2006
% 208.36/208.55 |- mesh__dateRevised mesh__D010950 2003-07-09
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010950 2004
% 208.36/208.55 |- skos__hiddenLabel mesh__D010950 Plasmacyte
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D010950 sjn
% 208.36/208.55 |- mesh__recordOriginator mesh__D010950 NLM
% 208.36/208.55 |- skos__hiddenLabel mesh__D010950 Cells, Plasma
% 208.36/208.55 |- skos__prefLabel mesh__D010950 Plasma Cells
% 208.36/208.55 |- skos__scopeNote mesh__D010950
% 208.36/208.55 Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. %28%Rosen et al., Dictionary of Immunology, 1989, p169 %26% Abbas et al., Cellular and Molecular Immunology, 2d ed, p20%29%%A%
% 208.36/208.55 |- skos__annotation mesh__D010950
% 208.36/208.55 not for BLOOD CELLS: they are antibody-producing cells; A 11 qualif%A%
% 208.36/208.55 |- skos__annotation mesh__D032604
% 208.36/208.55 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D032604 2003
% 208.36/208.55 |- mesh__dateEstablished mesh__D032604 2003-01-01
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D032604 2004
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D032604 2005
% 208.36/208.55 |- skos__prefLabel mesh__D032604 Alangiaceae
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D032604 2006
% 208.36/208.55 |- mesh__historyNote mesh__D032604 2003
% 208.36/208.55 |- mesh__dateCreated mesh__D032604 2002-07-02
% 208.36/208.55 |- rdf__type mesh__D032604sskos__Concept
% 208.36/208.55 |- skos__scopeNote mesh__D032604
% 208.36/208.55 A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida, consisting of slow-growing evergreen trees common in tropical forests of south India and Burma. Members contain tetrahydroisoquinoline-monoterpene and iridoid glycosides.%A%
% 208.36/208.55 |- skos__broader mesh__D032604smesh__D019684
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D032604 2003
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010152 2006
% 208.36/208.55 |- mesh__dateEstablished mesh__D010152 1991-01-01
% 208.36/208.55 |- skos__scopeNote mesh__D010152
% 208.36/208.55 In animals, the social relationship established between a male and female for reproduction. It may include raising of young.%A%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010152 2005
% 208.36/208.55 |- skos__altLabel mesh__D010152 Bond, Pair
% 208.36/208.55 |- mesh__dateCreated mesh__D010152 1974-11-11
% 208.36/208.55 |- skos__hiddenLabel mesh__D010152 Pair Bonds
% 208.36/208.55 |- mesh__recordMaintainer mesh__D010152 PLS
% 208.36/208.55 |- skos__hiddenLabel mesh__D010152 Bonds, Pair
% 208.36/208.55 |- mesh__historyNote mesh__D010152
% 208.36/208.55 91%28%75%29%; was see under SEX BEHAVIOR, ANIMAL 1975-90
% 208.36/208.55 |- skos__prefLabel mesh__D010152 Pair Bond
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D010152 sjn
% 208.36/208.55 |- mesh__recordOriginator mesh__D010152 NLM
% 208.36/208.55 |- rdf__type mesh__D010152sskos__Concept
% 208.36/208.55 |- mesh__dateRevised mesh__D010152 2002-07-02
% 208.36/208.55 |- skos__annotation mesh__D010152 animal only; no qualif
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010152 2004
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D010152
% 208.36/208.55 91; was see under SEX BEHAVIOR, ANIMAL 1975-90
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010152 2003
% 208.36/208.55 |- skos__broader mesh__D010152smesh__D012726
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D004913 sjn
% 208.36/208.55 |- mesh__historyNote mesh__D004913 68
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D004913 68
% 208.36/208.55 |- skos__broader mesh__D004913smesh__D004912
% 208.36/208.55 |- skos__hiddenLabel mesh__D004913 Erythrocyte, Abnormal
% 208.36/208.55 |- mesh__dateRevised mesh__D004913 2003-07-09
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D004913 2005
% 208.36/208.55 |- skos__altLabel mesh__D004913 Abnormal Erythrocytes
% 208.36/208.55 |- skos__hiddenLabel mesh__D004913 Abnormal Erythrocyte
% 208.36/208.55 |- skos__prefLabel mesh__D004913 Erythrocytes, Abnormal
% 208.36/208.55 |- skos__historyNote mesh__D004913 Erythrocytes %28%1966-1967%29%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D004913 2006
% 208.36/208.55 |- mesh__dateCreated mesh__D004913 1999-01-01
% 208.36/208.55 |- skos__annotation mesh__D004913
% 208.36/208.55 = abnorm of size %26% shape; do not equate with ERYTHROCYTES /pathol; do not confuse with ERYTHROCYTE DEFORMABILITY which is the %22%ability of erythrocytes to change shape as they pass through narrow spaces, such as the microvasculature%22%; A 11 qualif; coord with disease /blood, not /compl%A%
% 208.36/208.55 |- mesh__recordMaintainer mesh__D004913 nns
% 208.36/208.55 |- mesh__dateEstablished mesh__D004913 1968-01-01
% 208.36/208.55 |- rdf__type mesh__D004913sskos__Concept
% 208.36/208.55 |- mesh__recordOriginator mesh__D004913 NLM
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D004913 2004
% 208.36/208.55 |- skos__broader mesh__D004115smesh__D011725
% 208.36/208.55 |- skos__altLabel mesh__D004115 Dimethpyrindene
% 208.36/208.55 |- mesh__recordOriginator mesh__D004115 NLM
% 208.36/208.55 |- skos__hiddenLabel mesh__D004115 Maleate, Dimethindene
% 208.36/208.55 |- skos__prefLabel mesh__D004115 Dimethindene
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D004115 sjn
% 208.36/208.55 |- skos__scopeNote mesh__D004115
% 208.36/208.55 A histamine H1 antagonist. It is used in hypersensitivity reactions, in rhinitis, for pruritus, and in some common cold remedies.%A%
% 208.36/208.55 |- mesh__dateCreated mesh__D004115 1999-01-01
% 208.36/208.55 |- rdf__type mesh__D004115sskos__Concept
% 208.36/208.55 |- skos__altLabel mesh__D004115 Forhistal
% 208.36/208.55 |- mesh__dateRevised mesh__D004115 2005-06-30
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D004115 2006
% 208.36/208.55 |- skos__altLabel mesh__D004115 Novartis Brand of Dimethindene Maleate
% 208.36/208.55 |- skos__altLabel mesh__D004115 Dimetindene
% 208.36/208.55 |- mesh__recordMaintainer mesh__D004115 exl
% 208.36/208.55 |- skos__broader mesh__D004115smesh__D007192
% 208.36/208.55 |- rdf__type mesh__D020580sskos__Concept
% 208.36/208.55 |- skos__historyNote mesh__D020580 Methylococcaceae %28%1977-1991%29%
% 208.36/208.55 |- mesh__recordOriginator mesh__D020580 ndw
% 208.36/208.55 |- skos__annotation mesh__D020580
% 208.36/208.55 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: METHYLOBACT%A%
% 208.36/208.55 |- skos__historyNote mesh__D020580 Methylococcaceae %28%1998-1999%29%
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D020580 2000
% 208.36/208.55 |- mesh__historyNote mesh__D020580 2000
% 208.36/208.55 |- mesh__dateRevised mesh__D020580 2005-06-30
% 208.36/208.55 |- skos__historyNote mesh__D020580
% 208.36/208.55 Gram-Negative Aerobic Bacteria %28%1992-1997%29%
% 208.36/208.55 |- skos__prefLabel mesh__D020580 Methylobacterium
% 208.36/208.55 |- mesh__recordMaintainer mesh__D020580 DRC
% 208.36/208.55 |- mesh__dateCreated mesh__D020580 1999-11-03
% 208.36/208.55 |- skos__broader mesh__D020580smesh__D042082
% 208.36/208.55 |- skos__scopeNote mesh__D020580
% 208.36/208.55 A genus of gram-negative, aerobic, facultatively methylotrophic rods occurring singly or occasionally in rosettes. Members of this genus are usually motile and are isolated from soil, dust, fresh water, lake sediments, leaf surfaces, rice, air, and hospital environments. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D020580 sjn
% 208.36/208.55 |- mesh__dateEstablished mesh__D020580 2000-01-01
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D020580 2006
% 208.36/208.55 |- mesh__dateCreated mesh__D014543 1974-11-19
% 208.36/208.55 |- skos__historyNote mesh__D014543 Phosphates %28%1973-1974%29%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D014543 2005
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D014543 sjn
% 208.36/208.55 |- mesh__dateRevised mesh__D014543 2003-07-09
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D014543
% 208.36/208.55 91; was see under PENTOSYLTRANSFERASES 1975-90
% 208.36/208.55 |- skos__scopeNote mesh__D014543
% 208.36/208.55 An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate. EC 2.4.2.3.%A%
% 208.36/208.55 |- skos__broader mesh__D014543smesh__D010430
% 208.36/208.55 |- mesh__historyNote mesh__D014543
% 208.36/208.55 91%28%75%29%; was see under PENTOSYLTRANSFERASES 1975-90
% 208.36/208.55 |- mesh__dateEstablished mesh__D014543 1991-01-01
% 208.36/208.55 |- skos__historyNote mesh__D014543 Uridine %28%1973-1974%29%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D014543 2004
% 208.36/208.55 |- mesh__recordOriginator mesh__D014543 NLM
% 208.36/208.55 |- mesh__recordMaintainer mesh__D014543 ssb
% 208.36/208.55 |- skos__hiddenLabel mesh__D014543
% 208.36/208.55 5 Fluoro 2%27% deoxyuridine Phosphorylase
% 208.36/208.55 |- rdf__type mesh__D014543sskos__Concept
% 208.36/208.55 |- skos__prefLabel mesh__D014543 Uridine Phosphorylase
% 208.36/208.55 |- skos__hiddenLabel mesh__D014543
% 208.36/208.55 Phosphorylase, 5-Fluoro-2%27%-deoxyuridine
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D014543 2006
% 208.36/208.55 |- skos__historyNote mesh__D014543 Pentosyltransferases %28%1973-1974%29%
% 208.36/208.55 |- skos__hiddenLabel mesh__D014543 Phosphorylase, Uridine
% 208.36/208.55 |- mesh__recordOriginator mesh__D008506 EC
% 208.36/208.55 |- skos__altLabel mesh__D008506 Waste, Medical
% 208.36/208.55 |- skos__broader mesh__D008506smesh__D014866
% 208.36/208.55 |- mesh__historyNote mesh__D008506
% 208.36/208.55 91%28%78%29%; was see under WASTE PRODUCTS 1978-90
% 208.36/208.55 |- rdf__type mesh__D008506sskos__Concept
% 208.36/208.55 |- mesh__dateCreated mesh__D008506 1977-05-13
% 208.36/208.55 |- skos__historyNote mesh__D008506 Refuse Disposal %28%1966-1977%29%
% 208.36/208.55 |- skos__hiddenLabel mesh__D008506 Medical Wastes
% 208.36/208.55 |- skos__hiddenLabel mesh__D008506 Wastes, Pathological
% 208.36/208.55 |- skos__prefLabel mesh__D008506 Medical Waste
% 208.36/208.55 |- mesh__dateRevised mesh__D008506 2005-06-30
% 208.36/208.55 |- skos__hiddenLabel mesh__D008506 Wastes, Medical
% 208.36/208.55 |- skos__hiddenLabel mesh__D008506 Pathological Wastes
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D008506 sjn
% 208.36/208.55 |- skos__altLabel mesh__D008506 Pathological Waste
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D008506
% 208.36/208.55 91; was see under WASTE PRODUCTS 1978-90
% 208.36/208.55 |- mesh__dateEstablished mesh__D008506 1991-01-01
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D008506 2006
% 208.36/208.55 |- skos__related mesh__D008506smesh__D017848
% 208.36/208.55 |- skos__scopeNote mesh__D008506
% 208.36/208.55 Blood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special disposal procedures.%A%
% 208.36/208.55 |- skos__annotation mesh__D008506
% 208.36/208.55 note next heading; DENTAL WASTE is also available; DF: MED WASTE%A%
% 208.36/208.55 |- mesh__recordMaintainer mesh__D008506 ssb
% 208.36/208.55 |- rdf__type mesh__D000523sskos__Concept
% 208.36/208.55 |- skos__annotation mesh__D000523 a synthetic progestational hormone
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D000523 2005
% 208.36/208.55 |- mesh__dateRevised mesh__D000523 2003-07-09
% 208.36/208.55 |- mesh__historyNote mesh__D000523
% 208.36/208.55 91%28%75%29%; was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs %26% derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974, was heading 1964-73 %28%Prov%29%%A%
% 208.36/208.55 |- mesh__recordOriginator mesh__D000523 NLM
% 208.36/208.55 |- skos__prefLabel mesh__D000523 Algestone
% 208.36/208.55 |- skos__altLabel mesh__D000523 Alphasone
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D000523 2006
% 208.36/208.55 |- mesh__dateEstablished mesh__D000523 1991-01-01
% 208.36/208.55 |- mesh__onlineNote mesh__D000523
% 208.36/208.55 use ALGESTONE to search ALPHASONE 1974-90; use ALGESTONE to search DIHYDROXYPROGESTERONE 1977-present %26% use ALGESTONE ACETOPHENIDE 1966-76 %28%as Prov 1966-73%29%%A%
% 208.36/208.55 |- skos__scopeNote mesh__D000523
% 208.36/208.55 16 alpha,17-Dihydroxypregn-4-ene-3,20-dione. Progestational dihydroxy derivative of PROGESTERONE. Its acetonide possesses anti-inflammatory properties.%A%
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D000523
% 208.36/208.55 91; was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs %26% derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974%A%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D000523 2004
% 208.36/208.55 |- skos__altLabel mesh__D000523 Dihydroxyprogesterone
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D000523 sjn
% 208.36/208.55 |- skos__broader mesh__D000523smesh__D011374
% 208.36/208.55 |- mesh__recordMaintainer mesh__D000523 lkt
% 208.36/208.55 |- mesh__dateCreated mesh__D000523 1999-01-01
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D018934 ags
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D018934
% 208.36/208.55 2000; see FOURNIER%27%S GANGRENE 1996-1999
% 208.36/208.55 |- skos__broader mesh__D018934smesh__D014569
% 208.36/208.55 |- mesh__recordMaintainer mesh__D018934 ags
% 208.36/208.55 |- mesh__dateCreated mesh__D018934 1995-02-17
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018934 2000
% 208.36/208.55 |- skos__broader mesh__D018934smesh__D001424
% 208.36/208.55 |- skos__altLabel mesh__D018934 Fournier%27%s Gangrene
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018934 2003
% 208.36/208.55 |- mesh__recordOriginator mesh__D018934 TGC
% 208.36/208.55 |- skos__altLabel mesh__D018934 Fournier%27%s Disease
% 208.36/208.55 |- rdf__type mesh__D018934sskos__Concept
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018934 2006
% 208.36/208.55 |- skos__hiddenLabel mesh__D018934 Fourniers Disease
% 208.36/208.55 |- skos__scopeNote mesh__D018934
% 208.36/208.55 An acute infective gangrene involving the scrotum, penis, or perineum caused by gram-positive organisms, enteric bacilli, and anaerobes, usually resulting from local trauma, operative procedures, or urinary tract disease.%A%
% 208.36/208.55 |- skos__hiddenLabel mesh__D018934 Fournier Gangrenes
% 208.36/208.55 |- skos__historyNote mesh__D018934 Gangrene %28%1966-1995%29%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018934 2002
% 208.36/208.55 |- skos__altLabel mesh__D018934 Fournier Disease
% 208.36/208.55 |- skos__hiddenLabel mesh__D018934 Gangrene, Fournier%27%s
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018934 2005
% 208.36/208.55 |- mesh__historyNote mesh__D018934 2000%28%1996%29%
% 208.36/208.55 |- skos__hiddenLabel mesh__D018934 Gangrene, Fournier
% 208.36/208.55 |- skos__prefLabel mesh__D018934 Fournier Gangrene
% 208.36/208.55 |- mesh__dateRevised mesh__D018934 2000-01-21
% 208.36/208.55 |- mesh__dateEstablished mesh__D018934 1996-01-01
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018934 2000A
% 208.36/208.55 |- skos__hiddenLabel mesh__D018934 Fourniers Gangrene
% 208.36/208.55 |- skos__annotation mesh__D018934
% 208.36/208.55 coord IM with specific site or organ/diseases term %28%NIM%29% or with specific bact infect %28%NIM%29% only if particularly discussed; usually in male%A%
% 208.36/208.55 |- skos__hiddenLabel mesh__D018934 Gangrenes, Fournier
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018934 2001
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018934 2004
% 208.36/208.55 |- skos__prefLabel mesh__D010951 Plasma Exchange
% 208.36/208.55 |- skos__historyNote mesh__D010951
% 208.36/208.55 Exchange Transfusion, Whole Blood %28%1968-1980%29%
% 208.36/208.55 |- mesh__dateRevised mesh__D010951 1989-05-16
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1993
% 208.36/208.55 |- mesh__historyNote mesh__D010951 81
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1998
% 208.36/208.55 |- mesh__recordOriginator mesh__D010951 SMH
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 2004
% 208.36/208.55 |- mesh__dateEstablished mesh__D010951 1981-01-01
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1992
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1995
% 208.36/208.55 |- skos__scopeNote mesh__D010951
% 208.36/208.55 Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions %28%PPF%29%, albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.%A%
% 208.36/208.55 |- skos__hiddenLabel mesh__D010951 Plasma Exchanges
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 2003
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 2006
% 208.36/208.55 |- mesh__dateCreated mesh__D010951 1980-05-12
% 208.36/208.55 |- skos__broader mesh__D010951smesh__D001803
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1991
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1994
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 2002
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 2005
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1990
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 2001
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1997
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D010951 81
% 208.36/208.55 |- rdf__type mesh__D010951sskos__Concept
% 208.36/208.55 |- skos__annotation mesh__D010951
% 208.36/208.55 do not use /util except by MeSH definition
% 208.36/208.55 |- mesh__recordMaintainer mesh__D010951 TGC
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 2000
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D010951 PLS
% 208.36/208.55 |- skos__hiddenLabel mesh__D010951 Exchanges, Plasma
% 208.36/208.55 |- skos__historyNote mesh__D010951 Plasmapheresis %28%1968-1980%29%
% 208.36/208.55 |- skos__historyNote mesh__D010951 Blood Transfusion %28%1968-1980%29%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1996
% 208.36/208.55 |- skos__hiddenLabel mesh__D010951 Exchange, Plasma
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010951 1999
% 208.36/208.55 |- skos__broader mesh__D018136smesh__D004267
% 208.36/208.55 |- skos__prefLabel mesh__D018136 Circoviridae
% 208.36/208.55 |- mesh__historyNote mesh__D018136 94
% 208.36/208.55 |- mesh__dateRevised mesh__D018136 2004-07-07
% 208.36/208.55 |- mesh__dateEstablished mesh__D018136 1994-01-01
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018136 2006
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D018136 sjn
% 208.36/208.55 |- skos__scopeNote mesh__D018136
% 208.36/208.55 A family of very small viruses containing circular, single-stranded DNA and possessing no envelope. The modes of transmission are not known.%A%
% 208.36/208.55 |- mesh__recordOriginator mesh__D018136 AGS
% 208.36/208.55 |- mesh__recordMaintainer mesh__D018136 ags
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D018136 2005
% 208.36/208.55 |- rdf__type mesh__D018136sskos__Concept
% 208.36/208.55 |- mesh__dateCreated mesh__D018136 1993-06-04
% 208.36/208.55 |- skos__annotation mesh__D018136 infection = CIRCOVIRIDAE INFECTIONS
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D018136 94
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 1999
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 1995
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 2000
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 1998
% 208.36/208.55 |- skos__broader mesh__D010153smesh__D014706
% 208.36/208.55 |- skos__hiddenLabel mesh__D010153 Paired Associate Learning
% 208.36/208.55 |- skos__hiddenLabel mesh__D010153 Learnings, Paired-Associate
% 208.36/208.55 |- skos__prefLabel mesh__D010153 Paired-Associate Learning
% 208.36/208.55 |- rdf__type mesh__D010153sskos__Concept
% 208.36/208.55 |- skos__scopeNote mesh__D010153
% 208.36/208.55 Learning in which the subject must respond with one word or syllable when presented with another word or syllable.%A%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 1994
% 208.36/208.55 |- skos__hiddenLabel mesh__D010153 Paired-Associate Learnings
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 2004
% 208.36/208.55 |- skos__hiddenLabel mesh__D010153 Learning, Paired-Associate
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 2002
% 208.36/208.55 |- mesh__dateRevised mesh__D010153 1992-05-15
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D010153 PLS
% 208.36/208.55 |- mesh__recordMaintainer mesh__D010153 TAP
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 2003
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 1997
% 208.36/208.55 |- mesh__recordOriginator mesh__D010153 NLM
% 208.36/208.55 |- mesh__dateCreated mesh__D010153 1999-01-01
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 2006
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 1993
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 1996
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 2001
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D010153 2005
% 208.36/208.55 |- mesh__publicMeSHNote mesh__D004116 73
% 208.36/208.55 |- skos__broader mesh__D004116smesh__D011283
% 208.36/208.55 |- skos__hiddenLabel mesh__D004116 Monohydrate, Dimethisterone
% 208.36/208.55 |- rdf__type mesh__D004116sskos__Concept
% 208.36/208.55 |- mesh__dateCreated mesh__D004116 1999-01-01
% 208.36/208.55 |- mesh__historyNote mesh__D004116 73%28%65%29%
% 208.36/208.55 |- mesh__recordOriginator mesh__D004116 NLM
% 208.36/208.55 |- mesh__dateRevised mesh__D004116 2003-07-09
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D004116 2004
% 208.36/208.55 |- mesh__dateEstablished mesh__D004116 1973-01-01
% 208.36/208.55 |- skos__prefLabel mesh__D004116 Dimethisterone
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D004116 2006
% 208.36/208.55 |- mesh__recordAuthorizer mesh__D004116 sjn
% 208.36/208.55 |- skos__scopeNote mesh__D004116
% 208.36/208.55 A synthetic progestational hormone without significant estrogenic or androgenic properties. It was formerly used as the progestational component in oral sequential contraceptives.%A%
% 208.36/208.55 |- mesh__activeMeSHYear mesh__D004116 2005
% 208.36/208.55 |- mesh__recordMaintainer mesh__D004116 lkt
% 208.36/208.55 |- skos__broader mesh__D008511Q000193smesh__D008511
% 208.36/208.55 |- mesh__preferredCombination mesh__D008511Q000193smesh__D004501
% 208.36/208.55 |- rdf__type mesh__D008511Q000193smesh__CompoundConcept
% 208.36/208.56 |- rdf__type mesh__D020581sskos__Concept
% 208.36/208.56 |- skos__broader mesh__D020581smesh__D006090
% 208.36/208.56 |- skos__scopeNote mesh__D020581
% 208.36/208.56 A genus of gram-negative rods which form exospores and are obligate methanotrophs.%A%
% 208.36/208.56 |- mesh__recordOriginator mesh__D020581 ndw
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D020581 sjn
% 208.36/208.56 |- mesh__dateEstablished mesh__D020581 2000-01-01
% 208.36/208.56 |- mesh__dateCreated mesh__D020581 1999-11-03
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D020581 2000
% 208.36/208.56 |- mesh__recordMaintainer mesh__D020581 SYSTEM
% 208.36/208.56 |- skos__broader mesh__D020581smesh__D042083
% 208.36/208.56 |- skos__prefLabel mesh__D020581 Methylosinus
% 208.36/208.56 |- skos__historyNote mesh__D020581 Methylococcaceae %28%1975-1999%29%
% 208.36/208.56 |- mesh__dateRevised mesh__D020581 2005-06-30
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D020581 2006
% 208.36/208.56 |- mesh__historyNote mesh__D020581 2000
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 1998
% 208.36/208.56 |- skos__hiddenLabel mesh__D014544 UTP, Magnesium
% 208.36/208.56 |- skos__broader mesh__D014544smesh__D014500
% 208.36/208.56 |- skos__altLabel mesh__D014544 Magnesium Uridine Triphosphate
% 208.36/208.56 |- mesh__dateEstablished mesh__D014544 1990-01-01
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 1994
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 2004
% 208.36/208.56 |- skos__hiddenLabel mesh__D014544 Mg UTP
% 208.36/208.56 |- skos__altLabel mesh__D014544 Magnesium UTP
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 2001
% 208.36/208.56 |- skos__historyNote mesh__D014544 Uracil Nucleotides %28%1966-1977%29%
% 208.36/208.56 |- rdf__type mesh__D014544sskos__Concept
% 208.36/208.56 |- mesh__recordOriginator mesh__D014544 RLS
% 208.36/208.56 |- mesh__historyNote mesh__D014544
% 208.36/208.56 90%28%78%29%; was see under URACIL NUCLEOTIDES 1978-89
% 208.36/208.56 |- skos__hiddenLabel mesh__D014544 Triphosphate, Magnesium Uridine
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 2003
% 208.36/208.56 |- mesh__recordMaintainer mesh__D014544 TGC
% 208.36/208.56 |- skos__altLabel mesh__D014544 UTP
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 1997
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 2000
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 2006
% 208.36/208.56 |- mesh__dateCreated mesh__D014544 1977-04-22
% 208.36/208.56 |- skos__scopeNote mesh__D014544
% 208.36/208.56 Uridine 5%27%-%28%tetrahydrogen triphosphate%29%. A uracil nucleotide containing three phosphate groups esterified to the sugar moiety.%A%
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 1993
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 1996
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D014544
% 208.36/208.56 90; was see under URACIL NUCLEOTIDES 1978-89
% 208.36/208.56 |- skos__hiddenLabel mesh__D014544 Triphosphate, Uridine
% 208.36/208.56 |- skos__prefLabel mesh__D014544 Uridine Triphosphate
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 2005
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 1999
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 2002
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D014544 PLS
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014544 1995
% 208.36/208.56 |- mesh__dateRevised mesh__D014544 1992-05-20
% 208.36/208.56 |- skos__broader mesh__D004194Q000628smesh__D004194
% 208.36/208.56 |- mesh__preferredCombination mesh__D004194Q000628smesh__D013812
% 208.36/208.56 |- rdf__type mesh__D004194Q000628smesh__CompoundConcept
% 208.36/208.56 |- mesh__recordOriginator mesh__D008507 EC
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008507 2004
% 208.36/208.56 |- skos__hiddenLabel mesh__D008507 Underserved Areas, Medically
% 208.36/208.56 |- skos__hiddenLabel mesh__D008507 Areas, Physician Shortage
% 208.36/208.56 |- rdf__type mesh__D008507sskos__Concept
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008507 2000
% 208.36/208.56 |- mesh__historyNote mesh__D008507 78
% 208.36/208.56 |- skos__hiddenLabel mesh__D008507 Medically Underserved Areas
% 208.36/208.56 |- mesh__dateEstablished mesh__D008507 1978-01-01
% 208.36/208.56 |- mesh__dateRevised mesh__D008507 1999-11-08
% 208.36/208.56 |- skos__hiddenLabel mesh__D008507 Physician Shortage Areas
% 208.36/208.56 |- skos__broader mesh__D008507smesh__D012040
% 208.36/208.56 |- skos__altLabel mesh__D008507 Health Service Corps, National
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008507 2001
% 208.36/208.56 |- skos__prefLabel mesh__D008507 Medically Underserved Area
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D008507 sjn
% 208.36/208.56 |- mesh__dateCreated mesh__D008507 1977-05-12
% 208.36/208.56 |- skos__altLabel mesh__D008507 Area, Medically Underserved
% 208.36/208.56 |- mesh__recordMaintainer mesh__D008507 KEV
% 208.36/208.56 |- skos__hiddenLabel mesh__D008507 Underserved Area, Medically
% 208.36/208.56 |- skos__hiddenLabel mesh__D008507 Shortage Areas, Physician
% 208.36/208.56 |- skos__related mesh__D008507smesh__D006297
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008507 2002
% 208.36/208.56 |- skos__broader mesh__D008507smesh__D006301
% 208.36/208.56 |- skos__annotation mesh__D008507
% 208.36/208.56 no qualif; specify geog; DF: MED UNDERSERV AREA
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008507 2005
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D008507 78
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008507 2003
% 208.36/208.56 |- skos__hiddenLabel mesh__D008507 Shortage Area, Physician
% 208.36/208.56 |- skos__hiddenLabel mesh__D008507 Area, Physician Shortage
% 208.36/208.56 |- skos__hiddenLabel mesh__D008507 Areas, Medically Underserved
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008507 2006
% 208.36/208.56 |- skos__scopeNote mesh__D008507
% 208.36/208.56 A geographic location which has insufficient health resources %28%manpower and/or facilities%29% to meet the medical needs of the resident population.%A%
% 208.36/208.56 |- mesh__dateEstablished mesh__D000524 1981-01-01
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D000524
% 208.36/208.56 94; was ALPHAVIRUSES 1981-93; ALPHAVIRUSES was see ARBOVIRUSES 1978-80%A%
% 208.36/208.56 |- skos__altLabel mesh__D000524 Alphaviruses
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D000524 2002
% 208.36/208.56 |- skos__hiddenLabel mesh__D000524 Group A Arbovirus
% 208.36/208.56 |- skos__hiddenLabel mesh__D000524 Alpha Viruses
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D000524 sjn
% 208.36/208.56 |- mesh__recordOriginator mesh__D000524 RC
% 208.36/208.56 |- skos__broader mesh__D000524smesh__D014035
% 208.36/208.56 |- skos__hiddenLabel mesh__D000524 Group A Arboviruses
% 208.36/208.56 |- rdf__type mesh__D000524sskos__Concept
% 208.36/208.56 |- mesh__dateCreated mesh__D000524 1980-05-14
% 208.36/208.56 |- skos__altLabel mesh__D000524 Arboviruses, Group A
% 208.36/208.56 |- mesh__historyNote mesh__D000524
% 208.36/208.56 94; was ALPHAVIRUSES 1981-93; ALPHAVIRUSES was see ARBOVIRUSES 1978-80%A%
% 208.36/208.56 |- skos__historyNote mesh__D000524 Arboviruses %28%1966-1980%29%
% 208.36/208.56 |- mesh__onlineNote mesh__D000524
% 208.36/208.56 use ALPHAVIRUS to search ALPHAVIRUSES 1981-93; use ARBOVIRUSES 1978-80%A%
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D000524 2006
% 208.36/208.56 |- skos__prefLabel mesh__D000524 Alphavirus
% 208.36/208.56 |- skos__hiddenLabel mesh__D000524 Arbovirus, Group A
% 208.36/208.56 |- skos__scopeNote mesh__D000524
% 208.36/208.56 A genus of TOGAVIRIDAE, also known as Group A arboviruses, serologically related to each other but not to other Togaviridae. The viruses are transmitted by mosquitoes. The type species is the SINDBIS VIRUS.%A%
% 208.36/208.56 |- mesh__dateRevised mesh__D000524 2001-07-25
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D000524 2004
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D000524 2005
% 208.36/208.56 |- mesh__recordMaintainer mesh__D000524 ags
% 208.36/208.56 |- skos__annotation mesh__D000524 infection = ALPHAVIRUS INFECTIONS
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D000524 2003
% 208.36/208.56 |- skos__altLabel mesh__D000524 Alpha Virus
% 208.36/208.56 |- skos__hiddenLabel mesh__D010952 Expanders, Blood
% 208.36/208.56 |- skos__scopeNote mesh__D010952
% 208.36/208.56 Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration.%A%
% 208.36/208.56 |- mesh__recordMaintainer mesh__D010952 ssb
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010952 2006
% 208.36/208.56 |- skos__hiddenLabel mesh__D010952 Expanders, Plasma Volume
% 208.36/208.56 |- skos__hiddenLabel mesh__D010952 Substitutes, Plasma
% 208.36/208.56 |- skos__related mesh__D010952smesh__D001802
% 208.36/208.56 |- skos__altLabel mesh__D010952 Plasma Volume Expanders
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D010952 sjn
% 208.36/208.56 |- skos__prefLabel mesh__D010952 Plasma Substitutes
% 208.36/208.56 |- rdf__type mesh__D010952sskos__Concept
% 208.36/208.56 |- mesh__dateRevised mesh__D010952 2005-06-30
% 208.36/208.56 |- skos__hiddenLabel mesh__D010952 Volume Expanders, Plasma
% 208.36/208.56 |- skos__altLabel mesh__D010952 Blood Expanders
% 208.36/208.56 |- skos__broader mesh__D010952smesh__D001802
% 208.36/208.56 |- mesh__dateCreated mesh__D010952 1999-01-01
% 208.36/208.56 |- skos__annotation mesh__D010952
% 208.36/208.56 do not confuse with BLOOD SUBSTITUTES which carry O2 to %26% CO2 from tissue; D25-26 qualif%A%
% 208.36/208.56 |- mesh__recordOriginator mesh__D010952 NLM
% 208.36/208.56 |- mesh__recordMaintainer mesh__D010154 PLS
% 208.36/208.56 |- skos__prefLabel mesh__D010154 Pakistan
% 208.36/208.56 |- mesh__recordOriginator mesh__D010154 NLM
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 1995
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 2000
% 208.36/208.56 |- skos__broader mesh__D010154smesh__D001211
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 2003
% 208.36/208.56 |- rdf__type mesh__D010154sskos__Concept
% 208.36/208.56 |- mesh__dateRevised mesh__D010154 1993-06-03
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 2001
% 208.36/208.56 |- mesh__dateCreated mesh__D010154 1999-01-01
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 2004
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 2002
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 1996
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D010154 PLS
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 2005
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 1997
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 2006
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 1998
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 1994
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D010154 1999
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Leukemias, Acute Erythroblastic
% 208.36/208.56 |- mesh__recordMaintainer mesh__D004915 sjn
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D004915 2002
% 208.36/208.56 |- skos__historyNote mesh__D004915 Erythremic Myelosis %28%1966-1967%29%
% 208.36/208.56 |- skos__broader mesh__D004915smesh__D015470
% 208.36/208.56 |- mesh__dateCreated mesh__D004915 1999-01-01
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D004915 2003
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D004915 sjn
% 208.36/208.56 |- skos__altLabel mesh__D004915 Myeloid Leukemia, Acute, M6
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Myeloses, Erythremic
% 208.36/208.56 |- mesh__dateEstablished mesh__D004915 1973-01-01
% 208.36/208.56 |- skos__altLabel mesh__D004915 Erythroblastic Leukemia, Acute
% 208.36/208.56 |- rdf__type mesh__D004915sskos__Concept
% 208.36/208.56 |- mesh__onlineNote mesh__D004915
% 208.36/208.56 use LEUKEMIA, ERYTHROBLASTIC, ACUTE to search ERYTHROLEUKEMIA 1973-88 %28%as Prov 1968-72%29% %26% ERYTHREMIC MYELOSIS 1966-83%A%
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Di Guglielmos Disease
% 208.36/208.56 |- skos__annotation mesh__D004915
% 208.36/208.56 do not use /blood supply /chem /second /secret /ultrastruct; Friend erythroleukemia cells: coord IM with FRIEND MURINE LEUKEMIA VIRUS %28%IM%29% + TUMOR CELLS, CULTURED %28%NIM%29%%A%
% 208.36/208.56 |- skos__altLabel mesh__D004915 Di Guglielmo Disease
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D004915 2006
% 208.36/208.56 |- skos__scopeNote mesh__D004915
% 208.36/208.56 A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.%A%
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Myelosis, Erythremic
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Disease, Di Guglielmo
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Acute Erythroblastic Leukemias
% 208.36/208.56 |- skos__altLabel mesh__D004915 Erythroleukemia
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D004915 2005
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D004915
% 208.36/208.56 89; ERYTHROLEUKEMIA was heading 1973-88; ERYTHREMIC MYELOSIS was heading 1963-83%A%
% 208.36/208.56 |- skos__altLabel mesh__D004915 Leukemia, Myeloid, Acute, M6
% 208.36/208.56 |- mesh__historyNote mesh__D004915
% 208.36/208.56 89; ERYTHROLEUKEMIA was heading 1973-88 %28%Prov 1968-72%29%; ERYTHREMIC MYELOSIS was heading 1963-83%A%
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Disease, Di Guglielmo%27%s
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Erythroblastic Leukemias, Acute
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Leukemia, Acute Erythroblastic
% 208.36/208.56 |- mesh__recordOriginator mesh__D004915 NLM
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Erythremic Myeloses
% 208.36/208.56 |- skos__prefLabel mesh__D004915 Leukemia, Erythroblastic, Acute
% 208.36/208.56 |- skos__altLabel mesh__D004915 Di Guglielmo%27%s Disease
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Acute Erythroblastic Leukemia
% 208.36/208.56 |- skos__hiddenLabel mesh__D004915 Erythroleukemias
% 208.36/208.56 |- skos__broader mesh__D004915smesh__D009196
% 208.36/208.56 |- skos__altLabel mesh__D004915 Erythremic Myelosis
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D004915 2004
% 208.36/208.56 |- mesh__dateRevised mesh__D004915 2001-08-03
% 208.36/208.56 |- mesh__dateCreated mesh__D004117 1999-01-01
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D004117 74
% 208.36/208.56 |- skos__scopeNote mesh__D004117
% 208.36/208.56 An organothiophosphorus cholinesterase inhibitor that is used as a systemic and contact insecticide.%A%
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D004117 sjn
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D004117 2006
% 208.36/208.56 |- mesh__dateRevised mesh__D004117 2005-06-30
% 208.36/208.56 |- skos__hiddenLabel mesh__D004117 Bi 58
% 208.36/208.56 |- skos__altLabel mesh__D004117 Phosphamide
% 208.36/208.56 |- mesh__recordMaintainer mesh__D004117 ssb
% 208.36/208.56 |- skos__prefLabel mesh__D004117 Dimethoate
% 208.36/208.56 |- skos__hiddenLabel mesh__D004117 Bi58
% 208.36/208.56 |- skos__historyNote mesh__D004117 Insecticides %28%1966-1971%29%
% 208.36/208.56 |- skos__annotation mesh__D004117 TN 111 for eff on insects
% 208.36/208.56 |- mesh__historyNote mesh__D004117 74%28%72%29%
% 208.36/208.56 |- mesh__recordOriginator mesh__D004117 NLM
% 208.36/208.56 |- skos__broader mesh__D004117smesh__D009946
% 208.36/208.56 |- mesh__dateEstablished mesh__D004117 1974-01-01
% 208.36/208.56 |- rdf__type mesh__D004117sskos__Concept
% 208.36/208.56 |- mesh__dateCreated mesh__D009600 1974-11-11
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 2001
% 208.36/208.56 |- mesh__recordOriginator mesh__D009600 NLM
% 208.36/208.56 |- skos__broader mesh__D009600smesh__D011804
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D009600 PLS
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 2005
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 1995
% 208.36/208.56 |- mesh__dateEstablished mesh__D009600 1975-09-01
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 2004
% 208.36/208.56 |- skos__scopeNote mesh__D009600
% 208.36/208.56 Quinolines substituted in any position by one or more nitro groups.%A%
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 2000
% 208.36/208.56 |- mesh__dateRevised mesh__D009600 1992-05-19
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 1993
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 1994
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 2003
% 208.36/208.56 |- rdf__type mesh__D009600sskos__Concept
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 1999
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 2002
% 208.36/208.56 |- mesh__recordMaintainer mesh__D009600 TAP
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 1998
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 1997
% 208.36/208.56 |- mesh__historyNote mesh__D009600 75
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 1996
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D009600 75
% 208.36/208.56 |- skos__prefLabel mesh__D009600 Nitroquinolines
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D009600 2006
% 208.36/208.56 |- skos__historyNote mesh__D009600 Quinolines %28%1966-1974%29%
% 208.36/208.56 |- skos__broader mesh__D009600smesh__D009574
% 208.36/208.56 |- mesh__dateEstablished mesh__D020582 2000-01-01
% 208.36/208.56 |- skos__scopeNote mesh__D020582
% 208.36/208.56 A genus of rod-shaped, oval, or bean-shaped bacteria found in soil and fresh water. Polar prosthecae are present and cells reproduce by budding at the tips of the prosthecae. Cells of this genus are aerobic and grow best with one-carbon compounds. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.36/208.56 |- mesh__recordMaintainer mesh__D020582 SYSTEM
% 208.36/208.56 |- skos__historyNote mesh__D020582
% 208.36/208.56 Budding and Appendaged Bacteria %28%1998-1999%29%
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D020582 sjn
% 208.36/208.56 |- skos__broader mesh__D020582smesh__D041921
% 208.36/208.56 |- mesh__dateCreated mesh__D020582 1999-11-03
% 208.36/208.56 |- skos__historyNote mesh__D020582 Bacteria %28%1966-1997%29%
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D020582 2000
% 208.36/208.56 |- skos__prefLabel mesh__D020582 Hyphomicrobium
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D020582 2006
% 208.36/208.56 |- mesh__historyNote mesh__D020582 2000
% 208.36/208.56 |- rdf__type mesh__D020582sskos__Concept
% 208.36/208.56 |- mesh__recordOriginator mesh__D020582 ndw
% 208.36/208.56 |- mesh__dateRevised mesh__D020582 2005-06-30
% 208.36/208.56 |- skos__broader mesh__D014545smesh__D002137
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014545 2004
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014545 2002
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Stones, Urinary
% 208.36/208.56 |- skos__broader mesh__D014545smesh__D014570
% 208.36/208.56 |- rdf__type mesh__D014545sskos__Concept
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Calculus, Urinary
% 208.36/208.56 |- skos__annotation mesh__D014545
% 208.36/208.56 GEN or unspecified; consider BLADDER CALCULI; KIDNEY CALCULI; URETERAL CALCULI; chem composition of calculi: use /chem; /ultrastruct permitted%A%
% 208.36/208.56 |- mesh__dateRevised mesh__D014545 2001-07-25
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Urinary Tract Stone
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Tract Stone, Urinary
% 208.36/208.56 |- mesh__recordOriginator mesh__D014545 NLM
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014545 2003
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Stone, Urinary
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Urinary Calculus
% 208.36/208.56 |- mesh__onlineNote mesh__D014545
% 208.36/208.56 to search for chem composition of urinary calculi, use URINARY CALCULI/anal 1987-90 %26% URINARY CALCULI/metab 1966-86%A%
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Stone, Urinary Tract
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014545 2006
% 208.36/208.56 |- skos__altLabel mesh__D014545 Urinary Tract Stones
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Stones, Urinary Tract
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D014545 2005
% 208.36/208.56 |- skos__scopeNote mesh__D014545
% 208.36/208.56 Calculi in any part of the urinary tract. According to their composition or pattern of chemical composition distribution, urinary calculi types may include alternating or combination, cystine, decubitus, encysted, fibrin, hemp seed, matrix, mulberry, oxalate, struvite, urostealith, and xanthic calculi.%A%
% 208.36/208.56 |- skos__prefLabel mesh__D014545 Urinary Calculi
% 208.36/208.56 |- mesh__dateCreated mesh__D014545 1999-01-01
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Calculi, Urinary
% 208.36/208.56 |- skos__altLabel mesh__D014545 Urinary Stones
% 208.36/208.56 |- mesh__recordMaintainer mesh__D014545 mdb
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Tract Stones, Urinary
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D014545 sjn
% 208.36/208.56 |- skos__hiddenLabel mesh__D014545 Urinary Stone
% 208.36/208.56 |- mesh__recordMaintainer mesh__D008508 jls
% 208.36/208.56 |- mesh__recordOriginator mesh__D008508 NLM
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008508 2001
% 208.36/208.56 |- mesh__dateRevised mesh__D008508 1999-11-03
% 208.36/208.56 |- skos__annotation mesh__D008508
% 208.36/208.56 IM; coord with specific dis /drug ther %28%IM%29% %26% specific drug /ther use %28%IM%29%; DF: MEDICATION ERR%A%
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008508 2000
% 208.36/208.56 |- skos__scopeNote mesh__D008508
% 208.36/208.56 Errors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the indicated proper drug dosage.%A%
% 208.36/208.56 |- skos__broader mesh__D008508smesh__D019300
% 208.36/208.56 |- skos__hiddenLabel mesh__D008508 Error, Medication
% 208.36/208.56 |- skos__broader mesh__D008508smesh__D004358
% 208.36/208.56 |- mesh__dateEstablished mesh__D008508 1967-01-01
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008508 2004
% 208.36/208.56 |- skos__prefLabel mesh__D008508 Medication Errors
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D008508 67
% 208.36/208.56 |- skos__altLabel mesh__D008508 Errors, Medication
% 208.36/208.56 |- mesh__historyNote mesh__D008508 67%28%66%29%
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008508 2003
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008508 2006
% 208.36/208.56 |- rdf__type mesh__D008508sskos__Concept
% 208.36/208.56 |- skos__hiddenLabel mesh__D008508 Medication Error
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008508 2002
% 208.36/208.56 |- mesh__dateCreated mesh__D008508 1999-01-01
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D008508 2005
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D008508 sjn
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Alprazolam Orion Brand
% 208.36/208.56 |- mesh__historyNote mesh__D000525 87
% 208.36/208.56 |- skos__altLabel mesh__D000525 Nu-Pharm Brand of Alprazolam
% 208.36/208.56 |- skos__altLabel mesh__D000525 Alphapharm Brand of Alprazolam
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D000525 sjn
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 NuAlpraz
% 208.36/208.56 |- skos__altLabel mesh__D000525 Esparon
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D000525 2004
% 208.36/208.56 |- skos__altLabel mesh__D000525 Temmler Brand of Alprazolam
% 208.36/208.56 |- skos__historyNote mesh__D000525 Benzazepines %28%1968-1973%29%
% 208.36/208.56 |- skos__historyNote mesh__D000525 Benzodiazepines %28%1975-1986%29%
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D000525 2005
% 208.36/208.56 |- skos__altLabel mesh__D000525 Kenral Brand of Alprazolam
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 D65MT
% 208.36/208.56 |- skos__altLabel mesh__D000525
% 208.36/208.56 Arzneimittelwerk Dresden Brand of Alprazolam
% 208.36/208.56 |- skos__altLabel mesh__D000525 Pharmacia Brand of Alprazolam
% 208.36/208.56 |- mesh__dateEstablished mesh__D000525 1987-01-01
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D000525 2006
% 208.36/208.56 |- skos__altLabel mesh__D000525 Apotex Brand of Alprazolam
% 208.36/208.56 |- skos__altLabel mesh__D000525 Novopharm Brand of Alprazolam
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Alprazolam Pharmacia Brand
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 U31,889
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 ApoAlpraz
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Alprazolam Alphapharm Brand
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Apo Alpraz
% 208.36/208.56 |- mesh__recordOriginator mesh__D000525 RLS
% 208.36/208.56 |- skos__broader mesh__D000525smesh__D001569
% 208.36/208.56 |- skos__altLabel mesh__D000525 Upjohn Brand of Alprazolam
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Alprazolam Temmler Brand
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D000525 87
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Alprazolam Nu-Pharm Brand
% 208.36/208.56 |- mesh__dateCreated mesh__D000525 1986-06-16
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Nu Pharm Brand of Alprazolam
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Alprazolam Upjohn Brand
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Nu Alpraz
% 208.36/208.56 |- skos__historyNote mesh__D000525 Azepines %28%1966-1967%29%
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Novo Alprazol
% 208.36/208.56 |- skos__altLabel mesh__D000525 Orion Brand of Alprazolam
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Alprazolam Novopharm Brand
% 208.36/208.56 |- skos__altLabel mesh__D000525 Trankimazin
% 208.36/208.56 |- skos__prefLabel mesh__D000525 Alprazolam
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Alprazolam Apotex Brand
% 208.36/208.56 |- skos__altLabel mesh__D000525 Tafil
% 208.36/208.56 |- rdf__type mesh__D000525sskos__Concept
% 208.36/208.56 |- mesh__recordMaintainer mesh__D000525 ssb
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 NovoAlprazol
% 208.36/208.56 |- skos__altLabel mesh__D000525 Alprazolan
% 208.36/208.56 |- skos__scopeNote mesh__D000525
% 208.36/208.56 A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. %28%From AMA Drug Evaluations Annual, 1994, p238%29%%A%
% 208.36/208.56 |- mesh__dateRevised mesh__D000525 2003-07-09
% 208.36/208.56 |- skos__hiddenLabel mesh__D000525 Alprazolam Kenral Brand
% 208.36/208.56 |- skos__altLabel mesh__D019230 Audit, Dental
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 1999
% 208.36/208.56 |- skos__historyNote mesh__D019230 Medical Audit %28%1980-1996%29%
% 208.36/208.56 |- skos__prefLabel mesh__D019230 Dental Audit
% 208.36/208.56 |- mesh__dateCreated mesh__D019230 1996-06-10
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 2004
% 208.36/208.56 |- skos__broader mesh__D019230smesh__D011787
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 1998
% 208.36/208.56 |- skos__scopeNote mesh__D019230
% 208.36/208.56 A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of dental care.%A%
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 2002
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 2003
% 208.36/208.56 |- mesh__historyNote mesh__D019230 97
% 208.36/208.56 |- skos__altLabel mesh__D019230 Audits, Dental
% 208.36/208.56 |- skos__annotation mesh__D019230 DF: DENT AUDIT
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 2006
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 1997
% 208.36/208.56 |- mesh__publicMeSHNote mesh__D019230 97
% 208.36/208.56 |- skos__broader mesh__D019230smesh__D011785
% 208.36/208.56 |- rdf__type mesh__D019230sskos__Concept
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 2001
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 2005
% 208.36/208.56 |- mesh__dateEstablished mesh__D019230 1997-01-01
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D019230 2000
% 208.36/208.56 |- skos__altLabel mesh__D019230 Dental Audits
% 208.36/208.56 |- skos__annotation mesh__D005210
% 208.36/208.56 infection = FASCIOLIASIS %26% do not bother to coord with FASCIOLA HEPATICA unless particularly discussed %28%index IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D005210 2004
% 208.36/208.56 |- mesh__dateRevised mesh__D005210 2003-07-09
% 208.36/208.56 |- skos__altLabel mesh__D005210 Liver Fluke
% 208.36/208.56 |- skos__scopeNote mesh__D005210
% 208.36/208.56 A species of helminth commonly called the sheep liver fluke. It occurs in the biliary passages, liver, and gallbladder during various stages of development. Snails and aquatic vegetation are the intermediate hosts. Occasionally seen in man, it is most common in sheep and cattle.%A%
% 208.36/208.56 |- mesh__recordMaintainer mesh__D005210 ags
% 208.36/208.56 |- skos__prefLabel mesh__D005210 Fasciola hepatica
% 208.36/208.56 |- rdf__type mesh__D005210sskos__Concept
% 208.36/208.56 |- mesh__recordOriginator mesh__D005210 NLM
% 208.36/208.56 |- mesh__recordAuthorizer mesh__D005210 sjn
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D005210 2006
% 208.36/208.56 |- mesh__dateCreated mesh__D005210 1999-01-01
% 208.36/208.56 |- skos__broader mesh__D005210smesh__D005209
% 208.36/208.56 |- mesh__activeMeSHYear mesh__D005210 2005
% 208.36/208.57 |- skos__scopeNote mesh__D018936
% 208.36/208.57 Antigens of the virions of HEPACIVIRUS, their surface, core, or other associated antigens.%A%
% 208.36/208.57 |- skos__prefLabel mesh__D018936 Hepatitis C Antigens
% 208.36/208.57 |- mesh__dateRevised mesh__D018936 2005-06-30
% 208.36/208.57 |- skos__broader mesh__D018936smesh__D018963
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D018936 sjn
% 208.36/208.57 |- mesh__onlineNote mesh__D018936
% 208.36/208.57 use HEPATITIS C ANTIGENS %28%NM%29% to search HEPATITIS NON-A, NON-B ANTIGEN 1984-95%A%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018936 2006
% 208.36/208.57 |- skos__historyNote mesh__D018936 Antigens, Viral %28%1984-1995%29%
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D018936
% 208.36/208.57 96; HEPATITIS NON-A, NON-B ANTIGEN was indexed under ANTIGENS, VIRAL 1984-95%A%
% 208.36/208.57 |- mesh__recordMaintainer mesh__D018936 ssb
% 208.36/208.57 |- mesh__dateEstablished mesh__D018936 1996-01-01
% 208.36/208.57 |- mesh__dateCreated mesh__D018936 1995-02-17
% 208.36/208.57 |- skos__hiddenLabel mesh__D018936 Hepatitis Non A, Non B Antigen
% 208.36/208.57 |- mesh__recordOriginator mesh__D018936 AGS
% 208.36/208.57 |- skos__altLabel mesh__D018936 Hepatitis C Antigen
% 208.36/208.57 |- mesh__historyNote mesh__D018936
% 208.36/208.57 96; was HEPATITIS NON-A, NON-B ANTIGEN %28%NM%29% 1984-95
% 208.36/208.57 |- rdf__type mesh__D018936sskos__Concept
% 208.36/208.57 |- mesh__recordMaintainer mesh__D010953 nns
% 208.36/208.57 |- mesh__dateEstablished mesh__D010953 1970-01-01
% 208.36/208.57 |- skos__broader mesh__D010953smesh__D001810
% 208.36/208.57 |- rdf__type mesh__D010953sskos__Concept
% 208.36/208.57 |- skos__altLabel mesh__D010953 Blood Plasma Volume
% 208.36/208.57 |- skos__hiddenLabel mesh__D010953 Blood Plasma Volumes
% 208.36/208.57 |- skos__hiddenLabel mesh__D010953 Volume, Plasma
% 208.36/208.57 |- skos__hiddenLabel mesh__D010953 Volume, Blood Plasma
% 208.36/208.57 |- mesh__dateRevised mesh__D010953 2003-07-09
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D010953 70
% 208.36/208.57 |- mesh__recordOriginator mesh__D010953 NLM
% 208.36/208.57 |- skos__prefLabel mesh__D010953 Plasma Volume
% 208.36/208.57 |- mesh__dateCreated mesh__D010953 1999-01-01
% 208.36/208.57 |- skos__scopeNote mesh__D010953
% 208.36/208.57 Volume of PLASMA in the circulation. It is usually measured by INDICATOR DILUTION TECHNIQUES.%A%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010953 2004
% 208.36/208.57 |- mesh__historyNote mesh__D010953 70%28%66%29%
% 208.36/208.57 |- skos__related mesh__D010953smesh__D018495
% 208.36/208.57 |- skos__hiddenLabel mesh__D010953 Volumes, Plasma
% 208.36/208.57 |- skos__hiddenLabel mesh__D010953 Plasma Volumes
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010953 2006
% 208.36/208.57 |- skos__hiddenLabel mesh__D010953 Volumes, Blood Plasma
% 208.36/208.57 |- skos__annotation mesh__D010953
% 208.36/208.57 coord IM with disease /physiopathol, not /blood
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D010953 sjn
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010953 2005
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018138 2005
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D018138 ags
% 208.36/208.57 |- mesh__dateCreated mesh__D018138 1993-06-04
% 208.36/208.57 |- mesh__recordMaintainer mesh__D018138 ags
% 208.36/208.57 |- skos__broader mesh__D018138smesh__D006564
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018138 2006
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018138 2006A
% 208.36/208.57 |- rdf__type mesh__D018138sskos__Concept
% 208.36/208.57 |- skos__scopeNote mesh__D018138
% 208.36/208.57 A subfamily of HERPESVIRIDAE characterized by a short replication cycle. The genera include: SIMPLEXVIRUS; VARICELLOVIRUS; MAREK%27%S DISEASE-LIKE VIRUSES; and INFECTIOUS LARYNGOTRACHEITIS-LIKE VIRUSES.%A%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018138 2003
% 208.36/208.57 |- skos__prefLabel mesh__D018138 Alphaherpesvirinae
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D018138 94
% 208.36/208.57 |- mesh__dateRevised mesh__D018138 2005-07-29
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018138 2004
% 208.36/208.57 |- skos__historyNote mesh__D018138 Herpesviridae %28%1988-1993%29%
% 208.36/208.57 |- mesh__recordOriginator mesh__D018138 AGS
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018138 2002
% 208.36/208.57 |- mesh__dateEstablished mesh__D018138 1994-01-01
% 208.36/208.57 |- skos__annotation mesh__D018138
% 208.36/208.57 infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%
% 208.36/208.57 |- mesh__historyNote mesh__D018138 94
% 208.36/208.57 |- skos__historyNote mesh__D010155 Palate %28%1966-1972%29%
% 208.36/208.57 |- rdf__type mesh__D010155sskos__Concept
% 208.36/208.57 |- mesh__onlineNote mesh__D010155
% 208.36/208.57 use PALATAL EXPANSION TECHNIQUE to search PALATAL EXPANSION TECHNIC 1973-90%A%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010155 2003
% 208.36/208.57 |- skos__hiddenLabel mesh__D010155 Palatal Expansion Techniques
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D010155 sjn
% 208.36/208.57 |- mesh__dateRevised mesh__D010155 1999-11-03
% 208.36/208.57 |- mesh__dateCreated mesh__D010155 1999-01-01
% 208.36/208.57 |- skos__hiddenLabel mesh__D010155 Technique, Palatal Expansion
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010155 2004
% 208.36/208.57 |- skos__altLabel mesh__D010155 Palatal Expansion Technic
% 208.36/208.57 |- skos__hiddenLabel mesh__D010155 Technic, Palatal Expansion
% 208.36/208.57 |- mesh__recordOriginator mesh__D010155 NLM
% 208.36/208.57 |- mesh__recordMaintainer mesh__D010155 kle
% 208.36/208.57 |- skos__hiddenLabel mesh__D010155 Expansion Technic, Palatal
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010155 2000
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010155 2005
% 208.36/208.57 |- mesh__dateEstablished mesh__D010155 1973-01-01
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010155 2001
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010155 2006
% 208.36/208.57 |- skos__hiddenLabel mesh__D010155 Expansion Technique, Palatal
% 208.36/208.57 |- skos__broader mesh__D010155smesh__D009971
% 208.36/208.57 |- skos__historyNote mesh__D010155
% 208.36/208.57 Orthodontics, Corrective %28%1966-1972%29%
% 208.36/208.57 |- skos__hiddenLabel mesh__D010155 Palatal Expansion Technics
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010155 2002
% 208.36/208.57 |- skos__hiddenLabel mesh__D010155 Expansion Techniques, Palatal
% 208.36/208.57 |- mesh__historyNote mesh__D010155
% 208.36/208.57 91; was PALATAL EXPANSION TECHNIC 1973-90
% 208.36/208.57 |- skos__prefLabel mesh__D010155 Palatal Expansion Technique
% 208.36/208.57 |- skos__hiddenLabel mesh__D010155 Expansion, Maxillary
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D010155
% 208.36/208.57 91; was PALATAL EXPANSION TECHNIC 1973-90
% 208.36/208.57 |- skos__scopeNote mesh__D010155
% 208.36/208.57 An orthodontic method used for correcting narrow or collapsed maxillary arches and functional cross-bite. %28%From Jablonski%27%s Dictionary of Dentistry%29%,%A%
% 208.36/208.57 |- skos__hiddenLabel mesh__D010155 Expansion Technics, Palatal
% 208.36/208.57 |- skos__hiddenLabel mesh__D004916 Erythromelalgias
% 208.36/208.57 |- mesh__dateRevised mesh__D004916 1993-06-02
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D004916 PLS
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 2001
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 2006
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 2000
% 208.36/208.57 |- mesh__recordMaintainer mesh__D004916 TAP
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 1995
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 2004
% 208.36/208.57 |- mesh__dateCreated mesh__D004916 1999-01-01
% 208.36/208.57 |- rdf__type mesh__D004916sskos__Concept
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 1999
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 2005
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 1994
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 1997
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 2003
% 208.36/208.57 |- skos__prefLabel mesh__D004916 Erythromelalgia
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 1998
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 2002
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004916 1996
% 208.36/208.57 |- skos__broader mesh__D004916smesh__D014652
% 208.36/208.57 |- skos__annotation mesh__D004916 painful burning %26% redness of limbs
% 208.36/208.57 |- skos__altLabel mesh__D004916 Erythermalgia
% 208.36/208.57 |- skos__scopeNote mesh__D004916
% 208.36/208.57 Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness.%A%
% 208.36/208.57 |- skos__hiddenLabel mesh__D004916 Erythermalgias
% 208.36/208.57 |- mesh__recordOriginator mesh__D004916 NLM
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 2000
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 1997
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 2004
% 208.36/208.57 |- mesh__recordMaintainer mesh__D004118 TGC
% 208.36/208.57 |- mesh__onlineNote mesh__D004118 search PHENETHYLAMINES 1968-74
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 1996
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 1999
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 2003
% 208.36/208.57 |- mesh__dateEstablished mesh__D004118 1991-01-01
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 2006
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 1998
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 1993
% 208.36/208.57 |- skos__prefLabel mesh__D004118 Dimethoxyphenylethylamine
% 208.36/208.57 |- mesh__historyNote mesh__D004118
% 208.36/208.57 91%28%75%29%; was see under PHENETHYLAMINES 1975-90
% 208.36/208.57 |- mesh__dateRevised mesh__D004118 1992-05-13
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 2005
% 208.36/208.57 |- mesh__recordOriginator mesh__D004118 NLM
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 1995
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D004118
% 208.36/208.57 91; was see under PHENETHYLAMINES 1975-90
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 2002
% 208.36/208.57 |- skos__broader mesh__D004118smesh__D010627
% 208.36/208.57 |- mesh__dateCreated mesh__D004118 1999-01-01
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 1994
% 208.36/208.57 |- rdf__type mesh__D004118sskos__Concept
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D004118 2001
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D004118 PLS
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D009601
% 208.36/208.57 91; was see under OXIDOREDUCTASES 1987-90
% 208.36/208.57 |- skos__broader mesh__D009601smesh__D010088
% 208.36/208.57 |- mesh__dateRevised mesh__D009601 2005-06-30
% 208.36/208.57 |- rdf__type mesh__D009601sskos__Concept
% 208.36/208.57 |- skos__historyNote mesh__D009601 Oxidoreductases %28%1966-1986%29%
% 208.36/208.57 |- mesh__recordMaintainer mesh__D009601 jmp
% 208.36/208.57 |- mesh__historyNote mesh__D009601
% 208.36/208.57 91%28%87%29%; was see under OXIDOREDUCTASES 1987-90
% 208.36/208.57 |- skos__prefLabel mesh__D009601 Nitroreductases
% 208.36/208.57 |- mesh__dateEstablished mesh__D009601 1991-01-01
% 208.36/208.57 |- skos__scopeNote mesh__D009601
% 208.36/208.57 Enzymes which reduce nitro groups %28%NITRO COMPOUNDS%29% and other nitrogenous compounds.%A%
% 208.36/208.57 |- skos__altLabel mesh__D009601
% 208.36/208.57 Oxidoreductases Acting on other Nitrogenous Compounds as Donors
% 208.36/208.57 |- mesh__recordOriginator mesh__D009601 RLS
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D009601 sjn
% 208.36/208.57 |- mesh__dateCreated mesh__D009601 1986-06-02
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D009601 2006
% 208.36/208.57 |- skos__annotation mesh__D009601 general; prefer specifics
% 208.36/208.57 |- mesh__recordMaintainer mesh__D020583 SYSTEM
% 208.36/208.57 |- skos__broader mesh__D020583smesh__D016946
% 208.36/208.57 |- skos__scopeNote mesh__D020583
% 208.36/208.57 A genus of gram-negative, rod-shaped, obligate aerobes which are motile by peritrichous flagella on solid medium and one lateral flagellum in liquid medium. Under microaerobic conditions Azorhizobium fixes nitrogen. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.36/208.57 |- skos__prefLabel mesh__D020583 Azorhizobium
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D020583 2006
% 208.36/208.57 |- mesh__historyNote mesh__D020583 2000
% 208.36/208.57 |- mesh__dateRevised mesh__D020583 2005-06-30
% 208.36/208.57 |- rdf__type mesh__D020583sskos__Concept
% 208.36/208.57 |- skos__historyNote mesh__D020583 Rhizobiaceae/genetics %28%1988-1996%29%
% 208.36/208.57 |- skos__historyNote mesh__D020583 Rhizobiaceae %28%1997-1999%29%
% 208.36/208.57 |- mesh__recordOriginator mesh__D020583 ndw
% 208.36/208.57 |- mesh__dateCreated mesh__D020583 1999-11-03
% 208.36/208.57 |- skos__broader mesh__D020583smesh__D041921
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D020583 sjn
% 208.36/208.57 |- mesh__dateEstablished mesh__D020583 2000-01-01
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D020583 2000
% 208.36/208.57 |- rdf__type mesh__D014546sskos__Concept
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D014546 2002
% 208.36/208.57 |- mesh__recordOriginator mesh__D014546 NLM
% 208.36/208.57 |- mesh__recordMaintainer mesh__D014546 PXP
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D014546 2004
% 208.36/208.57 |- skos__altLabel mesh__D014546 Catheterization, Urinary
% 208.36/208.57 |- mesh__dateRevised mesh__D014546 1997-06-20
% 208.36/208.57 |- skos__hiddenLabel mesh__D014546 Catheterizations, Urinary
% 208.36/208.57 |- skos__annotation mesh__D014546
% 208.36/208.57 do not use /util except by MeSH definition; coord IM with specific site %28%NIM%29% if pertinent; DF: URINARY CATH%A%
% 208.36/208.57 |- skos__hiddenLabel mesh__D014546 Urethral Catheterizations
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D014546 2003
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D014546 SJN
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D014546 2001
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D014546 2006
% 208.36/208.57 |- skos__hiddenLabel mesh__D014546 Ureteral Catheterizations
% 208.36/208.57 |- mesh__dateCreated mesh__D014546 1999-01-01
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D014546 1999
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D014546 2000
% 208.36/208.57 |- skos__scopeNote mesh__D014546
% 208.36/208.57 Employment or passage of a catheter into the bladder %28%urethral c.%29% or kidney %28%ureteral c.%29% for therapeutic or diagnostic purposes.%A%
% 208.36/208.57 |- skos__hiddenLabel mesh__D014546 Catheterizations, Ureteral
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D014546 2005
% 208.36/208.57 |- skos__broader mesh__D014546smesh__D002404
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D014546 1998
% 208.36/208.57 |- skos__hiddenLabel mesh__D014546 Urinary Catheterizations
% 208.36/208.57 |- skos__hiddenLabel mesh__D014546 Catheterizations, Urethral
% 208.36/208.57 |- skos__altLabel mesh__D014546 Urethral Catheterization
% 208.36/208.57 |- skos__altLabel mesh__D014546 Ureteral Catheterization
% 208.36/208.57 |- skos__prefLabel mesh__D014546 Urinary Catheterization
% 208.36/208.57 |- skos__broader mesh__D014546smesh__D003950
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 1998
% 208.36/208.57 |- skos__hiddenLabel mesh__D008509 Medication System
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 2002
% 208.36/208.57 |- mesh__dateRevised mesh__D008509 1996-06-10
% 208.36/208.57 |- skos__annotation mesh__D008509
% 208.36/208.57 an organizational concept in patient care for providing medication; do not confuse with DRUG DELIVERY SYSTEMS for admin of a drug to a patient or animal for %22%controlled delivery so that an optimum amount reaches the target site%22%; MEDICATION SYSTEMS, HOSPITAL is also available%A%
% 208.36/208.57 |- mesh__recordOriginator mesh__D008509 NLM
% 208.36/208.57 |- skos__hiddenLabel mesh__D008509 Systems, Medication
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D008509 PLS
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 2001
% 208.36/208.57 |- skos__prefLabel mesh__D008509 Medication Systems
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 2004
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 2000
% 208.36/208.57 |- skos__broader mesh__D008509smesh__D009934
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 2003
% 208.36/208.57 |- rdf__type mesh__D008509sskos__Concept
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 2006
% 208.36/208.57 |- mesh__recordMaintainer mesh__D008509 TGC
% 208.36/208.57 |- mesh__dateEstablished mesh__D008509 1973-01-01
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 1997
% 208.36/208.57 |- mesh__dateCreated mesh__D008509 1999-01-01
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 2005
% 208.36/208.57 |- skos__hiddenLabel mesh__D008509 System, Medication
% 208.36/208.57 |- skos__scopeNote mesh__D008509
% 208.36/208.57 Overall systems, traditional or automated, to provide medication to patients.%A%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D008509 1999
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D008509 73
% 208.36/208.57 |- mesh__historyNote mesh__D008509 73
% 208.36/208.57 |- skos__hiddenLabel mesh__D000526 H5628
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D000526 2006
% 208.36/208.57 |- skos__altLabel mesh__D000526 Astra Brand of Alprenolol Hydrochloride
% 208.36/208.57 |- mesh__dateRevised mesh__D000526 2005-06-30
% 208.36/208.57 |- skos__altLabel mesh__D000526 Alfeprol
% 208.36/208.57 |- skos__altLabel mesh__D000526
% 208.36/208.57 1-%28%o-Allylphenoxy%29%-3-%28%isopropylamino%29%-2-propanol
% 208.36/208.57 |- skos__broader mesh__D000526smesh__D011412
% 208.36/208.57 |- skos__scopeNote mesh__D000526
% 208.36/208.57 One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.%A%
% 208.36/208.57 |- skos__hiddenLabel mesh__D000526 Aptin Duriles
% 208.36/208.57 |- mesh__recordOriginator mesh__D000526 NLM
% 208.36/208.57 |- skos__historyNote mesh__D000526 Sympatholytics %28%1966-1971%29%
% 208.36/208.57 |- mesh__historyNote mesh__D000526 73%28%72%29%
% 208.36/208.57 |- skos__prefLabel mesh__D000526 Alprenolol
% 208.36/208.57 |- skos__altLabel mesh__D000526 Aptin-Duriles
% 208.36/208.57 |- mesh__recordMaintainer mesh__D000526 ssb
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D000526 73
% 208.36/208.57 |- mesh__dateCreated mesh__D000526 1999-01-01
% 208.36/208.57 |- skos__hiddenLabel mesh__D000526 H 56 28
% 208.36/208.57 |- skos__altLabel mesh__D000526 Made Brand of Alprenolol Hydrochloride
% 208.36/208.57 |- skos__hiddenLabel mesh__D000526 AptinDuriles
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D000526 sjn
% 208.36/208.57 |- rdf__type mesh__D000526sskos__Concept
% 208.36/208.57 |- skos__historyNote mesh__D000526 Amino Alcohols %28%1966-1971%29%
% 208.36/208.57 |- skos__altLabel mesh__D000526 Astra Brand of Alprenolol Benzoate
% 208.36/208.57 |- mesh__dateEstablished mesh__D000526 1973-01-01
% 208.36/208.57 |- skos__broader mesh__D000526smesh__D050198
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 1999
% 208.36/208.57 |- skos__hiddenLabel mesh__D019231 Prosthodontic Tooth Preparations
% 208.36/208.57 |- skos__hiddenLabel mesh__D019231 Preparations, Prosthodontic Tooth
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 2004
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 2001
% 208.36/208.57 |- skos__annotation mesh__D019231
% 208.36/208.57 restrict to prep procedures for prostheses; DENTAL CAVITY PREPARATION %28%for fillings %26% inlays%29% %26% ROOT CANAL PREPARATION are also available%A%
% 208.36/208.57 |- skos__hiddenLabel mesh__D019231 Preparation, Prosthodontic Tooth
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 2002
% 208.36/208.57 |- mesh__historyNote mesh__D019231 97
% 208.36/208.57 |- skos__related mesh__D019231smesh__D003737
% 208.36/208.57 |- skos__historyNote mesh__D019231
% 208.36/208.57 Dental Cavity Preparation %28%1966-1996%29%
% 208.36/208.57 |- skos__prefLabel mesh__D019231 Tooth Preparation, Prosthodontic
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 2005
% 208.36/208.57 |- mesh__dateEstablished mesh__D019231 1997-01-01
% 208.36/208.57 |- mesh__dateCreated mesh__D019231 1996-06-10
% 208.36/208.57 |- skos__hiddenLabel mesh__D019231 Tooth Preparations, Prosthodontic
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 2006
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 1997
% 208.36/208.57 |- rdf__type mesh__D019231sskos__Concept
% 208.36/208.57 |- skos__broader mesh__D019231smesh__D019246
% 208.36/208.57 |- skos__historyNote mesh__D019231
% 208.36/208.57 specific dental procedure %28%1966-1996%29%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 1998
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 2000
% 208.36/208.57 |- skos__hiddenLabel mesh__D019231 Prosthodontic Tooth Preparation
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D019231 2003
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D019231 97
% 208.36/208.57 |- skos__scopeNote mesh__D019231
% 208.36/208.57 The selected form given to a natural tooth when it is reduced by instrumentation to receive a prosthesis %28%e.g., artificial crown or a retainer for a fixed or removable prosthesis%29%. The selection of the form is guided by clinical circumstances and physical properties of the materials that make up the prosthesis. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p239%29%%A%
% 208.36/208.57 |- skos__broader mesh__D005211smesh__D014201
% 208.36/208.57 |- mesh__recordMaintainer mesh__D005211 lkt
% 208.36/208.57 |- skos__prefLabel mesh__D005211 Fascioliasis
% 208.36/208.57 |- rdf__type mesh__D005211sskos__Concept
% 208.36/208.57 |- mesh__dateRevised mesh__D005211 2004-07-07
% 208.36/208.57 |- skos__annotation mesh__D005211
% 208.36/208.57 do not confuse with FASCIOLOIDIASIS %28%caused by Fascioloides%29% or FASCIOLOPSIASIS %28%caused by Fasciolopsis%29%%A%
% 208.36/208.57 |- skos__hiddenLabel mesh__D005211 Fascioliases
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D005211 2006
% 208.36/208.57 |- mesh__dateCreated mesh__D005211 1999-01-01
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D005211 2005
% 208.36/208.57 |- skos__broader mesh__D005211smesh__D008109
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D005211 sjn
% 208.36/208.57 |- mesh__recordOriginator mesh__D005211 NLM
% 208.36/208.57 |- skos__scopeNote mesh__D005211
% 208.36/208.57 Liver disease caused by infections with parasitic flukes of the genus FASCIOLA, such as FASCIOLA HEPATICA.%A%
% 208.36/208.57 |- mesh__recordMaintainer mesh__D046628 ags
% 208.36/208.57 |- rdf__type mesh__D046628sskos__Concept
% 208.36/208.57 |- skos__broader mesh__D046628smesh__D001657
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D046628 2006
% 208.36/208.57 |- skos__historyNote mesh__D046628
% 208.36/208.57 Sphincter of Oddi/pathophysiology %28%1974-2004%29%
% 208.36/208.57 |- skos__scopeNote mesh__D046628
% 208.36/208.57 Organic or functional motility disorder involving the SPHINCTER OF ODDI and associated with biliary COLIC. Pathological changes are most often seen in the COMMON BILE DUCT sphincter, and less commonly the PANCREATIC DUCT sphincter.%A%
% 208.36/208.57 |- skos__historyNote mesh__D046628
% 208.36/208.57 Common Bile Duct Diseases %28%1985-2004%29%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D046628 2005
% 208.36/208.57 |- mesh__recordOriginator mesh__D046628 ags
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D046628 2005
% 208.36/208.57 |- mesh__dateEstablished mesh__D046628 2005-01-01
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D046628 sjn
% 208.36/208.57 |- skos__prefLabel mesh__D046628 Sphincter of Oddi Dysfunction
% 208.36/208.57 |- mesh__dateCreated mesh__D046628 2004-07-07
% 208.36/208.57 |- mesh__historyNote mesh__D046628 2005
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D018937
% 208.36/208.57 96; HEPATITIS C VIRUS ANTIBODIES was indexed under HEPATITIS ANTIBODIES 1992-95%A%
% 208.36/208.57 |- mesh__recordOriginator mesh__D018937 AGS
% 208.36/208.57 |- mesh__historyNote mesh__D018937
% 208.36/208.57 96; was HEPATITIS C VIRUS ANTIBODIES %28%NM%29% 1992-95
% 208.36/208.57 |- mesh__onlineNote mesh__D018937
% 208.36/208.57 use HEPATITIS C ANTIBODIES %28%NM%29% to search HEPATITIS C VIRUS ANTIBODIES 1992-95%A%
% 208.36/208.57 |- skos__hiddenLabel mesh__D018937 Anti HCV Antibodies
% 208.36/208.57 |- mesh__dateCreated mesh__D018937 1995-02-17
% 208.36/208.57 |- skos__broader mesh__D018937smesh__D006508
% 208.36/208.57 |- skos__altLabel mesh__D018937 Hepatitis C Virus Antibodies
% 208.36/208.57 |- mesh__dateRevised mesh__D018937 2005-06-30
% 208.36/208.57 |- skos__altLabel mesh__D018937 HCV Antibodies
% 208.36/208.57 |- rdf__type mesh__D018937sskos__Concept
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D018937 sjn
% 208.36/208.57 |- skos__altLabel mesh__D018937 Anti-Hepatitis C Virus Antibodies
% 208.36/208.57 |- skos__historyNote mesh__D018937 Hepatitis Antibodies %28%1992-1995%29%
% 208.36/208.57 |- skos__altLabel mesh__D018937 Anti-HCV Antibodies
% 208.36/208.57 |- skos__hiddenLabel mesh__D018937 Anti Hepatitis C Virus Antibodies
% 208.36/208.57 |- skos__scopeNote mesh__D018937
% 208.36/208.57 Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.%A%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018937 2006
% 208.36/208.57 |- skos__prefLabel mesh__D018937 Hepatitis C Antibodies
% 208.36/208.57 |- mesh__dateEstablished mesh__D018937 1996-01-01
% 208.36/208.57 |- mesh__recordMaintainer mesh__D018937 ssb
% 208.36/208.57 |- skos__scopeNote mesh__D010954
% 208.36/208.57 Any discrete, presumably solitary, mass of neoplastic plasma cells either in bone marrow or various extramedullary sites.%A%
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D010954 SJN
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010954 1999
% 208.36/208.57 |- skos__prefLabel mesh__D010954 Plasmacytoma
% 208.36/208.57 |- mesh__recordMaintainer mesh__D010954 TGC
% 208.36/208.57 |- skos__hiddenLabel mesh__D010954 Plasma Cell Tumors
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010954 2002
% 208.36/208.57 |- mesh__dateCreated mesh__D010954 1999-01-01
% 208.36/208.57 |- skos__hiddenLabel mesh__D010954 Plasmacytomas
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010954 1998
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010954 2004
% 208.36/208.57 |- mesh__dateEstablished mesh__D010954 1965-01-01
% 208.36/208.57 |- mesh__publicMeSHNote mesh__D010954 65; was PLASMOCYTOMA 1963-64
% 208.36/208.57 |- skos__annotation mesh__D010954
% 208.36/208.57 solitary = PLASMACYTOMA; multiple = MULTIPLE MYELOMA; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010954 2001
% 208.36/208.57 |- skos__hiddenLabel mesh__D010954 Tumors, Plasma Cell
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010954 2006
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010954 2003
% 208.36/208.57 |- skos__altLabel mesh__D010954 Plasma Cell Tumor
% 208.36/208.57 |- mesh__historyNote mesh__D010954 65; was PLASMOCYTOMA 1963-64
% 208.36/208.57 |- mesh__recordOriginator mesh__D010954 NLM
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010954 2000
% 208.36/208.57 |- skos__hiddenLabel mesh__D010954 Tumor, Plasma Cell
% 208.36/208.57 |- skos__hiddenLabel mesh__D010954 Plasmocytomas
% 208.36/208.57 |- mesh__dateRevised mesh__D010954 1997-06-20
% 208.36/208.57 |- skos__broader mesh__D010954smesh__D008223
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D010954 2005
% 208.36/208.57 |- skos__altLabel mesh__D010954 Plasmocytoma
% 208.36/208.57 |- rdf__type mesh__D010954sskos__Concept
% 208.36/208.57 |- skos__altLabel mesh__D018139 Herpesvirus 1, Saimirine
% 208.36/208.57 |- skos__hiddenLabel mesh__D018139 Herpes-T Viruses
% 208.36/208.57 |- skos__hiddenLabel mesh__D018139 Simplexviruses
% 208.36/208.57 |- skos__hiddenLabel mesh__D018139 Saimirine Herpesvirus 1
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018139 2003
% 208.36/208.57 |- skos__altLabel mesh__D018139 Herpesvirus papio 2
% 208.36/208.57 |- skos__broader mesh__D018139smesh__D018138
% 208.36/208.57 |- mesh__recordOriginator mesh__D018139 AGS
% 208.36/208.57 |- skos__scopeNote mesh__D018139
% 208.36/208.57 A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN.%A%
% 208.36/208.57 |- skos__altLabel mesh__D018139 Cercopithecine herpesvirus 16
% 208.36/208.57 |- mesh__dateCreated mesh__D018139 1993-06-04
% 208.36/208.57 |- skos__hiddenLabel mesh__D018139 Herpes labialis Viruses
% 208.36/208.57 |- skos__hiddenLabel mesh__D018139 Marmoset Herpesviruses
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018139 2006
% 208.36/208.57 |- skos__altLabel mesh__D018139 Herpes-T Virus
% 208.36/208.57 |- skos__hiddenLabel mesh__D018139 Herpes Simplex Viruses
% 208.36/208.57 |- skos__altLabel mesh__D018139 Marmoset Virus
% 208.36/208.57 |- skos__altLabel mesh__D018139 Herpes labialis Virus
% 208.36/208.57 |- mesh__recordAuthorizer mesh__D018139 sjn
% 208.36/208.57 |- rdf__type mesh__D018139sskos__Concept
% 208.36/208.57 |- mesh__onlineNote mesh__D018139
% 208.36/208.57 use SIMPLEXVIRUS to search FEVER BLISTER VIRUS 1976-93, MARMOSET VIRUS, HERPES-T VIRUS, %26% HERPESVIRUS PLATYRHINAE 1975-93, and HERPES SIMPLEX VIRUS %26% HERPESVIRUS HOMINIS 1966-93%A%
% 208.36/208.57 |- mesh__activeMeSHYear mesh__D018139 2005
% 208.36/208.57 |- skos__annotation mesh__D018139
% 208.36/208.57 note X ref HERPES SIMPLEX VIRUS: HERPES SIMPLEX VIRUS 1 and HERPES SIMPLEX VIRUS 2 are also available; do not confuse X ref HERPESVIRUS 1, SAIMIRINE with HERPESVIRUS 2, SAIMIRINE; infection = HERPES SIMPLEX or its indentions%A%
% 208.36/208.57 |- skos__altLabel mesh__D018139 Saimiriine herpesvirus 1
% 208.36/208.57 |- skos__altLabel mesh__D018139 Herpesvirus 1 %28%alpha%29%, Saimirine
% 208.36/208.57 |- skos__altLabel mesh__D018139 Herpesvirus platyrhinae
% 208.36/208.57 |- skos__hiddenLabel mesh__D018139 Marmoset Viruses
% 208.36/208.57 |- skos__hiddenLabel mesh__D018139 Herpesviruses, Marmoset
% 208.36/208.58 |- mesh__historyNote mesh__D018139
% 208.36/208.58 94; MARMOSET VIRUS was heading 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; HERPESVIRUS HOMINIS was heading 1963-93; HERPES-T VIRUS %26% HERPESVIRUS PLATYRHINAE were see MARMOSET VIRUS 1975-93; FEVER BLISTER VIRUS was see HERPESVIRUS HOMINIS 1976-93; HERPES SIMPLEX VIRUS was see HERPESVIRUS HOMINIS 1963-93%A%
% 208.36/208.58 |- mesh__recordMaintainer mesh__D018139 mdb
% 208.36/208.58 |- skos__hiddenLabel mesh__D018139 Herpesvirus, Marmoset
% 208.36/208.58 |- mesh__dateEstablished mesh__D018139 1994-01-01
% 208.36/208.58 |- skos__prefLabel mesh__D018139 Simplexvirus
% 208.36/208.58 |- skos__hiddenLabel mesh__D018139 Herpes T Virus
% 208.36/208.58 |- skos__altLabel mesh__D018139 Marmoset Herpesvirus
% 208.36/208.58 |- mesh__dateRevised mesh__D018139 2002-07-03
% 208.36/208.58 |- skos__altLabel mesh__D018139 Herpesvirus hominis
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D018139 2004
% 208.36/208.58 |- skos__altLabel mesh__D018139 Herpes Simplex Virus
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D018139
% 208.36/208.58 94; MARMOSET VIRUS was heading 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; HERPESVIRUS HOMINIS was heading 1963-93; HERPES-T VIRUS %26% HERPESVIRUS PLATYRHINAE were see MARMOSET VIRUS 1975-93; FEVER BLISTER VIRUS was see HERPESVIRUS HOMINIS 1976-93; HERPES SIMPLEX VIRUS was see HERPESVIRUS HOMINIS 1963-93;%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010156 2005
% 208.36/208.58 |- mesh__dateCreated mesh__D010156 1978-05-19
% 208.36/208.58 |- skos__prefLabel mesh__D010156 Palatal Muscles
% 208.36/208.58 |- skos__broader mesh__D010156smesh__D018482
% 208.36/208.58 |- skos__hiddenLabel mesh__D010156 Palatal Muscle
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010156 2006
% 208.36/208.58 |- skos__historyNote mesh__D010156 Muscles %28%1966-1978%29%
% 208.36/208.58 |- skos__hiddenLabel mesh__D010156 Muscles, Palatal
% 208.36/208.58 |- mesh__recordMaintainer mesh__D010156 lkt
% 208.36/208.58 |- mesh__dateRevised mesh__D010156 2003-07-09
% 208.36/208.58 |- skos__scopeNote mesh__D010156
% 208.36/208.58 The muscles of the palate are the glossopalatine, palatoglossus, levator palati%28%ni%29%, musculus uvulae, palatopharyngeus, and tensor palati%28%ni%29%.%A%
% 208.36/208.58 |- mesh__recordOriginator mesh__D010156 RC
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D010156 91; was see under MUSCLES 1979-90
% 208.36/208.58 |- skos__broader mesh__D010156smesh__D010159
% 208.36/208.58 |- mesh__historyNote mesh__D010156
% 208.36/208.58 91%28%79%29%; was see under MUSCLES 1979-90
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D010156 sjn
% 208.36/208.58 |- skos__annotation mesh__D010156
% 208.36/208.58 /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%
% 208.36/208.58 |- skos__hiddenLabel mesh__D010156 Muscle, Palatal
% 208.36/208.58 |- rdf__type mesh__D010156sskos__Concept
% 208.36/208.58 |- skos__historyNote mesh__D010156 Palate %28%1966-1978%29%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010156 2004
% 208.36/208.58 |- mesh__dateEstablished mesh__D010156 1991-01-01
% 208.36/208.58 |- skos__hiddenLabel mesh__D004917 TStat
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004917 2006
% 208.36/208.58 |- skos__hiddenLabel mesh__D004917 Phosphate, Erythromycin
% 208.36/208.58 |- skos__altLabel mesh__D004917 Erythromycin A
% 208.36/208.58 |- mesh__recordOriginator mesh__D004917 NLM
% 208.36/208.58 |- mesh__dateCreated mesh__D004917 1999-01-01
% 208.36/208.58 |- skos__hiddenLabel mesh__D004917 Lactate, Erythromycin
% 208.36/208.58 |- rdf__type mesh__D004917sskos__Concept
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D004917 sjn
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004917 2005
% 208.36/208.58 |- skos__hiddenLabel mesh__D004917 C, Erythromycin
% 208.36/208.58 |- skos__prefLabel mesh__D004917 Erythromycin
% 208.36/208.58 |- skos__hiddenLabel mesh__D004917 T Stat
% 208.36/208.58 |- mesh__dateRevised mesh__D004917 2004-07-07
% 208.36/208.58 |- mesh__recordMaintainer mesh__D004917 ssb
% 208.36/208.58 |- skos__scopeNote mesh__D004917
% 208.36/208.58 A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.%A%
% 208.36/208.58 |- skos__broader mesh__D004917smesh__D018942
% 208.36/208.58 |- skos__altLabel mesh__D004119 Dimethyl Adipinamidate
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004119 2004
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004119 2001
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D004119 sjn
% 208.36/208.58 |- mesh__historyNote mesh__D004119
% 208.36/208.58 91%28%78%29%; was see under IMIDOESTERS 1980-90; was see under IMIDES 1978-79%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004119 2003
% 208.36/208.58 |- mesh__dateEstablished mesh__D004119 1991-01-01
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004119 2006
% 208.36/208.58 |- skos__broader mesh__D004119smesh__D000272
% 208.36/208.58 |- skos__prefLabel mesh__D004119 Dimethyl Adipimidate
% 208.36/208.58 |- skos__hiddenLabel mesh__D004119 Adipimate, Dimethyl
% 208.36/208.58 |- skos__historyNote mesh__D004119 Imides %28%1966-1977%29%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004119 2005
% 208.36/208.58 |- skos__altLabel mesh__D004119 Dimethyl Adipimate
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D004119
% 208.36/208.58 91; was see under IMIDOESTERS 1980-90; was see under IMIDES 1978-79%A%
% 208.36/208.58 |- skos__hiddenLabel mesh__D004119 Adipinamidate, Dimethyl
% 208.36/208.58 |- mesh__dateRevised mesh__D004119 2000-06-21
% 208.36/208.58 |- mesh__recordMaintainer mesh__D004119 CCR
% 208.36/208.58 |- skos__broader mesh__D004119smesh__D007096
% 208.36/208.58 |- skos__historyNote mesh__D004119 Adipic Acids %28%1966-1977%29%
% 208.36/208.58 |- mesh__dateCreated mesh__D004119 1977-04-22
% 208.36/208.58 |- rdf__type mesh__D004119sskos__Concept
% 208.36/208.58 |- mesh__recordOriginator mesh__D004119 SH
% 208.36/208.58 |- skos__annotation mesh__D004119 D25-26 qualif
% 208.36/208.58 |- skos__hiddenLabel mesh__D004119 Adipimidate, Dimethyl
% 208.36/208.58 |- skos__scopeNote mesh__D004119
% 208.36/208.58 Bifunctional cross-linking agent that links covalently free amino groups of proteins or polypeptides, including those in cell membranes. It is used as reagent or fixative in immunohistochemistry and is a proposed antisickling agent.%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004119 2002
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D009602 sjn
% 208.36/208.58 |- skos__scopeNote mesh__D009602
% 208.36/208.58 A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties.%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009602 2002
% 208.36/208.58 |- mesh__dateCreated mesh__D009602 1999-01-01
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009602 2006
% 208.36/208.58 |- skos__broader mesh__D009602smesh__D009603
% 208.36/208.58 |- mesh__dateRevised mesh__D009602 1999-11-03
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009602 2005
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009602 2004
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009602 2001
% 208.36/208.58 |- mesh__recordMaintainer mesh__D009602 adp
% 208.36/208.58 |- mesh__recordOriginator mesh__D009602 NLM
% 208.36/208.58 |- skos__annotation mesh__D009602 carcinogens
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009602 2003
% 208.36/208.58 |- rdf__type mesh__D009602sskos__Concept
% 208.36/208.58 |- skos__prefLabel mesh__D009602 Nitrosamines
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009602 2000
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D020584 sjn
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D020584 2000
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D020584 2006
% 208.36/208.58 |- mesh__historyNote mesh__D020584 2000
% 208.36/208.58 |- rdf__type mesh__D020584sskos__Concept
% 208.36/208.58 |- skos__broader mesh__D020584smesh__D016946
% 208.36/208.58 |- skos__prefLabel mesh__D020584 Xanthobacter
% 208.36/208.58 |- mesh__recordOriginator mesh__D020584 ndw
% 208.36/208.58 |- skos__scopeNote mesh__D020584
% 208.36/208.58 A genus of gram-negative, aerobic, rod-shaped bacteria found in wet soil containing decaying organic material and in water. Cells tend to be pleomorphic if grown on media containing succinate or coccoid if grown in the presence of an alcohol as the sole carbon source. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.36/208.58 |- mesh__dateRevised mesh__D020584 2005-06-30
% 208.36/208.58 |- mesh__dateEstablished mesh__D020584 2000-01-01
% 208.36/208.58 |- mesh__recordMaintainer mesh__D020584 SYSTEM
% 208.36/208.58 |- skos__historyNote mesh__D020584
% 208.36/208.58 Gram-Negative Aerobic Bacteria %28%1985-1999%29%
% 208.36/208.58 |- mesh__dateCreated mesh__D020584 1999-11-03
% 208.36/208.58 |- skos__broader mesh__D020584smesh__D041921
% 208.36/208.58 |- skos__scopeNote mesh__D014547
% 208.36/208.58 Temporary or permanent diversion of the flow of urine through the ureter away from the bladder in the presence of a bladder disease or after cystectomy. There is a variety of techniques: direct anastomosis of ureter and bowel, cutaneous ureterostomy, ileal, jejunal or colon conduit, ureterosigmoidostomy, etc. %28%From Campbell%27%s Urology, 6th ed, p2654%29%%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D014547 2002
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D014547 2004
% 208.36/208.58 |- mesh__recordMaintainer mesh__D014547 PXP
% 208.36/208.58 |- skos__prefLabel mesh__D014547 Urinary Diversion
% 208.36/208.58 |- mesh__dateRevised mesh__D014547 1997-06-20
% 208.36/208.58 |- skos__hiddenLabel mesh__D014547 Conduit, Ileal
% 208.36/208.58 |- mesh__dateCreated mesh__D014547 1999-01-01
% 208.36/208.58 |- skos__broader mesh__D014547smesh__D013520
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D014547 2005
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D014547 1998
% 208.36/208.58 |- skos__hiddenLabel mesh__D014547 Conduits, Ileal
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D014547 SJN
% 208.36/208.58 |- mesh__recordOriginator mesh__D014547 NLM
% 208.36/208.58 |- skos__annotation mesh__D014547
% 208.36/208.58 GEN or unspecified; note specifics in tree; if not in tree, coord IM with organ /surg %28%NIM%29%; TN 189: do not coord with URETER; Manual 26.17.1; do not use /util except by MeSH defintion%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D014547 2006
% 208.36/208.58 |- skos__hiddenLabel mesh__D014547 Diversions, Urinary
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D014547 1999
% 208.36/208.58 |- skos__hiddenLabel mesh__D014547 Diversion, Urinary
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D014547 2000
% 208.36/208.58 |- skos__hiddenLabel mesh__D014547 Urinary Diversions
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D014547 2001
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D014547 2003
% 208.36/208.58 |- skos__hiddenLabel mesh__D014547 Ileal Conduits
% 208.36/208.58 |- rdf__type mesh__D014547sskos__Concept
% 208.36/208.58 |- mesh__dateEstablished mesh__D033701 2003-01-01
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D033701 2006A
% 208.36/208.58 |- skos__annotation mesh__D033701 GEN only; prefer specifics
% 208.36/208.58 |- mesh__recordOriginator mesh__D033701 jmp
% 208.36/208.58 |- skos__prefLabel mesh__D033701
% 208.36/208.58 Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins
% 208.36/208.58 |- skos__scopeNote mesh__D033701
% 208.36/208.58 A broad class of proteins involved in the transport of nucleobases, NUCLEOSIDES; NUCLEOTIDES; and NUCLEIC ACIDS; across membranes.%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D033701 2006
% 208.36/208.58 |- mesh__dateRevised mesh__D033701 2005-07-21
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D033701 ags
% 208.36/208.58 |- mesh__historyNote mesh__D033701 2003
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D033701 2003
% 208.36/208.58 |- rdf__type mesh__D033701sskos__Concept
% 208.36/208.58 |- mesh__recordMaintainer mesh__D033701 ags
% 208.36/208.58 |- mesh__dateCreated mesh__D033701 2002-07-03
% 208.36/208.58 |- skos__broader mesh__D033701smesh__D026901
% 208.36/208.58 |- skos__hiddenLabel mesh__D000527 Lipo PGE1
% 208.36/208.58 |- mesh__dateRevised mesh__D000527 2005-06-30
% 208.36/208.58 |- skos__altLabel mesh__D000527 Prostavasin
% 208.36/208.58 |- skos__altLabel mesh__D000527 PGE1alpha
% 208.36/208.58 |- skos__historyNote mesh__D000527 Prostaglandins %28%1966-1974%29%
% 208.36/208.58 |- skos__annotation mesh__D000527
% 208.36/208.58 /biosyn /physiol permitted; DF: note short X ref
% 208.36/208.58 |- skos__broader mesh__D000527smesh__D005229
% 208.36/208.58 |- skos__altLabel mesh__D000527 Viridal
% 208.36/208.58 |- skos__prefLabel mesh__D000527 Alprostadil
% 208.36/208.58 |- skos__altLabel mesh__D000527 Sugiran
% 208.36/208.58 |- skos__altLabel mesh__D000527 Astra Brand of Alprostadil
% 208.36/208.58 |- skos__altLabel mesh__D000527 Prostaglandin E1alpha
% 208.36/208.58 |- skos__broader mesh__D000527smesh__D011458
% 208.36/208.58 |- mesh__recordMaintainer mesh__D000527 lkw
% 208.36/208.58 |- skos__altLabel mesh__D000527 Pharmacia Brand 2 of Alprostadil
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D000527 2006
% 208.36/208.58 |- mesh__dateEstablished mesh__D000527 1986-01-01
% 208.36/208.58 |- skos__altLabel mesh__D000527 Hoyer Brand of Alprostadil
% 208.36/208.58 |- skos__altLabel mesh__D000527 AstraZeneca Brand of Alprostadil
% 208.36/208.58 |- skos__altLabel mesh__D000527 Vivus Brand of Alprostadil
% 208.36/208.58 |- mesh__historyNote mesh__D000527
% 208.36/208.58 86; see VASOPROSTAN %28%NM%29% 1995-97
% 208.36/208.58 |- skos__altLabel mesh__D000527 Minprog
% 208.36/208.58 |- skos__altLabel mesh__D000527 Prostaglandin E1
% 208.36/208.58 |- mesh__recordOriginator mesh__D000527 RLS
% 208.36/208.58 |- skos__altLabel mesh__D000527 Abbott Brand of Alprostadil
% 208.36/208.58 |- skos__altLabel mesh__D000527 Janssen Brand of Alprostadil
% 208.36/208.58 |- skos__historyNote mesh__D000527 Prostaglandins E %28%1975-1985%29%
% 208.36/208.58 |- skos__altLabel mesh__D000527 Muse
% 208.36/208.58 |- mesh__dateCreated mesh__D000527 1985-03-08
% 208.36/208.58 |- skos__altLabel mesh__D000527 Schwarz Brand of Alprostadil
% 208.36/208.58 |- skos__altLabel mesh__D000527 Paladin Brand of Alprostadil
% 208.36/208.58 |- skos__altLabel mesh__D000527 Prostine VR
% 208.36/208.58 |- rdf__type mesh__D000527sskos__Concept
% 208.36/208.58 |- skos__altLabel mesh__D000527 PGE1
% 208.36/208.58 |- skos__altLabel mesh__D000527 Lipo-PGE1
% 208.36/208.58 |- skos__altLabel mesh__D000527 Allphar Brand of Alprostadil
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D000527
% 208.36/208.58 86; VASOPROSTAN %28%now ALPROSTADIL%29% was indexed under VASODILATOR AGENTS 1995-97%A%
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D000527 sjn
% 208.36/208.58 |- skos__altLabel mesh__D000527 Pharmacia Brand 1 of Alprostadil
% 208.36/208.58 |- skos__scopeNote mesh__D000527
% 208.36/208.58 A potent vasodilator agent that increases peripheral blood flow. It inhibits platelet aggregation and has many other biological effects such as bronchodilation, mediation of inflammation, etc.%A%
% 208.36/208.58 |- skos__prefLabel mesh__D019232 Dental Restoration Failure
% 208.36/208.58 |- skos__broader mesh__D019232smesh__D003814
% 208.36/208.58 |- skos__broader mesh__D019232smesh__D017266
% 208.36/208.58 |- skos__annotation mesh__D019232
% 208.36/208.58 failure of a filling, inlay, crown, bridge, implant, any type of denture, etc.; coord IM with specific type of dent restoration or prosthesis %28%IM%29%; DF: DENT RESTORATION FAILURE%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 2000
% 208.36/208.58 |- skos__scopeNote mesh__D019232
% 208.36/208.58 Inability or inadequacy of a dental restoration or prosthesis to perform as expected.%A%
% 208.36/208.58 |- mesh__historyNote mesh__D019232 97
% 208.36/208.58 |- skos__altLabel mesh__D019232 Failure, Dental Prosthesis
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D019232 97
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 2005
% 208.36/208.58 |- skos__altLabel mesh__D019232 Dental Prosthesis Failures
% 208.36/208.58 |- skos__altLabel mesh__D019232 Prosthesis Failure, Dental
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 2001
% 208.36/208.58 |- skos__altLabel mesh__D019232 Dental Restoration Failures
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 2006
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 1997
% 208.36/208.58 |- skos__altLabel mesh__D019232 Prosthesis Failures, Dental
% 208.36/208.58 |- skos__altLabel mesh__D019232 Failure, Dental Restoration
% 208.36/208.58 |- rdf__type mesh__D019232sskos__Concept
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 2002
% 208.36/208.58 |- mesh__dateEstablished mesh__D019232 1997-01-01
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 1998
% 208.36/208.58 |- mesh__dateCreated mesh__D019232 1996-06-10
% 208.36/208.58 |- skos__altLabel mesh__D019232 Failures, Dental Restoration
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 2003
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 1999
% 208.36/208.58 |- skos__altLabel mesh__D019232 Restoration Failures, Dental
% 208.36/208.58 |- skos__altLabel mesh__D019232 Failures, Dental Prosthesis
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D019232 2004
% 208.36/208.58 |- skos__altLabel mesh__D019232 Restoration Failure, Dental
% 208.36/208.58 |- skos__historyNote mesh__D005212 Trematoda %28%1966-1981%29%
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D005212
% 208.36/208.58 82; FASCIOLOPSIS was heading 1963-81
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D005212 sjn
% 208.36/208.58 |- rdf__type mesh__D005212sskos__Concept
% 208.36/208.58 |- skos__prefLabel mesh__D005212 Fasciolidae
% 208.36/208.58 |- skos__broader mesh__D005212smesh__D014200
% 208.36/208.58 |- skos__annotation mesh__D005212
% 208.36/208.58 a family of trematodes; infection: coord IM with TREMATODE INFECTIONS %28%IM%29% but note specific FASCIOL- disease terms; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 208.36/208.58 |- skos__scopeNote mesh__D005212
% 208.36/208.58 A family of flukes of the class Trematoda occurring primarily in the liver of animals and man. There are six genera: Fasciola, Fasciolopsis, Fascioloides, Tenuifasciola, Parafasciolopsis, and Protofasciola. The adult form of Fasciolopsis occurs in the intestines of pigs and man.%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D005212 2005
% 208.36/208.58 |- mesh__dateCreated mesh__D005212 1981-05-15
% 208.36/208.58 |- mesh__dateEstablished mesh__D005212 1982-01-01
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D005212 2006
% 208.36/208.58 |- mesh__recordOriginator mesh__D005212 EC
% 208.36/208.58 |- mesh__historyNote mesh__D005212 82; FASCIOLOPSIS was heading 1963-81
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D005212 2004
% 208.36/208.58 |- mesh__onlineNote mesh__D005212
% 208.36/208.58 use FASCIOLIDAE to search FASCIOLOPSIS 1966-80
% 208.36/208.58 |- mesh__recordMaintainer mesh__D005212 ags
% 208.36/208.58 |- mesh__dateRevised mesh__D005212 2003-07-09
% 208.36/208.58 |- skos__broader mesh__D018938smesh__D004847
% 208.36/208.58 |- mesh__recordMaintainer mesh__D018938 nns
% 208.36/208.58 |- skos__hiddenLabel mesh__D018938 Cell, Caco-2
% 208.36/208.58 |- skos__annotation mesh__D018938
% 208.36/208.58 Caco stands for adenoCArcinoma of the COlon; almost always NIM with no subheadings; check HUMAN; do not routinely add ADENOCARCINOMA or COLONIC NEOPLASMS%A%
% 208.36/208.58 |- skos__hiddenLabel mesh__D018938 Cells, Caco-2
% 208.36/208.58 |- mesh__dateEstablished mesh__D018938 1996-01-01
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D018938 2004
% 208.36/208.58 |- skos__hiddenLabel mesh__D018938 Caco 2 Cells
% 208.36/208.58 |- skos__broader mesh__D018938smesh__D045744
% 208.36/208.58 |- rdf__type mesh__D018938sskos__Concept
% 208.36/208.58 |- mesh__historyNote mesh__D018938 96
% 208.36/208.58 |- skos__historyNote mesh__D018938 Tumor Cells, Cultured %28%1988-1995%29%
% 208.36/208.58 |- mesh__dateCreated mesh__D018938 1995-05-24
% 208.36/208.58 |- skos__prefLabel mesh__D018938 Caco-2 Cells
% 208.36/208.58 |- mesh__dateRevised mesh__D018938 2003-07-09
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D018938 2006
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D018938 96
% 208.36/208.58 |- skos__historyNote mesh__D018938 Cell Line %28%1984-1995%29%
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D018938 sjn
% 208.36/208.58 |- mesh__recordOriginator mesh__D018938 PXP
% 208.36/208.58 |- skos__hiddenLabel mesh__D018938 Caco-2 Cell
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D018938 2005
% 208.36/208.58 |- skos__scopeNote mesh__D018938
% 208.36/208.58 Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation.%A%
% 208.36/208.58 |- mesh__recordMaintainer mesh__D010955 ags
% 208.36/208.58 |- mesh__dateRevised mesh__D010955 2005-07-15
% 208.36/208.58 |- skos__hiddenLabel mesh__D010955 Phospholipids, Alkenyl Ether
% 208.36/208.58 |- skos__prefLabel mesh__D010955 Plasmalogens
% 208.36/208.58 |- skos__hiddenLabel mesh__D010955 Ether Phospholipids, Alkenyl
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010955 2006A
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010955 2004
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010955 2005
% 208.36/208.58 |- skos__hiddenLabel mesh__D010955 Compounds, Phosphatidal
% 208.36/208.58 |- skos__scopeNote mesh__D010955
% 208.36/208.58 GLYCEROPHOSPHOLIPIDS in which one of the two acyl chains is attached to glycerol with an ether alkenyl linkage instead of an ester as with the other glycerophospholipids.%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010955 2006
% 208.36/208.58 |- skos__annotation mesh__D010955
% 208.36/208.58 do not confuse X ref here with specific phosphatidyl compounds in MeSH%A%
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D010955 ags
% 208.36/208.58 |- skos__broader mesh__D010955smesh__D010742
% 208.36/208.58 |- mesh__dateCreated mesh__D010955 1999-01-01
% 208.36/208.58 |- rdf__type mesh__D010955sskos__Concept
% 208.36/208.58 |- mesh__recordOriginator mesh__D010955 NLM
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010157 2002
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010157 2005
% 208.36/208.58 |- mesh__dateRevised mesh__D010157 2000-06-22
% 208.36/208.58 |- skos__prefLabel mesh__D010157 Palatal Neoplasms
% 208.36/208.58 |- skos__annotation mesh__D010157
% 208.36/208.58 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010157 2006
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D010157 sjn
% 208.36/208.58 |- skos__broader mesh__D010157smesh__D009062
% 208.36/208.58 |- mesh__recordOriginator mesh__D010157 NLM
% 208.36/208.58 |- skos__broader mesh__D010157smesh__D007573
% 208.36/208.58 |- rdf__type mesh__D010157sskos__Concept
% 208.36/208.58 |- skos__hiddenLabel mesh__D010157 Palatal Neoplasm
% 208.36/208.58 |- mesh__dateCreated mesh__D010157 1999-01-01
% 208.36/208.58 |- skos__hiddenLabel mesh__D010157 Neoplasms, Palatal
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010157 2003
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010157 2001
% 208.36/208.58 |- mesh__recordMaintainer mesh__D010157 nns
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D010157 2004
% 208.36/208.58 |- skos__hiddenLabel mesh__D010157 Neoplasm, Palatal
% 208.36/208.58 |- skos__scopeNote mesh__D010157
% 208.36/208.58 Tumors or cancer of the PALATE, including those of the hard palate, soft palate and UVULA.%A%
% 208.36/208.58 |- skos__historyNote mesh__D004918 Propionates %28%1974%29%
% 208.36/208.58 |- skos__prefLabel mesh__D004918 Erythromycin Estolate
% 208.36/208.58 |- mesh__recordMaintainer mesh__D004918 ssb
% 208.36/208.58 |- mesh__dateRevised mesh__D004918 2004-07-07
% 208.36/208.58 |- mesh__historyNote mesh__D004918
% 208.36/208.58 91%28%75%29%; was see under ERYTHROMYCIN 1975-90
% 208.36/208.58 |- skos__historyNote mesh__D004918 Sodium Dodecyl Sulfate %28%1974%29%
% 208.36/208.58 |- mesh__dateEstablished mesh__D004918 1991-01-01
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D004918
% 208.36/208.58 91; was see under ERYTHROMYCIN 1975-90
% 208.36/208.58 |- skos__historyNote mesh__D004918 Erythromycin %28%1970-1974%29%
% 208.36/208.58 |- mesh__recordOriginator mesh__D004918 NLM
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004918 2006
% 208.36/208.58 |- skos__altLabel mesh__D004918 Erythromycin Propionate Lauryl Sulfate
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D004918 sjn
% 208.36/208.58 |- skos__altLabel mesh__D004918 Erythromycin Propionate Monododecyl Sulfate
% 208.36/208.58 |- skos__altLabel mesh__D004918 Erythromycin Propionate Dodecyl Sulfate
% 208.36/208.58 |- skos__scopeNote mesh__D004918
% 208.36/208.58 A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D004918 2005
% 208.36/208.58 |- skos__hiddenLabel mesh__D004918 Estolate, Erythromycin
% 208.36/208.58 |- skos__broader mesh__D004918smesh__D004917
% 208.36/208.58 |- rdf__type mesh__D004918sskos__Concept
% 208.36/208.58 |- mesh__dateCreated mesh__D004918 1974-11-19
% 208.36/208.58 |- skos__broader mesh__D015640smesh__D015398
% 208.36/208.58 |- skos__broader mesh__D015640smesh__D002468
% 208.36/208.58 |- skos__historyNote mesh__D015640 Electrophysiology %28%1966-1989%29%
% 208.36/208.58 |- rdf__type mesh__D015640sskos__Concept
% 208.36/208.58 |- mesh__recordOriginator mesh__D015640 AGS
% 208.36/208.58 |- mesh__recordMaintainer mesh__D015640 AGS
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 2003
% 208.36/208.58 |- skos__altLabel mesh__D015640 Gating, Ion Channel
% 208.36/208.58 |- mesh__dateRevised mesh__D015640 1996-06-10
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 2005
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 2000
% 208.36/208.58 |- skos__prefLabel mesh__D015640 Ion Channel Gating
% 208.36/208.58 |- mesh__historyNote mesh__D015640 90
% 208.36/208.58 |- mesh__dateCreated mesh__D015640 1989-06-19
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 2004
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 2001
% 208.36/208.58 |- skos__scopeNote mesh__D015640
% 208.36/208.58 The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential %28%voltage-gated%29%, drugs or chemical transmitters %28%ligand-gated%29%, or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability.%A%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 2006
% 208.36/208.58 |- skos__annotation mesh__D015640
% 208.36/208.58 %22%opening %26% closing of ion channels%22% after various types of stimulation; DF: GATING%A%
% 208.36/208.58 |- skos__historyNote mesh__D015640 Electric Conductivity %28%1966-1989%29%
% 208.36/208.58 |- mesh__dateEstablished mesh__D015640 1990-01-01
% 208.36/208.58 |- skos__hiddenLabel mesh__D015640 Gatings, Ion Channel
% 208.36/208.58 |- mesh__publicMeSHNote mesh__D015640 90
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 1998
% 208.36/208.58 |- skos__historyNote mesh__D015640 Membrane Potentials %28%1966-1989%29%
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 1997
% 208.36/208.58 |- mesh__recordAuthorizer mesh__D015640 PLS
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 1999
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D015640 2002
% 208.36/208.58 |- skos__hiddenLabel mesh__D015640 Ion Channel Gatings
% 208.36/208.58 |- skos__historyNote mesh__D015640 Ion Channels %28%1979-1989%29%
% 208.36/208.58 |- skos__annotation mesh__D009603 DF: NITROSO CPDS
% 208.36/208.58 |- skos__prefLabel mesh__D009603 Nitroso Compounds
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009603 2000
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009603 1996
% 208.36/208.58 |- mesh__dateCreated mesh__D009603 1999-01-01
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009603 2006
% 208.36/208.58 |- skos__hiddenLabel mesh__D009603 Compounds, Nitroso
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009603 1995
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009603 2004
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009603 2005
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009603 2002
% 208.36/208.58 |- mesh__recordMaintainer mesh__D009603 TAP
% 208.36/208.58 |- mesh__dateRevised mesh__D009603 1992-05-19
% 208.36/208.58 |- mesh__activeMeSHYear mesh__D009603 1993
% 208.44/208.58 |- mesh__activeMeSHYear mesh__D009603 1994
% 208.44/208.58 |- rdf__type mesh__D009603sskos__Concept
% 208.44/208.58 |- mesh__activeMeSHYear mesh__D009603 2003
% 208.44/208.58 |- mesh__activeMeSHYear mesh__D009603 1999
% 208.44/208.58 |- skos__broader mesh__D009603smesh__D009930
% 208.44/208.58 |- mesh__activeMeSHYear mesh__D009603 2001
% 208.44/208.58 |- mesh__activeMeSHYear mesh__D009603 1997
% 208.44/208.58 |- mesh__activeMeSHYear mesh__D009603 1998
% 208.44/208.58 |- mesh__recordOriginator mesh__D009603 NLM
% 208.44/208.58 |- mesh__recordAuthorizer mesh__D009603 PLS
% 208.44/208.58 |- skos__hiddenLabel mesh__D001620 Thromboglobulin, beta-2
% 208.44/208.58 |- skos__broader mesh__D001620smesh__D018925
% 208.44/208.58 |- mesh__dateEstablished mesh__D001620 1987-01-01
% 208.44/208.58 |- mesh__recordOriginator mesh__D001620 RLS
% 208.44/208.58 |- skos__historyNote mesh__D001620 Beta Globulins %28%1966-1979%29%
% 208.44/208.58 |- mesh__dateCreated mesh__D001620 1979-05-23
% 208.44/208.58 |- mesh__dateRevised mesh__D001620 2005-06-30
% 208.44/208.58 |- skos__broader mesh__D001620smesh__D001779
% 208.44/208.58 |- skos__broader mesh__D001620smesh__D001609
% 208.44/208.58 |- rdf__type mesh__D001620sskos__Concept
% 208.44/208.58 |- mesh__historyNote mesh__D001620
% 208.44/208.58 87%28%80%29%; was see under BETA GLOBULINS 1980-86
% 208.44/208.58 |- skos__hiddenLabel mesh__D001620 beta 2 Thromboglobulin
% 208.44/208.58 |- skos__hiddenLabel mesh__D001620 beta Thromboglobulin
% 208.44/208.59 |- skos__prefLabel mesh__D001620 beta-Thromboglobulin
% 208.44/208.59 |- skos__annotation mesh__D001620
% 208.44/208.59 /biosyn /physiol permitted; DF: BETA TG
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D001620
% 208.44/208.59 87; was see under BETA GLOBULINS 1980-86
% 208.44/208.59 |- mesh__recordMaintainer mesh__D001620 ssb
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D001620 sjn
% 208.44/208.59 |- skos__scopeNote mesh__D001620
% 208.44/208.59 A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders.%A%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D001620 2006
% 208.44/208.59 |- mesh__recordMaintainer mesh__D020585 SYSTEM
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D020585 2000
% 208.44/208.59 |- mesh__historyNote mesh__D020585 2000
% 208.44/208.59 |- skos__prefLabel mesh__D020585 Comamonas
% 208.44/208.59 |- rdf__type mesh__D020585sskos__Concept
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D020585 2006
% 208.44/208.59 |- skos__annotation mesh__D020585
% 208.44/208.59 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 208.44/208.59 |- mesh__recordOriginator mesh__D020585 ndw
% 208.44/208.59 |- mesh__dateRevised mesh__D020585 2005-06-30
% 208.44/208.59 |- mesh__dateEstablished mesh__D020585 2000-01-01
% 208.44/208.59 |- skos__broader mesh__D020585smesh__D042621
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D020585 sjn
% 208.44/208.59 |- skos__scopeNote mesh__D020585
% 208.44/208.59 A genus of gram-negative, straight or slightly curved rods which are motile by polar flagella and which accumulate poly-beta-hydroxybutyrate within the cells.%A%
% 208.44/208.59 |- mesh__dateCreated mesh__D020585 1999-11-03
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D014548 2001
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D014548 2005
% 208.44/208.59 |- skos__hiddenLabel mesh__D014548 Fistula, Urinary
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D014548 2002
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D014548 2006
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D014548 sjn
% 208.44/208.59 |- mesh__dateRevised mesh__D014548 1999-11-08
% 208.44/208.59 |- mesh__recordOriginator mesh__D014548 NLM
% 208.44/208.59 |- skos__prefLabel mesh__D014548 Urinary Fistula
% 208.44/208.59 |- skos__hiddenLabel mesh__D014548 Fistulas, Urinary
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D014548 2003
% 208.44/208.59 |- skos__scopeNote mesh__D014548
% 208.44/208.59 An abnormal passage in any organ of the urinary tract or between urinary organs and other organs.%A%
% 208.44/208.59 |- rdf__type mesh__D014548sskos__Concept
% 208.44/208.59 |- skos__annotation mesh__D014548
% 208.44/208.59 GEN or unspecified; coord IM with pre-coord urinary organ/diseases %28%IM%29%; fistula policy: Manual 23.19+; BLADDER FISTULA %26% VESICOVAGINAL FISTULA are available%A%
% 208.44/208.59 |- mesh__recordMaintainer mesh__D014548 KEV
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D014548 2000
% 208.44/208.59 |- skos__hiddenLabel mesh__D014548 Urinary Fistulas
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D014548 2004
% 208.44/208.59 |- skos__broader mesh__D014548smesh__D014570
% 208.44/208.59 |- skos__broader mesh__D014548smesh__D005402
% 208.44/208.59 |- mesh__dateCreated mesh__D014548 1999-01-01
% 208.44/208.59 |- mesh__dateCreated mesh__D033702 2002-07-03
% 208.44/208.59 |- mesh__dateRevised mesh__D033702 2005-06-30
% 208.44/208.59 |- skos__scopeNote mesh__D033702
% 208.44/208.59 Proteins involved in the transport of nucleobases such as PYRIMIDINES and PURINES across membranes.%A%
% 208.44/208.59 |- skos__broader mesh__D033702smesh__D033701
% 208.44/208.59 |- mesh__dateEstablished mesh__D033702 2003-01-01
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D033702 2006
% 208.44/208.59 |- skos__hiddenLabel mesh__D033702 Transport Proteins, Nucleobase
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D033702 2003
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D033702 sjn
% 208.44/208.59 |- mesh__recordOriginator mesh__D033702 jmp
% 208.44/208.59 |- skos__prefLabel mesh__D033702 Nucleobase Transport Proteins
% 208.44/208.59 |- rdf__type mesh__D033702sskos__Concept
% 208.44/208.59 |- mesh__recordMaintainer mesh__D033702 SYSTEM
% 208.44/208.59 |- mesh__historyNote mesh__D033702 2003
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D019233 sjn
% 208.44/208.59 |- skos__broader mesh__D019233smesh__D013812
% 208.44/208.59 |- skos__prefLabel mesh__D019233 Retreatment
% 208.44/208.59 |- rdf__type mesh__D019233sskos__Concept
% 208.44/208.59 |- mesh__dateCreated mesh__D019233 1996-06-10
% 208.44/208.59 |- skos__related mesh__D019233smesh__D012086
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D019233 2003
% 208.44/208.59 |- mesh__recordMaintainer mesh__D019233 jls
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D019233 2004
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D019233 97
% 208.44/208.59 |- mesh__dateRevised mesh__D019233 2000-06-22
% 208.44/208.59 |- mesh__historyNote mesh__D019233 97
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D019233 2001
% 208.44/208.59 |- mesh__recordOriginator mesh__D019233 TGC
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D019233 2005
% 208.44/208.59 |- mesh__dateEstablished mesh__D019233 1997-01-01
% 208.44/208.59 |- skos__hiddenLabel mesh__D019233 Retreatments
% 208.44/208.59 |- skos__annotation mesh__D019233
% 208.44/208.59 NIM; coord with specific type of ther %28%IM%29% + specific disease /ther %28%or other ther qualif%29% %28%IM%29%%A%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D019233 2002
% 208.44/208.59 |- skos__scopeNote mesh__D019233
% 208.44/208.59 The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful.%A%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D019233 2006
% 208.44/208.59 |- skos__broader mesh__D000528smesh__D003904
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D000528
% 208.44/208.59 91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85
% 208.44/208.59 |- skos__annotation mesh__D000528
% 208.44/208.59 infection: coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D000528 sjn
% 208.44/208.59 |- rdf__type mesh__D000528sskos__Concept
% 208.44/208.59 |- mesh__dateCreated mesh__D000528 1974-12-12
% 208.44/208.59 |- skos__scopeNote mesh__D000528
% 208.44/208.59 A mitosporic Loculoascomycetes fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. Its teleomorph is Lewia.%A%
% 208.44/208.59 |- mesh__dateRevised mesh__D000528 2005-06-30
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D000528 2006
% 208.44/208.59 |- mesh__historyNote mesh__D000528 91%28%75%29%
% 208.44/208.59 |- mesh__dateEstablished mesh__D000528 1991-01-01
% 208.44/208.59 |- mesh__recordMaintainer mesh__D000528 SYSTEM
% 208.44/208.59 |- mesh__recordOriginator mesh__D000528 NLM
% 208.44/208.59 |- skos__prefLabel mesh__D000528 Alternaria
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D011250 sjn
% 208.44/208.59 |- skos__prefLabel mesh__D011250 Pregnancy Complications, Hematologic
% 208.44/208.59 |- skos__altLabel mesh__D011250 Complications, Hematologic Pregnancy
% 208.44/208.59 |- mesh__recordMaintainer mesh__D011250 lkt
% 208.44/208.59 |- skos__hiddenLabel mesh__D011250 Hematologic Pregnancy Complication
% 208.44/208.59 |- skos__altLabel mesh__D011250 Hematologic Pregnancy Complications
% 208.44/208.59 |- mesh__dateRevised mesh__D011250 2005-06-30
% 208.44/208.59 |- skos__hiddenLabel mesh__D011250 Complications, Hematological Pregnancy
% 208.44/208.59 |- skos__altLabel mesh__D011250 Pregnancy Complications, Hematological
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D011250 2006
% 208.44/208.59 |- skos__scopeNote mesh__D011250
% 208.44/208.59 The co-occurrence of pregnancy and a blood disease %28%HEMATOLOGIC DISEASES%29% which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.%A%
% 208.44/208.59 |- skos__hiddenLabel mesh__D011250 Complication, Hematological Pregnancy
% 208.44/208.59 |- mesh__dateEstablished mesh__D011250 1964-01-01
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D011250 64
% 208.44/208.59 |- skos__annotation mesh__D011250
% 208.44/208.59 for disorders of formed elements or coagulation processes of blood in pregnancy, not for excess or deficiency of substances in the blood %28%as HYPOKALEMIA + PREGNANCY COMPLICATIONS not PREGNANCY COMPLICATIONS, HEMATOLOGIC%29%; coordinate IM with specific hematologic disease %28%IM%29%; check the tags FEMALE %26% PREGNANCY; hemorrhage during pregnancy goes under PREGNANCY COMPLICATIONS, CARDIOVASCULAR, not here; Manual 18.4.7; DF: PREGN COMPL HEMATOL%A%
% 208.44/208.59 |- skos__hiddenLabel mesh__D011250 Pregnancies, Hematologic Complications
% 208.44/208.59 |- skos__hiddenLabel mesh__D011250 Pregnancy Complication, Hematological
% 208.44/208.59 |- skos__hiddenLabel mesh__D011250 Pregnancy Complication, Hematologic
% 208.44/208.59 |- skos__hiddenLabel mesh__D011250 Hematological Pregnancy Complication
% 208.44/208.59 |- skos__hiddenLabel mesh__D011250 Complication, Hematologic Pregnancy
% 208.44/208.59 |- mesh__recordOriginator mesh__D011250 NLM
% 208.44/208.59 |- mesh__dateCreated mesh__D011250 1999-01-01
% 208.44/208.59 |- skos__hiddenLabel mesh__D011250 Hematological Pregnancy Complications
% 208.44/208.59 |- skos__broader mesh__D011250smesh__D006402
% 208.44/208.59 |- rdf__type mesh__D011250sskos__Concept
% 208.44/208.59 |- mesh__historyNote mesh__D011250 64
% 208.44/208.59 |- skos__broader mesh__D011250smesh__D011248
% 208.44/208.59 |- skos__altLabel mesh__D011250 Pregnancy, Hematologic Complications
% 208.44/208.59 |- mesh__dateCreated mesh__D005213 1999-01-01
% 208.44/208.59 |- rdf__type mesh__D005213sskos__Concept
% 208.44/208.59 |- skos__broader mesh__D005213smesh__D006374
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D005213 2005
% 208.44/208.59 |- mesh__dateRevised mesh__D005213 2003-07-30
% 208.44/208.59 |- mesh__historyNote mesh__D005213 68
% 208.44/208.59 |- skos__historyNote mesh__D005213 Trematode Infections %28%1966-1967%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D005213 2006
% 208.44/208.59 |- skos__hiddenLabel mesh__D005213 Fascioloidiases
% 208.44/208.59 |- mesh__recordOriginator mesh__D005213 NLM
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D005213 68
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D005213 sjn
% 208.44/208.59 |- skos__scopeNote mesh__D005213
% 208.44/208.59 Infection of cattle and other herbivores with the giant liver fluke Fascioloides magna. It is characterized by extensive destruction of the liver parenchyma.%A%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D005213 2004
% 208.44/208.59 |- mesh__recordMaintainer mesh__D005213 ags
% 208.44/208.59 |- skos__annotation mesh__D005213
% 208.44/208.59 trematode infect; usually animal; check tag ANIMALS; caused by FASCIOLOIDES; do not confuse with FASCIOLIASIS %28%caused by FASCIOLA%29% or FASCIOLOPSIASIS %28%caused by FASCIOLOPSIS%29%%A%
% 208.44/208.59 |- mesh__dateEstablished mesh__D005213 1968-01-01
% 208.44/208.59 |- skos__broader mesh__D005213smesh__D014201
% 208.44/208.59 |- skos__prefLabel mesh__D005213 Fascioloidiasis
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 2003
% 208.44/208.59 |- skos__broader mesh__D018939smesh__D010687
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D018939 96
% 208.44/208.59 |- skos__historyNote mesh__D018939 Holistic Health %28%1980-1995%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 2002
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 1996
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 2004
% 208.44/208.59 |- rdf__type mesh__D018939sskos__Concept
% 208.44/208.59 |- mesh__dateEstablished mesh__D018939 1996-01-01
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 1997
% 208.44/208.59 |- skos__scopeNote mesh__D018939
% 208.44/208.59 A philosophy of nursing practice that takes into account total patient care, considering the physical, emotional, social, economic, and spiritual needs of patients, their response to their illnesses, and the effect of illness on patients%27% abilities to meet self-care needs. %28%From Mosby%27%s Medical, Nursing, %26% Allied Health Dictionary, 4th ed, p745%29%%A%
% 208.44/208.59 |- mesh__historyNote mesh__D018939 96
% 208.44/208.59 |- skos__broader mesh__D018939smesh__D009732
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 2005
% 208.44/208.59 |- skos__broader mesh__D018939smesh__D013041
% 208.44/208.59 |- skos__prefLabel mesh__D018939 Holistic Nursing
% 208.44/208.59 |- skos__historyNote mesh__D018939 Nursing Care %28%1971-1995%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 1998
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 2006
% 208.44/208.59 |- mesh__dateCreated mesh__D018939 1995-02-17
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 2000
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 1999
% 208.44/208.59 |- skos__annotation mesh__D018939 SPEC; SPEC qualif; DF: HOLISTIC NURS
% 208.44/208.59 |- skos__altLabel mesh__D018939 Nursing, Holistic
% 208.44/208.59 |- skos__historyNote mesh__D018939 Philosophy, Nursing %28%1971-1995%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D018939 2001
% 208.44/208.59 |- mesh__recordMaintainer mesh__D010956 lkt
% 208.44/208.59 |- mesh__recordOriginator mesh__D010956 NLM
% 208.44/208.59 |- skos__broader mesh__D010956smesh__D016060
% 208.44/208.59 |- skos__prefLabel mesh__D010956 Plasmapheresis
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010956 2006
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D010956 68
% 208.44/208.59 |- skos__hiddenLabel mesh__D010956 Plasmaphereses
% 208.44/208.59 |- mesh__historyNote mesh__D010956 68%28%65%29%
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D010956 sjn
% 208.44/208.59 |- rdf__type mesh__D010956sskos__Concept
% 208.44/208.59 |- mesh__dateCreated mesh__D010956 1999-01-01
% 208.44/208.59 |- mesh__dateEstablished mesh__D010956 1968-01-01
% 208.44/208.59 |- skos__annotation mesh__D010956
% 208.44/208.59 do not use /util except by MeSH definition
% 208.44/208.59 |- skos__scopeNote mesh__D010956
% 208.44/208.59 Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.%A%
% 208.44/208.59 |- mesh__dateRevised mesh__D010956 2005-06-30
% 208.44/208.59 |- skos__broader mesh__D010956smesh__D001781
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D029661 2003
% 208.44/208.59 |- mesh__dateCreated mesh__D029661 2001-07-25
% 208.44/208.59 |- mesh__dateEstablished mesh__D029661 2002-01-01
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D029661 2004
% 208.44/208.59 |- skos__annotation mesh__D029661
% 208.44/208.59 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.44/208.59 |- mesh__historyNote mesh__D029661 2002
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D029661 2002
% 208.44/208.59 |- rdf__type mesh__D029661sskos__Concept
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D029661 2005
% 208.44/208.59 |- skos__broader mesh__D029661smesh__D029401
% 208.44/208.59 |- skos__scopeNote mesh__D029661
% 208.44/208.59 A plant genus of the family BETULACEAE that is distinguished from birch %28%BETULA%29% by its usually stalked winter buds and by cones that remain on the branches after the small, winged nutlets are released.%A%
% 208.44/208.59 |- skos__prefLabel mesh__D029661 Alnus
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D029661 2006
% 208.44/208.59 |- skos__altLabel mesh__D029661 Alder
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D029661 2002
% 208.44/208.59 |- mesh__dateEstablished mesh__D010158 1966-01-01
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010158 2001
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D010158 SJN
% 208.44/208.59 |- mesh__onlineNote mesh__D010158
% 208.44/208.59 use PALATAL OBTURATORS to search CLEFT PALATE PROSTHESIS 1966-82%A%
% 208.44/208.59 |- skos__hiddenLabel mesh__D010158 Prosthesis, Cleft Palate
% 208.44/208.59 |- skos__hiddenLabel mesh__D010158 Prostheses, Cleft Palate
% 208.44/208.59 |- skos__hiddenLabel mesh__D010158 Palatal Obturator
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010158 2006
% 208.44/208.59 |- skos__hiddenLabel mesh__D010158 Palate Prosthesis, Cleft
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010158 1999
% 208.44/208.59 |- skos__hiddenLabel mesh__D010158 Obturator, Palatal
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010158 2002
% 208.44/208.59 |- skos__annotation mesh__D010158
% 208.44/208.59 do not use /util except by MeSH definition
% 208.44/208.59 |- rdf__type mesh__D010158sskos__Concept
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D010158
% 208.44/208.59 83; was CLEFT PALATE PROSTHESIS 1966-82
% 208.44/208.59 |- mesh__dateCreated mesh__D010158 1999-01-01
% 208.44/208.59 |- mesh__dateRevised mesh__D010158 1997-06-20
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010158 2003
% 208.44/208.59 |- skos__altLabel mesh__D010158 Obturators, Palatal
% 208.44/208.59 |- skos__scopeNote mesh__D010158
% 208.44/208.59 Appliances that close a cleft or fissure of the palate.%A%
% 208.44/208.59 |- skos__prefLabel mesh__D010158 Palatal Obturators
% 208.44/208.59 |- mesh__historyNote mesh__D010158
% 208.44/208.59 83; was CLEFT PALATE PROSTHESIS 1966-82
% 208.44/208.59 |- skos__hiddenLabel mesh__D010158 Cleft Palate Prostheses
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010158 2004
% 208.44/208.59 |- mesh__recordMaintainer mesh__D010158 PXP
% 208.44/208.59 |- mesh__recordOriginator mesh__D010158 NLM
% 208.44/208.59 |- skos__broader mesh__D010158smesh__D017266
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010158 2000
% 208.44/208.59 |- skos__hiddenLabel mesh__D010158 Palate Prostheses, Cleft
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010158 2005
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D010158 1998
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D004919 2000
% 208.44/208.59 |- mesh__recordMaintainer mesh__D004919 TPW
% 208.44/208.59 |- skos__hiddenLabel mesh__D004919 Erythroplasias
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D004919 2006
% 208.44/208.59 |- skos__prefLabel mesh__D004919 Erythroplasia
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D004919 2002
% 208.44/208.59 |- mesh__dateRevised mesh__D004919 1997-06-20
% 208.44/208.59 |- skos__broader mesh__D004919smesh__D011230
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D004919 2005
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D004919 1999
% 208.44/208.59 |- skos__scopeNote mesh__D004919
% 208.44/208.59 A condition of the mucous membrane characterized by erythematous papular lesions. %28%Dorland, 27th ed%29%%A%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D004919 2004
% 208.44/208.59 |- mesh__dateCreated mesh__D004919 1999-01-01
% 208.44/208.59 |- rdf__type mesh__D004919sskos__Concept
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D004919 1998
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D004919 2003
% 208.44/208.59 |- mesh__recordOriginator mesh__D004919 NLM
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D004919 2001
% 208.44/208.59 |- skos__annotation mesh__D004919
% 208.44/208.59 precancerous dis of the mucous membranes
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D004919 SJN
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D015641 2004
% 208.44/208.59 |- skos__annotation mesh__D015641
% 208.44/208.59 do not use /util except by MeSH definition; DF: RADIOGR INTERVENTIONAL%A%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D015641 2006
% 208.44/208.59 |- skos__broader mesh__D015641smesh__D002404
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D015641 1998
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D015641 2002
% 208.44/208.59 |- mesh__dateCreated mesh__D015641 1989-04-07
% 208.44/208.59 |- mesh__dateEstablished mesh__D015641 1990-01-01
% 208.44/208.59 |- mesh__dateRevised mesh__D015641 1997-06-20
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D015641 90
% 208.44/208.59 |- skos__historyNote mesh__D015641 Catheterization %28%1972-1989%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D015641 1999
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D015641 SJN
% 208.44/208.59 |- skos__historyNote mesh__D015641 Radiology %28%1977-1989%29%
% 208.44/208.59 |- mesh__recordOriginator mesh__D015641 AGS
% 208.44/208.59 |- mesh__historyNote mesh__D015641 90
% 208.44/208.59 |- skos__historyNote mesh__D015641 Technology, Radiologic %28%1972-1989%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D015641 2000
% 208.44/208.59 |- rdf__type mesh__D015641sskos__Concept
% 208.44/208.59 |- skos__broader mesh__D015641smesh__D011859
% 208.44/208.59 |- skos__historyNote mesh__D015641 Radiography %28%1972-1989%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D015641 2003
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D015641 2001
% 208.44/208.59 |- skos__prefLabel mesh__D015641 Radiography, Interventional
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D015641 2005
% 208.44/208.59 |- skos__altLabel mesh__D015641 Interventional Radiography
% 208.44/208.59 |- skos__scopeNote mesh__D015641
% 208.44/208.59 Diagnostic and therapeutic procedures that are invasive or surgical in nature, and require the expertise of a specially trained radiologist. In general, they are more invasive than diagnostic imaging but less invasive than major surgery. They often involve catheterization, fluoroscopy, or computed tomography. Some examples include percutaneous transhepatic cholangiography, percutaneous transthoracic biopsy, balloon angioplasty, and arterial embolization.%A%
% 208.44/208.59 |- mesh__recordMaintainer mesh__D015641 PXP
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 2000
% 208.44/208.59 |- skos__historyNote mesh__D009604 Guanidines %28%1966-1970%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 1994
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 2006
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 2003
% 208.44/208.59 |- mesh__historyNote mesh__D009604 73%28%71%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 2001
% 208.44/208.59 |- mesh__recordOriginator mesh__D009604 NLM
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 1995
% 208.44/208.59 |- skos__historyNote mesh__D009604 Carcinogens %28%1966-1970%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 2004
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 2002
% 208.44/208.59 |- mesh__dateRevised mesh__D009604 1992-05-19
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 1993
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 1998
% 208.44/208.59 |- rdf__type mesh__D009604sskos__Concept
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 1999
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 1996
% 208.44/208.59 |- skos__broader mesh__D009604smesh__D006146
% 208.44/208.59 |- mesh__dateCreated mesh__D009604 1999-01-01
% 208.44/208.59 |- skos__historyNote mesh__D009604 Nitroso Compounds %28%1966-1970%29%
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 1997
% 208.44/208.59 |- mesh__recordMaintainer mesh__D009604 TAP
% 208.44/208.59 |- skos__broader mesh__D009604smesh__D009603
% 208.44/208.59 |- mesh__dateEstablished mesh__D009604 1973-01-01
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D009604 PLS
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D009604 73
% 208.44/208.59 |- skos__prefLabel mesh__D009604 Nitrosoguanidines
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D009604 2005
% 208.44/208.59 |- skos__altLabel mesh__D001621 Betahistine Biphar
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 Methanesulfonate, Betahistine
% 208.44/208.59 |- mesh__historyNote mesh__D001621
% 208.44/208.59 91%28%67%29%; was see under PYRIDINES 1967-90
% 208.44/208.59 |- skos__altLabel mesh__D001621 Solvay Brand of Betahistine Hydrochloride
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 Betahistin ratiopharm
% 208.44/208.59 |- skos__altLabel mesh__D001621 Unimed Brand of Betahistine Hydrochloride
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D001621
% 208.44/208.59 91; was see under PYRIDINES 1967-90
% 208.44/208.59 |- skos__altLabel mesh__D001621
% 208.44/208.59 Fides Ecopharma Brand of Betahistine Hydrochloride
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 By Vertin
% 208.44/208.59 |- skos__altLabel mesh__D001621 Stadapharm Brand of Betahistine Mesylate
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 PT 9
% 208.44/208.59 |- skos__altLabel mesh__D001621 Bouchara Brand of Betahistine Hydrochloride
% 208.44/208.59 |- skos__altLabel mesh__D001621 Betaserc
% 208.44/208.59 |- skos__altLabel mesh__D001621 Betahistine Dihydrochloride
% 208.44/208.59 |- skos__altLabel mesh__D001621 Eurim Brand of Betahistine Hydrochloride
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 Hydrochloride, Betahistine
% 208.44/208.59 |- mesh__recordMaintainer mesh__D001621 CCR
% 208.44/208.59 |- skos__altLabel mesh__D001621 Vasomotal
% 208.44/208.59 |- mesh__recordOriginator mesh__D001621 NLM
% 208.44/208.59 |- skos__altLabel mesh__D001621 ratiopharm Brand of Betahistine Mesylate
% 208.44/208.59 |- rdf__type mesh__D001621sskos__Concept
% 208.44/208.59 |- skos__prefLabel mesh__D001621 Betahistine
% 208.44/208.59 |- skos__scopeNote mesh__D001621
% 208.44/208.59 A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in Meniere%27%s disease and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.%A%
% 208.44/208.59 |- skos__altLabel mesh__D001621 Hennig Brand of Betahistine Mesylate
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 Dihydrobromide, Betahistine
% 208.44/208.59 |- mesh__dateEstablished mesh__D001621 1991-01-01
% 208.44/208.59 |- skos__altLabel mesh__D001621 Ergha Brand of Betahistine Hydrochloride
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 PT9
% 208.44/208.59 |- mesh__dateRevised mesh__D001621 2005-06-30
% 208.44/208.59 |- skos__altLabel mesh__D001621 Aliud Brand of Betahistine Mesylate
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 Mesylate, Betahistine
% 208.44/208.59 |- skos__altLabel mesh__D001621
% 208.44/208.59 Byk Gulden Brand of Betahistine Hydrochloride
% 208.44/208.59 |- skos__broader mesh__D001621smesh__D011725
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D001621 2006
% 208.44/208.59 |- skos__altLabel mesh__D001621 Betahistine Methanesulfonate
% 208.44/208.59 |- skos__altLabel mesh__D001621 Betahistine Methanesulphonate
% 208.44/208.59 |- skos__altLabel mesh__D001621 Dexo Brand of Betahistine Mesylate
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 Dihydrochloride, Betahistine
% 208.44/208.59 |- skos__altLabel mesh__D001621 Medopharm Brand of Betahistine Mesylate
% 208.44/208.59 |- skos__altLabel mesh__D001621 Gerard Brand of Betahistine Hydrochloride
% 208.44/208.59 |- skos__hiddenLabel mesh__D001621 Methanesulphonate, Betahistine
% 208.44/208.59 |- skos__altLabel mesh__D001621 Altana Pharma Brand of Betahistine Mesylate
% 208.44/208.59 |- mesh__dateCreated mesh__D001621 1999-01-01
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D001621 sjn
% 208.44/208.59 |- mesh__publicMeSHNote mesh__D020586 2000
% 208.44/208.59 |- mesh__dateRevised mesh__D020586 2005-06-30
% 208.44/208.59 |- skos__historyNote mesh__D020586 Chromatiaceae %28%1988-1999%29%
% 208.44/208.59 |- skos__broader mesh__D020586smesh__D002841
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D020586 sjn
% 208.44/208.59 |- skos__prefLabel mesh__D020586 Thiocapsa
% 208.44/208.59 |- rdf__type mesh__D020586sskos__Concept
% 208.44/208.59 |- mesh__historyNote mesh__D020586 2000
% 208.44/208.59 |- mesh__recordOriginator mesh__D020586 ndw
% 208.44/208.59 |- mesh__recordMaintainer mesh__D020586 SYSTEM
% 208.44/208.59 |- mesh__dateCreated mesh__D020586 1999-11-03
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D020586 2006
% 208.44/208.59 |- skos__broader mesh__D020586smesh__D016964
% 208.44/208.59 |- mesh__dateEstablished mesh__D020586 2000-01-01
% 208.44/208.59 |- skos__scopeNote mesh__D020586
% 208.44/208.59 A genus of anoxygenic, photosynthetic, nonmotile, spherical to slightly ovoid bacterial cells occurring singly, or in aggregates of two or four, and usually surrounded with slime. It is found in stagnant water, mud of ponds, estuaries, and microbial mats of salt marshes. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.44/208.59 |- mesh__recordOriginator mesh__D014549 NLM
% 208.44/208.59 |- skos__broader mesh__D014549smesh__D014555
% 208.44/208.59 |- skos__related mesh__D014549smesh__D016496
% 208.44/208.59 |- mesh__dateRevised mesh__D014549 2004-07-08
% 208.44/208.59 |- skos__related mesh__D014549smesh__D016741
% 208.44/208.59 |- rdf__type mesh__D014549sskos__Concept
% 208.44/208.59 |- skos__hiddenLabel mesh__D014549 Incontinence, Urinary
% 208.44/208.59 |- skos__prefLabel mesh__D014549 Urinary Incontinence
% 208.44/208.59 |- mesh__dateCreated mesh__D014549 1999-01-01
% 208.44/208.59 |- skos__scopeNote mesh__D014549
% 208.44/208.59 Inability to control the passage of URINE.
% 208.44/208.59 |- mesh__activeMeSHYear mesh__D014549 2005
% 208.44/208.59 |- mesh__recordMaintainer mesh__D014549 ssb
% 208.44/208.59 |- skos__altLabel mesh__D014549 Bladder, Overactive
% 208.44/208.59 |- mesh__recordAuthorizer mesh__D014549 sjn
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D014549 2006
% 208.44/208.60 |- skos__hiddenLabel mesh__D014549 Incontinence, Urge
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D033703
% 208.44/208.60 2003; NUCLEOSIDE TRANSPORTER %28%now NUCLEOSIDE TRANSPORT PROTEINS%29% was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1983-2002%A%
% 208.44/208.60 |- mesh__recordMaintainer mesh__D033703 SYSTEM
% 208.44/208.60 |- skos__historyNote mesh__D033703 Membrane Proteins %28%1983-2002%29%
% 208.44/208.60 |- skos__hiddenLabel mesh__D033703 Transporter, Nucleoside
% 208.44/208.60 |- mesh__historyNote mesh__D033703
% 208.44/208.60 2003; use NUCLEOSIDE TRANSPORT PROTEINS %28%NM%29% 1983-2002
% 208.44/208.60 |- skos__prefLabel mesh__D033703 Nucleoside Transport Proteins
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D033703 2006
% 208.44/208.60 |- mesh__dateCreated mesh__D033703 2002-07-03
% 208.44/208.60 |- skos__hiddenLabel mesh__D033703 Transport Proteins, Nucleoside
% 208.44/208.60 |- mesh__dateEstablished mesh__D033703 2003-01-01
% 208.44/208.60 |- rdf__type mesh__D033703sskos__Concept
% 208.44/208.60 |- skos__scopeNote mesh__D033703
% 208.44/208.60 Proteins involved in the transport of NUCLEOSIDES across cellular membranes.%A%
% 208.44/208.60 |- mesh__dateRevised mesh__D033703 2005-06-30
% 208.44/208.60 |- skos__historyNote mesh__D033703 Carrier Proteins %28%1983-2002%29%
% 208.44/208.60 |- skos__broader mesh__D033703smesh__D033701
% 208.44/208.60 |- mesh__recordOriginator mesh__D033703 jmp
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D033703 sjn
% 208.44/208.60 |- skos__altLabel mesh__D033703 Nucleoside Transporter
% 208.44/208.60 |- skos__historyNote mesh__D019234 Dentin %28%1966-1996%29%
% 208.44/208.60 |- mesh__dateEstablished mesh__D019234 1997-01-01
% 208.44/208.60 |- skos__hiddenLabel mesh__D019234 Fluid, Dentinal
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 1998
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 2002
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 2003
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 1999
% 208.44/208.60 |- skos__prefLabel mesh__D019234 Dentinal Fluid
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 2004
% 208.44/208.60 |- skos__scopeNote mesh__D019234
% 208.44/208.60 The lymph or fluid of dentin. It is a transudate of extracellular fluid, mainly cytoplasm of odontoblastic processes, from the dental pulp via the dentinal tubules. It is also called dental lymph. %28%From Stedman, 26th ed, p665%29%%A%
% 208.44/208.60 |- skos__annotation mesh__D019234 dentin lymph or transudate
% 208.44/208.60 |- mesh__historyNote mesh__D019234 97
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 2005
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 2000
% 208.44/208.60 |- skos__broader mesh__D019234smesh__D005122
% 208.44/208.60 |- skos__hiddenLabel mesh__D019234 Dentinal Fluids
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 2006
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D019234 97
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 1997
% 208.44/208.60 |- rdf__type mesh__D019234sskos__Concept
% 208.44/208.60 |- skos__hiddenLabel mesh__D019234 Fluids, Dentinal
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019234 2001
% 208.44/208.60 |- mesh__dateCreated mesh__D019234 1996-06-18
% 208.44/208.60 |- mesh__recordMaintainer mesh__D000529 ssb
% 208.44/208.60 |- skos__hiddenLabel mesh__D000529 Therapies, Complementary
% 208.44/208.60 |- skos__altLabel mesh__D000529 Therapy, Alternative
% 208.44/208.60 |- skos__hiddenLabel mesh__D000529 Therapies, Alternative
% 208.44/208.60 |- skos__prefLabel mesh__D000529 Complementary Therapies
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D000529
% 208.44/208.60 2002; see ALTERNATIVE MEDICINE %28%1986-2001%29%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D000529 2005
% 208.44/208.60 |- rdf__type mesh__D000529sskos__Concept
% 208.44/208.60 |- skos__annotation mesh__D000529
% 208.44/208.60 General or unspecified; prefer specifics; not for %22%alternative health care delivery system%22% %28%= DELIVERY OF HEALTH CARE%29% or specific health service.%A%
% 208.44/208.60 |- mesh__recordOriginator mesh__D000529 EC
% 208.44/208.60 |- mesh__dateRevised mesh__D000529 2004-07-07
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D000529 2006
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D000529 sjn
% 208.44/208.60 |- skos__broader mesh__D000529smesh__D013812
% 208.44/208.60 |- mesh__historyNote mesh__D000529 2002%28%1986%29%
% 208.44/208.60 |- skos__scopeNote mesh__D000529
% 208.44/208.60 Therapeutic practices which are not currently considered an integral part of conventional allopathic medical practice. They may lack biomedical explanations but as they become better researched some %28%PHYSICAL THERAPY; DIET; ACUPUNCTURE%29% become widely accepted whereas others %28%humors, radium therapy%29% quietly fade away, yet are important historical footnotes. Therapies are termed as Complementary when used in addition to conventional treatments and as Alternative when used instead of conventional treatment.%A%
% 208.44/208.60 |- skos__altLabel mesh__D000529 Therapy, Complementary
% 208.44/208.60 |- skos__altLabel mesh__D000529 Medicine, Complementary
% 208.44/208.60 |- mesh__dateCreated mesh__D000529 1985-02-25
% 208.44/208.60 |- skos__altLabel mesh__D000529 Medicine, Alternative
% 208.44/208.60 |- mesh__dateEstablished mesh__D000529 1986-01-01
% 208.44/208.60 |- rdf__type mesh__D011251sskos__Concept
% 208.44/208.60 |- skos__annotation mesh__D011251
% 208.44/208.60 bacterial, fungal or viral infections: PREGNANCY COMPLICATIONS, PARASITIC is also available; coordinate IM with specific infectious disease %28%IM%29%; check the tags FEMALE %26% PREGNANCY; Manual 18.4.7; DF: PREGN COMPL INFECT%A%
% 208.44/208.60 |- skos__hiddenLabel mesh__D011251 Pregnancy Complication, Infectious
% 208.44/208.60 |- mesh__dateCreated mesh__D011251 1999-01-01
% 208.44/208.60 |- mesh__recordOriginator mesh__D011251 NLM
% 208.44/208.60 |- mesh__historyNote mesh__D011251 64
% 208.44/208.60 |- skos__broader mesh__D011251smesh__D011248
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D011251 64
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D011251 sjn
% 208.44/208.60 |- skos__scopeNote mesh__D011251
% 208.44/208.60 The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION.%A%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D011251 2006
% 208.44/208.60 |- skos__prefLabel mesh__D011251 Pregnancy Complications, Infectious
% 208.44/208.60 |- skos__broader mesh__D011251smesh__D007239
% 208.44/208.60 |- skos__hiddenLabel mesh__D011251 Pregnancies, Infectious Complications
% 208.44/208.60 |- skos__hiddenLabel mesh__D011251 Infectious Pregnancy Complication
% 208.44/208.60 |- mesh__dateEstablished mesh__D011251 1964-01-01
% 208.44/208.60 |- skos__altLabel mesh__D011251 Complications, Infectious Pregnancy
% 208.44/208.60 |- mesh__dateRevised mesh__D011251 2005-06-30
% 208.44/208.60 |- mesh__recordMaintainer mesh__D011251 lkt
% 208.44/208.60 |- skos__hiddenLabel mesh__D011251 Complication, Infectious Pregnancy
% 208.44/208.60 |- skos__altLabel mesh__D011251 Infectious Pregnancy Complications
% 208.44/208.60 |- skos__altLabel mesh__D011251 Pregnancy, Infectious Complications
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 1999
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 2003
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 1996
% 208.44/208.60 |- mesh__dateRevised mesh__D005214 1993-05-28
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 2000
% 208.44/208.60 |- skos__broader mesh__D005214smesh__D009502
% 208.44/208.60 |- skos__hiddenLabel mesh__D005214 Neutron, Fast
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 2004
% 208.44/208.60 |- skos__prefLabel mesh__D005214 Fast Neutrons
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 1997
% 208.44/208.60 |- skos__hiddenLabel mesh__D005214 Neutrons, Fast
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 2001
% 208.44/208.60 |- skos__historyNote mesh__D005214 Neutrons %28%1966-1970%29%
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D005214 91; was see under NEUTRONS 1971-90
% 208.44/208.60 |- skos__hiddenLabel mesh__D005214 Fast Neutron
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 2002
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 1994
% 208.44/208.60 |- mesh__historyNote mesh__D005214
% 208.44/208.60 91%28%71%29%; was see under NEUTRONS 1971-90
% 208.44/208.60 |- skos__annotation mesh__D005214 elementary particles; IM
% 208.44/208.60 |- mesh__dateCreated mesh__D005214 1999-01-01
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 1995
% 208.44/208.60 |- rdf__type mesh__D005214sskos__Concept
% 208.44/208.60 |- mesh__dateEstablished mesh__D005214 1991-01-01
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 2005
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 1998
% 208.44/208.60 |- skos__scopeNote mesh__D005214
% 208.44/208.60 Neutrons, the energy of which exceeds some arbitrary level, usually around one million electron volts.%A%
% 208.44/208.60 |- mesh__recordMaintainer mesh__D005214 TGC
% 208.44/208.60 |- mesh__recordOriginator mesh__D005214 NLM
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D005214 PLS
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005214 2006
% 208.44/208.60 |- skos__annotation mesh__D010957 GEN; prefer specifics
% 208.44/208.60 |- skos__historyNote mesh__D010957 Genetics %28%1966-1967%29%
% 208.44/208.60 |- skos__scopeNote mesh__D010957
% 208.44/208.60 Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.%A%
% 208.44/208.60 |- mesh__dateRevised mesh__D010957 2004-07-30
% 208.44/208.60 |- skos__historyNote mesh__D010957
% 208.44/208.60 Extrachromosomal Inheritance %28%1968-1974%29%
% 208.44/208.60 |- mesh__recordMaintainer mesh__D010957 jls
% 208.44/208.60 |- skos__broader mesh__D010957smesh__D040342
% 208.44/208.60 |- rdf__type mesh__D010957sskos__Concept
% 208.44/208.60 |- skos__related mesh__D010957smesh__D005111
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D010957 jls
% 208.44/208.60 |- mesh__onlineNote mesh__D010957
% 208.44/208.60 use PLASMIDS to search EPISOMES 1975-77
% 208.44/208.60 |- skos__altLabel mesh__D010957 Episome
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010957 2005A
% 208.44/208.60 |- mesh__recordOriginator mesh__D010957 NLM
% 208.44/208.60 |- skos__related mesh__D010957smesh__D005822
% 208.44/208.60 |- mesh__historyNote mesh__D010957
% 208.44/208.60 78%28%75%29%; was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77%A%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010957 2005
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010957 2004
% 208.44/208.60 |- mesh__dateEstablished mesh__D010957 1978-01-01
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D010957
% 208.44/208.60 78; was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77%A%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010957 2006
% 208.44/208.60 |- skos__altLabel mesh__D010957 Plasmid
% 208.44/208.60 |- skos__prefLabel mesh__D010957 Plasmids
% 208.44/208.60 |- mesh__dateCreated mesh__D010957 1974-11-11
% 208.44/208.60 |- mesh__dateCreated mesh__D029662 2001-08-03
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029662 2006
% 208.44/208.60 |- skos__broader mesh__D029662smesh__D029401
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029662 2004
% 208.44/208.60 |- skos__scopeNote mesh__D029662
% 208.44/208.60 A plant genus of the family BETULACEAE. The tree has smooth, resinous, varicolored or white bark, marked by horizontal pores %28%lenticels%29%, which usually peels horizontally in thin sheets.%A%
% 208.44/208.60 |- skos__prefLabel mesh__D029662 Betula
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029662 2005
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029662 2003
% 208.44/208.60 |- skos__annotation mesh__D029662
% 208.44/208.60 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.44/208.60 |- mesh__recordOriginator mesh__D029662 ssb
% 208.44/208.60 |- mesh__dateEstablished mesh__D029662 2002-01-01
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029662 2002
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D029662 sjn
% 208.44/208.60 |- mesh__recordMaintainer mesh__D029662 jls
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D029662 2002
% 208.44/208.60 |- skos__altLabel mesh__D029662 Birch
% 208.44/208.60 |- rdf__type mesh__D029662sskos__Concept
% 208.44/208.60 |- mesh__historyNote mesh__D029662 2002
% 208.44/208.60 |- skos__hiddenLabel mesh__D010159 Papilla, Incisive
% 208.44/208.60 |- mesh__recordMaintainer mesh__D010159 lkt
% 208.44/208.60 |- mesh__recordOriginator mesh__D010159 NLM
% 208.44/208.60 |- skos__prefLabel mesh__D010159 Palate
% 208.44/208.60 |- mesh__dateCreated mesh__D010159 1999-01-01
% 208.44/208.60 |- skos__broader mesh__D010159smesh__D009055
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010159 2006
% 208.44/208.60 |- skos__hiddenLabel mesh__D010159 Papillas, Incisive
% 208.44/208.60 |- skos__broader mesh__D010159smesh__D007568
% 208.44/208.60 |- skos__hiddenLabel mesh__D010159 Incisive Papillas
% 208.44/208.60 |- skos__hiddenLabel mesh__D010159 Palates
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010159 2005
% 208.44/208.60 |- rdf__type mesh__D010159sskos__Concept
% 208.44/208.60 |- mesh__dateRevised mesh__D010159 2003-07-09
% 208.44/208.60 |- skos__scopeNote mesh__D010159
% 208.44/208.60 The structure that forms the roof of the mouth. It consists of the anterior hard palate %28%PALATE, HARD%29% and the posterior soft palate %28%PALATE, SOFT%29%.%A%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010159 2004
% 208.44/208.60 |- skos__annotation mesh__D010159
% 208.44/208.60 X ref INCISIVE PAPILLA, a projection on the palate posterior to the central incisors: do not add INCISOR; PALATE, HARD and PALATE, SOFT are also available%A%
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D010159 sjn
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 2001
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 1998
% 208.44/208.60 |- mesh__dateEstablished mesh__D015642 1990-01-01
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D015642 jls
% 208.44/208.60 |- skos__historyNote mesh__D015642 Radiology %28%1977-1989%29%
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D015642 90
% 208.44/208.60 |- skos__altLabel mesh__D015642 Interventional Radiology
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 1999
% 208.44/208.60 |- mesh__recordMaintainer mesh__D015642 jls
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 2002
% 208.44/208.60 |- mesh__dateCreated mesh__D015642 1989-04-07
% 208.44/208.60 |- rdf__type mesh__D015642sskos__Concept
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 2003
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 2005
% 208.44/208.60 |- skos__broader mesh__D015642smesh__D011871
% 208.44/208.60 |- mesh__dateRevised mesh__D015642 2004-08-02
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 2005A
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 2004
% 208.44/208.60 |- mesh__historyNote mesh__D015642 90
% 208.44/208.60 |- mesh__recordOriginator mesh__D015642 AGS
% 208.44/208.60 |- skos__annotation mesh__D015642
% 208.44/208.60 SPEC: SPEC qualif; for diag use RADIOGRAPHY, INTERVENTIONAL; DF: RADIOL INTERVENTIONAL%A%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 2006
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D015642 2000
% 208.44/208.60 |- skos__prefLabel mesh__D015642 Radiology, Interventional
% 208.44/208.60 |- skos__scopeNote mesh__D015642
% 208.44/208.60 Subspecialty of radiology that combines organ system radiography, catheter techniques and sectional imaging.%A%
% 208.44/208.60 |- skos__scopeNote mesh__D009605
% 208.44/208.60 An alkylating carcinogen that produces gastrointestinal and probably lung and nervous system tumors.%A%
% 208.44/208.60 |- mesh__historyNote mesh__D009605
% 208.44/208.60 91%28%75%29%; was see under URETHANE 1975-90
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D009605 2004
% 208.44/208.60 |- mesh__dateEstablished mesh__D009605 1991-01-01
% 208.44/208.60 |- skos__prefLabel mesh__D009605 Nitrosomethylurethane
% 208.44/208.60 |- rdf__type mesh__D009605sskos__Concept
% 208.44/208.60 |- mesh__dateCreated mesh__D009605 1974-11-19
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D009605 2001
% 208.44/208.60 |- mesh__recordOriginator mesh__D009605 NLM
% 208.44/208.60 |- skos__altLabel mesh__D009605 Methylnitrosourethane
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D009605 2002
% 208.44/208.60 |- skos__broader mesh__D009605smesh__D009603
% 208.44/208.60 |- mesh__recordMaintainer mesh__D009605 CCR
% 208.44/208.60 |- skos__broader mesh__D009605smesh__D014520
% 208.44/208.60 |- skos__historyNote mesh__D009605 Urethane %28%1972-1974%29%
% 208.44/208.60 |- skos__historyNote mesh__D009605 Nitroso Compounds %28%1972-1974%29%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D009605 2005
% 208.44/208.60 |- skos__annotation mesh__D009605 D26-26 qualif
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D009605 91; was see under URETHANE 1975-90
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D009605 sjn
% 208.44/208.60 |- mesh__dateRevised mesh__D009605 2000-06-22
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D009605 2006
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D009605 2003
% 208.44/208.60 |- skos__broader mesh__D001622smesh__D000644
% 208.44/208.60 |- rdf__type mesh__D001622sskos__Concept
% 208.44/208.60 |- skos__altLabel mesh__D001622 Logeais Brand of Betaine Cyclobutyrate
% 208.44/208.60 |- skos__altLabel mesh__D001622 Beaufour Brand of Betaine Citrate
% 208.44/208.60 |- skos__hiddenLabel mesh__D001622 Betaine, Glycine
% 208.44/208.60 |- skos__hiddenLabel mesh__D001622 AcidinPepsin
% 208.44/208.60 |- skos__altLabel mesh__D001622 Orphan Brand of Betaine
% 208.44/208.60 |- skos__altLabel mesh__D001622
% 208.44/208.60 Fournier Brand of Betaine Ascorbate and Hydrate
% 208.44/208.60 |- skos__altLabel mesh__D001622 Citrate de B%C3%%A9%ta%C3%%AF%ne Beaufour
% 208.44/208.60 |- skos__altLabel mesh__D001622 Byk Brand of Betaine Phosphate
% 208.44/208.60 |- skos__altLabel mesh__D001622 Boizot Brand of Betaine Aspartate
% 208.44/208.60 |- skos__hiddenLabel mesh__D001622 Acidin Pepsin
% 208.44/208.60 |- skos__broader mesh__D001622smesh__D050337
% 208.44/208.60 |- skos__altLabel mesh__D001622 Glycine Betaine
% 208.44/208.60 |- skos__scopeNote mesh__D001622
% 208.44/208.60 A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1341%29%%A%
% 208.44/208.60 |- mesh__dateEstablished mesh__D001622 1968-01-01
% 208.44/208.60 |- skos__hiddenLabel mesh__D001622 Betaine Orphan Brand
% 208.44/208.60 |- mesh__dateRevised mesh__D001622 2005-06-30
% 208.44/208.60 |- skos__hiddenLabel mesh__D001622 Scorbob%C3%%A9%ta%C3%%AF%ne
% 208.44/208.60 |- skos__hiddenLabel mesh__D001622 Scorbo b%C3%%A9%ta%C3%%AF%ne
% 208.44/208.60 |- skos__prefLabel mesh__D001622 Betaine
% 208.44/208.60 |- mesh__dateCreated mesh__D001622 1999-01-01
% 208.44/208.60 |- skos__hiddenLabel mesh__D001622 Stea16
% 208.44/208.60 |- mesh__historyNote mesh__D001622 68%28%64%29%
% 208.44/208.60 |- skos__altLabel mesh__D001622 Lycine
% 208.44/208.60 |- mesh__recordOriginator mesh__D001622 NLM
% 208.44/208.60 |- skos__altLabel mesh__D001622 Oxyneurine
% 208.44/208.60 |- skos__altLabel mesh__D001622 UPSA Brand of Betaine Citrate
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D001622 2006
% 208.44/208.60 |- mesh__recordMaintainer mesh__D001622 ssb
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D001622 68
% 208.44/208.60 |- skos__hiddenLabel mesh__D001622 Hydrochloride, Betaine
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D001622 sjn
% 208.44/208.60 |- mesh__dateCreated mesh__D020587 1999-11-05
% 208.44/208.60 |- rdf__type mesh__D020587sskos__Concept
% 208.44/208.60 |- mesh__recordMaintainer mesh__D020587 ags
% 208.44/208.60 |- mesh__recordOriginator mesh__D020587 ndw
% 208.44/208.60 |- mesh__historyNote mesh__D020587 2000
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D020587 2000
% 208.44/208.60 |- mesh__dateRevised mesh__D020587 2005-06-30
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D020587 2006
% 208.44/208.60 |- skos__scopeNote mesh__D020587
% 208.44/208.60 A genus of vibrioid or rod-shaped cells which are motile by polar flagella. Internal photosynthetic membranes are present as lamellar stacks and contain bacteriochlorophyll a or b and carotenoids. Growth occurs photoautotrophically under anaerobic conditions. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.44/208.60 |- skos__broader mesh__D020587smesh__D042001
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D020587 sjn
% 208.44/208.60 |- mesh__dateEstablished mesh__D020587 2000-01-01
% 208.44/208.60 |- skos__prefLabel mesh__D020587 Ectothiorhodospira
% 208.44/208.60 |- skos__prefLabel mesh__D033704 Nucleotide Transport Proteins
% 208.44/208.60 |- mesh__recordOriginator mesh__D033704 jmp
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D033704 sjn
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D033704 2006
% 208.44/208.60 |- skos__altLabel mesh__D033704 Nucleotide Translocase
% 208.44/208.60 |- skos__scopeNote mesh__D033704
% 208.44/208.60 Proteins involved in the transport of NUCLEOTIDES across cellular membranes.%A%
% 208.44/208.60 |- rdf__type mesh__D033704sskos__Concept
% 208.44/208.60 |- skos__hiddenLabel mesh__D033704 Transport Proteins, Nucleotide
% 208.44/208.60 |- mesh__dateCreated mesh__D033704 2002-07-03
% 208.44/208.60 |- mesh__dateEstablished mesh__D033704 2003-01-01
% 208.44/208.60 |- skos__historyNote mesh__D033704
% 208.44/208.60 Mitochondrial ADP, ATP Translocases %28%1982-2002%29%
% 208.44/208.60 |- mesh__dateRevised mesh__D033704 2005-06-30
% 208.44/208.60 |- mesh__recordMaintainer mesh__D033704 SYSTEM
% 208.44/208.60 |- skos__broader mesh__D033704smesh__D033701
% 208.44/208.60 |- mesh__historyNote mesh__D033704
% 208.44/208.60 2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1982-2002
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D033704
% 208.44/208.60 2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1982-2002
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 2001
% 208.44/208.60 |- skos__prefLabel mesh__D019235 Ephemerovirus
% 208.44/208.60 |- skos__annotation mesh__D019235
% 208.44/208.60 a genus of the family Rhabdoviridae, primarily infecting cattle; infection = RHABDOVIRIDAE INFECTIONS%A%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 2005
% 208.44/208.60 |- rdf__type mesh__D019235sskos__Concept
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D019235 97
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 2000
% 208.44/208.60 |- mesh__historyNote mesh__D019235 97
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 2004
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 1999
% 208.44/208.60 |- skos__broader mesh__D019235smesh__D012209
% 208.44/208.60 |- skos__hiddenLabel mesh__D019235 Ephemeroviruses
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 2003
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 1998
% 208.44/208.60 |- skos__scopeNote mesh__D019235
% 208.44/208.60 A genus of the family RHABDOVIRIDAE which primarily infect cattle. EPHEMERAL FEVER VIRUS, BOVINE is the type species.%A%
% 208.44/208.60 |- mesh__dateEstablished mesh__D019235 1997-01-01
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 2002
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 1997
% 208.44/208.60 |- mesh__dateCreated mesh__D019235 1996-06-10
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D019235 2006
% 208.44/208.60 |- skos__altLabel mesh__D011252 Neoplastic Pregnancy Complications
% 208.44/208.60 |- skos__hiddenLabel mesh__D011252 Complication, Neoplastic Pregnancy
% 208.44/208.60 |- skos__altLabel mesh__D011252 Pregnancy, Neoplastic Complications
% 208.44/208.60 |- skos__prefLabel mesh__D011252 Pregnancy Complications, Neoplastic
% 208.44/208.60 |- skos__historyNote mesh__D011252 specific neoplasms %28%1966-1982%29%
% 208.44/208.60 |- skos__historyNote mesh__D011252
% 208.44/208.60 Pregnancy Complications %28%1966-1982%29%
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D011252 83
% 208.44/208.60 |- skos__scopeNote mesh__D011252
% 208.44/208.60 The co-occurrence of pregnancy and NEOPLASMS. The neoplastic disease may precede or follow FERTILIZATION.%A%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D011252 2006
% 208.44/208.60 |- skos__annotation mesh__D011252
% 208.44/208.60 coordinate IM with specific histologic type %28%IM%29% + precoordinated organ/neopl term %28%IM%29%; check the tags FEMALE %26% PREGNANCY; Manual 18.4.7; DF: PREGN COMPL NEOPL%A%
% 208.44/208.60 |- mesh__historyNote mesh__D011252 83
% 208.44/208.60 |- skos__broader mesh__D011252smesh__D011248
% 208.44/208.60 |- skos__hiddenLabel mesh__D011252 Neoplastic Pregnancy Complication
% 208.44/208.60 |- skos__broader mesh__D011252smesh__D009369
% 208.44/208.60 |- skos__hiddenLabel mesh__D011252 Pregnancies, Neoplastic Complications
% 208.44/208.60 |- mesh__recordOriginator mesh__D011252 VDK
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D011252 sjn
% 208.44/208.60 |- skos__hiddenLabel mesh__D011252 Pregnancy Complication, Neoplastic
% 208.44/208.60 |- mesh__dateRevised mesh__D011252 2005-06-30
% 208.44/208.60 |- rdf__type mesh__D011252sskos__Concept
% 208.44/208.60 |- mesh__dateEstablished mesh__D011252 1983-01-01
% 208.44/208.60 |- skos__altLabel mesh__D011252 Complications, Neoplastic Pregnancy
% 208.44/208.60 |- mesh__recordMaintainer mesh__D011252 lkt
% 208.44/208.60 |- mesh__dateCreated mesh__D011252 1982-04-26
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D005215 sjn
% 208.44/208.60 |- mesh__recordOriginator mesh__D005215 NLM
% 208.44/208.60 |- skos__annotation mesh__D005215
% 208.44/208.60 human %26% animal; differs from STARVATION in matter of degree: TN 80; FOOD DEPRIVATION is also available%A%
% 208.44/208.60 |- mesh__recordMaintainer mesh__D005215 TAP
% 208.44/208.60 |- skos__broader mesh__D005215smesh__D004032
% 208.44/208.60 |- skos__scopeNote mesh__D005215 Abstaining from all food.
% 208.44/208.60 |- mesh__dateRevised mesh__D005215 2002-07-03
% 208.44/208.60 |- skos__broader mesh__D005215smesh__D005247
% 208.44/208.60 |- mesh__dateCreated mesh__D005215 1999-01-01
% 208.44/208.60 |- rdf__type mesh__D005215sskos__Concept
% 208.44/208.60 |- skos__related mesh__D005215smesh__D013217
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005215 2005
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005215 2006
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005215 2003
% 208.44/208.60 |- skos__related mesh__D005215smesh__D006815
% 208.44/208.60 |- skos__prefLabel mesh__D005215 Fasting
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D005215 2004
% 208.44/208.60 |- skos__altLabel mesh__D010958 Glutamyl Plasminogen
% 208.44/208.60 |- skos__altLabel mesh__D010958 Profibrinolysin
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D010958 65
% 208.44/208.60 |- skos__scopeNote mesh__D010958
% 208.44/208.60 Precursor of fibrinolysin %28%plasmin%29%. It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent.%A%
% 208.44/208.60 |- skos__hiddenLabel mesh__D010958 1-Plasminogen, Glutamic Acid
% 208.44/208.60 |- skos__broader mesh__D010958smesh__D001609
% 208.44/208.60 |- mesh__dateCreated mesh__D010958 1999-01-01
% 208.44/208.60 |- mesh__dateRevised mesh__D010958 2003-07-09
% 208.44/208.60 |- rdf__type mesh__D010958sskos__Concept
% 208.44/208.60 |- mesh__recordAuthorizer mesh__D010958 sjn
% 208.44/208.60 |- skos__altLabel mesh__D010958 Glutamic Acid 1-Plasminogen
% 208.44/208.60 |- mesh__historyNote mesh__D010958 65%28%63%29%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010958 2005
% 208.44/208.60 |- skos__broader mesh__D010958smesh__D004792
% 208.44/208.60 |- mesh__recordMaintainer mesh__D010958 ssb
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010958 2004
% 208.44/208.60 |- mesh__dateEstablished mesh__D010958 1965-01-01
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D010958 2006
% 208.44/208.60 |- skos__hiddenLabel mesh__D010958 Glu Plasminogen
% 208.44/208.60 |- skos__hiddenLabel mesh__D010958 Glutamic Acid 1 Plasminogen
% 208.44/208.60 |- mesh__recordOriginator mesh__D010958 NLM
% 208.44/208.60 |- skos__hiddenLabel mesh__D010958 Plasminogen, Glutamyl
% 208.44/208.60 |- skos__prefLabel mesh__D010958 Plasminogen
% 208.44/208.60 |- skos__annotation mesh__D010958
% 208.44/208.60 an enzyme precursor %26% fibrinolytic agent; /antag: do not confuse with PLASMINOGEN INACTIVATORS which modulate PLASMINOGEN ACTIVATORS, not PLASMINOGEN%A%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029663 2004
% 208.44/208.60 |- mesh__historyNote mesh__D029663 2002
% 208.44/208.60 |- skos__scopeNote mesh__D029663
% 208.44/208.60 A plant genus of the family BIGNONIACEAE that is a source of lapachol.%A%
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029663 2003
% 208.44/208.60 |- mesh__dateCreated mesh__D029663 2001-07-25
% 208.44/208.60 |- skos__annotation mesh__D029663
% 208.44/208.60 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.44/208.60 |- mesh__dateEstablished mesh__D029663 2002-01-01
% 208.44/208.60 |- skos__broader mesh__D029663smesh__D029402
% 208.44/208.60 |- mesh__publicMeSHNote mesh__D029663 2002
% 208.44/208.60 |- skos__prefLabel mesh__D029663 Tabebuia
% 208.44/208.60 |- rdf__type mesh__D029663sskos__Concept
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029663 2006
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029663 2002
% 208.44/208.60 |- skos__altLabel mesh__D029663 Pau d%27%arco
% 208.44/208.60 |- mesh__activeMeSHYear mesh__D029663 2005
% 208.44/208.60 |- skos__hiddenLabel mesh__D015643 Succinate, Eyrthromycin Ethyl
% 208.44/208.60 |- skos__altLabel mesh__D015643 Eyrthromycin Ethyl Succinate
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D015643 2006
% 208.44/208.61 |- mesh__dateEstablished mesh__D015643 1990-01-01
% 208.44/208.61 |- mesh__dateCreated mesh__D015643 1989-05-25
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D015643 sjn
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D015643 2005
% 208.44/208.61 |- mesh__recordMaintainer mesh__D015643 ssb
% 208.44/208.61 |- mesh__dateRevised mesh__D015643 2004-07-07
% 208.44/208.61 |- skos__broader mesh__D015643smesh__D004917
% 208.44/208.61 |- skos__scopeNote mesh__D015643
% 208.44/208.61 A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.%A%
% 208.44/208.61 |- mesh__historyNote mesh__D015643 90
% 208.44/208.61 |- skos__historyNote mesh__D015643 Erythromycin %28%1966-1989%29%
% 208.44/208.61 |- rdf__type mesh__D015643sskos__Concept
% 208.44/208.61 |- skos__prefLabel mesh__D015643 Erythromycin Ethylsuccinate
% 208.44/208.61 |- skos__hiddenLabel mesh__D015643 Ethyl Succinate, Eyrthromycin
% 208.44/208.61 |- mesh__recordOriginator mesh__D015643 RLS
% 208.44/208.61 |- skos__hiddenLabel mesh__D015643 Ethylsuccinate, Erythromycin
% 208.44/208.61 |- skos__hiddenLabel mesh__D015643 EMycin E
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D015643 90
% 208.44/208.61 |- mesh__dateCreated mesh__D009606 1999-01-01
% 208.44/208.61 |- skos__scopeNote mesh__D009606
% 208.44/208.61 A genus of gram-negative, ellipsoidal or rod-shaped bacteria whose major source of energy and reducing power is from the oxidation of ammonia to nitrite. Its species occur in soils, oceans, lakes, rivers, and sewage disposal systems.%A%
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D009606 sjn
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009606 2006
% 208.44/208.61 |- mesh__dateRevised mesh__D009606 2005-06-30
% 208.44/208.61 |- skos__broader mesh__D009606smesh__D043369
% 208.44/208.61 |- skos__prefLabel mesh__D009606 Nitrosomonas
% 208.44/208.61 |- mesh__recordOriginator mesh__D009606 NLM
% 208.44/208.61 |- rdf__type mesh__D009606sskos__Concept
% 208.44/208.61 |- mesh__recordMaintainer mesh__D009606 SYSTEM
% 208.44/208.61 |- mesh__dateRevised mesh__D001623 2003-07-09
% 208.44/208.61 |- skos__prefLabel mesh__D001623 Betamethasone
% 208.44/208.61 |- mesh__recordOriginator mesh__D001623 NLM
% 208.44/208.61 |- mesh__dateCreated mesh__D001623 1999-01-01
% 208.44/208.61 |- skos__altLabel mesh__D001623 Flubenisolone
% 208.44/208.61 |- skos__scopeNote mesh__D001623
% 208.44/208.61 A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p724%29%%A%
% 208.44/208.61 |- mesh__historyNote mesh__D001623 64%28%63%29%
% 208.44/208.61 |- mesh__recordMaintainer mesh__D001623 ssb
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D001623 2005
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D001623 sjn
% 208.44/208.61 |- mesh__dateEstablished mesh__D001623 1964-01-01
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D001623 2006
% 208.44/208.61 |- skos__broader mesh__D001623smesh__D013259
% 208.44/208.61 |- rdf__type mesh__D001623sskos__Concept
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D001623 64
% 208.44/208.61 |- skos__broader mesh__D001623smesh__D011246
% 208.44/208.61 |- skos__altLabel mesh__D001623 Betadexamethasone
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D001623 2004
% 208.44/208.61 |- mesh__recordMaintainer mesh__D020588 SYSTEM
% 208.44/208.61 |- skos__historyNote mesh__D020588 Xanthomonas %28%1993-1999%29%
% 208.44/208.61 |- skos__prefLabel mesh__D020588 Stenotrophomonas
% 208.44/208.61 |- mesh__dateEstablished mesh__D020588 2000-01-01
% 208.44/208.61 |- skos__broader mesh__D020588smesh__D044166
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D020588 2000
% 208.44/208.61 |- mesh__dateRevised mesh__D020588 2005-06-30
% 208.44/208.61 |- rdf__type mesh__D020588sskos__Concept
% 208.44/208.61 |- mesh__historyNote mesh__D020588 2000
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D020588 sjn
% 208.44/208.61 |- skos__scopeNote mesh__D020588
% 208.44/208.61 A genus of gram-negative, aerobic, motile, rod-shaped bacteria formerly classified as part of the genus XANTHOMONAS.%A%
% 208.44/208.61 |- mesh__dateCreated mesh__D020588 1999-11-03
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D020588 2006
% 208.44/208.61 |- skos__annotation mesh__D020588
% 208.44/208.61 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 208.44/208.61 |- mesh__recordOriginator mesh__D020588 ndw
% 208.44/208.61 |- skos__prefLabel mesh__D033705
% 208.44/208.61 Equilibrative Nucleoside Transport Proteins
% 208.44/208.61 |- rdf__type mesh__D033705sskos__Concept
% 208.44/208.61 |- mesh__dateCreated mesh__D033705 2002-07-03
% 208.44/208.61 |- skos__altLabel mesh__D033705 Equilibrative Nucleoside Transport Protein
% 208.44/208.61 |- skos__broader mesh__D033705smesh__D033703
% 208.44/208.61 |- mesh__dateRevised mesh__D033705 2005-06-30
% 208.44/208.61 |- skos__scopeNote mesh__D033705
% 208.44/208.61 A class of sodium-independent nucleoside transporters that mediate the facilitative transport of NUCLEOSIDES.%A%
% 208.44/208.61 |- mesh__recordOriginator mesh__D033705 jmp
% 208.44/208.61 |- skos__historyNote mesh__D033705 Carrier Proteins %28%1997-2002%29%
% 208.44/208.61 |- mesh__historyNote mesh__D033705
% 208.44/208.61 2003; use EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS %28%NM%29% 1997-2002%A%
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D033705 sjn
% 208.44/208.61 |- mesh__recordMaintainer mesh__D033705 SYSTEM
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D033705 2006
% 208.44/208.61 |- mesh__dateEstablished mesh__D033705 2003-01-01
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D033705
% 208.44/208.61 2003; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEIN was indexed under CARRIER PROTEINS 1997-2002%A%
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D011253 sjn
% 208.44/208.61 |- skos__altLabel mesh__D011253 Pregnancy, Adolescent
% 208.44/208.61 |- mesh__historyNote mesh__D011253 79
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Pregnancies, Teen
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Adolescent Pregnancies
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D011253 2005
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Pregnancies, Preteen
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Pregnancies, Teenage
% 208.44/208.61 |- skos__historyNote mesh__D011253 Adolescence %28%1966-1978%29%
% 208.44/208.61 |- skos__broader mesh__D011253smesh__D008423
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Pregnancies, Adolescent
% 208.44/208.61 |- mesh__recordMaintainer mesh__D011253 sjn
% 208.44/208.61 |- mesh__recordOriginator mesh__D011253 AEP
% 208.44/208.61 |- skos__historyNote mesh__D011253 Pregnancy %28%1966-1978%29%
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D011253 79
% 208.44/208.61 |- rdf__type mesh__D011253sskos__Concept
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Adolescence, Pregnancy in
% 208.44/208.61 |- skos__annotation mesh__D011253
% 208.44/208.61 IM; use only for pregnancy as a social, cultural, or psychological problem in adolescents; for other aspects of PREGNANCY %28%IM%29% in adolescents, use PREGNANCY %28%IM%29% + ADOLESCENT %28%check tag%29%; includes pregnancy in children under 13; check tags HUMAN; FEMALE; PREGNANCY %26% ADOLESCENT or CHILD if under 13%A%
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Preteen Pregnancies
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Teen Pregnancies
% 208.44/208.61 |- mesh__dateEstablished mesh__D011253 1979-01-01
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Teenage Pregnancies
% 208.44/208.61 |- mesh__dateRevised mesh__D011253 2004-07-13
% 208.44/208.61 |- mesh__dateCreated mesh__D011253 1978-03-20
% 208.44/208.61 |- skos__scopeNote mesh__D011253
% 208.44/208.61 Pregnancy in human adolescent females under the age of 19.%A%
% 208.44/208.61 |- skos__altLabel mesh__D011253 Teenage Pregnancy
% 208.44/208.61 |- skos__prefLabel mesh__D011253 Pregnancy in Adolescence
% 208.44/208.61 |- skos__altLabel mesh__D011253 Adolescent Pregnancy
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Pregnancy, Teen
% 208.44/208.61 |- skos__hiddenLabel mesh__D011253 Pregnancy, Preteen
% 208.44/208.61 |- skos__altLabel mesh__D011253 Teen Pregnancy
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D011253 2006
% 208.44/208.61 |- skos__altLabel mesh__D011253 Pregnancy, Teenage
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 2006
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1998
% 208.44/208.61 |- mesh__recordOriginator mesh__D005216 VDK
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D005216 PLS
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1992
% 208.44/208.61 |- skos__hiddenLabel mesh__D005216 Body, Fat
% 208.44/208.61 |- skos__broader mesh__D005216smesh__D000825
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 2003
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1994
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 2005
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1991
% 208.44/208.61 |- mesh__recordMaintainer mesh__D005216 TGC
% 208.44/208.61 |- skos__prefLabel mesh__D005216 Fat Body
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 2002
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D005216
% 208.44/208.61 89; was see under ADIPOSE TISSUE 1980-88
% 208.44/208.61 |- mesh__dateCreated mesh__D005216 1979-05-24
% 208.44/208.61 |- mesh__historyNote mesh__D005216
% 208.44/208.61 89%28%80%29%; was see under ADIPOSE TISSUE 1980-88
% 208.44/208.61 |- mesh__dateRevised mesh__D005216 1989-03-14
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1990
% 208.44/208.61 |- rdf__type mesh__D005216sskos__Concept
% 208.44/208.61 |- skos__hiddenLabel mesh__D005216 Bodies, Fat
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 2001
% 208.44/208.61 |- mesh__dateEstablished mesh__D005216 1989-01-01
% 208.44/208.61 |- skos__hiddenLabel mesh__D005216 Fat Bodies
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1997
% 208.44/208.61 |- skos__annotation mesh__D005216 in amphibia %26% insects
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 2000
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1999
% 208.44/208.61 |- skos__historyNote mesh__D005216 Adipose Tissue %28%1966-1979%29%
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1993
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 2004
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1996
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005216 1995
% 208.44/208.61 |- skos__scopeNote mesh__D005216
% 208.44/208.61 A nutritional reservoir of fatty tissue found mainly in insects and amphibians.%A%
% 208.44/208.61 |- skos__historyNote mesh__D010959 Plasminogen Activators %28%1976-1985%29%
% 208.44/208.61 |- skos__broader mesh__D010959smesh__D010960
% 208.44/208.61 |- skos__historyNote mesh__D010959 Enzyme Activation %28%1974-1975%29%
% 208.44/208.61 |- skos__broader mesh__D010959smesh__D001779
% 208.44/208.61 |- skos__altLabel mesh__D010959 Genentech Brand of Alteplase
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Alteplase Genentech Brand
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Plasminogen Activator, Tissue
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Alteplase Promeco Brand
% 208.44/208.61 |- skos__altLabel mesh__D010959 Lysatec rt-PA
% 208.44/208.61 |- skos__altLabel mesh__D010959 Hoffmann-La Roche Brand of Alteplase
% 208.44/208.61 |- mesh__recordMaintainer mesh__D010959 ssb
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D010959
% 208.44/208.61 98; see ALTEPLASE 1992-97; see PLASMINOGEN ACTIVATOR, TISSUE-TYPE 1986-91%A%
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Plasminogen Activator, Tissue Type
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Lysatec rt PA
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Tissue Activator D 44
% 208.44/208.61 |- skos__altLabel mesh__D010959 Promeco Brand of Alteplase
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Tissue Type Plasminogen Activator
% 208.44/208.61 |- skos__prefLabel mesh__D010959 Tissue Plasminogen Activator
% 208.44/208.61 |- skos__broader mesh__D010959smesh__D012697
% 208.44/208.61 |- skos__altLabel mesh__D010959 Tissue-Type Plasminogen Activator
% 208.44/208.61 |- skos__altLabel mesh__D010959 T-Plasminogen Activator
% 208.44/208.61 |- skos__altLabel mesh__D010959 Tissue Activator D-44
% 208.44/208.61 |- mesh__dateEstablished mesh__D010959 1986-01-01
% 208.44/208.61 |- skos__scopeNote mesh__D010959
% 208.44/208.61 A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to PLASMIN. It has fibrin-binding activity and is immunologically different from URINARY PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. EC 3.4.21.68.%A%
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 T Plasminogen Activator
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Hoffmann La Roche Brand of Alteplase
% 208.44/208.61 |- mesh__dateRevised mesh__D010959 2005-06-30
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D010959 2006
% 208.44/208.61 |- skos__altLabel mesh__D010959 Alteplase
% 208.44/208.61 |- skos__historyNote mesh__D010959 Peptide Hydrolases %28%1975%29%
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Lysatec rtPA
% 208.44/208.61 |- skos__annotation mesh__D010959 DF: TTPA
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Activator, Tissue Plasminogen
% 208.44/208.61 |- mesh__recordOriginator mesh__D010959 RLS
% 208.44/208.61 |- rdf__type mesh__D010959sskos__Concept
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Activator, T-Plasminogen
% 208.44/208.61 |- skos__hiddenLabel mesh__D010959 Activator, Tissue-Type Plasminogen
% 208.44/208.61 |- mesh__dateCreated mesh__D010959 1985-06-12
% 208.44/208.61 |- skos__altLabel mesh__D010959 TTPA
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D010959 sjn
% 208.44/208.61 |- skos__altLabel mesh__D010959 Boehringer Ingelheim Brand of Alteplase
% 208.44/208.61 |- mesh__historyNote mesh__D010959 98%28%86%29%
% 208.44/208.61 |- skos__altLabel mesh__D010959 Plasminogen Activator, Tissue-Type
% 208.44/208.61 |- skos__broader mesh__D021681smesh__D003904
% 208.44/208.61 |- skos__altLabel mesh__D021681 Monosporium apiospermum
% 208.44/208.61 |- skos__scopeNote mesh__D021681
% 208.44/208.61 A mitosporic fungal genus previously called Monosporium. Teleomorphs include PSEUDALLESCHERIA.%A%
% 208.44/208.61 |- skos__historyNote mesh__D021681 Mitosporic Fungi %28%1981-2000%29%
% 208.44/208.61 |- mesh__dateRevised mesh__D021681 2005-06-30
% 208.44/208.61 |- mesh__dateCreated mesh__D021681 2000-06-22
% 208.44/208.61 |- skos__prefLabel mesh__D021681 Scedosporium
% 208.44/208.61 |- skos__altLabel mesh__D021681 Monosporium
% 208.44/208.61 |- mesh__historyNote mesh__D021681 2001
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D021681 sjn
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D021681
% 208.44/208.61 2001; for MONOSPORIUM APIOSPERMUM see PSEUDALLESCHERIA 1986-2000%A%
% 208.44/208.61 |- mesh__recordMaintainer mesh__D021681 SYSTEM
% 208.44/208.61 |- skos__annotation mesh__D021681
% 208.44/208.61 infection: coord IM with probably MADUROMYCOSIS %28%IM%29% or other mycosis %28%IM%29%%A%
% 208.44/208.61 |- skos__historyNote mesh__D021681 Pseudallescheria %28%1982-2000%29%
% 208.44/208.61 |- mesh__recordOriginator mesh__D021681 ags
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D021681 2006
% 208.44/208.61 |- mesh__dateEstablished mesh__D021681 2001-01-01
% 208.44/208.61 |- rdf__type mesh__D021681sskos__Concept
% 208.44/208.61 |- skos__altLabel mesh__D015644 Myocamicin
% 208.44/208.61 |- skos__prefLabel mesh__D015644 Miocamycin
% 208.44/208.61 |- skos__annotation mesh__D015644
% 208.44/208.61 do not use /biosyn unless by living matter
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D015644 2005
% 208.44/208.61 |- mesh__dateCreated mesh__D015644 1989-10-17
% 208.44/208.61 |- skos__hiddenLabel mesh__D015644 PM 88908
% 208.44/208.61 |- skos__altLabel mesh__D015644 9,3%27%%27%-Di-O-Acetylmidecamycin
% 208.44/208.61 |- mesh__dateRevised mesh__D015644 2004-07-07
% 208.44/208.61 |- skos__hiddenLabel mesh__D015644 PM88908
% 208.44/208.61 |- skos__altLabel mesh__D015644 9,3%27%%27%-Diacetylmidecamycin
% 208.44/208.61 |- rdf__type mesh__D015644sskos__Concept
% 208.44/208.61 |- skos__scopeNote mesh__D015644
% 208.44/208.61 A macrolide antibiotic that has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections.%A%
% 208.44/208.61 |- skos__hiddenLabel mesh__D015644 9,3%27%%27% Diacetylmidecamycin
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D015644 sjn
% 208.44/208.61 |- mesh__recordMaintainer mesh__D015644 ssb
% 208.44/208.61 |- skos__historyNote mesh__D015644 Leucomycins %28%1981-1989%29%
% 208.44/208.61 |- skos__altLabel mesh__D015644 Miokamycin
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D015644 90
% 208.44/208.61 |- mesh__historyNote mesh__D015644 90
% 208.44/208.61 |- skos__broader mesh__D015644smesh__D018942
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D015644 2006
% 208.44/208.61 |- skos__hiddenLabel mesh__D015644 9,3%27%%27% Di O Acetylmidecamycin
% 208.44/208.61 |- skos__altLabel mesh__D015644 Ponsinomycin
% 208.44/208.61 |- mesh__recordOriginator mesh__D015644 RLS
% 208.44/208.61 |- skos__altLabel mesh__D015644 Miocamycine
% 208.44/208.61 |- mesh__dateEstablished mesh__D015644 1990-01-01
% 208.44/208.61 |- mesh__dateCreated mesh__D009607 1999-01-01
% 208.44/208.61 |- mesh__dateRevised mesh__D009607 1992-05-19
% 208.44/208.61 |- skos__annotation mesh__D009607 DF: NITROSOUREA CPDS
% 208.44/208.61 |- skos__historyNote mesh__D009607 Urea %28%1966-1970%29%
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 1997
% 208.44/208.61 |- skos__historyNote mesh__D009607 Nitroso Compounds %28%1966-1970%29%
% 208.44/208.61 |- mesh__recordMaintainer mesh__D009607 TAP
% 208.44/208.61 |- mesh__dateEstablished mesh__D009607 1973-01-01
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D009607 PLS
% 208.44/208.61 |- skos__broader mesh__D009607smesh__D009603
% 208.44/208.61 |- skos__hiddenLabel mesh__D009607 Compounds, Nitrosourea
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D009607 73
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 2005
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 2000
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 2003
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 1994
% 208.44/208.61 |- mesh__recordOriginator mesh__D009607 NLM
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 2006
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 2001
% 208.44/208.61 |- rdf__type mesh__D009607sskos__Concept
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 2004
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 1998
% 208.44/208.61 |- mesh__historyNote mesh__D009607 73%28%71%29%
% 208.44/208.61 |- skos__broader mesh__D009607smesh__D014508
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 1995
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 1996
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 1993
% 208.44/208.61 |- skos__prefLabel mesh__D009607 Nitrosourea Compounds
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 2002
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009607 1999
% 208.44/208.61 |- skos__broader mesh__D001624smesh__D001623
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D001624
% 208.44/208.61 91; was see under BETAMETHASONE 1976-90
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D001624 2005
% 208.44/208.61 |- skos__historyNote mesh__D001624
% 208.44/208.61 Betamethasone %28%1974%29% /AA %28%1975%29%
% 208.44/208.61 |- mesh__historyNote mesh__D001624
% 208.44/208.61 91%28%76%29%; was see under BETAMETHASONE 1976-90
% 208.44/208.61 |- skos__historyNote mesh__D001624 Valerates %28%1974-1975%29%
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D001624 2006
% 208.44/208.61 |- rdf__type mesh__D001624sskos__Concept
% 208.44/208.61 |- mesh__dateCreated mesh__D001624 1975-07-21
% 208.44/208.61 |- mesh__recordMaintainer mesh__D001624 ssb
% 208.44/208.61 |- skos__hiddenLabel mesh__D001624 Betamethasone 17 Valerate
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D001624 sjn
% 208.44/208.61 |- skos__scopeNote mesh__D001624
% 208.44/208.61 The 17-valerate derivative of BETAMETHASONE. It has substantial topical anti-inflammatory activity and relatively low systemic anti-inflammatory activity.%A%
% 208.44/208.61 |- skos__hiddenLabel mesh__D001624 17-Valerate, Betamethasone
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D001624 2004
% 208.44/208.61 |- skos__altLabel mesh__D001624 Flubenisolonvalerate
% 208.44/208.61 |- skos__prefLabel mesh__D001624 Betamethasone 17-Valerate
% 208.44/208.61 |- mesh__recordOriginator mesh__D001624 RLS
% 208.44/208.61 |- mesh__dateEstablished mesh__D001624 1991-01-01
% 208.44/208.61 |- mesh__dateRevised mesh__D001624 2003-07-09
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D020589 sjn
% 208.44/208.61 |- mesh__dateCreated mesh__D020589 1999-11-03
% 208.44/208.61 |- mesh__dateEstablished mesh__D020589 2000-01-01
% 208.44/208.61 |- skos__broader mesh__D020589smesh__D009346
% 208.44/208.61 |- skos__broader mesh__D020589smesh__D006088
% 208.44/208.61 |- skos__prefLabel mesh__D020589 Vitreoscilla
% 208.44/208.61 |- rdf__type mesh__D020589sskos__Concept
% 208.44/208.61 |- skos__scopeNote mesh__D020589
% 208.44/208.61 A genus of gram-negative, aerobic or microaerophilic, colorless filaments. It is nonfruiting, motile by gliding, and found in freshwater sediments and cow dung. One species %28%V. stercoraria%29% is considered morphologically to be a streptobacillus. That species is strictly aerobic and produces a homodimeric bacterial hemoglobin, especially under oxygen-limited growth conditions. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.44/208.61 |- mesh__historyNote mesh__D020589 2000
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D020589 2006
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D020589 2000
% 208.44/208.61 |- mesh__dateRevised mesh__D020589 2005-06-30
% 208.44/208.61 |- mesh__recordOriginator mesh__D020589 ndw
% 208.44/208.61 |- mesh__recordMaintainer mesh__D020589 SYSTEM
% 208.44/208.61 |- skos__altLabel mesh__D019237 CEJ
% 208.44/208.61 |- skos__scopeNote mesh__D019237
% 208.44/208.61 The constricted part of the tooth at the junction of the crown and root or roots. It is often referred to as the cementoenamel junction %28%CEJ%29%, the line at which the cementum covering the root of a tooth and the enamel of the tooth meet. %28%Jablonski, Dictionary of Dentistry, 1992, p530, p433%29%%A%
% 208.44/208.61 |- mesh__dateEstablished mesh__D019237 1997-01-01
% 208.44/208.61 |- skos__broader mesh__D019237smesh__D019589
% 208.44/208.61 |- skos__hiddenLabel mesh__D019237 Junctions, Cementoenamel
% 208.44/208.61 |- skos__hiddenLabel mesh__D019237 Junction, Cementoenamel
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D019237 sjn
% 208.44/208.61 |- skos__prefLabel mesh__D019237 Tooth Cervix
% 208.44/208.61 |- skos__annotation mesh__D019237
% 208.44/208.61 IM; coord with specific tooth %28%IM%29% if pertinent; DF: note short X ref%A%
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D019237 2006
% 208.44/208.61 |- mesh__dateRevised mesh__D019237 2003-07-09
% 208.44/208.61 |- mesh__recordMaintainer mesh__D019237 lkt
% 208.44/208.61 |- mesh__dateCreated mesh__D019237 1996-06-10
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D019237 2005
% 208.44/208.61 |- rdf__type mesh__D019237sskos__Concept
% 208.44/208.61 |- skos__hiddenLabel mesh__D019237 Cementoenamel Junctions
% 208.44/208.61 |- skos__hiddenLabel mesh__D019237 Cervix, Tooth
% 208.44/208.61 |- skos__altLabel mesh__D019237 Cervix Dentis
% 208.44/208.61 |- mesh__historyNote mesh__D019237 97
% 208.44/208.61 |- mesh__recordOriginator mesh__D019237 TGC
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D019237 2004
% 208.44/208.61 |- skos__altLabel mesh__D019237 Cementoenamel Junction
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D019237 97
% 208.44/208.61 |- skos__broader mesh__D011254smesh__D011248
% 208.44/208.61 |- skos__hiddenLabel mesh__D011254 Pregnancy in Diabete
% 208.44/208.61 |- skos__hiddenLabel mesh__D011254 Pregnancy in Diabetic
% 208.44/208.61 |- skos__annotation mesh__D011254
% 208.44/208.61 DIABETES MELLITUS, not DIABETES INSIPIDUS; coordinate IM with specific type of diabetes mellitus %28%IM%29% if pertinent; DF: PREGN IN DIABETES%A%
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D011254 sjn
% 208.44/208.61 |- rdf__type mesh__D011254sskos__Concept
% 208.44/208.61 |- mesh__dateCreated mesh__D011254 1999-01-01
% 208.44/208.61 |- mesh__recordMaintainer mesh__D011254 lkt
% 208.44/208.61 |- skos__altLabel mesh__D011254 Pregnancy in Diabetes
% 208.44/208.61 |- mesh__dateRevised mesh__D011254 2005-06-30
% 208.44/208.61 |- skos__prefLabel mesh__D011254 Pregnancy in Diabetics
% 208.44/208.61 |- mesh__historyNote mesh__D011254 2001%28%1965%29%
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D011254 2006
% 208.44/208.61 |- skos__related mesh__D011254smesh__D016640
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D011254
% 208.44/208.61 2001; see PREGNANCY IN DIABETICS 1965-2000
% 208.44/208.61 |- skos__scopeNote mesh__D011254
% 208.44/208.61 The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy %28%DIABETES, GESTATIONAL%29% which resolves at the end of pregnancy.%A%
% 208.44/208.61 |- mesh__recordOriginator mesh__D011254 NLM
% 208.44/208.61 |- skos__broader mesh__D005217smesh__D004655
% 208.44/208.61 |- skos__scopeNote mesh__D005217
% 208.44/208.61 Emulsions of fats or lipids used primarily in parenteral feeding.%A%
% 208.44/208.61 |- skos__historyNote mesh__D005217 Oils %28%1966-1978%29%
% 208.44/208.61 |- mesh__historyNote mesh__D005217 79
% 208.44/208.61 |- mesh__recordOriginator mesh__D005217 RLS
% 208.44/208.61 |- skos__historyNote mesh__D005217 Lipids %28%1966-1978%29%
% 208.44/208.61 |- skos__historyNote mesh__D005217 Fats %28%1966-1978%29%
% 208.44/208.61 |- rdf__type mesh__D005217sskos__Concept
% 208.44/208.61 |- skos__hiddenLabel mesh__D005217 Emulsions, Intravenous Lipid
% 208.44/208.61 |- mesh__dateEstablished mesh__D005217 1979-01-01
% 208.44/208.61 |- skos__hiddenLabel mesh__D005217 Intravenous Fat Emulsions
% 208.44/208.61 |- skos__prefLabel mesh__D005217 Fat Emulsions, Intravenous
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D005217 sjn
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D005217 79
% 208.44/208.61 |- skos__hiddenLabel mesh__D005217 Intravenous Lipid Emulsions
% 208.44/208.61 |- skos__broader mesh__D005217smesh__D004041
% 208.44/208.61 |- mesh__dateCreated mesh__D005217 1977-12-09
% 208.44/208.61 |- skos__altLabel mesh__D005217 Lipid Emulsions, Intravenous
% 208.44/208.61 |- skos__historyNote mesh__D005217 Dietary Fats %28%1966-1978%29%
% 208.44/208.61 |- skos__annotation mesh__D005217 coordinate with disease /ther
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D005217 2006
% 208.44/208.61 |- skos__hiddenLabel mesh__D005217 Emulsions, Intravenous Fat
% 208.44/208.61 |- mesh__recordMaintainer mesh__D005217 ssb
% 208.44/208.61 |- mesh__dateRevised mesh__D005217 2005-06-30
% 208.44/208.61 |- skos__broader mesh__D003813Q000266smesh__D003813
% 208.44/208.61 |- mesh__preferredCombination mesh__D003813Q000266smesh__D006665
% 208.44/208.61 |- rdf__type mesh__D003813Q000266smesh__CompoundConcept
% 208.44/208.61 |- skos__historyNote mesh__D015645 Antibiotics %28%1966-1980%29%
% 208.44/208.61 |- rdf__type mesh__D015645sskos__Concept
% 208.44/208.61 |- mesh__recordOriginator mesh__D015645 RLS
% 208.44/208.61 |- skos__annotation mesh__D015645
% 208.44/208.61 do not use /biosyn unless by living matter
% 208.44/208.61 |- skos__altLabel mesh__D015645 Tylosine
% 208.44/208.61 |- skos__altLabel mesh__D015645 Fradizine
% 208.44/208.61 |- mesh__onlineNote mesh__D015645
% 208.44/208.61 use ANTIBIOTICS to search TYLOSIN 1966-80; use LEUCOMYCINS 1981-89%A%
% 208.44/208.61 |- skos__prefLabel mesh__D015645 Tylosin
% 208.44/208.61 |- skos__broader mesh__D015645smesh__D018942
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D015645 2006
% 208.44/208.61 |- skos__historyNote mesh__D015645 Leucomycins %28%1981-1989%29%
% 208.44/208.61 |- skos__scopeNote mesh__D015645
% 208.44/208.61 Macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans.%A%
% 208.44/208.61 |- skos__hiddenLabel mesh__D015645 Hydrochloride, Tylosin
% 208.44/208.61 |- mesh__dateCreated mesh__D015645 1989-05-25
% 208.44/208.61 |- mesh__publicMeSHNote mesh__D015645
% 208.44/208.61 90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1964-80%A%
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D015645 2005
% 208.44/208.61 |- mesh__dateEstablished mesh__D015645 1990-01-01
% 208.44/208.61 |- mesh__dateRevised mesh__D015645 2004-07-07
% 208.44/208.61 |- mesh__recordAuthorizer mesh__D015645 sjn
% 208.44/208.61 |- mesh__recordMaintainer mesh__D015645 ssb
% 208.44/208.61 |- mesh__historyNote mesh__D015645
% 208.44/208.61 90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1964-80%A%
% 208.44/208.61 |- skos__scopeNote mesh__D009608
% 208.44/208.61 Nitrous acid %28%HNO2%29%. A weak acid that exists only in solution. It can form water-soluble nitrites and stable esters. %28%From Merck Index, 11th ed%29%%A%
% 208.44/208.61 |- skos__hiddenLabel mesh__D009608 Acid, Nitrous
% 208.44/208.61 |- mesh__dateRevised mesh__D009608 1993-06-04
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009608 2002
% 208.44/208.61 |- mesh__activeMeSHYear mesh__D009608 2005
% 208.44/208.62 |- skos__broader mesh__D009608smesh__D017672
% 208.44/208.62 |- skos__prefLabel mesh__D009608 Nitrous Acid
% 208.44/208.62 |- skos__annotation mesh__D009608 do not confuse with NITRIC ACID
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 2003
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 1994
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 2006
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D009608 PLS
% 208.44/208.62 |- rdf__type mesh__D009608sskos__Concept
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 1998
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 2004
% 208.44/208.62 |- mesh__dateEstablished mesh__D009608 1991-01-01
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 1995
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 1996
% 208.44/208.62 |- skos__broader mesh__D009608smesh__D000148
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 2000
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 1999
% 208.44/208.62 |- mesh__historyNote mesh__D009608
% 208.44/208.62 91%28%75%29%; was see under NITRITES 1975-90
% 208.44/208.62 |- mesh__dateCreated mesh__D009608 1999-01-01
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D009608 91; was see under NITRITES 1975-90
% 208.44/208.62 |- mesh__recordOriginator mesh__D009608 NLM
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 1997
% 208.44/208.62 |- mesh__recordMaintainer mesh__D009608 TPW
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009608 2001
% 208.44/208.62 |- mesh__onlineNote mesh__D009608 search NITRITES 1966-74
% 208.44/208.62 |- skos__broader mesh__D001625smesh__D011720
% 208.44/208.62 |- mesh__dateCreated mesh__D001625 1974-11-19
% 208.44/208.62 |- skos__scopeNote mesh__D001625
% 208.44/208.62 A histamine H2 agonist used clinically to test gastric secretory function.%A%
% 208.44/208.62 |- skos__hiddenLabel mesh__D001625 Monohydrochloride, Betazole
% 208.44/208.62 |- skos__altLabel mesh__D001625 Ametazole
% 208.44/208.62 |- mesh__dateEstablished mesh__D001625 1991-01-01
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D001625
% 208.44/208.62 91; was see under PYRAZOLES 1975-90
% 208.44/208.62 |- skos__historyNote mesh__D001625 Ethylamines %28%1972-1974%29%
% 208.44/208.62 |- skos__hiddenLabel mesh__D001625 96791, Lilly
% 208.44/208.62 |- mesh__dateRevised mesh__D001625 2005-06-30
% 208.44/208.62 |- mesh__recordMaintainer mesh__D001625 ssb
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D001625 2006
% 208.44/208.62 |- skos__historyNote mesh__D001625 Pyrazoles %28%1968-1974%29%
% 208.44/208.62 |- rdf__type mesh__D001625sskos__Concept
% 208.44/208.62 |- mesh__historyNote mesh__D001625
% 208.44/208.62 91%28%75%29%; was see under PYRAZOLES 1975-90
% 208.44/208.62 |- skos__hiddenLabel mesh__D001625 Dihydrochloride, Betazole
% 208.44/208.62 |- skos__prefLabel mesh__D001625 Betazole
% 208.44/208.62 |- mesh__recordOriginator mesh__D001625 NLM
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D001625 sjn
% 208.44/208.62 |- rdf__type mesh__D034001sskos__Concept
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D034001 2004
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D034001 2003
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D034001 2003
% 208.44/208.62 |- skos__altLabel mesh__D034001 Adaptor Protein Subunits
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D034001 2006
% 208.44/208.62 |- skos__prefLabel mesh__D034001 Adaptor Protein Complex Subunits
% 208.44/208.62 |- skos__scopeNote mesh__D034001
% 208.44/208.62 The subunits that make up the large, medium and small chains of adaptor proteins.%A%
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D034001 2005
% 208.44/208.62 |- mesh__dateCreated mesh__D034001 2002-07-02
% 208.44/208.62 |- mesh__dateEstablished mesh__D034001 2003-01-01
% 208.44/208.62 |- skos__broader mesh__D034001smesh__D033942
% 208.44/208.62 |- mesh__historyNote mesh__D034001 2003
% 208.44/208.62 |- skos__hiddenLabel mesh__D006310 Ear Mold
% 208.44/208.62 |- mesh__recordOriginator mesh__D006310 NLM
% 208.44/208.62 |- skos__hiddenLabel mesh__D006310 Mold, Ear
% 208.44/208.62 |- mesh__dateCreated mesh__D006310 1999-01-01
% 208.44/208.62 |- rdf__type mesh__D006310sskos__Concept
% 208.44/208.62 |- skos__scopeNote mesh__D006310
% 208.44/208.62 Wearable sound-amplifying devices that are intended to compensate for impaired hearing. These generic devices include air-conduction hearing aids and bone-conduction hearing aids. %28%UMDNS, 1999%29%%A%
% 208.44/208.62 |- skos__broader mesh__D006310smesh__D012682
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D006310 sjn
% 208.44/208.62 |- skos__hiddenLabel mesh__D006310 Hearing Aid
% 208.44/208.62 |- skos__hiddenLabel mesh__D006310 Molds, Ear
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D006310 2006
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D006310 2002
% 208.44/208.62 |- skos__annotation mesh__D006310
% 208.44/208.62 %22%hearing aid%22% is correct translation for %22%proth%C3%%A8%se auditive%22%, not %22%auditory prosthesis%22% unless you mean COCHLEAR IMPLANT%A%
% 208.44/208.62 |- mesh__recordMaintainer mesh__D006310 jls
% 208.44/208.62 |- mesh__dateRevised mesh__D006310 2001-08-13
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D006310 2005
% 208.44/208.62 |- skos__prefLabel mesh__D006310 Hearing Aids
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D006310 2004
% 208.44/208.62 |- skos__hiddenLabel mesh__D006310 Aid, Hearing
% 208.44/208.62 |- skos__hiddenLabel mesh__D006310 Aids, Hearing
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D006310 2003
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D011255
% 208.44/208.62 80; was see under PREGNANCY 1975-79
% 208.44/208.62 |- skos__hiddenLabel mesh__D011255 Pregnancy Maintenances
% 208.44/208.62 |- skos__scopeNote mesh__D011255
% 208.44/208.62 Physiological mechanisms that sustain the state of PREGNANCY.%A%
% 208.44/208.62 |- skos__annotation mesh__D011255
% 208.44/208.62 check tags FEMALE %26% PREGNANCY; DF: PREGN MAINTENANCE
% 208.44/208.62 |- rdf__type mesh__D011255sskos__Concept
% 208.44/208.62 |- skos__prefLabel mesh__D011255 Pregnancy Maintenance
% 208.44/208.62 |- mesh__recordOriginator mesh__D011255 NLM
% 208.44/208.62 |- skos__hiddenLabel mesh__D011255 Maintenance, Pregnancy
% 208.44/208.62 |- mesh__dateRevised mesh__D011255 2004-07-07
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D011255 2005
% 208.44/208.62 |- skos__broader mesh__D011255smesh__D011247
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D011255 sjn
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D011255 2006
% 208.44/208.62 |- mesh__historyNote mesh__D011255
% 208.44/208.62 80%28%75%29%; was see under PREGNANCY 1975-79
% 208.44/208.62 |- mesh__dateCreated mesh__D011255 1974-11-11
% 208.44/208.62 |- skos__hiddenLabel mesh__D011255 Maintenances, Pregnancy
% 208.44/208.62 |- mesh__recordMaintainer mesh__D011255 lkt
% 208.44/208.62 |- mesh__dateEstablished mesh__D011255 1980-01-01
% 208.44/208.62 |- skos__scopeNote mesh__D005218
% 208.44/208.62 A condition in which the death of adipose tissue results in neutral fats being split into fatty acids and glycerol.%A%
% 208.44/208.62 |- skos__altLabel mesh__D005218 Steatonecrosis
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005218 2005
% 208.44/208.62 |- mesh__recordOriginator mesh__D005218 VDK
% 208.44/208.62 |- skos__hiddenLabel mesh__D005218 Fat Necroses
% 208.44/208.62 |- rdf__type mesh__D005218sskos__Concept
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D005218 91; was see under NECROSIS 1977-90
% 208.44/208.62 |- mesh__dateEstablished mesh__D005218 1991-01-01
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D005218 sjn
% 208.44/208.62 |- skos__historyNote mesh__D005218 Necrosis %28%1966-1976%29%
% 208.44/208.62 |- skos__hiddenLabel mesh__D005218 Steatonecroses
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005218 2002
% 208.44/208.62 |- mesh__dateCreated mesh__D005218 1976-04-27
% 208.44/208.62 |- mesh__dateRevised mesh__D005218 1999-11-03
% 208.44/208.62 |- skos__prefLabel mesh__D005218 Fat Necrosis
% 208.44/208.62 |- mesh__historyNote mesh__D005218
% 208.44/208.62 91%28%77%29%; was see under NECROSIS 1977-90
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005218 2001
% 208.44/208.62 |- mesh__recordMaintainer mesh__D005218 KEV
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005218 2004
% 208.44/208.62 |- skos__broader mesh__D005218smesh__D009336
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005218 2000
% 208.44/208.62 |- skos__hiddenLabel mesh__D005218 Necrosis, Fat
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005218 2003
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005218 2006
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646
% 208.44/208.62 Ventriculographies, First-Pass Radionuclide
% 208.44/208.62 |- skos__historyNote mesh__D015646 Heart %28%1977-1989%29%
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646
% 208.44/208.62 First-Pass Radionuclide Ventriculographies
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015646 2005
% 208.44/208.62 |- skos__annotation mesh__D015646
% 208.44/208.62 %22%ventriculo-%22% refers to the heart, not the cerebral ventricles; used for the right or left ventricle but is preferred for right: for the left ventricle GATED BLOOD-POOL IMAGING is preferred; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: VENTRICULOGR FIRST PASS%A%
% 208.44/208.62 |- skos__historyNote mesh__D015646
% 208.44/208.62 Radionuclide Angiography %28%1983-1989%29%
% 208.44/208.62 |- mesh__dateRevised mesh__D015646 1997-06-20
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015646 1999
% 208.44/208.62 |- rdf__type mesh__D015646sskos__Concept
% 208.44/208.62 |- skos__broader mesh__D015646smesh__D015635
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 First Pass Ventriculography
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 Ventriculography, First Pass
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015646 2006
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 Radionuclide Angiography, First Pass
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 Radionuclide Angiographies, First-Pass
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015646 2002
% 208.44/208.62 |- skos__related mesh__D015646smesh__D015637
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D015646 SJN
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646
% 208.44/208.62 Ventriculography, First-Pass Radionuclide
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D015646 90
% 208.44/208.62 |- skos__altLabel mesh__D015646 Radionuclide Ventriculography, First-Pass
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 Angiographies, First-Pass Radionuclide
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 First Pass Radionuclide Angiography
% 208.44/208.62 |- mesh__dateCreated mesh__D015646 1989-06-19
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015646 2003
% 208.44/208.62 |- skos__historyNote mesh__D015646 Heart Ventricle %28%1977-1989%29%
% 208.44/208.62 |- mesh__historyNote mesh__D015646 90
% 208.44/208.62 |- skos__altLabel mesh__D015646 First-Pass Ventriculography
% 208.44/208.62 |- mesh__dateEstablished mesh__D015646 1990-01-01
% 208.44/208.62 |- skos__scopeNote mesh__D015646
% 208.44/208.62 Radionuclide ventriculography where a bolus of radionuclide is injected and data are recorded from one pass through the heart ventricle. Left and right ventricular function can be analyzed independently during this technique. First-pass ventriculography is preferred over GATED BLOOD-POOL IMAGING for assessing right ventricular function.%A%
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646
% 208.44/208.62 Radionuclide Ventriculography, First Pass
% 208.44/208.62 |- skos__prefLabel mesh__D015646 Ventriculography, First-Pass
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 First-Pass Ventriculographies
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015646 2004
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646
% 208.44/208.62 Radionuclide Ventriculographies, First-Pass
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015646 2000
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 First-Pass Radionuclide Ventriculography
% 208.44/208.62 |- mesh__recordMaintainer mesh__D015646 PXP
% 208.44/208.62 |- mesh__recordOriginator mesh__D015646 AGS
% 208.44/208.62 |- skos__altLabel mesh__D015646 First-Pass Radionuclide Angiography
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 Angiography, First-Pass Radionuclide
% 208.44/208.62 |- skos__hiddenLabel mesh__D015646 First-Pass Radionuclide Angiographies
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015646 1998
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015646 2001
% 208.44/208.62 |- skos__altLabel mesh__D015646 Radionuclide Angiography, First-Pass
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009609 2001
% 208.44/208.62 |- skos__prefLabel mesh__D009609 Nitrous Oxide
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009609 2000
% 208.44/208.62 |- mesh__recordOriginator mesh__D009609 NLM
% 208.44/208.62 |- skos__scopeNote mesh__D009609
% 208.44/208.62 Nitrogen oxide %28%N2O%29%. A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.%A%
% 208.44/208.62 |- mesh__recordMaintainer mesh__D009609 adp
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009609 2004
% 208.44/208.62 |- mesh__dateRevised mesh__D009609 1999-11-03
% 208.44/208.62 |- skos__hiddenLabel mesh__D009609 Gas, Laughing
% 208.44/208.62 |- mesh__dateCreated mesh__D009609 1999-01-01
% 208.44/208.62 |- skos__annotation mesh__D009609
% 208.44/208.62 an inhalation anesthetic %26% nonnarcotic analgesic
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D009609 sjn
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009609 2003
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009609 2006
% 208.44/208.62 |- skos__altLabel mesh__D009609 Laughing Gas
% 208.44/208.62 |- skos__broader mesh__D009609smesh__D009589
% 208.44/208.62 |- rdf__type mesh__D009609sskos__Concept
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009609 2002
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D009609 2005
% 208.44/208.62 |- skos__hiddenLabel mesh__D009609 Oxide, Nitrous
% 208.44/208.62 |- skos__annotation mesh__D001626
% 208.44/208.62 ammonium cpds; BETHANECHOL is available; DF: BETHANECHOL CPDS%A%
% 208.44/208.62 |- mesh__recordOriginator mesh__D001626 NLM
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D001626 sjn
% 208.44/208.62 |- mesh__dateCreated mesh__D001626 1999-01-01
% 208.44/208.62 |- mesh__dateEstablished mesh__D001626 1968-01-01
% 208.44/208.62 |- skos__prefLabel mesh__D001626 Bethanechol Compounds
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D001626 2006
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D001626 68
% 208.44/208.62 |- rdf__type mesh__D001626sskos__Concept
% 208.44/208.62 |- skos__broader mesh__D001626smesh__D050337
% 208.44/208.62 |- mesh__dateRevised mesh__D001626 2005-06-30
% 208.44/208.62 |- skos__hiddenLabel mesh__D001626 Compounds, Bethanechol
% 208.44/208.62 |- mesh__recordMaintainer mesh__D001626 ssb
% 208.44/208.62 |- skos__broader mesh__D001626smesh__D000644
% 208.44/208.62 |- mesh__historyNote mesh__D001626
% 208.44/208.62 68; was BETHANECHOL 1964-67 %28%Prov%29%; URECHOLINE was URECHOLINE CHLORIDE see under BETHANECHOL COMPOUNDS 1968-76%A%
% 208.44/208.62 |- mesh__onlineNote mesh__D001626
% 208.44/208.62 use BETHANECHOL COMPOUNDS to search BETHANECHOL 1966-67 %28%as Prov 1966-67%29% %26% URECHOLINE CHLORIDE 1968-76%A%
% 208.44/208.62 |- mesh__dateCreated mesh__D034002 2002-07-02
% 208.44/208.62 |- mesh__dateEstablished mesh__D034002 2003-01-01
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D034002 2003
% 208.44/208.62 |- mesh__recordOriginator mesh__D034002 jmp
% 208.44/208.62 |- mesh__historyNote mesh__D034002 2003
% 208.44/208.62 |- skos__prefLabel mesh__D034002 Adaptor Protein Complex sigma Subunits
% 208.44/208.62 |- skos__historyNote mesh__D034002 Adaptor Proteins %28%1995-2002%29%
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D034002 2006
% 208.44/208.62 |- skos__hiddenLabel mesh__D034002 Sigma Adaptins
% 208.44/208.62 |- skos__altLabel mesh__D034002
% 208.44/208.62 Clathrin Assembly Protein Complex sigma Subunit
% 208.44/208.62 |- skos__scopeNote mesh__D034002
% 208.44/208.62 A family of small adaptin protein complex subunits of approximately 19 KDa in size.%A%
% 208.44/208.62 |- mesh__recordMaintainer mesh__D034002 jmp
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D034002 2005
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D034002 sjn
% 208.44/208.62 |- mesh__dateRevised mesh__D034002 2004-07-07
% 208.44/208.62 |- skos__broader mesh__D034002smesh__D034001
% 208.44/208.62 |- skos__altLabel mesh__D034002 Sigma-Adaptins
% 208.44/208.62 |- rdf__type mesh__D034002sskos__Concept
% 208.44/208.62 |- skos__altLabel mesh__D006311 Paracusis
% 208.44/208.62 |- skos__broader mesh__D006311smesh__D004427
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D006311 2006
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D006311 2005
% 208.44/208.62 |- skos__related mesh__D006311smesh__D019986
% 208.44/208.62 |- skos__prefLabel mesh__D006311 Hearing Disorders
% 208.44/208.62 |- mesh__recordOriginator mesh__D006311 NLM
% 208.44/208.62 |- mesh__recordMaintainer mesh__D006311 lkt
% 208.44/208.62 |- mesh__dateRevised mesh__D006311 2004-07-07
% 208.44/208.62 |- skos__broader mesh__D006311smesh__D012678
% 208.44/208.62 |- skos__annotation mesh__D006311
% 208.44/208.62 GEN or unspecified; consider also DEAFNESS and HEARING LOSS and its indentations%A%
% 208.44/208.62 |- skos__scopeNote mesh__D006311
% 208.44/208.62 Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices, including the sensorineural pathways.%A%
% 208.44/208.62 |- skos__hiddenLabel mesh__D006311 Hearing, Distorted
% 208.44/208.62 |- mesh__dateCreated mesh__D006311 1999-01-01
% 208.44/208.62 |- skos__hiddenLabel mesh__D006311 Hearing Disorder
% 208.44/208.62 |- rdf__type mesh__D006311sskos__Concept
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D006311 sjn
% 208.44/208.62 |- skos__hiddenLabel mesh__D047728 Progressive Myopia
% 208.44/208.62 |- mesh__historyNote mesh__D047728 2005
% 208.44/208.62 |- skos__hiddenLabel mesh__D047728 Pathological Myopias
% 208.44/208.62 |- skos__hiddenLabel mesh__D047728 Progressive Myopias
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D047728 2006
% 208.44/208.62 |- skos__historyNote mesh__D047728 Myopia %28%1965-2004%29%
% 208.44/208.62 |- rdf__type mesh__D047728sskos__Concept
% 208.44/208.62 |- skos__altLabel mesh__D047728 Myopia, Pathological
% 208.44/208.62 |- mesh__dateEstablished mesh__D047728 2005-01-01
% 208.44/208.62 |- mesh__recordOriginator mesh__D047728 ags
% 208.44/208.62 |- mesh__recordMaintainer mesh__D047728 jls
% 208.44/208.62 |- skos__hiddenLabel mesh__D047728 Degenerative Myopia
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D047728 2005
% 208.44/208.62 |- skos__prefLabel mesh__D047728 Myopia, Degenerative
% 208.44/208.62 |- skos__broader mesh__D047728smesh__D009216
% 208.44/208.62 |- skos__hiddenLabel mesh__D047728 Myopias, Pathological
% 208.44/208.62 |- mesh__dateRevised mesh__D047728 2004-07-29
% 208.44/208.62 |- skos__hiddenLabel mesh__D047728 Pathological Myopia
% 208.44/208.62 |- skos__hiddenLabel mesh__D047728 Degenerative Myopias
% 208.44/208.62 |- skos__hiddenLabel mesh__D047728 Myopias, Progressive
% 208.44/208.62 |- mesh__dateCreated mesh__D047728 2004-07-07
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D047728 2005
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D047728 2005A
% 208.44/208.62 |- skos__scopeNote mesh__D047728
% 208.44/208.62 Excessive axial myopia associated with complications %28%especially posterior staphyloma and CHOROIDAL NEOVASCULARIZATION%29% that can lead to BLINDNESS.%A%
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D047728 jls
% 208.44/208.62 |- skos__hiddenLabel mesh__D047728 Myopias, Degenerative
% 208.44/208.62 |- skos__altLabel mesh__D019239 Practice Patterns, Dental
% 208.44/208.62 |- mesh__dateRevised mesh__D019239 1999-11-03
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D019239 2000
% 208.44/208.62 |- skos__hiddenLabel mesh__D019239 Practice Patterns, Dentist%27%s
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D019239 2006
% 208.44/208.62 |- skos__broader mesh__D019239smesh__D003695
% 208.44/208.62 |- skos__hiddenLabel mesh__D019239 Pattern, Dentist%27%s Practice
% 208.44/208.62 |- skos__hiddenLabel mesh__D019239 Dentists Practice Patterns
% 208.44/208.62 |- skos__altLabel mesh__D019239 Dental Practice Pattern
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D019239 2001
% 208.44/208.62 |- skos__annotation mesh__D019239
% 208.44/208.62 practice in dentistry related to diag %26% treatment
% 208.44/208.62 |- skos__hiddenLabel mesh__D019239 Practice Pattern, Dentist%27%s
% 208.44/208.62 |- skos__broader mesh__D019239smesh__D010346
% 208.44/208.62 |- rdf__type mesh__D019239sskos__Concept
% 208.44/208.62 |- mesh__recordOriginator mesh__D019239 TGC
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D019239 2003
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D019239 97
% 208.44/208.62 |- mesh__dateCreated mesh__D019239 1996-06-13
% 208.44/208.62 |- skos__historyNote mesh__D019239 Professional Practice %28%1987-1995%29%
% 208.44/208.62 |- mesh__historyNote mesh__D019239 97
% 208.44/208.62 |- skos__altLabel mesh__D019239 Pattern, Dental Practice
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D019239 2004
% 208.44/208.62 |- skos__altLabel mesh__D019239 Practice Pattern, Dental
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D019239 2002
% 208.44/208.62 |- skos__historyNote mesh__D019239
% 208.44/208.62 Physician%27%s Practice Patterns %28%1990-1996%29%
% 208.44/208.62 |- mesh__recordMaintainer mesh__D019239 kle
% 208.44/208.62 |- skos__hiddenLabel mesh__D019239 Dentist%27%s Practice Pattern
% 208.44/208.62 |- skos__altLabel mesh__D019239 Dental Practice Patterns
% 208.44/208.62 |- skos__prefLabel mesh__D019239 Dentist%27%s Practice Patterns
% 208.44/208.62 |- skos__hiddenLabel mesh__D019239 Patterns, Dentist%27%s Practice
% 208.44/208.62 |- skos__altLabel mesh__D019239 Patterns, Dental Practice
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D019239 sjn
% 208.44/208.62 |- skos__hiddenLabel mesh__D019239 Dentist Practice Patterns
% 208.44/208.62 |- skos__scopeNote mesh__D019239
% 208.44/208.62 Patterns of practice in dentistry related to diagnosis and treatment.%A%
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D019239 2005
% 208.44/208.62 |- mesh__dateEstablished mesh__D019239 1997-01-01
% 208.44/208.62 |- mesh__dateRevised mesh__D011256 2005-06-30
% 208.44/208.62 |- rdf__type mesh__D011256sskos__Concept
% 208.44/208.62 |- mesh__historyNote mesh__D011256 88
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D011256 88
% 208.44/208.62 |- skos__historyNote mesh__D011256 Pregnancy %28%1966-1987%29%
% 208.44/208.62 |- mesh__recordMaintainer mesh__D011256 lkt
% 208.44/208.62 |- skos__prefLabel mesh__D011256 Pregnancy Outcome
% 208.44/208.62 |- skos__altLabel mesh__D011256 Pregnancy Outcomes
% 208.44/208.62 |- skos__broader mesh__D011256smesh__D011379
% 208.44/208.62 |- skos__annotation mesh__D011256
% 208.44/208.62 general or unspecified: prefer specific outcome; DF: PREGN OUTCOME%A%
% 208.44/208.62 |- mesh__recordOriginator mesh__D011256 EC
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D011256 2006
% 208.44/208.62 |- skos__altLabel mesh__D011256 Outcomes, Pregnancy
% 208.44/208.62 |- mesh__dateCreated mesh__D011256 1987-03-23
% 208.44/208.62 |- mesh__dateEstablished mesh__D011256 1988-01-01
% 208.44/208.62 |- skos__historyNote mesh__D011256
% 208.44/208.62 Pregnancy Complications %28%1966-1987%29%
% 208.44/208.62 |- skos__broader mesh__D011256smesh__D011247
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D011256 sjn
% 208.44/208.62 |- skos__altLabel mesh__D011256 Outcome, Pregnancy
% 208.44/208.62 |- skos__scopeNote mesh__D011256
% 208.44/208.62 Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.%A%
% 208.44/208.62 |- skos__hiddenLabel mesh__D005219 Relationship, Father-Child
% 208.44/208.62 |- mesh__dateEstablished mesh__D005219 1968-01-01
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 2001
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 1996
% 208.44/208.62 |- mesh__recordMaintainer mesh__D005219 TAP
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 1999
% 208.44/208.62 |- skos__hiddenLabel mesh__D005219 Relationships, Father-Child
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D005219 68
% 208.44/208.62 |- skos__altLabel mesh__D005219 Father-Child Relationship
% 208.44/208.62 |- skos__hiddenLabel mesh__D005219 Father Child Relationship
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 2000
% 208.44/208.62 |- skos__hiddenLabel mesh__D005219 Relations, Father-Child
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 1998
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 1993
% 208.44/208.62 |- skos__historyNote mesh__D005219 Parent-Child Relations %28%1966-1967%29%
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 2004
% 208.44/208.62 |- skos__annotation mesh__D005219 human only; DF: FATHER CHILD RELAT
% 208.44/208.62 |- mesh__dateCreated mesh__D005219 1999-01-01
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D005219 PLS
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 1995
% 208.44/208.62 |- skos__prefLabel mesh__D005219 Father-Child Relations
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 2003
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 2006
% 208.44/208.62 |- mesh__dateRevised mesh__D005219 1992-05-15
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 1994
% 208.44/208.62 |- skos__hiddenLabel mesh__D005219 Father-Child Relation
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 2005
% 208.44/208.62 |- mesh__historyNote mesh__D005219 68
% 208.44/208.62 |- skos__broader mesh__D005219smesh__D010287
% 208.44/208.62 |- skos__hiddenLabel mesh__D005219 Father Child Relations
% 208.44/208.62 |- skos__scopeNote mesh__D005219
% 208.44/208.62 Interaction between the father and the child.
% 208.44/208.62 |- skos__hiddenLabel mesh__D005219 Father-Child Relationships
% 208.44/208.62 |- rdf__type mesh__D005219sskos__Concept
% 208.44/208.62 |- skos__hiddenLabel mesh__D005219 Relation, Father-Child
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 2002
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D005219 1997
% 208.44/208.62 |- mesh__recordOriginator mesh__D005219 NLM
% 208.44/208.62 |- skos__altLabel mesh__D015647 SKF38393
% 208.44/208.62 |- skos__altLabel mesh__D015647 SKF-38393
% 208.44/208.62 |- mesh__recordMaintainer mesh__D015647 ssb
% 208.44/208.62 |- skos__prefLabel mesh__D015647
% 208.44/208.62 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
% 208.44/208.62 |- skos__historyNote mesh__D015647 Benzazepines %28%1966-1989%29%
% 208.44/208.62 |- skos__altLabel mesh__D015647 SKF 38393-A
% 208.44/208.62 |- skos__hiddenLabel mesh__D015647 SK%26%F 38393
% 208.44/208.62 |- skos__hiddenLabel mesh__D015647 SK%26%F38393
% 208.44/208.62 |- skos__altLabel mesh__D015647 R-SK%26%F 38393
% 208.44/208.62 |- mesh__dateEstablished mesh__D015647 1990-01-01
% 208.44/208.62 |- skos__hiddenLabel mesh__D015647 SKF 38393A
% 208.44/208.62 |- skos__altLabel mesh__D015647
% 208.44/208.62 1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015647 2006
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D015647 2005; see SK%26%F-38393 1989-2004
% 208.44/208.62 |- skos__historyNote mesh__D015647 Dopaminergic Agents %28%1989%29%
% 208.44/208.62 |- mesh__recordOriginator mesh__D015647 RLS
% 208.44/208.62 |- mesh__historyNote mesh__D015647 2005%28%1990%29%
% 208.44/208.62 |- skos__hiddenLabel mesh__D015647 RSK%26%F 38393
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D015647 2005
% 208.44/208.62 |- mesh__dateRevised mesh__D015647 2004-07-07
% 208.44/208.62 |- skos__scopeNote mesh__D015647
% 208.44/208.62 A selective D1 dopamine receptor agonist used primarily as a research tool.%A%
% 208.44/208.62 |- rdf__type mesh__D015647sskos__Concept
% 208.44/208.62 |- skos__hiddenLabel mesh__D015647 SKF 38393
% 208.44/208.62 |- skos__broader mesh__D015647smesh__D001552
% 208.44/208.62 |- mesh__dateCreated mesh__D015647 1989-09-01
% 208.44/208.62 |- mesh__recordAuthorizer mesh__D015647 sjn
% 208.44/208.62 |- skos__hiddenLabel mesh__D015647 SKF 38393 A
% 208.44/208.62 |- rdf__type mesh__D034801sskos__Concept
% 208.44/208.62 |- skos__historyNote mesh__D034801 Mastocytosis %28%1985-2002%29%
% 208.44/208.62 |- mesh__recordOriginator mesh__D034801 lkt
% 208.44/208.62 |- mesh__activeMeSHYear mesh__D034801 2005
% 208.44/208.62 |- mesh__publicMeSHNote mesh__D034801
% 208.44/208.62 2003; for MASTOCYTOMA BENIGN see MASTOCYTOSIS 1987-2002
% 208.44/208.62 |- skos__annotation mesh__D034801
% 208.44/208.62 unifocal lesion only; multi-focal lesions use MASTOCYTOSIS, CUTANEOUS%A%
% 208.44/208.62 |- skos__broader mesh__D034801smesh__D008415
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D034801 sjn
% 208.44/208.63 |- skos__altLabel mesh__D034801 Mastocytoma, Skin
% 208.44/208.63 |- skos__altLabel mesh__D034801 Skin Mastocytoma
% 208.44/208.63 |- mesh__dateCreated mesh__D034801 2002-07-02
% 208.44/208.63 |- skos__altLabel mesh__D034801 Benign Mastocytoma
% 208.44/208.63 |- mesh__dateEstablished mesh__D034801 2003-01-01
% 208.44/208.63 |- mesh__historyNote mesh__D034801
% 208.44/208.63 2003; for MASTOCYTOMA BENIGN use MASTOCYTOSIS 1987-2002
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D034801 2004
% 208.44/208.63 |- skos__scopeNote mesh__D034801
% 208.44/208.63 A solid tumor consisting of a dense infiltration of MAST CELLS. It is generally benign.%A%
% 208.44/208.63 |- mesh__recordMaintainer mesh__D034801 lkt
% 208.44/208.63 |- skos__prefLabel mesh__D034801 Mastocytoma
% 208.44/208.63 |- skos__hiddenLabel mesh__D034801 Cutaneous Mastocytoma
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D034801 2006
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D034801 2003
% 208.44/208.63 |- rdf__type mesh__D001627sskos__Concept
% 208.44/208.63 |- skos__prefLabel mesh__D001627 Bethanidine
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D001627
% 208.44/208.63 91; was see under GUANIDINES 1975-90
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001627 2005
% 208.44/208.63 |- skos__altLabel mesh__D001627 Wellcome Brand of Betanidine Sulfate
% 208.44/208.63 |- skos__historyNote mesh__D001627 Benzyl Compounds %28%1972-1974%29%
% 208.44/208.63 |- skos__altLabel mesh__D001627 Betanidine
% 208.44/208.63 |- mesh__recordOriginator mesh__D001627 NLM
% 208.44/208.63 |- mesh__dateCreated mesh__D001627 1974-11-19
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D001627 sjn
% 208.44/208.63 |- mesh__historyNote mesh__D001627
% 208.44/208.63 91%28%75%29%; was see under GUANIDINES 1975-90
% 208.44/208.63 |- skos__altLabel mesh__D001627 Bethanidine, Sulfate %28%2:1%29%
% 208.44/208.63 |- skos__hiddenLabel mesh__D001627 Sulfate, Bethanidine
% 208.44/208.63 |- skos__broader mesh__D001627smesh__D006146
% 208.44/208.63 |- mesh__dateRevised mesh__D001627 2004-07-07
% 208.44/208.63 |- mesh__dateEstablished mesh__D001627 1991-01-01
% 208.44/208.63 |- mesh__recordMaintainer mesh__D001627 mdb
% 208.44/208.63 |- skos__scopeNote mesh__D001627
% 208.44/208.63 A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.%A%
% 208.44/208.63 |- skos__historyNote mesh__D001627 Guanidines %28%1968-1974%29%
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001627 2006
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D006312 2006
% 208.44/208.63 |- skos__historyNote mesh__D006312 Deafness %28%1966-1978%29%
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D006312 sjn
% 208.44/208.63 |- skos__hiddenLabel mesh__D006312 Loss, Bilateral Hearing
% 208.44/208.63 |- skos__hiddenLabel mesh__D006312 Hearing Losses, Bilateral
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D006312 2005
% 208.44/208.63 |- mesh__dateEstablished mesh__D006312 1991-01-01
% 208.44/208.63 |- skos__hiddenLabel mesh__D006312 Bilateral Hearing Loss
% 208.44/208.63 |- skos__hiddenLabel mesh__D006312 Bilateral Hearing Losses
% 208.44/208.63 |- skos__scopeNote mesh__D006312 Partial hearing loss in both ears.
% 208.44/208.63 |- mesh__dateRevised mesh__D006312 2004-07-07
% 208.44/208.63 |- skos__annotation mesh__D006312
% 208.44/208.63 differentiate from DEAFNESS, total hearing loss in both ears%A%
% 208.44/208.63 |- skos__broader mesh__D006312smesh__D034381
% 208.44/208.63 |- mesh__historyNote mesh__D006312
% 208.44/208.63 91%28%79%29%; was see under HEARING LOSS, PARTIAL 1979-90
% 208.44/208.63 |- rdf__type mesh__D006312sskos__Concept
% 208.44/208.63 |- skos__hiddenLabel mesh__D006312 Losses, Bilateral Hearing
% 208.44/208.63 |- mesh__recordMaintainer mesh__D006312 lkt
% 208.44/208.63 |- mesh__recordOriginator mesh__D006312 RC
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D006312
% 208.44/208.63 91; was see under HEARING LOSS, PARTIAL 1979-90
% 208.44/208.63 |- skos__prefLabel mesh__D006312 Hearing Loss, Bilateral
% 208.44/208.63 |- mesh__dateCreated mesh__D006312 1978-05-22
% 208.44/208.63 |- skos__hiddenLabel mesh__D011257 Proteins, Pregnancy
% 208.44/208.63 |- mesh__dateRevised mesh__D011257 2005-06-30
% 208.44/208.63 |- skos__historyNote mesh__D011257 Pregnancy %28%1966-1979%29%
% 208.44/208.63 |- skos__historyNote mesh__D011257 Placental Hormones %28%1966-1979%29%
% 208.44/208.63 |- skos__historyNote mesh__D011257 Proteins %28%1966-1979%29%
% 208.44/208.63 |- skos__historyNote mesh__D011257 Placenta %28%1966-1979%29%
% 208.44/208.63 |- skos__prefLabel mesh__D011257 Pregnancy Proteins
% 208.44/208.63 |- skos__scopeNote mesh__D011257
% 208.44/208.63 Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific %28%present only during pregnancy%29% or pregnancy-associated %28%present during pregnancy or under other conditions such as hormone therapy or certain malignancies.%29%%A%
% 208.44/208.63 |- skos__historyNote mesh__D011257 specific protein
% 208.44/208.63 |- skos__altLabel mesh__D011257 Placental Proteins
% 208.44/208.63 |- skos__hiddenLabel mesh__D011257 Proteins, Placental
% 208.44/208.63 |- mesh__dateCreated mesh__D011257 1979-02-22
% 208.44/208.63 |- skos__broader mesh__D011257smesh__D011506
% 208.44/208.63 |- skos__annotation mesh__D011257
% 208.44/208.63 GEN; prefer specifics; DF: PREGN PROTEINS
% 208.44/208.63 |- mesh__dateEstablished mesh__D011257 1980-01-01
% 208.44/208.63 |- mesh__recordMaintainer mesh__D011257 SYSTEM
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011257 2006
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D011257 sjn
% 208.44/208.63 |- mesh__historyNote mesh__D011257 80
% 208.44/208.63 |- mesh__recordOriginator mesh__D011257 RLS
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D011257 80
% 208.44/208.63 |- rdf__type mesh__D011257sskos__Concept
% 208.44/208.63 |- rdf__type mesh__D016740sskos__Concept
% 208.44/208.63 |- skos__altLabel mesh__D016740 Jingluo
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016740 2003
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016740 2005
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D016740 92
% 208.44/208.63 |- mesh__dateRevised mesh__D016740 2001-07-25
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016740 2004
% 208.44/208.63 |- mesh__recordMaintainer mesh__D016740 ssb
% 208.44/208.63 |- skos__broader mesh__D016740smesh__D015670
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016740 2002
% 208.44/208.63 |- mesh__dateCreated mesh__D016740 1991-05-31
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016740 2006
% 208.44/208.63 |- skos__scopeNote mesh__D016740
% 208.44/208.63 Classical loci in acupuncture. They are main and collateral channels, regarded as a network of passages, through which vital energy circulates and along which acupoints %28%ACUPUNCTURE POINTS%29% are distributed. The meridians are a series of 14 lines upon which more than 400 acupoints are located on the body. %28%The Pinyin Chinese-English Dictionary, p. 359; Dr. Wu Lancheng, Academy of Traditional Chinese Medicine, Beijing%29%%A%
% 208.44/208.63 |- skos__altLabel mesh__D016740 Ching Lo
% 208.44/208.63 |- mesh__dateEstablished mesh__D016740 1992-01-01
% 208.44/208.63 |- skos__prefLabel mesh__D016740 Meridians
% 208.44/208.63 |- skos__annotation mesh__D016740
% 208.44/208.63 classical loci in acupuncture; not for meridians in ophthalmology: index under OPTICS %28%IM%29% + EYE; CORNEA; VISUAL FIELD or other applicable ophthalmol term %28%IM%29%%A%
% 208.44/208.63 |- mesh__historyNote mesh__D016740 92
% 208.44/208.63 |- skos__hiddenLabel mesh__D016740 Luo, Jing
% 208.44/208.63 |- skos__historyNote mesh__D016740 Acupuncture %28%1968-1991%29%
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D016740 sjn
% 208.44/208.63 |- skos__altLabel mesh__D016740 Jing Luo
% 208.44/208.63 |- mesh__recordOriginator mesh__D016740 TGC
% 208.44/208.63 |- skos__broader mesh__D002720smesh__D013843
% 208.44/208.63 |- skos__annotation mesh__D002720
% 208.44/208.63 an anti-anxiety agent %26% central muscle relaxant
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D002720 sjn
% 208.44/208.63 |- mesh__recordOriginator mesh__D002720 NLM
% 208.44/208.63 |- mesh__dateRevised mesh__D002720 2005-06-30
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D002720 2006
% 208.44/208.63 |- mesh__recordMaintainer mesh__D002720 ssb
% 208.44/208.63 |- skos__prefLabel mesh__D002720 Chlormezanone
% 208.44/208.63 |- mesh__dateCreated mesh__D002720 1999-01-01
% 208.44/208.63 |- skos__scopeNote mesh__D002720
% 208.44/208.63 A non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm.%A%
% 208.44/208.63 |- skos__altLabel mesh__D002720 Chlormethazanone
% 208.44/208.63 |- rdf__type mesh__D002720sskos__Concept
% 208.44/208.63 |- skos__scopeNote mesh__D040041
% 208.44/208.63 Family of MITES, in the superfamily Acaroidea, order Astigmata. They are frequently found in cereal-based foodstuffs including GRAIN and FLOUR.%A%
% 208.44/208.63 |- skos__broader mesh__D040041smesh__D008925
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D040041 2005
% 208.44/208.63 |- mesh__dateCreated mesh__D040041 2002-07-02
% 208.44/208.63 |- mesh__dateEstablished mesh__D040041 2003-01-01
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D040041 2006
% 208.44/208.63 |- mesh__recordOriginator mesh__D040041 ags
% 208.44/208.63 |- mesh__dateRevised mesh__D040041 2003-07-09
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D040041 sjn
% 208.44/208.63 |- rdf__type mesh__D040041sskos__Concept
% 208.44/208.63 |- skos__historyNote mesh__D040041 Mites %28%1967-2002%29%
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D040041 2003
% 208.44/208.63 |- skos__altLabel mesh__D040041 Mites, Storage
% 208.44/208.63 |- mesh__recordMaintainer mesh__D040041 ags
% 208.44/208.63 |- skos__altLabel mesh__D040041 Storage Mites
% 208.44/208.63 |- mesh__historyNote mesh__D040041 2003
% 208.44/208.63 |- skos__altLabel mesh__D040041 Mites, Store Product
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D040041 2004
% 208.44/208.63 |- skos__prefLabel mesh__D040041 Acaridae
% 208.44/208.63 |- skos__hiddenLabel mesh__D034802 EWS Proto Oncogene Protein
% 208.44/208.63 |- skos__hiddenLabel mesh__D034802 Proto-Oncogene Protein, EWS
% 208.44/208.63 |- skos__altLabel mesh__D034802 Ewing Sarcoma Breakpointregion 1 Protein
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D034802
% 208.44/208.63 2003; EWS PROTEIN was indexed under RIBONUCLEOPROTEINS 1995-2002%A%
% 208.44/208.63 |- skos__broader mesh__D034802smesh__D034441
% 208.44/208.63 |- mesh__recordOriginator mesh__D034802 jmp
% 208.44/208.63 |- skos__scopeNote mesh__D034802
% 208.44/208.63 A ubiquitous hnRNP protein found in the CELL NUCLEUS and the CYTOPLASM. Translocations that result in the formation of fusion proteins containing parts of RNA-binding protein EWS may play a role in neoplastic processes such as Ewing Sarcoma %28%SARCOMA, EWING%27%S%29%.%A%
% 208.44/208.63 |- skos__hiddenLabel mesh__D034802 RNA Binding Protein EWS
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D034802 2004
% 208.44/208.63 |- skos__hiddenLabel mesh__D034802 EWS, RNA-Binding Protein
% 208.44/208.63 |- skos__altLabel mesh__D034802 EWS Protein
% 208.44/208.63 |- mesh__dateCreated mesh__D034802 2002-07-03
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D034802 2006A
% 208.44/208.63 |- mesh__recordMaintainer mesh__D034802 ags
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D034802 2006
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D034802 2003
% 208.44/208.63 |- rdf__type mesh__D034802sskos__Concept
% 208.44/208.63 |- mesh__dateRevised mesh__D034802 2005-07-21
% 208.44/208.63 |- skos__altLabel mesh__D034802 EWS Proto-Oncogene Protein
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D034802 2005
% 208.44/208.63 |- mesh__historyNote mesh__D034802
% 208.44/208.63 2003; for EWS PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1995-2002%A%
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D034802 ags
% 208.44/208.63 |- mesh__dateEstablished mesh__D034802 2003-01-01
% 208.44/208.63 |- skos__broader mesh__D034802smesh__D011518
% 208.44/208.63 |- skos__historyNote mesh__D034802 Ribonucleoproteins %28%1995-2002%29%
% 208.44/208.63 |- skos__prefLabel mesh__D034802 RNA-Binding Protein EWS
% 208.44/208.63 |- skos__hiddenLabel mesh__D001628 Tea, Medicinal
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 2003
% 208.44/208.63 |- skos__hiddenLabel mesh__D001628 Herbal Tea
% 208.44/208.63 |- mesh__recordMaintainer mesh__D001628 ags
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 2001
% 208.44/208.63 |- skos__altLabel mesh__D001628 Herbal Teas
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 2006A
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 2000
% 208.44/208.63 |- mesh__dateRevised mesh__D001628 2005-07-12
% 208.44/208.63 |- skos__broader mesh__D001628smesh__D019602
% 208.44/208.63 |- skos__annotation mesh__D001628
% 208.44/208.63 orange %26% grapefruit juices: coord IM with CITRUS FRUIT %28%IM%29%; ALCOHOLIC BEVERAGES %26% specifics %26% CARBONATED BEVERAGES are also available%A%
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D001628 ags
% 208.44/208.63 |- skos__hiddenLabel mesh__D001628 Beverage
% 208.44/208.63 |- mesh__dateCreated mesh__D001628 1999-01-01
% 208.44/208.63 |- skos__scopeNote mesh__D001628
% 208.44/208.63 Liquids that are suitable for drinking. %28%From Merriam Webster Collegiate Dictionary, 10th ed%29%%A%
% 208.44/208.63 |- mesh__recordOriginator mesh__D001628 NLM
% 208.44/208.63 |- skos__hiddenLabel mesh__D001628 Tea, Herbal
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 1999
% 208.44/208.63 |- skos__hiddenLabel mesh__D001628 Medicinal Teas
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 2006
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 2002
% 208.44/208.63 |- rdf__type mesh__D001628sskos__Concept
% 208.44/208.63 |- skos__hiddenLabel mesh__D001628 Medicinal Tea
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 2004
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 1998
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D001628 2005
% 208.44/208.63 |- skos__prefLabel mesh__D001628 Beverages
% 208.44/208.63 |- rdf__type mesh__D012350sskos__Concept
% 208.44/208.63 |- mesh__recordOriginator mesh__D012350 RLS
% 208.44/208.63 |- skos__historyNote mesh__D012350 Amino Acyl T RNA %28%1978-1987%29%
% 208.44/208.63 |- mesh__dateCreated mesh__D012350 1987-05-07
% 208.44/208.63 |- skos__scopeNote mesh__D012350
% 208.44/208.63 A transfer RNA which is specific for carrying cysteine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.44/208.63 |- skos__hiddenLabel mesh__D012350 RNA, Cys Transfer
% 208.44/208.63 |- skos__hiddenLabel mesh__D012350 Cys Transfer RNA
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 2000
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 1998
% 208.44/208.63 |- mesh__dateEstablished mesh__D012350 1991-01-01
% 208.44/208.63 |- skos__annotation mesh__D012350
% 208.44/208.63 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.44/208.63 |- skos__prefLabel mesh__D012350 RNA, Transfer, Cys
% 208.44/208.63 |- skos__hiddenLabel mesh__D012350 tRNA, Cysteine-Specific
% 208.44/208.63 |- skos__altLabel mesh__D012350 Cysteine-Specific tRNA
% 208.44/208.63 |- skos__altLabel mesh__D012350 tRNACys
% 208.44/208.63 |- skos__altLabel mesh__D012350 tRNA%28%Cys%29%
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 2003
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 2001
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 1997
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 2005
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 1999
% 208.44/208.63 |- mesh__historyNote mesh__D012350
% 208.44/208.63 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 2004
% 208.44/208.63 |- skos__hiddenLabel mesh__D012350 Cysteine Specific tRNA
% 208.44/208.63 |- mesh__recordMaintainer mesh__D012350 TGC
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 2006
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D012350 PLS
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D012350 2002
% 208.44/208.63 |- skos__altLabel mesh__D012350 Transfer RNA, Cys
% 208.44/208.63 |- mesh__dateRevised mesh__D012350 1996-06-10
% 208.44/208.63 |- skos__broader mesh__D012350smesh__D012345
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D012350
% 208.44/208.63 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.44/208.63 |- skos__historyNote mesh__D012350 RNA, Transfer %28%1966-1987%29%
% 208.44/208.63 |- mesh__dateRevised mesh__D006313 2004-07-07
% 208.44/208.63 |- skos__altLabel mesh__D006313 Central Hearing Loss
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D006313 2006
% 208.44/208.63 |- skos__scopeNote mesh__D006313
% 208.44/208.63 Hearing loss due to disease of the AUDITORY PATHWAYS %28%in the CENTRAL NERVOUS SYSTEM%29% which originate in the COCHLEAR NUCLEI of the PONS and then ascend bilaterally to the MIDBRAIN, the THALAMUS, and then the AUDITORY CORTEX in the TEMPORAL LOBE. Bilateral lesions of the auditory pathways are usually required to cause central hearing loss. Cortical deafness refers to loss of hearing due to bilateral auditory cortex lesions. Unilateral BRAIN STEM lesions involving the cochlear nuclei may result in unilateral hearing loss.%A%
% 208.44/208.63 |- skos__broader mesh__D006313smesh__D006319
% 208.44/208.63 |- mesh__recordMaintainer mesh__D006313 lkt
% 208.44/208.63 |- mesh__recordOriginator mesh__D006313 RC
% 208.44/208.63 |- skos__broader mesh__D006313smesh__D001304
% 208.44/208.63 |- mesh__dateCreated mesh__D006313 1978-05-22
% 208.44/208.63 |- skos__annotation mesh__D006313
% 208.44/208.63 coord IM with VESTIBULOCOCHLEAR NERVE DISEASES %28%IM%29% for hearing loss due to cochlear nerve dis%A%
% 208.44/208.63 |- skos__altLabel mesh__D006313 Deafness, Cortical
% 208.44/208.63 |- skos__historyNote mesh__D006313 Deafness %28%1966-1978%29%
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D006313 sjn
% 208.44/208.63 |- mesh__dateEstablished mesh__D006313 1991-01-01
% 208.44/208.63 |- rdf__type mesh__D006313sskos__Concept
% 208.44/208.63 |- skos__prefLabel mesh__D006313 Hearing Loss, Central
% 208.44/208.63 |- mesh__historyNote mesh__D006313
% 208.44/208.63 91%28%79%29%; was see under HEARING LOSS, SENSORINEURAL 1979-90%A%
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D006313
% 208.44/208.63 91; was see under HEARING LOSS, SENSORINEURAL 1979-90
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D006313 2005
% 208.44/208.63 |- skos__related mesh__D006313smesh__D000160
% 208.44/208.63 |- skos__altLabel mesh__D011258 Test, Pregnancy
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011258 2002
% 208.44/208.63 |- skos__scopeNote mesh__D011258
% 208.44/208.63 Tests to determine whether or not an individual is pregnant.%A%
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011258 1999
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D011258 SJN
% 208.44/208.63 |- skos__broader mesh__D011258smesh__D003942
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011258 2005
% 208.44/208.63 |- skos__altLabel mesh__D011258 Tests, Pregnancy
% 208.44/208.63 |- mesh__dateCreated mesh__D011258 1999-01-01
% 208.44/208.63 |- mesh__dateRevised mesh__D011258 1997-06-20
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011258 2006
% 208.44/208.63 |- rdf__type mesh__D011258sskos__Concept
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011258 2000
% 208.44/208.63 |- skos__broader mesh__D011258smesh__D003944
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011258 2003
% 208.44/208.63 |- mesh__recordMaintainer mesh__D011258 PXP
% 208.44/208.63 |- skos__annotation mesh__D011258
% 208.44/208.63 human %26% animal; check tags FEMALE %26% PREGNANCY; DF: PREGN TESTS%A%
% 208.44/208.63 |- mesh__recordOriginator mesh__D011258 NLM
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011258 2001
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011258 1998
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D011258 2004
% 208.44/208.63 |- skos__altLabel mesh__D011258 Pregnancy Test
% 208.44/208.63 |- skos__prefLabel mesh__D011258 Pregnancy Tests
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Urinary Sphincters, Artificial
% 208.44/208.63 |- mesh__dateRevised mesh__D016741 1997-06-20
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D016741 SJN
% 208.44/208.63 |- mesh__recordMaintainer mesh__D016741 PXP
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016741 2003
% 208.44/208.63 |- skos__historyNote mesh__D016741 Implants, Artificial %28%1976-1991%29%
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Sphincters, Artificial Genitourinary
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Artificial Urinary Sphincter
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016741 2005
% 208.44/208.63 |- mesh__recordOriginator mesh__D016741 TGC
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016741 2000
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Sphincter, Artificial Genitourinary
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016741 2004
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016741 2001
% 208.44/208.63 |- mesh__dateCreated mesh__D016741 1991-05-02
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016741 2006
% 208.44/208.63 |- skos__historyNote mesh__D016741
% 208.44/208.63 Urinary Incontinence/surgery %28%1969-1991%29%
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Sphincter, Artificial Urinary
% 208.44/208.63 |- skos__altLabel mesh__D016741 Genitourinary Sphincter, Artificial
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D016741 92
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Genitourinary Sphincters, Artificial
% 208.44/208.63 |- mesh__historyNote mesh__D016741 92
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Sphincters, Artificial Urinary
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Artificial Genitourinary Sphincters
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016741 1998
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016741 2002
% 208.44/208.63 |- skos__broader mesh__D016741smesh__D001187
% 208.44/208.63 |- rdf__type mesh__D016741sskos__Concept
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Artificial Urinary Sphincters
% 208.44/208.63 |- skos__annotation mesh__D016741 /psychol permitted
% 208.44/208.63 |- mesh__dateEstablished mesh__D016741 1992-01-01
% 208.44/208.63 |- skos__broader mesh__D016741smesh__D019736
% 208.44/208.63 |- skos__prefLabel mesh__D016741 Urinary Sphincter, Artificial
% 208.44/208.63 |- skos__hiddenLabel mesh__D016741 Artificial Genitourinary Sphincter
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D016741 1999
% 208.44/208.63 |- skos__scopeNote mesh__D016741
% 208.44/208.63 An artifical implanted device, usually in the form of an inflatable silicone cuff, inserted in or around the bladder neck in the surgical treatment of urinary incontinence caused by sphincter weakness. Often it is placed around the bulbous urethra in adult males. The artificial urinary sphincter is considered an alternative to urinary diversion.%A%
% 208.44/208.63 |- mesh__recordOriginator mesh__D002721 NLM
% 208.44/208.63 |- skos__hiddenLabel mesh__D002721 omega Chloroacetophenone
% 208.44/208.63 |- skos__hiddenLabel mesh__D002721 alpha Chloroacetophenone
% 208.44/208.63 |- mesh__recordMaintainer mesh__D002721 jmp
% 208.44/208.63 |- skos__altLabel mesh__D002721 alpha-Chloroacetophenone
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D002721 91; was CHLOROACETOPHENONE 1963-90
% 208.44/208.63 |- skos__hiddenLabel mesh__D002721 2 Chloroacetophenone
% 208.44/208.63 |- mesh__dateRevised mesh__D002721 2000-06-21
% 208.44/208.63 |- skos__broader mesh__D002721smesh__D000098
% 208.44/208.63 |- skos__scopeNote mesh__D002721
% 208.44/208.63 A potent eye, throat, and skin irritant. One of its uses is as a riot control agent.%A%
% 208.44/208.63 |- mesh__onlineNote mesh__D002721
% 208.44/208.63 use OMEGA-CHLOROACETOPHENONE to search CHLOROACETOPHENONE 1966-90%A%
% 208.44/208.63 |- mesh__dateCreated mesh__D002721 1999-01-01
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D002721 2006
% 208.44/208.63 |- skos__prefLabel mesh__D002721 omega-Chloroacetophenone
% 208.44/208.63 |- mesh__historyNote mesh__D002721 91; was CHLOROACETOPHENONE 1963-90
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D002721 2005
% 208.44/208.63 |- skos__altLabel mesh__D002721 2-Chloro-1-phenylethanone
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D002721 2002
% 208.44/208.63 |- rdf__type mesh__D002721sskos__Concept
% 208.44/208.63 |- skos__hiddenLabel mesh__D002721 2 Chloro 1 phenylethanone
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D002721 2004
% 208.44/208.63 |- skos__altLabel mesh__D002721 Chloracetophenone
% 208.44/208.63 |- skos__annotation mesh__D002721 D25-26 qualif
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D002721 2001
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D002721 2003
% 208.44/208.63 |- skos__altLabel mesh__D002721 2-Chloroacetophenone
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D002721 sjn
% 208.44/208.63 |- skos__broader mesh__D015649smesh__D003070
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D015649
% 208.44/208.63 90; CO-VIDARABINE %28%now PENTOSTATIN%29% was indexed under VIDARABINE/*analogs %26% derivatives 1976-97%A%
% 208.44/208.63 |- skos__historyNote mesh__D015649
% 208.44/208.63 Coformycin/analogs %26% derivatives %28%1979-1989%29%
% 208.44/208.63 |- skos__hiddenLabel mesh__D015649 2%27% Deoxycoformycin
% 208.44/208.63 |- skos__altLabel mesh__D015649 Wyeth Brand of Pentostatin
% 208.44/208.63 |- mesh__recordOriginator mesh__D015649 RLS
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D015649 2006
% 208.44/208.63 |- skos__altLabel mesh__D015649 Warner-Lambert Brand of Pentostatin
% 208.44/208.63 |- mesh__historyNote mesh__D015649
% 208.44/208.63 90; for CO-VIDARABINE use PENTOSTATIN 1982-97
% 208.44/208.63 |- skos__historyNote mesh__D015649 Deoxyribonucleosides %28%1971-1978%29%
% 208.44/208.63 |- skos__hiddenLabel mesh__D015649 CI825
% 208.44/208.63 |- skos__prefLabel mesh__D015649 Pentostatin
% 208.44/208.63 |- skos__broader mesh__D015649smesh__D003853
% 208.44/208.63 |- skos__hiddenLabel mesh__D015649 Co vidarabine
% 208.44/208.63 |- rdf__type mesh__D015649sskos__Concept
% 208.44/208.63 |- skos__historyNote mesh__D015649 Azepines %28%1966-1978%29%
% 208.44/208.63 |- mesh__recordAuthorizer mesh__D015649 sjn
% 208.44/208.63 |- skos__altLabel mesh__D015649 Supergen Brand of Pentostatin
% 208.44/208.63 |- skos__hiddenLabel mesh__D015649 NSC 218321
% 208.44/208.63 |- skos__hiddenLabel mesh__D015649 NSC218321
% 208.44/208.63 |- skos__scopeNote mesh__D015649
% 208.44/208.63 A potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.%A%
% 208.44/208.63 |- mesh__dateCreated mesh__D015649 1989-05-25
% 208.44/208.63 |- skos__altLabel mesh__D015649 Deoxycoformycin
% 208.44/208.63 |- skos__hiddenLabel mesh__D015649 Covidarabine
% 208.44/208.63 |- mesh__dateRevised mesh__D015649 2005-06-30
% 208.44/208.63 |- mesh__recordMaintainer mesh__D015649 lkw
% 208.44/208.63 |- skos__hiddenLabel mesh__D015649 CI 825
% 208.44/208.63 |- skos__altLabel mesh__D015649 Lederle Brand of Pentostatin
% 208.44/208.63 |- skos__altLabel mesh__D015649 2%27%-Deoxycoformycin
% 208.44/208.63 |- skos__altLabel mesh__D015649 Prasfarma Brand of Pentostatin
% 208.44/208.63 |- mesh__dateEstablished mesh__D015649 1990-01-01
% 208.44/208.63 |- skos__scopeNote mesh__D040042
% 208.44/208.63 Family of parasitic MITES, in the superfamily Sarcoptoidea, order Astigmata. Genera include Psoroptes and Chorioptes.%A%
% 208.44/208.63 |- skos__prefLabel mesh__D040042 Psoroptidae
% 208.44/208.63 |- mesh__historyNote mesh__D040042 2003
% 208.44/208.63 |- mesh__dateEstablished mesh__D040042 2003-01-01
% 208.44/208.63 |- mesh__dateRevised mesh__D040042 2003-07-09
% 208.44/208.63 |- skos__altLabel mesh__D040042 Mites, Sheep Scab
% 208.44/208.63 |- mesh__dateCreated mesh__D040042 2002-07-03
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D040042 2006
% 208.44/208.63 |- skos__annotation mesh__D040042
% 208.44/208.63 infestation: coord IM with MITE INFESTATIONS %28%IM%29%
% 208.44/208.63 |- rdf__type mesh__D040042sskos__Concept
% 208.44/208.63 |- skos__historyNote mesh__D040042 Mites %28%1966-2002%29%
% 208.44/208.63 |- skos__broader mesh__D040042smesh__D008925
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D040042 2004
% 208.44/208.63 |- mesh__activeMeSHYear mesh__D040042 2005
% 208.44/208.63 |- mesh__publicMeSHNote mesh__D040042 2003
% 208.44/208.63 |- skos__hiddenLabel mesh__D001629 Berlin Chemie Brand of Bezafibrate
% 208.44/208.63 |- skos__hiddenLabel mesh__D001629 BM 15.075
% 208.44/208.64 |- skos__altLabel mesh__D001629 B%C3%%A9%fizal
% 208.44/208.64 |- skos__altLabel mesh__D001629 Betapharm Brand of Bezafibrate
% 208.44/208.64 |- skos__altLabel mesh__D001629 Lakeside Brand of Bezafibrate
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 BezaLande
% 208.44/208.64 |- skos__broader mesh__D001629smesh__D002087
% 208.44/208.64 |- skos__altLabel mesh__D001629 Roche Brand of Bezafibrate
% 208.44/208.64 |- skos__historyNote mesh__D001629 Phenylbutyrates %28%1977-1978%29%
% 208.44/208.64 |- skos__historyNote mesh__D001629
% 208.44/208.64 Clofibrate/analogs %26% derivatives %28%1978-1983%29%
% 208.44/208.64 |- mesh__publicMeSHNote mesh__D001629 84
% 208.44/208.64 |- skos__altLabel mesh__D001629 Eulitop
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 BezaPuren
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D001629 2006
% 208.44/208.64 |- skos__altLabel mesh__D001629 Isis Brand of Bezafibrate
% 208.44/208.64 |- skos__altLabel mesh__D001629 Hexal Brand of Bezafibrate
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Isis Brand
% 208.44/208.64 |- skos__altLabel mesh__D001629 Teva Brand of Bezafibrate
% 208.44/208.64 |- skos__prefLabel mesh__D001629 Bezafibrate
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Roche Brand
% 208.44/208.64 |- mesh__dateCreated mesh__D001629 1983-03-17
% 208.44/208.64 |- skos__historyNote mesh__D001629 Benzamides %28%1977-1978%29%
% 208.44/208.64 |- mesh__recordOriginator mesh__D001629 RLS
% 208.44/208.64 |- skos__altLabel mesh__D001629 Merckle Brand of Bezafibrate
% 208.44/208.64 |- skos__altLabel mesh__D001629 durabezur
% 208.44/208.64 |- skos__broader mesh__D001629smesh__D002995
% 208.44/208.64 |- skos__altLabel mesh__D001629 Difaterol
% 208.44/208.64 |- skos__altLabel mesh__D001629 Boehringer Mannheim Brand of Bezafibrate
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D001629 2005
% 208.44/208.64 |- mesh__dateEstablished mesh__D001629 1984-01-01
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Azupharma Brand
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Merckle Brand
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Hennig Brand
% 208.44/208.64 |- skos__altLabel mesh__D001629 TAD Brand of Bezafibrate
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Elfar Brand
% 208.44/208.64 |- skos__altLabel mesh__D001629 Berlin-Chemie Brand of Bezafibrate
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Lakeside Brand
% 208.44/208.64 |- skos__altLabel mesh__D001629 Cryopharma Brand of Bezafibrate
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate TAD Brand
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Berlin-Chemie Brand
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Bayer Brand
% 208.44/208.64 |- mesh__recordMaintainer mesh__D001629 mdb
% 208.44/208.64 |- mesh__recordAuthorizer mesh__D001629 sjn
% 208.44/208.64 |- skos__altLabel mesh__D001629 Hennig Brand of Bezafibrate
% 208.44/208.64 |- mesh__historyNote mesh__D001629 84
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Teva Brand
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Synthelabo Brand
% 208.44/208.64 |- mesh__dateRevised mesh__D001629 2004-07-07
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Betapharm Brand
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Cryopharma Brand
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Beza Puren
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Bezafibrate Hexal Brand
% 208.44/208.64 |- skos__altLabel mesh__D001629 Elfar Brand of Bezafibrate
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 BM15.075
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 PB, Bezafibrat
% 208.44/208.64 |- rdf__type mesh__D001629sskos__Concept
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 B, Regadrin
% 208.44/208.64 |- skos__altLabel mesh__D001629 Synthelabo Brand of Bezafibrate
% 208.44/208.64 |- skos__altLabel mesh__D001629 Azupharma Brand of Bezafibrate
% 208.44/208.64 |- skos__scopeNote mesh__D001629
% 208.44/208.64 Antilipemic agent that lowers cholesterol and triglycerides. It decreases low density lipoproteins and increases high density lipoproteins.%A%
% 208.44/208.64 |- skos__hiddenLabel mesh__D001629 Beza Lande
% 208.44/208.64 |- skos__altLabel mesh__D001629 Bayer Brand of Bezafibrate
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 2002
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 1998
% 208.44/208.64 |- mesh__dateRevised mesh__D012351 1996-06-10
% 208.44/208.64 |- mesh__dateEstablished mesh__D012351 1991-01-01
% 208.44/208.64 |- skos__annotation mesh__D012351
% 208.44/208.64 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.44/208.64 |- skos__hiddenLabel mesh__D012351 tRNA, Glutamine-Specific
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 2003
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 1997
% 208.44/208.64 |- mesh__recordOriginator mesh__D012351 RLS
% 208.44/208.64 |- skos__altLabel mesh__D012351 Glutamine-Specific tRNA
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 2005
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 1999
% 208.44/208.64 |- skos__historyNote mesh__D012351 Amino Acyl T RNA %28%1978-1987%29%
% 208.44/208.64 |- skos__hiddenLabel mesh__D012351 Gln Transfer RNA
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 2004
% 208.44/208.64 |- mesh__recordMaintainer mesh__D012351 TGC
% 208.44/208.64 |- mesh__dateCreated mesh__D012351 1987-05-07
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 2006
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 2000
% 208.44/208.64 |- skos__altLabel mesh__D012351 tRNA%28%Gln%29%
% 208.44/208.64 |- skos__scopeNote mesh__D012351
% 208.44/208.64 A transfer RNA which is specific for carrying glutamine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D012351 2001
% 208.44/208.64 |- skos__altLabel mesh__D012351 tRNAGln
% 208.44/208.64 |- skos__hiddenLabel mesh__D012351 RNA, Gln Transfer
% 208.44/208.64 |- skos__prefLabel mesh__D012351 RNA, Transfer, Gln
% 208.44/208.64 |- skos__broader mesh__D012351smesh__D012345
% 208.44/208.64 |- mesh__publicMeSHNote mesh__D012351
% 208.44/208.64 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.44/208.64 |- skos__historyNote mesh__D012351 RNA, Transfer %28%1966-1987%29%
% 208.44/208.64 |- skos__hiddenLabel mesh__D012351 Glutamine Specific tRNA
% 208.44/208.64 |- mesh__historyNote mesh__D012351
% 208.44/208.64 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.44/208.64 |- rdf__type mesh__D012351sskos__Concept
% 208.44/208.64 |- skos__altLabel mesh__D012351 Transfer RNA, Gln
% 208.44/208.64 |- mesh__recordAuthorizer mesh__D012351 PLS
% 208.44/208.64 |- mesh__historyNote mesh__D006314
% 208.44/208.64 91%28%79%29%; was see under HEARING LOSS, PARTIAL 1979-90
% 208.44/208.64 |- skos__broader mesh__D006314smesh__D034381
% 208.44/208.64 |- mesh__publicMeSHNote mesh__D006314
% 208.44/208.64 91; was see under HEARING LOSS, PARTIAL 1979-90
% 208.44/208.64 |- mesh__dateCreated mesh__D006314 1978-05-22
% 208.44/208.64 |- mesh__recordOriginator mesh__D006314 RC
% 208.44/208.64 |- mesh__recordAuthorizer mesh__D006314 ags
% 208.44/208.64 |- skos__historyNote mesh__D006314 Deafness %28%1966-1978%29%
% 208.44/208.64 |- mesh__dateRevised mesh__D006314 2005-07-13
% 208.44/208.64 |- mesh__recordMaintainer mesh__D006314 ags
% 208.44/208.64 |- mesh__dateEstablished mesh__D006314 1991-01-01
% 208.44/208.64 |- rdf__type mesh__D006314sskos__Concept
% 208.44/208.64 |- skos__annotation mesh__D006314
% 208.44/208.64 HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL is also available.%A%
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D006314 2005
% 208.44/208.64 |- skos__prefLabel mesh__D006314 Hearing Loss, Conductive
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D006314 2006A
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D006314 2006
% 208.44/208.64 |- skos__altLabel mesh__D006314 Conductive Hearing Loss
% 208.44/208.64 |- skos__scopeNote mesh__D006314
% 208.44/208.64 Hearing loss due to interference with the mechanical reception or amplification of sound to the COCHLEA. The interference is in the outer or middle ear involving the EAR CANAL; TYMPANIC MEMBRANE; or EAR OSSICLES.%A%
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D011259 2001
% 208.44/208.64 |- mesh__dateCreated mesh__D011259 1999-01-01
% 208.44/208.64 |- skos__broader mesh__D011259smesh__D007159
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D011259 2006
% 208.44/208.64 |- skos__historyNote mesh__D011259 Pregnancy Tests %28%1966-1972%29%
% 208.44/208.64 |- skos__altLabel mesh__D011259 Immunologic Pregnancy Tests
% 208.44/208.64 |- skos__altLabel mesh__D011259 Tests, Immunological Pregnancy
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D011259 2002
% 208.44/208.64 |- skos__altLabel mesh__D011259 Pregnancy Tests, Immunological
% 208.44/208.64 |- mesh__recordAuthorizer mesh__D011259 SJN
% 208.44/208.64 |- skos__altLabel mesh__D011259 Pregnancy Test, Immunologic
% 208.44/208.64 |- rdf__type mesh__D011259sskos__Concept
% 208.44/208.64 |- skos__altLabel mesh__D011259 Tests, Immunologic Pregnancy
% 208.44/208.64 |- skos__altLabel mesh__D011259 Test, Immunologic Pregnancy
% 208.44/208.64 |- mesh__publicMeSHNote mesh__D011259 73
% 208.44/208.64 |- skos__prefLabel mesh__D011259 Pregnancy Tests, Immunologic
% 208.44/208.64 |- mesh__dateRevised mesh__D011259 1997-06-20
% 208.44/208.64 |- skos__broader mesh__D011259smesh__D011258
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D011259 2003
% 208.44/208.64 |- mesh__historyNote mesh__D011259 73
% 208.44/208.64 |- skos__hiddenLabel mesh__D011259 Test, Immunological Pregnancy
% 208.44/208.64 |- skos__annotation mesh__D011259
% 208.44/208.64 human %26% animal; check tags FEMALE %26% PREGNANCY; DF: PREGN TESTS IMMUNOL%A%
% 208.44/208.64 |- mesh__dateEstablished mesh__D011259 1973-01-01
% 208.44/208.64 |- skos__hiddenLabel mesh__D011259 Immunological Pregnancy Test
% 208.44/208.64 |- skos__altLabel mesh__D011259 Immunological Pregnancy Tests
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D011259 1998
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D011259 2004
% 208.44/208.64 |- skos__hiddenLabel mesh__D011259 Pregnancy Test, Immunological
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D011259 2000
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D011259 1999
% 208.44/208.64 |- mesh__recordMaintainer mesh__D011259 PXP
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D011259 2005
% 208.44/208.64 |- skos__altLabel mesh__D011259 Immunologic Pregnancy Test
% 208.44/208.64 |- mesh__recordOriginator mesh__D011259 NLM
% 208.44/208.64 |- mesh__dateEstablished mesh__D016742 1992-01-01
% 208.44/208.64 |- mesh__recordOriginator mesh__D016742 MXR
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D016742 2002
% 208.44/208.64 |- skos__scopeNote mesh__D016742
% 208.44/208.64 An organized and comprehensive program of health care that identifies and reduces a woman%27%s reproductive risks before conception through risk assessment, health promotion, and interventions. Preconception care programs may be designed to include the male partner in providing counseling and educational information in preparation for fatherhood, such as genetic counseling and testing, financial and family planning, etc. This concept is different from PRENATAL CARE, which occurs during pregnancy.%A%
% 208.44/208.64 |- mesh__historyNote mesh__D016742 92
% 208.44/208.64 |- skos__annotation mesh__D016742
% 208.44/208.64 may refer to prospective mother or father
% 208.44/208.64 |- skos__related mesh__D016742smesh__D011295
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D016742 1998
% 208.44/208.64 |- skos__broader mesh__D016742smesh__D014932
% 208.44/208.64 |- mesh__dateRevised mesh__D016742 1997-06-20
% 208.44/208.64 |- mesh__recordAuthorizer mesh__D016742 SJN
% 208.44/208.64 |- rdf__type mesh__D016742sskos__Concept
% 208.44/208.64 |- skos__broader mesh__D016742smesh__D005791
% 208.44/208.64 |- mesh__recordMaintainer mesh__D016742 PXP
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D016742 1999
% 208.44/208.64 |- mesh__dateCreated mesh__D016742 1991-05-07
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D016742 2000
% 208.44/208.64 |- skos__hiddenLabel mesh__D016742 Care, Preconception
% 208.44/208.64 |- skos__prefLabel mesh__D016742 Preconception Care
% 208.44/208.64 |- mesh__activeMeSHYear mesh__D016742 2003
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D016742 2001
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D016742 2005
% 208.74/208.95 |- skos__historyNote mesh__D016742 Pregnancy %28%1981-1991%29%
% 208.74/208.95 |- skos__broader mesh__D016742smesh__D008427
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D016742 2004
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D016742 2006
% 208.74/208.95 |- mesh__publicMeSHNote mesh__D016742 92
% 208.74/208.95 |- mesh__dateCreated mesh__D002722 1999-01-01
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 1998
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 2000
% 208.74/208.95 |- mesh__dateRevised mesh__D002722 1992-05-11
% 208.74/208.95 |- mesh__recordMaintainer mesh__D002722 TGC
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 1995
% 208.74/208.95 |- mesh__recordAuthorizer mesh__D002722 PLS
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 2005
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 1999
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 2001
% 208.74/208.95 |- mesh__publicMeSHNote mesh__D002722 74
% 208.74/208.95 |- mesh__dateEstablished mesh__D002722 1974-01-01
% 208.74/208.95 |- mesh__historyNote mesh__D002722 74
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 1996
% 208.74/208.95 |- skos__prefLabel mesh__D002722 Chlorobenzenes
% 208.74/208.95 |- mesh__recordOriginator mesh__D002722 NLM
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 1993
% 208.74/208.95 |- skos__broader mesh__D002722smesh__D006843
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 2006
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 2003
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 1997
% 208.74/208.95 |- rdf__type mesh__D002722sskos__Concept
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 2002
% 208.74/208.95 |- skos__broader mesh__D002722smesh__D001555
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 2004
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002722 1994
% 208.74/208.95 |- skos__broader mesh__D040841smesh__D004467
% 208.74/208.95 |- mesh__historyNote mesh__D040841 2003
% 208.74/208.95 |- mesh__publicMeSHNote mesh__D040841 2003
% 208.74/208.95 |- skos__hiddenLabel mesh__D040841 Resources Allocation
% 208.74/208.95 |- skos__prefLabel mesh__D040841 Resource Allocation
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D040841 2003
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D040841 2004
% 208.74/208.95 |- skos__hiddenLabel mesh__D040841 Resource Allocations
% 208.74/208.95 |- mesh__dateCreated mesh__D040841 2002-07-02
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D040841 2005
% 208.74/208.95 |- skos__annotation mesh__D040841
% 208.74/208.95 for health care resource allocation, use HEALTH CARE RATIONING; use both terms only when a discussion of health care resource allocation is accompanied by a more theoretical discussion of the concept of equity in the distribution of limited resources%A%
% 208.74/208.95 |- skos__altLabel mesh__D040841 Allocation of Resources
% 208.74/208.95 |- skos__hiddenLabel mesh__D040841 Allocation, Resource
% 208.74/208.95 |- rdf__type mesh__D040841sskos__Concept
% 208.74/208.95 |- skos__hiddenLabel mesh__D040841 Allocations, Resource
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D040841 2006
% 208.74/208.95 |- mesh__dateEstablished mesh__D040841 2003-01-01
% 208.74/208.95 |- skos__scopeNote mesh__D040841
% 208.74/208.95 Societal or individual decisions about the equitable distribution of available resources.%A%
% 208.74/208.95 |- skos__historyNote mesh__D012352 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.95 |- rdf__type mesh__D012352sskos__Concept
% 208.74/208.95 |- skos__altLabel mesh__D012352 tRNAGlu
% 208.74/208.95 |- mesh__recordOriginator mesh__D012352 RLS
% 208.74/208.95 |- skos__hiddenLabel mesh__D012352 RNA, Glu Transfer
% 208.74/208.95 |- skos__broader mesh__D012352smesh__D012345
% 208.74/208.95 |- mesh__publicMeSHNote mesh__D012352
% 208.74/208.95 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 1997
% 208.74/208.95 |- mesh__recordMaintainer mesh__D012352 TGC
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 2001
% 208.74/208.95 |- skos__hiddenLabel mesh__D012352 Acid-Specific tRNA, Glutamic
% 208.74/208.95 |- skos__historyNote mesh__D012352 RNA, Transfer %28%1966-1987%29%
% 208.74/208.95 |- skos__hiddenLabel mesh__D012352 Glu Transfer RNA
% 208.74/208.95 |- skos__prefLabel mesh__D012352 RNA, Transfer, Glu
% 208.74/208.95 |- mesh__dateCreated mesh__D012352 1987-05-07
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 2004
% 208.74/208.95 |- skos__hiddenLabel mesh__D012352 tRNA, Glutamic Acid-Specific
% 208.74/208.95 |- skos__annotation mesh__D012352
% 208.74/208.95 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.74/208.95 |- skos__altLabel mesh__D012352 Transfer RNA, Glu
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 2000
% 208.74/208.95 |- mesh__dateEstablished mesh__D012352 1991-01-01
% 208.74/208.95 |- skos__scopeNote mesh__D012352
% 208.74/208.95 A transfer RNA which is specific for carrying glutamic acid to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 1999
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 2003
% 208.74/208.95 |- mesh__historyNote mesh__D012352
% 208.74/208.95 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.95 |- skos__altLabel mesh__D012352 Glutamic Acid-Specific tRNA
% 208.74/208.95 |- skos__altLabel mesh__D012352 tRNA%28%Glu%29%
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 1998
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 2006
% 208.74/208.95 |- mesh__dateRevised mesh__D012352 1996-06-10
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 2002
% 208.74/208.95 |- skos__hiddenLabel mesh__D012352 Glutamic Acid Specific tRNA
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012352 2005
% 208.74/208.95 |- mesh__recordAuthorizer mesh__D012352 PLS
% 208.74/208.95 |- rdf__type mesh__D006315sskos__Concept
% 208.74/208.95 |- mesh__recordAuthorizer mesh__D006315 sjn
% 208.74/208.95 |- skos__historyNote mesh__D006315 Deafness %28%1966-1978%29%
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D006315 2005
% 208.74/208.95 |- mesh__dateEstablished mesh__D006315 1991-01-01
% 208.74/208.95 |- mesh__historyNote mesh__D006315
% 208.74/208.95 91%28%79%29%; was see under HEARING LOSS, PARTIAL 1979-90
% 208.74/208.95 |- skos__broader mesh__D006315smesh__D034381
% 208.74/208.95 |- mesh__dateRevised mesh__D006315 2004-07-07
% 208.74/208.95 |- mesh__publicMeSHNote mesh__D006315
% 208.74/208.95 91; was see under HEARING LOSS, PARTIAL 1979-90
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D006315 2006
% 208.74/208.95 |- skos__altLabel mesh__D006315 Hearing Loss, Psychogenic
% 208.74/208.95 |- skos__hiddenLabel mesh__D006315 Psychogenic Hearing Loss
% 208.74/208.95 |- skos__hiddenLabel mesh__D006315 Nonorganic Hearing Loss
% 208.74/208.95 |- skos__scopeNote mesh__D006315
% 208.74/208.95 Hearing loss without a physical basis. Often observed in patients with psychological or behavioral disorders.%A%
% 208.74/208.95 |- skos__broader mesh__D006315smesh__D001526
% 208.74/208.95 |- mesh__recordMaintainer mesh__D006315 lkt
% 208.74/208.95 |- mesh__dateCreated mesh__D006315 1978-05-22
% 208.74/208.95 |- mesh__recordOriginator mesh__D006315 RC
% 208.74/208.95 |- skos__hiddenLabel mesh__D006315 Functional Hearing Loss
% 208.74/208.95 |- skos__altLabel mesh__D006315 Hearing Loss, Nonorganic
% 208.74/208.95 |- skos__prefLabel mesh__D006315 Hearing Loss, Functional
% 208.74/208.95 |- skos__related mesh__D016743smesh__D007298
% 208.74/208.95 |- mesh__historyNote mesh__D016743 92
% 208.74/208.95 |- skos__altLabel mesh__D016743 Competency, Mental
% 208.74/208.95 |- skos__annotation mesh__D016743
% 208.74/208.95 in mental retard or organic or psychiat mental disord; coord IM with concomitant disord /psychol %28%IM%29%; competency to consent: coord IM with INFORMED CONSENT %28%IM%29%%A%
% 208.74/208.95 |- skos__broader mesh__D016743smesh__D011579
% 208.74/208.95 |- skos__altLabel mesh__D016743 Mental Competence
% 208.74/208.95 |- mesh__publicMeSHNote mesh__D016743 92
% 208.74/208.95 |- skos__related mesh__D016743smesh__D016312
% 208.74/208.95 |- rdf__type mesh__D016743sskos__Concept
% 208.74/208.95 |- skos__prefLabel mesh__D016743 Mental Competency
% 208.74/208.95 |- skos__hiddenLabel mesh__D016743 Mental Incompetence
% 208.74/208.95 |- mesh__dateEstablished mesh__D016743 1992-01-01
% 208.74/208.95 |- skos__altLabel mesh__D016743 Incompetence, Mental
% 208.74/208.95 |- skos__related mesh__D016743smesh__D007258
% 208.74/208.95 |- skos__broader mesh__D016743smesh__D001520
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D016743 2003
% 208.74/208.95 |- skos__hiddenLabel mesh__D016743 Competence, Mental
% 208.74/208.95 |- mesh__recordMaintainer mesh__D016743 jrf
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D016743 2005
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D016743 2004
% 208.74/208.95 |- mesh__recordAuthorizer mesh__D016743 sjn
% 208.74/208.95 |- skos__historyNote mesh__D016743 Mental Disorders %28%1966-1991%29%
% 208.74/208.95 |- skos__related mesh__D016743smesh__D032882
% 208.74/208.95 |- skos__historyNote mesh__D016743 Forensic Psychiatry %28%1966-1991%29%
% 208.74/208.95 |- skos__hiddenLabel mesh__D016743 Mental Incompetency
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D016743 2006
% 208.74/208.95 |- mesh__recordOriginator mesh__D016743 TGC
% 208.74/208.95 |- skos__scopeNote mesh__D016743
% 208.74/208.95 The ability to understand the nature and effect of the act in which the individual is engaged. %28%From Black%27%s Law Dictionary, 6th ed%29%.%A%
% 208.74/208.95 |- skos__related mesh__D016743smesh__D007872
% 208.74/208.95 |- mesh__dateRevised mesh__D016743 2002-07-03
% 208.74/208.95 |- skos__broader mesh__D016743smesh__D007603
% 208.74/208.95 |- mesh__dateCreated mesh__D016743 1991-07-26
% 208.74/208.95 |- skos__historyNote mesh__D016743 Mental Retardation %28%1966-1991%29%
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002723 2005
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002723 1999
% 208.74/208.95 |- mesh__dateEstablished mesh__D002723 1975-09-01
% 208.74/208.95 |- skos__broader mesh__D002723smesh__D001565
% 208.74/208.95 |- mesh__dateCreated mesh__D002723 1974-11-11
% 208.74/208.95 |- mesh__recordAuthorizer mesh__D002723 SJN
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002723 2006
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002723 2000
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002723 2003
% 208.74/208.95 |- mesh__dateRevised mesh__D002723 1998-06-10
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002723 2001
% 208.74/208.95 |- rdf__type mesh__D002723sskos__Concept
% 208.74/208.95 |- mesh__recordOriginator mesh__D002723 NLM
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002723 2004
% 208.74/208.95 |- skos__historyNote mesh__D002723 Benzoates %28%1966-1974%29%
% 208.74/208.95 |- mesh__publicMeSHNote mesh__D002723 75
% 208.74/208.95 |- mesh__recordMaintainer mesh__D002723 ADP
% 208.74/208.95 |- mesh__historyNote mesh__D002723 75
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D002723 2002
% 208.74/208.95 |- skos__prefLabel mesh__D002723 Chlorobenzoates
% 208.74/208.95 |- skos__scopeNote mesh__D002723
% 208.74/208.95 Benzoic acid or benzoic acid esters substituted with one or more chlorine atoms.%A%
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 2002
% 208.74/208.95 |- mesh__recordMaintainer mesh__D012353 TGC
% 208.74/208.95 |- skos__altLabel mesh__D012353 tRNAGly
% 208.74/208.95 |- skos__historyNote mesh__D012353 RNA, Transfer %28%1966-1987%29%
% 208.74/208.95 |- skos__altLabel mesh__D012353 Iso tRNA%28%Gly%29%
% 208.74/208.95 |- skos__hiddenLabel mesh__D012353 Gly Transfer RNA
% 208.74/208.95 |- mesh__recordAuthorizer mesh__D012353 PLS
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 2004
% 208.74/208.95 |- skos__prefLabel mesh__D012353 RNA, Transfer, Gly
% 208.74/208.95 |- skos__historyNote mesh__D012353 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.95 |- mesh__dateEstablished mesh__D012353 1991-01-01
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 1999
% 208.74/208.95 |- skos__annotation mesh__D012353
% 208.74/208.95 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.74/208.95 |- mesh__recordOriginator mesh__D012353 RLS
% 208.74/208.95 |- skos__hiddenLabel mesh__D012353 RNA, Gly Transfer
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 2003
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 2001
% 208.74/208.95 |- skos__scopeNote mesh__D012353
% 208.74/208.95 A transfer RNA which is specific for carrying glycine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 2006
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 1998
% 208.74/208.95 |- skos__hiddenLabel mesh__D012353 tRNA, Glycine-Specific
% 208.74/208.95 |- skos__altLabel mesh__D012353 tRNA%28%Gly%29%
% 208.74/208.95 |- mesh__dateCreated mesh__D012353 1987-05-07
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 2000
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 2005
% 208.74/208.95 |- mesh__historyNote mesh__D012353
% 208.74/208.95 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.95 |- skos__hiddenLabel mesh__D012353 Glycine Specific tRNA
% 208.74/208.95 |- rdf__type mesh__D012353sskos__Concept
% 208.74/208.95 |- skos__altLabel mesh__D012353 Glycine-Specific tRNA
% 208.74/208.95 |- mesh__dateRevised mesh__D012353 1996-06-10
% 208.74/208.95 |- mesh__publicMeSHNote mesh__D012353
% 208.74/208.95 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.95 |- skos__altLabel mesh__D012353 Transfer RNA, Gly
% 208.74/208.95 |- skos__broader mesh__D012353smesh__D012345
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D012353 1997
% 208.74/208.95 |- mesh__dateEstablished mesh__D006316 1991-01-01
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D006316 2005
% 208.74/208.95 |- skos__scopeNote mesh__D006316
% 208.74/208.95 Hearing loss in frequencies above 1000 hertz.
% 208.74/208.95 |- mesh__dateRevised mesh__D006316 2004-07-07
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D006316 2006
% 208.74/208.95 |- skos__hiddenLabel mesh__D006316 High-Frequency Hearing Loss
% 208.74/208.95 |- mesh__recordAuthorizer mesh__D006316 sjn
% 208.74/208.95 |- mesh__historyNote mesh__D006316
% 208.74/208.95 91%28%79%29%; was see under HEARING LOSS, PARTIAL 1979-90
% 208.74/208.95 |- skos__broader mesh__D006316smesh__D034381
% 208.74/208.95 |- skos__hiddenLabel mesh__D006316 Hearing Loss, High Frequency
% 208.74/208.95 |- mesh__recordOriginator mesh__D006316 RC
% 208.74/208.95 |- mesh__publicMeSHNote mesh__D006316
% 208.74/208.95 91; was see under HEARING LOSS, PARTIAL 1979-90
% 208.74/208.95 |- mesh__dateCreated mesh__D006316 1978-05-22
% 208.74/208.95 |- rdf__type mesh__D006316sskos__Concept
% 208.74/208.95 |- skos__prefLabel mesh__D006316 Hearing Loss, High-Frequency
% 208.74/208.95 |- skos__historyNote mesh__D006316 Deafness %28%1966-1978%29%
% 208.74/208.95 |- mesh__recordMaintainer mesh__D006316 lkt
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D022781 2006
% 208.74/208.95 |- skos__hiddenLabel mesh__D022781 Hepatic Cell
% 208.74/208.95 |- mesh__activeMeSHYear mesh__D022781 2002
% 208.74/208.95 |- skos__prefLabel mesh__D022781 Hepatocytes
% 208.74/208.96 |- skos__hiddenLabel mesh__D022781 Cells, Hepatic
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D022781 2001
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D022781 2005
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D022781 2001
% 208.74/208.96 |- skos__altLabel mesh__D022781 Liver Cells
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D022781 2004
% 208.74/208.96 |- rdf__type mesh__D022781sskos__Concept
% 208.74/208.96 |- skos__scopeNote mesh__D022781
% 208.74/208.96 The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.%A%
% 208.74/208.96 |- skos__hiddenLabel mesh__D022781 Cells, Liver
% 208.74/208.96 |- skos__hiddenLabel mesh__D022781 Cell, Hepatic
% 208.74/208.96 |- skos__hiddenLabel mesh__D022781 Liver Cell
% 208.74/208.96 |- skos__historyNote mesh__D022781 Liver %28%1966-2000%29%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D022781 2003
% 208.74/208.96 |- skos__broader mesh__D022781smesh__D004847
% 208.74/208.96 |- skos__altLabel mesh__D022781 Hepatic Cells
% 208.74/208.96 |- skos__hiddenLabel mesh__D022781 Cell, Liver
% 208.74/208.96 |- mesh__dateCreated mesh__D022781 2000-06-22
% 208.74/208.96 |- skos__hiddenLabel mesh__D022781 Hepatocyte
% 208.74/208.96 |- mesh__dateEstablished mesh__D022781 2001-01-01
% 208.74/208.96 |- mesh__historyNote mesh__D022781 2001
% 208.74/208.96 |- mesh__dateRevised mesh__D016744 2005-06-30
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D016744 sjn
% 208.74/208.96 |- skos__altLabel mesh__D016744 M Locus
% 208.74/208.96 |- mesh__recordMaintainer mesh__D016744 nns
% 208.74/208.96 |- skos__broader mesh__D016744smesh__D005796
% 208.74/208.96 |- skos__scopeNote mesh__D016744
% 208.74/208.96 Genetic loci responsible for the encoding of minor lymphocyte stimulatory antigens. There are at least two unlinked loci %28%in the mouse%29% and they appear to be separate from the MAJOR HISTOCOMPATIBILITY COMPLEX and MINOR HISTOCOMPATIBILITY LOCI. The mouse mammary tumor virus %28%see MAMMARY TUMOR VIRUS, MOUSE%29% has the ability to integrate into these loci. The antigens induce strong T-cell proliferative responses in mixed lymphocyte reactions.%A%
% 208.74/208.96 |- skos__hiddenLabel mesh__D016744 Locus, M
% 208.74/208.96 |- skos__hiddenLabel mesh__D016744 Locus, Mls
% 208.74/208.96 |- mesh__dateEstablished mesh__D016744 1992-01-01
% 208.74/208.96 |- skos__altLabel mesh__D016744 Lymphocyte Stimulatory Loci, Minor
% 208.74/208.96 |- mesh__historyNote mesh__D016744 92
% 208.74/208.96 |- skos__altLabel mesh__D016744 Mls Loci
% 208.74/208.96 |- skos__hiddenLabel mesh__D016744 Mls Locus
% 208.74/208.96 |- skos__broader mesh__D016744smesh__D007125
% 208.74/208.96 |- rdf__type mesh__D016744sskos__Concept
% 208.74/208.96 |- skos__hiddenLabel mesh__D016744 Loci, Mls
% 208.74/208.96 |- skos__prefLabel mesh__D016744 Minor Lymphocyte Stimulatory Loci
% 208.74/208.96 |- mesh__recordOriginator mesh__D016744 AGS
% 208.74/208.96 |- skos__related mesh__D016744smesh__D016747
% 208.74/208.96 |- mesh__dateCreated mesh__D016744 1991-04-29
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D016744 92
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016744 2006
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D002724 sjn
% 208.74/208.96 |- skos__broader mesh__D002724smesh__D000440
% 208.74/208.96 |- rdf__type mesh__D002724sskos__Concept
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D002724 2004
% 208.74/208.96 |- mesh__dateRevised mesh__D002724 2003-07-09
% 208.74/208.96 |- skos__scopeNote mesh__D002724
% 208.74/208.96 A colorless to white crystalline compound with a camphoraceous odor and taste. It is a widely used preservative in various pharmaceutical solutions, especially injectables. Also, it is an active ingredient in certain oral sedatives and topical anesthetics.%A%
% 208.74/208.96 |- skos__altLabel mesh__D002724 Trichlorbutanol
% 208.74/208.96 |- skos__broader mesh__D002724smesh__D002728
% 208.74/208.96 |- mesh__dateCreated mesh__D002724 1999-01-01
% 208.74/208.96 |- skos__altLabel mesh__D002724 Acetonchloroform
% 208.74/208.96 |- skos__prefLabel mesh__D002724 Chlorobutanol
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D002724 2005
% 208.74/208.96 |- mesh__recordMaintainer mesh__D002724 ssb
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D002724 2006
% 208.74/208.96 |- skos__altLabel mesh__D002724 Chlorbutol
% 208.74/208.96 |- mesh__recordOriginator mesh__D002724 NLM
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D048028 2006
% 208.74/208.96 |- mesh__recordOriginator mesh__D048028 ags
% 208.74/208.96 |- rdf__type mesh__D048028sskos__Concept
% 208.74/208.96 |- mesh__dateEstablished mesh__D048028 2005-01-01
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D048028 2005
% 208.74/208.96 |- skos__scopeNote mesh__D048028
% 208.74/208.96 Deoxyribonucleic acid that makes up the genetic material of ALGAE.%A%
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D048028 2005
% 208.74/208.96 |- mesh__dateCreated mesh__D048028 2004-07-07
% 208.74/208.96 |- skos__broader mesh__D048028smesh__D004247
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D048028 sjn
% 208.74/208.96 |- skos__altLabel mesh__D048028 Algal DNA
% 208.74/208.96 |- mesh__historyNote mesh__D048028 2005
% 208.74/208.96 |- mesh__recordMaintainer mesh__D048028 ags
% 208.74/208.96 |- skos__prefLabel mesh__D048028 DNA, Algal
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 2000
% 208.74/208.96 |- mesh__dateEstablished mesh__D012354 1991-01-01
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 2006
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 1998
% 208.74/208.96 |- mesh__historyNote mesh__D012354
% 208.74/208.96 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.96 |- skos__hiddenLabel mesh__D012354 RNA, His Transfer
% 208.74/208.96 |- skos__altLabel mesh__D012354 Histidine-Specific tRNA
% 208.74/208.96 |- mesh__dateRevised mesh__D012354 1996-06-10
% 208.74/208.96 |- skos__altLabel mesh__D012354 tRNA%28%His%29%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 2005
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 2002
% 208.74/208.96 |- skos__scopeNote mesh__D012354
% 208.74/208.96 A transfer RNA which is specific for carrying histidine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.74/208.96 |- rdf__type mesh__D012354sskos__Concept
% 208.74/208.96 |- skos__broader mesh__D012354smesh__D012345
% 208.74/208.96 |- skos__hiddenLabel mesh__D012354 tRNA, Histidine-Specific
% 208.74/208.96 |- skos__hiddenLabel mesh__D012354 Histidine Specific tRNA
% 208.74/208.96 |- skos__altLabel mesh__D012354 tRNAHis
% 208.74/208.96 |- mesh__recordOriginator mesh__D012354 RLS
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D012354 PLS
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D012354
% 208.74/208.96 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.96 |- skos__prefLabel mesh__D012354 RNA, Transfer, His
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 1997
% 208.74/208.96 |- skos__historyNote mesh__D012354 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.96 |- skos__altLabel mesh__D012354 Transfer RNA, His
% 208.74/208.96 |- skos__hiddenLabel mesh__D012354 His Transfer RNA
% 208.74/208.96 |- skos__historyNote mesh__D012354 RNA, Transfer %28%1966-1987%29%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 2004
% 208.74/208.96 |- mesh__dateCreated mesh__D012354 1987-05-07
% 208.74/208.96 |- mesh__recordMaintainer mesh__D012354 TGC
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 2001
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 1999
% 208.74/208.96 |- skos__annotation mesh__D012354
% 208.74/208.96 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012354 2003
% 208.74/208.96 |- skos__scopeNote mesh__D006317
% 208.74/208.96 Hearing loss due to exposure to explosive loud noise or chronic exposure to sound level greater than 85 dB. The hearing loss is often in the frequency range 4000-6000 hertz.%A%
% 208.74/208.96 |- rdf__type mesh__D006317sskos__Concept
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D006317 79; was ACOUSTIC TRAUMA 1963-78
% 208.74/208.96 |- mesh__onlineNote mesh__D006317
% 208.74/208.96 use HEARING LOSS, NOISE-INDUCED to search ACOUSTIC TRAUMA 1966-78%A%
% 208.74/208.96 |- skos__broader mesh__D006317smesh__D006319
% 208.74/208.96 |- mesh__dateCreated mesh__D006317 1999-01-01
% 208.74/208.96 |- mesh__recordOriginator mesh__D006317 NLM
% 208.74/208.96 |- skos__historyNote mesh__D006317 Deafness %28%1966-1978%29%
% 208.74/208.96 |- skos__historyNote mesh__D006317 Acoustic Trauma %28%1966-1978%29%
% 208.74/208.96 |- skos__hiddenLabel mesh__D006317 Hearing Loss, Noise Induced
% 208.74/208.96 |- skos__prefLabel mesh__D006317 Hearing Loss, Noise-Induced
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D006317 2006
% 208.74/208.96 |- mesh__recordMaintainer mesh__D006317 lkt
% 208.74/208.96 |- skos__historyNote mesh__D006317 Noise %28%1966-1978%29%
% 208.74/208.96 |- mesh__dateRevised mesh__D006317 2004-07-07
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D006317 2005
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D006317 sjn
% 208.74/208.96 |- skos__hiddenLabel mesh__D006317 Noise-Induced Hearing Loss
% 208.74/208.96 |- mesh__historyNote mesh__D006317 79; was ACOUSTIC TRAUMA 1963-78
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 IL 6 Dependent DNA Binding Protein
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 Transcription Factor, LAP
% 208.74/208.96 |- skos__altLabel mesh__D022782 Liver-Enriched Inhibitory Protein, LIP
% 208.74/208.96 |- mesh__dateCreated mesh__D022782 2000-06-23
% 208.74/208.96 |- mesh__recordOriginator mesh__D022782 jmp
% 208.74/208.96 |- skos__altLabel mesh__D022782 C-EBP beta
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 Transcription Factor, AGP-EBP
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D022782 ags
% 208.74/208.96 |- skos__scopeNote mesh__D022782
% 208.74/208.96 A CCAAT-enhancer-binding protein found in LIVER; INTESTINES; LUNG and ADIPOSE TISSUE. It is an important mediator of INTERLEUKIN-6 signaling.%A%
% 208.74/208.96 |- mesh__dateEstablished mesh__D022782 2001-01-01
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 C EBP beta
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D022782 2006A
% 208.74/208.96 |- skos__altLabel mesh__D022782 IL-6-Dependent DNA Binding Protein
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D022782
% 208.74/208.96 2001; C-EBP BETA %28%now CCAAT-ENHANCER-BINDING PROTEIN-BETA%29% was indexed under DNA-BINDING PROTEINS and NUCLEAR PROTEINS 1994-2000; LIVER-ENRICHED INHIBITING PROTEIN was indexed under REPRESSOR PROTEINS 1995-2000%A%
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 Inhibiting Protein, Liver-Enriched
% 208.74/208.96 |- skos__historyNote mesh__D022782 Nuclear Proteins %28%1994-2000%29%
% 208.74/208.96 |- skos__altLabel mesh__D022782 IL-6 DBP
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 C EBPbeta
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 C EBP Related Protein 2
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 Liver Enriched Inhibiting Protein
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D022782 2006
% 208.74/208.96 |- skos__altLabel mesh__D022782 40-C-EBP Protein
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 AGP EBP Transcription Factor
% 208.74/208.96 |- skos__altLabel mesh__D022782 C-EBPbeta
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 2, C-EBP-Related Protein
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 Interleukin 6 Nuclear Factor
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 Liver Enriched Inhibitory Protein, LIP
% 208.74/208.96 |- skos__altLabel mesh__D022782 AGP-EBP Transcription Factor
% 208.74/208.96 |- skos__historyNote mesh__D022782 DNA-Binding Proteins %28%1994-2000%29%
% 208.74/208.96 |- skos__prefLabel mesh__D022782 CCAAT-Enhancer-Binding Protein-beta
% 208.74/208.96 |- skos__altLabel mesh__D022782 CRP2 Protein
% 208.74/208.96 |- skos__altLabel mesh__D022782 Interleukin-6 Nuclear Factor
% 208.74/208.96 |- skos__altLabel mesh__D022782 C-EBP-Related Protein 2
% 208.74/208.96 |- skos__altLabel mesh__D022782 C-EBP-beta
% 208.74/208.96 |- rdf__type mesh__D022782sskos__Concept
% 208.74/208.96 |- skos__altLabel mesh__D022782 NF-IL6
% 208.74/208.96 |- mesh__historyNote mesh__D022782
% 208.74/208.96 2001; use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1994-2000; for LIVER-ENRICHED INHIBITING PROTEIN use CCAAT-ENHANCER-BINDING PROTEIN-BETA %28%NM%29% 1995-2000;%A%
% 208.74/208.96 |- skos__altLabel mesh__D022782 23-C-EBP Protein
% 208.74/208.96 |- skos__broader mesh__D022782smesh__D022762
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 Protein-beta, CCAAT-Enhancer-Binding
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 Nuclear Factor, Interleukin-6
% 208.74/208.96 |- skos__altLabel mesh__D022782 LAP Transcription Factor
% 208.74/208.96 |- skos__hiddenLabel mesh__D022782 CCAAT Enhancer Binding Protein beta
% 208.74/208.96 |- mesh__recordMaintainer mesh__D022782 ags
% 208.74/208.96 |- mesh__dateRevised mesh__D022782 2005-07-11
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 1997
% 208.74/208.96 |- skos__historyNote mesh__D016745 Tooth Root %28%1966-1991%29%
% 208.74/208.96 |- skos__scopeNote mesh__D016745
% 208.74/208.96 A procedure for smoothing of the roughened root surface or cementum of a tooth after subgingival curettage or scaling, as part of periodontal therapy.%A%
% 208.74/208.96 |- mesh__historyNote mesh__D016745 92
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 1993
% 208.74/208.96 |- rdf__type mesh__D016745sskos__Concept
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 1996
% 208.74/208.96 |- skos__broader mesh__D016745smesh__D013357
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 2002
% 208.74/208.96 |- skos__annotation mesh__D016745
% 208.74/208.96 in periodontal ther to smooth root surface or cementum; do not use /util except by MeSH definition; do not confuse with ROOT SCALING see DENTAL SCALING%A%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 1999
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 1992
% 208.74/208.96 |- mesh__dateCreated mesh__D016745 1991-04-29
% 208.74/208.96 |- skos__prefLabel mesh__D016745 Root Planing
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 2004
% 208.74/208.96 |- mesh__dateEstablished mesh__D016745 1992-01-01
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 1995
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 1998
% 208.74/208.96 |- skos__broader mesh__D016745smesh__D012534
% 208.74/208.96 |- skos__hiddenLabel mesh__D016745 Root Planings
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 2003
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 1994
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 2001
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 2006
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D016745 92
% 208.74/208.96 |- skos__hiddenLabel mesh__D016745 Planings, Root
% 208.74/208.96 |- skos__hiddenLabel mesh__D016745 Planing, Root
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 2000
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016745 2005
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D002725 sjn
% 208.74/208.96 |- mesh__dateCreated mesh__D002725 1999-01-01
% 208.74/208.96 |- mesh__recordOriginator mesh__D002725 NLM
% 208.74/208.96 |- mesh__dateRevised mesh__D002725 2004-07-19
% 208.74/208.96 |- mesh__recordMaintainer mesh__D002725 jls
% 208.74/208.96 |- skos__scopeNote mesh__D002725
% 208.74/208.96 A commonly used laboratory solvent. It was previously used as an anesthetic, but was banned from use in the U.S. due to its suspected carcinogenicity.%A%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D002725 2005
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D002725 2006
% 208.74/208.96 |- skos__broader mesh__D002725smesh__D006843
% 208.74/208.96 |- skos__prefLabel mesh__D002725 Chloroform
% 208.74/208.96 |- skos__broader mesh__D002725smesh__D022882
% 208.74/208.96 |- rdf__type mesh__D002725sskos__Concept
% 208.74/208.96 |- skos__altLabel mesh__D002725 Trichloromethane
% 208.74/208.96 |- skos__prefLabel mesh__D007410 Intestinal Diseases
% 208.74/208.96 |- mesh__onlineNote mesh__D007410
% 208.74/208.96 search INTESTINAL MICROORGANISMS under INTESTINES 1966-67%A%
% 208.74/208.96 |- mesh__historyNote mesh__D007410
% 208.74/208.96 INTESTINAL MICROORGANISMS was heading 1963-67; general or unspecified inflamm dis was indexed under ENTERITIS or INTESTINAL DISEASES 1966-79%A%
% 208.74/208.96 |- mesh__dateCreated mesh__D007410 1999-01-01
% 208.74/208.96 |- skos__hiddenLabel mesh__D007410 Disease, Intestinal
% 208.74/208.96 |- rdf__type mesh__D007410sskos__Concept
% 208.74/208.96 |- skos__annotation mesh__D007410
% 208.74/208.96 GEN: prefer specifics; inflamm dis = GASTROENTERITIS or specifics; consider also INFLAMMATORY BOWEL DISEASE; gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS%A%
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D007410
% 208.74/208.96 INTESTINAL MICROORGANISMS was heading 1963-67; general or unspecified inflammatory disease is indexed here, was indexed under INTESTINAL DISEASES or ENTERITIS 1963-79%A%
% 208.74/208.96 |- skos__hiddenLabel mesh__D007410 Intestinal Disease
% 208.74/208.96 |- mesh__recordOriginator mesh__D007410 NLM
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D007410 sjn
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D007410 2006
% 208.74/208.96 |- skos__broader mesh__D007410smesh__D005767
% 208.74/208.96 |- skos__hiddenLabel mesh__D007410 Diseases, Intestinal
% 208.74/208.96 |- mesh__dateRevised mesh__D007410 2003-07-09
% 208.74/208.96 |- skos__scopeNote mesh__D007410
% 208.74/208.96 Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.%A%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D007410 2005
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D007410 2004
% 208.74/208.96 |- mesh__recordMaintainer mesh__D007410 lkt
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D048029 2005
% 208.74/208.96 |- skos__altLabel mesh__D048029 TRAF6
% 208.74/208.96 |- skos__historyNote mesh__D048029 Proteins %28%1996-2004%29%
% 208.74/208.96 |- mesh__dateCreated mesh__D048029 2004-07-07
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D048029
% 208.74/208.96 2005; TNF RECEPTOR-ASSOCIATED FACTOR 6 was indexed under PROTEINS 1996-2004%A%
% 208.74/208.96 |- skos__altLabel mesh__D048029 TRAF-6 Protein
% 208.74/208.96 |- skos__hiddenLabel mesh__D048029 TNF Receptor Associated Factor 6
% 208.74/208.96 |- mesh__dateEstablished mesh__D048029 2005-01-01
% 208.74/208.96 |- skos__hiddenLabel mesh__D048029 TRAF 6 Protein
% 208.74/208.96 |- mesh__recordOriginator mesh__D048029 jmp
% 208.74/208.96 |- mesh__historyNote mesh__D048029 2005%28%1996%29%
% 208.74/208.96 |- skos__scopeNote mesh__D048029
% 208.74/208.96 A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signalling and activation of JNK MITOGEN-ACTIVATED PROTEIN KINASES.%A%
% 208.74/208.96 |- skos__prefLabel mesh__D048029 TNF Receptor-Associated Factor 6
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D048029 sjn
% 208.74/208.96 |- skos__broader mesh__D048029smesh__D047988
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D048029 2006
% 208.74/208.96 |- mesh__recordMaintainer mesh__D048029 jmp
% 208.74/208.96 |- rdf__type mesh__D048029sskos__Concept
% 208.74/208.96 |- skos__hiddenLabel mesh__D012355 RNA, Ile Transfer
% 208.74/208.96 |- mesh__dateCreated mesh__D012355 1987-05-07
% 208.74/208.96 |- skos__scopeNote mesh__D012355
% 208.74/208.96 A transfer RNA which is specific for carrying isoleucine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.74/208.96 |- skos__hiddenLabel mesh__D012355 Isoleucine Specific tRNA
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 2001
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 2005
% 208.74/208.96 |- skos__prefLabel mesh__D012355 RNA, Transfer, Ile
% 208.74/208.96 |- rdf__type mesh__D012355sskos__Concept
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 2000
% 208.74/208.96 |- skos__broader mesh__D012355smesh__D012345
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D012355
% 208.74/208.96 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.96 |- mesh__historyNote mesh__D012355
% 208.74/208.96 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.96 |- skos__altLabel mesh__D012355 Isoleucine-Specific tRNA
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 1997
% 208.74/208.96 |- skos__altLabel mesh__D012355 tRNAIle
% 208.74/208.96 |- skos__hiddenLabel mesh__D012355 Ile Transfer RNA
% 208.74/208.96 |- skos__altLabel mesh__D012355 Transfer RNA, Ile
% 208.74/208.96 |- mesh__dateRevised mesh__D012355 1996-06-10
% 208.74/208.96 |- skos__historyNote mesh__D012355 RNA, Transfer %28%1966-1987%29%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 2004
% 208.74/208.96 |- mesh__recordMaintainer mesh__D012355 TGC
% 208.74/208.96 |- skos__hiddenLabel mesh__D012355 tRNA, Isoleucine-Specific
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 2002
% 208.74/208.96 |- skos__annotation mesh__D012355
% 208.74/208.96 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.74/208.96 |- mesh__recordOriginator mesh__D012355 RLS
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 1999
% 208.74/208.96 |- skos__altLabel mesh__D012355 tRNA%28%Ile%29%
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D012355 PLS
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 2003
% 208.74/208.96 |- skos__historyNote mesh__D012355 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.96 |- mesh__dateEstablished mesh__D012355 1991-01-01
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 2006
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D012355 1998
% 208.74/208.96 |- skos__hiddenLabel mesh__D003020 Clothings
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D003020 2002
% 208.74/208.96 |- mesh__dateCreated mesh__D003020 1999-01-01
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D003020 2006
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D003020 1999
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D003020 2004
% 208.74/208.96 |- mesh__dateRevised mesh__D003020 1997-06-20
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D003020 2005
% 208.74/208.96 |- skos__broader mesh__D003020smesh__D008420
% 208.74/208.96 |- rdf__type mesh__D003020sskos__Concept
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D003020 2001
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D003020 1998
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D003020 2003
% 208.74/208.96 |- mesh__recordOriginator mesh__D003020 NLM
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D003020 2000
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D003020 SJN
% 208.74/208.96 |- skos__prefLabel mesh__D003020 Clothing
% 208.74/208.96 |- mesh__recordMaintainer mesh__D003020 JLS
% 208.74/208.96 |- mesh__dateCreated mesh__D022783 2000-06-22
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D022783
% 208.74/208.96 2006; see TRANSFUSION-ASSOCIATED VIRUS 2001-2005
% 208.74/208.96 |- mesh__recordMaintainer mesh__D022783 ags
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D022783 sjn
% 208.74/208.96 |- rdf__type mesh__D022783sskos__Concept
% 208.74/208.96 |- skos__altLabel mesh__D022783 SEN-V
% 208.74/208.96 |- mesh__recordOriginator mesh__D022783 ags
% 208.74/208.96 |- skos__annotation mesh__D022783
% 208.74/208.96 a specific virus, not any virus transmitted by transfusion; infection: coord IM with DNA VIRUS INFECTIONS %28%IM%29%%A%
% 208.74/208.96 |- skos__hiddenLabel mesh__D022783 Virus, TT
% 208.74/208.96 |- mesh__historyNote mesh__D022783 2006 %28%2001%29%
% 208.74/208.96 |- skos__broader mesh__D022783smesh__D049811
% 208.74/208.96 |- skos__hiddenLabel mesh__D022783 Virus, Transfusion-Transmitted
% 208.74/208.96 |- skos__hiddenLabel mesh__D022783 Viruses, TT
% 208.74/208.96 |- skos__hiddenLabel mesh__D022783 TT Viruses
% 208.74/208.96 |- mesh__dateEstablished mesh__D022783 2001-01-01
% 208.74/208.96 |- skos__altLabel mesh__D022783 TT Virus
% 208.74/208.96 |- skos__prefLabel mesh__D022783 Torque teno virus
% 208.74/208.96 |- skos__hiddenLabel mesh__D022783 Transfusion Transmitted Virus
% 208.74/208.96 |- skos__hiddenLabel mesh__D022783 SEN viruses
% 208.74/208.96 |- skos__hiddenLabel mesh__D022783 virus, SEN
% 208.74/208.96 |- skos__historyNote mesh__D022783 DNA Viruses %28%1998-2000%29%
% 208.74/208.96 |- skos__altLabel mesh__D022783 Transfusion-Transmitted Virus
% 208.74/208.96 |- skos__historyNote mesh__D022783 Hepatitis Viruses %28%1998-1999%29%
% 208.74/208.96 |- skos__hiddenLabel mesh__D022783 viruses, SEN
% 208.74/208.96 |- skos__scopeNote mesh__D022783
% 208.74/208.96 A species of non-enveloped DNA virus in the genus ANELLOVIRUS, associated with BLOOD TRANSFUSIONS; and HEPATITIS. However, no etiological role has been found for TTV in hepatitis.%A%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D022783 2006
% 208.74/208.96 |- skos__altLabel mesh__D022783 SENV
% 208.74/208.96 |- mesh__dateRevised mesh__D022783 2005-06-30
% 208.74/208.96 |- skos__hiddenLabel mesh__D022783 Torque teno viruses
% 208.74/208.96 |- skos__historyNote mesh__D049920
% 208.74/208.96 Gram-Negative Aerobic Rods and Cocci %28%1995-2000%29%
% 208.74/208.96 |- mesh__recordOriginator mesh__D049920 ags
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D049920 2006
% 208.74/208.96 |- skos__prefLabel mesh__D049920 Ralstonia pickettii
% 208.74/208.96 |- skos__annotation mesh__D049920
% 208.74/208.96 infection: coordinate IM with GRAM NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D049920 2006; see RALSTONIA 2002-2005
% 208.74/208.96 |- rdf__type mesh__D049920sskos__Concept
% 208.74/208.96 |- mesh__recordMaintainer mesh__D049920 ags
% 208.74/208.96 |- skos__broader mesh__D049920smesh__D043367
% 208.74/208.96 |- skos__historyNote mesh__D049920 Ralstonia %28%2004-2005%29%
% 208.74/208.96 |- skos__scopeNote mesh__D049920
% 208.74/208.96 The type species in the genus RALSTONIA. It is often found in the hospital ward as a contaminant of antiseptic and disinfectant solutions.%A%
% 208.74/208.96 |- mesh__dateEstablished mesh__D049920 2006-01-01
% 208.74/208.96 |- skos__historyNote mesh__D049920 Betaproteobacteria %28%1995-2004%29%
% 208.74/208.96 |- mesh__dateCreated mesh__D049920 2005-06-30
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D049920 sjn
% 208.74/208.96 |- mesh__historyNote mesh__D049920 2006; use RALSTONIA 2002-2005
% 208.74/208.96 |- skos__scopeNote mesh__D016746
% 208.74/208.96 A nursing specialty created to answer the need for developing a global perspective in the practice of nursing in a world of interdependent nations and people. The focus of this nursing discipline is on the integration of international and transcultural content into the training. Courses include study in the area of cultural differences, nursing in other countries, and international health issues and organizations, as an example.%A%
% 208.74/208.96 |- rdf__type mesh__D016746sskos__Concept
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016746 2005
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D016746 sjn
% 208.74/208.96 |- mesh__historyNote mesh__D016746 92
% 208.74/208.96 |- mesh__recordMaintainer mesh__D016746 kle
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016746 2002
% 208.74/208.96 |- skos__historyNote mesh__D016746 Nursing Care %28%1975-1991%29%
% 208.74/208.96 |- mesh__dateCreated mesh__D016746 1991-04-29
% 208.74/208.96 |- mesh__dateRevised mesh__D016746 1999-11-03
% 208.74/208.96 |- skos__prefLabel mesh__D016746 Transcultural Nursing
% 208.74/208.96 |- skos__broader mesh__D016746smesh__D013041
% 208.74/208.96 |- skos__annotation mesh__D016746
% 208.74/208.96 SPEC: SPEC qualif; on an international or cultural level only; coord IM with nurs specialty %28%IM%29% if pertinent + culture or ethnic group %28%IM%29% if pertinent; specify geog; DF: TRANSCULTURAL NURS%A%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016746 2004
% 208.74/208.96 |- mesh__recordOriginator mesh__D016746 MXR
% 208.74/208.96 |- mesh__dateEstablished mesh__D016746 1992-01-01
% 208.74/208.96 |- skos__historyNote mesh__D016746 Primary Nursing Care %28%1977-1991%29%
% 208.74/208.96 |- skos__historyNote mesh__D016746 Nursing %28%1977-1991%29%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016746 2001
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016746 2003
% 208.74/208.96 |- skos__altLabel mesh__D016746 Nursing, Transcultural
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016746 2000
% 208.74/208.96 |- mesh__publicMeSHNote mesh__D016746 92
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D016746 2006
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D002726 2005
% 208.74/208.96 |- skos__hiddenLabel mesh__D002726 Acid, Chlorogenic
% 208.74/208.96 |- rdf__type mesh__D002726sskos__Concept
% 208.74/208.96 |- skos__prefLabel mesh__D002726 Chlorogenic Acid
% 208.74/208.96 |- skos__broader mesh__D002726smesh__D002934
% 208.74/208.96 |- mesh__recordAuthorizer mesh__D002726 sjn
% 208.74/208.96 |- skos__altLabel mesh__D002726 3-Caffeoylquinic Acid
% 208.74/208.96 |- skos__hiddenLabel mesh__D002726 3 Caffeoylquinic Acid
% 208.74/208.96 |- mesh__dateCreated mesh__D002726 1999-01-01
% 208.74/208.96 |- mesh__dateRevised mesh__D002726 2004-07-19
% 208.74/208.96 |- mesh__recordMaintainer mesh__D002726 jls
% 208.74/208.96 |- mesh__recordOriginator mesh__D002726 NLM
% 208.74/208.96 |- skos__broader mesh__D002726smesh__D003509
% 208.74/208.96 |- skos__scopeNote mesh__D002726
% 208.74/208.96 A naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. %28%From J Chromatogr A 1996;741%28%2%29%:223-31; Biosci Biotechnol Biochem 1996;60%28%5%29%:765-68%29%.%A%
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D002726 2006
% 208.74/208.96 |- skos__hiddenLabel mesh__D002726 Acid, 3-Caffeoylquinic
% 208.74/208.96 |- rdf__type mesh__D007411sskos__Concept
% 208.74/208.96 |- skos__altLabel mesh__D007411 Parasitic Intestinal Diseases
% 208.74/208.96 |- skos__hiddenLabel mesh__D007411 Diseases, Parasitic Intestinal
% 208.74/208.96 |- skos__broader mesh__D007411smesh__D010272
% 208.74/208.96 |- skos__hiddenLabel mesh__D007411 Disease, Parasitic Intestinal
% 208.74/208.96 |- skos__scopeNote mesh__D007411
% 208.74/208.96 Infections of the INTESTINES with PARASITES, commonly involving PROTOZOA or PARASITIC WORMS. Infections with roundworms %28%NEMATODE INFECTIONS%29% and tapeworms %28%CESTODE INFECTIONS%29% are also known as HELMINTHIASIS.%A%
% 208.74/208.96 |- mesh__recordMaintainer mesh__D007411 ags
% 208.74/208.96 |- skos__prefLabel mesh__D007411 Intestinal Diseases, Parasitic
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D007411 2006
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D007411 2006A
% 208.74/208.96 |- skos__hiddenLabel mesh__D007411 Parasitic Intestinal Disease
% 208.74/208.96 |- mesh__recordOriginator mesh__D007411 NLM
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D007411 2005
% 208.74/208.96 |- mesh__activeMeSHYear mesh__D007411 2004
% 208.74/208.97 |- mesh__recordAuthorizer mesh__D007411 ags
% 208.74/208.97 |- skos__hiddenLabel mesh__D007411 Intestinal Disease, Parasitic
% 208.74/208.97 |- skos__annotation mesh__D007411
% 208.74/208.97 GEN; prefer specific indentations; otherwise coord IM with specific parasitic disease %28%IM%29% + specific precoord intestinal disease %28%IM%29%%A%
% 208.74/208.97 |- mesh__dateRevised mesh__D007411 2005-08-02
% 208.74/208.97 |- skos__broader mesh__D007411smesh__D007410
% 208.74/208.97 |- mesh__dateCreated mesh__D007411 1999-01-01
% 208.74/208.97 |- skos__prefLabel mesh__D048828 beta-N-Acetyl-Galactosaminidase
% 208.74/208.97 |- skos__historyNote mesh__D048828 Acetic Acids %28%1973-1978%29%
% 208.74/208.97 |- mesh__recordAuthorizer mesh__D048828 sjn
% 208.74/208.97 |- mesh__recordMaintainer mesh__D048828 jmp
% 208.74/208.97 |- skos__hiddenLabel mesh__D048828 beta N Acetyl Galactosaminidase
% 208.74/208.97 |- mesh__publicMeSHNote mesh__D048828
% 208.74/208.97 2005; BETA-N-ACETYL-GALACTOAMINIDASE was indexed under GALACTOSAMINIDASE 1982-2004, under ACETYLGALACTOSAMINE 1978-1981, %26% under ACETAMIDES %26% ACETIC ACIDS 1973-1978%A%
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D048828 2006
% 208.74/208.97 |- skos__scopeNote mesh__D048828
% 208.74/208.97 A hexosiminidase that specifically hydrolyzes terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-beta-D-galactosaminides.%A%
% 208.74/208.97 |- rdf__type mesh__D048828sskos__Concept
% 208.74/208.97 |- skos__altLabel mesh__D048828 N-Acetyl-beta-Galactosaminidase
% 208.74/208.97 |- skos__historyNote mesh__D048828 Acetylgalactosamine %28%1978-1981%29%
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D048828 2005
% 208.74/208.97 |- mesh__recordOriginator mesh__D048828 jmp
% 208.74/208.97 |- mesh__dateEstablished mesh__D048828 2005-01-01
% 208.74/208.97 |- skos__broader mesh__D048828smesh__D006596
% 208.74/208.97 |- skos__historyNote mesh__D048828 Hexosaminidases %28%1982-2004%29%
% 208.74/208.97 |- skos__historyNote mesh__D048828 Acetamides %28%1973-1978%29%
% 208.74/208.97 |- skos__hiddenLabel mesh__D048828 N Acetyl beta Galactosaminidase
% 208.74/208.97 |- mesh__historyNote mesh__D048828 2005%28%1973%29%
% 208.74/208.97 |- skos__hiddenLabel mesh__D048828 beta N Acetylgalactosaminidase
% 208.74/208.97 |- skos__altLabel mesh__D048828 beta-N-Acetylgalactosaminidase
% 208.74/208.97 |- mesh__dateCreated mesh__D048828 2004-07-08
% 208.74/208.97 |- skos__altLabel mesh__D012356 Transfer RNA, Leu
% 208.74/208.97 |- skos__altLabel mesh__D012356 tRNALeu
% 208.74/208.97 |- skos__historyNote mesh__D012356 RNA, Transfer %28%1966-1987%29%
% 208.74/208.97 |- rdf__type mesh__D012356sskos__Concept
% 208.74/208.97 |- mesh__dateCreated mesh__D012356 1987-05-07
% 208.74/208.97 |- skos__historyNote mesh__D012356 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 2000
% 208.74/208.97 |- mesh__dateEstablished mesh__D012356 1991-01-01
% 208.74/208.97 |- mesh__recordOriginator mesh__D012356 RLS
% 208.74/208.97 |- skos__altLabel mesh__D012356 Leucine-Specific tRNA
% 208.74/208.97 |- skos__annotation mesh__D012356
% 208.74/208.97 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.74/208.97 |- mesh__historyNote mesh__D012356
% 208.74/208.97 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.97 |- skos__altLabel mesh__D012356 tRNA%28%Leu%29%
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 1997
% 208.74/208.97 |- mesh__recordMaintainer mesh__D012356 TGC
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 2003
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 2001
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 1998
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 2004
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 2002
% 208.74/208.97 |- skos__prefLabel mesh__D012356 RNA, Transfer, Leu
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 1999
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 2005
% 208.74/208.97 |- skos__hiddenLabel mesh__D012356 Leu Transfer RNA
% 208.74/208.97 |- mesh__recordAuthorizer mesh__D012356 PLS
% 208.74/208.97 |- skos__hiddenLabel mesh__D012356 Leucine Specific tRNA
% 208.74/208.97 |- skos__hiddenLabel mesh__D012356 tRNA, Leucine-Specific
% 208.74/208.97 |- skos__hiddenLabel mesh__D012356 RNA, Leu Transfer
% 208.74/208.97 |- skos__scopeNote mesh__D012356
% 208.74/208.97 A transfer RNA which is specific for carrying leucine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D012356 2006
% 208.74/208.97 |- mesh__dateRevised mesh__D012356 1996-06-10
% 208.74/208.97 |- skos__broader mesh__D012356smesh__D012345
% 208.74/208.97 |- mesh__publicMeSHNote mesh__D012356
% 208.74/208.97 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.74/208.97 |- skos__historyNote mesh__D006319 Deafness %28%1966-1978%29%
% 208.74/208.97 |- mesh__publicMeSHNote mesh__D006319 79
% 208.74/208.97 |- mesh__dateCreated mesh__D006319 1978-05-22
% 208.74/208.97 |- skos__altLabel mesh__D006319 Sensorineural Hearing Loss
% 208.74/208.97 |- skos__annotation mesh__D006319
% 208.74/208.97 HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL is also available%A%
% 208.74/208.97 |- mesh__dateEstablished mesh__D006319 1979-01-01
% 208.74/208.97 |- skos__prefLabel mesh__D006319 Hearing Loss, Sensorineural
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D006319 2006
% 208.74/208.97 |- mesh__dateRevised mesh__D006319 2004-07-07
% 208.74/208.97 |- skos__scopeNote mesh__D006319
% 208.74/208.97 Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.%A%
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D006319 2005
% 208.74/208.97 |- mesh__recordOriginator mesh__D006319 RC
% 208.74/208.97 |- skos__altLabel mesh__D006319 Cochlear Hearing Loss
% 208.74/208.97 |- mesh__recordMaintainer mesh__D006319 lkt
% 208.74/208.97 |- mesh__recordAuthorizer mesh__D006319 sjn
% 208.74/208.97 |- mesh__historyNote mesh__D006319 79
% 208.74/208.97 |- rdf__type mesh__D006319sskos__Concept
% 208.74/208.97 |- skos__broader mesh__D006319smesh__D034381
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D017041 2006
% 208.74/208.97 |- mesh__recordMaintainer mesh__D017041 jrf
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Ethics Committees, Institutional
% 208.74/208.97 |- mesh__recordAuthorizer mesh__D017041 sjn
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Ethics Committee
% 208.74/208.97 |- mesh__dateCreated mesh__D017041 1991-07-26
% 208.74/208.97 |- rdf__type mesh__D017041sskos__Concept
% 208.74/208.97 |- skos__related mesh__D017041smesh__D026724
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D017041 2003
% 208.74/208.97 |- mesh__dateEstablished mesh__D017041 1992-01-01
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Committees, Institutional Ethics
% 208.74/208.97 |- mesh__historyNote mesh__D017041 92
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Regional Ethics Committee
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Institutional Ethics Committee
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D017041 2004
% 208.74/208.97 |- mesh__recordOriginator mesh__D017041 PLS
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Committee, Regional Ethics
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Committee, Ethics
% 208.74/208.97 |- skos__related mesh__D017041smesh__D026683
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Ethics Committee, Institutional
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Committees, Ethics
% 208.74/208.97 |- skos__broader mesh__D017041smesh__D011367
% 208.74/208.97 |- skos__broader mesh__D017041smesh__D004989
% 208.74/208.97 |- skos__scopeNote mesh__D017041
% 208.74/208.97 Committees established by professional societies, health facilities, or other institutions to consider decisions that have bioethical implications. The role of these committees may include consultation, education, mediation, and/or review of policies and practices. Committees that consider the ethical dimensions of patient care are ETHICS COMMITTEES, CLINICAL; committees established to protect the welfare of research subjects are ETHICS COMMITTEES, RESEARCH.%A%
% 208.74/208.97 |- skos__historyNote mesh__D017041
% 208.74/208.97 Professional Staff Committees %28%1975-1991%29%
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Ethics Committees, Regional
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Committees, Regional Ethics
% 208.74/208.97 |- mesh__activeMeSHYear mesh__D017041 2005
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Ethics Committee, Regional
% 208.74/208.97 |- skos__hiddenLabel mesh__D017041 Committee, Institutional Ethics
% 208.74/208.97 |- skos__related mesh__D017041smesh__D035661
% 208.74/208.97 |- skos__prefLabel mesh__D017041 Ethics Committees
% 208.82/208.97 |- skos__historyNote mesh__D017041 Ethics, Medical %28%1966-1991%29%
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D017041 92
% 208.82/208.97 |- mesh__dateRevised mesh__D017041 2002-07-03
% 208.82/208.97 |- mesh__historyNote mesh__D049921 2006
% 208.82/208.97 |- mesh__dateCreated mesh__D049921 2005-06-30
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D049921 sjn
% 208.82/208.97 |- skos__broader mesh__D049921smesh__D043365
% 208.82/208.97 |- mesh__recordMaintainer mesh__D049921 ags
% 208.82/208.97 |- skos__prefLabel mesh__D049921 Wautersia
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D049921 2006
% 208.82/208.97 |- mesh__recordOriginator mesh__D049921 ags
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D049921 2006
% 208.82/208.97 |- mesh__dateEstablished mesh__D049921 2006-01-01
% 208.82/208.97 |- skos__scopeNote mesh__D049921
% 208.82/208.97 A genus of gram-negative, aerobic, rod-shaped bacteria, in the family RALSTONIACEAE, that are mobile by means of peritrichous FLAGELLA. Species in this genus were formerly in the genus RALSTONIA.%A%
% 208.82/208.97 |- rdf__type mesh__D049921sskos__Concept
% 208.82/208.97 |- skos__altLabel mesh__D016747 Minor Lymphocyte Stimulatory Determinants
% 208.82/208.97 |- mesh__recordOriginator mesh__D016747 AGS
% 208.82/208.97 |- skos__scopeNote mesh__D016747
% 208.82/208.97 Endogenous superantigens responsible for inducing strong proliferative responses in T-cells in mixed lymphocyte reactions %28%see LYMPHOCYTE CULTURE TEST, MIXED%29%. They are encoded by mouse mammary tumor viruses that have integrated into the germ line as DNA proviruses %28%MINOR LYMPHOCYTE STIMULATORY LOCI%29%.%A%
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747 Minor Lymphocyte Stimulating Antigens
% 208.82/208.97 |- skos__broader mesh__D016747smesh__D018089
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747
% 208.82/208.97 Determinants, Minor Lymphocyte-Stimulating
% 208.82/208.97 |- mesh__onlineNote mesh__D016747
% 208.82/208.97 use MINOR LYMPHOCYTE STIMULATORY ANTIGENS %28%NM%29% to search MLS ANTIGENS 1987-91%A%
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747 Lymphocyte-Stimulating Antigens, Minor
% 208.82/208.97 |- skos__altLabel mesh__D016747 Lymphocyte Stimulatory Antigens, Minor
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747 Antigens, Minor Lymphocyte-Stimulating
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747
% 208.82/208.97 Lymphocyte-Stimulating Determinants, Minor
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747 Antigens, Mls
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D016747 sjn
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747
% 208.82/208.97 Minor Lymphocyte Stimulating Determinants
% 208.82/208.97 |- skos__prefLabel mesh__D016747 Minor Lymphocyte Stimulatory Antigens
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D016747 2006
% 208.82/208.97 |- rdf__type mesh__D016747sskos__Concept
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747 Lymphocyte Activating Determinants
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747 Determinants, Mls
% 208.82/208.97 |- skos__altLabel mesh__D016747 Minor Lymphocyte-Stimulating Determinants
% 208.82/208.97 |- skos__annotation mesh__D016747 DF: note short X ref
% 208.82/208.97 |- skos__altLabel mesh__D016747 Mls Antigens
% 208.82/208.97 |- mesh__historyNote mesh__D016747
% 208.82/208.97 92; was MLS ANTIGENS %28%NM%29% 1987-91
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D016747
% 208.82/208.97 92; MLS ANTIGENS was indexed under ANTIGENS, SURFACE 1987-91%A%
% 208.82/208.97 |- skos__hiddenLabel mesh__D016747 Determinants, Lymphocyte-Activating
% 208.82/208.97 |- skos__altLabel mesh__D016747 Mls Determinants
% 208.82/208.97 |- mesh__dateRevised mesh__D016747 2005-06-30
% 208.82/208.97 |- skos__altLabel mesh__D016747 Minor Lymphocyte-Stimulating Antigens
% 208.82/208.97 |- skos__altLabel mesh__D016747 Lymphocyte-Activating Determinants
% 208.82/208.97 |- mesh__dateEstablished mesh__D016747 1992-01-01
% 208.82/208.97 |- mesh__recordMaintainer mesh__D016747 ssb
% 208.82/208.97 |- skos__broader mesh__D016747smesh__D000954
% 208.82/208.97 |- mesh__dateCreated mesh__D016747 1991-07-12
% 208.82/208.97 |- skos__altLabel mesh__D016747 Antigens, Minor Lymphocyte Stimulatory
% 208.82/208.97 |- skos__prefLabel mesh__D035901 Hypocrea
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D035901 2006
% 208.82/208.97 |- mesh__dateRevised mesh__D035901 2005-06-30
% 208.82/208.97 |- mesh__dateCreated mesh__D035901 2002-07-03
% 208.82/208.97 |- skos__altLabel mesh__D035901 Gliocladium virens
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D035901 sjn
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D035901 2003
% 208.82/208.97 |- mesh__dateEstablished mesh__D035901 2003-01-01
% 208.82/208.97 |- mesh__recordMaintainer mesh__D035901 SYSTEM
% 208.82/208.97 |- skos__historyNote mesh__D035901 Hypocreales %28%1993-2002%29%
% 208.82/208.97 |- rdf__type mesh__D035901sskos__Concept
% 208.82/208.97 |- mesh__recordOriginator mesh__D035901 ags
% 208.82/208.97 |- mesh__historyNote mesh__D035901 2003
% 208.82/208.97 |- skos__scopeNote mesh__D035901
% 208.82/208.97 A genus of fungus in the family Hypocreaceae, order HYPOCREALES. Anamorphs include TRICHODERMA.%A%
% 208.82/208.97 |- skos__broader mesh__D035901smesh__D006999
% 208.82/208.97 |- skos__altLabel mesh__D002727 Astra Brand of Chloroguanide Hydrochloride
% 208.82/208.97 |- mesh__dateRevised mesh__D002727 2005-06-30
% 208.82/208.97 |- skos__altLabel mesh__D002727 Proguanil Hydrochloride
% 208.82/208.97 |- skos__hiddenLabel mesh__D002727 Hydrochloride, Proguanil
% 208.82/208.97 |- mesh__dateCreated mesh__D002727 1999-01-01
% 208.82/208.97 |- skos__altLabel mesh__D002727 Paludrin
% 208.82/208.97 |- mesh__recordMaintainer mesh__D002727 lkw
% 208.82/208.97 |- skos__prefLabel mesh__D002727 Chloroguanide
% 208.82/208.97 |- skos__broader mesh__D002727smesh__D001645
% 208.82/208.97 |- skos__hiddenLabel mesh__D002727 Hydrochloride, Chloroguanide
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D002727 2006
% 208.82/208.97 |- skos__altLabel mesh__D002727 Chlorguanid
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D002727 sjn
% 208.82/208.97 |- mesh__recordOriginator mesh__D002727 NLM
% 208.82/208.97 |- skos__scopeNote mesh__D002727
% 208.82/208.97 A biguanide compound which has little antimalarial activity until metabolized in the body to the active antimalarial agent cycloguanil. The usefulness of proguanil is limited by the rapid development of drug resistance by the malarial parasite. The hydrochloride is used for the casual prophylaxis of falciparum malaria, to suppress other forms of malaria, and to reduce transmission of infection %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p405%29%%A%
% 208.82/208.97 |- skos__altLabel mesh__D002727
% 208.82/208.97 AstraZeneca Brand of Chloroguanide Hydrochloride
% 208.82/208.97 |- rdf__type mesh__D002727sskos__Concept
% 208.82/208.97 |- skos__altLabel mesh__D002727 Proguanil
% 208.82/208.97 |- skos__altLabel mesh__D002727 Zeneca Brand of Chloroguanide Hydrochloride
% 208.82/208.97 |- skos__broader mesh__D009206Q000378smesh__D009206
% 208.82/208.97 |- rdf__type mesh__D009206Q000378smesh__CompoundConcept
% 208.82/208.97 |- mesh__recordOriginator mesh__D007412 NLM
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D007412 2006
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D007412 sjn
% 208.82/208.97 |- mesh__dateRevised mesh__D007412 2003-07-09
% 208.82/208.97 |- mesh__recordMaintainer mesh__D007412 lkt
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D007412 2005
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D007412 2004
% 208.82/208.97 |- skos__prefLabel mesh__D007412 Intestinal Fistula
% 208.82/208.97 |- skos__hiddenLabel mesh__D007412 Fistula, Colovesical
% 208.82/208.97 |- skos__broader mesh__D007412smesh__D007410
% 208.82/208.97 |- skos__annotation mesh__D007412
% 208.82/208.97 fistula policy: Manual 23.19+; RECTAL FISTULA %26% RECTOVAGINAL FISTULA are also available%A%
% 208.82/208.97 |- skos__hiddenLabel mesh__D007412 Fistula, Cholecystoduodenal
% 208.82/208.97 |- mesh__dateCreated mesh__D007412 1999-01-01
% 208.82/208.97 |- skos__hiddenLabel mesh__D007412 Fistula, Intestinal
% 208.82/208.97 |- rdf__type mesh__D007412sskos__Concept
% 208.82/208.97 |- skos__hiddenLabel mesh__D007412 Fistula, Enterocutaneous
% 208.82/208.97 |- skos__broader mesh__D007412smesh__D016154
% 208.82/208.97 |- skos__scopeNote mesh__D007412
% 208.82/208.97 An abnormal anatomical passage between the INTESTINE, and another segment of the intestine or other organs. External intestinal fistula is connected to the SKIN %28%enterocutaneous fistula%29%. Internal intestinal fistula can be connected to a number of organs, such as STOMACH %28%gastrocolic fistula%29%, the BILIARY TRACT %28%cholecystoduodenal fistula%29%, or the BLADDER of the URINARY TRACT %28%colovesical fistula%29%. Risk factors include inflammatory processes, cancer, radiation treatment, and surgical misadventures %28%MEDICAL ERRORS%29%.%A%
% 208.82/208.97 |- skos__broader mesh__D012357smesh__D012345
% 208.82/208.97 |- skos__prefLabel mesh__D012357 RNA, Transfer, Lys
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 2006
% 208.82/208.97 |- skos__altLabel mesh__D012357 tRNA%28%Lys%29%
% 208.82/208.97 |- rdf__type mesh__D012357sskos__Concept
% 208.82/208.97 |- skos__historyNote mesh__D012357 Amino Acyl T RNA %28%1978-1987%29%
% 208.82/208.97 |- skos__hiddenLabel mesh__D012357 tRNA, Lysine-Specific
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 2000
% 208.82/208.97 |- mesh__dateEstablished mesh__D012357 1991-01-01
% 208.82/208.97 |- skos__altLabel mesh__D012357 Transfer RNA, Lys
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 1997
% 208.82/208.97 |- skos__annotation mesh__D012357
% 208.82/208.97 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.82/208.97 |- mesh__historyNote mesh__D012357
% 208.82/208.97 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.82/208.97 |- skos__historyNote mesh__D012357 RNA, Transfer %28%1966-1987%29%
% 208.82/208.97 |- mesh__dateCreated mesh__D012357 1987-05-07
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 2001
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 2003
% 208.82/208.97 |- mesh__recordOriginator mesh__D012357 RLS
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 1998
% 208.82/208.97 |- skos__hiddenLabel mesh__D012357 RNA, Lys Transfer
% 208.82/208.97 |- skos__altLabel mesh__D012357 Lysine-Specific tRNA
% 208.82/208.97 |- mesh__recordMaintainer mesh__D012357 TGC
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 2002
% 208.82/208.97 |- skos__altLabel mesh__D012357 tRNALys
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 2004
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D012357 PLS
% 208.82/208.97 |- skos__hiddenLabel mesh__D012357 Lys Transfer RNA
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 1999
% 208.82/208.97 |- mesh__dateRevised mesh__D012357 1996-06-10
% 208.82/208.97 |- skos__scopeNote mesh__D012357
% 208.82/208.97 A transfer RNA which is specific for carrying lysine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D012357 2005
% 208.82/208.97 |- skos__hiddenLabel mesh__D012357 Lysine Specific tRNA
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D012357
% 208.82/208.97 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.82/208.97 |- mesh__dateRevised mesh__D017840 2003-07-09
% 208.82/208.97 |- skos__broader mesh__D017840smesh__D017819
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D017840 2004
% 208.82/208.97 |- skos__hiddenLabel mesh__D017840 Russell Viper
% 208.82/208.97 |- mesh__dateEstablished mesh__D017840 1994-01-01
% 208.82/208.97 |- mesh__recordMaintainer mesh__D017840 ags
% 208.82/208.97 |- mesh__recordOriginator mesh__D017840 TGC
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D017840 2006
% 208.82/208.97 |- skos__historyNote mesh__D017840 Snakes %28%1966-1993%29%
% 208.82/208.97 |- rdf__type mesh__D017840sskos__Concept
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D017840 2005
% 208.82/208.97 |- skos__annotation mesh__D017840
% 208.82/208.97 a genus of vipers; its venom: coord IM with VIPER VENOMS %28%IM%29%%A%
% 208.82/208.97 |- skos__altLabel mesh__D017840 Vipera russelii
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D017840 sjn
% 208.82/208.97 |- skos__hiddenLabel mesh__D017840 russelii, Vipera
% 208.82/208.97 |- mesh__historyNote mesh__D017840 94
% 208.82/208.97 |- skos__scopeNote mesh__D017840
% 208.82/208.97 A genus of snakes of the family VIPERIDAE. It is distributed in West Pakistan, most of India, Burma, Ceylon, Thailand, southeast China, Taiwan, and a few islands of Indonesia. It hisses loudly when disturbed and strikes with great force and speed. Very prolific, it gives birth to 20-60 young. This viper is the leading cause of snakebite in India and Burma. %28%Moore: Poisonous Snakes of the World, 1980, p127%29%%A%
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D017840 94
% 208.82/208.97 |- skos__hiddenLabel mesh__D017840 Viper, Russell%27%s
% 208.82/208.97 |- skos__hiddenLabel mesh__D017840 Russells Viper
% 208.82/208.97 |- skos__prefLabel mesh__D017840 Russell%27%s Viper
% 208.82/208.97 |- mesh__dateCreated mesh__D017840 1993-02-16
% 208.82/208.97 |- mesh__dateCreated mesh__D017042 1991-05-30
% 208.82/208.97 |- skos__annotation mesh__D017042
% 208.82/208.97 check the tags PREGNANCY %26% FEMALE; consider also PHENYLALANINE HYDROXYLASE /defic; DF: PKU MATERNAL%A%
% 208.82/208.97 |- skos__altLabel mesh__D017042 Maternal Phenylketonuria
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D017042 1992
% 208.82/208.97 |- rdf__type mesh__D017042sskos__Concept
% 208.82/208.97 |- skos__altLabel mesh__D017042 Pregnancy in Phenylketonuria
% 208.82/208.97 |- mesh__historyNote mesh__D017042 1992
% 208.82/208.97 |- skos__altLabel mesh__D017042
% 208.82/208.97 Phenylalanine-Hydroxylase Deficiency Disease, Maternal
% 208.82/208.97 |- skos__altLabel mesh__D017042 PKU, Maternal
% 208.82/208.97 |- skos__hiddenLabel mesh__D017042 Pregnancy in Phenylketonurias
% 208.82/208.97 |- skos__historyNote mesh__D017042 Phenylketonuria %28%1966-1991%29%
% 208.82/208.97 |- skos__altLabel mesh__D017042
% 208.82/208.97 Maternal Phenylalanine Hydroxylase Deficiency Disease
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D017042 sjn
% 208.82/208.97 |- mesh__recordOriginator mesh__D017042 PLS
% 208.82/208.97 |- skos__hiddenLabel mesh__D017042 in Phenylketonurias, Pregnancy
% 208.82/208.97 |- skos__hiddenLabel mesh__D017042 Phenylketonuria, Pregnancy in
% 208.82/208.97 |- skos__broader mesh__D017042smesh__D010661
% 208.82/208.97 |- skos__hiddenLabel mesh__D017042 in Phenylketonuria, Pregnancy
% 208.82/208.97 |- mesh__dateEstablished mesh__D017042 1992-01-01
% 208.82/208.97 |- skos__prefLabel mesh__D017042 Phenylketonuria, Maternal
% 208.82/208.97 |- skos__hiddenLabel mesh__D017042 Phenylketonurias, Pregnancy in
% 208.82/208.97 |- mesh__recordMaintainer mesh__D017042 lkt
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D017042 2006
% 208.82/208.97 |- mesh__dateRevised mesh__D017042 2005-06-30
% 208.82/208.97 |- skos__broader mesh__D017042smesh__D011248
% 208.82/208.97 |- skos__scopeNote mesh__D017042
% 208.82/208.97 A condition occurring in untreated or partially treated females with PHENYLKETONURIA when they become pregnant. This may result in damages to the FETUS, including MICROCEPHALY; MENTAL RETARDATION; congenital heart disease; FETAL GROWTH RETARDATION; and CRANIOFACIAL ABNORMALITIES. %28%From Am J Med Genet 1997 Mar 3;69%28%1%29%:89-95%29%%A%
% 208.82/208.97 |- skos__related mesh__D017042smesh__D010651
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 1996
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 1995
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 2004
% 208.82/208.97 |- skos__annotation mesh__D003820
% 208.82/208.97 D25-26 qualif; includes sonic-action cleansers
% 208.82/208.97 |- skos__broader mesh__D003820smesh__D003802
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 2000
% 208.82/208.97 |- skos__historyNote mesh__D003820 Oral Hygiene %28%1973-1978%29%
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D003820
% 208.82/208.97 91; was see under DENTIFRICES 1979-90
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 1994
% 208.82/208.97 |- skos__historyNote mesh__D003820 Dental Prosthesis %28%1966-1978%29%
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 2003
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D003820 PLS
% 208.82/208.97 |- mesh__dateCreated mesh__D003820 1977-12-08
% 208.82/208.97 |- rdf__type mesh__D003820sskos__Concept
% 208.82/208.97 |- skos__scopeNote mesh__D003820
% 208.82/208.97 Substances used to clean dentures; they are usually alkaline peroxides or hypochlorites, may contain enzymes and release oxygen. Use also for sonic action cleaners.%A%
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 1999
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 1993
% 208.82/208.97 |- skos__historyNote mesh__D003820 Dentifrices %28%1966-1978%29%
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 1998
% 208.82/208.97 |- skos__altLabel mesh__D003820 Cleansers, Denture
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 2006
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 1992
% 208.82/208.97 |- mesh__recordOriginator mesh__D003820 SH
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 2002
% 208.82/208.97 |- mesh__dateRevised mesh__D003820 1991-06-26
% 208.82/208.97 |- mesh__historyNote mesh__D003820
% 208.82/208.97 91%28%79%29%; was see under DENTIFRICES 1979-90
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 1997
% 208.82/208.97 |- mesh__recordMaintainer mesh__D003820 TAP
% 208.82/208.97 |- mesh__dateEstablished mesh__D003820 1991-01-01
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 2005
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003820 2001
% 208.82/208.97 |- skos__prefLabel mesh__D003820 Denture Cleansers
% 208.82/208.97 |- mesh__dateCreated mesh__D050476 2005-06-30
% 208.82/208.97 |- skos__altLabel mesh__D050476 Bowman%27%s Capsule
% 208.82/208.97 |- mesh__historyNote mesh__D050476 2006
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D050476 2006
% 208.82/208.97 |- mesh__recordMaintainer mesh__D050476 lkt
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D050476 sjn
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D050476 2006
% 208.82/208.97 |- rdf__type mesh__D050476sskos__Concept
% 208.82/208.97 |- skos__historyNote mesh__D050476 Kidney Tubules %28%1967-2005%29%
% 208.82/208.97 |- skos__hiddenLabel mesh__D050476 Capsule, Bowman
% 208.82/208.97 |- skos__prefLabel mesh__D050476 Bowman Capsule
% 208.82/208.97 |- skos__broader mesh__D050476smesh__D007684
% 208.82/208.97 |- skos__hiddenLabel mesh__D050476 Bowmans Capsule
% 208.82/208.97 |- mesh__dateEstablished mesh__D050476 2006-01-01
% 208.82/208.97 |- skos__scopeNote mesh__D050476
% 208.82/208.97 A double-walled epithelial capsule that is the bulbous closed proximal end of the kidney tubular system. It surrounds the cluster of convoluted capillaries of KIDNEY GLOMERULUS and is continuous with the convoluted PROXIMAL KIDNEY TUBULE.%A%
% 208.82/208.97 |- mesh__recordOriginator mesh__D050476 lkt
% 208.82/208.97 |- skos__hiddenLabel mesh__D050476 Capsule, Bowman%27%s
% 208.82/208.97 |- skos__historyNote mesh__D050476 Kidney Glomerulus %28%1966-2005%29%
% 208.82/208.97 |- skos__prefLabel mesh__D003022 Clotrimazole
% 208.82/208.97 |- mesh__recordMaintainer mesh__D003022 ssb
% 208.82/208.97 |- mesh__dateRevised mesh__D003022 2005-06-30
% 208.82/208.97 |- skos__hiddenLabel mesh__D003022 b 5097, Bay
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D003022 2006
% 208.82/208.97 |- skos__altLabel mesh__D003022 Kanesten
% 208.82/208.97 |- skos__altLabel mesh__D003022 Klotrimazole
% 208.82/208.97 |- skos__hiddenLabel mesh__D003022 5097, Bay b
% 208.82/208.97 |- skos__hiddenLabel mesh__D003022 b 5097, FB
% 208.82/208.97 |- mesh__historyNote mesh__D003022
% 208.82/208.97 91%28%75%29%; was see under IMIDAZOLES 1975-90
% 208.82/208.97 |- mesh__publicMeSHNote mesh__D003022
% 208.82/208.97 91; was see under IMIDAZOLES 1975-90
% 208.82/208.97 |- skos__scopeNote mesh__D003022
% 208.82/208.97 An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane.%A%
% 208.82/208.97 |- mesh__recordOriginator mesh__D003022 NLM
% 208.82/208.97 |- skos__historyNote mesh__D003022 Trityl Compounds %28%1974%29%
% 208.82/208.97 |- rdf__type mesh__D003022sskos__Concept
% 208.82/208.97 |- mesh__dateEstablished mesh__D003022 1991-01-01
% 208.82/208.97 |- skos__hiddenLabel mesh__D003022 5097, FB b
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D003022 sjn
% 208.82/208.97 |- mesh__dateCreated mesh__D003022 1974-11-11
% 208.82/208.97 |- skos__broader mesh__D003022smesh__D007093
% 208.82/208.97 |- skos__historyNote mesh__D003022 Imidazoles %28%1971-1974%29%
% 208.82/208.97 |- mesh__recordOriginator mesh__D016748 TGC
% 208.82/208.97 |- skos__scopeNote mesh__D016748
% 208.82/208.97 Creation of a small incised opening in a vein to permit the passage of a needle or cannula for withdrawal of blood, administration of medication, or in diagnostic or therapeutic catheterization. %28%Dorland, 28th ed.; Stedman, 26th ed.%29%%A%
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D016748 2003
% 208.82/208.97 |- skos__hiddenLabel mesh__D016748 Venostomies
% 208.82/208.97 |- skos__annotation mesh__D016748
% 208.82/208.97 usually for insertion of a catheter; do not use /util except by MeSH definition%A%
% 208.82/208.97 |- mesh__activeMeSHYear mesh__D016748 2001
% 208.82/208.97 |- mesh__dateRevised mesh__D016748 1997-06-20
% 208.82/208.97 |- mesh__recordAuthorizer mesh__D016748 SJN
% 208.82/208.97 |- skos__altLabel mesh__D016748 Cutdown, Venous
% 208.82/208.97 |- skos__hiddenLabel mesh__D016748 Vein Cutdowns
% 208.82/208.98 |- skos__altLabel mesh__D016748 Venostomy
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D016748 2006
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D016748 2000
% 208.82/208.98 |- rdf__type mesh__D016748sskos__Concept
% 208.82/208.98 |- mesh__publicMeSHNote mesh__D016748 92
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D016748 2005
% 208.82/208.98 |- skos__hiddenLabel mesh__D016748 Cutdowns, Vein
% 208.82/208.98 |- mesh__historyNote mesh__D016748 92
% 208.82/208.98 |- mesh__recordMaintainer mesh__D016748 PXP
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D016748 1999
% 208.82/208.98 |- skos__hiddenLabel mesh__D016748 Venous Cutdowns
% 208.82/208.98 |- skos__hiddenLabel mesh__D016748 Cutdowns, Venous
% 208.82/208.98 |- mesh__dateCreated mesh__D016748 1991-04-29
% 208.82/208.98 |- skos__broader mesh__D016748smesh__D014656
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D016748 2002
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D016748 1998
% 208.82/208.98 |- skos__altLabel mesh__D016748 Vein Cutdown
% 208.82/208.98 |- skos__hiddenLabel mesh__D016748 Cutdown, Vein
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D016748 2004
% 208.82/208.98 |- skos__prefLabel mesh__D016748 Venous Cutdown
% 208.82/208.98 |- mesh__dateEstablished mesh__D016748 1992-01-01
% 208.82/208.98 |- skos__broader mesh__D041141smesh__D012281
% 208.82/208.98 |- mesh__dateRevised mesh__D041141 2005-06-30
% 208.82/208.98 |- skos__scopeNote mesh__D041141
% 208.82/208.98 A species of gram-negative bacteria that causes rickettsialpox. The vector is a mouse mite and the reservoirs are mites and mice.%A%
% 208.82/208.98 |- skos__prefLabel mesh__D041141 Rickettsia akari
% 208.82/208.98 |- mesh__recordMaintainer mesh__D041141 SYSTEM
% 208.82/208.98 |- mesh__publicMeSHNote mesh__D041141 2003
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D041141 2006
% 208.82/208.98 |- rdf__type mesh__D041141sskos__Concept
% 208.82/208.98 |- mesh__dateCreated mesh__D041141 2002-07-03
% 208.82/208.98 |- skos__annotation mesh__D041141
% 208.82/208.98 infection: coord IM with RICKETTSIA INFECTIONS %28%IM%29%
% 208.82/208.98 |- mesh__historyNote mesh__D041141 2003
% 208.82/208.98 |- mesh__recordAuthorizer mesh__D041141 sjn
% 208.82/208.98 |- mesh__recordOriginator mesh__D041141 ags
% 208.82/208.98 |- mesh__dateEstablished mesh__D041141 2003-01-01
% 208.82/208.98 |- skos__historyNote mesh__D041141 Rickettsia %28%1972-2002%29%
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D002728 1999
% 208.82/208.98 |- mesh__recordMaintainer mesh__D002728 ADP
% 208.82/208.98 |- mesh__recordOriginator mesh__D002728 NLM
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D002728 2006
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D002728 1998
% 208.82/208.98 |- mesh__dateCreated mesh__D002728 1974-11-11
% 208.82/208.98 |- skos__scopeNote mesh__D002728
% 208.82/208.98 Any of the compounds derived from a group of glycols or polyhydroxy alcohols by chlorine substitution for part of the hydroxyl groups. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D002728 2001
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D002728 2004
% 208.82/208.98 |- mesh__recordAuthorizer mesh__D002728 SJN
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D002728 2000
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D002728 2005
% 208.82/208.98 |- skos__altLabel mesh__D002728 Chlorhydrins
% 208.82/208.98 |- skos__prefLabel mesh__D002728 Chlorohydrins
% 208.82/208.98 |- rdf__type mesh__D002728sskos__Concept
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D002728 2003
% 208.82/208.98 |- mesh__publicMeSHNote mesh__D002728 75
% 208.82/208.98 |- mesh__historyNote mesh__D002728 75
% 208.82/208.98 |- mesh__dateEstablished mesh__D002728 1975-09-01
% 208.82/208.98 |- skos__broader mesh__D002728smesh__D000438
% 208.82/208.98 |- mesh__dateRevised mesh__D002728 1997-06-20
% 208.82/208.98 |- skos__historyNote mesh__D002728 Alcohols %28%1966-1974%29%
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D002728 2002
% 208.82/208.98 |- skos__prefLabel mesh__D013450 Sulfones
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 1996
% 208.82/208.98 |- mesh__recordMaintainer mesh__D013450 TGC
% 208.82/208.98 |- mesh__dateRevised mesh__D013450 1992-05-20
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 1998
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 2002
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 1997
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 1994
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 1999
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 1993
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 2003
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 1995
% 208.82/208.98 |- mesh__dateCreated mesh__D013450 1999-01-01
% 208.82/208.98 |- rdf__type mesh__D013450sskos__Concept
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 2005
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 2000
% 208.82/208.98 |- mesh__recordOriginator mesh__D013450 NLM
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 2004
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 2001
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D013450 2006
% 208.82/208.98 |- mesh__recordAuthorizer mesh__D013450 PLS
% 208.82/208.98 |- skos__broader mesh__D013450smesh__D013457
% 208.82/208.98 |- skos__broader mesh__D007413smesh__D007422
% 208.82/208.98 |- skos__related mesh__D007413smesh__D007419
% 208.82/208.98 |- skos__hiddenLabel mesh__D007413 Gland, Intestinal
% 208.82/208.98 |- mesh__publicMeSHNote mesh__D007413 67
% 208.82/208.98 |- mesh__recordOriginator mesh__D007413 NLM
% 208.82/208.98 |- skos__scopeNote mesh__D007413
% 208.82/208.98 Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells %28%ENTEROCYTES%29% with MICROVILLI.%A%
% 208.82/208.98 |- skos__annotation mesh__D007413
% 208.82/208.98 /cytol: consider also specific cell types available in MeSH; for X ref INTESTINAL EPITHELIUM, do not routinely coordinate with EPITHELIUM unless it is specifically discussed%A%
% 208.82/208.98 |- skos__hiddenLabel mesh__D007413 Epithelium, Intestinal
% 208.82/208.98 |- mesh__recordAuthorizer mesh__D007413 sjn
% 208.82/208.98 |- mesh__dateCreated mesh__D007413 1999-01-01
% 208.82/208.98 |- rdf__type mesh__D007413sskos__Concept
% 208.82/208.98 |- mesh__recordMaintainer mesh__D007413 lkt
% 208.82/208.98 |- skos__hiddenLabel mesh__D007413 Mucosa, Intestinal
% 208.82/208.98 |- skos__broader mesh__D007413smesh__D009092
% 208.82/208.98 |- skos__hiddenLabel mesh__D007413 Intestinal Gland
% 208.82/208.98 |- skos__prefLabel mesh__D007413 Intestinal Mucosa
% 208.82/208.98 |- mesh__dateEstablished mesh__D007413 1967-01-01
% 208.82/208.98 |- skos__hiddenLabel mesh__D007413 Glands, Intestinal
% 208.82/208.98 |- mesh__activeMeSHYear mesh__D007413 2006
% 208.83/208.98 |- mesh__historyNote mesh__D007413 67%28%65%29%
% 208.83/208.98 |- mesh__dateRevised mesh__D007413 2005-06-30
% 208.83/208.98 |- skos__hiddenLabel mesh__D012358 RNA, Met Transfer
% 208.83/208.98 |- skos__annotation mesh__D012358
% 208.83/208.98 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.83/208.98 |- skos__historyNote mesh__D012358 RNA, Transfer %28%1966-1987%29%
% 208.83/208.98 |- skos__altLabel mesh__D012358 Methionine-Specific tRNA
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D012358 2003
% 208.83/208.98 |- skos__altLabel mesh__D012358 tRNA%28%Met%29%
% 208.83/208.98 |- skos__altLabel mesh__D012358 Initiator tRNA
% 208.83/208.98 |- mesh__recordMaintainer mesh__D012358 nns
% 208.83/208.98 |- skos__historyNote mesh__D012358 Amino Acyl T RNA %28%1978-1987%29%
% 208.83/208.98 |- skos__hiddenLabel mesh__D012358 tRNA, Initiator
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D012358 2004
% 208.83/208.98 |- skos__altLabel mesh__D012358 Transfer RNA, Met
% 208.83/208.98 |- mesh__historyNote mesh__D012358
% 208.83/208.98 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.83/208.98 |- mesh__dateCreated mesh__D012358 1987-05-07
% 208.83/208.98 |- skos__prefLabel mesh__D012358 RNA, Transfer, Met
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D012358 2001
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D012358 sjn
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D012358 2005
% 208.83/208.98 |- mesh__recordOriginator mesh__D012358 RLS
% 208.83/208.98 |- mesh__dateRevised mesh__D012358 2000-06-22
% 208.83/208.98 |- skos__hiddenLabel mesh__D012358 tRNAm, Methionine-Specific
% 208.83/208.98 |- skos__altLabel mesh__D012358 tRNAMet
% 208.83/208.98 |- skos__altLabel mesh__D012358 Methionine-Specific tRNAm
% 208.83/208.98 |- skos__hiddenLabel mesh__D012358 Methionine Specific tRNA
% 208.83/208.98 |- skos__broader mesh__D012358smesh__D012345
% 208.83/208.98 |- mesh__publicMeSHNote mesh__D012358
% 208.83/208.98 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D012358 2002
% 208.83/208.98 |- skos__hiddenLabel mesh__D012358 tRNA, Methionine-Specific
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D012358 2006
% 208.83/208.98 |- rdf__type mesh__D012358sskos__Concept
% 208.83/208.98 |- skos__hiddenLabel mesh__D012358 Met Transfer RNA
% 208.83/208.98 |- skos__scopeNote mesh__D012358
% 208.83/208.98 A transfer RNA which is specific for carrying methionine to sites on the ribosomes. During initiation of protein synthesis, tRNA%28%f%29%Met in prokaryotic cells and tRNA%28%i%29%Met in eukaryotic cells binds to the start codon %28%CODON, INITIATOR%29%.%A%
% 208.83/208.98 |- mesh__dateEstablished mesh__D012358 1991-01-01
% 208.83/208.98 |- skos__hiddenLabel mesh__D012358 Methionine Specific tRNAm
% 208.83/208.98 |- mesh__dateRevised mesh__D017841 2003-07-09
% 208.83/208.98 |- skos__annotation mesh__D017841
% 208.83/208.98 a genus of vipers; its venom: coord IM with CROTALID VENOMS %28%IM%29%%A%
% 208.83/208.98 |- skos__broader mesh__D017841smesh__D017819
% 208.83/208.98 |- skos__hiddenLabel mesh__D017841 Habus
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017841 2004
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017841 2006
% 208.83/208.98 |- mesh__publicMeSHNote mesh__D017841 94
% 208.83/208.98 |- rdf__type mesh__D017841sskos__Concept
% 208.83/208.98 |- mesh__dateEstablished mesh__D017841 1994-01-01
% 208.83/208.98 |- mesh__historyNote mesh__D017841 94
% 208.83/208.98 |- mesh__recordOriginator mesh__D017841 TGC
% 208.83/208.98 |- skos__scopeNote mesh__D017841
% 208.83/208.98 A genus of snakes of the family VIPERIDAE. About 30 species are currently recognized, found in southeast Asia and adjacent island chains. The Okinawa habu frequently enters dwellings in search of rats and mice; the Chinese habu is often found in suburban and agricultural areas. They are quite irritable. %28%Moore: Poisonous Snakes of the World, 1980, p136%29%%A%
% 208.83/208.98 |- skos__historyNote mesh__D017841 Snakes %28%1966-1993%29%
% 208.83/208.98 |- skos__altLabel mesh__D017841 Habu
% 208.83/208.98 |- skos__prefLabel mesh__D017841 Trimeresurus
% 208.83/208.98 |- mesh__dateCreated mesh__D017841 1993-02-16
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D017841 sjn
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017841 2005
% 208.83/208.98 |- mesh__recordMaintainer mesh__D017841 ags
% 208.83/208.98 |- skos__altLabel mesh__D017043 Meibomian Cyst
% 208.83/208.98 |- mesh__recordOriginator mesh__D017043 PLS
% 208.83/208.98 |- mesh__dateRevised mesh__D017043 1999-11-03
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017043 2001
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017043 2005
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017043 2002
% 208.83/208.98 |- skos__historyNote mesh__D017043 Meibomian Glands %28%1975-1990%29%
% 208.83/208.98 |- skos__scopeNote mesh__D017043
% 208.83/208.98 A non-neoplastic cyst of the MEIBOMIAN GLANDS of the eyelid.%A%
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017043 2006
% 208.83/208.98 |- skos__hiddenLabel mesh__D017043 Cyst, Meibomian
% 208.83/208.98 |- skos__historyNote mesh__D017043 Cysts %28%1966-1991%29%
% 208.83/208.98 |- skos__historyNote mesh__D017043 Eyelid Diseases %28%1970-1991%29%
% 208.83/208.98 |- mesh__publicMeSHNote mesh__D017043 92
% 208.83/208.98 |- skos__prefLabel mesh__D017043 Chalazion
% 208.83/208.98 |- rdf__type mesh__D017043sskos__Concept
% 208.83/208.98 |- skos__broader mesh__D017043smesh__D003560
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017043 2003
% 208.83/208.98 |- mesh__dateCreated mesh__D017043 1991-05-30
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D017043 sjn
% 208.83/208.98 |- mesh__dateEstablished mesh__D017043 1992-01-01
% 208.83/208.98 |- skos__hiddenLabel mesh__D017043 Chalazions
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017043 2000
% 208.83/208.98 |- mesh__historyNote mesh__D017043 92
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D017043 2004
% 208.83/208.98 |- skos__broader mesh__D017043smesh__D005141
% 208.83/208.98 |- mesh__recordMaintainer mesh__D017043 KEV
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 2005
% 208.83/208.98 |- mesh__dateRevised mesh__D003821 1992-05-18
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 2000
% 208.83/208.98 |- skos__prefLabel mesh__D003821 Denture Identification Marking
% 208.83/208.98 |- mesh__recordMaintainer mesh__D003821 MXR
% 208.83/208.98 |- skos__hiddenLabel mesh__D003821 Identification Marking, Denture
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 2004
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D003821 PLS
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 1995
% 208.83/208.98 |- rdf__type mesh__D003821sskos__Concept
% 208.83/208.98 |- skos__hiddenLabel mesh__D003821 Denture Identification Markings
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 2003
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 1999
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 1994
% 208.83/208.98 |- mesh__recordOriginator mesh__D003821 RC
% 208.83/208.98 |- skos__hiddenLabel mesh__D003821 Marking, Denture Identification
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 1998
% 208.83/208.98 |- skos__hiddenLabel mesh__D003821 Identification Markings, Denture
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 1993
% 208.83/208.98 |- skos__broader mesh__D003821smesh__D013674
% 208.83/208.98 |- mesh__dateCreated mesh__D003821 1983-04-21
% 208.83/208.98 |- skos__annotation mesh__D003821 marking of dentures or dent prostheses
% 208.83/208.98 |- mesh__historyNote mesh__D003821 84
% 208.83/208.98 |- skos__hiddenLabel mesh__D003821 Markings, Denture Identification
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 1997
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 2002
% 208.83/208.98 |- skos__historyNote mesh__D003821 Denture, Complete %28%1966-1983%29%
% 208.83/208.98 |- skos__historyNote mesh__D003821 Forensic Dentistry %28%1966-1983%29%
% 208.83/208.98 |- mesh__publicMeSHNote mesh__D003821 84
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 2006
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 1996
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003821 2001
% 208.83/208.98 |- mesh__dateEstablished mesh__D003821 1984-01-01
% 208.83/208.98 |- skos__scopeNote mesh__D003821
% 208.83/208.98 Any system of defining ownership of dentures or dental prostheses.%A%
% 208.83/208.98 |- skos__hiddenLabel mesh__D050477 Urinary Human FSH
% 208.83/208.98 |- skos__historyNote mesh__D050477 Menotropins %28%1998-2005%29%
% 208.83/208.98 |- skos__hiddenLabel mesh__D050477 FSH, Urinary Human
% 208.83/208.98 |- skos__altLabel mesh__D050477 Follicle-Stimulating Hormone, Human Urine
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D050477 2006
% 208.83/208.98 |- skos__hiddenLabel mesh__D050477
% 208.83/208.98 Follicle Stimulating Hormone, Human Urine
% 208.83/208.98 |- skos__historyNote mesh__D050477
% 208.83/208.98 Follicle Stimulating Hormone %28%1993-2005%29%
% 208.83/208.98 |- rdf__type mesh__D050477sskos__Concept
% 208.83/208.98 |- mesh__dateCreated mesh__D050477 2005-06-30
% 208.83/208.98 |- skos__scopeNote mesh__D050477
% 208.83/208.98 A protein extract of human menopausal urine in which LUTEINIZING HORMONE has been partially or completely removed. Urofollitropin represents FOLLICLE STIMULATING HORMONE from the urine. In highly purified preparations, LH and other urinary proteins are removed.%A%
% 208.83/208.98 |- mesh__recordMaintainer mesh__D050477 lkt
% 208.83/208.98 |- mesh__historyNote mesh__D050477 2006; use MENOTROPINS 1998-2005
% 208.83/208.98 |- mesh__recordOriginator mesh__D050477 lkt
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D050477 sjn
% 208.83/208.98 |- mesh__publicMeSHNote mesh__D050477 2006; see MENOTROPINS 1998-2005
% 208.83/208.98 |- skos__prefLabel mesh__D050477 Urofollitropin
% 208.83/208.98 |- skos__broader mesh__D050477smesh__D008596
% 208.83/208.98 |- mesh__dateEstablished mesh__D050477 2006-01-01
% 208.83/208.98 |- skos__altLabel mesh__D050477 Human FSH, Urinary
% 208.83/208.98 |- skos__altLabel mesh__D003023 Chloroxacillin
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003023 2006
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D003023 sjn
% 208.83/208.98 |- skos__broader mesh__D003023smesh__D010068
% 208.83/208.98 |- skos__hiddenLabel mesh__D003023 Cloxacillin, Sodium
% 208.83/208.98 |- mesh__recordMaintainer mesh__D003023 ssb
% 208.83/208.98 |- mesh__dateEstablished mesh__D003023 1967-01-01
% 208.83/208.98 |- skos__prefLabel mesh__D003023 Cloxacillin
% 208.83/208.98 |- mesh__historyNote mesh__D003023 67%28%65%29%
% 208.83/208.98 |- skos__hiddenLabel mesh__D003023 Sodium, Cloxacillin
% 208.83/208.98 |- rdf__type mesh__D003023sskos__Concept
% 208.83/208.98 |- mesh__recordOriginator mesh__D003023 NLM
% 208.83/208.98 |- skos__scopeNote mesh__D003023
% 208.83/208.98 A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN.%A%
% 208.83/208.98 |- mesh__dateCreated mesh__D003023 1999-01-01
% 208.83/208.98 |- mesh__dateRevised mesh__D003023 2004-07-07
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D003023 2005
% 208.83/208.98 |- skos__altLabel mesh__D003023 Sodium Cloxacillin
% 208.83/208.98 |- mesh__publicMeSHNote mesh__D003023 67
% 208.83/208.98 |- skos__scopeNote mesh__D016749
% 208.83/208.98 A databank established by the Health Care Quality Improvement Act of 1986 authorizing the Department of Health and Human Services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians%27% malpractice, licensure, hospital privileges, concealing of pertinent information, and the like.%A%
% 208.83/208.98 |- skos__historyNote mesh__D016749 Malpractice %28%1989-1991%29%
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D016749 sjn
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D016749 2005
% 208.83/208.98 |- mesh__dateEstablished mesh__D016749 1992-01-01
% 208.83/208.98 |- skos__annotation mesh__D016749
% 208.83/208.98 add UNITED STATES %28%NIM%29% CATALOG: use NAF entry
% 208.83/208.98 |- skos__hiddenLabel mesh__D016749 Databank, National Practitioner
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D016749 2006
% 208.83/208.98 |- mesh__dateCreated mesh__D016749 1991-04-29
% 208.83/208.98 |- skos__hiddenLabel mesh__D016749 National Practitioner Databanks
% 208.83/208.98 |- skos__hiddenLabel mesh__D016749 Databanks, National Practitioner
% 208.83/208.98 |- mesh__recordOriginator mesh__D016749 TGC
% 208.83/208.98 |- skos__hiddenLabel mesh__D016749 Practitioner Databank, National
% 208.83/208.98 |- rdf__type mesh__D016749sskos__Concept
% 208.83/208.98 |- skos__hiddenLabel mesh__D016749 Practitioner Databanks, National
% 208.83/208.98 |- mesh__historyNote mesh__D016749 92
% 208.83/208.98 |- mesh__dateRevised mesh__D016749 2004-07-13
% 208.83/208.98 |- skos__historyNote mesh__D016749 Information Systems %28%1989-1991%29%
% 208.83/208.98 |- skos__altLabel mesh__D016749 National Practitioner Databank
% 208.83/208.98 |- mesh__recordMaintainer mesh__D016749 sjn
% 208.83/208.98 |- skos__broader mesh__D016749smesh__D016208
% 208.83/208.98 |- mesh__publicMeSHNote mesh__D016749 92
% 208.83/208.98 |- skos__prefLabel mesh__D016749 National Practitioner Data Bank
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D002729 2006
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D002729 2002
% 208.83/208.98 |- mesh__publicMeSHNote mesh__D002729 66
% 208.83/208.98 |- mesh__dateRevised mesh__D002729 1998-06-10
% 208.83/208.98 |- mesh__dateEstablished mesh__D002729 1966-01-01
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D002729 2005
% 208.83/208.98 |- skos__annotation mesh__D002729
% 208.83/208.98 P-CHLOROMERCURIBENZOIC ACID is available
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D002729 2004
% 208.83/208.98 |- skos__prefLabel mesh__D002729 Chloromercuribenzoates
% 208.83/208.98 |- mesh__historyNote mesh__D002729 66%28%64%29%
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D002729 2003
% 208.83/208.98 |- rdf__type mesh__D002729sskos__Concept
% 208.83/208.98 |- mesh__recordOriginator mesh__D002729 NLM
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D002729 2001
% 208.83/208.98 |- skos__scopeNote mesh__D002729
% 208.83/208.98 Chloride and mercury-containing derivatives of benzoic acid.%A%
% 208.83/208.98 |- skos__historyNote mesh__D002729 Benzoates %28%1966%29%
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D002729 SJN
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D002729 2000
% 208.83/208.98 |- skos__broader mesh__D002729smesh__D008626
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D002729 1999
% 208.83/208.98 |- mesh__dateCreated mesh__D002729 1999-01-01
% 208.83/208.98 |- mesh__recordMaintainer mesh__D002729 ADP
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 2000
% 208.83/208.98 |- mesh__recordOriginator mesh__D013451 NLM
% 208.83/208.98 |- rdf__type mesh__D013451sskos__Concept
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 2003
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 1995
% 208.83/208.98 |- mesh__dateCreated mesh__D013451 1999-01-01
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 2001
% 208.83/208.98 |- skos__prefLabel mesh__D013451 Sulfonic Acids
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 2005
% 208.83/208.98 |- skos__annotation mesh__D013451 do not confuse with SULFINIC ACIDS
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D013451 PLS
% 208.83/208.98 |- skos__scopeNote mesh__D013451
% 208.83/208.98 Inorganic or organic oxy acids of sulfur which contain the RSO2%28%OH%29% radical.%A%
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 2004
% 208.83/208.98 |- skos__hiddenLabel mesh__D013451 Acids, Sulfonic
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 2006
% 208.83/208.98 |- mesh__dateRevised mesh__D013451 1993-06-04
% 208.83/208.98 |- mesh__recordMaintainer mesh__D013451 TPW
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 2002
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 1996
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 1998
% 208.83/208.98 |- skos__broader mesh__D013451smesh__D013456
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 1997
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 1994
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D013451 1999
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Intestinal Cancers
% 208.83/208.98 |- skos__altLabel mesh__D007414 Neoplasms, Intestinal
% 208.83/208.98 |- mesh__dateRevised mesh__D007414 2003-07-09
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D007414 2004
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Neoplasm, Intestines
% 208.83/208.98 |- mesh__recordMaintainer mesh__D007414 lkt
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Intestines Cancers
% 208.83/208.98 |- skos__scopeNote mesh__D007414 Tumors or cancer of the INTESTINES.
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Cancer, Intestinal
% 208.83/208.98 |- skos__broader mesh__D007414smesh__D007410
% 208.83/208.98 |- rdf__type mesh__D007414sskos__Concept
% 208.83/208.98 |- skos__annotation mesh__D007414
% 208.83/208.98 GEN: prefer specific precoord; coord IM with histol type of neopl %28%IM%29%%A%
% 208.83/208.98 |- skos__broader mesh__D007414smesh__D005770
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Neoplasm, Intestinal
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Intestinal Neoplasm
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Cancers, Intestinal
% 208.83/208.98 |- skos__altLabel mesh__D007414 Cancer of the Intestines
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Intestines Neoplasm
% 208.83/208.98 |- skos__altLabel mesh__D007414 Intestines Neoplasms
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Cancers, Intestines
% 208.83/208.98 |- mesh__recordOriginator mesh__D007414 NLM
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D007414 2005
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D007414 sjn
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Neoplasms, Intestines
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D007414 2006
% 208.83/208.98 |- skos__prefLabel mesh__D007414 Intestinal Neoplasms
% 208.83/208.98 |- skos__altLabel mesh__D007414 Intestinal Cancer
% 208.83/208.98 |- skos__altLabel mesh__D007414 Intestines Cancer
% 208.83/208.98 |- skos__hiddenLabel mesh__D007414 Cancer, Intestines
% 208.83/208.98 |- mesh__dateCreated mesh__D007414 1999-01-01
% 208.83/208.98 |- skos__altLabel mesh__D012359 T RNA Methyltransferases
% 208.83/208.98 |- mesh__recordAuthorizer mesh__D012359 sjn
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D012359 2004
% 208.83/208.98 |- mesh__dateCreated mesh__D012359 1999-01-01
% 208.83/208.98 |- mesh__recordOriginator mesh__D012359 NLM
% 208.83/208.98 |- mesh__publicMeSHNote mesh__D012359
% 208.83/208.98 98; see RNA, TRANSFER, METHYLTRANSFERASES 1974-97
% 208.83/208.98 |- skos__scopeNote mesh__D012359
% 208.83/208.98 Enzymes that catalyze the S-adenosyl-L-methionine-dependent methylation of ribonucleotide bases within a transfer RNA molecule. EC 2.1.1.%A%
% 208.83/208.98 |- skos__annotation mesh__D012359 DF: note short X ref
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D012359 2005
% 208.83/208.98 |- skos__hiddenLabel mesh__D012359 Methyltransferases, tRNA
% 208.83/208.98 |- skos__altLabel mesh__D012359 RNA Methylases
% 208.83/208.98 |- mesh__historyNote mesh__D012359 98%28%74%29%
% 208.83/208.98 |- mesh__recordMaintainer mesh__D012359 ssb
% 208.83/208.98 |- mesh__activeMeSHYear mesh__D012359 2006
% 208.83/208.98 |- rdf__type mesh__D012359sskos__Concept
% 208.83/208.98 |- skos__broader mesh__D012359smesh__D008780
% 208.83/208.98 |- skos__altLabel mesh__D012359 RNA, Transfer, Methyltransferases
% 208.83/208.98 |- mesh__dateRevised mesh__D012359 2003-07-09
% 208.83/208.98 |- skos__prefLabel mesh__D012359 tRNA Methyltransferases
% 208.83/208.98 |- skos__hiddenLabel mesh__D012359 RNA Methyltransferases, T
% 208.83/208.98 |- skos__hiddenLabel mesh__D012359 Methylases, RNA
% 208.83/208.98 |- mesh__dateEstablished mesh__D012359 1974-01-01
% 208.83/208.98 |- skos__hiddenLabel mesh__D012359 Methyltransferases, T RNA
% 208.83/208.98 |- skos__hiddenLabel mesh__D023081 CBF Protein, CCAAT Binding
% 208.83/208.98 |- skos__altLabel mesh__D023081 CCAAT-Binding-Factor
% 208.83/208.99 |- skos__altLabel mesh__D023081 CBF-B Protein, CCAAT-Binding
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT-Binding CBF-A Protein
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CBF C Protein, CCAAT Binding
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT-Binding CBF Protein
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT Binding Factor, A Subunit
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT Binding Transcription Factor
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT-Binding CBF-C Protein
% 208.83/208.99 |- skos__altLabel mesh__D023081 CBF Protein, CCAAT-Binding
% 208.83/208.99 |- skos__altLabel mesh__D023081 CBF-C Protein, CCAAT-Binding
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 Transcription Factor, CCAAT-Binding
% 208.83/208.99 |- mesh__historyNote mesh__D023081
% 208.83/208.99 2001; use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1988-2000
% 208.83/208.99 |- skos__altLabel mesh__D023081 CBF-A Protein, CCAAT-Binding
% 208.83/208.99 |- mesh__recordOriginator mesh__D023081 jmp
% 208.83/208.99 |- skos__historyNote mesh__D023081 DNA-Binding Proteins %28%1988-2000%29%
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CBF B Protein, CCAAT Binding
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT Binding Factor, B Subunit
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D023081 2006
% 208.83/208.99 |- mesh__dateRevised mesh__D023081 2005-06-30
% 208.83/208.99 |- skos__prefLabel mesh__D023081 CCAAT-Binding Factor
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 Factor, A-Subunit CCAAT-Binding
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CBF A Protein, CCAAT Binding
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT-Binding CBF-B Protein
% 208.83/208.99 |- rdf__type mesh__D023081sskos__Concept
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 NF Y Protein
% 208.83/208.99 |- skos__altLabel mesh__D023081 CCAAT-Binding Protein, CP1
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 Factor, C-Subunit CCAAT-Binding
% 208.83/208.99 |- skos__altLabel mesh__D023081 CCAAT-Binding Transcription Factor
% 208.83/208.99 |- skos__broader mesh__D023081smesh__D022762
% 208.83/208.99 |- mesh__dateCreated mesh__D023081 2000-06-23
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 Protein, NF-Y
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D023081 sjn
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT Binding Factor, C Subunit
% 208.83/208.99 |- skos__scopeNote mesh__D023081
% 208.83/208.99 A heterotrimeric DNA-binding protein that binds to CCAAT motifs in the promoters of eukaryotic genes. It is composed of three subunits: A, B and C.%A%
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT Binding Protein, CP1
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D023081
% 208.83/208.99 2001; CCAAT-BINDING FACTOR was indexed under DNA-BINDING PROTEINS 1988-2000%A%
% 208.83/208.99 |- mesh__recordMaintainer mesh__D023081 DRC
% 208.83/208.99 |- mesh__dateEstablished mesh__D023081 2001-01-01
% 208.83/208.99 |- skos__altLabel mesh__D023081 NF-Y Protein
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 Factor, B-Subunit CCAAT-Binding
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CP1 CCAAT-Binding Protein
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 Protein, CCAAT-Binding CBF-A
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 Protein, CCAAT-Binding CBF-B
% 208.83/208.99 |- skos__hiddenLabel mesh__D023081 CCAAT Binding Factor
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Cobra, Asiatic
% 208.83/208.99 |- rdf__type mesh__D017842sskos__Concept
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D017842 sjn
% 208.83/208.99 |- skos__broader mesh__D017842smesh__D017815
% 208.83/208.99 |- skos__related mesh__D017842smesh__D003040
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Cobra, Water
% 208.83/208.99 |- skos__altLabel mesh__D017842 Egyptian Cobra
% 208.83/208.99 |- skos__scopeNote mesh__D017842
% 208.83/208.99 A genus of poisonous snakes of the subfamily Elapinae of the family ELAPIDAE. There are six recognized species, all inhabiting Africa except the Asiatic %28%Indian%29% cobra, Naja naja. Some species %22%spit%22% their venom into the eyes of their %22%enemies%22%. So-called spitting cobras show a high degree of accuracy in aiming for the eyes. The ringhals, the most highly specialized of the spitting cobras, is limited to southern Africa. Its spray destroys eye tissue and can cause blindness; its bite can cause death. %28%Moore: Poisonous Snakes of the World, 1980, p80%29%%A%
% 208.83/208.99 |- mesh__historyNote mesh__D017842 94
% 208.83/208.99 |- skos__prefLabel mesh__D017842 Cobra
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Cobras
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D017842 94
% 208.83/208.99 |- skos__historyNote mesh__D017842 Snakes %28%1966-1993%29%
% 208.83/208.99 |- skos__altLabel mesh__D017842 Asiatic Cobra
% 208.83/208.99 |- skos__altLabel mesh__D017842 Haemachatus
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Water Cobras
% 208.83/208.99 |- mesh__dateEstablished mesh__D017842 1994-01-01
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Egyptian Cobras
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Cobras, Egyptian
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Cobras, Asiatic
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Cobra, Egyptian
% 208.83/208.99 |- mesh__dateCreated mesh__D017842 1993-02-16
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017842 2005
% 208.83/208.99 |- mesh__recordOriginator mesh__D017842 TGC
% 208.83/208.99 |- skos__annotation mesh__D017842 a genus of poisonous snakes
% 208.83/208.99 |- mesh__recordMaintainer mesh__D017842 ags
% 208.83/208.99 |- mesh__dateRevised mesh__D017842 2003-07-09
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017842 2004
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Asiatic Cobras
% 208.83/208.99 |- skos__altLabel mesh__D017842 Water Cobra
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017842 2006
% 208.83/208.99 |- skos__hiddenLabel mesh__D017842 Cobras, Water
% 208.83/208.99 |- skos__altLabel mesh__D017842 Ringhals
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D017044 sjn
% 208.83/208.99 |- mesh__dateEstablished mesh__D017044 1992-01-01
% 208.83/208.99 |- skos__altLabel mesh__D017044 ARPKD
% 208.83/208.99 |- skos__altLabel mesh__D017044
% 208.83/208.99 Autosomal Recessive Polycystic Kidney Disease
% 208.83/208.99 |- mesh__recordMaintainer mesh__D017044 lkt
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017044 2006
% 208.83/208.99 |- skos__altLabel mesh__D017044
% 208.83/208.99 Polycystic Kidney Disease, Infantile, Type I
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D017044
% 208.83/208.99 1992; see KIDNEY, POLYCYCSTIC, AUTOSOMAL RECESSIVE 1992-2000%A%
% 208.83/208.99 |- skos__broader mesh__D017044smesh__D007690
% 208.83/208.99 |- skos__altLabel mesh__D017044 Autosomal Recessive Polycystic Kidney
% 208.83/208.99 |- skos__scopeNote mesh__D017044
% 208.83/208.99 A genetic disorder with autosomal recessive inheritance, characterized by multiple CYSTS in both KIDNEYS and associated LIVER lesions. Serious manifestations are usually present at BIRTH with high PERINATAL MORTALITY.%A%
% 208.83/208.99 |- mesh__dateRevised mesh__D017044 2005-06-30
% 208.83/208.99 |- rdf__type mesh__D017044sskos__Concept
% 208.83/208.99 |- skos__prefLabel mesh__D017044 Polycystic Kidney, Autosomal Recessive
% 208.83/208.99 |- mesh__dateCreated mesh__D017044 1991-05-30
% 208.83/208.99 |- mesh__recordOriginator mesh__D017044 AGS
% 208.83/208.99 |- skos__historyNote mesh__D017044 Kidney, Polycystic %28%1966-1991%29%
% 208.83/208.99 |- mesh__historyNote mesh__D017044 1992
% 208.83/208.99 |- skos__altLabel mesh__D017044
% 208.83/208.99 Polycystic Kidney and Hepatic Disease 1 %28%Autosomal Recessive%29%
% 208.83/208.99 |- skos__altLabel mesh__D017044 Kidney, Polycystic, Autosomal Recessive
% 208.83/208.99 |- skos__hiddenLabel mesh__D003822 Liners, Denture
% 208.83/208.99 |- rdf__type mesh__D003822sskos__Concept
% 208.83/208.99 |- skos__related mesh__D003822smesh__D012826
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003822 2001
% 208.83/208.99 |- mesh__dateCreated mesh__D003822 1999-01-01
% 208.83/208.99 |- mesh__recordMaintainer mesh__D003822 PXP
% 208.83/208.99 |- skos__hiddenLabel mesh__D003822 Denture Liner
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003822 2003
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003822 1999
% 208.83/208.99 |- skos__broader mesh__D003822smesh__D003778
% 208.83/208.99 |- mesh__recordOriginator mesh__D003822 NLM
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003822 2000
% 208.83/208.99 |- skos__scopeNote mesh__D003822
% 208.83/208.99 Material applied to the tissue side of a denture to provide a soft lining to the parts of a denture coming in contact with soft tissue. It cushions contact of the denture with the tissues.%A%
% 208.83/208.99 |- mesh__dateRevised mesh__D003822 1997-06-20
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003822 1998
% 208.83/208.99 |- mesh__dateEstablished mesh__D003822 1965-01-01
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D003822 65
% 208.83/208.99 |- skos__prefLabel mesh__D003822 Denture Liners
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003822 2006
% 208.83/208.99 |- skos__altLabel mesh__D003822 Cushion Liners
% 208.83/208.99 |- mesh__historyNote mesh__D003822 65
% 208.83/208.99 |- skos__annotation mesh__D003822
% 208.83/208.99 coord IM with specific denture term %28%IM or NIM%29%
% 208.83/208.99 |- skos__hiddenLabel mesh__D003822 Liner, Denture
% 208.83/208.99 |- skos__hiddenLabel mesh__D003822 Liners, Cushion
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003822 2005
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D003822 SJN
% 208.83/208.99 |- skos__hiddenLabel mesh__D003822 Liner, Cushion
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003822 2002
% 208.83/208.99 |- skos__hiddenLabel mesh__D003822 Cushion Liner
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003822 2004
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D003024
% 208.83/208.99 91; was see under DIBENZAZEPINES 1975-90
% 208.83/208.99 |- rdf__type mesh__D003024sskos__Concept
% 208.83/208.99 |- mesh__recordOriginator mesh__D003024 NLM
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003024 2002
% 208.83/208.99 |- skos__scopeNote mesh__D003024
% 208.83/208.99 A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.%A%
% 208.83/208.99 |- mesh__dateEstablished mesh__D003024 1991-01-01
% 208.83/208.99 |- skos__broader mesh__D003024smesh__D003984
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003024 2005
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D003024 sjn
% 208.83/208.99 |- skos__prefLabel mesh__D003024 Clozapine
% 208.83/208.99 |- skos__historyNote mesh__D003024 Dibenzazepines %28%1971-1974%29%
% 208.83/208.99 |- mesh__recordMaintainer mesh__D003024 TWD
% 208.83/208.99 |- mesh__dateCreated mesh__D003024 1974-11-19
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003024 2003
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003024 2006
% 208.83/208.99 |- skos__historyNote mesh__D003024 Piperazines %28%1971-1974%29%
% 208.83/208.99 |- mesh__dateRevised mesh__D003024 2000-06-21
% 208.83/208.99 |- mesh__historyNote mesh__D003024
% 208.83/208.99 91%28%75%29%; was see under DIBENZAZEPINES 1975-90
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003024 2004
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003024 2001
% 208.83/208.99 |- mesh__dateCreated mesh__D041941 2003-07-09
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D041941 2004
% 208.83/208.99 |- skos__broader mesh__D041941smesh__D001628
% 208.83/208.99 |- skos__hiddenLabel mesh__D041941 Milk Substitute
% 208.83/208.99 |- skos__scopeNote mesh__D041941
% 208.83/208.99 Food BEVERAGES that are used as nutritional substitutes for MILK.%A%
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D041941 2005
% 208.83/208.99 |- mesh__dateEstablished mesh__D041941 2004-01-01
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D041941 2006
% 208.83/208.99 |- skos__prefLabel mesh__D041941 Milk Substitutes
% 208.83/208.99 |- rdf__type mesh__D041941sskos__Concept
% 208.83/208.99 |- mesh__historyNote mesh__D041941 2004; use MILK 1998-2003
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D041941 2004; see MILK 1998-2003
% 208.83/208.99 |- skos__historyNote mesh__D041941 Milk %28%1968-2003%29%
% 208.83/208.99 |- skos__prefLabel mesh__D013452 Sulfonium Compounds
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 2005
% 208.83/208.99 |- skos__scopeNote mesh__D013452
% 208.83/208.99 Sulfur compounds in which the sulfur atom is attached to three organic radicals and an electronegative element or radical.%A%
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 2004
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 2006
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 2000
% 208.83/208.99 |- mesh__historyNote mesh__D013452
% 208.83/208.99 91%28%75%29%; was see under ONIUM COMPOUNDS 1975-90
% 208.83/208.99 |- skos__historyNote mesh__D013452 Onium Compounds %28%1968-1974%29%
% 208.83/208.99 |- mesh__dateEstablished mesh__D013452 1991-01-01
% 208.83/208.99 |- mesh__recordOriginator mesh__D013452 NLM
% 208.83/208.99 |- skos__hiddenLabel mesh__D013452 Compounds, Sulfine
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D013452
% 208.83/208.99 91; was see under ONIUM COMPOUNDS 1975-90
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 2001
% 208.83/208.99 |- skos__hiddenLabel mesh__D013452 Compounds, Sulfonium
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D013452 PLS
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 1996
% 208.83/208.99 |- skos__broader mesh__D013452smesh__D013457
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 1998
% 208.83/208.99 |- mesh__recordMaintainer mesh__D013452 TGC
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 1997
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 1994
% 208.83/208.99 |- mesh__dateRevised mesh__D013452 1992-05-20
% 208.83/208.99 |- skos__annotation mesh__D013452 DF: SULFONIUM CPDS
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 1999
% 208.83/208.99 |- skos__broader mesh__D013452smesh__D009861
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 2002
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 1993
% 208.83/208.99 |- rdf__type mesh__D013452sskos__Concept
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 1995
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013452 2003
% 208.83/208.99 |- mesh__dateCreated mesh__D013452 1974-11-11
% 208.83/208.99 |- skos__broader mesh__D007415smesh__D007410
% 208.83/208.99 |- rdf__type mesh__D007415sskos__Concept
% 208.83/208.99 |- mesh__dateRevised mesh__D007415 2005-07-01
% 208.83/208.99 |- skos__annotation mesh__D007415
% 208.83/208.99 coord IM with specific precoord intestinal dis %28%IM%29%; INTESTINAL PSEUDO-OBSTRUCTION is also available%A%
% 208.83/208.99 |- skos__hiddenLabel mesh__D007415 Obstruction, Intestinal
% 208.83/208.99 |- skos__prefLabel mesh__D007415 Intestinal Obstruction
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D007415 2006
% 208.83/208.99 |- mesh__dateCreated mesh__D007415 1999-01-01
% 208.83/208.99 |- skos__hiddenLabel mesh__D007415 Intestinal Obstructions
% 208.83/208.99 |- mesh__recordMaintainer mesh__D007415 sjn
% 208.83/208.99 |- mesh__recordOriginator mesh__D007415 NLM
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D007415 sjn
% 208.83/208.99 |- skos__scopeNote mesh__D007415
% 208.83/208.99 Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.%A%
% 208.83/208.99 |- skos__broader mesh__D051571smesh__D011493
% 208.83/208.99 |- mesh__recordMaintainer mesh__D051571 ags
% 208.83/208.99 |- skos__altLabel mesh__D051571 Protein Kinase C%28%alpha%29%
% 208.83/208.99 |- mesh__dateRevised mesh__D051571 2005-07-18
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D051571 ags
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D051571
% 208.83/208.99 2006; PROTEIN KINASE C ALPHA was indexed under PROTEIN KINASE C 2004-2006, %26% under ISOENZYMES 1999-2003%A%
% 208.83/208.99 |- mesh__recordOriginator mesh__D051571 AKE
% 208.83/208.99 |- skos__scopeNote mesh__D051571
% 208.83/208.99 A cytoplasmic serine threonine kinase involved in regulating CELL DIFFERENTIATION and CELLULAR PROLIFERATION. Overexpression of this enzyme has been shown to promote PHOSPHORYLATION of BCL-2 PROTO-ONCOGENE PROTEINS and chemoresistance in human acute leukemia cells.%A%
% 208.83/208.99 |- skos__altLabel mesh__D051571 Protein Kinase C alpha
% 208.83/208.99 |- skos__altLabel mesh__D051571 PKC-alpha Serine-Threonine Kinase
% 208.83/208.99 |- rdf__type mesh__D051571sskos__Concept
% 208.83/208.99 |- skos__hiddenLabel mesh__D051571 Serine-Threonine Kinase, PKC-alpha
% 208.83/208.99 |- skos__prefLabel mesh__D051571 Protein Kinase C-alpha
% 208.83/208.99 |- mesh__dateEstablished mesh__D051571 2006-01-01
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D051571 2006A
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D051571 2006
% 208.83/208.99 |- mesh__historyNote mesh__D051571 2006%28%1999%29%
% 208.83/208.99 |- mesh__dateCreated mesh__D051571 2005-06-30
% 208.83/208.99 |- skos__hiddenLabel mesh__D051571 PKC alpha Serine Threonine Kinase
% 208.83/208.99 |- skos__historyNote mesh__D023082 Proteins %28%1998-2000%29%
% 208.83/208.99 |- mesh__dateEstablished mesh__D023082 2001-01-01
% 208.83/208.99 |- skos__broader mesh__D023082smesh__D023181
% 208.83/208.99 |- mesh__recordMaintainer mesh__D023082 jmp
% 208.83/208.99 |- skos__prefLabel mesh__D023082 Defensins
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D023082
% 208.83/208.99 2001; DEFENSINS was indexed under PROTEINS %28%1999-2000%29% %26% BLOOD PROTEINS %28%1985-1998%29%%A%
% 208.83/208.99 |- mesh__recordOriginator mesh__D023082 ags
% 208.83/208.99 |- skos__historyNote mesh__D023082 Blood Proteins %28%1985-1998%29%
% 208.83/208.99 |- skos__scopeNote mesh__D023082
% 208.83/208.99 Family of antimicrobial peptides that have been identified in humans, animals, and plants. They are thought to play a role in host defenses against infections, inflammation, wound repair, and acquired immunity.%A%
% 208.83/208.99 |- mesh__historyNote mesh__D023082
% 208.83/208.99 2001; use DEFENSINS %28%NM%29% to search DEFENSINS 1985-2000
% 208.83/208.99 |- mesh__dateRevised mesh__D023082 2005-06-30
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D023082 sjn
% 208.83/208.99 |- mesh__dateCreated mesh__D023082 2000-06-22
% 208.83/208.99 |- rdf__type mesh__D023082sskos__Concept
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D023082 2006
% 208.83/208.99 |- skos__altLabel mesh__D017843 Ligamenta Flava
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017843 2000
% 208.83/208.99 |- mesh__recordOriginator mesh__D017843 TGC
% 208.83/208.99 |- skos__broader mesh__D017843smesh__D008023
% 208.83/208.99 |- skos__historyNote mesh__D017843 Ligaments %28%1966-1993%29%
% 208.83/208.99 |- mesh__recordMaintainer mesh__D017843 KEV
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017843 2003
% 208.83/208.99 |- mesh__dateRevised mesh__D017843 1999-11-03
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017843 2001
% 208.83/208.99 |- mesh__dateCreated mesh__D017843 1993-02-16
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017843 2005
% 208.83/208.99 |- skos__hiddenLabel mesh__D017843 Ligaments, Flaval
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017843 2004
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D017843 sjn
% 208.83/208.99 |- skos__hiddenLabel mesh__D017843 Flaval Ligaments
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017843 2006
% 208.83/208.99 |- rdf__type mesh__D017843sskos__Concept
% 208.83/208.99 |- skos__prefLabel mesh__D017843 Ligamentum Flavum
% 208.83/208.99 |- skos__altLabel mesh__D017843 Flaval Ligament
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017843 2002
% 208.83/208.99 |- skos__scopeNote mesh__D017843
% 208.83/208.99 The paired bands of yellow elastic tissue that connect adjoining laminae of the vertebrae. With the laminae, it forms the posterior wall of the spinal canal and helps hold the body erect.%A%
% 208.83/208.99 |- mesh__dateEstablished mesh__D017843 1994-01-01
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D017843 94
% 208.83/208.99 |- skos__hiddenLabel mesh__D017843 Ligament, Flaval
% 208.83/208.99 |- mesh__historyNote mesh__D017843 94
% 208.83/208.99 |- skos__scopeNote mesh__D017045
% 208.83/208.99 A genus of gram-positive, coccoid bacteria mainly isolated from milk and milk products. These bacteria are also found in plants and nonsterile frozen and dry foods. Previously thought to be a member of the genus STREPTOCOCCUS %28%group N%29%, it is now recognized as a separate genus.%A%
% 208.83/208.99 |- skos__annotation mesh__D017045
% 208.83/208.99 usually non-pathogenic; in milk %26% milk products
% 208.83/208.99 |- skos__historyNote mesh__D017045 Gram-Positive Bacteria %28%1988%29%
% 208.83/208.99 |- skos__historyNote mesh__D017045 Streptococcus %28%1988-1991%29%
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D017045 sjn
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D017045 2006
% 208.83/208.99 |- mesh__recordOriginator mesh__D017045 PXP
% 208.83/208.99 |- mesh__dateCreated mesh__D017045 1991-05-30
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D017045 92
% 208.83/208.99 |- skos__broader mesh__D017045smesh__D013289
% 208.83/208.99 |- skos__prefLabel mesh__D017045 Lactococcus
% 208.83/208.99 |- rdf__type mesh__D017045sskos__Concept
% 208.83/208.99 |- mesh__recordMaintainer mesh__D017045 SYSTEM
% 208.83/208.99 |- mesh__dateRevised mesh__D017045 2005-06-30
% 208.83/208.99 |- mesh__historyNote mesh__D017045 92
% 208.83/208.99 |- mesh__dateEstablished mesh__D017045 1992-01-01
% 208.83/208.99 |- rdf__type mesh__D003823sskos__Concept
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 1995
% 208.83/208.99 |- skos__prefLabel mesh__D003823 Denture Rebasing
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 1999
% 208.83/208.99 |- skos__hiddenLabel mesh__D003823 Rebasing, Denture
% 208.83/208.99 |- skos__hiddenLabel mesh__D003823 Relinings, Denture
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 2000
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 1996
% 208.83/208.99 |- skos__annotation mesh__D003823
% 208.83/208.99 coord IM with specific denture term %28%IM or NIM%29%
% 208.83/208.99 |- mesh__historyNote mesh__D003823 65
% 208.83/208.99 |- skos__hiddenLabel mesh__D003823 Relining, Denture
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 1993
% 208.83/208.99 |- skos__hiddenLabel mesh__D003823 Denture Relinings
% 208.83/208.99 |- skos__hiddenLabel mesh__D003823 Denture Rebasings
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D003823 65
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D003823 PLS
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 2005
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 2001
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 1997
% 208.83/208.99 |- skos__scopeNote mesh__D003823
% 208.83/208.99 The process of refitting a denture by replacing the denture base material without changing the occlusal relations of the teeth. Rebasing may include adding to the denture base to compensate for resorptive changes to subjacent structures.%A%
% 208.83/208.99 |- skos__broader mesh__D003823smesh__D003778
% 208.83/208.99 |- mesh__recordOriginator mesh__D003823 NLM
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 2006
% 208.83/208.99 |- mesh__dateCreated mesh__D003823 1999-01-01
% 208.83/208.99 |- mesh__recordMaintainer mesh__D003823 MXR
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 2003
% 208.83/208.99 |- mesh__dateRevised mesh__D003823 1992-05-11
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 1994
% 208.83/208.99 |- skos__hiddenLabel mesh__D003823 Rebasings, Denture
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 2002
% 208.83/208.99 |- mesh__dateEstablished mesh__D003823 1965-01-01
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 1998
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003823 2004
% 208.83/208.99 |- skos__broader mesh__D003823smesh__D013674
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D050479 2006
% 208.83/208.99 |- mesh__recordOriginator mesh__D050479 DRC
% 208.83/208.99 |- skos__hiddenLabel mesh__D050479 Transport Proteins, Neurotransmitter
% 208.83/208.99 |- skos__hiddenLabel mesh__D050479 Transporter Proteins, Neurotransmitter
% 208.83/208.99 |- skos__broader mesh__D050479smesh__D026901
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D050479 sjn
% 208.83/208.99 |- skos__hiddenLabel mesh__D050479 Transporters, Neurotransmitter
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D050479 2006
% 208.83/208.99 |- rdf__type mesh__D050479sskos__Concept
% 208.83/208.99 |- mesh__recordMaintainer mesh__D050479 DRC
% 208.83/208.99 |- skos__prefLabel mesh__D050479 Neurotransmitter Transport Proteins
% 208.83/208.99 |- skos__altLabel mesh__D050479 Neurotransmitter Transporters
% 208.83/208.99 |- mesh__dateEstablished mesh__D050479 2006-01-01
% 208.83/208.99 |- skos__scopeNote mesh__D050479
% 208.83/208.99 Membrane transport proteins found predominately in NEURONS and neuroendocrine cells that facilitate neurotransmitter transport. They include two distinct families of proteins that transport NEUROTRANSMITTERS across the PLASMA MEMBRANE and that transport NEUROTRANSMITTERS into SECRETORY VESICLES.%A%
% 208.83/208.99 |- mesh__dateCreated mesh__D050479 2005-06-30
% 208.83/208.99 |- mesh__historyNote mesh__D050479 2006
% 208.83/208.99 |- skos__altLabel mesh__D050479 Neurotransmitter Transporter Proteins
% 208.83/208.99 |- mesh__dateCreated mesh__D003025 1999-01-01
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003025 2005
% 208.83/208.99 |- mesh__recordOriginator mesh__D003025 NLM
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003025 2006
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003025 2003
% 208.83/208.99 |- skos__altLabel mesh__D003025 Talipes Equinovarus
% 208.83/208.99 |- mesh__recordMaintainer mesh__D003025 kle
% 208.83/208.99 |- skos__altLabel mesh__D003025 Equinovarus
% 208.83/208.99 |- skos__prefLabel mesh__D003025 Clubfoot
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D003025 2004
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D003025 sjn
% 208.83/208.99 |- skos__broader mesh__D003025smesh__D005532
% 208.83/208.99 |- skos__annotation mesh__D003025
% 208.83/208.99 X ref EQUINOVARUS: do not confuse with EQUINUS DEFORMITY; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 208.83/208.99 |- mesh__dateRevised mesh__D003025 2002-07-03
% 208.83/208.99 |- rdf__type mesh__D003025sskos__Concept
% 208.83/208.99 |- skos__scopeNote mesh__D003025
% 208.83/208.99 A deformed foot in which the foot is plantarflexed, inverted and adducted.%A%
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D041942 2006
% 208.83/208.99 |- rdf__type mesh__D041942sskos__Concept
% 208.83/208.99 |- mesh__historyNote mesh__D041942 2004
% 208.83/208.99 |- skos__broader mesh__D041942smesh__D041941
% 208.83/208.99 |- skos__historyNote mesh__D041942 Milk %28%1965-2003%29%
% 208.83/208.99 |- skos__scopeNote mesh__D041942 A beverage prepared from SOYBEANS.
% 208.83/208.99 |- mesh__dateCreated mesh__D041942 2003-07-09
% 208.83/208.99 |- mesh__dateEstablished mesh__D041942 2004-01-01
% 208.83/208.99 |- skos__prefLabel mesh__D041942 Soy Milk
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D041942 2004
% 208.83/208.99 |- skos__hiddenLabel mesh__D041942 Beverages, Soy
% 208.83/208.99 |- skos__broader mesh__D041942smesh__D045730
% 208.83/208.99 |- skos__altLabel mesh__D041942 Soy Beverage
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D041942 2004
% 208.83/208.99 |- skos__hiddenLabel mesh__D041942 Soy Beverages
% 208.83/208.99 |- skos__altLabel mesh__D041942 Milk, Soy
% 208.83/208.99 |- skos__hiddenLabel mesh__D041942 Beverage, Soy
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D041942 2005
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013453 2001
% 208.83/208.99 |- mesh__dateEstablished mesh__D013453 1972-01-01
% 208.83/208.99 |- skos__prefLabel mesh__D013453 Sulfonylurea Compounds
% 208.83/208.99 |- skos__hiddenLabel mesh__D013453 Compounds, Sulfonylurea
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013453 2004
% 208.83/208.99 |- mesh__recordMaintainer mesh__D013453 jmp
% 208.83/208.99 |- mesh__recordAuthorizer mesh__D013453 sjn
% 208.83/208.99 |- rdf__type mesh__D013453sskos__Concept
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013453 2000
% 208.83/208.99 |- mesh__dateCreated mesh__D013453 1999-01-01
% 208.83/208.99 |- mesh__historyNote mesh__D013453 72
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013453 2003
% 208.83/208.99 |- mesh__publicMeSHNote mesh__D013453 72
% 208.83/208.99 |- skos__broader mesh__D013453smesh__D013450
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013453 2006
% 208.83/208.99 |- mesh__dateRevised mesh__D013453 1999-11-03
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013453 2002
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D013453 2005
% 208.83/208.99 |- skos__broader mesh__D013453smesh__D014508
% 208.83/208.99 |- mesh__recordOriginator mesh__D013453 NLM
% 208.83/208.99 |- skos__historyNote mesh__D013453 Hypoglycemic Agents %28%1966-1971%29%
% 208.83/208.99 |- skos__annotation mesh__D013453 hypoglycemics; DF: SULFONYLUREA CPDS
% 208.83/208.99 |- skos__hiddenLabel mesh__D007416 Perforations, Intestinal
% 208.83/208.99 |- mesh__activeMeSHYear mesh__D007416 2005
% 208.83/208.99 |- skos__hiddenLabel mesh__D007416 Perforation, Intestinal
% 208.83/208.99 |- skos__annotation mesh__D007416
% 208.83/208.99 caused by dis or inj; coord IM with specific intestine %28%IM%29% or specific precoord intestinal dis %28%IM%29%; intestinal rupture does not go here: index with INTESTINES /inj or specific intestine /inj %28%IM%29% + RUPTURE %28%NIM%29% or specific intestine %28%IM%29% or specific precoord intestinal dis %28%IM%29% + RUPTURE, SPONTANEOUS %28%NIM%29%%A%
% 208.83/208.99 |- mesh__recordOriginator mesh__D007416 NLM
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D007416 2006
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D007416 sjn
% 208.83/209.00 |- mesh__dateCreated mesh__D007416 1999-01-01
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D007416 2004
% 208.83/209.00 |- mesh__dateRevised mesh__D007416 2003-07-09
% 208.83/209.00 |- mesh__recordMaintainer mesh__D007416 lkt
% 208.83/209.00 |- skos__prefLabel mesh__D007416 Intestinal Perforation
% 208.83/209.00 |- skos__broader mesh__D007416smesh__D007410
% 208.83/209.00 |- skos__scopeNote mesh__D007416
% 208.83/209.00 Opening or penetration through the wall of the INTESTINES.%A%
% 208.83/209.00 |- rdf__type mesh__D007416sskos__Concept
% 208.83/209.00 |- skos__hiddenLabel mesh__D007416 Intestinal Perforations
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D051572
% 208.83/209.00 2006; PROTO-ONCOGENE PROTEIN C-HCK was indexed under PROTEIN-TYROSINE KINASE %26% PROTO-ONCOGENE PROTEINS 1991-2005%A%
% 208.83/209.00 |- mesh__dateCreated mesh__D051572 2005-06-30
% 208.83/209.00 |- skos__prefLabel mesh__D051572 Proto-Oncogene Proteins c-hck
% 208.83/209.00 |- rdf__type mesh__D051572sskos__Concept
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 Proto Oncogene Proteins c hck
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 c hck Proteins
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 Proto Oncogene Protein c hck
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 hck Proto Oncogene Proteins
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D051572 sjn
% 208.83/209.00 |- skos__altLabel mesh__D051572 c-hck Proteins
% 208.83/209.00 |- skos__altLabel mesh__D051572 Proto-Oncogene Protein hck
% 208.83/209.00 |- skos__scopeNote mesh__D051572
% 208.83/209.00 Members of the src-family tyrosine kinase family that are strongly expressed in MYELOID CELLS and B-LYMPHOCYTES.%A%
% 208.83/209.00 |- skos__altLabel mesh__D051572 hck Proto-Oncogene Proteins
% 208.83/209.00 |- mesh__historyNote mesh__D051572 2006%28%1991%29%
% 208.83/209.00 |- mesh__recordMaintainer mesh__D051572 DRC
% 208.83/209.00 |- mesh__recordOriginator mesh__D051572 DRC
% 208.83/209.00 |- skos__altLabel mesh__D051572 c-hck Proto-Oncogene Proteins
% 208.83/209.00 |- mesh__dateEstablished mesh__D051572 2006-01-01
% 208.83/209.00 |- skos__broader mesh__D051572smesh__D011518
% 208.83/209.00 |- skos__altLabel mesh__D051572 Proto-Oncogene Protein c-hck
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 Tyrosine Protein Kinase HCK
% 208.83/209.00 |- skos__broader mesh__D051572smesh__D019061
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 Proto Oncogene Protein hck
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 Proto-Oncogene Proteins, hck
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 c hck Proto Oncogene Proteins
% 208.83/209.00 |- skos__altLabel mesh__D051572 Tyrosine-Protein Kinase HCK
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D051572 2006
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 c-hck, Proto-Oncogene Protein
% 208.83/209.00 |- skos__hiddenLabel mesh__D051572 Proto-Oncogene Proteins, c-hck
% 208.83/209.00 |- skos__altLabel mesh__D051572 Hematopoietic Cell Kinase
% 208.83/209.00 |- skos__prefLabel mesh__D023881 Colonography, Computed Tomographic
% 208.83/209.00 |- skos__related mesh__D023881smesh__D003113
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023881 2005
% 208.83/209.00 |- skos__broader mesh__D023881smesh__D014057
% 208.83/209.00 |- skos__historyNote mesh__D023881
% 208.83/209.00 Colonic Diseases/radiography %28%1994-2001%29%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023881 2002
% 208.83/209.00 |- mesh__dateEstablished mesh__D023881 2002-01-01
% 208.83/209.00 |- skos__altLabel mesh__D023881 CT Colonography
% 208.83/209.00 |- skos__related mesh__D023881smesh__D014057
% 208.83/209.00 |- skos__historyNote mesh__D023881 Colon/radiography %28%1994-2001%29%
% 208.83/209.00 |- rdf__type mesh__D023881sskos__Concept
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023881 2004
% 208.83/209.00 |- mesh__dateCreated mesh__D023881 2001-07-25
% 208.83/209.00 |- skos__broader mesh__D023881smesh__D003938
% 208.83/209.00 |- skos__altLabel mesh__D023881 Virtual Colonoscopy
% 208.83/209.00 |- skos__altLabel mesh__D023881 Computed Tomographic Colonography
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023881 2003
% 208.83/209.00 |- mesh__historyNote mesh__D023881 2002
% 208.83/209.00 |- skos__historyNote mesh__D023881
% 208.83/209.00 Tomography, X-Ray Computed %28%1994-2001%29%
% 208.83/209.00 |- skos__scopeNote mesh__D023881
% 208.83/209.00 A non-invasive imaging method that uses computed tomographic data combined with specialized imaging software to examine the colon.%A%
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D023881 2002
% 208.83/209.00 |- skos__annotation mesh__D023881 DF: CT Colonography
% 208.83/209.00 |- skos__historyNote mesh__D023881 Colonoscopy/methods %28%1994-2001%29%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023881 2006
% 208.83/209.00 |- skos__altLabel mesh__D023881 Colonoscopy, Virtual
% 208.83/209.00 |- skos__hiddenLabel mesh__D023881 Colonography, CT
% 208.83/209.00 |- skos__scopeNote mesh__D023083
% 208.83/209.00 DEFENSINS found mainly in epithelial cells.
% 208.83/209.00 |- skos__historyNote mesh__D023083 Proteins %28%1993-2000%29%
% 208.83/209.00 |- mesh__historyNote mesh__D023083 2001
% 208.83/209.00 |- skos__broader mesh__D023083smesh__D023082
% 208.83/209.00 |- mesh__recordMaintainer mesh__D023083 ssb
% 208.83/209.00 |- mesh__dateCreated mesh__D023083 2000-06-22
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D023083 2001
% 208.83/209.00 |- mesh__recordOriginator mesh__D023083 ags
% 208.83/209.00 |- rdf__type mesh__D023083sskos__Concept
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023083 2006
% 208.83/209.00 |- mesh__dateRevised mesh__D023083 2005-06-30
% 208.83/209.00 |- skos__prefLabel mesh__D023083 beta-Defensins
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D023083 sjn
% 208.83/209.00 |- mesh__dateEstablished mesh__D023083 2001-01-01
% 208.83/209.00 |- skos__hiddenLabel mesh__D023083 beta Defensins
% 208.83/209.00 |- mesh__dateEstablished mesh__D017844 1994-01-01
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D017844 jls
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D017844 94
% 208.83/209.00 |- skos__hiddenLabel mesh__D017844 Ligaments, Ankle Lateral
% 208.83/209.00 |- skos__altLabel mesh__D017844 Ankle Lateral Ligament
% 208.83/209.00 |- skos__altLabel mesh__D017844
% 208.83/209.00 Ligamentum Laterale Articulationis Talocruralis
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017844 2003
% 208.83/209.00 |- mesh__dateCreated mesh__D017844 1993-02-16
% 208.83/209.00 |- skos__scopeNote mesh__D017844
% 208.83/209.00 There are two lateral ligaments of the ankle - internal and external. The internal lateral ligament is attached to the apex and anterior and posterior bodies of the inner malleolus and inserted into the navicular bone, the inferior calcaneo-navicular ligament, the sustentaculum tali of the os calcis, and the inner side of the astragalus. The external lateral ligament, also called the lateral collateral ligament, consists of three distinct fasciculi - the calcaneofibular, the anterior talofibular, and the posterior talofibular.%A%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017844 2005
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017844 2004
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017844 2006
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017844 2005A
% 208.83/209.00 |- mesh__recordOriginator mesh__D017844 TGC
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017844 2000
% 208.83/209.00 |- rdf__type mesh__D017844sskos__Concept
% 208.83/209.00 |- skos__hiddenLabel mesh__D017844 Ankle Lateral Ligaments
% 208.83/209.00 |- skos__historyNote mesh__D017844 Ligaments %28%1966-1993%29%
% 208.83/209.00 |- skos__hiddenLabel mesh__D017844 Lateral Ligaments, Ankle
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017844 2001
% 208.83/209.00 |- skos__historyNote mesh__D017844 Ligaments, Articular %28%1966-1993%29%
% 208.83/209.00 |- mesh__dateRevised mesh__D017844 2004-07-28
% 208.83/209.00 |- mesh__historyNote mesh__D017844 94
% 208.83/209.00 |- skos__broader mesh__D017844smesh__D017885
% 208.83/209.00 |- mesh__recordMaintainer mesh__D017844 jls
% 208.83/209.00 |- skos__hiddenLabel mesh__D017844 Ligament, Ankle Lateral
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017844 2002
% 208.83/209.00 |- skos__prefLabel mesh__D017844 Lateral Ligament, Ankle
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 1996
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 1995
% 208.83/209.00 |- mesh__dateEstablished mesh__D017046 1992-01-01
% 208.83/209.00 |- mesh__recordOriginator mesh__D017046 PLS
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 2006
% 208.83/209.00 |- mesh__dateCreated mesh__D017046 1991-06-20
% 208.83/209.00 |- skos__scopeNote mesh__D017046
% 208.83/209.00 Reductions in all or any portion of the costs of providing goods or services. Savings may be incurred by the provider or the consumer.%A%
% 208.83/209.00 |- mesh__recordMaintainer mesh__D017046 PLS
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D017046 NLM
% 208.83/209.00 |- skos__hiddenLabel mesh__D017046 Cost Saving
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 2005
% 208.83/209.00 |- skos__broader mesh__D017046smesh__D003363
% 208.83/209.00 |- skos__prefLabel mesh__D017046 Cost Savings
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 2002
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 1999
% 208.83/209.00 |- skos__historyNote mesh__D017046 Cost Control %28%1979-1991%29%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 2004
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 2001
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 1998
% 208.83/209.00 |- rdf__type mesh__D017046sskos__Concept
% 208.83/209.00 |- mesh__historyNote mesh__D017046 92
% 208.83/209.00 |- skos__hiddenLabel mesh__D017046 Saving, Cost
% 208.83/209.00 |- skos__annotation mesh__D017046
% 208.83/209.00 a saving for the provider of goods or services or for the recipient or consumer%A%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 2003
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D017046 92
% 208.83/209.00 |- skos__hiddenLabel mesh__D017046 Savings, Cost
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 2000
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017046 1997
% 208.83/209.00 |- mesh__dateRevised mesh__D017046 1993-09-16
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D003824 SJN
% 208.83/209.00 |- mesh__historyNote mesh__D003824 65
% 208.83/209.00 |- skos__annotation mesh__D003824
% 208.83/209.00 labeling for ownership or identification = DENTURE IDENTIFICATION MARKING%A%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003824 2002
% 208.83/209.00 |- mesh__dateEstablished mesh__D003824 1965-01-01
% 208.83/209.00 |- skos__prefLabel mesh__D003824 Denture, Complete
% 208.83/209.00 |- skos__hiddenLabel mesh__D003824 Dentures, Complete
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003824 2005
% 208.83/209.00 |- skos__hiddenLabel mesh__D003824 Complete Denture
% 208.83/209.00 |- mesh__recordMaintainer mesh__D003824 PXP
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003824 2006
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003824 2000
% 208.83/209.00 |- mesh__dateRevised mesh__D003824 1997-06-20
% 208.83/209.00 |- mesh__dateCreated mesh__D003824 1999-01-01
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003824 2003
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D003824 65
% 208.83/209.00 |- skos__hiddenLabel mesh__D003824 Complete Dentures
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003824 2001
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003824 1998
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003824 2004
% 208.83/209.00 |- skos__broader mesh__D003824smesh__D003778
% 208.83/209.00 |- mesh__recordOriginator mesh__D003824 NLM
% 208.83/209.00 |- rdf__type mesh__D003824sskos__Concept
% 208.83/209.00 |- skos__scopeNote mesh__D003824
% 208.83/209.00 A denture replacing all natural teeth and associated structures in both the maxilla and mandible.%A%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003824 1999
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 2002
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 1994
% 208.83/209.00 |- rdf__type mesh__D003026sskos__Concept
% 208.83/209.00 |- mesh__historyNote mesh__D003026
% 208.83/209.00 91%28%75%29%; was see under PROTAMINES 1975-90
% 208.83/209.00 |- mesh__onlineNote mesh__D003026 search PROTAMINES 1966-74
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D003026 PLS
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D003026
% 208.83/209.00 91; was see under PROTAMINES 1975-90
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 2001
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 2000
% 208.83/209.00 |- mesh__dateEstablished mesh__D003026 1991-01-01
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 2004
% 208.83/209.00 |- skos__prefLabel mesh__D003026 Clupeine
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 1997
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 2006
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 1999
% 208.83/209.00 |- mesh__recordOriginator mesh__D003026 NLM
% 208.83/209.00 |- mesh__dateRevised mesh__D003026 1992-05-11
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 2003
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 1993
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 2005
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 1996
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 1995
% 208.83/209.00 |- mesh__recordMaintainer mesh__D003026 TAP
% 208.83/209.00 |- skos__broader mesh__D003026smesh__D011479
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003026 1998
% 208.83/209.00 |- mesh__dateCreated mesh__D003026 1999-01-01
% 208.83/209.00 |- skos__broader mesh__D041943smesh__D007225
% 208.83/209.00 |- skos__historyNote mesh__D041943 Infant Nutrition %28%1968-2003%29%
% 208.83/209.00 |- skos__hiddenLabel mesh__D041943 Formulas, Infant
% 208.83/209.00 |- skos__related mesh__D041943smesh__D007225
% 208.83/209.00 |- skos__hiddenLabel mesh__D041943 Formula, Infant
% 208.83/209.00 |- skos__broader mesh__D041943smesh__D008892
% 208.83/209.00 |- mesh__historyNote mesh__D041943 2004
% 208.83/209.00 |- skos__broader mesh__D041943smesh__D041941
% 208.83/209.00 |- skos__hiddenLabel mesh__D041943 Formula, Baby
% 208.83/209.00 |- skos__historyNote mesh__D041943 Milk %28%1969-2003%29%
% 208.83/209.00 |- skos__scopeNote mesh__D041943
% 208.83/209.00 Liquid formulations for the nutrition of INFANTS, useful for those with special needs or MILK HYPERSENSITIVITY or those whose mothers are unable to breastfeed %28%BREAST FEEDING%29%.%A%
% 208.83/209.00 |- mesh__dateCreated mesh__D041943 2003-07-09
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D041943 2004
% 208.83/209.00 |- skos__altLabel mesh__D041943 Baby Formula
% 208.83/209.00 |- skos__annotation mesh__D041943 coordinate with major ingredient
% 208.83/209.00 |- skos__hiddenLabel mesh__D041943 Infant Formulas
% 208.83/209.00 |- skos__hiddenLabel mesh__D041943 Baby Formulas
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D041943 2004
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D041943 2005
% 208.83/209.00 |- skos__prefLabel mesh__D041943 Infant Formula
% 208.83/209.00 |- mesh__dateEstablished mesh__D041943 2004-01-01
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D041943 2006
% 208.83/209.00 |- skos__broader mesh__D041943smesh__D005526
% 208.83/209.00 |- rdf__type mesh__D041943sskos__Concept
% 208.83/209.00 |- skos__hiddenLabel mesh__D041943 Formulas, Baby
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D049128
% 208.83/209.00 2005; SPHINGOLIPID ACTIVATOR PROTEINS was indexed under GLYCOPROTEINS 1977-2004%A%
% 208.83/209.00 |- skos__broader mesh__D049128smesh__D003067
% 208.83/209.00 |- mesh__dateEstablished mesh__D049128 2005-01-01
% 208.83/209.00 |- mesh__historyNote mesh__D049128 2005%28%1977%29%
% 208.83/209.00 |- mesh__dateRevised mesh__D049128 2005-06-30
% 208.83/209.00 |- skos__altLabel mesh__D049128 G%28%M1%29% Activator Protein
% 208.83/209.00 |- rdf__type mesh__D049128sskos__Concept
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D049128 sjn
% 208.83/209.00 |- mesh__recordOriginator mesh__D049128 jmp
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D049128 2006
% 208.83/209.00 |- skos__altLabel mesh__D049128 Ganglioside Degradation Activator Protein
% 208.83/209.00 |- skos__prefLabel mesh__D049128 Sphingolipid Activator Proteins
% 208.83/209.00 |- skos__altLabel mesh__D049128 Hexosaminidase Activating Factor
% 208.83/209.00 |- skos__scopeNote mesh__D049128
% 208.83/209.00 A family of glycoprotein cofactors that are required for the efficient catabolization of SPHINGOLIPIDS by specific acid hydrolases such as GLUCOSYLCERAMIDASE; GALACTOCEREBROSIDASE; BETA-N-ACETYLHEXOSAMINIDASE; and CEREBROSIDE-SULFATASE.%A%
% 208.83/209.00 |- mesh__recordMaintainer mesh__D049128 SYSTEM
% 208.83/209.00 |- mesh__dateCreated mesh__D049128 2004-07-07
% 208.83/209.00 |- skos__historyNote mesh__D049128 Glycoproteins %28%1977-2004%29%
% 208.83/209.00 |- skos__altLabel mesh__D049128 GM1 Activator Protein
% 208.83/209.00 |- mesh__dateCreated mesh__D013454 1999-01-01
% 208.83/209.00 |- mesh__historyNote mesh__D013454 66
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 2003
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 1994
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 2001
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 2006
% 208.83/209.00 |- skos__prefLabel mesh__D013454 Sulfoxides
% 208.83/209.00 |- mesh__recordMaintainer mesh__D013454 TPW
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 2000
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 2005
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 1997
% 208.83/209.00 |- skos__scopeNote mesh__D013454
% 208.83/209.00 Organic compounds that have the general formula R-SO-R. They are obtained by oxidation of mercaptans %28%analogous to the ketones%29%. %28%From Hackh%27%s Chemical Dictionary, 4th ed%29%%A%
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D013454 PLS
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 1996
% 208.83/209.00 |- mesh__dateEstablished mesh__D013454 1966-01-01
% 208.83/209.00 |- skos__broader mesh__D013454smesh__D013457
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 2002
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D013454 66
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 1999
% 208.83/209.00 |- mesh__dateRevised mesh__D013454 1993-06-04
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 2004
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 1995
% 208.83/209.00 |- mesh__recordOriginator mesh__D013454 NLM
% 208.83/209.00 |- rdf__type mesh__D013454sskos__Concept
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D013454 1998
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D007417 2006
% 208.83/209.00 |- skos__scopeNote mesh__D007417
% 208.83/209.00 Discrete abnormal tissue masses that protrude into the lumen of the INTESTINE. A polyp is attached to the intestinal wall either by a stalk, pedunculus, or by a broad base.%A%
% 208.83/209.00 |- skos__annotation mesh__D007417 INTESTINAL POLYPOSIS is also available
% 208.83/209.00 |- skos__hiddenLabel mesh__D007417 Polyps, Intestinal
% 208.83/209.00 |- mesh__dateEstablished mesh__D007417 1968-01-01
% 208.83/209.00 |- mesh__dateCreated mesh__D007417 1977-12-06
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D007417 2004
% 208.83/209.00 |- mesh__dateRevised mesh__D007417 2003-07-09
% 208.83/209.00 |- mesh__historyNote mesh__D007417 68
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D007417 sjn
% 208.83/209.00 |- rdf__type mesh__D007417sskos__Concept
% 208.83/209.00 |- skos__historyNote mesh__D007417 Polyps %28%1966-1967%29%
% 208.83/209.00 |- skos__hiddenLabel mesh__D007417 Intestinal Polyp
% 208.83/209.00 |- skos__prefLabel mesh__D007417 Intestinal Polyps
% 208.83/209.00 |- skos__historyNote mesh__D007417 Intestinal Diseases %28%1966-1967%29%
% 208.83/209.00 |- mesh__recordMaintainer mesh__D007417 lkt
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D007417 68
% 208.83/209.00 |- mesh__recordOriginator mesh__D007417 SMH
% 208.83/209.00 |- skos__broader mesh__D007417smesh__D011127
% 208.83/209.00 |- skos__hiddenLabel mesh__D007417 Polyp, Intestinal
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D007417 2005
% 208.83/209.00 |- skos__altLabel mesh__D051573 Pim-1 Kinase
% 208.83/209.00 |- skos__altLabel mesh__D051573 Proto-Oncogene Protein c-pim-1
% 208.83/209.00 |- mesh__recordOriginator mesh__D051573 DRC
% 208.83/209.00 |- mesh__historyNote mesh__D051573 2006%28%1988%29%
% 208.83/209.00 |- skos__altLabel mesh__D051573 pim-1 Proto-Oncogene Protein
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D051573
% 208.83/209.00 2006; PROTO-ONCOGENE PROTEIN C-PIM-1 was indexed under PROTO-ONCOGENE PROTEINS 1988-2005, %26% under PROTEIN-SERINE-THREONINE KINASES 1989-2005, %26% under PROTEIN-TYROSINE KINASE 1988%A%
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 c pim 1 Protein
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 pim-1, Proto-Oncogene Protein
% 208.83/209.00 |- skos__altLabel mesh__D051573 Proto-Oncogene Protein pim-1
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 c-pim-1, Proto-Oncogene Protein
% 208.83/209.00 |- skos__broader mesh__D051573smesh__D011518
% 208.83/209.00 |- mesh__dateCreated mesh__D051573 2005-06-30
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D051573 2006
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 Kinase, Pim-1
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 c-pim-1, Proto-Oncogene Proteins
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 Proto Oncogene Protein pim 1
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 Pim 1 Kinase
% 208.83/209.00 |- mesh__recordMaintainer mesh__D051573 DRC
% 208.83/209.00 |- skos__altLabel mesh__D051573 c-pim-1 Protein
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D051573 sjn
% 208.83/209.00 |- mesh__dateEstablished mesh__D051573 2006-01-01
% 208.83/209.00 |- skos__prefLabel mesh__D051573 Proto-Oncogene Proteins c-pim-1
% 208.83/209.00 |- skos__broader mesh__D051573smesh__D017346
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 pim 1 Proto Oncogene Protein
% 208.83/209.00 |- rdf__type mesh__D051573sskos__Concept
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 Proto Oncogene Protein c pim 1
% 208.83/209.00 |- skos__scopeNote mesh__D051573
% 208.83/209.00 Serine-threonine protein kinases that relay signals from CYTOKINE RECEPTORS and are involved in control of CELL GROWTH PROCESSES; CELL DIFFERENTIATION; and APOPTOSIS.%A%
% 208.83/209.00 |- skos__hiddenLabel mesh__D051573 Proto Oncogene Proteins c pim 1
% 208.83/209.00 |- mesh__historyNote mesh__D023882 2002
% 208.83/209.00 |- skos__altLabel mesh__D023882 Eye Dominance
% 208.83/209.00 |- mesh__dateRevised mesh__D023882 2003-07-09
% 208.83/209.00 |- skos__broader mesh__D023882smesh__D043722
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D023882 2002
% 208.83/209.00 |- skos__scopeNote mesh__D023882
% 208.83/209.00 The functional superiority and preferential use of one eye over the other. The term is usually applied to superiority in sighting %28%VISUAL PERCEPTION%29% or motor task but not difference in VISUAL ACUITY or dysfunction of one of the eyes. Ocular dominance can be modified by visual input and neurotrophic factors.%A%
% 208.83/209.00 |- skos__historyNote mesh__D023882 Dominance, Cerebral %28%1967-2001%29%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023882 2006
% 208.83/209.00 |- skos__hiddenLabel mesh__D023882 Ocular Dominance
% 208.83/209.00 |- skos__broader mesh__D023882smesh__D009424
% 208.83/209.00 |- skos__hiddenLabel mesh__D023882 Dominance, Eye
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023882 2005
% 208.83/209.00 |- mesh__dateCreated mesh__D023882 2001-07-25
% 208.83/209.00 |- rdf__type mesh__D023882sskos__Concept
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023882 2004
% 208.83/209.00 |- mesh__dateEstablished mesh__D023882 2002-01-01
% 208.83/209.00 |- skos__prefLabel mesh__D023882 Dominance, Ocular
% 208.83/209.00 |- mesh__recordOriginator mesh__D023084 ags
% 208.83/209.00 |- mesh__recordMaintainer mesh__D023084 ssb
% 208.83/209.00 |- mesh__dateCreated mesh__D023084 2000-06-21
% 208.83/209.00 |- mesh__dateRevised mesh__D023084 2005-06-30
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D023084 sjn
% 208.83/209.00 |- skos__hiddenLabel mesh__D023084 Peptides, Neutrophil Antimicrobial
% 208.83/209.00 |- skos__historyNote mesh__D023084 Anti-Infective Agents %28%1997-2000%29%
% 208.83/209.00 |- skos__hiddenLabel mesh__D023084 alpha Defensins
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D023084 2001
% 208.83/209.00 |- mesh__historyNote mesh__D023084 2001
% 208.83/209.00 |- skos__broader mesh__D023084smesh__D023082
% 208.83/209.00 |- skos__hiddenLabel mesh__D023084 Neutrophil Antimicrobial Peptides
% 208.83/209.00 |- rdf__type mesh__D023084sskos__Concept
% 208.83/209.00 |- skos__scopeNote mesh__D023084
% 208.83/209.00 DEFENSINS found in azurophilic granules of neutrophils and in the secretory granules of intestinal PANETH CELLS.%A%
% 208.83/209.00 |- mesh__dateEstablished mesh__D023084 2001-01-01
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D023084 2006
% 208.83/209.00 |- skos__prefLabel mesh__D023084 alpha-Defensins
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 2001
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 1999
% 208.83/209.00 |- skos__hiddenLabel mesh__D017047 Insurance, Cost-Sharing
% 208.83/209.00 |- skos__annotation mesh__D017047
% 208.83/209.00 restrict to insurance: sharing of costs by both insured %26% insurer%A%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 2004
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 1998
% 208.83/209.00 |- rdf__type mesh__D017047sskos__Concept
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 2000
% 208.83/209.00 |- mesh__dateRevised mesh__D017047 1993-09-16
% 208.83/209.00 |- mesh__dateEstablished mesh__D017047 1992-01-01
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 2003
% 208.83/209.00 |- skos__prefLabel mesh__D017047 Cost Sharing
% 208.83/209.00 |- mesh__recordMaintainer mesh__D017047 PLS
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 1997
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D017047
% 208.83/209.00 92; COST SHARING INSURANCE was see DEDUCTIBLES AND COINSURANCE 1978-91%A%
% 208.83/209.00 |- skos__related mesh__D017047smesh__D006264
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 1996
% 208.83/209.00 |- skos__broader mesh__D017047smesh__D003365
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 1995
% 208.83/209.00 |- mesh__recordOriginator mesh__D017047 PLS
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 2006
% 208.83/209.00 |- mesh__onlineNote mesh__D017047
% 208.83/209.00 use DEDUCTIBLES AND COINSURANCE to search COST SHARING INSURANCE 1978-91%A%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 2002
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D017047 NLM
% 208.83/209.00 |- skos__hiddenLabel mesh__D017047 Sharing, Cost
% 208.83/209.00 |- skos__broader mesh__D017047smesh__D007341
% 208.83/209.00 |- skos__scopeNote mesh__D017047
% 208.83/209.00 Provisions of an insurance policy that require the insured to pay some portion of covered expenses. Several forms of sharing are in use, e.g., deductibles, coinsurance, and copayments. Cost sharing does not refer to or include amounts paid in premiums for the coverage. %28%From Dictionary of Health Services Management, 2d ed%29%%A%
% 208.83/209.00 |- mesh__historyNote mesh__D017047
% 208.83/209.00 92; COST SHARING INSURANCE was see DEDUCTIBLES AND COINSURANCE 1978-91%A%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D017047 2005
% 208.83/209.00 |- skos__related mesh__D017047smesh__D008329
% 208.83/209.00 |- mesh__dateCreated mesh__D017047 1991-06-20
% 208.83/209.00 |- skos__hiddenLabel mesh__D017047 Cost Sharing Insurance
% 208.83/209.00 |- skos__historyNote mesh__D017047
% 208.83/209.00 Deductibles and Coinsurance %28%1968-1991%29%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003825 2006
% 208.83/209.00 |- mesh__publicMeSHNote mesh__D003825 65
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003825 2001
% 208.83/209.00 |- mesh__dateCreated mesh__D003825 1999-01-01
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003825 2003
% 208.83/209.00 |- mesh__recordOriginator mesh__D003825 NLM
% 208.83/209.00 |- skos__prefLabel mesh__D003825 Denture, Complete, Immediate
% 208.83/209.00 |- skos__broader mesh__D003825smesh__D003824
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003825 2004
% 208.83/209.00 |- mesh__dateEstablished mesh__D003825 1965-01-01
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003825 1998
% 208.83/209.00 |- rdf__type mesh__D003825sskos__Concept
% 208.83/209.00 |- mesh__recordAuthorizer mesh__D003825 SJN
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003825 2002
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003825 1999
% 208.83/209.00 |- mesh__historyNote mesh__D003825 65
% 208.83/209.00 |- mesh__recordMaintainer mesh__D003825 PXP
% 208.83/209.00 |- skos__scopeNote mesh__D003825
% 208.83/209.00 A complete denture constructed for replacement of natural teeth immediately after their removal. It does not fit the mouth perfectly and is intended only for functional and cosmetic purposes during the healing process after total extraction. It is to be replaced by the fitted permanent denture.%A%
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003825 2000
% 208.83/209.00 |- mesh__activeMeSHYear mesh__D003825 2005
% 208.83/209.00 |- mesh__dateRevised mesh__D003825 1997-06-20
% 208.83/209.00 |- skos__prefLabel mesh__D036201 Receptor, EphB5
% 208.83/209.00 |- skos__altLabel mesh__D036201 Receptor Tyrosine Kinase Cek9
% 208.83/209.00 |- mesh__recordMaintainer mesh__D036201 jmp
% 208.83/209.00 |- skos__altLabel mesh__D036201 Cek9 Kinase
% 208.83/209.01 |- mesh__activeMeSHYear mesh__D036201 2006
% 208.83/209.01 |- skos__historyNote mesh__D036201
% 208.83/209.01 Receptor Protein-Tyrosine Kinases %28%1993-2002%29%
% 208.83/209.01 |- mesh__dateRevised mesh__D036201 2005-06-30
% 208.83/209.01 |- mesh__publicMeSHNote mesh__D036201
% 208.83/209.01 2003; RECEPTOR TYROSINE KINASE CEK9 %28%now RECEPTOR, EPHB5 %29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1996-2002%A%
% 208.83/209.01 |- skos__altLabel mesh__D036201 EphB5 Receptor
% 208.83/209.01 |- skos__broader mesh__D036201smesh__D036081
% 208.83/209.01 |- skos__scopeNote mesh__D036201
% 208.83/209.01 An eph family receptor found at high levels in adult THYMUS and RETINA. In embryonic tissues it is found in many developing organs.%A%
% 208.83/209.01 |- mesh__recordAuthorizer mesh__D036201 sjn
% 208.83/209.01 |- mesh__dateEstablished mesh__D036201 2003-01-01
% 208.83/209.01 |- mesh__historyNote mesh__D036201
% 208.83/209.01 2003; use RECEPTOR, EPHB5 %28%NM%29% 1996-2002, for EPHB5 RECEPTOR use EPHB2 RECEPTOR %28%NM%29% 1999-2002%A%
% 208.86/209.01 |- mesh__dateCreated mesh__D036201 2002-07-03
% 208.86/209.01 |- rdf__type mesh__D036201sskos__Concept
% 208.86/209.01 |- mesh__recordOriginator mesh__D036201 jmp
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cephalgia, Histamine
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Syndrome, Horton%27%s
% 208.86/209.01 |- skos__altLabel mesh__D003027 Neuralgic Migraine
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Headache, Chronic Cluster
% 208.86/209.01 |- mesh__dateEstablished mesh__D003027 1991-01-01
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Neuralgic Migraines
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cluster Headache Syndromes
% 208.86/209.01 |- skos__altLabel mesh__D003027 Ciliary Neuralgia
% 208.86/209.01 |- skos__altLabel mesh__D003027 Histamine Cephalgia
% 208.86/209.01 |- rdf__type mesh__D003027sskos__Concept
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Syndrome, Horton
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Hortons Syndrome
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Headache Syndrome, Cluster
% 208.86/209.01 |- skos__scopeNote mesh__D003027
% 208.86/209.01 A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A%
% 208.86/209.01 |- mesh__historyNote mesh__D003027 1991%28%1978%29%
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Headache, Episodic Cluster
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cluster Headaches, Episodic
% 208.86/209.01 |- skos__altLabel mesh__D003027 Chronic Cluster Headache
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Headache Syndromes, Cluster
% 208.86/209.01 |- skos__broader mesh__D003027smesh__D051303
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cluster Headaches, Atypical
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Syndromes, Cluster Headache
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Neuralgias, Ciliary
% 208.86/209.01 |- skos__historyNote mesh__D003027 Headache %28%1966-1977%29%
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Atypical Cluster Headaches
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D003027
% 208.86/209.01 1991; see VASCULAR HEADACHE 1978-1990
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Headaches, Atypical Cluster
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Migraine, Neuralgic
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Ciliary Neuralgias
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Headaches, Chronic Cluster
% 208.86/209.01 |- mesh__dateCreated mesh__D003027 1977-05-13
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Episodic Cluster Headaches
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Headaches, Cluster
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cephalgias, Histamine
% 208.86/209.01 |- skos__altLabel mesh__D003027 Headache, Cluster
% 208.86/209.01 |- mesh__recordOriginator mesh__D003027 AEP
% 208.86/209.01 |- skos__altLabel mesh__D003027 Horton Syndrome
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Headache, Atypical Cluster
% 208.86/209.01 |- mesh__dateRevised mesh__D003027 2005-06-30
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Neuralgia, Ciliary
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003027 2006
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cluster Headache, Episodic
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Syndrome, Cluster Headache
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Headaches, Episodic Cluster
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cluster Headache, Chronic
% 208.86/209.01 |- skos__historyNote mesh__D003027 Vascular Headache %28%1966-1977%29%
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Histamine Cephalgias
% 208.86/209.01 |- skos__altLabel mesh__D003027 Cluster Headache Syndrome
% 208.86/209.01 |- mesh__recordMaintainer mesh__D003027 lkt
% 208.86/209.01 |- skos__prefLabel mesh__D003027 Cluster Headache
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cluster Headaches
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D003027 sjn
% 208.86/209.01 |- skos__altLabel mesh__D003027 Horton%27%s Syndrome
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Chronic Cluster Headaches
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Migraines, Neuralgic
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cluster Headache, Atypical
% 208.86/209.01 |- skos__hiddenLabel mesh__D003027 Cluster Headaches, Chronic
% 208.86/209.01 |- skos__related mesh__D008510smesh__D016303
% 208.86/209.01 |- skos__historyNote mesh__D008510
% 208.86/209.01 Pharmacy Service, Hospital %28%1966-1967%29%
% 208.86/209.01 |- skos__prefLabel mesh__D008510 Medication Systems, Hospital
% 208.86/209.01 |- skos__related mesh__D008510smesh__D050316
% 208.86/209.01 |- skos__altLabel mesh__D008510 Hospital Unit Dose Drug Distribution System
% 208.86/209.01 |- skos__scopeNote mesh__D008510
% 208.86/209.01 Overall systems, traditional or automated, to provide medication to patients in hospitals. Elements of the system are: handling the physician%27%s order, transcription of the order by nurse and/or pharmacist, filling the medication order, transfer to the nursing unit, and administration to the patient.%A%
% 208.86/209.01 |- skos__altLabel mesh__D008510 Medication System, Hospital
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 System, Medication Hospital
% 208.86/209.01 |- skos__altLabel mesh__D008510 Hospital Drug Distribution Systems
% 208.86/209.01 |- mesh__dateCreated mesh__D008510 1999-01-01
% 208.86/209.01 |- skos__altLabel mesh__D008510 System Hospital Medication
% 208.86/209.01 |- skos__annotation mesh__D008510
% 208.86/209.01 an organizational concept in hospital patient care for providing medication; do not confuse with DRUG DELIVERY SYSTEMS; DF: MEDICATION SYSTEMS HOSP%A%
% 208.86/209.01 |- skos__broader mesh__D008510smesh__D008509
% 208.86/209.01 |- skos__altLabel mesh__D008510
% 208.86/209.01 Hospital Unit Dose Drug Distribution Systems
% 208.86/209.01 |- skos__altLabel mesh__D008510 Drug Distribution Systems, Hospital
% 208.86/209.01 |- skos__altLabel mesh__D008510 Systems, Medication Hospital
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D008510 2006
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 Systems, Hospital Medication
% 208.86/209.01 |- skos__altLabel mesh__D008510 Hospital Medication Systems
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 Medication Hospital System
% 208.86/209.01 |- skos__altLabel mesh__D008510 Drug Distribution System, Hospital
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 Hospital System, Medication
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 Hospital Medications, System
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 Hospital Medication, System
% 208.86/209.01 |- mesh__dateRevised mesh__D008510 2005-06-30
% 208.86/209.01 |- mesh__recordMaintainer mesh__D008510 ags
% 208.86/209.01 |- skos__broader mesh__D008510smesh__D006739
% 208.86/209.01 |- mesh__onlineNote mesh__D008510
% 208.86/209.01 use MEDICATION SYSTEMS, HOSPITAL to search HOSPITAL MEDICATION SYSTEMS 1968-77%A%
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 Hospital Systems, Medication
% 208.86/209.01 |- mesh__recordOriginator mesh__D008510 NLM
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 System Hospital Medications
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 System, Hospital Medication
% 208.86/209.01 |- rdf__type mesh__D008510sskos__Concept
% 208.86/209.01 |- skos__altLabel mesh__D008510 Hospital Medication System
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D008510 sjn
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 Medication, System Hospital
% 208.86/209.01 |- mesh__historyNote mesh__D008510
% 208.86/209.01 78; was HOSPITAL MEDICATION SYSTEMS 1968-77
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D008510
% 208.86/209.01 78; was HOSPITAL MEDICATION SYSTEMS 1968-77
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 Medications, System Hospital
% 208.86/209.01 |- skos__hiddenLabel mesh__D008510 Medication Hospital Systems
% 208.86/209.01 |- mesh__dateEstablished mesh__D008510 1968-01-01
% 208.86/209.01 |- skos__annotation mesh__D013455 S-32
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D013455 SJN
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D013455 2005
% 208.86/209.01 |- skos__related mesh__D013455smesh__D013462
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D013455 2002
% 208.86/209.01 |- mesh__recordOriginator mesh__D013455 NLM
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D013455 1999
% 208.86/209.01 |- skos__scopeNote mesh__D013455
% 208.86/209.01 An element that is a member of the chalcogen family. It has an atomic symbol S, atomic number 16, and atomic weight 32.066. It is found in the amino acids cysteine and methionine.%A%
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D013455 2004
% 208.86/209.01 |- rdf__type mesh__D013455sskos__Concept
% 208.86/209.01 |- skos__related mesh__D013455smesh__D013460
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D013455 2001
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D013455 1998
% 208.86/209.01 |- mesh__dateRevised mesh__D013455 1997-06-20
% 208.86/209.01 |- skos__prefLabel mesh__D013455 Sulfur
% 208.86/209.01 |- mesh__dateCreated mesh__D013455 1999-01-01
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D013455 2003
% 208.86/209.01 |- mesh__recordMaintainer mesh__D013455 ADP
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D013455 2000
% 208.86/209.01 |- skos__broader mesh__D013455smesh__D018011
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D013455 2006
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D007418 2005
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Pseudo-Obstructions, Intestinal
% 208.86/209.01 |- skos__prefLabel mesh__D007418 Intestinal Pseudo-Obstruction
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Intestinal Pseudoobstructions
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Ileus, Paralytic
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Myopathy, Visceral
% 208.86/209.01 |- skos__altLabel mesh__D007418 Intestinal Pseudoobstruction
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418
% 208.86/209.01 Pseudo-Obstruction, Idiopathic Intestinal
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Visceral Myopathies
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418
% 208.86/209.01 Intestinal Pseudo-Obstructions, Idiopathic
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D007418
% 208.86/209.01 87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86%A%
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Intestinal Pseudo-Obstructions
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D007418 2006
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Pseudoobstruction, Intestinal
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Myopathies, Visceral
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418
% 208.86/209.01 Intestinal Pseudo Obstruction, Idiopathic
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D007418 2004
% 208.86/209.01 |- skos__altLabel mesh__D007418 Intestinal Pseudo-Obstruction, Idiopathic
% 208.86/209.01 |- mesh__dateEstablished mesh__D007418 1987-01-01
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D007418 sjn
% 208.86/209.01 |- mesh__dateRevised mesh__D007418 2003-07-09
% 208.86/209.01 |- rdf__type mesh__D007418sskos__Concept
% 208.86/209.01 |- mesh__historyNote mesh__D007418
% 208.86/209.01 87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86, was Prov 1971-74%A%
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Pseudoobstructions, Intestinal
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418
% 208.86/209.01 Idiopathic Intestinal Pseudo-Obstructions
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Idiopathic Intestinal Pseudo-Obstruction
% 208.86/209.01 |- skos__scopeNote mesh__D007418
% 208.86/209.01 A type of ILEUS, a functional not mechanical obstruction of the INTESTINES. This syndrome is caused by a large number of disorders involving the smooth muscles %28%MUSCLE, SMOOTH%29% or the NERVOUS SYSTEM.%A%
% 208.86/209.01 |- skos__annotation mesh__D007418
% 208.86/209.01 coord IM with specific precoord intestinal dis %28%IM%29%; INTESTINAL OBSTRUCTION and ILEUS are also available%A%
% 208.86/209.01 |- skos__altLabel mesh__D007418 Pseudo-Obstruction, Intestinal
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Intestinal Pseudo Obstruction
% 208.86/209.01 |- skos__historyNote mesh__D007418 Intestinal Obstruction %28%1966-1980%29%
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418 Pseudo Obstruction, Intestinal
% 208.86/209.01 |- mesh__dateCreated mesh__D007418 1980-04-07
% 208.86/209.01 |- mesh__recordMaintainer mesh__D007418 lkt
% 208.86/209.01 |- mesh__onlineNote mesh__D007418
% 208.86/209.01 use INTESTINAL PSEUDO-OBSTRUCTION to search INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC 1981-86 %26% PARALYTIC ILEUS 1971-86 %28%as Prov 1971-74%29%%A%
% 208.86/209.01 |- skos__hiddenLabel mesh__D007418
% 208.86/209.01 Pseudo-Obstructions, Idiopathic Intestinal
% 208.86/209.01 |- skos__broader mesh__D007418smesh__D045823
% 208.86/209.01 |- mesh__recordOriginator mesh__D007418 RC
% 208.86/209.01 |- skos__broader mesh__D018140smesh__D018138
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D018140 1994
% 208.86/209.01 |- skos__altLabel mesh__D018140 Goat herpesvirus
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D018140 2003
% 208.86/209.01 |- skos__altLabel mesh__D018140 Caprine herpesvirus 1
% 208.86/209.01 |- skos__hiddenLabel mesh__D018140 herpesviruses, Goat
% 208.86/209.01 |- skos__hiddenLabel mesh__D018140 Varicelloviruses
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D018140 2006
% 208.86/209.01 |- skos__scopeNote mesh__D018140
% 208.86/209.01 A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE. Its species include those causing CHICKENPOX and HERPES ZOSTER in humans %28%HERPESVIRUS 3, HUMAN%29%, as well as several animal viruses.%A%
% 208.86/209.01 |- mesh__dateRevised mesh__D018140 2001-07-25
% 208.86/209.01 |- rdf__type mesh__D018140sskos__Concept
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D018140 2005
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D018140 sjn
% 208.86/209.01 |- skos__hiddenLabel mesh__D018140 herpesvirus, Goat
% 208.86/209.01 |- skos__annotation mesh__D018140
% 208.86/209.01 infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%
% 208.86/209.01 |- mesh__recordOriginator mesh__D018140 AGS
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D018140 2002
% 208.86/209.01 |- mesh__dateCreated mesh__D018140 1993-06-04
% 208.86/209.01 |- mesh__dateEstablished mesh__D018140 1994-01-01
% 208.86/209.01 |- skos__hiddenLabel mesh__D018140 Goat herpesviruses
% 208.86/209.01 |- mesh__recordMaintainer mesh__D018140 ags
% 208.86/209.01 |- skos__prefLabel mesh__D018140 Varicellovirus
% 208.86/209.01 |- mesh__historyNote mesh__D018140 1994
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D018140 2004
% 208.86/209.01 |- skos__broader mesh__D051574smesh__D050579
% 208.86/209.01 |- skos__altLabel mesh__D051574 Classical Pathway C3 Convertase
% 208.86/209.01 |- mesh__recordMaintainer mesh__D051574 lkt
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D051574 2006
% 208.86/209.01 |- skos__historyNote mesh__D051574
% 208.86/209.01 Complement C3-C5 Convertases %28%1979-2005%29%
% 208.86/209.01 |- skos__scopeNote mesh__D051574
% 208.86/209.01 A serine protease that cleaves multiple COMPLEMENT 3 into COMPLEMENT 3A %28%anaphylatoxin%29% and COMPLEMENT 3B in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It is a complex of COMPLEMENT 4B and COMPLEMENT 2A %28%C4b2a%29%.%A%
% 208.86/209.01 |- mesh__historyNote mesh__D051574 2006
% 208.86/209.01 |- skos__historyNote mesh__D051574
% 208.86/209.01 Complement Pathway, Classical %28%1980-2005%29%
% 208.86/209.01 |- mesh__recordOriginator mesh__D051574 lkt
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D051574 2006
% 208.86/209.01 |- rdf__type mesh__D051574sskos__Concept
% 208.86/209.01 |- mesh__dateCreated mesh__D051574 2005-06-30
% 208.86/209.01 |- skos__altLabel mesh__D051574 Classical C3 Convertase
% 208.86/209.01 |- skos__altLabel mesh__D051574 C3 Convertase %28%C4b2a%29%
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D051574 sjn
% 208.86/209.01 |- skos__prefLabel mesh__D051574
% 208.86/209.01 Complement C3 Convertase, Classical Pathway
% 208.86/209.01 |- mesh__dateEstablished mesh__D051574 2006-01-01
% 208.86/209.01 |- skos__hiddenLabel mesh__D051574 C3 Convertase, Classical
% 208.86/209.01 |- skos__broader mesh__D004120smesh__D007096
% 208.86/209.01 |- skos__scopeNote mesh__D004120
% 208.86/209.01 The methyl imidoester of suberic acid used to produce cross links in proteins. Each end of the imidoester will react with an amino group in the protein molecule to form an amidine.%A%
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D004120 2001
% 208.86/209.01 |- skos__historyNote mesh__D004120 Imides %28%1973-1974%29%
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D004120 2000
% 208.86/209.01 |- mesh__dateRevised mesh__D004120 1998-06-10
% 208.86/209.01 |- rdf__type mesh__D004120sskos__Concept
% 208.86/209.01 |- mesh__historyNote mesh__D004120
% 208.86/209.01 91%28%75%29%; was see under IMIDOESTERS 1980-90; was see under IMIDES 1975-79%A%
% 208.86/209.01 |- skos__historyNote mesh__D004120 Dicarboxylic Acids %28%1974%29%
% 208.86/209.01 |- mesh__dateCreated mesh__D004120 1974-11-19
% 208.86/209.01 |- skos__altLabel mesh__D004120 Dimethylsuberimidate
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D004120 SJN
% 208.86/209.01 |- skos__altLabel mesh__D004120 Bismethyl Suberimidate
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D004120 2006
% 208.86/209.01 |- mesh__dateEstablished mesh__D004120 1991-01-01
% 208.86/209.01 |- mesh__recordOriginator mesh__D004120 NLM
% 208.86/209.01 |- skos__prefLabel mesh__D004120 Dimethyl Suberimidate
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D004120 2002
% 208.86/209.01 |- mesh__recordMaintainer mesh__D004120 JAG
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D004120 2004
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D004120 1999
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D004120 2005
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D004120
% 208.86/209.01 91; was see under IMIDOESTERS 1980-90; was see under IMIDES 1975-79%A%
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D004120 2003
% 208.86/209.01 |- skos__hiddenLabel mesh__D004120 Suberimidate, Bismethyl
% 208.86/209.01 |- skos__hiddenLabel mesh__D004120 Suberimidate, Dimethyl
% 208.86/209.01 |- skos__historyNote mesh__D017846 Ligaments, Articular %28%1968-1993%29%
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Posterior Longitudinal Ligaments
% 208.86/209.01 |- mesh__historyNote mesh__D017846 94
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 2001
% 208.86/209.01 |- skos__prefLabel mesh__D017846 Longitudinal Ligaments
% 208.86/209.01 |- skos__scopeNote mesh__D017846
% 208.86/209.01 Two extensive fibrous bands running the length of the vertebral column. The anterior longitudinal ligament %28%ligamentum longitudinale anterius; lacertus medius%29% interconnects the anterior surfaces of the vertebral bodies; the posterior longitudinal ligament %28%ligamentum longitudinale posterius%29% interconnects the posterior surfaces. The commonest clinical consideration is OSSIFICATION OF POSTERIOR LONGITUDINAL LIGAMENT. %28%From Stedman, 25th ed%29%%A%
% 208.86/209.01 |- skos__annotation mesh__D017846
% 208.86/209.01 spinal ligaments; LIGAMENTUM FLAVUM, a vertebral ligament, is also available%A%
% 208.86/209.01 |- skos__historyNote mesh__D017846 Ligaments %28%1967-1993%29%
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Ligaments, Longitudinal
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Anterior Longitudinal Ligaments
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 1999
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Longitudinal Ligaments, Posterior
% 208.86/209.01 |- mesh__dateEstablished mesh__D017846 1994-01-01
% 208.86/209.01 |- skos__altLabel mesh__D017846 Ligamentum Longitudinale
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 2000
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Ligament, Longitudinal
% 208.86/209.01 |- mesh__dateCreated mesh__D017846 1993-02-16
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Ligament, Anterior Longitudinal
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Longitudinal Ligament, Posterior
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 2004
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Ligament, Posterior Longitudinal
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 1998
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Longitudinal Ligament
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D017846 94
% 208.86/209.01 |- skos__broader mesh__D017846smesh__D008023
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 2003
% 208.86/209.01 |- rdf__type mesh__D017846sskos__Concept
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 1995
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Ligaments, Anterior Longitudinal
% 208.86/209.01 |- skos__related mesh__D017846smesh__D017887
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Longitudinal Ligament, Anterior
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 2002
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 1994
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 2006
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 1997
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Ligaments, Posterior Longitudinal
% 208.86/209.01 |- skos__hiddenLabel mesh__D017846 Longitudinal Ligaments, Anterior
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 2005
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017846 1996
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017048 2004
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Treatment Cost
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D017048 SJN
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Cost, Treatment
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D017048 92
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017048 1999
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Costs, Healthcare
% 208.86/209.01 |- mesh__historyNote mesh__D017048 92
% 208.86/209.01 |- skos__scopeNote mesh__D017048
% 208.86/209.01 The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost.%A%
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017048 2005
% 208.86/209.01 |- mesh__recordOriginator mesh__D017048 PLS
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Cost, Health Care
% 208.86/209.01 |- skos__broader mesh__D017048smesh__D003695
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Cost, Healthcare
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Costs, Health Care
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Costs, Treatment
% 208.86/209.01 |- skos__historyNote mesh__D017048
% 208.86/209.01 Costs and Cost Analysis %28%1966-1991%29%
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017048 2000
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Medical Care Cost
% 208.86/209.01 |- skos__historyNote mesh__D017048 Health Expenditures %28%1968-1991%29%
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Healthcare Cost
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017048 2006
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Costs, Health
% 208.86/209.01 |- skos__prefLabel mesh__D017048 Health Care Costs
% 208.86/209.01 |- mesh__dateRevised mesh__D017048 1997-06-20
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Health Cost
% 208.86/209.01 |- mesh__recordMaintainer mesh__D017048 TPW
% 208.86/209.01 |- skos__altLabel mesh__D017048 Health Costs
% 208.86/209.01 |- skos__altLabel mesh__D017048 Costs, Medical Care
% 208.86/209.01 |- mesh__dateCreated mesh__D017048 1991-06-20
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017048 2001
% 208.86/209.01 |- mesh__dateEstablished mesh__D017048 1992-01-01
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Cost, Medical Care
% 208.86/209.01 |- skos__broader mesh__D017048smesh__D003365
% 208.86/209.01 |- skos__annotation mesh__D017048
% 208.86/209.01 actual cost of providing care: do not confuse with HEALTH EXPENDITURES %28%the amount paid for the service%29% or with FEES AND CHARGES %28%the amount charged regardless of cost%29%; do not confuse with COST OF ILLNESS which is a personal cost %28%psychol, social, etc.%29% as well as a monetary cost for services%A%
% 208.86/209.01 |- skos__altLabel mesh__D017048 Healthcare Costs
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017048 2002
% 208.86/209.01 |- rdf__type mesh__D017048sskos__Concept
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017048 2003
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Health Care Cost
% 208.86/209.01 |- skos__related mesh__D017048smesh__D005102
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D017048 1998
% 208.86/209.01 |- skos__hiddenLabel mesh__D017048 Cost, Health
% 208.86/209.01 |- skos__prefLabel mesh__D003826 Denture, Complete, Lower
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003826 2000
% 208.86/209.01 |- mesh__dateRevised mesh__D003826 1997-06-20
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003826 2004
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003826 1998
% 208.86/209.01 |- rdf__type mesh__D003826sskos__Concept
% 208.86/209.01 |- skos__scopeNote mesh__D003826
% 208.86/209.01 A complete denture replacing all the natural mandibular teeth and associated structures. It is completely supported by the oral tissue and underlying mandibular bone.%A%
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D003826 65
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003826 2001
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003826 1999
% 208.86/209.01 |- mesh__recordOriginator mesh__D003826 NLM
% 208.86/209.01 |- skos__broader mesh__D003826smesh__D003824
% 208.86/209.01 |- mesh__historyNote mesh__D003826 65
% 208.86/209.01 |- mesh__dateEstablished mesh__D003826 1965-01-01
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D003826 SJN
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003826 2005
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003826 2002
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003826 2006
% 208.86/209.01 |- mesh__recordMaintainer mesh__D003826 PXP
% 208.86/209.01 |- mesh__dateCreated mesh__D003826 1999-01-01
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003826 2003
% 208.86/209.01 |- mesh__dateEstablished mesh__D003028 1991-01-01
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003028 2006
% 208.86/209.01 |- mesh__dateRevised mesh__D003028 2000-06-22
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003028 2003
% 208.86/209.01 |- skos__hiddenLabel mesh__D003028 Carbodiimide, CME
% 208.86/209.01 |- mesh__historyNote mesh__D003028
% 208.86/209.01 91%28%75%29%; was see under CARBODIIMIDES 1975-90
% 208.86/209.01 |- mesh__publicMeSHNote mesh__D003028
% 208.86/209.01 91; was see under CARBODIIMIDES 1975-90
% 208.86/209.01 |- skos__altLabel mesh__D003028 CMEC
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003028 2005
% 208.86/209.01 |- skos__historyNote mesh__D003028 Morpholines %28%1974%29%
% 208.86/209.01 |- skos__historyNote mesh__D003028 Tosyl Compounds %28%1974%29%
% 208.86/209.01 |- rdf__type mesh__D003028sskos__Concept
% 208.86/209.01 |- mesh__recordMaintainer mesh__D003028 CCR
% 208.86/209.01 |- mesh__recordOriginator mesh__D003028 MEG
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D003028 sjn
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003028 2002
% 208.86/209.01 |- mesh__dateCreated mesh__D003028 1974-11-19
% 208.86/209.01 |- skos__prefLabel mesh__D003028 CME-Carbodiimide
% 208.86/209.01 |- skos__historyNote mesh__D003028 Carbodiimides %28%1974%29%
% 208.86/209.01 |- skos__broader mesh__D003028smesh__D002234
% 208.86/209.01 |- skos__altLabel mesh__D003028
% 208.86/209.01 4-%28%2-%28%%28%Cyclohexylimidocarbonyl%29%amino%29%ethyl%29%-4-methylmorpholinium
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003028 2001
% 208.86/209.01 |- skos__altLabel mesh__D003028 CME Carbodiimide
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D003028 2004
% 208.86/209.01 |- skos__related mesh__D008511smesh__D004501
% 208.86/209.01 |- mesh__recordMaintainer mesh__D008511 sjn
% 208.86/209.01 |- skos__broader mesh__D008511smesh__D006281
% 208.86/209.01 |- skos__scopeNote mesh__D008511
% 208.86/209.01 The art and science of preventing, diagnosing, and treating disease, as well as the maintenance of health.%A%
% 208.86/209.01 |- skos__related mesh__D008511smesh__D006666
% 208.86/209.01 |- mesh__recordAuthorizer mesh__D008511 sjn
% 208.86/209.01 |- skos__prefLabel mesh__D008511 Medicine
% 208.86/209.01 |- mesh__recordOriginator mesh__D008511 NLM
% 208.86/209.01 |- mesh__dateRevised mesh__D008511 2004-07-13
% 208.86/209.01 |- skos__annotation mesh__D008511
% 208.86/209.01 medicine only as a field, profession or discipline: differentiate from DELIVERY OF HEALTH CARE where the patient is emphasized %28%see MeSH definition there%29%; very general; avoid; it is divided broadly into experimental medicine %28% = BIOMEDICAL RESEARCH%29% %26% CLINICAL MEDICINE, a specialty devoted to the diag %26% management of human patients; /legislation %26% jurisprudence = LEGISLATION, MEDICAL or JURISPRUDENCE or FORENSIC MEDICINE; legal med = FORENSIC MEDICINE or JURISPRUDENCE%A%
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D008511 2006
% 208.86/209.01 |- mesh__activeMeSHYear mesh__D008511 2005
% 208.86/209.01 |- mesh__dateCreated mesh__D008511 1999-01-01
% 208.86/209.01 |- skos__related mesh__D008511smesh__D004470
% 208.86/209.02 |- skos__related mesh__D008511smesh__D007883
% 208.86/209.02 |- rdf__type mesh__D008511sskos__Concept
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 2000
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 1996
% 208.86/209.02 |- mesh__recordMaintainer mesh__D013456 PLS
% 208.86/209.02 |- skos__prefLabel mesh__D013456 Sulfur Acids
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 1999
% 208.86/209.02 |- skos__hiddenLabel mesh__D013456 Acids, Sulfur
% 208.86/209.02 |- mesh__dateEstablished mesh__D013456 1994-01-01
% 208.86/209.02 |- skos__annotation mesh__D013456 do not confuse with SULFURIC ACIDS
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D013456 PLS
% 208.86/209.02 |- mesh__historyNote mesh__D013456
% 208.86/209.02 94; was NON MESH 1971-93; SULFUROUS ACIDS was heading 1968-93%A%
% 208.86/209.02 |- skos__broader mesh__D013456smesh__D013457
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 2004
% 208.86/209.02 |- rdf__type mesh__D013456sskos__Concept
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 2002
% 208.86/209.02 |- mesh__dateRevised mesh__D013456 1995-06-29
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 1998
% 208.86/209.02 |- skos__scopeNote mesh__D013456
% 208.86/209.02 Inorganic or organic acids that contain sulfur as an integral part of the molecule.%A%
% 208.86/209.02 |- skos__broader mesh__D013456smesh__D000148
% 208.86/209.02 |- mesh__dateCreated mesh__D013456 1999-01-01
% 208.86/209.02 |- mesh__onlineNote mesh__D013456
% 208.86/209.02 use SULFUR ACIDS to search SULFUROUS ACIDS 1968-93
% 208.86/209.02 |- mesh__recordOriginator mesh__D013456 NLM
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 2003
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 2006
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D013456
% 208.86/209.02 94; SULFUROUS ACIDS was heading 1968-93
% 208.86/209.02 |- skos__hiddenLabel mesh__D013456 Acids, Sulfurous
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 2001
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 2005
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013456 1997
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D007419 SJN
% 208.86/209.02 |- skos__hiddenLabel mesh__D007419 Secretions, Intestinal
% 208.86/209.02 |- skos__hiddenLabel mesh__D007419 Intestinal Secretion
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D007419 2004
% 208.86/209.02 |- skos__hiddenLabel mesh__D007419 Secretion, Intestinal
% 208.86/209.02 |- skos__prefLabel mesh__D007419 Intestinal Secretions
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D007419 2003
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D007419 2006
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D007419 1999
% 208.86/209.02 |- mesh__recordOriginator mesh__D007419 NLM
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D007419 2005
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D007419 2002
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D007419 1998
% 208.86/209.02 |- mesh__dateRevised mesh__D007419 1997-06-20
% 208.86/209.02 |- rdf__type mesh__D007419sskos__Concept
% 208.86/209.02 |- skos__broader mesh__D007419smesh__D012634
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D007419 2001
% 208.86/209.02 |- skos__related mesh__D007419smesh__D005768
% 208.86/209.02 |- mesh__recordMaintainer mesh__D007419 PXP
% 208.86/209.02 |- mesh__dateCreated mesh__D007419 1999-01-01
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D007419 2000
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018141 2006
% 208.86/209.02 |- skos__broader mesh__D018141smesh__D006564
% 208.86/209.02 |- mesh__dateRevised mesh__D018141 2005-07-13
% 208.86/209.02 |- rdf__type mesh__D018141sskos__Concept
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018141 2005
% 208.86/209.02 |- skos__prefLabel mesh__D018141 Betaherpesvirinae
% 208.86/209.02 |- skos__scopeNote mesh__D018141
% 208.86/209.02 A subfamily of HERPESVIRIDAE characterized by a relatively long replication cycle. Genera include: CYTOMEGALOVIRUS; MUROMEGALOVIRUS; and ROSEOLOVIRUS.%A%
% 208.86/209.02 |- mesh__recordMaintainer mesh__D018141 ags
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D018141 94
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018141 2004
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018141 2006A
% 208.86/209.02 |- mesh__historyNote mesh__D018141 94
% 208.86/209.02 |- skos__annotation mesh__D018141
% 208.86/209.02 infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D018141 ags
% 208.86/209.02 |- mesh__recordOriginator mesh__D018141 AGS
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018141 2002
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018141 2003
% 208.86/209.02 |- mesh__dateCreated mesh__D018141 1993-06-04
% 208.86/209.02 |- mesh__dateEstablished mesh__D018141 1994-01-01
% 208.86/209.02 |- mesh__recordMaintainer mesh__D051575 DRC
% 208.86/209.02 |- mesh__historyNote mesh__D051575 2006%28%1987%29%
% 208.86/209.02 |- mesh__dateCreated mesh__D051575 2005-06-30
% 208.86/209.02 |- skos__broader mesh__D051575smesh__D019061
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 Proto Oncogene Protein yes
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D051575
% 208.86/209.02 2006; PROTO-ONCOGENE PROTEIN C-YES was indexed under SCR-FAMILY KINASES 2005, %26% under PROTO-ONCOGENE PROTEINS 1987-2005, %26% under PROTEIN-TYROSINE KINASE 1987-2004%A%
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 c-yes, Proto-Oncogene Protein
% 208.86/209.02 |- skos__altLabel mesh__D051575 yes Proto-Oncogene Protein
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D051575 2006
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 yes Proto Oncogene Protein
% 208.86/209.02 |- skos__altLabel mesh__D051575 Proto-Oncogene Protein c-yes
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D051575 sjn
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 yes, Proto-Oncogene Protein
% 208.86/209.02 |- mesh__recordOriginator mesh__D051575 DRC
% 208.86/209.02 |- skos__scopeNote mesh__D051575
% 208.86/209.02 Members of the src-family tyrosine kinases that are activated during the transition from G2 PHASE to M PHASE of the CELL CYCLE. It is highly homologous to PROTO-ONCOGENE PROTEIN PP60%28%C-SRC%29%.%A%
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 Proto Oncogene Proteins c yes
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 c yes Protein
% 208.86/209.02 |- mesh__dateEstablished mesh__D051575 2006-01-01
% 208.86/209.02 |- skos__broader mesh__D051575smesh__D011518
% 208.86/209.02 |- rdf__type mesh__D051575sskos__Concept
% 208.86/209.02 |- skos__altLabel mesh__D051575 Proto-Oncogene Protein yes
% 208.86/209.02 |- skos__altLabel mesh__D051575 c-yes Proto-Oncogene Protein
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 c-yes, Proto-Oncogene Proteins
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 Proto Oncogene Protein c yes
% 208.86/209.02 |- skos__prefLabel mesh__D051575 Proto-Oncogene Proteins c-yes
% 208.86/209.02 |- skos__altLabel mesh__D051575 c-yes Protein
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 Proto-Oncogene Protein, yes
% 208.86/209.02 |- skos__hiddenLabel mesh__D051575 Proto-Oncogene Protein, c-yes
% 208.86/209.02 |- skos__altLabel mesh__D004121 Dimethylsulfoxide
% 208.86/209.02 |- mesh__historyNote mesh__D004121 65%28%64%29%
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D004121 65
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D004121 2006
% 208.86/209.02 |- mesh__recordMaintainer mesh__D004121 exl
% 208.86/209.02 |- skos__hiddenLabel mesh__D004121 Sulphoxide, Dimethyl
% 208.86/209.02 |- skos__altLabel mesh__D004121 Shire Brand of Dimethyl Sulfoxide
% 208.86/209.02 |- skos__broader mesh__D004121smesh__D013454
% 208.86/209.02 |- skos__altLabel mesh__D004121 Dimethylsulphinyl
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D004121 sjn
% 208.86/209.02 |- skos__altLabel mesh__D004121 Dimethyl Sulphoxide
% 208.86/209.02 |- skos__altLabel mesh__D004121 DMSO
% 208.86/209.02 |- skos__altLabel mesh__D004121
% 208.86/209.02 Research Ind. Corp. Brand 1 of Dimethyl Sulfoxide
% 208.86/209.02 |- skos__prefLabel mesh__D004121 Dimethyl Sulfoxide
% 208.86/209.02 |- skos__altLabel mesh__D004121 Merckle Brand of Dimethyl Sulfoxide
% 208.86/209.02 |- mesh__dateRevised mesh__D004121 2005-06-30
% 208.86/209.02 |- skos__scopeNote mesh__D004121
% 208.86/209.02 A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during cryopreservation. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.%A%
% 208.86/209.02 |- skos__altLabel mesh__D004121 Sulfinylbis%28%methane%29%
% 208.86/209.02 |- mesh__dateCreated mesh__D004121 1999-01-01
% 208.86/209.02 |- skos__altLabel mesh__D004121 Dimethylsulphoxide
% 208.86/209.02 |- mesh__dateEstablished mesh__D004121 1965-01-01
% 208.86/209.02 |- skos__hiddenLabel mesh__D004121 Sulfoxide, Dimethyl
% 208.86/209.02 |- rdf__type mesh__D004121sskos__Concept
% 208.86/209.02 |- skos__altLabel mesh__D004121
% 208.86/209.02 Research Ind. Corp. Brand 2 of Dimethyl Sulfoxide
% 208.86/209.02 |- mesh__recordOriginator mesh__D004121 NLM
% 208.86/209.02 |- skos__scopeNote mesh__D017847
% 208.86/209.02 The central portion of the common tendon of the QUADRICEPS FEMORIS. It is attached to the apex of the PATELLA and to the lower part of the tubercle of the TIBIA.%A%
% 208.86/209.02 |- mesh__dateCreated mesh__D017847 1993-02-16
% 208.86/209.02 |- mesh__recordOriginator mesh__D017847 TGC
% 208.86/209.02 |- skos__annotation mesh__D017847
% 208.86/209.02 an artic ligament between patella %26% tibia: do not confuse with MEDIAL COLLATERAL LIGAMENT, KNEE, between tibia %26% femur%A%
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D017847 sjn
% 208.86/209.02 |- skos__prefLabel mesh__D017847 Patellar Ligament
% 208.86/209.02 |- mesh__recordMaintainer mesh__D017847 ags
% 208.86/209.02 |- rdf__type mesh__D017847sskos__Concept
% 208.86/209.02 |- mesh__dateEstablished mesh__D017847 1994-01-01
% 208.86/209.02 |- skos__historyNote mesh__D017847 Ligaments %28%1968-1993%29%
% 208.86/209.02 |- skos__altLabel mesh__D017847 Ligamentum Patellae
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017847 2006
% 208.86/209.02 |- skos__related mesh__D017847smesh__D016119
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D017847 94
% 208.86/209.02 |- skos__broader mesh__D017847smesh__D008023
% 208.86/209.02 |- skos__related mesh__D017847smesh__D017888
% 208.86/209.02 |- skos__historyNote mesh__D017847 Ligaments, Articular %28%1968-1993%29%
% 208.86/209.02 |- skos__hiddenLabel mesh__D017847 Ligaments, Patellar
% 208.86/209.02 |- mesh__historyNote mesh__D017847 94
% 208.86/209.02 |- skos__hiddenLabel mesh__D017847 Ligament, Patellar
% 208.86/209.02 |- skos__related mesh__D017847smesh__D016118
% 208.86/209.02 |- mesh__dateRevised mesh__D017847 2005-06-30
% 208.86/209.02 |- skos__hiddenLabel mesh__D017847 Patellar Ligaments
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 2004
% 208.86/209.02 |- mesh__historyNote mesh__D017049 92
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 2002
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 1996
% 208.86/209.02 |- skos__hiddenLabel mesh__D017049 Health Cost, Employer
% 208.86/209.02 |- mesh__dateCreated mesh__D017049 1991-06-20
% 208.86/209.02 |- mesh__recordMaintainer mesh__D017049 PLS
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D017049 NLM
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 1997
% 208.86/209.02 |- skos__altLabel mesh__D017049 Health Costs, Employer
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 2005
% 208.86/209.02 |- skos__historyNote mesh__D017049 Health Expenditures %28%1968-1991%29%
% 208.86/209.02 |- skos__scopeNote mesh__D017049
% 208.86/209.02 That portion of total HEALTH CARE COSTS borne by an individual%27%s or group%27%s employing organization.%A%
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 2000
% 208.86/209.02 |- mesh__recordOriginator mesh__D017049 PLS
% 208.86/209.02 |- mesh__dateRevised mesh__D017049 1993-09-16
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 1995
% 208.86/209.02 |- skos__hiddenLabel mesh__D017049 Employer Health Cost
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 2006
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 2001
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 1998
% 208.86/209.02 |- skos__broader mesh__D017049smesh__D017048
% 208.86/209.02 |- mesh__dateEstablished mesh__D017049 1992-01-01
% 208.86/209.02 |- skos__annotation mesh__D017049 health care cost paid by employer
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 2003
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D017049 92
% 208.86/209.02 |- skos__prefLabel mesh__D017049 Employer Health Costs
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D017049 1999
% 208.86/209.02 |- skos__historyNote mesh__D017049
% 208.86/209.02 Costs and Cost Analysis %28%1966-1991%29%
% 208.86/209.02 |- rdf__type mesh__D017049sskos__Concept
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003827 2006
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003827 2000
% 208.86/209.02 |- mesh__dateRevised mesh__D003827 1997-06-20
% 208.86/209.02 |- skos__scopeNote mesh__D003827
% 208.86/209.02 A complete denture replacing all the natural maxillary teeth and associated maxillary structures. It is completely supported by the oral tissue and underlying maxillary bone.%A%
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003827 2004
% 208.86/209.02 |- mesh__dateEstablished mesh__D003827 1965-01-01
% 208.86/209.02 |- skos__broader mesh__D003827smesh__D003824
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D003827 65
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003827 2005
% 208.86/209.02 |- mesh__dateCreated mesh__D003827 1999-01-01
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003827 2003
% 208.86/209.02 |- rdf__type mesh__D003827sskos__Concept
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003827 2002
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003827 1999
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D003827 SJN
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003827 1998
% 208.86/209.02 |- mesh__recordOriginator mesh__D003827 NLM
% 208.86/209.02 |- skos__prefLabel mesh__D003827 Denture, Complete, Upper
% 208.86/209.02 |- mesh__historyNote mesh__D003827 65
% 208.86/209.02 |- mesh__recordMaintainer mesh__D003827 PXP
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003827 2001
% 208.86/209.02 |- mesh__dateRevised mesh__D003029 2005-06-30
% 208.86/209.02 |- mesh__recordOriginator mesh__D003029 NLM
% 208.86/209.02 |- skos__scopeNote mesh__D003029
% 208.86/209.02 Exogenous substances used to promote blood coagulation. The endogenous BLOOD COAGULATION FACTORS are considered to be coagulants only when administered as drugs.%A%
% 208.86/209.02 |- mesh__dateCreated mesh__D003029 1999-01-01
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D003029 2006
% 208.86/209.02 |- rdf__type mesh__D003029sskos__Concept
% 208.86/209.02 |- skos__prefLabel mesh__D003029 Coagulants
% 208.86/209.02 |- mesh__recordMaintainer mesh__D003029 ssb
% 208.86/209.02 |- mesh__historyNote mesh__D003029 75; was see under HEMOSTATICS 1963-74
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D003029 sjn
% 208.86/209.02 |- skos__historyNote mesh__D003029 Hemostatics %28%1966-1974%29%
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D003029
% 208.86/209.02 75; was see under HEMOSTATICS 1963-74
% 208.86/209.02 |- mesh__onlineNote mesh__D003029 search HEMOSTATICS 1966-74
% 208.86/209.02 |- skos__broader mesh__D003029smesh__D006401
% 208.86/209.02 |- skos__related mesh__D003029smesh__D013917
% 208.86/209.02 |- skos__related mesh__D003029smesh__D001779
% 208.86/209.02 |- skos__annotation mesh__D003029
% 208.86/209.02 consider also BLOOD COAGULATION /drug eff
% 208.86/209.02 |- mesh__dateEstablished mesh__D003029 1975-09-01
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 2000
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 1998
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 1997
% 208.86/209.02 |- skos__hiddenLabel mesh__D008512 Medicine in Arts
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 1996
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D008512 PLS
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 2006
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 2002
% 208.86/209.02 |- skos__hiddenLabel mesh__D008512 in Arts, Medicine
% 208.86/209.02 |- skos__annotation mesh__D008512
% 208.86/209.02 no qualif; coord IM with med aspect %28%IM%29% + specific art heading %28%IM%29%; DF: MED ART%A%
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 2005
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 2004
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 1995
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 1991
% 208.86/209.02 |- mesh__dateCreated mesh__D008512 1999-01-01
% 208.86/209.02 |- mesh__recordOriginator mesh__D008512 NLM
% 208.86/209.02 |- rdf__type mesh__D008512sskos__Concept
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 2003
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 1993
% 208.86/209.02 |- mesh__recordMaintainer mesh__D008512 TGC
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 1994
% 208.86/209.02 |- skos__hiddenLabel mesh__D008512 Art, Medicine in
% 208.86/209.02 |- skos__hiddenLabel mesh__D008512 in Art, Medicine
% 208.86/209.02 |- skos__prefLabel mesh__D008512 Medicine in Art
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 2001
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 1992
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D008512 1999
% 208.86/209.02 |- skos__broader mesh__D008512smesh__D001154
% 208.86/209.02 |- skos__hiddenLabel mesh__D008512 Arts, Medicine in
% 208.86/209.02 |- mesh__dateRevised mesh__D008512 1990-05-17
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D013457 SJN
% 208.86/209.02 |- skos__scopeNote mesh__D013457
% 208.86/209.02 Inorganic or organic compounds that contain sulfur as an integral part of the molecule.%A%
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013457 1999
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D013457 98
% 208.86/209.02 |- skos__prefLabel mesh__D013457 Sulfur Compounds
% 208.86/209.02 |- rdf__type mesh__D013457sskos__Concept
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013457 2002
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013457 1998
% 208.86/209.02 |- mesh__dateCreated mesh__D013457 1999-01-01
% 208.86/209.02 |- mesh__recordOriginator mesh__D013457 NLM
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013457 2004
% 208.86/209.02 |- skos__annotation mesh__D013457
% 208.86/209.02 GEN or unspecified; prefer specific groups or specific drugs; DF: SULFUR CPDS%A%
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013457 2003
% 208.86/209.02 |- skos__broader mesh__D013457smesh__D009930
% 208.86/209.02 |- skos__hiddenLabel mesh__D013457 Compounds, Sulfur
% 208.86/209.02 |- mesh__recordMaintainer mesh__D013457 ADP
% 208.86/209.02 |- mesh__dateRevised mesh__D013457 1997-06-20
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013457 2001
% 208.86/209.02 |- mesh__dateEstablished mesh__D013457 1998-01-01
% 208.86/209.02 |- mesh__historyNote mesh__D013457 98; use explode 1968-97
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013457 2006
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013457 2000
% 208.86/209.02 |- skos__broader mesh__D013457smesh__D007287
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D013457 2005
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D018940 1996
% 208.86/209.02 |- skos__hiddenLabel mesh__D018940 Elasmobranch
% 208.86/209.02 |- mesh__dateEstablished mesh__D018940 1996-01-01
% 208.86/209.02 |- skos__scopeNote mesh__D018940
% 208.86/209.02 A subclass of cartilaginous fish comprising the SHARKS; rays; skates %28%SKATES %28%FISH%29%;%29%, and sawfish. Elasmobranchs are typically predaceous, relying more on smell %28%the olfactory capsules are relatively large%29% than sight %28%the eyes are relatively small%29% for obtaining their food.%A%
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D018940 ags
% 208.86/209.02 |- mesh__recordOriginator mesh__D018940 PXP
% 208.86/209.02 |- mesh__dateCreated mesh__D018940 1995-06-05
% 208.86/209.02 |- skos__prefLabel mesh__D018940 Elasmobranchii
% 208.86/209.02 |- skos__altLabel mesh__D018940 Elasmobranchs
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018940 2006A
% 208.86/209.02 |- mesh__dateRevised mesh__D018940 2005-07-29
% 208.86/209.02 |- mesh__historyNote mesh__D018940 1996
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018940 2004
% 208.86/209.02 |- mesh__recordMaintainer mesh__D018940 ags
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018940 2006
% 208.86/209.02 |- rdf__type mesh__D018940sskos__Concept
% 208.86/209.02 |- skos__annotation mesh__D018940
% 208.86/209.02 GEN or unspecified; SHARKS; DOGFISH; SKATES %28%FISH%29% are also available%A%
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018940 2005
% 208.86/209.02 |- skos__historyNote mesh__D018940 Fishes %28%1966-1995%29%
% 208.86/209.02 |- skos__hiddenLabel mesh__D018940 Elasmobranchius
% 208.86/209.02 |- skos__broader mesh__D018940smesh__D005399
% 208.86/209.02 |- skos__hiddenLabel mesh__D018142 Lymphoproliferative Virus
% 208.86/209.02 |- skos__prefLabel mesh__D018142 Gammaherpesvirinae
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018142 2006
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D018142 sjn
% 208.86/209.02 |- mesh__dateCreated mesh__D018142 1993-06-18
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D018142 94
% 208.86/209.02 |- mesh__dateEstablished mesh__D018142 1994-01-01
% 208.86/209.02 |- rdf__type mesh__D018142sskos__Concept
% 208.86/209.02 |- skos__hiddenLabel mesh__D018142 Viruses, Lymphoproliferative
% 208.86/209.02 |- mesh__recordMaintainer mesh__D018142 ags
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018142 2003
% 208.86/209.02 |- skos__scopeNote mesh__D018142
% 208.86/209.02 A subfamily of HERPESVIRIDAE characterized by variable reproductive cycles. The genera include: LYMPHOCRYPTOVIRUS and RHADINOVIRUS.%A%
% 208.86/209.02 |- skos__hiddenLabel mesh__D018142 Virus, Lymphoproliferative
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018142 2004
% 208.86/209.02 |- mesh__dateRevised mesh__D018142 2001-07-25
% 208.86/209.02 |- skos__broader mesh__D018142smesh__D004263
% 208.86/209.02 |- mesh__historyNote mesh__D018142 94
% 208.86/209.02 |- skos__broader mesh__D018142smesh__D006564
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018142 2002
% 208.86/209.02 |- skos__annotation mesh__D018142
% 208.86/209.02 infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%; if discussed as tumor viruses, add TUMOR VIRUS INFECTIONS %28%IM%29%%A%
% 208.86/209.02 |- mesh__recordOriginator mesh__D018142 AGS
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D018142 2005
% 208.86/209.02 |- skos__altLabel mesh__D018142 Lymphoproliferative Viruses
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D004920 2006A
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D004920 2004
% 208.86/209.02 |- rdf__type mesh__D004920sskos__Concept
% 208.86/209.02 |- skos__scopeNote mesh__D004920
% 208.86/209.02 The production of red blood cells %28%ERYTHROCYTES%29%. In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction.%A%
% 208.86/209.02 |- mesh__recordMaintainer mesh__D004920 ags
% 208.86/209.02 |- mesh__recordOriginator mesh__D004920 NLM
% 208.86/209.02 |- mesh__dateCreated mesh__D004920 1999-01-01
% 208.86/209.02 |- mesh__recordAuthorizer mesh__D004920 ags
% 208.86/209.02 |- skos__broader mesh__D004920smesh__D006410
% 208.86/209.02 |- skos__hiddenLabel mesh__D004920 Erythropoieses
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D004920 2006
% 208.86/209.02 |- mesh__dateRevised mesh__D004920 2005-07-08
% 208.86/209.02 |- skos__prefLabel mesh__D004920 Erythropoiesis
% 208.86/209.02 |- mesh__activeMeSHYear mesh__D004920 2005
% 208.86/209.02 |- skos__hiddenLabel mesh__D004122 Phosphate Synthetase, Dolichyl
% 208.86/209.02 |- mesh__publicMeSHNote mesh__D004122
% 208.86/209.02 97; was DIMETHYLALLYLTRANSFERASE 1979-96 %28%see under TRANSFERASES 1979-90%29%%A%
% 208.88/209.02 |- mesh__activeMeSHYear mesh__D004122 2005
% 208.88/209.02 |- mesh__activeMeSHYear mesh__D004122 2004
% 208.88/209.02 |- mesh__dateEstablished mesh__D004122 1991-01-01
% 208.88/209.02 |- skos__historyNote mesh__D004122 Transferases %28%1966-1978%29%
% 208.88/209.02 |- skos__hiddenLabel mesh__D004122 Pyrophosphate Synthetase, Geranylgeranyl
% 208.88/209.02 |- skos__hiddenLabel mesh__D004122 Synthetase, Dolichyl Phosphate
% 208.88/209.02 |- skos__hiddenLabel mesh__D004122 Synthetase, Nerylpyrophosphate
% 208.88/209.02 |- mesh__recordAuthorizer mesh__D004122 sjn
% 208.88/209.02 |- mesh__dateRevised mesh__D004122 2003-07-09
% 208.88/209.02 |- mesh__historyNote mesh__D004122
% 208.88/209.02 97; was DIMETHYLALLYLTRANSFERASE 1979-96 %28%see under TRANSFERASES 1979-90%29%%A%
% 208.88/209.02 |- skos__altLabel mesh__D004122 Geranylpyrophosphate Synthetase
% 208.88/209.02 |- skos__prefLabel mesh__D004122 Dimethylallyltranstransferase
% 208.88/209.02 |- mesh__recordMaintainer mesh__D004122 ssb
% 208.88/209.02 |- rdf__type mesh__D004122sskos__Concept
% 208.88/209.02 |- skos__scopeNote mesh__D004122
% 208.88/209.02 An enzyme that, in the pathway of cholesterol biosynthesis, catalyzes the condensation of isopentenyl pyrophosphate and dimethylallylpyrophosphate to yield pyrophosphate and geranylpyrophosphate. The enzyme then catalyzes the condensation of the latter compound with another molecule of isopentenyl pyrophosphate to yield pyrophosphate and farnesylpyrophosphate. EC 2.5.1.1.%A%
% 208.88/209.02 |- skos__altLabel mesh__D004122 Prenyltransferase
% 208.88/209.02 |- skos__historyNote mesh__D004122 Allyl Compounds %28%1971-1978%29%
% 208.88/209.02 |- skos__hiddenLabel mesh__D004122 Synthetase, Geranylgeranyl Pyrophosphate
% 208.88/209.02 |- skos__altLabel mesh__D004122 Geranylgeranyl Pyrophosphate Synthetase
% 208.88/209.02 |- skos__altLabel mesh__D004122 Dimethylallyltransferase
% 208.88/209.02 |- skos__altLabel mesh__D004122 Nerylpyrophosphate Synthetase
% 208.88/209.02 |- skos__altLabel mesh__D004122 Dolichyl Phosphate Synthetase
% 208.88/209.02 |- skos__broader mesh__D004122smesh__D019883
% 208.88/209.02 |- mesh__dateCreated mesh__D004122 1978-05-18
% 208.88/209.02 |- skos__hiddenLabel mesh__D004122 Synthetase, Geranylpyrophosphate
% 208.88/209.02 |- skos__hiddenLabel mesh__D004122 Synthetase, Farnesylpyrophosphate
% 208.88/209.02 |- mesh__activeMeSHYear mesh__D004122 2006
% 208.88/209.02 |- mesh__recordOriginator mesh__D004122 RLS
% 208.88/209.02 |- skos__altLabel mesh__D004122 Farnesylpyrophosphate Synthetase
% 208.88/209.02 |- skos__prefLabel mesh__D017848 Blood-Borne Pathogens
% 208.88/209.02 |- mesh__activeMeSHYear mesh__D017848 2006A
% 208.88/209.02 |- mesh__publicMeSHNote mesh__D017848 94
% 208.88/209.02 |- mesh__recordMaintainer mesh__D017848 ags
% 208.88/209.02 |- mesh__activeMeSHYear mesh__D017848 2006
% 208.88/209.02 |- skos__annotation mesh__D017848
% 208.88/209.02 coord with specific pathogen %28%IM%29% if pertinent; do not routinely add as a coordinate for infections in the blood %28%VIREMIA; BACTEREMIA; FUNGEMIA; PARASITEMIA%29%%A%
% 208.88/209.02 |- mesh__activeMeSHYear mesh__D017848 2005
% 208.88/209.02 |- skos__broader mesh__D017848smesh__D000456
% 208.88/209.02 |- skos__broader mesh__D017848smesh__D005658
% 208.88/209.02 |- mesh__historyNote mesh__D017848 94
% 208.88/209.02 |- mesh__recordOriginator mesh__D017848 TGC
% 208.88/209.02 |- skos__scopeNote mesh__D017848
% 208.88/209.02 Infectious organisms in the BLOOD, of which the predominant medical interest is their contamination of blood-soiled linens, towels, gowns, BANDAGES, other items from individuals in risk categories, NEEDLES and other sharp objects, MEDICAL WASTE and DENTAL WASTE, all of which health workers are exposed to. This concept is differentiated from the clinical conditions of BACTEREMIA; VIREMIA; and FUNGEMIA where the organism is present in the blood of a patient as the result of a natural infectious process.%A%
% 208.88/209.02 |- skos__broader mesh__D017848smesh__D011527
% 208.88/209.02 |- skos__related mesh__D017848smesh__D016635
% 208.88/209.02 |- skos__altLabel mesh__D017848 Bloodborne Pathogens
% 208.88/209.02 |- mesh__dateEstablished mesh__D017848 1994-01-01
% 208.88/209.02 |- skos__broader mesh__D017848smesh__D001419
% 208.88/209.02 |- mesh__dateCreated mesh__D017848 1993-02-16
% 208.88/209.02 |- skos__broader mesh__D017848smesh__D014712
% 208.88/209.02 |- skos__broader mesh__D017848smesh__D001105
% 208.88/209.02 |- mesh__dateRevised mesh__D017848 2005-08-03
% 208.88/209.02 |- skos__altLabel mesh__D017848 Pathogens, Blood-Borne
% 208.88/209.02 |- mesh__activeMeSHYear mesh__D017848 2004
% 208.88/209.02 |- mesh__recordAuthorizer mesh__D017848 ags
% 208.88/209.02 |- rdf__type mesh__D017848sskos__Concept
% 208.88/209.02 |- skos__historyNote mesh__D017848 specific organism %28%1987-1993%29%
% 208.88/209.02 |- skos__broader mesh__D042241smesh__D003933
% 208.88/209.02 |- mesh__activeMeSHYear mesh__D042241 2006
% 208.88/209.02 |- skos__annotation mesh__D042241
% 208.88/209.02 IM general only; index NIM if discussed
% 208.88/209.02 |- rdf__type mesh__D042241sskos__Concept
% 208.88/209.02 |- skos__hiddenLabel mesh__D042241 Early Diagnoses
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D042241 2004
% 208.88/209.03 |- mesh__historyNote mesh__D042241 2004
% 208.88/209.03 |- skos__hiddenLabel mesh__D042241 Diagnosis, Early
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D042241 2004
% 208.88/209.03 |- mesh__dateCreated mesh__D042241 2003-07-09
% 208.88/209.03 |- skos__prefLabel mesh__D042241 Early Diagnosis
% 208.88/209.03 |- skos__scopeNote mesh__D042241
% 208.88/209.03 Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME.%A%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D042241 2005
% 208.88/209.03 |- mesh__dateEstablished mesh__D042241 2004-01-01
% 208.88/209.03 |- skos__hiddenLabel mesh__D042241 Diagnoses, Early
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D003828
% 208.88/209.03 74; TELESCOPIC PROSTHESIS was see DENTURE, OVERLAY 1974-92%A%
% 208.88/209.03 |- mesh__recordOriginator mesh__D003828 NLM
% 208.88/209.03 |- skos__hiddenLabel mesh__D003828 Dentures, Overlay
% 208.88/209.03 |- skos__altLabel mesh__D003828 Overdenture
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003828 2005
% 208.88/209.03 |- mesh__dateCreated mesh__D003828 1999-01-01
% 208.88/209.03 |- mesh__recordMaintainer mesh__D003828 PXP
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003828 2001
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003828 2003
% 208.88/209.03 |- skos__hiddenLabel mesh__D003828 Overlay Dentures
% 208.88/209.03 |- rdf__type mesh__D003828sskos__Concept
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003828 2000
% 208.88/209.03 |- mesh__dateRevised mesh__D003828 1997-06-20
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003828 1999
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003828 1998
% 208.88/209.03 |- skos__annotation mesh__D003828
% 208.88/209.03 coord IM with specific denture term %28%IM or NIM%29%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003828 2002
% 208.88/209.03 |- skos__prefLabel mesh__D003828 Denture, Overlay
% 208.88/209.03 |- skos__hiddenLabel mesh__D003828 Overdentures
% 208.88/209.03 |- skos__scopeNote mesh__D003828
% 208.88/209.03 Removable prosthesis constructed over natural teeth or implanted studs.%A%
% 208.88/209.03 |- skos__hiddenLabel mesh__D003828 Overlay Denture
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003828 2006
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D003828 SJN
% 208.88/209.03 |- mesh__dateEstablished mesh__D003828 1974-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003828 2004
% 208.88/209.03 |- mesh__onlineNote mesh__D003828
% 208.88/209.03 use DENTURE, OVERLAY to search TELESCOPIC PROSTHESIS 1974-92%A%
% 208.88/209.03 |- mesh__historyNote mesh__D003828
% 208.88/209.03 74; TELESCOPIC PROSTHESIS was see DENTURE, OVERLAY 1974-92%A%
% 208.88/209.03 |- skos__broader mesh__D003828smesh__D003778
% 208.88/209.03 |- rdf__type mesh__D014550sskos__Concept
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 2004
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 1996
% 208.88/209.03 |- mesh__recordMaintainer mesh__D014550 TGC
% 208.88/209.03 |- skos__prefLabel mesh__D014550 Urinary Incontinence, Stress
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 2002
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 2006
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 1998
% 208.88/209.03 |- skos__hiddenLabel mesh__D014550 Stress Incontinence, Urinary
% 208.88/209.03 |- skos__annotation mesh__D014550
% 208.88/209.03 stress refers to coughing, sneezing %26% other forces
% 208.88/209.03 |- mesh__dateRevised mesh__D014550 1993-06-03
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 1997
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 1994
% 208.88/209.03 |- mesh__dateCreated mesh__D014550 1999-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 1999
% 208.88/209.03 |- skos__hiddenLabel mesh__D014550 Incontinence, Urinary Stress
% 208.88/209.03 |- skos__altLabel mesh__D014550 Urinary Stress Incontinence
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 2000
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 1995
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 2001
% 208.88/209.03 |- mesh__recordOriginator mesh__D014550 NLM
% 208.88/209.03 |- skos__scopeNote mesh__D014550
% 208.88/209.03 The involuntary discharge of urine as a result of anatomic displacement which exerts an opening pull on the bladder orifice. It often occurs during coughing or other forceful stresses. %28%From Dorland, 27th ed%29%%A%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 2003
% 208.88/209.03 |- skos__broader mesh__D014550smesh__D014549
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D014550 PLS
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014550 2005
% 208.88/209.03 |- skos__hiddenLabel mesh__D008513 Literature, Medicine in
% 208.88/209.03 |- skos__prefLabel mesh__D008513 Medicine in Literature
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D008513 2005
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D008513 2004
% 208.88/209.03 |- mesh__dateCreated mesh__D008513 1999-01-01
% 208.88/209.03 |- rdf__type mesh__D008513sskos__Concept
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D008513 2003
% 208.88/209.03 |- mesh__dateRevised mesh__D008513 2001-07-25
% 208.88/209.03 |- mesh__recordMaintainer mesh__D008513 mdb
% 208.88/209.03 |- skos__hiddenLabel mesh__D008513 in Literature, Medicine
% 208.88/209.03 |- skos__broader mesh__D008513smesh__D008091
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D008513 2002
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D008513 sjn
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D008513 2006
% 208.88/209.03 |- mesh__recordOriginator mesh__D008513 NLM
% 208.88/209.03 |- skos__annotation mesh__D008513
% 208.88/209.03 no qualif; coord IM with med aspect %28%IM%29% + specific lit heading %28%IM%29% + literary type if pertinent %28%as POETRY; DRAMA, etc.%29% %28%IM%29%; DF: MED LIT%A%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000530 2004
% 208.88/209.03 |- mesh__historyNote mesh__D000530 2001%28%1975%29%
% 208.88/209.03 |- mesh__dateCreated mesh__D000530 1974-11-11
% 208.88/209.03 |- skos__historyNote mesh__D000530 Drug Combinations %28%1974%29%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000530 2003
% 208.88/209.03 |- mesh__recordMaintainer mesh__D000530 sjn
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D000530 sjn
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D000530
% 208.88/209.03 2000; see ALTHESIN 1980-2000 %26% PREGNANEDIONES 1975-79
% 208.88/209.03 |- skos__prefLabel mesh__D000530 Alfaxalone Alfadolone Mixture
% 208.88/209.03 |- skos__scopeNote mesh__D000530
% 208.88/209.03 A 3:1 mixture of alfaxalone with alfadolone acetate that previously had been used as a general anesthetic. It is no longer actively marketed. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1445%29%%A%
% 208.88/209.03 |- skos__historyNote mesh__D000530 Hydroxysteroids %28%1974%29%
% 208.88/209.03 |- skos__hiddenLabel mesh__D000530 CT 1341
% 208.88/209.03 |- mesh__dateEstablished mesh__D000530 1980-01-01
% 208.88/209.03 |- skos__hiddenLabel mesh__D000530 Alfadolone Mixture, Alfaxalone
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000530 2006
% 208.88/209.03 |- rdf__type mesh__D000530sskos__Concept
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000530 2005
% 208.88/209.03 |- mesh__dateRevised mesh__D000530 2002-07-24
% 208.88/209.03 |- skos__historyNote mesh__D000530 Pregnanediones %28%1974%29%
% 208.88/209.03 |- mesh__recordOriginator mesh__D000530 NLM
% 208.88/209.03 |- skos__broader mesh__D000530smesh__D011277
% 208.88/209.03 |- skos__hiddenLabel mesh__D000530 CT1341
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D013458 2001
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D013458 2003
% 208.88/209.03 |- skos__prefLabel mesh__D013458 Sulfur Dioxide
% 208.88/209.03 |- mesh__dateEstablished mesh__D013458 1966-01-01
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D013458 sjn
% 208.88/209.03 |- rdf__type mesh__D013458sskos__Concept
% 208.88/209.03 |- skos__broader mesh__D013458smesh__D013461
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D013458 66
% 208.88/209.03 |- skos__altLabel mesh__D013458 Sulfurous Anhydride
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D013458 2002
% 208.88/209.03 |- skos__scopeNote mesh__D013458
% 208.88/209.03 A highly toxic, colorless, nonflammable gas. It is used as a pharmaceutical aid and antioxidant. It is also an environmental air pollutant.%A%
% 208.88/209.03 |- skos__hiddenLabel mesh__D013458 Anhydride, Sulfurous
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D013458 2004
% 208.88/209.03 |- mesh__dateRevised mesh__D013458 1999-11-09
% 208.88/209.03 |- skos__annotation mesh__D013458 an air pollutant
% 208.88/209.03 |- mesh__recordMaintainer mesh__D013458 adp
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D013458 2005
% 208.88/209.03 |- mesh__recordOriginator mesh__D013458 NLM
% 208.88/209.03 |- skos__broader mesh__D013458smesh__D005740
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D013458 2006
% 208.88/209.03 |- mesh__historyNote mesh__D013458 66%28%64%29%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D013458 2000
% 208.88/209.03 |- skos__hiddenLabel mesh__D013458 Dioxide, Sulfur
% 208.88/209.03 |- mesh__dateCreated mesh__D013458 1999-01-01
% 208.88/209.03 |- skos__historyNote mesh__D018941
% 208.88/209.03 Antigens, Differentiation, B-Lymphocyte %28%1988-1995%29%
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D018941 sjn
% 208.88/209.03 |- mesh__recordMaintainer mesh__D018941 ssb
% 208.88/209.03 |- skos__scopeNote mesh__D018941
% 208.88/209.03 Differentiation antigens expressed on B-lymphocytes and B-cell precursors. They are involved in regulation of B-cell proliferation.%A%
% 208.88/209.03 |- skos__historyNote mesh__D018941 Antigens, CD %28%1990-1995%29%
% 208.88/209.03 |- mesh__dateCreated mesh__D018941 1995-05-26
% 208.88/209.03 |- mesh__historyNote mesh__D018941
% 208.88/209.03 96; was B CELL ANTIGEN CD19 %28%NM%29% 1987-95
% 208.88/209.03 |- skos__altLabel mesh__D018941 CD19 Antigen
% 208.88/209.03 |- skos__altLabel mesh__D018941 B Cell Antigen CD19
% 208.88/209.03 |- mesh__dateEstablished mesh__D018941 1996-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D018941 2006
% 208.88/209.03 |- rdf__type mesh__D018941sskos__Concept
% 208.88/209.03 |- mesh__onlineNote mesh__D018941
% 208.88/209.03 use ANTIGENS, CD19 %28%NM%29% to search B CELL ANTIGEN CD19 1987-95%A%
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D018941
% 208.88/209.03 96; B CELL ANTIGEN CD19 was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95; %26% ANTIGENS, SURFACE 1987-88%A%
% 208.88/209.03 |- skos__historyNote mesh__D018941 Antigens, Surface %28%1987-1988%29%
% 208.88/209.03 |- skos__broader mesh__D018941smesh__D000944
% 208.88/209.03 |- skos__prefLabel mesh__D018941 Antigens, CD19
% 208.88/209.03 |- skos__altLabel mesh__D018941 CD19 Antigens
% 208.88/209.03 |- skos__hiddenLabel mesh__D018941 Antigen, CD19
% 208.88/209.03 |- skos__broader mesh__D018941smesh__D015703
% 208.88/209.03 |- mesh__recordOriginator mesh__D018941 AGS
% 208.88/209.03 |- mesh__dateRevised mesh__D018941 2005-06-30
% 208.88/209.03 |- skos__annotation mesh__D018941 B-lymphocyte differentiation antigens
% 208.88/209.03 |- rdf__type mesh__D051577sskos__Concept
% 208.88/209.03 |- skos__historyNote mesh__D051577
% 208.88/209.03 Complement Pathway, Classical %28%1983-2005%29%
% 208.88/209.03 |- mesh__recordMaintainer mesh__D051577 lkt
% 208.88/209.03 |- mesh__historyNote mesh__D051577 2006
% 208.88/209.03 |- skos__broader mesh__D051577smesh__D050579
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D051577 2006
% 208.88/209.03 |- mesh__dateCreated mesh__D051577 2005-06-30
% 208.88/209.03 |- skos__historyNote mesh__D051577
% 208.88/209.03 Complement Activating Enzymes %28%1983-2005%29%
% 208.88/209.03 |- skos__hiddenLabel mesh__D051577 C5 Convertase, Classical
% 208.88/209.03 |- skos__prefLabel mesh__D051577
% 208.88/209.03 Complement C5 Convertase, Classical Pathway
% 208.88/209.03 |- skos__altLabel mesh__D051577 Classical Pathway C5 Convertase
% 208.88/209.03 |- skos__altLabel mesh__D051577 C5 Convertase %28%C4b2a3b%29%
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D051577 sjn
% 208.88/209.03 |- mesh__dateEstablished mesh__D051577 2006-01-01
% 208.88/209.03 |- skos__altLabel mesh__D051577 Classical C5 Convertase
% 208.88/209.03 |- mesh__recordOriginator mesh__D051577 lkt
% 208.88/209.03 |- skos__scopeNote mesh__D051577
% 208.88/209.03 A serine protease that cleaves multiple COMPLEMENT 5 into COMPLEMENT 5A %28%anaphylatoxin%29% and COMPLEMENT 5B in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It is a complex of CLASSICAL PATHWAY C3 CONVERTASE %28%C4b2a%29% with an additional COMPLEMENT C3B, or C4b2a3b.%A%
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D051577 2006
% 208.88/209.03 |- skos__annotation mesh__D018143
% 208.88/209.03 infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%
% 208.88/209.03 |- rdf__type mesh__D018143sskos__Concept
% 208.88/209.03 |- mesh__dateCreated mesh__D018143 1993-06-04
% 208.88/209.03 |- mesh__recordOriginator mesh__D018143 AGS
% 208.88/209.03 |- skos__scopeNote mesh__D018143
% 208.88/209.03 A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans and new world primates. The type species human herpesvirus 4 %28%HERPESVIRUS 4, HUMAN%29% is better known as the Epstein-Barr virus.%A%
% 208.88/209.03 |- skos__broader mesh__D018143smesh__D018142
% 208.88/209.03 |- mesh__recordMaintainer mesh__D018143 sjn
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D018143 sjn
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D018143 94
% 208.88/209.03 |- mesh__dateEstablished mesh__D018143 1994-01-01
% 208.88/209.03 |- skos__hiddenLabel mesh__D018143 Lymphocryptoviruses
% 208.88/209.03 |- mesh__historyNote mesh__D018143 94
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D018143 2005
% 208.88/209.03 |- mesh__dateRevised mesh__D018143 2004-07-13
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D018143 2006
% 208.88/209.03 |- skos__prefLabel mesh__D018143 Lymphocryptovirus
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D010160 2006
% 208.88/209.03 |- mesh__recordMaintainer mesh__D010160 lkt
% 208.88/209.03 |- mesh__dateCreated mesh__D010160 1978-05-19
% 208.88/209.03 |- skos__prefLabel mesh__D010160 Palate, Soft
% 208.88/209.03 |- mesh__recordOriginator mesh__D010160 RC
% 208.88/209.03 |- skos__hiddenLabel mesh__D010160 Palatinum, Velum
% 208.88/209.03 |- mesh__dateRevised mesh__D010160 2003-07-09
% 208.88/209.03 |- skos__altLabel mesh__D010160 Velum Palatinum
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D010160 79
% 208.88/209.03 |- skos__broader mesh__D010160smesh__D010159
% 208.88/209.03 |- skos__hiddenLabel mesh__D010160 Palates, Soft
% 208.88/209.03 |- rdf__type mesh__D010160sskos__Concept
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D010160 sjn
% 208.88/209.03 |- mesh__historyNote mesh__D010160 79
% 208.88/209.03 |- mesh__dateEstablished mesh__D010160 1979-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D010160 2005
% 208.88/209.03 |- skos__historyNote mesh__D010160 Palate %28%1966-1978%29%
% 208.88/209.03 |- skos__scopeNote mesh__D010160
% 208.88/209.03 A movable fold suspended from the posterior border of the hard palate. The uvula hangs from the middle of the lower border.%A%
% 208.88/209.03 |- skos__altLabel mesh__D010160 Soft Palate
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D010160 2004
% 208.88/209.03 |- rdf__type mesh__D004921sskos__Concept
% 208.88/209.03 |- skos__prefLabel mesh__D004921 Erythropoietin
% 208.88/209.03 |- mesh__recordOriginator mesh__D004921 NLM
% 208.88/209.03 |- mesh__dateCreated mesh__D004921 1999-01-01
% 208.88/209.03 |- skos__scopeNote mesh__D004921
% 208.88/209.03 Glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation.%A%
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D004921 sjn
% 208.88/209.03 |- mesh__recordMaintainer mesh__D004921 ssb
% 208.88/209.03 |- skos__broader mesh__D004921smesh__D003115
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004921 2006
% 208.88/209.03 |- mesh__dateRevised mesh__D004921 2005-06-30
% 208.88/209.03 |- skos__related mesh__D004921smesh__D017467
% 208.88/209.03 |- skos__annotation mesh__D004921 /biosyn /physiol permitted
% 208.88/209.03 |- skos__broader mesh__D018100Q000037smesh__D018100
% 208.88/209.03 |- mesh__preferredCombination mesh__D018100Q000037smesh__D006633
% 208.88/209.03 |- rdf__type mesh__D018100Q000037smesh__CompoundConcept
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 1996
% 208.88/209.03 |- mesh__dateCreated mesh__D004123 1999-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 1999
% 208.88/209.03 |- mesh__dateRevised mesh__D004123 1992-05-13
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 2004
% 208.88/209.03 |- skos__broader mesh__D004123smesh__D008744
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 2002
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D004123 PLS
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 1997
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D004123 74
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 1994
% 208.88/209.03 |- mesh__recordOriginator mesh__D004123 NLM
% 208.88/209.03 |- rdf__type mesh__D004123sskos__Concept
% 208.88/209.03 |- skos__historyNote mesh__D004123 METHYLAMINES %28%1972-1973%29%
% 208.88/209.03 |- mesh__dateEstablished mesh__D004123 1974-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 2005
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 1995
% 208.88/209.03 |- skos__prefLabel mesh__D004123 Dimethylamines
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 2000
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 1998
% 208.88/209.03 |- mesh__recordMaintainer mesh__D004123 TGC
% 208.88/209.03 |- mesh__historyNote mesh__D004123 74%28%72%29%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 2003
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 2006
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 1993
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D004123 2001
% 208.88/209.03 |- skos__broader mesh__D017849smesh__D000830
% 208.88/209.03 |- skos__scopeNote mesh__D017849
% 208.88/209.03 Animals produced by the mating of littermates or siblings over multiple generations. The resultant strain of animals is virtually identical genotypically. Highly inbred animal lines allow the study of certain traits in a relatively pure form. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Animal Inbred Strain
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Animal, Inbred Strains
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D017849 2005
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Strain, Inbred Animal
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Strains, Inbred Animal
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Inbred Strains Animal
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Animal Strains, Inbred
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D017849 94
% 208.88/209.03 |- mesh__historyNote mesh__D017849 94
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Inbred Animal Strain
% 208.88/209.03 |- skos__altLabel mesh__D017849 Inbred Strain of Animal
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Animals Inbred Strain
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Animal Inbred Strains
% 208.88/209.03 |- skos__altLabel mesh__D017849 Inbred Strains of Animals
% 208.88/209.03 |- mesh__recordMaintainer mesh__D017849 nns
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Strains Animal, Inbred
% 208.88/209.03 |- mesh__dateCreated mesh__D017849 1993-02-16
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Inbred Strain, Animal
% 208.88/209.03 |- skos__annotation mesh__D017849
% 208.88/209.03 IM GEN or unspecified; coord NIM with specific exper animal %28%NIM%29%; when IM, qualif permitted; do not forget also to check tag ANIMALS%A%
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Animals Inbred Strains
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Animal Strain, Inbred
% 208.88/209.03 |- skos__altLabel mesh__D017849 Inbred Animal Strains
% 208.88/209.03 |- skos__historyNote mesh__D017849 Inbreeding %28%1970-1993%29%
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Strains, Animal Inbred
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Strains Animals, Inbred
% 208.88/209.03 |- mesh__recordOriginator mesh__D017849 TGC
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Inbred Strains Animals
% 208.88/209.03 |- rdf__type mesh__D017849sskos__Concept
% 208.88/209.03 |- skos__prefLabel mesh__D017849 Animals, Inbred Strains
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D017849 sjn
% 208.88/209.03 |- mesh__dateEstablished mesh__D017849 1994-01-01
% 208.88/209.03 |- skos__altLabel mesh__D017849 Inbred Strains, Animal
% 208.88/209.03 |- mesh__dateRevised mesh__D017849 2004-07-07
% 208.88/209.03 |- skos__hiddenLabel mesh__D017849 Strain, Animal Inbred
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D017849 2006
% 208.88/209.03 |- skos__broader mesh__D017849smesh__D000828
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003829 2002
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003829 1998
% 208.88/209.03 |- skos__altLabel mesh__D003829 Bridgeworks, Dental
% 208.88/209.03 |- skos__hiddenLabel mesh__D003829 Dentures, Partial
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D003829 SJN
% 208.88/209.03 |- skos__broader mesh__D003829smesh__D003778
% 208.88/209.03 |- skos__hiddenLabel mesh__D003829 Partial Dentures
% 208.88/209.03 |- skos__altLabel mesh__D003829 Dental Bridgework
% 208.88/209.03 |- skos__prefLabel mesh__D003829 Denture, Partial
% 208.88/209.03 |- skos__annotation mesh__D003829
% 208.88/209.03 labeling for ownership or identification = DENTURE IDENTIFICATION MARKING%A%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003829 2006
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003829 2001
% 208.88/209.03 |- mesh__recordOriginator mesh__D003829 NLM
% 208.88/209.03 |- skos__scopeNote mesh__D003829
% 208.88/209.03 A denture replacing one or more %28%but not all%29% natural teeth. It is supported and retained by underlying tissue and some or all of the remaining teeth.%A%
% 208.88/209.03 |- mesh__dateEstablished mesh__D003829 1965-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003829 2005
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003829 2004
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003829 2000
% 208.88/209.03 |- mesh__recordMaintainer mesh__D003829 TGC
% 208.88/209.03 |- skos__altLabel mesh__D003829 Dental Bridgeworks
% 208.88/209.03 |- mesh__dateRevised mesh__D003829 1997-06-20
% 208.88/209.03 |- mesh__dateCreated mesh__D003829 1999-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003829 2003
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D003829
% 208.88/209.03 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.88/209.03 |- skos__hiddenLabel mesh__D003829 Partial Denture
% 208.88/209.03 |- mesh__historyNote mesh__D003829
% 208.88/209.03 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.88/209.03 |- rdf__type mesh__D003829sskos__Concept
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D003829 1999
% 208.88/209.03 |- skos__altLabel mesh__D003829 Bridgework, Dental
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014551 2006
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014551 1998
% 208.88/209.03 |- skos__hiddenLabel mesh__D014551 Tract, Urinary
% 208.88/209.03 |- mesh__historyNote mesh__D014551 72
% 208.88/209.03 |- skos__related mesh__D014551smesh__D014567
% 208.88/209.03 |- skos__hiddenLabel mesh__D014551 Tracts, Urinary
% 208.88/209.03 |- mesh__dateCreated mesh__D014551 1999-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014551 1999
% 208.88/209.03 |- skos__prefLabel mesh__D014551 Urinary Tract
% 208.88/209.03 |- skos__broader mesh__D014551smesh__D014566
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014551 2002
% 208.88/209.03 |- mesh__dateRevised mesh__D014551 1997-06-20
% 208.88/209.03 |- skos__annotation mesh__D014551
% 208.88/209.03 GEN: prefer specific organ; /radiogr = UROGRAPHY but for general only: prefer /radiogr with specific organs of the urinary tract; /surg: consider also UROLOGIC SURGICAL PROCEDURES; dis = UROLOGIC DISEASES; neopl = UROLOGIC NEOPLASMS but prefer specifics%A%
% 208.88/209.03 |- mesh__dateEstablished mesh__D014551 1972-01-01
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D014551 SJN
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014551 2003
% 208.88/209.03 |- rdf__type mesh__D014551sskos__Concept
% 208.88/209.03 |- skos__hiddenLabel mesh__D014551 Urinary Tracts
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014551 2005
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014551 2000
% 208.88/209.03 |- mesh__publicMeSHNote mesh__D014551 72
% 208.88/209.03 |- skos__historyNote mesh__D014551 Urogenital System %28%1966-1971%29%
% 208.88/209.03 |- mesh__recordOriginator mesh__D014551 NLM
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014551 2004
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D014551 2001
% 208.88/209.03 |- mesh__recordMaintainer mesh__D014551 TGC
% 208.88/209.03 |- skos__broader mesh__D004194Q000635smesh__D004194
% 208.88/209.03 |- mesh__preferredCombination mesh__D004194Q000635smesh__D018562
% 208.88/209.03 |- rdf__type mesh__D004194Q000635smesh__CompoundConcept
% 208.88/209.03 |- rdf__type mesh__D008514sskos__Concept
% 208.88/209.03 |- skos__broader mesh__D008514smesh__D008519
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D008514 sjn
% 208.88/209.03 |- mesh__recordOriginator mesh__D008514 NLM
% 208.88/209.03 |- mesh__recordMaintainer mesh__D008514 jls
% 208.88/209.03 |- skos__altLabel mesh__D008514 Arabic Medicine
% 208.88/209.03 |- skos__prefLabel mesh__D008514 Medicine, Arabic
% 208.88/209.03 |- skos__broader mesh__D008514smesh__D006666
% 208.88/209.03 |- skos__annotation mesh__D008514
% 208.88/209.03 is not medicine in Arab countries %28% = MEDICINE + specific country%29%; no qualif; Manual 32.13; Avicenna %28%also called Ibn Sina%29% is indexed as Avicenna in field 15 + check tags BIOGRAPHY + HISTORY OF MEDICINE, MEDIEVAL: TN 12; DF: MED ARABIC%A%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D008514 2006
% 208.88/209.03 |- mesh__dateRevised mesh__D008514 2004-07-07
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D008514 2005
% 208.88/209.03 |- mesh__dateCreated mesh__D008514 1999-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 2002
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 1996
% 208.88/209.03 |- skos__related mesh__D000531smesh__D009051
% 208.88/209.03 |- mesh__recordOriginator mesh__D000531 NLM
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 1997
% 208.88/209.03 |- mesh__dateCreated mesh__D000531 1999-01-01
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 1994
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 2005
% 208.88/209.03 |- mesh__recordAuthorizer mesh__D000531 PLS
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 2000
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 1995
% 208.88/209.03 |- skos__annotation mesh__D000531
% 208.88/209.03 no qualif; consider also ATMOSPHERIC PRESSURE; /adv eff = probably ALTITUDE SICKNESS%A%
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 2006
% 208.88/209.03 |- skos__prefLabel mesh__D000531 Altitude
% 208.88/209.03 |- mesh__recordMaintainer mesh__D000531 PLS
% 208.88/209.03 |- skos__hiddenLabel mesh__D000531 Altitudes
% 208.88/209.03 |- rdf__type mesh__D000531sskos__Concept
% 208.88/209.03 |- mesh__dateRevised mesh__D000531 1991-11-02
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 2001
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 1998
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 1992
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 2003
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 1999
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 1993
% 208.88/209.03 |- skos__broader mesh__D000531smesh__D004777
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 2004
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D000531 1991
% 208.88/209.03 |- skos__historyNote mesh__D013459 Fluorides %28%1966-1979%29%
% 208.88/209.03 |- rdf__type mesh__D013459sskos__Concept
% 208.88/209.03 |- skos__scopeNote mesh__D013459
% 208.88/209.03 Sulfur hexafluoride. An inert gas used mainly as a test gas in respiratory physiology. Other uses include its injection in vitreoretinal surgery to restore the vitreous chamber and as a tracer in monitoring the dispersion and deposition of air pollutants.%A%
% 208.88/209.03 |- mesh__recordOriginator mesh__D013459 RLS
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D013459 1994
% 208.88/209.03 |- mesh__activeMeSHYear mesh__D013459 2000
% 208.88/209.04 |- mesh__dateEstablished mesh__D013459 1991-01-01
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 2004
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D013459
% 208.88/209.04 91; was see under FLUORIDES 1980-90
% 208.88/209.04 |- mesh__dateCreated mesh__D013459 1979-05-25
% 208.88/209.04 |- skos__broader mesh__D013459smesh__D005459
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 1995
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 1996
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 2001
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D013459 PLS
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 2005
% 208.88/209.04 |- skos__broader mesh__D013459smesh__D013457
% 208.88/209.04 |- mesh__recordMaintainer mesh__D013459 TPW
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 1997
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 2002
% 208.88/209.04 |- skos__broader mesh__D013459smesh__D005740
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 2006
% 208.88/209.04 |- skos__prefLabel mesh__D013459 Sulfur Hexafluoride
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 1998
% 208.88/209.04 |- skos__annotation mesh__D013459
% 208.88/209.04 an inert gas used in resp physiol studies
% 208.88/209.04 |- mesh__dateRevised mesh__D013459 1993-06-03
% 208.88/209.04 |- skos__historyNote mesh__D013459 Gases %28%1966-1979%29%
% 208.88/209.04 |- skos__hiddenLabel mesh__D013459 Hexafluoride, Sulfur
% 208.88/209.04 |- skos__historyNote mesh__D013459 Sulfur %28%1966-1979%29%
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 1999
% 208.88/209.04 |- mesh__historyNote mesh__D013459
% 208.88/209.04 91%28%80%29%; was see under FLUORIDES 1980-90
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D013459 2003
% 208.88/209.04 |- rdf__type mesh__D024181sskos__Concept
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D024181 2006
% 208.88/209.04 |- skos__hiddenLabel mesh__D024181 Collagen, Type XIII
% 208.88/209.04 |- mesh__historyNote mesh__D024181 2002; use COLLAGEN %28%1992-2001%29%
% 208.88/209.04 |- skos__annotation mesh__D024181
% 208.88/209.04 precursors: coord IM with PROCOLLAGEN %28%IM%29%
% 208.88/209.04 |- mesh__dateRevised mesh__D024181 2004-07-07
% 208.88/209.04 |- skos__broader mesh__D024181smesh__D024041
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D024181 2005
% 208.88/209.04 |- mesh__recordMaintainer mesh__D024181 jmp
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D024181 sjn
% 208.88/209.04 |- skos__altLabel mesh__D024181 Collagen Type XIII, alpha1 Chain
% 208.88/209.04 |- mesh__dateEstablished mesh__D024181 2002-01-01
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D024181
% 208.88/209.04 2002; see COLLAGEN %28%1992-2001%29%
% 208.88/209.04 |- skos__historyNote mesh__D024181 Collagen %28%1992-2001%29%
% 208.88/209.04 |- skos__scopeNote mesh__D024181
% 208.88/209.04 A non-fibrillar collagen found as a ubiquitously expressed membrane- associated protein. Type XIII collagen contains both collagenous and non-collagenous domains along with a transmembrane domain within its N-terminal region.%A%
% 208.88/209.04 |- skos__prefLabel mesh__D024181 Collagen Type XIII
% 208.88/209.04 |- skos__altLabel mesh__D024181 Collagen alpha1%28%XIII%29%
% 208.88/209.04 |- skos__hiddenLabel mesh__D024181 Procollagen, Type XIII
% 208.88/209.04 |- skos__altLabel mesh__D024181 Type XIII Procollagen
% 208.88/209.04 |- mesh__dateCreated mesh__D024181 2001-07-25
% 208.88/209.04 |- mesh__recordOriginator mesh__D024181 jmp
% 208.88/209.04 |- skos__altLabel mesh__D024181 Type XIII Collagen
% 208.88/209.04 |- skos__broader mesh__D018942smesh__D047028
% 208.88/209.04 |- mesh__recordMaintainer mesh__D018942 ags
% 208.88/209.04 |- mesh__dateRevised mesh__D018942 2005-07-27
% 208.88/209.04 |- mesh__dateCreated mesh__D018942 1995-05-26
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D018942 96
% 208.88/209.04 |- skos__hiddenLabel mesh__D018942 Polyketides, Macrolide
% 208.88/209.04 |- skos__hiddenLabel mesh__D018942 Ketolides, Macrolide
% 208.88/209.04 |- skos__prefLabel mesh__D018942 Macrolides
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018942 2006
% 208.88/209.04 |- mesh__historyNote mesh__D018942 96
% 208.88/209.04 |- rdf__type mesh__D018942sskos__Concept
% 208.88/209.04 |- mesh__recordOriginator mesh__D018942 JRT
% 208.88/209.04 |- skos__altLabel mesh__D018942 Polyketide Macrolides
% 208.88/209.04 |- mesh__dateEstablished mesh__D018942 1996-01-01
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D018942 ags
% 208.88/209.04 |- skos__broader mesh__D018942smesh__D007783
% 208.88/209.04 |- skos__hiddenLabel mesh__D018942 Macrolides, Polyketide
% 208.88/209.04 |- skos__altLabel mesh__D018942 Macrolide Ketolides
% 208.88/209.04 |- skos__scopeNote mesh__D018942
% 208.88/209.04 A group of macrocyclic compounds formed by chain extension of multiple PROPIONATES and cyclized into a large %28%typically 12, 14, 16%29% membered lactone. They are often glycosylated. Many of them are ANTIBIOTICS.%A%
% 208.88/209.04 |- skos__broader mesh__D018942smesh__D006027
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018942 2006A
% 208.88/209.04 |- skos__hiddenLabel mesh__D018144 Rhadinoviruses
% 208.88/209.04 |- skos__scopeNote mesh__D018144
% 208.88/209.04 A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting New World primates and other species. HERPESVIRUS 2, SAIMIRIINE is the type species.%A%
% 208.88/209.04 |- skos__hiddenLabel mesh__D018144 ateles, Herpesvirus
% 208.88/209.04 |- skos__prefLabel mesh__D018144 Rhadinovirus
% 208.88/209.04 |- skos__hiddenLabel mesh__D018144 Herpesvirus 2, Equine
% 208.88/209.04 |- mesh__recordMaintainer mesh__D018144 ags
% 208.88/209.04 |- skos__altLabel mesh__D018144 Murine herpesvirus 68
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018144 2004
% 208.88/209.04 |- mesh__historyNote mesh__D018144 94
% 208.88/209.04 |- skos__altLabel mesh__D018144 Equine Herpesvirus 2
% 208.88/209.04 |- skos__altLabel mesh__D018144 Equid herpesvirus 2
% 208.88/209.04 |- mesh__dateRevised mesh__D018144 2001-07-25
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018144 2005
% 208.88/209.04 |- skos__altLabel mesh__D018144 Murid herpesvirus 4
% 208.88/209.04 |- skos__broader mesh__D018144smesh__D018142
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018144 2002
% 208.88/209.04 |- mesh__recordOriginator mesh__D018144 AGS
% 208.88/209.04 |- mesh__dateCreated mesh__D018144 1993-06-04
% 208.88/209.04 |- skos__altLabel mesh__D018144 Mouse herpesvirus strain 68
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018144 2006
% 208.88/209.04 |- mesh__dateEstablished mesh__D018144 1994-01-01
% 208.88/209.04 |- skos__annotation mesh__D018144
% 208.88/209.04 infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%
% 208.88/209.04 |- rdf__type mesh__D018144sskos__Concept
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D018144 sjn
% 208.88/209.04 |- skos__altLabel mesh__D018144 Herpesvirus ateles
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D018144 94
% 208.88/209.04 |- skos__altLabel mesh__D018144 Ateline herpesvirus 2
% 208.88/209.04 |- skos__hiddenLabel mesh__D018144 herpesvirus 68, Murine
% 208.88/209.04 |- skos__altLabel mesh__D018144 Herpesvirus 2 %28%gamma%29%, Ateline
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018144 2003
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D010161 PLS
% 208.88/209.04 |- mesh__recordOriginator mesh__D010161 NLM
% 208.88/209.04 |- mesh__recordMaintainer mesh__D010161 TGC
% 208.88/209.04 |- rdf__type mesh__D010161sskos__Concept
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 2002
% 208.88/209.04 |- skos__broader mesh__D010161smesh__D010163
% 208.88/209.04 |- skos__annotation mesh__D010161
% 208.88/209.04 IM; SPEC: SPEC qualif; as NIM coord, no qualif; check tags HISTORICAL ARTICLE %26% ANCIENT or MEDIEVAL; for prehist, ANCIENT tag is all right; paleodontology is for pre-Columbian, nothing later; DF: PALEODONTOL%A%
% 208.88/209.04 |- skos__scopeNote mesh__D010161
% 208.88/209.04 The study of the teeth of early forms of life through fossil remains.%A%
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 2003
% 208.88/209.04 |- mesh__dateCreated mesh__D010161 1999-01-01
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 1996
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 2005
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 1998
% 208.88/209.04 |- mesh__dateRevised mesh__D010161 1994-04-11
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 2004
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 1997
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 2006
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 2000
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 1999
% 208.88/209.04 |- skos__prefLabel mesh__D010161 Paleodontology
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 2001
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010161 1995
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Feline Sarcoma Proto Oncogene Protein
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 fes, Proto-Oncogene Protein
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D051578 sjn
% 208.88/209.04 |- skos__altLabel mesh__D051578 fes Proto-Oncogene Proteins
% 208.88/209.04 |- mesh__dateEstablished mesh__D051578 2006-01-01
% 208.88/209.04 |- skos__altLabel mesh__D051578 c-fes Proteins
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 c-fes, Proto-Oncogene Proteins
% 208.88/209.04 |- skos__altLabel mesh__D051578 Proto-Oncogene Protein fes
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Proto-Oncogene Proteins, fes
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 fps Proto Oncogene Protein
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Proteins, c-fes
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D051578
% 208.88/209.04 2006; PROTO-ONCOGENE PROTEIN C-FES was indexed under PROTEIN-TYROSINE KINASE %26% PROTO-ONCOGENE PROTEINS 1986-2005%A%
% 208.88/209.04 |- skos__altLabel mesh__D051578 c-fes Proto-Oncogene Proteins
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Proto-Oncogene Protein, fps
% 208.88/209.04 |- skos__prefLabel mesh__D051578 Proto-Oncogene Proteins c-fes
% 208.88/209.04 |- skos__broader mesh__D051578smesh__D011505
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Proto Oncogene Protein fes
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D051578 2006
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Tyrosine Kinase, c-fes
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Proto Oncogene Proteins c fes
% 208.88/209.04 |- mesh__historyNote mesh__D051578 2006%28%1986%29%
% 208.88/209.04 |- skos__altLabel mesh__D051578 fps Proto-Oncogene Protein
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Proto-Oncogene Proteins, c-fes
% 208.88/209.04 |- skos__altLabel mesh__D051578 Proto-Oncogene Protein c-fes
% 208.88/209.04 |- mesh__recordMaintainer mesh__D051578 DRC
% 208.88/209.04 |- mesh__recordOriginator mesh__D051578 DRC
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 c fes Tyrosine Kinase
% 208.88/209.04 |- skos__altLabel mesh__D051578 c-fes Tyrosine Kinase
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 c fes Proto Oncogene Proteins
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 c fes Proteins
% 208.88/209.04 |- rdf__type mesh__D051578sskos__Concept
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Kinase, c-fes Tyrosine
% 208.88/209.04 |- mesh__dateCreated mesh__D051578 2005-06-30
% 208.88/209.04 |- skos__altLabel mesh__D051578 Feline Sarcoma Proto-Oncogene Protein
% 208.88/209.04 |- skos__scopeNote mesh__D051578
% 208.88/209.04 Proto-oncogene proteins fes are protein-tyrosine kinases with a central SH2 DOMAIN. It has been implicated in SIGNAL TRANSDUCTION PATHWAYS for CELL DIFFERENTIATION of a variety of cell types including MYELOID PROGENITOR CELLS. Fes proto-oncogene proteins also bind TUBULIN and promotes MICROTUBULE assembly.%A%
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 fes Proto Oncogene Proteins
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 Proto Oncogene Protein c fes
% 208.88/209.04 |- skos__hiddenLabel mesh__D051578 c-fes, Proto-Oncogene Protein
% 208.88/209.04 |- skos__broader mesh__D051578smesh__D011518
% 208.88/209.04 |- mesh__historyNote mesh__D004124
% 208.88/209.04 92; was DIMETHYLAMINOAZOBENZENE 1963-91
% 208.88/209.04 |- skos__annotation mesh__D004124
% 208.88/209.04 usually NIM in DAB-induced exper cancer: no qualif; when IM, D25-26 qualif; DF: note short X ref%A%
% 208.88/209.04 |- skos__scopeNote mesh__D004124
% 208.88/209.04 A reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, p. 89%29% published in 1985, this compound %22%may reasonably be anticipated to be a carcinogen.%22% %28%Merck, 11th ed%29%%A%
% 208.88/209.04 |- skos__altLabel mesh__D004124 Methyl Yellow
% 208.88/209.04 |- skos__hiddenLabel mesh__D004124 p Dimethylaminoazobenzene
% 208.88/209.04 |- skos__hiddenLabel mesh__D004124 4 Dimethylaminoazobenzene
% 208.88/209.04 |- skos__altLabel mesh__D004124 4-Dimethylaminoazobenzene
% 208.88/209.04 |- skos__broader mesh__D004124smesh__D000814
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D004124 NLM
% 208.88/209.04 |- mesh__onlineNote mesh__D004124
% 208.88/209.04 use P-DIMETHYLAMINOAZOBENZENE to search DIMETHYLAMINOAZOBENZENE 1966-91%A%
% 208.88/209.04 |- rdf__type mesh__D004124sskos__Concept
% 208.88/209.04 |- skos__prefLabel mesh__D004124 p-Dimethylaminoazobenzene
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D004124 2006
% 208.88/209.04 |- mesh__recordOriginator mesh__D004124 NLM
% 208.88/209.04 |- skos__altLabel mesh__D004124 Butter Yellow
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D004124
% 208.88/209.04 92; was DIMETHYLAMINOAZOBENZENE 1963-91
% 208.88/209.04 |- mesh__dateCreated mesh__D004124 1999-01-01
% 208.88/209.04 |- mesh__dateRevised mesh__D004124 2005-07-06
% 208.88/209.04 |- mesh__recordMaintainer mesh__D004124 NLM
% 208.88/209.04 |- skos__hiddenLabel mesh__D014552 Urinary Tract Infection
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 1995
% 208.88/209.04 |- skos__broader mesh__D014552smesh__D007239
% 208.88/209.04 |- skos__hiddenLabel mesh__D014552 Infections, Urinary Tract
% 208.88/209.04 |- skos__hiddenLabel mesh__D014552 Tract Infections, Urinary
% 208.88/209.04 |- skos__broader mesh__D014552smesh__D014570
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 2000
% 208.88/209.04 |- skos__annotation mesh__D014552
% 208.88/209.04 infection in any organ of the urinary tract; GEN or unspecified; prefer specific organ/diseases coord with infection term; /drug ther: consider also ANTI-INFECTIVE AGENTS, URINARY%A%
% 208.88/209.04 |- skos__hiddenLabel mesh__D014552 Infection, Urinary Tract
% 208.88/209.04 |- mesh__recordOriginator mesh__D014552 NLM
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 2003
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 2001
% 208.88/209.04 |- skos__scopeNote mesh__D014552
% 208.88/209.04 Infections affecting those structures of the body which participate in the secretion and elimination of urine, i.e., the kidney, the ureters, the urinary bladder, and the urethra.%A%
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 2005
% 208.88/209.04 |- rdf__type mesh__D014552sskos__Concept
% 208.88/209.04 |- skos__prefLabel mesh__D014552 Urinary Tract Infections
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 2004
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D014552 PLS
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 1996
% 208.88/209.04 |- skos__hiddenLabel mesh__D014552 Tract Infection, Urinary
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 2006
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 1998
% 208.88/209.04 |- mesh__recordMaintainer mesh__D014552 TGC
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 2002
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 1997
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 1994
% 208.88/209.04 |- mesh__dateCreated mesh__D014552 1999-01-01
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D014552 1999
% 208.88/209.04 |- mesh__dateRevised mesh__D014552 1993-06-03
% 208.88/209.04 |- skos__related mesh__D014552smesh__D000892
% 208.88/209.04 |- skos__broader mesh__D008515smesh__D008519
% 208.88/209.04 |- mesh__recordMaintainer mesh__D008515 ssb
% 208.88/209.04 |- skos__hiddenLabel mesh__D008515 Medicine, Siddha
% 208.88/209.04 |- mesh__dateRevised mesh__D008515 2003-07-09
% 208.88/209.04 |- skos__scopeNote mesh__D008515
% 208.88/209.04 The traditional Hindu system of medicine which is based on customs, beliefs, and practices of the Hindu culture. Ayurveda means %22%the science of Life%22%: veda - science, ayur - life.%A%
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D008515 sjn
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D008515 2005
% 208.88/209.04 |- skos__prefLabel mesh__D008515 Medicine, Ayurvedic
% 208.88/209.04 |- mesh__dateCreated mesh__D008515 1999-01-01
% 208.88/209.04 |- mesh__recordOriginator mesh__D008515 NLM
% 208.88/209.04 |- skos__annotation mesh__D008515 Manual 32.13; DF: MED AYURVEDIC
% 208.88/209.04 |- mesh__historyNote mesh__D008515 81; was MEDICINE, HINDU 1964-80
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D008515 2006
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D008515 81; was MEDICINE, HINDU 1964-80
% 208.88/209.04 |- mesh__onlineNote mesh__D008515
% 208.88/209.04 use MEDICINE, AYURVEDIC to search MEDICINE, HINDU 1966-80%A%
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D008515 2004
% 208.88/209.04 |- rdf__type mesh__D008515sskos__Concept
% 208.88/209.04 |- skos__altLabel mesh__D008515 Medicine, Hindu
% 208.88/209.04 |- skos__altLabel mesh__D008515 Ayurvedic Medicine
% 208.88/209.04 |- mesh__dateEstablished mesh__D008515 1964-01-01
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D000532 2002
% 208.88/209.04 |- skos__hiddenLabel mesh__D000532 Sicknesses, Mountain
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D000532 2004
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D000532 91; was see under ANOXIA 1975-90
% 208.88/209.04 |- mesh__recordOriginator mesh__D000532 NLM
% 208.88/209.04 |- mesh__dateCreated mesh__D000532 1999-01-01
% 208.88/209.04 |- skos__hiddenLabel mesh__D000532 Altitude Sicknesses
% 208.88/209.04 |- skos__hiddenLabel mesh__D000532 Sicknesses, Altitude
% 208.88/209.04 |- mesh__recordMaintainer mesh__D000532 KEV
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D000532 2000
% 208.88/209.04 |- skos__hiddenLabel mesh__D000532 Sickness, Altitude
% 208.88/209.04 |- skos__altLabel mesh__D000532 Mountain Sickness
% 208.88/209.04 |- rdf__type mesh__D000532sskos__Concept
% 208.88/209.04 |- skos__scopeNote mesh__D000532
% 208.88/209.04 A morbid condition of ANOXIA caused by the reduced available oxygen at high altitudes.%A%
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D000532 sjn
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D000532 2005
% 208.88/209.04 |- skos__hiddenLabel mesh__D000532 Sickness, Mountain
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D000532 2001
% 208.88/209.04 |- skos__broader mesh__D000532smesh__D000860
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D000532 2006
% 208.88/209.04 |- mesh__dateEstablished mesh__D000532 1991-01-01
% 208.88/209.04 |- mesh__historyNote mesh__D000532
% 208.88/209.04 91%28%75%29%; was see under ANOXIA 1975-90
% 208.88/209.04 |- mesh__dateRevised mesh__D000532 1999-11-03
% 208.88/209.04 |- mesh__onlineNote mesh__D000532 search ANOXIA 1966-74
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D000532 2003
% 208.88/209.04 |- skos__hiddenLabel mesh__D000532 Mountain Sicknesses
% 208.88/209.04 |- skos__prefLabel mesh__D000532 Altitude Sickness
% 208.88/209.04 |- skos__hiddenLabel mesh__D024182 Heterodisomy, Uniparental
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D024182 2005
% 208.88/209.04 |- mesh__dateCreated mesh__D024182 2001-07-25
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D024182 2002
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D024182 2003
% 208.88/209.04 |- mesh__historyNote mesh__D024182 2002
% 208.88/209.04 |- skos__altLabel mesh__D024182 Disomy, Uniparental
% 208.88/209.04 |- skos__historyNote mesh__D024182 Chromosome Aberrations %28%1989-2001%29%
% 208.88/209.04 |- skos__hiddenLabel mesh__D024182 Uniparental Heterodisomies
% 208.88/209.04 |- skos__hiddenLabel mesh__D024182 Isodisomies, Uniparental
% 208.88/209.04 |- mesh__dateEstablished mesh__D024182 2002-01-01
% 208.88/209.04 |- skos__scopeNote mesh__D024182
% 208.88/209.04 The presence in a cell of two paired chromosomes from the same parent, with no chromosome of that pair from the other parent. This chromosome composition stems from non-disjunction %28%NONDISJUNCTION, GENETIC%29% events during MEIOSIS. The disomy may be composed of both homologous chromosomes from one parent %28%heterodisomy%29% or a duplicate of one chromosome %28%isodisomy%29%.%A%
% 208.88/209.04 |- skos__prefLabel mesh__D024182 Uniparental Disomy
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D024182 sjn
% 208.88/209.04 |- skos__hiddenLabel mesh__D024182 Heterodisomies, Uniparental
% 208.88/209.04 |- mesh__recordOriginator mesh__D024182 nns
% 208.88/209.04 |- skos__hiddenLabel mesh__D024182 Disomies, Uniparental
% 208.88/209.04 |- skos__broader mesh__D024182smesh__D002869
% 208.88/209.04 |- skos__hiddenLabel mesh__D024182 Uniparental Isodisomies
% 208.88/209.04 |- mesh__recordMaintainer mesh__D024182 nns
% 208.88/209.04 |- rdf__type mesh__D024182sskos__Concept
% 208.88/209.04 |- skos__hiddenLabel mesh__D024182 Uniparental Disomies
% 208.88/209.04 |- skos__historyNote mesh__D024182
% 208.88/209.04 Chromosome Abnormalities %28%1980-2001%29%
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D024182 2006
% 208.88/209.04 |- mesh__dateRevised mesh__D024182 2002-07-03
% 208.88/209.04 |- skos__historyNote mesh__D024182 Aneuploidy %28%1980-2001%29%
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D024182 2004
% 208.88/209.04 |- skos__broader mesh__D024182smesh__D009630
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018943 2006
% 208.88/209.04 |- mesh__historyNote mesh__D018943 96
% 208.88/209.04 |- skos__prefLabel mesh__D018943 Anthracyclines
% 208.88/209.04 |- rdf__type mesh__D018943sskos__Concept
% 208.88/209.04 |- mesh__recordMaintainer mesh__D018943 ssb
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D018943 96
% 208.88/209.04 |- mesh__dateRevised mesh__D018943 2004-07-07
% 208.88/209.04 |- skos__scopeNote mesh__D018943
% 208.88/209.04 Organic compounds that have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.%A%
% 208.88/209.04 |- mesh__dateCreated mesh__D018943 1995-06-05
% 208.88/209.04 |- skos__broader mesh__D018943smesh__D009279
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D018943 sjn
% 208.88/209.04 |- mesh__recordOriginator mesh__D018943 JRT
% 208.88/209.04 |- mesh__dateEstablished mesh__D018943 1996-01-01
% 208.88/209.04 |- skos__broader mesh__D018943smesh__D000617
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018943 2005
% 208.88/209.04 |- skos__historyNote mesh__D010960 Peptide Hydrolases %28%1975%29%
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D010960 76
% 208.88/209.04 |- mesh__dateCreated mesh__D010960 1975-07-25
% 208.88/209.04 |- skos__historyNote mesh__D010960 Enzyme Activation %28%1974-1975%29%
% 208.88/209.04 |- skos__broader mesh__D010960smesh__D012697
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010960 2006
% 208.88/209.04 |- skos__prefLabel mesh__D010960 Plasminogen Activators
% 208.88/209.04 |- mesh__dateEstablished mesh__D010960 1976-01-01
% 208.88/209.04 |- skos__altLabel mesh__D010960 Plasminogen Activator
% 208.88/209.04 |- mesh__historyNote mesh__D010960 76
% 208.88/209.04 |- skos__historyNote mesh__D010960 Plasminogen %28%1974-1975%29%
% 208.88/209.04 |- skos__broader mesh__D010960smesh__D001779
% 208.88/209.04 |- skos__hiddenLabel mesh__D010960 Uterine Tissue Plasminogen Activator
% 208.88/209.04 |- rdf__type mesh__D010960sskos__Concept
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D010960 sjn
% 208.88/209.04 |- mesh__recordMaintainer mesh__D010960 ssb
% 208.88/209.04 |- skos__scopeNote mesh__D010960
% 208.88/209.04 A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to PLASMIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation.%A%
% 208.88/209.04 |- mesh__recordOriginator mesh__D010960 RLS
% 208.88/209.04 |- skos__annotation mesh__D010960
% 208.88/209.04 /antag: consider also PLASMINOGEN INACTIVATORS
% 208.88/209.04 |- mesh__dateRevised mesh__D010960 2005-06-30
% 208.88/209.04 |- mesh__onlineNote mesh__D018145
% 208.88/209.04 use PAPILLOMAVIRUSES to search INFECTIOUS HUMAN WART VIRUS 1975-93%A%
% 208.88/209.04 |- mesh__dateRevised mesh__D018145 2003-07-09
% 208.88/209.04 |- skos__prefLabel mesh__D018145 Papillomavirus, Human
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018145 2005
% 208.88/209.04 |- skos__hiddenLabel mesh__D018145 Human Papilloma Viruses
% 208.88/209.04 |- skos__hiddenLabel mesh__D018145 Papillomaviruses, Human
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018145 2006
% 208.88/209.04 |- skos__altLabel mesh__D018145 Papilloma Virus, Human
% 208.88/209.04 |- skos__hiddenLabel mesh__D018145 Human Papilloma Virus
% 208.88/209.04 |- skos__broader mesh__D018145smesh__D010213
% 208.88/209.04 |- skos__altLabel mesh__D018145 Human Wart Virus, Infectious
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D018145
% 208.88/209.04 94; INFECTIOUS HUMAN WART VIRUS was see PAPILLOMAVIRUSES 1975-93%A%
% 208.88/209.04 |- rdf__type mesh__D018145sskos__Concept
% 208.88/209.04 |- skos__annotation mesh__D018145
% 208.88/209.04 infection: coord IM with PAPILLOMAVIRUS INFECTIONS %28%IM%29%; consider also WARTS%A%
% 208.88/209.04 |- skos__historyNote mesh__D018145 Papillomavirus %28%1975-1993%29%
% 208.88/209.04 |- skos__altLabel mesh__D018145 Infectious Human Wart Virus
% 208.88/209.04 |- skos__scopeNote mesh__D018145
% 208.88/209.04 A species of PAPILLOMAVIRUS causing WARTS in humans. These benign, squamous EPITHELIAL NEOPLASMS can sometimes progress to malignancy.%A%
% 208.88/209.04 |- skos__altLabel mesh__D018145 Human papillomavirus
% 208.88/209.04 |- mesh__historyNote mesh__D018145
% 208.88/209.04 94; INFECTIOUS HUMAN WART VIRUS was see PAPILLOMAVIRUSES 1975-93%A%
% 208.88/209.04 |- mesh__recordOriginator mesh__D018145 AGS
% 208.88/209.04 |- mesh__dateCreated mesh__D018145 1993-06-04
% 208.88/209.04 |- mesh__dateEstablished mesh__D018145 1994-01-01
% 208.88/209.04 |- skos__hiddenLabel mesh__D018145 Papilloma Viruses, Human
% 208.88/209.04 |- skos__hiddenLabel mesh__D018145 Human Papillomaviruses
% 208.88/209.04 |- mesh__recordMaintainer mesh__D018145 ags
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D018145 2004
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D018145 sjn
% 208.88/209.04 |- skos__scopeNote mesh__D010162
% 208.88/209.04 The study of ancient inscriptions and modes of writing. It includes the deciphering of manuscripts and other forms to determine their date, provenance, etc. %28%Webster%27%s 1st ed%29%%A%
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 2006
% 208.88/209.04 |- mesh__recordMaintainer mesh__D010162 TGC
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 1999
% 208.88/209.04 |- mesh__dateRevised mesh__D010162 1994-04-21
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D010162 PLS
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 2002
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 1995
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 2005
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 1998
% 208.88/209.04 |- mesh__recordOriginator mesh__D010162 NLM
% 208.88/209.04 |- rdf__type mesh__D010162sskos__Concept
% 208.88/209.04 |- skos__annotation mesh__D010162
% 208.88/209.04 study of manuscripts %26% inscriptions; IM; med paleography: do not coord with MEDICINE; DF: PALEOGR%A%
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 2001
% 208.88/209.04 |- skos__broader mesh__D010162smesh__D006236
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 2004
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 1997
% 208.88/209.04 |- skos__prefLabel mesh__D010162 Paleography
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 2000
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 2003
% 208.88/209.04 |- mesh__dateCreated mesh__D010162 1999-01-01
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D010162 1996
% 208.88/209.04 |- mesh__recordOriginator mesh__D004923 SH
% 208.88/209.04 |- skos__prefLabel mesh__D004923 Erythrosine
% 208.88/209.04 |- skos__scopeNote mesh__D004923
% 208.88/209.04 A tetraiodofluorescein used as a red coloring in some foods %28%cherries, fish%29%, as a disclosure of DENTAL PLAQUE, and as a stain of some cell types. It has structural similarity to THYROXINE.%A%
% 208.88/209.04 |- mesh__recordMaintainer mesh__D004923 ssb
% 208.88/209.04 |- mesh__dateEstablished mesh__D004923 1991-01-01
% 208.88/209.04 |- skos__historyNote mesh__D004923 Fluoresceins %28%1966-1978%29%
% 208.88/209.04 |- mesh__historyNote mesh__D004923
% 208.88/209.04 91%28%79%29%; was see under FLUORESCEINS 1979-90
% 208.88/209.04 |- skos__annotation mesh__D004923
% 208.88/209.04 do not confuse with Erythrocin, a brand of ERYTHROMYCIN
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D004923 2006
% 208.88/209.04 |- skos__altLabel mesh__D004923 FDC Red No. 3
% 208.88/209.04 |- skos__altLabel mesh__D004923 Erythrosin
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D004923 2005
% 208.88/209.04 |- rdf__type mesh__D004923sskos__Concept
% 208.88/209.04 |- mesh__dateCreated mesh__D004923 1978-02-07
% 208.88/209.04 |- mesh__dateRevised mesh__D004923 2002-07-03
% 208.88/209.04 |- skos__altLabel mesh__D004923 Erythrosine B
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D004923 2004
% 208.88/209.04 |- skos__altLabel mesh__D004923 FD %26% C Red No. 3
% 208.88/209.04 |- skos__altLabel mesh__D004923 Erythrosin B
% 208.88/209.04 |- skos__altLabel mesh__D004923 F D %26% C %23%3
% 208.88/209.04 |- mesh__activeMeSHYear mesh__D004923 2003
% 208.88/209.04 |- skos__broader mesh__D004923smesh__D005452
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D004923
% 208.88/209.04 91; was see under FLUORESCEINS 1979-90
% 208.88/209.04 |- skos__altLabel mesh__D004923
% 208.88/209.04 2%27%,4%27%,5%27%,7%27%-Tetraiodofluorescein
% 208.88/209.04 |- mesh__recordAuthorizer mesh__D004923 sjn
% 208.88/209.04 |- mesh__recordOriginator mesh__D051579 DRC
% 208.88/209.04 |- rdf__type mesh__D051579sskos__Concept
% 208.88/209.04 |- mesh__publicMeSHNote mesh__D051579
% 208.88/209.04 2006; NEUROGRANIN was indexed under CALMODULIN-BINDING PROTEINS %26% NERVE TISSUE PROTEINS 1991-2005%A%
% 208.88/209.04 |- skos__broader mesh__D051579smesh__D009419
% 208.88/209.04 |- mesh__dateCreated mesh__D051579 2005-06-30
% 208.88/209.04 |- skos__scopeNote mesh__D051579
% 208.88/209.04 A BRAIN-specific substrate for PROTEIN KINASE C that binds CALMODULIN and is involved in regulation of CALCIUM SIGNALING.%A%
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D051579 sjn
% 208.88/209.05 |- skos__prefLabel mesh__D051579 Neurogranin
% 208.88/209.05 |- skos__altLabel mesh__D051579 P17 Protein Kinase C Substrate
% 208.88/209.05 |- skos__broader mesh__D051579smesh__D002148
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D051579 2006
% 208.88/209.05 |- mesh__dateEstablished mesh__D051579 2006-01-01
% 208.88/209.05 |- skos__altLabel mesh__D051579 RC3 Protein %28%Neurogranin%29%
% 208.88/209.05 |- mesh__recordMaintainer mesh__D051579 DRC
% 208.88/209.05 |- mesh__historyNote mesh__D051579 2006%28%1991%29%
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D004125
% 208.88/209.05 91; was see under THIOCARBAMATES 1975-90
% 208.88/209.05 |- rdf__type mesh__D004125sskos__Concept
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 1995
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 2005
% 208.88/209.05 |- mesh__dateEstablished mesh__D004125 1991-01-01
% 208.88/209.05 |- mesh__recordOriginator mesh__D004125 NLM
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 2006
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 1998
% 208.88/209.05 |- skos__prefLabel mesh__D004125 Dimethyldithiocarbamate
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 2003
% 208.88/209.05 |- mesh__historyNote mesh__D004125
% 208.88/209.05 91%28%75%29%; was see under THIOCARBAMATES 1975-90
% 208.88/209.05 |- mesh__dateCreated mesh__D004125 1974-11-19
% 208.88/209.05 |- skos__broader mesh__D004125smesh__D013859
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 2000
% 208.88/209.05 |- skos__historyNote mesh__D004125 Thiocarbamates %28%1966-1974%29%
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 1999
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 1996
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 2004
% 208.88/209.05 |- mesh__dateRevised mesh__D004125 1993-06-04
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 2001
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 1997
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 2002
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D004125 PLS
% 208.88/209.05 |- skos__scopeNote mesh__D004125
% 208.88/209.05 A chemical that acts as a dopamine beta-hydroxylase inhibitor. Its salts are agricultural fungicides. It is inferior to diethyldithiocarbamate as a chelating agent.%A%
% 208.88/209.05 |- mesh__recordMaintainer mesh__D004125 TPW
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004125 1994
% 208.88/209.05 |- skos__hiddenLabel mesh__D014553 Physiologies, Urinary Tract
% 208.88/209.05 |- skos__prefLabel mesh__D014553 Urinary Tract Physiology
% 208.88/209.05 |- skos__annotation mesh__D014553
% 208.88/209.05 avoid: too general; DF: URINARY TRACT PHYSIOL
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D014553 2005
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D014553 sjn
% 208.88/209.05 |- rdf__type mesh__D014553sskos__Concept
% 208.88/209.05 |- skos__scopeNote mesh__D014553
% 208.88/209.05 Functions and activities of the urinary tract as a whole or of any of its parts.%A%
% 208.88/209.05 |- skos__hiddenLabel mesh__D014553 Tract Physiologies, Urinary
% 208.88/209.05 |- mesh__recordMaintainer mesh__D014553 lkt
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D014553 2006
% 208.88/209.05 |- skos__altLabel mesh__D014553 Physiology, Urinary Tract
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D014553 98
% 208.88/209.05 |- skos__broader mesh__D014553smesh__D012101
% 208.88/209.05 |- mesh__recordOriginator mesh__D014553 NLM
% 208.88/209.05 |- mesh__dateRevised mesh__D014553 2004-07-07
% 208.88/209.05 |- skos__historyNote mesh__D014553
% 208.88/209.05 Urinary Tract/physiology %28%1969-1997%29%
% 208.88/209.05 |- mesh__dateCreated mesh__D014553 1999-01-01
% 208.88/209.05 |- mesh__historyNote mesh__D014553 98; use explode 1970-97
% 208.88/209.05 |- skos__hiddenLabel mesh__D014553 Tract Physiology, Urinary
% 208.88/209.05 |- mesh__dateEstablished mesh__D014553 1998-01-01
% 208.88/209.05 |- skos__hiddenLabel mesh__D014553 Urinary Tract Physiologies
% 208.88/209.05 |- skos__altLabel mesh__D008516 Zhong Yi Xue
% 208.88/209.05 |- mesh__onlineNote mesh__D008516
% 208.88/209.05 to search MEDICINE, CHINESE %26% CHINESE MEDICINE use MEDICINE, CHINESE TRADITIONAL 1975-83 %26% MEDICINE, ORIENTAL TRADITIONAL 1967-74%A%
% 208.88/209.05 |- skos__related mesh__D008516smesh__D015670
% 208.88/209.05 |- mesh__recordMaintainer mesh__D008516 ssb
% 208.88/209.05 |- skos__related mesh__D008516smesh__D004365
% 208.88/209.05 |- mesh__dateRevised mesh__D008516 2002-07-03
% 208.88/209.05 |- skos__related mesh__D008516smesh__D016711
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D008516 2005
% 208.88/209.05 |- mesh__dateCreated mesh__D008516 1999-01-01
% 208.88/209.05 |- skos__broader mesh__D008516smesh__D008518
% 208.88/209.05 |- skos__altLabel mesh__D008516 Chinese Medicine, Traditional
% 208.88/209.05 |- skos__altLabel mesh__D008516 Traditional Chinese Medicine
% 208.88/209.05 |- skos__hiddenLabel mesh__D008516 Hsueh, Chung I
% 208.88/209.05 |- skos__altLabel mesh__D008516 Chung I Hsueh
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D008516 2006
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D008516 2003
% 208.88/209.05 |- skos__scopeNote mesh__D008516
% 208.88/209.05 A system of traditional medicine which is based on the beliefs and practices of the Chinese culture.%A%
% 208.88/209.05 |- skos__annotation mesh__D008516
% 208.88/209.05 is not medicine in China %28% = MEDICINE + CHINA%29%; Manual 32.13; medicinal plants in Chinese med: consider DRUGS, CHINESE HERBAL; index differentiation of signs %26% symptoms %28%bianzheng shizhi%29% under MEDICINE, CHINESE TRADITIONAL %28%IM%29% + DIAGNOSIS, DIFFERENTIAL %28%IM%29%; Oriental taking of pulses = PULSE + appropriate acupuncture or Oriental medicine terms; DF: MED CHINESE TRADITIONAL%A%
% 208.88/209.05 |- skos__related mesh__D008516smesh__D016710
% 208.88/209.05 |- skos__prefLabel mesh__D008516 Medicine, Chinese Traditional
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D008516 sjn
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D008516 2004
% 208.88/209.05 |- skos__related mesh__D008516smesh__D038861
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D008516
% 208.88/209.05 88; was see under MEDICINE, ORIENTAL TRADITIONAL 1984-87; was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83; was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80%A%
% 208.88/209.05 |- mesh__historyNote mesh__D008516
% 208.88/209.05 88%28%84%29%; was see under MEDICINE, ORIENTAL TRADITIONAL 1984-87; was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83; was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80%A%
% 208.88/209.05 |- skos__altLabel mesh__D008516 Traditional Medicine, Chinese
% 208.88/209.05 |- mesh__recordOriginator mesh__D008516 NLM
% 208.88/209.05 |- rdf__type mesh__D008516sskos__Concept
% 208.88/209.05 |- skos__altLabel mesh__D008516 Chinese Traditional Medicine
% 208.88/209.05 |- mesh__dateEstablished mesh__D008516 1988-01-01
% 208.88/209.05 |- mesh__dateEstablished mesh__D000533 1978-01-01
% 208.88/209.05 |- skos__related mesh__D000533smesh__D026686
% 208.88/209.05 |- skos__annotation mesh__D000533 no qualif
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D000533 78
% 208.88/209.05 |- rdf__type mesh__D000533sskos__Concept
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000533 2005
% 208.88/209.05 |- skos__scopeNote mesh__D000533
% 208.88/209.05 Consideration and concern for others, as opposed to self-love or egoism, which can be a motivating influence.%A%
% 208.88/209.05 |- skos__historyNote mesh__D000533 Social Behavior %28%1969-1977%29%
% 208.88/209.05 |- mesh__historyNote mesh__D000533 78
% 208.88/209.05 |- mesh__recordMaintainer mesh__D000533 hjn
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000533 2006
% 208.88/209.05 |- mesh__dateRevised mesh__D000533 2002-07-02
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000533 2003
% 208.88/209.05 |- mesh__recordOriginator mesh__D000533 EC
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D000533 sjn
% 208.88/209.05 |- skos__broader mesh__D000533smesh__D012919
% 208.88/209.05 |- skos__related mesh__D000533smesh__D037921
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000533 2004
% 208.88/209.05 |- skos__prefLabel mesh__D000533 Altruism
% 208.88/209.05 |- mesh__dateCreated mesh__D000533 1977-04-22
% 208.88/209.05 |- mesh__dateEstablished mesh__D024981 2002-01-01
% 208.88/209.05 |- skos__historyNote mesh__D024981 Glucosyltransferases %28%1965-1971%29%
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D024981 2005
% 208.88/209.05 |- rdf__type mesh__D024981sskos__Concept
% 208.88/209.05 |- skos__scopeNote mesh__D024981
% 208.88/209.05 An enzyme that catalyzes the degradation of GLYCOGEN in animals by releasing glucose-1-phosphate from the terminal alpha-1,4-glycosidic bond. This enzyme exists in two forms: an active phosphorylated form %28% PHOSPHORYLASE A%29% and an inactive un-phosphorylated form %28%PHOSPHORYLASE B%29%. Both a and b forms of phosphorylase exist as homodimers. In mammals, the major isozymes of glycogen phosphorylase are found in muscle, liver and brain tissue.%A%
% 208.88/209.05 |- mesh__historyNote mesh__D024981 2002
% 208.88/209.05 |- skos__broader mesh__D024981smesh__D006005
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D024981 2004
% 208.88/209.05 |- skos__altLabel mesh__D024981 Phosphorylase ab
% 208.88/209.05 |- skos__annotation mesh__D024981 GEN or unspecified; prefer specifics
% 208.88/209.05 |- skos__historyNote mesh__D024981 Phosphorylases %28%1972-2001%29%
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D024981 2002
% 208.88/209.05 |- mesh__dateRevised mesh__D024981 2003-07-09
% 208.88/209.05 |- mesh__dateCreated mesh__D024981 2001-07-25
% 208.88/209.05 |- skos__hiddenLabel mesh__D024981 Phosphorylase, Glycogen
% 208.88/209.05 |- skos__prefLabel mesh__D024981 Glycogen Phosphorylase
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D024981 2006
% 208.88/209.05 |- skos__scopeNote mesh__D010961
% 208.88/209.05 A genus of coccidian protozoa that comprise the malaria parasites of mammals. Four species infect humans %28%although occasional infections with primate malarias may occur%29%. These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens.%A%
% 208.88/209.05 |- mesh__recordMaintainer mesh__D010961 ags
% 208.88/209.05 |- mesh__dateRevised mesh__D010961 2003-07-09
% 208.88/209.05 |- skos__broader mesh__D010961smesh__D016787
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D010961 sjn
% 208.88/209.05 |- skos__prefLabel mesh__D010961 Plasmodium
% 208.88/209.05 |- rdf__type mesh__D010961sskos__Concept
% 208.88/209.05 |- skos__related mesh__D010961smesh__D000962
% 208.88/209.05 |- skos__annotation mesh__D010961
% 208.88/209.05 GEN: prefer specifics; infection = MALARIA; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%
% 208.88/209.05 |- mesh__onlineNote mesh__D010961
% 208.88/209.05 use PLASMODIUM to search HAEMAMOEBA 1976-91
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010961 2005
% 208.88/209.05 |- mesh__recordOriginator mesh__D010961 NLM
% 208.88/209.05 |- mesh__historyNote mesh__D010961 HAEMAMOEBA was see PLASMODIUM 1976-91
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D010961
% 208.88/209.05 HAEMAMOEBA was see PLASMODIUM 1976-91
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010961 2006
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010961 2004
% 208.88/209.05 |- mesh__dateCreated mesh__D010961 1999-01-01
% 208.88/209.05 |- skos__broader mesh__D017293Q000172smesh__D017293
% 208.88/209.05 |- mesh__preferredCombination mesh__D017293Q000172smesh__D018455
% 208.88/209.05 |- rdf__type mesh__D017293Q000172smesh__CompoundConcept
% 208.88/209.05 |- skos__hiddenLabel mesh__D018146 Cytomegalovirus, Rat
% 208.88/209.05 |- skos__altLabel mesh__D018146 Herpesvirus 1 %28%beta%29%, Murid
% 208.88/209.05 |- skos__historyNote mesh__D018146 Cytomegalovirus %28%1966-1993%29%
% 208.88/209.05 |- skos__hiddenLabel mesh__D018146 Muromegaloviruses
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D018146 2003
% 208.88/209.05 |- skos__broader mesh__D018146smesh__D018141
% 208.88/209.05 |- skos__hiddenLabel mesh__D018146 Cytomegalovirus, Mouse
% 208.88/209.05 |- skos__annotation mesh__D018146
% 208.88/209.05 infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%
% 208.88/209.05 |- mesh__historyNote mesh__D018146 94
% 208.88/209.05 |- skos__hiddenLabel mesh__D018146 Cytomegaloviruses, Murine
% 208.88/209.05 |- skos__hiddenLabel mesh__D018146 Rat Cytomegaloviruses
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D018146 sjn
% 208.88/209.05 |- skos__altLabel mesh__D018146 Murine Cytomegalovirus
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D018146 2002
% 208.88/209.05 |- mesh__recordOriginator mesh__D018146 AGS
% 208.88/209.05 |- skos__altLabel mesh__D018146 Mouse Cytomegalovirus
% 208.88/209.05 |- skos__altLabel mesh__D018146 Murid herpesvirus 2
% 208.88/209.05 |- mesh__recordMaintainer mesh__D018146 ags
% 208.88/209.05 |- skos__prefLabel mesh__D018146 Muromegalovirus
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D018146 2006
% 208.88/209.05 |- mesh__dateEstablished mesh__D018146 1994-01-01
% 208.88/209.05 |- skos__scopeNote mesh__D018146
% 208.88/209.05 A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, causing infection involving several organs in mice and rats. Murid herpesvirus is the type species.%A%
% 208.88/209.05 |- mesh__onlineNote mesh__D018146 search CYTOMEGALOVIRUS 1966-93
% 208.88/209.05 |- skos__hiddenLabel mesh__D018146 Mouse Cytomegaloviruses
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D018146 2005
% 208.88/209.05 |- skos__hiddenLabel mesh__D018146 Cytomegaloviruses, Rat
% 208.88/209.05 |- skos__altLabel mesh__D018146 Murid herpesvirus 1
% 208.88/209.05 |- skos__hiddenLabel mesh__D018146 Cytomegaloviruses, Mouse
% 208.88/209.05 |- rdf__type mesh__D018146sskos__Concept
% 208.88/209.05 |- skos__altLabel mesh__D018146 Rat Cytomegalovirus
% 208.88/209.05 |- mesh__dateCreated mesh__D018146 1993-06-04
% 208.88/209.05 |- skos__hiddenLabel mesh__D018146 Murine Cytomegaloviruses
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D018146 94
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D018146 2004
% 208.88/209.05 |- mesh__dateRevised mesh__D018146 2001-07-25
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 1995
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 2005
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 1998
% 208.88/209.05 |- skos__broader mesh__D010163smesh__D000885
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 2000
% 208.88/209.05 |- skos__related mesh__D010163smesh__D009106
% 208.88/209.05 |- skos__prefLabel mesh__D010163 Paleontology
% 208.88/209.05 |- skos__scopeNote mesh__D010163
% 208.88/209.05 The study of early forms of life through fossil remains.%A%
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D010163 PLS
% 208.88/209.05 |- rdf__type mesh__D010163sskos__Concept
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 2002
% 208.88/209.05 |- skos__annotation mesh__D010163
% 208.88/209.05 IM; SPEC: SPEC qualif; as NIM coord, no qualif; do not routinely check tags HISTORICAL ARTICLE %26% ANCIENT or MEDIEVAL: check only when the hist %26% ancient or medieval med aspects are particularly discussed; for prehist, ANCIENT tag is all right; paleontology is for pre-Columbian, nothing later; DF: PALEONTOL%A%
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 2004
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 1997
% 208.88/209.05 |- mesh__recordOriginator mesh__D010163 NLM
% 208.88/209.05 |- mesh__dateRevised mesh__D010163 1994-04-11
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 2003
% 208.88/209.05 |- mesh__dateCreated mesh__D010163 1999-01-01
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 1996
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 2001
% 208.88/209.05 |- mesh__recordMaintainer mesh__D010163 TGC
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 2006
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010163 1999
% 208.88/209.05 |- mesh__dateRevised mesh__D004924 2002-07-03
% 208.88/209.05 |- skos__hiddenLabel mesh__D004924 Flight Reactions
% 208.88/209.05 |- skos__broader mesh__D004924smesh__D001519
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004924 2005
% 208.88/209.05 |- skos__annotation mesh__D004924 human %26% animal
% 208.88/209.05 |- mesh__recordOriginator mesh__D004924 NLM
% 208.88/209.05 |- skos__historyNote mesh__D004924 Behavior, Animal %28%1966-1967%29%
% 208.88/209.05 |- skos__hiddenLabel mesh__D004924 Escape Reactions
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004924 2006
% 208.88/209.05 |- mesh__dateCreated mesh__D004924 1999-01-01
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D004924 sjn
% 208.88/209.05 |- skos__hiddenLabel mesh__D004924 Reaction, Flight
% 208.88/209.05 |- mesh__dateEstablished mesh__D004924 1968-01-01
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004924 2003
% 208.88/209.05 |- skos__hiddenLabel mesh__D004924 Reaction, Escape
% 208.88/209.05 |- rdf__type mesh__D004924sskos__Concept
% 208.88/209.05 |- skos__historyNote mesh__D004924 Fear %28%1966-1967%29%
% 208.88/209.05 |- mesh__onlineNote mesh__D004924
% 208.88/209.05 use ESCAPE REACTION to search FLIGHT REACTION 1968-78
% 208.88/209.05 |- mesh__recordMaintainer mesh__D004924 TAP
% 208.88/209.05 |- skos__altLabel mesh__D004924 Flight Reaction
% 208.88/209.05 |- skos__scopeNote mesh__D004924
% 208.88/209.05 Innate response elicited by sensory stimuli associated with a threatening situation, or actual confrontation with an enemy.%A%
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004924 2004
% 208.88/209.05 |- skos__prefLabel mesh__D004924 Escape Reaction
% 208.88/209.05 |- skos__broader mesh__D004924smesh__D001522
% 208.88/209.05 |- mesh__historyNote mesh__D004924
% 208.88/209.05 68; FLIGHT REACTION was see under ESCAPE REACTION 1968-78%A%
% 208.88/209.05 |- skos__hiddenLabel mesh__D004924 Reactions, Flight
% 208.88/209.05 |- skos__hiddenLabel mesh__D004924 Reactions, Escape
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D004924 68
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 2006
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 1998
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 1993
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 2003
% 208.88/209.05 |- mesh__historyNote mesh__D004126 66%28%63%29%
% 208.88/209.05 |- skos__prefLabel mesh__D004126 Dimethylformamide
% 208.88/209.05 |- skos__annotation mesh__D004126 D25-26 qualif
% 208.88/209.05 |- mesh__dateCreated mesh__D004126 1999-01-01
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 1999
% 208.88/209.05 |- mesh__dateRevised mesh__D004126 1991-06-26
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 1996
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 2004
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D004126 66
% 208.88/209.05 |- mesh__recordOriginator mesh__D004126 NLM
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 1997
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 2000
% 208.88/209.05 |- mesh__recordMaintainer mesh__D004126 TAP
% 208.88/209.05 |- mesh__dateEstablished mesh__D004126 1966-01-01
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 1994
% 208.88/209.05 |- skos__broader mesh__D004126smesh__D005559
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 2001
% 208.88/209.05 |- rdf__type mesh__D004126sskos__Concept
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 1995
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 2005
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 1992
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D004126 2002
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D004126 PLS
% 208.88/209.05 |- mesh__dateCreated mesh__D020591 1999-11-03
% 208.88/209.05 |- mesh__historyNote mesh__D020591 2000
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D020591 sjn
% 208.88/209.05 |- skos__historyNote mesh__D020591
% 208.88/209.05 Gram-Negative Aerobic Bacteria %28%1977-1999%29%
% 208.88/209.05 |- skos__scopeNote mesh__D020591
% 208.88/209.05 A genus of gram-negative, straight or curved rods which are motile by means of a single, polar flagellum. Members of this genus are found in coastal waters and the open ocean. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.88/209.05 |- skos__prefLabel mesh__D020591 Alteromonas
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D020591 2000
% 208.88/209.05 |- mesh__dateEstablished mesh__D020591 2000-01-01
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D020591 2006
% 208.88/209.05 |- mesh__recordMaintainer mesh__D020591 SYSTEM
% 208.88/209.05 |- mesh__dateRevised mesh__D020591 2005-06-30
% 208.88/209.05 |- rdf__type mesh__D020591sskos__Concept
% 208.88/209.05 |- skos__broader mesh__D020591smesh__D034241
% 208.88/209.05 |- skos__broader mesh__D020591smesh__D016946
% 208.88/209.05 |- mesh__recordOriginator mesh__D020591 ndw
% 208.88/209.05 |- skos__annotation mesh__D014554
% 208.88/209.05 urine volume: index under URINE probably NIM
% 208.88/209.05 |- skos__hiddenLabel mesh__D014554 Urinations
% 208.88/209.05 |- rdf__type mesh__D014554sskos__Concept
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D014554 2006
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D014554 sjn
% 208.88/209.05 |- skos__broader mesh__D014554smesh__D014553
% 208.88/209.05 |- skos__prefLabel mesh__D014554 Urination
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D014554 2005
% 208.88/209.05 |- mesh__dateRevised mesh__D014554 2004-07-07
% 208.88/209.05 |- mesh__recordOriginator mesh__D014554 NLM
% 208.88/209.05 |- mesh__recordMaintainer mesh__D014554 lkt
% 208.88/209.05 |- mesh__dateCreated mesh__D014554 1999-01-01
% 208.88/209.05 |- skos__altLabel mesh__D008517 Herbal Therapy
% 208.88/209.05 |- skos__prefLabel mesh__D008517 Phytotherapy
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D008517 sjn
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D008517 2006
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D008517 2003
% 208.88/209.05 |- mesh__recordOriginator mesh__D008517 NLM
% 208.88/209.05 |- skos__altLabel mesh__D008517 Herb Therapy
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D008517 2004
% 208.88/209.05 |- mesh__dateRevised mesh__D008517 2001-07-25
% 208.88/209.05 |- mesh__historyNote mesh__D008517 2002%28%1963%29%
% 208.88/209.05 |- rdf__type mesh__D008517sskos__Concept
% 208.88/209.05 |- skos__scopeNote mesh__D008517
% 208.88/209.05 Use of plants or herbs to treat diseases or to alleviate pain.%A%
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D008517 2002
% 208.88/209.05 |- mesh__recordMaintainer mesh__D008517 ssb
% 208.88/209.05 |- skos__related mesh__D008517smesh__D010946
% 208.88/209.05 |- skos__annotation mesh__D008517
% 208.88/209.05 coord IM disease /drug ther %28%IM%29% + specific plant %28%IM%29% + PLANT PREPARATIONS or its indentations/ ther use %28%IM or NIM%29% + specific chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D008517
% 208.88/209.05 2002; see MEDICINE, HERBAL 1981-2001, see HERBALISM 1963-1980%A%
% 208.88/209.05 |- skos__related mesh__D008517smesh__D010936
% 208.88/209.05 |- skos__related mesh__D008517smesh__D004365
% 208.88/209.05 |- skos__broader mesh__D008517smesh__D000529
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D008517 2005
% 208.88/209.05 |- mesh__dateCreated mesh__D008517 1999-01-01
% 208.88/209.05 |- skos__related mesh__D008517smesh__D010944
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 1998
% 208.88/209.05 |- skos__broader mesh__D000534smesh__D017607
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 1995
% 208.88/209.05 |- skos__annotation mesh__D000534
% 208.88/209.05 astringents; also many indust uses; used also in vet med; D25-26 qualif; DF: ALUM CPDS%A%
% 208.88/209.05 |- skos__prefLabel mesh__D000534 Alum Compounds
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 2006
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 2001
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 1999
% 208.88/209.05 |- mesh__recordMaintainer mesh__D000534 TPW
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 2003
% 208.88/209.05 |- skos__hiddenLabel mesh__D000534 Compounds, Alum
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 1996
% 208.88/209.05 |- mesh__dateEstablished mesh__D000534 1991-01-01
% 208.88/209.05 |- mesh__dateRevised mesh__D000534 1993-06-04
% 208.88/209.05 |- mesh__onlineNote mesh__D000534
% 208.88/209.05 use ALUM COMPOUNDS to search ALUMINUM AMMONIUM SULFATE %26% ALUMINUM POTASSIUM SULFATE 1975-93%A%
% 208.88/209.05 |- skos__historyNote mesh__D000534 Sulfates %28%1973-1974%29%
% 208.88/209.05 |- mesh__dateCreated mesh__D000534 1974-11-19
% 208.88/209.05 |- skos__historyNote mesh__D000534 Aluminum %28%1973-1974%29%
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 2004
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 1997
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 2002
% 208.88/209.05 |- mesh__recordOriginator mesh__D000534 NLM
% 208.88/209.05 |- skos__scopeNote mesh__D000534
% 208.88/209.05 Aluminum metal sulfate compounds used medically as astringents and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leukorrhea, conjunctivitis, pharyngitis, metritis, and minor wounds.%A%
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D000534
% 208.88/209.05 91; was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE %26% ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93%A%
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 1994
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D000534 PLS
% 208.88/209.05 |- skos__broader mesh__D000534smesh__D013431
% 208.88/209.05 |- rdf__type mesh__D000534sskos__Concept
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 2005
% 208.88/209.05 |- mesh__historyNote mesh__D000534
% 208.88/209.05 91%28%75%29%; was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE %26% ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93%A%
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D000534 2000
% 208.88/209.05 |- skos__altLabel mesh__D024982 Myophosphorylase a and b
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D024982 2004
% 208.88/209.05 |- skos__altLabel mesh__D024982 Myophosphorylase
% 208.88/209.05 |- skos__historyNote mesh__D024982 Phosphorylases %28%1979-2001%29%
% 208.88/209.05 |- skos__scopeNote mesh__D024982
% 208.88/209.05 An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in muscle. Mutation of the gene coding this enzyme is the cause of McArdle disease %28%GLYCOGEN STORAGE DISEASE TYPE V%29%.%A%
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D024982 2002
% 208.88/209.05 |- skos__related mesh__D024982smesh__D006012
% 208.88/209.05 |- mesh__historyNote mesh__D024982 2002
% 208.88/209.05 |- mesh__dateRevised mesh__D024982 2003-07-09
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D024982 2006
% 208.88/209.05 |- skos__broader mesh__D024982smesh__D024981
% 208.88/209.05 |- skos__historyNote mesh__D024982 Glucosyltransferases %28%1967-1978%29%
% 208.88/209.05 |- mesh__dateEstablished mesh__D024982 2002-01-01
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D024982 2005
% 208.88/209.05 |- rdf__type mesh__D024982sskos__Concept
% 208.88/209.05 |- mesh__dateCreated mesh__D024982 2001-07-25
% 208.88/209.05 |- skos__prefLabel mesh__D024982 Glycogen Phosphorylase, Muscle Form
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D018945 96
% 208.88/209.05 |- skos__annotation mesh__D018945
% 208.88/209.05 chemokines; MONOCYTE CHEMOATTRACTANT PROTEIN-1 is also available%A%
% 208.88/209.05 |- skos__scopeNote mesh__D018945
% 208.88/209.05 Chemokines that are chemoattractants for monocytes. These CC chemokines %28%cysteines adjacent%29% number at least three including MONOCYTE CHEMOATTRACTANT PROTEIN-1.%A%
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D018945 sjn
% 208.88/209.05 |- mesh__dateEstablished mesh__D018945 1996-01-01
% 208.88/209.05 |- skos__prefLabel mesh__D018945 Monocyte Chemoattractant Proteins
% 208.88/209.05 |- skos__historyNote mesh__D018945 Chemotactic Factors %28%1991-1995%29%
% 208.88/209.05 |- mesh__recordOriginator mesh__D018945 AGS
% 208.88/209.05 |- mesh__dateCreated mesh__D018945 1995-02-21
% 208.88/209.05 |- rdf__type mesh__D018945sskos__Concept
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D018945 2006
% 208.88/209.05 |- skos__hiddenLabel mesh__D018945 Chemotactic Proteins, Monocyte
% 208.88/209.05 |- mesh__historyNote mesh__D018945 96
% 208.88/209.05 |- skos__broader mesh__D018945smesh__D018925
% 208.88/209.05 |- skos__hiddenLabel mesh__D018945 Chemoattractant Proteins, Monocyte
% 208.88/209.05 |- skos__altLabel mesh__D018945 Monocyte Chemotactic Proteins
% 208.88/209.05 |- mesh__dateRevised mesh__D018945 2005-06-30
% 208.88/209.05 |- mesh__recordMaintainer mesh__D018945 ssb
% 208.88/209.05 |- rdf__type mesh__D010962sskos__Concept
% 208.88/209.05 |- skos__scopeNote mesh__D010962
% 208.88/209.05 A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni.%A%
% 208.88/209.05 |- mesh__historyNote mesh__D010962 73
% 208.88/209.05 |- skos__historyNote mesh__D010962 Plasmodium %28%1966-1972%29%
% 208.88/209.05 |- mesh__recordAuthorizer mesh__D010962 sjn
% 208.88/209.05 |- skos__annotation mesh__D010962
% 208.88/209.05 in rodents; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010962 2005
% 208.88/209.05 |- mesh__dateEstablished mesh__D010962 1973-01-01
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010962 2006
% 208.88/209.05 |- skos__broader mesh__D010962smesh__D010961
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D010962 73
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D010962 2004
% 208.88/209.05 |- mesh__dateCreated mesh__D010962 1999-01-01
% 208.88/209.05 |- mesh__recordMaintainer mesh__D010962 ags
% 208.88/209.05 |- skos__prefLabel mesh__D010962 Plasmodium berghei
% 208.88/209.05 |- mesh__recordOriginator mesh__D010962 NLM
% 208.88/209.05 |- mesh__dateRevised mesh__D010962 2003-07-09
% 208.88/209.05 |- mesh__dateCreated mesh__D018147 1993-06-04
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D018147 2000
% 208.88/209.05 |- mesh__publicMeSHNote mesh__D018147 94
% 208.88/209.05 |- mesh__historyNote mesh__D018147 94
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D018147 1996
% 208.88/209.05 |- mesh__activeMeSHYear mesh__D018147 1995
% 208.88/209.06 |- skos__scopeNote mesh__D018147
% 208.88/209.06 A subfamily of the family POXVIRIDAE, containing eight genera comprising all the vertebrate poxviruses.%A%
% 208.88/209.06 |- skos__prefLabel mesh__D018147 Chordopoxvirinae
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 1994
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 2006
% 208.88/209.06 |- skos__annotation mesh__D018147
% 208.88/209.06 a subfamily of the family Poxviridae comprising all vertebrate %28%Chordo-%29%poxviruses; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 1999
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 2005
% 208.88/209.06 |- skos__broader mesh__D018147smesh__D011212
% 208.88/209.06 |- rdf__type mesh__D018147sskos__Concept
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 2002
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 1998
% 208.88/209.06 |- mesh__dateEstablished mesh__D018147 1994-01-01
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 2004
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 2001
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 1997
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018147 2003
% 208.88/209.06 |- mesh__dateRevised mesh__D010164 1994-04-11
% 208.88/209.06 |- mesh__recordOriginator mesh__D010164 NLM
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 2004
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 1997
% 208.88/209.06 |- skos__annotation mesh__D010164
% 208.88/209.06 IM; SPEC: SPEC qualif; as NIM coord, no qualif; check tags HISTORICAL ARTICLE %26% ANCIENT or MEDIEVAL; for prehist, ANCIENT tag is all right; paleopathol is for pre-Columbian, nothing later; consider also MUMMIES /pathol %26% do not coord with PALEOPATHOLOGY; DF: PALEOPATHOL%A%
% 208.88/209.06 |- skos__prefLabel mesh__D010164 Paleopathology
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 2001
% 208.88/209.06 |- skos__broader mesh__D010164smesh__D010163
% 208.88/209.06 |- mesh__dateCreated mesh__D010164 1999-01-01
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 2003
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 1996
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 2000
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 2006
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 1999
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 1995
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 2005
% 208.88/209.06 |- mesh__recordMaintainer mesh__D010164 TGC
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D010164 PLS
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 1998
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010164 2002
% 208.88/209.06 |- rdf__type mesh__D010164sskos__Concept
% 208.88/209.06 |- skos__scopeNote mesh__D010164
% 208.88/209.06 The study of disease in prehistoric times as revealed in bones, mummies, and archaeologic artifacts.%A%
% 208.88/209.06 |- skos__scopeNote mesh__D004925
% 208.88/209.06 A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.%A%
% 208.88/209.06 |- mesh__dateCreated mesh__D004925 1999-01-01
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004925 2006
% 208.88/209.06 |- mesh__dateRevised mesh__D004925 2005-06-30
% 208.88/209.06 |- mesh__recordMaintainer mesh__D004925 SYSTEM
% 208.88/209.06 |- skos__broader mesh__D004925smesh__D004755
% 208.88/209.06 |- rdf__type mesh__D004925sskos__Concept
% 208.88/209.06 |- mesh__recordOriginator mesh__D004925 NLM
% 208.88/209.06 |- skos__prefLabel mesh__D004925 Escherichia
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D004925 sjn
% 208.88/209.06 |- skos__annotation mesh__D004925
% 208.88/209.06 infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%
% 208.88/209.06 |- rdf__type mesh__D004127sskos__Concept
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 2000
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 2004
% 208.88/209.06 |- mesh__onlineNote mesh__D004127
% 208.88/209.06 use DIMETHYLHYDRAZINES to search 1,2 DIMETHYLHYDRAZINE 1975-77%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 2006
% 208.88/209.06 |- mesh__historyNote mesh__D004127
% 208.88/209.06 91%28%78%29%; was see under METHYLHYDRAZINES 1978-90; was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 2003
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 1997
% 208.88/209.06 |- mesh__dateEstablished mesh__D004127 1991-01-01
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 2005
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 1999
% 208.88/209.06 |- skos__broader mesh__D004127smesh__D008763
% 208.88/209.06 |- mesh__recordMaintainer mesh__D004127 JRT
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D004127
% 208.88/209.06 91; was see under METHYLHYDRAZINES 1978-90; was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 2002
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 1996
% 208.88/209.06 |- mesh__recordOriginator mesh__D004127 NLM
% 208.88/209.06 |- mesh__dateCreated mesh__D004127 1974-11-11
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 1998
% 208.88/209.06 |- skos__prefLabel mesh__D004127 Dimethylhydrazines
% 208.88/209.06 |- skos__annotation mesh__D004127 carcinogens; D25-26 qualif
% 208.88/209.06 |- skos__scopeNote mesh__D004127
% 208.88/209.06 Hydrazines substituted with two methyl groups in any position.%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004127 2001
% 208.88/209.06 |- skos__historyNote mesh__D004127 Hydrazines %28%1968-1974%29%
% 208.88/209.06 |- mesh__dateRevised mesh__D004127 1995-06-08
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D004127 PLS
% 208.88/209.06 |- skos__historyNote mesh__D009610 Hydrazones %28%1972-1974%29%
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D009610
% 208.88/209.06 91; was see under NITROFURANS 1975-90
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009610 2002
% 208.88/209.06 |- mesh__recordMaintainer mesh__D009610 jmp
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009610 2005
% 208.88/209.06 |- mesh__historyNote mesh__D009610
% 208.88/209.06 91%28%75%29%; was see under NITROFURANS 1975-90
% 208.88/209.06 |- skos__scopeNote mesh__D009610
% 208.88/209.06 An antibacterial growth promoter used in animal feeds.
% 208.88/209.06 |- skos__historyNote mesh__D009610 Nitrofurans %28%1971-1974%29%
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D009610 sjn
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009610 2006
% 208.88/209.06 |- skos__broader mesh__D009610smesh__D009581
% 208.88/209.06 |- mesh__dateCreated mesh__D009610 1974-11-19
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009610 2003
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009610 2001
% 208.88/209.06 |- skos__historyNote mesh__D009610 Amidines %28%1971-1974%29%
% 208.88/209.06 |- rdf__type mesh__D009610sskos__Concept
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009610 2004
% 208.88/209.06 |- mesh__dateEstablished mesh__D009610 1991-01-01
% 208.88/209.06 |- mesh__dateRevised mesh__D009610 2000-06-22
% 208.88/209.06 |- skos__prefLabel mesh__D009610 Nitrovin
% 208.88/209.06 |- mesh__recordOriginator mesh__D009610 NLM
% 208.88/209.06 |- skos__scopeNote mesh__D020592
% 208.88/209.06 A genus of gram-negative, facultatively anaerobic rods. It is a saprophytic, marine organism which is often isolated from spoiling fish.%A%
% 208.88/209.06 |- skos__historyNote mesh__D020592
% 208.88/209.06 Gram-Negative Facultatively Anaerobic Rods %28%1995-1999%29%
% 208.88/209.06 |- skos__annotation mesh__D020592
% 208.88/209.06 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 208.88/209.06 |- skos__broader mesh__D020592smesh__D006092
% 208.88/209.06 |- mesh__dateCreated mesh__D020592 1999-11-03
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D020592 sjn
% 208.88/209.06 |- mesh__dateEstablished mesh__D020592 2000-01-01
% 208.88/209.06 |- skos__prefLabel mesh__D020592 Shewanella
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D020592 2006
% 208.88/209.06 |- mesh__recordMaintainer mesh__D020592 SYSTEM
% 208.88/209.06 |- rdf__type mesh__D020592sskos__Concept
% 208.88/209.06 |- skos__broader mesh__D020592smesh__D034241
% 208.88/209.06 |- mesh__recordOriginator mesh__D020592 ndw
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D020592 2000
% 208.88/209.06 |- mesh__historyNote mesh__D020592 2000
% 208.88/209.06 |- mesh__dateRevised mesh__D020592 2005-06-30
% 208.88/209.06 |- skos__prefLabel mesh__D014555 Urination Disorders
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014555 2004
% 208.88/209.06 |- mesh__recordMaintainer mesh__D014555 KEV
% 208.88/209.06 |- mesh__recordOriginator mesh__D014555 NLM
% 208.88/209.06 |- skos__hiddenLabel mesh__D014555 Disorders, Urination
% 208.88/209.06 |- mesh__dateRevised mesh__D014555 1999-11-03
% 208.88/209.06 |- skos__broader mesh__D014555smesh__D014570
% 208.88/209.06 |- rdf__type mesh__D014555sskos__Concept
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014555 2003
% 208.88/209.06 |- skos__altLabel mesh__D014555 Nocturia
% 208.88/209.06 |- skos__scopeNote mesh__D014555
% 208.88/209.06 Disorders in the frequency of urination, the volume of urine produced or eliminated, or the ability to retain or void urine in normal fashion.%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014555 2001
% 208.88/209.06 |- skos__hiddenLabel mesh__D014555 Disorder, Urination
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014555 2006
% 208.88/209.06 |- skos__related mesh__D014555smesh__D020924
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014555 2000
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014555 2005
% 208.88/209.06 |- skos__hiddenLabel mesh__D014555 Urination Disorder
% 208.88/209.06 |- mesh__dateCreated mesh__D014555 1999-01-01
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D014555 sjn
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014555 2002
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D008518 2005
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D008518 2003
% 208.88/209.06 |- skos__hiddenLabel mesh__D008518 Traditional Oriental Medicine
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D008518 84; was MEDICINE, ORIENTAL 1966-83
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D008518 2006
% 208.88/209.06 |- rdf__type mesh__D008518sskos__Concept
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D008518 2004
% 208.88/209.06 |- skos__related mesh__D008518smesh__D015670
% 208.88/209.06 |- skos__hiddenLabel mesh__D008518 Traditional Oriental Medicines
% 208.88/209.06 |- skos__prefLabel mesh__D008518 Medicine, Oriental Traditional
% 208.88/209.06 |- mesh__dateRevised mesh__D008518 2001-07-25
% 208.88/209.06 |- skos__altLabel mesh__D008518 Oriental Medicine, Traditional
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D008518 2002
% 208.88/209.06 |- mesh__recordMaintainer mesh__D008518 ssb
% 208.88/209.06 |- skos__scopeNote mesh__D008518
% 208.88/209.06 A system of traditional medicine which is based on the customs, beliefs and practices of the Oriental people.%A%
% 208.88/209.06 |- skos__broader mesh__D008518smesh__D008519
% 208.88/209.06 |- skos__annotation mesh__D008518
% 208.88/209.06 do not use for %22%medicine in the Orient%22% %28% = MEDICINE %28%IM%29% + country%29%; specify Oriental country; Manual 32.13; Oriental taking of pulses = PULSE + appropriate acupuncture or Oriental medicine terms; DF: MED ORIENTAL TRADITIONAL%A%
% 208.88/209.06 |- skos__hiddenLabel mesh__D008518 Medicine, Traditional Oriental
% 208.88/209.06 |- skos__altLabel mesh__D008518 Traditional Medicine, Oriental
% 208.88/209.06 |- mesh__historyNote mesh__D008518 84; was MEDICINE, ORIENTAL 1966-83
% 208.88/209.06 |- mesh__onlineNote mesh__D008518
% 208.88/209.06 use MEDICINE, ORIENTAL TRADITIONAL to search MEDICINE, ORIENTAL 1966-83%A%
% 208.88/209.06 |- skos__altLabel mesh__D008518 Medicine, Oriental
% 208.88/209.06 |- mesh__dateCreated mesh__D008518 1999-01-01
% 208.88/209.06 |- skos__hiddenLabel mesh__D008518 Oriental Traditional Medicine
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D008518 sjn
% 208.88/209.06 |- mesh__recordOriginator mesh__D008518 NLM
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D000535 2003
% 208.88/209.06 |- skos__scopeNote mesh__D000535
% 208.88/209.06 A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D000535 2004
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D000535 sjn
% 208.88/209.06 |- skos__broader mesh__D000535smesh__D019565
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D000535 2001
% 208.88/209.06 |- mesh__dateCreated mesh__D000535 1999-01-01
% 208.88/209.06 |- skos__prefLabel mesh__D000535 Aluminum
% 208.88/209.06 |- rdf__type mesh__D000535sskos__Concept
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D000535 2005
% 208.88/209.06 |- skos__annotation mesh__D000535
% 208.88/209.06 Al-27; Al-23-26, 28-30 = ALUMINUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 208.88/209.06 |- mesh__recordMaintainer mesh__D000535 adp
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D000535 2002
% 208.88/209.06 |- mesh__recordOriginator mesh__D000535 NLM
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D000535 2006
% 208.88/209.06 |- mesh__dateRevised mesh__D000535 2000-06-21
% 208.88/209.06 |- skos__annotation mesh__D019240 coord with specific bacterium /virol
% 208.88/209.06 |- skos__altLabel mesh__D019240 Bacteriophage PM2
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D019240 2004
% 208.88/209.06 |- mesh__recordOriginator mesh__D019240 AGS
% 208.88/209.06 |- skos__altLabel mesh__D019240 PM2 Bacteriophage
% 208.88/209.06 |- skos__hiddenLabel mesh__D019240 PM2 Bacteriophages
% 208.88/209.06 |- skos__scopeNote mesh__D019240
% 208.88/209.06 A family of icosahedral, lipid-containing, non-enveloped bacteriophages containing one genus %28%Corticovirus%29%.%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D019240 2003
% 208.88/209.06 |- mesh__historyNote mesh__D019240 97
% 208.88/209.06 |- skos__prefLabel mesh__D019240 Corticoviridae
% 208.88/209.06 |- skos__hiddenLabel mesh__D019240 Bacteriophage, PM2
% 208.88/209.06 |- skos__broader mesh__D019240smesh__D001435
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D019240 97
% 208.88/209.06 |- rdf__type mesh__D019240sskos__Concept
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D019240 2006
% 208.88/209.06 |- mesh__recordMaintainer mesh__D019240 ags
% 208.88/209.06 |- mesh__dateEstablished mesh__D019240 1997-01-01
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D019240 2005
% 208.88/209.06 |- mesh__dateRevised mesh__D019240 2002-07-02
% 208.88/209.06 |- mesh__dateCreated mesh__D019240 1996-06-10
% 208.88/209.06 |- skos__hiddenLabel mesh__D019240 Bacteriophages, PM2
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D019240 sjn
% 208.88/209.06 |- skos__scopeNote mesh__D005220 Male parents, human or animal.
% 208.88/209.06 |- skos__historyNote mesh__D005220 Father-Child Relations %28%1968-1977%29%
% 208.88/209.06 |- skos__broader mesh__D005220smesh__D010290
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D005220 2005
% 208.88/209.06 |- rdf__type mesh__D005220sskos__Concept
% 208.88/209.06 |- skos__annotation mesh__D005220
% 208.88/209.06 human %26% animal; /psychol: consider also FATHER-CHILD RELATIONS%A%
% 208.88/209.06 |- mesh__historyNote mesh__D005220 78
% 208.88/209.06 |- skos__hiddenLabel mesh__D005220 Father
% 208.88/209.06 |- mesh__recordOriginator mesh__D005220 EC
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D005220 sjn
% 208.88/209.06 |- mesh__dateCreated mesh__D005220 1977-04-22
% 208.88/209.06 |- skos__historyNote mesh__D005220 Paternal Behavior %28%1969-1977%29%
% 208.88/209.06 |- mesh__dateRevised mesh__D005220 2004-07-13
% 208.88/209.06 |- mesh__recordMaintainer mesh__D005220 sjn
% 208.88/209.06 |- mesh__dateEstablished mesh__D005220 1978-01-01
% 208.88/209.06 |- skos__prefLabel mesh__D005220 Fathers
% 208.88/209.06 |- skos__historyNote mesh__D005220 Male %28%1966-1977%29%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D005220 2006
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D005220 78
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D018946 sjn
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D018946
% 208.88/209.06 96; RANTES PROTEIN, T-CELL was indexed under LYMPHOKINES 1988-95; RANTES PROTEIN, MURINE was indexed under LYMPHOKINES 1992-95%A%
% 208.88/209.06 |- mesh__dateEstablished mesh__D018946 1996-01-01
% 208.88/209.06 |- skos__historyNote mesh__D018946 Lymphokines %28%1988-1995%29%
% 208.88/209.06 |- skos__hiddenLabel mesh__D018946 T-Cell RANTES Protein
% 208.88/209.06 |- mesh__recordOriginator mesh__D018946 AGS
% 208.88/209.06 |- rdf__type mesh__D018946sskos__Concept
% 208.88/209.06 |- skos__broader mesh__D018946smesh__D018925
% 208.88/209.06 |- skos__annotation mesh__D018946
% 208.88/209.06 a chemokine; RANTES stands for Regulated on Activation, Normal T Expressed and Secreted, often preceded by rh %28% = recombinant human%29%%A%
% 208.88/209.06 |- skos__hiddenLabel mesh__D018946 Murine RANTES Protein
% 208.88/209.06 |- mesh__dateCreated mesh__D018946 1995-02-21
% 208.88/209.06 |- skos__hiddenLabel mesh__D018946 RANTES Protein, T Cell
% 208.88/209.06 |- mesh__onlineNote mesh__D018946
% 208.88/209.06 use RANTES %28%NM%29% to search RANTES PROTEIN, MURINE 1992-95 %26% RANTES PROTEIN, T-CELL 1988-95%A%
% 208.88/209.06 |- mesh__historyNote mesh__D018946
% 208.88/209.06 96; was RANTES PROTEIN, T-CELL %28%NM%29% 1988-95; RANTES PROTEIN, MURINE was NM 1992-95%A%
% 208.88/209.06 |- skos__altLabel mesh__D018946 RANTES Protein, T-Cell
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018946 2006
% 208.88/209.06 |- skos__prefLabel mesh__D018946 RANTES
% 208.88/209.06 |- mesh__recordMaintainer mesh__D018946 ssb
% 208.88/209.06 |- skos__scopeNote mesh__D018946
% 208.88/209.06 A chemokine that is a chemoattractant for eosinophils, monocytes, and lymphocytes. It is a potent and selective eosinophil chemotaxin that is stored in and released from platelets and activated T-cells.%A%
% 208.88/209.06 |- mesh__dateRevised mesh__D018946 2005-06-30
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010963 2005
% 208.88/209.06 |- skos__annotation mesh__D010963
% 208.88/209.06 infection = MALARIA, FALCIPARUM; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 208.88/209.06 |- mesh__recordOriginator mesh__D010963 NLM
% 208.88/209.06 |- rdf__type mesh__D010963sskos__Concept
% 208.88/209.06 |- mesh__dateRevised mesh__D010963 2003-07-09
% 208.88/209.06 |- mesh__recordMaintainer mesh__D010963 ags
% 208.88/209.06 |- skos__scopeNote mesh__D010963
% 208.88/209.06 A species of protozoa that is the causal agent of falciparum malaria %28%MALARIA, FALCIPARUM%29%. It is most prevalent in the tropics and subtropics.%A%
% 208.88/209.06 |- mesh__dateCreated mesh__D010963 1999-01-01
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010963 2004
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D010963 sjn
% 208.88/209.06 |- skos__prefLabel mesh__D010963 Plasmodium falciparum
% 208.88/209.06 |- skos__broader mesh__D010963smesh__D010961
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010963 2006
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D018148 sjn
% 208.88/209.06 |- mesh__recordOriginator mesh__D018148 AGS
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018148 2002
% 208.88/209.06 |- skos__hiddenLabel mesh__D018148 Swine Pox Viruses
% 208.88/209.06 |- mesh__recordMaintainer mesh__D018148 ags
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018148 2005
% 208.88/209.06 |- skos__altLabel mesh__D018148 Swine Pox Virus
% 208.88/209.06 |- rdf__type mesh__D018148sskos__Concept
% 208.88/209.06 |- skos__hiddenLabel mesh__D018148 Suipoxviruses
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D018148
% 208.88/209.06 94; SWINEPOX VIRUS was see POXVIRIDAE 1986-93; see under POXVIRIDAE 1981-85; see under POXVIRUSES 1975-80%A%
% 208.88/209.06 |- skos__prefLabel mesh__D018148 Suipoxvirus
% 208.88/209.06 |- mesh__onlineNote mesh__D018148
% 208.88/209.06 use POXVIRIDAE to search SWINEPOX VIRUS 1975-93
% 208.88/209.06 |- skos__hiddenLabel mesh__D018148 Swinepox viruses
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018148 2004
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018148 2003
% 208.88/209.06 |- mesh__dateRevised mesh__D018148 2001-07-25
% 208.88/209.06 |- mesh__historyNote mesh__D018148
% 208.88/209.06 94; SWINEPOX VIRUS was see POXVIRIDAE 1986-93; see under POXVIRIDAE 1981-85; see under POXVIRUSES 1975-80%A%
% 208.88/209.06 |- skos__scopeNote mesh__D018148
% 208.88/209.06 A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, containing one species, swinepox virus.%A%
% 208.88/209.06 |- skos__broader mesh__D018148smesh__D018147
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D018148 2006
% 208.88/209.06 |- skos__annotation mesh__D018148
% 208.88/209.06 infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%
% 208.88/209.06 |- mesh__dateCreated mesh__D018148 1993-06-30
% 208.88/209.06 |- mesh__dateEstablished mesh__D018148 1994-01-01
% 208.88/209.06 |- mesh__dateCreated mesh__D010165 1999-01-01
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010165 2003
% 208.88/209.06 |- skos__annotation mesh__D010165
% 208.88/209.06 Pd-106; Pd-102, 104, 105, 108, 110 = PALLADIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Pd-98-101, 103, 107, 109, 111-115 = PALLADIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010165 2006
% 208.88/209.06 |- mesh__recordOriginator mesh__D010165 NLM
% 208.88/209.06 |- mesh__dateRevised mesh__D010165 2001-07-25
% 208.88/209.06 |- skos__prefLabel mesh__D010165 Palladium
% 208.88/209.06 |- skos__broader mesh__D010165smesh__D019216
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010165 2005
% 208.88/209.06 |- skos__broader mesh__D010165smesh__D028561
% 208.88/209.06 |- skos__scopeNote mesh__D010165
% 208.88/209.06 A chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys.%A%
% 208.88/209.06 |- rdf__type mesh__D010165sskos__Concept
% 208.88/209.06 |- mesh__recordMaintainer mesh__D010165 jmp
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010165 2004
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D010165 2002
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D010165 sjn
% 208.88/209.06 |- mesh__onlineNote mesh__D004926
% 208.88/209.06 use SHIGELLA to search ALKALESCENS-DISPAR GROUP 1974; use ENTEROBACTERIACEAE 1966-73%A%
% 208.88/209.06 |- skos__related mesh__D004926smesh__D029968
% 208.88/209.06 |- mesh__recordMaintainer mesh__D004926 ags
% 208.88/209.06 |- skos__annotation mesh__D004926
% 208.88/209.06 not for %22%coliform bacillus%22% %28% = COLIFORM BACILLI see ENTEROBACTERIACEAE%29%; infection = ESCHERICHIA COLI INFECTIONS%A%
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D004926
% 208.88/209.06 ALKALESCENS-DISPAR GROUP was heading 1975-96 %28%see under ESCHERICHIA 1975-90%29%; was see under SHIGELLA 1974; was see under ENTEROBACTERIACEAE 1968-73%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004926 2006A
% 208.88/209.06 |- mesh__dateRevised mesh__D004926 2005-07-15
% 208.88/209.06 |- skos__scopeNote mesh__D004926
% 208.88/209.06 A species of gram-negative, facultatively anaerobic, rod-shaped bacteria %28%GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS%29% commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections.%A%
% 208.88/209.06 |- skos__prefLabel mesh__D004926 Escherichia coli
% 208.88/209.06 |- mesh__dateCreated mesh__D004926 1999-01-01
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004926 2006
% 208.88/209.06 |- skos__altLabel mesh__D004926 E coli
% 208.88/209.06 |- skos__broader mesh__D004926smesh__D004925
% 208.88/209.06 |- mesh__recordOriginator mesh__D004926 NLM
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D004926 ags
% 208.88/209.06 |- mesh__historyNote mesh__D004926
% 208.88/209.06 ALKALESCENS-DISPAR GROUP was heading 1975-96 %28%see under ESCHERICHIA 1975-90%29%; was see under SHIGELLA 1974; was see under ENTEROBACTERIACEAE 1963-73 %28%Prov 1963-67%29%%A%
% 208.88/209.06 |- rdf__type mesh__D004926sskos__Concept
% 208.88/209.06 |- skos__historyNote mesh__D037302 Invertebrates %28%1970-2002%29%
% 208.88/209.06 |- mesh__recordMaintainer mesh__D037302 ags
% 208.88/209.06 |- mesh__dateRevised mesh__D037302 2005-07-08
% 208.88/209.06 |- mesh__dateCreated mesh__D037302 2002-07-02
% 208.88/209.06 |- rdf__type mesh__D037302sskos__Concept
% 208.88/209.06 |- mesh__dateEstablished mesh__D037302 2003-01-01
% 208.88/209.06 |- skos__altLabel mesh__D037302 Sea Walnuts
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D037302 2006A
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D037302 2004
% 208.88/209.06 |- skos__broader mesh__D037302smesh__D007448
% 208.88/209.06 |- skos__historyNote mesh__D037302 Cnidaria %28%1969-1997%29%
% 208.88/209.06 |- skos__prefLabel mesh__D037302 Ctenophora
% 208.88/209.06 |- mesh__recordOriginator mesh__D037302 ags
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D037302 ags
% 208.88/209.06 |- skos__altLabel mesh__D037302 Ctenophores
% 208.88/209.06 |- mesh__historyNote mesh__D037302 2003
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D037302 2006
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D037302 2003
% 208.88/209.06 |- skos__altLabel mesh__D037302 Comb Jellies
% 208.88/209.06 |- skos__scopeNote mesh__D037302
% 208.88/209.06 Phylum of marine colenterates characterized by eight comb rows of fused cilia on the body surface. In contrast to CNIDARIA they lack stinging cells, but they are voracious predators and possess sticky cells %28%colloblasts%29% for capturing prey. Most species are transparent and many exhibit bioluminescence.%A%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D037302 2005
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004128 2004
% 208.88/209.06 |- skos__scopeNote mesh__D004128
% 208.88/209.06 A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents.%A%
% 208.88/209.06 |- skos__historyNote mesh__D004128 Dimethylamines %28%1974%29%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004128 2001
% 208.88/209.06 |- skos__historyNote mesh__D004128 Nitrosamines %28%1966-1974%29%
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004128 2006
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D004128 sjn
% 208.88/209.06 |- skos__prefLabel mesh__D004128 Dimethylnitrosamine
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004128 2003
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004128 2005
% 208.88/209.06 |- mesh__historyNote mesh__D004128
% 208.88/209.06 80%28%75%29%; was see under NITROSAMINES 1975-79
% 208.88/209.06 |- skos__altLabel mesh__D004128 Nitrosodimethylamine
% 208.88/209.06 |- mesh__dateCreated mesh__D004128 1974-11-11
% 208.88/209.06 |- mesh__recordMaintainer mesh__D004128 CCR
% 208.88/209.06 |- mesh__dateRevised mesh__D004128 2000-06-22
% 208.88/209.06 |- skos__historyNote mesh__D004128 Amines %28%1966-1971%29%
% 208.88/209.06 |- mesh__dateEstablished mesh__D004128 1980-01-01
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D004128
% 208.88/209.06 80; was see under NITROSAMINES 1975-79
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D004128 2002
% 208.88/209.06 |- rdf__type mesh__D004128sskos__Concept
% 208.88/209.06 |- mesh__recordOriginator mesh__D004128 NLM
% 208.88/209.06 |- skos__historyNote mesh__D004128 Methylamines %28%1971-1974%29%
% 208.88/209.06 |- skos__broader mesh__D004128smesh__D009602
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009611 2005
% 208.88/209.06 |- skos__broader mesh__D009611smesh__D009596
% 208.88/209.06 |- skos__prefLabel mesh__D009611 Nitroxinil
% 208.88/209.06 |- skos__altLabel mesh__D009611 Nitroxynil
% 208.88/209.06 |- skos__historyNote mesh__D009611 Nitriles %28%1972-1974%29%
% 208.88/209.06 |- mesh__recordOriginator mesh__D009611 NLM
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009611 2006
% 208.88/209.06 |- mesh__recordMaintainer mesh__D009611 CCR
% 208.88/209.06 |- mesh__historyNote mesh__D009611
% 208.88/209.06 91%28%75%29%; was see under NITROPHENOLS 1975-90
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009611 2002
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009611 2003
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D009611
% 208.88/209.06 91; was see under NITROPHENOLS 1975-90
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D009611 sjn
% 208.88/209.06 |- rdf__type mesh__D009611sskos__Concept
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009611 2004
% 208.88/209.06 |- mesh__dateRevised mesh__D009611 2000-06-22
% 208.88/209.06 |- mesh__dateEstablished mesh__D009611 1991-01-01
% 208.88/209.06 |- mesh__dateCreated mesh__D009611 1974-11-19
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D009611 2001
% 208.88/209.06 |- skos__scopeNote mesh__D009611
% 208.88/209.06 Proposed anthelmintic for fasciola and liver fluke infestations.%A%
% 208.88/209.06 |- skos__historyNote mesh__D009611 Nitrophenols %28%1972-1974%29%
% 208.88/209.06 |- mesh__dateRevised mesh__D020593 2005-06-30
% 208.88/209.06 |- skos__scopeNote mesh__D020593
% 208.88/209.06 A genus of gram-negative, facultatively anaerobic rod-shaped cells which are motile by peritrichous flagella. Late in the growth cycle, spheroplasts or coccoid bodies occur, resulting from disintegration of the cell wall. The natural habitat is the intestinal lumen of certain nematodes. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.88/209.06 |- skos__prefLabel mesh__D020593 Xenorhabdus
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D020593 2006
% 208.88/209.06 |- mesh__historyNote mesh__D020593 2000
% 208.88/209.06 |- skos__broader mesh__D020593smesh__D004755
% 208.88/209.06 |- rdf__type mesh__D020593sskos__Concept
% 208.88/209.06 |- mesh__recordOriginator mesh__D020593 ndw
% 208.88/209.06 |- skos__annotation mesh__D020593
% 208.88/209.06 XENORHABDUS LUMINESCENS see PHOTORHABDUS is also available%A%
% 208.88/209.06 |- mesh__recordAuthorizer mesh__D020593 sjn
% 208.88/209.06 |- skos__altLabel mesh__D020593 Xenorhabdus nematophilus
% 208.88/209.06 |- skos__historyNote mesh__D020593 Enterobacteriaceae %28%1983-1999%29%
% 208.88/209.06 |- mesh__publicMeSHNote mesh__D020593 2000
% 208.88/209.06 |- mesh__dateEstablished mesh__D020593 2000-01-01
% 208.88/209.06 |- mesh__dateCreated mesh__D020593 1999-11-03
% 208.88/209.06 |- mesh__recordMaintainer mesh__D020593 SYSTEM
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014556 2000
% 208.88/209.06 |- skos__related mesh__D014556smesh__D006456
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014556 2006
% 208.88/209.06 |- skos__related mesh__D014556smesh__D000474
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014556 1996
% 208.88/209.06 |- mesh__dateRevised mesh__D014556 1996-09-23
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014556 2005
% 208.88/209.06 |- skos__broader mesh__D014556smesh__D001826
% 208.88/209.06 |- skos__related mesh__D014556smesh__D011141
% 208.88/209.06 |- mesh__activeMeSHYear mesh__D014556 1999
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D014556 2002
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D014556 PLS
% 208.88/209.07 |- skos__related mesh__D014556smesh__D011776
% 208.88/209.07 |- mesh__dateCreated mesh__D014556 1999-01-01
% 208.88/209.07 |- skos__related mesh__D014556smesh__D006029
% 208.88/209.07 |- skos__related mesh__D014556smesh__D003555
% 208.88/209.07 |- skos__related mesh__D014556smesh__D011507
% 208.88/209.07 |- skos__related mesh__D014556smesh__D001002
% 208.88/209.07 |- skos__related mesh__D014556smesh__D008375
% 208.88/209.07 |- skos__related mesh__D014556smesh__D000419
% 208.88/209.07 |- skos__prefLabel mesh__D014556 Urine
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D014556 1998
% 208.88/209.07 |- mesh__recordOriginator mesh__D014556 NLM
% 208.88/209.07 |- skos__related mesh__D014556smesh__D000608
% 208.88/209.07 |- skos__annotation mesh__D014556
% 208.88/209.07 GEN only: prefer /urine with higher animals, substances %26% diseases: Manual 19.7+, 19.8.79; for microbiol, see TN 190; urine volume: index under URINE probably NIM%A%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D014556 2004
% 208.88/209.07 |- skos__related mesh__D014556smesh__D006417
% 208.88/209.07 |- mesh__recordMaintainer mesh__D014556 SJN
% 208.88/209.07 |- skos__related mesh__D014556smesh__D010661
% 208.88/209.07 |- skos__related mesh__D014556smesh__D001437
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D014556 2001
% 208.88/209.07 |- rdf__type mesh__D014556sskos__Concept
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D014556 2003
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D014556 1997
% 208.88/209.07 |- rdf__type mesh__D008519sskos__Concept
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D008519 2006
% 208.88/209.07 |- skos__altLabel mesh__D008519 Primitive Medicine
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D008519 sjn
% 208.88/209.07 |- skos__altLabel mesh__D008519 Traditional Medicine
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D008519 2004
% 208.88/209.07 |- skos__annotation mesh__D008519
% 208.88/209.07 IM; includes medicine among aborigines %26% other primitive cultures %26% folk medicine among non-primitive cultures; specify geog; DF: MED TRADITIONAL%A%
% 208.88/209.07 |- mesh__recordOriginator mesh__D008519 NLM
% 208.88/209.07 |- skos__related mesh__D008519smesh__D008419
% 208.88/209.07 |- skos__hiddenLabel mesh__D008519 Remedy, Folk
% 208.88/209.07 |- mesh__onlineNote mesh__D008519
% 208.88/209.07 use MEDICINE, TRADITIONAL to search MEDICINE, PRIMITIVE 1966-80, FOLK MEDICINE 1966-77, %26% FOLKLORE 1968-77%A%
% 208.88/209.07 |- skos__hiddenLabel mesh__D008519 Folk Remedy
% 208.88/209.07 |- skos__hiddenLabel mesh__D008519 Remedy, Home
% 208.88/209.07 |- skos__altLabel mesh__D008519 Indigenous Medicine
% 208.88/209.07 |- skos__hiddenLabel mesh__D008519 Remedies, Folk
% 208.88/209.07 |- skos__hiddenLabel mesh__D008519 Remedies, Home
% 208.88/209.07 |- skos__hiddenLabel mesh__D008519 Home Remedy
% 208.88/209.07 |- skos__altLabel mesh__D008519 Folk Medicine
% 208.88/209.07 |- mesh__dateCreated mesh__D008519 1999-01-01
% 208.88/209.07 |- mesh__dateRevised mesh__D008519 2001-07-25
% 208.88/209.07 |- skos__broader mesh__D008519smesh__D003469
% 208.88/209.07 |- skos__scopeNote mesh__D008519
% 208.88/209.07 Systems of medicine based on cultural beliefs and practices handed down from generation to generation. The concept includes mystical and magical rituals, herbal therapy, and other treatments which may not be explained by modern medicine.%A%
% 208.88/209.07 |- skos__broader mesh__D008519smesh__D000529
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D008519 2002
% 208.88/209.07 |- mesh__recordMaintainer mesh__D008519 ssb
% 208.88/209.07 |- mesh__historyNote mesh__D008519
% 208.88/209.07 81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77%A%
% 208.88/209.07 |- skos__related mesh__D008519smesh__D006303
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D008519 2005
% 208.88/209.07 |- skos__prefLabel mesh__D008519 Medicine, Traditional
% 208.88/209.07 |- skos__related mesh__D008519smesh__D019423
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D008519 2003
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D008519
% 208.88/209.07 81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77%A%
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Algeldrate Philopharm Brand
% 208.88/209.07 |- skos__altLabel mesh__D000536 Aldrox
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D000536 2006
% 208.88/209.07 |- skos__altLabel mesh__D000536 Hydrated Alumina
% 208.88/209.07 |- skos__historyNote mesh__D000536 Hydroxides %28%1966-1977%29%
% 208.88/209.07 |- skos__historyNote mesh__D000536 Aluminum %28%1966-1977%29%
% 208.88/209.07 |- skos__altLabel mesh__D000536
% 208.88/209.07 Rh%C3%%B4%ne-Poulenc Rorer Brand of Algeldrate
% 208.88/209.07 |- rdf__type mesh__D000536sskos__Concept
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Gel, Aluminum Hydroxide
% 208.88/209.07 |- mesh__dateCreated mesh__D000536 1977-05-16
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D000536
% 208.88/209.07 78; ALUMINUM HYDROXIDE GEL was heading 1973-77; ALUMINUM GELS was see under ANTACIDS 1963-72%A%
% 208.88/209.07 |- skos__altLabel mesh__D000536 Pharmacia Brand of Algeldrate
% 208.88/209.07 |- skos__altLabel mesh__D000536 Algeldrate
% 208.88/209.07 |- skos__altLabel mesh__D000536 Roques Brand of Algeldrate
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Algeldrate Axcan Brand
% 208.88/209.07 |- skos__altLabel mesh__D000536 Whitehall Brand of Algeldrate
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536
% 208.88/209.07 Rh%C3%%B4%ne Poulenc Rorer Brand of Algeldrate
% 208.88/209.07 |- mesh__dateRevised mesh__D000536 2005-06-30
% 208.88/209.07 |- skos__altLabel mesh__D000536 SmithKline Beecham Brand of Algeldrate
% 208.88/209.07 |- skos__altLabel mesh__D000536 Philopharm Brand of Algeldrate
% 208.88/209.07 |- skos__altLabel mesh__D000536 Basalgel
% 208.88/209.07 |- mesh__recordMaintainer mesh__D000536 lkw
% 208.88/209.07 |- skos__altLabel mesh__D000536 Axcan Brand of Algeldrate
% 208.88/209.07 |- mesh__dateEstablished mesh__D000536 1978-01-01
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D000536 sjn
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Hydroxide, Aluminum
% 208.88/209.07 |- mesh__onlineNote mesh__D000536
% 208.88/209.07 use ALUMINUM HYDROXIDE to search ALUMINUM HYDROXIDE GEL 1972-77 %28%as Prov 1972%29%; use ANTACIDS 1966-71%A%
% 208.88/209.07 |- skos__altLabel mesh__D000536 Sanofi Winthrop Brand of Algeldrate
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Algeldrate Whitehall Brand
% 208.88/209.07 |- skos__altLabel mesh__D000536 Wyeth Brand of Algeldrate
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Algeldrate Roques Brand
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Algeldrate Wyeth Brand
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Algeldrate Stiefel Brand
% 208.88/209.07 |- mesh__recordOriginator mesh__D000536 RLS
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Alumina, Hydrated
% 208.88/209.07 |- skos__broader mesh__D000536smesh__D017607
% 208.88/209.07 |- skos__scopeNote mesh__D000536
% 208.88/209.07 A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.%A%
% 208.88/209.07 |- skos__broader mesh__D000536smesh__D006878
% 208.88/209.07 |- mesh__historyNote mesh__D000536
% 208.88/209.07 78; ALUMINUM HYDROXIDE GEL was heading 1972-77 %28%Prov 1972%29%; ALUMINUM GELS was see under ANTACIDS 1963-72%A%
% 208.88/209.07 |- skos__altLabel mesh__D000536 Stiefel Brand of Algeldrate
% 208.88/209.07 |- skos__prefLabel mesh__D000536 Aluminum Hydroxide
% 208.88/209.07 |- skos__hiddenLabel mesh__D000536 Algeldrate Pharmacia Brand
% 208.88/209.07 |- skos__historyNote mesh__D000536 Antacids %28%1966-1971%29%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019241 2003
% 208.88/209.07 |- mesh__historyNote mesh__D019241 97
% 208.88/209.07 |- rdf__type mesh__D019241sskos__Concept
% 208.88/209.07 |- mesh__dateRevised mesh__D019241 2001-07-25
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019241 2006
% 208.88/209.07 |- mesh__dateCreated mesh__D019241 1996-06-10
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D019241 sjn
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019241 2005
% 208.88/209.07 |- mesh__recordMaintainer mesh__D019241 ags
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019241 2002
% 208.88/209.07 |- mesh__recordOriginator mesh__D019241 AGS
% 208.88/209.07 |- skos__annotation mesh__D019241 coord with specific Archaea /virol
% 208.88/209.07 |- skos__altLabel mesh__D019241 SSV1
% 208.88/209.07 |- skos__broader mesh__D019241smesh__D004267
% 208.88/209.07 |- skos__broader mesh__D019241smesh__D023641
% 208.88/209.07 |- skos__scopeNote mesh__D019241
% 208.88/209.07 A family of lemon-shaped DNA viruses infecting ARCHAEA and containing one genus: Fusellovirus.%A%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019241 2004
% 208.88/209.07 |- skos__prefLabel mesh__D019241 Fuselloviridae
% 208.88/209.07 |- mesh__dateEstablished mesh__D019241 1997-01-01
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D019241 97
% 208.88/209.07 |- skos__scopeNote mesh__D005221
% 208.88/209.07 The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.%A%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D005221 2003
% 208.88/209.07 |- skos__related mesh__D005221smesh__D001247
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D005221 2001
% 208.88/209.07 |- rdf__type mesh__D005221sskos__Concept
% 208.88/209.07 |- skos__annotation mesh__D005221
% 208.88/209.07 do not use for fatigue of isolated muscle fibers in physiol exper %28% = MUSCLE FATIGUE%29%%A%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D005221 2000
% 208.88/209.07 |- mesh__recordMaintainer mesh__D005221 KEV
% 208.88/209.07 |- skos__broader mesh__D005221smesh__D012816
% 208.88/209.07 |- mesh__dateRevised mesh__D005221 1999-11-03
% 208.88/209.07 |- mesh__dateCreated mesh__D005221 1999-01-01
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D005221 2006
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D005221 2002
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D005221 sjn
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D005221 2005
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D005221 2004
% 208.88/209.07 |- mesh__recordOriginator mesh__D005221 NLM
% 208.88/209.07 |- skos__prefLabel mesh__D005221 Fatigue
% 208.88/209.07 |- skos__scopeNote mesh__D018947
% 208.88/209.07 A group of islands in the southwest central Pacific, divided into AMERICAN SAMOA and the INDEPENDENT STATE OF SAMOA %28%Western Samoa%29%. First European contact was made in 1722 by Jacob Roggeveen, a Dutchman. In 1768 they were named Navigators Islands by Louis de Bougainville. The present name may derive from that of a local chieftain or from a local word meaning place of the moa, a now-extinct island bird. %28%From Webster%27%s New Geographical Dictionary, 1988, p1061 %26% Room, Brewer%27%s Dictionary of Names, 1992, p481%29%%A%
% 208.88/209.07 |- mesh__dateEstablished mesh__D018947 1996-01-01
% 208.88/209.07 |- skos__altLabel mesh__D018947 Samoa Islands
% 208.88/209.07 |- mesh__onlineNote mesh__D018947
% 208.88/209.07 use WESTERN SAMOA to search SAMOA 1994-95
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018947 2005
% 208.88/209.07 |- skos__prefLabel mesh__D018947 Samoa
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018947 1999
% 208.88/209.07 |- skos__altLabel mesh__D018947 Samoan Islands
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018947 2001
% 208.88/209.07 |- mesh__dateCreated mesh__D018947 1995-06-08
% 208.88/209.07 |- skos__altLabel mesh__D018947 Navigator Island
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018947 2000
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018947 2004
% 208.88/209.07 |- skos__altLabel mesh__D018947 Navigator Islands
% 208.88/209.07 |- skos__broader mesh__D018947smesh__D011114
% 208.88/209.07 |- mesh__recordOriginator mesh__D018947 TGC
% 208.88/209.07 |- mesh__historyNote mesh__D018947 96; was see WESTERN SAMOA 1994-95
% 208.88/209.07 |- skos__historyNote mesh__D018947 Western Samoa %28%1968-1995%29%
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D018947 SJN
% 208.88/209.07 |- rdf__type mesh__D018947sskos__Concept
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018947 2003
% 208.88/209.07 |- skos__annotation mesh__D018947
% 208.88/209.07 an island group in Polynesia; AMERICAN SAMOA %26% INDEPENDENT STATE OF SAMOA are also available%A%
% 208.88/209.07 |- mesh__dateRevised mesh__D018947 1998-06-11
% 208.88/209.07 |- skos__historyNote mesh__D018947 Pacific Islands %28%1967-1970%29%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018947 2002
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018947 2006
% 208.88/209.07 |- mesh__recordMaintainer mesh__D018947 JLS
% 208.88/209.07 |- skos__broader mesh__D010964smesh__D010961
% 208.88/209.07 |- rdf__type mesh__D010964sskos__Concept
% 208.88/209.07 |- skos__prefLabel mesh__D010964 Plasmodium gallinaceum
% 208.88/209.07 |- mesh__dateRevised mesh__D010964 2003-07-09
% 208.88/209.07 |- mesh__recordMaintainer mesh__D010964 ags
% 208.88/209.07 |- skos__annotation mesh__D010964
% 208.88/209.07 in chickens; infection = MALARIA, AVIAN %28%see note there%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010964 2004
% 208.88/209.07 |- skos__historyNote mesh__D010964 Plasmodium %28%1966-1985%29%
% 208.88/209.07 |- mesh__dateCreated mesh__D010964 1985-03-11
% 208.88/209.07 |- mesh__dateEstablished mesh__D010964 1991-01-01
% 208.88/209.07 |- mesh__recordOriginator mesh__D010964 EC
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010964 2006
% 208.88/209.07 |- mesh__historyNote mesh__D010964
% 208.88/209.07 91%28%86%29%; was see under PLASMODIUM 1986-90
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D010964
% 208.88/209.07 91; was see under PLASMODIUM 1986-90
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010964 2005
% 208.88/209.07 |- skos__scopeNote mesh__D010964
% 208.88/209.07 A protozoan parasite that causes avian malaria %28%MALARIA, AVIAN%29%, primarily in chickens, and is transmitted by the Aedes mosquito.%A%
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D010964 sjn
% 208.88/209.07 |- rdf__type mesh__D018149sskos__Concept
% 208.88/209.07 |- mesh__dateEstablished mesh__D018149 1994-01-01
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018149 2004
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D018149 sjn
% 208.88/209.07 |- skos__hiddenLabel mesh__D018149 Glucose Intolerances
% 208.88/209.07 |- mesh__dateCreated mesh__D018149 1993-06-03
% 208.88/209.07 |- skos__broader mesh__D018149smesh__D006943
% 208.88/209.07 |- mesh__historyNote mesh__D018149 94
% 208.88/209.07 |- mesh__recordMaintainer mesh__D018149 lkt
% 208.88/209.07 |- skos__related mesh__D018149smesh__D003920
% 208.88/209.07 |- mesh__dateRevised mesh__D018149 2003-07-09
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D018149 94
% 208.88/209.07 |- skos__related mesh__D018149smesh__D005951
% 208.88/209.07 |- skos__hiddenLabel mesh__D018149 Intolerance, Glucose
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018149 2006
% 208.88/209.07 |- skos__prefLabel mesh__D018149 Glucose Intolerance
% 208.88/209.07 |- skos__scopeNote mesh__D018149
% 208.88/209.07 A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.%A%
% 208.88/209.07 |- skos__hiddenLabel mesh__D018149 Intolerances, Glucose
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D018149 2005
% 208.88/209.07 |- skos__historyNote mesh__D018149 Blood Glucose %28%1966-1993%29%
% 208.88/209.07 |- mesh__recordOriginator mesh__D018149 PXP
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D010166 SJN
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D010166
% 208.88/209.07 96; was PALLIATIVE TREATMENT 1966-95
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010166 2005
% 208.88/209.07 |- skos__scopeNote mesh__D010166
% 208.88/209.07 Care alleviating symptoms without curing the underlying disease. %28%Stedman, 25th ed%29%%A%
% 208.88/209.07 |- skos__altLabel mesh__D010166 Palliative Treatment
% 208.88/209.07 |- mesh__recordMaintainer mesh__D010166 JLS
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010166 2006
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010166 1999
% 208.88/209.07 |- skos__altLabel mesh__D010166 Surgery, Palliative
% 208.88/209.07 |- skos__hiddenLabel mesh__D010166 Palliative Treatments
% 208.88/209.07 |- skos__hiddenLabel mesh__D010166 Care, Palliative
% 208.88/209.07 |- skos__altLabel mesh__D010166 Medicine, Palliative
% 208.88/209.07 |- skos__broader mesh__D010166smesh__D005791
% 208.88/209.07 |- skos__hiddenLabel mesh__D010166 Treatments, Palliative
% 208.88/209.07 |- rdf__type mesh__D010166sskos__Concept
% 208.88/209.07 |- skos__prefLabel mesh__D010166 Palliative Care
% 208.88/209.07 |- skos__altLabel mesh__D010166 Palliative Therapy
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010166 2000
% 208.88/209.07 |- mesh__recordOriginator mesh__D010166 NLM
% 208.88/209.07 |- skos__annotation mesh__D010166
% 208.88/209.07 = relief without cure; coord IM with disease /ther or /surg or /drug ther or other specific qualif %28%IM%29%; consider also PAIN /ther%A%
% 208.88/209.07 |- mesh__dateCreated mesh__D010166 1999-01-01
% 208.88/209.07 |- skos__altLabel mesh__D010166 Therapy, Palliative
% 208.88/209.07 |- skos__hiddenLabel mesh__D010166 Treatment, Palliative
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010166 2003
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010166 2001
% 208.88/209.07 |- mesh__dateRevised mesh__D010166 1998-06-10
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010166 2004
% 208.88/209.07 |- mesh__dateEstablished mesh__D010166 1966-01-01
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D010166 2002
% 208.88/209.07 |- mesh__historyNote mesh__D010166
% 208.88/209.07 96; was PALLIATIVE TREATMENT 1964-95 %28%Prov 1964-65%29%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 1997
% 208.88/209.07 |- skos__hiddenLabel mesh__D004927 E coli Infection
% 208.88/209.07 |- skos__broader mesh__D004927smesh__D004756
% 208.88/209.07 |- skos__altLabel mesh__D004927 E coli Infections
% 208.88/209.07 |- skos__altLabel mesh__D004927 Infections, Escherichia coli
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 2005
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 2002
% 208.88/209.07 |- mesh__recordMaintainer mesh__D004927 TAP
% 208.88/209.07 |- skos__hiddenLabel mesh__D004927 Infection, Escherichia coli
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 1994
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 2006
% 208.88/209.07 |- mesh__dateCreated mesh__D004927 1999-01-01
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D004927 PLS
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 1998
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 1995
% 208.88/209.07 |- rdf__type mesh__D004927sskos__Concept
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 2003
% 208.88/209.07 |- skos__annotation mesh__D004927
% 208.88/209.07 gram-neg bact infect; DF: E COLI INFECTIONS or E COLI INFECT%A%
% 208.88/209.07 |- skos__altLabel mesh__D004927 Infections, E coli
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 2000
% 208.88/209.07 |- skos__prefLabel mesh__D004927 Escherichia coli Infections
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 1999
% 208.88/209.07 |- mesh__dateRevised mesh__D004927 1993-06-02
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 2004
% 208.88/209.07 |- skos__hiddenLabel mesh__D004927 Infection, E coli
% 208.88/209.07 |- skos__hiddenLabel mesh__D004927 Escherichia coli Infection
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 1996
% 208.88/209.07 |- skos__scopeNote mesh__D004927
% 208.88/209.07 Infections with bacteria of the species ESCHERICHIA COLI.%A%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004927 2001
% 208.88/209.07 |- mesh__recordOriginator mesh__D004927 NLM
% 208.88/209.07 |- skos__historyNote mesh__D004129 Silicone Elastomers %28%1972-1974%29%
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D004129 sjn
% 208.88/209.07 |- mesh__dateCreated mesh__D004129 1974-11-19
% 208.88/209.07 |- mesh__dateEstablished mesh__D004129 1991-01-01
% 208.88/209.07 |- skos__scopeNote mesh__D004129
% 208.88/209.07 Silicone polymers which consist of silicon atoms substituted with methyl groups and linked by oxygen atoms. They comprise a series of biocompatible materials used as liquids, gels or solids; as film for artificial membranes, gels for implants, and liquids for drug vehicles; and as antifoaming agents.%A%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004129 2006
% 208.88/209.07 |- skos__annotation mesh__D004129 organosiloxane polymers; D25-26 qualif
% 208.88/209.07 |- skos__altLabel mesh__D004129 Polydimethylsiloxanes
% 208.88/209.07 |- skos__historyNote mesh__D004129 Silicones %28%1972-1974%29%
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D004129
% 208.88/209.07 91; was see under SILICONES 1975-90
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D004129 2005
% 208.88/209.07 |- skos__broader mesh__D004129smesh__D012828
% 208.88/209.07 |- skos__prefLabel mesh__D004129 Dimethylpolysiloxanes
% 208.88/209.07 |- mesh__historyNote mesh__D004129
% 208.88/209.07 91%28%75%29%; was see under SILICONES 1975-90
% 208.88/209.07 |- rdf__type mesh__D004129sskos__Concept
% 208.88/209.07 |- mesh__recordOriginator mesh__D004129 RLS
% 208.88/209.07 |- mesh__recordMaintainer mesh__D004129 jmp
% 208.88/209.07 |- mesh__dateRevised mesh__D004129 2004-07-07
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D009612 sjn
% 208.88/209.07 |- skos__altLabel mesh__D009612 NAD Pyrophosphorylase
% 208.88/209.07 |- mesh__dateEstablished mesh__D009612 1991-01-01
% 208.88/209.07 |- skos__hiddenLabel mesh__D009612 Adenylyltransferase, ATP-NMN
% 208.88/209.07 |- skos__prefLabel mesh__D009612
% 208.88/209.07 Nicotinamide-Nucleotide Adenylyltransferase
% 208.88/209.07 |- skos__hiddenLabel mesh__D009612 ATP NMN Adenylyltransferase
% 208.88/209.07 |- skos__altLabel mesh__D009612
% 208.88/209.07 Nicotinamide Mononucleotide Adenylyltransferase
% 208.88/209.07 |- mesh__dateCreated mesh__D009612 1978-03-13
% 208.88/209.07 |- skos__hiddenLabel mesh__D009612 Adenylyltransferase, NMN
% 208.88/209.07 |- skos__historyNote mesh__D009612 Transferases %28%1966-1967%29%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D009612 2006
% 208.88/209.07 |- skos__historyNote mesh__D009612
% 208.88/209.07 Nucleotidyltransferases %28%1966-1978%29%
% 208.88/209.07 |- skos__hiddenLabel mesh__D009612
% 208.88/209.07 Nicotinamide Nucleotide Adenylyltransferase
% 208.88/209.07 |- skos__hiddenLabel mesh__D009612 Pyrophosphorylase, NAD
% 208.88/209.07 |- mesh__dateRevised mesh__D009612 2003-07-09
% 208.88/209.07 |- skos__altLabel mesh__D009612 ATP-NMN Adenylyltransferase
% 208.88/209.07 |- skos__historyNote mesh__D009612
% 208.88/209.07 Nicotinamide Mononucleotide %28%1973-1978%29%
% 208.88/209.07 |- skos__historyNote mesh__D009612 Adenosine Triphosphate %28%1966-1978%29%
% 208.88/209.07 |- skos__hiddenLabel mesh__D009612
% 208.88/209.07 Mononucleotide Adenylyltransferase, Nicotinamide
% 208.88/209.07 |- mesh__historyNote mesh__D009612 98%28%79%29%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D009612 2005
% 208.88/209.07 |- skos__altLabel mesh__D009612 NMN Adenylyltransferase
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D009612 2004
% 208.88/209.07 |- mesh__recordMaintainer mesh__D009612 ssb
% 208.88/209.07 |- skos__annotation mesh__D009612 DF: note short X ref
% 208.88/209.07 |- rdf__type mesh__D009612sskos__Concept
% 208.88/209.07 |- skos__broader mesh__D009612smesh__D009713
% 208.88/209.07 |- mesh__recordOriginator mesh__D009612 CAB
% 208.88/209.07 |- skos__scopeNote mesh__D009612
% 208.88/209.07 An enzyme that catalyzes reversibly the transfer of the adenylyl moiety of ATP to the phosphoryl group of NMN to form NAD+ and pyrophosphate. The enzyme is found predominantly in the nuclei and catalyzes the final reaction in the major pathway for the biosynthesis of NAD in mammals. EC 2.7.7.1.%A%
% 208.88/209.07 |- skos__hiddenLabel mesh__D009612
% 208.88/209.07 Adenylyltransferase, Nicotinamide-Nucleotide
% 208.88/209.07 |- skos__hiddenLabel mesh__D009612
% 208.88/209.07 Adenylyltransferase, Nicotinamide Mononucleotide
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D009612
% 208.88/209.07 98; see NMN ADENYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1979-90%A%
% 208.88/209.07 |- skos__historyNote mesh__D020594 Enterobacteriaceae %28%1969-1999%29%
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D020594 2000
% 208.88/209.07 |- mesh__dateCreated mesh__D020594 1999-11-03
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D020594 2006
% 208.88/209.07 |- mesh__historyNote mesh__D020594 2000
% 208.88/209.07 |- rdf__type mesh__D020594sskos__Concept
% 208.88/209.07 |- mesh__recordOriginator mesh__D020594 ndw
% 208.88/209.07 |- skos__broader mesh__D020594smesh__D004755
% 208.88/209.07 |- skos__annotation mesh__D020594
% 208.88/209.07 infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%
% 208.88/209.07 |- mesh__dateRevised mesh__D020594 2005-06-30
% 208.88/209.07 |- skos__prefLabel mesh__D020594 Edwardsiella
% 208.88/209.07 |- skos__scopeNote mesh__D020594
% 208.88/209.07 A genus of small, straight gram-negative rods which are facultatively anaerobic, chemoorganotrophic, and usually motile by peritrichous flagella. Members of this genus are usually found in the intestines of cold-blooded animals and in fresh water. They are pathogenic for eels, CATFISHES, and other animals and are rare opportunistic pathogens for humans. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.88/209.07 |- mesh__dateEstablished mesh__D020594 2000-01-01
% 208.88/209.07 |- mesh__recordMaintainer mesh__D020594 SYSTEM
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D020594 sjn
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D014557 sjn
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D014557 2006
% 208.88/209.07 |- mesh__dateCreated mesh__D014557 1999-01-01
% 208.88/209.07 |- skos__prefLabel mesh__D014557 Urobilin
% 208.88/209.07 |- mesh__recordOriginator mesh__D014557 NLM
% 208.88/209.07 |- skos__broader mesh__D014557smesh__D001654
% 208.88/209.07 |- mesh__recordMaintainer mesh__D014557 ssb
% 208.88/209.07 |- skos__annotation mesh__D014557
% 208.88/209.07 a bile pigment; /biosyn /physiol permitted
% 208.88/209.07 |- rdf__type mesh__D014557sskos__Concept
% 208.88/209.07 |- mesh__dateRevised mesh__D014557 2005-06-30
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D000537 2004
% 208.88/209.07 |- skos__altLabel mesh__D000537 Alumina
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D000537 2005
% 208.88/209.07 |- mesh__dateCreated mesh__D000537 1977-04-15
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D000537 2003
% 208.88/209.07 |- skos__scopeNote mesh__D000537
% 208.88/209.07 An oxide of aluminum, occurring in nature as various minerals such as bauxite, corundum, etc. It is used as an adsorbent, desiccating agent, and catalyst, and in the manufacture of dental cements and refractories.%A%
% 208.88/209.07 |- mesh__dateEstablished mesh__D000537 1991-01-01
% 208.88/209.07 |- skos__hiddenLabel mesh__D000537 Ceramic, Alumina
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D000537 91; was see under ALUMINUM 1978-90
% 208.88/209.07 |- skos__prefLabel mesh__D000537 Aluminum Oxide
% 208.88/209.07 |- mesh__dateRevised mesh__D000537 2001-07-25
% 208.88/209.07 |- skos__broader mesh__D000537smesh__D017607
% 208.88/209.07 |- skos__historyNote mesh__D000537 Aluminum %28%1966-1977%29%
% 208.88/209.07 |- mesh__recordOriginator mesh__D000537 RLS
% 208.88/209.07 |- mesh__historyNote mesh__D000537
% 208.88/209.07 91%28%78%29%; was see under ALUMINUM 1978-90
% 208.88/209.07 |- mesh__recordMaintainer mesh__D000537 ssb
% 208.88/209.07 |- rdf__type mesh__D000537sskos__Concept
% 208.88/209.07 |- skos__historyNote mesh__D000537 Oxides %28%1966-1977%29%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D000537 2002
% 208.88/209.07 |- skos__hiddenLabel mesh__D000537 Oxide, Aluminum
% 208.88/209.07 |- skos__broader mesh__D000537smesh__D010087
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D000537 sjn
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D000537 2006
% 208.88/209.07 |- rdf__type mesh__D019242sskos__Concept
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019242 2006
% 208.88/209.07 |- mesh__dateEstablished mesh__D019242 1997-01-01
% 208.88/209.07 |- skos__broader mesh__D019242smesh__D003813
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D019242 SJN
% 208.88/209.07 |- skos__historyNote mesh__D019242 Dentistry %28%1966-1996%29%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019242 2001
% 208.88/209.07 |- mesh__recordMaintainer mesh__D019242 TGC
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019242 2005
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019242 1999
% 208.88/209.07 |- skos__altLabel mesh__D019242 Stomatology
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019242 2000
% 208.88/209.07 |- skos__prefLabel mesh__D019242 Oral Medicine
% 208.88/209.07 |- skos__annotation mesh__D019242
% 208.88/209.07 %22%a branch of dentistry dealing with dis of the oral %26% paraoral struct %26% the oral management of system dis%22%; SPEC: SPEC qualif; X ref STOMATOLOGY: seen most often in foreign lit: translate as %22%oral medicine%22%; %22%stomatol dis%22% = MOUTH DISEASES%A%
% 208.88/209.07 |- skos__altLabel mesh__D019242 Medicine, Oral
% 208.88/209.07 |- mesh__historyNote mesh__D019242
% 208.88/209.07 97; was see DENTISTRY 1980-96; STOMATOLOGY was see DENTISTRY 1989-96%A%
% 208.88/209.07 |- mesh__dateCreated mesh__D019242 1996-06-10
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019242 1998
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D019242
% 208.88/209.07 97; was see DENTISTRY 1980-96; STOMATOLOGY was see DENTISTRY 1989-96%A%
% 208.88/209.07 |- mesh__onlineNote mesh__D019242
% 208.88/209.07 use DENTISTRY to search ORAL MEDICINE 1980-96 %26% STOMATOLOGY 1989-96%A%
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019242 2004
% 208.88/209.07 |- skos__scopeNote mesh__D019242
% 208.88/209.07 A branch of dentistry dealing with diseases of the oral and paraoral structures and the oral management of systemic diseases. %28%Hall, What is Oral Medicine, Anyway? Clinical Update: National Naval Dental Center, March 1991, p7-8%29%%A%
% 208.88/209.07 |- mesh__dateRevised mesh__D019242 1997-06-20
% 208.88/209.07 |- skos__related mesh__D019242smesh__D009912
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019242 2002
% 208.88/209.07 |- mesh__activeMeSHYear mesh__D019242 2003
% 208.88/209.07 |- skos__related mesh__D019242smesh__D009059
% 208.88/209.07 |- skos__related mesh__D019242smesh__D003813
% 208.88/209.07 |- mesh__recordOriginator mesh__D019242 TGC
% 208.88/209.07 |- skos__altLabel mesh__D005222 Fatigue, Mental
% 208.88/209.07 |- skos__broader mesh__D005222smesh__D008606
% 208.88/209.07 |- mesh__publicMeSHNote mesh__D005222 95; was FATIGUE, MENTAL 1963-94
% 208.88/209.07 |- mesh__recordAuthorizer mesh__D005222 sjn
% 208.88/209.07 |- mesh__dateCreated mesh__D005222 1999-01-01
% 208.88/209.07 |- mesh__recordMaintainer mesh__D005222 JLS
% 208.88/209.07 |- mesh__recordOriginator mesh__D005222 NLM
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D005222 2006
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D005222 2005
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D005222 2004
% 208.88/209.08 |- mesh__historyNote mesh__D005222 95; was FATIGUE, MENTAL 1963-94
% 208.88/209.08 |- skos__broader mesh__D005222smesh__D001526
% 208.88/209.08 |- skos__prefLabel mesh__D005222 Mental Fatigue
% 208.88/209.08 |- mesh__dateRevised mesh__D005222 2002-07-03
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D005222 2003
% 208.88/209.08 |- mesh__onlineNote mesh__D005222
% 208.88/209.08 use MENTAL FATIGUE to search FATIGUE, MENTAL 1966-94
% 208.88/209.08 |- rdf__type mesh__D005222sskos__Concept
% 208.88/209.08 |- skos__scopeNote mesh__D005222
% 208.88/209.08 Fatigue arising in consequence of mental effort.
% 208.88/209.08 |- skos__altLabel mesh__D018948 Eastern Samoa
% 208.88/209.08 |- mesh__onlineNote mesh__D018948
% 208.88/209.08 use WESTERN SAMOA to search AMERICAN SAMOA 1976-95
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 2002
% 208.88/209.08 |- mesh__historyNote mesh__D018948 96; was see WESTERN SAMOA 1976-95
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 1998
% 208.88/209.08 |- mesh__dateCreated mesh__D018948 1995-06-08
% 208.88/209.08 |- skos__annotation mesh__D018948
% 208.88/209.08 an island group in Samoa; admin by US Dept of Interior
% 208.88/209.08 |- mesh__dateEstablished mesh__D018948 1996-01-01
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 2004
% 208.88/209.08 |- skos__prefLabel mesh__D018948 American Samoa
% 208.88/209.08 |- skos__historyNote mesh__D018948 Western Samoa %28%1968-1995%29%
% 208.88/209.08 |- rdf__type mesh__D018948sskos__Concept
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 2001
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 2003
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 1997
% 208.88/209.08 |- skos__broader mesh__D018948smesh__D018947
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 2000
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 1996
% 208.88/209.08 |- skos__historyNote mesh__D018948 Polynesia %28%1970-1974%29%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 2006
% 208.88/209.08 |- skos__scopeNote mesh__D018948
% 208.88/209.08 A group of islands of SAMOA, in the southwest central Pacific. Its capital is Pago Pago. The islands were ruled by native chiefs until about 1869. An object of American interest beginning in 1839, Pago Pago and trading and extraterritorial rights were granted to the United States in 1878. The United States, Germany, and England administered the islands jointly 1889-99, but in 1899 they were granted to the United States by treaty. The Department of the Interior has administered American Samoa since 1951. %28%From Webster%27%s New Geographical Dictionary, 1988, p44%29%%A%
% 208.88/209.08 |- skos__historyNote mesh__D018948 Pacific Islands %28%1966-1968%29%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 2005
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018948 1999
% 208.88/209.08 |- mesh__dateCreated mesh__D010965 1999-01-01
% 208.88/209.08 |- mesh__recordMaintainer mesh__D010965 ags
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010965 2004
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010965 2006
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D010965 sjn
% 208.88/209.08 |- skos__broader mesh__D010965smesh__D010961
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010965 2005
% 208.88/209.08 |- skos__annotation mesh__D010965
% 208.88/209.08 infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 208.88/209.08 |- skos__prefLabel mesh__D010965 Plasmodium malariae
% 208.88/209.08 |- rdf__type mesh__D010965sskos__Concept
% 208.88/209.08 |- mesh__dateRevised mesh__D010965 2003-07-09
% 208.88/209.08 |- mesh__recordOriginator mesh__D010965 NLM
% 208.88/209.08 |- skos__scopeNote mesh__D010965
% 208.88/209.08 A protozoan parasite that occurs primarily in subtropical and temperate areas. It is the causal agent of quartan malaria. As the parasite grows it exhibits little ameboid activity.%A%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010167 2001
% 208.88/209.08 |- skos__broader mesh__D010167smesh__D012877
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010167 2006
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010167 2002
% 208.88/209.08 |- skos__prefLabel mesh__D010167 Pallor
% 208.88/209.08 |- rdf__type mesh__D010167sskos__Concept
% 208.88/209.08 |- skos__hiddenLabel mesh__D010167 Pallors
% 208.88/209.08 |- mesh__dateCreated mesh__D010167 1999-01-01
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010167 2003
% 208.88/209.08 |- mesh__dateRevised mesh__D010167 1999-11-03
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D010167 sjn
% 208.88/209.08 |- mesh__recordMaintainer mesh__D010167 KEV
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010167 2004
% 208.88/209.08 |- skos__scopeNote mesh__D010167
% 208.88/209.08 A clinical manifestation consisting of an unnatural paleness of the skin.%A%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010167 2000
% 208.88/209.08 |- mesh__recordOriginator mesh__D010167 NLM
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010167 2005
% 208.88/209.08 |- skos__prefLabel mesh__D004928 Escin
% 208.88/209.08 |- mesh__dateRevised mesh__D004928 2005-06-30
% 208.88/209.08 |- mesh__dateCreated mesh__D004928 1974-11-19
% 208.88/209.08 |- skos__broader mesh__D004928smesh__D012503
% 208.88/209.08 |- skos__altLabel mesh__D004928 beta-Aescin
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D004928 91; was see under SAPONINS 1975-90
% 208.88/209.08 |- skos__historyNote mesh__D004928 Saponins %28%1971-1975%29%
% 208.88/209.08 |- skos__hiddenLabel mesh__D004928 beta Escin
% 208.88/209.08 |- skos__hiddenLabel mesh__D004928 beta Aescin
% 208.88/209.08 |- skos__altLabel mesh__D004928 Fepalitan
% 208.88/209.08 |- skos__altLabel mesh__D004928 opino-biomo
% 208.88/209.08 |- skos__altLabel mesh__D004928 Eskuzan
% 208.88/209.08 |- mesh__dateEstablished mesh__D004928 1991-01-01
% 208.88/209.08 |- mesh__recordOriginator mesh__D004928 NLM
% 208.88/209.08 |- skos__altLabel mesh__D004928 Sankyo Brand of Escin
% 208.88/209.08 |- skos__altLabel mesh__D004928 Feparil
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D004928 sjn
% 208.88/209.08 |- skos__altLabel mesh__D004928 biomo Brand of Escin
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D004928 2006
% 208.88/209.08 |- mesh__historyNote mesh__D004928
% 208.88/209.08 91%28%75%29%; was see under SAPONINS 1975-90
% 208.88/209.08 |- skos__historyNote mesh__D004928 Glycosides %28%1971-1974%29%
% 208.88/209.08 |- mesh__recordMaintainer mesh__D004928 exl
% 208.88/209.08 |- skos__altLabel mesh__D004928 Escina
% 208.88/209.08 |- rdf__type mesh__D004928sskos__Concept
% 208.88/209.08 |- skos__altLabel mesh__D004928 Madaus Brand of Escin
% 208.88/209.08 |- skos__altLabel mesh__D004928 Aescin
% 208.88/209.08 |- skos__scopeNote mesh__D004928
% 208.88/209.08 Saponin occurring in the seed of the horse chestnut tree. Inhibits edema formation and decreases vascular fragility.%A%
% 208.88/209.08 |- skos__historyNote mesh__D015650
% 208.88/209.08 Dihydroxycholecalciferols %28%1973-1989%29%
% 208.88/209.08 |- mesh__recordMaintainer mesh__D015650 ssb
% 208.88/209.08 |- mesh__historyNote mesh__D015650 90
% 208.88/209.08 |- skos__altLabel mesh__D015650 24R,25-Dihydroxycholecalciferol
% 208.88/209.08 |- skos__hiddenLabel mesh__D015650 Dihydroxyvitamin D3, 24,25
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015650 2006
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D015650 sjn
% 208.88/209.08 |- mesh__recordOriginator mesh__D015650 RLS
% 208.88/209.08 |- skos__hiddenLabel mesh__D015650 24,25 Dihydroxycholecalciferol
% 208.88/209.08 |- skos__altLabel mesh__D015650 24,25 Dihydroxyvitamin D3
% 208.88/209.08 |- mesh__dateRevised mesh__D015650 2005-06-30
% 208.88/209.08 |- skos__altLabel mesh__D015650 24,25-Dihydroxyvitamin D3
% 208.88/209.08 |- skos__scopeNote mesh__D015650
% 208.88/209.08 A physiologically active metabolite of VITAMIN D. The compound is involved in the regulation of calcium metabolism, alkaline phosphatase activity, and enhances the calcemic effect of CALCITRIOL.%A%
% 208.88/209.08 |- skos__altLabel mesh__D015650 24,25-Dihydroxycholecalciferol
% 208.88/209.08 |- mesh__dateEstablished mesh__D015650 1990-01-01
% 208.88/209.08 |- skos__annotation mesh__D015650
% 208.88/209.08 deficiency: coordinate 24,25-DIHYDROXYVITAMIN D 3 /defic %28%IM%29% with RICKETS %28%IM%29% or with VITAMIN D DEFICIENCY %28%IM%29%%A%
% 208.88/209.08 |- skos__altLabel mesh__D015650 %28%24R%29%-24,25-Dihydroxyvitamin D3
% 208.88/209.08 |- skos__prefLabel mesh__D015650 24,25-Dihydroxyvitamin D 3
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D015650 90
% 208.88/209.08 |- mesh__dateCreated mesh__D015650 1989-07-21
% 208.88/209.08 |- skos__hiddenLabel mesh__D015650 24,25 Dihydroxyvitamin D 3
% 208.88/209.08 |- skos__broader mesh__D015650smesh__D004100
% 208.88/209.08 |- rdf__type mesh__D015650sskos__Concept
% 208.88/209.08 |- skos__annotation mesh__D009613
% 208.88/209.08 award for medicine: coordinate with specific field or specialty but not with MEDICINE%A%
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D009613 sjn
% 208.88/209.08 |- mesh__dateCreated mesh__D009613 1999-01-01
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D009613 2006
% 208.88/209.08 |- skos__hiddenLabel mesh__D009613 Prize, Nobel
% 208.88/209.08 |- mesh__dateRevised mesh__D009613 2005-06-30
% 208.88/209.08 |- rdf__type mesh__D009613sskos__Concept
% 208.88/209.08 |- mesh__recordOriginator mesh__D009613 NLM
% 208.88/209.08 |- skos__broader mesh__D009613smesh__D001363
% 208.88/209.08 |- skos__prefLabel mesh__D009613 Nobel Prize
% 208.88/209.08 |- mesh__recordMaintainer mesh__D009613 ags
% 208.88/209.08 |- skos__hiddenLabel mesh__D001630 Hair Ball
% 208.88/209.08 |- mesh__dateCreated mesh__D001630 1999-01-01
% 208.88/209.08 |- skos__prefLabel mesh__D001630 Bezoars
% 208.88/209.08 |- rdf__type mesh__D001630sskos__Concept
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001630 2004
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001630 1998
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001630 2000
% 208.88/209.08 |- skos__scopeNote mesh__D001630
% 208.88/209.08 Concretions of swallowed hair, fruit or vegetable fibers, or similar substances found in the alimentary canal.%A%
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D001630 SJN
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001630 2003
% 208.88/209.08 |- skos__broader mesh__D001630smesh__D005547
% 208.88/209.08 |- skos__hiddenLabel mesh__D001630 Balls, Hair
% 208.88/209.08 |- skos__hiddenLabel mesh__D001630 Bezoar
% 208.88/209.08 |- skos__hiddenLabel mesh__D001630 Trichobezoar
% 208.88/209.08 |- mesh__dateRevised mesh__D001630 1997-06-20
% 208.88/209.08 |- skos__altLabel mesh__D001630 Trichobezoars
% 208.88/209.08 |- skos__hiddenLabel mesh__D001630 Ball, Hair
% 208.88/209.08 |- mesh__recordOriginator mesh__D001630 NLM
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001630 2006
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001630 2002
% 208.88/209.08 |- mesh__recordMaintainer mesh__D001630 TPW
% 208.88/209.08 |- skos__annotation mesh__D001630
% 208.88/209.08 concretions from ingested foreign matter; coord IM with organ %28%IM%29%, not organ/dis: Manual 21.39%A%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001630 2005
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001630 1999
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001630 2001
% 208.88/209.08 |- skos__scopeNote mesh__D020595
% 208.88/209.08 A genus of straight, gram-negative bacterial rods which are facultatively anaerobic and motile by peritrichous flagella. This genus is found in human and animal feces, soil, water, and dairy products. It is an opportunistic pathogen in humans. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.88/209.08 |- mesh__recordOriginator mesh__D020595 ndw
% 208.88/209.08 |- skos__prefLabel mesh__D020595 Hafnia
% 208.88/209.08 |- mesh__dateCreated mesh__D020595 1999-11-03
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D020595 sjn
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D020595 2000
% 208.88/209.08 |- mesh__dateEstablished mesh__D020595 2000-01-01
% 208.88/209.08 |- mesh__recordMaintainer mesh__D020595 SYSTEM
% 208.88/209.08 |- skos__annotation mesh__D020595
% 208.88/209.08 infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D020595 2006
% 208.88/209.08 |- mesh__historyNote mesh__D020595 2000
% 208.88/209.08 |- skos__historyNote mesh__D020595 Enterobacteriaceae %28%1966-1999%29%
% 208.88/209.08 |- mesh__dateRevised mesh__D020595 2005-06-30
% 208.88/209.08 |- rdf__type mesh__D020595sskos__Concept
% 208.88/209.08 |- skos__broader mesh__D020595smesh__D004755
% 208.88/209.08 |- mesh__dateCreated mesh__D014558 1999-01-01
% 208.88/209.08 |- mesh__dateRevised mesh__D014558 2005-06-30
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D014558 sjn
% 208.88/209.08 |- skos__annotation mesh__D014558
% 208.88/209.08 a bile pigment; /biosyn /physiol permitted
% 208.88/209.08 |- skos__prefLabel mesh__D014558 Urobilinogen
% 208.88/209.08 |- rdf__type mesh__D014558sskos__Concept
% 208.88/209.08 |- mesh__recordOriginator mesh__D014558 NLM
% 208.88/209.08 |- skos__broader mesh__D014558smesh__D001654
% 208.88/209.08 |- mesh__recordMaintainer mesh__D014558 ssb
% 208.88/209.08 |- skos__scopeNote mesh__D014558
% 208.88/209.08 A colorless compound formed in the intestines by the reduction of bilirubin. Some is excreted in the feces where it is oxidized to urobilin. Some is reabsorbed and re-excreted in the bile as bilirubin. At times, it is re-excreted in the urine, where it may be later oxidized to urobilin.%A%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D014558 2006
% 208.88/209.08 |- mesh__dateCreated mesh__D000538 1999-01-01
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 2002
% 208.88/209.08 |- skos__annotation mesh__D000538 %22%numerous types of clay%22%
% 208.88/209.08 |- mesh__dateRevised mesh__D000538 1993-06-04
% 208.88/209.08 |- skos__broader mesh__D000538smesh__D017640
% 208.88/209.08 |- rdf__type mesh__D000538sskos__Concept
% 208.88/209.08 |- skos__prefLabel mesh__D000538 Aluminum Silicates
% 208.88/209.08 |- skos__scopeNote mesh__D000538
% 208.88/209.08 Any of the numerous types of clay which contain varying proportions of Al2O3 and SiO2. They are made synthetically by heating aluminum fluoride at 1000-2000 degrees C with silica and water vapor. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 1995
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 2006
% 208.88/209.08 |- skos__hiddenLabel mesh__D000538 Silicates, Aluminum
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 2001
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 1999
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 2004
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D000538 PLS
% 208.88/209.08 |- mesh__recordMaintainer mesh__D000538 TPW
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 1994
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 1997
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 2000
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 2005
% 208.88/209.08 |- skos__broader mesh__D000538smesh__D000537
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 1998
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 2003
% 208.88/209.08 |- mesh__recordOriginator mesh__D000538 NLM
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D000538 1996
% 208.88/209.08 |- rdf__type mesh__D019243sskos__Concept
% 208.88/209.08 |- skos__altLabel mesh__D019243 Dental Microabrasions
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 2006
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 1998
% 208.88/209.08 |- skos__scopeNote mesh__D019243
% 208.88/209.08 Mechanical removal of a small amount of tooth structure %28%not more than a few tenths of a millimeter in depth%29% to eliminate superficial enamel discoloration defects not successfully removed by bleaching techniques. A common abrasive is a mixture of pumice and hydrochloric acid.%A%
% 208.88/209.08 |- skos__altLabel mesh__D019243 Dental Microabrasion
% 208.88/209.08 |- skos__prefLabel mesh__D019243 Enamel Microabrasion
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 1999
% 208.88/209.08 |- skos__altLabel mesh__D019243 Microabrasions, Enamel
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 2000
% 208.88/209.08 |- skos__altLabel mesh__D019243 Microabrasion, Enamel
% 208.88/209.08 |- skos__broader mesh__D019243smesh__D004955
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 2003
% 208.88/209.08 |- skos__annotation mesh__D019243 to remove surface discoloration
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D019243 97
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 2004
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 2001
% 208.88/209.08 |- skos__altLabel mesh__D019243 Microabrasion, Dental
% 208.88/209.08 |- mesh__dateEstablished mesh__D019243 1997-01-01
% 208.88/209.08 |- skos__altLabel mesh__D019243 Enamel Microabrasions
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 2002
% 208.88/209.08 |- mesh__historyNote mesh__D019243 97
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 1997
% 208.88/209.08 |- mesh__dateCreated mesh__D019243 1996-06-10
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D019243 2005
% 208.88/209.08 |- skos__altLabel mesh__D019243 Microabrasions, Dental
% 208.88/209.08 |- skos__historyNote mesh__D019243
% 208.88/209.08 Tooth Discoloration/therapy %28%1989-1996%29%
% 208.88/209.08 |- mesh__dateCreated mesh__D005223 1999-01-01
% 208.88/209.08 |- skos__scopeNote mesh__D005223
% 208.88/209.08 The glyceryl esters of a fatty acid, or of a mixture of fatty acids. They are generally odorless, colorless, and tasteless if pure, but they may be flavored according to origin. Fats are insoluble in water, soluble in most organic solvents. They occur in animal and vegetable tissue and are generally obtained by boiling or by extraction under pressure. They are important in the diet %28%DIETARY FATS%29% as a source of energy. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D005223 2006
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D005223 2005
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D005223 2004
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D005223 sjn
% 208.88/209.08 |- mesh__recordMaintainer mesh__D005223 ssb
% 208.88/209.08 |- mesh__recordOriginator mesh__D005223 NLM
% 208.88/209.08 |- mesh__dateRevised mesh__D005223 2003-07-09
% 208.88/209.08 |- skos__annotation mesh__D005223
% 208.88/209.08 table fats only or fats %22%outside the body%22%; differentiate from LIPIDS %28%%22%inside the body%22% but not body fat which = ADIPOSE TISSUE%29%; do not confuse with DIETARY FATS%A%
% 208.88/209.08 |- skos__broader mesh__D005223smesh__D008055
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D005223
% 208.88/209.08 /metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65%A%
% 208.88/209.08 |- mesh__historyNote mesh__D005223
% 208.88/209.08 /metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65%A%
% 208.88/209.08 |- rdf__type mesh__D005223sskos__Concept
% 208.88/209.08 |- skos__prefLabel mesh__D005223 Fats
% 208.88/209.08 |- skos__broader mesh__D018949smesh__D000945
% 208.88/209.08 |- skos__historyNote mesh__D018949 T-Lymphocytes %28%1988%29%
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D018949 sjn
% 208.88/209.08 |- mesh__dateCreated mesh__D018949 1995-05-26
% 208.88/209.08 |- rdf__type mesh__D018949sskos__Concept
% 208.88/209.08 |- skos__annotation mesh__D018949
% 208.88/209.08 T-lymphocyte differentiation antigens; but read MeSH definition%A%
% 208.88/209.08 |- mesh__historyNote mesh__D018949
% 208.88/209.08 96; was CD1 ANTIGENS %28%NM%29% 1988-95
% 208.88/209.08 |- skos__historyNote mesh__D018949
% 208.88/209.08 Antigens, Differentiation %28%1988-1991%29%
% 208.88/209.08 |- skos__altLabel mesh__D018949 CD1 Antigens
% 208.88/209.08 |- skos__prefLabel mesh__D018949 Antigens, CD1
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D018949 2006
% 208.88/209.08 |- mesh__recordMaintainer mesh__D018949 ssb
% 208.88/209.08 |- mesh__dateEstablished mesh__D018949 1996-01-01
% 208.88/209.08 |- skos__scopeNote mesh__D018949
% 208.88/209.08 Glycoproteins expressed on cortical thymocytes and on some dendritic cells and B-cells. Their structure is similar to that of MHC Class I and their function has been postulated as similar also. CD1 antigens are highly specific markers for human LANGERHANS CELLS.%A%
% 208.88/209.08 |- skos__hiddenLabel mesh__D018949 Antigen, CD1
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D018949
% 208.88/209.08 96; CD1 ANTIGENS was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION 1988-91; %26% T-LYMPHYCYTES 1988%A%
% 208.88/209.08 |- mesh__recordOriginator mesh__D018949 AGS
% 208.88/209.08 |- mesh__onlineNote mesh__D018949
% 208.88/209.08 use ANTIGENS, CD1 %28%NM%29% to search CD1 ANTIGENS 1988-95
% 208.88/209.08 |- skos__broader mesh__D018949smesh__D015703
% 208.88/209.08 |- skos__historyNote mesh__D018949 Antigens, CD %28%1990-1995%29%
% 208.88/209.08 |- skos__altLabel mesh__D018949 CD1 Antigen
% 208.88/209.08 |- mesh__dateRevised mesh__D018949 2005-06-30
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010966 2006
% 208.88/209.08 |- mesh__recordOriginator mesh__D010966 NLM
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010966 2005
% 208.88/209.08 |- skos__annotation mesh__D010966
% 208.88/209.08 infection = MALARIA, VIVAX; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 208.88/209.08 |- rdf__type mesh__D010966sskos__Concept
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D010966 sjn
% 208.88/209.08 |- skos__prefLabel mesh__D010966 Plasmodium vivax
% 208.88/209.08 |- skos__broader mesh__D010966smesh__D010961
% 208.88/209.08 |- mesh__dateRevised mesh__D010966 2003-07-09
% 208.88/209.08 |- skos__scopeNote mesh__D010966
% 208.88/209.08 A protozoan parasite that causes vivax malaria %28%MALARIA, VIVAX%29%. This species is found almost everywhere malaria is endemic and is the only one that has a range extending into the temperate regions.%A%
% 208.88/209.08 |- mesh__recordMaintainer mesh__D010966 ags
% 208.88/209.08 |- mesh__dateCreated mesh__D010966 1999-01-01
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010966 2004
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010168 2005
% 208.88/209.08 |- mesh__dateEstablished mesh__D010168 1991-01-01
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010168 2006
% 208.88/209.08 |- skos__scopeNote mesh__D010168
% 208.88/209.08 Salts and esters of the 16-carbon saturated monocarboxylic acid--palmitic acid.%A%
% 208.88/209.08 |- mesh__recordMaintainer mesh__D010168 ssb
% 208.88/209.08 |- mesh__dateRevised mesh__D010168 2003-07-09
% 208.88/209.08 |- mesh__historyNote mesh__D010168
% 208.88/209.08 91%28%75%29%; was see under PALMITIC ACIDS 1975-90
% 208.88/209.08 |- rdf__type mesh__D010168sskos__Concept
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D010168 sjn
% 208.88/209.08 |- skos__historyNote mesh__D010168 Fatty Acids %28%1966-1974%29%
% 208.88/209.08 |- mesh__dateCreated mesh__D010168 1974-11-11
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D010168
% 208.88/209.08 91; was see under PALMITIC ACIDS 1975-90
% 208.88/209.08 |- mesh__recordOriginator mesh__D010168 NLM
% 208.88/209.08 |- skos__altLabel mesh__D010168 Hexadecanoates
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D010168 2004
% 208.88/209.08 |- skos__prefLabel mesh__D010168 Palmitates
% 208.88/209.08 |- skos__broader mesh__D010168smesh__D010169
% 208.88/209.08 |- skos__prefLabel mesh__D004929 Esculin
% 208.88/209.08 |- mesh__onlineNote mesh__D004929 search BIOFLAVONOIDS 1966-74
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D004929
% 208.88/209.08 91; was see under COUMARINS 1989-90; was see under BIOFLAVONOIDS 1966-88%A%
% 208.88/209.08 |- mesh__dateEstablished mesh__D004929 1991-01-01
% 208.88/209.08 |- mesh__recordMaintainer mesh__D004929 ssb
% 208.88/209.08 |- skos__altLabel mesh__D004929 Esculoside
% 208.88/209.08 |- mesh__dateRevised mesh__D004929 2005-06-30
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D004929 2006
% 208.88/209.08 |- skos__broader mesh__D004929smesh__D005960
% 208.88/209.08 |- mesh__recordOriginator mesh__D004929 NLM
% 208.88/209.08 |- mesh__historyNote mesh__D004929
% 208.88/209.08 91%28%75%29%; was see under COUMARINS 1989-90; was see under BIOFLAVONOIDS 1966-88%A%
% 208.88/209.08 |- mesh__dateCreated mesh__D004929 1999-01-01
% 208.88/209.08 |- skos__broader mesh__D004929smesh__D003374
% 208.88/209.08 |- skos__altLabel mesh__D004929 Aesculin
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D004929 sjn
% 208.88/209.08 |- skos__altLabel mesh__D004929 Venoplant
% 208.88/209.08 |- rdf__type mesh__D004929sskos__Concept
% 208.88/209.08 |- skos__hiddenLabel mesh__D015651 Fungus Poisonings
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D015651 PLS
% 208.88/209.08 |- skos__historyNote mesh__D015651 Mushroom Poisoning %28%1985-1989%29%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 2004
% 208.88/209.08 |- skos__scopeNote mesh__D015651
% 208.88/209.08 Poisoning caused by the ingestion of mycotoxins %28%toxins of fungal origin%29%.%A%
% 208.88/209.08 |- skos__annotation mesh__D015651
% 208.88/209.08 %22%caused by ingestion of mycotoxins %28%toxins of fungal origin%29%%22%%A%
% 208.88/209.08 |- skos__altLabel mesh__D015651 Poisoning, Fungus
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 2002
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 2006
% 208.88/209.08 |- skos__historyNote mesh__D015651 Toxins %28%1966%29%
% 208.88/209.08 |- mesh__dateEstablished mesh__D015651 1990-01-01
% 208.88/209.08 |- mesh__historyNote mesh__D015651
% 208.88/209.08 90; was see MUSHROOM POISONING 1985-89
% 208.88/209.08 |- skos__hiddenLabel mesh__D015651 Poisonings, Fungus
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 1996
% 208.88/209.08 |- skos__prefLabel mesh__D015651 Mycotoxicosis
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 1998
% 208.88/209.08 |- skos__altLabel mesh__D015651 Fungus Poisoning
% 208.88/209.08 |- skos__broader mesh__D015651smesh__D011041
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 1997
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 1994
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 2000
% 208.88/209.08 |- mesh__dateRevised mesh__D015651 1992-05-15
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 1999
% 208.88/209.08 |- skos__hiddenLabel mesh__D015651 Mycotoxicoses
% 208.88/209.08 |- mesh__onlineNote mesh__D015651
% 208.88/209.08 use MUSHROOM POISONING to search MYCOTOXICOSIS 1985-89
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 1993
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 2001
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 1995
% 208.88/209.08 |- mesh__recordOriginator mesh__D015651 PXP
% 208.88/209.08 |- rdf__type mesh__D015651sskos__Concept
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 2003
% 208.88/209.08 |- mesh__dateCreated mesh__D015651 1989-05-15
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D015651 2005
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D015651
% 208.88/209.08 90; was see MUSHROOM POISONING 1985-89
% 208.88/209.08 |- skos__historyNote mesh__D015651 Mycotoxins %28%1967-1989%29%
% 208.88/209.08 |- mesh__recordMaintainer mesh__D015651 TGC
% 208.88/209.08 |- mesh__recordOriginator mesh__D009614 NLM
% 208.88/209.08 |- skos__annotation mesh__D009614 man-made radioactive element; IM
% 208.88/209.08 |- rdf__type mesh__D009614sskos__Concept
% 208.88/209.08 |- skos__scopeNote mesh__D009614
% 208.88/209.08 Nobelium. A man-made radioactive element of the actinide metal series. It has the atomic symbol No, atomic number 102, and atomic weight 259.%A%
% 208.88/209.08 |- skos__broader mesh__D009614smesh__D008671
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D009614 sjn
% 208.88/209.08 |- mesh__recordMaintainer mesh__D009614 jmp
% 208.88/209.08 |- skos__prefLabel mesh__D009614 Nobelium
% 208.88/209.08 |- mesh__dateCreated mesh__D009614 1999-01-01
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D009614 2006
% 208.88/209.08 |- skos__broader mesh__D009614smesh__D019216
% 208.88/209.08 |- mesh__dateRevised mesh__D009614 2005-06-30
% 208.88/209.08 |- skos__broader mesh__D001631smesh__D001211
% 208.88/209.08 |- skos__scopeNote mesh__D001631
% 208.88/209.08 A kingdom in the eastern Himalayas on the northeast border of India, bounded on the north by Tibet, on the east by Assam, on the south by Assam and West Bengal, and on the west by Sikkim and Tibet. From 1720 to 1970 it was under Chinese or Indian domination. In 1971 it became a member of the United Nations. The name comes from the Sanskrit bhota, the name for Tibet, + anta, end, with reference to its location at the southern extremity of Tibet. %28%From Webster%27%s New Geographical Dictionary, 1988, p144 %26% Room, Brewer%27%s Dictionary of Names, 1992, p64%29%%A%
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 2003
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 1997
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 2001
% 208.88/209.08 |- skos__prefLabel mesh__D001631 Bhutan
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 1996
% 208.88/209.08 |- mesh__dateRevised mesh__D001631 1995-02-17
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 2000
% 208.88/209.08 |- skos__annotation mesh__D001631 a kingdom in the eastern Himalayas
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 2006
% 208.88/209.08 |- mesh__recordMaintainer mesh__D001631 TGC
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 2005
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 1999
% 208.88/209.08 |- mesh__dateCreated mesh__D001631 1999-01-01
% 208.88/209.08 |- mesh__recordOriginator mesh__D001631 NLM
% 208.88/209.08 |- rdf__type mesh__D001631sskos__Concept
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 2004
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 1998
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D001631 2002
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D001631 PLS
% 208.88/209.08 |- mesh__activeMeSHYear mesh__D020596 2006
% 208.88/209.08 |- skos__broader mesh__D020596smesh__D004755
% 208.88/209.08 |- mesh__recordAuthorizer mesh__D020596 sjn
% 208.88/209.08 |- skos__historyNote mesh__D020596 Enterobacteriaceae %28%1974-1999%29%
% 208.88/209.08 |- mesh__dateCreated mesh__D020596 1999-11-03
% 208.88/209.08 |- mesh__recordOriginator mesh__D020596 ndw
% 208.88/209.08 |- mesh__publicMeSHNote mesh__D020596 2000
% 208.88/209.08 |- mesh__dateEstablished mesh__D020596 2000-01-01
% 208.88/209.08 |- skos__scopeNote mesh__D020596
% 208.88/209.08 A genus of gram-negative, facultatively anaerobic, straight rods which are motile by peritrichous flagella. These organisms are chemoorganotrophic and have both a respiratory and fermentative type of metabolism. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.88/209.08 |- skos__prefLabel mesh__D020596 Morganella
% 208.88/209.08 |- mesh__recordMaintainer mesh__D020596 SYSTEM
% 208.88/209.08 |- mesh__historyNote mesh__D020596 2000
% 208.88/209.09 |- rdf__type mesh__D020596sskos__Concept
% 208.88/209.09 |- mesh__dateRevised mesh__D020596 2005-06-30
% 208.88/209.09 |- skos__annotation mesh__D020596
% 208.88/209.09 infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%
% 208.88/209.09 |- skos__broader mesh__D014559smesh__D006836
% 208.88/209.09 |- skos__hiddenLabel mesh__D014559 Hydratase, Urocanate
% 208.88/209.09 |- skos__scopeNote mesh__D014559
% 208.88/209.09 An enzyme that catalyzes the conversion of 4,5-dihydro-4-oxo-5-imidazolepropanoate to urocanate and water. EC 4.2.1.49.%A%
% 208.88/209.09 |- skos__prefLabel mesh__D014559 Urocanate Hydratase
% 208.88/209.09 |- mesh__dateRevised mesh__D014559 2003-07-09
% 208.88/209.09 |- mesh__onlineNote mesh__D014559
% 208.88/209.09 use UROCANATE HYDRATASE to search UROCANASE 1972-94
% 208.88/209.09 |- skos__altLabel mesh__D014559 Urocanase
% 208.88/209.09 |- skos__altLabel mesh__D014559 Urocaninase
% 208.88/209.09 |- rdf__type mesh__D014559sskos__Concept
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D014559 2004
% 208.88/209.09 |- skos__historyNote mesh__D014559 Hydro-Lyases %28%1966-1971%29%
% 208.88/209.09 |- mesh__dateCreated mesh__D014559 1999-01-01
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D014559 sjn
% 208.88/209.09 |- mesh__recordMaintainer mesh__D014559 ssb
% 208.88/209.09 |- mesh__historyNote mesh__D014559
% 208.88/209.09 95; was UROCANASE 1972-94, see under HYDRO-LYASES 1972-90%A%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D014559 2005
% 208.88/209.09 |- mesh__dateEstablished mesh__D014559 1991-01-01
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D014559
% 208.88/209.09 95; was UROCANASE 1972-94, see under HYDRO-LYASES 1972-90%A%
% 208.88/209.09 |- mesh__recordOriginator mesh__D014559 NLM
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D014559 2006
% 208.88/209.09 |- rdf__type mesh__D025281sskos__Concept
% 208.88/209.09 |- mesh__recordMaintainer mesh__D025281 SYSTEM
% 208.88/209.09 |- skos__historyNote mesh__D025281 Fungi/ultrastructure %28%1966-2001%29%
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D025281 sjn
% 208.88/209.09 |- mesh__dateRevised mesh__D025281 2005-06-30
% 208.88/209.09 |- skos__broader mesh__D025281smesh__D005658
% 208.88/209.09 |- mesh__historyNote mesh__D025281 2002
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D025281 2002
% 208.88/209.09 |- mesh__dateCreated mesh__D025281 2001-07-25
% 208.88/209.09 |- mesh__recordOriginator mesh__D025281 ags
% 208.88/209.09 |- mesh__dateEstablished mesh__D025281 2002-01-01
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D025281 2006
% 208.88/209.09 |- skos__scopeNote mesh__D025281
% 208.88/209.09 The anatomical components of a fungus.
% 208.88/209.09 |- skos__prefLabel mesh__D025281 Fungal Components
% 208.88/209.09 |- skos__historyNote mesh__D025281
% 208.88/209.09 specific fungus/ultrastructure %28%1964-2001%29%
% 208.88/209.09 |- skos__annotation mesh__D025281 GEN or unspecified; prefer specifics
% 208.88/209.09 |- skos__annotation mesh__D019244
% 208.88/209.09 RNA molecules acting as molecular parasites of various RNA plant viruses; coord IM with specific plant virus /genet %28%IM or NIM%29% but note that CUCUMBER MOSAIC VIRUS SATELLITE is available%A%
% 208.88/209.09 |- skos__broader mesh__D019244smesh__D012313
% 208.88/209.09 |- skos__historyNote mesh__D019244 RNA %28%1981-1996%29%
% 208.88/209.09 |- mesh__dateCreated mesh__D019244 1996-06-10
% 208.88/209.09 |- mesh__recordOriginator mesh__D019244 AGS
% 208.88/209.09 |- skos__prefLabel mesh__D019244 RNA, Satellite
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D019244 sjn
% 208.88/209.09 |- skos__hiddenLabel mesh__D019244 RNAs, Satellite
% 208.88/209.09 |- skos__scopeNote mesh__D019244
% 208.88/209.09 Small, linear single-stranded RNA molecules functionally acting as molecular parasites of certain RNA plant viruses. Satellite RNAs exhibit four characteristic traits: %28%1%29% they require helper viruses to replicate; %28%2%29% they are unnecessary for the replication of helper viruses; %28%3%29% they are encapsidated in the coat protein of the helper virus; %28%4%29% they have no extensive sequence homology to the helper virus. Thus they differ from SATELLITE VIRUSES which encode their own coat protein, and from the genomic RNA; %28%=RNA, VIRAL%29%; of satellite viruses. %28%From Maramorosch, Viroids and Satellites, 1991, p143%29%%A%
% 208.88/209.09 |- skos__altLabel mesh__D019244 Satellite RNAs
% 208.88/209.09 |- skos__related mesh__D019244smesh__D006378
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D019244 2003
% 208.88/209.09 |- mesh__onlineNote mesh__D019244
% 208.88/209.09 use RNA, SATELLITE %28%NM%29% to search SATELLITE RNA 1981-96
% 208.88/209.09 |- skos__altLabel mesh__D019244 Satellite RNA
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D019244
% 208.88/209.09 97; SATELLITE RNA was indexed under RNA 1981-96
% 208.88/209.09 |- mesh__recordMaintainer mesh__D019244 mdb
% 208.88/209.09 |- mesh__historyNote mesh__D019244
% 208.88/209.09 97; was SATELLLITE RNA %28%NM%29% 1981-96
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D019244 2004
% 208.88/209.09 |- skos__related mesh__D019244smesh__D012526
% 208.88/209.09 |- skos__historyNote mesh__D019244 RNA, Viral %28%1974-1996%29%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D019244 2005
% 208.88/209.09 |- mesh__dateRevised mesh__D019244 2001-07-25
% 208.88/209.09 |- rdf__type mesh__D019244sskos__Concept
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D019244 2006
% 208.88/209.09 |- mesh__dateEstablished mesh__D019244 1997-01-01
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D019244 2002
% 208.88/209.09 |- rdf__type mesh__D000539sskos__Concept
% 208.88/209.09 |- skos__related mesh__D000539smesh__D003724
% 208.88/209.09 |- mesh__recordOriginator mesh__D000539 NLM
% 208.88/209.09 |- skos__related mesh__D000539smesh__D000541
% 208.88/209.09 |- skos__related mesh__D000539smesh__D000543
% 208.88/209.09 |- skos__broader mesh__D000539smesh__D007568
% 208.88/209.09 |- skos__scopeNote mesh__D000539
% 208.88/209.09 The thickest and spongiest part of the maxilla and mandible hollowed out into deep cavities for the teeth.%A%
% 208.88/209.09 |- mesh__dateEstablished mesh__D000539 1965-01-01
% 208.88/209.09 |- skos__annotation mesh__D000539
% 208.88/209.09 dis: coord with JAW DISEASES or specific precoord jaw dis %28%IM%29%; for /surg, prefer ALVEOLECTOMY or ALVEOLOPLASTY%A%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D000539 2006
% 208.88/209.09 |- skos__hiddenLabel mesh__D000539 Process, Alveolar
% 208.88/209.09 |- skos__hiddenLabel mesh__D000539 Alveolar Processes
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D000539 2004
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D000539 sjn
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D000539 2005
% 208.88/209.09 |- mesh__recordMaintainer mesh__D000539 lkt
% 208.88/209.09 |- skos__broader mesh__D000539smesh__D010519
% 208.88/209.09 |- skos__prefLabel mesh__D000539 Alveolar Process
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D000539 65
% 208.88/209.09 |- skos__hiddenLabel mesh__D000539 Processes, Alveolar
% 208.88/209.09 |- skos__hiddenLabel mesh__D000539 Ridge, Alveolar
% 208.88/209.09 |- mesh__historyNote mesh__D000539 65
% 208.88/209.09 |- mesh__dateCreated mesh__D000539 1999-01-01
% 208.88/209.09 |- mesh__dateRevised mesh__D000539 2003-07-09
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D011261 2006
% 208.88/209.09 |- mesh__recordMaintainer mesh__D011261 jls
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 First Trimester Pregnancies
% 208.88/209.09 |- skos__altLabel mesh__D011261 Trimester, First
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 Placental Phases, Early
% 208.88/209.09 |- mesh__dateCreated mesh__D011261 1975-07-25
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 First Trimester
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 Early Placental Phases
% 208.88/209.09 |- mesh__historyNote mesh__D011261
% 208.88/209.09 76; was PREGNANCY, FIRST TRIMESTER 1975
% 208.88/209.09 |- skos__altLabel mesh__D011261 Pregnancy, First Trimester
% 208.88/209.09 |- mesh__dateRevised mesh__D011261 2004-07-30
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 Pregnancy Trimesters, First
% 208.88/209.09 |- skos__prefLabel mesh__D011261 Pregnancy Trimester, First
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 First Pregnancy Trimesters
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D011261 2005A
% 208.88/209.09 |- skos__scopeNote mesh__D011261
% 208.88/209.09 The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period %28%MENSTRUATION%29% through the completion of 14 weeks %28%98 days%29% of gestation.%A%
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 Phases, Early Placental
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 First Pregnancy Trimester
% 208.88/209.09 |- skos__altLabel mesh__D011261 Early Placental Phase
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D011261 jls
% 208.88/209.09 |- rdf__type mesh__D011261sskos__Concept
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 First Trimesters
% 208.88/209.09 |- mesh__onlineNote mesh__D011261
% 208.88/209.09 use PREGNANCY TRIMESTER, FIRST to search PREGNANCY, FIRST TRIMESTER 1975%A%
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 Trimesters, First
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 Pregnancies, First Trimester
% 208.88/209.09 |- skos__historyNote mesh__D011261 Time Factors %28%1967-1974%29%
% 208.88/209.09 |- skos__historyNote mesh__D011261 Pregnancy %28%1966-1974%29%
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 Phase, Early Placental
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 First Trimester Pregnancy
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D011261 2005
% 208.88/209.09 |- mesh__dateEstablished mesh__D011261 1975-01-01
% 208.88/209.09 |- skos__broader mesh__D011261smesh__D011264
% 208.88/209.09 |- skos__historyNote mesh__D011261 Gestational Age %28%1968-1974%29%
% 208.88/209.09 |- skos__hiddenLabel mesh__D011261 Placental Phase, Early
% 208.88/209.09 |- mesh__recordOriginator mesh__D011261 SMH
% 208.88/209.09 |- skos__annotation mesh__D011261
% 208.88/209.09 human only; check tags HUMANS %26% FEMALE %26% PREGNANCY; DF: PREGN TRIMESTER FIRST%A%
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D011261
% 208.88/209.09 76; was PREGNANCY, FIRST TRIMESTER 1975
% 208.88/209.09 |- skos__broader mesh__D005224smesh__D005223
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D005224 2006
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D005224 2004
% 208.88/209.09 |- mesh__recordMaintainer mesh__D005224 ssb
% 208.88/209.09 |- mesh__dateRevised mesh__D005224 2003-07-09
% 208.88/209.09 |- skos__scopeNote mesh__D005224
% 208.88/209.09 Fats containing one or more double bonds, as from oleic acid, an unsaturated fatty acid.%A%
% 208.88/209.09 |- mesh__dateCreated mesh__D005224 1999-01-01
% 208.88/209.09 |- rdf__type mesh__D005224sskos__Concept
% 208.88/209.09 |- skos__prefLabel mesh__D005224 Fats, Unsaturated
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D005224 sjn
% 208.88/209.09 |- mesh__recordOriginator mesh__D005224 NLM
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D005224 2005
% 208.88/209.09 |- skos__altLabel mesh__D005224 Unsaturated Oils
% 208.88/209.09 |- skos__altLabel mesh__D005224 Unsaturated Fats
% 208.88/209.09 |- skos__broader mesh__D010967smesh__D010961
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D010967 2006
% 208.88/209.09 |- mesh__recordOriginator mesh__D010967 EC
% 208.88/209.09 |- skos__scopeNote mesh__D010967
% 208.88/209.09 A species of PLASMODIUM causing malaria in rodents.
% 208.88/209.09 |- rdf__type mesh__D010967sskos__Concept
% 208.88/209.09 |- skos__historyNote mesh__D010967 Plasmodium %28%1966-1987%29%
% 208.88/209.09 |- mesh__dateCreated mesh__D010967 1987-03-10
% 208.88/209.09 |- mesh__dateEstablished mesh__D010967 1988-01-01
% 208.88/209.09 |- mesh__dateRevised mesh__D010967 2003-07-09
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D010967 88
% 208.88/209.09 |- mesh__recordMaintainer mesh__D010967 ags
% 208.88/209.09 |- skos__prefLabel mesh__D010967 Plasmodium yoelii
% 208.88/209.09 |- skos__annotation mesh__D010967
% 208.88/209.09 in rodents; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord wtih ANTIBODIES, PROTOZOAN%A%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D010967 2004
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D010967 2005
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D010967 sjn
% 208.88/209.09 |- mesh__historyNote mesh__D010967 88
% 208.88/209.09 |- skos__altLabel mesh__D043343 Eifelfango Brand of Testosterone Propionate
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D043343 2004; see TESTOSTERONE 1977-2003
% 208.88/209.09 |- skos__historyNote mesh__D043343 Testosterone %28%1965-2003%29%
% 208.88/209.09 |- mesh__dateEstablished mesh__D043343 2004-01-01
% 208.88/209.09 |- skos__scopeNote mesh__D043343
% 208.88/209.09 An ester of TESTOSTERONE with a propionate substitution at the 17-beta position.%A%
% 208.88/209.09 |- mesh__dateCreated mesh__D043343 2003-07-09
% 208.88/209.09 |- mesh__dateRevised mesh__D043343 2005-06-30
% 208.88/209.09 |- skos__broader mesh__D043343smesh__D013739
% 208.88/209.09 |- skos__prefLabel mesh__D043343 Testosterone Propionate
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D043343 2006
% 208.88/209.09 |- mesh__recordOriginator mesh__D043343 lkt
% 208.88/209.09 |- mesh__recordMaintainer mesh__D043343 CCR
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D043343 sjn
% 208.88/209.09 |- skos__altLabel mesh__D043343 Ferring Brand of Testosterone Propionate
% 208.88/209.09 |- rdf__type mesh__D043343sskos__Concept
% 208.88/209.09 |- mesh__historyNote mesh__D043343 2004; use TESTOSTERONE 1977-2003
% 208.88/209.09 |- skos__hiddenLabel mesh__D043343 propionat Eifelfango, Testosteron
% 208.88/209.09 |- mesh__recordOriginator mesh__D010169 NLM
% 208.88/209.09 |- skos__hiddenLabel mesh__D010169 Acids, Palmitic
% 208.88/209.09 |- skos__annotation mesh__D010169
% 208.88/209.09 a group of fatty acids; do not confuse with PALMITIC ACID%A%
% 208.88/209.09 |- mesh__onlineNote mesh__D010169
% 208.88/209.09 use PALMITIC ACIDS to search PALMITIC ACID 1966-74
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D010169 2004
% 208.88/209.09 |- skos__prefLabel mesh__D010169 Palmitic Acids
% 208.88/209.09 |- skos__scopeNote mesh__D010169
% 208.88/209.09 A group of 16-carbon fatty acids that contain no double bonds.%A%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D010169 2005
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D010169 75; was PALMITIC ACID 1963-74
% 208.88/209.09 |- mesh__recordMaintainer mesh__D010169 ssb
% 208.88/209.09 |- skos__broader mesh__D010169smesh__D005227
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D010169 2006
% 208.88/209.09 |- mesh__historyNote mesh__D010169 75; was PALMITIC ACID 1963-74
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D010169 sjn
% 208.88/209.09 |- mesh__dateRevised mesh__D010169 2003-07-09
% 208.88/209.09 |- rdf__type mesh__D010169sskos__Concept
% 208.88/209.09 |- mesh__dateCreated mesh__D010169 1999-01-01
% 208.88/209.09 |- mesh__recordOriginator mesh__D015652 RLS
% 208.88/209.09 |- skos__altLabel mesh__D015652 25-Hydroxycalciferol
% 208.88/209.09 |- skos__prefLabel mesh__D015652 25-Hydroxyvitamin D 2
% 208.88/209.09 |- mesh__dateEstablished mesh__D015652 1990-01-01
% 208.88/209.09 |- mesh__dateCreated mesh__D015652 1989-09-06
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D015652 90
% 208.88/209.09 |- mesh__recordMaintainer mesh__D015652 ssb
% 208.88/209.09 |- skos__historyNote mesh__D015652 Ergocalciferols %28%1966-1989%29%
% 208.88/209.09 |- skos__hiddenLabel mesh__D015652 25 Hydroxyvitamin D 2
% 208.88/209.09 |- skos__altLabel mesh__D015652
% 208.88/209.09 9,10-Secoergosta-5,7,10%28%19%29%,22-tetraene-3 beta,25-diol
% 208.88/209.09 |- skos__scopeNote mesh__D015652
% 208.88/209.09 9,10-Secoergosta-5,7,10%28%19%29%,22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3.%A%
% 208.88/209.09 |- skos__hiddenLabel mesh__D015652 25 Hydroxyergocalciferol
% 208.88/209.09 |- skos__altLabel mesh__D015652 Ercalcidiol
% 208.88/209.09 |- rdf__type mesh__D015652sskos__Concept
% 208.88/209.09 |- skos__annotation mesh__D015652
% 208.88/209.09 deficiency: coordinate 25-HYDROXYVITAMIN D 2 /defic %28%IM%29% with RICKETS %28%IM%29% or with VITAMIN D DEFICIENCY %28%IM%29%%A%
% 208.88/209.09 |- skos__altLabel mesh__D015652 25-Hydroxyergocalciferol
% 208.88/209.09 |- skos__hiddenLabel mesh__D015652 25 Hydroxycalciferol
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D015652 sjn
% 208.88/209.09 |- mesh__historyNote mesh__D015652 90
% 208.88/209.09 |- skos__broader mesh__D015652smesh__D004872
% 208.88/209.09 |- skos__altLabel mesh__D015652 25-Hydroxyvitamin D2
% 208.88/209.09 |- mesh__dateRevised mesh__D015652 2005-06-30
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015652 2006
% 208.88/209.09 |- skos__hiddenLabel mesh__D015652 25 Hydroxyvitamin D2
% 208.88/209.09 |- rdf__type mesh__D009615sskos__Concept
% 208.88/209.09 |- mesh__dateRevised mesh__D009615 2005-06-30
% 208.88/209.09 |- mesh__recordOriginator mesh__D009615 NLM
% 208.88/209.09 |- mesh__recordMaintainer mesh__D009615 SYSTEM
% 208.88/209.09 |- mesh__dateCreated mesh__D009615 1999-01-01
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D009615 2006
% 208.88/209.09 |- skos__broader mesh__D009615smesh__D009618
% 208.88/209.09 |- skos__scopeNote mesh__D009615
% 208.88/209.09 A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for man and animals.%A%
% 208.88/209.09 |- skos__annotation mesh__D009615 infection = NOCARDIA INFECTIONS
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D009615 sjn
% 208.88/209.09 |- skos__prefLabel mesh__D009615 Nocardia
% 208.88/209.09 |- mesh__recordMaintainer mesh__D001632 ssb
% 208.88/209.09 |- mesh__historyNote mesh__D001632 68
% 208.88/209.09 |- skos__broader mesh__D001632smesh__D013267
% 208.88/209.09 |- skos__scopeNote mesh__D001632
% 208.88/209.09 Compounds with 1,2-diphenylethane. They are structurally like reduced STILBENES.%A%
% 208.88/209.09 |- mesh__dateEstablished mesh__D001632 1968-01-01
% 208.88/209.09 |- skos__prefLabel mesh__D001632 Bibenzyls
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D001632 2006
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D001632 68
% 208.88/209.09 |- mesh__recordOriginator mesh__D001632 NLM
% 208.88/209.09 |- mesh__dateCreated mesh__D001632 1999-01-01
% 208.88/209.09 |- mesh__dateRevised mesh__D001632 2004-07-07
% 208.88/209.09 |- rdf__type mesh__D001632sskos__Concept
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D001632 2005
% 208.88/209.09 |- skos__broader mesh__D001632smesh__D001593
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D001632 sjn
% 208.88/209.09 |- skos__historyNote mesh__D020597 Myxococcales %28%1978-1999%29%
% 208.88/209.09 |- skos__scopeNote mesh__D020597
% 208.88/209.09 A genus of the MYXOCOCCALES having vegetative cells which are straight rods with tapered ends and myxospores which are short and somewhat crooked. Fruiting bodies consist of spherical, ovoid, or club-shaped sporangioles on stalks. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.88/209.09 |- mesh__recordOriginator mesh__D020597 ndw
% 208.88/209.09 |- mesh__dateRevised mesh__D020597 2005-06-30
% 208.88/209.09 |- mesh__dateEstablished mesh__D020597 2000-01-01
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D020597 sjn
% 208.88/209.09 |- skos__historyNote mesh__D020597 Bacteria %28%1969-1977%29%
% 208.88/209.09 |- mesh__dateCreated mesh__D020597 1999-11-03
% 208.88/209.09 |- mesh__recordMaintainer mesh__D020597 SYSTEM
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D020597 2000
% 208.88/209.09 |- mesh__historyNote mesh__D020597 2000
% 208.88/209.09 |- rdf__type mesh__D020597sskos__Concept
% 208.88/209.09 |- skos__broader mesh__D020597smesh__D009231
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D020597 2006
% 208.88/209.09 |- skos__prefLabel mesh__D020597 Stigmatella
% 208.88/209.09 |- mesh__recordOriginator mesh__D025282 ags
% 208.88/209.09 |- mesh__dateEstablished mesh__D025282 2002-01-01
% 208.88/209.09 |- skos__annotation mesh__D025282 coord with specific fungus
% 208.88/209.09 |- rdf__type mesh__D025282sskos__Concept
% 208.88/209.09 |- mesh__dateCreated mesh__D025282 2001-07-25
% 208.88/209.09 |- mesh__recordMaintainer mesh__D025282 SYSTEM
% 208.88/209.09 |- skos__broader mesh__D025282smesh__D025281
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D025282 sjn
% 208.88/209.09 |- mesh__dateRevised mesh__D025282 2005-06-30
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D025282 2002
% 208.88/209.09 |- mesh__historyNote mesh__D025282 2002
% 208.88/209.09 |- skos__prefLabel mesh__D025282 Mycelium
% 208.88/209.09 |- skos__scopeNote mesh__D025282
% 208.88/209.09 The body of a fungus which is made up of HYPHAE.
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D025282 2006
% 208.88/209.09 |- skos__hiddenLabel mesh__D019245 Strength, Compressive
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D019245 2004
% 208.88/209.09 |- mesh__dateEstablished mesh__D019245 1997-01-01
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D019245 97
% 208.88/209.09 |- mesh__historyNote mesh__D019245 97
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D019245 2005
% 208.88/209.09 |- skos__prefLabel mesh__D019245 Compressive Strength
% 208.88/209.09 |- mesh__dateRevised mesh__D019245 2003-07-09
% 208.88/209.09 |- skos__broader mesh__D019245smesh__D001696
% 208.88/209.09 |- rdf__type mesh__D019245sskos__Concept
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D019245 2006
% 208.88/209.09 |- skos__scopeNote mesh__D019245
% 208.88/209.09 The maximum compression a material can withstand without failure. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed, p427%29%%A%
% 208.88/209.09 |- skos__hiddenLabel mesh__D019245 Strengths, Compressive
% 208.88/209.09 |- skos__annotation mesh__D019245
% 208.88/209.09 NIM; do not confuse with TENSILE STRENGTH
% 208.88/209.09 |- mesh__dateCreated mesh__D019245 1996-06-20
% 208.88/209.09 |- skos__hiddenLabel mesh__D019245 Compressive Strengths
% 208.88/209.09 |- skos__broader mesh__D019245smesh__D019563
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Second Trimester Pregnancy
% 208.88/209.09 |- mesh__dateEstablished mesh__D011262 1975-01-01
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Pregnancies, Second Trimester
% 208.88/209.09 |- mesh__dateCreated mesh__D011262 1975-07-25
% 208.88/209.09 |- mesh__historyNote mesh__D011262
% 208.88/209.09 76; was PREGNANCY, SECOND TRIMESTER 1975
% 208.88/209.09 |- mesh__recordOriginator mesh__D011262 SMH
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Second Pregnancy Trimester
% 208.88/209.09 |- mesh__dateRevised mesh__D011262 2004-07-13
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Second Pregnancy Trimesters
% 208.88/209.09 |- skos__altLabel mesh__D011262 Pregnancy, Second Trimester
% 208.88/209.09 |- mesh__recordMaintainer mesh__D011262 sjn
% 208.88/209.09 |- skos__annotation mesh__D011262
% 208.88/209.09 human only; check tags HUMANS %26% FEMALE %26% PREGNANCY; DF: PREGN TRIMESTER SECOND%A%
% 208.88/209.09 |- rdf__type mesh__D011262sskos__Concept
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Trimesters, Second
% 208.88/209.09 |- skos__altLabel mesh__D011262 Trimester, Second
% 208.88/209.09 |- skos__historyNote mesh__D011262 Time Factors %28%1967-1974%29%
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Second Trimester Pregnancies
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D011262 sjn
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D011262 2005
% 208.88/209.09 |- skos__broader mesh__D011262smesh__D011264
% 208.88/209.09 |- skos__historyNote mesh__D011262 Gestational Age %28%1968-1974%29%
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Second Trimesters
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D011262 2006
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Pregnancy Trimesters, Second
% 208.88/209.09 |- skos__prefLabel mesh__D011262 Pregnancy Trimester, Second
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Midtrimesters
% 208.88/209.09 |- skos__altLabel mesh__D011262 Midtrimester
% 208.88/209.09 |- skos__scopeNote mesh__D011262
% 208.88/209.09 The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week %28%99 to 196 days%29% of gestation.%A%
% 208.88/209.09 |- mesh__onlineNote mesh__D011262
% 208.88/209.09 use PREGNANCY TRIMESTER, SECOND to search PREGNANCY, SECOND TRIMESTER 1975%A%
% 208.88/209.09 |- skos__historyNote mesh__D011262 Pregnancy %28%1966-1974%29%
% 208.88/209.09 |- skos__hiddenLabel mesh__D011262 Second Trimester
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D011262
% 208.88/209.09 76; was PREGNANCY, SECOND TRIMESTER 1975
% 208.88/209.09 |- mesh__recordOriginator mesh__D010968 SH
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D010968 sjn
% 208.88/209.09 |- skos__historyNote mesh__D010968 Phthalic Acids %28%1970-1976%29%
% 208.88/209.09 |- mesh__dateCreated mesh__D010968 1976-04-13
% 208.88/209.09 |- mesh__dateEstablished mesh__D010968 1977-01-01
% 208.88/209.09 |- rdf__type mesh__D010968sskos__Concept
% 208.88/209.09 |- skos__broader mesh__D010968smesh__D020313
% 208.88/209.09 |- mesh__dateRevised mesh__D010968 2005-06-30
% 208.88/209.09 |- mesh__historyNote mesh__D010968 77
% 208.88/209.09 |- mesh__recordMaintainer mesh__D010968 ssb
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D010968 77
% 208.88/209.09 |- skos__prefLabel mesh__D010968 Plasticizers
% 208.88/209.09 |- skos__scopeNote mesh__D010968
% 208.88/209.09 Materials incorporated mechanically in plastics %28%usually PVC%29% to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment.%A%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D010968 2006
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D043344
% 208.88/209.09 2004, 1966-1999; see CHORDATA, NON-VERTEBRATE 2000-2003
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D043344 2004
% 208.88/209.09 |- skos__prefLabel mesh__D043344 Chordata
% 208.88/209.09 |- mesh__dateEstablished mesh__D043344 2004-01-01
% 208.88/209.09 |- mesh__dateCreated mesh__D043344 2003-07-09
% 208.88/209.09 |- skos__broader mesh__D043344smesh__D000818
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D043344 2005
% 208.88/209.09 |- skos__historyNote mesh__D043344
% 208.88/209.09 Chordata, Nonvertebrate %28%2000-2003%29%
% 208.88/209.09 |- skos__hiddenLabel mesh__D043344 Chordate
% 208.88/209.09 |- skos__altLabel mesh__D043344 Chordates
% 208.88/209.09 |- rdf__type mesh__D043344sskos__Concept
% 208.88/209.09 |- skos__historyNote mesh__D043344 Animals %28%1963-1999%29%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D043344 2006
% 208.88/209.09 |- mesh__historyNote mesh__D043344
% 208.88/209.09 2004, 1966-1999; use CHORDATA, NON-VERTEBRATE 2000-2003
% 208.88/209.09 |- skos__scopeNote mesh__D043344
% 208.88/209.09 Phylum in the domain Eukarya, comprised of animals either with fully developed backbones %28%VERTEBRATES%29%, or those with notochords only during some developmental stage %28%CHORDATA, NONVERTEBRATE%29%.%A%
% 208.88/209.09 |- mesh__historyNote mesh__D015653 90
% 208.88/209.09 |- skos__related mesh__D015653smesh__D014547
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015653 2000
% 208.88/209.09 |- mesh__dateCreated mesh__D015653 1989-06-19
% 208.88/209.09 |- mesh__recordOriginator mesh__D015653 AGS
% 208.88/209.09 |- rdf__type mesh__D015653sskos__Concept
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015653 2003
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015653 2001
% 208.88/209.09 |- skos__hiddenLabel mesh__D015653 Cystectomies
% 208.88/209.09 |- skos__annotation mesh__D015653
% 208.88/209.09 %22%cyst-%22% refers to the bladder, not to %22%cyst%22%; do not use /util except by MeSH definition%A%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015653 2005
% 208.88/209.09 |- skos__broader mesh__D015653smesh__D013520
% 208.88/209.09 |- skos__scopeNote mesh__D015653
% 208.88/209.09 Used for excision of the urinary bladder.
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015653 2004
% 208.88/209.09 |- skos__historyNote mesh__D015653 Bladder %28%1966-1989%29%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015653 2006
% 208.88/209.09 |- mesh__recordMaintainer mesh__D015653 PXP
% 208.88/209.09 |- skos__historyNote mesh__D015653 Bladder Neoplasms %28%1966-1989%29%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015653 2002
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015653 1998
% 208.88/209.09 |- mesh__dateRevised mesh__D015653 1997-06-20
% 208.88/209.09 |- mesh__dateEstablished mesh__D015653 1990-01-01
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D015653 SJN
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D015653 90
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D015653 1999
% 208.88/209.09 |- skos__prefLabel mesh__D015653 Cystectomy
% 208.88/209.09 |- rdf__type mesh__D009616sskos__Concept
% 208.88/209.09 |- mesh__historyNote mesh__D009616
% 208.88/209.09 74%28%72%29%; ACTINOMYCES ASTEROIDES was see NOCARDIA ASTEROIDES 1974-91%A%
% 208.88/209.09 |- mesh__recordAuthorizer mesh__D009616 sjn
% 208.88/209.09 |- skos__historyNote mesh__D009616 Nocardia %28%1966-1971%29%
% 208.88/209.09 |- mesh__dateCreated mesh__D009616 1999-01-01
% 208.88/209.09 |- skos__broader mesh__D009616smesh__D009615
% 208.88/209.09 |- mesh__publicMeSHNote mesh__D009616
% 208.88/209.09 74; ACTINOMYCES ASTEROIDES was see NOCARDIA ASTEROIDES 1974-91%A%
% 208.88/209.09 |- mesh__dateRevised mesh__D009616 2005-06-30
% 208.88/209.09 |- mesh__dateEstablished mesh__D009616 1974-01-01
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D009616 2006
% 208.88/209.09 |- mesh__recordOriginator mesh__D009616 NLM
% 208.88/209.09 |- mesh__onlineNote mesh__D009616
% 208.88/209.09 use NOCARDIA ASTEROIDES to search ACTINOMYCES ASTEROIDES 1974-91%A%
% 208.88/209.09 |- skos__annotation mesh__D009616
% 208.88/209.09 infection: coord IM with NOCARDIA INFECTIONS %28%IM%29%
% 208.88/209.09 |- mesh__recordMaintainer mesh__D009616 SYSTEM
% 208.88/209.09 |- skos__prefLabel mesh__D009616 Nocardia asteroides
% 208.88/209.09 |- skos__scopeNote mesh__D009616
% 208.88/209.09 A species of bacterium of the family NOCARDIACEAE, producing pulmonary infections in man.%A%
% 208.88/209.09 |- skos__prefLabel mesh__D001633 Bible
% 208.88/209.09 |- mesh__recordOriginator mesh__D001633 NLM
% 208.88/209.09 |- skos__annotation mesh__D001633
% 208.88/209.09 no qualif; Old and New Testament only: does not include Koran %28%index under ISLAM + specific aspect discussed in article%29%; includes Talmud CATALOG: use NAF entry%A%
% 208.88/209.09 |- mesh__activeMeSHYear mesh__D001633 2000
% 208.88/209.09 |- mesh__dateCreated mesh__D001633 1999-01-01
% 208.88/209.09 |- skos__broader mesh__D001633smesh__D008091
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001633 2005
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001633 1998
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001633 2001
% 208.88/209.10 |- mesh__recordMaintainer mesh__D001633 TGC
% 208.88/209.10 |- skos__scopeNote mesh__D001633
% 208.88/209.10 The book composed of writings generally accepted by Christians as inspired by God and of divine authority. %28%Webster, 3d ed%29%%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001633 2006
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001633 1999
% 208.88/209.10 |- mesh__dateRevised mesh__D001633 1996-06-10
% 208.88/209.10 |- skos__hiddenLabel mesh__D001633 Interpretation, Scriptural
% 208.88/209.10 |- skos__hiddenLabel mesh__D001633 Interpretations, Scriptural
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001633 2003
% 208.88/209.10 |- rdf__type mesh__D001633sskos__Concept
% 208.88/209.10 |- skos__hiddenLabel mesh__D001633 Bibles
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D001633 PLS
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001633 2002
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001633 2004
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001633 1997
% 208.88/209.10 |- skos__hiddenLabel mesh__D001633 Scriptural Interpretations
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D020598 2006
% 208.88/209.10 |- mesh__dateCreated mesh__D020598 1999-11-03
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 c myb Protein
% 208.88/209.10 |- skos__altLabel mesh__D020598 c-myb Proteins
% 208.88/209.10 |- mesh__recordMaintainer mesh__D020598 DRC
% 208.88/209.10 |- skos__scopeNote mesh__D020598
% 208.88/209.10 Cellular DNA-binding proteins encoded by the myb gene %28%GENES, MYB%29%. They are expressed in a wide variety of cells including thymocytes and lymphocytes, and regulate cell differentiation. Overexpression of myb is associated with autoimmune diseases and malignancies.%A%
% 208.88/209.10 |- skos__historyNote mesh__D020598
% 208.88/209.10 Proto-Oncogene Proteins %28%1986-1999%29%
% 208.88/209.10 |- mesh__historyNote mesh__D020598
% 208.88/209.10 2000; use PROTO-ONCOGENE PROTEINS C-MYB %28%NM%29% 1986-1999
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 Proto Oncogene Proteins c myb
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 Proto Oncogene Proteins myb
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 c myb Proteins
% 208.88/209.10 |- skos__broader mesh__D020598smesh__D014157
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 myb Proto Oncogene Proteins
% 208.88/209.10 |- skos__prefLabel mesh__D020598 Proto-Oncogene Proteins c-myb
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 Proto Oncogene Products c myb
% 208.88/209.10 |- skos__historyNote mesh__D020598 Trans-Activators %28%1990-1999%29%
% 208.88/209.10 |- mesh__dateEstablished mesh__D020598 2000-01-01
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 myb, Proto-Oncogene Protein
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 c-myb, Proto-Oncogene Proteins
% 208.88/209.10 |- skos__altLabel mesh__D020598 Proto-Oncogene Products c-myb
% 208.88/209.10 |- skos__broader mesh__D020598smesh__D004268
% 208.88/209.10 |- skos__altLabel mesh__D020598 Proto-Oncogene Proteins myb
% 208.88/209.10 |- mesh__dateRevised mesh__D020598 2005-06-30
% 208.88/209.10 |- mesh__recordOriginator mesh__D020598 ags
% 208.88/209.10 |- skos__altLabel mesh__D020598 c-myb Protein
% 208.88/209.10 |- skos__broader mesh__D020598smesh__D011518
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D020598
% 208.88/209.10 2000; PROTO-ONCOGENE PROTEIN MYB was indexed under PROTO-ONCOGENE PROTEINS 1986-1990 %26% TRANS-ACTIVATORS 1990-1999%A%
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 Proto Oncogene Protein myb
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D020598 sjn
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 Proto-Oncogene Proteins, myb
% 208.88/209.10 |- skos__altLabel mesh__D020598 myb Proto-Oncogene Proteins
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 myb, Proto-Oncogene Proteins
% 208.88/209.10 |- skos__hiddenLabel mesh__D020598 c-myb, Proto-Oncogene Products
% 208.88/209.10 |- skos__altLabel mesh__D020598 Proto-Oncogene Protein myb
% 208.88/209.10 |- rdf__type mesh__D020598sskos__Concept
% 208.88/209.10 |- skos__related mesh__D020598smesh__D020570
% 208.88/209.10 |- skos__broader mesh__D004093Q000172smesh__D004093
% 208.88/209.10 |- mesh__preferredCombination mesh__D004093Q000172smesh__D010661
% 208.88/209.10 |- rdf__type mesh__D004093Q000172smesh__CompoundConcept
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 2005
% 208.88/209.10 |- mesh__historyNote mesh__D019246 97
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 1997
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 2006
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 1998
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 2000
% 208.88/209.10 |- mesh__dateEstablished mesh__D019246 1997-01-01
% 208.88/209.10 |- rdf__type mesh__D019246sskos__Concept
% 208.88/209.10 |- skos__hiddenLabel mesh__D019246 Preparation, Tooth
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 2001
% 208.88/209.10 |- skos__broader mesh__D019246smesh__D003813
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D019246 97
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 1999
% 208.88/209.10 |- skos__hiddenLabel mesh__D019246 Tooth Preparations
% 208.88/209.10 |- skos__annotation mesh__D019246
% 208.88/209.10 GEN or unspecified; prefer specifics; coord IM with specific dental procedure %28%IM%29%%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 2002
% 208.88/209.10 |- mesh__dateCreated mesh__D019246 1996-06-10
% 208.88/209.10 |- skos__scopeNote mesh__D019246
% 208.88/209.10 Procedures carried out with regard to the teeth or tooth structures preparatory to specified dental therapeutic and surgical measures.%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 2003
% 208.88/209.10 |- skos__prefLabel mesh__D019246 Tooth Preparation
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019246 2004
% 208.88/209.10 |- skos__hiddenLabel mesh__D019246 Preparations, Tooth
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Trimesters, Last
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D011263 2006
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Third Pregnancy Trimesters
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Last Trimesters
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D011263 2005
% 208.88/209.10 |- skos__historyNote mesh__D011263 Gestational Age %28%1968-1974%29%
% 208.88/209.10 |- skos__altLabel mesh__D011263 Pregnancy, Third Trimester
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Trimester, Last
% 208.88/209.10 |- mesh__dateCreated mesh__D011263 1975-07-25
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Third Trimester Pregnancy
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D011263
% 208.88/209.10 76; was PREGNANCY, THIRD TRIMESTER 1975
% 208.88/209.10 |- skos__scopeNote mesh__D011263
% 208.88/209.10 The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week %28%197 to 294 days%29% of gestation.%A%
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Pregnancy Trimesters, Third
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Pregnancies, Third Trimester
% 208.88/209.10 |- mesh__recordOriginator mesh__D011263 SMH
% 208.88/209.10 |- mesh__recordMaintainer mesh__D011263 ags
% 208.88/209.10 |- rdf__type mesh__D011263sskos__Concept
% 208.88/209.10 |- mesh__dateRevised mesh__D011263 2005-07-18
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Third Trimester Pregnancies
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Third Pregnancy Trimester
% 208.88/209.10 |- mesh__dateEstablished mesh__D011263 1975-01-01
% 208.88/209.10 |- mesh__historyNote mesh__D011263
% 208.88/209.10 76; was PREGNANCY, THIRD TRIMESTER 1975
% 208.88/209.10 |- skos__prefLabel mesh__D011263 Pregnancy Trimester, Third
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D011263 ags
% 208.88/209.10 |- mesh__onlineNote mesh__D011263
% 208.88/209.10 use PREGNANCY TRIMESTER, THIRD to search PREGNANCY, THIRD TRIMESTER 1975%A%
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Trimesters, Third
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Third Trimester
% 208.88/209.10 |- skos__historyNote mesh__D011263 Pregnancy %28%1966-1974%29%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D011263 2006A
% 208.88/209.10 |- skos__hiddenLabel mesh__D011263 Third Trimesters
% 208.88/209.10 |- skos__altLabel mesh__D011263 Last Trimester
% 208.88/209.10 |- skos__annotation mesh__D011263
% 208.88/209.10 human only; check tags HUMANS %26% FEMALE %26% PREGNANCY; %22%at term%22%: consider better LABOR, OBSTETRIC; DF: PREGN TRIMESTER THIRD%A%
% 208.88/209.10 |- skos__altLabel mesh__D011263 Trimester, Third
% 208.88/209.10 |- skos__historyNote mesh__D011263 Time Factors %28%1967-1974%29%
% 208.88/209.10 |- skos__broader mesh__D011263smesh__D011264
% 208.88/209.10 |- skos__altLabel mesh__D005226 Fatty Acid Synthase
% 208.88/209.10 |- rdf__type mesh__D005226sskos__Concept
% 208.88/209.10 |- skos__hiddenLabel mesh__D005226 Synthase, Fatty Acid
% 208.88/209.10 |- mesh__dateEstablished mesh__D005226 1972-01-01
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D005226 72
% 208.88/209.10 |- mesh__dateRevised mesh__D005226 2004-07-07
% 208.88/209.10 |- mesh__historyNote mesh__D005226 72%28%71%29%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D005226 2005
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D005226 sjn
% 208.88/209.10 |- skos__historyNote mesh__D005226 Ligases %28%1966-1970%29%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D005226 2006
% 208.88/209.10 |- mesh__recordOriginator mesh__D005226 NLM
% 208.88/209.10 |- skos__prefLabel mesh__D005226 Fatty Acid Synthetase Complex
% 208.88/209.10 |- skos__historyNote mesh__D005226 Fatty Acids/BI %28%1966-1970%29%
% 208.88/209.10 |- skos__broader mesh__D005226smesh__D009097
% 208.88/209.10 |- skos__hiddenLabel mesh__D005226 Acid Synthase, Fatty
% 208.88/209.10 |- mesh__recordMaintainer mesh__D005226 jmp
% 208.88/209.10 |- mesh__dateCreated mesh__D005226 1999-01-01
% 208.88/209.10 |- skos__broader mesh__D014867Q000097smesh__D014867
% 208.88/209.10 |- mesh__preferredCombination mesh__D014867Q000097smesh__D001769
% 208.88/209.10 |- rdf__type mesh__D014867Q000097smesh__CompoundConcept
% 208.88/209.10 |- skos__broader mesh__D010969smesh__D011108
% 208.88/209.10 |- mesh__recordOriginator mesh__D010969 NLM
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D010969 2005
% 208.88/209.10 |- skos__annotation mesh__D010969 D25-26 qualif
% 208.88/209.10 |- skos__prefLabel mesh__D010969 Plastics
% 208.88/209.10 |- mesh__dateRevised mesh__D010969 2004-07-07
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D010969 2006
% 208.88/209.10 |- mesh__recordMaintainer mesh__D010969 jmp
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D010969 sjn
% 208.88/209.10 |- mesh__historyNote mesh__D010969
% 208.88/209.10 was in Cat D %26% J 1967-82, was in Cat J only 1963-66
% 208.88/209.10 |- skos__scopeNote mesh__D010969
% 208.88/209.10 Polymeric materials %28%usually organic%29% of large molecular weight which can be shaped by flow. Plastic usually refers to the final product with fillers, plasticizers, pigments, and stabilizers included %28%versus the resin, the homogeneous polymeric starting material%29%. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 208.88/209.10 |- mesh__dateCreated mesh__D010969 1999-01-01
% 208.88/209.10 |- rdf__type mesh__D010969sskos__Concept
% 208.88/209.10 |- skos__altLabel mesh__D015654 Human herpesvirus 6
% 208.88/209.10 |- skos__hiddenLabel mesh__D015654 Human B-Lymphotropic Viruses
% 208.88/209.10 |- skos__hiddenLabel mesh__D015654 Human B Lymphotropic Virus
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D015654
% 208.88/209.10 94; was HERPESVIRUS-6, HUMAN 1990-93; HUMAN HERPESVIRUS-6 was see HERPESVIRUS-6, HUMAN 1990-93%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015654 2003
% 208.88/209.10 |- mesh__dateRevised mesh__D015654 2001-07-25
% 208.88/209.10 |- skos__hiddenLabel mesh__D015654 B-Lymphotropic Virus, Human
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015654 2005
% 208.88/209.10 |- skos__scopeNote mesh__D015654
% 208.88/209.10 The type species of ROSEOLOVIRUS isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter NK cell activity. HHV-6; %28%HBLV%29% antibodies are elevated in patients with AIDS, Sjogren%27%s syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. HHV-6 is the cause of EXANTHEMA SUBITUM and has been implicated in encephalitis.%A%
% 208.88/209.10 |- mesh__onlineNote mesh__D015654
% 208.88/209.10 use HERPESVIRUS 6, HUMAN to search HERPESVIRUS-6, HUMAN %26% HUMAN HERPESVIRUS-6 1990-93%A%
% 208.88/209.10 |- skos__hiddenLabel mesh__D015654 Human Herpesvirus 6A
% 208.88/209.10 |- skos__altLabel mesh__D015654 HBLV
% 208.88/209.10 |- skos__hiddenLabel mesh__D015654 Human Herpesvirus 6B
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015654 2004
% 208.88/209.10 |- skos__annotation mesh__D015654
% 208.88/209.10 infection: coord IM with ROSEOLOVIRUS INFECTIONS %28%IM%29% but consider also EXANTHEMA SUBITUM%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015654 2006
% 208.88/209.10 |- mesh__recordOriginator mesh__D015654 AGS
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D015654 sjn
% 208.88/209.10 |- mesh__dateCreated mesh__D015654 1989-05-25
% 208.88/209.10 |- skos__hiddenLabel mesh__D015654 B-Lymphotropic Viruses, Human
% 208.88/209.10 |- mesh__historyNote mesh__D015654
% 208.88/209.10 94; was HERPESVIRUS-6, HUMAN 1990-93; HUMAN HERPESVIRUS-6 was see HERPESVIRUS-6, HUMAN 1990-93%A%
% 208.88/209.10 |- skos__altLabel mesh__D015654 Human B-Lymphotropic Virus
% 208.88/209.10 |- skos__historyNote mesh__D015654 Herpesviridae %28%1986-1989%29%
% 208.88/209.10 |- mesh__dateEstablished mesh__D015654 1990-01-01
% 208.88/209.10 |- skos__prefLabel mesh__D015654 Herpesvirus 6, Human
% 208.88/209.10 |- mesh__recordMaintainer mesh__D015654 ags
% 208.88/209.10 |- skos__altLabel mesh__D015654 HHV-6A
% 208.88/209.10 |- skos__broader mesh__D015654smesh__D019211
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015654 2002
% 208.88/209.10 |- skos__altLabel mesh__D015654 HHV-6
% 208.88/209.10 |- skos__related mesh__D015654smesh__D005077
% 208.88/209.10 |- skos__altLabel mesh__D015654 HHV-6B
% 208.88/209.10 |- rdf__type mesh__D015654sskos__Concept
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D048030 sjn
% 208.88/209.10 |- skos__altLabel mesh__D048030 Algal RNA
% 208.88/209.10 |- skos__broader mesh__D048030smesh__D012313
% 208.88/209.10 |- skos__prefLabel mesh__D048030 RNA, Algal
% 208.88/209.10 |- mesh__recordMaintainer mesh__D048030 ags
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D048030 2006
% 208.88/209.10 |- rdf__type mesh__D048030sskos__Concept
% 208.88/209.10 |- mesh__dateEstablished mesh__D048030 2005-01-01
% 208.88/209.10 |- mesh__historyNote mesh__D048030 2005
% 208.88/209.10 |- skos__historyNote mesh__D048030 RNA, Ribosomal %28%1974-2004%29%
% 208.88/209.10 |- mesh__recordOriginator mesh__D048030 ags
% 208.88/209.10 |- mesh__dateCreated mesh__D048030 2004-07-07
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D048030 2005
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D048030 2005
% 208.88/209.10 |- skos__scopeNote mesh__D048030
% 208.88/209.10 Ribonucleic acid in ALGAE having regulatory and catalytic roles as well as involvement in protein synthesis.%A%
% 208.88/209.10 |- mesh__dateCreated mesh__D009617 1999-01-01
% 208.88/209.10 |- skos__hiddenLabel mesh__D009617 Nocardia Infection
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 2002
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 1997
% 208.88/209.10 |- skos__annotation mesh__D009617 gram-pos bact infect
% 208.88/209.10 |- mesh__dateRevised mesh__D009617 1993-06-02
% 208.88/209.10 |- skos__prefLabel mesh__D009617 Nocardia Infections
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 2005
% 208.88/209.10 |- skos__scopeNote mesh__D009617
% 208.88/209.10 Infections with bacteria of the genus NOCARDIA.
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 1994
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 2006
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 2003
% 208.88/209.10 |- skos__altLabel mesh__D009617 Infections, Nocardia
% 208.88/209.10 |- skos__broader mesh__D009617smesh__D000193
% 208.88/209.10 |- mesh__recordMaintainer mesh__D009617 TAP
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 1995
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D009617 PLS
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 2004
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 2000
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 1998
% 208.88/209.10 |- rdf__type mesh__D009617sskos__Concept
% 208.88/209.10 |- skos__hiddenLabel mesh__D009617 Infection, Nocardia
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 2001
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 1999
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009617 1996
% 208.88/209.10 |- mesh__recordOriginator mesh__D009617 NLM
% 208.88/209.10 |- skos__prefLabel mesh__D001634 Bibliography
% 208.88/209.10 |- mesh__dateRevised mesh__D001634 1999-11-03
% 208.88/209.10 |- mesh__recordMaintainer mesh__D001634 kle
% 208.88/209.10 |- mesh__dateCreated mesh__D001634 1999-01-01
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001634 2002
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001634 2005
% 208.88/209.10 |- skos__broader mesh__D001634smesh__D007255
% 208.88/209.10 |- skos__broader mesh__D001634smesh__D011642
% 208.88/209.10 |- mesh__recordOriginator mesh__D001634 NLM
% 208.88/209.10 |- skos__scopeNote mesh__D001634
% 208.88/209.10 A list of works, documents or other publications, usually with some relationship between them, e.g., by a given author, on a given subject, or published in a given place, and differing from a catalog in that its contents are restricted to holdings of a single collection, library, or group of libraries. %28%The ALA Glossary of Library and Information Science, 1983%29%%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001634 2006
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001634 2000
% 208.88/209.10 |- skos__annotation mesh__D001634
% 208.88/209.10 IM for bibliog as a subject: do not confuse with Publication Type BIBLIOGRAPHY; for bibliog on specific subject, index under subject %28%IM%29% + BIBLIOGRAPHY %28%PT%29%; no qualif; policy: Manual 17.4.+, 33.4-33.9, 36.22; TN 121: differentiate from LITERATURE; med bibliog: see note on BIBLIOGRAPHY OF MEDICINE; lists of books: consider also BOOK SELECTION; DF: BIBLIOGR%A%
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D001634 sjn
% 208.88/209.10 |- skos__related mesh__D001634smesh__D004282
% 208.88/209.10 |- mesh__historyNote mesh__D001634
% 208.88/209.10 for articles that were or contained bibliographies 1963-90%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001634 2003
% 208.88/209.10 |- rdf__type mesh__D001634sskos__Concept
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001634 2001
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001634 2004
% 208.88/209.10 |- skos__hiddenLabel mesh__D001634 Bibliographies
% 208.88/209.10 |- skos__broader mesh__D020599smesh__D020583
% 208.88/209.10 |- mesh__dateEstablished mesh__D020599 2000-01-01
% 208.88/209.10 |- mesh__dateCreated mesh__D020599 1999-11-03
% 208.88/209.10 |- skos__historyNote mesh__D020599 Rhizobiaceae/genetics %28%1988-1999%29%
% 208.88/209.10 |- rdf__type mesh__D020599sskos__Concept
% 208.88/209.10 |- mesh__historyNote mesh__D020599 2000
% 208.88/209.10 |- mesh__recordOriginator mesh__D020599 ndw
% 208.88/209.10 |- mesh__recordMaintainer mesh__D020599 SYSTEM
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D020599 2000
% 208.88/209.10 |- mesh__dateRevised mesh__D020599 2005-06-30
% 208.88/209.10 |- skos__scopeNote mesh__D020599
% 208.88/209.10 A species of AZORHIZOBIUM which forms nodules on the roots of the tropical legume Sesbania rostrata. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 208.88/209.10 |- skos__prefLabel mesh__D020599 Azorhizobium caulinodans
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D020599 2006
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D020599 sjn
% 208.88/209.10 |- skos__altLabel mesh__D019247 AIDS Wasting Syndrome
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019247 2003
% 208.88/209.10 |- mesh__dateEstablished mesh__D019247 1997-01-01
% 208.88/209.10 |- mesh__recordMaintainer mesh__D019247 ags
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D019247 sjn
% 208.88/209.10 |- skos__altLabel mesh__D019247 Wasting Disease, HIV
% 208.88/209.10 |- skos__altLabel mesh__D019247 HIV Wasting Disease
% 208.88/209.10 |- mesh__dateCreated mesh__D019247 1996-06-10
% 208.88/209.10 |- skos__altLabel mesh__D019247 Wasting Syndrome, HIV
% 208.88/209.10 |- skos__hiddenLabel mesh__D019247 Wasting Syndrome, AIDS
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019247 2002
% 208.88/209.10 |- mesh__recordOriginator mesh__D019247 AGS
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019247 2006
% 208.88/209.10 |- skos__prefLabel mesh__D019247 HIV Wasting Syndrome
% 208.88/209.10 |- skos__historyNote mesh__D019247 HIV Infections %28%1991-1996%29%
% 208.88/209.10 |- rdf__type mesh__D019247sskos__Concept
% 208.88/209.10 |- skos__altLabel mesh__D019247 Slim Disease
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019247 2005
% 208.88/209.10 |- skos__broader mesh__D019247smesh__D015658
% 208.88/209.10 |- mesh__dateRevised mesh__D019247 2001-07-25
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D019247 97
% 208.88/209.10 |- mesh__historyNote mesh__D019247 97
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D019247 2004
% 208.88/209.10 |- skos__scopeNote mesh__D019247
% 208.88/209.10 Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. %28%From Harrison%27%s Principles of Internal Medicine, 13th ed, p1611%29%.%A%
% 208.88/209.10 |- skos__broader mesh__D019247smesh__D019282
% 208.88/209.10 |- skos__historyNote mesh__D011264 Gestational Age %28%1968-1974%29%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D011264 2005
% 208.88/209.10 |- mesh__historyNote mesh__D011264 98; use explode 1975-97
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D011264 sjn
% 208.88/209.10 |- mesh__dateEstablished mesh__D011264 1998-01-01
% 208.88/209.10 |- skos__hiddenLabel mesh__D011264 Trimester, Pregnancy
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D011264 98
% 208.88/209.10 |- rdf__type mesh__D011264sskos__Concept
% 208.88/209.10 |- mesh__dateCreated mesh__D011264 1999-01-01
% 208.88/209.10 |- skos__annotation mesh__D011264
% 208.88/209.10 human only; GEN or unspecified; prefer specifics; trimesters are indexed only when the point of the article or substantively discussed: they are not sought out routinely nor indexed when merely mentioned; DF: PREGN TRIMESTERS%A%
% 208.88/209.10 |- skos__historyNote mesh__D011264 specific trimester %28%1975-1997%29%
% 208.88/209.10 |- skos__broader mesh__D011264smesh__D011247
% 208.88/209.10 |- mesh__recordMaintainer mesh__D011264 sjn
% 208.88/209.10 |- skos__hiddenLabel mesh__D011264 Pregnancy Trimester
% 208.88/209.10 |- skos__prefLabel mesh__D011264 Pregnancy Trimesters
% 208.88/209.10 |- skos__historyNote mesh__D011264 Time Factors %28%1967-1974%29%
% 208.88/209.10 |- mesh__dateRevised mesh__D011264 2004-07-13
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D011264 2006
% 208.88/209.10 |- skos__altLabel mesh__D011264 Trimesters, Pregnancy
% 208.88/209.10 |- mesh__recordOriginator mesh__D011264 NLM
% 208.88/209.10 |- skos__historyNote mesh__D011264 Pregnancy %28%1966-1974%29%
% 208.88/209.10 |- skos__scopeNote mesh__D011264
% 208.88/209.10 The three approximately equal periods of a normal human PREGNANCY. Each trimester is about three months or 13 to 14 weeks in duration depending on the designation of the first day of gestation.%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D005227 2005
% 208.88/209.10 |- mesh__recordMaintainer mesh__D005227 ssb
% 208.88/209.10 |- mesh__historyNote mesh__D005227
% 208.88/209.10 /metabolism was FATTY ACID METABOLISM 1965
% 208.88/209.10 |- skos__hiddenLabel mesh__D005227 Saturated Fatty Acids
% 208.88/209.10 |- skos__hiddenLabel mesh__D005227 Acids, Saturated Fatty
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D005227
% 208.88/209.10 /metabolism was FATTY ACID METABOLISM 1965; SODIUM MORRHUATE was see under SCLEROSING SOLUTIONS 1963-74%A%
% 208.88/209.10 |- skos__hiddenLabel mesh__D005227 Acids, Esterified Fatty
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D005227 2006
% 208.88/209.10 |- skos__broader mesh__D005227smesh__D008055
% 208.88/209.10 |- skos__scopeNote mesh__D005227
% 208.88/209.10 Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated %28%FATTY ACIDS, UNSATURATED%29%. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D005227 2004
% 208.88/209.10 |- skos__prefLabel mesh__D005227 Fatty Acids
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D005227 sjn
% 208.88/209.10 |- skos__hiddenLabel mesh__D005227 Esterified Fatty Acids
% 208.88/209.10 |- mesh__dateRevised mesh__D005227 2003-07-09
% 208.88/209.10 |- mesh__recordOriginator mesh__D005227 NLM
% 208.88/209.10 |- skos__hiddenLabel mesh__D005227 Acids, Fatty
% 208.88/209.10 |- mesh__dateCreated mesh__D005227 1999-01-01
% 208.88/209.10 |- skos__hiddenLabel mesh__D005227 Acids, Aliphatic
% 208.88/209.10 |- rdf__type mesh__D005227sskos__Concept
% 208.88/209.10 |- mesh__historyNote mesh__D015655 90
% 208.88/209.10 |- skos__hiddenLabel mesh__D015655 1 Methyl 4 phenylpyridinium Ion
% 208.88/209.10 |- skos__hiddenLabel mesh__D015655 1 Methyl 4 phenylpyridinium
% 208.88/209.10 |- skos__prefLabel mesh__D015655 1-Methyl-4-phenylpyridinium
% 208.88/209.10 |- mesh__dateRevised mesh__D015655 2001-07-25
% 208.88/209.10 |- rdf__type mesh__D015655sskos__Concept
% 208.88/209.10 |- skos__altLabel mesh__D015655 N-Methyl-4-phenylpyridinium
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015655 2004
% 208.88/209.10 |- mesh__recordOriginator mesh__D015655 RLS
% 208.88/209.10 |- skos__scopeNote mesh__D015655
% 208.88/209.10 An active neurotoxic metabolite of 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE. The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to PARAQUAT, has also been used as an herbicide.%A%
% 208.88/209.10 |- skos__altLabel mesh__D015655 1-Methyl-4-phenylpyridinium Ion
% 208.88/209.10 |- skos__hiddenLabel mesh__D015655 1 Methyl 4 phenylpyridinium Chloride
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015655 2003
% 208.88/209.10 |- skos__hiddenLabel mesh__D015655 1 Methyl 4 phenylpyridine
% 208.88/209.10 |- skos__altLabel mesh__D015655 N-Methyl-4-phenylpyridine
% 208.88/209.10 |- skos__altLabel mesh__D015655 1-Methyl-4-phenylpyridine
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D015655 90
% 208.88/209.10 |- mesh__dateCreated mesh__D015655 1989-05-16
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015655 2006
% 208.88/209.10 |- skos__altLabel mesh__D015655 Cyperquat
% 208.88/209.10 |- skos__broader mesh__D015655smesh__D011726
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015655 2002
% 208.88/209.10 |- mesh__dateEstablished mesh__D015655 1990-01-01
% 208.88/209.10 |- skos__related mesh__D015655smesh__D020267
% 208.88/209.10 |- skos__historyNote mesh__D015655 Pyridinium Compounds %28%1968-1989%29%
% 208.88/209.10 |- skos__hiddenLabel mesh__D015655 N Methyl 4 phenylpyridine
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D015655 sjn
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D015655 2005
% 208.88/209.10 |- mesh__recordMaintainer mesh__D015655 ssb
% 208.88/209.10 |- mesh__recordMaintainer mesh__D048031 jls
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D048031 2005A
% 208.88/209.10 |- skos__altLabel mesh__D048031 c-jun Amino-Terminal Kinase
% 208.88/209.10 |- skos__hiddenLabel mesh__D048031 c jun N Terminal Kinase
% 208.88/209.10 |- skos__scopeNote mesh__D048031
% 208.88/209.10 A subgroup of mitogen-activated protein kinases that activate TRANSCRIPTION FACTOR AP-1 via the phosphorylation of C-JUN PROTEINS. They are components of intracellular signaling pathways that regulate CELL PROLIFERATION; APOPTOSIS; and CELL DIFFERENTIATION.%A%
% 208.88/209.10 |- skos__hiddenLabel mesh__D048031 jun NH2 Terminal Kinases
% 208.88/209.10 |- skos__historyNote mesh__D048031
% 208.88/209.10 Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1995-1999%29%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D048031 2006
% 208.88/209.10 |- rdf__type mesh__D048031sskos__Concept
% 208.88/209.10 |- skos__altLabel mesh__D048031 jun-NH2-Terminal Kinase
% 208.88/209.10 |- skos__annotation mesh__D048031 note specifics
% 208.88/209.10 |- mesh__dateCreated mesh__D048031 2004-07-07
% 208.88/209.10 |- skos__hiddenLabel mesh__D048031 JNK Mitogen Activated Protein Kinases
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D048031 2005
% 208.88/209.10 |- skos__broader mesh__D048031smesh__D020928
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D048031
% 208.88/209.10 2005; JNK MITOGEN-ACTIVATED PROTEIN KINASES was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1995-1999 %26% under PROTEIN-SERINE-THREONINE KINASES 1993-1994%A%
% 208.88/209.10 |- mesh__recordOriginator mesh__D048031 jmp
% 208.88/209.10 |- skos__historyNote mesh__D048031
% 208.88/209.10 Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 208.88/209.10 |- skos__prefLabel mesh__D048031 JNK Mitogen-Activated Protein Kinases
% 208.88/209.10 |- skos__hiddenLabel mesh__D048031 jun NH2 Terminal Kinase
% 208.88/209.10 |- skos__hiddenLabel mesh__D048031 c jun Amino Terminal Kinase
% 208.88/209.10 |- skos__hiddenLabel mesh__D048031 Amino-Terminal Kinase, c-jun
% 208.88/209.10 |- skos__altLabel mesh__D048031 c-jun N-Terminal Kinase
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D048031 jls
% 208.88/209.10 |- mesh__dateEstablished mesh__D048031 2005-01-01
% 208.88/209.10 |- skos__hiddenLabel mesh__D048031 N-Terminal Kinase, c-jun
% 208.88/209.10 |- skos__altLabel mesh__D048031 jun-NH2-Terminal Kinases
% 208.88/209.10 |- mesh__historyNote mesh__D048031 2005
% 208.88/209.10 |- mesh__dateRevised mesh__D048031 2004-07-28
% 208.88/209.10 |- skos__historyNote mesh__D048031
% 208.88/209.10 Protein-Serine-Threonine Kinases %28%1993-1994%29%
% 208.88/209.10 |- mesh__recordOriginator mesh__D009618 JW
% 208.88/209.10 |- mesh__publicMeSHNote mesh__D009618 76
% 208.88/209.10 |- skos__historyNote mesh__D009618 Actinomycetaceae %28%1975%29%
% 208.88/209.10 |- mesh__recordAuthorizer mesh__D009618 sjn
% 208.88/209.10 |- skos__historyNote mesh__D009618 Actinomycetales %28%1966-1974%29%
% 208.88/209.10 |- skos__prefLabel mesh__D009618 Nocardiaceae
% 208.88/209.10 |- skos__annotation mesh__D009618 in soil, animals %26% man
% 208.88/209.10 |- skos__scopeNote mesh__D009618
% 208.88/209.10 A family of gram-positive, aerobic actinomycetes found in soil and animal tissue. Some species are the cause of infection in man and animals.%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D009618 2006
% 208.88/209.10 |- skos__broader mesh__D009618smesh__D000192
% 208.88/209.10 |- rdf__type mesh__D009618sskos__Concept
% 208.88/209.10 |- mesh__dateCreated mesh__D009618 1975-07-18
% 208.88/209.10 |- mesh__dateRevised mesh__D009618 2005-06-30
% 208.88/209.10 |- mesh__recordMaintainer mesh__D009618 SYSTEM
% 208.88/209.10 |- mesh__dateEstablished mesh__D009618 1976-01-01
% 208.88/209.10 |- mesh__historyNote mesh__D009618 76
% 208.88/209.10 |- skos__annotation mesh__D001635
% 208.88/209.10 IM for bibliog of med as a subject; do not use for specific medical subjects: use BIBLIOGRAPHY instead but see note there; no qualif; Manual 33.9; DF: BIBLIOG MED or BIBLIOGR MED%A%
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001635 2006
% 208.88/209.10 |- mesh__activeMeSHYear mesh__D001635 2001
% 208.88/209.11 |- skos__altLabel mesh__D001635 Medicine, Bibliography
% 208.88/209.11 |- rdf__type mesh__D001635sskos__Concept
% 208.88/209.11 |- skos__altLabel mesh__D001635 Bibliographies, Medical
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001635 2003
% 208.88/209.11 |- skos__prefLabel mesh__D001635 Bibliography of Medicine
% 208.88/209.11 |- mesh__dateRevised mesh__D001635 1999-11-03
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001635 2004
% 208.88/209.11 |- mesh__recordMaintainer mesh__D001635 kle
% 208.88/209.11 |- skos__hiddenLabel mesh__D001635 Medicine Bibliography
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001635 2002
% 208.88/209.11 |- skos__hiddenLabel mesh__D001635 Medicine Bibliographies
% 208.88/209.11 |- skos__altLabel mesh__D001635 Medical Bibliographies
% 208.88/209.11 |- mesh__recordOriginator mesh__D001635 NLM
% 208.88/209.11 |- mesh__dateCreated mesh__D001635 1999-01-01
% 208.88/209.11 |- skos__broader mesh__D001635smesh__D001634
% 208.88/209.11 |- skos__altLabel mesh__D001635 Bibliography, Medical
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001635 2005
% 208.88/209.11 |- skos__altLabel mesh__D001635 Medical Bibliography
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001635 2000
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D001635 sjn
% 208.88/209.11 |- skos__altLabel mesh__D001635 Medicine, Bibliographies
% 208.88/209.11 |- skos__scopeNote mesh__D001635
% 208.88/209.11 A list of works, documents, and other publications on medical subjects and topics of interest to the field of medicine.%A%
% 208.88/209.11 |- mesh__recordOriginator mesh__D006320 NLM
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006320 2006
% 208.88/209.11 |- skos__hiddenLabel mesh__D006320 Test, Hearing
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006320 2002
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D006320 SJN
% 208.88/209.11 |- skos__broader mesh__D006320smesh__D003939
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006320 2003
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006320 2004
% 208.88/209.11 |- skos__prefLabel mesh__D006320 Hearing Tests
% 208.88/209.11 |- mesh__dateCreated mesh__D006320 1999-01-01
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006320 2000
% 208.88/209.11 |- skos__annotation mesh__D006320 NIM
% 208.88/209.11 |- mesh__dateRevised mesh__D006320 1997-06-20
% 208.88/209.11 |- rdf__type mesh__D006320sskos__Concept
% 208.88/209.11 |- skos__hiddenLabel mesh__D006320 Hearing Test
% 208.88/209.11 |- mesh__recordMaintainer mesh__D006320 PXP
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006320 1998
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006320 2001
% 208.88/209.11 |- skos__hiddenLabel mesh__D006320 Tests, Hearing
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006320 1999
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006320 2005
% 208.88/209.11 |- skos__broader mesh__D006281Q000364smesh__D006281
% 208.88/209.11 |- mesh__preferredCombination mesh__D006281Q000364smesh__D006280
% 208.88/209.11 |- rdf__type mesh__D006281Q000364smesh__CompoundConcept
% 208.88/209.11 |- mesh__publicMeSHNote mesh__D019248 97
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Technic, Jaw Fixation
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Technique, Jaw Fixation
% 208.88/209.11 |- skos__scopeNote mesh__D019248
% 208.88/209.11 The stable placement of surgically induced fractures of the mandible or maxilla through the use of elastics, wire ligatures, arch bars, or other splints. It is used often in the cosmetic surgery of retrognathism and prognathism. %28%From Dorland, 28th ed, p636%29%%A%
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Fixation Technics, Jaw
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D019248 2006
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D019248 SJN
% 208.88/209.11 |- mesh__dateEstablished mesh__D019248 1997-01-01
% 208.88/209.11 |- rdf__type mesh__D019248sskos__Concept
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Fixation Techniques, Jaw
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Jaw Fixation Technique
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D019248 2005
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D019248 1999
% 208.88/209.11 |- mesh__dateCreated mesh__D019248 1996-06-10
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D019248 2002
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Maxillomandibular Fixations
% 208.88/209.11 |- skos__altLabel mesh__D019248 Jaw Fixation Technics
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Jaw Fixation Technic
% 208.88/209.11 |- mesh__recordOriginator mesh__D019248 TGC
% 208.88/209.11 |- mesh__historyNote mesh__D019248 97
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D019248 1998
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Technics, Jaw Fixation
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D019248 2004
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D019248 2001
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Fixation Technic, Jaw
% 208.88/209.11 |- mesh__dateRevised mesh__D019248 1997-06-20
% 208.88/209.11 |- skos__broader mesh__D019248smesh__D019647
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Fixation Technique, Jaw
% 208.88/209.11 |- mesh__recordMaintainer mesh__D019248 PXP
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D019248 2003
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Fixation, Maxillomandibular
% 208.88/209.11 |- skos__annotation mesh__D019248
% 208.88/209.11 coord IM with MANDIBLE /surg or MAXILLA /surg %28%IM%29%; MANDIBULAR ADVANCEMENT is also available%A%
% 208.88/209.11 |- skos__prefLabel mesh__D019248 Jaw Fixation Techniques
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Techniques, Jaw Fixation
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D019248 2000
% 208.88/209.11 |- skos__hiddenLabel mesh__D019248 Fixations, Maxillomandibular
% 208.88/209.11 |- mesh__recordOriginator mesh__D005228 NLM
% 208.88/209.11 |- skos__annotation mesh__D005228
% 208.88/209.11 GEN or unspecified; prefer specific groups or specific acid%A%
% 208.88/209.11 |- rdf__type mesh__D005228sskos__Concept
% 208.88/209.11 |- mesh__dateRevised mesh__D005228 2003-07-09
% 208.88/209.11 |- skos__hiddenLabel mesh__D005228 Essential Fatty Acids
% 208.88/209.11 |- skos__broader mesh__D005228smesh__D005231
% 208.88/209.11 |- skos__hiddenLabel mesh__D005228 Acids, Essential Fatty
% 208.88/209.11 |- mesh__recordMaintainer mesh__D005228 ssb
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D005228 2004
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D005228 2006
% 208.88/209.11 |- skos__prefLabel mesh__D005228 Fatty Acids, Essential
% 208.88/209.11 |- mesh__dateCreated mesh__D005228 1999-01-01
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D005228 2005
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D005228 sjn
% 208.88/209.11 |- skos__scopeNote mesh__D005228
% 208.88/209.11 Long chain organic acid molecules that must be obtained from the diet. Examples are LINOLEIC ACIDS and LINOLENIC ACIDS.%A%
% 208.88/209.11 |- rdf__type mesh__D015656sskos__Concept
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D015656 2004
% 208.88/209.11 |- skos__related mesh__D015656smesh__D008170
% 208.88/209.11 |- mesh__recordMaintainer mesh__D015656 jls
% 208.88/209.11 |- skos__related mesh__D015656smesh__D000403
% 208.88/209.11 |- skos__hiddenLabel mesh__D015656 Breathing Mechanic
% 208.88/209.11 |- skos__hiddenLabel mesh__D015656 Mechanic, Respiratory
% 208.88/209.11 |- mesh__dateRevised mesh__D015656 2004-08-02
% 208.88/209.11 |- mesh__historyNote mesh__D015656 90
% 208.88/209.11 |- skos__hiddenLabel mesh__D015656 Respiratory Mechanic
% 208.88/209.11 |- skos__broader mesh__D015656smesh__D012119
% 208.88/209.11 |- skos__prefLabel mesh__D015656 Respiratory Mechanics
% 208.88/209.11 |- mesh__publicMeSHNote mesh__D015656 90
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D015656 2006
% 208.88/209.11 |- skos__historyNote mesh__D015656 Respiration %28%1966-1989%29%
% 208.88/209.11 |- mesh__dateEstablished mesh__D015656 1990-01-01
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D015656 jls
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D015656 2005
% 208.88/209.11 |- skos__scopeNote mesh__D015656
% 208.88/209.11 The physical or mechanical action of the LUNGS; DIAPHRAGM; RIBS; and CHEST WALL during respiration. It includes airflow, lung volume, neural and reflex controls, mechanoreceptors, breathing patterns, etc.%A%
% 208.88/209.11 |- skos__hiddenLabel mesh__D015656 Mechanics, Breathing
% 208.88/209.11 |- mesh__dateCreated mesh__D015656 1989-05-16
% 208.88/209.11 |- skos__hiddenLabel mesh__D015656 Mechanic, Breathing
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D015656 2005A
% 208.88/209.11 |- skos__hiddenLabel mesh__D015656 Mechanics, Respiratory
% 208.88/209.11 |- skos__altLabel mesh__D015656 Breathing Mechanics
% 208.88/209.11 |- mesh__recordOriginator mesh__D015656 TGC
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 2000
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 2003
% 208.88/209.11 |- skos__annotation mesh__D009619
% 208.88/209.11 sensory receptors for pain; DF: NOCICEPT
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 1994
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 2006
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 2001
% 208.88/209.11 |- skos__scopeNote mesh__D009619
% 208.88/209.11 Peripheral receptors for pain. Nociceptors include receptors which are sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli. All nociceptors are free nerve endings.%A%
% 208.88/209.11 |- skos__historyNote mesh__D009619 Pain %28%1966-1977%29%
% 208.88/209.11 |- skos__historyNote mesh__D009619 Neurons, Afferent %28%1969-1977%29%
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 1998
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 2004
% 208.88/209.11 |- mesh__recordOriginator mesh__D009619 RC
% 208.88/209.11 |- rdf__type mesh__D009619sskos__Concept
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 1995
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 1996
% 208.88/209.11 |- skos__hiddenLabel mesh__D009619 Pain Receptor
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 2002
% 208.88/209.11 |- skos__broader mesh__D009619smesh__D011984
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 1999
% 208.88/209.11 |- skos__altLabel mesh__D009619 Receptors, Pain
% 208.88/209.11 |- skos__prefLabel mesh__D009619 Nociceptors
% 208.88/209.11 |- skos__altLabel mesh__D009619 Pain Receptors
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 1997
% 208.88/209.11 |- mesh__dateCreated mesh__D009619 1977-04-11
% 208.88/209.11 |- mesh__dateRevised mesh__D009619 1993-06-18
% 208.88/209.11 |- mesh__recordMaintainer mesh__D009619 RAZ
% 208.88/209.11 |- mesh__historyNote mesh__D009619 78
% 208.88/209.11 |- mesh__dateEstablished mesh__D009619 1978-01-01
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D009619 PLS
% 208.88/209.11 |- skos__hiddenLabel mesh__D009619 Receptor, Pain
% 208.88/209.11 |- mesh__publicMeSHNote mesh__D009619 78
% 208.88/209.11 |- skos__hiddenLabel mesh__D009619 Nociceptor
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D009619 2005
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 2000
% 208.88/209.11 |- skos__altLabel mesh__D001636 Descriptive Bibliographies
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 2004
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 1997
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 2001
% 208.88/209.11 |- mesh__dateCreated mesh__D001636 1999-01-01
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D001636 PLS
% 208.88/209.11 |- skos__altLabel mesh__D001636 Bibliographies, Descriptive
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 2005
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 1998
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 2002
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 1995
% 208.88/209.11 |- mesh__historyNote mesh__D001636 INSCRIPTIONS was heading 1963-65
% 208.88/209.11 |- mesh__publicMeSHNote mesh__D001636 INSCRIPTIONS was heading 1963-65
% 208.88/209.11 |- skos__scopeNote mesh__D001636
% 208.88/209.11 The area of bibliography which makes known precisely the material conditions of books, i.e., the full name of the author, the exact title of the work, the date and place of publication, the publisher%27%s and printer%27%s names, the format, the pagination, typographical particulars, illustrations, and the price, and for old books, other characteristics such as the kind of paper, binding, etc. It is also called analytical bibliography and physical bibliography. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A%
% 208.88/209.11 |- skos__prefLabel mesh__D001636 Bibliography, Descriptive
% 208.88/209.11 |- mesh__dateRevised mesh__D001636 1994-05-31
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 2006
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 1999
% 208.88/209.11 |- skos__altLabel mesh__D001636 Descriptive Bibliography
% 208.88/209.11 |- mesh__recordOriginator mesh__D001636 NLM
% 208.88/209.11 |- mesh__recordMaintainer mesh__D001636 TGC
% 208.88/209.11 |- skos__broader mesh__D001636smesh__D001634
% 208.88/209.11 |- rdf__type mesh__D001636sskos__Concept
% 208.88/209.11 |- skos__annotation mesh__D001636
% 208.88/209.11 cataloging term; no qualif; DF: BIBLIOG DESCRIPTIVE or BIBLIOGR DESCRIPTIVE%A%
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 2003
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001636 1996
% 208.88/209.11 |- rdf__type mesh__D006321sskos__Concept
% 208.88/209.11 |- skos__related mesh__D006321smesh__D000790
% 208.88/209.11 |- skos__related mesh__D006321smesh__D000889
% 208.88/209.11 |- mesh__dateRevised mesh__D006321 2000-06-22
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006321 2006
% 208.88/209.11 |- skos__scopeNote mesh__D006321
% 208.88/209.11 The hollow, muscular organ that maintains the circulation of the blood.%A%
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006321 2001
% 208.88/209.11 |- mesh__considerAlso mesh__D006321
% 208.88/209.11 consider also terms at CARDI- and MYOCARDI-
% 208.88/209.11 |- skos__related mesh__D006321smesh__D002316
% 208.88/209.11 |- mesh__recordOriginator mesh__D006321 NLM
% 208.88/209.11 |- skos__related mesh__D006321smesh__D004562
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006321 2005
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006321 2004
% 208.88/209.11 |- skos__prefLabel mesh__D006321 Heart
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006321 2003
% 208.88/209.11 |- skos__related mesh__D006321smesh__D001450
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D006321 sjn
% 208.88/209.11 |- mesh__recordMaintainer mesh__D006321 nns
% 208.88/209.11 |- skos__broader mesh__D006321smesh__D002319
% 208.88/209.11 |- skos__annotation mesh__D006321
% 208.88/209.11 heart as pump, not tissue %28%MYOCARDIUM%29%; qualif permitted: /anat /drug eff /embryol %28%FETAL HEART also exists%29% /growth /innerv %28%HEART CONDUCTION SYSTEM also exists%29% /microbiol /parasitol /physiol %28%see also ATRIAL FUNCTION %26% VENTRICULAR FUNCTION %26% their specifics; see also MYOCARDIAL CONTRACTION %26% its specifics%29% /physiopathol /rad eff /radiogr %28%do not confuse with ANGIOCARDIOGRAPHY%29% /radionuclide /virol; /blood supply = CORONARY VESSELS but consider also CORONARY CIRCULATION; /drug eff: consider also MYOCARDIAL DEPRESSANTS see ANTI-ARRHYTHMIA AGENTS %26% CARDIOTONIC AGENTS; /transpl = HEART TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; /ultrasonogr = ECHOCARDIOGRAPHY or ECHOCARDIOGRAPHY, DOPPLER; inotropism: INOTROPISM, CARDIAC see MYOCARDIAL CONTRACTION %26% INOTROPIC AGENTS, POSITIVE CARDIAC are available but see MYOCARDIAL CONTRACTION note; chronotropism: see HEART RATE note; DIASTOLE %26% SYSTOLE are also available; heart-lung prep: index HEART /physiol %28%probably NIM%29%; Manual 21.48+; carditis = MYOCARDITIS; mural thrombosis: index HEART DIS %28%IM%29% + THROMBOSIS %28%IM%29%%A%
% 208.88/209.11 |- skos__related mesh__D006321smesh__D009206
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006321 2002
% 208.88/209.11 |- mesh__dateCreated mesh__D006321 1999-01-01
% 208.88/209.11 |- skos__altLabel mesh__D006321 Hearts
% 208.88/209.11 |- skos__altLabel mesh__D011266
% 208.88/209.11 Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease
% 208.88/209.11 |- skos__historyNote mesh__D011266 Glycoproteins %28%1966-1979%29%
% 208.88/209.11 |- skos__hiddenLabel mesh__D011266
% 208.88/209.11 Insulin Like Growth Factor Dependent IGF Binding Protein 4 Protease
% 208.88/209.11 |- skos__historyNote mesh__D011266 Alpha Macroglobulins %28%1976-1979%29%
% 208.88/209.11 |- skos__broader mesh__D011266smesh__D008666
% 208.88/209.11 |- skos__altLabel mesh__D011266
% 208.88/209.11 Insulin-Like-Growth Factor Binding Protein-4 Protease
% 208.88/209.11 |- mesh__publicMeSHNote mesh__D011266
% 208.88/209.11 2004; for PREGNANCY-ASSOCIATED ALPHA-PLASMA PROTEIN see PREGNANCY-ASSOCIATED ALPHA-PLASMA PROTEIN 1991-2003, see PREGNANCY PROTEINS 1980-1990%A%
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D011266 2006
% 208.88/209.11 |- skos__scopeNote mesh__D011266
% 208.88/209.11 A product of the PLACENTA, and DECIDUA, secreted into the maternal circulation during PREGNANCY. It has been identified as an IGF binding protein %28%IGFBP%29%-4 protease that proteolyzes IGFBP-4 and thus increases IGF bioavailability. It is found also in human FIBROBLASTS, ovarian FOLLICULAR FLUID, and GRANULOSA CELLS. The enzyme is a heterotetramer of about 500-kDa.%A%
% 208.88/209.11 |- skos__altLabel mesh__D011266 PAPP-alpha
% 208.88/209.11 |- mesh__historyNote mesh__D011266 2004 %28%1996%29%
% 208.88/209.11 |- skos__hiddenLabel mesh__D011266
% 208.88/209.11 Insulin Like Growth Factor Binding Protein 4 Protease
% 208.88/209.11 |- skos__broader mesh__D011266smesh__D011257
% 208.88/209.11 |- skos__prefLabel mesh__D011266 Pregnancy-Associated Plasma Protein-A
% 208.88/209.11 |- mesh__dateEstablished mesh__D011266 1991-01-01
% 208.88/209.11 |- skos__altLabel mesh__D011266 PAPP-A
% 208.88/209.11 |- mesh__dateRevised mesh__D011266 2004-07-13
% 208.88/209.11 |- skos__historyNote mesh__D011266 Pregnancy %28%1966-1979%29%
% 208.88/209.11 |- mesh__dateCreated mesh__D011266 1979-02-22
% 208.88/209.11 |- skos__historyNote mesh__D011266 Blood Proteins %28%1966-1979%29%
% 208.88/209.11 |- skos__altLabel mesh__D011266 Pregnancy-Associated alpha-Plasma Protein
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D011266 2005
% 208.88/209.11 |- mesh__recordOriginator mesh__D011266 RLS
% 208.88/209.11 |- skos__altLabel mesh__D011266 IGFBP-4-Specific Proteinase
% 208.88/209.11 |- skos__hiddenLabel mesh__D011266 Metalloproteinase, IGFBP-4
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D011266 sjn
% 208.88/209.11 |- rdf__type mesh__D011266sskos__Concept
% 208.88/209.11 |- skos__altLabel mesh__D011266 IGFBP-4 Metalloproteinase
% 208.88/209.11 |- skos__hiddenLabel mesh__D011266 PAPP alpha
% 208.88/209.11 |- skos__hiddenLabel mesh__D011266 IGFBP 4 Protease
% 208.88/209.11 |- skos__hiddenLabel mesh__D011266 Protease, IGFBP-4
% 208.88/209.11 |- skos__hiddenLabel mesh__D011266 IGFBP 4 Metalloproteinase
% 208.88/209.11 |- skos__altLabel mesh__D011266 IGFBP-4 Protease
% 208.88/209.11 |- mesh__recordMaintainer mesh__D011266 sjn
% 208.88/209.11 |- skos__hiddenLabel mesh__D011266 Pregnancy Associated Plasma Protein A
% 208.88/209.11 |- skos__historyNote mesh__D011266 Alpha Globulins %28%1966-1979%29%
% 208.88/209.11 |- skos__altLabel mesh__D011266 Pregnancy Associated alpha Plasma Protein
% 208.88/209.11 |- rdf__type mesh__D005229sskos__Concept
% 208.88/209.11 |- skos__historyNote mesh__D005229 Fatty Acids %28%1966-1972%29%
% 208.88/209.11 |- mesh__historyNote mesh__D005229
% 208.88/209.11 88; MONOUNSATURATED FATTY ACIDS was see FATTY ACIDS, MONOUNSATURATED 1988-93%A%
% 208.88/209.11 |- mesh__dateCreated mesh__D005229 1987-03-31
% 208.88/209.11 |- mesh__recordMaintainer mesh__D005229 ssb
% 208.88/209.11 |- skos__hiddenLabel mesh__D005229 Acids, Monounsaturated Fatty
% 208.88/209.11 |- skos__hiddenLabel mesh__D005229 Monounsaturated Fatty Acids
% 208.88/209.11 |- skos__broader mesh__D005229smesh__D005231
% 208.88/209.11 |- mesh__dateRevised mesh__D005229 2003-07-09
% 208.88/209.11 |- mesh__publicMeSHNote mesh__D005229
% 208.88/209.11 88; MONOUNSATURATED FATTY ACIDS was see FATTY ACIDS, MONOUNSATURATED 1988-93%A%
% 208.88/209.11 |- skos__scopeNote mesh__D005229
% 208.88/209.11 Fatty acids which are unsaturated in only one position.%A%
% 208.88/209.11 |- skos__prefLabel mesh__D005229 Fatty Acids, Monounsaturated
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D005229 2004
% 208.88/209.11 |- mesh__onlineNote mesh__D005229
% 208.88/209.11 use FATTY ACIDS, MONOUNSATURATED to search MONOUNSATURATED FATTY ACIDS 1988-93%A%
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D005229 2006
% 208.88/209.11 |- mesh__recordOriginator mesh__D005229 RLS
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D005229 sjn
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D005229 2005
% 208.88/209.11 |- mesh__dateEstablished mesh__D005229 1988-01-01
% 208.88/209.11 |- skos__historyNote mesh__D005229
% 208.88/209.11 Fatty Acids, Unsaturated %28%1973-1987%29%
% 208.88/209.11 |- mesh__historyNote mesh__D015657 90
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D015657 2004
% 208.88/209.11 |- mesh__publicMeSHNote mesh__D015657 90
% 208.88/209.11 |- skos__hiddenLabel mesh__D015657 Transport, Respiratory
% 208.88/209.11 |- skos__prefLabel mesh__D015657 Respiratory Transport
% 208.88/209.11 |- skos__broader mesh__D015657smesh__D001692
% 208.88/209.11 |- skos__historyNote mesh__D015657 Respiration %28%1966-1989%29%
% 208.88/209.11 |- mesh__dateEstablished mesh__D015657 1990-01-01
% 208.88/209.11 |- skos__hiddenLabel mesh__D015657 Respiratory Transports
% 208.88/209.11 |- skos__hiddenLabel mesh__D015657 Transports, Respiratory
% 208.88/209.11 |- skos__broader mesh__D015657smesh__D012119
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D015657 2006
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D015657 2005
% 208.88/209.11 |- mesh__recordMaintainer mesh__D015657 nns
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D015657 sjn
% 208.88/209.11 |- mesh__recordOriginator mesh__D015657 TGC
% 208.88/209.11 |- skos__scopeNote mesh__D015657
% 208.88/209.11 The processes of diffusion across the BLOOD-AIR BARRIER, and the chemical reactions coupled with diffusion that effect the rate of PULMONARY GAS EXCHANGE, generally at the alveolar level.%A%
% 208.88/209.11 |- mesh__dateCreated mesh__D015657 1989-05-16
% 208.88/209.11 |- rdf__type mesh__D015657sskos__Concept
% 208.88/209.11 |- mesh__dateRevised mesh__D015657 2003-07-09
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001637 2006
% 208.88/209.11 |- mesh__dateRevised mesh__D001637 2004-07-19
% 208.88/209.11 |- rdf__type mesh__D001637sskos__Concept
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D001637 2005
% 208.88/209.11 |- mesh__recordMaintainer mesh__D001637 jls
% 208.88/209.11 |- mesh__recordOriginator mesh__D001637 NLM
% 208.88/209.11 |- skos__altLabel mesh__D001637 National Bibliographies
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D001637 sjn
% 208.88/209.11 |- skos__scopeNote mesh__D001637
% 208.88/209.11 A bibliography which lists all the books and other publications published, or distributed in significant quantity, in a particular country. Sometimes the term is used with respect to the new publications published within a specific period, and sometimes with respect to all those published within a lengthy period of many years. It is also used to indicate a bibliography of publications about a country %28%whether written by its nationals or not%29% and those written in the language of the country as well as those published in it. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A%
% 208.88/209.11 |- skos__annotation mesh__D001637
% 208.88/209.11 cataloging term: no qualif; DF: BIBLIOG NATIONAL or BIBLIOGR NATIONAL%A%
% 208.88/209.11 |- skos__prefLabel mesh__D001637 Bibliography, National
% 208.88/209.11 |- skos__altLabel mesh__D001637 National Bibliography
% 208.88/209.11 |- skos__altLabel mesh__D001637 Bibliographies, National
% 208.88/209.11 |- skos__broader mesh__D001637smesh__D001634
% 208.88/209.11 |- mesh__dateCreated mesh__D001637 1999-01-01
% 208.88/209.11 |- skos__hiddenLabel mesh__D006322 Heart Aneurysms
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006322 1998
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006322 2006
% 208.88/209.11 |- skos__hiddenLabel mesh__D006322 Cardiac Aneurysms
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006322 2002
% 208.88/209.11 |- mesh__recordMaintainer mesh__D006322 TGC
% 208.88/209.11 |- skos__hiddenLabel mesh__D006322 Aneurysm, Cardiac
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006322 2005
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006322 2004
% 208.88/209.11 |- skos__altLabel mesh__D006322 Cardiac Aneurysm
% 208.88/209.11 |- skos__broader mesh__D006322smesh__D006331
% 208.88/209.11 |- skos__scopeNote mesh__D006322
% 208.88/209.11 An aneurysmal dilatation of a portion of the wall of the ventricle, usually the left, or, rarely, a saccular protrusion through it %28%false aneurysm of the heart%29%. It is usually consequent to myocardial infarction but other causes such as bacterial endocarditis or trauma have been described. %28%Dorland, 28th ed%29%%A%
% 208.88/209.11 |- skos__hiddenLabel mesh__D006322 Aneurysm, Heart
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006322 2003
% 208.88/209.11 |- skos__annotation mesh__D006322
% 208.88/209.11 of myocardium only: not for CORONARY ANEURYSM
% 208.88/209.11 |- skos__related mesh__D006322smesh__D003323
% 208.88/209.11 |- mesh__recordAuthorizer mesh__D006322 SJN
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006322 2001
% 208.88/209.11 |- mesh__recordOriginator mesh__D006322 NLM
% 208.88/209.11 |- mesh__dateCreated mesh__D006322 1999-01-01
% 208.88/209.11 |- skos__prefLabel mesh__D006322 Heart Aneurysm
% 208.88/209.11 |- rdf__type mesh__D006322sskos__Concept
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006322 2000
% 208.88/209.11 |- skos__broader mesh__D006322smesh__D000783
% 208.88/209.11 |- skos__hiddenLabel mesh__D006322 Aneurysms, Heart
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D006322 1999
% 208.88/209.11 |- mesh__dateRevised mesh__D006322 1997-06-20
% 208.88/209.11 |- skos__hiddenLabel mesh__D006322 Aneurysms, Cardiac
% 208.88/209.11 |- mesh__dateCreated mesh__D016750 1991-04-29
% 208.88/209.11 |- mesh__dateRevised mesh__D016750 2002-07-03
% 208.88/209.11 |- skos__altLabel mesh__D016750 Stiffman Syndrome
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D016750 2004
% 208.88/209.11 |- mesh__recordOriginator mesh__D016750 AGS
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D016750 2006
% 208.88/209.11 |- skos__hiddenLabel mesh__D016750 Stiff Man Syndrome
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D016750 2003
% 208.88/209.11 |- mesh__recordMaintainer mesh__D016750 mdb
% 208.88/209.11 |- skos__prefLabel mesh__D016750 Stiff-Person Syndrome
% 208.88/209.11 |- skos__historyNote mesh__D016750 Autoimmune Diseases %28%1988-1991%29%
% 208.88/209.11 |- skos__broader mesh__D016750smesh__D020274
% 208.88/209.11 |- mesh__historyNote mesh__D016750 2000%28%1992%29%
% 208.88/209.11 |- mesh__activeMeSHYear mesh__D016750 2005
% 208.97/209.11 |- skos__hiddenLabel mesh__D016750 Syndrome, Moersch-Woltmann
% 208.97/209.11 |- skos__altLabel mesh__D016750 Moersch-Woltmann Syndrome
% 208.97/209.11 |- skos__hiddenLabel mesh__D016750 Moersch Woltmann Syndrome
% 208.97/209.11 |- skos__historyNote mesh__D016750 Neuromuscular Diseases %28%1972-1991%29%
% 208.97/209.11 |- skos__hiddenLabel mesh__D016750 Syndrome, Stiff-Person
% 208.97/209.11 |- skos__broader mesh__D016750smesh__D013118
% 208.97/209.11 |- mesh__publicMeSHNote mesh__D016750
% 208.97/209.11 2000; see STIFF-MAN SYNDROME 1992-1999
% 208.97/209.11 |- skos__historyNote mesh__D016750 Fibromyalgia %28%1966-1976%29%
% 208.97/209.11 |- rdf__type mesh__D016750sskos__Concept
% 208.97/209.11 |- skos__historyNote mesh__D016750 Muscular Diseases %28%1966-1982%29%
% 208.97/209.11 |- skos__hiddenLabel mesh__D016750 Syndrome, Stiffman
% 208.97/209.11 |- mesh__dateEstablished mesh__D016750 1992-01-01
% 208.97/209.11 |- mesh__recordAuthorizer mesh__D016750 sjn
% 208.97/209.11 |- skos__broader mesh__D016750smesh__D009468
% 208.97/209.11 |- skos__altLabel mesh__D016750 Stiff-Man Syndrome
% 208.97/209.11 |- skos__historyNote mesh__D016750
% 208.97/209.11 Central Nervous System Diseases %28%1986-1991%29%
% 208.97/209.11 |- skos__hiddenLabel mesh__D016750 Stiff Person Syndrome
% 208.97/209.11 |- skos__scopeNote mesh__D016750
% 208.97/209.11 A condition characterized by persistent spasms %28%SPASM%29% involving multiple muscles, primarily in the lower limbs and trunk. The illness tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that become continuous. Minor sensory stimuli, such as noise and light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. Respiration may become impaired in advanced cases. %28%Adams et al., Principles of Neurology, 6th ed, p1492; Neurology 1998 Jul;51%28%1%29%:85-93%29%%A%
% 208.97/209.11 |- skos__hiddenLabel mesh__D016750 Syndrome, Stiff-Man
% 208.97/209.11 |- mesh__dateCreated mesh__D030421 2001-07-25
% 208.97/209.11 |- mesh__activeMeSHYear mesh__D030421 2005
% 208.97/209.11 |- skos__historyNote mesh__D030421 Nitrates %28%1990-2001%29%
% 208.97/209.11 |- mesh__dateEstablished mesh__D030421 2002-01-01
% 208.97/209.11 |- skos__altLabel mesh__D030421 Peroxonitrite
% 208.97/209.11 |- rdf__type mesh__D030421sskos__Concept
% 208.97/209.11 |- mesh__publicMeSHNote mesh__D030421
% 208.97/209.11 2002; PEROXYNITRITE was indexed under NITRATES 1990-2001
% 208.97/209.11 |- skos__hiddenLabel mesh__D030421 Peroxonitrites
% 208.97/209.11 |- mesh__activeMeSHYear mesh__D030421 2002
% 208.97/209.11 |- skos__hiddenLabel mesh__D030421 Acids, Peroxynitrous
% 208.97/209.11 |- mesh__historyNote mesh__D030421
% 208.97/209.11 2002; for PEROXYNITRITE use PEROXYNITROUS ACID %28%NM%29% 1990-2001%A%
% 208.97/209.11 |- skos__prefLabel mesh__D030421 Peroxynitrous Acid
% 208.97/209.11 |- skos__scopeNote mesh__D030421
% 208.97/209.11 A potent oxidant synthesized by the cell during its normal metabolism. Peroxynitrite is formed from the reaction of two free radicals, NITRIC OXIDE and the superoxide anion %28%SUPEROXIDES%29%.%A%
% 208.97/209.11 |- mesh__activeMeSHYear mesh__D030421 2004
% 208.97/209.11 |- skos__hiddenLabel mesh__D030421 Acid, Peroxynitrous
% 208.97/209.11 |- skos__broader mesh__D030421smesh__D026361
% 208.97/209.11 |- skos__hiddenLabel mesh__D030421 Peroxynitrites
% 208.97/209.11 |- skos__broader mesh__D030421smesh__D009608
% 208.97/209.11 |- skos__hiddenLabel mesh__D030421 Peroxynitrous Acids
% 208.97/209.11 |- mesh__activeMeSHYear mesh__D030421 2003
% 208.97/209.11 |- mesh__activeMeSHYear mesh__D030421 2006
% 208.97/209.11 |- skos__scopeNote mesh__D002730
% 208.97/209.11 Mercuriphenols substituted with one or more chlorine atoms and one or more nitro groups. Some of these are sulfhydryl reagents which act as chromophoric probes in enzymes and other proteins.%A%
% 208.97/209.11 |- mesh__activeMeSHYear mesh__D002730 2003
% 208.97/209.11 |- mesh__recordAuthorizer mesh__D002730 sjn
% 208.97/209.11 |- mesh__recordMaintainer mesh__D002730 CCR
% 208.97/209.11 |- skos__historyNote mesh__D002730 Mercury %28%1968-1976%29%
% 208.97/209.11 |- mesh__dateEstablished mesh__D002730 1991-01-01
% 208.97/209.11 |- mesh__recordOriginator mesh__D002730 RLS
% 208.97/209.11 |- skos__broader mesh__D002730smesh__D010663
% 208.97/209.11 |- mesh__publicMeSHNote mesh__D002730
% 208.97/209.11 91; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79%A%
% 208.97/209.12 |- mesh__historyNote mesh__D002730
% 208.97/209.12 91%28%77%29%; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79%A%
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002730 2006
% 208.97/209.12 |- mesh__dateRevised mesh__D002730 2000-06-22
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002730 2005
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002730 2002
% 208.97/209.12 |- skos__historyNote mesh__D002730 Nitrophenols %28%1968-1976%29%
% 208.97/209.12 |- mesh__dateCreated mesh__D002730 1976-04-19
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002730 2004
% 208.97/209.12 |- skos__prefLabel mesh__D002730 Chloromercurinitrophenols
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002730 2001
% 208.97/209.12 |- skos__historyNote mesh__D002730
% 208.97/209.12 Organometallic Compounds %28%1968-1976%29%
% 208.97/209.12 |- rdf__type mesh__D002730sskos__Concept
% 208.97/209.12 |- mesh__dateCreated mesh__D015658 1989-05-25
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D015658
% 208.97/209.12 90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION %26% HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89%A%
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 HIV Infection
% 208.97/209.12 |- mesh__dateEstablished mesh__D015658 1990-01-01
% 208.97/209.12 |- mesh__onlineNote mesh__D015658
% 208.97/209.12 use ACQUIRED IMMUNODEFICIENCY SYNDROME to search HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION 1989; HIV INFECTION 1988-89; HTLV-III INFECTION %26% HTLV-III LAV INFECTION 1987-89%A%
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658
% 208.97/209.12 T Lymphotropic Virus Type III Infections, Human
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D015658 2006
% 208.97/209.12 |- skos__prefLabel mesh__D015658 HIV Infections
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D015658 sjn
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D015658 2005
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 Infections, HTLV-III
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 Infection, HTLV-III
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 HTLV-III Infection
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 Infections, HTLV-III-LAV
% 208.97/209.12 |- skos__altLabel mesh__D015658
% 208.97/209.12 T-Lymphotropic Virus Type III Infections, Human
% 208.97/209.12 |- skos__historyNote mesh__D015658
% 208.97/209.12 Acquired Immunodeficiency Syndrome %28%1983-1989%29%
% 208.97/209.12 |- skos__annotation mesh__D015658
% 208.97/209.12 caused by a lentivirus; GEN or unspecified; coord IM with HIV-1 %28%IM%29% or HIV-2 %28%IM%29%; note specific indentions under HIV INFECTIONS; DF: HIV INFECT%A%
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 HTLV III LAV Infections
% 208.97/209.12 |- skos__broader mesh__D015658smesh__D016180
% 208.97/209.12 |- rdf__type mesh__D015658sskos__Concept
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 HTLV-III-LAV Infection
% 208.97/209.12 |- skos__broader mesh__D015658smesh__D007153
% 208.97/209.12 |- mesh__historyNote mesh__D015658
% 208.97/209.12 90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION %26% HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89%A%
% 208.97/209.12 |- skos__historyNote mesh__D015658 HIV Seropositivity %28%1988-1989%29%
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 Infections, HIV
% 208.97/209.12 |- mesh__recordOriginator mesh__D015658 AGS
% 208.97/209.12 |- skos__related mesh__D015658smesh__D016483
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 HTLV III Infections
% 208.97/209.12 |- skos__altLabel mesh__D015658 HTLV-III-LAV Infections
% 208.97/209.12 |- skos__altLabel mesh__D015658 HTLV-III Infections
% 208.97/209.12 |- skos__broader mesh__D015658smesh__D015229
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 Infection, HIV
% 208.97/209.12 |- mesh__dateRevised mesh__D015658 2004-07-13
% 208.97/209.12 |- skos__hiddenLabel mesh__D015658 Infection, HTLV-III-LAV
% 208.97/209.12 |- skos__scopeNote mesh__D015658
% 208.97/209.12 Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex %28%ARC%29%, to acquired immunodeficiency syndrome %28%AIDS%29%.%A%
% 208.97/209.12 |- mesh__recordMaintainer mesh__D015658 sjn
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 2005
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 1998
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 2001
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 2003
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 1996
% 208.97/209.12 |- skos__annotation mesh__D001638 a psychother technique; DF: BIBLIOTHER
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 2000
% 208.97/209.12 |- skos__broader mesh__D001638smesh__D012046
% 208.97/209.12 |- mesh__dateRevised mesh__D001638 1995-05-31
% 208.97/209.12 |- skos__scopeNote mesh__D001638
% 208.97/209.12 A form of supportive psychotherapy in which the patient is given carefully selected material to read.%A%
% 208.97/209.12 |- mesh__recordOriginator mesh__D001638 NLM
% 208.97/209.12 |- mesh__recordMaintainer mesh__D001638 TGC
% 208.97/209.12 |- skos__hiddenLabel mesh__D001638 Bibliotherapies
% 208.97/209.12 |- skos__broader mesh__D001638smesh__D011613
% 208.97/209.12 |- mesh__dateCreated mesh__D001638 1999-01-01
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 2002
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D001638 PLS
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 2006
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 1999
% 208.97/209.12 |- skos__prefLabel mesh__D001638 Bibliotherapy
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 2004
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001638 1997
% 208.97/209.12 |- rdf__type mesh__D001638sskos__Concept
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D012360
% 208.97/209.12 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.12 |- skos__altLabel mesh__D012360 Phenylalanine-Specific tRNA
% 208.97/209.12 |- skos__historyNote mesh__D012360 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.12 |- skos__scopeNote mesh__D012360
% 208.97/209.12 A transfer RNA which is specific for carrying phenylalanine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.97/209.12 |- skos__broader mesh__D012360smesh__D012345
% 208.97/209.12 |- skos__historyNote mesh__D012360 RNA, Transfer %28%1966-1987%29%
% 208.97/209.12 |- rdf__type mesh__D012360sskos__Concept
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 2000
% 208.97/209.12 |- mesh__recordOriginator mesh__D012360 RLS
% 208.97/209.12 |- skos__hiddenLabel mesh__D012360 Phenylalanine Specific tRNA
% 208.97/209.12 |- mesh__dateEstablished mesh__D012360 1991-01-01
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 2001
% 208.97/209.12 |- skos__altLabel mesh__D012360 Transfer RNA, Phe
% 208.97/209.12 |- skos__annotation mesh__D012360
% 208.97/209.12 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.97/209.12 |- skos__prefLabel mesh__D012360 RNA, Transfer, Phe
% 208.97/209.12 |- skos__hiddenLabel mesh__D012360 RNA, Phe Transfer
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 1998
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 2003
% 208.97/209.12 |- skos__altLabel mesh__D012360 tRNAPhe
% 208.97/209.12 |- mesh__historyNote mesh__D012360
% 208.97/209.12 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.12 |- mesh__dateCreated mesh__D012360 1987-05-14
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 2005
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 1997
% 208.97/209.12 |- skos__hiddenLabel mesh__D012360 Phe Transfer RNA
% 208.97/209.12 |- mesh__recordMaintainer mesh__D012360 TGC
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D012360 PLS
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 1999
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 2004
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 2002
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012360 2006
% 208.97/209.12 |- mesh__dateRevised mesh__D012360 1996-06-10
% 208.97/209.12 |- skos__hiddenLabel mesh__D012360 tRNA, Phenylalanine-Specific
% 208.97/209.12 |- skos__altLabel mesh__D012360 tRNA%28%Phe%29%
% 208.97/209.12 |- skos__hiddenLabel mesh__D006323 Arrest, Heart
% 208.97/209.12 |- skos__related mesh__D006323smesh__D016757
% 208.97/209.12 |- mesh__recordOriginator mesh__D006323 NLM
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D006323 2003
% 208.97/209.12 |- skos__hiddenLabel mesh__D006323 Arrest, Cardiac
% 208.97/209.12 |- mesh__recordMaintainer mesh__D006323 nns
% 208.97/209.12 |- skos__prefLabel mesh__D006323 Heart Arrest
% 208.97/209.12 |- skos__related mesh__D006323smesh__D006324
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D006323
% 208.97/209.12 ASYSTOLE was see under ARRHYTHMIA 1969-90
% 208.97/209.12 |- mesh__dateCreated mesh__D006323 1999-01-01
% 208.97/209.12 |- rdf__type mesh__D006323sskos__Concept
% 208.97/209.12 |- skos__altLabel mesh__D006323 Cardiac Arrest
% 208.97/209.12 |- skos__altLabel mesh__D006323 Asystole
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D006323 sjn
% 208.97/209.12 |- mesh__dateRevised mesh__D006323 2001-07-25
% 208.97/209.12 |- skos__broader mesh__D006323smesh__D006331
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D006323 2002
% 208.97/209.12 |- mesh__historyNote mesh__D006323
% 208.97/209.12 ASYSTOLE was see under ARRHYTHMIA 1969-90
% 208.97/209.12 |- skos__scopeNote mesh__D006323 Cessation of the heart beat.
% 208.97/209.12 |- mesh__onlineNote mesh__D006323
% 208.97/209.12 use HEART ARREST to search ASYSTOLE 1969-74
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D006323 2006
% 208.97/209.12 |- skos__hiddenLabel mesh__D006323 Arrest, Cardiopulmonary
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D006323 2005
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D006323 2004
% 208.97/209.12 |- skos__hiddenLabel mesh__D006323 Asystoles
% 208.97/209.12 |- skos__related mesh__D006323smesh__D016887
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 1, Schwangerschaftsprotein
% 208.97/209.12 |- mesh__dateCreated mesh__D011268 1979-02-22
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D011268 2006
% 208.97/209.12 |- skos__prefLabel mesh__D011268 Pregnancy-Specific beta 1-Glycoproteins
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 1-Glycoproteins, Pregnancy-Specific beta
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 beta-Globulin, Trophoblastic
% 208.97/209.12 |- skos__historyNote mesh__D011268 Blood Proteins %28%1966-1979%29%
% 208.97/209.12 |- skos__altLabel mesh__D011268 Pregnancy-Specific beta 1-Glycoprotein
% 208.97/209.12 |- skos__altLabel mesh__D011268 Pregnancy Specific beta 1 Glycoprotein
% 208.97/209.12 |- skos__altLabel mesh__D011268 beta 1-Glycoprotein, Pregnancy-Specific
% 208.97/209.12 |- mesh__recordOriginator mesh__D011268 RLS
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D011268 2005
% 208.97/209.12 |- skos__altLabel mesh__D011268 beta-1 Glycoprotein, Trophoblast-Specific
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Pregnancy Associated Plasma Protein B
% 208.97/209.12 |- rdf__type mesh__D011268sskos__Concept
% 208.97/209.12 |- skos__altLabel mesh__D011268 Schwangerschaftsprotein 1
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Trophoblast Specific beta 1 Glycoprotein
% 208.97/209.12 |- skos__scopeNote mesh__D011268
% 208.97/209.12 Glycoproteins with the electrophoretic mobility of BETA-GLOBULINS, secreted by the placental TROPHOBLASTS into the maternal bloodstream during PREGNANCY. They can be detected 18 days after OVULATION and reach 200 mg/ml at the end of pregnancy. They are associated with fetal well-being.%A%
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 beta-1 Globulin, Pregnancy-Specific
% 208.97/209.12 |- skos__altLabel mesh__D011268 beta 1-Globulin, Trophoblast-Specific
% 208.97/209.12 |- mesh__dateRevised mesh__D011268 2004-07-07
% 208.97/209.12 |- skos__altLabel mesh__D011268 Pregnancy-Associated beta-Plasma Protein
% 208.97/209.12 |- skos__altLabel mesh__D011268 PAPP-C
% 208.97/209.12 |- skos__altLabel mesh__D011268 Pregnancy Specific beta1-Glycoprotein.
% 208.97/209.12 |- mesh__dateEstablished mesh__D011268 1991-01-01
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Protein, SP1 Pregnancy
% 208.97/209.12 |- skos__altLabel mesh__D011268 Pregnancy Specific beta-1 Glycoprotein
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Pregnancy Specific beta 1 Glycoproteins
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Pregnancy Associated Plasma Protein C
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Pregnancy Protein, SP1
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D011268 sjn
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Trophoblast-Specific beta-1 Glycoprotein
% 208.97/209.12 |- mesh__historyNote mesh__D011268 2005%28%1980%29%
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 beta 1-Glycoproteins, Pregnancy-Specific
% 208.97/209.12 |- skos__altLabel mesh__D011268 Trophoblastic beta%28%1%29%-Globulin
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Trophoblast-Specific beta 1-Globulin
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 PSBG 1
% 208.97/209.12 |- skos__altLabel mesh__D011268 PAPP-B
% 208.97/209.12 |- skos__historyNote mesh__D011268 Glycoproteins %28%1966-1979%29%
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 beta 1 Globulin, Trophoblast Specific
% 208.97/209.12 |- skos__historyNote mesh__D011268 Beta Globulins %28%1966-1979%29%
% 208.97/209.12 |- skos__altLabel mesh__D011268 SP1 Pregnancy Protein
% 208.97/209.12 |- skos__altLabel mesh__D011268 Trophoblastic beta-Globulin
% 208.97/209.12 |- skos__altLabel mesh__D011268 Trophoblast-Specific beta 1-Glycoprotein
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Pregnancy Specific beta 1 Globulin
% 208.97/209.12 |- skos__altLabel mesh__D011268 Pregnancy-Specific beta-1 Globulin
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 PAPP B
% 208.97/209.12 |- skos__altLabel mesh__D011268 Trophoblastic beta 1-Glycoprotein
% 208.97/209.12 |- skos__historyNote mesh__D011268 Pregnancy %28%1966-1979%29%
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D011268
% 208.97/209.12 2005; see PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1990-2004; see PREGNANCY PROTEINS 1980-1990; for PREGNANCY-ASSOCIATED BETA-PLASMA PROTEIN see PREGNANCY-ASSOCIATED BETA-PLASMA PROTEIN 1996-2003, see PREGNANCY-ASSOCIATED BETA PLASMA PROTEIN 1991-1995, see PREGNANCY PROTEINS 1980-1990%A%
% 208.97/209.12 |- skos__hiddenLabel mesh__D011268 Trophoblastic beta Globulin
% 208.97/209.12 |- mesh__recordMaintainer mesh__D011268 jmp
% 208.97/209.12 |- skos__broader mesh__D011268smesh__D011257
% 208.97/209.12 |- skos__altLabel mesh__D011268 PSBG-1
% 208.97/209.12 |- skos__historyNote mesh__D011268 Serum Globulins %28%1966-1979%29%
% 208.97/209.12 |- skos__altLabel mesh__D016751 ET-NANBH
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D016751 2006
% 208.97/209.12 |- skos__broader mesh__D016751smesh__D006525
% 208.97/209.12 |- skos__historyNote mesh__D016751
% 208.97/209.12 Hepatitis, Viral, Human %28%1990-1991%29%
% 208.97/209.12 |- skos__altLabel mesh__D016751 Hepatitis, Water-Borne
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D016751 2005
% 208.97/209.12 |- skos__hiddenLabel mesh__D016751 Water-Borne Hepatitides
% 208.97/209.12 |- skos__prefLabel mesh__D016751 Hepatitis E
% 208.97/209.12 |- mesh__historyNote mesh__D016751 92
% 208.97/209.12 |- mesh__recordOriginator mesh__D016751 AGS
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D016751 92
% 208.97/209.12 |- skos__altLabel mesh__D016751
% 208.97/209.12 Hepatitis, Viral, Non-A, Non-B, Enterically-Transmitted
% 208.97/209.12 |- rdf__type mesh__D016751sskos__Concept
% 208.97/209.12 |- skos__altLabel mesh__D016751 Epidemic Non-A, Non-B Hepatitis
% 208.97/209.12 |- skos__broader mesh__D016751smesh__D012327
% 208.97/209.12 |- skos__hiddenLabel mesh__D016751 Water-Borne Hepatitis
% 208.97/209.12 |- mesh__dateRevised mesh__D016751 2004-07-07
% 208.97/209.12 |- skos__scopeNote mesh__D016751
% 208.97/209.12 Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.%A%
% 208.97/209.12 |- skos__hiddenLabel mesh__D016751 Epidemic Non A, Non B Hepatitis
% 208.97/209.12 |- skos__hiddenLabel mesh__D016751 Hepatitis, Water Borne
% 208.97/209.12 |- skos__hiddenLabel mesh__D016751
% 208.97/209.12 Enterically Transmitted Non A, Non B Hepatitis
% 208.97/209.12 |- mesh__dateCreated mesh__D016751 1991-04-29
% 208.97/209.12 |- skos__hiddenLabel mesh__D016751 Hepatitides, Water-Borne
% 208.97/209.12 |- skos__altLabel mesh__D016751
% 208.97/209.12 Enterically-Transmitted Non-A, Non-B Hepatitis
% 208.97/209.12 |- mesh__recordMaintainer mesh__D016751 lkt
% 208.97/209.12 |- mesh__dateEstablished mesh__D016751 1992-01-01
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D016751 sjn
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002731 2002
% 208.97/209.12 |- mesh__dateRevised mesh__D002731 2000-06-21
% 208.97/209.12 |- mesh__historyNote mesh__D002731
% 208.97/209.12 94; was CHLOROMERCURIPHENYLSULFONATE %28%see under PHENYLMERCURY COMPOUNDS 1977-90, see under ORGANOMETALLIC COMPOUNDS 1975-76%29%; CHLOROMERCURIBENZENESULFONATE was see CHLOROMERCURIPHENYLSULFONATE 1975-93%A%
% 208.97/209.12 |- skos__hiddenLabel mesh__D002731 4 Chloromercuribenzenesulfonate
% 208.97/209.12 |- skos__altLabel mesh__D002731 Chloromercuribenzenesulfonate
% 208.97/209.12 |- skos__altLabel mesh__D002731 PCMBS
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002731 2005
% 208.97/209.12 |- skos__historyNote mesh__D002731 Benzenesulfonates %28%1974%29%
% 208.97/209.12 |- mesh__recordMaintainer mesh__D002731 CCR
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002731 2001
% 208.97/209.12 |- skos__hiddenLabel mesh__D002731 Acid, Chloromercuribenzene-p-sulphonic
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002731 2004
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D002731 sjn
% 208.97/209.12 |- skos__historyNote mesh__D002731 Sulfonic Acids %28%1966-1973%29%
% 208.97/209.12 |- skos__annotation mesh__D002731 DF: note short X ref
% 208.97/209.12 |- mesh__recordOriginator mesh__D002731 NLM
% 208.97/209.12 |- skos__broader mesh__D002731smesh__D001557
% 208.97/209.12 |- rdf__type mesh__D002731sskos__Concept
% 208.97/209.12 |- mesh__onlineNote mesh__D002731
% 208.97/209.12 use 4-CHLOROMERCURIBENZENESULFONATE to search CHLOROMERCURIPHENYLSULFONATE %26% CHLOROMERCURIBENZENESULFONATE 1975-93%A%
% 208.97/209.12 |- skos__historyNote mesh__D002731 Benzene %28%1966-1967%29%
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002731 2003
% 208.97/209.12 |- skos__hiddenLabel mesh__D002731 p Chloromercuriphenylsulphonate
% 208.97/209.12 |- skos__broader mesh__D002731smesh__D010663
% 208.97/209.12 |- skos__historyNote mesh__D002731
% 208.97/209.12 Organometallic Compounds %28%1968-1974%29%
% 208.97/209.12 |- skos__scopeNote mesh__D002731
% 208.97/209.12 A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology.%A%
% 208.97/209.12 |- skos__historyNote mesh__D002731 Mercury %28%1966-1974%29%
% 208.97/209.12 |- skos__hiddenLabel mesh__D002731 Chloromercuribenzene p sulphonic Acid
% 208.97/209.12 |- skos__altLabel mesh__D002731 PCMPS
% 208.97/209.12 |- skos__altLabel mesh__D002731 Chloromercuriphenylsulfonate
% 208.97/209.12 |- mesh__dateCreated mesh__D002731 1974-11-19
% 208.97/209.12 |- skos__altLabel mesh__D002731 p-Chloromercuriphenylsulphonate
% 208.97/209.12 |- skos__prefLabel mesh__D002731 4-Chloromercuribenzenesulfonate
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D002731
% 208.97/209.12 94; was CHLOROMERCURIPHENYLSULFONATE %28%see under PHENYLMERCURY COMPOUNDS 1977-90, see under ORGANOMETALLIC COMPOUNDS 1975-76%29%; CHLOROMERCURIBENZENESULFONATE was see CHLOROMERCURIPHENYLSULFONATE 1975-93%A%
% 208.97/209.12 |- mesh__dateEstablished mesh__D002731 1991-01-01
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D002731 2006
% 208.97/209.12 |- skos__broader mesh__D009206Q000382smesh__D009206
% 208.97/209.12 |- mesh__preferredCombination mesh__D009206Q000382smesh__D006321Q000382
% 208.97/209.12 |- rdf__type mesh__D009206Q000382smesh__CompoundConcept
% 208.97/209.12 |- mesh__historyNote mesh__D001639
% 208.97/209.12 BICARBONATE ION was %28%NM%29% 1981-93
% 208.97/209.12 |- skos__altLabel mesh__D001639 Hydrogen Carbonates
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D001639 sjn
% 208.97/209.12 |- skos__hiddenLabel mesh__D001639 Ions, Carbonic Acid
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001639 2002
% 208.97/209.12 |- skos__broader mesh__D001639smesh__D002254
% 208.97/209.12 |- mesh__dateRevised mesh__D001639 2001-07-25
% 208.97/209.12 |- mesh__onlineNote mesh__D001639
% 208.97/209.12 use BICARBONATES %28%NM%29% to search BICARBONATE ION 1981-93
% 208.97/209.12 |- mesh__dateCreated mesh__D001639 1999-01-01
% 208.97/209.12 |- skos__hiddenLabel mesh__D001639 Carbonates, Hydrogen
% 208.97/209.12 |- skos__scopeNote mesh__D001639
% 208.97/209.12 Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.%A%
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001639 2006
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001639 2004
% 208.97/209.12 |- rdf__type mesh__D001639sskos__Concept
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001639 2005
% 208.97/209.12 |- mesh__recordMaintainer mesh__D001639 jmp
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D001639 2003
% 208.97/209.12 |- skos__altLabel mesh__D001639 Bicarbonate Ion
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D001639
% 208.97/209.12 BICARBONATE ION was indexed under BICARBONATES 1981-93
% 208.97/209.12 |- skos__hiddenLabel mesh__D001639 Carbonate, Hydrogen
% 208.97/209.12 |- mesh__recordOriginator mesh__D001639 NLM
% 208.97/209.12 |- skos__prefLabel mesh__D001639 Bicarbonates
% 208.97/209.12 |- skos__hiddenLabel mesh__D001639 Ions, Bicarbonate
% 208.97/209.12 |- mesh__dateRevised mesh__D012361 1996-06-10
% 208.97/209.12 |- mesh__dateEstablished mesh__D012361 1991-01-01
% 208.97/209.12 |- skos__hiddenLabel mesh__D012361 Pro Transfer RNA
% 208.97/209.12 |- skos__annotation mesh__D012361
% 208.97/209.12 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.97/209.12 |- skos__hiddenLabel mesh__D012361 tRNA, Proline-Specific
% 208.97/209.12 |- skos__historyNote mesh__D012361 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 1998
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 2003
% 208.97/209.12 |- skos__altLabel mesh__D012361 Transfer RNA, Pro
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 2005
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 1997
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 2000
% 208.97/209.12 |- mesh__recordOriginator mesh__D012361 RLS
% 208.97/209.12 |- mesh__recordMaintainer mesh__D012361 TGC
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 1999
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 2004
% 208.97/209.12 |- skos__prefLabel mesh__D012361 RNA, Transfer, Pro
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 2001
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 2006
% 208.97/209.12 |- mesh__dateCreated mesh__D012361 1987-05-07
% 208.97/209.12 |- skos__altLabel mesh__D012361 Proline-Specific tRNA
% 208.97/209.12 |- skos__hiddenLabel mesh__D012361 RNA, Pro Transfer
% 208.97/209.12 |- skos__hiddenLabel mesh__D012361 Proline Specific tRNA
% 208.97/209.12 |- skos__altLabel mesh__D012361 tRNA%28%Pro%29%
% 208.97/209.12 |- skos__scopeNote mesh__D012361
% 208.97/209.12 A transfer RNA which is specific for carrying proline to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.97/209.12 |- skos__altLabel mesh__D012361 tRNAPro
% 208.97/209.12 |- mesh__historyNote mesh__D012361
% 208.97/209.12 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D012361
% 208.97/209.12 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D012361 PLS
% 208.97/209.12 |- skos__broader mesh__D012361smesh__D012345
% 208.97/209.12 |- skos__historyNote mesh__D012361 RNA, Transfer %28%1966-1987%29%
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D012361 2002
% 208.97/209.12 |- rdf__type mesh__D012361sskos__Concept
% 208.97/209.12 |- skos__scopeNote mesh__D006324
% 208.97/209.12 A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals %28%CARDIOPLEGIC SOLUTIONS%29% or cold temperature %28%such as chilled perfusate%29%.%A%
% 208.97/209.12 |- skos__annotation mesh__D006324
% 208.97/209.12 note category: a technique, not a disease; do not coordinate with HYPOTHERMIA, INDUCED unless this is particularly discussed%A%
% 208.97/209.12 |- mesh__dateCreated mesh__D006324 1999-01-01
% 208.97/209.12 |- rdf__type mesh__D006324sskos__Concept
% 208.97/209.12 |- skos__altLabel mesh__D006324 Induced Heart Arrest
% 208.97/209.12 |- mesh__recordMaintainer mesh__D006324 lkt
% 208.97/209.12 |- mesh__recordOriginator mesh__D006324 NLM
% 208.97/209.12 |- skos__broader mesh__D006324smesh__D006348
% 208.97/209.12 |- skos__hiddenLabel mesh__D006324 Cardioplegias
% 208.97/209.12 |- skos__prefLabel mesh__D006324 Heart Arrest, Induced
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D006324 2006
% 208.97/209.12 |- skos__related mesh__D006324smesh__D002314
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D006324 sjn
% 208.97/209.12 |- skos__altLabel mesh__D006324 Cardiac Arrest, Induced
% 208.97/209.12 |- skos__altLabel mesh__D006324 Induced Cardiac Arrest
% 208.97/209.12 |- skos__altLabel mesh__D006324 Cardioplegia
% 208.97/209.12 |- mesh__dateRevised mesh__D006324 2005-06-30
% 208.97/209.12 |- skos__hiddenLabel mesh__D050480 Sodium Neurotransmitter Symporters
% 208.97/209.12 |- skos__prefLabel mesh__D050480
% 208.97/209.12 Plasma Membrane Neurotransmitter Transport Proteins
% 208.97/209.12 |- skos__hiddenLabel mesh__D050480 Symporters, Sodium-Neurotransmitter
% 208.97/209.12 |- skos__broader mesh__D050480smesh__D050479
% 208.97/209.12 |- rdf__type mesh__D050480sskos__Concept
% 208.97/209.12 |- skos__altLabel mesh__D050480
% 208.97/209.12 Neurotransmitter Transport Proteins, Plasma Membrane
% 208.97/209.12 |- skos__altLabel mesh__D050480
% 208.97/209.12 Neurotransmitter Transporters, Plasma Membrane
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D050480 2006
% 208.97/209.12 |- mesh__historyNote mesh__D050480 2006
% 208.97/209.12 |- mesh__recordOriginator mesh__D050480 DRC
% 208.97/209.12 |- skos__altLabel mesh__D050480
% 208.97/209.12 Plasma Membrane Neurotransmitter Transporter Proteins
% 208.97/209.12 |- skos__scopeNote mesh__D050480
% 208.97/209.12 A family of neurotransmitter transporter proteins that facilitate NEUROTRANSMITTER reuptake into PRESYNAPTIC TERMINALS. They may play a role in regulating the intensity and duration of neurotransmission.%A%
% 208.97/209.12 |- skos__altLabel mesh__D050480
% 208.97/209.12 Plasma Membrane Neurotransmitter Transporters
% 208.97/209.12 |- skos__annotation mesh__D050480
% 208.97/209.12 don%27%t confuse sodium chloride-dependent neurotransmitter symporters with SODIUM-POTASSIUM-CHLORIDE SYMPORTERS%A%
% 208.97/209.12 |- skos__hiddenLabel mesh__D050480
% 208.97/209.12 Sodium Chloride Dependent Neurotransmitter Symporters
% 208.97/209.12 |- skos__altLabel mesh__D050480 Sodium-Neurotransmitter Symporters
% 208.97/209.12 |- mesh__dateCreated mesh__D050480 2005-06-30
% 208.97/209.12 |- mesh__recordMaintainer mesh__D050480 DRC
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D050480 sjn
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D050480 2006
% 208.97/209.12 |- mesh__dateEstablished mesh__D050480 2006-01-01
% 208.97/209.12 |- mesh__dateEstablished mesh__D044443 2004-01-01
% 208.97/209.12 |- skos__historyNote mesh__D044443 Algae %28%1965-1995%29%
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D044443 2006
% 208.97/209.12 |- skos__scopeNote mesh__D044443
% 208.97/209.12 A genus of ALGAE in the family CHARACEAE. They are found in shallow to deep waters of soft water or acid lakes and bogs.%A%
% 208.97/209.12 |- mesh__recordMaintainer mesh__D044443 SYSTEM
% 208.97/209.12 |- mesh__publicMeSHNote mesh__D044443 2004; see ALGAE, GREEN 1998-2003
% 208.97/209.12 |- skos__historyNote mesh__D044443 Algae, Green %28%1967-2003%29%
% 208.97/209.12 |- skos__prefLabel mesh__D044443 Nitella
% 208.97/209.12 |- mesh__historyNote mesh__D044443 2004; use ALGAE, GREEN 1998-2003
% 208.97/209.12 |- skos__broader mesh__D044443smesh__D044522
% 208.97/209.12 |- rdf__type mesh__D044443sskos__Concept
% 208.97/209.12 |- mesh__dateRevised mesh__D044443 2005-06-30
% 208.97/209.12 |- mesh__recordOriginator mesh__D044443 ags
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D044443 sjn
% 208.97/209.12 |- mesh__dateCreated mesh__D044443 2003-07-09
% 208.97/209.12 |- mesh__dateCreated mesh__D011269 1999-01-01
% 208.97/209.12 |- skos__broader mesh__D011269smesh__D011271
% 208.97/209.12 |- skos__scopeNote mesh__D011269
% 208.97/209.12 A type of ectopic pregnancy in which the EMBRYO implants in the ABDOMINAL CAVITY instead of in the ENDOMETRIUM of the UTERUS.%A%
% 208.97/209.12 |- mesh__activeMeSHYear mesh__D011269 2006
% 208.97/209.12 |- mesh__recordAuthorizer mesh__D011269 sjn
% 208.97/209.12 |- skos__hiddenLabel mesh__D011269 Abdominal Pregnancies
% 208.97/209.12 |- skos__altLabel mesh__D011269 Abdominal Pregnancy
% 208.97/209.12 |- skos__prefLabel mesh__D011269 Pregnancy, Abdominal
% 208.97/209.12 |- rdf__type mesh__D011269sskos__Concept
% 208.97/209.12 |- skos__hiddenLabel mesh__D011269 Pregnancies, Abdominal
% 208.97/209.12 |- mesh__dateRevised mesh__D011269 2005-06-30
% 208.97/209.12 |- mesh__recordMaintainer mesh__D011269 lkt
% 208.97/209.12 |- skos__annotation mesh__D011269
% 208.97/209.12 check the tags FEMALE %26% PREGNANCY; heterotopic or combined uterine %26% abdominal pregnancy: see note at PREGNANCY, ECTOPIC; DF: PREGN ABDOMINAL%A%
% 208.97/209.12 |- mesh__recordOriginator mesh__D011269 NLM
% 208.97/209.12 |- mesh__recordMaintainer mesh__D016752 ags
% 208.97/209.13 |- skos__annotation mesh__D016752 infection = HEPATITIS E
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D016752 2002
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D016752 2006
% 208.97/209.13 |- skos__prefLabel mesh__D016752 Hepatitis E virus
% 208.97/209.13 |- mesh__dateEstablished mesh__D016752 1992-01-01
% 208.97/209.13 |- skos__historyNote mesh__D016752 Hepatitis Viruses %28%1990-1991%29%
% 208.97/209.13 |- mesh__historyNote mesh__D016752 92
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D016752 sjn
% 208.97/209.13 |- mesh__recordOriginator mesh__D016752 AGS
% 208.97/209.13 |- rdf__type mesh__D016752sskos__Concept
% 208.97/209.13 |- skos__scopeNote mesh__D016752
% 208.97/209.13 A positive-stranded RNA virus species in an unassigned genus, Hepatitis E-like Viruses, causing enterically-transmitted non-A, non-B hepatitis %28%HEPATITIS E%29%.%A%
% 208.97/209.13 |- skos__broader mesh__D016752smesh__D012328
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D016752 2003
% 208.97/209.13 |- skos__broader mesh__D016752smesh__D006518
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D016752 2005
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D016752 92
% 208.97/209.13 |- mesh__dateRevised mesh__D016752 2001-07-25
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D016752 2004
% 208.97/209.13 |- mesh__dateCreated mesh__D016752 1991-06-21
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 1999
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 2004
% 208.97/209.13 |- mesh__historyNote mesh__D012362
% 208.97/209.13 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 2006
% 208.97/209.13 |- mesh__recordMaintainer mesh__D012362 TGC
% 208.97/209.13 |- skos__hiddenLabel mesh__D012362 tRNA, Serine-Specific
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D012362 PLS
% 208.97/209.13 |- skos__altLabel mesh__D012362 tRNASer
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 2002
% 208.97/209.13 |- mesh__dateRevised mesh__D012362 1996-06-10
% 208.97/209.13 |- skos__prefLabel mesh__D012362 RNA, Transfer, Ser
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D012362
% 208.97/209.13 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.13 |- skos__broader mesh__D012362smesh__D012345
% 208.97/209.13 |- rdf__type mesh__D012362sskos__Concept
% 208.97/209.13 |- skos__historyNote mesh__D012362 RNA, Transfer %28%1966-1987%29%
% 208.97/209.13 |- skos__altLabel mesh__D012362 tRNA%28%Ser%29%
% 208.97/209.13 |- skos__altLabel mesh__D012362 Serine-Specific tRNA
% 208.97/209.13 |- skos__hiddenLabel mesh__D012362 Serine Specific tRNA
% 208.97/209.13 |- mesh__recordOriginator mesh__D012362 RLS
% 208.97/209.13 |- mesh__dateCreated mesh__D012362 1987-05-08
% 208.97/209.13 |- skos__historyNote mesh__D012362 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.13 |- skos__scopeNote mesh__D012362
% 208.97/209.13 A transfer RNA which is specific for carrying serine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.97/209.13 |- skos__annotation mesh__D012362
% 208.97/209.13 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 2000
% 208.97/209.13 |- skos__hiddenLabel mesh__D012362 Ser Transfer RNA
% 208.97/209.13 |- skos__altLabel mesh__D012362 Transfer RNA, Ser
% 208.97/209.13 |- mesh__dateEstablished mesh__D012362 1991-01-01
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 1998
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 2003
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 2001
% 208.97/209.13 |- skos__hiddenLabel mesh__D012362 RNA, Ser Transfer
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 2005
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012362 1997
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D006325 sjn
% 208.97/209.13 |- skos__hiddenLabel mesh__D006325 Atrium, Heart
% 208.97/209.13 |- skos__broader mesh__D006325smesh__D006321
% 208.97/209.13 |- rdf__type mesh__D006325sskos__Concept
% 208.97/209.13 |- skos__annotation mesh__D006325 NIM: Manual 21.51
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006325 2005
% 208.97/209.13 |- skos__hiddenLabel mesh__D006325 Atrium, Right
% 208.97/209.13 |- skos__hiddenLabel mesh__D006325 Atrium, Left
% 208.97/209.13 |- mesh__historyNote mesh__D006325 2004%28%1966%29%
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006325 2006
% 208.97/209.13 |- skos__altLabel mesh__D006325 Heart Atrium
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006325 2004
% 208.97/209.13 |- mesh__recordOriginator mesh__D006325 NLM
% 208.97/209.13 |- mesh__recordMaintainer mesh__D006325 nns
% 208.97/209.13 |- mesh__dateCreated mesh__D006325 1999-01-01
% 208.97/209.13 |- mesh__dateEstablished mesh__D006325 1968-01-01
% 208.97/209.13 |- skos__hiddenLabel mesh__D006325 Atria, Heart
% 208.97/209.13 |- skos__scopeNote mesh__D006325
% 208.97/209.13 The chambers of the heart, to which the BLOOD returns from the circulation.%A%
% 208.97/209.13 |- skos__related mesh__D006325smesh__D016275
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D006325 2004; see HEART ATRIUM 1966-2003
% 208.97/209.13 |- mesh__dateRevised mesh__D006325 2003-07-09
% 208.97/209.13 |- skos__prefLabel mesh__D006325 Heart Atria
% 208.97/209.13 |- skos__scopeNote mesh__D050481
% 208.97/209.13 A family of neurotransmitter transporter proteins that are INTEGRAL MEMBRANE PROTEINS of the LIPID BILAYER of SECRETORY VESICLES. They are ANTIPORTERS that exchange vesicular PROTONS for cytoplasmic NEUROTRANSMITTER and play an essential role in regulating neurotransmission.%A%
% 208.97/209.13 |- skos__prefLabel mesh__D050481
% 208.97/209.13 Vesicular Neurotransmitter Transport Proteins
% 208.97/209.13 |- mesh__recordMaintainer mesh__D050481 DRC
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D050481 2006
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D050481 2006
% 208.97/209.13 |- skos__hiddenLabel mesh__D050481 Vesicular Neurotransmitter Transporters
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D050481 sjn
% 208.97/209.13 |- skos__broader mesh__D050481smesh__D050479
% 208.97/209.13 |- skos__altLabel mesh__D050481
% 208.97/209.13 Vesicle Neurotransmitter Transporter Proteins
% 208.97/209.13 |- mesh__recordOriginator mesh__D050481 DRC
% 208.97/209.13 |- rdf__type mesh__D050481sskos__Concept
% 208.97/209.13 |- mesh__dateEstablished mesh__D050481 2006-01-01
% 208.97/209.13 |- skos__altLabel mesh__D050481
% 208.97/209.13 Neurotransmitter Transport Proteins, Vesicular
% 208.97/209.13 |- skos__annotation mesh__D050481
% 208.97/209.13 do not confuse with VESICULAR TRANSPORT PROTEINS
% 208.97/209.13 |- mesh__dateCreated mesh__D050481 2005-06-30
% 208.97/209.13 |- skos__altLabel mesh__D050481
% 208.97/209.13 Vesicular Neurotransmitter Transporter Proteins
% 208.97/209.13 |- skos__hiddenLabel mesh__D050481 Transporters, Vesicular Neurotransmitter
% 208.97/209.13 |- mesh__historyNote mesh__D050481 2006
% 208.97/209.13 |- skos__broader mesh__D050481smesh__D017920
% 208.97/209.13 |- skos__altLabel mesh__D050481 Neurotransmitter Transporters, Vesicular
% 208.97/209.13 |- mesh__dateCreated mesh__D044444 2003-07-09
% 208.97/209.13 |- skos__historyNote mesh__D044444 Algae, Green %28%1969-2003%29%
% 208.97/209.13 |- skos__historyNote mesh__D044444 Algae %28%1964-2003%29%
% 208.97/209.13 |- skos__broader mesh__D044444smesh__D000460
% 208.97/209.13 |- mesh__historyNote mesh__D044444 2004; use ALGAE, GREEN 1998-2003
% 208.97/209.13 |- mesh__dateEstablished mesh__D044444 2004-01-01
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D044444 2004; see ALGAE, GREEN 1998-2003
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D044444 2006
% 208.97/209.13 |- mesh__recordMaintainer mesh__D044444 SYSTEM
% 208.97/209.13 |- rdf__type mesh__D044444sskos__Concept
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D044444 sjn
% 208.97/209.13 |- skos__scopeNote mesh__D044444
% 208.97/209.13 A genus of GREEN ALGAE in the family Scenedesmaceae. It forms colonies of usually four or eight cylindrical cells that are widely distributed in freshwater and SOIL.%A%
% 208.97/209.13 |- mesh__recordOriginator mesh__D044444 ags
% 208.97/209.13 |- skos__prefLabel mesh__D044444 Scenedesmus
% 208.97/209.13 |- mesh__dateRevised mesh__D044444 2005-06-30
% 208.97/209.13 |- skos__altLabel mesh__D016753 IL-10
% 208.97/209.13 |- skos__scopeNote mesh__D016753
% 208.97/209.13 Factor that is a coregulator of mast cell growth. It is produced by T-cells and B-cells and shows extensive homology with the Epstein-Barr virus BCRFI gene.%A%
% 208.97/209.13 |- mesh__recordMaintainer mesh__D016753 ssb
% 208.97/209.13 |- mesh__dateCreated mesh__D016753 1991-06-27
% 208.97/209.13 |- skos__altLabel mesh__D016753 Cytokine Synthesis Inhibitory Factor
% 208.97/209.13 |- skos__historyNote mesh__D016753 Interleukins %28%1990-1991%29%
% 208.97/209.13 |- rdf__type mesh__D016753sskos__Concept
% 208.97/209.13 |- mesh__dateEstablished mesh__D016753 1992-01-01
% 208.97/209.13 |- skos__annotation mesh__D016753 DF: IL 10 or IL10
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D016753 sjn
% 208.97/209.13 |- skos__altLabel mesh__D016753 CSIF-10
% 208.97/209.13 |- mesh__dateRevised mesh__D016753 2005-06-30
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D016753
% 208.97/209.13 92; INTERLEUKIN-10 %28%NM%29% was indexed under INTERLEUKINS 1990-91%A%
% 208.97/209.13 |- mesh__historyNote mesh__D016753
% 208.97/209.13 92; was INTERLEUKIN-10 %28%NM%29% 1990-91
% 208.97/209.13 |- mesh__recordOriginator mesh__D016753 AGS
% 208.97/209.13 |- skos__hiddenLabel mesh__D016753 Interleukin 10
% 208.97/209.13 |- mesh__onlineNote mesh__D016753
% 208.97/209.13 use INTERLEUKIN-10 %28%NM%29% to search INTERLEUKIN-10 1990-91
% 208.97/209.13 |- skos__altLabel mesh__D016753 IL10
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D016753 2006
% 208.97/209.13 |- skos__broader mesh__D016753smesh__D007378
% 208.97/209.13 |- skos__prefLabel mesh__D016753 Interleukin-10
% 208.97/209.13 |- mesh__dateCreated mesh__D002733 1976-05-19
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 1997
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 2005
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 2002
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 1996
% 208.97/209.13 |- mesh__historyNote mesh__D002733 77
% 208.97/209.13 |- rdf__type mesh__D002733sskos__Concept
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 2004
% 208.97/209.13 |- skos__broader mesh__D002733smesh__D010636
% 208.97/209.13 |- skos__prefLabel mesh__D002733 Chlorophenols
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 2001
% 208.97/209.13 |- mesh__recordMaintainer mesh__D002733 PLS
% 208.97/209.13 |- skos__scopeNote mesh__D002733
% 208.97/209.13 Phenols substituted with one or more chlorine atoms in any position.%A%
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 2003
% 208.97/209.13 |- skos__altLabel mesh__D002733 Hydroxychlorobenzenes
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 2000
% 208.97/209.13 |- skos__historyNote mesh__D002733 Phenols %28%1966-1976%29%
% 208.97/209.13 |- skos__historyNote mesh__D002733 Chlorobenzenes %28%1974-1976%29%
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D002733
% 208.97/209.13 77; PENTACHLOROPHENOL was see under PHENOLS 1971-76
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D002733 PLS
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 1995
% 208.97/209.13 |- mesh__dateEstablished mesh__D002733 1977-01-01
% 208.97/209.13 |- mesh__recordOriginator mesh__D002733 RLS
% 208.97/209.13 |- skos__broader mesh__D002733smesh__D002722
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 1999
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 1994
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 1998
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002733 2006
% 208.97/209.13 |- mesh__dateRevised mesh__D002733 1993-06-02
% 208.97/209.13 |- skos__hiddenLabel mesh__D012363 tRNA, Threonine-Specific
% 208.97/209.13 |- skos__altLabel mesh__D012363 Threonine-Specific tRNA
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 2001
% 208.97/209.13 |- skos__altLabel mesh__D012363 Transfer RNA, Thr
% 208.97/209.13 |- skos__altLabel mesh__D012363 tRNAThr
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D012363
% 208.97/209.13 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.13 |- skos__broader mesh__D012363smesh__D012345
% 208.97/209.13 |- skos__historyNote mesh__D012363 RNA, Transfer %28%1966-1987%29%
% 208.97/209.13 |- rdf__type mesh__D012363sskos__Concept
% 208.97/209.13 |- mesh__historyNote mesh__D012363
% 208.97/209.13 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.13 |- skos__hiddenLabel mesh__D012363 Threonine Specific tRNA
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D012363 PLS
% 208.97/209.13 |- skos__hiddenLabel mesh__D012363 RNA, Thr Transfer
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 2002
% 208.97/209.13 |- skos__annotation mesh__D012363
% 208.97/209.13 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.97/209.13 |- skos__hiddenLabel mesh__D012363 Thr Transfer RNA
% 208.97/209.13 |- mesh__dateRevised mesh__D012363 1996-06-10
% 208.97/209.13 |- skos__altLabel mesh__D012363 tRNA%28%Thr%29%
% 208.97/209.13 |- mesh__dateEstablished mesh__D012363 1991-01-01
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 1998
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 2003
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 2005
% 208.97/209.13 |- mesh__recordOriginator mesh__D012363 RLS
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 1997
% 208.97/209.13 |- skos__scopeNote mesh__D012363
% 208.97/209.13 A transfer RNA which is specific for carrying threonine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.97/209.13 |- mesh__dateCreated mesh__D012363 1987-05-08
% 208.97/209.13 |- skos__prefLabel mesh__D012363 RNA, Transfer, Thr
% 208.97/209.13 |- skos__historyNote mesh__D012363 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 1999
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 2004
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 2006
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012363 2000
% 208.97/209.13 |- mesh__recordMaintainer mesh__D012363 TGC
% 208.97/209.13 |- skos__hiddenLabel mesh__D006326 Auscultation, Heart
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006326 1999
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006326 2005
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006326 2006
% 208.97/209.13 |- skos__hiddenLabel mesh__D006326 Auscultations, Cardiac
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006326 2003
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D006326 SJN
% 208.97/209.13 |- skos__broader mesh__D006326smesh__D006334
% 208.97/209.13 |- skos__broader mesh__D006326smesh__D001314
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006326 2004
% 208.97/209.13 |- mesh__dateCreated mesh__D006326 1999-01-01
% 208.97/209.13 |- skos__hiddenLabel mesh__D006326 Cardiac Auscultations
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006326 2000
% 208.97/209.13 |- skos__hiddenLabel mesh__D006326 Auscultation, Cardiac
% 208.97/209.13 |- skos__scopeNote mesh__D006326
% 208.97/209.13 Act of listening for sounds within the heart.
% 208.97/209.13 |- skos__hiddenLabel mesh__D006326 Heart Auscultations
% 208.97/209.13 |- mesh__dateRevised mesh__D006326 1997-06-20
% 208.97/209.13 |- mesh__recordMaintainer mesh__D006326 PXP
% 208.97/209.13 |- skos__hiddenLabel mesh__D006326 Auscultations, Heart
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006326 2001
% 208.97/209.13 |- skos__prefLabel mesh__D006326 Heart Auscultation
% 208.97/209.13 |- mesh__recordOriginator mesh__D006326 NLM
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006326 2002
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006326 1998
% 208.97/209.13 |- rdf__type mesh__D006326sskos__Concept
% 208.97/209.13 |- skos__annotation mesh__D006326
% 208.97/209.13 /drug eff /rad eff permitted; do not use /util except by MeSH definition; /instrum: STETHOSCOPES is also available%A%
% 208.97/209.13 |- skos__altLabel mesh__D006326 Cardiac Auscultation
% 208.97/209.13 |- skos__related mesh__D006326smesh__D010701
% 208.97/209.13 |- skos__scopeNote mesh__D050482
% 208.97/209.13 A group of membrane transport proteins that transport biogenic amine derivatives of catechol across the PLASMA MEMBRANE. Catecholamine plasma membrane transporter proteins regulate neural transmission as well as catecholamine metabolism and recycling.%A%
% 208.97/209.13 |- mesh__recordOriginator mesh__D050482 DRC
% 208.97/209.13 |- mesh__recordMaintainer mesh__D050482 DRC
% 208.97/209.13 |- skos__hiddenLabel mesh__D050482
% 208.97/209.13 Neurotransmitter Transport Proteins, Catecholamine Specific
% 208.97/209.13 |- rdf__type mesh__D050482sskos__Concept
% 208.97/209.13 |- skos__prefLabel mesh__D050482
% 208.97/209.13 Catecholamine Plasma Membrane Transport Proteins
% 208.97/209.13 |- skos__hiddenLabel mesh__D050482
% 208.97/209.13 Neurotransmitter Transporters, Catecholamine Specific
% 208.97/209.13 |- skos__altLabel mesh__D050482
% 208.97/209.13 Neurotransmitter Transporters, Catecholamine-Specific
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D050482
% 208.97/209.13 2006; CATACHOLAMINE TRANSPORT PROTEIN was indexed under MEMBRANE TRANSPORT PROTEINS 2004 %26% CARRIER PROTEINS 1980-2004%A%
% 208.97/209.13 |- skos__altLabel mesh__D050482 Catecholamine Carrier
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D050482 sjn
% 208.97/209.13 |- skos__altLabel mesh__D050482 Catecholamine Transport Protein
% 208.97/209.13 |- skos__hiddenLabel mesh__D050482
% 208.97/209.13 Catecholamine-Specific Neurotransmitter Transporters
% 208.97/209.13 |- skos__broader mesh__D050482smesh__D050480
% 208.97/209.13 |- skos__hiddenLabel mesh__D050482 Transport Protein, Catecholamine
% 208.97/209.13 |- mesh__dateEstablished mesh__D050482 2006-01-01
% 208.97/209.13 |- skos__historyNote mesh__D050482
% 208.97/209.13 Membrane Transport Proteins %28%1980-2005%29%
% 208.97/209.13 |- skos__altLabel mesh__D050482 Catecholamine Plasma Membrane Transporters
% 208.97/209.13 |- skos__altLabel mesh__D050482
% 208.97/209.13 Catecholamine Plasma Membrane Transporter Proteins
% 208.97/209.13 |- mesh__historyNote mesh__D050482 2006%28%1980%29%
% 208.97/209.13 |- skos__altLabel mesh__D050482
% 208.97/209.13 Neurotransmitter Transport Proteins, Catecholamine-Specific
% 208.97/209.13 |- mesh__dateCreated mesh__D050482 2005-06-30
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D050482 2006
% 208.97/209.13 |- skos__hiddenLabel mesh__D050482
% 208.97/209.13 Transporters, Catecholamine-Specific Neurotransmitter
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D044445 sjn
% 208.97/209.13 |- mesh__recordOriginator mesh__D044445 ags
% 208.97/209.13 |- mesh__recordMaintainer mesh__D044445 SYSTEM
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D044445 2004; see ALGAE, GREEN 2000-2003
% 208.97/209.13 |- mesh__dateRevised mesh__D044445 2005-06-30
% 208.97/209.13 |- skos__prefLabel mesh__D044445 Ulva
% 208.97/209.13 |- mesh__historyNote mesh__D044445 2004; use ALGAE, GREEN 2000-2003
% 208.97/209.13 |- mesh__dateEstablished mesh__D044445 2004-01-01
% 208.97/209.13 |- skos__altLabel mesh__D044445 Sea Lettuces
% 208.97/209.13 |- skos__scopeNote mesh__D044445
% 208.97/209.13 A genus of GREEN ALGAE in the family Ulvaceae. Commonly know as sea lettuces, they grow attached to rocks and KELP in marine and estuarine waters.%A%
% 208.97/209.13 |- mesh__dateCreated mesh__D044445 2003-07-09
% 208.97/209.13 |- skos__altLabel mesh__D044445 Ulva arasakii
% 208.97/209.13 |- skos__broader mesh__D044445smesh__D000460
% 208.97/209.13 |- skos__historyNote mesh__D044445 Algae, Green %28%1969-2003%29%
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D044445 2006
% 208.97/209.13 |- rdf__type mesh__D044445sskos__Concept
% 208.97/209.13 |- skos__historyNote mesh__D016754 Boron %28%1966-1992%29%
% 208.97/209.13 |- skos__scopeNote mesh__D016754
% 208.97/209.13 A technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons.%A%
% 208.97/209.13 |- skos__altLabel mesh__D016754 Therapy, Boron Neutron Capture
% 208.97/209.13 |- skos__altLabel mesh__D016754 Boron-Neutron Capture Therapy
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D016754 93
% 208.97/209.13 |- mesh__recordOriginator mesh__D016754 JLS
% 208.97/209.13 |- skos__annotation mesh__D016754
% 208.97/209.13 do not use /util except by MeSH definition; coord IM with disease /radiother %28%IM%29%; DF: BNCT%A%
% 208.97/209.13 |- skos__historyNote mesh__D016754
% 208.97/209.13 Radiotherapy, High-Energy %28%1966-1992%29%
% 208.97/209.13 |- mesh__dateCreated mesh__D016754 1992-05-07
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D016754 2006
% 208.97/209.13 |- skos__prefLabel mesh__D016754 Boron Neutron Capture Therapy
% 208.97/209.13 |- skos__altLabel mesh__D016754 Neutron Capture Therapy, Boron
% 208.97/209.13 |- mesh__dateEstablished mesh__D016754 1993-01-01
% 208.97/209.13 |- skos__broader mesh__D016754smesh__D017247
% 208.97/209.13 |- mesh__historyNote mesh__D016754 93
% 208.97/209.13 |- skos__hiddenLabel mesh__D016754 Therapy, Boron-Neutron Capture
% 208.97/209.13 |- skos__historyNote mesh__D016754 Neutrons %28%1966-1992%29%
% 208.97/209.13 |- rdf__type mesh__D016754sskos__Concept
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D016754 sjn
% 208.97/209.13 |- mesh__recordMaintainer mesh__D016754 lkt
% 208.97/209.13 |- mesh__dateRevised mesh__D016754 2005-06-30
% 208.97/209.13 |- skos__prefLabel mesh__D002734 Chlorophyll
% 208.97/209.13 |- skos__broader mesh__D002734smesh__D008665
% 208.97/209.13 |- mesh__dateRevised mesh__D002734 2005-06-30
% 208.97/209.13 |- rdf__type mesh__D002734sskos__Concept
% 208.97/209.13 |- skos__scopeNote mesh__D002734
% 208.97/209.13 Porphyrin derivatives containing magnesium that act to convert light energy in photosynthetic organisms.%A%
% 208.97/209.13 |- skos__broader mesh__D002734smesh__D011166
% 208.97/209.13 |- skos__broader mesh__D002734smesh__D045725
% 208.97/209.13 |- skos__related mesh__D002734smesh__D010788
% 208.97/209.13 |- skos__hiddenLabel mesh__D002734 740, Chlorophyll
% 208.97/209.13 |- mesh__dateCreated mesh__D002734 1999-01-01
% 208.97/209.13 |- mesh__recordMaintainer mesh__D002734 ssb
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D002734 sjn
% 208.97/209.13 |- mesh__recordOriginator mesh__D002734 NLM
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D002734 2006
% 208.97/209.13 |- mesh__dateEstablished mesh__D012364 1991-01-01
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 2003
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 1999
% 208.97/209.13 |- skos__hiddenLabel mesh__D012364 tRNA, Tryptophan-Specific
% 208.97/209.13 |- skos__prefLabel mesh__D012364 RNA, Transfer, Trp
% 208.97/209.13 |- mesh__historyNote mesh__D012364
% 208.97/209.13 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.13 |- skos__altLabel mesh__D012364 TRNATrp
% 208.97/209.13 |- skos__hiddenLabel mesh__D012364 Tryptophan Specific tRNA
% 208.97/209.13 |- skos__hiddenLabel mesh__D012364 Trp Transfer RNA
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 2006
% 208.97/209.13 |- skos__hiddenLabel mesh__D012364 RNA, Trp Transfer
% 208.97/209.13 |- skos__altLabel mesh__D012364 tRNA%28%Trp%29%
% 208.97/209.13 |- mesh__dateRevised mesh__D012364 1996-06-10
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 1998
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 2002
% 208.97/209.13 |- skos__altLabel mesh__D012364 Tryptophan-Specific tRNA
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 2005
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D012364 PLS
% 208.97/209.13 |- skos__historyNote mesh__D012364 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.13 |- rdf__type mesh__D012364sskos__Concept
% 208.97/209.13 |- mesh__dateCreated mesh__D012364 1987-05-08
% 208.97/209.13 |- skos__scopeNote mesh__D012364
% 208.97/209.13 A transfer RNA which is specific for carrying tryptophan to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D012364
% 208.97/209.13 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.13 |- mesh__recordOriginator mesh__D012364 RLS
% 208.97/209.13 |- skos__broader mesh__D012364smesh__D012345
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 1997
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 2001
% 208.97/209.13 |- mesh__recordMaintainer mesh__D012364 TGC
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 2004
% 208.97/209.13 |- skos__historyNote mesh__D012364 RNA, Transfer %28%1966-1987%29%
% 208.97/209.13 |- skos__altLabel mesh__D012364 Transfer RNA, Trp
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D012364 2000
% 208.97/209.13 |- skos__annotation mesh__D012364
% 208.97/209.13 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006327 2000
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Dissociations, Auriculo-Ventricular
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Block, Atrioventricular
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006327 2004
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Dissociation, Auriculo-Ventricular
% 208.97/209.13 |- mesh__dateCreated mesh__D006327 1999-01-01
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006327 2001
% 208.97/209.13 |- skos__broader mesh__D006327smesh__D001145
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Heart Blocks
% 208.97/209.13 |- mesh__recordOriginator mesh__D006327 NLM
% 208.97/209.13 |- skos__annotation mesh__D006327 a type of arrhythmia
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Block, Heart
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006327 2002
% 208.97/209.13 |- mesh__dateRevised mesh__D006327 1999-11-03
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Auriculo-Ventricular Dissociations
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Blocks, Atrioventricular
% 208.97/209.13 |- rdf__type mesh__D006327sskos__Concept
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D006327 sjn
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Atrioventricular Blocks
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006327 2005
% 208.97/209.13 |- skos__scopeNote mesh__D006327
% 208.97/209.13 Impairment of conduction in heart excitation. It is often applied specifically to atrioventricular heart block. %28%Dorland, 27th ed%29%%A%
% 208.97/209.13 |- skos__prefLabel mesh__D006327 Heart Block
% 208.97/209.13 |- mesh__recordMaintainer mesh__D006327 TAP
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Auriculo Ventricular Dissociation
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006327 2006
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D006327 2003
% 208.97/209.13 |- skos__hiddenLabel mesh__D006327 Blocks, Heart
% 208.97/209.13 |- skos__scopeNote mesh__D050483
% 208.97/209.13 Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.%A%
% 208.97/209.13 |- skos__altLabel mesh__D050483 DAT Dopamine Transporter
% 208.97/209.13 |- skos__hiddenLabel mesh__D050483 Transporter Proteins, Dopamine
% 208.97/209.13 |- mesh__dateCreated mesh__D050483 2005-06-30
% 208.97/209.13 |- skos__prefLabel mesh__D050483
% 208.97/209.13 Dopamine Plasma Membrane Transport Proteins
% 208.97/209.13 |- skos__altLabel mesh__D050483
% 208.97/209.13 Neurotransmitter Transport Proteins, Dopamine-Specific
% 208.97/209.13 |- mesh__activeMeSHYear mesh__D050483 2006
% 208.97/209.13 |- skos__hiddenLabel mesh__D050483
% 208.97/209.13 Transporters, Dopamine-Specific Neurotransmitter
% 208.97/209.13 |- skos__altLabel mesh__D050483 Dopamine Carriers
% 208.97/209.13 |- mesh__recordOriginator mesh__D050483 DRC
% 208.97/209.13 |- rdf__type mesh__D050483sskos__Concept
% 208.97/209.13 |- skos__hiddenLabel mesh__D050483 Dopamine Transporter, DAT
% 208.97/209.13 |- skos__altLabel mesh__D050483 Dopamine Transporter Proteins
% 208.97/209.13 |- mesh__recordMaintainer mesh__D050483 DRC
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D050483 sjn
% 208.97/209.13 |- skos__altLabel mesh__D050483 DAT Dopamine Transporter Proteins
% 208.97/209.13 |- mesh__publicMeSHNote mesh__D050483
% 208.97/209.13 2006; DOPAMINE TRANSPORTER PROTEINS was indexed under MEMBRANE TRANSPORT PROTEINS 2005, CARRIER PROTEINS 1993-2004, NERVE TISSUE PROTEINS; MEMBRANE GLYOPROTEINS %26% MEMBRANE PROTEINS 1987-2004; DOPAMINE UPTAKE COMPLEX was indexed under MEMBRANE PROTEINS %26% NERVE TISSUE PROTEINS 1993-2004, DOPAMINE/metab 1991-1992%A%
% 208.97/209.13 |- skos__broader mesh__D050483smesh__D050482
% 208.97/209.13 |- skos__altLabel mesh__D050483 Dopamine Transporter
% 208.97/209.13 |- skos__altLabel mesh__D050483
% 208.97/209.13 Dopamine Plasma Membrane Transporter Proteins
% 208.97/209.13 |- skos__hiddenLabel mesh__D050483
% 208.97/209.13 Neurotransmitter Transporters, Dopamine Specific
% 208.97/209.13 |- skos__hiddenLabel mesh__D050483
% 208.97/209.13 Dopamine-Specific Neurotransmitter Transporters
% 208.97/209.13 |- skos__altLabel mesh__D050483
% 208.97/209.13 Neurotransmitter Transporters, Dopamine-Specific
% 208.97/209.13 |- skos__hiddenLabel mesh__D050483 Transporter, Dopamine
% 208.97/209.13 |- mesh__historyNote mesh__D050483 2006%28%1987%29%
% 208.97/209.13 |- skos__historyNote mesh__D050483
% 208.97/209.13 Membrane Transport Proteins %28%1987-2005%29%
% 208.97/209.13 |- mesh__dateEstablished mesh__D050483 2006-01-01
% 208.97/209.13 |- skos__hiddenLabel mesh__D050483 Transporter, DAT Dopamine
% 208.97/209.13 |- skos__broader mesh__D050483smesh__D027981
% 208.97/209.13 |- skos__hiddenLabel mesh__D050483 Carriers, Dopamine
% 208.97/209.13 |- skos__hiddenLabel mesh__D050483
% 208.97/209.13 Neurotransmitter Transport Proteins, Dopamine Specific
% 208.97/209.13 |- skos__historyNote mesh__D044446 Algae, Green %28%1970-2003%29%
% 208.97/209.13 |- skos__scopeNote mesh__D044446
% 208.97/209.13 A genus of GREEN ALGAE in the family Volvocaceae. They form spherical colonies of hundreds or thousands of bi-flagellated cells in a semi-transparent gelatinous ball.%A%
% 208.97/209.13 |- mesh__recordAuthorizer mesh__D044446 sjn
% 208.97/209.13 |- skos__prefLabel mesh__D044446 Volvox
% 208.97/209.13 |- mesh__recordOriginator mesh__D044446 ags
% 208.97/209.13 |- mesh__dateCreated mesh__D044446 2003-07-09
% 208.97/209.13 |- mesh__dateRevised mesh__D044446 2005-06-30
% 208.97/209.13 |- skos__broader mesh__D044446smesh__D000460
% 208.97/209.13 |- mesh__historyNote mesh__D044446 2004; use ALGAE, GREEN 1998-2003
% 208.97/209.13 |- mesh__dateEstablished mesh__D044446 2004-01-01
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D044446 2004; see ALGAE, GREEN 1998-2003
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D044446 2006
% 208.97/209.14 |- rdf__type mesh__D044446sskos__Concept
% 208.97/209.14 |- mesh__recordMaintainer mesh__D044446 SYSTEM
% 208.97/209.14 |- skos__altLabel mesh__D016755 Proto-Oncogene Products c-jun
% 208.97/209.14 |- skos__hiddenLabel mesh__D016755 jun Proto Oncogene Proteins
% 208.97/209.14 |- skos__broader mesh__D016755smesh__D009687
% 208.97/209.14 |- skos__altLabel mesh__D016755 c-fos-Associated Protein p39
% 208.97/209.14 |- skos__altLabel mesh__D016755 fos-Associated Protein p39
% 208.97/209.14 |- skos__broader mesh__D016755smesh__D050976
% 208.97/209.14 |- skos__historyNote mesh__D016755
% 208.97/209.14 Proto-Oncogene Proteins %28%1987-1991%29%
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D016755 sjn
% 208.97/209.14 |- skos__hiddenLabel mesh__D016755 Proto Oncogene Proteins c jun
% 208.97/209.14 |- skos__altLabel mesh__D016755 jun Proto-Oncogene Proteins
% 208.97/209.14 |- mesh__dateRevised mesh__D016755 2005-06-30
% 208.97/209.14 |- mesh__recordOriginator mesh__D016755 AGS
% 208.97/209.14 |- skos__altLabel mesh__D016755 c-jun Proteins
% 208.97/209.14 |- skos__hiddenLabel mesh__D016755 p39 c jun
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D016755 2006
% 208.97/209.14 |- mesh__onlineNote mesh__D016755
% 208.97/209.14 use PROTO-ONCOGENE PROTEINS C-JUN %28%NM%29% to search PROTO-ONCOGENE PROTEIN JUN %28%NM%29% 1988-91%A%
% 208.97/209.14 |- mesh__historyNote mesh__D016755
% 208.97/209.14 92; was PROTO-ONCOGENE PROTEIN JUN %28%NM%29% 1988-91
% 208.97/209.14 |- skos__altLabel mesh__D016755 p39%28%c-jun%29%
% 208.97/209.14 |- skos__altLabel mesh__D016755 jun Proto-Oncogene Product p39
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D016755
% 208.97/209.14 92; PROTO-ONCOGENE PROTEIN JUN %28%NM%29% was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1988-91%A%
% 208.97/209.14 |- skos__historyNote mesh__D016755 Transcription Factors %28%1987-1991%29%
% 208.97/209.14 |- skos__related mesh__D016755smesh__D018808
% 208.97/209.14 |- skos__altLabel mesh__D016755 Proto-Oncogene Proteins jun
% 208.97/209.14 |- skos__hiddenLabel mesh__D016755 c fos Associated Protein p39
% 208.97/209.14 |- skos__broader mesh__D016755smesh__D011518
% 208.97/209.14 |- skos__annotation mesh__D016755
% 208.97/209.14 /drug eff /ultrastruct permitted; DF: note short X refs
% 208.97/209.14 |- rdf__type mesh__D016755sskos__Concept
% 208.97/209.14 |- skos__altLabel mesh__D016755 p39 c-jun
% 208.97/209.14 |- skos__hiddenLabel mesh__D016755 c jun Proteins
% 208.97/209.14 |- skos__scopeNote mesh__D016755
% 208.97/209.14 Cellular DNA-binding proteins encoded by the c-jun genes %28%GENES, JUN%29%. They are involved in growth-related transcriptional control. There appear to be three distinct functions: dimerization %28%with c-fos%29%, DNA-binding, and transcriptional activation. Oncogenic transformation can take place by constitutive expression of c-jun.%A%
% 208.97/209.14 |- mesh__dateEstablished mesh__D016755 1992-01-01
% 208.97/209.14 |- skos__hiddenLabel mesh__D016755 fos Associated Protein p39
% 208.97/209.14 |- mesh__recordMaintainer mesh__D016755 DRC
% 208.97/209.14 |- mesh__dateCreated mesh__D016755 1991-07-12
% 208.97/209.14 |- skos__prefLabel mesh__D016755 Proto-Oncogene Proteins c-jun
% 208.97/209.14 |- skos__historyNote mesh__D016755 DNA-Binding Proteins %28%1987-1991%29%
% 208.97/209.14 |- skos__hiddenLabel mesh__D016755 Proto Oncogene Products c jun
% 208.97/209.14 |- skos__hiddenLabel mesh__D016755 Proto Oncogene Proteins jun
% 208.97/209.14 |- skos__hiddenLabel mesh__D016755 jun Proto Oncogene Product p39
% 208.97/209.14 |- rdf__type mesh__D002735sskos__Concept
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D002735 sjn
% 208.97/209.14 |- mesh__recordOriginator mesh__D002735 NLM
% 208.97/209.14 |- skos__broader mesh__D002735smesh__D002734
% 208.97/209.14 |- skos__prefLabel mesh__D002735 Chlorophyllides
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D002735
% 208.97/209.14 91; was see under CHLOROPHYLL 1975-90
% 208.97/209.14 |- mesh__dateCreated mesh__D002735 1974-11-19
% 208.97/209.14 |- mesh__dateRevised mesh__D002735 2005-06-30
% 208.97/209.14 |- mesh__historyNote mesh__D002735
% 208.97/209.14 91%28%75%29%; was see under CHLOROPHYLL 1975-90
% 208.97/209.14 |- skos__annotation mesh__D002735 products of chlorophil hydrolysis
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D002735 2006
% 208.97/209.14 |- mesh__dateEstablished mesh__D002735 1991-01-01
% 208.97/209.14 |- skos__historyNote mesh__D002735 Chlorophyll %28%1972-1974%29%
% 208.97/209.14 |- skos__scopeNote mesh__D002735
% 208.97/209.14 Products of the hydrolysis of chlorophylls in which the phytic acid side chain has been removed and the carboxylic acids saponified.%A%
% 208.97/209.14 |- mesh__recordMaintainer mesh__D002735 ssb
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D007420 2005
% 208.97/209.14 |- skos__scopeNote mesh__D007420
% 208.97/209.14 A segment of the LOWER GASTROINTESTINAL TRACT that includes the CECUM; the COLON; and the RECTUM.%A%
% 208.97/209.14 |- skos__altLabel mesh__D007420 Large Intestine
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D007420 2006
% 208.97/209.14 |- mesh__recordOriginator mesh__D007420 NLM
% 208.97/209.14 |- skos__prefLabel mesh__D007420 Intestine, Large
% 208.97/209.14 |- mesh__onlineNote mesh__D007420
% 208.97/209.14 search INTESTINAL MICROORGANISMS under INTESTINES 1966-67%A%
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D007420 sjn
% 208.97/209.14 |- mesh__dateCreated mesh__D007420 1999-01-01
% 208.97/209.14 |- skos__annotation mesh__D007420
% 208.97/209.14 GEN: prefer specifics; inflammation: coord IM with GASTROENTERITIS %28%IM%29%%A%
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D007420 2004
% 208.97/209.14 |- mesh__recordMaintainer mesh__D007420 lkt
% 208.97/209.14 |- mesh__historyNote mesh__D007420
% 208.97/209.14 INTESTINAL MICROORGANISMS was heading 1963-67
% 208.97/209.14 |- rdf__type mesh__D007420sskos__Concept
% 208.97/209.14 |- skos__broader mesh__D007420smesh__D007422
% 208.97/209.14 |- mesh__dateRevised mesh__D007420 2003-07-09
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D007420
% 208.97/209.14 INTESTINAL MICROORGANISMS was heading 1963-67
% 208.97/209.14 |- skos__broader mesh__D007420smesh__D041741
% 208.97/209.14 |- skos__hiddenLabel mesh__D012365 RNA, Tyr Transfer
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 1998
% 208.97/209.14 |- skos__hiddenLabel mesh__D012365 Tyr Transfer RNA
% 208.97/209.14 |- skos__altLabel mesh__D012365 Transfer RNA, Tyr
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 2000
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 2005
% 208.97/209.14 |- mesh__historyNote mesh__D012365
% 208.97/209.14 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.14 |- skos__prefLabel mesh__D012365 RNA, Transfer, Tyr
% 208.97/209.14 |- skos__hiddenLabel mesh__D012365 Tyrosine Specific tRNA
% 208.97/209.14 |- skos__altLabel mesh__D012365 Tyrosine-Specific tRNA
% 208.97/209.14 |- rdf__type mesh__D012365sskos__Concept
% 208.97/209.14 |- mesh__dateRevised mesh__D012365 1996-06-10
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D012365
% 208.97/209.14 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 2002
% 208.97/209.14 |- skos__broader mesh__D012365smesh__D012345
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 1997
% 208.97/209.14 |- mesh__recordMaintainer mesh__D012365 TGC
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D012365 PLS
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 2004
% 208.97/209.14 |- skos__altLabel mesh__D012365 tRNATyr
% 208.97/209.14 |- skos__historyNote mesh__D012365 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.14 |- skos__historyNote mesh__D012365 RNA, Transfer %28%1966-1987%29%
% 208.97/209.14 |- skos__altLabel mesh__D012365 tRNA%28%Tyr%29%
% 208.97/209.14 |- skos__annotation mesh__D012365
% 208.97/209.14 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.97/209.14 |- skos__scopeNote mesh__D012365
% 208.97/209.14 A transfer RNA which is specific for carrying tyrosine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.97/209.14 |- mesh__dateCreated mesh__D012365 1987-05-08
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 2003
% 208.97/209.14 |- mesh__dateEstablished mesh__D012365 1991-01-01
% 208.97/209.14 |- mesh__recordOriginator mesh__D012365 RLS
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 1999
% 208.97/209.14 |- skos__hiddenLabel mesh__D012365 tRNA, Tyrosine-Specific
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 2001
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012365 2006
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D039502
% 208.97/209.14 2003; CBP80 PROTEIN was indexed under RNA-BINDING PROTEINS 1994-2002; CAF20 PROTEIN was indexed under RNA-BINDING PROTEINS 1997-2002; CBP20 PROTEIN was indexed under RNA-BINDING PROTEINS 1996-2002%A%
% 208.97/209.14 |- skos__hiddenLabel mesh__D039502 Cap Binding Complex 80 kDa protein
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D039502 2006
% 208.97/209.14 |- mesh__recordOriginator mesh__D039502 jmp
% 208.97/209.14 |- skos__altLabel mesh__D039502 CBP80 Protein
% 208.97/209.14 |- skos__altLabel mesh__D039502 NCBP2 Protein
% 208.97/209.14 |- skos__prefLabel mesh__D039502 Nuclear Cap-Binding Protein Complex
% 208.97/209.14 |- skos__hiddenLabel mesh__D039502 Cap Binding Protein Complex, Nuclear
% 208.97/209.14 |- mesh__historyNote mesh__D039502
% 208.97/209.14 2003; for CBP80 PROTEIN use RNA CAP-BINDING PROTEINS 1994-2002; for CAF20 PROTEIN use RNA CAP-BINDING PROTEINS 1997-2002; for CBP20 PROTEIN use RNA CAP-BINDING PROTEINS 1996-2002%A%
% 208.97/209.14 |- skos__hiddenLabel mesh__D039502
% 208.97/209.14 Nuclear Cap Binding Protein Subunit 1, 80 kDa
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D039502 ags
% 208.97/209.14 |- mesh__dateCreated mesh__D039502 2002-07-03
% 208.97/209.14 |- mesh__dateRevised mesh__D039502 2005-07-21
% 208.97/209.14 |- skos__hiddenLabel mesh__D039502
% 208.97/209.14 Nuclear Cap Binding Protein Subunit 2, 20 kDa
% 208.97/209.14 |- skos__altLabel mesh__D039502 Nuclear Cap Binding Protein, 80-kDa
% 208.97/209.14 |- skos__broader mesh__D039502smesh__D039381
% 208.97/209.14 |- skos__altLabel mesh__D039502 NCBP1 Protein
% 208.97/209.14 |- skos__historyNote mesh__D039502 RNA-Binding Proteins %28%1981-2002%29%
% 208.97/209.14 |- skos__altLabel mesh__D039502 CAF20 Gene Product
% 208.97/209.14 |- skos__hiddenLabel mesh__D039502 Nuclear Cap Binding Protein Complex
% 208.97/209.14 |- skos__hiddenLabel mesh__D039502 Nuclear Cap Binding Protein, 80 kDa
% 208.97/209.14 |- mesh__dateEstablished mesh__D039502 2003-01-01
% 208.97/209.14 |- skos__altLabel mesh__D039502 Cap-Binding Protein Complex, Nuclear
% 208.97/209.14 |- skos__scopeNote mesh__D039502
% 208.97/209.14 A heterodimeric protein complex of RNA cap-binding proteins, which binds with high affinity to the 5%27% MRNA CAP STRUCTURE in the CELL NUCLEUS. The complex contains two subunits, one of 80-kDa molecular weight and another of 20-kDa molecular weight.%A%
% 208.97/209.14 |- rdf__type mesh__D039502sskos__Concept
% 208.97/209.14 |- skos__altLabel mesh__D039502 Cap-Binding Complex 80-kDa protein
% 208.97/209.14 |- mesh__recordMaintainer mesh__D039502 ags
% 208.97/209.14 |- skos__altLabel mesh__D039502 CBP20 Protein
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D039502 2006A
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D039502 2005
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D006328 2000
% 208.97/209.14 |- skos__prefLabel mesh__D006328 Heart Catheterization
% 208.97/209.14 |- mesh__recordMaintainer mesh__D006328 PXP
% 208.97/209.14 |- mesh__dateRevised mesh__D006328 1997-06-20
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D006328 1998
% 208.97/209.14 |- rdf__type mesh__D006328sskos__Concept
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D006328 2001
% 208.97/209.14 |- skos__altLabel mesh__D006328 Catheterization, Cardiac
% 208.97/209.14 |- skos__scopeNote mesh__D006328
% 208.97/209.14 Procedure which includes placement of catheter, recording of intracardiac and intravascular pressure, obtaining blood samples for chemical analysis, and cardiac output measurement, etc. Specific angiographic injection techniques are also involved.%A%
% 208.97/209.14 |- mesh__recordOriginator mesh__D006328 NLM
% 208.97/209.14 |- skos__altLabel mesh__D006328 Cardiac Catheterization
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D006328 1999
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D006328 2005
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D006328 2002
% 208.97/209.14 |- skos__hiddenLabel mesh__D006328 Catheterizations, Cardiac
% 208.97/209.14 |- skos__hiddenLabel mesh__D006328 Heart Catheterizations
% 208.97/209.14 |- skos__hiddenLabel mesh__D006328 Cardiac Catheterizations
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D006328 2006
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D006328 2003
% 208.97/209.14 |- skos__broader mesh__D006328smesh__D006334
% 208.97/209.14 |- skos__hiddenLabel mesh__D006328 Catheterizations, Heart
% 208.97/209.14 |- skos__annotation mesh__D006328
% 208.97/209.14 /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: HEART CATH%A%
% 208.97/209.14 |- skos__broader mesh__D006328smesh__D002404
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D006328 2004
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D006328 SJN
% 208.97/209.14 |- skos__related mesh__D006328smesh__D011669
% 208.97/209.14 |- skos__altLabel mesh__D006328 Catheterization, Heart
% 208.97/209.14 |- mesh__dateCreated mesh__D006328 1999-01-01
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D017050 2001
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D017050 2006
% 208.97/209.14 |- skos__annotation mesh__D017050
% 208.97/209.14 may be one instance of care, a series of episodes or a sequence of care: read MeSH definition; no qualif%A%
% 208.97/209.14 |- skos__altLabel mesh__D017050 Patient Care Episodes
% 208.97/209.14 |- skos__hiddenLabel mesh__D017050 Care Episodes
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D017050 2000
% 208.97/209.14 |- skos__hiddenLabel mesh__D017050 Care Episode
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D017050 2005
% 208.97/209.14 |- mesh__dateEstablished mesh__D017050 1992-01-01
% 208.97/209.14 |- skos__scopeNote mesh__D017050
% 208.97/209.14 An interval of care by a health care facility or provider for a specific medical problem or condition. It may be continuous or it may consist of a series of intervals marked by one or more brief separations from care, and can also identify the sequence of care %28%e.g., emergency, inpatient, outpatient%29%, thus serving as one measure of health care provided.%A%
% 208.97/209.14 |- skos__hiddenLabel mesh__D017050 Episode, Patient Care
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D017050 1999
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D017050 SJN
% 208.97/209.14 |- skos__prefLabel mesh__D017050 Episode of Care
% 208.97/209.14 |- rdf__type mesh__D017050sskos__Concept
% 208.97/209.14 |- skos__hiddenLabel mesh__D017050 Patient Care Episode
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D017050 92
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D017050 1998
% 208.97/209.14 |- skos__altLabel mesh__D017050 Episodes of Care
% 208.97/209.14 |- mesh__dateRevised mesh__D017050 1997-06-20
% 208.97/209.14 |- mesh__historyNote mesh__D017050 92
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D017050 2002
% 208.97/209.14 |- skos__hiddenLabel mesh__D017050 Episodes, Patient Care
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D017050 2004
% 208.97/209.14 |- mesh__recordOriginator mesh__D017050 PLS
% 208.97/209.14 |- mesh__dateCreated mesh__D017050 1991-06-20
% 208.97/209.14 |- mesh__recordMaintainer mesh__D017050 PXP
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D017050 2003
% 208.97/209.14 |- skos__broader mesh__D017050smesh__D005791
% 208.97/209.14 |- skos__altLabel mesh__D050484 NET Protein, Neuronal
% 208.97/209.14 |- skos__broader mesh__D050484smesh__D050482
% 208.97/209.14 |- skos__hiddenLabel mesh__D050484 Transporter Protein, Norepinephrine
% 208.97/209.14 |- skos__altLabel mesh__D050484
% 208.97/209.14 Noradrenaline Plasma Membrane Transport Proteins
% 208.97/209.14 |- skos__hiddenLabel mesh__D050484
% 208.97/209.14 Transporters, Noradrenaline-Specific Neurotransmitter
% 208.97/209.14 |- skos__hiddenLabel mesh__D050484
% 208.97/209.14 Noradrenaline-Specific Neurotransmitter Transporters
% 208.97/209.14 |- skos__historyNote mesh__D050484 Symporters %28%2005%29%
% 208.97/209.14 |- skos__prefLabel mesh__D050484
% 208.97/209.14 Norepinephrine Plasma Membrane Transport Proteins
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D050484
% 208.97/209.14 2006; NOREPINEPHRINE TRANSPORTER PROTEIN was indexed under SYMPORTERS 2005 %26% under CARRIER PROTEINS 1991-2004%A%
% 208.97/209.14 |- skos__hiddenLabel mesh__D050484
% 208.97/209.14 Sodium Dependent Noradrenaline Transporter
% 208.97/209.14 |- skos__altLabel mesh__D050484 Norepinephrine Transporter
% 208.97/209.14 |- mesh__dateCreated mesh__D050484 2005-06-30
% 208.97/209.14 |- skos__broader mesh__D050484smesh__D027981
% 208.97/209.14 |- skos__historyNote mesh__D050484 Carrier Proteins %28%1991-2004%29%
% 208.97/209.14 |- skos__altLabel mesh__D050484 Noradrenaline Transporter
% 208.97/209.14 |- mesh__recordMaintainer mesh__D050484 DRC
% 208.97/209.14 |- skos__altLabel mesh__D050484
% 208.97/209.14 Neurotransmitter Transporters, Noradrenaline-Specific
% 208.97/209.14 |- skos__altLabel mesh__D050484 Norepinephrine Transporter Protein
% 208.97/209.14 |- skos__hiddenLabel mesh__D050484 Transporter, Norepinephrine
% 208.97/209.14 |- skos__altLabel mesh__D050484 Sodium-Dependent Noradrenaline Transporter
% 208.97/209.14 |- skos__altLabel mesh__D050484 Norepinephrine Plasma Membrane Transporters
% 208.97/209.14 |- skos__altLabel mesh__D050484
% 208.97/209.14 Norepinephrine Plasma Membrane Transporter Proteins
% 208.97/209.14 |- mesh__historyNote mesh__D050484 2006%28%1991%29%
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D050484 2006
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D050484 sjn
% 208.97/209.14 |- skos__hiddenLabel mesh__D050484 Transporter, Noradrenaline
% 208.97/209.14 |- mesh__recordOriginator mesh__D050484 DRC
% 208.97/209.14 |- rdf__type mesh__D050484sskos__Concept
% 208.97/209.14 |- skos__hiddenLabel mesh__D050484 Neuronal NET Protein
% 208.97/209.14 |- skos__hiddenLabel mesh__D050484
% 208.97/209.14 Noradrenaline Transporter, Sodium-Dependent
% 208.97/209.14 |- skos__hiddenLabel mesh__D050484
% 208.97/209.14 Neurotransmitter Transporters, Noradrenaline Specific
% 208.97/209.14 |- mesh__dateEstablished mesh__D050484 2006-01-01
% 208.97/209.14 |- skos__scopeNote mesh__D050484
% 208.97/209.14 Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of noradrenergic neurons. They remove NOREPINEPHRINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. It regulates signal amplitude and duration at noradrenergic synapses and is the target of ADRENERGIC UPTAKE INHIBITORS.%A%
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D003030 sjn
% 208.97/209.14 |- mesh__onlineNote mesh__D003030
% 208.97/209.14 use HYDROLASES to search STAPHYLOCOAGULASE 1966-67
% 208.97/209.14 |- mesh__historyNote mesh__D003030
% 208.97/209.14 66%28%64%29%; was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67%A%
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D003030
% 208.97/209.14 66; was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67%A%
% 208.97/209.14 |- skos__broader mesh__D003030smesh__D001426
% 208.97/209.14 |- skos__hiddenLabel mesh__D003030 Clumping Factor, Staphylococcal
% 208.97/209.14 |- skos__hiddenLabel mesh__D003030 Factor, Staphylococcal Clumping
% 208.97/209.14 |- skos__scopeNote mesh__D003030
% 208.97/209.14 Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen.%A%
% 208.97/209.14 |- mesh__dateRevised mesh__D003030 2005-06-30
% 208.97/209.14 |- skos__annotation mesh__D003030
% 208.97/209.14 do not routinely add when indexing coagulase negative organisms; index only when discussed%A%
% 208.97/209.14 |- skos__hiddenLabel mesh__D003030
% 208.97/209.14 Staphylococcus aureus strain 8325 4 of Coagulase
% 208.97/209.14 |- mesh__dateEstablished mesh__D003030 1966-01-01
% 208.97/209.14 |- mesh__dateCreated mesh__D003030 1999-01-01
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D003030 2006
% 208.97/209.14 |- skos__broader mesh__D003030smesh__D010450
% 208.97/209.14 |- mesh__recordMaintainer mesh__D003030 ssb
% 208.97/209.14 |- mesh__recordOriginator mesh__D003030 NLM
% 208.97/209.14 |- rdf__type mesh__D003030sskos__Concept
% 208.97/209.14 |- skos__altLabel mesh__D003030 Clumping Factor %28%Staphylococcal%29%
% 208.97/209.14 |- skos__prefLabel mesh__D003030 Coagulase
% 208.97/209.14 |- skos__scopeNote mesh__D049930
% 208.97/209.14 A plant genus of the family POACEAE. The RHIZOME contains SESQUITERPENES and is the source of vetiver oil used in PERFUME.%A%
% 208.97/209.14 |- mesh__dateCreated mesh__D049930 2005-06-30
% 208.97/209.14 |- mesh__recordOriginator mesh__D049930 ssb
% 208.97/209.14 |- mesh__dateEstablished mesh__D049930 2006-01-01
% 208.97/209.14 |- skos__broader mesh__D049930smesh__D006109
% 208.97/209.14 |- skos__prefLabel mesh__D049930 Vetiveria
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D049930 2006
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D049930 sjn
% 208.97/209.14 |- mesh__historyNote mesh__D049930 2006
% 208.97/209.14 |- skos__annotation mesh__D049930
% 208.97/209.14 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.97/209.14 |- skos__altLabel mesh__D049930 Andropogon zizanioides
% 208.97/209.14 |- skos__altLabel mesh__D049930 Vetiver Grass
% 208.97/209.14 |- rdf__type mesh__D049930sskos__Concept
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D049930 2006
% 208.97/209.14 |- mesh__recordMaintainer mesh__D049930 ssb
% 208.97/209.14 |- skos__historyNote mesh__D016756 IgG %28%1970-1991%29%
% 208.97/209.14 |- mesh__recordMaintainer mesh__D016756 jmp
% 208.97/209.14 |- mesh__dateCreated mesh__D016756 1991-04-29
% 208.97/209.14 |- skos__altLabel mesh__D016756 Antibodies, Intravenous
% 208.97/209.14 |- skos__hiddenLabel mesh__D016756 Intravenous Immune Globulin
% 208.97/209.14 |- skos__hiddenLabel mesh__D016756 Globulin N
% 208.97/209.14 |- skos__hiddenLabel mesh__D016756 GlobulinN
% 208.97/209.14 |- skos__altLabel mesh__D016756 Intravenous Antibodies
% 208.97/209.14 |- skos__scopeNote mesh__D016756
% 208.97/209.14 Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.%A%
% 208.97/209.14 |- mesh__historyNote mesh__D016756
% 208.97/209.14 92; GLOBULIN-N was NM 1986-91; VENOGLOBULIN was NM 1983-91; GAMMONATIV %26% INTRAGLOBIN were NM 1982-91; SANDOGLOBULIN %26% MODIFIED IMMUNE GLOBULIN %28%ANTI-ECHOVIRUS ANTIBODY%29% were NM 1981-91%A%
% 208.97/209.14 |- mesh__onlineNote mesh__D016756
% 208.97/209.14 use IMMUNOGLOBULINS, INTRAVENOUS %28%NM%29% to search GLOBULIN-N %28%NM%29% 1986-91, VENOGLOBULIN %28%NM%29% 1983-91, GAMMONATIV %28%NM%29% %26% INTRAGLOBIN %28%NM%29% 1982-91, and SANDOGLOBULIN %28%NM%29% %26% MODIFIED IMMUNE GLOBULIN %28%ANTI-ECHOVIRUS ANTIBODY%29% %28%NM%29% 1981-91.%A%
% 208.97/209.14 |- skos__altLabel mesh__D016756 Intravenous IG
% 208.97/209.14 |- skos__altLabel mesh__D016756 Gamimmune
% 208.97/209.14 |- skos__hiddenLabel mesh__D016756 Immunoglobulins, IV
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D016756 2006
% 208.97/209.14 |- skos__hiddenLabel mesh__D016756 VenoglobulinI
% 208.97/209.14 |- skos__broader mesh__D016756smesh__D007074
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D016756 sjn
% 208.97/209.14 |- skos__altLabel mesh__D016756 Intravenous Immunoglobulins
% 208.97/209.14 |- skos__altLabel mesh__D016756 IV Immunoglobulins
% 208.97/209.14 |- mesh__dateRevised mesh__D016756 2005-06-30
% 208.97/209.14 |- skos__altLabel mesh__D016756 Gamimmune N
% 208.97/209.14 |- skos__altLabel mesh__D016756 Immune Globulin, Intravenous
% 208.97/209.14 |- skos__altLabel mesh__D016756 IVIG
% 208.97/209.14 |- skos__broader mesh__D016756smesh__D000906
% 208.97/209.14 |- mesh__dateEstablished mesh__D016756 1992-01-01
% 208.97/209.14 |- skos__prefLabel mesh__D016756 Immunoglobulins, Intravenous
% 208.97/209.14 |- skos__historyNote mesh__D016756 Immunoglobulins %28%1970-1991%29%
% 208.97/209.14 |- skos__hiddenLabel mesh__D016756 Venoglobulin I
% 208.97/209.14 |- rdf__type mesh__D016756sskos__Concept
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D016756
% 208.97/209.14 92; GLOBULIN-N was indexed under IGG, IGA, %26% DRUG COMBINATIONS 1986-91; VENOGLOBULIN was indexed under GAMMA GLOBULINS, FIBRINOLYSIN, %26% DRUG COMBINATIONS 1983-91; INTRAGLOBIN was indexed under IGG/analogs 1982-91; GAMMONATIV was indexed under IGG 1982-90; MODIFIED IMMUNE GLOBULIN %28%ANTI-ECHOVIRUS ANTIBODY%29% was indexed under IMMUNOGLOBULINS %26% ANTIBODIES, VIRAL 1981-90; SANDOGLOBULIN was indexed under IGG 1981-91%A%
% 208.97/209.14 |- mesh__recordOriginator mesh__D016756 AGS
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D002736 ags
% 208.97/209.14 |- skos__prefLabel mesh__D002736 Chloroplasts
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D002736 2005
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D002736 2006
% 208.97/209.14 |- mesh__recordMaintainer mesh__D002736 ags
% 208.97/209.14 |- mesh__historyNote mesh__D002736 66%28%64%29%
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D002736 66
% 208.97/209.14 |- skos__broader mesh__D002736smesh__D018087
% 208.97/209.14 |- mesh__recordOriginator mesh__D002736 NLM
% 208.97/209.14 |- rdf__type mesh__D002736sskos__Concept
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D002736 2004
% 208.97/209.14 |- mesh__dateRevised mesh__D002736 2005-07-27
% 208.97/209.14 |- skos__scopeNote mesh__D002736
% 208.97/209.14 Plant cell inclusion bodies that contain the photosynthetic pigment chlorophyll, which is associated with the membrane of THYLAKOIDS. Chloroplasts occur in cells of leaves and young stems of higher plants.%A%
% 208.97/209.14 |- mesh__dateEstablished mesh__D002736 1966-01-01
% 208.97/209.14 |- skos__altLabel mesh__D002736 Chloroplast
% 208.97/209.14 |- mesh__dateCreated mesh__D002736 1999-01-01
% 208.97/209.14 |- skos__annotation mesh__D002736
% 208.97/209.14 coord IM with PLANTS; ALGAE; or specific plant or alga usually NIM%A%
% 208.97/209.14 |- skos__related mesh__D002736smesh__D010788
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D002736 2006A
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D007421
% 208.97/209.14 INTESTINAL MICROORGANISMS was heading 1963-67
% 208.97/209.14 |- skos__altLabel mesh__D007421 Small Intestine
% 208.97/209.14 |- skos__annotation mesh__D007421
% 208.97/209.14 GEN; inflammation = ENTERITIS but ENTEROCOLITIS; DUODENITIS %26% ILEITIS are available%A%
% 208.97/209.14 |- mesh__onlineNote mesh__D007421
% 208.97/209.14 search INTESTINAL MICROORGANISMS under INTESTINES 1966-67%A%
% 208.97/209.14 |- mesh__dateCreated mesh__D007421 1999-01-01
% 208.97/209.14 |- skos__prefLabel mesh__D007421 Intestine, Small
% 208.97/209.14 |- skos__broader mesh__D007421smesh__D007422
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D007421 2004
% 208.97/209.14 |- mesh__dateRevised mesh__D007421 2003-07-09
% 208.97/209.14 |- mesh__historyNote mesh__D007421
% 208.97/209.14 INTESTINAL MICROORGANISMS was heading 1963-67
% 208.97/209.14 |- rdf__type mesh__D007421sskos__Concept
% 208.97/209.14 |- mesh__recordOriginator mesh__D007421 NLM
% 208.97/209.14 |- skos__hiddenLabel mesh__D007421 Intestines, Small
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D007421 sjn
% 208.97/209.14 |- skos__hiddenLabel mesh__D007421 Small Intestines
% 208.97/209.14 |- skos__scopeNote mesh__D007421
% 208.97/209.14 The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM.%A%
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D007421 2005
% 208.97/209.14 |- mesh__recordMaintainer mesh__D007421 lkt
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D007421 2006
% 208.97/209.14 |- skos__hiddenLabel mesh__D012366 RNA, Val Transfer
% 208.97/209.14 |- mesh__recordOriginator mesh__D012366 RLS
% 208.97/209.14 |- mesh__dateCreated mesh__D012366 1987-05-08
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D012366 PLS
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D012366
% 208.97/209.14 91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.14 |- skos__historyNote mesh__D012366 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.14 |- skos__broader mesh__D012366smesh__D012345
% 208.97/209.14 |- skos__hiddenLabel mesh__D012366 Val Transfer RNA
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 1997
% 208.97/209.14 |- skos__altLabel mesh__D012366 tRNAVal
% 208.97/209.14 |- skos__scopeNote mesh__D012366
% 208.97/209.14 A transfer RNA which is specific for carrying valine to sites on the ribosomes in preparation for protein synthesis.%A%
% 208.97/209.14 |- skos__hiddenLabel mesh__D012366 Valine Specific tRNA
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 2004
% 208.97/209.14 |- skos__historyNote mesh__D012366 RNA, Transfer %28%1966-1987%29%
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 2001
% 208.97/209.14 |- mesh__recordMaintainer mesh__D012366 TGC
% 208.97/209.14 |- skos__annotation mesh__D012366
% 208.97/209.14 IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 208.97/209.14 |- skos__altLabel mesh__D012366 Transfer RNA, Val
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 2003
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 1999
% 208.97/209.14 |- skos__hiddenLabel mesh__D012366 tRNA, Valine-Specific
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 2000
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 2006
% 208.97/209.14 |- mesh__dateEstablished mesh__D012366 1991-01-01
% 208.97/209.14 |- skos__altLabel mesh__D012366 tRNA%28%Val%29%
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 1998
% 208.97/209.14 |- mesh__historyNote mesh__D012366
% 208.97/209.14 91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%
% 208.97/209.14 |- skos__altLabel mesh__D012366 Valine-Specific tRNA
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 2005
% 208.97/209.14 |- mesh__dateRevised mesh__D012366 1996-06-10
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D012366 2002
% 208.97/209.14 |- rdf__type mesh__D012366sskos__Concept
% 208.97/209.14 |- skos__prefLabel mesh__D012366 RNA, Transfer, Val
% 208.97/209.14 |- skos__broader mesh__D004044Q000172smesh__D004044
% 208.97/209.14 |- mesh__preferredCombination mesh__D004044Q000172smesh__D011488
% 208.97/209.14 |- rdf__type mesh__D004044Q000172smesh__CompoundConcept
% 208.97/209.14 |- mesh__historyNote mesh__D039503
% 208.97/209.14 2003; use INTEGRIN ALPHA6 %28%NM%29% 1994-2002
% 208.97/209.14 |- skos__hiddenLabel mesh__D039503 alpha6, Integrin
% 208.97/209.14 |- skos__related mesh__D039503smesh__D039161
% 208.97/209.14 |- skos__altLabel mesh__D039503 CD49f Antigen
% 208.97/209.14 |- mesh__recordMaintainer mesh__D039503 ssb
% 208.97/209.14 |- skos__hiddenLabel mesh__D039503 Integrin, alpha6
% 208.97/209.14 |- skos__scopeNote mesh__D039503
% 208.97/209.14 An integrin alpha subunit that primarily associates with INTEGRIN BETA1 or INTEGRIN BETA4 to form laminin-binding heterodimers. Integrin alpha6 has two alternatively spliced isoforms: integrin alpha6A and integrin alpha6B, which differ in their cytoplasmic domains and are regulated in a tissue-specific and developmental stage-specific manner.%A%
% 208.97/209.14 |- skos__altLabel mesh__D039503 CD49f Antigens
% 208.97/209.14 |- skos__altLabel mesh__D039503 alpha6 Integrin
% 208.97/209.14 |- skos__altLabel mesh__D039503 Antigens, CD49f
% 208.97/209.14 |- skos__altLabel mesh__D039503 alpha%28%6%29% Integrin
% 208.97/209.14 |- skos__hiddenLabel mesh__D039503 alpha6B, Integrin
% 208.97/209.14 |- mesh__recordAuthorizer mesh__D039503 sjn
% 208.97/209.14 |- skos__prefLabel mesh__D039503 Integrin alpha6
% 208.97/209.14 |- skos__broader mesh__D039503smesh__D015703
% 208.97/209.14 |- rdf__type mesh__D039503sskos__Concept
% 208.97/209.14 |- mesh__dateRevised mesh__D039503 2005-06-30
% 208.97/209.14 |- skos__hiddenLabel mesh__D039503 Antigen, CD49f
% 208.97/209.14 |- mesh__recordOriginator mesh__D039503 MDJ
% 208.97/209.14 |- skos__historyNote mesh__D039503 Antigens, CD %28%1994-2002%29%
% 208.97/209.14 |- mesh__dateCreated mesh__D039503 2002-07-02
% 208.97/209.14 |- mesh__publicMeSHNote mesh__D039503
% 208.97/209.14 2003; INTEGRIN ALPHA6 was indexed under ANTIGENS, CD 1994-2002%A%
% 208.97/209.14 |- skos__related mesh__D039503smesh__D039121
% 208.97/209.14 |- skos__hiddenLabel mesh__D039503 alpha6A, Integrin
% 208.97/209.14 |- mesh__dateEstablished mesh__D039503 2003-01-01
% 208.97/209.14 |- skos__broader mesh__D039503smesh__D039001
% 208.97/209.14 |- mesh__activeMeSHYear mesh__D039503 2006
% 208.97/209.14 |- skos__related mesh__D006329smesh__D001145
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 2000
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 1994
% 208.97/209.15 |- skos__hiddenLabel mesh__D006329 Kent Bundle
% 208.97/209.15 |- rdf__type mesh__D006329sskos__Concept
% 208.97/209.15 |- skos__hiddenLabel mesh__D006329 System, Heart Conduction
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 2001
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 1998
% 208.97/209.15 |- skos__annotation mesh__D006329
% 208.97/209.15 disord = ARRHYTHMIA or HEART BLOCK %26% their specifics
% 208.97/209.15 |- mesh__recordOriginator mesh__D006329 NLM
% 208.97/209.15 |- skos__broader mesh__D006329smesh__D006321
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 1995
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 1996
% 208.97/209.15 |- skos__scopeNote mesh__D006329
% 208.97/209.15 An impulse-conducting system composed of modified cardiac muscle and having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart.%A%
% 208.97/209.15 |- mesh__dateRevised mesh__D006329 1992-05-15
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 1993
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 1999
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 2002
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 1997
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 2005
% 208.97/209.15 |- skos__hiddenLabel mesh__D006329 Heart Conduction Systems
% 208.97/209.15 |- skos__hiddenLabel mesh__D006329 Conduction Systems, Heart
% 208.97/209.15 |- skos__prefLabel mesh__D006329 Heart Conduction System
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 2003
% 208.97/209.15 |- skos__hiddenLabel mesh__D006329 Conduction System, Heart
% 208.97/209.15 |- mesh__dateCreated mesh__D006329 1999-01-01
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 2006
% 208.97/209.15 |- skos__hiddenLabel mesh__D006329 Systems, Heart Conduction
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D006329 PLS
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D006329 2004
% 208.97/209.15 |- mesh__recordMaintainer mesh__D006329 TAP
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017051 2002
% 208.97/209.15 |- skos__annotation mesh__D017051 for the dying; /psychol permitted
% 208.97/209.15 |- rdf__type mesh__D017051sskos__Concept
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D017051 sjn
% 208.97/209.15 |- skos__scopeNote mesh__D017051
% 208.97/209.15 Specialized health care, supportive in nature, provided to a dying person. A holistic approach is often taken, providing patients and their families with legal, financial, emotional, or spiritual counseling in addition to meeting patients%27% immediate physical needs. Care may be provided in the home, in the hospital, in specialized facilities %28%HOSPICES%29%, or in specially designated areas of long-term care facilities. The concept also includes bereavement care for the family. %28%From Dictionary of Health Services Management, 2d ed%29%%A%
% 208.97/209.15 |- mesh__historyNote mesh__D017051 92
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017051 2004
% 208.97/209.15 |- skos__hiddenLabel mesh__D017051 Program, Hospice
% 208.97/209.15 |- mesh__recordOriginator mesh__D017051 PLS
% 208.97/209.15 |- skos__broader mesh__D017051smesh__D013727
% 208.97/209.15 |- mesh__dateRevised mesh__D017051 1999-11-03
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017051 2001
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017051 2003
% 208.97/209.15 |- skos__historyNote mesh__D017051 Hospices %28%1977-1991%29%
% 208.97/209.15 |- skos__hiddenLabel mesh__D017051 Care, Bereavement
% 208.97/209.15 |- skos__hiddenLabel mesh__D017051 Hospice Program
% 208.97/209.15 |- mesh__dateEstablished mesh__D017051 1992-01-01
% 208.97/209.15 |- skos__related mesh__D017051smesh__D012144
% 208.97/209.15 |- mesh__dateCreated mesh__D017051 1991-06-20
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017051 2000
% 208.97/209.15 |- mesh__recordMaintainer mesh__D017051 jls
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017051 2006
% 208.97/209.15 |- skos__prefLabel mesh__D017051 Hospice Care
% 208.97/209.15 |- skos__hiddenLabel mesh__D017051 Care, Hospice
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017051 2005
% 208.97/209.15 |- skos__hiddenLabel mesh__D017051 Programs, Hospice
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D017051 92
% 208.97/209.15 |- skos__altLabel mesh__D050485 GAT-3 Transporter
% 208.97/209.15 |- skos__altLabel mesh__D050485 GAT1 Transporter
% 208.97/209.15 |- skos__altLabel mesh__D050485 GAT-1 Transporter
% 208.97/209.15 |- skos__related mesh__D050485smesh__D018757
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485 Transporter, GAT-4
% 208.97/209.15 |- rdf__type mesh__D050485sskos__Concept
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485 Transporters, GABA
% 208.97/209.15 |- mesh__dateRevised mesh__D050485 2005-07-14
% 208.97/209.15 |- skos__scopeNote mesh__D050485
% 208.97/209.15 A family of plasma membrane neurotransmitter transporter proteins that regulates that extracellular levels of the inhibitory neurotransmitter GAMMA-AMINOBUTYRIC ACID. They differ from GABA RECEPTORS, which signal cellular responses to GAMMA-AMINOBUTYRIC ACID. They control GABA reuptake into PRESYNAPTIC TERMINALS in the CENTRAL NERVOUS SYSTEM through high-affinity sodium-dependent transport.%A%
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485 GAT 1 Transporter
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485 Transporter, GAT2
% 208.97/209.15 |- mesh__historyNote mesh__D050485 2006%28%1979%29%
% 208.97/209.15 |- skos__altLabel mesh__D050485 GABA Plasma Membrane Transporter Proteins
% 208.97/209.15 |- skos__historyNote mesh__D050485
% 208.97/209.15 Membrane Transport Proteins %28%1980-2005%29%
% 208.97/209.15 |- skos__broader mesh__D050485smesh__D050480
% 208.97/209.15 |- mesh__recordMaintainer mesh__D050485 ags
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485 GAT 2 Transporter
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D050485
% 208.97/209.15 2006; GABA TRANSPORTERS was indexed under MEMBRANE TRANSPORT PROTEINS 2002-2005, CARRIER PROTEINS %26% under MEMBRANE PROTEINS 1979-2001%A%
% 208.97/209.15 |- skos__altLabel mesh__D050485
% 208.97/209.15 Neurotransmitter Transport Proteins, GABA-Specific
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485 Transporter, GAT-2
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D050485 2006
% 208.97/209.15 |- mesh__dateEstablished mesh__D050485 2006-01-01
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485 GAT 3 Transporter
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485
% 208.97/209.15 Gamma Aminobutyric Acid Plasma Membrane Transport Proteins
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485 Transporter 2, GABA
% 208.97/209.15 |- skos__altLabel mesh__D050485 GAT-2 Transporter
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485
% 208.97/209.15 Neurotransmitter Transport Proteins, GABA Specific
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D050485 ags
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485
% 208.97/209.15 GABA-Specific Neurotransmitter Transporters
% 208.97/209.15 |- skos__altLabel mesh__D050485
% 208.97/209.15 Gamma-Aminobutyric Acid Plasma Membrane Transport Proteins
% 208.97/209.15 |- skos__altLabel mesh__D050485 GAT3 Transporter
% 208.97/209.15 |- mesh__dateCreated mesh__D050485 2005-06-30
% 208.97/209.15 |- mesh__recordOriginator mesh__D050485 DRC
% 208.97/209.15 |- skos__related mesh__D050485smesh__D018079
% 208.97/209.15 |- skos__prefLabel mesh__D050485 GABA Plasma Membrane Transport Proteins
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D050485 2006A
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485
% 208.97/209.15 Neurotransmitter Transporters, GABA Specific
% 208.97/209.15 |- skos__altLabel mesh__D050485 GABA Transporters
% 208.97/209.15 |- skos__altLabel mesh__D050485
% 208.97/209.15 Neurotransmitter Transporters, GABA-Specific
% 208.97/209.15 |- skos__altLabel mesh__D050485 GAT-4 Transporter
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485
% 208.97/209.15 Transporters, GABA-Specific Neurotransmitter
% 208.97/209.15 |- skos__hiddenLabel mesh__D050485 GAT 4 Transporter
% 208.97/209.15 |- skos__altLabel mesh__D050485 GAT2 Transporter
% 208.97/209.15 |- skos__broader mesh__D050485smesh__D027981
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D003031 SJN
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D003031 68
% 208.97/209.15 |- mesh__historyNote mesh__D003031
% 208.97/209.15 68%28%64%29%; was in Cat J only 1964-81
% 208.97/209.15 |- mesh__recordMaintainer mesh__D003031 JLS
% 208.97/209.15 |- mesh__dateCreated mesh__D003031 1999-01-01
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003031 2006
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003031 2002
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003031 1999
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003031 2004
% 208.97/209.15 |- skos__annotation mesh__D003031
% 208.97/209.15 /adv eff permitted but do not use for COAL MINING + PNEUMOCONIOSIS or ANTHRACOSILICOSIS unless particularly discussed as coal%A%
% 208.97/209.15 |- skos__hiddenLabel mesh__D003031 Coals
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003031 2005
% 208.97/209.15 |- mesh__dateEstablished mesh__D003031 1968-01-01
% 208.97/209.15 |- rdf__type mesh__D003031sskos__Concept
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003031 1998
% 208.97/209.15 |- skos__scopeNote mesh__D003031
% 208.97/209.15 A natural fuel formed by partial decomposition of vegetable matter under certain environmental conditions.%A%
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003031 2003
% 208.97/209.15 |- mesh__dateRevised mesh__D003031 1997-06-20
% 208.97/209.15 |- skos__prefLabel mesh__D003031 Coal
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003031 2001
% 208.97/209.15 |- skos__broader mesh__D003031smesh__D005579
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003031 2000
% 208.97/209.15 |- mesh__recordOriginator mesh__D003031 NLM
% 208.97/209.15 |- rdf__type mesh__D049931sskos__Concept
% 208.97/209.15 |- skos__annotation mesh__D049931
% 208.97/209.15 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.97/209.15 |- skos__historyNote mesh__D049931 Fabaceae %28%1982-2005%29%
% 208.97/209.15 |- skos__scopeNote mesh__D049931
% 208.97/209.15 A plant genus of the family FABACEAE. Members contain piperidine alkaloids %28%PIPERIDINES%29%.%A%
% 208.97/209.15 |- skos__prefLabel mesh__D049931 Sesbania
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D049931 2006
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D049931 2006
% 208.97/209.15 |- mesh__recordOriginator mesh__D049931 ssb
% 208.97/209.15 |- skos__broader mesh__D049931smesh__D007887
% 208.97/209.15 |- mesh__dateEstablished mesh__D049931 2006-01-01
% 208.97/209.15 |- mesh__recordMaintainer mesh__D049931 ssb
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D049931 sjn
% 208.97/209.15 |- mesh__historyNote mesh__D049931 2006
% 208.97/209.15 |- mesh__dateCreated mesh__D049931 2005-06-30
% 208.97/209.15 |- mesh__dateCreated mesh__D016757 1991-04-29
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D016757 2004
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D016757 92
% 208.97/209.15 |- mesh__recordOriginator mesh__D016757 MXR
% 208.97/209.15 |- skos__hiddenLabel mesh__D016757 Cardiac Death, Sudden
% 208.97/209.15 |- skos__altLabel mesh__D016757 Sudden Cardiac Death
% 208.97/209.15 |- skos__broader mesh__D016757smesh__D003645
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D016757 2003
% 208.97/209.15 |- skos__hiddenLabel mesh__D016757 Sudden Death, Cardiac
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D016757 sjn
% 208.97/209.15 |- skos__scopeNote mesh__D016757
% 208.97/209.15 Sudden death %28%DEATH, SUDDEN%29% that is due to HEART ARREST.%A%
% 208.97/209.15 |- skos__altLabel mesh__D016757 Cardiac Sudden Death
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D016757 2002
% 208.97/209.15 |- mesh__recordMaintainer mesh__D016757 nns
% 208.97/209.15 |- skos__hiddenLabel mesh__D016757 Death, Sudden Cardiac
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D016757 2006
% 208.97/209.15 |- skos__broader mesh__D016757smesh__D006323
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D016757 2005
% 208.97/209.15 |- skos__prefLabel mesh__D016757 Death, Sudden, Cardiac
% 208.97/209.15 |- rdf__type mesh__D016757sskos__Concept
% 208.97/209.15 |- skos__related mesh__D016757smesh__D006323
% 208.97/209.15 |- skos__hiddenLabel mesh__D016757 Death, Cardiac Sudden
% 208.97/209.15 |- mesh__dateEstablished mesh__D016757 1992-01-01
% 208.97/209.15 |- mesh__dateRevised mesh__D016757 2001-07-25
% 208.97/209.15 |- mesh__historyNote mesh__D016757 92
% 208.97/209.15 |- skos__historyNote mesh__D016757 Death, Sudden %28%1966-1991%29%
% 208.97/209.15 |- skos__prefLabel mesh__D002737 Chloroprene
% 208.97/209.15 |- mesh__dateCreated mesh__D002737 1978-05-01
% 208.97/209.15 |- skos__broader mesh__D002737smesh__D000466
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D002737 2006
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D002737 2003
% 208.97/209.15 |- skos__historyNote mesh__D002737 Butadienes %28%1966-1978%29%
% 208.97/209.15 |- mesh__dateEstablished mesh__D002737 1991-01-01
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D002737
% 208.97/209.15 91; was see under BUTADIENES 1979-90
% 208.97/209.15 |- rdf__type mesh__D002737sskos__Concept
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D002737 2004
% 208.97/209.15 |- mesh__recordMaintainer mesh__D002737 CCR
% 208.97/209.15 |- mesh__recordOriginator mesh__D002737 SH
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D002737 2001
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D002737 sjn
% 208.97/209.15 |- skos__historyNote mesh__D002737 Neoprene %28%1975-1978%29%
% 208.97/209.15 |- mesh__dateRevised mesh__D002737 2000-06-22
% 208.97/209.15 |- mesh__historyNote mesh__D002737
% 208.97/209.15 91%28%79%29%; was see under BUTADIENES 1979-90
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D002737 2005
% 208.97/209.15 |- skos__scopeNote mesh__D002737
% 208.97/209.15 Toxic, possibly carcinogenic, monomer of neoprene, a synthetic rubber; causes damage to skin, lungs, CNS, kidneys, liver, blood cells and fetuses. Synonym: 2-chlorobutadiene.%A%
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D002737 2002
% 208.97/209.15 |- skos__prefLabel mesh__D007422 Intestines
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D007422 sjn
% 208.97/209.15 |- skos__annotation mesh__D007422
% 208.97/209.15 GEN; /secret = INTESTINAL MUCOSA /secret or INTESTINAL SECRETIONS; invagination = INTUSSUSCEPTION; /surg: consider also ENTEROSTOMY %26% GASTROENTEROSTOMY; inflammation or inflamm dis: see note on INTESTINAL DISEASES; gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS%A%
% 208.97/209.15 |- skos__related mesh__D007422smesh__D005763
% 208.97/209.15 |- skos__related mesh__D007422smesh__D004766
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D007422 2006
% 208.97/209.15 |- skos__hiddenLabel mesh__D007422 Intestine
% 208.97/209.15 |- mesh__recordMaintainer mesh__D007422 sjn
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D007422
% 208.97/209.15 /microbiology was INTESTINAL MICROORGANISMS 1963-67
% 208.97/209.15 |- mesh__considerAlso mesh__D007422 consider also terms at ENTER-
% 208.97/209.15 |- mesh__onlineNote mesh__D007422
% 208.97/209.15 use INTESTINES to search INTESTINAL MICROORGANISMS 1966-67%A%
% 208.97/209.15 |- skos__broader mesh__D007422smesh__D041981
% 208.97/209.15 |- mesh__dateCreated mesh__D007422 1999-01-01
% 208.97/209.15 |- mesh__historyNote mesh__D007422
% 208.97/209.15 /microbiology was INTESTINAL MICROORGANISMS 1963-67
% 208.97/209.15 |- mesh__dateRevised mesh__D007422 2005-07-01
% 208.97/209.15 |- rdf__type mesh__D007422sskos__Concept
% 208.97/209.15 |- skos__scopeNote mesh__D007422
% 208.97/209.15 The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.%A%
% 208.97/209.15 |- mesh__recordOriginator mesh__D007422 NLM
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 2004
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 2002
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 1996
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D012367 PLS
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 2003
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 1999
% 208.97/209.15 |- skos__annotation mesh__D012367
% 208.97/209.15 IM; /drug eff /ultrastruct permitted; coord with specific virus %28%IM%29%%A%
% 208.97/209.15 |- mesh__recordMaintainer mesh__D012367 KEV
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 2006
% 208.97/209.15 |- skos__scopeNote mesh__D012367
% 208.97/209.15 Ribonucleic acid that makes up the genetic material of viruses.%A%
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 1998
% 208.97/209.15 |- skos__broader mesh__D012367smesh__D012313
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 2001
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 2005
% 208.97/209.15 |- mesh__dateRevised mesh__D012367 1995-06-08
% 208.97/209.15 |- mesh__dateCreated mesh__D012367 1999-01-01
% 208.97/209.15 |- rdf__type mesh__D012367sskos__Concept
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 2000
% 208.97/209.15 |- skos__altLabel mesh__D012367 Viral RNA
% 208.97/209.15 |- mesh__recordOriginator mesh__D012367 NLM
% 208.97/209.15 |- skos__prefLabel mesh__D012367 RNA, Viral
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D012367 1997
% 208.97/209.15 |- skos__broader mesh__D017850smesh__D004467
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017850 2002
% 208.97/209.15 |- skos__related mesh__D017850smesh__D011306
% 208.97/209.15 |- mesh__recordOriginator mesh__D017850 TGC
% 208.97/209.15 |- skos__related mesh__D017850smesh__D016527
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017850 2004
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017850 2001
% 208.97/209.15 |- rdf__type mesh__D017850sskos__Concept
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017850 2006
% 208.97/209.15 |- mesh__dateEstablished mesh__D017850 1994-01-01
% 208.97/209.15 |- mesh__dateRevised mesh__D017850 1999-11-03
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017850 2003
% 208.97/209.15 |- skos__related mesh__D017850smesh__D005252
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D017850 sjn
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017850 2005
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017850 2000
% 208.97/209.15 |- skos__altLabel mesh__D017850 Pharmaceutical Economics
% 208.97/209.15 |- mesh__dateCreated mesh__D017850 1993-05-27
% 208.97/209.15 |- skos__historyNote mesh__D017850 Economics %28%1966-1979%29%
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D017850 94
% 208.97/209.15 |- mesh__historyNote mesh__D017850 94
% 208.97/209.15 |- skos__historyNote mesh__D017850 Pharmacy %28%1966-1979%29%
% 208.97/209.15 |- skos__scopeNote mesh__D017850
% 208.97/209.15 Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. %28%From J Res Pharm Econ 1989;1%28%1%29%; PharmacoEcon 1992;1%28%1%29%%29%%A%
% 208.97/209.15 |- skos__prefLabel mesh__D017850 Economics, Pharmaceutical
% 208.97/209.15 |- skos__annotation mesh__D017850
% 208.97/209.15 GEN or unspecified only: pref /econ with specific drugs or specific pharmaceutical subject; Manual 19.8.27; DF: ECON PHARM%A%
% 208.97/209.15 |- skos__historyNote mesh__D017850 Pharmacy/economics %28%1980-1993%29%
% 208.97/209.15 |- skos__altLabel mesh__D017850 Pharmacoeconomics
% 208.97/209.15 |- mesh__recordMaintainer mesh__D017850 kle
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D031521 2003
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D031521 2004
% 208.97/209.15 |- mesh__dateCreated mesh__D031521 2002-07-03
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D031521 2003
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D031521 2006
% 208.97/209.15 |- skos__annotation mesh__D031521
% 208.97/209.15 DOSE FRACTIONATION; CELL FRACTIONATION and FRACTIONATION, FIELD FLOW are also available%A%
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D031521 2005
% 208.97/209.15 |- mesh__historyNote mesh__D031521 2003
% 208.97/209.15 |- rdf__type mesh__D031521sskos__Concept
% 208.97/209.15 |- mesh__dateEstablished mesh__D031521 2003-01-01
% 208.97/209.15 |- skos__broader mesh__D031521smesh__D005591
% 208.97/209.15 |- skos__historyNote mesh__D031521 Fractionation %28%1980-2002%29%
% 208.97/209.15 |- skos__scopeNote mesh__D031521
% 208.97/209.15 Separation of molecules and particles by a simultaneous action of carrier liquid flow and focusing field forces %28%electrical, sedimentation, or thermal%29%, without a stationary phase.%A%
% 208.97/209.15 |- skos__altLabel mesh__D031521 SdFFF
% 208.97/209.15 |- skos__prefLabel mesh__D031521 Fractionation, Field Flow
% 208.97/209.15 |- skos__altLabel mesh__D031521 Field Flow Fractionation
% 208.97/209.15 |- skos__historyNote mesh__D031521 Chromatography %28%1980-2002%29%
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 Mortalities, Hospital
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 Hospital Mortality, In
% 208.97/209.15 |- skos__altLabel mesh__D017052 Mortality, In-Hospital
% 208.97/209.15 |- skos__altLabel mesh__D017052 In Hospital Mortality
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 Mortalities, In house
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 In-house Mortalities
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017052 2004
% 208.97/209.15 |- mesh__historyNote mesh__D017052 92
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017052 1998
% 208.97/209.15 |- skos__scopeNote mesh__D017052
% 208.97/209.15 A vital statistic measuring or recording the rate of death from any cause in hospitalized populations.%A%
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D017052 92
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 Mortality, In Hospital
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 Mortalities, In-Hospital
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017052 2000
% 208.97/209.15 |- mesh__recordMaintainer mesh__D017052 WDJ
% 208.97/209.15 |- mesh__recordOriginator mesh__D017052 PLS
% 208.97/209.15 |- skos__altLabel mesh__D017052 Hospital Mortalities
% 208.97/209.15 |- mesh__dateEstablished mesh__D017052 1992-01-01
% 208.97/209.15 |- skos__altLabel mesh__D017052 Inhospital Mortalities
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017052 1999
% 208.97/209.15 |- skos__annotation mesh__D017052
% 208.97/209.15 death statist from any cause in hosp patients; DF: HOSP MORTAL%A%
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 Hospital Mortalities, In
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017052 2005
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017052 2001
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 Mortality, In-house
% 208.97/209.15 |- skos__altLabel mesh__D017052 Mortalities, Inhospital
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 In-Hospital Mortalities
% 208.97/209.15 |- skos__broader mesh__D017052smesh__D009026
% 208.97/209.15 |- skos__prefLabel mesh__D017052 Hospital Mortality
% 208.97/209.15 |- skos__historyNote mesh__D017052 Mortality %28%1966-1991%29%
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 In-house Mortality
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017052 2006
% 208.97/209.15 |- rdf__type mesh__D017052sskos__Concept
% 208.97/209.15 |- skos__altLabel mesh__D017052 Mortality, Inhospital
% 208.97/209.15 |- skos__altLabel mesh__D017052 In Hospital Mortalities
% 208.97/209.15 |- skos__altLabel mesh__D017052 In-Hospital Mortality
% 208.97/209.15 |- skos__altLabel mesh__D017052 Mortality, Hospital
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017052 2002
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D017052 2003
% 208.97/209.15 |- mesh__dateRevised mesh__D017052 1997-07-10
% 208.97/209.15 |- skos__altLabel mesh__D017052 Mortalities, In-house
% 208.97/209.15 |- skos__altLabel mesh__D017052 Inhospital Mortality
% 208.97/209.15 |- mesh__dateCreated mesh__D017052 1991-06-20
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D017052 SJN
% 208.97/209.15 |- skos__hiddenLabel mesh__D017052 Mortalities, In Hospital
% 208.97/209.15 |- mesh__recordMaintainer mesh__D003830 TGC
% 208.97/209.15 |- skos__hiddenLabel mesh__D003830 Fixed Partial Dentures
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003830 2000
% 208.97/209.15 |- skos__altLabel mesh__D003830 Fixed Bridge
% 208.97/209.15 |- mesh__dateRevised mesh__D003830 1997-06-20
% 208.97/209.15 |- mesh__recordOriginator mesh__D003830 NLM
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D003830
% 208.97/209.15 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003830 2004
% 208.97/209.15 |- rdf__type mesh__D003830sskos__Concept
% 208.97/209.15 |- mesh__historyNote mesh__D003830
% 208.97/209.15 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.97/209.15 |- skos__hiddenLabel mesh__D003830 Partial Dentures, Fixed
% 208.97/209.15 |- skos__hiddenLabel mesh__D003830 Partial Denture, Fixed
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003830 2003
% 208.97/209.15 |- skos__hiddenLabel mesh__D003830 Pontics
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003830 1999
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D003830 SJN
% 208.97/209.15 |- mesh__dateEstablished mesh__D003830 1965-01-01
% 208.97/209.15 |- skos__broader mesh__D003830smesh__D003829
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003830 2002
% 208.97/209.15 |- skos__scopeNote mesh__D003830
% 208.97/209.15 A partial denture attached to prepared natural teeth, roots, or implants by cementation.%A%
% 208.97/209.15 |- skos__hiddenLabel mesh__D003830 Dentures, Fixed Partial
% 208.97/209.15 |- skos__hiddenLabel mesh__D003830 Denture, Fixed Partial
% 208.97/209.15 |- mesh__dateCreated mesh__D003830 1999-01-01
% 208.97/209.15 |- skos__hiddenLabel mesh__D003830 Bridges, Fixed
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003830 2006
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003830 1998
% 208.97/209.15 |- skos__prefLabel mesh__D003830 Denture, Partial, Fixed
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003830 2001
% 208.97/209.15 |- skos__hiddenLabel mesh__D003830 Bridge, Fixed
% 208.97/209.15 |- skos__hiddenLabel mesh__D003830 Fixed Bridges
% 208.97/209.15 |- skos__altLabel mesh__D003830 Fixed Partial Denture
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003830 2005
% 208.97/209.15 |- mesh__dateEstablished mesh__D050486 2006-01-01
% 208.97/209.15 |- skos__altLabel mesh__D050486
% 208.97/209.15 5-Hydroxytryptamine Plasma Membrane Transport Protein
% 208.97/209.15 |- skos__altLabel mesh__D050486 Platelet Serotonin Transporter
% 208.97/209.15 |- skos__historyNote mesh__D050486 Nerve Tissue Proteins %28%1992-2005%29%
% 208.97/209.15 |- skos__historyNote mesh__D050486 Membrane Glycoproteins %28%1992-2005%29%
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D050486 2006
% 208.97/209.15 |- skos__altLabel mesh__D050486
% 208.97/209.15 Neurotransmitter Transporters, Serotonin-Specific
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486
% 208.97/209.15 5 Hydroxytryptamine Plasma Membrane Transport Protein
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486 Transporter, Sodium-Dependent Serotonin
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486 Transporter, Serotonin
% 208.97/209.15 |- mesh__recordMaintainer mesh__D050486 DRC
% 208.97/209.15 |- skos__altLabel mesh__D050486 Sodium-Dependent Serotonin Transporter
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486 Transporter, Platelets Serotonin
% 208.97/209.15 |- skos__altLabel mesh__D050486 Serotonin Transporter, Platelets
% 208.97/209.15 |- mesh__recordAuthorizer mesh__D050486 sjn
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486
% 208.97/209.15 Serotonin-Specific Neurotransmitter Transporters
% 208.97/209.15 |- skos__altLabel mesh__D050486 SERT Proteins
% 208.97/209.15 |- skos__scopeNote mesh__D050486
% 208.97/209.15 Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of serotonergic neurons. They are different than SEROTONIN RECEPTORS, which signal cellular responses to SEROTONIN. They remove SEROTONIN from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. Regulates signal amplitude and duration at serotonergic synapses and is the site of action of the SEROTONIN UPTAKE INHIBITORS.%A%
% 208.97/209.15 |- mesh__historyNote mesh__D050486 2006%28%1992%29%
% 208.97/209.15 |- mesh__dateCreated mesh__D050486 2005-06-30
% 208.97/209.15 |- skos__altLabel mesh__D050486
% 208.97/209.15 Neurotransmitter Transport Proteins, Serotonin-Specific
% 208.97/209.15 |- skos__related mesh__D050486smesh__D011985
% 208.97/209.15 |- skos__broader mesh__D050486smesh__D050480
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486 Sodium Dependent Serotonin Transporter
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486 Transporter, Platelet Serotonin
% 208.97/209.15 |- mesh__publicMeSHNote mesh__D050486
% 208.97/209.15 2006; SEROTONIN TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 2005, MEMBRANE GLYCOPROTEINS, NERVE TISSUE PROTEINS %26% MEMBRANE TRANSPORT PROTEINS 1992-2005, CARRIER PROTEINS 1992-2004; SEROTONECTIN was indexed under CARRIER PROTEINS 1983-2005%A%
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486
% 208.97/209.15 Neurotransmitter Transporters, Serotonin Specific
% 208.97/209.15 |- skos__prefLabel mesh__D050486
% 208.97/209.15 Serotonin Plasma Membrane Transport Proteins
% 208.97/209.15 |- skos__altLabel mesh__D050486 Serotonin Transporter
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486 Platelets Serotonin Transporter
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486 Serotonin Transporter, Platelet
% 208.97/209.15 |- skos__broader mesh__D050486smesh__D027981
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486
% 208.97/209.15 Transporters, Serotonin-Specific Neurotransmitter
% 208.97/209.15 |- skos__altLabel mesh__D050486
% 208.97/209.15 Serotonin Plasma Membrane Transporter Proteins
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486
% 208.97/209.15 Neurotransmitter Transport Proteins, Serotonin Specific
% 208.97/209.15 |- skos__hiddenLabel mesh__D050486 Serotonin Transporter, Sodium-Dependent
% 208.97/209.15 |- rdf__type mesh__D050486sskos__Concept
% 208.97/209.15 |- mesh__recordOriginator mesh__D050486 DRC
% 208.97/209.15 |- skos__altLabel mesh__D050486 5HT Transporter
% 208.97/209.15 |- skos__historyNote mesh__D050486 Carrier Proteins %28%1992-2004%29%
% 208.97/209.15 |- skos__historyNote mesh__D050486 Membrane Transport Proteins %28%2005%29%
% 208.97/209.15 |- mesh__activeMeSHYear mesh__D003032 1999
% 208.97/209.15 |- skos__broader mesh__D003032smesh__D008906
% 208.97/209.16 |- skos__related mesh__D003032smesh__D012829
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003032 2005
% 208.97/209.16 |- skos__hiddenLabel mesh__D003032 Coal Minings
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003032 2004
% 208.97/209.16 |- skos__related mesh__D003032smesh__D011009
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003032 1998
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003032 2001
% 208.97/209.16 |- mesh__dateRevised mesh__D003032 1997-06-20
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003032 2003
% 208.97/209.16 |- rdf__type mesh__D003032sskos__Concept
% 208.97/209.16 |- mesh__recordOriginator mesh__D003032 NLM
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003032 2000
% 208.97/209.16 |- skos__hiddenLabel mesh__D003032 Minings, Coal
% 208.97/209.16 |- skos__related mesh__D003032smesh__D000874
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D003032 SJN
% 208.97/209.16 |- mesh__recordMaintainer mesh__D003032 JLS
% 208.97/209.16 |- skos__annotation mesh__D003032
% 208.97/209.16 SPEC: SPEC qualif; consider also PNEUMOCONIOSIS but particularly SILICOSIS %26% ANTHRACOSILICOSIS%A%
% 208.97/209.16 |- skos__prefLabel mesh__D003032 Coal Mining
% 208.97/209.16 |- skos__hiddenLabel mesh__D003032 Mining, Coal
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003032 2002
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003032 2006
% 208.97/209.16 |- mesh__dateCreated mesh__D003032 1999-01-01
% 208.97/209.16 |- mesh__dateEstablished mesh__D049932 2006-01-01
% 208.97/209.16 |- mesh__recordOriginator mesh__D049932 nns
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D049932 sjn
% 208.97/209.16 |- mesh__historyNote mesh__D049932 2006
% 208.97/209.16 |- mesh__dateCreated mesh__D049932 2005-06-30
% 208.97/209.16 |- skos__prefLabel mesh__D049932 Nijmegen Breakage Syndrome
% 208.97/209.16 |- skos__broader mesh__D049932smesh__D049914
% 208.97/209.16 |- mesh__recordMaintainer mesh__D049932 nns
% 208.97/209.16 |- skos__hiddenLabel mesh__D049932 Breakage Syndrome, Nijmegen
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D049932 2006
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D049932 2006
% 208.97/209.16 |- skos__scopeNote mesh__D049932
% 208.97/209.16 A chromosome instability syndrome resulting from a defective response to DNA double-strand breaks. In addition to characteristic FACIES and MICROCEPHALY, patients have a range of findings including RADIOSENSITIVITY, immunodeficiency, increased cancer risk, and growth retardation. Causative mutations occur in the NBS1 gene, located on human chromosome 8q21. NBS1 codes for nibrin, the key regulator protein of the R/M/N %28%RAD50/MRE11/NBS1%29% protein complex which senses and mediates cellular response to DNA DAMAGE caused by IONIZING RADIATION.%A%
% 208.97/209.16 |- skos__hiddenLabel mesh__D049932 Syndrome, Nijmegen Breakage
% 208.97/209.16 |- rdf__type mesh__D049932sskos__Concept
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 c-jun Gene
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 v-jun Gene
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 v-jun Oncogene
% 208.97/209.16 |- mesh__dateEstablished mesh__D016758 1992-01-01
% 208.97/209.16 |- skos__altLabel mesh__D016758 jun Genes
% 208.97/209.16 |- mesh__recordOriginator mesh__D016758 AGS
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 jun Proto Oncogene
% 208.97/209.16 |- skos__broader mesh__D016758smesh__D011519
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 c jun Proto Oncogenes
% 208.97/209.16 |- skos__prefLabel mesh__D016758 Genes, jun
% 208.97/209.16 |- skos__historyNote mesh__D016758 Proto-Oncogenes %28%1987-1991%29%
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D016758 92
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D016758 2006
% 208.97/209.16 |- skos__related mesh__D016758smesh__D016759
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 jun Gene
% 208.97/209.16 |- skos__annotation mesh__D016758
% 208.97/209.16 jun stands for %22%JU-Nana%22%, Japanese for 17 %28%avian sarcoma virus 17%29%%A%
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 Oncogenes, jun
% 208.97/209.16 |- rdf__type mesh__D016758sskos__Concept
% 208.97/209.16 |- skos__related mesh__D016758smesh__D016755
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D016758 sjn
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 c jun Genes
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 Proto-Oncogenes, jun
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 v jun Oncogenes
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 c-jun Proto-Oncogene
% 208.97/209.16 |- skos__historyNote mesh__D016758 Genes, Viral %28%1987-1991%29%
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 Proto-Oncogene, jun
% 208.97/209.16 |- skos__scopeNote mesh__D016758
% 208.97/209.16 Retrovirus-associated DNA sequences %28%jun%29% originally isolated from the avian sarcoma virus 17 %28%ASV 17%29%. The proto-oncogene jun %28%c-jun%29% codes for a nuclear protein which is involved in growth-related transcriptional control. Insertion of c-jun into ASV-17 or the constitutive expression of the c-jun protein produces tumorgenicity. The human c-jun gene is located at 1p31-32 on the short arm of chromosome 1.%A%
% 208.97/209.16 |- mesh__historyNote mesh__D016758 92
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 jun Oncogenes
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 v jun Genes
% 208.97/209.16 |- mesh__recordMaintainer mesh__D016758 nns
% 208.97/209.16 |- mesh__dateRevised mesh__D016758 2005-06-30
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 Oncogene, jun
% 208.97/209.16 |- skos__hiddenLabel mesh__D016758 jun Proto-Oncogenes
% 208.97/209.16 |- skos__historyNote mesh__D016758 Oncogenes %28%1987-1991%29%
% 208.97/209.16 |- mesh__dateCreated mesh__D016758 1991-07-12
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D002738 sjn
% 208.97/209.16 |- mesh__dateCreated mesh__D002738 1999-01-01
% 208.97/209.16 |- skos__altLabel mesh__D002738 Arechine
% 208.97/209.16 |- mesh__recordOriginator mesh__D002738 NLM
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002738 2001
% 208.97/209.16 |- skos__broader mesh__D002738smesh__D000634
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002738 2006
% 208.97/209.16 |- skos__prefLabel mesh__D002738 Chloroquine
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002738 2004
% 208.97/209.16 |- skos__scopeNote mesh__D002738
% 208.97/209.16 The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.%A%
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002738 2005
% 208.97/209.16 |- skos__altLabel mesh__D002738 Chloroquine Sulphate
% 208.97/209.16 |- rdf__type mesh__D002738sskos__Concept
% 208.97/209.16 |- skos__altLabel mesh__D002738 Khingamin
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002738 2003
% 208.97/209.16 |- skos__altLabel mesh__D002738 Chingamin
% 208.97/209.16 |- skos__altLabel mesh__D002738 Chlorochin
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002738 2002
% 208.97/209.16 |- mesh__dateRevised mesh__D002738 2000-06-21
% 208.97/209.16 |- skos__hiddenLabel mesh__D002738 Sulfate, Chloroquine
% 208.97/209.16 |- skos__hiddenLabel mesh__D002738 Sulphate, Chloroquine
% 208.97/209.16 |- mesh__recordMaintainer mesh__D002738 TWD
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D013460 sjn
% 208.97/209.16 |- skos__annotation mesh__D013460 S-33,34,36; NIM
% 208.97/209.16 |- skos__scopeNote mesh__D013460
% 208.97/209.16 Stable sulfur atoms that have the same atomic number as the element sulfur, but differ in atomic weight. S-33, 34, and 36 are stable sulfur isotopes.%A%
% 208.97/209.16 |- rdf__type mesh__D013460sskos__Concept
% 208.97/209.16 |- skos__hiddenLabel mesh__D013460 Isotopes, Sulfur
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013460 2004
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013460 2002
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013460 2006
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013460 2003
% 208.97/209.16 |- mesh__dateCreated mesh__D013460 1999-01-01
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013460 2001
% 208.97/209.16 |- mesh__recordOriginator mesh__D013460 NLM
% 208.97/209.16 |- mesh__recordMaintainer mesh__D013460 nns
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013460 2005
% 208.97/209.16 |- skos__prefLabel mesh__D013460 Sulfur Isotopes
% 208.97/209.16 |- skos__broader mesh__D013460smesh__D007554
% 208.97/209.16 |- mesh__dateRevised mesh__D013460 2000-06-22
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 2006
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 2002
% 208.97/209.16 |- mesh__dateCreated mesh__D007423 1976-04-13
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 2005
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 2004
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 1999
% 208.97/209.16 |- skos__scopeNote mesh__D007423
% 208.97/209.16 Counterpulsation in which a pumping unit synchronized with the patient%27%s electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole. As the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure. The result is a decrease in left ventricular work and increased myocardial and peripheral perfusion.%A%
% 208.97/209.16 |- skos__broader mesh__D007423smesh__D015908
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 2003
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 1998
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 1997
% 208.97/209.16 |- skos__hiddenLabel mesh__D007423 Pumping, Intra Aortic Balloon
% 208.97/209.16 |- skos__altLabel mesh__D007423 Pumping, Intra-Aortic Balloon
% 208.97/209.16 |- mesh__recordMaintainer mesh__D007423 AGS
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 2001
% 208.97/209.16 |- rdf__type mesh__D007423sskos__Concept
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 1996
% 208.97/209.16 |- skos__historyNote mesh__D007423 Assisted Circulation %28%1967-1976%29%
% 208.97/209.16 |- mesh__recordOriginator mesh__D007423 SMH
% 208.97/209.16 |- skos__altLabel mesh__D007423 Intraaortic Balloon Pumping
% 208.97/209.16 |- skos__hiddenLabel mesh__D007423 Intra Aortic Balloon Pumping
% 208.97/209.16 |- skos__hiddenLabel mesh__D007423 Balloon Pumping, Intra-Aortic
% 208.97/209.16 |- skos__hiddenLabel mesh__D007423 Pumping, Intraaortic Balloon
% 208.97/209.16 |- skos__prefLabel mesh__D007423 Intra-Aortic Balloon Pumping
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 2000
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D007423
% 208.97/209.16 86; was see under ASSISTED CIRCULATION 1977-85
% 208.97/209.16 |- mesh__dateEstablished mesh__D007423 1986-01-01
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D007423 PLS
% 208.97/209.16 |- skos__hiddenLabel mesh__D007423 Balloon Pumping, Intraaortic
% 208.97/209.16 |- mesh__dateRevised mesh__D007423 1994-01-25
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D007423 1995
% 208.97/209.16 |- mesh__historyNote mesh__D007423
% 208.97/209.16 86%28%77%29%; was see under ASSISTED CIRCULATION 1977-85
% 208.97/209.16 |- skos__annotation mesh__D007423 DF: IABP
% 208.97/209.16 |- skos__altLabel mesh__D045542
% 208.97/209.16 2,7,9-Tricarboxy-1H-Pyrrolo-%28%2,3-f%29%Quinoline-4,5-Dione
% 208.97/209.16 |- mesh__historyNote mesh__D045542
% 208.97/209.16 2004; use PQQ COFACTOR %28%NM%29% 1981-2003
% 208.97/209.16 |- skos__hiddenLabel mesh__D045542 PQQ, Coenzyme
% 208.97/209.16 |- skos__hiddenLabel mesh__D045542 Cofactor, PQQ
% 208.97/209.16 |- skos__broader mesh__D045542smesh__D015363
% 208.97/209.16 |- mesh__dateCreated mesh__D045542 2003-07-09
% 208.97/209.16 |- skos__altLabel mesh__D045542 Coenzyme PQQ
% 208.97/209.16 |- skos__scopeNote mesh__D045542
% 208.97/209.16 A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.%A%
% 208.97/209.16 |- skos__altLabel mesh__D045542 2,7,9-Tricarboxypyrroloquinoline Quinone
% 208.97/209.16 |- skos__hiddenLabel mesh__D045542 Pyrrolo Quinoline Quinone
% 208.97/209.16 |- skos__hiddenLabel mesh__D045542 Coenzyme, PQQ
% 208.97/209.16 |- skos__hiddenLabel mesh__D045542 Quinone, Pyrrolo-Quinoline
% 208.97/209.16 |- skos__altLabel mesh__D045542 Methoxatin
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D045542 2006
% 208.97/209.16 |- skos__broader mesh__D045542smesh__D003067
% 208.97/209.16 |- rdf__type mesh__D045542sskos__Concept
% 208.97/209.16 |- skos__altLabel mesh__D045542
% 208.97/209.16 4,5-Dihydro-4,5-Dioxo-1-H-Pyrrolo%28%2,3-f%29%Quinoline-2,7,9-Tricarboxylic Acid
% 208.97/209.16 |- skos__altLabel mesh__D045542 Pyrroloquinoline Quinone
% 208.97/209.16 |- skos__altLabel mesh__D045542 Pyrrolo-Quinoline Quinone
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D045542 2005
% 208.97/209.16 |- skos__altLabel mesh__D045542 PQQ Coenzyme
% 208.97/209.16 |- skos__prefLabel mesh__D045542 PQQ Cofactor
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D045542 2004
% 208.97/209.16 |- mesh__dateEstablished mesh__D045542 2004-01-01
% 208.97/209.16 |- skos__hiddenLabel mesh__D045542 Quinone, Pyrroloquinoline
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D045542
% 208.97/209.16 2004; METHOXATIN %28%now PQQ COFACTOR%29% was indexed under QUINOLONES 1981-2003%A%
% 208.97/209.16 |- skos__altLabel mesh__D012368 Ro 20-1724
% 208.97/209.16 |- mesh__historyNote mesh__D012368 2005%28%1975%29%
% 208.97/209.16 |- mesh__recordMaintainer mesh__D012368 ssb
% 208.97/209.16 |- mesh__dateEstablished mesh__D012368 1991-01-01
% 208.97/209.16 |- skos__historyNote mesh__D012368 Imidazoles %28%1972-1974%29%
% 208.97/209.16 |- skos__scopeNote mesh__D012368 Inhibitor of phosphodiesterases.
% 208.97/209.16 |- skos__historyNote mesh__D012368 Benzyl Compounds %28%1972-1974%29%
% 208.97/209.16 |- skos__altLabel mesh__D012368 Ro 20 1724
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D012368 sjn
% 208.97/209.16 |- mesh__dateCreated mesh__D012368 1974-11-19
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D012368 2006
% 208.97/209.16 |- mesh__recordOriginator mesh__D012368 NLM
% 208.97/209.16 |- rdf__type mesh__D012368sskos__Concept
% 208.97/209.16 |- mesh__dateRevised mesh__D012368 2005-06-30
% 208.97/209.16 |- skos__altLabel mesh__D012368 Ro 201724
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D012368
% 208.97/209.16 2005; see RO 21 1724 1991-2004;see IMIDAZOLES 1975-1990
% 208.97/209.16 |- skos__altLabel mesh__D012368 Ro 1724
% 208.97/209.16 |- skos__prefLabel mesh__D012368
% 208.97/209.16 4-%28%3-Butoxy-4-methoxybenzyl%29%-2-imidazolidinone
% 208.97/209.16 |- skos__broader mesh__D012368smesh__D007093
% 208.97/209.16 |- skos__historyNote mesh__D012368 Ethers %28%1974%29%
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017851 2005
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D017851 94
% 208.97/209.16 |- skos__scopeNote mesh__D017851
% 208.97/209.16 A class of enzymes that transfers phosphate groups and has a carboxyl group as an acceptor. EC 2.7.2.%A%
% 208.97/209.16 |- skos__broader mesh__D017851smesh__D010770
% 208.97/209.16 |- mesh__dateCreated mesh__D017851 1993-06-18
% 208.97/209.16 |- mesh__historyNote mesh__D017851 94
% 208.97/209.16 |- skos__historyNote mesh__D017851 Phosphotransferases %28%1966-1993%29%
% 208.97/209.16 |- mesh__dateEstablished mesh__D017851 1994-01-01
% 208.97/209.16 |- skos__prefLabel mesh__D017851
% 208.97/209.16 Phosphotransferases %28%Carboxyl Group Acceptor%29%
% 208.97/209.16 |- skos__annotation mesh__D017851 DF: PHOSPHOTRANSFERASES CARBOXYL
% 208.97/209.16 |- mesh__dateRevised mesh__D017851 2003-07-09
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017851 2004
% 208.97/209.16 |- rdf__type mesh__D017851sskos__Concept
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017851 2006
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017053 2001
% 208.97/209.16 |- skos__altLabel mesh__D017053 Control, Infection
% 208.97/209.16 |- skos__historyNote mesh__D017053
% 208.97/209.16 Communicable Disease Control %28%1966-1991%29%
% 208.97/209.16 |- mesh__recordOriginator mesh__D017053 PLS
% 208.97/209.16 |- mesh__dateRevised mesh__D017053 1999-11-03
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017053 2002
% 208.97/209.16 |- skos__broader mesh__D017053smesh__D003140
% 208.97/209.16 |- skos__historyNote mesh__D017053
% 208.97/209.16 Cross Infection/prevention %26% control %28%1966-1991%29%
% 208.97/209.16 |- mesh__onlineNote mesh__D017053
% 208.97/209.16 use INFECTION CONTROL to search INFECTION/prevention %26% control 1966-91%A%
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017053 2005
% 208.97/209.16 |- skos__prefLabel mesh__D017053 Infection Control
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017053 2006
% 208.97/209.16 |- mesh__recordMaintainer mesh__D017053 kle
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D017053
% 208.97/209.16 92; was INFECTION/prevention %26% control 1966-91
% 208.97/209.16 |- mesh__historyNote mesh__D017053
% 208.97/209.16 92; was INFECTION/prevention %26% control 1966-91
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D017053 sjn
% 208.97/209.16 |- skos__scopeNote mesh__D017053
% 208.97/209.16 Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms.%A%
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017053 2000
% 208.97/209.16 |- skos__historyNote mesh__D017053
% 208.97/209.16 Infection/prevention %26% control %28%1966-1991%29%
% 208.97/209.16 |- rdf__type mesh__D017053sskos__Concept
% 208.97/209.16 |- skos__annotation mesh__D017053
% 208.97/209.16 differentiate from COMMUNICABLE DISEASE CONTROL which tends to be on a large geog, demog or social level %28%e.g., city, underprivileged, elementary school, prison%29% while INFECTION CONTROL tends to be restricted within hosp or other health care facilities; if in doubt, use term of author; DF: INFECT CONTROL%A%
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017053 2003
% 208.97/209.16 |- mesh__dateCreated mesh__D017053 1991-07-19
% 208.97/209.16 |- mesh__dateEstablished mesh__D017053 1992-01-01
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D017053 2004
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003831 2001
% 208.97/209.16 |- rdf__type mesh__D003831sskos__Concept
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003831 2003
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003831 2000
% 208.97/209.16 |- mesh__dateRevised mesh__D003831 1997-06-20
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003831 1999
% 208.97/209.16 |- mesh__recordOriginator mesh__D003831 NLM
% 208.97/209.16 |- mesh__dateCreated mesh__D003831 1999-01-01
% 208.97/209.16 |- skos__broader mesh__D003831smesh__D003829
% 208.97/209.16 |- mesh__historyNote mesh__D003831
% 208.97/209.16 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003831 2006
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003831 1998
% 208.97/209.16 |- mesh__recordMaintainer mesh__D003831 PXP
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D003831 SJN
% 208.97/209.16 |- mesh__dateEstablished mesh__D003831 1965-01-01
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003831 2005
% 208.97/209.16 |- skos__scopeNote mesh__D003831
% 208.97/209.16 A partial denture constructed before the teeth it replaces are removed. It is then inserted immediately after the removal of the natural teeth for functional and cosmetic reasons during the healing process. It is to be replaced later by the fitted partial denture.%A%
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003831 2002
% 208.97/209.16 |- skos__prefLabel mesh__D003831 Denture, Partial, Immediate
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D003831
% 208.97/209.16 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003831 2004
% 208.97/209.16 |- mesh__recordOriginator mesh__D050487 DRC
% 208.97/209.16 |- skos__broader mesh__D050487smesh__D027981
% 208.97/209.16 |- skos__related mesh__D050487smesh__D018684
% 208.97/209.16 |- mesh__recordMaintainer mesh__D050487 DRC
% 208.97/209.16 |- skos__hiddenLabel mesh__D050487
% 208.97/209.16 Neurotransmitter Transport Proteins, Glycine Specific
% 208.97/209.16 |- mesh__dateCreated mesh__D050487 2005-06-30
% 208.97/209.16 |- skos__altLabel mesh__D050487
% 208.97/209.16 Neurotransmitter Transport Proteins, Glycine-Specific
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D050487 2006
% 208.97/209.16 |- skos__altLabel mesh__D050487
% 208.97/209.16 Neurotransmitter Transporters, Glycine-Specific
% 208.97/209.16 |- rdf__type mesh__D050487sskos__Concept
% 208.97/209.16 |- skos__historyNote mesh__D050487
% 208.97/209.16 Amino Acid Transport Systems, Neutral %28%1987-2005%29%
% 208.97/209.16 |- mesh__historyNote mesh__D050487 2006%28%1987%29%
% 208.97/209.16 |- skos__broader mesh__D050487smesh__D026921
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D050487 sjn
% 208.97/209.16 |- skos__altLabel mesh__D050487
% 208.97/209.16 Glycine Plasma Membrane Transporter Proteins
% 208.97/209.16 |- skos__broader mesh__D050487smesh__D050480
% 208.97/209.16 |- skos__prefLabel mesh__D050487 Glycine Plasma Membrane Transport Proteins
% 208.97/209.16 |- skos__hiddenLabel mesh__D050487
% 208.97/209.16 Glycine-Specific Neurotransmitter Transporters
% 208.97/209.16 |- skos__altLabel mesh__D050487 GLYT Proteins
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D050487
% 208.97/209.16 2006; GLYCINE TRANSPORTER was indexed under AMINO ACID TRANSPORT SYSTEMS, NEUTRAL 2002-2005 %26% under CARRIER PROTEINS 1987-2001%A%
% 208.97/209.16 |- skos__scopeNote mesh__D050487
% 208.97/209.16 A family of sodium chloride-dependent neurotransmitter symporters that transport the amino acid GLYCINE. They differ from GLYCINE RECEPTORS, which signal cellular responses to GLYCINE. They are located primarily on the PLASMA MEMBRANE of NEURONS; GLIAL CELLS; EPITHELIAL CELLS; and RED BLOOD CELLS where they remove inhibitory neurotransmitter glycine from the EXTRACELLULAR SPACE. Glycine plasma membrane transport proteins are different than%A%
% 208.97/209.16 |- skos__altLabel mesh__D050487 Glycine Transporter
% 208.97/209.16 |- skos__related mesh__D050487smesh__D018009
% 208.97/209.16 |- skos__hiddenLabel mesh__D050487
% 208.97/209.16 Transporters, Glycine-Specific Neurotransmitter
% 208.97/209.16 |- skos__hiddenLabel mesh__D050487
% 208.97/209.16 Neurotransmitter Transporters, Glycine Specific
% 208.97/209.16 |- mesh__dateEstablished mesh__D050487 2006-01-01
% 208.97/209.16 |- skos__hiddenLabel mesh__D003033 Tar, Coal
% 208.97/209.16 |- rdf__type mesh__D003033sskos__Concept
% 208.97/209.16 |- skos__annotation mesh__D003033 D25-26 qualif
% 208.97/209.16 |- skos__broader mesh__D003033smesh__D013638
% 208.97/209.16 |- skos__prefLabel mesh__D003033 Coal Tar
% 208.97/209.16 |- mesh__dateRevised mesh__D003033 2003-07-09
% 208.97/209.16 |- skos__scopeNote mesh__D003033
% 208.97/209.16 A by-product of the destructive distillation of coal used as a topical antieczematic. It is an antipruritic and keratoplastic agent used also in the treatment of psoriasis and other skin conditions. Occupational exposure to soots, tars, and certain mineral oils is known to be carcinogenic according to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29% %28%Merck Index, 11th ed%29%.%A%
% 208.97/209.16 |- mesh__recordMaintainer mesh__D003033 ssb
% 208.97/209.16 |- mesh__recordOriginator mesh__D003033 NLM
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003033 2006
% 208.97/209.16 |- mesh__dateCreated mesh__D003033 1999-01-01
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003033 2005
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D003033 sjn
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D003033 2004
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D049933 sjn
% 208.97/209.16 |- mesh__dateEstablished mesh__D049933 2006-01-01
% 208.97/209.16 |- mesh__historyNote mesh__D049933 2006
% 208.97/209.16 |- skos__scopeNote mesh__D049933
% 208.97/209.16 COUMARINS with an amino group, exemplified by NOVOBIOCIN.%A%
% 208.97/209.16 |- skos__prefLabel mesh__D049933 Aminocoumarins
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D049933 2006
% 208.97/209.16 |- mesh__dateCreated mesh__D049933 2005-06-30
% 208.97/209.16 |- skos__historyNote mesh__D049933 Coumarins %28%1999-2005%29%
% 208.97/209.16 |- skos__altLabel mesh__D049933 Amino-Coumarins
% 208.97/209.16 |- rdf__type mesh__D049933sskos__Concept
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D049933 2006
% 208.97/209.16 |- mesh__recordOriginator mesh__D049933 ssb
% 208.97/209.16 |- skos__hiddenLabel mesh__D049933 Amino Coumarins
% 208.97/209.16 |- mesh__recordMaintainer mesh__D049933 ssb
% 208.97/209.16 |- skos__broader mesh__D049933smesh__D003374
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Oncogene Protein v jun
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 gag-jun, p65
% 208.97/209.16 |- mesh__onlineNote mesh__D016759
% 208.97/209.16 use ONCOGENE PROTEIN P65%28%GAG-JUN%29% %28%NM%29% to search ONCOGENE PROTEIN JUN %28%NM%29% 1987-91%A%
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Oncogene Product v jun
% 208.97/209.16 |- skos__annotation mesh__D016759
% 208.97/209.16 IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X refs%A%
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Oncogene Protein, jun
% 208.97/209.16 |- mesh__recordOriginator mesh__D016759 AGS
% 208.97/209.16 |- skos__scopeNote mesh__D016759
% 208.97/209.16 Transforming protein coded by jun oncogenes %28%GENES, JUN%29%. This is a gag-onc fusion protein of about 65 kDa derived from avian sarcoma virus. v-jun lacks a negative regulatory domain that regulates transcription in c-jun.%A%
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 v jun Protein
% 208.97/209.16 |- mesh__dateEstablished mesh__D016759 1992-01-01
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 p65 gag jun
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 gag-jun Fusion Proteins
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Product v-jun, Oncogene
% 208.97/209.16 |- skos__altLabel mesh__D016759 p65%28%gag-jun%29%
% 208.97/209.16 |- skos__altLabel mesh__D016759 Oncogene Protein v-jun
% 208.97/209.16 |- mesh__dateCreated mesh__D016759 1991-07-12
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D016759 sjn
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Protein v-jun, Oncogene
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 jun, Oncogene Protein
% 208.97/209.16 |- skos__altLabel mesh__D016759 Oncogene Protein jun
% 208.97/209.16 |- skos__altLabel mesh__D016759 Oncogene Product v-jun
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Fusion Proteins, gag jun
% 208.97/209.16 |- mesh__recordMaintainer mesh__D016759 nns
% 208.97/209.16 |- mesh__dateRevised mesh__D016759 2005-06-30
% 208.97/209.16 |- skos__altLabel mesh__D016759 v-jun Protein
% 208.97/209.16 |- skos__broader mesh__D016759smesh__D015681
% 208.97/209.16 |- skos__prefLabel mesh__D016759 Oncogene Protein p65%28%gag-jun%29%
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 v-jun, Oncogene Protein
% 208.97/209.16 |- skos__altLabel mesh__D016759 jun Oncogene Protein
% 208.97/209.16 |- skos__altLabel mesh__D016759 Fusion Proteins, gag-jun
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Protein jun, Oncogene
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Protein, jun Oncogene
% 208.97/209.16 |- skos__historyNote mesh__D016759 Retroviridae Proteins %28%1987-1989%29%
% 208.97/209.16 |- mesh__historyNote mesh__D016759
% 208.97/209.16 92; was ONCOGENE PROTEIN JUN %28%NM%29% 1987-91
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Protein, v-jun
% 208.97/209.16 |- skos__altLabel mesh__D016759 p65 gag-jun
% 208.97/209.16 |- rdf__type mesh__D016759sskos__Concept
% 208.97/209.16 |- skos__historyNote mesh__D016759
% 208.97/209.16 Retroviridae Proteins, Oncogenic %28%1990-1991%29%
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 v-jun, Oncogene Product
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D016759
% 208.97/209.16 92; ONCOGENE PROTEIN JUN %28%NM%29% was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-91 %26% under RETROVIRIDAE PROTEINS 1987-89%A%
% 208.97/209.16 |- skos__hiddenLabel mesh__D016759 Proteins, gag-jun Fusion
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D016759 2006
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D027481 2006
% 208.97/209.16 |- mesh__historyNote mesh__D027481 2002
% 208.97/209.16 |- mesh__dateRevised mesh__D027481 2003-07-09
% 208.97/209.16 |- skos__annotation mesh__D027481
% 208.97/209.16 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D027481 sjn
% 208.97/209.16 |- mesh__dateEstablished mesh__D027481 2002-01-01
% 208.97/209.16 |- rdf__type mesh__D027481sskos__Concept
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D027481 2002
% 208.97/209.16 |- skos__altLabel mesh__D027481 Umbrella Tree
% 208.97/209.16 |- mesh__dateCreated mesh__D027481 2001-07-25
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D027481 2004
% 208.97/209.16 |- skos__scopeNote mesh__D027481
% 208.97/209.16 The ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound. Flowers are five-parted and arranged in compound flat-topped umbels. The fruit is a berry or %28%rarely%29% a drupe %28%a one-seeded fruit%29%. It is well known for plant preparations used as adaptogens %28%immune support and anti-fatigue%29%.%A%
% 208.97/209.16 |- mesh__recordOriginator mesh__D027481 ssb
% 208.97/209.16 |- mesh__recordMaintainer mesh__D027481 ssb
% 208.97/209.16 |- skos__prefLabel mesh__D027481 Araliaceae
% 208.97/209.16 |- skos__broader mesh__D027481smesh__D019684
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D027481 2005
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002739 2006
% 208.97/209.16 |- mesh__recordMaintainer mesh__D002739 TWD
% 208.97/209.16 |- mesh__onlineNote mesh__D002739
% 208.97/209.16 use HYDROXYQUINOLINES to search CHLOROQUINOLINOLS 1966-74 %28%as Prov%29%%A%
% 208.97/209.16 |- mesh__historyNote mesh__D002739
% 208.97/209.16 91%28%65%29%; was see under HYDROXYQUINOLINES 1965-90 %28%Prov 1965-74%29%%A%
% 208.97/209.16 |- skos__prefLabel mesh__D002739 Chloroquinolinols
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002739 2004
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D002739 sjn
% 208.97/209.16 |- mesh__recordOriginator mesh__D002739 NLM
% 208.97/209.16 |- skos__scopeNote mesh__D002739
% 208.97/209.16 8-Hydroxyquinolinols chlorinated on the number 5 and/or 7 carbon atom%28%s%29%. They are antibacterial, antiprotozoal, and antidiarrheal, especially in amebiasis, and have also been used as antiseborrheics. The compounds are mostly used topically, but have been used also as animal feed additives. They may cause optic and other neuropathies and are most frequently administered in combination with other agents.%A%
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002739 2005
% 208.97/209.16 |- rdf__type mesh__D002739sskos__Concept
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002739 2001
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002739 2003
% 208.97/209.16 |- mesh__dateEstablished mesh__D002739 1991-01-01
% 208.97/209.16 |- skos__broader mesh__D002739smesh__D015125
% 208.97/209.16 |- mesh__dateRevised mesh__D002739 2000-06-22
% 208.97/209.16 |- mesh__dateCreated mesh__D002739 1999-01-01
% 208.97/209.16 |- mesh__publicMeSHNote mesh__D002739
% 208.97/209.16 91; was see under HYDROXYQUINOLINES 1975-90
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D002739 2002
% 208.97/209.16 |- mesh__historyNote mesh__D013461 75
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013461 2001
% 208.97/209.16 |- mesh__recordOriginator mesh__D013461 NLM
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013461 1999
% 208.97/209.16 |- mesh__recordAuthorizer mesh__D013461 PLS
% 208.97/209.16 |- skos__broader mesh__D013461smesh__D013457
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013461 2003
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013461 1995
% 208.97/209.16 |- mesh__dateCreated mesh__D013461 1999-01-01
% 208.97/209.16 |- rdf__type mesh__D013461sskos__Concept
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013461 2005
% 208.97/209.16 |- skos__broader mesh__D013461smesh__D010087
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013461 2004
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013461 2002
% 208.97/209.16 |- mesh__activeMeSHYear mesh__D013461 2006
% 208.97/209.16 |- mesh__dateRevised mesh__D013461 1993-06-03
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D013461 75
% 208.97/209.17 |- mesh__dateEstablished mesh__D013461 1975-09-01
% 208.97/209.17 |- skos__prefLabel mesh__D013461 Sulfur Oxides
% 208.97/209.17 |- mesh__recordMaintainer mesh__D013461 TPW
% 208.97/209.17 |- skos__hiddenLabel mesh__D013461 Oxides, Sulfur
% 208.97/209.17 |- skos__historyNote mesh__D013461 Oxides %28%1966-1974%29%
% 208.97/209.17 |- skos__historyNote mesh__D013461 Sulfur %28%1966-1974%29%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013461 1996
% 208.97/209.17 |- skos__scopeNote mesh__D013461 Inorganic oxides of sulfur.
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013461 1998
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013461 2000
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013461 1997
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013461 1994
% 208.97/209.17 |- skos__annotation mesh__D013461 inorganic; SULFUR DIOXIDE is available
% 208.97/209.17 |- mesh__dateCreated mesh__D007424 1999-01-01
% 208.97/209.17 |- skos__hiddenLabel mesh__D007424 Fluids, Intracellular
% 208.97/209.17 |- rdf__type mesh__D007424sskos__Concept
% 208.97/209.17 |- mesh__recordMaintainer mesh__D007424 nns
% 208.97/209.17 |- skos__scopeNote mesh__D007424 The fluid inside CELLS.
% 208.97/209.17 |- skos__broader mesh__D007424smesh__D042541
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D007424
% 208.97/209.17 91; was see under BODY FLUIDS 1975-90
% 208.97/209.17 |- skos__hiddenLabel mesh__D007424 Intracellular Fluids
% 208.97/209.17 |- skos__hiddenLabel mesh__D007424 Fluid, Intracellular
% 208.97/209.17 |- skos__annotation mesh__D007424
% 208.97/209.17 do not confuse with INTERSTITIAL FLUID see EXTRACELLULAR FLUID%A%
% 208.97/209.17 |- mesh__recordOriginator mesh__D007424 NLM
% 208.97/209.17 |- mesh__onlineNote mesh__D007424 search BODY FLUIDS 1966-74
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D007424 2006
% 208.97/209.17 |- skos__prefLabel mesh__D007424 Intracellular Fluid
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D007424 sjn
% 208.97/209.17 |- skos__broader mesh__D007424smesh__D013347
% 208.97/209.17 |- mesh__historyNote mesh__D007424
% 208.97/209.17 91%28%75%29%; was see under BODY FLUIDS 1975-90
% 208.97/209.17 |- mesh__dateEstablished mesh__D007424 1991-01-01
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D007424 2005
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D007424 2004
% 208.97/209.17 |- mesh__dateRevised mesh__D007424 2003-07-09
% 208.97/209.17 |- skos__broader mesh__D007424smesh__D001826
% 208.97/209.17 |- rdf__type mesh__D051580sskos__Concept
% 208.97/209.17 |- skos__hiddenLabel mesh__D051580 Neuronal Calcium Sensor Proteins
% 208.97/209.17 |- mesh__dateCreated mesh__D051580 2005-06-30
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D051580 sjn
% 208.97/209.17 |- skos__broader mesh__D051580smesh__D052139
% 208.97/209.17 |- skos__scopeNote mesh__D051580
% 208.97/209.17 A family of intracellular calcium-sensing proteins found predominately in NEURONS and PHOTORECEPTORS. They contain EF HAND MOTIFS and undergo conformational changes upon calcium-binding. Neuronal calcium-sensor proteins interact with other regulatory proteins to mediate physiological responses to a change in intracellular calcium concentration.%A%
% 208.97/209.17 |- mesh__recordMaintainer mesh__D051580 DRC
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D051580 2006
% 208.97/209.17 |- skos__hiddenLabel mesh__D051580 Calcium-Sensor Proteins, Neuronal
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D051580 2006
% 208.97/209.17 |- skos__prefLabel mesh__D051580 Neuronal Calcium-Sensor Proteins
% 208.97/209.17 |- mesh__historyNote mesh__D051580 2006
% 208.97/209.17 |- skos__broader mesh__D051580smesh__D009419
% 208.97/209.17 |- mesh__recordOriginator mesh__D051580 DRC
% 208.97/209.17 |- mesh__dateEstablished mesh__D051580 2006-01-01
% 208.97/209.17 |- mesh__recordOriginator mesh__D012369 NLM
% 208.97/209.17 |- mesh__dateRevised mesh__D012369 2004-07-07
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D012369
% 208.97/209.17 2005; see RO 4-1284 1991-2004; see QUINOLIZINES 1988-1990; see QUINOLIZINES 1975-1987%A%
% 208.97/209.17 |- mesh__historyNote mesh__D012369 2005%28%1988%29%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D012369 2005
% 208.97/209.17 |- skos__historyNote mesh__D012369 Quinolizines %28%1970%29%
% 208.97/209.17 |- skos__scopeNote mesh__D012369 Proposed catecholamine depletor.
% 208.97/209.17 |- skos__prefLabel mesh__D012369
% 208.97/209.17 2H-Benzo%28%a%29%quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D012369 2006
% 208.97/209.17 |- mesh__recordMaintainer mesh__D012369 jmp
% 208.97/209.17 |- rdf__type mesh__D012369sskos__Concept
% 208.97/209.17 |- mesh__dateCreated mesh__D012369 1974-11-19
% 208.97/209.17 |- mesh__dateEstablished mesh__D012369 1991-01-01
% 208.97/209.17 |- skos__altLabel mesh__D012369 Ro4-1284
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D012369 sjn
% 208.97/209.17 |- skos__broader mesh__D012369smesh__D011807
% 208.97/209.17 |- skos__altLabel mesh__D012369 Ro 41284
% 208.97/209.17 |- skos__broader mesh__D017852smesh__D010770
% 208.97/209.17 |- mesh__dateCreated mesh__D017852 1993-06-18
% 208.97/209.17 |- mesh__historyNote mesh__D017852 94
% 208.97/209.17 |- skos__historyNote mesh__D017852 Phosphotransferases %28%1966-1993%29%
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D017852 94
% 208.97/209.17 |- skos__scopeNote mesh__D017852
% 208.97/209.17 A group of enzymes that catalyzes the transfer of a phosphate group onto a nitrogenous group acceptor. EC 2.7.3.%A%
% 208.97/209.17 |- skos__annotation mesh__D017852 DF: PHOSPHOTRANSFERASES NITROGENOUS
% 208.97/209.17 |- mesh__dateRevised mesh__D017852 2003-07-09
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017852 2004
% 208.97/209.17 |- rdf__type mesh__D017852sskos__Concept
% 208.97/209.17 |- skos__prefLabel mesh__D017852
% 208.97/209.17 Phosphotransferases %28%Nitrogenous Group Acceptor%29%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017852 2006
% 208.97/209.17 |- mesh__dateEstablished mesh__D017852 1994-01-01
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017852 2005
% 208.97/209.17 |- skos__broader mesh__D017054smesh__D007348
% 208.97/209.17 |- skos__altLabel mesh__D017054 Medigap Policy
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017054 2005
% 208.97/209.17 |- mesh__dateEstablished mesh__D017054 1992-01-01
% 208.97/209.17 |- skos__hiddenLabel mesh__D017054 Policy, Medigap
% 208.97/209.17 |- skos__altLabel mesh__D017054 Medigap Insurance
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017054 2001
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017054 2006
% 208.97/209.17 |- skos__annotation mesh__D017054
% 208.97/209.17 insures the gap between payments by private insurers %26% Medicare; specify geog%A%
% 208.97/209.17 |- skos__historyNote mesh__D017054 Medicare %28%1977-1991%29%
% 208.97/209.17 |- mesh__dateRevised mesh__D017054 1999-11-03
% 208.97/209.17 |- skos__hiddenLabel mesh__D017054 Policies, Medigap
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017054 2002
% 208.97/209.17 |- skos__historyNote mesh__D017054 Insurance, Health %28%1977-1991%29%
% 208.97/209.17 |- skos__prefLabel mesh__D017054 Insurance, Medigap
% 208.97/209.17 |- mesh__dateCreated mesh__D017054 1991-06-20
% 208.97/209.17 |- rdf__type mesh__D017054sskos__Concept
% 208.97/209.17 |- skos__hiddenLabel mesh__D017054 Medigap Policies
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017054 2003
% 208.97/209.17 |- mesh__recordMaintainer mesh__D017054 kle
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D017054 92
% 208.97/209.17 |- mesh__historyNote mesh__D017054 92
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017054 2004
% 208.97/209.17 |- skos__scopeNote mesh__D017054
% 208.97/209.17 A supplemental health insurance policy sold by private insurance companies and designed to pay for health care costs and services that are not paid for either by Medicare alone or by a combination of Medicare and existing private health insurance benefits. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A%
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D017054 sjn
% 208.97/209.17 |- mesh__recordOriginator mesh__D017054 PLS
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017054 2000
% 208.97/209.17 |- rdf__type mesh__D003832sskos__Concept
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003832 2004
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D003832
% 208.97/209.17 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003832 2000
% 208.97/209.17 |- mesh__dateRevised mesh__D003832 1997-06-20
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003832 2003
% 208.97/209.17 |- mesh__recordOriginator mesh__D003832 NLM
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003832 1999
% 208.97/209.17 |- mesh__dateCreated mesh__D003832 1999-01-01
% 208.97/209.17 |- skos__broader mesh__D003832smesh__D003829
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003832 1998
% 208.97/209.17 |- mesh__dateEstablished mesh__D003832 1965-01-01
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D003832 SJN
% 208.97/209.17 |- mesh__historyNote mesh__D003832
% 208.97/209.17 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.97/209.17 |- skos__prefLabel mesh__D003832 Denture, Partial, Removable
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003832 2006
% 208.97/209.17 |- skos__scopeNote mesh__D003832
% 208.97/209.17 A partial denture designed and constructed to be removed readily from the mouth.%A%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003832 2002
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003832 2005
% 208.97/209.17 |- mesh__recordMaintainer mesh__D003832 PXP
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003832 2001
% 208.97/209.17 |- skos__scopeNote mesh__D050488
% 208.97/209.17 Displacement of the great toe %28%HALLUX%29% towards the midline or away from the other TOES. It can be congenital or acquired.%A%
% 208.97/209.17 |- skos__broader mesh__D050488smesh__D005530
% 208.97/209.17 |- mesh__dateEstablished mesh__D050488 2006-01-01
% 208.97/209.17 |- skos__hiddenLabel mesh__D050488 Varus, Hallux
% 208.97/209.17 |- skos__prefLabel mesh__D050488 Hallux Varus
% 208.97/209.17 |- mesh__recordMaintainer mesh__D050488 ags
% 208.97/209.17 |- mesh__historyNote mesh__D050488 2006
% 208.97/209.17 |- mesh__dateCreated mesh__D050488 2005-06-30
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D050488 2006
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D050488 sjn
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D050488 2006
% 208.97/209.17 |- mesh__recordOriginator mesh__D050488 ags
% 208.97/209.17 |- rdf__type mesh__D050488sskos__Concept
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Coated Pit, Cell-Membrane
% 208.97/209.17 |- skos__prefLabel mesh__D003034 Coated Pits, Cell-Membrane
% 208.97/209.17 |- mesh__dateCreated mesh__D003034 1982-04-22
% 208.97/209.17 |- rdf__type mesh__D003034sskos__Concept
% 208.97/209.17 |- skos__annotation mesh__D003034
% 208.97/209.17 A 11 qualif except /cytol; /genet permitted; DF: COATED PITS%A%
% 208.97/209.17 |- mesh__recordOriginator mesh__D003034 AEP
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Pits, Cell-Membrane Coated
% 208.97/209.17 |- mesh__dateEstablished mesh__D003034 1991-01-01
% 208.97/209.17 |- skos__scopeNote mesh__D003034
% 208.97/209.17 Specialized regions of the cell membrane composed of pits coated with a bristle covering made of the protein CLATHRIN. These pits are the entry route for macromolecules bound by cell surface receptors. The pits are then internalized into the cytoplasm to form the COATED VESICLES.%A%
% 208.97/209.17 |- skos__altLabel mesh__D003034 Cell-Membrane Coated Pits
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Bristle-Coated Pit
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D003034 sjn
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Cell Membrane Coated Pits
% 208.97/209.17 |- skos__historyNote mesh__D003034 Endocytosis %28%1973-1982%29%
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Bristle Coated Pits
% 208.97/209.17 |- skos__altLabel mesh__D003034 Bristle-Coated Pits
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003034 2005
% 208.97/209.17 |- mesh__dateRevised mesh__D003034 2000-06-22
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Pit, Bristle-Coated
% 208.97/209.17 |- skos__historyNote mesh__D003034 Cell Membrane %28%1966-1982%29%
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Pits, Bristle-Coated
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D003034
% 208.97/209.17 91; was see under RECEPTOSOMES 1983-90
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Cell-Membrane Coated Pit
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Coated Pits, Cell Membrane
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003034 2003
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003034 2006
% 208.97/209.17 |- mesh__recordMaintainer mesh__D003034 PXP
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003034 2001
% 208.97/209.17 |- skos__related mesh__D003034smesh__D002966
% 208.97/209.17 |- skos__broader mesh__D003034smesh__D021961
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003034 2004
% 208.97/209.17 |- mesh__historyNote mesh__D003034
% 208.97/209.17 91%28%83%29%; was see under RECEPTOSOMES 1983-90
% 208.97/209.17 |- skos__hiddenLabel mesh__D003034 Pit, Cell-Membrane Coated
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003034 2002
% 208.97/209.17 |- skos__altLabel mesh__D049934 1H-2-Benzopyran-1-ones
% 208.97/209.17 |- skos__historyNote mesh__D049934 Coumarins %28%1971-2005%29%
% 208.97/209.17 |- mesh__dateEstablished mesh__D049934 2006-01-01
% 208.97/209.17 |- rdf__type mesh__D049934sskos__Concept
% 208.97/209.17 |- skos__altLabel mesh__D049934 1-Isochromen-1-ones
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D049934 2006
% 208.97/209.17 |- mesh__recordMaintainer mesh__D049934 ssb
% 208.97/209.17 |- skos__scopeNote mesh__D049934
% 208.97/209.17 Compounds that differ from COUMARINS in having the positions of the ring and ketone oxygens reversed so the keto oxygen is at the 1-position of the molecule.%A%
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D049934 sjn
% 208.97/209.17 |- mesh__historyNote mesh__D049934 2006
% 208.97/209.17 |- mesh__recordOriginator mesh__D049934 ssb
% 208.97/209.17 |- skos__broader mesh__D049934smesh__D003374
% 208.97/209.17 |- mesh__dateCreated mesh__D049934 2005-06-30
% 208.97/209.17 |- skos__prefLabel mesh__D049934 Isocoumarins
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D049934 2006
% 208.97/209.17 |- skos__broader mesh__D007703Q000037smesh__D007703
% 208.97/209.17 |- mesh__preferredCombination mesh__D007703Q000037smesh__D000806
% 208.97/209.17 |- rdf__type mesh__D007703Q000037smesh__CompoundConcept
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D013462 74
% 208.97/209.17 |- mesh__dateCreated mesh__D013462 1999-01-01
% 208.97/209.17 |- rdf__type mesh__D013462sskos__Concept
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 2005
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 2000
% 208.97/209.17 |- skos__broader mesh__D013462smesh__D013460
% 208.97/209.17 |- skos__broader mesh__D013462smesh__D011868
% 208.97/209.17 |- skos__annotation mesh__D013462
% 208.97/209.17 S-29-31, 35, 37, 38; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%
% 208.97/209.17 |- mesh__recordOriginator mesh__D013462 NLM
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 2004
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 2001
% 208.97/209.17 |- skos__hiddenLabel mesh__D013462 Radioisotopes, Sulfur
% 208.97/209.17 |- skos__prefLabel mesh__D013462 Sulfur Radioisotopes
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 2006
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D013462 PLS
% 208.97/209.17 |- mesh__recordMaintainer mesh__D013462 TPW
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 1996
% 208.97/209.17 |- mesh__dateRevised mesh__D013462 1993-06-04
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 1998
% 208.97/209.17 |- mesh__historyNote mesh__D013462 74
% 208.97/209.17 |- skos__scopeNote mesh__D013462
% 208.97/209.17 Unstable isotopes of sulfur that decay or disintegrate spontaneously emitting radiation. S 29-31, 35, 37, and 38 are radioactive sulfur isotopes.%A%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 2002
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 1997
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 1994
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 1999
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 2003
% 208.97/209.17 |- mesh__onlineNote mesh__D013462 search SULFUR ISOTOPES 1966-73
% 208.97/209.17 |- mesh__dateEstablished mesh__D013462 1974-01-01
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013462 1995
% 208.97/209.17 |- skos__scopeNote mesh__D007425
% 208.97/209.17 Thin structures that encapsulate subcellular structures or ORGANELLES in EUKARYOTIC CELLS. They include a variety of membranes associated with the CELL NUCLEUS; the MITOCHONDRIA; the GOLGI APPARATUS; the ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES.%A%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D007425 2006B
% 208.97/209.17 |- mesh__recordOriginator mesh__D007425 VDK
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D007425 2006
% 208.97/209.17 |- mesh__dateRevised mesh__D007425 2005-07-21
% 208.97/209.17 |- skos__hiddenLabel mesh__D007425 Membrane, Intracellular
% 208.97/209.17 |- skos__prefLabel mesh__D007425 Intracellular Membranes
% 208.97/209.17 |- skos__broader mesh__D007425smesh__D002462
% 208.97/209.17 |- mesh__dateEstablished mesh__D007425 1979-01-01
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D007425 79
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D007425 ags
% 208.97/209.17 |- mesh__dateCreated mesh__D007425 1978-05-19
% 208.97/209.17 |- mesh__recordMaintainer mesh__D007425 ags
% 208.97/209.17 |- skos__historyNote mesh__D007425 Membranes %28%1966-1978%29%
% 208.97/209.17 |- mesh__historyNote mesh__D007425 79
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D007425 2006A
% 208.97/209.17 |- skos__broader mesh__D007425smesh__D013347
% 208.97/209.17 |- rdf__type mesh__D007425sskos__Concept
% 208.97/209.17 |- skos__related mesh__D007425smesh__D033921
% 208.97/209.17 |- skos__hiddenLabel mesh__D007425 Intracellular Membrane
% 208.97/209.17 |- skos__altLabel mesh__D007425 Membranes, Intracellular
% 208.97/209.17 |- skos__broader mesh__D017853smesh__D010770
% 208.97/209.17 |- mesh__dateCreated mesh__D017853 1993-06-18
% 208.97/209.17 |- mesh__historyNote mesh__D017853 94
% 208.97/209.17 |- skos__historyNote mesh__D017853 Phosphotransferases %28%1966-1993%29%
% 208.97/209.17 |- mesh__recordMaintainer mesh__D017853 ssb
% 208.97/209.17 |- skos__scopeNote mesh__D017853
% 208.97/209.17 A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.%A%
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D017853 sjn
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017853 2005
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017853 2004
% 208.97/209.17 |- mesh__dateRevised mesh__D017853 2003-07-09
% 208.97/209.17 |- rdf__type mesh__D017853sskos__Concept
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017853 2006
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D017853 94
% 208.97/209.17 |- skos__prefLabel mesh__D017853
% 208.97/209.17 Phosphotransferases %28%Alcohol Group Acceptor%29%
% 208.97/209.17 |- skos__annotation mesh__D017853 DF: PHOSPHOTRANSFERASES ALCOHOL
% 208.97/209.17 |- mesh__recordOriginator mesh__D017853 TPW
% 208.97/209.17 |- mesh__dateEstablished mesh__D017853 1994-01-01
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D017055 92; was see CRITICAL CARE 1980-91
% 208.97/209.17 |- mesh__onlineNote mesh__D017055
% 208.97/209.17 use CRITICAL CARE to search INTENSIVE CARE 1980-91
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017055 1999
% 208.97/209.17 |- skos__prefLabel mesh__D017055 Intensive Care
% 208.97/209.17 |- mesh__historyNote mesh__D017055 92; was see CRITICAL CARE 1980-91
% 208.97/209.17 |- rdf__type mesh__D017055sskos__Concept
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017055 2003
% 208.97/209.17 |- mesh__dateCreated mesh__D017055 1991-06-20
% 208.97/209.17 |- mesh__dateEstablished mesh__D017055 1992-01-01
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017055 2000
% 208.97/209.17 |- skos__scopeNote mesh__D017055
% 208.97/209.17 Advanced and highly specialized care provided to medical or surgical patients whose conditions are life-threatening and require comprehensive care and constant monitoring. It is usually administered in specially equipped units of a health care facility.%A%
% 208.97/209.17 |- skos__related mesh__D017055smesh__D003422
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017055 2004
% 208.97/209.17 |- mesh__recordOriginator mesh__D017055 PLS
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D017055 SJN
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017055 2001
% 208.97/209.17 |- skos__broader mesh__D017055smesh__D003422
% 208.97/209.17 |- skos__altLabel mesh__D017055 Intensive Care, Surgical
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017055 2005
% 208.97/209.17 |- mesh__dateRevised mesh__D017055 1997-06-20
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017055 2002
% 208.97/209.17 |- skos__hiddenLabel mesh__D017055 Care, Surgical Intensive
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017055 2006
% 208.97/209.17 |- mesh__recordMaintainer mesh__D017055 PXP
% 208.97/209.17 |- skos__hiddenLabel mesh__D017055 Care, Intensive
% 208.97/209.17 |- skos__annotation mesh__D017055
% 208.97/209.17 coord IM with disease /ther or /surg %28%IM%29%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D017055 1998
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D003833 SJN
% 208.97/209.17 |- skos__hiddenLabel mesh__D003833 Prosthesis Dental, Interim
% 208.97/209.17 |- mesh__historyNote mesh__D003833
% 208.97/209.17 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003833 1998
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003833 2002
% 208.97/209.17 |- skos__altLabel mesh__D003833 Interim Prosthesis Dental
% 208.97/209.17 |- skos__hiddenLabel mesh__D003833 Dental Prostheses, Interim
% 208.97/209.17 |- skos__hiddenLabel mesh__D003833 Prosthesis Dentals, Interim
% 208.97/209.17 |- skos__broader mesh__D003833smesh__D003829
% 208.97/209.17 |- mesh__recordMaintainer mesh__D003833 PXP
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003833 2006
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003833 2001
% 208.97/209.17 |- skos__hiddenLabel mesh__D003833 Dentals, Interim Prosthesis
% 208.97/209.17 |- skos__prefLabel mesh__D003833 Denture, Partial, Temporary
% 208.97/209.17 |- skos__hiddenLabel mesh__D003833 Prostheses, Interim Dental
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003833 2005
% 208.97/209.17 |- skos__scopeNote mesh__D003833
% 208.97/209.17 A partial denture intended for short-term use in a temporary or emergency situation.%A%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003833 2000
% 208.97/209.17 |- skos__hiddenLabel mesh__D003833 Prosthesis, Interim Dental
% 208.97/209.17 |- mesh__dateRevised mesh__D003833 1997-06-20
% 208.97/209.17 |- mesh__recordOriginator mesh__D003833 NLM
% 208.97/209.17 |- rdf__type mesh__D003833sskos__Concept
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003833 2004
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D003833
% 208.97/209.17 65; CROWN AND BRIDGEWORK was heading 1963-64
% 208.97/209.17 |- skos__hiddenLabel mesh__D003833 Interim Dental Prostheses
% 208.97/209.17 |- mesh__dateEstablished mesh__D003833 1965-01-01
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003833 2003
% 208.97/209.17 |- skos__hiddenLabel mesh__D003833 Interim Prosthesis Dentals
% 208.97/209.17 |- skos__altLabel mesh__D003833 Dental Prosthesis, Interim
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003833 1999
% 208.97/209.17 |- mesh__dateCreated mesh__D003833 1999-01-01
% 208.97/209.17 |- skos__hiddenLabel mesh__D003833 Dental, Interim Prosthesis
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D050489 sjn
% 208.97/209.17 |- mesh__recordOriginator mesh__D050489 ags
% 208.97/209.17 |- skos__related mesh__D050489smesh__D006215
% 208.97/209.17 |- mesh__recordMaintainer mesh__D050489 ags
% 208.97/209.17 |- mesh__dateEstablished mesh__D050489 2006-01-01
% 208.97/209.17 |- skos__hiddenLabel mesh__D050489 Bunionettes
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D050489 2006
% 208.97/209.17 |- skos__hiddenLabel mesh__D050489 Bunion, Tailors
% 208.97/209.17 |- skos__altLabel mesh__D050489 Tailor%27%s Bunion
% 208.97/209.17 |- skos__prefLabel mesh__D050489 Bunion, Tailor%27%s
% 208.97/209.17 |- skos__hiddenLabel mesh__D050489 Tailors Bunion
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D050489 2006
% 208.97/209.17 |- rdf__type mesh__D050489sskos__Concept
% 208.97/209.17 |- skos__historyNote mesh__D050489 Hallux Valgus %28%1972-2005%29%
% 208.97/209.17 |- skos__scopeNote mesh__D050489
% 208.97/209.17 Abnormal swelling of the outer aspect of the fifth metatarsal head affecting the fifth METATARSOPHALANGEAL JOINT.%A%
% 208.97/209.17 |- mesh__historyNote mesh__D050489 2006
% 208.97/209.17 |- skos__altLabel mesh__D050489 Bunionette
% 208.97/209.17 |- skos__hiddenLabel mesh__D050489 Bunions, Tailor%27%s
% 208.97/209.17 |- mesh__dateCreated mesh__D050489 2005-06-30
% 208.97/209.17 |- skos__broader mesh__D050489smesh__D005531
% 208.97/209.17 |- skos__hiddenLabel mesh__D050489 Tailor%27%s Bunions
% 208.97/209.17 |- skos__related mesh__D003035smesh__D003037
% 208.97/209.17 |- skos__broader mesh__D003035smesh__D028561
% 208.97/209.17 |- skos__scopeNote mesh__D003035
% 208.97/209.17 A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis.%A%
% 208.97/209.17 |- mesh__dateCreated mesh__D003035 1999-01-01
% 208.97/209.17 |- mesh__recordOriginator mesh__D003035 NLM
% 208.97/209.17 |- skos__annotation mesh__D003035 Co-59
% 208.97/209.17 |- skos__prefLabel mesh__D003035 Cobalt
% 208.97/209.17 |- skos__related mesh__D003035smesh__D003036
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D003035 2006
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D003035 sjn
% 208.97/209.17 |- mesh__recordMaintainer mesh__D003035 ssb
% 208.97/209.17 |- skos__broader mesh__D003035smesh__D019216
% 208.97/209.17 |- mesh__dateRevised mesh__D003035 2005-06-30
% 208.97/209.17 |- rdf__type mesh__D003035sskos__Concept
% 208.97/209.17 |- rdf__type mesh__D049935sskos__Concept
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D049935 2006
% 208.97/209.17 |- skos__annotation mesh__D049935
% 208.97/209.17 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.97/209.17 |- skos__scopeNote mesh__D049935
% 208.97/209.17 A plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida. Members contain cytotoxic furofuran LIGNANS and isoquinoline ALKALOIDS.%A%
% 208.97/209.17 |- mesh__recordOriginator mesh__D049935 ssb
% 208.97/209.17 |- skos__broader mesh__D049935smesh__D019684
% 208.97/209.17 |- mesh__dateEstablished mesh__D049935 2006-01-01
% 208.97/209.17 |- mesh__recordMaintainer mesh__D049935 ssb
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D049935 sjn
% 208.97/209.17 |- mesh__historyNote mesh__D049935 2006
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D049935 2006
% 208.97/209.17 |- skos__prefLabel mesh__D049935 Hernandiaceae
% 208.97/209.17 |- mesh__dateCreated mesh__D049935 2005-06-30
% 208.97/209.17 |- mesh__recordMaintainer mesh__D013463 TPW
% 208.97/209.17 |- mesh__historyNote mesh__D013463
% 208.97/209.17 91%28%75%29%; was see under SULFURIC ACIDS 1975-90; SULFATES, ORGANIC was see SULFURIC ACIDS 1977-93; THIOSULFURIC ACID ESTERS was heading 1975-93 %28%see under SULFURIC ACIDS 1975-90%29%%A%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 2002
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 1996
% 208.97/209.17 |- skos__scopeNote mesh__D013463 Organic esters of sulfuric acid.
% 208.97/209.17 |- skos__altLabel mesh__D013463 Sulfates, Organic
% 208.97/209.17 |- mesh__onlineNote mesh__D013463
% 208.97/209.17 search SULFURIC ACIDS 1968-74; use SULFURIC ACIDS to search SULFATES, ORGANIC 1977-93; use SULFURIC ACID ESTERS to search THIOSULFURIC ACID ESTERS 1975-93%A%
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 1998
% 208.97/209.17 |- skos__hiddenLabel mesh__D013463 Esters, Sulfuric Acid
% 208.97/209.17 |- mesh__publicMeSHNote mesh__D013463
% 208.97/209.17 91; was see under SULFURIC ACIDS 1975-90; SULFATES, ORGANIC was see SULFURIC ACIDS 1977-93; THIOSULFURIC ACID ESTERS was heading 1975-93 %28%see under SULFURIC ACIDS 1975-90%29%%A%
% 208.97/209.17 |- skos__hiddenLabel mesh__D013463 Esters, Thiosulfuric Acid
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 1997
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 1994
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 1999
% 208.97/209.17 |- skos__altLabel mesh__D013463 Organic Sulfates
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 2000
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 2003
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 1995
% 208.97/209.17 |- mesh__recordOriginator mesh__D013463 NLM
% 208.97/209.17 |- mesh__dateCreated mesh__D013463 1999-01-01
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 2001
% 208.97/209.17 |- rdf__type mesh__D013463sskos__Concept
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 2005
% 208.97/209.17 |- mesh__recordAuthorizer mesh__D013463 PLS
% 208.97/209.17 |- skos__prefLabel mesh__D013463 Sulfuric Acid Esters
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 2004
% 208.97/209.17 |- mesh__activeMeSHYear mesh__D013463 2006
% 208.97/209.17 |- skos__broader mesh__D013463smesh__D013464
% 208.97/209.17 |- mesh__dateRevised mesh__D013463 1993-06-25
% 208.97/209.17 |- mesh__dateEstablished mesh__D013463 1991-01-01
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Gene, Intracisternal A-Particle
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 A-Particle Gene, Intracisternal
% 208.97/209.18 |- mesh__dateCreated mesh__D007426 1985-03-11
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D007426
% 208.97/209.18 92; was INTRACISTERNAL A-PARTICLE GENES 1986-91 %28%see under PROTO-ONCOGENES 1986-90%29%%A%
% 208.97/209.18 |- skos__altLabel mesh__D007426 Intracisternal A-Particle Genes
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D007426 sjn
% 208.97/209.18 |- skos__broader mesh__D007426smesh__D005814
% 208.97/209.18 |- mesh__recordOriginator mesh__D007426 AEP
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Intracisternal A Particle Genes
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 IAP Element
% 208.97/209.18 |- skos__broader mesh__D007426smesh__D018626
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Element, Intracisternal A-Particle
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007426 2006
% 208.97/209.18 |- mesh__historyNote mesh__D007426
% 208.97/209.18 92; was INTRACISTERNAL A-PARTICLE GENES 1986-91 %28%see under PROTO-ONCOGENES 1986-90%29%%A%
% 208.97/209.18 |- skos__historyNote mesh__D007426
% 208.97/209.18 Repetitive Sequences, Nucleic Acid %28%1981-1985%29%
% 208.97/209.18 |- skos__historyNote mesh__D007426 Base Sequence %28%1980-1985%29%
% 208.97/209.18 |- skos__scopeNote mesh__D007426
% 208.97/209.18 Genes of IAP elements %28%a family of retrovirus-like genetic elements%29% which code for virus-like particles %28%IAPs%29% found regularly in rodent early embryos. %28%%22%Intracisternal%22% refers to the cisternae of the endoplasmic reticulum.%29% Under certain circumstances, such as DNA hypomethylation they are transcribed. Their transcripts are found in a variety of neoplasms, including plasmacytomas, neuroblastoma, rhabdomyosarcomas, teratocarcinomas, and colon carcinomas.%A%
% 208.97/209.18 |- mesh__onlineNote mesh__D007426
% 208.97/209.18 use GENES, INTRACISTERNAL A-PARTICLE to search INTRACISTERNAL A-PARTICLE GENES 1986-91%A%
% 208.97/209.18 |- mesh__recordMaintainer mesh__D007426 nns
% 208.97/209.18 |- skos__historyNote mesh__D007426 Genes, Viral %28%1980-1985%29%
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Intracisternal A Particle Elements
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Intracisternal A-Particle Gene
% 208.97/209.18 |- skos__altLabel mesh__D007426 Gene, Intracisternal A Particle
% 208.97/209.18 |- skos__historyNote mesh__D007426 Oncogenes %28%1983-1985%29%
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Genes, Intracisternal A Particle
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 A-Particle Elements, Intracisternal
% 208.97/209.18 |- skos__prefLabel mesh__D007426 Genes, Intracisternal A-Particle
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Intracisternal A-Particle Element
% 208.97/209.18 |- skos__historyNote mesh__D007426 Retroviridae %28%1980-1985%29%
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Element, IAP
% 208.97/209.18 |- mesh__dateRevised mesh__D007426 2005-06-30
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 A-Particle Genes, Intracisternal
% 208.97/209.18 |- skos__altLabel mesh__D007426 IAP Elements
% 208.97/209.18 |- rdf__type mesh__D007426sskos__Concept
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Elements, IAP
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 A-Particle Element, Intracisternal
% 208.97/209.18 |- mesh__dateEstablished mesh__D007426 1991-01-01
% 208.97/209.18 |- skos__hiddenLabel mesh__D007426 Elements, Intracisternal A-Particle
% 208.97/209.18 |- mesh__dateEstablished mesh__D017854 1994-01-01
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017854 2005
% 208.97/209.18 |- skos__altLabel mesh__D017854 Pyrophosphokinases
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017854 2004
% 208.97/209.18 |- mesh__dateRevised mesh__D017854 2003-07-09
% 208.97/209.18 |- rdf__type mesh__D017854sskos__Concept
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017854 2006
% 208.97/209.18 |- skos__altLabel mesh__D017854 Pyrophosphotransferases
% 208.97/209.18 |- skos__scopeNote mesh__D017854
% 208.97/209.18 A class of phosphotransferases that catalyzes the transfer of diphosphate-containing groups. EC 2.7.6.%A%
% 208.97/209.18 |- skos__broader mesh__D017854smesh__D010770
% 208.97/209.18 |- mesh__dateCreated mesh__D017854 1993-06-18
% 208.97/209.18 |- skos__prefLabel mesh__D017854 Diphosphotransferases
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D017854 94
% 208.97/209.18 |- mesh__historyNote mesh__D017854 94
% 208.97/209.18 |- skos__historyNote mesh__D017854 Phosphotransferases %28%1966-1993%29%
% 208.97/209.18 |- rdf__type mesh__D017056sskos__Concept
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Scientist, Laboratory
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 2003
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 1995
% 208.97/209.18 |- mesh__dateRevised mesh__D017056 1992-03-25
% 208.97/209.18 |- mesh__recordMaintainer mesh__D017056 TAP
% 208.97/209.18 |- mesh__dateCreated mesh__D017056 1991-06-20
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Assistant, Laboratory
% 208.97/209.18 |- mesh__historyNote mesh__D017056 92
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 2004
% 208.97/209.18 |- skos__scopeNote mesh__D017056
% 208.97/209.18 Those health care professionals, technicians, and assistants staffing a research or health care facility where specimens are grown, tested, or evaluated and the results of such measures are recorded.%A%
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Laboratory Assistant
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D017056 92
% 208.97/209.18 |- mesh__recordOriginator mesh__D017056 PLS
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 1996
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Laboratory Technician
% 208.97/209.18 |- skos__annotation mesh__D017056
% 208.97/209.18 coord IM with type of lab or occup %28%IM%29%, as hosp lab personnel = LABORATORY PERSONNEL %28%IM%29% + LABORATORIES, HOSPITAL %28%IM%29% or hematol lab personnel = LABORATORY PERSONNEL %28%IM%29% + HEMATOLOGY %28%IM%29%%A%
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Laboratory Scientist
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 2005
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 1997
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Personnel, Laboratory
% 208.97/209.18 |- mesh__dateEstablished mesh__D017056 1992-01-01
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 2000
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 2006
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 1993
% 208.97/209.18 |- skos__broader mesh__D017056smesh__D006282
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Technicians, Laboratory
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 1998
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D017056 PLS
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Scientists, Laboratory
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 2001
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Technician, Laboratory
% 208.97/209.18 |- skos__prefLabel mesh__D017056 Laboratory Personnel
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 1994
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 1999
% 208.97/209.18 |- skos__hiddenLabel mesh__D017056 Assistants, Laboratory
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017056 2002
% 208.97/209.18 |- mesh__dateCreated mesh__D003834 1999-01-01
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Attachments, Intracoronal
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003834 2006
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003834 2001
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Attachment, Intracoronal
% 208.97/209.18 |- mesh__dateRevised mesh__D003834 1999-11-03
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Attachments, Denture Precision
% 208.97/209.18 |- rdf__type mesh__D003834sskos__Concept
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Intracoronal Attachments
% 208.97/209.18 |- skos__altLabel mesh__D003834 Slotted Attachments, Dental
% 208.97/209.18 |- skos__prefLabel mesh__D003834 Denture Precision Attachment
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003834 2002
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Precision Attachment Denture
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Attachment, Denture Precision
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D003834 sjn
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003834 2003
% 208.97/209.18 |- skos__altLabel mesh__D003834 Slotted Attachment, Dental
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Denture Precision Attachments
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Attachment Denture, Precision
% 208.97/209.18 |- skos__altLabel mesh__D003834 Denture, Precision Attachment
% 208.97/209.18 |- skos__annotation mesh__D003834 restrict to partial dentures
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Precision Attachment Dentures
% 208.97/209.18 |- skos__altLabel mesh__D003834 Dental Slotted Attachments
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003834 2004
% 208.97/209.18 |- skos__historyNote mesh__D003834 Denture, Partial %28%1966-1969%29%
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Precision Attachments, Denture
% 208.97/209.18 |- skos__altLabel mesh__D003834 Attachments, Dental Slotted
% 208.97/209.18 |- mesh__recordOriginator mesh__D003834 NLM
% 208.97/209.18 |- skos__historyNote mesh__D003834
% 208.97/209.18 Denture, Partial, Removable %28%1966-1969%29%
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D003834 70
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003834 2005
% 208.97/209.18 |- skos__altLabel mesh__D003834 Dental Slotted Attachment
% 208.97/209.18 |- skos__scopeNote mesh__D003834
% 208.97/209.18 A precision device used for attaching a fixed or removable partial denture to the crown of an abutment tooth or a restoration. One type is the intracoronal attachment and the other type is the extracoronal attachment. It consists of a female portion within the coronal portion of the crown of an abutment and a fitted male portion attached to the denture proper. %28%Jablonski, Dictionary of Dentistry, 1992, p85; from Boucher%27%s Clinical Dental Terminology, 4th ed, p264%29%%A%
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Dentures, Precision Attachment
% 208.97/209.18 |- skos__altLabel mesh__D003834 Attachment, Dental Slotted
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003834 2000
% 208.97/209.18 |- skos__broader mesh__D003834smesh__D003829
% 208.97/209.18 |- mesh__dateEstablished mesh__D003834 1970-01-01
% 208.97/209.18 |- mesh__recordMaintainer mesh__D003834 KEV
% 208.97/209.18 |- mesh__historyNote mesh__D003834 70
% 208.97/209.18 |- skos__hiddenLabel mesh__D003834 Attachment Dentures, Precision
% 208.97/209.18 |- skos__altLabel mesh__D003834 Precision Attachment, Denture
% 208.97/209.18 |- mesh__dateRevised mesh__D003036 2000-06-22
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003036 2006
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003036 2003
% 208.97/209.18 |- skos__broader mesh__D003036smesh__D007554
% 208.97/209.18 |- skos__annotation mesh__D003036 Co-59; NIM
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003036 2004
% 208.97/209.18 |- skos__hiddenLabel mesh__D003036 Isotopes, Cobalt
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003036 2001
% 208.97/209.18 |- mesh__recordMaintainer mesh__D003036 nns
% 208.97/209.18 |- rdf__type mesh__D003036sskos__Concept
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003036 2002
% 208.97/209.18 |- skos__prefLabel mesh__D003036 Cobalt Isotopes
% 208.97/209.18 |- mesh__recordOriginator mesh__D003036 NLM
% 208.97/209.18 |- skos__scopeNote mesh__D003036
% 208.97/209.18 Stable cobalt atoms that have the same atomic number as the element cobalt, but differ in atomic weight. Co-59 is a stable cobalt isotope.%A%
% 208.97/209.18 |- mesh__dateCreated mesh__D003036 1999-01-01
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D003036 sjn
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003036 2005
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D049936 sjn
% 208.97/209.18 |- rdf__type mesh__D049936sskos__Concept
% 208.97/209.18 |- mesh__dateEstablished mesh__D049936 2006-01-01
% 208.97/209.18 |- mesh__historyNote mesh__D049936 2006
% 208.97/209.18 |- skos__altLabel mesh__D049936 Hornworts
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D049936 2006
% 208.97/209.18 |- skos__annotation mesh__D049936
% 208.97/209.18 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 208.97/209.18 |- mesh__dateCreated mesh__D049936 2005-06-30
% 208.97/209.18 |- mesh__recordMaintainer mesh__D049936 ssb
% 208.97/209.18 |- skos__prefLabel mesh__D049936 Anthocerotophyta
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D049936 2006
% 208.97/209.18 |- skos__broader mesh__D049936smesh__D019669
% 208.97/209.18 |- mesh__recordOriginator mesh__D049936 ssb
% 208.97/209.18 |- skos__scopeNote mesh__D049936
% 208.97/209.18 A plant division that includes hornworts, named for the horn-like appearance of the spore-producing plant %28%sporophyte%29%.%A%
% 208.97/209.18 |- skos__scopeNote mesh__D013464
% 208.97/209.18 Inorganic and organic derivatives of sulfuric acid %28%H2SO4%29%. The salts and esters of sulfuric acid are known as SULFATES and SULFURIC ACID ESTERS respectively.%A%
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 1998
% 208.97/209.18 |- skos__broader mesh__D013464smesh__D013456
% 208.97/209.18 |- mesh__dateEstablished mesh__D013464 1968-01-01
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 1997
% 208.97/209.18 |- mesh__dateRevised mesh__D013464 1993-06-04
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 1994
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 1999
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 2002
% 208.97/209.18 |- skos__prefLabel mesh__D013464 Sulfuric Acids
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 1995
% 208.97/209.18 |- mesh__dateCreated mesh__D013464 1999-01-01
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 2003
% 208.97/209.18 |- rdf__type mesh__D013464sskos__Concept
% 208.97/209.18 |- mesh__historyNote mesh__D013464 68; was SULFURIC ACID 1963-67
% 208.97/209.18 |- skos__annotation mesh__D013464 do not confuse with SULFUR ACIDS
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 2005
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 2004
% 208.97/209.18 |- mesh__onlineNote mesh__D013464
% 208.97/209.18 use SULFURIC ACIDS to search SULFURIC ACID 1966-68
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D013464 68; was SULFURIC ACID 1963-67
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 2006
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 2000
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 2001
% 208.97/209.18 |- mesh__recordOriginator mesh__D013464 NLM
% 208.97/209.18 |- mesh__recordMaintainer mesh__D013464 TPW
% 208.97/209.18 |- skos__hiddenLabel mesh__D013464 Acids, Sulfuric
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D013464 PLS
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D013464 1996
% 208.97/209.18 |- skos__altLabel mesh__D007427 Subarachnoid Pressure
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007427 2005
% 208.97/209.18 |- skos__hiddenLabel mesh__D007427 Pressures, Intracerebral
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D007427 SJN
% 208.97/209.18 |- skos__scopeNote mesh__D007427
% 208.97/209.18 Pressure within the cranial cavity. It is influenced by brain mass, the circulatory system, CSF dynamics, and skull rigidity.%A%
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007427 2006
% 208.97/209.18 |- mesh__recordMaintainer mesh__D007427 TGC
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007427 2003
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007427 1998
% 208.97/209.18 |- mesh__dateCreated mesh__D007427 1999-01-01
% 208.97/209.18 |- skos__hiddenLabel mesh__D007427 Subarachnoid Pressures
% 208.97/209.18 |- mesh__recordOriginator mesh__D007427 NLM
% 208.97/209.18 |- skos__hiddenLabel mesh__D007427 Intracerebral Pressures
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007427 2004
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007427 1999
% 208.97/209.18 |- skos__broader mesh__D007427smesh__D015170
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007427 2000
% 208.97/209.18 |- skos__hiddenLabel mesh__D007427 Intracranial Pressures
% 208.97/209.18 |- skos__hiddenLabel mesh__D007427 Pressure, Intracranial
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007427 2001
% 208.97/209.18 |- rdf__type mesh__D007427sskos__Concept
% 208.97/209.18 |- mesh__dateRevised mesh__D007427 1997-06-20
% 208.97/209.18 |- skos__hiddenLabel mesh__D007427 Pressure, Subarachnoid
% 208.97/209.18 |- skos__hiddenLabel mesh__D007427 Pressure, Intracerebral
% 208.97/209.18 |- skos__hiddenLabel mesh__D007427 Pressures, Subarachnoid
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007427 2002
% 208.97/209.18 |- skos__prefLabel mesh__D007427 Intracranial Pressure
% 208.97/209.18 |- skos__hiddenLabel mesh__D007427 Pressures, Intracranial
% 208.97/209.18 |- skos__annotation mesh__D007427
% 208.97/209.18 INTRACRANIAL HYPOTENSION %26% INTRACRANIAL HYPERTENSION are also available%A%
% 208.97/209.18 |- skos__broader mesh__D020003Q000031smesh__D020003
% 208.97/209.18 |- mesh__preferredCombination mesh__D020003Q000031smesh__D000442
% 208.97/209.18 |- rdf__type mesh__D020003Q000031smesh__CompoundConcept
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017855 2006
% 208.97/209.18 |- skos__altLabel mesh__D017855
% 208.97/209.18 Phosphotransferases %28%Other Substituted Phosphate Groups%29%
% 208.97/209.18 |- mesh__dateCreated mesh__D017855 1993-06-04
% 208.97/209.18 |- mesh__recordOriginator mesh__D017855 TPW
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D017855 94
% 208.97/209.18 |- mesh__dateEstablished mesh__D017855 1994-01-01
% 208.97/209.18 |- skos__prefLabel mesh__D017855
% 208.97/209.18 Transferases %28%Other Substituted Phosphate Groups%29%
% 208.97/209.18 |- skos__broader mesh__D017855smesh__D010770
% 208.97/209.18 |- mesh__historyNote mesh__D017855 94
% 208.97/209.18 |- skos__historyNote mesh__D017855 Phosphotransferases %28%1966-1993%29%
% 208.97/209.18 |- skos__scopeNote mesh__D017855
% 208.97/209.18 A class of enzymes that transfers substituted phosphate groups. EC 2.7.8.%A%
% 208.97/209.18 |- mesh__recordMaintainer mesh__D017855 ssb
% 208.97/209.18 |- skos__annotation mesh__D017855 DF: TRANSFERASES OSPG
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017855 2005
% 208.97/209.18 |- rdf__type mesh__D017855sskos__Concept
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017855 2004
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D017855 sjn
% 208.97/209.18 |- mesh__dateRevised mesh__D017855 2003-07-09
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 2005
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D017057 92
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 1999
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 2000
% 208.97/209.18 |- skos__related mesh__D017057smesh__D017664
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 2004
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 1998
% 208.97/209.18 |- rdf__type mesh__D017057sskos__Concept
% 208.97/209.18 |- mesh__historyNote mesh__D017057 92
% 208.97/209.18 |- skos__annotation mesh__D017057
% 208.97/209.18 uninsured or underinsured; DF: MED UNINSURED
% 208.97/209.18 |- mesh__dateEstablished mesh__D017057 1992-01-01
% 208.97/209.18 |- skos__scopeNote mesh__D017057
% 208.97/209.18 Individuals or groups with no or inadequate health insurance coverage. Those falling into this category usually comprise three primary groups: the medically indigent %28%MEDICAL INDIGENCY%29%; those whose clinical condition makes them medically uninsurable; and the working uninsured.%A%
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 2003
% 208.97/209.18 |- mesh__recordMaintainer mesh__D017057 PLS
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 1997
% 208.97/209.18 |- skos__prefLabel mesh__D017057 Medically Uninsured
% 208.97/209.18 |- skos__broader mesh__D017057smesh__D009272
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 2002
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 1996
% 208.97/209.18 |- mesh__dateRevised mesh__D017057 1994-06-16
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 1995
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 2006
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D017057 PLS
% 208.97/209.18 |- mesh__recordOriginator mesh__D017057 PLS
% 208.97/209.18 |- mesh__dateCreated mesh__D017057 1991-06-20
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D017057 2001
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 1997
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D003835 PLS
% 208.97/209.18 |- skos__historyNote mesh__D003835 Dental Auxiliaries %28%1979%29%
% 208.97/209.18 |- skos__hiddenLabel mesh__D003835 Denturist
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 2006
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 2003
% 208.97/209.18 |- skos__prefLabel mesh__D003835 Denturists
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 1994
% 208.97/209.18 |- rdf__type mesh__D003835sskos__Concept
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 2002
% 208.97/209.18 |- skos__broader mesh__D003835smesh__D003800
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 2004
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 1998
% 208.97/209.18 |- mesh__dateEstablished mesh__D003835 1991-01-01
% 208.97/209.18 |- mesh__historyNote mesh__D003835
% 208.97/209.18 91%28%80%29%; was see under DENTAL AUXILIARIES 1980-90; was see DENTAL AUXILIARIES 1979%A%
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 1995
% 208.97/209.18 |- mesh__dateRevised mesh__D003835 1992-05-14
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 1999
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 2000
% 208.97/209.18 |- skos__annotation mesh__D003835
% 208.97/209.18 dent technicians working with patients requiring dentures %28%prep, repair, fitting%29%%A%
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 1996
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D003835
% 208.97/209.18 91; was see under DENTAL AUXILIARIES 1980-90; was see DENTAL AUXILIARIES 1979%A%
% 208.97/209.18 |- skos__historyNote mesh__D003835 Dental Technicians %28%1966-1978%29%
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 1993
% 208.97/209.18 |- mesh__dateCreated mesh__D003835 1979-03-09
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 2005
% 208.97/209.18 |- mesh__recordMaintainer mesh__D003835 TAP
% 208.97/209.18 |- mesh__recordOriginator mesh__D003835 SMH
% 208.97/209.18 |- skos__scopeNote mesh__D003835
% 208.97/209.18 Dental technicians who provide dentures for patients without benefit of a dentist%27%s professional services. Their duties include taking impressions and bite registrations for preparing and repairing dentures and fitting dentures. They are rarely found in the United States, where their practice is illegal in many states, but are becoming increasingly common in Canada.%A%
% 208.97/209.18 |- mesh__onlineNote mesh__D003835 search DENTAL AUXILIARIES 1979
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003835 2001
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 2004
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 1997
% 208.97/209.18 |- mesh__dateEstablished mesh__D003037 1974-01-01
% 208.97/209.18 |- skos__broader mesh__D003037smesh__D011868
% 208.97/209.18 |- skos__hiddenLabel mesh__D003037 Radioisotopes, Cobalt
% 208.97/209.18 |- skos__prefLabel mesh__D003037 Cobalt Radioisotopes
% 208.97/209.18 |- skos__broader mesh__D003037smesh__D003036
% 208.97/209.18 |- rdf__type mesh__D003037sskos__Concept
% 208.97/209.18 |- mesh__recordMaintainer mesh__D003037 TPW
% 208.97/209.18 |- mesh__onlineNote mesh__D003037 search COBALT ISOTOPES 1966-73
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 2000
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 1994
% 208.97/209.18 |- mesh__dateCreated mesh__D003037 1999-01-01
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 2001
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D003037 74
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 1995
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D003037 PLS
% 208.97/209.18 |- skos__scopeNote mesh__D003037
% 208.97/209.18 Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes.%A%
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 2005
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 2002
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 1998
% 208.97/209.18 |- skos__annotation mesh__D003037
% 208.97/209.18 Co-54-64 except Co-59; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%; often discussed with RADIOISOTOPE TELETHERAPY %28%IM%29%%A%
% 208.97/209.18 |- mesh__recordOriginator mesh__D003037 NLM
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 2006
% 208.97/209.18 |- mesh__historyNote mesh__D003037 74
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 2003
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 1999
% 208.97/209.18 |- mesh__dateRevised mesh__D003037 1993-06-01
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D003037 1996
% 208.97/209.18 |- mesh__dateRevised mesh__D008520 2005-06-30
% 208.97/209.18 |- skos__broader mesh__D008520smesh__D004077
% 208.97/209.18 |- skos__altLabel mesh__D008520 beta-Methyldigoxin
% 208.97/209.18 |- skos__altLabel mesh__D008520 Metildigoxin
% 208.97/209.18 |- skos__hiddenLabel mesh__D008520 beta Methyldigoxin
% 208.97/209.18 |- mesh__recordOriginator mesh__D008520 SH
% 208.97/209.18 |- skos__altLabel mesh__D008520 4%27%%27%%27%-O-Methyldigoxin
% 208.97/209.18 |- mesh__dateEstablished mesh__D008520 1991-01-01
% 208.97/209.18 |- mesh__historyNote mesh__D008520
% 208.97/209.18 91%28%79%29%; was see under DIGOXIN 1979-90
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D008520 2006
% 208.97/209.18 |- skos__altLabel mesh__D008520 Kern Brand of Medigoxin
% 208.97/209.18 |- skos__prefLabel mesh__D008520 Medigoxin
% 208.97/209.18 |- mesh__dateCreated mesh__D008520 1978-03-20
% 208.97/209.18 |- rdf__type mesh__D008520sskos__Concept
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D008520 sjn
% 208.97/209.18 |- skos__historyNote mesh__D008520 Digoxin %28%1966-1978%29%
% 208.97/209.18 |- skos__hiddenLabel mesh__D008520 4%27%%27%%27% O Methyldigoxin
% 208.97/209.18 |- skos__altLabel mesh__D008520 Roche Brand of Medigoxin
% 208.97/209.18 |- mesh__recordMaintainer mesh__D008520 CCR
% 208.97/209.18 |- skos__scopeNote mesh__D008520
% 208.97/209.18 A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure %28%HEART FAILURE, CONGESTIVE%29%.%A%
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D008520 91; was see under DIGOXIN 1979-90
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007428 2001
% 208.97/209.18 |- skos__hiddenLabel mesh__D007428 Test, Passive Transfer
% 208.97/209.18 |- mesh__dateRevised mesh__D007428 1997-06-20
% 208.97/209.18 |- skos__hiddenLabel mesh__D007428 Test, Intradermal
% 208.97/209.18 |- skos__hiddenLabel mesh__D007428 Intradermal Test
% 208.97/209.18 |- skos__hiddenLabel mesh__D007428 Tests, Intradermal
% 208.97/209.18 |- skos__altLabel mesh__D007428 Prausnitz-Kustner Test
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007428 2002
% 208.97/209.18 |- skos__broader mesh__D007428smesh__D012882
% 208.97/209.18 |- rdf__type mesh__D007428sskos__Concept
% 208.97/209.18 |- mesh__historyNote mesh__D007428
% 208.97/209.18 91%28%75%29%; was see under SKIN TESTS 1975-90
% 208.97/209.18 |- skos__hiddenLabel mesh__D007428 Passive Transfer Tests
% 208.97/209.18 |- mesh__recordMaintainer mesh__D007428 PXP
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D007428 SJN
% 208.97/209.18 |- skos__scopeNote mesh__D007428
% 208.97/209.18 Skin tests in which the sensitizer is injected.
% 208.97/209.18 |- mesh__dateEstablished mesh__D007428 1991-01-01
% 208.97/209.18 |- skos__hiddenLabel mesh__D007428 Tests, Passive Transfer
% 208.97/209.18 |- skos__hiddenLabel mesh__D007428 Prausnitz Kustner Test
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007428 2005
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D007428
% 208.97/209.18 91; was see under SKIN TESTS 1975-90
% 208.97/209.18 |- mesh__recordOriginator mesh__D007428 NLM
% 208.97/209.18 |- skos__hiddenLabel mesh__D007428 Test, Prausnitz-Kustner
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007428 2006
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007428 2003
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007428 1998
% 208.97/209.18 |- mesh__onlineNote mesh__D007428 search SKIN TESTS 1966-74
% 208.97/209.18 |- mesh__dateCreated mesh__D007428 1999-01-01
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007428 2000
% 208.97/209.18 |- skos__annotation mesh__D007428 NIM
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007428 2004
% 208.97/209.18 |- skos__prefLabel mesh__D007428 Intradermal Tests
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D007428 1999
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D018150 2004
% 208.97/209.18 |- skos__hiddenLabel mesh__D018150 Viruses, Bird Pox
% 208.97/209.18 |- skos__broader mesh__D018150smesh__D018147
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D018150 2003
% 208.97/209.18 |- mesh__onlineNote mesh__D018150
% 208.97/209.18 use FOWLPOX VIRUS to search BIRD POX VIRUS %26% POXVIRUS AVIUM 1975-93%A%
% 208.97/209.18 |- mesh__publicMeSHNote mesh__D018150
% 208.97/209.18 94; BIRD POX VIRUS %26% POXVIRUS AVIUM were see FOWL POX VIRUS 1975-93%A%
% 208.97/209.18 |- skos__hiddenLabel mesh__D018150 Bird Pox Viruses
% 208.97/209.18 |- skos__scopeNote mesh__D018150
% 208.97/209.18 A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising bird poxviruses. The type species is FOWLPOX VIRUS. Transmission is mechanical by arthropods.%A%
% 208.97/209.18 |- skos__hiddenLabel mesh__D018150 Avipoxviruses
% 208.97/209.18 |- mesh__dateRevised mesh__D018150 2001-07-25
% 208.97/209.18 |- skos__hiddenLabel mesh__D018150 Pox Virus, Bird
% 208.97/209.18 |- mesh__recordAuthorizer mesh__D018150 sjn
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D018150 2006
% 208.97/209.18 |- skos__hiddenLabel mesh__D018150 Pox Viruses, Bird
% 208.97/209.18 |- mesh__activeMeSHYear mesh__D018150 2002
% 208.97/209.18 |- mesh__dateCreated mesh__D018150 1993-06-04
% 208.97/209.19 |- mesh__activeMeSHYear mesh__D018150 2005
% 208.97/209.19 |- mesh__recordOriginator mesh__D018150 AGS
% 208.97/209.19 |- rdf__type mesh__D018150sskos__Concept
% 208.97/209.19 |- skos__annotation mesh__D018150
% 208.97/209.19 infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%
% 208.97/209.19 |- skos__hiddenLabel mesh__D018150 Virus, Bird Pox
% 208.97/209.19 |- skos__altLabel mesh__D018150 Bird Pox Virus
% 208.97/209.19 |- mesh__historyNote mesh__D018150
% 208.97/209.19 94; BIRD POX VIRUS %26% POXVIRUS AVIUM were see FOWL POX VIRUS 1975-93%A%
% 208.97/209.19 |- skos__altLabel mesh__D018150 Poxvirus avium
% 208.97/209.19 |- mesh__recordMaintainer mesh__D018150 ags
% 208.97/209.19 |- skos__prefLabel mesh__D018150 Avipoxvirus
% 208.97/209.19 |- mesh__dateEstablished mesh__D018150 1994-01-01
% 208.97/209.19 |- mesh__activeMeSHYear mesh__D004130 2006
% 208.97/209.19 |- skos__altLabel mesh__D004130 Dimethyltryptamine
% 208.97/209.19 |- mesh__publicMeSHNote mesh__D004130
% 208.97/209.19 91; was see under TRYPTAMINES 1989-90; was DIMETHYLTRYPTAMINE 1975-88%A%
% 208.97/209.19 |- mesh__activeMeSHYear mesh__D004130 2002
% 208.97/209.19 |- skos__prefLabel mesh__D004130 N,N-Dimethyltryptamine
% 208.97/209.19 |- mesh__activeMeSHYear mesh__D004130 2003
% 208.97/209.19 |- skos__scopeNote mesh__D004130
% 208.97/209.19 An N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica %28%Apocynaceae%29% and in mammalian brain, blood, and urine. It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others.%A%
% 208.97/209.19 |- mesh__dateCreated mesh__D004130 1999-01-01
% 208.97/209.19 |- mesh__activeMeSHYear mesh__D004130 2004
% 208.97/209.19 |- mesh__recordOriginator mesh__D004130 NLM
% 208.97/209.19 |- mesh__onlineNote mesh__D004130
% 208.97/209.19 use N,N-DIMETHYLTRYPTAMINE to search DIMETHYLTRYPTAMINE 1973-88 %28%as Prov 1973-74%29%%A%
% 208.97/209.19 |- skos__broader mesh__D004130smesh__D014363
% 208.97/209.19 |- mesh__recordMaintainer mesh__D004130 TWD
% 208.97/209.19 |- mesh__recordAuthorizer mesh__D004130 sjn
% 208.97/209.19 |- rdf__type mesh__D004130sskos__Concept
% 208.97/209.19 |- mesh__activeMeSHYear mesh__D004130 2001
% 208.97/209.19 |- skos__hiddenLabel mesh__D004130 N,N Dimethyltryptamine
% 208.97/209.19 |- mesh__activeMeSHYear mesh__D004130 2005
% 208.97/209.19 |- mesh__dateRevised mesh__D004130 2000-06-22
% 208.97/209.19 |- mesh__dateEstablished mesh__D004130 1991-01-01
% 208.97/209.19 |- mesh__historyNote mesh__D004130
% 208.97/209.19 91%28%89%29%; was see under TRYPTAMINES 1989-90; was DIMETHYLTRYPTAMINE 1973-88 %28%Prov 1973-74%29%%A%
% 208.97/209.19 |- skos__broader mesh__D017856smesh__D010770
% 208.97/209.19 |- mesh__dateCreated mesh__D017856 1993-06-18
% 209.04/209.19 |- mesh__historyNote mesh__D017856 94
% 209.04/209.19 |- skos__historyNote mesh__D017856 Phosphotransferases %28%1966-1993%29%
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D017856 94
% 209.04/209.19 |- mesh__dateEstablished mesh__D017856 1994-01-01
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017856 2005
% 209.04/209.19 |- skos__scopeNote mesh__D017856
% 209.04/209.19 A group of enzymes that catalyzes the transfer of a phosphate group onto a phosphate group acceptor. EC 2.7.4.%A%
% 209.04/209.19 |- rdf__type mesh__D017856sskos__Concept
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017856 2004
% 209.04/209.19 |- skos__prefLabel mesh__D017856
% 209.04/209.19 Phosphotransferases %28%Phosphate Group Acceptor%29%
% 209.04/209.19 |- mesh__dateRevised mesh__D017856 2003-07-09
% 209.04/209.19 |- skos__annotation mesh__D017856 DF: PHOSPHOSTRANSFERASES PHOSPHATE
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017856 2006
% 209.04/209.19 |- skos__scopeNote mesh__D017058
% 209.04/209.19 Persons living in the United States of Mexican descent.%A%
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017058 2004
% 209.04/209.19 |- rdf__type mesh__D017058sskos__Concept
% 209.04/209.19 |- skos__annotation mesh__D017058 specify geog if relevant
% 209.04/209.19 |- skos__broader mesh__D017058smesh__D006630
% 209.04/209.19 |- skos__prefLabel mesh__D017058 Mexican Americans
% 209.04/209.19 |- skos__hiddenLabel mesh__D017058 Americans, Mexican
% 209.04/209.19 |- mesh__dateRevised mesh__D017058 2003-10-30
% 209.04/209.19 |- skos__hiddenLabel mesh__D017058 American, Mexican
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017058 2004B
% 209.04/209.19 |- skos__altLabel mesh__D017058 Chicanos
% 209.04/209.19 |- skos__hiddenLabel mesh__D017058 Mexican American
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017058 2006
% 209.04/209.19 |- mesh__dateEstablished mesh__D017058 1992-01-01
% 209.04/209.19 |- mesh__recordOriginator mesh__D017058 PLS
% 209.04/209.19 |- mesh__dateCreated mesh__D017058 1991-06-20
% 209.04/209.19 |- skos__historyNote mesh__D017058 Mexico/ethnology %28%1978-1991%29%
% 209.04/209.19 |- mesh__recordMaintainer mesh__D017058 jls
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D017058 jls
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017058 2004A
% 209.04/209.19 |- mesh__historyNote mesh__D017058
% 209.04/209.19 92; was see HISPANIC AMERICANS 1978-91; CHICANOS was see HISPANIC AMERICANS 1990-91%A%
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D017058
% 209.04/209.19 92; was see HISPANIC AMERICANS 1978-91; CHICANOS was see HISPANIC AMERICANS 1990-91%A%
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017058 2005
% 209.04/209.19 |- skos__historyNote mesh__D017058 Hispanic Americans %28%1977-1991%29%
% 209.04/209.19 |- mesh__onlineNote mesh__D017058
% 209.04/209.19 use HISPANIC AMERICANS to search MEXICAN AMERICANS 1978-91 %26% CHICANOS 1990-91%A%
% 209.04/209.19 |- skos__hiddenLabel mesh__D017058 Chicano
% 209.04/209.19 |- skos__altLabel mesh__D017058 Chicanas
% 209.04/209.19 |- skos__hiddenLabel mesh__D017058 Chicana
% 209.04/209.19 |- mesh__dateRevised mesh__D003836 2005-06-30
% 209.04/209.19 |- mesh__dateCreated mesh__D003836 1999-01-01
% 209.04/209.19 |- rdf__type mesh__D003836sskos__Concept
% 209.04/209.19 |- skos__prefLabel mesh__D003836 Deodorants
% 209.04/209.19 |- mesh__recordMaintainer mesh__D003836 lkt
% 209.04/209.19 |- mesh__recordOriginator mesh__D003836 NLM
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D003836 sjn
% 209.04/209.19 |- skos__broader mesh__D003836smesh__D003358
% 209.04/209.19 |- skos__scopeNote mesh__D003836
% 209.04/209.19 Agents that remove, correct, repress, or mask undesirable ODORS. In personal hygiene, deodorants often contain astringent preparations that reduce SWEATING, referred to as ANTIPERSPIRANTS. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D003836 2006
% 209.04/209.19 |- skos__broader mesh__D003038smesh__D014805
% 209.04/209.19 |- skos__broader mesh__D003038smesh__D003067
% 209.04/209.19 |- skos__altLabel mesh__D003038 Deoxyadenosinecobalamins
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D003038 2006
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D003038 74
% 209.04/209.19 |- skos__annotation mesh__D003038
% 209.04/209.19 deficiency: coordinate COBAMIDES /defic %28%IM%29% with VITAMIN B 12 DEFICIENCY %28%IM%29%%A%
% 209.04/209.19 |- skos__prefLabel mesh__D003038 Cobamides
% 209.04/209.19 |- mesh__recordOriginator mesh__D003038 NLM
% 209.04/209.19 |- mesh__recordMaintainer mesh__D003038 ssb
% 209.04/209.19 |- rdf__type mesh__D003038sskos__Concept
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D003038 sjn
% 209.04/209.19 |- skos__historyNote mesh__D003038 Vitamin B 12 %28%1966-1971%29%
% 209.04/209.19 |- skos__hiddenLabel mesh__D003038 B12 Coenzymes, Vitamin
% 209.04/209.19 |- mesh__dateCreated mesh__D003038 1999-01-01
% 209.04/209.19 |- mesh__dateRevised mesh__D003038 2005-06-30
% 209.04/209.19 |- skos__hiddenLabel mesh__D003038 Coenzymes, Vitamin B12
% 209.04/209.19 |- skos__altLabel mesh__D003038 Vitamin B 12 Coenzymes
% 209.04/209.19 |- skos__altLabel mesh__D003038 Vitamin B12 Coenzymes
% 209.04/209.19 |- mesh__dateEstablished mesh__D003038 1974-01-01
% 209.04/209.19 |- mesh__historyNote mesh__D003038 74%28%72%29%
% 209.04/209.19 |- skos__historyNote mesh__D003038 Coenzymes %28%1966-1971%29%
% 209.04/209.19 |- mesh__dateCreated mesh__D008521 1999-01-01
% 209.04/209.19 |- skos__broader mesh__D008521smesh__D019083
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 2000
% 209.04/209.19 |- skos__scopeNote mesh__D008521
% 209.04/209.19 Scattered islands in the Mediterranean Sea. The chief islands are the Balearic Islands %28%belong to Spain; Majorca and Minorca are among these%29%, Corsica %28%belongs to France%29%, Crete %28%belongs to Greece%29%, CYPRUS %28%a republic%29%, the Cyclades, Dodecanese and Ionian Islands %28%belong to Greece%29%, MALTA %28%a republic%29%, Sardinia and SICILY %28%belong to Italy%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p747%29%%A%
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 2003
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 2001
% 209.04/209.19 |- mesh__dateRevised mesh__D008521 2005-07-12
% 209.04/209.19 |- skos__prefLabel mesh__D008521 Mediterranean Islands
% 209.04/209.19 |- mesh__recordOriginator mesh__D008521 NLM
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 1998
% 209.04/209.19 |- rdf__type mesh__D008521sskos__Concept
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 2004
% 209.04/209.19 |- skos__annotation mesh__D008521
% 209.04/209.19 CYPRUS; MALTA; %26% SICILY are available; for Corsica, coord with FRANCE; for Crete, coord with GREECE%A%
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 1999
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 2002
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 1996
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 2006A
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 2005
% 209.04/209.19 |- mesh__recordMaintainer mesh__D008521 ags
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D008521 ags
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 1997
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008521 2006
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D013466 72
% 209.04/209.19 |- mesh__recordMaintainer mesh__D013466 ssb
% 209.04/209.19 |- skos__annotation mesh__D013466 do not confuse with SULFOTRANSFERASES
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D013466 2004
% 209.04/209.19 |- mesh__recordOriginator mesh__D013466 NLM
% 209.04/209.19 |- rdf__type mesh__D013466sskos__Concept
% 209.04/209.19 |- mesh__dateCreated mesh__D013466 1999-01-01
% 209.04/209.19 |- mesh__historyNote mesh__D013466 72
% 209.04/209.19 |- skos__scopeNote mesh__D013466
% 209.04/209.19 Enzymes which transfer sulfur atoms to various acceptor molecules. EC 2.8.1.%A%
% 209.04/209.19 |- skos__historyNote mesh__D013466 Transferases %28%1966-1971%29%
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D013466 2006
% 209.04/209.19 |- mesh__dateEstablished mesh__D013466 1972-01-01
% 209.04/209.19 |- skos__prefLabel mesh__D013466 Sulfurtransferases
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D013466 sjn
% 209.04/209.19 |- mesh__dateRevised mesh__D013466 2003-07-09
% 209.04/209.19 |- skos__broader mesh__D013466smesh__D019885
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D013466 2005
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D007429 2004
% 209.04/209.19 |- skos__annotation mesh__D007429
% 209.04/209.19 OCULAR HYPERTENSION %26% OCULAR HYPOTENSION are also available%A%
% 209.04/209.19 |- skos__hiddenLabel mesh__D007429 Tensions, Ocular
% 209.04/209.19 |- skos__hiddenLabel mesh__D007429 Pressures, Intraocular
% 209.04/209.19 |- skos__related mesh__D007429smesh__D015814
% 209.04/209.19 |- mesh__dateRevised mesh__D007429 2003-07-09
% 209.04/209.19 |- rdf__type mesh__D007429sskos__Concept
% 209.04/209.19 |- skos__altLabel mesh__D007429 Ocular Tension
% 209.04/209.19 |- skos__hiddenLabel mesh__D007429 Ocular Tensions
% 209.04/209.19 |- skos__related mesh__D007429smesh__D009798
% 209.04/209.19 |- skos__hiddenLabel mesh__D007429 Pressure, Intraocular
% 209.04/209.19 |- skos__related mesh__D007429smesh__D005901
% 209.04/209.19 |- skos__hiddenLabel mesh__D007429 Tension, Ocular
% 209.04/209.19 |- skos__hiddenLabel mesh__D007429 Intraocular Pressures
% 209.04/209.19 |- mesh__recordOriginator mesh__D007429 NLM
% 209.04/209.19 |- skos__prefLabel mesh__D007429 Intraocular Pressure
% 209.04/209.19 |- skos__related mesh__D007429smesh__D014065
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D007429 sjn
% 209.04/209.19 |- mesh__dateCreated mesh__D007429 1999-01-01
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D007429 2005
% 209.04/209.19 |- skos__broader mesh__D007429smesh__D043722
% 209.04/209.19 |- mesh__recordMaintainer mesh__D007429 nns
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D007429 2006
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D018151 2003
% 209.04/209.19 |- skos__hiddenLabel mesh__D018151 Pox Viruses, Goat
% 209.04/209.19 |- skos__altLabel mesh__D018151 Sheep Pox Virus
% 209.04/209.19 |- mesh__dateEstablished mesh__D018151 1994-01-01
% 209.04/209.19 |- skos__prefLabel mesh__D018151 Capripoxvirus
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D018151 2006
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D018151 2005
% 209.04/209.19 |- rdf__type mesh__D018151sskos__Concept
% 209.04/209.19 |- skos__historyNote mesh__D018151 Poxviridae %28%1985-1993%29%
% 209.04/209.19 |- skos__hiddenLabel mesh__D018151 Goat Pox Viruses
% 209.04/209.19 |- skos__hiddenLabel mesh__D018151 Sheeppox viruses
% 209.04/209.19 |- skos__hiddenLabel mesh__D018151 Sheep Pox Viruses
% 209.04/209.19 |- mesh__dateRevised mesh__D018151 2001-07-25
% 209.04/209.19 |- mesh__recordMaintainer mesh__D018151 ags
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D018151 94
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D018151 sjn
% 209.04/209.19 |- skos__hiddenLabel mesh__D018151 Goatpox viruses
% 209.04/209.19 |- skos__altLabel mesh__D018151 Goat Pox Virus
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D018151 2002
% 209.04/209.19 |- mesh__dateCreated mesh__D018151 1993-06-04
% 209.04/209.19 |- skos__hiddenLabel mesh__D018151 Pox Viruses, Sheep
% 209.04/209.19 |- skos__hiddenLabel mesh__D018151 Pox Virus, Sheep
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D018151 2004
% 209.04/209.19 |- mesh__recordOriginator mesh__D018151 AGS
% 209.04/209.19 |- skos__annotation mesh__D018151
% 209.04/209.19 infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%
% 209.04/209.19 |- skos__hiddenLabel mesh__D018151 Capripoxviruses
% 209.04/209.19 |- skos__broader mesh__D018151smesh__D018147
% 209.04/209.19 |- skos__scopeNote mesh__D018151
% 209.04/209.19 A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising poxviruses infecting sheep, goats, and cattle. Transmission is usually mechanical by arthropods, but also includes contact, airborne routes, and non-living reservoirs %28%fomites%29%.%A%
% 209.04/209.19 |- mesh__historyNote mesh__D018151 94
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D004131 sjn
% 209.04/209.19 |- skos__broader mesh__D004131smesh__D009593
% 209.04/209.19 |- mesh__recordMaintainer mesh__D004131 ssb
% 209.04/209.19 |- mesh__historyNote mesh__D004131
% 209.04/209.19 91%28%75%29%; was see under NITROIMIDAZOLES 1975-90
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D004131 2006
% 209.04/209.19 |- mesh__dateEstablished mesh__D004131 1991-01-01
% 209.04/209.19 |- mesh__dateRevised mesh__D004131 2005-06-30
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D004131
% 209.04/209.19 91; was see under NITROIMIDAZOLES 1975-90
% 209.04/209.19 |- mesh__dateCreated mesh__D004131 1974-11-19
% 209.04/209.19 |- skos__historyNote mesh__D004131 Nitroimidazoles %28%1974%29%
% 209.04/209.19 |- skos__prefLabel mesh__D004131 Dimetridazole
% 209.04/209.19 |- mesh__recordOriginator mesh__D004131 RLS
% 209.04/209.19 |- rdf__type mesh__D004131sskos__Concept
% 209.04/209.19 |- skos__scopeNote mesh__D004131
% 209.04/209.19 A compound used to treat histomoniasis in poultry.
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017857 2006
% 209.04/209.19 |- skos__altLabel mesh__D017857 Sea Snakes
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D017857 sjn
% 209.04/209.19 |- skos__hiddenLabel mesh__D017857 Snake, Sea
% 209.04/209.19 |- skos__historyNote mesh__D017857 Snakes %28%1966-1993%29%
% 209.04/209.19 |- mesh__historyNote mesh__D017857 94
% 209.04/209.19 |- skos__scopeNote mesh__D017857
% 209.04/209.19 A family of sea snakes comprising about 50 species with flattened oar-like tails used as sculls. They are found mostly in the coastal waters of south Asia and Australia. The largest reach a length of almost 9 feet but most species are only about a third as long. They are all venomous. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp331-3; Moore: Poisonous Snakes of the World, 1980, p159%29%%A%
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D017857 94
% 209.04/209.19 |- mesh__dateEstablished mesh__D017857 1994-01-01
% 209.04/209.19 |- skos__annotation mesh__D017857 a family of poisonous sea snakes
% 209.04/209.19 |- mesh__dateCreated mesh__D017857 1993-02-16
% 209.04/209.19 |- rdf__type mesh__D017857sskos__Concept
% 209.04/209.19 |- mesh__recordOriginator mesh__D017857 TGC
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017857 2005
% 209.04/209.19 |- mesh__recordMaintainer mesh__D017857 ags
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017857 2004
% 209.04/209.19 |- skos__related mesh__D017857smesh__D006870
% 209.04/209.19 |- skos__prefLabel mesh__D017857 Hydrophidae
% 209.04/209.19 |- mesh__dateRevised mesh__D017857 2003-07-09
% 209.04/209.19 |- skos__hiddenLabel mesh__D017857 Snakes, Sea
% 209.04/209.19 |- skos__hiddenLabel mesh__D017857 Sea Snake
% 209.04/209.19 |- skos__broader mesh__D017857smesh__D012911
% 209.04/209.19 |- skos__hiddenLabel mesh__D017059 Model, Econometric
% 209.04/209.19 |- skos__prefLabel mesh__D017059 Models, Econometric
% 209.04/209.19 |- mesh__recordOriginator mesh__D017059 PLS
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 2006
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 2002
% 209.04/209.19 |- skos__scopeNote mesh__D017059
% 209.04/209.19 The application of mathematical formulas and statistical techniques to the testing and quantifying of economic theories and the solution of economic problems.%A%
% 209.04/209.19 |- skos__annotation mesh__D017059
% 209.04/209.19 models of econ theory %26% for solution of econ problems: a type of MODELS, ECONOMIC; no qualif; apply TN 128 for relation to MODELS, THEORETICAL%A%
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 2005
% 209.04/209.19 |- mesh__dateCreated mesh__D017059 1991-06-20
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D017059 PLS
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 2001
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 1999
% 209.04/209.19 |- mesh__dateRevised mesh__D017059 1996-06-10
% 209.04/209.19 |- skos__hiddenLabel mesh__D017059 Econometric Model
% 209.04/209.19 |- mesh__recordMaintainer mesh__D017059 TGC
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 2004
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 1998
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D017059 92
% 209.04/209.19 |- rdf__type mesh__D017059sskos__Concept
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 2000
% 209.04/209.19 |- mesh__historyNote mesh__D017059 92
% 209.04/209.19 |- mesh__dateEstablished mesh__D017059 1992-01-01
% 209.04/209.19 |- skos__broader mesh__D017059smesh__D018803
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 2003
% 209.04/209.19 |- skos__altLabel mesh__D017059 Econometric Models
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D017059 1997
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D003837
% 209.04/209.19 74; DEOXYGLUCOSE was see under GLUCOSE 1973-74, was see under HEXOSES 1967-72%A%
% 209.04/209.19 |- mesh__historyNote mesh__D003837 74
% 209.04/209.19 |- skos__broader mesh__D003837smesh__D002241
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D003837 2005
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D003837 2006
% 209.04/209.19 |- mesh__dateRevised mesh__D003837 2004-07-07
% 209.04/209.19 |- skos__prefLabel mesh__D003837 Deoxy Sugars
% 209.04/209.19 |- mesh__dateEstablished mesh__D003837 1974-01-01
% 209.04/209.19 |- mesh__recordMaintainer mesh__D003837 ssb
% 209.04/209.19 |- mesh__dateCreated mesh__D003837 1999-01-01
% 209.04/209.19 |- rdf__type mesh__D003837sskos__Concept
% 209.04/209.19 |- mesh__recordOriginator mesh__D003837 NLM
% 209.04/209.19 |- skos__hiddenLabel mesh__D003837 Sugars, Deoxy
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D003837 sjn
% 209.04/209.19 |- mesh__dateCreated mesh__D003039 1977-04-27
% 209.04/209.19 |- skos__historyNote mesh__D003039 Venoms %28%1966-1974%29%
% 209.04/209.19 |- skos__hiddenLabel mesh__D003039 Neurotoxins, Cobra
% 209.04/209.19 |- rdf__type mesh__D003039sskos__Concept
% 209.04/209.19 |- skos__annotation mesh__D003039
% 209.04/209.19 /antag permitted but consider also ANTITOXINS
% 209.04/209.19 |- skos__historyNote mesh__D003039 Snakes %28%1966-1974%29%
% 209.04/209.19 |- skos__historyNote mesh__D003039 Peptides %28%1966-1975%29%
% 209.04/209.19 |- mesh__recordOriginator mesh__D003039 SH
% 209.04/209.19 |- mesh__historyNote mesh__D003039
% 209.04/209.19 91%28%78%29%; was see under COBRA VENOMS 1978-90
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D003039
% 209.04/209.19 91; was see under COBRA VENOMS 1978-90
% 209.04/209.19 |- mesh__recordMaintainer mesh__D003039 ssb
% 209.04/209.19 |- skos__prefLabel mesh__D003039 Cobra Neurotoxins
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D003039 sjn
% 209.04/209.19 |- skos__broader mesh__D003039smesh__D003040
% 209.04/209.19 |- mesh__dateEstablished mesh__D003039 1991-01-01
% 209.04/209.19 |- skos__scopeNote mesh__D003039
% 209.04/209.19 Toxins, contained in cobra %28%Naja%29% venom that block cholinergic receptors; two specific proteins have been described, the small %28%short, Type I%29% and the large %28%long, Type II%29% which also exist in other Elapid venoms.%A%
% 209.04/209.19 |- mesh__dateRevised mesh__D003039 2005-06-30
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D003039 2006
% 209.04/209.19 |- skos__historyNote mesh__D003039 Snake Venoms %28%1975-1977%29%
% 209.04/209.19 |- skos__prefLabel mesh__D008522 Mediterranean Sea
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 1998
% 209.04/209.19 |- rdf__type mesh__D008522sskos__Concept
% 209.04/209.19 |- mesh__dateEstablished mesh__D008522 1987-01-01
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 2004
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 2000
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 1999
% 209.04/209.19 |- mesh__recordOriginator mesh__D008522 RC
% 209.04/209.19 |- skos__broader mesh__D008522smesh__D009792
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 2001
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 1993
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 2005
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 1996
% 209.04/209.19 |- mesh__dateCreated mesh__D008522 1986-04-02
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D008522 PLS
% 209.04/209.19 |- mesh__recordMaintainer mesh__D008522 TGC
% 209.04/209.19 |- mesh__historyNote mesh__D008522 87
% 209.04/209.19 |- mesh__dateRevised mesh__D008522 1992-05-14
% 209.04/209.19 |- skos__annotation mesh__D008522 no qualif
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 1997
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 1994
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 2006
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 2002
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 1995
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D008522 2003
% 209.04/209.19 |- skos__historyNote mesh__D013467 Benzene Derivatives %28%1968-1974%29%
% 209.04/209.19 |- skos__altLabel mesh__D013467 Chemia Brand of Sulindac
% 209.04/209.19 |- skos__historyNote mesh__D013467 Indenes %28%1966-1978%29%
% 209.04/209.19 |- mesh__dateCreated mesh__D013467 1978-02-08
% 209.04/209.19 |- rdf__type mesh__D013467sskos__Concept
% 209.04/209.19 |- skos__broader mesh__D013467smesh__D007192
% 209.04/209.19 |- skos__altLabel mesh__D013467 Klinoril
% 209.04/209.19 |- mesh__dateEstablished mesh__D013467 1990-01-01
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D013467 sjn
% 209.04/209.19 |- skos__hiddenLabel mesh__D013467 Novo Sundac
% 209.04/209.19 |- skos__altLabel mesh__D013467 Alphapharm Brand of Sulindac
% 209.04/209.19 |- skos__altLabel mesh__D013467 Apotex Brand of Sulindac
% 209.04/209.19 |- mesh__recordMaintainer mesh__D013467 CCR
% 209.04/209.19 |- skos__hiddenLabel mesh__D013467 Apo Sulin
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D013467 2006
% 209.04/209.19 |- skos__altLabel mesh__D013467 Nu-Pharm Brand of Sulindac
% 209.04/209.19 |- skos__hiddenLabel mesh__D013467 Nu Sulindac
% 209.04/209.19 |- skos__altLabel mesh__D013467 Novopharm Brand of Sulindac
% 209.04/209.19 |- skos__altLabel mesh__D013467 Cahill May Roberts Brand of Sulindac
% 209.04/209.19 |- skos__altLabel mesh__D013467 Arthrocine
% 209.04/209.19 |- mesh__dateRevised mesh__D013467 2005-06-30
% 209.04/209.19 |- skos__hiddenLabel mesh__D013467 MK231
% 209.04/209.19 |- mesh__recordOriginator mesh__D013467 SH
% 209.04/209.19 |- skos__prefLabel mesh__D013467 Sulindac
% 209.04/209.19 |- skos__hiddenLabel mesh__D013467 MK 231
% 209.04/209.19 |- skos__altLabel mesh__D013467 Merck Brand of Sulindac
% 209.04/209.19 |- skos__altLabel mesh__D013467 Chibret
% 209.04/209.19 |- mesh__historyNote mesh__D013467
% 209.04/209.19 90%28%79%29%; was see under INDENES 1979-89
% 209.04/209.19 |- skos__hiddenLabel mesh__D013467 Nu Pharm Brand of Sulindac
% 209.04/209.19 |- skos__historyNote mesh__D013467 Benzene %28%1966-1967%29%
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D013467 90; was see under INDENES 1979-89
% 209.04/209.19 |- skos__altLabel mesh__D013467 Kendrick Brand of Sulindac
% 209.04/209.19 |- skos__scopeNote mesh__D013467
% 209.04/209.19 A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects.%A%
% 209.04/209.19 |- skos__altLabel mesh__D013467 Merck Sharp %26% Dohme Brand of Sulindac
% 209.04/209.19 |- skos__historyNote mesh__D013467 Benzylidene Compounds %28%1975-1978%29%
% 209.04/209.19 |- skos__altLabel mesh__D018950 Receptors, Lipopolysaccharide
% 209.04/209.19 |- skos__altLabel mesh__D018950 CD14 Antigen
% 209.04/209.19 |- skos__altLabel mesh__D018950 CD14 Antigens
% 209.04/209.19 |- skos__broader mesh__D018950smesh__D011971
% 209.04/209.19 |- skos__prefLabel mesh__D018950 Antigens, CD14
% 209.04/209.19 |- skos__historyNote mesh__D018950 Receptors, Immunologic %28%1983-1995%29%
% 209.04/209.19 |- skos__altLabel mesh__D018950 Lipopolysaccharide Receptors
% 209.04/209.19 |- mesh__dateEstablished mesh__D018950 1996-01-01
% 209.04/209.19 |- skos__historyNote mesh__D018950 Antigens, CD %28%1990-1995%29%
% 209.04/209.19 |- mesh__recordOriginator mesh__D018950 AGS
% 209.04/209.19 |- skos__broader mesh__D018950smesh__D015703
% 209.04/209.19 |- skos__altLabel mesh__D018950 LPS Receptor
% 209.04/209.19 |- skos__altLabel mesh__D018950 Receptor, Lipoglycan
% 209.04/209.19 |- skos__annotation mesh__D018950 myelomonocytic differentiation antigen
% 209.04/209.19 |- mesh__dateRevised mesh__D018950 2005-06-30
% 209.04/209.19 |- mesh__historyNote mesh__D018950
% 209.04/209.19 96; was CD14 MONOCYTE DIFFERENTIATION ANTIGEN %28%NM%29% 1988-95 %26% LIPOGLYCAN RECEPTOR %28%NM%29% 1983-95%A%
% 209.04/209.19 |- mesh__dateCreated mesh__D018950 1995-06-08
% 209.04/209.19 |- mesh__publicMeSHNote mesh__D018950
% 209.04/209.19 96; CD14 MONOCYTE DIFFERENTIATION ANTIGEN was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-95; %26% ANTIGENS, DIFFERENTIATION 1988; LIPOGLYCAN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1983-95%A%
% 209.04/209.19 |- skos__scopeNote mesh__D018950
% 209.04/209.19 Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including monocytes, macrophages, and some granulocytes. They function as receptors for the complex of lipopolysaccharide %28%LPS%29% and LPS-binding protein.%A%
% 209.04/209.19 |- mesh__activeMeSHYear mesh__D018950 2006
% 209.04/209.19 |- mesh__recordAuthorizer mesh__D018950 sjn
% 209.04/209.19 |- rdf__type mesh__D018950sskos__Concept
% 209.04/209.19 |- skos__historyNote mesh__D018950
% 209.04/209.19 Antigens, Differentiation, Myelomonocytic %28%1989-1995%29%
% 209.04/209.19 |- skos__historyNote mesh__D018950 Antigens, Differentiation %28%1988%29%
% 209.04/209.19 |- mesh__recordMaintainer mesh__D018950 ssb
% 209.04/209.19 |- skos__altLabel mesh__D018950 Lipoglycan Receptor
% 209.04/209.19 |- skos__broader mesh__D018950smesh__D015214
% 209.04/209.19 |- skos__altLabel mesh__D018950 CD14 Monocyte Differentiation Antigen
% 209.04/209.19 |- mesh__onlineNote mesh__D018950
% 209.04/209.19 use ANTIGENS, CD14 %28%NM%29% to search CD14 MONOCYTE DIFFERENTIATION ANTIGEN 1988-95 %26% LIPOGLYCAN RECEPTOR 1983-95%A%
% 209.04/209.19 |- skos__altLabel mesh__D018950 Receptor, LPS
% 209.04/209.19 |- skos__hiddenLabel mesh__D032621 Breeding, Molecular
% 209.04/209.20 |- skos__hiddenLabel mesh__D032621 Shuffling, DNA
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D032621 2003
% 209.04/209.20 |- skos__hiddenLabel mesh__D032621 Shufflings, DNA
% 209.04/209.20 |- skos__altLabel mesh__D032621 Molecular Breeding
% 209.04/209.20 |- skos__hiddenLabel mesh__D032621 Molecular Breedings
% 209.04/209.20 |- mesh__dateCreated mesh__D032621 2002-07-02
% 209.04/209.20 |- skos__prefLabel mesh__D032621 DNA Shuffling
% 209.04/209.20 |- skos__hiddenLabel mesh__D032621 Breedings, Molecular
% 209.04/209.20 |- skos__altLabel mesh__D032621 In Vitro Exon Shuffling
% 209.04/209.20 |- skos__hiddenLabel mesh__D032621 DNA Shufflings
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D032621 2005
% 209.04/209.20 |- skos__broader mesh__D032621smesh__D005818
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D032621 2003
% 209.04/209.20 |- mesh__dateEstablished mesh__D032621 2003-01-01
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D032621 2006
% 209.04/209.20 |- skos__related mesh__D032621smesh__D015202
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D032621 2004
% 209.04/209.20 |- skos__scopeNote mesh__D032621
% 209.04/209.20 The use of DNA recombination %28%RECOMBINATION, GENETIC%29% to prepare a large gene library of novel, chimeric genes from a population of randomly fragmented DNA from related gene sequences.%A%
% 209.04/209.20 |- rdf__type mesh__D032621sskos__Concept
% 209.04/209.20 |- mesh__historyNote mesh__D032621 2003
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D018152 94
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 2005
% 209.04/209.20 |- rdf__type mesh__D018152sskos__Concept
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 1999
% 209.04/209.20 |- skos__scopeNote mesh__D018152
% 209.04/209.20 A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, consisting of ether-sensitive viruses of leporids and squirrels. They commonly cause tumors and are usually transmitted mechanically by arthropods. MYXOMA VIRUS is the type species.%A%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 2002
% 209.04/209.20 |- skos__prefLabel mesh__D018152 Leporipoxvirus
% 209.04/209.20 |- mesh__dateCreated mesh__D018152 1993-06-04
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 1995
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 1998
% 209.04/209.20 |- mesh__dateEstablished mesh__D018152 1994-01-01
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 1994
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 2004
% 209.04/209.20 |- skos__broader mesh__D018152smesh__D018147
% 209.04/209.20 |- mesh__historyNote mesh__D018152 94
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 2001
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 2003
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 1997
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 2000
% 209.04/209.20 |- skos__broader mesh__D018152smesh__D004263
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 1996
% 209.04/209.20 |- skos__annotation mesh__D018152
% 209.04/209.20 a genus of the subfamily Chordopoxvirinae; from Latin lepori-, rabbit; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018152 2006
% 209.04/209.20 |- skos__hiddenLabel mesh__D018152 Leporipoxviruses
% 209.04/209.20 |- skos__historyNote mesh__D018152 Poxviridae %28%1989-1993%29%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004930 2005
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D004930 ags
% 209.04/209.20 |- skos__scopeNote mesh__D004930
% 209.04/209.20 Inuktitut-speakers generally associated with the northern polar region.%A%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004930 2006
% 209.04/209.20 |- mesh__dateCreated mesh__D004930 1999-01-01
% 209.04/209.20 |- mesh__recordOriginator mesh__D004930 NLM
% 209.04/209.20 |- skos__hiddenLabel mesh__D004930 Inuit
% 209.04/209.20 |- skos__hiddenLabel mesh__D004930 Eskimo
% 209.04/209.20 |- mesh__recordMaintainer mesh__D004930 ags
% 209.04/209.20 |- skos__broader mesh__D004930smesh__D005006
% 209.04/209.20 |- skos__prefLabel mesh__D004930 Inuits
% 209.04/209.20 |- mesh__dateRevised mesh__D004930 2005-07-15
% 209.04/209.20 |- skos__hiddenLabel mesh__D004930 Aleut
% 209.04/209.20 |- skos__annotation mesh__D004930 specify geog if pertinent
% 209.04/209.20 |- skos__hiddenLabel mesh__D004930 Inupiat
% 209.04/209.20 |- rdf__type mesh__D004930sskos__Concept
% 209.04/209.20 |- skos__broader mesh__D004930smesh__D044467
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004930 2006A
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004930 2004
% 209.04/209.20 |- skos__hiddenLabel mesh__D004930 Kalaallit
% 209.04/209.20 |- skos__broader mesh__D008055Q000172smesh__D008055
% 209.04/209.20 |- rdf__type mesh__D008055Q000172smesh__CompoundConcept
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004132 2006
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004132 2002
% 209.04/209.20 |- mesh__onlineNote mesh__D004132
% 209.04/209.20 use DIFLUBENZURON to search DIMILIN 1977-90
% 209.04/209.20 |- skos__altLabel mesh__D004132 Dioflubenzuron
% 209.04/209.20 |- mesh__recordOriginator mesh__D004132 RLS
% 209.04/209.20 |- skos__hiddenLabel mesh__D004132 TH 6040
% 209.04/209.20 |- skos__historyNote mesh__D004132 Insect Control %28%1974-1976%29%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004132 2005
% 209.04/209.20 |- mesh__dateEstablished mesh__D004132 1991-01-01
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D004132
% 209.04/209.20 91; was DIMILIN see under JUVENILE HORMONES 1977-90
% 209.04/209.20 |- skos__broader mesh__D004132smesh__D010671
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004132 2004
% 209.04/209.20 |- skos__broader mesh__D004132smesh__D007605
% 209.04/209.20 |- mesh__recordMaintainer mesh__D004132 CCR
% 209.04/209.20 |- mesh__dateCreated mesh__D004132 1976-04-27
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D004132 sjn
% 209.04/209.20 |- skos__historyNote mesh__D004132 Juvenile Hormones %28%1975-1976%29%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004132 2003
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004132 2001
% 209.04/209.20 |- skos__scopeNote mesh__D004132
% 209.04/209.20 An insect growth regulator which interferes with the formation of the insect cuticle. It is effective in the control of mosquitoes and flies.%A%
% 209.04/209.20 |- mesh__historyNote mesh__D004132
% 209.04/209.20 91%28%77%29%; was DIMILIN see under JUVENILE HORMONES 1977-90
% 209.04/209.20 |- skos__hiddenLabel mesh__D004132 TH6040
% 209.04/209.20 |- mesh__dateRevised mesh__D004132 2000-06-22
% 209.04/209.20 |- rdf__type mesh__D004132sskos__Concept
% 209.04/209.20 |- skos__historyNote mesh__D004132 Mosquito Control %28%1974-1976%29%
% 209.04/209.20 |- skos__prefLabel mesh__D004132 Diflubenzuron
% 209.04/209.20 |- skos__historyNote mesh__D004132 Phenylurea Compounds %28%1974-1976%29%
% 209.04/209.20 |- skos__scopeNote mesh__D017858
% 209.04/209.20 An order of fish comprising salmons, trouts, whitefish, graylings, and other families. They are both marine and freshwater fish, found in all oceans and are quite numerous in the Northern Hemisphere. %28%From Nelson: Fishes of the World%29%%A%
% 209.04/209.20 |- skos__hiddenLabel mesh__D017858 Salmoniforme
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D017858 2006
% 209.04/209.20 |- skos__annotation mesh__D017858
% 209.04/209.20 GEN or unspecified: prefer specific families or specific genera%A%
% 209.04/209.20 |- mesh__recordOriginator mesh__D017858 TGC
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D017858 2005
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D017858 sjn
% 209.04/209.20 |- mesh__historyNote mesh__D017858 94
% 209.04/209.20 |- mesh__dateEstablished mesh__D017858 1994-01-01
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D017858 2004
% 209.04/209.20 |- mesh__dateCreated mesh__D017858 1992-12-28
% 209.04/209.20 |- skos__broader mesh__D017858smesh__D005399
% 209.04/209.20 |- mesh__recordMaintainer mesh__D017858 ags
% 209.04/209.20 |- skos__prefLabel mesh__D017858 Salmoniformes
% 209.04/209.20 |- mesh__dateRevised mesh__D017858 2003-07-09
% 209.04/209.20 |- rdf__type mesh__D017858sskos__Concept
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D017858 94
% 209.04/209.20 |- mesh__dateRevised mesh__D003838 1993-06-02
% 209.04/209.20 |- mesh__dateCreated mesh__D003838 1977-04-22
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 1996
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 2005
% 209.04/209.20 |- skos__broader mesh__D003838smesh__D003854
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 2002
% 209.04/209.20 |- skos__hiddenLabel mesh__D003838 Phosphates, Deoxyadenosine
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 1997
% 209.04/209.20 |- skos__historyNote mesh__D003838 Adenine Nucleotides %28%1966-1977%29%
% 209.04/209.20 |- skos__hiddenLabel mesh__D003838 Nucleotides, Deoxyadenine
% 209.04/209.20 |- skos__prefLabel mesh__D003838 Deoxyadenine Nucleotides
% 209.04/209.20 |- skos__altLabel mesh__D003838 Deoxyadenosine Phosphates
% 209.04/209.20 |- skos__annotation mesh__D003838 /biosyn /physiol permitted
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 2006
% 209.04/209.20 |- skos__historyNote mesh__D003838 Deoxyribonucleotides %28%1973-1977%29%
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D003838 78
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 2003
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 2000
% 209.04/209.20 |- rdf__type mesh__D003838sskos__Concept
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 1994
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 2004
% 209.04/209.20 |- mesh__recordOriginator mesh__D003838 RLS
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 1998
% 209.04/209.20 |- mesh__recordMaintainer mesh__D003838 TAP
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 1995
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 2001
% 209.04/209.20 |- mesh__historyNote mesh__D003838 78
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D003838 PLS
% 209.04/209.20 |- mesh__dateEstablished mesh__D003838 1978-01-01
% 209.04/209.20 |- skos__broader mesh__D003838smesh__D000227
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D003838 1999
% 209.04/209.20 |- skos__scopeNote mesh__D003838
% 209.04/209.20 Adenine nucleotides which contain deoxyribose as the sugar moiety.%A%
% 209.04/209.20 |- skos__hiddenLabel mesh__D014560 Acid, Urocanic
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D014560 sjn
% 209.04/209.20 |- skos__historyNote mesh__D014560 Imidazoles %28%1969-1974%29%
% 209.04/209.20 |- skos__scopeNote mesh__D014560 4-Imidazoleacrylic acid.
% 209.04/209.20 |- mesh__recordMaintainer mesh__D014560 ssb
% 209.04/209.20 |- skos__hiddenLabel mesh__D014560 Acid, Glyoxalinylacrylic
% 209.04/209.20 |- skos__prefLabel mesh__D014560 Urocanic Acid
% 209.04/209.20 |- skos__broader mesh__D014560smesh__D007093
% 209.04/209.20 |- rdf__type mesh__D014560sskos__Concept
% 209.04/209.20 |- skos__historyNote mesh__D014560 Acrylates %28%1969-1974%29%
% 209.04/209.20 |- mesh__dateEstablished mesh__D014560 1991-01-01
% 209.04/209.20 |- mesh__historyNote mesh__D014560
% 209.04/209.20 91%28%75%29%; was see under IMIDAZOLES 1975-90
% 209.04/209.20 |- mesh__recordOriginator mesh__D014560 NLM
% 209.04/209.20 |- skos__altLabel mesh__D014560 Glyoxalinylacrylic Acid
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D014560
% 209.04/209.20 91; was see under IMIDAZOLES 1975-90
% 209.04/209.20 |- mesh__dateRevised mesh__D014560 2005-06-30
% 209.04/209.20 |- mesh__dateCreated mesh__D014560 1974-11-19
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D014560 2006
% 209.04/209.20 |- skos__broader mesh__D014560smesh__D000179
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D008523 2006
% 209.04/209.20 |- skos__historyNote mesh__D008523 Information Systems %28%1966-1977%29%
% 209.04/209.20 |- skos__prefLabel mesh__D008523 MEDLARS
% 209.04/209.20 |- skos__annotation mesh__D008523 IM CATALOG: use NAF entry
% 209.04/209.20 |- skos__scopeNote mesh__D008523
% 209.04/209.20 A computerized biomedical bibliographic storage and retrieval system operated by the NATIONAL LIBRARY OF MEDICINE. MEDLARS stands for Medical Literature Analysis and Retrieval System, which was first introduced in 1964 and evolved into an online system in 1971 called MEDLINE %28%MEDLARS Online%29%. As other online databases were developed, MEDLARS became the name of the entire NLM information system while MEDLINE became the name of the premier database. MEDLARS was used to produce the former printed Cumulated Index Medicus, and the printed monthly Index Medicus, until that publication ceased in December 2004.%A%
% 209.04/209.20 |- skos__hiddenLabel mesh__D008523 MEDLARS MEDLINE Information System
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D008523 2005
% 209.04/209.20 |- skos__broader mesh__D008523smesh__D016247
% 209.04/209.20 |- mesh__dateRevised mesh__D008523 2004-07-07
% 209.04/209.20 |- skos__altLabel mesh__D008523 MEDLARS-MEDLINE Information System
% 209.04/209.20 |- rdf__type mesh__D008523sskos__Concept
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D008523
% 209.04/209.20 1991; see MEDLARS-MEDLINE INFORMATION SYSTEM 1978-1990
% 209.04/209.20 |- skos__historyNote mesh__D008523
% 209.04/209.20 National Library of Medicine %28%U.S.%29% %28%1966-1977%29%
% 209.04/209.20 |- skos__broader mesh__D008523smesh__D007256
% 209.04/209.20 |- mesh__dateCreated mesh__D008523 1977-05-11
% 209.04/209.20 |- mesh__recordMaintainer mesh__D008523 ags
% 209.04/209.20 |- skos__hiddenLabel mesh__D008523 Information System, MEDLARS-MEDLINE
% 209.04/209.20 |- skos__altLabel mesh__D008523
% 209.04/209.20 Medical Literature Analysis and Retrieval System
% 209.04/209.20 |- mesh__recordOriginator mesh__D008523 EC
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D008523 sjn
% 209.04/209.20 |- mesh__historyNote mesh__D008523 1991 %28%1978%29%
% 209.04/209.20 |- skos__hiddenLabel mesh__D008523 System, MEDLARS-MEDLINE Information
% 209.04/209.20 |- mesh__dateEstablished mesh__D008523 1978-01-01
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D000540
% 209.04/209.20 91; was see under SURGERY, ORAL, PREPROSTHETIC 1980-90
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Ridge Augmentations, Alveolar
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D000540 2005
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Maxillary Ridge Augmentations
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D000540 SJN
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Augmentation, Mandibular Ridge
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Ridge Augmentation, Maxillary
% 209.04/209.20 |- skos__historyNote mesh__D000540 Mandible/surgery %28%1966-1979%29%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D000540 1999
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Ridge Augmentation, Mandibular
% 209.04/209.20 |- mesh__recordOriginator mesh__D000540 SMH
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Augmentations, Mandibular Ridge
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Mandibular Ridge Augmentations
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Augmentation, Maxillary Ridge
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D000540 2006
% 209.04/209.20 |- skos__historyNote mesh__D000540 Alveoloplasty %28%1966-1979%29%
% 209.04/209.20 |- mesh__dateRevised mesh__D000540 1997-06-20
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Augmentation, Alveolar Ridge
% 209.04/209.20 |- mesh__dateEstablished mesh__D000540 1991-01-01
% 209.04/209.20 |- skos__scopeNote mesh__D000540
% 209.04/209.20 Preprosthetic surgery involving rib, cartilage, or iliac crest bone grafts, usually autologous, or synthetic implants for rebuilding the alveolar ridge.%A%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D000540 2000
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Ridge Augmentation, Alveolar
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Augmentations, Alveolar Ridge
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Augmentations, Maxillary Ridge
% 209.04/209.20 |- skos__annotation mesh__D000540
% 209.04/209.20 do not use /util except by MeSH definition
% 209.04/209.20 |- rdf__type mesh__D000540sskos__Concept
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Ridge Augmentations, Mandibular
% 209.04/209.20 |- mesh__historyNote mesh__D000540
% 209.04/209.20 91%28%80%29%; was see under SURGERY, ORAL, PREPROSTHETIC 1980-90%A%
% 209.04/209.20 |- mesh__recordMaintainer mesh__D000540 PXP
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Alveolar Ridge Augmentations
% 209.04/209.20 |- skos__prefLabel mesh__D000540 Alveolar Ridge Augmentation
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D000540 2001
% 209.04/209.20 |- mesh__dateCreated mesh__D000540 1979-04-27
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D000540 2003
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D000540 2002
% 209.04/209.20 |- skos__hiddenLabel mesh__D000540 Ridge Augmentations, Maxillary
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D000540 2004
% 209.04/209.20 |- skos__historyNote mesh__D000540
% 209.04/209.20 Mandibular Diseases/surgery %28%1966-1979%29%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D000540 1998
% 209.04/209.20 |- skos__broader mesh__D000540smesh__D013516
% 209.04/209.20 |- skos__historyNote mesh__D013468 Propanolamines %28%1974-1979%29%
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D013468 sjn
% 209.04/209.20 |- skos__broader mesh__D013468smesh__D011412
% 209.04/209.20 |- skos__broader mesh__D013468smesh__D010627
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D013468 2006
% 209.04/209.20 |- mesh__recordOriginator mesh__D013468 SH
% 209.04/209.20 |- mesh__dateRevised mesh__D013468 2005-06-30
% 209.04/209.20 |- mesh__recordMaintainer mesh__D013468 ssb
% 209.04/209.20 |- mesh__dateEstablished mesh__D013468 1991-01-01
% 209.04/209.20 |- skos__scopeNote mesh__D013468
% 209.04/209.20 A peripheral vasodilator that was formerly used in the management of peripheral and cerebral vascular disorders. It is hepatotoxic and fatalities have occurred. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1312%29%%A%
% 209.04/209.20 |- skos__prefLabel mesh__D013468 Suloctidil
% 209.04/209.20 |- mesh__dateCreated mesh__D013468 1979-05-30
% 209.04/209.20 |- skos__historyNote mesh__D013468 Amino Alcohols %28%1966-1973%29%
% 209.04/209.20 |- rdf__type mesh__D013468sskos__Concept
% 209.04/209.20 |- mesh__historyNote mesh__D013468
% 209.04/209.20 91%28%80%29%; was see under PROPANOLAMINES 1980-90
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D013468
% 209.04/209.20 91; was see under PROPANOLAMINES 1980-90
% 209.04/209.20 |- skos__prefLabel mesh__D018951 Antigens, CD20
% 209.04/209.20 |- skos__scopeNote mesh__D018951
% 209.04/209.20 Unglycosylated phosphoproteins expressed only on B-cells. They are regulators of transmembrane Ca2+ conductance and thought to play a role in B-cell activation and proliferation.%A%
% 209.04/209.20 |- mesh__recordMaintainer mesh__D018951 ssb
% 209.04/209.20 |- skos__altLabel mesh__D018951 CD20 Antigen
% 209.04/209.20 |- skos__historyNote mesh__D018951 Antigens, CD %28%1990-1995%29%
% 209.04/209.20 |- skos__hiddenLabel mesh__D018951 Antigen, CD20
% 209.04/209.20 |- mesh__dateCreated mesh__D018951 1995-05-26
% 209.04/209.20 |- mesh__historyNote mesh__D018951
% 209.04/209.20 96; was CD20 ANTIGEN %28%NM%29% 1988-95
% 209.04/209.20 |- skos__broader mesh__D018951smesh__D000944
% 209.04/209.20 |- mesh__dateEstablished mesh__D018951 1996-01-01
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018951 2006
% 209.04/209.20 |- skos__broader mesh__D018951smesh__D015703
% 209.04/209.20 |- mesh__recordOriginator mesh__D018951 AGS
% 209.04/209.20 |- rdf__type mesh__D018951sskos__Concept
% 209.04/209.20 |- mesh__dateRevised mesh__D018951 2005-06-30
% 209.04/209.20 |- skos__altLabel mesh__D018951 CD20 Antigens
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D018951
% 209.04/209.20 96; CD20 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95%A%
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D018951 sjn
% 209.04/209.20 |- skos__historyNote mesh__D018951
% 209.04/209.20 Antigens, Differentiation, B-Lymphocyte %28%1988-1995%29%
% 209.04/209.20 |- mesh__onlineNote mesh__D018951
% 209.04/209.20 use ANTIGENS, CD20 %28%NM%29% to search CD20 ANTIGEN 1988-95
% 209.04/209.20 |- skos__annotation mesh__D018951 B-lymphocyte differentiation antigens
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 1998
% 209.04/209.20 |- mesh__dateRevised mesh__D018153 1995-06-08
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 2004
% 209.04/209.20 |- skos__prefLabel mesh__D018153 Czech Republic
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 2002
% 209.04/209.20 |- mesh__dateCreated mesh__D018153 1993-05-26
% 209.04/209.20 |- mesh__recordOriginator mesh__D018153 TGC
% 209.04/209.20 |- mesh__historyNote mesh__D018153 94
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 2003
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 1997
% 209.04/209.20 |- mesh__onlineNote mesh__D018153
% 209.04/209.20 use CZECHOSLOVAKIA to search CZECH REPUBLIC 1966-93
% 209.04/209.20 |- mesh__dateEstablished mesh__D018153 1994-01-01
% 209.04/209.20 |- skos__broader mesh__D018153smesh__D003604
% 209.04/209.20 |- skos__scopeNote mesh__D018153
% 209.04/209.20 Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.%A%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 2006
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 1996
% 209.04/209.20 |- mesh__recordMaintainer mesh__D018153 PLS
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 2001
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D018153 PLS
% 209.04/209.20 |- rdf__type mesh__D018153sskos__Concept
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 2005
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 1999
% 209.04/209.20 |- skos__broader mesh__D018153smesh__D005061
% 209.04/209.20 |- skos__historyNote mesh__D018153 Czechoslovakia %28%1966-1993%29%
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D018153 2000
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D010170 2005
% 209.04/209.20 |- skos__altLabel mesh__D010170 Stearoyl CoA Hydrolase
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Hydrolase, Palmitoyl-CoA
% 209.04/209.20 |- mesh__recordMaintainer mesh__D010170 ssb
% 209.04/209.20 |- mesh__recordOriginator mesh__D010170 RLS
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 CoA Hydrolase, Acyl
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Long Chain Fatty Acyl CoA Hydrolase
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Hydrolase, Stearoyl CoA
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D010170 2006
% 209.04/209.20 |- skos__altLabel mesh__D010170 Oleoyl-CoA Acylhydrolase
% 209.04/209.20 |- mesh__historyNote mesh__D010170
% 209.04/209.20 91%28%78%29%; was see under THIOLESTER HYDROLASES 1978-90
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Oleoyl CoA Acylhydrolase
% 209.04/209.20 |- mesh__dateEstablished mesh__D010170 1991-01-01
% 209.04/209.20 |- skos__historyNote mesh__D010170 Thiolester Hydrolases %28%1973-1977%29%
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 CoA Deacylase, Palmitoyl
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Deacylase, Palmitoyl CoA
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Acylhydrolase, Oleoyl-CoA
% 209.04/209.20 |- skos__altLabel mesh__D010170 Fatty Acyl Thioesterase
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D010170 sjn
% 209.04/209.20 |- rdf__type mesh__D010170sskos__Concept
% 209.04/209.20 |- mesh__dateRevised mesh__D010170 2003-07-09
% 209.04/209.20 |- skos__broader mesh__D010170smesh__D013869
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 CoA Hydrolase, Stearoyl
% 209.04/209.20 |- skos__scopeNote mesh__D010170
% 209.04/209.20 Enzyme catalyzing reversibly the hydrolysis of palmitoyl-CoA or other long-chain acyl coenzyme A compounds to yield CoA and palmitate or other acyl esters. The enzyme is involved in the esterification of fatty acids to form triglycerides. EC 3.1.2.2.%A%
% 209.04/209.20 |- skos__altLabel mesh__D010170 Long-Chain Fatty-Acyl-CoA Hydrolase
% 209.04/209.20 |- skos__altLabel mesh__D010170 Palmitoyl CoA Deacylase
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Hydrolase, Long-Chain Fatty-Acyl-CoA
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Fatty-Acyl-CoA Hydrolase, Long-Chain
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Thioesterase, Palmitoyl
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Hydrolase, Acyl CoA
% 209.04/209.20 |- mesh__dateCreated mesh__D010170 1977-05-17
% 209.04/209.20 |- skos__altLabel mesh__D010170 Palmitoyl Coenzyme A Hydrolase
% 209.04/209.20 |- skos__prefLabel mesh__D010170 Palmitoyl-CoA Hydrolase
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Thioesterase, Fatty Acyl
% 209.04/209.20 |- skos__hiddenLabel mesh__D010170 Palmitoyl CoA Hydrolase
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D010170
% 209.04/209.20 91; was see under THIOLESTER HYDROLASES 1978-90
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D010170 2004
% 209.04/209.20 |- skos__altLabel mesh__D010170 Palmitoyl Thioesterase
% 209.04/209.20 |- skos__prefLabel mesh__D004931 Esophageal Achalasia
% 209.04/209.20 |- mesh__onlineNote mesh__D004931
% 209.04/209.20 use ESOPHAGEAL ACHALASIA to search CARDIOSPASM 1966-84
% 209.04/209.20 |- mesh__dateCreated mesh__D004931 1999-01-01
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D004931
% 209.04/209.20 85; was ACHALASIA OF ESOPHAGUS see CARDIOSPASM 1974-84; was ACHALASIA see under CARDIOSPASM 1963-73; CARDIOSPASM was heading 1963-84%A%
% 209.04/209.20 |- mesh__dateRevised mesh__D004931 2005-06-30
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004931 2006
% 209.04/209.20 |- skos__hiddenLabel mesh__D004931 Cardiospasms
% 209.04/209.20 |- mesh__recordMaintainer mesh__D004931 lkt
% 209.04/209.20 |- mesh__historyNote mesh__D004931
% 209.04/209.20 85; was ACHALASIA OF ESOPHAGUS see CARDIOSPASM 1974-84; was ACHALASIA see under CARDIOSPASM 1963-73; CARDIOSPASM was heading 1963-84%A%
% 209.04/209.20 |- skos__altLabel mesh__D004931 Achalasia, Esophageal
% 209.04/209.20 |- mesh__recordOriginator mesh__D004931 NLM
% 209.04/209.20 |- skos__hiddenLabel mesh__D004931 Esophageal Achalasias
% 209.04/209.20 |- skos__altLabel mesh__D004931 Cardiospasm
% 209.04/209.20 |- skos__hiddenLabel mesh__D004931 Achalasias, Esophageal
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D004931 sjn
% 209.04/209.20 |- skos__scopeNote mesh__D004931
% 209.04/209.20 A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER %28%near the CARDIA%29% fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus %28%megaesophagus%29%.%A%
% 209.04/209.20 |- skos__annotation mesh__D004931
% 209.04/209.20 CARDIOSPASM refers to spasm of the CARDIA, not the heart; not for esophageal spasm %28% = ESOPHAGEAL SPASM, DIFFUSE%29%%A%
% 209.04/209.20 |- skos__broader mesh__D004931smesh__D015154
% 209.04/209.20 |- rdf__type mesh__D004931sskos__Concept
% 209.04/209.20 |- mesh__dateCreated mesh__D004133 1974-11-19
% 209.04/209.20 |- skos__historyNote mesh__D004133 Triazenes %28%1974%29%
% 209.04/209.20 |- skos__hiddenLabel mesh__D004133 4,4%27% Diazoaminobenzamidine
% 209.04/209.20 |- mesh__recordOriginator mesh__D004133 RLS
% 209.04/209.20 |- rdf__type mesh__D004133sskos__Concept
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004133 2002
% 209.04/209.20 |- skos__historyNote mesh__D004133 Amidines %28%1969-1974%29%
% 209.04/209.20 |- mesh__recordMaintainer mesh__D004133 CCR
% 209.04/209.20 |- skos__broader mesh__D004133smesh__D014226
% 209.04/209.20 |- skos__prefLabel mesh__D004133 Diminazene
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D004133 91; was see under AMIDINES 1975-90
% 209.04/209.20 |- skos__scopeNote mesh__D004133 An effective trypanocidal agent.
% 209.04/209.20 |- mesh__dateRevised mesh__D004133 2000-06-22
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004133 2006
% 209.04/209.20 |- skos__altLabel mesh__D004133 4,4%27%-Diazoaminobenzamidine
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D004133 sjn
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004133 2005
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004133 2004
% 209.04/209.20 |- skos__broader mesh__D004133smesh__D001550
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004133 2001
% 209.04/209.20 |- mesh__historyNote mesh__D004133
% 209.04/209.20 91%28%75%29%; was see under AMIDINES 1975-90
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D004133 2003
% 209.04/209.20 |- mesh__dateEstablished mesh__D004133 1991-01-01
% 209.04/209.20 |- mesh__onlineNote mesh__D017859 use SALMONIDAE to search ESOX 1987-93
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D017859 2006
% 209.04/209.20 |- skos__hiddenLabel mesh__D017859 Muskellunges
% 209.04/209.20 |- skos__broader mesh__D017859smesh__D023661
% 209.04/209.20 |- skos__altLabel mesh__D017859 Pike
% 209.04/209.20 |- skos__altLabel mesh__D017859 Chain Pickerel
% 209.04/209.20 |- mesh__publicMeSHNote mesh__D017859
% 209.04/209.20 94; ESOX was see SALMONIDAE 1987-93
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D017859 2005
% 209.04/209.20 |- skos__hiddenLabel mesh__D017859 Pike, Northern
% 209.04/209.20 |- skos__altLabel mesh__D017859 Amur Pike
% 209.04/209.20 |- skos__prefLabel mesh__D017859 Esocidae
% 209.04/209.20 |- skos__hiddenLabel mesh__D017859 Pickerel, Grass
% 209.04/209.20 |- skos__scopeNote mesh__D017859
% 209.04/209.20 A family of freshwater fish of the order ESOCIFORMES, comprising the pikes, inhabiting the waters of the Northern Hemisphere. There is one genus, Esox, with five species: northern pike, grass pickerel, chain pickerel, muskellunge, and Amur pike.%A%
% 209.04/209.20 |- skos__hiddenLabel mesh__D017859 Pike, Amur
% 209.04/209.20 |- skos__hiddenLabel mesh__D017859 Pickerel, Chain
% 209.04/209.20 |- skos__altLabel mesh__D017859 Muskellunge
% 209.04/209.20 |- mesh__recordOriginator mesh__D017859 TGC
% 209.04/209.20 |- mesh__activeMeSHYear mesh__D017859 2004
% 209.04/209.20 |- mesh__recordMaintainer mesh__D017859 ags
% 209.04/209.20 |- mesh__dateCreated mesh__D017859 1992-12-28
% 209.04/209.20 |- mesh__recordAuthorizer mesh__D017859 sjn
% 209.04/209.20 |- skos__altLabel mesh__D017859 Grass Pickerel
% 209.04/209.20 |- rdf__type mesh__D017859sskos__Concept
% 209.04/209.20 |- mesh__dateRevised mesh__D017859 2003-07-09
% 209.04/209.20 |- skos__altLabel mesh__D017859 Northern Pike
% 209.04/209.20 |- mesh__dateEstablished mesh__D017859 1994-01-01
% 209.04/209.20 |- mesh__historyNote mesh__D017859 94; ESOX was see SALMONIDAE 1987-93
% 209.04/209.20 |- skos__altLabel mesh__D028581 Lanthanides
% 209.04/209.20 |- skos__altLabel mesh__D028581 Lanthanoids
% 209.04/209.20 |- skos__hiddenLabel mesh__D028581 Elements, Lanthanoid Series
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D028581 2005
% 209.04/209.21 |- mesh__dateCreated mesh__D028581 2001-07-25
% 209.04/209.21 |- skos__prefLabel mesh__D028581 Lanthanoid Series Elements
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D028581 2006
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D028581
% 209.04/209.21 2002; for LANTHANIDES see METALS, RARE EARTH 1976-2001
% 209.04/209.21 |- rdf__type mesh__D028581sskos__Concept
% 209.04/209.21 |- skos__broader mesh__D028581smesh__D008674
% 209.04/209.21 |- skos__scopeNote mesh__D028581
% 209.04/209.21 Elements of the lanthanoid series including atomic number 57 %28%LATHANUM%29% through atomic number 71 %28%LUTETIUM%29%.%A%
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D028581 2003
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D028581 2004
% 209.04/209.21 |- mesh__dateEstablished mesh__D028581 2002-01-01
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D028581 2002
% 209.04/209.21 |- mesh__historyNote mesh__D028581
% 209.04/209.21 2002; for LANTHANIDES use METALS, RARE EARTH 1976-2001
% 209.04/209.21 |- skos__broader mesh__D028581smesh__D004602
% 209.04/209.21 |- skos__scopeNote mesh__D003839
% 209.04/209.21 Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.%A%
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 1993
% 209.04/209.21 |- skos__broader mesh__D003839smesh__D003853
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 1999
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 1994
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 1997
% 209.04/209.21 |- mesh__historyNote mesh__D003839
% 209.04/209.21 90; was DEOXYADENOSINE 1971-89 %28%Prov 1971-72%29%
% 209.04/209.21 |- mesh__dateRevised mesh__D003839 1992-05-13
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 1998
% 209.04/209.21 |- skos__prefLabel mesh__D003839 Deoxyadenosines
% 209.04/209.21 |- skos__annotation mesh__D003839 /biosyn /physiol permitted
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D003839 90; was DEOXYADENOSINE 1973-89
% 209.04/209.21 |- skos__altLabel mesh__D003839 Adenine Deoxyribonucleosides
% 209.04/209.21 |- skos__altLabel mesh__D003839 Adenylyldeoxyribonucleosides
% 209.04/209.21 |- skos__hiddenLabel mesh__D003839 Deoxyribonucleosides, Adenine
% 209.04/209.21 |- mesh__recordOriginator mesh__D003839 NLM
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 2001
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 1996
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 2006
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 2000
% 209.04/209.21 |- mesh__recordMaintainer mesh__D003839 TGC
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 2004
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 2005
% 209.04/209.21 |- mesh__onlineNote mesh__D003839
% 209.04/209.21 use DEOXYADENOSINES to search DEOXYADENOSINE 1971-89%28%Prov 1971-72%29%%A%
% 209.04/209.21 |- rdf__type mesh__D003839sskos__Concept
% 209.04/209.21 |- skos__broader mesh__D003839smesh__D000241
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 2003
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D003839 PLS
% 209.04/209.21 |- skos__historyNote mesh__D003839 Adenosine %28%1966-1970%29%
% 209.04/209.21 |- mesh__dateCreated mesh__D003839 1999-01-01
% 209.04/209.21 |- mesh__dateEstablished mesh__D003839 1973-01-01
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 2002
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D003839 1995
% 209.04/209.21 |- skos__broader mesh__D014561smesh__D002816
% 209.04/209.21 |- skos__altLabel mesh__D014561 Urochordates
% 209.04/209.21 |- mesh__historyNote mesh__D014561 73
% 209.04/209.21 |- mesh__dateRevised mesh__D014561 2003-07-09
% 209.04/209.21 |- rdf__type mesh__D014561sskos__Concept
% 209.04/209.21 |- mesh__dateCreated mesh__D014561 1999-01-01
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D014561 sjn
% 209.04/209.21 |- skos__historyNote mesh__D014561 Chordata %28%1966-1972%29%
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D014561 2004
% 209.04/209.21 |- mesh__dateEstablished mesh__D014561 1973-01-01
% 209.04/209.21 |- skos__prefLabel mesh__D014561 Urochordata
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D014561 2006
% 209.04/209.21 |- skos__altLabel mesh__D014561 Tunicata
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D014561 2005
% 209.04/209.21 |- skos__scopeNote mesh__D014561
% 209.04/209.21 A subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the Ascidians.%A%
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D014561 73
% 209.04/209.21 |- mesh__recordOriginator mesh__D014561 NLM
% 209.04/209.21 |- mesh__recordMaintainer mesh__D014561 ags
% 209.04/209.21 |- skos__altLabel mesh__D014561 Tunicates
% 209.04/209.21 |- mesh__dateCreated mesh__D008524 1999-01-01
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D008524
% 209.04/209.21 91; was see under PREGNADIENES 1972-90
% 209.04/209.21 |- mesh__recordOriginator mesh__D008524 NLM
% 209.04/209.21 |- mesh__recordMaintainer mesh__D008524 CCR
% 209.04/209.21 |- rdf__type mesh__D008524sskos__Concept
% 209.04/209.21 |- skos__hiddenLabel mesh__D008524 Medrogestone Wyeth Brand
% 209.04/209.21 |- mesh__dateEstablished mesh__D008524 1991-01-01
% 209.04/209.21 |- skos__scopeNote mesh__D008524
% 209.04/209.21 6,17-Dimethylpregna-4,6-diene-3,20-dione. A synthetic progestational hormone with actions similar to those of progesterone. It is used in the treatment of menstrual irregularities and has also been employed in the treatment of prostatic hypertrophy and endometrial carcinoma.%A%
% 209.04/209.21 |- skos__prefLabel mesh__D008524 Medrogestone
% 209.04/209.21 |- skos__historyNote mesh__D008524 Pregnadienes %28%1966-1971%29%
% 209.04/209.21 |- mesh__dateRevised mesh__D008524 2005-06-30
% 209.04/209.21 |- skos__altLabel mesh__D008524 Biodim Brand of Medrogestone
% 209.04/209.21 |- skos__broader mesh__D008524smesh__D011245
% 209.04/209.21 |- skos__altLabel mesh__D008524 Solvay Brand of Medrogestone
% 209.04/209.21 |- skos__hiddenLabel mesh__D008524 Medrogestone Biodim Brand
% 209.04/209.21 |- mesh__historyNote mesh__D008524
% 209.04/209.21 91%28%72%29%; was see under PREGNADIENES 1972-90
% 209.04/209.21 |- skos__altLabel mesh__D008524 Wyeth Brand of Medrogestone
% 209.04/209.21 |- skos__hiddenLabel mesh__D008524 Medrogestone Solvay Brand
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D008524 2006
% 209.04/209.21 |- skos__annotation mesh__D008524 a synthetic progestational hormone
% 209.04/209.21 |- skos__historyNote mesh__D008524
% 209.04/209.21 Progestational Hormones %28%1966-1971%29%
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D008524 sjn
% 209.04/209.21 |- skos__scopeNote mesh__D000541
% 209.04/209.21 Subtotal or complete excision of the alveolar process of the maxilla or mandible. %28%Dorland, 28th ed%29%%A%
% 209.04/209.21 |- mesh__recordMaintainer mesh__D000541 PXP
% 209.04/209.21 |- rdf__type mesh__D000541sskos__Concept
% 209.04/209.21 |- mesh__recordOriginator mesh__D000541 NLM
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000541 2006
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000541 2002
% 209.04/209.21 |- mesh__historyNote mesh__D000541 65
% 209.04/209.21 |- mesh__dateEstablished mesh__D000541 1965-01-01
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000541 2005
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000541 2001
% 209.04/209.21 |- mesh__dateCreated mesh__D000541 1999-01-01
% 209.04/209.21 |- skos__broader mesh__D000541smesh__D013516
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000541 1999
% 209.04/209.21 |- skos__annotation mesh__D000541
% 209.04/209.21 excision of part of the ALVEOLAR PROCESS %28%see note there%29%; do not confuse with ALVEOLOPLASTY; do not use /util except by MeSH definition%A%
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D000541 65
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000541 2004
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000541 2000
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000541 1998
% 209.04/209.21 |- skos__hiddenLabel mesh__D000541 Alveolectomies
% 209.04/209.21 |- skos__prefLabel mesh__D000541 Alveolectomy
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000541 2003
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D000541 SJN
% 209.04/209.21 |- mesh__dateRevised mesh__D000541 1997-06-20
% 209.04/209.21 |- skos__altLabel mesh__D013469 Almirall Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Spyfarma Brand of Sulpiride
% 209.04/209.21 |- mesh__historyNote mesh__D013469 74
% 209.04/209.21 |- mesh__recordOriginator mesh__D013469 NLM
% 209.04/209.21 |- skos__hiddenLabel mesh__D013469 Sanofi Synthelabo Brand of Sulpiride
% 209.04/209.21 |- skos__hiddenLabel mesh__D013469 Vertigo Meresa
% 209.04/209.21 |- skos__altLabel mesh__D013469 Hoechst Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Fumouzer Brand of Sulpiride
% 209.04/209.21 |- mesh__dateCreated mesh__D013469 1999-01-01
% 209.04/209.21 |- skos__altLabel mesh__D013469 Areu Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Desitin Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Sulperide
% 209.04/209.21 |- mesh__dateRevised mesh__D013469 2005-06-30
% 209.04/209.21 |- skos__altLabel mesh__D013469 Hormosan Brand of Sulpiride
% 209.04/209.21 |- mesh__recordMaintainer mesh__D013469 CCR
% 209.04/209.21 |- skos__altLabel mesh__D013469 Allphar Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Vertigo-Meresa
% 209.04/209.21 |- skos__altLabel mesh__D013469 Erempharma Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Uriach Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Hennig Brand of Sulpiride
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D013469 74
% 209.04/209.21 |- skos__altLabel mesh__D013469 Rosemont Brand of Sulpiride
% 209.04/209.21 |- skos__broader mesh__D013469smesh__D001549
% 209.04/209.21 |- skos__scopeNote mesh__D013469
% 209.04/209.21 A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. %28%From Merck Index, 11th ed%29%%A%
% 209.04/209.21 |- rdf__type mesh__D013469sskos__Concept
% 209.04/209.21 |- skos__altLabel mesh__D013469 Hexal Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Meresa
% 209.04/209.21 |- skos__altLabel mesh__D013469 Dolmatil
% 209.04/209.21 |- skos__altLabel mesh__D013469 Psicofarma Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Pharmacia Brand of Sulpiride
% 209.04/209.21 |- skos__prefLabel mesh__D013469 Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Centrum Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Sanofi-Synthelabo Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 Dolorgiet Brand of Sulpiride
% 209.04/209.21 |- skos__hiddenLabel mesh__D013469 vertigo neogama
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D013469 2006
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D013469 sjn
% 209.04/209.21 |- mesh__dateEstablished mesh__D013469 1974-01-01
% 209.04/209.21 |- skos__altLabel mesh__D013469 Krewel Brand of Sulpiride
% 209.04/209.21 |- skos__altLabel mesh__D013469 vertigo-neogama
% 209.04/209.21 |- skos__altLabel mesh__D018952 CD34 Antigens
% 209.04/209.21 |- mesh__dateRevised mesh__D018952 2005-06-30
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018952 2006
% 209.04/209.21 |- rdf__type mesh__D018952sskos__Concept
% 209.04/209.21 |- mesh__historyNote mesh__D018952
% 209.04/209.21 96; was CD34 ANTIGEN %28%NM%29% 1988-95
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D018952 sjn
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D018952
% 209.04/209.21 96; CD34 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION 1988-91%A%
% 209.04/209.21 |- skos__historyNote mesh__D018952
% 209.04/209.21 Antigens, Differentiation %28%1988-1991%29%
% 209.04/209.21 |- mesh__recordMaintainer mesh__D018952 ssb
% 209.04/209.21 |- mesh__dateEstablished mesh__D018952 1996-01-01
% 209.04/209.21 |- skos__hiddenLabel mesh__D018952 Antigen, CD34
% 209.04/209.21 |- skos__scopeNote mesh__D018952
% 209.04/209.21 Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.%A%
% 209.04/209.21 |- skos__annotation mesh__D018952 differentiation antigens
% 209.04/209.21 |- skos__altLabel mesh__D018952 CD34 Antigen
% 209.04/209.21 |- skos__broader mesh__D018952smesh__D015703
% 209.04/209.21 |- mesh__recordOriginator mesh__D018952 AGS
% 209.04/209.21 |- mesh__dateCreated mesh__D018952 1995-05-26
% 209.04/209.21 |- skos__historyNote mesh__D018952 Antigens, CD %28%1990-1995%29%
% 209.04/209.21 |- skos__prefLabel mesh__D018952 Antigens, CD34
% 209.04/209.21 |- mesh__onlineNote mesh__D018952
% 209.04/209.21 use ANTIGENS, CD34 %28%NM%29% to search CD34 ANTIGEN 1988-95
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 2003
% 209.04/209.21 |- skos__scopeNote mesh__D018154
% 209.04/209.21 Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.%A%
% 209.04/209.21 |- skos__broader mesh__D018154smesh__D005061
% 209.04/209.21 |- mesh__dateRevised mesh__D018154 1996-06-10
% 209.04/209.21 |- skos__altLabel mesh__D018154 Slovak Republic
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 2004
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 2001
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 2002
% 209.04/209.21 |- mesh__historyNote mesh__D018154 94
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 1997
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 2005
% 209.04/209.21 |- skos__historyNote mesh__D018154 Czechoslovakia %28%1966-1993%29%
% 209.04/209.21 |- skos__prefLabel mesh__D018154 Slovakia
% 209.04/209.21 |- mesh__dateCreated mesh__D018154 1993-06-03
% 209.04/209.21 |- skos__broader mesh__D018154smesh__D003604
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 2006
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 1998
% 209.04/209.21 |- mesh__dateEstablished mesh__D018154 1994-01-01
% 209.04/209.21 |- mesh__recordMaintainer mesh__D018154 TGC
% 209.04/209.21 |- mesh__recordOriginator mesh__D018154 TGC
% 209.04/209.21 |- rdf__type mesh__D018154sskos__Concept
% 209.04/209.21 |- mesh__onlineNote mesh__D018154
% 209.04/209.21 use CZECHOSLOVAKIA to search SLOVAKIA 1966-93
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D018154 PLS
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 1999
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018154 2000
% 209.04/209.21 |- skos__hiddenLabel mesh__D010171 CoA, Hexadecanoyl
% 209.04/209.21 |- mesh__dateCreated mesh__D010171 1977-05-20
% 209.04/209.21 |- skos__prefLabel mesh__D010171 Palmitoyl Coenzyme A
% 209.04/209.21 |- skos__hiddenLabel mesh__D010171 CoA, Palmityl
% 209.04/209.21 |- mesh__dateEstablished mesh__D010171 1991-01-01
% 209.04/209.21 |- mesh__recordOriginator mesh__D010171 RLS
% 209.04/209.21 |- mesh__dateRevised mesh__D010171 2003-07-09
% 209.04/209.21 |- skos__altLabel mesh__D010171 Palmitoyl CoA
% 209.04/209.21 |- mesh__recordMaintainer mesh__D010171 ssb
% 209.04/209.21 |- skos__historyNote mesh__D010171 Palmitic Acids %28%1966-1977%29%
% 209.04/209.21 |- skos__hiddenLabel mesh__D010171 A, Palmitoyl Coenzyme
% 209.04/209.21 |- rdf__type mesh__D010171sskos__Concept
% 209.04/209.21 |- skos__broader mesh__D010171smesh__D000214
% 209.04/209.21 |- skos__hiddenLabel mesh__D010171 CoA, Palmitoyl
% 209.04/209.21 |- skos__historyNote mesh__D010171 Palmitates %28%1975-1977%29%
% 209.04/209.21 |- skos__hiddenLabel mesh__D010171 Coenzyme A, Palmitoyl
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D010171
% 209.04/209.21 91; was see under ACYL COENZYME A 1978-90
% 209.04/209.21 |- skos__historyNote mesh__D010171 Coenzyme A %28%1966-1977%29%
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010171 2005
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D010171 sjn
% 209.04/209.21 |- skos__altLabel mesh__D010171 Palmityl CoA
% 209.04/209.21 |- skos__altLabel mesh__D010171 Hexadecanoyl CoA
% 209.04/209.21 |- mesh__historyNote mesh__D010171
% 209.04/209.21 91%28%78%29%; was see under ACYL COENZYME A 1978-90
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010171 2004
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010171 2006
% 209.04/209.21 |- skos__scopeNote mesh__D010171
% 209.04/209.21 A fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.%A%
% 209.04/209.21 |- skos__broader mesh__D004932smesh__D006975
% 209.04/209.21 |- skos__scopeNote mesh__D004932
% 209.04/209.21 Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation %28%PORTAL SYSTEM%29% to the systemic venous circulation. Often they are observed in individuals with portal hypertension %28%HYPERTENSION, PORTAL%29%.%A%
% 209.04/209.21 |- skos__hiddenLabel mesh__D004932 Varix, Esophageal
% 209.04/209.21 |- skos__altLabel mesh__D004932 Esophageal Varix
% 209.04/209.21 |- skos__hiddenLabel mesh__D004932 Varix, Gastric
% 209.04/209.21 |- skos__altLabel mesh__D004932 Gastric Varices
% 209.04/209.21 |- skos__broader mesh__D004932smesh__D004935
% 209.04/209.21 |- mesh__historyNote mesh__D004932 85; was ESOPHAGEAL VARICES 1963-84
% 209.04/209.21 |- skos__hiddenLabel mesh__D004932 Varices, Gastric
% 209.04/209.21 |- mesh__dateRevised mesh__D004932 2004-07-07
% 209.04/209.21 |- mesh__recordOriginator mesh__D004932 NLM
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D004932 2006
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D004932 sjn
% 209.04/209.21 |- mesh__recordMaintainer mesh__D004932 lkt
% 209.04/209.21 |- skos__hiddenLabel mesh__D004932 Varices, Esophageal
% 209.04/209.21 |- mesh__onlineNote mesh__D004932
% 209.04/209.21 use ESOPHAGEAL AND GASTRIC VARICES to search ESOPHAGEAL VARICES 1966-84%A%
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D004932 85; was ESOPHAGEAL VARICES 1963-84
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D004932 2005
% 209.04/209.21 |- rdf__type mesh__D004932sskos__Concept
% 209.04/209.21 |- skos__annotation mesh__D004932
% 209.04/209.21 do not specify esophageal or gastric aspect unless particularly discussed; hemorrhaging esophageal or gastric varices: coord IM with HEMORRHAGE, GASTROINTESTINAL %28%IM%29%%A%
% 209.04/209.21 |- mesh__dateCreated mesh__D004932 1999-01-01
% 209.04/209.21 |- skos__prefLabel mesh__D004932 Esophageal and Gastric Varices
% 209.04/209.21 |- mesh__recordMaintainer mesh__D004134 ssb
% 209.04/209.21 |- mesh__dateRevised mesh__D004134 2003-07-09
% 209.04/209.21 |- mesh__dateCreated mesh__D004134 1983-03-17
% 209.04/209.21 |- skos__altLabel mesh__D004134 1,2-Ditetradecyl-glycero-3-phosphocholine
% 209.04/209.21 |- skos__hiddenLabel mesh__D004134
% 209.04/209.21 1,2 Ditetradecyl glycero 3 phosphocholine
% 209.04/209.21 |- rdf__type mesh__D004134sskos__Concept
% 209.04/209.21 |- skos__altLabel mesh__D004134
% 209.04/209.21 1,2-Ditetradecanoyl-glycero-3-phosphocholine
% 209.04/209.21 |- skos__broader mesh__D004134smesh__D010713
% 209.04/209.21 |- skos__historyNote mesh__D004134 Myristates %28%1977-1980%29%
% 209.04/209.21 |- skos__hiddenLabel mesh__D004134
% 209.04/209.21 1,2 Dimyristoyl glycero 3 phosphorylcholine
% 209.04/209.21 |- skos__altLabel mesh__D004134 DMCP
% 209.04/209.21 |- skos__annotation mesh__D004134
% 209.04/209.21 used in study of biol membranes; DF: DMPC
% 209.04/209.21 |- skos__hiddenLabel mesh__D004134
% 209.04/209.21 1,2 Ditetradecanoyl glycero 3 phosphocholine
% 209.04/209.21 |- skos__altLabel mesh__D004134 DMPC
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D004134 2006
% 209.04/209.21 |- mesh__recordOriginator mesh__D004134 RLS
% 209.04/209.21 |- mesh__historyNote mesh__D004134 84
% 209.04/209.21 |- mesh__dateEstablished mesh__D004134 1984-01-01
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D004134 2005
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D004134 2004
% 209.04/209.21 |- skos__altLabel mesh__D004134 1,2-Dimyristoyl-glycero-3-phosphorylcholine
% 209.04/209.21 |- skos__prefLabel mesh__D004134 Dimyristoylphosphatidylcholine
% 209.04/209.21 |- skos__altLabel mesh__D004134 Dimyristoyllecithin
% 209.04/209.21 |- skos__historyNote mesh__D004134 Phosphatidylcholines %28%1980-1983%29%
% 209.04/209.21 |- skos__scopeNote mesh__D004134
% 209.04/209.21 A synthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes.%A%
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D004134 sjn
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D004134 84
% 209.04/209.21 |- skos__hiddenLabel mesh__D014562 Congo Eels
% 209.04/209.21 |- skos__altLabel mesh__D014562 Caudata
% 209.04/209.21 |- mesh__dateCreated mesh__D014562 1999-01-01
% 209.04/209.21 |- skos__scopeNote mesh__D014562
% 209.04/209.21 An order of the Amphibia class which includes salamanders and newts. They are characterized by usually having slim bodies and tails, four limbs of about equal size %28%except in Sirenidae%29%, and a reduction in skull bones.%A%
% 209.04/209.21 |- mesh__recordOriginator mesh__D014562 NLM
% 209.04/209.21 |- mesh__historyNote mesh__D014562 81; was SALAMANDERS 1963-80
% 209.04/209.21 |- mesh__dateRevised mesh__D014562 2003-07-09
% 209.04/209.21 |- rdf__type mesh__D014562sskos__Concept
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D014562 2005
% 209.04/209.21 |- skos__broader mesh__D014562smesh__D000663
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D014562 81; was SALAMANDERS 1963-80
% 209.04/209.21 |- skos__annotation mesh__D014562
% 209.04/209.21 includes SALAMANDERS %28%note X ref below%29%, mudpuppies %28% = NECTURUS %26% specific%29% %26% NEWTS %28% = SALAMANDRIDAE %26% specifics%29%; NIM when exper animal: no qualif; when IM, qualif permitted%A%
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D014562 2004
% 209.04/209.21 |- skos__hiddenLabel mesh__D014562 Eels, Congo
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D014562 2006
% 209.04/209.21 |- mesh__recordMaintainer mesh__D014562 ags
% 209.04/209.21 |- mesh__onlineNote mesh__D014562
% 209.04/209.21 use URODELA to search SALAMANDERS 1966-80
% 209.04/209.21 |- skos__hiddenLabel mesh__D014562 Salamander
% 209.04/209.21 |- skos__prefLabel mesh__D014562 Urodela
% 209.04/209.21 |- skos__hiddenLabel mesh__D014562 Congo Eel
% 209.04/209.21 |- skos__altLabel mesh__D014562 Amphiuma
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D014562 sjn
% 209.04/209.21 |- skos__annotation mesh__D008525 a synthetic progestational hormone
% 209.04/209.21 |- skos__scopeNote mesh__D008525
% 209.04/209.21 %28%6 alpha%29%-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.%A%
% 209.04/209.21 |- mesh__recordMaintainer mesh__D008525 CCR
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D008525 sjn
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D008525 2006
% 209.04/209.21 |- mesh__recordOriginator mesh__D008525 NLM
% 209.04/209.21 |- skos__prefLabel mesh__D008525 Medroxyprogesterone
% 209.04/209.21 |- mesh__dateCreated mesh__D008525 1999-01-01
% 209.04/209.21 |- skos__hiddenLabel mesh__D008525 Medroxyprogesterone Strakan Brand
% 209.04/209.21 |- mesh__dateRevised mesh__D008525 2005-06-30
% 209.04/209.21 |- skos__altLabel mesh__D008525 Strakan Brand of Medroxyprogesterone
% 209.04/209.21 |- mesh__onlineNote mesh__D008525
% 209.04/209.21 use MEDROXYPROGESTERONE to search METHYPREGNONE 1977-93
% 209.04/209.21 |- mesh__historyNote mesh__D008525
% 209.04/209.21 METHYPREGNONE was see MEDROXYPROGESTERONE 1977-93
% 209.04/209.21 |- rdf__type mesh__D008525sskos__Concept
% 209.04/209.21 |- skos__altLabel mesh__D008525 Methylhydroxyprogesterone
% 209.04/209.21 |- skos__broader mesh__D008525smesh__D011374
% 209.04/209.21 |- skos__hiddenLabel mesh__D008525
% 209.04/209.21 17 alpha Hydroxy 6 alpha Methylprogesterone
% 209.04/209.21 |- skos__altLabel mesh__D008525 17 alpha-Hydroxy-6 alpha-Methylprogesterone
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D008525
% 209.04/209.21 METHYPREGNONE was see MEDROXYPROGESTERONE 1977-93
% 209.04/209.21 |- skos__hiddenLabel mesh__D000542 Allergic Alveolitides, Extrinsic
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D000542 PLS
% 209.04/209.21 |- mesh__dateCreated mesh__D000542 1976-04-27
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 2006
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 1996
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 1995
% 209.04/209.21 |- mesh__dateRevised mesh__D000542 1993-03-03
% 209.04/209.21 |- mesh__recordMaintainer mesh__D000542 TGC
% 209.04/209.21 |- skos__broader mesh__D000542smesh__D017563
% 209.04/209.21 |- skos__hiddenLabel mesh__D000542 Hypersensitivity Pneumonitides
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 2005
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 1994
% 209.04/209.21 |- mesh__dateEstablished mesh__D000542 1977-01-01
% 209.04/209.21 |- skos__historyNote mesh__D000542
% 209.04/209.21 Respiratory Hypersensitivity %28%1966-1976%29%
% 209.04/209.21 |- skos__altLabel mesh__D000542 Pneumonitis, Hypersensitivity
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 1999
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D000542 77
% 209.04/209.21 |- skos__broader mesh__D000542smesh__D012130
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 2004
% 209.04/209.21 |- skos__scopeNote mesh__D000542
% 209.04/209.21 Conditions in which inhalation of organic dusts results in hypersensitivity reactions at the alveolar level, associated with the production of precipitins.%A%
% 209.04/209.21 |- skos__hiddenLabel mesh__D000542 Alveolitides, Extrinsic Allergic
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 2002
% 209.04/209.21 |- skos__hiddenLabel mesh__D000542 Pneumonitides, Hypersensitivity
% 209.04/209.21 |- skos__annotation mesh__D000542 a type of resp hypersensitivity
% 209.04/209.21 |- skos__hiddenLabel mesh__D000542 Extrinsic Allergic Alveolitis
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 1998
% 209.04/209.21 |- mesh__recordOriginator mesh__D000542 VDK
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 2003
% 209.04/209.21 |- skos__hiddenLabel mesh__D000542 Extrinsic Allergic Alveolitides
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 2001
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 1997
% 209.04/209.21 |- mesh__historyNote mesh__D000542 77
% 209.04/209.21 |- skos__altLabel mesh__D000542 Allergic Alveolitis, Extrinsic
% 209.04/209.21 |- skos__altLabel mesh__D000542 Hypersensitivity Pneumonitis
% 209.04/209.21 |- skos__prefLabel mesh__D000542 Alveolitis, Extrinsic Allergic
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D000542 2000
% 209.04/209.21 |- rdf__type mesh__D000542sskos__Concept
% 209.04/209.21 |- skos__annotation mesh__D018953
% 209.04/209.21 a type of alternative med; do not confuse with KINESIS; KINETICS or KINESTHESIS; DF: KINESIOL APPLIED%A%
% 209.04/209.21 |- skos__broader mesh__D018953smesh__D026201
% 209.04/209.21 |- mesh__dateCreated mesh__D018953 1995-02-21
% 209.04/209.21 |- mesh__dateRevised mesh__D018953 2005-06-30
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D018953 96
% 209.04/209.21 |- skos__prefLabel mesh__D018953 Kinesiology, Applied
% 209.04/209.21 |- mesh__recordOriginator mesh__D018953 TGC
% 209.04/209.21 |- skos__altLabel mesh__D018953 Applied Kinesiology
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D018953 sjn
% 209.04/209.21 |- skos__scopeNote mesh__D018953
% 209.04/209.21 The study of muscles and the movement of the human body. In holistic medicine it is the balance of movement and the interaction of a person%27%s energy systems. Applied kinesiology is the name given by its inventor, Dr. George Goodheart, to the system of applying muscle testing diagnostically and therapeutically to different aspects of health care. %28%Thorsons Introductory Guide to Kinesiology, 1992, p13%29%%A%
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D018953 2006
% 209.04/209.21 |- mesh__dateEstablished mesh__D018953 1996-01-01
% 209.04/209.21 |- mesh__historyNote mesh__D018953 96
% 209.04/209.21 |- rdf__type mesh__D018953sskos__Concept
% 209.04/209.21 |- mesh__recordMaintainer mesh__D018953 lkt
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 1994
% 209.04/209.21 |- mesh__publicMeSHNote mesh__D010970
% 209.04/209.21 91; was see under PLANT PROTEINS 1975-90
% 209.04/209.21 |- mesh__dateCreated mesh__D010970 1974-11-19
% 209.04/209.21 |- mesh__recordAuthorizer mesh__D010970 PLS
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 1995
% 209.04/209.21 |- skos__hiddenLabel mesh__D010970 Plastocyanin, Silver
% 209.04/209.21 |- skos__altLabel mesh__D010970 Plastocyanine
% 209.04/209.21 |- skos__scopeNote mesh__D010970
% 209.04/209.21 A copper-containing plant protein that is a fundamental link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds.%A%
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 1998
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 1993
% 209.04/209.21 |- skos__broader mesh__D010970smesh__D008667
% 209.04/209.21 |- mesh__dateRevised mesh__D010970 1992-05-19
% 209.04/209.21 |- rdf__type mesh__D010970sskos__Concept
% 209.04/209.21 |- mesh__recordMaintainer mesh__D010970 TAP
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 1999
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 1996
% 209.04/209.21 |- skos__historyNote mesh__D010970 Plant Proteins %28%1970-1974%29%
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 2005
% 209.04/209.21 |- skos__prefLabel mesh__D010970 Plastocyanin
% 209.04/209.21 |- mesh__dateEstablished mesh__D010970 1991-01-01
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 2000
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 1997
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 2006
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 2003
% 209.04/209.21 |- skos__annotation mesh__D010970 a plant protein
% 209.04/209.21 |- mesh__recordOriginator mesh__D010970 NLM
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 2001
% 209.04/209.21 |- skos__historyNote mesh__D010970 Copper %28%1970-1974%29%
% 209.04/209.21 |- skos__broader mesh__D010970smesh__D010940
% 209.04/209.21 |- mesh__activeMeSHYear mesh__D010970 2004
% 209.04/209.22 |- mesh__historyNote mesh__D010970
% 209.04/209.22 91%28%75%29%; was see under PLANT PROTEINS 1975-90
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010970 2002
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 2004
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 1996
% 209.04/209.22 |- skos__prefLabel mesh__D018155 Orthopoxvirus
% 209.04/209.22 |- skos__hiddenLabel mesh__D018155 Orthopoxviruses
% 209.04/209.22 |- skos__scopeNote mesh__D018155
% 209.04/209.22 A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS.%A%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 2000
% 209.04/209.22 |- mesh__dateRevised mesh__D018155 2005-07-12
% 209.04/209.22 |- mesh__historyNote mesh__D018155 94
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 1997
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 2005
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 2001
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 2006
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 1998
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 2002
% 209.04/209.22 |- mesh__dateCreated mesh__D018155 1993-06-04
% 209.04/209.22 |- rdf__type mesh__D018155sskos__Concept
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 1994
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 1999
% 209.04/209.22 |- mesh__recordOriginator mesh__D018155 AGS
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D018155 ags
% 209.04/209.22 |- skos__broader mesh__D018155smesh__D018147
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 1995
% 209.04/209.22 |- mesh__recordMaintainer mesh__D018155 ags
% 209.04/209.22 |- skos__historyNote mesh__D018155 Poxviridae %28%1977-1993%29%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 2003
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D018155 94
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018155 2006A
% 209.04/209.22 |- mesh__dateEstablished mesh__D018155 1994-01-01
% 209.04/209.22 |- skos__annotation mesh__D018155
% 209.04/209.22 a genus of the subfamily Chordopoxvirinae; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%%A%
% 209.04/209.22 |- rdf__type mesh__D010172sskos__Concept
% 209.04/209.22 |- mesh__dateCreated mesh__D010172 1977-05-17
% 209.04/209.22 |- skos__scopeNote mesh__D010172
% 209.04/209.22 A long-chain fatty acid ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids.%A%
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D010172 sjn
% 209.04/209.22 |- skos__prefLabel mesh__D010172 Palmitoylcarnitine
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D010172
% 209.04/209.22 91; was see under CARNITINE 1978-90
% 209.04/209.22 |- skos__altLabel mesh__D010172 Hexadecanoylcarnitine
% 209.04/209.22 |- mesh__dateRevised mesh__D010172 2005-06-30
% 209.04/209.22 |- skos__historyNote mesh__D010172 Carnitine %28%1966-1977%29%
% 209.04/209.22 |- mesh__recordOriginator mesh__D010172 RLS
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010172 2006
% 209.04/209.22 |- skos__altLabel mesh__D010172 Palmitylcarnitine
% 209.04/209.22 |- mesh__recordMaintainer mesh__D010172 ssb
% 209.04/209.22 |- mesh__historyNote mesh__D010172
% 209.04/209.22 91%28%78%29%; was see under CARNITINE 1978-90
% 209.04/209.22 |- skos__historyNote mesh__D010172 Palmitic Acids %28%1966-1977%29%
% 209.04/209.22 |- skos__annotation mesh__D010172
% 209.04/209.22 deficiency: coordinate PALMITOYLCARNITINE /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%%A%
% 209.04/209.22 |- skos__broader mesh__D010172smesh__D002331
% 209.04/209.22 |- mesh__dateEstablished mesh__D010172 1991-01-01
% 209.04/209.22 |- mesh__dateRevised mesh__D004933 2003-07-09
% 209.04/209.22 |- mesh__historyNote mesh__D004933 70%28%66%29%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004933 2006
% 209.04/209.22 |- skos__scopeNote mesh__D004933
% 209.04/209.22 Congenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA.%A%
% 209.04/209.22 |- skos__altLabel mesh__D004933 Atresia, Esophageal
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004933 2005
% 209.04/209.22 |- skos__broader mesh__D004933smesh__D004935
% 209.04/209.22 |- rdf__type mesh__D004933sskos__Concept
% 209.04/209.22 |- mesh__recordOriginator mesh__D004933 NLM
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004933 2004
% 209.04/209.22 |- mesh__dateCreated mesh__D004933 1999-01-01
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D004933 sjn
% 209.04/209.22 |- mesh__recordMaintainer mesh__D004933 lkt
% 209.04/209.22 |- skos__hiddenLabel mesh__D004933 Atresias, Esophageal
% 209.04/209.22 |- skos__hiddenLabel mesh__D004933 Esophageal Atresias
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D004933 70
% 209.04/209.22 |- skos__prefLabel mesh__D004933 Esophageal Atresia
% 209.04/209.22 |- mesh__dateEstablished mesh__D004933 1970-01-01
% 209.04/209.22 |- skos__broader mesh__D004933smesh__D004065
% 209.04/209.22 |- mesh__recordOriginator mesh__D004135 NLM
% 209.04/209.22 |- rdf__type mesh__D004135sskos__Concept
% 209.04/209.22 |- mesh__dateEstablished mesh__D004135 1991-01-01
% 209.04/209.22 |- skos__scopeNote mesh__D004135 A coccidiostat for poultry.
% 209.04/209.22 |- skos__altLabel mesh__D004135 Dinitrotoluamide
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D004135 sjn
% 209.04/209.22 |- skos__historyNote mesh__D004135 Benzamides %28%1974%29%
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D004135
% 209.04/209.22 91; was see under BENZAMIDES 1975-90
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004135 2006
% 209.04/209.22 |- mesh__dateCreated mesh__D004135 1974-11-19
% 209.04/209.22 |- mesh__recordMaintainer mesh__D004135 exl
% 209.04/209.22 |- skos__altLabel mesh__D004135 Methyldinitrobenzamide
% 209.04/209.22 |- mesh__dateRevised mesh__D004135 2005-06-30
% 209.04/209.22 |- skos__historyNote mesh__D004135 Nitrobenzenes %28%1974%29%
% 209.04/209.22 |- skos__broader mesh__D004135smesh__D001549
% 209.04/209.22 |- mesh__historyNote mesh__D004135
% 209.04/209.22 91%28%75%29%; was see under BENZAMIDES 1975-90
% 209.04/209.22 |- skos__prefLabel mesh__D004135 Dinitolmide
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D014563 sjn
% 209.04/209.22 |- skos__broader mesh__D014563smesh__D014553
% 209.04/209.22 |- skos__historyNote mesh__D014563 specific urologic disease
% 209.04/209.22 |- skos__historyNote mesh__D014563 Urination %28%1966-1977%29%
% 209.04/209.22 |- rdf__type mesh__D014563sskos__Concept
% 209.04/209.22 |- skos__historyNote mesh__D014563 specific urinary tract heading
% 209.04/209.22 |- skos__historyNote mesh__D014563 Urologic Diseases %28%1966-1977%29%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D014563 2005
% 209.04/209.22 |- mesh__historyNote mesh__D014563 78
% 209.04/209.22 |- mesh__dateEstablished mesh__D014563 1978-01-01
% 209.04/209.22 |- skos__annotation mesh__D014563
% 209.04/209.22 same relation to URINARY TRACT that HEMODYNAMIC PROCESSES is to CARDIOVASCULAR SYSTEM; urine volume: index under URINE probably NIM%A%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D014563 2006
% 209.04/209.22 |- mesh__dateRevised mesh__D014563 2004-07-07
% 209.04/209.22 |- mesh__recordMaintainer mesh__D014563 lkt
% 209.04/209.22 |- skos__historyNote mesh__D014563 Urinary Tract %28%1972-1977%29%
% 209.04/209.22 |- skos__hiddenLabel mesh__D014563 Urodynamic
% 209.04/209.22 |- skos__scopeNote mesh__D014563
% 209.04/209.22 The mechanical laws of fluid dynamics as they apply to urine transport.%A%
% 209.04/209.22 |- skos__prefLabel mesh__D014563 Urodynamics
% 209.04/209.22 |- mesh__dateCreated mesh__D014563 1977-04-22
% 209.04/209.22 |- mesh__recordOriginator mesh__D014563 SMH
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D014563 78
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 2000
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 1996
% 209.04/209.22 |- skos__hiddenLabel mesh__D008526 Oblongata, Medulla
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 2006
% 209.04/209.22 |- mesh__recordMaintainer mesh__D008526 TAP
% 209.04/209.22 |- skos__broader mesh__D008526smesh__D012249
% 209.04/209.22 |- skos__hiddenLabel mesh__D008526 Oblongatas, Medulla
% 209.04/209.22 |- skos__hiddenLabel mesh__D008526 Myelencephalons
% 209.04/209.22 |- mesh__dateRevised mesh__D008526 1992-05-15
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D008526 PLS
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 2005
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 2004
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 1995
% 209.04/209.22 |- mesh__dateCreated mesh__D008526 1999-01-01
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 2002
% 209.04/209.22 |- skos__altLabel mesh__D008526 Myelencephalon
% 209.04/209.22 |- rdf__type mesh__D008526sskos__Concept
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 1993
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 2003
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 1994
% 209.04/209.22 |- mesh__recordOriginator mesh__D008526 NLM
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 1999
% 209.04/209.22 |- skos__prefLabel mesh__D008526 Medulla Oblongata
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 2001
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 1997
% 209.04/209.22 |- skos__hiddenLabel mesh__D008526 Medulla Oblongatas
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008526 1998
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D000543 SJN
% 209.04/209.22 |- mesh__dateRevised mesh__D000543 1997-06-20
% 209.04/209.22 |- skos__related mesh__D000543smesh__D003825
% 209.04/209.22 |- mesh__dateCreated mesh__D000543 1999-01-01
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000543 2006
% 209.04/209.22 |- mesh__recordOriginator mesh__D000543 NLM
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000543 1999
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000543 2005
% 209.04/209.22 |- mesh__dateEstablished mesh__D000543 1965-01-01
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000543 2002
% 209.04/209.22 |- mesh__recordMaintainer mesh__D000543 PXP
% 209.04/209.22 |- skos__scopeNote mesh__D000543
% 209.04/209.22 Conservative contouring of the alveolar process, in preparation for immediate or future denture construction. %28%Dorland, 28th ed%29%%A%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000543 1998
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000543 2004
% 209.04/209.22 |- skos__prefLabel mesh__D000543 Alveoloplasty
% 209.04/209.22 |- skos__hiddenLabel mesh__D000543 Alveoloplasties
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000543 2001
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D000543 65
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000543 2003
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000543 2000
% 209.04/209.22 |- rdf__type mesh__D000543sskos__Concept
% 209.04/209.22 |- skos__annotation mesh__D000543
% 209.04/209.22 refers to ALVEOLAR PROCESS %28%see note there%29%; do not confuse with ALVEOLECTOMY; do not use /util except by MeSH definition%A%
% 209.04/209.22 |- mesh__historyNote mesh__D000543 65
% 209.04/209.22 |- skos__broader mesh__D000543smesh__D013516
% 209.04/209.22 |- mesh__dateRevised mesh__D018954 2003-07-09
% 209.04/209.22 |- mesh__dateEstablished mesh__D018954 1996-01-01
% 209.04/209.22 |- skos__annotation mesh__D018954
% 209.04/209.22 %22%essential to meet the health needs of a population%22%; IM GEN; for specific drug as essential, coord IM with drug %28%IM%29%%A%
% 209.04/209.22 |- skos__hiddenLabel mesh__D018954 Essential Drugs
% 209.04/209.22 |- mesh__dateCreated mesh__D018954 1995-02-17
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018954 2005
% 209.04/209.22 |- mesh__recordMaintainer mesh__D018954 ssb
% 209.04/209.22 |- skos__historyNote mesh__D018954 Drugs %28%1978-1995%29%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018954 2004
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D018954 96
% 209.04/209.22 |- skos__scopeNote mesh__D018954
% 209.04/209.22 Drugs considered essential to meet the health needs of a population as well as to control drug costs. %28%World Health Organization Action Programme on Essential Drugs, 1994, p3%29%%A%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018954 2006
% 209.04/209.22 |- mesh__recordOriginator mesh__D018954 TGC
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D018954 sjn
% 209.04/209.22 |- mesh__historyNote mesh__D018954 96
% 209.04/209.22 |- rdf__type mesh__D018954sskos__Concept
% 209.04/209.22 |- skos__prefLabel mesh__D018954 Drugs, Essential
% 209.04/209.22 |- skos__broader mesh__D018954smesh__D004364
% 209.04/209.22 |- skos__historyNote mesh__D010971 Quinones %28%1972-1974%29%
% 209.04/209.22 |- mesh__recordMaintainer mesh__D010971 CCR
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D010971 sjn
% 209.04/209.22 |- mesh__dateCreated mesh__D010971 1974-11-19
% 209.04/209.22 |- mesh__historyNote mesh__D010971
% 209.04/209.22 91%28%75%29%; was see under QUINONES 1975-90
% 209.04/209.22 |- mesh__dateRevised mesh__D010971 2000-06-21
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D010971 91; was see under QUINONES 1975-90
% 209.04/209.22 |- skos__scopeNote mesh__D010971
% 209.04/209.22 Polyunsaturated side-chain quinone derivative which is an important link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds.%A%
% 209.04/209.22 |- skos__historyNote mesh__D010971 Plant Proteins %28%1972-1974%29%
% 209.04/209.22 |- rdf__type mesh__D010971sskos__Concept
% 209.04/209.22 |- skos__broader mesh__D010971smesh__D016227
% 209.04/209.22 |- mesh__dateEstablished mesh__D010971 1991-01-01
% 209.04/209.22 |- skos__hiddenLabel mesh__D010971 Plastoquinone 9
% 209.04/209.22 |- skos__altLabel mesh__D010971 Plastoquinone-9
% 209.04/209.22 |- mesh__recordOriginator mesh__D010971 NLM
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010971 2005
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010971 2001
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010971 2003
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010971 2006
% 209.04/209.22 |- skos__prefLabel mesh__D010971 Plastoquinone
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010971 2002
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010971 2004
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018156 2006
% 209.04/209.22 |- mesh__recordMaintainer mesh__D018156 JLS
% 209.04/209.22 |- skos__historyNote mesh__D018156 Publishing %28%1966-1993%29%
% 209.04/209.22 |- mesh__dateEstablished mesh__D018156 1994-01-01
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D018156 98; see JOURNALISM 1994-97
% 209.04/209.22 |- mesh__dateCreated mesh__D018156 1993-06-02
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D018156 SJN
% 209.04/209.22 |- rdf__type mesh__D018156sskos__Concept
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018156 1999
% 209.04/209.22 |- mesh__recordOriginator mesh__D018156 TGC
% 209.04/209.22 |- skos__broader mesh__D018156smesh__D020452
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018156 2003
% 209.04/209.22 |- mesh__historyNote mesh__D018156 98
% 209.04/209.22 |- skos__scopeNote mesh__D018156
% 209.04/209.22 The collection, writing, and editing of current interest material on topics related to biomedicine for presentation through the mass media, including newspapers, magazines, radio, or television, usually for a public audience such as health care consumers.%A%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018156 2000
% 209.04/209.22 |- skos__prefLabel mesh__D018156 Journalism, Medical
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018156 2004
% 209.04/209.22 |- skos__historyNote mesh__D018156 Periodicals %28%1966-1993%29%
% 209.04/209.22 |- mesh__dateRevised mesh__D018156 1998-06-10
% 209.04/209.22 |- skos__annotation mesh__D018156
% 209.04/209.22 IM; JOURNALISM, DENTAL is also available
% 209.04/209.22 |- skos__altLabel mesh__D018156 Medical Journalism
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018156 2001
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018156 2005
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D018156 2002
% 209.04/209.22 |- mesh__dateRevised mesh__D010173 2001-07-25
% 209.04/209.22 |- mesh__recordMaintainer mesh__D010173 mdb
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010173 2003
% 209.04/209.22 |- mesh__dateCreated mesh__D010173 1999-01-01
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010173 2005
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010173 2004
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D010173 sjn
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010173 2006
% 209.04/209.22 |- mesh__recordOriginator mesh__D010173 NLM
% 209.04/209.22 |- skos__hiddenLabel mesh__D010173 Palpations
% 209.04/209.22 |- skos__scopeNote mesh__D010173
% 209.04/209.22 Application of fingers with light pressure to the surface of the body to determine consistence of parts beneath in physical diagnosis; includes palpation for determining the outlines of organs.%A%
% 209.04/209.22 |- rdf__type mesh__D010173sskos__Concept
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D010173 2002
% 209.04/209.22 |- skos__prefLabel mesh__D010173 Palpation
% 209.04/209.22 |- skos__broader mesh__D010173smesh__D010808
% 209.04/209.22 |- skos__annotation mesh__D010173
% 209.04/209.22 do not confuse with %22%palpitation%22% %28% = HEART RATE; ARRHYTHMIA or specific arrhythmia%29%%A%
% 209.04/209.22 |- mesh__recordMaintainer mesh__D004934 lkt
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004934 2006
% 209.04/209.22 |- mesh__recordOriginator mesh__D004934 NLM
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004934 2005
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D004934 sjn
% 209.04/209.22 |- rdf__type mesh__D004934sskos__Concept
% 209.04/209.22 |- skos__scopeNote mesh__D004934
% 209.04/209.22 Any fluid-filled closed cavity or sac %28%CYSTS%29% that is lined by an EPITHELIUM and found in the ESOPHAGUS region.%A%
% 209.04/209.22 |- skos__broader mesh__D004934smesh__D003560
% 209.04/209.22 |- skos__annotation mesh__D004934 non-neoplastic
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004934 2004
% 209.04/209.22 |- mesh__dateCreated mesh__D004934 1999-01-01
% 209.04/209.22 |- skos__prefLabel mesh__D004934 Esophageal Cyst
% 209.04/209.22 |- skos__hiddenLabel mesh__D004934 Esophageal Cysts
% 209.04/209.22 |- mesh__dateRevised mesh__D004934 2003-07-09
% 209.04/209.22 |- skos__hiddenLabel mesh__D004934 Cysts, Esophageal
% 209.04/209.22 |- skos__hiddenLabel mesh__D004934 Cyst, Esophageal
% 209.04/209.22 |- skos__broader mesh__D004934smesh__D004935
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 2005
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 1995
% 209.04/209.22 |- mesh__dateCreated mesh__D004136 1976-04-13
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 2006
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 2003
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 1993
% 209.04/209.22 |- mesh__recordMaintainer mesh__D004136 TGC
% 209.04/209.22 |- skos__prefLabel mesh__D004136 Dinitrobenzenes
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 1998
% 209.04/209.22 |- mesh__recordOriginator mesh__D004136 RLS
% 209.04/209.22 |- skos__annotation mesh__D004136
% 209.04/209.22 includes ortho-, meta- %26% para-dinitrobenzenes
% 209.04/209.22 |- mesh__historyNote mesh__D004136
% 209.04/209.22 91%28%77%29%; was see under NITROBENZENES 1977-90
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 2004
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 1999
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 1996
% 209.04/209.22 |- skos__broader mesh__D004136smesh__D009578
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 2000
% 209.04/209.22 |- skos__scopeNote mesh__D004136
% 209.04/209.22 Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions.%A%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 1997
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 2001
% 209.04/209.22 |- mesh__dateRevised mesh__D004136 1992-05-13
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 2002
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D004136
% 209.04/209.22 91; was see under NITROBENZENES 1977-90
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D004136 PLS
% 209.04/209.22 |- skos__hiddenLabel mesh__D004136 Compounds, Dinitrophenyl
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D004136 1994
% 209.04/209.22 |- skos__historyNote mesh__D004136 Nitrobenzenes %28%1966-1976%29%
% 209.04/209.22 |- skos__historyNote mesh__D004136 Dinitrophenols %28%1966-1976%29%
% 209.04/209.22 |- mesh__dateEstablished mesh__D004136 1991-01-01
% 209.04/209.22 |- rdf__type mesh__D004136sskos__Concept
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D014564 2006
% 209.04/209.22 |- skos__broader mesh__D014564smesh__D016146
% 209.04/209.22 |- mesh__historyNote mesh__D014564 98; use explode 1972-97
% 209.04/209.22 |- skos__annotation mesh__D014564
% 209.04/209.22 general or unspecified; prefer specifics or specific parts of urogenital system /abnorm; DF: UROGENITAL ABNORM%A%
% 209.04/209.22 |- mesh__dateEstablished mesh__D014564 1998-01-01
% 209.04/209.22 |- skos__scopeNote mesh__D014564
% 209.04/209.22 Congenital structural abnormalities of the UROGENITAL SYSTEM in either the male or the female.%A%
% 209.04/209.22 |- skos__hiddenLabel mesh__D014564 Urogenital Abnormality
% 209.04/209.22 |- skos__hiddenLabel mesh__D014564 Abnormality, Urogenital
% 209.04/209.22 |- mesh__dateCreated mesh__D014564 1999-01-01
% 209.04/209.22 |- skos__hiddenLabel mesh__D014564 Genitourinary Abnormality
% 209.04/209.22 |- skos__hiddenLabel mesh__D014564 Abnormality, Genitourinary
% 209.04/209.22 |- skos__altLabel mesh__D014564 Abnormalities, Urogenital
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D014564 sjn
% 209.04/209.22 |- skos__broader mesh__D014564smesh__D000013
% 209.04/209.22 |- skos__historyNote mesh__D014564
% 209.04/209.22 Urogenital System/abnormalities %28%1966-1997%29%
% 209.04/209.22 |- skos__prefLabel mesh__D014564 Urogenital Abnormalities
% 209.04/209.22 |- rdf__type mesh__D014564sskos__Concept
% 209.04/209.22 |- skos__hiddenLabel mesh__D014564 Abnormalities, Genitourinary
% 209.04/209.22 |- skos__altLabel mesh__D014564 Genitourinary Abnormalities
% 209.04/209.22 |- mesh__recordMaintainer mesh__D014564 lkt
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D014564 98
% 209.04/209.22 |- mesh__recordOriginator mesh__D014564 NLM
% 209.04/209.22 |- mesh__dateRevised mesh__D014564 2005-06-30
% 209.04/209.22 |- mesh__dateCreated mesh__D008527 1999-01-01
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Childhood Medulloblastomas
% 209.04/209.22 |- skos__altLabel mesh__D008527
% 209.04/209.22 Sarcoma, Cerebellar, Circumscribed Arachnoidal
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008527 2000
% 209.04/209.22 |- mesh__recordOriginator mesh__D008527 NLM
% 209.04/209.22 |- skos__annotation mesh__D008527
% 209.04/209.22 coord IM with CEREBELLAR NEOPLASMS %28%IM%29%
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Medullomyoblastomas
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008527 2006
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008527 2003
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008527 2001
% 209.04/209.22 |- skos__altLabel mesh__D008527 Medulloblastoma, Desmoplastic
% 209.04/209.22 |- skos__scopeNote mesh__D008527
% 209.04/209.22 A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood %28%see NEUROECTODERMAL TUMOR, PRIMITIVE%29%. The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1%29%%A%
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008527 2004
% 209.04/209.22 |- skos__prefLabel mesh__D008527 Medulloblastoma
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Adult Medulloblastoma
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008527 2002
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Medulloblastomas, Childhood
% 209.04/209.22 |- skos__broader mesh__D008527smesh__D005910
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Desmoplastic Medulloblastomas
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Medulloblastomas
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Desmoplastic Medulloblastoma
% 209.04/209.22 |- rdf__type mesh__D008527sskos__Concept
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Medulloblastoma, Melanocytic
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Medulloblastomas, Melanocytic
% 209.04/209.22 |- skos__broader mesh__D008527smesh__D018242
% 209.04/209.22 |- mesh__recordMaintainer mesh__D008527 KEV
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Childhood Medulloblastoma
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Melanocytic Medulloblastomas
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Medulloblastomas, Adult
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Medulloblastomas, Desmoplastic
% 209.04/209.22 |- skos__hiddenLabel mesh__D008527 Adult Medulloblastomas
% 209.04/209.22 |- mesh__dateRevised mesh__D008527 1999-11-03
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D008527 sjn
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D008527 2005
% 209.04/209.22 |- skos__altLabel mesh__D000544 Senile Dementia, Alzheimer Type
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000544 2006A
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Dementias, Presenile
% 209.04/209.22 |- skos__altLabel mesh__D000544 Dementia, Alzheimer Type
% 209.04/209.22 |- mesh__dateRevised mesh__D000544 2005-07-29
% 209.04/209.22 |- skos__related mesh__D000544smesh__D016900
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D000544 jls
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000544 2006
% 209.04/209.22 |- skos__altLabel mesh__D000544 Presenile Alzheimer Dementia
% 209.04/209.22 |- skos__related mesh__D000544smesh__D016229
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Disease, Alzheimer%27%s
% 209.04/209.22 |- skos__broader mesh__D000544smesh__D024801
% 209.04/209.22 |- skos__related mesh__D000544smesh__D016875
% 209.04/209.22 |- mesh__recordMaintainer mesh__D000544 jls
% 209.04/209.22 |- rdf__type mesh__D000544sskos__Concept
% 209.04/209.22 |- skos__altLabel mesh__D000544 Late Onset Alzheimer Disease
% 209.04/209.22 |- skos__related mesh__D000544smesh__D018888
% 209.04/209.22 |- skos__altLabel mesh__D000544 Focal Onset Alzheimer%27%s Disease
% 209.04/209.22 |- skos__prefLabel mesh__D000544 Alzheimer Disease
% 209.04/209.22 |- skos__altLabel mesh__D000544 Early Onset Alzheimer Disease
% 209.04/209.22 |- mesh__dateCreated mesh__D000544 1999-01-01
% 209.04/209.22 |- mesh__activeMeSHYear mesh__D000544 2005
% 209.04/209.22 |- skos__altLabel mesh__D000544 Dementia, Primary Senile Degenerative
% 209.04/209.22 |- mesh__historyNote mesh__D000544
% 209.04/209.22 1998%28%1963%29%; for DEMENTIA, PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE SENILE use DEMENTIA 1981-1999; for DEMENTIA SENILE use DEMENTIA 1966-1999%A%
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Alzheimer Dementia, Presenile
% 209.04/209.22 |- skos__related mesh__D000544smesh__D016657
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Dementia, Presenile Alzheimer
% 209.04/209.22 |- mesh__publicMeSHNote mesh__D000544
% 209.04/209.22 1998; see ALZHEIMER%27%S DISEASE 1984-1997, see DEMENTIA, PRESENILE 1967-1983, see PSYCHOSES, PRESENILE 1963-1966; for DEMENTIA PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE, SENILE see DEMENTIA 1981-1999; for DEMENTIA, SENILE see DEMENTIA 1966-1999%A%
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Senile Dementias
% 209.04/209.22 |- skos__scopeNote mesh__D000544
% 209.04/209.22 A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. %28%From Adams et al., Principles of Neurology, 6th ed, pp1049-57%29%%A%
% 209.04/209.22 |- skos__related mesh__D000544smesh__D016564
% 209.04/209.22 |- skos__altLabel mesh__D000544 Dementia, Senile
% 209.04/209.22 |- skos__broader mesh__D000544smesh__D003704
% 209.04/209.22 |- skos__related mesh__D000544smesh__D020232
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Senile Dementia
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Presenile Dementia
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Dementias, Senile
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Presenile Dementias
% 209.04/209.22 |- skos__altLabel mesh__D000544 Alzheimer%27%s Disease
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Disease, Alzheimer
% 209.04/209.22 |- skos__altLabel mesh__D000544 Senile Dementia, Acute Confusional
% 209.04/209.22 |- skos__altLabel mesh__D000544 Primary Senile Degenerative Dementia
% 209.04/209.22 |- skos__hiddenLabel mesh__D000544 Alzheimer Type Dementia
% 209.04/209.22 |- skos__altLabel mesh__D000544 Alzheimer Type Senile Dementia
% 209.04/209.22 |- mesh__dateEstablished mesh__D000544 1984-01-01
% 209.04/209.22 |- mesh__recordOriginator mesh__D000544 NLM
% 209.04/209.22 |- skos__altLabel mesh__D018955 OKM5 Antigen
% 209.04/209.22 |- skos__altLabel mesh__D018955 Platelet Glycoprotein IIIb
% 209.04/209.22 |- skos__altLabel mesh__D018955 SR-BI Receptor
% 209.04/209.22 |- mesh__recordAuthorizer mesh__D018955 sjn
% 209.04/209.22 |- skos__hiddenLabel mesh__D018955 Antigen, OKM5
% 209.04/209.22 |- skos__altLabel mesh__D018955
% 209.04/209.22 FAT %28%Fatty Acid Translocase%29% - CD36 Antigen
% 209.04/209.22 |- skos__hiddenLabel mesh__D018955 Glycoprotein IIIb, Platelet
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018955 2006
% 209.04/209.23 |- skos__broader mesh__D018955smesh__D015703
% 209.04/209.23 |- skos__altLabel mesh__D018955 Scavenger Receptors, Class B, Type I
% 209.04/209.23 |- skos__altLabel mesh__D018955 CD36 Antigens
% 209.04/209.23 |- skos__prefLabel mesh__D018955 Antigens, CD36
% 209.04/209.23 |- skos__hiddenLabel mesh__D018955 Platelet Glycoprotein, GPIV
% 209.04/209.23 |- skos__altLabel mesh__D018955 CD36 Antigen
% 209.04/209.23 |- skos__hiddenLabel mesh__D018955 Receptor, Thrombospondin
% 209.04/209.23 |- skos__altLabel mesh__D018955 Thrombospondin Receptors
% 209.04/209.23 |- mesh__recordOriginator mesh__D018955 AGS
% 209.04/209.23 |- skos__altLabel mesh__D018955 SR-BI Protein
% 209.04/209.23 |- mesh__dateRevised mesh__D018955 2005-06-30
% 209.04/209.23 |- skos__altLabel mesh__D018955 GPIIIb Platelet Glycoprotein
% 209.04/209.23 |- skos__hiddenLabel mesh__D018955 Platelet Glycoprotein, GPIIIb
% 209.04/209.23 |- rdf__type mesh__D018955sskos__Concept
% 209.04/209.23 |- skos__altLabel mesh__D018955 CD36 Protein
% 209.04/209.23 |- mesh__recordMaintainer mesh__D018955 jmp
% 209.04/209.23 |- skos__altLabel mesh__D018955 Platelet Membrane Glycoprotein IIIb
% 209.04/209.23 |- skos__hiddenLabel mesh__D018955 Glycoprotein IV, Platelet
% 209.04/209.23 |- skos__altLabel mesh__D018955 Platelet Membrane Glycoprotein IV
% 209.04/209.23 |- skos__scopeNote mesh__D018955
% 209.04/209.23 Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.%A%
% 209.04/209.23 |- mesh__dateCreated mesh__D018955 1995-05-26
% 209.04/209.23 |- mesh__historyNote mesh__D018955 1996
% 209.04/209.23 |- skos__broader mesh__D018955smesh__D050612
% 209.04/209.23 |- skos__altLabel mesh__D018955 Thrombospondin Receptor
% 209.04/209.23 |- skos__altLabel mesh__D018955 Adipocyte Membrane Protein p88
% 209.04/209.23 |- skos__altLabel mesh__D018955 GPIV Platelet Glycoprotein
% 209.04/209.23 |- mesh__dateEstablished mesh__D018955 1996-01-01
% 209.04/209.23 |- skos__altLabel mesh__D018955 Platelet Glycoprotein IV
% 209.04/209.23 |- skos__broader mesh__D018955smesh__D011956
% 209.04/209.23 |- skos__hiddenLabel mesh__D018955 Antigen, CD36
% 209.04/209.23 |- skos__altLabel mesh__D018955
% 209.04/209.23 CD36 Antigen %28%Collagen Type I Receptor, Thrombospondin Receptor%29%
% 209.04/209.23 |- skos__altLabel mesh__D018955 Receptors, Thrombospondin
% 209.04/209.23 |- skos__broader mesh__D018955smesh__D051122
% 209.04/209.23 |- skos__altLabel mesh__D018955 CD36 Fatty Acid Transporter
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D018955
% 209.04/209.23 1996; CD36 ANTIGEN was indexed under ANTIGENS, CD 1990-1995 %26% ANTIGENS, DIFFERENTIATION 1989-1991; CD36 ANTIGEN %28%COLLAGEN TYPE I RECEPTOR, THROMBSPONDIN RECEPTOR%29% was indexed under ANTIGENS, CD36 2004; ORGANIC ANION TRANSPORTERS 1996-2004 %26% under MEMBRANE GLYCOPROTEINS 1996-2004; SCAVENGER RECEPTORS, CLASS B, TYPE I was indexed under RECEPTORS, IMMUNOLOGIC 2005%A%
% 209.04/209.23 |- skos__broader mesh__D018955smesh__D010980
% 209.04/209.23 |- skos__broader mesh__D010972smesh__D001779
% 209.04/209.23 |- skos__scopeNote mesh__D010972
% 209.04/209.23 A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION.%A%
% 209.04/209.23 |- rdf__type mesh__D010972sskos__Concept
% 209.04/209.23 |- skos__hiddenLabel mesh__D010972 Factor, Platelet Activating
% 209.04/209.23 |- skos__altLabel mesh__D010972 1-Alkyl-2-acetyl-sn-glycerophosphocholine
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D010972 sjn
% 209.04/209.23 |- mesh__historyNote mesh__D010972 1983%28%1979%29%
% 209.04/209.23 |- skos__prefLabel mesh__D010972 Platelet Activating Factor
% 209.04/209.23 |- skos__altLabel mesh__D010972 Platelet-Activating Substance
% 209.04/209.23 |- skos__altLabel mesh__D010972 Thrombocyte Aggregating Activity
% 209.04/209.23 |- skos__broader mesh__D010972smesh__D002794
% 209.04/209.23 |- skos__hiddenLabel mesh__D010972
% 209.04/209.23 1 Alkyl 2 acetyl sn glycerophosphocholine
% 209.04/209.23 |- mesh__recordOriginator mesh__D010972 RLS
% 209.04/209.23 |- skos__altLabel mesh__D010972 Platelet Aggregating Factor
% 209.04/209.23 |- mesh__dateCreated mesh__D010972 1982-05-11
% 209.04/209.23 |- skos__hiddenLabel mesh__D010972 PAF Acether
% 209.04/209.23 |- mesh__recordMaintainer mesh__D010972 jmp
% 209.04/209.23 |- mesh__dateRevised mesh__D010972 2005-06-30
% 209.04/209.23 |- skos__hiddenLabel mesh__D010972 Aggregating Factor, Platelet
% 209.04/209.23 |- skos__altLabel mesh__D010972 Phosphorylcholine, Acetyl Glyceryl Ether
% 209.04/209.23 |- skos__altLabel mesh__D010972 PAF-Acether
% 209.04/209.23 |- skos__broader mesh__D010972smesh__D010742
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D010972
% 209.04/209.23 1983; PLATELET AGGREGATING FACTOR was indexed under PLATLET ACTIVATING FACTOR 2002-2005 %26% BLOOD COAGULATION FACTORS 1979-2001%A%
% 209.04/209.23 |- skos__altLabel mesh__D010972 Acetyl Glyceryl Ether Phosphorylcholine
% 209.04/209.23 |- skos__altLabel mesh__D010972 AGEPC
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010972 2006
% 209.04/209.23 |- skos__broader mesh__D010972smesh__D012898
% 209.04/209.23 |- skos__altLabel mesh__D010972 Platelet Aggregation Enhancing Factor
% 209.04/209.23 |- mesh__dateEstablished mesh__D010972 1983-01-01
% 209.04/209.23 |- skos__hiddenLabel mesh__D010972 Platelet Activating Substance
% 209.04/209.23 |- skos__historyNote mesh__D010972
% 209.04/209.23 Lysophosphatidylcholines %28%1966-1980%29%
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 1999
% 209.04/209.23 |- skos__hiddenLabel mesh__D018157 Parapoxviruses
% 209.04/209.23 |- skos__broader mesh__D018157smesh__D018147
% 209.04/209.23 |- rdf__type mesh__D018157sskos__Concept
% 209.04/209.23 |- mesh__dateCreated mesh__D018157 1993-06-30
% 209.04/209.23 |- skos__scopeNote mesh__D018157
% 209.04/209.23 A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, which infect ungulates and may infect humans. ORF VIRUS is the type species.%A%
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 2002
% 209.04/209.23 |- skos__annotation mesh__D018157
% 209.04/209.23 a genus of the family Poxviridae; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%%A%
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 1995
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 2003
% 209.04/209.23 |- skos__prefLabel mesh__D018157 Parapoxvirus
% 209.04/209.23 |- mesh__dateEstablished mesh__D018157 1994-01-01
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 2004
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D018157 94
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 1996
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 2005
% 209.04/209.23 |- mesh__historyNote mesh__D018157 94
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 1997
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 2006
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 2000
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 1998
% 209.04/209.23 |- skos__historyNote mesh__D018157 Poxviridae %28%1978-1993%29%
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 2001
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018157 1994
% 209.04/209.23 |- skos__altLabel mesh__D010174 Booklets
% 209.04/209.23 |- rdf__type mesh__D010174sskos__Concept
% 209.04/209.23 |- mesh__dateRevised mesh__D010174 1993-06-03
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 2001
% 209.04/209.23 |- skos__scopeNote mesh__D010174
% 209.04/209.23 Printed publications usually having a format with no binding and no cover and having fewer than some set number of pages. They are often devoted to a single subject.%A%
% 209.04/209.23 |- skos__hiddenLabel mesh__D010174 Booklet
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 2004
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 1997
% 209.04/209.23 |- skos__prefLabel mesh__D010174 Pamphlets
% 209.04/209.23 |- skos__hiddenLabel mesh__D010174 Brochure
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 2000
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 2003
% 209.04/209.23 |- mesh__dateCreated mesh__D010174 1999-01-01
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 1996
% 209.04/209.23 |- skos__hiddenLabel mesh__D010174 Pamphlet
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 2006
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 1999
% 209.04/209.23 |- mesh__recordMaintainer mesh__D010174 PLS
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D010174 PLS
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 2002
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 1995
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 2005
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 1998
% 209.04/209.23 |- skos__broader mesh__D010174smesh__D011642
% 209.04/209.23 |- skos__altLabel mesh__D010174 Brochures
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010174 1994
% 209.04/209.23 |- mesh__recordOriginator mesh__D010174 NLM
% 209.04/209.23 |- rdf__type mesh__D004935sskos__Concept
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D004935 2004
% 209.04/209.23 |- mesh__dateCreated mesh__D004935 1999-01-01
% 209.04/209.23 |- mesh__recordMaintainer mesh__D004935 lkt
% 209.04/209.23 |- skos__related mesh__D004935smesh__D004933
% 209.04/209.23 |- skos__scopeNote mesh__D004935
% 209.04/209.23 Pathological processes in the ESOPHAGUS.
% 209.04/209.23 |- skos__prefLabel mesh__D004935 Esophageal Diseases
% 209.04/209.23 |- mesh__recordOriginator mesh__D004935 NLM
% 209.04/209.23 |- skos__annotation mesh__D004935
% 209.04/209.23 inflamm dis = ESOPHAGITIS; hemorrhage: coord IM with HEMORRHAGE, GASTROINTESTINAL %28%IM%29%; motility disord = ESOPHAGEAL MOTILITY DISORDERS or specific; esophageal varix or varices = ESOPHAGEAL AND GASTRIC VARICES %26% see note there%A%
% 209.04/209.23 |- skos__broader mesh__D004935smesh__D005767
% 209.04/209.23 |- skos__hiddenLabel mesh__D004935 Diseases, Esophageal
% 209.04/209.23 |- skos__hiddenLabel mesh__D004935 Disease, Esophageal
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D004935 sjn
% 209.04/209.23 |- mesh__dateRevised mesh__D004935 2003-07-09
% 209.04/209.23 |- skos__hiddenLabel mesh__D004935 Esophageal Disease
% 209.04/209.23 |- mesh__dateEstablished mesh__D004935 1966-01-01
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D004935 66
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D004935 2006
% 209.04/209.23 |- mesh__historyNote mesh__D004935 66
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D004935 2005
% 209.04/209.23 |- skos__altLabel mesh__D004137 Chlorodinitrobenzene
% 209.04/209.23 |- skos__broader mesh__D004137smesh__D009578
% 209.04/209.23 |- skos__broader mesh__D004137smesh__D004136
% 209.04/209.23 |- mesh__dateRevised mesh__D004137 2005-06-30
% 209.04/209.23 |- skos__broader mesh__D004137smesh__D002722
% 209.04/209.23 |- skos__prefLabel mesh__D004137 Dinitrochlorobenzene
% 209.04/209.23 |- skos__annotation mesh__D004137 D25-26 qualif; DF: note short X ref
% 209.04/209.23 |- mesh__dateEstablished mesh__D004137 1987-01-01
% 209.04/209.23 |- skos__historyNote mesh__D004137 Chlorine %28%1971-1974%29%
% 209.04/209.23 |- mesh__historyNote mesh__D004137
% 209.04/209.23 87%28%75%29%; was see under NITROBENZENES 1975-86
% 209.04/209.23 |- mesh__dateCreated mesh__D004137 1974-11-11
% 209.04/209.23 |- rdf__type mesh__D004137sskos__Concept
% 209.04/209.23 |- skos__altLabel mesh__D004137 DNCB
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D004137
% 209.04/209.23 87; was see under NITROBENZENES 1975-86
% 209.04/209.23 |- mesh__recordOriginator mesh__D004137 NLM
% 209.04/209.23 |- mesh__recordMaintainer mesh__D004137 ssb
% 209.04/209.23 |- skos__broader mesh__D004137smesh__D006241
% 209.04/209.23 |- skos__hiddenLabel mesh__D004137 1 Chloro 2,4 Dinitrobenzene
% 209.04/209.23 |- skos__altLabel mesh__D004137 1-Chloro-2,4-Dinitrobenzene
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D004137 2006
% 209.04/209.23 |- skos__historyNote mesh__D004137 Nitrobenzenes %28%1971-1974%29%
% 209.04/209.23 |- skos__scopeNote mesh__D004137
% 209.04/209.23 A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.%A%
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D004137 sjn
% 209.04/209.23 |- mesh__recordMaintainer mesh__D009620 TGC
% 209.04/209.23 |- skos__scopeNote mesh__D009620
% 209.04/209.23 The inferior %28%caudal%29% ganglion of the vagus %28%10th cranial%29% nerve. The unipolar nodose ganglion cells are sensory cells with central projections to the medulla and peripheral processes traveling in various branches of the vagus nerve.%A%
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 2002
% 209.04/209.23 |- skos__hiddenLabel mesh__D009620 Ganglion, Nodose
% 209.04/209.23 |- skos__altLabel mesh__D009620 Nodose Ganglia
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 1999
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 1996
% 209.04/209.23 |- skos__annotation mesh__D009620
% 209.04/209.23 a ganglion of the vagus %28%10th cranial%29% nerve; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D009620 PLS
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 2000
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 2005
% 209.04/209.23 |- skos__broader mesh__D009620smesh__D017950
% 209.04/209.23 |- skos__prefLabel mesh__D009620 Nodose Ganglion
% 209.04/209.23 |- mesh__dateCreated mesh__D009620 1999-01-01
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 1997
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 2006
% 209.04/209.23 |- skos__hiddenLabel mesh__D009620 Ganglia, Nodose
% 209.04/209.23 |- mesh__historyNote mesh__D009620
% 209.04/209.23 91%28%75%29%; was see under VAGUS NERVE 1975-90
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 2001
% 209.04/209.23 |- mesh__dateRevised mesh__D009620 1994-06-03
% 209.04/209.23 |- mesh__onlineNote mesh__D009620 search VAGUS NERVE 1966-74
% 209.04/209.23 |- skos__broader mesh__D009620smesh__D014630
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 2003
% 209.04/209.23 |- rdf__type mesh__D009620sskos__Concept
% 209.04/209.23 |- mesh__dateEstablished mesh__D009620 1991-01-01
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 1995
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 2004
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D009620
% 209.04/209.23 91; was see under VAGUS NERVE 1975-90
% 209.04/209.23 |- mesh__recordOriginator mesh__D009620 NLM
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D009620 1998
% 209.04/209.23 |- mesh__recordMaintainer mesh__D014565 lkt
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Cancer, Genito-urinary
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Neoplasm, Genito-urinary
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Cancers, Urogenital
% 209.04/209.23 |- mesh__recordOriginator mesh__D014565 NLM
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Genitourinary Neoplasm
% 209.04/209.23 |- mesh__dateRevised mesh__D014565 2005-06-30
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Neoplasm, Genitourinary
% 209.04/209.23 |- mesh__dateCreated mesh__D014565 1999-01-01
% 209.04/209.23 |- skos__altLabel mesh__D014565 Genitourinary Neoplasms
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Cancers, Genitourinary
% 209.04/209.23 |- skos__annotation mesh__D014565
% 209.04/209.23 general or unspecified; prefer specifics; coordinate IM with histological type of neoplasm %28%IM%29%%A%
% 209.04/209.23 |- skos__scopeNote mesh__D014565
% 209.04/209.23 Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.%A%
% 209.04/209.23 |- skos__altLabel mesh__D014565 Genito-urinary Cancer
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Neoplasm, Urogenital
% 209.04/209.23 |- skos__altLabel mesh__D014565 Urogenital Cancer
% 209.04/209.23 |- skos__altLabel mesh__D014565 Neoplasms, Urogenital
% 209.04/209.23 |- skos__altLabel mesh__D014565 Neoplasms, Genitourinary
% 209.04/209.23 |- skos__altLabel mesh__D014565 Genito-urinary Neoplasm
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Genito urinary Cancer
% 209.04/209.23 |- skos__broader mesh__D014565smesh__D009371
% 209.04/209.23 |- rdf__type mesh__D014565sskos__Concept
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Cancer, Urogenital
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Cancers, Genito-urinary
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Cancer, Genitourinary
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Neoplasms, Genito-urinary
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Urogenital Cancers
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Genito-urinary Neoplasms
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D014565 sjn
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Genitourinary Cancers
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Urogenital Neoplasm
% 209.04/209.23 |- skos__hiddenLabel mesh__D014565 Genito-urinary Cancers
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D014565 2006
% 209.04/209.23 |- skos__broader mesh__D014565smesh__D016146
% 209.04/209.23 |- skos__prefLabel mesh__D014565 Urogenital Neoplasms
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 NuMefenamic
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 Nu Mefenamic
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 Acid, Mefenaminic
% 209.04/209.23 |- skos__altLabel mesh__D008528 Parke Davis Brand of Mefenamic Acid
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 PMS Mefenamic Acid
% 209.04/209.23 |- mesh__historyNote mesh__D008528 72%28%65%29%
% 209.04/209.23 |- skos__altLabel mesh__D008528 Pharmascience Brand of Mefenamic Acid
% 209.04/209.23 |- skos__prefLabel mesh__D008528 Mefenamic Acid
% 209.04/209.23 |- skos__altLabel mesh__D008528 Mefic
% 209.04/209.23 |- skos__altLabel mesh__D008528 APS Brand of Mefenamic Acid
% 209.04/209.23 |- skos__altLabel mesh__D008528 Apotex Brand of Mefenamic Acid
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D008528 sjn
% 209.04/209.23 |- skos__altLabel mesh__D008528 Ponstan Forte
% 209.04/209.23 |- skos__altLabel mesh__D008528 First Horizon Brand of Mefenamic Acid
% 209.04/209.23 |- skos__altLabel mesh__D008528 Ashbourne Brand of Mefenamic Acid
% 209.04/209.23 |- skos__altLabel mesh__D008528 G%C3%%B6%decke Brand of Mefenamic Acid
% 209.04/209.23 |- skos__altLabel mesh__D008528 Nu-Pharm Brand of Mefenamic Acid
% 209.04/209.23 |- skos__altLabel mesh__D008528 Chemidex Brand of Mefenamic Acid
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 ApoMefenamic
% 209.04/209.23 |- skos__altLabel mesh__D008528 Elan Brand of Mefenamic Acid
% 209.04/209.23 |- mesh__dateCreated mesh__D008528 1999-01-01
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 Nu Pharm Brand of Mefenamic Acid
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 Forte, Ponstan
% 209.04/209.23 |- skos__altLabel mesh__D008528 Pinewood Brand of Mefenamic Acid
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D008528 2006
% 209.04/209.23 |- rdf__type mesh__D008528sskos__Concept
% 209.04/209.23 |- skos__scopeNote mesh__D008528
% 209.04/209.23 A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.%A%
% 209.04/209.23 |- mesh__dateRevised mesh__D008528 2005-06-30
% 209.04/209.23 |- mesh__recordMaintainer mesh__D008528 CCR
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 Acid, Mefenamic
% 209.04/209.23 |- skos__altLabel mesh__D008528 Parkemed
% 209.04/209.23 |- mesh__recordOriginator mesh__D008528 NLM
% 209.04/209.23 |- mesh__dateEstablished mesh__D008528 1972-01-01
% 209.04/209.23 |- skos__altLabel mesh__D008528 Farmasierra Brand of Mefenamic Acid
% 209.04/209.23 |- skos__altLabel mesh__D008528 Ponsyl
% 209.04/209.23 |- skos__altLabel mesh__D008528 Pfizer Brand of Mefenamic Acid
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 Warner Lambert Brand of Mefenamic Acid
% 209.04/209.23 |- skos__altLabel mesh__D008528 Warner-Lambert Brand of Mefenamic Acid
% 209.04/209.23 |- skos__hiddenLabel mesh__D008528 Apo Mefenamic
% 209.04/209.23 |- skos__altLabel mesh__D008528 Antigen Brand of Mefenamic Acid
% 209.04/209.23 |- skos__altLabel mesh__D008528 Clonmel Brand of Mefenamic Acid
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D008528 72
% 209.04/209.23 |- skos__altLabel mesh__D008528 Rowa Brand of Mefenamic Acid
% 209.04/209.23 |- skos__broader mesh__D008528smesh__D000879
% 209.04/209.23 |- skos__altLabel mesh__D008528 Mefenaminic Acid
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D000545 2006
% 209.04/209.23 |- skos__prefLabel mesh__D000545 Amanita
% 209.04/209.23 |- mesh__historyNote mesh__D000545
% 209.04/209.23 91%28%75%29%; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A%
% 209.04/209.23 |- mesh__dateEstablished mesh__D000545 1991-01-01
% 209.04/209.23 |- mesh__recordMaintainer mesh__D000545 SYSTEM
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D000545 sjn
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D000545
% 209.04/209.23 91; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A%
% 209.04/209.23 |- skos__broader mesh__D000545smesh__D000363
% 209.04/209.23 |- skos__annotation mesh__D000545
% 209.04/209.23 a poisonous basidiomycete; coord NIM for MUSHROOM POISONING %28%IM%29% by Amanita%A%
% 209.04/209.23 |- mesh__dateRevised mesh__D000545 2005-06-30
% 209.04/209.23 |- skos__scopeNote mesh__D000545
% 209.04/209.23 A genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous.%A%
% 209.04/209.23 |- rdf__type mesh__D000545sskos__Concept
% 209.04/209.23 |- mesh__dateCreated mesh__D000545 1974-12-12
% 209.04/209.23 |- mesh__recordOriginator mesh__D000545 NLM
% 209.04/209.23 |- mesh__recordMaintainer mesh__D019250 PXP
% 209.04/209.23 |- skos__altLabel mesh__D019250 Implants, Single-Tooth Dental
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D019250 2000
% 209.04/209.23 |- mesh__recordOriginator mesh__D019250 TGC
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D019250 2006
% 209.04/209.23 |- rdf__type mesh__D019250sskos__Concept
% 209.04/209.23 |- skos__altLabel mesh__D019250 Dental Implant, Single-Tooth
% 209.04/209.23 |- mesh__dateEstablished mesh__D019250 1997-01-01
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D019250 2001
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Single Tooth Dental Implants
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Dental Implants, Single Tooth
% 209.04/209.23 |- skos__scopeNote mesh__D019250
% 209.04/209.23 Devices, usually alloplastic, surgically inserted into or onto the jawbone, which support a single prosthetic tooth and serve either as abutments or as cosmetic replacements for missing teeth.%A%
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Implants, Single-Tooth
% 209.04/209.23 |- skos__prefLabel mesh__D019250 Dental Implants, Single-Tooth
% 209.04/209.23 |- skos__broader mesh__D019250smesh__D015921
% 209.04/209.23 |- skos__altLabel mesh__D019250 Implant, Single-Tooth Dental
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Dental Implant, Single Tooth
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D019250 97
% 209.04/209.23 |- skos__altLabel mesh__D019250 Single-Tooth Dental Implant
% 209.04/209.23 |- mesh__dateCreated mesh__D019250 1996-06-10
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Implant, Single-Tooth
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Implants, Single Tooth Dental
% 209.04/209.23 |- skos__altLabel mesh__D019250 Single-Tooth Implants
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D019250 2002
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D019250 2003
% 209.04/209.23 |- skos__annotation mesh__D019250 DF: DENT IMPLANTS SINGLE TOOTH
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D019250 sjn
% 209.04/209.23 |- skos__altLabel mesh__D019250 Single-Tooth Dental Implants
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Single Tooth Dental Implant
% 209.04/209.23 |- mesh__historyNote mesh__D019250 97
% 209.04/209.23 |- mesh__dateRevised mesh__D019250 1999-11-03
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Single-Tooth Implant
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D019250 2005
% 209.04/209.23 |- skos__historyNote mesh__D019250 Dental Implants %28%1990-1996%29%
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D019250 2004
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Single Tooth Implants
% 209.04/209.23 |- skos__hiddenLabel mesh__D019250 Implant, Single Tooth Dental
% 209.04/209.23 |- skos__annotation mesh__D005230 DF: note short X ref
% 209.04/209.23 |- mesh__dateRevised mesh__D005230 2003-07-09
% 209.04/209.23 |- mesh__dateCreated mesh__D005230 1999-01-01
% 209.04/209.23 |- skos__hiddenLabel mesh__D005230 Acids, Free Fatty
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D005230 2005
% 209.04/209.23 |- skos__scopeNote mesh__D005230
% 209.04/209.23 FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form.%A%
% 209.04/209.23 |- skos__hiddenLabel mesh__D005230 Acids, Nonesterified Fatty
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D005230 2006
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D005230 sjn
% 209.04/209.23 |- skos__prefLabel mesh__D005230 Fatty Acids, Nonesterified
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D005230 68
% 209.04/209.23 |- mesh__dateEstablished mesh__D005230 1968-01-01
% 209.04/209.23 |- mesh__recordOriginator mesh__D005230 NLM
% 209.04/209.23 |- skos__altLabel mesh__D005230 Free Fatty Acids
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D005230 2004
% 209.04/209.23 |- skos__altLabel mesh__D005230 NEFA
% 209.04/209.23 |- skos__altLabel mesh__D005230 Fatty Acids, Free
% 209.04/209.23 |- mesh__historyNote mesh__D005230 68%28%66%29%
% 209.04/209.23 |- mesh__recordMaintainer mesh__D005230 ssb
% 209.04/209.23 |- skos__broader mesh__D005230smesh__D005227
% 209.04/209.23 |- rdf__type mesh__D005230sskos__Concept
% 209.04/209.23 |- skos__hiddenLabel mesh__D005230 Nonesterified Fatty Acids
% 209.04/209.23 |- skos__annotation mesh__D018956
% 209.04/209.23 T-lymphocyte differentiation antigens; but read MeSH definition%A%
% 209.04/209.23 |- skos__broader mesh__D018956smesh__D000944
% 209.04/209.23 |- skos__broader mesh__D018956smesh__D015703
% 209.04/209.23 |- skos__prefLabel mesh__D018956 Antigens, CD5
% 209.04/209.23 |- mesh__dateCreated mesh__D018956 1995-05-26
% 209.04/209.23 |- mesh__onlineNote mesh__D018956
% 209.04/209.23 use ANTIGENS, CD5 %28%NM%29% to search CD5 ANTIGEN 1988-95
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018956 2006
% 209.04/209.23 |- mesh__historyNote mesh__D018956
% 209.04/209.23 96; was CD5 ANTIGEN %28%NM%29% 1988-95
% 209.04/209.23 |- mesh__dateRevised mesh__D018956 2005-06-30
% 209.04/209.23 |- mesh__recordMaintainer mesh__D018956 ssb
% 209.04/209.23 |- skos__hiddenLabel mesh__D018956 Leu 1 Antigen
% 209.04/209.23 |- rdf__type mesh__D018956sskos__Concept
% 209.04/209.23 |- skos__historyNote mesh__D018956
% 209.04/209.23 Antigens, Differentiation %28%1990-1991%29%
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D018956
% 209.04/209.23 96; CD5 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION 1990-91%A%
% 209.04/209.23 |- skos__hiddenLabel mesh__D018956 Antigen, CD5
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D018956 sjn
% 209.04/209.23 |- mesh__dateEstablished mesh__D018956 1996-01-01
% 209.04/209.23 |- skos__altLabel mesh__D018956 CD5 Antigen
% 209.04/209.23 |- skos__scopeNote mesh__D018956
% 209.04/209.23 Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5. %28%From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156%29%%A%
% 209.04/209.23 |- skos__historyNote mesh__D018956 Antigens, CD %28%1990-1995%29%
% 209.04/209.23 |- mesh__recordOriginator mesh__D018956 AGS
% 209.04/209.23 |- skos__altLabel mesh__D018956 Leu-1 Antigen
% 209.04/209.23 |- skos__broader mesh__D018956smesh__D000945
% 209.04/209.23 |- skos__altLabel mesh__D018956 T1 Antigen
% 209.04/209.23 |- skos__altLabel mesh__D018956 CD5 Antigens
% 209.04/209.23 |- skos__broader mesh__D010973smesh__D045122
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010973 2005
% 209.04/209.23 |- skos__prefLabel mesh__D010973 Platelet Adhesiveness
% 209.04/209.23 |- mesh__dateEstablished mesh__D010973 1972-01-01
% 209.04/209.23 |- skos__scopeNote mesh__D010973
% 209.04/209.23 The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other %22%foreign%22% surfaces.%A%
% 209.04/209.23 |- mesh__recordOriginator mesh__D010973 NLM
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010973 2006
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D010973 2004
% 209.04/209.23 |- mesh__historyNote mesh__D010973 72%28%69%29%
% 209.04/209.23 |- skos__hiddenLabel mesh__D010973 Adhesivenesses, Platelet
% 209.04/209.23 |- skos__hiddenLabel mesh__D010973 Adhesiveness, Platelet
% 209.04/209.23 |- mesh__dateCreated mesh__D010973 1999-01-01
% 209.04/209.23 |- skos__related mesh__D010973smesh__D010980
% 209.04/209.23 |- mesh__dateRevised mesh__D010973 2003-07-09
% 209.04/209.23 |- skos__broader mesh__D010973smesh__D015539
% 209.04/209.23 |- mesh__recordAuthorizer mesh__D010973 sjn
% 209.04/209.23 |- mesh__recordMaintainer mesh__D010973 nns
% 209.04/209.23 |- rdf__type mesh__D010973sskos__Concept
% 209.04/209.23 |- skos__historyNote mesh__D010973 Blood Platelets %28%1966-1968%29%
% 209.04/209.23 |- mesh__publicMeSHNote mesh__D010973 72
% 209.04/209.23 |- skos__hiddenLabel mesh__D010973 Platelet Adhesivenesses
% 209.04/209.23 |- skos__scopeNote mesh__D018158
% 209.04/209.23 A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, causing tumors in primates. The type species is YABA MONKEY TUMOR VIRUS.%A%
% 209.04/209.23 |- mesh__recordMaintainer mesh__D018158 ags
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018158 2006
% 209.04/209.23 |- mesh__dateEstablished mesh__D018158 1994-01-01
% 209.04/209.23 |- mesh__activeMeSHYear mesh__D018158 2005
% 209.04/209.23 |- mesh__dateCreated mesh__D018158 1993-06-04
% 209.04/209.23 |- rdf__type mesh__D018158sskos__Concept
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D018158 94
% 209.04/209.24 |- skos__hiddenLabel mesh__D018158 Yatapoxviruses
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018158 2004
% 209.04/209.24 |- mesh__dateRevised mesh__D018158 2001-07-25
% 209.04/209.24 |- skos__prefLabel mesh__D018158 Yatapoxvirus
% 209.04/209.24 |- skos__broader mesh__D018158smesh__D004263
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018158 2003
% 209.04/209.24 |- skos__annotation mesh__D018158
% 209.04/209.24 infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%
% 209.04/209.24 |- skos__hiddenLabel mesh__D018158 Tanapox viruses
% 209.04/209.24 |- mesh__historyNote mesh__D018158 94
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D018158 sjn
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018158 2002
% 209.04/209.24 |- skos__broader mesh__D018158smesh__D018147
% 209.04/209.24 |- mesh__recordOriginator mesh__D018158 AGS
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 1997
% 209.04/209.24 |- mesh__dateCreated mesh__D010175 1999-01-01
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 2003
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 1996
% 209.04/209.24 |- mesh__recordOriginator mesh__D010175 NLM
% 209.04/209.24 |- skos__annotation mesh__D010175 IM CATALOG: use NAF entry
% 209.04/209.24 |- mesh__dateRevised mesh__D010175 1993-06-03
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 2001
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 2006
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 1999
% 209.04/209.24 |- skos__altLabel mesh__D010175 PAHO
% 209.04/209.24 |- skos__historyNote mesh__D010175
% 209.04/209.24 World Health Organization %28%1966-1972%29%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 1995
% 209.04/209.24 |- mesh__dateEstablished mesh__D010175 1973-01-01
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 2005
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 2000
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 1998
% 209.04/209.24 |- skos__prefLabel mesh__D010175 Pan American Health Organization
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D010175 73
% 209.04/209.24 |- skos__historyNote mesh__D010175 International Agencies %28%1966-1972%29%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 1994
% 209.04/209.24 |- skos__scopeNote mesh__D010175
% 209.04/209.24 WHO regional office for the Americas acting as a coordinating agency for the improvement of health conditions in the hemisphere. The four main functions are: control or eradication of communicable diseases, strengthening of national and local health services, education and training, and research.%A%
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D010175 PLS
% 209.04/209.24 |- skos__broader mesh__D010175smesh__D014944
% 209.04/209.24 |- rdf__type mesh__D010175sskos__Concept
% 209.04/209.24 |- mesh__recordMaintainer mesh__D010175 PLS
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 2002
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010175 2004
% 209.04/209.24 |- mesh__historyNote mesh__D010175 73
% 209.04/209.24 |- rdf__type mesh__D004936sskos__Concept
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004936 2004
% 209.04/209.24 |- skos__altLabel mesh__D004936 Diverticula, Esophageal
% 209.04/209.24 |- skos__scopeNote mesh__D004936
% 209.04/209.24 Saccular protrusion beyond the wall of the ESOPHAGUS.
% 209.04/209.24 |- skos__related mesh__D004936smesh__D045723
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D004936
% 209.04/209.24 92; was ESOPHAGEAL DIVERTICULA 1963-91
% 209.04/209.24 |- mesh__dateRevised mesh__D004936 2003-07-09
% 209.04/209.24 |- mesh__onlineNote mesh__D004936
% 209.04/209.24 use ESOPHAGEAL DIVERTICULUM to search ESOPHAGEAL DIVERTICULA 1966-91%A%
% 209.04/209.24 |- skos__annotation mesh__D004936
% 209.04/209.24 inflamm divertic or diverticulitis: coord IM with DIVERTICULITIS %28%IM%29%%A%
% 209.04/209.24 |- skos__broader mesh__D004936smesh__D004240
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004936 2005
% 209.04/209.24 |- mesh__historyNote mesh__D004936
% 209.04/209.24 92; was ESOPHAGEAL DIVERTICULA 1963-91
% 209.04/209.24 |- skos__altLabel mesh__D004936 Esophageal Diverticula
% 209.04/209.24 |- mesh__recordOriginator mesh__D004936 NLM
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004936 2006
% 209.04/209.24 |- mesh__dateCreated mesh__D004936 1999-01-01
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D004936 sjn
% 209.04/209.24 |- skos__altLabel mesh__D004936 Esophageal Diverticulum
% 209.04/209.24 |- mesh__recordMaintainer mesh__D004936 lkt
% 209.04/209.24 |- skos__prefLabel mesh__D004936 Diverticulum, Esophageal
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 1997
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 2000
% 209.04/209.24 |- mesh__historyNote mesh__D004138
% 209.04/209.24 91%28%72%29%; was see under CRESOLS 1972-90
% 209.04/209.24 |- skos__broader mesh__D004138smesh__D009574
% 209.04/209.24 |- skos__historyNote mesh__D004138 Cresols %28%1966-1971%29%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 2001
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 1994
% 209.04/209.24 |- mesh__dateRevised mesh__D004138 1992-05-13
% 209.04/209.24 |- skos__broader mesh__D004138smesh__D003408
% 209.04/209.24 |- rdf__type mesh__D004138sskos__Concept
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 2005
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 2002
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D004138 PLS
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 1995
% 209.04/209.24 |- mesh__dateEstablished mesh__D004138 1991-01-01
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 2006
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 2003
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 1993
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 1998
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D004138 91; was see under CRESOLS 1972-90
% 209.04/209.24 |- mesh__dateCreated mesh__D004138 1999-01-01
% 209.04/209.24 |- skos__prefLabel mesh__D004138 Dinitrocresols
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 2004
% 209.04/209.24 |- mesh__recordMaintainer mesh__D004138 TGC
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 1999
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004138 1996
% 209.04/209.24 |- mesh__recordOriginator mesh__D004138 NLM
% 209.04/209.24 |- skos__historyNote mesh__D009621 Glycosides %28%1966-1975%29%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009621 2005
% 209.04/209.24 |- skos__historyNote mesh__D009621 Antibiotics %28%1966%29%
% 209.04/209.24 |- skos__hiddenLabel mesh__D009621 U15167
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009621 2006
% 209.04/209.24 |- skos__historyNote mesh__D009621 Naphthacenes %28%1966-1975%29%
% 209.04/209.24 |- skos__scopeNote mesh__D009621
% 209.04/209.24 An anthrocycline from a Streptomyces nogalater variant. It is a cytolytic antineoplastic that inhibits DNA-dependent RNA synthesis by binding to DNA.%A%
% 209.04/209.24 |- mesh__dateCreated mesh__D009621 1975-07-23
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D009621 sjn
% 209.04/209.24 |- mesh__recordMaintainer mesh__D009621 ssb
% 209.04/209.24 |- rdf__type mesh__D009621sskos__Concept
% 209.04/209.24 |- mesh__historyNote mesh__D009621
% 209.04/209.24 91%28%76%29%; was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80%A%
% 209.04/209.24 |- skos__historyNote mesh__D009621
% 209.04/209.24 Antibiotics, Antineoplastic %28%1967-1975%29%
% 209.04/209.24 |- mesh__dateEstablished mesh__D009621 1991-01-01
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D009621
% 209.04/209.24 91; was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80%A%
% 209.04/209.24 |- skos__prefLabel mesh__D009621 Nogalamycin
% 209.04/209.24 |- skos__hiddenLabel mesh__D009621 U 15167
% 209.04/209.24 |- skos__broader mesh__D009621smesh__D003630
% 209.04/209.24 |- mesh__dateRevised mesh__D009621 2004-07-07
% 209.04/209.24 |- mesh__recordOriginator mesh__D009621 SH
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D014566 2006
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D014566 ags
% 209.04/209.24 |- skos__hiddenLabel mesh__D014566 System, Urogenital
% 209.04/209.24 |- mesh__recordMaintainer mesh__D014566 ags
% 209.04/209.24 |- skos__hiddenLabel mesh__D014566 Genitourinary Systems
% 209.04/209.24 |- skos__scopeNote mesh__D014566
% 209.04/209.24 All the organs involved in reproduction and the formation and release of URINE. It includes the kidneys, ureters, BLADDER; URETHRA, and the organs of reproduction - ovaries, UTERUS; FALLOPIAN TUBES; VAGINA; and CLITORIS in women and the testes; SEMINAL VESICLES; PROSTATE; seminal ducts; and PENIS in men.%A%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D014566 2005
% 209.04/209.24 |- skos__hiddenLabel mesh__D014566 Urogenital Systems
% 209.04/209.24 |- mesh__dateRevised mesh__D014566 2005-07-08
% 209.04/209.24 |- skos__altLabel mesh__D014566 Genitourinary System
% 209.04/209.24 |- skos__hiddenLabel mesh__D014566 Systems, Genitourinary
% 209.04/209.24 |- mesh__runningHead mesh__D014566 A5 - ANATOMY-UROGENITAL SYSTEM
% 209.04/209.24 |- skos__related mesh__D014566smesh__D014567
% 209.04/209.24 |- mesh__recordOriginator mesh__D014566 NLM
% 209.04/209.24 |- skos__hiddenLabel mesh__D014566 System, Genitourinary
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D014566 2006A
% 209.04/209.24 |- skos__hiddenLabel mesh__D014566 Systems, Urogenital
% 209.04/209.24 |- skos__prefLabel mesh__D014566 Urogenital System
% 209.04/209.24 |- mesh__dateCreated mesh__D014566 1999-01-01
% 209.04/209.24 |- rdf__type mesh__D014566sskos__Concept
% 209.04/209.24 |- skos__annotation mesh__D014566
% 209.04/209.24 must be both uro + genital; GEN or unspecified; prefer specifics; UROGENITAL ABNORMALITIES is available but consider also specific urogenital organs with /abnorm; UROGRAPHY is available but consider also specific organs with /radiogr; /surg: consider also UROGENITAL SURGICAL PROCEDURES%A%
% 209.04/209.24 |- skos__historyNote mesh__D008529 Furans %28%1972-1975%29%
% 209.04/209.24 |- mesh__historyNote mesh__D008529
% 209.04/209.24 91%28%76%29%; was see under DIURETICS, SULFAMYL 1976-90
% 209.04/209.24 |- mesh__dateCreated mesh__D008529 1975-07-23
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D008529 2006
% 209.04/209.24 |- rdf__type mesh__D008529sskos__Concept
% 209.04/209.24 |- skos__prefLabel mesh__D008529 Mefruside
% 209.04/209.24 |- skos__scopeNote mesh__D008529
% 209.04/209.24 A benzene-sulfonamide-furan. It is used as a diuretic that affects the concentrating ability of the KIDNEY, increases SODIUM CHLORIDE excretion, but may not spare POTASSIUM. It inhibits CARBONIC ANHYDRASES and may increase the blood URIC ACID level.%A%
% 209.04/209.24 |- mesh__dateRevised mesh__D008529 2005-06-30
% 209.04/209.24 |- skos__historyNote mesh__D008529 Diuretics, Sulfamyl %28%1974-1975%29%
% 209.04/209.24 |- mesh__recordMaintainer mesh__D008529 ssb
% 209.04/209.24 |- mesh__recordOriginator mesh__D008529 SH
% 209.04/209.24 |- mesh__dateEstablished mesh__D008529 1991-01-01
% 209.04/209.24 |- skos__broader mesh__D008529smesh__D013449
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D008529
% 209.04/209.24 91; was see under DIURETICS, SULFAMYL 1976-90
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D008529 sjn
% 209.04/209.24 |- skos__broader mesh__D000546smesh__D009842
% 209.04/209.24 |- skos__broader mesh__D000546smesh__D010456
% 209.04/209.24 |- mesh__historyNote mesh__D000546 75
% 209.04/209.24 |- skos__historyNote mesh__D000546 Oligopeptides %28%1974%29%
% 209.04/209.24 |- skos__hiddenLabel mesh__D000546 Alpha Amanitin
% 209.04/209.24 |- skos__broader mesh__D000546smesh__D009183
% 209.04/209.24 |- skos__scopeNote mesh__D000546
% 209.04/209.24 Cyclic peptides extracted from carpophores of various mushroom species. They are potent inhibitors of RNA polymerases in most eukaryotic species, blocking the production of mRNA and protein synthesis. These peptides are important in the study of transcription. Alpha-amanitin is the main toxin from the species Amanitia phalloides, poisonous if ingested by humans or animals.%A%
% 209.04/209.24 |- rdf__type mesh__D000546sskos__Concept
% 209.04/209.24 |- mesh__recordOriginator mesh__D000546 NLM
% 209.04/209.24 |- skos__prefLabel mesh__D000546 Amanitins
% 209.04/209.24 |- skos__historyNote mesh__D000546 Mycotoxins %28%1974%29%
% 209.04/209.24 |- skos__annotation mesh__D000546
% 209.04/209.24 /antag permitted but consider also ANTITOXINS
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D000546 2006
% 209.04/209.24 |- mesh__dateCreated mesh__D000546 1974-11-11
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D000546 jls
% 209.04/209.24 |- mesh__dateEstablished mesh__D000546 1975-09-01
% 209.04/209.24 |- mesh__recordMaintainer mesh__D000546 jls
% 209.04/209.24 |- mesh__dateRevised mesh__D000546 2005-07-29
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D000546 75
% 209.04/209.24 |- skos__hiddenLabel mesh__D000546 Alpha Amanitine
% 209.04/209.24 |- skos__historyNote mesh__D000546 Peptides, Cyclic %28%1974%29%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D000546 2006A
% 209.04/209.24 |- skos__broader mesh__D019251smesh__D014771
% 209.04/209.24 |- mesh__dateEstablished mesh__D019251 1997-01-01
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D019251
% 209.04/209.24 97; VIRAL N PROTEIN was indexed under VIRAL CORE PROTEINS 1986-96, CAPSID 1983-96, and VIRAL PROTEINS 1983-85%A%
% 209.04/209.24 |- mesh__onlineNote mesh__D019251
% 209.04/209.24 use NUCLEOCAPSID %28%NM%29% to search VIRAL N PROTEIN 1983-96
% 209.04/209.24 |- mesh__historyNote mesh__D019251
% 209.04/209.24 97; was VIRAL N PROTEIN %28%NM%29% 1983-96
% 209.04/209.24 |- mesh__dateCreated mesh__D019251 1996-06-10
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D019251 sjn
% 209.04/209.24 |- skos__related mesh__D019251smesh__D019590
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D019251 2006
% 209.04/209.24 |- rdf__type mesh__D019251sskos__Concept
% 209.04/209.24 |- skos__prefLabel mesh__D019251 Nucleocapsid
% 209.04/209.24 |- skos__historyNote mesh__D019251 Capsid %28%1977-1996%29%
% 209.04/209.24 |- skos__scopeNote mesh__D019251
% 209.04/209.24 A protein-nucleic acid complex which forms part or all of a virion. It consists of a CAPSID plus enclosed nucleic acid. Depending on the virus, the nucleocapsid may correspond to a naked core or be surrounded by a membranous envelope.%A%
% 209.04/209.24 |- mesh__dateRevised mesh__D019251 2005-06-30
% 209.04/209.24 |- mesh__recordOriginator mesh__D019251 AGS
% 209.04/209.24 |- mesh__recordMaintainer mesh__D019251 SYSTEM
% 209.04/209.24 |- skos__hiddenLabel mesh__D019251 Nucleocapsids
% 209.04/209.24 |- skos__historyNote mesh__D019251 Viral Core Proteins %28%1986-1996%29%
% 209.04/209.24 |- skos__annotation mesh__D019251
% 209.04/209.24 a protein-nucleic acid complex of a virion
% 209.04/209.24 |- skos__historyNote mesh__D019251 Viral Proteins %28%1966-1985%29%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D005231 2005
% 209.04/209.24 |- mesh__recordMaintainer mesh__D005231 ssb
% 209.04/209.24 |- skos__hiddenLabel mesh__D005231 Unsaturated Fatty Acids
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D005231 2006
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D005231 73
% 209.04/209.24 |- skos__scopeNote mesh__D005231
% 209.04/209.24 FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds.%A%
% 209.04/209.24 |- skos__altLabel mesh__D005231 Fatty Acids, Polyunsaturated
% 209.04/209.24 |- skos__prefLabel mesh__D005231 Fatty Acids, Unsaturated
% 209.04/209.24 |- mesh__dateEstablished mesh__D005231 1973-01-01
% 209.04/209.24 |- skos__historyNote mesh__D005231 Fatty Acids, Essential %28%1966-1972%29%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D005231 2004
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D005231 sjn
% 209.04/209.24 |- skos__hiddenLabel mesh__D005231 Acids, Unsaturated Fatty
% 209.04/209.24 |- skos__broader mesh__D005231smesh__D005227
% 209.04/209.24 |- mesh__historyNote mesh__D005231 73
% 209.04/209.24 |- rdf__type mesh__D005231sskos__Concept
% 209.04/209.24 |- mesh__recordOriginator mesh__D005231 NLM
% 209.04/209.24 |- mesh__dateRevised mesh__D005231 2003-07-09
% 209.04/209.24 |- mesh__dateCreated mesh__D005231 1999-01-01
% 209.04/209.24 |- skos__annotation mesh__D005231
% 209.04/209.24 GEN or unspecified; prefer specific groups or specific acid%A%
% 209.04/209.24 |- skos__hiddenLabel mesh__D005231 Acids, Polyunsaturated Fatty
% 209.04/209.24 |- mesh__dateEstablished mesh__D046648 2005-01-01
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D046648
% 209.04/209.24 2005; see HEMATOMA, SUBDURAL 2000-2004
% 209.04/209.24 |- skos__broader mesh__D046648smesh__D006408
% 209.04/209.24 |- skos__hiddenLabel mesh__D046648 Intracranial Subdural Hematomas
% 209.04/209.24 |- skos__hiddenLabel mesh__D046648 Subdural Hematomas, Intracranial
% 209.04/209.24 |- mesh__historyNote mesh__D046648
% 209.04/209.24 2005; use HEMATOMA, SUBDURAL 2000-2004
% 209.04/209.24 |- skos__altLabel mesh__D046648 Traumatic Intracranial Subdural Hematoma
% 209.04/209.24 |- mesh__dateCreated mesh__D046648 2004-07-07
% 209.04/209.24 |- skos__prefLabel mesh__D046648 Hematoma, Subdural, Intracranial
% 209.04/209.24 |- rdf__type mesh__D046648sskos__Concept
% 209.04/209.24 |- skos__scopeNote mesh__D046648
% 209.04/209.24 Subdural hematoma occurring over the surface of the cerebral hemisphere.%A%
% 209.04/209.24 |- mesh__recordMaintainer mesh__D046648 ags
% 209.04/209.24 |- skos__altLabel mesh__D046648 Hematoma, Subdural, Cranial
% 209.04/209.24 |- mesh__recordOriginator mesh__D046648 ags
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D046648 sjn
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D046648 2005
% 209.04/209.24 |- skos__hiddenLabel mesh__D046648 Subdural Hematoma, Intracranial
% 209.04/209.24 |- skos__hiddenLabel mesh__D046648 Hematomas, Intracranial Subdural
% 209.04/209.24 |- skos__hiddenLabel mesh__D046648 Hematoma, Intracranial Subdural
% 209.04/209.24 |- skos__altLabel mesh__D046648 Subdural Hematoma, Traumatic Intracranial
% 209.04/209.24 |- skos__altLabel mesh__D046648 Intracranial Subdural Hematoma
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D046648 2006
% 209.04/209.24 |- skos__historyNote mesh__D046648 Hematoma, Subdural %28%1965-2004%29%
% 209.04/209.24 |- skos__altLabel mesh__D018957 HRF20
% 209.04/209.24 |- skos__scopeNote mesh__D018957
% 209.04/209.24 Small glycoproteins found on both hematopoietic and non-hematopoietic cells. CD59 restricts the cytolytic activity of homologous complement by binding to C8 and C9 and blocking the assembly of the membrane attack complex. %28%From Barclay et al., The Leukocyte Antigen FactsBook, 1993, p234%29%%A%
% 209.04/209.24 |- mesh__recordMaintainer mesh__D018957 ssb
% 209.04/209.24 |- mesh__dateCreated mesh__D018957 1995-05-26
% 209.04/209.24 |- skos__prefLabel mesh__D018957 Antigens, CD59
% 209.04/209.24 |- rdf__type mesh__D018957sskos__Concept
% 209.04/209.24 |- mesh__dateRevised mesh__D018957 2005-06-30
% 209.04/209.24 |- skos__broader mesh__D018957smesh__D008562
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D018957 sjn
% 209.04/209.24 |- mesh__dateEstablished mesh__D018957 1996-01-01
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018957 2006
% 209.04/209.24 |- skos__altLabel mesh__D018957 Membrane Attack Complex Inhibition Factor
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D018957
% 209.04/209.24 1996; CD59 ANTIGEN was indexed under ANTIGENS, CD 1990-1995; MEMBRANE GLYCOPROTEINS 1989-1995; %26% ANTIGENS, DIFFERENTIATION 1989-1991; MEMBRANE ATTACK COMPLEX INHIBITION FACTOR %28%now ANTIGENS, CD59%29% was indexed under PROTEINS 1992-1997 %26% BLOOD PROTEINS 1990-1991; PROTECTIN was indexed under ION CHANNELS 1996-1999%A%
% 209.04/209.24 |- skos__altLabel mesh__D018957 CD59 Antigens
% 209.04/209.24 |- skos__altLabel mesh__D018957 Protectin
% 209.04/209.24 |- mesh__recordOriginator mesh__D018957 AGS
% 209.04/209.24 |- skos__historyNote mesh__D018957
% 209.04/209.24 Antigens, Differentiation %28%1989-1991%29%
% 209.04/209.24 |- skos__historyNote mesh__D018957 Membrane Glycoproteins %28%1989-1995%29%
% 209.04/209.24 |- skos__altLabel mesh__D018957 Homologous Restriction Factor 20
% 209.04/209.24 |- skos__altLabel mesh__D018957 MACIF
% 209.04/209.24 |- skos__altLabel mesh__D018957 Membrane Inhibitor of Reactive Lysis
% 209.04/209.24 |- skos__historyNote mesh__D018957 Antigens, CD %28%1990-1995%29%
% 209.04/209.24 |- mesh__historyNote mesh__D018957
% 209.04/209.24 1996; use CD59 ANTIGEN %28%NM%29% 1989-1995, for PROTECTIN use CATIONIC PROTEIN, URATE-CALCIUM OXALATE STONE %28%NM%29% 1996-1999%A%
% 209.04/209.24 |- skos__broader mesh__D018957smesh__D015703
% 209.04/209.24 |- skos__altLabel mesh__D018957 CD59 Antigen
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010974 2006
% 209.04/209.24 |- skos__prefLabel mesh__D010974 Platelet Aggregation
% 209.04/209.24 |- mesh__dateEstablished mesh__D010974 1976-01-01
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010974 2004
% 209.04/209.24 |- mesh__dateCreated mesh__D010974 1999-01-01
% 209.04/209.24 |- mesh__onlineNote mesh__D010974 search PLATELET ADHESIVENESS 1974
% 209.04/209.24 |- skos__related mesh__D010974smesh__D010980
% 209.04/209.24 |- skos__historyNote mesh__D010974 Platelet Adhesiveness %28%1969-1974%29%
% 209.04/209.24 |- mesh__dateRevised mesh__D010974 2003-07-09
% 209.04/209.24 |- skos__hiddenLabel mesh__D010974 Aggregation, Platelet
% 209.04/209.24 |- mesh__recordOriginator mesh__D010974 NLM
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D010974
% 209.04/209.24 76; was see under PLATELET ADHESIVENESS 1974-75
% 209.04/209.24 |- skos__historyNote mesh__D010974 Blood Platelets %28%1966-1974%29%
% 209.04/209.24 |- skos__scopeNote mesh__D010974
% 209.04/209.24 The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents %28%e.g., THROMBIN; COLLAGEN%29% and is part of the mechanism leading to the formation of a THROMBUS.%A%
% 209.04/209.24 |- rdf__type mesh__D010974sskos__Concept
% 209.04/209.24 |- skos__broader mesh__D010974smesh__D015539
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D010974 sjn
% 209.04/209.24 |- mesh__recordMaintainer mesh__D010974 nns
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010974 2005
% 209.04/209.24 |- mesh__historyNote mesh__D010974
% 209.04/209.24 76%28%75%29%; was see under PLATELET ADHESIVENESS 1974-75
% 209.04/209.24 |- skos__broader mesh__D009729Q000331smesh__D009729
% 209.04/209.24 |- mesh__preferredCombination mesh__D009729Q000331smesh__D007884
% 209.04/209.24 |- rdf__type mesh__D009729Q000331smesh__CompoundConcept
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 2005
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 1999
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 2002
% 209.04/209.24 |- rdf__type mesh__D018159sskos__Concept
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 1998
% 209.04/209.24 |- skos__scopeNote mesh__D018159
% 209.04/209.24 An accumulation of endolymph in the inner ear resulting in deafness and tinnitus, and sometimes vertigo %28%MENIERE%27%S DISEASE%29%. Induced experimentally, it often serves as an animal model for Meniere%27%s disease. %28%From Dorland, 27th ed.%29%%A%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 2004
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 2001
% 209.04/209.24 |- skos__prefLabel mesh__D018159 Endolymphatic Hydrops
% 209.04/209.24 |- mesh__dateEstablished mesh__D018159 1994-01-01
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 2003
% 209.04/209.24 |- skos__annotation mesh__D018159
% 209.04/209.24 endolymphatic refers to the endolymph of the inner ear; note see related%A%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 1997
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 2000
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D018159 94
% 209.04/209.24 |- skos__broader mesh__D018159smesh__D007759
% 209.04/209.24 |- skos__historyNote mesh__D018159 Meniere%27%s Disease %28%1966-1993%29%
% 209.04/209.24 |- skos__historyNote mesh__D018159 Labyrinthine Fluids %28%1966-1991%29%
% 209.04/209.24 |- skos__hiddenLabel mesh__D018159 Hydrops, Endolymphatic
% 209.04/209.24 |- mesh__historyNote mesh__D018159 94
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 1996
% 209.04/209.24 |- skos__related mesh__D018159smesh__D008575
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 1995
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 2006
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D018159 1994
% 209.04/209.24 |- mesh__dateCreated mesh__D018159 1993-05-27
% 209.04/209.24 |- mesh__recordMaintainer mesh__D010176 PLS
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 1995
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 2005
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D010176 PLS
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 1998
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 2002
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 1994
% 209.04/209.24 |- rdf__type mesh__D010176sskos__Concept
% 209.04/209.24 |- skos__prefLabel mesh__D010176 Panama
% 209.04/209.24 |- skos__annotation mesh__D010176 do not confuse with PANAMA CANAL ZONE
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 2004
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 1997
% 209.04/209.24 |- mesh__recordOriginator mesh__D010176 NLM
% 209.04/209.24 |- mesh__dateRevised mesh__D010176 1993-06-03
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 2001
% 209.04/209.24 |- skos__broader mesh__D010176smesh__D002489
% 209.04/209.24 |- mesh__dateCreated mesh__D010176 1999-01-01
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 2003
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 1996
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 2000
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 2006
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D010176 1999
% 209.04/209.24 |- mesh__recordMaintainer mesh__D004937 ags
% 209.04/209.24 |- skos__broader mesh__D004937smesh__D016154
% 209.04/209.24 |- skos__annotation mesh__D004937
% 209.04/209.24 fistula policy: Manual 23.19+; ESOPHAGOTRACHEAL FISTULA see TRACHEOESOPHAGEAL FISTULA is also available%A%
% 209.04/209.24 |- skos__hiddenLabel mesh__D004937 Fistula, Esophageal
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004937 2005
% 209.04/209.24 |- skos__prefLabel mesh__D004937 Esophageal Fistula
% 209.04/209.24 |- skos__broader mesh__D004937smesh__D004935
% 209.04/209.24 |- mesh__dateCreated mesh__D004937 1999-01-01
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004937 2006
% 209.04/209.24 |- skos__hiddenLabel mesh__D004937 Esophageal Fistulas
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004937 2006A
% 209.04/209.24 |- mesh__dateRevised mesh__D004937 2005-08-02
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D004937 ags
% 209.04/209.24 |- rdf__type mesh__D004937sskos__Concept
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004937 2004
% 209.04/209.24 |- mesh__recordOriginator mesh__D004937 NLM
% 209.04/209.24 |- skos__hiddenLabel mesh__D004937 Fistulas, Esophageal
% 209.04/209.24 |- skos__scopeNote mesh__D004937
% 209.04/209.24 Abnormal passage communicating with the ESOPHAGUS. The most common type is TRACHEOESOPHAGEAL FISTULA between the esophagus and the TRACHEA.%A%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004139 2005
% 209.04/209.24 |- skos__prefLabel mesh__D004139 Dinitrofluorobenzene
% 209.04/209.24 |- skos__historyNote mesh__D004139 Nitrobenzenes %28%1969-1974%29%
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004139 2002
% 209.04/209.24 |- skos__altLabel mesh__D004139 DNFB
% 209.04/209.24 |- mesh__recordOriginator mesh__D004139 NLM
% 209.04/209.24 |- skos__broader mesh__D004139smesh__D004136
% 209.04/209.24 |- mesh__historyNote mesh__D004139
% 209.04/209.24 91%28%75%29%; was see under NITROBENZENES 1975-90
% 209.04/209.24 |- skos__scopeNote mesh__D004139
% 209.04/209.24 Irritants and reagents for labeling terminal amino acid groups.%A%
% 209.04/209.24 |- mesh__dateRevised mesh__D004139 2000-06-22
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004139 2001
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D004139 sjn
% 209.04/209.24 |- mesh__publicMeSHNote mesh__D004139
% 209.04/209.24 91; was see under NITROBENZENES 1975-90
% 209.04/209.24 |- mesh__dateCreated mesh__D004139 1974-11-19
% 209.04/209.24 |- skos__historyNote mesh__D004139 Fluorine %28%1969-1974%29%
% 209.04/209.24 |- skos__altLabel mesh__D004139 Fluorodinitrobenzene
% 209.04/209.24 |- rdf__type mesh__D004139sskos__Concept
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004139 2004
% 209.04/209.24 |- skos__hiddenLabel mesh__D004139 1 Fluoro 2,4 dinitrobenzene
% 209.04/209.24 |- skos__altLabel mesh__D004139 1-Fluoro-2,4-dinitrobenzene
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004139 2006
% 209.04/209.24 |- mesh__recordMaintainer mesh__D004139 CCR
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D004139 2003
% 209.04/209.24 |- skos__broader mesh__D004139smesh__D009578
% 209.04/209.24 |- mesh__dateEstablished mesh__D004139 1991-01-01
% 209.04/209.24 |- mesh__recordAuthorizer mesh__D009622 PLS
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 2000
% 209.04/209.24 |- mesh__recordMaintainer mesh__D009622 TAP
% 209.04/209.24 |- skos__related mesh__D009622smesh__D000161
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 2003
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 2001
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 1995
% 209.04/209.24 |- rdf__type mesh__D009622sskos__Concept
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 1998
% 209.04/209.24 |- mesh__dateRevised mesh__D009622 1992-05-15
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 2004
% 209.04/209.24 |- skos__broader mesh__D009622smesh__D004787
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 1999
% 209.04/209.24 |- skos__prefLabel mesh__D009622 Noise
% 209.04/209.24 |- skos__broader mesh__D009622smesh__D013016
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 1993
% 209.04/209.24 |- skos__hiddenLabel mesh__D009622 Noises
% 209.04/209.24 |- mesh__recordOriginator mesh__D009622 NLM
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 2002
% 209.04/209.24 |- skos__broader mesh__D009622smesh__D004777
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 2005
% 209.04/209.24 |- mesh__activeMeSHYear mesh__D009622 1996
% 209.04/209.24 |- skos__related mesh__D009622smesh__D006317
% 209.04/209.24 |- skos__annotation mesh__D009622
% 209.04/209.24 restrict to noise as a type of sound: do not use for %22%noise%22% as artifacts or interference with data in various techniques or electrical interference %28% = ELECTRICITY%29%; /adv eff: consider also HEARING LOSS, NOISE-INDUCED/%A%
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009622 2006
% 209.04/209.25 |- mesh__dateCreated mesh__D009622 1999-01-01
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009622 1997
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009622 1994
% 209.04/209.25 |- skos__scopeNote mesh__D014567
% 209.04/209.25 Radiography of any part of the urinary tract.
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014567 2000
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014567 2005
% 209.04/209.25 |- mesh__recordMaintainer mesh__D014567 PXP
% 209.04/209.25 |- skos__prefLabel mesh__D014567 Urography
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014567 1999
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014567 2002
% 209.04/209.25 |- mesh__dateCreated mesh__D014567 1999-01-01
% 209.04/209.25 |- skos__annotation mesh__D014567
% 209.04/209.25 GEN only: prefer specific organ with /radiogr; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: UROGR%A%
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014567 1998
% 209.04/209.25 |- skos__broader mesh__D014567smesh__D003950
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014567 2004
% 209.04/209.25 |- rdf__type mesh__D014567sskos__Concept
% 209.04/209.25 |- skos__broader mesh__D014567smesh__D011859
% 209.04/209.25 |- mesh__dateRevised mesh__D014567 1997-06-20
% 209.04/209.25 |- mesh__recordOriginator mesh__D014567 NLM
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014567 2003
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D014567 SJN
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014567 2001
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014567 2006
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D033721
% 209.04/209.25 2003; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 was indexed under MEMBRANE TRANSPORT PROTEINS 2001, MEMBRANE PROTEINS %26% CARRIER PROTEINS 1997-2002%A%
% 209.04/209.25 |- mesh__recordMaintainer mesh__D033721 SYSTEM
% 209.04/209.25 |- skos__altLabel mesh__D033721
% 209.04/209.25 Equilibrative NBMPR-Sensitive Nucleoside Transporter
% 209.04/209.25 |- skos__prefLabel mesh__D033721 Equilibrative Nucleoside Transporter 1
% 209.04/209.25 |- mesh__historyNote mesh__D033721
% 209.04/209.25 2003; use EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 %28%NM%29% 1997-2002%A%
% 209.04/209.25 |- mesh__dateEstablished mesh__D033721 2003-01-01
% 209.04/209.25 |- skos__hiddenLabel mesh__D033721
% 209.04/209.25 Equilibrative Nitrobenzylmercaptopurine Riboside Sensitive Nucleoside Transporter
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D033721 sjn
% 209.04/209.25 |- skos__hiddenLabel mesh__D033721
% 209.04/209.25 Equilibrative NBMPR Sensitive Nucleoside Transporter
% 209.04/209.25 |- skos__altLabel mesh__D033721
% 209.04/209.25 Solute Carrier Family 29 %28%Nucleoside Transporters%29%, Member 1
% 209.04/209.25 |- mesh__dateCreated mesh__D033721 2002-07-03
% 209.04/209.25 |- skos__altLabel mesh__D033721 SLC29A1 Transporter
% 209.04/209.25 |- mesh__dateRevised mesh__D033721 2005-06-30
% 209.04/209.25 |- skos__broader mesh__D033721smesh__D033705
% 209.04/209.25 |- skos__scopeNote mesh__D033721
% 209.04/209.25 A subtype of equilibrative nucleoside transporter proteins that is sensitive to inhibition by 4-nitrobenzylthioinosine.%A%
% 209.04/209.25 |- skos__historyNote mesh__D033721 Membrane Proteins %28%1997-2001%29%
% 209.04/209.25 |- skos__historyNote mesh__D033721 Carrier Proteins %28%1997-2001%29%
% 209.04/209.25 |- mesh__recordOriginator mesh__D033721 jmp
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D033721 2006
% 209.04/209.25 |- skos__altLabel mesh__D033721
% 209.04/209.25 Equilibrative Nitrobenzylmercaptopurine Riboside-Sensitive Nucleoside Transporter
% 209.04/209.25 |- rdf__type mesh__D033721sskos__Concept
% 209.04/209.25 |- skos__historyNote mesh__D033721
% 209.04/209.25 Membrane Transport Proteins %28%2001-2002%29%
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Amantadinratiopharm
% 209.04/209.25 |- mesh__historyNote mesh__D000547 68%28%65%29%
% 209.04/209.25 |- skos__altLabel mesh__D000547 Azupharma Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 AmantaHCIAZU
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 AZU, Amantadin
% 209.04/209.25 |- skos__altLabel mesh__D000547 neuraxpharm Brand of Amantadine Sulfate
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Amantadin ratiopharm
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D000547 2006
% 209.04/209.25 |- skos__altLabel mesh__D000547 Hexal Brand of Amantadine Sulfate
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 PMS Amantadine
% 209.04/209.25 |- skos__altLabel mesh__D000547 Krewel Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Sulfate, Amantadine
% 209.04/209.25 |- skos__altLabel mesh__D000547 Amantadin AZU
% 209.04/209.25 |- rdf__type mesh__D000547sskos__Concept
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Amanta Sulfate AZU
% 209.04/209.25 |- skos__altLabel mesh__D000547 Novartis Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 AL, Amantadin
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Amantadin neuraxpharm
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D000547 68
% 209.04/209.25 |- mesh__dateCreated mesh__D000547 1999-01-01
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547
% 209.04/209.25 Ciba Geigy Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Amantadinneuraxpharm
% 209.04/209.25 |- skos__altLabel mesh__D000547 Mantadix
% 209.04/209.25 |- skos__altLabel mesh__D000547 Merz Brand of Amantadine Sulfate
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 InfectoFlu
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D000547 2005
% 209.04/209.25 |- mesh__dateRevised mesh__D000547 2004-07-07
% 209.04/209.25 |- skos__altLabel mesh__D000547 Stada Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__altLabel mesh__D000547 Alliance Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__altLabel mesh__D000547
% 209.04/209.25 Ciba-Geigy Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__altLabel mesh__D000547 Thiemann Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__altLabel mesh__D000547 Genpharm Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Juventus, Amantadina
% 209.04/209.25 |- skos__altLabel mesh__D000547 Solvay Brand of Amantadine Hydrochloride
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D000547 sjn
% 209.04/209.25 |- skos__altLabel mesh__D000547 Du Pont Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 AmantaSulfateAZU
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Llorente, Amantadina
% 209.04/209.25 |- skos__altLabel mesh__D000547 Azupharma Brand of Amantadine Sulfate
% 209.04/209.25 |- skos__broader mesh__D000547smesh__D000218
% 209.04/209.25 |- skos__altLabel mesh__D000547 Stada Brand of Amantadine Sulfate
% 209.04/209.25 |- skos__altLabel mesh__D000547 Endo Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__altLabel mesh__D000547
% 209.04/209.25 ratiopharm Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__altLabel mesh__D000547 Adamantylamine
% 209.04/209.25 |- skos__altLabel mesh__D000547
% 209.04/209.25 Pharmascience Brand of Amantadine Hydrochloride
% 209.04/209.25 |- mesh__recordMaintainer mesh__D000547 mdb
% 209.04/209.25 |- skos__altLabel mesh__D000547 Aliud Brand of Amantadine Sulfate
% 209.04/209.25 |- skos__altLabel mesh__D000547 Orion Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 GenAmantadine
% 209.04/209.25 |- skos__altLabel mesh__D000547 Desitin Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__prefLabel mesh__D000547 Amantadine
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Stada, Amantadin
% 209.04/209.25 |- skos__altLabel mesh__D000547 1-Aminoadamantane
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Hydrochloride, Amantadine
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 1 Aminoadamantane
% 209.04/209.25 |- skos__altLabel mesh__D000547 Neuro Hexal Brand of Amantadine Sulfate
% 209.04/209.25 |- skos__altLabel mesh__D000547 Llorente Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__altLabel mesh__D000547 Endantadine
% 209.04/209.25 |- skos__altLabel mesh__D000547
% 209.04/209.25 Infectopharm Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__altLabel mesh__D000547 AbZ Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Amanta HCI AZU
% 209.04/209.25 |- skos__scopeNote mesh__D000547
% 209.04/209.25 An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.%A%
% 209.04/209.25 |- skos__altLabel mesh__D000547 Juventus Brand of Amantadine Hydrochloride
% 209.04/209.25 |- skos__altLabel mesh__D000547 Hormosan Brand of Amantadine Sulfate
% 209.04/209.25 |- mesh__recordOriginator mesh__D000547 NLM
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 PMSAmantadine
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Infecto Flu
% 209.04/209.25 |- skos__hiddenLabel mesh__D000547 Gen Amantadine
% 209.04/209.25 |- mesh__dateEstablished mesh__D000547 1968-01-01
% 209.04/209.25 |- skos__hiddenLabel mesh__D019252 Digoras
% 209.04/209.25 |- skos__prefLabel mesh__D019252 Radiography, Dental, Digital
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D019252 2001
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D019252
% 209.04/209.25 98; see RADIOVISIOGRAPHY, DENTAL 1997
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D019252 SJN
% 209.04/209.25 |- skos__broader mesh__D019252smesh__D011856
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D019252 2006
% 209.04/209.25 |- mesh__recordMaintainer mesh__D019252 AGS
% 209.04/209.25 |- rdf__type mesh__D019252sskos__Concept
% 209.04/209.25 |- skos__altLabel mesh__D019252 Digital Radiography, Dental
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D019252 2000
% 209.04/209.25 |- mesh__dateEstablished mesh__D019252 1997-01-01
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D019252 2005
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D019252 1999
% 209.04/209.25 |- skos__hiddenLabel mesh__D019252 SensARay
% 209.04/209.25 |- mesh__dateCreated mesh__D019252 1996-06-10
% 209.04/209.25 |- mesh__historyNote mesh__D019252 98%28%97%29%
% 209.04/209.25 |- skos__hiddenLabel mesh__D019252 Radiography, Dental Digital
% 209.04/209.25 |- skos__hiddenLabel mesh__D019252 Visualices
% 209.04/209.25 |- skos__broader mesh__D019252smesh__D011861
% 209.04/209.25 |- skos__scopeNote mesh__D019252
% 209.04/209.25 A rapid, low-dose, digital imaging system using a small intraoral sensor instead of radiographic film, an intensifying screen, and a charge-coupled device. It presents the possibility of reduced patient exposure and minimal distortion, although resolution and latitude are inferior to standard dental radiography. A receiver is placed in the mouth, routing signals to a computer which images the signals on a screen or in print. It includes digitizing from x-ray film or any other detector. %28%From MEDLINE abstracts; personal communication from Dr. Charles Berthold, NIDR%29%%A%
% 209.04/209.25 |- skos__annotation mesh__D019252
% 209.04/209.25 a type of intraoral radiogr; do not use /util except by MeSH definition; DF: RADIOGR DENT DIGITAL%A%
% 209.04/209.25 |- skos__altLabel mesh__D019252 Dental Digital Radiography
% 209.04/209.25 |- skos__altLabel mesh__D019252 Radiovisiography, Dental
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D019252 2002
% 209.04/209.25 |- skos__hiddenLabel mesh__D019252 Sens A Ray
% 209.04/209.25 |- skos__hiddenLabel mesh__D019252 Scanoras
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D019252 2004
% 209.04/209.25 |- skos__historyNote mesh__D019252 Radiography, Dental %28%1989-1996%29%
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D019252 2003
% 209.04/209.25 |- mesh__recordOriginator mesh__D019252 TGC
% 209.04/209.25 |- mesh__dateRevised mesh__D019252 1998-06-11
% 209.04/209.25 |- rdf__type mesh__D005232sskos__Concept
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D005232 sjn
% 209.04/209.25 |- skos__scopeNote mesh__D005232
% 209.04/209.25 Short-chain fatty acids of up to six carbon atoms in length. They are the major end products of microbial fermentation in the ruminant digestive tract and have also been implicated in the causation of neurological diseases in humans.%A%
% 209.04/209.25 |- mesh__recordMaintainer mesh__D005232 ssb
% 209.04/209.25 |- skos__historyNote mesh__D005232 Fatty Acids %28%1966-1972%29%
% 209.04/209.25 |- mesh__recordOriginator mesh__D005232 NLM
% 209.04/209.25 |- skos__annotation mesh__D005232
% 209.04/209.25 GEN or unspecified; prefer specific groups or specific acid%A%
% 209.04/209.25 |- skos__hiddenLabel mesh__D005232 Volatile Fatty Acids
% 209.04/209.25 |- mesh__dateEstablished mesh__D005232 1973-01-01
% 209.04/209.25 |- mesh__dateCreated mesh__D005232 1999-01-01
% 209.04/209.25 |- skos__broader mesh__D005232smesh__D005227
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D005232 2006
% 209.04/209.25 |- skos__altLabel mesh__D005232 Fatty Acids, Short-Chain
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D005232 2005
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D005232 2004
% 209.04/209.25 |- skos__prefLabel mesh__D005232 Fatty Acids, Volatile
% 209.04/209.25 |- mesh__historyNote mesh__D005232 73
% 209.04/209.25 |- skos__hiddenLabel mesh__D005232 Short-Chain Fatty Acids
% 209.04/209.25 |- skos__hiddenLabel mesh__D005232 Fatty Acids, Short Chain
% 209.04/209.25 |- mesh__dateRevised mesh__D005232 2003-07-09
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D005232 73
% 209.04/209.25 |- skos__hiddenLabel mesh__D046649 Subdural Hematoma, Spinal
% 209.04/209.25 |- mesh__recordOriginator mesh__D046649 ags
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D046649 sjn
% 209.04/209.25 |- skos__broader mesh__D046649smesh__D006408
% 209.04/209.25 |- skos__prefLabel mesh__D046649 Hematoma, Subdural, Spinal
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D046649 2006
% 209.04/209.25 |- skos__hiddenLabel mesh__D046649 Subdural Hematomas, Spinal
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D046649
% 209.04/209.25 2005; see HEMATOMA, SUBDURAL %28%2000-2004%29%
% 209.04/209.25 |- skos__hiddenLabel mesh__D046649 Hematomas, Spinal Subdural
% 209.04/209.25 |- mesh__dateEstablished mesh__D046649 2005-01-01
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D046649 2005
% 209.04/209.25 |- skos__hiddenLabel mesh__D046649 Hematoma, Spinal Subdural
% 209.04/209.25 |- skos__altLabel mesh__D046649 Subdural Hematoma, Spinal, Traumatic
% 209.04/209.25 |- skos__altLabel mesh__D046649 Spinal Subdural Hematoma
% 209.04/209.25 |- skos__scopeNote mesh__D046649
% 209.04/209.25 Subdural hematoma of the SPINAL CANAL.
% 209.04/209.25 |- skos__altLabel mesh__D046649 Spinal Subdural Hematoma, Traumatic
% 209.04/209.25 |- mesh__recordMaintainer mesh__D046649 ags
% 209.04/209.25 |- mesh__historyNote mesh__D046649
% 209.04/209.25 2005; use HEMATOMA, SUBDURAL %28%2000-2004%29%
% 209.04/209.25 |- mesh__dateCreated mesh__D046649 2004-07-07
% 209.04/209.25 |- skos__historyNote mesh__D046649 Hematoma, Subdural %28%1969-2004%29%
% 209.04/209.25 |- rdf__type mesh__D046649sskos__Concept
% 209.04/209.25 |- skos__hiddenLabel mesh__D046649 Spinal Subdural Hematomas
% 209.04/209.25 |- skos__historyNote mesh__D018958 Membrane Proteins %28%1985-1992%29%
% 209.04/209.25 |- skos__annotation mesh__D018958 differentiation antigens
% 209.04/209.25 |- skos__prefLabel mesh__D018958 Antigens, CD55
% 209.04/209.25 |- skos__broader mesh__D018958smesh__D015703
% 209.04/209.25 |- skos__altLabel mesh__D018958 Decay-Accelerating Factor
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D018958 2006
% 209.04/209.25 |- mesh__onlineNote mesh__D018958
% 209.04/209.25 use ANTIGENS, CD55 %28%NM%29% to search DECAY-ACCELERATING FACTOR 1985-95%A%
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D018958
% 209.04/209.25 96; DECAY-ACCELERATING FACTOR was indexed under ANTIGENS, CD 1990-95; MEMBRANE GLYCOPROTEINS 1988-95; MEMBRANE PROTEINS 1985-92; %26% BLOOD PROTEINS 1985-86%A%
% 209.04/209.25 |- mesh__recordMaintainer mesh__D018958 ssb
% 209.04/209.25 |- mesh__historyNote mesh__D018958
% 209.04/209.25 96; was DECAY-ACCELERATING FACTOR %28%NM%29% 1985-95
% 209.04/209.25 |- mesh__dateRevised mesh__D018958 2005-06-30
% 209.04/209.25 |- skos__broader mesh__D018958smesh__D008562
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D018958 sjn
% 209.04/209.25 |- skos__hiddenLabel mesh__D018958 Decay Accelerating Factor
% 209.04/209.25 |- mesh__dateEstablished mesh__D018958 1996-01-01
% 209.04/209.25 |- skos__historyNote mesh__D018958 Antigens, CD %28%1990-1995%29%
% 209.04/209.25 |- skos__altLabel mesh__D018958 CD55 Antigens
% 209.04/209.25 |- skos__historyNote mesh__D018958 Blood Proteins %28%1985-1986%29%
% 209.04/209.25 |- mesh__recordOriginator mesh__D018958 AGS
% 209.04/209.25 |- mesh__dateCreated mesh__D018958 1995-05-26
% 209.04/209.25 |- skos__altLabel mesh__D018958 CD55 Antigen
% 209.04/209.25 |- skos__historyNote mesh__D018958 Membrane Glycoproteins %28%1988-1995%29%
% 209.04/209.25 |- rdf__type mesh__D018958sskos__Concept
% 209.04/209.25 |- skos__scopeNote mesh__D018958
% 209.04/209.25 Glycoproteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 convertase or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.%A%
% 209.04/209.25 |- skos__hiddenLabel mesh__D010975 Drugs, Antiplatelet
% 209.04/209.25 |- skos__hiddenLabel mesh__D010975 Antagonists, Blood Platelet
% 209.04/209.25 |- skos__altLabel mesh__D010975 Blood Platelet Aggregation Inhibitors
% 209.04/209.25 |- skos__annotation mesh__D010975 DF: PLATELET INHIB
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D010975 sjn
% 209.04/209.25 |- mesh__historyNote mesh__D010975 88
% 209.04/209.25 |- mesh__dateEstablished mesh__D010975 1988-01-01
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010975 2006
% 209.04/209.25 |- mesh__recordOriginator mesh__D010975 SCD
% 209.04/209.25 |- skos__altLabel mesh__D010975 Platelet Antiaggregants
% 209.04/209.25 |- skos__hiddenLabel mesh__D010975 Inhibitors, Platelet Aggregation
% 209.04/209.25 |- mesh__dateRevised mesh__D010975 2005-06-30
% 209.04/209.25 |- skos__hiddenLabel mesh__D010975 Antagonists, Platelet
% 209.04/209.25 |- skos__altLabel mesh__D010975 Blood Platelet Antagonists
% 209.04/209.25 |- skos__hiddenLabel mesh__D010975 Inhibitors, Platelet
% 209.04/209.25 |- skos__scopeNote mesh__D010975
% 209.04/209.25 Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.%A%
% 209.04/209.25 |- skos__altLabel mesh__D010975 Blood Platelet Antiaggregants
% 209.04/209.25 |- skos__historyNote mesh__D010975 Blood Platelets %28%1966-1987%29%
% 209.04/209.25 |- skos__hiddenLabel mesh__D010975 Aggregation Inhibitors, Platelet
% 209.04/209.25 |- mesh__dateCreated mesh__D010975 1987-03-13
% 209.04/209.25 |- skos__historyNote mesh__D010975 Platelet Adhesiveness %28%1972-1987%29%
% 209.04/209.25 |- skos__hiddenLabel mesh__D010975 Antiaggregants, Blood Platelet
% 209.04/209.25 |- skos__hiddenLabel mesh__D010975 Agents, Antiplatelet
% 209.04/209.25 |- rdf__type mesh__D010975sskos__Concept
% 209.04/209.25 |- skos__historyNote mesh__D010975 Platelet Aggregation %28%1976-1987%29%
% 209.04/209.25 |- mesh__recordMaintainer mesh__D010975 ssb
% 209.04/209.25 |- skos__prefLabel mesh__D010975 Platelet Aggregation Inhibitors
% 209.04/209.25 |- skos__altLabel mesh__D010975 Antiplatelet Drugs
% 209.04/209.25 |- skos__broader mesh__D010975smesh__D006401
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D010975 88
% 209.04/209.25 |- skos__altLabel mesh__D010975 Antiaggregants, Platelet
% 209.04/209.25 |- mesh__dateRevised mesh__D010177 1999-12-01
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1990
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1994
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 2000
% 209.04/209.25 |- rdf__type mesh__D010177sskos__Concept
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D010177 ags
% 209.04/209.25 |- mesh__recordMaintainer mesh__D010177 ags
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1989
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 2004
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1997
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 2002
% 209.04/209.25 |- mesh__dateCreated mesh__D010177 1999-01-01
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1993
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 2003
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1996
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1991
% 209.04/209.25 |- skos__prefLabel mesh__D010177 Panama Canal Zone
% 209.04/209.25 |- skos__broader mesh__D010177smesh__D010176
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 2006
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1999
% 209.04/209.25 |- skos__annotation mesh__D010177 do not confuse with PANAMA
% 209.04/209.25 |- mesh__recordOriginator mesh__D010177 NLM
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1992
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 2000A
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1995
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 2001
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 2005
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D010177 1998
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Esophagus Cancers
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D004938 2005
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D004938 2006
% 209.04/209.25 |- mesh__dateCreated mesh__D004938 1999-01-01
% 209.04/209.25 |- mesh__recordMaintainer mesh__D004938 lkt
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Neoplasm, Esophagus
% 209.04/209.25 |- mesh__recordOriginator mesh__D004938 NLM
% 209.04/209.25 |- skos__scopeNote mesh__D004938 Tumors or cancer of the ESOPHAGUS.
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Esophageal Cancers
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D004938 sjn
% 209.04/209.25 |- rdf__type mesh__D004938sskos__Concept
% 209.04/209.25 |- skos__broader mesh__D004938smesh__D005770
% 209.04/209.25 |- skos__altLabel mesh__D004938 Esophagus Cancer
% 209.04/209.25 |- skos__annotation mesh__D004938
% 209.04/209.25 coord IM with histol type of neopl %28%IM%29%
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D004938 2004
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Neoplasm, Esophageal
% 209.04/209.25 |- skos__altLabel mesh__D004938 Esophageal Cancer
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Cancer, Esophageal
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Neoplasms, Esophagus
% 209.04/209.25 |- skos__prefLabel mesh__D004938 Esophageal Neoplasms
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Cancers, Esophageal
% 209.04/209.25 |- skos__altLabel mesh__D004938 Cancer of the Esophagus
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Cancers, Esophagus
% 209.04/209.25 |- skos__broader mesh__D004938smesh__D006258
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Esophagus Neoplasms
% 209.04/209.25 |- skos__altLabel mesh__D004938 Esophagus Neoplasm
% 209.04/209.25 |- skos__broader mesh__D004938smesh__D004935
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Esophageal Neoplasm
% 209.04/209.25 |- skos__hiddenLabel mesh__D004938 Cancer, Esophagus
% 209.04/209.25 |- mesh__dateRevised mesh__D004938 2003-07-09
% 209.04/209.25 |- skos__altLabel mesh__D004938 Neoplasms, Esophageal
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 Deethylase, Ethoxycoumarin
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D015660 2006
% 209.04/209.25 |- skos__altLabel mesh__D015660 7-Ethoxycoumarin O-Deethylase
% 209.04/209.25 |- skos__altLabel mesh__D015660 7-Ethoxycoumarin O-Dealkylase
% 209.04/209.25 |- skos__altLabel mesh__D015660 Cytochrome P-450-Dependent O-Dealkylase
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin Monooxygenase
% 209.04/209.25 |- skos__broader mesh__D015660smesh__D001189
% 209.04/209.25 |- mesh__dateRevised mesh__D015660 2004-07-07
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 Dealkylase, 7-Ethoxycoumarin
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin O Dealkylase
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin Dealkylase
% 209.04/209.25 |- rdf__type mesh__D015660sskos__Concept
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 O-Depropylase, 7-Propoxycoumarin
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin Hydroxylase
% 209.04/209.25 |- mesh__recordMaintainer mesh__D015660 ssb
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 Monooxygenase, 7-Ethoxycoumarin
% 209.04/209.25 |- skos__altLabel mesh__D015660 7-Propoxycoumarin O-Depropylase
% 209.04/209.25 |- skos__altLabel mesh__D015660 7-Ethoxycoumarin Hydroxylase
% 209.04/209.25 |- mesh__historyNote mesh__D015660 90
% 209.04/209.25 |- skos__altLabel mesh__D015660 Ethoxycoumarin Deethylase
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 Hydroxylase, 7-Ethoxycoumarin
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 P-450-Dependent O-Dealkylase, Cytochrome
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 Ethoxycoumarin O Deethylase
% 209.04/209.25 |- mesh__recordOriginator mesh__D015660 RLS
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D015660 90
% 209.04/209.25 |- skos__altLabel mesh__D015660 7-Ethoxycoumarin Monooxygenase
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 7 Alkoxycoumarin O Dealkylase
% 209.04/209.25 |- skos__altLabel mesh__D015660 7-Ethoxycoumarin Dealkylase
% 209.04/209.25 |- skos__historyNote mesh__D015660 Oxygenases %28%1966-1989%29%
% 209.04/209.25 |- skos__altLabel mesh__D015660 7-Ethoxycoumarin O-De-Ethylase
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin O Deethylase
% 209.04/209.25 |- skos__altLabel mesh__D015660 Ethoxycoumarin O-Deethylase
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 7 Propoxycoumarin O Depropylase
% 209.04/209.25 |- skos__scopeNote mesh__D015660
% 209.04/209.25 A drug-metabolizing enzyme found in the hepatic, placental and intestinal microsomes that metabolizes 7-alkoxycoumarin to 7-hydroxycoumarin. The enzyme is cytochrome P-450- dependent.%A%
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 O-Deethylase, 7-Ethoxycoumarin
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D015660 2005
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D015660 sjn
% 209.04/209.25 |- skos__prefLabel mesh__D015660 7-Alkoxycoumarin O-Dealkylase
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 Cytochrome P 450 Dependent O Dealkylase
% 209.04/209.25 |- mesh__dateEstablished mesh__D015660 1990-01-01
% 209.04/209.25 |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin O De Ethylase
% 209.04/209.25 |- mesh__dateCreated mesh__D015660 1989-05-25
% 209.04/209.25 |- rdf__type mesh__D009623sskos__Concept
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 1998
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 2004
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D009623 PLS
% 209.04/209.25 |- mesh__dateEstablished mesh__D009623 1991-01-01
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 2000
% 209.04/209.25 |- skos__hiddenLabel mesh__D009623 Noises, Occupational
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 1999
% 209.04/209.25 |- skos__scopeNote mesh__D009623
% 209.04/209.25 Noise present in occupational, industrial, and factory situations.%A%
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 2001
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D009623 91; was see under NOISE 1979-90
% 209.04/209.25 |- mesh__dateCreated mesh__D009623 1978-05-22
% 209.04/209.25 |- skos__broader mesh__D009623smesh__D009622
% 209.04/209.25 |- skos__annotation mesh__D009623
% 209.04/209.25 coord IM with specific occupation %28%IM%29% if pertinent; consider also HEARING LOSS, NOISE-INDUCED; DF: NOISE OCCUP%A%
% 209.04/209.25 |- skos__altLabel mesh__D009623 Occupational Noise
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 2005
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 1996
% 209.04/209.25 |- skos__historyNote mesh__D009623 Occupational Medicine %28%1966-1978%29%
% 209.04/209.25 |- skos__hiddenLabel mesh__D009623 Occupational Noises
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 2006
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 1997
% 209.04/209.25 |- skos__historyNote mesh__D009623 Noise %28%1966-1978%29%
% 209.04/209.25 |- mesh__historyNote mesh__D009623
% 209.04/209.25 91%28%79%29%; was see under NOISE 1979-90
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 2002
% 209.04/209.25 |- mesh__dateRevised mesh__D009623 1995-05-18
% 209.04/209.25 |- skos__prefLabel mesh__D009623 Noise, Occupational
% 209.04/209.25 |- mesh__recordOriginator mesh__D009623 RC
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D009623 2003
% 209.04/209.25 |- mesh__recordMaintainer mesh__D009623 KEV
% 209.04/209.25 |- mesh__recordMaintainer mesh__D001640 ssb
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D001640 2004
% 209.04/209.25 |- rdf__type mesh__D001640sskos__Concept
% 209.04/209.25 |- skos__historyNote mesh__D001640 Dioxoles %28%1972-1974%29%
% 209.04/209.25 |- mesh__dateRevised mesh__D001640 2003-07-09
% 209.04/209.25 |- skos__historyNote mesh__D001640 Isoquinolines %28%1971-1974%29%
% 209.04/209.25 |- skos__historyNote mesh__D001640 Alkaloids %28%1972-1974%29%
% 209.04/209.25 |- mesh__dateCreated mesh__D001640 1974-11-11
% 209.04/209.25 |- mesh__dateEstablished mesh__D001640 1980-01-01
% 209.04/209.25 |- skos__altLabel mesh__D001640
% 209.04/209.25 6-%28%5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo%28%4,5-g%29%isoquinolin-5-yl%29%furo%28%3,4-e%29%1,3-benzodioxol-8%28%6H%29%one
% 209.04/209.25 |- skos__broader mesh__D001640smesh__D044182
% 209.04/209.25 |- mesh__recordOriginator mesh__D001640 NLM
% 209.04/209.25 |- mesh__historyNote mesh__D001640
% 209.04/209.25 80%28%75%29%; was see under ISOQUINOLINES 1975-79
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D001640 sjn
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D001640 2006
% 209.04/209.25 |- skos__prefLabel mesh__D001640 Bicuculline
% 209.04/209.25 |- mesh__publicMeSHNote mesh__D001640
% 209.04/209.25 80; was see under ISOQUINOLINES 1975-79
% 209.04/209.25 |- skos__broader mesh__D001640smesh__D000470
% 209.04/209.25 |- skos__scopeNote mesh__D001640
% 209.04/209.25 Isoquinoline alkaloid from Dicentra cucullaria and other plants that is a competitive antagonist at GABA-A receptors and thus causes convulsions.%A%
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D001640 2005
% 209.04/209.25 |- skos__hiddenLabel mesh__D014568 Urokinase Type Plasminogen Activator
% 209.04/209.25 |- skos__historyNote mesh__D014568 Fibrinolytic Agents %28%1966-1974%29%
% 209.04/209.25 |- mesh__activeMeSHYear mesh__D014568 2006
% 209.04/209.25 |- skos__altLabel mesh__D014568 Plasminogen Activator, Urokinase-Type
% 209.04/209.25 |- mesh__recordAuthorizer mesh__D014568 sjn
% 209.04/209.26 |- skos__hiddenLabel mesh__D014568 Activator, Urinary Plasminogen
% 209.04/209.26 |- mesh__dateCreated mesh__D014568 1999-01-01
% 209.04/209.26 |- skos__hiddenLabel mesh__D014568
% 209.04/209.26 Single Chain Urokinase Type Plasminogen Activator
% 209.04/209.26 |- skos__broader mesh__D014568smesh__D010960
% 209.04/209.26 |- skos__annotation mesh__D014568 DF: U-PA
% 209.04/209.26 |- skos__hiddenLabel mesh__D014568 Activator, U-Plasminogen
% 209.04/209.26 |- skos__hiddenLabel mesh__D014568 U Plasminogen Activator
% 209.04/209.26 |- rdf__type mesh__D014568sskos__Concept
% 209.04/209.26 |- mesh__recordMaintainer mesh__D014568 ssb
% 209.04/209.26 |- mesh__recordOriginator mesh__D014568 NLM
% 209.04/209.26 |- skos__altLabel mesh__D014568 Urokinase
% 209.04/209.26 |- skos__altLabel mesh__D014568 U-Plasminogen Activator
% 209.04/209.26 |- skos__prefLabel mesh__D014568 Urinary Plasminogen Activator
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D014568
% 209.04/209.26 2000; see UROKINASE 1984-1999, see PEPTIDE PEPTIDOHYDROLASES 1975-1983, see FIBRINOLYTIC AGENTS 1966-1974, see STREPTODORNASE AND STREPTOKINASE 1963-1965, UROKINASE-TYPE PLASMINOGEN ACTIVATOR was indexed under PLASMINOGEN ACTIVATORS %26% UROKINASE 1984-1999%A%
% 209.04/209.26 |- skos__altLabel mesh__D014568 Urokinase-Type Plasminogen Activator
% 209.04/209.26 |- mesh__historyNote mesh__D014568
% 209.04/209.26 2000%28%1963%29%; for UROKINASE-TYPE PLASMINOGEN ACTIVATOR use URINARY PLASMINOGEN ACTIVATOR %28%NM%29% 1984-1999%A%
% 209.04/209.26 |- mesh__dateEstablished mesh__D014568 1984-01-01
% 209.04/209.26 |- skos__hiddenLabel mesh__D014568 Plasminogen Activator, Urinary
% 209.04/209.26 |- mesh__dateRevised mesh__D014568 2005-06-30
% 209.04/209.26 |- skos__altLabel mesh__D014568 U-PA
% 209.04/209.26 |- skos__broader mesh__D014568smesh__D012697
% 209.04/209.26 |- skos__scopeNote mesh__D014568
% 209.04/209.26 A proteolytic enzyme that converts plasminogen to plasmin where the preferential cleavage is between arginine and valine. It was isolated originally from human urine, but is found in most tissues of most vertebrates. EC 3.4.21.73.%A%
% 209.04/209.26 |- skos__altLabel mesh__D033722
% 209.04/209.26 Nitrobenzylmercaptopurine Riboside %28%NBMPR%29%-Insensitive, Equilibrative Nucleoside Transporter
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D033722
% 209.04/209.26 2003; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2 was indexed under MEMBRANE TRANSPORT PROTEINS 2002, CARRIER PROTEINS 1998-2001 %26% MEMBRANE PROTEINS 1998-2001%A%
% 209.04/209.26 |- mesh__historyNote mesh__D033722
% 209.04/209.26 2003; use EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2 %28%NM%29% 1998-2002%A%
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D033722 2005
% 209.04/209.26 |- skos__historyNote mesh__D033722 Membrane Transport Proteins %28%2002%29%
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D033722 2003
% 209.04/209.26 |- mesh__dateEstablished mesh__D033722 2003-01-01
% 209.04/209.26 |- skos__altLabel mesh__D033722
% 209.04/209.26 Equilibrative, Nitrobenzylmercaptopurine Riboside %28%NBMPR%29%-Insensitive Nucleoside Transporter
% 209.04/209.26 |- skos__broader mesh__D033722smesh__D033705
% 209.04/209.26 |- skos__historyNote mesh__D033722 Carrier Proteins %28%1998-2001%29%
% 209.04/209.26 |- skos__altLabel mesh__D033722
% 209.04/209.26 Solute Carrier-Family 29 %28%Nucleoside Transporters%29%, Member 2
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D033722 sjn
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D033722 2006
% 209.04/209.26 |- skos__historyNote mesh__D033722 Membrane Proteins %28%1998-2001%29%
% 209.04/209.26 |- mesh__dateCreated mesh__D033722 2002-07-03
% 209.04/209.26 |- skos__scopeNote mesh__D033722
% 209.04/209.26 A subtype of equilibrative nucleoside transporter proteins that is insensitive to inhibition by 4-nitrobenzylthioinosine.%A%
% 209.04/209.26 |- skos__altLabel mesh__D033722 SLC29A2 Protein
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D033722 2004
% 209.04/209.26 |- rdf__type mesh__D033722sskos__Concept
% 209.04/209.26 |- mesh__recordMaintainer mesh__D033722 jmp
% 209.04/209.26 |- mesh__recordOriginator mesh__D033722 jmp
% 209.04/209.26 |- skos__prefLabel mesh__D033722 Equilibrative-Nucleoside Transporter 2
% 209.04/209.26 |- skos__broader mesh__D019253smesh__D011518
% 209.04/209.26 |- skos__hiddenLabel mesh__D019253 Proto Oncogene Proteins c bcl 2
% 209.04/209.26 |- mesh__dateRevised mesh__D019253 2005-06-30
% 209.04/209.26 |- skos__broader mesh__D019253smesh__D051017
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D019253
% 209.04/209.26 97; PROTO-ONCOGENE PROTEIN BCL-2 was indexed under PROTO-ONCOGENE PROTEINS 1989-96%A%
% 209.04/209.26 |- skos__hiddenLabel mesh__D019253 Proto-Oncogene Proteins, bcl-2
% 209.04/209.26 |- skos__historyNote mesh__D019253
% 209.04/209.26 Proto-Oncogene Proteins %28%1989-1996%29%
% 209.04/209.26 |- mesh__recordOriginator mesh__D019253 AGS
% 209.04/209.26 |- skos__hiddenLabel mesh__D019253 bcl 2 Proto Oncogene Proteins
% 209.04/209.26 |- mesh__recordMaintainer mesh__D019253 DRC
% 209.04/209.26 |- skos__scopeNote mesh__D019253
% 209.04/209.26 Membrane proteins encoded by the BCL-2 GENES and serving as potent inhibitors of cell death by APOPTOSIS. The proteins are found on mitochondrial, microsomal, and NUCLEAR MEMBRANE sites within many cell types. Overexpression of bcl-2 proteins, due to a translocation of the gene, is associated with follicular lymphoma.%A%
% 209.04/209.26 |- skos__prefLabel mesh__D019253 Proto-Oncogene Proteins c-bcl-2
% 209.04/209.26 |- skos__altLabel mesh__D019253 c-bcl-2 Proteins
% 209.04/209.26 |- mesh__dateEstablished mesh__D019253 1997-01-01
% 209.04/209.26 |- skos__altLabel mesh__D019253 bcl-2 Proto-Oncogene Proteins
% 209.04/209.26 |- mesh__onlineNote mesh__D019253
% 209.04/209.26 use PROTO-ONCOGENE PROTEINS C-BCL-2 %28%NM%29% to search PROTO-ONCOGENE PROTEIN BCL-2 1989-96%A%
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D019253 2006
% 209.04/209.26 |- rdf__type mesh__D019253sskos__Concept
% 209.04/209.26 |- skos__hiddenLabel mesh__D019253 c-bcl-2, Proto-Oncogene Proteins
% 209.04/209.26 |- mesh__dateCreated mesh__D019253 1996-06-10
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D019253 sjn
% 209.04/209.26 |- skos__hiddenLabel mesh__D019253 c bcl 2 Proteins
% 209.04/209.26 |- skos__hiddenLabel mesh__D019253 B Cell Leukemia 2 Family Proteins
% 209.04/209.26 |- mesh__historyNote mesh__D019253
% 209.04/209.26 97; was PROTO-ONCOGENE PROTEIN BCL-2 %28%NM%29% 1989-96
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D000548 ags
% 209.04/209.26 |- skos__prefLabel mesh__D000548 Amaranth Dye
% 209.04/209.26 |- mesh__dateRevised mesh__D000548 2005-07-07
% 209.04/209.26 |- mesh__dateEstablished mesh__D000548 1991-01-01
% 209.04/209.26 |- mesh__dateCreated mesh__D000548 1974-11-19
% 209.04/209.26 |- rdf__type mesh__D000548sskos__Concept
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D000548
% 209.04/209.26 2002; see AMARANTH 1991-2001, see AZO COMPOUNDS 1975-1990; for C.I. ACID RED 27, C.I. 16185, %26% FD%26%C RED NO. 2 see AMARANTH 1975-1993%A%
% 209.04/209.26 |- skos__annotation mesh__D000548
% 209.04/209.26 AMARANTH PLANT see AMARANTHUS is also available; D25-26 qualif%A%
% 209.04/209.26 |- skos__scopeNote mesh__D000548
% 209.04/209.26 A sulfonic acid-based naphthylazo dye used as a coloring agent for foodstuffs and medicines and as a dye and chemical indicator. It was banned by the FDA in 1976 for use in foods, drugs, and cosmetics. %28%From Merck Index, 11th ed%29%%A%
% 209.04/209.26 |- skos__broader mesh__D000548smesh__D009282
% 209.04/209.26 |- mesh__historyNote mesh__D000548 1991%28%1975%29%
% 209.04/209.26 |- skos__historyNote mesh__D000548 Naphthalenesulfonates %28%1974%29%
% 209.04/209.26 |- skos__historyNote mesh__D000548 Azo Compounds %28%1969-1975%29%
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D000548 2006
% 209.04/209.26 |- skos__hiddenLabel mesh__D000548 Dye, Amaranth
% 209.04/209.26 |- mesh__recordMaintainer mesh__D000548 ags
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D000548 2006A
% 209.04/209.26 |- skos__altLabel mesh__D000548 Red Dye No. 2
% 209.04/209.26 |- skos__broader mesh__D000548smesh__D001391
% 209.04/209.26 |- mesh__recordOriginator mesh__D000548 NLM
% 209.04/209.26 |- skos__scopeNote mesh__D011270
% 209.04/209.26 The process of bearing developing young %28%EMBRYOS or FETUSES%29% in utero in non-human mammals, beginning from FERTILIZATION to BIRTH.%A%
% 209.04/209.26 |- mesh__dateCreated mesh__D011270 1999-01-01
% 209.04/209.26 |- mesh__recordMaintainer mesh__D011270 lkt
% 209.04/209.26 |- skos__broader mesh__D011270smesh__D011247
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D011270 2006
% 209.04/209.26 |- skos__hiddenLabel mesh__D011270 Animal Pregnancy
% 209.04/209.26 |- skos__hiddenLabel mesh__D011270 Animal Pregnancies
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D011270 2005
% 209.04/209.26 |- mesh__dateRevised mesh__D011270 2004-07-07
% 209.04/209.26 |- rdf__type mesh__D011270sskos__Concept
% 209.04/209.26 |- skos__prefLabel mesh__D011270 Pregnancy, Animal
% 209.04/209.26 |- skos__related mesh__D011270smesh__D000831
% 209.04/209.26 |- skos__hiddenLabel mesh__D011270 Pregnancies, Animal
% 209.04/209.26 |- mesh__recordOriginator mesh__D011270 NLM
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D011270 sjn
% 209.04/209.26 |- skos__annotation mesh__D011270
% 209.04/209.26 IM for articles on normal animal pregn but check also tag PREGNANCY; for NIM animal pregnancy do not index PREGNANCY, ANIMAL: merely check tag PREGNANCY; check tags ANIMALS %26% FEMALE also; Manual 18.4.6; DF: PREGN ANIMAL%A%
% 209.04/209.26 |- skos__broader mesh__D005233smesh__D000438
% 209.04/209.26 |- mesh__dateCreated mesh__D005233 1999-01-01
% 209.04/209.26 |- skos__historyNote mesh__D005233 Alcohols %28%1966-1971%29%
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D005233 2006
% 209.04/209.26 |- skos__prefLabel mesh__D005233 Fatty Alcohols
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D005233 sjn
% 209.04/209.26 |- mesh__recordMaintainer mesh__D005233 ssb
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D005233 2005
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D005233 2004
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D005233
% 209.04/209.26 72; SODIUM TETRADECYL SULFATE was SODIUM TETRADECYL SULFATES see under SCLEROSING SOLUTIONS 1963-74%A%
% 209.04/209.26 |- mesh__recordOriginator mesh__D005233 NLM
% 209.04/209.26 |- skos__scopeNote mesh__D005233
% 209.04/209.26 Usually high-molecular-weight, straight-chain primary alcohols, but can also range from as few as 4 carbons, derived from natural fats and oils, including lauryl, stearyl, oleyl, and linoleyl alcohols. They are used in pharmaceuticals, cosmetics, detergents, plastics, and lube oils and in textile manufacture. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%
% 209.04/209.26 |- mesh__dateRevised mesh__D005233 2003-07-09
% 209.04/209.26 |- mesh__dateEstablished mesh__D005233 1972-01-01
% 209.04/209.26 |- mesh__historyNote mesh__D005233 72
% 209.04/209.26 |- skos__broader mesh__D005233smesh__D008055
% 209.04/209.26 |- skos__hiddenLabel mesh__D005233 Alcohols, Fatty
% 209.04/209.26 |- rdf__type mesh__D005233sskos__Concept
% 209.04/209.26 |- skos__altLabel mesh__D018959 CD57 Antigens
% 209.04/209.26 |- skos__historyNote mesh__D018959
% 209.04/209.26 Antigens, Differentiation, T-Lymphocyte %28%1989-1993%29%
% 209.04/209.26 |- skos__altLabel mesh__D018959 CD57 Antigen
% 209.04/209.26 |- skos__altLabel mesh__D018959 Leu-7 Antigen
% 209.04/209.26 |- skos__scopeNote mesh__D018959
% 209.04/209.26 Oligosaccharide antigenic determinants found principally on NK cells and T-cells. Their role in the immune response is poorly understood.%A%
% 209.04/209.26 |- skos__historyNote mesh__D018959
% 209.04/209.26 Antigens, Differentiation %28%1989-1993%29%
% 209.04/209.26 |- mesh__dateCreated mesh__D018959 1995-05-26
% 209.04/209.26 |- rdf__type mesh__D018959sskos__Concept
% 209.04/209.26 |- skos__hiddenLabel mesh__D018959 Antigen, HNK-1
% 209.04/209.26 |- skos__hiddenLabel mesh__D018959 Leu 7 Antigen
% 209.04/209.26 |- mesh__recordMaintainer mesh__D018959 ssb
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D018959 2006
% 209.04/209.26 |- skos__annotation mesh__D018959 T-lymphocyte differentiation antigens
% 209.04/209.26 |- mesh__dateEstablished mesh__D018959 1996-01-01
% 209.04/209.26 |- skos__hiddenLabel mesh__D018959 HNK 1 Antigen
% 209.04/209.26 |- skos__hiddenLabel mesh__D018959 Antigen, CD57
% 209.04/209.26 |- mesh__historyNote mesh__D018959
% 209.04/209.26 96; was HNK-1 ANTIGEN %28%NM%29% 1989-95
% 209.04/209.26 |- mesh__recordOriginator mesh__D018959 AGS
% 209.04/209.26 |- mesh__onlineNote mesh__D018959
% 209.04/209.26 use ANTIGENS, CD57 %28%NM%29% to search HNK-1 ANTIGEN 1989-95
% 209.04/209.26 |- skos__broader mesh__D018959smesh__D015703
% 209.04/209.26 |- skos__altLabel mesh__D018959 HNK-1 Antigen
% 209.04/209.26 |- skos__prefLabel mesh__D018959 Antigens, CD57
% 209.04/209.26 |- skos__historyNote mesh__D018959 Antigens, CD %28%1990-1995%29%
% 209.04/209.26 |- mesh__dateRevised mesh__D018959 2005-06-30
% 209.04/209.26 |- skos__broader mesh__D018959smesh__D000945
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D018959 sjn
% 209.04/209.26 |- skos__hiddenLabel mesh__D018959 Antigen, Leu-7
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D018959
% 209.04/209.26 96; HNK-1 ANTIGEN was indexed under ANTIGENS, CD 1990-95; ANTIGENS DIFFERENTIATION, T-LYMPHOCYTE 1989-95; %26% ANTIGENS, DIFFERENTIATION 1989-93%A%
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Count, Platelet
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Counts, Platelet
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Blood Platelet Counts
% 209.04/209.26 |- skos__scopeNote mesh__D010976
% 209.04/209.26 The number of PLATELETS per unit volume in a sample of venous BLOOD.%A%
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010976 2006
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Numbers, Platelet
% 209.04/209.26 |- mesh__dateEstablished mesh__D010976 1980-01-01
% 209.04/209.26 |- skos__prefLabel mesh__D010976 Platelet Count
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Platelet Counts
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010976 2005
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Numbers, Blood Platelet
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D010976 80
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D010976 sjn
% 209.04/209.26 |- mesh__recordOriginator mesh__D010976 SMH
% 209.04/209.26 |- skos__altLabel mesh__D010976 Blood Platelet Number
% 209.04/209.26 |- skos__broader mesh__D010976smesh__D010979
% 209.04/209.26 |- skos__altLabel mesh__D010976 Platelet Number
% 209.04/209.26 |- skos__historyNote mesh__D010976 Blood Cell Count %28%1966-1979%29%
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Number, Blood Platelet
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Platelet Numbers, Blood
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Platelet Numbers
% 209.04/209.26 |- mesh__historyNote mesh__D010976 80
% 209.04/209.26 |- rdf__type mesh__D010976sskos__Concept
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Platelet Count, Blood
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Number, Platelet
% 209.04/209.26 |- mesh__dateRevised mesh__D010976 2003-07-09
% 209.04/209.26 |- skos__annotation mesh__D010976
% 209.04/209.26 usually NIM; coord with disease /blood, not /physiopathol%A%
% 209.04/209.26 |- mesh__recordMaintainer mesh__D010976 nns
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Count, Blood Platelet
% 209.04/209.26 |- skos__historyNote mesh__D010976 Blood Platelets %28%1966-1979%29%
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Counts, Blood Platelet
% 209.04/209.26 |- mesh__dateCreated mesh__D010976 1979-03-12
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Platelet Number, Blood
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010976 2004
% 209.04/209.26 |- skos__broader mesh__D010976smesh__D001772
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Blood Platelet Numbers
% 209.04/209.26 |- skos__altLabel mesh__D010976 Blood Platelet Count
% 209.04/209.26 |- skos__hiddenLabel mesh__D010976 Platelet Counts, Blood
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D029681 sjn
% 209.04/209.26 |- mesh__recordOriginator mesh__D029681 jmp
% 209.04/209.26 |- skos__hiddenLabel mesh__D029681 Proteins, Arabidopsis thaliana
% 209.04/209.26 |- mesh__dateCreated mesh__D029681 2001-07-25
% 209.04/209.26 |- skos__hiddenLabel mesh__D029681 thaliana Proteins, Arabidopsis
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D029681 2002
% 209.04/209.26 |- mesh__dateEstablished mesh__D029681 2002-01-01
% 209.04/209.26 |- mesh__historyNote mesh__D029681 2002
% 209.04/209.26 |- skos__scopeNote mesh__D029681
% 209.04/209.26 Proteins that originate from plants species belonging to the genus ARABIDOPSIS. The most intensely studied species of Arabidopsis, Arabidopsis thaliana, is commonly used in laboratory experiments.%A%
% 209.04/209.26 |- skos__historyNote mesh__D029681 Plant Proteins %28%1994-2001%29%
% 209.04/209.26 |- rdf__type mesh__D029681sskos__Concept
% 209.04/209.26 |- mesh__recordMaintainer mesh__D029681 SYSTEM
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D029681 2006
% 209.04/209.26 |- mesh__dateRevised mesh__D029681 2005-06-30
% 209.04/209.26 |- skos__related mesh__D029681smesh__D017360
% 209.04/209.26 |- skos__prefLabel mesh__D029681 Arabidopsis Proteins
% 209.04/209.26 |- skos__altLabel mesh__D029681 Thale Cress Proteins
% 209.04/209.26 |- skos__broader mesh__D029681smesh__D010940
% 209.04/209.26 |- skos__prefLabel mesh__D010178 Pancoast%27%s Syndrome
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 2000
% 209.04/209.26 |- skos__scopeNote mesh__D010178
% 209.04/209.26 Destructive lesions of the thoracic inlet with involvement of the brachial and sympathetic plexus or carcinoma of the lung apex. It is characterized by pain in the shoulder region radiating toward the axilla and scapula, sensory and motor disorders and wasting of the muscles of the hand, the Bernard-Horner syndrome, and compression of the blood vessels with edema. %28%Jablonski%27%s Dictionary of Syndromes and Eponymic Diseases, 2d ed%29%%A%
% 209.04/209.26 |- mesh__recordOriginator mesh__D010178 NLM
% 209.04/209.26 |- mesh__dateCreated mesh__D010178 1999-01-01
% 209.04/209.26 |- rdf__type mesh__D010178sskos__Concept
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 2003
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 1996
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 2001
% 209.04/209.26 |- skos__broader mesh__D010178smesh__D008175
% 209.04/209.26 |- mesh__recordMaintainer mesh__D010178 KEV
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D010178 PLS
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 2004
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 1997
% 209.04/209.26 |- skos__annotation mesh__D010178 an apicocostovertebral syndrome
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 2002
% 209.04/209.26 |- skos__hiddenLabel mesh__D010178 Syndrome, Pancoast%27%s
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 2005
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 1998
% 209.04/209.26 |- mesh__dateRevised mesh__D010178 1995-06-08
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 2006
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D010178 1999
% 209.04/209.26 |- skos__hiddenLabel mesh__D010178 Pancoast Syndrome
% 209.04/209.26 |- skos__hiddenLabel mesh__D010178 Pancoasts Syndrome
% 209.04/209.26 |- skos__hiddenLabel mesh__D004939 Esophageal Perforations
% 209.04/209.26 |- skos__broader mesh__D004939smesh__D004935
% 209.04/209.26 |- skos__annotation mesh__D004939
% 209.04/209.26 esophageal rupture does not go here: index ESOPHAGUS /inj %28%IM%29% + RUPTURE %28%NIM%29% or ESOPHAGEAL DISEASES %28%IM%29% + RUPTURE, SPONTANEOUS %28%NIM%29%%A%
% 209.04/209.26 |- rdf__type mesh__D004939sskos__Concept
% 209.04/209.26 |- mesh__recordMaintainer mesh__D004939 lkt
% 209.04/209.26 |- skos__hiddenLabel mesh__D004939 Perforation, Esophageal
% 209.04/209.26 |- mesh__dateRevised mesh__D004939 2004-07-07
% 209.04/209.26 |- mesh__recordOriginator mesh__D004939 NLM
% 209.04/209.26 |- skos__prefLabel mesh__D004939 Esophageal Perforation
% 209.04/209.26 |- skos__scopeNote mesh__D004939
% 209.04/209.26 An opening or hole in the ESOPHAGUS that is caused by TRAUMA, injury, or pathological process.%A%
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D004939 sjn
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D004939 2005
% 209.04/209.26 |- skos__broader mesh__D004939smesh__D014947
% 209.04/209.26 |- skos__hiddenLabel mesh__D004939 Perforations, Esophageal
% 209.04/209.26 |- mesh__dateCreated mesh__D004939 1999-01-01
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D004939 2006
% 209.04/209.26 |- skos__broader mesh__D015661smesh__D020563
% 209.04/209.26 |- skos__broader mesh__D015661smesh__D006092
% 209.04/209.26 |- mesh__recordMaintainer mesh__D015661 SYSTEM
% 209.04/209.26 |- mesh__dateEstablished mesh__D015661 1990-01-01
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D015661 90
% 209.04/209.26 |- mesh__recordOriginator mesh__D015661 EGC
% 209.04/209.26 |- mesh__historyNote mesh__D015661 90
% 209.04/209.26 |- mesh__dateCreated mesh__D015661 1989-07-03
% 209.04/209.26 |- skos__scopeNote mesh__D015661
% 209.04/209.26 A family of coccoid to rod-shaped nonsporeforming, gram-negative, nonmotile, facultatively anaerobic bacteria that includes the genera ACTINOBACILLUS; HAEMOPHILUS; MANNHEIMIA; and PASTEURELLA.%A%
% 209.04/209.26 |- skos__historyNote mesh__D015661 Pasteurella %28%1974-1989%29%
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D015661 sjn
% 209.04/209.26 |- skos__prefLabel mesh__D015661 Pasteurellaceae
% 209.04/209.26 |- rdf__type mesh__D015661sskos__Concept
% 209.04/209.26 |- mesh__dateRevised mesh__D015661 2005-06-30
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D015661 2006
% 209.04/209.26 |- skos__annotation mesh__D015661 infection = PASTEURELLACEAE INFECTIONS
% 209.04/209.26 |- mesh__dateCreated mesh__D009624 1978-05-22
% 209.04/209.26 |- skos__hiddenLabel mesh__D009624 Transportation Noises
% 209.04/209.26 |- mesh__dateRevised mesh__D009624 2001-07-25
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D009624 2005
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D009624 2004
% 209.04/209.26 |- mesh__recordMaintainer mesh__D009624 mdb
% 209.04/209.26 |- skos__historyNote mesh__D009624 Noise %28%1966-1978%29%
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D009624 91; was see under NOISE 1979-90
% 209.04/209.26 |- skos__hiddenLabel mesh__D009624 Noises, Transportation
% 209.04/209.26 |- rdf__type mesh__D009624sskos__Concept
% 209.04/209.26 |- skos__prefLabel mesh__D009624 Noise, Transportation
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D009624 2003
% 209.04/209.26 |- skos__annotation mesh__D009624
% 209.04/209.26 coord IM with specific mode of transport %28%AIRCRAFT; AUTOMOBILES; RAILROADS; etc.%29% %28%IM%29%; consider also HEARING LOSS, NOISE-INDUCED%A%
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D009624 sjn
% 209.04/209.26 |- mesh__recordOriginator mesh__D009624 RC
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D009624 2002
% 209.04/209.26 |- mesh__historyNote mesh__D009624
% 209.04/209.26 91%28%79%29%; was see under NOISE 1979-90
% 209.04/209.26 |- mesh__dateEstablished mesh__D009624 1991-01-01
% 209.04/209.26 |- skos__broader mesh__D009624smesh__D009622
% 209.04/209.26 |- skos__hiddenLabel mesh__D009624 Transportation Noise
% 209.04/209.26 |- skos__historyNote mesh__D009624 Aircraft %28%1966-1978%29%
% 209.04/209.26 |- skos__scopeNote mesh__D009624
% 209.04/209.26 Noise associated with transportation, particularly aircraft and automobiles.%A%
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D009624 2006
% 209.04/209.26 |- rdf__type mesh__D001641sskos__Concept
% 209.04/209.26 |- skos__prefLabel mesh__D001641 Bicuspid
% 209.04/209.26 |- skos__scopeNote mesh__D001641
% 209.04/209.26 One of the eight permanent teeth, two on either side in each jaw, between the canines %28%CUSPID%29% and the molars %28%MOLAR%29%, serving for grinding and crushing food. The upper have two cusps %28%bicuspid%29% but the lower have one to three. %28%Jablonski, Dictionary of Dentistry, 1992, p822%29%%A%
% 209.04/209.26 |- mesh__dateRevised mesh__D001641 2003-07-09
% 209.04/209.26 |- skos__hiddenLabel mesh__D001641 Premolars
% 209.04/209.26 |- skos__altLabel mesh__D001641 Premolar
% 209.04/209.26 |- mesh__recordMaintainer mesh__D001641 lkt
% 209.04/209.26 |- skos__broader mesh__D001641smesh__D014070
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D001641 2006
% 209.04/209.26 |- mesh__dateEstablished mesh__D001641 1965-01-01
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D001641 2005
% 209.04/209.26 |- skos__annotation mesh__D001641
% 209.04/209.26 between the canine %26% molar teeth; NIM when merely locational%A%
% 209.04/209.26 |- mesh__recordOriginator mesh__D001641 NLM
% 209.04/209.26 |- mesh__historyNote mesh__D001641 65
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D001641 sjn
% 209.04/209.26 |- mesh__dateCreated mesh__D001641 1999-01-01
% 209.04/209.26 |- skos__hiddenLabel mesh__D001641 Bicuspids
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D001641 65
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D001641 2004
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D014569 SJN
% 209.04/209.26 |- rdf__type mesh__D014569sskos__Concept
% 209.04/209.26 |- mesh__recordMaintainer mesh__D014569 MSR
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D014569 2001
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D014569 2004
% 209.04/209.26 |- skos__annotation mesh__D014569
% 209.04/209.26 not used for indexing; DF:UROL MALE GENITAL DIS CATALOG: do not use%A%
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D014569 2000
% 209.04/209.26 |- skos__scopeNote mesh__D014569
% 209.04/209.26 A collective term for urinary tract diseases in male and female and diseases of the male genitalia.%A%
% 209.04/209.26 |- mesh__recordOriginator mesh__D014569 SMH
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D014569 2003
% 209.04/209.26 |- skos__altLabel mesh__D014569 Urological and Male Genital Diseases
% 209.04/209.26 |- mesh__dateRevised mesh__D014569 1998-06-11
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D014569 2006
% 209.04/209.26 |- mesh__runningHead mesh__D014569
% 209.04/209.26 C12 - DISEASES-UROLOGIC AND MALE GENITAL
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D014569 2002
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D014569 1999
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D014569 2005
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D014569 98
% 209.04/209.26 |- mesh__dateEstablished mesh__D014569 1998-01-01
% 209.04/209.26 |- skos__prefLabel mesh__D014569 Urologic and Male Genital Diseases
% 209.04/209.26 |- mesh__historyNote mesh__D014569 98; use explode 1978-97
% 209.04/209.26 |- mesh__dateCreated mesh__D014569 1977-03-29
% 209.04/209.26 |- skos__related mesh__D019254smesh__D019253
% 209.04/209.26 |- skos__altLabel mesh__D019254 bcl-2 Genes
% 209.04/209.26 |- mesh__recordMaintainer mesh__D019254 nns
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 Gene, bcl-2
% 209.04/209.26 |- skos__historyNote mesh__D019254 Oncogenes %28%1984-1996%29%
% 209.04/209.26 |- skos__broader mesh__D019254smesh__D011519
% 209.04/209.26 |- mesh__dateRevised mesh__D019254 2005-06-30
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 Proto-Oncogenes, c-bcl-2
% 209.04/209.26 |- skos__scopeNote mesh__D019254
% 209.04/209.26 The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t%28%14;18%29% translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.%A%
% 209.04/209.26 |- mesh__historyNote mesh__D019254 97
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 bcl 2 Genes
% 209.04/209.26 |- skos__prefLabel mesh__D019254 Genes, bcl-2
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 c bcl 2 Proto Oncogenes
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 Gene, c-bcl-2
% 209.04/209.26 |- mesh__recordOriginator mesh__D019254 AGS
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 c-bcl-2 Proto-Oncogene
% 209.04/209.26 |- mesh__dateCreated mesh__D019254 1996-06-13
% 209.04/209.26 |- skos__altLabel mesh__D019254 c-bcl-2 Proto-Oncogenes
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 c-bcl-2 Gene
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D019254 2006
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 Genes, c-bcl-2
% 209.04/209.26 |- rdf__type mesh__D019254sskos__Concept
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D019254 97
% 209.04/209.26 |- mesh__dateEstablished mesh__D019254 1997-01-01
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 c bcl 2 Genes
% 209.04/209.26 |- skos__historyNote mesh__D019254 Proto-Oncogenes %28%1988-1996%29%
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 bcl-2 Gene
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 Proto-Oncogene, c-bcl-2
% 209.04/209.26 |- skos__hiddenLabel mesh__D019254 Genes, bcl 2
% 209.04/209.26 |- skos__annotation mesh__D019254 bcl stands for %22%B-Cell Leukemia%22%
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D019254 sjn
% 209.04/209.26 |- rdf__type mesh__D000549sskos__Concept
% 209.04/209.26 |- mesh__recordOriginator mesh__D000549 NLM
% 209.04/209.26 |- skos__broader mesh__D000549smesh__D000644
% 209.04/209.26 |- mesh__recordMaintainer mesh__D000549 ssb
% 209.04/209.26 |- mesh__dateCreated mesh__D000549 1999-01-01
% 209.04/209.26 |- skos__hiddenLabel mesh__D000549 Chloride, Ambenonium
% 209.04/209.26 |- skos__altLabel mesh__D000549
% 209.04/209.26 Sanofi Winthrop Brand of Ambenonium Chloride
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D000549 sjn
% 209.04/209.26 |- mesh__historyNote mesh__D000549
% 209.04/209.26 65; AMBESTIGMINUM was see AMBENONIUM CHLORIDE 1977-94
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D000549 2006
% 209.04/209.26 |- skos__broader mesh__D000549smesh__D050339
% 209.04/209.26 |- mesh__dateEstablished mesh__D000549 1965-01-01
% 209.04/209.26 |- mesh__dateRevised mesh__D000549 2005-06-30
% 209.04/209.26 |- skos__scopeNote mesh__D000549
% 209.04/209.26 A quaternary ammonium compound that is an inhibitor of cholinesterase activity with actions similar to those of NEOSTIGMINE, but of longer duration. Ambenonium is given by mouth in the treatment of myasthenia gravis. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1112%29%%A%
% 209.04/209.26 |- mesh__publicMeSHNote mesh__D000549
% 209.04/209.26 65; AMBESTIGMINUM was see AMBENONIUM CHLORIDE 1977-94
% 209.04/209.26 |- skos__prefLabel mesh__D000549 Ambenonium Chloride
% 209.04/209.26 |- mesh__onlineNote mesh__D000549
% 209.04/209.26 use AMBENONIUM CHLORIDE to search AMBESTIGMINUM 1977-94
% 209.04/209.26 |- mesh__activeMeSHYear mesh__D011271 2006
% 209.04/209.26 |- mesh__recordOriginator mesh__D011271 NLM
% 209.04/209.26 |- skos__annotation mesh__D011271
% 209.04/209.26 check the tags FEMALE %26% PREGNANCY; heterotopic = PREGNANCY %28%IM%29% + PREGNANCY, ECTOPIC or its specifics %28%IM%29% + site %28%NIM%29%; DF: PREGN ECTOPIC%A%
% 209.04/209.26 |- skos__hiddenLabel mesh__D011271 Ectopic Pregnancies
% 209.04/209.26 |- skos__broader mesh__D011271smesh__D011248
% 209.04/209.26 |- mesh__recordAuthorizer mesh__D011271 sjn
% 209.04/209.26 |- skos__hiddenLabel mesh__D011271 Pregnancies, Ectopic
% 209.04/209.26 |- skos__altLabel mesh__D011271 Ovarian Pregnancy
% 209.04/209.26 |- mesh__dateRevised mesh__D011271 2005-06-30
% 209.04/209.26 |- skos__scopeNote mesh__D011271
% 209.04/209.26 A potentially life-threatening condition in which the EMBRYO implants outside the cavity of the UTERUS. Most ectopic pregnancies %28%%3E%96%25%%29% occur in the FALLOPIAN TUBES, known as TUBAL PREGNANCY. They can be in other locations, such as UTERINE CERVIX; OVARY; and abdominal cavity %28%PREGNANCY, ABDOMINAL%29%.%A%
% 209.04/209.26 |- skos__prefLabel mesh__D011271 Pregnancy, Ectopic
% 209.04/209.26 |- rdf__type mesh__D011271sskos__Concept
% 209.04/209.26 |- skos__hiddenLabel mesh__D011271 Ovarian Pregnancies
% 209.04/209.26 |- mesh__recordMaintainer mesh__D011271 lkt
% 209.04/209.27 |- mesh__dateCreated mesh__D011271 1999-01-01
% 209.04/209.27 |- skos__hiddenLabel mesh__D011271 Pregnancies, Ovarian
% 209.04/209.27 |- skos__altLabel mesh__D011271 Ectopic Pregnancy
% 209.04/209.27 |- skos__altLabel mesh__D005234 Liver Steatosis
% 209.04/209.27 |- skos__broader mesh__D005234smesh__D008107
% 209.04/209.27 |- rdf__type mesh__D005234sskos__Concept
% 209.04/209.27 |- skos__scopeNote mesh__D005234
% 209.04/209.27 Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.%A%
% 209.04/209.27 |- mesh__recordMaintainer mesh__D005234 lkt
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D005234 sjn
% 209.04/209.27 |- mesh__dateCreated mesh__D005234 1999-01-01
% 209.04/209.27 |- mesh__recordOriginator mesh__D005234 NLM
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D005234 2006
% 209.04/209.27 |- mesh__dateRevised mesh__D005234 2004-07-07
% 209.04/209.27 |- skos__hiddenLabel mesh__D005234 Steatosis, Liver
% 209.04/209.27 |- skos__prefLabel mesh__D005234 Fatty Liver
% 209.04/209.27 |- skos__hiddenLabel mesh__D005234 Liver, Fatty
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D005234 2005
% 209.04/209.27 |- skos__hiddenLabel mesh__D010977 Factor 3, Platelet
% 209.04/209.27 |- skos__scopeNote mesh__D010977
% 209.04/209.27 A lipoprotein with pronounced electronegative surface charge found in association with platelet membrane and platelet granules. In the sequence of blood coagulation reactions, it is required for activation of factor VIII and for the conversion of prothrombin to thrombin.%A%
% 209.04/209.27 |- mesh__dateRevised mesh__D010977 2005-06-30
% 209.04/209.27 |- skos__altLabel mesh__D010977 PF3
% 209.04/209.27 |- rdf__type mesh__D010977sskos__Concept
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D010977
% 209.04/209.27 91; was see under BLOOD COAGULATION FACTORS 1975-90
% 209.04/209.27 |- skos__historyNote mesh__D010977 Blood Platelets %28%1974%29%
% 209.04/209.27 |- mesh__recordOriginator mesh__D010977 NLM
% 209.04/209.27 |- mesh__historyNote mesh__D010977
% 209.04/209.27 91%28%75%29%; was see under BLOOD COAGULATION FACTORS 1975-90
% 209.04/209.27 |- skos__prefLabel mesh__D010977 Platelet Factor 3
% 209.04/209.27 |- mesh__recordMaintainer mesh__D010977 ssb
% 209.04/209.27 |- skos__historyNote mesh__D010977 Lipoproteins %28%1974%29%
% 209.04/209.27 |- skos__altLabel mesh__D010977 PF 3
% 209.04/209.27 |- mesh__dateCreated mesh__D010977 1974-11-19
% 209.04/209.27 |- skos__broader mesh__D010977smesh__D008074
% 209.04/209.27 |- skos__historyNote mesh__D010977 Blood Coagulation Factors %28%1974%29%
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D010977 2006
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D010977 sjn
% 209.04/209.27 |- mesh__dateEstablished mesh__D010977 1991-01-01
% 209.04/209.27 |- skos__annotation mesh__D010977 a coagulant
% 209.04/209.27 |- skos__broader mesh__D010977smesh__D001779
% 209.04/209.27 |- skos__prefLabel mesh__D029682 Amsinckia
% 209.04/209.27 |- mesh__dateCreated mesh__D029682 2001-07-25
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D029682 2002
% 209.04/209.27 |- skos__broader mesh__D029682smesh__D028082
% 209.04/209.27 |- mesh__dateRevised mesh__D029682 2002-07-02
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D029682 2005
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D029682 sjn
% 209.04/209.27 |- rdf__type mesh__D029682sskos__Concept
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D029682 2006
% 209.04/209.27 |- mesh__recordMaintainer mesh__D029682 ssb
% 209.04/209.27 |- skos__scopeNote mesh__D029682
% 209.04/209.27 A plant genus of the family BORAGINACEAE. Members contain PYRROLIZIDINE ALKALOIDS. The common name of burweed is also used for Triumfetta %28%TILIACEAE%29%.%A%
% 209.04/209.27 |- skos__annotation mesh__D029682
% 209.04/209.27 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.04/209.27 |- mesh__historyNote mesh__D029682 2002
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D029682 2003
% 209.04/209.27 |- mesh__dateEstablished mesh__D029682 2002-01-01
% 209.04/209.27 |- mesh__recordOriginator mesh__D029682 ssb
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D029682 2004
% 209.04/209.27 |- mesh__recordOriginator mesh__D010179 NLM
% 209.04/209.27 |- mesh__dateCreated mesh__D010179 1999-01-01
% 209.04/209.27 |- mesh__recordMaintainer mesh__D010179 sjn
% 209.04/209.27 |- rdf__type mesh__D010179sskos__Concept
% 209.04/209.27 |- skos__annotation mesh__D010179
% 209.04/209.27 /enzymol: consider also PANCREATIN for %22%pancreatic enzymes%22% particularly in ther; /surg: consider also PANCREATECTOMY; note that ISLETS OF LANGERHANS TRANSPLANTATION is also available; inflammation = PANCREATITIS; pancreatic A, B, C cells: index under ISLETS OF LANGERHANS; D cells = SOMATOSTATIN-SECRETING CELLS%A%
% 209.04/209.27 |- mesh__dateRevised mesh__D010179 2005-07-01
% 209.04/209.27 |- skos__prefLabel mesh__D010179 Pancreas
% 209.04/209.27 |- skos__scopeNote mesh__D010179
% 209.04/209.27 A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion %28%EXOCRINE PANCREAS%29% is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.%A%
% 209.04/209.27 |- skos__related mesh__D010179smesh__D010180
% 209.04/209.27 |- skos__broader mesh__D010179smesh__D004064
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D010179 sjn
% 209.04/209.27 |- skos__related mesh__D010179smesh__D010193
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D010179 2006
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D015662 90
% 209.04/209.27 |- skos__prefLabel mesh__D015662 Trimethoprim-Sulfamethoxazole Combination
% 209.04/209.27 |- skos__hiddenLabel mesh__D015662
% 209.04/209.27 Trimethoprim Sulfamethoxazole Combination
% 209.04/209.27 |- skos__altLabel mesh__D015662 Eslectin
% 209.04/209.27 |- skos__hiddenLabel mesh__D015662 Biseptol480
% 209.04/209.27 |- skos__historyNote mesh__D015662 Sulfamethoxazole %28%1966-1989%29%
% 209.04/209.27 |- skos__altLabel mesh__D015662 TMP-SMX
% 209.04/209.27 |- skos__altLabel mesh__D015662 Centrin
% 209.04/209.27 |- skos__annotation mesh__D015662 DF: TMP SMX
% 209.04/209.27 |- skos__altLabel mesh__D015662 Cotrimoxazole
% 209.04/209.27 |- mesh__dateRevised mesh__D015662 2004-07-07
% 209.04/209.27 |- rdf__type mesh__D015662sskos__Concept
% 209.04/209.27 |- skos__altLabel mesh__D015662 TMP SMX
% 209.04/209.27 |- mesh__dateCreated mesh__D015662 1989-09-01
% 209.04/209.27 |- skos__hiddenLabel mesh__D015662
% 209.04/209.27 Sulfamethoxazole Trimethoprim Combination
% 209.04/209.27 |- skos__broader mesh__D015662smesh__D013420
% 209.04/209.27 |- skos__hiddenLabel mesh__D015662 Trimethoprim Sulfamethoxazole
% 209.04/209.27 |- skos__altLabel mesh__D015662 Sulfamethoxazole-Trimethoprim Combination
% 209.04/209.27 |- mesh__historyNote mesh__D015662 90
% 209.04/209.27 |- mesh__recordMaintainer mesh__D015662 ssb
% 209.04/209.27 |- skos__scopeNote mesh__D015662
% 209.04/209.27 This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.%A%
% 209.04/209.27 |- skos__hiddenLabel mesh__D015662 Biseptol 480
% 209.04/209.27 |- skos__altLabel mesh__D015662 Insozalin
% 209.04/209.27 |- skos__historyNote mesh__D015662 Drug Combinations %28%1971-1989%29%
% 209.04/209.27 |- skos__altLabel mesh__D015662 Trimedin
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D015662 2006
% 209.04/209.27 |- skos__altLabel mesh__D015662 Centran
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D015662 sjn
% 209.04/209.27 |- skos__altLabel mesh__D015662 Trimethoprim-Sulfamethoxazole
% 209.04/209.27 |- mesh__recordOriginator mesh__D015662 RLS
% 209.04/209.27 |- skos__broader mesh__D015662smesh__D014295
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D015662 2005
% 209.04/209.27 |- skos__historyNote mesh__D015662 Trimethoprim %28%1972-1989%29%
% 209.04/209.27 |- mesh__dateEstablished mesh__D015662 1990-01-01
% 209.04/209.27 |- skos__altLabel mesh__D015662 Co-Trimoxazole
% 209.04/209.27 |- skos__altLabel mesh__D015662 Trimezole
% 209.04/209.27 |- rdf__type mesh__D009625sskos__Concept
% 209.04/209.27 |- mesh__dateRevised mesh__D009625 1996-06-10
% 209.04/209.27 |- skos__broader mesh__D009625smesh__D009059
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 2003
% 209.04/209.27 |- skos__hiddenLabel mesh__D009625 Gangrenous Stomatitis
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 2001
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 1999
% 209.04/209.27 |- skos__hiddenLabel mesh__D009625 Gangrenous Stomatitides
% 209.04/209.27 |- skos__prefLabel mesh__D009625 Noma
% 209.04/209.27 |- mesh__recordOriginator mesh__D009625 NLM
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D009625 PLS
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 2000
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 1997
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 1998
% 209.04/209.27 |- skos__scopeNote mesh__D009625
% 209.04/209.27 A severe gangrenous process occurring predominantly in debilitated and malnourished children, especially in underdeveloped countries. It typically begins as a small vesicle or ulcer on the gingiva that rapidly becomes necrotic and spreads to produce extensive destruction of the buccal and labial mucosa and tissues of the face, which may result in severe disfigurement and even death. Various bacteria have been implicated in the etiology. %28%Dorland, 27th ed%29%%A%
% 209.04/209.27 |- skos__hiddenLabel mesh__D009625 Nomas
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 2006
% 209.04/209.27 |- skos__hiddenLabel mesh__D009625 Stomatitides, Gangrenous
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 2002
% 209.04/209.27 |- skos__altLabel mesh__D009625 Stomatitis, Gangrenous
% 209.04/209.27 |- mesh__dateCreated mesh__D009625 1999-01-01
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 2004
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009625 2005
% 209.04/209.27 |- skos__altLabel mesh__D009625 Cancrum Oris
% 209.04/209.27 |- mesh__recordMaintainer mesh__D009625 TGC
% 209.04/209.27 |- skos__annotation mesh__D009625
% 209.04/209.27 severe gangrene of gingiva often spreading to face
% 209.04/209.27 |- mesh__dateRevised mesh__D001642 1997-06-20
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001642 2006
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001642 2002
% 209.04/209.27 |- mesh__dateEstablished mesh__D001642 1990-01-01
% 209.04/209.27 |- mesh__recordMaintainer mesh__D001642 TPW
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001642 2005
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001642 1999
% 209.04/209.27 |- skos__historyNote mesh__D001642 Exercise Test %28%1966-1982%29%
% 209.04/209.27 |- skos__historyNote mesh__D001642 Exertion %28%1966-1982%29%
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001642 2001
% 209.04/209.27 |- skos__scopeNote mesh__D001642
% 209.04/209.27 The use of a bicycle for transportation or recreation. It does not include the use of a bicycle in studying the body%27%s response to physical exertion %28%BICYCLE ERGOMETRY TEST see EXERCISE TEST%29%.%A%
% 209.04/209.27 |- skos__annotation mesh__D001642
% 209.04/209.27 for transport or recreation: not for test of phys exertion %28% = probably BICYCLE ERGOMETRY TEST see EXERCISE TEST%29%; /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%
% 209.04/209.27 |- mesh__dateCreated mesh__D001642 1982-04-28
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001642 2004
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001642 1998
% 209.04/209.27 |- rdf__type mesh__D001642sskos__Concept
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001642 2000
% 209.04/209.27 |- skos__prefLabel mesh__D001642 Bicycling
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D001642 SJN
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001642 2003
% 209.04/209.27 |- mesh__historyNote mesh__D001642
% 209.04/209.27 90%28%83%29%; was see under SPORTS 1983-89
% 209.04/209.27 |- skos__broader mesh__D001642smesh__D013177
% 209.04/209.27 |- mesh__recordOriginator mesh__D001642 EC
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D001642 90; was see under SPORTS 1983-89
% 209.04/209.27 |- mesh__recordMaintainer mesh__D019255 AKE
% 209.04/209.27 |- skos__scopeNote mesh__D019255
% 209.04/209.27 A flavoprotein enzyme that catalyzes the univalent reduction of OXYGEN using NADPH as an electron donor to create SUPEROXIDE ANION. The enzyme is dependent on a variety of CYTOCHROMES. Defects in the production of superoxide ions by enzymes such as NADPH oxidase result in GRANULOMATOUS DISEASE, CHRONIC.%A%
% 209.04/209.27 |- skos__broader mesh__D019255smesh__D009247
% 209.04/209.27 |- mesh__dateEstablished mesh__D019255 1997-01-01
% 209.04/209.27 |- skos__altLabel mesh__D019255 NAD%28%P%29%H oxidase
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D019255 sjn
% 209.04/209.27 |- mesh__dateCreated mesh__D019255 1996-06-10
% 209.04/209.27 |- skos__hiddenLabel mesh__D019255 Oxidase, NADPH
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D019255 2006
% 209.04/209.27 |- rdf__type mesh__D019255sskos__Concept
% 209.04/209.27 |- skos__broader mesh__D019255smesh__D005420
% 209.04/209.27 |- skos__historyNote mesh__D019255 Oxidoreductases %28%1972-1978%29%
% 209.04/209.27 |- skos__historyNote mesh__D019255 NADP %28%1972-1980%29%
% 209.04/209.27 |- mesh__dateRevised mesh__D019255 2005-06-30
% 209.04/209.27 |- skos__historyNote mesh__D019255
% 209.04/209.27 NADH, NADPH Oxidoreductases %28%1979-1996%29%
% 209.04/209.27 |- skos__prefLabel mesh__D019255 NADPH Oxidase
% 209.04/209.27 |- mesh__historyNote mesh__D019255 1997
% 209.04/209.27 |- mesh__recordOriginator mesh__D019255 TPW
% 209.04/209.27 |- skos__related mesh__D019255smesh__D006105
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D019255
% 209.04/209.27 1997; NAD%28%P%29%H OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 2000-2005; NADPH OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 1979-1996, NADP 1972-1980 %26% OXIDOREDUCTASES 1972-1978;%A%
% 209.04/209.27 |- skos__prefLabel mesh__D011272 Pregnancy, Multiple
% 209.04/209.27 |- skos__broader mesh__D011272smesh__D011247
% 209.04/209.27 |- skos__annotation mesh__D011272
% 209.04/209.27 human %26% animal; this is the mother: TWINS; TRIPLETS; etc. is the offspring; specify TWINS, etc. NIM if pertinent; in ref to animals, do not use PREGNANCY, MULTIPLE for animals naturally having litters; consider LITTER SIZE; not for %22%heterotopic pregnancy%22%: see note at PREGNANCY, ECTOPIC; check tags FEMALE %26% PREGNANCY; Manual 28.16.4, 34.14; DF: PREGN MULTIPLE%A%
% 209.04/209.27 |- mesh__recordOriginator mesh__D011272 NLM
% 209.04/209.27 |- rdf__type mesh__D011272sskos__Concept
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D011272 sjn
% 209.04/209.27 |- skos__related mesh__D011272smesh__D018607
% 209.04/209.27 |- mesh__dateCreated mesh__D011272 1999-01-01
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D011272 2005
% 209.04/209.27 |- skos__scopeNote mesh__D011272
% 209.04/209.27 The condition of bearing two or more FETUSES simultaneously. %28%Stedman, 25th ed%29%%A%
% 209.04/209.27 |- skos__hiddenLabel mesh__D011272 Pregnancies, Multiple
% 209.04/209.27 |- skos__hiddenLabel mesh__D011272 Multiple Pregnancies
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D011272 2006
% 209.04/209.27 |- mesh__dateRevised mesh__D011272 2004-07-07
% 209.04/209.27 |- skos__altLabel mesh__D011272 Multiple Pregnancy
% 209.04/209.27 |- mesh__recordMaintainer mesh__D011272 lkt
% 209.04/209.27 |- skos__broader mesh__D005235smesh__D008108
% 209.04/209.27 |- rdf__type mesh__D005235sskos__Concept
% 209.04/209.27 |- skos__prefLabel mesh__D005235 Fatty Liver, Alcoholic
% 209.04/209.27 |- mesh__dateCreated mesh__D005235 1977-04-22
% 209.04/209.27 |- mesh__dateEstablished mesh__D005235 1978-01-01
% 209.04/209.27 |- mesh__recordOriginator mesh__D005235 SMH
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D005235 2006
% 209.04/209.27 |- skos__broader mesh__D005235smesh__D005234
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D005235 78
% 209.04/209.27 |- mesh__historyNote mesh__D005235 78
% 209.04/209.27 |- mesh__dateRevised mesh__D005235 2004-07-07
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D005235 2005
% 209.04/209.27 |- skos__historyNote mesh__D005235 Fatty Liver %28%1966-1977%29%
% 209.04/209.27 |- skos__historyNote mesh__D005235 Alcoholism %28%1966-1977%29%
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D005235 sjn
% 209.04/209.27 |- mesh__recordMaintainer mesh__D005235 lkt
% 209.04/209.27 |- skos__altLabel mesh__D005235 Alcoholic Fatty Liver
% 209.04/209.27 |- skos__scopeNote mesh__D005235
% 209.04/209.27 Lipid infiltration of the hepatic parenchymal cells that is due to ALCOHOL ABUSE. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of TRIGLYCERIDES accumulated.%A%
% 209.04/209.27 |- skos__broader mesh__D005459Q000506smesh__D005459
% 209.04/209.27 |- mesh__preferredCombination mesh__D005459Q000506smesh__D005458
% 209.04/209.27 |- rdf__type mesh__D005459Q000506smesh__CompoundConcept
% 209.04/209.27 |- skos__historyNote mesh__D010978 Glycoproteins %28%1974-1975%29%
% 209.04/209.27 |- skos__hiddenLabel mesh__D010978 gamma Thromboglobulin
% 209.04/209.27 |- skos__altLabel mesh__D010978 gamma-Thromboglobulin
% 209.04/209.27 |- skos__hiddenLabel mesh__D010978 Factor 4, Platelet
% 209.04/209.27 |- skos__altLabel mesh__D010978 PF 4
% 209.04/209.27 |- skos__broader mesh__D010978smesh__D001779
% 209.04/209.27 |- skos__historyNote mesh__D010978
% 209.04/209.27 Blood Coagulation Factors %28%1973-1975%29%
% 209.04/209.27 |- mesh__dateRevised mesh__D010978 2005-06-30
% 209.04/209.27 |- skos__prefLabel mesh__D010978 Platelet Factor 4
% 209.04/209.27 |- skos__historyNote mesh__D010978 Blood Platelets %28%1974-1975%29%
% 209.04/209.27 |- skos__altLabel mesh__D010978 PF4
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D010978 2006
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D010978
% 209.04/209.27 84; was see under BLOOD COAGULATION FACTORS 1976-83
% 209.04/209.27 |- skos__altLabel mesh__D010978 Antiheparin Factor
% 209.04/209.27 |- mesh__dateCreated mesh__D010978 1975-07-25
% 209.04/209.27 |- skos__broader mesh__D010978smesh__D018925
% 209.04/209.27 |- mesh__recordMaintainer mesh__D010978 ssb
% 209.04/209.27 |- skos__broader mesh__D010978smesh__D011509
% 209.04/209.27 |- mesh__dateEstablished mesh__D010978 1984-01-01
% 209.04/209.27 |- skos__hiddenLabel mesh__D010978 Protein, Heparin Neutralizing
% 209.04/209.27 |- mesh__recordOriginator mesh__D010978 RLS
% 209.04/209.27 |- skos__scopeNote mesh__D010978
% 209.04/209.27 A high-molecular-weight proteoglycan-platelet factor complex which is released from blood platelets by thrombin. It acts as a mediator in the heparin-neutralizing capacity of the blood and plays a role in platelet aggregation. At high ionic strength %28%I=0.75%29%, the complex dissociates into the active component %28%molecular weight 29,000%29% and the proteoglycan carrier %28%chondroitin 4-sulfate, molecular weight 350,000%29%. The molecule exists in the form of a dimer consisting of 8 moles of platelet factor 4 and 2 moles of proteoglycan.%A%
% 209.04/209.27 |- skos__altLabel mesh__D010978 Heparin Neutralizing Protein
% 209.04/209.27 |- mesh__historyNote mesh__D010978
% 209.04/209.27 84%28%76%29%; was see under BLOOD COAGULATION FACTORS 1976-83
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D010978 sjn
% 209.04/209.27 |- rdf__type mesh__D010978sskos__Concept
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D029683 2002
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D029683 2005
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D029683 2002
% 209.04/209.27 |- rdf__type mesh__D029683sskos__Concept
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D029683 2006
% 209.04/209.27 |- skos__prefLabel mesh__D029683 Borago
% 209.04/209.27 |- mesh__dateCreated mesh__D029683 2001-07-25
% 209.04/209.27 |- skos__broader mesh__D029683smesh__D028082
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D029683 2003
% 209.04/209.27 |- mesh__dateEstablished mesh__D029683 2002-01-01
% 209.04/209.27 |- skos__altLabel mesh__D029683 Borage
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D029683 2004
% 209.04/209.27 |- skos__annotation mesh__D029683
% 209.04/209.27 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.04/209.27 |- skos__scopeNote mesh__D029683
% 209.04/209.27 A plant genus of the family BORAGINACEAE.
% 209.04/209.27 |- mesh__historyNote mesh__D029683 2002
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D015663 sjn
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Osteoporosis, Post Menopausal
% 209.04/209.27 |- skos__altLabel mesh__D015663 Postmenopausal Bone Loss
% 209.04/209.27 |- mesh__historyNote mesh__D015663
% 209.04/209.27 90; BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; %26% POSTMENOPAUSAL BONE LOSS were see OSTEOPOROSIS 1987-89%A%
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D015663
% 209.04/209.27 90; BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; %26% POSTMENOPAUSAL BONE LOSS were see OSTEOPOROSIS 1987-89%A%
% 209.04/209.27 |- skos__historyNote mesh__D015663 Osteoporosis %28%1966-1989%29%
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Osteoporoses, Post-Menopausal
% 209.04/209.27 |- skos__altLabel mesh__D015663 Postmenopausal Osteoporosis
% 209.04/209.27 |- skos__broader mesh__D015663smesh__D010024
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Perimenopausal Bone Losses
% 209.04/209.27 |- mesh__recordMaintainer mesh__D015663 sjn
% 209.04/209.27 |- rdf__type mesh__D015663sskos__Concept
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Bone Losses, Postmenopausal
% 209.04/209.27 |- skos__altLabel mesh__D015663 Osteoporosis, Post-Menopausal
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D015663 2005
% 209.04/209.27 |- skos__scopeNote mesh__D015663
% 209.04/209.27 Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.%A%
% 209.04/209.27 |- skos__altLabel mesh__D015663 Bone Loss, Perimenopausal
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Postmenopausal Bone Losses
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Post-Menopausal Osteoporoses
% 209.04/209.27 |- skos__annotation mesh__D015663
% 209.04/209.27 in females; don%27%t forget also check tags HUMANS + FEMALE; corresponding age-related osteoporosis in men goes under OSTEOPOROSIS%A%
% 209.04/209.27 |- mesh__onlineNote mesh__D015663
% 209.04/209.27 use OSTEOPOROSIS to search BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; %26% POSTMENOPAUSAL BONE LOSS 1987-89%A%
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Bone Losses, Perimenopausal
% 209.04/209.27 |- skos__altLabel mesh__D015663 Bone Loss, Postmenopausal
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D015663 2006
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Postmenopausal Osteoporoses
% 209.04/209.27 |- mesh__dateRevised mesh__D015663 2004-07-13
% 209.04/209.27 |- mesh__dateCreated mesh__D015663 1989-05-25
% 209.04/209.27 |- mesh__dateEstablished mesh__D015663 1990-01-01
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Post-Menopausal Osteoporosis
% 209.04/209.27 |- skos__altLabel mesh__D015663 Perimenopausal Bone Loss
% 209.04/209.27 |- skos__historyNote mesh__D015663 Menopause %28%1966-1989%29%
% 209.04/209.27 |- skos__hiddenLabel mesh__D015663 Osteoporoses, Postmenopausal
% 209.04/209.27 |- skos__prefLabel mesh__D015663 Osteoporosis, Postmenopausal
% 209.04/209.27 |- mesh__recordOriginator mesh__D015663 AGS
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D009626 sjn
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009626 2002
% 209.04/209.27 |- mesh__recordMaintainer mesh__D009626 kle
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D009626
% 209.04/209.27 99; was TERMINOLOGY see NOMENCLATURE 1966-98
% 209.04/209.27 |- skos__hiddenLabel mesh__D009626 Terminologies
% 209.04/209.27 |- skos__broader mesh__D009626smesh__D008037
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009626 2006
% 209.04/209.27 |- mesh__historyNote mesh__D009626 99%28%66%29%
% 209.04/209.27 |- skos__annotation mesh__D009626
% 209.04/209.27 IM; no qualif; Manual 33.15; %22%medical nomenclature%22%: do not coord with MEDICINE%A%
% 209.04/209.27 |- mesh__dateCreated mesh__D009626 1999-01-01
% 209.04/209.27 |- skos__hiddenLabel mesh__D009626 Etymologies
% 209.04/209.27 |- mesh__dateRevised mesh__D009626 1999-11-03
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009626 2004
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009626 2005
% 209.04/209.27 |- skos__scopeNote mesh__D009626
% 209.04/209.27 The terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.%A%
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009626 2001
% 209.04/209.27 |- rdf__type mesh__D009626sskos__Concept
% 209.04/209.27 |- skos__prefLabel mesh__D009626 Terminology
% 209.04/209.27 |- skos__hiddenLabel mesh__D009626 Nomenclatures
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009626 2003
% 209.04/209.27 |- mesh__recordOriginator mesh__D009626 NLM
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D009626 2000
% 209.04/209.27 |- mesh__recordOriginator mesh__D001643 NLM
% 209.04/209.27 |- mesh__onlineNote mesh__D001643 search BRIDGED COMPOUNDS 1966-74
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D001643 PLS
% 209.04/209.27 |- mesh__recordMaintainer mesh__D001643 JRT
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 2002
% 209.04/209.27 |- mesh__dateEstablished mesh__D001643 1991-01-01
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 2006
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D001643
% 209.04/209.27 91; was see under BRIDGED COMPOUNDS 1975-90
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 1999
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 2001
% 209.04/209.27 |- skos__broader mesh__D001643smesh__D001952
% 209.04/209.27 |- mesh__dateCreated mesh__D001643 1999-01-01
% 209.04/209.27 |- skos__prefLabel mesh__D001643 Bicyclo Compounds
% 209.04/209.27 |- rdf__type mesh__D001643sskos__Concept
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 2005
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 1998
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 2000
% 209.04/209.27 |- mesh__dateRevised mesh__D001643 1995-06-08
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 2004
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 1997
% 209.04/209.27 |- skos__hiddenLabel mesh__D001643 Compounds, Bicyclo
% 209.04/209.27 |- skos__annotation mesh__D001643 DF: BICYCLO CPDS
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 2003
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D001643 1996
% 209.04/209.27 |- mesh__historyNote mesh__D001643
% 209.04/209.27 91%28%75%29%; was see under BRIDGED COMPOUNDS 1975-90
% 209.04/209.27 |- skos__altLabel mesh__D019256 Cadmium Dichloride
% 209.04/209.27 |- skos__historyNote mesh__D019256 Cadmium %28%1980-1996%29%
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D019256 2000
% 209.04/209.27 |- skos__scopeNote mesh__D019256
% 209.04/209.27 A cadmium halide in the form of colorless crystals, soluble in water, methanol, and ethanol. It is used in photography, in dyeing, and calico printing, and as a solution to precipitate sulfides. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D019256 2005
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D019256 2001
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D019256 2006
% 209.04/209.27 |- rdf__type mesh__D019256sskos__Concept
% 209.04/209.27 |- mesh__dateEstablished mesh__D019256 1997-01-01
% 209.04/209.27 |- mesh__publicMeSHNote mesh__D019256
% 209.04/209.27 97; CADMIUM CHLORIDE was indexed under CADMIUM %26% CHLORIDES 1980-96%A%
% 209.04/209.27 |- skos__broader mesh__D019256smesh__D019187
% 209.04/209.27 |- mesh__recordMaintainer mesh__D019256 adp
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D019256 2002
% 209.04/209.27 |- skos__altLabel mesh__D019256 CdCl2
% 209.04/209.27 |- skos__broader mesh__D019256smesh__D002712
% 209.04/209.27 |- skos__historyNote mesh__D019256 Chlorides %28%1980-1996%29%
% 209.04/209.27 |- mesh__recordAuthorizer mesh__D019256 sjn
% 209.04/209.27 |- mesh__dateCreated mesh__D019256 1996-06-10
% 209.04/209.27 |- mesh__historyNote mesh__D019256
% 209.04/209.27 97; was CADMIUM CHLORIDE %28%NM%29% 1980-96
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D019256 2003
% 209.04/209.27 |- skos__prefLabel mesh__D019256 Cadmium Chloride
% 209.04/209.27 |- skos__hiddenLabel mesh__D019256 Chloride, Cadmium
% 209.04/209.27 |- skos__hiddenLabel mesh__D019256 Dichloride, Cadmium
% 209.04/209.27 |- mesh__dateRevised mesh__D019256 1999-11-03
% 209.04/209.27 |- mesh__activeMeSHYear mesh__D019256 2004
% 209.04/209.27 |- mesh__recordOriginator mesh__D019256 TPW
% 209.04/209.27 |- mesh__onlineNote mesh__D019256
% 209.04/209.27 use CADMIUM CHLORIDE %28%NM%29% to search CADMIUM CHLORIDE 1980-96%A%
% 209.04/209.27 |- skos__annotation mesh__D011273
% 209.04/209.27 check tags FEMALE %26% PREGNANCY; DF: PREGN PROLONGED
% 209.04/209.28 |- skos__hiddenLabel mesh__D011273 Pregnancies, Prolonged
% 209.04/209.28 |- skos__hiddenLabel mesh__D011273 Prolonged Pregnancies
% 209.04/209.28 |- mesh__recordMaintainer mesh__D011273 lkt
% 209.04/209.28 |- skos__altLabel mesh__D011273 Prolonged Pregnancy
% 209.04/209.28 |- mesh__dateCreated mesh__D011273 1999-01-01
% 209.04/209.28 |- skos__scopeNote mesh__D011273
% 209.04/209.28 A term used to describe pregnancies that exceed the upper limit of a normal gestational period. In humans, a prolonged pregnancy is defined as one that extends beyond 42 weeks %28%294 days%29% after the first day of the last menstrual period %28%MENSTRUATION%29%, or birth with gestational age of 41 weeks or more.%A%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D011273 2006
% 209.04/209.28 |- mesh__recordOriginator mesh__D011273 NLM
% 209.04/209.28 |- skos__broader mesh__D011273smesh__D011248
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D011273 sjn
% 209.04/209.28 |- rdf__type mesh__D011273sskos__Concept
% 209.04/209.28 |- mesh__dateRevised mesh__D011273 2005-06-30
% 209.04/209.28 |- skos__prefLabel mesh__D011273 Pregnancy, Prolonged
% 209.04/209.28 |- skos__broader mesh__D005236smesh__D005517
% 209.04/209.28 |- mesh__dateCreated mesh__D005236 1999-01-01
% 209.04/209.28 |- skos__broader mesh__D005236smesh__D010939
% 209.04/209.28 |- rdf__type mesh__D005236sskos__Concept
% 209.04/209.28 |- skos__annotation mesh__D005236
% 209.04/209.28 a hemolytic anemia caused by fava bean or its pollen
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D005236 sjn
% 209.04/209.28 |- skos__hiddenLabel mesh__D005236 Favisms
% 209.04/209.28 |- mesh__recordMaintainer mesh__D005236 nns
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D005236 2005
% 209.04/209.28 |- mesh__recordOriginator mesh__D005236 NLM
% 209.04/209.28 |- skos__broader mesh__D005236smesh__D005955
% 209.04/209.28 |- mesh__dateRevised mesh__D005236 2001-07-25
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D005236 2006
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D005236 2003
% 209.04/209.28 |- skos__scopeNote mesh__D005236
% 209.04/209.28 Hemolytic anemia due to the ingestion of fava beans or after inhalation of pollen from the Vicia fava plant by persons with glucose-6-phosphate dehydrogenase deficient erythrocytes.%A%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D005236 2004
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D005236 2002
% 209.04/209.28 |- skos__prefLabel mesh__D005236 Favism
% 209.04/209.28 |- skos__broader mesh__D005236smesh__D000743
% 209.04/209.28 |- skos__hiddenLabel mesh__D010979 Function Test, Platelet
% 209.04/209.28 |- rdf__type mesh__D010979sskos__Concept
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D010979 1999
% 209.04/209.28 |- skos__hiddenLabel mesh__D010979 Platelet Function Test
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D010979 2003
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D010979 SJN
% 209.04/209.28 |- skos__hiddenLabel mesh__D010979 Tests, Platelet Function
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D010979 2002
% 209.04/209.28 |- skos__prefLabel mesh__D010979 Platelet Function Tests
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D010979 2005
% 209.04/209.28 |- mesh__recordOriginator mesh__D010979 SMH
% 209.04/209.28 |- skos__hiddenLabel mesh__D010979 Function Tests, Platelet
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D010979 2004
% 209.04/209.28 |- skos__annotation mesh__D010979 NIM
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D010979 2006
% 209.04/209.28 |- mesh__historyNote mesh__D010979 80
% 209.04/209.28 |- skos__broader mesh__D010979smesh__D006403
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D010979 2000
% 209.04/209.28 |- mesh__dateEstablished mesh__D010979 1980-01-01
% 209.04/209.28 |- skos__historyNote mesh__D010979 Platelet Aggregation %28%1975-1979%29%
% 209.04/209.28 |- skos__historyNote mesh__D010979 Platelet Adhesiveness %28%1969-1979%29%
% 209.04/209.28 |- skos__historyNote mesh__D010979 Blood Platelets %28%1966-1979%29%
% 209.04/209.28 |- skos__hiddenLabel mesh__D010979 Test, Platelet Function
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D010979 2001
% 209.04/209.28 |- mesh__dateRevised mesh__D010979 1997-06-20
% 209.04/209.28 |- mesh__dateCreated mesh__D010979 1979-03-07
% 209.04/209.28 |- mesh__recordMaintainer mesh__D010979 PXP
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D010979 1998
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D010979 80
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029684 2006
% 209.04/209.28 |- skos__scopeNote mesh__D029684
% 209.04/209.28 A plant genus of the family BORAGINACEAE. Members contain lithospermans and lithospermic acid.%A%
% 209.04/209.28 |- skos__annotation mesh__D029684
% 209.04/209.28 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D029684 sjn
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029684 2003
% 209.04/209.28 |- mesh__recordMaintainer mesh__D029684 ssb
% 209.04/209.28 |- skos__altLabel mesh__D029684 Gromwell
% 209.04/209.28 |- skos__altLabel mesh__D029684 Lithospermi
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029684 2004
% 209.04/209.28 |- mesh__historyNote mesh__D029684 2002
% 209.04/209.28 |- mesh__dateEstablished mesh__D029684 2002-01-01
% 209.04/209.28 |- mesh__recordOriginator mesh__D029684 ssb
% 209.04/209.28 |- skos__prefLabel mesh__D029684 Lithospermum
% 209.04/209.28 |- skos__broader mesh__D029684smesh__D028082
% 209.04/209.28 |- mesh__dateRevised mesh__D029684 2002-07-03
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D029684 2002
% 209.04/209.28 |- mesh__dateCreated mesh__D029684 2001-07-25
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029684 2005
% 209.04/209.28 |- skos__altLabel mesh__D029684 Puccoon
% 209.04/209.28 |- rdf__type mesh__D029684sskos__Concept
% 209.04/209.28 |- skos__altLabel mesh__D009627 Linamiphen
% 209.04/209.28 |- skos__altLabel mesh__D009627 Nomifensine Maleate %28%1:1%29%
% 209.04/209.28 |- skos__scopeNote mesh__D009627
% 209.04/209.28 An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p266%29%%A%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D009627 2006
% 209.04/209.28 |- skos__hiddenLabel mesh__D009627 Hoe 984
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D009627 sjn
% 209.04/209.28 |- skos__historyNote mesh__D009627 Isoquinolines %28%1969-1977%29%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D009627 2004
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D009627
% 209.04/209.28 86; was see under ISOQUINOLINES 1978-85
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D009627 2005
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D009627 2002
% 209.04/209.28 |- rdf__type mesh__D009627sskos__Concept
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D009627 2003
% 209.04/209.28 |- skos__hiddenLabel mesh__D009627 Maleate, Nomifensine
% 209.04/209.28 |- mesh__dateCreated mesh__D009627 1977-04-22
% 209.04/209.28 |- skos__historyNote mesh__D009627 Quinolines %28%1966-1968%29%
% 209.04/209.28 |- skos__altLabel mesh__D009627 Nomifensin
% 209.04/209.28 |- skos__hiddenLabel mesh__D009627 Hoe984
% 209.04/209.28 |- mesh__recordOriginator mesh__D009627 SH
% 209.04/209.28 |- mesh__historyNote mesh__D009627
% 209.04/209.28 86%28%78%29%; was see under ISOQUINOLINES 1978-85
% 209.04/209.28 |- skos__prefLabel mesh__D009627 Nomifensine
% 209.04/209.28 |- mesh__recordMaintainer mesh__D009627 ssb
% 209.04/209.28 |- mesh__dateRevised mesh__D009627 2001-07-25
% 209.04/209.28 |- skos__broader mesh__D009627smesh__D007546
% 209.04/209.28 |- mesh__dateEstablished mesh__D009627 1986-01-01
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001644 2006
% 209.04/209.28 |- mesh__historyNote mesh__D001644 84
% 209.04/209.28 |- rdf__type mesh__D001644sskos__Concept
% 209.04/209.28 |- mesh__dateEstablished mesh__D001644 1984-01-01
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D001644 sjn
% 209.04/209.28 |- skos__historyNote mesh__D001644 Actinomycetaceae %28%1975-1983%29%
% 209.04/209.28 |- skos__scopeNote mesh__D001644
% 209.04/209.28 A rod-shaped, gram-positive, non-acid-fast, non-spore-forming, non-motile bacterium that is a genus of the family Bifidobacteriaceae, order Bifidobacteriales, class ACTINOBACTERIA. It inhabits the intestines and feces of humans as well as the human vagina.%A%
% 209.04/209.28 |- mesh__recordOriginator mesh__D001644 RC
% 209.04/209.28 |- skos__annotation mesh__D001644
% 209.04/209.28 infection: coord IM with BIFIDOBACTERIALES INFECTIONS %28%IM%29%; DF: BIFIDOBACT%A%
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D001644 84
% 209.04/209.28 |- skos__broader mesh__D001644smesh__D039903
% 209.04/209.28 |- mesh__recordMaintainer mesh__D001644 SYSTEM
% 209.04/209.28 |- skos__prefLabel mesh__D001644 Bifidobacterium
% 209.04/209.28 |- mesh__dateRevised mesh__D001644 2005-06-30
% 209.04/209.28 |- skos__historyNote mesh__D001644 Actinomycetales %28%1967-1974%29%
% 209.04/209.28 |- mesh__dateCreated mesh__D001644 1983-03-10
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020000 1999
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020000 2005
% 209.04/209.28 |- skos__altLabel mesh__D020000 Clinical Decision Support Systems
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020000 2000
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020000 2006
% 209.04/209.28 |- rdf__type mesh__D020000sskos__Concept
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020000 2001
% 209.04/209.28 |- mesh__dateEstablished mesh__D020000 1998-01-01
% 209.04/209.28 |- skos__prefLabel mesh__D020000 Decision Support Systems, Clinical
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020000 2003
% 209.04/209.28 |- mesh__historyNote mesh__D020000 98
% 209.04/209.28 |- mesh__dateCreated mesh__D020000 1997-06-20
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020000 2004
% 209.04/209.28 |- skos__broader mesh__D020000smesh__D007256
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020000 2002
% 209.04/209.28 |- skos__scopeNote mesh__D020000
% 209.04/209.28 Computer-based information systems used to integrate clinical and patient information and provide support for decision-making in patient care.%A%
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D020000 98
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020000 1998
% 209.04/209.28 |- rdf__type mesh__D019257sskos__Concept
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D019257 sjn
% 209.04/209.28 |- mesh__recordMaintainer mesh__D019257 jmp
% 209.04/209.28 |- skos__historyNote mesh__D019257 Ergolines %28%1981-1996%29%
% 209.04/209.28 |- mesh__recordOriginator mesh__D019257 TPW
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D019257
% 209.04/209.28 97; QUINPIROLE was indexed under ERGOLINES 1981-96
% 209.04/209.28 |- skos__altLabel mesh__D019257 Quinpirole Monohydrochloride
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019257 2003
% 209.04/209.28 |- skos__scopeNote mesh__D019257 A dopamine D2/D3 receptor agonist.
% 209.04/209.28 |- mesh__historyNote mesh__D019257 97; was QUINPIROLE %28%NM%29% 1981-96
% 209.04/209.28 |- mesh__dateRevised mesh__D019257 2001-07-25
% 209.04/209.28 |- skos__broader mesh__D019257smesh__D011804
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019257 2004
% 209.04/209.28 |- mesh__dateEstablished mesh__D019257 1997-01-01
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019257 2005
% 209.04/209.28 |- skos__broader mesh__D019257smesh__D006575
% 209.04/209.28 |- skos__prefLabel mesh__D019257 Quinpirole
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019257 2002
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019257 2006
% 209.04/209.28 |- mesh__onlineNote mesh__D019257
% 209.04/209.28 use QUINPIROLE %28%NM%29% to search QUINPIROLE 1981-96
% 209.04/209.28 |- mesh__dateCreated mesh__D019257 1996-06-10
% 209.04/209.28 |- skos__hiddenLabel mesh__D011274 Tubal Pregnancies
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D011274 sjn
% 209.04/209.28 |- mesh__dateRevised mesh__D011274 2005-06-30
% 209.04/209.28 |- skos__prefLabel mesh__D011274 Pregnancy, Tubal
% 209.04/209.28 |- mesh__recordMaintainer mesh__D011274 lkt
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D011274 2006
% 209.04/209.28 |- skos__altLabel mesh__D011274 Tubal Pregnancy
% 209.04/209.28 |- skos__broader mesh__D011274smesh__D011271
% 209.04/209.28 |- skos__scopeNote mesh__D011274
% 209.04/209.28 The most common %28%%3E%96%25%%29% type of ectopic pregnancy in which the extrauterine EMBRYO IMPLANTATION occurs in the FALLOPIAN TUBE, usually in the ampullary region where FERTILIZATION takes place.%A%
% 209.04/209.28 |- rdf__type mesh__D011274sskos__Concept
% 209.04/209.28 |- skos__annotation mesh__D011274
% 209.04/209.28 check the tags FEMALE %26% PREGNANCY; heterotopic or combined uterine %26% tubal pregnancy: see note on PREGNANCY, ECTOPIC; DF: PREGN TUBAL%A%
% 209.04/209.28 |- mesh__recordOriginator mesh__D011274 NLM
% 209.04/209.28 |- mesh__dateCreated mesh__D011274 1999-01-01
% 209.04/209.28 |- skos__hiddenLabel mesh__D011274 Pregnancies, Tubal
% 209.04/209.28 |- skos__broader mesh__D014955Q000293smesh__D014955
% 209.04/209.28 |- mesh__preferredCombination mesh__D014955Q000293smesh__D014954
% 209.04/209.28 |- rdf__type mesh__D014955Q000293smesh__CompoundConcept
% 209.04/209.28 |- mesh__dateCreated mesh__D029685 2001-07-25
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029685 2004
% 209.04/209.28 |- skos__annotation mesh__D029685
% 209.04/209.28 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.04/209.28 |- mesh__dateEstablished mesh__D029685 2002-01-01
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D029685 2002
% 209.04/209.28 |- mesh__historyNote mesh__D029685 2002
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029685 2005
% 209.04/209.28 |- skos__scopeNote mesh__D029685
% 209.04/209.28 A plant genus of the family BORAGINACEAE.
% 209.04/209.28 |- skos__prefLabel mesh__D029685 Pulmonaria
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029685 2006
% 209.04/209.28 |- rdf__type mesh__D029685sskos__Concept
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029685 2002
% 209.04/209.28 |- skos__altLabel mesh__D029685 Lungwort
% 209.04/209.28 |- skos__broader mesh__D029685smesh__D028082
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029685 2003
% 209.04/209.28 |- mesh__historyNote mesh__D009628
% 209.04/209.28 91%28%79%29%; was see under PHENOTHIAZINES 1979-90
% 209.04/209.28 |- skos__historyNote mesh__D009628 Phenothiazines %28%1966-1978%29%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D009628 2006
% 209.04/209.28 |- mesh__dateCreated mesh__D009628 1978-02-08
% 209.04/209.28 |- skos__altLabel mesh__D009628 Azaclorzine
% 209.04/209.28 |- skos__altLabel mesh__D009628 Nonachlazin
% 209.04/209.28 |- skos__altLabel mesh__D009628 Nonakhlazin
% 209.04/209.28 |- rdf__type mesh__D009628sskos__Concept
% 209.04/209.28 |- mesh__dateEstablished mesh__D009628 1991-01-01
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D009628 sjn
% 209.04/209.28 |- skos__prefLabel mesh__D009628 Nonachlazine
% 209.04/209.28 |- skos__broader mesh__D009628smesh__D010640
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D009628
% 209.04/209.28 91; was see under PHENOTHIAZINES 1979-90
% 209.04/209.28 |- mesh__recordOriginator mesh__D009628 SH
% 209.04/209.28 |- skos__scopeNote mesh__D009628
% 209.04/209.28 Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent.%A%
% 209.04/209.28 |- mesh__dateRevised mesh__D009628 2005-06-30
% 209.04/209.28 |- mesh__recordMaintainer mesh__D009628 ssb
% 209.04/209.28 |- skos__historyNote mesh__D009628 Piperazines %28%1966-1978%29%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 2006
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 1999
% 209.04/209.28 |- mesh__dateRevised mesh__D001645 1992-05-08
% 209.04/209.28 |- mesh__historyNote mesh__D001645 66%28%65%29%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 2003
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 1996
% 209.04/209.28 |- rdf__type mesh__D001645sskos__Concept
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D001645 PLS
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 1993
% 209.04/209.28 |- skos__prefLabel mesh__D001645 Biguanides
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 2002
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 2004
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 1997
% 209.04/209.28 |- skos__broader mesh__D001645smesh__D006146
% 209.04/209.28 |- mesh__recordOriginator mesh__D001645 NLM
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D001645 66
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 2000
% 209.04/209.28 |- mesh__recordMaintainer mesh__D001645 TAP
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 1994
% 209.04/209.28 |- mesh__dateCreated mesh__D001645 1999-01-01
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 2005
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 1998
% 209.04/209.28 |- mesh__dateEstablished mesh__D001645 1966-01-01
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 2001
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D001645 1995
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D034021 2004
% 209.04/209.28 |- mesh__historyNote mesh__D034021
% 209.04/209.28 2003; for AUXILIN use ADAPTOR PROTEINS %28%NM%29% 1993-2002
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D034021
% 209.04/209.28 2003; AUXILIN was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1993-2002%A%
% 209.04/209.28 |- skos__altLabel mesh__D034021 Auxilin
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D034021 2006
% 209.04/209.28 |- skos__broader mesh__D034021smesh__D033921
% 209.04/209.28 |- mesh__dateEstablished mesh__D034021 2003-01-01
% 209.04/209.28 |- skos__scopeNote mesh__D034021
% 209.04/209.28 A family of proteins that play a role as cofactors in the process of CLATHRIN recycling in cells.%A%
% 209.04/209.28 |- skos__historyNote mesh__D034021 Membrane Proteins %28%1993-2002%29%
% 209.04/209.28 |- skos__prefLabel mesh__D034021 Auxilins
% 209.04/209.28 |- skos__historyNote mesh__D034021 Carrier Proteins %28%1993-2002%29%
% 209.04/209.28 |- rdf__type mesh__D034021sskos__Concept
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D034021 2003
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D034021 2005
% 209.04/209.28 |- mesh__dateCreated mesh__D034021 2002-07-02
% 209.04/209.28 |- mesh__recordOriginator mesh__D006330 NLM
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D006330 2005
% 209.04/209.28 |- skos__altLabel mesh__D006330 Heart Defect, Congenital
% 209.04/209.28 |- mesh__recordMaintainer mesh__D006330 mdb
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D006330 2006
% 209.04/209.28 |- skos__prefLabel mesh__D006330 Heart Defects, Congenital
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D006330 sjn
% 209.04/209.28 |- skos__broader mesh__D006330smesh__D006331
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D006330 2003
% 209.04/209.28 |- skos__scopeNote mesh__D006330
% 209.04/209.28 Imperfections or malformations of the heart, existing at birth.%A%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D006330 2004
% 209.04/209.28 |- skos__annotation mesh__D006330
% 209.04/209.28 GEN only; do not use as coord for specific term /abnorm; cyanotic defects probably go here but do not also index under CYANOSIS unless especially discussed%A%
% 209.04/209.28 |- skos__broader mesh__D006330smesh__D018376
% 209.04/209.28 |- rdf__type mesh__D006330sskos__Concept
% 209.04/209.28 |- skos__hiddenLabel mesh__D006330 Heart Abnormality
% 209.04/209.28 |- skos__hiddenLabel mesh__D006330 Defect, Congenital Heart
% 209.04/209.28 |- skos__hiddenLabel mesh__D006330 Cordis, Ectopia
% 209.04/209.28 |- skos__hiddenLabel mesh__D006330 Abnormalities, Heart
% 209.04/209.28 |- skos__altLabel mesh__D006330 Defects, Congenital Heart
% 209.04/209.28 |- skos__altLabel mesh__D006330 Heart Abnormalities
% 209.04/209.28 |- skos__altLabel mesh__D006330 Congenital Heart Defects
% 209.04/209.28 |- skos__altLabel mesh__D006330 Congenital Heart Defect
% 209.04/209.28 |- skos__altLabel mesh__D006330 Abnormality, Heart
% 209.04/209.28 |- mesh__dateCreated mesh__D006330 1999-01-01
% 209.04/209.28 |- mesh__dateRevised mesh__D006330 2002-07-02
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020001 2006
% 209.04/209.28 |- rdf__type mesh__D020001sskos__Concept
% 209.04/209.28 |- skos__altLabel mesh__D020001 n-Butanol
% 209.04/209.28 |- skos__altLabel mesh__D020001 n-Butyl Alcohol
% 209.04/209.28 |- skos__hiddenLabel mesh__D020001 n Butyl Alcohol
% 209.04/209.28 |- skos__hiddenLabel mesh__D020001 Alcohol, n-Butyl
% 209.04/209.28 |- mesh__dateRevised mesh__D020001 2003-07-09
% 209.04/209.28 |- skos__broader mesh__D020001smesh__D000440
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020001 2004
% 209.04/209.28 |- skos__hiddenLabel mesh__D020001 1 Butanol
% 209.04/209.28 |- mesh__dateEstablished mesh__D020001 1998-01-01
% 209.04/209.28 |- skos__annotation mesh__D020001 BUTANOLS is also available
% 209.04/209.28 |- skos__prefLabel mesh__D020001 1-Butanol
% 209.04/209.28 |- skos__hiddenLabel mesh__D020001 n Butanol
% 209.04/209.28 |- mesh__dateCreated mesh__D020001 1997-06-20
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D020001
% 209.04/209.28 98; N-BUTYL ALCOHOL %28%now 1-BUTANOL%29% was indexed under ALCOHOLS, BUTYL 1980-97%A%
% 209.04/209.28 |- mesh__historyNote mesh__D020001 98; use 1-BUTANOL %28%NM%29% 1980-97
% 209.04/209.28 |- skos__historyNote mesh__D020001 Butanols %28%1980-1997%29%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D020001 2005
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019258 2002
% 209.04/209.28 |- mesh__recordOriginator mesh__D019258 AGS
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019258 2003
% 209.04/209.28 |- mesh__dateCreated mesh__D019258 1996-06-10
% 209.04/209.28 |- mesh__dateRevised mesh__D019258 2000-06-22
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D019258 sjn
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D019258
% 209.04/209.28 97; SAQUINAVIR was indexed under ISOQUINOLINES %26% QUINOLINES 1993-96 and HIV PROTEASE/antagonists %26% inhibitors 1990-92%A%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019258 2004
% 209.04/209.28 |- skos__broader mesh__D019258smesh__D011804
% 209.04/209.28 |- skos__hiddenLabel mesh__D019258 Monomethanesulfonate, Saquinavir
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019258 2005
% 209.04/209.28 |- skos__hiddenLabel mesh__D019258 Ro 318959
% 209.04/209.28 |- mesh__historyNote mesh__D019258 97; was SAQUINAVIR %28%NM%29% 1990-96
% 209.04/209.28 |- skos__altLabel mesh__D019258 Saquinivir
% 209.04/209.28 |- skos__prefLabel mesh__D019258 Saquinavir
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019258 2006
% 209.04/209.28 |- skos__historyNote mesh__D019258 Quinolines %28%1993-1996%29%
% 209.04/209.28 |- skos__altLabel mesh__D019258 Saquinavir Mesylate
% 209.04/209.28 |- mesh__dateEstablished mesh__D019258 1997-01-01
% 209.04/209.28 |- mesh__recordMaintainer mesh__D019258 TWD
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D019258 2001
% 209.04/209.28 |- rdf__type mesh__D019258sskos__Concept
% 209.04/209.28 |- skos__historyNote mesh__D019258
% 209.04/209.28 HIV Protease/antagonists %26% inhibitors %28%1990-1992%29%
% 209.04/209.28 |- skos__broader mesh__D019258smesh__D007546
% 209.04/209.28 |- skos__hiddenLabel mesh__D019258 Ro 31 8959
% 209.04/209.28 |- mesh__onlineNote mesh__D019258
% 209.04/209.28 use SAQUINAVIR %28%NM%29% to search SAQUINAVIR 1990-96
% 209.04/209.28 |- skos__historyNote mesh__D019258 Isoquinolines %28%1993-1996%29%
% 209.04/209.28 |- skos__scopeNote mesh__D019258
% 209.04/209.28 An HIV protease inhibitor which acts as an analog of an HIV protease cleavage site. It is a highly specific inhibitor of HIV-1 and HIV-2 proteases.%A%
% 209.04/209.28 |- skos__historyNote mesh__D011275 Pregnancy %28%1966-1972%29%
% 209.04/209.28 |- mesh__dateRevised mesh__D011275 2004-07-13
% 209.04/209.28 |- mesh__dateCreated mesh__D011275 1999-01-01
% 209.04/209.28 |- mesh__recordOriginator mesh__D011275 NLM
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D011275
% 209.04/209.28 91; was see under PREGNANCY 1973-90
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D011275 sjn
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D011275 2006
% 209.04/209.28 |- mesh__dateEstablished mesh__D011275 1991-01-01
% 209.04/209.28 |- skos__related mesh__D011275smesh__D049168
% 209.04/209.28 |- skos__scopeNote mesh__D011275
% 209.04/209.28 Pregnancy, usually accidental, that is not desired by the parent or parents.%A%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D011275 2005
% 209.04/209.28 |- mesh__historyNote mesh__D011275
% 209.04/209.28 91%28%73%29%; was see under PREGNANCY 1973-90
% 209.04/209.28 |- mesh__recordMaintainer mesh__D011275 sjn
% 209.04/209.28 |- skos__hiddenLabel mesh__D011275 Pregnancies, Unwanted
% 209.04/209.28 |- skos__hiddenLabel mesh__D011275 Unwanted Pregnancy
% 209.04/209.28 |- skos__broader mesh__D011275smesh__D011247
% 209.04/209.28 |- rdf__type mesh__D011275sskos__Concept
% 209.04/209.28 |- skos__annotation mesh__D011275
% 209.04/209.28 PREGNANCY, UNPLANNED is also available; check tags HUMANS %26% FEMALE %26% PREGNANCY; DF: PREGN UNWANTED%A%
% 209.04/209.28 |- skos__altLabel mesh__D011275 Unwanted Pregnancies
% 209.04/209.28 |- skos__prefLabel mesh__D011275 Pregnancy, Unwanted
% 209.04/209.28 |- skos__broader mesh__D020820Q000139smesh__D020820
% 209.04/209.28 |- mesh__preferredCombination mesh__D020820Q000139smesh__D004409
% 209.04/209.28 |- rdf__type mesh__D020820Q000139smesh__CompoundConcept
% 209.04/209.28 |- mesh__recordMaintainer mesh__D029686 sjn
% 209.04/209.28 |- rdf__type mesh__D029686sskos__Concept
% 209.04/209.28 |- mesh__dateCreated mesh__D029686 2001-07-25
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029686 2005
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029686 2004
% 209.04/209.28 |- mesh__dateRevised mesh__D029686 2002-07-03
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029686 2003
% 209.04/209.28 |- skos__broader mesh__D029686smesh__D019607
% 209.04/209.28 |- skos__annotation mesh__D029686
% 209.04/209.28 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.04/209.28 |- mesh__recordOriginator mesh__D029686 ssb
% 209.04/209.28 |- skos__prefLabel mesh__D029686 Lepidium
% 209.04/209.28 |- mesh__dateEstablished mesh__D029686 2002-01-01
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D029686 2002
% 209.04/209.28 |- mesh__recordAuthorizer mesh__D029686 sjn
% 209.04/209.28 |- skos__altLabel mesh__D029686 Maca
% 209.04/209.28 |- mesh__historyNote mesh__D029686 2002
% 209.04/209.28 |- skos__scopeNote mesh__D029686
% 209.04/209.28 A plant genus of the family BRASSICACEAE growing in Peru mountains. It is the source of maca root.%A%
% 209.04/209.28 |- mesh__activeMeSHYear mesh__D029686 2006
% 209.04/209.28 |- mesh__publicMeSHNote mesh__D009629 69
% 209.04/209.28 |- skos__hiddenLabel mesh__D009629 Therapy, Client Centered
% 209.04/209.29 |- mesh__historyNote mesh__D009629 69%28%65%29%
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 2005
% 209.04/209.29 |- mesh__dateRevised mesh__D009629 1995-05-31
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 2001
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 2003
% 209.04/209.29 |- skos__altLabel mesh__D009629 Therapy, Nondirective
% 209.04/209.29 |- skos__altLabel mesh__D009629 Client-Centered Therapy
% 209.04/209.29 |- mesh__recordOriginator mesh__D009629 NLM
% 209.04/209.29 |- skos__altLabel mesh__D009629 Therapy, Rogerian
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 2006
% 209.04/209.29 |- rdf__type mesh__D009629sskos__Concept
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 2002
% 209.04/209.29 |- skos__prefLabel mesh__D009629 Nondirective Therapy
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 2004
% 209.04/209.29 |- skos__annotation mesh__D009629
% 209.04/209.29 a psychother technique; DF: NONDIRECTIVE THER
% 209.04/209.29 |- skos__scopeNote mesh__D009629
% 209.04/209.29 A procedure in which the therapist refrains from directing the client, but instead reflects back to the client what the latter has said, sometimes restating the client%27%s remark.%A%
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 1998
% 209.04/209.29 |- skos__hiddenLabel mesh__D009629 Client-Centered Therapies
% 209.04/209.29 |- skos__hiddenLabel mesh__D009629 Therapies, Nondirective
% 209.04/209.29 |- skos__hiddenLabel mesh__D009629 Nondirective Therapies
% 209.04/209.29 |- skos__altLabel mesh__D009629 Rogerian Therapy
% 209.04/209.29 |- skos__hiddenLabel mesh__D009629 Client Centered Therapy
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 1996
% 209.04/209.29 |- mesh__recordMaintainer mesh__D009629 TGC
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 1999
% 209.04/209.29 |- skos__broader mesh__D009629smesh__D011613
% 209.04/209.29 |- skos__altLabel mesh__D009629 Therapy, Client-Centered
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 1997
% 209.04/209.29 |- mesh__dateCreated mesh__D009629 1999-01-01
% 209.04/209.29 |- mesh__dateEstablished mesh__D009629 1969-01-01
% 209.04/209.29 |- mesh__recordAuthorizer mesh__D009629 PLS
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D009629 2000
% 209.04/209.29 |- skos__hiddenLabel mesh__D009629 Therapies, Client-Centered
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D001646 2003
% 209.04/209.29 |- skos__broader mesh__D001646smesh__D012634
% 209.04/209.29 |- rdf__type mesh__D001646sskos__Concept
% 209.04/209.29 |- skos__scopeNote mesh__D001646
% 209.04/209.29 An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum.%A%
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D001646 2004
% 209.04/209.29 |- skos__altLabel mesh__D001646 Sludge, Biliary
% 209.04/209.29 |- mesh__dateCreated mesh__D001646 1999-01-01
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D001646 2002
% 209.04/209.29 |- skos__prefLabel mesh__D001646 Bile
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D001646 2005
% 209.04/209.29 |- mesh__recordMaintainer mesh__D001646 sjn
% 209.04/209.29 |- mesh__dateRevised mesh__D001646 2001-08-08
% 209.04/209.29 |- mesh__recordOriginator mesh__D001646 NLM
% 209.04/209.29 |- mesh__activeMeSHYear mesh__D001646 2006
% 209.14/209.29 |- skos__annotation mesh__D001646
% 209.14/209.29 stasis = CHOLESTASIS; drugs stimulating or increasing flow of bile = CHOLAGOGUES AND CHOLERETICS%A%
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D001646 sjn
% 209.14/209.29 |- skos__altLabel mesh__D020800 p75 Neurotrophin Receptor
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020800 2006
% 209.14/209.29 |- skos__scopeNote mesh__D020800
% 209.14/209.29 A low affinity receptor that binds NERVE GROWTH FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; and neurotrophin 4.%A%
% 209.14/209.29 |- mesh__historyNote mesh__D020800 2000%28%1994%29%
% 209.14/209.29 |- skos__altLabel mesh__D020800 Nerve Growth Factor Receptor p75
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800 Receptor, NGF
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800 GP80 LNGFR
% 209.14/209.29 |- mesh__recordOriginator mesh__D020800 jmp
% 209.14/209.29 |- skos__altLabel mesh__D020800 Nerve Growth Factor Receptor, Low-Affinity
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800 NGFR, gp75
% 209.14/209.29 |- mesh__dateCreated mesh__D020800 1999-11-05
% 209.14/209.29 |- skos__annotation mesh__D020800
% 209.14/209.29 do not confuse with RECEPTORS, NERVE GROWTH FACTOR
% 209.14/209.29 |- skos__prefLabel mesh__D020800 Receptor, Nerve Growth Factor
% 209.14/209.29 |- skos__altLabel mesh__D020800 GP80-LNGFR
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D020800
% 209.14/209.29 2000; NERVE GROWTH FACTOR RECEPTOR P75 %28%now RECEPTOR, NERVE GROWTH FACTOR%29% was indexed under RECEPTORS, NERVE GROWTH FACTOR 1994-1999; P75 NEUROTROPHIN RECEPTOR was indexed under RECEPTORS, NERVE GROWTH FACTOR 2000-2005%A%
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800 Receptor, p75 Neurotrophin
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800 Neurotrophin Receptor, p75
% 209.14/209.29 |- mesh__recordMaintainer mesh__D020800 jmp
% 209.14/209.29 |- mesh__dateRevised mesh__D020800 2005-06-30
% 209.14/209.29 |- mesh__dateEstablished mesh__D020800 2000-01-01
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800 p75, Neurotropin Receptor
% 209.14/209.29 |- skos__altLabel mesh__D020800 Neurotrophin Receptor p75
% 209.14/209.29 |- skos__altLabel mesh__D020800 NGFR Protein
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800 Receptor p75, Neurotrophin
% 209.14/209.29 |- skos__altLabel mesh__D020800 gp75 NGFR
% 209.14/209.29 |- skos__altLabel mesh__D020800 NGF Receptor
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D020800 sjn
% 209.14/209.29 |- rdf__type mesh__D020800sskos__Concept
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800
% 209.14/209.29 Nerve Growth Factor Receptor, Low Affinity
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800 Receptor p75, Neurotropin
% 209.14/209.29 |- skos__broader mesh__D020800smesh__D017475
% 209.14/209.29 |- skos__altLabel mesh__D020800 Neurotropin Receptor p75
% 209.14/209.29 |- skos__hiddenLabel mesh__D020800 p75, Neurotrophin Receptor
% 209.14/209.29 |- skos__annotation mesh__D006331
% 209.14/209.29 usually dis of function: differentiate from CARDIOMYOPATHIES, dis of myocardial tissue %28%see note there%29%; cyanotic heart dis is probably HEART DEFECTS, CONGENITAL %26% not CYANOSIS unless especially discussed; parasitic dis of the heart: coord PARASITIC DISEASES or specific parasitic dis %28%IM%29% with CARDIOMYOPATHIES %28%IM%29%, not HEART DISEASES; heart dis, unspecified or specific, with rheumatic fever is probably RHEUMATIC HEART DISEASE: see note there%A%
% 209.14/209.29 |- skos__hiddenLabel mesh__D006331 Disease, Heart
% 209.14/209.29 |- rdf__type mesh__D006331sskos__Concept
% 209.14/209.29 |- mesh__onlineNote mesh__D006331
% 209.14/209.29 pre-explosion = HEART DISEASES %28%PX%29%
% 209.14/209.29 |- mesh__recordMaintainer mesh__D006331 sjn
% 209.14/209.29 |- mesh__dateCreated mesh__D006331 1999-01-01
% 209.14/209.29 |- mesh__dateRevised mesh__D006331 2004-07-13
% 209.14/209.29 |- mesh__recordOriginator mesh__D006331 NLM
% 209.14/209.29 |- skos__hiddenLabel mesh__D006331 Diseases, Cardiac
% 209.14/209.29 |- skos__prefLabel mesh__D006331 Heart Diseases
% 209.14/209.29 |- skos__hiddenLabel mesh__D006331 Heart Disease
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D006331 2005
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D006331 sjn
% 209.14/209.29 |- skos__related mesh__D006331smesh__D009449
% 209.14/209.29 |- skos__broader mesh__D006331smesh__D002318
% 209.14/209.29 |- skos__hiddenLabel mesh__D006331 Cardiac Disease
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D006331 2006
% 209.14/209.29 |- skos__altLabel mesh__D006331 Cardiac Diseases
% 209.14/209.29 |- skos__hiddenLabel mesh__D006331 Diseases, Heart
% 209.14/209.29 |- skos__hiddenLabel mesh__D006331 Disease, Cardiac
% 209.14/209.29 |- mesh__historyNote mesh__D020002
% 209.14/209.29 98; use TERT-BUTYL ALCOHOL %28%NM%29% 1981-97
% 209.14/209.29 |- rdf__type mesh__D020002sskos__Concept
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020002 2005
% 209.14/209.29 |- skos__hiddenLabel mesh__D020002 tert Butanol
% 209.14/209.29 |- skos__historyNote mesh__D020002 Butanols %28%1981-1997%29%
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020002 2006
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D020002
% 209.14/209.29 98; TERT-BUTYL ALCOHOL was indexed under ALCOHOLS, BUTYL 1981-97%A%
% 209.14/209.29 |- skos__hiddenLabel mesh__D020002 Alcohol, tert-Butyl
% 209.14/209.29 |- skos__altLabel mesh__D020002 t-Butanol
% 209.14/209.29 |- skos__hiddenLabel mesh__D020002 tertiary Butyl Alcohol
% 209.14/209.29 |- mesh__dateEstablished mesh__D020002 1998-01-01
% 209.14/209.29 |- mesh__dateRevised mesh__D020002 2003-07-09
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D020002 sjn
% 209.14/209.29 |- skos__hiddenLabel mesh__D020002 Alcohol, tertiary-Butyl
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020002 2004
% 209.14/209.29 |- skos__broader mesh__D020002smesh__D000440
% 209.14/209.29 |- skos__altLabel mesh__D020002 tert-Butanol
% 209.14/209.29 |- skos__hiddenLabel mesh__D020002 t Butanol
% 209.14/209.29 |- mesh__recordMaintainer mesh__D020002 ssb
% 209.14/209.29 |- mesh__dateCreated mesh__D020002 1997-06-20
% 209.14/209.29 |- mesh__recordOriginator mesh__D020002 ADP
% 209.14/209.29 |- skos__hiddenLabel mesh__D020002 tert Butyl Alcohol
% 209.14/209.29 |- skos__prefLabel mesh__D020002 tert-Butyl Alcohol
% 209.14/209.29 |- skos__altLabel mesh__D020002 tertiary-Butyl Alcohol
% 209.14/209.29 |- mesh__historyNote mesh__D047748
% 209.14/209.29 2005; for INAPPROPRIATE ACTH SECRETION SYNDROME use HYPERPITUITARISM 2000-2004%A%
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D047748 2005
% 209.14/209.29 |- skos__hiddenLabel mesh__D047748 Hypersecretion, Pituitary ACTH
% 209.14/209.29 |- skos__historyNote mesh__D047748 Cushing Syndrome %28%1973-2004%29%
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D047748 2006
% 209.14/209.29 |- skos__hiddenLabel mesh__D047748 ACTH Hypersecretion, Pituitary
% 209.14/209.29 |- rdf__type mesh__D047748sskos__Concept
% 209.14/209.29 |- skos__prefLabel mesh__D047748 Pituitary ACTH Hypersecretion
% 209.14/209.29 |- skos__related mesh__D047748smesh__D003480
% 209.14/209.29 |- skos__altLabel mesh__D047748 Cushing Disease
% 209.14/209.29 |- mesh__recordMaintainer mesh__D047748 lkt
% 209.14/209.29 |- mesh__dateEstablished mesh__D047748 2005-01-01
% 209.14/209.29 |- skos__broader mesh__D047748smesh__D006964
% 209.14/209.29 |- mesh__recordOriginator mesh__D047748 lkt
% 209.14/209.29 |- skos__altLabel mesh__D047748
% 209.14/209.29 Adrenocorticotropic Hormone, Inappropriate Secretion
% 209.14/209.29 |- skos__annotation mesh__D047748
% 209.14/209.29 do not confuse X ref CUSHING DISEASE with CUSHING SYNDROME%A%
% 209.14/209.29 |- skos__altLabel mesh__D047748
% 209.14/209.29 Inappropriate Adrenocorticotropic Hormone Secretion
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D047748 sjn
% 209.14/209.29 |- skos__hiddenLabel mesh__D047748 Disease, Cushing
% 209.14/209.29 |- mesh__dateCreated mesh__D047748 2004-07-07
% 209.14/209.29 |- skos__scopeNote mesh__D047748
% 209.14/209.29 A disease of the PITUITARY GLAND characterized by the excess amount of ADRENOCORTICOTROPIC HORMONE secreted. This leads to hypersecretion of cortisol %28%HYDROCORTISONE%29% by the ADRENAL GLANDS resulting in CUSHING SYNDROME.%A%
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D047748
% 209.14/209.29 2005; for INAPPROPRIATE ACTH SECRETION SYNDROME see HYPERPITUITARISM 2000-2004%A%
% 209.14/209.29 |- skos__historyNote mesh__D047748 Pituitary Neoplasms %28%1973-2004%29%
% 209.14/209.29 |- rdf__type mesh__D019259sskos__Concept
% 209.14/209.29 |- skos__broader mesh__D019259smesh__D016047
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D019259 2005
% 209.14/209.29 |- mesh__historyNote mesh__D019259 97; was LAMIVUDINE %28%NM%29% 1991-96
% 209.14/209.29 |- skos__altLabel mesh__D019259 GR109714X
% 209.14/209.29 |- mesh__dateRevised mesh__D019259 2001-07-25
% 209.14/209.29 |- skos__hiddenLabel mesh__D019259 BCH189
% 209.14/209.29 |- skos__historyNote mesh__D019259
% 209.14/209.29 Zalcitabine/analogs %26% derivatives %28%1993-1996%29%
% 209.14/209.29 |- mesh__recordMaintainer mesh__D019259 ssb
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D019259 2004
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D019259
% 209.14/209.29 97; LAMIVUDINE was indexed under ZALCITABINE/analogs %26% derivatives 1993-96 and CYTOSINE/analogs %26% derivatives 1991-92%A%
% 209.14/209.29 |- skos__historyNote mesh__D019259
% 209.14/209.29 Cytosine/analogs %26% derivatives %28%1991-1992%29%
% 209.14/209.29 |- skos__altLabel mesh__D019259 3TC
% 209.14/209.29 |- skos__altLabel mesh__D019259 2%27%,3%27%-Dideoxy-3%27%-thiacytidine
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D019259 2003
% 209.14/209.29 |- skos__prefLabel mesh__D019259 Lamivudine
% 209.14/209.29 |- mesh__dateEstablished mesh__D019259 1997-01-01
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D019259 sjn
% 209.14/209.29 |- skos__hiddenLabel mesh__D019259 BCH 189
% 209.14/209.29 |- mesh__dateCreated mesh__D019259 1996-06-10
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D019259 2002
% 209.14/209.29 |- skos__scopeNote mesh__D019259
% 209.14/209.29 A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3%27% carbon of the pentose ring. It is used to treat HIV disease.%A%
% 209.14/209.29 |- skos__hiddenLabel mesh__D019259 2%27%,3%27% Dideoxy 3%27% thiacytidine
% 209.14/209.29 |- mesh__recordOriginator mesh__D019259 AGS
% 209.14/209.29 |- mesh__onlineNote mesh__D019259
% 209.14/209.29 use LAMIVUDINE %28%NM%29% to search LAMIVUDINE 1991-96
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D019259 2006
% 209.14/209.29 |- mesh__dateRevised mesh__D011276 2003-07-09
% 209.14/209.29 |- mesh__dateCreated mesh__D011276 1999-01-01
% 209.14/209.29 |- mesh__recordMaintainer mesh__D011276 lkt
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011276 2006
% 209.14/209.29 |- skos__broader mesh__D011276smesh__D011374
% 209.14/209.29 |- skos__broader mesh__D011276smesh__D011278
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011276 2005
% 209.14/209.29 |- mesh__recordOriginator mesh__D011276 NLM
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D011276 sjn
% 209.14/209.29 |- rdf__type mesh__D011276sskos__Concept
% 209.14/209.29 |- skos__scopeNote mesh__D011276
% 209.14/209.29 An inactive metabolite of PROGESTERONE by reduction at C5, C3, and C20 position. Pregnanediol has two hydroxyl groups, at 3-alpha and 20-alpha. It is detectable in URINE after OVULATION and is found in great quantities in the pregnancy urine.%A%
% 209.14/209.29 |- skos__prefLabel mesh__D011276 Pregnanediol
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011276 2004
% 209.14/209.29 |- skos__hiddenLabel mesh__D005239 Fears
% 209.14/209.29 |- mesh__recordOriginator mesh__D005239 NLM
% 209.14/209.29 |- skos__scopeNote mesh__D005239
% 209.14/209.29 The affective response to an actual current external danger which subsides with the elimination of the threatening condition.%A%
% 209.14/209.29 |- mesh__dateCreated mesh__D005239 1999-01-01
% 209.14/209.29 |- mesh__dateRevised mesh__D005239 1998-06-10
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D005239 2000
% 209.14/209.29 |- rdf__type mesh__D005239sskos__Concept
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D005239 SJN
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D005239 2001
% 209.14/209.29 |- skos__related mesh__D005239smesh__D010698
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D005239 1999
% 209.14/209.29 |- skos__broader mesh__D005239smesh__D004644
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D005239 2005
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D005239 2002
% 209.14/209.29 |- skos__prefLabel mesh__D005239 Fear
% 209.14/209.29 |- mesh__recordMaintainer mesh__D005239 ADP
% 209.14/209.29 |- skos__annotation mesh__D005239 human %26% animal
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D005239 2006
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D005239 2003
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D005239 2004
% 209.14/209.29 |- mesh__historyNote mesh__D029687 2002
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D029687 2003
% 209.14/209.29 |- skos__scopeNote mesh__D029687
% 209.14/209.29 A plant genus of the family CRUCIFERAE.
% 209.14/209.29 |- skos__annotation mesh__D029687
% 209.14/209.29 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.14/209.29 |- mesh__dateCreated mesh__D029687 2001-07-25
% 209.14/209.29 |- mesh__dateEstablished mesh__D029687 2002-01-01
% 209.14/209.29 |- skos__prefLabel mesh__D029687 Capsella
% 209.14/209.29 |- mesh__dateRevised mesh__D029687 2002-07-03
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D029687 2002
% 209.14/209.29 |- skos__broader mesh__D029687smesh__D019607
% 209.14/209.29 |- skos__altLabel mesh__D029687 Shepherd%27%s Purse
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D029687 2006
% 209.14/209.29 |- rdf__type mesh__D029687sskos__Concept
% 209.14/209.29 |- skos__altLabel mesh__D029687 Shepherds Purse
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D029687 2005
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D029687 2004
% 209.14/209.29 |- mesh__recordOriginator mesh__D015667 EGC
% 209.14/209.29 |- mesh__historyNote mesh__D015667
% 209.14/209.29 1990; for ACUPUNCTURE ANESTHESIA use ACUPUNCTURE ANESTHESIA 1991-2001; use ACUPUNCTURE 1990%A%
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D015667 2006
% 209.14/209.29 |- skos__historyNote mesh__D015667 Analgesia %28%1972-1989%29%
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D015667 2002
% 209.14/209.29 |- mesh__dateEstablished mesh__D015667 1990-01-01
% 209.14/209.29 |- skos__scopeNote mesh__D015667
% 209.14/209.29 Analgesia produced by the insertion of ACUPUNCTURE needles at certain ACUPUNCTURE POINTS on the body. This activates small myelinated nerve fibers in the muscle which transmit impulses to the spinal cord and then activate three centers - the spinal cord, midbrain and pituitary/hypothalamus - to produce analgesia.%A%
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D015667 sjn
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D015667 2005
% 209.14/209.29 |- skos__prefLabel mesh__D015667 Acupuncture Analgesia
% 209.14/209.29 |- mesh__recordMaintainer mesh__D015667 ssb
% 209.14/209.29 |- skos__altLabel mesh__D015667 Anesthesia, Acupuncture
% 209.14/209.29 |- skos__historyNote mesh__D015667 Acupuncture %28%1972-1989%29%
% 209.14/209.29 |- mesh__dateRevised mesh__D015667 2001-07-25
% 209.14/209.29 |- mesh__dateCreated mesh__D015667 1989-04-07
% 209.14/209.29 |- skos__broader mesh__D015667smesh__D000698
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D015667 2004
% 209.14/209.29 |- rdf__type mesh__D015667sskos__Concept
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D015667
% 209.14/209.29 1990; for ACUPUNCTURE ANESTHESIA see ACUPUNCTURE ANESTHESIA 1990-2001; see ACUPUNCTURE 1990%A%
% 209.14/209.29 |- skos__altLabel mesh__D015667 Analgesia, Acupuncture
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D015667 2003
% 209.14/209.29 |- skos__broader mesh__D015667smesh__D015670
% 209.14/209.29 |- skos__broader mesh__D034821smesh__D019684
% 209.14/209.29 |- mesh__historyNote mesh__D034821 2003
% 209.14/209.29 |- skos__scopeNote mesh__D034821
% 209.14/209.29 A plant family of the order Commelinales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29% that are often somewhat succulent. The leaves are alternate, simple, parallel-veined, and usually with a closed sheathing base. The flowers are often in cymes and have 3 petals and 3 sepals.%A%
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D034821 2005
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D034821 2003
% 209.14/209.29 |- mesh__dateCreated mesh__D034821 2002-07-03
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D034821 2006
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D034821 2003
% 209.14/209.29 |- rdf__type mesh__D034821sskos__Concept
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D034821 2004
% 209.14/209.29 |- mesh__dateEstablished mesh__D034821 2003-01-01
% 209.14/209.29 |- skos__annotation mesh__D034821
% 209.14/209.29 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.14/209.29 |- skos__prefLabel mesh__D034821 Commelinaceae
% 209.14/209.29 |- mesh__dateCreated mesh__D001647 1999-01-01
% 209.14/209.29 |- mesh__recordOriginator mesh__D001647 NLM
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D001647 2000
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D001647 2005
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D001647 sjn
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D001647 2006
% 209.14/209.29 |- skos__hiddenLabel mesh__D001647 Acids, Bile
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D001647 2001
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D001647 2003
% 209.14/209.29 |- rdf__type mesh__D001647sskos__Concept
% 209.14/209.29 |- skos__scopeNote mesh__D001647
% 209.14/209.29 Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones.%A%
% 209.14/209.29 |- skos__hiddenLabel mesh__D001647 Salts, Bile
% 209.14/209.29 |- skos__prefLabel mesh__D001647 Bile Acids and Salts
% 209.14/209.29 |- mesh__recordMaintainer mesh__D001647 adp
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D001647 2004
% 209.14/209.29 |- skos__annotation mesh__D001647
% 209.14/209.29 /biosyn /physiol permitted; DF: BILE ACIDS
% 209.14/209.29 |- mesh__dateRevised mesh__D001647 1999-11-03
% 209.14/209.29 |- skos__broader mesh__D001647smesh__D013256
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D001647 2002
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020801 2006
% 209.14/209.29 |- skos__historyNote mesh__D020801
% 209.14/209.29 Receptors, Cell Surface %28%1991-1999%29%
% 209.14/209.29 |- skos__altLabel mesh__D020801 CNTF Receptor
% 209.14/209.29 |- mesh__dateCreated mesh__D020801 1999-11-03
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D020801 sjn
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D020801
% 209.14/209.29 2000; CILIARY NEUROTROPHIC FACTOR RECEPTOR %28%now RECEPTOR, CILIARY NEUROTROPHIC FACTOR%29% was indexed under RECEPTORS, NERVE GROWTH FACTOR 1995-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1997-1999, RECEPTORS, GROWTH FACTOR 1993-1994, %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1991-1999%A%
% 209.14/209.29 |- skos__prefLabel mesh__D020801 Receptor, Ciliary Neurotrophic Factor
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020801 2003
% 209.14/209.29 |- skos__historyNote mesh__D020801
% 209.14/209.29 Receptors, Nerve Growth Factor %28%1995-1999%29%
% 209.14/209.29 |- skos__scopeNote mesh__D020801
% 209.14/209.29 The ciliary neurotrophic factor receptor is comprised of three components: the ciliary neutrophilic factor receptor alpha subunit, the leukemia inhibitory factor receptor and the gp130 signal transducer. The specificity of the receptor for ciliary neurotrophic factor is determined by the alpha subunit, while signal transduction is mediated through the GP130 subunit. Although the receptor regulates neuronal development, it is structurally similar to the cytokine receptor for INTERLEUKIN-6; %28%RECEPTORS, INTERLEUKIN-6%29%.%A%
% 209.14/209.29 |- mesh__recordMaintainer mesh__D020801 mdb
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020801 2002
% 209.14/209.29 |- mesh__dateRevised mesh__D020801 2001-07-25
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020801 2004
% 209.14/209.29 |- mesh__recordOriginator mesh__D020801 jmp
% 209.14/209.29 |- skos__altLabel mesh__D020801
% 209.14/209.29 Ciliary Neurotrophic Factor Receptor alpha Subunit
% 209.14/209.29 |- mesh__historyNote mesh__D020801
% 209.14/209.29 2000; use RECEPTOR, CILIARY NEUROTROPHIC FACTOR %28%NM%29% 1991-1999%A%
% 209.14/209.29 |- rdf__type mesh__D020801sskos__Concept
% 209.14/209.29 |- skos__hiddenLabel mesh__D020801 Receptor, CNTF
% 209.14/209.29 |- skos__annotation mesh__D020801 DF: CNTF RECEPT
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020801 2005
% 209.14/209.29 |- skos__broader mesh__D020801smesh__D017475
% 209.14/209.29 |- skos__historyNote mesh__D020801
% 209.14/209.29 Receptor Protein-Tyrosine Kinases %28%1997-1999%29%
% 209.14/209.29 |- skos__altLabel mesh__D020801 Ciliary Neurotrophic Factor Receptor
% 209.14/209.29 |- mesh__dateEstablished mesh__D020801 2000-01-01
% 209.14/209.29 |- skos__historyNote mesh__D020801
% 209.14/209.29 Receptors, Growth Factor %28%1993-1994%29%
% 209.14/209.29 |- skos__altLabel mesh__D006332 Heart Hypertrophy
% 209.14/209.29 |- rdf__type mesh__D006332sskos__Concept
% 209.14/209.29 |- mesh__dateCreated mesh__D006332 1999-01-01
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D006332
% 209.14/209.29 2000; see HEART HYPERTROPHY 1993-1999; see HEART ENLARGEMENT 1963-1992%A%
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D006332 2005
% 209.14/209.29 |- skos__scopeNote mesh__D006332
% 209.14/209.29 Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure %28%HEART FAILURE, CONGESTIVE%29% or several forms of CARDIOMYOPATHIES.%A%
% 209.14/209.29 |- skos__hiddenLabel mesh__D006332 Heart, Enlarged
% 209.14/209.29 |- skos__altLabel mesh__D006332 Enlarged Heart
% 209.14/209.29 |- skos__broader mesh__D006332smesh__D006984
% 209.14/209.29 |- mesh__historyNote mesh__D006332 2000%28%1963%29%
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D006332 2006
% 209.14/209.29 |- mesh__recordOriginator mesh__D006332 NLM
% 209.14/209.29 |- mesh__recordMaintainer mesh__D006332 lkt
% 209.14/209.29 |- skos__hiddenLabel mesh__D006332 Enlargement, Heart
% 209.14/209.29 |- mesh__dateRevised mesh__D006332 2004-07-07
% 209.14/209.29 |- skos__broader mesh__D006332smesh__D006331
% 209.14/209.29 |- skos__annotation mesh__D006332
% 209.14/209.29 GEN or unspecified; prefer HYPERTROPHY, LEFT VENTRICULAR or HYPERTROPHY, RIGHT VENTRICULAR; note X ref CARDIAC HYPERTROPHY: do not confuse with CARDIOMYOPATHY, HYPERTROPHIC%A%
% 209.14/209.29 |- skos__prefLabel mesh__D006332 Cardiomegaly
% 209.14/209.29 |- skos__altLabel mesh__D006332 Heart Enlargement
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D006332 sjn
% 209.14/209.29 |- mesh__dateRevised mesh__D020003 2003-07-09
% 209.14/209.29 |- skos__hiddenLabel mesh__D020003 n Octyl Alcohol
% 209.14/209.29 |- skos__altLabel mesh__D020003 n-Octanol
% 209.14/209.29 |- mesh__recordMaintainer mesh__D020003 ssb
% 209.14/209.29 |- mesh__dateCreated mesh__D020003 1997-06-20
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020003 2004
% 209.14/209.29 |- mesh__recordOriginator mesh__D020003 ADP
% 209.14/209.29 |- skos__annotation mesh__D020003 OCTANOLS is also available
% 209.14/209.29 |- skos__altLabel mesh__D020003 n-Octyl Alcohol
% 209.14/209.29 |- skos__hiddenLabel mesh__D020003 n Octanol
% 209.14/209.29 |- skos__broader mesh__D020003smesh__D000442
% 209.14/209.29 |- skos__historyNote mesh__D020003 Octanols %28%1981-1997%29%
% 209.14/209.29 |- skos__hiddenLabel mesh__D020003 Alcohol, n-Octyl
% 209.14/209.29 |- rdf__type mesh__D020003sskos__Concept
% 209.14/209.29 |- mesh__dateEstablished mesh__D020003 1998-01-01
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020003 2005
% 209.14/209.29 |- skos__scopeNote mesh__D020003
% 209.14/209.29 A colorless, slightly viscous liquid used as a defoaming or wetting agent. It is also used as a solvent for protective coatings, waxes, and oils, and as a raw material for plasticizers. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D020003
% 209.14/209.29 98; 1-OCTANOL was indexed under ALCOHOLS, OCTYL 1981-97
% 209.14/209.29 |- skos__hiddenLabel mesh__D020003 1 Octanol
% 209.14/209.29 |- skos__prefLabel mesh__D020003 1-Octanol
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D020003 2006
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D020003 sjn
% 209.14/209.29 |- mesh__historyNote mesh__D020003 98; use 1-OCTANOL %28%NM%29% 1981-97
% 209.14/209.29 |- mesh__dateEstablished mesh__D011277 1974-01-01
% 209.14/209.29 |- mesh__publicMeSHNote mesh__D011277 74
% 209.14/209.29 |- skos__altLabel mesh__D011277 Dioxopregnanes
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 1995
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 2005
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 1998
% 209.14/209.29 |- mesh__dateRevised mesh__D011277 1993-06-03
% 209.14/209.29 |- skos__prefLabel mesh__D011277 Pregnanediones
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 2002
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 1994
% 209.14/209.29 |- rdf__type mesh__D011277sskos__Concept
% 209.14/209.29 |- mesh__historyNote mesh__D011277 74
% 209.14/209.29 |- mesh__recordMaintainer mesh__D011277 PLS
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 2004
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 1997
% 209.14/209.29 |- mesh__dateCreated mesh__D011277 1999-01-01
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 2001
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 2003
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 1996
% 209.14/209.29 |- mesh__recordAuthorizer mesh__D011277 PLS
% 209.14/209.29 |- skos__altLabel mesh__D011277 Diketopregnanes
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 2000
% 209.14/209.29 |- mesh__recordOriginator mesh__D011277 NLM
% 209.14/209.29 |- mesh__activeMeSHYear mesh__D011277 2006
% 209.14/209.29 |- skos__scopeNote mesh__D011277
% 209.14/209.29 Pregnane derivatives in which two side-chain methyl groups or two methylene groups in the ring skeleton %28%or a combination thereof%29% have been oxidized to keto groups.%A%
% 209.14/209.30 |- mesh__activeMeSHYear mesh__D011277 1999
% 209.14/209.30 |- skos__broader mesh__D011277smesh__D011278
% 209.14/209.30 |- skos__historyNote mesh__D016760
% 209.14/209.30 Proto-Oncogene Proteins %28%1985-1991%29%
% 209.14/209.30 |- skos__broader mesh__D016760smesh__D011518
% 209.14/209.30 |- skos__altLabel mesh__D016760 Proto-Oncogene Proteins fos
% 209.14/209.30 |- skos__altLabel mesh__D016760 p55 c-fos
% 209.14/209.30 |- skos__related mesh__D016760smesh__D018808
% 209.14/209.30 |- mesh__recordOriginator mesh__D016760 AGS
% 209.14/209.30 |- skos__altLabel mesh__D016760 c-fos Proteins
% 209.14/209.30 |- skos__hiddenLabel mesh__D016760 Proto Oncogene Products c fos
% 209.14/209.30 |- skos__hiddenLabel mesh__D016760 Fos Related Antigens
% 209.14/209.30 |- mesh__activeMeSHYear mesh__D016760 2006
% 209.14/209.30 |- mesh__recordMaintainer mesh__D016760 ags
% 209.14/209.30 |- skos__altLabel mesh__D016760 p55%28%c-fos%29%
% 209.14/209.30 |- skos__broader mesh__D016760smesh__D050976
% 209.14/209.30 |- skos__altLabel mesh__D016760 fos Proto-Oncogene Proteins
% 209.14/209.30 |- skos__hiddenLabel mesh__D016760 Proto Oncogene Proteins c fos
% 209.14/209.30 |- mesh__activeMeSHYear mesh__D016760 2006A
% 209.14/209.30 |- skos__hiddenLabel mesh__D016760 p55 c fos
% 209.14/209.30 |- mesh__dateRevised mesh__D016760 2005-07-08
% 209.14/209.30 |- mesh__publicMeSHNote mesh__D016760
% 209.14/209.30 92; PROTO-ONCOGENE PROTEIN FOS %28%NM%29% was indexed under PROTO-ONCOGENE PROTEINS 1985-91; FOS B PROTEIN %28%NM%29% was indexed under NUCLEAR PROTEINS 1990-91%A%
% 209.14/209.30 |- skos__broader mesh__D016760smesh__D009687
% 209.14/209.30 |- skos__altLabel mesh__D016760 Proto-Oncogene Products c-fos
% 209.14/209.30 |- skos__hiddenLabel mesh__D016760 Proto Oncogene Proteins fos
% 209.14/209.30 |- skos__hiddenLabel mesh__D016760 c fos Proteins
% 209.14/209.30 |- mesh__dateEstablished mesh__D016760 1992-01-01
% 209.14/209.30 |- mesh__dateCreated mesh__D016760 1991-07-12
% 209.14/209.30 |- skos__annotation mesh__D016760
% 209.14/209.30 /drug eff /ultrastruct permitted; not for c-fos 39 %28% = C-FOS-ASSOCIATED PROTEIN P39 see PROTO-ONCOGENE PROTEINS C-JUN%29%; DF: note short X refs%A%
% 209.14/209.30 |- rdf__type mesh__D016760sskos__Concept
% 209.14/209.30 |- mesh__onlineNote mesh__D016760
% 209.14/209.30 use PROTO-ONCOGENE PROTEINS C-FOS %28%NM%29% to search PROTO-ONCOGENE PROTEIN FOS %28%NM%29% 1985-91 %26% FOS B PROTEIN %28%NM%29% 1990-91%A%
% 209.14/209.30 |- mesh__historyNote mesh__D016760
% 209.14/209.30 92; was PROTO-ONCOGENE PROTEIN FOS %28%NM%29% 1985-91; FOS B PROTEIN was FOS B PROTEIN %28%NM%29% 1990-91%A%
% 209.14/209.30 |- skos__altLabel mesh__D016760 FRAs
% 209.14/209.30 |- skos__prefLabel mesh__D016760 Proto-Oncogene Proteins c-fos
% 209.14/209.30 |- mesh__recordAuthorizer mesh__D016760 ags
% 209.14/209.30 |- skos__scopeNote mesh__D016760
% 209.14/209.30 Cellular DNA-binding proteins encoded by the c-fos genes %28%GENES, FOS%29%. They are involved in growth-related transcriptional control. c-fos combines with c-jun %28%PROTO-ONCOGENE PROTEINS C-JUN%29% to form a c-fos/c-jun heterodimer %28%TRANSCRIPTION FACTOR AP-1%29% that binds to the TRE %28%TPA-responsive element%29% in promoters of certain genes.%A%
% 209.14/209.30 |- skos__hiddenLabel mesh__D016760 fos Proto Oncogene Proteins
% 209.14/209.30 |- skos__altLabel mesh__D016760 Fos-Related Antigens
% 209.14/209.30 |- mesh__dateRevised mesh__D002740 2005-06-30
% 209.16/209.30 |- skos__prefLabel mesh__D002740 Chlorothiazide
% 209.16/209.30 |- mesh__dateCreated mesh__D002740 1999-01-01
% 209.16/209.30 |- rdf__type mesh__D002740sskos__Concept
% 209.16/209.30 |- mesh__recordMaintainer mesh__D002740 ssb
% 209.16/209.30 |- mesh__historyNote mesh__D002740
% 209.16/209.30 CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adv eff-pois-tox was CHLOROTHIAZIDE TOXICOLOGY 1963-65%A%
% 209.16/209.30 |- skos__broader mesh__D002740smesh__D001581
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D002740
% 209.16/209.30 CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adverse effects /poisoning /toxicity were CHLOROTHIAZIDE TOXICOLOGY 1963-65%A%
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D002740 2006
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D002740 sjn
% 209.16/209.30 |- mesh__recordOriginator mesh__D002740 NLM
% 209.16/209.30 |- skos__scopeNote mesh__D002740
% 209.16/209.30 A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p812%29%%A%
% 209.16/209.30 |- mesh__recordOriginator mesh__D029688 ssb
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D029688
% 209.16/209.30 2002; for TURNIP %26% RUTABAGA see BRASSICA 1998-2001
% 209.16/209.30 |- mesh__historyNote mesh__D029688
% 209.16/209.30 2002; for TURNIP %26% RUTABAGA use BRASSICA 1998-2001
% 209.16/209.30 |- skos__broader mesh__D029688smesh__D001937
% 209.16/209.30 |- mesh__dateEstablished mesh__D029688 2002-01-01
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D029688 sjn
% 209.16/209.30 |- mesh__recordMaintainer mesh__D029688 sjn
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D029688 2006
% 209.16/209.30 |- rdf__type mesh__D029688sskos__Concept
% 209.16/209.30 |- skos__prefLabel mesh__D029688 Brassica napus
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D029688 2005
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D029688 2004
% 209.16/209.30 |- skos__historyNote mesh__D029688 Brassica %28%1998-2001%29%
% 209.16/209.30 |- mesh__dateCreated mesh__D029688 2001-07-25
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D029688 2003
% 209.16/209.30 |- skos__annotation mesh__D029688
% 209.16/209.30 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.16/209.30 |- mesh__dateRevised mesh__D029688 2002-07-03
% 209.16/209.30 |- skos__scopeNote mesh__D029688
% 209.16/209.30 A plant species of the family BRASSICACEAE best known for the edible roots.%A%
% 209.16/209.30 |- skos__altLabel mesh__D040061 Peptide Initiation Factor EIF-5
% 209.16/209.30 |- skos__hiddenLabel mesh__D040061 Initiation Factor-5, Eukaryotic
% 209.16/209.30 |- skos__hiddenLabel mesh__D040061 Eukaryotic Peptide Initiation Factor 5
% 209.16/209.30 |- skos__prefLabel mesh__D040061 Eukaryotic Initiation Factor-5
% 209.16/209.30 |- mesh__historyNote mesh__D040061
% 209.16/209.30 2003; use EUKARYOTIC INITIATION FACTOR-5 %28%NM%29% 1982-2002
% 209.16/209.30 |- skos__hiddenLabel mesh__D040061 Eukaryotic Initiation Factor 5
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D040061
% 209.16/209.30 2003; EIF-5 %28%now EUKARYOTIC INITIATION FACTOR-5%29% was indexed under PEPTIDE INITIATION FACTORS 1982-2002%A%
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D040061 jls
% 209.16/209.30 |- rdf__type mesh__D040061sskos__Concept
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D040061 2006
% 209.16/209.30 |- skos__altLabel mesh__D040061 Eukaryotic Peptide Initiation Factor-5
% 209.16/209.30 |- mesh__dateEstablished mesh__D040061 2003-01-01
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D040061 2005
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D040061 2005A
% 209.16/209.30 |- skos__broader mesh__D040061smesh__D039642
% 209.16/209.30 |- mesh__dateRevised mesh__D040061 2004-07-27
% 209.16/209.30 |- skos__historyNote mesh__D040061
% 209.16/209.30 Peptide Initiation Factors %28%1982-2002%29%
% 209.16/209.30 |- skos__hiddenLabel mesh__D040061 Peptide Initiation Factor EIF 5
% 209.16/209.30 |- mesh__recordOriginator mesh__D040061 jmp
% 209.16/209.30 |- skos__broader mesh__D040061smesh__D020690
% 209.16/209.30 |- skos__scopeNote mesh__D040061
% 209.16/209.30 A eukaryotic initiation factor that interacts with the 40S initiation complex and promotes the hydrolysis of the bound GTP. The hydrolysis of GTP causes the release of EUKARYOTIC INITIATION FACTOR-2 and EUKARYOTIC INITIATION FACTOR-3 from the 40S subunit and the subsequent joining of the 60S ribosomal subunit to the 40S complex to form the functional 80S initiation complex%A%
% 209.16/209.30 |- mesh__recordMaintainer mesh__D040061 jls
% 209.16/209.30 |- skos__altLabel mesh__D040061 EIF-5
% 209.16/209.30 |- mesh__dateCreated mesh__D040061 2002-07-03
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D034822 2006
% 209.16/209.30 |- skos__prefLabel mesh__D034822 Commelina
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D034822 2003
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D034822 2004
% 209.16/209.30 |- rdf__type mesh__D034822sskos__Concept
% 209.16/209.30 |- skos__broader mesh__D034822smesh__D034821
% 209.16/209.30 |- skos__scopeNote mesh__D034822
% 209.16/209.30 A plant genus of the family COMMELINACEAE of perennial herbs with blue flowers.%A%
% 209.16/209.30 |- skos__altLabel mesh__D034822 Dayflower
% 209.16/209.30 |- skos__annotation mesh__D034822
% 209.16/209.30 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.16/209.30 |- mesh__historyNote mesh__D034822 2003
% 209.16/209.30 |- mesh__dateCreated mesh__D034822 2002-07-03
% 209.16/209.30 |- mesh__dateEstablished mesh__D034822 2003-01-01
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D034822 2005
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D034822 2003
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 1991
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D001648 PLS
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 2005
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 1998
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 1995
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 2002
% 209.16/209.30 |- skos__broader mesh__D001648smesh__D001653
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D001648
% 209.16/209.30 91; was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980%A%
% 209.16/209.30 |- skos__hiddenLabel mesh__D001648 Bile Canaliculus
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 2006
% 209.16/209.30 |- mesh__recordOriginator mesh__D001648 RC
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 1999
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 1992
% 209.16/209.30 |- mesh__dateRevised mesh__D001648 1990-04-13
% 209.16/209.30 |- rdf__type mesh__D001648sskos__Concept
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 2003
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 1996
% 209.16/209.30 |- skos__historyNote mesh__D001648
% 209.16/209.30 Bile Ducts, Intrahepatic %28%1966-1980%29%
% 209.16/209.30 |- skos__scopeNote mesh__D001648
% 209.16/209.30 Minute intercellular channels that occur between liver cells and carry bile towards interlobar bile ducts. Also called bile capillaries.%A%
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 1993
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 2000
% 209.16/209.30 |- skos__annotation mesh__D001648 also called %22%bile capillaries%22%
% 209.16/209.30 |- mesh__dateCreated mesh__D001648 1980-04-09
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 2004
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 1997
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 2001
% 209.16/209.30 |- mesh__recordMaintainer mesh__D001648 NLM
% 209.16/209.30 |- mesh__dateEstablished mesh__D001648 1991-01-01
% 209.16/209.30 |- mesh__onlineNote mesh__D001648 search BILE DUCTS, INTRAHEPATIC 1980
% 209.16/209.30 |- mesh__historyNote mesh__D001648
% 209.16/209.30 91%28%81%29%; was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980%A%
% 209.16/209.30 |- skos__hiddenLabel mesh__D001648 Canaliculus, Bile
% 209.16/209.30 |- skos__hiddenLabel mesh__D001648 Canaliculi, Bile
% 209.16/209.30 |- skos__prefLabel mesh__D001648 Bile Canaliculi
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001648 1994
% 209.16/209.30 |- mesh__recordMaintainer mesh__D012370 CCR
% 209.16/209.30 |- skos__hiddenLabel mesh__D012370 Hydrochloride, Robenidine
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D012370
% 209.16/209.30 91; was see under GUANIDINES 1975-90
% 209.16/209.30 |- skos__altLabel mesh__D012370 Robenzidene
% 209.16/209.30 |- skos__scopeNote mesh__D012370
% 209.16/209.30 An anticoccidial agent mainly for poultry.
% 209.16/209.30 |- skos__prefLabel mesh__D012370 Robenidine
% 209.16/209.30 |- skos__altLabel mesh__D012370 Alpharma Brand of Robenidine Hydrochloride
% 209.16/209.30 |- skos__broader mesh__D012370smesh__D006146
% 209.16/209.30 |- mesh__dateEstablished mesh__D012370 1991-01-01
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D012370 sjn
% 209.16/209.30 |- mesh__dateRevised mesh__D012370 2005-06-30
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D012370 2006
% 209.16/209.30 |- mesh__dateCreated mesh__D012370 1974-11-19
% 209.16/209.30 |- mesh__recordOriginator mesh__D012370 NLM
% 209.16/209.30 |- skos__historyNote mesh__D012370 Guanidines %28%1971-1974%29%
% 209.16/209.30 |- mesh__historyNote mesh__D012370
% 209.16/209.30 91%28%75%29%; was see under GUANIDINES 1975-90
% 209.16/209.30 |- rdf__type mesh__D012370sskos__Concept
% 209.16/209.30 |- skos__historyNote mesh__D012370 Chlorobenzenes %28%1974%29%
% 209.16/209.30 |- skos__historyNote mesh__D020802 Spinal Cord Diseases %28%1967-1999%29%
% 209.16/209.30 |- mesh__dateEstablished mesh__D020802 2000-01-01
% 209.16/209.30 |- skos__historyNote mesh__D020802 Abscess/complications %28%1966-1999%29%
% 209.16/209.30 |- skos__broader mesh__D020802smesh__D000038
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Intracranial Epidural Abscess
% 209.16/209.30 |- skos__broader mesh__D020802smesh__D020819
% 209.16/209.30 |- skos__broader mesh__D020802smesh__D013118
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Extradural Abscess, Intracranial
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D020802 2003
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Extradural Abscess, Spinal
% 209.16/209.30 |- skos__altLabel mesh__D020802 Abscess, Extradural
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Abscess, Spinal Epidural
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Abscess, Intracranial Epidural
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Extradural Abscesses, Intracranial
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Abscesses, Intracranial Extradural
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D020802 2002
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Abscess, Cranial Extradural
% 209.16/209.30 |- skos__historyNote mesh__D020802
% 209.16/209.30 Spinal Cord Compression/etiology %28%1966-1999%29%
% 209.16/209.30 |- skos__annotation mesh__D020802
% 209.16/209.30 coord %28%IM%29% with site %28%IM%29% + precoord organism infect %28%IM%29% + specific CNS infect term %28%IM%29%%A%
% 209.16/209.30 |- mesh__historyNote mesh__D020802 2000
% 209.16/209.30 |- mesh__dateCreated mesh__D020802 1999-11-03
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Abscess, Spinal Extradural
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Intracranial Extradural Abscesses
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D020802 2001
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D020802 2000
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D020802 2006
% 209.16/209.30 |- skos__broader mesh__D020802smesh__D002494
% 209.16/209.30 |- skos__broader mesh__D020802smesh__D020806
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Abscess, Intracranial Extradural
% 209.16/209.30 |- rdf__type mesh__D020802sskos__Concept
% 209.16/209.30 |- skos__altLabel mesh__D020802 Cranial Extradural Abscess
% 209.16/209.30 |- skos__prefLabel mesh__D020802 Epidural Abscess
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D020802 2000
% 209.16/209.30 |- skos__altLabel mesh__D020802 Intracranial Extradural Abscess
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D020802 2005
% 209.16/209.30 |- skos__altLabel mesh__D020802 Spinal Extradural Abscess
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Spinal Epidural Abscess
% 209.16/209.30 |- skos__altLabel mesh__D020802 Abscess, Epidural
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Abscess, Cranial Epidural
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Epidural Abscess, Cranial
% 209.16/209.30 |- skos__altLabel mesh__D020802 Epidural Abscess, Intracranial
% 209.16/209.30 |- skos__scopeNote mesh__D020802
% 209.16/209.30 Circumscribed collections of suppurative material occurring in the spinal or intracranial EPIDURAL SPACE. The majority of epidural abscesses occur in the spinal canal and are associated with OSTEOMYELITIS of a vertebral body; ANALGESIA, EPIDURAL; and other conditions. Clinical manifestations include local and radicular pain, weakness, sensory loss, URINARY INCONTINENCE, and FECAL INCONTINENCE. Cranial epidural abscesses are usually associated with OSTEOMYELITIS of a cranial bone, SINUSITIS, or OTITIS MEDIA. %28%From Adams et al., Principles of Neurology, 6th ed, p710 and pp1240-1; J Neurol Neurosurg Psychiatry 1998 Aug;65%28%2%29%:209-12%29%%A%
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D020802 2004
% 209.16/209.30 |- skos__hiddenLabel mesh__D020802 Extradural Abscess
% 209.16/209.30 |- mesh__recordOriginator mesh__D006333 NLM
% 209.16/209.30 |- skos__hiddenLabel mesh__D006333 Congestive Heart Failure
% 209.16/209.30 |- skos__altLabel mesh__D006333 Heart Decompensation
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D006333 2003
% 209.16/209.30 |- skos__prefLabel mesh__D006333 Heart Failure, Congestive
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D006333 sjn
% 209.16/209.30 |- mesh__recordMaintainer mesh__D006333 nns
% 209.16/209.30 |- rdf__type mesh__D006333sskos__Concept
% 209.16/209.30 |- mesh__dateRevised mesh__D006333 2001-07-25
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D006333 2002
% 209.16/209.30 |- skos__annotation mesh__D006333
% 209.16/209.30 %22%scompenso di cuore%22% is %22%heart decompensation%22% in Italian; do not confuse with CARDIOMYOPATHY, CONGESTIVE; heart failure that is not congestive is CARDIAC OUTPUT, LOW%A%
% 209.16/209.30 |- skos__hiddenLabel mesh__D006333 Failure, Congestive Heart
% 209.16/209.30 |- mesh__dateCreated mesh__D006333 1999-01-01
% 209.16/209.30 |- skos__broader mesh__D006333smesh__D006331
% 209.16/209.30 |- skos__scopeNote mesh__D006333
% 209.16/209.30 A complication of HEART DISEASES. Defective cardiac filling and/or impaired contraction and emptying, resulting in the heart%27%s inability to pump a sufficient amount of blood to meet the needs of the body tissues or to be able to do so only with an elevated filling pressure. %28%from Braunwald, Heart Disease, 5th ed%29%%A%
% 209.16/209.30 |- skos__hiddenLabel mesh__D006333 Decompensation, Heart
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D006333 2006
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D006333 2005
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D006333 2004
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D011278 PLS
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 2000
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 1994
% 209.16/209.30 |- mesh__recordOriginator mesh__D011278 NLM
% 209.16/209.30 |- rdf__type mesh__D011278sskos__Concept
% 209.16/209.30 |- skos__prefLabel mesh__D011278 Pregnanes
% 209.16/209.30 |- skos__annotation mesh__D011278 do not confuse with PREGNENES
% 209.16/209.30 |- skos__scopeNote mesh__D011278
% 209.16/209.30 Saturated derivatives of the steroid pregnane. The 5-beta series includes PROGESTERONE and related hormones; the 5-alpha series includes forms generally excreted in the urine.%A%
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 2004
% 209.16/209.30 |- mesh__dateEstablished mesh__D011278 1968-01-01
% 209.16/209.30 |- mesh__dateRevised mesh__D011278 1993-06-03
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 1997
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 2002
% 209.16/209.30 |- mesh__dateCreated mesh__D011278 1999-01-01
% 209.16/209.30 |- mesh__historyNote mesh__D011278 68
% 209.16/209.30 |- skos__broader mesh__D011278smesh__D013256
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 2003
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 1996
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 2006
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 1999
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D011278 68
% 209.16/209.30 |- mesh__recordMaintainer mesh__D011278 PLS
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 2001
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 1995
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 2005
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D011278 1998
% 209.16/209.30 |- mesh__dateEstablished mesh__D016761 1992-01-01
% 209.16/209.30 |- mesh__dateCreated mesh__D016761 1991-07-12
% 209.16/209.30 |- skos__hiddenLabel mesh__D016761 p75 gag fos fox
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D016761 2006
% 209.16/209.30 |- skos__hiddenLabel mesh__D016761 Oncogene Products v fos
% 209.16/209.30 |- skos__altLabel mesh__D016761 Oncogene Proteins fos
% 209.16/209.30 |- mesh__historyNote mesh__D016761
% 209.16/209.30 92; was ONCOGENE PROTEIN FOS %28%NM%29% 1990-91
% 209.16/209.30 |- skos__altLabel mesh__D016761 Oncogene Products v-fos
% 209.16/209.30 |- mesh__recordOriginator mesh__D016761 AGS
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D016761
% 209.16/209.30 92; ONCOGENE PROTEIN FOS %28%NM%29% was indexed under ONCOGENE PROTEINS, VIRAL 1990-91%A%
% 209.16/209.30 |- skos__scopeNote mesh__D016761
% 209.16/209.30 Transforming proteins coded by fos oncogenes. These proteins have been found in the Finkel-Biskis-Jinkins %28%FBJ-MSV%29% and Finkel-Biskis-Reilly %28%FBR-MSV%29% murine sarcoma viruses which induce osteogenic sarcomas in mice. The FBJ-MSV v-fos gene encodes a p55-kDa protein and the FBR-MSV v-fos gene encodes a p75-kDa fusion protein.%A%
% 209.16/209.30 |- skos__altLabel mesh__D016761 p75%28%gag-fos%29%
% 209.16/209.30 |- skos__altLabel mesh__D016761 fos Oncogene Proteins
% 209.16/209.30 |- skos__altLabel mesh__D016761 Oncogene Protein p75%28%gag-fos-fox%29%
% 209.16/209.30 |- skos__hiddenLabel mesh__D016761 p75 gag fos
% 209.16/209.30 |- skos__hiddenLabel mesh__D016761 Oncogene Proteins v fos
% 209.16/209.30 |- skos__historyNote mesh__D016761
% 209.16/209.30 Oncogene Proteins, Viral %28%1989-1991%29%
% 209.16/209.30 |- skos__altLabel mesh__D016761 p75 gag-fos-fox
% 209.16/209.30 |- rdf__type mesh__D016761sskos__Concept
% 209.16/209.30 |- skos__historyNote mesh__D016761 Retroviridae Proteins %28%1987-1988%29%
% 209.16/209.30 |- skos__altLabel mesh__D016761 Oncogene Protein p55%28%v-fos%29%
% 209.16/209.30 |- skos__hiddenLabel mesh__D016761 gag-fos-fox Fusion Proteins
% 209.16/209.30 |- skos__hiddenLabel mesh__D016761 v fos Proteins
% 209.16/209.30 |- mesh__recordMaintainer mesh__D016761 SYSTEM
% 209.16/209.30 |- skos__annotation mesh__D016761
% 209.16/209.30 IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D016761 sjn
% 209.16/209.30 |- skos__broader mesh__D016761smesh__D015682
% 209.16/209.30 |- mesh__onlineNote mesh__D016761
% 209.16/209.30 use ONCOGENE PROTEINS V-FOS %28%NM%29% to search ONCOGENE PROTEIN FOS %28%NM%29% 1990-91%A%
% 209.16/209.30 |- mesh__dateRevised mesh__D016761 2005-06-30
% 209.16/209.30 |- skos__prefLabel mesh__D016761 Oncogene Proteins v-fos
% 209.16/209.30 |- skos__altLabel mesh__D016761 v-fos Proteins
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D002741
% 209.16/209.30 65; TRIANISOESTROL was see CHLOROTRIANISENE 1978-93
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D002741 2006
% 209.16/209.30 |- skos__broader mesh__D002741smesh__D013267
% 209.16/209.30 |- mesh__dateCreated mesh__D002741 1999-01-01
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D002741 sjn
% 209.16/209.30 |- mesh__recordOriginator mesh__D002741 NLM
% 209.16/209.30 |- mesh__historyNote mesh__D002741
% 209.16/209.30 65%28%64%29%; TRIANISOESTROL was see CHLOROTRIANISENE 1978-93
% 209.16/209.30 |- mesh__dateRevised mesh__D002741 2005-06-30
% 209.16/209.30 |- mesh__onlineNote mesh__D002741
% 209.16/209.30 use CHLOROTRIANISENE to search TRIANISOESTROL 1978-93
% 209.16/209.30 |- skos__prefLabel mesh__D002741 Chlorotrianisene
% 209.16/209.30 |- mesh__recordMaintainer mesh__D002741 lkw
% 209.16/209.30 |- rdf__type mesh__D002741sskos__Concept
% 209.16/209.30 |- skos__scopeNote mesh__D002741
% 209.16/209.30 A powerful synthetic, non-steroidal estrogen.
% 209.16/209.30 |- mesh__dateEstablished mesh__D002741 1965-01-01
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D015669 2006
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D015669 2005
% 209.16/209.30 |- skos__broader mesh__D015669smesh__D016740
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D015669 sjn
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D015669 2002
% 209.16/209.30 |- skos__hiddenLabel mesh__D015669 Points, Acupuncture
% 209.16/209.30 |- mesh__recordMaintainer mesh__D015669 ssb
% 209.16/209.30 |- rdf__type mesh__D015669sskos__Concept
% 209.16/209.30 |- skos__scopeNote mesh__D015669
% 209.16/209.30 Designated locations along nerves or organ meridians for inserting acupuncture needles.%A%
% 209.16/209.30 |- skos__hiddenLabel mesh__D015669 Acupoint
% 209.16/209.30 |- mesh__historyNote mesh__D015669 90
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D015669 2004
% 209.16/209.30 |- skos__altLabel mesh__D015669 Acupoints
% 209.16/209.30 |- skos__prefLabel mesh__D015669 Acupuncture Points
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D015669 90
% 209.16/209.30 |- skos__hiddenLabel mesh__D015669 Point, Acupuncture
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D015669 2003
% 209.16/209.30 |- skos__hiddenLabel mesh__D015669 Acupuncture Point
% 209.16/209.30 |- mesh__dateEstablished mesh__D015669 1990-01-01
% 209.16/209.30 |- mesh__dateCreated mesh__D015669 1989-04-07
% 209.16/209.30 |- mesh__recordOriginator mesh__D015669 EGC
% 209.16/209.30 |- mesh__dateRevised mesh__D015669 2001-07-25
% 209.16/209.30 |- skos__historyNote mesh__D015669 Acupuncture %28%1966-1989%29%
% 209.16/209.30 |- rdf__type mesh__D034823sskos__Concept
% 209.16/209.30 |- mesh__dateEstablished mesh__D034823 2003-01-01
% 209.16/209.30 |- skos__scopeNote mesh__D034823
% 209.16/209.30 A plant genus of the family COMMELINACEAE that is used in genotoxic bioassays.%A%
% 209.16/209.30 |- skos__altLabel mesh__D034823 Spiderwort
% 209.16/209.30 |- skos__annotation mesh__D034823
% 209.16/209.30 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.16/209.30 |- skos__broader mesh__D034823smesh__D034821
% 209.16/209.30 |- skos__prefLabel mesh__D034823 Tradescantia
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D034823 2005
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D034823 2003
% 209.16/209.30 |- mesh__historyNote mesh__D034823 2003
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D034823 2006
% 209.16/209.30 |- mesh__dateCreated mesh__D034823 2002-07-03
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D034823 2004
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D034823 2003
% 209.16/209.30 |- mesh__dateEstablished mesh__D001649 1980-01-01
% 209.16/209.30 |- skos__historyNote mesh__D001649 specific bile duct
% 209.16/209.30 |- skos__hiddenLabel mesh__D001649 Duct Diseases, Bile
% 209.16/209.30 |- skos__hiddenLabel mesh__D001649 Duct Disease, Bile
% 209.16/209.30 |- skos__scopeNote mesh__D001649
% 209.16/209.30 Diseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.%A%
% 209.16/209.30 |- mesh__recordOriginator mesh__D001649 SMH
% 209.16/209.30 |- mesh__publicMeSHNote mesh__D001649 80
% 209.16/209.30 |- skos__hiddenLabel mesh__D001649 Diseases, Bile Duct
% 209.16/209.30 |- skos__historyNote mesh__D001649 Bile Ducts %28%1966-1979%29%
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001649 2006
% 209.16/209.30 |- skos__hiddenLabel mesh__D001649 Disease, Bile Duct
% 209.16/209.30 |- skos__historyNote mesh__D001649 Biliary Tract Diseases %28%1966-1979%29%
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001649 2004
% 209.16/209.30 |- skos__broader mesh__D001649smesh__D001660
% 209.16/209.30 |- mesh__recordMaintainer mesh__D001649 lkt
% 209.16/209.30 |- rdf__type mesh__D001649sskos__Concept
% 209.16/209.30 |- skos__prefLabel mesh__D001649 Bile Duct Diseases
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D001649 2005
% 209.16/209.30 |- skos__historyNote mesh__D001649 Cholestasis %28%1966-1979%29%
% 209.16/209.30 |- mesh__dateCreated mesh__D001649 1979-05-29
% 209.16/209.30 |- mesh__historyNote mesh__D001649 80
% 209.16/209.30 |- skos__annotation mesh__D001649
% 209.16/209.30 inflamm dis = CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS + BILE DUCT DISEASES%A%
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D001649 sjn
% 209.16/209.30 |- mesh__dateRevised mesh__D001649 2003-07-09
% 209.16/209.30 |- skos__hiddenLabel mesh__D001649 Bile Duct Disease
% 209.16/209.30 |- skos__prefLabel mesh__D012371 Robotics
% 209.16/209.30 |- skos__historyNote mesh__D012371 Automation %28%1966-1986%29%
% 209.16/209.30 |- skos__hiddenLabel mesh__D012371 Operations, Remote %28%Robotics%29%
% 209.16/209.30 |- mesh__recordMaintainer mesh__D012371 sjn
% 209.16/209.30 |- skos__broader mesh__D012371smesh__D001331
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D012371 2006
% 209.16/209.30 |- mesh__dateEstablished mesh__D012371 1987-01-01
% 209.16/209.30 |- mesh__recordOriginator mesh__D012371 SH
% 209.16/209.30 |- mesh__activeMeSHYear mesh__D012371 2005
% 209.16/209.30 |- mesh__dateCreated mesh__D012371 1986-04-08
% 209.16/209.30 |- skos__historyNote mesh__D012371 Bionics %28%1966-1986%29%
% 209.16/209.30 |- skos__hiddenLabel mesh__D012371 Operation, Remote %28%Robotics%29%
% 209.16/209.30 |- skos__broader mesh__D012371smesh__D001185
% 209.16/209.30 |- skos__broader mesh__D012371smesh__D004581
% 209.16/209.30 |- mesh__dateRevised mesh__D012371 2004-07-13
% 209.16/209.30 |- rdf__type mesh__D012371sskos__Concept
% 209.16/209.30 |- mesh__historyNote mesh__D012371 87; was see AUTOMATION 1963-86
% 209.16/209.30 |- mesh__onlineNote mesh__D012371 search AUTOMATION 1966-86
% 209.16/209.30 |- mesh__recordAuthorizer mesh__D012371 sjn
% 209.16/209.30 |- skos__hiddenLabel mesh__D012371 Remote Operation %28%Robotics%29%
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D012371 87; was see AUTOMATION 1963-86
% 209.16/209.31 |- skos__scopeNote mesh__D012371
% 209.16/209.31 The application of electronic, computerized control systems to mechanical devices designed to perform human functions. Formerly restricted to industry, but nowadays applied to artificial organs controlled by bionic %28%bioelectronic%29% devices, like automated insulin pumps and other prostheses.%A%
% 209.16/209.31 |- skos__altLabel mesh__D020803 Herpes Encephalitis
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Herpetic Meningoencephalitides
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Meningoencephalitis, Herpes Simplex
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Herpetic Encephalitides
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020803 2005
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Encephalitis, Herpes
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D020803 2000
% 209.16/209.31 |- rdf__type mesh__D020803sskos__Concept
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Meningoencephalitis, Herpetic
% 209.16/209.31 |- skos__scopeNote mesh__D020803
% 209.16/209.31 An acute %28%or rarely chronic%29% inflammatory process of the brain caused by SIMPLEXVIRUS infections which may be fatal. The majority of infections are caused by human herpesvirus 1 %28%HERPESVIRUS 1, HUMAN%29% and less often by human herpesvirus 2 %28%HERPESVIRUS 2, HUMAN%29%. Clinical manifestations include FEVER; HEADACHE; SEIZURES; HALLUCINATIONS; behavioral alterations; APHASIA; hemiparesis; and COMA. Pathologically, the condition is marked by a hemorrhagic necrosis involving the medial and inferior TEMPORAL LOBE and orbital regions of the FRONTAL LOBE. %28%From Adams et al., Principles of Neurology, 6th ed, pp751-4%29%%A%
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020803 2006
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Encephalitides, Herpes Simplex
% 209.16/209.31 |- skos__altLabel mesh__D020803 Herpetic Meningoencephalitis
% 209.16/209.31 |- mesh__recordMaintainer mesh__D020803 sjn
% 209.16/209.31 |- skos__altLabel mesh__D020803 Herpetic Encephalitis
% 209.16/209.31 |- mesh__dateCreated mesh__D020803 1999-11-08
% 209.16/209.31 |- skos__altLabel mesh__D020803 Acute Necrotizing Encephalitis, Herpetic
% 209.16/209.31 |- skos__altLabel mesh__D020803 Herpes Simplex Encephalitis
% 209.16/209.31 |- mesh__dateEstablished mesh__D020803 2000-01-01
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Encephalitis, Herpetic
% 209.16/209.31 |- skos__prefLabel mesh__D020803 Encephalitis, Herpes Simplex
% 209.16/209.31 |- mesh__recordOriginator mesh__D020803 KEV
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Herpes Simplex Meningoencephalitides
% 209.16/209.31 |- skos__altLabel mesh__D020803 Herpes Simplex Meningoencephalitis
% 209.16/209.31 |- skos__broader mesh__D020803smesh__D006566
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D020803 sjn
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Meningoencephalitides, Herpetic
% 209.16/209.31 |- skos__broader mesh__D020803smesh__D018792
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Herpes Simplex Encephalitides
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Meningoencephalitides, Herpes Simplex
% 209.16/209.31 |- skos__hiddenLabel mesh__D020803 Encephalitides, Herpetic
% 209.16/209.31 |- skos__annotation mesh__D020803
% 209.16/209.31 coord IM with specific SIMPLEXVIRUS if given; DF: ENCEPH HERPES SIMPLEX%A%
% 209.16/209.31 |- mesh__dateRevised mesh__D020803 2004-07-13
% 209.16/209.31 |- mesh__historyNote mesh__D020803 2000
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Function Tests, Cardiac
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006334 2001
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Test, Cardiac Function
% 209.16/209.31 |- rdf__type mesh__D006334sskos__Concept
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Function Tests, Heart
% 209.16/209.31 |- mesh__recordOriginator mesh__D006334 NLM
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Tests, Cardiac Function
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006334 2000
% 209.16/209.31 |- mesh__recordMaintainer mesh__D006334 PXP
% 209.16/209.31 |- skos__prefLabel mesh__D006334 Heart Function Tests
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Heart Function Test
% 209.16/209.31 |- mesh__dateCreated mesh__D006334 1999-01-01
% 209.16/209.31 |- skos__broader mesh__D006334smesh__D003935
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Function Test, Heart
% 209.16/209.31 |- mesh__dateRevised mesh__D006334 1997-06-20
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006334 1999
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Function Test, Cardiac
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006334 2006
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006334 2002
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006334 1998
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Cardiac Function Test
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Tests, Heart Function
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006334 2005
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006334 2004
% 209.16/209.31 |- skos__annotation mesh__D006334 /drug eff /rad eff permitted
% 209.16/209.31 |- skos__altLabel mesh__D006334 Cardiac Function Tests
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D006334 SJN
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006334 2003
% 209.16/209.31 |- skos__hiddenLabel mesh__D006334 Test, Heart Function
% 209.16/209.31 |- mesh__dateEstablished mesh__D020005 1998-01-01
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020005 2005
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020005 2003
% 209.16/209.31 |- skos__broader mesh__D020005smesh__D000438
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020005 2002
% 209.16/209.31 |- mesh__dateCreated mesh__D020005 1997-06-20
% 209.16/209.31 |- skos__prefLabel mesh__D020005 Propanols
% 209.16/209.31 |- skos__scopeNote mesh__D020005
% 209.16/209.31 Isomeric forms and derivatives of PROPANOL %28%C3H7OH%29%.
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020005 1999
% 209.16/209.31 |- rdf__type mesh__D020005sskos__Concept
% 209.16/209.31 |- skos__hiddenLabel mesh__D020005 Propyl Alcohols
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020005 1998
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020005 2001
% 209.16/209.31 |- skos__altLabel mesh__D020005 Alcohols, Propyl
% 209.16/209.31 |- mesh__historyNote mesh__D020005 98
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020005 2006
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020005 2000
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D020005 98
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020005 2004
% 209.16/209.31 |- mesh__dateEstablished mesh__D050490 2006-01-01
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D050490 ags
% 209.16/209.31 |- skos__hiddenLabel mesh__D050490 tpr-met Fusion Proteins
% 209.16/209.31 |- skos__hiddenLabel mesh__D050490 Protein tpr-met, Oncogene
% 209.16/209.31 |- skos__hiddenLabel mesh__D050490 tpr-met, Oncogene Protein
% 209.16/209.31 |- rdf__type mesh__D050490sskos__Concept
% 209.16/209.31 |- skos__scopeNote mesh__D050490
% 209.16/209.31 The GENETIC TRANSLATION product from a GENE FUSION between a sequence from the tpr protein gene on the human CHROMOSOME 1 and the gene for PROTO-ONCOGENE PROTEINS C-MET.%A%
% 209.16/209.31 |- skos__hiddenLabel mesh__D050490 Oncogene Protein tpr met
% 209.16/209.31 |- skos__broader mesh__D050490smesh__D015514
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D050490
% 209.16/209.31 2006; see ONCOGENE PROTEINS, FUSION 1990-2005
% 209.16/209.31 |- mesh__dateCreated mesh__D050490 2005-06-30
% 209.16/209.31 |- mesh__recordOriginator mesh__D050490 nns
% 209.16/209.31 |- skos__altLabel mesh__D050490 Fusion Proteins, tpr-met
% 209.16/209.31 |- mesh__historyNote mesh__D050490
% 209.16/209.31 2006; use ONCOGENE PROTEINS, FUSION 1990-2005
% 209.16/209.31 |- skos__prefLabel mesh__D050490 Oncogene Protein tpr-met
% 209.16/209.31 |- skos__hiddenLabel mesh__D050490 Fusion Proteins, tpr met
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D050490 2006A
% 209.16/209.31 |- mesh__recordMaintainer mesh__D050490 ags
% 209.16/209.31 |- mesh__dateRevised mesh__D050490 2005-07-27
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D050490 2006
% 209.16/209.31 |- rdf__type mesh__D011279sskos__Concept
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D011279 2005
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D011279 sjn
% 209.16/209.31 |- skos__altLabel mesh__D011279 5beta-Pregnane-3alpha,17alpha,20alpha-triol
% 209.16/209.31 |- mesh__dateCreated mesh__D011279 1999-01-01
% 209.16/209.31 |- skos__broader mesh__D011279smesh__D019326
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D011279 2004
% 209.16/209.31 |- skos__altLabel mesh__D011279 5-beta-Pregnane-3,17,20-triol
% 209.16/209.31 |- mesh__dateEstablished mesh__D011279 1966-01-01
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D011279 66
% 209.16/209.31 |- skos__prefLabel mesh__D011279 Pregnanetriol
% 209.16/209.31 |- mesh__recordMaintainer mesh__D011279 lkt
% 209.16/209.31 |- mesh__dateRevised mesh__D011279 2003-07-09
% 209.16/209.31 |- mesh__historyNote mesh__D011279 66%28%64%29%
% 209.16/209.31 |- skos__broader mesh__D011279smesh__D011278
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D011279 2006
% 209.16/209.31 |- mesh__recordOriginator mesh__D011279 NLM
% 209.16/209.31 |- skos__scopeNote mesh__D011279
% 209.16/209.31 A metabolite of 17-ALPHA-HYDROXYPROTESTERONE, normally produced in small quantities by the GONADS and the ADRENAL GLANDS, found in URINE. An elevated urinary pregnanetriol is associated with CONGENITAL ADRENAL HYPERPLASIA with a deficiency of STEROID 21-HYDROXYLASE.%A%
% 209.16/209.31 |- mesh__historyNote mesh__D016762 92
% 209.16/209.31 |- skos__hiddenLabel mesh__D016762 c-fos Gene
% 209.16/209.31 |- skos__historyNote mesh__D016762 Oncogenes %28%1983-1991%29%
% 209.16/209.31 |- skos__altLabel mesh__D016762 v-fos Oncogenes
% 209.16/209.31 |- skos__related mesh__D016762smesh__D016760
% 209.16/209.31 |- skos__broader mesh__D016762smesh__D011519
% 209.16/209.31 |- mesh__dateEstablished mesh__D016762 1992-01-01
% 209.16/209.31 |- rdf__type mesh__D016762sskos__Concept
% 209.16/209.31 |- skos__altLabel mesh__D016762 c-fos Proto-Oncogenes
% 209.16/209.31 |- skos__hiddenLabel mesh__D016762 v-fos Gene
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D016762 sjn
% 209.16/209.31 |- skos__hiddenLabel mesh__D016762 v fos Genes
% 209.16/209.31 |- skos__altLabel mesh__D016762 fos Genes
% 209.16/209.31 |- skos__related mesh__D016762smesh__D016761
% 209.16/209.31 |- mesh__dateRevised mesh__D016762 2005-06-30
% 209.16/209.31 |- skos__scopeNote mesh__D016762
% 209.16/209.31 Retrovirus-associated DNA sequences %28%fos%29% originally isolated from the Finkel-Biskis-Jinkins %28%FBJ-MSV%29% and Finkel-Biskis-Reilly %28%FBR-MSV%29% murine sarcoma viruses. The proto-oncogene protein c-fos codes for a nuclear protein which is involved in growth-related transcriptional control. The insertion of c-fos into FBJ-MSV or FBR-MSV induces osteogenic sarcomas in mice. The human c-fos gene is located at 14q21-31 on the long arm of chromosome 14.%A%
% 209.16/209.31 |- skos__historyNote mesh__D016762 Proto-Oncogenes %28%1985-1991%29%
% 209.16/209.31 |- skos__prefLabel mesh__D016762 Genes, fos
% 209.16/209.31 |- mesh__dateCreated mesh__D016762 1991-07-12
% 209.16/209.31 |- skos__hiddenLabel mesh__D016762 fos Gene
% 209.16/209.31 |- skos__hiddenLabel mesh__D016762 c fos Genes
% 209.16/209.31 |- skos__hiddenLabel mesh__D016762 v-fos Oncogene
% 209.16/209.31 |- skos__hiddenLabel mesh__D016762 v fos Oncogenes
% 209.16/209.31 |- skos__annotation mesh__D016762
% 209.16/209.31 fos stands for %22%Finkel%22% %26% %22%Osteogenic Sarcoma%22%
% 209.16/209.31 |- mesh__recordOriginator mesh__D016762 AGS
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D016762 2006
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D016762 92
% 209.16/209.31 |- skos__hiddenLabel mesh__D016762 c fos Proto Oncogenes
% 209.16/209.31 |- mesh__recordMaintainer mesh__D016762 nns
% 209.16/209.31 |- skos__hiddenLabel mesh__D016762 c-fos Proto-Oncogene
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002742 2005
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002742 2002
% 209.16/209.31 |- skos__broader mesh__D002742smesh__D000578
% 209.16/209.31 |- skos__altLabel mesh__D002742 Chlordimeform
% 209.16/209.31 |- skos__scopeNote mesh__D002742
% 209.16/209.31 An acaricide used against many organophosphate and carbamate resistant pests. It acts as an uncoupling agent and monoamine oxidase inhibitor.%A%
% 209.16/209.31 |- skos__historyNote mesh__D002742 Toluene %28%1972-1974%29%
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002742 2004
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002742 2001
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D002742 91; was see under AMIDINES 1975-90
% 209.16/209.31 |- mesh__dateCreated mesh__D002742 1974-11-11
% 209.16/209.31 |- rdf__type mesh__D002742sskos__Concept
% 209.16/209.31 |- mesh__historyNote mesh__D002742
% 209.16/209.31 91%28%75%29%; was see under AMIDINES 1975-90
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002742 2003
% 209.16/209.31 |- mesh__recordMaintainer mesh__D002742 CCR
% 209.16/209.31 |- skos__annotation mesh__D002742 TN 111 for eff on insects, etc.
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D002742 sjn
% 209.16/209.31 |- mesh__recordOriginator mesh__D002742 NLM
% 209.16/209.31 |- mesh__dateEstablished mesh__D002742 1991-01-01
% 209.16/209.31 |- skos__prefLabel mesh__D002742 Chlorphenamidine
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002742 2006
% 209.16/209.31 |- skos__historyNote mesh__D002742 Amidines %28%1971-1974%29%
% 209.16/209.31 |- mesh__dateRevised mesh__D002742 2000-06-22
% 209.16/209.31 |- skos__altLabel mesh__D040861 Business Ethics
% 209.16/209.31 |- mesh__recordOriginator mesh__D040861 hjn
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D040861 sjn
% 209.16/209.31 |- mesh__dateEstablished mesh__D040861 2003-01-01
% 209.16/209.31 |- skos__scopeNote mesh__D040861
% 209.16/209.31 The moral obligations governing the conduct of commercial or industrial enterprises.%A%
% 209.16/209.31 |- mesh__dateRevised mesh__D040861 2003-07-25
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D040861 2004
% 209.16/209.31 |- skos__related mesh__D040861smesh__D004991
% 209.16/209.31 |- skos__altLabel mesh__D040861 Corporate Ethics
% 209.16/209.31 |- mesh__recordMaintainer mesh__D040861 sjn
% 209.16/209.31 |- skos__related mesh__D040861smesh__D003132
% 209.16/209.31 |- skos__prefLabel mesh__D040861 Ethics, Business
% 209.16/209.31 |- skos__broader mesh__D040861smesh__D004989
% 209.16/209.31 |- skos__related mesh__D040861smesh__D007221
% 209.16/209.31 |- rdf__type mesh__D040861sskos__Concept
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D040861 2006
% 209.16/209.31 |- mesh__dateCreated mesh__D040861 2002-07-02
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D040861 2005
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D040861 2003
% 209.16/209.31 |- mesh__historyNote mesh__D040861 2003
% 209.16/209.31 |- mesh__recordOriginator mesh__D012372 EC
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D012372 2005
% 209.16/209.31 |- mesh__historyNote mesh__D012372 88
% 209.16/209.31 |- skos__broader mesh__D012372smesh__D013223
% 209.16/209.31 |- skos__broader mesh__D012372smesh__D012680
% 209.16/209.31 |- skos__hiddenLabel mesh__D012372 Curve, ROC
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D012372 sjn
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D012372 2004
% 209.16/209.31 |- skos__prefLabel mesh__D012372 ROC Curve
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D012372 2002
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D012372 2006
% 209.16/209.31 |- skos__annotation mesh__D012372 ROC: note 1st X ref; no qualif
% 209.16/209.31 |- skos__hiddenLabel mesh__D012372 Analyses, ROC
% 209.16/209.31 |- skos__hiddenLabel mesh__D012372 ROC Curves
% 209.16/209.31 |- skos__hiddenLabel mesh__D012372 ROC Analyses
% 209.16/209.31 |- skos__hiddenLabel mesh__D012372 Characteristics, Receiver Operating
% 209.16/209.31 |- skos__hiddenLabel mesh__D012372 Curves, ROC
% 209.16/209.31 |- skos__altLabel mesh__D012372 Analysis, ROC
% 209.16/209.31 |- rdf__type mesh__D012372sskos__Concept
% 209.16/209.31 |- mesh__recordMaintainer mesh__D012372 ags
% 209.16/209.31 |- mesh__dateEstablished mesh__D012372 1988-01-01
% 209.16/209.31 |- mesh__dateCreated mesh__D012372 1987-04-06
% 209.16/209.31 |- skos__hiddenLabel mesh__D012372 Receiver Operating Characteristics
% 209.16/209.31 |- skos__hiddenLabel mesh__D012372 Characteristic, Receiver Operating
% 209.16/209.31 |- skos__altLabel mesh__D012372 ROC Analysis
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D012372 2003
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D012372 88
% 209.16/209.31 |- mesh__dateRevised mesh__D012372 2001-07-25
% 209.16/209.31 |- skos__scopeNote mesh__D012372
% 209.16/209.31 A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli.%A%
% 209.16/209.31 |- skos__broader mesh__D020804smesh__D018792
% 209.16/209.31 |- rdf__type mesh__D020804sskos__Concept
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020804 2001
% 209.16/209.31 |- skos__altLabel mesh__D020804 Varicella Encephalitis
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020804 2006
% 209.16/209.31 |- skos__altLabel mesh__D020804 Encephalitis, Herpes Zoster
% 209.16/209.31 |- skos__scopeNote mesh__D020804
% 209.16/209.31 Inflammation of brain tissue caused by infection with the varicella-zoster virus %28%HERPESVIRUS 3, HUMAN%29%. This condition is associated with immunocompromised states, including the ACQUIRED IMMUNODEFICIENCY SYNDROME. Pathologically, the virus tends to induce a vasculopathy and infect oligodendrocytes and ependymal cells, leading to CEREBRAL INFARCTION, multifocal regions of demyelination, and periventricular necrosis. Manifestations of varicella encephalitis usually occur 5-7 days after onset of HERPES ZOSTER and include HEADACHE; VOMITING; lethargy; focal neurologic deficits; FEVER; and COMA. %28%From Joynt, Clinical Neurology, 1996, Ch 26, pp29-32; Hum Pathol 1996 Sep;27%28%9%29%:927-38%29%%A%
% 209.16/209.31 |- skos__altLabel mesh__D020804 Herpes Zoster Encephalitis
% 209.16/209.31 |- skos__altLabel mesh__D020804 Encephalitis, Varicella
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020804 2002
% 209.16/209.31 |- skos__hiddenLabel mesh__D020804 Varicella Encephalitides
% 209.16/209.31 |- mesh__dateEstablished mesh__D020804 2000-01-01
% 209.16/209.31 |- skos__prefLabel mesh__D020804 Encephalitis, Varicella Zoster
% 209.16/209.31 |- skos__hiddenLabel mesh__D020804 Virus Encephalitis, VZ
% 209.16/209.31 |- skos__altLabel mesh__D020804 Encephalitis, VZ Virus
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D020804 2000
% 209.16/209.31 |- skos__historyNote mesh__D020804 Encephalitis %28%1966-1999%29%
% 209.16/209.31 |- skos__historyNote mesh__D020804 Herpes Zoster %28%1966-1999%29%
% 209.16/209.31 |- skos__altLabel mesh__D020804 Herpes Zoster Meningoencephalitis
% 209.16/209.31 |- skos__broader mesh__D020804smesh__D006566
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020804 2003
% 209.16/209.31 |- mesh__dateCreated mesh__D020804 1999-11-08
% 209.16/209.31 |- mesh__historyNote mesh__D020804 2000
% 209.16/209.31 |- skos__altLabel mesh__D020804 Encephalitis, Human Herpesvirus 3
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020804 2004
% 209.16/209.31 |- skos__hiddenLabel mesh__D020804 Zoster Encephalitis, Varicella
% 209.16/209.31 |- skos__hiddenLabel mesh__D020804 Zoster Encephalitis, Herpes
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020804 2005
% 209.16/209.31 |- skos__annotation mesh__D020804 DF: ENCEPH VARICELLA ZOSTER
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020804 2000
% 209.16/209.31 |- skos__altLabel mesh__D020804 Varicella Zoster Encephalitis
% 209.16/209.31 |- mesh__dateCreated mesh__D006335 1999-01-01
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 2002
% 209.16/209.31 |- skos__altLabel mesh__D006335 Cardiac Rupture, Traumatic
% 209.16/209.31 |- mesh__dateRevised mesh__D006335 1994-02-08
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 1999
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Ruptures, Traumatic Heart
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 2006
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Injury, Heart
% 209.16/209.31 |- skos__scopeNote mesh__D006335
% 209.16/209.31 General or unspecified injuries to the heart.
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Traumatic Heart Ruptures
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Traumatic Heart Rupture
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 1998
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Rupture, Traumatic Heart
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 1997
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 2005
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 2004
% 209.16/209.31 |- mesh__recordMaintainer mesh__D006335 TGC
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 2001
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 1996
% 209.16/209.31 |- skos__prefLabel mesh__D006335 Heart Injuries
% 209.16/209.31 |- skos__annotation mesh__D006335
% 209.16/209.31 coord IM with specific part of heart /inj %28%NIM%29%
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Cardiac Ruptures, Traumatic
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Traumatic Cardiac Rupture
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 2003
% 209.16/209.31 |- skos__broader mesh__D006335smesh__D013898
% 209.16/209.31 |- mesh__recordOriginator mesh__D006335 NLM
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Ruptures, Traumatic Cardiac
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D006335 PLS
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 2000
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Heart Ruptures, Traumatic
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Rupture, Traumatic Cardiac
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006335 1995
% 209.16/209.31 |- rdf__type mesh__D006335sskos__Concept
% 209.16/209.31 |- skos__altLabel mesh__D006335 Injuries, Heart
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Heart Injury
% 209.16/209.31 |- skos__hiddenLabel mesh__D006335 Traumatic Cardiac Ruptures
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D050491
% 209.16/209.31 2006; SODIUM-GLUTAMATE COTRANSPORTER was indexed under AMINO ACID TRANSPORT SYSTEM X-AG %26% SYMPORTERS 2003-2005, CARRIER PROTEINS 1984-2002%A%
% 209.16/209.31 |- mesh__dateCreated mesh__D050491 2005-06-30
% 209.16/209.31 |- skos__hiddenLabel mesh__D050491
% 209.16/209.31 Neurotransmitter Transport Proteins, Glutamate Specific
% 209.16/209.31 |- mesh__recordMaintainer mesh__D050491 DRC
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D050491 sjn
% 209.16/209.31 |- skos__scopeNote mesh__D050491
% 209.16/209.31 A family of plasma membrane neurotransmitter transporter proteins that couple the uptake of GLUTAMATE with the import of SODIUM ions and PROTONS and the export of POTASSIUM ions. In the CENTRAL NERVOUS SYSTEM they regulate neurotransmission through synaptic reuptake of the excitatory neurotransmitter glutamate. Outside the central nervous system they function as signal mediators and regulators of glutamate metabolism.%A%
% 209.16/209.31 |- skos__altLabel mesh__D050491 Excitatory Amino Acid Transport Proteins
% 209.16/209.31 |- mesh__dateEstablished mesh__D050491 2006-01-01
% 209.16/209.31 |- mesh__recordOriginator mesh__D050491 DRC
% 209.16/209.31 |- skos__broader mesh__D050491smesh__D050480
% 209.16/209.31 |- skos__hiddenLabel mesh__D050491
% 209.16/209.31 Neurotransmitter Transporters, Glutamate Specific
% 209.16/209.31 |- skos__prefLabel mesh__D050491
% 209.16/209.31 Glutamate Plasma Membrane Transport Proteins
% 209.16/209.31 |- skos__altLabel mesh__D050491
% 209.16/209.31 Neurotransmitter Transporters, Glutamate-Specific
% 209.16/209.31 |- skos__altLabel mesh__D050491
% 209.16/209.31 Neurotransmitter Transport Proteins, Glutamate-Specific
% 209.16/209.31 |- skos__historyNote mesh__D050491 Symporters %28%1984-2005%29%
% 209.16/209.31 |- mesh__historyNote mesh__D050491 2006%28%1984%29%
% 209.16/209.31 |- skos__historyNote mesh__D050491
% 209.16/209.31 Amino Acid Transport System X-AG %28%1984-2005%29%
% 209.16/209.31 |- skos__hiddenLabel mesh__D050491 Cotransporter, Sodium-Glutamate
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D050491 2006
% 209.16/209.31 |- skos__broader mesh__D050491smesh__D027322
% 209.16/209.31 |- skos__altLabel mesh__D050491 Sodium-Glutamate Transporter
% 209.16/209.31 |- skos__hiddenLabel mesh__D050491 Sodium Glutamate Transporter
% 209.16/209.31 |- skos__altLabel mesh__D050491 EAAT Proteins
% 209.16/209.31 |- skos__hiddenLabel mesh__D050491 Sodium Glutamate Cotransporter
% 209.16/209.31 |- skos__broader mesh__D050491smesh__D027981
% 209.16/209.31 |- skos__hiddenLabel mesh__D050491
% 209.16/209.31 Transporters, Glutamate-Specific Neurotransmitter
% 209.16/209.31 |- skos__altLabel mesh__D050491
% 209.16/209.31 Glutamate Plasma Membrane Transporter Proteins
% 209.16/209.31 |- rdf__type mesh__D050491sskos__Concept
% 209.16/209.31 |- skos__hiddenLabel mesh__D050491
% 209.16/209.31 Glutamate-Specific Neurotransmitter Transporters
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002743 2006
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002743 2002
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002743 2005
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D002743 74
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002743 2001
% 209.16/209.31 |- skos__prefLabel mesh__D002743 Chlorphenesin
% 209.16/209.31 |- skos__broader mesh__D002743smesh__D011409
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002743 2004
% 209.16/209.31 |- mesh__recordOriginator mesh__D002743 NLM
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D002743 sjn
% 209.16/209.31 |- rdf__type mesh__D002743sskos__Concept
% 209.16/209.31 |- mesh__recordMaintainer mesh__D002743 CCR
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D002743 2003
% 209.16/209.31 |- mesh__historyNote mesh__D002743 74%28%64%29%
% 209.16/209.31 |- skos__scopeNote mesh__D002743
% 209.16/209.31 A centrally acting muscle relaxant. Its mode of action is unknown. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1203%29%%A%
% 209.16/209.31 |- mesh__dateEstablished mesh__D002743 1974-01-01
% 209.16/209.31 |- mesh__dateRevised mesh__D002743 2000-06-22
% 209.16/209.31 |- mesh__dateCreated mesh__D002743 1999-01-01
% 209.16/209.31 |- skos__altLabel mesh__D012373 Typhus, Sao Paulo
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D012373 2006
% 209.16/209.31 |- mesh__dateCreated mesh__D012373 1999-01-01
% 209.16/209.31 |- mesh__recordAuthorizer mesh__D012373 sjn
% 209.16/209.31 |- rdf__type mesh__D012373sskos__Concept
% 209.16/209.31 |- mesh__recordOriginator mesh__D012373 NLM
% 209.16/209.31 |- mesh__recordMaintainer mesh__D012373 ags
% 209.16/209.31 |- skos__scopeNote mesh__D012373
% 209.16/209.31 An acute febrile illness caused by RICKETTSIA RICKETTSII. It is transmitted to humans by bites of infected ticks and occurs only in North and South America. Characteristics include a sudden onset with headache and chills and fever lasting about two to three weeks. A cutaneous rash commonly appears on the extremities and trunk about the fourth day of illness.%A%
% 209.16/209.31 |- skos__prefLabel mesh__D012373 Rocky Mountain Spotted Fever
% 209.16/209.31 |- mesh__dateRevised mesh__D012373 2003-07-09
% 209.16/209.31 |- mesh__historyNote mesh__D012373
% 209.16/209.31 SAO PAULO TYPHUS was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-76%A%
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D012373 2005
% 209.16/209.31 |- skos__broader mesh__D012373smesh__D017282
% 209.16/209.31 |- skos__broader mesh__D012373smesh__D012282
% 209.16/209.31 |- skos__altLabel mesh__D012373 Sao Paulo Typhus
% 209.16/209.31 |- skos__annotation mesh__D012373
% 209.16/209.31 caused by Rickettsia rickettsii; for X ref, in titles %26% translations use diacrit: S%C3%%A3%o Paulo%A%
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D012373 2004
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020805 2003
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020805 2002
% 209.16/209.31 |- skos__altLabel mesh__D020805 Infections, CNS, Viral
% 209.16/209.31 |- skos__altLabel mesh__D020805 Viral Diseases, Central Nervous System
% 209.16/209.31 |- mesh__historyNote mesh__D020805 2000
% 209.16/209.31 |- skos__altLabel mesh__D020805 Viral Infections, Central Nervous System
% 209.16/209.31 |- skos__broader mesh__D020805smesh__D002494
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020805 2001
% 209.16/209.31 |- rdf__type mesh__D020805sskos__Concept
% 209.16/209.31 |- skos__hiddenLabel mesh__D020805 Viral CNS Infection
% 209.16/209.31 |- skos__scopeNote mesh__D020805
% 209.16/209.31 Viral infections of the brain, spinal cord, meninges, or perimeningeal spaces.%A%
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020805 2006
% 209.16/209.31 |- skos__hiddenLabel mesh__D020805 Infection, Viral CNS
% 209.16/209.31 |- skos__hiddenLabel mesh__D020805 Viral CNS Infections
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020805 2000
% 209.16/209.31 |- mesh__dateEstablished mesh__D020805 2000-01-01
% 209.16/209.31 |- skos__annotation mesh__D020805
% 209.16/209.31 coord IM with specific virus disease %28%IM%29% and specific site/dis term if pertinent; DF: CNS VIRAL DIS%A%
% 209.16/209.31 |- skos__hiddenLabel mesh__D020805 CNS Infection, Viral
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020805 2005
% 209.16/209.31 |- skos__prefLabel mesh__D020805 Central Nervous System Viral Diseases
% 209.16/209.31 |- skos__historyNote mesh__D020805
% 209.16/209.31 Central Nervous System Diseases %28%1966-1999%29%
% 209.16/209.31 |- skos__historyNote mesh__D020805 Meningitis, Viral %28%1967-1999%29%
% 209.16/209.31 |- skos__broader mesh__D020805smesh__D014777
% 209.16/209.31 |- skos__altLabel mesh__D020805 Infections, Viral CNS
% 209.16/209.31 |- mesh__dateCreated mesh__D020805 1999-11-03
% 209.16/209.31 |- skos__hiddenLabel mesh__D020805 CNS Infections, Viral
% 209.16/209.31 |- skos__historyNote mesh__D020805 Virus Diseases %28%1966-1999%29%
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D020805 2004
% 209.16/209.31 |- skos__altLabel mesh__D020805 Central Nervous System Viral Infections
% 209.16/209.31 |- skos__historyNote mesh__D020805 Encephalitis %28%1967-1999%29%
% 209.16/209.31 |- mesh__publicMeSHNote mesh__D020805 2000
% 209.16/209.31 |- skos__broader mesh__D006336smesh__D006348
% 209.16/209.31 |- mesh__dateRevised mesh__D006336 1997-06-20
% 209.16/209.31 |- skos__hiddenLabel mesh__D006336 Cardiac Massages
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006336 1998
% 209.16/209.31 |- skos__annotation mesh__D006336
% 209.16/209.31 do not use /util except by MeSH definition
% 209.16/209.31 |- skos__hiddenLabel mesh__D006336 Heart Massages
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006336 2004
% 209.16/209.31 |- mesh__activeMeSHYear mesh__D006336 2005
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D006336 2002
% 209.16/209.32 |- skos__hiddenLabel mesh__D006336 Massages, Cardiac
% 209.16/209.32 |- skos__hiddenLabel mesh__D006336 Massage, Cardiac
% 209.16/209.32 |- skos__altLabel mesh__D006336 Cardiac Massage
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D006336 2003
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D006336 SJN
% 209.16/209.32 |- rdf__type mesh__D006336sskos__Concept
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D006336 2001
% 209.16/209.32 |- mesh__dateCreated mesh__D006336 1999-01-01
% 209.16/209.32 |- skos__scopeNote mesh__D006336
% 209.16/209.32 Rhythmic compression of the heart by pressure applied manually over the sternum %28%closed heart massage%29% or directly to the heart through an opening in the chest wall %28%open heart massage%29%. It is done to reinstate and maintain circulation. %28%Dorland, 28th ed%29%%A%
% 209.16/209.32 |- skos__broader mesh__D006336smesh__D012151
% 209.16/209.32 |- skos__hiddenLabel mesh__D006336 Massage, Heart
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D006336 2000
% 209.16/209.32 |- mesh__recordOriginator mesh__D006336 NLM
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D006336 1999
% 209.16/209.32 |- skos__hiddenLabel mesh__D006336 Massages, Heart
% 209.16/209.32 |- mesh__recordMaintainer mesh__D006336 PXP
% 209.16/209.32 |- skos__prefLabel mesh__D006336 Heart Massage
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D006336 2006
% 209.16/209.32 |- skos__hiddenLabel mesh__D020007 Implant, Experimental
% 209.16/209.32 |- skos__prefLabel mesh__D020007 Implants, Experimental
% 209.16/209.32 |- rdf__type mesh__D020007sskos__Concept
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020007 1998
% 209.16/209.32 |- skos__hiddenLabel mesh__D020007 Experimental Implant
% 209.16/209.32 |- mesh__historyNote mesh__D020007 98
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020007 2006
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020007 2001
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020007 2004
% 209.16/209.32 |- skos__hiddenLabel mesh__D020007 Experimental Implants
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020007 2000
% 209.16/209.32 |- mesh__dateEstablished mesh__D020007 1998-01-01
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020007 2005
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020007 2003
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D020007 98
% 209.16/209.32 |- skos__historyNote mesh__D020007
% 209.16/209.32 Prostheses and Implants %28%1966-1997%29%
% 209.16/209.32 |- skos__broader mesh__D020007smesh__D019736
% 209.16/209.32 |- skos__scopeNote mesh__D020007
% 209.16/209.32 Artificial substitutes for body parts and materials inserted into organisms during experimental studies.%A%
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020007 2002
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020007 1999
% 209.16/209.32 |- mesh__dateCreated mesh__D020007 1997-06-20
% 209.16/209.32 |- skos__altLabel mesh__D050492 Vesicular Amine Transporter Proteins
% 209.16/209.32 |- mesh__recordOriginator mesh__D050492 DRC
% 209.16/209.32 |- skos__prefLabel mesh__D050492
% 209.16/209.32 Vesicular Biogenic Amine Transport Proteins
% 209.16/209.32 |- skos__altLabel mesh__D050492 Vesicular Amine Transport Proteins
% 209.16/209.32 |- mesh__dateCreated mesh__D050492 2005-06-30
% 209.16/209.32 |- mesh__historyNote mesh__D050492 2006%28%1992%29%
% 209.16/209.32 |- mesh__recordMaintainer mesh__D050492 DRC
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D050492 sjn
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D050492 2006
% 209.16/209.32 |- skos__broader mesh__D050492smesh__D050481
% 209.16/209.32 |- mesh__dateEstablished mesh__D050492 2006-01-01
% 209.16/209.32 |- rdf__type mesh__D050492sskos__Concept
% 209.16/209.32 |- skos__hiddenLabel mesh__D050492 Amine Transporter, Vesicular
% 209.16/209.32 |- skos__altLabel mesh__D050492 Vesicular Amine Transporter
% 209.16/209.32 |- skos__altLabel mesh__D050492 Biogenic Amine Transporters, Vesicular
% 209.16/209.32 |- skos__scopeNote mesh__D050492
% 209.16/209.32 Integral membrane proteins of the LIPID BILAYER of SECRETORY VESICLES that catalyze transport and storage of biogenic amine NEUROTRANSMITTERS such as ACETYLCHOLINE; SEROTONIN; MELATONIN; HISTAMINE; and CATECHOLAMINES. The transporters exchange vesicular protons for cytoplasmic neurotransmitters.%A%
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D050492
% 209.16/209.32 2006; VESICULAR AMINE TRANSPORTER was indexed under MEMBRANE GLYCOPROTEINS 1997-2005, under NEUROPEPTIDES 1997-2005, %26% under GLYCOPROTEINS 1992-1996%A%
% 209.16/209.32 |- skos__altLabel mesh__D050492 Vesicular Biogenic Amine Transporters
% 209.16/209.32 |- rdf__type mesh__D016764sskos__Concept
% 209.16/209.32 |- skos__hiddenLabel mesh__D016764 Cell Polarities
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 1997
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 2001
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 1994
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 1999
% 209.16/209.32 |- mesh__dateCreated mesh__D016764 1991-05-02
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 1993
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 2003
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 1995
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 2005
% 209.16/209.32 |- mesh__recordMaintainer mesh__D016764 TAP
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 2004
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D016764 92
% 209.16/209.32 |- skos__prefLabel mesh__D016764 Cell Polarity
% 209.16/209.32 |- skos__scopeNote mesh__D016764
% 209.16/209.32 Orientation of intracellular structures especially with respect to the apical and basolateral domains of the plasma membrane. Polarized cells must direct proteins from the Golgi apparatus to the appropriate domain since tight junctions prevent proteins from diffusing between the two domains.%A%
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 2002
% 209.16/209.32 |- skos__broader mesh__D016764smesh__D002468
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 2006
% 209.16/209.32 |- mesh__dateRevised mesh__D016764 1992-05-07
% 209.16/209.32 |- mesh__dateEstablished mesh__D016764 1992-01-01
% 209.16/209.32 |- skos__hiddenLabel mesh__D016764 Polarities, Cell
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D016764 PLS
% 209.16/209.32 |- mesh__historyNote mesh__D016764 92
% 209.16/209.32 |- skos__hiddenLabel mesh__D016764 Polarity, Cell
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 1996
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 2000
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016764 1998
% 209.16/209.32 |- mesh__recordOriginator mesh__D016764 AGS
% 209.16/209.32 |- skos__annotation mesh__D016764
% 209.16/209.32 orientation of intracell struct to plasma membrane
% 209.16/209.32 |- skos__altLabel mesh__D002744
% 209.16/209.32 Schering-Plough Brand of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__altLabel mesh__D002744 Vortech Brand 2 of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__prefLabel mesh__D002744 Chlorpheniramine
% 209.16/209.32 |- mesh__dateRevised mesh__D002744 2005-06-30
% 209.16/209.32 |- skos__altLabel mesh__D002744 Llorens Brand of Chlorpheniramine Maleate
% 209.16/209.32 |- mesh__recordMaintainer mesh__D002744 lkw
% 209.16/209.32 |- skos__hiddenLabel mesh__D002744 Tannate, Chlorpheniramine
% 209.16/209.32 |- mesh__historyNote mesh__D002744 65%28%63%29%
% 209.16/209.32 |- skos__altLabel mesh__D002744 Schering Brand of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__altLabel mesh__D002744 Vortech Brand 3 of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__altLabel mesh__D002744
% 209.16/209.32 Halsey Drug Brand of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__altLabel mesh__D002744 Bayer Brand of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__altLabel mesh__D002744 Rugby Brand of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__altLabel mesh__D002744 Chlorphenamine
% 209.16/209.32 |- skos__hiddenLabel mesh__D002744 Maleate, Chlorpheniramine
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D002744 65
% 209.16/209.32 |- skos__annotation mesh__D002744 a histamine H1 antag %26% antipruritic
% 209.16/209.32 |- mesh__dateCreated mesh__D002744 1999-01-01
% 209.16/209.32 |- skos__altLabel mesh__D002744 Chlorprophenpyridamine
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D002744 2006
% 209.16/209.32 |- skos__altLabel mesh__D002744 Vortech Brand 1 of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__altLabel mesh__D002744 Cloro-Trimeton
% 209.16/209.32 |- skos__altLabel mesh__D002744
% 209.16/209.32 Stafford-Miller Brand of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__altLabel mesh__D002744 Schein Brand of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__altLabel mesh__D002744 Intra Brand of Chlorpheniramine Maleate
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D002744 sjn
% 209.16/209.32 |- mesh__recordOriginator mesh__D002744 NLM
% 209.16/209.32 |- skos__altLabel mesh__D002744 Hogil Brand 1 of Chlorpheniramine Maleate
% 209.16/209.32 |- skos__broader mesh__D002744smesh__D010632
% 209.16/209.32 |- skos__altLabel mesh__D002744 Hogil Brand 2 of Chlorpheniramine Maleate
% 209.16/209.32 |- mesh__dateEstablished mesh__D002744 1965-01-01
% 209.16/209.32 |- skos__scopeNote mesh__D002744
% 209.16/209.32 A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.%A%
% 209.16/209.32 |- rdf__type mesh__D002744sskos__Concept
% 209.16/209.32 |- skos__historyNote mesh__D048048 Information Systems %28%1980-2004%29%
% 209.16/209.32 |- skos__prefLabel mesh__D048048 Dental Informatics
% 209.16/209.32 |- mesh__dateEstablished mesh__D048048 2005-01-01
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D048048 sjn
% 209.16/209.32 |- mesh__dateCreated mesh__D048048 2004-07-07
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D048048 2005
% 209.16/209.32 |- skos__broader mesh__D048048smesh__D048088
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D048048 2006
% 209.16/209.32 |- mesh__recordMaintainer mesh__D048048 jls
% 209.16/209.32 |- skos__hiddenLabel mesh__D048048 Informatics, Dental
% 209.16/209.32 |- mesh__recordOriginator mesh__D048048 jls
% 209.16/209.32 |- rdf__type mesh__D048048sskos__Concept
% 209.16/209.32 |- skos__scopeNote mesh__D048048
% 209.16/209.32 The application of computer and information sciences to improve dental practice, research, education and management.%A%
% 209.16/209.32 |- mesh__historyNote mesh__D048048 2005
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D048048 2005
% 209.16/209.32 |- skos__broader mesh__D034841Q000293smesh__D034841
% 209.16/209.32 |- mesh__preferredCombination mesh__D034841Q000293smesh__D000007
% 209.16/209.32 |- rdf__type mesh__D034841Q000293smesh__CompoundConcept
% 209.16/209.32 |- mesh__dateCreated mesh__D012374 1980-04-09
% 209.16/209.32 |- rdf__type mesh__D012374sskos__Concept
% 209.16/209.32 |- skos__historyNote mesh__D012374 Rods and Cones %28%1966-1980%29%
% 209.16/209.32 |- skos__hiddenLabel mesh__D012374 Outer Segment, Rod
% 209.16/209.32 |- mesh__recordOriginator mesh__D012374 RC
% 209.16/209.32 |- skos__hiddenLabel mesh__D012374 Segment, Rod Outer
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D012374 2000
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D012374 SJN
% 209.16/209.32 |- skos__broader mesh__D012374smesh__D017948
% 209.16/209.32 |- skos__scopeNote mesh__D012374
% 209.16/209.32 The portion of the retinal rod cell between the inner segment and the pigment epithelium layer of the retina.%A%
% 209.16/209.32 |- mesh__dateEstablished mesh__D012374 1991-01-01
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D012374 2003
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D012374 2001
% 209.16/209.32 |- mesh__recordMaintainer mesh__D012374 NDW
% 209.16/209.32 |- skos__hiddenLabel mesh__D012374 Rod Outer Segment
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D012374 2005
% 209.16/209.32 |- mesh__dateRevised mesh__D012374 1998-06-11
% 209.16/209.32 |- skos__hiddenLabel mesh__D012374 Outer Segments, Rod
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D012374 1999
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D012374 2004
% 209.16/209.32 |- skos__prefLabel mesh__D012374 Rod Outer Segments
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D012374 2006
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D012374 2002
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D012374
% 209.16/209.32 91; was see under RODS AND CONES 1981-90
% 209.16/209.32 |- skos__hiddenLabel mesh__D012374 Segments, Rod Outer
% 209.16/209.32 |- mesh__historyNote mesh__D012374
% 209.16/209.32 91%28%81%29%; was see under RODS AND CONES 1981-90
% 209.16/209.32 |- skos__broader mesh__D020806smesh__D001424
% 209.16/209.32 |- skos__prefLabel mesh__D020806
% 209.16/209.32 Central Nervous System Bacterial Infections
% 209.16/209.32 |- rdf__type mesh__D020806sskos__Concept
% 209.16/209.32 |- skos__broader mesh__D020806smesh__D002494
% 209.16/209.32 |- skos__annotation mesh__D020806
% 209.16/209.32 coord IM with precoord bacterial infection %28%IM%29% and specific site/dis term %28%IM%29% if pertinent; DF: CNS BACT INFECT%A%
% 209.16/209.32 |- skos__historyNote mesh__D020806 Meningitis %28%1967-1999%29%
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D020806 2000
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020806 2006
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020806 2002
% 209.16/209.32 |- skos__altLabel mesh__D020806
% 209.16/209.32 Infections, Bacterial, Central Nervous System
% 209.16/209.32 |- mesh__dateEstablished mesh__D020806 2000-01-01
% 209.16/209.32 |- skos__scopeNote mesh__D020806
% 209.16/209.32 Bacterial infections of the brain, spinal cord, and meninges, including infections involving the perimeningeal spaces.%A%
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020806 2005
% 209.16/209.32 |- skos__historyNote mesh__D020806 Brain Diseases %28%1966-1999%29%
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020806 2001
% 209.16/209.32 |- skos__historyNote mesh__D020806 Brain Abscess %28%1965-1999%29%
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020806 2004
% 209.16/209.32 |- skos__altLabel mesh__D020806
% 209.16/209.32 Bacterial Infections, Central Nervous System
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020806 2000
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020806 2003
% 209.16/209.32 |- mesh__historyNote mesh__D020806 2000
% 209.16/209.32 |- mesh__dateCreated mesh__D020806 1999-11-03
% 209.16/209.32 |- skos__broader mesh__D004064Q000002smesh__D004064
% 209.16/209.32 |- mesh__preferredCombination mesh__D004064Q000002smesh__D004065
% 209.16/209.32 |- rdf__type mesh__D004064Q000002smesh__CompoundConcept
% 209.16/209.32 |- skos__hiddenLabel mesh__D006337 Murmurs, Cardiac
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D006337 2004
% 209.16/209.32 |- skos__related mesh__D006337smesh__D010701
% 209.16/209.32 |- mesh__recordMaintainer mesh__D006337 nns
% 209.16/209.32 |- skos__hiddenLabel mesh__D006337 Cardiac Murmur
% 209.16/209.32 |- mesh__recordOriginator mesh__D006337 NLM
% 209.16/209.32 |- mesh__dateCreated mesh__D006337 1999-01-01
% 209.16/209.32 |- skos__broader mesh__D006337smesh__D012816
% 209.16/209.32 |- mesh__historyNote mesh__D006337
% 209.16/209.32 91%28%75%29%; was see under HEART AUSCULTATION in Cat E 1972-90%A%
% 209.16/209.32 |- skos__hiddenLabel mesh__D006337 Murmur, Heart
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D006337
% 209.16/209.32 91; was see under HEART AUSCULTATION in Cat E 1972-90
% 209.16/209.32 |- skos__related mesh__D006337smesh__D006326
% 209.16/209.32 |- skos__altLabel mesh__D006337 Cardiac Murmurs
% 209.16/209.32 |- skos__hiddenLabel mesh__D006337 Murmurs, Heart
% 209.16/209.32 |- skos__hiddenLabel mesh__D006337 Murmur, Cardiac
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D006337 sjn
% 209.16/209.32 |- mesh__dateRevised mesh__D006337 2003-07-09
% 209.16/209.32 |- mesh__onlineNote mesh__D006337 search HEART AUSCULTATION 1972-74
% 209.16/209.32 |- skos__prefLabel mesh__D006337 Heart Murmurs
% 209.16/209.32 |- rdf__type mesh__D006337sskos__Concept
% 209.16/209.32 |- mesh__dateEstablished mesh__D006337 1991-01-01
% 209.16/209.32 |- skos__broader mesh__D006337smesh__D006347
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D006337 2005
% 209.16/209.32 |- skos__scopeNote mesh__D006337
% 209.16/209.32 Heart sounds caused by vibrations resulting from the flow of BLOOD through the HEART. They are classified by time of occurrence during the cardiac cycle and duration, and graded by the intensity of sound on a scale of I to VI. They may be normal or abnormal.%A%
% 209.16/209.32 |- skos__annotation mesh__D006337
% 209.16/209.32 do not confuse with HEART SOUNDS, a physiol concept; /etiol: coord with specific heart valve disease %28%IM%29%%A%
% 209.16/209.32 |- skos__hiddenLabel mesh__D006337 Heart Murmur
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D006337 2006
% 209.16/209.32 |- skos__broader mesh__D006337smesh__D006349
% 209.16/209.32 |- skos__related mesh__D006337smesh__D006347
% 209.16/209.32 |- skos__broader mesh__D020008smesh__D010879
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D020008 2006
% 209.16/209.32 |- skos__altLabel mesh__D020008 Pharmacia Brand of Delavirdine Mesylate
% 209.16/209.32 |- skos__hiddenLabel mesh__D020008 U90152
% 209.16/209.32 |- mesh__dateCreated mesh__D020008 1997-06-20
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D020008 sjn
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D020008
% 209.16/209.32 98; DELAVIRDINE was indexed under PIPERAZINES %26% INDOLES 1993-97%A%
% 209.16/209.32 |- mesh__recordOriginator mesh__D020008 AGS
% 209.16/209.32 |- skos__hiddenLabel mesh__D020008 U 90152S
% 209.16/209.32 |- skos__historyNote mesh__D020008 Indoles %28%1993-1997%29%
% 209.16/209.32 |- skos__altLabel mesh__D020008 U-90152S
% 209.16/209.32 |- skos__broader mesh__D020008smesh__D007211
% 209.16/209.32 |- mesh__recordMaintainer mesh__D020008 exl
% 209.16/209.32 |- skos__scopeNote mesh__D020008
% 209.16/209.32 A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1.%A%
% 209.16/209.32 |- skos__hiddenLabel mesh__D020008 U 90152
% 209.16/209.32 |- mesh__dateRevised mesh__D020008 2005-06-30
% 209.16/209.32 |- mesh__dateEstablished mesh__D020008 1998-01-01
% 209.16/209.32 |- skos__hiddenLabel mesh__D020008 Mesylate, Delavirdine
% 209.16/209.32 |- skos__historyNote mesh__D020008 Piperazines %28%1993-1997%29%
% 209.16/209.32 |- rdf__type mesh__D020008sskos__Concept
% 209.16/209.32 |- skos__hiddenLabel mesh__D020008 U90152S
% 209.16/209.32 |- skos__altLabel mesh__D020008 Parke Davis Brand of Delavirdine Mesylate
% 209.16/209.32 |- skos__altLabel mesh__D020008 Agouron Brand of Delavirdine Mesylate
% 209.16/209.32 |- skos__prefLabel mesh__D020008 Delavirdine
% 209.16/209.32 |- mesh__historyNote mesh__D020008
% 209.16/209.32 98; use DELAVIRDINE %28%NM%29% 1993-97
% 209.16/209.32 |- rdf__type mesh__D050493sskos__Concept
% 209.16/209.32 |- skos__historyNote mesh__D050493 Glycoproteins %28%1992-1996%29%
% 209.16/209.32 |- mesh__historyNote mesh__D050493 2006%28%1992%29%
% 209.16/209.32 |- skos__altLabel mesh__D050493 Vesicular Monoamine Transporter Proteins
% 209.16/209.32 |- skos__hiddenLabel mesh__D050493 Monoamine Transporter, Vesicular
% 209.16/209.32 |- skos__altLabel mesh__D050493 Monoamine Vesicular Transporter
% 209.16/209.32 |- skos__prefLabel mesh__D050493 Vesicular Monoamine Transport Proteins
% 209.16/209.32 |- skos__broader mesh__D050493smesh__D050492
% 209.16/209.32 |- skos__scopeNote mesh__D050493
% 209.16/209.32 A family of vesicular amine transporter proteins that catalyze the transport and storage of CATECHOLAMINES and indolamines into SECRETORY VESICLES.%A%
% 209.16/209.32 |- mesh__dateCreated mesh__D050493 2005-06-30
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D050493
% 209.16/209.32 2006; VESICULAR AMINE TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 2005; MEMBRANE GLYCORPOTEINS %26% NEUROPEPTIDES 1997-2005, %26% under GLYCOPROTEINS 1992-1996%A%
% 209.16/209.32 |- skos__altLabel mesh__D050493 Chromaffin Granule Amine Transporter
% 209.16/209.32 |- skos__hiddenLabel mesh__D050493 Vesicular Monoamine Transporters
% 209.16/209.32 |- mesh__recordMaintainer mesh__D050493 DRC
% 209.16/209.32 |- skos__hiddenLabel mesh__D050493 VMAT 1 Vesicular Monoamine Transporter
% 209.16/209.32 |- skos__altLabel mesh__D050493 Vesicular Monoamine Transporter
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D050493 2006
% 209.16/209.32 |- skos__hiddenLabel mesh__D050493 Vesicular Transporter, Monoamine
% 209.16/209.32 |- skos__altLabel mesh__D050493 Monoamine Vesicular Transport Proteins
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D050493 sjn
% 209.16/209.32 |- skos__annotation mesh__D050493 see SCR for organism-specific terms
% 209.16/209.32 |- skos__altLabel mesh__D050493 VMAT2 Vesicular Monoamine Transporter
% 209.16/209.32 |- skos__historyNote mesh__D050493 Neuropeptides %28%1992-2004%29%
% 209.16/209.32 |- skos__historyNote mesh__D050493 Membrane Glycoproteins %28%1996-2004%29%
% 209.16/209.32 |- skos__altLabel mesh__D050493 VMAT-1 Vesicular Monoamine Transporter
% 209.16/209.32 |- skos__altLabel mesh__D050493 Monoamine Transporters, Vesicular
% 209.16/209.32 |- mesh__recordOriginator mesh__D050493 DRC
% 209.16/209.32 |- mesh__dateEstablished mesh__D050493 2006-01-01
% 209.16/209.32 |- skos__historyNote mesh__D050493 Membrane Transport Proteins %28%2005%29%
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D016765 sjn
% 209.16/209.32 |- skos__hiddenLabel mesh__D016765 Feline Enteric Coronaviruses
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016765 2003
% 209.16/209.32 |- skos__hiddenLabel mesh__D016765 Enteric Coronavirus, Feline
% 209.16/209.32 |- skos__hiddenLabel mesh__D016765 Enteric Coronaviruses, Feline
% 209.16/209.32 |- skos__altLabel mesh__D016765 Coronavirus, Feline Enteric
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016765 2005
% 209.16/209.32 |- skos__hiddenLabel mesh__D016765 Feline Coronavirus
% 209.16/209.32 |- mesh__recordOriginator mesh__D016765 AGS
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016765 2004
% 209.16/209.32 |- skos__hiddenLabel mesh__D016765 Feline Coronaviruses
% 209.16/209.32 |- skos__altLabel mesh__D016765 Peritonitis Virus, Infectious Feline
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016765 2006
% 209.16/209.32 |- mesh__recordMaintainer mesh__D016765 ags
% 209.16/209.32 |- mesh__dateCreated mesh__D016765 1991-05-02
% 209.16/209.32 |- skos__annotation mesh__D016765
% 209.16/209.32 infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29%; infection by FIPV = FELINE INFECTIOUS PERITONITIS%A%
% 209.16/209.32 |- skos__hiddenLabel mesh__D016765 Coronaviruses, Feline
% 209.16/209.32 |- skos__altLabel mesh__D016765 Infectious Peritonitis Virus, Feline
% 209.16/209.32 |- skos__prefLabel mesh__D016765 Coronavirus, Feline
% 209.16/209.32 |- mesh__historyNote mesh__D016765 2002 %28%1992%29%
% 209.16/209.32 |- skos__broader mesh__D016765smesh__D017934
% 209.16/209.32 |- skos__scopeNote mesh__D016765
% 209.16/209.32 A species of CORONAVIRUS infecting cats of all ages and commonly found in catteries and zoos. Cats are often found carrying the virus but only a small proportion develop disease. Feline coronavirus and Feline infectious peritonitis virus %28%FIPV%29% are virtually the same virus in genetic and antigenetic terms, and are morphologically indistinguishable. Since they only differ in their disease potential %28%with FIPV causing a more serious illness%29%, they are considered biotypes of each other. %28%From Hoskins, JD. Update on Feline Coronavirus Disease. http://maxshouse.com.FIP%25%20Update.htm %28%April 3, 2001%29%%29%%A%
% 209.16/209.32 |- mesh__dateRevised mesh__D016765 2001-07-25
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D016765
% 209.16/209.32 2002; see INFECTIOUS PERITONITIS VIRUS, FELINE 1994-2001, see FELINE INFECTIOUS PERITONITIS VIRUS 1992-1993; for INFECTIOUS PERITONITIS VIRUS, FELINE see FELINE INFECTIOUS PERITONITIS VIRUS 1992-93%A%
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D016765 2002
% 209.16/209.32 |- skos__altLabel mesh__D016765 Feline Enteric Coronavirus
% 209.16/209.32 |- skos__altLabel mesh__D016765 FIPV
% 209.16/209.32 |- rdf__type mesh__D016765sskos__Concept
% 209.16/209.32 |- mesh__dateEstablished mesh__D016765 1992-01-01
% 209.16/209.32 |- skos__hiddenLabel mesh__D016765 Coronaviruses, Feline Enteric
% 209.16/209.32 |- skos__altLabel mesh__D016765 FECV
% 209.16/209.32 |- skos__historyNote mesh__D016765 Coronaviridae %28%1977-1991%29%
% 209.16/209.32 |- mesh__dateEstablished mesh__D002745 1991-01-01
% 209.16/209.32 |- mesh__historyNote mesh__D002745 91%28%66%29%
% 209.16/209.32 |- skos__broader mesh__D002745smesh__D010645
% 209.16/209.32 |- mesh__dateRevised mesh__D002745 2005-06-30
% 209.16/209.32 |- mesh__recordMaintainer mesh__D002745 lkw
% 209.16/209.32 |- mesh__dateCreated mesh__D002745 1999-01-01
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D002745 2006
% 209.16/209.32 |- skos__prefLabel mesh__D002745 Chlorphentermine
% 209.16/209.32 |- skos__scopeNote mesh__D002745
% 209.16/209.32 A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of DEXTROAMPHETAMINE. It has been implicated in lipid storage disorders and pulmonary hypertension. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1223%29%%A%
% 209.16/209.32 |- rdf__type mesh__D002745sskos__Concept
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D002745 91; see PHENTERMINE 1966-90
% 209.16/209.32 |- skos__hiddenLabel mesh__D002745 Hydrochloride, Chlorphentermine
% 209.16/209.32 |- mesh__recordOriginator mesh__D002745 NLM
% 209.16/209.32 |- skos__altLabel mesh__D002745
% 209.16/209.32 Warner Chilcott Brand of Chlorphentermine Hydrochloride
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D002745 sjn
% 209.16/209.32 |- skos__altLabel mesh__D007430 Care, Intraoperative
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D007430 2000
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D007430 2005
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D007430 2006
% 209.16/209.32 |- skos__annotation mesh__D007430
% 209.16/209.32 during surg; use qualif discreetly; DF: INTRAOP CARE
% 209.16/209.32 |- mesh__dateEstablished mesh__D007430 1980-01-01
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D007430 1998
% 209.16/209.32 |- mesh__dateRevised mesh__D007430 1997-06-20
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D007430 2001
% 209.16/209.32 |- mesh__historyNote mesh__D007430 80
% 209.16/209.32 |- skos__altLabel mesh__D007430 Peroperative Care
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D007430 2003
% 209.16/209.32 |- mesh__dateCreated mesh__D007430 1979-03-12
% 209.16/209.32 |- skos__prefLabel mesh__D007430 Intraoperative Care
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D007430 1999
% 209.16/209.32 |- skos__scopeNote mesh__D007430
% 209.16/209.32 Patient care procedures performed during the operation that are ancillary to the actual surgery. It includes monitoring, fluid therapy, medication, transfusion, anesthesia, radiography, and laboratory tests.%A%
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D007430 2004
% 209.16/209.32 |- skos__broader mesh__D007430smesh__D013514
% 209.16/209.32 |- mesh__recordOriginator mesh__D007430 SMH
% 209.16/209.32 |- rdf__type mesh__D007430sskos__Concept
% 209.16/209.32 |- mesh__publicMeSHNote mesh__D007430 80
% 209.16/209.32 |- mesh__recordAuthorizer mesh__D007430 SJN
% 209.16/209.32 |- mesh__recordMaintainer mesh__D007430 PXP
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D007430 2002
% 209.16/209.32 |- skos__broader mesh__D007430smesh__D019990
% 209.16/209.32 |- skos__altLabel mesh__D007430 Care, Peroperative
% 209.16/209.32 |- mesh__dateEstablished mesh__D021101 2001-01-01
% 209.16/209.32 |- mesh__activeMeSHYear mesh__D021101 2001
% 209.16/209.32 |- skos__broader mesh__D021101smesh__D020161
% 209.18/209.32 |- skos__scopeNote mesh__D021101
% 209.18/209.32 A method for ordering genetic loci along CHROMOSOMES. The method involves fusing irradiated donor cells with host cells from another species. Following cell fusion, fragments of DNA from the irradiated cells become integrated into the chromosomes of the host cells. Molecular probing of DNA obtained from the fused cells is used to determine if two or more genetic loci are located within the same fragment of donor cell DNA.%A%
% 209.18/209.32 |- mesh__dateCreated mesh__D021101 2000-06-22
% 209.18/209.32 |- mesh__activeMeSHYear mesh__D021101 2003
% 209.18/209.32 |- mesh__publicMeSHNote mesh__D021101 2001
% 209.18/209.32 |- skos__historyNote mesh__D021101 Chromosome Mapping %28%1968-1998%29%
% 209.18/209.32 |- skos__historyNote mesh__D021101
% 209.18/209.32 Physical Chromosome Mapping %28%1999-2000%29%
% 209.18/209.32 |- rdf__type mesh__D021101sskos__Concept
% 209.18/209.32 |- mesh__activeMeSHYear mesh__D021101 2004
% 209.18/209.32 |- mesh__historyNote mesh__D021101 2001
% 209.18/209.32 |- mesh__activeMeSHYear mesh__D021101 2002
% 209.18/209.32 |- skos__hiddenLabel mesh__D021101 Mapping, Radiation Hybrid
% 209.18/209.32 |- skos__hiddenLabel mesh__D021101 Radiation Hybrid
% 209.18/209.32 |- skos__prefLabel mesh__D021101 Radiation Hybrid Mapping
% 209.18/209.32 |- skos__hiddenLabel mesh__D021101 Hybrid Maps, Radiation
% 209.18/209.32 |- skos__hiddenLabel mesh__D021101 Hybrids, Radiation
% 209.18/209.32 |- skos__hiddenLabel mesh__D021101 Radiation Hybrid Map
% 209.18/209.32 |- skos__hiddenLabel mesh__D021101 Map, Radiation Hybrid
% 209.18/209.32 |- mesh__activeMeSHYear mesh__D021101 2005
% 209.18/209.32 |- skos__hiddenLabel mesh__D021101 Hybrid, Radiation
% 209.18/209.32 |- mesh__activeMeSHYear mesh__D021101 2006
% 209.18/209.32 |- skos__altLabel mesh__D048049 ERK MAP Kinases
% 209.18/209.32 |- skos__annotation mesh__D048049 note specifics
% 209.18/209.32 |- mesh__historyNote mesh__D048049
% 209.18/209.32 2005; for EXTRACELLULAR SIGNAL-REGULATED KINASES use MITOGEN-ACTIVATED PROTEIN KINASES 1994-2004%A%
% 209.18/209.32 |- skos__hiddenLabel mesh__D048049
% 209.18/209.32 MAP Kinases, Extracellular Signal Regulated
% 209.18/209.32 |- skos__hiddenLabel mesh__D048049 Kinases, Extracellular Signal-Regulated
% 209.18/209.32 |- skos__hiddenLabel mesh__D048049
% 209.18/209.32 Extracellular Signal Regulated MAP Kinases
% 209.18/209.32 |- mesh__recordAuthorizer mesh__D048049 ags
% 209.18/209.32 |- mesh__dateCreated mesh__D048049 2004-07-07
% 209.18/209.32 |- mesh__activeMeSHYear mesh__D048049 2005
% 209.18/209.32 |- mesh__activeMeSHYear mesh__D048049 2006A
% 209.18/209.32 |- skos__hiddenLabel mesh__D048049 Extracellular Signal Regulated Kinases
% 209.18/209.32 |- skos__altLabel mesh__D048049 MAP Kinases, Extracellular Signal-Regulated
% 209.18/209.32 |- mesh__activeMeSHYear mesh__D048049 2006
% 209.18/209.32 |- skos__prefLabel mesh__D048049 Extracellular Signal-Regulated MAP Kinases
% 209.18/209.32 |- mesh__dateEstablished mesh__D048049 2005-01-01
% 209.18/209.32 |- skos__historyNote mesh__D048049
% 209.18/209.32 Mitogen-Activated Protein Kinases %28%1992-2004%29%
% 209.18/209.32 |- rdf__type mesh__D048049sskos__Concept
% 209.18/209.32 |- mesh__dateRevised mesh__D048049 2005-07-19
% 209.18/209.32 |- mesh__recordMaintainer mesh__D048049 ags
% 209.18/209.32 |- skos__scopeNote mesh__D048049
% 209.18/209.32 A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS.%A%
% 209.18/209.32 |- skos__broader mesh__D048049smesh__D020928
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D048049
% 209.18/209.33 2005; see MITOGEN-ACTIVATED PROTEIN KINASES 1994-2004
% 209.18/209.33 |- mesh__recordOriginator mesh__D048049 jmp
% 209.18/209.33 |- skos__altLabel mesh__D048049 Extracellular Signal-Regulated Kinases
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 2002
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 1996
% 209.18/209.33 |- skos__broader mesh__D012375smesh__D010571
% 209.18/209.33 |- mesh__recordOriginator mesh__D012375 NLM
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 1998
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 2003
% 209.18/209.33 |- mesh__dateRevised mesh__D012375 1992-05-18
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 1997
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 2005
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 1994
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 1999
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 2004
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 1993
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 2006
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 2000
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 1995
% 209.18/209.33 |- skos__prefLabel mesh__D012375 Rodent Control
% 209.18/209.33 |- mesh__dateCreated mesh__D012375 1999-01-01
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012375 2001
% 209.18/209.33 |- skos__annotation mesh__D012375
% 209.18/209.33 coord IM with specific rodent %28%IM%29%
% 209.18/209.33 |- skos__hiddenLabel mesh__D012375 Control, Rodent
% 209.18/209.33 |- rdf__type mesh__D012375sskos__Concept
% 209.18/209.33 |- skos__related mesh__D012375smesh__D012378
% 209.18/209.33 |- skos__scopeNote mesh__D012375
% 209.18/209.33 The reduction or regulation of the population of noxious, destructive, or dangerous rodents through chemical, biological, or other means.%A%
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D012375 PLS
% 209.18/209.33 |- mesh__recordMaintainer mesh__D012375 TAP
% 209.18/209.33 |- skos__broader mesh__D020807smesh__D010272
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020807 2000
% 209.18/209.33 |- mesh__dateEstablished mesh__D020807 2000-01-01
% 209.18/209.33 |- skos__altLabel mesh__D020807
% 209.18/209.33 Infections, Central Nervous System, Parasitic
% 209.18/209.33 |- mesh__dateCreated mesh__D020807 1999-11-03
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020807 2004
% 209.18/209.33 |- skos__historyNote mesh__D020807 Parasitic Diseases %28%1966-1999%29%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020807 2003
% 209.18/209.33 |- skos__annotation mesh__D020807
% 209.18/209.33 coord IM with precoord parasitic infection %28%IM%29% and site/dis term %28%IM%29% if pertinent; DF: CNS PARASITIC INFECT%A%
% 209.18/209.33 |- skos__historyNote mesh__D020807 Helminthiasis %28%1966-1999%29%
% 209.18/209.33 |- mesh__historyNote mesh__D020807 2000
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D020807 2000
% 209.18/209.33 |- skos__scopeNote mesh__D020807
% 209.18/209.33 Infections of the brain, spinal cord, and meninges caused by parasites, primarily PROTOZOA and HELMINTHS.%A%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020807 2002
% 209.18/209.33 |- skos__broader mesh__D020807smesh__D002494
% 209.18/209.33 |- rdf__type mesh__D020807sskos__Concept
% 209.18/209.33 |- skos__prefLabel mesh__D020807
% 209.18/209.33 Central Nervous System Parasitic Infections
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020807 2006
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020807 2001
% 209.18/209.33 |- skos__altLabel mesh__D020807
% 209.18/209.33 Parasitic Infections, Central Nervous System
% 209.18/209.33 |- skos__altLabel mesh__D020807
% 209.18/209.33 Infections, Parasitic, Central Nervous System
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020807 2005
% 209.18/209.33 |- skos__annotation mesh__D006338
% 209.18/209.33 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific site in heart %28%NIM%29% + histol type of neopl %28%IM%29%%A%
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D006338 PLS
% 209.18/209.33 |- skos__altLabel mesh__D006338 Neoplasms, Cardiac
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 2000
% 209.18/209.33 |- skos__hiddenLabel mesh__D006338 Cardiac Neoplasm
% 209.18/209.33 |- mesh__dateCreated mesh__D006338 1999-01-01
% 209.18/209.33 |- mesh__dateRevised mesh__D006338 1995-06-08
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 2001
% 209.18/209.33 |- skos__broader mesh__D006338smesh__D013899
% 209.18/209.33 |- rdf__type mesh__D006338sskos__Concept
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 2002
% 209.18/209.33 |- skos__prefLabel mesh__D006338 Heart Neoplasms
% 209.18/209.33 |- skos__hiddenLabel mesh__D006338 Neoplasm, Cardiac
% 209.18/209.33 |- mesh__recordOriginator mesh__D006338 NLM
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 1998
% 209.18/209.33 |- mesh__recordMaintainer mesh__D006338 KEV
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 2005
% 209.18/209.33 |- skos__hiddenLabel mesh__D006338 Heart Neoplasm
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 1999
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 1996
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 2006
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 2003
% 209.18/209.33 |- skos__altLabel mesh__D006338 Neoplasms, Heart
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 1997
% 209.18/209.33 |- skos__altLabel mesh__D006338 Cardiac Neoplasms
% 209.18/209.33 |- skos__hiddenLabel mesh__D006338 Neoplasm, Heart
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006338 2004
% 209.18/209.33 |- skos__broader mesh__D006338smesh__D006331
% 209.18/209.33 |- skos__related mesh__D017060smesh__D010342
% 209.18/209.33 |- mesh__onlineNote mesh__D017060
% 209.18/209.33 use CONSUMER SATISFACTION to search PATIENT SATISFACTION 1982-91%A%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017060 2002
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017060 2003
% 209.18/209.33 |- mesh__historyNote mesh__D017060
% 209.18/209.33 92; was see CONSUMER SATISFACTION 1982-91
% 209.18/209.33 |- skos__broader mesh__D017060smesh__D003258
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017060 2005
% 209.18/209.33 |- mesh__recordOriginator mesh__D017060 PLS
% 209.18/209.33 |- mesh__dateCreated mesh__D017060 1991-06-20
% 209.18/209.33 |- skos__broader mesh__D017060smesh__D017531
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017060 2004
% 209.18/209.33 |- skos__hiddenLabel mesh__D017060 Patient Preferences
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017060 2000
% 209.18/209.33 |- skos__hiddenLabel mesh__D017060 Satisfaction, Patient
% 209.18/209.33 |- mesh__recordMaintainer mesh__D017060 jls
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017060 2006
% 209.18/209.33 |- skos__hiddenLabel mesh__D017060 Preferences, Patient
% 209.18/209.33 |- skos__prefLabel mesh__D017060 Patient Satisfaction
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D017060 sjn
% 209.18/209.33 |- skos__scopeNote mesh__D017060
% 209.18/209.33 The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial.%A%
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D017060
% 209.18/209.33 92; was see CONSUMER SATISFACTION 1982-91
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017060 2001
% 209.18/209.33 |- skos__historyNote mesh__D017060 Consumer Satisfaction %28%1966-1991%29%
% 209.18/209.33 |- mesh__dateEstablished mesh__D017060 1992-01-01
% 209.18/209.33 |- rdf__type mesh__D017060sskos__Concept
% 209.18/209.33 |- mesh__dateRevised mesh__D017060 1999-11-03
% 209.18/209.33 |- skos__hiddenLabel mesh__D017060 Preference, Patient
% 209.18/209.33 |- skos__broader mesh__D017060smesh__D010342
% 209.18/209.33 |- mesh__historyNote mesh__D050494 2006%28%1992%29%
% 209.18/209.33 |- mesh__dateEstablished mesh__D050494 2006-01-01
% 209.18/209.33 |- skos__historyNote mesh__D050494 Membrane Transport Proteins %28%2005%29%
% 209.18/209.33 |- skos__hiddenLabel mesh__D050494 Transporter, Vesicular Acetylcholine
% 209.18/209.33 |- skos__prefLabel mesh__D050494 Vesicular Acetylcholine Transport Proteins
% 209.18/209.33 |- skos__broader mesh__D050494smesh__D050492
% 209.18/209.33 |- mesh__dateCreated mesh__D050494 2005-06-30
% 209.18/209.33 |- skos__hiddenLabel mesh__D050494 Acetylcholine Transporter, Vesicular
% 209.18/209.33 |- skos__altLabel mesh__D050494 Vesicular Acetylcholine Transporter
% 209.18/209.33 |- mesh__recordMaintainer mesh__D050494 DRC
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D050494 sjn
% 209.18/209.33 |- skos__hiddenLabel mesh__D050494 Vesicular Acetylcholine Transporters
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D050494
% 209.18/209.33 2006; VESICULAR ACETYLCHOLINE TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 1992-2005%A%
% 209.18/209.33 |- skos__scopeNote mesh__D050494
% 209.18/209.33 Vesicular amine transporter proteins that transport the neurotransmitter ACETYLCHOLINE into small SECRETORY VESICLES. Proteins of this family contain 12 transmembrane domains and exchange vesicular PROTONS for cytoplasmic acetylcholine.%A%
% 209.18/209.33 |- skos__hiddenLabel mesh__D050494 Transporters, Vesicular Acetylcholine
% 209.18/209.33 |- skos__historyNote mesh__D050494 Carrier Proteins %28%1992-2004%29%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D050494 2006
% 209.18/209.33 |- skos__altLabel mesh__D050494 Acetylcholine Transporters, Vesicular
% 209.18/209.33 |- skos__annotation mesh__D050494 see SCR for organism-specific terms
% 209.18/209.33 |- mesh__recordOriginator mesh__D050494 DRC
% 209.18/209.33 |- rdf__type mesh__D050494sskos__Concept
% 209.18/209.33 |- skos__altLabel mesh__D050494
% 209.18/209.33 Vesicular Acetylcholine Transporter Proteins
% 209.18/209.33 |- skos__altLabel mesh__D050494 VAChT Proteins
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D003040 2006
% 209.18/209.33 |- mesh__dateCreated mesh__D003040 1977-04-22
% 209.18/209.33 |- skos__historyNote mesh__D003040 Venoms %28%1966-1974%29%
% 209.18/209.33 |- skos__altLabel mesh__D003040 Cobra Venom
% 209.18/209.33 |- skos__annotation mesh__D003040
% 209.18/209.33 /antag permitted but consider also ANTIVENINS; /enzymol permitted%A%
% 209.18/209.33 |- skos__historyNote mesh__D003040 Snakes %28%1966-1974%29%
% 209.18/209.33 |- mesh__dateRevised mesh__D003040 2005-06-30
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D003040 78
% 209.18/209.33 |- rdf__type mesh__D003040sskos__Concept
% 209.18/209.33 |- skos__altLabel mesh__D003040 Naja Venom
% 209.18/209.33 |- skos__historyNote mesh__D003040 Toxins %28%1966-1977%29%
% 209.18/209.33 |- skos__hiddenLabel mesh__D003040 Venom, Cobra
% 209.18/209.33 |- mesh__recordOriginator mesh__D003040 SH
% 209.18/209.33 |- skos__scopeNote mesh__D003040
% 209.18/209.33 Venoms from snakes of the genus Naja %28%family Elapidae%29%. They contain many specific proteins that have cytotoxic, hemolytic, neurotoxic, and other properties. Like other elapid venoms, they are rich in enzymes. They include cobramines and cobralysins.%A%
% 209.18/209.33 |- skos__prefLabel mesh__D003040 Cobra Venoms
% 209.18/209.33 |- mesh__historyNote mesh__D003040 78
% 209.18/209.33 |- skos__hiddenLabel mesh__D003040 Venom, Naja
% 209.18/209.33 |- skos__hiddenLabel mesh__D003040 Venoms, Cobra
% 209.18/209.33 |- skos__historyNote mesh__D003040 Snake Venoms %28%1975-1977%29%
% 209.18/209.33 |- skos__broader mesh__D003040smesh__D004546
% 209.18/209.33 |- mesh__recordMaintainer mesh__D003040 ssb
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D003040 sjn
% 209.18/209.33 |- skos__altLabel mesh__D003040 Naja Venoms
% 209.18/209.33 |- mesh__dateEstablished mesh__D003040 1978-01-01
% 209.18/209.33 |- skos__hiddenLabel mesh__D003040 Venoms, Naja
% 209.18/209.33 |- skos__scopeNote mesh__D016766
% 209.18/209.33 Common coronavirus infection of cats caused by the feline infectious peritonitis virus %28%CORONAVIRUS, FELINE%29%. The disease is characterized by a long incubation period, fever, depression, loss of appetite, wasting, and progressive abdominal enlargement. Infection of cells of the monocyte-macrophage lineage appears to be essential in FIP pathogenesis.%A%
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D016766 92
% 209.18/209.33 |- skos__altLabel mesh__D016766 Infectious Peritonitis, Feline
% 209.18/209.33 |- mesh__dateEstablished mesh__D016766 1992-01-01
% 209.18/209.33 |- mesh__dateRevised mesh__D016766 2001-07-25
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D016766 2002
% 209.18/209.33 |- mesh__recordMaintainer mesh__D016766 ags
% 209.18/209.33 |- skos__historyNote mesh__D016766 Cat Diseases %28%1966-1991%29%
% 209.18/209.33 |- mesh__historyNote mesh__D016766 92
% 209.18/209.33 |- skos__altLabel mesh__D016766 Peritonitis, Infectious, Feline
% 209.18/209.33 |- rdf__type mesh__D016766sskos__Concept
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D016766 sjn
% 209.18/209.33 |- skos__annotation mesh__D016766 DF: FELINE INFECT PERITONITIS
% 209.18/209.33 |- skos__hiddenLabel mesh__D016766 Infectious Peritonitides, Feline
% 209.18/209.33 |- mesh__recordOriginator mesh__D016766 AGS
% 209.18/209.33 |- skos__prefLabel mesh__D016766 Feline Infectious Peritonitis
% 209.18/209.33 |- skos__broader mesh__D016766smesh__D018352
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D016766 2003
% 209.18/209.33 |- skos__hiddenLabel mesh__D016766 Peritonitis, Feline Infectious
% 209.18/209.33 |- skos__historyNote mesh__D016766 Coronavirus Infections %28%1978-1991%29%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D016766 2005
% 209.18/209.33 |- mesh__dateCreated mesh__D016766 1991-05-02
% 209.18/209.33 |- skos__broader mesh__D016766smesh__D002371
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D016766 2004
% 209.18/209.33 |- skos__hiddenLabel mesh__D016766 Feline Infectious Peritonitides
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D016766 2006
% 209.18/209.33 |- skos__hiddenLabel mesh__D002746 Hydrochloride, Chlorpromazine
% 209.18/209.33 |- skos__scopeNote mesh__D002746
% 209.18/209.33 The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine%27%s antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.%A%
% 209.18/209.33 |- mesh__recordMaintainer mesh__D002746 ssb
% 209.18/209.33 |- skos__broader mesh__D002746smesh__D010640
% 209.18/209.33 |- mesh__recordOriginator mesh__D002746 NLM
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D002746 sjn
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D002746 2006
% 209.18/209.33 |- skos__prefLabel mesh__D002746 Chlorpromazine
% 209.18/209.33 |- mesh__historyNote mesh__D002746
% 209.18/209.33 /adv eff-pois-tox was CHLORPROMAZINE TOXICOLOGY 1963-65
% 209.18/209.33 |- mesh__dateRevised mesh__D002746 2005-06-30
% 209.18/209.33 |- rdf__type mesh__D002746sskos__Concept
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D002746
% 209.18/209.33 /adverse effects /poisoning /toxicity were CHLORPROMAZINE TOXICOLOGY 1963-65%A%
% 209.18/209.33 |- mesh__dateCreated mesh__D002746 1999-01-01
% 209.18/209.33 |- skos__altLabel mesh__D007431 Surgical Injuries
% 209.18/209.33 |- skos__hiddenLabel mesh__D007431 Complications, Intraoperative
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D007431 2006
% 209.18/209.33 |- mesh__dateEstablished mesh__D007431 1980-01-01
% 209.18/209.33 |- skos__hiddenLabel mesh__D007431 Intraoperative Complication
% 209.18/209.33 |- mesh__historyNote mesh__D007431 80
% 209.18/209.33 |- skos__hiddenLabel mesh__D007431 Complications, Peroperative
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D007431 2003
% 209.18/209.33 |- mesh__dateCreated mesh__D007431 1979-03-12
% 209.18/209.33 |- mesh__recordMaintainer mesh__D007431 KEV
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D007431 2000
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D007431 2004
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D007431 sjn
% 209.18/209.33 |- skos__hiddenLabel mesh__D007431 Surgical Injury
% 209.18/209.33 |- skos__hiddenLabel mesh__D007431 Peroperative Complication
% 209.18/209.33 |- rdf__type mesh__D007431sskos__Concept
% 209.18/209.33 |- skos__altLabel mesh__D007431 Complication, Peroperative
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D007431 2001
% 209.18/209.33 |- skos__scopeNote mesh__D007431
% 209.18/209.33 Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure.%A%
% 209.18/209.33 |- mesh__dateRevised mesh__D007431 1999-11-08
% 209.18/209.33 |- skos__broader mesh__D007431smesh__D010335
% 209.18/209.33 |- skos__annotation mesh__D007431
% 209.18/209.33 few qualif apply; IM; coord with Cat E4 term %28%IM%29% if pertinent with or without /adv eff depending on its relation to the intraop compl: for policy apply principles of POSTOPERATIVE COMPLICATIONS, Manual 23.18+; for iatrogenic compl %28%as X ref SURGICAL INJURIES%29% or other: TN 179; DF: INTRAOP COMPL%A%
% 209.18/209.33 |- skos__hiddenLabel mesh__D007431 Injury, Surgical
% 209.18/209.33 |- skos__prefLabel mesh__D007431 Intraoperative Complications
% 209.18/209.33 |- skos__altLabel mesh__D007431 Complication, Intraoperative
% 209.18/209.33 |- skos__altLabel mesh__D007431 Peroperative Complications
% 209.18/209.33 |- mesh__recordOriginator mesh__D007431 SMH
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D007431 2005
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D007431 80
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D007431 2002
% 209.18/209.33 |- skos__hiddenLabel mesh__D048848 Protein Kinase, ASK1
% 209.18/209.33 |- skos__altLabel mesh__D048848 ASK1 Protein Kinase
% 209.18/209.33 |- skos__altLabel mesh__D048848
% 209.18/209.33 Mitogen-Activated Kinase Kinase Kinase Kinase 5
% 209.18/209.33 |- rdf__type mesh__D048848sskos__Concept
% 209.18/209.33 |- skos__scopeNote mesh__D048848
% 209.18/209.33 A 150-kDa MAP kinase kinase kinase that may play a role in the induction of APOPTOSIS. It has specificity for MAP KINASE KINASE 3; MAP KINASE KINASE 4; and MAP KINASE KINASE 6.%A%
% 209.18/209.33 |- mesh__dateCreated mesh__D048848 2004-07-07
% 209.18/209.33 |- skos__hiddenLabel mesh__D048848
% 209.18/209.33 Mitogen Activated Kinase Kinase Kinase Kinase 5
% 209.18/209.33 |- skos__historyNote mesh__D048848
% 209.18/209.33 Mitogen-Activated Protein Kinase Kinase Kinases %28%2000-2004%29%
% 209.18/209.33 |- skos__altLabel mesh__D048848 MAPK Kinase Kinase 5
% 209.18/209.33 |- skos__broader mesh__D048848smesh__D020930
% 209.18/209.33 |- skos__hiddenLabel mesh__D048848 Protein Kinase, MAP3K5
% 209.18/209.33 |- skos__prefLabel mesh__D048848 MAP Kinase Kinase Kinase 5
% 209.18/209.33 |- mesh__recordOriginator mesh__D048848 jmp
% 209.18/209.33 |- skos__altLabel mesh__D048848 MAPKKK5
% 209.18/209.33 |- skos__historyNote mesh__D048848
% 209.18/209.33 Protein-Serine-Threonine Kinases %28%1995-1999%29%
% 209.18/209.33 |- skos__altLabel mesh__D048848 MAP3K5 Protein Kinase
% 209.18/209.33 |- skos__altLabel mesh__D048848 Apoptosis Signal-Regulating Kinase 1
% 209.18/209.33 |- skos__hiddenLabel mesh__D048848 Apoptosis Signal Regulating Kinase 1
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D048848
% 209.18/209.33 2005: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 4 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES 1996-1999%A%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D048848 2005
% 209.18/209.33 |- mesh__recordMaintainer mesh__D048848 jmp
% 209.18/209.33 |- mesh__dateEstablished mesh__D048848 2005-01-01
% 209.18/209.33 |- mesh__historyNote mesh__D048848 2005%28%1996%29%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D048848 2006
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D048848 sjn
% 209.18/209.33 |- rdf__type mesh__D012376sskos__Concept
% 209.18/209.33 |- skos__hiddenLabel mesh__D012376 Disease, Rodent
% 209.18/209.33 |- mesh__recordMaintainer mesh__D012376 ags
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D012376 sjn
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012376 2004
% 209.18/209.33 |- skos__hiddenLabel mesh__D012376 Diseases, Rodent
% 209.18/209.33 |- skos__hiddenLabel mesh__D012376 Rodent Disease
% 209.18/209.33 |- mesh__recordOriginator mesh__D012376 NLM
% 209.18/209.33 |- skos__scopeNote mesh__D012376
% 209.18/209.33 Diseases of rodents of the order RODENTIA. This term includes diseases of Sciuridae %28%squirrels%29%, Geomyidae %28%gophers%29%, Heteromyidae %28%pouched mice%29%, Castoridae %28%beavers%29%, Cricetidae %28%rats and mice%29%, Muridae %28%Old World rats and mice%29%, Erethizontidae %28%porcupines%29%, and Caviidae %28%guinea pigs%29%.%A%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012376 2006
% 209.18/209.33 |- skos__broader mesh__D012376smesh__D000820
% 209.18/209.33 |- mesh__dateRevised mesh__D012376 2003-07-30
% 209.18/209.33 |- skos__prefLabel mesh__D012376 Rodent Diseases
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D012376 2005
% 209.18/209.33 |- skos__annotation mesh__D012376
% 209.18/209.33 IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific rodent dis %28%IM%29%; coord IM with specific rodent %28%IM%29%; don%27%t forget also RODENTIA %28%NIM%29% %26% check tag ANIMALS; DF: RODENT DIS%A%
% 209.18/209.33 |- mesh__dateCreated mesh__D012376 1999-01-01
% 209.18/209.33 |- skos__scopeNote mesh__D020808
% 209.18/209.33 Infections of the brain, spinal cord, or meninges by single celled organisms of the subkingdom PROTOZOA. The central nervous system may be the primary or secondary site of protozoal infection. Examples of primary infections include cerebral amebiasis, granulomatous amebic encephalitis, primary amebic meningoencephalitis, and TRYPANOSOMIASIS, AFRICAN. Cerebral malaria, cerebral babesiosis, and chagasic meningoencephalitis are examples of secondary infections. These diseases may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts. %28%From Joynt, Clinical Neurology, 1998, Ch27, pp37-47%29%%A%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020808 2004
% 209.18/209.33 |- skos__altLabel mesh__D020808
% 209.18/209.33 Infection, Central Nervous System, Protozoal
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020808 2001
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020808 2003
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020808 2000
% 209.18/209.33 |- mesh__historyNote mesh__D020808 2000
% 209.18/209.33 |- mesh__dateCreated mesh__D020808 1999-11-05
% 209.18/209.33 |- skos__hiddenLabel mesh__D020808 Cerebral Protozoal Infection
% 209.18/209.33 |- skos__broader mesh__D020808smesh__D011528
% 209.18/209.33 |- skos__annotation mesh__D020808
% 209.18/209.33 coord IM with specific protozoan infection %28%IM%29% and specific site/dis term %28%IM%29% if pertinent; DF: CNS PROTOZOAL INFECT%A%
% 209.18/209.33 |- rdf__type mesh__D020808sskos__Concept
% 209.18/209.33 |- skos__hiddenLabel mesh__D020808 Infection, Cerebral Protozoal
% 209.18/209.33 |- skos__hiddenLabel mesh__D020808 Protozoal Meningoencephalitides
% 209.18/209.33 |- skos__historyNote mesh__D020808 Amebiasis %28%1966-1999%29%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020808 2006
% 209.18/209.33 |- skos__broader mesh__D020808smesh__D020807
% 209.18/209.33 |- skos__hiddenLabel mesh__D020808 Infections, Cerebral Protozoal
% 209.18/209.33 |- skos__hiddenLabel mesh__D020808 Protozoal Infection, Cerebral
% 209.18/209.33 |- skos__altLabel mesh__D020808 Protozoal Infections, Cerebral
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D020808 2000
% 209.18/209.33 |- skos__altLabel mesh__D020808
% 209.18/209.33 Protozoal Infections, Central Nervous System
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020808 2005
% 209.18/209.33 |- skos__prefLabel mesh__D020808
% 209.18/209.33 Central Nervous System Protozoal Infections
% 209.18/209.33 |- skos__hiddenLabel mesh__D020808 Meningoencephalitides, Protozoal
% 209.18/209.33 |- skos__altLabel mesh__D020808 Protozoal Meningoencephalitis
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D020808 2002
% 209.18/209.33 |- mesh__dateEstablished mesh__D020808 2000-01-01
% 209.18/209.33 |- skos__altLabel mesh__D020808
% 209.18/209.33 Infections, Protozoal, Central Nervous System
% 209.18/209.33 |- skos__hiddenLabel mesh__D006339 Rate, Heart
% 209.18/209.33 |- mesh__historyNote mesh__D006339 66%28%64%29%
% 209.18/209.33 |- skos__altLabel mesh__D006339 Chronotropism, Cardiac
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D006339 sjn
% 209.18/209.33 |- mesh__dateEstablished mesh__D006339 1966-01-01
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D006339 66
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006339 2005
% 209.18/209.33 |- skos__scopeNote mesh__D006339
% 209.18/209.33 The number of times the HEART VENTRICLES contract per unit of time, usually per minute.%A%
% 209.18/209.33 |- skos__hiddenLabel mesh__D006339 Rates, Heart
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006339 2006
% 209.18/209.33 |- skos__hiddenLabel mesh__D006339 Chronotropisms, Cardiac
% 209.18/209.33 |- skos__hiddenLabel mesh__D006339 Rates, Pulse
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D006339 2004
% 209.18/209.33 |- mesh__recordMaintainer mesh__D006339 nns
% 209.18/209.33 |- skos__broader mesh__D006339smesh__D045472
% 209.18/209.33 |- skos__annotation mesh__D006339
% 209.18/209.33 policy: Manual 23.27+; chronotropic action of drugs = HEART RATE /drug eff %28%IM%29% + drug with /pharmacol %28%IM%29% + STIMULATION, CHEMICAL %28%NIM%29% for positive chronotropic action %26% DEPRESSION, CHEMICAL %28%NIM%29% for negative; for inotropic action see note on MYOCARDIAL CONTRACTION%A%
% 209.18/209.33 |- skos__hiddenLabel mesh__D006339 Rate, Pulse
% 209.18/209.33 |- mesh__dateCreated mesh__D006339 1999-01-01
% 209.18/209.33 |- skos__hiddenLabel mesh__D006339 Cardiac Chronotropism
% 209.18/209.33 |- skos__prefLabel mesh__D006339 Heart Rate
% 209.18/209.33 |- mesh__recordOriginator mesh__D006339 NLM
% 209.18/209.33 |- skos__hiddenLabel mesh__D006339 Cardiac Chronotropisms
% 209.18/209.33 |- skos__hiddenLabel mesh__D006339 Heart Rates
% 209.18/209.33 |- mesh__dateRevised mesh__D006339 2003-07-09
% 209.18/209.33 |- rdf__type mesh__D006339sskos__Concept
% 209.18/209.33 |- skos__hiddenLabel mesh__D006339 Pulse Rates
% 209.18/209.33 |- skos__related mesh__D006339smesh__D011674
% 209.18/209.33 |- rdf__type mesh__D017061sskos__Concept
% 209.18/209.33 |- mesh__dateRevised mesh__D017061 1993-09-16
% 209.18/209.33 |- skos__broader mesh__D017061smesh__D007348
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 1999
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D017061 NLM
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 1995
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 2001
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 1998
% 209.18/209.33 |- mesh__recordOriginator mesh__D017061 PLS
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 2004
% 209.18/209.33 |- skos__prefLabel mesh__D017061 Prepaid Health Plans
% 209.18/209.33 |- mesh__historyNote mesh__D017061 92
% 209.18/209.33 |- skos__related mesh__D017061smesh__D006125
% 209.18/209.33 |- skos__hiddenLabel mesh__D017061 Prepaid Health Plan
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 2000
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 2003
% 209.18/209.33 |- skos__altLabel mesh__D017061 Health Plans, Prepaid
% 209.18/209.33 |- mesh__dateCreated mesh__D017061 1991-06-20
% 209.18/209.33 |- mesh__recordMaintainer mesh__D017061 PLS
% 209.18/209.33 |- skos__historyNote mesh__D017061 Insurance, Health %28%1966-1991%29%
% 209.18/209.33 |- skos__hiddenLabel mesh__D017061 Plan, Prepaid Health
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 1997
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D017061 92
% 209.18/209.33 |- mesh__dateEstablished mesh__D017061 1992-01-01
% 209.18/209.33 |- skos__hiddenLabel mesh__D017061 Plans, Prepaid Health
% 209.18/209.33 |- skos__historyNote mesh__D017061
% 209.18/209.33 Health Maintenance Organizations %28%1972-1991%29%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 2006
% 209.18/209.33 |- skos__scopeNote mesh__D017061
% 209.18/209.33 Contracts between an insurer and a subscriber or a group of subscribers whereby a specified set of health benefits is provided in return for a periodic premium.%A%
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 1996
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 2002
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D017061 2005
% 209.18/209.33 |- skos__hiddenLabel mesh__D017061 Health Plan, Prepaid
% 209.18/209.33 |- skos__hiddenLabel mesh__D050495
% 209.18/209.33 Vesicular GABA Glycine Transport Proteins
% 209.18/209.33 |- skos__prefLabel mesh__D050495
% 209.18/209.33 Vesicular Inhibitory Amino Acid Transport Proteins
% 209.18/209.33 |- skos__hiddenLabel mesh__D050495
% 209.18/209.33 Vesicular GABA Glycine Transporter Proteins
% 209.18/209.33 |- skos__hiddenLabel mesh__D050495 Transporter Proteins, VGAT
% 209.18/209.33 |- skos__altLabel mesh__D050495 VGAT Transporter Proteins
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D050495 2006A
% 209.18/209.33 |- skos__altLabel mesh__D050495
% 209.18/209.33 Vesicular Inhibitory Amino Acid Transporter Proteins
% 209.18/209.33 |- skos__altLabel mesh__D050495 VIAAT Transporter Proteins
% 209.18/209.33 |- mesh__dateEstablished mesh__D050495 2006-01-01
% 209.18/209.33 |- mesh__recordAuthorizer mesh__D050495 ags
% 209.18/209.33 |- mesh__publicMeSHNote mesh__D050495 2006
% 209.18/209.33 |- skos__altLabel mesh__D050495 Vesicular GABA-Glycine Transport Proteins
% 209.18/209.33 |- mesh__historyNote mesh__D050495 2006
% 209.18/209.33 |- mesh__dateRevised mesh__D050495 2005-07-15
% 209.18/209.33 |- skos__scopeNote mesh__D050495
% 209.18/209.33 A family of vesicular neurotransmitter transporter proteins that sequester the inhibitory neurotransmitters GLYCINE; GAMMA-AMINOBUTYRIC ACID; and possibly GAMMA-HYDROXYBUTYRATE into SECRETORY VESICLES.%A%
% 209.18/209.33 |- mesh__dateCreated mesh__D050495 2005-06-30
% 209.18/209.33 |- mesh__activeMeSHYear mesh__D050495 2006
% 209.18/209.33 |- skos__altLabel mesh__D050495 Vesicular GABA-Glycine Transporter Proteins
% 209.18/209.33 |- mesh__recordOriginator mesh__D050495 DRC
% 209.18/209.33 |- rdf__type mesh__D050495sskos__Concept
% 209.18/209.33 |- skos__hiddenLabel mesh__D050495 Transporter Proteins, VIAAT
% 209.18/209.33 |- skos__broader mesh__D050495smesh__D050481
% 209.18/209.33 |- mesh__recordMaintainer mesh__D050495 ags
% 209.18/209.33 |- rdf__type mesh__D003041sskos__Concept
% 209.18/209.33 |- skos__prefLabel mesh__D003041 Coca
% 209.18/209.33 |- mesh__recordMaintainer mesh__D003041 ssb
% 209.18/209.33 |- skos__broader mesh__D003041smesh__D030921
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003041 2004
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D003041 sjn
% 209.18/209.34 |- skos__altLabel mesh__D003041 Erythroxylon
% 209.18/209.34 |- mesh__dateRevised mesh__D003041 2001-07-25
% 209.18/209.34 |- skos__annotation mesh__D003041 do not confuse with cocoa see CACAO
% 209.18/209.34 |- skos__scopeNote mesh__D003041
% 209.18/209.34 Any of several South American shrubs of the Erythroxylon genus %28%and family%29% that yield COCAINE; the leaves are chewed with alum for CNS stimulation.%A%
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003041 2005
% 209.18/209.34 |- mesh__dateCreated mesh__D003041 1999-01-01
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003041 2006
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003041 2002
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003041 2003
% 209.18/209.34 |- mesh__recordOriginator mesh__D003041 NLM
% 209.18/209.34 |- skos__historyNote mesh__D016767
% 209.18/209.34 Bile Ducts, Intrahepatic/abnormalities %28%1985-1992%29%
% 209.18/209.34 |- skos__historyNote mesh__D016767
% 209.18/209.34 Bile Duct Diseases/congenital %28%1966-1992%29%
% 209.18/209.34 |- mesh__dateEstablished mesh__D016767 1993-01-01
% 209.18/209.34 |- rdf__type mesh__D016767sskos__Concept
% 209.18/209.34 |- skos__hiddenLabel mesh__D016767 Carolis Disease
% 209.18/209.34 |- skos__hiddenLabel mesh__D016767 Syndrome, Caroli%27%s
% 209.18/209.34 |- skos__hiddenLabel mesh__D016767 Disease, Caroli%27%s
% 209.18/209.34 |- skos__scopeNote mesh__D016767
% 209.18/209.34 Congenital cystic dilatation of the intrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC%29%. It consists of 2 types: simple Caroli disease is characterized by bile duct dilatation %28%ectasia%29% alone; and complex Caroli disease is characterized by bile duct dilatation with extensive hepatic fibrosis and portal hypertension %28%HYPERTENSION, PORTAL%29%. Benign renal tubular ectasia is associated with both types of Caroli disease.%A%
% 209.18/209.34 |- skos__broader mesh__D016767smesh__D015529
% 209.18/209.34 |- mesh__recordOriginator mesh__D016767 JLS
% 209.18/209.34 |- skos__prefLabel mesh__D016767 Caroli Disease
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D016767 2005
% 209.18/209.34 |- skos__altLabel mesh__D016767 Caroli%27%s Syndrome
% 209.18/209.34 |- mesh__recordMaintainer mesh__D016767 lkt
% 209.18/209.34 |- mesh__dateCreated mesh__D016767 1992-05-07
% 209.18/209.34 |- mesh__dateRevised mesh__D016767 2003-07-09
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D016767 sjn
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D016767 2004
% 209.18/209.34 |- skos__altLabel mesh__D016767 Caroli%27%s Disease
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D016767 2006
% 209.18/209.34 |- skos__hiddenLabel mesh__D016767 Disease, Caroli
% 209.18/209.34 |- skos__historyNote mesh__D016767 Biliary Dyskinesia %28%1966-1984%29%
% 209.18/209.34 |- skos__hiddenLabel mesh__D016767 Carolis Syndrome
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D016767
% 209.18/209.34 2004; see CAROLI%27%S DISEASE 1993-2003
% 209.18/209.34 |- skos__annotation mesh__D016767
% 209.18/209.34 do not coord with INFANT, NEWBORN, DISEASES; DF: CAROLI DIS%A%
% 209.18/209.34 |- mesh__historyNote mesh__D016767 2004 %28%1993%29%
% 209.18/209.34 |- skos__hiddenLabel mesh__D016767 Caroli Syndrome
% 209.18/209.34 |- mesh__recordOriginator mesh__D035921 jmp
% 209.18/209.34 |- mesh__dateRevised mesh__D035921 2005-06-30
% 209.18/209.34 |- skos__related mesh__D035921smesh__D006508
% 209.18/209.34 |- rdf__type mesh__D035921sskos__Concept
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D035921 sjn
% 209.18/209.34 |- mesh__recordMaintainer mesh__D035921 ssb
% 209.18/209.34 |- mesh__dateEstablished mesh__D035921 2003-01-01
% 209.18/209.34 |- skos__hiddenLabel mesh__D035921 Antigens, Hepatitis A
% 209.18/209.34 |- skos__scopeNote mesh__D035921
% 209.18/209.34 Antigens produced by various strains of HEPATITIS A VIRUS such as the human hepatitis A virus %28%HEPATITIS A VIRUS, HUMAN%29%.%A%
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D035921 2006
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D035921
% 209.18/209.34 2003; HEPATITIS A ANTIGENS was indexed under ANTIGENS, VIRAL 1985-2002%A%
% 209.18/209.34 |- mesh__historyNote mesh__D035921
% 209.18/209.34 2003; use HEPATITIS A ANTIGENS %28%NM%29% 1985-2002
% 209.18/209.34 |- skos__prefLabel mesh__D035921 Hepatitis A Antigens
% 209.18/209.34 |- skos__broader mesh__D035921smesh__D018963
% 209.18/209.34 |- skos__altLabel mesh__D035921 Hepatitis A Virus Antigens
% 209.18/209.34 |- skos__historyNote mesh__D035921 Antigens, Viral %28%1985-2002%29%
% 209.18/209.34 |- mesh__dateCreated mesh__D035921 2002-07-02
% 209.18/209.34 |- skos__annotation mesh__D035921
% 209.18/209.34 for antigens to human virus, coord IM with HEPATITIS A VIRUS, HUMAN /immunol %28%IM%29%%A%
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D002747 2006
% 209.18/209.34 |- skos__altLabel mesh__D002747 Farmasierra Brand of Chlorpropamide
% 209.18/209.34 |- skos__scopeNote mesh__D002747
% 209.18/209.34 A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p277%29%%A%
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D002747 sjn
% 209.18/209.34 |- rdf__type mesh__D002747sskos__Concept
% 209.18/209.34 |- mesh__recordOriginator mesh__D002747 NLM
% 209.18/209.34 |- mesh__dateCreated mesh__D002747 1999-01-01
% 209.18/209.34 |- mesh__recordMaintainer mesh__D002747 lkw
% 209.18/209.34 |- skos__altLabel mesh__D002747 Byk Gulden Brand of Chlorpropamide
% 209.18/209.34 |- skos__altLabel mesh__D002747 Pfizer Brand of Chlorpropamide
% 209.18/209.34 |- mesh__dateRevised mesh__D002747 2005-06-30
% 209.18/209.34 |- skos__altLabel mesh__D002747 Apotex Brand of Chlorpropamide
% 209.18/209.34 |- skos__prefLabel mesh__D002747 Chlorpropamide
% 209.18/209.34 |- skos__altLabel mesh__D002747 Clorpropamid
% 209.18/209.34 |- skos__broader mesh__D002747smesh__D013453
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Regions, Intergenic
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Intercistronic Regions
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Sequences, Intergenic
% 209.18/209.34 |- skos__altLabel mesh__D021901 DNA, Spacer
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 DNAs, Spacer
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 DNAs, Intergenic
% 209.18/209.34 |- skos__scopeNote mesh__D021901
% 209.18/209.34 Any of the DNA in between gene-coding DNA, including untranslated regions, 5%27% and 3%27% flanking regions, INTRONS, non-functional pseudogenes, and non-functional repetitive sequences. This DNA may or may not encode regulatory functions.%A%
% 209.18/209.34 |- mesh__dateCreated mesh__D021901 2000-06-22
% 209.18/209.34 |- skos__altLabel mesh__D021901 Intercistronic Sequence
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Region, Intergenic
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D021901 sjn
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Regions, Intercistronic
% 209.18/209.34 |- skos__altLabel mesh__D021901 Intercistronic Region
% 209.18/209.34 |- mesh__dateRevised mesh__D021901 2005-06-30
% 209.18/209.34 |- skos__altLabel mesh__D021901 Sequence, Intergenic
% 209.18/209.34 |- mesh__recordMaintainer mesh__D021901 nns
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Intercistronic Sequences
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Intergenic Sequences
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 DNAs, Junk
% 209.18/209.34 |- skos__altLabel mesh__D021901 Intergenic DNA
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Sequences, Intercistronic
% 209.18/209.34 |- mesh__recordOriginator mesh__D021901 nns
% 209.18/209.34 |- mesh__historyNote mesh__D021901 2001
% 209.18/209.34 |- skos__broader mesh__D021901smesh__D040481
% 209.18/209.34 |- skos__historyNote mesh__D021901 Base Sequence %28%1983-2000%29%
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Sequence, Intercistronic
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D021901 2006
% 209.18/209.34 |- skos__broader mesh__D021901smesh__D004247
% 209.18/209.34 |- rdf__type mesh__D021901sskos__Concept
% 209.18/209.34 |- skos__altLabel mesh__D021901 Junk DNA
% 209.18/209.34 |- mesh__dateEstablished mesh__D021901 2001-01-01
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Junk DNAs
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Intergenic Regions
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D021901 2001
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Spacer DNAs
% 209.18/209.34 |- skos__prefLabel mesh__D021901 DNA, Intergenic
% 209.18/209.34 |- skos__historyNote mesh__D021901 DNA or specifics %28%1984-2000%29%
% 209.18/209.34 |- skos__annotation mesh__D021901
% 209.18/209.34 note that DNA, RIBOSOMAL SPACER is available
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Intergenic DNAs
% 209.18/209.34 |- skos__hiddenLabel mesh__D021901 Region, Intercistronic
% 209.18/209.34 |- skos__hiddenLabel mesh__D007432 Periods, Intraoperative
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 1996
% 209.18/209.34 |- mesh__recordMaintainer mesh__D007432 NLM
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 2004
% 209.18/209.34 |- skos__hiddenLabel mesh__D007432 Periods, Peroperative
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 1991
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D007432
% 209.18/209.34 91; was see under SURGERY, OPERATIVE 1980-90
% 209.18/209.34 |- rdf__type mesh__D007432sskos__Concept
% 209.18/209.34 |- mesh__recordOriginator mesh__D007432 SMH
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 1997
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 1994
% 209.18/209.34 |- skos__broader mesh__D007432smesh__D013514
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 2002
% 209.18/209.34 |- skos__hiddenLabel mesh__D007432 Peroperative Periods
% 209.18/209.34 |- skos__scopeNote mesh__D007432
% 209.18/209.34 The period during a surgical operation.
% 209.18/209.34 |- mesh__dateEstablished mesh__D007432 1991-01-01
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 2005
% 209.18/209.34 |- skos__hiddenLabel mesh__D007432 Period, Peroperative
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 1995
% 209.18/209.34 |- mesh__dateRevised mesh__D007432 1990-04-13
% 209.18/209.34 |- skos__hiddenLabel mesh__D007432 Period, Intraoperative
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 1998
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 2006
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 1992
% 209.18/209.34 |- skos__hiddenLabel mesh__D007432 Intraoperative Periods
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 2000
% 209.18/209.34 |- skos__annotation mesh__D007432
% 209.18/209.34 almost never IM; use qualif discreetly; DF: INTRAOP PERIOD%A%
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D007432 PLS
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 1999
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 2003
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 2001
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D007432 1993
% 209.18/209.34 |- mesh__dateCreated mesh__D007432 1979-03-12
% 209.18/209.34 |- skos__prefLabel mesh__D007432 Intraoperative Period
% 209.18/209.34 |- mesh__historyNote mesh__D007432
% 209.18/209.34 91%28%80%29%; was see under SURGERY, OPERATIVE 1980-90
% 209.18/209.34 |- skos__hiddenLabel mesh__D012377 Beaver
% 209.18/209.34 |- skos__hiddenLabel mesh__D012377 Rodent
% 209.18/209.34 |- skos__altLabel mesh__D012377 Rodents
% 209.18/209.34 |- skos__altLabel mesh__D012377 Dipodidae
% 209.18/209.34 |- skos__hiddenLabel mesh__D012377 Capybara
% 209.18/209.34 |- skos__hiddenLabel mesh__D012377 Rodentias
% 209.18/209.34 |- skos__altLabel mesh__D012377 Hydrochaeris
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D012377 2006
% 209.18/209.34 |- skos__annotation mesh__D012377 GEN or unspecified; prefer specifics
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D012377 sjn
% 209.18/209.34 |- mesh__dateRevised mesh__D012377 2004-07-07
% 209.18/209.34 |- skos__scopeNote mesh__D012377
% 209.18/209.34 A mammalian order which consists of 29 families and many genera.%A%
% 209.18/209.34 |- skos__hiddenLabel mesh__D012377 Hydrochaeri
% 209.18/209.34 |- skos__prefLabel mesh__D012377 Rodentia
% 209.18/209.34 |- skos__altLabel mesh__D012377 Beavers
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D012377 2005
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D012377 1982; see RODENTS 1963-1981
% 209.18/209.34 |- mesh__recordOriginator mesh__D012377 NLM
% 209.18/209.34 |- mesh__dateCreated mesh__D012377 1999-01-01
% 209.18/209.34 |- skos__hiddenLabel mesh__D012377 Jerboa
% 209.18/209.34 |- rdf__type mesh__D012377sskos__Concept
% 209.18/209.34 |- mesh__historyNote mesh__D012377 1982; use RODENTS 1963-1981
% 209.18/209.34 |- skos__broader mesh__D012377smesh__D008322
% 209.18/209.34 |- mesh__recordMaintainer mesh__D012377 ags
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D020809 2004
% 209.18/209.34 |- skos__prefLabel mesh__D020809 Central Nervous System Helminthiasis
% 209.18/209.34 |- skos__historyNote mesh__D020809 Helminthiasis %28%1968-1999%29%
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D020809 2000
% 209.18/209.34 |- mesh__dateEstablished mesh__D020809 2000-01-01
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D020809 2005
% 209.18/209.34 |- skos__broader mesh__D020809smesh__D020807
% 209.18/209.34 |- rdf__type mesh__D020809sskos__Concept
% 209.18/209.34 |- skos__scopeNote mesh__D020809
% 209.18/209.34 Infections of the BRAIN; SPINAL CORD; or MENINGES caused by HELMINTHS %28%parasitic worms%29%.%A%
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D020809 2001
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D020809 2006
% 209.18/209.34 |- skos__altLabel mesh__D020809 Helminthiasis, Central Nervous System
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D020809 2000
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D020809 2003
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D020809 2002
% 209.18/209.34 |- mesh__dateCreated mesh__D020809 1999-11-03
% 209.18/209.34 |- skos__hiddenLabel mesh__D020809 Helminthiasis, Cerebral
% 209.18/209.34 |- mesh__historyNote mesh__D020809 2000
% 209.18/209.34 |- mesh__dateCreated mesh__D017860 1993-06-29
% 209.18/209.34 |- mesh__recordMaintainer mesh__D017860 ags
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D017860 sjn
% 209.18/209.34 |- mesh__dateRevised mesh__D017860 2001-07-25
% 209.18/209.34 |- skos__annotation mesh__D017860 coord IM with specific plant /virol
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D017860
% 209.18/209.34 94; TOBACCO RINGSPOT VIRUSES was see NEPOVIRUS 1994-96
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017860 2005
% 209.18/209.34 |- skos__broader mesh__D017860smesh__D019180
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017860 2002
% 209.18/209.34 |- mesh__recordOriginator mesh__D017860 AGS
% 209.18/209.34 |- skos__hiddenLabel mesh__D017860 Nepoviruses
% 209.18/209.34 |- rdf__type mesh__D017860sskos__Concept
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017860 2003
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017860 2006
% 209.18/209.34 |- mesh__onlineNote mesh__D017860
% 209.18/209.34 use NEPOVIRUS to search TOBACCO RINGSPOT VIRUSES 1994-96
% 209.18/209.34 |- skos__hiddenLabel mesh__D017860 Tobacco ringspot viruses
% 209.18/209.34 |- skos__prefLabel mesh__D017860 Nepovirus
% 209.18/209.34 |- skos__historyNote mesh__D017860 Plant Viruses %28%1985-1993%29%
% 209.18/209.34 |- skos__scopeNote mesh__D017860
% 209.18/209.34 A genus of polyhedral plant viruses of the family COMOVIRIDAE causing ringspots and spotting on leaves or sometimes symptomless infection. Transmission occurs by seeds, soil nematodes, or experimentally by mechanical inoculation. Tobacco ringspot virus is the type species.%A%
% 209.18/209.34 |- mesh__dateEstablished mesh__D017860 1994-01-01
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017860 2004
% 209.18/209.34 |- mesh__historyNote mesh__D017860
% 209.18/209.34 94; TOBACCO RINGSPOT VIRUSES was see NEPOVIRUS 1994-96
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Studies, Small-Area
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Analysis, Small-Area Variation
% 209.18/209.34 |- skos__annotation mesh__D017062
% 209.18/209.34 restrict to small geog or demog areas; no qualif; DF: SMALL AREA ANAL%A%
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 2005
% 209.18/209.34 |- mesh__dateCreated mesh__D017062 1991-06-20
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 2000
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 1998
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 1995
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Analyses, Small-Area
% 209.18/209.34 |- skos__scopeNote mesh__D017062
% 209.18/209.34 A method of analyzing the variation in utilization of health care in small geographic or demographic areas. It often studies, for example, the usage rates for a given service or procedure in several small areas, documenting the variation among the areas. By comparing high- and low-use areas, the analysis attempts to determine whether there is a pattern to such use and to identify variables that are associated with and contribute to the variation.%A%
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Small Area Variation
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Study, Small-Area
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 2006
% 209.18/209.34 |- rdf__type mesh__D017062sskos__Concept
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 2001
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Analysis, Small Area
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 1999
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Analyses, Small-Area Variation
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Small Area Studies
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Variation Analyses, Small-Area
% 209.18/209.34 |- skos__prefLabel mesh__D017062 Small-Area Analysis
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 2003
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Variation Analysis, Small Area
% 209.18/209.34 |- mesh__recordMaintainer mesh__D017062 PLS
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 1996
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 1993
% 209.18/209.34 |- mesh__dateRevised mesh__D017062 1992-05-22
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Small-Area Variation Analyses
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Small-Area Analyses
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D017062 PLS
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Variations, Small-Area
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 2002
% 209.18/209.34 |- skos__altLabel mesh__D017062 Variation Analysis, Small-Area
% 209.18/209.34 |- mesh__historyNote mesh__D017062 92
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 2004
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 1997
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Small-Area Variations
% 209.18/209.34 |- skos__altLabel mesh__D017062 Small-Area Variation Analysis
% 209.18/209.34 |- skos__broader mesh__D017062smesh__D016000
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Variation, Small-Area
% 209.18/209.34 |- skos__altLabel mesh__D017062 Analysis, Small-Area
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Small-Area Study
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Small Area Analysis
% 209.18/209.34 |- mesh__recordOriginator mesh__D017062 PLS
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D017062 1994
% 209.18/209.34 |- mesh__dateEstablished mesh__D017062 1992-01-01
% 209.18/209.34 |- skos__hiddenLabel mesh__D017062 Small Area Variation Analysis
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D017062 92
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003840 2005
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Deoxycholic Acid, 12beta Isomer
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Acid, Choleic
% 209.18/209.34 |- skos__historyNote mesh__D003840 Bile Acids and Salts %28%1966-1972%29%
% 209.18/209.34 |- mesh__recordOriginator mesh__D003840 NLM
% 209.18/209.34 |- mesh__dateEstablished mesh__D003840 1974-01-01
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Deoxycholate, Sodium
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D003840 sjn
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003840 2006
% 209.18/209.34 |- skos__annotation mesh__D003840 /biosyn /physiol permitted
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Deoxycholic Acid, 3beta Isomer
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 3beta-Isomer Deoxycholic Acid
% 209.18/209.34 |- skos__altLabel mesh__D003840 Sodium Deoxycholate
% 209.18/209.34 |- skos__altLabel mesh__D003840 Desoxycholic Acid
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 5alpha-Isomer Deoxycholic Acid
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D003840 74
% 209.18/209.34 |- mesh__dateCreated mesh__D003840 1999-01-01
% 209.18/209.34 |- mesh__historyNote mesh__D003840 74%28%73%29%
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Acid, Deoxycholic
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 12beta-Isomer Deoxycholic Acid
% 209.18/209.34 |- skos__scopeNote mesh__D003840
% 209.18/209.34 A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.%A%
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Deoxycholic Acid, 5alpha Isomer
% 209.18/209.34 |- skos__broader mesh__D003840smesh__D002793
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Acid, Dihydroxycholanoic
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Acid, Desoxycholic
% 209.18/209.34 |- mesh__recordMaintainer mesh__D003840 ssb
% 209.18/209.34 |- mesh__dateRevised mesh__D003840 2003-07-09
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Acid, 5alpha-Isomer Deoxycholic
% 209.18/209.34 |- rdf__type mesh__D003840sskos__Concept
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003840 2004
% 209.18/209.34 |- skos__hiddenLabel mesh__D003840 Acid, Lagodeoxycholic
% 209.18/209.34 |- skos__prefLabel mesh__D003840 Deoxycholic Acid
% 209.18/209.34 |- skos__altLabel mesh__D003840 Dihydroxycholanoic Acid
% 209.18/209.34 |- skos__altLabel mesh__D050496 Glutamate Transporters, Vesicular
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D050496 2006
% 209.18/209.34 |- skos__altLabel mesh__D050496 VGLUT Transport Proteins
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D050496 2006
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D050496 sjn
% 209.18/209.34 |- mesh__recordOriginator mesh__D050496 DRC
% 209.18/209.34 |- rdf__type mesh__D050496sskos__Concept
% 209.18/209.34 |- skos__scopeNote mesh__D050496
% 209.18/209.34 A family of vesicular neurotransmitter transporter proteins that were originally characterized as sodium dependent inorganic phosphate cotransporters. Vesicular glutamate transport proteins sequester the excitatory neurotransmitter GLUTAMATE from the CYTOPLASM into SECRETORY VESICLES in exchange for lumenal PROTONS.%A%
% 209.18/209.34 |- skos__broader mesh__D050496smesh__D050481
% 209.18/209.34 |- mesh__dateEstablished mesh__D050496 2006-01-01
% 209.18/209.34 |- skos__altLabel mesh__D050496 Vesicular Glutamate Transporter Proteins
% 209.18/209.34 |- skos__hiddenLabel mesh__D050496 Transporters, Vesicular Glutamate
% 209.18/209.34 |- skos__hiddenLabel mesh__D050496 Transport Proteins, VGLUT
% 209.18/209.34 |- skos__hiddenLabel mesh__D050496 Vesicular Glutamate Transporters
% 209.18/209.34 |- skos__prefLabel mesh__D050496 Vesicular Glutamate Transport Proteins
% 209.18/209.34 |- mesh__historyNote mesh__D050496 2006
% 209.18/209.34 |- mesh__dateCreated mesh__D050496 2005-06-30
% 209.18/209.34 |- mesh__recordMaintainer mesh__D050496 DRC
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003042 2006
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003042 2004
% 209.18/209.34 |- skos__altLabel mesh__D003042 Cocaine HCl
% 209.18/209.34 |- mesh__dateCreated mesh__D003042 1999-01-01
% 209.18/209.34 |- skos__prefLabel mesh__D003042 Cocaine
% 209.18/209.34 |- skos__annotation mesh__D003042
% 209.18/209.34 cocaine derivatives = COCAINE /analogs;CRACK COCAINE is available; cocaine addiction = COCAINE-RELATED DISORDERS%A%
% 209.18/209.34 |- rdf__type mesh__D003042sskos__Concept
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003042 2005
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D003042 2003
% 209.18/209.34 |- mesh__recordMaintainer mesh__D003042 tpw
% 209.18/209.34 |- mesh__recordOriginator mesh__D003042 NLM
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D003042
% 209.18/209.34 COCAINE DERIVATIVES was see under COCAINE 1975-77; was see under TROPANES 1969-74%A%
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D003042 sjn
% 209.18/209.34 |- skos__scopeNote mesh__D003042
% 209.18/209.34 An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.%A%
% 209.18/209.34 |- skos__hiddenLabel mesh__D003042 Hydrochloride, Cocaine
% 209.18/209.34 |- mesh__onlineNote mesh__D003042
% 209.18/209.34 use COCAINE/analogs %26% derivatives to search COCAINE DERIVATIVES 1975-77; use TROPANES 1969-74%A%
% 209.18/209.34 |- skos__hiddenLabel mesh__D003042 HCl, Cocaine
% 209.18/209.34 |- skos__broader mesh__D003042smesh__D014326
% 209.18/209.34 |- mesh__historyNote mesh__D003042
% 209.18/209.34 COCAINE DERIVATIVES was see under COCAINE 1975-77; was see under TROPANES 1969-74%A%
% 209.18/209.34 |- mesh__dateRevised mesh__D003042 2002-07-03
% 209.18/209.34 |- skos__broader mesh__D014070Q000293smesh__D014070
% 209.18/209.34 |- mesh__preferredCombination mesh__D014070Q000293smesh__D018677
% 209.18/209.34 |- rdf__type mesh__D014070Q000293smesh__CompoundConcept
% 209.18/209.34 |- mesh__dateEstablished mesh__D041161 2003-01-01
% 209.18/209.34 |- skos__broader mesh__D041161smesh__D012281
% 209.18/209.34 |- mesh__historyNote mesh__D041161 2003
% 209.18/209.34 |- skos__prefLabel mesh__D041161 Rickettsia felis
% 209.18/209.34 |- mesh__recordOriginator mesh__D041161 ags
% 209.18/209.34 |- skos__annotation mesh__D041161
% 209.18/209.34 infection: coord IM with RICKETTSIA INFECTIONS %28%IM%29%
% 209.18/209.34 |- mesh__dateCreated mesh__D041161 2002-07-03
% 209.18/209.34 |- skos__scopeNote mesh__D041161
% 209.18/209.34 A species of gram-negative bacteria transmitted by the flea Ctenocephalides felis, and known to infect CATS, oppossums, and humans.%A%
% 209.18/209.34 |- mesh__dateRevised mesh__D041161 2005-06-30
% 209.18/209.34 |- rdf__type mesh__D041161sskos__Concept
% 209.18/209.34 |- skos__historyNote mesh__D041161 Rickettsia %28%1990-2002%29%
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D041161 2006
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D041161 sjn
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D041161 2003
% 209.18/209.34 |- mesh__recordMaintainer mesh__D041161 SYSTEM
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D035922
% 209.18/209.34 2003; HEPATITIS A ANTIBODIES was indexed under HEPATITIS ANTIBODIES 1985-2002, ANTIBODIES, VIRAL 1981-1984%A%
% 209.18/209.34 |- skos__scopeNote mesh__D035922
% 209.18/209.34 Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins.%A%
% 209.18/209.34 |- mesh__dateCreated mesh__D035922 2002-07-02
% 209.18/209.34 |- skos__broader mesh__D035922smesh__D006508
% 209.18/209.34 |- skos__altLabel mesh__D035922 Anti-HAV
% 209.18/209.34 |- skos__historyNote mesh__D035922 Hepatitis Antibodies %28%1985-2002%29%
% 209.18/209.34 |- mesh__dateRevised mesh__D035922 2005-06-30
% 209.18/209.34 |- mesh__recordOriginator mesh__D035922 jmp
% 209.18/209.34 |- skos__hiddenLabel mesh__D035922 Anti HAV
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D035922 sjn
% 209.18/209.34 |- mesh__recordMaintainer mesh__D035922 ssb
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D035922 2006
% 209.18/209.34 |- mesh__dateEstablished mesh__D035922 2003-01-01
% 209.18/209.34 |- mesh__historyNote mesh__D035922
% 209.18/209.34 2003; use HEPATITIS A ANTIBODIES %28%NM%29% 1981-2002
% 209.18/209.34 |- skos__related mesh__D035922smesh__D035921
% 209.18/209.34 |- skos__hiddenLabel mesh__D035922 Antibodies, Hepatitis A
% 209.18/209.34 |- skos__prefLabel mesh__D035922 Hepatitis A Antibodies
% 209.18/209.34 |- skos__altLabel mesh__D035922 Hepatitis A Virus Antibodies
% 209.18/209.34 |- skos__annotation mesh__D035922
% 209.18/209.34 for antibodies to human virus, coordinate IM with HEPATITIS A VIRUS, HUMAN /immunol %28%IM%29%%A%
% 209.18/209.34 |- rdf__type mesh__D035922sskos__Concept
% 209.18/209.34 |- skos__historyNote mesh__D035922 Antibodies, Viral %28%1981-1984%29%
% 209.18/209.34 |- skos__scopeNote mesh__D002748
% 209.18/209.34 A carbamate that is used as an herbicide and as a plant growth regulator.%A%
% 209.18/209.34 |- skos__altLabel mesh__D002748 Isopropyl N-%28%3-Chlorophenol%29%carbamate
% 209.18/209.34 |- mesh__dateEstablished mesh__D002748 1991-01-01
% 209.18/209.34 |- rdf__type mesh__D002748sskos__Concept
% 209.18/209.34 |- skos__altLabel mesh__D002748 CIPC
% 209.18/209.34 |- mesh__dateCreated mesh__D002748 1999-01-01
% 209.18/209.34 |- mesh__historyNote mesh__D002748
% 209.18/209.34 91%28%72%29%; was see under HERBICIDES, CARBAMATE 1972-90
% 209.18/209.34 |- skos__historyNote mesh__D002748 Carbamates %28%1966-1971%29%
% 209.18/209.34 |- skos__prefLabel mesh__D002748 Chlorpropham
% 209.18/209.34 |- mesh__dateRevised mesh__D002748 2004-07-07
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D002748 2005
% 209.18/209.34 |- mesh__publicMeSHNote mesh__D002748
% 209.18/209.34 91; was see under HERBICIDES, CARBAMATE 1972-90
% 209.18/209.34 |- mesh__recordMaintainer mesh__D002748 ssb
% 209.18/209.34 |- mesh__activeMeSHYear mesh__D002748 2006
% 209.18/209.34 |- skos__broader mesh__D002748smesh__D048448
% 209.18/209.34 |- skos__historyNote mesh__D002748 Herbicides %28%1966-1971%29%
% 209.18/209.34 |- mesh__recordAuthorizer mesh__D002748 sjn
% 209.18/209.34 |- mesh__recordOriginator mesh__D002748 NLM
% 209.18/209.34 |- skos__scopeNote mesh__D021902
% 209.18/209.34 Gram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections%A%
% 209.18/209.34 |- skos__altLabel mesh__D021902 Klebsiella aerogenes
% 209.18/209.34 |- mesh__recordOriginator mesh__D021902 jmp
% 209.18/209.34 |- skos__broader mesh__D021902smesh__D004754
% 209.18/209.34 |- skos__historyNote mesh__D021902 Klebsiella pneumoniae %28%1992-2000%29%
% 209.18/209.34 |- skos__annotation mesh__D021902
% 209.18/209.34 infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%
% 209.18/209.34 |- skos__historyNote mesh__D021902 Enterobacter %28%1966-1991%29%
% 209.18/209.34 |- mesh__dateCreated mesh__D021902 2000-06-27
% 209.18/209.34 |- skos__altLabel mesh__D021902 Aerobacter aerogenes
% 209.18/209.34 |- mesh__dateEstablished mesh__D021902 2001-01-01
% 209.18/209.35 |- skos__altLabel mesh__D021902 Klebsiella mobilus
% 209.18/209.35 |- mesh__recordMaintainer mesh__D021902 SYSTEM
% 209.18/209.35 |- skos__prefLabel mesh__D021902 Enterobacter aerogenes
% 209.18/209.35 |- skos__related mesh__D021902smesh__D007711
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D021902
% 209.18/209.35 2001; for AEROBACTER AEROGENES see KLEBSIELLA PNEUMONIAE 1992-2000, ENTEROBACTER 1976-1991, %26% AEROBACTER AEROGENES 1963-1975%A%
% 209.18/209.35 |- mesh__historyNote mesh__D021902
% 209.18/209.35 2001; for AEROBACTER AEROGENES use KLEBSIELLA PNEUMONIAE 1992-2000 %26% ENTEROBACTER 1963-1991%A%
% 209.18/209.35 |- mesh__dateRevised mesh__D021902 2005-06-30
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D021902 2006
% 209.18/209.35 |- rdf__type mesh__D021902sskos__Concept
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D021902 sjn
% 209.18/209.35 |- skos__broader mesh__D007433smesh__D007434
% 209.18/209.35 |- rdf__type mesh__D007433sskos__Concept
% 209.18/209.35 |- mesh__recordOriginator mesh__D007433 NLM
% 209.18/209.35 |- skos__prefLabel mesh__D007433 Intrauterine Device Expulsion
% 209.18/209.35 |- skos__historyNote mesh__D007433 Intrauterine Devices %28%1967-1974%29%
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D007433 sjn
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007433 2005
% 209.18/209.35 |- mesh__recordMaintainer mesh__D007433 lkt
% 209.18/209.35 |- skos__altLabel mesh__D007433 IUD Expulsion
% 209.18/209.35 |- skos__scopeNote mesh__D007433
% 209.18/209.35 Spontaneous loss of INTRAUTERINE DEVICES from the UTERUS.%A%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007433 2006
% 209.18/209.35 |- skos__annotation mesh__D007433 DF: IUD EXPULSION
% 209.18/209.35 |- skos__hiddenLabel mesh__D007433 Intrauterine Device Expulsions
% 209.18/209.35 |- skos__broader mesh__D007433smesh__D004868
% 209.18/209.35 |- mesh__dateCreated mesh__D007433 1974-11-19
% 209.18/209.35 |- mesh__historyNote mesh__D007433
% 209.18/209.35 78%28%75%29%; was see under INTRAUTERINE DEVICES 1975-77
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D007433
% 209.18/209.35 78; was see under INTRAUTERINE DEVICES 1975-77
% 209.18/209.35 |- mesh__dateEstablished mesh__D007433 1978-01-01
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007433 2004
% 209.18/209.35 |- mesh__dateRevised mesh__D007433 2003-07-09
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D012378 2006
% 209.18/209.35 |- mesh__recordOriginator mesh__D012378 NLM
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D012378 2005
% 209.18/209.35 |- mesh__dateCreated mesh__D012378 1999-01-01
% 209.18/209.35 |- skos__scopeNote mesh__D012378
% 209.18/209.35 Substances used to destroy or inhibit the action of rats, mice, or other rodents.%A%
% 209.18/209.35 |- skos__broader mesh__D012378smesh__D010575
% 209.18/209.35 |- rdf__type mesh__D012378sskos__Concept
% 209.18/209.35 |- mesh__dateRevised mesh__D012378 2003-07-09
% 209.18/209.35 |- mesh__recordMaintainer mesh__D012378 ssb
% 209.18/209.35 |- skos__prefLabel mesh__D012378 Rodenticides
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D012378 2004
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D012378 sjn
% 209.18/209.35 |- skos__annotation mesh__D012378
% 209.18/209.35 specify rodent if pertinent but not with /drug eff
% 209.18/209.35 |- mesh__dateRevised mesh__D017861 2005-06-30
% 209.18/209.35 |- mesh__recordOriginator mesh__D017861 PXP
% 209.18/209.35 |- skos__prefLabel mesh__D017861 Porphyromonas
% 209.18/209.35 |- mesh__historyNote mesh__D017861 94
% 209.18/209.35 |- mesh__recordMaintainer mesh__D017861 SYSTEM
% 209.18/209.35 |- skos__broader mesh__D017861smesh__D001438
% 209.18/209.35 |- mesh__dateEstablished mesh__D017861 1994-01-01
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D017861 sjn
% 209.18/209.35 |- skos__scopeNote mesh__D017861
% 209.18/209.35 A genus of gram-negative, anaerobic, nonsporeforming, nonmotile rods or coccobacilli. Organisms in this genus had originally been classified as members of the BACTEROIDES genus but overwhelming biochemical and chemical findings indicated the need to separate them from other Bacteroides species, and hence, this new genus was created.%A%
% 209.18/209.35 |- mesh__dateCreated mesh__D017861 1993-02-16
% 209.18/209.35 |- skos__annotation mesh__D017861
% 209.18/209.35 infection: coord IM with BACTEROIDACEAE INFECTIONS %28%IM%29%
% 209.18/209.35 |- skos__historyNote mesh__D017861 Bacteroides %28%1988-1993%29%
% 209.18/209.35 |- rdf__type mesh__D017861sskos__Concept
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017861 2006
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D017861 94
% 209.18/209.35 |- mesh__recordOriginator mesh__D017063 PLS
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Assessment, Outcome %28%Health Care%29%
% 209.18/209.35 |- skos__altLabel mesh__D017063 Assessment, Outcomes
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D017063 ags
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 2001
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Research, Outcomes
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Assessments, Patient Outcome
% 209.18/209.35 |- skos__broader mesh__D017063smesh__D010043
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 2005
% 209.18/209.35 |- skos__altLabel mesh__D017063 Assessment, Patient Outcomes
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 1998
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Study, Outcome
% 209.18/209.35 |- mesh__dateRevised mesh__D017063 1999-12-16
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Assessments, Outcome %28%Health Care%29%
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Measures, Outcome
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Assessments, Patient Outcomes
% 209.18/209.35 |- skos__historyNote mesh__D017063
% 209.18/209.35 Outcome and Process Assessment %28%Health Care%29% %28%1979-1991%29%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 2000A
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 2006
% 209.18/209.35 |- rdf__type mesh__D017063sskos__Concept
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 1999
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Studies, Outcome
% 209.18/209.35 |- skos__altLabel mesh__D017063 Assessment, Patient Outcome
% 209.18/209.35 |- skos__scopeNote mesh__D017063
% 209.18/209.35 Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states %28%such as elevated blood pressure%29%.%A%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 2002
% 209.18/209.35 |- skos__annotation mesh__D017063
% 209.18/209.35 note category: for admin aspects of patient assessment; outcome only: for outcome assessment with process assessment, OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% and TREATMENT OUTCOME are available; DF: OUTCOME ASSESS%A%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 2003
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Patient Outcomes Assessments
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Outcomes Assessment, Patient
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Assessments, Outcomes
% 209.18/209.35 |- mesh__historyNote mesh__D017063
% 209.18/209.35 92; PATIENT OUTCOME ASSESSMENT was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A%
% 209.18/209.35 |- skos__altLabel mesh__D017063 Outcomes Assessment
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Outcomes Assessments
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 2004
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Outcome Assessments, Patient
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Patient Outcome Assessments
% 209.18/209.35 |- skos__altLabel mesh__D017063 Outcome Assessment, Patient
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Measure, Outcome
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017063 2000
% 209.18/209.35 |- mesh__recordMaintainer mesh__D017063 ags
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Outcome Study
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Outcome Assessments %28%Health Care%29%
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Patient Outcomes Assessment
% 209.18/209.35 |- skos__prefLabel mesh__D017063 Outcome Assessment %28%Health Care%29%
% 209.18/209.35 |- skos__altLabel mesh__D017063 Outcomes Assessments, Patient
% 209.18/209.35 |- mesh__dateEstablished mesh__D017063 1992-01-01
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D017063
% 209.18/209.35 92; PATIENT OUTCOME ASSESSMENT was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A%
% 209.18/209.35 |- mesh__onlineNote mesh__D017063
% 209.18/209.35 use OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% to search PATIENT OUTCOME ASSESSMENT 1979-91%A%
% 209.18/209.35 |- skos__hiddenLabel mesh__D017063 Outcome Measure
% 209.18/209.35 |- mesh__dateCreated mesh__D017063 1991-06-20
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 2006
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 2000
% 209.18/209.35 |- skos__hiddenLabel mesh__D003841 Deoxyribonucleoside, Cytosine
% 209.18/209.35 |- skos__altLabel mesh__D003841 CDR
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 2001
% 209.18/209.35 |- skos__altLabel mesh__D003841 Cytosine Deoxyriboside
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 1996
% 209.18/209.35 |- mesh__recordOriginator mesh__D003841 NLM
% 209.18/209.35 |- mesh__dateCreated mesh__D003841 1999-01-01
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 2002
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 1997
% 209.18/209.35 |- skos__altLabel mesh__D003841 Cytosine Deoxyribonucleoside
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 2003
% 209.18/209.35 |- rdf__type mesh__D003841sskos__Concept
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 1998
% 209.18/209.35 |- skos__historyNote mesh__D003841 Nucleosides %28%1966-1972%29%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 1993
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 2004
% 209.18/209.35 |- mesh__recordMaintainer mesh__D003841 TGC
% 209.18/209.35 |- skos__prefLabel mesh__D003841 Deoxycytidine
% 209.18/209.35 |- skos__broader mesh__D003841smesh__D003853
% 209.18/209.35 |- mesh__dateRevised mesh__D003841 1992-05-13
% 209.18/209.35 |- mesh__historyNote mesh__D003841 75%28%73%29%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 1994
% 209.18/209.35 |- skos__hiddenLabel mesh__D003841 Deoxyriboside, Cytosine
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 1999
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D003841 PLS
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 2005
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D003841 75
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003841 1995
% 209.18/209.35 |- skos__broader mesh__D003841smesh__D003562
% 209.18/209.35 |- skos__prefLabel mesh__D050497 Stillbirth
% 209.18/209.35 |- skos__scopeNote mesh__D050497
% 209.18/209.35 The event that a FETUS is born dead or stillborn.
% 209.18/209.35 |- mesh__historyNote mesh__D050497
% 209.18/209.35 2006; use PREGNANCY OUTCOME 2004-2005, use FETAL DEATH 1963-2003%A%
% 209.18/209.35 |- rdf__type mesh__D050497sskos__Concept
% 209.18/209.35 |- mesh__dateCreated mesh__D050497 2005-06-30
% 209.18/209.35 |- mesh__recordMaintainer mesh__D050497 lkt
% 209.18/209.35 |- skos__hiddenLabel mesh__D050497 Stillbirths
% 209.18/209.35 |- skos__historyNote mesh__D050497 Fetal Death %28%1965-2003%29%
% 209.18/209.35 |- mesh__recordOriginator mesh__D050497 lkt
% 209.18/209.35 |- skos__historyNote mesh__D050497 Pregnancy Outcome %28%2004-2005%29%
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D050497 sjn
% 209.18/209.35 |- mesh__dateEstablished mesh__D050497 2006-01-01
% 209.18/209.35 |- skos__historyNote mesh__D050497 Pregnancy %28%1965-2003%29%
% 209.18/209.35 |- skos__broader mesh__D050497smesh__D011256
% 209.18/209.35 |- skos__related mesh__D050497smesh__D005313
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D050497
% 209.18/209.35 2006; see PREGNANCY OUTCOME 2004-2005, see FETAL DEATH 1963-2003%A%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D050497 2006
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003043 2004
% 209.18/209.35 |- mesh__dateRevised mesh__D003043 2005-07-21
% 209.18/209.35 |- rdf__type mesh__D003043sskos__Concept
% 209.18/209.35 |- mesh__historyNote mesh__D003043 77
% 209.18/209.35 |- mesh__dateCreated mesh__D003043 1976-05-19
% 209.18/209.35 |- skos__annotation mesh__D003043
% 209.18/209.35 do not confuse with NEOPLASMS, MULTIPLE PRIMARY; Manual 24.4.1.14%A%
% 209.18/209.35 |- mesh__recordOriginator mesh__D003043 VDK
% 209.18/209.35 |- skos__broader mesh__D003043smesh__D009385
% 209.18/209.35 |- skos__scopeNote mesh__D003043
% 209.18/209.35 The combination of two or more different factors in the production of cancer.%A%
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D003043 77
% 209.18/209.35 |- skos__hiddenLabel mesh__D003043 Cocarcinogeneses
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003043 2006A
% 209.18/209.35 |- skos__historyNote mesh__D003043 Neoplasms %28%1966-1976%29%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003043 2006
% 209.18/209.35 |- mesh__dateEstablished mesh__D003043 1977-01-01
% 209.18/209.35 |- skos__prefLabel mesh__D003043 Cocarcinogenesis
% 209.18/209.35 |- mesh__recordMaintainer mesh__D003043 ags
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D003043 ags
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D003043 2005
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D016769 2002
% 209.18/209.35 |- skos__annotation mesh__D016769
% 209.18/209.35 not used for indexing CATALOG: do not use
% 209.18/209.35 |- skos__prefLabel mesh__D016769 Embolism and Thrombosis
% 209.18/209.35 |- mesh__dateCreated mesh__D016769 1991-08-23
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D016769 2006
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D016769 2005
% 209.18/209.35 |- rdf__type mesh__D016769sskos__Concept
% 209.18/209.35 |- mesh__historyNote mesh__D016769 98; use explode 1992-97
% 209.18/209.35 |- mesh__dateEstablished mesh__D016769 1998-01-01
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D016769 2001
% 209.18/209.35 |- mesh__recordOriginator mesh__D016769 AGS
% 209.18/209.35 |- mesh__recordMaintainer mesh__D016769 MSR
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D016769 SJN
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D016769 1999
% 209.18/209.35 |- skos__scopeNote mesh__D016769
% 209.18/209.35 A collective term for diseases characterized by the formation, development, or presence of a thrombus %28%THROMBOSIS%29% and the blocking of a vessel by the thrombus brought to its site by the blood current %28%EMBOLISM%29%. %28%From Dorland, 28th ed%29%%A%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D016769 2000
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D016769 2004
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D016769 98
% 209.18/209.35 |- skos__hiddenLabel mesh__D016769 Thrombosis and Embolism
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D016769 2003
% 209.18/209.35 |- skos__broader mesh__D016769smesh__D014652
% 209.18/209.35 |- mesh__dateRevised mesh__D016769 1998-06-10
% 209.18/209.35 |- mesh__dateEstablished mesh__D041162 2003-01-01
% 209.18/209.35 |- rdf__type mesh__D041162sskos__Concept
% 209.18/209.35 |- skos__historyNote mesh__D041162 Staphylococcus %28%1981-2002%29%
% 209.18/209.35 |- mesh__historyNote mesh__D041162 2003
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D041162 2006
% 209.18/209.35 |- mesh__recordOriginator mesh__D041162 ags
% 209.18/209.35 |- mesh__dateCreated mesh__D041162 2002-07-03
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D041162 2003
% 209.18/209.35 |- mesh__recordMaintainer mesh__D041162 SYSTEM
% 209.18/209.35 |- mesh__dateRevised mesh__D041162 2005-06-30
% 209.18/209.35 |- skos__scopeNote mesh__D041162
% 209.18/209.35 A species of STAPHYLOCOCCUS found on the skin of humans %28%and non-human primates%29%, often causing hospital-acquired infections %28%CROSS INFECTION%29%.%A%
% 209.18/209.35 |- skos__broader mesh__D041162smesh__D013210
% 209.18/209.35 |- skos__annotation mesh__D041162
% 209.18/209.35 infection: coord IM with STAPHYLOCOCCAL INFECTIONS %28%IM%29%; DF: STAPH HAEMOLYTICUS%A%
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D041162 sjn
% 209.18/209.35 |- skos__prefLabel mesh__D041162 Staphylococcus haemolyticus
% 209.18/209.35 |- skos__altLabel mesh__D035923 Hepatitis D Antigen
% 209.18/209.35 |- skos__historyNote mesh__D035923 Antigens, Viral %28%1988-1995%29%
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D035923
% 209.18/209.35 2003; HEPATITIS D ANTIGENS %28%now HEPATITUS DELTA ANTIGENS%29% was indexed under HEPATITIS ANTIGENS 1996-2002, ANTIGENS, VIRAL 1988-1996 %26% HEPATITIS B ANTIGENS 1981-1987%A%
% 209.18/209.35 |- skos__altLabel mesh__D035923 delta Antigen
% 209.18/209.35 |- skos__broader mesh__D035923smesh__D018963
% 209.18/209.35 |- skos__hiddenLabel mesh__D035923 Antigen, Hepatitis D
% 209.18/209.35 |- skos__altLabel mesh__D035923 Hepatitis D Antigens
% 209.18/209.35 |- skos__altLabel mesh__D035923 HDAg
% 209.18/209.35 |- skos__scopeNote mesh__D035923
% 209.18/209.35 Antigens produced by various strains of HEPATITIS D VIRUS.%A%
% 209.18/209.35 |- mesh__dateCreated mesh__D035923 2002-07-02
% 209.18/209.35 |- mesh__historyNote mesh__D035923
% 209.18/209.35 2003; use HEPATITIS DELTA ANTIGENS %28%NM%29% 1981-2002
% 209.18/209.35 |- rdf__type mesh__D035923sskos__Concept
% 209.18/209.35 |- skos__historyNote mesh__D035923 Hepatitis Antigens %28%1996-2002%29%
% 209.18/209.35 |- skos__hiddenLabel mesh__D035923 Antigens, Hepatitis D
% 209.18/209.35 |- mesh__dateRevised mesh__D035923 2005-06-30
% 209.18/209.35 |- skos__hiddenLabel mesh__D035923 Antigens, Hepatitis delta
% 209.18/209.35 |- skos__hiddenLabel mesh__D035923 Antigen, delta
% 209.18/209.35 |- mesh__recordOriginator mesh__D035923 jmp
% 209.18/209.35 |- skos__prefLabel mesh__D035923 Hepatitis delta Antigens
% 209.18/209.35 |- skos__historyNote mesh__D035923 Hepatitis B Antigens %28%1981-1987%29%
% 209.18/209.35 |- mesh__dateEstablished mesh__D035923 2003-01-01
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D035923 sjn
% 209.18/209.35 |- mesh__recordMaintainer mesh__D035923 ssb
% 209.18/209.35 |- skos__hiddenLabel mesh__D035923 delta Antigens, Hepatitis
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D035923 2006
% 209.18/209.35 |- skos__prefLabel mesh__D002749 Chlorprothixene
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D002749 2001
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D002749 sjn
% 209.18/209.35 |- mesh__recordOriginator mesh__D002749 NLM
% 209.18/209.35 |- mesh__dateCreated mesh__D002749 1999-01-01
% 209.18/209.35 |- mesh__dateRevised mesh__D002749 2000-06-22
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D002749 2005
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D002749 2002
% 209.18/209.35 |- skos__altLabel mesh__D002749 Chlorprotixen
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D002749 2006
% 209.18/209.35 |- mesh__recordMaintainer mesh__D002749 TWD
% 209.18/209.35 |- skos__broader mesh__D002749smesh__D013892
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D002749 2003
% 209.18/209.35 |- skos__scopeNote mesh__D002749
% 209.18/209.35 A thioxanthine with effects similar to the phenothiazine antipsychotics.%A%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D002749 2004
% 209.18/209.35 |- rdf__type mesh__D002749sskos__Concept
% 209.18/209.35 |- rdf__type mesh__D013471sskos__Concept
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 2004
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 1994
% 209.18/209.35 |- skos__prefLabel mesh__D013471 Sunburn
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 2000
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 2006
% 209.18/209.35 |- skos__hiddenLabel mesh__D013471 Sunburns
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 2003
% 209.18/209.35 |- mesh__dateCreated mesh__D013471 1999-01-01
% 209.18/209.35 |- mesh__recordMaintainer mesh__D013471 PLS
% 209.18/209.35 |- skos__broader mesh__D013471smesh__D010787
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 2005
% 209.18/209.35 |- skos__annotation mesh__D013471
% 209.18/209.35 /prev: consider also SUNSCREENING AGENTS
% 209.18/209.35 |- mesh__dateRevised mesh__D013471 1992-05-22
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D013471 PLS
% 209.18/209.35 |- skos__broader mesh__D013471smesh__D002056
% 209.18/209.35 |- skos__scopeNote mesh__D013471
% 209.18/209.35 An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight.%A%
% 209.18/209.35 |- skos__related mesh__D013471smesh__D013473
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 1997
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 2002
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 1999
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 1993
% 209.18/209.35 |- mesh__recordOriginator mesh__D013471 NLM
% 209.18/209.35 |- skos__related mesh__D013471smesh__D013474
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 1996
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 2001
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 1995
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D013471 1998
% 209.18/209.35 |- skos__broader mesh__D021903smesh__D021901
% 209.18/209.35 |- skos__prefLabel mesh__D021903 DNA, Ribosomal Spacer
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D021903 2003
% 209.18/209.35 |- skos__scopeNote mesh__D021903
% 209.18/209.35 The intergenic DNA segments that are between the ribosomal RNA genes %28%internal transcribed spacers%29% and between the tandemly repeated units of rDNA %28%external transcribed spacers and nontranscribed spacers%29%.%A%
% 209.18/209.35 |- mesh__dateCreated mesh__D021903 2000-06-22
% 209.18/209.35 |- mesh__dateEstablished mesh__D021903 2001-01-01
% 209.18/209.35 |- mesh__historyNote mesh__D021903 2001
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D021903 2004
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D021903 2001
% 209.18/209.35 |- skos__historyNote mesh__D021903 RNA, Ribosomal %28%1984-2000%29%
% 209.18/209.35 |- skos__annotation mesh__D021903
% 209.18/209.35 DNA, RIBOSOMAL and DNA, SPACER see DNA, INTERGENIC are also available%A%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D021903 2005
% 209.18/209.35 |- skos__altLabel mesh__D021903 Ribosomal Spacer DNA
% 209.18/209.35 |- skos__broader mesh__D021903smesh__D004275
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D021903 2002
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D021903 2006
% 209.18/209.35 |- rdf__type mesh__D021903sskos__Concept
% 209.18/209.35 |- skos__historyNote mesh__D021903 DNA, Ribosomal %28%1984-2000%29%
% 209.18/209.35 |- skos__hiddenLabel mesh__D021903 Spacer DNA, Ribosomal
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D021903 2001
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Intrauterine Contraceptive Device
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007434 2001
% 209.18/209.35 |- mesh__dateRevised mesh__D007434 1999-11-08
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Migration, IUD
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Intrauterine Contraceptive Devices
% 209.18/209.35 |- rdf__type mesh__D007434sskos__Concept
% 209.18/209.35 |- mesh__dateEstablished mesh__D007434 1967-01-01
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Intrauterine Pessaries
% 209.18/209.35 |- skos__altLabel mesh__D007434 IUD Migration
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Intrauterine Device
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Migrations, Intrauterine Device
% 209.18/209.35 |- mesh__recordMaintainer mesh__D007434 adp
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 IUD Migrations
% 209.18/209.35 |- skos__altLabel mesh__D007434 IUDs
% 209.18/209.35 |- mesh__recordOriginator mesh__D007434 NLM
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007434 2003
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Pessary, Intrauterine
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Intracervical Pessary
% 209.18/209.35 |- mesh__dateCreated mesh__D007434 1999-01-01
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Device, Intrauterine
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007434 2002
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Intracervical Pessaries
% 209.18/209.35 |- skos__annotation mesh__D007434
% 209.18/209.35 coord IM with material of which device is made %28%NIM%29%; pregnancy despite use of IUD = IUD with no qualif, not IUD /adv eff; DF: IUD%A%
% 209.18/209.35 |- skos__broader mesh__D007434smesh__D003274
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Migrations, IUD
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007434 2004
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007434 2005
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Devices, Intrauterine Contraceptive
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Migration, Intrauterine Device
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Device Migrations, Intrauterine
% 209.18/209.35 |- skos__altLabel mesh__D007434 IUD, Unmedicated
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Contraceptive Device, Intrauterine
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Pessary, Intracervical
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007434 2006
% 209.18/209.35 |- mesh__historyNote mesh__D007434 67
% 209.18/209.35 |- skos__prefLabel mesh__D007434 Intrauterine Devices
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Devices, Intrauterine
% 209.18/209.35 |- skos__scopeNote mesh__D007434
% 209.18/209.35 Contraceptive devices placed high in the uterine fundus with a string extending from the device through the cervical as into the vagina. %28%UMDNS, 1999%29%%A%
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Intrauterine Pessary
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D007434 2000
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Device Migration, Intrauterine
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D007434 sjn
% 209.18/209.35 |- skos__altLabel mesh__D007434 Contraceptive Devices, Intrauterine
% 209.18/209.35 |- skos__historyNote mesh__D007434 Contraceptive Devices %28%1966%29%
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Unmedicated IUD
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Intrauterine Device Migrations
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D007434 67
% 209.18/209.35 |- skos__hiddenLabel mesh__D007434 Device, Intrauterine Contraceptive
% 209.18/209.35 |- skos__altLabel mesh__D007434 IUD
% 209.18/209.35 |- skos__broader mesh__D017862smesh__D004267
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D017862 94
% 209.18/209.35 |- mesh__historyNote mesh__D017862 94
% 209.18/209.35 |- skos__altLabel mesh__D017862 Algal Viruses
% 209.18/209.35 |- skos__hiddenLabel mesh__D017862 Algal Virus
% 209.18/209.35 |- skos__annotation mesh__D017862
% 209.18/209.35 a family of plant viruses infecting algae; from PHYCOs %28%Greek for alga%29% DNA viruses%A%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 1997
% 209.18/209.35 |- skos__broader mesh__D017862smesh__D010942
% 209.18/209.35 |- skos__hiddenLabel mesh__D017862 Virus, Algal
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 1999
% 209.18/209.35 |- mesh__recordOriginator mesh__D017862 AGS
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 2002
% 209.18/209.35 |- skos__hiddenLabel mesh__D017862 Viruses, Algal
% 209.18/209.35 |- mesh__dateCreated mesh__D017862 1993-06-04
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 1998
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 2004
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 2001
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D017862 PLS
% 209.18/209.35 |- mesh__dateRevised mesh__D017862 1996-06-10
% 209.18/209.35 |- skos__prefLabel mesh__D017862 Phycodnaviridae
% 209.18/209.35 |- rdf__type mesh__D017862sskos__Concept
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 2006
% 209.18/209.35 |- mesh__dateEstablished mesh__D017862 1994-01-01
% 209.18/209.35 |- skos__scopeNote mesh__D017862
% 209.18/209.35 A family of DNA plant viruses that infect eukaryotic algae.%A%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 2003
% 209.18/209.35 |- mesh__recordMaintainer mesh__D017862 AGS
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 2005
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017862 2000
% 209.18/209.35 |- mesh__historyNote mesh__D017064
% 209.18/209.35 92; was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A%
% 209.18/209.35 |- mesh__onlineNote mesh__D017064
% 209.18/209.35 use OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% to search PROCESS ASSESSMENT 1979-91%A%
% 209.18/209.35 |- mesh__dateRevised mesh__D017064 2004-07-13
% 209.18/209.35 |- skos__prefLabel mesh__D017064 Process Assessment %28%Health Care%29%
% 209.18/209.35 |- mesh__activeMeSHYear mesh__D017064 2005
% 209.18/209.35 |- skos__hiddenLabel mesh__D017064 Assessments, Process
% 209.18/209.35 |- rdf__type mesh__D017064sskos__Concept
% 209.18/209.35 |- skos__broader mesh__D017064smesh__D010043
% 209.18/209.35 |- mesh__dateEstablished mesh__D017064 1992-01-01
% 209.18/209.35 |- skos__hiddenLabel mesh__D017064 Process Measure
% 209.18/209.35 |- skos__hiddenLabel mesh__D017064 Assessment, Process %28%Health Care%29%
% 209.18/209.35 |- skos__hiddenLabel mesh__D017064 Measure, Process
% 209.18/209.35 |- mesh__recordOriginator mesh__D017064 PLS
% 209.18/209.35 |- skos__hiddenLabel mesh__D017064 Assessments, Process %28%Health Care%29%
% 209.18/209.35 |- skos__hiddenLabel mesh__D017064 Process Assessments
% 209.18/209.35 |- skos__hiddenLabel mesh__D017064 Measures, Process
% 209.18/209.35 |- skos__annotation mesh__D017064
% 209.18/209.35 note category; process only: for outcome assessment with process assessment, OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% is available; DF: PROCESS ASSESS%A%
% 209.18/209.35 |- mesh__publicMeSHNote mesh__D017064
% 209.18/209.35 92; was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A%
% 209.18/209.35 |- skos__hiddenLabel mesh__D017064 Process Assessments %28%Health Care%29%
% 209.18/209.35 |- mesh__recordMaintainer mesh__D017064 sjn
% 209.18/209.35 |- mesh__recordAuthorizer mesh__D017064 sjn
% 209.18/209.35 |- skos__scopeNote mesh__D017064
% 209.18/209.35 An evaluation procedure that focuses on how care is delivered, based on the premise that there are standards of performance for activities undertaken in delivering patient care, in which the specific actions taken, events occurring, and human interactions are compared with accepted standards.%A%
% 209.18/209.36 |- skos__altLabel mesh__D017064 Assessment, Process
% 209.18/209.36 |- mesh__dateCreated mesh__D017064 1991-06-20
% 209.18/209.36 |- skos__hiddenLabel mesh__D017064 Process Assessment
% 209.18/209.36 |- skos__historyNote mesh__D017064
% 209.18/209.36 Outcome and Process Assessment %28%Health Care%29% %28%1979-1991%29%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017064 2006
% 209.18/209.36 |- skos__broader mesh__D003842smesh__D017853
% 209.18/209.36 |- mesh__dateRevised mesh__D003842 2003-07-09
% 209.18/209.36 |- skos__hiddenLabel mesh__D003842 Kinase, Deoxycytidine
% 209.18/209.36 |- skos__prefLabel mesh__D003842 Deoxycytidine Kinase
% 209.18/209.36 |- skos__historyNote mesh__D003842 Deoxycytidine %28%1973-1978%29%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003842 2006
% 209.18/209.36 |- mesh__recordOriginator mesh__D003842 RLS
% 209.18/209.36 |- mesh__historyNote mesh__D003842
% 209.18/209.36 91%28%79%29%; was see under PHOSPHOTRANSFERASES, ATP 1979-90
% 209.18/209.36 |- mesh__dateEstablished mesh__D003842 1991-01-01
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003842 2005
% 209.18/209.36 |- mesh__dateCreated mesh__D003842 1977-12-09
% 209.18/209.36 |- skos__scopeNote mesh__D003842
% 209.18/209.36 An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus %28%HERPESVIRUS HOMINIS%29%. EC 2.7.1.74.%A%
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D003842
% 209.18/209.36 91; was see under PHOSPHOTRANSFERASES, ATP 1979-90
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003842 2004
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D003842 sjn
% 209.18/209.36 |- rdf__type mesh__D003842sskos__Concept
% 209.18/209.36 |- skos__historyNote mesh__D003842 Phosphotransferases %28%1966-1978%29%
% 209.18/209.36 |- mesh__recordMaintainer mesh__D003842 ssb
% 209.18/209.36 |- skos__hiddenLabel mesh__D050498 Live Births
% 209.18/209.36 |- rdf__type mesh__D050498sskos__Concept
% 209.18/209.36 |- mesh__dateEstablished mesh__D050498 2006-01-01
% 209.18/209.36 |- mesh__recordOriginator mesh__D050498 lkt
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D050498
% 209.18/209.36 2006; see PREGNANCY OUTCOME 2004-2005
% 209.18/209.36 |- skos__broader mesh__D050498smesh__D011256
% 209.18/209.36 |- mesh__dateCreated mesh__D050498 2005-06-30
% 209.18/209.36 |- skos__scopeNote mesh__D050498
% 209.18/209.36 The event that a FETUS is born alive with heartbeats or RESPIRATION regardless of GESTATIONAL AGE. Such a newborn is called a liveborn INFANT.%A%
% 209.18/209.36 |- skos__historyNote mesh__D050498 Pregnancy Outcome %28%2004-2005%29%
% 209.18/209.36 |- mesh__historyNote mesh__D050498 2006; use PREGNANCY OUTCOME 2004-2005
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D050498 sjn
% 209.18/209.36 |- mesh__recordMaintainer mesh__D050498 lkt
% 209.18/209.36 |- skos__prefLabel mesh__D050498 Live Birth
% 209.18/209.36 |- skos__historyNote mesh__D050498 Pregnancy %28%1967-2003%29%
% 209.18/209.36 |- skos__annotation mesh__D050498
% 209.18/209.36 use only in relation to the outcome of the pregnancy; use BIRTH for the physiologic process of giving birth%A%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D050498 2006
% 209.18/209.36 |- skos__historyNote mesh__D050498 Infant, Newborn %28%1967-2003%29%
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D003044 79; was see under SPOROZOA 1963-78
% 209.18/209.36 |- mesh__recordOriginator mesh__D003044 NLM
% 209.18/209.36 |- skos__annotation mesh__D003044
% 209.18/209.36 infection = COCCIDIOSIS; /drug eff: consider also COCCIDIOSTATS; %22%coccidial%22% refers to COCCIDIA: do not confuse with %22%coccidioidal%22% %28%refers to COCCIDIOIDES, a fungus%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.18/209.36 |- skos__broader mesh__D003044smesh__D016782
% 209.18/209.36 |- mesh__dateEstablished mesh__D003044 1979-01-01
% 209.18/209.36 |- mesh__dateRevised mesh__D003044 2003-07-09
% 209.18/209.36 |- mesh__historyNote mesh__D003044
% 209.18/209.36 79%28%75%29%; was see under SPOROZOA 1963-78
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D003044 sjn
% 209.18/209.36 |- skos__prefLabel mesh__D003044 Coccidia
% 209.18/209.36 |- mesh__onlineNote mesh__D003044 search SPOROZOA 1966-74
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003044 2006
% 209.18/209.36 |- skos__related mesh__D003044smesh__D003049
% 209.18/209.36 |- skos__scopeNote mesh__D003044
% 209.18/209.36 A subclass of protozoans commonly parasitic in the epithelial cells of the intestinal tract but also found in the liver and other organs. Its organisms are found in both vertebrates and higher invertebrates and comprise two orders: EIMERIIDA and EUCOCCIDIIDA.%A%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003044 2005
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003044 2004
% 209.18/209.36 |- mesh__dateCreated mesh__D003044 1999-01-01
% 209.18/209.36 |- rdf__type mesh__D003044sskos__Concept
% 209.18/209.36 |- mesh__recordMaintainer mesh__D003044 ags
% 209.18/209.36 |- skos__historyNote mesh__D003044 Sporozoa %28%1966-1974%29%
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961 Hydrogen Deuterium Exchange Measurement
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961 Deuterium Exchange Measurements
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961 Exchange Measurement, Hydrogen-Deuterium
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961 Exchange Measurements, Deuterium
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961
% 209.18/209.36 Measurements, Hydrogen-Deuterium Exchange
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961 Hydrogen-Deuterium Exchange Measurements
% 209.18/209.36 |- rdf__type mesh__D041961sskos__Concept
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D041961 2004
% 209.18/209.36 |- skos__altLabel mesh__D041961 Hydrogen-Deuterium Exchange Measurement
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961 Measurements, Deuterium Exchange
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D041961 2006
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961 Measurement, Hydrogen-Deuterium Exchange
% 209.18/209.36 |- mesh__dateEstablished mesh__D041961 2004-01-01
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961 Measurement, Deuterium Exchange
% 209.18/209.36 |- mesh__historyNote mesh__D041961 2004
% 209.18/209.36 |- skos__historyNote mesh__D041961 Spectrophotometry %28%1966-2003%29%
% 209.18/209.36 |- skos__scopeNote mesh__D041961
% 209.18/209.36 A research technique to measure solvent exposed regions of molecules that is used to provide insight about PROTEIN CONFORMATION.%A%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D041961 2005
% 209.18/209.36 |- skos__historyNote mesh__D041961 Deuterium %28%1965-2003%29%
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961 Exchange Measurement, Deuterium
% 209.18/209.36 |- skos__historyNote mesh__D041961 Hydrogen %28%1965-2003%29%
% 209.18/209.36 |- skos__hiddenLabel mesh__D041961
% 209.18/209.36 Exchange Measurements, Hydrogen-Deuterium
% 209.18/209.36 |- mesh__dateCreated mesh__D041961 2003-07-09
% 209.18/209.36 |- skos__prefLabel mesh__D041961 Deuterium Exchange Measurement
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D041961 2004
% 209.18/209.36 |- skos__broader mesh__D041961smesh__D002623
% 209.18/209.36 |- skos__historyNote mesh__D035924 Oxepins %28%1980-2002%29%
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D035924
% 209.18/209.36 2003; ZOAPATLE was indexed under OXEPINS 1980-2002
% 209.18/209.36 |- skos__annotation mesh__D035924
% 209.18/209.36 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.18/209.36 |- mesh__dateCreated mesh__D035924 2002-07-03
% 209.18/209.36 |- skos__broader mesh__D035924smesh__D019659
% 209.18/209.36 |- skos__scopeNote mesh__D035924
% 209.18/209.36 A plant genus of the family ASTERACEAE. Steroidal activity has been observed in animals. Members of this genus contain sesquiterpene lactones such as tomentosin, OXEPINS such as zoapatanol, and kaurene type DITERPENES.%A%
% 209.18/209.36 |- rdf__type mesh__D035924sskos__Concept
% 209.18/209.36 |- mesh__historyNote mesh__D035924
% 209.18/209.36 2003; for ZOAPATLE use MONTANOA %28%NM%29% 1980-2002
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D035924 2005
% 209.18/209.36 |- skos__prefLabel mesh__D035924 Montanoa
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D035924 2003
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D035924 2006
% 209.18/209.36 |- skos__altLabel mesh__D035924 Zoapatle
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D035924 2004
% 209.18/209.36 |- mesh__dateEstablished mesh__D035924 2003-01-01
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 2006
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 2003
% 209.18/209.36 |- mesh__dateCreated mesh__D013472 1999-01-01
% 209.18/209.36 |- mesh__recordOriginator mesh__D013472 NLM
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 2001
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 2005
% 209.18/209.36 |- skos__related mesh__D013472smesh__D006370
% 209.18/209.36 |- skos__prefLabel mesh__D013472 Sunlight
% 209.18/209.36 |- skos__annotation mesh__D013472
% 209.18/209.36 /adv eff permitted but consider also SUNBURN %26% SUNSTROKE; using sunlight therapeutically = HELIOTHERAPY%A%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 2000
% 209.18/209.36 |- mesh__recordMaintainer mesh__D013472 TGC
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 1997
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D013472 PLS
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 1999
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 1996
% 209.18/209.36 |- skos__broader mesh__D013472smesh__D014887
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 1998
% 209.18/209.36 |- mesh__dateRevised mesh__D013472 1995-02-23
% 209.18/209.36 |- rdf__type mesh__D013472sskos__Concept
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 2004
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013472 2002
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D007435 78
% 209.18/209.36 |- rdf__type mesh__D007435sskos__Concept
% 209.18/209.36 |- skos__prefLabel mesh__D007435 Intrauterine Devices, Copper
% 209.18/209.36 |- mesh__recordOriginator mesh__D007435 SMH
% 209.18/209.36 |- skos__hiddenLabel mesh__D007435 Copper-Releasing IUD
% 209.18/209.36 |- mesh__historyNote mesh__D007435 78
% 209.18/209.36 |- skos__broader mesh__D007435smesh__D007436
% 209.18/209.36 |- skos__historyNote mesh__D007435
% 209.18/209.36 Intrauterine Devices, Medicated %28%1975-1977%29%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007435 2000
% 209.18/209.36 |- skos__hiddenLabel mesh__D007435 IUDs, Copper-Releasing
% 209.18/209.36 |- skos__hiddenLabel mesh__D007435 Copper Releasing IUD
% 209.18/209.36 |- skos__hiddenLabel mesh__D007435 Copper Intrauterine Device
% 209.18/209.36 |- skos__hiddenLabel mesh__D007435 Device, Copper Intrauterine
% 209.18/209.36 |- skos__hiddenLabel mesh__D007435 Devices, Copper Intrauterine
% 209.18/209.36 |- skos__altLabel mesh__D007435 Copper Intrauterine Devices
% 209.18/209.36 |- mesh__dateEstablished mesh__D007435 1978-01-01
% 209.18/209.36 |- mesh__dateCreated mesh__D007435 1977-04-22
% 209.18/209.36 |- skos__hiddenLabel mesh__D007435 Intrauterine Device, Copper
% 209.18/209.36 |- mesh__dateRevised mesh__D007435 1997-06-20
% 209.18/209.36 |- skos__hiddenLabel mesh__D007435 IUD, Copper-Releasing
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007435 2006
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007435 2002
% 209.18/209.36 |- skos__historyNote mesh__D007435 Intrauterine Devices %28%1967-1977%29%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007435 2005
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007435 2004
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007435 1999
% 209.18/209.36 |- mesh__recordMaintainer mesh__D007435 PXP
% 209.18/209.36 |- skos__altLabel mesh__D007435 Copper-Releasing IUDs
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D007435 SJN
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007435 2003
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007435 1998
% 209.18/209.36 |- skos__altLabel mesh__D007435 IUD, Copper Releasing
% 209.18/209.36 |- skos__scopeNote mesh__D007435
% 209.18/209.36 Intrauterine contraceptive devices that depend on the release of metallic copper.%A%
% 209.18/209.36 |- skos__annotation mesh__D007435
% 209.18/209.36 pregn despite use: see note under INTRAUTERINE DEVICES; DF: IUD COPPER%A%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007435 2001
% 209.18/209.36 |- mesh__dateEstablished mesh__D017863 1994-01-01
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 2001
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 1999
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D017863 PLS
% 209.18/209.36 |- mesh__dateRevised mesh__D017863 1996-06-10
% 209.18/209.36 |- skos__annotation mesh__D017863
% 209.18/209.36 a genus of plant viruses; from POTato X virus; coord IM with specific plant /virol %28%IM or NIM%29%%A%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 1998
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 2004
% 209.18/209.36 |- rdf__type mesh__D017863sskos__Concept
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 2000
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 2006
% 209.18/209.36 |- skos__historyNote mesh__D017863 Plant Viruses %28%1988-1993%29%
% 209.18/209.36 |- skos__hiddenLabel mesh__D017863 Potexviruses
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 2003
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 2005
% 209.18/209.36 |- skos__hiddenLabel mesh__D017863 Virus X, Potato
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D017863 94
% 209.18/209.36 |- skos__scopeNote mesh__D017863
% 209.18/209.36 A genus of plant viruses that cause mosaic and ringspot symptoms. Transmission occurs mechanically.%A%
% 209.18/209.36 |- mesh__recordMaintainer mesh__D017863 AGS
% 209.18/209.36 |- skos__prefLabel mesh__D017863 Potexvirus
% 209.18/209.36 |- mesh__dateCreated mesh__D017863 1993-06-15
% 209.18/209.36 |- skos__broader mesh__D017863smesh__D012328
% 209.18/209.36 |- skos__broader mesh__D017863smesh__D010942
% 209.18/209.36 |- mesh__historyNote mesh__D017863 94
% 209.18/209.36 |- mesh__recordOriginator mesh__D017863 AGS
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 2002
% 209.18/209.36 |- skos__historyNote mesh__D017863 Mosaic Viruses %28%1983-1993%29%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017863 1997
% 209.18/209.36 |- mesh__historyNote mesh__D017065 1992
% 209.18/209.36 |- skos__prefLabel mesh__D017065
% 209.18/209.36 Practice Guideline %5B%Publication Type%5D%
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D017065 sjn
% 209.18/209.36 |- rdf__type mesh__D017065sskos__Concept
% 209.18/209.36 |- skos__altLabel mesh__D017065 Practice Guideline %28%PT%29%
% 209.18/209.36 |- skos__annotation mesh__D017065
% 209.18/209.36 publication type only; restrict to health care; for guidelines in other fields consider publication type GUIDELINE; practice guidelines as a subject are indexed with the main heading PRACTICE GUIDELINES%A%
% 209.18/209.36 |- skos__scopeNote mesh__D017065
% 209.18/209.36 Work consisting of a set of directions or principles to assist the health care practitioner with patient care decisions about appropriate diagnostic, therapeutic, or other clinical procedures for specific clinical circumstances. Practice guidelines may be developed by government agencies at any level, institutions, organizations such as professional societies or governing boards, or by the convening of expert panels. They can provide a foundation for assessing and evaluating the quality and effectiveness of health care in terms of measuring improved health, reduction of variation in services or procedures performed, and reduction of variation in outcomes of health care delivered.%A%
% 209.18/209.36 |- skos__altLabel mesh__D017065 Practice Guideline
% 209.18/209.36 |- mesh__recordOriginator mesh__D017065 PLS
% 209.18/209.36 |- mesh__dateRevised mesh__D017065 2005-06-30
% 209.18/209.36 |- mesh__dateCreated mesh__D017065 1995-06-23
% 209.18/209.36 |- mesh__recordMaintainer mesh__D017065 jls
% 209.18/209.36 |- skos__altLabel mesh__D017065 Clinical Practice Guideline %28%PT%29%
% 209.18/209.36 |- mesh__dateEstablished mesh__D017065 1996-01-01
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017065 2006
% 209.18/209.36 |- skos__broader mesh__D017065smesh__D016431
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 1999
% 209.18/209.36 |- mesh__dateCreated mesh__D003843 1999-01-01
% 209.18/209.36 |- mesh__onlineNote mesh__D003843
% 209.18/209.36 to search DEOXYCYTIDYLIC ACIDS use DEOXYCYTIDINE MONOPHOSPHATE 1975-77 %26% CYTOSINE NUCLEOTIDES 1966-74%A%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 2002
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 1998
% 209.18/209.36 |- skos__historyNote mesh__D003843 Cytosine Nucleotides %28%1966-1974%29%
% 209.18/209.36 |- skos__prefLabel mesh__D003843 Deoxycytidine Monophosphate
% 209.18/209.36 |- mesh__dateEstablished mesh__D003843 1991-01-01
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 2001
% 209.18/209.36 |- skos__annotation mesh__D003843 /biosyn /physiol permitted
% 209.18/209.36 |- mesh__recordMaintainer mesh__D003843 TAP
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 1997
% 209.18/209.36 |- skos__scopeNote mesh__D003843
% 209.18/209.36 Deoxycytidine %28%dihydrogen phosphate%29%. A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2%27%-,3%27%- or 5- positions.%A%
% 209.18/209.36 |- skos__hiddenLabel mesh__D003843 Acids, Deoxycytidylic
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 2006
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 2000
% 209.18/209.36 |- mesh__historyNote mesh__D003843
% 209.18/209.36 91%28%78%29%; was see under DEOXYCYTOSINE NUCLEOTIDES 1978-90; was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A%
% 209.18/209.36 |- skos__hiddenLabel mesh__D003843 Acid, Deoxycytidylic
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 1996
% 209.18/209.36 |- mesh__recordOriginator mesh__D003843 NLM
% 209.18/209.36 |- skos__altLabel mesh__D003843 Deoxycytidylic Acid
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 2005
% 209.18/209.36 |- mesh__dateRevised mesh__D003843 1995-05-18
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D003843 PLS
% 209.18/209.36 |- rdf__type mesh__D003843sskos__Concept
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 2004
% 209.18/209.36 |- skos__broader mesh__D003843smesh__D003845
% 209.18/209.36 |- skos__altLabel mesh__D003843 DCMP
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003843 2003
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D003843
% 209.18/209.36 91; was see under DEOXYCYTOSINE NUCLEOTIDES 1978-90; was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A%
% 209.18/209.36 |- skos__hiddenLabel mesh__D003843 Monophosphate, Deoxycytidine
% 209.18/209.36 |- skos__scopeNote mesh__D050499
% 209.18/209.36 A stage of development at which the ADRENAL GLANDS undergo maturation leading to the capability of producing increasing amounts of adrenal androgens, DEHYDROEPIANDROSTERONE and ANDROSTENEDIONE. Adrenarche usually begins at about 7 or 8 years of age before the signs of PUBERTY and continues throughout puberty.%A%
% 209.18/209.36 |- mesh__recordOriginator mesh__D050499 lkt
% 209.18/209.36 |- skos__historyNote mesh__D050499 Adrenal Glands %28%1973-2005%29%
% 209.18/209.36 |- mesh__dateEstablished mesh__D050499 2006-01-01
% 209.18/209.36 |- skos__prefLabel mesh__D050499 Adrenarche
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D050499 2006
% 209.18/209.36 |- skos__broader mesh__D050499smesh__D011627
% 209.18/209.36 |- mesh__historyNote mesh__D050499 2006
% 209.18/209.36 |- skos__historyNote mesh__D050499 Puberty, Precocious %28%1966-2005%29%
% 209.18/209.36 |- mesh__dateCreated mesh__D050499 2005-06-30
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D050499 2006
% 209.18/209.36 |- rdf__type mesh__D050499sskos__Concept
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D050499 sjn
% 209.18/209.36 |- mesh__recordMaintainer mesh__D050499 lkt
% 209.18/209.36 |- mesh__recordOriginator mesh__D003045 NLM
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D003045 2006
% 209.18/209.36 |- skos__scopeNote mesh__D003045
% 209.18/209.36 A mitosporic fungal genus which causes COCCIDIOIDOMYCOSIS.%A%
% 209.18/209.36 |- mesh__recordMaintainer mesh__D003045 SYSTEM
% 209.18/209.36 |- skos__prefLabel mesh__D003045 Coccidioides
% 209.18/209.36 |- skos__annotation mesh__D003045
% 209.18/209.36 do not confuse with the sporozoon COCCIDIA; %22%coccidioidal%22% refers to COCCIDIOIDES: do not confuse with %22%coccidial%22% %28%refers to COCCIDIA%29%; infection = COCCIDIOIDOMYCOSIS%A%
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D003045 sjn
% 209.18/209.36 |- mesh__dateCreated mesh__D003045 1999-01-01
% 209.18/209.36 |- rdf__type mesh__D003045sskos__Concept
% 209.18/209.36 |- skos__broader mesh__D003045smesh__D003904
% 209.18/209.36 |- mesh__dateRevised mesh__D003045 2005-06-30
% 209.18/209.36 |- mesh__recordOriginator mesh__D041962 ags
% 209.18/209.36 |- skos__broader mesh__D041962smesh__D006088
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D041962
% 209.18/209.36 2004; for BEGGIATOACEAE see BEGGIATOACEAE 1976-2003
% 209.18/209.36 |- mesh__dateCreated mesh__D041962 2003-07-09
% 209.18/209.36 |- mesh__dateEstablished mesh__D041962 2004-01-01
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D041962 sjn
% 209.18/209.36 |- skos__broader mesh__D041962smesh__D020563
% 209.18/209.36 |- mesh__dateRevised mesh__D041962 2005-06-30
% 209.18/209.36 |- mesh__recordMaintainer mesh__D041962 SYSTEM
% 209.18/209.36 |- skos__prefLabel mesh__D041962 Thiotrichaceae
% 209.18/209.36 |- mesh__historyNote mesh__D041962 2004
% 209.18/209.36 |- rdf__type mesh__D041962sskos__Concept
% 209.18/209.36 |- skos__scopeNote mesh__D041962
% 209.18/209.36 A family of colorless sulfur bacteria in the order Thiotrichales, class GAMMAPROTEOBACTERIA.%A%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D041962 2006
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D035925 2006
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D035925 jls
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D035925 2003
% 209.18/209.36 |- skos__hiddenLabel mesh__D035925 Iron Regulatory Proteins
% 209.18/209.36 |- skos__altLabel mesh__D035925 Iron-Responsive Elements-Binding Protein
% 209.18/209.36 |- mesh__dateCreated mesh__D035925 2002-07-03
% 209.18/209.36 |- skos__altLabel mesh__D035925 IRE-BP
% 209.18/209.36 |- skos__hiddenLabel mesh__D035925 Iron Responsive Elements Binding Protein
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D035925 2005
% 209.18/209.36 |- skos__historyNote mesh__D035925 Iron-Sulfur Proteins %28%1991-2002%29%
% 209.18/209.36 |- skos__scopeNote mesh__D035925
% 209.18/209.36 Proteins that regulate cellular and organismal iron homeostasis. They play an important biological role by maintaining iron levels that are adequate for metabolic need, but below the toxicity threshold.%A%
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D035925
% 209.18/209.36 2003; IRON REGULATORY FACTOR now IRON-REGULATORY PROTEINS was indexed under RNA-BINDING PROTEINS %26% IRON-SULFUR PROTEINS 1991-2002, CARRIER PROTEINS 1990%A%
% 209.18/209.36 |- skos__hiddenLabel mesh__D035925 Regulatory Factor, Iron
% 209.18/209.36 |- skos__hiddenLabel mesh__D035925 Iron Regulatory Protein
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D035925 2005A
% 209.18/209.36 |- skos__prefLabel mesh__D035925 Iron-Regulatory Proteins
% 209.18/209.36 |- skos__historyNote mesh__D035925 Carrier Proteins %28%1990%29%
% 209.18/209.36 |- mesh__dateRevised mesh__D035925 2004-07-28
% 209.18/209.36 |- mesh__dateEstablished mesh__D035925 2003-01-01
% 209.18/209.36 |- skos__altLabel mesh__D035925 Iron Regulatory Factor
% 209.18/209.36 |- skos__altLabel mesh__D035925 Iron-Regulatory Protein
% 209.18/209.36 |- skos__altLabel mesh__D035925 IRE-Binding Protein
% 209.18/209.36 |- rdf__type mesh__D035925sskos__Concept
% 209.18/209.36 |- skos__historyNote mesh__D035925 Ribonucleoproteins %28%1992-2002%29%
% 209.18/209.36 |- skos__hiddenLabel mesh__D035925 Iron Response Proteins
% 209.18/209.36 |- skos__altLabel mesh__D035925 Iron-Response Proteins
% 209.18/209.36 |- mesh__recordOriginator mesh__D035925 jmp
% 209.18/209.36 |- mesh__historyNote mesh__D035925
% 209.18/209.36 2003; use IRON-REGULATORY PROTEINS %28%NM%29% 1990-2002
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D035925 2004
% 209.18/209.36 |- skos__broader mesh__D035925smesh__D011506
% 209.18/209.36 |- skos__hiddenLabel mesh__D035925 Iron Responsive Element Binding Proteins
% 209.18/209.36 |- skos__hiddenLabel mesh__D035925 IRE Binding Protein
% 209.18/209.36 |- mesh__recordMaintainer mesh__D035925 jls
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D013473 2006
% 209.18/209.36 |- skos__prefLabel mesh__D013473 Sunscreening Agents
% 209.18/209.36 |- skos__hiddenLabel mesh__D013473 Agents, Sunscreening
% 209.18/209.36 |- mesh__dateRevised mesh__D013473 2005-06-30
% 209.18/209.36 |- skos__broader mesh__D013473smesh__D011837
% 209.18/209.36 |- skos__broader mesh__D013473smesh__D003358
% 209.18/209.36 |- skos__annotation mesh__D013473 D25-26 qualif
% 209.18/209.36 |- mesh__recordOriginator mesh__D013473 NLM
% 209.18/209.36 |- mesh__dateEstablished mesh__D013473 1972-01-01
% 209.18/209.36 |- skos__scopeNote mesh__D013473
% 209.18/209.36 Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation.%A%
% 209.18/209.36 |- skos__broader mesh__D013473smesh__D003879
% 209.18/209.36 |- mesh__dateCreated mesh__D013473 1999-01-01
% 209.18/209.36 |- mesh__recordMaintainer mesh__D013473 ssb
% 209.18/209.36 |- rdf__type mesh__D013473sskos__Concept
% 209.18/209.36 |- mesh__historyNote mesh__D013473 72%28%66%29%
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D013473 72
% 209.18/209.36 |- skos__altLabel mesh__D013473 Sunscreens
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D013473 sjn
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Devices, Hormone-Releasing Intrauterine
% 209.18/209.36 |- skos__historyNote mesh__D007436 Intrauterine Devices %28%1967-1974%29%
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Hormone-Releasing Intrauterine Device
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Hormone Releasing IUD
% 209.18/209.36 |- skos__scopeNote mesh__D007436
% 209.18/209.36 Intrauterine devices that release contraceptive agents.%A%
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Hormone-Releasing Intrauterine Devices
% 209.18/209.36 |- rdf__type mesh__D007436sskos__Concept
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Device, Hormone-Releasing Intrauterine
% 209.18/209.36 |- mesh__recordOriginator mesh__D007436 NLM
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 IUDs, Hormone-Releasing
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 2002
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D007436 PLS
% 209.18/209.36 |- skos__altLabel mesh__D007436 IUD, Hormone Releasing
% 209.18/209.36 |- skos__broader mesh__D007436smesh__D007434
% 209.18/209.36 |- skos__annotation mesh__D007436
% 209.18/209.36 %22%IUDs that release contraceptive agents%22%; coord IM with specific contraceptive agent %28%IM%29%; pregn despite use: see note on INTRAUTERINE DEVICES; DF: IUD MEDICATED%A%
% 209.18/209.36 |- mesh__recordMaintainer mesh__D007436 TGC
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 IUD, Hormone-Releasing
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 2003
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Intrauterine Device, Hormone-Releasing
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Intrauterine Devices, Hormone Releasing
% 209.18/209.36 |- skos__altLabel mesh__D007436 Hormone-Releasing IUDs
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436
% 209.18/209.36 Device, Progesterone-Releasing Intrauterine
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Device, Medicated Intrauterine
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Hormone-Releasing IUD
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D007436
% 209.18/209.36 79; was see under INTRAUTERINE DEVICES 1975-78
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436
% 209.18/209.36 Intrauterine Devices, Progesterone Releasing
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436
% 209.18/209.36 Progesterone-Releasing Intrauterine Device
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Medicated Intrauterine Device
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 2004
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436
% 209.18/209.36 Devices, Progesterone-Releasing Intrauterine
% 209.18/209.36 |- mesh__dateCreated mesh__D007436 1974-11-19
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436
% 209.18/209.36 Progesterone-Releasing Intrauterine Devices
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 2005
% 209.18/209.36 |- mesh__dateEstablished mesh__D007436 1979-01-01
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 2000
% 209.18/209.36 |- skos__altLabel mesh__D007436 Medicated Intrauterine Devices
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Intrauterine Device, Medicated
% 209.18/209.36 |- mesh__dateRevised mesh__D007436 1996-06-10
% 209.18/209.36 |- skos__prefLabel mesh__D007436 Intrauterine Devices, Medicated
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 1997
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 1998
% 209.18/209.36 |- mesh__historyNote mesh__D007436
% 209.18/209.36 79%28%75%29%; was see under INTRAUTERINE DEVICES 1975-78
% 209.18/209.36 |- skos__altLabel mesh__D007436 Intrauterine Devices, Hormone-Releasing
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436
% 209.18/209.36 Intrauterine Device, Progesterone-Releasing
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 2006
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 2001
% 209.18/209.36 |- skos__hiddenLabel mesh__D007436 Devices, Medicated Intrauterine
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D007436 1999
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017864 2004
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017864 2002
% 209.18/209.36 |- rdf__type mesh__D017864sskos__Concept
% 209.18/209.36 |- mesh__recordMaintainer mesh__D017864 ags
% 209.18/209.36 |- skos__annotation mesh__D017864 coord IM with specific plant /virol
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017864 2006
% 209.18/209.36 |- mesh__recordOriginator mesh__D017864 AGS
% 209.18/209.36 |- mesh__dateEstablished mesh__D017864 1994-01-01
% 209.18/209.36 |- skos__scopeNote mesh__D017864
% 209.18/209.36 A genus of plant viruses that infects ANGIOSPERMS. Transmission occurs mechanically and through soil, with one species transmitted via a fungal vector. The type species is Tomato bushy stunt virus.%A%
% 209.18/209.36 |- mesh__historyNote mesh__D017864
% 209.18/209.36 94; TOMATO BUSHY STUNT VIRUSES was see TOMBUSVIRUS 1994-96%A%
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017864 2003
% 209.18/209.36 |- skos__broader mesh__D017864smesh__D019183
% 209.18/209.36 |- mesh__activeMeSHYear mesh__D017864 2005
% 209.18/209.36 |- skos__historyNote mesh__D017864 Plant Viruses %28%1975-1993%29%
% 209.18/209.36 |- skos__prefLabel mesh__D017864 Tombusvirus
% 209.18/209.36 |- mesh__recordAuthorizer mesh__D017864 sjn
% 209.18/209.36 |- mesh__dateRevised mesh__D017864 2001-07-25
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D017864
% 209.18/209.36 94; TOMATO BUSHY STUNT VIRUSES was see TOMBUSVIRUS 1994-96%A%
% 209.18/209.36 |- mesh__onlineNote mesh__D017864
% 209.18/209.36 use TOMBUSVIRUS to search TOMATO BUSHY STUNT VIRUSES 1994-96%A%
% 209.18/209.36 |- mesh__dateCreated mesh__D017864 1993-06-03
% 209.18/209.36 |- skos__prefLabel mesh__D003844 DCMP Deaminase
% 209.18/209.36 |- mesh__recordMaintainer mesh__D003844 ssb
% 209.18/209.36 |- skos__altLabel mesh__D003844 Deoxycytidylate Deaminase
% 209.18/209.36 |- skos__historyNote mesh__D003844 Deoxycytidine Monophosphate %28%1975%29%
% 209.18/209.36 |- mesh__publicMeSHNote mesh__D003844
% 209.18/209.36 97; was DEOXYCYTIDYLATE DEAMINASE 1976-96 %28%see under NUCLEOTIDE DEAMINASES 1976-90%29%; DCMP DEAMINASE was see DEOXYCYTIDYLATE DEAMINASE 1976-96%A%
% 209.18/209.37 |- mesh__dateCreated mesh__D003844 1975-07-25
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003844 2006
% 209.18/209.37 |- skos__altLabel mesh__D003844 Deoxycytidine Monophosphate Deaminase
% 209.18/209.37 |- skos__broader mesh__D003844smesh__D009709
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003844 2005
% 209.18/209.37 |- skos__scopeNote mesh__D003844
% 209.18/209.37 An enzyme that catalyzes the hydrolytic deamination of deoxycytidylic acid to deoxyuridylic acid and ammonia. It plays an important role in the regulation of the pool of deoxynucleotides in higher organisms. The enzyme also acts on some 5-substituted deoxycytidylic acids. EC 3.5.4.12.%A%
% 209.18/209.37 |- skos__hiddenLabel mesh__D003844 Aminohydrolase, Deoxycytidylate
% 209.18/209.37 |- skos__hiddenLabel mesh__D003844 Deaminase, Deoxycytidylate
% 209.18/209.37 |- rdf__type mesh__D003844sskos__Concept
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003844 2004
% 209.18/209.37 |- mesh__recordOriginator mesh__D003844 RLS
% 209.18/209.37 |- skos__historyNote mesh__D003844 Aminohydrolases %28%1970-1974%29%
% 209.18/209.37 |- skos__historyNote mesh__D003844 Cytosine Nucleotides %28%1970-1974%29%
% 209.18/209.37 |- mesh__historyNote mesh__D003844
% 209.18/209.37 97; was DEOXYCYTIDYLATE DEAMINASE 1976-96 %28%see under NUCLEOTIDE DEAMINASES 1976-90%29%; DCMP DEAMINASE was see DEOXYCYTIDYLATE DEAMINASE 1976-96%A%
% 209.18/209.37 |- skos__hiddenLabel mesh__D003844 Monophosphate Deaminase, Deoxycytidine
% 209.18/209.37 |- skos__hiddenLabel mesh__D003844 Deaminase, Deoxycytidine Monophosphate
% 209.18/209.37 |- skos__hiddenLabel mesh__D003844 Deaminase, DCMP
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D003844 sjn
% 209.18/209.37 |- mesh__dateRevised mesh__D003844 2003-07-09
% 209.18/209.37 |- skos__historyNote mesh__D003844 Nucleotide Deaminases %28%1975%29%
% 209.18/209.37 |- skos__historyNote mesh__D003844 Deoxyribonucleotides %28%1973-1974%29%
% 209.18/209.37 |- skos__altLabel mesh__D003844 Deoxycytidylate Aminohydrolase
% 209.18/209.37 |- mesh__dateEstablished mesh__D003844 1991-01-01
% 209.18/209.37 |- mesh__recordMaintainer mesh__D003046 ssb
% 209.18/209.37 |- mesh__dateRevised mesh__D003046 2005-06-30
% 209.18/209.37 |- mesh__dateCreated mesh__D003046 1974-11-19
% 209.18/209.37 |- skos__historyNote mesh__D003046 Antigens, Fungal %28%1973-1974%29%
% 209.18/209.37 |- skos__historyNote mesh__D003046 Coccidioides/IM %28%1973-1974%29%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003046 2006
% 209.18/209.37 |- skos__broader mesh__D003046smesh__D000946
% 209.18/209.37 |- mesh__historyNote mesh__D003046
% 209.18/209.37 91%28%75%29%; was see under ANTIGENS, FUNGAL 1975-90
% 209.18/209.37 |- skos__scopeNote mesh__D003046
% 209.18/209.37 A sterile solution containing the by-products of growth products of Coccidioides immitis, injected intracutaneously as a test for coccidioidomycosis.%A%
% 209.18/209.37 |- rdf__type mesh__D003046sskos__Concept
% 209.18/209.37 |- mesh__recordOriginator mesh__D003046 NLM
% 209.18/209.37 |- mesh__dateEstablished mesh__D003046 1991-01-01
% 209.18/209.37 |- skos__prefLabel mesh__D003046 Coccidioidin
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D003046 sjn
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D003046
% 209.18/209.37 91; was see under ANTIGENS, FUNGAL 1975-90
% 209.18/209.37 |- mesh__dateCreated mesh__D041963 2003-07-09
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D041963
% 209.18/209.37 2004; for CYTOPHAGALES use CYTOPHAGALES 1976-2003
% 209.18/209.37 |- skos__broader mesh__D041963smesh__D001419
% 209.18/209.37 |- mesh__recordOriginator mesh__D041963 ags
% 209.18/209.37 |- mesh__recordMaintainer mesh__D041963 SYSTEM
% 209.18/209.37 |- skos__prefLabel mesh__D041963 Bacteroidetes
% 209.18/209.37 |- rdf__type mesh__D041963sskos__Concept
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D041963 2006
% 209.18/209.37 |- mesh__dateEstablished mesh__D041963 2004-01-01
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D041963 sjn
% 209.18/209.37 |- mesh__dateRevised mesh__D041963 2005-06-30
% 209.18/209.37 |- skos__scopeNote mesh__D041963
% 209.18/209.37 A phylum of bacteria comprised of three classes: Bacteroides, Flavobacteria, and Sphingobacteria.%A%
% 209.18/209.37 |- mesh__historyNote mesh__D041963 2004
% 209.18/209.37 |- skos__hiddenLabel mesh__D049148 Acids Activations, Amino
% 209.18/209.37 |- skos__hiddenLabel mesh__D049148 Amino Acylations
% 209.18/209.37 |- skos__hiddenLabel mesh__D049148 Amino Acids Activation
% 209.18/209.37 |- skos__hiddenLabel mesh__D049148 Acylations, Amino
% 209.18/209.37 |- skos__altLabel mesh__D049148 Amino Acylation
% 209.18/209.37 |- skos__hiddenLabel mesh__D049148 Acids Activation, Amino
% 209.18/209.37 |- rdf__type mesh__D049148sskos__Concept
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D049148 2006
% 209.18/209.37 |- skos__broader mesh__D049148smesh__D010452
% 209.18/209.37 |- skos__hiddenLabel mesh__D049148 Aminoacylations
% 209.18/209.37 |- skos__broader mesh__D049148smesh__D000215
% 209.18/209.37 |- skos__scopeNote mesh__D049148
% 209.18/209.37 A reaction that introduces an aminoacyl group to a molecule. TRANSFER RNA AMINOACYLATION is the first step in GENETIC TRANSLATION.%A%
% 209.18/209.37 |- skos__hiddenLabel mesh__D049148 Amino Acids Activations
% 209.18/209.37 |- mesh__recordOriginator mesh__D049148 nns
% 209.18/209.37 |- mesh__recordMaintainer mesh__D049148 nns
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D049148 sjn
% 209.18/209.37 |- mesh__dateEstablished mesh__D049148 2005-01-01
% 209.18/209.37 |- mesh__historyNote mesh__D049148 2005
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D049148 2005
% 209.18/209.37 |- skos__prefLabel mesh__D049148 Aminoacylation
% 209.18/209.37 |- mesh__dateCreated mesh__D049148 2004-07-07
% 209.18/209.37 |- skos__hiddenLabel mesh__D049148 Acylation, Amino
% 209.18/209.37 |- skos__annotation mesh__D049148
% 209.18/209.37 not for activation of enzymes, receptors, cells, etc. by amino acids: index ENZYME ACTIVATION or specific term with /metab%A%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D049148 2005
% 209.18/209.37 |- skos__prefLabel mesh__D035926 Hepatophyta
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D035926 2003
% 209.18/209.37 |- mesh__recordMaintainer mesh__D035926 ssb
% 209.18/209.37 |- skos__broader mesh__D035926smesh__D019669
% 209.18/209.37 |- rdf__type mesh__D035926sskos__Concept
% 209.18/209.37 |- mesh__dateCreated mesh__D035926 2002-07-03
% 209.18/209.37 |- mesh__dateRevised mesh__D035926 2005-06-30
% 209.18/209.37 |- skos__annotation mesh__D035926
% 209.18/209.37 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D035926 sjn
% 209.18/209.37 |- skos__altLabel mesh__D035926 Liverworts
% 209.18/209.37 |- mesh__dateEstablished mesh__D035926 2003-01-01
% 209.18/209.37 |- skos__scopeNote mesh__D035926
% 209.18/209.37 A plant division. They are simple plants that lack vascular tissue and possess rudimentary rootlike organs %28%rhizoids%29%. Like MOSSES, liverworts have alternation of generations between haploid gamete-bearing forms %28%gametophytes%29% and diploid spore-bearing forms %28%sporophytes%29%.%A%
% 209.18/209.37 |- mesh__recordOriginator mesh__D035926 ssb
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D035926 2006
% 209.18/209.37 |- mesh__historyNote mesh__D035926 2003
% 209.18/209.37 |- skos__broader mesh__D013474smesh__D006359
% 209.18/209.37 |- skos__scopeNote mesh__D013474
% 209.18/209.37 A condition produced by exposure to the sun, and marked by convulsions, coma, and a high temperature of the skin. It is distinguished from HEAT STROKE which is caused by excessive heat, natural or artificial, and is marked by dry skin, vertigo, headache, thirst, nausea and muscular cramps. %28%From Dorland, 27th ed%29%%A%
% 209.18/209.37 |- mesh__recordMaintainer mesh__D013474 TGC
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 1996
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 2002
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 1998
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 1997
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 1999
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 2003
% 209.18/209.37 |- mesh__dateCreated mesh__D013474 1999-01-01
% 209.18/209.37 |- mesh__dateRevised mesh__D013474 1994-12-27
% 209.18/209.37 |- rdf__type mesh__D013474sskos__Concept
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 2005
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 2000
% 209.18/209.37 |- mesh__recordOriginator mesh__D013474 NLM
% 209.18/209.37 |- skos__hiddenLabel mesh__D013474 Sunstrokes
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 2004
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 2001
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013474 2006
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D013474 PLS
% 209.18/209.37 |- skos__annotation mesh__D013474 a form of heat exhaustion
% 209.18/209.37 |- skos__prefLabel mesh__D013474 Sunstroke
% 209.18/209.37 |- skos__prefLabel mesh__D007437 Intrinsic Factor
% 209.18/209.37 |- mesh__recordOriginator mesh__D007437 NLM
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D007437 sjn
% 209.18/209.37 |- mesh__dateCreated mesh__D007437 1999-01-01
% 209.18/209.37 |- rdf__type mesh__D007437sskos__Concept
% 209.18/209.37 |- mesh__recordMaintainer mesh__D007437 SYSTEM
% 209.18/209.37 |- skos__scopeNote mesh__D007437
% 209.18/209.37 A glycoprotein secreted by the cells of the gastric glands that is required for the absorption of VITAMIN B 12. Deficiency of intrinsic factor results in ANEMIA, PERNICIOUS.%A%
% 209.18/209.37 |- skos__broader mesh__D007437smesh__D009088
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D007437 2006
% 209.18/209.37 |- skos__hiddenLabel mesh__D007437 Factor, Intrinsic
% 209.18/209.37 |- mesh__dateRevised mesh__D007437 2005-06-30
% 209.18/209.37 |- skos__broader mesh__D017865smesh__D010942
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D017865 2004
% 209.18/209.37 |- skos__historyNote mesh__D017865 Plant Viruses %28%1966-1993%29%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D017865 2002
% 209.18/209.37 |- rdf__type mesh__D017865sskos__Concept
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D017865 2006
% 209.18/209.37 |- mesh__dateCreated mesh__D017865 1993-06-04
% 209.18/209.37 |- mesh__recordOriginator mesh__D017865 AGS
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D017865 94
% 209.18/209.37 |- skos__broader mesh__D017865smesh__D002043
% 209.18/209.37 |- skos__hiddenLabel mesh__D017865 Tospoviruses
% 209.18/209.37 |- mesh__dateEstablished mesh__D017865 1994-01-01
% 209.18/209.37 |- skos__annotation mesh__D017865 coord IM with specific plant /virol
% 209.18/209.37 |- mesh__historyNote mesh__D017865 94
% 209.18/209.37 |- skos__scopeNote mesh__D017865
% 209.18/209.37 A genus of plant viruses in the family BUNYAVIRIDAE. Tomato spotted wilt virus is the type species. Transmission occurs by at least nine species of thrips.%A%
% 209.18/209.37 |- mesh__dateRevised mesh__D017865 2001-07-25
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D017865 sjn
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D017865 2003
% 209.18/209.37 |- mesh__recordMaintainer mesh__D017865 ags
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D017865 2005
% 209.18/209.37 |- skos__prefLabel mesh__D017865 Tospovirus
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 2000
% 209.18/209.37 |- mesh__dateRevised mesh__D003845 1992-05-13
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D003845
% 209.18/209.37 78; DEOXYCYTIDINE MONOPHOSPHATE was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A%
% 209.18/209.37 |- skos__hiddenLabel mesh__D003845 Phosphates, Deoxycytidine
% 209.18/209.37 |- rdf__type mesh__D003845sskos__Concept
% 209.18/209.37 |- skos__hiddenLabel mesh__D003845 Nucleotides, Deoxycytosine
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 2004
% 209.18/209.37 |- skos__historyNote mesh__D003845 Deoxyribonucleotides %28%1973-1977%29%
% 209.18/209.37 |- skos__historyNote mesh__D003845 Cytosine Nucleotides %28%1966-1977%29%
% 209.18/209.37 |- skos__prefLabel mesh__D003845 Deoxycytosine Nucleotides
% 209.18/209.37 |- mesh__recordMaintainer mesh__D003845 TGC
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 1995
% 209.18/209.37 |- mesh__historyNote mesh__D003845 78
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 2003
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D003845 PLS
% 209.18/209.37 |- skos__altLabel mesh__D003845 Deoxycytidine Phosphates
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 1999
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 1994
% 209.18/209.37 |- mesh__dateCreated mesh__D003845 1977-04-22
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 1998
% 209.18/209.37 |- skos__scopeNote mesh__D003845
% 209.18/209.37 Cytosine nucleotides which contain deoxyribose as the sugar moiety.%A%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 1993
% 209.18/209.37 |- skos__broader mesh__D003845smesh__D003854
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 2002
% 209.18/209.37 |- mesh__dateEstablished mesh__D003845 1978-01-01
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 1997
% 209.18/209.37 |- skos__broader mesh__D003845smesh__D003597
% 209.18/209.37 |- mesh__recordOriginator mesh__D003845 RLS
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 2006
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 2001
% 209.18/209.37 |- skos__annotation mesh__D003845 /biosyn /physiol permitted
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 1996
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003845 2005
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 2003
% 209.18/209.37 |- skos__broader mesh__D003047smesh__D009181
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 1999
% 209.18/209.37 |- skos__annotation mesh__D003047
% 209.18/209.37 fungus dis caused by COCCIDIOIDES, not COCCIDIA
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 1996
% 209.18/209.37 |- skos__scopeNote mesh__D003047
% 209.18/209.37 Infection with a fungus of the genus COCCIDIOIDES, species C. immitis. The primary form is an acute, benign, self-limited respiratory infection due to inhalation of spores and varying in severity. The secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. %28%From Dorland, 27th ed%29%%A%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 2004
% 209.18/209.37 |- rdf__type mesh__D003047sskos__Concept
% 209.18/209.37 |- skos__prefLabel mesh__D003047 Coccidioidomycosis
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 2000
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 1997
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 2001
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 1994
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 2002
% 209.18/209.37 |- mesh__dateRevised mesh__D003047 1993-06-02
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D003047 PLS
% 209.18/209.37 |- skos__hiddenLabel mesh__D003047 Coccidioidomycoses
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 1995
% 209.18/209.37 |- mesh__dateCreated mesh__D003047 1999-01-01
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 2005
% 209.18/209.37 |- mesh__recordOriginator mesh__D003047 NLM
% 209.18/209.37 |- mesh__recordMaintainer mesh__D003047 TAP
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 1998
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003047 2006
% 209.18/209.37 |- mesh__dateRevised mesh__D008530 2003-07-09
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D008530 2006
% 209.18/209.37 |- mesh__onlineNote mesh__D008530
% 209.18/209.37 use MEGACINS to search MEGACIN 1975-78; use BACTERIOCINS 1968-74; use ANTIBIOTICS 1966-67%A%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D008530 2005
% 209.18/209.37 |- rdf__type mesh__D008530sskos__Concept
% 209.18/209.37 |- skos__historyNote mesh__D008530 Megacin %28%1975-1978%29%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D008530 2004
% 209.18/209.37 |- mesh__dateCreated mesh__D008530 1999-01-01
% 209.18/209.37 |- mesh__historyNote mesh__D008530
% 209.18/209.37 91%28%79%29%; was see under BACTERIOCINS 1979-90; was MEGACIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A%
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D008530 sjn
% 209.18/209.37 |- mesh__dateEstablished mesh__D008530 1991-01-01
% 209.18/209.37 |- skos__historyNote mesh__D008530 Antibiotics %28%1966-1967%29%
% 209.18/209.37 |- skos__prefLabel mesh__D008530 Megacins
% 209.18/209.37 |- mesh__recordOriginator mesh__D008530 NLM
% 209.18/209.37 |- mesh__recordMaintainer mesh__D008530 jmp
% 209.18/209.37 |- skos__historyNote mesh__D008530 Bacteriocins %28%1968-1974%29%
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D008530
% 209.18/209.37 91; was see under BACTERIOCINS 1979-80; was MEGACIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A%
% 209.18/209.37 |- skos__scopeNote mesh__D008530
% 209.18/209.37 Bacteriocins elaborated by mutant strains of Bacillus megaterium. They are protein or protein-lipopolysaccharide complexes lethal to other strains of the same species.%A%
% 209.18/209.37 |- skos__broader mesh__D008530smesh__D001430
% 209.18/209.37 |- rdf__type mesh__D022201sskos__Concept
% 209.18/209.37 |- skos__broader mesh__D022201smesh__D002875
% 209.18/209.37 |- mesh__recordOriginator mesh__D022201 nns
% 209.18/209.37 |- mesh__dateCreated mesh__D022201 2000-06-21
% 209.18/209.37 |- skos__broader mesh__D022201smesh__D005822
% 209.18/209.37 |- skos__prefLabel mesh__D022201 Chromosomes, Artificial
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D022201 2001
% 209.18/209.37 |- skos__historyNote mesh__D022201 Chromosomes %28%1992-2000%29%
% 209.18/209.37 |- mesh__recordMaintainer mesh__D022201 jls
% 209.18/209.37 |- skos__scopeNote mesh__D022201
% 209.18/209.37 DNA constructs that are composed of, at least, elements such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintenance in progeny cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.%A%
% 209.18/209.37 |- mesh__historyNote mesh__D022201 2001
% 209.18/209.37 |- skos__annotation mesh__D022201
% 209.18/209.37 coord with specific organism /genet only if particularly discussed; for insertion of the artificial chromosome, coord with GENE TRANSFER TECHNIQUES%A%
% 209.18/209.37 |- skos__hiddenLabel mesh__D022201 Chromosome, Artificial
% 209.18/209.37 |- mesh__dateRevised mesh__D022201 2004-07-19
% 209.18/209.37 |- skos__hiddenLabel mesh__D022201 Artificial Chromosome
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D022201 2006
% 209.18/209.37 |- mesh__dateEstablished mesh__D022201 2001-01-01
% 209.18/209.37 |- skos__altLabel mesh__D022201 Artificial Chromosomes
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D022201 sjn
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D022201 2005
% 209.18/209.37 |- skos__prefLabel mesh__D041964 Flexibacteraceae
% 209.18/209.37 |- mesh__dateCreated mesh__D041964 2003-07-09
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D041964
% 209.18/209.37 2004; for CYTOPHAGACEAE see CYTOPHAGACEAE 1975-2003
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D041964 sjn
% 209.18/209.37 |- mesh__dateRevised mesh__D041964 2005-06-30
% 209.18/209.37 |- mesh__dateEstablished mesh__D041964 2004-01-01
% 209.18/209.37 |- mesh__historyNote mesh__D041964 2004
% 209.18/209.37 |- mesh__recordOriginator mesh__D041964 ags
% 209.18/209.37 |- rdf__type mesh__D041964sskos__Concept
% 209.18/209.37 |- skos__broader mesh__D041964smesh__D016946
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D041964 2006
% 209.18/209.37 |- skos__broader mesh__D041964smesh__D041963
% 209.18/209.37 |- skos__scopeNote mesh__D041964
% 209.18/209.37 A family of bacteria in the order Sphingobacteriales, class Sphingobacteria.%A%
% 209.18/209.37 |- skos__annotation mesh__D041964
% 209.18/209.37 infection = FLEXIBACTERACEAE INFECTIONS
% 209.18/209.37 |- mesh__recordMaintainer mesh__D041964 SYSTEM
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1993
% 209.18/209.37 |- mesh__dateCreated mesh__D013475 1999-01-01
% 209.18/209.37 |- mesh__recordOriginator mesh__D013475 NLM
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 2003
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 2001
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1995
% 209.18/209.37 |- rdf__type mesh__D013475sskos__Concept
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D013475 PLS
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 2005
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 2004
% 209.18/209.37 |- skos__annotation mesh__D013475 no qualif
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1991
% 209.18/209.37 |- mesh__historyNote mesh__D013475 68
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 2006
% 209.18/209.37 |- skos__broader mesh__D013475smesh__D010553
% 209.18/209.37 |- skos__prefLabel mesh__D013475 Superego
% 209.18/209.37 |- mesh__dateRevised mesh__D013475 1989-05-16
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 2002
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D013475 68
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1996
% 209.18/209.37 |- mesh__dateEstablished mesh__D013475 1968-01-01
% 209.18/209.37 |- skos__broader mesh__D013475smesh__D011574
% 209.18/209.37 |- skos__hiddenLabel mesh__D013475 Superegos
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1998
% 209.18/209.37 |- skos__scopeNote mesh__D013475
% 209.18/209.37 The component of the personality associated with ethics, standards, and self-criticism - the %22%conscience%22%. It is derived mainly from identification with parents and parent substitutes.%A%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1992
% 209.18/209.37 |- mesh__recordMaintainer mesh__D013475 TGC
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1990
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1997
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 2000
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1994
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D013475 1999
% 209.18/209.37 |- mesh__recordMaintainer mesh__D007438 nns
% 209.18/209.37 |- mesh__onlineNote mesh__D007438
% 209.18/209.37 use BASE SEQUENCE to search INTRONS %26% INTERVENING SEQUENCES 1981-86%A%
% 209.18/209.37 |- skos__prefLabel mesh__D007438 Introns
% 209.18/209.37 |- skos__scopeNote mesh__D007438
% 209.18/209.37 Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes.%A%
% 209.18/209.37 |- mesh__recordOriginator mesh__D007438 SCD
% 209.18/209.37 |- mesh__dateRevised mesh__D007438 2005-06-30
% 209.18/209.37 |- rdf__type mesh__D007438sskos__Concept
% 209.18/209.37 |- mesh__dateCreated mesh__D007438 1986-06-18
% 209.18/209.37 |- skos__hiddenLabel mesh__D007438 Intervening Sequence
% 209.18/209.37 |- skos__broader mesh__D007438smesh__D021901
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D007438 sjn
% 209.18/209.37 |- skos__historyNote mesh__D007438 Genes %28%1977-1980%29%
% 209.18/209.37 |- skos__altLabel mesh__D007438 Sequences, Intervening
% 209.18/209.37 |- skos__hiddenLabel mesh__D007438 Intron
% 209.18/209.37 |- mesh__historyNote mesh__D007438
% 209.18/209.37 87; INTERVENING SEQUENCES %26% INTRONS were see BASE SEQUENCE 1981-86%A%
% 209.18/209.37 |- skos__hiddenLabel mesh__D007438 Sequence, Intervening
% 209.18/209.37 |- skos__altLabel mesh__D007438 Intervening Sequences
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D007438 2006
% 209.18/209.37 |- skos__historyNote mesh__D007438 Base Sequence %28%1977-1986%29%
% 209.18/209.37 |- skos__broader mesh__D007438smesh__D040461
% 209.18/209.37 |- mesh__dateEstablished mesh__D007438 1987-01-01
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D007438
% 209.18/209.37 87; INTERVENING SEQUENCES %26% INTRONS were see BASE SEQUENCE 1981-86%A%
% 209.18/209.37 |- skos__historyNote mesh__D007438 Genes, Structural %28%1977-1986%29%
% 209.18/209.37 |- mesh__dateEstablished mesh__D018160 1994-01-01
% 209.18/209.37 |- skos__altLabel mesh__D018160 Nuclear and Cytoplasmic Receptors
% 209.18/209.37 |- skos__altLabel mesh__D018160 Nuclear Hormone Receptors
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D018160 2002
% 209.18/209.37 |- mesh__dateCreated mesh__D018160 1993-06-30
% 209.18/209.37 |- rdf__type mesh__D018160sskos__Concept
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D018160 94
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D018160 sjn
% 209.18/209.37 |- skos__related mesh__D018160smesh__D014157
% 209.18/209.37 |- skos__historyNote mesh__D018160
% 209.18/209.37 Receptors, Cell Surface %28%1983-1993%29%
% 209.18/209.37 |- skos__altLabel mesh__D018160 Nuclear Receptors
% 209.18/209.37 |- skos__hiddenLabel mesh__D018160 Receptors, Nuclear Hormone
% 209.18/209.37 |- skos__prefLabel mesh__D018160 Receptors, Cytoplasmic and Nuclear
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D018160 2003
% 209.18/209.37 |- skos__hiddenLabel mesh__D018160 Receptors, Cytoplasmic Hormone
% 209.18/209.37 |- skos__broader mesh__D018160smesh__D011506
% 209.18/209.37 |- skos__annotation mesh__D018160
% 209.18/209.37 GEN; prefer specifics; for hormone receptors, see note on RECEPTORS, CELL SURFACE; DF: RECEPT CYTOPLASMIC%A%
% 209.18/209.37 |- skos__altLabel mesh__D018160 Receptors, Cytosolic and Nuclear
% 209.18/209.37 |- mesh__historyNote mesh__D018160 94
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D018160 2001
% 209.18/209.37 |- skos__altLabel mesh__D018160 Cytoplasmic and Nuclear Receptors
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D018160 2005
% 209.18/209.37 |- mesh__dateRevised mesh__D018160 2000-06-22
% 209.18/209.37 |- mesh__recordOriginator mesh__D018160 RAZ
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D018160 2004
% 209.18/209.37 |- skos__scopeNote mesh__D018160
% 209.18/209.37 Proteins in the cytoplasm or nucleus that specifically bind signaling molecules and trigger changes which influence the behavior of cells. The major groups are the steroid hormone receptors %28%RECEPTORS, STEROID%29%, which usually are found in the cytoplasm, and the thyroid hormone receptors %28%RECEPTORS, THYROID HORMONE%29%, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands.%A%
% 209.18/209.37 |- skos__altLabel mesh__D018160 Receptors, Nuclear and Cytoplasmic
% 209.18/209.37 |- skos__altLabel mesh__D018160 Cytosol and Nuclear Receptors
% 209.18/209.37 |- skos__altLabel mesh__D018160 Cytoplasmic Receptors
% 209.18/209.37 |- skos__altLabel mesh__D018160 Cytosolic and Nuclear Receptors
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D018160 2006
% 209.18/209.37 |- mesh__recordMaintainer mesh__D018160 jmp
% 209.18/209.37 |- skos__altLabel mesh__D018160 Cytoplasmic Hormone Receptors
% 209.18/209.37 |- skos__altLabel mesh__D018160 Receptors, Cytosol and Nuclear
% 209.18/209.37 |- mesh__recordMaintainer mesh__D004140 JRT
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 2006
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 1998
% 209.18/209.37 |- mesh__dateRevised mesh__D004140 1995-06-08
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D004140 64
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 2003
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 2000
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 1999
% 209.18/209.37 |- mesh__recordOriginator mesh__D004140 NLM
% 209.18/209.37 |- mesh__dateEstablished mesh__D004140 1964-01-01
% 209.18/209.37 |- mesh__dateCreated mesh__D004140 1999-01-01
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 2004
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 1996
% 209.18/209.37 |- skos__scopeNote mesh__D004140
% 209.18/209.37 Organic compounds that contain two nitro groups attached to a phenol.%A%
% 209.18/209.37 |- skos__broader mesh__D004140smesh__D009596
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 2001
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 1997
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D004140 PLS
% 209.18/209.37 |- rdf__type mesh__D004140sskos__Concept
% 209.18/209.37 |- skos__annotation mesh__D004140
% 209.18/209.37 uncoupling agents %26% indust fungicides
% 209.18/209.37 |- skos__prefLabel mesh__D004140 Dinitrophenols
% 209.18/209.37 |- mesh__historyNote mesh__D004140 64%28%63%29%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 2005
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D004140 2002
% 209.18/209.37 |- mesh__recordAuthorizer mesh__D017866 sjn
% 209.18/209.37 |- skos__broader mesh__D017866smesh__D010770
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D017866 94
% 209.18/209.37 |- mesh__dateCreated mesh__D017866 1993-06-18
% 209.18/209.37 |- mesh__historyNote mesh__D017866 94
% 209.18/209.37 |- skos__historyNote mesh__D017866 Phosphotransferases %28%1966-1993%29%
% 209.18/209.37 |- mesh__recordOriginator mesh__D017866 TPW
% 209.18/209.37 |- skos__scopeNote mesh__D017866
% 209.18/209.37 A group of enzymes that transfers two phosphate groups from a donor such as ATP to two different acceptors. %28%From Enzyme Nomenclature, 1992%29% EC 2.7.9.%A%
% 209.18/209.37 |- mesh__dateEstablished mesh__D017866 1994-01-01
% 209.18/209.37 |- skos__prefLabel mesh__D017866
% 209.18/209.37 Phosphotransferases %28%Paired Acceptors%29%
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D017866 2005
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D017866 2004
% 209.18/209.37 |- mesh__dateRevised mesh__D017866 2003-07-09
% 209.18/209.37 |- skos__annotation mesh__D017866 DF: PHOSPHOTRANSFERASES PAIRED
% 209.18/209.37 |- rdf__type mesh__D017866sskos__Concept
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D017866 2006
% 209.18/209.37 |- mesh__recordMaintainer mesh__D017866 ssb
% 209.18/209.37 |- mesh__publicMeSHNote mesh__D003846 91; was see under DOPAMINE 1975-90
% 209.18/209.37 |- skos__altLabel mesh__D003846 Methyldopamine
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003846 2001
% 209.18/209.37 |- skos__altLabel mesh__D003846 Deoxyadrenaline
% 209.18/209.37 |- mesh__activeMeSHYear mesh__D003846 2003
% 209.18/209.37 |- mesh__historyNote mesh__D003846
% 209.18/209.37 91%28%75%29%; was see under DOPAMINE 1975-90
% 209.18/209.37 |- skos__altLabel mesh__D003846 Desoxyadrenaline
% 209.18/209.37 |- mesh__recordOriginator mesh__D003846 NLM
% 209.18/209.37 |- skos__historyNote mesh__D003846 Dopamine %28%1971-1974%29%
% 209.18/209.37 |- mesh__recordMaintainer mesh__D003846 CCR
% 209.18/209.37 |- mesh__dateCreated mesh__D003846 1974-11-27
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D003846 sjn
% 209.18/209.38 |- mesh__dateEstablished mesh__D003846 1991-01-01
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003846 2006
% 209.18/209.38 |- skos__broader mesh__D003846smesh__D004837
% 209.18/209.38 |- skos__altLabel mesh__D003846 Desoxyepinephrine
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003846 2005
% 209.18/209.38 |- mesh__dateRevised mesh__D003846 2000-06-22
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003846 2002
% 209.18/209.38 |- skos__prefLabel mesh__D003846 Deoxyepinephrine
% 209.18/209.38 |- skos__broader mesh__D003846smesh__D004298
% 209.18/209.38 |- rdf__type mesh__D003846sskos__Concept
% 209.18/209.38 |- skos__historyNote mesh__D003846 Methane %28%1973-1974%29%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003846 2004
% 209.18/209.38 |- skos__scopeNote mesh__D003846
% 209.18/209.38 Sympathomimetic, vasoconstrictor agent.
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003048 2002
% 209.18/209.38 |- skos__annotation mesh__D003048
% 209.18/209.38 protozoan infect caused by COCCIDIA, not COCCIDIOIDES; /drug ther: consider also COCCIDIOSTATS%A%
% 209.18/209.38 |- skos__hiddenLabel mesh__D003048 Coccidioses
% 209.18/209.38 |- mesh__recordOriginator mesh__D003048 NLM
% 209.18/209.38 |- skos__broader mesh__D003048smesh__D011528
% 209.18/209.38 |- skos__related mesh__D003048smesh__D003049
% 209.18/209.38 |- mesh__historyNote mesh__D003048
% 209.18/209.38 BESNOITIASIS was see PROTOZOAN INFECTIONS 1985-94, was heading 1968-84; EIMERIA INFECTIONS %26% ISOSPORA INFECTIONS were see COCCIDIOSIS 1975-91, were see under COCCIDIOSIS 1967-74%A%
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D003048 sjn
% 209.18/209.38 |- mesh__dateCreated mesh__D003048 1999-01-01
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003048 2005
% 209.18/209.38 |- skos__prefLabel mesh__D003048 Coccidiosis
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003048 2006
% 209.18/209.38 |- mesh__dateRevised mesh__D003048 2000-06-22
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003048 2003
% 209.18/209.38 |- skos__scopeNote mesh__D003048
% 209.18/209.38 Protozoan infection found in animals and man. It is caused by several different genera of COCCIDIA.%A%
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D003048
% 209.18/209.38 BESNOITIASIS was see PROTOZOAN INFECTIONS 1985-94, was heading 1968-84; EIMERIA INFECTIONS %26% ISOSPORA INFECTIONS were see COCCIDIOSIS 1975-91, were see under COCCIDIOSIS 1967-74%A%
% 209.18/209.38 |- mesh__recordMaintainer mesh__D003048 PXP
% 209.18/209.38 |- skos__hiddenLabel mesh__D003048 Besnoitiases
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003048 2004
% 209.18/209.38 |- mesh__onlineNote mesh__D003048
% 209.18/209.38 use PROTOZOAN INFECTIONS to search BESNOITIASIS 1968-94; use COCCIDIOSIS to search EIMERIA INFECTIONS %26% ISOSPORA INFECTIONS 1967-91%A%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003048 2001
% 209.18/209.38 |- rdf__type mesh__D003048sskos__Concept
% 209.18/209.38 |- skos__hiddenLabel mesh__D003048 Besnoitioses
% 209.18/209.38 |- skos__altLabel mesh__D003048 Besnoitiosis
% 209.18/209.38 |- mesh__dateCreated mesh__D008531 1999-01-01
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D008531 2006
% 209.18/209.38 |- mesh__recordOriginator mesh__D008531 NLM
% 209.18/209.38 |- skos__prefLabel mesh__D008531 Megacolon
% 209.18/209.38 |- skos__broader mesh__D008531smesh__D003108
% 209.18/209.38 |- rdf__type mesh__D008531sskos__Concept
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D008531 2004
% 209.18/209.38 |- skos__scopeNote mesh__D008531
% 209.18/209.38 Dilatation of the COLON, often to alarming dimensions. There are various types of megacolon including congenital megacolon in HIRSCHSPRUNG DISEASE, idiopathic megacolon in CONSTIPATION, and TOXIC MEGACOLON.%A%
% 209.18/209.38 |- mesh__recordMaintainer mesh__D008531 lkt
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D008531 2005
% 209.18/209.38 |- skos__hiddenLabel mesh__D008531 Megacolons
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D008531 sjn
% 209.18/209.38 |- mesh__dateRevised mesh__D008531 2003-07-09
% 209.18/209.38 |- skos__hiddenLabel mesh__D022202 Bacterial Artificial Chromosome
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D022202 2005
% 209.18/209.38 |- mesh__recordOriginator mesh__D022202 nns
% 209.18/209.38 |- skos__broader mesh__D022202smesh__D022201
% 209.18/209.38 |- skos__broader mesh__D022202smesh__D002876
% 209.18/209.38 |- skos__altLabel mesh__D022202 Bacterial Artificial Chromosomes
% 209.18/209.38 |- skos__altLabel mesh__D022202 BACs %28%Chromosomes%29%
% 209.18/209.38 |- skos__annotation mesh__D022202
% 209.18/209.38 coord with specific bacterium /genet only if particularly discussed%A%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D022202 2004
% 209.18/209.38 |- mesh__dateRevised mesh__D022202 2003-07-09
% 209.18/209.38 |- skos__prefLabel mesh__D022202 Chromosomes, Artificial, Bacterial
% 209.18/209.38 |- mesh__recordMaintainer mesh__D022202 nns
% 209.18/209.38 |- skos__scopeNote mesh__D022202
% 209.18/209.38 DNA constructs that are composed of, at least, a REPLICATION ORIGIN, for successful replication, propagation to and maintainance as an extra chromosome in bacteria. In addition, they can carry large amounts %28%about 200 kilobases%29% of other sequence for a variety of bioengineering purposes.%A%
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D022202
% 209.18/209.38 2002; see CHROMOSOMES, BACTERIAL ARTIFICIAL 2001
% 209.18/209.38 |- mesh__dateEstablished mesh__D022202 2001-01-01
% 209.18/209.38 |- skos__hiddenLabel mesh__D022202 Artificial Chromosome, Bacterial
% 209.18/209.38 |- mesh__historyNote mesh__D022202 2002%28%2001%29%
% 209.18/209.38 |- skos__altLabel mesh__D022202 Chromosomes, Bacterial Artificial
% 209.18/209.38 |- skos__hiddenLabel mesh__D022202 Chromosome, Bacterial Artificial
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D022202 sjn
% 209.18/209.38 |- skos__historyNote mesh__D022202 Chromosomes, Bacterial %28%1994-2000%29%
% 209.18/209.38 |- rdf__type mesh__D022202sskos__Concept
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D022202 2006
% 209.18/209.38 |- mesh__dateCreated mesh__D022202 2000-06-21
% 209.18/209.38 |- skos__altLabel mesh__D022202 BAC %28%Chromosome%29%
% 209.18/209.38 |- skos__altLabel mesh__D022202 Artificial Chromosomes, Bacterial
% 209.18/209.38 |- skos__prefLabel mesh__D041965 Flavobacteriaceae
% 209.18/209.38 |- rdf__type mesh__D041965sskos__Concept
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D041965 sjn
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D041965 2004
% 209.18/209.38 |- skos__annotation mesh__D041965
% 209.18/209.38 infection = FLAVOBACTERIACEAE INFECTIONS
% 209.18/209.38 |- mesh__dateRevised mesh__D041965 2005-06-30
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D041965 2006
% 209.18/209.38 |- mesh__dateEstablished mesh__D041965 2004-01-01
% 209.18/209.38 |- mesh__historyNote mesh__D041965 2004
% 209.18/209.38 |- skos__scopeNote mesh__D041965
% 209.18/209.38 A family of bacteria in the order Sphingobacteriales, class Sphingobacteria. They are gram-negative rods, mostly saprophytic in terrestrial and aquatic habitats.%A%
% 209.18/209.38 |- mesh__recordMaintainer mesh__D041965 SYSTEM
% 209.18/209.38 |- mesh__recordOriginator mesh__D041965 ags
% 209.18/209.38 |- skos__broader mesh__D041965smesh__D016946
% 209.18/209.38 |- mesh__dateCreated mesh__D041965 2003-07-09
% 209.18/209.38 |- skos__broader mesh__D041965smesh__D041963
% 209.18/209.38 |- mesh__dateCreated mesh__D046650 2004-07-07
% 209.18/209.38 |- mesh__historyNote mesh__D046650 2005
% 209.18/209.38 |- mesh__recordMaintainer mesh__D046650 jls
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D046650 2005
% 209.18/209.38 |- skos__historyNote mesh__D046650 Subject Headings %28%1969-2004%29%
% 209.18/209.38 |- skos__scopeNote mesh__D046650
% 209.18/209.38 Controlled vocabulary thesaurus produced by the NATIONAL LIBRARY OF MEDICINE. It consists of sets of terms naming descriptors in a hierarchical structure that permits searching at various levels of specificity.%A%
% 209.18/209.38 |- skos__hiddenLabel mesh__D046650 Medical Subject Heading
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D046650 jls
% 209.18/209.38 |- mesh__recordOriginator mesh__D046650 ags
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D046650 2005
% 209.18/209.38 |- mesh__dateEstablished mesh__D046650 2005-01-01
% 209.18/209.38 |- skos__broader mesh__D046650smesh__D013358
% 209.18/209.38 |- skos__hiddenLabel mesh__D046650 Subject Headings, Medical
% 209.18/209.38 |- skos__prefLabel mesh__D046650 Medical Subject Headings
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D046650 2005A
% 209.18/209.38 |- skos__hiddenLabel mesh__D046650 Subject Heading, Medical
% 209.18/209.38 |- skos__related mesh__D046650smesh__D016239
% 209.18/209.38 |- mesh__dateRevised mesh__D046650 2004-11-15
% 209.18/209.38 |- rdf__type mesh__D046650sskos__Concept
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D046650 2006
% 209.18/209.38 |- skos__altLabel mesh__D046650 MeSH Headings
% 209.18/209.38 |- skos__annotation mesh__D046650 CATALOG: use NAF entry
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013476 2005
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013476 2006
% 209.18/209.38 |- mesh__recordMaintainer mesh__D013476 lkt
% 209.18/209.38 |- mesh__recordOriginator mesh__D013476 NLM
% 209.18/209.38 |- skos__scopeNote mesh__D013476
% 209.18/209.38 The FERTILIZATION of an OVUM that takes place when a FETUS is already present in the UTERUS. Superfetation results in an unusual PREGNANCY with fetuses of different ages and sizes developing in utero simultaneously.%A%
% 209.18/209.38 |- skos__broader mesh__D013476smesh__D011272
% 209.18/209.38 |- skos__prefLabel mesh__D013476 Superfetation
% 209.18/209.38 |- skos__hiddenLabel mesh__D013476 Superfetations
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D013476 sjn
% 209.18/209.38 |- mesh__dateCreated mesh__D013476 1999-01-01
% 209.18/209.38 |- mesh__dateRevised mesh__D013476 2004-07-07
% 209.18/209.38 |- rdf__type mesh__D013476sskos__Concept
% 209.18/209.38 |- skos__hiddenLabel mesh__D007439 Introversions %28%Psychology%29%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 1997
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D007439 PLS
% 209.18/209.38 |- skos__broader mesh__D007439smesh__D010553
% 209.18/209.38 |- mesh__recordMaintainer mesh__D007439 JLS
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 2001
% 209.18/209.38 |- rdf__type mesh__D007439sskos__Concept
% 209.18/209.38 |- skos__historyNote mesh__D007439 Personality %28%1966-1967%29%
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D007439 68
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 2002
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 1994
% 209.18/209.38 |- skos__annotation mesh__D007439 no qualif; DF: INTROVERSION
% 209.18/209.38 |- mesh__dateRevised mesh__D007439 1993-06-04
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 2005
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 1995
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 2006
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 2003
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 1998
% 209.18/209.38 |- mesh__dateCreated mesh__D007439 1999-01-01
% 209.18/209.38 |- skos__altLabel mesh__D007439 Introversion
% 209.18/209.38 |- mesh__dateEstablished mesh__D007439 1968-01-01
% 209.18/209.38 |- mesh__recordOriginator mesh__D007439 NLM
% 209.18/209.38 |- mesh__historyNote mesh__D007439 68
% 209.18/209.38 |- skos__prefLabel mesh__D007439 Introversion %28%Psychology%29%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 2004
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 1999
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 1996
% 209.18/209.38 |- skos__broader mesh__D007439smesh__D011574
% 209.18/209.38 |- skos__scopeNote mesh__D007439
% 209.18/209.38 A state in which attention is largely directed inward upon one%27%s self.%A%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D007439 2000
% 209.18/209.38 |- mesh__onlineNote mesh__D018161
% 209.18/209.38 use RECEPTORS, MINERALOCORTICOID %28%NM%29% to search MINERALOCORTICOID RECEPTORS 1980-93%A%
% 209.18/209.38 |- skos__altLabel mesh__D018161 Mineralocorticoid Receptor
% 209.18/209.38 |- mesh__historyNote mesh__D018161
% 209.18/209.38 94; was MINERALOCORTICOID RECEPTOR %28%NM%29% 1980-93
% 209.18/209.38 |- skos__altLabel mesh__D018161 Corticoid I Receptor
% 209.18/209.38 |- mesh__dateEstablished mesh__D018161 1994-01-01
% 209.18/209.38 |- skos__historyNote mesh__D018161 Receptors, Steroid %28%1980-1993%29%
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D018161
% 209.18/209.38 94; MINERALOCORTICOID RECEPTOR was indexed under RECEPTORS, STEROID 1980-93%A%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 2002
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 2003
% 209.18/209.38 |- skos__prefLabel mesh__D018161 Receptors, Mineralocorticoid
% 209.18/209.38 |- skos__broader mesh__D018161smesh__D011987
% 209.18/209.38 |- skos__hiddenLabel mesh__D018161 Mineralocorticoids Receptors
% 209.18/209.38 |- mesh__recordMaintainer mesh__D018161 KEV
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 2005
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 2004
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D018161 PLS
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 1996
% 209.18/209.38 |- mesh__dateRevised mesh__D018161 1995-06-08
% 209.18/209.38 |- skos__hiddenLabel mesh__D018161 Receptor, Mineralocorticoid
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 2000
% 209.18/209.38 |- skos__scopeNote mesh__D018161
% 209.18/209.38 Cytoplasmic proteins that specifically bind mineralocorticoids and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA. Mineralocorticoids were named for their actions on extracellular electrolyte concentrations. The most important example is aldosterone.%A%
% 209.18/209.38 |- skos__hiddenLabel mesh__D018161 Receptor, Corticoid I
% 209.18/209.38 |- skos__altLabel mesh__D018161 Corticoid Type I Receptors
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 2006
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 1998
% 209.18/209.38 |- mesh__dateCreated mesh__D018161 1993-06-21
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 1997
% 209.18/209.38 |- skos__annotation mesh__D018161
% 209.18/209.38 coord IM with specific mineralocorticoid %28%IM%29%; DF: RECEPT MINERALOCORTICOID%A%
% 209.18/209.38 |- skos__hiddenLabel mesh__D018161 Corticoid I Receptors
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 2001
% 209.18/209.38 |- skos__altLabel mesh__D018161 Mineralocorticoid Receptors
% 209.18/209.38 |- skos__altLabel mesh__D018161 Receptors, Mineralocorticoids
% 209.18/209.38 |- skos__altLabel mesh__D018161 Receptors, Corticoid I
% 209.18/209.38 |- mesh__recordOriginator mesh__D018161 RAZ
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018161 1999
% 209.18/209.38 |- rdf__type mesh__D018161sskos__Concept
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D004141 2004
% 209.18/209.38 |- mesh__recordMaintainer mesh__D004141 ags
% 209.18/209.38 |- mesh__onlineNote mesh__D004141
% 209.18/209.38 use DINOFLAGELLIDA to search DINOFLAGELLATES 1975-85 %26% use MASTIGOPHORA 1969-74; use DINOFLAGELLIDA to search RED TIDE 1975 %26% use MASTIGOPHORA 1974; use DINOFLAGELLIDA to search GONYAULAX, GYMNODINIUM %26% PERIDINIUM 1979-85%A%
% 209.18/209.38 |- mesh__historyNote mesh__D004141
% 209.18/209.38 86; was DINOFLAGELLATES 1979-85, was DINOFLAGELLATES see under MASTIGOPHORA 1969-78; RED TIDE was heading 1979-85, was see under MASTIGOPHORA 1974-78; GONYAULAX, GYMNODINIUM %26% PERIDINIUM were see RED TIDE 1979-85%A%
% 209.18/209.38 |- skos__altLabel mesh__D004141 Dinoflagellates
% 209.18/209.38 |- skos__prefLabel mesh__D004141 Dinoflagellida
% 209.18/209.38 |- skos__related mesh__D004141smesh__D012530
% 209.18/209.38 |- rdf__type mesh__D004141sskos__Concept
% 209.18/209.38 |- skos__scopeNote mesh__D004141
% 209.18/209.38 Protozoans of the class PHYTOMASTIGOPHOREA, found mainly in the oceans. They are characterized by the presence of transverse and longitudinal flagella which propel the organisms in a rotating manner through the water.%A%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D004141 2005
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D004141
% 209.18/209.38 86; was DINOFLAGELLATES 1979-85, was DINOFLAGELLATES see under MASTIGOPHORA 1969-78; RED TIDE was heading 1979-85, was see under MASTIGOPHORA 1974-78; GONYAULAX, GYMNODINIUM %26% PERIDINIUM were see RED TIDE 1979-85%A%
% 209.18/209.38 |- skos__historyNote mesh__D004141 Mastigophora %28%1966-1974%29%
% 209.18/209.38 |- mesh__dateRevised mesh__D004141 2003-07-09
% 209.18/209.38 |- skos__related mesh__D004141smesh__D010839
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D004141 2006
% 209.18/209.38 |- mesh__recordOriginator mesh__D004141 NLM
% 209.18/209.38 |- skos__broader mesh__D004141smesh__D016821
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D004141 sjn
% 209.18/209.38 |- mesh__dateCreated mesh__D004141 1999-01-01
% 209.18/209.38 |- mesh__dateEstablished mesh__D004141 1979-01-01
% 209.18/209.38 |- skos__hiddenLabel mesh__D017867
% 209.18/209.38 Cyclic Nucleotide Regulated Protein Kinases
% 209.18/209.38 |- mesh__dateCreated mesh__D017867 1993-08-26
% 209.18/209.38 |- mesh__dateEstablished mesh__D017867 1998-01-01
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D017867 2005
% 209.18/209.38 |- mesh__recordMaintainer mesh__D017867 jmp
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D017867 98
% 209.18/209.38 |- mesh__dateRevised mesh__D017867 2004-07-07
% 209.18/209.38 |- skos__annotation mesh__D017867
% 209.18/209.38 GEN; prefer specifics; used for mapping supplementary chemicals; DF: CYCL NUC REG KINASES%A%
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D017867 sjn
% 209.18/209.38 |- skos__broader mesh__D017867smesh__D017346
% 209.18/209.38 |- rdf__type mesh__D017867sskos__Concept
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D017867 2006
% 209.18/209.38 |- mesh__historyNote mesh__D017867 98; use explode 1994-97
% 209.18/209.38 |- skos__broader mesh__D017867smesh__D047908
% 209.18/209.38 |- skos__historyNote mesh__D017867 Protein Kinases %28%1973-1993%29%
% 209.18/209.38 |- mesh__recordOriginator mesh__D017867 TPW
% 209.18/209.38 |- skos__prefLabel mesh__D017867
% 209.18/209.38 Cyclic Nucleotide-Regulated Protein Kinases
% 209.18/209.38 |- skos__scopeNote mesh__D017867
% 209.18/209.38 A group of enzymes that catalyzes the phosphorylation of serine or threonine residues of proteins and is dependent on cyclic nucleotides.%A%
% 209.18/209.38 |- skos__altLabel mesh__D003847 2-Deoxyglucose
% 209.18/209.38 |- skos__scopeNote mesh__D003847
% 209.18/209.38 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.%A%
% 209.18/209.38 |- skos__hiddenLabel mesh__D003847 2 Deoxy D glucose
% 209.18/209.38 |- skos__hiddenLabel mesh__D003847 2 Desoxy D glucose
% 209.18/209.38 |- mesh__historyNote mesh__D003847
% 209.18/209.38 91%28%75%29%; was see under DEOXY SUGARS 1975-90; was see under GLUCOSE 1973-74; was see under HEXOSES 1967-72%A%
% 209.18/209.38 |- mesh__onlineNote mesh__D003847
% 209.18/209.38 use GLUCOSE to search DEOXYGLUCOSE 1973-74 %26% use HEXOSES 1967-72%A%
% 209.18/209.38 |- skos__prefLabel mesh__D003847 Deoxyglucose
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003847 2005
% 209.18/209.38 |- skos__altLabel mesh__D003847 2-Deoxy-D-glucose
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D003847
% 209.18/209.38 91; was see under DEOXY SUGARS 1975-90; was see under GLUCOSE 1973-74; was see under HEXOSES 1967-72%A%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003847 2006
% 209.18/209.38 |- skos__hiddenLabel mesh__D003847 2 Deoxyglucose
% 209.18/209.38 |- mesh__recordMaintainer mesh__D003847 ssb
% 209.18/209.38 |- mesh__dateRevised mesh__D003847 2004-07-07
% 209.18/209.38 |- skos__annotation mesh__D003847
% 209.18/209.38 /blood = DEOXYGLUCOSE /blood %28%NIM%29% + BLOOD GLUCOSE %28%IM%29%; do not use /defic /physiol%A%
% 209.18/209.38 |- skos__altLabel mesh__D003847 2-Desoxy-D-glucose
% 209.18/209.38 |- mesh__recordOriginator mesh__D003847 NLM
% 209.18/209.38 |- mesh__dateCreated mesh__D003847 1999-01-01
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D003847 sjn
% 209.18/209.38 |- rdf__type mesh__D003847sskos__Concept
% 209.18/209.38 |- skos__broader mesh__D003847smesh__D003837
% 209.18/209.38 |- mesh__dateEstablished mesh__D003847 1991-01-01
% 209.18/209.38 |- skos__hiddenLabel mesh__D036223 Kinase HEK2, Receptor-Tyrosine
% 209.18/209.38 |- skos__hiddenLabel mesh__D036223 HEK2, Receptor-Tyrosine Kinase
% 209.18/209.38 |- mesh__recordMaintainer mesh__D036223 jmp
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D036223 sjn
% 209.18/209.38 |- rdf__type mesh__D036223sskos__Concept
% 209.18/209.38 |- mesh__dateRevised mesh__D036223 2005-06-30
% 209.18/209.38 |- mesh__dateCreated mesh__D036223 2002-07-03
% 209.18/209.38 |- skos__scopeNote mesh__D036223
% 209.18/209.38 An eph family receptor found in a number of tissues including BRAIN; LUNG; KIDNEY; PANCREAS; INTESTINE; and HEART. During embryogenesis EphB3 receptor is expressed at high levels in the brain.%A%
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D036223
% 209.18/209.38 2003; CEK10 PROTEIN %28%now RECEPTOR, EPHB3%29% was indexed under PROTEIN-TYROSINE KINASE 1993-2002, EPHB3 RECEPTOR was indexed under RECEPTOR PROTEIN TYROSINE KINASES 2001-2002%A%
% 209.18/209.38 |- skos__altLabel mesh__D036223 HEK2 Protein
% 209.18/209.38 |- skos__historyNote mesh__D036223
% 209.18/209.38 Receptor Protein-Tyrosine Kinases %28%2001-2002%29%
% 209.18/209.38 |- skos__altLabel mesh__D036223 Cek10 Protein
% 209.18/209.38 |- skos__hiddenLabel mesh__D036223 Receptor Tyrosine Kinase HEK2
% 209.18/209.38 |- skos__broader mesh__D036223smesh__D036081
% 209.18/209.38 |- mesh__recordOriginator mesh__D036223 jmp
% 209.18/209.38 |- skos__altLabel mesh__D036223 Receptor-Tyrosine Kinase HEK2
% 209.18/209.38 |- mesh__dateEstablished mesh__D036223 2003-01-01
% 209.18/209.38 |- skos__prefLabel mesh__D036223 Receptor, EphB3
% 209.18/209.38 |- skos__altLabel mesh__D036223 EphB3 Receptor
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D036223 2006
% 209.18/209.38 |- mesh__historyNote mesh__D036223
% 209.18/209.38 2003; use RECEPTOR, EPHB3 %28%NM%29% 1993-2002; for EPHB3 RECEPTOR use RECEPTORS, EPH FAMILY %28%NM%29% 2001-2002%A%
% 209.18/209.38 |- skos__historyNote mesh__D036223
% 209.18/209.38 Protein-Tyrosine Kinase %28%1993-2002%29%
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D003049 75
% 209.18/209.38 |- mesh__dateRevised mesh__D003049 2003-07-09
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003049 2005
% 209.18/209.38 |- skos__broader mesh__D003049smesh__D000981
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003049 2006
% 209.18/209.38 |- mesh__recordOriginator mesh__D003049 NLM
% 209.18/209.38 |- mesh__dateEstablished mesh__D003049 1975-09-01
% 209.18/209.38 |- skos__scopeNote mesh__D003049
% 209.18/209.38 Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals.%A%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D003049 2004
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D003049 sjn
% 209.18/209.38 |- mesh__historyNote mesh__D003049 75
% 209.18/209.38 |- skos__hiddenLabel mesh__D003049 Agents, Anticoccidial
% 209.18/209.38 |- rdf__type mesh__D003049sskos__Concept
% 209.18/209.38 |- skos__annotation mesh__D003049
% 209.18/209.38 consider also COCCIDIA /drug eff %26% COCCIDIOSIS /drug ther %28%%26% not COCCIDIOIDES %26% COCCIDIOIDOMYCOSIS%29%%A%
% 209.18/209.38 |- mesh__recordMaintainer mesh__D003049 ssb
% 209.18/209.38 |- mesh__dateCreated mesh__D003049 1974-11-19
% 209.18/209.38 |- skos__historyNote mesh__D003049 Antiprotozoal Agents %28%1969-1974%29%
% 209.18/209.38 |- skos__prefLabel mesh__D003049 Coccidiostats
% 209.18/209.38 |- mesh__recordMaintainer mesh__D008532 lkt
% 209.18/209.38 |- rdf__type mesh__D008532sskos__Concept
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D008532 sjn
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D008532 2004
% 209.18/209.38 |- skos__scopeNote mesh__D008532
% 209.18/209.38 An acute form of MEGACOLON, severe pathological dilatation of the COLON. It is associated with clinical conditions such as ULCERATIVE COLITIS; CROHN DISEASE; AMEBIC DYSENTERY; or CLOSTRIDIUM ENTEROCOLITIS.%A%
% 209.18/209.38 |- mesh__recordOriginator mesh__D008532 NLM
% 209.18/209.38 |- mesh__historyNote mesh__D008532
% 209.18/209.38 91%28%75%29%%28%64-66%29%; was see under COLITIS, ULCERATIVE 1964-90 %28%Prov 1964-66%29%%A%
% 209.18/209.38 |- skos__broader mesh__D008532smesh__D008531
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D008532
% 209.18/209.38 91; was see under COLITIS, ULCERATIVE 1967-90
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D008532 2005
% 209.18/209.38 |- mesh__onlineNote mesh__D008532
% 209.18/209.38 use COLITIS, ULCERATIVE to search MEGACOLON, TOXIC 1966-74%A%
% 209.18/209.38 |- mesh__dateRevised mesh__D008532 2003-07-09
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D008532 2006
% 209.18/209.38 |- mesh__dateEstablished mesh__D008532 1991-01-01
% 209.18/209.38 |- skos__altLabel mesh__D008532 Toxic Megacolon
% 209.18/209.38 |- mesh__dateCreated mesh__D008532 1999-01-01
% 209.18/209.38 |- skos__prefLabel mesh__D008532 Megacolon, Toxic
% 209.18/209.38 |- skos__altLabel mesh__D013477 Optic Tectum
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 1999
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 2004
% 209.18/209.38 |- mesh__historyNote mesh__D013477 71
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 1995
% 209.18/209.38 |- rdf__type mesh__D013477sskos__Concept
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 2000
% 209.18/209.38 |- skos__altLabel mesh__D013477 Tectum, Optic
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 1998
% 209.18/209.38 |- mesh__dateCreated mesh__D013477 1999-01-01
% 209.18/209.38 |- skos__historyNote mesh__D013477 Corpora Quadrigemina %28%1966-1970%29%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 2003
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 1994
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 2006
% 209.18/209.38 |- mesh__dateEstablished mesh__D013477 1971-01-01
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D013477 PLS
% 209.18/209.38 |- mesh__recordMaintainer mesh__D013477 TAP
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 2002
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D013477 71
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 2005
% 209.18/209.38 |- mesh__dateRevised mesh__D013477 1992-05-18
% 209.18/209.38 |- mesh__recordOriginator mesh__D013477 NLM
% 209.18/209.38 |- skos__prefLabel mesh__D013477 Superior Colliculus
% 209.18/209.38 |- skos__hiddenLabel mesh__D013477 Optic Tectums
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 1997
% 209.18/209.38 |- skos__altLabel mesh__D013477 Colliculus, Superior
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 1993
% 209.18/209.38 |- skos__hiddenLabel mesh__D013477 Tectums, Optic
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 1996
% 209.18/209.38 |- skos__broader mesh__D013477smesh__D003336
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D013477 2001
% 209.18/209.38 |- skos__hiddenLabel mesh__D018960 Receptor, Hyaluronan
% 209.18/209.38 |- mesh__dateEstablished mesh__D018960 1996-01-01
% 209.18/209.38 |- skos__altLabel mesh__D018960 CD44 Antigen
% 209.18/209.38 |- mesh__historyNote mesh__D018960
% 209.18/209.38 96; was HYALURONIC ACID BINDING PROTEIN %28%NM%29% 1980-95; CD44 ANTIGENS was see RECEPTORS, LYMPHOCYTE HOMING 1992-93; CD44 ANTIGEN was see RECEPTORS, LYMPHOCYTE HOMING 1991-92%A%
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018960 2006
% 209.18/209.38 |- mesh__recordMaintainer mesh__D018960 ssb
% 209.18/209.38 |- rdf__type mesh__D018960sskos__Concept
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D018960
% 209.18/209.38 96; HYALURONIC ACID BINDING PROTEIN was indexed under CARRIER PROTEINS 1980-95; RECEPTORS, LYPHOCYTE HOMING 1991-95%A%
% 209.18/209.38 |- skos__prefLabel mesh__D018960 Antigens, CD44
% 209.18/209.38 |- skos__annotation mesh__D018960 lymphocyte homing receptors
% 209.18/209.38 |- skos__altLabel mesh__D018960 Hyaluronan-Binding Protein
% 209.18/209.38 |- mesh__onlineNote mesh__D018960
% 209.18/209.38 use ANTIGENS, CD44 %28%NM%29% to search HYALURONIC ACID BINDING PROTEIN 1980-95; use RECEPTORS, LYMPHOCYTE HOMING to search CD44 ANTIGENS 1992-93 %26% CD44 ANTIGEN 1991-92%A%
% 209.18/209.38 |- skos__altLabel mesh__D018960 Hyaluronic Acid Binding Protein
% 209.18/209.38 |- mesh__dateRevised mesh__D018960 2005-06-30
% 209.18/209.38 |- skos__broader mesh__D018960smesh__D016201
% 209.18/209.38 |- skos__historyNote mesh__D018960 Carrier Proteins %28%1980-1995%29%
% 209.18/209.38 |- skos__hiddenLabel mesh__D018960 Hyaluronan Binding Protein
% 209.18/209.38 |- skos__altLabel mesh__D018960 CD44 Antigens
% 209.18/209.38 |- skos__historyNote mesh__D018960
% 209.18/209.38 Receptors, Cell Surface %28%1984-1995%29%
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D018960 sjn
% 209.18/209.38 |- skos__altLabel mesh__D018960 Hyaluronan Receptor
% 209.18/209.38 |- skos__hiddenLabel mesh__D018960 Antigen, CD44
% 209.18/209.38 |- skos__altLabel mesh__D018960 Receptors, Hyaluronan
% 209.18/209.38 |- skos__scopeNote mesh__D018960
% 209.18/209.38 Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary thymocytes, granulocytes, macrophages, erythrocytes, and fibroblasts. CD44 antigens are the principle cell surface receptors for hyaluronate and this interaction mediates binding of lymphocytes to high endothelial venules. %28%From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156%29%%A%
% 209.18/209.38 |- skos__altLabel mesh__D018960 Hyaluronan Receptors
% 209.18/209.38 |- skos__historyNote mesh__D018960
% 209.18/209.38 Receptors, Lymphocyte Homing %28%1991-1995%29%
% 209.18/209.38 |- mesh__recordOriginator mesh__D018960 AGS
% 209.18/209.38 |- mesh__dateCreated mesh__D018960 1995-05-26
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018162 2002
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018162 2005
% 209.18/209.38 |- mesh__dateCreated mesh__D018162 1993-06-04
% 209.18/209.38 |- mesh__recordOriginator mesh__D018162 AGS
% 209.18/209.38 |- rdf__type mesh__D018162sskos__Concept
% 209.18/209.38 |- mesh__recordMaintainer mesh__D018162 ags
% 209.18/209.38 |- mesh__dateEstablished mesh__D018162 1994-01-01
% 209.18/209.38 |- skos__prefLabel mesh__D018162 Coltivirus
% 209.18/209.38 |- skos__annotation mesh__D018162
% 209.18/209.38 infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%
% 209.18/209.38 |- skos__broader mesh__D018162smesh__D012087
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018162 2004
% 209.18/209.38 |- skos__hiddenLabel mesh__D018162 Coltiviruses
% 209.18/209.38 |- skos__scopeNote mesh__D018162
% 209.18/209.38 A genus of REOVIRIDAE infecting Ixodidae ticks and transmitted by them to humans, deer, and small animals. The type species is COLORADO TICK FEVER VIRUS.%A%
% 209.18/209.38 |- mesh__historyNote mesh__D018162 94
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018162 2003
% 209.18/209.38 |- mesh__dateRevised mesh__D018162 2001-07-25
% 209.18/209.38 |- mesh__publicMeSHNote mesh__D018162 94
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D018162 sjn
% 209.18/209.38 |- mesh__activeMeSHYear mesh__D018162 2006
% 209.18/209.38 |- mesh__recordAuthorizer mesh__D004940 sjn
% 209.18/209.38 |- mesh__recordMaintainer mesh__D004940 lkt
% 209.18/209.38 |- mesh__dateCreated mesh__D004940 1999-01-01
% 209.18/209.38 |- skos__altLabel mesh__D004940 Stenosis, Esophageal
% 209.18/209.39 |- skos__hiddenLabel mesh__D004940 Esophageal Stenoses
% 209.18/209.39 |- rdf__type mesh__D004940sskos__Concept
% 209.18/209.39 |- skos__annotation mesh__D004940
% 209.18/209.39 caustic stenosis is indexed ESOPHAGEAL STENOSIS /chem ind + BURNS, CHEMICAL%A%
% 209.18/209.39 |- mesh__dateRevised mesh__D004940 2004-07-07
% 209.18/209.39 |- skos__hiddenLabel mesh__D004940 Stenoses, Esophageal
% 209.18/209.39 |- skos__broader mesh__D004940smesh__D004935
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004940 2005
% 209.18/209.39 |- skos__scopeNote mesh__D004940
% 209.18/209.39 A stricture of the ESOPHAGUS. Most are acquired but can be congenital.%A%
% 209.18/209.39 |- skos__hiddenLabel mesh__D004940 Stricture, Esophageal
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004940 2006
% 209.18/209.39 |- skos__altLabel mesh__D004940 Esophageal Stricture
% 209.18/209.39 |- mesh__recordOriginator mesh__D004940 NLM
% 209.18/209.39 |- skos__prefLabel mesh__D004940 Esophageal Stenosis
% 209.18/209.39 |- skos__altLabel mesh__D051596 Hippocalcin-Like Protein 3
% 209.18/209.39 |- skos__hiddenLabel mesh__D051596 Hippocalcin Like Protein 3
% 209.18/209.39 |- mesh__dateCreated mesh__D051596 2005-06-30
% 209.18/209.39 |- skos__hiddenLabel mesh__D051596 Visinin Like 1 Protein
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D051596 sjn
% 209.18/209.39 |- rdf__type mesh__D051596sskos__Concept
% 209.18/209.39 |- skos__broader mesh__D051596smesh__D051580
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D051596
% 209.18/209.39 2006; NEUROCALCIN was indexed under RECEPTORS, CALCIUM-SENSING 2004-2005, under NERVE TISSUE PROTEINS 1992-2005, %26% under CALCIUM-BINDING PROTEINS 1992-2003%A%
% 209.18/209.39 |- skos__altLabel mesh__D051596 Visinin-Like Protein
% 209.18/209.39 |- mesh__recordMaintainer mesh__D051596 DRC
% 209.18/209.39 |- skos__prefLabel mesh__D051596 Neurocalcin
% 209.18/209.39 |- mesh__recordOriginator mesh__D051596 DRC
% 209.18/209.39 |- skos__altLabel mesh__D051596 Visinin-Like 1 Protein
% 209.18/209.39 |- mesh__dateEstablished mesh__D051596 2006-01-01
% 209.18/209.39 |- skos__scopeNote mesh__D051596
% 209.18/209.39 A neuronal calcium sensor protein that is expressed as several isoforms and can interact with ACTIN; TUBULIN; and CLATHRIN.%A%
% 209.18/209.39 |- skos__hiddenLabel mesh__D051596 Visinin Like Protein
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D051596 2006
% 209.18/209.39 |- mesh__historyNote mesh__D051596 2006%28%1992%29%
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868 Kinases, cAMP-Dependent Protein
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868
% 209.18/209.39 Protein Kinase Type II, Cyclic AMP Dependent
% 209.18/209.39 |- skos__altLabel mesh__D017868 Protein Kinase A
% 209.18/209.39 |- skos__prefLabel mesh__D017868 Cyclic AMP-Dependent Protein Kinases
% 209.18/209.39 |- skos__annotation mesh__D017868 DF: CAMP PROTEIN KINASES
% 209.18/209.39 |- skos__altLabel mesh__D017868 cAMP-Dependent Protein Kinases
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D017868 sjn
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868 Protein Kinase, cAMP-Dependent
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868 Cyclic AMP Dependent Protein Kinase
% 209.18/209.39 |- rdf__type mesh__D017868sskos__Concept
% 209.18/209.39 |- mesh__recordMaintainer mesh__D017868 jmp
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868
% 209.18/209.39 Adenosine Cyclic Monophosphate Dependent Protein Kinases
% 209.18/209.39 |- mesh__dateRevised mesh__D017868 2004-07-07
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D017868 2005
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868 Protein Kinases, cAMP-Dependent
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868 cAMP Dependent Protein Kinase
% 209.18/209.39 |- skos__scopeNote mesh__D017868
% 209.18/209.39 A group of enzymes that are dependent on cyclic AMP and catalyze the phosphorylation of serine or threonine residues on proteins.%A%
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868 Kinase, cAMP-Dependent Protein
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D017868 2006
% 209.18/209.39 |- mesh__dateCreated mesh__D017868 1993-06-21
% 209.18/209.39 |- skos__altLabel mesh__D017868
% 209.18/209.39 Adenosine Cyclic Monophosphate-Dependent Protein Kinases
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D017868
% 209.18/209.39 94; was CYCLIC AMP-DEPENDENT PROTEIN KINASE see PROTEIN KINASES 1984-93%A%
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868 cAMP Dependent Protein Kinases
% 209.18/209.39 |- mesh__recordOriginator mesh__D017868 TPW
% 209.18/209.39 |- skos__broader mesh__D017868smesh__D017867
% 209.18/209.39 |- mesh__onlineNote mesh__D017868
% 209.18/209.39 use PROTEIN KINASES to search CYCLIC AMP-DEPENDENT PROTEIN KINASE 1984-93%A%
% 209.18/209.39 |- mesh__historyNote mesh__D017868
% 209.18/209.39 94; was CYCLIC AMP-DEPENDENT PROTEIN KINASE see PROTEIN KINASES 1984-93%A%
% 209.18/209.39 |- skos__altLabel mesh__D017868 Cyclic AMP-Dependent Protein Kinase
% 209.18/209.39 |- mesh__dateEstablished mesh__D017868 1994-01-01
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868 Cyclic AMP Dependent Protein Kinases
% 209.18/209.39 |- skos__hiddenLabel mesh__D017868
% 209.18/209.39 Catalytic Subunit Cyclic AMP Dependent Protein Kinase
% 209.18/209.39 |- skos__historyNote mesh__D017868 Protein Kinases %28%1973-1993%29%
% 209.18/209.39 |- skos__altLabel mesh__D017868 cAMP-Dependent Protein Kinase
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D042261 2005
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D042261 2004
% 209.18/209.39 |- rdf__type mesh__D042261sskos__Concept
% 209.18/209.39 |- skos__scopeNote mesh__D042261
% 209.18/209.39 Instruments for RETINOSCOPY that determines the refractive state of the EYE, such as the degree of NEARSIGHTEDNESS; FARSIGHTEDNESS; or ASTIGMATISM. In principle, a retinoscope provides a light source to illuminate the RETINA, and then locates the aerial image of the retina in space to obtain an index of the refractive quality of the patient%27%s lens system.%A%
% 209.18/209.39 |- skos__prefLabel mesh__D042261 Retinoscopes
% 209.18/209.39 |- mesh__historyNote mesh__D042261 2004
% 209.18/209.39 |- skos__broader mesh__D042261smesh__D019721
% 209.18/209.39 |- mesh__dateCreated mesh__D042261 2003-07-09
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D042261 2004
% 209.18/209.39 |- skos__altLabel mesh__D042261 Retinoscope
% 209.18/209.39 |- mesh__dateEstablished mesh__D042261 2004-01-01
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D042261 2006
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 2002
% 209.18/209.39 |- skos__hiddenLabel mesh__D003848 Phosphates, Deoxyguanosine
% 209.18/209.39 |- skos__broader mesh__D003848smesh__D003854
% 209.18/209.39 |- mesh__dateCreated mesh__D003848 1977-04-22
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 1996
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 1993
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 2005
% 209.18/209.39 |- skos__prefLabel mesh__D003848 Deoxyguanine Nucleotides
% 209.18/209.39 |- skos__annotation mesh__D003848 /biosyn /physiol permitted
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 1997
% 209.18/209.39 |- skos__historyNote mesh__D003848 Deoxyribonucleotides %28%1973-1977%29%
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 2006
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 2000
% 209.18/209.39 |- mesh__dateRevised mesh__D003848 1992-05-13
% 209.18/209.39 |- skos__broader mesh__D003848smesh__D006150
% 209.18/209.39 |- skos__altLabel mesh__D003848 Deoxyguanosine Phosphates
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 2003
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D003848 78
% 209.18/209.39 |- mesh__recordMaintainer mesh__D003848 TGC
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 2001
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 1994
% 209.18/209.39 |- rdf__type mesh__D003848sskos__Concept
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 2004
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D003848 PLS
% 209.18/209.39 |- mesh__historyNote mesh__D003848 78
% 209.18/209.39 |- skos__scopeNote mesh__D003848
% 209.18/209.39 Guanine nucleotides which contain deoxyribose as the sugar moiety.%A%
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 1998
% 209.18/209.39 |- mesh__recordOriginator mesh__D003848 RLS
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 1995
% 209.18/209.39 |- skos__hiddenLabel mesh__D003848 Nucleotides, Deoxyguanine
% 209.18/209.39 |- mesh__dateEstablished mesh__D003848 1978-01-01
% 209.18/209.39 |- skos__historyNote mesh__D003848 Guanine Nucleotides %28%1966-1977%29%
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D003848 1999
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D014570 2006
% 209.18/209.39 |- skos__hiddenLabel mesh__D014570 Urinary Tract Disease
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D014570 2003
% 209.18/209.39 |- skos__scopeNote mesh__D014570
% 209.18/209.39 Diseases of the urinary tract in both male and female. It does not include the male genitalia for which UROGENITAL DISEASES is used for general discussions of diseases of both the urinary tract and the genitalia.%A%
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D014570 sjn
% 209.18/209.39 |- skos__hiddenLabel mesh__D014570 Disease, Urinary Tract
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D014570 2005
% 209.18/209.39 |- skos__hiddenLabel mesh__D014570 Disease, Urological
% 209.18/209.39 |- skos__hiddenLabel mesh__D014570 Disease, Urologic
% 209.18/209.39 |- skos__altLabel mesh__D014570 Urinary Tract Diseases
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D014570 2002
% 209.18/209.39 |- skos__prefLabel mesh__D014570 Urologic Diseases
% 209.18/209.39 |- skos__annotation mesh__D014570
% 209.18/209.39 urinary tract dis only: do not confuse with UROGENITAL DISEASES which is uro + genital; GEN or unspecified: prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, UROLOGICAL; DF: UROL DIS%A%
% 209.18/209.39 |- skos__hiddenLabel mesh__D014570 Urologic Disease
% 209.18/209.39 |- skos__hiddenLabel mesh__D014570 Diseases, Urologic
% 209.18/209.39 |- skos__hiddenLabel mesh__D014570 Diseases, Urological
% 209.18/209.39 |- skos__hiddenLabel mesh__D014570 Diseases, Urinary Tract
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D014570 2001
% 209.18/209.39 |- mesh__recordOriginator mesh__D014570 NLM
% 209.18/209.39 |- mesh__dateRevised mesh__D014570 1999-11-03
% 209.18/209.39 |- mesh__historyNote mesh__D014570 65
% 209.18/209.39 |- mesh__dateEstablished mesh__D014570 1965-01-01
% 209.18/209.39 |- skos__hiddenLabel mesh__D014570 Urological Disease
% 209.18/209.39 |- rdf__type mesh__D014570sskos__Concept
% 209.18/209.39 |- mesh__dateCreated mesh__D014570 1999-01-01
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D014570 2000
% 209.18/209.39 |- skos__altLabel mesh__D014570 Urological Diseases
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D014570 2004
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D014570 65
% 209.18/209.39 |- skos__broader mesh__D014570smesh__D014569
% 209.18/209.39 |- mesh__recordMaintainer mesh__D014570 kle
% 209.18/209.39 |- rdf__type mesh__D036224sskos__Concept
% 209.18/209.39 |- skos__prefLabel mesh__D036224 Receptor, EphB4
% 209.18/209.39 |- skos__altLabel mesh__D036224 EPHB4 Protein
% 209.18/209.39 |- skos__scopeNote mesh__D036224
% 209.18/209.39 An eph family receptor found a variety of adult and embryonic tissues. Unlike the majority of proteins in this class there is little or no expression of EphB4 receptor in the BRAIN. It has been found at high levels in developing mammary glands and in invasive mammary tumors.%A%
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D036224
% 209.18/209.39 2003; HEPATOMA TRANSMEMBRANE KINASE %28%now RECEPTOR, EPHB4%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002; EPHB4 RECEPTOR was indexed under RECEPTOR PROTEIN TYROSINE-KINASE 2000-2002%A%
% 209.18/209.39 |- skos__hiddenLabel mesh__D036224 Kinase, Hepatoma Transmembrane
% 209.18/209.39 |- skos__historyNote mesh__D036224
% 209.18/209.39 Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 209.18/209.39 |- mesh__historyNote mesh__D036224
% 209.18/209.39 2003; use RECEPTOR, EPHB4 %28%NM%29% 1994-2002; for EPHB4 RECPTOR use RECEPTORS, EPH FAMILY 2000-2002%A%
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D036224 sjn
% 209.18/209.39 |- skos__hiddenLabel mesh__D036224 Transmembrane Kinase, Hepatoma
% 209.18/209.39 |- mesh__dateRevised mesh__D036224 2005-06-30
% 209.18/209.39 |- mesh__dateCreated mesh__D036224 2002-07-03
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D036224 2006
% 209.18/209.39 |- skos__altLabel mesh__D036224 Hepatoma Transmembrane Kinase
% 209.18/209.39 |- skos__broader mesh__D036224smesh__D036081
% 209.18/209.39 |- mesh__recordOriginator mesh__D036224 jmp
% 209.18/209.39 |- mesh__dateEstablished mesh__D036224 2003-01-01
% 209.18/209.39 |- skos__altLabel mesh__D036224 EphB4 Receptor
% 209.18/209.39 |- mesh__recordMaintainer mesh__D036224 jmp
% 209.18/209.39 |- skos__prefLabel mesh__D008533 Megakaryocytes
% 209.18/209.39 |- skos__hiddenLabel mesh__D008533 Megakaryocyte
% 209.18/209.39 |- skos__scopeNote mesh__D008533
% 209.18/209.39 Very large BONE MARROW CELLS which release mature BLOOD PLATELETS.%A%
% 209.18/209.39 |- mesh__recordMaintainer mesh__D008533 nns
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D008533 2005
% 209.18/209.39 |- mesh__dateRevised mesh__D008533 2003-07-09
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D008533 2006
% 209.18/209.39 |- mesh__dateCreated mesh__D008533 1999-01-01
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D008533 sjn
% 209.18/209.39 |- mesh__recordOriginator mesh__D008533 NLM
% 209.18/209.39 |- rdf__type mesh__D008533sskos__Concept
% 209.18/209.39 |- skos__broader mesh__D008533smesh__D015672
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D008533 2004
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D000550 sjn
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Suppression Amblyopias
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Amblyopias
% 209.18/209.39 |- rdf__type mesh__D000550sskos__Concept
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D000550 2006
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Suppression Amblyopia
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Lazy Eyes
% 209.18/209.39 |- skos__prefLabel mesh__D000550 Amblyopia
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Developmental Amblyopia
% 209.18/209.39 |- skos__scopeNote mesh__D000550
% 209.18/209.39 A nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.%A%
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Amblyopia, Anisometropic
% 209.18/209.39 |- skos__altLabel mesh__D000550 Amblyopia, Stimulus Deprivation-Induced
% 209.18/209.39 |- mesh__dateRevised mesh__D000550 2004-07-19
% 209.18/209.39 |- skos__broader mesh__D000550smesh__D014786
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Developmental Amblyopias
% 209.18/209.39 |- mesh__recordMaintainer mesh__D000550 jls
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Deprivation-Induced Amblyopias, Stimulus
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Anisometropic Amblyopias
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Amblyopias, Suppression
% 209.18/209.39 |- skos__broader mesh__D000550smesh__D001927
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Stimulus Deprivation Induced Amblyopia
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Amblyopias, Stimulus Deprivation-Induced
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Stimulus Deprivation-Induced Amblyopias
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Amblyopias, Developmental
% 209.18/209.39 |- mesh__dateCreated mesh__D000550 1999-01-01
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Amblyopias, Anisometropic
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Amblyopia, Stimulus Deprivation Induced
% 209.18/209.39 |- mesh__recordOriginator mesh__D000550 NLM
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Eye, Lazy
% 209.18/209.39 |- skos__altLabel mesh__D000550 Stimulus Deprivation-Induced Amblyopia
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D000550 2005
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Eyes, Lazy
% 209.18/209.39 |- skos__hiddenLabel mesh__D000550 Deprivation-Induced Amblyopia, Stimulus
% 209.18/209.39 |- mesh__recordMaintainer mesh__D013478 lkt
% 209.18/209.39 |- skos__scopeNote mesh__D013478
% 209.18/209.39 DUODENAL OBSTRUCTION by the superior mesenteric artery %28%MESENTERIC ARTERY, SUPERIOR%29% which travels in the root of the MESENTERY and crosses over the DUODENUM. The syndrome is characterized by the dilated proximal duodenum and STOMACH, bloating, ABDOMINAL CRAMPS, and VOMITING. Often it is observed in patient with body casts after spinal surgery.%A%
% 209.18/209.39 |- skos__altLabel mesh__D013478 Duodenal Compression Syndrome, Mesenteric
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D013478 2006
% 209.18/209.39 |- skos__historyNote mesh__D013478 Duodenal Obstruction %28%1966-1979%29%
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D013478 sjn
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D013478
% 209.18/209.39 91; was see under DUODENAL OBSTRUCTION 1980-90
% 209.18/209.39 |- mesh__dateRevised mesh__D013478 2003-07-09
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D013478 2005
% 209.18/209.39 |- skos__altLabel mesh__D013478 Mesenteric Duodenal Compression Syndrome
% 209.18/209.39 |- skos__hiddenLabel mesh__D013478 Syndrome, Cast
% 209.18/209.39 |- mesh__dateEstablished mesh__D013478 1991-01-01
% 209.18/209.39 |- mesh__historyNote mesh__D013478
% 209.18/209.39 91%28%80%29%; was see under DUODENAL OBSTRUCTION 1980-90
% 209.18/209.39 |- skos__historyNote mesh__D013478 Mesenteric Arteries %28%1966-1979%29%
% 209.18/209.39 |- mesh__dateCreated mesh__D013478 1979-05-30
% 209.18/209.39 |- skos__prefLabel mesh__D013478 Superior Mesenteric Artery Syndrome
% 209.18/209.39 |- skos__broader mesh__D013478smesh__D004380
% 209.18/209.39 |- mesh__recordOriginator mesh__D013478 SMH
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D013478 2004
% 209.18/209.39 |- skos__altLabel mesh__D013478 Cast Syndrome
% 209.18/209.39 |- rdf__type mesh__D013478sskos__Concept
% 209.18/209.39 |- skos__hiddenLabel mesh__D018961 Instructional Technologies
% 209.18/209.39 |- mesh__recordOriginator mesh__D018961 TGC
% 209.18/209.39 |- skos__scopeNote mesh__D018961
% 209.18/209.39 Systematic identification, development, organization, or utilization of educational resources and the management of these processes. It is occasionally used also in a more limited sense to describe the use of equipment-oriented techniques or audiovisual aids in educational settings. %28%Thesaurus of ERIC Descriptors, December 1993, p132%29%%A%
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D018961 96
% 209.18/209.39 |- skos__related mesh__D018961smesh__D013664
% 209.18/209.39 |- mesh__dateEstablished mesh__D018961 1996-01-01
% 209.18/209.39 |- skos__hiddenLabel mesh__D018961 Educational Technologies
% 209.18/209.39 |- mesh__recordMaintainer mesh__D018961 ags
% 209.18/209.39 |- skos__altLabel mesh__D018961 Technology, Educational
% 209.18/209.39 |- mesh__dateRevised mesh__D018961 2004-07-07
% 209.18/209.39 |- skos__broader mesh__D018961smesh__D013672
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D018961 2005
% 209.18/209.39 |- skos__hiddenLabel mesh__D018961 Technologies, Instructional
% 209.18/209.39 |- mesh__dateCreated mesh__D018961 1995-03-17
% 209.18/209.39 |- skos__annotation mesh__D018961
% 209.18/209.39 IM; coord with field or medium of educ %28%IM%29%; DF: EDUC TECHNOL%A%
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D018961 sjn
% 209.18/209.39 |- skos__hiddenLabel mesh__D018961 Technologies, Educational
% 209.18/209.39 |- skos__altLabel mesh__D018961 Technology, Instructional
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D018961 2006
% 209.18/209.39 |- skos__prefLabel mesh__D018961 Educational Technology
% 209.18/209.39 |- mesh__historyNote mesh__D018961 96
% 209.18/209.39 |- rdf__type mesh__D018961sskos__Concept
% 209.18/209.39 |- mesh__dateRevised mesh__D018163 2001-07-25
% 209.18/209.39 |- skos__historyNote mesh__D018163 RNA Viruses %28%1975-1977%29%
% 209.18/209.39 |- mesh__recordMaintainer mesh__D018163 ags
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D018163 sjn
% 209.18/209.39 |- skos__broader mesh__D018163smesh__D012087
% 209.18/209.39 |- mesh__historyNote mesh__D018163
% 209.18/209.39 1994; for CHANGUINOLA VIRUS use REOVIRIDAE 1976-1993; for CHENUDA VIRUS see REOVIRIDAE 1976-1993; for KEMEROVO VIRUS, REOVIRIDAE 1981-1990%A%
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D018163 2002
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D018163 2004
% 209.18/209.39 |- mesh__dateCreated mesh__D018163 1993-06-04
% 209.18/209.39 |- mesh__recordOriginator mesh__D018163 AGS
% 209.18/209.39 |- skos__hiddenLabel mesh__D018163 Orbiviruses
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D018163 2003
% 209.18/209.39 |- skos__prefLabel mesh__D018163 Orbivirus
% 209.18/209.39 |- mesh__dateEstablished mesh__D018163 1994-01-01
% 209.18/209.39 |- skos__annotation mesh__D018163
% 209.18/209.39 infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%
% 209.18/209.39 |- skos__scopeNote mesh__D018163
% 209.18/209.39 A genus of REOVIRIDAE infecting a wide range of arthropods and vertebrates including humans. It comprises at least twelve serological subgroups. Transmission is by vectors such as midges, mosquitoes, sandflies, and ticks.%A%
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D018163 2006
% 209.18/209.39 |- skos__historyNote mesh__D018163 Reoviridae %28%1976-1993%29%
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D018163
% 209.18/209.39 1994; for CHANGUINOLA VIRUS see REOVIRIDAE 1976-1993; for CHENUDA VIRUS see KEMEROVO VIRUS 1994-2001, see REOVIRIDAE 1976-1993; for KEMEROVO VIRUS see KEMEROVO VIRUS 1994-2001, see KEMEROVO GROUP VIRUSES 1979-1993, REOVIRIDAE 1981-1990, see REOVIRUSES 1975-1980%A%
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D018163 2005
% 209.18/209.39 |- rdf__type mesh__D018163sskos__Concept
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D010180 2005
% 209.18/209.39 |- mesh__dateEstablished mesh__D010180 1967-01-01
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D010180 1998
% 209.18/209.39 |- skos__related mesh__D010180smesh__D010193
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D010180 SJN
% 209.18/209.39 |- rdf__type mesh__D010180sskos__Concept
% 209.18/209.39 |- skos__prefLabel mesh__D010180 Pancreatectomy
% 209.18/209.39 |- skos__broader mesh__D010180smesh__D013505
% 209.18/209.39 |- mesh__recordMaintainer mesh__D010180 PXP
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D010180 2002
% 209.18/209.39 |- mesh__dateRevised mesh__D010180 1997-06-20
% 209.18/209.39 |- mesh__historyNote mesh__D010180 67%28%65%29%
% 209.18/209.39 |- mesh__recordOriginator mesh__D010180 NLM
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D010180 67
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D010180 2001
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D010180 2004
% 209.18/209.39 |- skos__scopeNote mesh__D010180
% 209.18/209.39 Surgical removal of the pancreas. %28%Dorland, 28th ed%29%
% 209.18/209.39 |- skos__hiddenLabel mesh__D010180 Pancreatectomies
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D010180 2000
% 209.18/209.39 |- skos__annotation mesh__D010180
% 209.18/209.39 do not use /util except by MeSH definition
% 209.18/209.39 |- mesh__dateCreated mesh__D010180 1999-01-01
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D010180 2006
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D010180 2003
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D010180 1999
% 209.18/209.39 |- skos__broader mesh__D004941smesh__D004935
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004941 2004
% 209.18/209.39 |- skos__annotation mesh__D004941 ESOPHAGITIS, PEPTIC is also available
% 209.18/209.39 |- mesh__recordOriginator mesh__D004941 NLM
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004941 2005
% 209.18/209.39 |- mesh__recordMaintainer mesh__D004941 lkt
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D004941 sjn
% 209.18/209.39 |- skos__broader mesh__D004941smesh__D005759
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004941 2006
% 209.18/209.39 |- skos__scopeNote mesh__D004941
% 209.18/209.39 INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.%A%
% 209.18/209.39 |- mesh__dateRevised mesh__D004941 2003-07-09
% 209.18/209.39 |- skos__prefLabel mesh__D004941 Esophagitis
% 209.18/209.39 |- mesh__dateCreated mesh__D004941 1999-01-01
% 209.18/209.39 |- skos__hiddenLabel mesh__D004941 Esophagitides
% 209.18/209.39 |- rdf__type mesh__D004941sskos__Concept
% 209.18/209.39 |- skos__prefLabel mesh__D051597 Hippocalcin
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D051597
% 209.18/209.39 2006; HIPPOCALCIN was indexed under CALCIUM-BINDING PROTEINS %26% NERVE TISSUE PROTEINS 1992-2005%A%
% 209.18/209.39 |- mesh__recordOriginator mesh__D051597 DRC
% 209.18/209.39 |- skos__altLabel mesh__D051597 Recoverin-Like Calcium-Binding Protein P23k
% 209.18/209.39 |- mesh__historyNote mesh__D051597 2006%28%1992%29%
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D051597 2006
% 209.18/209.39 |- skos__scopeNote mesh__D051597
% 209.18/209.39 A neuronal calcium-sensor protein that was initially found in the NEURONS of the HIPPOCAMPUS. It interacts with NEURONAL APOPTOSIS-INHIBITORY PROTEIN.%A%
% 209.18/209.39 |- mesh__dateCreated mesh__D051597 2005-06-30
% 209.18/209.39 |- skos__hiddenLabel mesh__D051597 P23k Recoverin Like Protein
% 209.18/209.39 |- skos__hiddenLabel mesh__D051597 Recoverin-Like Protein, P23k
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D051597 ags
% 209.18/209.39 |- mesh__dateEstablished mesh__D051597 2006-01-01
% 209.18/209.39 |- mesh__dateRevised mesh__D051597 2005-07-21
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D051597 2006A
% 209.18/209.39 |- skos__hiddenLabel mesh__D051597
% 209.18/209.39 Recoverin Like Calcium Binding Protein P23k
% 209.18/209.39 |- skos__altLabel mesh__D051597 P23k Recoverin-Like Protein
% 209.18/209.39 |- rdf__type mesh__D051597sskos__Concept
% 209.18/209.39 |- mesh__recordMaintainer mesh__D051597 ags
% 209.18/209.39 |- skos__broader mesh__D051597smesh__D051580
% 209.18/209.39 |- skos__historyNote mesh__D004143 Succinates %28%1966-1977%29%
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004143 2003
% 209.18/209.39 |- skos__hiddenLabel mesh__D004143 Sulfosuccinate, Dioctyl
% 209.18/209.39 |- skos__altLabel mesh__D004143 Docusate
% 209.18/209.39 |- skos__altLabel mesh__D004143 Sodium Dioctyl Sulfosuccinate
% 209.18/209.39 |- skos__altLabel mesh__D004143 DOSS
% 209.18/209.39 |- skos__scopeNote mesh__D004143
% 209.18/209.39 All-purpose surfactant, wetting agent, and solubilizer used in the drug, cosmetics, and food industries. It has also been used in laxatives and as cerumenolytics. It is usually administered as either the calcium, potassium, or sodium salt.%A%
% 209.18/209.39 |- skos__altLabel mesh__D004143 Docusate Sodium
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004143 2002
% 209.18/209.39 |- skos__hiddenLabel mesh__D004143 Sodium, Docusate
% 209.18/209.39 |- skos__altLabel mesh__D004143
% 209.18/209.39 Sodium Bis%28%2-ethylhexyl%29%sulfosuccinate
% 209.18/209.39 |- skos__historyNote mesh__D004143 Surface-Active Agents %28%1966-1977%29%
% 209.18/209.39 |- mesh__recordOriginator mesh__D004143 SH
% 209.18/209.39 |- skos__altLabel mesh__D004143 Sodium Dioctylsulphosuccinate
% 209.18/209.39 |- rdf__type mesh__D004143sskos__Concept
% 209.18/209.39 |- mesh__dateCreated mesh__D004143 1977-04-22
% 209.18/209.39 |- skos__hiddenLabel mesh__D004143 Sulfosuccinates, Dioctyl
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D004143 sjn
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004143 2006
% 209.18/209.39 |- skos__hiddenLabel mesh__D004143 Potassium, Docusate
% 209.18/209.39 |- skos__altLabel mesh__D004143 Docusate Potassium
% 209.18/209.39 |- skos__hiddenLabel mesh__D004143 Dioctylsulphosuccinate, Sodium
% 209.18/209.39 |- skos__altLabel mesh__D004143 Dioctyl Sulfosuccinate
% 209.18/209.39 |- skos__altLabel mesh__D004143 Dioctylsulfosuccinate
% 209.18/209.39 |- mesh__dateRevised mesh__D004143 2001-07-25
% 209.18/209.39 |- mesh__recordMaintainer mesh__D004143 ssb
% 209.18/209.39 |- skos__broader mesh__D004143smesh__D019822
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D004143
% 209.18/209.39 96; was DIOCTYL SULFOSUCCINATES 1978-95 %28%see under SUCCINATES 1978-90%29%; DIOCTYL SULFOSUCCINIC ACID was indexed under DIOCTYL SULFOSUCCINATES 1978-95; ALCOHOLS, OCTYL 1973-78; ALKYL SULFONATES 1974-76; %26% SUCCINATES 1968-78%A%
% 209.18/209.39 |- skos__altLabel mesh__D004143 Docusate Calcium
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004143 2005
% 209.18/209.39 |- mesh__dateEstablished mesh__D004143 1991-01-01
% 209.18/209.39 |- skos__hiddenLabel mesh__D004143 Calcium, Docusate
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D004143 2004
% 209.18/209.39 |- skos__hiddenLabel mesh__D004143 Dioctyl Sulfosuccinate, Sodium
% 209.18/209.39 |- mesh__historyNote mesh__D004143
% 209.18/209.39 96; was DIOCTYL SULFOSUCCINATES 1978-95 %28%see under SUCCINATES 1978-90%29%; DIOCTYL SULFOSUCCINIC ACID was NM 1968-95%A%
% 209.18/209.39 |- skos__prefLabel mesh__D004143 Dioctyl Sulfosuccinic Acid
% 209.18/209.39 |- skos__hiddenLabel mesh__D017869 Cyclic GMP Dependent Protein Kinases
% 209.18/209.39 |- mesh__dateEstablished mesh__D017869 1994-01-01
% 209.18/209.39 |- mesh__historyNote mesh__D017869
% 209.18/209.39 1994; for PROTEIN KINASE G use CYCLIC GMP-DEPENDENT PROTEIN KINASES %28%NM%29% 1999-2000%A%
% 209.18/209.39 |- skos__hiddenLabel mesh__D017869 Kinases, cGMP-Dependent Protein
% 209.18/209.39 |- rdf__type mesh__D017869sskos__Concept
% 209.18/209.39 |- mesh__recordMaintainer mesh__D017869 jmp
% 209.18/209.39 |- mesh__dateRevised mesh__D017869 2004-07-07
% 209.18/209.39 |- skos__altLabel mesh__D017869
% 209.18/209.39 Guanosine Cyclic 3%27%,5%27%-Phosphate-Dependent Protein Kinase
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D017869 2005
% 209.18/209.39 |- skos__hiddenLabel mesh__D017869 Cyclic GMP Dependent Protein Kinase
% 209.18/209.39 |- skos__hiddenLabel mesh__D017869
% 209.18/209.39 Guanosine Cyclic 3%27%,5%27% Phosphate Dependent Protein Kinase
% 209.18/209.39 |- mesh__activeMeSHYear mesh__D017869 2006
% 209.18/209.39 |- mesh__recordAuthorizer mesh__D017869 sjn
% 209.18/209.39 |- skos__broader mesh__D017869smesh__D017867
% 209.18/209.39 |- skos__altLabel mesh__D017869 Protein Kinase G
% 209.18/209.39 |- skos__prefLabel mesh__D017869 Cyclic GMP-Dependent Protein Kinases
% 209.18/209.39 |- skos__altLabel mesh__D017869
% 209.18/209.39 Guanosine Cyclic Monophosphate-Dependent Protein Kinases
% 209.18/209.39 |- skos__altLabel mesh__D017869 cGMP-Dependent Protein Kinases
% 209.18/209.39 |- mesh__dateCreated mesh__D017869 1993-06-04
% 209.18/209.39 |- skos__historyNote mesh__D017869 Protein Kinases %28%1982-1993%29%
% 209.18/209.39 |- skos__hiddenLabel mesh__D017869
% 209.18/209.39 Guanosine Cyclic Monophosphate Dependent Protein Kinases
% 209.18/209.39 |- skos__hiddenLabel mesh__D017869 Protein Kinases, cGMP-Dependent
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D017869
% 209.18/209.39 1994; PROTEIN KINASE G was indexed under PROTEIN KINASES 1999-2000%A%
% 209.18/209.39 |- skos__scopeNote mesh__D017869
% 209.18/209.39 A group of enzymes that are dependent on cyclic GMP and catalyzes the phosphorylation of serine or threonine residues of proteins.%A%
% 209.18/209.39 |- skos__altLabel mesh__D017869 Cyclic GMP-Dependent Protein Kinase
% 209.18/209.39 |- skos__hiddenLabel mesh__D017869 cGMP Dependent Protein Kinases
% 209.18/209.39 |- mesh__recordOriginator mesh__D017869 TPW
% 209.18/209.39 |- skos__hiddenLabel mesh__D042262 Shadow Tests
% 209.18/209.39 |- skos__broader mesh__D042262smesh__D009887
% 209.18/209.39 |- mesh__publicMeSHNote mesh__D042262 2004
% 209.18/209.39 |- skos__hiddenLabel mesh__D042262 Skiametries
% 209.18/209.40 |- mesh__dateCreated mesh__D042262 2003-07-09
% 209.18/209.40 |- skos__prefLabel mesh__D042262 Retinoscopy
% 209.18/209.40 |- skos__altLabel mesh__D042262 Skiametry
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D042262 2006
% 209.18/209.40 |- skos__altLabel mesh__D042262 Shadow Test
% 209.18/209.40 |- skos__hiddenLabel mesh__D042262 Retinoscopies
% 209.18/209.40 |- skos__scopeNote mesh__D042262
% 209.18/209.40 An objective determination of the refractive state of the eye %28%NEARSIGHTEDNESS; FARSIGHTEDNESS; ASTIGMATISM%29%. By using a RETINOSCOPE, the amount of correction and the power of lens needed can be determined.%A%
% 209.18/209.40 |- skos__related mesh__D042262smesh__D012029
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D042262 2005
% 209.18/209.40 |- skos__historyNote mesh__D042262 Refraction, Ocular %28%1966-2003%29%
% 209.18/209.40 |- mesh__historyNote mesh__D042262 2004
% 209.18/209.40 |- skos__altLabel mesh__D042262 Skiascopy
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D042262 2004
% 209.18/209.40 |- skos__hiddenLabel mesh__D042262 Skiascopies
% 209.18/209.40 |- rdf__type mesh__D042262sskos__Concept
% 209.18/209.40 |- mesh__dateEstablished mesh__D042262 2004-01-01
% 209.18/209.40 |- skos__annotation mesh__D003849 /biosyn /physiol permitted
% 209.18/209.40 |- skos__historyNote mesh__D003849 Deoxyribonucleosides %28%1973-1977%29%
% 209.18/209.40 |- mesh__dateRevised mesh__D003849 1990-05-30
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 2001
% 209.18/209.40 |- mesh__historyNote mesh__D003849 78
% 209.18/209.40 |- skos__broader mesh__D003849smesh__D003853
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 2003
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D003849 78
% 209.18/209.40 |- skos__scopeNote mesh__D003849
% 209.18/209.40 A nucleoside consisting of the base guanine and the sugar deoxyribose.%A%
% 209.18/209.40 |- skos__broader mesh__D003849smesh__D006151
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 1994
% 209.18/209.40 |- rdf__type mesh__D003849sskos__Concept
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 2004
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 1998
% 209.18/209.40 |- skos__prefLabel mesh__D003849 Deoxyguanosine
% 209.18/209.40 |- mesh__recordMaintainer mesh__D003849 PLS
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 1995
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 2002
% 209.18/209.40 |- mesh__dateEstablished mesh__D003849 1978-01-01
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 1999
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 1992
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D003849 NLM
% 209.18/209.40 |- skos__historyNote mesh__D003849 Guanosine %28%1972-1977%29%
% 209.18/209.40 |- mesh__dateCreated mesh__D003849 1977-04-22
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 1996
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 1993
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 2000
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 2005
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 1997
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 1991
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D003849 2006
% 209.18/209.40 |- mesh__recordOriginator mesh__D003849 RLS
% 209.18/209.40 |- skos__altLabel mesh__D014571 Urologic Cancer
% 209.18/209.40 |- skos__altLabel mesh__D014571 Urological Cancer
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D014571 sjn
% 209.18/209.40 |- mesh__recordMaintainer mesh__D014571 lkt
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Neoplasms, Urinary Tract
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Cancers, Urological
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Cancers, Urinary Tract
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Neoplasms, Urological
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Neoplasm, Urological
% 209.18/209.40 |- skos__altLabel mesh__D014571 Cancer of the Urinary Tract
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Urologic Cancers
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Cancer, Urologic
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Cancer, Urological
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Urinary Tract Cancers
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Urological Neoplasm
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Tract Neoplasms, Urinary
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Urinary Tract Neoplasm
% 209.18/209.40 |- skos__altLabel mesh__D014571 Urinary Tract Cancer
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Urological Cancers
% 209.18/209.40 |- skos__scopeNote mesh__D014571
% 209.18/209.40 Tumors or cancer of the URINARY TRACT in either the male or the female.%A%
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Cancers, Urologic
% 209.18/209.40 |- skos__historyNote mesh__D014571 Urogenital Neoplasms %28%1966-1977%29%
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Neoplasm, Urinary Tract
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Cancer, Urinary Tract
% 209.18/209.40 |- skos__altLabel mesh__D014571 Urinary Tract Neoplasms
% 209.18/209.40 |- mesh__dateCreated mesh__D014571 1977-03-29
% 209.18/209.40 |- mesh__recordOriginator mesh__D014571 SMH
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Urologic Neoplasm
% 209.18/209.40 |- mesh__dateRevised mesh__D014571 2005-06-30
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Neoplasm, Urologic
% 209.18/209.40 |- skos__broader mesh__D014571smesh__D014565
% 209.18/209.40 |- skos__annotation mesh__D014571
% 209.18/209.40 general or unspecified: prefer specifics; coordinate IM with histological type of neoplasm %28%IM%29%; DF: UROL NEOPL%A%
% 209.18/209.40 |- skos__prefLabel mesh__D014571 Urologic Neoplasms
% 209.18/209.40 |- skos__altLabel mesh__D014571 Urological Neoplasms
% 209.18/209.40 |- skos__altLabel mesh__D014571 Neoplasms, Urologic
% 209.18/209.40 |- rdf__type mesh__D014571sskos__Concept
% 209.18/209.40 |- mesh__dateEstablished mesh__D014571 1978-01-01
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D014571 78
% 209.18/209.40 |- skos__hiddenLabel mesh__D014571 Tract Neoplasm, Urinary
% 209.18/209.40 |- mesh__historyNote mesh__D014571 78
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D014571 2006
% 209.18/209.40 |- mesh__recordMaintainer mesh__D036225 ags
% 209.18/209.40 |- mesh__recordOriginator mesh__D036225 jmp
% 209.18/209.40 |- rdf__type mesh__D036225sskos__Concept
% 209.18/209.40 |- skos__altLabel mesh__D036225 EPHT2 Protein
% 209.18/209.40 |- mesh__historyNote mesh__D036225
% 209.18/209.40 2003; for RECEPTOR, EPHB1, ELK PROTEIN EPHT2 PROTEIN %26% NEURONALLY EXPRESSED EPH-TYROSINE KINASE use RECEPTORS, EPH FAMILY 1999-2002%A%
% 209.18/209.40 |- skos__altLabel mesh__D036225 EphB1 Receptor
% 209.18/209.40 |- skos__altLabel mesh__D036225
% 209.18/209.40 Neuronally Expressed EPH-Related Tyrosine Kinase
% 209.18/209.40 |- skos__scopeNote mesh__D036225
% 209.18/209.40 An eph family receptor found primarily in the nervous system. In the embryonic BRAIN EphB1 receptor expression occurs in the mantle layer and increases with the progression of embryogenesis. In adult brain it is found in the several regions including the CEREBELLUM; CEREBRAL CORTEX; and CAUDATE NUCLEUS; and PUTAMEN.%A%
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D036225 2006A
% 209.18/209.40 |- skos__broader mesh__D036225smesh__D036081
% 209.18/209.40 |- skos__hiddenLabel mesh__D036225
% 209.18/209.40 Neuronally Expressed EPH Related Tyrosine Kinase
% 209.18/209.40 |- skos__prefLabel mesh__D036225 Receptor, EphB1
% 209.18/209.40 |- mesh__dateEstablished mesh__D036225 2003-01-01
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D036225 ags
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D036225 2006
% 209.18/209.40 |- skos__historyNote mesh__D036225
% 209.18/209.40 Receptor Protein-Tyrosine Kinases %28%1997-2002%29%
% 209.18/209.40 |- mesh__dateRevised mesh__D036225 2005-07-12
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D036225
% 209.18/209.40 2003; EPHB1 RECEPTOR, ELK PROTEIN EPHT2 PROTEIN %26% NEURONALLY EXPRESSED EPH-TYROSINE KINASE were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002%A%
% 209.18/209.40 |- mesh__dateCreated mesh__D036225 2002-07-03
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D008534 2005
% 209.18/209.40 |- mesh__dateRevised mesh__D008534 2003-07-09
% 209.18/209.40 |- mesh__historyNote mesh__D008534
% 209.18/209.40 91%28%75%29%; was see under ERYTHROCYTES, ABNORMAL 1975-90; was see under ERYTHROCYTES 1963-74%A%
% 209.18/209.40 |- skos__scopeNote mesh__D008534
% 209.18/209.40 Red blood cell precursors, corresponding to ERYTHROBLASTS, that are larger than normal, usually resulting from a FOLIC ACID DEFICIENCY or VITAMIN B 12 DEFICIENCY.%A%
% 209.18/209.40 |- skos__related mesh__D008534smesh__D000749
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D008534 2006
% 209.18/209.40 |- mesh__dateCreated mesh__D008534 1999-01-01
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D008534
% 209.18/209.40 91; was see under ERYTHROCYTES, ABNORMAL 1975-90; was see under ERYTHROCYTES 1963-74%A%
% 209.18/209.40 |- mesh__recordMaintainer mesh__D008534 nns
% 209.18/209.40 |- mesh__dateEstablished mesh__D008534 1991-01-01
% 209.18/209.40 |- skos__broader mesh__D008534smesh__D004913
% 209.18/209.40 |- rdf__type mesh__D008534sskos__Concept
% 209.18/209.40 |- mesh__onlineNote mesh__D008534 search ERYTHROCYTES 1966-74
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D008534 2004
% 209.18/209.40 |- skos__hiddenLabel mesh__D008534 Megaloblast
% 209.18/209.40 |- skos__broader mesh__D008534smesh__D004900
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D008534 sjn
% 209.18/209.40 |- skos__prefLabel mesh__D008534 Megaloblasts
% 209.18/209.40 |- mesh__recordOriginator mesh__D008534 NLM
% 209.18/209.40 |- skos__altLabel mesh__D000551 Europharma Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 NA 872
% 209.18/209.40 |- skos__altLabel mesh__D000551 Mack Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Sankyo Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551
% 209.18/209.40 Lichtenstein Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Farmasan Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Degort%27%s Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Duramucal
% 209.18/209.40 |- skos__altLabel mesh__D000551 Fustery Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Isis Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- mesh__dateEstablished mesh__D000551 1991-01-01
% 209.18/209.40 |- skos__altLabel mesh__D000551
% 209.18/209.40 SmithKline Beecham Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- mesh__dateCreated mesh__D000551 1976-04-16
% 209.18/209.40 |- skos__altLabel mesh__D000551 Surbronc
% 209.18/209.40 |- skos__altLabel mesh__D000551 Pulmopharm Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Contac Husten Trunk
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 NA872
% 209.18/209.40 |- skos__altLabel mesh__D000551 Promeco Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Chiesi Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__scopeNote mesh__D000551
% 209.18/209.40 A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.%A%
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551
% 209.18/209.40 Berlin Chemie Brand of Abmbroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Sekretovit
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Contac HustenTrunk
% 209.18/209.40 |- skos__altLabel mesh__D000551
% 209.18/209.40 Boehringer Ingelheim Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- mesh__historyNote mesh__D000551
% 209.18/209.40 91%28%77%29%; was see under BROMHEXINE 1977-90
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 AmbroPuren
% 209.18/209.40 |- skos__altLabel mesh__D000551 Esparma Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Stada Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Rentschler Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Betapharm Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551
% 209.18/209.40 Glaxo Wellcome Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- mesh__recordOriginator mesh__D000551 SH
% 209.18/209.40 |- skos__altLabel mesh__D000551 Bromhexine Metabolite VIII
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Larylin Husten L%C3%%B6%ser
% 209.18/209.40 |- mesh__recordMaintainer mesh__D000551 jls
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Ambroxol Marjan Brand
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Ambro Puren
% 209.18/209.40 |- skos__prefLabel mesh__D000551 Ambroxol
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 stas Hustenl%C3%%B6%ser
% 209.18/209.40 |- skos__altLabel mesh__D000551 Nattermann Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Ambrol%C3%%B6%s
% 209.18/209.40 |- skos__altLabel mesh__D000551 P%C3%%A4%dia Brand of Ambroxol
% 209.18/209.40 |- skos__altLabel mesh__D000551 Marjan Brand of Ambroxol
% 209.18/209.40 |- skos__altLabel mesh__D000551 Hexal Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D000551 jls
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 stasHustenl%C3%%B6%ser
% 209.18/209.40 |- skos__altLabel mesh__D000551 Diba Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Orion Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Metabolite VIII, Bromhexine
% 209.18/209.40 |- skos__historyNote mesh__D000551 Cyclohexylamines %28%1974%29%
% 209.18/209.40 |- skos__altLabel mesh__D000551
% 209.18/209.40 Schaper %26% Br%C3%%BC%mmer Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Teva Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__historyNote mesh__D000551 Aniline Compounds %28%1974%29%
% 209.18/209.40 |- skos__altLabel mesh__D000551 Wernigerode Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Ringelheimer Pulmonal
% 209.18/209.40 |- skos__altLabel mesh__D000551 Mucosolvan
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 AM, Bisolvon
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Hustenl%C3%%B6%ser, Therapin
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D000551 2005
% 209.18/209.40 |- skos__altLabel mesh__D000551 Muco-Fips
% 209.18/209.40 |- skos__altLabel mesh__D000551 Merck Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Thomae Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__altLabel mesh__D000551 Cascan Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- rdf__type mesh__D000551sskos__Concept
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Muco Fips
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Larylin HustenL%C3%%B6%ser
% 209.18/209.40 |- skos__historyNote mesh__D000551
% 209.18/209.40 Bromhexine/analogs %26% derivatives %28%1975-1976%29%
% 209.18/209.40 |- skos__altLabel mesh__D000551 Ambroxocompren
% 209.18/209.40 |- skos__altLabel mesh__D000551 Hefa Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D000551
% 209.18/209.40 91; was see under BROMHEXINE 1977-90
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Ambroxol P%C3%%A4%dia Brand
% 209.18/209.40 |- skos__altLabel mesh__D000551 Ambrohexal
% 209.18/209.40 |- mesh__dateRevised mesh__D000551 2005-07-29
% 209.18/209.40 |- skos__altLabel mesh__D000551
% 209.18/209.40 Berlin-Chemie Brand of Abmbroxol Hydrochloride
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Hustenl%C3%%B6%ser, Pect
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D000551 2006
% 209.18/209.40 |- skos__altLabel mesh__D000551 Carnot Brand of Ambroxol Hydrochloride
% 209.18/209.40 |- skos__broader mesh__D000551smesh__D001964
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D000551 2006A
% 209.18/209.40 |- skos__altLabel mesh__D000551
% 209.18/209.40 4-%28%%28%%28%2-Amino-3,5-dibromophenyl%29%methyl%29%amino%29%cyclohexanol
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 Pulmonal, Ringelheimer
% 209.18/209.40 |- skos__hiddenLabel mesh__D000551 MucoFips
% 209.18/209.40 |- skos__broader mesh__D013284Q000002smesh__D013284
% 209.18/209.40 |- mesh__preferredCombination mesh__D013284Q000002smesh__D018640
% 209.18/209.40 |- rdf__type mesh__D013284Q000002smesh__CompoundConcept
% 209.18/209.40 |- skos__scopeNote mesh__D013479
% 209.18/209.40 Obstruction of the superior vena cava caused by neoplasm, thrombosis, aneurysm, or external compression and causing suffusion and/or cyanosis of the face, neck, and upper arms.%A%
% 209.18/209.40 |- mesh__dateRevised mesh__D013479 1996-06-10
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 2001
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 2003
% 209.18/209.40 |- mesh__historyNote mesh__D013479 86
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 2000
% 209.18/209.40 |- mesh__dateEstablished mesh__D013479 1986-01-01
% 209.18/209.40 |- mesh__recordMaintainer mesh__D013479 TPW
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 1997
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 2006
% 209.18/209.40 |- skos__prefLabel mesh__D013479 Superior Vena Cava Syndrome
% 209.18/209.40 |- skos__historyNote mesh__D013479 Vascular Diseases %28%1966-1985%29%
% 209.18/209.40 |- skos__historyNote mesh__D013479 Thrombosis %28%1966-1985%29%
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D013479 PLS
% 209.18/209.40 |- skos__broader mesh__D013479smesh__D014652
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D013479 86
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 2005
% 209.18/209.40 |- skos__annotation mesh__D013479 caval obstruction
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 2002
% 209.18/209.40 |- mesh__recordOriginator mesh__D013479 VDK
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 1999
% 209.18/209.40 |- rdf__type mesh__D013479sskos__Concept
% 209.18/209.40 |- skos__historyNote mesh__D013479 Vena Cava, Superior %28%1966-1985%29%
% 209.18/209.40 |- mesh__dateCreated mesh__D013479 1985-03-20
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 2004
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D013479 1998
% 209.18/209.40 |- skos__altLabel mesh__D013479 Superior Vena Cava Obstruction
% 209.18/209.40 |- skos__altLabel mesh__D018962 Venesection
% 209.18/209.40 |- skos__hiddenLabel mesh__D018962 Phlebotomies
% 209.18/209.40 |- skos__related mesh__D018962smesh__D001815
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D018962 sjn
% 209.18/209.40 |- skos__broader mesh__D018962smesh__D011677
% 209.18/209.40 |- skos__related mesh__D018962smesh__D024763
% 209.18/209.40 |- mesh__recordMaintainer mesh__D018962 sjn
% 209.18/209.40 |- skos__scopeNote mesh__D018962
% 209.18/209.40 The techniques used to draw blood from a vein for diagnostic purposes or for treatment of certain blood disorders such as erythrocytosis, hemochromatosis, polycythemia vera, and porphyria cutanea tarda.%A%
% 209.18/209.40 |- skos__related mesh__D018962smesh__D007262
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D018962
% 209.18/209.40 1996; see BLOODLETTING 1987-1995; VENESECTION see BLOODLETTING 1987-1995; VENIPUNCTURE see BLOODLETTING 1989-1995%A%
% 209.18/209.40 |- mesh__recordOriginator mesh__D018962 TGC
% 209.18/209.40 |- mesh__dateCreated mesh__D018962 1995-05-26
% 209.18/209.40 |- mesh__dateEstablished mesh__D018962 1996-01-01
% 209.18/209.40 |- skos__prefLabel mesh__D018962 Phlebotomy
% 209.18/209.40 |- skos__annotation mesh__D018962
% 209.18/209.40 for hist articles %26% hist contexts use BLOODLETTING
% 209.18/209.40 |- mesh__historyNote mesh__D018962
% 209.18/209.40 1996; use BLOODLETTING 1987-1995; VENESECTION use BLOODLETTING 1987-1995; VENIPUNCTURE use BLOODLETTING 1989-1995%A%
% 209.18/209.40 |- skos__hiddenLabel mesh__D018962 Venipunctures
% 209.18/209.40 |- rdf__type mesh__D018962sskos__Concept
% 209.18/209.40 |- skos__related mesh__D018962smesh__D007275
% 209.18/209.40 |- skos__hiddenLabel mesh__D018962 Venesections
% 209.18/209.40 |- mesh__dateRevised mesh__D018962 2004-07-13
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D018962 2006
% 209.18/209.40 |- skos__historyNote mesh__D018962 Bloodletting %28%1966-1995%29%
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D018962 2005
% 209.18/209.40 |- skos__broader mesh__D018962smesh__D001800
% 209.18/209.40 |- mesh__historyNote mesh__D018164 94
% 209.18/209.40 |- skos__annotation mesh__D018164
% 209.18/209.40 infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D018164 2003
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D018164 2006
% 209.18/209.40 |- skos__scopeNote mesh__D018164
% 209.18/209.40 A species of ORBIVIRUS causing a fatal disease in deer. It is transmitted by flies of the genus Culicoides.%A%
% 209.18/209.40 |- skos__prefLabel mesh__D018164 Hemorrhagic Disease Virus, Epizootic
% 209.18/209.40 |- mesh__dateRevised mesh__D018164 2001-07-25
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D018164 sjn
% 209.18/209.40 |- skos__broader mesh__D018164smesh__D018163
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D018164 94
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D018164 2005
% 209.18/209.40 |- skos__altLabel mesh__D018164 Epizootic hemorrhagic disease virus
% 209.18/209.40 |- rdf__type mesh__D018164sskos__Concept
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D018164 2002
% 209.18/209.40 |- mesh__dateCreated mesh__D018164 1993-06-04
% 209.18/209.40 |- mesh__recordOriginator mesh__D018164 AGS
% 209.18/209.40 |- skos__historyNote mesh__D018164 Reoviridae %28%1970-1993%29%
% 209.18/209.40 |- mesh__dateEstablished mesh__D018164 1994-01-01
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D018164 2004
% 209.18/209.40 |- mesh__recordMaintainer mesh__D018164 ags
% 209.18/209.40 |- skos__broader mesh__D010181smesh__D010182
% 209.18/209.40 |- skos__hiddenLabel mesh__D010181 Cysts, Pancreatic
% 209.18/209.40 |- rdf__type mesh__D010181sskos__Concept
% 209.18/209.40 |- mesh__recordMaintainer mesh__D010181 lkt
% 209.18/209.40 |- skos__annotation mesh__D010181
% 209.18/209.40 non-neoplastic; pancreatic pseudocyst = PANCREATIC PSEUDOCYST%A%
% 209.18/209.40 |- mesh__dateRevised mesh__D010181 2004-07-07
% 209.18/209.40 |- skos__hiddenLabel mesh__D010181 Cyst, Pancreatic
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D010181 sjn
% 209.18/209.40 |- skos__broader mesh__D010181smesh__D003560
% 209.18/209.40 |- skos__hiddenLabel mesh__D010181 Pancreatic Cysts
% 209.18/209.40 |- mesh__dateCreated mesh__D010181 1999-01-01
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D010181 2006
% 209.18/209.40 |- skos__prefLabel mesh__D010181 Pancreatic Cyst
% 209.18/209.40 |- mesh__recordOriginator mesh__D010181 NLM
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D010181 2005
% 209.18/209.40 |- skos__scopeNote mesh__D010181
% 209.18/209.40 A true cyst of the PANCREAS, distinguished from the much more common PANCREATIC PSEUDOCYST by possessing a lining of mucous EPITHELIUM. Pancreatic cysts are categorized as congenital, retention, neoplastic, parasitic, enterogenous, or dermoid. Congenital cysts occur more frequently as solitary cysts but may be multiple. Retention cysts are gross enlargements of PANCREATIC DUCTS secondary to ductal obstruction. %28%From Bockus Gastroenterology, 4th ed, p4145%29%%A%
% 209.18/209.40 |- skos__hiddenLabel mesh__D004942 Reflux Esophagitis
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004942 2005
% 209.18/209.40 |- skos__altLabel mesh__D004942 Esophagitis, Reflux
% 209.18/209.40 |- skos__broader mesh__D004942smesh__D010437
% 209.18/209.40 |- skos__hiddenLabel mesh__D004942 Peptic Esophagitides
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004942 2006
% 209.18/209.40 |- skos__hiddenLabel mesh__D004942 Esophagitides, Peptic
% 209.18/209.40 |- skos__prefLabel mesh__D004942 Esophagitis, Peptic
% 209.18/209.40 |- mesh__dateRevised mesh__D004942 2003-07-09
% 209.18/209.40 |- mesh__recordOriginator mesh__D004942 NLM
% 209.18/209.40 |- mesh__recordMaintainer mesh__D004942 lkt
% 209.18/209.40 |- skos__scopeNote mesh__D004942
% 209.18/209.40 INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM.%A%
% 209.18/209.40 |- mesh__dateCreated mesh__D004942 1999-01-01
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D004942 sjn
% 209.18/209.40 |- rdf__type mesh__D004942sskos__Concept
% 209.18/209.40 |- skos__hiddenLabel mesh__D004942 Reflux Esophagitides
% 209.18/209.40 |- skos__broader mesh__D004942smesh__D004941
% 209.18/209.40 |- skos__hiddenLabel mesh__D004942 Peptic Esophagitis
% 209.18/209.40 |- skos__hiddenLabel mesh__D004942 Esophagitides, Reflux
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004942 2004
% 209.18/209.40 |- skos__hiddenLabel mesh__D051598 Imagings, Whole Body
% 209.18/209.40 |- skos__broader mesh__D051598smesh__D003952
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D051598 2006
% 209.18/209.40 |- skos__hiddenLabel mesh__D051598 Scans, Whole Body
% 209.18/209.40 |- skos__altLabel mesh__D051598 Whole Body Scan
% 209.18/209.40 |- skos__broader mesh__D051598smesh__D008919
% 209.18/209.40 |- mesh__historyNote mesh__D051598 2006
% 209.18/209.40 |- skos__hiddenLabel mesh__D051598 Imaging, Whole Body
% 209.18/209.40 |- skos__hiddenLabel mesh__D051598 Screening, Whole Body
% 209.18/209.40 |- skos__hiddenLabel mesh__D051598 Whole Body Imagings
% 209.18/209.40 |- skos__altLabel mesh__D051598 Whole Body Scanning
% 209.18/209.40 |- skos__scopeNote mesh__D051598
% 209.18/209.40 The creation of a visual display of the inside of the entire body of a human or animal for the purposes of diagnostic evaluation. This is most commonly achieved by using MAGNETIC RESONANCE IMAGING; or POSITRON EMISSION TOMOGRAPHY.%A%
% 209.18/209.40 |- skos__hiddenLabel mesh__D051598 Whole Body Screenings
% 209.18/209.40 |- mesh__recordOriginator mesh__D051598 ags
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D051598 2006
% 209.18/209.40 |- mesh__dateCreated mesh__D051598 2005-06-30
% 209.18/209.40 |- rdf__type mesh__D051598sskos__Concept
% 209.18/209.40 |- skos__hiddenLabel mesh__D051598 Screenings, Whole Body
% 209.18/209.40 |- mesh__recordMaintainer mesh__D051598 ags
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D051598 sjn
% 209.18/209.40 |- mesh__dateEstablished mesh__D051598 2006-01-01
% 209.18/209.40 |- skos__hiddenLabel mesh__D051598 Scan, Whole Body
% 209.18/209.40 |- skos__prefLabel mesh__D051598 Whole Body Imaging
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 1996
% 209.18/209.40 |- skos__historyNote mesh__D004144 Saponins %28%1966-1975%29%
% 209.18/209.40 |- skos__historyNote mesh__D004144 Hydroxysteroids %28%1972-1975%29%
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 2000
% 209.18/209.40 |- skos__historyNote mesh__D004144 Spirostans %28%1968-1978%29%
% 209.18/209.40 |- skos__broader mesh__D004144smesh__D012502
% 209.18/209.40 |- rdf__type mesh__D004144sskos__Concept
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 1995
% 209.18/209.40 |- mesh__historyNote mesh__D004144
% 209.18/209.40 91%28%79%29%; was see under SAPOGENINS 1979-90
% 209.18/209.40 |- mesh__dateRevised mesh__D004144 1992-05-13
% 209.18/209.40 |- skos__annotation mesh__D004144 a sapogenin
% 209.18/209.40 |- skos__scopeNote mesh__D004144
% 209.18/209.40 %28%25R%29%-Spirost-5-en-3-beta-ol. A steroid sapogenin which is isolated from various plants. Can be converted to ecdysone, pregnenolone, and progesterone. Synonym: nitogenin.%A%
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 2006
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 2002
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 1994
% 209.18/209.40 |- mesh__recordMaintainer mesh__D004144 TGC
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D004144 PLS
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 1993
% 209.18/209.40 |- mesh__recordOriginator mesh__D004144 RLS
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 2005
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 2004
% 209.18/209.40 |- mesh__dateEstablished mesh__D004144 1991-01-01
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D004144
% 209.18/209.40 91; was see under SAPOGENINS 1979-90
% 209.18/209.40 |- skos__altLabel mesh__D004144 Yamogenin
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 1999
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 2003
% 209.18/209.40 |- skos__prefLabel mesh__D004144 Diosgenin
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 1998
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 1997
% 209.18/209.40 |- mesh__dateCreated mesh__D004144 1977-12-16
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D004144 2001
% 209.18/209.40 |- skos__related mesh__D014572smesh__D033441
% 209.18/209.40 |- skos__related mesh__D014572smesh__D014570
% 209.18/209.40 |- mesh__recordMaintainer mesh__D014572 lkt
% 209.18/209.40 |- mesh__dateCreated mesh__D014572 1999-01-01
% 209.18/209.40 |- rdf__type mesh__D014572sskos__Concept
% 209.18/209.40 |- skos__broader mesh__D014572smesh__D013043
% 209.18/209.40 |- mesh__recordOriginator mesh__D014572 NLM
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D014572 2004
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D014572 2006
% 209.18/209.40 |- skos__annotation mesh__D014572 SPEC; DF: UROL
% 209.18/209.40 |- skos__prefLabel mesh__D014572 Urology
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D014572 2003
% 209.18/209.40 |- skos__scopeNote mesh__D014572
% 209.18/209.40 A surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male. Common urological problems include urinary obstruction, URINARY INCONTINENCE, infections, and UROGENITAL NEOPLASMS.%A%
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D014572 2005
% 209.18/209.40 |- mesh__recordAuthorizer mesh__D014572 sjn
% 209.18/209.40 |- skos__related mesh__D014572smesh__D013520
% 209.18/209.40 |- mesh__dateRevised mesh__D014572 2002-07-03
% 209.18/209.40 |- rdf__type mesh__D036226sskos__Concept
% 209.18/209.40 |- mesh__dateCreated mesh__D036226 2002-07-03
% 209.18/209.40 |- mesh__publicMeSHNote mesh__D036226 2003; see PLANTS 1995-2002
% 209.18/209.40 |- mesh__activeMeSHYear mesh__D036226 2004
% 209.18/209.41 |- skos__related mesh__D036226smesh__D018525
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D036226 2003
% 209.18/209.41 |- mesh__historyNote mesh__D036226 2003%28%1995%29%
% 209.18/209.41 |- skos__annotation mesh__D036226 coord with specific plant
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D036226 2006
% 209.18/209.41 |- skos__broader mesh__D036226smesh__D010944
% 209.18/209.41 |- skos__historyNote mesh__D036226 Plants %28%1995-2002%29%
% 209.18/209.41 |- skos__altLabel mesh__D036226 Seedlings
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D036226 2005
% 209.18/209.41 |- skos__prefLabel mesh__D036226 Seedling
% 209.18/209.41 |- skos__scopeNote mesh__D036226
% 209.18/209.41 Very young plant after GERMINATION of SEEDS.
% 209.18/209.41 |- mesh__dateEstablished mesh__D036226 2003-01-01
% 209.18/209.41 |- mesh__dateRevised mesh__D008535 2003-07-09
% 209.18/209.41 |- skos__broader mesh__D008535smesh__D011245
% 209.18/209.41 |- skos__scopeNote mesh__D008535
% 209.18/209.41 17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer.%A%
% 209.18/209.41 |- skos__annotation mesh__D008535 a synthetic progestational hormone
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D008535 sjn
% 209.18/209.41 |- mesh__dateEstablished mesh__D008535 1972-01-01
% 209.18/209.41 |- mesh__recordOriginator mesh__D008535 NLM
% 209.18/209.41 |- mesh__historyNote mesh__D008535 72%28%63%29%
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D008535 2006
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D008535 2005
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D008535 2004
% 209.18/209.41 |- mesh__dateCreated mesh__D008535 1999-01-01
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D008535 72
% 209.18/209.41 |- rdf__type mesh__D008535sskos__Concept
% 209.18/209.41 |- skos__prefLabel mesh__D008535 Megestrol
% 209.18/209.41 |- mesh__recordMaintainer mesh__D008535 lkt
% 209.18/209.41 |- skos__broader mesh__D000552smesh__D018986
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Unit, Emergency Mobile
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D000552 SJN
% 209.18/209.41 |- rdf__type mesh__D000552sskos__Concept
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Mobile Emergency Unit
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000552 2006
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Emergency Mobile Unit
% 209.18/209.41 |- mesh__dateRevised mesh__D000552 1998-06-10
% 209.18/209.41 |- skos__prefLabel mesh__D000552 Ambulances
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Units, Emergency Mobile
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000552 2005
% 209.18/209.41 |- mesh__recordOriginator mesh__D000552 NLM
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000552 2002
% 209.18/209.41 |- mesh__recordMaintainer mesh__D000552 JLS
% 209.18/209.41 |- mesh__dateCreated mesh__D000552 1999-01-01
% 209.18/209.41 |- skos__altLabel mesh__D000552 Mobile Emergency Units
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000552 1999
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000552 2004
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Emergency Units, Mobile
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000552 2001
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Mobile Units, Emergency
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Ambulance
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Units, Mobile Emergency
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000552 2003
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Mobile Unit, Emergency
% 209.18/209.41 |- skos__scopeNote mesh__D000552
% 209.18/209.41 A vehicle equipped for transporting patients in need of emergency care.%A%
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000552 2000
% 209.18/209.41 |- skos__broader mesh__D000552smesh__D014187
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Emergency Unit, Mobile
% 209.18/209.41 |- skos__hiddenLabel mesh__D000552 Unit, Mobile Emergency
% 209.18/209.41 |- mesh__recordMaintainer mesh__D018963 ssb
% 209.18/209.41 |- skos__scopeNote mesh__D018963
% 209.18/209.41 Antigens from any of the hepatitis viruses including surface, core, and other associated antigens.%A%
% 209.18/209.41 |- mesh__recordOriginator mesh__D018963 AGS
% 209.18/209.41 |- mesh__dateCreated mesh__D018963 1995-02-22
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D018963 sjn
% 209.18/209.41 |- rdf__type mesh__D018963sskos__Concept
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018963 2006
% 209.18/209.41 |- skos__prefLabel mesh__D018963 Hepatitis Antigens
% 209.18/209.41 |- skos__broader mesh__D018963smesh__D000956
% 209.18/209.41 |- mesh__dateEstablished mesh__D018963 1996-01-01
% 209.18/209.41 |- mesh__historyNote mesh__D018963 96
% 209.18/209.41 |- mesh__dateRevised mesh__D018963 2005-06-30
% 209.18/209.41 |- skos__altLabel mesh__D018963 Antigens, Hepatitis
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D018963 96
% 209.18/209.41 |- skos__annotation mesh__D018963 GEN or unspecified; prefer specifics
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D010980 sjn
% 209.18/209.41 |- mesh__dateCreated mesh__D010980 1986-06-16
% 209.18/209.41 |- skos__broader mesh__D010980smesh__D008562
% 209.18/209.41 |- skos__altLabel mesh__D010980 PM-GPs
% 209.18/209.41 |- skos__hiddenLabel mesh__D010980 Glycoproteins, Platelet
% 209.18/209.41 |- rdf__type mesh__D010980sskos__Concept
% 209.18/209.41 |- skos__hiddenLabel mesh__D010980 Membrane Glycoproteins, Platelet
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D010980 87
% 209.18/209.41 |- skos__broader mesh__D010980smesh__D011971
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010980 2006
% 209.18/209.41 |- skos__prefLabel mesh__D010980 Platelet Membrane Glycoproteins
% 209.18/209.41 |- mesh__dateEstablished mesh__D010980 1987-01-01
% 209.18/209.41 |- mesh__recordMaintainer mesh__D010980 jmp
% 209.18/209.41 |- skos__hiddenLabel mesh__D010980 Glycoproteins, Platelet Membrane
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010980 2004
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010980 2005
% 209.18/209.41 |- skos__annotation mesh__D010980
% 209.18/209.41 /biosyn /drug eff /physiol /ultrastruct permitted
% 209.18/209.41 |- skos__scopeNote mesh__D010980
% 209.18/209.41 Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors.%A%
% 209.18/209.41 |- mesh__recordOriginator mesh__D010980 RLS
% 209.18/209.41 |- mesh__historyNote mesh__D010980 87
% 209.18/209.41 |- mesh__dateRevised mesh__D010980 2003-07-09
% 209.18/209.41 |- skos__historyNote mesh__D010980 Glycoproteins %28%1966-1986%29%
% 209.18/209.41 |- skos__historyNote mesh__D010980 Membrane Proteins %28%1966-1986%29%
% 209.18/209.41 |- mesh__dateEstablished mesh__D018165 1994-01-01
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018165 2006
% 209.18/209.41 |- skos__hiddenLabel mesh__D018165 Orthoreoviruses
% 209.18/209.41 |- mesh__historyNote mesh__D018165 1994
% 209.18/209.41 |- skos__scopeNote mesh__D018165
% 209.18/209.41 A genus of the family REOVIRIDAE infecting vertebrates only. Transmission is horizontal and infected species include humans, birds, cattle, monkeys, sheep, swine, baboons, and bats. MAMMALIAN ORTHOREOVIRUS is the type species.%A%
% 209.18/209.41 |- skos__annotation mesh__D018165
% 209.18/209.41 infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018165 2005
% 209.18/209.41 |- rdf__type mesh__D018165sskos__Concept
% 209.18/209.41 |- skos__altLabel mesh__D018165 Nelson Bay orthoreovirus
% 209.18/209.41 |- skos__prefLabel mesh__D018165 Orthoreovirus
% 209.18/209.41 |- skos__broader mesh__D018165smesh__D012087
% 209.18/209.41 |- mesh__dateRevised mesh__D018165 2001-07-25
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018165 2004
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D018165 sjn
% 209.18/209.41 |- mesh__recordMaintainer mesh__D018165 ags
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D018165 1994
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018165 2002
% 209.18/209.41 |- skos__altLabel mesh__D018165 Baboon orthoreovirus
% 209.18/209.41 |- mesh__dateCreated mesh__D018165 1993-06-04
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018165 2003
% 209.18/209.41 |- mesh__recordOriginator mesh__D018165 AGS
% 209.18/209.41 |- mesh__dateRevised mesh__D010182 2004-07-07
% 209.18/209.41 |- skos__hiddenLabel mesh__D010182 Diseases, Pancreatic
% 209.18/209.41 |- rdf__type mesh__D010182sskos__Concept
% 209.18/209.41 |- skos__related mesh__D010182smesh__D006946
% 209.18/209.41 |- skos__hiddenLabel mesh__D010182 Pancreatic Disease
% 209.18/209.41 |- mesh__recordOriginator mesh__D010182 NLM
% 209.18/209.41 |- mesh__dateCreated mesh__D010182 1999-01-01
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010182 2005
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D010182 66
% 209.18/209.41 |- skos__broader mesh__D010182smesh__D004066
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010182 2006
% 209.18/209.41 |- mesh__dateEstablished mesh__D010182 1966-01-01
% 209.18/209.41 |- skos__annotation mesh__D010182 inflamm dis = PANCREATITIS
% 209.18/209.41 |- mesh__historyNote mesh__D010182 66
% 209.18/209.41 |- mesh__recordMaintainer mesh__D010182 lkt
% 209.18/209.41 |- skos__scopeNote mesh__D010182
% 209.18/209.41 Pathological processes of the PANCREAS.
% 209.18/209.41 |- skos__hiddenLabel mesh__D010182 Disease, Pancreatic
% 209.18/209.41 |- skos__prefLabel mesh__D010182 Pancreatic Diseases
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D010182 sjn
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D004943 66
% 209.18/209.41 |- mesh__historyNote mesh__D004943 66%28%64%29%
% 209.18/209.41 |- skos__prefLabel mesh__D004943 Esophagogastric Junction
% 209.18/209.41 |- skos__hiddenLabel mesh__D004943 Junctions, Gastroesophageal
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D004943 2005
% 209.18/209.41 |- skos__broader mesh__D004943smesh__D013270
% 209.18/209.41 |- mesh__recordOriginator mesh__D004943 NLM
% 209.18/209.41 |- skos__hiddenLabel mesh__D004943 Junction, Gastroesophageal
% 209.18/209.41 |- skos__hiddenLabel mesh__D004943 Junction, Esophagogastric
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D004943 2006
% 209.18/209.41 |- mesh__dateCreated mesh__D004943 1999-01-01
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D004943 sjn
% 209.18/209.41 |- skos__scopeNote mesh__D004943
% 209.18/209.41 The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.%A%
% 209.18/209.41 |- mesh__recordMaintainer mesh__D004943 lkt
% 209.18/209.41 |- rdf__type mesh__D004943sskos__Concept
% 209.18/209.41 |- mesh__dateEstablished mesh__D004943 1966-01-01
% 209.18/209.41 |- skos__broader mesh__D004943smesh__D004947
% 209.18/209.41 |- skos__annotation mesh__D004943
% 209.18/209.41 diseases: coordinate IM with ESOPHAGEAL DISEASES %28%IM%29% or specific esophageal disease %28%IM%29%; neoplasms: coordinate IM with STOMACH NEOPLASMS %28%IM%29% or ESOPHAGEAL NEOPLASMS %28%IM%29% depending on text%A%
% 209.18/209.41 |- skos__altLabel mesh__D004943 Gastroesophageal Junction
% 209.18/209.41 |- skos__hiddenLabel mesh__D004943 Gastroesophageal Junctions
% 209.18/209.41 |- mesh__dateRevised mesh__D004943 2004-07-07
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 Synthetase, ADP-Glucose
% 209.18/209.41 |- skos__altLabel mesh__D051599 ADP-Glucose Pyrophosphorylase
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 ADP Glucose Synthase
% 209.18/209.41 |- mesh__dateCreated mesh__D051599 2005-06-30
% 209.18/209.41 |- skos__altLabel mesh__D051599 ADPGlucose Pyrophosphorylase
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 Synthase, ADP-Glucose
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D051599 2006
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D051599
% 209.18/209.41 2006; GLUCOSE-1-PHOSPHATE ADENYLYLTRANSFERASE was indexed under NUCLEOTIDYLTRANSFERASES 1976-2005, under GLUCOSEPHOSPHATES 1972-1975, under ADENINE NUCLEOTIDES 1970-1972, %26% under ATP 1972-1975%A%
% 209.18/209.41 |- mesh__recordOriginator mesh__D051599 AKE
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D051599 sjn
% 209.18/209.41 |- skos__altLabel mesh__D051599 ADP-Glucose Synthase
% 209.18/209.41 |- skos__altLabel mesh__D051599
% 209.18/209.41 Adenosine Diphosphate Glucose Pyrophosphorylase
% 209.18/209.41 |- mesh__recordMaintainer mesh__D051599 AKE
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 ADP Glucose Pyrophosphorylase
% 209.18/209.41 |- mesh__dateEstablished mesh__D051599 2006-01-01
% 209.18/209.41 |- skos__altLabel mesh__D051599 ADP-Glucose Synthetase
% 209.18/209.41 |- skos__scopeNote mesh__D051599
% 209.18/209.41 An ATP-dependent enzyme that catalyzes the addition of ADP to alpha-D-glucose 1-phosphate to form ADP-glucose and diphosphate. The reaction is the rate-limiting reaction in prokaryotic GLYCOGEN and plant STARCH biosynthesis.%A%
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 Synthetase, ADPG
% 209.18/209.41 |- rdf__type mesh__D051599sskos__Concept
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599
% 209.18/209.41 Pyrophosphorylase, Adenosine Diphosphoglucose
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 Pyrophosphorylase, ADPGlucose
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 ADP Glucose Synthetase
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 Adenylyltransferase, Glucose-1-Phosphate
% 209.18/209.41 |- mesh__historyNote mesh__D051599
% 209.18/209.41 2006%28%1980%29%; use NUCLEOTIDYLTRANSFERASES 1976-1979, GLUCOSEPHOSPHATES 1972-1975, ADENINE NUCLEOTIDES 1970-1972, %26% ATP 1972-1975%A%
% 209.18/209.41 |- skos__altLabel mesh__D051599 ADPG Synthetase
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 Pyrophosphorylase, ADP-Glucose
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599 Glucose 1 Phosphate Adenylyltransferase
% 209.18/209.41 |- skos__prefLabel mesh__D051599 Glucose-1-Phosphate Adenylyltransferase
% 209.18/209.41 |- skos__broader mesh__D051599smesh__D009713
% 209.18/209.41 |- skos__hiddenLabel mesh__D051599
% 209.18/209.41 Diphosphoglucose Pyrophosphorylase, Adenosine
% 209.18/209.41 |- skos__altLabel mesh__D051599
% 209.18/209.41 Adenosine Diphosphoglucose Pyrophosphorylase
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D004145 2006
% 209.18/209.41 |- skos__hiddenLabel mesh__D004145 Resin, Buchu
% 209.18/209.41 |- skos__historyNote mesh__D004145 Bioflavonoids %28%1973-1974%29%
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D004145 sjn
% 209.18/209.41 |- skos__scopeNote mesh__D004145
% 209.18/209.41 A bioflavonoid that strengthens vascular walls.
% 209.18/209.41 |- skos__prefLabel mesh__D004145 Diosmin
% 209.18/209.41 |- mesh__historyNote mesh__D004145
% 209.18/209.41 91%28%75%29%; was see under BIOFLAVONOIDS 1975-90
% 209.18/209.41 |- mesh__recordMaintainer mesh__D004145 ssb
% 209.18/209.41 |- skos__broader mesh__D004145smesh__D047309
% 209.18/209.41 |- skos__altLabel mesh__D004145 Barosmin
% 209.18/209.41 |- mesh__dateEstablished mesh__D004145 1991-01-01
% 209.18/209.41 |- skos__altLabel mesh__D004145 Buchu Resin
% 209.18/209.41 |- mesh__dateCreated mesh__D004145 1974-11-19
% 209.18/209.41 |- mesh__dateRevised mesh__D004145 2005-06-30
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D004145
% 209.18/209.41 91; was see under BIOFLAVONOIDS 1975-90
% 209.18/209.41 |- rdf__type mesh__D004145sskos__Concept
% 209.18/209.41 |- mesh__recordOriginator mesh__D004145 NLM
% 209.18/209.41 |- skos__broader mesh__D050486Q000037smesh__D050486
% 209.18/209.41 |- mesh__preferredCombination mesh__D050486Q000037smesh__D017367
% 209.18/209.41 |- rdf__type mesh__D050486Q000037smesh__CompoundConcept
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D014573 PLS
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 2004
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 2002
% 209.18/209.41 |- mesh__dateRevised mesh__D014573 1992-05-18
% 209.18/209.41 |- mesh__recordOriginator mesh__D014573 EC
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 2006
% 209.18/209.41 |- skos__altLabel mesh__D014573 Department, Hospital Urology
% 209.18/209.41 |- mesh__historyNote mesh__D014573
% 209.18/209.41 91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90
% 209.18/209.41 |- mesh__recordMaintainer mesh__D014573 TGC
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D014573
% 209.18/209.41 91; was see under HOSPITAL DEPARTMENTS Aug 1977-90
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 2003
% 209.18/209.41 |- skos__historyNote mesh__D014573 Urology %28%1966-Jul 1977%29%
% 209.18/209.41 |- skos__hiddenLabel mesh__D014573 Departments, Hospital Urology
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 2001
% 209.18/209.41 |- skos__altLabel mesh__D014573 Urology Departments, Hospital
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 2005
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 1997
% 209.18/209.41 |- mesh__dateCreated mesh__D014573 1977-05-19
% 209.18/209.41 |- skos__hiddenLabel mesh__D014573 Hospital Urology Departments
% 209.18/209.41 |- skos__altLabel mesh__D014573 Hospital Urology Department
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 1999
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 2000
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 1996
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 1993
% 209.18/209.41 |- skos__historyNote mesh__D014573
% 209.18/209.41 Hospital Departments %28%1968-Jul 1977%29%
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 1995
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 1998
% 209.18/209.41 |- skos__scopeNote mesh__D014573
% 209.18/209.41 Hospital department responsible for the administration and provision of diagnostic and therapeutic services for the urologic patient.%A%
% 209.18/209.41 |- skos__prefLabel mesh__D014573 Urology Department, Hospital
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D014573 1994
% 209.18/209.41 |- rdf__type mesh__D014573sskos__Concept
% 209.18/209.41 |- skos__broader mesh__D014573smesh__D006748
% 209.18/209.41 |- skos__annotation mesh__D014573 DF: UROL DEP
% 209.18/209.41 |- mesh__dateEstablished mesh__D014573 1991-01-01
% 209.18/209.41 |- skos__scopeNote mesh__D008536
% 209.18/209.41 1-Deoxy-1-%28%methylamino%29%-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium.%A%
% 209.18/209.41 |- mesh__dateCreated mesh__D008536 1976-04-16
% 209.18/209.41 |- skos__broader mesh__D008536smesh__D013012
% 209.18/209.41 |- skos__altLabel mesh__D008536 Methylglucamine
% 209.18/209.41 |- skos__historyNote mesh__D008536 Amino Sugars %28%1971-1976%29%
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D008536 2006
% 209.18/209.41 |- skos__historyNote mesh__D008536 Sorbitol %28%1969-1976%29%
% 209.18/209.41 |- mesh__recordOriginator mesh__D008536 RLS
% 209.18/209.41 |- mesh__recordMaintainer mesh__D008536 ssb
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D008536 sjn
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D008536 2005
% 209.18/209.41 |- mesh__dateRevised mesh__D008536 2004-07-07
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D008536 91; was see under SORBITOL 1977-90
% 209.18/209.41 |- rdf__type mesh__D008536sskos__Concept
% 209.18/209.41 |- mesh__dateEstablished mesh__D008536 1991-01-01
% 209.18/209.41 |- skos__broader mesh__D008536smesh__D006595
% 209.18/209.41 |- skos__prefLabel mesh__D008536 Meglumine
% 209.18/209.41 |- mesh__historyNote mesh__D008536
% 209.18/209.41 91%28%77%29%; was see under SORBITOL 1977-90
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000553 2001
% 209.18/209.41 |- mesh__dateCreated mesh__D000553 1999-01-01
% 209.18/209.41 |- skos__hiddenLabel mesh__D000553 Outpatient Health Service
% 209.18/209.41 |- skos__hiddenLabel mesh__D000553 Care, Ambulatory
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000553 1999
% 209.18/209.41 |- skos__altLabel mesh__D000553 Outpatient Care
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000553 2004
% 209.18/209.41 |- skos__broader mesh__D000553smesh__D005791
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000553 2000
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000553 1998
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000553 2003
% 209.18/209.41 |- skos__hiddenLabel mesh__D000553 Clinic Visit
% 209.18/209.41 |- mesh__historyNote mesh__D000553 68%28%66%29%
% 209.18/209.41 |- mesh__dateEstablished mesh__D000553 1968-01-01
% 209.18/209.41 |- skos__hiddenLabel mesh__D000553 Visit, Clinic
% 209.18/209.41 |- skos__hiddenLabel mesh__D000553 Health Service, Outpatient
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D000553 SJN
% 209.18/209.41 |- mesh__dateRevised mesh__D000553 1997-06-20
% 209.18/209.41 |- skos__hiddenLabel mesh__D000553 Care, Outpatient
% 209.18/209.41 |- mesh__recordMaintainer mesh__D000553 PXP
% 209.18/209.41 |- skos__altLabel mesh__D000553 Outpatient Health Services
% 209.18/209.41 |- skos__prefLabel mesh__D000553 Ambulatory Care
% 209.18/209.41 |- rdf__type mesh__D000553sskos__Concept
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000553 2006
% 209.18/209.41 |- mesh__recordOriginator mesh__D000553 NLM
% 209.18/209.41 |- skos__scopeNote mesh__D000553
% 209.18/209.41 Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility.%A%
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000553 2002
% 209.18/209.41 |- skos__hiddenLabel mesh__D000553 Visits, Clinic
% 209.18/209.41 |- skos__altLabel mesh__D000553 Services, Outpatient Health
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D000553 68
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D000553 2005
% 209.18/209.41 |- skos__hiddenLabel mesh__D000553 Service, Outpatient Health
% 209.18/209.41 |- rdf__type mesh__D010981sskos__Concept
% 209.18/209.41 |- skos__altLabel mesh__D010981 Deficiency, Platelet Storage Pool
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010981 1999
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010981 2000
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D010981 SJN
% 209.18/209.41 |- skos__broader mesh__D010981smesh__D001778
% 209.18/209.41 |- skos__hiddenLabel mesh__D010981 Deficiencies, Storage Pool
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010981 2006
% 209.18/209.41 |- skos__broader mesh__D010981smesh__D001791
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010981 2004
% 209.18/209.41 |- mesh__historyNote mesh__D010981
% 209.18/209.41 91%28%86%29%; was see under BLOOD PLATELET DISORDERS 1986-90
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010981 2005
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010981 2002
% 209.18/209.41 |- skos__broader mesh__D010981smesh__D006474
% 209.18/209.41 |- skos__altLabel mesh__D010981 Storage Pool Deficiency, Platelet
% 209.18/209.41 |- skos__altLabel mesh__D010981 Storage Pool Deficiency
% 209.18/209.41 |- mesh__dateRevised mesh__D010981 1998-06-10
% 209.18/209.41 |- mesh__recordMaintainer mesh__D010981 NNS
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D010981
% 209.18/209.41 91; was see under BLOOD PLATELET DISORDERS 1986-90
% 209.18/209.41 |- mesh__dateCreated mesh__D010981 1985-03-11
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010981 2003
% 209.18/209.41 |- skos__prefLabel mesh__D010981 Platelet Storage Pool Deficiency
% 209.18/209.41 |- skos__scopeNote mesh__D010981
% 209.18/209.41 Disorder characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored.%A%
% 209.18/209.41 |- skos__hiddenLabel mesh__D010981 Storage Pool Deficiencies
% 209.18/209.41 |- mesh__dateEstablished mesh__D010981 1991-01-01
% 209.18/209.41 |- skos__altLabel mesh__D010981 Deficiency, Storage Pool
% 209.18/209.41 |- skos__historyNote mesh__D010981
% 209.18/209.41 Blood Platelet Disorders %28%1967-1985%29%
% 209.18/209.41 |- mesh__recordOriginator mesh__D010981 VDK
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010981 2001
% 209.18/209.41 |- skos__historyNote mesh__D018166 Health Planning %28%1968-1992%29%
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D018166 sjn
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018166 2006
% 209.18/209.41 |- mesh__publicMeSHNote mesh__D018166 94
% 209.18/209.41 |- skos__broader mesh__D018166smesh__D006291
% 209.18/209.41 |- skos__historyNote mesh__D018166
% 209.18/209.41 Delivery of Health Care %28%1970-1993%29%
% 209.18/209.41 |- skos__prefLabel mesh__D018166 Health Care Reform
% 209.18/209.41 |- mesh__dateEstablished mesh__D018166 1994-01-01
% 209.18/209.41 |- mesh__recordOriginator mesh__D018166 TGC
% 209.18/209.41 |- rdf__type mesh__D018166sskos__Concept
% 209.18/209.41 |- skos__hiddenLabel mesh__D018166 Reforms, Healthcare
% 209.18/209.41 |- skos__broader mesh__D018166smesh__D003695
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018166 2000
% 209.18/209.41 |- skos__hiddenLabel mesh__D018166 Healthcare Reforms
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018166 2003
% 209.18/209.41 |- skos__hiddenLabel mesh__D018166 Reforms, Health Care
% 209.18/209.41 |- skos__scopeNote mesh__D018166
% 209.18/209.41 Innovation and improvement of the health care system by reappraisal, amendment of services, and removal of faults and abuses in providing and distributing health services to patients. It includes a re-alignment of health services and health insurance to maximum demographic elements %28%the unemployed, indigent, uninsured, elderly, inner cities, rural areas%29% with reference to coverage, hospitalization, pricing and cost containment, insurers%27% and employers%27% costs, pre-existing medical conditions, prescribed drugs, equipment, and services.%A%
% 209.18/209.41 |- mesh__dateRevised mesh__D018166 1999-11-03
% 209.18/209.41 |- skos__related mesh__D018166smesh__D018855
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018166 2004
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018166 2001
% 209.18/209.41 |- skos__historyNote mesh__D018166 Health Services %28%1977-1993%29%
% 209.18/209.41 |- mesh__dateCreated mesh__D018166 1993-05-28
% 209.18/209.41 |- skos__historyNote mesh__D018166 Health Policy %28%1981-1993%29%
% 209.18/209.41 |- skos__hiddenLabel mesh__D018166 Reform, Healthcare
% 209.18/209.41 |- skos__hiddenLabel mesh__D018166 Reform, Health Care
% 209.18/209.41 |- skos__hiddenLabel mesh__D018166 Health Care Reforms
% 209.18/209.41 |- mesh__recordMaintainer mesh__D018166 kle
% 209.18/209.41 |- skos__altLabel mesh__D018166 Healthcare Reform
% 209.18/209.41 |- skos__annotation mesh__D018166
% 209.18/209.41 not restricted to US; specify state or country
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018166 2002
% 209.18/209.41 |- mesh__historyNote mesh__D018166 94
% 209.18/209.41 |- skos__broader mesh__D018166smesh__D006285
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D018166 2005
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Ducts, Accessory Pancreatic
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010183 2006
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010183 2001
% 209.18/209.41 |- skos__altLabel mesh__D010183 Wirsung%27%s Duct
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Wirsung Duct
% 209.18/209.41 |- skos__altLabel mesh__D010183 Duct of Santorini
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Pancreatic Duct, Main
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Minor Duodenal Papilla
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Santorinis Duct
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Ducts, Main Pancreatic
% 209.18/209.41 |- skos__altLabel mesh__D010183 Santorini%27%s Duct
% 209.18/209.41 |- mesh__recordMaintainer mesh__D010183 jls
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Duct, Pancreatic
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Accessory Pancreatic Ducts
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Duct, Accessory Pancreatic
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Ducts, Pancreatic
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010183 2005
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Duct, Main Pancreatic
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Duodenal Papillas, Minor
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010183 2004
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Pancreatic Duct, Accessory
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Pancreatic Duct
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Papillas, Minor Duodenal
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Main Pancreatic Ducts
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Pancreatic Ducts, Main
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010183 2003
% 209.18/209.41 |- skos__broader mesh__D010183smesh__D010179
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Duct, Wirsung%27%s
% 209.18/209.41 |- skos__scopeNote mesh__D010183
% 209.18/209.41 Ducts that collect PANCREATIC JUICE from the PANCREAS and supply it to the DUODENUM.%A%
% 209.18/209.41 |- mesh__recordOriginator mesh__D010183 NLM
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010183 2005B
% 209.18/209.41 |- skos__annotation mesh__D010183
% 209.18/209.41 note X ref DUODENAL PAPILLA, MINOR: do not confuse with DUODENAL PAPILLA, MAJOR see VATER%27%S AMPULLA; %22%duodenal papilla%22% unspecified is probably DUODENAL PAPILLA, MAJOR%A%
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Wirsungs Duct
% 209.18/209.41 |- skos__altLabel mesh__D010183 Duct of Wirsung
% 209.18/209.41 |- skos__hiddenLabel mesh__D010183 Papilla, Minor Duodenal
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010183 2005A
% 209.18/209.41 |- mesh__recordAuthorizer mesh__D010183 jls
% 209.18/209.41 |- mesh__dateCreated mesh__D010183 1999-01-01
% 209.18/209.41 |- mesh__activeMeSHYear mesh__D010183 2002
% 209.18/209.42 |- rdf__type mesh__D010183sskos__Concept
% 209.18/209.42 |- skos__hiddenLabel mesh__D010183 Minor Duodenal Papillas
% 209.18/209.42 |- skos__hiddenLabel mesh__D010183 Pancreatic Ducts, Accessory
% 209.18/209.42 |- skos__hiddenLabel mesh__D010183 Duct, Santorini%27%s
% 209.18/209.42 |- skos__hiddenLabel mesh__D010183 Santorini Duct
% 209.18/209.42 |- mesh__dateRevised mesh__D010183 2004-07-30
% 209.18/209.42 |- skos__prefLabel mesh__D010183 Pancreatic Ducts
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004944 2004
% 209.18/209.42 |- skos__annotation mesh__D004944
% 209.18/209.42 do not use /util except by MeSH definition
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004944 2003
% 209.18/209.42 |- mesh__dateCreated mesh__D004944 1999-01-01
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004944 2002
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004944 1999
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004944 2001
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004944 1998
% 209.18/209.42 |- skos__prefLabel mesh__D004944 Esophagoplasty
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004944 2006
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004944 2000
% 209.18/209.42 |- mesh__recordOriginator mesh__D004944 NLM
% 209.18/209.42 |- skos__broader mesh__D004944smesh__D013505
% 209.18/209.42 |- rdf__type mesh__D004944sskos__Concept
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004944 2005
% 209.18/209.42 |- mesh__recordMaintainer mesh__D004944 PXP
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D004944 SJN
% 209.18/209.42 |- skos__scopeNote mesh__D004944
% 209.18/209.42 A plastic operation on the esophagus. %28%Dorland, 28th ed%29%%A%
% 209.18/209.42 |- mesh__dateRevised mesh__D004944 1997-06-20
% 209.18/209.42 |- skos__hiddenLabel mesh__D004944 Esophagoplasties
% 209.18/209.42 |- mesh__dateRevised mesh__D004146 1992-05-13
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 2005
% 209.18/209.42 |- mesh__onlineNote mesh__D004146 use DIOXINS to search DIOXANES 1966-74
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 2004
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 2002
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 1999
% 209.18/209.42 |- mesh__recordOriginator mesh__D004146 NLM
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D004146 PLS
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 2003
% 209.18/209.42 |- mesh__dateEstablished mesh__D004146 1991-01-01
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 1998
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 1997
% 209.18/209.42 |- skos__scopeNote mesh__D004146
% 209.18/209.42 1,4-Diethylene dioxides. Industrial solvents. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, dioxane itself may %22%reasonably be anticipated to be a carcinogen.%22% %28%Merck Index, 11th ed%29%%A%
% 209.18/209.42 |- mesh__dateCreated mesh__D004146 1999-01-01
% 209.18/209.42 |- mesh__publicMeSHNote mesh__D004146
% 209.18/209.42 91,63-67; was see under DIOXINS 1968-90; was heading 1963-67%A%
% 209.18/209.42 |- mesh__recordMaintainer mesh__D004146 TAP
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 1996
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 2001
% 209.18/209.42 |- skos__broader mesh__D004146smesh__D004147
% 209.18/209.42 |- skos__annotation mesh__D004146 indust solvents
% 209.18/209.42 |- rdf__type mesh__D004146sskos__Concept
% 209.18/209.42 |- skos__prefLabel mesh__D004146 Dioxanes
% 209.18/209.42 |- mesh__historyNote mesh__D004146
% 209.18/209.42 91%28%75%29%63-67; was see under DIOXINS 1968-90; was heading 1963-67%A%
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 1995
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 2000
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 2006
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 1994
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004146 1993
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D014574 2006
% 209.18/209.42 |- mesh__recordMaintainer mesh__D014574 ssb
% 209.18/209.42 |- skos__prefLabel mesh__D014574 Uronic Acids
% 209.18/209.42 |- mesh__dateRevised mesh__D014574 2004-07-07
% 209.18/209.42 |- skos__broader mesh__D014574smesh__D013400
% 209.18/209.42 |- skos__broader mesh__D014574smesh__D000145
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D014574 sjn
% 209.18/209.42 |- skos__hiddenLabel mesh__D014574 Acids, Uronic
% 209.18/209.42 |- mesh__dateCreated mesh__D014574 1999-01-01
% 209.18/209.42 |- mesh__recordOriginator mesh__D014574 NLM
% 209.18/209.42 |- rdf__type mesh__D014574sskos__Concept
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D014574 2005
% 209.18/209.42 |- skos__scopeNote mesh__D014574
% 209.18/209.42 Acids derived from monosaccharides by the oxidation of the terminal %28%-CH2OH%29% group farthest removed from the carbonyl group to a %28%-COOH%29% group. %28%From Stedmans, 26th ed%29%%A%
% 209.18/209.42 |- skos__hiddenLabel mesh__D008537 Tarsal Gland
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D008537 2004
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D008537 2005
% 209.18/209.42 |- mesh__dateCreated mesh__D008537 1999-01-01
% 209.18/209.42 |- mesh__historyNote mesh__D008537
% 209.18/209.42 91%28%75%29%; was see under EYELIDS 1975-90
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D008537 2001
% 209.18/209.42 |- skos__broader mesh__D008537smesh__D005143
% 209.18/209.42 |- skos__hiddenLabel mesh__D008537 Gland, Meibomian
% 209.18/209.42 |- rdf__type mesh__D008537sskos__Concept
% 209.18/209.42 |- skos__related mesh__D008537smesh__D017043
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D008537 2003
% 209.18/209.42 |- skos__prefLabel mesh__D008537 Meibomian Glands
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D008537 2000
% 209.18/209.42 |- skos__scopeNote mesh__D008537
% 209.18/209.42 The sebaceous glands situated on the inner surface of the eyelids between the tarsal plates and CONJUNCTIVA.%A%
% 209.18/209.42 |- skos__hiddenLabel mesh__D008537 Gland, Tarsal
% 209.18/209.42 |- mesh__dateEstablished mesh__D008537 1991-01-01
% 209.18/209.42 |- mesh__recordMaintainer mesh__D008537 KEV
% 209.18/209.42 |- mesh__publicMeSHNote mesh__D008537 91; was see under EYELIDS 1975-90
% 209.18/209.42 |- skos__annotation mesh__D008537
% 209.18/209.42 dis: coord IM with EYELID DISEASES %28%IM%29%; neopl: coord IM with EYELID NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 209.18/209.42 |- mesh__dateRevised mesh__D008537 1999-11-03
% 209.18/209.42 |- skos__hiddenLabel mesh__D008537 Meibomian Gland
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D008537 2002
% 209.18/209.42 |- skos__hiddenLabel mesh__D008537 Glands, Tarsal
% 209.18/209.42 |- skos__broader mesh__D008537smesh__D012627
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D008537 sjn
% 209.18/209.42 |- skos__altLabel mesh__D008537 Tarsal Glands
% 209.18/209.42 |- mesh__onlineNote mesh__D008537 search EYELIDS 1966-74
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D008537 2006
% 209.18/209.42 |- skos__hiddenLabel mesh__D008537 Glands, Meibomian
% 209.18/209.42 |- mesh__recordOriginator mesh__D008537 NLM
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Facilities, Ambulatory Care
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Facility, Ambulatory Care
% 209.18/209.42 |- mesh__onlineNote mesh__D000554
% 209.18/209.42 use AMBULATORY CARE FACILITIES to search AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82 %26% HEALTH CENTERS 1979%A%
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D000554 2001
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D000554 2006
% 209.18/209.42 |- skos__altLabel mesh__D000554 Ambulatory Care Facilities, Non-Hospital
% 209.18/209.42 |- mesh__dateRevised mesh__D000554 1999-11-03
% 209.18/209.42 |- skos__prefLabel mesh__D000554 Ambulatory Care Facilities
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Centers, Ambulatory Health
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Activities, Clinic
% 209.18/209.42 |- skos__broader mesh__D000554smesh__D006268
% 209.18/209.42 |- mesh__publicMeSHNote mesh__D000554
% 209.18/209.42 83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979%A%
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D000554 2002
% 209.18/209.42 |- skos__historyNote mesh__D000554 Health Facilities %28%1968-1978%29%
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D000554 sjn
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Free-Standing Clinic
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Clinic, Outpatient
% 209.18/209.42 |- skos__altLabel mesh__D000554 Outpatient Clinic
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Ambulatory Health Center
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Center, Ambulatory Health
% 209.18/209.42 |- mesh__historyNote mesh__D000554
% 209.18/209.42 83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979%A%
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D000554 2003
% 209.18/209.42 |- skos__annotation mesh__D000554 IM
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Free-Standing Clinics
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Center, Family Planning
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Clinics, Free Standing
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Clinic, Free-Standing
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Center, Abortion
% 209.18/209.42 |- skos__scopeNote mesh__D000554
% 209.18/209.42 Those facilities which administer health services to individuals who do not require hospitalization or institutionalization.%A%
% 209.18/209.42 |- mesh__dateCreated mesh__D000554 1978-04-26
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Family Planning Center
% 209.18/209.42 |- mesh__recordOriginator mesh__D000554 EC
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Centers, Family Planning
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D000554 2004
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Clinics, Outpatient
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Ambulatory Health Centers
% 209.18/209.42 |- skos__altLabel mesh__D000554 Outpatient Clinics
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Ambulatory Care Facility
% 209.18/209.42 |- mesh__dateEstablished mesh__D000554 1979-01-01
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Activity, Clinic
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Centers, Abortion
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D000554 2000
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D000554 2005
% 209.18/209.42 |- rdf__type mesh__D000554sskos__Concept
% 209.18/209.42 |- skos__altLabel mesh__D000554 Ambulatory Care Facilities, Nonhospital
% 209.18/209.42 |- mesh__recordMaintainer mesh__D000554 kle
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Clinic Activity
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Abortion Center
% 209.18/209.42 |- skos__hiddenLabel mesh__D000554 Health Center, Ambulatory
% 209.18/209.42 |- skos__altLabel mesh__D000554 Ambulatory Care Facilities, Non Hospital
% 209.18/209.42 |- skos__related mesh__D018965smesh__D016368
% 209.18/209.42 |- mesh__publicMeSHNote mesh__D018965
% 209.18/209.42 96; was RIBOSOMAL FRAMESHIFT see FRAMESHIFT MUTATION 1991-95%A%
% 209.18/209.42 |- skos__historyNote mesh__D018965 Translation, Genetic %28%1979-1995%29%
% 209.18/209.42 |- mesh__dateEstablished mesh__D018965 1996-01-01
% 209.18/209.42 |- skos__hiddenLabel mesh__D018965 Frame Shift, Ribosomal
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D018965 2005
% 209.18/209.42 |- skos__scopeNote mesh__D018965
% 209.18/209.42 A directed change in translational READING FRAMES that allows the production of a single protein from two or more OVERLAPPING GENES. The process is programmed by the nucleotide sequence of the MRNA and is sometimes also affected by the secondary or tertiary mRNA structure. It has been described mainly in VIRUSES %28%especially RETROVIRUSES%29%; RETROTRANSPOSONS; and bacterial insertion elements but also in some cellular genes.%A%
% 209.18/209.42 |- skos__hiddenLabel mesh__D018965 Translational Frameshifting
% 209.18/209.42 |- skos__historyNote mesh__D018965 Frameshift Mutation %28%1991-1995%29%
% 209.18/209.42 |- skos__annotation mesh__D018965
% 209.18/209.42 do not confuse with FRAMESHIFT MUTATION, non-physiol insertion or deletion of coding sequence nucleotides%A%
% 209.18/209.42 |- skos__prefLabel mesh__D018965 Frameshifting, Ribosomal
% 209.18/209.42 |- skos__hiddenLabel mesh__D018965 Frameshift, Ribosomal
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D018965 2006A
% 209.18/209.42 |- skos__hiddenLabel mesh__D018965 Frame Shifts, Ribosomal
% 209.18/209.42 |- skos__altLabel mesh__D018965 Ribosomal Frame Shift
% 209.18/209.42 |- skos__hiddenLabel mesh__D018965 Ribosomal Frameshifts
% 209.18/209.42 |- mesh__dateRevised mesh__D018965 2005-07-28
% 209.18/209.42 |- skos__altLabel mesh__D018965 Ribosomal Frameshift
% 209.18/209.42 |- mesh__onlineNote mesh__D018965
% 209.18/209.42 use FRAMESHIFT MUTATION to search RIBOSOMAL FRAMESHIFT 1991-95%A%
% 209.18/209.42 |- skos__hiddenLabel mesh__D018965 Ribosomal Frame Shifts
% 209.18/209.42 |- mesh__recordMaintainer mesh__D018965 ags
% 209.18/209.42 |- mesh__historyNote mesh__D018965
% 209.18/209.42 96; was RIBOSOMAL FRAMESHIFT see FRAMESHIFT MUTATION 1991-95%A%
% 209.18/209.42 |- skos__altLabel mesh__D018965 Ribosomal Frameshifting
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D018965 ags
% 209.18/209.42 |- skos__historyNote mesh__D018965 Ribosomes %28%1979-1995%29%
% 209.18/209.42 |- skos__altLabel mesh__D018965 Frameshifting, Translational
% 209.18/209.42 |- mesh__dateCreated mesh__D018965 1995-02-22
% 209.18/209.42 |- skos__broader mesh__D018965smesh__D005786
% 209.18/209.42 |- skos__altLabel mesh__D018965 Ribosomal Frame Shifting
% 209.18/209.42 |- rdf__type mesh__D018965sskos__Concept
% 209.18/209.42 |- skos__hiddenLabel mesh__D018965 Frameshifts, Ribosomal
% 209.18/209.42 |- skos__hiddenLabel mesh__D018965 Frame Shifting, Ribosomal
% 209.18/209.42 |- skos__broader mesh__D018965smesh__D014176
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D018965 2006
% 209.18/209.42 |- mesh__recordOriginator mesh__D018965 AGS
% 209.18/209.42 |- skos__hiddenLabel mesh__D010982 Factor, Platelet-Derived Growth
% 209.18/209.42 |- mesh__dateEstablished mesh__D010982 1984-01-01
% 209.18/209.42 |- skos__broader mesh__D010982smesh__D006133
% 209.18/209.42 |- mesh__publicMeSHNote mesh__D010982 84
% 209.18/209.42 |- skos__historyNote mesh__D010982 Peptides %28%1977-1983%29%
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D010982 sjn
% 209.18/209.42 |- mesh__recordOriginator mesh__D010982 RLS
% 209.18/209.42 |- mesh__dateCreated mesh__D010982 1983-05-31
% 209.18/209.42 |- skos__historyNote mesh__D010982 Growth Substances %28%1977-1983%29%
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D010982 2006
% 209.18/209.42 |- mesh__dateRevised mesh__D010982 2005-06-30
% 209.18/209.42 |- skos__broader mesh__D010982smesh__D036341
% 209.18/209.42 |- mesh__recordMaintainer mesh__D010982 ssb
% 209.18/209.42 |- skos__annotation mesh__D010982 /biosyn /physiol permitted; DF: PDGF
% 209.18/209.42 |- skos__scopeNote mesh__D010982
% 209.18/209.42 Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication.%A%
% 209.18/209.42 |- skos__historyNote mesh__D010982 Blood Proteins %28%1977-1983%29%
% 209.18/209.42 |- skos__hiddenLabel mesh__D010982 Growth Factor, Platelet-Derived
% 209.18/209.42 |- skos__broader mesh__D010982smesh__D001798
% 209.18/209.42 |- skos__prefLabel mesh__D010982 Platelet-Derived Growth Factor
% 209.18/209.42 |- skos__related mesh__D010982smesh__D017479
% 209.18/209.42 |- skos__altLabel mesh__D010982 Platelet Derived Growth Factor
% 209.18/209.42 |- mesh__historyNote mesh__D010982 84
% 209.18/209.42 |- rdf__type mesh__D010982sskos__Concept
% 209.18/209.42 |- skos__altLabel mesh__D018167 1,25-Dihydroxyvitamin D 3 Receptor
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 Receptors, 1,25-Dihydroxyvitamin D3
% 209.18/209.42 |- skos__altLabel mesh__D018167 Calcitriol Receptor
% 209.18/209.42 |- mesh__recordOriginator mesh__D018167 RAZ
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 Receptor, Vitamin D3
% 209.18/209.42 |- skos__historyNote mesh__D018167 Receptors, Steroid %28%1980-1993%29%
% 209.18/209.42 |- skos__altLabel mesh__D018167 Receptors, Vitamin D3
% 209.18/209.42 |- skos__altLabel mesh__D018167 Vitamin D3 Receptor
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxyvitamin D3 Receptors
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 D Receptors, Vitamin
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 Receptor, 1,25-Dihydroxycholecalciferol
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 D3 Receptor, 1,25-Dihydroxyvitamin
% 209.18/209.42 |- skos__altLabel mesh__D018167 Receptors, Vitamin D 3
% 209.18/209.42 |- skos__altLabel mesh__D018167 1,25-Dihydroxyvitamin D3 Receptors
% 209.18/209.42 |- mesh__historyNote mesh__D018167
% 209.18/209.42 94; was 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR %28%NM%29% 1980-93; VITAMIN D3 RECEPTOR was %28%NM%29% 1988-93%A%
% 209.18/209.42 |- skos__altLabel mesh__D018167 Receptors, 1,25-Dihydroxyvitamin D 3
% 209.18/209.42 |- skos__broader mesh__D018167smesh__D018160
% 209.18/209.42 |- skos__altLabel mesh__D018167 1,25-Dihydroxyvitamin D3 Receptor
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxycholecalciferol Receptors
% 209.18/209.42 |- skos__altLabel mesh__D018167 Receptors, Cholecalciferol
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 Receptor, Vitamin D
% 209.18/209.42 |- skos__altLabel mesh__D018167 Receptors, Vitamin D
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 D3 Receptors, 1,25-Dihydroxyvitamin
% 209.18/209.42 |- skos__altLabel mesh__D018167 Vitamin D Receptors
% 209.18/209.42 |- mesh__dateRevised mesh__D018167 2005-06-30
% 209.18/209.42 |- mesh__dateCreated mesh__D018167 1993-06-21
% 209.18/209.42 |- skos__altLabel mesh__D018167 Vitamin D Receptor
% 209.18/209.42 |- skos__altLabel mesh__D018167 1,25-Dihydroxycholecalciferol Receptor
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 D3 Receptor, Vitamin
% 209.18/209.42 |- mesh__recordMaintainer mesh__D018167 ssb
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 D3 Receptors, Vitamin
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxyvitamin D 3 Receptor
% 209.18/209.42 |- skos__altLabel mesh__D018167 Vitamin D 3 Receptors
% 209.18/209.42 |- skos__prefLabel mesh__D018167 Receptors, Calcitriol
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 D Receptor, Vitamin
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxycholecalciferol Receptor
% 209.18/209.42 |- skos__broader mesh__D018167smesh__D014157
% 209.18/209.42 |- skos__annotation mesh__D018167 DF: RECEPT CALCITRIOL
% 209.18/209.42 |- skos__altLabel mesh__D018167 Vitamin D 3 Receptor
% 209.18/209.42 |- skos__altLabel mesh__D018167 Cholecalciferol Receptors
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxyvitamin D3 Receptor
% 209.18/209.42 |- skos__altLabel mesh__D018167 1,25-Dihydroxycholecalciferol Receptors
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 Receptors, 1,25-Dihydroxycholecalciferol
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D018167 sjn
% 209.18/209.42 |- skos__altLabel mesh__D018167 Vitamin D3 Receptors
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 Receptor, 1,25-Dihydroxyvitamin D3
% 209.18/209.42 |- mesh__onlineNote mesh__D018167
% 209.18/209.42 use RECEPTORS, CALCITRIOL %28%NM%29% to search 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR 1980-93 %26% VITAMIN D3 RECEPTOR 1988-93%A%
% 209.18/209.42 |- mesh__publicMeSHNote mesh__D018167
% 209.18/209.42 94; 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR was indexed under RECEPTORS, STEROID 1980-93; VITAMIN D3 RECEPTOR was indexed under RECEPTORS, STEROID 1988-93%A%
% 209.18/209.42 |- skos__scopeNote mesh__D018167
% 209.18/209.42 Proteins, usually found in the cytoplasm, that specifically bind calcitriol, migrate to the nucleus, and regulate transcription of specific segments of DNA with the participation of D receptor interacting proteins %28%called DRIP%29%. Vitamin D is converted in the liver and kidney to calcitriol and ultimately acts through these receptors.%A%
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D018167 2006
% 209.18/209.42 |- mesh__dateEstablished mesh__D018167 1994-01-01
% 209.18/209.42 |- rdf__type mesh__D018167sskos__Concept
% 209.18/209.42 |- skos__altLabel mesh__D018167 Calcitriol Receptors
% 209.18/209.42 |- skos__hiddenLabel mesh__D018167 Receptor, Calcitriol
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D010184 2006
% 209.18/209.42 |- mesh__recordMaintainer mesh__D010184 ssb
% 209.18/209.42 |- skos__broader mesh__D010184smesh__D014020
% 209.18/209.42 |- skos__prefLabel mesh__D010184 Pancreatic Extracts
% 209.18/209.42 |- skos__hiddenLabel mesh__D010184 Extracts, Pancreatic
% 209.18/209.42 |- rdf__type mesh__D010184sskos__Concept
% 209.18/209.42 |- skos__annotation mesh__D010184
% 209.18/209.42 extracts of pancreas or pancreatic fractions containing uncharacterized factors; do not confuse with chemical substances %22%extracted%22% from the pancreas, as %22%peptides extracted from the mouse pancreas%22% %28% = PEPTIDES /anal + PANCREAS /anal%29%; PANCREATIN, a pancreatic extract, is also available%A%
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D010184 sjn
% 209.18/209.42 |- mesh__dateCreated mesh__D010184 1999-01-01
% 209.18/209.42 |- skos__scopeNote mesh__D010184
% 209.18/209.42 Extracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities. PANCREATIN is a specific extract containing digestive enzymes and used to treat pancreatic insufficiency.%A%
% 209.18/209.42 |- mesh__dateRevised mesh__D010184 2005-06-30
% 209.18/209.42 |- mesh__recordOriginator mesh__D010184 NLM
% 209.18/209.42 |- mesh__dateRevised mesh__D004945 1999-11-04
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D004945 sjn
% 209.18/209.42 |- skos__hiddenLabel mesh__D004945 Esophagoscopies
% 209.18/209.42 |- mesh__dateCreated mesh__D004945 1999-01-01
% 209.18/209.42 |- skos__hiddenLabel mesh__D004945 Procedures, Esophagoscopic Surgical
% 209.18/209.42 |- skos__scopeNote mesh__D004945
% 209.18/209.42 Endoscopic examination, therapy or surgery of the esophagus.%A%
% 209.18/209.42 |- skos__hiddenLabel mesh__D004945 Procedure, Esophagoscopic Surgical
% 209.18/209.42 |- skos__prefLabel mesh__D004945 Esophagoscopy
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004945 2006
% 209.18/209.42 |- skos__altLabel mesh__D004945 Esophagoscopic Surgery
% 209.18/209.42 |- skos__broader mesh__D004945smesh__D016145
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004945 2002
% 209.18/209.42 |- rdf__type mesh__D004945sskos__Concept
% 209.18/209.42 |- skos__hiddenLabel mesh__D004945 Esophagoscopic Surgeries
% 209.18/209.42 |- mesh__recordMaintainer mesh__D004945 nns
% 209.18/209.42 |- skos__hiddenLabel mesh__D004945 Surgeries, Esophagoscopic
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004945 2005
% 209.18/209.42 |- skos__hiddenLabel mesh__D004945 Esophagoscopic Surgical Procedure
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004945 2001
% 209.18/209.42 |- skos__altLabel mesh__D004945 Surgical Procedures, Esophagoscopic
% 209.18/209.42 |- skos__altLabel mesh__D004945 Surgery, Esophagoscopic
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004945 2004
% 209.18/209.42 |- skos__hiddenLabel mesh__D004945 Surgical Procedure, Esophagoscopic
% 209.18/209.42 |- mesh__recordOriginator mesh__D004945 NLM
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004945 2000
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004945 2003
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004147 2004
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004147 2002
% 209.18/209.42 |- mesh__dateEstablished mesh__D004147 1968-01-01
% 209.18/209.42 |- mesh__dateRevised mesh__D004147 2000-06-22
% 209.18/209.42 |- skos__scopeNote mesh__D004147
% 209.18/209.42 Chlorinated hydrocarbons containing heteroatoms that are present as contaminants of herbicides. Dioxins are carcinogenic, teratogenic, and mutagenic. They have been banned from use by the FDA.%A%
% 209.18/209.42 |- mesh__recordOriginator mesh__D004147 NLM
% 209.18/209.42 |- mesh__historyNote mesh__D004147 68
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004147 2005
% 209.18/209.42 |- rdf__type mesh__D004147sskos__Concept
% 209.18/209.42 |- mesh__recordMaintainer mesh__D004147 adp
% 209.18/209.42 |- skos__prefLabel mesh__D004147 Dioxins
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D004147 sjn
% 209.18/209.42 |- mesh__publicMeSHNote mesh__D004147 68; DIOXANES was heading 1963-67
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004147 2006
% 209.18/209.42 |- skos__broader mesh__D004147smesh__D006573
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004147 2003
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D004147 2001
% 209.18/209.42 |- mesh__dateCreated mesh__D004147 1999-01-01
% 209.18/209.42 |- mesh__publicMeSHNote mesh__D009630 82
% 209.18/209.42 |- mesh__recordAuthorizer mesh__D009630 sjn
% 209.18/209.42 |- mesh__dateEstablished mesh__D009630 1982-01-01
% 209.18/209.42 |- skos__hiddenLabel mesh__D009630 Non-Disjunctions, Genetic
% 209.18/209.42 |- mesh__dateRevised mesh__D009630 2004-07-07
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D009630 2006
% 209.18/209.42 |- skos__historyNote mesh__D009630 Cell Division %28%1966-1967%29%
% 209.18/209.42 |- skos__broader mesh__D009630smesh__D020090
% 209.18/209.42 |- skos__broader mesh__D009630smesh__D002869
% 209.18/209.42 |- skos__historyNote mesh__D009630 Meiosis %28%1968-1981%29%
% 209.18/209.42 |- skos__hiddenLabel mesh__D009630 Non Disjunction, Genetic
% 209.18/209.42 |- skos__altLabel mesh__D009630 Non-Disjunction, Genetic
% 209.18/209.42 |- mesh__recordOriginator mesh__D009630 AEP
% 209.18/209.42 |- rdf__type mesh__D009630sskos__Concept
% 209.18/209.42 |- mesh__activeMeSHYear mesh__D009630 2005
% 209.18/209.42 |- skos__hiddenLabel mesh__D009630 Genetic Non-Disjunctions
% 209.18/209.42 |- skos__historyNote mesh__D009630 Chromosomes %28%1966-1967%29%
% 209.18/209.42 |- mesh__historyNote mesh__D009630 82
% 209.18/209.42 |- skos__scopeNote mesh__D009630
% 209.18/209.42 The failure of homologous CHROMOSOMES or CHROMATIDS to segregate during MITOSIS or MEIOSIS with the result that one daughter cell has both of a pair of parental chromosomes or chromatids and the other has none.%A%
% 209.28/209.42 |- skos__historyNote mesh__D009630 Chromosome Aberrations %28%1968-1981%29%
% 209.28/209.42 |- mesh__recordMaintainer mesh__D009630 nns
% 209.28/209.42 |- skos__broader mesh__D009630smesh__D016296
% 209.28/209.42 |- skos__prefLabel mesh__D009630 Nondisjunction, Genetic
% 209.28/209.42 |- skos__hiddenLabel mesh__D009630 Genetic Non Disjunction
% 209.28/209.42 |- skos__altLabel mesh__D009630 Genetic Nondisjunction
% 209.28/209.42 |- skos__altLabel mesh__D009630 Genetic Non-Disjunction
% 209.28/209.42 |- skos__hiddenLabel mesh__D009630 Nondisjunctions, Genetic
% 209.28/209.42 |- skos__hiddenLabel mesh__D009630 Genetic Nondisjunctions
% 209.28/209.42 |- mesh__dateCreated mesh__D009630 1981-02-23
% 209.28/209.42 |- skos__historyNote mesh__D014575 Porphyrinogens %28%1975%29%
% 209.28/209.42 |- skos__altLabel mesh__D014575 Uroporphyrinogen Carboxy-Lyase
% 209.28/209.42 |- skos__hiddenLabel mesh__D014575 Uroporphyrinogen Carboxy Lyase
% 209.28/209.42 |- mesh__publicMeSHNote mesh__D014575
% 209.28/209.42 91; was see under CARBOXY-LYASES 1976-90
% 209.28/209.42 |- mesh__recordMaintainer mesh__D014575 ags
% 209.28/209.42 |- skos__hiddenLabel mesh__D014575 Decarboxylase, Uroporphyrinogen
% 209.28/209.42 |- mesh__recordOriginator mesh__D014575 RLS
% 209.28/209.42 |- mesh__dateEstablished mesh__D014575 1991-01-01
% 209.28/209.42 |- skos__historyNote mesh__D014575 Porphyrins %28%1974%29%
% 209.28/209.42 |- skos__hiddenLabel mesh__D014575 Decarboxylase, Uroporphyrinogen III
% 209.28/209.42 |- skos__historyNote mesh__D014575 Carboxy-Lyases %28%1974-1975%29%
% 209.28/209.42 |- mesh__historyNote mesh__D014575
% 209.28/209.42 91%28%76%29%; was see under CARBOXY-LYASES 1976-90
% 209.28/209.42 |- skos__altLabel mesh__D014575 Uroporphyrinogen III Decarboxylase
% 209.28/209.42 |- skos__annotation mesh__D014575
% 209.28/209.42 /defic permitted but consider also PORPHYRIA CUTANEA TARDA and HEPATOERYTHROPOIETIC PORPHYRIA%A%
% 209.28/209.42 |- mesh__recordAuthorizer mesh__D014575 ags
% 209.28/209.42 |- skos__broader mesh__D014575smesh__D002262
% 209.28/209.42 |- rdf__type mesh__D014575sskos__Concept
% 209.28/209.42 |- mesh__dateCreated mesh__D014575 1975-07-25
% 209.28/209.42 |- mesh__dateRevised mesh__D014575 2005-07-12
% 209.28/209.42 |- mesh__activeMeSHYear mesh__D014575 2005
% 209.28/209.42 |- mesh__activeMeSHYear mesh__D014575 2006A
% 209.28/209.42 |- skos__hiddenLabel mesh__D014575 Carboxy-Lyase, Uroporphyrinogen
% 209.28/209.42 |- skos__scopeNote mesh__D014575
% 209.28/209.42 An enzyme that catalyzes the decarboxylation of UROPORPHYRINOGEN III to coproporphyrinogen III by the conversion of four acetate groups to four methyl groups. It is the fifth enzyme in the 8-enzyme biosynthetic pathway of HEME. Several forms of cutaneous PORPHYRIAS are results of this enzyme deficiency as in PORPHYRIA CUTANEA TARDA; and HEPATOERYTHROPOIETIC PORPHYRIA.%A%
% 209.28/209.42 |- mesh__activeMeSHYear mesh__D014575 2006
% 209.28/209.42 |- skos__prefLabel mesh__D014575 Uroporphyrinogen Decarboxylase
% 209.28/209.42 |- skos__altLabel mesh__D008538
% 209.28/209.42 Idiopathic Blepharospasm-Oromandibular Dystonia Syndrome
% 209.28/209.42 |- skos__hiddenLabel mesh__D008538 Blepharospasm Oromandibular Dystonia
% 209.28/209.42 |- skos__hiddenLabel mesh__D008538
% 209.28/209.42 Idiopathic Blepharospasm Oromandibular Dystonia Syndrome
% 209.28/209.42 |- skos__hiddenLabel mesh__D008538 Orofacial Dyskinesias, Idiopathic
% 209.28/209.42 |- rdf__type mesh__D008538sskos__Concept
% 209.28/209.42 |- mesh__dateEstablished mesh__D008538 1991-01-01
% 209.28/209.42 |- skos__scopeNote mesh__D008538
% 209.28/209.42 A syndrome characterized by orofacial DYSTONIA; including BLEPHAROSPASM; forceful jaw opening; lip retraction; platysma muscle spasm; and tongue protrusion. It primarily affects older adults, with an incidence peak in the seventh decade of life. %28%From Adams et al., Principles of Neurology, 6th ed, p108%29%%A%
% 209.28/209.42 |- skos__prefLabel mesh__D008538 Meige Syndrome
% 209.28/209.42 |- mesh__publicMeSHNote mesh__D008538
% 209.28/209.42 1991; see BASAL GANGLIA DISEASES 1985-1990
% 209.28/209.42 |- skos__hiddenLabel mesh__D008538 Blepharospasm-Oromandibular Dyskinesias
% 209.28/209.42 |- skos__hiddenLabel mesh__D008538 Dyskinesias, Idiopathic Orofacial
% 209.28/209.42 |- skos__hiddenLabel mesh__D008538 Dystonias, Blepharospasm-Oromandibular
% 209.28/209.42 |- mesh__activeMeSHYear mesh__D008538 2006
% 209.28/209.42 |- mesh__historyNote mesh__D008538 1991%28%1985%29%
% 209.28/209.42 |- skos__altLabel mesh__D008538 Idiopathic Orofacial Dyskinesia
% 209.28/209.42 |- mesh__recordOriginator mesh__D008538 RC
% 209.28/209.42 |- skos__historyNote mesh__D008538 Facial Muscles %28%1966-1984%29%
% 209.28/209.42 |- mesh__dateCreated mesh__D008538 1984-06-05
% 209.28/209.42 |- skos__hiddenLabel mesh__D008538 Dyskinesia, Idiopathic Orofacial
% 209.28/209.42 |- mesh__recordMaintainer mesh__D008538 sjn
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538 Blepharospasm-Oromandibular Dystonias
% 209.28/209.43 |- skos__historyNote mesh__D008538 Dystonia %28%1982-1984%29%
% 209.28/209.43 |- skos__altLabel mesh__D008538 Brueghel Syndrome
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538
% 209.28/209.43 Blepharospasm Oromandibular Dystonia Syndrome
% 209.28/209.43 |- skos__annotation mesh__D008538
% 209.28/209.43 note X refs: do not confuse with Meige Syndrome of familial lymphedema %28% = MILROY%27%S DISEASE see LYMPHEDEMA%29% nor with MEIGS SYNDROME%A%
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538 Blepharospasm Oromandibular Dyskinesia
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538 Dystonia, Blepharospasm-Oromandibular
% 209.28/209.43 |- skos__broader mesh__D008538smesh__D020821
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538 Dyskinesia, Blepharospasm-Oromandibular
% 209.28/209.43 |- mesh__dateRevised mesh__D008538 2005-07-01
% 209.28/209.43 |- skos__altLabel mesh__D008538
% 209.28/209.43 Blepharospasm-Oromandibular Dystonia Syndrome
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538
% 209.28/209.43 Blepharospasm Oromandibular Dystonia Syndrome, Idiopathic
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538
% 209.28/209.43 Dystonia Syndromes, Blepharospasm-Oromandibular
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538 Orofacial Dyskinesia, Idiopathic
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538
% 209.28/209.43 Dystonia Syndrome, Blepharospasm-Oromandibular
% 209.28/209.43 |- skos__altLabel mesh__D008538 Blepharospasm-Oromandibular Dystonia
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538
% 209.28/209.43 Blepharospasm-Oromandibular Dystonia Syndromes
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538 Idiopathic Orofacial Dyskinesias
% 209.28/209.43 |- skos__altLabel mesh__D008538
% 209.28/209.43 Syndrome, Blepharospasm-Oromandibular Dystonia
% 209.28/209.43 |- skos__historyNote mesh__D008538 Blepharospasm %28%1975-1984%29%
% 209.28/209.43 |- skos__altLabel mesh__D008538
% 209.28/209.43 Blepharospasm-Oromandibular Dystonia Syndrome, Idiopathic
% 209.28/209.43 |- skos__altLabel mesh__D008538 Blepharospasm-Oromandibular Dyskinesia
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D008538 sjn
% 209.28/209.43 |- skos__broader mesh__D008538smesh__D001480
% 209.28/209.43 |- skos__hiddenLabel mesh__D008538 Dyskinesias, Blepharospasm-Oromandibular
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 1998
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 2004
% 209.28/209.43 |- skos__annotation mesh__D000555 IM
% 209.28/209.43 |- skos__prefLabel mesh__D000555 Ambulatory Care Information Systems
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 2001
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 1997
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 2003
% 209.28/209.43 |- skos__broader mesh__D000555smesh__D006751
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 2000
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 1996
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D000555 PLS
% 209.28/209.43 |- mesh__dateEstablished mesh__D000555 1991-01-01
% 209.28/209.43 |- rdf__type mesh__D000555sskos__Concept
% 209.28/209.43 |- mesh__recordOriginator mesh__D000555 EC
% 209.28/209.43 |- mesh__dateRevised mesh__D000555 1994-05-05
% 209.28/209.43 |- skos__scopeNote mesh__D000555
% 209.28/209.43 Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of ambulatory care services and facilities.%A%
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 2006
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 1995
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D000555
% 209.28/209.43 91; was see under INFORMATION SYSTEMS 1987-90
% 209.28/209.43 |- skos__broader mesh__D000555smesh__D008331
% 209.28/209.43 |- mesh__dateCreated mesh__D000555 1986-06-17
% 209.28/209.43 |- mesh__recordMaintainer mesh__D000555 TGC
% 209.28/209.43 |- mesh__historyNote mesh__D000555
% 209.28/209.43 91%28%87%29%; was see under INFORMATION SYSTEMS 1987-90
% 209.28/209.43 |- skos__altLabel mesh__D000555 Information Systems, Ambulatory Care
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 1999
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 2005
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000555 2002
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 2004
% 209.28/209.43 |- skos__hiddenLabel mesh__D019260 Emotion, Expressed
% 209.28/209.43 |- skos__hiddenLabel mesh__D019260 Expressed Emotions
% 209.28/209.43 |- skos__scopeNote mesh__D019260
% 209.28/209.43 Frequency and quality of negative emotions, e.g., anger or hostility, expressed by family members or significant others, that often lead to a high relapse rate, especially in schizophrenic patients. %28%APA, Thesaurus of Psychological Index Terms, 7th ed%29%%A%
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 2001
% 209.28/209.43 |- skos__broader mesh__D019260smesh__D004644
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 2006
% 209.28/209.43 |- mesh__dateEstablished mesh__D019260 1997-01-01
% 209.28/209.43 |- rdf__type mesh__D019260sskos__Concept
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 1998
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 1997
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D019260 97
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 1999
% 209.28/209.43 |- mesh__dateCreated mesh__D019260 1996-06-10
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 2002
% 209.28/209.43 |- skos__hiddenLabel mesh__D019260 Emotions, Expressed
% 209.28/209.43 |- skos__historyNote mesh__D019260 Emotions %28%1966-1996%29%
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 2003
% 209.28/209.43 |- skos__annotation mesh__D019260
% 209.28/209.43 negative emotions like anger %26% hostility: coord IM with specific emotion %28%IM%29% if relevant%A%
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 2000
% 209.28/209.43 |- mesh__historyNote mesh__D019260 97
% 209.28/209.43 |- skos__prefLabel mesh__D019260 Expressed Emotion
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D019260 2005
% 209.28/209.43 |- rdf__type mesh__D005240sskos__Concept
% 209.28/209.43 |- skos__broader mesh__D005240smesh__D016020
% 209.28/209.43 |- skos__scopeNote mesh__D005240
% 209.28/209.43 Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project.%A%
% 209.28/209.43 |- skos__prefLabel mesh__D005240 Feasibility Studies
% 209.28/209.43 |- skos__annotation mesh__D005240
% 209.28/209.43 IM GEN only; coord NIM with specific subject %28%IM%29%; no qualif%A%
% 209.28/209.43 |- mesh__dateCreated mesh__D005240 1979-05-31
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D005240 sjn
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D005240 2005
% 209.28/209.43 |- skos__broader mesh__D005240smesh__D012106
% 209.28/209.43 |- mesh__dateRevised mesh__D005240 2001-07-25
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D005240 2006
% 209.28/209.43 |- skos__hiddenLabel mesh__D005240 Study, Feasibility
% 209.28/209.43 |- skos__hiddenLabel mesh__D005240 Studies, Feasibility
% 209.28/209.43 |- skos__hiddenLabel mesh__D005240 Feasibility Study
% 209.28/209.43 |- mesh__historyNote mesh__D005240 80
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D005240 2003
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D005240 80
% 209.28/209.43 |- mesh__dateEstablished mesh__D005240 1980-01-01
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D005240 2004
% 209.28/209.43 |- mesh__recordOriginator mesh__D005240 EC
% 209.28/209.43 |- mesh__recordMaintainer mesh__D005240 ags
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D005240 2002
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 1997
% 209.28/209.43 |- skos__annotation mesh__D018966
% 209.28/209.43 print %26% non-print materials in libraries: not restricted to books%A%
% 209.28/209.43 |- skos__broader mesh__D018966smesh__D003146
% 209.28/209.43 |- mesh__historyNote mesh__D018966 96
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 1999
% 209.28/209.43 |- skos__prefLabel mesh__D018966 Library Materials
% 209.28/209.43 |- mesh__dateEstablished mesh__D018966 1996-01-01
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 2000
% 209.28/209.43 |- skos__scopeNote mesh__D018966
% 209.28/209.43 Print and non-print materials collected, processed, and stored by libraries. They comprise books, periodicals, pamphlets, reports, microforms, maps, manuscripts, motion pictures, and all other forms of audiovisual records. %28%Harrod, The Librarians%27% Glossary, 4th ed, p497%29%%A%
% 209.28/209.43 |- skos__hiddenLabel mesh__D018966 Materials, Library
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 2001
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 2003
% 209.28/209.43 |- skos__hiddenLabel mesh__D018966 Material, Library
% 209.28/209.43 |- skos__hiddenLabel mesh__D018966 Library Material
% 209.28/209.43 |- mesh__dateCreated mesh__D018966 1995-02-22
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 2005
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 2004
% 209.28/209.43 |- rdf__type mesh__D018966sskos__Concept
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 1996
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 2002
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D018966 96
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 2006
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018966 1998
% 209.28/209.43 |- skos__altLabel mesh__D010983 Blood Plateletpheresis
% 209.28/209.43 |- mesh__dateEstablished mesh__D010983 1991-01-01
% 209.28/209.43 |- skos__historyNote mesh__D010983 Plasmapheresis %28%1978%29%
% 209.28/209.43 |- skos__historyNote mesh__D010983 Blood Transfusion %28%1966-1978%29%
% 209.28/209.43 |- skos__altLabel mesh__D010983 Thrombocytapheresis
% 209.28/209.43 |- skos__hiddenLabel mesh__D010983 Thrombocytophereses
% 209.28/209.43 |- mesh__historyNote mesh__D010983
% 209.28/209.43 91%28%79%29%; was see under BLOOD COMPONENT REMOVAL 1986-90; was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978%A%
% 209.28/209.43 |- skos__hiddenLabel mesh__D010983 Plateletphereses, Blood
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D010983
% 209.28/209.43 91; was see under BLOOD COMPONENT REMOVAL 1986-90; was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978%A%
% 209.28/209.43 |- mesh__dateCreated mesh__D010983 1978-01-26
% 209.28/209.43 |- skos__hiddenLabel mesh__D010983 Plateletpheresis, Blood
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D010983 2006
% 209.28/209.43 |- skos__hiddenLabel mesh__D010983 Blood Plateletphereses
% 209.28/209.43 |- skos__historyNote mesh__D010983 Blood Platelets %28%1966-1978%29%
% 209.28/209.43 |- skos__hiddenLabel mesh__D010983 Thrombocytaphereses
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D010983 sjn
% 209.28/209.43 |- mesh__recordOriginator mesh__D010983 SMH
% 209.28/209.43 |- skos__broader mesh__D010983smesh__D016238
% 209.28/209.43 |- skos__historyNote mesh__D010983 Cell Separation %28%1972-1978%29%
% 209.28/209.43 |- skos__scopeNote mesh__D010983
% 209.28/209.43 The preparation of platelet concentrates with the return of red cells and platelet-poor plasma to the donor.%A%
% 209.28/209.43 |- mesh__onlineNote mesh__D010983 search PLASMAPHERESIS 1978
% 209.28/209.43 |- skos__hiddenLabel mesh__D010983 Plateletphereses
% 209.28/209.43 |- skos__prefLabel mesh__D010983 Plateletpheresis
% 209.28/209.43 |- mesh__dateRevised mesh__D010983 2005-06-30
% 209.28/209.43 |- rdf__type mesh__D010983sskos__Concept
% 209.28/209.43 |- skos__annotation mesh__D010983
% 209.28/209.43 do not use /util except by MeSH definition; removal of platelets %26% return of plateletless blood to donor: do not confuse with PLATELET TRANSFUSION%A%
% 209.28/209.43 |- mesh__recordMaintainer mesh__D010983 lkt
% 209.28/209.43 |- skos__altLabel mesh__D010983 Thrombocytopheresis
% 209.28/209.43 |- skos__prefLabel mesh__D018168 Receptors, Retinoic Acid
% 209.28/209.43 |- skos__hiddenLabel mesh__D018168 Proteins, Retinoic Acid-Binding
% 209.28/209.43 |- mesh__historyNote mesh__D018168
% 209.28/209.43 94; was RETINOIC ACID-BINDING PROTEINS %28%NM%29% 1976-93
% 209.28/209.43 |- skos__annotation mesh__D018168 DF: RECEPT RETINOIC ACID
% 209.28/209.43 |- skos__broader mesh__D018168smesh__D014157
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D018168
% 209.28/209.43 94; RETINOIC ACID-BINDING PROTEINS was indexed under CARRIER PROTEINS 1979-93 and under PROTEINS %26% PROTEIN BINDING 1976-78%A%
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018168 2005
% 209.28/209.43 |- mesh__dateRevised mesh__D018168 2004-07-07
% 209.28/209.43 |- skos__historyNote mesh__D018168 Proteins %28%1976-1978%29%
% 209.28/209.43 |- mesh__recordOriginator mesh__D018168 RAZ
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D018168 2006
% 209.28/209.43 |- skos__related mesh__D018168smesh__D012177
% 209.28/209.43 |- mesh__recordMaintainer mesh__D018168 ssb
% 209.28/209.43 |- mesh__onlineNote mesh__D018168
% 209.28/209.43 use RECEPTORS, RETINOIC ACID %28%NM%29% to search RETINOIC ACID-BINDING PROTEINS 1980-93%A%
% 209.28/209.43 |- mesh__dateEstablished mesh__D018168 1994-01-01
% 209.28/209.43 |- skos__scopeNote mesh__D018168
% 209.28/209.43 Proteins in the nucleus or cytoplasm that specifically bind RETINOIC ACID or RETINOL and trigger changes in the behavior of cells. Retinoic acid receptors, like steroid receptors, are ligand-activated transcription regulators. Several types have been recognized.%A%
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D018168 sjn
% 209.28/209.43 |- rdf__type mesh__D018168sskos__Concept
% 209.28/209.43 |- skos__historyNote mesh__D018168 Carrier Proteins %28%1979-1993%29%
% 209.28/209.43 |- skos__historyNote mesh__D018168 Protein Binding %28%1976-1978%29%
% 209.28/209.43 |- skos__hiddenLabel mesh__D018168 Retinoic Acid Binding Proteins
% 209.28/209.43 |- skos__hiddenLabel mesh__D018168 Receptor, Retinoic Acid
% 209.28/209.43 |- skos__broader mesh__D018168smesh__D018160
% 209.28/209.43 |- skos__altLabel mesh__D018168 Retinoic Acid Receptors
% 209.28/209.43 |- skos__altLabel mesh__D018168 Retinoic Acid Receptor
% 209.28/209.43 |- mesh__dateCreated mesh__D018168 1993-06-21
% 209.28/209.43 |- mesh__recordOriginator mesh__D010185 NLM
% 209.28/209.43 |- skos__hiddenLabel mesh__D010185 Pancreatic Fistulas
% 209.28/209.43 |- skos__prefLabel mesh__D010185 Pancreatic Fistula
% 209.28/209.43 |- skos__hiddenLabel mesh__D010185 Fistula, Pancreatic
% 209.28/209.43 |- skos__broader mesh__D010185smesh__D010182
% 209.28/209.43 |- mesh__dateRevised mesh__D010185 2004-07-07
% 209.28/209.43 |- mesh__recordMaintainer mesh__D010185 lkt
% 209.28/209.43 |- rdf__type mesh__D010185sskos__Concept
% 209.28/209.43 |- mesh__dateCreated mesh__D010185 1999-01-01
% 209.28/209.43 |- skos__hiddenLabel mesh__D010185 Fistulas, Pancreatic
% 209.28/209.43 |- skos__scopeNote mesh__D010185
% 209.28/209.43 Abnormal passage communicating with the PANCREAS.
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D010185 2005
% 209.28/209.43 |- skos__broader mesh__D010185smesh__D016154
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D010185 sjn
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D010185 2006
% 209.28/209.43 |- skos__annotation mesh__D010185 fistula policy: Manual 23.19+
% 209.28/209.43 |- skos__hiddenLabel mesh__D004946 Esophagostomy, Cervical
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004946 1998
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004946 2006
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004946 2001
% 209.28/209.43 |- rdf__type mesh__D004946sskos__Concept
% 209.28/209.43 |- skos__broader mesh__D004946smesh__D013505
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004946 2005
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004946 2000
% 209.28/209.43 |- mesh__dateEstablished mesh__D004946 1988-01-01
% 209.28/209.43 |- skos__hiddenLabel mesh__D004946 Esophagostomies
% 209.28/209.43 |- skos__hiddenLabel mesh__D004946 Esophagostomies, Cervical
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004946 2004
% 209.28/209.43 |- mesh__recordMaintainer mesh__D004946 PXP
% 209.28/209.43 |- skos__scopeNote mesh__D004946
% 209.28/209.43 Surgical formation of an external opening %28%stoma%29% into the esophagus.%A%
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D004946 SJN
% 209.28/209.43 |- skos__annotation mesh__D004946
% 209.28/209.43 do not use /util except by MeSH definition
% 209.28/209.43 |- mesh__dateRevised mesh__D004946 1997-06-20
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004946 2003
% 209.28/209.43 |- skos__broader mesh__D004946smesh__D010030
% 209.28/209.43 |- mesh__dateCreated mesh__D004946 1987-03-19
% 209.28/209.43 |- skos__hiddenLabel mesh__D004946 Cervical Esophagostomies
% 209.28/209.43 |- skos__historyNote mesh__D004946 Esophagus/surgery %28%1966-1987%29%
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004946 1999
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004946 2002
% 209.28/209.43 |- mesh__historyNote mesh__D004946 88
% 209.28/209.43 |- mesh__recordOriginator mesh__D004946 SCD
% 209.28/209.43 |- skos__prefLabel mesh__D004946 Esophagostomy
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D004946 88
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D037322 2003
% 209.28/209.43 |- skos__altLabel mesh__D037322 Thyrotropin, beta Chain
% 209.28/209.43 |- mesh__dateCreated mesh__D037322 2002-07-03
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D037322 2005
% 209.28/209.43 |- skos__scopeNote mesh__D037322
% 209.28/209.43 The beta subunit of thyroid stimulating hormone, thyrotropin. It is a 112-amino acid glycopolypeptide of about 16 kD. Full biological activity of TSH requires the non-covalently bound heterodimers of an alpha and a beta subunit.%A%
% 209.28/209.43 |- skos__historyNote mesh__D037322 Thyrotropin %28%1975-2002%29%
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D037322 2004
% 209.28/209.43 |- skos__altLabel mesh__D037322 Thyroid Stimulating Hormone, beta Subunit
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D037322 2006
% 209.28/209.43 |- skos__hiddenLabel mesh__D037322 TSH beta
% 209.28/209.43 |- skos__altLabel mesh__D037322 TSH, beta Subunit
% 209.28/209.43 |- mesh__historyNote mesh__D037322
% 209.28/209.43 2003; use THYROTROPIN, BETA SUBUNIT %28%NM%29% 1983-2002
% 209.28/209.43 |- skos__altLabel mesh__D037322 TSHB Gene Product
% 209.28/209.43 |- skos__broader mesh__D037322smesh__D013972
% 209.28/209.43 |- skos__altLabel mesh__D037322 TSH, beta Chain
% 209.28/209.43 |- mesh__dateEstablished mesh__D037322 2003-01-01
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D037322
% 209.28/209.43 2003; THYROTROPIN, BETA SUBUNIT was indexed under THYROTROPIN 1983-2002%A%
% 209.28/209.43 |- rdf__type mesh__D037322sskos__Concept
% 209.28/209.43 |- skos__altLabel mesh__D037322 Thyrotropin, beta Polypeptide Chain
% 209.28/209.43 |- skos__altLabel mesh__D037322 Thyrotropin-beta
% 209.28/209.43 |- skos__hiddenLabel mesh__D037322 Thyrotropin beta
% 209.28/209.43 |- skos__prefLabel mesh__D037322 Thyrotropin, beta Subunit
% 209.28/209.43 |- skos__altLabel mesh__D037322 TSH-beta
% 209.28/209.43 |- mesh__onlineNote mesh__D004148 search DIOXOLES 1968-74
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 1997
% 209.28/209.43 |- mesh__recordMaintainer mesh__D004148 TAP
% 209.28/209.43 |- skos__prefLabel mesh__D004148 Dioxolanes
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 2001
% 209.28/209.43 |- mesh__dateRevised mesh__D004148 1992-05-13
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 2002
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D004148 PLS
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 1994
% 209.28/209.43 |- mesh__historyNote mesh__D004148
% 209.28/209.43 91%28%75%29%; was see under DIOXOLES 1975-90
% 209.28/209.43 |- mesh__dateEstablished mesh__D004148 1991-01-01
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 2005
% 209.28/209.43 |- rdf__type mesh__D004148sskos__Concept
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 1995
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 2006
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 2003
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 1998
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 1993
% 209.28/209.43 |- mesh__dateCreated mesh__D004148 1999-01-01
% 209.28/209.43 |- mesh__recordOriginator mesh__D004148 NLM
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D004148 91; was see under DIOXOLES 1975-90
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 2004
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 1999
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 1996
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D004148 2000
% 209.28/209.43 |- skos__broader mesh__D004148smesh__D004149
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 2006
% 209.28/209.43 |- mesh__recordOriginator mesh__D009631 NLM
% 209.28/209.43 |- skos__hiddenLabel mesh__D009631 Cyst, Nonodontogenic
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 1996
% 209.28/209.43 |- rdf__type mesh__D009631sskos__Concept
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 2005
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 1995
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D009631 65
% 209.28/209.43 |- skos__hiddenLabel mesh__D009631 Nonodontogenic Cyst
% 209.28/209.43 |- skos__prefLabel mesh__D009631 Nonodontogenic Cysts
% 209.28/209.43 |- mesh__dateCreated mesh__D009631 1999-01-01
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 2004
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 1994
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 2002
% 209.28/209.43 |- mesh__dateRevised mesh__D009631 1993-06-02
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 2003
% 209.28/209.43 |- skos__annotation mesh__D009631
% 209.28/209.43 non-neoplastic; of jaw; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/dis term %28%IM%29%%A%
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 1999
% 209.28/209.43 |- skos__scopeNote mesh__D009631
% 209.28/209.43 Cysts formed from epithelial inclusions in the lines of fusion of the embryonic processes which form the jaws. They include nasopalatine or incisive canal cyst, incisive papilla cyst, globulomaxillary cyst, median palatal cyst, median alveolar cyst, median mandibular cyst, and nasoalveolar cyst.%A%
% 209.28/209.43 |- mesh__recordMaintainer mesh__D009631 TGC
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 2001
% 209.28/209.43 |- skos__hiddenLabel mesh__D009631 Cysts, Nonodontogenic
% 209.28/209.43 |- mesh__dateEstablished mesh__D009631 1965-01-01
% 209.28/209.43 |- skos__broader mesh__D009631smesh__D007570
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D009631 PLS
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 1998
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 2000
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D009631 1997
% 209.28/209.43 |- mesh__historyNote mesh__D009631 65
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D023302 2006
% 209.28/209.43 |- mesh__dateCreated mesh__D023302 2000-07-06
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D023302 2005
% 209.28/209.43 |- skos__prefLabel mesh__D023302 Protein Footprinting
% 209.28/209.43 |- mesh__recordMaintainer mesh__D023302 lkt
% 209.28/209.43 |- mesh__historyNote mesh__D023302 2001
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D023302 2004
% 209.28/209.43 |- mesh__dateRevised mesh__D023302 2002-07-03
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D023302 2003
% 209.28/209.43 |- mesh__dateEstablished mesh__D023302 2001-01-01
% 209.28/209.43 |- skos__hiddenLabel mesh__D023302 Footprint, Protein
% 209.28/209.43 |- skos__scopeNote mesh__D023302
% 209.28/209.43 A method for determining points of contact between interacting proteins or binding sites of proteins to nucleic acids. Protein footprinting utilizes a protein cutting reagent or protease. Protein cleavage is inhibited where the proteins, or nucleic acids and protein, contact each other. After completion of the cutting reaction, the remaining peptide fragments are analyzed by electrophoresis.%A%
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D023302 2001
% 209.28/209.43 |- skos__broader mesh__D023302smesh__D010449
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D023302 sjn
% 209.28/209.43 |- rdf__type mesh__D023302sskos__Concept
% 209.28/209.43 |- skos__hiddenLabel mesh__D023302 Footprinting, Protein
% 209.28/209.43 |- skos__hiddenLabel mesh__D023302 Protein Footprint
% 209.28/209.43 |- mesh__recordOriginator mesh__D023302 nns
% 209.28/209.43 |- skos__altLabel mesh__D023302 Footprints, Protein
% 209.28/209.43 |- skos__altLabel mesh__D014576 Uroporphyrinogen Isomerase
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D014576 2005A
% 209.28/209.43 |- skos__historyNote mesh__D014576 Isomerases %28%1971-1974%29%
% 209.28/209.43 |- skos__altLabel mesh__D014576 Cosynthase
% 209.28/209.43 |- mesh__historyNote mesh__D014576 2005 %28%1975%29%
% 209.28/209.43 |- skos__broader mesh__D014576smesh__D006836
% 209.28/209.43 |- mesh__dateCreated mesh__D014576 1974-11-19
% 209.28/209.43 |- skos__hiddenLabel mesh__D014576 Isomerase, Uroporphyrinogen
% 209.28/209.43 |- mesh__dateRevised mesh__D014576 2004-10-20
% 209.28/209.43 |- skos__altLabel mesh__D014576 Uroporphyrinogen III Cosynthetase
% 209.28/209.43 |- skos__hiddenLabel mesh__D014576 Synthase, Uroporphyrinogen-III
% 209.28/209.43 |- skos__hiddenLabel mesh__D014576 Cosynthetase, Uroporphyrinogen III
% 209.28/209.43 |- rdf__type mesh__D014576sskos__Concept
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D014576 2005
% 209.28/209.43 |- mesh__recordOriginator mesh__D014576 NLM
% 209.28/209.43 |- skos__altLabel mesh__D014576 Uroporphyrinogen-III Synthase
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D014576 2006
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D014576
% 209.28/209.43 2005; see UROPORPHYRINOGEN-III SYNTHASE 1998-2004, see UROPORPHYRINOGEN III SYNTHASE 1991-1997, see HYDRO-LYASES 1985-1990, see ISOMERASES 1975-1984%A%
% 209.28/209.43 |- skos__hiddenLabel mesh__D014576 Uroporphyrinogen III Synthase
% 209.28/209.43 |- skos__historyNote mesh__D014576 Porphobilinogen %28%1973-1974%29%
% 209.28/209.43 |- skos__prefLabel mesh__D014576 Uroporphyrinogen III Synthetase
% 209.28/209.43 |- skos__scopeNote mesh__D014576
% 209.28/209.43 An enzyme that catalyzes the cyclization of hydroxymethylbilane to yield UROPORPHYRINOGEN III and water. It is the fourth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by UROS gene. Mutations of UROS gene result in CONGENITAL ERYTHROPOIETIC PORPHYRIA.%A%
% 209.28/209.43 |- skos__hiddenLabel mesh__D014576 Synthetase, Uroporphyrinogen III
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D014576 sjn
% 209.28/209.43 |- mesh__dateEstablished mesh__D014576 1991-01-01
% 209.28/209.43 |- mesh__recordMaintainer mesh__D014576 sjn
% 209.28/209.43 |- rdf__type mesh__D008539sskos__Concept
% 209.28/209.43 |- mesh__recordMaintainer mesh__D008539 lkt
% 209.28/209.43 |- skos__annotation mesh__D008539 do not confuse with MEIGE SYNDROME
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D008539 sjn
% 209.28/209.43 |- mesh__dateEstablished mesh__D008539 1965-01-01
% 209.28/209.43 |- mesh__dateCreated mesh__D008539 1999-01-01
% 209.28/209.43 |- skos__broader mesh__D008539smesh__D010051
% 209.28/209.43 |- skos__prefLabel mesh__D008539 Meigs Syndrome
% 209.28/209.43 |- mesh__recordOriginator mesh__D008539 NLM
% 209.28/209.43 |- skos__hiddenLabel mesh__D008539 Meig Syndrome
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D008539 2006
% 209.28/209.43 |- skos__hiddenLabel mesh__D008539 Meig%27%s Syndrome
% 209.28/209.43 |- mesh__dateRevised mesh__D008539 2005-06-30
% 209.28/209.43 |- skos__altLabel mesh__D008539 Meigs%27% Syndrome
% 209.28/209.43 |- mesh__historyNote mesh__D008539 2006 %28%1964%29%
% 209.28/209.43 |- mesh__publicMeSHNote mesh__D008539
% 209.28/209.43 2006; see MEIGS%27% SYNDROME 1964-2005
% 209.28/209.43 |- skos__scopeNote mesh__D008539
% 209.28/209.43 The triad of benign FIBROMA or other ovarian tumors with ASCITES, and HYDROTHORAX due to large PLEURAL EFFUSIONS.%A%
% 209.28/209.43 |- skos__altLabel mesh__D000556 Ambulatory Surgical Procedure
% 209.28/209.43 |- skos__prefLabel mesh__D000556 Ambulatory Surgical Procedures
% 209.28/209.43 |- mesh__historyNote mesh__D000556 98%28%80%29%
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000556 2000
% 209.28/209.43 |- skos__altLabel mesh__D000556 Office Surgery
% 209.28/209.43 |- skos__historyNote mesh__D000556 Ambulatory Care %28%1966-1979%29%
% 209.28/209.43 |- skos__historyNote mesh__D000556
% 209.28/209.43 Outpatient Clinics, Hospital %28%1966-1979%29%
% 209.28/209.43 |- skos__altLabel mesh__D000556 Surgical Procedure, Ambulatory
% 209.28/209.43 |- skos__hiddenLabel mesh__D000556 Ambulatory Surgeries
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000556 2004
% 209.28/209.43 |- mesh__dateCreated mesh__D000556 1979-04-25
% 209.28/209.43 |- mesh__recordMaintainer mesh__D000556 PXP
% 209.28/209.43 |- skos__annotation mesh__D000556
% 209.28/209.43 outpatient surg performed in MD%27%s office, surgicenter or hosp%A%
% 209.28/209.43 |- skos__altLabel mesh__D000556 Procedure, Ambulatory Surgical
% 209.28/209.43 |- skos__altLabel mesh__D000556 Surgery, Ambulatory
% 209.28/209.43 |- mesh__recordAuthorizer mesh__D000556 SJN
% 209.28/209.43 |- mesh__recordOriginator mesh__D000556 SMH
% 209.28/209.43 |- skos__altLabel mesh__D000556 Surgical Procedures, Ambulatory
% 209.28/209.43 |- mesh__activeMeSHYear mesh__D000556 2003
% 209.28/209.44 |- rdf__type mesh__D000556sskos__Concept
% 209.28/209.44 |- skos__altLabel mesh__D000556 Procedures, Ambulatory Surgical
% 209.28/209.44 |- skos__hiddenLabel mesh__D000556 Outpatient Surgeries
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D000556 2002
% 209.28/209.44 |- skos__altLabel mesh__D000556 Surgery, Outpatient
% 209.28/209.44 |- skos__altLabel mesh__D000556 Ambulatory Surgery
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D000556 1999
% 209.28/209.44 |- skos__hiddenLabel mesh__D000556 Surgeries, Outpatient
% 209.28/209.44 |- skos__related mesh__D000556smesh__D013531
% 209.28/209.44 |- mesh__dateEstablished mesh__D000556 1980-01-01
% 209.28/209.44 |- mesh__dateRevised mesh__D000556 1997-06-20
% 209.28/209.44 |- skos__hiddenLabel mesh__D000556 Surgeries, Office
% 209.28/209.44 |- skos__hiddenLabel mesh__D000556 Surgeries, Ambulatory
% 209.28/209.44 |- skos__hiddenLabel mesh__D000556 Surgeries, Day
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D000556 2006
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D000556 1998
% 209.28/209.44 |- skos__scopeNote mesh__D000556
% 209.28/209.44 Surgery performed on an outpatient basis. It may be hospital-based or performed in an office or surgicenter.%A%
% 209.28/209.44 |- skos__broader mesh__D000556smesh__D013514
% 209.28/209.44 |- skos__hiddenLabel mesh__D000556 Office Surgeries
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D000556 98; see AMBULATORY SURGERY 1980-97
% 209.28/209.44 |- skos__hiddenLabel mesh__D000556 Day Surgeries
% 209.28/209.44 |- skos__altLabel mesh__D000556 Outpatient Surgery
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D000556 2001
% 209.28/209.44 |- skos__altLabel mesh__D000556 Day Surgery
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D000556 2005
% 209.28/209.44 |- skos__broader mesh__D019261smesh__D008032
% 209.28/209.44 |- mesh__recordMaintainer mesh__D019261 ags
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D019261 sjn
% 209.28/209.44 |- mesh__dateRevised mesh__D019261 1999-11-03
% 209.28/209.44 |- mesh__recordOriginator mesh__D019261 RAZ
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019261 2000
% 209.28/209.44 |- skos__scopeNote mesh__D019261
% 209.28/209.44 The dorsal posterior subdivision of the diencephalon. The epithalamus is generally considered to include the habenular nuclei %28%HABENULA%29% and associated fiber bundles, the PINEAL BODY, and the epithelial roof of the third ventricle. The anterior and posterior paraventricular nuclei of the thalamus are included with the THALAMIC NUCLEI although they develop from the same pronuclear mass as the epithalamic nuclei and are sometimes considered part of the epithalamus.%A%
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019261 2003
% 209.28/209.44 |- mesh__dateEstablished mesh__D019261 1997-01-01
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019261 2001
% 209.28/209.44 |- mesh__historyNote mesh__D019261 97
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019261 2005
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019261 2004
% 209.28/209.44 |- skos__prefLabel mesh__D019261 Epithalamus
% 209.28/209.44 |- skos__broader mesh__D019261smesh__D004027
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019261 2006
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D019261 97
% 209.28/209.44 |- rdf__type mesh__D019261sskos__Concept
% 209.28/209.44 |- mesh__dateCreated mesh__D019261 1996-06-10
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019261 2002
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1993
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 2005
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1999
% 209.28/209.44 |- mesh__historyNote mesh__D005241 66%28%63%29%
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 2002
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1990
% 209.28/209.44 |- skos__prefLabel mesh__D005241 Feathers
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 2006
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1996
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D005241 66
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 2003
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1997
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 2000
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 2004
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1994
% 209.28/209.44 |- mesh__recordOriginator mesh__D005241 NLM
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1991
% 209.28/209.44 |- mesh__dateEstablished mesh__D005241 1966-01-01
% 209.28/209.44 |- skos__broader mesh__D005241smesh__D000825
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 2001
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1995
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D005241 NLM
% 209.28/209.44 |- rdf__type mesh__D005241sskos__Concept
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1992
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1989
% 209.28/209.44 |- mesh__dateCreated mesh__D005241 1999-01-01
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005241 1998
% 209.28/209.44 |- mesh__recordMaintainer mesh__D005241 GJB
% 209.28/209.44 |- mesh__dateRevised mesh__D005241 1978-11-07
% 209.28/209.44 |- skos__hiddenLabel mesh__D005241 Feather
% 209.28/209.44 |- skos__altLabel mesh__D018967 R-64766
% 209.28/209.44 |- mesh__dateRevised mesh__D018967 2004-07-07
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D018967
% 209.28/209.44 96; RISPERIDONE was indexed under ISOXAZOLES %26% PIPERIDINES 1988-95%A%
% 209.28/209.44 |- skos__hiddenLabel mesh__D018967 R64766
% 209.28/209.44 |- mesh__onlineNote mesh__D018967
% 209.28/209.44 use RISPERIDONE %28%NM%29% to search RISPERIDONE 1988-95
% 209.28/209.44 |- skos__hiddenLabel mesh__D018967 Consta, Risperdal
% 209.28/209.44 |- skos__prefLabel mesh__D018967 Risperidone
% 209.28/209.44 |- skos__historyNote mesh__D018967 Piperidines %28%1988-1995%29%
% 209.28/209.44 |- mesh__dateCreated mesh__D018967 1995-06-05
% 209.28/209.44 |- skos__hiddenLabel mesh__D018967 R 64766
% 209.28/209.44 |- mesh__dateEstablished mesh__D018967 1996-01-01
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018967 2005
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D018967 sjn
% 209.28/209.44 |- rdf__type mesh__D018967sskos__Concept
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018967 2006
% 209.28/209.44 |- skos__hiddenLabel mesh__D018967 R64,766
% 209.28/209.44 |- mesh__historyNote mesh__D018967
% 209.28/209.44 96; was RISPERIDONE %28%NM%29% 1988-95
% 209.28/209.44 |- skos__scopeNote mesh__D018967
% 209.28/209.44 A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.%A%
% 209.28/209.44 |- skos__hiddenLabel mesh__D018967 R 64,766
% 209.28/209.44 |- skos__historyNote mesh__D018967 Isoxazoles %28%1988-1995%29%
% 209.28/209.44 |- mesh__recordMaintainer mesh__D018967 ssb
% 209.28/209.44 |- mesh__recordOriginator mesh__D018967 TPW
% 209.28/209.44 |- skos__broader mesh__D018967smesh__D011744
% 209.28/209.44 |- skos__related mesh__D010984smesh__D009944
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010984 2003
% 209.28/209.44 |- skos__altLabel mesh__D010984 Platinum Black
% 209.28/209.44 |- skos__broader mesh__D010984smesh__D028561
% 209.28/209.44 |- skos__annotation mesh__D010984
% 209.28/209.44 Pt-195; Pt-194, 196, 198 = PLATINUM %28%IM%29% + ISOTOPES %28%NIM%29%; Pt-173-193, 197, 199, 200 = PLATINUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010984 2006
% 209.28/209.44 |- mesh__recordOriginator mesh__D010984 NLM
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010984 2004
% 209.28/209.44 |- mesh__dateCreated mesh__D010984 1999-01-01
% 209.28/209.44 |- skos__broader mesh__D010984smesh__D019216
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010984 2002
% 209.28/209.44 |- rdf__type mesh__D010984sskos__Concept
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D010984 sjn
% 209.28/209.44 |- skos__scopeNote mesh__D010984
% 209.28/209.44 Platinum. A heavy, soft, whitish metal, resembling tin, atomic number 78, atomic weight 195.09, symbol Pt. %28%From Dorland, 28th ed%29% It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder %28%platinum black%29% and as a spongy substance %28%spongy platinum%29% and may have been known in Pliny%27%s time as %22%alutiae%22%.%A%
% 209.28/209.44 |- mesh__dateRevised mesh__D010984 2001-07-25
% 209.28/209.44 |- mesh__recordMaintainer mesh__D010984 jmp
% 209.28/209.44 |- skos__prefLabel mesh__D010984 Platinum
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010984 2005
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 2005
% 209.28/209.44 |- mesh__historyNote mesh__D018169 94
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 1997
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 2006
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 2000
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 1998
% 209.28/209.44 |- mesh__dateRevised mesh__D018169 2005-07-12
% 209.28/209.44 |- skos__annotation mesh__D018169
% 209.28/209.44 a genus of the subfamily Chordopoxvirinae; mollusci- refers to agent of the disease molluscum contagiosum, not to mollusks; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%%A%
% 209.28/209.44 |- skos__prefLabel mesh__D018169 Molluscipoxvirus
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 2001
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 1994
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 1999
% 209.28/209.44 |- skos__scopeNote mesh__D018169
% 209.28/209.44 A genus of POXVIRIDAE, subfamily CHORDOPOXVIRINAE, infecting humans. Transmission is by direct contact among children, by sexual contact among young adults, or by fomites. MOLLUSCUM CONTAGIOSUM VIRUS is the type species.%A%
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D018169 ags
% 209.28/209.44 |- skos__broader mesh__D018169smesh__D018147
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 2002
% 209.28/209.44 |- rdf__type mesh__D018169sskos__Concept
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 1995
% 209.28/209.44 |- mesh__recordOriginator mesh__D018169 AGS
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 2003
% 209.28/209.44 |- mesh__dateCreated mesh__D018169 1993-06-04
% 209.28/209.44 |- mesh__dateEstablished mesh__D018169 1994-01-01
% 209.28/209.44 |- skos__hiddenLabel mesh__D018169 Molluscipoxviruses
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 2004
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D018169 94
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 1996
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018169 2006A
% 209.28/209.44 |- mesh__recordMaintainer mesh__D018169 ags
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010186 2006
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010186 1999
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010186 2002
% 209.28/209.44 |- skos__historyNote mesh__D010186 Pancreas %28%1966-1979%29%
% 209.28/209.44 |- mesh__dateEstablished mesh__D010186 1980-01-01
% 209.28/209.44 |- skos__hiddenLabel mesh__D010186 Function Tests, Pancreatic
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010186 2005
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D010186 SJN
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010186 1998
% 209.28/209.44 |- skos__hiddenLabel mesh__D010186 Test, Pancreatic Function
% 209.28/209.44 |- skos__prefLabel mesh__D010186 Pancreatic Function Tests
% 209.28/209.44 |- mesh__recordMaintainer mesh__D010186 PXP
% 209.28/209.44 |- skos__broader mesh__D010186smesh__D003938
% 209.28/209.44 |- skos__historyNote mesh__D010186 Pancreatic Diseases %28%1966-1979%29%
% 209.28/209.44 |- rdf__type mesh__D010186sskos__Concept
% 209.28/209.44 |- mesh__dateRevised mesh__D010186 1997-06-20
% 209.28/209.44 |- mesh__dateCreated mesh__D010186 1979-03-12
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010186 2001
% 209.28/209.44 |- skos__scopeNote mesh__D010186
% 209.28/209.44 Tests based on the biochemistry and physiology of the exocrine pancreas and involving analysis of blood, duodenal contents, feces, or urine for products of pancreatic secretion.%A%
% 209.28/209.44 |- mesh__recordOriginator mesh__D010186 SMH
% 209.28/209.44 |- skos__hiddenLabel mesh__D010186 Pancreatic Function Test
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010186 2004
% 209.28/209.44 |- skos__hiddenLabel mesh__D010186 Tests, Pancreatic Function
% 209.28/209.44 |- skos__historyNote mesh__D010186 specific pancreatic disease
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010186 2000
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D010186 80
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010186 2003
% 209.28/209.44 |- mesh__historyNote mesh__D010186 80
% 209.28/209.44 |- skos__hiddenLabel mesh__D010186 Function Test, Pancreatic
% 209.28/209.44 |- rdf__type mesh__D004947sskos__Concept
% 209.28/209.44 |- skos__prefLabel mesh__D004947 Esophagus
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004947 2005
% 209.28/209.44 |- mesh__recordMaintainer mesh__D004947 ags
% 209.28/209.44 |- skos__related mesh__D004947smesh__D004945
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004947 2004
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004947 2006A
% 209.28/209.44 |- skos__annotation mesh__D004947
% 209.28/209.44 /blood supply: ESOPHAGEAL AND GASTRIC VARICES is available: see note there; /surg: consider also ESOPHAGECTOMY; ESOPHAGOPLASTY; or ESOPHAGOSTOMY; inflammation = ESOPHAGITIS; hemorrhage = ESOPHAGEAL DISEASES %28%IM%29% + GASTROINTESTINAL HEMORRHAGE %28%NIM%29%; rupture: index under ESOPHAGUS /inj %28%IM%29% + RUPTURE %28%NIM%29% or ESOPHAGEAL DISEASES %28%IM%29% + RUPTURE, SPONTANEOUS %28%NIM%29%; peristalsis of the esophagus = ESOPHAGUS /physiol %28%IM%29% + PERISTALSIS %28%NIM%29%; esophageal intubation = ESOPHAGUS %28%IM%29% + INTUBATION %28%IM%29%; esophageal obturator airway = ESOPHAGUS %28%IM%29% + INTUBATION /instrum %28%IM%29%%A%
% 209.28/209.44 |- skos__related mesh__D004947smesh__D004946
% 209.28/209.44 |- skos__scopeNote mesh__D004947
% 209.28/209.44 The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.%A%
% 209.28/209.44 |- mesh__dateCreated mesh__D004947 1999-01-01
% 209.28/209.44 |- mesh__dateRevised mesh__D004947 2005-07-13
% 209.28/209.44 |- mesh__recordOriginator mesh__D004947 NLM
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D004947 ags
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004947 2006
% 209.28/209.44 |- skos__broader mesh__D004947smesh__D041742
% 209.28/209.44 |- skos__related mesh__D004947smesh__D004944
% 209.28/209.44 |- skos__related mesh__D004947smesh__D016629
% 209.28/209.44 |- skos__historyNote mesh__D004149 Heterocyclic Compounds %28%1966-1967%29%
% 209.28/209.44 |- rdf__type mesh__D004149sskos__Concept
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 2005
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 1995
% 209.28/209.44 |- mesh__recordOriginator mesh__D004149 NLM
% 209.28/209.44 |- mesh__historyNote mesh__D004149 68
% 209.28/209.44 |- skos__broader mesh__D004149smesh__D006573
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 2006
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 2003
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 1998
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 1993
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 2000
% 209.28/209.44 |- mesh__dateCreated mesh__D004149 1999-01-01
% 209.28/209.44 |- mesh__recordMaintainer mesh__D004149 TAP
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 2004
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 1999
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 1996
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 2001
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D004149 68
% 209.28/209.44 |- mesh__dateRevised mesh__D004149 1992-05-13
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 1997
% 209.28/209.44 |- skos__prefLabel mesh__D004149 Dioxoles
% 209.28/209.44 |- mesh__dateEstablished mesh__D004149 1968-01-01
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 2002
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D004149 PLS
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D004149 1994
% 209.28/209.44 |- skos__scopeNote mesh__D009632
% 209.28/209.44 A blood protein %28%NSILA%29% which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of Cohn fraction III, 10%25% of the activity is found in the supernatant %28%NSILA-S%29% and the remaining activity in the precipitate %28%NSILA-P%29%. The latter is a large molecular compound, much less stable than the soluble fraction. NSILA-S is a more potent growth factor than insulin and exhibits sulfation activity.%A%
% 209.28/209.44 |- mesh__dateRevised mesh__D009632 2005-06-30
% 209.28/209.44 |- mesh__dateEstablished mesh__D009632 1977-01-01
% 209.28/209.44 |- skos__historyNote mesh__D009632 Insulin %28%1966-1976%29%
% 209.28/209.44 |- rdf__type mesh__D009632sskos__Concept
% 209.28/209.44 |- skos__hiddenLabel mesh__D009632 Insulin-Like Activity, Nonsuppressible
% 209.28/209.44 |- skos__hiddenLabel mesh__D009632 Activity, Nonsuppressible Insulin-Like
% 209.28/209.44 |- mesh__recordOriginator mesh__D009632 RLS
% 209.28/209.44 |- skos__historyNote mesh__D009632 Blood Proteins %28%1966-1976%29%
% 209.28/209.44 |- skos__broader mesh__D009632smesh__D013002
% 209.28/209.44 |- skos__altLabel mesh__D009632 NSILA
% 209.28/209.44 |- mesh__dateCreated mesh__D009632 1976-05-19
% 209.28/209.44 |- skos__altLabel mesh__D009632 Nonsuppressible Insulinlike Activity
% 209.28/209.44 |- skos__hiddenLabel mesh__D009632 Activity, Nonsuppressible Insulinlike
% 209.28/209.44 |- skos__prefLabel mesh__D009632 Nonsuppressible Insulin-Like Activity
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D009632 sjn
% 209.28/209.44 |- skos__hiddenLabel mesh__D009632 Insulinlike Activity, Nonsuppressible
% 209.28/209.44 |- skos__hiddenLabel mesh__D009632 Nonsuppressible Insulin Like Activity
% 209.28/209.44 |- mesh__recordMaintainer mesh__D009632 ssb
% 209.28/209.44 |- mesh__historyNote mesh__D009632 77
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D009632 77
% 209.28/209.44 |- skos__annotation mesh__D009632
% 209.28/209.44 note category; a blood protein mimicking blood insulin
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D009632 2006
% 209.28/209.44 |- skos__hiddenLabel mesh__D023303 1,3 Oxazolidine 2 one
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D023303
% 209.28/209.44 2001; 1,3-OXAZOLIDINE-2-ONE %28%now OXAZOLIDIONES%29% was indexed under OXAZOLES 1995-2000%A%
% 209.28/209.44 |- mesh__historyNote mesh__D023303
% 209.28/209.44 2001; use OXAZOLIDINONES %28%NM%29% 1995-2000
% 209.28/209.44 |- mesh__dateRevised mesh__D023303 2005-06-30
% 209.28/209.44 |- skos__historyNote mesh__D023303 Oxazoles %28%1995-2000%29%
% 209.28/209.44 |- skos__altLabel mesh__D023303 1,3-Oxazolidin-2-one
% 209.28/209.44 |- skos__altLabel mesh__D023303 2-oxazolidinone
% 209.28/209.44 |- mesh__dateEstablished mesh__D023303 2001-01-01
% 209.28/209.44 |- skos__hiddenLabel mesh__D023303 2 oxazolidinone
% 209.28/209.44 |- skos__hiddenLabel mesh__D023303 2 Oxazolidone
% 209.28/209.44 |- skos__prefLabel mesh__D023303 Oxazolidinones
% 209.28/209.44 |- skos__hiddenLabel mesh__D023303 1,3 Oxazolidin 2 one
% 209.28/209.44 |- skos__broader mesh__D023303smesh__D010080
% 209.28/209.44 |- skos__altLabel mesh__D023303 2-Oxazolidone
% 209.28/209.44 |- skos__altLabel mesh__D023303 1,3-Oxazolidine-2-one
% 209.28/209.44 |- rdf__type mesh__D023303sskos__Concept
% 209.28/209.44 |- skos__scopeNote mesh__D023303
% 209.28/209.44 Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents.%A%
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D023303 2006
% 209.28/209.44 |- skos__hiddenLabel mesh__D023303 Oxazolidin 2 one
% 209.28/209.44 |- mesh__recordOriginator mesh__D023303 jmp
% 209.28/209.44 |- mesh__dateCreated mesh__D023303 2000-06-23
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D023303 sjn
% 209.28/209.44 |- mesh__recordMaintainer mesh__D023303 ssb
% 209.28/209.44 |- rdf__type mesh__D014577sskos__Concept
% 209.28/209.44 |- mesh__dateCreated mesh__D014577 1975-07-25
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D014577 sjn
% 209.28/209.44 |- skos__broader mesh__D014577smesh__D011165
% 209.28/209.44 |- mesh__historyNote mesh__D014577
% 209.28/209.44 91%28%76%29%; was see under PORPHYRINOGENS 1976-90
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D014577 2006
% 209.28/209.44 |- skos__prefLabel mesh__D014577 Uroporphyrinogens
% 209.28/209.44 |- mesh__recordOriginator mesh__D014577 RLS
% 209.28/209.44 |- skos__historyNote mesh__D014577 Porphyrinogens %28%1975%29%
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D014577
% 209.28/209.44 91; was see under PORPHYRINOGENS 1976-90
% 209.28/209.44 |- mesh__dateRevised mesh__D014577 2005-06-30
% 209.28/209.44 |- skos__historyNote mesh__D014577 Porphyrins %28%1971-1974%29%
% 209.28/209.44 |- mesh__dateEstablished mesh__D014577 1991-01-01
% 209.28/209.44 |- skos__annotation mesh__D014577 porphyrins
% 209.28/209.44 |- mesh__recordMaintainer mesh__D014577 ssb
% 209.28/209.44 |- skos__scopeNote mesh__D014577
% 209.28/209.44 Porphyrinogens which are intermediates in heme biosynthesis. They have four acetic acid and four propionic acid side chains attached to the pyrrole rings. Uroporphyrinogen I and III are formed from polypyrryl methane in the presence of uroporphyrinogen III cosynthetase and uroporphyrin I synthetase, respectively. They can yield uroporphyrins by autooxidation or coproporphyrinogens by decarboxylation.%A%
% 209.28/209.44 |- skos__hiddenLabel mesh__D000557 Amblystomas
% 209.28/209.44 |- skos__altLabel mesh__D000557 Axolotl
% 209.28/209.44 |- mesh__dateCreated mesh__D000557 1999-01-01
% 209.28/209.44 |- skos__scopeNote mesh__D000557
% 209.28/209.44 A genus of the Ambystomatidae family. The best known species of this genus are the axolotl forms AMBYSTOMA MEXICANUM and Ambystoma tigrinum. They may retain gills and remain aquatic without developing all of the adult characteristics. However, under proper changes in the environment they metamorphose.%A%
% 209.28/209.44 |- skos__altLabel mesh__D000557 Amblystoma
% 209.28/209.44 |- rdf__type mesh__D000557sskos__Concept
% 209.28/209.44 |- mesh__historyNote mesh__D000557 72
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D000557 2005
% 209.28/209.44 |- skos__annotation mesh__D000557
% 209.28/209.44 salamander; NIM when exper animal: no qualif; when IM, qualif permitted%A%
% 209.28/209.44 |- skos__prefLabel mesh__D000557 Ambystoma
% 209.28/209.44 |- mesh__recordOriginator mesh__D000557 NLM
% 209.28/209.44 |- mesh__dateRevised mesh__D000557 2003-07-09
% 209.28/209.44 |- mesh__dateEstablished mesh__D000557 1972-01-01
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D000557 72
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D000557 2006
% 209.28/209.44 |- mesh__recordMaintainer mesh__D000557 ags
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D000557 sjn
% 209.28/209.44 |- skos__broader mesh__D000557smesh__D000559
% 209.28/209.44 |- skos__historyNote mesh__D000557 Urodela %28%1966-1971%29%
% 209.28/209.44 |- skos__hiddenLabel mesh__D000557 Axolotls
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D000557 2004
% 209.28/209.44 |- skos__hiddenLabel mesh__D000557 Ambystomas
% 209.28/209.44 |- skos__historyNote mesh__D019262 Thalamic Nuclei %28%1971-1996%29%
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D019262 97
% 209.28/209.44 |- skos__hiddenLabel mesh__D019262 Nuclei, Habenular
% 209.28/209.44 |- mesh__dateCreated mesh__D019262 1996-06-10
% 209.28/209.44 |- skos__scopeNote mesh__D019262
% 209.28/209.44 A small protuberance at the dorsal, posterior corner of the wall of the third ventricle, adjacent to the dorsal thalamus and pineal body. It contains the habenular nuclei and is a major part of the epithalamus. %28%From Lockard, Desk Reference for Neuroscience, 2nd ed, p121%29%%A%
% 209.28/209.44 |- skos__prefLabel mesh__D019262 Habenula
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019262 2002
% 209.28/209.44 |- skos__historyNote mesh__D019262 Diencephalon %28%1967-1996%29%
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019262 2003
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D019262 sjn
% 209.28/209.44 |- mesh__dateRevised mesh__D019262 1999-11-03
% 209.28/209.44 |- mesh__historyNote mesh__D019262 97
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019262 2005
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019262 2004
% 209.28/209.44 |- mesh__recordOriginator mesh__D019262 RAZ
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019262 2000
% 209.28/209.44 |- skos__hiddenLabel mesh__D019262 Nucleus, Habenular
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019262 2006
% 209.28/209.44 |- rdf__type mesh__D019262sskos__Concept
% 209.28/209.44 |- mesh__dateEstablished mesh__D019262 1997-01-01
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D019262 2001
% 209.28/209.44 |- skos__broader mesh__D019262smesh__D019261
% 209.28/209.44 |- skos__historyNote mesh__D019262 Thalamus %28%1966-1996%29%
% 209.28/209.44 |- skos__altLabel mesh__D019262 Habenular Nucleus
% 209.28/209.44 |- mesh__recordMaintainer mesh__D019262 ags
% 209.28/209.44 |- skos__hiddenLabel mesh__D019262 Habenulas
% 209.28/209.44 |- skos__broader mesh__D019039Q000172smesh__D019039
% 209.28/209.44 |- mesh__preferredCombination mesh__D019039Q000172smesh__D013915
% 209.28/209.44 |- rdf__type mesh__D019039Q000172smesh__CompoundConcept
% 209.28/209.44 |- mesh__recordOriginator mesh__D005242 NLM
% 209.28/209.44 |- mesh__dateRevised mesh__D005242 1997-06-20
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D005242 SJN
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005242 2003
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D005242 70
% 209.28/209.44 |- mesh__historyNote mesh__D005242 70%28%66%29%
% 209.28/209.44 |- skos__hiddenLabel mesh__D005242 Incontinence, Fecal
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005242 2001
% 209.28/209.44 |- skos__hiddenLabel mesh__D005242 Fecal Incontinences
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005242 2004
% 209.28/209.44 |- skos__annotation mesh__D005242
% 209.28/209.44 of organic origin: differentiate from ENCOPRESIS, of psychol origin%A%
% 209.28/209.44 |- skos__related mesh__D005242smesh__D004688
% 209.28/209.44 |- rdf__type mesh__D005242sskos__Concept
% 209.28/209.44 |- mesh__dateEstablished mesh__D005242 1970-01-01
% 209.28/209.44 |- mesh__dateCreated mesh__D005242 1999-01-01
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005242 2002
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005242 1998
% 209.28/209.44 |- skos__prefLabel mesh__D005242 Fecal Incontinence
% 209.28/209.44 |- skos__scopeNote mesh__D005242
% 209.28/209.44 Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.%A%
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005242 2005
% 209.28/209.44 |- skos__related mesh__D005242smesh__D019841
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005242 1999
% 209.28/209.44 |- skos__hiddenLabel mesh__D005242 Incontinences, Fecal
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005242 2006
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D005242 2000
% 209.28/209.44 |- skos__broader mesh__D005242smesh__D012002
% 209.28/209.44 |- mesh__recordMaintainer mesh__D005242 TGC
% 209.28/209.44 |- skos__annotation mesh__D018968 differentiation antigens
% 209.28/209.44 |- mesh__recordOriginator mesh__D018968 AGS
% 209.28/209.44 |- skos__altLabel mesh__D018968 LFA-3
% 209.28/209.44 |- skos__scopeNote mesh__D018968
% 209.28/209.44 Glycoproteins with a wide distribution on hematopoietic and non-hematopoietic cells and strongly expressed on macrophages. CD58 mediates cell adhesion by binding to CD2; %28%ANTIGENS, CD2%29%; and this enhances antigen-specific T-cell activation.%A%
% 209.28/209.44 |- skos__altLabel mesh__D018968 CD58 Antigen
% 209.28/209.44 |- skos__prefLabel mesh__D018968 Antigens, CD58
% 209.28/209.44 |- mesh__onlineNote mesh__D018968
% 209.28/209.44 use ANTIGENS, CD58 %28%NM%29% to search LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 1988-95%A%
% 209.28/209.44 |- skos__hiddenLabel mesh__D018968 Lymphocyte Function Associated Antigen 3
% 209.28/209.44 |- skos__historyNote mesh__D018968 Membrane Glycoproteins %28%1988-1995%29%
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D018968 sjn
% 209.28/209.44 |- mesh__dateEstablished mesh__D018968 1996-01-01
% 209.28/209.44 |- skos__historyNote mesh__D018968 Antigens, Surface %28%1988-1992%29%
% 209.28/209.44 |- rdf__type mesh__D018968sskos__Concept
% 209.28/209.44 |- skos__broader mesh__D018968smesh__D015703
% 209.28/209.44 |- skos__broader mesh__D018968smesh__D008562
% 209.28/209.44 |- mesh__historyNote mesh__D018968
% 209.28/209.44 96; was LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 %28%NM%29% 1988-95%A%
% 209.28/209.44 |- mesh__recordMaintainer mesh__D018968 ssb
% 209.28/209.44 |- skos__historyNote mesh__D018968 Antigens, CD %28%1990-1995%29%
% 209.28/209.44 |- mesh__dateCreated mesh__D018968 1995-06-08
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D018968
% 209.28/209.44 96; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 was indexed under ANTIGENS, CD 1990-95; ANTIGENS DIFFERENTIATION 1990-91; MEMBRANE GLYCOPROTEINS 1988-95; %26% ANTIGENS, SURFACE 1988-92%A%
% 209.28/209.44 |- skos__altLabel mesh__D018968 Lymphocyte Function Associated Antigen-3
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D018968 2006
% 209.28/209.44 |- skos__hiddenLabel mesh__D018968 Antigen, CD58
% 209.28/209.44 |- skos__historyNote mesh__D018968
% 209.28/209.44 Antigens, Differentiation %28%1990-1991%29%
% 209.28/209.44 |- mesh__dateRevised mesh__D018968 2005-06-30
% 209.28/209.44 |- skos__altLabel mesh__D018968 CD58 Antigens
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010985 2002
% 209.28/209.44 |- skos__broader mesh__D010985smesh__D019465
% 209.28/209.44 |- mesh__recordAuthorizer mesh__D010985 sjn
% 209.28/209.44 |- skos__hiddenLabel mesh__D010985 Impression, Basilar
% 209.28/209.44 |- mesh__dateRevised mesh__D010985 1999-11-03
% 209.28/209.44 |- mesh__publicMeSHNote mesh__D010985 67
% 209.28/209.44 |- skos__prefLabel mesh__D010985 Platybasia
% 209.28/209.44 |- skos__broader mesh__D010985smesh__D013122
% 209.28/209.44 |- mesh__dateEstablished mesh__D010985 1967-01-01
% 209.28/209.44 |- skos__historyNote mesh__D010985
% 209.28/209.44 Occipital Bone/abnormalities %28%1966%29%
% 209.28/209.44 |- rdf__type mesh__D010985sskos__Concept
% 209.28/209.44 |- skos__hiddenLabel mesh__D010985 Impressions, Basilar
% 209.28/209.44 |- skos__hiddenLabel mesh__D010985 Basilar Impressions
% 209.28/209.44 |- mesh__historyNote mesh__D010985 67
% 209.28/209.44 |- skos__broader mesh__D010985smesh__D001848
% 209.28/209.44 |- skos__scopeNote mesh__D010985
% 209.28/209.44 A developmental deformity of the occipital bone and upper end of the cervical spine, in which the latter appears to have pushed the floor of the occipital bone upward. %28%Dorland, 27th ed%29%%A%
% 209.28/209.44 |- skos__related mesh__D010985smesh__D001139
% 209.28/209.44 |- mesh__activeMeSHYear mesh__D010985 2005
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010985 2000
% 209.28/209.45 |- mesh__recordMaintainer mesh__D010985 KEV
% 209.28/209.45 |- mesh__recordOriginator mesh__D010985 NLM
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010985 2003
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010985 2006
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010985 2001
% 209.28/209.45 |- skos__hiddenLabel mesh__D010985 Platybasias
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010985 2004
% 209.28/209.45 |- skos__altLabel mesh__D010985 Basilar Impression
% 209.28/209.45 |- mesh__dateCreated mesh__D010985 1999-01-01
% 209.28/209.45 |- skos__annotation mesh__D010985
% 209.28/209.45 occipital bone abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 2000
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 2005
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 1995
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 1998
% 209.28/209.45 |- skos__hiddenLabel mesh__D010187 Hormones, Pancreatic
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D010187 PLS
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 1994
% 209.28/209.45 |- rdf__type mesh__D010187sskos__Concept
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 2002
% 209.28/209.45 |- skos__related mesh__D010187smesh__D018026
% 209.28/209.45 |- mesh__dateRevised mesh__D010187 1993-06-21
% 209.28/209.45 |- mesh__historyNote mesh__D010187 74
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 2004
% 209.28/209.45 |- skos__prefLabel mesh__D010187 Pancreatic Hormones
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 1997
% 209.28/209.45 |- mesh__recordMaintainer mesh__D010187 RAZ
% 209.28/209.45 |- skos__scopeNote mesh__D010187
% 209.28/209.45 Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete pancreatic polypeptide.%A%
% 209.28/209.45 |- mesh__dateCreated mesh__D010187 1999-01-01
% 209.28/209.45 |- mesh__recordOriginator mesh__D010187 NLM
% 209.28/209.45 |- skos__broader mesh__D010187smesh__D006728
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 2003
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 2001
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 1996
% 209.28/209.45 |- mesh__dateEstablished mesh__D010187 1974-01-01
% 209.28/209.45 |- skos__annotation mesh__D010187 /biosyn /physiol permitted
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 2006
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010187 1999
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D010187 74
% 209.28/209.45 |- mesh__historyNote mesh__D004948
% 209.28/209.45 90%28%80%29%; was see under STRABISMUS 1980-89; was see STRABISMUS 1975-79%A%
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D004948 sjn
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esotropias
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esodeviations
% 209.28/209.45 |- mesh__onlineNote mesh__D004948
% 209.28/209.45 use STRABISMUS to search ESOTROPIA 1975-89
% 209.28/209.45 |- skos__altLabel mesh__D004948 Internal Strabismus
% 209.28/209.45 |- mesh__recordMaintainer mesh__D004948 ags
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D004948 2005
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esotropias, Monocular
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Secondary Esotropias
% 209.28/209.45 |- rdf__type mesh__D004948sskos__Concept
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Cross Eye
% 209.28/209.45 |- skos__altLabel mesh__D004948 Convergent Strabismus
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Monocular Esotropias
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esotropias, Primary
% 209.28/209.45 |- skos__altLabel mesh__D004948 Cross-Eye
% 209.28/209.45 |- mesh__recordOriginator mesh__D004948 RC
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esotropia, Monocular
% 209.28/209.45 |- skos__altLabel mesh__D004948 Esodeviation
% 209.28/209.45 |- skos__prefLabel mesh__D004948 Esotropia
% 209.28/209.45 |- mesh__dateCreated mesh__D004948 1979-05-22
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D004948 2004
% 209.28/209.45 |- skos__altLabel mesh__D004948 Strabismus, Convergent
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esotropias, Secondary
% 209.28/209.45 |- mesh__dateRevised mesh__D004948 2001-07-25
% 209.28/209.45 |- mesh__dateEstablished mesh__D004948 1990-01-01
% 209.28/209.45 |- skos__broader mesh__D004948smesh__D013285
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esotropia, Secondary
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D004948 2003
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esotropia, Intermittent
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D004948 2002
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Cross-Eyes
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esotropias, Intermittent
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esophorias
% 209.28/209.45 |- skos__altLabel mesh__D004948 Strabismus, Internal
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Intermittent Esotropias
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Esotropia, Primary
% 209.28/209.45 |- skos__annotation mesh__D004948
% 209.28/209.45 do not confuse with EXOTROPIA, eye turning outward
% 209.28/209.45 |- skos__scopeNote mesh__D004948
% 209.28/209.45 A form of ocular misalignment characterized by an excessive convergence of the visual axes, resulting in a %22%cross-eye%22% appearance. An example of this condition occurs when paralysis of the lateral rectus muscle causes an abnormal inward deviation of one eye on attempted gaze.%A%
% 209.28/209.45 |- skos__historyNote mesh__D004948 Strabismus %28%1966-1979%29%
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D004948
% 209.28/209.45 90; was see under STRABISMUS 1980-89; was see STRABISMUS 1975-79%A%
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D004948 2006
% 209.28/209.45 |- skos__hiddenLabel mesh__D004948 Primary Esotropias
% 209.28/209.45 |- mesh__dateRevised mesh__D015670 2004-08-03
% 209.28/209.45 |- skos__annotation mesh__D015670
% 209.28/209.45 do not confuse with ACUPUNCTURE, the specialty; ACUPUNCTURE, EAR is also available; Oriental taking of pulses = PULSE + appropriate acupuncture or Oriental medicine terms%A%
% 209.28/209.45 |- mesh__historyNote mesh__D015670 1990
% 209.28/209.45 |- skos__related mesh__D015670smesh__D008516
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D015670 2005A
% 209.28/209.45 |- rdf__type mesh__D015670sskos__Concept
% 209.28/209.45 |- skos__historyNote mesh__D015670 Acupuncture %28%1966-1989%29%
% 209.28/209.45 |- mesh__recordOriginator mesh__D015670 EGC
% 209.28/209.45 |- skos__broader mesh__D015670smesh__D000529
% 209.28/209.45 |- mesh__recordMaintainer mesh__D015670 jls
% 209.28/209.45 |- skos__scopeNote mesh__D015670
% 209.28/209.45 Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. It is sometimes used in conjunction with heat, moxibustion, acupressure, or electric stimulation.%A%
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D015670 2005
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D015670 2002
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D015670 1990
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D015670 jls
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D015670 2003
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D015670 2006
% 209.28/209.45 |- skos__prefLabel mesh__D015670 Acupuncture Therapy
% 209.28/209.45 |- mesh__dateCreated mesh__D015670 1989-04-07
% 209.28/209.45 |- skos__related mesh__D015670smesh__D026881
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D015670 2004
% 209.28/209.45 |- skos__altLabel mesh__D015670 Therapy, Acupuncture
% 209.28/209.45 |- mesh__dateEstablished mesh__D015670 1990-01-01
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D009633 2003
% 209.28/209.45 |- skos__historyNote mesh__D009633 Communication %28%1966-1969%29%
% 209.28/209.45 |- skos__broader mesh__D009633smesh__D003142
% 209.28/209.45 |- rdf__type mesh__D009633sskos__Concept
% 209.28/209.45 |- mesh__historyNote mesh__D009633 71%28%70%29%
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D009633 2004
% 209.28/209.45 |- skos__historyNote mesh__D009633 Verbal Behavior %28%1966-1969%29%
% 209.28/209.45 |- mesh__dateEstablished mesh__D009633 1971-01-01
% 209.28/209.45 |- skos__hiddenLabel mesh__D009633 Nonverbal Communications
% 209.28/209.45 |- skos__annotation mesh__D009633
% 209.28/209.45 human only; for animals use ANIMAL COMMUNICATION or VOCALIZATION, ANIMAL; consider also MANUAL COMMUNICATION %26% SIGN LANGUAGE%A%
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D009633 2005
% 209.28/209.45 |- skos__hiddenLabel mesh__D009633 Communication, Nonverbal
% 209.28/209.45 |- mesh__recordOriginator mesh__D009633 NLM
% 209.28/209.45 |- mesh__dateCreated mesh__D009633 1999-01-01
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D009633 2006
% 209.28/209.45 |- skos__hiddenLabel mesh__D009633 Communications, Nonverbal
% 209.28/209.45 |- mesh__recordMaintainer mesh__D009633 PLS
% 209.28/209.45 |- mesh__dateRevised mesh__D009633 2002-07-03
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D009633 71
% 209.28/209.45 |- skos__scopeNote mesh__D009633
% 209.28/209.45 Transmission of emotions, ideas, and attitudes between individuals in ways other than the spoken language.%A%
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D009633 sjn
% 209.28/209.45 |- skos__prefLabel mesh__D009633 Nonverbal Communication
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D001650 2005
% 209.28/209.45 |- skos__hiddenLabel mesh__D001650 Neoplasm, Bile Duct
% 209.28/209.45 |- skos__altLabel mesh__D001650 Cancer of Bile Duct
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D001650 2006
% 209.28/209.45 |- skos__prefLabel mesh__D001650 Bile Duct Neoplasms
% 209.28/209.45 |- skos__annotation mesh__D001650
% 209.28/209.45 coord IM with specific bile duct %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 209.28/209.45 |- skos__altLabel mesh__D001650 Cancer of the Bile Duct
% 209.28/209.45 |- skos__altLabel mesh__D001650 Neoplasms, Bile Duct
% 209.28/209.45 |- skos__hiddenLabel mesh__D001650 Cancer, Bile Duct
% 209.28/209.45 |- skos__hiddenLabel mesh__D001650 Bile Duct Neoplasm
% 209.28/209.45 |- skos__hiddenLabel mesh__D001650 Bile Duct Cancers
% 209.28/209.45 |- rdf__type mesh__D001650sskos__Concept
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D001650 sjn
% 209.28/209.45 |- mesh__recordOriginator mesh__D001650 NLM
% 209.28/209.45 |- skos__scopeNote mesh__D001650 Tumors or cancer of the BILE DUCTS.
% 209.28/209.45 |- mesh__dateRevised mesh__D001650 2003-07-09
% 209.28/209.45 |- skos__broader mesh__D001650smesh__D001649
% 209.28/209.45 |- mesh__dateCreated mesh__D001650 1999-01-01
% 209.28/209.45 |- mesh__recordMaintainer mesh__D001650 lkt
% 209.28/209.45 |- skos__broader mesh__D001650smesh__D001661
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D001650 2004
% 209.28/209.45 |- skos__hiddenLabel mesh__D001650 Cancers, Bile Duct
% 209.28/209.45 |- skos__prefLabel mesh__D014578 Uroporphyrins
% 209.28/209.45 |- mesh__recordOriginator mesh__D014578 NLM
% 209.28/209.45 |- mesh__dateRevised mesh__D014578 2005-06-30
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D014578
% 209.28/209.45 91; was see under PORPHYRINS 1975-90
% 209.28/209.45 |- mesh__dateEstablished mesh__D014578 1991-01-01
% 209.28/209.45 |- skos__annotation mesh__D014578 porphyrins
% 209.28/209.45 |- skos__broader mesh__D014578smesh__D011166
% 209.28/209.45 |- rdf__type mesh__D014578sskos__Concept
% 209.28/209.45 |- mesh__dateCreated mesh__D014578 1974-11-19
% 209.28/209.45 |- mesh__historyNote mesh__D014578
% 209.28/209.45 91%28%75%29%; was see under PORPHYRINS 1975-90
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D014578 sjn
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D014578 2006
% 209.28/209.45 |- skos__scopeNote mesh__D014578
% 209.28/209.45 Porphyrins with four acetic acid and four propionic acid side chains attached to the pyrrole rings.%A%
% 209.28/209.45 |- skos__historyNote mesh__D014578 Porphyrins %28%1968-1974%29%
% 209.28/209.45 |- mesh__recordMaintainer mesh__D014578 ssb
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D019263 2005
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D019263
% 209.28/209.45 97; was see DEPRESSIVE DISORDER 1981-96
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D019263 1999
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D019263 1998
% 209.28/209.45 |- skos__hiddenLabel mesh__D019263 Dysthymic Disorders
% 209.28/209.45 |- mesh__dateCreated mesh__D019263 1996-06-18
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D019263 2001
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D019263 2004
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D019263 SJN
% 209.28/209.45 |- mesh__historyNote mesh__D019263
% 209.28/209.45 97; was see DEPRESSIVE DISORDER 1981-96
% 209.28/209.45 |- mesh__dateEstablished mesh__D019263 1997-01-01
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D019263 2000
% 209.28/209.45 |- skos__historyNote mesh__D019263 Depressive Disorder %28%1981-1996%29%
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D019263 2003
% 209.28/209.45 |- mesh__recordOriginator mesh__D019263 JLS
% 209.28/209.45 |- mesh__recordMaintainer mesh__D019263 JLS
% 209.28/209.45 |- skos__prefLabel mesh__D019263 Dysthymic Disorder
% 209.28/209.45 |- skos__broader mesh__D019263smesh__D003866
% 209.28/209.45 |- skos__scopeNote mesh__D019263
% 209.28/209.45 Chronically depressed mood that occurs for most of the day more days than not for at least 2 years. The required minimum duration in children to make this diagnosis is 1 year. During periods of depressed mood, at least 2 of the following additional symptoms are present: poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self esteem, poor concentration or difficulty making decisions, and feelings of hopelessness. %28%DSM-IV%29%%A%
% 209.28/209.45 |- mesh__onlineNote mesh__D019263
% 209.28/209.45 use DEPRESSIVE DISORDER to search DYSTHYMIC DISORDER 1981-96%A%
% 209.28/209.45 |- skos__hiddenLabel mesh__D019263 Disorder, Dysthymic
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D019263 2006
% 209.28/209.45 |- rdf__type mesh__D019263sskos__Concept
% 209.28/209.45 |- mesh__dateRevised mesh__D019263 1997-06-20
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D019263 2002
% 209.28/209.45 |- skos__hiddenLabel mesh__D000558 mexicanums, Ambystoma
% 209.28/209.45 |- mesh__dateRevised mesh__D000558 2003-07-09
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D000558 sjn
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D000558 2006
% 209.28/209.45 |- skos__prefLabel mesh__D000558 Ambystoma mexicanum
% 209.28/209.45 |- skos__hiddenLabel mesh__D000558 mexicanum, Ambystoma
% 209.28/209.45 |- skos__hiddenLabel mesh__D000558 Mexican Axolotl
% 209.28/209.45 |- skos__hiddenLabel mesh__D000558 Mexican Axolotls
% 209.28/209.45 |- mesh__dateEstablished mesh__D000558 1991-01-01
% 209.28/209.45 |- mesh__dateCreated mesh__D000558 1980-04-02
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D000558 2004
% 209.28/209.45 |- mesh__recordMaintainer mesh__D000558 ags
% 209.28/209.45 |- skos__hiddenLabel mesh__D000558 Ambystoma mexicanums
% 209.28/209.45 |- skos__broader mesh__D000558smesh__D000557
% 209.28/209.45 |- mesh__historyNote mesh__D000558
% 209.28/209.45 91%28%81%29%; was see under AMBYSTOMA 1981-90
% 209.28/209.45 |- skos__scopeNote mesh__D000558
% 209.28/209.45 An axolotl found in Mexican mountain lakes and accounting for about 30 percent of the urodeles used in research.%A%
% 209.28/209.45 |- skos__hiddenLabel mesh__D000558 Axolotls, Mexican
% 209.28/209.45 |- rdf__type mesh__D000558sskos__Concept
% 209.28/209.45 |- skos__altLabel mesh__D000558 Axolotl, Mexican
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D000558
% 209.28/209.45 91; was see under AMBYSTOMA 1981-90
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D000558 2005
% 209.28/209.45 |- skos__historyNote mesh__D000558 Ambystoma %28%1972-1980%29%
% 209.28/209.45 |- skos__annotation mesh__D000558
% 209.28/209.45 salamander; NIM when exper animal: no qualif; when IM, qualif permitted%A%
% 209.28/209.45 |- mesh__recordOriginator mesh__D000558 EC
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 3beta Hydroxy 5alpha pregnan 20 one
% 209.28/209.45 |- mesh__recordOriginator mesh__D011280 NLM
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 alpha-pregnan-20-one, 3 alpha-Hydroxy-5
% 209.28/209.45 |- rdf__type mesh__D011280sskos__Concept
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 beta-pregnan-20-one, 3 alpha-Hydroxy-5
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D011280 2006
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D011280
% 209.28/209.45 91; was see under PREGNANES 1975-90
% 209.28/209.45 |- skos__altLabel mesh__D011280 Eltanolone
% 209.28/209.45 |- skos__altLabel mesh__D011280 Allopregnanolone
% 209.28/209.45 |- skos__altLabel mesh__D011280 3-Hydroxypregnan-20-one
% 209.28/209.45 |- skos__historyNote mesh__D011280 Ketosteroids %28%1972-1974%29%
% 209.28/209.45 |- skos__scopeNote mesh__D011280
% 209.28/209.45 A pregnane found in the urine of pregnant women and sows. It has anesthetic, hypnotic, and sedative properties.%A%
% 209.28/209.45 |- skos__altLabel mesh__D011280 Epipregnanolone
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 alpha-Hydroxy-5 beta-pregnan-20-one, 3
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 3 alpha Hydroxy 5 alpha pregnan 20 one
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 Pregnan 3alpha ol 20 one
% 209.28/209.45 |- skos__altLabel mesh__D011280 3 alpha, 5 beta-Tetrahydroprogesterone
% 209.28/209.45 |- skos__altLabel mesh__D011280 3 alpha-Hydroxy-5 alpha-pregnan-20-one
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D011280 2004
% 209.28/209.45 |- skos__historyNote mesh__D011280 Hydroxysteroids %28%1972-1974%29%
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 3 Hydroxypregnan 20 one
% 209.28/209.45 |- skos__altLabel mesh__D011280 Pregnan-3alpha-ol-20-one
% 209.28/209.45 |- mesh__dateEstablished mesh__D011280 1991-01-01
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 alpha-Hydroxy-5 alpha-pregnan-20-one, 3
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 beta-ol-20-one, Allopregnan-3
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 3 alpha, 5 beta Tetrahydroprogesterone
% 209.28/209.45 |- mesh__dateRevised mesh__D011280 2003-07-09
% 209.28/209.45 |- skos__prefLabel mesh__D011280 Pregnanolone
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D011280 sjn
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 Allopregnan 3 beta ol 20 one
% 209.28/209.45 |- skos__altLabel mesh__D011280 Pregnanolone, %28%3alpha,5beta%29%-isomer
% 209.28/209.45 |- mesh__recordMaintainer mesh__D011280 lkt
% 209.28/209.45 |- skos__historyNote mesh__D011280 Pregnanes %28%1969-1974%29%
% 209.28/209.45 |- skos__hiddenLabel mesh__D011280 3 alpha Hydroxy 5 beta pregnan 20 one
% 209.28/209.45 |- mesh__historyNote mesh__D011280
% 209.28/209.45 91%28%75%29%; was see under PREGNANES 1975-90
% 209.28/209.45 |- skos__broader mesh__D011280smesh__D011278
% 209.28/209.45 |- skos__annotation mesh__D011280 do not confuse with PREGNENOLONE
% 209.28/209.45 |- skos__altLabel mesh__D011280 Allopregnan-3 beta-ol-20-one
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D011280 2005
% 209.28/209.45 |- skos__altLabel mesh__D011280 3beta-Hydroxy-5alpha-pregnan-20-one
% 209.28/209.45 |- mesh__dateCreated mesh__D011280 1974-11-19
% 209.28/209.45 |- skos__altLabel mesh__D011280 3 alpha-Hydroxy-5 beta-pregnan-20-one
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D005243 2004
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D005243 sjn
% 209.28/209.45 |- mesh__recordOriginator mesh__D005243 NLM
% 209.28/209.45 |- rdf__type mesh__D005243sskos__Concept
% 209.28/209.45 |- mesh__dateCreated mesh__D005243 1999-01-01
% 209.28/209.45 |- skos__related mesh__D005243smesh__D008551
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D005243 2005
% 209.28/209.45 |- mesh__dateRevised mesh__D005243 2003-07-25
% 209.28/209.45 |- skos__annotation mesh__D005243
% 209.28/209.45 /parasitol: often coord with PARASITE EGG COUNT; consider also DEFECATION; CONSTIPATION; DIARRHEA; FECAL IMPACTION %26% FECAL INCONTINENCE; fecalith: index FECAL IMPACTION; fecal blood: index under OCCULT BLOOD %26% not also here%A%
% 209.28/209.45 |- skos__related mesh__D005243smesh__D008372
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D005243 2006
% 209.28/209.45 |- skos__prefLabel mesh__D005243 Feces
% 209.28/209.45 |- mesh__recordMaintainer mesh__D005243 sjn
% 209.28/209.45 |- skos__broader mesh__D005243smesh__D005441
% 209.28/209.45 |- skos__scopeNote mesh__D005243
% 209.28/209.45 Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.%A%
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D018969
% 209.28/209.45 2005; see INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-1995%A%
% 209.28/209.45 |- rdf__type mesh__D018969sskos__Concept
% 209.28/209.45 |- mesh__recordOriginator mesh__D018969 TPW
% 209.28/209.45 |- skos__altLabel mesh__D018969 IGF-Binding Proteins
% 209.28/209.45 |- mesh__dateRevised mesh__D018969 2005-06-30
% 209.28/209.45 |- mesh__recordMaintainer mesh__D018969 SYSTEM
% 209.28/209.45 |- skos__scopeNote mesh__D018969
% 209.28/209.45 A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. %28%Int J Gynaecol Obstet 1992;39%28%1%29%:3-9%29%%A%
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D018969 2006
% 209.28/209.45 |- skos__annotation mesh__D018969
% 209.28/209.45 GEN or unspecified; prefer specifics; /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%
% 209.28/209.45 |- skos__altLabel mesh__D018969 IGFBP
% 209.28/209.45 |- mesh__historyNote mesh__D018969 2005%28%1996%29%
% 209.28/209.45 |- mesh__dateEstablished mesh__D018969 1996-01-01
% 209.28/209.45 |- skos__hiddenLabel mesh__D018969 IGF Binding Proteins
% 209.28/209.45 |- skos__prefLabel mesh__D018969
% 209.28/209.45 Insulin-Like Growth Factor Binding Proteins
% 209.28/209.45 |- skos__altLabel mesh__D018969 Somatomedin-Binding Proteins
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D018969 sjn
% 209.28/209.45 |- skos__broader mesh__D018969smesh__D002352
% 209.28/209.45 |- skos__hiddenLabel mesh__D018969 Somatomedin Binding Proteins
% 209.28/209.45 |- skos__historyNote mesh__D018969 Carrier Proteins %28%1980-1995%29%
% 209.28/209.45 |- mesh__dateCreated mesh__D018969 1995-06-16
% 209.28/209.45 |- rdf__type mesh__D010986sskos__Concept
% 209.28/209.45 |- mesh__dateEstablished mesh__D010986 1965-01-01
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D010986 sjn
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010986 2005
% 209.28/209.45 |- skos__prefLabel mesh__D010986 Platyhelminths
% 209.28/209.45 |- skos__broader mesh__D010986smesh__D006376
% 209.28/209.45 |- skos__scopeNote mesh__D010986
% 209.28/209.45 A phylum of acoelomate, bilaterally symmetrical flatworms, without a definite anus. It includes three classes: Cestoda, Turbellaria, and Trematoda.%A%
% 209.28/209.45 |- mesh__historyNote mesh__D010986 65
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010986 2006
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010986 2004
% 209.28/209.45 |- mesh__dateCreated mesh__D010986 1999-01-01
% 209.28/209.45 |- skos__annotation mesh__D010986
% 209.28/209.45 infection = CESTODE INFECTIONS or TREMATODE INFECTIONS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 209.28/209.45 |- mesh__recordOriginator mesh__D010986 NLM
% 209.28/209.45 |- mesh__recordMaintainer mesh__D010986 ags
% 209.28/209.45 |- skos__altLabel mesh__D010986 Flatworms
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D010986 65
% 209.28/209.45 |- mesh__dateRevised mesh__D010986 2003-07-09
% 209.28/209.45 |- rdf__type mesh__D043362sskos__Concept
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D043362 sjn
% 209.28/209.45 |- skos__prefLabel mesh__D043362 Rhodocyclaceae
% 209.28/209.45 |- mesh__recordOriginator mesh__D043362 ags
% 209.28/209.45 |- mesh__historyNote mesh__D043362 2004
% 209.28/209.45 |- mesh__recordMaintainer mesh__D043362 SYSTEM
% 209.28/209.45 |- mesh__dateCreated mesh__D043362 2003-07-09
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D043362 2004
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D043362 2006
% 209.28/209.45 |- mesh__dateRevised mesh__D043362 2005-06-30
% 209.28/209.45 |- mesh__dateEstablished mesh__D043362 2004-01-01
% 209.28/209.45 |- skos__scopeNote mesh__D043362
% 209.28/209.45 A family of gram-negative bacteria in the order Rhodocyclales, class BETAPROTEOBACTERIA. It includes many genera previously assigned to the family PSEUDOMONADACEAE.%A%
% 209.28/209.45 |- skos__broader mesh__D043362smesh__D020562
% 209.28/209.45 |- skos__scopeNote mesh__D010188
% 209.28/209.45 A malabsorption condition resulting from greater than 10%25% reduction in the secretion of pancreatic digestive enzymes %28%LIPASE; PROTEASES; and AMYLASE%29% by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS.%A%
% 209.28/209.45 |- skos__hiddenLabel mesh__D010188 Exocrine Pancreatic Insufficiencies
% 209.28/209.45 |- mesh__recordOriginator mesh__D010188 RC
% 209.28/209.45 |- mesh__historyNote mesh__D010188 2005 %28%1981%29%
% 209.28/209.45 |- skos__hiddenLabel mesh__D010188 Insufficiencies, Exocrine Pancreatic
% 209.28/209.45 |- skos__altLabel mesh__D010188 Pancreatic Insufficiency
% 209.28/209.45 |- mesh__recordMaintainer mesh__D010188 lkt
% 209.28/209.45 |- skos__hiddenLabel mesh__D010188 Pancreatic Insufficiencies
% 209.28/209.45 |- skos__hiddenLabel mesh__D010188 Insufficiencies, Pancreatic
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010188 2006
% 209.28/209.45 |- skos__hiddenLabel mesh__D010188 Pancreatic Insufficiencies, Exocrine
% 209.28/209.45 |- mesh__dateCreated mesh__D010188 1980-04-09
% 209.28/209.45 |- skos__broader mesh__D010188smesh__D010182
% 209.28/209.45 |- skos__historyNote mesh__D010188 Pancreatitis %28%1966-1980%29%
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D010188
% 209.28/209.45 2005; see PANCREATIC INSUFFICIENCY 1981-2004
% 209.28/209.45 |- skos__hiddenLabel mesh__D010188 Pancreatic Insufficiency, Exocrine
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D010188 2005
% 209.28/209.45 |- mesh__dateEstablished mesh__D010188 1981-01-01
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D010188 sjn
% 209.28/209.45 |- skos__hiddenLabel mesh__D010188 Insufficiency, Pancreatic
% 209.28/209.45 |- skos__prefLabel mesh__D010188 Exocrine Pancreatic Insufficiency
% 209.28/209.45 |- rdf__type mesh__D010188sskos__Concept
% 209.28/209.45 |- skos__historyNote mesh__D010188 Pancreatic Diseases %28%1966-1980%29%
% 209.28/209.45 |- skos__hiddenLabel mesh__D010188 Insufficiency, Exocrine Pancreatic
% 209.28/209.45 |- mesh__dateRevised mesh__D010188 2004-07-07
% 209.28/209.45 |- mesh__recordMaintainer mesh__D004949 exl
% 209.28/209.45 |- skos__altLabel mesh__D004949 Abbott Brand of Estazolam
% 209.28/209.45 |- mesh__recordOriginator mesh__D004949 NLM
% 209.28/209.45 |- skos__prefLabel mesh__D004949 Estazolam
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D004949 sjn
% 209.28/209.45 |- skos__historyNote mesh__D004949 Benzazepines %28%1972-1974%29%
% 209.28/209.45 |- mesh__historyNote mesh__D004949
% 209.28/209.45 91%28%80%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1980-90; was D 40TA see under BENZODIAZEPINE TRANQUILIZERS 1975-79%A%
% 209.28/209.45 |- skos__altLabel mesh__D004949 Hormona Brand of Estazolam
% 209.28/209.45 |- mesh__dateEstablished mesh__D004949 1991-01-01
% 209.28/209.45 |- skos__altLabel mesh__D004949 Takeda Brand of Estazolam
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D004949 2006
% 209.28/209.45 |- skos__broader mesh__D004949smesh__D001569
% 209.28/209.45 |- mesh__dateCreated mesh__D004949 1974-11-27
% 209.28/209.45 |- mesh__dateRevised mesh__D004949 2005-06-30
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D004949
% 209.28/209.45 91; was see under BENZODIAZEPINE TRANQUILIZERS 1980-90; was D 40TA see under BENZODIAZEPINE TRANQUILIZERS 1975-79%A%
% 209.28/209.45 |- skos__scopeNote mesh__D004949
% 209.28/209.45 A benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than DIAZEPAM or NITRAZEPAM.%A%
% 209.28/209.45 |- skos__altLabel mesh__D004949 D40TA
% 209.28/209.45 |- rdf__type mesh__D004949sskos__Concept
% 209.28/209.45 |- mesh__onlineNote mesh__D004949 use ESTAZOLAM to search D 40TA 1975-79
% 209.28/209.45 |- skos__historyNote mesh__D004949 Triazoles %28%1972-1974%29%
% 209.28/209.45 |- skos__scopeNote mesh__D015671
% 209.28/209.45 A form of acupuncture with electrical impulses passing through the needles to stimulate NERVE TISSUE. It can be used for ANALGESIA; ANESTHESIA; PHYSICAL REHABILITATION; and treatment for diseases.%A%
% 209.28/209.45 |- skos__broader mesh__D015671smesh__D004599
% 209.28/209.45 |- mesh__historyNote mesh__D015671 90
% 209.28/209.45 |- mesh__publicMeSHNote mesh__D015671 90
% 209.28/209.45 |- skos__broader mesh__D015671smesh__D004561
% 209.28/209.45 |- skos__historyNote mesh__D015671 Acupuncture %28%1966-1989%29%
% 209.28/209.45 |- mesh__recordAuthorizer mesh__D015671 sjn
% 209.28/209.45 |- skos__broader mesh__D015671smesh__D003131
% 209.28/209.45 |- rdf__type mesh__D015671sskos__Concept
% 209.28/209.45 |- mesh__dateCreated mesh__D015671 1989-04-07
% 209.28/209.45 |- skos__broader mesh__D015671smesh__D015670
% 209.28/209.45 |- mesh__dateRevised mesh__D015671 2005-06-30
% 209.28/209.45 |- mesh__recordMaintainer mesh__D015671 lkt
% 209.28/209.45 |- mesh__recordOriginator mesh__D015671 EGC
% 209.28/209.45 |- skos__broader mesh__D015671smesh__D000758
% 209.28/209.45 |- mesh__dateEstablished mesh__D015671 1990-01-01
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D015671 2006
% 209.28/209.45 |- skos__prefLabel mesh__D015671 Electroacupuncture
% 209.28/209.45 |- skos__hiddenLabel mesh__D009634 Female Pseudo-Turner Syndromes
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D009634 2006A
% 209.28/209.45 |- skos__related mesh__D009634smesh__D044542
% 209.28/209.45 |- skos__related mesh__D009634smesh__D009456
% 209.28/209.45 |- skos__hiddenLabel mesh__D009634 Male Turner Syndrome
% 209.28/209.45 |- skos__prefLabel mesh__D009634 Noonan Syndrome
% 209.28/209.45 |- mesh__historyNote mesh__D009634 79
% 209.28/209.45 |- skos__altLabel mesh__D009634 Turner%27%s Syndrome, Male
% 209.28/209.45 |- mesh__activeMeSHYear mesh__D009634 2005
% 209.28/209.45 |- mesh__recordMaintainer mesh__D009634 ags
% 209.28/209.46 |- skos__hiddenLabel mesh__D009634 Male Turner%27%s Syndrome
% 209.28/209.46 |- mesh__dateRevised mesh__D009634 2005-07-21
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D009634 ags
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009634 2006
% 209.28/209.46 |- skos__hiddenLabel mesh__D009634 Pseudo-Turner Syndromes, Female
% 209.28/209.46 |- skos__related mesh__D009634smesh__D014424
% 209.28/209.46 |- mesh__dateCreated mesh__D009634 1977-12-05
% 209.28/209.46 |- mesh__dateEstablished mesh__D009634 1979-01-01
% 209.28/209.46 |- skos__hiddenLabel mesh__D009634 Turners Syndrome, Male
% 209.28/209.46 |- skos__historyNote mesh__D009634 Turner%27%s Syndrome %28%1966-1978%29%
% 209.28/209.46 |- mesh__recordOriginator mesh__D009634 AEP
% 209.28/209.46 |- skos__hiddenLabel mesh__D009634 Syndrome, Female Pseudo-Turner
% 209.28/209.46 |- skos__broader mesh__D009634smesh__D003240
% 209.28/209.46 |- skos__hiddenLabel mesh__D009634 Syndromes, Female Pseudo-Turner
% 209.28/209.46 |- rdf__type mesh__D009634sskos__Concept
% 209.28/209.46 |- skos__broader mesh__D009634smesh__D019465
% 209.28/209.46 |- skos__hiddenLabel mesh__D009634 Pseudo-Turner Syndrome, Female
% 209.28/209.46 |- skos__hiddenLabel mesh__D009634 Female Pseudo Turner Syndrome
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D009634 79
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009634 2005A
% 209.28/209.46 |- skos__scopeNote mesh__D009634
% 209.28/209.46 A multifaceted disorder characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, CRYPTORCHIDISM, multiple cardiac abnormalities %28%most commonly including PULMONARY VALVE STENOSIS%29%, and some degree of MENTAL RETARDATION. The phenotype bears similarities to that of TURNER SYNDROME that occurs only in females and has its basis in a 45, X karyotype abnormality. However, Noonan syndrome occurs in both males and females with a normal sex chromosome constitution %28%46,XX and 46,XY%29%. NS1 is due to mutations at chromosome location 12q24.1, in PTPN11, a gene encoding the non-receptor type 11 PROTEIN TYROSINE PHOSPHATASE. LEOPARD SYNDROME, a disorder that has clinical features overlapping those of Noonan Syndrome, is also due to mutations in PTPN11. In addition, there is a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras %28%RAS PROTEINS%29%.%A%
% 209.28/209.46 |- mesh__recordMaintainer mesh__D001651 lkt
% 209.28/209.46 |- skos__broader mesh__D001651smesh__D002779
% 209.28/209.46 |- mesh__dateCreated mesh__D001651 1979-05-29
% 209.28/209.46 |- mesh__recordOriginator mesh__D001651 SMH
% 209.28/209.46 |- rdf__type mesh__D001651sskos__Concept
% 209.28/209.46 |- skos__historyNote mesh__D001651
% 209.28/209.46 specific extrahepatic bile duct %28%1966-1979%29%
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D001651 80
% 209.28/209.46 |- skos__altLabel mesh__D001651 Bile Duct Obstruction, Extrahepatic
% 209.28/209.46 |- mesh__dateRevised mesh__D001651 2003-07-09
% 209.28/209.46 |- skos__related mesh__D001651smesh__D041781
% 209.28/209.46 |- skos__historyNote mesh__D001651 Bile Ducts %28%1966-1979%29%
% 209.28/209.46 |- mesh__historyNote mesh__D001651 80
% 209.28/209.46 |- skos__scopeNote mesh__D001651
% 209.28/209.46 Impairment of bile flow in the large BILE DUCTS by mechanical obstruction or stricture due to benign or malignant processes.%A%
% 209.28/209.46 |- skos__altLabel mesh__D001651 Extrahepatic Cholestasis
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D001651 2004
% 209.28/209.46 |- skos__hiddenLabel mesh__D001651 Extrahepatic Biliary Stasis
% 209.28/209.46 |- skos__prefLabel mesh__D001651 Cholestasis, Extrahepatic
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D001651 sjn
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D001651 2005
% 209.28/209.46 |- skos__historyNote mesh__D001651 Biliary Tract Diseases %28%1966-1979%29%
% 209.28/209.46 |- skos__annotation mesh__D001651
% 209.28/209.46 coord IM with specific bile duct %28%IM%29% or specific precoord bile duct dis %28%IM%29%%A%
% 209.28/209.46 |- skos__altLabel mesh__D001651 Biliary Stasis, Extrahepatic
% 209.28/209.46 |- mesh__dateEstablished mesh__D001651 1980-01-01
% 209.28/209.46 |- skos__historyNote mesh__D001651 Cholestasis %28%1966-1979%29%
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D001651 2006
% 209.28/209.46 |- mesh__dateEstablished mesh__D014579 1991-01-01
% 209.28/209.46 |- mesh__dateRevised mesh__D014579 2005-06-30
% 209.28/209.46 |- rdf__type mesh__D014579sskos__Concept
% 209.28/209.46 |- skos__annotation mesh__D014579
% 209.28/209.46 antihypertensives; from urophyses of fish; /biosyn /physiol permitted%A%
% 209.28/209.46 |- skos__scopeNote mesh__D014579
% 209.28/209.46 Teleost hormones. A family of small peptides isolated from urophyses of bony fishes. They have many different physiological effects, including long-lasting hypotensive activity and have been proposed as antihypertensives. There are at least four different compounds: urotensin I, urotensin II, urotensin III, and urotensin IV.%A%
% 209.28/209.46 |- skos__historyNote mesh__D014579 Fishes %28%1966-1978%29%
% 209.28/209.46 |- skos__broader mesh__D014579smesh__D036361
% 209.28/209.46 |- mesh__recordOriginator mesh__D014579 SH
% 209.28/209.46 |- mesh__historyNote mesh__D014579
% 209.28/209.46 91%28%79%29%; was see under PEPTIDES 1979-90
% 209.28/209.46 |- skos__prefLabel mesh__D014579 Urotensins
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D014579 sjn
% 209.28/209.46 |- skos__broader mesh__D014579smesh__D007705
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D014579 2006
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D014579 91; was see under PEPTIDES 1979-90
% 209.28/209.46 |- mesh__dateCreated mesh__D014579 1977-12-09
% 209.28/209.46 |- mesh__recordMaintainer mesh__D014579 ssb
% 209.28/209.46 |- skos__historyNote mesh__D014579 Peptides %28%1966-1978%29%
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D019264
% 209.28/209.46 97; was ADOPTIVE CELL TRANSFER see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90%A%
% 209.28/209.46 |- skos__prefLabel mesh__D019264 Adoptive Transfer
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 1998
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 2002
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 2004
% 209.28/209.46 |- skos__scopeNote mesh__D019264
% 209.28/209.46 Form of passive immunization where previously sensitized immunologic agents %28%cells or serum%29% are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy %28%IMMUNOTHERAPY, ADOPTIVE%29%.%A%
% 209.28/209.46 |- skos__hiddenLabel mesh__D019264 Adoptive Cell Transfers
% 209.28/209.46 |- skos__historyNote mesh__D019264 Immunization, Passive %28%1983-1990%29%
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 2003
% 209.28/209.46 |- mesh__onlineNote mesh__D019264
% 209.28/209.46 use IMMUNOTHERAPY, ADOPTIVE to search ADOPTIVE CELL TRANSFER 1991-96; use IMMUNIZATION, PASSIVE 1983-90%A%
% 209.28/209.46 |- skos__hiddenLabel mesh__D019264 Cell Transfer, Adoptive
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 1997
% 209.28/209.46 |- mesh__historyNote mesh__D019264
% 209.28/209.46 97; was ADOPTIVE CELL TRANSFER see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90%A%
% 209.28/209.46 |- skos__hiddenLabel mesh__D019264 Cell Transfers, Adoptive
% 209.28/209.46 |- skos__hiddenLabel mesh__D019264 Adoptive Transfers
% 209.28/209.46 |- skos__broader mesh__D019264smesh__D007116
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 2001
% 209.28/209.46 |- skos__annotation mesh__D019264
% 209.28/209.46 a form of passive immuniz by transpl of lymphocytes; do not use /util except by MeSH definition%A%
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 2006
% 209.28/209.46 |- mesh__dateEstablished mesh__D019264 1997-01-01
% 209.28/209.46 |- skos__historyNote mesh__D019264
% 209.28/209.46 Immunotherapy, Adoptive %28%1991-1996%29%
% 209.28/209.46 |- rdf__type mesh__D019264sskos__Concept
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 2000
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 2005
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019264 1999
% 209.28/209.46 |- mesh__dateCreated mesh__D019264 1996-06-10
% 209.28/209.46 |- skos__broader mesh__D000559smesh__D014562
% 209.28/209.46 |- mesh__recordOriginator mesh__D000559 EC
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D000559 2004
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D000559 sjn
% 209.28/209.46 |- mesh__recordMaintainer mesh__D000559 ags
% 209.28/209.46 |- skos__hiddenLabel mesh__D000559 Mole Salamander
% 209.28/209.46 |- skos__prefLabel mesh__D000559 Ambystomatidae
% 209.28/209.46 |- skos__scopeNote mesh__D000559
% 209.28/209.46 A family of the class Urodela which includes 4 living genera, about 33 species, and occurs only in North America. Adults are usually terrestrial, but the larval forms are aquatic.%A%
% 209.28/209.46 |- rdf__type mesh__D000559sskos__Concept
% 209.28/209.46 |- mesh__dateCreated mesh__D000559 1980-04-02
% 209.28/209.46 |- skos__hiddenLabel mesh__D000559 Mole Salamanders
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D000559 81
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D000559 2005
% 209.28/209.46 |- skos__hiddenLabel mesh__D000559 Salamanders, Mole
% 209.28/209.46 |- skos__annotation mesh__D000559
% 209.28/209.46 a family of salamanders; NIM when exper animal: no qualif; when IM, qualif permitted%A%
% 209.28/209.46 |- mesh__dateRevised mesh__D000559 2003-07-09
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D000559 2006
% 209.28/209.46 |- mesh__historyNote mesh__D000559 81
% 209.28/209.46 |- mesh__dateEstablished mesh__D000559 1981-01-01
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 2005
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 1998
% 209.28/209.46 |- mesh__dateRevised mesh__D011281 1993-06-03
% 209.28/209.46 |- rdf__type mesh__D011281sskos__Concept
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 1994
% 209.28/209.46 |- skos__historyNote mesh__D011281 Pregnanes %28%1966-1972%29%
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 2002
% 209.28/209.46 |- mesh__recordMaintainer mesh__D011281 PLS
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 2001
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 2004
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D011281 PLS
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 1997
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 2000
% 209.28/209.46 |- mesh__dateCreated mesh__D011281 1999-01-01
% 209.28/209.46 |- skos__scopeNote mesh__D011281
% 209.28/209.46 Pregnane derivatives containing three double bonds in the ring structures.%A%
% 209.28/209.46 |- mesh__historyNote mesh__D011281 73
% 209.28/209.46 |- mesh__dateEstablished mesh__D011281 1973-01-01
% 209.28/209.46 |- skos__broader mesh__D011281smesh__D011278
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 2006
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 2003
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 1999
% 209.28/209.46 |- skos__prefLabel mesh__D011281 Pregnatrienes
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 1996
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D011281 73
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011281 1995
% 209.28/209.46 |- mesh__recordOriginator mesh__D011281 NLM
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005244 2005
% 209.28/209.46 |- mesh__dateEstablished mesh__D005244 1964-01-01
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005244 2004
% 209.28/209.46 |- mesh__dateRevised mesh__D005244 2003-07-09
% 209.28/209.46 |- mesh__historyNote mesh__D005244 2004 %28%1964%29%
% 209.28/209.46 |- skos__scopeNote mesh__D005244
% 209.28/209.46 Formation of a firm impassable mass of stool in the RECTUM or distal COLON.%A%
% 209.28/209.46 |- rdf__type mesh__D005244sskos__Concept
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D005244
% 209.28/209.46 2004; see FECES, IMPACTED 1964-2003
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D005244 sjn
% 209.28/209.46 |- skos__broader mesh__D005244smesh__D007415
% 209.28/209.46 |- mesh__recordOriginator mesh__D005244 NLM
% 209.28/209.46 |- skos__prefLabel mesh__D005244 Fecal Impaction
% 209.28/209.46 |- skos__altLabel mesh__D005244 Fecalith
% 209.28/209.46 |- mesh__dateCreated mesh__D005244 1999-01-01
% 209.28/209.46 |- mesh__recordMaintainer mesh__D005244 lkt
% 209.28/209.46 |- skos__hiddenLabel mesh__D005244 Impaction, Fecal
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005244 2006
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010987 2005
% 209.28/209.46 |- skos__hiddenLabel mesh__D010987 Platypus, Duckbilled
% 209.28/209.46 |- skos__scopeNote mesh__D010987
% 209.28/209.46 A small aquatic oviparous mammal of the order Monotremata found in Australia and Tasmania.%A%
% 209.28/209.46 |- mesh__historyNote mesh__D010987
% 209.28/209.46 91%28%75%29%; was see under MONOTREMATA 1975-90; DUCKMOLE was see PLATYPUS 9175-95%A%
% 209.28/209.46 |- skos__prefLabel mesh__D010987 Platypus
% 209.28/209.46 |- mesh__recordOriginator mesh__D010987 NLM
% 209.28/209.46 |- rdf__type mesh__D010987sskos__Concept
% 209.28/209.46 |- mesh__dateRevised mesh__D010987 2003-07-09
% 209.28/209.46 |- mesh__recordMaintainer mesh__D010987 ags
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D010987
% 209.28/209.46 91; was see under MONOTREMATA 1975-95; DUCKMOLE was see PLATYPUS 1975-95%A%
% 209.28/209.46 |- skos__altLabel mesh__D010987 Duckbilled Platypus
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010987 2004
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D010987 sjn
% 209.28/209.46 |- mesh__dateCreated mesh__D010987 1974-11-19
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010987 2006
% 209.28/209.46 |- mesh__dateEstablished mesh__D010987 1991-01-01
% 209.28/209.46 |- skos__annotation mesh__D010987 IM; qualif permitted
% 209.28/209.46 |- skos__broader mesh__D010987smesh__D009007
% 209.28/209.46 |- mesh__onlineNote mesh__D010987
% 209.28/209.46 use PLATYPUS to search DUCKMOLE 1975-95
% 209.28/209.46 |- mesh__dateEstablished mesh__D043363 2004-01-01
% 209.28/209.46 |- mesh__dateCreated mesh__D043363 2003-07-09
% 209.28/209.46 |- mesh__dateRevised mesh__D043363 2005-06-30
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D043363 2004
% 209.28/209.46 |- mesh__recordMaintainer mesh__D043363 SYSTEM
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D043363 2006
% 209.28/209.46 |- skos__scopeNote mesh__D043363
% 209.28/209.46 A family of gram-negative bacteria in the order Hydrogenophilales, class BETAPROTEOBACTERIA.%A%
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D043363 sjn
% 209.28/209.46 |- skos__broader mesh__D043363smesh__D020562
% 209.28/209.46 |- mesh__recordOriginator mesh__D043363 ags
% 209.28/209.46 |- skos__prefLabel mesh__D043363 Hydrogenophilaceae
% 209.28/209.46 |- rdf__type mesh__D043363sskos__Concept
% 209.28/209.46 |- mesh__historyNote mesh__D043363 2004
% 209.28/209.46 |- mesh__dateCreated mesh__D010189 1999-01-01
% 209.28/209.46 |- skos__hiddenLabel mesh__D010189 Juices, Pancreatic
% 209.28/209.46 |- skos__annotation mesh__D010189
% 209.28/209.46 /secret permitted but consider PANCREAS /secret if pertinent%A%
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010189 2003
% 209.28/209.46 |- skos__related mesh__D010189smesh__D002919
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010189 2006
% 209.28/209.46 |- mesh__recordOriginator mesh__D010189 NLM
% 209.28/209.46 |- skos__broader mesh__D010189smesh__D012634
% 209.28/209.46 |- skos__hiddenLabel mesh__D010189 Pancreatic Juices
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010189 2001
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010189 2005
% 209.28/209.46 |- skos__scopeNote mesh__D010189
% 209.28/209.46 The fluid containing digestive enzymes secreted by the pancreas in response to food in the duodenum.%A%
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010189 2000
% 209.28/209.46 |- rdf__type mesh__D010189sskos__Concept
% 209.28/209.46 |- skos__related mesh__D010189smesh__D014362
% 209.28/209.46 |- mesh__dateRevised mesh__D010189 1999-11-03
% 209.28/209.46 |- skos__hiddenLabel mesh__D010189 Juice, Pancreatic
% 209.28/209.46 |- skos__prefLabel mesh__D010189 Pancreatic Juice
% 209.28/209.46 |- skos__related mesh__D010189smesh__D014357
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010189 2004
% 209.28/209.46 |- mesh__recordMaintainer mesh__D010189 KEV
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010189 2002
% 209.28/209.46 |- skos__related mesh__D010189smesh__D002918
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D010189 sjn
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cells, Erythropoietic Stem
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Erythropoietic Stem Cell
% 209.28/209.46 |- skos__altLabel mesh__D015672 Stem Cells, Erythroid
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cells, Erythroid Progenitor
% 209.28/209.46 |- skos__altLabel mesh__D015672 Erythropoietic Progenitor Cells
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Erythroid Burst-Forming Units
% 209.28/209.46 |- skos__altLabel mesh__D015672 Progenitor Cells, Erythropoietic
% 209.28/209.46 |- skos__scopeNote mesh__D015672
% 209.28/209.46 Committed, erythroid stem cells derived from MYELOID PROGENITOR CELLS. The progenitor cells develop in two phases: erythroid burst-forming units %28%BFU-E%29% followed by erythroid colony-forming units %28%CFU-E%29%; BFU-E differentiate into CFU-E on stimulation by ERYTHROPOIETIN, and then further differentiate into ERYTHROBLASTS when stimulated by other factors.%A%
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Stem Cell, Erythroid
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Progenitor Cell, Erythroid
% 209.28/209.46 |- mesh__dateRevised mesh__D015672 2003-07-09
% 209.28/209.46 |- skos__historyNote mesh__D015672 Erythrocytes %28%1972-1989%29%
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Progenitor Cell, Erythropoietic
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D015672 90
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Stem Cells, Erythropoietic
% 209.28/209.46 |- skos__broader mesh__D015672smesh__D023461
% 209.28/209.46 |- skos__prefLabel mesh__D015672 Erythroid Progenitor Cells
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Erythroid Stem Cells
% 209.28/209.46 |- skos__altLabel mesh__D015672 CFU-E
% 209.28/209.46 |- skos__historyNote mesh__D015672
% 209.28/209.46 Hematopoietic Stem Cells %28%1977-1989%29%
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Progenitor Cells, Erythroid
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cell, Erythropoietic Progenitor
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cell, Erythropoietic Stem
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Burst Forming Units, Erythroid
% 209.28/209.46 |- skos__broader mesh__D015672smesh__D041905
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Precursor Cell, Erythroid
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Units, Erythroid Burst-Forming
% 209.28/209.46 |- mesh__dateCreated mesh__D015672 1989-05-15
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cells, Erythroid Precursor
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Burst-Forming Unit, Erythroid
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cell, Erythroid Progenitor
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cells, Erythropoietic Progenitor
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D015672 2005
% 209.28/209.46 |- skos__altLabel mesh__D015672 Erythroid Precursor Cells
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 BFU-Es
% 209.28/209.46 |- mesh__historyNote mesh__D015672 90
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D015672 sjn
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 BFU E
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Stem Cell, Erythropoietic
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Unit, Erythroid Burst-Forming
% 209.28/209.46 |- mesh__dateEstablished mesh__D015672 1990-01-01
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Erythroid Progenitor Cell
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cell, Erythroid Precursor
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Erythroid Precursor Cell
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D015672 2006
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Erythroid Burst-Forming Unit
% 209.28/209.46 |- skos__altLabel mesh__D015672 Erythropoietic Stem Cells
% 209.28/209.46 |- mesh__recordOriginator mesh__D015672 AGS
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cell, Erythroid Stem
% 209.28/209.46 |- skos__historyNote mesh__D015672 Erythroblasts %28%1977-1989%29%
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Erythropoietic Progenitor Cell
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Precursor Cells, Erythroid
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Erythroid Stem Cell
% 209.28/209.46 |- skos__hiddenLabel mesh__D015672 Cells, Erythroid Stem
% 209.28/209.46 |- mesh__recordMaintainer mesh__D015672 nns
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D015672 2004
% 209.28/209.46 |- rdf__type mesh__D015672sskos__Concept
% 209.28/209.46 |- skos__altLabel mesh__D015672 BFU-E
% 209.28/209.46 |- mesh__dateCreated mesh__D009635 1974-11-11
% 209.28/209.46 |- mesh__dateEstablished mesh__D009635 1975-09-01
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009635 2006
% 209.28/209.46 |- skos__historyNote mesh__D009635 Norsteroids %28%1968-1974%29%
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D009635 SJN
% 209.28/209.46 |- mesh__recordOriginator mesh__D009635 NLM
% 209.28/209.46 |- mesh__historyNote mesh__D009635 75
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009635 2002
% 209.28/209.46 |- skos__scopeNote mesh__D009635
% 209.28/209.46 Androstanes in which ring contractions have occurred or which are lacking carbon-18. Compounds with any degree of unsaturation are included. Androstanes which are lacking carbon-19 are ESTRANES.%A%
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009635 2003
% 209.28/209.46 |- skos__broader mesh__D009635smesh__D009654
% 209.28/209.46 |- skos__prefLabel mesh__D009635 Norandrostanes
% 209.28/209.46 |- rdf__type mesh__D009635sskos__Concept
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009635 1998
% 209.28/209.46 |- mesh__dateRevised mesh__D009635 1997-06-20
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009635 2004
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009635 2000
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009635 1999
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D009635 75
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009635 2001
% 209.28/209.46 |- mesh__recordMaintainer mesh__D009635 TGC
% 209.28/209.46 |- skos__historyNote mesh__D009635 Androstanes %28%1968-1974%29%
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D009635 2005
% 209.28/209.46 |- skos__hiddenLabel mesh__D001652 Bile Duct
% 209.28/209.46 |- skos__related mesh__D001652smesh__D002758
% 209.28/209.46 |- mesh__recordOriginator mesh__D001652 NLM
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D001652 sjn
% 209.28/209.46 |- skos__hiddenLabel mesh__D001652 Ducts, Bile
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D001652 2006
% 209.28/209.46 |- skos__hiddenLabel mesh__D001652 Duct, Bile
% 209.28/209.46 |- skos__related mesh__D001652smesh__D002760
% 209.28/209.46 |- mesh__dateCreated mesh__D001652 1999-01-01
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D001652 2005
% 209.28/209.46 |- skos__related mesh__D001652smesh__D011171
% 209.28/209.46 |- mesh__recordMaintainer mesh__D001652 lkt
% 209.28/209.46 |- rdf__type mesh__D001652sskos__Concept
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D001652 2004
% 209.28/209.46 |- skos__annotation mesh__D001652
% 209.28/209.46 /abnorm: BILIARY ATRESIA is also available; inflammation = CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS %28%IM%29% + BILE DUCT DISEASES %28%IM%29%%A%
% 209.28/209.46 |- skos__scopeNote mesh__D001652
% 209.28/209.46 The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.%A%
% 209.28/209.46 |- skos__prefLabel mesh__D001652 Bile Ducts
% 209.28/209.46 |- mesh__dateRevised mesh__D001652 2003-07-09
% 209.28/209.46 |- skos__broader mesh__D001652smesh__D001659
% 209.28/209.46 |- skos__annotation mesh__D019265
% 209.28/209.46 a type of spectrum anal; DF: note short X ref
% 209.28/209.46 |- mesh__recordOriginator mesh__D019265 JLS
% 209.28/209.46 |- skos__broader mesh__D019265smesh__D003952
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Near-Infrared Spectroscopy
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019265 2005A
% 209.28/209.46 |- mesh__recordMaintainer mesh__D019265 jls
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Spectrometries, Near-Infrared
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019265 2006
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D019265 jls
% 209.28/209.46 |- rdf__type mesh__D019265sskos__Concept
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Near-Infrared Spectrometry
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Spectroscopy, Near Infrared
% 209.28/209.46 |- mesh__dateCreated mesh__D019265 1996-06-10
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Spectroscopy, NIR
% 209.28/209.46 |- skos__historyNote mesh__D019265
% 209.28/209.46 Spectrophotometry, Infrared %28%1991-1996%29%
% 209.28/209.46 |- skos__broader mesh__D019265smesh__D013057
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Spectroscopies, NIR
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Spectrometry, Near Infrared
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019265 2005
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Near-Infrared Spectroscopies
% 209.28/209.46 |- skos__prefLabel mesh__D019265 Spectroscopy, Near-Infrared
% 209.28/209.46 |- mesh__dateRevised mesh__D019265 2004-08-02
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Near-Infrared Spectrometries
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019265 2004
% 209.28/209.46 |- skos__altLabel mesh__D019265 Spectrometry, Near-Infrared
% 209.28/209.46 |- skos__scopeNote mesh__D019265
% 209.28/209.46 A noninvasive technique that uses the differential absorption properties of hemoglobin and myoglobin to evaluate tissue oxygenation and indirectly can measure regional hemodynamics and blood flow. Near-infrared light %28%NIR%29% can propagate through tissues and at particular wavelengths is differentially absorbed by oxygenated vs. deoxygenated forms of hemoglobin and myoglobin. Illumination of intact tissue with NIR allows qualitative assessment of changes in the tissue concentration of these molecules. The analysis is also used to determine body composition.%A%
% 209.28/209.46 |- mesh__dateEstablished mesh__D019265 1997-01-01
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 Spectroscopies, Near-Infrared
% 209.28/209.46 |- skos__hiddenLabel mesh__D019265 NIR Spectroscopies
% 209.28/209.46 |- mesh__historyNote mesh__D019265 97
% 209.28/209.46 |- skos__altLabel mesh__D019265 NIR Spectroscopy
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D019265 97
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D019265 2003
% 209.28/209.46 |- rdf__type mesh__D011282sskos__Concept
% 209.28/209.46 |- mesh__dateEstablished mesh__D011282 1974-01-01
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D011282 74
% 209.28/209.46 |- skos__prefLabel mesh__D011282 Pregnenediones
% 209.28/209.46 |- mesh__recordOriginator mesh__D011282 NLM
% 209.28/209.46 |- mesh__dateRevised mesh__D011282 1993-06-03
% 209.28/209.46 |- skos__scopeNote mesh__D011282
% 209.28/209.46 Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures.%A%
% 209.28/209.46 |- mesh__historyNote mesh__D011282 74
% 209.28/209.46 |- skos__altLabel mesh__D011282 Diketopregnenes
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 2004
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 1997
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 2002
% 209.28/209.46 |- skos__altLabel mesh__D011282 Dioxopregnenes
% 209.28/209.46 |- mesh__dateCreated mesh__D011282 1999-01-01
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 2006
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 1999
% 209.28/209.46 |- mesh__recordMaintainer mesh__D011282 PLS
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 2003
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 1996
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 2001
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 2005
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 1995
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 1998
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D011282 PLS
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 1994
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D011282 2000
% 209.28/209.46 |- skos__broader mesh__D011282smesh__D011283
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 2003
% 209.28/209.46 |- mesh__recordAuthorizer mesh__D005245 PLS
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 2001
% 209.28/209.46 |- mesh__dateEstablished mesh__D005245 1968-01-01
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 1995
% 209.28/209.46 |- mesh__dateRevised mesh__D005245 1994-05-05
% 209.28/209.46 |- skos__hiddenLabel mesh__D005245 Schedules, Fee
% 209.28/209.46 |- rdf__type mesh__D005245sskos__Concept
% 209.28/209.46 |- mesh__recordMaintainer mesh__D005245 TGC
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 2000
% 209.28/209.46 |- skos__historyNote mesh__D005245 Economics %28%1966-1967%29%
% 209.28/209.46 |- mesh__historyNote mesh__D005245 68
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 1999
% 209.28/209.46 |- skos__prefLabel mesh__D005245 Fee Schedules
% 209.28/209.46 |- mesh__dateCreated mesh__D005245 1999-01-01
% 209.28/209.46 |- skos__hiddenLabel mesh__D005245 Schedule, Fee
% 209.28/209.46 |- skos__hiddenLabel mesh__D005245 Fee Schedule
% 209.28/209.46 |- skos__related mesh__D005245smesh__D005249
% 209.28/209.46 |- skos__broader mesh__D005245smesh__D009934
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 2006
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 1998
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 2002
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 1997
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 2005
% 209.28/209.46 |- mesh__recordOriginator mesh__D005245 NLM
% 209.28/209.46 |- skos__scopeNote mesh__D005245
% 209.28/209.46 A listing of established professional service charges, for specified dental and medical procedures.%A%
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 2004
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D005245 1996
% 209.28/209.46 |- mesh__publicMeSHNote mesh__D005245 68
% 209.28/209.46 |- rdf__type mesh__D010988sskos__Concept
% 209.28/209.46 |- mesh__activeMeSHYear mesh__D010988 2002
% 209.28/209.47 |- mesh__dateRevised mesh__D010988 1999-11-03
% 209.28/209.47 |- skos__prefLabel mesh__D010988 Play and Playthings
% 209.28/209.47 |- skos__hiddenLabel mesh__D010988 Toy
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D010988 78; was PLAY 1963-77
% 209.28/209.47 |- mesh__onlineNote mesh__D010988
% 209.28/209.47 use PLAY AND PLAYTHINGS to search PLAY 1966-77
% 209.28/209.47 |- skos__broader mesh__D010988smesh__D011998
% 209.28/209.47 |- skos__hiddenLabel mesh__D010988 Playthings and Play
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010988 2001
% 209.28/209.47 |- mesh__dateCreated mesh__D010988 1999-01-01
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010988 2004
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010988 2000
% 209.28/209.47 |- mesh__recordOriginator mesh__D010988 NLM
% 209.28/209.47 |- skos__scopeNote mesh__D010988
% 209.28/209.47 Spontaneous or voluntary recreational activities pursued for enjoyment and accessories or equipment used in the activities; includes games, toys, etc.%A%
% 209.28/209.47 |- mesh__historyNote mesh__D010988 78; was PLAY 1963-77
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010988 2006
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010988 2003
% 209.28/209.47 |- skos__hiddenLabel mesh__D010988 Plaything
% 209.28/209.47 |- skos__annotation mesh__D010988
% 209.28/209.47 /psychol permitted but do not confuse with PLAY THERAPY; includes games; DF: PLAY%A%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010988 2005
% 209.28/209.47 |- mesh__recordMaintainer mesh__D010988 kle
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D010988 sjn
% 209.28/209.47 |- skos__hiddenLabel mesh__D010988 Plays
% 209.28/209.47 |- skos__hiddenLabel mesh__D010988 Puppet
% 209.28/209.47 |- skos__hiddenLabel mesh__D043364 1,4 beta D Xylanohydrolase
% 209.28/209.47 |- skos__hiddenLabel mesh__D043364 Endo 1,4 Xylanase II
% 209.28/209.47 |- skos__broader mesh__D043364smesh__D014995
% 209.28/209.47 |- mesh__historyNote mesh__D043364
% 209.28/209.47 2004; use ENDO-1,4-BETA XYLANASES %28%NM%29% 1980-2003; for XYLANASE B use ENDO-1,4-BETA XYLANASES %28%NM%29% 1990-2003; for XYLANASE C use ENDO-1,4-BETA XYLANASES %28%NM%29% 1992-2003; for XYLANASE D use ENDO-1,4-BETA XYLANASES %28%NM%29% 1993-2003%A%
% 209.28/209.47 |- skos__altLabel mesh__D043364 Endo-1,4-beta-Xylanase
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D043364 2006
% 209.28/209.47 |- mesh__recordOriginator mesh__D043364 AKE
% 209.28/209.47 |- mesh__dateEstablished mesh__D043364 2004-01-01
% 209.28/209.47 |- skos__historyNote mesh__D043364 Xylans %28%1977-1980%29%
% 209.28/209.47 |- skos__hiddenLabel mesh__D043364 Endo 1,4 beta Xylanase II
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D043364 2005
% 209.28/209.47 |- skos__altLabel mesh__D043364 beta Xylanase
% 209.28/209.47 |- skos__altLabel mesh__D043364 Endoxylanase
% 209.28/209.47 |- rdf__type mesh__D043364sskos__Concept
% 209.28/209.47 |- skos__hiddenLabel mesh__D043364 Xylanases, Endo-1,4-beta
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D043364
% 209.28/209.47 2004; ENDO-1,4 BETA XYLANASES was indexed under XYLOSIDASES 1995-2003, under GLYCOSIDE HYDROLASES 1980-1994 %26% under XYLANS 1977-1980, XYLANASE B was indexed under XYLOSIDASES 1995-2003 %26% under GLYCOSIDE HYDROLASES 1990-1994, XYLANASE C was indexed under XYLOSIDASES 1995-2003 %26% under GLYCOSIDE HYDROLASES 1992-1994, XYLANASE D was indexed under XYLOSIDASES %26% BETA-GLUCOSIDASE 1995-2003, under GLYCOSIDE HYDROLASES 1993-1994%A%
% 209.28/209.47 |- skos__hiddenLabel mesh__D043364 Beta 1 4 Endoxylanase
% 209.28/209.47 |- skos__altLabel mesh__D043364 Beta-1-4-Endoxylanase
% 209.28/209.47 |- mesh__recordMaintainer mesh__D043364 AKE
% 209.28/209.47 |- skos__altLabel mesh__D043364 1,4-beta-D-Xylanohydrolase
% 209.28/209.47 |- skos__hiddenLabel mesh__D043364 Xylanase, beta
% 209.28/209.47 |- skos__hiddenLabel mesh__D043364 Endo 1,4 beta Xylanase
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D043364 2004
% 209.28/209.47 |- skos__altLabel mesh__D043364 Endo-1,4-Xylanase II
% 209.28/209.47 |- skos__hiddenLabel mesh__D043364 Endo 1,4 beta Xylanases
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D043364 sjn
% 209.28/209.47 |- skos__scopeNote mesh__D043364
% 209.28/209.47 Enzymes which catalyze the endohydrolysis of 1,4-beta-D-xylosidic linkages in XYLANS.%A%
% 209.28/209.47 |- skos__historyNote mesh__D043364 Glycoside Hydrolases %28%1980-1994%29%
% 209.28/209.47 |- skos__prefLabel mesh__D043364 Endo-1,4-beta Xylanases
% 209.28/209.47 |- skos__historyNote mesh__D043364 Xylosidases %28%1995-2003%29%
% 209.28/209.47 |- mesh__dateCreated mesh__D043364 2003-07-09
% 209.28/209.47 |- skos__broader mesh__D015673smesh__D009468
% 209.28/209.47 |- skos__broader mesh__D015673smesh__D014777
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673
% 209.28/209.47 Infectious Mononucleosis Like Syndrome, Chronic
% 209.28/209.47 |- skos__related mesh__D015673smesh__D005356
% 209.28/209.47 |- mesh__recordMaintainer mesh__D015673 ags
% 209.28/209.47 |- skos__historyNote mesh__D015673 Muscular Diseases %28%1966-1989%29%
% 209.28/209.47 |- skos__altLabel mesh__D015673 Chronic Fatigue Syndrome
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Syndrome, Chronic Fatigue-Fibromyalgia
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Fatigue Syndromes, Postviral
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D015673 2004
% 209.28/209.47 |- rdf__type mesh__D015673sskos__Concept
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D015673 90
% 209.28/209.47 |- skos__altLabel mesh__D015673 Myalgic Encephalomyelitis
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Fatigue-Fibromyalgia Syndrome, Chronic
% 209.28/209.47 |- skos__historyNote mesh__D015673 Virus Diseases %28%1986-1989%29%
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Disorders, Chronic Fatigue
% 209.28/209.47 |- skos__altLabel mesh__D015673 Fatigue Syndrome, Postviral
% 209.28/209.47 |- skos__altLabel mesh__D015673 Chronic Fatigue-Fibromyalgia Syndrome
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Chronic Fatigue Syndromes
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D015673 sjn
% 209.28/209.47 |- skos__altLabel mesh__D015673 Postviral Fatigue Syndrome
% 209.28/209.47 |- skos__altLabel mesh__D015673 Royal Free Disease
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Fatigue Syndromes, Chronic
% 209.28/209.47 |- skos__broader mesh__D015673smesh__D009135
% 209.28/209.47 |- skos__altLabel mesh__D015673 Chronic Fatigue Disorder
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Fatigue-Fibromyalgia Syndromes, Chronic
% 209.28/209.47 |- mesh__dateCreated mesh__D015673 1989-05-25
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Chronic Fatigue Disorders
% 209.28/209.47 |- skos__annotation mesh__D015673
% 209.28/209.47 a clinical entity: do not confuse with %22%chronic fatigue%22% %28% = FATIGUE %28%IM%29% + CHRONIC DISEASE %28%NIM%29%%29%; DF: CFIDS%A%
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Fatigue Disorders, Chronic
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Chronic Fatigue-Fibromyalgia Syndromes
% 209.28/209.47 |- mesh__dateEstablished mesh__D015673 1990-01-01
% 209.28/209.47 |- mesh__historyNote mesh__D015673 90
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Postviral Fatigue Syndromes
% 209.28/209.47 |- mesh__recordOriginator mesh__D015673 AGS
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Fatigue Disorder, Chronic
% 209.28/209.47 |- skos__altLabel mesh__D015673
% 209.28/209.47 Infectious Mononucleosis-Like Syndrome, Chronic
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D015673 2005
% 209.28/209.47 |- skos__broader mesh__D015673smesh__D004679
% 209.28/209.47 |- skos__altLabel mesh__D015673
% 209.28/209.47 Chronic Fatigue and Immune Dysfunction Syndrome
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Syndromes, Postviral Fatigue
% 209.28/209.47 |- skos__altLabel mesh__D015673 Encephalomyelitis, Myalgic
% 209.28/209.47 |- skos__prefLabel mesh__D015673 Fatigue Syndrome, Chronic
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D015673 2002
% 209.28/209.47 |- skos__historyNote mesh__D015673 Encephalomyelitis %28%1966-1989%29%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D015673 2006
% 209.28/209.47 |- mesh__dateRevised mesh__D015673 2001-07-25
% 209.28/209.47 |- skos__historyNote mesh__D015673 Fatigue %28%1977-1989%29%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D015673 2003
% 209.28/209.47 |- skos__scopeNote mesh__D015673
% 209.28/209.47 A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. %28%From Semin Neurol 1998;18%28%2%29%:237-42; Ann Intern Med 1994 Dec 15;121%28%12%29%: 953-9%29%%A%
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Syndromes, Chronic Fatigue-Fibromyalgia
% 209.28/209.47 |- skos__hiddenLabel mesh__D015673 Chronic Fatigue Fibromyalgia Syndrome
% 209.28/209.47 |- skos__historyNote mesh__D009636 Heterocyclic Compounds %28%1966-1970%29%
% 209.28/209.47 |- skos__historyNote mesh__D009636 Bridged Compounds %28%1966-1970%29%
% 209.28/209.47 |- skos__historyNote mesh__D009636 Camphor %28%1966-1970%29%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D009636 2006
% 209.28/209.47 |- skos__historyNote mesh__D009636 Polycyclic Compounds %28%1966-1970%29%
% 209.28/209.47 |- mesh__dateCreated mesh__D009636 1999-01-01
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D009636 2004
% 209.28/209.47 |- mesh__dateRevised mesh__D009636 2003-07-09
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D009636 2005
% 209.28/209.47 |- mesh__recordMaintainer mesh__D009636 ssb
% 209.28/209.47 |- skos__prefLabel mesh__D009636 Norbornanes
% 209.28/209.47 |- mesh__recordOriginator mesh__D009636 NLM
% 209.28/209.47 |- rdf__type mesh__D009636sskos__Concept
% 209.28/209.47 |- mesh__dateEstablished mesh__D009636 1974-01-01
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D009636 74
% 209.28/209.47 |- skos__historyNote mesh__D009636 Terpenes %28%1970-1971%29%
% 209.28/209.47 |- skos__altLabel mesh__D009636 Norcamphanes
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D009636 sjn
% 209.28/209.47 |- skos__broader mesh__D009636smesh__D039821
% 209.28/209.47 |- mesh__historyNote mesh__D009636 74%28%72%29%
% 209.28/209.47 |- skos__annotation mesh__D009636 includes norbornenes
% 209.28/209.47 |- skos__hiddenLabel mesh__D001653 Bile Duct, Intrahepatic
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D001653 1999
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D001653 2006
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D001653 SJN
% 209.28/209.47 |- skos__scopeNote mesh__D001653
% 209.28/209.47 Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.%A%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D001653 2005
% 209.28/209.47 |- mesh__dateCreated mesh__D001653 1999-01-01
% 209.28/209.47 |- skos__broader mesh__D001653smesh__D008099
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D001653 2002
% 209.28/209.47 |- skos__prefLabel mesh__D001653 Bile Ducts, Intrahepatic
% 209.28/209.47 |- rdf__type mesh__D001653sskos__Concept
% 209.28/209.47 |- mesh__dateRevised mesh__D001653 1998-06-10
% 209.28/209.47 |- mesh__recordOriginator mesh__D001653 NLM
% 209.28/209.47 |- skos__annotation mesh__D001653
% 209.28/209.47 do not confuse with BILE DUCTS, EXTRAHEPATIC; do not confuse with HEPATIC DUCT, COMMON, the external junction of right %26% left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES %28%IM%29%; neopl: coord IM with BILE DUCT NEOPLASMS %28%IM%29%; inflammation: coord IM with CHOLANGITIS %28%IM%29%; BILE DUCT OBSTRUCTION, INTRAHEPATIC see CHOLESTASIS, INTRAHEPATIC is also available%A%
% 209.28/209.47 |- skos__broader mesh__D001653smesh__D001652
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D001653 2004
% 209.28/209.47 |- skos__hiddenLabel mesh__D001653 Intrahepatic Bile Ducts
% 209.28/209.47 |- skos__hiddenLabel mesh__D001653 Intrahepatic Bile Duct
% 209.28/209.47 |- skos__hiddenLabel mesh__D001653 Duct, Intrahepatic Bile
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D001653 2001
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D001653 2003
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D001653 2000
% 209.28/209.47 |- skos__hiddenLabel mesh__D001653 Ducts, Intrahepatic Bile
% 209.28/209.47 |- mesh__recordMaintainer mesh__D001653 MSR
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 2006
% 209.28/209.47 |- rdf__type mesh__D019266sskos__Concept
% 209.28/209.47 |- mesh__dateEstablished mesh__D019266 1997-01-01
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 2001
% 209.28/209.47 |- mesh__dateCreated mesh__D019266 1996-06-19
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D019266 97
% 209.28/209.47 |- skos__broader mesh__D019266smesh__D017614
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 2005
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 2000
% 209.28/209.47 |- skos__altLabel mesh__D019266 Dietary Iron
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 1999
% 209.28/209.47 |- skos__annotation mesh__D019266
% 209.28/209.47 /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther%A%
% 209.28/209.47 |- skos__historyNote mesh__D019266 Iron %28%1966-1996%29%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 1998
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 2004
% 209.28/209.47 |- skos__scopeNote mesh__D019266
% 209.28/209.47 Iron or iron compounds used in foods or as food. Dietary iron is important in oxygen transport and the synthesis of the iron-porphyrin proteins hemoglobin, myoglobin, cytochromes, and cytochrome oxidase. Insufficient amounts of dietary iron can lead to iron-deficiency anemia.%A%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 2002
% 209.28/209.47 |- skos__prefLabel mesh__D019266 Iron, Dietary
% 209.28/209.47 |- mesh__historyNote mesh__D019266 97
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 2003
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019266 1997
% 209.28/209.47 |- skos__annotation mesh__D011283 do not confuse with PREGNANES
% 209.28/209.47 |- rdf__type mesh__D011283sskos__Concept
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 2001
% 209.28/209.47 |- mesh__dateCreated mesh__D011283 1999-01-01
% 209.28/209.47 |- mesh__recordMaintainer mesh__D011283 PLS
% 209.28/209.47 |- skos__scopeNote mesh__D011283 Unsaturated derivatives of PREGNANES.
% 209.28/209.47 |- skos__broader mesh__D011283smesh__D011278
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 2003
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 1996
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 2005
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 1998
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 2004
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 1997
% 209.28/209.47 |- mesh__historyNote mesh__D011283 73
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D011283 73
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 1994
% 209.28/209.47 |- skos__historyNote mesh__D011283 Pregnanes %28%1966-1972%29%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 2002
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 2006
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 1999
% 209.28/209.47 |- skos__prefLabel mesh__D011283 Pregnenes
% 209.28/209.47 |- mesh__dateEstablished mesh__D011283 1973-01-01
% 209.28/209.47 |- mesh__recordOriginator mesh__D011283 NLM
% 209.28/209.47 |- mesh__dateRevised mesh__D011283 1993-06-03
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 1995
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D011283 PLS
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011283 2000
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D005246 2002
% 209.28/209.47 |- mesh__recordMaintainer mesh__D005246 lkt
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D005246 sjn
% 209.28/209.47 |- skos__annotation mesh__D005246
% 209.28/209.47 note category; FEEDBACK, BIOCHEMICAL and FEEDBACK, PSYCHOLOGICAL are also available%A%
% 209.28/209.47 |- mesh__dateCreated mesh__D005246 1999-01-01
% 209.28/209.47 |- mesh__recordOriginator mesh__D005246 NLM
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D005246 2006
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D005246 1965
% 209.28/209.47 |- skos__related mesh__D005246smesh__D001676
% 209.28/209.47 |- skos__broader mesh__D005246smesh__D003491
% 209.28/209.47 |- skos__scopeNote mesh__D005246
% 209.28/209.47 A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system.%A%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D005246 2005
% 209.28/209.47 |- skos__prefLabel mesh__D005246 Feedback
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D005246 2004
% 209.28/209.47 |- skos__related mesh__D005246smesh__D025461
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D005246 2003
% 209.28/209.47 |- skos__related mesh__D005246smesh__D007721
% 209.28/209.47 |- mesh__dateRevised mesh__D005246 2001-07-25
% 209.28/209.47 |- mesh__historyNote mesh__D005246 1965
% 209.28/209.47 |- mesh__dateEstablished mesh__D005246 1965-01-01
% 209.28/209.47 |- rdf__type mesh__D005246sskos__Concept
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010989 2004
% 209.28/209.47 |- skos__prefLabel mesh__D010989 Play Therapy
% 209.28/209.47 |- skos__historyNote mesh__D010989 Psychotherapy, Group %28%1966-1968%29%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010989 2006
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010989 2003
% 209.28/209.47 |- mesh__dateEstablished mesh__D010989 1969-01-01
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D010989 sjn
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010989 2005
% 209.28/209.47 |- skos__broader mesh__D010989smesh__D011613
% 209.28/209.47 |- skos__historyNote mesh__D010989 Projective Techniques %28%1966-1967%29%
% 209.28/209.47 |- skos__altLabel mesh__D010989 Therapy, Play
% 209.28/209.47 |- skos__hiddenLabel mesh__D010989 Therapies, Play
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D010989
% 209.28/209.47 69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNIQUES 1963-67%A%
% 209.28/209.47 |- mesh__dateRevised mesh__D010989 2001-07-25
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D010989 2002
% 209.28/209.47 |- skos__historyNote mesh__D010989 Play %28%1966-1968%29%
% 209.28/209.47 |- skos__annotation mesh__D010989 a psychother technique; DF: PLAY THER
% 209.28/209.47 |- skos__broader mesh__D010989smesh__D026421
% 209.28/209.47 |- mesh__onlineNote mesh__D010989
% 209.28/209.47 search ACTING OUT 1968 %26% PROJECTIVE TECHNIQUES 1966-67
% 209.28/209.47 |- rdf__type mesh__D010989sskos__Concept
% 209.28/209.47 |- skos__scopeNote mesh__D010989
% 209.28/209.47 A treatment technique utilizing play as a medium for expression and communication between patient and therapist.%A%
% 209.28/209.47 |- mesh__historyNote mesh__D010989
% 209.28/209.47 69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNIQUES 1963-67%A%
% 209.28/209.47 |- skos__historyNote mesh__D010989 Acting Out %28%1968%29%
% 209.28/209.47 |- mesh__recordOriginator mesh__D010989 NLM
% 209.28/209.47 |- mesh__recordMaintainer mesh__D010989 ssb
% 209.28/209.47 |- skos__hiddenLabel mesh__D010989 Play Therapies
% 209.28/209.47 |- mesh__dateCreated mesh__D010989 1999-01-01
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D043365 2004
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D043365 sjn
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D043365 2006
% 209.28/209.47 |- mesh__recordOriginator mesh__D043365 ags
% 209.28/209.47 |- skos__scopeNote mesh__D043365
% 209.28/209.47 A family of gram-negative bacteria in the order Burkholderiales, class BETAPROTEOBACTERIA. It is comprised of a single genus RALSTONIA.%A%
% 209.28/209.47 |- skos__prefLabel mesh__D043365 Ralstoniaceae
% 209.28/209.47 |- skos__broader mesh__D043365smesh__D016946
% 209.28/209.47 |- rdf__type mesh__D043365sskos__Concept
% 209.28/209.47 |- mesh__historyNote mesh__D043365 2004
% 209.28/209.47 |- mesh__recordMaintainer mesh__D043365 SYSTEM
% 209.28/209.47 |- mesh__dateRevised mesh__D043365 2005-06-30
% 209.28/209.47 |- mesh__dateEstablished mesh__D043365 2004-01-01
% 209.28/209.47 |- skos__broader mesh__D043365smesh__D020562
% 209.28/209.47 |- mesh__dateCreated mesh__D043365 2003-07-09
% 209.28/209.47 |- skos__broader mesh__D003813Q000295smesh__D003813
% 209.28/209.47 |- mesh__preferredCombination mesh__D003813Q000295smesh__D003762
% 209.28/209.47 |- rdf__type mesh__D003813Q000295smesh__CompoundConcept
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Mammary Neoplasm
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Carcinoma, Animal Mammary
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D015674 2004
% 209.28/209.47 |- mesh__recordOriginator mesh__D015674 PXP
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Neoplasm, Animal Mammary
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D015674 2006
% 209.28/209.47 |- skos__broader mesh__D015674smesh__D009371
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D015674 sjn
% 209.28/209.47 |- mesh__dateCreated mesh__D015674 1989-05-15
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Carcinomas, Animal Mammary
% 209.28/209.47 |- mesh__historyNote mesh__D015674 2004 %28%1990%29%
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Mammary Carcinomas, Animal
% 209.28/209.47 |- skos__annotation mesh__D015674
% 209.28/209.47 animal only but MAMMARY NEOPLASMS, EXPERIMENTAL is also available; coord IM with histol type of neopl %28%IM%29% + precoord animal/dis term %28%IM%29% + specific animal %28%NIM%29%; do not coord with NEOPLASMS, EXPERIMENTAL; check tag ANIMALS%A%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D015674 2005
% 209.28/209.47 |- mesh__dateEstablished mesh__D015674 1990-01-01
% 209.28/209.47 |- mesh__recordMaintainer mesh__D015674 lkt
% 209.28/209.47 |- skos__historyNote mesh__D015674 Mammae %28%1968-1989%29%
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D015674
% 209.28/209.47 2004; see MAMMARY NEOPLASMS 1990-2003
% 209.28/209.47 |- mesh__dateRevised mesh__D015674 2003-07-30
% 209.28/209.47 |- skos__historyNote mesh__D015674 Neoplasms/veterinary %28%1967-1989%29%
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Neoplasm, Mammary
% 209.28/209.47 |- skos__prefLabel mesh__D015674 Mammary Neoplasms, Animal
% 209.28/209.47 |- skos__altLabel mesh__D015674 Animal Mammary Carcinoma
% 209.28/209.47 |- skos__altLabel mesh__D015674 Neoplasms, Mammary
% 209.28/209.47 |- skos__scopeNote mesh__D015674
% 209.28/209.47 Tumors or cancer of the MAMMARY GLAND in animals %28%MAMMARY GLANDS, ANIMAL%29%.%A%
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Animal Mammary Carcinomas
% 209.28/209.47 |- skos__altLabel mesh__D015674 Mammary Neoplasms
% 209.28/209.47 |- rdf__type mesh__D015674sskos__Concept
% 209.28/209.47 |- skos__broader mesh__D015674smesh__D000820
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Neoplasms, Animal Mammary
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Animal Mammary Neoplasm
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Animal Mammary Neoplasms
% 209.28/209.47 |- skos__hiddenLabel mesh__D015674 Mammary Neoplasm, Animal
% 209.28/209.47 |- mesh__recordOriginator mesh__D009637 RLS
% 209.28/209.47 |- skos__altLabel mesh__D009637 Dihydronorguaiaretic Acid
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D009637 sjn
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D009637 2006
% 209.28/209.47 |- mesh__historyNote mesh__D009637
% 209.28/209.47 91%28%87%29%; was see under CATECHOLS 1987-90
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D009637
% 209.28/209.47 91; was see under CATECHOLS 1987-90
% 209.28/209.47 |- mesh__dateRevised mesh__D009637 2005-06-30
% 209.28/209.47 |- skos__annotation mesh__D009637 DF: NDGA
% 209.28/209.47 |- skos__altLabel mesh__D009637
% 209.28/209.47 4,4%27%-%28%2,3 Dimethyl-1,4-butanediyl%29%bis%28%1,2-benzenediol%29%
% 209.28/209.47 |- skos__altLabel mesh__D009637 meso-Nordihydroguaiaretic Acid
% 209.28/209.47 |- rdf__type mesh__D009637sskos__Concept
% 209.28/209.47 |- skos__broader mesh__D009637smesh__D017705
% 209.28/209.47 |- skos__altLabel mesh__D009637
% 209.28/209.47 Nordihydroguaiaretic Acid, %28%R*,S*%29%-Isomer
% 209.28/209.47 |- skos__prefLabel mesh__D009637 Nordihydroguaiaretic Acid
% 209.28/209.47 |- skos__scopeNote mesh__D009637
% 209.28/209.47 A potent lipoxygenase inhibitor that interferes with arachidonic acid metabolism. The compound also inhibits formyltetrahydrofolate synthetase, carboxylesterase, and cyclooxygenase to a lesser extent. It also serves as an antioxidant in fats and oils.%A%
% 209.28/209.47 |- mesh__dateCreated mesh__D009637 1986-04-09
% 209.28/209.47 |- mesh__recordMaintainer mesh__D009637 ssb
% 209.28/209.47 |- skos__historyNote mesh__D009637 Catechols %28%1966-1986%29%
% 209.28/209.47 |- mesh__dateEstablished mesh__D009637 1991-01-01
% 209.28/209.47 |- skos__broader mesh__D009637smesh__D002396
% 209.28/209.47 |- mesh__dateRevised mesh__D001654 2005-06-30
% 209.28/209.47 |- skos__broader mesh__D001654smesh__D045725
% 209.28/209.47 |- mesh__dateCreated mesh__D001654 1999-01-01
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D001654 2006
% 209.28/209.47 |- mesh__recordOriginator mesh__D001654 NLM
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D001654 sjn
% 209.28/209.47 |- rdf__type mesh__D001654sskos__Concept
% 209.28/209.47 |- skos__altLabel mesh__D001654 Bile Pigment
% 209.28/209.47 |- skos__broader mesh__D001654smesh__D010860
% 209.28/209.47 |- skos__scopeNote mesh__D001654
% 209.28/209.47 Linear TETRAPYRROLES that give a characteristic color to BILE including: BILIRUBIN; BILIVERDIN; and bilicyanin.%A%
% 209.28/209.47 |- mesh__recordMaintainer mesh__D001654 ssb
% 209.28/209.47 |- skos__prefLabel mesh__D001654 Bile Pigments
% 209.28/209.47 |- skos__hiddenLabel mesh__D001654 Pigments, Bile
% 209.28/209.47 |- skos__hiddenLabel mesh__D001654 Pigment, Bile
% 209.28/209.47 |- mesh__dateRevised mesh__D020010 2004-07-07
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D020010 2005
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D020010 sjn
% 209.28/209.47 |- skos__broader mesh__D020010smesh__D019529
% 209.28/209.47 |- skos__scopeNote mesh__D020010
% 209.28/209.47 The sexual attraction or relationship between members of the opposite SEX.%A%
% 209.28/209.47 |- mesh__historyNote mesh__D020010
% 209.28/209.47 98; use SEXUALITY 1997; use SEX BEHAVIOR 1990-96
% 209.28/209.47 |- mesh__recordOriginator mesh__D020010 JLS
% 209.28/209.47 |- mesh__dateEstablished mesh__D020010 1998-01-01
% 209.28/209.47 |- skos__prefLabel mesh__D020010 Heterosexuality
% 209.28/209.47 |- mesh__recordMaintainer mesh__D020010 lkt
% 209.28/209.47 |- mesh__dateCreated mesh__D020010 1997-06-20
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D020010
% 209.28/209.47 98; see SEXUALITY 1997; see SEX BEHAVIOR 1990-96
% 209.28/209.47 |- skos__hiddenLabel mesh__D020010 Heterosexual
% 209.28/209.47 |- rdf__type mesh__D020010sskos__Concept
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D020010 2006
% 209.28/209.47 |- skos__scopeNote mesh__D019267
% 209.28/209.47 Membrane glycoproteins from influenza viruses which are involved in hemagglutination, virus attachment, and envelope fusion. Fourteen distinct subtypes of HA glycoproteins and nine of NA glycoproteins have been identified from INFLUENZA A VIRUS; no subtypes have been identified for Influenza B or Influenza C viruses.%A%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D019267 2006
% 209.28/209.47 |- rdf__type mesh__D019267sskos__Concept
% 209.28/209.47 |- mesh__dateRevised mesh__D019267 2005-06-30
% 209.28/209.47 |- mesh__onlineNote mesh__D019267
% 209.28/209.47 use HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS %28%NM%29% to search HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS 1980-96%A%
% 209.28/209.47 |- skos__historyNote mesh__D019267 Hemagglutinins, Viral %28%1983-1996%29%
% 209.28/209.47 |- skos__historyNote mesh__D019267 Glycoproteins %28%1980-1982%29%
% 209.28/209.47 |- skos__broader mesh__D019267smesh__D006389
% 209.28/209.47 |- skos__annotation mesh__D019267 DF: HGIV
% 209.28/209.47 |- mesh__dateEstablished mesh__D019267 1997-01-01
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D019267
% 209.28/209.47 97; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS was indexed under HEMAGGLUTININS, VIRAL 1983-96 %26% GLYCOPROTEINS 1980-82%A%
% 209.28/209.47 |- mesh__recordMaintainer mesh__D019267 ssb
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D019267 sjn
% 209.28/209.47 |- mesh__historyNote mesh__D019267
% 209.28/209.47 97; was HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS %28%NM%29% 1980-96%A%
% 209.28/209.47 |- mesh__dateCreated mesh__D019267 1996-06-10
% 209.28/209.47 |- mesh__recordOriginator mesh__D019267 AGS
% 209.28/209.47 |- skos__prefLabel mesh__D019267
% 209.28/209.47 Hemagglutinin Glycoproteins, Influenza Virus
% 209.28/209.47 |- skos__hiddenLabel mesh__D011284 5 Pregnen 3 beta ol 20 one
% 209.28/209.47 |- skos__altLabel mesh__D011284 5-Pregnen-3-beta-ol-20-one
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011284 2005
% 209.28/209.47 |- mesh__dateRevised mesh__D011284 2003-07-09
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011284 2004
% 209.28/209.47 |- skos__annotation mesh__D011284 do not confuse with PREGNANOLONE
% 209.28/209.47 |- mesh__recordMaintainer mesh__D011284 lkt
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D011284 2006
% 209.28/209.47 |- skos__broader mesh__D011284smesh__D006889
% 209.28/209.47 |- skos__broader mesh__D011284smesh__D045167
% 209.28/209.47 |- skos__broader mesh__D011284smesh__D011283
% 209.28/209.47 |- mesh__recordOriginator mesh__D011284 NLM
% 209.28/209.47 |- rdf__type mesh__D011284sskos__Concept
% 209.28/209.47 |- mesh__recordAuthorizer mesh__D011284 sjn
% 209.28/209.47 |- skos__scopeNote mesh__D011284
% 209.28/209.47 A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.%A%
% 209.28/209.47 |- skos__prefLabel mesh__D011284 Pregnenolone
% 209.28/209.47 |- mesh__dateCreated mesh__D011284 1999-01-01
% 209.28/209.47 |- skos__hiddenLabel mesh__D038421 Hemispherectomy, Total
% 209.28/209.47 |- mesh__historyNote mesh__D038421 2003
% 209.28/209.47 |- mesh__dateEstablished mesh__D038421 2003-01-01
% 209.28/209.47 |- rdf__type mesh__D038421sskos__Concept
% 209.28/209.47 |- skos__hiddenLabel mesh__D038421 Hemispherectomy, Functional
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D038421 2004
% 209.28/209.47 |- skos__scopeNote mesh__D038421
% 209.28/209.47 A neurosurgical procedure that removes or disconnects the epileptogenic CEREBRAL CORTEX of a hemisphere. Hemispherectomy is usually performed for patients with intractable unilateral EPILEPSY due to malformations of cortical development or brain lesions. Depending on the epileptogenic area in the hemisphere, cortical removal can be total or partial.%A%
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D038421 2006
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D038421 2003
% 209.28/209.47 |- mesh__activeMeSHYear mesh__D038421 2005
% 209.28/209.47 |- skos__altLabel mesh__D038421 Functional Hemispherectomy
% 209.28/209.47 |- mesh__publicMeSHNote mesh__D038421 2003
% 209.28/209.47 |- skos__historyNote mesh__D038421 Hemiplegia %28%1965-2002%29%
% 209.28/209.47 |- skos__prefLabel mesh__D038421 Hemispherectomy
% 209.28/209.47 |- skos__hiddenLabel mesh__D038421 Hemispherectomy, Partial
% 209.28/209.47 |- mesh__dateCreated mesh__D038421 2002-07-03
% 209.28/209.47 |- skos__broader mesh__D038421smesh__D002541
% 209.28/209.47 |- skos__historyNote mesh__D038421 Epilepsy %28%1965-2002%29%
% 209.28/209.48 |- skos__scopeNote mesh__D005247
% 209.28/209.48 Behavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals.%A%
% 209.28/209.48 |- skos__broader mesh__D005247smesh__D001522
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005247 2006
% 209.28/209.48 |- skos__hiddenLabel mesh__D005247 Behavior, Feeding
% 209.28/209.48 |- skos__historyNote mesh__D005247 Nutrition %28%1966-1968%29%
% 209.28/209.48 |- skos__broader mesh__D005247smesh__D001519
% 209.28/209.48 |- skos__historyNote mesh__D005247 Behavior %28%1966-1968%29%
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005247 2004
% 209.28/209.48 |- skos__hiddenLabel mesh__D005247 Feeding Pattern
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005247 2005
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D005247 sjn
% 209.28/209.48 |- mesh__historyNote mesh__D005247
% 209.28/209.48 69; FEEDING PATTERNS was see under FEEDING BEHAVIOR 1969-78%A%
% 209.28/209.48 |- skos__hiddenLabel mesh__D005247 Behavior, Eating
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005247 2003
% 209.28/209.48 |- mesh__recordMaintainer mesh__D005247 JLS
% 209.28/209.48 |- mesh__recordOriginator mesh__D005247 NLM
% 209.28/209.48 |- mesh__onlineNote mesh__D005247
% 209.28/209.48 use FEEDING BEHAVIOR to search FEEDING PATTERNS 1969-78
% 209.28/209.48 |- skos__hiddenLabel mesh__D005247 Behaviors, Eating
% 209.28/209.48 |- skos__hiddenLabel mesh__D005247 Patterns, Feeding
% 209.28/209.48 |- mesh__dateRevised mesh__D005247 2002-07-02
% 209.28/209.48 |- skos__hiddenLabel mesh__D005247 Feeding Behaviors
% 209.28/209.48 |- skos__prefLabel mesh__D005247 Feeding Behavior
% 209.28/209.48 |- skos__altLabel mesh__D005247 Eating Behavior
% 209.28/209.48 |- rdf__type mesh__D005247sskos__Concept
% 209.28/209.48 |- skos__hiddenLabel mesh__D005247 Pattern, Feeding
% 209.28/209.48 |- mesh__dateEstablished mesh__D005247 1969-01-01
% 209.28/209.48 |- mesh__dateCreated mesh__D005247 1999-01-01
% 209.28/209.48 |- skos__hiddenLabel mesh__D005247 Eating Behaviors
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D005247 69
% 209.28/209.48 |- skos__annotation mesh__D005247
% 209.28/209.48 human %26% animal; = manner of eating or feeding %28%TN 63%29%: differentiate from EATING, the act of eating or feeding; permitted for feeding behavior of insects, as mosquitoes on skin, ticks sucking blood, maggots on flesh, etc., but NIM with feeding organism IM%A%
% 209.28/209.48 |- skos__hiddenLabel mesh__D005247 Behaviors, Feeding
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D024401
% 209.28/209.48 2002; see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991; for CA I HIROSHIMA-1, CARBONIC ANHYDRASE B see CARBONIC DEHYDRATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-2001; for CARBONIC ANHYDRASE ISOENZYME B see CARBONIC DEHYDRATASE 1992-2001 %26% CARBONIC ANHYDRASE 1984-2001%A%
% 209.28/209.48 |- skos__prefLabel mesh__D024401 Carbonic Anhydrase I
% 209.28/209.48 |- skos__altLabel mesh__D024401 Carbonic Anhydrase Isoenzyme B
% 209.28/209.48 |- mesh__dateCreated mesh__D024401 2001-07-25
% 209.28/209.48 |- mesh__recordOriginator mesh__D024401 jmp
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D024401 2004
% 209.28/209.48 |- skos__hiddenLabel mesh__D024401 Carbonic Anhydrase I Hiroshima 1
% 209.28/209.48 |- skos__altLabel mesh__D024401 Carbonic Anhydrase I Hiroshima-1
% 209.28/209.48 |- skos__altLabel mesh__D024401 Carbonic Anhydrase B
% 209.28/209.48 |- mesh__recordMaintainer mesh__D024401 ssb
% 209.28/209.48 |- skos__broader mesh__D024401smesh__D002256
% 209.28/209.48 |- skos__annotation mesh__D024401
% 209.28/209.48 /antag: coord with CARBONIC ANHYDRASE INHIBITORS
% 209.28/209.48 |- mesh__dateEstablished mesh__D024401 2002-01-01
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D024401 sjn
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D024401 2006
% 209.28/209.48 |- skos__hiddenLabel mesh__D024401 CA I Hiroshima 1
% 209.28/209.48 |- skos__hiddenLabel mesh__D024401 Anhydrase B, Carbonic
% 209.28/209.48 |- mesh__dateRevised mesh__D024401 2003-07-09
% 209.28/209.48 |- skos__historyNote mesh__D024401 Carbonic Anhydrases %28%1965-2001%29%
% 209.28/209.48 |- rdf__type mesh__D024401sskos__Concept
% 209.28/209.48 |- mesh__historyNote mesh__D024401
% 209.28/209.48 2002; use CARBONIC ANHYDRASES 1983-2001; for CA I HIROSHIMA-1 %26% CARBONIC ANHYDRASE B use CARBONIC ANHYDRASES 1983-2001; for CARBONIC ANHYDRASE ISOENZYME B use CARBONIC ANHYDRASES 1984-2001%A%
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D024401 2005
% 209.28/209.48 |- skos__scopeNote mesh__D024401
% 209.28/209.48 A cytosolic carbonic anhydrase isoenzyme primarily expressed in ERYTHROCYTES, vascular endothelial cells, and the gastrointestinal mucosa. EC 4.2.1.-%A%
% 209.28/209.48 |- skos__broader mesh__D043366smesh__D044602
% 209.28/209.48 |- skos__scopeNote mesh__D043366
% 209.28/209.48 An exocellulase with specificity for the hydrolysis of 1,4-beta-D-glucosidic linkages in CELLULOSE and cellotetraose. It catalyzes the hydrolysis of terminal non-reducing ends of beta-D-glucosides with release of CELLOBIOSE.%A%
% 209.28/209.48 |- mesh__historyNote mesh__D043366
% 209.28/209.48 2004; use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 1974-2003; for EXOGLUCANASE II use GLUCAN 1,3-BETA-GLUCOSIDASE %28%NM%29% 1992-2003%A%
% 209.28/209.48 |- skos__altLabel mesh__D043366 CEL1 Protein
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D043366 2005
% 209.28/209.48 |- skos__prefLabel mesh__D043366 Cellulose 1,4-beta-Cellobiosidase
% 209.28/209.48 |- skos__hiddenLabel mesh__D043366 Exo Cellobiohydrolase
% 209.28/209.48 |- skos__altLabel mesh__D043366 Exoglucanase II
% 209.28/209.48 |- skos__hiddenLabel mesh__D043366 1,4-beta-Cellobiosidase, Cellulose
% 209.28/209.48 |- mesh__recordMaintainer mesh__D043366 jmp
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D043366 2006
% 209.28/209.48 |- rdf__type mesh__D043366sskos__Concept
% 209.28/209.48 |- skos__altLabel mesh__D043366 1,4-beta-D-Glucan Cellobiohydrolase
% 209.28/209.48 |- skos__historyNote mesh__D043366 Cellulase %28%1974-2003%29%
% 209.28/209.48 |- skos__hiddenLabel mesh__D043366 Beta Glucancellobiohydrolase
% 209.28/209.48 |- skos__hiddenLabel mesh__D043366 1,4 beta D Glucan Cellobiohydrolase
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D043366 2004
% 209.28/209.48 |- skos__altLabel mesh__D043366 Cellobiohydrolase
% 209.28/209.48 |- mesh__recordOriginator mesh__D043366 AKE
% 209.28/209.48 |- skos__hiddenLabel mesh__D043366 Cellulose 1,4 beta Cellobiosidase
% 209.28/209.48 |- skos__hiddenLabel mesh__D043366 Cellobiohydrolase, 1,4-beta-D-Glucan
% 209.28/209.48 |- skos__altLabel mesh__D043366 Exo-Cellobiohydrolase
% 209.28/209.48 |- skos__altLabel mesh__D043366 CbhI Protein
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D043366
% 209.28/209.48 2004; EXO-CELLOBIOHYDROLASE %28%now CELLULOSE 1,4-BETA-CELLOBIOSIDASE%29% was indexed under CELLULASE 1974-2003; EXOGLUCANASE II was indexed under BETA-GLUCOSIDASE 1992-2003%A%
% 209.28/209.48 |- skos__altLabel mesh__D043366 Beta-Glucancellobiohydrolase
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D043366 sjn
% 209.28/209.48 |- mesh__dateEstablished mesh__D043366 2004-01-01
% 209.28/209.48 |- mesh__dateCreated mesh__D043366 2003-07-09
% 209.28/209.48 |- skos__hiddenLabel mesh__D015675 Vitamin K Dependent Bone Protein
% 209.28/209.48 |- skos__hiddenLabel mesh__D015675 Bone 4-Carboxyglutamic Protein
% 209.28/209.48 |- skos__altLabel mesh__D015675 Vitamin K-Dependent Bone Protein
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D015675 2006
% 209.28/209.48 |- skos__prefLabel mesh__D015675 Osteocalcin
% 209.28/209.48 |- skos__historyNote mesh__D015675
% 209.28/209.48 Calcium-Binding Proteins %28%1980-1989%29%
% 209.28/209.48 |- mesh__dateEstablished mesh__D015675 1990-01-01
% 209.28/209.48 |- skos__hiddenLabel mesh__D015675 Bone gamma Carboxyglutamic Acid Protein
% 209.28/209.48 |- mesh__historyNote mesh__D015675
% 209.28/209.48 90; GLA-PROTEIN was see OSTEOCACLIN 1990-96
% 209.28/209.48 |- skos__historyNote mesh__D015675 Proteins %28%1980-1981%29%
% 209.28/209.48 |- mesh__recordOriginator mesh__D015675 AGS
% 209.28/209.48 |- skos__hiddenLabel mesh__D015675 Protein, Bone Gla
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D015675
% 209.28/209.48 90; GLA-PROTEIN was see OSTEOCALCIN 1990-96
% 209.28/209.48 |- skos__historyNote mesh__D015675 1-Carboxyglutamic Acid %28%1978-1981%29%
% 209.28/209.48 |- skos__historyNote mesh__D015675 Binding Proteins %28%1978-1980%29%
% 209.28/209.48 |- skos__hiddenLabel mesh__D015675 4 Carboxyglutamic Protein, Bone
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D015675 sjn
% 209.28/209.48 |- mesh__dateRevised mesh__D015675 2004-07-07
% 209.28/209.48 |- skos__altLabel mesh__D015675 Gla Protein, Bone
% 209.28/209.48 |- skos__altLabel mesh__D015675 4-Carboxyglutamic Protein, Bone
% 209.28/209.48 |- rdf__type mesh__D015675sskos__Concept
% 209.28/209.48 |- skos__scopeNote mesh__D015675
% 209.28/209.48 Vitamin K-dependent calcium-binding protein synthesized by OSTEOBLASTS and found primarily in BONES. Serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. The protein contains three residues of the amino acid gamma-carboxyglutamic acid %28%Gla%29%, which, in the presence of CALCIUM, promotes binding to HYDROXYAPATITE and subsequent accumulation in BONE MATRIX.%A%
% 209.28/209.48 |- skos__historyNote mesh__D015675 Calcium %28%1978-1980%29%
% 209.28/209.48 |- skos__altLabel mesh__D015675 Bone Gla Protein
% 209.28/209.48 |- skos__altLabel mesh__D015675
% 209.28/209.48 Calcium-Binding Protein, Vitamin K-Dependent
% 209.28/209.48 |- skos__altLabel mesh__D015675 Bone gamma-Carboxyglutamic Acid Protein
% 209.28/209.48 |- mesh__onlineNote mesh__D015675
% 209.28/209.48 use OSTEOCALCIN to search GLA-PROTEIN 1990-96
% 209.28/209.48 |- skos__hiddenLabel mesh__D015675 Protein, Bone 4-Carboxyglutamic
% 209.28/209.48 |- skos__broader mesh__D015675smesh__D002135
% 209.28/209.48 |- skos__hiddenLabel mesh__D015675
% 209.28/209.48 Calcium Binding Protein, Vitamin K Dependent
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D015675 2005
% 209.28/209.48 |- mesh__dateCreated mesh__D015675 1989-09-06
% 209.28/209.48 |- mesh__recordMaintainer mesh__D015675 ssb
% 209.28/209.48 |- mesh__historyNote mesh__D048051 2005%28%1994%29%
% 209.28/209.48 |- skos__altLabel mesh__D048051 p38 Protein Kinase
% 209.28/209.48 |- skos__hiddenLabel mesh__D048051 MAPK, p38
% 209.28/209.48 |- skos__altLabel mesh__D048051 p38 MAP Kinase
% 209.28/209.48 |- skos__altLabel mesh__D048051 p38 MAPK
% 209.28/209.48 |- skos__broader mesh__D048051smesh__D020928
% 209.28/209.48 |- skos__historyNote mesh__D048051
% 209.28/209.48 Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 209.28/209.48 |- mesh__dateRevised mesh__D048051 2005-07-12
% 209.28/209.48 |- skos__altLabel mesh__D048051 Mitogen-Activated Protein Kinase p38
% 209.28/209.48 |- mesh__dateCreated mesh__D048051 2004-07-08
% 209.28/209.48 |- skos__hiddenLabel mesh__D048051 Protein Kinase, p38
% 209.28/209.48 |- mesh__recordOriginator mesh__D048051 jmp
% 209.28/209.48 |- skos__prefLabel mesh__D048051 p38 Mitogen-Activated Protein Kinases
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D048051 2006A
% 209.28/209.48 |- skos__hiddenLabel mesh__D048051 MAP Kinase, p38
% 209.28/209.48 |- skos__historyNote mesh__D048051
% 209.28/209.48 Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1994-2000%29%
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D048051 2005
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D048051 ags
% 209.28/209.48 |- skos__hiddenLabel mesh__D048051 p38 Mitogen Activated Protein Kinases
% 209.28/209.48 |- skos__hiddenLabel mesh__D048051 Mitogen Activated Protein Kinase p38
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D048051
% 209.28/209.48 2005; P38 MITOGEN-ACTIVATED PROTEIN KINASES was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2001-2004 %26% under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000%A%
% 209.28/209.48 |- skos__scopeNote mesh__D048051
% 209.28/209.48 A mitogen-activated protein kinase subfamily that regulates a variety of cellular processes including CELL GROWTH PROCESSES; CELL DIFFERENTIATION; APOPTOSIS; and cellular responses to INFLAMMATION. The P38 MAP kinases are regulated by CYTOKINE RECEPTORS and can be activated in response to bacterial pathogens.%A%
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D048051 2006
% 209.28/209.48 |- mesh__recordMaintainer mesh__D048051 ags
% 209.28/209.48 |- skos__altLabel mesh__D048051 p38 SAPK
% 209.28/209.48 |- mesh__dateEstablished mesh__D048051 2005-01-01
% 209.28/209.48 |- rdf__type mesh__D048051sskos__Concept
% 209.28/209.48 |- skos__altLabel mesh__D009638 Abbott Brand of Levophed Bitartrate
% 209.28/209.48 |- skos__altLabel mesh__D009638 Norepinephrine l-Tartrate %28%1:1%29%
% 209.28/209.48 |- mesh__historyNote mesh__D009638
% 209.28/209.48 ARTERENOL was see NOREPINEPHRINE 1974-93; LEVONOREPINEPHRINE was heading 1963-65%A%
% 209.28/209.48 |- skos__hiddenLabel mesh__D009638 tartrate renaudin, Noradr%C3%%A9%naline
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D009638
% 209.28/209.48 ARTERENOL was see NOREPINEPHRINE 1974-93; LEVONOREPINEPHRINE was heading 1963-65%A%
% 209.28/209.48 |- rdf__type mesh__D009638sskos__Concept
% 209.28/209.48 |- skos__hiddenLabel mesh__D009638 Hydrochloride, Norepinephrine
% 209.28/209.48 |- skos__prefLabel mesh__D009638 Norepinephrine
% 209.28/209.48 |- skos__hiddenLabel mesh__D009638 Bitartrate, Noradrenaline
% 209.28/209.48 |- skos__hiddenLabel mesh__D009638 Bitartrate, Norepinephrine
% 209.28/209.48 |- mesh__recordMaintainer mesh__D009638 ssb
% 209.28/209.48 |- skos__altLabel mesh__D009638 Levonorepinephrine
% 209.28/209.48 |- skos__altLabel mesh__D009638 Noradrenaline Bitartrate
% 209.28/209.48 |- skos__broader mesh__D009638smesh__D002395
% 209.28/209.48 |- mesh__recordOriginator mesh__D009638 NLM
% 209.28/209.48 |- skos__altLabel mesh__D009638
% 209.28/209.48 Aventis Brand of Norepinephrine Hydrochloride
% 209.28/209.48 |- skos__related mesh__D009638smesh__D011941
% 209.28/209.48 |- skos__scopeNote mesh__D009638
% 209.28/209.48 Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.%A%
% 209.28/209.48 |- skos__broader mesh__D009638smesh__D004983
% 209.28/209.48 |- skos__hiddenLabel mesh__D009638 renaudin, Noradr%C3%%A9%naline tartrate
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D009638 sjn
% 209.28/209.48 |- skos__broader mesh__D009638smesh__D000605
% 209.28/209.48 |- skos__altLabel mesh__D009638 Levarterenol
% 209.28/209.48 |- skos__hiddenLabel mesh__D009638 Bitartrate, Levophed
% 209.28/209.48 |- skos__altLabel mesh__D009638 Renaudin Brand of Norepinephrine Bitartrate
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D009638 2006
% 209.28/209.48 |- mesh__dateRevised mesh__D009638 2005-06-30
% 209.28/209.48 |- mesh__onlineNote mesh__D009638
% 209.28/209.48 use NOREPINEPHRINE to search ARTERENOL 1974-93
% 209.28/209.48 |- skos__broader mesh__D009638smesh__D004837
% 209.28/209.48 |- skos__altLabel mesh__D009638 Noradrenaline
% 209.28/209.48 |- mesh__dateCreated mesh__D009638 1999-01-01
% 209.28/209.48 |- skos__altLabel mesh__D009638 Levophed Bitartrate
% 209.28/209.48 |- skos__prefLabel mesh__D001655 Bile Reflux
% 209.28/209.48 |- mesh__recordMaintainer mesh__D001655 lkt
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D001655 2004
% 209.28/209.48 |- skos__broader mesh__D001655smesh__D004383
% 209.28/209.48 |- skos__broader mesh__D001655smesh__D001660
% 209.28/209.48 |- skos__scopeNote mesh__D001655
% 209.28/209.48 Retrograde bile flow. Reflux of bile can be from the duodenum to the stomach %28%DUODENOGASTRIC REFLUX%29%; to the esophagus %28%GASTROESOPHAGEAL REFLUX%29%; or to the PANCREAS.%A%
% 209.28/209.48 |- mesh__recordOriginator mesh__D001655 RC
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D001655
% 209.28/209.48 91; was see under BILIARY TRACT DISEASES 1981-90
% 209.28/209.48 |- skos__hiddenLabel mesh__D001655 Reflux, Bile
% 209.28/209.48 |- mesh__dateRevised mesh__D001655 2003-07-09
% 209.28/209.48 |- skos__historyNote mesh__D001655 Gastritis %28%1966-1980%29%
% 209.28/209.48 |- mesh__dateEstablished mesh__D001655 1991-01-01
% 209.28/209.48 |- mesh__historyNote mesh__D001655
% 209.28/209.48 91%28%81%29%; was see under BILIARY TRACT DISEASES 1981-90
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D001655 sjn
% 209.28/209.48 |- mesh__dateCreated mesh__D001655 1980-04-04
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D001655 2006
% 209.28/209.48 |- skos__historyNote mesh__D001655 Bile %28%1966-1980%29%
% 209.28/209.48 |- rdf__type mesh__D001655sskos__Concept
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D001655 2005
% 209.28/209.48 |- skos__annotation mesh__D006340 mammals only
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D006340 2005
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D006340 sjn
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D006340 2004
% 209.28/209.48 |- skos__historyNote mesh__D006340 Heart Rate %28%1966-1986%29%
% 209.28/209.48 |- mesh__recordOriginator mesh__D006340 VDK
% 209.28/209.48 |- skos__broader mesh__D006340smesh__D006339
% 209.28/209.48 |- skos__hiddenLabel mesh__D006340 Rate, Fetal Heart
% 209.28/209.48 |- rdf__type mesh__D006340sskos__Concept
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D006340 87
% 209.28/209.48 |- mesh__dateEstablished mesh__D006340 1987-01-01
% 209.28/209.48 |- skos__scopeNote mesh__D006340
% 209.28/209.48 The heart rate of the FETUS. The normal range at term is between 120 and 160 beats per minute.%A%
% 209.28/209.48 |- skos__hiddenLabel mesh__D006340 Rates, Fetal Heart
% 209.28/209.48 |- skos__altLabel mesh__D006340 Fetal Heart Rate
% 209.28/209.48 |- mesh__dateRevised mesh__D006340 2003-07-09
% 209.28/209.48 |- skos__historyNote mesh__D006340 Fetal Heart %28%1966-1986%29%
% 209.28/209.48 |- mesh__dateCreated mesh__D006340 1986-04-18
% 209.28/209.48 |- skos__hiddenLabel mesh__D006340 Heart Rates, Fetal
% 209.28/209.48 |- skos__prefLabel mesh__D006340 Heart Rate, Fetal
% 209.28/209.48 |- mesh__historyNote mesh__D006340 87
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D006340 2006
% 209.28/209.48 |- mesh__recordMaintainer mesh__D006340 nns
% 209.28/209.48 |- skos__hiddenLabel mesh__D006340 Fetal Heart Rates
% 209.28/209.48 |- skos__scopeNote mesh__D020011
% 209.28/209.48 Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent.%A%
% 209.28/209.48 |- mesh__historyNote mesh__D020011 98
% 209.28/209.48 |- mesh__recordMaintainer mesh__D020011 ssb
% 209.28/209.48 |- mesh__dateRevised mesh__D020011 2003-07-09
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D020011 98
% 209.28/209.48 |- skos__prefLabel mesh__D020011 Protective Agents
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D020011 2004
% 209.28/209.48 |- skos__hiddenLabel mesh__D020011 Agents, Protective
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D020011 sjn
% 209.28/209.48 |- skos__altLabel mesh__D020011 Protective Drugs
% 209.28/209.48 |- mesh__recordOriginator mesh__D020011 ADP
% 209.28/209.48 |- mesh__dateEstablished mesh__D020011 1998-01-01
% 209.28/209.48 |- rdf__type mesh__D020011sskos__Concept
% 209.28/209.48 |- skos__broader mesh__D020011smesh__D020313
% 209.28/209.48 |- skos__annotation mesh__D020011
% 209.28/209.48 GEN: prefer specific groups of protective agents; D25-26 qualif%A%
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D020011 2006
% 209.28/209.48 |- skos__hiddenLabel mesh__D020011 Drugs, Protective
% 209.28/209.48 |- skos__broader mesh__D020011smesh__D045505
% 209.28/209.48 |- mesh__dateCreated mesh__D020011 1997-06-20
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D020011 2005
% 209.28/209.48 |- skos__altLabel mesh__D019268 Anti-Neutrophil Cytoplasmic Antibodies
% 209.28/209.48 |- mesh__recordOriginator mesh__D019268 AGS
% 209.28/209.48 |- mesh__dateCreated mesh__D019268 1996-06-10
% 209.28/209.48 |- skos__broader mesh__D019268smesh__D001323
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 Cytoplasmic Antibodies, Antineutrophil
% 209.28/209.48 |- mesh__recordMaintainer mesh__D019268 ssb
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D019268 sjn
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 Antibody, Antineutrophil Cytoplasmic
% 209.28/209.48 |- skos__historyNote mesh__D019268 Autoantibodies %28%1991-1996%29%
% 209.28/209.48 |- skos__altLabel mesh__D019268 Antineutrophil Cytoplasmic Antibody
% 209.28/209.48 |- skos__altLabel mesh__D019268 Antineutrophil Cytoplasmic Antibodies
% 209.28/209.48 |- skos__broader mesh__D019268smesh__D015415
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 Cytoplasmic Antibody, Antineutrophil
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 Anti Neutrophil Cytoplasmic Antibody
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 p ANCA
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 Cytoplasmic Antibodies, Anti-Neutrophil
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 Antibody, Anti-Neutrophil Cytoplasmic
% 209.28/209.48 |- mesh__dateRevised mesh__D019268 2005-06-30
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 c ANCA
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 Anti Neutrophil Cytoplasmic Antibodies
% 209.28/209.48 |- skos__scopeNote mesh__D019268
% 209.28/209.48 Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for WEGENER%27%S GRANULOMATOSIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA %28%cytoplasmic%29%, p-ANCA %28%perinuclear%29%, and atypical ANCA.%A%
% 209.28/209.48 |- mesh__onlineNote mesh__D019268
% 209.28/209.48 use ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC %28%NM%29% to search C-ANCA 1991-96%A%
% 209.28/209.48 |- skos__annotation mesh__D019268
% 209.28/209.48 do not coordinate with ANTIBODY FORMATION for /biosyn;
% 209.28/209.48 |- skos__altLabel mesh__D019268 ANCA
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D019268
% 209.28/209.48 97; C-ANCA was indexed under AUTOANTIBODIES 1991-96
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D019268 2006
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 Antibodies, Anti-Neutrophil Cytoplasmic
% 209.28/209.48 |- skos__prefLabel mesh__D019268 Antibodies, Antineutrophil Cytoplasmic
% 209.28/209.48 |- mesh__dateEstablished mesh__D019268 1997-01-01
% 209.28/209.48 |- skos__altLabel mesh__D019268 Anti-Neutrophil Cytoplasmic Antibody
% 209.28/209.48 |- mesh__historyNote mesh__D019268 97; was C-ANCA %28%NM%29% 1991-96
% 209.28/209.48 |- rdf__type mesh__D019268sskos__Concept
% 209.28/209.48 |- skos__hiddenLabel mesh__D019268 Cytoplasmic Antibody, Anti-Neutrophil
% 209.28/209.48 |- skos__hiddenLabel mesh__D011285 Pregnenolone 16 alpha Carbonitrile
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D011285 74
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D011285 2002
% 209.28/209.48 |- mesh__recordOriginator mesh__D011285 NLM
% 209.28/209.48 |- skos__broader mesh__D011285smesh__D011284
% 209.28/209.48 |- skos__altLabel mesh__D011285 Pregnenolone 16 alpha-Carbonitrile
% 209.28/209.48 |- skos__hiddenLabel mesh__D011285 Carbonitrile, Pregnenolone
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D011285 sjn
% 209.28/209.48 |- mesh__dateRevised mesh__D011285 2000-06-22
% 209.28/209.48 |- rdf__type mesh__D011285sskos__Concept
% 209.28/209.48 |- skos__annotation mesh__D011285 DF: PCN
% 209.28/209.48 |- skos__prefLabel mesh__D011285 Pregnenolone Carbonitrile
% 209.28/209.48 |- mesh__dateCreated mesh__D011285 1999-01-01
% 209.28/209.48 |- skos__altLabel mesh__D011285 PCN
% 209.28/209.48 |- skos__hiddenLabel mesh__D011285 16 alpha-Carbonitrile, Pregnenolone
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D011285 2003
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D011285 2001
% 209.28/209.48 |- mesh__historyNote mesh__D011285 74
% 209.28/209.48 |- mesh__dateEstablished mesh__D011285 1974-01-01
% 209.28/209.48 |- mesh__recordMaintainer mesh__D011285 CCR
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D011285 2005
% 209.28/209.48 |- skos__broader mesh__D011285smesh__D009570
% 209.28/209.48 |- skos__scopeNote mesh__D011285
% 209.28/209.48 A catatoxic steroid and microsomal enzyme inducer having significant effects on the induction of cytochrome P450. It has also demonstrated the potential for protective capability against acetaminophen-induced liver damage.%A%
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D011285 2004
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D011285 2006
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005248 2006
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005248 2003
% 209.28/209.48 |- mesh__dateRevised mesh__D005248 1997-06-20
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D005248 98
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D005248 SJN
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005248 2001
% 209.28/209.48 |- mesh__historyNote mesh__D005248 98; use explode 1970-97
% 209.28/209.48 |- skos__prefLabel mesh__D005248 Feeding Methods
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005248 2004
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005248 2002
% 209.28/209.48 |- skos__hiddenLabel mesh__D005248 Methods, Feeding
% 209.28/209.48 |- mesh__dateCreated mesh__D005248 1999-01-01
% 209.28/209.48 |- skos__hiddenLabel mesh__D005248 Method, Feeding
% 209.28/209.48 |- skos__broader mesh__D005248smesh__D013812
% 209.28/209.48 |- rdf__type mesh__D005248sskos__Concept
% 209.28/209.48 |- skos__scopeNote mesh__D005248
% 209.28/209.48 Methods of giving food to humans or animals.
% 209.28/209.48 |- mesh__dateEstablished mesh__D005248 1998-01-01
% 209.28/209.48 |- mesh__recordMaintainer mesh__D005248 TGC
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005248 1998
% 209.28/209.48 |- skos__annotation mesh__D005248
% 209.28/209.48 human %26% animal; GEN or unspecified; prefer specifics
% 209.28/209.48 |- skos__hiddenLabel mesh__D005248 Feeding Method
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005248 2005
% 209.28/209.48 |- mesh__recordOriginator mesh__D005248 NLM
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005248 1999
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D005248 2000
% 209.28/209.48 |- mesh__dateRevised mesh__D024402 2003-07-09
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D024402 2005
% 209.28/209.48 |- mesh__dateCreated mesh__D024402 2001-07-25
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D024402 2004
% 209.28/209.48 |- mesh__historyNote mesh__D024402
% 209.28/209.48 2002; use CARBONIC ANHYDRASES 1983-2001; for CARBONIC ANHYDRASE C use CARBONIC ANHYDRASES 1984-2001; for CARBONIC ANHYDRASE ISOENZYME C use CARBONIC ANHDYRASES 1983-2001%A%
% 209.28/209.48 |- mesh__recordMaintainer mesh__D024402 ssb
% 209.28/209.48 |- skos__historyNote mesh__D024402 Carbonic Anhydrases %28%1967-2001%29%
% 209.28/209.48 |- skos__scopeNote mesh__D024402
% 209.28/209.48 A cytosolic carbonic anhydrase isoenzyme found widely distributed in cells of almost all tissues. Deficiencies of carbonic anhydrase II produce a syndrome characterized by OSTEOPETROSIS, renal tubular acidosis %28%ACIDOSIS, RENAL TUBULAR%29% and cerebral calcification. EC 4.2.1.-%A%
% 209.28/209.48 |- skos__annotation mesh__D024402
% 209.28/209.48 /antag: coord with CARBONIC ANHYDRASE INHIBITORS
% 209.28/209.48 |- mesh__dateEstablished mesh__D024402 2002-01-01
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D024402 sjn
% 209.28/209.48 |- skos__broader mesh__D024402smesh__D002256
% 209.28/209.48 |- skos__altLabel mesh__D024402 Carbonic Anhydrase Isoenzyme C
% 209.28/209.48 |- rdf__type mesh__D024402sskos__Concept
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D024402 2006
% 209.28/209.48 |- skos__prefLabel mesh__D024402 Carbonic Anhydrase II
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D024402
% 209.28/209.48 2002; see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991; for CARBONIC ANHYDRASE C see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1984-1991; for CARBONIC ANHYDRASE ISOENZYME C see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991%A%
% 209.28/209.48 |- skos__altLabel mesh__D024402 Carbonic Anhydrase C
% 209.28/209.48 |- mesh__recordOriginator mesh__D024402 jmp
% 209.28/209.48 |- skos__broader mesh__D010944Q000502smesh__D010944
% 209.28/209.48 |- mesh__preferredCombination mesh__D010944Q000502smesh__D018521
% 209.28/209.48 |- rdf__type mesh__D010944Q000502smesh__CompoundConcept
% 209.28/209.48 |- mesh__dateRevised mesh__D043367 2005-06-30
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D043367 2006
% 209.28/209.48 |- rdf__type mesh__D043367sskos__Concept
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D043367 sjn
% 209.28/209.48 |- mesh__dateEstablished mesh__D043367 2004-01-01
% 209.28/209.48 |- mesh__recordOriginator mesh__D043367 ags
% 209.28/209.48 |- skos__broader mesh__D043367smesh__D043365
% 209.28/209.48 |- skos__historyNote mesh__D043367 Betaproteobacteria %28%2000-2003%29%
% 209.28/209.48 |- skos__scopeNote mesh__D043367
% 209.28/209.48 The sole genus in the family RALSTONIACEAE, comprised of many species. They are associated with a variety of infections including MENINGITIS; PERITONITIS; and URINARY TRACT INFECTIONS.%A%
% 209.28/209.48 |- skos__prefLabel mesh__D043367 Ralstonia
% 209.28/209.48 |- mesh__historyNote mesh__D043367 2004
% 209.28/209.48 |- skos__annotation mesh__D043367
% 209.28/209.48 infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 209.28/209.48 |- mesh__recordMaintainer mesh__D043367 ags
% 209.28/209.48 |- mesh__dateCreated mesh__D043367 2003-07-09
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D043367 2004
% 209.28/209.48 |- skos__altLabel mesh__D015676 SPARC Glycoprotein
% 209.28/209.48 |- skos__historyNote mesh__D015676
% 209.28/209.48 Calcium-Binding Proteins %28%1986-1989%29%
% 209.28/209.48 |- mesh__recordMaintainer mesh__D015676 jmp
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D015676 2002
% 209.28/209.48 |- skos__altLabel mesh__D015676 BM 40 Protein
% 209.28/209.48 |- mesh__publicMeSHNote mesh__D015676 90
% 209.28/209.48 |- skos__historyNote mesh__D015676 Carrier Proteins %28%1980-1989%29%
% 209.28/209.48 |- skos__broader mesh__D015676smesh__D006023
% 209.28/209.48 |- mesh__recordOriginator mesh__D015676 AGS
% 209.28/209.48 |- rdf__type mesh__D015676sskos__Concept
% 209.28/209.48 |- mesh__dateCreated mesh__D015676 1989-05-15
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D015676 2003
% 209.28/209.48 |- mesh__historyNote mesh__D015676 90
% 209.28/209.48 |- skos__broader mesh__D015676smesh__D002135
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D015676 2005
% 209.28/209.48 |- skos__prefLabel mesh__D015676 Osteonectin
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D015676 sjn
% 209.28/209.48 |- mesh__dateRevised mesh__D015676 2000-06-22
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D015676 2004
% 209.28/209.48 |- skos__scopeNote mesh__D015676
% 209.28/209.48 Non-collagenous, calcium-binding glycoprotein of developing bone. It links collagen to mineral in the bone matrix. In the synonym SPARC glycoprotein, the acronym stands for Secreted Protein, Acidic and Rich in Cysteine.%A%
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D015676 2001
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D015676 2006
% 209.28/209.48 |- skos__altLabel mesh__D015676 Basement Membrane Tumor Protein
% 209.28/209.48 |- mesh__dateEstablished mesh__D015676 1990-01-01
% 209.28/209.48 |- skos__altLabel mesh__D015676 BM-40
% 209.28/209.48 |- skos__altLabel mesh__D048052
% 209.28/209.48 Meiosis-Activated Myelin Basic Protein Kinase p44%28%mpk%29%
% 209.28/209.48 |- skos__hiddenLabel mesh__D048052 Kinase, ERK1
% 209.28/209.48 |- skos__hiddenLabel mesh__D048052 Extracellular Signal Regulated Kinase 1
% 209.28/209.48 |- skos__altLabel mesh__D048052 Extracellular Signal-Regulated Kinase 1
% 209.28/209.48 |- skos__hiddenLabel mesh__D048052 p44mpk, PSTkinase
% 209.28/209.48 |- mesh__dateEstablished mesh__D048052 2005-01-01
% 209.28/209.48 |- skos__altLabel mesh__D048052
% 209.28/209.48 Protein-Serine-Threonine Kinase p44%28%mpk%29%
% 209.28/209.48 |- mesh__dateRevised mesh__D048052 2005-07-20
% 209.28/209.48 |- skos__altLabel mesh__D048052 MAPK3 Mitogen-Activated Protein Kinase
% 209.28/209.48 |- mesh__recordAuthorizer mesh__D048052 ags
% 209.28/209.48 |- mesh__activeMeSHYear mesh__D048052 2005
% 209.28/209.48 |- skos__scopeNote mesh__D048052
% 209.28/209.48 A 44-kDa extracellular signal-regulated MAP kinase that may play a role the initiation and regulation of MEIOSIS; MITOSIS; and postmitotic functions in differentiated cells. It phosphorylates a number of TRANSCRIPTION FACTORS; and MICROTUBULE-ASSOCIATED PROTEINS.%A%
% 209.28/209.48 |- skos__hiddenLabel mesh__D048052 Microtubule Associated Protein 2 Kinase
% 209.28/209.48 |- skos__altLabel mesh__D048052 Microtubule-Associated Protein-2 Kinase
% 209.28/209.48 |- skos__altLabel mesh__D048052 ERK1 Kinase
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D048052 2006
% 209.28/209.49 |- skos__hiddenLabel mesh__D048052 MAPK3 Mitogen Activated Protein Kinase
% 209.28/209.49 |- mesh__dateCreated mesh__D048052 2004-07-07
% 209.28/209.49 |- rdf__type mesh__D048052sskos__Concept
% 209.28/209.49 |- skos__altLabel mesh__D048052 PSTkinase p44mpk
% 209.28/209.49 |- mesh__recordMaintainer mesh__D048052 ags
% 209.28/209.49 |- skos__hiddenLabel mesh__D048052 Mitogen Activated Protein Kinase 3
% 209.28/209.49 |- skos__altLabel mesh__D048052 p44 MAPK
% 209.28/209.49 |- mesh__historyNote mesh__D048052 2005%28%2000%29%
% 209.28/209.49 |- mesh__recordOriginator mesh__D048052 jmp
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D048052 2006A
% 209.28/209.49 |- skos__broader mesh__D048052smesh__D048049
% 209.28/209.49 |- skos__historyNote mesh__D048052
% 209.28/209.49 Mitogen-Activated Protein Kinases %28%1990-2004%29%
% 209.28/209.49 |- skos__prefLabel mesh__D048052 Mitogen-Activated Protein Kinase 3
% 209.28/209.49 |- skos__hiddenLabel mesh__D048052 Kinase, Microtubule-Associated Protein-2
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D048052
% 209.28/209.49 2005; MITOGEN-ACTIVATED PROTEIN KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004 %26% under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999%A%
% 209.28/209.49 |- skos__scopeNote mesh__D009639
% 209.28/209.49 A synthetic hormone with anabolic and androgenic properties and moderate progestational activity.%A%
% 209.28/209.49 |- skos__altLabel mesh__D009639 Laphal Brand of Norethandrolone
% 209.28/209.49 |- mesh__recordMaintainer mesh__D009639 lkw
% 209.28/209.49 |- skos__prefLabel mesh__D009639 Norethandrolone
% 209.28/209.49 |- skos__broader mesh__D009639smesh__D009652
% 209.28/209.49 |- skos__altLabel mesh__D009639 Ethylnortestosterone
% 209.28/209.49 |- mesh__dateRevised mesh__D009639 2004-07-07
% 209.28/209.49 |- skos__altLabel mesh__D009639 Ethylestrenolone
% 209.28/209.49 |- mesh__recordOriginator mesh__D009639 NLM
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D009639 2006
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D009639 sjn
% 209.28/209.49 |- mesh__dateCreated mesh__D009639 1999-01-01
% 209.28/209.49 |- skos__hiddenLabel mesh__D009639 Norethandrolone Laphal Brand
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D009639 2005
% 209.28/209.49 |- rdf__type mesh__D009639sskos__Concept
% 209.28/209.49 |- mesh__recordOriginator mesh__D001656 RC
% 209.28/209.49 |- skos__broader mesh__D001656smesh__D004065
% 209.28/209.49 |- mesh__dateCreated mesh__D001656 1986-04-03
% 209.28/209.49 |- skos__scopeNote mesh__D001656
% 209.28/209.49 Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.%A%
% 209.28/209.49 |- mesh__recordMaintainer mesh__D001656 lkt
% 209.28/209.49 |- mesh__dateRevised mesh__D001656 2003-07-09
% 209.28/209.49 |- skos__annotation mesh__D001656
% 209.28/209.49 do not coord with INFANT, NEWBORN, DISEASES
% 209.28/209.49 |- skos__prefLabel mesh__D001656 Biliary Atresia
% 209.28/209.49 |- skos__altLabel mesh__D001656 Atresia, Biliary
% 209.28/209.49 |- mesh__dateEstablished mesh__D001656 1987-01-01
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D001656 2006
% 209.28/209.49 |- rdf__type mesh__D001656sskos__Concept
% 209.28/209.49 |- skos__historyNote mesh__D001656
% 209.28/209.49 Bile Ducts/abnormalities %28%1966-1986%29%
% 209.28/209.49 |- skos__broader mesh__D001656smesh__D001649
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D001656 2005
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D001656 sjn
% 209.28/209.49 |- mesh__historyNote mesh__D001656 87
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D001656 87
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D001656 2004
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006341 2003
% 209.28/209.49 |- skos__hiddenLabel mesh__D006341 Rupture, Heart
% 209.28/209.49 |- mesh__recordMaintainer mesh__D006341 TGC
% 209.28/209.49 |- skos__historyNote mesh__D006341 Myocardial Infarction %28%1966-1977%29%
% 209.28/209.49 |- skos__historyNote mesh__D006341 Heart Diseases %28%1966-1977%29%
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D006341 78
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006341 2004
% 209.28/209.49 |- skos__hiddenLabel mesh__D006341 Ruptures, Heart
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D006341 SJN
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006341 2002
% 209.28/209.49 |- rdf__type mesh__D006341sskos__Concept
% 209.28/209.49 |- mesh__dateEstablished mesh__D006341 1978-01-01
% 209.28/209.49 |- skos__prefLabel mesh__D006341 Heart Rupture
% 209.28/209.49 |- skos__historyNote mesh__D006341 Rupture, Spontaneous %28%1966-1977%29%
% 209.28/209.49 |- skos__hiddenLabel mesh__D006341 Cardiac Ruptures
% 209.28/209.49 |- skos__annotation mesh__D006341
% 209.28/209.49 rupt of any part of heart as result of heart pathol: do not confuse with HEART RUPTURE, TRAUMATIC see HEART INJURIES; coord IM with specific part %28%IM%29% if pertinent but VENTRICULAR SEPTAL RUPTURE is available; usually caused by myocard infarct %28% = HEART RUPTURE, POST-INFARCTION%29%%A%
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006341 1998
% 209.28/209.49 |- mesh__dateCreated mesh__D006341 1977-04-27
% 209.28/209.49 |- skos__broader mesh__D006341smesh__D006331
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006341 2000
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006341 2005
% 209.28/209.49 |- skos__altLabel mesh__D006341 Cardiac Rupture
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006341 1999
% 209.28/209.49 |- skos__hiddenLabel mesh__D006341 Ruptures, Cardiac
% 209.28/209.49 |- skos__hiddenLabel mesh__D006341 Rupture, Cardiac
% 209.28/209.49 |- skos__hiddenLabel mesh__D006341 Heart Ruptures
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006341 2006
% 209.28/209.49 |- mesh__dateRevised mesh__D006341 1997-06-20
% 209.28/209.49 |- mesh__recordOriginator mesh__D006341 VDK
% 209.28/209.49 |- mesh__historyNote mesh__D006341 78
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006341 2001
% 209.28/209.49 |- skos__scopeNote mesh__D006341
% 209.28/209.49 Laceration or tearing of the walls of the heart, of the interatrial or interventricular septum, of the papillary muscles or chordae tendineae, or of any of the valves of the heart. Rupture may be due to a variety of pathological entities, however, the majority are secondary to myocardial infarction %28%HEART RUPTURE, POST-INFARCTION%29%.%A%
% 209.28/209.49 |- skos__altLabel mesh__D019269 PtdInsP2
% 209.28/209.49 |- mesh__dateEstablished mesh__D019269 1997-01-01
% 209.28/209.49 |- skos__prefLabel mesh__D019269 Phosphatidylinositol 4,5-Diphosphate
% 209.28/209.49 |- mesh__dateRevised mesh__D019269 2004-07-07
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D019269 2005
% 209.28/209.49 |- skos__hiddenLabel mesh__D019269 Phosphatidylinositol 4,5 Bisphosphate
% 209.28/209.49 |- skos__altLabel mesh__D019269 Phosphatidylinositol 4,5-Biphosphate
% 209.28/209.49 |- skos__altLabel mesh__D019269 PIP2
% 209.28/209.49 |- skos__historyNote mesh__D019269
% 209.28/209.49 Phosphatidylinositol Phosphates %28%1994-1996%29%
% 209.28/209.49 |- skos__hiddenLabel mesh__D019269 Phosphatidylinositol 4,5 Biphosphate
% 209.28/209.49 |- skos__altLabel mesh__D019269 Phosphatidylinositol-4,5-Bisphosphate
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D019269 2006
% 209.28/209.49 |- mesh__onlineNote mesh__D019269
% 209.28/209.49 use PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE %28%NM%29% to search PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE 1981-96%A%
% 209.28/209.49 |- skos__scopeNote mesh__D019269
% 209.28/209.49 A phosphoinositide present in all eukaryotic cells, particularly in the plasma membrane. It is the major substrate for receptor-stimulated phosphoinositidase C, with the consequent formation of inositol 1,4,5-triphosphate and diacylglycerol, and probably also for receptor-stimulated inositol phospholipid 3-kinase. %28%Kendrew, The Encyclopedia of Molecular Biology, 1994%29%%A%
% 209.28/209.49 |- skos__historyNote mesh__D019269 Phosphatidylinositols %28%1981-1993%29%
% 209.28/209.49 |- mesh__dateCreated mesh__D019269 1996-06-10
% 209.28/209.49 |- skos__broader mesh__D019269smesh__D018129
% 209.28/209.49 |- mesh__recordMaintainer mesh__D019269 jmp
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D019269 sjn
% 209.28/209.49 |- rdf__type mesh__D019269sskos__Concept
% 209.28/209.49 |- mesh__historyNote mesh__D019269
% 209.28/209.49 97; see PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE %28%NM%29% 1981-96%A%
% 209.28/209.49 |- skos__hiddenLabel mesh__D019269 Phosphatidylinositol 4,5 Diphosphate
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D019269
% 209.28/209.49 97; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE was indexed under PHOSPHATIDYLINOSITOL PHOSPHATES 1994-96 %26% PHOSPHOINOSITIDES 1981-93%A%
% 209.28/209.49 |- mesh__recordOriginator mesh__D019269 TPW
% 209.28/209.49 |- skos__annotation mesh__D019269 DF: note short X refs
% 209.28/209.49 |- skos__hiddenLabel mesh__D019269 4,5-Biphosphate, Phosphatidylinositol
% 209.28/209.49 |- skos__hiddenLabel mesh__D019269 4,5-Diphosphate, Phosphatidylinositol
% 209.28/209.49 |- skos__altLabel mesh__D019269 PtIns 4,5-P2
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D005249 2004
% 209.28/209.49 |- mesh__recordOriginator mesh__D005249 NLM
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D005249 68
% 209.28/209.49 |- mesh__dateRevised mesh__D005249 2002-07-18
% 209.28/209.49 |- skos__related mesh__D005249smesh__D011907
% 209.28/209.49 |- skos__hiddenLabel mesh__D005249 Remunerations
% 209.28/209.49 |- skos__hiddenLabel mesh__D005249 Charge
% 209.28/209.49 |- skos__historyNote mesh__D005249 Economics %28%1966-1967%29%
% 209.28/209.49 |- skos__annotation mesh__D005249 DF: FEES
% 209.28/209.49 |- skos__altLabel mesh__D005249 Charges and Fees
% 209.28/209.49 |- mesh__dateCreated mesh__D005249 1999-01-01
% 209.28/209.49 |- rdf__type mesh__D005249sskos__Concept
% 209.28/209.49 |- skos__broader mesh__D005249smesh__D004467
% 209.28/209.49 |- skos__hiddenLabel mesh__D005249 Fee
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D005249 2005
% 209.28/209.49 |- mesh__historyNote mesh__D005249 68
% 209.28/209.49 |- skos__prefLabel mesh__D005249 Fees and Charges
% 209.28/209.49 |- mesh__recordMaintainer mesh__D005249 sjn
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D005249 2006
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D005249 2003
% 209.28/209.49 |- skos__scopeNote mesh__D005249
% 209.28/209.49 Amounts charged to the patient as payer for health care services.%A%
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D005249 sjn
% 209.28/209.49 |- mesh__dateEstablished mesh__D005249 1968-01-01
% 209.28/209.49 |- skos__hiddenLabel mesh__D024403 Carbonic Anhydrase, Muscle Specific
% 209.28/209.49 |- skos__prefLabel mesh__D024403 Carbonic Anhydrase III
% 209.28/209.49 |- skos__broader mesh__D024403smesh__D002256
% 209.28/209.49 |- mesh__dateEstablished mesh__D024403 2002-01-01
% 209.28/209.49 |- mesh__historyNote mesh__D024403
% 209.28/209.49 2002; use CARBONIC ANHYDRASES 1983-2001
% 209.28/209.49 |- mesh__recordOriginator mesh__D024403 jmp
% 209.28/209.49 |- rdf__type mesh__D024403sskos__Concept
% 209.28/209.49 |- mesh__dateCreated mesh__D024403 2001-07-25
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D024403 2006
% 209.28/209.49 |- mesh__dateRevised mesh__D024403 2003-07-09
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D024403 2005
% 209.28/209.49 |- skos__altLabel mesh__D024403 Carbonic Anhydrase, Muscle-Specific
% 209.28/209.49 |- skos__annotation mesh__D024403
% 209.28/209.49 /antag: coord with CARBONIC ANHYDRASE INHIBITORS
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D024403
% 209.28/209.49 2002; see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991%A%
% 209.28/209.49 |- mesh__recordMaintainer mesh__D024403 ssb
% 209.28/209.49 |- skos__scopeNote mesh__D024403
% 209.28/209.49 A cytosolic carbonic anhydrase isoenzyme primarily expressed in skeletal muscle %28%MUSCLES, SKELETAL%29%. EC 4.2.1.-%A%
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D024403 2004
% 209.28/209.49 |- skos__historyNote mesh__D024403 Carbonic Anhydrases %28%1972-2001%29%
% 209.28/209.49 |- skos__hiddenLabel mesh__D024403 Muscle-Specific Carbonic Anhydrase
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D024403 sjn
% 209.28/209.49 |- skos__hiddenLabel mesh__D024403 Anhydrase, Muscle-Specific Carbonic
% 209.28/209.49 |- skos__broader mesh__D043368smesh__D043367
% 209.28/209.49 |- mesh__historyNote mesh__D043368 2004
% 209.28/209.49 |- skos__altLabel mesh__D043368 Pseudomonas solanacearum
% 209.28/209.49 |- skos__scopeNote mesh__D043368
% 209.28/209.49 A species of Ralstonia previously classed in the genera PSEUDOMONAS and BURKHOLDERIA. It is an important plant pathogen.%A%
% 209.28/209.49 |- skos__historyNote mesh__D043368
% 209.28/209.49 Gram-Negative Aerobic Rods and Cocci %28%1995-2003%29%
% 209.28/209.49 |- mesh__recordMaintainer mesh__D043368 SYSTEM
% 209.28/209.49 |- mesh__dateEstablished mesh__D043368 2004-01-01
% 209.28/209.49 |- mesh__dateCreated mesh__D043368 2003-07-09
% 209.28/209.49 |- mesh__dateRevised mesh__D043368 2005-06-30
% 209.28/209.49 |- skos__altLabel mesh__D043368 Burkholderia solanacearum
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D043368 2004
% 209.28/209.49 |- skos__historyNote mesh__D043368 Betaproteobacteria %28%1995-2003%29%
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D043368 sjn
% 209.28/209.49 |- mesh__recordOriginator mesh__D043368 ags
% 209.28/209.49 |- rdf__type mesh__D043368sskos__Concept
% 209.28/209.49 |- skos__prefLabel mesh__D043368 Ralstonia solanacearum
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D043368 2006
% 209.28/209.49 |- mesh__recordOriginator mesh__D048053 jmp
% 209.28/209.49 |- skos__scopeNote mesh__D048053
% 209.28/209.49 A 97-kDa extracellular signal-regulated MAP kinase. Mitogen-activated protein kinase 6 levels increase during cellular differentiation, while in proliferating cells the enzyme is degraded rapidly via the PROTEASOME ENDOPEPTIDASE COMPLEX.%A%
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D048053
% 209.28/209.49 2005; MITOGEN-ACTIVATED PROTEIN KINASE 6 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000 %26% under PROTEIN KINASES 1991-1993%A%
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D048053 2005
% 209.28/209.49 |- skos__altLabel mesh__D048053 p97%28%MAPK%29% Protein
% 209.28/209.49 |- mesh__recordMaintainer mesh__D048053 jmp
% 209.28/209.49 |- skos__hiddenLabel mesh__D048053 Extracellular Signal Regulated Kinase 3
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D048053 2006
% 209.28/209.49 |- skos__hiddenLabel mesh__D048053 Kinase, ERK3
% 209.28/209.49 |- mesh__dateEstablished mesh__D048053 2005-01-01
% 209.28/209.49 |- rdf__type mesh__D048053sskos__Concept
% 209.28/209.49 |- mesh__dateCreated mesh__D048053 2004-07-07
% 209.28/209.49 |- skos__altLabel mesh__D048053 p97MAPK Protein
% 209.28/209.49 |- skos__prefLabel mesh__D048053 Mitogen-Activated Protein Kinase 6
% 209.28/209.49 |- skos__hiddenLabel mesh__D048053 MAPK6 Mitogen Activated Protein Kinase
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D048053 sjn
% 209.28/209.49 |- mesh__historyNote mesh__D048053 2005%28%1991%29%
% 209.28/209.49 |- skos__broader mesh__D048053smesh__D048049
% 209.28/209.49 |- skos__altLabel mesh__D048053 Extracellular Signal-Regulated Kinase 3
% 209.28/209.49 |- skos__altLabel mesh__D048053 ERK3 Kinase
% 209.28/209.49 |- skos__hiddenLabel mesh__D048053 Mitogen Activated Protein Kinase 6
% 209.28/209.49 |- skos__altLabel mesh__D048053 MAPK6 Mitogen-Activated Protein Kinase
% 209.28/209.49 |- skos__historyNote mesh__D048053
% 209.28/209.49 Mitogen-Activated Protein Kinases %28%1991-2004%29%
% 209.28/209.49 |- mesh__recordMaintainer mesh__D001657 ags
% 209.28/209.49 |- skos__hiddenLabel mesh__D001657 Dyskinesia, Gallbladder
% 209.28/209.49 |- skos__hiddenLabel mesh__D001657 Gallbladder Dyskinesias
% 209.28/209.49 |- mesh__dateCreated mesh__D001657 1999-01-01
% 209.28/209.49 |- mesh__recordOriginator mesh__D001657 NLM
% 209.28/209.49 |- mesh__dateRevised mesh__D001657 2005-08-01
% 209.28/209.49 |- skos__hiddenLabel mesh__D001657 Dyskinesias, Gallbladder
% 209.28/209.49 |- skos__broader mesh__D001657smesh__D003137
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D001657 ags
% 209.28/209.49 |- skos__hiddenLabel mesh__D001657 Dyskinesias, Biliary
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D001657 2005
% 209.28/209.49 |- skos__hiddenLabel mesh__D001657 Dyskinesia, Biliary
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D001657 2006
% 209.28/209.49 |- skos__prefLabel mesh__D001657 Biliary Dyskinesia
% 209.28/209.49 |- rdf__type mesh__D001657sskos__Concept
% 209.28/209.49 |- skos__scopeNote mesh__D001657
% 209.28/209.49 A motility disorder characterized by biliary COLIC, absence of GALLSTONES, and an abnormal GALLBLADDER ejection fraction. It is caused by gallbladder dyskinesia and/or SPHINCTER OF ODDI DYSFUNCTION.%A%
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D001657 2006A
% 209.28/209.49 |- skos__hiddenLabel mesh__D001657 Biliary Dyskinesias
% 209.28/209.49 |- skos__altLabel mesh__D020811 Health Care Technology
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D020811 sjn
% 209.28/209.49 |- mesh__dateCreated mesh__D020811 1999-11-08
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020811 2004
% 209.28/209.49 |- mesh__dateEstablished mesh__D020811 2000-01-01
% 209.28/209.49 |- skos__scopeNote mesh__D020811
% 209.28/209.49 The application of technology to the solution of medical problems.%A%
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D020811
% 209.28/209.49 2000; BIOMEDICAL TECHNOLOGY use TECHNOLOGY, MEDICAL %28%1991-1999%29%; HEALTH CARE TECHNOLOGY %26% HEALTH TECHNOLOGY use TECHNOLOGY, MEDICAL %28%1998-1999%29%%A%
% 209.28/209.49 |- mesh__historyNote mesh__D020811
% 209.28/209.49 2000; BIOMEDICAL TECHNOLOGY was see TECHNOLOGY, MEDICAL %28%1991-1999%29%; HEALTH CARE TECHNOLOGY %26% HEALTH TECHNOLOGY see TECHNOLOGY, MEDICAL %28%1998-1999%29%%A%
% 209.28/209.49 |- skos__altLabel mesh__D020811 Technology, Biomedical
% 209.28/209.49 |- rdf__type mesh__D020811sskos__Concept
% 209.28/209.49 |- skos__related mesh__D020811smesh__D001698
% 209.28/209.49 |- skos__historyNote mesh__D020811 Technology, Medical %28%1991-1999%29%
% 209.28/209.49 |- skos__altLabel mesh__D020811 Technology, Health
% 209.28/209.49 |- skos__prefLabel mesh__D020811 Biomedical Technology
% 209.28/209.49 |- skos__altLabel mesh__D020811 Health Technology
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020811 2006
% 209.28/209.49 |- mesh__recordOriginator mesh__D020811 jls
% 209.28/209.49 |- mesh__recordMaintainer mesh__D020811 jls
% 209.28/209.49 |- skos__broader mesh__D020811smesh__D013672
% 209.28/209.49 |- skos__annotation mesh__D020811
% 209.28/209.49 very general - application of technology to medical problems%A%
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020811 2005
% 209.28/209.49 |- skos__altLabel mesh__D020811 Biomedical Technologies
% 209.28/209.49 |- mesh__dateRevised mesh__D020811 2003-07-22
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 2005
% 209.28/209.49 |- skos__historyNote mesh__D006342 Myocardial Infarction %28%1979-1986%29%
% 209.28/209.49 |- mesh__dateEstablished mesh__D006342 1991-01-01
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 2001
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 1997
% 209.28/209.49 |- skos__broader mesh__D006342smesh__D006341
% 209.28/209.49 |- mesh__dateCreated mesh__D006342 1986-06-24
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Post-Infarction Heart Ruptures
% 209.28/209.49 |- mesh__recordMaintainer mesh__D006342 AGS
% 209.28/209.49 |- skos__annotation mesh__D006342
% 209.28/209.49 do not coord with MYOCARDIAL INFARCTION unless specifically discussed%A%
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 1993
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Ruptures, Post-Infarction Heart
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 2000
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 2004
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 1996
% 209.28/209.49 |- mesh__historyNote mesh__D006342
% 209.28/209.49 91%28%87%29%; was see under HEART RUPTURE 1987-90
% 209.28/209.49 |- skos__altLabel mesh__D006342 Cardiac Rupture, Post-Infarction
% 209.28/209.49 |- skos__altLabel mesh__D006342 Post-Infarction Heart Rupture
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Post Infarction Heart Rupture
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Rupture, Post-Infarction Cardiac
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Post-Infarction Cardiac Rupture
% 209.28/209.49 |- mesh__recordOriginator mesh__D006342 VDK
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Rupture, Post-Infarction Heart
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 2003
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 1999
% 209.28/209.49 |- skos__historyNote mesh__D006342 Heart Rupture %28%1978-1986%29%
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Heart Rupture, Post Infarction
% 209.28/209.49 |- rdf__type mesh__D006342sskos__Concept
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Ruptures, Post-Infarction Cardiac
% 209.28/209.49 |- skos__prefLabel mesh__D006342 Heart Rupture, Post-Infarction
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 1995
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D006342
% 209.28/209.49 91; was see under HEART RUPTURE 1987-90
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Cardiac Ruptures, Post-Infarction
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 2002
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Post-Infarction Cardiac Ruptures
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 2006
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Heart Ruptures, Post-Infarction
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 1998
% 209.28/209.49 |- mesh__dateRevised mesh__D006342 1992-05-20
% 209.28/209.49 |- skos__scopeNote mesh__D006342
% 209.28/209.49 Rupture of the heart after myocardial infarction.
% 209.28/209.49 |- skos__hiddenLabel mesh__D006342 Cardiac Rupture, Post Infarction
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D006342 PLS
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D006342 1994
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020013 2000
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Calcium Wave
% 209.28/209.49 |- skos__related mesh__D020013smesh__D015220
% 209.28/209.49 |- skos__scopeNote mesh__D020013
% 209.28/209.49 Signal transduction mechanisms whereby calcium mobilization %28%from outside the cell or from intracellular storage pools%29% to the cytoplasm is triggered by external stimuli. Calcium signals are often seen to propagate as waves, oscillations, spikes or puffs. The calcium acts as an intracellular messenger by activating calcium-responsive proteins.%A%
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Spike, Calcium
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020013 2004
% 209.28/209.49 |- skos__historyNote mesh__D020013 Signal Transduction %28%1989-1998%29%
% 209.28/209.49 |- skos__historyNote mesh__D020013 Calcium/physiology %28%1981-1988%29%
% 209.28/209.49 |- skos__related mesh__D020013smesh__D002147
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Oscillations, Calcium
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Spikes, Calcium
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020013 1999
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020013 2003
% 209.28/209.49 |- skos__broader mesh__D020013smesh__D015290
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020013 2002
% 209.28/209.49 |- skos__annotation mesh__D020013
% 209.28/209.49 calcium mobilization in context of signal transduction goes here, in other cases index CALCIUM/metab%A%
% 209.28/209.49 |- mesh__dateEstablished mesh__D020013 1999-01-01
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Puff, Calcium
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Calcium Oscillation
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Wave, Calcium
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020013 2006
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Calcium Spike
% 209.28/209.49 |- mesh__historyNote mesh__D020013 99
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Puffs, Calcium
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Waves, Calcium
% 209.28/209.49 |- skos__prefLabel mesh__D020013 Calcium Signaling
% 209.28/209.49 |- skos__related mesh__D020013smesh__D015544
% 209.28/209.49 |- rdf__type mesh__D020013sskos__Concept
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Calcium Signalings
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Signaling, Calcium
% 209.28/209.49 |- mesh__dateCreated mesh__D020013 1998-06-10
% 209.28/209.49 |- skos__altLabel mesh__D020013 Calcium Oscillations
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D020013 99
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020013 2001
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D020013 2005
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Calcium Puff
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Signalings, Calcium
% 209.28/209.49 |- skos__historyNote mesh__D020013 Calcium/metabolism %28%1981-1988%29%
% 209.28/209.49 |- skos__broader mesh__D020013smesh__D017136
% 209.28/209.49 |- skos__hiddenLabel mesh__D020013 Oscillation, Calcium
% 209.28/209.49 |- skos__annotation mesh__D011287
% 209.28/209.49 no qualif; coord IM with object of prejudice %28%IM%29%
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D011287 2002
% 209.28/209.49 |- skos__hiddenLabel mesh__D011287 Bias, Sex
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D011287 2005
% 209.28/209.49 |- skos__broader mesh__D011287smesh__D011593
% 209.28/209.49 |- mesh__dateRevised mesh__D011287 2001-07-25
% 209.28/209.49 |- skos__scopeNote mesh__D011287
% 209.28/209.49 A preconceived judgment made without adequate evidence and not easily alterable by presentation of contrary evidence.%A%
% 209.28/209.49 |- skos__hiddenLabel mesh__D011287 Bias, Gender
% 209.28/209.49 |- rdf__type mesh__D011287sskos__Concept
% 209.28/209.49 |- skos__hiddenLabel mesh__D011287 Discrimination, Social
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D011287 2004
% 209.28/209.49 |- skos__hiddenLabel mesh__D011287 Discrimination, Sex
% 209.28/209.49 |- skos__altLabel mesh__D011287 Sex Bias
% 209.28/209.49 |- mesh__dateCreated mesh__D011287 1999-01-01
% 209.28/209.49 |- mesh__recordMaintainer mesh__D011287 nns
% 209.28/209.49 |- mesh__recordOriginator mesh__D011287 NLM
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D011287 2003
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D011287 sjn
% 209.28/209.49 |- skos__hiddenLabel mesh__D011287 Prejudices
% 209.28/209.49 |- skos__altLabel mesh__D011287 Gender Bias
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D011287 2006
% 209.28/209.49 |- skos__prefLabel mesh__D011287 Prejudice
% 209.28/209.49 |- mesh__dateRevised mesh__D016770 1993-06-04
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 2001
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 1995
% 209.28/209.49 |- mesh__historyNote mesh__D016770 92
% 209.28/209.49 |- mesh__recordOriginator mesh__D016770 PXP
% 209.28/209.49 |- mesh__recordAuthorizer mesh__D016770 PLS
% 209.28/209.49 |- mesh__dateCreated mesh__D016770 1991-05-02
% 209.28/209.49 |- rdf__type mesh__D016770sskos__Concept
% 209.28/209.49 |- mesh__dateEstablished mesh__D016770 1992-01-01
% 209.28/209.49 |- skos__altLabel mesh__D016770 Infections, Ciliophora
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 2002
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 1998
% 209.28/209.49 |- skos__annotation mesh__D016770
% 209.28/209.49 protozoan infect; GEN or unspecified; most common infect is BALANTIDIASIS%A%
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 1996
% 209.28/209.49 |- skos__hiddenLabel mesh__D016770 Ciliophora Infection
% 209.28/209.49 |- skos__hiddenLabel mesh__D016770 Infection, Ciliophora
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 1999
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 1997
% 209.28/209.49 |- mesh__recordMaintainer mesh__D016770 JLS
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 2005
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D016770 92
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 2003
% 209.28/209.49 |- skos__broader mesh__D016770smesh__D011528
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 2006
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 2000
% 209.28/209.49 |- skos__prefLabel mesh__D016770 Ciliophora Infections
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 2004
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D016770 1994
% 209.28/209.49 |- skos__scopeNote mesh__D016770
% 209.28/209.49 Infections with protozoa of the phylum CILIOPHORA.
% 209.28/209.49 |- mesh__dateCreated mesh__D030441 2001-07-25
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D030441 2005
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D030441 2003
% 209.28/209.49 |- skos__annotation mesh__D030441
% 209.28/209.49 do not confuse X ref SAUSSUREA COSTUS with COSTUS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.28/209.49 |- skos__scopeNote mesh__D030441
% 209.28/209.49 A plant genus of the family ASTERACEAE, order Asterales, subclass Asteridae. It is a source of costus root oil and should not be confused with the genus COSTUS.%A%
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D030441 2002
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D030441 2006
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D030441 2004
% 209.28/209.49 |- mesh__historyNote mesh__D030441 2002
% 209.28/209.49 |- skos__prefLabel mesh__D030441 Saussurea
% 209.28/209.49 |- skos__broader mesh__D030441smesh__D019659
% 209.28/209.49 |- mesh__dateEstablished mesh__D030441 2002-01-01
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D030441 2002
% 209.28/209.49 |- rdf__type mesh__D030441sskos__Concept
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D002750 2002
% 209.28/209.49 |- skos__scopeNote mesh__D002750
% 209.28/209.49 Local anti-infective agent used for skin, gastrointestinal, and vaginal infections with fungi, protozoa, and certain bacteria. In animals, it causes central nervous system damage and is not administered parenterally. It is also used as antiseptic, fungistat, or deodorant.%A%
% 209.28/209.49 |- mesh__dateRevised mesh__D002750 2000-06-21
% 209.28/209.49 |- mesh__publicMeSHNote mesh__D002750
% 209.28/209.49 91,63-82; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82%A%
% 209.28/209.49 |- skos__altLabel mesh__D002750 Chloroquinaldol
% 209.28/209.49 |- skos__altLabel mesh__D002750 5,7-Dichloro-2-methyl-8-quinolinol
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D002750 2003
% 209.28/209.49 |- mesh__recordMaintainer mesh__D002750 TWD
% 209.28/209.49 |- skos__altLabel mesh__D002750 Chlorchinaldine
% 209.28/209.49 |- mesh__dateEstablished mesh__D002750 1963-01-01
% 209.28/209.49 |- mesh__dateCreated mesh__D002750 1999-01-01
% 209.28/209.49 |- skos__hiddenLabel mesh__D002750 5,7 Dichloro 2 methyl 8 quinolinol
% 209.28/209.49 |- mesh__activeMeSHYear mesh__D002750 2004
% 209.28/209.49 |- rdf__type mesh__D002750sskos__Concept
% 209.28/209.49 |- skos__altLabel mesh__D002750 Chlorchinaldol
% 209.28/209.50 |- mesh__activeMeSHYear mesh__D002750 2005
% 209.28/209.50 |- mesh__recordAuthorizer mesh__D002750 sjn
% 209.28/209.50 |- mesh__recordOriginator mesh__D002750 NLM
% 209.28/209.50 |- mesh__activeMeSHYear mesh__D002750 2001
% 209.28/209.50 |- skos__broader mesh__D002750smesh__D002739
% 209.28/209.50 |- mesh__activeMeSHYear mesh__D002750 2006
% 209.28/209.50 |- skos__prefLabel mesh__D002750 Chlorquinaldol
% 209.28/209.50 |- mesh__historyNote mesh__D002750
% 209.28/209.50 91%28%83%29%63; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82%A%
% 209.28/209.50 |- skos__broader mesh__D024404smesh__D002256
% 209.35/209.50 |- skos__historyNote mesh__D024404 Carbonic Anhydrases %28%1992-2001%29%
% 209.35/209.50 |- mesh__dateEstablished mesh__D024404 2002-01-01
% 209.35/209.50 |- mesh__historyNote mesh__D024404
% 209.35/209.50 2002; use CARBONIC ANHYDRASES 1992-2001
% 209.35/209.50 |- rdf__type mesh__D024404sskos__Concept
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D024404 2006
% 209.35/209.50 |- skos__altLabel mesh__D024404 Carbonic Anhydrase Isozyme V
% 209.35/209.50 |- mesh__dateRevised mesh__D024404 2003-07-09
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D024404 2005
% 209.35/209.50 |- skos__prefLabel mesh__D024404 Carbonic Anhydrase V
% 209.35/209.50 |- skos__scopeNote mesh__D024404
% 209.35/209.50 A carbonic anhydrase isoenzyme found in MITOCHONDRIA where it provides bicarbonate ions that are components in the urea cycle and in GLUCONEOGENESIS.%A%
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D024404 2004
% 209.35/209.50 |- mesh__dateCreated mesh__D024404 2001-07-25
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D024404
% 209.35/209.50 2002; see CARBONIC DEHYDATASE 1992-2001
% 209.35/209.50 |- skos__annotation mesh__D024404
% 209.35/209.50 /antag: coord with CARBONIC ANHYDRASE INHIBITORS
% 209.35/209.50 |- skos__broader mesh__D043369smesh__D016946
% 209.35/209.50 |- mesh__recordMaintainer mesh__D043369 SYSTEM
% 209.35/209.50 |- skos__broader mesh__D043369smesh__D020562
% 209.35/209.50 |- mesh__dateCreated mesh__D043369 2003-07-09
% 209.35/209.50 |- skos__prefLabel mesh__D043369 Nitrosomonadaceae
% 209.35/209.50 |- mesh__historyNote mesh__D043369 2004
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D043369 2004
% 209.35/209.50 |- skos__scopeNote mesh__D043369
% 209.35/209.50 A family of gram-negative nitrifying bacteria, in the order Nitrosomonadales, class BETAPROTEOBACTERIA.%A%
% 209.35/209.50 |- rdf__type mesh__D043369sskos__Concept
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D043369 2006
% 209.35/209.50 |- mesh__dateEstablished mesh__D043369 2004-01-01
% 209.35/209.50 |- mesh__dateRevised mesh__D043369 2005-06-30
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D043369 sjn
% 209.35/209.50 |- mesh__recordOriginator mesh__D043369 ags
% 209.35/209.50 |- mesh__recordOriginator mesh__D015678 AGS
% 209.35/209.50 |- mesh__historyNote mesh__D015678 90
% 209.35/209.50 |- skos__annotation mesh__D015678
% 209.35/209.50 coordinate IM with specific protein %28%IM%29% + specific virus %28%IM%29%%A%
% 209.35/209.50 |- skos__hiddenLabel mesh__D015678 VP1, Structural Polypeptide
% 209.35/209.50 |- skos__prefLabel mesh__D015678 Viral Structural Proteins
% 209.35/209.50 |- skos__hiddenLabel mesh__D015678 Structural Polypeptide VP1
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D015678 2006
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D015678 sjn
% 209.35/209.50 |- skos__broader mesh__D015678smesh__D014764
% 209.35/209.50 |- mesh__dateCreated mesh__D015678 1989-05-25
% 209.35/209.50 |- mesh__dateEstablished mesh__D015678 1990-01-01
% 209.35/209.50 |- skos__scopeNote mesh__D015678
% 209.35/209.50 Viral proteins that are components of the mature assembled VIRUS PARTICLES. They may include nucleocapsid core proteins %28%gag proteins%29%, enzymes packaged within the virus particle %28%pol proteins%29%, and membrane components %28%env proteins%29%. These do not include the proteins encoded in the VIRAL GENOME that are produced in infected cells but which are not packaged in the mature virus particle,i.e. the so called non-structural proteins %28%VIRAL NONSTRUCTURAL PROTEINS.%29%%A%
% 209.35/209.50 |- mesh__recordMaintainer mesh__D015678 nns
% 209.35/209.50 |- mesh__dateRevised mesh__D015678 2005-06-30
% 209.35/209.50 |- skos__historyNote mesh__D015678 Viral Proteins %28%1973-1989%29%
% 209.35/209.50 |- skos__hiddenLabel mesh__D015678 Proteins, Viral Structural
% 209.35/209.50 |- rdf__type mesh__D015678sskos__Concept
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D015678 90
% 209.35/209.50 |- skos__hiddenLabel mesh__D015678 Structural Proteins, Viral
% 209.35/209.50 |- skos__hiddenLabel mesh__D048054 Mitogen Activated Protein Kinase 7
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D048054
% 209.35/209.50 2005; MITOGEN-ACTIVATED PROTEIN KINASE 7 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 1999-2004%A%
% 209.35/209.50 |- skos__altLabel mesh__D048054 MAPK7 Mitogen-Activated Protein Kinase
% 209.35/209.50 |- mesh__historyNote mesh__D048054 2005%28%1999%29%
% 209.35/209.50 |- skos__historyNote mesh__D048054
% 209.35/209.50 Mitogen-Activated Protein Kinases %28%1999-2004%29%
% 209.35/209.50 |- mesh__recordMaintainer mesh__D048054 jmp
% 209.35/209.50 |- skos__broader mesh__D048054smesh__D048049
% 209.35/209.50 |- skos__hiddenLabel mesh__D048054
% 209.35/209.50 Mitogen Activated Protein Kinase 7 Isoform 2
% 209.35/209.50 |- skos__scopeNote mesh__D048054
% 209.35/209.50 A 110-kDa extracellular signal-regulated MAP kinase that is activated in response to cellular stress and by GROWTH FACTOR RECEPTOR-mediated pathways.%A%
% 209.35/209.50 |- skos__altLabel mesh__D048054 BMK1 Kinase
% 209.35/209.50 |- mesh__recordOriginator mesh__D048054 jmp
% 209.35/209.50 |- skos__hiddenLabel mesh__D048054 Kinase, ERK5
% 209.35/209.50 |- skos__altLabel mesh__D048054 Extracellular Signal-Regulated Kinase 5
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D048054 2006
% 209.35/209.50 |- mesh__dateEstablished mesh__D048054 2005-01-01
% 209.35/209.50 |- skos__altLabel mesh__D048054 Big MAP Kinase 1
% 209.35/209.50 |- rdf__type mesh__D048054sskos__Concept
% 209.35/209.50 |- skos__prefLabel mesh__D048054 Mitogen-Activated Protein Kinase 7
% 209.35/209.50 |- skos__hiddenLabel mesh__D048054 MAPK7 Mitogen Activated Protein Kinase
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D048054 2005
% 209.35/209.50 |- skos__altLabel mesh__D048054 ERK5 Kinase
% 209.35/209.50 |- mesh__dateCreated mesh__D048054 2004-07-07
% 209.35/209.50 |- skos__hiddenLabel mesh__D048054
% 209.35/209.50 Mitogen Activated Protein Kinase 7 Isoform 1
% 209.35/209.50 |- skos__hiddenLabel mesh__D048054 Extracellular Signal Regulated Kinase 5
% 209.35/209.50 |- skos__hiddenLabel mesh__D048054 Kinase, BMK1
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D048054 sjn
% 209.35/209.50 |- mesh__recordMaintainer mesh__D001658 lkt
% 209.35/209.50 |- skos__scopeNote mesh__D001658
% 209.35/209.50 Abnormal passage in any organ of the biliary tract or between biliary organs and other organs.%A%
% 209.35/209.50 |- mesh__dateRevised mesh__D001658 2003-07-09
% 209.35/209.50 |- skos__prefLabel mesh__D001658 Biliary Fistula
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D001658 2005
% 209.35/209.50 |- skos__hiddenLabel mesh__D001658 Biliary Fistulas
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D001658 2006
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D001658 sjn
% 209.35/209.50 |- rdf__type mesh__D001658sskos__Concept
% 209.35/209.50 |- mesh__recordOriginator mesh__D001658 NLM
% 209.35/209.50 |- skos__annotation mesh__D001658
% 209.35/209.50 coord IM with specific precoord biliary tract/dis heading %28%IM%29%; fistula policy: Manual 23.19+%A%
% 209.35/209.50 |- skos__hiddenLabel mesh__D001658 Fistula, Biliary
% 209.35/209.50 |- skos__hiddenLabel mesh__D001658 Fistulas, Biliary
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D001658 2004
% 209.35/209.50 |- skos__broader mesh__D001658smesh__D016154
% 209.35/209.50 |- mesh__dateCreated mesh__D001658 1999-01-01
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D012380 2004
% 209.35/209.50 |- mesh__recordMaintainer mesh__D012380 hjn
% 209.35/209.50 |- mesh__historyNote mesh__D012380
% 209.35/209.50 69; ROLE CONCEPT was see under ROLE 1969-78, was see under PSYCHOLOGY, SOCIAL 1966-68%A%
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D012380
% 209.35/209.50 69; ROLE CONCEPT was see under PSYCHOLOGY, SOCIAL 1966-68%A%
% 209.35/209.50 |- skos__hiddenLabel mesh__D012380 Role Concepts
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D012380 sjn
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D012380 2006
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D012380 2003
% 209.35/209.50 |- skos__hiddenLabel mesh__D012380 Roles
% 209.35/209.50 |- mesh__recordOriginator mesh__D012380 NLM
% 209.35/209.50 |- rdf__type mesh__D012380sskos__Concept
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D012380 2005
% 209.35/209.50 |- mesh__onlineNote mesh__D012380
% 209.35/209.50 use ROLE to search ROLE CONCEPT 1969-78; use PSYCHOLOGY, SOCIAL 1966-68%A%
% 209.35/209.50 |- skos__broader mesh__D012380smesh__D006126
% 209.35/209.50 |- skos__hiddenLabel mesh__D012380 Concepts, Role
% 209.35/209.50 |- skos__scopeNote mesh__D012380
% 209.35/209.50 The expected and characteristic pattern of behavior exhibited by an individual as a member of a particular social group.%A%
% 209.35/209.50 |- mesh__dateCreated mesh__D012380 1999-01-01
% 209.35/209.50 |- skos__historyNote mesh__D012380 Psychology, Social %28%1966-1968%29%
% 209.35/209.50 |- mesh__dateRevised mesh__D012380 2002-07-03
% 209.35/209.50 |- skos__hiddenLabel mesh__D012380 Concept, Role
% 209.35/209.50 |- skos__annotation mesh__D012380 GEN; prefer specifics
% 209.35/209.50 |- mesh__dateEstablished mesh__D012380 1969-01-01
% 209.35/209.50 |- skos__prefLabel mesh__D012380 Role
% 209.35/209.50 |- skos__historyNote mesh__D020812 Membrane Glycoproteins %28%1991-1993%29%
% 209.35/209.50 |- skos__hiddenLabel mesh__D020812 Receptor, Neurotrophin 3
% 209.35/209.50 |- mesh__recordMaintainer mesh__D020812 jmp
% 209.35/209.50 |- mesh__dateRevised mesh__D020812 2005-06-30
% 209.35/209.50 |- mesh__dateEstablished mesh__D020812 2000-01-01
% 209.35/209.50 |- mesh__dateCreated mesh__D020812 1999-11-04
% 209.35/209.50 |- skos__altLabel mesh__D020812 NTRK3 Receptor
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D020812 sjn
% 209.35/209.50 |- skos__scopeNote mesh__D020812
% 209.35/209.50 A protein-tyrosine kinase receptor that is specific for NEUROTROPHIN 3. It is widely expressed in nervous tissue and may play a role in mediating the effects of NEUROTROPHIN 3 on the proliferation and differentiation of NEURONS.%A%
% 209.35/209.50 |- skos__altLabel mesh__D020812 Neurotrophin 3 Receptor
% 209.35/209.50 |- skos__historyNote mesh__D020812
% 209.35/209.50 Receptors, Growth Factor %28%1993-1999%29%
% 209.35/209.50 |- rdf__type mesh__D020812sskos__Concept
% 209.35/209.50 |- skos__broader mesh__D020812smesh__D020794
% 209.35/209.50 |- skos__altLabel mesh__D020812
% 209.35/209.50 Neurotrophic Tyrosine-Kinase-Receptor Type 3
% 209.35/209.50 |- skos__broader mesh__D020812smesh__D017475
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D020812 2006
% 209.35/209.50 |- skos__altLabel mesh__D020812
% 209.35/209.50 Receptor, Neurotrophic-Tyrosine-Kinase Type 3
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D020812
% 209.35/209.50 2000; TRKC PROTEIN %28%now RECEPTOR, TYPE 3 NEUROTROPHIC TYROSINE KINASE%29% was indexed under RECEPTORS, NERVE GROWTH FACTOR 1995-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999, RECEPTORS, GROWTH FACTOR 1993-1994, MEMBRANE GLYCOPROTEINS 1991-1993 %26% PROTEIN-TYROSINE KINASE 1991-1993%A%
% 209.35/209.50 |- skos__altLabel mesh__D020812 Protein-Tyrosine Kinase TRKC
% 209.35/209.50 |- skos__hiddenLabel mesh__D020812 Kinase TRKC, Protein-Tyrosine
% 209.35/209.50 |- skos__altLabel mesh__D020812 NTRK3 Protein
% 209.35/209.50 |- skos__altLabel mesh__D020812 trkC Protein
% 209.35/209.50 |- mesh__recordOriginator mesh__D020812 jmp
% 209.35/209.50 |- skos__prefLabel mesh__D020812 Receptor, trkC
% 209.35/209.50 |- skos__historyNote mesh__D020812
% 209.35/209.50 Receptors, Nerve Growth Factor %28%1995-1999%29%
% 209.35/209.50 |- skos__annotation mesh__D020812 DF: RECEPT TRKC
% 209.35/209.50 |- skos__historyNote mesh__D020812
% 209.35/209.50 Receptor Protein-Tyrosine Kinases %28%1994-1999%29%
% 209.35/209.50 |- mesh__historyNote mesh__D020812
% 209.35/209.50 2000; use RECEPTOR, TYPE 3 NEUROTROPHIC TYROSINE KINASE %28%NM%29% 1991-1999%A%
% 209.35/209.50 |- skos__hiddenLabel mesh__D020812 Protein Tyrosine Kinase TRKC
% 209.35/209.50 |- skos__hiddenLabel mesh__D020812 TRKC, Protein-Tyrosine Kinase
% 209.35/209.50 |- skos__hiddenLabel mesh__D020812 Receptor, NTRK3
% 209.35/209.50 |- skos__historyNote mesh__D020812
% 209.35/209.50 Protein-Tyrosine Kinase %28%1991-1993%29%
% 209.35/209.50 |- skos__altLabel mesh__D020812 trkC Receptor
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D006343 2005
% 209.35/209.50 |- skos__hiddenLabel mesh__D006343 Defects, Heart Septal
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D006343 sjn
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D006343 2006
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D006343 2000
% 209.35/209.50 |- skos__scopeNote mesh__D006343
% 209.35/209.50 Defects in the cardiac septa, resulting in abnormal communications between the opposite chambers of the heart.%A%
% 209.35/209.50 |- mesh__recordMaintainer mesh__D006343 kle
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D006343 2003
% 209.35/209.50 |- mesh__dateEstablished mesh__D006343 1964-01-01
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D006343 2001
% 209.35/209.50 |- skos__annotation mesh__D006343
% 209.35/209.50 GEN or unspecified; prefer specifics; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 209.35/209.50 |- skos__broader mesh__D006343smesh__D006330
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D006343 2004
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D006343 64
% 209.35/209.50 |- skos__hiddenLabel mesh__D006343 Heart Septal Defect
% 209.35/209.50 |- rdf__type mesh__D006343sskos__Concept
% 209.35/209.50 |- skos__hiddenLabel mesh__D006343 Septal Defects, Heart
% 209.35/209.50 |- skos__hiddenLabel mesh__D006343 Septal Defect, Heart
% 209.35/209.50 |- skos__prefLabel mesh__D006343 Heart Septal Defects
% 209.35/209.50 |- mesh__dateCreated mesh__D006343 1999-01-01
% 209.35/209.50 |- skos__hiddenLabel mesh__D006343 Defect, Heart Septal
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D006343 2002
% 209.35/209.50 |- mesh__historyNote mesh__D006343 64
% 209.35/209.50 |- mesh__dateRevised mesh__D006343 1999-11-03
% 209.35/209.50 |- mesh__recordOriginator mesh__D006343 NLM
% 209.35/209.50 |- mesh__dateRevised mesh__D020014 2003-07-09
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D020014 2004
% 209.35/209.50 |- mesh__dateEstablished mesh__D020014 1999-01-01
% 209.35/209.50 |- skos__broader mesh__D020014smesh__D045744
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D020014 99
% 209.35/209.50 |- skos__historyNote mesh__D020014 Cell Line %28%1976-1998%29%
% 209.35/209.50 |- rdf__type mesh__D020014sskos__Concept
% 209.35/209.50 |- skos__annotation mesh__D020014
% 209.35/209.50 almost always NIM with no subheadings; check HUMAN; do not routinely add ERYTHROLEUKEMIA%A%
% 209.35/209.50 |- skos__hiddenLabel mesh__D020014 Cells, K562
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D020014 2005
% 209.35/209.50 |- mesh__historyNote mesh__D020014 99
% 209.35/209.50 |- skos__historyNote mesh__D020014 Tumor Cells, Cultured %28%1988-1998%29%
% 209.35/209.50 |- skos__broader mesh__D020014smesh__D015672
% 209.35/209.50 |- skos__scopeNote mesh__D020014
% 209.35/209.50 An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS.%A%
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D020014 2006
% 209.35/209.50 |- skos__prefLabel mesh__D020014 K562 Cells
% 209.35/209.50 |- mesh__dateCreated mesh__D020014 1998-06-10
% 209.35/209.50 |- skos__hiddenLabel mesh__D044462 Protease Activated Receptors
% 209.35/209.50 |- skos__hiddenLabel mesh__D044462 Receptors, Endopeptidase-Activated
% 209.35/209.50 |- skos__hiddenLabel mesh__D044462 Proteinase Activated Receptors
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D044462 2006
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D044462 2004
% 209.35/209.50 |- skos__altLabel mesh__D044462 Proteinase-Activated Receptors
% 209.35/209.50 |- skos__hiddenLabel mesh__D044462 Receptors, Protease-Activated
% 209.35/209.50 |- skos__hiddenLabel mesh__D044462 Endopeptidase Activated Receptors
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D044462 2005
% 209.35/209.50 |- skos__historyNote mesh__D044462 Receptors, Thrombin %28%1994-2003%29%
% 209.35/209.50 |- rdf__type mesh__D044462sskos__Concept
% 209.35/209.50 |- skos__hiddenLabel mesh__D044462 Receptors, Proteinase Activated
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D044462 2004
% 209.35/209.50 |- skos__altLabel mesh__D044462 Endopeptidase-Activated Receptors
% 209.35/209.50 |- mesh__dateEstablished mesh__D044462 2004-01-01
% 209.35/209.50 |- mesh__dateCreated mesh__D044462 2003-07-09
% 209.35/209.50 |- skos__altLabel mesh__D044462 Protease-Activated Receptors
% 209.35/209.50 |- skos__scopeNote mesh__D044462
% 209.35/209.50 A class of receptors that are activated by the action of PROTEINASES. The most notable examples are the THROMBIN RECEPTORS. The receptors contain cryptic ligands that are exposed upon the selective proteolysis of specific N-terminal cleavage sites.%A%
% 209.35/209.50 |- mesh__historyNote mesh__D044462 2004
% 209.35/209.50 |- skos__prefLabel mesh__D044462 Receptors, Proteinase-Activated
% 209.35/209.50 |- skos__broader mesh__D044462smesh__D011956
% 209.35/209.50 |- skos__prefLabel mesh__D011288 Prekallikrein
% 209.35/209.50 |- skos__historyNote mesh__D011288 Enzyme Precursors %28%1973-1975%29%
% 209.35/209.50 |- mesh__dateCreated mesh__D011288 1975-07-25
% 209.35/209.50 |- skos__broader mesh__D011288smesh__D007610
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D011288 sjn
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D011288
% 209.35/209.50 89; was see under KALLIKREIN 1976-88
% 209.35/209.50 |- skos__hiddenLabel mesh__D011288 Prokallikrein A, Plasma
% 209.35/209.50 |- skos__scopeNote mesh__D011288
% 209.35/209.50 A plasma protein which is the precursor of kallikrein. Plasma that is deficient in prekallikrein has been found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin, and plasmin formation. The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease.%A%
% 209.35/209.50 |- mesh__dateRevised mesh__D011288 2005-06-30
% 209.35/209.50 |- rdf__type mesh__D011288sskos__Concept
% 209.35/209.50 |- skos__altLabel mesh__D011288 Fletcher Factor
% 209.35/209.50 |- mesh__historyNote mesh__D011288
% 209.35/209.50 89%28%76%29%; was see under KALLIKREINS 1976-88
% 209.35/209.50 |- skos__hiddenLabel mesh__D011288 Factor, Fletcher
% 209.35/209.50 |- skos__historyNote mesh__D011288
% 209.35/209.50 Blood Coagulation Factors %28%1973-1975%29%
% 209.35/209.50 |- skos__hiddenLabel mesh__D011288 Prokallikrein, Plasma
% 209.35/209.50 |- skos__historyNote mesh__D011288 Kallikrein %28%1973-1975%29%
% 209.35/209.50 |- skos__altLabel mesh__D011288 Plasma Prokallikrein
% 209.35/209.50 |- skos__related mesh__D011288smesh__D003029
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D011288 2006
% 209.35/209.50 |- mesh__dateEstablished mesh__D011288 1989-01-01
% 209.35/209.50 |- mesh__recordOriginator mesh__D011288 RLS
% 209.35/209.50 |- mesh__recordMaintainer mesh__D011288 ssb
% 209.35/209.50 |- skos__altLabel mesh__D011288 Kallikreinogen
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 1998
% 209.35/209.50 |- skos__broader mesh__D016771smesh__D011528
% 209.35/209.50 |- mesh__recordOriginator mesh__D016771 PXP
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 2000
% 209.35/209.50 |- rdf__type mesh__D016771sskos__Concept
% 209.35/209.50 |- skos__hiddenLabel mesh__D016771 Sarcomastigophora Infection
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 1996
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 2001
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 1999
% 209.35/209.50 |- skos__annotation mesh__D016771
% 209.35/209.50 protozoan infect; GEN: prefer specifics
% 209.35/209.50 |- skos__altLabel mesh__D016771 Infections, Sarcomastigophora
% 209.35/209.50 |- mesh__dateCreated mesh__D016771 1991-05-02
% 209.35/209.50 |- mesh__dateRevised mesh__D016771 1993-06-03
% 209.35/209.50 |- mesh__dateEstablished mesh__D016771 1992-01-01
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 2005
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 1997
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D016771 PLS
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 2002
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 2003
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 2006
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 1994
% 209.35/209.50 |- skos__scopeNote mesh__D016771
% 209.35/209.50 Infections with protozoa of the phylum SARCOMASTIGOPHORA.%A%
% 209.35/209.50 |- skos__hiddenLabel mesh__D016771 Infection, Sarcomastigophora
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 2004
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D016771 92
% 209.35/209.50 |- mesh__recordMaintainer mesh__D016771 TGC
% 209.35/209.50 |- mesh__historyNote mesh__D016771 92
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D016771 1995
% 209.35/209.50 |- skos__prefLabel mesh__D016771 Sarcomastigophora Infections
% 209.35/209.50 |- mesh__dateCreated mesh__D002751 1999-01-01
% 209.35/209.50 |- skos__altLabel mesh__D002751 Chlorotetracycline
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D002751 sjn
% 209.35/209.50 |- rdf__type mesh__D002751sskos__Concept
% 209.35/209.50 |- mesh__recordOriginator mesh__D002751 NLM
% 209.35/209.50 |- skos__hiddenLabel mesh__D002751 Chlortetracycline, 4 Epimer
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D002751 2005
% 209.35/209.50 |- skos__hiddenLabel mesh__D002751 Hydrochloride, Chlortetracycline
% 209.35/209.50 |- skos__altLabel mesh__D002751 Aureomycine
% 209.35/209.50 |- skos__scopeNote mesh__D002751
% 209.35/209.50 A TETRACYCLINE with a 7-chloro substitution.
% 209.35/209.50 |- skos__hiddenLabel mesh__D002751 4-Epimer Chlortetracycline
% 209.35/209.50 |- skos__hiddenLabel mesh__D002751 Monohydrochloride, Chlortetracycline
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D002751 2006
% 209.35/209.50 |- skos__prefLabel mesh__D002751 Chlortetracycline
% 209.35/209.50 |- skos__broader mesh__D002751smesh__D013754
% 209.35/209.50 |- mesh__dateRevised mesh__D002751 2004-07-07
% 209.35/209.50 |- skos__hiddenLabel mesh__D002751 Bisulfate, Chlortetracycline
% 209.35/209.50 |- skos__hiddenLabel mesh__D002751 Calcium Salt Chlortetracycline
% 209.35/209.50 |- skos__hiddenLabel mesh__D002751 Salt Chlortetracycline, Calcium
% 209.35/209.50 |- mesh__recordMaintainer mesh__D002751 ssb
% 209.35/209.50 |- skos__hiddenLabel mesh__D024405 Gastroepiploic Arteries
% 209.35/209.50 |- skos__hiddenLabel mesh__D024405 Arteries, Gastroepiploic
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D024405 2005
% 209.35/209.50 |- skos__prefLabel mesh__D024405 Gastroepiploic Artery
% 209.35/209.50 |- rdf__type mesh__D024405sskos__Concept
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D024405 2006
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D024405 2002
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D024405 2003
% 209.35/209.50 |- skos__historyNote mesh__D024405
% 209.35/209.50 Arteries/transplantation %28%1990-2001%29%
% 209.35/209.50 |- mesh__dateEstablished mesh__D024405 2002-01-01
% 209.35/209.50 |- skos__scopeNote mesh__D024405
% 209.35/209.50 Abdominal artery that follows the curvature of the stomach. The right gasteroepiploic artery is frequently used in coronary artery bypass grafting, myocardial revascularization, and other vascular reconstruction.%A%
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D024405 2002
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D024405 2004
% 209.35/209.50 |- mesh__dateCreated mesh__D024405 2001-07-25
% 209.35/209.50 |- skos__hiddenLabel mesh__D024405 Artery, Gastroepiploic
% 209.35/209.50 |- skos__broader mesh__D024405smesh__D001158
% 209.35/209.50 |- mesh__historyNote mesh__D024405 2002
% 209.35/209.50 |- skos__historyNote mesh__D024405 Stomach/blood supply %28%1967-2001%29%
% 209.35/209.50 |- skos__broader mesh__D048055smesh__D048031
% 209.35/209.50 |- skos__altLabel mesh__D048055 c-jun Kinase-1
% 209.35/209.50 |- skos__altLabel mesh__D048055 c-jun N-Terminal Kinase 1
% 209.35/209.50 |- mesh__recordMaintainer mesh__D048055 jmp
% 209.35/209.50 |- skos__prefLabel mesh__D048055 Mitogen-Activated Protein Kinase 8
% 209.35/209.50 |- skos__hiddenLabel mesh__D048055 Mitogen Activated Protein Kinase 8
% 209.35/209.50 |- skos__scopeNote mesh__D048055
% 209.35/209.50 A c-jun amino-terminal kinase that is activated by environmental stress and pro-inflammatory cytokines. Several isoforms of the protein with molecular sizes of 43 and 48 KD exist due to multiple ALTERNATIVE SPLICING.%A%
% 209.35/209.50 |- skos__hiddenLabel mesh__D048055 c jun Kinase 1
% 209.35/209.50 |- mesh__publicMeSHNote mesh__D048055
% 209.35/209.50 2005; MITOGEN-ACTIVATED PROTEIN KINASE 8 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004%A%
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D048055 sjn
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D048055 2006
% 209.35/209.50 |- skos__hiddenLabel mesh__D048055 SAPK1 Mitogen Activated Protein Kinase
% 209.35/209.50 |- skos__hiddenLabel mesh__D048055 Stress Activated Protein Kinase 1
% 209.35/209.50 |- skos__altLabel mesh__D048055 Stress-Activated Protein Kinase JNK1
% 209.35/209.50 |- skos__hiddenLabel mesh__D048055 SAP Kinase 1
% 209.35/209.50 |- skos__altLabel mesh__D048055 JNK1 Kinase
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D048055 2005
% 209.35/209.50 |- rdf__type mesh__D048055sskos__Concept
% 209.35/209.50 |- skos__hiddenLabel mesh__D048055 Stress Activated Protein Kinase gamma
% 209.35/209.50 |- mesh__dateCreated mesh__D048055 2004-07-07
% 209.35/209.50 |- skos__hiddenLabel mesh__D048055 Stress Activated Protein Kinase JNK1
% 209.35/209.50 |- mesh__recordOriginator mesh__D048055 jmp
% 209.35/209.50 |- skos__hiddenLabel mesh__D048055 MAPK8 Mitogen Activated Protein Kinase
% 209.35/209.50 |- skos__altLabel mesh__D048055 Stress-Activated Protein Kinase 1
% 209.35/209.50 |- skos__altLabel mesh__D048055 SAPK1 Mitogen-Activated Protein Kinase
% 209.35/209.50 |- skos__hiddenLabel mesh__D048055 c jun N Terminal Kinase 1
% 209.35/209.50 |- skos__altLabel mesh__D048055 SAP Kinase-1
% 209.35/209.50 |- mesh__dateEstablished mesh__D048055 2005-01-01
% 209.35/209.50 |- skos__historyNote mesh__D048055
% 209.35/209.50 Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 209.35/209.50 |- skos__altLabel mesh__D048055 MAPK8 Mitogen-Activated Protein Kinase
% 209.35/209.50 |- skos__altLabel mesh__D048055 Stress-Activated Protein Kinase gamma
% 209.35/209.50 |- mesh__historyNote mesh__D048055 2005%28%2000%29%
% 209.35/209.50 |- skos__hiddenLabel mesh__D001659 Tract, Biliary
% 209.35/209.50 |- rdf__type mesh__D001659sskos__Concept
% 209.35/209.50 |- skos__annotation mesh__D001659
% 209.35/209.50 /abnorm: BILIARY ATRESIA is also available; /radiogr permitted but CHOLECYSTOGRAPHY for gallbladder x-ray %26% CHOLANGIOGRAPHY for bile duct x-ray are available; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS; empyema = EMPYEMA, GALLBLADDER see CHOLECYSTITIS or EMPYEMA %28%IM%29% + BILIARY TRACT DISEASES %28%IM%29% if not of gallbladder; inflammation = CHOLECYSTITIS or CHOLANGITIS%A%
% 209.35/209.50 |- mesh__recordMaintainer mesh__D001659 lkt
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D001659 2004
% 209.35/209.50 |- skos__altLabel mesh__D001659 Biliary System
% 209.35/209.50 |- skos__hiddenLabel mesh__D001659 Tree, Biliary
% 209.35/209.50 |- mesh__dateCreated mesh__D001659 1999-01-01
% 209.35/209.50 |- skos__related mesh__D001659smesh__D002756
% 209.35/209.50 |- skos__altLabel mesh__D001659 Biliary Tree
% 209.35/209.50 |- skos__scopeNote mesh__D001659 The BILE DUCTS and the GALLBLADDER.
% 209.35/209.50 |- skos__hiddenLabel mesh__D001659 System, Biliary
% 209.35/209.50 |- mesh__dateRevised mesh__D001659 2003-07-09
% 209.35/209.50 |- skos__related mesh__D001659smesh__D002758
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D001659 sjn
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D001659 2005
% 209.35/209.50 |- mesh__recordOriginator mesh__D001659 NLM
% 209.35/209.50 |- skos__prefLabel mesh__D001659 Biliary Tract
% 209.35/209.50 |- skos__broader mesh__D001659smesh__D004064
% 209.35/209.50 |- skos__related mesh__D001659smesh__D002765
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D001659 2006
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D012381 2003
% 209.35/209.50 |- mesh__onlineNote mesh__D012381 search PSYCHODRAMA 1968-74
% 209.35/209.50 |- skos__scopeNote mesh__D012381
% 209.35/209.50 The adopting or performing the role of another significant individual in order to gain insight into the behavior of that person.%A%
% 209.35/209.50 |- rdf__type mesh__D012381sskos__Concept
% 209.35/209.50 |- skos__prefLabel mesh__D012381 Role Playing
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D012381 2005
% 209.35/209.50 |- mesh__dateEstablished mesh__D012381 1991-01-01
% 209.35/209.50 |- mesh__recordAuthorizer mesh__D012381 sjn
% 209.35/209.50 |- mesh__dateRevised mesh__D012381 2001-07-25
% 209.35/209.50 |- skos__hiddenLabel mesh__D012381 Role Playings
% 209.35/209.50 |- mesh__recordOriginator mesh__D012381 NLM
% 209.35/209.50 |- mesh__historyNote mesh__D012381
% 209.35/209.50 91%28%75%29%; was see under PSYCHODRAMA 1975-90
% 209.35/209.50 |- skos__annotation mesh__D012381 no qualif
% 209.35/209.50 |- mesh__dateCreated mesh__D012381 1999-01-01
% 209.35/209.50 |- skos__broader mesh__D012381smesh__D011577
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D012381 2002
% 209.35/209.50 |- mesh__activeMeSHYear mesh__D012381 2004
% 209.35/209.51 |- skos__hiddenLabel mesh__D012381 Playings, Role
% 209.35/209.51 |- mesh__recordMaintainer mesh__D012381 ssb
% 209.35/209.51 |- skos__hiddenLabel mesh__D012381 Playing, Role
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D012381
% 209.35/209.51 91; was see under PSYCHODRAMA 1975-90
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D012381 2006
% 209.35/209.51 |- mesh__recordOriginator mesh__D020813 jmp
% 209.35/209.51 |- skos__prefLabel mesh__D020813 Receptor, trkB
% 209.35/209.51 |- skos__annotation mesh__D020813 DF: RECEPT TRKB
% 209.35/209.51 |- skos__historyNote mesh__D020813
% 209.35/209.51 Protein-Tyrosine Kinase %28%1990-1993%29%
% 209.35/209.51 |- skos__hiddenLabel mesh__D020813
% 209.35/209.51 Brain Derived Neurotrophic Factor Receptor
% 209.35/209.51 |- skos__historyNote mesh__D020813
% 209.35/209.51 Receptors, Growth Factor %28%1990-1993%29%
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D020813
% 209.35/209.51 2000; TRKB%28%GP145%29% PROTEIN was indexed under RECEPTORS, NERVE GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999, and under MEMBRANE GLYCOPROTEINS, PROTEIN-TYROSINE KINASE %26% RECEPTORS, GROWTH FACTOR 1990-1999; BDNF RECEPTOR was indexed under RECEPTORS, NERVE GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASE 1995-1999%A%
% 209.35/209.51 |- skos__hiddenLabel mesh__D020813 Receptor, NTRK2
% 209.35/209.51 |- skos__altLabel mesh__D020813 Brain-Derived Neurotrophic Factor Receptor
% 209.35/209.51 |- skos__historyNote mesh__D020813 Membrane Glycoproteins %28%1990-1993%29%
% 209.35/209.51 |- rdf__type mesh__D020813sskos__Concept
% 209.35/209.51 |- skos__broader mesh__D020813smesh__D017475
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020813 2006
% 209.35/209.51 |- mesh__dateEstablished mesh__D020813 2000-01-01
% 209.35/209.51 |- skos__hiddenLabel mesh__D020813 Receptor, BDNF
% 209.35/209.51 |- mesh__dateRevised mesh__D020813 2005-06-30
% 209.35/209.51 |- skos__altLabel mesh__D020813 NTRK2 Receptor
% 209.35/209.51 |- mesh__dateCreated mesh__D020813 1999-11-03
% 209.35/209.51 |- skos__altLabel mesh__D020813 trkB Receptor
% 209.35/209.51 |- skos__broader mesh__D020813smesh__D020794
% 209.35/209.51 |- skos__scopeNote mesh__D020813
% 209.35/209.51 A protein-tyrosine kinase receptor that is specific for BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; neurotrophin 4 and neurotrophin 5. It is widely expressed in nervous tissue and plays a role in mediating the effects of neurotrophins on growth and differentiation of neuronal cells.%A%
% 209.35/209.51 |- skos__altLabel mesh__D020813 trkB%28%gp145%29% Protein
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D020813 sjn
% 209.35/209.51 |- mesh__historyNote mesh__D020813
% 209.35/209.51 2000; for TRKB%28%GP145%29% PROTEIN use RECEPTOR, TYPE 2 NEUROTROPHIC TYROSINE KINASE %28%NM%29% 1990-1999; for BDNF RECEPTOR use RECEPTOR, TYPE 2 NEUROTROPHIC TYROSINE KINASE %28%NM%29% 1995-1999%A%
% 209.35/209.51 |- skos__altLabel mesh__D020813
% 209.35/209.51 Neurotrophic Factor, Brain-Derived, Receptor
% 209.35/209.51 |- mesh__recordMaintainer mesh__D020813 jmp
% 209.35/209.51 |- skos__altLabel mesh__D020813
% 209.35/209.51 Neurotrophic Tyrosine-Kinase Receptor Type 2
% 209.35/209.51 |- skos__historyNote mesh__D020813
% 209.35/209.51 Receptors, Nerve Growth Factor %28%1994-1999%29%
% 209.35/209.51 |- skos__historyNote mesh__D020813
% 209.35/209.51 Receptor Protein-Tyrosine Kinase %28%1994-1999%29%
% 209.35/209.51 |- skos__altLabel mesh__D020813
% 209.35/209.51 Receptor, Neurotrophic Tyrosine-Kinase Type 2
% 209.35/209.51 |- skos__altLabel mesh__D020813 BDNF Receptor
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006344 2006
% 209.35/209.51 |- skos__scopeNote mesh__D006344
% 209.35/209.51 Defects in the septum between the atria of the heart, due to failure of fusion between either the septum secundum or the septum primum and the endocardial cushions.%A%
% 209.35/209.51 |- skos__annotation mesh__D006344
% 209.35/209.51 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Foramen Ovales, Patent
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Atrial Septal Defect
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006344 2002
% 209.35/209.51 |- skos__prefLabel mesh__D006344 Heart Septal Defects, Atrial
% 209.35/209.51 |- skos__altLabel mesh__D006344 Atrial Septal Defects
% 209.35/209.51 |- mesh__dateRevised mesh__D006344 1999-11-03
% 209.35/209.51 |- mesh__recordOriginator mesh__D006344 NLM
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Septal Defect, Atrial
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Septal Defects, Atrial
% 209.35/209.51 |- skos__broader mesh__D006344smesh__D006343
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006344 2003
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Patent Foramen Ovales
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D006344 sjn
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006344 2004
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006344 2000
% 209.35/209.51 |- mesh__recordMaintainer mesh__D006344 kle
% 209.35/209.51 |- rdf__type mesh__D006344sskos__Concept
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Defects, Atrial Septal
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Defect, Atrial Septal
% 209.35/209.51 |- mesh__dateEstablished mesh__D006344 1964-01-01
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006344 2001
% 209.35/209.51 |- mesh__dateCreated mesh__D006344 1999-01-01
% 209.35/209.51 |- mesh__historyNote mesh__D006344 64
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Ovales, Patent Foramen
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006344 2005
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Ovale, Patent Foramen
% 209.35/209.51 |- skos__hiddenLabel mesh__D006344 Patent Foramen Ovale
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D006344 64
% 209.35/209.51 |- skos__altLabel mesh__D044463 Protease-Activated Receptor 1
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D044463 2005
% 209.35/209.51 |- skos__hiddenLabel mesh__D044463 Protease Activated Receptor 1
% 209.35/209.51 |- skos__hiddenLabel mesh__D044463 PAR 1 Receptor
% 209.35/209.51 |- skos__hiddenLabel mesh__D044463 Proteinase Activated Receptor 1
% 209.35/209.51 |- rdf__type mesh__D044463sskos__Concept
% 209.35/209.51 |- skos__historyNote mesh__D044463 Receptors, Thrombin %28%1997-2003%29%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D044463 2004
% 209.35/209.51 |- skos__altLabel mesh__D044463 PAR-1 Receptor
% 209.35/209.51 |- skos__hiddenLabel mesh__D044463 Receptor, PAR 1
% 209.35/209.51 |- skos__hiddenLabel mesh__D044463 Receptor, PAR1
% 209.35/209.51 |- skos__altLabel mesh__D044463 Proteinase-Activated Receptor 1
% 209.35/209.51 |- mesh__dateCreated mesh__D044463 2003-07-09
% 209.35/209.51 |- skos__broader mesh__D044463smesh__D018179
% 209.35/209.51 |- skos__altLabel mesh__D044463 PAR1 Receptor
% 209.35/209.51 |- skos__prefLabel mesh__D044463 Receptor, PAR-1
% 209.35/209.51 |- mesh__historyNote mesh__D044463
% 209.35/209.51 2004; use RECEPTOR, PROTEINASE-ACTIVATED 1 %28%NM%29% 1997-2003%A%
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D044463
% 209.35/209.51 2004; PROTEASE-ACTIVATED RECEPTOR-1 %28%now RECEPTOR, PROTIENASE-ACTIVATED%29% was indexed under RECEPTORS, THROMBIN 1997-2003%A%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D044463 2006
% 209.35/209.51 |- mesh__dateEstablished mesh__D044463 2004-01-01
% 209.35/209.51 |- skos__scopeNote mesh__D044463
% 209.35/209.51 A thrombin receptor subtype that couples to HETEROTRIMERIC GTP-BINDING PROTEINS resulting in the activation of a variety of signaling mechanisms including decreased intracellular CYCLIC AMP, increased PHOSPHOLIPASE C and increased PHOSPHOLIPASE A2.%A%
% 209.35/209.51 |- mesh__historyNote mesh__D011289 77
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 2004
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 1997
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 2001
% 209.35/209.51 |- skos__annotation mesh__D011289
% 209.35/209.51 do not use /compl for develop into leukemia
% 209.35/209.51 |- skos__broader mesh__D011289smesh__D011230
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 2003
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D011289 77
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 1996
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D011289 PLS
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 2000
% 209.35/209.51 |- mesh__recordOriginator mesh__D011289 VDK
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 2006
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 1999
% 209.35/209.51 |- mesh__recordMaintainer mesh__D011289 KEV
% 209.35/209.51 |- skos__hiddenLabel mesh__D011289 Preleukemias
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 2005
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 1998
% 209.35/209.51 |- mesh__dateCreated mesh__D011289 1976-04-27
% 209.35/209.51 |- skos__scopeNote mesh__D011289
% 209.35/209.51 Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.%A%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D011289 2002
% 209.35/209.51 |- mesh__dateRevised mesh__D011289 1995-06-08
% 209.35/209.51 |- skos__broader mesh__D011289smesh__D006402
% 209.35/209.51 |- mesh__dateEstablished mesh__D011289 1977-01-01
% 209.35/209.51 |- rdf__type mesh__D011289sskos__Concept
% 209.35/209.51 |- skos__prefLabel mesh__D011289 Preleukemia
% 209.35/209.51 |- skos__altLabel mesh__D016772 Infections, Mastigophora
% 209.35/209.51 |- mesh__historyNote mesh__D016772 92
% 209.35/209.51 |- skos__annotation mesh__D016772
% 209.35/209.51 protozoan infect; GEN: prefer specifics
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 2002
% 209.35/209.51 |- mesh__recordOriginator mesh__D016772 PXP
% 209.35/209.51 |- mesh__dateEstablished mesh__D016772 1992-01-01
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 2001
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 1997
% 209.35/209.51 |- rdf__type mesh__D016772sskos__Concept
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 1999
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D016772 PLS
% 209.35/209.51 |- skos__prefLabel mesh__D016772 Mastigophora Infections
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 1996
% 209.35/209.51 |- skos__hiddenLabel mesh__D016772 Infection, Mastigophora
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 2000
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 1995
% 209.35/209.51 |- mesh__recordMaintainer mesh__D016772 TGC
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 1998
% 209.35/209.51 |- mesh__dateRevised mesh__D016772 1993-06-02
% 209.35/209.51 |- skos__broader mesh__D016772smesh__D016771
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D016772 92
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 2004
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 1994
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 2006
% 209.35/209.51 |- mesh__dateCreated mesh__D016772 1991-05-02
% 209.35/209.51 |- skos__hiddenLabel mesh__D016772 Mastigophora Infection
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 2003
% 209.35/209.51 |- skos__scopeNote mesh__D016772
% 209.35/209.51 Infections with protozoa of the subphylum MASTIGOPHORA.%A%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016772 2005
% 209.35/209.51 |- rdf__type mesh__D002752sskos__Concept
% 209.35/209.51 |- mesh__recordMaintainer mesh__D002752 ssb
% 209.35/209.51 |- skos__scopeNote mesh__D002752
% 209.35/209.51 A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.%A%
% 209.35/209.51 |- skos__broader mesh__D002752smesh__D013449
% 209.35/209.51 |- skos__altLabel mesh__D002752 Chlorphthalidolone
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D002752 2006
% 209.35/209.51 |- skos__altLabel mesh__D002752 Oxodoline
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D002752 sjn
% 209.35/209.51 |- skos__altLabel mesh__D002752 Chlortalidone
% 209.35/209.51 |- mesh__recordOriginator mesh__D002752 NLM
% 209.35/209.51 |- skos__prefLabel mesh__D002752 Chlorthalidone
% 209.35/209.51 |- mesh__dateRevised mesh__D002752 2005-06-30
% 209.35/209.51 |- skos__broader mesh__D002752smesh__D001577
% 209.35/209.51 |- skos__altLabel mesh__D002752 Phthalamudine
% 209.35/209.51 |- mesh__dateCreated mesh__D002752 1999-01-01
% 209.35/209.51 |- skos__broader mesh__D002752smesh__D010797
% 209.35/209.51 |- skos__altLabel mesh__D048056 MAPK9 Mitogen-Activated Protein Kinase
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D048056 2005
% 209.35/209.51 |- rdf__type mesh__D048056sskos__Concept
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D048056 ags
% 209.35/209.51 |- mesh__dateCreated mesh__D048056 2004-07-07
% 209.35/209.51 |- mesh__recordMaintainer mesh__D048056 ags
% 209.35/209.51 |- skos__historyNote mesh__D048056
% 209.35/209.51 Mitogen-Activated Protein Kinases %28%2001-2004%29%
% 209.35/209.51 |- skos__prefLabel mesh__D048056 Mitogen-Activated Protein Kinase 9
% 209.35/209.51 |- skos__hiddenLabel mesh__D048056 Mitogen Activated Protein Kinase 9
% 209.35/209.51 |- skos__broader mesh__D048056smesh__D048031
% 209.35/209.51 |- skos__altLabel mesh__D048056 c-jun N-terminal Kinase 2
% 209.35/209.51 |- skos__hiddenLabel mesh__D048056 Stress Activated Protein Kinase JNK2
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D048056 2006A
% 209.35/209.51 |- mesh__dateRevised mesh__D048056 2005-07-07
% 209.35/209.51 |- skos__historyNote mesh__D048056 Protein Kinases %28%1994-2000%29%
% 209.35/209.51 |- skos__scopeNote mesh__D048056
% 209.35/209.51 A c-jun amino-terminal kinase that is activated by environmental stress and pro-inflammatory cytokines. Several isoforms of the protein with molecular sizes of 48 and 54 KD exist due to multiple ALTERNATIVE SPLICING.%A%
% 209.35/209.51 |- skos__altLabel mesh__D048056 Stress-Activated Protein Kinase JNK2
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D048056
% 209.35/209.51 2005; MITOGEN-ACTIVATED PROTEIN KINASE 9 was indexed under MITOGEN-ACITVATED PROTEIN KINASES 2001-2004; under PROTEIN KINASES 1994-2000%A%
% 209.35/209.51 |- skos__hiddenLabel mesh__D048056 Kinase-2, c-jun
% 209.35/209.51 |- skos__hiddenLabel mesh__D048056 JNK2 Stress Activated Protein Kinase
% 209.35/209.51 |- skos__altLabel mesh__D048056 c-jun Kinase-2
% 209.35/209.51 |- skos__altLabel mesh__D048056 JNK2 Kinase
% 209.35/209.51 |- skos__hiddenLabel mesh__D048056 MAPK9 Mitogen Activated Protein Kinase
% 209.35/209.51 |- skos__hiddenLabel mesh__D048056 c jun N terminal Kinase 2
% 209.35/209.51 |- mesh__historyNote mesh__D048056 2005%28%1994%29%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D048056 2006
% 209.35/209.51 |- skos__hiddenLabel mesh__D048056 c jun Kinase 2
% 209.35/209.51 |- mesh__recordOriginator mesh__D048056 jmp
% 209.35/209.51 |- skos__altLabel mesh__D048056 JNK2 Stress-Activated Protein Kinase
% 209.35/209.51 |- mesh__dateEstablished mesh__D048056 2005-01-01
% 209.35/209.51 |- skos__hiddenLabel mesh__D012382 Monohydrochloride, Rolitetracycline
% 209.35/209.51 |- skos__altLabel mesh__D012382 Pyrrolidinomethyltetracycline
% 209.35/209.51 |- skos__broader mesh__D012382smesh__D013754
% 209.35/209.51 |- mesh__dateCreated mesh__D012382 1999-01-01
% 209.35/209.51 |- skos__hiddenLabel mesh__D012382 Hydrochloride, Rolitetracycline
% 209.35/209.51 |- mesh__recordMaintainer mesh__D012382 ssb
% 209.35/209.51 |- skos__hiddenLabel mesh__D012382 Nitrate, Rolitetracycline
% 209.35/209.51 |- skos__altLabel mesh__D012382 Revrin
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D012382 2006
% 209.35/209.51 |- mesh__dateRevised mesh__D012382 2004-07-07
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D012382 2005
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D012382 sjn
% 209.35/209.51 |- skos__prefLabel mesh__D012382 Rolitetracycline
% 209.35/209.51 |- skos__hiddenLabel mesh__D012382
% 209.35/209.51 Sesquihydrate Rolitetracycline Mononitrate
% 209.35/209.51 |- skos__hiddenLabel mesh__D012382
% 209.35/209.51 Mononitrate, Sesquihydrate Rolitetracycline
% 209.35/209.51 |- rdf__type mesh__D012382sskos__Concept
% 209.35/209.51 |- skos__hiddenLabel mesh__D012382 Mononitrate, Rolitetracycline
% 209.35/209.51 |- mesh__recordOriginator mesh__D012382 NLM
% 209.35/209.51 |- skos__scopeNote mesh__D012382 A pyrrolidinylmethyl TETRACYCLINE.
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020814 2005
% 209.35/209.51 |- skos__broader mesh__D020814smesh__D004927
% 209.35/209.51 |- rdf__type mesh__D020814sskos__Concept
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020814 2002
% 209.35/209.51 |- skos__annotation mesh__D020814 DF: MENINGITIS E COLI
% 209.35/209.51 |- skos__hiddenLabel mesh__D020814 Meningitides, Escherichia coli
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020814 2006
% 209.35/209.51 |- skos__altLabel mesh__D020814 Escherichia coli Meningitis
% 209.35/209.51 |- mesh__dateEstablished mesh__D020814 2000-01-01
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D020814 2000
% 209.35/209.51 |- skos__broader mesh__D020814smesh__D016920
% 209.35/209.51 |- mesh__dateCreated mesh__D020814 1999-11-04
% 209.35/209.51 |- skos__scopeNote mesh__D020814
% 209.35/209.51 A form of gram-negative meningitis that tends to occur in neonates, in association with anatomical abnormalities %28%which feature communication between the meninges and cutaneous structures%29% or as OPPORTUNISTIC INFECTIONS in association with IMMUNOLOGIC DEFICIENCY SYNDROMES. In premature neonates the clinical presentation may be limited to ANOREXIA; VOMITING; lethargy; or respiratory distress. Full-term infants may have as additional features FEVER; SEIZURES; and bulging of the anterior fontanelle. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp398-400%29%%A%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020814 2003
% 209.35/209.51 |- skos__historyNote mesh__D020814 Meningitis, Bacterial %28%1966-1999%29%
% 209.35/209.51 |- skos__hiddenLabel mesh__D020814 Escherichia coli Meningitides
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020814 2000
% 209.35/209.51 |- mesh__historyNote mesh__D020814 2000
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020814 2004
% 209.35/209.51 |- skos__prefLabel mesh__D020814 Meningitis, Escherichia coli
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020814 2001
% 209.35/209.51 |- skos__hiddenLabel mesh__D006345 Septal Defect, Ventricular
% 209.35/209.51 |- mesh__dateCreated mesh__D006345 1999-01-01
% 209.35/209.51 |- mesh__historyNote mesh__D006345 64
% 209.35/209.51 |- skos__annotation mesh__D006345
% 209.35/209.51 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006345 2006
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006345 2001
% 209.35/209.51 |- skos__prefLabel mesh__D006345 Heart Septal Defects, Ventricular
% 209.35/209.51 |- skos__hiddenLabel mesh__D006345 Defect, Ventricular Septal
% 209.35/209.51 |- skos__broader mesh__D006345smesh__D006343
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006345 2005
% 209.35/209.51 |- skos__scopeNote mesh__D006345
% 209.35/209.51 Congenital defects in the septum between the cardiac ventricles, most often due to failure of the bulbar septum to completely close the interventricular foramen.%A%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006345 2004
% 209.35/209.51 |- mesh__recordOriginator mesh__D006345 NLM
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006345 2000
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006345 2003
% 209.35/209.51 |- mesh__dateRevised mesh__D006345 1999-11-03
% 209.35/209.51 |- skos__hiddenLabel mesh__D006345 Defects, Ventricular Septal
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D006345 sjn
% 209.35/209.51 |- skos__hiddenLabel mesh__D006345 Ventricular Septal Defect
% 209.35/209.51 |- skos__hiddenLabel mesh__D006345 Septal Defects, Ventricular
% 209.35/209.51 |- mesh__dateEstablished mesh__D006345 1964-01-01
% 209.35/209.51 |- rdf__type mesh__D006345sskos__Concept
% 209.35/209.51 |- skos__altLabel mesh__D006345 Ventricular Septal Defects
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D006345 2002
% 209.35/209.51 |- mesh__recordMaintainer mesh__D006345 kle
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D006345 64
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020016 2002
% 209.35/209.51 |- mesh__recordOriginator mesh__D020016 NNS
% 209.35/209.51 |- skos__scopeNote mesh__D020016
% 209.35/209.51 A hemostatic disorder characterized by a poor anticoagulant response to activated protein C %28%APC%29%. The activated form of Factor V %28%Factor Va%29% is more slowly degraded by activated protein C. Factor V Leiden mutation %28%R506Q%29% is the most common cause of APC resistance.%A%
% 209.35/209.51 |- mesh__dateRevised mesh__D020016 2001-07-25
% 209.35/209.51 |- skos__broader mesh__D020016smesh__D020147
% 209.35/209.51 |- skos__broader mesh__D020016smesh__D019851
% 209.35/209.51 |- mesh__historyNote mesh__D020016 99
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020016 2006
% 209.35/209.51 |- skos__broader mesh__D020016smesh__D025861
% 209.35/209.51 |- mesh__recordMaintainer mesh__D020016 nns
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020016 2003
% 209.35/209.51 |- mesh__dateCreated mesh__D020016 1998-06-10
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020016 2004
% 209.35/209.51 |- skos__hiddenLabel mesh__D020016 Resistance, APC
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D020016 sjn
% 209.35/209.51 |- skos__altLabel mesh__D020016 APC Resistance
% 209.35/209.51 |- mesh__dateEstablished mesh__D020016 1999-01-01
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D020016 99
% 209.35/209.51 |- skos__related mesh__D020016smesh__D020151
% 209.35/209.51 |- skos__prefLabel mesh__D020016 Activated Protein C Resistance
% 209.35/209.51 |- rdf__type mesh__D020016sskos__Concept
% 209.35/209.51 |- skos__historyNote mesh__D020016 Factor V/genetics %28%1994-1998%29%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D020016 2005
% 209.35/209.51 |- skos__historyNote mesh__D020016 Protein C %28%1993-1998%29%
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D044464 sjn
% 209.35/209.51 |- skos__altLabel mesh__D044464 Trypsin Receptor
% 209.35/209.51 |- skos__hiddenLabel mesh__D044464 Receptors, Trypsin
% 209.35/209.51 |- mesh__dateEstablished mesh__D044464 2004-01-01
% 209.35/209.51 |- skos__altLabel mesh__D044464 Protease-Activated Receptor 2
% 209.35/209.51 |- mesh__historyNote mesh__D044464
% 209.35/209.51 2004; use RECEPTOR, PAR-2 %28%NM%29% 1994-2003; for TRYPSIN RECEPTOR use RECEPTOR, PAR-2 %28%NM%29% 1986-2003%A%
% 209.35/209.51 |- mesh__recordMaintainer mesh__D044464 jmp
% 209.35/209.51 |- mesh__dateCreated mesh__D044464 2003-07-09
% 209.35/209.51 |- skos__hiddenLabel mesh__D044464 PAR 2 Receptor
% 209.35/209.51 |- skos__broader mesh__D044464smesh__D044462
% 209.35/209.51 |- skos__prefLabel mesh__D044464 Receptor, PAR-2
% 209.35/209.51 |- skos__hiddenLabel mesh__D044464 Receptor, PAR2
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D044464 2006
% 209.35/209.51 |- skos__altLabel mesh__D044464 Trypsin Receptors
% 209.35/209.51 |- skos__hiddenLabel mesh__D044464 Protease Activated Receptor 2
% 209.35/209.51 |- skos__altLabel mesh__D044464 PAR-2 Receptor
% 209.35/209.51 |- skos__broader mesh__D044464smesh__D043562
% 209.35/209.51 |- skos__scopeNote mesh__D044464
% 209.35/209.51 A G-protein-coupled, proteinase-activated receptor that is expressed in a variety of tissues including ENDOTHELIUM; LEUKOCYTES; and the GASTROINTESTINAL TRACT. The receptor is activated by TRYPSIN, which cleaves off the N-terminal peptide from the receptor. The new N-terminal peptide is a cryptic ligand for the receptor. The uncleaved receptor can also be activated by the N-terminal peptide present on the activated THROMBIN RECEPTOR and by small synthetic peptides that contain the unmasked N-terminal sequence.%A%
% 209.35/209.51 |- skos__altLabel mesh__D044464 Proteinase Activated Receptor 2
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D044464 2005
% 209.35/209.51 |- skos__hiddenLabel mesh__D044464 Receptor, PAR 2
% 209.35/209.51 |- rdf__type mesh__D044464sskos__Concept
% 209.35/209.51 |- skos__altLabel mesh__D044464 Receptor, Trypsin
% 209.35/209.51 |- skos__hiddenLabel mesh__D044464 Receptor 2, Protease-Activated
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D044464
% 209.35/209.51 2004; PROTEINASE ACTIVATED RECEPTOR 2 %28%now RECEPTOR, PAR-2%29% was indexed under RECEPTORS, THROMBIN 1994-2003; TRYPSIN RECEPTOR %28%now RECEPTOR, PAR-2%29% was indexed under RECEPTORS, CELL SURFACE 1986-2003%A%
% 209.35/209.51 |- mesh__recordOriginator mesh__D044464 jmp
% 209.35/209.51 |- skos__altLabel mesh__D044464 PAR2 Receptor
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D044464 2004
% 209.35/209.51 |- skos__historyNote mesh__D044464 Receptors, Thrombin %28%1994-2003%29%
% 209.35/209.51 |- mesh__dateCreated mesh__D016773 1991-05-02
% 209.35/209.51 |- mesh__historyNote mesh__D016773
% 209.35/209.51 92; was see LEISHMANIASIS 1979-91; ORIENTAL SORE was see LEISHMANIASIS 1979-91, was see under LEISHMANIASIS 1963-78%A%
% 209.35/209.51 |- skos__prefLabel mesh__D016773 Leishmaniasis, Cutaneous
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 1997
% 209.35/209.51 |- rdf__type mesh__D016773sskos__Concept
% 209.35/209.51 |- skos__altLabel mesh__D016773 Leishmaniasis, Old World
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D016773
% 209.35/209.51 92; was see LEISHMANIASIS 1979-91; ORIENTAL SORE was see LEISHMANIASIS 1979-91%A%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 1999
% 209.35/209.51 |- skos__hiddenLabel mesh__D016773 Leishmaniases, Cutaneous
% 209.35/209.51 |- skos__annotation mesh__D016773
% 209.35/209.51 caused by L. aethiopica, L. braziliensis, L. major, L. mexicana or L. tropica; LEISHMANIASIS, DIFFUSE CUTANEOUS %26% LEISHMANIASIS, MUCOCUTANEOUS are also available%A%
% 209.35/209.51 |- skos__hiddenLabel mesh__D016773 Cutaneous Leishmaniasis
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 1996
% 209.35/209.51 |- skos__hiddenLabel mesh__D016773 Sore, Oriental
% 209.35/209.51 |- skos__altLabel mesh__D016773 Leishmaniasis, American
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 2002
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 1995
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 1998
% 209.35/209.51 |- skos__broader mesh__D016773smesh__D007896
% 209.35/209.51 |- mesh__onlineNote mesh__D016773
% 209.35/209.51 use LEISHMANIASIS to search LEISHMANIASIS, CUTANEOUS 1979-91 %26% ORIENTAL SORE 1966-91%A%
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 2004
% 209.35/209.51 |- mesh__dateEstablished mesh__D016773 1992-01-01
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 2001
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 1994
% 209.35/209.51 |- skos__hiddenLabel mesh__D016773 Old World Leishmaniasis
% 209.35/209.51 |- skos__hiddenLabel mesh__D016773 Cutaneous Leishmaniases
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 2006
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D016773 PLS
% 209.35/209.51 |- skos__scopeNote mesh__D016773
% 209.35/209.51 An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.%A%
% 209.35/209.51 |- mesh__dateRevised mesh__D016773 1993-06-03
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 2003
% 209.35/209.51 |- mesh__recordMaintainer mesh__D016773 PXP
% 209.35/209.51 |- skos__hiddenLabel mesh__D016773 New World Leishmaniasis
% 209.35/209.51 |- skos__hiddenLabel mesh__D016773 American Leishmaniasis
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 2005
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D016773 2000
% 209.35/209.51 |- skos__historyNote mesh__D016773 Leishmaniasis %28%1966-1991%29%
% 209.35/209.51 |- mesh__recordOriginator mesh__D016773 PXP
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D002753
% 209.35/209.51 91; was see under BENZOXAZOLES 1966-90
% 209.35/209.51 |- mesh__dateRevised mesh__D002753 2005-06-30
% 209.35/209.51 |- skos__altLabel mesh__D002753 Ortho Brand of Chlorzoxazone
% 209.35/209.51 |- mesh__recordMaintainer mesh__D002753 lkw
% 209.35/209.51 |- rdf__type mesh__D002753sskos__Concept
% 209.35/209.51 |- mesh__dateEstablished mesh__D002753 1991-01-01
% 209.35/209.51 |- skos__broader mesh__D002753smesh__D001583
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D002753 2006
% 209.35/209.51 |- mesh__dateCreated mesh__D002753 1999-01-01
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D002753 sjn
% 209.35/209.51 |- skos__scopeNote mesh__D002753
% 209.35/209.51 A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. %28%From Martindale, The Extra Pharmacopoea, 30th ed, p1202%29%%A%
% 209.35/209.51 |- skos__prefLabel mesh__D002753 Chlorzoxazone
% 209.35/209.51 |- mesh__historyNote mesh__D002753
% 209.35/209.51 91%28%66%29%; was see under BENZOXAZOLES 1966-90
% 209.35/209.51 |- mesh__recordOriginator mesh__D002753 NLM
% 209.35/209.51 |- skos__altLabel mesh__D002753 McNeil Brand of Chlorzoxazone
% 209.35/209.51 |- skos__prefLabel mesh__D048057 Mitogen-Activated Protein Kinase 10
% 209.35/209.51 |- skos__hiddenLabel mesh__D048057 3F12 Kinase, p49
% 209.35/209.51 |- skos__altLabel mesh__D048057 c-jun N-Terminal Kinase 3
% 209.35/209.51 |- skos__altLabel mesh__D048057 p49%28%3F12%29% SAP Kinase
% 209.35/209.51 |- skos__historyNote mesh__D048057
% 209.35/209.51 Protein-Serine-Threonine Kinases %28%1995-1999%29%
% 209.35/209.51 |- skos__altLabel mesh__D048057
% 209.35/209.51 Mitogen Activated Protein Kinase p49%28%3F12%29%
% 209.35/209.51 |- mesh__recordOriginator mesh__D048057 jmp
% 209.35/209.51 |- skos__hiddenLabel mesh__D048057 c jun Kinase 3
% 209.35/209.51 |- mesh__dateEstablished mesh__D048057 2005-01-01
% 209.35/209.51 |- skos__historyNote mesh__D048057
% 209.35/209.51 Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 209.35/209.51 |- skos__altLabel mesh__D048057 MAP Kinase p49%28%3F12%29%
% 209.35/209.51 |- skos__altLabel mesh__D048057 p54-SAPK%28%beta%29%
% 209.35/209.51 |- skos__altLabel mesh__D048057 c-jun Kinase 3
% 209.35/209.51 |- skos__hiddenLabel mesh__D048057 Stress Activated Protein Kinase JNK3
% 209.35/209.51 |- skos__hiddenLabel mesh__D048057 Kinase 3, c-jun
% 209.35/209.51 |- skos__broader mesh__D048057smesh__D048031
% 209.35/209.51 |- mesh__publicMeSHNote mesh__D048057
% 209.35/209.51 2005; MITOGEN-ACTIVATED PROTEIN KINASE 10 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under PROTEIN-SERINE-THREONINE KINASES 1995-1999%A%
% 209.35/209.51 |- skos__altLabel mesh__D048057 MAPK10 Mitogen-Activated Protein Kinase
% 209.35/209.51 |- skos__hiddenLabel mesh__D048057 MAPK10 Mitogen Activated Protein Kinase
% 209.35/209.51 |- skos__altLabel mesh__D048057 Stress-Activated Protein Kinase JNK3
% 209.35/209.51 |- mesh__historyNote mesh__D048057 2005%28%1995%29%
% 209.35/209.51 |- skos__altLabel mesh__D048057 p49 3F12 Kinase
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D048057 2006
% 209.35/209.51 |- mesh__recordMaintainer mesh__D048057 jmp
% 209.35/209.51 |- skos__altLabel mesh__D048057 JNK3 Mitogen Activated Protein Kinase
% 209.35/209.51 |- mesh__recordAuthorizer mesh__D048057 sjn
% 209.35/209.51 |- mesh__activeMeSHYear mesh__D048057 2005
% 209.35/209.51 |- rdf__type mesh__D048057sskos__Concept
% 209.35/209.51 |- skos__hiddenLabel mesh__D048057 c jun N Terminal Kinase 3
% 209.35/209.51 |- skos__hiddenLabel mesh__D048057 Mitogen Activated Protein Kinase 10
% 209.35/209.51 |- mesh__dateCreated mesh__D048057 2004-07-07
% 209.35/209.51 |- skos__scopeNote mesh__D048057
% 209.35/209.51 A c-jun amino-terminal kinase that is found predominantly within NEURONS of the BRAIN, suggesting a role in stress-induced neuronal APOPTOSIS. Several isoforms of the protein with molecular sizes of 47 kDa and 52 kDa exist due to multiple ALTERNATIVE SPLICING.%A%
% 209.35/209.51 |- skos__altLabel mesh__D012383 Roumania
% 209.35/209.52 |- mesh__dateCreated mesh__D012383 1999-01-01
% 209.35/209.52 |- mesh__recordOriginator mesh__D012383 NLM
% 209.35/209.52 |- mesh__dateRevised mesh__D012383 1995-05-23
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 2004
% 209.35/209.52 |- skos__altLabel mesh__D012383 Rumania
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 2002
% 209.35/209.52 |- mesh__recordMaintainer mesh__D012383 KEV
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 2006
% 209.35/209.52 |- skos__annotation mesh__D012383
% 209.35/209.52 do not spell Roumania; despite current spelling, %28%RUM%29% continues to be the language symbol%A%
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 2003
% 209.35/209.52 |- skos__broader mesh__D012383smesh__D005061
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 2001
% 209.35/209.52 |- mesh__onlineNote mesh__D012383 use ROMANIA to search RUMANIA 1966-78
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 2005
% 209.35/209.52 |- rdf__type mesh__D012383sskos__Concept
% 209.35/209.52 |- mesh__historyNote mesh__D012383 79; was RUMANIA 1963-78
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 1997
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 2000
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 1999
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D012383 PLS
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 1996
% 209.35/209.52 |- skos__prefLabel mesh__D012383 Romania
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012383 1998
% 209.35/209.52 |- skos__prefLabel mesh__D020815 Polyproteins
% 209.35/209.52 |- mesh__dateEstablished mesh__D020815 2000-01-01
% 209.35/209.52 |- mesh__dateRevised mesh__D020815 2005-06-30
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D020815 sjn
% 209.35/209.52 |- mesh__recordOriginator mesh__D020815 nns
% 209.35/209.52 |- skos__broader mesh__D020815smesh__D011506
% 209.35/209.52 |- rdf__type mesh__D020815sskos__Concept
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D020815 2000; see PROTEINS 1988-1999
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D020815 2006
% 209.35/209.52 |- skos__scopeNote mesh__D020815
% 209.35/209.52 Proteins which are synthesized as a single polymer and then cleaved into several distinct proteins.%A%
% 209.35/209.52 |- mesh__recordMaintainer mesh__D020815 SYSTEM
% 209.35/209.52 |- mesh__historyNote mesh__D020815 2000; use PROTEINS 1988-1999
% 209.35/209.52 |- mesh__dateCreated mesh__D020815 1999-11-03
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D006346 sjn
% 209.35/209.52 |- skos__annotation mesh__D006346
% 209.35/209.52 /abnorm = HEART SEPTAL DEFECTS or its specifics; heart septal dis: coord IM with CARDIOMYOPATHIES %28%IM%29%%A%
% 209.35/209.52 |- mesh__recordMaintainer mesh__D006346 sjn
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D006346 2006
% 209.35/209.52 |- skos__prefLabel mesh__D006346 Heart Septum
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D006346 2005
% 209.35/209.52 |- mesh__historyNote mesh__D006346
% 209.35/209.52 HEART SEPTUM, ATRIAL %26% HEART SEPTUM, VENTRICULAR were headings 1963%A%
% 209.35/209.52 |- skos__hiddenLabel mesh__D006346 Septum, Heart
% 209.35/209.52 |- skos__altLabel mesh__D006346 Heart Septa
% 209.35/209.52 |- skos__altLabel mesh__D006346 Oval Foramen
% 209.35/209.52 |- skos__hiddenLabel mesh__D006346 Foramen, Oval
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D006346
% 209.35/209.52 HEART SEPTUM, ATRIAL %26% HEART SEPTUM, VENTRICULAR were headings 1963%A%
% 209.35/209.52 |- rdf__type mesh__D006346sskos__Concept
% 209.35/209.52 |- mesh__dateRevised mesh__D006346 2004-07-13
% 209.35/209.52 |- mesh__recordOriginator mesh__D006346 NLM
% 209.35/209.52 |- skos__hiddenLabel mesh__D006346 Septa, Heart
% 209.35/209.52 |- mesh__dateCreated mesh__D006346 1999-01-01
% 209.35/209.52 |- skos__broader mesh__D006346smesh__D006321
% 209.35/209.52 |- skos__scopeNote mesh__D006346
% 209.35/209.52 The thin membranous structure between the two heart atria or the thick muscular structure between the two heart ventricles.%A%
% 209.35/209.52 |- mesh__recordOriginator mesh__D044465 jls
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D044465 sjn
% 209.35/209.52 |- skos__hiddenLabel mesh__D044465 Races, Caucasoid
% 209.35/209.52 |- skos__broader mesh__D044465smesh__D044469
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D044465 2006
% 209.35/209.52 |- mesh__dateEstablished mesh__D044465 2004-01-01
% 209.35/209.52 |- skos__hiddenLabel mesh__D044465 Caucasian Races
% 209.35/209.52 |- skos__hiddenLabel mesh__D044465 Races, Caucasian
% 209.35/209.52 |- mesh__historyNote mesh__D044465 2004%28%1966%29%
% 209.35/209.52 |- skos__hiddenLabel mesh__D044465 Caucasoid Races
% 209.35/209.52 |- skos__altLabel mesh__D044465 Caucasian Race
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D044465 2005
% 209.35/209.52 |- rdf__type mesh__D044465sskos__Concept
% 209.35/209.52 |- mesh__dateCreated mesh__D044465 2003-07-14
% 209.35/209.52 |- skos__hiddenLabel mesh__D044465 Race, Caucasian
% 209.35/209.52 |- skos__annotation mesh__D044465 specify geog if relevant
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D044465 2004
% 209.35/209.52 |- mesh__recordMaintainer mesh__D044465 jls
% 209.35/209.52 |- skos__hiddenLabel mesh__D044465 White
% 209.35/209.52 |- skos__hiddenLabel mesh__D044465 Race, Caucasoid
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D044465
% 209.35/209.52 2004; see WHITES 1978-2003; see CAUCASOID RACE 1978-2003; see CAUCASIA RACE 1963-1977%A%
% 209.35/209.52 |- skos__scopeNote mesh__D044465
% 209.35/209.52 Individuals whose ancestral origins are in the continent of Europe.%A%
% 209.35/209.52 |- skos__prefLabel mesh__D044465 European Continental Ancestry Group
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 1995
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 1998
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D016774 PLS
% 209.35/209.52 |- mesh__dateRevised mesh__D016774 1993-06-03
% 209.35/209.52 |- skos__hiddenLabel mesh__D016774 Cutaneous Leishmaniasis, Diffuse
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 2004
% 209.35/209.52 |- mesh__recordMaintainer mesh__D016774 PXP
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 1994
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 2000
% 209.35/209.52 |- skos__hiddenLabel mesh__D016774 Diffuse Cutaneous Leishmaniases
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 2006
% 209.35/209.52 |- skos__scopeNote mesh__D016774
% 209.35/209.52 A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.%A%
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 2003
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D016774 92
% 209.35/209.52 |- skos__hiddenLabel mesh__D016774 Diffuse Cutaneous Leishmaniasis
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 2005
% 209.35/209.52 |- mesh__dateCreated mesh__D016774 1991-05-02
% 209.35/209.52 |- skos__annotation mesh__D016774
% 209.35/209.52 caused by L. aethiopica, L. braziliensis, L. mexicana or L. pifanoi; see MeSH definition for locales%A%
% 209.35/209.52 |- skos__hiddenLabel mesh__D016774 Cutaneous Leishmaniases, Diffuse
% 209.35/209.52 |- mesh__historyNote mesh__D016774 92
% 209.35/209.52 |- skos__prefLabel mesh__D016774 Leishmaniasis, Diffuse Cutaneous
% 209.35/209.52 |- skos__historyNote mesh__D016774 Leishmaniasis %28%1966-1991%29%
% 209.35/209.52 |- mesh__dateEstablished mesh__D016774 1992-01-01
% 209.35/209.52 |- rdf__type mesh__D016774sskos__Concept
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 2002
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 1997
% 209.35/209.52 |- mesh__recordOriginator mesh__D016774 PXP
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 1999
% 209.35/209.52 |- skos__broader mesh__D016774smesh__D016773
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 1996
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016774 2001
% 209.35/209.52 |- skos__hiddenLabel mesh__D016774 Leishmaniases, Diffuse Cutaneous
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002754 2004
% 209.35/209.52 |- rdf__type mesh__D002754sskos__Concept
% 209.35/209.52 |- mesh__recordOriginator mesh__D002754 VDK
% 209.35/209.52 |- mesh__recordMaintainer mesh__D002754 kle
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002754 2003
% 209.35/209.52 |- skos__scopeNote mesh__D002754
% 209.35/209.52 Congenital bony or membranous occlusion of one or both choanae, due to failure of the embryonic bucconasal membrane to rupture.%A%
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D002754 86
% 209.35/209.52 |- skos__broader mesh__D002754smesh__D009668
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002754 2002
% 209.35/209.52 |- skos__broader mesh__D002754smesh__D015619
% 209.35/209.52 |- mesh__historyNote mesh__D002754 86
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002754 2001
% 209.35/209.52 |- skos__altLabel mesh__D002754 Atresia, Choanal
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D002754 sjn
% 209.35/209.52 |- skos__prefLabel mesh__D002754 Choanal Atresia
% 209.35/209.52 |- mesh__dateRevised mesh__D002754 1999-11-03
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002754 2006
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002754 2000
% 209.35/209.52 |- mesh__dateEstablished mesh__D002754 1986-01-01
% 209.35/209.52 |- skos__historyNote mesh__D002754 Nose/abnormalities %28%1966-1974%29%
% 209.35/209.52 |- skos__annotation mesh__D002754
% 209.35/209.52 nose abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 209.35/209.52 |- skos__hiddenLabel mesh__D002754 Atresias, Choanal
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002754 2005
% 209.35/209.52 |- mesh__dateCreated mesh__D002754 1985-06-06
% 209.35/209.52 |- skos__historyNote mesh__D002754
% 209.35/209.52 Nasal Cavity/abnormalities %28%1975-1985%29%
% 209.35/209.52 |- skos__hiddenLabel mesh__D002754 Choanal Atresias
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 2003
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 2005
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 2004
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 2002
% 209.35/209.52 |- skos__annotation mesh__D012384
% 209.35/209.52 the city ancient or modern Rome: do not confuse with ROMAN WORLD %28%see MeSH definition%29%; Manual 36.14%A%
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 2006
% 209.35/209.52 |- mesh__recordOriginator mesh__D012384 NLM
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 1996
% 209.35/209.52 |- skos__broader mesh__D012384smesh__D007558
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 1998
% 209.35/209.52 |- mesh__dateRevised mesh__D012384 1994-05-12
% 209.35/209.52 |- skos__prefLabel mesh__D012384 Rome
% 209.35/209.52 |- rdf__type mesh__D012384sskos__Concept
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 1997
% 209.35/209.52 |- mesh__dateCreated mesh__D012384 1999-01-01
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 2000
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 1999
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 2001
% 209.35/209.52 |- mesh__recordMaintainer mesh__D012384 TGC
% 209.35/209.52 |- skos__broader mesh__D012384smesh__D002947
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D012384 PLS
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D012384 1995
% 209.35/209.52 |- skos__hiddenLabel mesh__D020816 Supersecondary Protein Structures
% 209.35/209.52 |- skos__scopeNote mesh__D020816
% 209.35/209.52 Commonly observed structural components of proteins formed by simple combinations of adjacent secondary structures. A commonly observed structure may be composed of a CONSERVED SEQUENCE which can be represented by a CONSENSUS SEQUENCE.%A%
% 209.35/209.52 |- skos__related mesh__D020816smesh__D016384
% 209.35/209.52 |- mesh__dateCreated mesh__D020816 1999-11-08
% 209.35/209.52 |- skos__altLabel mesh__D020816 Protein Motifs
% 209.35/209.52 |- mesh__recordOriginator mesh__D020816 nns
% 209.35/209.52 |- mesh__historyNote mesh__D020816 2000
% 209.35/209.52 |- skos__annotation mesh__D020816
% 209.35/209.52 IM general; coord NIM with specific protein %28%IM%29%; PROTEIN DOMAINS see PROTEIN STRUCTURE, TERTIARY is available; if the amino acid motif is a representative of conserved sequence then also index CONSENSUS SEQUENCE; DF: AA MOTIFS%A%
% 209.35/209.52 |- skos__hiddenLabel mesh__D020816 Motif, Amino Acid
% 209.35/209.52 |- skos__broader mesh__D020816smesh__D017433
% 209.35/209.52 |- skos__hiddenLabel mesh__D020816 Motifs, Protein
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D020816 2005
% 209.35/209.52 |- skos__hiddenLabel mesh__D020816 Protein Motif
% 209.35/209.52 |- skos__altLabel mesh__D020816 Supersecondary Protein Structure
% 209.35/209.52 |- mesh__dateRevised mesh__D020816 2004-07-07
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D020816 sjn
% 209.35/209.52 |- skos__hiddenLabel mesh__D020816 Motif, Protein
% 209.35/209.52 |- rdf__type mesh__D020816sskos__Concept
% 209.35/209.52 |- skos__related mesh__D020816smesh__D017124
% 209.35/209.52 |- skos__prefLabel mesh__D020816 Amino Acid Motifs
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D020816 2006
% 209.35/209.52 |- skos__hiddenLabel mesh__D020816 Amino Acid Motif
% 209.35/209.52 |- skos__hiddenLabel mesh__D020816 Protein Structures, Supersecondary
% 209.35/209.52 |- skos__altLabel mesh__D020816 Motifs, Amino Acid
% 209.35/209.52 |- mesh__recordMaintainer mesh__D020816 nns
% 209.35/209.52 |- mesh__dateEstablished mesh__D020816 2000-01-01
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D020816 2000
% 209.35/209.52 |- skos__broader mesh__D020816smesh__D000595
% 209.35/209.52 |- skos__broader mesh__D039521smesh__D018845
% 209.35/209.52 |- rdf__type mesh__D039521sskos__Concept
% 209.35/209.52 |- skos__hiddenLabel mesh__D039521 Leu M5 Antigens
% 209.35/209.52 |- mesh__historyNote mesh__D039521
% 209.35/209.52 2003; for CD11C ANTIGEN %26% ANTIGENS, CD11C use INTEGRIN ALPHAXBETA2 1995-2002%A%
% 209.35/209.52 |- mesh__recordOriginator mesh__D039521 MDJ
% 209.35/209.52 |- skos__scopeNote mesh__D039521
% 209.35/209.52 An integrin alpha subunit of approximately 150-kDa molecular weight. It is expressed at high levels on monocytes and combines with CD18 ANTIGEN to form the cell surface receptor INTEGRIN ALPHAXBETA2. The subunit contains a conserved I domain which is characteristic of several of alpha integrins.%A%
% 209.35/209.52 |- skos__hiddenLabel mesh__D039521 alphaX, Integrin
% 209.35/209.52 |- skos__broader mesh__D039521smesh__D039001
% 209.35/209.52 |- skos__hiddenLabel mesh__D039521 Antigens, Leu-M5
% 209.35/209.52 |- mesh__dateCreated mesh__D039521 2002-07-02
% 209.35/209.52 |- skos__altLabel mesh__D039521 Leu-M5 Antigens
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D039521 2006
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D039521
% 209.35/209.52 2003; for CD11C ANTIGEN %26% ANTIGENS, CD11C see COMPLEMENT 4-BINDING PROTEIN 1995-2002%A%
% 209.35/209.52 |- skos__altLabel mesh__D039521 Integrin alphaX
% 209.35/209.52 |- skos__historyNote mesh__D039521 Integrin alphaXbeta2 %28%1995-2002%29%
% 209.35/209.52 |- skos__prefLabel mesh__D039521 Antigens, CD11c
% 209.35/209.52 |- skos__altLabel mesh__D039521 CD11c Antigen
% 209.35/209.52 |- skos__hiddenLabel mesh__D039521 Antigen, CD11c
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D039521 sjn
% 209.35/209.52 |- mesh__recordMaintainer mesh__D039521 ssb
% 209.35/209.52 |- mesh__dateEstablished mesh__D039521 2003-01-01
% 209.35/209.52 |- skos__altLabel mesh__D039521 CD11c Antigens
% 209.35/209.52 |- mesh__dateRevised mesh__D039521 2005-06-30
% 209.35/209.52 |- skos__hiddenLabel mesh__D006347 Sounds, Cardiac
% 209.35/209.52 |- skos__related mesh__D006347smesh__D010701
% 209.35/209.52 |- mesh__recordOriginator mesh__D006347 NLM
% 209.35/209.52 |- mesh__dateRevised mesh__D006347 2003-07-09
% 209.35/209.52 |- skos__altLabel mesh__D006347 Cardiac Sounds
% 209.35/209.52 |- skos__annotation mesh__D006347
% 209.35/209.52 note category: do not confuse with HEART MURMURS, a disease concept%A%
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D006347
% 209.35/209.52 91; was see under HEART AUSCULTATION 1963-90; was in Cat E 1963-90%A%
% 209.35/209.52 |- skos__hiddenLabel mesh__D006347 Cardiac Sound
% 209.35/209.52 |- mesh__recordMaintainer mesh__D006347 nns
% 209.35/209.52 |- rdf__type mesh__D006347sskos__Concept
% 209.35/209.52 |- mesh__onlineNote mesh__D006347 search HEART AUSCULTATION 1966-74
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D006347 sjn
% 209.35/209.52 |- skos__hiddenLabel mesh__D006347 Sounds, Heart
% 209.35/209.52 |- mesh__dateCreated mesh__D006347 1999-01-01
% 209.35/209.52 |- skos__hiddenLabel mesh__D006347 Heart Sound
% 209.35/209.52 |- skos__related mesh__D006347smesh__D006326
% 209.35/209.52 |- mesh__historyNote mesh__D006347
% 209.35/209.52 91%28%75%29%; was see under HEART AUSCULTATION 1963-90; was in Cat E 1963-90%A%
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D006347 2006
% 209.35/209.52 |- skos__scopeNote mesh__D006347
% 209.35/209.52 The sounds heard over the cardiac region produced by the functioning of the heart. There are four distinct sounds: the first occurs at the beginning of SYSTOLE and is heard as a %22%lubb%22% sound; the second is produced by the closing of the AORTIC VALVE and PULMONARY VALVE and is heard as a %22%dupp%22% sound; the third is produced by vibrations of the ventricular walls when suddenly distended by the rush of blood from the HEART ATRIA; and the fourth is produced by atrial contraction and ventricular filling.%A%
% 209.35/209.52 |- skos__hiddenLabel mesh__D006347 Sound, Cardiac
% 209.35/209.52 |- skos__hiddenLabel mesh__D006347 Sound, Heart
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D006347 2004
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D006347 2005
% 209.35/209.52 |- skos__broader mesh__D006347smesh__D045472
% 209.35/209.52 |- mesh__dateEstablished mesh__D006347 1991-01-01
% 209.35/209.52 |- skos__prefLabel mesh__D006347 Heart Sounds
% 209.35/209.52 |- skos__related mesh__D006347smesh__D006337
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Dysfunctions, Psychosexual
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Disorder, Psychosexual
% 209.35/209.52 |- skos__altLabel mesh__D020018 Psychosexual Disorders
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Psychosexual Dysfunction
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D020018 sjn
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D020018 2006
% 209.35/209.52 |- mesh__dateCreated mesh__D020018 1997-07-14
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Dysfunctions, Psychological Sexual
% 209.35/209.52 |- skos__broader mesh__D020018smesh__D019968
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Disorders, Sexual Aversion
% 209.35/209.52 |- skos__prefLabel mesh__D020018 Sexual Dysfunctions, Psychological
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Disorders, Psychosexual
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Psychosexual Disorder
% 209.35/209.52 |- mesh__dateRevised mesh__D020018 2005-06-30
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Psychological Sexual Dysfunction
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Dysfunction, Psychosexual
% 209.35/209.52 |- skos__scopeNote mesh__D020018
% 209.35/209.52 Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty. %28%APA, DSM-IV, 1994%29%%A%
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Sexual Arousal Disorders
% 209.35/209.52 |- mesh__historyNote mesh__D020018 99%28%81%29%
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Sexual Aversion Disorders
% 209.35/209.52 |- mesh__recordOriginator mesh__D020018 JLS
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Arousal Disorders, Sexual
% 209.35/209.52 |- skos__altLabel mesh__D020018 Psychosexual Dysfunctions
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Disorders, Sexual Arousal
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Disorders, Orgasmic
% 209.35/209.52 |- mesh__dateEstablished mesh__D020018 1998-01-01
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Orgasmic Disorders
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Dysfunction, Psychological Sexual
% 209.35/209.52 |- rdf__type mesh__D020018sskos__Concept
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Sexual Dysfunction, Psychological
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Psychological Sexual Dysfunctions
% 209.35/209.52 |- mesh__recordMaintainer mesh__D020018 lkt
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D020018
% 209.35/209.52 99; see SEXUAL DYSFUNCTIONS 1998; see PSYCHOSEXUAL DISORDERS was heading 1981-98; for FRIGIDITY see FRIGIDITY 1966-97; for PSYCHOSEXUAL DISORDERS see PSYCHOSEXUAL DISORDERS 1981-97%A%
% 209.35/209.52 |- skos__hiddenLabel mesh__D020018 Aversion Disorders, Sexual
% 209.35/209.52 |- skos__historyNote mesh__D025501 6-Phosphofructokinase %28%1977-2001%29%
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D025501 2006
% 209.35/209.52 |- rdf__type mesh__D025501sskos__Concept
% 209.35/209.52 |- skos__prefLabel mesh__D025501 Phosphofructokinase-1, Liver Type
% 209.35/209.52 |- skos__hiddenLabel mesh__D025501 Phosphofructokinase 1, Liver Type
% 209.35/209.52 |- skos__altLabel mesh__D025501 Phosphofructo-1-kinase Isozyme B
% 209.35/209.52 |- mesh__historyNote mesh__D025501 2002
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D025501 2005
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D025501 2002
% 209.35/209.52 |- skos__altLabel mesh__D025501 6-Phosphofructokinase, Liver Type
% 209.35/209.52 |- mesh__dateCreated mesh__D025501 2001-07-25
% 209.35/209.52 |- skos__scopeNote mesh__D025501
% 209.35/209.52 An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In human liver, the 6-phosphofructose-1-kinase exists as the homotetramer of L subunits.%A%
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D025501 sjn
% 209.35/209.52 |- mesh__dateEstablished mesh__D025501 2002-01-01
% 209.35/209.52 |- mesh__dateRevised mesh__D025501 2004-07-13
% 209.35/209.52 |- mesh__recordMaintainer mesh__D025501 sjn
% 209.35/209.52 |- skos__broader mesh__D025501smesh__D010732
% 209.35/209.52 |- mesh__recordOriginator mesh__D025501 lkt
% 209.35/209.52 |- skos__hiddenLabel mesh__D044466 Asiatic Races
% 209.35/209.52 |- skos__prefLabel mesh__D044466 Asian Continental Ancestry Group
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D044466 sjn
% 209.35/209.52 |- skos__broader mesh__D044466smesh__D044469
% 209.35/209.52 |- mesh__dateCreated mesh__D044466 2003-07-09
% 209.35/209.52 |- skos__hiddenLabel mesh__D044466 Race, Mongoloid
% 209.35/209.52 |- skos__hiddenLabel mesh__D044466 Races, Mongoloid
% 209.35/209.52 |- mesh__recordOriginator mesh__D044466 jls
% 209.35/209.52 |- skos__altLabel mesh__D044466 Asiatic Race
% 209.35/209.52 |- rdf__type mesh__D044466sskos__Concept
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D044466 2006
% 209.35/209.52 |- mesh__historyNote mesh__D044466 2004%28%1966%29%
% 209.35/209.52 |- skos__scopeNote mesh__D044466
% 209.35/209.52 Individuals whose ancestral origins are in the continent of Asia.%A%
% 209.35/209.52 |- mesh__dateEstablished mesh__D044466 2004-01-01
% 209.35/209.52 |- skos__hiddenLabel mesh__D044466 Mongoloid Races
% 209.35/209.52 |- mesh__recordMaintainer mesh__D044466 jls
% 209.35/209.52 |- skos__hiddenLabel mesh__D044466 Races, Asiatic
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D044466 2005
% 209.35/209.52 |- skos__hiddenLabel mesh__D044466 Race, Asiatic
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D044466 2004
% 209.35/209.52 |- skos__hiddenLabel mesh__D044466 Asian
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D044466 2004; see Mongoloid Race 1966-2003
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 2006
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 2003
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 2001
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 2005
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D016775 PLS
% 209.35/209.52 |- mesh__dateRevised mesh__D016775 1993-06-03
% 209.35/209.52 |- mesh__historyNote mesh__D016775 92
% 209.35/209.52 |- skos__prefLabel mesh__D016775 Sarcodina Infections
% 209.35/209.52 |- skos__hiddenLabel mesh__D016775 Sarcodina Infection
% 209.35/209.52 |- skos__hiddenLabel mesh__D016775 Infection, Sarcodina
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 2000
% 209.35/209.52 |- skos__annotation mesh__D016775
% 209.35/209.52 protozoan infect; GEN or unspecified; most common infect is AMEBIASIS or its specifics%A%
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 1997
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D016775 92
% 209.35/209.52 |- rdf__type mesh__D016775sskos__Concept
% 209.35/209.52 |- mesh__recordOriginator mesh__D016775 PXP
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 1999
% 209.35/209.52 |- mesh__dateCreated mesh__D016775 1991-05-02
% 209.35/209.52 |- skos__scopeNote mesh__D016775
% 209.35/209.52 Infections with protozoa of the subphylum SARCODINA.
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 1996
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 1995
% 209.35/209.52 |- skos__altLabel mesh__D016775 Infections, Sarcodina
% 209.35/209.52 |- skos__broader mesh__D016775smesh__D016771
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 1998
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 2004
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 2002
% 209.35/209.52 |- mesh__recordMaintainer mesh__D016775 TGC
% 209.35/209.52 |- mesh__dateEstablished mesh__D016775 1992-01-01
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D016775 1994
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 2003
% 209.35/209.52 |- skos__historyNote mesh__D002755 Decision Making %28%1974%29%
% 209.35/209.52 |- skos__broader mesh__D002755smesh__D003657
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 1995
% 209.35/209.52 |- mesh__onlineNote mesh__D002755 search DECISION MAKING 1974
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 1999
% 209.35/209.52 |- skos__scopeNote mesh__D002755
% 209.35/209.52 The act of making a selection among two or more alternatives, usually after a period of deliberation.%A%
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 1994
% 209.35/209.52 |- mesh__dateCreated mesh__D002755 1999-01-01
% 209.35/209.52 |- skos__hiddenLabel mesh__D002755 Choice Behaviors
% 209.35/209.52 |- skos__hiddenLabel mesh__D002755 Behaviors, Choice
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 2006
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 1998
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D002755
% 209.35/209.52 79; was see under DECISION MAKING 1974-78; CAREER CHOICE was see under DECISION MAKING 1975-80%A%
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 1993
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 2002
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 2005
% 209.35/209.52 |- mesh__historyNote mesh__D002755
% 209.35/209.52 79%28%75%29%; was see under DECISION MAKING 1974-78
% 209.35/209.52 |- mesh__dateRevised mesh__D002755 1992-05-07
% 209.35/209.52 |- mesh__recordMaintainer mesh__D002755 TAP
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 1997
% 209.35/209.52 |- mesh__dateEstablished mesh__D002755 1979-01-01
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 2001
% 209.35/209.52 |- skos__hiddenLabel mesh__D002755 Behavior, Choice
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 2004
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 1996
% 209.35/209.52 |- mesh__recordOriginator mesh__D002755 NLM
% 209.35/209.52 |- rdf__type mesh__D002755sskos__Concept
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D002755 2000
% 209.35/209.52 |- skos__prefLabel mesh__D002755 Choice Behavior
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D002755 PLS
% 209.35/209.52 |- skos__scopeNote mesh__D007440
% 209.35/209.52 Introduction of a tube into a hollow organ to restore or maintain patency if obstructed. It is differentiated from CATHETERIZATION in that the insertion of a catheter is usually performed for the introducing or withdrawing of fluids from the body.%A%
% 209.35/209.52 |- mesh__dateRevised mesh__D007440 1997-06-20
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D007440 2003
% 209.35/209.52 |- skos__broader mesh__D007440smesh__D008919
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D007440 1999
% 209.35/209.52 |- mesh__dateCreated mesh__D007440 1999-01-01
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D007440 1998
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D007440 2006
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D007440 2002
% 209.35/209.52 |- mesh__publicMeSHNote mesh__D007440 66
% 209.35/209.52 |- skos__hiddenLabel mesh__D007440 Intubations
% 209.35/209.52 |- mesh__recordMaintainer mesh__D007440 TGC
% 209.35/209.52 |- skos__annotation mesh__D007440
% 209.35/209.52 do not use /util except by MeSH definition; for intub proced in dis, coord with dis /ther, not /surg; esophageal intub = ESOPHAGUS %28%IM%29% + INTUBATION %28%IM%29%, not INTUBATION, GASTROINTESTINAL; esophageal obturator airway = ESOPHAGUS %28%IM%29% + INTUBATION /instrum %28%IM%29%%A%
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D007440 2005
% 209.35/209.52 |- mesh__recordOriginator mesh__D007440 NLM
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D007440 2001
% 209.35/209.52 |- skos__related mesh__D007440smesh__D015505
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D007440 2004
% 209.35/209.52 |- rdf__type mesh__D007440sskos__Concept
% 209.35/209.52 |- skos__prefLabel mesh__D007440 Intubation
% 209.35/209.52 |- mesh__activeMeSHYear mesh__D007440 2000
% 209.35/209.52 |- mesh__historyNote mesh__D007440 66
% 209.35/209.52 |- mesh__recordAuthorizer mesh__D007440 SJN
% 209.35/209.52 |- mesh__dateEstablished mesh__D007440 1966-01-01
% 209.35/209.52 |- skos__altLabel mesh__D012385 Ronidazol
% 209.35/209.52 |- mesh__dateCreated mesh__D012385 1974-11-19
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D012385
% 209.35/209.53 91; was see under NITROIMIDAZOLES 1975-90
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012385 2006
% 209.35/209.53 |- mesh__dateEstablished mesh__D012385 1991-01-01
% 209.35/209.53 |- skos__prefLabel mesh__D012385 Ronidazole
% 209.35/209.53 |- skos__broader mesh__D012385smesh__D009593
% 209.35/209.53 |- mesh__dateRevised mesh__D012385 2005-06-30
% 209.35/209.53 |- rdf__type mesh__D012385sskos__Concept
% 209.35/209.53 |- skos__historyNote mesh__D012385 Nitroimidazoles %28%1974%29%
% 209.35/209.53 |- skos__historyNote mesh__D012385 Carbamates %28%1974%29%
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D012385 sjn
% 209.35/209.53 |- mesh__historyNote mesh__D012385
% 209.35/209.53 91%28%75%29%; was see under NITROIMIDAZOLES 1975-90
% 209.35/209.53 |- mesh__recordOriginator mesh__D012385 NLM
% 209.35/209.53 |- mesh__recordMaintainer mesh__D012385 ssb
% 209.35/209.53 |- skos__scopeNote mesh__D012385
% 209.35/209.53 Antiprotozoal and antimicrobial agent used mainly in veterinary practice.%A%
% 209.35/209.53 |- skos__altLabel mesh__D012385 Hesse Brand of Ronidazole
% 209.35/209.53 |- mesh__dateEstablished mesh__D020817 2000-01-01
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020817 2005
% 209.35/209.53 |- mesh__dateCreated mesh__D020817 1999-11-08
% 209.35/209.53 |- skos__prefLabel mesh__D020817 Asperger Syndrome
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020817 2004
% 209.35/209.53 |- skos__scopeNote mesh__D020817
% 209.35/209.53 A childhood disorder predominately affecting boys and similar to autism %28%AUTISTIC DISORDER%29%. It is characterized by severe, sustained, clinically significant impairment of social interaction, and restricted repetitive and stereotyped patterns of behavior. In contrast to autism, there are no clinically significant delays in language or cognitive development. %28%From DSM-IV%29%%A%
% 209.35/209.53 |- skos__altLabel mesh__D020817 Asperger%27%s Syndrome
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D020817 2000
% 209.35/209.53 |- skos__broader mesh__D020817smesh__D002659
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020817 2003
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020817 2002
% 209.35/209.53 |- skos__altLabel mesh__D020817 Asperger%27%s Disorder
% 209.35/209.53 |- skos__hiddenLabel mesh__D020817 Asperger Disorder
% 209.35/209.53 |- mesh__historyNote mesh__D020817 2000
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020817 2001
% 209.35/209.53 |- skos__hiddenLabel mesh__D020817 Aspergers Syndrome
% 209.35/209.53 |- rdf__type mesh__D020817sskos__Concept
% 209.35/209.53 |- skos__historyNote mesh__D020817 Autistic Disorder %28%1981-1999%29%
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020817 2006
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020817 2000
% 209.35/209.53 |- skos__hiddenLabel mesh__D020817 Aspergers Disorder
% 209.35/209.53 |- skos__altLabel mesh__D006348 Procedure, Cardiac Surgical
% 209.35/209.53 |- skos__related mesh__D006348smesh__D013903
% 209.35/209.53 |- rdf__type mesh__D006348sskos__Concept
% 209.35/209.53 |- mesh__dateCreated mesh__D006348 1999-01-01
% 209.35/209.53 |- skos__altLabel mesh__D006348 Surgical Procedures, Heart
% 209.35/209.53 |- skos__altLabel mesh__D006348 Heart Surgical Procedure
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D006348 98; was HEART SURGERY 1963-97
% 209.35/209.53 |- skos__altLabel mesh__D006348 Heart Surgical Procedures
% 209.35/209.53 |- mesh__recordOriginator mesh__D006348 NLM
% 209.35/209.53 |- skos__prefLabel mesh__D006348 Cardiac Surgical Procedures
% 209.35/209.53 |- skos__annotation mesh__D006348
% 209.35/209.53 GEN only: do not use for surg of specific part of heart %28% = specific heart term /surg%29% or specific heart dis %28% = disease /surg%29%; HEART TRANSPLANTATION %26% HEART-LUNG TRANSPLANTATION are also available%A%
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D006348 2006
% 209.35/209.53 |- skos__altLabel mesh__D006348 Procedure, Heart Surgical
% 209.35/209.53 |- mesh__historyNote mesh__D006348 98; was HEART SURGERY 1963-97
% 209.35/209.53 |- skos__broader mesh__D006348smesh__D019616
% 209.35/209.53 |- skos__altLabel mesh__D006348 Procedures, Cardiac Surgical
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D006348 sjn
% 209.35/209.53 |- skos__scopeNote mesh__D006348 Surgery performed on the heart.
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D006348 2004
% 209.35/209.53 |- skos__altLabel mesh__D006348 Surgical Procedures, Cardiac
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D006348 2005
% 209.35/209.53 |- mesh__recordMaintainer mesh__D006348 jls
% 209.35/209.53 |- skos__altLabel mesh__D006348 Procedures, Heart Surgical
% 209.35/209.53 |- skos__broader mesh__D006348smesh__D013504
% 209.35/209.53 |- mesh__dateRevised mesh__D006348 2002-07-03
% 209.35/209.53 |- skos__altLabel mesh__D006348 Cardiac Surgical Procedure
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D006348 2003
% 209.35/209.53 |- skos__altLabel mesh__D006348 Surgical Procedure, Heart
% 209.35/209.53 |- skos__altLabel mesh__D006348 Surgical Procedure, Cardiac
% 209.35/209.53 |- skos__related mesh__D020019smesh__D013621
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020019 2003
% 209.35/209.53 |- mesh__recordMaintainer mesh__D020019 ags
% 209.35/209.53 |- mesh__historyNote mesh__D020019 1999
% 209.35/209.53 |- skos__scopeNote mesh__D020019
% 209.35/209.53 Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA %28%primarily T. solium in humans%29%. Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. %28%From Joynt, Clinical Neurology, 1998, Ch27, pp46-50%29%%A%
% 209.35/209.53 |- skos__altLabel mesh__D020019 Cysticercosis, Brain
% 209.35/209.53 |- skos__altLabel mesh__D020019 Central Nervous System Cysticercosis
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020019 2000A
% 209.35/209.53 |- skos__historyNote mesh__D020019 Brain Diseases %28%1966-1998%29%
% 209.35/209.53 |- rdf__type mesh__D020019sskos__Concept
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020019 2002
% 209.35/209.53 |- mesh__dateCreated mesh__D020019 1998-06-10
% 209.35/209.53 |- skos__annotation mesh__D020019
% 209.35/209.53 coord IM with specific site/dis term %28%IM%29% if pertinent
% 209.35/209.53 |- skos__prefLabel mesh__D020019 Neurocysticercosis
% 209.35/209.53 |- skos__broader mesh__D020019smesh__D003551
% 209.35/209.53 |- skos__historyNote mesh__D020019 Cysticercosis %28%1966-1998%29%
% 209.35/209.53 |- mesh__dateRevised mesh__D020019 1999-12-13
% 209.35/209.53 |- mesh__dateEstablished mesh__D020019 1999-01-01
% 209.35/209.53 |- skos__broader mesh__D020019smesh__D020809
% 209.35/209.53 |- mesh__recordOriginator mesh__D020019 AGS
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D020019 1999
% 209.35/209.53 |- skos__hiddenLabel mesh__D020019 Brain Cysticercosis
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D020019 ags
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020019 2006
% 209.35/209.53 |- skos__altLabel mesh__D020019 Cysticercosis, Central Nervous System
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020019 2001
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020019 2004
% 209.35/209.53 |- skos__hiddenLabel mesh__D020019 Neurocysticercoses
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020019 2000
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020019 2005
% 209.35/209.53 |- rdf__type mesh__D025502sskos__Concept
% 209.35/209.53 |- mesh__dateRevised mesh__D025502 2003-07-09
% 209.35/209.53 |- skos__altLabel mesh__D025502 6-Phosphofructokinase, Platelet Type
% 209.35/209.53 |- skos__altLabel mesh__D025502 Phosphofructo-1-kinase Isozyme C
% 209.35/209.53 |- skos__historyNote mesh__D025502 6-Phosphofructokinase %28%1977-2001%29%
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D025502 2006
% 209.35/209.53 |- mesh__dateEstablished mesh__D025502 2002-01-01
% 209.35/209.53 |- mesh__dateCreated mesh__D025502 2001-07-25
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D025502 2005
% 209.35/209.53 |- mesh__historyNote mesh__D025502 2002
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D025502 2002
% 209.35/209.53 |- skos__prefLabel mesh__D025502 Phosphofructokinase-1, Type C
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D025502 2004
% 209.35/209.53 |- skos__broader mesh__D025502smesh__D010732
% 209.35/209.53 |- skos__scopeNote mesh__D025502
% 209.35/209.53 An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In the humans, 6-phosphofructose-1-kinase isozyme C is found in platelets, brain, heart, kidney, colon and testis. This isozyme C can exist as the homotetramer of C subunits %28%P subunits%29%, or heterotetramer of C type and L type subunits.%A%
% 209.35/209.53 |- skos__hiddenLabel mesh__D025502 Phosphofructokinase 1, Type C
% 209.35/209.53 |- skos__annotation mesh__D003050
% 209.35/209.53 a bone of the spine; do not confuse with COCCYGEAL REGION, merely locational; coord IM with specific disease %28%IM%29%%A%
% 209.35/209.53 |- mesh__recordMaintainer mesh__D003050 sjn
% 209.35/209.53 |- mesh__dateCreated mesh__D003050 1999-01-01
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 1992
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 1998
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 2006
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 2001
% 209.35/209.53 |- skos__broader mesh__D003050smesh__D013131
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 1993
% 209.35/209.53 |- mesh__dateRevised mesh__D003050 2002-10-23
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 1999
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 2003
% 209.35/209.53 |- rdf__type mesh__D003050sskos__Concept
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 1991
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 1996
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 2004
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 2003A
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 1997
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 2002
% 209.35/209.53 |- mesh__recordOriginator mesh__D003050 NLM
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 1994
% 209.35/209.53 |- skos__prefLabel mesh__D003050 Coccyx
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D003050 sjn
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 1995
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 2000
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003050 2005
% 209.35/209.53 |- skos__prefLabel mesh__D044467 American Native Continental Ancestry Group
% 209.35/209.53 |- mesh__dateCreated mesh__D044467 2003-07-09
% 209.35/209.53 |- mesh__dateEstablished mesh__D044467 2004-01-01
% 209.35/209.53 |- mesh__historyNote mesh__D044467 2004
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D044467 2005
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D044467 2004
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D044467 sjn
% 209.35/209.53 |- rdf__type mesh__D044467sskos__Concept
% 209.35/209.53 |- skos__broader mesh__D044467smesh__D044469
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D044467 2006
% 209.35/209.53 |- skos__scopeNote mesh__D044467
% 209.35/209.53 Individuals whose ancestral origins are in the continents of the Americas.%A%
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D044467 2004
% 209.35/209.53 |- mesh__recordMaintainer mesh__D044467 jls
% 209.35/209.53 |- mesh__recordOriginator mesh__D044467 jls
% 209.35/209.53 |- mesh__dateEstablished mesh__D049950 2006-01-01
% 209.35/209.53 |- skos__altLabel mesh__D049950 Primary Hyperparathyroidism
% 209.35/209.53 |- mesh__recordOriginator mesh__D049950 lkt
% 209.35/209.53 |- skos__hiddenLabel mesh__D049950 Primary Hyperparathyroidisms
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D049950 2006
% 209.35/209.53 |- skos__prefLabel mesh__D049950 Hyperparathyroidism, Primary
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D049950 sjn
% 209.35/209.53 |- mesh__historyNote mesh__D049950 2006
% 209.35/209.53 |- skos__scopeNote mesh__D049950
% 209.35/209.53 A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.%A%
% 209.35/209.53 |- skos__broader mesh__D049950smesh__D006961
% 209.35/209.53 |- skos__historyNote mesh__D049950 Hyperparathyroidism %28%1964-2005%29%
% 209.35/209.53 |- rdf__type mesh__D049950sskos__Concept
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D049950 2006
% 209.35/209.53 |- mesh__recordMaintainer mesh__D049950 lkt
% 209.35/209.53 |- skos__hiddenLabel mesh__D049950 Hyperparathyroidisms, Primary
% 209.35/209.53 |- mesh__dateCreated mesh__D049950 2005-06-30
% 209.35/209.53 |- skos__historyNote mesh__D016776
% 209.35/209.53 Intestinal Diseases, Parasitic %28%1983-1991%29%
% 209.35/209.53 |- skos__broader mesh__D016776smesh__D007411
% 209.35/209.53 |- mesh__dateEstablished mesh__D016776 1992-01-01
% 209.35/209.53 |- skos__broader mesh__D016776smesh__D000562
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D016776 sjn
% 209.35/209.53 |- mesh__historyNote mesh__D016776 92
% 209.35/209.53 |- skos__altLabel mesh__D016776 Infections, Blastocystis
% 209.35/209.53 |- skos__hiddenLabel mesh__D016776 Blastocystis Infection
% 209.35/209.53 |- skos__historyNote mesh__D016776 Protozoan Infections %28%1983-1991%29%
% 209.35/209.53 |- rdf__type mesh__D016776sskos__Concept
% 209.35/209.53 |- mesh__dateCreated mesh__D016776 1991-05-02
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D016776 2005
% 209.35/209.53 |- skos__prefLabel mesh__D016776 Blastocystis Infections
% 209.35/209.53 |- mesh__recordMaintainer mesh__D016776 sjn
% 209.35/209.53 |- skos__scopeNote mesh__D016776
% 209.35/209.53 Infections with PROTOZOA of the genus BLASTOCYSTIS. The species B. hominis is responsible for most infections. Parasitologic surveys have generally found small numbers of this species in human stools, but higher positivity rates and organism numbers in AIDS patients and other immunosuppressed patients %28%IMMUNOCOMPROMISED HOST%29%. Symptoms include ABDOMINAL PAIN; DIARRHEA; CONSTIPATION; VOMITING; and FATIGUE.%A%
% 209.35/209.53 |- skos__hiddenLabel mesh__D016776 Infection, Blastocystis
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D016776 92
% 209.35/209.53 |- mesh__dateRevised mesh__D016776 2004-07-13
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D016776 2006
% 209.35/209.53 |- mesh__recordOriginator mesh__D016776 PXP
% 209.35/209.53 |- skos__altLabel mesh__D002756 Cholagogues, Choleretics
% 209.35/209.53 |- mesh__dateCreated mesh__D002756 1999-01-01
% 209.35/209.53 |- skos__altLabel mesh__D002756 Choleretics and Cholagogues
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D002756 2006
% 209.35/209.53 |- skos__annotation mesh__D002756 DF: CHOLAGOGUES
% 209.35/209.53 |- skos__scopeNote mesh__D002756
% 209.35/209.53 Gastrointestinal agents that stimulate the flow of bile into the duodenum %28%cholagogues%29% or stimulate the production of bile by the liver %28%choleretic%29%.%A%
% 209.35/209.53 |- skos__prefLabel mesh__D002756 Cholagogues and Choleretics
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D002756 sjn
% 209.35/209.53 |- mesh__recordOriginator mesh__D002756 NLM
% 209.35/209.53 |- skos__broader mesh__D002756smesh__D005765
% 209.35/209.53 |- rdf__type mesh__D002756sskos__Concept
% 209.35/209.53 |- mesh__recordMaintainer mesh__D002756 ssb
% 209.35/209.53 |- mesh__dateRevised mesh__D002756 2005-06-30
% 209.35/209.53 |- mesh__recordOriginator mesh__D007441 NLM
% 209.35/209.53 |- skos__prefLabel mesh__D007441 Intubation, Gastrointestinal
% 209.35/209.53 |- skos__broader mesh__D007441smesh__D007440
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D007441 sjn
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D007441
% 209.35/209.53 66; DUODENAL INTUBATION was heading 1963-65
% 209.35/209.53 |- mesh__dateEstablished mesh__D007441 1966-01-01
% 209.35/209.53 |- mesh__dateCreated mesh__D007441 1999-01-01
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D007441 2006
% 209.35/209.53 |- skos__hiddenLabel mesh__D007441 Intubations, Nasogastric
% 209.35/209.53 |- mesh__dateRevised mesh__D007441 2001-07-25
% 209.35/209.53 |- skos__annotation mesh__D007441
% 209.35/209.53 do not use /util except by MeSH definition; for intub in dis, coord with dis /ther, not /surg; esophageal intub %26% esophageal obturator airway do not go here: see note on INTUBATION%A%
% 209.35/209.53 |- skos__hiddenLabel mesh__D007441 Nasogastric Intubation
% 209.35/209.53 |- skos__hiddenLabel mesh__D007441 Gastrointestinal Intubation
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D007441 2005
% 209.35/209.53 |- mesh__recordMaintainer mesh__D007441 lkt
% 209.35/209.53 |- mesh__historyNote mesh__D007441
% 209.35/209.53 66; DUODENAL INTUBATION was heading 1963-65
% 209.35/209.53 |- rdf__type mesh__D007441sskos__Concept
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D007441 2004
% 209.35/209.53 |- skos__hiddenLabel mesh__D007441 Intubations, Gastrointestinal
% 209.35/209.53 |- skos__scopeNote mesh__D007441
% 209.35/209.53 The insertion of a tube into the stomach, intestines, or other portion of the gastrointestinal tract to allow for the passage of food products, etc.%A%
% 209.35/209.53 |- skos__hiddenLabel mesh__D007441 Gastrointestinal Intubations
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D007441 2002
% 209.35/209.53 |- skos__hiddenLabel mesh__D007441 Nasogastric Intubations
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D007441 2003
% 209.35/209.53 |- mesh__recordOriginator mesh__D012386 EC
% 209.35/209.53 |- rdf__type mesh__D012386sskos__Concept
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 1997
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 1994
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 1999
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 1993
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 2000
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 1995
% 209.35/209.53 |- skos__prefLabel mesh__D012386 Rooming-in Care
% 209.35/209.53 |- skos__hiddenLabel mesh__D012386 Rooming-in Cares
% 209.35/209.53 |- skos__hiddenLabel mesh__D012386 Care, Rooming-in
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D012386
% 209.35/209.53 91; was see under INFANT CARE 1979-90
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D012386 PLS
% 209.35/209.53 |- mesh__recordMaintainer mesh__D012386 TGC
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 2003
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 2001
% 209.35/209.53 |- skos__scopeNote mesh__D012386
% 209.35/209.53 Care of the newborn infant in a crib near the mother%27%s bed, instead of in a nursery, during the hospital stay.%A%
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 2005
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 2004
% 209.35/209.53 |- skos__hiddenLabel mesh__D012386 Rooming in Care
% 209.35/209.53 |- mesh__historyNote mesh__D012386
% 209.35/209.53 91%28%79%29%; was see under INFANT CARE 1979-90
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 2006
% 209.35/209.53 |- mesh__dateCreated mesh__D012386 1978-05-10
% 209.35/209.53 |- skos__annotation mesh__D012386
% 209.35/209.53 care of a neonate in a crib near the mother%27%s bed in a hosp; check the tag INFANT, NEWBORN%A%
% 209.35/209.53 |- skos__hiddenLabel mesh__D012386 Cares, Rooming-in
% 209.35/209.53 |- mesh__dateRevised mesh__D012386 1992-05-18
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 2002
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 1996
% 209.35/209.53 |- skos__broader mesh__D012386smesh__D007224
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D012386 1998
% 209.35/209.53 |- mesh__dateEstablished mesh__D012386 1991-01-01
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D020818 sjn
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020818 2004
% 209.35/209.53 |- skos__annotation mesh__D020818
% 209.35/209.53 coord IM with precoord organism/infection %28%IM%29% and specific site/dis term %28%IM%29% if pertinent%A%
% 209.35/209.53 |- skos__hiddenLabel mesh__D020818 Myeloradiculopathies, Schistosomal
% 209.35/209.53 |- skos__scopeNote mesh__D020818
% 209.35/209.53 SCHISTOSOMIASIS of the brain, spinal cord, or meninges caused by infections with trematodes of the genus SCHISTOSOMA %28%primarily SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; and SCHISTOSOMA HAEMATOBIUM in humans%29%. S. japonicum infections of the nervous system may cause an acute meningoencephalitis or a chronic encephalopathy. S. mansoni and S. haematobium nervous system infections are associated with acute transverse myelitis involving the lower portions of the spinal cord. %28%From Joynt, Clinical Neurology, 1998, Ch27, pp61-2%29%%A%
% 209.35/209.53 |- skos__altLabel mesh__D020818 Central Nervous System Schistosomiasis
% 209.35/209.53 |- skos__prefLabel mesh__D020818 Neuroschistosomiasis
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020818 2003
% 209.35/209.53 |- mesh__historyNote mesh__D020818 2000
% 209.35/209.53 |- skos__historyNote mesh__D020818 Schistosomiasis %28%1965-1999%29%
% 209.35/209.53 |- mesh__recordOriginator mesh__D020818 KEV
% 209.35/209.53 |- mesh__dateCreated mesh__D020818 1999-11-03
% 209.35/209.53 |- mesh__dateRevised mesh__D020818 2001-07-25
% 209.35/209.53 |- skos__hiddenLabel mesh__D020818 Myelitis, Schistosomal
% 209.35/209.53 |- rdf__type mesh__D020818sskos__Concept
% 209.35/209.53 |- skos__hiddenLabel mesh__D020818 Schistosomal Myelopathies
% 209.35/209.53 |- skos__hiddenLabel mesh__D020818 Neuroschistosomiases
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D020818 2000
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020818 2006
% 209.35/209.53 |- skos__hiddenLabel mesh__D020818 Myeloradiculopathy, Schistosomal
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020818 2002
% 209.35/209.53 |- skos__hiddenLabel mesh__D020818 Schistosomal Myeloradiculopathies
% 209.35/209.53 |- skos__broader mesh__D020818smesh__D012552
% 209.35/209.53 |- skos__hiddenLabel mesh__D020818 Myelopathies, Schistosomal
% 209.35/209.53 |- mesh__dateEstablished mesh__D020818 2000-01-01
% 209.35/209.53 |- mesh__recordMaintainer mesh__D020818 nns
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D020818 2005
% 209.35/209.53 |- skos__broader mesh__D020818smesh__D020809
% 209.35/209.53 |- skos__hiddenLabel mesh__D020818 Myelopathy, Schistosomal
% 209.35/209.53 |- skos__altLabel mesh__D020818 Schistosomiasis, Central Nervous System
% 209.35/209.53 |- rdf__type mesh__D006349sskos__Concept
% 209.35/209.53 |- mesh__dateEstablished mesh__D006349 1967-01-01
% 209.35/209.53 |- skos__historyNote mesh__D006349 specific heart valve disease
% 209.35/209.53 |- skos__broader mesh__D006349smesh__D006331
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D006349 2005
% 209.35/209.53 |- skos__prefLabel mesh__D006349 Heart Valve Diseases
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Heart Valve Disease
% 209.35/209.53 |- skos__annotation mesh__D006349
% 209.35/209.53 coord IM with specific valve %28%IM%29%
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D006349
% 209.35/209.53 67; AORTIC VALVE DISEASES was heading 1963-66
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D006349 2006
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Valvular Heart Disease
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D006349 2003
% 209.35/209.53 |- skos__scopeNote mesh__D006349
% 209.35/209.53 Diseases caused by or resulting in abnormal functioning of heart valves.%A%
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Heart Diseases, Valvular
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Disease, Heart Valve
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Disease, Valvular Heart
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Valve Diseases, Heart
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D006349 2004
% 209.35/209.53 |- mesh__onlineNote mesh__D006349
% 209.35/209.53 use HEART VALVE DISEASES to search AORTIC VALVE DISEASES 1966%A%
% 209.35/209.53 |- mesh__recordMaintainer mesh__D006349 nns
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Valve Disease, Heart
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Diseases, Heart Valve
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D006349 2002
% 209.35/209.53 |- mesh__dateRevised mesh__D006349 2001-07-25
% 209.35/209.53 |- skos__altLabel mesh__D006349 Valvular Heart Diseases
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Heart Disease, Valvular
% 209.35/209.53 |- mesh__recordOriginator mesh__D006349 NLM
% 209.35/209.53 |- skos__hiddenLabel mesh__D006349 Diseases, Valvular Heart
% 209.35/209.53 |- mesh__dateCreated mesh__D006349 1999-01-01
% 209.35/209.53 |- skos__historyNote mesh__D006349 Heart Diseases %28%1966%29%
% 209.35/209.53 |- mesh__historyNote mesh__D006349
% 209.35/209.53 67; AORTIC VALVE DISEASES was heading 1963-66
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D006349 sjn
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 1993
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 1999
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 2003
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 2000
% 209.35/209.53 |- rdf__type mesh__D003051sskos__Concept
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D003051
% 209.35/209.53 COCHLEAR DUCT was DUCTUS COCHLEARIS see under LABYRINTH 1963-78; BASILAR MEMBRANE was see under LABYRINTH 1960-89%A%
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 1996
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 2004
% 209.35/209.53 |- skos__hiddenLabel mesh__D003051 Cochleas
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 1997
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 2001
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D003051 PLS
% 209.35/209.53 |- skos__related mesh__D003051smesh__D017084
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 1994
% 209.35/209.53 |- mesh__dateRevised mesh__D003051 1992-05-07
% 209.35/209.53 |- mesh__recordMaintainer mesh__D003051 MXR
% 209.35/209.53 |- skos__broader mesh__D003051smesh__D007758
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 1995
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 2005
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 2002
% 209.35/209.53 |- mesh__dateCreated mesh__D003051 1999-01-01
% 209.35/209.53 |- skos__annotation mesh__D003051 dis = COCHLEAR DISEASES
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 1998
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D003051 2006
% 209.35/209.53 |- skos__scopeNote mesh__D003051
% 209.35/209.53 The part of the internal ear that is concerned with hearing. It forms the anterior part of the labyrinth, is conical, and is placed almost horizontally anterior to the vestibule.%A%
% 209.35/209.53 |- skos__prefLabel mesh__D003051 Cochlea
% 209.35/209.53 |- mesh__recordOriginator mesh__D003051 NLM
% 209.35/209.53 |- mesh__recordMaintainer mesh__D044468 jls
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D044468 2005
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Pacific Island American
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D044468 2006A
% 209.35/209.53 |- rdf__type mesh__D044468sskos__Concept
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Ancestry Groups, Oceanic
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Oceanic Ancestry Groups
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D044468 2006
% 209.35/209.53 |- mesh__dateEstablished mesh__D044468 2004-01-01
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Group, Oceanic Ancestry
% 209.35/209.53 |- skos__altLabel mesh__D044468 Pacific Island Americans
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Races, Australian
% 209.35/209.53 |- mesh__historyNote mesh__D044468 2004
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Australoid Races
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Race, Australian
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Groups, Oceanic Ancestry
% 209.35/209.53 |- skos__scopeNote mesh__D044468
% 209.35/209.53 Individuals whose ancestral origins are in the islands of the central and South Pacific, including Micronesia, Melanesia, Polynesia, and traditionally Australasia.%A%
% 209.35/209.53 |- mesh__recordAuthorizer mesh__D044468 jls
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Australian Aborigines
% 209.35/209.53 |- mesh__dateRevised mesh__D044468 2005-09-28
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Ancestry Group, Oceanic
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Aborigine, Australian
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D044468 2004
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Australian Aborigine
% 209.35/209.53 |- mesh__recordOriginator mesh__D044468 jls
% 209.35/209.53 |- skos__broader mesh__D044468smesh__D044469
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D044468 2006B
% 209.35/209.53 |- mesh__publicMeSHNote mesh__D044468
% 209.35/209.53 2004; for ABORIGINES, AUSTRALIAN see OCEANIC ANCESTRY GROUP 2006-; see ABORIGINES 1991-2003; for AUSTRALOID RACE see AUSTRALOID RACE 1978-2003, see AUSTRALIAN RACE 1963-1977%A%
% 209.35/209.53 |- skos__prefLabel mesh__D044468 Oceanic Ancestry Group
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Pacific Islander American
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D044468 2006C
% 209.35/209.53 |- mesh__dateCreated mesh__D044468 2003-07-09
% 209.35/209.53 |- skos__hiddenLabel mesh__D044468 Races, Australoid
% 209.35/209.53 |- skos__altLabel mesh__D044468 Australian Race
% 209.35/209.53 |- skos__hiddenLabel mesh__D049951 Inactivation, X Chromosome
% 209.35/209.53 |- skos__historyNote mesh__D049951 X Chromosome %28%1983-2005%29%
% 209.35/209.53 |- skos__prefLabel mesh__D049951 X Chromosome Inactivation
% 209.35/209.53 |- skos__altLabel mesh__D049951 X-Inactivation
% 209.35/209.53 |- mesh__activeMeSHYear mesh__D049951 2006
% 209.35/209.53 |- skos__historyNote mesh__D049951
% 209.35/209.53 Dosage Compensation, Genetic %28%1982-2005%29%
% 209.35/209.53 |- skos__hiddenLabel mesh__D049951 X Inactivations
% 209.35/209.53 |- mesh__dateCreated mesh__D049951 2005-06-30
% 209.35/209.53 |- skos__hiddenLabel mesh__D049951 Inactivation, X
% 209.35/209.53 |- skos__altLabel mesh__D049951 X Inactivation
% 209.35/209.53 |- skos__broader mesh__D049951smesh__D004303
% 209.35/209.53 |- skos__hiddenLabel mesh__D049951 Chromosome Inactivation, X
% 209.35/209.53 |- skos__scopeNote mesh__D049951
% 209.35/209.53 A dosage compensation process occurring at an early embryonic stage in mammalian development whereby, at random, one X CHROMOSOME of the pair is repressed in the somatic cells of females.%A%
% 209.35/209.53 |- skos__hiddenLabel mesh__D049951 Hypothesis, Lyon
% 209.35/209.54 |- mesh__dateEstablished mesh__D049951 2006-01-01
% 209.35/209.54 |- rdf__type mesh__D049951sskos__Concept
% 209.35/209.54 |- mesh__recordOriginator mesh__D049951 nns
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D049951 sjn
% 209.35/209.54 |- skos__altLabel mesh__D049951 Lyonization
% 209.35/209.54 |- mesh__recordMaintainer mesh__D049951 nns
% 209.35/209.54 |- mesh__historyNote mesh__D049951
% 209.35/209.54 2006; use DOSAGE COMPENSATION, GENETIC 1982-2005
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D049951
% 209.35/209.54 2006; see DOSAGE COMPENSATION %28%GENETICS%29% 1982-2005
% 209.35/209.54 |- skos__prefLabel mesh__D002757 Cholanes
% 209.35/209.54 |- skos__annotation mesh__D002757 do not confuse with CHOLENES
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 2005
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 1997
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D002757 68
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 2002
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 2004
% 209.35/209.54 |- rdf__type mesh__D002757sskos__Concept
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 1996
% 209.35/209.54 |- mesh__historyNote mesh__D002757 68
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 2001
% 209.35/209.54 |- skos__broader mesh__D002757smesh__D013256
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 2003
% 209.35/209.54 |- mesh__recordOriginator mesh__D002757 NLM
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 2000
% 209.35/209.54 |- mesh__dateRevised mesh__D002757 1992-05-11
% 209.35/209.54 |- mesh__dateEstablished mesh__D002757 1968-01-01
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D002757 PLS
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 1995
% 209.35/209.54 |- mesh__recordMaintainer mesh__D002757 TGC
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 1999
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 1994
% 209.35/209.54 |- mesh__dateCreated mesh__D002757 1999-01-01
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 2006
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 1998
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002757 1993
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 1993
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 1999
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 2000
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 2005
% 209.35/209.54 |- skos__hiddenLabel mesh__D007442 Intratracheal Intubations
% 209.35/209.54 |- mesh__dateRevised mesh__D007442 1991-05-15
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 1996
% 209.35/209.54 |- mesh__recordMaintainer mesh__D007442 TGC
% 209.35/209.54 |- skos__altLabel mesh__D007442 Intubation, Endotracheal
% 209.35/209.54 |- skos__annotation mesh__D007442
% 209.35/209.54 do not use /util except by MeSH definition; for intub in dis, coord with dis /ther, not /surg%A%
% 209.35/209.54 |- skos__hiddenLabel mesh__D007442 Intubations, Endotracheal
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 2006
% 209.35/209.54 |- mesh__recordOriginator mesh__D007442 NLM
% 209.35/209.54 |- skos__hiddenLabel mesh__D007442 Intubations, Intratracheal
% 209.35/209.54 |- skos__hiddenLabel mesh__D007442 Endotracheal Intubation
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 2001
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 1997
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 2003
% 209.35/209.54 |- skos__broader mesh__D007442smesh__D007440
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 1994
% 209.35/209.54 |- rdf__type mesh__D007442sskos__Concept
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 2004
% 209.35/209.54 |- skos__hiddenLabel mesh__D007442 Endotracheal Intubations
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 1995
% 209.35/209.54 |- skos__prefLabel mesh__D007442 Intubation, Intratracheal
% 209.35/209.54 |- mesh__dateCreated mesh__D007442 1999-01-01
% 209.35/209.54 |- skos__hiddenLabel mesh__D007442 Intratracheal Intubation
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 2002
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 1992
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D007442 PLS
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007442 1998
% 209.35/209.54 |- skos__scopeNote mesh__D012387
% 209.35/209.54 Materials placed inside a root canal for the purpose of obturating or sealing it. The materials may be gutta-percha, silver cones, paste mixtures, or other substances. %28%Dorland, 28th ed, p631 %26% Boucher%27%s Clinical Dental Terminology, 4th ed, p187%29%%A%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 2002
% 209.35/209.54 |- mesh__dateRevised mesh__D012387 1996-06-10
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 2003
% 209.35/209.54 |- mesh__recordMaintainer mesh__D012387 JLS
% 209.35/209.54 |- mesh__recordOriginator mesh__D012387 NLM
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 2005
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 2004
% 209.35/209.54 |- skos__altLabel mesh__D012387 Sealants, Root Canal
% 209.35/209.54 |- skos__broader mesh__D012387smesh__D003764
% 209.35/209.54 |- skos__annotation mesh__D012387
% 209.35/209.54 IM; coord with specific material if pertinent %28%IM%29%; D25-26 qualif%A%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 2006
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 2000
% 209.35/209.54 |- skos__hiddenLabel mesh__D012387 Canal Sealants, Root
% 209.35/209.54 |- mesh__historyNote mesh__D012387 72%28%70%29%
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D012387 PLS
% 209.35/209.54 |- mesh__dateEstablished mesh__D012387 1972-01-01
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 2001
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 1998
% 209.35/209.54 |- rdf__type mesh__D012387sskos__Concept
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 1997
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D012387 72
% 209.35/209.54 |- mesh__dateCreated mesh__D012387 1999-01-01
% 209.35/209.54 |- skos__prefLabel mesh__D012387 Root Canal Filling Materials
% 209.35/209.54 |- skos__historyNote mesh__D012387 Dental Materials %28%1966-1969%29%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012387 1999
% 209.35/209.54 |- mesh__historyNote mesh__D020819 2000
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D020819 2000
% 209.35/209.54 |- skos__altLabel mesh__D020819 Parameningeal Infections
% 209.35/209.54 |- skos__altLabel mesh__D020819 Infections, Perimeningeal
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D020819 2002
% 209.35/209.54 |- rdf__type mesh__D020819sskos__Concept
% 209.35/209.54 |- skos__annotation mesh__D020819
% 209.35/209.54 coord IM with specific infection term %28%IM%29%
% 209.35/209.54 |- skos__broader mesh__D020819smesh__D002494
% 209.35/209.54 |- skos__prefLabel mesh__D020819 Perimeningeal Infections
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D020819 2006
% 209.35/209.54 |- skos__hiddenLabel mesh__D020819 Infection, Parameningeal
% 209.35/209.54 |- skos__hiddenLabel mesh__D020819 Parameningeal Infection
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D020819 2001
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D020819 2005
% 209.35/209.54 |- skos__hiddenLabel mesh__D020819 Perimeningeal Infection
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D020819 2000
% 209.35/209.54 |- mesh__dateEstablished mesh__D020819 2000-01-01
% 209.35/209.54 |- skos__hiddenLabel mesh__D020819 Infection, Perimeningeal
% 209.35/209.54 |- mesh__dateCreated mesh__D020819 1999-11-03
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D020819 2004
% 209.35/209.54 |- skos__altLabel mesh__D020819 Infections, Parameningeal
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D020819 2003
% 209.35/209.54 |- skos__scopeNote mesh__D020819
% 209.35/209.54 Infectious processes, including abscesses, effusions, and empyemas which occur in the epidural or subdural spaces surrounding the brain and spinal cord.%A%
% 209.35/209.54 |- rdf__type mesh__D031541sskos__Concept
% 209.35/209.54 |- mesh__dateRevised mesh__D031541 2004-07-07
% 209.35/209.54 |- mesh__dateCreated mesh__D031541 2002-07-03
% 209.35/209.54 |- skos__historyNote mesh__D031541
% 209.35/209.54 Spectrometry, Fluorescence %28%1971-2002%29%
% 209.35/209.54 |- skos__prefLabel mesh__D031541 Fluorescence Resonance Energy Transfer
% 209.35/209.54 |- mesh__dateEstablished mesh__D031541 2003-01-01
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D031541 sjn
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D031541 2005
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D031541 2003
% 209.35/209.54 |- mesh__historyNote mesh__D031541 2003
% 209.35/209.54 |- skos__annotation mesh__D031541
% 209.35/209.54 coord as appropriate with MICROSCOPY and its indentations%A%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D031541 2006
% 209.35/209.54 |- skos__broader mesh__D031541smesh__D013050
% 209.35/209.54 |- skos__scopeNote mesh__D031541
% 209.35/209.54 A type of FLUORESCENCE SPECTROSCOPY using two FLUORESCENT DYES with overlapping emission and absorption spectra, which is used to indicate proximity of labeled molecules. This technique is useful for studying interactions of molecules and PROTEIN FOLDING.%A%
% 209.35/209.54 |- mesh__recordMaintainer mesh__D031541 ssb
% 209.35/209.54 |- mesh__recordOriginator mesh__D031541 ssb
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 2006
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 2001
% 209.35/209.54 |- skos__annotation mesh__D017072
% 209.35/209.54 the newer part of the corpus striatum, hence neo-; also called %22%striatum%22%%A%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 1998
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 1997
% 209.35/209.54 |- mesh__dateCreated mesh__D017072 1992-05-22
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D017072 93
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 1994
% 209.35/209.54 |- rdf__type mesh__D017072sskos__Concept
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 1993
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 1999
% 209.35/209.54 |- mesh__dateEstablished mesh__D017072 1993-01-01
% 209.35/209.54 |- skos__broader mesh__D017072smesh__D003342
% 209.35/209.54 |- skos__historyNote mesh__D017072 Corpus Striatum %28%1974-1992%29%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 1995
% 209.35/209.54 |- mesh__historyNote mesh__D017072 93
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 2002
% 209.35/209.54 |- skos__historyNote mesh__D017072 Basal Ganglia %28%1966-1973%29%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 2003
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 2005
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 2004
% 209.35/209.54 |- skos__scopeNote mesh__D017072
% 209.35/209.54 The phylogenetically newer part of the CORPUS STRIATUM consisting of the CAUDATE NUCLEUS and PUTAMEN. It is often called simply the striatum.%A%
% 209.35/209.54 |- skos__prefLabel mesh__D017072 Neostriatum
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 2000
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017072 1996
% 209.35/209.54 |- skos__historyNote mesh__D003850 Deoxyribonucleases %28%1966-1982%29%
% 209.35/209.54 |- skos__altLabel mesh__D003850 DNA Nicking Enzyme
% 209.35/209.54 |- skos__altLabel mesh__D003850 DNA Endonuclease
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D003850 sjn
% 209.35/209.54 |- mesh__dateEstablished mesh__D003850 1985-01-01
% 209.35/209.54 |- skos__hiddenLabel mesh__D003850 T7 Endonuclease I
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003850 2005
% 209.35/209.54 |- skos__hiddenLabel mesh__D003850 Endonuclease, DNA
% 209.35/209.54 |- mesh__onlineNote mesh__D003850
% 209.35/209.54 use DEOXYRIBONUCLEASES to search STREPTODORNASE 1966-93
% 209.35/209.54 |- skos__hiddenLabel mesh__D003850 T4 Endonuclease II
% 209.35/209.54 |- skos__historyNote mesh__D003850 Endonucleases %28%1973-1982%29%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003850 2006
% 209.35/209.54 |- mesh__dateCreated mesh__D003850 1984-05-24
% 209.35/209.54 |- skos__altLabel mesh__D003850 Thymonuclease
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D003850
% 209.35/209.54 85; STREPTORDORNASE was see DEOXYRIBONUCLEASES 1966-93
% 209.35/209.54 |- skos__prefLabel mesh__D003850 Deoxyribonuclease I
% 209.35/209.54 |- skos__altLabel mesh__D003850 Endonuclease I
% 209.35/209.54 |- skos__altLabel mesh__D003850 DNase I
% 209.35/209.54 |- skos__annotation mesh__D003850
% 209.35/209.54 do not confuse X ref STREPTODORNASE with STREPTODORNASE AND STREPTOKINASE: see note there; DF: note short X ref%A%
% 209.35/209.54 |- skos__scopeNote mesh__D003850
% 209.35/209.54 An enzyme capable of hydrolyzing highly polymerized DNA by splitting phosphodiester linkages, preferentially adjacent to a pyrimidine nucleotide. This catalyzes endonucleolytic cleavage of DNA yielding 5%27%-phosphodi- and oligonucleotide end-products. The enzyme has a preference for double-stranded DNA.%A%
% 209.35/209.54 |- skos__historyNote mesh__D003850 Endodeoxyribonucleases %28%1983-1984%29%
% 209.35/209.54 |- skos__altLabel mesh__D003850 Pancreatic DNase
% 209.35/209.54 |- skos__altLabel mesh__D003850 DNAase I
% 209.35/209.54 |- mesh__recordMaintainer mesh__D003850 ssb
% 209.35/209.54 |- mesh__recordOriginator mesh__D003850 RLS
% 209.35/209.54 |- mesh__historyNote mesh__D003850
% 209.35/209.54 85; STREPTODORNASE was see DEOXYRIBONUCLEASES 1966-93
% 209.35/209.54 |- skos__broader mesh__D003850smesh__D004706
% 209.35/209.54 |- mesh__dateRevised mesh__D003850 2003-07-09
% 209.35/209.54 |- skos__hiddenLabel mesh__D003850 DNase, Pancreatic
% 209.35/209.54 |- rdf__type mesh__D003850sskos__Concept
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003850 2004
% 209.35/209.54 |- skos__hiddenLabel mesh__D003052 Perilymphatic Ducts
% 209.35/209.54 |- mesh__dateEstablished mesh__D003052 1991-01-01
% 209.35/209.54 |- mesh__dateCreated mesh__D003052 1978-05-19
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 1994
% 209.35/209.54 |- mesh__dateRevised mesh__D003052 1990-04-13
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 2002
% 209.35/209.54 |- mesh__recordMaintainer mesh__D003052 NLM
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D003052 91; was see under COCHLEA 1979-90
% 209.35/209.54 |- skos__hiddenLabel mesh__D003052 Cochlear Aqueducts
% 209.35/209.54 |- skos__prefLabel mesh__D003052 Cochlear Aqueduct
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 1995
% 209.35/209.54 |- skos__hiddenLabel mesh__D003052 Duct, Perilymphatic
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 2005
% 209.35/209.54 |- skos__historyNote mesh__D003052 Cochlea %28%1966-1978%29%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 1992
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 1998
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 2006
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 2000
% 209.35/209.54 |- skos__hiddenLabel mesh__D003052 Aqueduct, Cochlear
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 1999
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 1993
% 209.35/209.54 |- mesh__recordOriginator mesh__D003052 RC
% 209.35/209.54 |- mesh__historyNote mesh__D003052
% 209.35/209.54 91%28%79%29%; was see under COCHLEA 1979-90
% 209.35/209.54 |- skos__annotation mesh__D003052 do not confuse with COCHLEAR DUCT
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 2003
% 209.35/209.54 |- skos__scopeNote mesh__D003052
% 209.35/209.54 A channel containing perilymph passing through the temporal bone, connecting the scala tympani of the cochlea to the subarachnoid space.%A%
% 209.35/209.54 |- rdf__type mesh__D003052sskos__Concept
% 209.35/209.54 |- skos__altLabel mesh__D003052 Perilymphatic Duct
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 2001
% 209.35/209.54 |- skos__hiddenLabel mesh__D003052 Aqueducts, Cochlear
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 1996
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 2004
% 209.35/209.54 |- skos__hiddenLabel mesh__D003052 Ducts, Perilymphatic
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D003052 PLS
% 209.35/209.54 |- skos__broader mesh__D003052smesh__D003051
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 1997
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D003052 1991
% 209.35/209.54 |- skos__hiddenLabel mesh__D044469 Stocks, Racial
% 209.35/209.54 |- skos__annotation mesh__D044469 GEN or unspecified; prefer specifics
% 209.35/209.54 |- skos__broader mesh__D044469smesh__D044382
% 209.35/209.54 |- skos__hiddenLabel mesh__D044469 Population Groups, Continental
% 209.35/209.54 |- skos__hiddenLabel mesh__D044469 Racial Stock
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D044469 2004B
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D044469
% 209.35/209.54 2004%28%1968%29%; see RACIAL STOCKS 1968-2003
% 209.35/209.54 |- mesh__recordMaintainer mesh__D044469 jls
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D044469 2004
% 209.35/209.54 |- mesh__recordOriginator mesh__D044469 jls
% 209.35/209.54 |- skos__hiddenLabel mesh__D044469 Population Group, Continental
% 209.35/209.54 |- skos__scopeNote mesh__D044469
% 209.35/209.54 Groups of individuals whose putative ancestry is from native continental populations based on similarities in physical appearance.%A%
% 209.35/209.54 |- mesh__historyNote mesh__D044469
% 209.35/209.54 2004%28%1968%29%; use RACIAL STOCKS 1968-2003
% 209.35/209.54 |- skos__hiddenLabel mesh__D044469 Group, Continental Population
% 209.35/209.54 |- mesh__dateEstablished mesh__D044469 2004-01-01
% 209.35/209.54 |- mesh__dateCreated mesh__D044469 2003-07-14
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D044469 2005
% 209.35/209.54 |- skos__prefLabel mesh__D044469 Continental Population Groups
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D044469 2004A
% 209.35/209.54 |- mesh__dateRevised mesh__D044469 2003-10-30
% 209.35/209.54 |- skos__hiddenLabel mesh__D044469 Groups, Continental Population
% 209.35/209.54 |- skos__altLabel mesh__D044469 Race
% 209.35/209.54 |- rdf__type mesh__D044469sskos__Concept
% 209.35/209.54 |- skos__hiddenLabel mesh__D044469 Stock, Racial
% 209.35/209.54 |- skos__hiddenLabel mesh__D044469 Continental Population Group
% 209.35/209.54 |- skos__hiddenLabel mesh__D044469 Races
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D044469 2006
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D044469 jls
% 209.35/209.54 |- mesh__historyNote mesh__D016778 1992
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D016778 2003
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D016778 2001
% 209.35/209.54 |- skos__altLabel mesh__D016778 Plasmodium falciparum Malaria
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D016778 2005
% 209.35/209.54 |- skos__broader mesh__D016778smesh__D008288
% 209.35/209.54 |- mesh__dateCreated mesh__D016778 1991-05-02
% 209.35/209.54 |- skos__scopeNote mesh__D016778
% 209.35/209.54 Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.%A%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D016778 2004
% 209.35/209.54 |- mesh__recordMaintainer mesh__D016778 TGC
% 209.35/209.54 |- skos__historyNote mesh__D016778 Malaria %28%1966-1991%29%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D016778 2006
% 209.35/209.54 |- skos__hiddenLabel mesh__D016778 Malaria, Plasmodium falciparum
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D016778 2002
% 209.35/209.54 |- mesh__recordOriginator mesh__D016778 PXP
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D016778 1992
% 209.35/209.54 |- mesh__dateEstablished mesh__D016778 1992-01-01
% 209.35/209.54 |- skos__hiddenLabel mesh__D016778 Falciparum Malaria
% 209.35/209.54 |- mesh__dateRevised mesh__D016778 2000-06-22
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D016778 sjn
% 209.35/209.54 |- rdf__type mesh__D016778sskos__Concept
% 209.35/209.54 |- skos__prefLabel mesh__D016778 Malaria, Falciparum
% 209.35/209.54 |- skos__broader mesh__D001980Q000530smesh__D001980
% 209.35/209.54 |- mesh__preferredCombination mesh__D001980Q000530smesh__D001995
% 209.35/209.54 |- rdf__type mesh__D001980Q000530smesh__CompoundConcept
% 209.35/209.54 |- skos__hiddenLabel mesh__D002758 Cholangiographies
% 209.35/209.54 |- skos__broader mesh__D002758smesh__D011860
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002758 2003
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002758 2002
% 209.35/209.54 |- skos__annotation mesh__D002758
% 209.35/209.54 do not use /util except by MeSH definition; DF: CHOLANGIOGR%A%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002758 2004
% 209.35/209.54 |- skos__prefLabel mesh__D002758 Cholangiography
% 209.35/209.54 |- rdf__type mesh__D002758sskos__Concept
% 209.35/209.54 |- mesh__recordMaintainer mesh__D002758 PXP
% 209.35/209.54 |- mesh__dateCreated mesh__D002758 1999-01-01
% 209.35/209.54 |- skos__scopeNote mesh__D002758
% 209.35/209.54 Radiographic examination of the bile ducts.
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002758 2000
% 209.35/209.54 |- skos__broader mesh__D002758smesh__D003938
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D002758 SJN
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002758 1998
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002758 2005
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002758 1999
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002758 2001
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D002758 2006
% 209.35/209.54 |- mesh__dateRevised mesh__D002758 1997-06-20
% 209.35/209.54 |- mesh__recordOriginator mesh__D002758 NLM
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D013480 2003
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D013480
% 209.35/209.54 91; was see under OVULATION 1975-90
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D013480 2006
% 209.35/209.54 |- mesh__dateEstablished mesh__D013480 1991-01-01
% 209.35/209.54 |- skos__broader mesh__D013480smesh__D010060
% 209.35/209.54 |- mesh__historyNote mesh__D013480
% 209.35/209.54 91%28%75%29%; was see under OVULATION 1975-90
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D013480 2004
% 209.35/209.54 |- skos__broader mesh__D013480smesh__D010062
% 209.35/209.54 |- skos__scopeNote mesh__D013480
% 209.35/209.54 Occurrence or induction of release of more ova than are normally released at the same time in a given species. The term applies to both animals and humans.%A%
% 209.35/209.54 |- skos__hiddenLabel mesh__D013480 Superovulations
% 209.35/209.54 |- mesh__recordMaintainer mesh__D013480 lkt
% 209.35/209.54 |- mesh__recordOriginator mesh__D013480 NLM
% 209.35/209.54 |- skos__prefLabel mesh__D013480 Superovulation
% 209.35/209.54 |- mesh__dateCreated mesh__D013480 1974-11-11
% 209.35/209.54 |- mesh__dateRevised mesh__D013480 2001-07-25
% 209.35/209.54 |- rdf__type mesh__D013480sskos__Concept
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D013480 sjn
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D013480 2005
% 209.35/209.54 |- skos__annotation mesh__D013480
% 209.35/209.54 note categories; qualif permitted as for PREGNANCY
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D013480 2002
% 209.35/209.54 |- skos__annotation mesh__D007443
% 209.35/209.54 coord IM with specific precoord intestinal dis term; ileocolic intussusception = ILEAL DISEASES %28%IM%29% + INTUSSUSCEPTION %28%IM%29% but not also COLONIC DISEASES; ileocecal intussusception = ILEOCECAL VALVE %28%IM%29% + INTUSSUSCEPTION %28%IM%29% + ILEAL DISEASES %28%NIM%29% but not also CECAL DISEASES; cecocolic intussusception = CECAL DISEASES %28%IM%29% + INTUSSUSCEPTION %28%IM%29% but not also COLONIC DISEASES%A%
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007443 2006
% 209.35/209.54 |- skos__altLabel mesh__D007443 Invagination, Intestinal
% 209.35/209.54 |- skos__hiddenLabel mesh__D007443 Intestinal Invaginations
% 209.35/209.54 |- skos__hiddenLabel mesh__D007443 Intussusceptions
% 209.35/209.54 |- skos__prefLabel mesh__D007443 Intussusception
% 209.35/209.54 |- mesh__dateRevised mesh__D007443 2003-07-09
% 209.35/209.54 |- mesh__recordMaintainer mesh__D007443 lkt
% 209.35/209.54 |- skos__altLabel mesh__D007443 Intususception
% 209.35/209.54 |- skos__hiddenLabel mesh__D007443 Invaginations, Intestinal
% 209.35/209.54 |- skos__hiddenLabel mesh__D007443 Intestinal Invagination
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007443 2004
% 209.35/209.54 |- skos__broader mesh__D007443smesh__D007415
% 209.35/209.54 |- rdf__type mesh__D007443sskos__Concept
% 209.35/209.54 |- mesh__recordOriginator mesh__D007443 NLM
% 209.35/209.54 |- mesh__dateCreated mesh__D007443 1999-01-01
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D007443 sjn
% 209.35/209.54 |- skos__hiddenLabel mesh__D007443 Intususceptions
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D007443 2005
% 209.35/209.54 |- skos__scopeNote mesh__D007443
% 209.35/209.54 A form of intestinal obstruction caused by the PROLAPSE of a part of the intestine into the adjoining intestinal lumen. There are four types: colic, involving segments of the LARGE INTESTINE; enteric, involving only the SMALL INTESTINE; ileocecal, in which the ILEOCECAL VALVE prolapses into the CECUM, drawing the ILEUM along with it; and ileocolic, in which the ileum prolapses through the ileocecal valve into the COLON.%A%
% 209.35/209.54 |- skos__annotation mesh__D012388 D25-D26 qualif
% 209.35/209.54 |- rdf__type mesh__D012388sskos__Concept
% 209.35/209.54 |- mesh__recordOriginator mesh__D012388 RC
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D012388 84
% 209.35/209.54 |- skos__hiddenLabel mesh__D012388 Medicaments, Root Canal
% 209.35/209.54 |- mesh__dateEstablished mesh__D012388 1984-01-01
% 209.35/209.54 |- skos__prefLabel mesh__D012388 Root Canal Irrigants
% 209.35/209.54 |- skos__broader mesh__D012388smesh__D001697
% 209.35/209.54 |- mesh__recordMaintainer mesh__D012388 jmp
% 209.35/209.54 |- skos__scopeNote mesh__D012388
% 209.35/209.54 Chemicals used mainly to disinfect root canals after pulpectomy and before obturation. The major ones are camphorated monochlorophenol, EDTA, formocresol, hydrogen peroxide, metacresylacetate, and sodium hypochlorite. Root canal irrigants include also rinsing solutions of distilled water, sodium chloride, etc.%A%
% 209.35/209.54 |- skos__altLabel mesh__D012388 Root Canal Medicaments
% 209.35/209.54 |- mesh__dateRevised mesh__D012388 1999-11-03
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012388 2001
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012388 2004
% 209.35/209.54 |- skos__historyNote mesh__D012388 Root Canal Therapy %28%1966-1983%29%
% 209.35/209.54 |- skos__hiddenLabel mesh__D012388 Canal Medicaments, Root
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012388 2000
% 209.35/209.54 |- skos__hiddenLabel mesh__D012388 Canal Irrigants, Root
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D012388 sjn
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012388 2003
% 209.35/209.54 |- mesh__dateCreated mesh__D012388 1983-04-22
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012388 2006
% 209.35/209.54 |- skos__historyNote mesh__D012388 Irrigation %28%1966-1983%29%
% 209.35/209.54 |- mesh__historyNote mesh__D012388 84
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012388 2002
% 209.35/209.54 |- skos__hiddenLabel mesh__D012388 Irrigants, Root Canal
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D012388 2005
% 209.35/209.54 |- mesh__historyNote mesh__D017871
% 209.35/209.54 1998%28%1994%29%; use CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE %28%NM%29% 1990-1993%A%
% 209.35/209.54 |- skos__historyNote mesh__D017871 Protein Kinases %28%1990-1993%29%
% 209.35/209.54 |- skos__scopeNote mesh__D017871
% 209.35/209.54 A calmodulin-dependent enzyme that catalyzes the phosphorylation of proteins. This enzyme is also sometimes dependent on calcium. A wide range of proteins can act as acceptor, including vimentin, synapsin, glycogen synthase, myosin light chains, and the microtubule-associated proteins. %28%From Enzyme Nomenclature, 1992, p277%29%%A%
% 209.35/209.54 |- mesh__dateEstablished mesh__D017871 1994-01-01
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017871 2005
% 209.35/209.54 |- mesh__recordMaintainer mesh__D017871 jmp
% 209.35/209.54 |- skos__hiddenLabel mesh__D017871 Protein Kinases, Calmodulin-Dependent
% 209.35/209.54 |- skos__broader mesh__D017871smesh__D017346
% 209.35/209.54 |- mesh__recordOriginator mesh__D017871 TPW
% 209.35/209.54 |- rdf__type mesh__D017871sskos__Concept
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017871 2006
% 209.35/209.54 |- skos__hiddenLabel mesh__D017871 Calmodulin Kinase
% 209.35/209.54 |- mesh__dateRevised mesh__D017871 2004-07-07
% 209.35/209.54 |- skos__prefLabel mesh__D017871
% 209.35/209.54 Ca%28%2+%29%-Calmodulin Dependent Protein Kinase
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D017871 sjn
% 209.35/209.54 |- skos__altLabel mesh__D017871 Calmodulin-Kinase
% 209.35/209.54 |- skos__altLabel mesh__D017871 Calmodulin-Dependent Protein Kinases
% 209.35/209.54 |- skos__hiddenLabel mesh__D017871 Kinases, Calmodulin-Dependent Protein
% 209.35/209.54 |- skos__altLabel mesh__D017871
% 209.35/209.54 Calcium-Calmodulin Dependent Protein Kinases
% 209.35/209.54 |- mesh__dateCreated mesh__D017871 1993-06-15
% 209.35/209.54 |- mesh__publicMeSHNote mesh__D017871
% 209.35/209.54 1998; see CALMODULIN-DEPENDENT PROTEIN KINASES 1994-1997 %26% PROTEIN KINASES 1990-1993%A%
% 209.35/209.54 |- skos__broader mesh__D017871smesh__D047908
% 209.35/209.54 |- skos__hiddenLabel mesh__D017871 Calmodulin Dependent Protein Kinases
% 209.35/209.54 |- skos__annotation mesh__D017871 DF: CALMODULIN KINASE
% 209.35/209.54 |- mesh__activeMeSHYear mesh__D017073 1999
% 209.35/209.54 |- skos__historyNote mesh__D017073
% 209.35/209.54 Angioplasty, Transluminal, Percutaneous Coronary %28%1989-1992%29%
% 209.35/209.54 |- mesh__recordAuthorizer mesh__D017073 SJN
% 209.35/209.54 |- skos__hiddenLabel mesh__D017073 Atherectomies, Percutaneous Transluminal
% 209.35/209.54 |- skos__hiddenLabel mesh__D017073 Transluminal Atherectomy, Percutaneous
% 209.35/209.54 |- skos__hiddenLabel mesh__D017073 Percutaneous Transluminal Atherectomies
% 209.35/209.54 |- mesh__dateRevised mesh__D017073 1997-06-20
% 209.35/209.55 |- skos__historyNote mesh__D017073 Atherosclerosis %28%1987-1992%29%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017073 2003
% 209.35/209.55 |- mesh__recordMaintainer mesh__D017073 PXP
% 209.35/209.55 |- mesh__dateEstablished mesh__D017073 1993-01-01
% 209.35/209.55 |- skos__hiddenLabel mesh__D017073 Transluminal Atherectomies
% 209.35/209.55 |- skos__altLabel mesh__D017073 Transluminal Atherectomy
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017073 2002
% 209.35/209.55 |- skos__prefLabel mesh__D017073 Atherectomy
% 209.35/209.55 |- skos__related mesh__D017073smesh__D004691
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017073 2004
% 209.35/209.55 |- mesh__recordOriginator mesh__D017073 AGS
% 209.35/209.55 |- skos__altLabel mesh__D017073 Percutaneous Atherectomy
% 209.35/209.55 |- skos__hiddenLabel mesh__D017073 Atherectomies
% 209.35/209.55 |- skos__annotation mesh__D017073
% 209.35/209.55 do not use /util except by MeSH definition
% 209.35/209.55 |- skos__hiddenLabel mesh__D017073 Atherectomy, Percutaneous Transluminal
% 209.35/209.55 |- skos__hiddenLabel mesh__D017073 Atherectomies, Percutaneous
% 209.35/209.55 |- rdf__type mesh__D017073sskos__Concept
% 209.35/209.55 |- skos__historyNote mesh__D017073 Angioplasty, Balloon %28%1986-1992%29%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017073 2000
% 209.35/209.55 |- skos__altLabel mesh__D017073 Percutaneous Transluminal Atherectomy
% 209.35/209.55 |- skos__broader mesh__D017073smesh__D017130
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017073 2005
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017073 1998
% 209.35/209.55 |- mesh__historyNote mesh__D017073 93
% 209.35/209.55 |- skos__scopeNote mesh__D017073
% 209.35/209.55 Endovascular procedure in which atheromatous plaque is excised by a cutting or rotating catheter. It differs from balloon and laser angioplasty procedures which enlarge vessels by dilation but frequently do not remove much plaque. If the plaque is removed by surgical excision under general anesthesia rather than by an endovascular procedure through a catheter, it is called ENDARTERECTOMY.%A%
% 209.35/209.55 |- skos__hiddenLabel mesh__D017073 Atherectomies, Transluminal
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017073 2001
% 209.35/209.55 |- skos__hiddenLabel mesh__D017073 Transluminal Atherectomies, Percutaneous
% 209.35/209.55 |- skos__hiddenLabel mesh__D017073 Atherectomy, Transluminal
% 209.35/209.55 |- skos__hiddenLabel mesh__D017073 Atherectomy, Percutaneous
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D017073 93
% 209.35/209.55 |- mesh__dateCreated mesh__D017073 1992-05-07
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017073 2006
% 209.35/209.55 |- skos__hiddenLabel mesh__D017073 Percutaneous Atherectomies
% 209.35/209.55 |- skos__hiddenLabel mesh__D003851 DNA Nucleases
% 209.35/209.55 |- skos__altLabel mesh__D003851 DNAase
% 209.35/209.55 |- skos__prefLabel mesh__D003851 Deoxyribonucleases
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D003851 2006
% 209.35/209.55 |- skos__scopeNote mesh__D003851
% 209.35/209.55 Enzymes which catalyze the hydrolases of ester bonds within DNA. EC 3.1.-.%A%
% 209.35/209.55 |- mesh__recordOriginator mesh__D003851 NLM
% 209.35/209.55 |- skos__altLabel mesh__D003851 Desoxyribonucleases
% 209.35/209.55 |- skos__hiddenLabel mesh__D003851 DNase, Acid
% 209.35/209.55 |- skos__annotation mesh__D003851
% 209.35/209.55 differentiate STREPTODORNASE referred to here and STREPTODORNASE AND STREPTOKINASE %28%see note there%29%%A%
% 209.35/209.55 |- skos__broader mesh__D003851smesh__D004950
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D003851 sjn
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D003851
% 209.35/209.55 83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65%A%
% 209.35/209.55 |- mesh__dateEstablished mesh__D003851 1966-01-01
% 209.35/209.55 |- mesh__dateCreated mesh__D003851 1999-01-01
% 209.35/209.55 |- skos__altLabel mesh__D003851 DNase
% 209.35/209.55 |- mesh__historyNote mesh__D003851
% 209.35/209.55 83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65%A%
% 209.35/209.55 |- skos__hiddenLabel mesh__D003851 DNase, Alkaline
% 209.35/209.55 |- mesh__dateRevised mesh__D003851 2003-07-09
% 209.35/209.55 |- rdf__type mesh__D003851sskos__Concept
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D003851 2004
% 209.35/209.55 |- mesh__recordMaintainer mesh__D003851 ssb
% 209.35/209.55 |- skos__altLabel mesh__D003851 Nucleases, DNA
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D003851 2005
% 209.35/209.55 |- mesh__onlineNote mesh__D003851
% 209.35/209.55 use DEOXYRIBONUCLEASES to search DEOXYRIBONUCLEASE 1966-83%A%
% 209.35/209.55 |- skos__scopeNote mesh__D003053
% 209.35/209.55 Spiral tube in the bony canal of the cochlea, lying on its outer wall between the scala vestibuli and SCALA TYMPANI.%A%
% 209.35/209.55 |- skos__hiddenLabel mesh__D003053 Media, Scala
% 209.35/209.55 |- skos__hiddenLabel mesh__D003053 Cochlear Ducts
% 209.35/209.55 |- skos__altLabel mesh__D003053 Ductus Cochlearis
% 209.35/209.55 |- skos__altLabel mesh__D003053 Scala Media
% 209.35/209.55 |- skos__broader mesh__D003053smesh__D003051
% 209.35/209.55 |- mesh__dateCreated mesh__D003053 1999-01-01
% 209.35/209.55 |- mesh__historyNote mesh__D003053
% 209.35/209.55 91%28%79%29%; was see under COCHLEA 1979-90; was DUCTUS COCHLEARIS see under LABYRINTH 1963-78%A%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D003053 2006
% 209.35/209.55 |- skos__annotation mesh__D003053 do not confuse with COCHLEAR AQUEDUCT
% 209.35/209.55 |- skos__hiddenLabel mesh__D003053 Scala Medias
% 209.35/209.55 |- mesh__recordOriginator mesh__D003053 NLM
% 209.35/209.55 |- rdf__type mesh__D003053sskos__Concept
% 209.35/209.55 |- mesh__onlineNote mesh__D003053
% 209.35/209.55 use COCHLEAR DUCT to search DUCTUS COCHLEARIS 1975-78; use LABYRINTH 1966-74%A%
% 209.35/209.55 |- mesh__recordMaintainer mesh__D003053 ags
% 209.35/209.55 |- skos__hiddenLabel mesh__D003053 Cochlearis, Ductus
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D003053 sjn
% 209.35/209.55 |- skos__hiddenLabel mesh__D003053 Medias, Scala
% 209.35/209.55 |- skos__prefLabel mesh__D003053 Cochlear Duct
% 209.35/209.55 |- skos__hiddenLabel mesh__D003053 Ducts, Cochlear
% 209.35/209.55 |- mesh__dateEstablished mesh__D003053 1991-01-01
% 209.35/209.55 |- skos__hiddenLabel mesh__D003053 Duct, Cochlear
% 209.35/209.55 |- mesh__dateRevised mesh__D003053 2005-06-30
% 209.35/209.55 |- skos__historyNote mesh__D003053 Labyrinth %28%1966-1978%29%
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D003053
% 209.35/209.55 91; was see under COCHLEA 1979-90; was DUCTUS COCHLEARIS see under LABYRINTH 1963-78%A%
% 209.35/209.55 |- skos__historyNote mesh__D016779 Brain Diseases %28%1966-1991%29%
% 209.35/209.55 |- skos__annotation mesh__D016779
% 209.35/209.55 coord IM with Plasmodium species %28%IM%29% but do not coord with PLASMODIUM FALCIPARUM unless particularly discussed%A%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D016779 2001
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D016779 2003
% 209.35/209.55 |- mesh__historyNote mesh__D016779 1992
% 209.35/209.55 |- skos__broader mesh__D016779smesh__D020808
% 209.35/209.55 |- skos__altLabel mesh__D016779 Cerebral Malaria
% 209.35/209.55 |- skos__broader mesh__D016779smesh__D008288
% 209.35/209.55 |- skos__scopeNote mesh__D016779
% 209.35/209.55 A condition characterized by somnolence or coma in the presence of an acute infection with PLASMODIUM FALCIPARUM %28%and rarely other Plasmodium species%29%. Initial clinical manifestations include HEADACHES; SEIZURES; and alterations of mentation followed by a rapid progression to COMA. Pathologic features include cerebral capillaries filled with parasitized erythrocytes and multiple small foci of cortical and subcortical necrosis. %28%From Adams et al., Principles of Neurology, 6th ed, p136%29%%A%
% 209.35/209.55 |- skos__historyNote mesh__D016779 Malaria %28%1966-1991%29%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D016779 2005
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D016779 2004
% 209.35/209.55 |- mesh__recordOriginator mesh__D016779 PXP
% 209.35/209.55 |- skos__hiddenLabel mesh__D016779 Meningitis, Malaria
% 209.35/209.55 |- skos__broader mesh__D016779smesh__D016778
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D016779 2006A
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D016779 2002
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D016779 2006
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D016779 ags
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D016779 1992
% 209.35/209.55 |- mesh__dateEstablished mesh__D016779 1992-01-01
% 209.35/209.55 |- mesh__recordMaintainer mesh__D016779 ags
% 209.35/209.55 |- skos__prefLabel mesh__D016779 Malaria, Cerebral
% 209.35/209.55 |- rdf__type mesh__D016779sskos__Concept
% 209.35/209.55 |- mesh__dateCreated mesh__D016779 1999-11-03
% 209.35/209.55 |- mesh__dateRevised mesh__D016779 2005-07-15
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 2004
% 209.35/209.55 |- mesh__historyNote mesh__D002759 94; was CHOLANGIOMA 1963-93
% 209.35/209.55 |- skos__broader mesh__D002759smesh__D000236
% 209.35/209.55 |- rdf__type mesh__D002759sskos__Concept
% 209.35/209.55 |- skos__hiddenLabel mesh__D002759 Bile Duct Adenoma
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D002759 94; was CHOLANGIOMA 1963-93
% 209.35/209.55 |- mesh__recordOriginator mesh__D002759 NLM
% 209.35/209.55 |- skos__hiddenLabel mesh__D002759 Bile Duct Adenomas
% 209.35/209.55 |- mesh__dateCreated mesh__D002759 1999-01-01
% 209.35/209.55 |- skos__scopeNote mesh__D002759
% 209.35/209.55 A benign tumor of the intrahepatic bile ducts.
% 209.35/209.55 |- mesh__onlineNote mesh__D002759
% 209.35/209.55 use ADENOMA, BILE DUCT to search CHOLANGIOMA 1966-93
% 209.35/209.55 |- skos__altLabel mesh__D002759 Cholangioma
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 2002
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 1998
% 209.35/209.55 |- mesh__recordMaintainer mesh__D002759 KEV
% 209.35/209.55 |- mesh__dateRevised mesh__D002759 1995-06-08
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 2005
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 1999
% 209.35/209.55 |- skos__hiddenLabel mesh__D002759 Adenomas, Bile Duct
% 209.35/209.55 |- skos__annotation mesh__D002759
% 209.35/209.55 /blood supply /chem /secret /ultrastruct permitted; coord IM with BILE DUCTS, INTRAHEPATIC %28%IM%29% + BILE DUCT NEOPLASMS %28%IM%29%%A%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 2006
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 2000
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 1996
% 209.35/209.55 |- skos__prefLabel mesh__D002759 Adenoma, Bile Duct
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D002759 PLS
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 2003
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 1997
% 209.35/209.55 |- skos__hiddenLabel mesh__D002759 Cholangiomas
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D002759 2001
% 209.35/209.55 |- rdf__type mesh__D013481sskos__Concept
% 209.35/209.55 |- mesh__dateEstablished mesh__D013481 1984-01-01
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D013481 sjn
% 209.35/209.55 |- mesh__historyNote mesh__D013481
% 209.35/209.55 1994; was SUPEROXIDE 1975-1993 %28%see under OXYGEN 1975-1983%29%%A%
% 209.35/209.55 |- skos__scopeNote mesh__D013481
% 209.35/209.55 Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides.%A%
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D013481
% 209.35/209.55 1994; was SUPEROXIDE 1975-1993 %28%see under OXYGEN 1975-1983%29%%A%
% 209.35/209.55 |- skos__prefLabel mesh__D013481 Superoxides
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D013481 2006
% 209.35/209.55 |- mesh__recordMaintainer mesh__D013481 ssb
% 209.35/209.55 |- skos__broader mesh__D013481smesh__D017382
% 209.35/209.55 |- mesh__onlineNote mesh__D013481
% 209.35/209.55 use SUPEROXIDES to search SUPEROXIDE 1975-1993
% 209.35/209.55 |- skos__historyNote mesh__D013481 Oxygen %28%1974%29%
% 209.35/209.55 |- skos__broader mesh__D013481smesh__D010545
% 209.35/209.55 |- skos__related mesh__D013481smesh__D017382
% 209.35/209.55 |- skos__related mesh__D013481smesh__D016897
% 209.35/209.55 |- skos__altLabel mesh__D013481 Superoxide Radical
% 209.35/209.55 |- skos__altLabel mesh__D013481 Superoxide
% 209.35/209.55 |- mesh__dateRevised mesh__D013481 2005-06-30
% 209.35/209.55 |- mesh__dateCreated mesh__D013481 1974-11-11
% 209.35/209.55 |- skos__altLabel mesh__D013481 Superoxide Anion
% 209.35/209.55 |- mesh__recordOriginator mesh__D013481 NLM
% 209.35/209.55 |- skos__related mesh__D013481smesh__D013482
% 209.35/209.55 |- skos__historyNote mesh__D013481 Anions %28%1974%29%
% 209.35/209.55 |- mesh__recordOriginator mesh__D007444 NLM
% 209.35/209.55 |- skos__broader mesh__D007444smesh__D013213
% 209.35/209.55 |- rdf__type mesh__D007444sskos__Concept
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D007444 sjn
% 209.35/209.55 |- skos__prefLabel mesh__D007444 Inulin
% 209.35/209.55 |- skos__scopeNote mesh__D007444
% 209.35/209.55 A starch found in the tubers and roots of many plants. Since it is hydrolyzable to FRUCTOSE, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function.%A%
% 209.35/209.55 |- skos__broader mesh__D007444smesh__D005630
% 209.35/209.55 |- mesh__dateCreated mesh__D007444 1999-01-01
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D007444 2005
% 209.35/209.55 |- skos__annotation mesh__D007444
% 209.35/209.55 usually /diag use in KIDNEY FUNCTION TESTS; do not confuse with INSULIN%A%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D007444 2006
% 209.35/209.55 |- mesh__recordMaintainer mesh__D007444 jmp
% 209.35/209.55 |- mesh__dateRevised mesh__D007444 2004-07-07
% 209.35/209.55 |- skos__altLabel mesh__D045563 Indoloquinones
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D045563 2004
% 209.35/209.55 |- skos__annotation mesh__D045563
% 209.35/209.55 coord with appropriate specific chemical terms if pertinent%A%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D045563 2006
% 209.35/209.55 |- rdf__type mesh__D045563sskos__Concept
% 209.35/209.55 |- mesh__dateEstablished mesh__D045563 2004-01-01
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D045563 2005
% 209.35/209.55 |- skos__hiddenLabel mesh__D045563 Indole Quinones
% 209.35/209.55 |- skos__broader mesh__D045563smesh__D011809
% 209.35/209.55 |- skos__prefLabel mesh__D045563 Indolequinones
% 209.35/209.55 |- skos__scopeNote mesh__D045563
% 209.35/209.55 INDOLES which have two keto groups forming QUINONES like structures of the indole aromatic ring.%A%
% 209.35/209.55 |- mesh__historyNote mesh__D045563 2004
% 209.35/209.55 |- skos__broader mesh__D045563smesh__D007211
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D045563 2004
% 209.35/209.55 |- skos__altLabel mesh__D045563 Indole-Quinones
% 209.35/209.55 |- mesh__dateCreated mesh__D045563 2003-07-09
% 209.35/209.55 |- skos__historyNote mesh__D045563 Indoles %28%1990-2003%29%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1999
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1992
% 209.35/209.55 |- mesh__dateRevised mesh__D012389 1978-11-01
% 209.35/209.55 |- skos__prefLabel mesh__D012389 Root Canal Obturation
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 2002
% 209.35/209.55 |- mesh__dateCreated mesh__D012389 1999-01-01
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1990
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1995
% 209.35/209.55 |- mesh__historyNote mesh__D012389 66; was DENTAL PULP OBTURATION 1965
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1998
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 2004
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D012389 NLM
% 209.35/209.55 |- skos__hiddenLabel mesh__D012389 Root Canal Obturations
% 209.35/209.55 |- skos__hiddenLabel mesh__D012389 Obturation, Root Canal
% 209.35/209.55 |- mesh__dateEstablished mesh__D012389 1966-01-01
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1994
% 209.35/209.55 |- skos__hiddenLabel mesh__D012389 Canal Obturation, Root
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 2003
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D012389
% 209.35/209.55 66; was DENTAL PULP OBTURATION 1965
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 2001
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 2006
% 209.35/209.55 |- skos__broader mesh__D012389smesh__D012390
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1989
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1991
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1997
% 209.35/209.55 |- skos__annotation mesh__D012389
% 209.35/209.55 do not use /util except by MeSH definition
% 209.35/209.55 |- mesh__recordMaintainer mesh__D012389 SMH
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 2000
% 209.35/209.55 |- skos__hiddenLabel mesh__D012389 Canal Obturations, Root
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 2005
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1993
% 209.35/209.55 |- rdf__type mesh__D012389sskos__Concept
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D012389 1996
% 209.35/209.55 |- mesh__recordOriginator mesh__D012389 NLM
% 209.35/209.55 |- skos__hiddenLabel mesh__D012389 Obturations, Root Canal
% 209.35/209.55 |- skos__scopeNote mesh__D017074
% 209.35/209.55 Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.%A%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 2006
% 209.35/209.55 |- mesh__dateCreated mesh__D017074 1992-05-07
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 2000
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 1996
% 209.35/209.55 |- skos__hiddenLabel mesh__D017074 Common Variable Immunodeficiencies
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 2005
% 209.35/209.55 |- skos__annotation mesh__D017074
% 209.35/209.55 an immunodefic syndrome with hypogammaglobulinemia
% 209.35/209.55 |- mesh__recordMaintainer mesh__D017074 AGS
% 209.35/209.55 |- rdf__type mesh__D017074sskos__Concept
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 1999
% 209.35/209.55 |- mesh__dateEstablished mesh__D017074 1993-01-01
% 209.35/209.55 |- skos__altLabel mesh__D017074 Immunodeficiency, Common Variable
% 209.35/209.55 |- skos__hiddenLabel mesh__D017074 Immunodeficiencies, Common Variable
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D017074 PLS
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 2002
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 1995
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 1998
% 209.35/209.55 |- mesh__historyNote mesh__D017074 93
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 2004
% 209.35/209.55 |- mesh__dateRevised mesh__D017074 1994-07-06
% 209.35/209.55 |- skos__prefLabel mesh__D017074 Common Variable Immunodeficiency
% 209.35/209.55 |- skos__broader mesh__D017074smesh__D007153
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 2003
% 209.35/209.55 |- mesh__recordOriginator mesh__D017074 AGS
% 209.35/209.55 |- skos__historyNote mesh__D017074
% 209.35/209.55 Immunologic Deficiency Syndromes %28%1975-1992%29%
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D017074 93
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 2001
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D017074 1997
% 209.35/209.55 |- skos__broader mesh__D003852smesh__D009698
% 209.35/209.55 |- mesh__dateRevised mesh__D003852 2005-06-30
% 209.35/209.55 |- mesh__dateEstablished mesh__D003852 1984-01-01
% 209.35/209.55 |- mesh__historyNote mesh__D003852
% 209.35/209.55 84%28%76%29%; was see under NUCLEOPROTEINS 1976-83
% 209.35/209.55 |- mesh__recordOriginator mesh__D003852 RLS
% 209.35/209.55 |- rdf__type mesh__D003852sskos__Concept
% 209.35/209.55 |- skos__scopeNote mesh__D003852
% 209.35/209.55 Proteins conjugated with deoxyribonucleic acids %28%DNA%29% or specific DNA.%A%
% 209.35/209.55 |- skos__historyNote mesh__D003852 specific DNA %28%1966-1975%29%
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D003852
% 209.35/209.55 84; was see under NUCLEOPROTEINS 1976-83
% 209.35/209.55 |- skos__prefLabel mesh__D003852 Deoxyribonucleoproteins
% 209.35/209.55 |- mesh__dateCreated mesh__D003852 1975-07-25
% 209.35/209.55 |- skos__historyNote mesh__D003852 DNA %28%1966-1975%29%
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D003852 sjn
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D003852 2006
% 209.35/209.55 |- skos__historyNote mesh__D003852 Nucleoproteins %28%1966-1975%29%
% 209.35/209.55 |- mesh__recordMaintainer mesh__D003852 SYSTEM
% 209.35/209.55 |- skos__hiddenLabel mesh__D003054 Prosthesis, Cochlear
% 209.35/209.55 |- mesh__recordMaintainer mesh__D003054 lkt
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D003054 sjn
% 209.35/209.55 |- skos__historyNote mesh__D003054 Electric Stimulation %28%1966-1979%29%
% 209.35/209.55 |- skos__related mesh__D003054smesh__D019929
% 209.35/209.55 |- skos__hiddenLabel mesh__D003054 Prostheses, Cochlear
% 209.35/209.55 |- skos__prefLabel mesh__D003054 Cochlear Implants
% 209.35/209.55 |- mesh__dateRevised mesh__D003054 2002-07-02
% 209.35/209.55 |- mesh__dateCreated mesh__D003054 1978-12-21
% 209.35/209.55 |- skos__broader mesh__D003054smesh__D019736
% 209.35/209.55 |- skos__broader mesh__D003054smesh__D004567
% 209.35/209.55 |- skos__hiddenLabel mesh__D003054 Auditory Prostheses
% 209.35/209.55 |- mesh__historyNote mesh__D003054 98%28%80%29%
% 209.35/209.55 |- skos__scopeNote mesh__D003054
% 209.35/209.55 Electronic hearing devices typically used for patients with normal outer and middle ear function, but defective inner ear function. In the COCHLEA, the hair cells %28%HAIR CELLS, VESTIBULAR%29% may be absent or damaged but there are residual nerve fibers. The device electrically stimulates the COCHLEAR NERVE to create sound sensation.%A%
% 209.35/209.55 |- skos__historyNote mesh__D003054 Prosthesis %28%1966-1979%29%
% 209.35/209.55 |- skos__altLabel mesh__D003054 Auditory Prosthesis
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D003054 2006
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D003054
% 209.35/209.55 98; see COCHLEAR IMPLANT 1987-97, see AUDITORY PROSTHESIS 1980-86%A%
% 209.35/209.55 |- skos__historyNote mesh__D003054 Deafness %28%1966-1979%29%
% 209.35/209.55 |- skos__hiddenLabel mesh__D003054 Cochlear Prostheses
% 209.35/209.55 |- skos__historyNote mesh__D003054 Hearing Aids %28%1966-1979%29%
% 209.35/209.55 |- skos__hiddenLabel mesh__D003054 Prostheses, Auditory
% 209.35/209.55 |- skos__altLabel mesh__D003054 Implants, Cochlear
% 209.35/209.55 |- skos__hiddenLabel mesh__D003054 Implant, Cochlear
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D003054 2005
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D003054 2004
% 209.35/209.55 |- skos__historyNote mesh__D003054 Cochlea %28%1966-1979%29%
% 209.35/209.55 |- skos__hiddenLabel mesh__D003054 Prosthesis, Auditory
% 209.35/209.55 |- skos__altLabel mesh__D003054 Cochlear Prosthesis
% 209.35/209.55 |- skos__broader mesh__D003054smesh__D006310
% 209.35/209.55 |- skos__hiddenLabel mesh__D003054 Cochlear Implant
% 209.35/209.55 |- mesh__dateEstablished mesh__D003054 1980-01-01
% 209.35/209.55 |- rdf__type mesh__D003054sskos__Concept
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D003054 2003
% 209.35/209.55 |- skos__annotation mesh__D003054
% 209.35/209.55 subcutaneous electronic implants: do not confuse with French %22%prothese auditive%22% translated as %22%hearing aid%22% %26% indexed under HEARING AIDS%A%
% 209.35/209.55 |- mesh__recordOriginator mesh__D003054 RC
% 209.35/209.55 |- mesh__dateRevised mesh__D013482 2003-07-09
% 209.35/209.55 |- mesh__dateCreated mesh__D013482 1999-01-01
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Fe-Zn Superoxide
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Mn-Superoxide
% 209.35/209.55 |- skos__altLabel mesh__D013482 Manganese Superoxide Dismutase
% 209.35/209.55 |- skos__altLabel mesh__D013482 Fe-Superoxide Dismutase
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Fe-Zn
% 209.35/209.55 |- skos__prefLabel mesh__D013482 Superoxide Dismutase
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Superoxide
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Iron
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Cu-Zn
% 209.35/209.55 |- mesh__historyNote mesh__D013482 74%28%73%29%
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Cu Zn Superoxide Dismutase
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Cobalt
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D013482 2005
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Cu-Superoxide
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Ag Zn Superoxide Dismutase
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Fe-Superoxide
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Cu-Zn Superoxide
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Manganese Superoxide
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Cuprozinc
% 209.35/209.55 |- skos__historyNote mesh__D013482 Oxidoreductases %28%1966-1972%29%
% 209.35/209.55 |- skos__altLabel mesh__D013482 Hemocuprein
% 209.35/209.55 |- skos__altLabel mesh__D013482 Erythrocuprein
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Fe Superoxide Dismutase
% 209.35/209.55 |- skos__scopeNote mesh__D013482
% 209.35/209.55 An oxidoreductase that catalyzes the reaction between superoxide anions and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. EC 1.15.1.1.%A%
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D013482 74
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Cuprozinc Superoxide
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D013482 2006
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Manganese
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Cobalt Superoxide
% 209.35/209.55 |- skos__altLabel mesh__D013482 Cuprozinc Superoxide Dismutase
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Ag-Zn Superoxide
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Mn Superoxide Dismutase
% 209.35/209.55 |- mesh__dateEstablished mesh__D013482 1974-01-01
% 209.35/209.55 |- skos__altLabel mesh__D013482 Mn-SOD
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Cu Superoxide Dismutase
% 209.35/209.55 |- mesh__recordMaintainer mesh__D013482 ssb
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D013482 sjn
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Dismutase, Iron Superoxide
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Fe Zn Superoxide Dismutase
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Mn SOD
% 209.35/209.55 |- rdf__type mesh__D013482sskos__Concept
% 209.35/209.55 |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Ag-Zn
% 209.35/209.55 |- skos__broader mesh__D013482smesh__D010088
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D013482 2004
% 209.35/209.55 |- mesh__recordOriginator mesh__D013482 NLM
% 209.35/209.55 |- skos__scopeNote mesh__D007445
% 209.35/209.55 Materials and equipment in stock; includes drugs in pharmacies, blood in blood banks, etc.%A%
% 209.35/209.55 |- mesh__historyNote mesh__D007445
% 209.35/209.55 91%28%78%29%; was see under MATERIALS MANAGEMENT, HOSPITAL 1978-90%A%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D007445 2000
% 209.35/209.55 |- mesh__dateCreated mesh__D007445 1977-05-11
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D007445 2001
% 209.35/209.55 |- skos__prefLabel mesh__D007445 Inventories, Hospital
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D007445 2005
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D007445 sjn
% 209.35/209.55 |- skos__altLabel mesh__D007445 Inventory, Hospital
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D007445 2006
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D007445 2002
% 209.35/209.55 |- mesh__recordMaintainer mesh__D007445 JLS
% 209.35/209.55 |- skos__broader mesh__D007445smesh__D008421
% 209.35/209.55 |- skos__altLabel mesh__D007445 Hospital Inventories
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D007445 2003
% 209.35/209.55 |- mesh__recordOriginator mesh__D007445 EC
% 209.35/209.55 |- skos__altLabel mesh__D007445 Hospital Inventory
% 209.35/209.55 |- mesh__dateRevised mesh__D007445 1999-11-05
% 209.35/209.55 |- mesh__dateEstablished mesh__D007445 1991-01-01
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D007445
% 209.35/209.55 91; was see under MATERIALS MANAGEMENT, HOSPITAL 1978-90
% 209.35/209.55 |- rdf__type mesh__D007445sskos__Concept
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D007445 2004
% 209.35/209.55 |- skos__scopeNote mesh__D045564
% 209.35/209.55 Recombinases that involved in the propagation of DNA TRANSPOSONS. They bind to transposon sequences found at two different sites along the same stretch of DNA and bring them into close proximity. The enzymes then catalyze the double strand cleavage, exchange of double strands and rejoining of DNA helices so that the DNA transposon is formed into a circular PLASMID.%A%
% 209.35/209.55 |- skos__prefLabel mesh__D045564 Transposon Resolvases
% 209.35/209.55 |- rdf__type mesh__D045564sskos__Concept
% 209.35/209.55 |- skos__historyNote mesh__D045564
% 209.35/209.55 DNA Nucleotidyltransferases %28%1992-1997%29%
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D045564 2005
% 209.35/209.55 |- mesh__recordMaintainer mesh__D045564 jmp
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D045564 2004
% 209.35/209.55 |- mesh__recordAuthorizer mesh__D045564 sjn
% 209.35/209.55 |- skos__historyNote mesh__D045564
% 209.35/209.55 Nucleotidyltransferases %28%1981-1995%29%
% 209.35/209.55 |- mesh__dateEstablished mesh__D045564 2004-01-01
% 209.35/209.55 |- mesh__dateCreated mesh__D045564 2003-07-09
% 209.35/209.55 |- skos__historyNote mesh__D045564 Transposase %28%1998-2003%29%
% 209.35/209.55 |- skos__annotation mesh__D045564
% 209.35/209.55 Don%27%t confuse with HOLLIDAY JUNCTION RESOLVASES
% 209.35/209.55 |- mesh__historyNote mesh__D045564 2004
% 209.35/209.55 |- skos__broader mesh__D045564smesh__D045522
% 209.35/209.55 |- skos__altLabel mesh__D045564 Resolvases, Transposon
% 209.35/209.55 |- mesh__publicMeSHNote mesh__D045564 2004
% 209.35/209.55 |- mesh__recordOriginator mesh__D045564 jmp
% 209.35/209.55 |- skos__broader mesh__D045564smesh__D009713
% 209.35/209.55 |- mesh__activeMeSHYear mesh__D045564 2006
% 209.35/209.55 |- skos__altLabel mesh__D045564 TnpR Protein
% 209.35/209.55 |- skos__broader mesh__D017075smesh__D007833
% 209.35/209.55 |- skos__altLabel mesh__D017075 Laser Thermocoagulation
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D017075
% 209.35/209.56 93; was see LIGHT COAGULATION 1992; was heading 1968-85
% 209.35/209.56 |- skos__hiddenLabel mesh__D017075 Laser Coagulations
% 209.35/209.56 |- skos__scopeNote mesh__D017075
% 209.35/209.56 The coagulation of tissues using lasers. These lasers produce light in the visible green wavelength that is selectively absorbed by hemoglobin, and thus it is possible to seal bleeding blood vessels.%A%
% 209.35/209.56 |- mesh__recordOriginator mesh__D017075 MXR
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017075 2004
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017075 1998
% 209.35/209.56 |- skos__hiddenLabel mesh__D017075 Thermocoagulations, Laser
% 209.35/209.56 |- skos__prefLabel mesh__D017075 Laser Coagulation
% 209.35/209.56 |- mesh__recordMaintainer mesh__D017075 TGC
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017075 2001
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017075 2003
% 209.35/209.56 |- mesh__onlineNote mesh__D017075
% 209.35/209.56 use LIGHT COAGULATION to search LASER COAGULATION 1992 %26% use LASERS/TU 1968-85%A%
% 209.35/209.56 |- skos__broader mesh__D017075smesh__D008028
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017075 2000
% 209.35/209.56 |- mesh__dateCreated mesh__D017075 1992-05-20
% 209.35/209.56 |- skos__annotation mesh__D017075
% 209.35/209.56 do not confuse with LIGHT COAGULATION or with LASER SURGERY; do not use /util except by MeSH definition; coord IM with Cat A or C term with /surg; DF: LASER COAG%A%
% 209.35/209.56 |- skos__historyNote mesh__D017075 Light Coagulation %28%1966-1992%29%
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D017075 SJN
% 209.35/209.56 |- mesh__dateEstablished mesh__D017075 1993-01-01
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017075 2006
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017075 2005
% 209.35/209.56 |- skos__hiddenLabel mesh__D017075 Coagulations, Laser
% 209.35/209.56 |- skos__altLabel mesh__D017075 Thermocoagulation, Laser
% 209.35/209.56 |- mesh__historyNote mesh__D017075
% 209.35/209.56 93; was see LIGHT COAGULATION 1992; was heading 1968-85
% 209.35/209.56 |- rdf__type mesh__D017075sskos__Concept
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017075 2002
% 209.35/209.56 |- skos__hiddenLabel mesh__D017075 Laser Thermocoagulations
% 209.35/209.56 |- skos__altLabel mesh__D017075 Coagulation, Laser
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017075 1999
% 209.35/209.56 |- mesh__dateRevised mesh__D017075 1997-06-20
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003853 2003
% 209.35/209.56 |- skos__annotation mesh__D003853 GEN or unspecified; prefer specific
% 209.35/209.56 |- skos__historyNote mesh__D003853 Nucleosides %28%1966-1972%29%
% 209.35/209.56 |- mesh__onlineNote mesh__D003853
% 209.35/209.56 use DEOXYRIBONUCLEOSIDES to search RIBONUCLEOSIDES, DEOXY 1971-72 %28%as Prov%29%%A%
% 209.35/209.56 |- rdf__type mesh__D003853sskos__Concept
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003853 2004
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003853 2005
% 209.35/209.56 |- skos__prefLabel mesh__D003853 Deoxyribonucleosides
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003853 2006
% 209.35/209.56 |- skos__broader mesh__D003853smesh__D009705
% 209.35/209.56 |- skos__historyNote mesh__D003853 specific nucleoside %28%1966-1972%29%
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003853 2001
% 209.35/209.56 |- mesh__recordMaintainer mesh__D003853 adp
% 209.35/209.56 |- mesh__recordOriginator mesh__D003853 NLM
% 209.35/209.56 |- mesh__dateRevised mesh__D003853 2000-06-22
% 209.35/209.56 |- mesh__dateCreated mesh__D003853 1999-01-01
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003853 2002
% 209.35/209.56 |- mesh__historyNote mesh__D003853
% 209.35/209.56 73; was RIBONUCLEOSIDES, DEOXY 1971-72 %28%Prov%29%
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D003853 sjn
% 209.35/209.56 |- skos__scopeNote mesh__D003853
% 209.35/209.56 A purine or pyrimidine base bonded to DEOXYRIBOSE.
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D003853 73
% 209.35/209.56 |- mesh__dateEstablished mesh__D003853 1973-01-01
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 2000
% 209.35/209.56 |- skos__hiddenLabel mesh__D003055 Potential, Cochlear Microphonic
% 209.35/209.56 |- mesh__recordMaintainer mesh__D003055 AGS
% 209.35/209.56 |- mesh__dateCreated mesh__D003055 1978-12-14
% 209.35/209.56 |- mesh__dateEstablished mesh__D003055 1991-01-01
% 209.35/209.56 |- skos__hiddenLabel mesh__D003055 Microphonic Potential, Cochlear
% 209.35/209.56 |- skos__historyNote mesh__D003055 Electrophysiology %28%1966%29%
% 209.35/209.56 |- skos__hiddenLabel mesh__D003055 Potentials, Cochlear Microphonic
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 2006
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 2002
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D003055 PLS
% 209.35/209.56 |- skos__prefLabel mesh__D003055 Cochlear Microphonic Potentials
% 209.35/209.56 |- skos__historyNote mesh__D003055 Evoked Potentials %28%1967-1979%29%
% 209.35/209.56 |- skos__historyNote mesh__D003055 Action Potentials %28%1967-1979%29%
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 1999
% 209.35/209.56 |- mesh__dateRevised mesh__D003055 1995-02-23
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 2005
% 209.35/209.56 |- skos__hiddenLabel mesh__D003055 Cochlear Microphonic Potential
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 2004
% 209.35/209.56 |- skos__historyNote mesh__D003055 Cochlea %28%1966-1979%29%
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 1998
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 1997
% 209.35/209.56 |- rdf__type mesh__D003055sskos__Concept
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 2003
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 2001
% 209.35/209.56 |- skos__broader mesh__D003055smesh__D005072
% 209.35/209.56 |- mesh__recordOriginator mesh__D003055 RC
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003055 1996
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D003055
% 209.35/209.56 91; was see under EVOKED POTENTIALS, AUDITORY 1980-90
% 209.35/209.56 |- skos__scopeNote mesh__D003055
% 209.35/209.56 The electric response of the cochlear hair cells to acoustic stimulation.%A%
% 209.35/209.56 |- skos__hiddenLabel mesh__D003055 Microphonic Potentials, Cochlear
% 209.35/209.56 |- mesh__historyNote mesh__D003055
% 209.35/209.56 91%28%80%29%; was see under EVOKED POTENTIALS, AUDITORY 1980-90%A%
% 209.35/209.56 |- mesh__recordMaintainer mesh__D013483 TGC
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013483 2002
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013483 1999
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013483 2001
% 209.35/209.56 |- mesh__recordOriginator mesh__D013483 NLM
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013483 1998
% 209.35/209.56 |- skos__prefLabel mesh__D013483 Superstitions
% 209.35/209.56 |- rdf__type mesh__D013483sskos__Concept
% 209.35/209.56 |- mesh__dateRevised mesh__D013483 1997-06-20
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013483 2004
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013483 2000
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013483 2006
% 209.35/209.56 |- skos__scopeNote mesh__D013483
% 209.35/209.56 A belief or practice which lacks adequate basis for proof; an embodiment of fear of the unknown, magic, and ignorance.%A%
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013483 2003
% 209.35/209.56 |- mesh__dateCreated mesh__D013483 1999-01-01
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013483 2005
% 209.35/209.56 |- skos__hiddenLabel mesh__D013483 Superstition
% 209.35/209.56 |- skos__broader mesh__D013483smesh__D003469
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D013483 SJN
% 209.35/209.56 |- skos__broader mesh__D009206Q000601smesh__D009206
% 209.35/209.56 |- mesh__preferredCombination mesh__D009206Q000601smesh__D006348
% 209.35/209.56 |- rdf__type mesh__D009206Q000601smesh__CompoundConcept
% 209.35/209.56 |- skos__prefLabel mesh__D007446 Inversion, Chromosome
% 209.35/209.56 |- skos__altLabel mesh__D007446 Inversion, Chromosomal
% 209.35/209.56 |- mesh__dateRevised mesh__D007446 2005-07-18
% 209.35/209.56 |- skos__hiddenLabel mesh__D007446 Sequence Inversion
% 209.35/209.56 |- rdf__type mesh__D007446sskos__Concept
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D007446
% 209.35/209.56 2005; see INVERSION %28%GENETICS%29% 1978-2004, see CHROMOSOME ABERRATIONS 1969-1977%A%
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D007446 ags
% 209.35/209.56 |- skos__hiddenLabel mesh__D007446 Chromosomal Inversions
% 209.35/209.56 |- skos__historyNote mesh__D007446 Chromosome Aberrations %28%1968-1974%29%
% 209.35/209.56 |- mesh__recordMaintainer mesh__D007446 ags
% 209.35/209.56 |- mesh__historyNote mesh__D007446 2005%28%1969%29%
% 209.35/209.56 |- skos__hiddenLabel mesh__D007446 Inversions, Chromosomal
% 209.35/209.56 |- mesh__dateCreated mesh__D007446 1999-01-01
% 209.35/209.56 |- skos__hiddenLabel mesh__D007446 Inversions, Sequence
% 209.35/209.56 |- skos__scopeNote mesh__D007446
% 209.35/209.56 An aberration in which a chromosomal segment is deleted and reinserted in the same place but turned 180 degrees from its original orientation, so that the gene sequence for the segment is reversed with respect to that of the rest of the chromosome.%A%
% 209.35/209.56 |- skos__broader mesh__D007446smesh__D016296
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007446 2006A
% 209.35/209.56 |- mesh__recordOriginator mesh__D007446 NLM
% 209.35/209.56 |- skos__altLabel mesh__D007446 Chromosome Inversion
% 209.35/209.56 |- skos__hiddenLabel mesh__D007446 Chromosome Inversions
% 209.35/209.56 |- skos__hiddenLabel mesh__D007446 Inversions, Chromosome
% 209.35/209.56 |- skos__hiddenLabel mesh__D007446 Sequence Inversions
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007446 2006
% 209.35/209.56 |- mesh__dateEstablished mesh__D007446 1978-01-01
% 209.35/209.56 |- skos__historyNote mesh__D007446
% 209.35/209.56 Chromosome Abnormalities %28%1966-1967%29%
% 209.35/209.56 |- skos__altLabel mesh__D007446 Inversion, Sequence
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007446 2005
% 209.35/209.56 |- skos__broader mesh__D007446smesh__D002869
% 209.35/209.56 |- skos__hiddenLabel mesh__D007446 Chromosomal Inversion
% 209.35/209.56 |- skos__hiddenLabel mesh__D045565 Endonuclease, Cruciform Cutting
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D045565 2004
% 209.35/209.56 |- skos__hiddenLabel mesh__D045565 Resolvase, Holliday Junction
% 209.35/209.56 |- skos__altLabel mesh__D045565 Resolvases, Holliday Junction
% 209.35/209.56 |- mesh__recordMaintainer mesh__D045565 jmp
% 209.35/209.56 |- skos__historyNote mesh__D045565 Endonucleases %28%1989-2003%29%
% 209.35/209.56 |- skos__broader mesh__D045565smesh__D045522
% 209.35/209.56 |- skos__broader mesh__D045565smesh__D004706
% 209.35/209.56 |- mesh__dateCreated mesh__D045565 2003-07-09
% 209.35/209.56 |- mesh__recordOriginator mesh__D045565 jmp
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D045565
% 209.35/209.56 2004; HOLLIDAY JUNCTION RESOLVASES was indexed under ENDONUCLEASES 1989-2003%A%
% 209.35/209.56 |- skos__scopeNote mesh__D045565
% 209.35/209.56 Enzymes that recognize CRUCIFORM DNA structures and introduce paired incisions that help to resolve the structure into two DNA helices.%A%
% 209.35/209.56 |- skos__altLabel mesh__D045565 Cruciform DNA Resolving Endonuclease
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D045565 2006
% 209.35/209.56 |- skos__annotation mesh__D045565
% 209.35/209.56 do not confuse with TRANSPOSON RESOLVASES
% 209.35/209.56 |- rdf__type mesh__D045565sskos__Concept
% 209.35/209.56 |- skos__altLabel mesh__D045565 Holliday Junction Resolvase
% 209.35/209.56 |- mesh__dateEstablished mesh__D045565 2004-01-01
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D045565 2005
% 209.35/209.56 |- skos__prefLabel mesh__D045565 Holliday Junction Resolvases
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D045565 sjn
% 209.35/209.56 |- skos__altLabel mesh__D045565 Cruciform Cutting Endonuclease
% 209.35/209.56 |- mesh__historyNote mesh__D045565
% 209.35/209.56 2004; use HOLLIDAY JUNCTION RESOLVASES %28%NM%29% 1989-2003
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 2002
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 1999
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 1996
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 2004
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 2001
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 1995
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 1998
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 2006
% 209.35/209.56 |- rdf__type mesh__D017874sskos__Concept
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 2003
% 209.35/209.56 |- mesh__dateEstablished mesh__D017874 1994-01-01
% 209.35/209.56 |- mesh__dateCreated mesh__D017874 1992-12-28
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 1994
% 209.35/209.56 |- skos__hiddenLabel mesh__D017874 Proteins, Immediate Early
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 2005
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 2000
% 209.35/209.56 |- skos__scopeNote mesh__D017874
% 209.35/209.56 Proteins that are coded by immediate-early genes, in the absence of de novo protein synthesis. The term was originally used exclusively for viral regulatory proteins that were synthesized just after viral integration into the host cell. It is also used to describe cellular proteins which are synthesized immediately after the resting cell is stimulated by extracellular signals.%A%
% 209.35/209.56 |- skos__broader mesh__D017874smesh__D015520
% 209.35/209.56 |- skos__historyNote mesh__D017874 Viral Proteins %28%1974-1993%29%
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D017874 94
% 209.35/209.56 |- skos__hiddenLabel mesh__D017874 Immediate Early Proteins
% 209.35/209.56 |- mesh__historyNote mesh__D017874 94
% 209.35/209.56 |- skos__broader mesh__D017874smesh__D011506
% 209.35/209.56 |- skos__altLabel mesh__D017874 Proteins, Immediate-Early
% 209.35/209.56 |- skos__prefLabel mesh__D017874 Immediate-Early Proteins
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017874 1997
% 209.35/209.56 |- skos__annotation mesh__D017874
% 209.35/209.56 proteins coded by immed-early genes: read MeSH definition for history of %22%immediate-early%22%%A%
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Computer-Assisted Designs
% 209.35/209.56 |- skos__prefLabel mesh__D017076 Computer-Aided Design
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Computer Aided Design
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Computer Aided Manufacturing
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Manufacturing, Computer-Assisted
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Design, Computer-Assisted
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D017076 sjn
% 209.35/209.56 |- skos__historyNote mesh__D017076 Computers %28%1968-1992%29%
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Manufacturing, Computer-Aided
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Computer-Aided Designs
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D017076 93
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017076 2006
% 209.35/209.56 |- mesh__dateCreated mesh__D017076 1992-05-07
% 209.35/209.56 |- skos__scopeNote mesh__D017076
% 209.35/209.56 The use of computers for designing and/or manufacturing of anything, including drugs, surgical procedures, orthotics, and prosthetics.%A%
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Designs, Computer-Aided
% 209.35/209.56 |- mesh__dateRevised mesh__D017076 2004-07-07
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017076 2005
% 209.35/209.56 |- skos__altLabel mesh__D017076 Computer-Assisted Design
% 209.35/209.56 |- skos__broader mesh__D017076smesh__D003196
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Computer Assisted Design
% 209.35/209.56 |- rdf__type mesh__D017076sskos__Concept
% 209.35/209.56 |- mesh__dateEstablished mesh__D017076 1993-01-01
% 209.35/209.56 |- skos__annotation mesh__D017076 in design of equipment or drugs
% 209.35/209.56 |- mesh__recordMaintainer mesh__D017076 jls
% 209.35/209.56 |- skos__altLabel mesh__D017076 Computer-Assisted Manufacturing
% 209.35/209.56 |- mesh__recordOriginator mesh__D017076 MXR
% 209.35/209.56 |- mesh__historyNote mesh__D017076 93
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Designs, Computer-Assisted
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Computer Assisted Manufacturing
% 209.35/209.56 |- skos__hiddenLabel mesh__D017076 Design, Computer-Aided
% 209.35/209.56 |- mesh__historyNote mesh__D003854
% 209.35/209.56 73; was RIBONUCLEOTIDES, DEOXY 1971-72 %28%Prov%29%
% 209.35/209.56 |- skos__annotation mesh__D003854 GEN or unspecified; prefer specific
% 209.35/209.56 |- rdf__type mesh__D003854sskos__Concept
% 209.35/209.56 |- mesh__dateEstablished mesh__D003854 1973-01-01
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003854 2004
% 209.35/209.56 |- skos__prefLabel mesh__D003854 Deoxyribonucleotides
% 209.35/209.56 |- skos__historyNote mesh__D003854 Nucleotides %28%1966-1972%29%
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003854 2005
% 209.35/209.56 |- mesh__onlineNote mesh__D003854
% 209.35/209.56 use DEOXYRIBONUCLEOTIDES to search RIBONUCLEOTIDES, DEOXY 1971-72 %28%as Prov%29%%A%
% 209.35/209.56 |- skos__broader mesh__D003854smesh__D009711
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003854 2001
% 209.35/209.56 |- mesh__recordOriginator mesh__D003854 NLM
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003854 2006
% 209.35/209.56 |- mesh__dateCreated mesh__D003854 1999-01-01
% 209.35/209.56 |- mesh__dateRevised mesh__D003854 2000-06-22
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D003854 sjn
% 209.35/209.56 |- mesh__recordMaintainer mesh__D003854 adp
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003854 2002
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D003854 73
% 209.35/209.56 |- skos__scopeNote mesh__D003854
% 209.35/209.56 A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group.%A%
% 209.35/209.56 |- skos__historyNote mesh__D003854 specific nucleotide %28%1966-1972%29%
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003854 2003
% 209.35/209.56 |- skos__hiddenLabel mesh__D003056 Nerve, Auditory
% 209.35/209.56 |- skos__hiddenLabel mesh__D003056 Auditory Nerves
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003056 2005
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003056 2004
% 209.35/209.56 |- mesh__dateCreated mesh__D003056 1999-01-01
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003056 2001
% 209.35/209.56 |- rdf__type mesh__D003056sskos__Concept
% 209.35/209.56 |- skos__scopeNote mesh__D003056
% 209.35/209.56 The cochlear part of the 8th cranial nerve %28%VESTIBULOCOCHLEAR NERVE%29%. The cochlear nerve fibers originate from neurons of the SPIRAL GANGLION and project peripherally to cochlear hair cells and centrally to the cochlear nuclei %28%COCHLEAR NUCLEUS%29% of the BRAIN STEM. They mediate the sense of hearing.%A%
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003056 2003
% 209.35/209.56 |- skos__altLabel mesh__D003056 Auditory Nerve
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003056 2000
% 209.35/209.56 |- mesh__recordOriginator mesh__D003056 NLM
% 209.35/209.56 |- skos__broader mesh__D003056smesh__D000159
% 209.35/209.56 |- skos__hiddenLabel mesh__D003056 Nerve, Cochlear
% 209.35/209.56 |- skos__hiddenLabel mesh__D003056 Nerves, Auditory
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D003056 sjn
% 209.35/209.56 |- mesh__dateRevised mesh__D003056 1999-11-08
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003056 2002
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D003056
% 209.35/209.56 1963; for AUDITORY NERVE see ACOUSTIC NERVE 1979-1999; for ACOUSTIC NERVE see VESTIBULOCOCHLEAR NERVE 1963-1999%A%
% 209.35/209.56 |- skos__annotation mesh__D003056
% 209.35/209.56 dis: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES %28%IM%29%; neopl: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 209.35/209.56 |- mesh__historyNote mesh__D003056
% 209.35/209.56 1963; for AUDITORY NERVE use VESTIBULOCOCHLEAR NERVE 1979-1999; for ACOUSTIC NERVE use VESTIBULOCOCHLEAR NERVE 1963-1999%A%
% 209.35/209.56 |- skos__hiddenLabel mesh__D003056 Nerves, Cochlear
% 209.35/209.56 |- skos__hiddenLabel mesh__D003056 Nerves, Acoustic
% 209.35/209.56 |- skos__hiddenLabel mesh__D003056 Acoustic Nerves
% 209.35/209.56 |- skos__prefLabel mesh__D003056 Cochlear Nerve
% 209.35/209.56 |- skos__altLabel mesh__D003056 Acoustic Nerve
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D003056 2006
% 209.35/209.56 |- skos__hiddenLabel mesh__D003056 Cochlear Nerves
% 209.35/209.56 |- skos__hiddenLabel mesh__D003056 Nerve, Acoustic
% 209.35/209.56 |- mesh__recordMaintainer mesh__D003056 adp
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D013484 sjn
% 209.35/209.56 |- mesh__historyNote mesh__D013484 88
% 209.35/209.56 |- rdf__type mesh__D013484sskos__Concept
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013484 2004
% 209.35/209.56 |- mesh__recordOriginator mesh__D013484 EC
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013484 2006
% 209.35/209.56 |- mesh__dateEstablished mesh__D013484 1988-01-01
% 209.35/209.56 |- skos__scopeNote mesh__D013484
% 209.35/209.56 Applies to the movements of the forearm in turning the palm forward or upward and when applied to the foot, a combination of adduction and inversion of the foot.%A%
% 209.35/209.56 |- skos__historyNote mesh__D013484 Movement %28%1966-1987%29%
% 209.35/209.56 |- mesh__recordMaintainer mesh__D013484 nns
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D013484 2005
% 209.35/209.56 |- skos__annotation mesh__D013484
% 209.35/209.56 refers to foot or forearm; do not confuse with SUPINE POSITION%A%
% 209.35/209.56 |- skos__prefLabel mesh__D013484 Supination
% 209.35/209.56 |- mesh__dateCreated mesh__D013484 1987-04-06
% 209.35/209.56 |- skos__hiddenLabel mesh__D013484 Supinations
% 209.35/209.56 |- mesh__dateRevised mesh__D013484 2003-07-09
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D013484 88
% 209.35/209.56 |- skos__historyNote mesh__D013484 Posture %28%1966-1987%29%
% 209.35/209.56 |- skos__broader mesh__D013484smesh__D009068
% 209.35/209.56 |- rdf__type mesh__D007447sskos__Concept
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 2001
% 209.35/209.56 |- skos__prefLabel mesh__D007447 Invertebrate Hormones
% 209.35/209.56 |- skos__historyNote mesh__D007447 Hormones %28%1966%29%
% 209.35/209.56 |- skos__annotation mesh__D007447
% 209.35/209.56 coord IM with specific invertebrate %28%IM%29%
% 209.35/209.56 |- mesh__dateCreated mesh__D007447 1999-01-01
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 2000
% 209.35/209.56 |- mesh__recordMaintainer mesh__D007447 TGC
% 209.35/209.56 |- skos__historyNote mesh__D007447 Insects %28%1966%29%
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 1999
% 209.35/209.56 |- mesh__historyNote mesh__D007447 67
% 209.35/209.56 |- mesh__dateRevised mesh__D007447 1995-03-17
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 1997
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 1998
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 2006
% 209.35/209.56 |- skos__broader mesh__D007447smesh__D006728
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 2002
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 1996
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D007447 67
% 209.35/209.56 |- mesh__dateEstablished mesh__D007447 1967-01-01
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 2004
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 2005
% 209.35/209.56 |- skos__altLabel mesh__D007447 Hormones, Invertebrate
% 209.35/209.56 |- skos__scopeNote mesh__D007447
% 209.35/209.56 Hormones produced by invertebrates, usually insects, mollusks, annelids, and helminths.%A%
% 209.35/209.56 |- mesh__recordOriginator mesh__D007447 NLM
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D007447 2003
% 209.35/209.56 |- mesh__recordAuthorizer mesh__D007447 PLS
% 209.35/209.56 |- skos__scopeNote mesh__D026601
% 209.35/209.56 A PROTEIN O-METHYLTRANSFERASE that recognizes and catalyzes the methyl esterification of ISOASPARTIC ACID and D-ASPARTIC ACID residues in peptides and proteins. It initiates the repair of proteins damaged by the spontaneous decomposition of normal L-aspartic acid and L-asparagine residues.%A%
% 209.35/209.56 |- skos__historyNote mesh__D026601
% 209.35/209.56 Protein Methyltransferases %28%1984-2001%29%
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 L Isoaspartyl Protein Carboxymethyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Gene Product, PCMT1
% 209.35/209.56 |- skos__altLabel mesh__D026601 Protein-L-Isoaspartate Methyltransferase
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D026601
% 209.35/209.56 2002; PROTEIN-D-ASPARTATE METHYLTRANSFERASE %28%now PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE%29% was indexed under PROTEIN METHYLTRANSFERASES 1984-2001%A%
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Protein D Aspartate L Isoaspartate Methyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Methyltransferase, Isoaspartyl-Aspartyl Protein
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 PIMT, Methyltransferase
% 209.35/209.56 |- skos__altLabel mesh__D026601 Protein-beta-Aspartate Methyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Methyltransferase, D-Aspartyl-L-Isoaspartyl
% 209.35/209.56 |- mesh__dateEstablished mesh__D026601 2002-01-01
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Methyltransferase, Protein-L-Isoaspartate
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Protein beta Aspartate Methyltransferase
% 209.35/209.56 |- skos__altLabel mesh__D026601 D-Aspartyl-L-Isoaspartyl Methyltransferase
% 209.35/209.56 |- skos__altLabel mesh__D026601 Protein L-Isoaspartate O-Methyltransferase
% 209.35/209.56 |- mesh__dateCreated mesh__D026601 2001-07-25
% 209.35/209.56 |- skos__altLabel mesh__D026601
% 209.35/209.56 Isoaspartyl-Aspartyl Protein Methyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Methyltransferase, Protein-beta-Aspartate
% 209.35/209.56 |- skos__altLabel mesh__D026601 pcm Gene Product
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D026601 2006
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Protein D Aspartate Methyltransferase
% 209.35/209.56 |- skos__altLabel mesh__D026601 Protein-D-Aspartate Methyltransferase
% 209.35/209.56 |- skos__altLabel mesh__D026601 PCMT1 Gene Product
% 209.35/209.56 |- mesh__historyNote mesh__D026601
% 209.35/209.56 2002; use PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE %28%NM%29% 1984-2001%A%
% 209.35/209.56 |- skos__prefLabel mesh__D026601
% 209.35/209.56 Protein D-Aspartate-L-Isoaspartate Methyltransferase
% 209.35/209.56 |- skos__altLabel mesh__D026601 Methyltransferase PIMT
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Protein L Isoaspartate D Aspartate O Methyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 L-Isoaspartate O-Methyltransferase, Protein
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Methyltransferase, Protein-D-Aspartate
% 209.35/209.56 |- skos__altLabel mesh__D026601 Protein L-Isoaspartyl Methyltransferase
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D026601 2005
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Methyltransferase, Protein D-Aspartate-L-Isoaspartate
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Protein L Isoaspartate O Methyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 D Aspartyl L Isoaspartyl Methyltransferase
% 209.35/209.56 |- mesh__dateRevised mesh__D026601 2003-07-09
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Methyltransferase, Protein L-Isoaspartyl
% 209.35/209.56 |- skos__altLabel mesh__D026601
% 209.35/209.56 Protein-L-Isoaspartate-D-Aspartate-O-Methyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Methyltransferase, Protein-D-Asp
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Protein L Isoaspartyl Methyltransferase
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D026601 2004
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Protein Carboxymethyltransferase, L-Isoaspartyl
% 209.35/209.56 |- skos__broader mesh__D026601smesh__D011497
% 209.35/209.56 |- skos__altLabel mesh__D026601 Protein-D-Asp Methyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Protein Methyltransferase, Isoaspartyl-Aspartyl
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Protein D Asp Methyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 O-Methyltransferase, Protein L-Isoaspartate
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Carboxymethyltransferase, L-Isoaspartyl Protein
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Protein L Isoaspartate Methyltransferase
% 209.35/209.56 |- skos__altLabel mesh__D026601
% 209.35/209.56 L-Isoaspartyl Protein Carboxymethyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 L-Isoaspartyl Methyltransferase, Protein
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601
% 209.35/209.56 Isoaspartyl Aspartyl Protein Methyltransferase
% 209.35/209.56 |- skos__hiddenLabel mesh__D026601 Gene Product, pcm
% 209.35/209.56 |- rdf__type mesh__D026601sskos__Concept
% 209.35/209.56 |- mesh__historyNote mesh__D045566 2004;
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D045566 2004
% 209.35/209.56 |- skos__prefLabel mesh__D045566 DNA, Cruciform
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D045566 2004;
% 209.35/209.56 |- skos__altLabel mesh__D045566 Cruciform DNA
% 209.35/209.56 |- skos__broader mesh__D045566smesh__D004247
% 209.35/209.56 |- mesh__dateCreated mesh__D045566 2003-07-09
% 209.35/209.56 |- rdf__type mesh__D045566sskos__Concept
% 209.35/209.56 |- skos__hiddenLabel mesh__D045566 DNA, Holliday Junction
% 209.35/209.56 |- skos__altLabel mesh__D045566 Holliday Junction DNA
% 209.35/209.56 |- skos__related mesh__D045566smesh__D045565
% 209.35/209.56 |- skos__scopeNote mesh__D045566
% 209.35/209.56 A cross-shaped DNA structure that can be observed under the electron microscope. It is formed by the incomplete exchange of strands between two double-stranded helices.%A%
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D045566 2006
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D045566 2005
% 209.35/209.56 |- skos__altLabel mesh__D045566 Holliday Junctions
% 209.35/209.56 |- mesh__dateEstablished mesh__D045566 2004-01-01
% 209.35/209.56 |- skos__altLabel mesh__D045566 DNA Cruciforms
% 209.35/209.56 |- mesh__activeMeSHYear mesh__D017875 2005
% 209.35/209.56 |- mesh__recordOriginator mesh__D017875 TPW
% 209.35/209.56 |- mesh__publicMeSHNote mesh__D017875 94
% 209.35/209.56 |- skos__historyNote mesh__D017875 Isomerases %28%1984-1993%29%
% 209.35/209.56 |- mesh__dateCreated mesh__D017875 1993-06-18
% 209.35/209.56 |- skos__historyNote mesh__D017875 Phosphotransferases %28%1966-1993%29%
% 209.35/209.56 |- mesh__historyNote mesh__D017875 94
% 209.35/209.56 |- skos__broader mesh__D017875smesh__D019751
% 209.35/209.57 |- skos__altLabel mesh__D017875 Phosphomutases
% 209.35/209.57 |- mesh__dateEstablished mesh__D017875 1994-01-01
% 209.35/209.57 |- skos__scopeNote mesh__D017875
% 209.35/209.57 A group of enzymes that catalyze an intramolecular transfer of a phosphate group. It has been shown in some cases that the enzyme has a functional phosphate group, which can act as the donor. These were previously listed under PHOSPHOTRANSFERASES %28%EC 2.7.-%29%. %28%From Enzyme Nomenclature, 1992%29% EC 5.4.2.%A%
% 209.35/209.57 |- mesh__activeMeSHYear mesh__D017875 2004
% 209.35/209.57 |- skos__annotation mesh__D017875 DF: note short X ref
% 209.35/209.57 |- mesh__recordAuthorizer mesh__D017875 sjn
% 209.35/209.57 |- mesh__activeMeSHYear mesh__D017875 2006
% 209.35/209.57 |- mesh__dateRevised mesh__D017875 2003-07-09
% 209.35/209.57 |- rdf__type mesh__D017875sskos__Concept
% 209.35/209.57 |- skos__prefLabel mesh__D017875 Phosphotransferases %28%Phosphomutases%29%
% 209.35/209.57 |- mesh__recordMaintainer mesh__D017875 ssb
% 209.35/209.57 |- mesh__recordMaintainer mesh__D050700 ags
% 209.35/209.57 |- mesh__publicMeSHNote mesh__D050700
% 209.35/209.57 2006; E2F5 TRANSCRIPTION FACTOR, E2F Transcription Factor 5 Protein, %26% TRANSCRIPTION FACTOR E2F-5 were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTIONS FACTORS 2004-2005%A%
% 209.35/209.57 |- mesh__dateRevised mesh__D050700 2005-07-13
% 209.35/209.57 |- rdf__type mesh__D050700sskos__Concept
% 209.35/209.57 |- skos__altLabel mesh__D050700 E2F Transcription Factor 5 Protein
% 209.35/209.57 |- skos__hiddenLabel mesh__D050700 E2F-5, Transcription Factor
% 209.35/209.57 |- mesh__historyNote mesh__D050700 2006%28%2004%29%
% 209.35/209.57 |- mesh__recordAuthorizer mesh__D050700 ags
% 209.35/209.57 |- skos__hiddenLabel mesh__D050700 Transcription Factor E2F 5
% 209.35/209.57 |- skos__scopeNote mesh__D050700
% 209.35/209.57 An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F5 recruits chromatin remodeling factors indirectly to target gene promoters through RETINOBLASTOMA LIKE PROTEIN P130.%A%
% 209.35/209.57 |- skos__altLabel mesh__D050700 Transcription Factor E2F-5
% 209.35/209.57 |- skos__annotation mesh__D050700 see SCR for organism-specific terms
% 209.35/209.57 |- skos__historyNote mesh__D050700 Transcription Factors %28%1991-2005%29%
% 209.35/209.57 |- mesh__recordOriginator mesh__D050700 DRC
% 209.35/209.57 |- skos__historyNote mesh__D050700 Cell Cycle Proteins %28%1991-2005%29%
% 209.35/209.57 |- mesh__dateEstablished mesh__D050700 2006-01-01
% 209.35/209.57 |- mesh__activeMeSHYear mesh__D050700 2006A
% 209.35/209.57 |- skos__prefLabel mesh__D050700 E2F5 Transcription Factor
% 209.35/209.57 |- skos__hiddenLabel mesh__D050700 Transcription Factor, E2F5
% 209.35/209.57 |- skos__broader mesh__D050700smesh__D050684
% 209.35/209.57 |- mesh__activeMeSHYear mesh__D050700 2006
% 209.35/209.57 |- skos__historyNote mesh__D050700 DNA-Binding Proteins %28%1991-2005%29%
% 209.35/209.57 |- mesh__dateCreated mesh__D050700 2005-06-30
% 209.35/209.57 |- skos__historyNote mesh__D017077 Culture Media %28%1967-1992%29%
% 209.35/209.57 |- skos__broader mesh__D017077smesh__D003470
% 209.35/209.57 |- skos__altLabel mesh__D017077 Conditioned Culture Medium
% 209.35/209.57 |- skos__prefLabel mesh__D017077 Culture Media, Conditioned
% 209.35/209.57 |- mesh__activeMeSHYear mesh__D017077 2005
% 209.35/209.57 |- mesh__dateEstablished mesh__D017077 1993-01-01
% 209.35/209.57 |- mesh__activeMeSHYear mesh__D017077 2006
% 209.35/209.57 |- mesh__dateRevised mesh__D017077 2003-07-09
% 209.35/209.57 |- skos__altLabel mesh__D017077 Conditioned Media
% 209.35/209.57 |- skos__altLabel mesh__D017077 Conditioned Medium
% 209.35/209.57 |- mesh__dateCreated mesh__D017077 1992-05-07
% 209.35/209.57 |- skos__scopeNote mesh__D017077
% 209.35/209.57 Culture media containing biologically active components obtained from previously cultured cells or tissues that have released into the media substances affecting certain cell functions %28%e.g., growth, lysis%29%.%A%
% 209.35/209.57 |- mesh__recordMaintainer mesh__D017077 ssb
% 209.35/209.57 |- skos__altLabel mesh__D017077 Conditioned Culture Media
% 209.35/209.57 |- mesh__recordAuthorizer mesh__D017077 sjn
% 209.35/209.57 |- rdf__type mesh__D017077sskos__Concept
% 209.35/209.57 |- mesh__recordOriginator mesh__D017077 MXR
% 209.35/209.57 |- skos__annotation mesh__D017077
% 209.35/209.57 culture media containing biol active components from previously cultured matter; NIM; D25-26 qualif%A%
% 209.35/209.57 |- skos__hiddenLabel mesh__D017077 Media, Conditioned
% 209.35/209.57 |- mesh__publicMeSHNote mesh__D017077 93
% 209.35/209.57 |- skos__altLabel mesh__D017077 Culture Medium, Conditioned
% 209.35/209.57 |- mesh__historyNote mesh__D017077 93
% 209.35/209.57 |- skos__hiddenLabel mesh__D017077 Medium, Conditioned
% 209.35/209.57 |- mesh__activeMeSHYear mesh__D017077 2004
% 209.35/209.57 |- mesh__activeMeSHYear mesh__D003855 2005
% 209.35/209.57 |- skos__broader mesh__D003855smesh__D003837
% 209.35/209.57 |- mesh__recordAuthorizer mesh__D003855 sjn
% 209.35/209.57 |- rdf__type mesh__D003855sskos__Concept
% 209.35/209.57 |- mesh__recordMaintainer mesh__D003855 ssb
% 209.35/209.57 |- mesh__dateRevised mesh__D003855 2004-07-07
% 209.35/209.57 |- mesh__dateEstablished mesh__D003855 1974-01-01
% 209.35/209.57 |- mesh__historyNote mesh__D003855 74
% 209.35/209.57 |- mesh__dateCreated mesh__D003855 1999-01-01
% 209.35/209.57 |- skos__altLabel mesh__D003855 2-Deoxyribose
% 209.35/209.57 |- mesh__publicMeSHNote mesh__D003855 74
% 209.35/209.57 |- mesh__activeMeSHYear mesh__D003855 2006
% 209.35/209.57 |- skos__prefLabel mesh__D003855 Deoxyribose
% 209.35/209.57 |- skos__hiddenLabel mesh__D003855 2 Deoxyribose
% 209.35/209.57 |- mesh__recordOriginator mesh__D003855 NLM
% 209.35/209.57 |- rdf__type mesh__D003057sskos__Concept
% 209.35/209.57 |- skos__hiddenLabel mesh__D003057 Progeria Like Syndrome
% 209.35/209.57 |- skos__altLabel mesh__D003057 Type C Cockayne Syndrome
% 209.35/209.57 |- skos__altLabel mesh__D003057 Type III Cockayne Syndrome
% 209.35/209.57 |- skos__hiddenLabel mesh__D003057 Syndrome, Progeria-Like
% 209.35/209.57 |- skos__altLabel mesh__D003057 Type A Cockayne Syndrome
% 209.35/209.57 |- skos__altLabel mesh__D003057 Group B Cockayne Syndrome
% 209.35/209.57 |- skos__prefLabel mesh__D003057 Cockayne Syndrome
% 209.35/209.57 |- skos__altLabel mesh__D003057 Cockayne Syndrome, Type B
% 209.35/209.57 |- skos__altLabel mesh__D003057 Cockayne Syndrome, Group C
% 209.35/209.57 |- mesh__dateRevised mesh__D003057 2005-06-30
% 209.35/209.57 |- mesh__recordOriginator mesh__D003057 VDK
% 209.35/209.57 |- skos__broader mesh__D003057smesh__D049914
% 209.35/209.57 |- skos__historyNote mesh__D003057 Dwarfism %28%1966-1980%29%
% 209.35/209.57 |- skos__altLabel mesh__D003057 Cockayne Syndrome, Type A
% 209.35/209.57 |- skos__altLabel mesh__D003057 Cockayne Syndrome, Group B
% 209.35/209.57 |- skos__broader mesh__D003057smesh__D004392
% 209.35/209.57 |- skos__related mesh__D003057smesh__D008607
% 209.35/209.57 |- skos__altLabel mesh__D003057 Group A Cockayne Syndrome
% 209.35/209.57 |- mesh__historyNote mesh__D003057
% 209.35/209.57 91%28%81%29%; was see under DWARFISM 1981-90
% 209.35/209.57 |- skos__altLabel mesh__D003057 Type B Cockayne Syndrome
% 209.43/209.57 |- skos__altLabel mesh__D003057 Cockayne Syndrome, Group A
% 209.43/209.57 |- mesh__recordMaintainer mesh__D003057 lkt
% 209.43/209.57 |- mesh__dateCreated mesh__D003057 1980-05-09
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D003057 91; was see under DWARFISM 1981-90
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003057 2006
% 209.43/209.57 |- skos__broader mesh__D003057smesh__D020271
% 209.43/209.57 |- skos__altLabel mesh__D003057 Type II Cockayne Syndrome
% 209.43/209.57 |- skos__altLabel mesh__D003057 Progeria-Like Syndrome
% 209.43/209.57 |- mesh__dateEstablished mesh__D003057 1991-01-01
% 209.43/209.57 |- skos__historyNote mesh__D003057
% 209.43/209.57 Photosensitivity Disorders %28%1966-1980%29%
% 209.43/209.57 |- skos__altLabel mesh__D003057 Type I Cockayne Syndrome
% 209.43/209.57 |- skos__altLabel mesh__D003057 Group C Cockayne Syndrome
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D003057 sjn
% 209.43/209.57 |- skos__altLabel mesh__D003057 Cockayne Syndrome, Type C
% 209.43/209.57 |- skos__scopeNote mesh__D003057
% 209.43/209.57 A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I %28%classical; CSA%29% is early childhood onset in the second year of life; type II %28%congenital; CSB%29% is early onset at birth with severe symptoms; type III %28%xeroderma pigmentosum; XP%29% is late childhood onset with mild symptoms.%A%
% 209.43/209.57 |- skos__hiddenLabel mesh__D003057 Syndrome, Cockayne
% 209.43/209.57 |- skos__broader mesh__D003057smesh__D000015
% 209.43/209.57 |- skos__prefLabel mesh__D008540 Meiosis
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008540 2006
% 209.43/209.57 |- skos__hiddenLabel mesh__D008540 Meioses
% 209.43/209.57 |- skos__scopeNote mesh__D008540
% 209.43/209.57 A type of CELL NUCLEUS division, occurring during maturation of the GERM CELLS. Two successive cell nucleus divisions following a single chromosome duplication %28%S PHASE%29% result in daughter cells with half the number of CHROMOSOMES as the parent cells.%A%
% 209.43/209.57 |- mesh__dateEstablished mesh__D008540 1968-01-01
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D008540 sjn
% 209.43/209.57 |- rdf__type mesh__D008540sskos__Concept
% 209.43/209.57 |- mesh__historyNote mesh__D008540 68
% 209.43/209.57 |- mesh__dateCreated mesh__D008540 1999-01-01
% 209.43/209.57 |- skos__historyNote mesh__D008540 Cell Division %28%1966-1967%29%
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D008540 68
% 209.43/209.57 |- skos__related mesh__D008540smesh__D016200
% 209.43/209.57 |- mesh__recordOriginator mesh__D008540 NLM
% 209.43/209.57 |- mesh__recordMaintainer mesh__D008540 nns
% 209.43/209.57 |- skos__broader mesh__D008540smesh__D048750
% 209.43/209.57 |- mesh__dateRevised mesh__D008540 2005-06-30
% 209.43/209.57 |- skos__altLabel mesh__D008540 Meiotic M Phase
% 209.43/209.57 |- mesh__dateCreated mesh__D013485 1980-03-07
% 209.43/209.57 |- skos__broader mesh__D013485smesh__D052288
% 209.43/209.57 |- skos__altLabel mesh__D013485 Support, Non-U.S. Gov%27%t
% 209.43/209.57 |- mesh__historyNote mesh__D013485 2005 %28%1981%29%
% 209.43/209.57 |- rdf__type mesh__D013485sskos__Concept
% 209.43/209.57 |- mesh__dateEstablished mesh__D013485 1981-01-01
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D013485 sjn
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D013485 2006
% 209.43/209.57 |- skos__altLabel mesh__D013485 Support, Non U.S. Govt
% 209.43/209.57 |- mesh__recordMaintainer mesh__D013485 jls
% 209.43/209.57 |- mesh__dateRevised mesh__D013485 2005-06-30
% 209.43/209.57 |- mesh__recordOriginator mesh__D013485 SMH
% 209.43/209.57 |- skos__altLabel mesh__D013485 Support, Non U.S. Gov%27%t
% 209.43/209.57 |- skos__prefLabel mesh__D013485 Research Support, Non-U.S. Gov%27%t
% 209.43/209.57 |- skos__annotation mesh__D013485
% 209.43/209.57 for all articles noted as supported by American sources %28%societies, institutes, state governments, universities, private organizations, etc.%29% or by foreign sources %28%national, departmental, provincial, academic %26% private organizations%29%, etc; CATALOG: do not use%A%
% 209.43/209.57 |- skos__altLabel mesh__D013485 Support, Non-U.S. Govt
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D007448 2006
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D007448 2006A
% 209.43/209.57 |- mesh__recordOriginator mesh__D007448 NLM
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D007448 2004
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D007448 sjn
% 209.43/209.57 |- skos__prefLabel mesh__D007448 Invertebrates
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D007448 2005
% 209.43/209.57 |- skos__broader mesh__D007448smesh__D000818
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D007448
% 209.43/209.57 BRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85%A%
% 209.43/209.57 |- mesh__historyNote mesh__D007448
% 209.43/209.57 BRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85%A%
% 209.43/209.57 |- skos__annotation mesh__D007448
% 209.43/209.57 avoid: too general; prefer specific classes, orders, families %26% genera; IM; qualif permitted but use /embryol %26% /parasitol with caution%A%
% 209.43/209.57 |- skos__scopeNote mesh__D007448 Animals that have no spinal column.
% 209.43/209.57 |- rdf__type mesh__D007448sskos__Concept
% 209.43/209.57 |- mesh__recordMaintainer mesh__D007448 sjn
% 209.43/209.57 |- mesh__onlineNote mesh__D007448
% 209.43/209.57 pre-explosion - INVERTEBRATES %28%PX%29%
% 209.43/209.57 |- mesh__dateCreated mesh__D007448 1999-01-01
% 209.43/209.57 |- mesh__dateRevised mesh__D007448 2005-08-15
% 209.43/209.57 |- skos__broader mesh__D018170smesh__D013449
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D018170 2006
% 209.43/209.57 |- rdf__type mesh__D018170sskos__Concept
% 209.43/209.57 |- skos__hiddenLabel mesh__D018170 Succinate, Sumatriptan
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D018170 sjn
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D018170
% 209.43/209.57 94; SUMATRIPTAN was indexed under INDOLES %26% SULFONAMIDES 1988-93%A%
% 209.43/209.57 |- skos__prefLabel mesh__D018170 Sumatriptan
% 209.43/209.57 |- mesh__dateEstablished mesh__D018170 1994-01-01
% 209.43/209.57 |- skos__altLabel mesh__D018170
% 209.43/209.57 3-%28%2-%28%Dimethylamino%29%ethyl%29%-N-methyl-1H-indole-5-methanesulfonamide
% 209.43/209.57 |- mesh__onlineNote mesh__D018170
% 209.43/209.57 use SUMATRIPTAN %28%NM%29% to search SUMATRIPTAN 1988-93
% 209.43/209.57 |- skos__scopeNote mesh__D018170
% 209.43/209.57 A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.%A%
% 209.43/209.57 |- skos__historyNote mesh__D018170 Indoles %28%1988-1993%29%
% 209.43/209.57 |- skos__hiddenLabel mesh__D018170 GR43175
% 209.43/209.57 |- mesh__historyNote mesh__D018170
% 209.43/209.57 94; was SUMATRIPTAN %28%NM%29% 1988-93
% 209.43/209.57 |- skos__hiddenLabel mesh__D018170 GR 43175
% 209.43/209.57 |- mesh__recordMaintainer mesh__D018170 ssb
% 209.43/209.57 |- mesh__dateRevised mesh__D018170 2005-06-30
% 209.43/209.57 |- mesh__dateCreated mesh__D018170 1993-06-04
% 209.43/209.57 |- skos__historyNote mesh__D018170 Sulfonamides %28%1988-1993%29%
% 209.43/209.57 |- mesh__recordOriginator mesh__D018170 TPW
% 209.43/209.57 |- skos__broader mesh__D018170smesh__D014363
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D026602 2003
% 209.43/209.57 |- skos__scopeNote mesh__D026602
% 209.43/209.57 Nerve cells where transmission is mediated by NITRIC OXIDE.%A%
% 209.43/209.57 |- skos__altLabel mesh__D026602 Nitroxidergic Neurons
% 209.43/209.57 |- skos__broader mesh__D026602smesh__D009474
% 209.43/209.57 |- mesh__dateCreated mesh__D026602 2001-07-25
% 209.43/209.57 |- skos__altLabel mesh__D026602 Neurons, Nitrergic
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D026602 2004
% 209.43/209.57 |- skos__altLabel mesh__D026602 Neurons, Nitroxidergic
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D026602 2002
% 209.43/209.57 |- skos__prefLabel mesh__D026602 Nitrergic Neurons
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D026602 2005
% 209.43/209.57 |- mesh__historyNote mesh__D026602 2002
% 209.43/209.57 |- skos__hiddenLabel mesh__D026602 Nitrergic Neuron
% 209.43/209.57 |- skos__hiddenLabel mesh__D026602 Neuron, Nitroxidergic
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D026602 2006
% 209.43/209.57 |- skos__altLabel mesh__D026602 Nitroxidergic Nerves
% 209.43/209.57 |- skos__hiddenLabel mesh__D026602 Neuron, Nitrergic
% 209.43/209.57 |- rdf__type mesh__D026602sskos__Concept
% 209.43/209.57 |- mesh__dateEstablished mesh__D026602 2002-01-01
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D026602 2002
% 209.43/209.57 |- skos__hiddenLabel mesh__D026602 Nitroxidergic Neuron
% 209.43/209.57 |- skos__historyNote mesh__D026602 Neurons %28%1992-2001%29%
% 209.43/209.57 |- skos__prefLabel mesh__D004150 Dipeptidases
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D004150 2004
% 209.43/209.57 |- mesh__dateCreated mesh__D004150 1999-01-01
% 209.43/209.57 |- mesh__recordMaintainer mesh__D004150 ssb
% 209.43/209.57 |- mesh__recordOriginator mesh__D004150 NLM
% 209.43/209.57 |- rdf__type mesh__D004150sskos__Concept
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D004150 sjn
% 209.43/209.57 |- skos__scopeNote mesh__D004150
% 209.43/209.57 EXOPEPTIDASES that specifically act on dipeptides. EC 3.4.13.%A%
% 209.43/209.57 |- mesh__dateRevised mesh__D004150 2003-07-09
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D004150 2006
% 209.43/209.57 |- skos__broader mesh__D004150smesh__D020689
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D004150 2005
% 209.43/209.57 |- skos__related mesh__D045567smesh__D015321
% 209.43/209.57 |- skos__hiddenLabel mesh__D045567 V D J Recombinase
% 209.43/209.57 |- mesh__dateCreated mesh__D045567 2003-07-09
% 209.43/209.57 |- skos__hiddenLabel mesh__D045567 Recombinases, VDJ
% 209.43/209.57 |- mesh__dateEstablished mesh__D045567 2004-01-01
% 209.43/209.57 |- skos__altLabel mesh__D045567 V-%28%D%29%-J Recombinase
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D045567
% 209.43/209.57 2004; VDJ RECOMBINASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1986-2003%A%
% 209.43/209.57 |- skos__altLabel mesh__D045567 V-D-J Recombinase
% 209.43/209.57 |- skos__prefLabel mesh__D045567 VDJ Recombinases
% 209.43/209.57 |- skos__hiddenLabel mesh__D045567 Recombinases, Immunoglobulin
% 209.43/209.57 |- skos__hiddenLabel mesh__D045567 Recombinase, VDJ
% 209.43/209.57 |- skos__altLabel mesh__D045567 VDJ Recombinase
% 209.43/209.57 |- rdf__type mesh__D045567sskos__Concept
% 209.43/209.57 |- skos__broader mesh__D045567smesh__D045522
% 209.43/209.57 |- skos__hiddenLabel mesh__D045567 Recombinase, Immunoglobulin
% 209.43/209.57 |- mesh__historyNote mesh__D045567
% 209.43/209.57 2004; use VDJ RECOMBINASES %28%NM%29% 1986-2003
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D045567 2006
% 209.43/209.57 |- skos__broader mesh__D045567smesh__D009713
% 209.43/209.57 |- skos__historyNote mesh__D045567
% 209.43/209.57 DNA Nucleotidyltransferases %28%1986-2003%29%
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D045567 2005
% 209.43/209.57 |- skos__altLabel mesh__D045567 V%28%D%29%J Recombinase
% 209.43/209.57 |- skos__altLabel mesh__D045567 Immunoglobulin Recombinase
% 209.43/209.57 |- skos__hiddenLabel mesh__D045567 Recombinase, V-D-J
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D045567 2004
% 209.43/209.57 |- skos__scopeNote mesh__D045567
% 209.43/209.57 Recombinases involved in the rearrangement of immunity-related GENES such as IMMUNOGLOBULIN GENES and T-CELL RECEPTOR GENES.%A%
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D050701 2006B
% 209.43/209.57 |- skos__hiddenLabel mesh__D050701 Transcription Factor E2F 6
% 209.43/209.57 |- mesh__recordMaintainer mesh__D050701 ags
% 209.43/209.57 |- skos__altLabel mesh__D050701 E2F Transcription Factor 6 Protein
% 209.43/209.57 |- skos__historyNote mesh__D050701 Transcription Factors %28%1991-2005%29%
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D050701 2006
% 209.43/209.57 |- skos__scopeNote mesh__D050701
% 209.43/209.57 An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F6 recruits chromatin remodeling factors directly to target gene promoters and lacks the transactivation domain responsible for binding to the retinoblastoma family of tumor suppressors.%A%
% 209.43/209.57 |- rdf__type mesh__D050701sskos__Concept
% 209.43/209.57 |- skos__broader mesh__D050701smesh__D050684
% 209.43/209.57 |- mesh__dateEstablished mesh__D050701 2006-01-01
% 209.43/209.57 |- mesh__dateCreated mesh__D050701 2005-06-30
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D050701 2006A
% 209.43/209.57 |- skos__altLabel mesh__D050701 Transcription Factor E2F-6
% 209.43/209.57 |- mesh__historyNote mesh__D050701 2006%28%2004%29%
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D050701
% 209.43/209.57 2006; E2F6 TRANSCRIPTION FACTOR, E2F TRANSCRIPTION FACTOR 6 PROTEIN, %26% TRANSCRIPTION FACTOR E2F-6 were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTIONS FACTORS 2004-2005%A%
% 209.43/209.57 |- skos__prefLabel mesh__D050701 E2F6 Transcription Factor
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D050701 ags
% 209.43/209.57 |- skos__historyNote mesh__D050701 DNA-Binding Proteins %28%1991-2005%29%
% 209.43/209.57 |- skos__historyNote mesh__D050701 Cell Cycle Proteins %28%1991-2005%29%
% 209.43/209.57 |- skos__hiddenLabel mesh__D050701 Transcription Factor, E2F6
% 209.43/209.57 |- mesh__recordOriginator mesh__D050701 DRC
% 209.43/209.57 |- skos__annotation mesh__D050701 see SCR for organism-specific terms
% 209.43/209.57 |- skos__hiddenLabel mesh__D050701 E2F-6, Transcription Factor
% 209.43/209.57 |- mesh__dateRevised mesh__D050701 2005-08-02
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D017078 93
% 209.43/209.57 |- skos__broader mesh__D017078smesh__D003935
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D017078 SJN
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D017078 2005
% 209.43/209.57 |- skos__prefLabel mesh__D017078 Laser-Doppler Flowmetry
% 209.43/209.57 |- skos__annotation mesh__D017078
% 209.43/209.57 measurement of Doppler eff of laser light in microcirc studies %26% diag; index laser velocimeters %26% Doppler velocimeters here with /instrum %26% do not coord with LASERS or DOPPLER EFFECT%A%
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D017078 2001
% 209.43/209.57 |- skos__hiddenLabel mesh__D017078 Laser Doppler Velocimetry
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D017078 2006
% 209.43/209.57 |- skos__altLabel mesh__D017078 Doppler-Laser Flowmetry
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D017078 2002
% 209.43/209.57 |- mesh__dateCreated mesh__D017078 1992-05-20
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D017078 1998
% 209.43/209.57 |- mesh__dateRevised mesh__D017078 1997-06-20
% 209.43/209.57 |- skos__hiddenLabel mesh__D017078 Velocimetry, Laser Doppler
% 209.43/209.57 |- mesh__recordMaintainer mesh__D017078 PXP
% 209.43/209.57 |- skos__hiddenLabel mesh__D017078 Laser Doppler Flowmetry
% 209.43/209.57 |- skos__altLabel mesh__D017078 Laser-Doppler Velocimetry
% 209.43/209.57 |- rdf__type mesh__D017078sskos__Concept
% 209.43/209.57 |- skos__scopeNote mesh__D017078
% 209.43/209.57 A method of non-invasive, continuous measurement of microcirculation. The technique is based on the values of the Doppler effect of low-power laser light scattered randomly by static structures and moving tissue particulates.%A%
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D017078 1999
% 209.43/209.57 |- skos__hiddenLabel mesh__D017078 Flowmetry, Laser Doppler
% 209.43/209.57 |- mesh__dateEstablished mesh__D017078 1993-01-01
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D017078 2003
% 209.43/209.57 |- skos__historyNote mesh__D017078 Doppler Effect %28%1975-1992%29%
% 209.43/209.57 |- skos__hiddenLabel mesh__D017078 Flowmetry, Doppler-Laser
% 209.43/209.57 |- mesh__historyNote mesh__D017078 93
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D017078 2004
% 209.43/209.57 |- skos__altLabel mesh__D017078 Flowmetry, Laser-Doppler
% 209.43/209.57 |- mesh__recordOriginator mesh__D017078 TGC
% 209.43/209.57 |- skos__broader mesh__D017078smesh__D012212
% 209.43/209.57 |- skos__historyNote mesh__D017078 Lasers %28%1966-1992%29%
% 209.43/209.57 |- skos__hiddenLabel mesh__D017078 Doppler Laser Flowmetry
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D017078 2000
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D003856
% 209.43/209.57 78; FLUORODEOXYURIDYLATE was see under URACIL NUCLEOTIDES 1975-77%A%
% 209.43/209.57 |- mesh__recordMaintainer mesh__D003856 TGC
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 2004
% 209.43/209.57 |- skos__historyNote mesh__D003856 Deoxyribonucleotides %28%1973-1977%29%
% 209.43/209.57 |- skos__scopeNote mesh__D003856
% 209.43/209.57 Uracil nucleotides which contain deoxyribose as the sugar moiety.%A%
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 2000
% 209.43/209.57 |- mesh__recordOriginator mesh__D003856 RLS
% 209.43/209.57 |- mesh__dateRevised mesh__D003856 1992-05-13
% 209.43/209.57 |- mesh__dateCreated mesh__D003856 1977-05-17
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 2003
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 1995
% 209.43/209.57 |- skos__historyNote mesh__D003856 Uracil Nucleotides %28%1966-1977%29%
% 209.43/209.57 |- mesh__historyNote mesh__D003856 78
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 1999
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 1994
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D003856 PLS
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 1993
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 1998
% 209.43/209.57 |- skos__annotation mesh__D003856 /biosyn /physiol permitted
% 209.43/209.57 |- mesh__dateEstablished mesh__D003856 1978-01-01
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 2006
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 1997
% 209.43/209.57 |- skos__prefLabel mesh__D003856 Deoxyuracil Nucleotides
% 209.43/209.57 |- skos__altLabel mesh__D003856 Deoxyuridine Phosphates
% 209.43/209.57 |- skos__hiddenLabel mesh__D003856 Phosphates, Deoxyuridine
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 2002
% 209.43/209.57 |- skos__broader mesh__D003856smesh__D003854
% 209.43/209.57 |- skos__hiddenLabel mesh__D003856 Nucleotides, Deoxyuracil
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 2005
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 1996
% 209.43/209.57 |- skos__broader mesh__D003856smesh__D014500
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003856 2001
% 209.43/209.57 |- rdf__type mesh__D003856sskos__Concept
% 209.43/209.57 |- rdf__type mesh__D003058sskos__Concept
% 209.43/209.57 |- mesh__recordOriginator mesh__D003058 NLM
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D003058 sjn
% 209.43/209.57 |- mesh__publicMeSHNote mesh__D003058
% 209.43/209.57 72; for DICTYOPTERA see ORTHOPTERA 1986-98, see DICTYOPTERA 1975-85%A%
% 209.43/209.57 |- skos__prefLabel mesh__D003058 Cockroaches
% 209.43/209.57 |- skos__altLabel mesh__D003058 Cockroach
% 209.43/209.57 |- skos__broader mesh__D003058smesh__D007313
% 209.43/209.57 |- mesh__dateRevised mesh__D003058 2003-07-09
% 209.43/209.57 |- skos__historyNote mesh__D003058 Insects %28%1966-1971%29%
% 209.43/209.57 |- mesh__dateCreated mesh__D003058 1999-01-01
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003058 2005
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003058 2006
% 209.43/209.57 |- mesh__dateEstablished mesh__D003058 1972-01-01
% 209.43/209.57 |- skos__scopeNote mesh__D003058
% 209.43/209.57 Insects of the order Dictyoptera comprising several families including Blaberidae, BLATTELLIDAE, Blattidae %28%containing the American cockroach PERIPLANETA americana%29%, Cryptocercidae, and Polyphagidae.%A%
% 209.43/209.57 |- skos__annotation mesh__D003058
% 209.43/209.57 do not use /drug eff for insecticides: TN 111
% 209.43/209.57 |- skos__altLabel mesh__D003058 Dictyoptera
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D003058 2004
% 209.43/209.57 |- mesh__recordMaintainer mesh__D003058 ags
% 209.43/209.57 |- mesh__historyNote mesh__D003058
% 209.43/209.57 72; for DICTYOPTERA use ORTHOPTERA 1975-98
% 209.43/209.57 |- skos__broader mesh__D004194Q000662smesh__D004194
% 209.43/209.57 |- mesh__preferredCombination mesh__D004194Q000662smesh__D000820
% 209.43/209.57 |- rdf__type mesh__D004194Q000662smesh__CompoundConcept
% 209.43/209.57 |- mesh__recordOriginator mesh__D008541 NLM
% 209.43/209.57 |- skos__prefLabel mesh__D008541 Mekong Valley
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 2001
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1995
% 209.43/209.57 |- rdf__type mesh__D008541sskos__Concept
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 2004
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1991
% 209.43/209.57 |- mesh__dateCreated mesh__D008541 1999-01-01
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 2000
% 209.43/209.57 |- mesh__historyNote mesh__D008541 75
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1994
% 209.43/209.57 |- skos__scopeNote mesh__D008541
% 209.43/209.57 The geographic area of the Mekong Valley in general or when the specific country or countries are not indicated. Usually includes Cambodia, Indochina, and Laos.%A%
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 2003
% 209.43/209.57 |- mesh__recordMaintainer mesh__D008541 HMM
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1990
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1993
% 209.43/209.57 |- mesh__dateRevised mesh__D008541 1978-03-30
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1999
% 209.43/209.57 |- skos__broader mesh__D008541smesh__D001210
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1992
% 209.43/209.57 |- mesh__recordAuthorizer mesh__D008541 NLM
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1998
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1997
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1989
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 2006
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 2002
% 209.43/209.57 |- mesh__dateEstablished mesh__D008541 1975-01-01
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 1996
% 209.43/209.57 |- mesh__activeMeSHYear mesh__D008541 2005
% 209.43/209.58 |- mesh__historyNote mesh__D013486
% 209.43/209.58 2005; was SUPPORT, U.S. Gov%27%t, Non-P.H.S. 1981-2004; was UNITED STATES GOV%27%T SUPPORTED %28%used for U.S. gov%27%t agencies other than P.H.S.%29% 1979-1980; UNITED STATES GOV%27%T SUPPORTED, N.I.H. %26% UNITED STATES GOV%27%T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-77 %28%UNITED STATES was U.S. 1977; GOV%27%T WAS GOVERNMENT 1975-1976%29%%A%
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D013486 ags
% 209.43/209.58 |- rdf__type mesh__D013486sskos__Concept
% 209.43/209.58 |- mesh__recordOriginator mesh__D013486 NLM
% 209.43/209.58 |- skos__annotation mesh__D013486
% 209.43/209.58 for all articles noted as supported by US Government agencies other than PHS %26% NIH %28%which is RESEARCH SUPPORT, U.S. GOV%27%T, P.H.S.;%29%; National Science Foundation support is checked here, National Academy of Sciences %26% National Research Council support are checked RESEARCH SUPPORT, NON-U.S. GOVT; CATALOG: do not use%A%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D013486 2006
% 209.43/209.58 |- skos__prefLabel mesh__D013486
% 209.43/209.58 Research Support, U.S. Gov%27%t, Non-P.H.S.
% 209.43/209.58 |- skos__altLabel mesh__D013486 Support, U.S. Gov%27%t, Non P.H.S.
% 209.43/209.58 |- skos__broader mesh__D013486smesh__D052288
% 209.43/209.58 |- mesh__dateCreated mesh__D013486 1975-02-04
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D013486 2006A
% 209.43/209.58 |- mesh__recordMaintainer mesh__D013486 ags
% 209.43/209.58 |- mesh__dateEstablished mesh__D013486 1979-01-01
% 209.43/209.58 |- skos__altLabel mesh__D013486 Support, U.S. Govt, Non-P.H.S.
% 209.43/209.58 |- skos__altLabel mesh__D013486 Support, U.S. Govt, Non P.H.S.
% 209.43/209.58 |- mesh__dateRevised mesh__D013486 2005-07-28
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D013486 2006B
% 209.43/209.58 |- skos__altLabel mesh__D013486
% 209.43/209.58 United States Gov%27%t Supported, Non-P.H.S.
% 209.43/209.58 |- mesh__historyNote mesh__D007449 68%28%64%29%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 1996
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 2004
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 2005
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 2002
% 209.43/209.58 |- skos__hiddenLabel mesh__D007449 Investment
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D007449 NLM
% 209.43/209.58 |- mesh__dateEstablished mesh__D007449 1968-01-01
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 2003
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 1995
% 209.43/209.58 |- rdf__type mesh__D007449sskos__Concept
% 209.43/209.58 |- mesh__recordOriginator mesh__D007449 NLM
% 209.43/209.58 |- skos__prefLabel mesh__D007449 Investments
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 2001
% 209.43/209.58 |- mesh__recordMaintainer mesh__D007449 PLS
% 209.43/209.58 |- mesh__dateCreated mesh__D007449 1999-01-01
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 1999
% 209.43/209.58 |- skos__scopeNote mesh__D007449
% 209.43/209.58 Use for articles on the investing of funds for income or profit.%A%
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D007449 68
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 2000
% 209.43/209.58 |- mesh__dateRevised mesh__D007449 1993-09-16
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 1997
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 1998
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D007449 2006
% 209.43/209.58 |- skos__broader mesh__D007449smesh__D004467
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D018171
% 209.43/209.58 94; AGRIN was indexed under NERVE TISSUE PROTEINS 1988-93%A%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 2002
% 209.43/209.58 |- mesh__historyNote mesh__D018171 94; was AGRIN %28%NM%29% 1988-93
% 209.43/209.58 |- skos__broader mesh__D018171smesh__D009419
% 209.43/209.58 |- mesh__onlineNote mesh__D018171
% 209.43/209.58 use AGRIN %28%NM%29% to search AGRIN 1988-93
% 209.43/209.58 |- mesh__dateEstablished mesh__D018171 1994-01-01
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 1996
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 2003
% 209.43/209.58 |- skos__annotation mesh__D018171 a nerve tissue protein
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 2000
% 209.43/209.58 |- skos__scopeNote mesh__D018171
% 209.43/209.58 A protein component of the synaptic basal lamina. It has been shown to induce clustering of acetylcholine receptors on the surface of muscle fibers and other synaptic molecules in both synapse regeneration and development.%A%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 1998
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 2005
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 1997
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 2004
% 209.43/209.58 |- mesh__dateCreated mesh__D018171 1993-06-16
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 1994
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 2001
% 209.43/209.58 |- skos__prefLabel mesh__D018171 Agrin
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 1999
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 2006
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018171 1995
% 209.43/209.58 |- rdf__type mesh__D018171sskos__Concept
% 209.43/209.58 |- skos__historyNote mesh__D018171 Nerve Tissue Proteins %28%1988-1993%29%
% 209.43/209.58 |- skos__hiddenLabel mesh__D026603 D Aspartate
% 209.43/209.58 |- skos__scopeNote mesh__D026603 The D-isomer of ASPARTIC ACID.
% 209.43/209.58 |- rdf__type mesh__D026603sskos__Concept
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D026603 2005
% 209.43/209.58 |- skos__broader mesh__D026603smesh__D001224
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D026603 2002
% 209.43/209.58 |- skos__altLabel mesh__D026603
% 209.43/209.58 3-hydroxy-N-%28%2-methyl-1-oxo-2-propenyl%29%-
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D026603 2004
% 209.43/209.58 |- mesh__dateCreated mesh__D026603 2001-07-25
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D026603 2003
% 209.43/209.58 |- skos__prefLabel mesh__D026603 D-Aspartic Acid
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D026603 2002
% 209.43/209.58 |- skos__hiddenLabel mesh__D026603 D Aspartic Acid
% 209.43/209.58 |- mesh__dateEstablished mesh__D026603 2002-01-01
% 209.43/209.58 |- skos__historyNote mesh__D026603 Aspartic Acid %28%1966-2001%29%
% 209.43/209.58 |- mesh__historyNote mesh__D026603 2002
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D026603 2006
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004151 2004
% 209.43/209.58 |- skos__prefLabel mesh__D004151 Dipeptides
% 209.43/209.58 |- mesh__dateRevised mesh__D004151 2000-06-22
% 209.43/209.58 |- skos__broader mesh__D004151smesh__D009842
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004151 2002
% 209.43/209.58 |- skos__scopeNote mesh__D004151
% 209.43/209.58 Peptides composed of two amino acid units.
% 209.43/209.58 |- rdf__type mesh__D004151sskos__Concept
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004151 2005
% 209.43/209.58 |- mesh__recordOriginator mesh__D004151 NLM
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004151 2006
% 209.43/209.58 |- mesh__recordMaintainer mesh__D004151 adp
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D004151 sjn
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004151 2001
% 209.43/209.58 |- mesh__dateCreated mesh__D004151 1999-01-01
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004151 2003
% 209.43/209.58 |- mesh__dateCreated mesh__D045568 2003-07-09
% 209.43/209.58 |- skos__hiddenLabel mesh__D045568 Tetra Oxanes
% 209.43/209.58 |- skos__altLabel mesh__D045568 Tetra-Oxanes
% 209.43/209.58 |- mesh__recordMaintainer mesh__D045568 ssb
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D045568 2004
% 209.43/209.58 |- rdf__type mesh__D045568sskos__Concept
% 209.43/209.58 |- mesh__recordOriginator mesh__D045568 ssb
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D045568 sjn
% 209.43/209.58 |- skos__altLabel mesh__D045568 Tetroxanes
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D045568 2006
% 209.43/209.58 |- skos__annotation mesh__D045568
% 209.43/209.58 coord with appropriate specific chemical terms if pertinent%A%
% 209.43/209.58 |- mesh__dateRevised mesh__D045568 2005-06-30
% 209.43/209.58 |- mesh__dateEstablished mesh__D045568 2004-01-01
% 209.43/209.58 |- skos__scopeNote mesh__D045568
% 209.43/209.58 Compounds with two peroxide groups, that is, two pairs of adjacent OXYGEN atoms. They may have activity against PLASMODIUM similar to the ARTEMISININS.%A%
% 209.43/209.58 |- mesh__historyNote mesh__D045568 2004
% 209.43/209.58 |- skos__prefLabel mesh__D045568 Tetraoxanes
% 209.43/209.58 |- skos__broader mesh__D045568smesh__D010545
% 209.43/209.58 |- skos__scopeNote mesh__D017877
% 209.43/209.58 A family of ESOCIFORMES comprising the mudminnows. There are three genera: Dallia, Novumbra, and Umbra, with much disagreement about their taxonomic interrelations. The Umbridae are freshwater fish inhabiting parts of the Northern Hemisphere.%A%
% 209.43/209.58 |- mesh__recordOriginator mesh__D017877 TGC
% 209.43/209.58 |- mesh__historyNote mesh__D017877 1994
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D017877 1994
% 209.43/209.58 |- skos__broader mesh__D017877smesh__D023661
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D017877 sjn
% 209.43/209.58 |- skos__hiddenLabel mesh__D017877 Mudminnow
% 209.43/209.58 |- mesh__recordMaintainer mesh__D017877 ags
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017877 2005
% 209.43/209.58 |- skos__prefLabel mesh__D017877 Umbridae
% 209.43/209.58 |- skos__annotation mesh__D017877
% 209.43/209.58 note X ref; MINNOWS see CYPRINIDAE is also available
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017877 2004
% 209.43/209.58 |- rdf__type mesh__D017877sskos__Concept
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017877 2006
% 209.43/209.58 |- mesh__dateRevised mesh__D017877 2003-07-09
% 209.43/209.58 |- mesh__dateCreated mesh__D017877 1992-12-28
% 209.43/209.58 |- skos__altLabel mesh__D017877 Mudminnows
% 209.43/209.58 |- mesh__dateEstablished mesh__D017877 1994-01-01
% 209.43/209.58 |- skos__hiddenLabel mesh__D050702 Transcription Factor E2F 7
% 209.43/209.58 |- rdf__type mesh__D050702sskos__Concept
% 209.43/209.58 |- skos__altLabel mesh__D050702 Transcription Factor E2F-7
% 209.43/209.58 |- skos__historyNote mesh__D050702 DNA-Binding Proteins %28%1991-2005%29%
% 209.43/209.58 |- skos__annotation mesh__D050702 see SCR for organism-specific terms
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D050702
% 209.43/209.58 2006; E2F7 TRANSCRIPTION FACTOR; E2F TRANSCRIPTION FACTOR 7 PROTEIN; %26% TRANSCRIPTION FACTOR E2F-7 were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTIONS FACTORS 1991-2005%A%
% 209.43/209.58 |- skos__hiddenLabel mesh__D050702 Transcription Factor, E2F7
% 209.43/209.58 |- mesh__dateRevised mesh__D050702 2005-07-13
% 209.43/209.58 |- skos__historyNote mesh__D050702 Transcription Factors %28%1991-2005%29%
% 209.43/209.58 |- skos__scopeNote mesh__D050702
% 209.43/209.58 An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F7 has two separate DNA-binding domains and binds to DNA independently of a dimerization partner.%A%
% 209.43/209.58 |- skos__broader mesh__D050702smesh__D050684
% 209.43/209.58 |- skos__altLabel mesh__D050702 E2F Transcription Factor 7 Protein
% 209.43/209.58 |- mesh__dateEstablished mesh__D050702 2006-01-01
% 209.43/209.58 |- mesh__dateCreated mesh__D050702 2005-06-30
% 209.43/209.58 |- mesh__historyNote mesh__D050702 2006%28%1991%29%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D050702 2006A
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D050702 ags
% 209.43/209.58 |- mesh__recordOriginator mesh__D050702 DRC
% 209.43/209.58 |- skos__historyNote mesh__D050702 Cell Cycle Proteins %28%1991-2005%29%
% 209.43/209.58 |- skos__prefLabel mesh__D050702 E2F7 Transcription Factor
% 209.43/209.58 |- mesh__recordMaintainer mesh__D050702 ags
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D050702 2006
% 209.43/209.58 |- mesh__dateCreated mesh__D017079 1992-05-26
% 209.43/209.58 |- rdf__type mesh__D017079sskos__Concept
% 209.43/209.58 |- mesh__historyNote mesh__D017079 93
% 209.43/209.58 |- skos__broader mesh__D017079smesh__D010807
% 209.43/209.58 |- skos__scopeNote mesh__D017079
% 209.43/209.58 The exercise capacity of an individual as measured by endurance %28%maximal exercise duration and/or maximal attained work load%29% during an EXERCISE TEST.%A%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017079 2004
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D017079 93
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017079 2005
% 209.43/209.58 |- skos__hiddenLabel mesh__D017079 Tolerance, Exercise
% 209.43/209.58 |- skos__prefLabel mesh__D017079 Exercise Tolerance
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017079 2006
% 209.43/209.58 |- mesh__dateRevised mesh__D017079 2003-07-09
% 209.43/209.58 |- mesh__dateEstablished mesh__D017079 1993-01-01
% 209.43/209.58 |- skos__historyNote mesh__D017079 Exercise Test %28%1966-1992%29%
% 209.43/209.58 |- mesh__dateRevised mesh__D003857 1995-06-08
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 1998
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 2002
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D003857 66
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 2006
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 1997
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 2001
% 209.43/209.58 |- mesh__dateEstablished mesh__D003857 1966-01-01
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 2005
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 1996
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 2000
% 209.43/209.58 |- mesh__recordOriginator mesh__D003857 NLM
% 209.43/209.58 |- mesh__historyNote mesh__D003857 66%28%64%29%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 2004
% 209.43/209.58 |- rdf__type mesh__D003857sskos__Concept
% 209.43/209.58 |- mesh__recordMaintainer mesh__D003857 JRT
% 209.43/209.58 |- skos__annotation mesh__D003857 an antimetabolite
% 209.43/209.58 |- skos__prefLabel mesh__D003857 Deoxyuridine
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 2003
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D003857 PLS
% 209.43/209.58 |- skos__altLabel mesh__D003857
% 209.43/209.58 %28%beta 1-%28%2-Deoxyribopyranosyl%29%%29%thymidine
% 209.43/209.58 |- skos__broader mesh__D003857smesh__D003853
% 209.43/209.58 |- mesh__dateCreated mesh__D003857 1999-01-01
% 209.43/209.58 |- skos__broader mesh__D003857smesh__D014529
% 209.43/209.58 |- skos__scopeNote mesh__D003857
% 209.43/209.58 2%27%-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies.%A%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003857 1999
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D003059
% 209.43/209.58 91,63-85; was see under NUTS 1986-90; was heading 1963-85%A%
% 209.43/209.58 |- mesh__dateCreated mesh__D003059 1999-01-01
% 209.43/209.58 |- skos__annotation mesh__D003059
% 209.43/209.58 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003059 2005
% 209.43/209.58 |- skos__scopeNote mesh__D003059
% 209.43/209.58 A plant genus of the family ARECACEAE. It is a tropical palm tree that yields a large, edible hard-shelled fruit from which oil and fiber are also obtained.%A%
% 209.43/209.58 |- mesh__recordOriginator mesh__D003059 NLM
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003059 2006
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D003059 sjn
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003059 2003
% 209.43/209.58 |- skos__prefLabel mesh__D003059 Cocos
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003059 2004
% 209.43/209.58 |- mesh__historyNote mesh__D003059
% 209.43/209.58 91%28%86%29%63; was see under NUTS 1986-90; was heading 1963-85; was in Cat J only 1963-80%A%
% 209.43/209.58 |- mesh__recordMaintainer mesh__D003059 ssb
% 209.43/209.58 |- rdf__type mesh__D003059sskos__Concept
% 209.43/209.58 |- mesh__dateRevised mesh__D003059 2002-07-03
% 209.43/209.58 |- skos__altLabel mesh__D003059 Cocoanut
% 209.43/209.58 |- skos__broader mesh__D003059smesh__D028023
% 209.43/209.58 |- mesh__dateEstablished mesh__D003059 1991-01-01
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D008542 2002
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D008542 sjn
% 209.43/209.58 |- mesh__historyNote mesh__D008542 68
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D008542 2003
% 209.43/209.58 |- mesh__recordOriginator mesh__D008542 NLM
% 209.43/209.58 |- skos__scopeNote mesh__D008542
% 209.43/209.58 The collective name for the islands of the Pacific Ocean northeast of Australia, including NEW CALEDONIA; VANUATU; New Hebrides, Solomon Islands, Admiralty Islands, Bismarck Archipelago, FIJI, etc. Melanesia %28%from the Greek melas, black + nesos, island%29% is so called from the black color of the natives who are generally considered to be descended originally from the Negroid Papuans and the Polynesians or Malays. %28%From Webster%27%s New Geographical Dictionary, 1988, p748 %26% Room, Brewer%27%s Dictionary of Names, 1992, p344%29%%A%
% 209.43/209.58 |- mesh__recordMaintainer mesh__D008542 mdb
% 209.43/209.58 |- skos__annotation mesh__D008542
% 209.43/209.58 a group of islands northeast of Australia; includes, in addition to indentions %26% X refs, Norfolk Island; Melanesians are of Negroid race unless otherwise specified%A%
% 209.43/209.58 |- skos__broader mesh__D008542smesh__D010139
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D008542 2006
% 209.43/209.58 |- mesh__dateRevised mesh__D008542 2001-07-25
% 209.43/209.58 |- skos__prefLabel mesh__D008542 Melanesia
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D008542 2005
% 209.43/209.58 |- rdf__type mesh__D008542sskos__Concept
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D008542 2004
% 209.43/209.58 |- mesh__dateCreated mesh__D008542 1999-01-01
% 209.43/209.58 |- skos__annotation mesh__D013487
% 209.43/209.58 for all articles noted as supported by PHS %26% its bureaus %26% services; includes support by any institute of NIH; support by BRSG %28%Biomedical Research Support Grants%29% goes here; CATALOG: do not use%A%
% 209.43/209.58 |- skos__altLabel mesh__D013487 Support, U.S. Govt, P.H.S.
% 209.43/209.58 |- mesh__historyNote mesh__D013487
% 209.43/209.58 2005; was SUPPORT, U.S. Gov%27%t P.H.S 1981-2004; was UNITED STATES GOV%27%T SUPPORTED, P.H.S. 1979-1980; UNITED STATES GOV%27%T SUPPORTED, N.I.H. %26% UNITED STATES GOV%27%T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-1977 %28%UNITED STATES was U.S. 1977; GOV%27%T was GOVERNMENT 1975-1976%29%%A%
% 209.43/209.58 |- mesh__recordMaintainer mesh__D013487 jls
% 209.43/209.58 |- mesh__dateEstablished mesh__D013487 1979-01-01
% 209.43/209.58 |- mesh__dateRevised mesh__D013487 2005-06-30
% 209.43/209.58 |- skos__altLabel mesh__D013487 Support, U.S. Gov%27%t, N.I.H.
% 209.43/209.58 |- skos__altLabel mesh__D013487 United States Gov%27%t Supported, P.H.S.
% 209.43/209.58 |- skos__prefLabel mesh__D013487 Research Support, U.S. Gov%27%t, P.H.S.
% 209.43/209.58 |- mesh__recordOriginator mesh__D013487 NLM
% 209.43/209.58 |- rdf__type mesh__D013487sskos__Concept
% 209.43/209.58 |- skos__broader mesh__D013487smesh__D052288
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D013487 2006
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D013487 sjn
% 209.43/209.58 |- mesh__dateCreated mesh__D013487 1975-02-04
% 209.43/209.58 |- mesh__recordMaintainer mesh__D018970 jmp
% 209.43/209.58 |- skos__altLabel mesh__D018970 IGFBP-1
% 209.43/209.58 |- skos__historyNote mesh__D018970 Carrier Proteins %28%1992-1995%29%
% 209.43/209.58 |- skos__prefLabel mesh__D018970
% 209.43/209.58 Insulin-Like Growth Factor Binding Protein 1
% 209.43/209.58 |- mesh__dateRevised mesh__D018970 2004-07-07
% 209.43/209.58 |- mesh__recordOriginator mesh__D018970 TPW
% 209.43/209.58 |- skos__altLabel mesh__D018970 IGF-Binding Protein 1
% 209.43/209.58 |- skos__broader mesh__D018970smesh__D018969
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D018970 sjn
% 209.43/209.58 |- mesh__historyNote mesh__D018970 2005%28%1992%29%
% 209.43/209.58 |- skos__scopeNote mesh__D018970
% 209.43/209.58 One of the six homologous proteins that specifically bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions. The function of this protein is not completely defined. However, several studies demonstrate that it inhibits IGF binding to cell surface receptors and thereby inhibits IGF-mediated mitogenic and cell metabolic actions. %28%Proc Soc Exp Biol Med 1993;204%28%1%29%:4-29%29%%A%
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D018970
% 209.43/209.58 2005; see INSULIN-LIKE-GROWTH-FACTOR-BINDING PROTEIN-1 1996-2005; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 was indexed under CARRIER PROTEINS 1992-95%A%
% 209.43/209.58 |- rdf__type mesh__D018970sskos__Concept
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018970 2005
% 209.43/209.58 |- mesh__dateCreated mesh__D018970 1995-06-08
% 209.43/209.58 |- skos__annotation mesh__D018970
% 209.43/209.58 /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018970 2006
% 209.43/209.58 |- skos__hiddenLabel mesh__D018970
% 209.43/209.58 Insulin Like Growth Factor Binding Protein 1
% 209.43/209.58 |- skos__hiddenLabel mesh__D018970 IGF Binding Protein 1
% 209.43/209.58 |- mesh__dateEstablished mesh__D018970 1996-01-01
% 209.43/209.58 |- mesh__dateRevised mesh__D032641 2005-06-30
% 209.43/209.58 |- skos__prefLabel mesh__D032641 Eurotiales
% 209.43/209.58 |- skos__scopeNote mesh__D032641
% 209.43/209.58 An order of fungi in the phylum ASCOMYCOTA characterized by the presence of well defined peridia and cleistothecial asci. Notable anamorphs %28%mitosporic forms%29% of Eurotiales include PENICILLIUM and ASPERGILLUS.%A%
% 209.43/209.58 |- mesh__recordOriginator mesh__D032641 ags
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D032641 2006
% 209.43/209.58 |- mesh__dateCreated mesh__D032641 2002-07-03
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D032641 sjn
% 209.43/209.58 |- mesh__recordMaintainer mesh__D032641 SYSTEM
% 209.43/209.58 |- rdf__type mesh__D032641sskos__Concept
% 209.43/209.58 |- mesh__historyNote mesh__D032641 2003
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D032641 2003
% 209.43/209.58 |- mesh__dateEstablished mesh__D032641 2003-01-01
% 209.43/209.58 |- skos__broader mesh__D032641smesh__D001203
% 209.43/209.58 |- mesh__onlineNote mesh__D018172
% 209.43/209.58 use UNITED STATES OFFICE OF RESEARCH INTEGRITY to search NIH OFFICE OF SCIENTIFIC INTEGRITY, NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY %26% OFFICE OF SCIENTIFIC INTEGRITY %28%U.S.%29% 1991-93%A%
% 209.43/209.58 |- skos__altLabel mesh__D018172
% 209.43/209.58 U.S. Office of the Assistant Secretary for Health Office of Research Integrity
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018172 2005
% 209.43/209.58 |- mesh__recordMaintainer mesh__D018172 ags
% 209.43/209.58 |- skos__altLabel mesh__D018172
% 209.43/209.58 United States Office of the Assistant Secretary for Health Office of Research Integrity
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018172 2006
% 209.43/209.58 |- skos__altLabel mesh__D018172 Office of Research Integrity %28%U.S.%29%
% 209.43/209.58 |- mesh__recordOriginator mesh__D018172 TGC
% 209.43/209.58 |- skos__broader mesh__D018172smesh__D014492
% 209.43/209.58 |- mesh__dateEstablished mesh__D018172 1994-01-01
% 209.43/209.58 |- rdf__type mesh__D018172sskos__Concept
% 209.43/209.58 |- skos__prefLabel mesh__D018172 United States Office of Research Integrity
% 209.43/209.58 |- mesh__dateCreated mesh__D018172 1993-06-03
% 209.43/209.58 |- skos__annotation mesh__D018172
% 209.43/209.58 add UNITED STATES %28%NIM%29%; DF: ORI CATALOG: use NAF entry%A%
% 209.43/209.58 |- skos__scopeNote mesh__D018172
% 209.43/209.58 An office of the UNITED STATES PUBLIC HEALTH SERVICE organized in June 1992 to promote research integrity and investigate misconduct in research supported by the Public Health Service. It consolidates the Office of Scientific Integrity of the National Institutes of Health and the Office of Scientific Integrity Review in the Office of the Assistant Secretary for Health.%A%
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D018172
% 209.43/209.58 94; NIH OFFICE OF SCIENTIFIC INTEGRITY was heading 1991-93; NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY %26% OFFICE OF SCIENTIFIC INTEGRITY %28%U.S.%29% were see NIH OFFICE OF SCIENTIFIC INTEGRITY 1991-93%A%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D018172 2006A
% 209.43/209.58 |- mesh__dateRevised mesh__D018172 2005-07-13
% 209.43/209.58 |- mesh__historyNote mesh__D018172
% 209.43/209.58 1994; NIH OFFICE OF SCIENTIFIC INTEGRITY was heading 1991-1993; NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY %26% OFFICE OF SCIENTIFIC INTEGRITY %28%U.S.%29% were see NIH OFFICE OF SCIENTIFIC INTEGRITY 1991-1993%A%
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D018172 ags
% 209.43/209.58 |- skos__altLabel mesh__D018172 Office of Research Integrity
% 209.43/209.58 |- rdf__type mesh__D004950sskos__Concept
% 209.43/209.58 |- skos__broader mesh__D004950smesh__D006867
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004950 2004
% 209.43/209.58 |- mesh__dateCreated mesh__D004950 1999-01-01
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004950 2006
% 209.43/209.58 |- mesh__dateRevised mesh__D004950 2003-07-09
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004950 2005
% 209.43/209.58 |- mesh__recordOriginator mesh__D004950 NLM
% 209.43/209.58 |- skos__prefLabel mesh__D004950 Esterases
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D004950 sjn
% 209.43/209.58 |- mesh__recordMaintainer mesh__D004950 ssb
% 209.43/209.58 |- skos__scopeNote mesh__D004152
% 209.43/209.58 Enzymes which cleave dipeptides from the amino terminal of a polypeptide. Dipeptidyl peptidase I, II, III, IV are known. They hydrolyze the beta-naphthylamides of glycine-arginine, lysine-alanine, arginine-arginine and glycine-proline, respectively. DIPEPTIDYL PEPTIDASE I is cathepsin C. EC 3.4.14.-.%A%
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D004152 sjn
% 209.43/209.58 |- rdf__type mesh__D004152sskos__Concept
% 209.43/209.58 |- mesh__historyNote mesh__D004152
% 209.43/209.58 86%28%80%29%; was see under ENDOPEPTIDASES 1980-85
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D004152
% 209.43/209.58 86; was see under PEPTIDE PEPTIDOHYDROLASES 1980-85
% 209.43/209.58 |- skos__historyNote mesh__D004152
% 209.43/209.58 Peptide Peptidohydrolases %28%1966-1979%29%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004152 2005
% 209.43/209.58 |- skos__altLabel mesh__D004152 Dipeptidylpeptide Hydrolases
% 209.43/209.58 |- mesh__dateCreated mesh__D004152 1979-05-23
% 209.43/209.58 |- skos__broader mesh__D004152smesh__D020689
% 209.43/209.58 |- skos__altLabel mesh__D004152 Dipeptidyl Aminopeptidases
% 209.43/209.58 |- mesh__recordMaintainer mesh__D004152 ssb
% 209.43/209.58 |- skos__historyNote mesh__D004152 Dipeptidases %28%1966-1979%29%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004152 2006
% 209.43/209.58 |- mesh__dateRevised mesh__D004152 2003-07-09
% 209.43/209.58 |- mesh__dateEstablished mesh__D004152 1986-01-01
% 209.43/209.58 |- skos__prefLabel mesh__D004152 Dipeptidyl Peptidases
% 209.43/209.58 |- mesh__recordOriginator mesh__D004152 RLS
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D004152 2004
% 209.43/209.58 |- skos__historyNote mesh__D004152 Cathepsins %28%1966-1979%29%
% 209.43/209.58 |- skos__broader mesh__D019840Q000031smesh__D019840
% 209.43/209.58 |- mesh__preferredCombination mesh__D019840Q000031smesh__D020005
% 209.43/209.58 |- rdf__type mesh__D019840Q000031smesh__CompoundConcept
% 209.43/209.58 |- mesh__recordMaintainer mesh__D017878 jmp
% 209.43/209.58 |- mesh__recordOriginator mesh__D017878 TPW
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D017878
% 209.43/209.58 2001; see DIDS 1981-2000; 4,4%27%-DISOTHIOCYANOSTILBEN-2,2%27%-DISULFONIC ACID was indexed under SITS/analogs %26% derivatives 1981-1993 %26% STILBENES 1977-1980%A%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017878 2003
% 209.43/209.58 |- mesh__dateEstablished mesh__D017878 1994-01-01
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017878 2005
% 209.43/209.58 |- mesh__dateCreated mesh__D017878 1993-02-16
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017878 2004
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017878 2001
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017878 2006
% 209.43/209.58 |- rdf__type mesh__D017878sskos__Concept
% 209.43/209.58 |- skos__prefLabel mesh__D017878
% 209.43/209.58 4,4%27%-Diisothiocyanostilbene-2,2%27%-Disulfonic Acid
% 209.43/209.58 |- skos__scopeNote mesh__D017878
% 209.43/209.58 An inhibitor of anion conductance including band 3-mediated anion transport.%A%
% 209.43/209.58 |- mesh__historyNote mesh__D017878
% 209.43/209.58 2001%28%1994%29%; use DIDS %28%NM%29% 1977-93
% 209.43/209.58 |- skos__broader mesh__D017878smesh__D017879
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D017878 sjn
% 209.43/209.58 |- skos__historyNote mesh__D017878
% 209.43/209.58 SITS/analogs %26% derivatives %28%1981-1993%29%
% 209.43/209.58 |- mesh__dateRevised mesh__D017878 2000-06-22
% 209.43/209.58 |- skos__broader mesh__D017878smesh__D013267
% 209.43/209.58 |- skos__altLabel mesh__D017878 DIDS
% 209.43/209.58 |- skos__annotation mesh__D017878 DF: DIDS
% 209.43/209.58 |- skos__historyNote mesh__D017878 Stilbenes %28%1977-1980%29%
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D017878 2002
% 209.43/209.58 |- skos__altLabel mesh__D017878
% 209.43/209.58 4,4%27%-Diisothiocyano-2,2%27%-Stilbene Disulfonic Acid
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D050703 2006A
% 209.43/209.58 |- mesh__publicMeSHNote mesh__D050703
% 209.43/209.58 2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, %26% TRANSCRIPTION FACTORS 1993-2005%A%
% 209.43/209.58 |- skos__altLabel mesh__D050703 E2F-2 Protein
% 209.43/209.58 |- mesh__recordAuthorizer mesh__D050703 ags
% 209.43/209.58 |- mesh__historyNote mesh__D050703 2006%28%1993%29%
% 209.43/209.58 |- skos__historyNote mesh__D050703 Transcription Factors %28%1993-2005%29%
% 209.43/209.58 |- mesh__recordOriginator mesh__D050703 DRC
% 209.43/209.58 |- skos__annotation mesh__D050703 see SCR for organism-specific terms
% 209.43/209.58 |- skos__hiddenLabel mesh__D050703 Transcription Factor E2F 2
% 209.43/209.58 |- skos__altLabel mesh__D050703 Transcription Factor E2F-2
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D050703 2006
% 209.43/209.58 |- skos__hiddenLabel mesh__D050703 E2F-2, Transcription Factor
% 209.43/209.58 |- mesh__recordMaintainer mesh__D050703 ags
% 209.43/209.58 |- skos__altLabel mesh__D050703 E2F2 Protein
% 209.43/209.58 |- skos__altLabel mesh__D050703 E2F Transcription Factor 2 Protein
% 209.43/209.58 |- mesh__dateRevised mesh__D050703 2005-07-13
% 209.43/209.58 |- rdf__type mesh__D050703sskos__Concept
% 209.43/209.58 |- skos__hiddenLabel mesh__D050703 Transcription Factor, E2F2
% 209.43/209.58 |- mesh__dateEstablished mesh__D050703 2006-01-01
% 209.43/209.58 |- skos__scopeNote mesh__D050703
% 209.43/209.58 An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A. E2F2 activates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis.%A%
% 209.43/209.58 |- skos__prefLabel mesh__D050703 E2F2 Transcription Factor
% 209.43/209.58 |- skos__broader mesh__D050703smesh__D050684
% 209.43/209.58 |- mesh__dateCreated mesh__D050703 2005-06-30
% 209.43/209.58 |- mesh__dateCreated mesh__D003858 1974-11-11
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003858 2006
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003858 1997
% 209.43/209.58 |- mesh__dateEstablished mesh__D003858 1991-01-01
% 209.43/209.58 |- skos__hiddenLabel mesh__D003858 Burden, Dependency
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003858 2005
% 209.43/209.58 |- mesh__activeMeSHYear mesh__D003858 1996
% 209.43/209.58 |- skos__altLabel mesh__D003858 Dependency
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003858 2002
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003858 2004
% 209.43/209.59 |- mesh__historyNote mesh__D003858
% 209.43/209.59 91%28%75%29%; was see under PERSONALITY 1975-90
% 209.43/209.59 |- rdf__type mesh__D003858sskos__Concept
% 209.43/209.59 |- skos__annotation mesh__D003858 no qualif; DF: DEPENDENCY
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003858 2001
% 209.43/209.59 |- skos__scopeNote mesh__D003858
% 209.43/209.59 The tendency of an individual or individuals to rely on others for advice, guidance, or support.%A%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003858 1995
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003858 2003
% 209.43/209.59 |- skos__broader mesh__D003858smesh__D010551
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003858 2000
% 209.43/209.59 |- skos__prefLabel mesh__D003858 Dependency %28%Psychology%29%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003858 1999
% 209.43/209.59 |- skos__hiddenLabel mesh__D003858 Dependencies %28%Psychology%29%
% 209.43/209.59 |- mesh__recordOriginator mesh__D003858 NLM
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003858 1994
% 209.43/209.59 |- mesh__recordMaintainer mesh__D003858 JLS
% 209.43/209.59 |- mesh__dateRevised mesh__D003858 1993-06-04
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D003858
% 209.43/209.59 91; was see under PERSONALITY 1975-90
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003858 1998
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D003858 PLS
% 209.43/209.59 |- skos__historyNote mesh__D014580 Chenodeoxycholic Acid %28%1973-1979%29%
% 209.43/209.59 |- skos__broader mesh__D014580smesh__D003840
% 209.43/209.59 |- skos__altLabel mesh__D014580 Galen Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Norgine Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Zambon Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Aventis Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- mesh__dateRevised mesh__D014580 2005-06-30
% 209.43/209.59 |- skos__historyNote mesh__D014580 Bile Acids and Salts %28%1966-1972%29%
% 209.43/209.59 |- skos__altLabel mesh__D014580 Ursodiol
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014580 2006
% 209.43/209.59 |- skos__hiddenLabel mesh__D014580 Ursodeoxycholate, Sodium
% 209.43/209.59 |- skos__altLabel mesh__D014580 CP Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Ursacholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580
% 209.43/209.59 Sanofi Synthelabo Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- mesh__historyNote mesh__D014580
% 209.43/209.59 91%28%80%29%; was see under DEOXYCHOLIC ACID 1980-90
% 209.43/209.59 |- skos__altLabel mesh__D014580 Provalis Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Antigen Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Estedi Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- mesh__dateEstablished mesh__D014580 1991-01-01
% 209.43/209.59 |- skos__annotation mesh__D014580
% 209.43/209.59 /biosyn /defic /physiol permitted; urso- refers to its first isol from URSIDAE %28%Latin ursus%29%%A%
% 209.43/209.59 |- skos__hiddenLabel mesh__D014580 Acid, Deoxyursocholic
% 209.43/209.59 |- skos__hiddenLabel mesh__D014580 Acid, Ursodeoxycholic
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D014580 sjn
% 209.43/209.59 |- skos__altLabel mesh__D014580 Falk Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580
% 209.43/209.59 3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
% 209.43/209.59 |- skos__scopeNote mesh__D014580
% 209.43/209.59 An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.%A%
% 209.43/209.59 |- mesh__dateCreated mesh__D014580 1979-05-30
% 209.43/209.59 |- skos__altLabel mesh__D014580 Orphan Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- mesh__recordOriginator mesh__D014580 SH
% 209.43/209.59 |- skos__altLabel mesh__D014580 Niddapharm Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__hiddenLabel mesh__D014580
% 209.43/209.59 3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid
% 209.43/209.59 |- mesh__recordMaintainer mesh__D014580 lkw
% 209.43/209.59 |- skos__prefLabel mesh__D014580 Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Axcan Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Farmasa Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Vita Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D014580
% 209.43/209.59 91; was see under DEOXYCHOLIC ACID 1980-90
% 209.43/209.59 |- skos__hiddenLabel mesh__D014580 Acid, Ursacholic
% 209.43/209.59 |- skos__altLabel mesh__D014580 Heumann Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- skos__historyNote mesh__D014580
% 209.43/209.59 Deoxycholic Acid %28%1973-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 209.43/209.59 |- skos__altLabel mesh__D014580 Deoxyursocholic Acid
% 209.43/209.59 |- skos__altLabel mesh__D014580 Tramedico Brand of Ursodeoxycholic Acid
% 209.43/209.59 |- rdf__type mesh__D014580sskos__Concept
% 209.43/209.59 |- mesh__historyNote mesh__D008543 78; was MELANIN 1963-77
% 209.43/209.59 |- skos__scopeNote mesh__D008543
% 209.43/209.59 Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin %28%SKIN PIGMENTATION%29%, hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration.%A%
% 209.43/209.59 |- mesh__onlineNote mesh__D008543 use MELANINS to search MELANIN 1966-77
% 209.43/209.59 |- skos__altLabel mesh__D008543 Melanin
% 209.43/209.59 |- skos__prefLabel mesh__D008543 Melanins
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D008543 2006
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D008543 sjn
% 209.43/209.59 |- mesh__dateCreated mesh__D008543 1999-01-01
% 209.43/209.59 |- mesh__recordOriginator mesh__D008543 NLM
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D008543 78; was MELANIN 1963-77
% 209.43/209.59 |- skos__broader mesh__D008543smesh__D014443
% 209.43/209.59 |- mesh__dateRevised mesh__D008543 2005-06-30
% 209.43/209.59 |- skos__broader mesh__D008543smesh__D010860
% 209.43/209.59 |- mesh__recordMaintainer mesh__D008543 ssb
% 209.43/209.59 |- rdf__type mesh__D008543sskos__Concept
% 209.43/209.59 |- mesh__dateCreated mesh__D000560 1977-04-22
% 209.43/209.59 |- skos__altLabel mesh__D000560 Penicillin Hx
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D000560 2006
% 209.43/209.59 |- rdf__type mesh__D000560sskos__Concept
% 209.43/209.59 |- mesh__dateEstablished mesh__D000560 1985-01-01
% 209.43/209.59 |- skos__historyNote mesh__D000560 Antibiotics %28%1966-1972%29%
% 209.43/209.59 |- skos__hiddenLabel mesh__D000560 FL1060
% 209.43/209.59 |- skos__historyNote mesh__D000560 Thiazoles %28%1966-1972%29%
% 209.43/209.59 |- skos__broader mesh__D000560smesh__D010406
% 209.43/209.59 |- skos__prefLabel mesh__D000560 Amdinocillin
% 209.43/209.59 |- skos__historyNote mesh__D000560 Penicillanic Acids %28%1973-1977%29%
% 209.43/209.59 |- mesh__dateRevised mesh__D000560 2004-07-07
% 209.43/209.59 |- skos__hiddenLabel mesh__D000560 FL 1060
% 209.43/209.59 |- mesh__historyNote mesh__D000560
% 209.43/209.59 85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84
% 209.43/209.59 |- mesh__recordMaintainer mesh__D000560 ssb
% 209.43/209.59 |- skos__scopeNote mesh__D000560
% 209.43/209.59 Amidinopenicillanic acid derivative with broad spectrum antibacterial action. It is poorly absorbed if given orally and is used in urinary infections and typhus.%A%
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D000560
% 209.43/209.59 85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84; AMDINOCILLIN PIVOXIL was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84%A%
% 209.43/209.59 |- mesh__onlineNote mesh__D000560
% 209.43/209.59 use AMDINOCILLIN to search MECILLINAM 1978-84
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D000560 sjn
% 209.43/209.59 |- mesh__recordOriginator mesh__D000560 SH
% 209.43/209.59 |- skos__altLabel mesh__D000560 Mecillinam
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D000560 2005
% 209.43/209.59 |- skos__hiddenLabel mesh__D013488 Suppositories, Vaginal
% 209.43/209.59 |- mesh__recordMaintainer mesh__D013488 ssb
% 209.43/209.59 |- skos__prefLabel mesh__D013488 Suppositories
% 209.43/209.59 |- mesh__dateRevised mesh__D013488 2003-07-09
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D013488 sjn
% 209.43/209.59 |- skos__scopeNote mesh__D013488
% 209.43/209.59 Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature.%A%
% 209.43/209.59 |- skos__annotation mesh__D013488
% 209.43/209.59 IM GEN only; coord NIM %28%no qualif%29% with specific drug IM
% 209.43/209.59 |- mesh__dateCreated mesh__D013488 1999-01-01
% 209.43/209.59 |- rdf__type mesh__D013488sskos__Concept
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D013488 2005
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D013488 2004
% 209.43/209.59 |- skos__broader mesh__D013488smesh__D004304
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D013488 2006
% 209.43/209.59 |- mesh__recordOriginator mesh__D013488 NLM
% 209.43/209.59 |- skos__hiddenLabel mesh__D013488 Suppositories, Rectal
% 209.43/209.59 |- skos__hiddenLabel mesh__D013488 Suppository, Vaginal
% 209.43/209.59 |- skos__altLabel mesh__D013488 Vaginal Suppository
% 209.43/209.59 |- skos__hiddenLabel mesh__D018971 IGF Binding Protein 2
% 209.43/209.59 |- mesh__dateEstablished mesh__D018971 1996-01-01
% 209.43/209.59 |- mesh__dateRevised mesh__D018971 2004-07-07
% 209.43/209.59 |- skos__historyNote mesh__D018971 Carrier Proteins %28%1991-1995%29%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018971 2005
% 209.43/209.59 |- skos__altLabel mesh__D018971 IGFBP-2
% 209.43/209.59 |- skos__hiddenLabel mesh__D018971
% 209.43/209.59 Insulin Like Growth Factor Binding Protein 2
% 209.43/209.59 |- mesh__onlineNote mesh__D018971
% 209.43/209.59 use INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2 %28%NM%29% to search INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 1991-95%A%
% 209.43/209.59 |- mesh__dateCreated mesh__D018971 1995-06-08
% 209.43/209.59 |- skos__annotation mesh__D018971
% 209.43/209.59 /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%
% 209.43/209.59 |- rdf__type mesh__D018971sskos__Concept
% 209.43/209.59 |- skos__broader mesh__D018971smesh__D018969
% 209.43/209.59 |- mesh__recordOriginator mesh__D018971 TPW
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018971 2006
% 209.43/209.59 |- skos__hiddenLabel mesh__D018971 IGFBP 2
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D018971
% 209.43/209.59 96; INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 was indexed under CARRIER PROTEINS 1991-95%A%
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D018971 sjn
% 209.43/209.59 |- skos__scopeNote mesh__D018971
% 209.43/209.59 One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%
% 209.43/209.59 |- mesh__historyNote mesh__D018971
% 209.43/209.59 96; was INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 %28%NM%29% 1991-95%A%
% 209.43/209.59 |- skos__altLabel mesh__D018971 IGF-Binding Protein 2
% 209.43/209.59 |- mesh__recordMaintainer mesh__D018971 jmp
% 209.43/209.59 |- skos__prefLabel mesh__D018971
% 209.43/209.59 Insulin-Like Growth Factor Binding Protein 2
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 1997
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 2004
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 2000
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 1994
% 209.43/209.59 |- skos__hiddenLabel mesh__D018173 Circovirus Infection
% 209.43/209.59 |- skos__hiddenLabel mesh__D018173 Infection, Circovirus
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 1999
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 2006
% 209.43/209.59 |- rdf__type mesh__D018173sskos__Concept
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D018173 94
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 2001
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 1995
% 209.43/209.59 |- skos__altLabel mesh__D018173 Infections, Circoviridae
% 209.43/209.59 |- skos__broader mesh__D018173smesh__D004266
% 209.43/209.59 |- skos__scopeNote mesh__D018173
% 209.43/209.59 Virus diseases caused by the CIRCOVIRIDAE.
% 209.43/209.59 |- skos__hiddenLabel mesh__D018173 Circoviridae Infection
% 209.43/209.59 |- skos__hiddenLabel mesh__D018173 Infection, Circoviridae
% 209.43/209.59 |- mesh__historyNote mesh__D018173 94
% 209.43/209.59 |- skos__prefLabel mesh__D018173 Circoviridae Infections
% 209.43/209.59 |- mesh__dateCreated mesh__D018173 1993-06-04
% 209.43/209.59 |- skos__annotation mesh__D018173 GEN or unspecified
% 209.43/209.59 |- mesh__dateEstablished mesh__D018173 1994-01-01
% 209.43/209.59 |- skos__altLabel mesh__D018173 Infections, Circovirus
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 2002
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 1996
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 2003
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 1998
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D018173 2005
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Cancer, Pancreatic
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Cancer, Pancreas
% 209.43/209.59 |- skos__annotation mesh__D010190
% 209.43/209.59 coord IM with histol type of neopl %28%IM%29%; available are ALPHA-CELL TUMOR see GLUCAGONOMA; BETA-CELL TUMOR see INSULINOMA; and pancreatic delta-cell tumor see SOMATOSTATINOMA%A%
% 209.43/209.59 |- skos__broader mesh__D010190smesh__D004067
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Pancreatic Cancers
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Neoplasm, Pancreas
% 209.43/209.59 |- skos__altLabel mesh__D010190 Pancreas Cancer
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Neoplasm, Pancreatic
% 209.43/209.59 |- skos__broader mesh__D010190smesh__D010182
% 209.43/209.59 |- mesh__recordMaintainer mesh__D010190 ags
% 209.43/209.59 |- rdf__type mesh__D010190sskos__Concept
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D010190 ags
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Pancreas Cancers
% 209.43/209.59 |- skos__prefLabel mesh__D010190 Pancreatic Neoplasms
% 209.43/209.59 |- skos__altLabel mesh__D010190 Neoplasms, Pancreatic
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Cancers, Pancreatic
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Cancers, Pancreas
% 209.43/209.59 |- mesh__recordOriginator mesh__D010190 NLM
% 209.43/209.59 |- mesh__dateRevised mesh__D010190 2005-07-15
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Neoplasms, Pancreas
% 209.43/209.59 |- skos__broader mesh__D010190smesh__D004701
% 209.43/209.59 |- skos__altLabel mesh__D010190 Pancreatic Cancer
% 209.43/209.59 |- skos__altLabel mesh__D010190 Pancreas Neoplasms
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D010190 2006A
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Pancreas Neoplasm
% 209.43/209.59 |- skos__scopeNote mesh__D010190
% 209.43/209.59 Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors %28%INSULINOMA%29%.%A%
% 209.43/209.59 |- mesh__dateCreated mesh__D010190 1999-01-01
% 209.43/209.59 |- skos__hiddenLabel mesh__D010190 Pancreatic Neoplasm
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D010190 2006
% 209.43/209.59 |- skos__altLabel mesh__D010190 Cancer of the Pancreas
% 209.43/209.59 |- skos__prefLabel mesh__D004951 Esterification
% 209.43/209.59 |- skos__annotation mesh__D004951 almost never IM
% 209.43/209.59 |- rdf__type mesh__D004951sskos__Concept
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004951 2003
% 209.43/209.59 |- skos__historyNote mesh__D004951 Esters %28%1968-1975%29%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004951 2001
% 209.43/209.59 |- skos__scopeNote mesh__D004951
% 209.43/209.59 The process of converting an acid into an alkyl or aryl derivative. Most frequently the process consists of the reaction of an acid with an alcohol in the presence of a trace of mineral acid as catalyst or the reaction of an acyl chloride with an alcohol. Esterification can also be accomplished by enzymatic processes.%A%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004951 2004
% 209.43/209.59 |- skos__broader mesh__D004951smesh__D008660
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004951 2002
% 209.43/209.59 |- mesh__dateCreated mesh__D004951 1975-07-25
% 209.43/209.59 |- skos__hiddenLabel mesh__D004951 Esterifications
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004951 2005
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004951 1998
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004951 2006
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004951 1999
% 209.43/209.59 |- skos__broader mesh__D004951smesh__D002625
% 209.43/209.59 |- mesh__recordOriginator mesh__D004951 RLS
% 209.43/209.59 |- mesh__historyNote mesh__D004951
% 209.43/209.59 91%28%76%29%; was see under CHEMISTRY, ORGANIC 1976-90
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D004951
% 209.43/209.59 91; was see under CHEMISTRY, ORGANIC 1976-90
% 209.43/209.59 |- mesh__dateEstablished mesh__D004951 1991-01-01
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D004951 SJN
% 209.43/209.59 |- mesh__dateRevised mesh__D004951 1997-06-20
% 209.43/209.59 |- mesh__recordMaintainer mesh__D004951 PXP
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004951 2000
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004153 2005
% 209.43/209.59 |- skos__broader mesh__D004153smesh__D005370
% 209.43/209.59 |- skos__annotation mesh__D004153
% 209.43/209.59 infection = DIPETALONEMA INFECTIONS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004153 2006
% 209.43/209.59 |- mesh__dateRevised mesh__D004153 2003-07-09
% 209.43/209.59 |- skos__scopeNote mesh__D004153
% 209.43/209.59 A filarial nematode parasite of mammalian blood with the vector being a tick or small fly.%A%
% 209.43/209.59 |- mesh__dateCreated mesh__D004153 1999-01-01
% 209.43/209.59 |- mesh__recordOriginator mesh__D004153 NLM
% 209.43/209.59 |- skos__prefLabel mesh__D004153 Dipetalonema
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D004153 sjn
% 209.43/209.59 |- mesh__onlineNote mesh__D004153
% 209.43/209.59 use DIPETALONEMA to search ACANTHOCHEILONEMA 1966-85
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D004153 2004
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D004153 86; was ACANTHOCHEILONEMA 1963-85
% 209.43/209.59 |- mesh__recordMaintainer mesh__D004153 ags
% 209.43/209.59 |- rdf__type mesh__D004153sskos__Concept
% 209.43/209.59 |- mesh__historyNote mesh__D004153 86; was ACANTHOCHEILONEMA 1963-85
% 209.43/209.59 |- skos__altLabel mesh__D004153 Acanthocheilonema
% 209.43/209.59 |- skos__historyNote mesh__D017879 Thiocyanates %28%1966-1993%29%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 2000
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 2003
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 1999
% 209.43/209.59 |- mesh__dateEstablished mesh__D017879 1994-01-01
% 209.43/209.59 |- mesh__dateCreated mesh__D017879 1993-02-16
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 1994
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 2001
% 209.43/209.59 |- rdf__type mesh__D017879sskos__Concept
% 209.43/209.59 |- skos__broader mesh__D017879smesh__D013457
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 2005
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 2004
% 209.43/209.59 |- skos__broader mesh__D017879smesh__D017953
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 1995
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 2006
% 209.43/209.59 |- skos__prefLabel mesh__D017879 Isothiocyanates
% 209.43/209.59 |- skos__scopeNote mesh__D017879
% 209.43/209.59 Organic compounds with the general formula R-NCS.
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 2002
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 1996
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D017879 94
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 1998
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D017879 1997
% 209.43/209.59 |- mesh__historyNote mesh__D017879 94
% 209.43/209.59 |- skos__hiddenLabel mesh__D050704 Transcription Factor, E2F-4
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D050704 ags
% 209.43/209.59 |- skos__broader mesh__D050704smesh__D050684
% 209.43/209.59 |- skos__hiddenLabel mesh__D050704 Transcription Factor, E2F4
% 209.43/209.59 |- skos__altLabel mesh__D050704 Transcription Factor E2F-4
% 209.43/209.59 |- mesh__dateCreated mesh__D050704 2005-06-30
% 209.43/209.59 |- mesh__recordOriginator mesh__D050704 DRC
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D050704 2006A
% 209.43/209.59 |- skos__historyNote mesh__D050704 DNA-Binding Proteins %28%1994-2005%29%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D050704 2006
% 209.43/209.59 |- skos__hiddenLabel mesh__D050704 E2F-4, Transcription Factor
% 209.43/209.59 |- skos__altLabel mesh__D050704 E2F Transcription Factor 4 Protein
% 209.43/209.59 |- mesh__recordMaintainer mesh__D050704 ags
% 209.43/209.59 |- rdf__type mesh__D050704sskos__Concept
% 209.43/209.59 |- skos__annotation mesh__D050704 see SCR for organism-specific terms
% 209.43/209.59 |- skos__scopeNote mesh__D050704
% 209.43/209.59 An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F4 recruits chromatin remodeling factors indirectly to target gene PROMOTER REGIONS through RETINOBLASTOMA LIKE PROTEIN P130 and RETINOBLASTOMA LIKE PROTEIN P107.%A%
% 209.43/209.59 |- skos__altLabel mesh__D050704 E2F-4 Transcription Factor
% 209.43/209.59 |- skos__hiddenLabel mesh__D050704 Transcription Factor E2F 4
% 209.43/209.59 |- skos__historyNote mesh__D050704 Transcription Factors %28%1994-2005%29%
% 209.43/209.59 |- skos__altLabel mesh__D050704 E2F-4 Protein
% 209.43/209.59 |- mesh__historyNote mesh__D050704 2006%28%1994%29%
% 209.43/209.59 |- mesh__dateRevised mesh__D050704 2005-07-13
% 209.43/209.59 |- skos__hiddenLabel mesh__D050704 E2F 4 Transcription Factor
% 209.43/209.59 |- skos__prefLabel mesh__D050704 E2F4 Transcription Factor
% 209.43/209.59 |- skos__hiddenLabel mesh__D050704 E2F 4 Protein
% 209.43/209.59 |- mesh__dateEstablished mesh__D050704 2006-01-01
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D050704
% 209.43/209.59 2006; E2F4 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1994-2005%A%
% 209.43/209.59 |- skos__altLabel mesh__D003859 Personality Disorder, Dependent
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003859 2006
% 209.43/209.59 |- skos__altLabel mesh__D003859 Passive-Dependent Personality
% 209.43/209.59 |- skos__hiddenLabel mesh__D003859 Dependent Personality Disorders
% 209.43/209.59 |- mesh__recordOriginator mesh__D003859 NLM
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003859 2003
% 209.43/209.59 |- mesh__dateRevised mesh__D003859 1999-11-03
% 209.43/209.59 |- skos__prefLabel mesh__D003859 Dependent Personality Disorder
% 209.43/209.59 |- skos__hiddenLabel mesh__D003859 Passive Dependent Personality
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D003859 sjn
% 209.43/209.59 |- mesh__onlineNote mesh__D003859
% 209.43/209.59 use DEPENDENT PERSONALITY DISORDER to search PASSIVE-DEPENDENT PERSONALITY 1975-80%A%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003859 2002
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003859 2004
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D003859
% 209.43/209.59 91; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-DEPENDENT PERSONALITY see under PERSONALITY DISORDERS 1975-80%A%
% 209.43/209.59 |- rdf__type mesh__D003859sskos__Concept
% 209.43/209.59 |- mesh__dateEstablished mesh__D003859 1991-01-01
% 209.43/209.59 |- mesh__dateCreated mesh__D003859 1974-11-11
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003859 2000
% 209.43/209.59 |- mesh__historyNote mesh__D003859
% 209.43/209.59 91%28%81%29%; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-DEPENDENT PERSONALITY see under PERSONALITY DISORDERS 1975-80%A%
% 209.43/209.59 |- skos__hiddenLabel mesh__D003859 Disorder, Dependent Personality
% 209.43/209.59 |- skos__broader mesh__D003859smesh__D010554
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003859 2005
% 209.43/209.59 |- skos__scopeNote mesh__D003859
% 209.43/209.59 A personality disorder characterized by a pervasive and excessive need to be taken care of that leads to submissive and clinging behavior and fears of separation, beginning by early adulthood and present in a variety of contexts. %28%From DSM-IV, 1994%29%%A%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D003859 2001
% 209.43/209.59 |- mesh__recordMaintainer mesh__D003859 jls
% 209.43/209.59 |- skos__hiddenLabel mesh__D003859 Personality, Passive-Dependent
% 209.43/209.59 |- skos__broader mesh__D014581smesh__D017445
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 2005
% 209.43/209.59 |- mesh__recordMaintainer mesh__D014581 PLS
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 2002
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 2003
% 209.43/209.59 |- skos__hiddenLabel mesh__D014581 Urticarias
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 2006
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 1995
% 209.43/209.59 |- mesh__dateCreated mesh__D014581 1999-01-01
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 2004
% 209.43/209.59 |- skos__broader mesh__D014581smesh__D006969
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 1998
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 1996
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 1999
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D014581 PLS
% 209.43/209.59 |- skos__annotation mesh__D014581
% 209.43/209.59 a form of immediate hypersensitivity; note X ref
% 209.43/209.59 |- skos__prefLabel mesh__D014581 Urticaria
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 2000
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 1997
% 209.43/209.59 |- skos__altLabel mesh__D014581 Hives
% 209.43/209.59 |- mesh__dateRevised mesh__D014581 1994-05-27
% 209.43/209.59 |- mesh__recordOriginator mesh__D014581 NLM
% 209.43/209.59 |- rdf__type mesh__D014581sskos__Concept
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D014581 2001
% 209.43/209.59 |- skos__scopeNote mesh__D014581
% 209.43/209.59 A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.%A%
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D008544 72
% 209.43/209.59 |- skos__annotation mesh__D008544 do not confuse with MELANOPHORES
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D008544 2005
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D008544 2002
% 209.43/209.59 |- skos__broader mesh__D008544smesh__D004847
% 209.43/209.59 |- skos__hiddenLabel mesh__D008544 Melanocyte
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D008544 2006
% 209.43/209.59 |- mesh__historyNote mesh__D008544 72%28%69%29%
% 209.43/209.59 |- mesh__dateCreated mesh__D008544 1999-01-01
% 209.43/209.59 |- mesh__dateEstablished mesh__D008544 1972-01-01
% 209.43/209.59 |- mesh__recordMaintainer mesh__D008544 mdb
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D008544 2003
% 209.43/209.59 |- mesh__dateRevised mesh__D008544 2001-07-25
% 209.43/209.59 |- rdf__type mesh__D008544sskos__Concept
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D008544 sjn
% 209.43/209.59 |- skos__scopeNote mesh__D008544
% 209.43/209.59 Epidermal dendritic pigment cells which control long-term morphological color changes by alteration in their number or in the amount of pigment they produce and store in the pigment containing organelles called MELANOSOMES; MELANOPHORES are larger cells which do not exist in mammals.%A%
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D008544 2004
% 209.43/209.59 |- skos__prefLabel mesh__D008544 Melanocytes
% 209.43/209.59 |- mesh__recordOriginator mesh__D008544 NLM
% 209.43/209.59 |- skos__historyNote mesh__D008544 Chromatophores %28%1966-1968%29%
% 209.43/209.59 |- skos__broader mesh__D000561smesh__D000560
% 209.43/209.59 |- skos__altLabel mesh__D000561 Pivamdinocillin
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D000561
% 209.43/209.59 91; was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84%A%
% 209.43/209.59 |- mesh__historyNote mesh__D000561
% 209.43/209.59 91%28%85%29%; was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84%A%
% 209.43/209.59 |- mesh__recordAuthorizer mesh__D000561 sjn
% 209.43/209.59 |- skos__altLabel mesh__D000561 Pivmecillinam
% 209.43/209.59 |- skos__hiddenLabel mesh__D000561 Hydrochloride, Pivmecillinam
% 209.43/209.59 |- skos__hiddenLabel mesh__D000561 FL 1039
% 209.43/209.59 |- skos__altLabel mesh__D000561 Leo Brand of Pivmecillinam Hydrochloride
% 209.43/209.59 |- mesh__dateRevised mesh__D000561 2005-06-30
% 209.43/209.59 |- mesh__dateEstablished mesh__D000561 1991-01-01
% 209.43/209.59 |- skos__scopeNote mesh__D000561
% 209.43/209.59 Pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin.%A%
% 209.43/209.59 |- skos__prefLabel mesh__D000561 Amdinocillin Pivoxil
% 209.43/209.59 |- skos__hiddenLabel mesh__D000561 Pivoxil, Amdinocillin
% 209.43/209.59 |- skos__hiddenLabel mesh__D000561 Pivaloyl Ester, Mecillinam
% 209.43/209.59 |- mesh__recordOriginator mesh__D000561 SH
% 209.43/209.59 |- skos__hiddenLabel mesh__D000561 FL1039
% 209.43/209.59 |- skos__historyNote mesh__D000561 Antibiotics %28%1966-1972%29%
% 209.43/209.59 |- mesh__dateCreated mesh__D000561 1977-04-22
% 209.43/209.59 |- skos__historyNote mesh__D000561 Thiazoles %28%1966-1977%29%
% 209.43/209.59 |- skos__altLabel mesh__D000561 Mecillinam Pivaloyl Ester
% 209.43/209.59 |- mesh__recordMaintainer mesh__D000561 lkw
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D000561 2006
% 209.43/209.59 |- mesh__onlineNote mesh__D000561
% 209.43/209.59 use AMDINOCILLIN PIVOXIL to search PIVMECILLINAM 1978-84
% 209.43/209.59 |- rdf__type mesh__D000561sskos__Concept
% 209.43/209.59 |- skos__historyNote mesh__D000561 Penicillanic Acids %28%1973-1977%29%
% 209.43/209.59 |- skos__historyNote mesh__D013489 Genes %28%1966-1967%29%
% 209.43/209.59 |- mesh__recordMaintainer mesh__D013489 TPW
% 209.43/209.59 |- skos__broader mesh__D013489smesh__D009154
% 209.43/209.59 |- mesh__activeMeSHYear mesh__D013489 2005
% 209.43/209.59 |- skos__altLabel mesh__D013489 Genetic Suppression
% 209.43/209.59 |- mesh__recordOriginator mesh__D013489 NLM
% 209.43/209.59 |- skos__prefLabel mesh__D013489 Suppression, Genetic
% 209.43/209.59 |- mesh__dateRevised mesh__D013489 2002-07-03
% 209.43/209.59 |- skos__hiddenLabel mesh__D013489 Suppressor Mutations
% 209.43/209.59 |- skos__hiddenLabel mesh__D013489 Genetic Suppressions
% 209.43/209.59 |- mesh__dateEstablished mesh__D013489 1970-01-01
% 209.43/209.59 |- mesh__publicMeSHNote mesh__D013489 80; was GENES, SUPPRESSOR 1970-79
% 209.43/209.60 |- skos__scopeNote mesh__D013489
% 209.43/209.60 Mutation process that restores the wild-type PHENOTYPE in an organism possessing a mutationally altered GENOTYPE. The second %22%suppressor%22% mutation may be on a different gene, on the same gene but located at a distance from the site of the primary mutation, or in extrachromosomal genes %28%EXTRACHROMOSOMAL INHERITANCE%29%.%A%
% 209.43/209.60 |- mesh__activeMeSHYear mesh__D013489 2004
% 209.43/209.60 |- mesh__recordAuthorizer mesh__D013489 sjn
% 209.43/209.60 |- skos__hiddenLabel mesh__D013489 Mutations, Suppressor
% 209.43/209.60 |- skos__hiddenLabel mesh__D013489 Suppressions, Genetic
% 209.43/209.60 |- rdf__type mesh__D013489sskos__Concept
% 209.43/209.60 |- mesh__dateCreated mesh__D013489 1999-01-01
% 209.43/209.60 |- mesh__activeMeSHYear mesh__D013489 2003
% 209.43/209.60 |- mesh__historyNote mesh__D013489
% 209.43/209.60 80; was GENES, SUPPRESSOR 1968-79 %28%Prov 1968-69%29%
% 209.43/209.60 |- skos__broader mesh__D013489smesh__D016296
% 209.43/209.60 |- skos__hiddenLabel mesh__D013489 Mutation, Suppressor
% 209.43/209.60 |- mesh__activeMeSHYear mesh__D013489 2006
% 209.43/209.60 |- skos__historyNote mesh__D013489 Genes, Suppressor %28%1968-1979%29%
% 209.43/209.60 |- skos__hiddenLabel mesh__D018972 3, IGF-Binding Protein
% 209.43/209.60 |- skos__hiddenLabel mesh__D018972 IGF Binding Protein 3
% 209.43/209.60 |- skos__hiddenLabel mesh__D018972 Protein 3, IGF-Binding
% 209.43/209.60 |- mesh__dateCreated mesh__D018972 1995-06-08
% 209.43/209.60 |- mesh__recordAuthorizer mesh__D018972 sjn
% 209.43/209.60 |- skos__annotation mesh__D018972
% 209.43/209.60 /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%
% 209.43/209.60 |- rdf__type mesh__D018972sskos__Concept
% 209.43/209.60 |- mesh__activeMeSHYear mesh__D018972 2006
% 209.43/209.60 |- skos__altLabel mesh__D018972 IGFBP-3
% 209.43/209.60 |- mesh__onlineNote mesh__D018972
% 209.43/209.60 use INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS %28%NM%29% to search INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 1980-95%A%
% 209.43/209.60 |- mesh__dateEstablished mesh__D018972 1996-01-01
% 209.43/209.60 |- skos__altLabel mesh__D018972 IGF-Binding Protein 3
% 209.43/209.60 |- skos__prefLabel mesh__D018972
% 209.43/209.60 Insulin-Like Growth Factor Binding Protein 3
% 209.43/209.60 |- mesh__publicMeSHNote mesh__D018972
% 209.43/209.60 96; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-95%A%
% 209.43/209.60 |- mesh__historyNote mesh__D018972
% 209.43/209.60 96; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 was SY to INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 1980-95%A%
% 209.45/209.60 |- skos__scopeNote mesh__D018972
% 209.45/209.60 One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%
% 209.45/209.60 |- skos__historyNote mesh__D018972 Carrier Proteins %28%1980-1995%29%
% 209.45/209.60 |- mesh__recordMaintainer mesh__D018972 jmp
% 209.45/209.60 |- mesh__recordOriginator mesh__D018972 TPW
% 209.45/209.60 |- mesh__dateRevised mesh__D018972 2004-07-07
% 209.45/209.60 |- skos__broader mesh__D018972smesh__D018969
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018972 2005
% 209.45/209.60 |- mesh__recordMaintainer mesh__D018174 ags
% 209.45/209.60 |- skos__prefLabel mesh__D018174 Arterivirus Infections
% 209.45/209.60 |- skos__hiddenLabel mesh__D018174 Infection, Arterivirus
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018174 2003
% 209.45/209.60 |- skos__altLabel mesh__D018174 Infections, Arterivirus
% 209.45/209.60 |- skos__hiddenLabel mesh__D018174 Arterivirus Infection
% 209.45/209.60 |- skos__broader mesh__D018174smesh__D030341
% 209.45/209.60 |- mesh__recordOriginator mesh__D018174 AGS
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D018174 sjn
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018174 2006
% 209.45/209.60 |- rdf__type mesh__D018174sskos__Concept
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018174 2002
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018174 2005
% 209.45/209.60 |- mesh__dateRevised mesh__D018174 2001-07-25
% 209.45/209.60 |- skos__scopeNote mesh__D018174
% 209.45/209.60 Infections caused by viruses of the genus ARTERIVIRUS.
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D018174 94
% 209.45/209.60 |- mesh__dateCreated mesh__D018174 1993-06-04
% 209.45/209.60 |- skos__annotation mesh__D018174 caused by an RNA virus
% 209.45/209.60 |- mesh__historyNote mesh__D018174 94
% 209.45/209.60 |- mesh__dateEstablished mesh__D018174 1994-01-01
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018174 2004
% 209.45/209.60 |- mesh__historyNote mesh__D010191 79
% 209.45/209.60 |- skos__scopeNote mesh__D010191
% 209.45/209.60 A 36-amino acid polypeptide secreted by the PANCREAS that has physiological regulatory functions. Plasma pancreatic polypeptide increases after ingestion of food, with age, and in disease states. A lack of pancreatic polypeptide in the ISLETS OF LANGERHANS has been associated with the OBESITY in rats and mice.%A%
% 209.45/209.60 |- mesh__recordOriginator mesh__D010191 RLS
% 209.45/209.60 |- skos__broader mesh__D010191smesh__D009479
% 209.45/209.60 |- rdf__type mesh__D010191sskos__Concept
% 209.45/209.60 |- skos__historyNote mesh__D010191 Peptides %28%1966-1978%29%
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D010191 79
% 209.45/209.60 |- mesh__recordMaintainer mesh__D010191 ssb
% 209.45/209.60 |- skos__prefLabel mesh__D010191 Pancreatic Polypeptide
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D010191 sjn
% 209.45/209.60 |- skos__broader mesh__D010191smesh__D010187
% 209.45/209.60 |- mesh__dateEstablished mesh__D010191 1979-01-01
% 209.45/209.60 |- mesh__dateRevised mesh__D010191 2005-06-30
% 209.45/209.60 |- skos__historyNote mesh__D010191 Hormones %28%1966-1973%29%
% 209.45/209.60 |- skos__broader mesh__D010191smesh__D036361
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010191 2006
% 209.45/209.60 |- skos__historyNote mesh__D010191 Pancreatic Hormones %28%1974-1978%29%
% 209.45/209.60 |- skos__hiddenLabel mesh__D010191 Polypeptide, Pancreatic
% 209.45/209.60 |- mesh__dateCreated mesh__D010191 1978-05-18
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D004952
% 209.45/209.60 91; was see under CARBOXYLIC ACIDS 1968-90
% 209.45/209.60 |- mesh__recordMaintainer mesh__D004952 TAP
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 2004
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 1997
% 209.45/209.60 |- skos__prefLabel mesh__D004952 Esters
% 209.45/209.60 |- skos__broader mesh__D004952smesh__D002264
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 2005
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 2000
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 1998
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 1993
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D004952 PLS
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 2001
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 1994
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 2006
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 1999
% 209.45/209.60 |- mesh__recordOriginator mesh__D004952 NLM
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 2002
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 1995
% 209.45/209.60 |- skos__annotation mesh__D004952 NIM; avoid qualif
% 209.45/209.60 |- mesh__dateEstablished mesh__D004952 1991-01-01
% 209.45/209.60 |- skos__historyNote mesh__D004952 specific alcohol %28%1968-1990%29%
% 209.45/209.60 |- mesh__dateCreated mesh__D004952 1999-01-01
% 209.45/209.60 |- rdf__type mesh__D004952sskos__Concept
% 209.45/209.60 |- mesh__historyNote mesh__D004952
% 209.45/209.60 91%28%68%29%; was see under CARBOXYLIC ACIDS 1968-90
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 2003
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004952 1996
% 209.45/209.60 |- skos__historyNote mesh__D004952 specific acid %28%1968-1990%29%
% 209.45/209.60 |- mesh__dateRevised mesh__D004952 1992-06-25
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004154 2002
% 209.45/209.60 |- skos__annotation mesh__D004154 /drug ther: consider FILARICIDES
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004154 2003
% 209.45/209.60 |- mesh__dateCreated mesh__D004154 1999-01-01
% 209.45/209.60 |- skos__prefLabel mesh__D004154 Dipetalonema Infections
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004154 2004
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004154 2000
% 209.45/209.60 |- mesh__historyNote mesh__D004154
% 209.45/209.60 91%28%86%29%; was see under FILARIASIS 1986-90; was ACANTHOCHEILONEMIASIS see under FILARIASIS 1975-85 %26% see under NEMATODE INFECTIONS 1967-74%A%
% 209.45/209.60 |- mesh__recordOriginator mesh__D004154 NLM
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004154 2001
% 209.45/209.60 |- rdf__type mesh__D004154sskos__Concept
% 209.45/209.60 |- skos__altLabel mesh__D004154 Infections, Dipetalonema
% 209.45/209.60 |- mesh__onlineNote mesh__D004154
% 209.45/209.60 use DIPETALONEMA INFECTIONS to search ACANTHOCHEILONEMIASIS 1975-85 %26% NEMATODE INFECTIONS 1967-74%A%
% 209.45/209.60 |- mesh__dateEstablished mesh__D004154 1991-01-01
% 209.45/209.60 |- skos__scopeNote mesh__D004154
% 209.45/209.60 Infections with nematodes of the genus DIPETALONEMA.
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004154 2005
% 209.45/209.60 |- skos__hiddenLabel mesh__D004154 Infection, Dipetalonema
% 209.45/209.60 |- mesh__dateRevised mesh__D004154 1998-06-10
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D004154
% 209.45/209.60 91; was see under FILARIASIS 1986-90; was ACANTHOCHEILONEMIASIS see under FILARIASIS 1975-85 %26% see under NEMATODE INFECTIONS 1967-74%A%
% 209.45/209.60 |- skos__broader mesh__D004154smesh__D005368
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004154 2006
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004154 1999
% 209.45/209.60 |- skos__hiddenLabel mesh__D004154 Dipetalonema Infection
% 209.45/209.60 |- skos__hiddenLabel mesh__D004154 Acanthocheilonemiases
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D004154 SJN
% 209.45/209.60 |- mesh__recordMaintainer mesh__D004154 MSR
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D050705 2006
% 209.45/209.60 |- skos__hiddenLabel mesh__D050705 Receptors, Guanylate Cyclase Coupled
% 209.45/209.60 |- mesh__historyNote mesh__D050705 2006
% 209.45/209.60 |- skos__altLabel mesh__D050705 Guanylyl Cyclase-Linked Receptors
% 209.45/209.60 |- skos__hiddenLabel mesh__D050705 Receptors, Guanylyl Cyclase
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D050705 2006
% 209.45/209.60 |- mesh__recordOriginator mesh__D050705 jmp
% 209.45/209.60 |- rdf__type mesh__D050705sskos__Concept
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D050705 sjn
% 209.45/209.60 |- mesh__recordMaintainer mesh__D050705 jmp
% 209.45/209.60 |- mesh__dateEstablished mesh__D050705 2006-01-01
% 209.45/209.60 |- mesh__dateCreated mesh__D050705 2005-06-30
% 209.45/209.60 |- skos__scopeNote mesh__D050705
% 209.45/209.60 A class of cellular membrane receptors that either have an intrinsic guanylate cyclase activity or are closely coupled to specific guanylate cyclases within the cell.%A%
% 209.45/209.60 |- skos__broader mesh__D050705smesh__D011956
% 209.45/209.60 |- skos__hiddenLabel mesh__D050705 Cyclase-Linked Receptors, Guanylyl
% 209.45/209.60 |- skos__altLabel mesh__D050705 Guanylate Cyclase-Coupled Receptors
% 209.45/209.60 |- skos__broader mesh__D050705smesh__D006162
% 209.45/209.60 |- skos__hiddenLabel mesh__D050705 Receptors, Guanylyl Cyclase-Linked
% 209.45/209.60 |- skos__hiddenLabel mesh__D050705 Cyclase Receptors, Guanylyl
% 209.45/209.60 |- skos__historyNote mesh__D050705
% 209.45/209.60 Receptors, Cell Surface %28%1971-2005%29%
% 209.45/209.60 |- skos__historyNote mesh__D050705 Guanylate Cyclase %28%1971-2005%29%
% 209.45/209.60 |- skos__hiddenLabel mesh__D050705 Guanylyl Cyclase Linked Receptors
% 209.45/209.60 |- skos__hiddenLabel mesh__D050705 Guanylate Cyclase Coupled Receptors
% 209.45/209.60 |- skos__hiddenLabel mesh__D050705 Cyclase-Coupled Receptors, Guanylate
% 209.45/209.60 |- skos__altLabel mesh__D050705 Guanylyl Cyclase Receptors
% 209.45/209.60 |- skos__prefLabel mesh__D050705 Receptors, Guanylate Cyclase-Coupled
% 209.45/209.60 |- skos__scopeNote mesh__D014582
% 209.45/209.60 The most common form of cutaneous mastocytosis %28%MASTOCYTOSIS, CUTANEOUS%29% that occurs primarily in children. It is characterized by the multiple small reddish-brown pigmented pruritic macules and papules.%A%
% 209.45/209.60 |- mesh__recordOriginator mesh__D014582 NLM
% 209.45/209.60 |- mesh__dateEstablished mesh__D014582 1965-01-01
% 209.45/209.60 |- skos__prefLabel mesh__D014582 Urticaria Pigmentosa
% 209.45/209.60 |- mesh__recordMaintainer mesh__D014582 lkt
% 209.45/209.60 |- mesh__dateCreated mesh__D014582 1999-01-01
% 209.45/209.60 |- skos__broader mesh__D014582smesh__D034701
% 209.45/209.60 |- rdf__type mesh__D014582sskos__Concept
% 209.45/209.60 |- skos__broader mesh__D014582smesh__D010859
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D014582 2004
% 209.45/209.60 |- skos__hiddenLabel mesh__D014582 Cutaneous Mastocytoses, Maculopapular
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D014582 65
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D014582 2006
% 209.45/209.60 |- skos__altLabel mesh__D014582 Maculopapular Cutaneous Mastocytosis
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D014582 2003
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D014582 2005
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D014582 sjn
% 209.45/209.60 |- mesh__historyNote mesh__D014582 65%28%63%29%
% 209.45/209.60 |- skos__annotation mesh__D014582
% 209.45/209.60 X ref MACULOPAPULAR CUTANEOUS MASTOCYTOSIS: MASTOCYTOSIS, CUTANEOUS is also available%A%
% 209.45/209.60 |- mesh__dateRevised mesh__D014582 2002-07-03
% 209.45/209.60 |- skos__hiddenLabel mesh__D014582 Cutaneous Mastocytosis, Maculopapular
% 209.45/209.60 |- skos__hiddenLabel mesh__D014582 Maculopapular Cutaneous Mastocytoses
% 209.45/209.60 |- skos__prefLabel mesh__D008545 Melanoma
% 209.45/209.60 |- mesh__dateCreated mesh__D008545 1999-01-01
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 2000
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 2003
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 2001
% 209.45/209.60 |- mesh__recordOriginator mesh__D008545 NLM
% 209.45/209.60 |- mesh__dateRevised mesh__D008545 1996-06-10
% 209.45/209.60 |- skos__hiddenLabel mesh__D008545 Malignant Melanomas
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D008545 PLS
% 209.45/209.60 |- rdf__type mesh__D008545sskos__Concept
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 1998
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 2004
% 209.45/209.60 |- skos__annotation mesh__D008545
% 209.45/209.60 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; MELANOMA, EXPERIMENTAL is also available%A%
% 209.45/209.60 |- skos__altLabel mesh__D008545 Malignant Melanoma
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 1999
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 2002
% 209.45/209.60 |- skos__hiddenLabel mesh__D008545 Melanoma, Malignant
% 209.45/209.60 |- skos__scopeNote mesh__D008545
% 209.45/209.60 A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. %28%Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445%29%%A%
% 209.45/209.60 |- skos__broader mesh__D008545smesh__D018326
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 2005
% 209.45/209.60 |- mesh__recordMaintainer mesh__D008545 TGC
% 209.45/209.60 |- skos__hiddenLabel mesh__D008545 Melanomas, Malignant
% 209.45/209.60 |- skos__broader mesh__D008545smesh__D018358
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 2006
% 209.45/209.60 |- skos__hiddenLabel mesh__D008545 Melanomas
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D008545 1997
% 209.45/209.60 |- mesh__recordMaintainer mesh__D000562 TGC
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D000562 2003
% 209.45/209.60 |- skos__related mesh__D000562smesh__D000563
% 209.45/209.60 |- skos__hiddenLabel mesh__D000562 Abscesses, Amebic
% 209.45/209.60 |- mesh__recordOriginator mesh__D000562 NLM
% 209.45/209.60 |- mesh__dateCreated mesh__D000562 1999-01-01
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D000562 2004
% 209.45/209.60 |- skos__altLabel mesh__D000562 Amoebiasis
% 209.45/209.60 |- skos__annotation mesh__D000562
% 209.45/209.60 caused by %22%any of various amebae%22%; /drug ther: consider also AMEBICIDES; note X ref ABSCESS, AMEBIC: LIVER ABSCESS, AMEBIC is also available%A%
% 209.45/209.60 |- skos__hiddenLabel mesh__D000562 Amebic Abscess
% 209.45/209.60 |- mesh__dateRevised mesh__D000562 1997-06-20
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D000562 SJN
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D000562 2005
% 209.45/209.60 |- skos__hiddenLabel mesh__D000562 Amebiases
% 209.45/209.60 |- skos__scopeNote mesh__D000562
% 209.45/209.60 Infection with any of various amebae. It is an asymptomatic carrier state in most individuals, but diseases ranging from chronic, mild diarrhea to fulminant dysentery may occur.%A%
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D000562 2006
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D000562 2000
% 209.45/209.60 |- skos__hiddenLabel mesh__D000562 Amebic Abscesses
% 209.45/209.60 |- rdf__type mesh__D000562sskos__Concept
% 209.45/209.60 |- skos__hiddenLabel mesh__D000562 Amebomas
% 209.45/209.60 |- skos__prefLabel mesh__D000562 Amebiasis
% 209.45/209.60 |- skos__broader mesh__D000562smesh__D016775
% 209.45/209.60 |- skos__hiddenLabel mesh__D000562 Iodamoebiases
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D000562 2001
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D000562 1998
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D000562 2002
% 209.45/209.60 |- skos__hiddenLabel mesh__D000562 Amoebiases
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D000562 1999
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 2006
% 209.45/209.60 |- skos__scopeNote mesh__D018973
% 209.45/209.60 Property, such as patents, trademarks, and copyright, that results from creative effort. The Patent and Copyright Clause %28%Art. 1, Sec. 8, cl. 8%29% of the United States Constitution provides for promoting the progress of science and useful arts by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries. %28%From Black%27%s Law Dictionary, 5th ed, p1014%29%%A%
% 209.45/209.60 |- mesh__historyNote mesh__D018973 96
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 1996
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 2004
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 1999
% 209.45/209.60 |- skos__hiddenLabel mesh__D018973 Properties, Intellectual
% 209.45/209.60 |- skos__broader mesh__D018973smesh__D007603
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D018973 96
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 1997
% 209.45/209.60 |- skos__hiddenLabel mesh__D018973 Property, Intellectual
% 209.45/209.60 |- mesh__dateEstablished mesh__D018973 1996-01-01
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 2000
% 209.45/209.60 |- skos__historyNote mesh__D018973 Copyright %28%1993-1995%29%
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 2001
% 209.45/209.60 |- skos__prefLabel mesh__D018973 Intellectual Property
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 2005
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 2002
% 209.45/209.60 |- skos__hiddenLabel mesh__D018973 Intellectual Properties
% 209.45/209.60 |- skos__historyNote mesh__D018973 Patents %28%1992-1995%29%
% 209.45/209.60 |- mesh__dateCreated mesh__D018973 1995-06-05
% 209.45/209.60 |- rdf__type mesh__D018973sskos__Concept
% 209.45/209.60 |- skos__annotation mesh__D018973
% 209.45/209.60 refers to PATENTS, trademarks, COPYRIGHT, espec under US Constitution; no qualif; specify geog%A%
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 2003
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018973 1998
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 1995
% 209.45/209.60 |- skos__hiddenLabel mesh__D010990 Principles, Pleasure-Pain
% 209.45/209.60 |- mesh__dateEstablished mesh__D010990 1973-01-01
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 2002
% 209.45/209.60 |- skos__hiddenLabel mesh__D010990 Pleasure-Pain Principles
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 1993
% 209.45/209.60 |- mesh__historyNote mesh__D010990 73%28%64%29%
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D010990 73
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 1994
% 209.45/209.60 |- skos__hiddenLabel mesh__D010990 Principle, Pleasure-Pain
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D010990 PLS
% 209.45/209.60 |- mesh__recordMaintainer mesh__D010990 TGC
% 209.45/209.60 |- mesh__dateCreated mesh__D010990 1999-01-01
% 209.45/209.60 |- rdf__type mesh__D010990sskos__Concept
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 1999
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 1992
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 2006
% 209.45/209.60 |- skos__broader mesh__D010990smesh__D011574
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 1997
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 2001
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 1998
% 209.45/209.60 |- mesh__recordOriginator mesh__D010990 NLM
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 2004
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 2005
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 1996
% 209.45/209.60 |- skos__hiddenLabel mesh__D010990 Pleasure Pain Principle
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 2000
% 209.45/209.60 |- skos__scopeNote mesh__D010990
% 209.45/209.60 The psychoanalytic concept that man instinctively seeks to avoid pain and discomfort and strives for gratification and pleasure.%A%
% 209.45/209.60 |- mesh__dateRevised mesh__D010990 1991-06-11
% 209.45/209.60 |- skos__prefLabel mesh__D010990 Pleasure-Pain Principle
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010990 2003
% 209.45/209.60 |- skos__annotation mesh__D010990 no qualif
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D018175 PLS
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 2001
% 209.45/209.60 |- mesh__dateEstablished mesh__D018175 1994-01-01
% 209.45/209.60 |- mesh__dateRevised mesh__D018175 1996-06-10
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 1999
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 2006
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 2000
% 209.45/209.60 |- skos__hiddenLabel mesh__D018175 Birnaviridae Infection
% 209.45/209.60 |- skos__annotation mesh__D018175 GEN or unspecified; prefer specifics
% 209.45/209.60 |- rdf__type mesh__D018175sskos__Concept
% 209.45/209.60 |- skos__broader mesh__D018175smesh__D012327
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D018175
% 209.45/209.60 94; BIRNAVIRUS INFECTIONS was see BIRNAVIRIDAE INFECTIONS 1994-96%A%
% 209.45/209.60 |- mesh__onlineNote mesh__D018175
% 209.45/209.60 use BIRNAVIRIDAE INFECTIONS to search BIRNAVIRUS INFECTIONS 1994-96%A%
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 1998
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 2005
% 209.45/209.60 |- skos__scopeNote mesh__D018175
% 209.45/209.60 Virus diseases caused by the BIRNAVIRIDAE.
% 209.45/209.60 |- mesh__recordMaintainer mesh__D018175 AGS
% 209.45/209.60 |- mesh__historyNote mesh__D018175
% 209.45/209.60 94; BIRNAVIRUS INFECTIONS was see BIRNAVIRIDAE INFECTIONS 1994-96%A%
% 209.45/209.60 |- skos__hiddenLabel mesh__D018175 Infection, Birnaviridae
% 209.45/209.60 |- skos__prefLabel mesh__D018175 Birnaviridae Infections
% 209.45/209.60 |- mesh__recordOriginator mesh__D018175 AGS
% 209.45/209.60 |- skos__altLabel mesh__D018175 Infections, Birnaviridae
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 2002
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 1997
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 2004
% 209.45/209.60 |- mesh__dateCreated mesh__D018175 1993-06-04
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D018175 2003
% 209.45/209.60 |- skos__hiddenLabel mesh__D010192 Pancreatic Pseudocysts
% 209.45/209.60 |- mesh__recordOriginator mesh__D010192 RC
% 209.45/209.60 |- mesh__dateRevised mesh__D010192 2004-07-07
% 209.45/209.60 |- mesh__dateEstablished mesh__D010192 1991-01-01
% 209.45/209.60 |- skos__hiddenLabel mesh__D010192 Pseudocyst, Pancreatic
% 209.45/209.60 |- skos__historyNote mesh__D010192 Pancreatic Cyst %28%1966-1980%29%
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010192 2006
% 209.45/209.60 |- mesh__recordMaintainer mesh__D010192 lkt
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D010192
% 209.45/209.60 91; was see under PANCREATIC CYST 1981-90
% 209.45/209.60 |- skos__hiddenLabel mesh__D010192 Pseudocysts, Pancreatic
% 209.45/209.60 |- mesh__dateCreated mesh__D010192 1980-04-09
% 209.45/209.60 |- mesh__historyNote mesh__D010192
% 209.45/209.60 91%28%81%29%; was see under PANCREATIC CYST 1981-90
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D010192 2005
% 209.45/209.60 |- skos__scopeNote mesh__D010192
% 209.45/209.60 Cyst-like space not lined by EPITHELIUM and contained within the PANCREAS. Pancreatic pseudocysts account for most of the cystic collections in the pancreas and are often associated with chronic PANCREATITIS.%A%
% 209.45/209.60 |- skos__broader mesh__D010192smesh__D010181
% 209.45/209.60 |- skos__prefLabel mesh__D010192 Pancreatic Pseudocyst
% 209.45/209.60 |- rdf__type mesh__D010192sskos__Concept
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D010192 sjn
% 209.45/209.60 |- skos__prefLabel mesh__D004953 Estetrol
% 209.45/209.60 |- skos__hiddenLabel mesh__D004953 15 alpha Hydroxy Estriol
% 209.45/209.60 |- mesh__dateRevised mesh__D004953 2003-07-09
% 209.45/209.60 |- mesh__dateCreated mesh__D004953 1974-11-19
% 209.45/209.60 |- skos__altLabel mesh__D004953 15-alpha-Hydroxy-Estriol
% 209.45/209.60 |- mesh__historyNote mesh__D004953
% 209.45/209.60 91%28%75%29%; was see under ESTRIOL 1975-90
% 209.45/209.60 |- mesh__dateEstablished mesh__D004953 1991-01-01
% 209.45/209.60 |- skos__altLabel mesh__D004953 15 alpha-Hydroxyestriol
% 209.45/209.60 |- rdf__type mesh__D004953sskos__Concept
% 209.45/209.60 |- mesh__publicMeSHNote mesh__D004953 91; was see under ESTRIOL 1975-90
% 209.45/209.60 |- skos__historyNote mesh__D004953 Estriol %28%1973-1974%29%
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004953 2004
% 209.45/209.60 |- skos__hiddenLabel mesh__D004953 15 alpha Hydroxyestriol
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004953 2005
% 209.45/209.60 |- mesh__recordOriginator mesh__D004953 NLM
% 209.45/209.60 |- mesh__recordMaintainer mesh__D004953 lkt
% 209.45/209.60 |- skos__broader mesh__D004953smesh__D004964
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D004953 sjn
% 209.45/209.60 |- skos__scopeNote mesh__D004953
% 209.45/209.60 A metabolite of ESTRIOL with a 15-alpha-hydroxyl group. Estetrol can be converted from estriol sulfate or DEHYDROEPIANDROSTERONE SULFATE by the fetal-placental unit.%A%
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004953 2006
% 209.45/209.60 |- skos__altLabel mesh__D004155 Diphenylhydramin
% 209.45/209.60 |- skos__altLabel mesh__D004155 Benhydramin
% 209.45/209.60 |- mesh__recordAuthorizer mesh__D004155 sjn
% 209.45/209.60 |- mesh__activeMeSHYear mesh__D004155 2006
% 209.45/209.60 |- skos__hiddenLabel mesh__D004155 Citrate, Diphenhydramine
% 209.45/209.60 |- skos__altLabel mesh__D004155 Diphenhydramine Citrate %28%1:1%29%
% 209.45/209.60 |- skos__broader mesh__D004155smesh__D005021
% 209.45/209.60 |- skos__altLabel mesh__D004155 Diphenylhydramine
% 209.45/209.60 |- mesh__dateCreated mesh__D004155 1999-01-01
% 209.45/209.60 |- skos__hiddenLabel mesh__D004155 Hydrochloride, Diphenhydramine
% 209.45/209.60 |- skos__altLabel mesh__D004155 2-Diphenylmethoxy-N,N-dimethylethylamine
% 209.45/209.60 |- mesh__dateRevised mesh__D004155 2005-06-30
% 209.45/209.60 |- skos__altLabel mesh__D004155 Benzhydramine
% 209.45/209.60 |- skos__broader mesh__D004155smesh__D001559
% 209.45/209.60 |- skos__prefLabel mesh__D004155 Diphenhydramine
% 209.45/209.60 |- skos__scopeNote mesh__D004155
% 209.45/209.60 A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.%A%
% 209.45/209.60 |- mesh__recordMaintainer mesh__D004155 lkw
% 209.45/209.60 |- rdf__type mesh__D004155sskos__Concept
% 209.45/209.60 |- mesh__recordOriginator mesh__D004155 NLM
% 209.45/209.61 |- mesh__recordMaintainer mesh__D050706 ags
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D050706 2006
% 209.45/209.61 |- skos__hiddenLabel mesh__D050706 Dolphin, Spinner
% 209.45/209.61 |- skos__hiddenLabel mesh__D050706 Dolphins, Striped
% 209.45/209.61 |- skos__hiddenLabel mesh__D050706 Dolphin, Striped
% 209.45/209.61 |- skos__altLabel mesh__D050706 Stenella longirostris
% 209.45/209.61 |- rdf__type mesh__D050706sskos__Concept
% 209.45/209.61 |- skos__hiddenLabel mesh__D050706 Spinner Dolphin
% 209.45/209.61 |- skos__scopeNote mesh__D050706
% 209.45/209.61 A genus comprised of spinner, spotted, and striped DOLPHINS, in the family Delphinidae. Schools of Stenella, that may number in the thousands, often associate with schools of TUNA, and are thus vulnerable to accidental harvesting.%A%
% 209.45/209.61 |- skos__hiddenLabel mesh__D050706 Dolphins, Spotted
% 209.45/209.61 |- skos__hiddenLabel mesh__D050706 Striped Dolphins
% 209.45/209.61 |- mesh__recordOriginator mesh__D050706 ags
% 209.45/209.61 |- skos__hiddenLabel mesh__D050706 Spotted Dolphin
% 209.45/209.61 |- skos__hiddenLabel mesh__D050706 Dolphin, Spotted
% 209.45/209.61 |- skos__altLabel mesh__D050706 Stenella frontalis
% 209.45/209.61 |- skos__hiddenLabel mesh__D050706 Dolphins, Spinner
% 209.45/209.61 |- skos__historyNote mesh__D050706 Dolphins %28%1966-2005%29%
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D050706 sjn
% 209.45/209.61 |- skos__broader mesh__D050706smesh__D004289
% 209.45/209.61 |- mesh__dateEstablished mesh__D050706 2006-01-01
% 209.45/209.61 |- mesh__dateCreated mesh__D050706 2005-06-30
% 209.45/209.61 |- skos__prefLabel mesh__D050706 Stenella
% 209.45/209.61 |- mesh__historyNote mesh__D050706 2006; use DOLPHINS 1998-2005
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D050706 2006; see DOLPHINS 1998-2005
% 209.45/209.61 |- skos__altLabel mesh__D050706 Stenella coeruleoalba
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 2002
% 209.45/209.61 |- mesh__dateCreated mesh__D014583 1999-01-01
% 209.45/209.61 |- rdf__type mesh__D014583sskos__Concept
% 209.45/209.61 |- skos__broader mesh__D014583smesh__D013020
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 2004
% 209.45/209.61 |- mesh__dateRevised mesh__D014583 1995-05-23
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 2001
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 2006
% 209.45/209.61 |- mesh__recordOriginator mesh__D014583 NLM
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 2003
% 209.45/209.61 |- mesh__recordMaintainer mesh__D014583 KEV
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 2005
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 2000
% 209.45/209.61 |- skos__prefLabel mesh__D014583 Uruguay
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 1997
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 1999
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 1996
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014583 1998
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D014583 PLS
% 209.45/209.61 |- skos__altLabel mesh__D008546 Experimental Melanoma
% 209.45/209.61 |- mesh__dateEstablished mesh__D008546 1987-01-01
% 209.45/209.61 |- rdf__type mesh__D008546sskos__Concept
% 209.45/209.61 |- mesh__recordOriginator mesh__D008546 VDK
% 209.45/209.61 |- skos__hiddenLabel mesh__D008546 Cloudman S91 Melanoma
% 209.45/209.61 |- skos__hiddenLabel mesh__D008546 Melanoma, Harding Passey
% 209.45/209.61 |- skos__hiddenLabel mesh__D008546 S91 Melanoma, Cloudman
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D008546 sjn
% 209.45/209.61 |- skos__altLabel mesh__D008546 Harding Passey Melanoma
% 209.45/209.61 |- skos__altLabel mesh__D008546 Experimental Melanomas
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D008546 87
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008546 2005
% 209.45/209.61 |- skos__altLabel mesh__D008546 Melanomas, Experimental
% 209.45/209.61 |- skos__hiddenLabel mesh__D008546 Harding-Passey Melanoma
% 209.45/209.61 |- mesh__historyNote mesh__D008546 87
% 209.45/209.61 |- mesh__dateRevised mesh__D008546 2004-07-13
% 209.45/209.61 |- skos__hiddenLabel mesh__D008546 Melanomas, B16
% 209.45/209.61 |- skos__prefLabel mesh__D008546 Melanoma, Experimental
% 209.45/209.61 |- skos__hiddenLabel mesh__D008546 B16 Melanomas
% 209.45/209.61 |- skos__scopeNote mesh__D008546
% 209.45/209.61 Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.%A%
% 209.45/209.61 |- skos__historyNote mesh__D008546 Melanoma %28%1966-1986%29%
% 209.45/209.61 |- mesh__recordMaintainer mesh__D008546 sjn
% 209.45/209.61 |- skos__broader mesh__D008546smesh__D008545
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008546 2006
% 209.45/209.61 |- skos__altLabel mesh__D008546 B16 Melanoma
% 209.45/209.61 |- skos__annotation mesh__D008546
% 209.45/209.61 coordinate IM with pre-coordinated organ/neoplasm term %28%IM%29%; DF: MELANOMA EXPER%A%
% 209.45/209.61 |- mesh__dateCreated mesh__D008546 1986-06-24
% 209.45/209.61 |- skos__broader mesh__D008546smesh__D009374
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D000563 2005
% 209.45/209.61 |- mesh__dateCreated mesh__D000563 1999-01-01
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D000563 2004
% 209.45/209.61 |- skos__prefLabel mesh__D000563 Amebicides
% 209.45/209.61 |- mesh__recordMaintainer mesh__D000563 ssb
% 209.45/209.61 |- skos__annotation mesh__D000563
% 209.45/209.61 GEN or unspecified; prefer specific amebicide; consider also AMOEBA /drug eff %26% AMEBIASIS /drug ther%A%
% 209.45/209.61 |- skos__broader mesh__D000563smesh__D000981
% 209.45/209.61 |- skos__scopeNote mesh__D000563
% 209.45/209.61 Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal.%A%
% 209.45/209.61 |- mesh__recordOriginator mesh__D000563 NLM
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D000563 2006
% 209.45/209.61 |- skos__altLabel mesh__D000563 Amoebicides
% 209.45/209.61 |- rdf__type mesh__D000563sskos__Concept
% 209.45/209.61 |- mesh__dateRevised mesh__D000563 2003-07-09
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D000563 sjn
% 209.45/209.61 |- skos__annotation mesh__D018974
% 209.45/209.61 /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%
% 209.45/209.61 |- mesh__recordOriginator mesh__D018974 TPW
% 209.45/209.61 |- skos__scopeNote mesh__D018974
% 209.45/209.61 One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%
% 209.45/209.61 |- skos__altLabel mesh__D018974 IGF-Binding Protein 4
% 209.45/209.61 |- mesh__dateRevised mesh__D018974 2004-09-20
% 209.45/209.61 |- skos__hiddenLabel mesh__D018974
% 209.45/209.61 Insulin Like Growth Factor Binding Protein 4
% 209.45/209.61 |- rdf__type mesh__D018974sskos__Concept
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018974 2006
% 209.45/209.61 |- skos__broader mesh__D018974smesh__D018969
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018974 2005
% 209.45/209.61 |- mesh__dateCreated mesh__D018974 1995-06-08
% 209.45/209.61 |- skos__altLabel mesh__D018974 IGFBP-4
% 209.45/209.61 |- mesh__historyNote mesh__D018974 2005%28%1991%29%
% 209.45/209.61 |- skos__historyNote mesh__D018974 Carrier Proteins %28%1991-1995%29%
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018974 2005A
% 209.45/209.61 |- skos__prefLabel mesh__D018974
% 209.45/209.61 Insulin-Like Growth Factor Binding Protein 4
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D018974 sjn
% 209.45/209.61 |- skos__hiddenLabel mesh__D018974 IGF Binding Protein 4
% 209.45/209.61 |- mesh__recordMaintainer mesh__D018974 sjn
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D018974
% 209.45/209.61 2005; see INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEIN 4 1996-2005; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4 was indexed under CARRIER PROTEINS 1991-95%A%
% 209.45/209.61 |- mesh__dateEstablished mesh__D018974 1996-01-01
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010991 2000
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D010991 SJN
% 209.45/209.61 |- rdf__type mesh__D010991sskos__Concept
% 209.45/209.61 |- mesh__dateCreated mesh__D010991 1999-01-01
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010991 1999
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010991 2006
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010991 2002
% 209.45/209.61 |- skos__broader mesh__D010991smesh__D003935
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010991 1998
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010991 2004
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010991 2005
% 209.45/209.61 |- skos__broader mesh__D010991smesh__D019937
% 209.45/209.61 |- skos__scopeNote mesh__D010991
% 209.45/209.61 Recording of change in the size of a part as modified by the circulation in it.%A%
% 209.45/209.61 |- mesh__dateRevised mesh__D010991 1997-06-20
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010991 2003
% 209.45/209.61 |- mesh__recordOriginator mesh__D010991 NLM
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010991 2001
% 209.45/209.61 |- skos__hiddenLabel mesh__D010991 Plethysmographies
% 209.45/209.61 |- skos__prefLabel mesh__D010991 Plethysmography
% 209.45/209.61 |- skos__annotation mesh__D010991
% 209.45/209.61 NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; %22%venous occlusion plethysmography%22% %26% %22%strain gauge plethysmography%22% go here; DF: PLETHYSMOGR%A%
% 209.45/209.61 |- mesh__recordMaintainer mesh__D010991 PXP
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018176 2005
% 209.45/209.61 |- mesh__recordOriginator mesh__D018176 AGS
% 209.45/209.61 |- skos__prefLabel mesh__D018176 Torovirus Infections
% 209.45/209.61 |- skos__scopeNote mesh__D018176
% 209.45/209.61 Infections with viruses of the genus TOROVIRUS, family CORONAVIRIDAE.%A%
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018176 2002
% 209.45/209.61 |- mesh__dateRevised mesh__D018176 2001-07-25
% 209.45/209.61 |- mesh__dateCreated mesh__D018176 1993-06-04
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D018176 94
% 209.45/209.61 |- mesh__historyNote mesh__D018176 94
% 209.45/209.61 |- skos__broader mesh__D018176smesh__D003333
% 209.45/209.61 |- mesh__dateEstablished mesh__D018176 1994-01-01
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018176 2004
% 209.45/209.61 |- skos__hiddenLabel mesh__D018176 Torovirus Infection
% 209.45/209.61 |- skos__annotation mesh__D018176
% 209.45/209.61 caused by a member of the family Coronaviridae
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018176 2003
% 209.45/209.61 |- mesh__recordMaintainer mesh__D018176 ags
% 209.45/209.61 |- skos__hiddenLabel mesh__D018176 Infection, Torovirus
% 209.45/209.61 |- skos__altLabel mesh__D018176 Infections, Torovirus
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018176 2006
% 209.45/209.61 |- rdf__type mesh__D018176sskos__Concept
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D018176 sjn
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D010193 SJN
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010193 2004
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010193 2002
% 209.45/209.61 |- skos__annotation mesh__D010193
% 209.45/209.61 do not use /util except by MeSH definition
% 209.45/209.61 |- mesh__recordMaintainer mesh__D010193 PXP
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010193 2006
% 209.45/209.61 |- skos__historyNote mesh__D010193 Pancreas/surgery %28%1966-1987%29%
% 209.45/209.61 |- skos__hiddenLabel mesh__D010193 Pancreatojejunostomies
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D010193 88
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010193 2003
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010193 1999
% 209.45/209.61 |- skos__hiddenLabel mesh__D010193 Pancreaticojejunostomies
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010193 2001
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010193 2005
% 209.45/209.61 |- mesh__dateRevised mesh__D010193 1997-06-20
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010193 1998
% 209.45/209.61 |- skos__historyNote mesh__D010193 Pancreatitis/surgery %28%1966-1987%29%
% 209.45/209.61 |- skos__altLabel mesh__D010193 Pancreatojejunostomy
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010193 2000
% 209.45/209.61 |- skos__prefLabel mesh__D010193 Pancreaticojejunostomy
% 209.45/209.61 |- skos__historyNote mesh__D010193 Jejunum/surgery %28%1966-1987%29%
% 209.45/209.61 |- mesh__dateCreated mesh__D010193 1987-03-19
% 209.45/209.61 |- mesh__historyNote mesh__D010193 88
% 209.45/209.61 |- skos__scopeNote mesh__D010193
% 209.45/209.61 Surgical anastomosis of the pancreatic duct, or the divided end of the transected pancreas, with the jejunum. %28%Dorland, 28th ed%29%%A%
% 209.45/209.61 |- rdf__type mesh__D010193sskos__Concept
% 209.45/209.61 |- mesh__recordOriginator mesh__D010193 SCD
% 209.45/209.61 |- mesh__dateEstablished mesh__D010193 1988-01-01
% 209.45/209.61 |- skos__historyNote mesh__D010193
% 209.45/209.61 Pancreatic ducts/surgery %28%1966-1987%29%
% 209.45/209.61 |- skos__broader mesh__D010193smesh__D013505
% 209.45/209.61 |- skos__broader mesh__D010193smesh__D000714
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D004954 2006
% 209.45/209.61 |- mesh__dateCreated mesh__D004954 1999-01-01
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D004954 67; was BEAUTY 1963-66
% 209.45/209.61 |- skos__prefLabel mesh__D004954 Esthetics
% 209.45/209.61 |- skos__broader mesh__D004954smesh__D013850
% 209.45/209.61 |- mesh__dateRevised mesh__D004954 1999-11-03
% 209.45/209.61 |- rdf__type mesh__D004954sskos__Concept
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D004954 2000
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D004954 2003
% 209.45/209.61 |- mesh__historyNote mesh__D004954 67; was BEAUTY 1963-66
% 209.45/209.61 |- mesh__recordMaintainer mesh__D004954 jls
% 209.45/209.61 |- mesh__recordOriginator mesh__D004954 NLM
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D004954 2001
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D004954 2004
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D004954 sjn
% 209.45/209.61 |- skos__scopeNote mesh__D004954
% 209.45/209.61 The branch of philosophy dealing with the nature of the beautiful. It includes beauty, esthetic experience, esthetic judgment, esthetic aspects of medicine, etc.%A%
% 209.45/209.61 |- mesh__dateEstablished mesh__D004954 1967-01-01
% 209.45/209.61 |- skos__altLabel mesh__D004954 Aesthetics
% 209.45/209.61 |- skos__broader mesh__D004954smesh__D010684
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D004954 2002
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D004954 2005
% 209.45/209.61 |- mesh__onlineNote mesh__D004954 use ESTHETICS to search BEAUTY 1966
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D004156 2005
% 209.45/209.61 |- mesh__recordOriginator mesh__D004156 NLM
% 209.45/209.61 |- skos__altLabel mesh__D004156 Polyphenoloxidase
% 209.45/209.61 |- mesh__historyNote mesh__D004156 92; was DIPHENOL OXIDASES 1968-91
% 209.45/209.61 |- mesh__dateRevised mesh__D004156 2004-07-07
% 209.45/209.61 |- skos__hiddenLabel mesh__D004156 Oxidases, Diphenol
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D004156 sjn
% 209.45/209.61 |- mesh__dateCreated mesh__D004156 1999-01-01
% 209.45/209.61 |- mesh__recordMaintainer mesh__D004156 ssb
% 209.45/209.61 |- skos__broader mesh__D004156smesh__D006899
% 209.45/209.61 |- skos__prefLabel mesh__D004156 Catechol Oxidase
% 209.45/209.61 |- skos__hiddenLabel mesh__D004156 Oxidase, Polyphenol
% 209.45/209.61 |- skos__altLabel mesh__D004156 Diphenol Oxidase
% 209.45/209.61 |- skos__historyNote mesh__D004156 Oxidoreductases %28%1966-1967%29%
% 209.45/209.61 |- skos__hiddenLabel mesh__D004156 Oxidase, Diphenol
% 209.45/209.61 |- skos__altLabel mesh__D004156 Diphenol Oxidases
% 209.45/209.61 |- mesh__dateEstablished mesh__D004156 1968-01-01
% 209.45/209.61 |- rdf__type mesh__D004156sskos__Concept
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D004156 92; was DIPHENOL OXIDASES 1968-91
% 209.45/209.61 |- skos__scopeNote mesh__D004156
% 209.45/209.61 An enzyme of the oxidoreductase class that catalyzes the reaction between catechol and oxygen to yield benzoquinone and water. It is a complex of copper-containing proteins that acts also on a variety of substituted catechols. EC 1.10.3.1.%A%
% 209.45/209.61 |- skos__hiddenLabel mesh__D004156 Oxidase, Catechol
% 209.45/209.61 |- skos__altLabel mesh__D004156 Polyphenol Oxidase
% 209.45/209.61 |- mesh__onlineNote mesh__D004156
% 209.45/209.61 use CATECHOL OXIDASE to search DIPHENOL OXIDASES 1968-91
% 209.45/209.61 |- skos__historyNote mesh__D004156 Tyrosine Decarboxylase %28%1966-1967%29%
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D004156 2006
% 209.45/209.61 |- skos__hiddenLabel mesh__D014584 Virtual System
% 209.45/209.61 |- mesh__recordMaintainer mesh__D014584 jls
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014584 2005
% 209.45/209.61 |- skos__annotation mesh__D014584 IM; no qualif
% 209.45/209.61 |- skos__related mesh__D014584smesh__D049250
% 209.45/209.61 |- skos__scopeNote mesh__D014584
% 209.45/209.61 The portion of an interactive computer program that issues messages to and receives commands from a user.%A%
% 209.45/209.61 |- skos__prefLabel mesh__D014584 User-Computer Interface
% 209.45/209.61 |- skos__hiddenLabel mesh__D014584 System, Virtual
% 209.45/209.61 |- skos__hiddenLabel mesh__D014584 User-Computer Interfaces
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D014584 sjn
% 209.45/209.61 |- skos__hiddenLabel mesh__D014584 Systems, Virtual
% 209.45/209.61 |- mesh__recordOriginator mesh__D014584 EC
% 209.45/209.61 |- mesh__dateRevised mesh__D014584 2004-07-07
% 209.45/209.61 |- skos__hiddenLabel mesh__D014584 Interfaces, User Computer
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D014584 91; was see under SOFTWARE 1987-90
% 209.45/209.61 |- mesh__dateCreated mesh__D014584 1986-06-18
% 209.45/209.61 |- skos__broader mesh__D014584smesh__D012984
% 209.45/209.61 |- rdf__type mesh__D014584sskos__Concept
% 209.45/209.61 |- skos__hiddenLabel mesh__D014584 User Computer Interfaces
% 209.45/209.61 |- skos__hiddenLabel mesh__D014584 Interfaces, User-Computer
% 209.45/209.61 |- skos__altLabel mesh__D014584 Interface, User Computer
% 209.45/209.61 |- mesh__dateEstablished mesh__D014584 1991-01-01
% 209.45/209.61 |- mesh__historyNote mesh__D014584
% 209.45/209.61 91%28%87%29%; was see under SOFTWARE 1987-90
% 209.45/209.61 |- skos__hiddenLabel mesh__D014584 Interface, User-Computer
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D014584 2006
% 209.45/209.61 |- skos__altLabel mesh__D014584 User Computer Interface
% 209.45/209.61 |- skos__broader mesh__D007461Q000031smesh__D007461
% 209.45/209.61 |- mesh__preferredCombination mesh__D007461Q000031smesh__D000085
% 209.45/209.61 |- rdf__type mesh__D007461Q000031smesh__CompoundConcept
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008547 2001
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008547 2004
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008547 2005
% 209.45/209.61 |- mesh__dateCreated mesh__D008547 1999-01-01
% 209.45/209.61 |- skos__prefLabel mesh__D008547 Melanophores
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008547 2000
% 209.45/209.61 |- mesh__historyNote mesh__D008547
% 209.45/209.61 78%28%75%29%; was see under CHROMATOPHORES 1963-77
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008547 2003
% 209.45/209.61 |- rdf__type mesh__D008547sskos__Concept
% 209.45/209.61 |- skos__historyNote mesh__D008547 Chromatophores %28%1966-1974%29%
% 209.45/209.61 |- mesh__onlineNote mesh__D008547 search CHROMATOPHORES 1966-74
% 209.45/209.61 |- mesh__dateRevised mesh__D008547 1998-06-10
% 209.45/209.61 |- skos__broader mesh__D008547smesh__D002856
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008547 1999
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008547 2002
% 209.45/209.61 |- skos__hiddenLabel mesh__D008547 Melanophore
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D008547
% 209.45/209.61 78; was see under CHROMATOPHORES 1963-77
% 209.45/209.61 |- mesh__recordMaintainer mesh__D008547 NNS
% 209.45/209.61 |- mesh__recordOriginator mesh__D008547 NLM
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D008547 SJN
% 209.45/209.61 |- skos__annotation mesh__D008547 do not confuse with MELANOCYTES
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D008547 2006
% 209.45/209.61 |- mesh__dateEstablished mesh__D008547 1978-01-01
% 209.45/209.61 |- skos__scopeNote mesh__D008547
% 209.45/209.61 Chromatophores %28%large pigment cells of fish, amphibia, reptiles and many invertebrates%29% which contain melanin. Short term color changes are brought about by an active redistribution of the melanophores pigment containing organelles %28%MELANOSOMES%29%. Mammals do not have melanophores; however they have retained smaller pigment cells known as MELANOCYTES.%A%
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D000564 sjn
% 209.45/209.61 |- skos__scopeNote mesh__D000564
% 209.45/209.61 An immature epithelial tumor of the JAW originating from the epithelial rests of Malassez or from other epithelial remnants of the ENAMEL from the developmental period. It is a slowly growing tumor, usually benign, but displays a marked propensity for invasive growth.%A%
% 209.45/209.61 |- mesh__dateEstablished mesh__D000564 1965-01-01
% 209.45/209.61 |- mesh__dateRevised mesh__D000564 2005-06-30
% 209.45/209.61 |- skos__related mesh__D000564smesh__D000565
% 209.45/209.61 |- skos__annotation mesh__D000564
% 209.45/209.61 benign or malignant; coordinate IM with probably JAW NEOPLASMS %28%IM%29% or precoordinated jaw/neoplasm term %28%IM%29%%A%
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D000564 2006
% 209.45/209.61 |- rdf__type mesh__D000564sskos__Concept
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D000564 1965; see ADAMANTINOMA 1963-1964
% 209.45/209.61 |- mesh__recordOriginator mesh__D000564 NLM
% 209.45/209.61 |- skos__prefLabel mesh__D000564 Ameloblastoma
% 209.45/209.61 |- skos__broader mesh__D000564smesh__D009808
% 209.45/209.61 |- mesh__historyNote mesh__D000564 1965 %28%1963%29%
% 209.45/209.61 |- skos__hiddenLabel mesh__D000564 Ameloblastomas
% 209.45/209.61 |- mesh__dateCreated mesh__D000564 1999-01-01
% 209.45/209.61 |- mesh__recordMaintainer mesh__D000564 ags
% 209.45/209.61 |- skos__scopeNote mesh__D027701
% 209.45/209.61 A family of proteins involved in the transport of organic cations. They play an important role in the elimination of a variety of endogenous substances, xenobiotics, and their metabolites from the body.%A%
% 209.45/209.61 |- mesh__dateRevised mesh__D027701 2005-06-30
% 209.45/209.61 |- mesh__dateEstablished mesh__D027701 2002-01-01
% 209.45/209.61 |- mesh__historyNote mesh__D027701 2002
% 209.45/209.61 |- mesh__recordOriginator mesh__D027701 jmp
% 209.45/209.61 |- skos__broader mesh__D027701smesh__D027682
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D027701 2006
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D027701 sjn
% 209.45/209.61 |- mesh__dateCreated mesh__D027701 2001-07-25
% 209.45/209.61 |- mesh__recordMaintainer mesh__D027701 SYSTEM
% 209.45/209.61 |- skos__prefLabel mesh__D027701 Organic Cation Transport Proteins
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D027701 2002
% 209.45/209.61 |- rdf__type mesh__D027701sskos__Concept
% 209.45/209.61 |- skos__altLabel mesh__D027701 Membrane Transport-Proteins, Organic Cation
% 209.45/209.61 |- skos__historyNote mesh__D027701 Ion Pumps %28%1992-2001%29%
% 209.45/209.61 |- skos__broader mesh__D012701Q000819smesh__D012701
% 209.45/209.61 |- mesh__preferredCombination mesh__D012701Q000819smesh__D017366
% 209.45/209.61 |- rdf__type mesh__D012701Q000819smesh__CompoundConcept
% 209.45/209.61 |- skos__altLabel mesh__D018975 IGF-Binding Protein 5
% 209.45/209.61 |- skos__altLabel mesh__D018975 IGFBP-5
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D018975
% 209.45/209.61 2005; see INSULIN-LIKE GROWTH-FACTOR-BINDING-PROTEIN-5 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-5 was indexed under CARRIER PROTEINS 1991-1995%A%
% 209.45/209.61 |- mesh__dateEstablished mesh__D018975 1996-01-01
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018975 2005
% 209.45/209.61 |- mesh__recordOriginator mesh__D018975 TPW
% 209.45/209.61 |- mesh__recordMaintainer mesh__D018975 jmp
% 209.45/209.61 |- skos__hiddenLabel mesh__D018975
% 209.45/209.61 Insulin Like Growth Factor Binding Protein 5
% 209.45/209.61 |- skos__broader mesh__D018975smesh__D018969
% 209.45/209.61 |- mesh__dateCreated mesh__D018975 1995-06-16
% 209.45/209.61 |- skos__prefLabel mesh__D018975
% 209.45/209.61 Insulin-Like Growth Factor Binding Protein 5
% 209.45/209.61 |- mesh__dateRevised mesh__D018975 2004-07-07
% 209.45/209.61 |- skos__hiddenLabel mesh__D018975 IGF Binding Protein 5
% 209.45/209.61 |- mesh__historyNote mesh__D018975 2005%28%1991%29%
% 209.45/209.61 |- skos__annotation mesh__D018975
% 209.45/209.61 /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D018975 sjn
% 209.45/209.61 |- skos__historyNote mesh__D018975 Carrier Proteins %28%1991-1995%29%
% 209.45/209.61 |- skos__scopeNote mesh__D018975
% 209.45/209.61 One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%
% 209.45/209.61 |- rdf__type mesh__D018975sskos__Concept
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018975 2006
% 209.45/209.61 |- skos__prefLabel mesh__D010992 Plethysmography, Impedance
% 209.45/209.61 |- skos__annotation mesh__D010992
% 209.45/209.61 NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; do not confuse X ref RHEOGRAPHY with %22%rheography%22% as a synonym for the study of flow dynamics of body %26% other fluids %28% = RHEOLOGY%29%; DF: PLETHYSMOGR IMPEDANCE%A%
% 209.45/209.61 |- mesh__dateRevised mesh__D010992 1997-06-20
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D010992 66
% 209.45/209.61 |- skos__hiddenLabel mesh__D010992 Plethysmographies, Impedance
% 209.45/209.61 |- skos__altLabel mesh__D010992 Rheography
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010992 2004
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010992 2005
% 209.45/209.61 |- mesh__recordOriginator mesh__D010992 NLM
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010992 2001
% 209.45/209.61 |- skos__hiddenLabel mesh__D010992 Rheographies
% 209.45/209.61 |- skos__broader mesh__D010992smesh__D010991
% 209.45/209.61 |- mesh__dateEstablished mesh__D010992 1966-01-01
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010992 2003
% 209.45/209.61 |- mesh__historyNote mesh__D010992 66
% 209.45/209.61 |- mesh__recordMaintainer mesh__D010992 PXP
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010992 2000
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D010992 SJN
% 209.45/209.61 |- skos__scopeNote mesh__D010992
% 209.45/209.61 Recording changes in electrical impedance between electrodes placed on opposite sides of a part of the body, as a measure of volume changes in the path of the current. %28%Stedman, 25th ed%29%%A%
% 209.45/209.61 |- skos__hiddenLabel mesh__D010992 Impedance Plethysmographies
% 209.45/209.61 |- rdf__type mesh__D010992sskos__Concept
% 209.45/209.61 |- skos__altLabel mesh__D010992 Impedance Plethysmography
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010992 2002
% 209.45/209.61 |- mesh__dateCreated mesh__D010992 1999-01-01
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010992 1999
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010992 2006
% 209.45/209.61 |- skos__broader mesh__D010992smesh__D004568
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010992 1998
% 209.45/209.61 |- skos__hiddenLabel mesh__D018177 Flavivirus Infection
% 209.45/209.61 |- mesh__historyNote mesh__D018177 94
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 1997
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 2004
% 209.45/209.61 |- skos__annotation mesh__D018177
% 209.45/209.61 caused by members of the Flavivirus genus: do not confuse with FLAVIVIRIDAE INFECTIONS caused by members of the Flaviviridae family; GEN or unspecified; prefer specifics%A%
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 2002
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 1996
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 2003
% 209.45/209.61 |- mesh__dateCreated mesh__D018177 1993-06-04
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D018177 94
% 209.45/209.61 |- mesh__dateEstablished mesh__D018177 1994-01-01
% 209.45/209.61 |- skos__prefLabel mesh__D018177 Flavivirus Infections
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 1999
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 2006
% 209.45/209.61 |- skos__scopeNote mesh__D018177
% 209.45/209.61 Infections with viruses of the genus FLAVIVIRUS, family FLAVIVIRIDAE.%A%
% 209.45/209.61 |- rdf__type mesh__D018177sskos__Concept
% 209.45/209.61 |- skos__altLabel mesh__D018177 Infections, Flavivirus
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 1995
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 2001
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 1998
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 2005
% 209.45/209.61 |- skos__broader mesh__D018177smesh__D018178
% 209.45/209.61 |- skos__hiddenLabel mesh__D018177 Infection, Flavivirus
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 2000
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D018177 1994
% 209.45/209.61 |- mesh__publicMeSHNote mesh__D010194
% 209.45/209.61 67; was see PANCREATIC EXTRACTS 1963-66
% 209.45/209.61 |- mesh__recordMaintainer mesh__D010194 ssb
% 209.45/209.61 |- mesh__activeMeSHYear mesh__D010194 2006
% 209.45/209.61 |- mesh__historyNote mesh__D010194
% 209.45/209.61 67%28%64%29%; was see PANCREATIC EXTRACTS 1963-66
% 209.45/209.61 |- mesh__dateEstablished mesh__D010194 1967-01-01
% 209.45/209.61 |- mesh__recordAuthorizer mesh__D010194 sjn
% 209.45/209.61 |- rdf__type mesh__D010194sskos__Concept
% 209.45/209.61 |- mesh__dateRevised mesh__D010194 2005-06-30
% 209.45/209.61 |- skos__broader mesh__D010194smesh__D006867
% 209.45/209.62 |- mesh__recordOriginator mesh__D010194 NLM
% 209.45/209.62 |- mesh__dateCreated mesh__D010194 1999-01-01
% 209.45/209.62 |- skos__prefLabel mesh__D010194 Pancreatin
% 209.45/209.62 |- skos__scopeNote mesh__D010194
% 209.45/209.62 A mammalian pancreatic extract composed of enzymes with protease, amylase and lipase activities. It is used as a digestant in pancreatic malfunction.%A%
% 209.45/209.62 |- skos__broader mesh__D010194smesh__D010184
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004955 2002
% 209.45/209.62 |- skos__broader mesh__D004955smesh__D003813
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D004955 65
% 209.45/209.62 |- mesh__historyNote mesh__D004955 65
% 209.45/209.62 |- rdf__type mesh__D004955sskos__Concept
% 209.45/209.62 |- skos__hiddenLabel mesh__D004955 Cosmetic Dentistries
% 209.45/209.62 |- skos__hiddenLabel mesh__D004955 Dentistry, Cosmetic
% 209.45/209.62 |- mesh__dateEstablished mesh__D004955 1965-01-01
% 209.45/209.62 |- skos__scopeNote mesh__D004955
% 209.45/209.62 Skills, techniques, standards, and principles used to improve the art and symmetry of the teeth and face to improve the appearance as well as the function of the teeth, mouth, and face. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed, p108%29%%A%
% 209.45/209.62 |- skos__altLabel mesh__D004955 Cosmetic Dentistry
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004955 2003
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004955 2004
% 209.45/209.62 |- mesh__dateRevised mesh__D004955 1999-11-03
% 209.45/209.62 |- skos__altLabel mesh__D004955 Dental Esthetics
% 209.45/209.62 |- skos__annotation mesh__D004955
% 209.45/209.62 includes teeth, mouth or face; DF: ESTHETICS DENT
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004955 2000
% 209.45/209.62 |- skos__altLabel mesh__D004955 Aesthetics, Dental
% 209.45/209.62 |- skos__prefLabel mesh__D004955 Esthetics, Dental
% 209.45/209.62 |- skos__hiddenLabel mesh__D004955 Dentistries, Cosmetic
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004955 2005
% 209.45/209.62 |- mesh__recordMaintainer mesh__D004955 jls
% 209.45/209.62 |- mesh__recordOriginator mesh__D004955 NLM
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004955 2001
% 209.45/209.62 |- skos__altLabel mesh__D004955 Dental Esthetic
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004955 2006
% 209.45/209.62 |- mesh__dateCreated mesh__D004955 1999-01-01
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D004955 sjn
% 209.45/209.62 |- skos__altLabel mesh__D004955 Esthetic, Dental
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D004157
% 209.45/209.62 91; was see under ISONIPECOTIC ACIDS 1975-90
% 209.45/209.62 |- skos__hiddenLabel mesh__D004157 Monohydrochloride, Diphenoxylate
% 209.45/209.62 |- skos__historyNote mesh__D004157 Isonipecotic Acids %28%1970-1974%29%
% 209.45/209.62 |- skos__prefLabel mesh__D004157 Diphenoxylate
% 209.45/209.62 |- mesh__dateRevised mesh__D004157 2005-06-30
% 209.45/209.62 |- skos__broader mesh__D004157smesh__D007540
% 209.45/209.62 |- rdf__type mesh__D004157sskos__Concept
% 209.45/209.62 |- skos__historyNote mesh__D004157 Nitriles %28%1974%29%
% 209.45/209.62 |- skos__scopeNote mesh__D004157
% 209.45/209.62 A MEPERIDINE congener used as an antidiarrheal, usually in combination with atropine. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity.%A%
% 209.45/209.62 |- mesh__dateCreated mesh__D004157 1974-11-11
% 209.45/209.62 |- mesh__recordOriginator mesh__D004157 NLM
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004157 2006
% 209.45/209.62 |- skos__hiddenLabel mesh__D004157 Hydrochloride, Diphenoxylate
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D004157 sjn
% 209.45/209.62 |- mesh__historyNote mesh__D004157
% 209.45/209.62 91%28%75%29%; was see under ISONIPECOTIC ACIDS 1975-90
% 209.45/209.62 |- mesh__dateEstablished mesh__D004157 1991-01-01
% 209.45/209.62 |- mesh__recordMaintainer mesh__D004157 exl
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D009640 2006
% 209.45/209.62 |- skos__hiddenLabel mesh__D009640 Nor QD
% 209.45/209.62 |- skos__altLabel mesh__D009640 Norethisterone
% 209.45/209.62 |- mesh__recordMaintainer mesh__D009640 lkt
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D009640 2005
% 209.45/209.62 |- skos__hiddenLabel mesh__D009640 NorQD
% 209.45/209.62 |- mesh__dateCreated mesh__D009640 1999-01-01
% 209.45/209.62 |- rdf__type mesh__D009640sskos__Concept
% 209.45/209.62 |- skos__scopeNote mesh__D009640
% 209.45/209.62 A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.%A%
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D009640 2004
% 209.45/209.62 |- mesh__recordOriginator mesh__D009640 NLM
% 209.45/209.62 |- mesh__dateRevised mesh__D009640 2003-07-09
% 209.45/209.62 |- skos__broader mesh__D009640smesh__D009652
% 209.45/209.62 |- skos__altLabel mesh__D009640 Norpregneninolone
% 209.45/209.62 |- skos__prefLabel mesh__D009640 Norethindrone
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D009640 sjn
% 209.45/209.62 |- skos__altLabel mesh__D009640 Ethinylnortestosterone
% 209.45/209.62 |- mesh__recordOriginator mesh__D008548 NLM
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D008548 2003
% 209.45/209.62 |- rdf__type mesh__D008548sskos__Concept
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D008548 2001
% 209.45/209.62 |- skos__broader mesh__D008548smesh__D017495
% 209.45/209.62 |- skos__annotation mesh__D008548
% 209.45/209.62 for neurocutaneous melanosis, coord with NEUROCUTANEOUS SYNDROMES%A%
% 209.45/209.62 |- mesh__recordMaintainer mesh__D008548 KEV
% 209.45/209.62 |- skos__hiddenLabel mesh__D008548 Chloasmas
% 209.45/209.62 |- skos__hiddenLabel mesh__D008548 Freckle
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D008548 2000
% 209.45/209.62 |- skos__scopeNote mesh__D008548
% 209.45/209.62 Disorders of increased melanin pigmentation that develop without preceding inflammatory disease.%A%
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D008548 FRECKLES was see LENTIGO 1963-79
% 209.45/209.62 |- mesh__historyNote mesh__D008548 FRECKLES was see LENTIGO 1963-79
% 209.45/209.62 |- skos__hiddenLabel mesh__D008548 Melanoses
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D008548 2006
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D008548 2002
% 209.45/209.62 |- skos__altLabel mesh__D008548 Melanism
% 209.45/209.62 |- mesh__dateRevised mesh__D008548 1999-11-03
% 209.45/209.62 |- skos__prefLabel mesh__D008548 Melanosis
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D008548 sjn
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D008548 2004
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D008548 2005
% 209.45/209.62 |- mesh__dateCreated mesh__D008548 1999-01-01
% 209.45/209.62 |- mesh__onlineNote mesh__D008548 use LENTIGO to search FRECKLES 1966-79
% 209.45/209.62 |- skos__hiddenLabel mesh__D008548 Melasmas
% 209.45/209.62 |- skos__altLabel mesh__D008548 Melasma
% 209.45/209.62 |- mesh__dateEstablished mesh__D000565 1965-01-01
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D000565 65
% 209.45/209.62 |- mesh__dateRevised mesh__D000565 2005-06-30
% 209.45/209.62 |- skos__scopeNote mesh__D000565
% 209.45/209.62 Cylindrical epithelial cells in the innermost layer of the ENAMEL ORGAN. Their functions include contribution to the development of the dentinoenamel junction by the deposition of a layer of the matrix, thus producing the foundation for the prisms %28%the structural units of the DENTAL ENAMEL%29%, and production of the matrix for the enamel prisms and interprismatic substance. %28%From Jablonski%27%s Dictionary of Dentistry, 1992%29%%A%
% 209.45/209.62 |- skos__broader mesh__D000565smesh__D004847
% 209.45/209.62 |- rdf__type mesh__D000565sskos__Concept
% 209.45/209.62 |- mesh__historyNote mesh__D000565 65
% 209.45/209.62 |- skos__hiddenLabel mesh__D000565 Ameloblast
% 209.45/209.62 |- skos__related mesh__D000565smesh__D000564
% 209.45/209.62 |- mesh__recordOriginator mesh__D000565 NLM
% 209.45/209.62 |- mesh__dateCreated mesh__D000565 1999-01-01
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D000565 2006
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D000565 sjn
% 209.45/209.62 |- skos__prefLabel mesh__D000565 Ameloblasts
% 209.45/209.62 |- mesh__recordMaintainer mesh__D000565 ags
% 209.45/209.62 |- mesh__dateRevised mesh__D019270 2004-07-27
% 209.45/209.62 |- skos__altLabel mesh__D019270 D-Isoglucosamine
% 209.45/209.62 |- skos__scopeNote mesh__D019270
% 209.45/209.62 An amino sugar formed when glucose non-enzymatically reacts with the N-terminal amino group of proteins. The fructose moiety is derived from glucose by the %22%classical%22% Amadori rearrangement.%A%
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D019270 2005
% 209.45/209.62 |- mesh__onlineNote mesh__D019270
% 209.45/209.62 use FRUCTOSAMINE %28%NM%29% to search FRUCTOSAMINE 1983-96
% 209.45/209.62 |- mesh__recordMaintainer mesh__D019270 jls
% 209.45/209.62 |- mesh__dateCreated mesh__D019270 1996-06-10
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D019270 2005A
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D019270 jls
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D019270
% 209.45/209.62 97; FRUCTOSAMINE was indexed under HEXOSAMINES 1983-96
% 209.45/209.62 |- skos__historyNote mesh__D019270 Hexosamines %28%1983-1996%29%
% 209.45/209.62 |- skos__hiddenLabel mesh__D019270 D Isoglucosamine
% 209.45/209.62 |- mesh__historyNote mesh__D019270
% 209.45/209.62 97; was FRUCTOSAMINE %28%NM%29% 1983-96
% 209.45/209.62 |- mesh__dateEstablished mesh__D019270 1997-01-01
% 209.45/209.62 |- skos__broader mesh__D019270smesh__D006595
% 209.45/209.62 |- mesh__recordOriginator mesh__D019270 TPW
% 209.45/209.62 |- rdf__type mesh__D019270sskos__Concept
% 209.45/209.62 |- skos__prefLabel mesh__D019270 Fructosamine
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D019270 2006
% 209.45/209.62 |- skos__broader mesh__D027702smesh__D027701
% 209.45/209.62 |- mesh__historyNote mesh__D027702
% 209.45/209.62 2002; use ORGANIC CATION TRANSPORTER 1 %28%NM%29% 1995-2001
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D027702 2003
% 209.45/209.62 |- skos__hiddenLabel mesh__D027702 Protein, OCT1 Transport
% 209.45/209.62 |- skos__altLabel mesh__D027702 OCT1 Protein
% 209.45/209.62 |- mesh__dateEstablished mesh__D027702 2002-01-01
% 209.45/209.62 |- skos__altLabel mesh__D027702
% 209.45/209.62 Solute Carrier Family 22 %28%Organic Cation Transporter%29%, Member 1
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D027702 2004
% 209.45/209.62 |- skos__hiddenLabel mesh__D027702 Transport Protein, OCT1
% 209.45/209.62 |- skos__historyNote mesh__D027702 Membrane Proteins %28%1995-2001%29%
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D027702
% 209.45/209.62 2002; OCT1 PROTEIN now ORGANIC CATION TRANSPORTER 1 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1995-2001%A%
% 209.45/209.62 |- mesh__recordOriginator mesh__D027702 jmp
% 209.45/209.62 |- skos__hiddenLabel mesh__D027702 Transporter, SLC22A1
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D027702 sjn
% 209.45/209.62 |- mesh__recordMaintainer mesh__D027702 jmp
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D027702 2002
% 209.45/209.62 |- skos__altLabel mesh__D027702 OCT1 Transport Protein
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D027702 2005
% 209.45/209.62 |- skos__prefLabel mesh__D027702 Organic Cation Transporter 1
% 209.45/209.62 |- skos__scopeNote mesh__D027702
% 209.45/209.62 An organic cation transporter found in kidney. It is localized to the basal lateral membrane and is likely to be involved in the renal secretion of organic cations.%A%
% 209.45/209.62 |- mesh__dateCreated mesh__D027702 2001-07-25
% 209.45/209.62 |- skos__altLabel mesh__D027702 SLC22A1 Transporter
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D027702 2006
% 209.45/209.62 |- rdf__type mesh__D027702sskos__Concept
% 209.45/209.62 |- skos__historyNote mesh__D027702 Carrier Proteins %28%1995-2001%29%
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D005250 2006
% 209.45/209.62 |- mesh__recordMaintainer mesh__D005250 kle
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D005250 sjn
% 209.45/209.62 |- skos__altLabel mesh__D005250 Dental Fees
% 209.45/209.62 |- mesh__dateCreated mesh__D005250 1999-01-01
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D005250 2002
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D005250 68
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D005250 2005
% 209.45/209.62 |- mesh__recordOriginator mesh__D005250 NLM
% 209.45/209.62 |- skos__annotation mesh__D005250 DF: FEES DENT
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D005250 2001
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D005250 2004
% 209.45/209.62 |- skos__broader mesh__D005250smesh__D005249
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D005250 2000
% 209.45/209.62 |- skos__broader mesh__D005250smesh__D004468
% 209.45/209.62 |- skos__historyNote mesh__D005250 Economics, Dental %28%1966-1967%29%
% 209.45/209.62 |- mesh__dateEstablished mesh__D005250 1968-01-01
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D005250 2003
% 209.45/209.62 |- rdf__type mesh__D005250sskos__Concept
% 209.45/209.62 |- skos__altLabel mesh__D005250 Dental Fee
% 209.45/209.62 |- skos__scopeNote mesh__D005250
% 209.45/209.62 Amounts charged to the patient as payer for dental services.%A%
% 209.45/209.62 |- skos__altLabel mesh__D005250 Fee, Dental
% 209.45/209.62 |- mesh__historyNote mesh__D005250 68
% 209.45/209.62 |- mesh__dateRevised mesh__D005250 1999-11-03
% 209.45/209.62 |- skos__prefLabel mesh__D005250 Fees, Dental
% 209.45/209.62 |- skos__hiddenLabel mesh__D018976
% 209.45/209.62 Insulin Like Growth Factor Binding Protein 6
% 209.45/209.62 |- skos__hiddenLabel mesh__D018976 IGF Binding Protein 6
% 209.45/209.62 |- skos__altLabel mesh__D018976 IGF-Binding Protein 6
% 209.45/209.62 |- mesh__recordMaintainer mesh__D018976 jmp
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D018976 sjn
% 209.45/209.62 |- skos__altLabel mesh__D018976 IGFBP-6
% 209.45/209.62 |- mesh__dateCreated mesh__D018976 1995-06-16
% 209.45/209.62 |- mesh__dateRevised mesh__D018976 2004-07-07
% 209.45/209.62 |- mesh__dateEstablished mesh__D018976 1996-01-01
% 209.45/209.62 |- skos__annotation mesh__D018976
% 209.45/209.62 /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%
% 209.45/209.62 |- mesh__recordOriginator mesh__D018976 TPW
% 209.45/209.62 |- mesh__historyNote mesh__D018976 2005%28%1992%29%
% 209.45/209.62 |- rdf__type mesh__D018976sskos__Concept
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018976 2006
% 209.45/209.62 |- skos__historyNote mesh__D018976 Carrier Proteins %28%1992-1995%29%
% 209.45/209.62 |- skos__scopeNote mesh__D018976
% 209.45/209.62 One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%
% 209.45/209.62 |- skos__prefLabel mesh__D018976
% 209.45/209.62 Insulin-Like Growth Factor Binding Protein 6
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D018976
% 209.45/209.62 2005; see INSULIN-LIKE-GROWTH-FACTOR-BINDING PROTEIN 6 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6 was indexed under CARRIER PROTEINS 1992-1995%A%
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018976 2005
% 209.45/209.62 |- skos__broader mesh__D018976smesh__D018969
% 209.45/209.62 |- mesh__recordOriginator mesh__D010993 NLM
% 209.45/209.62 |- skos__annotation mesh__D010993
% 209.45/209.62 used in resp funct tests; do not use /util except by MeSH definition; DF: PLETHYSMOGR WHOLE BODY%A%
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010993 2006
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010993 2001
% 209.45/209.62 |- skos__hiddenLabel mesh__D010993 Plethysmographies, Whole Body
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010993 2004
% 209.45/209.62 |- skos__scopeNote mesh__D010993
% 209.45/209.62 Measurement of the volume of gas in the lungs, including that which is trapped in poorly communicating air spaces. It is of particular use in chronic obstructive pulmonary disease and emphysema. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010993 2005
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010993 2000
% 209.45/209.62 |- skos__hiddenLabel mesh__D010993 Whole Body Plethysmographies
% 209.45/209.62 |- skos__prefLabel mesh__D010993 Plethysmography, Whole Body
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D010993 SJN
% 209.45/209.62 |- skos__broader mesh__D010993smesh__D010991
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010993 2003
% 209.45/209.62 |- skos__hiddenLabel mesh__D010993 Body Plethysmography, Whole
% 209.45/209.62 |- skos__hiddenLabel mesh__D010993 Body Plethysmographies, Whole
% 209.45/209.62 |- mesh__historyNote mesh__D010993 73%28%71%29%
% 209.45/209.62 |- skos__historyNote mesh__D010993 Plethysmography %28%1966-1970%29%
% 209.45/209.62 |- mesh__recordMaintainer mesh__D010993 PXP
% 209.45/209.62 |- mesh__dateEstablished mesh__D010993 1973-01-01
% 209.45/209.62 |- skos__historyNote mesh__D010993
% 209.45/209.62 Respiratory Function Tests %28%1966-1970%29%
% 209.45/209.62 |- mesh__dateCreated mesh__D010993 1999-01-01
% 209.45/209.62 |- rdf__type mesh__D010993sskos__Concept
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010993 2002
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010993 1999
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D010993 73
% 209.45/209.62 |- skos__altLabel mesh__D010993 Whole Body Plethysmography
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010993 1998
% 209.45/209.62 |- mesh__dateRevised mesh__D010993 1997-06-20
% 209.45/209.62 |- skos__broader mesh__D010993smesh__D012129
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 2003
% 209.45/209.62 |- skos__hiddenLabel mesh__D018178 Flaviviridae Infection
% 209.45/209.62 |- mesh__historyNote mesh__D018178 94
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 2004
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 1997
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 2001
% 209.45/209.62 |- skos__annotation mesh__D018178
% 209.45/209.62 caused by members of the Flaviviridae family: do not confuse with FLAVIVIRUS INFECTIONS caused by members of the Flavivirus genus; GEN or unspecified; prefer specifics%A%
% 209.45/209.62 |- skos__prefLabel mesh__D018178 Flaviviridae Infections
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 2002
% 209.45/209.62 |- skos__broader mesh__D018178smesh__D012327
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 1998
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 2005
% 209.45/209.62 |- mesh__dateCreated mesh__D018178 1993-06-04
% 209.45/209.62 |- skos__hiddenLabel mesh__D018178 Infection, Flaviviridae
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 1994
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 1999
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 2006
% 209.45/209.62 |- rdf__type mesh__D018178sskos__Concept
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 1995
% 209.45/209.62 |- mesh__dateEstablished mesh__D018178 1994-01-01
% 209.45/209.62 |- skos__scopeNote mesh__D018178
% 209.45/209.62 Infections with viruses of the family FLAVIVIRIDAE.
% 209.45/209.62 |- skos__altLabel mesh__D018178 Infections, Flaviviridae
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 2000
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D018178 94
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D018178 1996
% 209.45/209.62 |- skos__prefLabel mesh__D010195 Pancreatitis
% 209.45/209.62 |- skos__broader mesh__D010195smesh__D010182
% 209.45/209.62 |- skos__hiddenLabel mesh__D010195 Pancreatitides
% 209.45/209.62 |- mesh__recordMaintainer mesh__D010195 lkt
% 209.45/209.62 |- rdf__type mesh__D010195sskos__Concept
% 209.45/209.62 |- skos__scopeNote mesh__D010195
% 209.45/209.62 INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS %28%International Symposium on Acute Pancreatitis, Atlanta, 1992%29%. The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.%A%
% 209.45/209.62 |- mesh__dateCreated mesh__D010195 1999-01-01
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D010195 sjn
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D010195 2006
% 209.45/209.62 |- mesh__dateRevised mesh__D010195 2005-06-30
% 209.45/209.62 |- mesh__recordOriginator mesh__D010195 NLM
% 209.45/209.62 |- skos__annotation mesh__D004956
% 209.45/209.62 animal only; a natural physiol process; summer dormancy corresponding to HIBERNATION, winter dormancy%A%
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D004956
% 209.45/209.62 91; was see under ADAPTATION, PHYSIOLOGICAL 1966-90
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004956 2006
% 209.45/209.62 |- mesh__recordOriginator mesh__D004956 NLM
% 209.45/209.62 |- skos__broader mesh__D004956smesh__D000222
% 209.45/209.62 |- rdf__type mesh__D004956sskos__Concept
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004956 2005
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D004956 sjn
% 209.45/209.62 |- mesh__dateEstablished mesh__D004956 1991-01-01
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004956 2004
% 209.45/209.62 |- mesh__dateRevised mesh__D004956 2003-07-09
% 209.45/209.62 |- mesh__recordMaintainer mesh__D004956 lkt
% 209.45/209.62 |- mesh__historyNote mesh__D004956
% 209.45/209.62 91%28%66%29%; was see under ADAPTATION, PHYSIOLOGICAL 1966-90
% 209.45/209.62 |- mesh__dateCreated mesh__D004956 1999-01-01
% 209.45/209.62 |- skos__scopeNote mesh__D004956
% 209.45/209.62 In certain living species, a period of dormancy during the summer months marked by decreased metabolism.%A%
% 209.45/209.62 |- skos__prefLabel mesh__D004956 Estivation
% 209.45/209.62 |- skos__hiddenLabel mesh__D004158 Acids, Diphenylacetic
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 2001
% 209.45/209.62 |- rdf__type mesh__D004158sskos__Concept
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 1993
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 1994
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 2000
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 2006
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 1999
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D004158 PLS
% 209.45/209.62 |- mesh__dateRevised mesh__D004158 1992-05-13
% 209.45/209.62 |- mesh__recordMaintainer mesh__D004158 TGC
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 2004
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 1997
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 2005
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 1998
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 2002
% 209.45/209.62 |- mesh__historyNote mesh__D004158 68
% 209.45/209.62 |- skos__prefLabel mesh__D004158 Diphenylacetic Acids
% 209.45/209.62 |- mesh__dateCreated mesh__D004158 1999-01-01
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 2003
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 1996
% 209.45/209.62 |- mesh__recordOriginator mesh__D004158 NLM
% 209.45/209.62 |- skos__broader mesh__D004158smesh__D010648
% 209.45/209.62 |- mesh__publicMeSHNote mesh__D004158 68
% 209.45/209.62 |- mesh__dateEstablished mesh__D004158 1968-01-01
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D004158 1995
% 209.45/209.62 |- skos__broader mesh__D009641smesh__D009652
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D009641 2006
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D009641 sjn
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D009641 2005
% 209.45/209.62 |- rdf__type mesh__D009641sskos__Concept
% 209.45/209.62 |- skos__scopeNote mesh__D009641
% 209.45/209.62 A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and endometriosis. As a contraceptive, it has usually been administered in combination with MESTRANOL.%A%
% 209.45/209.62 |- mesh__dateCreated mesh__D009641 1999-01-01
% 209.45/209.62 |- skos__prefLabel mesh__D009641 Norethynodrel
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D009641 2004
% 209.45/209.62 |- mesh__dateRevised mesh__D009641 2003-07-09
% 209.45/209.62 |- mesh__recordMaintainer mesh__D009641 lkt
% 209.45/209.62 |- mesh__recordOriginator mesh__D009641 NLM
% 209.45/209.62 |- mesh__dateCreated mesh__D014586 1999-01-01
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 1994
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 2000
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 1999
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 1993
% 209.45/209.62 |- mesh__recordMaintainer mesh__D014586 PLS
% 209.45/209.62 |- skos__altLabel mesh__D014586 Union of Soviet Socialist Republics
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 1995
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 2001
% 209.45/209.62 |- mesh__dateRevised mesh__D014586 1992-05-22
% 209.45/209.62 |- mesh__recordOriginator mesh__D014586 NLM
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 2003
% 209.45/209.62 |- rdf__type mesh__D014586sskos__Concept
% 209.45/209.62 |- skos__broader mesh__D014586smesh__D017516
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 2005
% 209.45/209.62 |- mesh__recordAuthorizer mesh__D014586 PLS
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 2004
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 2002
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 2006
% 209.45/209.62 |- skos__annotation mesh__D014586
% 209.45/209.62 GEN; each former Soviet republic is available as a heading; MOSCOW is also available; note spelling: no periods%A%
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 1996
% 209.45/209.62 |- skos__altLabel mesh__D014586 Soviet Union
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 1998
% 209.45/209.62 |- mesh__activeMeSHYear mesh__D014586 1997
% 209.45/209.62 |- skos__prefLabel mesh__D014586 USSR
% 209.48/209.62 |- mesh__publicMeSHNote mesh__D008549
% 209.48/209.62 91; was see under ARSENICALS 1975-90
% 209.48/209.62 |- skos__historyNote mesh__D008549 Arsenicals %28%1968-1974%29%
% 209.48/209.62 |- mesh__recordMaintainer mesh__D008549 jmp
% 209.48/209.62 |- mesh__activeMeSHYear mesh__D008549 2002
% 209.48/209.62 |- skos__hiddenLabel mesh__D008549 B, Mel
% 209.48/209.62 |- skos__hiddenLabel mesh__D008549 MelarsenoxidBAL
% 209.48/209.62 |- mesh__recordAuthorizer mesh__D008549 sjn
% 209.48/209.62 |- mesh__dateCreated mesh__D008549 1974-11-19
% 209.48/209.62 |- mesh__activeMeSHYear mesh__D008549 2006
% 209.48/209.62 |- skos__broader mesh__D008549smesh__D001152
% 209.48/209.62 |- skos__historyNote mesh__D008549 Triazines %28%1968-1974%29%
% 209.48/209.62 |- mesh__recordOriginator mesh__D008549 NLM
% 209.48/209.62 |- skos__prefLabel mesh__D008549 Melarsoprol
% 209.48/209.62 |- mesh__dateRevised mesh__D008549 2000-06-21
% 209.48/209.62 |- mesh__activeMeSHYear mesh__D008549 2004
% 209.48/209.62 |- mesh__activeMeSHYear mesh__D008549 2005
% 209.48/209.62 |- mesh__activeMeSHYear mesh__D008549 2001
% 209.48/209.62 |- rdf__type mesh__D008549sskos__Concept
% 209.48/209.62 |- mesh__activeMeSHYear mesh__D008549 2003
% 209.48/209.62 |- skos__scopeNote mesh__D008549
% 209.48/209.62 Arsenical used in trypanosomiases. It may cause fatal encephalopathy and other undesirable side effects.%A%
% 209.48/209.62 |- mesh__historyNote mesh__D008549
% 209.48/209.62 91%28%75%29%; was see under ARSENICALS 1975-90
% 209.48/209.62 |- skos__hiddenLabel mesh__D008549 Melarsenoxid BAL
% 209.48/209.62 |- mesh__dateEstablished mesh__D008549 1991-01-01
% 209.48/209.62 |- skos__hiddenLabel mesh__D000566 Amelogeneses
% 209.48/209.62 |- mesh__recordOriginator mesh__D000566 NLM
% 209.48/209.62 |- rdf__type mesh__D000566sskos__Concept
% 209.48/209.62 |- mesh__historyNote mesh__D000566 65
% 209.48/209.62 |- mesh__dateEstablished mesh__D000566 1965-01-01
% 209.48/209.62 |- mesh__recordAuthorizer mesh__D000566 sjn
% 209.48/209.62 |- mesh__dateCreated mesh__D000566 1999-01-01
% 209.48/209.62 |- mesh__activeMeSHYear mesh__D000566 2006
% 209.48/209.62 |- skos__prefLabel mesh__D000566 Amelogenesis
% 209.48/209.62 |- mesh__publicMeSHNote mesh__D000566 65
% 209.48/209.62 |- mesh__activeMeSHYear mesh__D000566 2005
% 209.48/209.62 |- mesh__recordMaintainer mesh__D000566 lkt
% 209.48/209.62 |- skos__broader mesh__D000566smesh__D009805
% 209.48/209.62 |- mesh__dateRevised mesh__D000566 2004-07-07
% 209.48/209.62 |- skos__annotation mesh__D000566
% 209.48/209.62 formation of dent enamel; DENTINOGENESIS, formation of dentin, is also available%A%
% 209.48/209.62 |- skos__scopeNote mesh__D000566
% 209.48/209.62 The elaboration of dental enamel by ameloblasts, beginning with its participation in the formation of the dentino-enamel junction to the production of the matrix for the enamel prisms and interprismatic substance. %28%Jablonski, Dictionary of Dentistry, 1992%29%%A%
% 209.48/209.62 |- rdf__type mesh__D019271sskos__Concept
% 209.48/209.62 |- mesh__onlineNote mesh__D019271
% 209.48/209.62 use HYPOXANTHINE %28%NM%29% to search HYPOXANTHINE 1981-96
% 209.48/209.62 |- skos__annotation mesh__D019271 do not confuse with HYPOXANTHINES
% 209.48/209.62 |- skos__prefLabel mesh__D019271 Hypoxanthine
% 209.48/209.62 |- mesh__historyNote mesh__D019271
% 209.48/209.62 97; was HYPOXANTHINE %28%NM%29% 1981-96
% 209.48/209.62 |- skos__broader mesh__D019271smesh__D007042
% 209.48/209.63 |- mesh__recordOriginator mesh__D019271 TPW
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D019271
% 209.48/209.63 97; HYPOXANTHINE was indexed under HYPOXANTHINES 1981-96
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D019271 2001
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D019271 2003
% 209.48/209.63 |- mesh__dateRevised mesh__D019271 2000-06-22
% 209.48/209.63 |- mesh__dateEstablished mesh__D019271 1997-01-01
% 209.48/209.63 |- mesh__recordMaintainer mesh__D019271 TWD
% 209.48/209.63 |- skos__historyNote mesh__D019271 Hypoxanthines %28%1981-1996%29%
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D019271 2005
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D019271 2004
% 209.48/209.63 |- mesh__dateCreated mesh__D019271 1996-06-10
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D019271 2002
% 209.48/209.63 |- skos__scopeNote mesh__D019271
% 209.48/209.63 A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.%A%
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D019271 2006
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D019271 sjn
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D027703 2004
% 209.48/209.63 |- skos__scopeNote mesh__D027703
% 209.48/209.63 A family of flowering plants in the order Caryophyllales, with about 60 genera and more than 800 species of plants, with a few shrubs, trees, and vines. The leaves usually have nonindented edges.%A%
% 209.48/209.63 |- skos__prefLabel mesh__D027703 Amaranthaceae
% 209.48/209.63 |- mesh__recordMaintainer mesh__D027703 ssb
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D027703 2005
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D027703 2006
% 209.48/209.63 |- rdf__type mesh__D027703sskos__Concept
% 209.48/209.63 |- skos__annotation mesh__D027703
% 209.48/209.63 GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D027703 sjn
% 209.48/209.63 |- mesh__dateRevised mesh__D027703 2003-07-09
% 209.48/209.63 |- mesh__historyNote mesh__D027703 2002
% 209.48/209.63 |- skos__broader mesh__D027703smesh__D019684
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D027703 2002
% 209.48/209.63 |- mesh__dateCreated mesh__D027703 2001-07-25
% 209.48/209.63 |- mesh__dateEstablished mesh__D027703 2002-01-01
% 209.48/209.63 |- mesh__recordOriginator mesh__D027703 ssb
% 209.48/209.63 |- skos__prefLabel mesh__D005251 Fees, Medical
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D005251 68
% 209.48/209.63 |- mesh__historyNote mesh__D005251 68
% 209.48/209.63 |- mesh__dateRevised mesh__D005251 1999-11-03
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005251 2005
% 209.48/209.63 |- skos__altLabel mesh__D005251 Medical Fee
% 209.48/209.63 |- skos__altLabel mesh__D005251 Medical Fees
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005251 2004
% 209.48/209.63 |- skos__broader mesh__D005251smesh__D005249
% 209.48/209.63 |- mesh__recordMaintainer mesh__D005251 kle
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D005251 sjn
% 209.48/209.63 |- skos__related mesh__D005251smesh__D015895
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005251 2002
% 209.48/209.63 |- skos__altLabel mesh__D005251 Fee, Medical
% 209.48/209.63 |- mesh__dateEstablished mesh__D005251 1968-01-01
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005251 2003
% 209.48/209.63 |- rdf__type mesh__D005251sskos__Concept
% 209.48/209.63 |- skos__scopeNote mesh__D005251
% 209.48/209.63 Amounts charged to the patient as payer for medical services.%A%
% 209.48/209.63 |- mesh__recordOriginator mesh__D005251 NLM
% 209.48/209.63 |- skos__historyNote mesh__D005251 Economics, Medical %28%1966-1967%29%
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005251 2001
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005251 2000
% 209.48/209.63 |- skos__broader mesh__D005251smesh__D004470
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005251 2006
% 209.48/209.63 |- mesh__dateCreated mesh__D005251 1999-01-01
% 209.48/209.63 |- skos__annotation mesh__D005251 DF: FEES MED
% 209.48/209.63 |- mesh__onlineNote mesh__D018977
% 209.48/209.63 use TRACE ELEMENTS to search MICRONUTRIENTS 1994-95
% 209.48/209.63 |- skos__historyNote mesh__D018977 Trace Elements %28%1966-1995%29%
% 209.48/209.63 |- mesh__recordMaintainer mesh__D018977 ssb
% 209.48/209.63 |- mesh__historyNote mesh__D018977 96; was see TRACE ELEMENTS 1994-95
% 209.48/209.63 |- rdf__type mesh__D018977sskos__Concept
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D018977 2006
% 209.48/209.63 |- skos__hiddenLabel mesh__D018977 Micronutrient
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D018977 sjn
% 209.48/209.63 |- skos__prefLabel mesh__D018977 Micronutrients
% 209.48/209.63 |- skos__annotation mesh__D018977
% 209.48/209.63 coord IM with specific micronutrient %28%IM%29%
% 209.48/209.63 |- mesh__dateCreated mesh__D018977 1995-05-24
% 209.48/209.63 |- mesh__dateEstablished mesh__D018977 1996-01-01
% 209.48/209.63 |- skos__broader mesh__D018977smesh__D006133
% 209.48/209.63 |- skos__scopeNote mesh__D018977
% 209.48/209.63 Essential dietary elements or organic compounds that are required in only small quantities for normal physiologic processes to occur.%A%
% 209.48/209.63 |- skos__related mesh__D018977smesh__D014131
% 209.48/209.63 |- mesh__recordOriginator mesh__D018977 TGC
% 209.48/209.63 |- mesh__dateRevised mesh__D018977 2005-06-30
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D018977 96; was see TRACE ELEMENTS 1994-95
% 209.48/209.63 |- skos__annotation mesh__D010994
% 209.48/209.63 /surg: consider also PNEUMONOLYSIS; inflammation = PLEURISY; PLEURAL CAVITY is also available%A%
% 209.48/209.63 |- mesh__recordOriginator mesh__D010994 NLM
% 209.48/209.63 |- skos__broader mesh__D010994smesh__D012704
% 209.48/209.63 |- skos__broader mesh__D010994smesh__D012137
% 209.48/209.63 |- skos__hiddenLabel mesh__D010994 Pleura, Parietal
% 209.48/209.63 |- mesh__dateCreated mesh__D010994 1999-01-01
% 209.48/209.63 |- rdf__type mesh__D010994sskos__Concept
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D010994 sjn
% 209.48/209.63 |- skos__prefLabel mesh__D010994 Pleura
% 209.48/209.63 |- skos__related mesh__D010994smesh__D011025
% 209.48/209.63 |- skos__scopeNote mesh__D010994
% 209.48/209.63 The thin serous membrane enveloping the lungs %28%LUNG%29% and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid.%A%
% 209.48/209.63 |- mesh__recordMaintainer mesh__D010994 lkt
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D010994 2006
% 209.48/209.63 |- skos__hiddenLabel mesh__D010994 Pleura, Visceral
% 209.48/209.63 |- skos__related mesh__D010994smesh__D010998
% 209.48/209.63 |- mesh__dateRevised mesh__D010994 2005-06-30
% 209.48/209.63 |- skos__historyNote mesh__D043370 Nitrosomonas %28%1965-2003%29%
% 209.48/209.63 |- skos__prefLabel mesh__D043370 Nitrosomonas europaea
% 209.48/209.63 |- mesh__dateRevised mesh__D043370 2005-06-30
% 209.48/209.63 |- rdf__type mesh__D043370sskos__Concept
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D043370 2004
% 209.48/209.63 |- skos__broader mesh__D043370smesh__D009606
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D043370 sjn
% 209.48/209.63 |- mesh__recordOriginator mesh__D043370 ags
% 209.48/209.63 |- mesh__recordMaintainer mesh__D043370 SYSTEM
% 209.48/209.63 |- mesh__historyNote mesh__D043370 2004
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D043370 2006
% 209.48/209.63 |- mesh__dateCreated mesh__D043370 2003-07-09
% 209.48/209.63 |- mesh__dateEstablished mesh__D043370 2004-01-01
% 209.48/209.63 |- skos__scopeNote mesh__D043370
% 209.48/209.63 The type species of the genus NITROSOMONAS, a gram-negative chemolithotroph that oxidizes ammonia to nitrite. It is found in soil, sewage, freshwater, and on building walls, and especially in polluted areas where air contains high levels of nitrogen compounds.%A%
% 209.48/209.63 |- skos__broader mesh__D018179smesh__D043562
% 209.48/209.63 |- skos__historyNote mesh__D018179 Proteins %28%2000-2003%29%
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D018179 2004
% 209.48/209.63 |- skos__historyNote mesh__D018179
% 209.48/209.63 Receptors, Cell Surface %28%1981-1993%29%
% 209.48/209.63 |- mesh__historyNote mesh__D018179
% 209.48/209.63 1994; use THROMBIN RECEPTOR %28%NM%29% 1981-1993; for TRAP PEPTIDE use RECEPTORS, THROMBIN %28%NM%29% 2000-2003%A%
% 209.48/209.63 |- mesh__recordMaintainer mesh__D018179 jmp
% 209.48/209.63 |- mesh__dateRevised mesh__D018179 2003-07-09
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D018179 2005
% 209.48/209.63 |- skos__scopeNote mesh__D018179
% 209.48/209.63 A family of proteinase-activated receptors that are specific for THROMBIN. They are found primarily on PLATELETS and on ENDOTHELIAL CELLS. Activation of thrombin receptors occurs through the proteolytic action of THROMBIN, which cleaves the N-terminal peptide from the receptor to reveal a new N-terminal peptide that is a cryptic ligand for the receptor. The receptors signal through HETEROTRIMERIC GTP-BINDING PROTEINS. Small synthetic peptides that contain the unmasked N-terminal peptide sequence can also activate the receptor in the absence of proteolytic activity.%A%
% 209.48/209.63 |- skos__hiddenLabel mesh__D018179 Receptor, Thrombin
% 209.48/209.63 |- skos__broader mesh__D018179smesh__D010980
% 209.48/209.63 |- skos__hiddenLabel mesh__D018179 Peptide, TRAP
% 209.48/209.63 |- mesh__recordOriginator mesh__D018179 RAZ
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D018179 2006
% 209.48/209.63 |- mesh__dateCreated mesh__D018179 1993-06-30
% 209.48/209.63 |- skos__altLabel mesh__D018179 Thrombin Receptors
% 209.48/209.63 |- rdf__type mesh__D018179sskos__Concept
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D018179
% 209.48/209.63 1994; THROMBIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1993; TRAP PEPTIDE was indexed under PROTEINS 2000-2003%A%
% 209.48/209.63 |- skos__altLabel mesh__D018179 Thrombin Receptor Activator Peptide
% 209.48/209.63 |- skos__prefLabel mesh__D018179 Receptors, Thrombin
% 209.48/209.63 |- skos__altLabel mesh__D018179 Thrombin Receptor Activating Peptide Ligand
% 209.48/209.63 |- skos__broader mesh__D018179smesh__D018000
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D018179 sjn
% 209.48/209.63 |- skos__altLabel mesh__D018179 Thrombin Receptor
% 209.48/209.63 |- skos__altLabel mesh__D018179 TRAP Peptide
% 209.48/209.63 |- skos__broader mesh__D018179smesh__D044462
% 209.48/209.63 |- skos__annotation mesh__D018179 DF: RECEPT THROMBIN
% 209.48/209.63 |- mesh__dateEstablished mesh__D018179 1994-01-01
% 209.48/209.63 |- rdf__type mesh__D010196sskos__Concept
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D010196
% 209.48/209.63 2000; see PANCREATOPEPTIDASE 1965-1999; for PANCREATIC ELASTASE see PANCREATOPEPTIDASE 1991-1999%A%
% 209.48/209.63 |- mesh__dateEstablished mesh__D010196 1965-01-01
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D010196 sjn
% 209.48/209.63 |- mesh__dateCreated mesh__D010196 1999-01-01
% 209.48/209.63 |- skos__altLabel mesh__D010196 Pancreatopeptidase
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D010196 2005
% 209.48/209.63 |- skos__altLabel mesh__D010196 Pancreatic Elastase I
% 209.48/209.63 |- mesh__recordOriginator mesh__D010196 NLM
% 209.48/209.63 |- skos__altLabel mesh__D010196 Elastase
% 209.48/209.63 |- skos__prefLabel mesh__D010196 Pancreatic Elastase
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D010196 2004
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D010196 2006
% 209.48/209.63 |- skos__scopeNote mesh__D010196
% 209.48/209.63 A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36.%A%
% 209.48/209.63 |- mesh__recordMaintainer mesh__D010196 ssb
% 209.48/209.63 |- skos__hiddenLabel mesh__D010196 Elastase, Pancreatic
% 209.48/209.63 |- skos__broader mesh__D010196smesh__D012697
% 209.48/209.63 |- mesh__historyNote mesh__D010196 2000%28%1965%29%
% 209.48/209.63 |- skos__hiddenLabel mesh__D010196 Elastase I, Pancreatic
% 209.48/209.63 |- mesh__dateRevised mesh__D010196 2003-07-09
% 209.48/209.63 |- skos__annotation mesh__D010196 LEUKOCYTE ELASTASE is also available
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 2002
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 1997
% 209.48/209.63 |- rdf__type mesh__D004957sskos__Concept
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 2005
% 209.48/209.63 |- skos__prefLabel mesh__D004957 Estonia
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 2001
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 1996
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 2004
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 2000
% 209.48/209.63 |- mesh__recordMaintainer mesh__D004957 PLS
% 209.48/209.63 |- mesh__recordOriginator mesh__D004957 NLM
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 2003
% 209.48/209.63 |- mesh__dateCreated mesh__D004957 1999-01-01
% 209.48/209.63 |- skos__broader mesh__D004957smesh__D001454
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 1995
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 1999
% 209.48/209.63 |- mesh__dateRevised mesh__D004957 1994-03-17
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D004957 PLS
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 1998
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004957 2006
% 209.48/209.63 |- skos__prefLabel mesh__D004159 Diphenylamine
% 209.48/209.63 |- rdf__type mesh__D004159sskos__Concept
% 209.48/209.63 |- skos__scopeNote mesh__D004159
% 209.48/209.63 In humans it may be irritating to mucous membranes. Methemoglobinemia has been produced experimentally. In veterinary use, it is one of active ingredients in topical agents for prevention and treatment of screwworm infestation. An indicator in tests for nitrate poisoning.%A%
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004159 2005
% 209.48/209.63 |- mesh__recordOriginator mesh__D004159 NLM
% 209.48/209.63 |- mesh__dateCreated mesh__D004159 1974-11-19
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D004159 sjn
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004159 2006
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004159 2003
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004159 2001
% 209.48/209.63 |- mesh__historyNote mesh__D004159
% 209.48/209.63 91%28%75%29%; was see under ANILINE COMPOUNDS 1975-90
% 209.48/209.63 |- mesh__recordMaintainer mesh__D004159 CCR
% 209.48/209.63 |- mesh__dateRevised mesh__D004159 2000-06-22
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004159 2004
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D004159 2002
% 209.48/209.63 |- skos__historyNote mesh__D004159 Aniline Compounds %28%1969-1974%29%
% 209.48/209.63 |- skos__broader mesh__D004159smesh__D000814
% 209.48/209.63 |- mesh__dateEstablished mesh__D004159 1991-01-01
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D004159
% 209.48/209.63 91; was see under ANILINE COMPOUNDS 1975-90
% 209.48/209.63 |- skos__broader mesh__D006412Q000637smesh__D006412
% 209.48/209.63 |- mesh__preferredCombination mesh__D006412Q000637smesh__D018380
% 209.48/209.63 |- rdf__type mesh__D006412Q000637smesh__CompoundConcept
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D009642 2001
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D009642 2004
% 209.48/209.63 |- skos__historyNote mesh__D009642 Hydrocarbons, Fluorinated %28%1974%29%
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D009642
% 209.48/209.63 91; was see under FENFLURAMINE 1975-90
% 209.48/209.63 |- skos__prefLabel mesh__D009642 Norfenfluramine
% 209.48/209.63 |- mesh__recordMaintainer mesh__D009642 CCR
% 209.48/209.63 |- skos__broader mesh__D009642smesh__D005277
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D009642 2003
% 209.48/209.63 |- mesh__recordOriginator mesh__D009642 NLM
% 209.48/209.63 |- skos__historyNote mesh__D009642 Phenethylamines %28%1973-1974%29%
% 209.48/209.63 |- mesh__dateCreated mesh__D009642 1974-11-19
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D009642 sjn
% 209.48/209.63 |- mesh__dateEstablished mesh__D009642 1991-01-01
% 209.48/209.63 |- skos__scopeNote mesh__D009642
% 209.48/209.63 A FENFLURAMINE analog that inhibits serotonin uptake and may provoke release of serotonin. It is used as an appetite depressant and an experimental tool in animal studies.%A%
% 209.48/209.63 |- mesh__dateRevised mesh__D009642 2000-06-22
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D009642 2006
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D009642 2002
% 209.48/209.63 |- mesh__historyNote mesh__D009642
% 209.48/209.63 91%28%75%29%; was see under FENFLURAMINE 1975-90
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D009642 2005
% 209.48/209.63 |- rdf__type mesh__D009642sskos__Concept
% 209.48/209.63 |- mesh__historyNote mesh__D014587
% 209.48/209.63 91%28%75%29%; was see under BASIDIOMYCETES 1975-90
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D014587 sjn
% 209.48/209.63 |- rdf__type mesh__D014587sskos__Concept
% 209.48/209.63 |- skos__annotation mesh__D014587
% 209.48/209.63 an order of basidiomycetes; parasitic on POACEAE %26% corn
% 209.48/209.63 |- mesh__onlineNote mesh__D014587 search BASIDIOMYCETES 1966-74
% 209.48/209.63 |- skos__prefLabel mesh__D014587 Ustilaginales
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D014587 2006
% 209.48/209.63 |- mesh__recordMaintainer mesh__D014587 SYSTEM
% 209.48/209.63 |- mesh__recordOriginator mesh__D014587 NLM
% 209.48/209.63 |- skos__broader mesh__D014587smesh__D001487
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D014587
% 209.48/209.63 91; was see under BASIDIOMYCETES 1975-90
% 209.48/209.63 |- mesh__dateRevised mesh__D014587 2005-06-30
% 209.48/209.63 |- mesh__dateEstablished mesh__D014587 1991-01-01
% 209.48/209.63 |- mesh__dateCreated mesh__D014587 1999-01-01
% 209.48/209.63 |- skos__scopeNote mesh__D014587
% 209.48/209.63 An order of basidiomycetous fungi; some species are parasitic on grasses %28%POACEAE%29% and maize.%A%
% 209.48/209.63 |- skos__hiddenLabel mesh__D033741 Transport Protein, ANT-1
% 209.48/209.63 |- skos__historyNote mesh__D033741
% 209.48/209.63 Adenine Nucleotide Translocase %28%1999-2002%29%
% 209.48/209.63 |- skos__prefLabel mesh__D033741 Adenine Nucleotide Translocator 1
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D033741
% 209.48/209.63 2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002
% 209.48/209.63 |- skos__altLabel mesh__D033741
% 209.48/209.63 Solute Carrier Family 25%28%Mitochondrial Carrier; Adenine Nucleotide Translocator%29%, Member 4
% 209.48/209.63 |- skos__broader mesh__D033741smesh__D000226
% 209.48/209.63 |- skos__hiddenLabel mesh__D033741 ANT 1 Transport Protein
% 209.48/209.63 |- skos__altLabel mesh__D033741
% 209.48/209.63 Adenine Nucleotide Translocator, Muscle Isoform
% 209.48/209.63 |- mesh__dateEstablished mesh__D033741 2003-01-01
% 209.48/209.63 |- skos__altLabel mesh__D033741 ANT1 Transport Protein
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D033741 2006
% 209.48/209.63 |- skos__scopeNote mesh__D033741
% 209.48/209.63 A subtype of mitochondrial ADP, ATP translocase found primarily in heart muscle %28%MYOCARDIUM%29% and skeletal muscle %28%MUSCLE, SKELETAL%29%.%A%
% 209.48/209.63 |- skos__altLabel mesh__D033741 SLC25A4 Protein
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D033741 2004
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D033741 2005
% 209.48/209.63 |- rdf__type mesh__D033741sskos__Concept
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D033741 2003
% 209.48/209.63 |- skos__altLabel mesh__D033741 Adenine Nucleotide Carrier Protein
% 209.48/209.63 |- mesh__historyNote mesh__D033741
% 209.48/209.63 2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002
% 209.48/209.63 |- skos__altLabel mesh__D033741 ANT-1 Transport Protein
% 209.48/209.63 |- mesh__dateCreated mesh__D033741 2002-07-02
% 209.48/209.63 |- mesh__dateCreated mesh__D000567 1999-01-01
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D000567 2006
% 209.48/209.63 |- mesh__recordOriginator mesh__D000567 NLM
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D000567 2005
% 209.48/209.63 |- mesh__dateEstablished mesh__D000567 1965-01-01
% 209.48/209.63 |- skos__broader mesh__D000567smesh__D014071
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D000567 2002
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D000567 2004
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D000567 sjn
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D000567 2001
% 209.48/209.63 |- mesh__dateRevised mesh__D000567 1999-11-03
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D000567 2003
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D000567 65
% 209.48/209.63 |- skos__annotation mesh__D000567
% 209.48/209.63 a tooth abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D000567 2000
% 209.48/209.63 |- skos__prefLabel mesh__D000567 Amelogenesis Imperfecta
% 209.48/209.63 |- skos__scopeNote mesh__D000567
% 209.48/209.63 An autosomal dominant or X-linked disorder in which there is faulty development of the dental enamel owing to agenesis, hypoplasia, or hypocalcification of the enamel. It is marked by enamel that is very thin and friable and frequently stained in various shades of brown. %28%Dorland, 27th ed%29%%A%
% 209.48/209.63 |- rdf__type mesh__D000567sskos__Concept
% 209.48/209.63 |- mesh__historyNote mesh__D000567 65
% 209.48/209.63 |- mesh__recordMaintainer mesh__D000567 kle
% 209.48/209.63 |- skos__hiddenLabel mesh__D019272 Elastase, Leukocyte
% 209.48/209.63 |- mesh__dateCreated mesh__D019272 1996-06-10
% 209.48/209.63 |- mesh__onlineNote mesh__D019272
% 209.48/209.63 use LEUKOCYTE ELASTASE %28%NM%29% to search LEUKOCYTE ELASTASE 1988-96%A%
% 209.48/209.63 |- skos__altLabel mesh__D019272 Lysosomal Elastase
% 209.48/209.63 |- skos__altLabel mesh__D019272 Polymorphonuclear Leukocyte Elastase
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D019272 sjn
% 209.48/209.63 |- skos__broader mesh__D019272smesh__D010196
% 209.48/209.63 |- skos__hiddenLabel mesh__D019272 Elastase, Neutrophil
% 209.48/209.63 |- skos__historyNote mesh__D019272 Pancreatopeptidase %28%1988-1996%29%
% 209.48/209.63 |- skos__hiddenLabel mesh__D019272 Elastase, Granulocyte
% 209.48/209.63 |- skos__altLabel mesh__D019272 Neutrophil Elastase
% 209.48/209.63 |- skos__hiddenLabel mesh__D019272 Elastase, Lysosomal
% 209.48/209.63 |- mesh__historyNote mesh__D019272
% 209.48/209.63 97; was LEUKOCYTE ELASTASE %28%NM%29% 1988-96
% 209.48/209.63 |- skos__hiddenLabel mesh__D019272 Elastase, Polymorphonuclear Leukocyte
% 209.48/209.63 |- skos__scopeNote mesh__D019272
% 209.48/209.63 An enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37.%A%
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D019272 2005
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D019272 2004
% 209.48/209.63 |- mesh__recordOriginator mesh__D019272 TPW
% 209.48/209.63 |- skos__prefLabel mesh__D019272 Leukocyte Elastase
% 209.48/209.63 |- skos__altLabel mesh__D019272 Granulocyte Elastase
% 209.48/209.63 |- skos__hiddenLabel mesh__D019272 Elastase, PMN
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D019272 2006
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D019272
% 209.48/209.63 97; LEUKOCYTE ELASTASE was indexed under PANCREATOPEPTIDASE 1988-96%A%
% 209.48/209.63 |- mesh__dateEstablished mesh__D019272 1997-01-01
% 209.48/209.63 |- rdf__type mesh__D019272sskos__Concept
% 209.48/209.63 |- mesh__dateRevised mesh__D019272 2003-07-09
% 209.48/209.63 |- skos__altLabel mesh__D019272 PMN Elastase
% 209.48/209.63 |- skos__hiddenLabel mesh__D019272 Leukocyte Elastase, Polymorphonuclear
% 209.48/209.63 |- mesh__recordMaintainer mesh__D019272 ssb
% 209.48/209.63 |- skos__hiddenLabel mesh__D005252 Pharmaceutic Fee
% 209.48/209.63 |- skos__altLabel mesh__D005252 Fee, Pharmacy
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005252 2001
% 209.48/209.63 |- skos__annotation mesh__D005252
% 209.48/209.63 costs to the patient or third-party payer: do not confuse with DRUG COSTS which are costs to a health facility or organiz; DF: FEES PHARM%A%
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D005252 68
% 209.48/209.63 |- skos__hiddenLabel mesh__D005252 Fee, Pharmaceutic
% 209.48/209.63 |- mesh__dateEstablished mesh__D005252 1968-01-01
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005252 2003
% 209.48/209.63 |- skos__hiddenLabel mesh__D005252 Pharmaceutic Fees
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005252 2004
% 209.48/209.63 |- skos__prefLabel mesh__D005252 Fees, Pharmaceutical
% 209.48/209.63 |- skos__scopeNote mesh__D005252
% 209.48/209.63 Amounts charged to the patient or third-party payer for medication. It includes the pharmacist%27%s professional fee and cost of ingredients, containers, etc.%A%
% 209.48/209.63 |- skos__altLabel mesh__D005252 Pharmacy Fee
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005252 2002
% 209.48/209.63 |- rdf__type mesh__D005252sskos__Concept
% 209.48/209.63 |- mesh__historyNote mesh__D005252 68
% 209.48/209.63 |- skos__hiddenLabel mesh__D005252 Pharmaceutical Fee
% 209.48/209.63 |- skos__hiddenLabel mesh__D005252 Fees, Pharmacy
% 209.48/209.63 |- skos__altLabel mesh__D005252 Fees, Pharmaceutic
% 209.48/209.63 |- skos__hiddenLabel mesh__D005252 Pharmacy Fees
% 209.48/209.63 |- mesh__dateCreated mesh__D005252 1999-01-01
% 209.48/209.63 |- skos__historyNote mesh__D005252 Prescriptions %28%1966-1967%29%
% 209.48/209.63 |- skos__historyNote mesh__D005252 Pharmacy %28%1966-1967%29%
% 209.48/209.63 |- mesh__dateRevised mesh__D005252 1999-11-03
% 209.48/209.63 |- mesh__recordMaintainer mesh__D005252 kle
% 209.48/209.63 |- skos__hiddenLabel mesh__D005252 Fee, Pharmaceutical
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D005252 sjn
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005252 2000
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005252 2005
% 209.48/209.63 |- skos__broader mesh__D005252smesh__D005249
% 209.48/209.63 |- mesh__recordOriginator mesh__D005252 NLM
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D005252 2006
% 209.48/209.63 |- skos__altLabel mesh__D005252 Pharmaceutical Fees
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D018978 2005
% 209.48/209.63 |- mesh__recordMaintainer mesh__D018978 lkt
% 209.48/209.63 |- skos__altLabel mesh__D018978 Moulting
% 209.48/209.63 |- rdf__type mesh__D018978sskos__Concept
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D018978 2006
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D018978 96
% 209.48/209.63 |- skos__hiddenLabel mesh__D018978 Ecdyses
% 209.48/209.63 |- mesh__dateCreated mesh__D018978 1995-05-24
% 209.48/209.63 |- skos__prefLabel mesh__D018978 Molting
% 209.48/209.63 |- skos__altLabel mesh__D018978 Ecdysis
% 209.48/209.63 |- mesh__historyNote mesh__D018978 96
% 209.48/209.63 |- mesh__recordOriginator mesh__D018978 PXP
% 209.48/209.63 |- mesh__dateRevised mesh__D018978 2004-07-07
% 209.48/209.63 |- skos__hiddenLabel mesh__D018978 Moltings
% 209.48/209.63 |- skos__broader mesh__D018978smesh__D008675
% 209.48/209.63 |- skos__related mesh__D018978smesh__D004441
% 209.48/209.63 |- mesh__dateEstablished mesh__D018978 1996-01-01
% 209.48/209.63 |- skos__hiddenLabel mesh__D018978 Moultings
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D018978 sjn
% 209.48/209.63 |- skos__scopeNote mesh__D018978
% 209.48/209.63 Periodic casting off FEATHERS; HAIR; or cuticle. Molting is a process of sloughing or desquamation, especially the shedding of an outer covering and the development of a new one. This phenomenon permits growth in ARTHROPODS, skin renewal in AMPHIBIANS and REPTILES, and the shedding of winter coats in BIRDS and MAMMALS.%A%
% 209.48/209.63 |- skos__related mesh__D018978smesh__D004440
% 209.48/209.63 |- mesh__dateCreated mesh__D010995 1999-01-01
% 209.48/209.63 |- mesh__publicMeSHNote mesh__D010995 66
% 209.48/209.63 |- mesh__historyNote mesh__D010995 66
% 209.48/209.63 |- mesh__dateRevised mesh__D010995 1997-06-20
% 209.48/209.63 |- skos__broader mesh__D010995smesh__D012140
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D010995 1998
% 209.48/209.63 |- rdf__type mesh__D010995sskos__Concept
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D010995 2000
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D010995 1999
% 209.48/209.63 |- mesh__recordAuthorizer mesh__D010995 SJN
% 209.48/209.63 |- mesh__recordOriginator mesh__D010995 NLM
% 209.48/209.63 |- mesh__dateEstablished mesh__D010995 1966-01-01
% 209.48/209.63 |- skos__hiddenLabel mesh__D010995 Pleural Disease
% 209.48/209.63 |- mesh__activeMeSHYear mesh__D010995 2005
% 209.48/209.64 |- mesh__recordMaintainer mesh__D010995 TGC
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010995 2001
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010995 2003
% 209.48/209.64 |- skos__prefLabel mesh__D010995 Pleural Diseases
% 209.48/209.64 |- skos__hiddenLabel mesh__D010995 Disease, Pleural
% 209.48/209.64 |- skos__hiddenLabel mesh__D010995 Diseases, Pleural
% 209.48/209.64 |- skos__annotation mesh__D010995 inflamm dis = PLEURISY
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010995 2006
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010995 2002
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010995 2004
% 209.48/209.64 |- skos__altLabel mesh__D043371 Fatty Acids, Omega 6
% 209.48/209.64 |- skos__hiddenLabel mesh__D043371 N 6 Fatty Acids
% 209.48/209.64 |- mesh__dateEstablished mesh__D043371 2004-01-01
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D043371 2004
% 209.48/209.64 |- skos__altLabel mesh__D043371 N-6 Fatty Acids
% 209.48/209.64 |- skos__altLabel mesh__D043371 Omega-6 Fatty Acids
% 209.48/209.64 |- mesh__historyNote mesh__D043371 2004
% 209.48/209.64 |- skos__hiddenLabel mesh__D043371 Fatty Acids, N-6
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D043371 2005
% 209.48/209.64 |- skos__scopeNote mesh__D043371
% 209.48/209.64 FATTY ACIDS which have the first unsaturated bond in the sixth position from the omega carbon. A typical American diet tends to contain substantially more omega-6 than OMEGA-3 FATTY ACIDS.%A%
% 209.48/209.64 |- skos__historyNote mesh__D043371
% 209.48/209.64 Fatty Acids, Unsaturated %28%1980-2003%29%
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D043371 2006
% 209.48/209.64 |- mesh__dateCreated mesh__D043371 2003-07-09
% 209.48/209.64 |- skos__hiddenLabel mesh__D043371 Acids, Omega-6 Fatty
% 209.48/209.64 |- skos__hiddenLabel mesh__D043371 Omega 6 Fatty Acids
% 209.48/209.64 |- skos__hiddenLabel mesh__D043371 Acids, N-6 Fatty
% 209.48/209.64 |- rdf__type mesh__D043371sskos__Concept
% 209.48/209.64 |- skos__broader mesh__D043371smesh__D005231
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D043371 2004
% 209.48/209.64 |- skos__prefLabel mesh__D043371 Fatty Acids, Omega-6
% 209.48/209.64 |- skos__broader mesh__D010197smesh__D000732
% 209.48/209.64 |- skos__historyNote mesh__D010197 Curare-Like Agents %28%1970-1971%29%
% 209.48/209.64 |- mesh__recordMaintainer mesh__D010197 CCR
% 209.48/209.64 |- skos__altLabel mesh__D010197 Pancuronium Organon
% 209.48/209.64 |- skos__scopeNote mesh__D010197
% 209.48/209.64 A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release.%A%
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D010197 sjn
% 209.48/209.64 |- skos__historyNote mesh__D010197 Androstanes %28%1968-1971%29%
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010197 2006
% 209.48/209.64 |- skos__prefLabel mesh__D010197 Pancuronium
% 209.48/209.64 |- mesh__dateRevised mesh__D010197 2005-06-30
% 209.48/209.64 |- skos__altLabel mesh__D010197
% 209.48/209.64 Organon Teknika Brand of Pancuronium Bromide
% 209.48/209.64 |- mesh__recordOriginator mesh__D010197 NLM
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D010197 74
% 209.48/209.64 |- skos__altLabel mesh__D010197 Organon Brand of Pancuronium Bromide
% 209.48/209.64 |- mesh__historyNote mesh__D010197 74%28%72%29%
% 209.48/209.64 |- rdf__type mesh__D010197sskos__Concept
% 209.48/209.64 |- mesh__dateEstablished mesh__D010197 1974-01-01
% 209.48/209.64 |- skos__hiddenLabel mesh__D010197 Bromide, Pancuronium
% 209.48/209.64 |- skos__altLabel mesh__D010197 Schwabe Brand of Pancuronium Bromide
% 209.48/209.64 |- mesh__dateCreated mesh__D010197 1999-01-01
% 209.48/209.64 |- skos__prefLabel mesh__D004958 Estradiol
% 209.48/209.64 |- skos__altLabel mesh__D004958 Estradiol-17 beta
% 209.48/209.64 |- mesh__recordMaintainer mesh__D004958 lkt
% 209.48/209.64 |- mesh__dateCreated mesh__D004958 1999-01-01
% 209.48/209.64 |- skos__altLabel mesh__D004958 Estradiol-17beta
% 209.48/209.64 |- skos__broader mesh__D004958smesh__D004963
% 209.48/209.64 |- skos__altLabel mesh__D004958 Oestradiol
% 209.48/209.64 |- mesh__historyNote mesh__D004958
% 209.48/209.64 63; for OVOCYCLIN use ESTRADIOL DIPROPIONATE %28%NM%29% 1980-98; /therapeutic use was ESTRADIOL, THERAPEUTIC 1965%A%
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D004958
% 209.48/209.64 63; OVOCYCLIN was indexed under ESTRADIOL/analogs %26% derivatives 1980-98; /therapeutic use was ESTRADIOL, THERAPEUTIC 1965%A%
% 209.48/209.64 |- skos__altLabel mesh__D004958 17 beta-Estradiol
% 209.48/209.64 |- skos__scopeNote mesh__D004958
% 209.48/209.64 Generally refers to the 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In humans, it is produced primarily by the cyclic ovaries and the PLACENTA. It is also produced by the adipose tissue of men and postmenopausal women. The 17-alpha-isomer of estradiol binds weakly to estrogen receptors %28%RECEPTORS, ESTROGEN%29% and exhibits little estrogenic activity in estrogen-responsive tissues. Various isomers can be synthesized.%A%
% 209.48/209.64 |- skos__hiddenLabel mesh__D004958 Estradiol 17 beta
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D004958 2006
% 209.48/209.64 |- skos__related mesh__D004958smesh__D011959
% 209.48/209.64 |- skos__broader mesh__D004958smesh__D045166
% 209.48/209.64 |- skos__hiddenLabel mesh__D004958 Estradiol 17 alpha
% 209.48/209.64 |- rdf__type mesh__D004958sskos__Concept
% 209.48/209.64 |- skos__hiddenLabel mesh__D004958 17 beta Estradiol
% 209.48/209.64 |- skos__altLabel mesh__D004958 17 beta-Oestradiol
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D004958 2005
% 209.48/209.64 |- skos__altLabel mesh__D004958 Estradiol, %28%17-alpha%29%-Isomer
% 209.48/209.64 |- skos__hiddenLabel mesh__D004958 Estradiol 17beta
% 209.48/209.64 |- mesh__recordOriginator mesh__D004958 NLM
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D004958 2004
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D004958 sjn
% 209.48/209.64 |- skos__hiddenLabel mesh__D004958 17 beta Oestradiol
% 209.48/209.64 |- mesh__dateRevised mesh__D004958 2003-07-09
% 209.48/209.64 |- skos__hiddenLabel mesh__D009643 AM 715
% 209.48/209.64 |- skos__historyNote mesh__D009643 Anti-Infective Agents %28%1966-1985%29%
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D009643 86
% 209.48/209.64 |- skos__prefLabel mesh__D009643 Norfloxacin
% 209.48/209.64 |- mesh__recordOriginator mesh__D009643 SH
% 209.48/209.64 |- mesh__recordMaintainer mesh__D009643 ssb
% 209.48/209.64 |- skos__scopeNote mesh__D009643
% 209.48/209.64 A synthetic fluoroquinolone %28%FLUOROQUINOLONES%29% with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.%A%
% 209.48/209.64 |- skos__altLabel mesh__D009643 MK0366
% 209.48/209.64 |- skos__historyNote mesh__D009643
% 209.48/209.64 Anti-Infective Agents, Urinary %28%1966-1985%29%
% 209.48/209.64 |- skos__hiddenLabel mesh__D009643 MK 366
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D009643 2006
% 209.48/209.64 |- skos__broader mesh__D009643smesh__D024841
% 209.48/209.64 |- skos__altLabel mesh__D009643 MK-366
% 209.48/209.64 |- mesh__dateEstablished mesh__D009643 1986-01-01
% 209.48/209.64 |- skos__historyNote mesh__D009643 Nalidixic Acid %28%1966-1985%29%
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D009643 2005
% 209.48/209.64 |- skos__altLabel mesh__D009643 MK366
% 209.48/209.64 |- skos__hiddenLabel mesh__D009643 AM0715
% 209.48/209.64 |- skos__hiddenLabel mesh__D009643 MK 0366
% 209.48/209.64 |- skos__hiddenLabel mesh__D009643 AM 0715
% 209.48/209.64 |- skos__altLabel mesh__D009643 AM-715
% 209.48/209.64 |- mesh__dateCreated mesh__D009643 1985-06-06
% 209.48/209.64 |- mesh__historyNote mesh__D009643 86
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D009643 sjn
% 209.48/209.64 |- rdf__type mesh__D009643sskos__Concept
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D009643 2004
% 209.48/209.64 |- mesh__dateRevised mesh__D009643 2003-07-09
% 209.48/209.64 |- skos__hiddenLabel mesh__D001660 Tract Diseases, Biliary
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D001660 2005
% 209.48/209.64 |- mesh__dateEstablished mesh__D001660 1966-01-01
% 209.48/209.64 |- skos__broader mesh__D001660smesh__D004066
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D001660 2006
% 209.48/209.64 |- skos__hiddenLabel mesh__D001660 Biliary Tract Disease
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D001660 66
% 209.48/209.64 |- skos__scopeNote mesh__D001660
% 209.48/209.64 Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.%A%
% 209.48/209.64 |- skos__related mesh__D001660smesh__D002758
% 209.48/209.64 |- skos__hiddenLabel mesh__D001660 Tract Disease, Biliary
% 209.48/209.64 |- mesh__recordOriginator mesh__D001660 NLM
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D001660 sjn
% 209.48/209.64 |- rdf__type mesh__D001660sskos__Concept
% 209.48/209.64 |- skos__prefLabel mesh__D001660 Biliary Tract Diseases
% 209.48/209.64 |- mesh__dateRevised mesh__D001660 2003-07-09
% 209.48/209.64 |- skos__annotation mesh__D001660
% 209.48/209.64 GEN: prefer specifics; biliary empyema = EMPYEMA %28%IM%29% + BILIARY TRACT DISEASES %28%IM%29% or if of gallbladder, EMPYEMA, GALLBLADDER see CHOLECYSTITIS; inflamm dis = CHOLECYSTITIS or CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS%A%
% 209.48/209.64 |- skos__hiddenLabel mesh__D001660 Disease, Biliary Tract
% 209.48/209.64 |- mesh__recordMaintainer mesh__D001660 lkt
% 209.48/209.64 |- mesh__historyNote mesh__D001660 66
% 209.48/209.64 |- mesh__dateCreated mesh__D001660 1999-01-01
% 209.48/209.64 |- skos__hiddenLabel mesh__D001660 Diseases, Biliary Tract
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D001660 2004
% 209.48/209.64 |- skos__scopeNote mesh__D014588
% 209.48/209.64 A genus of basidiomycetous smut fungi comprising the loose smuts.%A%
% 209.48/209.64 |- mesh__dateRevised mesh__D014588 2005-06-30
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D014588 2006
% 209.48/209.64 |- skos__broader mesh__D014588smesh__D014587
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D014588
% 209.48/209.64 91; was see under BASIDIOMYCETES 1975-90
% 209.48/209.64 |- mesh__recordMaintainer mesh__D014588 SYSTEM
% 209.48/209.64 |- mesh__dateCreated mesh__D014588 1974-12-12
% 209.48/209.64 |- skos__prefLabel mesh__D014588 Ustilago
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D014588 sjn
% 209.48/209.64 |- mesh__dateEstablished mesh__D014588 1991-01-01
% 209.48/209.64 |- skos__annotation mesh__D014588 a basidiomycete representing the smuts
% 209.48/209.64 |- rdf__type mesh__D014588sskos__Concept
% 209.48/209.64 |- mesh__historyNote mesh__D014588
% 209.48/209.64 91%28%75%29%; was see under BASIDIOMYCETES 1975-90
% 209.48/209.64 |- mesh__recordOriginator mesh__D014588 NLM
% 209.48/209.64 |- mesh__dateCreated mesh__D033742 2002-07-02
% 209.48/209.64 |- skos__altLabel mesh__D033742
% 209.48/209.64 Solute Carrier-Family 25%28%Mitochondrial Carrier; Adenine Nucleotide Translocator%29%, Member 5
% 209.48/209.64 |- skos__historyNote mesh__D033742
% 209.48/209.64 Adenine Nucleotide Translocase %28%1999-2002%29%
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D033742 2006
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D033742
% 209.48/209.64 2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D033742 2004
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D033742 2005
% 209.48/209.64 |- skos__broader mesh__D033742smesh__D000226
% 209.48/209.64 |- skos__hiddenLabel mesh__D033742 ANT 2 Transport Protein
% 209.48/209.64 |- rdf__type mesh__D033742sskos__Concept
% 209.48/209.64 |- skos__altLabel mesh__D033742
% 209.48/209.64 Adenine Nucleotide Translocator, Fibroblast Isoform
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D033742 2003
% 209.48/209.64 |- mesh__historyNote mesh__D033742
% 209.48/209.64 2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002
% 209.48/209.64 |- mesh__dateEstablished mesh__D033742 2003-01-01
% 209.48/209.64 |- skos__scopeNote mesh__D033742
% 209.48/209.64 A subtype of mitochondrial ADP, ATP translocase found primarily in FIBROBLASTS.%A%
% 209.48/209.64 |- skos__altLabel mesh__D033742 ANT-2 Transport Protein
% 209.48/209.64 |- skos__hiddenLabel mesh__D033742 Transport Protein, ANT-2
% 209.48/209.64 |- skos__altLabel mesh__D033742 SLC25A5 Protein
% 209.48/209.64 |- skos__prefLabel mesh__D033742 Adenine Nucleotide Translocator 2
% 209.48/209.64 |- skos__altLabel mesh__D033742 ANT2 Transport Protein
% 209.48/209.64 |- skos__hiddenLabel mesh__D033742 Transport Protein, ANT2
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D000568 2001
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D000568 2006
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D000568 2003
% 209.48/209.64 |- mesh__recordMaintainer mesh__D000568 jls
% 209.48/209.64 |- skos__prefLabel mesh__D000568 Amenorrhea
% 209.48/209.64 |- skos__hiddenLabel mesh__D000568 Postpartum Amenorrheas
% 209.48/209.64 |- skos__broader mesh__D000568smesh__D008599
% 209.48/209.64 |- skos__hiddenLabel mesh__D000568 Amenorrhea, Postpartum
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D000568 2002
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D000568 2004
% 209.48/209.64 |- skos__annotation mesh__D000568
% 209.48/209.64 %22%postpartum amenorrhea%22% is indexed under AMENORRHEA %28%IM%29% + PUERPERIUM %28%IM%29% %26% not LACTATION unless lactation is particularly discussed%A%
% 209.48/209.64 |- mesh__recordOriginator mesh__D000568 NLM
% 209.48/209.64 |- mesh__dateCreated mesh__D000568 1999-01-01
% 209.48/209.64 |- mesh__dateRevised mesh__D000568 1999-11-09
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D000568 2000
% 209.48/209.64 |- skos__related mesh__D000568smesh__D009839
% 209.48/209.64 |- skos__scopeNote mesh__D000568 Absence of menstruation.
% 209.48/209.64 |- rdf__type mesh__D000568sskos__Concept
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D000568 sjn
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D000568 2005
% 209.48/209.64 |- skos__historyNote mesh__D005253 Cats %28%1969-1974%29%
% 209.48/209.64 |- skos__altLabel mesh__D005253 Feline Sarcoma Viruses
% 209.48/209.64 |- skos__prefLabel mesh__D005253 Sarcoma Viruses, Feline
% 209.48/209.64 |- skos__altLabel mesh__D005253 Gardner-Arnstein feline sarcoma virus
% 209.48/209.64 |- skos__hiddenLabel mesh__D005253 Feline Sarcoma Virus, Snyder Theilen
% 209.48/209.64 |- mesh__dateEstablished mesh__D005253 1991-01-01
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D005253 2004
% 209.48/209.64 |- skos__altLabel mesh__D005253 Feline Sarcoma Virus, Hardy-Zuckerman
% 209.48/209.64 |- mesh__dateRevised mesh__D005253 2001-07-25
% 209.48/209.64 |- skos__historyNote mesh__D005253 Retroviridae %28%1970-1974%29%
% 209.48/209.64 |- skos__altLabel mesh__D005253 Feline Sarcoma Virus, Snyder-Theilen
% 209.48/209.64 |- mesh__recordOriginator mesh__D005253 NLM
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D005253
% 209.48/209.64 2002; see SARCOMA VIRUS, FELINE 1994-2001, see FELINE FIBROSARCOMA VIRUS 1991-1993, see RETROVIRIDAE 1981-1990, see LEUKOVIRUSES 1978-1980, see LEUKEMOGENIC VIRUSES 1975-1977%A%
% 209.48/209.64 |- skos__historyNote mesh__D005253 Oncogenic Viruses %28%1970-1974%29%
% 209.48/209.64 |- mesh__recordMaintainer mesh__D005253 ags
% 209.48/209.64 |- mesh__historyNote mesh__D005253 2002 %28%1975%29%
% 209.48/209.64 |- rdf__type mesh__D005253sskos__Concept
% 209.48/209.64 |- skos__altLabel mesh__D005253 Feline Sarcoma Virus, Gardner-Arnstein
% 209.48/209.64 |- skos__altLabel mesh__D005253 Hardy-Zuckerman feline sarcoma virus
% 209.48/209.64 |- mesh__dateCreated mesh__D005253 1974-12-12
% 209.48/209.64 |- skos__broader mesh__D005253smesh__D017988
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D005253 2005
% 209.48/209.64 |- skos__scopeNote mesh__D005253
% 209.48/209.64 Species of GAMMARETROVIRUS isolated from fibrosarcoma in cats. The viruses are actually recombinant feline leukemia viruses %28%FeLV%29% where part of the genome has been replaced by cellular oncogenes. It is unique to individuals and not transmitted naturally to other cats. FeSVs are replication defective and require FeLV to reproduce.%A%
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D005253 2002
% 209.48/209.64 |- skos__hiddenLabel mesh__D005253 Gardner Arnstein feline sarcoma virus
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D005253 2006
% 209.48/209.64 |- skos__annotation mesh__D005253
% 209.48/209.64 infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%; DF: FESV%A%
% 209.48/209.64 |- skos__hiddenLabel mesh__D005253 Feline Sarcoma Virus, Hardy Zuckerman
% 209.48/209.64 |- skos__historyNote mesh__D005253 Fibrosarcoma %28%1969-1974%29%
% 209.48/209.64 |- skos__altLabel mesh__D005253 Snyder-Theilen feline sarcoma virus
% 209.48/209.64 |- skos__hiddenLabel mesh__D005253 Feline Sarcoma Virus, Gardner Arnstein
% 209.48/209.64 |- skos__hiddenLabel mesh__D005253 Hardy Zuckerman feline sarcoma virus
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D005253 2003
% 209.48/209.64 |- skos__hiddenLabel mesh__D005253 Snyder Theilen feline sarcoma virus
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D005253 sjn
% 209.48/209.64 |- skos__historyNote mesh__D005253
% 209.48/209.64 Vertebrate Viruses, Unclassified %28%1970-1974%29%
% 209.48/209.64 |- skos__altLabel mesh__D018979 Inclusion Body Myositis
% 209.48/209.64 |- mesh__recordOriginator mesh__D018979 TGC
% 209.48/209.64 |- skos__altLabel mesh__D018979 Sporadic Inclusion Body Myositis
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D018979 2003
% 209.48/209.64 |- rdf__type mesh__D018979sskos__Concept
% 209.48/209.64 |- skos__scopeNote mesh__D018979
% 209.48/209.64 Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. %28%Adams et al., Principles of Neurology, 6th ed, pp1409-10%29%%A%
% 209.48/209.64 |- skos__annotation mesh__D018979
% 209.48/209.64 do not coord with INCLUSION BODIES but coord with INCLUSION BODIES, VIRAL if relevant %28%IM or NIM%29%%A%
% 209.48/209.64 |- mesh__dateRevised mesh__D018979 1999-11-04
% 209.48/209.64 |- skos__altLabel mesh__D018979 Inclusion Body Myositis, Sporadic
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D018979 2002
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D018979 96
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D018979 2005
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D018979 2004
% 209.48/209.64 |- skos__altLabel mesh__D018979 Myopathy, Inclusion Body, Sporadic
% 209.48/209.64 |- mesh__historyNote mesh__D018979 96
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D018979 2006
% 209.48/209.64 |- skos__historyNote mesh__D018979 Myositis %28%1968-1995%29%
% 209.48/209.64 |- mesh__dateCreated mesh__D018979 1995-05-24
% 209.48/209.64 |- skos__broader mesh__D018979smesh__D009220
% 209.48/209.64 |- skos__hiddenLabel mesh__D018979 Myositides, Inclusion Body
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D018979 2000
% 209.48/209.64 |- skos__prefLabel mesh__D018979 Myositis, Inclusion Body
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D018979 sjn
% 209.48/209.64 |- mesh__dateEstablished mesh__D018979 1996-01-01
% 209.48/209.64 |- skos__hiddenLabel mesh__D018979 Inclusion Body Myositides
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D018979 2001
% 209.48/209.64 |- mesh__recordMaintainer mesh__D018979 KEV
% 209.48/209.64 |- skos__altLabel mesh__D018979 Myositis, Inclusion Body, Sporadic
% 209.48/209.64 |- skos__hiddenLabel mesh__D010996 Pleural Effusions
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 1998
% 209.48/209.64 |- mesh__dateEstablished mesh__D010996 1968-01-01
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 2002
% 209.48/209.64 |- skos__scopeNote mesh__D010996
% 209.48/209.64 Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.%A%
% 209.48/209.64 |- rdf__type mesh__D010996sskos__Concept
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D010996 PLS
% 209.48/209.64 |- skos__hiddenLabel mesh__D010996 Effusions, Pleural
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 1999
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 1997
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 2005
% 209.48/209.64 |- mesh__recordMaintainer mesh__D010996 TGC
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 2003
% 209.48/209.64 |- skos__hiddenLabel mesh__D010996 Effusion, Pleural
% 209.48/209.64 |- mesh__dateRevised mesh__D010996 1996-06-10
% 209.48/209.64 |- mesh__onlineNote mesh__D010996
% 209.48/209.64 use PLEURAL EFFUSION to search PLEURAL EFFUSIONS 1966-67
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 2006
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 2000
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D010996 68; was PLEURAL EFFUSIONS 1963-67
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 2004
% 209.48/209.64 |- mesh__recordOriginator mesh__D010996 NLM
% 209.48/209.64 |- mesh__dateCreated mesh__D010996 1999-01-01
% 209.48/209.64 |- skos__prefLabel mesh__D010996 Pleural Effusion
% 209.48/209.64 |- mesh__historyNote mesh__D010996
% 209.48/209.64 68; was in Cat A %26% C 1968-83, was PLEURAL EFFUSIONS in Cat A %26% C 1963-67%A%
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010996 2001
% 209.48/209.64 |- skos__broader mesh__D010996smesh__D010995
% 209.48/209.64 |- skos__annotation mesh__D010996
% 209.48/209.64 note category; presence of fluid in the pleural space; PLEURAL EFFUSION, MALIGNANT is also available%A%
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D043372 sjn
% 209.48/209.64 |- mesh__recordOriginator mesh__D043372 ags
% 209.48/209.64 |- mesh__recordMaintainer mesh__D043372 SYSTEM
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D043372 2006
% 209.48/209.64 |- mesh__dateCreated mesh__D043372 2003-07-09
% 209.48/209.64 |- mesh__dateEstablished mesh__D043372 2004-01-01
% 209.48/209.64 |- mesh__historyNote mesh__D043372 2004
% 209.48/209.64 |- skos__broader mesh__D043372smesh__D006088
% 209.48/209.64 |- rdf__type mesh__D043372sskos__Concept
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D043372 2004
% 209.48/209.64 |- skos__scopeNote mesh__D043372
% 209.48/209.64 A family of gram-negative bacteria in the order Nitrosomonadales, class BETAPROTEOBACTERIA. It contains a single genus Gallionella.%A%
% 209.48/209.64 |- skos__broader mesh__D043372smesh__D020562
% 209.48/209.64 |- mesh__dateRevised mesh__D043372 2005-06-30
% 209.48/209.64 |- skos__prefLabel mesh__D043372 Gallionellaceae
% 209.48/209.64 |- rdf__type mesh__D010198sskos__Concept
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 2001
% 209.48/209.64 |- skos__hiddenLabel mesh__D010198 Pancytopenias
% 209.48/209.64 |- mesh__recordOriginator mesh__D010198 VDK
% 209.48/209.64 |- mesh__dateRevised mesh__D010198 1990-05-29
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 2004
% 209.48/209.64 |- skos__broader mesh__D010198smesh__D006402
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 1997
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D010198 NLM
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 2000
% 209.48/209.64 |- skos__annotation mesh__D010198
% 209.48/209.64 combined defic of erythrocytes, leukocytes %26% platelets
% 209.48/209.64 |- skos__prefLabel mesh__D010198 Pancytopenia
% 209.48/209.64 |- mesh__dateEstablished mesh__D010198 1977-01-01
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 2003
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 1993
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 1996
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 2006
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D010198 77
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 1999
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 2002
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 1992
% 209.48/209.64 |- skos__scopeNote mesh__D010198
% 209.48/209.64 Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.%A%
% 209.48/209.64 |- mesh__recordMaintainer mesh__D010198 PLS
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 2005
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 1995
% 209.48/209.64 |- mesh__dateCreated mesh__D010198 1976-05-19
% 209.48/209.64 |- mesh__historyNote mesh__D010198 77
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 1998
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 1991
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D010198 1994
% 209.48/209.64 |- skos__historyNote mesh__D004959 Estradiol %28%1966-1977%29%
% 209.48/209.64 |- mesh__dateCreated mesh__D004959 1999-11-08
% 209.48/209.64 |- skos__hiddenLabel mesh__D004959 Antagonists, Estradiol
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D004959 sjn
% 209.48/209.64 |- skos__annotation mesh__D004959 DF: ESTRADIOL ANTAG
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D004959 2006
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D004959 78
% 209.48/209.64 |- mesh__recordOriginator mesh__D004959 RLS
% 209.48/209.64 |- mesh__dateEstablished mesh__D004959 1978-01-01
% 209.48/209.64 |- mesh__recordMaintainer mesh__D004959 ssb
% 209.48/209.64 |- rdf__type mesh__D004959sskos__Concept
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D004959 2005
% 209.48/209.64 |- skos__prefLabel mesh__D004959 Estradiol Antagonists
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D004959 2004
% 209.48/209.64 |- mesh__dateRevised mesh__D004959 2003-07-09
% 209.48/209.64 |- mesh__historyNote mesh__D004959 78
% 209.48/209.64 |- skos__scopeNote mesh__D004959
% 209.48/209.64 Compounds which inhibit or antagonize the biosynthesis or action of estradiol.%A%
% 209.48/209.64 |- skos__broader mesh__D004959smesh__D004965
% 209.48/209.64 |- mesh__historyNote mesh__D015681 91; was GAG-ONC FUSION PROTEINS 1990
% 209.48/209.64 |- mesh__recordOriginator mesh__D015681 AGS
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 gag myc Fused Protein p110
% 209.48/209.64 |- mesh__onlineNote mesh__D015681
% 209.48/209.64 use FUSION PROTEINS, GAG-ONC to search GAG-ONC FUSION PROTEINS 1990%A%
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 Protein v-fes, Oncogene
% 209.48/209.64 |- mesh__recordAuthorizer mesh__D015681 sjn
% 209.48/209.64 |- mesh__dateCreated mesh__D015681 1989-05-25
% 209.48/209.64 |- skos__annotation mesh__D015681
% 209.48/209.64 IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 p140 gag fps
% 209.48/209.64 |- skos__historyNote mesh__D015681 Viral Proteins %28%1980-1985%29%
% 209.48/209.64 |- skos__historyNote mesh__D015681 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 pp85 gag fes
% 209.48/209.64 |- mesh__activeMeSHYear mesh__D015681 2006
% 209.48/209.64 |- skos__broader mesh__D015681smesh__D015682
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 v-fes, Oncogene Protein
% 209.48/209.64 |- skos__altLabel mesh__D015681 gag-onc Fusion Proteins
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 gag-fes, p140
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 gag-fps, p140
% 209.48/209.64 |- mesh__dateEstablished mesh__D015681 1990-01-01
% 209.48/209.64 |- mesh__dateRevised mesh__D015681 2005-06-30
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 Fujinami Sarcoma Virus P140 gag fps
% 209.48/209.64 |- skos__broader mesh__D015681smesh__D015683
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 gag-ros Fusion Proteins
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 gag-pol-myc, p200
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 gag onc Fusion Proteins
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 Proteins, gag-onc Fusion
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 Oncogene Protein v fes
% 209.48/209.64 |- mesh__publicMeSHNote mesh__D015681
% 209.48/209.64 91; was GAG-ONC FUSION PROTEINS 1990
% 209.48/209.64 |- skos__broader mesh__D015681smesh__D015514
% 209.48/209.64 |- skos__prefLabel mesh__D015681 Fusion Proteins, gag-onc
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 Fusion Proteins, gag ros
% 209.48/209.64 |- skos__scopeNote mesh__D015681
% 209.48/209.64 General name for the translation products of a fusion mRNA consisting of a gag gene and a viral oncogene %28%v-onc%29%. These products are thought to have the ability to transform cells.%A%
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 Proteins, gag-ros Fusion
% 209.48/209.64 |- mesh__recordMaintainer mesh__D015681 nns
% 209.48/209.64 |- rdf__type mesh__D015681sskos__Concept
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 p140 gag fes
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 gag-fes, pp85
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 Fusion Proteins, gag onc
% 209.48/209.64 |- skos__hiddenLabel mesh__D015681 p200 gag pol myc
% 209.48/209.64 |- skos__hiddenLabel mesh__D009644 Wy 3707
% 209.48/209.64 |- skos__broader mesh__D009644smesh__D009652
% 209.48/209.64 |- skos__historyNote mesh__D009644 Contraceptives, Oral %28%1966-1971%29%
% 209.48/209.64 |- skos__hiddenLabel mesh__D009644 Norgestrel Wyeth Brand
% 209.48/209.64 |- skos__hiddenLabel mesh__D009644 DL Norgestrel
% 209.48/209.64 |- mesh__recordMaintainer mesh__D009644 jls
% 209.48/209.64 |- skos__scopeNote mesh__D009644
% 209.48/209.64 A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or %28%+-%29%-form has about half the potency of the levo form %28%LEVONORGESTREL%29%. Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.%A%
% 209.48/209.65 |- mesh__dateEstablished mesh__D009644 1972-01-01
% 209.48/209.65 |- skos__hiddenLabel mesh__D009644 Norgestrel Schering Brand
% 209.48/209.65 |- skos__historyNote mesh__D009644
% 209.48/209.65 Progestational Hormones %28%1966-1971%29%
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D009644 2005
% 209.48/209.65 |- skos__altLabel mesh__D009644 Wyeth Brand of Norgestrel
% 209.48/209.65 |- skos__altLabel mesh__D009644 Schering Brand of Norgestrel
% 209.48/209.65 |- skos__prefLabel mesh__D009644 Norgestrel
% 209.48/209.65 |- skos__altLabel mesh__D009644 DL-Norgestrel
% 209.48/209.65 |- mesh__dateCreated mesh__D009644 1999-01-01
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D009644 2006
% 209.48/209.65 |- skos__historyNote mesh__D009644 Ketones %28%1966-1971%29%
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D009644 72
% 209.48/209.65 |- skos__historyNote mesh__D009644 Pregnanes %28%1968-1971%29%
% 209.48/209.65 |- mesh__historyNote mesh__D009644 72
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D009644 jls
% 209.48/209.65 |- mesh__dateRevised mesh__D009644 2004-07-29
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D009644 2005A
% 209.48/209.65 |- rdf__type mesh__D009644sskos__Concept
% 209.48/209.65 |- skos__hiddenLabel mesh__D009644 Wy3707
% 209.48/209.65 |- mesh__recordOriginator mesh__D009644 NLM
% 209.48/209.65 |- skos__broader mesh__D001661smesh__D001660
% 209.48/209.65 |- skos__historyNote mesh__D001661 Bile Duct Neoplasms %28%1966-1979%29%
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001661 2006
% 209.48/209.65 |- mesh__recordMaintainer mesh__D001661 lkt
% 209.48/209.65 |- mesh__dateCreated mesh__D001661 1979-05-29
% 209.48/209.65 |- skos__historyNote mesh__D001661 Gallbladder Neoplasms %28%1966-1979%29%
% 209.48/209.65 |- skos__altLabel mesh__D001661 Cancer of the Biliary Tract
% 209.48/209.65 |- skos__annotation mesh__D001661
% 209.48/209.65 GEN: prefer specifics; coord IM with histol type of neopl %28%IM%29%%A%
% 209.48/209.65 |- skos__scopeNote mesh__D001661
% 209.48/209.65 Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.%A%
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D001661 80
% 209.48/209.65 |- rdf__type mesh__D001661sskos__Concept
% 209.48/209.65 |- skos__hiddenLabel mesh__D001661 Cancer, Biliary Tract
% 209.48/209.65 |- skos__hiddenLabel mesh__D001661 Biliary Tract Cancers
% 209.48/209.65 |- mesh__dateRevised mesh__D001661 2003-07-09
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D001661 sjn
% 209.48/209.65 |- mesh__historyNote mesh__D001661 80
% 209.48/209.65 |- skos__hiddenLabel mesh__D001661 Biliary Tract Neoplasm
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001661 2004
% 209.48/209.65 |- mesh__dateEstablished mesh__D001661 1980-01-01
% 209.48/209.65 |- skos__hiddenLabel mesh__D001661 Neoplasm, Biliary Tract
% 209.48/209.65 |- skos__broader mesh__D001661smesh__D004067
% 209.48/209.65 |- skos__altLabel mesh__D001661 Neoplasms, Biliary Tract
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001661 2005
% 209.48/209.65 |- skos__hiddenLabel mesh__D001661 Cancers, Biliary Tract
% 209.48/209.65 |- skos__altLabel mesh__D001661 Cancer of Biliary Tract
% 209.48/209.65 |- skos__prefLabel mesh__D001661 Biliary Tract Neoplasms
% 209.48/209.65 |- mesh__recordOriginator mesh__D001661 SMH
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D014589 2001
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D014589 1998
% 209.48/209.65 |- mesh__recordOriginator mesh__D014589 NLM
% 209.48/209.65 |- mesh__dateCreated mesh__D014589 1999-01-01
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D014589 1999
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D014589 2002
% 209.48/209.65 |- skos__prefLabel mesh__D014589 Utah
% 209.48/209.65 |- mesh__dateRevised mesh__D014589 1997-06-20
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D014589 2003
% 209.48/209.65 |- skos__broader mesh__D014589smesh__D015206
% 209.48/209.65 |- rdf__type mesh__D014589sskos__Concept
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D014589 SJN
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D014589 2005
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D014589 2004
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D014589 2006
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D014589 2000
% 209.48/209.65 |- mesh__recordMaintainer mesh__D014589 PXP
% 209.48/209.65 |- skos__historyNote mesh__D019274 Botulinum Toxins %28%1982-1996%29%
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D019274 2006
% 209.48/209.65 |- mesh__dateRevised mesh__D019274 2005-06-30
% 209.48/209.65 |- skos__altLabel mesh__D019274 Botulinum Neurotoxin A
% 209.48/209.65 |- rdf__type mesh__D019274sskos__Concept
% 209.48/209.65 |- mesh__dateEstablished mesh__D019274 1997-01-01
% 209.48/209.65 |- skos__altLabel mesh__D019274 Allergan Brand of Botulinum A Toxin
% 209.48/209.65 |- skos__altLabel mesh__D019274 Speywood Brand of Botulinum A Toxin
% 209.48/209.65 |- skos__hiddenLabel mesh__D019274 Toxin, Botulinum A
% 209.48/209.65 |- skos__altLabel mesh__D019274 Botulinum A Toxin
% 209.48/209.65 |- skos__scopeNote mesh__D019274
% 209.48/209.65 A 150 kDa neurotoxic protein produced by CLOSTRIDIUM BOTULINUM. When consumed in contaminated food it can cause paralysis and death. In its purified form, it has been used in the treatment of BLEPHAROSPASM and STRABISMUS.%A%
% 209.48/209.65 |- skos__prefLabel mesh__D019274 Botulinum Toxin Type A
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D019274 97
% 209.48/209.65 |- skos__annotation mesh__D019274
% 209.48/209.65 /antag permitted but consider also BOTULINUM ANTITOXIN
% 209.48/209.65 |- mesh__recordMaintainer mesh__D019274 ssb
% 209.48/209.65 |- mesh__dateCreated mesh__D019274 1996-06-10
% 209.48/209.65 |- skos__altLabel mesh__D019274 Clostridium botulinum A Toxin
% 209.48/209.65 |- skos__altLabel mesh__D019274 Lasa Brand of Botulinum A Toxin
% 209.48/209.65 |- skos__altLabel mesh__D019274 Ispen Brand of Botulinum A Toxin
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D019274 sjn
% 209.48/209.65 |- skos__hiddenLabel mesh__D019274 Neurotoxin A, Botulinum
% 209.48/209.65 |- mesh__historyNote mesh__D019274 97
% 209.48/209.65 |- skos__broader mesh__D019274smesh__D001905
% 209.48/209.65 |- skos__altLabel mesh__D019274 Clostridium Botulinum Toxin Type A
% 209.48/209.65 |- skos__altLabel mesh__D019274 Merz Brand of Botulinum A Toxin
% 209.48/209.65 |- mesh__recordOriginator mesh__D019274 TPW
% 209.48/209.65 |- mesh__historyNote mesh__D000569 96; was AMERICA 1975-95
% 209.48/209.65 |- mesh__recordMaintainer mesh__D000569 mdb
% 209.48/209.65 |- skos__broader mesh__D000569smesh__D005842
% 209.48/209.65 |- skos__scopeNote mesh__D000569
% 209.48/209.65 The general name for NORTH AMERICA; CENTRAL AMERICA; and SOUTH AMERICA unspecified or combined.%A%
% 209.48/209.65 |- mesh__dateRevised mesh__D000569 2001-07-25
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D000569 2003
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D000569 sjn
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D000569 2004
% 209.48/209.65 |- skos__altLabel mesh__D000569 America
% 209.48/209.65 |- mesh__dateCreated mesh__D000569 1999-01-01
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D000569 2002
% 209.48/209.65 |- rdf__type mesh__D000569sskos__Concept
% 209.48/209.65 |- skos__prefLabel mesh__D000569 Americas
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D000569 2005
% 209.48/209.65 |- mesh__recordOriginator mesh__D000569 NLM
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D000569 2006
% 209.48/209.65 |- skos__annotation mesh__D000569
% 209.48/209.65 too general; avoid; prefer specific continents or countries; titles saying %22%American%22% are likely to be indexed to UNITED STATES, not here%A%
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D011291 SJN
% 209.48/209.65 |- skos__hiddenLabel mesh__D011291 Examination, Premarital
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011291 2005
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011291 1998
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011291 2002
% 209.48/209.65 |- skos__broader mesh__D011291smesh__D019937
% 209.48/209.65 |- rdf__type mesh__D011291sskos__Concept
% 209.48/209.65 |- skos__altLabel mesh__D011291 Examinations, Premarital
% 209.48/209.65 |- mesh__dateRevised mesh__D011291 1997-06-20
% 209.48/209.65 |- skos__prefLabel mesh__D011291 Premarital Examinations
% 209.48/209.65 |- mesh__recordMaintainer mesh__D011291 PXP
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011291 2001
% 209.48/209.65 |- skos__hiddenLabel mesh__D011291 Premarital Examination
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011291 2000
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011291 2004
% 209.48/209.65 |- mesh__dateCreated mesh__D011291 1999-01-01
% 209.48/209.65 |- mesh__recordOriginator mesh__D011291 NLM
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011291 2006
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011291 2003
% 209.48/209.65 |- skos__annotation mesh__D011291 IM; DF: PREMARITAL EXAM
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011291 1999
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Panleukopenias, Feline
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Plagues, Cat
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Feline Infectious Enteritides
% 209.48/209.65 |- skos__scopeNote mesh__D005254
% 209.48/209.65 A highly contagious DNA virus infection of the cat family and of mink, characterized by fever, enteritis and bone marrow changes. It is also called feline ataxia, feline agranulocytosis, feline infectious enteritis, cat fever, cat plague, show fever.%A%
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Feline Distempers
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Feline Panleukopenias
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Infectious Enteritides, Feline
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Enteritis, Feline Infectious
% 209.48/209.65 |- skos__altLabel mesh__D005254 Distemper, Feline
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Infectious Enteritis, Feline
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D005254 2004
% 209.48/209.65 |- skos__prefLabel mesh__D005254 Feline Panleukopenia
% 209.48/209.65 |- mesh__recordOriginator mesh__D005254 NLM
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Cat Plagues
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D005254 sjn
% 209.48/209.65 |- skos__annotation mesh__D005254
% 209.48/209.65 caused by a parvovirus; don%27%t forget also CATS %28%NIM%29% %26% check tag ANIMALS; in minks, coord with MINK %28%IM%29%%A%
% 209.48/209.65 |- skos__altLabel mesh__D005254 Feline Ataxia
% 209.48/209.65 |- skos__altLabel mesh__D005254 Agranulocytosis, Feline
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Plague, Cat
% 209.48/209.65 |- mesh__dateEstablished mesh__D005254 1970-01-01
% 209.48/209.65 |- skos__historyNote mesh__D005254 Cat Diseases %28%1966-1969%29%
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Ataxias, Feline
% 209.48/209.65 |- skos__altLabel mesh__D005254 Show Fever
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Distempers, Feline
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Feline Distemper
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Feline Ataxias
% 209.48/209.65 |- skos__broader mesh__D005254smesh__D010322
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Agranulocytoses, Feline
% 209.48/209.65 |- mesh__dateRevised mesh__D005254 2003-07-30
% 209.48/209.65 |- skos__broader mesh__D005254smesh__D002371
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D005254
% 209.48/209.65 97; was FELINE INFECTIOUS ENTERITIS 1970-96
% 209.48/209.65 |- mesh__historyNote mesh__D005254
% 209.48/209.65 97; was FELINE INFECTIOUS ENTERITIS 1970-96
% 209.48/209.65 |- skos__altLabel mesh__D005254 Panleukopenia, Feline
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D005254 2006
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Show Fevers
% 209.48/209.65 |- skos__altLabel mesh__D005254 Enteritis, Infectious, of Mink
% 209.48/209.65 |- mesh__dateCreated mesh__D005254 1999-01-01
% 209.48/209.65 |- skos__altLabel mesh__D005254 Cat Plague
% 209.48/209.65 |- skos__historyNote mesh__D005254 Virus Diseases %28%1966-1969%29%
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Fevers, Show
% 209.48/209.65 |- skos__altLabel mesh__D005254 Ataxia, Feline
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D005254 2005
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Fever, Show
% 209.48/209.65 |- rdf__type mesh__D005254sskos__Concept
% 209.48/209.65 |- mesh__recordMaintainer mesh__D005254 ags
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Feline Agranulocytosis
% 209.48/209.65 |- skos__altLabel mesh__D005254 Feline Infectious Enteritis
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Feline Agranulocytoses
% 209.48/209.65 |- skos__hiddenLabel mesh__D005254 Enteritides, Feline Infectious
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 2000
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 2005
% 209.48/209.65 |- mesh__recordMaintainer mesh__D010997 KEV
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 2003
% 209.48/209.65 |- mesh__recordOriginator mesh__D010997 NLM
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 2006
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 2001
% 209.48/209.65 |- mesh__dateRevised mesh__D010997 1995-06-08
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 2004
% 209.48/209.65 |- skos__broader mesh__D010997smesh__D010995
% 209.48/209.65 |- mesh__dateCreated mesh__D010997 1999-01-01
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 2002
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D010997 PLS
% 209.48/209.65 |- skos__annotation mesh__D010997
% 209.48/209.65 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%
% 209.48/209.65 |- skos__scopeNote mesh__D010997
% 209.48/209.65 Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.%A%
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 1998
% 209.48/209.65 |- skos__hiddenLabel mesh__D010997 Neoplasm, Pleural
% 209.48/209.65 |- rdf__type mesh__D010997sskos__Concept
% 209.48/209.65 |- skos__broader mesh__D010997smesh__D012142
% 209.48/209.65 |- skos__altLabel mesh__D010997 Neoplasms, Pleural
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 1996
% 209.48/209.65 |- skos__prefLabel mesh__D010997 Pleural Neoplasms
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 1999
% 209.48/209.65 |- skos__hiddenLabel mesh__D010997 Pleural Neoplasm
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D010997 1997
% 209.48/209.65 |- skos__altLabel mesh__D043373 Human FSH
% 209.48/209.65 |- skos__altLabel mesh__D043373 FSH, Human
% 209.48/209.65 |- mesh__dateEstablished mesh__D043373 2004-01-01
% 209.48/209.65 |- mesh__dateRevised mesh__D043373 2004-07-13
% 209.48/209.65 |- skos__altLabel mesh__D043373 hFSH
% 209.48/209.65 |- mesh__dateCreated mesh__D043373 2003-07-09
% 209.48/209.65 |- skos__altLabel mesh__D043373 Org-32489
% 209.48/209.65 |- mesh__historyNote mesh__D043373
% 209.48/209.65 2004; use FOLLICLE STIMULATING HORMONE 1987-2003; for ANTHROGON use FOLLICLE STIMULATING HORMONE 1985-2003%A%
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D043373 sjn
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D043373 2006
% 209.48/209.65 |- skos__altLabel mesh__D043373
% 209.48/209.65 FSH, human %28%follicle stimulating hormone%29%
% 209.48/209.65 |- skos__broader mesh__D043373smesh__D005640
% 209.48/209.65 |- mesh__recordOriginator mesh__D043373 lkt
% 209.48/209.65 |- skos__scopeNote mesh__D043373
% 209.48/209.65 A major gonadotropin secreted by the human adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and the LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. The alpha subunit is common in the three human pituitary glycoprotein hormones %28%TSH, LH, and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A%
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D043373 2005
% 209.48/209.65 |- skos__historyNote mesh__D043373
% 209.48/209.65 Follicle Stimulating Hormone %28%1966-2003%29%
% 209.48/209.65 |- mesh__recordMaintainer mesh__D043373 sjn
% 209.48/209.65 |- skos__annotation mesh__D043373
% 209.48/209.65 for alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; for beta subunit, coord with FOLLICLE STIMULATING HORMONE, BETA SUBUNIT%A%
% 209.48/209.65 |- skos__altLabel mesh__D043373 Gonal-F
% 209.48/209.65 |- rdf__type mesh__D043373sskos__Concept
% 209.48/209.65 |- skos__altLabel mesh__D043373 Human Follicle Stimulating Hormone
% 209.48/209.65 |- skos__prefLabel mesh__D043373 Follicle Stimulating Hormone, Human
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D043373
% 209.48/209.65 2004; see FOLLICLE STIMULATING HORMONE 1987-2003; for ANTHROGON see FOLLICLE STIMULATING HORMONE 1985-2003%A%
% 209.48/209.65 |- mesh__dateCreated mesh__D015682 1989-05-25
% 209.48/209.65 |- skos__annotation mesh__D015682
% 209.48/209.65 IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%
% 209.48/209.65 |- mesh__recordOriginator mesh__D015682 AGS
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D015682 2006
% 209.48/209.65 |- skos__hiddenLabel mesh__D015682 Proteins, Oncogenic Retroviridae
% 209.48/209.65 |- mesh__dateEstablished mesh__D015682 1990-01-01
% 209.48/209.65 |- skos__broader mesh__D015682smesh__D009856
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D015682 sjn
% 209.48/209.65 |- skos__historyNote mesh__D015682 Viral Proteins %28%1980-1985%29%
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D015682 90
% 209.48/209.65 |- skos__scopeNote mesh__D015682
% 209.48/209.65 Retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukemias, lymphomas, and mammary carcinomas. Not all retroviral proteins are oncogenic.%A%
% 209.48/209.65 |- skos__historyNote mesh__D015682 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.65 |- mesh__recordMaintainer mesh__D015682 SYSTEM
% 209.48/209.65 |- skos__broader mesh__D015682smesh__D012191
% 209.48/209.65 |- skos__prefLabel mesh__D015682 Retroviridae Proteins, Oncogenic
% 209.48/209.65 |- rdf__type mesh__D015682sskos__Concept
% 209.48/209.65 |- skos__hiddenLabel mesh__D015682 Oncogenic Retroviridae Proteins
% 209.48/209.65 |- mesh__dateRevised mesh__D015682 2005-06-30
% 209.48/209.65 |- mesh__historyNote mesh__D015682 90
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D009645 2005
% 209.48/209.65 |- skos__historyNote mesh__D009645 Norpregnanes %28%1974%29%
% 209.48/209.65 |- mesh__recordOriginator mesh__D009645 NLM
% 209.48/209.65 |- skos__scopeNote mesh__D009645
% 209.48/209.65 A synthetic steroid with progestational and contraceptive activities.%A%
% 209.48/209.65 |- mesh__historyNote mesh__D009645
% 209.48/209.65 91%28%75%29%; was see under NORPREGNATRIENES 1975-90
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D009645 2006
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D009645
% 209.48/209.65 91; was see under NORPREGNATRIENES 1975-90
% 209.48/209.65 |- mesh__dateCreated mesh__D009645 1974-11-14
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D009645 sjn
% 209.48/209.65 |- skos__hiddenLabel mesh__D009645 A 301
% 209.48/209.65 |- rdf__type mesh__D009645sskos__Concept
% 209.48/209.65 |- mesh__dateEstablished mesh__D009645 1991-01-01
% 209.48/209.65 |- skos__broader mesh__D009645smesh__D009651
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D009645 2004
% 209.48/209.65 |- skos__prefLabel mesh__D009645 Norgestrienone
% 209.48/209.65 |- mesh__dateRevised mesh__D009645 2003-07-09
% 209.48/209.65 |- skos__historyNote mesh__D009645 Ketosteroids %28%1973-1974%29%
% 209.48/209.65 |- skos__historyNote mesh__D009645 Hydroxysteroids %28%1973-1974%29%
% 209.48/209.65 |- skos__historyNote mesh__D009645 Pregnatrienes %28%1973-1974%29%
% 209.48/209.65 |- mesh__recordMaintainer mesh__D009645 lkt
% 209.48/209.65 |- skos__hiddenLabel mesh__D009645 A301
% 209.48/209.65 |- mesh__recordOriginator mesh__D001662 SCD
% 209.48/209.65 |- mesh__historyNote mesh__D001662 98%28%88%29%
% 209.48/209.65 |- rdf__type mesh__D001662sskos__Concept
% 209.48/209.65 |- skos__prefLabel mesh__D001662 Biliary Tract Surgical Procedures
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D001662 SJN
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001662 2003
% 209.48/209.65 |- skos__altLabel mesh__D001662 Biliary Surgical Procedures
% 209.48/209.65 |- mesh__dateRevised mesh__D001662 1997-06-20
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001662 2000
% 209.48/209.65 |- skos__altLabel mesh__D001662 Surgical Procedure, Biliary
% 209.48/209.65 |- skos__altLabel mesh__D001662 Surgical Procedures, Biliary Tract
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001662 2004
% 209.48/209.65 |- skos__altLabel mesh__D001662 Biliary Surgical Procedure
% 209.48/209.65 |- skos__scopeNote mesh__D001662
% 209.48/209.65 Any surgical procedure performed on the biliary tract.
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001662 2001
% 209.48/209.65 |- mesh__dateEstablished mesh__D001662 1988-01-01
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001662 1998
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001662 2005
% 209.48/209.65 |- skos__broader mesh__D001662smesh__D013505
% 209.48/209.65 |- skos__altLabel mesh__D001662 Surgical Procedures, Biliary
% 209.48/209.65 |- skos__altLabel mesh__D001662 Biliary Tract Surgical Procedure
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001662 2002
% 209.48/209.65 |- skos__altLabel mesh__D001662 Surgical Procedure, Biliary Tract
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D001662
% 209.48/209.65 98; see BILIARY TRACT SURGERY 1988-97
% 209.48/209.65 |- mesh__recordMaintainer mesh__D001662 PXP
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001662 1999
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D001662 2006
% 209.48/209.65 |- skos__historyNote mesh__D001662 Biliary Tract/surgery %28%1966-1987%29%
% 209.48/209.65 |- skos__annotation mesh__D001662
% 209.48/209.65 GEN only: prefer specific organ with /surg or specific biliary surg technique; do not use /util except by MeSH definition.%A%
% 209.48/209.65 |- mesh__dateCreated mesh__D001662 1987-03-23
% 209.48/209.65 |- skos__historyNote mesh__D001662
% 209.48/209.65 Biliary Tract Diseases/surgery %28%1966-1987%29%
% 209.48/209.65 |- mesh__historyNote mesh__D028001
% 209.48/209.65 2002; use ELEUTHEROCOCC %28%NM%29% 1987-2001
% 209.48/209.65 |- mesh__recordMaintainer mesh__D028001 sjn
% 209.48/209.65 |- mesh__dateRevised mesh__D028001 2003-07-25
% 209.48/209.65 |- skos__broader mesh__D028001smesh__D027481
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D028001 2005
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D028001 sjn
% 209.48/209.65 |- rdf__type mesh__D028001sskos__Concept
% 209.48/209.65 |- skos__annotation mesh__D028001
% 209.48/209.65 do not confuse X ref SIBERIAN GINSENG with GINSENG see PANAX; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.48/209.65 |- skos__altLabel mesh__D028001 Ginseng, Siberian
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D028001 2006
% 209.48/209.65 |- skos__prefLabel mesh__D028001 Eleutherococcus
% 209.48/209.65 |- skos__altLabel mesh__D028001 Eleuthero
% 209.48/209.65 |- mesh__recordOriginator mesh__D028001 ssb
% 209.48/209.65 |- mesh__dateEstablished mesh__D028001 2002-01-01
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D028001
% 209.48/209.65 2002; ELEUTHEROCOCC %28%now ELEUTHEROCOCCUS%29% was indexed under PLANT EXTRACTS 1987-2001%A%
% 209.48/209.65 |- skos__historyNote mesh__D028001 Plant Extracts %28%1987-2001%29%
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D028001 2004
% 209.48/209.65 |- skos__scopeNote mesh__D028001
% 209.48/209.65 A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It is best known as an adaptogen and a substitute for ginseng.%A%
% 209.48/209.65 |- mesh__dateCreated mesh__D028001 2001-07-25
% 209.48/209.65 |- skos__altLabel mesh__D028001 Siberian Ginseng
% 209.48/209.65 |- skos__broader mesh__D014599Q000530smesh__D014599
% 209.48/209.65 |- mesh__preferredCombination mesh__D014599Q000530smesh__D007047
% 209.48/209.65 |- rdf__type mesh__D014599Q000530smesh__CompoundConcept
% 209.48/209.65 |- mesh__historyNote mesh__D019275 97
% 209.48/209.65 |- skos__historyNote mesh__D019275 specific chemical %28%1966-1996%29%
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D019275 sjn
% 209.48/209.65 |- skos__broader mesh__D019275smesh__D007202
% 209.48/209.65 |- skos__prefLabel mesh__D019275 Radiopharmaceuticals
% 209.48/209.65 |- mesh__dateCreated mesh__D019275 1996-06-10
% 209.48/209.65 |- mesh__dateRevised mesh__D019275 2003-07-09
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D019275 2006
% 209.48/209.65 |- skos__scopeNote mesh__D019275
% 209.48/209.65 Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. %28%Martindale, The Extra Pharmacopoeia, 30th ed, p1161%29%%A%
% 209.48/209.65 |- rdf__type mesh__D019275sskos__Concept
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D019275 2005
% 209.48/209.65 |- skos__annotation mesh__D019275
% 209.48/209.65 pharmaceuticals as source of radiation in radiother %26% radioisotope scanning; D25-26 qualif%A%
% 209.48/209.65 |- mesh__recordOriginator mesh__D019275 TPW
% 209.48/209.65 |- mesh__recordMaintainer mesh__D019275 ssb
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D019275 2004
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D019275 97
% 209.48/209.65 |- mesh__dateEstablished mesh__D019275 1997-01-01
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 1998
% 209.48/209.65 |- mesh__recordOriginator mesh__D011292 NLM
% 209.48/209.65 |- rdf__type mesh__D011292sskos__Concept
% 209.48/209.65 |- mesh__dateEstablished mesh__D011292 1973-01-01
% 209.48/209.65 |- skos__related mesh__D011292smesh__D019072
% 209.48/209.65 |- mesh__historyNote mesh__D011292 73%28%69%29%
% 209.48/209.65 |- skos__scopeNote mesh__D011292
% 209.48/209.65 Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics %28%ANTIBIOTIC PROPHYLAXIS%29% and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION.%A%
% 209.48/209.65 |- skos__annotation mesh__D011292
% 209.48/209.65 coord IM with specific drug /ther use %28%IM%29%; includes anti-anxiety medication; does not include antibiotic premedication %28% = ANTIBIOTIC PROPHYLAXIS%29%%A%
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 2002
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 2004
% 209.48/209.65 |- skos__broader mesh__D011292smesh__D004358
% 209.48/209.65 |- mesh__dateCreated mesh__D011292 1999-01-01
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 1997
% 209.48/209.65 |- skos__hiddenLabel mesh__D011292 Premedications
% 209.48/209.65 |- skos__historyNote mesh__D011292
% 209.48/209.65 specific drug/therapeutic use %28%1966-1968%29%
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 2001
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 2006
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 2003
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D011292 PLS
% 209.48/209.65 |- skos__prefLabel mesh__D011292 Premedication
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 2000
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 1999
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 1996
% 209.48/209.65 |- mesh__dateRevised mesh__D011292 1995-05-31
% 209.48/209.65 |- mesh__recordMaintainer mesh__D011292 TGC
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D011292 2005
% 209.48/209.65 |- skos__related mesh__D011292smesh__D011229
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D011292 73
% 209.48/209.65 |- skos__hiddenLabel mesh__D005255 Feline Parvoviruses
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D005255 2006
% 209.48/209.65 |- mesh__publicMeSHNote mesh__D005255
% 209.48/209.65 1994; see FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980%A%
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D005255 2002
% 209.48/209.65 |- skos__scopeNote mesh__D005255
% 209.48/209.65 A species of PARVOVIRUS chiefly affecting young cats in endemic areas, but all felines are susceptible.%A%
% 209.48/209.65 |- skos__altLabel mesh__D005255 Feline parvovirus
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D005255 2003
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D005255 2004
% 209.48/209.65 |- skos__broader mesh__D005255smesh__D017992
% 209.48/209.65 |- skos__hiddenLabel mesh__D005255 Parvoviruses, Feline
% 209.48/209.65 |- mesh__dateRevised mesh__D005255 2001-07-25
% 209.48/209.65 |- mesh__recordAuthorizer mesh__D005255 sjn
% 209.48/209.65 |- mesh__dateEstablished mesh__D005255 1991-01-01
% 209.48/209.65 |- mesh__historyNote mesh__D005255 1994 %28%1975%29%
% 209.48/209.65 |- mesh__recordOriginator mesh__D005255 NLM
% 209.48/209.65 |- mesh__dateCreated mesh__D005255 1974-12-12
% 209.48/209.65 |- rdf__type mesh__D005255sskos__Concept
% 209.48/209.65 |- skos__annotation mesh__D005255
% 209.48/209.65 infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%
% 209.48/209.65 |- mesh__recordMaintainer mesh__D005255 ags
% 209.48/209.65 |- mesh__activeMeSHYear mesh__D005255 2005
% 209.48/209.65 |- skos__prefLabel mesh__D005255 Parvovirus, Feline
% 209.48/209.65 |- mesh__recordMaintainer mesh__D010998 lkt
% 209.48/209.65 |- skos__related mesh__D010998smesh__D010994
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D010998 2006
% 209.48/209.66 |- skos__hiddenLabel mesh__D010998 Pleuritides
% 209.48/209.66 |- mesh__dateRevised mesh__D010998 2005-06-30
% 209.48/209.66 |- skos__altLabel mesh__D010998 Pleuritis
% 209.48/209.66 |- mesh__dateCreated mesh__D010998 1999-01-01
% 209.48/209.66 |- skos__broader mesh__D010998smesh__D012141
% 209.48/209.66 |- mesh__recordOriginator mesh__D010998 NLM
% 209.48/209.66 |- skos__broader mesh__D010998smesh__D010995
% 209.48/209.66 |- skos__prefLabel mesh__D010998 Pleurisy
% 209.48/209.66 |- rdf__type mesh__D010998sskos__Concept
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D010998 sjn
% 209.48/209.66 |- skos__scopeNote mesh__D010998
% 209.48/209.66 INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.%A%
% 209.48/209.66 |- skos__hiddenLabel mesh__D010998 Pleurisies
% 209.48/209.66 |- skos__annotation mesh__D015683 coord with specific virus %28%IM%29%
% 209.48/209.66 |- rdf__type mesh__D015683sskos__Concept
% 209.48/209.66 |- skos__hiddenLabel mesh__D015683 Viral Proteins, gag
% 209.48/209.66 |- skos__broader mesh__D015683smesh__D012191
% 209.48/209.66 |- skos__altLabel mesh__D015683 gag Gene Products
% 209.48/209.66 |- mesh__dateRevised mesh__D015683 2005-06-30
% 209.48/209.66 |- skos__historyNote mesh__D015683 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.66 |- skos__hiddenLabel mesh__D015683 Protein, gag
% 209.48/209.66 |- skos__hiddenLabel mesh__D015683 Antigens, gag
% 209.48/209.66 |- skos__broader mesh__D015683smesh__D014758
% 209.48/209.66 |- skos__altLabel mesh__D015683 gag Polyprotein
% 209.48/209.66 |- skos__historyNote mesh__D015683 Antigens, Viral %28%1983-1989%29%
% 209.48/209.66 |- skos__hiddenLabel mesh__D015683 gag Proteins, Viral
% 209.48/209.66 |- skos__hiddenLabel mesh__D015683 Proteins, gag Viral
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D015683 2006
% 209.48/209.66 |- skos__hiddenLabel mesh__D015683 Polyprotein, gag
% 209.48/209.66 |- skos__altLabel mesh__D015683 Viral gag Proteins
% 209.48/209.66 |- mesh__dateEstablished mesh__D015683 1990-01-01
% 209.48/209.66 |- skos__prefLabel mesh__D015683 Gene Products, gag
% 209.48/209.66 |- skos__historyNote mesh__D015683 Viral Core Proteins %28%1986-1989%29%
% 209.48/209.66 |- skos__altLabel mesh__D015683 gag Viral Proteins
% 209.48/209.66 |- skos__hiddenLabel mesh__D015683 gag Gene Product
% 209.48/209.66 |- mesh__recordMaintainer mesh__D015683 SYSTEM
% 209.48/209.66 |- skos__scopeNote mesh__D015683
% 209.48/209.66 Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen.%A%
% 209.48/209.66 |- skos__altLabel mesh__D015683 Gene Product, gag
% 209.48/209.66 |- mesh__historyNote mesh__D015683 90
% 209.48/209.66 |- skos__altLabel mesh__D015683 gag Protein
% 209.48/209.66 |- skos__hiddenLabel mesh__D015683 Proteins, Viral gag
% 209.48/209.66 |- skos__altLabel mesh__D015683 gag Polyproteins
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D015683 90
% 209.48/209.66 |- skos__altLabel mesh__D015683 Retroviral Antigen gag Protein
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D015683 sjn
% 209.48/209.66 |- skos__altLabel mesh__D015683 gag Antigens
% 209.48/209.66 |- skos__broader mesh__D015683smesh__D020815
% 209.48/209.66 |- mesh__recordOriginator mesh__D015683 AGS
% 209.48/209.66 |- mesh__dateCreated mesh__D015683 1989-07-06
% 209.48/209.66 |- skos__hiddenLabel mesh__D015683 Polyproteins, gag
% 209.48/209.66 |- skos__historyNote mesh__D015683 Viral Proteins %28%1972-1989%29%
% 209.48/209.66 |- skos__historyNote mesh__D009646 Aminocaproic Acids %28%1966-1971%29%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D009646 2003
% 209.48/209.66 |- skos__scopeNote mesh__D009646
% 209.48/209.66 An unnatural amino acid that is used experimentally to study protein structure and function. It is structurally similar to METHIONINE, however it does not contain SULFUR.%A%
% 209.48/209.66 |- skos__prefLabel mesh__D009646 Norleucine
% 209.48/209.66 |- rdf__type mesh__D009646sskos__Concept
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D009646 2004
% 209.48/209.66 |- mesh__dateEstablished mesh__D009646 1991-01-01
% 209.48/209.66 |- mesh__historyNote mesh__D009646
% 209.48/209.66 91%28%72%29%; was see under AMINOCAPROIC ACIDS 1972-90
% 209.48/209.66 |- mesh__recordOriginator mesh__D009646 NLM
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D009646 2002
% 209.48/209.66 |- skos__hiddenLabel mesh__D009646 Norleucine, L Isomer
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D009646 2005
% 209.48/209.66 |- mesh__recordMaintainer mesh__D009646 jmp
% 209.48/209.66 |- skos__hiddenLabel mesh__D009646 L-Isomer Norleucine
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D009646
% 209.48/209.66 91; was see under AMINOCAPROIC ACIDS 1972-90
% 209.48/209.66 |- mesh__dateRevised mesh__D009646 2001-07-25
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D009646 sjn
% 209.48/209.66 |- mesh__dateCreated mesh__D009646 1999-01-01
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D009646 2006
% 209.48/209.66 |- skos__broader mesh__D009646smesh__D000614
% 209.48/209.66 |- mesh__dateCreated mesh__D001663 1999-01-01
% 209.48/209.66 |- skos__hiddenLabel mesh__D001663 Calcium Salt Bilirubin
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D001663 sjn
% 209.48/209.66 |- skos__annotation mesh__D001663
% 209.48/209.66 BILIRUBIN ENCEPHALOPATHY see KERNICTERUS is available
% 209.48/209.66 |- mesh__recordOriginator mesh__D001663 NLM
% 209.48/209.66 |- skos__broader mesh__D001663smesh__D001654
% 209.48/209.66 |- skos__altLabel mesh__D001663 Calcium Bilirubinate
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D001663 2006
% 209.48/209.66 |- skos__altLabel mesh__D001663 Bilirubin IX alpha
% 209.48/209.66 |- skos__hiddenLabel mesh__D001663 delta Bilirubin
% 209.48/209.66 |- skos__hiddenLabel mesh__D001663 Monosodium Salt Bilirubin
% 209.48/209.66 |- skos__hiddenLabel mesh__D001663 Bilirubinate, Calcium
% 209.48/209.66 |- skos__prefLabel mesh__D001663 Bilirubin
% 209.48/209.66 |- skos__hiddenLabel mesh__D001663 Salt Bilirubin, Calcium
% 209.48/209.66 |- skos__hiddenLabel mesh__D001663 Disodium Salt Bilirubin
% 209.48/209.66 |- skos__scopeNote mesh__D001663
% 209.48/209.66 A bile pigment that is a degradation product of HEME.
% 209.48/209.66 |- mesh__dateRevised mesh__D001663 2005-06-30
% 209.48/209.66 |- rdf__type mesh__D001663sskos__Concept
% 209.48/209.66 |- skos__related mesh__D001663smesh__D006932
% 209.48/209.66 |- mesh__recordMaintainer mesh__D001663 ssb
% 209.48/209.66 |- skos__altLabel mesh__D028002 Ginseng, Alaskan
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D028002 2006
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D028002
% 209.48/209.66 2002; for ECHINOPANAX see GINSENG 1984-2001
% 209.48/209.66 |- skos__altLabel mesh__D028002 Echinopanax
% 209.48/209.66 |- rdf__type mesh__D028002sskos__Concept
% 209.48/209.66 |- skos__historyNote mesh__D028002 Plants, Medicinal %28%1983-2001%29%
% 209.48/209.66 |- skos__annotation mesh__D028002
% 209.48/209.66 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D028002 2003
% 209.48/209.66 |- mesh__dateCreated mesh__D028002 2001-07-25
% 209.48/209.66 |- skos__scopeNote mesh__D028002
% 209.48/209.66 A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It is the source of cirensenosides %28%triterpenoid saponins%29%.%A%
% 209.48/209.66 |- mesh__recordOriginator mesh__D028002 ssb
% 209.48/209.66 |- mesh__recordMaintainer mesh__D028002 ssb
% 209.48/209.66 |- skos__altLabel mesh__D028002 Echinopanax horridus
% 209.48/209.66 |- skos__broader mesh__D028002smesh__D027481
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D028002 2004
% 209.48/209.66 |- mesh__dateEstablished mesh__D028002 2002-01-01
% 209.48/209.66 |- skos__altLabel mesh__D028002 Devil%27%s Club
% 209.48/209.66 |- skos__prefLabel mesh__D028002 Oplopanax
% 209.48/209.66 |- mesh__historyNote mesh__D028002
% 209.48/209.66 2002; for ECHINOPANAX use GINSENG 1984-2001
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D028002 2002
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D028002 sjn
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D028002 2005
% 209.48/209.66 |- skos__altLabel mesh__D019276 Glycocalix
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019276 2001
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019276 2006
% 209.48/209.66 |- skos__historyNote mesh__D019276 Polysaccharides %28%1976-1996%29%
% 209.48/209.66 |- skos__hiddenLabel mesh__D019276 Coat, Cell
% 209.48/209.66 |- mesh__dateEstablished mesh__D019276 1997-01-01
% 209.48/209.66 |- rdf__type mesh__D019276sskos__Concept
% 209.48/209.66 |- skos__prefLabel mesh__D019276 Glycocalyx
% 209.48/209.66 |- skos__scopeNote mesh__D019276
% 209.48/209.66 The carbohydrate-rich zone on the cell surface. This zone can be visualized by a variety of stains as well as by its affinity for lectins. Although most of the carbohydrate is attached to intrinsic plasma membrane molecules, the glycocalyx usually also contains both glycoproteins and proteoglycans that have been secreted into the extracellular space and then adsorbed onto the cell surface. %28%Alberts et al., Molecular Biology of the Cell, 3d ed, p502%29%%A%
% 209.48/209.66 |- skos__hiddenLabel mesh__D019276 Cell Coats
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019276 2005
% 209.48/209.66 |- skos__hiddenLabel mesh__D019276 Coats, Cell
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D019276 sjn
% 209.48/209.66 |- skos__historyNote mesh__D019276 Glycoproteins %28%1976-1996%29%
% 209.48/209.66 |- skos__altLabel mesh__D019276 Cell Coat
% 209.48/209.66 |- mesh__dateCreated mesh__D019276 1996-06-10
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D019276
% 209.48/209.66 97; GLYCOCALYX was indexed under GLYCOPROTEINS %26% POLYSACCHARIDES 1976-96%A%
% 209.48/209.66 |- skos__broader mesh__D019276smesh__D021961
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019276 2002
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019276 2004
% 209.48/209.66 |- skos__annotation mesh__D019276
% 209.48/209.66 a carbohydrate-rich zone on cell surface
% 209.48/209.66 |- mesh__recordMaintainer mesh__D019276 MSR
% 209.48/209.66 |- mesh__recordOriginator mesh__D019276 TPW
% 209.48/209.66 |- mesh__dateRevised mesh__D019276 2000-06-22
% 209.48/209.66 |- mesh__historyNote mesh__D019276 97; was GLYCOCALYX %28%NM%29% 1976-96
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019276 2003
% 209.48/209.66 |- skos__hiddenLabel mesh__D011293 Tensions, Premenstrual
% 209.48/209.66 |- skos__prefLabel mesh__D011293 Premenstrual Syndrome
% 209.48/209.66 |- skos__broader mesh__D011293smesh__D008599
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D011293 2004
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D011293
% 209.48/209.66 86; was PREMENSTRUAL TENSION 1963-85
% 209.48/209.66 |- mesh__dateCreated mesh__D011293 1999-01-01
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D011293 2006
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D011293 2003
% 209.48/209.66 |- mesh__historyNote mesh__D011293 86; was PREMENSTRUAL TENSION 1963-85
% 209.48/209.66 |- skos__scopeNote mesh__D011293
% 209.48/209.66 A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse %28%such as pain, water-retention, anxiety, cravings, and depression%29% and they diminish markedly 2 or 3 days after the initiation of menses.%A%
% 209.48/209.66 |- mesh__onlineNote mesh__D011293
% 209.48/209.66 use PREMENSTRUAL SYNDROME to search PREMENSTRUAL TENSION 1966-85%A%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D011293 2005
% 209.48/209.66 |- skos__hiddenLabel mesh__D011293 Premenstrual Syndromes
% 209.48/209.66 |- mesh__recordOriginator mesh__D011293 NLM
% 209.48/209.66 |- skos__hiddenLabel mesh__D011293 Tension, Premenstrual
% 209.48/209.66 |- mesh__recordMaintainer mesh__D011293 jls
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D011293 jls
% 209.48/209.66 |- skos__hiddenLabel mesh__D011293 Syndrome, Premenstrual
% 209.48/209.66 |- rdf__type mesh__D011293sskos__Concept
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D011293 2005A
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D011293 2002
% 209.48/209.66 |- skos__hiddenLabel mesh__D011293 Premenstrual Tensions
% 209.48/209.66 |- mesh__dateRevised mesh__D011293 2004-07-30
% 209.48/209.66 |- skos__hiddenLabel mesh__D011293 Syndromes, Premenstrual
% 209.48/209.66 |- skos__scopeNote mesh__D005256
% 209.48/209.66 A species of GAMMARETROVIRUS causing leukemia, lymphosarcoma, immune deficiency, or other degenerative diseases in cats. Several cellular oncogenes confer on FeLV the ability to induce sarcomas %28%see also SARCOMA VIRUSES, FELINE%29%.%A%
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D005256 sjn
% 209.48/209.66 |- rdf__type mesh__D005256sskos__Concept
% 209.48/209.66 |- skos__hiddenLabel mesh__D005256 Leukemia Viruses, Cat
% 209.48/209.66 |- mesh__recordOriginator mesh__D005256 NLM
% 209.48/209.66 |- skos__hiddenLabel mesh__D005256 Lymphoma Viruses, Feline
% 209.48/209.66 |- skos__broader mesh__D005256smesh__D017988
% 209.48/209.66 |- mesh__dateCreated mesh__D005256 1999-01-01
% 209.48/209.66 |- skos__prefLabel mesh__D005256 Leukemia Virus, Feline
% 209.48/209.66 |- mesh__recordMaintainer mesh__D005256 sjn
% 209.48/209.66 |- mesh__historyNote mesh__D005256 94; was FELINE LEUKEMIA VIRUS 1973-93
% 209.48/209.66 |- mesh__dateEstablished mesh__D005256 1973-01-01
% 209.48/209.66 |- skos__altLabel mesh__D005256 Feline Lymphoma Virus
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005256 2006
% 209.48/209.66 |- skos__hiddenLabel mesh__D005256 Cat Leukemia Viruses
% 209.48/209.66 |- skos__altLabel mesh__D005256 Cat Leukemia Virus
% 209.48/209.66 |- skos__historyNote mesh__D005256 Retroviridae %28%1966-1972%29%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005256 2005
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005256 2004
% 209.48/209.66 |- skos__related mesh__D005256smesh__D005253
% 209.48/209.66 |- skos__hiddenLabel mesh__D005256 Leukemia Viruses, Feline
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005256 2003
% 209.48/209.66 |- skos__annotation mesh__D005256
% 209.48/209.66 infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% or if so specified by author index instead under LEUKEMIA, FELINE %28%IM but see note there%29% or FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME %28%IM but see note there%29%; DF: FELV%A%
% 209.48/209.66 |- skos__hiddenLabel mesh__D005256 Leukemia Virus, Cat
% 209.48/209.66 |- skos__hiddenLabel mesh__D005256 Feline Lymphoma Viruses
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D005256
% 209.48/209.66 94; was FELINE LEUKEMIA VIRUS 1973-93
% 209.48/209.66 |- skos__altLabel mesh__D005256 Feline leukemia virus
% 209.48/209.66 |- skos__altLabel mesh__D005256 FeLV
% 209.48/209.66 |- skos__hiddenLabel mesh__D005256 Lymphoma Virus, Feline
% 209.48/209.66 |- skos__hiddenLabel mesh__D005256 Feline Leukemia Viruses
% 209.48/209.66 |- mesh__dateRevised mesh__D005256 2001-08-07
% 209.48/209.66 |- mesh__onlineNote mesh__D005256
% 209.48/209.66 use LEUKEMIA VIRUS, FELINE to search FELINE LEUKEMIA VIRUS 1973-93%A%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005256 2002
% 209.48/209.66 |- mesh__dateRevised mesh__D010999 2003-07-09
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D010999 2004
% 209.48/209.66 |- skos__historyNote mesh__D010999 Salamandridae %28%1975-1980%29%
% 209.48/209.66 |- skos__historyNote mesh__D010999 Urodela %28%1966-1974%29%
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D010999 sjn
% 209.48/209.66 |- skos__hiddenLabel mesh__D010999 Pleurodele
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D010999 2006
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D010999
% 209.48/209.66 91; was see under SALAMANDRIDAE 1981-90
% 209.48/209.66 |- mesh__historyNote mesh__D010999
% 209.48/209.66 91%28%81%29%; was see under SALAMANDRIDAE 1981-90
% 209.48/209.66 |- mesh__dateEstablished mesh__D010999 1991-01-01
% 209.48/209.66 |- skos__broader mesh__D010999smesh__D012455
% 209.48/209.66 |- skos__scopeNote mesh__D010999
% 209.48/209.66 A genus of aquatic newts belonging to the family Salamandridae and sometimes referred to as %22%spiny%22% tritons. There are two species P. waltlii and P. poireti. P. waltlii is commonly used in the laboratory. Since this genus adapts to aquarium living, it is easy to maintain in laboratories.%A%
% 209.48/209.66 |- mesh__dateCreated mesh__D010999 1980-05-12
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D010999 2005
% 209.48/209.66 |- skos__historyNote mesh__D010999 Amphibia %28%1966-1980%29%
% 209.48/209.66 |- skos__prefLabel mesh__D010999 Pleurodeles
% 209.48/209.66 |- rdf__type mesh__D010999sskos__Concept
% 209.48/209.66 |- mesh__recordMaintainer mesh__D010999 ags
% 209.48/209.66 |- skos__annotation mesh__D010999
% 209.48/209.66 aquatic newt; NIM when exper animal: no qualif; when IM, qualif permitted%A%
% 209.48/209.66 |- mesh__recordOriginator mesh__D010999 EC
% 209.48/209.66 |- skos__historyNote mesh__D015684 Reverse Transcriptase %28%1977-1989%29%
% 209.48/209.66 |- skos__related mesh__D015684smesh__D012194
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D015684 sjn
% 209.48/209.66 |- mesh__recordOriginator mesh__D015684 AGS
% 209.48/209.66 |- skos__hiddenLabel mesh__D015684 Protein, pol
% 209.48/209.66 |- skos__historyNote mesh__D015684 Viral Proteins %28%1977-1989%29%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D015684 2006
% 209.48/209.66 |- mesh__dateEstablished mesh__D015684 1990-01-01
% 209.48/209.66 |- skos__broader mesh__D015684smesh__D012191
% 209.48/209.66 |- mesh__recordMaintainer mesh__D015684 SYSTEM
% 209.48/209.66 |- skos__altLabel mesh__D015684 pol Polyprotein
% 209.48/209.66 |- skos__altLabel mesh__D015684 Gene Product, pol
% 209.48/209.66 |- skos__altLabel mesh__D015684 pol Protein
% 209.48/209.66 |- mesh__dateRevised mesh__D015684 2005-06-30
% 209.48/209.66 |- skos__hiddenLabel mesh__D015684 pol Gene Product
% 209.48/209.66 |- skos__altLabel mesh__D015684 pol Polyproteins
% 209.48/209.66 |- skos__broader mesh__D015684smesh__D014758
% 209.48/209.66 |- skos__scopeNote mesh__D015684
% 209.48/209.66 Retroviral proteins coded by the pol gene. They are usually synthesized as a protein precursor %28%POLYPROTEINS%29% and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Sometimes they are synthesized as a gag-pol fusion protein %28%FUSION PROTEINS, GAG-POL%29%. pol is short for polymerase, the enzyme class of reverse transcriptase.%A%
% 209.48/209.66 |- skos__related mesh__D015684smesh__D010447
% 209.48/209.66 |- skos__hiddenLabel mesh__D015684 Polyprotein, pol
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D015684 90
% 209.48/209.66 |- skos__broader mesh__D015684smesh__D020815
% 209.48/209.66 |- skos__hiddenLabel mesh__D015684 Polyproteins, pol
% 209.48/209.66 |- mesh__dateCreated mesh__D015684 1989-10-12
% 209.48/209.66 |- skos__historyNote mesh__D015684 Retroviridae Proteins %28%1983-1989%29%
% 209.48/209.66 |- skos__annotation mesh__D015684 coord with specific virus %28%IM%29%
% 209.48/209.66 |- rdf__type mesh__D015684sskos__Concept
% 209.48/209.66 |- skos__prefLabel mesh__D015684 Gene Products, pol
% 209.48/209.66 |- mesh__historyNote mesh__D015684 90
% 209.48/209.66 |- skos__related mesh__D015684smesh__D004720
% 209.48/209.66 |- skos__altLabel mesh__D015684 pol Gene Products
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D009647 sjn
% 209.48/209.66 |- rdf__type mesh__D009647sskos__Concept
% 209.48/209.66 |- mesh__recordMaintainer mesh__D009647 ssb
% 209.48/209.66 |- skos__broader mesh__D009647smesh__D004837
% 209.48/209.66 |- mesh__historyNote mesh__D009647 66%28%63%29%
% 209.48/209.66 |- skos__broader mesh__D009647smesh__D009638
% 209.48/209.66 |- skos__prefLabel mesh__D009647 Normetanephrine
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D009647 66
% 209.48/209.66 |- skos__scopeNote mesh__D009647
% 209.48/209.66 A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.%A%
% 209.48/209.66 |- mesh__dateEstablished mesh__D009647 1966-01-01
% 209.48/209.66 |- mesh__dateRevised mesh__D009647 2005-06-30
% 209.48/209.66 |- skos__hiddenLabel mesh__D009647 3 Methoxynoradrenaline
% 209.48/209.66 |- skos__altLabel mesh__D009647 Normetadrenaline
% 209.48/209.66 |- mesh__dateCreated mesh__D009647 1999-01-01
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D009647 2006
% 209.48/209.66 |- skos__altLabel mesh__D009647 3-Methoxynoradrenaline
% 209.48/209.66 |- skos__broader mesh__D009647smesh__D014408
% 209.48/209.66 |- mesh__recordOriginator mesh__D009647 NLM
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D001664
% 209.48/209.66 91; was see under BILIRUBIN 1976-90
% 209.48/209.66 |- rdf__type mesh__D001664sskos__Concept
% 209.48/209.66 |- mesh__recordOriginator mesh__D001664 RLS
% 209.48/209.66 |- skos__hiddenLabel mesh__D001664 IX alpha, Biliverdin
% 209.48/209.66 |- skos__historyNote mesh__D001664 Bilirubin %28%1969-1975%29%
% 209.48/209.66 |- mesh__dateRevised mesh__D001664 2005-07-30
% 209.48/209.66 |- skos__hiddenLabel mesh__D001664 IX, Biliverdin
% 209.48/209.66 |- skos__hiddenLabel mesh__D001664 alpha, Biliverdin IX
% 209.48/209.66 |- mesh__recordMaintainer mesh__D001664 jls
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D001664 2006A
% 209.48/209.66 |- skos__altLabel mesh__D001664 Biliverdin
% 209.48/209.66 |- mesh__dateEstablished mesh__D001664 1991-01-01
% 209.48/209.66 |- skos__prefLabel mesh__D001664 Biliverdine
% 209.48/209.66 |- skos__scopeNote mesh__D001664
% 209.48/209.66 1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinylbilenone. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of amphibia and of birds, but not in normal human bile or serum.%A%
% 209.48/209.66 |- skos__annotation mesh__D001664
% 209.48/209.66 a bile pigment in amphibia %26% birds but not in normal human bile; /biosyn /physiol permitted%A%
% 209.48/209.66 |- skos__altLabel mesh__D001664 Uteroverdine
% 209.48/209.66 |- skos__altLabel mesh__D001664 Ooecyan
% 209.48/209.66 |- skos__altLabel mesh__D001664 Dehydrobilirubin
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D001664 2006
% 209.48/209.66 |- mesh__dateCreated mesh__D001664 1975-07-18
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D001664 jls
% 209.48/209.66 |- skos__broader mesh__D001664smesh__D001663
% 209.48/209.66 |- mesh__historyNote mesh__D001664
% 209.48/209.66 91%28%76%29%; was see under BILIRUBIN 1976-90
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 1999
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 2002
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 1998
% 209.48/209.66 |- skos__broader mesh__D019277smesh__D013816
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 2004
% 209.48/209.66 |- skos__prefLabel mesh__D019277 Entropy
% 209.48/209.66 |- mesh__dateEstablished mesh__D019277 1997-01-01
% 209.48/209.66 |- mesh__historyNote mesh__D019277 97
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 2001
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D019277 97
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 2003
% 209.48/209.66 |- skos__hiddenLabel mesh__D019277 Entropies
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 1997
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 2000
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 2006
% 209.48/209.66 |- skos__scopeNote mesh__D019277
% 209.48/209.66 The measure of that part of the heat or energy of a system which is not available to perform work. Entropy increases in all natural %28%spontaneous and irreversible%29% processes. %28%From Dorland, 28th ed%29%%A%
% 209.48/209.66 |- rdf__type mesh__D019277sskos__Concept
% 209.48/209.66 |- mesh__dateCreated mesh__D019277 1996-06-10
% 209.48/209.66 |- skos__annotation mesh__D019277
% 209.48/209.66 a principle of thermodynamics wherein %22%heat or energy of a system is not available to perform work%22%; no qualif%A%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D019277 2005
% 209.48/209.66 |- skos__historyNote mesh__D019277 Thermodynamics %28%1966-1996%29%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D011294 2006
% 209.48/209.66 |- skos__historyNote mesh__D011294 Propylamines %28%1966-1974%29%
% 209.48/209.66 |- skos__hiddenLabel mesh__D011294 A Ba C 50,005
% 209.48/209.66 |- mesh__dateEstablished mesh__D011294 1987-01-01
% 209.48/209.66 |- mesh__recordOriginator mesh__D011294 RLS
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D011294 87
% 209.48/209.66 |- skos__hiddenLabel mesh__D011294 H8062
% 209.48/209.66 |- mesh__dateCreated mesh__D011294 1986-06-12
% 209.48/209.66 |- skos__hiddenLabel mesh__D011294 Hydrochloride, Prenalterol
% 209.48/209.66 |- mesh__recordMaintainer mesh__D011294 ssb
% 209.48/209.66 |- rdf__type mesh__D011294sskos__Concept
% 209.48/209.66 |- skos__prefLabel mesh__D011294 Prenalterol
% 209.48/209.66 |- skos__broader mesh__D011294smesh__D050198
% 209.48/209.66 |- skos__historyNote mesh__D011294
% 209.48/209.66 Practolol/analogs and derivatives %28%1975-1986%29%
% 209.48/209.66 |- skos__hiddenLabel mesh__D011294 ABaC50,005
% 209.48/209.66 |- skos__broader mesh__D011294smesh__D011412
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D011294 sjn
% 209.48/209.66 |- skos__hiddenLabel mesh__D011294 KWD2033
% 209.48/209.66 |- skos__hiddenLabel mesh__D011294 H13322
% 209.48/209.66 |- skos__scopeNote mesh__D011294
% 209.48/209.66 A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. It is effective in the treatment of acute cardiac failure, postmyocardial infarction low-output syndrome, shock, and reducing orthostatic hypotension in the Shy-Drager syndrome.%A%
% 209.48/209.66 |- mesh__historyNote mesh__D011294 87
% 209.48/209.66 |- mesh__dateRevised mesh__D011294 2005-06-30
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 1999
% 209.48/209.66 |- mesh__dateCreated mesh__D005257 1999-01-01
% 209.48/209.66 |- skos__prefLabel mesh__D005257 Fellowships and Scholarships
% 209.48/209.66 |- skos__scopeNote mesh__D005257
% 209.48/209.66 Stipends or grants-in-aid granted by foundations or institutions to individuals for study.%A%
% 209.48/209.66 |- skos__hiddenLabel mesh__D005257 Scholarships and Fellowships
% 209.48/209.66 |- mesh__dateEstablished mesh__D005257 1979-01-01
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 2006
% 209.48/209.66 |- skos__hiddenLabel mesh__D005257 Fellowship
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 1998
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 2002
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 1997
% 209.48/209.66 |- mesh__onlineNote mesh__D005257
% 209.48/209.66 to search SCHOLARSHIPS %26% FELLOWSHIPS use FELLOWSHIPS AND SCHOLARSHIPS 1975-78 %26% TRAINING SUPPORT 1966-74%A%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 2005
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 2004
% 209.48/209.66 |- mesh__recordOriginator mesh__D005257 NLM
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 1996
% 209.48/209.66 |- skos__historyNote mesh__D005257 Training Support %28%1966-1974%29%
% 209.48/209.66 |- skos__annotation mesh__D005257
% 209.48/209.66 SPEC qualif; specify agency or govt %26% geog if possible; DF: FELLOWSHIPS%A%
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 2003
% 209.48/209.66 |- mesh__dateRevised mesh__D005257 1995-05-18
% 209.48/209.66 |- mesh__recordMaintainer mesh__D005257 TAP
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D005257 PLS
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 2001
% 209.48/209.66 |- skos__hiddenLabel mesh__D005257 Scholarship
% 209.48/209.66 |- rdf__type mesh__D005257sskos__Concept
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D005257 2000
% 209.48/209.66 |- skos__broader mesh__D005257smesh__D014146
% 209.48/209.66 |- mesh__historyNote mesh__D005257
% 209.48/209.66 79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS %26% SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78%A%
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D005257
% 209.48/209.66 79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS %26% SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78%A%
% 209.48/209.66 |- skos__hiddenLabel mesh__D015685 Fused Protein, gag-pol
% 209.48/209.66 |- skos__hiddenLabel mesh__D015685 Fusion Proteins, gag pol
% 209.48/209.66 |- skos__altLabel mesh__D015685 gag-pol Fusion Proteins
% 209.48/209.66 |- mesh__dateCreated mesh__D015685 1989-07-07
% 209.48/209.66 |- mesh__recordMaintainer mesh__D015685 SYSTEM
% 209.48/209.66 |- mesh__dateEstablished mesh__D015685 1991-01-01
% 209.48/209.66 |- skos__broader mesh__D015685smesh__D015683
% 209.48/209.66 |- skos__scopeNote mesh__D015685
% 209.48/209.66 Polyprotein products of a fused portion of retroviral mRNA containing the gag and pol genes. The polyprotein is synthesized only five percent of the time since pol is out of frame with gag, and is generated by ribosomal frameshifting.%A%
% 209.48/209.66 |- skos__prefLabel mesh__D015685 Fusion Proteins, gag-pol
% 209.48/209.66 |- skos__annotation mesh__D015685 coord with specific virus %28%IM%29%
% 209.48/209.66 |- rdf__type mesh__D015685sskos__Concept
% 209.48/209.66 |- mesh__onlineNote mesh__D015685
% 209.48/209.66 use GENE PRODUCTS, GAG to search GAG-POL FUSION PROTEINS 1990%A%
% 209.48/209.66 |- mesh__recordAuthorizer mesh__D015685 sjn
% 209.48/209.66 |- skos__hiddenLabel mesh__D015685 gag pol Protein
% 209.48/209.66 |- skos__hiddenLabel mesh__D015685 Proteins, gag-pol Fusion
% 209.48/209.66 |- mesh__recordOriginator mesh__D015685 AGS
% 209.48/209.66 |- skos__historyNote mesh__D015685 Viral Proteins %28%1980-1985%29%
% 209.48/209.66 |- skos__hiddenLabel mesh__D015685 gag pol Fused Protein
% 209.48/209.66 |- skos__broader mesh__D015685smesh__D015684
% 209.48/209.66 |- skos__hiddenLabel mesh__D015685 Protein, gag-pol Fused
% 209.48/209.66 |- mesh__historyNote mesh__D015685
% 209.48/209.66 91%28%90%29%; was GAG-POL FUSION PROTEINS see under GENE PRODUCTS, GAG 1990%A%
% 209.48/209.66 |- skos__altLabel mesh__D015685 gag-pol Fused Protein
% 209.48/209.66 |- skos__altLabel mesh__D015685 gag-pol Protein
% 209.48/209.66 |- mesh__publicMeSHNote mesh__D015685
% 209.48/209.66 91; was GAG-POL FUSION PROTEINS see under GENE PRODUCTS, GAG 1990%A%
% 209.48/209.66 |- skos__hiddenLabel mesh__D015685 gag pol Fusion Proteins
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D015685 2006
% 209.48/209.66 |- mesh__dateRevised mesh__D015685 2005-06-30
% 209.48/209.66 |- skos__historyNote mesh__D015685 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.66 |- skos__hiddenLabel mesh__D015685 Protein, gag-pol
% 209.48/209.66 |- mesh__activeMeSHYear mesh__D001665 2003
% 209.48/209.66 |- skos__altLabel mesh__D001665 Reactive Site
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Binding Site
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 2002
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 1997
% 209.48/209.67 |- skos__altLabel mesh__D001665 Combining Site
% 209.48/209.67 |- skos__related mesh__D001665smesh__D011485
% 209.48/209.67 |- skos__prefLabel mesh__D001665 Binding Sites
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Sites, Combining
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 2004
% 209.48/209.67 |- rdf__type mesh__D001665sskos__Concept
% 209.48/209.67 |- mesh__historyNote mesh__D001665 68
% 209.48/209.67 |- mesh__dateRevised mesh__D001665 2005-07-28
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Site, Reactive
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 1998
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Reactive Sites
% 209.48/209.67 |- mesh__dateEstablished mesh__D001665 1968-01-01
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Site, Combining
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 2005
% 209.48/209.67 |- skos__annotation mesh__D001665
% 209.48/209.67 NIM; note category; restrict to site of binding: do not use as substitute for chem or metab mechanism of binding; do not coord with receptors terms unless the site of binding is particularly discussed%A%
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 1999
% 209.48/209.67 |- skos__scopeNote mesh__D001665
% 209.48/209.67 The reactive parts of a macromolecule that directly participate in its specific combination with another molecule.%A%
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 2006A
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 2000
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 2006
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Sites, Active
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Site, Binding
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Site, Active
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Combining Sites
% 209.48/209.67 |- mesh__dateCreated mesh__D001665 1999-01-01
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 2001
% 209.48/209.67 |- mesh__recordMaintainer mesh__D001665 ags
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D001665 68
% 209.48/209.67 |- mesh__recordOriginator mesh__D001665 NLM
% 209.48/209.67 |- skos__historyNote mesh__D001665 Enzymes %28%1966-1967%29%
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001665 1996
% 209.48/209.67 |- skos__historyNote mesh__D001665
% 209.48/209.67 Antigen-Antibody Reactions %28%1966-1967%29%
% 209.48/209.67 |- skos__related mesh__D001665smesh__D011956
% 209.48/209.67 |- skos__broader mesh__D001665smesh__D001669
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Sites, Binding
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Active Sites
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D001665 ags
% 209.48/209.67 |- skos__hiddenLabel mesh__D001665 Sites, Reactive
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D034041 2005
% 209.48/209.67 |- mesh__dateEstablished mesh__D034041 2003-01-01
% 209.48/209.67 |- rdf__type mesh__D034041sskos__Concept
% 209.48/209.67 |- mesh__historyNote mesh__D034041 2003
% 209.48/209.67 |- skos__prefLabel mesh__D034041 Monomeric Clathrin Assembly Proteins
% 209.48/209.67 |- mesh__dateCreated mesh__D034041 2002-07-03
% 209.48/209.67 |- skos__broader mesh__D034041smesh__D033942
% 209.48/209.67 |- skos__scopeNote mesh__D034041
% 209.48/209.67 A subclass of clathrin assembly proteins that occur as monomers.%A%
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D034041 2003
% 209.48/209.67 |- skos__altLabel mesh__D034041 Monomeric Clathrin Adaptor Proteins
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D034041 2004
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D034041 2006
% 209.48/209.67 |- skos__altLabel mesh__D034041 Clathrin Assembly Proteins, Monomeric
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D034041 2003
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D006350 65
% 209.48/209.67 |- mesh__dateEstablished mesh__D006350 1965-01-01
% 209.48/209.67 |- mesh__recordMaintainer mesh__D006350 jls
% 209.48/209.67 |- skos__hiddenLabel mesh__D006350 Heart Valve Prostheses
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D006350 2005
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D006350 jls
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D006350 2002
% 209.48/209.67 |- skos__hiddenLabel mesh__D006350 Valve Prosthesis, Heart
% 209.48/209.67 |- skos__prefLabel mesh__D006350 Heart Valve Prosthesis
% 209.48/209.67 |- skos__annotation mesh__D006350
% 209.48/209.67 coord IM with specific valve %28%IM%29%; for bioprostheses coord IM with BIOPROSTHESIS %28%IM%29% %26% do not specify source of biol material unless especially discussed%A%
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D006350 2004
% 209.48/209.67 |- mesh__historyNote mesh__D006350 65
% 209.48/209.67 |- skos__hiddenLabel mesh__D006350 Prostheses, Heart Valve
% 209.48/209.67 |- skos__altLabel mesh__D006350 Prosthesis, Heart Valve
% 209.48/209.67 |- skos__broader mesh__D006350smesh__D019736
% 209.48/209.67 |- rdf__type mesh__D006350sskos__Concept
% 209.48/209.67 |- skos__hiddenLabel mesh__D006350 Valve Prostheses, Cardiac
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D006350 2003
% 209.48/209.67 |- skos__hiddenLabel mesh__D006350 Valve Prosthesis, Cardiac
% 209.48/209.67 |- mesh__dateRevised mesh__D006350 2005-07-30
% 209.48/209.67 |- skos__hiddenLabel mesh__D006350 Prosthesis, Cardiac Valve
% 209.48/209.67 |- skos__hiddenLabel mesh__D006350 Prostheses, Cardiac Valve
% 209.48/209.67 |- skos__hiddenLabel mesh__D006350 Valve Prostheses, Heart
% 209.48/209.67 |- skos__related mesh__D006350smesh__D019918
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D006350 2006A
% 209.48/209.67 |- mesh__recordOriginator mesh__D006350 NLM
% 209.48/209.67 |- skos__altLabel mesh__D006350 Cardiac Valve Prosthesis
% 209.48/209.67 |- skos__hiddenLabel mesh__D006350 Cardiac Valve Prostheses
% 209.48/209.67 |- mesh__dateCreated mesh__D006350 1999-01-01
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D006350 2006
% 209.48/209.67 |- skos__scopeNote mesh__D006350
% 209.48/209.67 A device that substitutes for a heart valve. It may be composed of biological material %28%BIOPROSTHESIS%29% and/or synthetic material.%A%
% 209.48/209.67 |- mesh__dateCreated mesh__D019278 1996-06-10
% 209.48/209.67 |- skos__altLabel mesh__D019278 Stromelysin
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D019278
% 209.48/209.67 97; STROMELYSIN 1 was indexed under METALLOPROTEINASES 1988-96 %26% PEPTIDE PEPTIDOHYDROLASES 1985-87%A%
% 209.48/209.67 |- mesh__recordOriginator mesh__D019278 TPW
% 209.48/209.67 |- skos__altLabel mesh__D019278 Transin
% 209.48/209.67 |- skos__hiddenLabel mesh__D019278 Metalloproteinase 3, Matrix
% 209.48/209.67 |- mesh__recordMaintainer mesh__D019278 sjn
% 209.48/209.67 |- skos__altLabel mesh__D019278 Matrix Metalloproteinase 3
% 209.48/209.67 |- skos__scopeNote mesh__D019278
% 209.48/209.67 An extracellular endopeptidase of vertebrate tissues similar to INTERSTITIAL COLLAGENASE. It digests proteoglycan, fibronectin, collagen types III, IV, V, and IX, and activates procollagenase. %28%Enzyme Nomenclature, 1992%29% EC 3.4.24.17.%A%
% 209.48/209.67 |- skos__historyNote mesh__D019278 Metalloendopeptidases %28%1988-1996%29%
% 209.48/209.67 |- mesh__historyNote mesh__D019278
% 209.48/209.67 97; was STROMELYSIN 1 %28%NM%29% 1985-96
% 209.48/209.67 |- mesh__dateRevised mesh__D019278 2004-07-13
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D019278 2006
% 209.48/209.67 |- rdf__type mesh__D019278sskos__Concept
% 209.48/209.67 |- skos__annotation mesh__D019278
% 209.48/209.67 /antag is permitted but TISSUE INHIBITOR OF METALLOPROTEINASE-3 is available%A%
% 209.48/209.67 |- mesh__dateEstablished mesh__D019278 1997-01-01
% 209.48/209.67 |- mesh__onlineNote mesh__D019278
% 209.48/209.67 use STROMELYSIN 1 %28%NM%29% to search STROMELYSIN 1 1985-96
% 209.48/209.67 |- skos__prefLabel mesh__D019278 Stromelysin 1
% 209.48/209.67 |- skos__broader mesh__D019278smesh__D020782
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D019278 2005
% 209.48/209.67 |- skos__historyNote mesh__D019278
% 209.48/209.67 Peptide Peptidohydrolases %28%1985-1987%29%
% 209.48/209.67 |- skos__altLabel mesh__D019278 MMP-3
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D019278 sjn
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011295 2002
% 209.48/209.67 |- skos__hiddenLabel mesh__D011295 Care, Prenatal
% 209.48/209.67 |- mesh__recordOriginator mesh__D011295 NLM
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011295 2006
% 209.48/209.67 |- skos__scopeNote mesh__D011295
% 209.48/209.67 Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.%A%
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011295 1999
% 209.48/209.67 |- skos__prefLabel mesh__D011295 Prenatal Care
% 209.48/209.67 |- mesh__recordMaintainer mesh__D011295 PXP
% 209.48/209.67 |- mesh__dateRevised mesh__D011295 1997-06-20
% 209.48/209.67 |- skos__broader mesh__D011295smesh__D008427
% 209.48/209.67 |- skos__annotation mesh__D011295 check tags FEMALE %26% PREGNANCY
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011295 2000
% 209.48/209.67 |- rdf__type mesh__D011295sskos__Concept
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011295 2001
% 209.48/209.67 |- mesh__dateCreated mesh__D011295 1999-01-01
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011295 2003
% 209.48/209.67 |- skos__broader mesh__D011295smesh__D005791
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011295 2005
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D011295 SJN
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011295 1998
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011295 2004
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 2001
% 209.48/209.67 |- skos__hiddenLabel mesh__D005258 Felty Syndrome
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 2003
% 209.48/209.67 |- skos__hiddenLabel mesh__D005258 Feltys Syndrome
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 2000
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 1995
% 209.48/209.67 |- skos__annotation mesh__D005258 a type of rheum arthritis
% 209.48/209.67 |- rdf__type mesh__D005258sskos__Concept
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 1993
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 1994
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 2002
% 209.48/209.67 |- mesh__dateRevised mesh__D005258 1992-05-20
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 1999
% 209.48/209.67 |- skos__scopeNote mesh__D005258
% 209.48/209.67 A combination of rheumatoid arthritis, splenomegaly, leukopenia, pigmented spots on lower extremities, and other evidence of hypersplenism %28%anemia and thrombocytopenia%29%. %28%From Dorland, 27th ed%29%%A%
% 209.48/209.67 |- mesh__dateCreated mesh__D005258 1999-01-01
% 209.48/209.67 |- mesh__recordMaintainer mesh__D005258 PLS
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 2006
% 209.48/209.67 |- skos__broader mesh__D005258smesh__D001172
% 209.48/209.67 |- skos__hiddenLabel mesh__D005258 Syndrome, Felty%27%s
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 1997
% 209.48/209.67 |- mesh__recordOriginator mesh__D005258 NLM
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 1998
% 209.48/209.67 |- skos__prefLabel mesh__D005258 Felty%27%s Syndrome
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 2004
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 2005
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D005258 PLS
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D005258 1996
% 209.48/209.67 |- mesh__dateRevised mesh__D015686 2005-06-30
% 209.48/209.67 |- skos__historyNote mesh__D015686 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.67 |- skos__hiddenLabel mesh__D015686 Products, env Gene
% 209.48/209.67 |- skos__altLabel mesh__D015686 env Antigens
% 209.48/209.67 |- skos__scopeNote mesh__D015686
% 209.48/209.67 Retroviral proteins, often glycosylated, coded by the envelope %28%env%29% gene. They are usually synthesized as protein precursors %28%POLYPROTEINS%29% and later cleaved into the final viral envelope glycoproteins by a viral protease.%A%
% 209.48/209.67 |- mesh__dateCreated mesh__D015686 1989-05-25
% 209.48/209.67 |- skos__broader mesh__D015686smesh__D014759
% 209.48/209.67 |- rdf__type mesh__D015686sskos__Concept
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D015686 90
% 209.48/209.67 |- skos__broader mesh__D015686smesh__D020815
% 209.48/209.67 |- mesh__historyNote mesh__D015686 90
% 209.48/209.67 |- skos__historyNote mesh__D015686 Viral Proteins %28%1977-1985%29%
% 209.48/209.67 |- skos__annotation mesh__D015686
% 209.48/209.67 Env stands for %22%envelope%22%; IM; coord with specific virus %28%IM%29%%A%
% 209.48/209.67 |- skos__historyNote mesh__D015686
% 209.48/209.67 Viral Envelope Proteins %28%1984-1989%29%
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D015686 2006
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D015686 sjn
% 209.48/209.67 |- skos__altLabel mesh__D015686 env Polyprotein
% 209.48/209.67 |- skos__altLabel mesh__D015686 env Gene Products
% 209.48/209.67 |- skos__historyNote mesh__D015686 Antigens, Viral %28%1977-1989%29%
% 209.48/209.67 |- skos__hiddenLabel mesh__D015686 Polyprotein, env
% 209.48/209.67 |- skos__altLabel mesh__D015686 env Protein
% 209.48/209.67 |- skos__broader mesh__D015686smesh__D012191
% 209.48/209.67 |- mesh__recordOriginator mesh__D015686 AGS
% 209.48/209.67 |- skos__altLabel mesh__D015686 env Polyproteins
% 209.48/209.67 |- mesh__dateEstablished mesh__D015686 1990-01-01
% 209.48/209.67 |- skos__historyNote mesh__D015686 Antigens, Surface %28%1979-1989%29%
% 209.48/209.67 |- skos__hiddenLabel mesh__D015686 Protein, env
% 209.48/209.67 |- skos__hiddenLabel mesh__D015686 Glycoproteins, env
% 209.48/209.67 |- skos__hiddenLabel mesh__D015686 Polyproteins, env
% 209.48/209.67 |- skos__hiddenLabel mesh__D015686 Antigens, env
% 209.48/209.67 |- skos__prefLabel mesh__D015686 Gene Products, env
% 209.48/209.67 |- mesh__recordMaintainer mesh__D015686 SYSTEM
% 209.48/209.67 |- rdf__type mesh__D009649sskos__Concept
% 209.48/209.67 |- mesh__historyNote mesh__D009649 75; was see under NORPREGNANES 1974
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D009649
% 209.48/209.67 75; was see under NORPREGNANES 1974
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 2003
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 2001
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 1994
% 209.48/209.67 |- skos__scopeNote mesh__D009649
% 209.48/209.67 Pregnadienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.%A%
% 209.48/209.67 |- skos__broader mesh__D009649smesh__D009650
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 1999
% 209.48/209.67 |- mesh__recordOriginator mesh__D009649 NLM
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D009649 PLS
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 2000
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 1997
% 209.48/209.67 |- mesh__dateRevised mesh__D009649 1993-06-03
% 209.48/209.67 |- mesh__onlineNote mesh__D009649 search NORPREGNANES 1974
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 1998
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 2006
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 2002
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 1996
% 209.48/209.67 |- skos__prefLabel mesh__D009649 Norpregnadienes
% 209.48/209.67 |- mesh__dateCreated mesh__D009649 1999-01-01
% 209.48/209.67 |- mesh__recordMaintainer mesh__D009649 PLS
% 209.48/209.67 |- mesh__dateEstablished mesh__D009649 1975-09-01
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 2004
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 2005
% 209.48/209.67 |- skos__historyNote mesh__D009649 Norpregnanes %28%1974%29%
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D009649 1995
% 209.48/209.67 |- skos__related mesh__D001666smesh__D000915
% 209.48/209.67 |- mesh__recordMaintainer mesh__D001666 ssb
% 209.48/209.67 |- skos__altLabel mesh__D001666 Paratopes
% 209.48/209.67 |- skos__hiddenLabel mesh__D001666 Binding Site, Antibody
% 209.48/209.67 |- skos__historyNote mesh__D001666 Antigens %28%1966-1972%29%
% 209.48/209.67 |- skos__broader mesh__D001666smesh__D000906
% 209.48/209.67 |- skos__prefLabel mesh__D001666 Binding Sites, Antibody
% 209.48/209.67 |- mesh__dateRevised mesh__D001666 2005-06-30
% 209.48/209.67 |- skos__broader mesh__D001666smesh__D001665
% 209.48/209.67 |- mesh__dateCreated mesh__D001666 1999-01-01
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D001666 73
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D001666 2006
% 209.48/209.67 |- skos__historyNote mesh__D001666 Antibodies %28%1966-1972%29%
% 209.48/209.67 |- skos__hiddenLabel mesh__D001666 Antibody Binding Site
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D001666 sjn
% 209.48/209.67 |- mesh__dateEstablished mesh__D001666 1973-01-01
% 209.48/209.67 |- mesh__recordOriginator mesh__D001666 NLM
% 209.48/209.67 |- skos__altLabel mesh__D001666 Antibody Binding Sites
% 209.48/209.67 |- rdf__type mesh__D001666sskos__Concept
% 209.48/209.67 |- skos__scopeNote mesh__D001666
% 209.48/209.67 Local surface sites on antibodies which react with antigen determinant sites on antigens. They are formed from parts of the variable regions of FAB FRAGMENTS.%A%
% 209.48/209.67 |- skos__historyNote mesh__D001666 Binding Sites %28%1968-1972%29%
% 209.48/209.67 |- skos__broader mesh__D001666smesh__D000937
% 209.48/209.67 |- mesh__historyNote mesh__D001666 73; was in Cat D only 1973-76
% 209.48/209.67 |- skos__hiddenLabel mesh__D001666 Paratope
% 209.48/209.67 |- skos__annotation mesh__D020820
% 209.48/209.67 DYSKINESIA SYNDROMES see MOVEMENT DISORDERS is also available%A%
% 209.48/209.67 |- skos__hiddenLabel mesh__D020820 Abnormal Movement
% 209.48/209.67 |- mesh__recordMaintainer mesh__D020820 ags
% 209.48/209.67 |- skos__broader mesh__D020820smesh__D009461
% 209.48/209.67 |- skos__hiddenLabel mesh__D020820 Dyskinesia
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020820 2003
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020820 2000
% 209.48/209.67 |- skos__prefLabel mesh__D020820 Dyskinesias
% 209.48/209.67 |- mesh__recordOriginator mesh__D020820 KEV
% 209.48/209.67 |- skos__hiddenLabel mesh__D020820 Movement, Abnormal
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020820 2004
% 209.48/209.67 |- mesh__dateRevised mesh__D020820 1999-11-19
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020820 2005
% 209.48/209.67 |- mesh__historyNote mesh__D020820 2000
% 209.48/209.67 |- skos__altLabel mesh__D020820 Abnormal Movements
% 209.48/209.67 |- rdf__type mesh__D020820sskos__Concept
% 209.48/209.67 |- skos__related mesh__D020820smesh__D009069
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020820 2001
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020820 2006
% 209.48/209.67 |- skos__hiddenLabel mesh__D020820 Movement, Involuntary
% 209.48/209.67 |- skos__historyNote mesh__D020820 Movement Disorders %28%1966-1999%29%
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020820 2000A
% 209.48/209.67 |- skos__scopeNote mesh__D020820
% 209.48/209.67 Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes %28%see MOVEMENT DISORDERS%29%. Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.%A%
% 209.48/209.67 |- skos__altLabel mesh__D020820 Hemiballism
% 209.48/209.67 |- skos__hiddenLabel mesh__D020820 Movements, Abnormal
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D020820 2000
% 209.48/209.67 |- skos__hiddenLabel mesh__D020820 Involuntary Movement
% 209.48/209.67 |- mesh__dateCreated mesh__D020820 1999-11-05
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D020820 ags
% 209.48/209.67 |- skos__hiddenLabel mesh__D020820 Movements, Involuntary
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020820 2002
% 209.48/209.67 |- mesh__dateEstablished mesh__D020820 2000-01-01
% 209.48/209.67 |- skos__hiddenLabel mesh__D006351 Cardiac Valve
% 209.48/209.67 |- skos__hiddenLabel mesh__D006351 Valve, Cardiac
% 209.48/209.67 |- rdf__type mesh__D006351sskos__Concept
% 209.48/209.67 |- mesh__recordMaintainer mesh__D006351 nns
% 209.48/209.67 |- mesh__recordOriginator mesh__D006351 NLM
% 209.48/209.67 |- skos__hiddenLabel mesh__D006351 Valve, Heart
% 209.48/209.67 |- skos__annotation mesh__D006351 GEN or unspecified: prefer specifics
% 209.48/209.67 |- skos__prefLabel mesh__D006351 Heart Valves
% 209.48/209.67 |- mesh__dateRevised mesh__D006351 2003-07-09
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D006351 sjn
% 209.48/209.67 |- skos__hiddenLabel mesh__D006351 Valves, Cardiac
% 209.48/209.67 |- mesh__dateCreated mesh__D006351 1999-01-01
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D006351 2006
% 209.48/209.67 |- skos__broader mesh__D006351smesh__D006321
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D006351 2005
% 209.48/209.67 |- skos__scopeNote mesh__D006351
% 209.48/209.67 Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles.%A%
% 209.48/209.67 |- skos__hiddenLabel mesh__D006351 Valves, Heart
% 209.48/209.67 |- skos__hiddenLabel mesh__D006351 Heart Valve
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D006351 2004
% 209.48/209.67 |- skos__altLabel mesh__D006351 Cardiac Valves
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020022 2003
% 209.48/209.67 |- mesh__recordMaintainer mesh__D020022 KEV
% 209.48/209.67 |- skos__historyNote mesh__D020022
% 209.48/209.67 specific disease/genetics %28%1966-1998%29%
% 209.48/209.67 |- skos__altLabel mesh__D020022 Predisposition, Genetic
% 209.48/209.67 |- skos__hiddenLabel mesh__D020022 Genetic Predispositions
% 209.48/209.67 |- skos__related mesh__D020022smesh__D005820
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D020022 99
% 209.48/209.67 |- mesh__historyNote mesh__D020022 99
% 209.48/209.67 |- rdf__type mesh__D020022sskos__Concept
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020022 2006
% 209.48/209.67 |- skos__prefLabel mesh__D020022 Genetic Predisposition to Disease
% 209.48/209.67 |- skos__hiddenLabel mesh__D020022 Genetic Susceptibilities
% 209.48/209.67 |- skos__altLabel mesh__D020022 Genetic Susceptibility
% 209.48/209.67 |- mesh__dateCreated mesh__D020022 1998-06-10
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020022 2005
% 209.48/209.67 |- skos__broader mesh__D020022smesh__D004198
% 209.48/209.67 |- skos__broader mesh__D020022smesh__D005838
% 209.48/209.67 |- skos__scopeNote mesh__D020022
% 209.48/209.67 A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.%A%
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D020022 sjn
% 209.48/209.67 |- mesh__recordOriginator mesh__D020022 AGS
% 209.48/209.67 |- mesh__dateRevised mesh__D020022 2002-07-03
% 209.48/209.67 |- mesh__dateEstablished mesh__D020022 1999-01-01
% 209.48/209.67 |- skos__hiddenLabel mesh__D020022 Predispositions, Genetic
% 209.48/209.67 |- skos__altLabel mesh__D020022 Genetic Predisposition
% 209.48/209.67 |- skos__annotation mesh__D020022
% 209.48/209.67 latent susceptibility to dis only: coord with specific dis/genet; for positive genetic predisposition %28%like longevity%29% use specific trait/genet%A%
% 209.48/209.67 |- skos__hiddenLabel mesh__D020022 Susceptibilities, Genetic
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D020022 2004
% 209.48/209.67 |- skos__altLabel mesh__D020022 Susceptibility, Genetic
% 209.48/209.67 |- skos__altLabel mesh__D047768
% 209.48/209.67 Inositol 1,2-Cyclic Phosphate 2-Phosphohydrolase
% 209.48/209.67 |- skos__historyNote mesh__D047768 Annexin A3 %28%1980-2004%29%
% 209.48/209.67 |- skos__hiddenLabel mesh__D047768
% 209.48/209.67 1,2 Cyclic Inositol Phosphate Phosphodiesterase
% 209.48/209.67 |- mesh__recordOriginator mesh__D047768 jmp
% 209.48/209.67 |- skos__hiddenLabel mesh__D047768
% 209.48/209.67 Phosphodiesterase, 1,2-Cyclic-Inositol-Phosphate
% 209.48/209.67 |- skos__hiddenLabel mesh__D047768
% 209.48/209.67 Inositolphosphodiesterase, Glycerophosphoinositol
% 209.48/209.67 |- skos__altLabel mesh__D047768
% 209.48/209.67 1,2-Cyclic Inositolphosphate Phosphodiesterase
% 209.48/209.67 |- mesh__dateCreated mesh__D047768 2004-07-07
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D047768 2006
% 209.48/209.67 |- skos__scopeNote mesh__D047768
% 209.48/209.67 A phosphoric diester hydrolase with specificity for the cleavage of GLYCEROL from 1-%28%sn-glycero-3-phospho%29%-1D-myo-inositol. It also has specificity for hydrolysis of the cyclic phosphate bond in inositol 1,2-cyclic phosphate%A%
% 209.48/209.67 |- skos__hiddenLabel mesh__D047768
% 209.48/209.67 Inositolphosphate Phosphodiesterase, 1,2-Cyclic
% 209.48/209.67 |- rdf__type mesh__D047768sskos__Concept
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D047768 2005
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D047768
% 209.48/209.67 2005; for 1,2-CYCLIC INOSITOLPHOSPHATE PHOSPHODIESTERASE; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE; %26% INOSITOL 1,2-CYCLIC PHOSPHATE 2-PHOSPHOHYDROLASE see ANNEXIN A3 1980-2004; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE was indexed under PHOSPHODIESTERASES 1973-1992%A%
% 209.48/209.67 |- mesh__historyNote mesh__D047768
% 209.48/209.67 2005%28%1993%29%; for 1,2-CYCLIC INOSITOLPHOSPHATE PHOSPHODIESTERASE; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE; %26% INOSITOL 1,2-CYCLIC PHOSPHATE 2-PHOSPHOHYDROLASE use ANNEXIN A3 1980-2004%A%
% 209.48/209.67 |- skos__hiddenLabel mesh__D047768
% 209.48/209.67 1,2 Cyclic Inositolphosphate Phosphodiesterase
% 209.48/209.67 |- mesh__recordMaintainer mesh__D047768 jmp
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D047768 sjn
% 209.48/209.67 |- skos__broader mesh__D047768smesh__D010727
% 209.48/209.67 |- skos__hiddenLabel mesh__D047768
% 209.48/209.67 Inositol 1,2 Cyclic Phosphate 2 Phosphohydrolase
% 209.48/209.67 |- skos__prefLabel mesh__D047768
% 209.48/209.67 Glycerophosphoinositol Inositolphosphodiesterase
% 209.48/209.67 |- mesh__dateEstablished mesh__D047768 2005-01-01
% 209.48/209.67 |- skos__hiddenLabel mesh__D047768
% 209.48/209.67 Phosphodiesterase, 1,2-Cyclic Inositolphosphate
% 209.48/209.67 |- skos__altLabel mesh__D047768
% 209.48/209.67 1,2-Cyclic-Inositol-Phosphate Phosphodiesterase
% 209.48/209.67 |- skos__annotation mesh__D019279 dent cements; D25-26 qualif
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D019279 97
% 209.48/209.67 |- mesh__dateEstablished mesh__D019279 1997-01-01
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D019279 2005
% 209.48/209.67 |- mesh__dateRevised mesh__D019279 2004-07-07
% 209.48/209.67 |- mesh__historyNote mesh__D019279 97
% 209.48/209.67 |- skos__historyNote mesh__D019279 Dental Cements %28%1974-1996%29%
% 209.48/209.67 |- mesh__dateCreated mesh__D019279 1996-06-10
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D019279 sjn
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D019279 2006
% 209.48/209.67 |- mesh__recordMaintainer mesh__D019279 jmp
% 209.48/209.67 |- skos__altLabel mesh__D019279 Resin Cement
% 209.48/209.67 |- skos__broader mesh__D019279smesh__D012117
% 209.48/209.67 |- rdf__type mesh__D019279sskos__Concept
% 209.48/209.67 |- skos__prefLabel mesh__D019279 Resin Cements
% 209.48/209.67 |- skos__scopeNote mesh__D019279
% 209.48/209.67 Dental cements composed either of polymethyl methacrylate or dimethacrylate, produced by mixing an acrylic monomer liquid with acrylic polymers and mineral fillers. The cement is insoluble in water and is thus resistant to fluids in the mouth, but is also irritating to the dental pulp. It is used chiefly as a luting agent for fabricated and temporary restorations. %28%Jablonski%27%s Dictionary of Dentistry, 1992, p159%29%%A%
% 209.48/209.67 |- mesh__recordOriginator mesh__D019279 TPW
% 209.48/209.67 |- skos__broader mesh__D019279smesh__D003738
% 209.48/209.67 |- skos__hiddenLabel mesh__D019279 Cements, Resin
% 209.48/209.67 |- skos__hiddenLabel mesh__D019279 Cement, Resin
% 209.48/209.67 |- skos__historyNote mesh__D011296 Amniocentesis %28%1971-1972%29%
% 209.48/209.67 |- skos__altLabel mesh__D011296 Diagnosis, Prenatal
% 209.48/209.67 |- skos__related mesh__D011296smesh__D005817
% 209.48/209.67 |- skos__altLabel mesh__D011296 Diagnosis, Antenatal
% 209.48/209.67 |- skos__hiddenLabel mesh__D011296 Diagnoses, Prenatal
% 209.48/209.67 |- mesh__publicMeSHNote mesh__D011296 73
% 209.48/209.67 |- mesh__recordMaintainer mesh__D011296 jrf
% 209.48/209.67 |- skos__hiddenLabel mesh__D011296 Diagnoses, Antenatal
% 209.48/209.67 |- mesh__recordOriginator mesh__D011296 NLM
% 209.48/209.67 |- skos__related mesh__D011296smesh__D033142
% 209.48/209.67 |- skos__hiddenLabel mesh__D011296 Prenatal Diagnoses
% 209.48/209.67 |- rdf__type mesh__D011296sskos__Concept
% 209.48/209.67 |- mesh__dateEstablished mesh__D011296 1973-01-01
% 209.48/209.67 |- mesh__recordAuthorizer mesh__D011296 sjn
% 209.48/209.67 |- mesh__dateRevised mesh__D011296 2002-07-02
% 209.48/209.67 |- skos__related mesh__D011296smesh__D019836
% 209.48/209.67 |- mesh__dateCreated mesh__D011296 1999-01-01
% 209.48/209.67 |- skos__historyNote mesh__D011296
% 209.48/209.67 specific disease or abnormality/diagnosis %28%1966-1972%29%
% 209.48/209.67 |- skos__hiddenLabel mesh__D011296 Intrauterine Diagnoses
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011296 2003
% 209.48/209.67 |- skos__altLabel mesh__D011296 Antenatal Diagnosis
% 209.48/209.67 |- skos__altLabel mesh__D011296 Intrauterine Diagnosis
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011296 2005
% 209.48/209.67 |- skos__hiddenLabel mesh__D011296 Diagnoses, Intrauterine
% 209.48/209.67 |- skos__annotation mesh__D011296
% 209.48/209.67 check tags FEMALE %26% PREGNANCY; if a fetal dis is discussed, coord IM with FETAL DISEASES %28%IM%29% or FETAL DISEASES %28%IM%29% + specific dis in the fetus %28%IM%29%%A%
% 209.48/209.67 |- mesh__activeMeSHYear mesh__D011296 2004
% 209.48/209.67 |- skos__hiddenLabel mesh__D011296 Antenatal Diagnoses
% 209.48/209.67 |- skos__prefLabel mesh__D011296 Prenatal Diagnosis
% 209.48/209.67 |- mesh__historyNote mesh__D011296 73
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D011296 2006
% 209.48/209.68 |- skos__scopeNote mesh__D011296
% 209.48/209.68 Determination of the nature of a pathological condition or disease in the postimplantation embryo, fetus, or pregnant female before birth.%A%
% 209.48/209.68 |- skos__broader mesh__D011296smesh__D003944
% 209.48/209.68 |- skos__altLabel mesh__D011296 Diagnosis, Intrauterine
% 209.48/209.68 |- mesh__historyNote mesh__D005259
% 209.48/209.68 91%28%79%29%; was see under LYPRESSIN 1979-90; was PHELYPRESSIN see under VASOPRESSIN 1965-78 %28%Prov 1965-74%29%%A%
% 209.48/209.68 |- skos__broader mesh__D005259smesh__D008236
% 209.48/209.68 |- skos__hiddenLabel mesh__D005259 Vasopressin, Phenylalanyl Lysyl
% 209.48/209.68 |- skos__altLabel mesh__D005259 Octapressin
% 209.48/209.68 |- rdf__type mesh__D005259sskos__Concept
% 209.48/209.68 |- mesh__dateRevised mesh__D005259 2005-06-30
% 209.48/209.68 |- skos__altLabel mesh__D005259 PLV-2
% 209.48/209.68 |- skos__altLabel mesh__D005259 Octopressin
% 209.48/209.68 |- mesh__dateCreated mesh__D005259 1999-01-01
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D005259
% 209.48/209.68 91; was see under LYPRESSIN 1979-90; was PHELYPRESSIN see under VASOPRESSIN 1975-78%A%
% 209.48/209.68 |- mesh__dateEstablished mesh__D005259 1991-01-01
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D005259 2006
% 209.48/209.68 |- skos__annotation mesh__D005259 a vasoconstrictor
% 209.48/209.68 |- skos__prefLabel mesh__D005259 Felypressin
% 209.48/209.68 |- skos__altLabel mesh__D005259 Phelypressin
% 209.48/209.68 |- skos__broader mesh__D005259smesh__D014667
% 209.48/209.68 |- mesh__recordAuthorizer mesh__D005259 sjn
% 209.48/209.68 |- skos__hiddenLabel mesh__D005259 Phenylalanyl-Lysyl Vasopressin
% 209.48/209.68 |- skos__hiddenLabel mesh__D005259 Lysine Vasopressin, Phenylalanine
% 209.48/209.68 |- mesh__recordMaintainer mesh__D005259 ssb
% 209.48/209.68 |- skos__altLabel mesh__D005259 Vasopressin, Phenylalanyl-Lysyl
% 209.48/209.68 |- skos__scopeNote mesh__D005259
% 209.48/209.68 Synthetic analog of LYPRESSIN with more vasoconstrictor than antidiuretic action. It is used as a hemostatic.%A%
% 209.48/209.68 |- skos__hiddenLabel mesh__D005259 Vasopressin, Phenylalanine Lysine
% 209.48/209.68 |- mesh__onlineNote mesh__D005259
% 209.48/209.68 use FELYPRESSIN to search PHELYPRESSIN 1966-78
% 209.48/209.68 |- skos__altLabel mesh__D005259 Phenylalanine Lysine Vasopressin
% 209.48/209.68 |- mesh__recordOriginator mesh__D005259 NLM
% 209.48/209.68 |- mesh__dateCreated mesh__D015687 1989-05-15
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Hypoxias, Cell
% 209.48/209.68 |- skos__prefLabel mesh__D015687 Cell Hypoxia
% 209.48/209.68 |- mesh__recordMaintainer mesh__D015687 JLS
% 209.48/209.68 |- skos__altLabel mesh__D015687 Cell Anoxia
% 209.48/209.68 |- mesh__recordOriginator mesh__D015687 PXP
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Cell Anoxias
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 2001
% 209.48/209.68 |- rdf__type mesh__D015687sskos__Concept
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 2006
% 209.48/209.68 |- skos__annotation mesh__D015687 NIM; not for micro-organisms
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Anoxia, Cell
% 209.48/209.68 |- skos__scopeNote mesh__D015687
% 209.48/209.68 A condition of decreased oxygen content at the cellular level.%A%
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Anoxias, Cell
% 209.48/209.68 |- skos__broader mesh__D015687smesh__D019069
% 209.48/209.68 |- skos__altLabel mesh__D015687 Hypoxia, Cellular
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 2000
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 2005
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 1999
% 209.48/209.68 |- skos__historyNote mesh__D015687 Oxygen %28%1985-1989%29%
% 209.48/209.68 |- skos__altLabel mesh__D015687 Anoxia, Cellular
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Hypoxia, Cell
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 2004
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Cellular Anoxia
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Cellular Anoxias
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Cellular Hypoxias
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 1998
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 1997
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 2003
% 209.48/209.68 |- mesh__dateRevised mesh__D015687 1995-06-05
% 209.48/209.68 |- skos__historyNote mesh__D015687 Anoxia %28%1968-1989%29%
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 2002
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Hypoxias, Cellular
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D015687 90
% 209.48/209.68 |- mesh__recordAuthorizer mesh__D015687 PLS
% 209.48/209.68 |- mesh__dateEstablished mesh__D015687 1990-01-01
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Cellular Hypoxia
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Cell Hypoxias
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015687 1996
% 209.48/209.68 |- mesh__historyNote mesh__D015687 90
% 209.48/209.68 |- skos__hiddenLabel mesh__D015687 Anoxias, Cellular
% 209.48/209.68 |- skos__hiddenLabel mesh__D034841 Cavities, Abdominal
% 209.48/209.68 |- skos__broader mesh__D034841smesh__D000005
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D034841 2006
% 209.48/209.68 |- rdf__type mesh__D034841sskos__Concept
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D034841 2004
% 209.48/209.68 |- skos__annotation mesh__D034841
% 209.48/209.68 prefer specifics; ABDOMEN is also available, use author%27%s language%A%
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D034841 2005
% 209.48/209.68 |- skos__scopeNote mesh__D034841
% 209.48/209.68 The region in the abdomen extending from the thoracic DIAPHRAGM to the plane of the superior pelvic aperture %28%pelvic inlet%29%. The abdominal cavity contains the PERITONEUM and abdominal VISCERA, as well as the extraperitoneal space which includes the RETROPERITONEAL SPACE.%A%
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D034841 2003
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D034841 2003
% 209.48/209.68 |- skos__hiddenLabel mesh__D034841 Cavity, Abdominal
% 209.48/209.68 |- skos__hiddenLabel mesh__D034841 Abdominal Cavities
% 209.48/209.68 |- mesh__dateEstablished mesh__D034841 2003-01-01
% 209.48/209.68 |- skos__prefLabel mesh__D034841 Abdominal Cavity
% 209.48/209.68 |- mesh__historyNote mesh__D034841 2003
% 209.48/209.68 |- skos__altLabel mesh__D034841 Cavitas abdominis
% 209.48/209.68 |- mesh__dateCreated mesh__D034841 2002-07-02
% 209.48/209.68 |- skos__historyNote mesh__D034841 Abdomen %28%1964-2002%29%
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D001667 1999
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D001667 73
% 209.48/209.68 |- mesh__recordOriginator mesh__D001667 NLM
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D001667 2002
% 209.48/209.68 |- mesh__dateCreated mesh__D001667 1999-01-01
% 209.48/209.68 |- mesh__dateRevised mesh__D001667 1998-06-10
% 209.48/209.68 |- mesh__recordMaintainer mesh__D001667 MSR
% 209.48/209.68 |- skos__hiddenLabel mesh__D001667 Bindings, Competitive
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D001667 2006
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D001667 2001
% 209.48/209.68 |- rdf__type mesh__D001667sskos__Concept
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D001667 2005
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D001667 2000
% 209.48/209.68 |- skos__altLabel mesh__D001667 Competitive Binding
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D001667 2004
% 209.48/209.68 |- skos__historyNote mesh__D001667 Binding Sites %28%1968-1972%29%
% 209.48/209.68 |- skos__hiddenLabel mesh__D001667 Competitive Bindings
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D001667 2003
% 209.48/209.68 |- mesh__recordAuthorizer mesh__D001667 SJN
% 209.48/209.68 |- mesh__historyNote mesh__D001667 73
% 209.48/209.68 |- skos__prefLabel mesh__D001667 Binding, Competitive
% 209.48/209.68 |- skos__broader mesh__D001667smesh__D001665
% 209.48/209.68 |- mesh__dateEstablished mesh__D001667 1973-01-01
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Familial Dystonias, Idiopathic
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D020821 2001
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Adult-Onset Dystonia
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonias, Primary
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Familial Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Psychogenic Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonias, Hereditary
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Childhood Onset Dystonia
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D020821 2006
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonia, Childhood Onset
% 209.48/209.68 |- skos__altLabel mesh__D020821 Dystonia Disorders
% 209.48/209.68 |- mesh__dateEstablished mesh__D020821 2000-01-01
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Primary Dystonia
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Hereditary Dystonia
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonias, Focal
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Sporadic Dystonia
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonia, Idiopathic Familial
% 209.48/209.68 |- skos__altLabel mesh__D020821 Familial Dystonia, Autosomal Recessive
% 209.48/209.68 |- skos__altLabel mesh__D020821 Dystonia, Hereditary
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D020821 2003
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Primary Dystonias
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D020821 2002
% 209.48/209.68 |- skos__altLabel mesh__D020821 Dystonia, Psychogenic
% 209.48/209.68 |- skos__related mesh__D020821smesh__D004421
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonias, Secondary
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Psychogenic Dystonia
% 209.48/209.68 |- rdf__type mesh__D020821sskos__Concept
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Hereditary Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonias, Idiopathic Familial
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D020821 2004
% 209.48/209.68 |- mesh__dateCreated mesh__D020821 1999-11-08
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Secondary Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Adult Onset Idiopathic Torsion Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonias, Adult-Onset
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D020821 2000
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Pseudodystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonia, Sporadic
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Adult Onset Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonia, Adult-Onset
% 209.48/209.68 |- skos__altLabel mesh__D020821 Secondary Dystonia
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Idiopathic Familial Dystonia
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonia, Familial
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Idiopathic Familial Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonias, Familial
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonia Disorder
% 209.48/209.68 |- skos__prefLabel mesh__D020821 Dystonic Disorders
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Writer Cramp
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonic Disorder
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D020821 2000
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Sporadic Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Writers Cramp
% 209.48/209.68 |- skos__annotation mesh__D020821 DYSTONIA is also available
% 209.48/209.68 |- skos__broader mesh__D020821smesh__D009069
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonias, Childhood Onset
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Focal Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonia, Focal
% 209.48/209.68 |- skos__historyNote mesh__D020821 Dystonia %28%1966-1999%29%
% 209.48/209.68 |- mesh__historyNote mesh__D020821 2000
% 209.48/209.68 |- skos__altLabel mesh__D020821 Familial Dystonia, Autosomal Dominant
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Adult Onset Idiopathic Focal Dystonias
% 209.48/209.68 |- skos__hiddenLabel mesh__D020821 Dystonias, Psychogenic
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D020821 2005
% 209.48/209.68 |- skos__scopeNote mesh__D020821
% 209.48/209.68 Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias %28%e.g., dystonia musculorum deformans%29% and focal dystonias %28%e.g., writer%27%s cramp%29%. They are also classified by patterns of inheritance and by age of onset.%A%
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Right Ventricles
% 209.48/209.68 |- skos__altLabel mesh__D006352 Heart Ventricle
% 209.48/209.68 |- skos__altLabel mesh__D006352 Cardiac Ventricles
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Ventricle, Right
% 209.48/209.68 |- mesh__dateEstablished mesh__D006352 1968-01-01
% 209.48/209.68 |- skos__related mesh__D006352smesh__D016276
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Ventricle, Heart
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Ventricles, Heart
% 209.48/209.68 |- mesh__dateCreated mesh__D006352 1999-01-01
% 209.48/209.68 |- skos__related mesh__D006352smesh__D017725
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Ventricles, Left
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Ventricle, Left
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D006352 2006
% 209.48/209.68 |- mesh__recordMaintainer mesh__D006352 nns
% 209.48/209.68 |- mesh__recordOriginator mesh__D006352 NLM
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Left Ventricles
% 209.48/209.68 |- skos__broader mesh__D006352smesh__D006321
% 209.48/209.68 |- mesh__dateRevised mesh__D006352 2003-07-25
% 209.48/209.68 |- skos__altLabel mesh__D006352 Cardiac Ventricle
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Ventricles, Right
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D006352 2005
% 209.48/209.68 |- mesh__historyNote mesh__D006352 2004%28%1966%29%
% 209.48/209.68 |- mesh__recordAuthorizer mesh__D006352 sjn
% 209.48/209.68 |- skos__scopeNote mesh__D006352
% 209.48/209.68 The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation.%A%
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D006352 2004
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Ventricles, Cardiac
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D006352
% 209.48/209.68 2004; see HEART VENTRICLE 1966-2003
% 209.48/209.68 |- skos__prefLabel mesh__D006352 Heart Ventricles
% 209.48/209.68 |- skos__hiddenLabel mesh__D006352 Ventricle, Cardiac
% 209.48/209.68 |- rdf__type mesh__D006352sskos__Concept
% 209.48/209.68 |- skos__annotation mesh__D006352
% 209.48/209.68 NIM: Manual 21.51; /physiol: consider also VENTRICULAR FUNCTION %26% specifics; /radionuclide permitted but consider also RADIONUCLIDE VENTRICULOGRAPHY; ventric hypertrophy = HYPERTROPHY, LEFT VENTRICULAR or HYPERTROPHY, RIGHT VENTRICULAR; false ventric tendons: index under PURKINJE FIBERS but see note there; PAPILLARY MUSCLES %26% CHORDAE TENDINEAE are available but read MeSH definitions%A%
% 209.48/209.68 |- skos__broader mesh__D015632Q000633smesh__D015632
% 209.48/209.68 |- mesh__preferredCombination mesh__D015632Q000633smesh__D020267
% 209.48/209.68 |- rdf__type mesh__D015632Q000633smesh__CompoundConcept
% 209.48/209.68 |- mesh__recordMaintainer mesh__D011297 lkt
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D011297
% 209.48/209.68 82; PRENATAL INFLUENCES was heading 1963-72
% 209.48/209.68 |- skos__altLabel mesh__D011297 Delayed Effects, Prenatal Exposure
% 209.48/209.68 |- mesh__recordOriginator mesh__D011297 SMH
% 209.48/209.68 |- skos__altLabel mesh__D011297 Late Effects, Prenatal Exposure
% 209.48/209.68 |- skos__scopeNote mesh__D011297
% 209.48/209.68 The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION; STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH.%A%
% 209.48/209.68 |- skos__prefLabel mesh__D011297 Prenatal Exposure Delayed Effects
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D011297 2006
% 209.48/209.68 |- skos__broader mesh__D011297smesh__D049188
% 209.48/209.68 |- skos__annotation mesh__D011297
% 209.48/209.68 for mammals only; note PRECONCEPTION INJURIES; MATERNAL EXPOSURE %26% PATERNAL EXPOSURE are available for environmental exposure of mother or father; check tags FEMALE %26% PREGNANCY%A%
% 209.48/209.68 |- mesh__historyNote mesh__D011297
% 209.48/209.68 82; PRENATAL INFLUENCES was heading 1963-72
% 209.48/209.68 |- skos__related mesh__D011297smesh__D018812
% 209.48/209.68 |- mesh__recordAuthorizer mesh__D011297 sjn
% 209.48/209.68 |- mesh__dateCreated mesh__D011297 1981-05-19
% 209.48/209.68 |- mesh__dateEstablished mesh__D011297 1982-01-01
% 209.48/209.68 |- skos__related mesh__D011297smesh__D018811
% 209.48/209.68 |- mesh__dateRevised mesh__D011297 2005-06-30
% 209.48/209.68 |- rdf__type mesh__D011297sskos__Concept
% 209.48/209.68 |- mesh__onlineNote mesh__D011297
% 209.48/209.68 search PRENATAL INFLUENCES under PREGNANCY 1966-72
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D016780 2001
% 209.48/209.68 |- mesh__recordOriginator mesh__D016780 PXP
% 209.48/209.68 |- mesh__dateCreated mesh__D016780 1991-05-02
% 209.48/209.68 |- skos__prefLabel mesh__D016780 Malaria, Vivax
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D016780 2002
% 209.48/209.68 |- skos__altLabel mesh__D016780 Plasmodium vivax Malaria
% 209.48/209.68 |- rdf__type mesh__D016780sskos__Concept
% 209.48/209.68 |- skos__hiddenLabel mesh__D016780 Vivax Malaria
% 209.48/209.68 |- mesh__dateEstablished mesh__D016780 1992-01-01
% 209.48/209.68 |- mesh__recordAuthorizer mesh__D016780 sjn
% 209.48/209.68 |- skos__historyNote mesh__D016780 Malaria %28%1966-1991%29%
% 209.48/209.68 |- skos__broader mesh__D016780smesh__D008288
% 209.48/209.68 |- skos__scopeNote mesh__D016780
% 209.48/209.68 Malaria caused by PLASMODIUM VIVAX. This form of malaria is less severe than MALARIA, FALCIPARUM, but there is a higher probability for relapses to occur. Febrile paroxysms often occur every other day.%A%
% 209.48/209.68 |- mesh__dateRevised mesh__D016780 2000-06-22
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D016780 1992
% 209.48/209.68 |- skos__hiddenLabel mesh__D016780 Malaria, Plasmodium vivax
% 209.48/209.68 |- mesh__historyNote mesh__D016780 1992
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D016780 2005
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D016780 2003
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D016780 2006
% 209.48/209.68 |- mesh__recordMaintainer mesh__D016780 TGC
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D016780 2004
% 209.48/209.68 |- skos__altLabel mesh__D002760
% 209.48/209.68 Retrograde Cholangiopancreatography, Endoscopic
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D002760 2000
% 209.48/209.68 |- skos__related mesh__D002760smesh__D016717
% 209.48/209.68 |- skos__broader mesh__D002760smesh__D016145
% 209.48/209.68 |- skos__hiddenLabel mesh__D002760
% 209.48/209.68 Retrograde Cholangiopancreatographies, Endoscopic
% 209.48/209.68 |- skos__hiddenLabel mesh__D002760
% 209.48/209.68 Endoscopic Retrograde Cholangiopancreatographies
% 209.48/209.68 |- rdf__type mesh__D002760sskos__Concept
% 209.48/209.68 |- mesh__dateRevised mesh__D002760 1999-11-08
% 209.48/209.68 |- skos__historyNote mesh__D002760 Endoscopy %28%1966-1980%29%
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D002760 2004
% 209.48/209.68 |- skos__scopeNote mesh__D002760
% 209.48/209.68 Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER%27%S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic %28%Vater%29% papillotomy %28%SPHINCTEROTOMY, ENDOSCOPIC%29% may be performed during this procedure.%A%
% 209.48/209.68 |- skos__altLabel mesh__D002760
% 209.48/209.68 Endoscopic Retrograde Cholangiopancreatography
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D002760 2002
% 209.48/209.68 |- mesh__recordMaintainer mesh__D002760 KEV
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D002760 81
% 209.48/209.68 |- mesh__dateEstablished mesh__D002760 1981-01-01
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D002760 2003
% 209.48/209.68 |- mesh__dateCreated mesh__D002760 1980-04-04
% 209.48/209.68 |- skos__historyNote mesh__D002760 Pancreas %28%1966-1980%29%
% 209.48/209.68 |- skos__altLabel mesh__D002760 ERCP
% 209.48/209.68 |- skos__broader mesh__D002760smesh__D002758
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D002760 2006
% 209.48/209.68 |- mesh__recordOriginator mesh__D002760 RC
% 209.48/209.68 |- skos__historyNote mesh__D002760 Cholangiography %28%1966-1980%29%
% 209.48/209.68 |- mesh__recordAuthorizer mesh__D002760 sjn
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D002760 2001
% 209.48/209.68 |- mesh__historyNote mesh__D002760 81
% 209.48/209.68 |- skos__prefLabel mesh__D002760
% 209.48/209.68 Cholangiopancreatography, Endoscopic Retrograde
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D002760 2005
% 209.48/209.68 |- skos__hiddenLabel mesh__D002760
% 209.48/209.68 Cholangiopancreatographies, Endoscopic Retrograde
% 209.48/209.68 |- skos__annotation mesh__D002760 /instrum is probably DUODENOSCOPES
% 209.48/209.68 |- skos__hiddenLabel mesh__D015688 Protein src, Oncogene
% 209.48/209.68 |- skos__altLabel mesh__D015688 Oncogene Protein src
% 209.48/209.68 |- skos__altLabel mesh__D015688 src Oncogene Product pp60
% 209.48/209.68 |- skos__altLabel mesh__D015688 Oncogene Protein pp60%28%src%29%
% 209.48/209.68 |- skos__altLabel mesh__D015688 v-src Protein pp60
% 209.48/209.68 |- skos__hiddenLabel mesh__D015688 v src Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D015688 v src Protein pp60
% 209.48/209.68 |- mesh__recordMaintainer mesh__D015688 SYSTEM
% 209.48/209.68 |- mesh__recordAuthorizer mesh__D015688 sjn
% 209.48/209.68 |- skos__scopeNote mesh__D015688
% 209.48/209.68 A tyrosine-specific protein kinase encoded by the v-src oncogene of Rous sarcoma virus. The transforming activity of pp60%28%v-src%29% depends on both the lack of a critical carboxy-terminal tyrosine phosphorylation site at position 527, and the attachment of pp60%28%v-src%29% to the plasma membrane which is accomplished by myristylation of its N-terminal glycine.%A%
% 209.48/209.68 |- skos__altLabel mesh__D015688 Phosphoprotein pp60%28%v-src%29%
% 209.48/209.68 |- skos__altLabel mesh__D015688
% 209.48/209.68 Rous Sarcoma Virus-Transforming Protein pp60%28%v-src%29%
% 209.48/209.68 |- skos__historyNote mesh__D015688 Viral Proteins %28%1981-1985%29%
% 209.48/209.68 |- skos__hiddenLabel mesh__D015688 pp60 v src
% 209.48/209.68 |- skos__hiddenLabel mesh__D015688 v-src, pp60
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D015688 2006
% 209.48/209.68 |- skos__hiddenLabel mesh__D015688 Avian Sarcoma Virus Transforming Protein
% 209.48/209.68 |- mesh__dateEstablished mesh__D015688 1990-01-01
% 209.48/209.68 |- mesh__dateCreated mesh__D015688 1989-05-25
% 209.48/209.68 |- mesh__dateRevised mesh__D015688 2005-06-30
% 209.48/209.68 |- mesh__historyNote mesh__D015688
% 209.48/209.68 91; was ONCOGENE PROTEIN PP60%28%SRC%29% 1990; PP60%28%SRC%29% was see ONCOGENE PROTEIN PP60%28%SRC%29% 1990%A%
% 209.48/209.68 |- skos__historyNote mesh__D015688 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.68 |- skos__hiddenLabel mesh__D015688 src, Oncogene Protein
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D015688
% 209.48/209.68 91; was ONCOGENE PROTEIN PP60%28%SRC%29% 1990; PP60%28%SRC%29% was see ONCOGENE PROTEIN PP60%28%SRC%29% 1990%A%
% 209.48/209.68 |- skos__prefLabel mesh__D015688 Oncogene Protein pp60%28%v-src%29%
% 209.48/209.68 |- skos__altLabel mesh__D015688 pp60%28%v-src%29%
% 209.48/209.68 |- skos__altLabel mesh__D015688 src Oncogene Protein pp60
% 209.48/209.68 |- mesh__onlineNote mesh__D015688
% 209.48/209.68 use ONCOGENE PROTEIN PP60%28%V-SRC%29% to search ONCOGENE PROTEIN PP60%28%SRC%29% %26% PP60%28%SRC%29% 1990%A%
% 209.48/209.68 |- skos__altLabel mesh__D015688 Avian Sarcoma Virus-Transforming Protein
% 209.48/209.68 |- skos__broader mesh__D015688smesh__D015682
% 209.48/209.68 |- skos__hiddenLabel mesh__D015688 Protein pp60, v-src
% 209.48/209.68 |- skos__altLabel mesh__D015688 v-src Protein
% 209.48/209.68 |- skos__broader mesh__D015688smesh__D019061
% 209.48/209.68 |- mesh__recordOriginator mesh__D015688 AGS
% 209.48/209.68 |- rdf__type mesh__D015688sskos__Concept
% 209.48/209.68 |- skos__altLabel mesh__D015688 pp60 v-src
% 209.48/209.68 |- skos__altLabel mesh__D015688 p60%28%v-src%29%
% 209.48/209.68 |- skos__hiddenLabel mesh__D015688 pp60, v-src Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 ProteinChips
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Analyses, Protein Array
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microchip, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Array, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microarray, Protein Profiling
% 209.48/209.68 |- mesh__recordOriginator mesh__D040081 nns
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microchips, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Assays, Protein Microarray
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Assay, Protein Microarray
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Biochip, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Array Analysis, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Analysis, Protein Microarray
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Microarray
% 209.48/209.68 |- skos__altLabel mesh__D040081 Protein Biochips
% 209.48/209.68 |- mesh__historyNote mesh__D040081 2003
% 209.48/209.68 |- mesh__publicMeSHNote mesh__D040081 2003
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D040081 2006
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Chips, Protein Profiling
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Array
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Profiling Microarray, Protein
% 209.48/209.68 |- mesh__recordAuthorizer mesh__D040081 sjn
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Microarray Assays
% 209.48/209.68 |- mesh__dateRevised mesh__D040081 2005-06-30
% 209.48/209.68 |- skos__broader mesh__D040081smesh__D046228
% 209.48/209.68 |- rdf__type mesh__D040081sskos__Concept
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Biochips, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Assay, Protein Array
% 209.48/209.68 |- skos__related mesh__D040081smesh__D025941
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microarray, Protein
% 209.48/209.68 |- mesh__recordMaintainer mesh__D040081 ssb
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Chip, Protein Profiling
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Analyses, Protein Microarray
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Assays, Protein Array
% 209.48/209.68 |- skos__broader mesh__D040081smesh__D015336
% 209.48/209.68 |- skos__altLabel mesh__D040081 Protein Chips
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Profiling Microarrays, Protein
% 209.48/209.68 |- skos__altLabel mesh__D040081 Protein Profiling Microarrays
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Profiling Chip
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Biochip
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Array Analyses
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Chip
% 209.48/209.68 |- mesh__dateCreated mesh__D040081 2002-07-02
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Array Assays
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Profiling Chip, Protein
% 209.48/209.68 |- skos__altLabel mesh__D040081 Protein Microchips
% 209.48/209.68 |- skos__altLabel mesh__D040081 Protein Microarray Assay
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microarrays, Protein Profiling
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microarray Analyses, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Profiling Microarray
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microarray Assays, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Arrays, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Chip, Protein
% 209.48/209.68 |- skos__scopeNote mesh__D040081
% 209.48/209.68 Ligand-binding assays that measure protein-protein, protein-small molecule, or protein-nucleic acid interactions using a very large set of capturing molecules, i.e., those attached separately on a solid support, to measure the presence or interaction of target molecules in the sample.%A%
% 209.48/209.68 |- skos__altLabel mesh__D040081 Protein Array Assay
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Microchip
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Protein Microarray Analyses
% 209.48/209.68 |- mesh__dateEstablished mesh__D040081 2003-01-01
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Array Assays, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Profiling Chips, Protein
% 209.48/209.68 |- skos__prefLabel mesh__D040081 Protein Array Analysis
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Array Assay, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microarray Assay, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Analysis, Protein Array
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Array Analyses, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microarrays, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Chips, Protein
% 209.48/209.68 |- skos__hiddenLabel mesh__D040081 Microarray Analysis, Protein
% 209.48/209.68 |- mesh__dateCreated mesh__D001668 1999-01-01
% 209.48/209.68 |- skos__annotation mesh__D001668
% 209.48/209.68 IM for biobibliog as a subject; for biobibliog of a biographee coord NIM + BIOBIBLIOGRAPHY %28%PT%29%; no qualif; DF: BIOBIBLIOG or BIOBIBLIOGR%A%
% 209.48/209.68 |- mesh__activeMeSHYear mesh__D001668 2006
% 209.48/209.68 |- skos__altLabel mesh__D001668 Biobibliographies
% 209.48/209.68 |- skos__scopeNote mesh__D001668
% 209.48/209.68 A biography which includes a list of the writings of the subject person.%A%
% 209.48/209.69 |- mesh__dateRevised mesh__D001668 2002-07-31
% 209.48/209.69 |- rdf__type mesh__D001668sskos__Concept
% 209.48/209.69 |- mesh__recordMaintainer mesh__D001668 sjn
% 209.48/209.69 |- skos__prefLabel mesh__D001668 Biobibliography
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001668 2005
% 209.48/209.69 |- mesh__recordOriginator mesh__D001668 NLM
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D001668 sjn
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001668 2004
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001668 2003
% 209.48/209.69 |- skos__broader mesh__D001668smesh__D001634
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 1996
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 2002
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 1999
% 209.48/209.69 |- skos__hiddenLabel mesh__D012390 Root Canal Therapies
% 209.48/209.69 |- skos__prefLabel mesh__D012390 Root Canal Therapy
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 1997
% 209.48/209.69 |- skos__annotation mesh__D012390
% 209.48/209.69 do not use /util except by MeSH definition; the corresponding specialty is ENDODONTICS; reamers %26% broaches: index under ROOT CANAL PREPARATION /instrum; DF: ROOT CANAL THER%A%
% 209.48/209.69 |- mesh__recordOriginator mesh__D012390 NLM
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D012390 PLS
% 209.48/209.69 |- skos__hiddenLabel mesh__D012390 Therapies, Root Canal
% 209.48/209.69 |- mesh__dateRevised mesh__D012390 1995-06-08
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 2005
% 209.48/209.69 |- skos__altLabel mesh__D012390 Therapy, Root Canal
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 2003
% 209.48/209.69 |- skos__scopeNote mesh__D012390
% 209.48/209.69 A treatment modality in endodontics concerned with the therapy of diseases of the dental pulp. For preparatory procedures, ROOT CANAL PREPARATION is available.%A%
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D012390
% 209.48/209.69 65; was see under ENDODONTICS 1963-64
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 2006
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 2000
% 209.48/209.69 |- mesh__recordMaintainer mesh__D012390 TGC
% 209.48/209.69 |- mesh__dateCreated mesh__D012390 1999-01-01
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 2004
% 209.48/209.69 |- skos__broader mesh__D012390smesh__D004708
% 209.48/209.69 |- mesh__historyNote mesh__D012390 65; was see under ENDODONTICS 1963-64
% 209.48/209.69 |- rdf__type mesh__D012390sskos__Concept
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 2001
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012390 1998
% 209.48/209.69 |- skos__hiddenLabel mesh__D012390 Canal Therapies, Root
% 209.48/209.69 |- skos__hiddenLabel mesh__D012390 Canal Therapy, Root
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Choreas, Chronic Progressive
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Senile Choreas
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Dyskinesia, Paroxysmal
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020822 2006
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Chorea Syndrome
% 209.48/209.69 |- mesh__recordMaintainer mesh__D020822 ags
% 209.48/209.69 |- mesh__dateEstablished mesh__D020822 2000-01-01
% 209.48/209.69 |- skos__historyNote mesh__D020822 Chorea %28%1966-1999%29%
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Choreatic Disorder
% 209.48/209.69 |- mesh__dateCreated mesh__D020822 1999-11-05
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Sydenham Choreas
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020822 2003
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Hereditary Choreas, Benign
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Choreas, Rheumatic
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Progressive Choreas, Chronic
% 209.48/209.69 |- skos__annotation mesh__D020822 CHOREA is also available
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020822 2002
% 209.48/209.69 |- skos__prefLabel mesh__D020822 Choreatic Disorders
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Benign Hereditary Chorea
% 209.48/209.69 |- rdf__type mesh__D020822sskos__Concept
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020822 2004
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Chorea Acanthocytosis Syndromes
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Hereditary Choreas
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Paroxysmal Dyskinesia
% 209.48/209.69 |- mesh__recordOriginator mesh__D020822 KEV
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Benign Hereditary Choreas
% 209.48/209.69 |- skos__scopeNote mesh__D020822
% 209.48/209.69 Acquired and hereditary conditions which feature CHOREA as a primary manifestation of the disease process.%A%
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Rheumatic Choreas
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D020822 sjn
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Choreas, Benign Hereditary
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D020822 2000
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Chronic Progressive Chorea
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Choreatic Syndrome
% 209.48/209.69 |- skos__altLabel mesh__D020822 Sydenham Chorea
% 209.48/209.69 |- mesh__dateRevised mesh__D020822 2001-07-25
% 209.48/209.69 |- skos__altLabel mesh__D020822 Choreatic Syndromes
% 209.48/209.69 |- skos__altLabel mesh__D020822 Rheumatic Chorea
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Chorea, Hereditary
% 209.48/209.69 |- skos__altLabel mesh__D020822 Neuroacanthocytosis
% 209.48/209.69 |- skos__altLabel mesh__D020822 St. Vitus%27%s Dance
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Choreas, Senile
% 209.48/209.69 |- skos__altLabel mesh__D020822 Chorea Syndromes
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Progressive Chorea, Chronic
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Hereditary Chorea, Benign
% 209.48/209.69 |- skos__altLabel mesh__D020822 Chorea, Sydenham
% 209.48/209.69 |- skos__altLabel mesh__D020822 Paroxysmal Dyskinesias
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Chorea Disorder
% 209.48/209.69 |- mesh__historyNote mesh__D020822 2000
% 209.48/209.69 |- skos__altLabel mesh__D020822 Chorea Disorders
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Choreas, Hereditary
% 209.48/209.69 |- skos__broader mesh__D020822smesh__D009069
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020822 2005
% 209.48/209.69 |- skos__altLabel mesh__D020822 Senile Chorea
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Chronic Progressive Choreas
% 209.48/209.69 |- skos__hiddenLabel mesh__D020822 Choreas, Sydenham
% 209.48/209.69 |- skos__scopeNote mesh__D006353
% 209.48/209.69 Small pumps, often implantable, designed for temporarily assisting the heart, usually the left ventricle, to pump blood; they consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors; the devices are used after myocardial infarction or to wean the repaired heart from the heart-lung machine after open-heart surgery.%A%
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Artificial Ventricles
% 209.48/209.69 |- mesh__dateEstablished mesh__D006353 1990-01-01
% 209.48/209.69 |- skos__historyNote mesh__D006353 Assisted Circulation %28%1967-1985%29%
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Ventricles, Artificial Heart
% 209.48/209.69 |- rdf__type mesh__D006353sskos__Concept
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006353 2004
% 209.48/209.69 |- skos__historyNote mesh__D006353 Heart, Artificial %28%1967-1985%29%
% 209.48/209.69 |- mesh__dateRevised mesh__D006353 1997-06-20
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Ventricle, Artificial Heart
% 209.48/209.69 |- skos__altLabel mesh__D006353 Heart Ventricle, Artificial
% 209.48/209.69 |- skos__prefLabel mesh__D006353 Heart-Assist Devices
% 209.48/209.69 |- mesh__recordMaintainer mesh__D006353 PXP
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Device, Heart-Assist
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006353 2003
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Artificial Heart Ventricles
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Ventricles, Artificial
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Ventricle, Artificial
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006353 2002
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Heart Assist Devices
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Heart-Assist Device
% 209.48/209.69 |- skos__broader mesh__D006353smesh__D006354
% 209.48/209.69 |- skos__historyNote mesh__D006353 Pacemaker, Artificial %28%1966-1985%29%
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Device, Vascular-Assist
% 209.48/209.69 |- skos__altLabel mesh__D006353 Pumps, Heart-Assist
% 209.48/209.69 |- skos__broader mesh__D006353smesh__D001243
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Devices, Ventricle-Assist
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D006353
% 209.48/209.69 90; was see under ASSISTED CIRCULATION 1986-89
% 209.48/209.69 |- skos__altLabel mesh__D006353 Ventricle-Assist Device
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006353 2006
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Heart Ventricles, Artificial
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Heart-Assist Pumps
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Ventricle-Assist Devices
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006353 1999
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Artificial Heart Ventricle
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006353 2005
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Device, Ventricle-Assist
% 209.48/209.69 |- mesh__historyNote mesh__D006353
% 209.48/209.69 90%28%86%29%; was see under ASSISTED CIRCULATION 1986-89
% 209.48/209.69 |- mesh__recordOriginator mesh__D006353 SH
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Heart-Assist Pump
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006353 2001
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Vascular-Assist Device
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Devices, Heart-Assist
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Pumps, Heart Assist
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Pump, Heart-Assist
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Devices, Vascular-Assist
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006353 1998
% 209.48/209.69 |- mesh__dateCreated mesh__D006353 1985-06-07
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Vascular Assist Devices
% 209.48/209.69 |- skos__hiddenLabel mesh__D006353 Ventricle Assist Device
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006353 2000
% 209.48/209.69 |- skos__altLabel mesh__D006353 Vascular-Assist Devices
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D006353 SJN
% 209.48/209.69 |- rdf__type mesh__D020024sskos__Concept
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D020024 99
% 209.48/209.69 |- skos__altLabel mesh__D020024 Antagonists, Leukotriene
% 209.48/209.69 |- skos__broader mesh__D020024smesh__D006727
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020024 2006
% 209.48/209.69 |- skos__prefLabel mesh__D020024 Leukotriene Antagonists
% 209.48/209.69 |- skos__hiddenLabel mesh__D020024 Antagonists, Leukotriene Receptor
% 209.48/209.69 |- skos__altLabel mesh__D020024 Leukotriene Receptor Antagonists
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020024 2005
% 209.48/209.69 |- mesh__dateRevised mesh__D020024 2003-07-09
% 209.48/209.69 |- mesh__dateCreated mesh__D020024 1998-06-10
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020024 2004
% 209.48/209.69 |- mesh__historyNote mesh__D020024 99
% 209.48/209.69 |- mesh__dateEstablished mesh__D020024 1999-01-01
% 209.48/209.69 |- skos__altLabel mesh__D020024 Receptor Antagonists, Leukotriene
% 209.48/209.69 |- skos__scopeNote mesh__D020024
% 209.48/209.69 A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.%A%
% 209.48/209.69 |- skos__altLabel mesh__D011298 Feprazone
% 209.48/209.69 |- skos__hiddenLabel mesh__D011298 DA 2370
% 209.48/209.69 |- mesh__dateEstablished mesh__D011298 1991-01-01
% 209.48/209.69 |- mesh__dateRevised mesh__D011298 2005-06-30
% 209.48/209.69 |- skos__scopeNote mesh__D011298
% 209.48/209.69 A pyrazole that has analgesic, anti-inflammatory, and antipyretic properties. It has been used in mild to moderate pain, fever, and inflammation associated with musculoskeletal and joint disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p15%29%%A%
% 209.48/209.69 |- skos__historyNote mesh__D011298 Terpenes %28%1972-1974%29%
% 209.48/209.69 |- mesh__recordMaintainer mesh__D011298 ssb
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D011298 2006
% 209.48/209.69 |- skos__historyNote mesh__D011298 Pyrazoles %28%1972-1974%29%
% 209.48/209.69 |- skos__broader mesh__D011298smesh__D010653
% 209.48/209.69 |- mesh__dateCreated mesh__D011298 1974-11-19
% 209.48/209.69 |- skos__historyNote mesh__D011298 Alkenes %28%1974%29%
% 209.48/209.69 |- skos__altLabel mesh__D011298 Fenilprenazone
% 209.48/209.69 |- skos__altLabel mesh__D011298 Escaned Brand of Prenazone
% 209.48/209.69 |- skos__prefLabel mesh__D011298 Prenazone
% 209.48/209.69 |- rdf__type mesh__D011298sskos__Concept
% 209.48/209.69 |- skos__altLabel mesh__D011298 Phenylprenazone
% 209.48/209.69 |- skos__hiddenLabel mesh__D011298 DA2370
% 209.48/209.69 |- mesh__recordOriginator mesh__D011298 NLM
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D011298
% 209.48/209.69 91; was see under PHENYLBUTAZONE 1975-90
% 209.48/209.69 |- mesh__historyNote mesh__D011298
% 209.48/209.69 91%28%75%29%; was see under PHENYLBUTAZONE 1975-90
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D011298 sjn
% 209.48/209.69 |- skos__broader mesh__D016781smesh__D001922
% 209.48/209.69 |- skos__historyNote mesh__D016781 Toxoplasmosis %28%1966-1991%29%
% 209.48/209.69 |- skos__annotation mesh__D016781
% 209.48/209.69 coord IM with specific brain disease %28%IM%29% or specific site %28%IM%29% if pertinent; congenital: coord IM with TOXOPLASMOSIS, CONGENITAL %28%IM%29%%A%
% 209.48/209.69 |- rdf__type mesh__D016781sskos__Concept
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D016781 2001
% 209.48/209.69 |- mesh__dateRevised mesh__D016781 2000-06-22
% 209.48/209.69 |- skos__broader mesh__D016781smesh__D020808
% 209.48/209.69 |- skos__broader mesh__D016781smesh__D014123
% 209.48/209.69 |- skos__scopeNote mesh__D016781
% 209.48/209.69 Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES %28%see also AIDS-RELATED OPPORTUNISTIC INFECTIONS%29%. The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. %28%From Joynt, Clinical Neurology, 1998, Ch27, pp41-3%29%%A%
% 209.48/209.69 |- mesh__dateCreated mesh__D016781 1991-05-02
% 209.48/209.69 |- skos__historyNote mesh__D016781 Brain Diseases %28%1966-1991%29%
% 209.48/209.69 |- skos__altLabel mesh__D016781 Cerebral Toxoplasmosis
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D016781 2002
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D016781 1992
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D016781 2005
% 209.48/209.69 |- mesh__dateEstablished mesh__D016781 1992-01-01
% 209.48/209.69 |- skos__altLabel mesh__D016781 Central Nervous System Toxoplasmosis
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D016781 sjn
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D016781 2003
% 209.48/209.69 |- mesh__recordMaintainer mesh__D016781 KEV
% 209.48/209.69 |- skos__prefLabel mesh__D016781 Toxoplasmosis, Cerebral
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D016781 2006
% 209.48/209.69 |- skos__hiddenLabel mesh__D016781 Toxoplasmoses, Cerebral
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D016781 2004
% 209.48/209.69 |- mesh__recordOriginator mesh__D016781 PXP
% 209.48/209.69 |- mesh__historyNote mesh__D016781 1992
% 209.48/209.69 |- skos__hiddenLabel mesh__D016781 Toxoplasmosis, Intracranial
% 209.48/209.69 |- mesh__recordMaintainer mesh__D002761 lkt
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D002761 sjn
% 209.48/209.69 |- rdf__type mesh__D002761sskos__Concept
% 209.48/209.69 |- skos__broader mesh__D002761smesh__D001649
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D002761 2004
% 209.48/209.69 |- mesh__recordOriginator mesh__D002761 NLM
% 209.48/209.69 |- mesh__dateCreated mesh__D002761 1999-01-01
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D002761 2005
% 209.48/209.69 |- skos__prefLabel mesh__D002761 Cholangitis
% 209.48/209.69 |- skos__hiddenLabel mesh__D002761 Cholangitides
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D002761 2006
% 209.48/209.69 |- mesh__dateRevised mesh__D002761 2003-07-09
% 209.48/209.69 |- skos__related mesh__D002761smesh__D002764
% 209.48/209.69 |- skos__scopeNote mesh__D002761
% 209.48/209.69 Inflammation of the biliary ductal system %28%BILE DUCTS%29%; intrahepatic, extrahepatic, or both.%A%
% 209.48/209.69 |- mesh__dateRevised mesh__D015689 2005-06-30
% 209.48/209.69 |- skos__hiddenLabel mesh__D015689 p21 v ras
% 209.48/209.69 |- mesh__dateCreated mesh__D015689 1989-07-19
% 209.48/209.69 |- skos__hiddenLabel mesh__D015689 p21 v H ras
% 209.48/209.69 |- skos__altLabel mesh__D015689 p21%28%v-Ki-ras%29%
% 209.48/209.69 |- skos__altLabel mesh__D015689 ras Oncogene p21 Product
% 209.48/209.69 |- skos__altLabel mesh__D015689 p21 v-Ki-ras
% 209.48/209.69 |- skos__annotation mesh__D015689 coord with specific virus
% 209.48/209.69 |- skos__altLabel mesh__D015689 p21%28%v-K-ras%29%
% 209.48/209.69 |- skos__prefLabel mesh__D015689 Oncogene Protein p21%28%ras%29%
% 209.48/209.69 |- mesh__dateEstablished mesh__D015689 1990-01-01
% 209.48/209.69 |- skos__altLabel mesh__D015689 p21 v-Ha-ras
% 209.48/209.69 |- skos__altLabel mesh__D015689 p21 Transforming Viral Protein
% 209.48/209.69 |- mesh__recordOriginator mesh__D015689 AGS
% 209.48/209.69 |- skos__altLabel mesh__D015689 ras Oncogene Product p21
% 209.48/209.69 |- skos__hiddenLabel mesh__D015689 p21 v Ha ras
% 209.48/209.69 |- mesh__historyNote mesh__D015689 1990
% 209.48/209.69 |- skos__altLabel mesh__D015689 p21%28%v-H-ras%29%
% 209.48/209.69 |- skos__altLabel mesh__D015689 p21%28%v-Ha-ras%29%
% 209.48/209.69 |- skos__broader mesh__D015689smesh__D015682
% 209.48/209.69 |- skos__broader mesh__D015689smesh__D018631
% 209.48/209.69 |- rdf__type mesh__D015689sskos__Concept
% 209.48/209.69 |- skos__historyNote mesh__D015689 Neoplasm Proteins %28%1980-1986%29%
% 209.48/209.69 |- skos__hiddenLabel mesh__D015689 v-Ki-ras, p21
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D015689 sjn
% 209.48/209.69 |- skos__historyNote mesh__D015689
% 209.48/209.69 Oncogene Proteins, Viral %28%1986-1989%29%
% 209.48/209.69 |- skos__hiddenLabel mesh__D015689 v-H-ras, p21
% 209.48/209.69 |- skos__altLabel mesh__D015689 p21 v-H-ras
% 209.48/209.69 |- skos__altLabel mesh__D015689 p21 v-ras
% 209.48/209.69 |- skos__altLabel mesh__D015689 ras Oncogene Protein p21
% 209.48/209.69 |- skos__hiddenLabel mesh__D015689 v-ras, p21
% 209.48/209.69 |- skos__hiddenLabel mesh__D015689 p21 v Ki ras
% 209.48/209.69 |- mesh__recordMaintainer mesh__D015689 DRC
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D015689 1990
% 209.48/209.69 |- skos__scopeNote mesh__D015689
% 209.48/209.69 Transforming protein encoded by ras oncogenes. Point mutations in the cellular ras gene %28%c-ras%29% can also result in a mutant p21 protein that can transform mammalian cells. Oncogene protein p21%28%ras%29% has been directly implicated in human neoplasms, perhaps accounting for as much as 15-20%25% of all human tumors. This enzyme was formerly listed as EC 3.6.1.47.%A%
% 209.48/209.69 |- skos__hiddenLabel mesh__D015689 v-Ha-ras, p21
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D015689 2006
% 209.48/209.69 |- skos__broader mesh__D001669smesh__D001670
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D001669 SJN
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001669 2006
% 209.48/209.69 |- skos__scopeNote mesh__D001669
% 209.48/209.69 Biochemical functions, activities, and processes at organic and molecular levels in humans, animals, microorganisms, and plants.%A%
% 209.48/209.69 |- mesh__dateRevised mesh__D001669 1997-06-20
% 209.48/209.69 |- rdf__type mesh__D001669sskos__Concept
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D001669 98
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001669 2003
% 209.48/209.69 |- skos__annotation mesh__D001669
% 209.48/209.69 GEN or unspecified; prefer specifics; BIOLOGICAL PHENOMENA is also available; DF: BIOCHEM PHENOMENA%A%
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001669 2002
% 209.48/209.69 |- skos__altLabel mesh__D001669 Phenomena, Biochemical
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001669 2004
% 209.48/209.69 |- mesh__dateEstablished mesh__D001669 1998-01-01
% 209.48/209.69 |- skos__prefLabel mesh__D001669 Biochemical Phenomena
% 209.48/209.69 |- mesh__dateCreated mesh__D001669 1999-01-01
% 209.48/209.69 |- skos__historyNote mesh__D001669 Biochemistry %28%1966-1997%29%
% 209.48/209.69 |- mesh__historyNote mesh__D001669 98; use explode 1970-97
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001669 2000
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001669 1998
% 209.48/209.69 |- mesh__recordOriginator mesh__D001669 NLM
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001669 1999
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001669 2005
% 209.48/209.69 |- mesh__recordMaintainer mesh__D001669 TGC
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D001669 2001
% 209.48/209.69 |- skos__hiddenLabel mesh__D012391 Root Resorptions
% 209.48/209.69 |- skos__hiddenLabel mesh__D012391 Resorptions, Root
% 209.48/209.69 |- mesh__historyNote mesh__D012391 72%28%63%29%
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 2001
% 209.48/209.69 |- skos__hiddenLabel mesh__D012391 Resorption, Root
% 209.48/209.69 |- skos__scopeNote mesh__D012391
% 209.48/209.69 Resorption in which cementum or dentin is lost from the root of a tooth owing to cementoclastic or osteoclastic activity in conditions such as trauma of occlusion or neoplasms. %28%Dorland, 27th ed%29%%A%
% 209.48/209.69 |- skos__broader mesh__D012391smesh__D014091
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 2005
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 2002
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 2003
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 1994
% 209.48/209.69 |- mesh__recordOriginator mesh__D012391 NLM
% 209.48/209.69 |- mesh__recordMaintainer mesh__D012391 TGC
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 2006
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D012391 PLS
% 209.48/209.69 |- mesh__dateCreated mesh__D012391 1999-01-01
% 209.48/209.69 |- skos__annotation mesh__D012391
% 209.48/209.69 loss of cementum or dentin from root of tooth; only Cat C qualif%A%
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 2004
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 1995
% 209.48/209.69 |- rdf__type mesh__D012391sskos__Concept
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D012391 72
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 1998
% 209.48/209.69 |- mesh__dateEstablished mesh__D012391 1972-01-01
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 1996
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 2000
% 209.48/209.69 |- mesh__dateRevised mesh__D012391 1993-06-02
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 1999
% 209.48/209.69 |- skos__prefLabel mesh__D012391 Root Resorption
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D012391 1997
% 209.48/209.69 |- skos__historyNote mesh__D020823 G-Proteins %28%1993-1999%29%
% 209.48/209.69 |- rdf__type mesh__D020823sskos__Concept
% 209.48/209.69 |- skos__hiddenLabel mesh__D020823 ADP Ribosylation Factor 1
% 209.48/209.69 |- skos__prefLabel mesh__D020823 ADP-Ribosylation Factor 1
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020823 2006
% 209.48/209.69 |- skos__broader mesh__D020823smesh__D020755
% 209.48/209.69 |- mesh__dateCreated mesh__D020823 1999-11-03
% 209.48/209.69 |- skos__scopeNote mesh__D020823
% 209.48/209.69 ADP-RIBOSYLATION FACTOR 1 is involved in regulating intracellular transport by modulating the interaction of coat proteins with organelle membranes in the early secretory pathway. It is a component of COAT PROTEIN COMPLEX I. This enzyme was formerly listed as EC 3.6.1.47.%A%
% 209.48/209.69 |- mesh__dateRevised mesh__D020823 2005-06-30
% 209.48/209.69 |- mesh__historyNote mesh__D020823
% 209.48/209.69 2000; use ADP-RIBOSYLATION FACTOR 1 %28%NM%29% 1993-1999
% 209.48/209.69 |- skos__altLabel mesh__D020823 ARF1p
% 209.48/209.69 |- skos__broader mesh__D020823smesh__D020727
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D020823 sjn
% 209.48/209.69 |- mesh__recordMaintainer mesh__D020823 jmp
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D020823
% 209.48/209.69 2000; ADP RIBOSYLATION FACTOR 1 %28%now ADP-RIBOSYLATION FACTOR 1%29% was indexed under G-PROTEINS 1993-1999%A%
% 209.48/209.69 |- mesh__dateEstablished mesh__D020823 2000-01-01
% 209.48/209.69 |- skos__hiddenLabel mesh__D020823 Protein, ARF1
% 209.48/209.69 |- skos__altLabel mesh__D020823 ARF1 Protein
% 209.48/209.69 |- mesh__recordOriginator mesh__D020823 jmp
% 209.48/209.69 |- skos__altLabel mesh__D020823 ARF 1 Protein
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006354 2002
% 209.48/209.69 |- mesh__recordOriginator mesh__D006354 NLM
% 209.48/209.69 |- skos__altLabel mesh__D006354 Artificial Heart
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006354 2006
% 209.48/209.69 |- mesh__dateRevised mesh__D006354 1999-11-03
% 209.48/209.69 |- skos__hiddenLabel mesh__D006354 Artificial Hearts
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D006354 sjn
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006354 2003
% 209.48/209.69 |- mesh__recordMaintainer mesh__D006354 ndw
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006354 2000
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006354 2004
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006354 2001
% 209.48/209.69 |- skos__scopeNote mesh__D006354
% 209.48/209.69 A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. %28%Dorland, 28th ed%29%%A%
% 209.48/209.69 |- skos__broader mesh__D006354smesh__D001187
% 209.48/209.69 |- mesh__historyNote mesh__D006354 67
% 209.48/209.69 |- skos__prefLabel mesh__D006354 Heart, Artificial
% 209.48/209.69 |- skos__broader mesh__D006354smesh__D019736
% 209.48/209.69 |- rdf__type mesh__D006354sskos__Concept
% 209.48/209.69 |- mesh__dateCreated mesh__D006354 1999-01-01
% 209.48/209.69 |- skos__hiddenLabel mesh__D006354 Hearts, Artificial
% 209.48/209.69 |- mesh__dateEstablished mesh__D006354 1967-01-01
% 209.48/209.69 |- skos__annotation mesh__D006354
% 209.48/209.69 pump replacing whole or part of heart: do not confuse with HEART-LUNG MACHINE %28%external to heart%29%; /psychol permitted%A%
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D006354 67
% 209.48/209.69 |- skos__historyNote mesh__D006354 Artificial Organs %28%1966%29%
% 209.48/209.69 |- skos__historyNote mesh__D006354 Heart-Lung Machine %28%1966%29%
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D006354 2005
% 209.48/209.69 |- skos__historyNote mesh__D020025
% 209.48/209.69 Liver Neoplasms, Experimental %28%1986-1998%29%
% 209.48/209.69 |- mesh__dateRevised mesh__D020025 2004-07-07
% 209.48/209.69 |- mesh__dateCreated mesh__D020025 1998-06-10
% 209.48/209.69 |- rdf__type mesh__D020025sskos__Concept
% 209.48/209.69 |- skos__hiddenLabel mesh__D020025 Proliferators, Peroxisome
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020025 2005
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D020025 sjn
% 209.48/209.69 |- skos__related mesh__D020025smesh__D047492
% 209.48/209.69 |- skos__historyNote mesh__D020025 Antilipemic Agents %28%1976-1998%29%
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D020025 2006
% 209.48/209.69 |- skos__scopeNote mesh__D020025
% 209.48/209.69 A class of nongenotoxic CARCINOGENS that induce the production of hepatic PEROXISOMES and induce hepatic neoplasms after long-term administration.%A%
% 209.48/209.69 |- mesh__dateEstablished mesh__D020025 1999-01-01
% 209.48/209.69 |- mesh__recordMaintainer mesh__D020025 ssb
% 209.48/209.69 |- mesh__recordOriginator mesh__D020025 ADP
% 209.48/209.69 |- skos__broader mesh__D020025smesh__D002273
% 209.48/209.69 |- skos__related mesh__D020025smesh__D008830
% 209.48/209.69 |- mesh__historyNote mesh__D020025 99
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D020025 99
% 209.48/209.69 |- skos__prefLabel mesh__D020025 Peroxisome Proliferators
% 209.48/209.69 |- skos__broader mesh__D011299smesh__D010627
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D011299 2001
% 209.48/209.69 |- mesh__dateEstablished mesh__D011299 1966-01-01
% 209.48/209.69 |- skos__prefLabel mesh__D011299 Prenylamine
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D011299 2004
% 209.48/209.69 |- mesh__dateCreated mesh__D011299 1999-01-01
% 209.48/209.69 |- mesh__recordOriginator mesh__D011299 NLM
% 209.48/209.69 |- mesh__activeMeSHYear mesh__D011299 2003
% 209.48/209.69 |- mesh__recordAuthorizer mesh__D011299 sjn
% 209.48/209.69 |- mesh__publicMeSHNote mesh__D011299 66; was SEGONTIN 1963-65
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D011299 2006
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D011299 2002
% 209.48/209.70 |- skos__scopeNote mesh__D011299
% 209.48/209.70 A drug formerly used in the treatment of angina pectoris but superseded by less hazardous drugs. Prenylamine depletes myocardial catecholamine stores and has some calcium channel blocking activity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1406%29%%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D011299 2005
% 209.48/209.70 |- mesh__historyNote mesh__D011299 66; was SEGONTIN 1963-65
% 209.48/209.70 |- mesh__dateRevised mesh__D011299 2000-06-22
% 209.48/209.70 |- mesh__recordMaintainer mesh__D011299 CCR
% 209.48/209.70 |- rdf__type mesh__D011299sskos__Concept
% 209.48/209.70 |- skos__scopeNote mesh__D016782
% 209.48/209.70 A phylum of protozoa characterized by the presence of complex apical organelles generally consisting of a conoid that aids in penetrating host cells, rhoptries that possibly secrete a proteolytic enzyme, and subpellicular microtubules that may be related to motility.%A%
% 209.48/209.70 |- mesh__recordMaintainer mesh__D016782 ags
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D016782 2005
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D016782 sjn
% 209.48/209.70 |- skos__annotation mesh__D016782
% 209.48/209.70 GEN: prefer specifics; infection: coord IM with PROTOZOAN INFECTIONS %28%IM%29%; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%
% 209.48/209.70 |- mesh__historyNote mesh__D016782 1992
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D016782 2006
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D016782 2004
% 209.48/209.70 |- skos__broader mesh__D016782smesh__D011527
% 209.48/209.70 |- mesh__dateCreated mesh__D016782 1991-05-02
% 209.48/209.70 |- mesh__dateEstablished mesh__D016782 1992-01-01
% 209.48/209.70 |- skos__prefLabel mesh__D016782 Apicomplexa
% 209.48/209.70 |- mesh__recordOriginator mesh__D016782 PXP
% 209.48/209.70 |- rdf__type mesh__D016782sskos__Concept
% 209.48/209.70 |- mesh__dateRevised mesh__D016782 2003-07-09
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D016782 1992
% 209.48/209.70 |- skos__altLabel mesh__D016782 Sporozoa
% 209.48/209.70 |- skos__broader mesh__D002762smesh__D002782
% 209.48/209.70 |- mesh__dateCreated mesh__D002762 1999-01-01
% 209.48/209.70 |- skos__altLabel mesh__D002762 Vitamin D 3
% 209.48/209.70 |- skos__broader mesh__D002762smesh__D014807
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D002762 sjn
% 209.48/209.70 |- skos__altLabel mesh__D002762 Calciol
% 209.48/209.70 |- skos__prefLabel mesh__D002762 Cholecalciferol
% 209.48/209.70 |- skos__broader mesh__D002762smesh__D013261
% 209.48/209.70 |- mesh__dateRevised mesh__D002762 2005-06-30
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002762 2006
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D002762
% 209.48/209.70 94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66%A%
% 209.48/209.70 |- mesh__recordOriginator mesh__D002762 NLM
% 209.48/209.70 |- mesh__historyNote mesh__D002762
% 209.48/209.70 94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66%A%
% 209.48/209.70 |- skos__altLabel mesh__D002762
% 209.48/209.70 %28%3 beta,5Z,7E%29%-9,10-Secocholesta-5,7,10%28%19%29%-trien-3-ol
% 209.48/209.70 |- skos__annotation mesh__D002762
% 209.48/209.70 deficiency: coordinate CHOLECALCIFEROL /defic %28%IM%29% with VITAMIN D DEFICIENCY %28%IM%29%%A%
% 209.48/209.70 |- mesh__onlineNote mesh__D002762
% 209.48/209.70 use CHOLECALCIFEROL to search CHOLECALCIFEROLS 1975-93 %26% VITAMIN D 3 1966-74%A%
% 209.48/209.70 |- skos__scopeNote mesh__D002762
% 209.48/209.70 Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.%A%
% 209.48/209.70 |- skos__altLabel mesh__D002762 Vitamin D3
% 209.48/209.70 |- skos__related mesh__D002762smesh__D018167
% 209.48/209.70 |- mesh__dateEstablished mesh__D002762 1967-01-01
% 209.48/209.70 |- mesh__recordMaintainer mesh__D002762 ssb
% 209.48/209.70 |- rdf__type mesh__D002762sskos__Concept
% 209.48/209.70 |- skos__altLabel mesh__D029101 Bovine parainfluenza virus 3
% 209.48/209.70 |- mesh__dateRevised mesh__D029101 2004-07-30
% 209.48/209.70 |- mesh__recordMaintainer mesh__D029101 jls
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D029101 jls
% 209.48/209.70 |- mesh__dateEstablished mesh__D029101 2002-01-01
% 209.48/209.70 |- mesh__recordOriginator mesh__D029101 ags
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029101 2005A
% 209.48/209.70 |- skos__prefLabel mesh__D029101 Parainfluenza Virus 3, Bovine
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029101 2005
% 209.48/209.70 |- skos__scopeNote mesh__D029101
% 209.48/209.70 A species of RESPIROVIRUS, subfamily PARAMYXOVIRINAE, most often seen in conjunction with a secondary infection of MANNHEIMIA HAEMOLYTICA resulting in pneumonic pasteurellosis %28%PASTEURELLOSIS, PNEUMONIC%29%.%A%
% 209.48/209.70 |- skos__annotation mesh__D029101
% 209.48/209.70 infection: coord IM with RESPIROVIRUS INFECTIONS %28%IM%29% but consider also PASTEURELLOSIS, PNEUMONIC%A%
% 209.48/209.70 |- mesh__historyNote mesh__D029101
% 209.48/209.70 2002; use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 3 1976-1996%A%
% 209.48/209.70 |- mesh__dateCreated mesh__D029101 2001-07-25
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029101 2006
% 209.48/209.70 |- skos__broader mesh__D029101smesh__D018108
% 209.48/209.70 |- skos__historyNote mesh__D029101 Respirovirus %28%1965-2001%29%
% 209.48/209.70 |- skos__altLabel mesh__D029101 Shipping Fever Virus
% 209.48/209.70 |- skos__hiddenLabel mesh__D029101 Shipping Fever Viruses
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029101 2003
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D029101
% 209.48/209.70 2002; see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 3 1976-1996%A%
% 209.48/209.70 |- rdf__type mesh__D029101sskos__Concept
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029101 2004
% 209.48/209.70 |- skos__broader mesh__D040881smesh__D039001
% 209.48/209.70 |- skos__broader mesh__D040881smesh__D018845
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D040881
% 209.48/209.70 2003; for ANTIGENS, CD11A see LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 195-2002%A%
% 209.48/209.70 |- skos__hiddenLabel mesh__D040881 Antigen, CD11a
% 209.48/209.70 |- rdf__type mesh__D040881sskos__Concept
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D040881 2006
% 209.48/209.70 |- mesh__historyNote mesh__D040881
% 209.48/209.70 2003; for ANTIGENS, CD11A use LYPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 1995-2002%A%
% 209.48/209.70 |- skos__historyNote mesh__D040881
% 209.48/209.70 Lymphocyte Function-Associated Antigen-1 %28%1995-2002%29%
% 209.48/209.70 |- skos__altLabel mesh__D040881 CD11a Antigen
% 209.48/209.70 |- mesh__recordOriginator mesh__D040881 jmp
% 209.48/209.70 |- skos__scopeNote mesh__D040881
% 209.48/209.70 An alpha-integrin subunit found on lymphocytes, granulocytes, macrophages and monocytes. It combines with the integrin beta2 subunit %28%CD18 ANTIGEN%29% to form LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1.%A%
% 209.48/209.70 |- skos__hiddenLabel mesh__D040881 alphaL, Integrin
% 209.48/209.70 |- skos__altLabel mesh__D040881 Integrin alphaL
% 209.48/209.70 |- mesh__dateRevised mesh__D040881 2005-06-30
% 209.48/209.70 |- mesh__dateEstablished mesh__D040881 2003-01-01
% 209.48/209.70 |- mesh__recordMaintainer mesh__D040881 ssb
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D040881 sjn
% 209.48/209.70 |- mesh__dateCreated mesh__D040881 2002-07-02
% 209.48/209.70 |- skos__prefLabel mesh__D040881 Antigens, CD11a
% 209.48/209.70 |- mesh__recordMaintainer mesh__D012392 TAP
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 2002
% 209.48/209.70 |- skos__hiddenLabel mesh__D012392 Test, Rorschach
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 1993
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 1999
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 1996
% 209.48/209.70 |- skos__broader mesh__D012392smesh__D007282
% 209.48/209.70 |- mesh__dateRevised mesh__D012392 1992-05-18
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 2001
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 1995
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 1998
% 209.48/209.70 |- skos__prefLabel mesh__D012392 Rorschach Test
% 209.48/209.70 |- mesh__dateCreated mesh__D012392 1999-01-01
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 2000
% 209.48/209.70 |- skos__scopeNote mesh__D012392
% 209.48/209.70 A projective test used to evaluate a broad range of personality variables including pathology of thought and perception. The subject%27%s responses to inkblot prints are scored along with subjective interpretation by the test administrator.%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 1994
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 2004
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D012392 PLS
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 2006
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 2003
% 209.48/209.70 |- mesh__recordOriginator mesh__D012392 NLM
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 2005
% 209.48/209.70 |- rdf__type mesh__D012392sskos__Concept
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012392 1997
% 209.48/209.70 |- mesh__historyNote mesh__D020824 2000
% 209.48/209.70 |- mesh__dateRevised mesh__D020824 2004-07-13
% 209.48/209.70 |- skos__historyNote mesh__D020824 Neural Pathways %28%1967-1999%29%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D020824 2005
% 209.48/209.70 |- skos__broader mesh__D020824smesh__D000344
% 209.48/209.70 |- skos__prefLabel mesh__D020824 Spinocerebellar Tracts
% 209.48/209.70 |- mesh__dateCreated mesh__D020824 1999-11-03
% 209.48/209.70 |- mesh__dateEstablished mesh__D020824 2000-01-01
% 209.48/209.70 |- skos__hiddenLabel mesh__D020824 Spinocerebellar Tract
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D020824 2000
% 209.48/209.70 |- skos__hiddenLabel mesh__D020824 Tracts, Spinocerebellar
% 209.48/209.70 |- mesh__recordOriginator mesh__D020824 ags
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D020824 sjn
% 209.48/209.70 |- mesh__recordMaintainer mesh__D020824 sjn
% 209.48/209.70 |- skos__scopeNote mesh__D020824
% 209.48/209.70 Fibers that arise from cell groups within the spinal cord and pass directly to the cerebellum. They include the anterior, posterior, and rostral spinocerebellar tracts, and the cuneocerebellar tract. %28%From Parent, Carpenter%27%s Human Neuroanatomy, 9th ed, p607%29%%A%
% 209.48/209.70 |- rdf__type mesh__D020824sskos__Concept
% 209.48/209.70 |- skos__hiddenLabel mesh__D020824 Tract, Spinocerebellar
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D020824 2006
% 209.48/209.70 |- skos__annotation mesh__D006355
% 209.48/209.70 external: do not confuse with HEART, ARTIFICIAL %28%pump replacing whole or part of heart%29%%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006355 2004
% 209.48/209.70 |- skos__scopeNote mesh__D006355
% 209.48/209.70 Apparatus that provides mechanical circulatory support during open-heart surgery, by passing the heart to facilitate surgery on the organ. The basic function of the machine is to oxygenate the body%27%s venous supply of blood and then pump it back into the arterial system. The machine also provides intracardiac suction, filtration, and temperature control. Some of the more important components of these machines include pumps, oxygenators, temperature regulators, and filters. %28%UMDNS, 1999%29%%A%
% 209.48/209.70 |- mesh__recordMaintainer mesh__D006355 adp
% 209.48/209.70 |- skos__broader mesh__D006355smesh__D001187
% 209.48/209.70 |- rdf__type mesh__D006355sskos__Concept
% 209.48/209.70 |- skos__hiddenLabel mesh__D006355 Machine, Heart-Lung
% 209.48/209.70 |- mesh__dateCreated mesh__D006355 1999-01-01
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006355 2002
% 209.48/209.70 |- mesh__recordOriginator mesh__D006355 NLM
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006355 2005
% 209.48/209.70 |- skos__prefLabel mesh__D006355 Heart-Lung Machine
% 209.48/209.70 |- skos__hiddenLabel mesh__D006355 Heart Lung Machine
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D006355
% 209.48/209.70 98; see HEART, MECHANICAL 1963-97, for HEART-LUNG MACHINE see HEART, MECHANICAL 1967-97%A%
% 209.48/209.70 |- mesh__dateRevised mesh__D006355 1999-11-08
% 209.48/209.70 |- skos__hiddenLabel mesh__D006355 Heart-Lung Machines
% 209.48/209.70 |- mesh__historyNote mesh__D006355 98%28%63%29%
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D006355 sjn
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006355 2006
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006355 2000
% 209.48/209.70 |- skos__hiddenLabel mesh__D006355 Machines, Heart-Lung
% 209.48/209.70 |- skos__related mesh__D006355smesh__D010106
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006355 2003
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006355 2001
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D016783 2006
% 209.48/209.70 |- skos__scopeNote mesh__D016783
% 209.48/209.70 An order of parasitic PROTOZOA found in blood cells and epithelial cells of vertebrates and invertebrates. Life cycles involve both sexual and asexual phases.%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D016783 2004
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D016783 sjn
% 209.48/209.70 |- mesh__historyNote mesh__D016783 1992
% 209.48/209.70 |- skos__broader mesh__D016783smesh__D003044
% 209.48/209.70 |- mesh__recordOriginator mesh__D016783 PXP
% 209.48/209.70 |- skos__annotation mesh__D016783
% 209.48/209.70 infection: coord IM with COCCIDIOSIS %28%IM%29%; /drug eff: consider also COCCIDIOSTATS; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%
% 209.48/209.70 |- rdf__type mesh__D016783sskos__Concept
% 209.48/209.70 |- mesh__dateRevised mesh__D016783 2003-07-09
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D016783 1992
% 209.48/209.70 |- mesh__dateCreated mesh__D016783 1991-05-02
% 209.48/209.70 |- mesh__recordMaintainer mesh__D016783 ags
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D016783 2005
% 209.48/209.70 |- mesh__dateEstablished mesh__D016783 1992-01-01
% 209.48/209.70 |- skos__prefLabel mesh__D016783 Eucoccidiida
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002763 2006
% 209.48/209.70 |- skos__prefLabel mesh__D002763 Cholecystectomy
% 209.48/209.70 |- mesh__dateRevised mesh__D002763 2003-07-09
% 209.48/209.70 |- mesh__recordMaintainer mesh__D002763 lkt
% 209.48/209.70 |- skos__scopeNote mesh__D002763 Surgical removal of the GALLBLADDER.
% 209.48/209.70 |- skos__broader mesh__D002763smesh__D001662
% 209.48/209.70 |- skos__hiddenLabel mesh__D002763 Cholecystectomies
% 209.48/209.70 |- rdf__type mesh__D002763sskos__Concept
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D002763 sjn
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002763 2004
% 209.48/209.70 |- mesh__dateCreated mesh__D002763 1999-01-01
% 209.48/209.70 |- skos__related mesh__D002763smesh__D017562
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002763 2005
% 209.48/209.70 |- mesh__recordOriginator mesh__D002763 NLM
% 209.48/209.70 |- skos__broader mesh__D012393smesh__D012871
% 209.48/209.70 |- skos__hiddenLabel mesh__D012393 Rosacea, Granulomatous
% 209.48/209.70 |- mesh__recordOriginator mesh__D012393 NLM
% 209.48/209.70 |- skos__prefLabel mesh__D012393 Rosacea
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D012393
% 209.48/209.70 2005, 1963-1992; see ACNE ROSACEA 1993-2004
% 209.48/209.70 |- mesh__dateCreated mesh__D012393 1999-01-01
% 209.48/209.70 |- skos__scopeNote mesh__D012393
% 209.48/209.70 A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular %28%National Rosacea Society%27%s Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7%29%.%A%
% 209.48/209.70 |- skos__hiddenLabel mesh__D012393 Rosacea, Papulopustular
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012393 2006
% 209.48/209.70 |- skos__hiddenLabel mesh__D012393 Rosacea, Erythematotelangiectatic
% 209.48/209.70 |- skos__altLabel mesh__D012393 Acne Rosacea
% 209.48/209.70 |- mesh__historyNote mesh__D012393 2005, 1963-1992
% 209.48/209.70 |- mesh__dateRevised mesh__D012393 2004-07-07
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012393 2005
% 209.48/209.70 |- skos__hiddenLabel mesh__D012393 Rosacea, Ocular
% 209.48/209.70 |- mesh__recordMaintainer mesh__D012393 lkt
% 209.48/209.70 |- rdf__type mesh__D012393sskos__Concept
% 209.48/209.70 |- skos__hiddenLabel mesh__D012393 Rosacea, Phymatous
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D012393 sjn
% 209.48/209.70 |- mesh__dateCreated mesh__D020825 1999-11-03
% 209.48/209.70 |- mesh__dateRevised mesh__D020825 2005-06-30
% 209.48/209.70 |- skos__scopeNote mesh__D020825
% 209.48/209.70 Proteins containing a region of conserved sequence, about 200 amino acids long, which encodes a particular sequence specific DNA binding domain %28%the T-box domain%29%. These proteins are transcription factors that control developmental pathways. The prototype of this family is the mouse Brachyury %28%or T%29% gene product.%A%
% 209.48/209.70 |- skos__hiddenLabel mesh__D020825 T Box Domain Proteins
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D020825 sjn
% 209.48/209.70 |- skos__historyNote mesh__D020825 DNA-Binding Proteins %28%1996-1999%29%
% 209.48/209.70 |- skos__broader mesh__D020825smesh__D014157
% 209.48/209.70 |- skos__broader mesh__D020825smesh__D004268
% 209.48/209.70 |- mesh__recordMaintainer mesh__D020825 ags
% 209.48/209.70 |- skos__historyNote mesh__D020825 Transcription Factors %28%1996-1999%29%
% 209.48/209.70 |- mesh__recordOriginator mesh__D020825 nns
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D020825 2000
% 209.48/209.70 |- mesh__historyNote mesh__D020825 2000
% 209.48/209.70 |- skos__prefLabel mesh__D020825 T-Box Domain Proteins
% 209.48/209.70 |- rdf__type mesh__D020825sskos__Concept
% 209.48/209.70 |- skos__hiddenLabel mesh__D020825 Proteins, T-Box Domain
% 209.48/209.70 |- mesh__dateEstablished mesh__D020825 2000-01-01
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D020825 2006
% 209.48/209.70 |- skos__broader mesh__D006356smesh__D012817
% 209.48/209.70 |- skos__scopeNote mesh__D006356
% 209.48/209.70 Substernal pain or burning sensation, usually associated with regurgitation of gastric juice into the esophagus.%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006356 2000
% 209.48/209.70 |- rdf__type mesh__D006356sskos__Concept
% 209.48/209.70 |- skos__hiddenLabel mesh__D006356 Pyroses
% 209.48/209.70 |- mesh__dateEstablished mesh__D006356 1964-01-01
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006356 2001
% 209.48/209.70 |- skos__related mesh__D006356smesh__D005764
% 209.48/209.70 |- mesh__dateCreated mesh__D006356 1999-01-01
% 209.48/209.70 |- mesh__historyNote mesh__D006356 64
% 209.48/209.70 |- skos__altLabel mesh__D006356 Pyrosis
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006356 2005
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D006356 64
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006356 2006
% 209.48/209.70 |- mesh__recordOriginator mesh__D006356 NLM
% 209.48/209.70 |- mesh__recordMaintainer mesh__D006356 KEV
% 209.48/209.70 |- mesh__dateRevised mesh__D006356 1999-11-03
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006356 2002
% 209.48/209.70 |- skos__prefLabel mesh__D006356 Heartburn
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006356 2003
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D006356 sjn
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006356 2004
% 209.48/209.70 |- skos__annotation mesh__D020027 a species of archaea
% 209.48/209.70 |- skos__scopeNote mesh__D020027
% 209.48/209.70 A species of strictly anaerobic, hyperthermophilic archaea which lives in geothermally-heated marine sediments. It exhibits heterotropic growth by fermentation or sulfur respiration.%A%
% 209.48/209.70 |- mesh__dateRevised mesh__D020027 2005-06-30
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D020027 99
% 209.48/209.70 |- skos__historyNote mesh__D020027 Archaea %28%1989-1998%29%
% 209.48/209.70 |- mesh__historyNote mesh__D020027 99
% 209.48/209.70 |- rdf__type mesh__D020027sskos__Concept
% 209.48/209.70 |- mesh__recordOriginator mesh__D020027 AGS
% 209.48/209.70 |- skos__broader mesh__D020027smesh__D019711
% 209.48/209.70 |- mesh__dateCreated mesh__D020027 1998-06-10
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D020027 2006
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D020027 sjn
% 209.48/209.70 |- mesh__recordMaintainer mesh__D020027 SYSTEM
% 209.48/209.70 |- mesh__dateEstablished mesh__D020027 1999-01-01
% 209.48/209.70 |- skos__prefLabel mesh__D020027 Pyrococcus furiosus
% 209.48/209.70 |- mesh__recordOriginator mesh__D002764 NLM
% 209.48/209.70 |- skos__broader mesh__D002764smesh__D005705
% 209.48/209.70 |- skos__altLabel mesh__D002764 Gallbladder Inflammation
% 209.48/209.70 |- mesh__dateRevised mesh__D002764 2003-07-09
% 209.48/209.70 |- skos__altLabel mesh__D002764 Empyema, Gall Bladder
% 209.48/209.70 |- skos__hiddenLabel mesh__D002764 Inflammation, Gallbladder
% 209.48/209.70 |- rdf__type mesh__D002764sskos__Concept
% 209.48/209.70 |- skos__hiddenLabel mesh__D002764 Gall Bladder Empyema
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002764 2004
% 209.48/209.70 |- skos__scopeNote mesh__D002764
% 209.48/209.70 Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.%A%
% 209.48/209.70 |- mesh__dateCreated mesh__D002764 1999-01-01
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002764 2005
% 209.48/209.70 |- mesh__recordMaintainer mesh__D002764 lkt
% 209.48/209.70 |- skos__annotation mesh__D002764
% 209.48/209.70 note specifics; X ref EMPYEMA, GALLBLADDER: restrict to gallbladder; %22%biliary empyema%22%: unless of gallbladder, index under EMPYEMA %28%IM%29% + BILIARY TRACT DISEASES %28%IM%29% or specific biliary precoord%A%
% 209.48/209.70 |- skos__hiddenLabel mesh__D002764 Gallbladder Empyema
% 209.48/209.70 |- skos__related mesh__D002764smesh__D002761
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002764 2006
% 209.48/209.70 |- skos__prefLabel mesh__D002764 Cholecystitis
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D002764 sjn
% 209.48/209.70 |- mesh__dateEstablished mesh__D029901 2002-01-01
% 209.48/209.70 |- skos__annotation mesh__D029901
% 209.48/209.70 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029901 2004
% 209.48/209.70 |- mesh__dateCreated mesh__D029901 2001-07-25
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029901 2002
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D029901 2002
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029901 2005
% 209.48/209.70 |- skos__broader mesh__D029901smesh__D007887
% 209.48/209.70 |- skos__prefLabel mesh__D029901 Maackia
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029901 2006
% 209.48/209.70 |- skos__scopeNote mesh__D029901
% 209.48/209.70 A plant genus of the family FABACEAE. It contains a hemagglutinin.%A%
% 209.48/209.70 |- skos__altLabel mesh__D029901 Macckia
% 209.48/209.70 |- rdf__type mesh__D029901sskos__Concept
% 209.48/209.70 |- mesh__historyNote mesh__D029901 2002
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D029901 2003
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D048068 sjn
% 209.48/209.70 |- mesh__recordMaintainer mesh__D048068 ssb
% 209.48/209.70 |- skos__hiddenLabel mesh__D048068 PPAR beta
% 209.48/209.70 |- skos__altLabel mesh__D048068 PPARbeta
% 209.48/209.70 |- skos__historyNote mesh__D048068 Transcription Factors %28%1993-2004%29%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D048068 2006
% 209.48/209.70 |- rdf__type mesh__D048068sskos__Concept
% 209.48/209.70 |- skos__scopeNote mesh__D048068
% 209.48/209.70 One of the PPAR nuclear transcription factors.
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D048068
% 209.48/209.70 2005; PPAR BETA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D048068 2005
% 209.48/209.70 |- mesh__dateEstablished mesh__D048068 2005-01-01
% 209.48/209.70 |- mesh__dateCreated mesh__D048068 2004-07-07
% 209.48/209.70 |- mesh__recordOriginator mesh__D048068 ssb
% 209.48/209.70 |- mesh__historyNote mesh__D048068 2005%28%1992%29%
% 209.48/209.70 |- skos__prefLabel mesh__D048068 PPAR-beta
% 209.48/209.70 |- skos__broader mesh__D048068smesh__D047492
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D012394 2006
% 209.48/209.70 |- mesh__recordMaintainer mesh__D012394 sjn
% 209.48/209.70 |- mesh__dateRevised mesh__D012394 2005-07-01
% 209.48/209.70 |- skos__hiddenLabel mesh__D012394 Compounds, Triphenylmethane Aniline
% 209.48/209.70 |- skos__altLabel mesh__D012394 Magentas
% 209.48/209.70 |- skos__altLabel mesh__D012394 Fuchsin
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D012394 sjn
% 209.48/209.70 |- mesh__historyNote mesh__D012394
% 209.48/209.70 FUCHSINS was FUCHSIN see under ROSANILINE DYES 1963-80
% 209.48/209.70 |- skos__broader mesh__D012394smesh__D000814
% 209.48/209.70 |- rdf__type mesh__D012394sskos__Concept
% 209.48/209.70 |- skos__hiddenLabel mesh__D012394 Aniline Compounds, Triphenylmethane
% 209.48/209.70 |- mesh__recordOriginator mesh__D012394 NLM
% 209.48/209.70 |- skos__scopeNote mesh__D012394
% 209.48/209.70 Compounds that contain the triphenylmethane aniline structure found in rosaniline. Many of them have a characteristic magenta color and are used as COLORING AGENTS.%A%
% 209.48/209.70 |- mesh__onlineNote mesh__D012394
% 209.48/209.70 use ROSANILINE DYES to search FUCHSIN 1966-80
% 209.48/209.70 |- skos__altLabel mesh__D012394 Triphenylmethane Aniline Compounds
% 209.48/209.70 |- skos__altLabel mesh__D012394 Fuchsins
% 209.48/209.70 |- skos__hiddenLabel mesh__D012394 Dyes, Rosaniline
% 209.48/209.70 |- mesh__dateCreated mesh__D012394 1999-01-01
% 209.48/209.70 |- skos__prefLabel mesh__D012394 Rosaniline Dyes
% 209.48/209.70 |- skos__broader mesh__D004041Q000737smesh__D004041
% 209.48/209.70 |- mesh__preferredCombination mesh__D004041Q000737smesh__D005223Q000737
% 209.48/209.70 |- rdf__type mesh__D004041Q000737smesh__CompoundConcept
% 209.48/209.70 |- skos__broader mesh__D020826smesh__D020692
% 209.48/209.70 |- skos__altLabel mesh__D020826 rab3A Protein
% 209.48/209.70 |- mesh__recordMaintainer mesh__D020826 jmp
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D020826
% 209.48/209.70 2000; RAB3A PROTEIN was indexed under G-PROTEINS 1992-1999%A%
% 209.48/209.70 |- skos__hiddenLabel mesh__D020826 GTP-Binding Protein, rab3A
% 209.48/209.70 |- mesh__dateCreated mesh__D020826 1999-11-03
% 209.48/209.70 |- mesh__dateRevised mesh__D020826 2005-06-30
% 209.48/209.70 |- skos__prefLabel mesh__D020826 rab3A GTP-Binding Protein
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D020826 sjn
% 209.48/209.70 |- skos__hiddenLabel mesh__D020826 rab3A GTP Binding Protein
% 209.48/209.70 |- skos__altLabel mesh__D020826 smg25a GTP Binding Protein
% 209.48/209.70 |- skos__historyNote mesh__D020826 G-Proteins %28%1992-1999%29%
% 209.48/209.70 |- skos__scopeNote mesh__D020826
% 209.48/209.70 The most abundant member of the RAB3 GTP-BINDING PROTEINS. It is involved in calcium-dependent EXOCYTOSIS and is localized to neurons and neuroendocrine cells. This enzyme was formerly listed as EC 3.6.1.47.%A%
% 209.48/209.70 |- mesh__recordOriginator mesh__D020826 jmp
% 209.48/209.70 |- rdf__type mesh__D020826sskos__Concept
% 209.48/209.70 |- mesh__dateEstablished mesh__D020826 2000-01-01
% 209.48/209.70 |- mesh__historyNote mesh__D020826
% 209.48/209.70 2000; for RAB3A PROTEIN see RAB3 GTP-BINDING PROTEINS %28%NM%29% 1992-1999;%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D020826 2006
% 209.48/209.70 |- skos__altLabel mesh__D020826 smg p25A Protein
% 209.48/209.70 |- skos__annotation mesh__D020826 DF: RAB3A PROTEIN
% 209.48/209.70 |- skos__hiddenLabel mesh__D020826 p25A Protein, smg
% 209.48/209.70 |- skos__broader mesh__D006357smesh__D000820
% 209.48/209.70 |- skos__historyNote mesh__D006357 Rickettsial Infections %28%1966-1969%29%
% 209.48/209.70 |- skos__broader mesh__D006357smesh__D017282
% 209.48/209.70 |- mesh__recordMaintainer mesh__D006357 ags
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D006357 sjn
% 209.48/209.70 |- mesh__dateRevised mesh__D006357 2003-07-09
% 209.48/209.70 |- skos__prefLabel mesh__D006357 Heartwater Disease
% 209.48/209.70 |- skos__hiddenLabel mesh__D006357 Disease, Heartwater
% 209.48/209.70 |- rdf__type mesh__D006357sskos__Concept
% 209.48/209.70 |- skos__historyNote mesh__D006357 Cattle Diseases %28%1966-1969%29%
% 209.48/209.70 |- mesh__dateCreated mesh__D006357 1999-01-01
% 209.48/209.70 |- skos__broader mesh__D006357smesh__D016873
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006357 2006
% 209.48/209.70 |- mesh__historyNote mesh__D006357 70
% 209.48/209.70 |- mesh__dateEstablished mesh__D006357 1970-01-01
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006357 2005
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D006357 70
% 209.48/209.70 |- skos__scopeNote mesh__D006357
% 209.48/209.70 A tick-borne septicemic disease of domestic and wild ruminants caused by EHRLICHIA RUMINANTIUM.%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D006357 2004
% 209.48/209.70 |- mesh__recordOriginator mesh__D006357 NLM
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D016785 2004
% 209.48/209.70 |- mesh__recordMaintainer mesh__D016785 ags
% 209.48/209.70 |- mesh__dateRevised mesh__D016785 2003-07-09
% 209.48/209.70 |- skos__scopeNote mesh__D016785
% 209.48/209.70 A species of parasitic protozoa that infects humans and most domestic mammals. Its oocysts measure five microns in diameter. These organisms exhibit alternating cycles of sexual and asexual reproduction.%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D016785 2006
% 209.48/209.70 |- mesh__dateEstablished mesh__D016785 1992-01-01
% 209.48/209.70 |- skos__broader mesh__D016785smesh__D003458
% 209.48/209.70 |- skos__historyNote mesh__D016785 Cryptosporidium %28%1985-1991%29%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D016785 2005
% 209.48/209.70 |- mesh__publicMeSHNote mesh__D016785 92
% 209.48/209.70 |- mesh__recordOriginator mesh__D016785 PXP
% 209.48/209.70 |- mesh__historyNote mesh__D016785 92
% 209.48/209.70 |- rdf__type mesh__D016785sskos__Concept
% 209.48/209.70 |- mesh__dateCreated mesh__D016785 1991-05-02
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D016785 sjn
% 209.48/209.70 |- skos__prefLabel mesh__D016785 Cryptosporidium parvum
% 209.48/209.70 |- skos__annotation mesh__D016785
% 209.48/209.70 infection: coord IM with CRYPTOSPORIDIOSIS %28%IM%29%; /drug eff: consider also COCCIDIOSTATS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002765 2002
% 209.48/209.70 |- skos__scopeNote mesh__D002765
% 209.48/209.70 Radiography of the gallbladder after ingestion of a contrast medium.%A%
% 209.48/209.70 |- mesh__recordAuthorizer mesh__D002765 SJN
% 209.48/209.70 |- rdf__type mesh__D002765sskos__Concept
% 209.48/209.70 |- skos__annotation mesh__D002765
% 209.48/209.70 do not use /util except by MeSH definition; DF: CHOLECYSTOGR%A%
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002765 2003
% 209.48/209.70 |- skos__broader mesh__D002765smesh__D003938
% 209.48/209.70 |- mesh__dateCreated mesh__D002765 1999-01-01
% 209.48/209.70 |- mesh__recordMaintainer mesh__D002765 PXP
% 209.48/209.70 |- skos__hiddenLabel mesh__D002765 Cholecystographies
% 209.48/209.70 |- mesh__activeMeSHYear mesh__D002765 2004
% 209.48/209.71 |- mesh__dateRevised mesh__D002765 1997-06-20
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D002765 2000
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D002765 1998
% 209.48/209.71 |- skos__broader mesh__D002765smesh__D011860
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D002765 2005
% 209.48/209.71 |- skos__prefLabel mesh__D002765 Cholecystography
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D002765 2001
% 209.48/209.71 |- mesh__recordOriginator mesh__D002765 NLM
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D002765 1999
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D002765 2006
% 209.48/209.71 |- skos__scopeNote mesh__D035141
% 209.48/209.71 Programs in which participation is not required.
% 209.48/209.71 |- mesh__historyNote mesh__D035141 2003
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D035141 2006
% 209.48/209.71 |- skos__hiddenLabel mesh__D035141 Voluntary Program
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D035141 2003
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D035141 2005
% 209.48/209.71 |- skos__broader mesh__D035141smesh__D009934
% 209.48/209.71 |- skos__related mesh__D035141smesh__D037141
% 209.48/209.71 |- skos__hiddenLabel mesh__D035141 Programs, Voluntary
% 209.48/209.71 |- rdf__type mesh__D035141sskos__Concept
% 209.48/209.71 |- skos__hiddenLabel mesh__D035141 Program, Voluntary
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D035141 2003
% 209.48/209.71 |- skos__prefLabel mesh__D035141 Voluntary Programs
% 209.48/209.71 |- mesh__dateCreated mesh__D035141 2002-07-03
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D035141 2004
% 209.48/209.71 |- mesh__dateEstablished mesh__D035141 2003-01-01
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029902 2002
% 209.48/209.71 |- mesh__dateCreated mesh__D029902 2001-07-25
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029902 2004
% 209.48/209.71 |- skos__scopeNote mesh__D029902
% 209.48/209.71 A plant genus of the family FABACEAE. It is distinct from Sweet Clover %28%MELILOTUS%29%, from Bush Clover %28%LESPEDEZA%29%, and from Red Clover %28%TRIFOLIUM%29%.%A%
% 209.48/209.71 |- skos__annotation mesh__D029902
% 209.48/209.71 note X ref CLOVER: BUSH CLOVER see LESPEDEZA; SWEET CLOVER see MELILOTUS; and RED CLOVER see TRIFOLIUM are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029902 2005
% 209.48/209.71 |- mesh__dateRevised mesh__D029902 2005-07-18
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D029902 2002
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D029902 ags
% 209.48/209.71 |- rdf__type mesh__D029902sskos__Concept
% 209.48/209.71 |- skos__broader mesh__D029902smesh__D007887
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029902 2006
% 209.48/209.71 |- mesh__recordOriginator mesh__D029902 ssb
% 209.48/209.71 |- mesh__historyNote mesh__D029902 2002
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029902 2006A
% 209.48/209.71 |- mesh__dateEstablished mesh__D029902 2002-01-01
% 209.48/209.71 |- skos__prefLabel mesh__D029902 Medicago
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029902 2003
% 209.48/209.71 |- mesh__recordMaintainer mesh__D029902 ags
% 209.48/209.71 |- skos__broader mesh__D021121smesh__D015336
% 209.48/209.71 |- skos__hiddenLabel mesh__D021121 bDNA Assays
% 209.48/209.71 |- skos__altLabel mesh__D021121 bDNA Assay
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D021121 2002
% 209.48/209.71 |- skos__hiddenLabel mesh__D021121 Assays, bDNA
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D021121 2006
% 209.48/209.71 |- skos__broader mesh__D021121smesh__D009693
% 209.48/209.71 |- skos__hiddenLabel mesh__D021121 Assays, Branched DNA
% 209.48/209.71 |- mesh__dateEstablished mesh__D021121 2001-01-01
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D021121 2001
% 209.48/209.71 |- mesh__dateCreated mesh__D021121 2000-06-21
% 209.48/209.71 |- skos__hiddenLabel mesh__D021121 Branched DNA Assays
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D021121 2005
% 209.48/209.71 |- skos__prefLabel mesh__D021121 Branched DNA Signal Amplification Assay
% 209.48/209.71 |- skos__hiddenLabel mesh__D021121 Assay, Branched DNA
% 209.48/209.71 |- skos__altLabel mesh__D021121 Branched DNA Assay
% 209.48/209.71 |- skos__historyNote mesh__D021121
% 209.48/209.71 Molecular Probe Techniques %28%1991-2000%29%
% 209.48/209.71 |- skos__hiddenLabel mesh__D021121 Assay, bDNA
% 209.48/209.71 |- rdf__type mesh__D021121sskos__Concept
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D021121 2004
% 209.48/209.71 |- mesh__historyNote mesh__D021121 2001
% 209.48/209.71 |- skos__scopeNote mesh__D021121
% 209.48/209.71 A molecular probe technique that utilizes branched DNA %28%bDNA%29% as a means to amplify the hybridization signal. One end of the bDNA molecule is designed to bind a specific target, while the other end of the bDNA molecule contains many branches of DNA that are designed to bind a probe used for signal detection.%A%
% 209.48/209.71 |- skos__annotation mesh__D021121 DF: BDNA ASSAY
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D021121 2001
% 209.48/209.71 |- skos__altLabel mesh__D021121 bDNA Signal Amplification Assay
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D021121 2003
% 209.48/209.71 |- mesh__historyNote mesh__D048069 2005
% 209.48/209.71 |- skos__scopeNote mesh__D048069
% 209.48/209.71 A family of proteins that were originally identified by their ability to cause NECROSIS of NEOPLASMS. Their necrotic effect on cells is mediated through TUMOR NECROSIS FACTOR RECEPTORS which induce APOPTOSIS.%A%
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D048069 2006
% 209.48/209.71 |- skos__broader mesh__D048069smesh__D036341
% 209.48/209.71 |- rdf__type mesh__D048069sskos__Concept
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D048069 sjn
% 209.48/209.71 |- mesh__recordMaintainer mesh__D048069 ssb
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D048069 2005
% 209.48/209.71 |- mesh__dateCreated mesh__D048069 2004-07-07
% 209.48/209.71 |- skos__hiddenLabel mesh__D048069 Receptor Ligands, TNF
% 209.48/209.71 |- skos__broader mesh__D048069smesh__D016207
% 209.48/209.71 |- mesh__recordOriginator mesh__D048069 jmp
% 209.48/209.71 |- skos__altLabel mesh__D048069 TNF Receptor Ligands
% 209.48/209.71 |- mesh__dateRevised mesh__D048069 2005-06-30
% 209.48/209.71 |- mesh__dateEstablished mesh__D048069 2005-01-01
% 209.48/209.71 |- skos__prefLabel mesh__D048069 Tumor Necrosis Factors
% 209.48/209.71 |- skos__hiddenLabel mesh__D048069 Necrosis Factors, Tumor
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D012395 2005
% 209.48/209.71 |- skos__scopeNote mesh__D012395
% 209.48/209.71 A bright bluish pink compound that has been used as a dye, biological stain, and diagnostic aid.%A%
% 209.48/209.71 |- mesh__recordMaintainer mesh__D012395 ssb
% 209.48/209.71 |- skos__hiddenLabel mesh__D012395 Bengal, Rose
% 209.48/209.71 |- rdf__type mesh__D012395sskos__Concept
% 209.48/209.71 |- skos__prefLabel mesh__D012395 Rose Bengal
% 209.48/209.71 |- skos__annotation mesh__D012395 D25-26n qualif
% 209.48/209.71 |- mesh__dateRevised mesh__D012395 2001-07-25
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D012395 sjn
% 209.48/209.71 |- mesh__dateCreated mesh__D012395 1999-01-01
% 209.48/209.71 |- mesh__recordOriginator mesh__D012395 NLM
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D012395 2004
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D012395 2002
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D012395 2006
% 209.48/209.71 |- skos__broader mesh__D012395smesh__D005452
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D012395 2003
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 SMG p21A GTP Binding Protein
% 209.48/209.71 |- mesh__recordOriginator mesh__D020827 jmp
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 rap1A GTP Binding Protein
% 209.48/209.71 |- skos__altLabel mesh__D020827 smg p21A Protein
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 p21A Protein, smg
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 Krev 1 Protein
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 GTP-Binding Protein, rap1A
% 209.48/209.71 |- skos__altLabel mesh__D020827 rap1A Protein
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D020827
% 209.48/209.71 2000; RAP1A PROTEIN, K-REV-1 PROTEIN %26% SMG P21A were indexed under G-PROTEINS 1991-1999%A%
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 GTP-Binding Protein, Krev-1
% 209.48/209.71 |- rdf__type mesh__D020827sskos__Concept
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 GTP-Binding Protein, rap1
% 209.48/209.71 |- skos__scopeNote mesh__D020827
% 209.48/209.71 A genetically related subfamily of RAP GTP-BINDING PROTEINS that share homology with RAS PROTEINS. They bind to Ras effectors but do not activate them, therefore they may antagonize the effects of RAS PROTEINS. This enzyme was formerly listed as EC 3.6.1.47.%A%
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 rap1 GTP Binding Proteins
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020827 2006
% 209.48/209.71 |- skos__altLabel mesh__D020827 smg p21 GTP-Binding Protein
% 209.48/209.71 |- skos__prefLabel mesh__D020827 rap1 GTP-Binding Proteins
% 209.48/209.71 |- skos__altLabel mesh__D020827 rap1A GTP-Binding Protein
% 209.48/209.71 |- mesh__dateCreated mesh__D020827 1999-11-03
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 Krev 1 GTP Binding Protein
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 GTP-Binding Proteins, rap1
% 209.48/209.71 |- skos__altLabel mesh__D020827 SMG p21A GTP-Binding Protein
% 209.48/209.71 |- mesh__dateEstablished mesh__D020827 2000-01-01
% 209.48/209.71 |- skos__historyNote mesh__D020827 G-Proteins %28%1991-1999%29%
% 209.48/209.71 |- mesh__dateRevised mesh__D020827 2005-06-30
% 209.48/209.71 |- mesh__historyNote mesh__D020827
% 209.48/209.71 2000; for RAP1A PROTEIN, K-REV-1 PROTEIN %26% SMG P21A use RAP GTP-BINDING PROTEINS %28%NM%29% 1991-1999%A%
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D020827 sjn
% 209.48/209.71 |- mesh__recordMaintainer mesh__D020827 jmp
% 209.48/209.71 |- skos__altLabel mesh__D020827 Krev-1 GTP-Binding Protein
% 209.48/209.71 |- skos__broader mesh__D020827smesh__D020668
% 209.48/209.71 |- skos__altLabel mesh__D020827 Krev-1 Protein
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 smg p21 GTP Binding Protein
% 209.48/209.71 |- skos__hiddenLabel mesh__D020827 rap1 GTP Binding Protein
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006358 2001
% 209.48/209.71 |- skos__prefLabel mesh__D006358 Heat
% 209.48/209.71 |- mesh__considerAlso mesh__D006358 consider also terms at THERM-
% 209.48/209.71 |- rdf__type mesh__D006358sskos__Concept
% 209.48/209.71 |- mesh__recordOriginator mesh__D006358 NLM
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006358 2000
% 209.48/209.71 |- mesh__dateCreated mesh__D006358 1999-01-01
% 209.48/209.71 |- skos__related mesh__D006358smesh__D017694
% 209.48/209.71 |- skos__broader mesh__D006358smesh__D013816
% 209.48/209.71 |- mesh__dateRevised mesh__D006358 1997-06-20
% 209.48/209.71 |- skos__related mesh__D006358smesh__D002151
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006358 1999
% 209.48/209.71 |- skos__related mesh__D006358smesh__D006979
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006358 2006
% 209.48/209.71 |- skos__broader mesh__D006358smesh__D013696
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006358 2002
% 209.48/209.71 |- mesh__recordMaintainer mesh__D006358 TGC
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006358 2004
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006358 1998
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006358 2005
% 209.48/209.71 |- skos__related mesh__D006358smesh__D014329
% 209.48/209.71 |- skos__related mesh__D006358smesh__D003889
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D006358 SJN
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006358 2003
% 209.48/209.71 |- skos__annotation mesh__D006358
% 209.48/209.71 differentiate from HEATING %28%the environment%29%; /ther use: consider also HYPERTHERMIA, INDUCED; HEAT /adv eff: consider also HEAT STRESS DISORDERS %26% its specifics%A%
% 209.48/209.71 |- skos__scopeNote mesh__D006358
% 209.48/209.71 The form of energy and the sensation of an increase in temperature. Its interest in medicine is largely with reference to its physiological effects, its therapeutic use, and its use in procedures in physics and physical chemistry.%A%
% 209.48/209.71 |- skos__related mesh__D020029smesh__D001482
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020029 2005
% 209.48/209.71 |- mesh__dateCreated mesh__D020029 1998-06-10
% 209.48/209.71 |- skos__broader mesh__D020029smesh__D009690
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D020029 99; see BASE COMPOSITION 1980-98
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D020029 sjn
% 209.48/209.71 |- skos__altLabel mesh__D020029 Base Pair
% 209.48/209.71 |- skos__scopeNote mesh__D020029
% 209.48/209.71 Pairing of purine and pyrimidine bases by hydrogen bonding in double-stranded DNA or RNA.%A%
% 209.48/209.71 |- rdf__type mesh__D020029sskos__Concept
% 209.48/209.71 |- skos__prefLabel mesh__D020029 Base Pairing
% 209.48/209.71 |- skos__related mesh__D020029smesh__D020137
% 209.48/209.71 |- mesh__historyNote mesh__D020029 99; use BASE COMPOSITION 1980-98
% 209.48/209.71 |- skos__historyNote mesh__D020029
% 209.48/209.71 Nucleic Acid Conformation %28%1972-1998%29%
% 209.48/209.71 |- mesh__dateEstablished mesh__D020029 1999-01-01
% 209.48/209.71 |- mesh__dateRevised mesh__D020029 2004-07-07
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020029 2006
% 209.48/209.71 |- mesh__recordOriginator mesh__D020029 NNS
% 209.48/209.71 |- skos__historyNote mesh__D020029 Base Composition %28%1980-1998%29%
% 209.48/209.71 |- mesh__recordMaintainer mesh__D020029 nns
% 209.48/209.71 |- skos__annotation mesh__D020029 coord with DNA or RNA or specific
% 209.48/209.71 |- skos__altLabel mesh__D020029 Base Pairs
% 209.48/209.71 |- skos__hiddenLabel mesh__D020029 Base Pairings
% 209.48/209.71 |- skos__broader mesh__D003060smesh__D005395
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D003060
% 209.48/209.71 91; was see under FISH OILS 1983-90; was see under FISH LIVER OILS 1963-82%A%
% 209.48/209.71 |- rdf__type mesh__D003060sskos__Concept
% 209.48/209.71 |- mesh__recordMaintainer mesh__D003060 ssb
% 209.48/209.71 |- mesh__dateCreated mesh__D003060 1999-01-01
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D003060 2004
% 209.48/209.71 |- skos__broader mesh__D003060smesh__D005224
% 209.48/209.71 |- skos__scopeNote mesh__D003060
% 209.48/209.71 Oil obtained from fresh livers of the cod family, Gadidae. It is a source of vitamins A and D.%A%
% 209.48/209.71 |- mesh__onlineNote mesh__D003060 search FISH OILS 1966-74
% 209.48/209.71 |- skos__prefLabel mesh__D003060 Cod Liver Oil
% 209.48/209.71 |- mesh__recordOriginator mesh__D003060 NLM
% 209.48/209.71 |- skos__broader mesh__D003060smesh__D004042
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D003060 sjn
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D003060 2006
% 209.48/209.71 |- mesh__dateRevised mesh__D003060 2003-07-09
% 209.48/209.71 |- mesh__dateEstablished mesh__D003060 1991-01-01
% 209.48/209.71 |- mesh__historyNote mesh__D003060
% 209.48/209.71 91%28%75%29%; was see under FISH OILS 1983-90; was see under FISH LIVER OILS 1963-82%A%
% 209.48/209.71 |- skos__hiddenLabel mesh__D003060 Oil, Cod Liver
% 209.48/209.71 |- skos__hiddenLabel mesh__D003060 Liver Oil, Cod
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D003060 2005
% 209.48/209.71 |- skos__broader mesh__D012965Q000737smesh__D012965
% 209.48/209.71 |- rdf__type mesh__D012965Q000737smesh__CompoundConcept
% 209.48/209.71 |- mesh__historyNote mesh__D016786 92
% 209.48/209.71 |- rdf__type mesh__D016786sskos__Concept
% 209.48/209.71 |- skos__broader mesh__D016786smesh__D004539
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D016786 sjn
% 209.48/209.71 |- mesh__recordOriginator mesh__D016786 PXP
% 209.48/209.71 |- mesh__dateEstablished mesh__D016786 1992-01-01
% 209.48/209.71 |- skos__scopeNote mesh__D016786
% 209.48/209.71 A species of coccidian protozoa that mainly infects domestic poultry.%A%
% 209.48/209.71 |- skos__annotation mesh__D016786
% 209.48/209.71 infection: coord IM with COCCIDIOSIS %28%IM%29%; drug eff: consider also COCCIDIOSTATS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.48/209.71 |- skos__prefLabel mesh__D016786 Eimeria tenella
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D016786 2004
% 209.48/209.71 |- skos__historyNote mesh__D016786 Eimeria %28%1966-1991%29%
% 209.48/209.71 |- mesh__dateRevised mesh__D016786 2003-07-09
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D016786 2006
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D016786 92
% 209.48/209.71 |- mesh__recordMaintainer mesh__D016786 ags
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D016786 2005
% 209.48/209.71 |- mesh__dateCreated mesh__D016786 1991-05-02
% 209.48/209.71 |- skos__related mesh__D002766smesh__D011949
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D002766 sjn
% 209.48/209.71 |- mesh__historyNote mesh__D002766
% 209.48/209.71 PANCREOZYMIN was heading 1963-76 %28%Prov 1963-66%29%, was see under GASTROINTESTINAL HORMONES 1963-66%A%
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D002766 2006
% 209.48/209.71 |- skos__prefLabel mesh__D002766 Cholecystokinin
% 209.48/209.71 |- mesh__dateCreated mesh__D002766 1999-01-01
% 209.48/209.71 |- mesh__recordOriginator mesh__D002766 NLM
% 209.48/209.71 |- skos__scopeNote mesh__D002766
% 209.48/209.71 A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine %28%or digestive%29% enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.%A%
% 209.48/209.71 |- mesh__recordMaintainer mesh__D002766 ssb
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D002766 PANCREOZYMIN was heading 1967-76
% 209.48/209.71 |- skos__broader mesh__D002766smesh__D010455
% 209.48/209.71 |- skos__altLabel mesh__D002766 Uropancreozymin
% 209.48/209.71 |- mesh__dateRevised mesh__D002766 2005-06-30
% 209.48/209.71 |- rdf__type mesh__D002766sskos__Concept
% 209.48/209.71 |- skos__altLabel mesh__D002766 Pancreozymin
% 209.48/209.71 |- skos__altLabel mesh__D002766 Cholecystokinin 33
% 209.48/209.71 |- mesh__onlineNote mesh__D002766
% 209.48/209.71 use CHOLECYSTOKININ to search PANCREOZYMIN 1966-76 %28%as Prov 1966%29%%A%
% 209.48/209.71 |- skos__related mesh__D002766smesh__D005765
% 209.48/209.71 |- skos__broader mesh__D002766smesh__D009479
% 209.48/209.71 |- skos__broader mesh__D002766smesh__D005768
% 209.48/209.71 |- skos__scopeNote mesh__D029903 A plant genus of the family FABACEAE.
% 209.48/209.71 |- mesh__historyNote mesh__D029903 2002
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029903 2006A
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029903 2005
% 209.48/209.71 |- skos__prefLabel mesh__D029903 Melilotus
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D029903 2002
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D029903 ags
% 209.48/209.71 |- rdf__type mesh__D029903sskos__Concept
% 209.48/209.71 |- skos__broader mesh__D029903smesh__D007887
% 209.48/209.71 |- mesh__dateCreated mesh__D029903 2001-07-25
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029903 2006
% 209.48/209.71 |- mesh__recordOriginator mesh__D029903 ssb
% 209.48/209.71 |- mesh__dateEstablished mesh__D029903 2002-01-01
% 209.48/209.71 |- skos__altLabel mesh__D029903 Clover, Sweet
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029903 2003
% 209.48/209.71 |- mesh__recordMaintainer mesh__D029903 ags
% 209.48/209.71 |- mesh__dateRevised mesh__D029903 2005-07-19
% 209.48/209.71 |- skos__annotation mesh__D029903
% 209.48/209.71 note X ref SWEET CLOVER: CLOVER see MEDICAGO; BUSH CLOVER see LESPEDEZA; and RED CLOVER see TRIFOLIUM are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D029903 2004
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D007451 2003
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D007451 sjn
% 209.48/209.71 |- skos__broader mesh__D007451smesh__D014283
% 209.48/209.71 |- skos__prefLabel mesh__D007451 Iodamide
% 209.48/209.71 |- mesh__recordMaintainer mesh__D007451 CCR
% 209.48/209.71 |- mesh__dateCreated mesh__D007451 1974-11-19
% 209.48/209.71 |- skos__historyNote mesh__D007451 Iodobenzoates %28%1974%29%
% 209.48/209.71 |- skos__scopeNote mesh__D007451
% 209.48/209.71 An ionic monomeric contrast medium. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p706%29%%A%
% 209.48/209.71 |- skos__annotation mesh__D007451 D25-26 qualif
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D007451
% 209.48/209.71 91; was see under IODOBENZOATES 1975-90
% 209.48/209.71 |- skos__historyNote mesh__D007451 Acetamides %28%1974%29%
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D007451 2006
% 209.48/209.71 |- mesh__historyNote mesh__D007451
% 209.48/209.71 91%28%75%29%; was see under IODOBENZOATES 1975-90
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D007451 2005
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D007451 2002
% 209.48/209.71 |- mesh__dateRevised mesh__D007451 2000-06-22
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D007451 2004
% 209.48/209.71 |- rdf__type mesh__D007451sskos__Concept
% 209.48/209.71 |- mesh__dateEstablished mesh__D007451 1991-01-01
% 209.48/209.71 |- mesh__recordOriginator mesh__D007451 NLM
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D007451 2001
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D021122 2001
% 209.48/209.71 |- skos__altLabel mesh__D021122 Protomer
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D021122 2006
% 209.48/209.71 |- mesh__dateRevised mesh__D021122 2003-07-25
% 209.48/209.71 |- skos__altLabel mesh__D021122 Protein Subunit
% 209.48/209.71 |- mesh__dateEstablished mesh__D021122 2001-01-01
% 209.48/209.71 |- skos__prefLabel mesh__D021122 Protein Subunits
% 209.48/209.71 |- skos__broader mesh__D021122smesh__D011506
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D021122 2005
% 209.48/209.71 |- mesh__recordOriginator mesh__D021122 nns
% 209.48/209.71 |- skos__hiddenLabel mesh__D021122 Subunits, Protein
% 209.48/209.71 |- mesh__dateCreated mesh__D021122 2000-06-22
% 209.48/209.71 |- mesh__recordMaintainer mesh__D021122 sjn
% 209.48/209.71 |- rdf__type mesh__D021122sskos__Concept
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D021122 2004
% 209.48/209.71 |- skos__hiddenLabel mesh__D021122 Subunit, Protein
% 209.48/209.71 |- mesh__historyNote mesh__D021122 2001
% 209.48/209.71 |- skos__historyNote mesh__D021122 Protein Conformation %28%1972-2000%29%
% 209.48/209.71 |- skos__scopeNote mesh__D021122
% 209.48/209.71 Single chains of amino acids that are the units of multimeric PROTEINS. Multimeric proteins can be composed of identical or non-identical subunits. One or more monomeric subunits may compose a protomer which itself is a subunit structure of a larger assembly.%A%
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D021122 sjn
% 209.48/209.71 |- mesh__dateEstablished mesh__D048868 2005-01-01
% 209.48/209.71 |- skos__scopeNote mesh__D048868
% 209.48/209.71 A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes%A%
% 209.48/209.71 |- mesh__historyNote mesh__D048868 2005
% 209.48/209.71 |- mesh__recordOriginator mesh__D048868 jmp
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D048868 2005
% 209.48/209.71 |- skos__broader mesh__D048868smesh__D002352
% 209.48/209.71 |- mesh__dateCreated mesh__D048868 2004-07-07
% 209.48/209.71 |- skos__altLabel mesh__D048868 Signal Transducing Adaptor Proteins
% 209.48/209.71 |- skos__historyNote mesh__D048868 Carrier Proteins %28%1991-2004%29%
% 209.48/209.71 |- skos__broader mesh__D048868smesh__D047908
% 209.48/209.71 |- mesh__recordMaintainer mesh__D048868 jmp
% 209.48/209.71 |- skos__prefLabel mesh__D048868 Adaptor Proteins, Signal Transducing
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D048868 2006
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D048868 sjn
% 209.48/209.71 |- rdf__type mesh__D048868sskos__Concept
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D048868 2005
% 209.48/209.71 |- skos__altLabel mesh__D020828 Paralysis, Pseudobulbar
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Palsy, Spastic Bulbar
% 209.48/209.71 |- skos__altLabel mesh__D020828 Pseudobulbar Syndrome
% 209.48/209.71 |- skos__prefLabel mesh__D020828 Pseudobulbar Palsy
% 209.48/209.71 |- mesh__historyNote mesh__D020828
% 209.48/209.71 2000; for PSEUDOBULBAR PARALYSIS and PARALYSIS, PSEUDOBULBAR use PARALYSIS 1985-1999%A%
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Mutism, Pseudobulbar
% 209.48/209.71 |- mesh__dateCreated mesh__D020828 1999-11-05
% 209.48/209.71 |- skos__broader mesh__D020828smesh__D010243
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Pseudobulbar Pareses
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020828 2005
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Paralyses, Pseudobulbar
% 209.48/209.71 |- skos__altLabel mesh__D020828 Pseudobulbar Paresis
% 209.48/209.71 |- skos__historyNote mesh__D020828
% 209.48/209.71 Bulbar Palsy, Progressive %28%1966-1982%29%
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Spastic Bulbar Palsies
% 209.48/209.71 |- mesh__dateEstablished mesh__D020828 2000-01-01
% 209.48/209.71 |- skos__altLabel mesh__D020828 Spastic Bulbar Palsy
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Palsies, Spastic Bulbar
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Syndromes, Pseudobulbar
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Dysarthrias, Pseudobulbar
% 209.48/209.71 |- rdf__type mesh__D020828sskos__Concept
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020828 2004
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Pseudobulbar Dysarthria
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Pseudobulbar Paralyses
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Pseudobulbar Mutisms
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020828 2002
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Pareses, Pseudobulbar
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Bulbar Palsy, Spastic
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020828 2003
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D020828
% 209.48/209.71 2000; for PSEUDOBULBAR PARALYSIS and PARALYSIS, PSEUDOBULBAR see PARALYSIS 1985-1999%A%
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Palsies, Pseudobulbar
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Mutisms, Pseudobulbar
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020828 2001
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Pseudobulbar Palsies
% 209.48/209.71 |- skos__scopeNote mesh__D020828
% 209.48/209.71 A syndrome characterized by DYSARTHRIA, dysphagia, dysphonia, impairment of voluntary movements of tongue and facial muscles, and emotional lability. This condition is caused by diseases that affect the motor fibers that travel from the cerebral cortex to the lower BRAIN STEM %28%i.e., corticobulbar tracts%29%; including MULTIPLE SCLEROSIS; MOTOR NEURON DISEASE; and CEREBROVASCULAR DISORDERS. %28%From Adams et al., Principles of Neurology, 6th ed, p489%29%%A%
% 209.48/209.71 |- skos__historyNote mesh__D020828 Paralysis %28%1982-1999%29%
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Paresis, Pseudobulbar
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Pseudobulbar Dysarthrias
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Palsy, Pseudobulbar
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Syndrome, Pseudobulbar
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Pseudobulbar Syndromes
% 209.48/209.71 |- skos__altLabel mesh__D020828 Pseudobulbar Paralysis
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020828 2000
% 209.48/209.71 |- skos__hiddenLabel mesh__D020828 Bulbar Palsies, Spastic
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D020828 2006
% 209.48/209.71 |- skos__hiddenLabel mesh__D006359 Exhaustion, Heat
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006359 1999
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006359 2006
% 209.48/209.71 |- skos__hiddenLabel mesh__D006359 Collapse, Heat
% 209.48/209.71 |- mesh__recordAuthorizer mesh__D006359 SJN
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006359 2004
% 209.48/209.71 |- skos__prefLabel mesh__D006359 Heat Exhaustion
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006359 2005
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006359 2001
% 209.48/209.71 |- skos__annotation mesh__D006359
% 209.48/209.71 subnormal body temp: do not confuse with HEAT STROKE where body temp is dangerously high; SUNSTROKE is also available%A%
% 209.48/209.71 |- skos__scopeNote mesh__D006359
% 209.48/209.71 An effect of excessive exposure to heat occurring commonly among workers in furnace rooms, foundries, etc., although it may occur from exposure to the sun%27%s heat %28%SUNSTROKE%29%. It is marked by subnormal temperature, with dizziness, headache, nausea, and sometimes delirium and/or collapse. It is distinguished from HEAT STROKE, in which the body temperature may be dangerously elevated. %28%Dorland, 27th ed%29%%A%
% 209.48/209.71 |- mesh__recordMaintainer mesh__D006359 SJN
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006359 2003
% 209.48/209.71 |- skos__hiddenLabel mesh__D006359 Prostration, Heat
% 209.48/209.71 |- mesh__recordOriginator mesh__D006359 NLM
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006359 2000
% 209.48/209.71 |- skos__altLabel mesh__D006359 Heat Prostration
% 209.48/209.71 |- mesh__dateRevised mesh__D006359 1998-06-10
% 209.48/209.71 |- skos__broader mesh__D006359smesh__D018882
% 209.48/209.71 |- rdf__type mesh__D006359sskos__Concept
% 209.48/209.71 |- mesh__dateCreated mesh__D006359 1999-01-01
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D006359 2002
% 209.48/209.71 |- skos__altLabel mesh__D017081 Cholecystectomy, Celioscopic
% 209.48/209.71 |- mesh__historyNote mesh__D017081 93
% 209.48/209.71 |- skos__prefLabel mesh__D017081 Cholecystectomy, Laparoscopic
% 209.48/209.71 |- mesh__publicMeSHNote mesh__D017081 93
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D017081 2003
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D017081 2002
% 209.48/209.71 |- mesh__recordMaintainer mesh__D017081 KEV
% 209.48/209.71 |- mesh__dateCreated mesh__D017081 1992-05-26
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D017081 2005
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D017081 2004
% 209.48/209.71 |- mesh__dateEstablished mesh__D017081 1993-01-01
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D017081 2006
% 209.48/209.71 |- skos__hiddenLabel mesh__D017081 Laparoscopic Cholecystectomies
% 209.48/209.71 |- skos__hiddenLabel mesh__D017081 Cholecystectomies, Celioscopic
% 209.48/209.71 |- skos__broader mesh__D017081smesh__D002763
% 209.48/209.71 |- mesh__activeMeSHYear mesh__D017081 2000
% 209.48/209.72 |- skos__hiddenLabel mesh__D017081 Cholecystectomies, Laparoscopic
% 209.48/209.72 |- rdf__type mesh__D017081sskos__Concept
% 209.48/209.72 |- mesh__recordOriginator mesh__D017081 MXR
% 209.48/209.72 |- skos__broader mesh__D017081smesh__D010535
% 209.48/209.72 |- skos__hiddenLabel mesh__D017081 Celioscopic Cholecystectomies
% 209.48/209.72 |- mesh__dateRevised mesh__D017081 1999-11-08
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D017081 2001
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D017081 sjn
% 209.48/209.72 |- skos__scopeNote mesh__D017081
% 209.48/209.72 Excision of the gallbladder through an abdominal incision using a laparoscope.%A%
% 209.48/209.72 |- skos__hiddenLabel mesh__D017081 Celioscopic Cholecystectomy
% 209.48/209.72 |- skos__historyNote mesh__D017081 Laparoscopy %28%1989-1992%29%
% 209.48/209.72 |- skos__altLabel mesh__D017081 Laparoscopic Cholecystectomy
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D003061
% 209.48/209.72 CODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74%A%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D003061 2002
% 209.48/209.72 |- skos__annotation mesh__D003061 codeine derivatives = CODEINE /analogs
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D003061 2003
% 209.48/209.72 |- mesh__dateRevised mesh__D003061 2000-06-21
% 209.48/209.72 |- mesh__onlineNote mesh__D003061
% 209.48/209.72 use CODEINE/analogs %26% derivatives to search CODEINE DERIVATIVES 1975-77; use MORPHINANS 1969-74%A%
% 209.48/209.72 |- skos__scopeNote mesh__D003061
% 209.48/209.72 An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.%A%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D003061 2001
% 209.48/209.72 |- skos__hiddenLabel mesh__D003061 N Methylmorphine
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D003061 2006
% 209.48/209.72 |- mesh__recordMaintainer mesh__D003061 TWD
% 209.48/209.72 |- skos__altLabel mesh__D003061 N-Methylmorphine
% 209.48/209.72 |- mesh__recordOriginator mesh__D003061 NLM
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D003061 2005
% 209.48/209.72 |- skos__prefLabel mesh__D003061 Codeine
% 209.48/209.72 |- rdf__type mesh__D003061sskos__Concept
% 209.48/209.72 |- mesh__historyNote mesh__D003061
% 209.48/209.72 CODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74%A%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D003061 2004
% 209.48/209.72 |- mesh__dateCreated mesh__D003061 1999-01-01
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D003061 sjn
% 209.48/209.72 |- skos__broader mesh__D003061smesh__D009022
% 209.48/209.72 |- mesh__recordOriginator mesh__D016787 PXP
% 209.48/209.72 |- skos__scopeNote mesh__D016787
% 209.48/209.72 An order of heteroxenous protozoa in which the macrogamete and microgamont develop independently. A conoid is usually absent.%A%
% 209.48/209.72 |- skos__broader mesh__D016787smesh__D016782
% 209.48/209.72 |- mesh__dateCreated mesh__D016787 1991-05-02
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D016787 2001; see HAEMOSPORINA 1992-2000
% 209.48/209.72 |- skos__altLabel mesh__D016787 Haemosporina
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D016787 2004
% 209.48/209.72 |- mesh__historyNote mesh__D016787 2001%28%1992%29%
% 209.48/209.72 |- skos__prefLabel mesh__D016787 Haemosporida
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D016787 sjn
% 209.48/209.72 |- mesh__dateRevised mesh__D016787 2003-07-09
% 209.48/209.72 |- skos__annotation mesh__D016787
% 209.48/209.72 an order of protozoa to which Plasmodium belongs
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D016787 2006
% 209.48/209.72 |- mesh__dateEstablished mesh__D016787 1992-01-01
% 209.48/209.72 |- mesh__recordMaintainer mesh__D016787 ags
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D016787 2005
% 209.48/209.72 |- rdf__type mesh__D016787sskos__Concept
% 209.48/209.72 |- mesh__dateCreated mesh__D035941 2002-07-02
% 209.48/209.72 |- skos__hiddenLabel mesh__D035941 Soluble Aconitase 1
% 209.48/209.72 |- skos__hiddenLabel mesh__D035941 Repressor Protein, Ferritin
% 209.48/209.72 |- skos__broader mesh__D035941smesh__D035925
% 209.48/209.72 |- skos__broader mesh__D035941smesh__D016601
% 209.48/209.72 |- skos__broader mesh__D035941smesh__D007506
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D035941 2006
% 209.48/209.72 |- skos__hiddenLabel mesh__D035941 IRE BP1
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D035941 2004
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D035941
% 209.48/209.72 2003; FERRITIN REPRESSOR PROTEIN was indexed under IRON-SULFUR PROTEINS %26% RNA-BINDING PROTEINS 1991-2002, IRE-BP1, IRON REGULATORY PROTEIN 1, IRP-1 PROTEIN %26% IRP1 PROTEIN were indexed under IRON-SULFUR PROTEINS %26% RNA-BINDING PROTEINS 1995-2002%A%
% 209.48/209.72 |- skos__altLabel mesh__D035941 Ferritin Repressor Protein
% 209.48/209.72 |- skos__altLabel mesh__D035941 ACO1 Protein
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D035941 2005
% 209.48/209.72 |- skos__broader mesh__D035941smesh__D000154
% 209.48/209.72 |- skos__altLabel mesh__D035941 IRP-1 Protein
% 209.48/209.72 |- skos__historyNote mesh__D035941 Iron-Sulfur Proteins %28%1995-2002%29%
% 209.48/209.72 |- skos__prefLabel mesh__D035941 Iron Regulatory Protein 1
% 209.48/209.72 |- skos__scopeNote mesh__D035941
% 209.48/209.72 A multifunctional iron-sulfur protein that is both an iron regulatory protein and cytoplasmic form of aconitate hydratase. It binds to iron regulatory elements found on mRNAs involved in iron metabolism and regulates their translation. Its RNA binding ability and its aconitate hydrolase activity are dependent upon availability of IRON.%A%
% 209.48/209.72 |- mesh__historyNote mesh__D035941
% 209.48/209.72 2003; for FERRITIN REPRESSOR PROTEIN use IRON-REGULATORY PROTEINS %28%NM%29% 1991-2002, for IRE-BP1, IRON REGULATORY PROTEIN 1, IRP-1 PROTEIN %26% IRP1 PROTEIN use IRON-REGULATORY PROTEINS %28%NM%29% 1995-2002%A%
% 209.48/209.72 |- mesh__dateEstablished mesh__D035941 2003-01-01
% 209.48/209.72 |- skos__altLabel mesh__D035941 IRE-BP1
% 209.48/209.72 |- rdf__type mesh__D035941sskos__Concept
% 209.48/209.72 |- skos__altLabel mesh__D035941 IRP1 Protein
% 209.48/209.72 |- mesh__dateRevised mesh__D035941 2003-07-09
% 209.48/209.72 |- skos__altLabel mesh__D035941 Aconitase 1, Soluble
% 209.48/209.72 |- skos__historyNote mesh__D035941 Ribonucleoproteins %28%1995-2002%29%
% 209.48/209.72 |- skos__hiddenLabel mesh__D035941 IRP 1 Protein
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D002767 2006
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D002767 2002
% 209.48/209.72 |- skos__scopeNote mesh__D002767
% 209.48/209.72 Establishment of an opening into the gallbladder either for drainage or surgical communication with another part of the digestive tract, usually the duodenum or jejunum.%A%
% 209.48/209.72 |- mesh__recordOriginator mesh__D002767 SCD
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D002767 1998
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D002767 2005
% 209.48/209.72 |- mesh__recordMaintainer mesh__D002767 PXP
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D002767 2001
% 209.48/209.72 |- rdf__type mesh__D002767sskos__Concept
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D002767 2004
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D002767 SJN
% 209.48/209.72 |- skos__broader mesh__D002767smesh__D000714
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D002767 2000
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D002767 88
% 209.48/209.72 |- mesh__dateCreated mesh__D002767 1987-03-20
% 209.48/209.72 |- mesh__dateEstablished mesh__D002767 1988-01-01
% 209.48/209.72 |- skos__hiddenLabel mesh__D002767 Cholecystostomies
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D002767 2003
% 209.48/209.72 |- skos__annotation mesh__D002767
% 209.48/209.72 do not use /util except by MeSH definition
% 209.48/209.72 |- mesh__historyNote mesh__D002767 88
% 209.48/209.72 |- skos__historyNote mesh__D002767 Drainage %28%1966-1987%29%
% 209.48/209.72 |- mesh__dateRevised mesh__D002767 1997-06-20
% 209.48/209.72 |- skos__prefLabel mesh__D002767 Cholecystostomy
% 209.48/209.72 |- skos__historyNote mesh__D002767 Gallbladder/surgery %28%1966-1987%29%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D002767 1999
% 209.48/209.72 |- skos__broader mesh__D002767smesh__D001662
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D029904 2006
% 209.48/209.72 |- skos__scopeNote mesh__D029904
% 209.48/209.72 A plant genus of the family FABACEAE that is a source of aromatic resinous balsams %28%Balsam of Tolu and Balsam of Peru%29% used in perfumery and as a constituent in cough syrups and lozenge.%A%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D029904 2003
% 209.48/209.72 |- skos__annotation mesh__D029904
% 209.48/209.72 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.48/209.72 |- mesh__historyNote mesh__D029904 2002
% 209.48/209.72 |- mesh__dateEstablished mesh__D029904 2002-01-01
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D029904 2004
% 209.48/209.72 |- skos__prefLabel mesh__D029904 Myroxylon
% 209.48/209.72 |- mesh__dateCreated mesh__D029904 2001-07-25
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D029904 2005
% 209.48/209.72 |- mesh__dateRevised mesh__D029904 2002-07-03
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D029904 2002
% 209.48/209.72 |- rdf__type mesh__D029904sskos__Concept
% 209.48/209.72 |- skos__broader mesh__D029904smesh__D007887
% 209.48/209.72 |- skos__hiddenLabel mesh__D021921 Stenosis, Supravalvular Aortic
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D021921 2003
% 209.48/209.72 |- skos__hiddenLabel mesh__D021921 Aortic Supravalvular Stenoses
% 209.48/209.72 |- mesh__dateEstablished mesh__D021921 2001-01-01
% 209.48/209.72 |- skos__altLabel mesh__D021921 Supravalvular Aortic Stenosis
% 209.48/209.72 |- skos__historyNote mesh__D021921 Aortic Valve Stenosis %28%1965-2000%29%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D021921 2004
% 209.48/209.72 |- rdf__type mesh__D021921sskos__Concept
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D021921 2005
% 209.48/209.72 |- skos__hiddenLabel mesh__D021921 Supravalvular Stenoses, Aortic
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D021921 2001
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D021921 2006
% 209.48/209.72 |- skos__hiddenLabel mesh__D021921 Stenosis, Aortic Supravalvular
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D021921
% 209.48/209.72 2001; see AORTIC VALVE STENOSIS 1980-2000
% 209.48/209.72 |- skos__altLabel mesh__D021921 Aortic Supravalvular Stenosis
% 209.48/209.72 |- skos__broader mesh__D021921smesh__D001024
% 209.48/209.72 |- skos__scopeNote mesh__D021921
% 209.48/209.72 A narrowing of the aorta in the region above the aortic valve.%A%
% 209.48/209.72 |- skos__prefLabel mesh__D021921 Aortic Stenosis, Supravalvular
% 209.48/209.72 |- skos__hiddenLabel mesh__D021921 Supravalvular Stenosis, Aortic
% 209.48/209.72 |- skos__hiddenLabel mesh__D021921 Stenoses, Aortic Supravalvular
% 209.48/209.72 |- mesh__dateCreated mesh__D021921 2000-06-21
% 209.48/209.72 |- mesh__historyNote mesh__D021921
% 209.48/209.72 2001; use AORTIC VALVE STENOSIS 1980-2000
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D021921 2002
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 1998
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 2006
% 209.48/209.72 |- mesh__dateRevised mesh__D007452 1993-06-02
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 2002
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 1997
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D007452 PLS
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D007452 91; was see under IODINE 1971-90
% 209.48/209.72 |- mesh__recordMaintainer mesh__D007452 TPW
% 209.48/209.72 |- skos__scopeNote mesh__D007452
% 209.48/209.72 Inorganic salts of iodic acid %28%HIO3%29%.
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 2005
% 209.48/209.72 |- mesh__recordOriginator mesh__D007452 NLM
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 2001
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 1996
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 2004
% 209.48/209.72 |- rdf__type mesh__D007452sskos__Concept
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 2000
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 1995
% 209.48/209.72 |- skos__annotation mesh__D007452 salts of iodic acid
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 2003
% 209.48/209.72 |- skos__broader mesh__D007452smesh__D000838
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 1994
% 209.48/209.72 |- mesh__dateEstablished mesh__D007452 1991-01-01
% 209.48/209.72 |- skos__prefLabel mesh__D007452 Iodates
% 209.48/209.72 |- skos__historyNote mesh__D007452 Iodine %28%1966-1970%29%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D007452 1999
% 209.48/209.72 |- skos__broader mesh__D007452smesh__D017613
% 209.48/209.72 |- mesh__dateCreated mesh__D007452 1999-01-01
% 209.48/209.72 |- mesh__historyNote mesh__D007452
% 209.48/209.72 91%28%71%29%; was see under IODINE 1971-90
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 1994
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 1999
% 209.48/209.72 |- skos__annotation mesh__D012397 an immunol technique
% 209.48/209.72 |- skos__prefLabel mesh__D012397 Rosette Formation
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 1993
% 209.48/209.72 |- mesh__dateEstablished mesh__D012397 1978-01-01
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 1995
% 209.48/209.72 |- mesh__recordOriginator mesh__D012397 SMH
% 209.48/209.72 |- skos__hiddenLabel mesh__D012397 Formations, Rosette
% 209.48/209.72 |- skos__altLabel mesh__D012397 Immunocytoadherence
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 2003
% 209.48/209.72 |- mesh__recordMaintainer mesh__D012397 TAP
% 209.48/209.72 |- mesh__historyNote mesh__D012397 78
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 2000
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 2005
% 209.48/209.72 |- skos__scopeNote mesh__D012397
% 209.48/209.72 The in vitro formation of clusters consisting of a cell %28%usually a lymphocyte%29% surrounded by antigenic cells or antigen-bearing particles %28%usually erythrocytes, which may or may not be coated with antibody or antibody and complement%29%. The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells.%A%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 2004
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D012397 78
% 209.48/209.72 |- skos__hiddenLabel mesh__D012397 Rosette Formations
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D012397 PLS
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 2001
% 209.48/209.72 |- skos__broader mesh__D012397smesh__D007158
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 2006
% 209.48/209.72 |- skos__hiddenLabel mesh__D012397 Formation, Rosette
% 209.48/209.72 |- skos__hiddenLabel mesh__D012397 Immunocytoadherences
% 209.48/209.72 |- mesh__dateRevised mesh__D012397 1992-05-18
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 1996
% 209.48/209.72 |- skos__historyNote mesh__D012397
% 209.48/209.72 Immune Adherence Reaction %28%1971-1977%29%
% 209.48/209.72 |- mesh__dateCreated mesh__D012397 1977-03-01
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 1998
% 209.48/209.72 |- rdf__type mesh__D012397sskos__Concept
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 1997
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D012397 2002
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D020829 2002
% 209.48/209.72 |- mesh__historyNote mesh__D020829 2000
% 209.48/209.72 |- skos__broader mesh__D020829smesh__D019669
% 209.48/209.72 |- mesh__recordOriginator mesh__D020829 ags
% 209.48/209.72 |- rdf__type mesh__D020829sskos__Concept
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D020829 2006
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D020829 sjn
% 209.48/209.72 |- mesh__dateEstablished mesh__D020829 2000-01-01
% 209.48/209.72 |- skos__historyNote mesh__D020829 Plants, Medicinal %28%1976-1999%29%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D020829 2005
% 209.48/209.72 |- skos__historyNote mesh__D020829 Plants %28%1971-1999%29%
% 209.48/209.72 |- skos__annotation mesh__D020829
% 209.48/209.72 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.48/209.72 |- skos__scopeNote mesh__D020829
% 209.48/209.72 The only living genus of the order Equisetales, class Equisetopsida %28%Sphenopsida%29%, division Equisetophyta %28%Sphenophyta%29%; distantly related to ferns. It grows in moist places. The hollow, jointed, ridged stems contain SILICATES.%A%
% 209.48/209.72 |- mesh__dateCreated mesh__D020829 1999-11-03
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D020829 2004
% 209.48/209.72 |- mesh__dateRevised mesh__D020829 2001-07-25
% 209.48/209.72 |- mesh__recordMaintainer mesh__D020829 ssb
% 209.48/209.72 |- skos__altLabel mesh__D020829 Horsetail
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D020829 2000
% 209.48/209.72 |- skos__prefLabel mesh__D020829 Equisetum
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D020829 2003
% 209.48/209.72 |- skos__prefLabel mesh__D017880 Limb Deformities, Congenital
% 209.48/209.72 |- skos__historyNote mesh__D017880
% 209.48/209.72 Extremities/abnormalities %28%1968-1997%29%
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D017880 sjn
% 209.48/209.72 |- mesh__recordOriginator mesh__D017880 TGC
% 209.48/209.72 |- mesh__dateCreated mesh__D017880 1993-08-26
% 209.48/209.72 |- skos__hiddenLabel mesh__D017880 Congenital Limb Deformity
% 209.48/209.72 |- skos__broader mesh__D017880smesh__D009139
% 209.48/209.72 |- skos__hiddenLabel mesh__D017880 Deformities, Congenital Limb
% 209.48/209.72 |- rdf__type mesh__D017880sskos__Concept
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D017880 98
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D017880 2006
% 209.48/209.72 |- mesh__dateRevised mesh__D017880 2005-06-30
% 209.48/209.72 |- mesh__historyNote mesh__D017880 98; use explode 1994-97
% 209.48/209.72 |- skos__hiddenLabel mesh__D017880 Deformity, Congenital Limb
% 209.48/209.72 |- skos__annotation mesh__D017880
% 209.48/209.72 general or unspecified; LOWER EXTREMITY DEFORMITIES, CONGENITAL and UPPER EXTREMITY DEFORMITIES, CONGENITAL are available as well as /abnorm with specifics treed under UPPER EXTREMITIES and LOWER EXTREMITIES; DF: LIMB DEFORMITIES CONGEN%A%
% 209.48/209.72 |- skos__hiddenLabel mesh__D017880 Limb Deformity, Congenital
% 209.48/209.72 |- skos__altLabel mesh__D017880 Congenital Limb Deformities
% 209.48/209.72 |- mesh__recordMaintainer mesh__D017880 ags
% 209.48/209.72 |- skos__scopeNote mesh__D017880
% 209.48/209.72 Congenital structural deformities of the upper and lower extremities collectively or unspecified.%A%
% 209.48/209.72 |- mesh__dateEstablished mesh__D017880 1998-01-01
% 209.48/209.72 |- skos__broader mesh__D017082smesh__D014690
% 209.48/209.72 |- skos__scopeNote mesh__D017082
% 209.48/209.72 The venous pressure measured in the PORTAL VEIN.
% 209.48/209.72 |- mesh__dateCreated mesh__D017082 1992-05-22
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D017082 2006
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D017082 93
% 209.48/209.72 |- skos__hiddenLabel mesh__D017082 Pressure, Portal
% 209.48/209.72 |- mesh__dateRevised mesh__D017082 2003-07-09
% 209.48/209.72 |- rdf__type mesh__D017082sskos__Concept
% 209.48/209.72 |- mesh__dateEstablished mesh__D017082 1993-01-01
% 209.48/209.72 |- mesh__historyNote mesh__D017082 93
% 209.48/209.72 |- skos__prefLabel mesh__D017082 Portal Pressure
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D017082 2005
% 209.48/209.72 |- skos__historyNote mesh__D017082 Blood Pressure %28%1966-1992%29%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D017082 2004
% 209.48/209.72 |- skos__hiddenLabel mesh__D003062 Sense Codons
% 209.48/209.72 |- skos__prefLabel mesh__D003062 Codon
% 209.48/209.72 |- mesh__dateEstablished mesh__D003062 1991-01-01
% 209.48/209.72 |- skos__annotation mesh__D003062 GEN or unspecified; prefer specifics
% 209.48/209.72 |- skos__altLabel mesh__D003062 Codon, Sense
% 209.48/209.72 |- mesh__recordOriginator mesh__D003062 NLM
% 209.48/209.72 |- skos__broader mesh__D003062smesh__D040461
% 209.48/209.72 |- skos__broader mesh__D003062smesh__D005815
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D003062 sjn
% 209.48/209.72 |- mesh__historyNote mesh__D003062
% 209.48/209.72 91%28%75%29%; was see under RNA, MESSENGER 1975-90
% 209.48/209.72 |- skos__scopeNote mesh__D003062
% 209.48/209.72 A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal %28%CODON, TERMINATOR%29%. Most codons are universal, but some organisms do not produce the transfer RNAs %28%RNA, TRANSFER%29% complementary to all codons. These codons are referred to as unassigned codons %28%CODONS, NONSENSE%29%.%A%
% 209.48/209.72 |- mesh__dateCreated mesh__D003062 1999-01-01
% 209.48/209.72 |- skos__hiddenLabel mesh__D003062 Codons
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D003062 2006
% 209.48/209.72 |- skos__related mesh__D003062smesh__D016364
% 209.48/209.72 |- mesh__dateRevised mesh__D003062 2005-06-30
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D003062
% 209.48/209.72 91; was see under RNA, MESSENGER 1975-90
% 209.48/209.72 |- skos__related mesh__D003062smesh__D005815
% 209.48/209.72 |- skos__broader mesh__D003062smesh__D012333
% 209.48/209.72 |- mesh__recordMaintainer mesh__D003062 nns
% 209.48/209.72 |- rdf__type mesh__D003062sskos__Concept
% 209.48/209.72 |- skos__hiddenLabel mesh__D003062 Codons, Sense
% 209.48/209.72 |- mesh__onlineNote mesh__D003062 search RNA, MESSENGER 1974
% 209.48/209.72 |- skos__broader mesh__D019357Q000031smesh__D019357
% 209.48/209.72 |- mesh__preferredCombination mesh__D019357Q000031smesh__D002951
% 209.48/209.72 |- rdf__type mesh__D019357Q000031smesh__CompoundConcept
% 209.48/209.72 |- mesh__dateCreated mesh__D016788 1991-05-02
% 209.48/209.72 |- skos__scopeNote mesh__D016788
% 209.48/209.72 A protozoan parasite of rodents transmitted by the mosquito Anopheles stephensi.%A%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D016788 2005
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D016788 92
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D016788 2004
% 209.48/209.72 |- mesh__recordMaintainer mesh__D016788 ags
% 209.48/209.72 |- mesh__dateRevised mesh__D016788 2003-07-09
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D016788 2006
% 209.48/209.72 |- mesh__recordOriginator mesh__D016788 PXP
% 209.48/209.72 |- skos__prefLabel mesh__D016788 Plasmodium chabaudi
% 209.48/209.72 |- mesh__dateEstablished mesh__D016788 1992-01-01
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D016788 sjn
% 209.48/209.72 |- skos__broader mesh__D016788smesh__D010961
% 209.48/209.72 |- rdf__type mesh__D016788sskos__Concept
% 209.48/209.72 |- skos__annotation mesh__D016788
% 209.48/209.72 in rodents; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.48/209.72 |- mesh__historyNote mesh__D016788 92
% 209.48/209.72 |- skos__historyNote mesh__D016788 Plasmodium %28%1966-1991%29%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D041181 2006
% 209.48/209.72 |- mesh__recordOriginator mesh__D041181 ags
% 209.48/209.72 |- rdf__type mesh__D041181sskos__Concept
% 209.48/209.72 |- mesh__publicMeSHNote mesh__D041181 2003
% 209.48/209.72 |- mesh__dateRevised mesh__D041181 2005-06-30
% 209.48/209.72 |- mesh__recordAuthorizer mesh__D041181 sjn
% 209.48/209.72 |- mesh__recordMaintainer mesh__D041181 SYSTEM
% 209.48/209.72 |- mesh__historyNote mesh__D041181 2003
% 209.48/209.72 |- mesh__dateCreated mesh__D041181 2002-07-03
% 209.48/209.72 |- skos__historyNote mesh__D041181 Staphylococcus %28%1984-2002%29%
% 209.48/209.72 |- skos__broader mesh__D041181smesh__D013210
% 209.48/209.72 |- skos__scopeNote mesh__D041181
% 209.48/209.72 A species of STAPHYLOCOCCUS similar to STAPHYLOCOCCUS HAEMOLYTICUS, but containing different esterases. The subspecies Staphylococcus hominis novobiosepticus is highly virulent and novobiocin resistant.%A%
% 209.48/209.72 |- skos__prefLabel mesh__D041181 Staphylococcus hominis
% 209.48/209.72 |- mesh__dateEstablished mesh__D041181 2003-01-01
% 209.48/209.72 |- skos__annotation mesh__D041181
% 209.48/209.72 infection: coord IM with STAPHYLOCOCCAL INFECTIONS %28%IM%29%; DF: STAPH HAEMOLYTICUS%A%
% 209.48/209.72 |- skos__broader mesh__D035942smesh__D016601
% 209.48/209.72 |- skos__hiddenLabel mesh__D035942 IRP 2 RNA binding protein
% 209.48/209.72 |- skos__historyNote mesh__D035942 Ribonucleoproteins %28%1995-2002%29%
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D035942 2006
% 209.48/209.72 |- skos__altLabel mesh__D035942 IRP2 Protein
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D035942 2004
% 209.48/209.72 |- skos__broader mesh__D035942smesh__D035925
% 209.48/209.72 |- skos__hiddenLabel mesh__D035942 RNA-binding protein, IRP-2
% 209.48/209.72 |- skos__altLabel mesh__D035942 IREB2 Protein
% 209.48/209.72 |- mesh__activeMeSHYear mesh__D035942 2005
% 209.48/209.72 |- skos__prefLabel mesh__D035942 Iron Regulatory Protein 2
% 209.48/209.72 |- skos__broader mesh__D035942smesh__D000154
% 209.48/209.72 |- skos__historyNote mesh__D035942 Iron-Sulfur Proteins %28%1995-2002%29%
% 209.48/209.72 |- mesh__dateCreated mesh__D035942 2002-07-03
% 209.48/209.72 |- skos__altLabel mesh__D035942 IRP-2 RNA-binding protein
% 209.48/209.72 |- skos__broader mesh__D035942smesh__D007506
% 209.48/209.72 |- rdf__type mesh__D035942sskos__Concept
% 209.48/209.72 |- mesh__dateRevised mesh__D035942 2003-07-09
% 209.48/209.72 |- skos__scopeNote mesh__D035942
% 209.48/209.72 A multifunctional iron-sulfur protein that is both an iron regulatory protein and cytoplasmic form of aconitate hydratase. It binds to iron regulatory elements found on mRNAs involved in iron metabolism and regulates their translation. Its rate of degradation is increased in the presence of IRON.%A%
% 209.48/209.72 |- skos__altLabel mesh__D035942 Iron-Responsive-Element Binding Protein 2
% 209.48/209.72 |- skos__altLabel mesh__D035942 IRE-BP2
% 209.48/209.72 |- mesh__historyNote mesh__D035942
% 209.48/209.72 2003; for IRON REGULATORY PROTEIN 2, IRE-BP2 %26% IRP-2 RNA-BINDING PROTEIN use IRON-REGULATORY PROTEINS %28%NM%29% 1995-2002%A%
% 209.58/209.72 |- mesh__dateEstablished mesh__D035942 2003-01-01
% 209.58/209.72 |- mesh__publicMeSHNote mesh__D035942
% 209.58/209.72 2003; IRON REGULATORY PROTEIN 2, IRE-BP2 %26% IRP-2 RNA-BINDING PROTEIN were indexed under RNA-BINDING PROTEINS %26% IRON-SULFUR PROTEINS 1995-2002%A%
% 209.58/209.72 |- mesh__publicMeSHNote mesh__D002768 88
% 209.58/209.72 |- skos__scopeNote mesh__D002768
% 209.58/209.72 Surgical formation of an opening %28%stoma%29% into the COMMON BILE DUCT for drainage or for direct communication with a site in the small intestine, primarily the DUODENUM or JEJUNUM.%A%
% 209.58/209.72 |- mesh__historyNote mesh__D002768 88
% 209.58/209.72 |- skos__hiddenLabel mesh__D002768 Choledochojejunostomies
% 209.58/209.72 |- mesh__dateRevised mesh__D002768 2003-07-09
% 209.58/209.72 |- skos__hiddenLabel mesh__D002768 Choledochoduodenostomies
% 209.58/209.72 |- skos__altLabel mesh__D002768 Choledojejunostomies
% 209.58/209.72 |- skos__historyNote mesh__D002768 Duodenum/surgery %28%1966-1987%29%
% 209.58/209.72 |- skos__historyNote mesh__D002768 Drainage %28%1966-1987%29%
% 209.58/209.72 |- skos__prefLabel mesh__D002768 Choledochostomy
% 209.58/209.72 |- skos__related mesh__D002768smesh__D017562
% 209.58/209.72 |- skos__historyNote mesh__D002768 Jejunum/surgery %28%1966-1987%29%
% 209.58/209.72 |- skos__historyNote mesh__D002768
% 209.58/209.72 Common Bile Duct Calculi/surgery %28%1966-1987%29%
% 209.58/209.72 |- skos__hiddenLabel mesh__D002768 Choledojejunostomy
% 209.58/209.72 |- skos__hiddenLabel mesh__D002768 Choledochostomies
% 209.58/209.72 |- skos__historyNote mesh__D002768
% 209.58/209.72 Common Bile Duct/surgery %28%1966-1987%29%
% 209.58/209.72 |- skos__broader mesh__D002768smesh__D001662
% 209.58/209.72 |- mesh__activeMeSHYear mesh__D002768 2006
% 209.58/209.72 |- mesh__dateEstablished mesh__D002768 1988-01-01
% 209.58/209.72 |- mesh__recordMaintainer mesh__D002768 lkt
% 209.58/209.72 |- mesh__dateCreated mesh__D002768 1987-03-19
% 209.58/209.72 |- mesh__recordOriginator mesh__D002768 SCD
% 209.58/209.72 |- mesh__recordAuthorizer mesh__D002768 sjn
% 209.58/209.72 |- mesh__activeMeSHYear mesh__D002768 2005
% 209.58/209.72 |- skos__broader mesh__D002768smesh__D000714
% 209.58/209.72 |- rdf__type mesh__D002768sskos__Concept
% 209.58/209.72 |- mesh__activeMeSHYear mesh__D002768 2004
% 209.58/209.72 |- mesh__activeMeSHYear mesh__D029905 2003
% 209.58/209.72 |- skos__annotation mesh__D029905
% 209.58/209.72 PACHYRHIZUS THUNBERGIANUS see PUERARIA; YAM see DIOSCOREA; YAM BEAN, AFRICAN see SPHENOSTYLIS; PSEUDO-YAM see IPOMOEA BATATAS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.58/209.72 |- mesh__dateEstablished mesh__D029905 2002-01-01
% 209.58/209.72 |- mesh__activeMeSHYear mesh__D029905 2004
% 209.58/209.72 |- skos__prefLabel mesh__D029905 Pachyrhizus
% 209.58/209.72 |- mesh__dateRevised mesh__D029905 2002-07-02
% 209.58/209.72 |- skos__altLabel mesh__D029905 Bean, Yam
% 209.58/209.72 |- mesh__activeMeSHYear mesh__D029905 2005
% 209.58/209.72 |- mesh__historyNote mesh__D029905 2002
% 209.58/209.72 |- mesh__publicMeSHNote mesh__D029905 2002
% 209.58/209.72 |- rdf__type mesh__D029905sskos__Concept
% 209.58/209.72 |- skos__broader mesh__D029905smesh__D007887
% 209.58/209.72 |- skos__scopeNote mesh__D029905
% 209.58/209.72 A plant genus of the family FABACEAE. Some Pachyrhizus have been reclassified to PUERARIA. Do not confuse with yam %28%IPOMOEA; or DIOSCOREA%29% or African yam bean %28%SPHENOSTYLIS%29%.%A%
% 209.58/209.72 |- skos__altLabel mesh__D029905 Jicama
% 209.58/209.72 |- mesh__activeMeSHYear mesh__D029905 2006
% 209.58/209.72 |- mesh__dateCreated mesh__D029905 2001-07-25
% 209.58/209.72 |- skos__historyNote mesh__D021922 Aortic Valve Stenosis %28%1972-2000%29%
% 209.58/209.72 |- mesh__activeMeSHYear mesh__D021922 2001
% 209.58/209.72 |- mesh__dateCreated mesh__D021922 2000-07-06
% 209.58/209.72 |- mesh__dateEstablished mesh__D021922 2001-01-01
% 209.58/209.72 |- skos__altLabel mesh__D021922 Subaortic Stenosis, Discrete
% 209.58/209.72 |- skos__hiddenLabel mesh__D021922 Subaortic Stenoses, Discrete
% 209.58/209.73 |- skos__hiddenLabel mesh__D021922 Discrete Subaortic Stenoses
% 209.58/209.73 |- skos__scopeNote mesh__D021922
% 209.58/209.73 An anatomic alteration in the mitral valve apparatus and interventricular septum leading to obstruction of left ventricular outflow. %28%from Eur J Cardiothorac Surg 1998;14%28%3%29%:296-303%29%%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D021922 2004
% 209.58/209.73 |- mesh__historyNote mesh__D021922
% 209.58/209.73 2001; use AORTIC VALVE STENOSIS 1986-2000
% 209.58/209.73 |- skos__hiddenLabel mesh__D021922 Stenoses, Discrete Subaortic
% 209.58/209.73 |- mesh__recordOriginator mesh__D021922 nns
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D021922 2003
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D021922
% 209.58/209.73 2001; see AORTIC VALVE STENOSIS 1986-2000
% 209.58/209.73 |- rdf__type mesh__D021922sskos__Concept
% 209.58/209.73 |- skos__historyNote mesh__D021922
% 209.58/209.73 Aortic Stenosis, Subvalvular %28%1986-2000%29%
% 209.58/209.73 |- skos__broader mesh__D021922smesh__D001020
% 209.58/209.73 |- skos__hiddenLabel mesh__D021922 Stenosis, Discrete Subaortic
% 209.58/209.73 |- mesh__recordMaintainer mesh__D021922 nns
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D021922 2002
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D021922 2006
% 209.58/209.73 |- skos__prefLabel mesh__D021922 Discrete Subaortic Stenosis
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D021922 ags
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D021922 2005
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453
% 209.58/209.73 Triiodothyronine 5%27%-Deiodinase, Reverse
% 209.58/209.73 |- mesh__recordMaintainer mesh__D007453 sjn
% 209.58/209.73 |- skos__scopeNote mesh__D007453
% 209.58/209.73 A hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8.%A%
% 209.58/209.73 |- mesh__recordOriginator mesh__D007453 RLS
% 209.58/209.73 |- skos__historyNote mesh__D007453 Peroxidases %28%1973-1975%29%
% 209.58/209.73 |- skos__historyNote mesh__D007453 Iodotyrosine %28%1973-1975%29%
% 209.58/209.73 |- skos__historyNote mesh__D007453 Iodides %28%1973-1975%29%
% 209.58/209.73 |- mesh__historyNote mesh__D007453
% 209.58/209.73 86%28%76%29%; was see under PEROXIDASES 1976-85
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 5%27%-Deiodinase, Iodothyronine
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Deiodinase, Triiodothyronine
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Peroxidase, Thyroid
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453
% 209.58/209.73 Reverse Triiodothyronine 5%27% Deiodinase
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D007453
% 209.58/209.73 86; was see under PEROXIDASES 1976-85
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D007453 sjn
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Deiodase, Iodotyrosine
% 209.58/209.73 |- mesh__dateEstablished mesh__D007453 1986-01-01
% 209.58/209.73 |- rdf__type mesh__D007453sskos__Concept
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007453 2006
% 209.58/209.73 |- skos__annotation mesh__D007453
% 209.58/209.73 /defic: consider also MONOIODOTYROSINE /metab %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29% + CONGENITAL HYPOTHYROIDISM%A%
% 209.58/209.73 |- skos__prefLabel mesh__D007453 Iodide Peroxidase
% 209.58/209.73 |- skos__altLabel mesh__D007453 5%27%-Deiodinase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Deiodinase, Iodotyrosine
% 209.58/209.73 |- skos__altLabel mesh__D007453 Thyroid Peroxidase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 5%27%-Deiodinase, Thyroxine
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453
% 209.58/209.73 5%27%-Deiodinase, Reverse Triiodothyronine
% 209.58/209.73 |- skos__altLabel mesh__D007453 Deiodinase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 T4 5%27% Deiodinase
% 209.58/209.73 |- skos__broader mesh__D007453smesh__D010544
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Peroxidase, Iodide
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Iodothyronine 5%27% Deiodinase
% 209.58/209.73 |- mesh__dateCreated mesh__D007453 1975-07-18
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 T4 Monodeiodinase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Tetraiodothyronine 5%27% Deiodinase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Thyroxine 5%27% Monodeiodinase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Thyroxine 5%27% Deiodinase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Deiodinase, Iodothyronine
% 209.58/209.73 |- skos__altLabel mesh__D007453 Iodotyrosine Deiodinase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 5%27% Deiodinase
% 209.58/209.73 |- skos__altLabel mesh__D007453 Iodotyrosine Deiodase
% 209.58/209.73 |- mesh__dateRevised mesh__D007453 2005-07-01
% 209.58/209.73 |- skos__altLabel mesh__D007453 T4-5%27%-Deiodinase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 Enzyme, Thyroxine Converting
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 5%27%-Monodeiodinase, Thyroxine
% 209.58/209.73 |- skos__altLabel mesh__D007453 Monodeiodinase
% 209.58/209.73 |- skos__altLabel mesh__D007453 Iodinase
% 209.58/209.73 |- skos__hiddenLabel mesh__D007453 5%27%-Deiodinase, Tetraiodothyronine
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D012398
% 209.58/209.73 91; was see under ALPHAVIRUSES 1981-90; was see under ARBOVIRUSES 1975-80%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D012398 2006
% 209.58/209.73 |- mesh__dateRevised mesh__D012398 2005-06-30
% 209.58/209.73 |- skos__hiddenLabel mesh__D012398 virus, Ross River
% 209.58/209.73 |- mesh__dateEstablished mesh__D012398 1991-01-01
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D012398 sjn
% 209.58/209.73 |- skos__prefLabel mesh__D012398 Ross River virus
% 209.58/209.73 |- mesh__recordMaintainer mesh__D012398 ags
% 209.58/209.73 |- rdf__type mesh__D012398sskos__Concept
% 209.58/209.73 |- mesh__historyNote mesh__D012398
% 209.58/209.73 91%28%75%29%; was see under ALPHAVIRUSES 1981-90; was see under ARBOVIRUSES 1975-80%A%
% 209.58/209.73 |- mesh__recordOriginator mesh__D012398 NLM
% 209.58/209.73 |- mesh__dateCreated mesh__D012398 1974-12-12
% 209.58/209.73 |- skos__hiddenLabel mesh__D012398 virus, Sagiyama
% 209.58/209.73 |- skos__scopeNote mesh__D012398
% 209.58/209.73 A species of ALPHAVIRUS associated with epidemic EXANTHEMA and polyarthritis in Australia.%A%
% 209.58/209.73 |- skos__broader mesh__D012398smesh__D000524
% 209.58/209.73 |- skos__annotation mesh__D012398
% 209.58/209.73 infection: coord IM with ALPHAVIRUS INFECTIONS %28%IM%29%
% 209.58/209.73 |- skos__scopeNote mesh__D017881
% 209.58/209.73 A genus of gram-negative, aerobic, rod-shaped bacteria whose organisms are part of the normal flora of the mucous membranes of the upper respiratory tract. Some species are pathogenic for man.%A%
% 209.58/209.73 |- skos__historyNote mesh__D017881 Moraxella %28%1969-1988%29%
% 209.58/209.73 |- mesh__recordMaintainer mesh__D017881 SYSTEM
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D017881 94
% 209.58/209.73 |- mesh__dateEstablished mesh__D017881 1994-01-01
% 209.58/209.73 |- rdf__type mesh__D017881sskos__Concept
% 209.58/209.73 |- skos__historyNote mesh__D017881 Neisseriaceae %28%1983-1993%29%
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D017881 sjn
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017881 2006
% 209.58/209.73 |- skos__prefLabel mesh__D017881 Kingella
% 209.58/209.73 |- mesh__recordOriginator mesh__D017881 PXP
% 209.58/209.73 |- skos__annotation mesh__D017881
% 209.58/209.73 bacterium of upper resp mucous membranes; infection: coord IM with NEISSERIACEAE INFECTIONS %28%IM%29%%A%
% 209.58/209.73 |- mesh__dateCreated mesh__D017881 1993-06-03
% 209.58/209.73 |- skos__broader mesh__D017881smesh__D009346
% 209.58/209.73 |- mesh__dateRevised mesh__D017881 2005-06-30
% 209.58/209.73 |- mesh__historyNote mesh__D017881 94
% 209.58/209.73 |- skos__broader mesh__D017083smesh__D008163
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Chemoluminescence Measurement
% 209.58/209.73 |- skos__altLabel mesh__D017083 Chemiluminescence Measurements
% 209.58/209.73 |- rdf__type mesh__D017083sskos__Concept
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Measurement, Chemiluminescence
% 209.58/209.73 |- mesh__recordOriginator mesh__D017083 TGC
% 209.58/209.73 |- skos__prefLabel mesh__D017083 Chemiluminescent Measurements
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Measurements, Chemiluminescence
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Assays, Chemiluminescent
% 209.58/209.73 |- mesh__historyNote mesh__D017083 2005%28%1993%29%
% 209.58/209.73 |- skos__altLabel mesh__D017083 Chemiluminescent Assays
% 209.58/209.73 |- skos__historyNote mesh__D017083 Luminescence %28%1966-1992%29%
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D017083 sjn
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017083 2005
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Chemiluminescence Measurement
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Measurements, Chemoluminescence
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Measurements, Chemiluminescent
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D017083
% 209.58/209.73 2005; see CHEMILUMINESCENCE 1993-2004
% 209.58/209.73 |- skos__scopeNote mesh__D017083
% 209.58/209.73 Measurement of light resulting from PHYSICAL CHEMILUMINESCENCE such as from LUMINESCENT PROTEINS and LUMINESCENT AGENTS.%A%
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Measurement, Chemoluminescence
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Measurement, Chemiluminescent
% 209.58/209.73 |- mesh__dateCreated mesh__D017083 1992-05-07
% 209.58/209.73 |- mesh__dateEstablished mesh__D017083 1993-01-01
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017083 2006
% 209.58/209.73 |- mesh__dateRevised mesh__D017083 2004-07-13
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Assay, Chemiluminescent
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Chemiluminescent Assay
% 209.58/209.73 |- mesh__recordMaintainer mesh__D017083 sjn
% 209.58/209.73 |- skos__altLabel mesh__D017083 Chemoluminescence Measurements
% 209.58/209.73 |- skos__hiddenLabel mesh__D017083 Chemiluminescent Measurement
% 209.58/209.73 |- skos__hiddenLabel mesh__D003861 Disorders, Depersonalization
% 209.58/209.73 |- skos__hiddenLabel mesh__D003861 Disorder, Depersonalization
% 209.58/209.73 |- mesh__dateRevised mesh__D003861 2002-07-03
% 209.58/209.73 |- skos__prefLabel mesh__D003861 Depersonalization
% 209.58/209.73 |- mesh__recordOriginator mesh__D003861 NLM
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D003861
% 209.58/209.73 98; see DEPERSONALIZATION DISORDER 1963-80; see DEPERSONALIZATION 1963-80%A%
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D003861 sjn
% 209.58/209.73 |- skos__hiddenLabel mesh__D003861 Derealizations
% 209.58/209.73 |- mesh__recordMaintainer mesh__D003861 jls
% 209.58/209.73 |- skos__hiddenLabel mesh__D003861 Depersonalizations
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003861 2004
% 209.58/209.73 |- mesh__dateCreated mesh__D003861 1999-01-01
% 209.58/209.73 |- rdf__type mesh__D003861sskos__Concept
% 209.58/209.73 |- mesh__historyNote mesh__D003861 98%28%63%29%
% 209.58/209.73 |- skos__hiddenLabel mesh__D003861 Depersonalization Disorders
% 209.58/209.73 |- skos__scopeNote mesh__D003861
% 209.58/209.73 State in which an individual perceives or experiences a sensation of unreality concerning the self or the environment; it is seen in disorders such as schizophrenia, affection disorders, organic mental disorders, and personality disorders. %28%APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003861 2003
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003861 2006
% 209.58/209.73 |- skos__broader mesh__D003861smesh__D001526
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003861 2005
% 209.58/209.73 |- skos__broader mesh__D003063smesh__D007448
% 209.58/209.73 |- skos__related mesh__D003063smesh__D003064
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003063 2005
% 209.58/209.73 |- skos__prefLabel mesh__D003063 Cnidaria
% 209.58/209.73 |- mesh__dateCreated mesh__D003063 1999-01-01
% 209.58/209.73 |- mesh__recordOriginator mesh__D003063 NLM
% 209.58/209.73 |- skos__altLabel mesh__D003063 Cnidarians
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003063 2006
% 209.58/209.73 |- mesh__dateRevised mesh__D003063 2003-07-09
% 209.58/209.73 |- mesh__recordMaintainer mesh__D003063 ags
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D003063 sjn
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D003063 1995; see COELENTERATA 1963-1994
% 209.58/209.73 |- rdf__type mesh__D003063sskos__Concept
% 209.58/209.73 |- skos__scopeNote mesh__D003063
% 209.58/209.73 A phylum of radially symmetrical invertebrates characterized by possession of stinging cells called nematocysts. It includes the classes ANTHOZOA; CUBOZOA; HYDROZOA, and SCYPHOZOA. Members carry CNIDARIAN VENOMS.%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003063 2004
% 209.58/209.73 |- mesh__historyNote mesh__D003063 1995 %28%1963%29%
% 209.58/209.73 |- skos__annotation mesh__D003063
% 209.58/209.73 poisoning: coord with CNIDARIAN VENOMS if pertinent
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D016789 sjn
% 209.58/209.73 |- skos__prefLabel mesh__D016789 Plasmodium cynomolgi
% 209.58/209.73 |- skos__broader mesh__D016789smesh__D010961
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D016789 2005
% 209.58/209.73 |- skos__annotation mesh__D016789
% 209.58/209.73 in macaques; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D016789 2006
% 209.58/209.73 |- mesh__recordOriginator mesh__D016789 PXP
% 209.58/209.73 |- mesh__dateCreated mesh__D016789 1991-05-02
% 209.58/209.73 |- mesh__recordMaintainer mesh__D016789 sjn
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D016789 92
% 209.58/209.73 |- rdf__type mesh__D016789sskos__Concept
% 209.58/209.73 |- skos__scopeNote mesh__D016789
% 209.58/209.73 A protozoan parasite that occurs naturally in the macaque. It is similar to PLASMODIUM VIVAX and produces a type of malaria similar to vivax malaria %28%MALARIA, VIVAX%29%. This species has been found to give rise to both natural and experimental human infections.%A%
% 209.58/209.73 |- mesh__dateRevised mesh__D016789 2004-07-13
% 209.58/209.73 |- mesh__historyNote mesh__D016789 92
% 209.58/209.73 |- skos__historyNote mesh__D016789 Plasmodium %28%1966-1991%29%
% 209.58/209.73 |- mesh__dateEstablished mesh__D016789 1992-01-01
% 209.58/209.73 |- mesh__onlineNote mesh__D002769
% 209.58/209.73 to search for chem composition of biliary calculi, use CHOLELITHIASIS/anal 1987-90 %26% CHOLELITHIASIS/metab 1966-86%A%
% 209.58/209.73 |- mesh__recordOriginator mesh__D002769 NLM
% 209.58/209.73 |- skos__annotation mesh__D002769
% 209.58/209.73 CHOLECYSTOLITHIASIS and CHOLEDOCHOLITHIASIS are also available%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D002769 2006
% 209.58/209.73 |- mesh__dateCreated mesh__D002769 1999-01-01
% 209.58/209.73 |- skos__scopeNote mesh__D002769
% 209.58/209.73 Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder %28%CHOLECYSTOLITHIASIS%29% or the common bile duct %28%CHOLEDOCHOLITHIASIS%29%.%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D002769 2005
% 209.58/209.73 |- rdf__type mesh__D002769sskos__Concept
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D002769 2004
% 209.58/209.73 |- skos__hiddenLabel mesh__D002769 Cholelithiases
% 209.58/209.73 |- skos__broader mesh__D002769smesh__D001660
% 209.58/209.73 |- mesh__recordMaintainer mesh__D002769 lkt
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D002769 sjn
% 209.58/209.73 |- mesh__dateRevised mesh__D002769 2003-07-09
% 209.58/209.73 |- skos__prefLabel mesh__D002769 Cholelithiasis
% 209.58/209.73 |- skos__hiddenLabel mesh__D013491 T-Cell Factors, Suppressor
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D013491 86
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D013491 sjn
% 209.58/209.73 |- mesh__dateEstablished mesh__D013491 1986-01-01
% 209.58/209.73 |- skos__hiddenLabel mesh__D013491 Suppressive Factors, T-Cell
% 209.58/209.73 |- skos__altLabel mesh__D013491 T-Suppressor Factors
% 209.58/209.73 |- mesh__recordOriginator mesh__D013491 SH
% 209.58/209.73 |- skos__broader mesh__D013491smesh__D008222
% 209.58/209.73 |- skos__historyNote mesh__D013491 Lymphokines %28%1966-1985%29%
% 209.58/209.73 |- skos__hiddenLabel mesh__D013491 Factors, T-Cell Suppressive
% 209.58/209.73 |- skos__altLabel mesh__D013491 Factors, T Suppressor
% 209.58/209.73 |- skos__altLabel mesh__D013491 T Cell Suppressor Factors
% 209.58/209.73 |- mesh__dateCreated mesh__D013491 1985-06-14
% 209.58/209.73 |- skos__prefLabel mesh__D013491 Suppressor Factors, Immunologic
% 209.58/209.73 |- mesh__dateRevised mesh__D013491 2005-06-30
% 209.58/209.73 |- skos__historyNote mesh__D013491 Suppressor Cells %28%1979-1985%29%
% 209.58/209.73 |- skos__hiddenLabel mesh__D013491 Suppressor T Cell Factors
% 209.58/209.73 |- rdf__type mesh__D013491sskos__Concept
% 209.58/209.73 |- skos__hiddenLabel mesh__D013491 Factors, Suppressor T-Cell
% 209.58/209.73 |- skos__hiddenLabel mesh__D013491 T Suppressor Factors
% 209.58/209.73 |- skos__altLabel mesh__D013491 Immunologic Suppressor Factors
% 209.58/209.73 |- skos__hiddenLabel mesh__D013491 Factors, T-Suppressor
% 209.58/209.73 |- skos__altLabel mesh__D013491 T-Cell Suppressive Factors
% 209.58/209.73 |- mesh__recordMaintainer mesh__D013491 ssb
% 209.58/209.73 |- skos__scopeNote mesh__D013491
% 209.58/209.73 Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility %28%I-J%29% and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory.%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D013491 2006
% 209.58/209.73 |- skos__annotation mesh__D013491
% 209.58/209.73 lymphokines; /biosyn /drug eff /physiol /ultrastruct permitted; DF: SUPPRESSOR FACTORS IMMUNOL%A%
% 209.58/209.73 |- skos__hiddenLabel mesh__D013491 Suppressor Factors, T
% 209.58/209.73 |- skos__hiddenLabel mesh__D013491 T Cell Suppressive Factors
% 209.58/209.73 |- skos__altLabel mesh__D013491 Factors, Immunologic Suppressor
% 209.58/209.73 |- mesh__historyNote mesh__D013491 86
% 209.58/209.73 |- skos__altLabel mesh__D013491 Suppressor T-Cell Factors
% 209.58/209.73 |- mesh__historyNote mesh__D029906 2002
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D029906 2006
% 209.58/209.73 |- skos__broader mesh__D029906smesh__D007887
% 209.58/209.73 |- skos__annotation mesh__D029906
% 209.58/209.73 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.58/209.73 |- mesh__dateEstablished mesh__D029906 2002-01-01
% 209.58/209.73 |- skos__altLabel mesh__D029906 Calabar Bean
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D029906 2005
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D029906 2004
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D029906 2002
% 209.58/209.73 |- skos__scopeNote mesh__D029906
% 209.58/209.73 A plant genus of the family FABACEAE that is a source of PHYSOSTIGMINE.%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D029906 2003
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D029906 2002
% 209.58/209.73 |- skos__prefLabel mesh__D029906 Physostigma
% 209.58/209.73 |- rdf__type mesh__D029906sskos__Concept
% 209.58/209.73 |- mesh__dateCreated mesh__D029906 2001-07-25
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 1997
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 1994
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 2003
% 209.58/209.73 |- skos__scopeNote mesh__D007454
% 209.58/209.73 Inorganic binary compounds of iodine or the I- ion.
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 1995
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 2004
% 209.58/209.73 |- rdf__type mesh__D007454sskos__Concept
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 2002
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 1998
% 209.58/209.73 |- mesh__dateCreated mesh__D007454 1999-01-01
% 209.58/209.73 |- mesh__dateRevised mesh__D007454 1993-06-02
% 209.58/209.73 |- skos__prefLabel mesh__D007454 Iodides
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D007454 PLS
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 1999
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 2005
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 2000
% 209.58/209.73 |- skos__broader mesh__D007454smesh__D017613
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 1996
% 209.58/209.73 |- skos__annotation mesh__D007454 inorganic cpds or iodide ion only
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 2006
% 209.58/209.73 |- skos__broader mesh__D007454smesh__D000838
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D007454 2001
% 209.58/209.73 |- mesh__recordOriginator mesh__D007454 NLM
% 209.58/209.73 |- mesh__recordMaintainer mesh__D007454 TPW
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D012399 2006
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D012399 2000
% 209.58/209.73 |- mesh__historyNote mesh__D012399 68
% 209.58/209.73 |- mesh__dateEstablished mesh__D012399 1968-01-01
% 209.58/209.73 |- skos__historyNote mesh__D012399 Aerospace Medicine %28%1966-1967%29%
% 209.58/209.73 |- skos__scopeNote mesh__D012399
% 209.58/209.73 Motion of a rigid body in which either one point is fixed, or all the points on a straight line are fixed. It is also the motion of a particle about a fixed point. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D012399 2001
% 209.58/209.73 |- skos__hiddenLabel mesh__D012399 Rotations
% 209.58/209.73 |- rdf__type mesh__D012399sskos__Concept
% 209.58/209.73 |- mesh__dateRevised mesh__D012399 1998-06-11
% 209.58/209.73 |- mesh__dateCreated mesh__D012399 1999-01-01
% 209.58/209.73 |- skos__historyNote mesh__D012399 Acceleration %28%1966-1967%29%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D012399 1999
% 209.58/209.73 |- skos__prefLabel mesh__D012399 Rotation
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D012399 SJN
% 209.58/209.73 |- skos__related mesh__D012399smesh__D002498
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D012399 2002
% 209.58/209.73 |- skos__broader mesh__D012399smesh__D009038
% 209.58/209.73 |- skos__related mesh__D012399smesh__D018470
% 209.58/209.73 |- skos__hiddenLabel mesh__D012399 Clinorotations
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D012399 2003
% 209.58/209.73 |- mesh__recordMaintainer mesh__D012399 JLS
% 209.58/209.73 |- mesh__recordOriginator mesh__D012399 NLM
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D012399 2005
% 209.58/209.73 |- skos__annotation mesh__D012399
% 209.58/209.73 /adv eff permitted; rotation of a body part on its axis is TORSION%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D012399 2004
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D012399 68
% 209.58/209.73 |- skos__altLabel mesh__D017882 Kingella kingii
% 209.58/209.73 |- skos__annotation mesh__D017882
% 209.58/209.73 formerly called Moraxella kingae; infection: coord IM with NEISSERIACEAE INFECTIONS %28%IM%29%%A%
% 209.58/209.73 |- mesh__dateRevised mesh__D017882 2005-06-30
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017882 2006
% 209.58/209.73 |- rdf__type mesh__D017882sskos__Concept
% 209.58/209.73 |- mesh__dateCreated mesh__D017882 1993-06-30
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D017882 94
% 209.58/209.73 |- mesh__recordOriginator mesh__D017882 PXP
% 209.58/209.73 |- mesh__dateEstablished mesh__D017882 1994-01-01
% 209.58/209.73 |- skos__historyNote mesh__D017882 Neisseriaceae %28%1983-1993%29%
% 209.58/209.73 |- skos__altLabel mesh__D017882 Moraxella kingii
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D017882 sjn
% 209.58/209.73 |- skos__altLabel mesh__D017882 Moraxella kingae
% 209.58/209.73 |- mesh__historyNote mesh__D017882 94
% 209.58/209.73 |- skos__broader mesh__D017882smesh__D017881
% 209.58/209.73 |- skos__scopeNote mesh__D017882
% 209.58/209.73 A species of gram-negative, aerobic, rod-shaped bacteria which is distinguished from other members of the genus KINGELLA by its beta hemolysis. It occurs normally in human mucous membranes of the upper respiratory tract, but can cause septic arthritis and endocarditis. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%
% 209.58/209.73 |- skos__historyNote mesh__D017882 Moraxella %28%1969-1988%29%
% 209.58/209.73 |- skos__prefLabel mesh__D017882 Kingella kingae
% 209.58/209.73 |- mesh__recordMaintainer mesh__D017882 SYSTEM
% 209.58/209.73 |- skos__hiddenLabel mesh__D017084 Spontaneous Otoacoustic Emissions
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 2002
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 1995
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 2003
% 209.58/209.73 |- mesh__historyNote mesh__D017084 93
% 209.58/209.73 |- skos__historyNote mesh__D017084 Acoustics %28%1984-1992%29%
% 209.58/209.73 |- skos__historyNote mesh__D017084 Cochlea %28%1983-1992%29%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 2005
% 209.58/209.73 |- skos__hiddenLabel mesh__D017084 Spontaneous Otoacoustic Emission
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 2004
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 2000
% 209.58/209.73 |- skos__historyNote mesh__D017084 Acoustic Stimulation %28%1984-1992%29%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 2006
% 209.58/209.73 |- skos__scopeNote mesh__D017084
% 209.58/209.73 Sinusoidal tones originating in the cochlea. These faint sounds, with levels between 10-30 decibels, are usually not recognized by the persons having them. However, the emissions can be recorded using sensitive microphones placed in the ear canals. The clinical significance of having or not having spontaneous otoacoustic emissions is unclear; however, some association between tinnitus and the spontaneous emissions has been reported.%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 1996
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 2001
% 209.58/209.73 |- skos__hiddenLabel mesh__D017084 Otoacoustic Emission, Spontaneous
% 209.58/209.73 |- mesh__dateCreated mesh__D017084 1992-05-22
% 209.58/209.73 |- skos__annotation mesh__D017084
% 209.58/209.73 note category; faint microphone-recordable sounds emitted by the cochlea%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 1998
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D017084 93
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 1997
% 209.58/209.73 |- skos__broader mesh__D017084smesh__D006309
% 209.58/209.73 |- skos__hiddenLabel mesh__D017084 Emissions, Spontaneous Otoacoustic
% 209.58/209.73 |- skos__prefLabel mesh__D017084 Otoacoustic Emissions, Spontaneous
% 209.58/209.73 |- rdf__type mesh__D017084sskos__Concept
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 1994
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 1993
% 209.58/209.73 |- mesh__dateEstablished mesh__D017084 1993-01-01
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D017084 1999
% 209.58/209.73 |- skos__hiddenLabel mesh__D017084 Emission, Spontaneous Otoacoustic
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 1996
% 209.58/209.73 |- skos__scopeNote mesh__D003862
% 209.58/209.73 Decline in value of capital assets of a permanent or fixed nature over time with use.%A%
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 2000
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 2003
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 2001
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 1997
% 209.58/209.73 |- skos__prefLabel mesh__D003862 Depreciation
% 209.58/209.73 |- mesh__recordOriginator mesh__D003862 EC
% 209.58/209.73 |- mesh__recordMaintainer mesh__D003862 TGC
% 209.58/209.73 |- rdf__type mesh__D003862sskos__Concept
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 2004
% 209.58/209.73 |- skos__hiddenLabel mesh__D003862 Depreciations
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 1998
% 209.58/209.73 |- mesh__dateRevised mesh__D003862 1992-05-14
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 1993
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 2002
% 209.58/209.73 |- mesh__dateEstablished mesh__D003862 1991-01-01
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 2005
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 1994
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 1999
% 209.58/209.73 |- skos__broader mesh__D003862smesh__D000066
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D003862
% 209.58/209.73 91; was see under ACCOUNTING 1978-90
% 209.58/209.73 |- skos__annotation mesh__D003862 NIM
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 2006
% 209.58/209.73 |- mesh__activeMeSHYear mesh__D003862 1995
% 209.58/209.73 |- mesh__historyNote mesh__D003862
% 209.58/209.73 91%28%78%29%; was see under ACCOUNTING 1978-90
% 209.58/209.73 |- mesh__dateCreated mesh__D003862 1977-05-05
% 209.58/209.73 |- mesh__recordAuthorizer mesh__D003862 PLS
% 209.58/209.73 |- mesh__dateEstablished mesh__D003064 1978-01-01
% 209.58/209.73 |- mesh__dateCreated mesh__D003064 1977-04-22
% 209.58/209.73 |- skos__annotation mesh__D003064
% 209.58/209.73 /antag permitted but consider also ANTIVENINS; coordinate with specific Cnidaria source%A%
% 209.58/209.73 |- skos__hiddenLabel mesh__D003064 Venoms, Sea Anemone
% 209.58/209.73 |- skos__historyNote mesh__D003064 Coelenterata %28%1966-1977%29%
% 209.58/209.73 |- skos__hiddenLabel mesh__D003064 Venoms, Cnidarian
% 209.58/209.73 |- skos__hiddenLabel mesh__D003064 Venom, Cnidarian
% 209.58/209.73 |- mesh__dateRevised mesh__D003064 2005-06-30
% 209.58/209.73 |- rdf__type mesh__D003064sskos__Concept
% 209.58/209.73 |- skos__hiddenLabel mesh__D003064 Portuguese Man of War Venom
% 209.58/209.73 |- skos__prefLabel mesh__D003064 Cnidarian Venoms
% 209.58/209.73 |- mesh__publicMeSHNote mesh__D003064
% 209.58/209.73 95; was COELENTERATE VENOMS 1978-94
% 209.58/209.73 |- mesh__onlineNote mesh__D003064
% 209.58/209.73 use CNIDARIAN VENOMS to search COELENTERATE VENOMS 1978-94%A%
% 209.58/209.73 |- skos__hiddenLabel mesh__D003064 Venoms, Jellyfish
% 209.58/209.74 |- skos__altLabel mesh__D003064 Jellyfish Venom
% 209.58/209.74 |- skos__hiddenLabel mesh__D003064 Venom, Chironex
% 209.58/209.74 |- skos__altLabel mesh__D003064 Sea Anemone Venoms
% 209.58/209.74 |- skos__scopeNote mesh__D003064
% 209.58/209.74 Venoms from jellyfish; CORALS; SEA ANEMONES; etc. They contain hemo-, cardio-, dermo- , and neuro-toxic substances and probably ENZYMES. They include palytoxin, sarcophine, and anthopleurine.%A%
% 209.58/209.74 |- mesh__recordOriginator mesh__D003064 SH
% 209.58/209.74 |- skos__hiddenLabel mesh__D003064 Venom, Jellyfish
% 209.58/209.74 |- skos__historyNote mesh__D003064 Venoms %28%1966-1977%29%
% 209.58/209.74 |- skos__hiddenLabel mesh__D003064 Venom, Portuguese Man-of-War
% 209.58/209.74 |- skos__hiddenLabel mesh__D003064 Venoms, Chironex
% 209.58/209.74 |- skos__broader mesh__D003064smesh__D008387
% 209.58/209.74 |- skos__related mesh__D003064smesh__D003063
% 209.58/209.74 |- skos__altLabel mesh__D003064 Cnidarian Venom
% 209.58/209.74 |- skos__historyNote mesh__D003064 Toxins %28%1966-1973%29%
% 209.58/209.74 |- mesh__historyNote mesh__D003064 95; was COELENTERATE VENOMS 1978-94
% 209.58/209.74 |- skos__hiddenLabel mesh__D003064 Venom, Sea Anemone
% 209.58/209.74 |- mesh__recordMaintainer mesh__D003064 ssb
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D003064 sjn
% 209.58/209.74 |- skos__broader mesh__D003064smesh__D014688
% 209.58/209.74 |- skos__historyNote mesh__D003064 Marine Toxins %28%1974-1977%29%
% 209.58/209.74 |- skos__altLabel mesh__D003064 Chironex Venom
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003064 2006
% 209.58/209.74 |- skos__historyNote mesh__D041981
% 209.58/209.74 Gastrointestinal System %28%1965-2003%29%
% 209.58/209.74 |- skos__hiddenLabel mesh__D041981 Digestive Tracts
% 209.58/209.74 |- mesh__historyNote mesh__D041981 2004
% 209.58/209.74 |- skos__scopeNote mesh__D041981
% 209.58/209.74 Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs %28%LIVER; BILIARY TRACT; PANCREAS%29%.%A%
% 209.58/209.74 |- skos__altLabel mesh__D041981 Digestive Tract
% 209.58/209.74 |- skos__altLabel mesh__D041981 GI Tract
% 209.58/209.74 |- skos__prefLabel mesh__D041981 Gastrointestinal Tract
% 209.58/209.74 |- mesh__dateCreated mesh__D041981 2003-07-09
% 209.58/209.74 |- skos__broader mesh__D041981smesh__D004064
% 209.58/209.74 |- skos__hiddenLabel mesh__D041981 GI Tracts
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D041981 2005
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D041981 2004
% 209.58/209.74 |- skos__hiddenLabel mesh__D041981 Gastrointestinal Tracts
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D041981 2006
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D041981 2004
% 209.58/209.74 |- rdf__type mesh__D041981sskos__Concept
% 209.58/209.74 |- mesh__dateEstablished mesh__D041981 2004-01-01
% 209.58/209.74 |- skos__scopeNote mesh__D013492
% 209.58/209.74 A pathologic process consisting in the formation of pus.%A%
% 209.58/209.74 |- skos__broader mesh__D013492smesh__D007249
% 209.58/209.74 |- mesh__recordMaintainer mesh__D013492 adp
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013492 2001
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D013492 sjn
% 209.58/209.74 |- rdf__type mesh__D013492sskos__Concept
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013492 2005
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013492 2002
% 209.58/209.74 |- skos__annotation mesh__D013492
% 209.58/209.74 NIM; TN 178: for suppurative dis %26% coord
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013492 2003
% 209.58/209.74 |- skos__broader mesh__D013492smesh__D007239
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013492 2006
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013492 2004
% 209.58/209.74 |- mesh__dateRevised mesh__D013492 1999-11-08
% 209.58/209.74 |- skos__prefLabel mesh__D013492 Suppuration
% 209.58/209.74 |- mesh__recordOriginator mesh__D013492 NLM
% 209.58/209.74 |- mesh__dateCreated mesh__D013492 1999-01-01
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013492 2000
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029907 2005
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029907 2004
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D029907 2002
% 209.58/209.74 |- mesh__dateCreated mesh__D029907 2001-07-25
% 209.58/209.74 |- mesh__historyNote mesh__D029907 2002
% 209.58/209.74 |- skos__annotation mesh__D029907
% 209.58/209.74 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029907 2003
% 209.58/209.74 |- skos__scopeNote mesh__D029907
% 209.58/209.74 A plant genus of the family FABACEAE that is a source of psoralen %28%FICUSIN%29%.%A%
% 209.58/209.74 |- skos__prefLabel mesh__D029907 Psoralea
% 209.58/209.74 |- rdf__type mesh__D029907sskos__Concept
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029907 2006
% 209.58/209.74 |- skos__broader mesh__D029907smesh__D007887
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029907 2002
% 209.58/209.74 |- mesh__dateEstablished mesh__D029907 2002-01-01
% 209.58/209.74 |- rdf__type mesh__D007455sskos__Concept
% 209.58/209.74 |- mesh__recordOriginator mesh__D007455 NLM
% 209.58/209.74 |- mesh__dateCreated mesh__D007455 1999-01-01
% 209.58/209.74 |- skos__related mesh__D007455smesh__D007456
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D007455 sjn
% 209.58/209.74 |- skos__annotation mesh__D007455 I-127
% 209.58/209.74 |- skos__scopeNote mesh__D007455
% 209.58/209.74 A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.%A%
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D007455 2006
% 209.58/209.74 |- mesh__recordMaintainer mesh__D007455 ssb
% 209.58/209.74 |- mesh__dateRevised mesh__D007455 2005-06-30
% 209.58/209.74 |- skos__prefLabel mesh__D007455 Iodine
% 209.58/209.74 |- skos__broader mesh__D007455smesh__D006219
% 209.58/209.74 |- skos__related mesh__D007455smesh__D007457
% 209.58/209.74 |- skos__broader mesh__D017883smesh__D020565
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D017883 sjn
% 209.58/209.74 |- mesh__dateCreated mesh__D017883 1993-06-03
% 209.58/209.74 |- mesh__recordOriginator mesh__D017883 PXP
% 209.58/209.74 |- skos__broader mesh__D017883smesh__D006090
% 209.58/209.74 |- skos__scopeNote mesh__D017883
% 209.58/209.74 A genus of gram-negative, spiral-shaped bacteria that is pathogenic and has been isolated from the GASTRIC MUCOSA of MAMMALS, including humans.%A%
% 209.58/209.74 |- mesh__historyNote mesh__D017883 94
% 209.58/209.74 |- skos__annotation mesh__D017883
% 209.58/209.74 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; GASTROSPIRILLUM HOMINIS and GASTROSPIRILLUM SUIS see HELICOBACTER HEILMANNII are available%A%
% 209.58/209.74 |- mesh__dateRevised mesh__D017883 2005-06-30
% 209.58/209.74 |- skos__historyNote mesh__D017883 Gram-Negative Bacteria %28%1989-1993%29%
% 209.58/209.74 |- mesh__dateEstablished mesh__D017883 1994-01-01
% 209.58/209.74 |- mesh__recordMaintainer mesh__D017883 SYSTEM
% 209.58/209.74 |- skos__prefLabel mesh__D017883 Gastrospirillum
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D017883 94
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017883 2006
% 209.58/209.74 |- rdf__type mesh__D017883sskos__Concept
% 209.58/209.74 |- skos__historyNote mesh__D017085 Thalassemia %28%1966-1992%29%
% 209.58/209.74 |- rdf__type mesh__D017085sskos__Concept
% 209.58/209.74 |- mesh__recordOriginator mesh__D017085 PXP
% 209.58/209.74 |- skos__broader mesh__D017085smesh__D013789
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D017085
% 209.58/209.74 93; was see THALASSEMIA 1988-92; HEMOGLOBIN H DISEASE was see THALASSEMIA 1982-92%A%
% 209.58/209.74 |- skos__hiddenLabel mesh__D017085 alpha Thalassemia
% 209.58/209.74 |- skos__hiddenLabel mesh__D017085 Disease, Hemoglobin H
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017085 2004
% 209.58/209.74 |- skos__related mesh__D017085smesh__D006447
% 209.58/209.74 |- skos__altLabel mesh__D017085 Hemoglobin H Disease
% 209.58/209.74 |- skos__hiddenLabel mesh__D017085 Thalassemia-alphas
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017085 2003
% 209.58/209.74 |- skos__scopeNote mesh__D017085
% 209.58/209.74 A disorder characterized by reduced synthesis of the alpha chains of hemoglobin. The severity of this condition can vary from mild anemia to death, depending on the number of genes deleted.%A%
% 209.58/209.74 |- skos__hiddenLabel mesh__D017085 Diseases, Hemoglobin H
% 209.58/209.74 |- skos__hiddenLabel mesh__D017085 Hemoglobin H Diseases
% 209.58/209.74 |- skos__prefLabel mesh__D017085 alpha-Thalassemia
% 209.58/209.74 |- skos__altLabel mesh__D017085 Thalassemia-alpha
% 209.58/209.74 |- skos__annotation mesh__D017085
% 209.58/209.74 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 209.58/209.74 |- skos__hiddenLabel mesh__D017085 alpha-Thalassemias
% 209.58/209.74 |- mesh__recordMaintainer mesh__D017085 nns
% 209.58/209.74 |- mesh__onlineNote mesh__D017085
% 209.58/209.74 use THALASSEMIA to search ALPHA-THALASSEMIA 1988-92 %26% HEMOGLOBIN H DISEASE 1982-92%A%
% 209.58/209.74 |- mesh__dateEstablished mesh__D017085 1993-01-01
% 209.58/209.74 |- mesh__dateCreated mesh__D017085 1992-05-07
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017085 2006
% 209.58/209.74 |- skos__hiddenLabel mesh__D017085 Thalassemia alpha
% 209.58/209.74 |- mesh__dateRevised mesh__D017085 2001-07-25
% 209.58/209.74 |- mesh__historyNote mesh__D017085
% 209.58/209.74 93; was see THALASSEMIA 1988-92; HEMOGLOBIN H DISEASE was see THALASSEMIA 1982-92%A%
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017085 2002
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017085 2005
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D017085 sjn
% 209.58/209.74 |- skos__prefLabel mesh__D003863 Depression
% 209.58/209.74 |- skos__hiddenLabel mesh__D003863 Depression, Emotional
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003863 2003
% 209.58/209.74 |- skos__related mesh__D003863smesh__D000928
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003863 2004
% 209.58/209.74 |- rdf__type mesh__D003863sskos__Concept
% 209.58/209.74 |- skos__hiddenLabel mesh__D003863 Depressions, Emotional
% 209.58/209.74 |- skos__broader mesh__D003863smesh__D001526
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003863 2005
% 209.58/209.74 |- skos__hiddenLabel mesh__D003863 Depressive Symptom
% 209.58/209.74 |- skos__annotation mesh__D003863
% 209.58/209.74 human %26% animal; /drug ther: consider also ANTIDEPRESSIVE AGENTS; do not confuse this or X ref %28%depression of %22%moderate intensity%22%%29% with DEPRESSIVE DISORDER %28%%22%prominent %26% relatively persistent%22% depression%29%: psychiatrists differentiate on basis of degree%A%
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003863 2006
% 209.58/209.74 |- mesh__dateRevised mesh__D003863 2002-07-03
% 209.58/209.74 |- skos__hiddenLabel mesh__D003863 Symptom, Depressive
% 209.58/209.74 |- mesh__recordOriginator mesh__D003863 NLM
% 209.58/209.74 |- skos__hiddenLabel mesh__D003863 Depressions
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D003863 sjn
% 209.58/209.74 |- skos__hiddenLabel mesh__D003863 Symptoms, Depressive
% 209.58/209.74 |- skos__altLabel mesh__D003863 Emotional Depression
% 209.58/209.74 |- skos__scopeNote mesh__D003863
% 209.58/209.74 Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.%A%
% 209.58/209.74 |- mesh__dateCreated mesh__D003863 1999-01-01
% 209.58/209.74 |- mesh__recordMaintainer mesh__D003863 JLS
% 209.58/209.74 |- skos__hiddenLabel mesh__D003863 Emotional Depressions
% 209.58/209.74 |- rdf__type mesh__D003065sskos__Concept
% 209.58/209.74 |- mesh__recordMaintainer mesh__D003065 ssb
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003065 2004
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D003065 sjn
% 209.58/209.74 |- skos__prefLabel mesh__D003065 Coenzyme A
% 209.58/209.74 |- skos__hiddenLabel mesh__D003065 A, Coenzyme
% 209.58/209.74 |- skos__broader mesh__D003065smesh__D003067
% 209.58/209.74 |- skos__altLabel mesh__D003065 CoA
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003065 2005
% 209.58/209.74 |- skos__annotation mesh__D003065 /biosyn /physiol permitted
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003065 2006
% 209.58/209.74 |- mesh__dateRevised mesh__D003065 2003-07-09
% 209.58/209.74 |- mesh__dateCreated mesh__D003065 1999-01-01
% 209.58/209.74 |- skos__broader mesh__D003065smesh__D000227
% 209.58/209.74 |- mesh__recordOriginator mesh__D003065 NLM
% 209.58/209.74 |- mesh__recordMaintainer mesh__D013493 TAP
% 209.58/209.74 |- skos__annotation mesh__D013493 in the HYPOTHALAMUS, ANTERIOR
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 2002
% 209.58/209.74 |- skos__prefLabel mesh__D013493 Suprachiasmatic Nucleus
% 209.58/209.74 |- skos__scopeNote mesh__D013493
% 209.58/209.74 An ovoid densely packed collection of small cells of the anterior hypothalamus lying close to the midline in a shallow impression of the optic chiasm.%A%
% 209.58/209.74 |- mesh__dateRevised mesh__D013493 1992-05-18
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 2001
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 1997
% 209.58/209.74 |- skos__hiddenLabel mesh__D013493 Nucleus, Suprachiasmatic
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D013493 83
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 1999
% 209.58/209.74 |- mesh__dateCreated mesh__D013493 1982-04-28
% 209.58/209.74 |- rdf__type mesh__D013493sskos__Concept
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 1993
% 209.58/209.74 |- mesh__dateEstablished mesh__D013493 1983-01-01
% 209.58/209.74 |- skos__historyNote mesh__D013493 Hypothalamus %28%1966-1982%29%
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 1996
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 2000
% 209.58/209.74 |- skos__broader mesh__D013493smesh__D007032
% 209.58/209.74 |- mesh__historyNote mesh__D013493 83
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 1995
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 1998
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 2004
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 2006
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 1994
% 209.58/209.74 |- mesh__recordOriginator mesh__D013493 RC
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 2003
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013493 2005
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D013493 PLS
% 209.58/209.74 |- skos__scopeNote mesh__D029908
% 209.58/209.74 A plant genus of the family FABACEAE a common weed of the southeast US. There has been folk use for alcoholism and liver protection. It contains puerarin, kakkalide, daidzein %28%isoflavonoids%29%, and kudzusaponins %28%oleanene-type triterpene glycosides%29%.%A%
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D029908 sjn
% 209.58/209.74 |- skos__annotation mesh__D029908
% 209.58/209.74 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.58/209.74 |- skos__altLabel mesh__D029908 Puerariae
% 209.58/209.74 |- mesh__recordMaintainer mesh__D029908 ssb
% 209.58/209.74 |- rdf__type mesh__D029908sskos__Concept
% 209.58/209.74 |- mesh__recordOriginator mesh__D029908 ssb
% 209.58/209.74 |- skos__prefLabel mesh__D029908 Pueraria
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029908 2006
% 209.58/209.74 |- skos__broader mesh__D029908smesh__D007887
% 209.58/209.74 |- mesh__dateCreated mesh__D029908 2001-07-25
% 209.58/209.74 |- mesh__historyNote mesh__D029908 2002
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029908 2005
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029908 2004
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D029908 2002
% 209.58/209.74 |- mesh__dateEstablished mesh__D029908 2002-01-01
% 209.58/209.74 |- skos__altLabel mesh__D029908 Pachyrhizus thunbergianus
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029908 2003
% 209.58/209.74 |- mesh__dateRevised mesh__D029908 2002-07-03
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D007456 2005
% 209.58/209.74 |- mesh__recordMaintainer mesh__D007456 nns
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D007456 2006
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D007456
% 209.58/209.74 /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A%
% 209.58/209.74 |- skos__scopeNote mesh__D007456
% 209.58/209.74 Stable iodine atoms that have the same atomic number as the element iodine, but differ in atomic weight. I-127 is the only naturally occurring stable iodine isotope.%A%
% 209.58/209.74 |- mesh__dateRevised mesh__D007456 2000-06-22
% 209.58/209.74 |- skos__hiddenLabel mesh__D007456 Isotopes, Iodine
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D007456 2003
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D007456 2001
% 209.58/209.74 |- mesh__recordOriginator mesh__D007456 NLM
% 209.58/209.74 |- skos__broader mesh__D007456smesh__D007554
% 209.58/209.74 |- skos__prefLabel mesh__D007456 Iodine Isotopes
% 209.58/209.74 |- mesh__onlineNote mesh__D007456
% 209.58/209.74 search IODINE ISOTOPES, DIAGNOSTIC under IODINE RADIOISOTOPES /DU 1966-76%A%
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D007456 2004
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D007456 sjn
% 209.58/209.74 |- rdf__type mesh__D007456sskos__Concept
% 209.58/209.74 |- skos__annotation mesh__D007456 I-127; NIM
% 209.58/209.74 |- mesh__dateCreated mesh__D007456 1999-01-01
% 209.58/209.74 |- mesh__historyNote mesh__D007456
% 209.58/209.74 /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A%
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D007456 2002
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017086 2002
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017086 2004
% 209.58/209.74 |- skos__prefLabel mesh__D017086 beta-Thalassemia
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D017086 sjn
% 209.58/209.74 |- skos__hiddenLabel mesh__D017086 Mediterranean Anemia
% 209.58/209.74 |- skos__altLabel mesh__D017086 Anemia, Cooley%27%s
% 209.58/209.74 |- skos__hiddenLabel mesh__D017086 Cooley%27%s Anemia
% 209.58/209.74 |- skos__hiddenLabel mesh__D017086 beta Thalassemia
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017086 2003
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D017086
% 209.58/209.74 93; was see THALASSEMIA 1988-92; ANEMIA, ERYTHROBLASTIC was see THALASSEMIA 1965-92, was heading 1963-64; ANEMIA, COOLEY%27%S was see THALASSEMIA 1963-92; ANEMIA, MEDITERRANEAN was see THALASSEMIA 1965-92; HEMOGLOBIN F DISEASE %26% THALASSEMIA MAJOR were see THALASSEMIA 1988-92%A%
% 209.58/209.74 |- skos__hiddenLabel mesh__D017086 Anemia, Cooleys
% 209.58/209.74 |- skos__broader mesh__D017086smesh__D013789
% 209.58/209.74 |- skos__scopeNote mesh__D017086
% 209.58/209.74 A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form %28%thalassemia minor%29%, which is asymptomatic, while in the homozygous form %28%thalassemia major, Cooley%27%s anemia, Mediterranean anemia, erythroblastic anemia%29%, which can result in severe complications and even death, hemoglobin A synthesis is absent.%A%
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017086 2006
% 209.58/209.74 |- skos__hiddenLabel mesh__D017086 Erythroblastic Anemia
% 209.58/209.74 |- mesh__dateCreated mesh__D017086 1992-05-07
% 209.58/209.74 |- skos__hiddenLabel mesh__D017086 Anemia, Cooley
% 209.58/209.74 |- mesh__historyNote mesh__D017086
% 209.58/209.74 93; was see THALASSEMIA 1988-92; ANEMIA, ERYTHROBLASTIC was see THALASSEMIA 1965-92, was heading 1963-64; ANEMIA, COOLEY%27%S was see THALASSEMIA 1963-92; ANEMIA, MEDITERRANEAN was see THALASSEMIA 1965-92; HEMOGLOBIN F DISEASE %26% THALASSEMIA MAJOR were see THALASSEMIA 1988-92%A%
% 209.58/209.74 |- skos__hiddenLabel mesh__D017086 Anemias, Erythroblastic
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D017086 2005
% 209.58/209.74 |- skos__historyNote mesh__D017086 Thalassemia %28%1966-1992%29%
% 209.58/209.74 |- skos__altLabel mesh__D017086 Anemia, Erythroblastic
% 209.58/209.74 |- rdf__type mesh__D017086sskos__Concept
% 209.58/209.74 |- mesh__onlineNote mesh__D017086
% 209.58/209.74 use THALASSEMIA to search ANEMIA, ERYTHROBLASTIC %26% ANEMIA, COOLEY%27%S %26% ANEMIA, MEDITERRANEAN 1966-92 and HEMOGLOBIN F DISEASE %26% THALASSEMIA MAJOR 1988-92%A%
% 209.58/209.74 |- skos__altLabel mesh__D017086 Anemia, Mediterranean
% 209.58/209.74 |- skos__hiddenLabel mesh__D017086 Disease, Hemoglobin F
% 209.58/209.74 |- mesh__dateEstablished mesh__D017086 1993-01-01
% 209.58/209.74 |- skos__annotation mesh__D017086
% 209.58/209.74 one of the congen hemolytic anemias; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 209.58/209.74 |- mesh__recordMaintainer mesh__D017086 nns
% 209.58/209.74 |- mesh__recordOriginator mesh__D017086 PXP
% 209.58/209.74 |- mesh__dateRevised mesh__D017086 2001-07-25
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 2005
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 1999
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 1994
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D003864 68
% 209.58/209.74 |- mesh__dateRevised mesh__D003864 1991-05-28
% 209.58/209.74 |- mesh__recordOriginator mesh__D003864 NLM
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 2002
% 209.58/209.74 |- mesh__historyNote mesh__D003864 68
% 209.58/209.74 |- skos__broader mesh__D003864smesh__D002620
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 2006
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 1995
% 209.58/209.74 |- skos__hiddenLabel mesh__D003864 Chemical Depressions
% 209.58/209.74 |- skos__altLabel mesh__D003864 Chemical Depression
% 209.58/209.74 |- mesh__dateCreated mesh__D003864 1999-01-01
% 209.58/209.74 |- mesh__dateEstablished mesh__D003864 1968-01-01
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 1996
% 209.58/209.74 |- skos__annotation mesh__D003864
% 209.58/209.74 never IM; TN 49: definition %26% use as NIM
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D003864 PLS
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 2003
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 1997
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 1992
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 2000
% 209.58/209.74 |- skos__hiddenLabel mesh__D003864 Depressions, Chemical
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 2004
% 209.58/209.74 |- rdf__type mesh__D003864sskos__Concept
% 209.58/209.74 |- skos__prefLabel mesh__D003864 Depression, Chemical
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 1998
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 1993
% 209.58/209.74 |- mesh__recordMaintainer mesh__D003864 TGC
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003864 2001
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 Ligases, Acid-Thiol
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 Acid Thiol Ligases
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 Ligases, Coenzyme A
% 209.58/209.74 |- skos__altLabel mesh__D003066 Co A Ligases
% 209.58/209.74 |- skos__altLabel mesh__D003066 Acyl Coenzyme A Synthetases
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003066 2005
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003066 2004
% 209.58/209.74 |- mesh__dateCreated mesh__D003066 1999-01-01
% 209.58/209.74 |- skos__historyNote mesh__D003066 Ligases %28%1966-1972%29%
% 209.58/209.74 |- mesh__recordMaintainer mesh__D003066 ssb
% 209.58/209.74 |- mesh__historyNote mesh__D003066 98%28%73%29%
% 209.58/209.74 |- skos__altLabel mesh__D003066 Acid-Thiol Ligases
% 209.58/209.74 |- mesh__dateEstablished mesh__D003066 1973-01-01
% 209.58/209.74 |- rdf__type mesh__D003066sskos__Concept
% 209.58/209.74 |- mesh__recordOriginator mesh__D003066 NLM
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 A Ligases, Coenzyme
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 Ligases, Co A
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 A Synthetases, Coenzyme
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D003066 sjn
% 209.58/209.74 |- skos__altLabel mesh__D003066 Acyl CoA Synthetases
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D003066
% 209.58/209.74 98; see COENZYME A SYNTHETASES 1973-97
% 209.58/209.74 |- skos__altLabel mesh__D003066 Coenzyme A Synthetases
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 A Ligases, Co
% 209.58/209.74 |- skos__scopeNote mesh__D003066
% 209.58/209.74 Enzymes that catalyze the formation of acyl-CoA derivatives. EC 6.2.1.%A%
% 209.58/209.74 |- mesh__dateRevised mesh__D003066 2003-07-09
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 Synthetases, Acyl CoA
% 209.58/209.74 |- skos__broader mesh__D003066smesh__D019730
% 209.58/209.74 |- skos__prefLabel mesh__D003066 Coenzyme A Ligases
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 CoA Synthetases, Acyl
% 209.58/209.74 |- skos__hiddenLabel mesh__D003066 Synthetases, Coenzyme A
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D003066 2006
% 209.58/209.74 |- rdf__type mesh__D049168sskos__Concept
% 209.58/209.74 |- skos__hiddenLabel mesh__D049168 Pregnancies, Unplanned
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D049168 2005
% 209.58/209.74 |- mesh__dateCreated mesh__D049168 2004-07-07
% 209.58/209.74 |- skos__hiddenLabel mesh__D049168 Unplanned Pregnancies
% 209.58/209.74 |- mesh__recordOriginator mesh__D049168 lkt
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D049168 sjn
% 209.58/209.74 |- skos__historyNote mesh__D049168 Pregnancy %28%1966-2004%29%
% 209.58/209.74 |- skos__scopeNote mesh__D049168
% 209.58/209.74 Unintended accidental pregnancy, including pregnancy resulting from failed contraceptive measures.%A%
% 209.58/209.74 |- mesh__dateEstablished mesh__D049168 2005-01-01
% 209.58/209.74 |- mesh__historyNote mesh__D049168 2005; use PREGNANCY 1980-2004
% 209.58/209.74 |- skos__annotation mesh__D049168 PREGNANCY, UNWANTED is also available
% 209.58/209.74 |- mesh__recordMaintainer mesh__D049168 lkt
% 209.58/209.74 |- skos__broader mesh__D049168smesh__D011247
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D049168 2005; see PREGNANCY 1980-2004
% 209.58/209.74 |- skos__prefLabel mesh__D049168 Pregnancy, Unplanned
% 209.58/209.74 |- skos__related mesh__D049168smesh__D011275
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D049168 2006
% 209.58/209.74 |- skos__altLabel mesh__D049168 Unplanned Pregnancy
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494 Progressive Supranuclear Palsy
% 209.58/209.74 |- skos__historyNote mesh__D013494 Paralysis %28%1966-1986%29%
% 209.58/209.74 |- skos__historyNote mesh__D013494 Paralysis, Bulbar %28%1966-1986%29%
% 209.58/209.74 |- skos__prefLabel mesh__D013494 Supranuclear Palsy, Progressive
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494 Supranuclear Palsies, Progressive
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494 Progressive Supranuclear Palsies
% 209.58/209.74 |- skos__broader mesh__D013494smesh__D009069
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494 Steele Richardson Olszewski Syndrome
% 209.58/209.74 |- rdf__type mesh__D013494sskos__Concept
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013494 2002
% 209.58/209.74 |- skos__scopeNote mesh__D013494
% 209.58/209.74 A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS %28%supranuclear ophthalmoplegia%29%; DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. %28%From Adams et al., Principles of Neurology, 6th ed, pp1076-7%29%%A%
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494
% 209.58/209.74 Supranuclear Ophthalmoplegia, Progressive
% 209.58/209.74 |- skos__altLabel mesh__D013494 Steele-Richardson-Olszewski Disease
% 209.58/209.74 |- skos__altLabel mesh__D013494 Ophthalmoplegia, Progressive Supranuclear
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494
% 209.58/209.74 Supranuclear Ophthalmoplegias, Progressive
% 209.58/209.74 |- mesh__dateEstablished mesh__D013494 1987-01-01
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013494 2004
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494 Syndrome, Steele-Richardson-Olszewski
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494
% 209.58/209.74 Progressive Supranuclear Ophthalmoplegias
% 209.58/209.74 |- skos__broader mesh__D013494smesh__D009886
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013494 2006
% 209.58/209.74 |- mesh__recordOriginator mesh__D013494 RC
% 209.58/209.74 |- skos__broader mesh__D013494smesh__D024801
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013494 2003
% 209.58/209.74 |- mesh__dateCreated mesh__D013494 1986-04-01
% 209.58/209.74 |- mesh__historyNote mesh__D013494 1987
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494 Steele Richardson Olszewski Disease
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D013494 2005
% 209.58/209.74 |- skos__altLabel mesh__D013494 Steele-Richardson-Olszewski Syndrome
% 209.58/209.74 |- mesh__recordMaintainer mesh__D013494 lkt
% 209.58/209.74 |- skos__altLabel mesh__D013494 Progressive Supranuclear Ophthalmoplegia
% 209.58/209.74 |- mesh__dateRevised mesh__D013494 2001-07-25
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D013494 1987
% 209.58/209.74 |- mesh__recordAuthorizer mesh__D013494 sjn
% 209.58/209.74 |- skos__historyNote mesh__D013494 Ophthalmoplegia %28%1979-1986%29%
% 209.58/209.74 |- skos__hiddenLabel mesh__D013494
% 209.58/209.74 Ophthalmoplegias, Progressive Supranuclear
% 209.58/209.74 |- skos__altLabel mesh__D013494 Palsy, Progressive Supranuclear
% 209.58/209.74 |- skos__broader mesh__D013494smesh__D001480
% 209.58/209.74 |- rdf__type mesh__D029909sskos__Concept
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029909 2006
% 209.58/209.74 |- skos__broader mesh__D029909smesh__D007887
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029909 2005
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029909 2002
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029909 2004
% 209.58/209.74 |- mesh__publicMeSHNote mesh__D029909 2002
% 209.58/209.74 |- mesh__dateEstablished mesh__D029909 2002-01-01
% 209.58/209.74 |- skos__scopeNote mesh__D029909 A plant genus of the family FABACEAE.
% 209.58/209.74 |- skos__prefLabel mesh__D029909 Sophora
% 209.58/209.74 |- mesh__activeMeSHYear mesh__D029909 2003
% 209.58/209.74 |- mesh__dateCreated mesh__D029909 2001-07-25
% 209.58/209.74 |- mesh__historyNote mesh__D029909 2002
% 209.58/209.74 |- skos__annotation mesh__D029909
% 209.58/209.74 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 1996
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D007457
% 209.58/209.75 74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 2006
% 209.58/209.75 |- skos__annotation mesh__D007457
% 209.58/209.75 I-117 through I-139 except I-127; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%
% 209.58/209.75 |- skos__prefLabel mesh__D007457 Iodine Radioisotopes
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 2002
% 209.58/209.75 |- mesh__recordMaintainer mesh__D007457 TPW
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 1997
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 1994
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 2003
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D007457 PLS
% 209.58/209.75 |- skos__broader mesh__D007457smesh__D007456
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 1995
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 2004
% 209.58/209.75 |- rdf__type mesh__D007457sskos__Concept
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 2000
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 1998
% 209.58/209.75 |- mesh__dateCreated mesh__D007457 1999-01-01
% 209.58/209.75 |- mesh__dateRevised mesh__D007457 1993-06-18
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 2001
% 209.58/209.75 |- mesh__recordOriginator mesh__D007457 NLM
% 209.58/209.75 |- skos__scopeNote mesh__D007457
% 209.58/209.75 Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 1999
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007457 2005
% 209.58/209.75 |- skos__broader mesh__D007457smesh__D011868
% 209.58/209.75 |- mesh__dateEstablished mesh__D007457 1974-01-01
% 209.58/209.75 |- skos__hiddenLabel mesh__D007457 Radioisotopes, Iodine
% 209.58/209.75 |- mesh__onlineNote mesh__D007457
% 209.58/209.75 search IODINE ISOTOPES 1966-73; search IODINE ISOTOPES, DIAGNOSTIC under IODINE RADIOISOTOPES /DU 1966-76%A%
% 209.58/209.75 |- mesh__historyNote mesh__D007457
% 209.58/209.75 74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 2003
% 209.58/209.75 |- skos__hiddenLabel mesh__D017885 Ligament, Collateral
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 2005
% 209.58/209.75 |- skos__hiddenLabel mesh__D017885 Ligament, Lateral
% 209.58/209.75 |- skos__altLabel mesh__D017885 Ligaments, Lateral
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 2002
% 209.58/209.75 |- skos__altLabel mesh__D017885 Ligaments, Collateral
% 209.58/209.75 |- skos__scopeNote mesh__D017885
% 209.58/209.75 A number of ligaments on either side of, and serving as a radius of movement of, a joint having a hingelike movement. They occur at the elbow, knee, wrist, metacarpo- and metatarsophalangeal, proximal interphalangeal, and distal interphalangeal joints of the hands and feet. %28%Stedman, 25th ed%29%%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 2001
% 209.58/209.75 |- mesh__historyNote mesh__D017885 94
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D017885 PLS
% 209.58/209.75 |- mesh__recordOriginator mesh__D017885 TGC
% 209.58/209.75 |- skos__hiddenLabel mesh__D017885 Collateral Ligament
% 209.58/209.75 |- skos__historyNote mesh__D017885 Ligaments %28%1966-1993%29%
% 209.58/209.75 |- skos__hiddenLabel mesh__D017885 Lateral Ligament
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 1997
% 209.58/209.75 |- mesh__recordMaintainer mesh__D017885 RAZ
% 209.58/209.75 |- mesh__dateEstablished mesh__D017885 1994-01-01
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 2000
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 1999
% 209.58/209.75 |- skos__historyNote mesh__D017885 Ligaments, Articular %28%1968-1993%29%
% 209.58/209.75 |- skos__annotation mesh__D017885
% 209.58/209.75 artic ligaments of extremities; coord IM with specific joint or bone %28%IM%29%%A%
% 209.58/209.75 |- mesh__dateCreated mesh__D017885 1993-02-16
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 1996
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 2004
% 209.58/209.75 |- skos__prefLabel mesh__D017885 Collateral Ligaments
% 209.58/209.75 |- skos__broader mesh__D017885smesh__D008023
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 1998
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017885 2006
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D017885 94
% 209.58/209.75 |- rdf__type mesh__D017885sskos__Concept
% 209.58/209.75 |- mesh__dateRevised mesh__D017885 1995-06-08
% 209.58/209.75 |- skos__annotation mesh__D017087
% 209.58/209.75 refers to domestic, laboratory or wild animals; ANIMAL WELFARE is also available%A%
% 209.58/209.75 |- mesh__dateEstablished mesh__D017087 1993-01-01
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017087 2006
% 209.58/209.75 |- mesh__recordMaintainer mesh__D017087 jls
% 209.58/209.75 |- mesh__dateCreated mesh__D017087 1992-05-07
% 209.58/209.75 |- mesh__dateRevised mesh__D017087 2003-07-09
% 209.58/209.75 |- mesh__onlineNote mesh__D017087
% 209.58/209.75 use ANIMAL WELFARE to search ANIMAL RIGHTS 1986-92 and SPECIESISM 1987-92%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017087 2005
% 209.58/209.75 |- skos__hiddenLabel mesh__D017087 Rights, Animal
% 209.58/209.75 |- rdf__type mesh__D017087sskos__Concept
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D017087 sjn
% 209.58/209.75 |- skos__scopeNote mesh__D017087
% 209.58/209.75 The moral and ethical bases of the protection of animals from cruelty and abuse. The rights are extended to domestic animals, laboratory animals, and wild animals.%A%
% 209.58/209.75 |- mesh__recordOriginator mesh__D017087 TGC
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D017087
% 209.58/209.75 93; was see ANIMAL WELFARE 1986-92; SPECIESISM was see ANIMAL WELFARE 1987-92%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017087 2004
% 209.58/209.75 |- mesh__historyNote mesh__D017087
% 209.58/209.75 93; was see ANIMAL WELFARE 1986-92; SPECIESISM was see ANIMAL WELFARE 1987-92%A%
% 209.58/209.75 |- skos__broader mesh__D017087smesh__D000827
% 209.58/209.75 |- skos__prefLabel mesh__D017087 Animal Rights
% 209.58/209.75 |- skos__historyNote mesh__D017087 Animal Welfare %28%1986-1992%29%
% 209.58/209.75 |- skos__altLabel mesh__D003865 Melancholia, Involutional
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D003865 sjn
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D003865
% 209.58/209.75 81; was PSYCHOSES, INVOLUTIONAL 1963-80
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Paraphrenias, Involutional
% 209.58/209.75 |- skos__scopeNote mesh__D003865
% 209.58/209.75 Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.%A%
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Involutional Psychoses
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003865 2005
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Major Depressive Disorders
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003865 2006
% 209.58/209.75 |- mesh__dateCreated mesh__D003865 1999-01-01
% 209.58/209.75 |- skos__altLabel mesh__D003865 Psychosis, Involutional
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Involutional Psychosis
% 209.58/209.75 |- skos__broader mesh__D003865smesh__D003866
% 209.58/209.75 |- skos__prefLabel mesh__D003865 Depressive Disorder, Major
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Involutional Melancholia
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Disorder, Major Depressive
% 209.58/209.75 |- skos__altLabel mesh__D003865 Major Depressive Disorder
% 209.58/209.75 |- skos__altLabel mesh__D003865 Depression, Involutional
% 209.58/209.75 |- mesh__recordMaintainer mesh__D003865 jls
% 209.58/209.75 |- skos__altLabel mesh__D003865 Paraphrenia, Involutional
% 209.58/209.75 |- mesh__dateRevised mesh__D003865 2004-07-07
% 209.58/209.75 |- rdf__type mesh__D003865sskos__Concept
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Psychoses, Involutional
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Disorders, Major Depressive
% 209.58/209.75 |- mesh__onlineNote mesh__D003865
% 209.58/209.75 use DEPRESSION, INVOLUTIONAL to search PSYCHOSES, INVOLUTIONAL %26% MELANCHOLIA, INVOLUTIONAL 1966-80%A%
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Depressive Disorders, Major
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Involutional Paraphrenia
% 209.58/209.75 |- mesh__historyNote mesh__D003865
% 209.58/209.75 81; was PSYCHOSES, INVOLUTIONAL 1963-80; MELANCHOLIA, INVOLUTIONAL was see under PSYCHOSES, INVOLUTIONAL 1963-78%A%
% 209.58/209.75 |- skos__hiddenLabel mesh__D003865 Involutional Depression
% 209.58/209.75 |- mesh__recordOriginator mesh__D003865 NLM
% 209.58/209.75 |- skos__altLabel mesh__D003067 Enzyme Cofactors
% 209.58/209.75 |- skos__broader mesh__D003067smesh__D045762
% 209.58/209.75 |- rdf__type mesh__D003067sskos__Concept
% 209.58/209.75 |- skos__scopeNote mesh__D003067
% 209.58/209.75 Small molecules that are required for the catalytic function of ENZYMES. Many VITAMINS are coenzymes.%A%
% 209.58/209.75 |- mesh__recordMaintainer mesh__D003067 ssb
% 209.58/209.75 |- skos__prefLabel mesh__D003067 Coenzymes
% 209.58/209.75 |- mesh__dateRevised mesh__D003067 2003-07-09
% 209.58/209.75 |- mesh__recordOriginator mesh__D003067 NLM
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D003067 sjn
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003067 2006
% 209.58/209.75 |- skos__altLabel mesh__D003067 Cofactors, Enzyme
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003067 2005
% 209.58/209.75 |- mesh__dateCreated mesh__D003067 1999-01-01
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003067 2004
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D008550 2003
% 209.58/209.75 |- skos__broader mesh__D008550smesh__D014363
% 209.58/209.75 |- mesh__historyNote mesh__D008550 68%28%65%29%
% 209.58/209.75 |- mesh__recordMaintainer mesh__D008550 lkt
% 209.58/209.75 |- skos__scopeNote mesh__D008550
% 209.58/209.75 A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D008550 2004
% 209.58/209.75 |- skos__prefLabel mesh__D008550 Melatonin
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D008550 sjn
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D008550 2005
% 209.58/209.75 |- skos__broader mesh__D008550smesh__D006728
% 209.58/209.75 |- mesh__dateCreated mesh__D008550 1999-01-01
% 209.58/209.75 |- mesh__dateEstablished mesh__D008550 1968-01-01
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D008550 2006
% 209.58/209.75 |- mesh__recordOriginator mesh__D008550 NLM
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D008550 68
% 209.58/209.75 |- mesh__dateRevised mesh__D008550 2002-07-02
% 209.58/209.75 |- rdf__type mesh__D008550sskos__Concept
% 209.58/209.75 |- skos__hiddenLabel mesh__D022221 Mammalian Artificial Chromosome
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D022221 2005
% 209.58/209.75 |- mesh__historyNote mesh__D022221 2002%28%2001%29%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D022221 2006
% 209.58/209.75 |- skos__altLabel mesh__D022221 Mammalian Artificial Chromosomes
% 209.58/209.75 |- skos__broader mesh__D022221smesh__D022201
% 209.58/209.75 |- skos__hiddenLabel mesh__D022221 Chromosome, Mammalian Artificial
% 209.58/209.75 |- skos__altLabel mesh__D022221 MACs %28%Chromosomes%29%
% 209.58/209.75 |- mesh__dateRevised mesh__D022221 2003-07-09
% 209.58/209.75 |- mesh__dateCreated mesh__D022221 2000-06-21
% 209.58/209.75 |- skos__scopeNote mesh__D022221
% 209.58/209.75 DNA constructs that are composed of, at least, all elements, such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintainance in progeny mammalian cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.%A%
% 209.58/209.75 |- mesh__recordOriginator mesh__D022221 nns
% 209.58/209.75 |- skos__broader mesh__D022221smesh__D033481
% 209.58/209.75 |- rdf__type mesh__D022221sskos__Concept
% 209.58/209.75 |- skos__altLabel mesh__D022221 Chromosomes, Mammalian Artificial
% 209.58/209.75 |- skos__altLabel mesh__D022221 Artificial Chromosomes, Mammalian
% 209.58/209.75 |- skos__annotation mesh__D022221
% 209.58/209.75 coord with specific animal /genet only if particularly discussed%A%
% 209.58/209.75 |- skos__historyNote mesh__D022221 Chromosomes %28%1994-2000%29%
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D022221 sjn
% 209.58/209.75 |- skos__prefLabel mesh__D022221 Chromosomes, Artificial, Mammalian
% 209.58/209.75 |- skos__hiddenLabel mesh__D022221 Artificial Chromosome, Mammalian
% 209.58/209.75 |- skos__altLabel mesh__D022221 MAC %28%Chromosome%29%
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D022221
% 209.58/209.75 2002; see CHROMOSOMES, MAMMALIAN ARTIFICIAL 2001
% 209.58/209.75 |- mesh__dateEstablished mesh__D022221 2001-01-01
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D022221 2004
% 209.58/209.75 |- mesh__recordMaintainer mesh__D022221 nns
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 1995
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 1998
% 209.58/209.75 |- mesh__historyNote mesh__D013495
% 209.58/209.75 83%28%75%29%; was see under HYPOTHALAMUS 1975-82
% 209.58/209.75 |- skos__hiddenLabel mesh__D013495 Nucleus, Supraoptic
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 2004
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 2000
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 2006
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 2003
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 2005
% 209.58/209.75 |- mesh__dateCreated mesh__D013495 1974-11-11
% 209.58/209.75 |- skos__annotation mesh__D013495 in the anterior hypothalamus
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D013495
% 209.58/209.75 83; was see under HYPOTHALAMUS 1975-82
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D013495 PLS
% 209.58/209.75 |- mesh__recordMaintainer mesh__D013495 TGC
% 209.58/209.75 |- skos__prefLabel mesh__D013495 Supraoptic Nucleus
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 2002
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 1997
% 209.58/209.75 |- mesh__dateRevised mesh__D013495 1994-05-12
% 209.58/209.75 |- rdf__type mesh__D013495sskos__Concept
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 1999
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 2001
% 209.58/209.75 |- mesh__dateEstablished mesh__D013495 1983-01-01
% 209.58/209.75 |- skos__broader mesh__D013495smesh__D007032
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D013495 1996
% 209.58/209.75 |- skos__scopeNote mesh__D013495
% 209.58/209.75 Hypothalamic nucleus overlying the beginning of the optic tract.%A%
% 209.58/209.75 |- mesh__recordOriginator mesh__D013495 NLM
% 209.58/209.75 |- mesh__dateRevised mesh__D007458 2000-06-21
% 209.58/209.75 |- mesh__recordOriginator mesh__D007458 NLM
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007458 2006
% 209.58/209.75 |- skos__prefLabel mesh__D007458 Iodipamide
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D007458 sjn
% 209.58/209.75 |- skos__broader mesh__D007458smesh__D014283
% 209.58/209.75 |- mesh__recordMaintainer mesh__D007458 CCR
% 209.58/209.75 |- skos__scopeNote mesh__D007458
% 209.58/209.75 A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007458 2001
% 209.58/209.75 |- skos__annotation mesh__D007458 D25-26 qualif
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007458 2004
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007458 2005
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007458 2003
% 209.58/209.75 |- rdf__type mesh__D007458sskos__Concept
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D007458 2002
% 209.58/209.75 |- skos__altLabel mesh__D007458 Adipiodon
% 209.58/209.75 |- mesh__dateCreated mesh__D007458 1999-01-01
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D018180 sjn
% 209.58/209.75 |- skos__broader mesh__D018180smesh__D018179
% 209.58/209.75 |- mesh__onlineNote mesh__D018180
% 209.58/209.75 use RECEPTORS, THROMBIN %28%NM%29% to search THROMBOMODULIN 1981-93%A%
% 209.58/209.75 |- skos__annotation mesh__D018180 a thrombin receptor
% 209.58/209.75 |- mesh__historyNote mesh__D018180
% 209.58/209.75 94; THROMBOMODULIN was SY to THROMBIN RECEPTOR %28%NM%29% 1981-93%A%
% 209.58/209.75 |- skos__prefLabel mesh__D018180 Thrombomodulin
% 209.58/209.75 |- mesh__dateCreated mesh__D018180 1993-06-30
% 209.58/209.75 |- skos__scopeNote mesh__D018180
% 209.58/209.75 A cell surface glycoprotein of endothelial cells that binds thrombin and serves as a cofactor in the activation of protein C and its regulation of blood coagulation.%A%
% 209.58/209.75 |- mesh__dateEstablished mesh__D018180 1994-01-01
% 209.58/209.75 |- mesh__recordOriginator mesh__D018180 RAZ
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D018180 2004
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D018180
% 209.58/209.75 94; RECEPTORS, THROMBIN was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93%A%
% 209.58/209.75 |- skos__historyNote mesh__D018180
% 209.58/209.75 Receptors, Cell Surface %28%1981-1993%29%
% 209.58/209.75 |- mesh__recordMaintainer mesh__D018180 jmp
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D018180 2006
% 209.58/209.75 |- rdf__type mesh__D018180sskos__Concept
% 209.58/209.75 |- mesh__dateRevised mesh__D018180 2003-07-09
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D018180 2005
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D004160 2005
% 209.58/209.75 |- skos__scopeNote mesh__D004160
% 209.58/209.75 Used as an indicator in titrating iron and for the colorimetric determination of chromium and the detection of cadmium, mercury, magnesium, aldehydes, and emetine.%A%
% 209.58/209.75 |- skos__historyNote mesh__D004160 Semicarbazides %28%1972-1974%29%
% 209.58/209.75 |- skos__altLabel mesh__D004160 S-Diphenylcarbazide
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D004160 2002
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D004160 2004
% 209.58/209.75 |- mesh__recordOriginator mesh__D004160 NLM
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D004160 2001
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D004160
% 209.58/209.75 91; was see under SEMICARBAZIDES 1975-90
% 209.58/209.75 |- skos__hiddenLabel mesh__D004160 S Diphenylcarbazide
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D004160 sjn
% 209.58/209.75 |- skos__altLabel mesh__D004160 1,5-Diphenylcarbazide
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D004160 2003
% 209.58/209.75 |- skos__annotation mesh__D004160 D25-26 qualif
% 209.58/209.75 |- rdf__type mesh__D004160sskos__Concept
% 209.58/209.75 |- skos__historyNote mesh__D004160 Benzene Derivatives %28%1972-1974%29%
% 209.58/209.75 |- mesh__recordMaintainer mesh__D004160 CCR
% 209.58/209.75 |- skos__prefLabel mesh__D004160 Diphenylcarbazide
% 209.58/209.75 |- mesh__dateRevised mesh__D004160 2000-06-22
% 209.58/209.75 |- mesh__dateEstablished mesh__D004160 1991-01-01
% 209.58/209.75 |- mesh__dateCreated mesh__D004160 1974-11-19
% 209.58/209.75 |- mesh__historyNote mesh__D004160
% 209.58/209.75 91%28%75%29%; was see under SEMICARBAZIDES 1975-90
% 209.58/209.75 |- skos__broader mesh__D004160smesh__D012663
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D004160 2006
% 209.58/209.75 |- skos__hiddenLabel mesh__D004160 1,5 Diphenylcarbazide
% 209.58/209.75 |- skos__broader mesh__D006280Q000193smesh__D006280
% 209.58/209.75 |- mesh__preferredCombination mesh__D006280Q000193smesh__D006281Q000193
% 209.58/209.75 |- rdf__type mesh__D006280Q000193smesh__CompoundConcept
% 209.58/209.75 |- skos__altLabel mesh__D017886 Calcium Hydroxyapatite
% 209.58/209.75 |- skos__prefLabel mesh__D017886 Durapatite
% 209.58/209.75 |- skos__broader mesh__D017886smesh__D006882
% 209.58/209.75 |- skos__hiddenLabel mesh__D017886 Interpore 200
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D017886
% 209.58/209.75 94; HYDROXYAPATITE was indexed under HYDROXYAPATITES 1981-93%A%
% 209.58/209.75 |- skos__altLabel mesh__D017886 Hydroxylapatite
% 209.58/209.75 |- mesh__onlineNote mesh__D017886
% 209.58/209.75 use DURAPATITE %28%NM%29% to search HYDROXYAPATITE 1981-93
% 209.58/209.75 |- mesh__recordOriginator mesh__D017886 TPW
% 209.58/209.75 |- skos__historyNote mesh__D017886 Hydroxyapatites %28%1981-1993%29%
% 209.58/209.75 |- mesh__historyNote mesh__D017886
% 209.58/209.75 94; was HYDROXYAPATITE %28%NM%29% 1981-93
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017886 2002
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017886 1999
% 209.58/209.75 |- skos__hiddenLabel mesh__D017886 Interpore500
% 209.58/209.75 |- skos__altLabel mesh__D017886 Hydroxyapatite
% 209.58/209.75 |- skos__scopeNote mesh__D017886
% 209.58/209.75 The mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis.%A%
% 209.58/209.75 |- skos__hiddenLabel mesh__D017886 Ossein Hydroxyapatite Compound
% 209.58/209.75 |- mesh__recordMaintainer mesh__D017886 KEV
% 209.58/209.75 |- skos__hiddenLabel mesh__D017886 Interpore200
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017886 2004
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D017886 SJN
% 209.58/209.75 |- mesh__dateCreated mesh__D017886 1993-02-16
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017886 2001
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017886 2006
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017886 1998
% 209.58/209.75 |- skos__hiddenLabel mesh__D017886 Hydroxyapatite, Calcium
% 209.58/209.75 |- skos__hiddenLabel mesh__D017886 Interpore 500
% 209.58/209.75 |- rdf__type mesh__D017886sskos__Concept
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017886 2003
% 209.58/209.75 |- mesh__dateRevised mesh__D017886 1997-06-20
% 209.58/209.75 |- mesh__dateEstablished mesh__D017886 1994-01-01
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017886 2000
% 209.58/209.75 |- skos__annotation mesh__D017886
% 209.58/209.75 mineral component of bones %26% teeth; used as a biocompatible material%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017886 2005
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 Opportunistic Infection, AIDS-Related
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 Opportunistic Infections, AIDS Related
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017088 2005
% 209.58/209.75 |- skos__scopeNote mesh__D017088
% 209.58/209.75 Opportunistic infections found in patients who test positive for human immunodeficiency virus %28%HIV%29%. The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi%27%s sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.%A%
% 209.58/209.75 |- mesh__dateRevised mesh__D017088 2004-07-13
% 209.58/209.75 |- skos__broader mesh__D017088smesh__D015658
% 209.58/209.75 |- rdf__type mesh__D017088sskos__Concept
% 209.58/209.75 |- skos__altLabel mesh__D017088 HIV-Related Opportunistic Infections
% 209.58/209.75 |- mesh__dateEstablished mesh__D017088 1993-01-01
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 AIDS-Related Opportunistic Infection
% 209.58/209.75 |- skos__related mesh__D017088smesh__D016919
% 209.58/209.75 |- skos__historyNote mesh__D017088 specific HIV infection %28%1983-1992%29%
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 Opportunistic Infection, HIV-Related
% 209.58/209.75 |- skos__annotation mesh__D017088
% 209.58/209.75 coord IM with HIV-1 or HIV-2 %28%IM or NIM if pertinent%29%; coord IM with specific opportunistic infect %28%IM%29%; DF: AIDS RELAT OPPORTUNISTIC INFECT%A%
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 Opportunistic Infections, HIV Related
% 209.58/209.75 |- skos__altLabel mesh__D017088 Opportunistic Infections, HIV-Related
% 209.58/209.75 |- mesh__historyNote mesh__D017088 93
% 209.58/209.75 |- skos__broader mesh__D017088smesh__D009894
% 209.58/209.75 |- skos__related mesh__D017088smesh__D016781
% 209.58/209.75 |- skos__historyNote mesh__D017088
% 209.58/209.75 specific opportunistic infection %28%1983-1992%29%
% 209.58/209.75 |- skos__altLabel mesh__D017088 Opportunistic Infections, AIDS-Related
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 HIV Related Opportunistic Infections
% 209.58/209.75 |- mesh__recordMaintainer mesh__D017088 sjn
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 Infections, HIV-Related Opportunistic
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D017088 sjn
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 HIV-Related Opportunistic Infection
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 AIDS Related Opportunistic Infections
% 209.58/209.75 |- mesh__dateCreated mesh__D017088 1992-05-13
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D017088 93
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D017088 2006
% 209.58/209.75 |- skos__historyNote mesh__D017088
% 209.58/209.75 Opportunistic Infections %28%1983-1992%29%
% 209.58/209.75 |- mesh__recordOriginator mesh__D017088 AGS
% 209.58/209.75 |- skos__hiddenLabel mesh__D017088 Infection, HIV-Related Opportunistic
% 209.58/209.75 |- skos__prefLabel mesh__D017088 AIDS-Related Opportunistic Infections
% 209.58/209.75 |- mesh__recordMaintainer mesh__D003866 JLS
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003866 2003
% 209.58/209.75 |- skos__scopeNote mesh__D003866
% 209.58/209.75 An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.%A%
% 209.58/209.75 |- mesh__dateRevised mesh__D003866 1997-06-20
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Depressions, Neurotic
% 209.58/209.75 |- skos__altLabel mesh__D003866 Depression, Unipolar
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Depressions, Endogenous
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Neurotic Depressions
% 209.58/209.75 |- skos__broader mesh__D003866smesh__D019964
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Endogenous Depression
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003866 1998
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003866 2001
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D003866
% 209.58/209.75 81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES see DEPRESSION, REACTIVE 1979-80, see under DEPRESSION, REACTIVE 1969-78%A%
% 209.58/209.75 |- mesh__historyNote mesh__D003866
% 209.58/209.75 81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES see DEPRESSION, REACTIVE 1979-80, see under DEPRESSION, REACTIVE 1969-78%A%
% 209.58/209.75 |- skos__historyNote mesh__D003866 Adjustment Disorders %28%1966-1980%29%
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Disorders, Depressive
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Endogenous Depressions
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003866 2000
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Disorder, Depressive
% 209.58/209.75 |- mesh__recordOriginator mesh__D003866 EC
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003866 2006
% 209.58/209.75 |- mesh__dateCreated mesh__D003866 1980-05-21
% 209.58/209.75 |- skos__annotation mesh__D003866
% 209.58/209.75 do not confuse with DEPRESSION: see note there; depression lasting over 2 years = DYSTHYMIC DISORDER%A%
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Unipolar Depressions
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Depressions, Unipolar
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Depressive Syndromes
% 209.58/209.75 |- skos__prefLabel mesh__D003866 Depressive Disorder
% 209.58/209.75 |- skos__altLabel mesh__D003866 Neurosis, Depressive
% 209.58/209.75 |- mesh__dateEstablished mesh__D003866 1981-01-01
% 209.58/209.75 |- rdf__type mesh__D003866sskos__Concept
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003866 2005
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Neuroses, Depressive
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Melancholias
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Depressive Neuroses
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Depressive Neurosis
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Neurotic Depression
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Depressive Disorders
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D003866 SJN
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003866 2004
% 209.58/209.75 |- skos__historyNote mesh__D003866 Depression %28%1966-1980%29%
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Syndromes, Depressive
% 209.58/209.75 |- mesh__onlineNote mesh__D003866
% 209.58/209.75 use ADJUSTMENT DISORDERS to search DEPRESSIVE NEUROSES 1969-80%A%
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003866 1999
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003866 2002
% 209.58/209.75 |- skos__hiddenLabel mesh__D003866 Syndrome, Depressive
% 209.58/209.75 |- skos__broader mesh__D001853Q000166smesh__D001853
% 209.58/209.75 |- mesh__preferredCombination mesh__D001853Q000166smesh__D001854
% 209.58/209.75 |- rdf__type mesh__D001853Q000166smesh__CompoundConcept
% 209.58/209.75 |- skos__prefLabel mesh__D003068 Coercion
% 209.58/209.75 |- skos__hiddenLabel mesh__D003068 Fertility Control, Involuntary
% 209.58/209.75 |- mesh__recordAuthorizer mesh__D003068 sjn
% 209.58/209.75 |- mesh__historyNote mesh__D003068 78
% 209.58/209.75 |- mesh__recordOriginator mesh__D003068 EC
% 209.58/209.75 |- mesh__dateCreated mesh__D003068 1977-04-22
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003068 2006
% 209.58/209.75 |- mesh__dateRevised mesh__D003068 2002-07-03
% 209.58/209.75 |- mesh__recordMaintainer mesh__D003068 hjn
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003068 2005
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003068 2004
% 209.58/209.75 |- skos__related mesh__D003068smesh__D037141
% 209.58/209.75 |- rdf__type mesh__D003068sskos__Concept
% 209.58/209.75 |- mesh__activeMeSHYear mesh__D003068 2003
% 209.58/209.75 |- mesh__dateEstablished mesh__D003068 1978-01-01
% 209.58/209.75 |- mesh__publicMeSHNote mesh__D003068 78
% 209.58/209.75 |- skos__broader mesh__D003068smesh__D012927
% 209.58/209.75 |- skos__scopeNote mesh__D003068
% 209.58/209.75 The use of force or intimidation to obtain compliance.
% 209.58/209.75 |- skos__broader mesh__D003068smesh__D012926
% 209.58/209.75 |- mesh__recordOriginator mesh__D008551 NLM
% 209.58/209.75 |- rdf__type mesh__D008551sskos__Concept
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D008551 2005
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D008551 2004
% 209.58/209.76 |- skos__broader mesh__D008551smesh__D005243
% 209.58/209.76 |- mesh__dateCreated mesh__D008551 1999-01-01
% 209.58/209.76 |- skos__scopeNote mesh__D008551
% 209.58/209.76 The black, tarry, foul-smelling FECES that contain degraded blood.%A%
% 209.58/209.76 |- skos__prefLabel mesh__D008551 Melena
% 209.58/209.76 |- mesh__recordMaintainer mesh__D008551 lkt
% 209.58/209.76 |- skos__hiddenLabel mesh__D008551 Melenas
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D008551 sjn
% 209.58/209.76 |- mesh__dateRevised mesh__D008551 2003-07-09
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D008551 2006
% 209.58/209.76 |- skos__broader mesh__D008551smesh__D006471
% 209.58/209.76 |- skos__altLabel mesh__D022222 Human Artificial Chromosomes
% 209.58/209.76 |- mesh__recordMaintainer mesh__D022222 sjn
% 209.58/209.76 |- skos__altLabel mesh__D022222 Chromosomes, Human Artificial
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D022222 sjn
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D022222
% 209.58/209.76 2002; see CHROMOSOMES, HUMAN ARTIFICIAL 2001
% 209.58/209.76 |- skos__hiddenLabel mesh__D022222 Artificial Chromosome, Human
% 209.58/209.76 |- skos__annotation mesh__D022222
% 209.58/209.76 coord with specific human chromosome /genet only if particularly discussed%A%
% 209.58/209.76 |- skos__altLabel mesh__D022222 Artificial Chromosomes, Human
% 209.58/209.76 |- skos__broader mesh__D022222smesh__D022221
% 209.58/209.76 |- skos__hiddenLabel mesh__D022222 Chromosome, Human Artificial
% 209.58/209.76 |- mesh__dateEstablished mesh__D022222 2001-01-01
% 209.58/209.76 |- mesh__dateRevised mesh__D022222 2004-07-13
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D022222 2006
% 209.58/209.76 |- skos__scopeNote mesh__D022222
% 209.58/209.76 DNA constructs that are composed of, at least, all elements, such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, required for successful replication, propagation to and maintainance in progeny human cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.%A%
% 209.58/209.76 |- skos__broader mesh__D022222smesh__D002877
% 209.58/209.76 |- skos__prefLabel mesh__D022222 Chromosomes, Artificial, Human
% 209.58/209.76 |- skos__altLabel mesh__D022222 HACs %28%Chromosomes%29%
% 209.58/209.76 |- skos__historyNote mesh__D022222 Chromosomes %28%1992-2000%29%
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D022222 2005
% 209.58/209.76 |- skos__hiddenLabel mesh__D022222 Human Artificial Chromosome
% 209.58/209.76 |- mesh__dateCreated mesh__D022222 2000-06-21
% 209.58/209.76 |- mesh__historyNote mesh__D022222 2002%28%2001%29%
% 209.58/209.76 |- rdf__type mesh__D022222sskos__Concept
% 209.58/209.76 |- skos__altLabel mesh__D022222 HAC %28%Chromosome%29%
% 209.58/209.76 |- mesh__recordOriginator mesh__D022222 nns
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013496 2003
% 209.58/209.76 |- skos__hiddenLabel mesh__D013496 TN762
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013496 2001
% 209.58/209.76 |- skos__broader mesh__D013496smesh__D010666
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013496 2005
% 209.58/209.76 |- skos__hiddenLabel mesh__D013496 R 25061
% 209.58/209.76 |- mesh__historyNote mesh__D013496
% 209.58/209.76 90%28%78%29%; was see under PHENYLPROPIONATES 1978-89
% 209.58/209.76 |- mesh__dateRevised mesh__D013496 2000-06-22
% 209.58/209.76 |- mesh__recordOriginator mesh__D013496 SH
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D013496 sjn
% 209.58/209.76 |- mesh__recordMaintainer mesh__D013496 CCR
% 209.58/209.76 |- skos__scopeNote mesh__D013496
% 209.58/209.76 An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic.%A%
% 209.58/209.76 |- skos__hiddenLabel mesh__D013496 R25061
% 209.58/209.76 |- rdf__type mesh__D013496sskos__Concept
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D013496
% 209.58/209.76 90; was see under PHENYLPROPIONATES 1978-89
% 209.58/209.76 |- skos__historyNote mesh__D013496 Benzene Derivatives %28%1968-1973%29%
% 209.58/209.76 |- mesh__dateEstablished mesh__D013496 1990-01-01
% 209.58/209.76 |- skos__hiddenLabel mesh__D013496 TN 762
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013496 2004
% 209.58/209.76 |- skos__prefLabel mesh__D013496 Suprofen
% 209.58/209.76 |- mesh__dateCreated mesh__D013496 1977-04-22
% 209.58/209.76 |- skos__historyNote mesh__D013496 Thiophenes %28%1966-1977%29%
% 209.58/209.76 |- skos__historyNote mesh__D013496 Phenylpropionates %28%1974-1977%29%
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013496 2002
% 209.58/209.76 |- skos__historyNote mesh__D013496 Propionates %28%1966-1973%29%
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013496 2006
% 209.58/209.76 |- skos__broader mesh__D001419Q000502smesh__D001419
% 209.58/209.76 |- mesh__preferredCombination mesh__D001419Q000502smesh__D018407
% 209.58/209.76 |- rdf__type mesh__D001419Q000502smesh__CompoundConcept
% 209.58/209.76 |- skos__prefLabel mesh__D007459 Iodized Oil
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D007459 2006
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D007459
% 209.58/209.76 94; was IODIZED OILS 1963-93; OIL, IODIZED was OILS, IODIZED 1963-93; LIPIODOL was heading 1975-93 %28%see under IODIZED OILS 1975-90%29%; IODOLIPOL was indexed under IODIZED OILS 1967-93%A%
% 209.58/209.76 |- mesh__historyNote mesh__D007459
% 209.58/209.76 94; was IODIZED OILS 1963-93; OIL, IODIZED was OILS, IODIZED 1963-93; LIPIODOL was heading 1975-93 %28%see under IODIZED OILS 1975-90%29%; IODOLIPOL was %28%NM%29% 1967-93%A%
% 209.58/209.76 |- skos__hiddenLabel mesh__D007459 Oils, Iodized
% 209.58/209.76 |- mesh__recordOriginator mesh__D007459 NLM
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D007459 sjn
% 209.58/209.76 |- rdf__type mesh__D007459sskos__Concept
% 209.58/209.76 |- mesh__recordMaintainer mesh__D007459 ssb
% 209.58/209.76 |- skos__annotation mesh__D007459 D25-26 qualif
% 209.58/209.76 |- skos__scopeNote mesh__D007459
% 209.58/209.76 The mixture contains 38-42%25% organically combined iodine that is used as a diagnostic aid %28%radiopaque medium%29%. %28%From Merck Index, 11th ed%29%%A%
% 209.58/209.76 |- mesh__dateCreated mesh__D007459 1999-01-01
% 209.58/209.76 |- skos__broader mesh__D007459smesh__D010938
% 209.58/209.76 |- mesh__onlineNote mesh__D007459
% 209.58/209.76 use IODIZED OIL to search IODIZED OILS 1966-93 %26% LIPIODOL 1975-93; use IODIZED OIL %28%NM%29% to search IODOLIPOL 1980-93%A%
% 209.58/209.76 |- skos__altLabel mesh__D007459 Iodolipol
% 209.58/209.76 |- skos__altLabel mesh__D007459 Oil, Iodized
% 209.58/209.76 |- skos__altLabel mesh__D007459 Iodized Oils
% 209.58/209.76 |- mesh__dateRevised mesh__D007459 2005-06-30
% 209.58/209.76 |- skos__altLabel mesh__D018181 Mouse, Inbred CFTR
% 209.58/209.76 |- mesh__historyNote mesh__D018181 94
% 209.58/209.76 |- skos__hiddenLabel mesh__D018181 CFTR Mouse
% 209.58/209.76 |- mesh__dateCreated mesh__D018181 1993-06-03
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D018181 sjn
% 209.58/209.76 |- skos__annotation mesh__D018181
% 209.58/209.76 NIM when exper animal: no qualif; when IM, qualif permitted; used a model for cystic fibrosis; do not forget also to check tag MICE%A%
% 209.58/209.76 |- skos__historyNote mesh__D018181 Mice %28%1992-1993%29%
% 209.58/209.76 |- skos__hiddenLabel mesh__D018181 CFTR Mouse, Inbred
% 209.58/209.76 |- skos__hiddenLabel mesh__D018181 Inbred CFTR Mice
% 209.58/209.76 |- mesh__recordMaintainer mesh__D018181 ags
% 209.58/209.76 |- skos__altLabel mesh__D018181 Mice, CFTR
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018181 2006
% 209.58/209.76 |- rdf__type mesh__D018181sskos__Concept
% 209.58/209.76 |- mesh__dateEstablished mesh__D018181 1994-01-01
% 209.58/209.76 |- skos__prefLabel mesh__D018181 Mice, Inbred CFTR
% 209.58/209.76 |- skos__altLabel mesh__D018181 Mouse, CFTR
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D018181 94
% 209.58/209.76 |- skos__hiddenLabel mesh__D018181 Inbred CFTR Mouse
% 209.58/209.76 |- skos__hiddenLabel mesh__D018181 CFTR Mice
% 209.58/209.76 |- skos__broader mesh__D018181smesh__D008815
% 209.58/209.76 |- skos__hiddenLabel mesh__D018181 CFTR Mice, Inbred
% 209.58/209.76 |- mesh__recordOriginator mesh__D018181 PXP
% 209.58/209.76 |- mesh__dateRevised mesh__D018181 2005-06-30
% 209.58/209.76 |- skos__scopeNote mesh__D018181
% 209.58/209.76 A strain of mice widely studied as a model for cystic fibrosis. These mice are generated from embryonic stem cells in which the CFTR %28%cystic fibrosis transmembrane conductance regulator%29% gene is inactivated by gene targeting. As a result, all mice have one copy of this altered gene in all their tissues. Mice homozygous for the disrupted gene exhibit many features common to young cystic fibrosis patients, including failure to thrive, meconium ileus, and alteration of mucous and serous glands.%A%
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D004161 2003
% 209.58/209.76 |- mesh__recordOriginator mesh__D004161 SH
% 209.58/209.76 |- rdf__type mesh__D004161sskos__Concept
% 209.58/209.76 |- skos__altLabel mesh__D004161 1,6-Diphenyl-1,3,5-hexatriene
% 209.58/209.76 |- skos__hiddenLabel mesh__D004161 1,6 Diphenylhexatriene
% 209.58/209.76 |- skos__prefLabel mesh__D004161 Diphenylhexatriene
% 209.58/209.76 |- skos__altLabel mesh__D004161 1,6-Diphenylhexatriene
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D004161 2006
% 209.58/209.76 |- mesh__dateRevised mesh__D004161 2000-06-22
% 209.58/209.76 |- mesh__dateEstablished mesh__D004161 1991-01-01
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D004161 2002
% 209.58/209.76 |- skos__broader mesh__D004161smesh__D011090
% 209.58/209.76 |- skos__historyNote mesh__D004161
% 209.58/209.76 Spectrometry, Fluorescence %28%1974-1979%29%
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D004161 91; was see under POLYENES 1980-90
% 209.58/209.76 |- mesh__historyNote mesh__D004161
% 209.58/209.76 91%28%80%29%; was see under POLYENES 1980-90
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D004161 2005
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D004161 sjn
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D004161 2001
% 209.58/209.76 |- skos__scopeNote mesh__D004161
% 209.58/209.76 A fluorescent compound that emits light only in specific configurations in certain lipid media. It is used as a tool in the study of membrane lipids.%A%
% 209.58/209.76 |- mesh__dateCreated mesh__D004161 1979-05-30
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D004161 2004
% 209.58/209.76 |- mesh__recordMaintainer mesh__D004161 CCR
% 209.58/209.76 |- skos__historyNote mesh__D004161 Polyenes %28%1966-1979%29%
% 209.58/209.76 |- skos__altLabel mesh__D017887
% 209.58/209.76 Posterior Longitudinal Ligament Calcification
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017887 2001
% 209.58/209.76 |- mesh__dateRevised mesh__D017887 1999-11-03
% 209.58/209.76 |- mesh__dateEstablished mesh__D017887 1994-01-01
% 209.58/209.76 |- mesh__recordOriginator mesh__D017887 TGC
% 209.58/209.76 |- skos__historyNote mesh__D017887
% 209.58/209.76 Ossification, Heterotopic %28%1967-1993%29%
% 209.58/209.76 |- skos__historyNote mesh__D017887 Calcinosis %28%1969-1993%29%
% 209.58/209.76 |- skos__broader mesh__D017887smesh__D013122
% 209.58/209.76 |- mesh__recordMaintainer mesh__D017887 KEV
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017887 2004
% 209.58/209.76 |- mesh__dateCreated mesh__D017887 1993-02-16
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D017887 sjn
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017887 2000
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017887 2006
% 209.58/209.76 |- skos__broader mesh__D017887smesh__D009999
% 209.58/209.76 |- rdf__type mesh__D017887sskos__Concept
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017887 2003
% 209.58/209.76 |- skos__altLabel mesh__D017887
% 209.58/209.76 Posterior Longitudinal Ligament Ossification
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017887 2005
% 209.58/209.76 |- skos__annotation mesh__D017887 DF: OPLL
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D017887 94
% 209.58/209.76 |- skos__altLabel mesh__D017887
% 209.58/209.76 Calcification of Posterior Longitudinal Ligament
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017887 2002
% 209.58/209.76 |- mesh__historyNote mesh__D017887 94
% 209.58/209.76 |- skos__scopeNote mesh__D017887
% 209.58/209.76 A calcification of the posterior longitudinal ligament of the spinal column, usually at the level of the cervical spine. It is often associated with anterior ankylosing hyperostosis.%A%
% 209.58/209.76 |- skos__prefLabel mesh__D017887
% 209.58/209.76 Ossification of Posterior Longitudinal Ligament
% 209.58/209.76 |- skos__altLabel mesh__D017089 ANK Repeat
% 209.58/209.76 |- skos__historyNote mesh__D017089 Membrane Proteins %28%1990-1992%29%
% 209.58/209.76 |- skos__hiddenLabel mesh__D017089 Repeat, Ankyrin-Like
% 209.58/209.76 |- skos__altLabel mesh__D017089 Ankyrin Repeats
% 209.58/209.76 |- skos__historyNote mesh__D017089 Amino Acid Sequence %28%1990-1992%29%
% 209.58/209.76 |- mesh__dateRevised mesh__D017089 2005-07-07
% 209.58/209.76 |- skos__broader mesh__D017089smesh__D020449
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017089 2006A
% 209.58/209.76 |- skos__broader mesh__D017089smesh__D020816
% 209.58/209.76 |- skos__hiddenLabel mesh__D017089 Repeats, Ankyrin-Like
% 209.58/209.76 |- rdf__type mesh__D017089sskos__Concept
% 209.58/209.76 |- mesh__recordMaintainer mesh__D017089 ags
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D017089 93
% 209.58/209.76 |- skos__hiddenLabel mesh__D017089 Ankyrin-Like Repeat
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D017089 ags
% 209.58/209.76 |- mesh__historyNote mesh__D017089 93
% 209.58/209.76 |- skos__scopeNote mesh__D017089
% 209.58/209.76 Protein motif that contains a 33-amino acid long sequence that often occurs in tandem arrays. This repeating sequence of 33-amino acids was discovered in ANKYRIN where it is involved in interaction with the anion exchanger %28%ANION EXCHANGE PROTEIN 1, ERYTHROCYTE%29%. Ankyrin repeats cooperatively fold into structures that mediate molecular recognition via protein-protein interactions.%A%
% 209.58/209.76 |- skos__hiddenLabel mesh__D017089 Repeat, ANK
% 209.58/209.76 |- skos__hiddenLabel mesh__D017089 Repeats, Ankyrin
% 209.58/209.76 |- skos__prefLabel mesh__D017089 Ankyrin Repeat
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017089 2005
% 209.58/209.76 |- skos__hiddenLabel mesh__D017089 Ankyrin Like Repeats
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017089 2006
% 209.58/209.76 |- mesh__dateEstablished mesh__D017089 1993-01-01
% 209.58/209.76 |- mesh__dateCreated mesh__D017089 1992-05-13
% 209.58/209.76 |- skos__hiddenLabel mesh__D017089 Repeat, Ankyrin
% 209.58/209.76 |- skos__hiddenLabel mesh__D017089 Repeats, ANK
% 209.58/209.76 |- mesh__recordOriginator mesh__D017089 PXP
% 209.58/209.76 |- skos__hiddenLabel mesh__D017089 ANK Repeats
% 209.58/209.76 |- mesh__dateCreated mesh__D003867 1999-01-01
% 209.58/209.76 |- mesh__recordMaintainer mesh__D003867 nns
% 209.58/209.76 |- skos__hiddenLabel mesh__D003867 Stereoscopic Visions
% 209.58/209.76 |- mesh__dateRevised mesh__D003867 2003-07-09
% 209.58/209.76 |- skos__altLabel mesh__D003867 Stereopsis
% 209.58/209.76 |- skos__hiddenLabel mesh__D003867 Perceptions, Depth
% 209.58/209.76 |- skos__scopeNote mesh__D003867 Perception of three-dimensionality.
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D003867 2006
% 209.58/209.76 |- skos__broader mesh__D003867smesh__D010465
% 209.58/209.76 |- mesh__recordOriginator mesh__D003867 NLM
% 209.58/209.76 |- skos__hiddenLabel mesh__D003867 Perception, Depth
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D003867 2005
% 209.58/209.76 |- skos__hiddenLabel mesh__D003867 Stereopses
% 209.58/209.76 |- skos__prefLabel mesh__D003867 Depth Perception
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D003867 sjn
% 209.58/209.76 |- skos__broader mesh__D003867smesh__D014796
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D003867 2004
% 209.58/209.76 |- skos__hiddenLabel mesh__D003867 Vision, Stereoscopic
% 209.58/209.76 |- skos__altLabel mesh__D003867 Stereoscopic Vision
% 209.58/209.76 |- skos__broader mesh__D003867smesh__D013028
% 209.58/209.76 |- rdf__type mesh__D003867sskos__Concept
% 209.58/209.76 |- skos__annotation mesh__D003867
% 209.58/209.76 disord of depth perception: coord IM with PERCEPTUAL DISORDERS %28%IM%29%%A%
% 209.58/209.76 |- skos__hiddenLabel mesh__D003867 Visions, Stereoscopic
% 209.58/209.76 |- skos__hiddenLabel mesh__D003867 Depth Perceptions
% 209.58/209.76 |- skos__related mesh__D003069smesh__D040503
% 209.58/209.76 |- skos__related mesh__D003069smesh__D018651
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D003069 2006
% 209.58/209.76 |- mesh__recordOriginator mesh__D003069 NLM
% 209.58/209.76 |- mesh__dateRevised mesh__D003069 2004-07-19
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D003069 sjn
% 209.58/209.76 |- mesh__dateCreated mesh__D003069 1999-01-01
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D003069 2005
% 209.58/209.76 |- mesh__recordMaintainer mesh__D003069 jls
% 209.58/209.76 |- rdf__type mesh__D003069sskos__Concept
% 209.58/209.76 |- skos__related mesh__D003069smesh__D002110
% 209.58/209.76 |- skos__scopeNote mesh__D003069
% 209.58/209.76 A beverage made from ground COFFEA beans %28%SEEDS%29% infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.%A%
% 209.58/209.76 |- skos__annotation mesh__D003069 for the plant use COFFEA
% 209.58/209.76 |- skos__prefLabel mesh__D003069 Coffee
% 209.58/209.76 |- skos__broader mesh__D003069smesh__D001628
% 209.58/209.76 |- mesh__dateEstablished mesh__D008552 1991-01-01
% 209.58/209.76 |- skos__scopeNote mesh__D008552
% 209.58/209.76 A 6-methyl PROGESTERONE acetate with reported glucocorticoid activity and effect on ESTRUS.%A%
% 209.58/209.76 |- mesh__historyNote mesh__D008552
% 209.58/209.76 97; was MELENGESTROL 1973-96 %28%see under PREGNADIENES 1973-90%29%%A%
% 209.58/209.76 |- mesh__dateCreated mesh__D008552 1999-01-01
% 209.58/209.76 |- mesh__recordOriginator mesh__D008552 NLM
% 209.58/209.76 |- skos__historyNote mesh__D008552 Pregnadienes %28%1966-1972%29%
% 209.58/209.76 |- skos__historyNote mesh__D008552
% 209.58/209.76 Progestational Hormones %28%1966-1972%29%
% 209.58/209.76 |- skos__broader mesh__D008552smesh__D011245
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D008552
% 209.58/209.76 97; was MELENGESTROL 1973-96 %28%see under PREGNADIENES 1973-90%29%%A%
% 209.58/209.76 |- mesh__dateRevised mesh__D008552 2003-07-09
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D008552 2006
% 209.58/209.76 |- skos__hiddenLabel mesh__D008552 Acetate, Melengestrol
% 209.58/209.76 |- rdf__type mesh__D008552sskos__Concept
% 209.58/209.76 |- skos__prefLabel mesh__D008552 Melengestrol Acetate
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D008552 2005
% 209.58/209.76 |- mesh__recordMaintainer mesh__D008552 lkt
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D008552 sjn
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D008552 2004
% 209.58/209.76 |- skos__historyNote mesh__D022223 Vaccines, Synthetic %28%1978-2000%29%
% 209.58/209.76 |- mesh__historyNote mesh__D022223 2001
% 209.58/209.76 |- mesh__recordOriginator mesh__D022223 ags
% 209.58/209.76 |- mesh__dateEstablished mesh__D022223 2001-01-01
% 209.58/209.76 |- skos__hiddenLabel mesh__D022223 Subunit Vaccines
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D022223 sjn
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D022223 2006
% 209.58/209.76 |- rdf__type mesh__D022223sskos__Concept
% 209.58/209.76 |- skos__annotation mesh__D022223
% 209.58/209.76 IM general only; coord NIM with specific vaccine %28%IM%29%
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D022223 2001
% 209.58/209.76 |- mesh__dateCreated mesh__D022223 2000-06-22
% 209.58/209.76 |- skos__prefLabel mesh__D022223 Vaccines, Subunit
% 209.58/209.76 |- skos__scopeNote mesh__D022223
% 209.58/209.76 Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides.%A%
% 209.58/209.76 |- skos__altLabel mesh__D022223 Peptide Vaccines
% 209.58/209.76 |- skos__broader mesh__D022223smesh__D014612
% 209.58/209.76 |- mesh__recordMaintainer mesh__D022223 ssb
% 209.58/209.76 |- mesh__dateRevised mesh__D022223 2005-06-30
% 209.58/209.76 |- skos__annotation mesh__D013497
% 209.58/209.76 dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES %28%IM%29%; neopl: coord IM with PERIPHERAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 209.58/209.76 |- skos__broader mesh__D013497smesh__D013979
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D013497
% 209.58/209.76 91; was see under SPINAL NERVES 1971-90
% 209.58/209.76 |- skos__hiddenLabel mesh__D013497 Sural Nerves
% 209.58/209.76 |- mesh__historyNote mesh__D013497
% 209.58/209.76 91%28%71%29%; was see under SPINAL NERVES 1971-90
% 209.58/209.76 |- mesh__dateRevised mesh__D013497 1999-11-03
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013497 2000
% 209.58/209.76 |- mesh__recordMaintainer mesh__D013497 kle
% 209.58/209.76 |- skos__hiddenLabel mesh__D013497 Nerve, Sural
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013497 2001
% 209.58/209.76 |- skos__hiddenLabel mesh__D013497 Nerves, Sural
% 209.58/209.76 |- skos__historyNote mesh__D013497 Leg/innervation %28%1966-1970%29%
% 209.58/209.76 |- mesh__recordOriginator mesh__D013497 NLM
% 209.58/209.76 |- skos__historyNote mesh__D013497 Spinal Nerves %28%1966-1970%29%
% 209.58/209.76 |- rdf__type mesh__D013497sskos__Concept
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013497 2003
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013497 2005
% 209.58/209.76 |- mesh__dateCreated mesh__D013497 1999-01-01
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013497 2004
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D013497 sjn
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013497 2002
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D013497 2006
% 209.58/209.76 |- skos__prefLabel mesh__D013497 Sural Nerve
% 209.58/209.76 |- mesh__dateEstablished mesh__D013497 1991-01-01
% 209.58/209.76 |- skos__scopeNote mesh__D013497
% 209.58/209.76 A branch of the tibial nerve which supplies sensory innervation to parts of the lower leg and foot.%A%
% 209.58/209.76 |- skos__related mesh__D018980smesh__D004549
% 209.58/209.76 |- mesh__dateEstablished mesh__D018980 1996-01-01
% 209.58/209.76 |- skos__scopeNote mesh__D018980
% 209.58/209.76 A contiguous gene syndrome associated with a heterozygous microdeletion in the chromosomal region 7q11.23, encompassing the ELASTIN gene. Clinical manifestations include supravalvular aortic stenosis %28%AORTIC STENOSIS, SUPRAVALVULAR%29%, MENTAL RETARDATION, elfin facies, impaired visuospatial constructive abilities, and transient hypercalcemia in infancy. The condition affects both sexes, with onset at birth or in early infancy.%A%
% 209.58/209.76 |- skos__hiddenLabel mesh__D018980 Williams Beuren Syndrome
% 209.58/209.76 |- skos__historyNote mesh__D018980 Aortic Valve Stenosis %28%1969-1995%29%
% 209.58/209.76 |- skos__altLabel mesh__D018980 Williams-Beuren Syndrome
% 209.58/209.76 |- skos__prefLabel mesh__D018980 Williams Syndrome
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D018980 sjn
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018980 2002
% 209.58/209.76 |- skos__broader mesh__D018980smesh__D025063
% 209.58/209.76 |- rdf__type mesh__D018980sskos__Concept
% 209.58/209.76 |- skos__hiddenLabel mesh__D018980 Syndrome, Elfin Facies
% 209.58/209.76 |- skos__altLabel mesh__D018980 Elfin Facies Syndrome
% 209.58/209.76 |- skos__hiddenLabel mesh__D018980 Syndrome, Williams
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D018980 96
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018980 2006
% 209.58/209.76 |- skos__altLabel mesh__D018980 Contiguous Gene Syndrome, Williams
% 209.58/209.76 |- mesh__dateRevised mesh__D018980 2001-07-25
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018980 2004
% 209.58/209.76 |- skos__related mesh__D018980smesh__D008607
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018980 2005
% 209.58/209.76 |- mesh__historyNote mesh__D018980 96
% 209.58/209.76 |- skos__hiddenLabel mesh__D018980 Syndrome, Williams-Beuren
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018980 2003
% 209.58/209.76 |- skos__broader mesh__D018980smesh__D021921
% 209.58/209.76 |- skos__annotation mesh__D018980
% 209.58/209.76 do not confuse with Williams-Campbell syndrome, congen bronchomalacia causing bronchiectasis%A%
% 209.58/209.76 |- skos__altLabel mesh__D018980 Williams Contiguous Gene Syndrome
% 209.58/209.76 |- mesh__recordOriginator mesh__D018980 TGC
% 209.58/209.76 |- skos__hiddenLabel mesh__D018980 Elfin Facies Syndromes
% 209.58/209.76 |- mesh__dateCreated mesh__D018980 1995-05-24
% 209.58/209.76 |- skos__broader mesh__D018980smesh__D008607
% 209.58/209.76 |- mesh__recordMaintainer mesh__D018980 nns
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 1996
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 2003
% 209.58/209.76 |- skos__scopeNote mesh__D018182
% 209.58/209.76 Infections with viruses of the genus PESTIVIRUS, family FLAVIVIRIDAE.%A%
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 1998
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 2005
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 1997
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 2004
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 1994
% 209.58/209.76 |- mesh__dateCreated mesh__D018182 1993-06-04
% 209.58/209.76 |- skos__hiddenLabel mesh__D018182 Infection, Pestivirus
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 2002
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 1999
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 2006
% 209.58/209.76 |- skos__broader mesh__D018182smesh__D018178
% 209.58/209.76 |- skos__prefLabel mesh__D018182 Pestivirus Infections
% 209.58/209.76 |- skos__altLabel mesh__D018182 Infections, Pestivirus
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 1995
% 209.58/209.76 |- skos__annotation mesh__D018182
% 209.58/209.76 caused by a flavivirus; GEN or unspecified; prefer specifics%A%
% 209.58/209.76 |- mesh__dateEstablished mesh__D018182 1994-01-01
% 209.58/209.76 |- rdf__type mesh__D018182sskos__Concept
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 2000
% 209.58/209.76 |- skos__hiddenLabel mesh__D018182 Pestivirus Infection
% 209.58/209.76 |- mesh__historyNote mesh__D018182 94
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D018182 94
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D018182 2001
% 209.58/209.76 |- skos__altLabel mesh__D004960 Estradiol Dehydrogenase
% 209.58/209.76 |- skos__hiddenLabel mesh__D004960 17 beta Estradiol Dehydrogenase
% 209.58/209.76 |- rdf__type mesh__D004960sskos__Concept
% 209.58/209.76 |- mesh__historyNote mesh__D004960
% 209.58/209.76 91%28%78%29%; was see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90; was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77%A%
% 209.58/209.76 |- skos__hiddenLabel mesh__D004960 17 beta-Dehydrogenase, Estradiol
% 209.58/209.76 |- skos__hiddenLabel mesh__D004960 Dehydrogenase, 17 beta-Estradiol
% 209.58/209.76 |- skos__hiddenLabel mesh__D004960 Estradiol 17 alpha Dehydrogenase
% 209.58/209.76 |- skos__scopeNote mesh__D004960
% 209.58/209.76 Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration. EC 1.1.1.62%A%
% 209.58/209.76 |- mesh__dateEstablished mesh__D004960 1991-01-01
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D004960 2004
% 209.58/209.76 |- skos__hiddenLabel mesh__D004960 17 alpha-Dehydrogenase, Estradiol
% 209.58/209.76 |- mesh__onlineNote mesh__D004960
% 209.58/209.76 use ESTRADIOL DEHYDROGENASES to search ESTRADIOL DEHYDROGENASE 1975-77%A%
% 209.58/209.76 |- skos__hiddenLabel mesh__D004960 Dehydrogenases, Estradiol
% 209.58/209.76 |- skos__hiddenLabel mesh__D004960 Estradiol 17 beta Dehydrogenase
% 209.58/209.76 |- mesh__publicMeSHNote mesh__D004960
% 209.58/209.76 91; was see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90; was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77%A%
% 209.58/209.76 |- mesh__recordOriginator mesh__D004960 NLM
% 209.58/209.76 |- skos__broader mesh__D004960smesh__D015067
% 209.58/209.76 |- mesh__dateCreated mesh__D004960 1974-11-19
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D004960 2006
% 209.58/209.76 |- skos__altLabel mesh__D004960 17 beta-Estradiol Dehydrogenase
% 209.58/209.76 |- skos__hiddenLabel mesh__D004960 Dehydrogenase, Estradiol
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D004960 sjn
% 209.58/209.76 |- mesh__recordMaintainer mesh__D004960 ssb
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D004960 2005
% 209.58/209.76 |- mesh__dateRevised mesh__D004960 2003-07-09
% 209.58/209.76 |- skos__historyNote mesh__D004960 Estradiol %28%1973-1974%29%
% 209.58/209.76 |- skos__historyNote mesh__D004960
% 209.58/209.76 Hydroxysteroid Dehydrogenases %28%1973-1974%29%
% 209.58/209.76 |- skos__prefLabel mesh__D004960 Estradiol Dehydrogenases
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017888 2004
% 209.58/209.76 |- mesh__dateCreated mesh__D017888 1993-02-16
% 209.58/209.76 |- skos__hiddenLabel mesh__D017888 Knee Medial Ligaments
% 209.58/209.76 |- skos__altLabel mesh__D017888 Knee Medial Collateral Ligament
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017888 2002
% 209.58/209.76 |- skos__hiddenLabel mesh__D017888 Collaterale Tibiales, Ligamentum
% 209.58/209.76 |- skos__hiddenLabel mesh__D017888 Collateral Ligament, Tibial
% 209.58/209.76 |- skos__historyNote mesh__D017888 Ligaments, Articular %28%1968-1993%29%
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017888 2006
% 209.58/209.76 |- skos__hiddenLabel mesh__D017888 Tibiales, Ligamentum Collaterale
% 209.58/209.76 |- rdf__type mesh__D017888sskos__Concept
% 209.58/209.76 |- skos__annotation mesh__D017888
% 209.58/209.76 an artic ligament between tibia %26% femur: do not confuse with PATELLAR LIGAMENT, between patella %26% tibia%A%
% 209.58/209.76 |- skos__historyNote mesh__D017888 Ligaments %28%1966-1993%29%
% 209.58/209.76 |- skos__hiddenLabel mesh__D017888 Tibiale, Ligamentum Collaterale
% 209.58/209.76 |- skos__hiddenLabel mesh__D017888 Tibial Collateral Ligaments
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017888 2003
% 209.58/209.76 |- mesh__recordOriginator mesh__D017888 TGC
% 209.58/209.76 |- mesh__dateRevised mesh__D017888 1999-11-03
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017888 2001
% 209.58/209.76 |- mesh__dateEstablished mesh__D017888 1994-01-01
% 209.58/209.76 |- mesh__activeMeSHYear mesh__D017888 2005
% 209.58/209.76 |- skos__hiddenLabel mesh__D017888 Ligamentum Collaterale Tibiales
% 209.58/209.76 |- skos__hiddenLabel mesh__D017888 Ligaments, Tibial Collateral
% 209.58/209.76 |- mesh__recordAuthorizer mesh__D017888 sjn
% 209.58/209.76 |- skos__altLabel mesh__D017888 Medial Ligament of Knee
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017888 2000
% 209.58/209.77 |- skos__hiddenLabel mesh__D017888 Ligament, Tibial Collateral
% 209.58/209.77 |- skos__hiddenLabel mesh__D017888 Knee Medial Ligament
% 209.58/209.77 |- mesh__historyNote mesh__D017888 94
% 209.58/209.77 |- skos__altLabel mesh__D017888 Tibial Collateral Ligament
% 209.58/209.77 |- skos__broader mesh__D017888smesh__D017885
% 209.58/209.77 |- skos__hiddenLabel mesh__D017888 Collaterale Tibiale, Ligamentum
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D017888 94
% 209.58/209.77 |- skos__altLabel mesh__D017888 Ligamentum Collaterale Tibiale
% 209.58/209.77 |- skos__altLabel mesh__D017888 Collateral Ligament, Medial, Knee
% 209.58/209.77 |- skos__hiddenLabel mesh__D017888 Collateral Ligaments, Tibial
% 209.58/209.77 |- mesh__recordMaintainer mesh__D017888 KEV
% 209.58/209.77 |- skos__prefLabel mesh__D017888 Medial Collateral Ligament, Knee
% 209.58/209.77 |- skos__scopeNote mesh__D017888
% 209.58/209.77 The ligament that travels from the medial epicondyle of the FEMUR to the medial margin and medial surface of the TIBIA. The medial meniscus is attached to its deep surface.%A%
% 209.58/209.77 |- skos__broader mesh__D042281smesh__D020561
% 209.58/209.77 |- mesh__recordOriginator mesh__D042281 ags
% 209.58/209.77 |- mesh__historyNote mesh__D042281 2004
% 209.58/209.77 |- mesh__dateCreated mesh__D042281 2003-07-09
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D042281 2006
% 209.58/209.77 |- mesh__dateEstablished mesh__D042281 2004-01-01
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D042281 2004
% 209.58/209.77 |- mesh__recordMaintainer mesh__D042281 SYSTEM
% 209.58/209.77 |- skos__prefLabel mesh__D042281 Holosporaceae
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D042281 sjn
% 209.58/209.77 |- rdf__type mesh__D042281sskos__Concept
% 209.58/209.77 |- mesh__dateRevised mesh__D042281 2005-06-30
% 209.58/209.77 |- skos__scopeNote mesh__D042281
% 209.58/209.77 A family of bacteria comprised of endosymbionts of PROTOZOA.%A%
% 209.58/209.77 |- skos__broader mesh__D003868smesh__D011806
% 209.58/209.77 |- mesh__dateEstablished mesh__D003868 1991-01-01
% 209.58/209.77 |- skos__altLabel mesh__D003868 Sorot
% 209.58/209.77 |- skos__altLabel mesh__D003868 LAB Brand of Dequalinium Chloride
% 209.58/209.77 |- skos__hiddenLabel mesh__D003868 Diundecenoate, Dequalinium
% 209.58/209.77 |- skos__altLabel mesh__D003868 Dequalinium Diacetate
% 209.58/209.77 |- mesh__recordOriginator mesh__D003868 SH
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D003868
% 209.58/209.77 1991; see QUINOLINIUM COMPOUNDS 1976-90; for DECHALINIUM %26% DEQUALONUM see DEQUALINIUM 1976-1993; DYNEXAN-MHP was indexed under DEQUALINIUM, POLYETHYLENES %26% SESQUITERPENES 1977-2000 and under POLYMERS %26% QUINOLINIUM COMPOUNDS 1974-1976%A%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D003868 2006
% 209.58/209.77 |- mesh__historyNote mesh__D003868
% 209.58/209.77 1991%28%1976%29%; see QUINOLINIUM COMPOUNDS 1976-1990; for DECHALINIUM %26% DEQUALONUM see DEQUALINIUM 1976-1993%A%
% 209.58/209.77 |- skos__altLabel mesh__D003868 Decamine
% 209.58/209.77 |- skos__altLabel mesh__D003868 Vemedia Brand of Dequalinium Chloride
% 209.58/209.77 |- skos__altLabel mesh__D003868 Merckle Brand of Dequalinium Chloride
% 209.58/209.77 |- mesh__recordMaintainer mesh__D003868 exl
% 209.58/209.77 |- skos__altLabel mesh__D003868 Ravensberg Brand of Dequalinium Chloride
% 209.58/209.77 |- skos__hiddenLabel mesh__D003868 Di-10-undecenoate, Dequalinium
% 209.58/209.77 |- skos__altLabel mesh__D003868 ratiopharm Brand of Dequalinium Chloride
% 209.58/209.77 |- mesh__dateRevised mesh__D003868 2005-06-30
% 209.58/209.77 |- skos__hiddenLabel mesh__D003868 Diiodide, Dequalinium
% 209.58/209.77 |- skos__altLabel mesh__D003868 Nourypharma Brand of Dequalinium Chloride
% 209.58/209.77 |- mesh__dateCreated mesh__D003868 1975-07-23
% 209.58/209.77 |- skos__hiddenLabel mesh__D003868 Acetate, Dequalinium
% 209.58/209.77 |- rdf__type mesh__D003868sskos__Concept
% 209.58/209.77 |- skos__altLabel mesh__D003868 Dequalinium Dichloride
% 209.58/209.77 |- skos__hiddenLabel mesh__D003868 Dynexan MHP
% 209.58/209.77 |- skos__hiddenLabel mesh__D003868 Dibromide, Dequalinium
% 209.58/209.77 |- skos__altLabel mesh__D003868 Wellspring Brand of Dequalinium Chloride
% 209.58/209.77 |- skos__altLabel mesh__D003868 Boots Brand of Dequalinium Chloride
% 209.58/209.77 |- skos__altLabel mesh__D003868 Inibsa Brand of Dequalinium Chloride
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D003868 sjn
% 209.58/209.77 |- skos__hiddenLabel mesh__D003868 Chloride, Dequalinium
% 209.58/209.77 |- skos__prefLabel mesh__D003868 Dequalinium
% 209.58/209.77 |- skos__historyNote mesh__D003868 Quinolinium Compounds %28%1970-1975%29%
% 209.58/209.77 |- skos__scopeNote mesh__D003868
% 209.58/209.77 A topical bacteriostat that is available as various salts. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.%A%
% 209.58/209.77 |- skos__hiddenLabel mesh__D003868 Diacetate, Dequalinium
% 209.58/209.77 |- skos__altLabel mesh__D003868
% 209.58/209.77 Allen %26% Hanburys Brand of Dequalinium Chloride
% 209.58/209.77 |- skos__hiddenLabel mesh__D003868 Dichloride, Dequalinium
% 209.58/209.77 |- skos__related mesh__D014590smesh__D018590
% 209.58/209.77 |- skos__altLabel mesh__D014590 Myometrial Contraction
% 209.58/209.77 |- skos__related mesh__D014590smesh__D010120
% 209.58/209.77 |- rdf__type mesh__D014590sskos__Concept
% 209.58/209.77 |- skos__hiddenLabel mesh__D014590 Contractions, Myometrial
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D014590 NLM
% 209.58/209.77 |- mesh__dateEstablished mesh__D014590 1975-09-01
% 209.58/209.77 |- skos__historyNote mesh__D014590 Uterus %28%1966-1974%29%
% 209.58/209.77 |- skos__hiddenLabel mesh__D014590 Contraction, Myometrial
% 209.58/209.77 |- mesh__recordOriginator mesh__D014590 NLM
% 209.58/209.77 |- skos__broader mesh__D014590smesh__D007743
% 209.58/209.77 |- skos__hiddenLabel mesh__D014590 Myometrial Contractions
% 209.58/209.77 |- skos__broader mesh__D014590smesh__D009119
% 209.58/209.77 |- skos__hiddenLabel mesh__D014590 Contractions, Uterine
% 209.58/209.77 |- mesh__dateRevised mesh__D014590 2005-07-06
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D014590 75
% 209.58/209.77 |- skos__scopeNote mesh__D014590 Contraction of the UTERINE MUSCLE.
% 209.58/209.77 |- mesh__historyNote mesh__D014590 75
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D014590 2006
% 209.58/209.77 |- mesh__recordMaintainer mesh__D014590 NLM
% 209.58/209.77 |- skos__prefLabel mesh__D014590 Uterine Contraction
% 209.58/209.77 |- skos__hiddenLabel mesh__D014590 Uterine Contractions
% 209.58/209.77 |- mesh__dateCreated mesh__D014590 1974-11-11
% 209.58/209.77 |- skos__related mesh__D014590smesh__D015149
% 209.58/209.77 |- skos__related mesh__D014590smesh__D007752
% 209.58/209.77 |- skos__hiddenLabel mesh__D014590 Contraction, Uterine
% 209.58/209.77 |- skos__related mesh__D014590smesh__D015148
% 209.58/209.77 |- mesh__dateCreated mesh__D008553 1977-12-15
% 209.58/209.77 |- mesh__recordMaintainer mesh__D008553 ssb
% 209.58/209.77 |- skos__scopeNote mesh__D008553
% 209.58/209.77 A disaccharide consisting of one galactose and one glucose moiety in an alpha %28%1-6%29% glycosidic linkage.%A%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008553 2006
% 209.58/209.77 |- skos__historyNote mesh__D008553 Disaccharides %28%1966-1978%29%
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D008553 sjn
% 209.58/209.77 |- rdf__type mesh__D008553sskos__Concept
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008553 2005
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D008553
% 209.58/209.77 91; was see under DISACCHARIDES 1979-90
% 209.58/209.77 |- mesh__dateRevised mesh__D008553 2004-07-07
% 209.58/209.77 |- skos__broader mesh__D008553smesh__D004187
% 209.58/209.77 |- skos__prefLabel mesh__D008553 Melibiose
% 209.58/209.77 |- mesh__recordOriginator mesh__D008553 RLS
% 209.58/209.77 |- mesh__historyNote mesh__D008553
% 209.58/209.77 91%28%79%29%; was see under DISACCHARIDES 1979-90
% 209.58/209.77 |- mesh__dateEstablished mesh__D008553 1991-01-01
% 209.58/209.77 |- mesh__dateRevised mesh__D000570 1992-03-25
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 2001
% 209.58/209.77 |- skos__hiddenLabel mesh__D000570 Societies, American Cancer
% 209.58/209.77 |- skos__historyNote mesh__D000570 Neoplasms %28%1966-1974%29%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 2005
% 209.58/209.77 |- skos__hiddenLabel mesh__D000570 Cancer Society, American
% 209.58/209.77 |- skos__hiddenLabel mesh__D000570 Cancer Societies, American
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 1996
% 209.58/209.77 |- mesh__onlineNote mesh__D000570
% 209.58/209.77 search VOLUNTARY HEALTH AGENCIES 1967-74
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 1993
% 209.58/209.77 |- skos__scopeNote mesh__D000570
% 209.58/209.77 A voluntary organization concerned with the prevention and treatment of cancer through education and research.%A%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 2000
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 1999
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D000570
% 209.58/209.77 91; was see under VOLUNTARY HEALTH AGENCIES 1975-90
% 209.58/209.77 |- skos__annotation mesh__D000570
% 209.58/209.77 add UNITED STATES or specific state %28%NIM%29% CATALOG: use NAF entry%A%
% 209.58/209.77 |- skos__historyNote mesh__D000570 Societies, Scientific %28%1966-1974%29%
% 209.58/209.77 |- skos__hiddenLabel mesh__D000570 Society, American Cancer
% 209.58/209.77 |- mesh__recordMaintainer mesh__D000570 TAP
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 1995
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 1998
% 209.58/209.77 |- skos__historyNote mesh__D000570 Societies, Medical %28%1966-1974%29%
% 209.58/209.77 |- mesh__recordOriginator mesh__D000570 NLM
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 2004
% 209.58/209.77 |- skos__historyNote mesh__D000570
% 209.58/209.77 Voluntary Health Agencies %28%1966-1974%29%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 2002
% 209.58/209.77 |- skos__broader mesh__D000570smesh__D014837
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 1994
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 2003
% 209.58/209.77 |- skos__historyNote mesh__D000570 specific neoplasm
% 209.58/209.77 |- mesh__historyNote mesh__D000570
% 209.58/209.77 91%28%75%29%; was see under VOLUNTARY HEALTH AGENCIES 1975-90
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D000570 PLS
% 209.58/209.77 |- skos__prefLabel mesh__D000570 American Cancer Society
% 209.58/209.77 |- skos__hiddenLabel mesh__D000570 American Cancer Societies
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 2006
% 209.58/209.77 |- rdf__type mesh__D000570sskos__Concept
% 209.58/209.77 |- mesh__dateCreated mesh__D000570 1999-01-01
% 209.58/209.77 |- mesh__dateEstablished mesh__D000570 1991-01-01
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000570 1997
% 209.58/209.77 |- skos__scopeNote mesh__D013498
% 209.58/209.77 A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. %28%From AMA Drug Evaluations Annual, 1992, p1643%29% It has also been shown to have potent antineoplastic properties.%A%
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D013498 sjn
% 209.58/209.77 |- skos__hiddenLabel mesh__D013498 Salt Suramin, Monosodium
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D013498 2002
% 209.58/209.77 |- skos__hiddenLabel mesh__D013498 Sodium, Suramin
% 209.58/209.77 |- skos__altLabel mesh__D013498 Suramin, Hexasodium Salt
% 209.58/209.77 |- skos__broader mesh__D013498smesh__D009282
% 209.58/209.77 |- rdf__type mesh__D013498sskos__Concept
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D013498 2003
% 209.58/209.77 |- mesh__dateRevised mesh__D013498 2000-06-22
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D013498 2005
% 209.58/209.77 |- mesh__recordMaintainer mesh__D013498 jmp
% 209.58/209.77 |- mesh__dateCreated mesh__D013498 1999-01-01
% 209.58/209.77 |- skos__hiddenLabel mesh__D013498 Monosodium Salt Suramin
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D013498 2004
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D013498 2001
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D013498 2006
% 209.58/209.77 |- skos__hiddenLabel mesh__D013498 Hexasodium Salt Suramin
% 209.58/209.77 |- mesh__recordOriginator mesh__D013498 NLM
% 209.58/209.77 |- skos__prefLabel mesh__D013498 Suramin
% 209.58/209.77 |- skos__hiddenLabel mesh__D013498 Salt Suramin, Hexasodium
% 209.58/209.77 |- skos__scopeNote mesh__D018981
% 209.58/209.77 An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors.%A%
% 209.58/209.77 |- mesh__recordOriginator mesh__D018981 TGC
% 209.58/209.77 |- mesh__recordMaintainer mesh__D018981 nns
% 209.58/209.77 |- rdf__type mesh__D018981sskos__Concept
% 209.58/209.77 |- mesh__dateEstablished mesh__D018981 1996-01-01
% 209.58/209.77 |- skos__broader mesh__D018981smesh__D002239
% 209.58/209.77 |- skos__historyNote mesh__D018981 Glycoproteins %28%1977-1995%29%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D018981 2006
% 209.58/209.77 |- skos__hiddenLabel mesh__D018981
% 209.58/209.77 Syndrome, Carbohydrate-Deficient Glycoprotein
% 209.58/209.77 |- skos__hiddenLabel mesh__D018981
% 209.58/209.77 Glycoprotein Syndromes, Carbohydrate-Deficient
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D018981 2004
% 209.58/209.77 |- skos__historyNote mesh__D018981
% 209.58/209.77 Carbohydrate Metabolism, Inborn Errors %28%1991-1995%29%
% 209.58/209.77 |- skos__hiddenLabel mesh__D018981
% 209.58/209.77 Syndromes, Carbohydrate-Deficient Glycoprotein
% 209.58/209.77 |- skos__hiddenLabel mesh__D018981
% 209.58/209.77 Carbohydrate-Deficient Glycoprotein Syndromes
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D018981 2005
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D018981 2002
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D018981 sjn
% 209.58/209.77 |- mesh__historyNote mesh__D018981 96
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D018981 2003
% 209.58/209.77 |- skos__annotation mesh__D018981
% 209.58/209.77 an inborn error of carbohydrate metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: CARB DEFIC GLYCOPROTEIN SYNDROME%A%
% 209.58/209.77 |- skos__hiddenLabel mesh__D018981
% 209.58/209.77 Glycoprotein Syndrome, Carbohydrate Deficient
% 209.58/209.77 |- mesh__dateCreated mesh__D018981 1995-05-24
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D018981 96
% 209.58/209.77 |- mesh__dateRevised mesh__D018981 2001-07-25
% 209.58/209.77 |- skos__altLabel mesh__D018981
% 209.58/209.77 Glycoprotein Syndrome, Carbohydrate-Deficient
% 209.58/209.77 |- skos__hiddenLabel mesh__D018981
% 209.58/209.77 Carbohydrate Deficient Glycoprotein Syndrome
% 209.58/209.77 |- skos__prefLabel mesh__D018981
% 209.58/209.77 Carbohydrate-Deficient Glycoprotein Syndrome
% 209.58/209.77 |- skos__altLabel mesh__D018183 Transplantation Chimeras
% 209.58/209.77 |- skos__altLabel mesh__D018183 Chimera, Transplantation
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D018183 2005
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D018183 2004
% 209.58/209.77 |- skos__historyNote mesh__D018183 Chimera %28%1978-1993%29%
% 209.58/209.77 |- skos__broader mesh__D018183smesh__D002678
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D018183 94
% 209.58/209.77 |- mesh__recordOriginator mesh__D018183 PXP
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D018183 2006
% 209.58/209.77 |- mesh__dateRevised mesh__D018183 2003-07-09
% 209.58/209.77 |- rdf__type mesh__D018183sskos__Concept
% 209.58/209.77 |- skos__altLabel mesh__D018183 Chimeras, Transplantation
% 209.58/209.77 |- mesh__historyNote mesh__D018183 94
% 209.58/209.77 |- mesh__dateCreated mesh__D018183 1993-06-03
% 209.58/209.77 |- skos__annotation mesh__D018183 DF: TRANSPL CHIMERA
% 209.58/209.77 |- mesh__dateEstablished mesh__D018183 1994-01-01
% 209.58/209.77 |- mesh__recordMaintainer mesh__D018183 ags
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D018183 sjn
% 209.58/209.77 |- skos__scopeNote mesh__D018183
% 209.58/209.77 An organism that, as a result of transplantation of donor tissue or cells, consists of two or more cell lines descended from at least two zygotes. This state may result in the induction of donor-specific TRANSPLANTATION TOLERANCE.%A%
% 209.58/209.77 |- skos__prefLabel mesh__D018183 Transplantation Chimera
% 209.58/209.77 |- mesh__recordMaintainer mesh__D004961 exl
% 209.58/209.77 |- skos__hiddenLabel mesh__D004961 Leo275
% 209.58/209.77 |- mesh__recordOriginator mesh__D004961 NLM
% 209.58/209.77 |- mesh__dateEstablished mesh__D004961 1991-01-01
% 209.58/209.77 |- mesh__onlineNote mesh__D004961
% 209.58/209.77 use ESTRAMUSTINE to search ESTRAMUSTINPHOSPHATE 1975-79
% 209.58/209.77 |- skos__prefLabel mesh__D004961 Estramustine
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D004961 sjn
% 209.58/209.77 |- mesh__historyNote mesh__D004961
% 209.58/209.77 91%28%80%29%; was see under NITROGEN MUSTARD COMPOUNDS 1980-90; was ESTRAMUSTINPHOSPHATE see under NITROGEN MUSTARD COMPOUNDS 1975-79%A%
% 209.58/209.77 |- skos__scopeNote mesh__D004961
% 209.58/209.77 A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties.%A%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D004961 2006
% 209.58/209.77 |- skos__historyNote mesh__D004961 Estranes %28%1972-1974%29%
% 209.58/209.77 |- skos__hiddenLabel mesh__D004961 Phosphate Sodium, Estramustine
% 209.58/209.77 |- skos__broader mesh__D004961smesh__D004958
% 209.58/209.77 |- mesh__dateRevised mesh__D004961 2005-06-30
% 209.58/209.77 |- skos__hiddenLabel mesh__D004961 Leo 275
% 209.58/209.77 |- skos__broader mesh__D004961smesh__D009588
% 209.58/209.77 |- rdf__type mesh__D004961sskos__Concept
% 209.58/209.77 |- skos__historyNote mesh__D004961
% 209.58/209.77 Nitrogen Mustard Compounds %28%1972-1974%29%
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D004961
% 209.58/209.77 91; was see under NITROGEN MUSTARD COMPOUNDS 1980-90; was ESTRAMUSTINPHOSPHATE see under NITROGEN MUSTARD COMPOUNDS 1975-79%A%
% 209.58/209.77 |- skos__hiddenLabel mesh__D004961 NSC 89199
% 209.58/209.77 |- skos__historyNote mesh__D004961
% 209.58/209.77 Organophosphorus Compounds %28%1973-1974%29%
% 209.58/209.77 |- mesh__dateCreated mesh__D004961 1974-11-19
% 209.58/209.77 |- skos__hiddenLabel mesh__D004961 Sodium, Estramustine Phosphate
% 209.58/209.77 |- skos__hiddenLabel mesh__D004961 NSC89199
% 209.58/209.77 |- skos__historyNote mesh__D004961 Carbamates %28%1972-1974%29%
% 209.58/209.77 |- skos__prefLabel mesh__D004163 Diphosphoglyceric Acids
% 209.58/209.77 |- mesh__historyNote mesh__D004163 74%28%73%29%
% 209.58/209.77 |- skos__historyNote mesh__D004163 Glyceric Acids %28%1968-1972%29%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D004163 2005
% 209.58/209.77 |- skos__hiddenLabel mesh__D004163 Acids, Diphosphoglyceric
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D004163 74
% 209.58/209.77 |- mesh__recordOriginator mesh__D004163 NLM
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D004163 2006
% 209.58/209.77 |- mesh__dateRevised mesh__D004163 2004-07-07
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D004163 sjn
% 209.58/209.77 |- mesh__dateCreated mesh__D004163 1999-01-01
% 209.58/209.77 |- mesh__dateEstablished mesh__D004163 1974-01-01
% 209.58/209.77 |- skos__historyNote mesh__D004163
% 209.58/209.77 Organophosphorus Compounds %28%1971-1972%29%
% 209.58/209.77 |- skos__broader mesh__D004163smesh__D005988
% 209.58/209.77 |- skos__altLabel mesh__D004163 Bisphosphoglycerates
% 209.58/209.77 |- mesh__recordMaintainer mesh__D004163 ssb
% 209.58/209.77 |- rdf__type mesh__D004163sskos__Concept
% 209.58/209.77 |- skos__broader mesh__D004163smesh__D009943
% 209.58/209.77 |- mesh__dateRevised mesh__D017889 1995-06-08
% 209.58/209.77 |- mesh__recordOriginator mesh__D017889 TGC
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Syndromes, Exfoliation
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Syndrome, Exfoliative
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Pseudo-Exfoliation Syndromes
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 1998
% 209.58/209.77 |- skos__prefLabel mesh__D017889 Exfoliation Syndrome
% 209.58/209.77 |- skos__scopeNote mesh__D017889
% 209.58/209.77 The deposition of flaky, translucent fibrillar material most conspicuous on the anterior lens capsule and pupillary margin but also in both surfaces of the iris, the zonules, trabecular meshwork, ciliary body, corneal endothelium, and orbital blood vessels. It sometimes forms a membrane on the anterior iris surface. Exfoliation refers to the shedding of pigment by the iris. %28%Newell, Ophthalmology, 7th ed, p380%29%%A%
% 209.58/209.77 |- skos__historyNote mesh__D017889 Lens Diseases %28%1977-1993%29%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 1997
% 209.58/209.77 |- mesh__recordMaintainer mesh__D017889 TAP
% 209.58/209.77 |- skos__altLabel mesh__D017889 Glaucoma Capsulare
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Syndrome, Pseudo-Exfoliation
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 2001
% 209.58/209.77 |- mesh__dateEstablished mesh__D017889 1994-01-01
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Pseudo Exfoliation Syndrome
% 209.58/209.77 |- skos__annotation mesh__D017889 shedding of pigment from the iris
% 209.58/209.77 |- skos__historyNote mesh__D017889 Eye Diseases %28%1966-1976%29%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 2006
% 209.58/209.77 |- skos__related mesh__D017889smesh__D005902
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Syndrome, Exfoliation
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 1996
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Syndromes, Exfoliative
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 2000
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D017889 94
% 209.58/209.77 |- skos__historyNote mesh__D017889 Glaucoma %28%1972-1993%29%
% 209.58/209.77 |- rdf__type mesh__D017889sskos__Concept
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 2005
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Syndromes, Pseudoexfoliation
% 209.58/209.77 |- skos__historyNote mesh__D017889 Glaucoma, Open-Angle %28%1982-1993%29%
% 209.58/209.77 |- skos__altLabel mesh__D017889 Exfoliative Syndrome
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 2004
% 209.58/209.77 |- skos__altLabel mesh__D017889 Pseudoexfoliation Syndrome
% 209.58/209.77 |- mesh__historyNote mesh__D017889 94
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Syndromes, Pseudo-Exfoliation
% 209.58/209.77 |- mesh__dateCreated mesh__D017889 1993-06-03
% 209.58/209.77 |- skos__historyNote mesh__D017889 Lens, Crystalline %28%1966-1976%29%
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Pseudoexfoliation Syndromes
% 209.58/209.77 |- skos__altLabel mesh__D017889 Pseudo-Exfoliation Syndrome
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Exfoliation Syndromes
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 2003
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 2002
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D017889 1999
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D017889 PLS
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Syndrome, Pseudoexfoliation
% 209.58/209.77 |- skos__broader mesh__D017889smesh__D007499
% 209.58/209.77 |- skos__hiddenLabel mesh__D017889 Exfoliative Syndromes
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D042282 sjn
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D042282 2004
% 209.58/209.77 |- mesh__recordMaintainer mesh__D042282 nns
% 209.58/209.77 |- mesh__recordOriginator mesh__D042282 nns
% 209.58/209.77 |- rdf__type mesh__D042282sskos__Concept
% 209.58/209.77 |- mesh__dateCreated mesh__D042282 2003-07-22
% 209.58/209.77 |- skos__related mesh__D042282smesh__D008866
% 209.58/209.77 |- mesh__dateRevised mesh__D042282 2004-07-07
% 209.58/209.77 |- skos__scopeNote mesh__D042282
% 209.58/209.77 The performance of dissections with the aid of a microscope.%A%
% 209.58/209.77 |- skos__hiddenLabel mesh__D042282 Microdissections
% 209.58/209.77 |- mesh__dateEstablished mesh__D042282 2004-01-01
% 209.58/209.77 |- mesh__historyNote mesh__D042282 2004
% 209.58/209.77 |- skos__broader mesh__D042282smesh__D004210
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D042282 2005
% 209.58/209.77 |- skos__prefLabel mesh__D042282 Microdissection
% 209.58/209.77 |- skos__historyNote mesh__D042282 Dissection %28%1966-2003%29%
% 209.58/209.77 |- skos__broader mesh__D042282smesh__D008846
% 209.58/209.77 |- skos__broader mesh__D042282smesh__D016591
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D042282 2006
% 209.58/209.77 |- mesh__recordOriginator mesh__D003869 NLM
% 209.58/209.77 |- rdf__type mesh__D003869sskos__Concept
% 209.58/209.77 |- skos__prefLabel mesh__D003869 Dermabrasion
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D003869 sjn
% 209.58/209.77 |- mesh__dateRevised mesh__D003869 2004-07-07
% 209.58/209.77 |- mesh__dateCreated mesh__D003869 1999-01-01
% 209.58/209.77 |- mesh__recordMaintainer mesh__D003869 nns
% 209.58/209.77 |- skos__broader mesh__D003869smesh__D003357
% 209.58/209.77 |- skos__scopeNote mesh__D003869
% 209.58/209.77 The mechanical planing of the SKIN with sand paper, emery paper, or wire brushes, to promote reepithelialization and smoothing of skin disfigured by ACNE scars or dermal NEVI.%A%
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D003869 2006
% 209.58/209.77 |- skos__broader mesh__D003869smesh__D019651
% 209.58/209.77 |- skos__hiddenLabel mesh__D003869 Dermabrasions
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D003869 2005
% 209.58/209.77 |- rdf__type mesh__D014591sskos__Concept
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D014591 sjn
% 209.58/209.77 |- skos__hiddenLabel mesh__D014591 Diseases, Uterine
% 209.58/209.77 |- mesh__publicMeSHNote mesh__D014591 66
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D014591 2006
% 209.58/209.77 |- skos__hiddenLabel mesh__D014591 Disease, Uterine
% 209.58/209.77 |- mesh__dateCreated mesh__D014591 1999-01-01
% 209.58/209.77 |- skos__broader mesh__D014591smesh__D005831
% 209.58/209.77 |- skos__scopeNote mesh__D014591
% 209.58/209.77 Pathological processes involving any part of the UTERUS.%A%
% 209.58/209.77 |- mesh__historyNote mesh__D014591 66
% 209.58/209.77 |- mesh__recordOriginator mesh__D014591 NLM
% 209.58/209.77 |- mesh__dateEstablished mesh__D014591 1966-01-01
% 209.58/209.77 |- mesh__recordMaintainer mesh__D014591 lkt
% 209.58/209.77 |- skos__hiddenLabel mesh__D014591 Uterine Disease
% 209.58/209.77 |- mesh__dateRevised mesh__D014591 2005-06-30
% 209.58/209.77 |- skos__prefLabel mesh__D014591 Uterine Diseases
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 2006
% 209.58/209.77 |- mesh__recordMaintainer mesh__D008554 PXP
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 1997
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 2005
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 1996
% 209.58/209.77 |- rdf__type mesh__D008554sskos__Concept
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D008554 PLS
% 209.58/209.77 |- skos__scopeNote mesh__D008554
% 209.58/209.77 A disease of humans and animals that resembles GLANDERS. It is caused by BURKHOLDERIA PSEUDOMALLEI and may range from a dormant infection to a condition that causes multiple abscesses, pneumonia, and bacteremia.%A%
% 209.58/209.77 |- skos__broader mesh__D008554smesh__D019121
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 2004
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 2002
% 209.58/209.77 |- skos__annotation mesh__D008554
% 209.58/209.77 caused by Burkholderia pseudomallei; in India, Malay %26% Indonesia%A%
% 209.58/209.77 |- skos__hiddenLabel mesh__D008554 Melioidoses
% 209.58/209.77 |- skos__prefLabel mesh__D008554 Melioidosis
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 2003
% 209.58/209.77 |- mesh__dateCreated mesh__D008554 1999-01-01
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 2001
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 1999
% 209.58/209.77 |- mesh__dateRevised mesh__D008554 1995-05-31
% 209.58/209.77 |- mesh__recordOriginator mesh__D008554 NLM
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 1998
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D008554 2000
% 209.58/209.77 |- skos__annotation mesh__D000571
% 209.58/209.77 add UNITED STATES %28%NIM%29%; DF: ADA CATALOG: use NAF entry%A%
% 209.58/209.77 |- skos__hiddenLabel mesh__D000571 Association, American Dental
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 1998
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 1993
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 1994
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 2000
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 1999
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 2003
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 2001
% 209.58/209.77 |- mesh__dateEstablished mesh__D000571 1966-01-01
% 209.58/209.77 |- skos__hiddenLabel mesh__D000571 Dental Association, American
% 209.58/209.77 |- mesh__historyNote mesh__D000571 66
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 1995
% 209.58/209.77 |- mesh__dateCreated mesh__D000571 1999-01-01
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 2004
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 2002
% 209.58/209.77 |- skos__prefLabel mesh__D000571 American Dental Association
% 209.58/209.77 |- skos__scopeNote mesh__D000571
% 209.58/209.77 Professional society representing the field of dentistry.%A%
% 209.58/209.77 |- skos__broader mesh__D000571smesh__D012953
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 2005
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 1996
% 209.58/209.77 |- mesh__recordMaintainer mesh__D000571 TAP
% 209.58/209.77 |- mesh__recordAuthorizer mesh__D000571 PLS
% 209.58/209.77 |- mesh__activeMeSHYear mesh__D000571 2006
% 209.58/209.78 |- mesh__recordOriginator mesh__D000571 NLM
% 209.58/209.78 |- rdf__type mesh__D000571sskos__Concept
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D000571 66
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000571 1997
% 209.58/209.78 |- mesh__dateRevised mesh__D000571 1992-03-25
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 1994
% 209.58/209.78 |- rdf__type mesh__D013499sskos__Concept
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 1999
% 209.58/209.78 |- skos__hiddenLabel mesh__D013499 Surface Property
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 2003
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 1993
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 2001
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 2005
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 1995
% 209.58/209.78 |- mesh__dateCreated mesh__D013499 1999-01-01
% 209.58/209.78 |- mesh__recordOriginator mesh__D013499 NLM
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 2004
% 209.58/209.78 |- mesh__historyNote mesh__D013499 70%28%68%29%
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D013499 PLS
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 2006
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 2002
% 209.58/209.78 |- skos__hiddenLabel mesh__D013499 Properties, Surface
% 209.58/209.78 |- mesh__dateRevised mesh__D013499 1992-05-26
% 209.58/209.78 |- mesh__dateEstablished mesh__D013499 1970-01-01
% 209.58/209.78 |- skos__hiddenLabel mesh__D013499 Property, Surface
% 209.58/209.78 |- skos__broader mesh__D013499smesh__D002627
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 1996
% 209.58/209.78 |- skos__annotation mesh__D013499 NIM
% 209.58/209.78 |- skos__prefLabel mesh__D013499 Surface Properties
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 1998
% 209.58/209.78 |- mesh__recordMaintainer mesh__D013499 TAP
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 2000
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D013499 1997
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D013499 70
% 209.58/209.78 |- rdf__type mesh__D018184sskos__Concept
% 209.58/209.78 |- mesh__dateCreated mesh__D018184 1993-06-04
% 209.58/209.78 |- skos__altLabel mesh__D018184 Infections, Paramyxoviridae
% 209.58/209.78 |- mesh__dateEstablished mesh__D018184 1994-01-01
% 209.58/209.78 |- skos__annotation mesh__D018184 GEN or unspecified; prefer specifics
% 209.58/209.78 |- skos__hiddenLabel mesh__D018184 Paramyxoviridae Infection
% 209.58/209.78 |- skos__hiddenLabel mesh__D018184 Infection, Paramyxoviridae
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D018184 sjn
% 209.58/209.78 |- skos__hiddenLabel mesh__D018184 Parainfluenza Virus Infection
% 209.58/209.78 |- skos__scopeNote mesh__D018184
% 209.58/209.78 Infections with viruses of the family PARAMYXOVIRIDAE. This includes MORBILLIVIRUS INFECTIONS; RESPIROVIRUS INFECTIONS; PNEUMOVIRUS INFECTIONS; HENIPAVIRUS INFECTIONS; AVULAVIRUS INFECTIONS; and RUBULAVIRUS INFECTIONS.%A%
% 209.58/209.78 |- skos__hiddenLabel mesh__D018184 Virus Infection, Parainfluenza
% 209.58/209.78 |- skos__prefLabel mesh__D018184 Paramyxoviridae Infections
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D018184
% 209.58/209.78 94; PARAINFLUENZA was heading 1994-96; was PARA-INFLUENZA 1963-93 %28%see under MYXOVIRUS INFECTIONS %28%now ORTHOMYXOVIRUS INFECTIONS%29% 1963-69%29%%A%
% 209.58/209.78 |- skos__hiddenLabel mesh__D018184 Infections, Parainfluenza Virus
% 209.58/209.78 |- skos__hiddenLabel mesh__D018184 Infection, Parainfluenza Virus
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018184 2005
% 209.58/209.78 |- mesh__recordMaintainer mesh__D018184 ags
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018184 2004
% 209.58/209.78 |- skos__hiddenLabel mesh__D018184 Virus Infections, Parainfluenza
% 209.58/209.78 |- skos__historyNote mesh__D018184
% 209.58/209.78 Paramyxovirus Infections %28%1977-1993%29%
% 209.58/209.78 |- mesh__onlineNote mesh__D018184
% 209.58/209.78 use PARAMYXOVIRIDAE INFECTIONS to search PARAINFLUENZA 1994-96 %26% PARA-INFLUENZA 1966-93%A%
% 209.58/209.78 |- skos__broader mesh__D018184smesh__D018701
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018184 2006
% 209.58/209.78 |- mesh__recordOriginator mesh__D018184 AGS
% 209.58/209.78 |- mesh__dateRevised mesh__D018184 2003-07-09
% 209.58/209.78 |- mesh__historyNote mesh__D018184
% 209.58/209.78 94; PARAINFLUENZA was heading 1994-96; was PARA-INFLUENZA 1963-93 %28%see under MYXOVIRUS INFECTIONS %28%now ORTHOMYXOVIRUS INFECTIONS%29% 1963-69%29%%A%
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 1996
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 2006
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 1999
% 209.58/209.78 |- skos__prefLabel mesh__D004962 Estranes
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 2001
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 2005
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 1995
% 209.58/209.78 |- mesh__recordOriginator mesh__D004962 NLM
% 209.58/209.78 |- skos__altLabel mesh__D004962 19-Norandrostanes
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D004962 68
% 209.58/209.78 |- skos__broader mesh__D004962smesh__D013256
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 1998
% 209.58/209.78 |- mesh__dateEstablished mesh__D004962 1968-01-01
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 2000
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D004962 PLS
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 1994
% 209.58/209.78 |- skos__hiddenLabel mesh__D004962 19 Norandrostanes
% 209.58/209.78 |- mesh__historyNote mesh__D004962 68
% 209.58/209.78 |- rdf__type mesh__D004962sskos__Concept
% 209.58/209.78 |- mesh__recordMaintainer mesh__D004962 PLS
% 209.58/209.78 |- mesh__dateRevised mesh__D004962 1993-06-03
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 2004
% 209.58/209.78 |- mesh__dateCreated mesh__D004962 1999-01-01
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 2002
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 1997
% 209.58/209.78 |- skos__scopeNote mesh__D004962
% 209.58/209.78 A group of compounds forming the nucleus of the estrogenic steroid family.%A%
% 209.58/209.78 |- skos__annotation mesh__D004962 do not confuse with ESTRENES
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004962 2003
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D004164 77
% 209.58/209.78 |- mesh__recordMaintainer mesh__D004164 ssb
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004164 2006
% 209.58/209.78 |- mesh__dateRevised mesh__D004164 2005-06-30
% 209.58/209.78 |- skos__scopeNote mesh__D004164
% 209.58/209.78 Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents.%A%
% 209.58/209.78 |- mesh__dateCreated mesh__D004164 1976-04-16
% 209.58/209.78 |- skos__altLabel mesh__D004164 Bisphosphonates
% 209.58/209.78 |- mesh__recordOriginator mesh__D004164 RLS
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D004164 sjn
% 209.58/209.78 |- mesh__dateEstablished mesh__D004164 1977-01-01
% 209.58/209.78 |- mesh__historyNote mesh__D004164 77
% 209.58/209.78 |- rdf__type mesh__D004164sskos__Concept
% 209.58/209.78 |- skos__prefLabel mesh__D004164 Diphosphonates
% 209.58/209.78 |- skos__broader mesh__D004164smesh__D009943
% 209.58/209.78 |- skos__historyNote mesh__D004164 Phosphonic Acids %28%1966-1976%29%
% 209.58/209.78 |- skos__historyNote mesh__D004164
% 209.58/209.78 Organophosphorus Compounds %28%1971-1976%29%
% 209.58/209.78 |- skos__prefLabel mesh__D014592 Uterine Hemorrhage
% 209.58/209.78 |- mesh__dateRevised mesh__D014592 2005-06-30
% 209.58/209.78 |- skos__hiddenLabel mesh__D014592 Uterine Bleedings
% 209.58/209.78 |- skos__annotation mesh__D014592
% 209.58/209.78 %22%vaginal bleeding%22% usually refers to uterine bleeding through the vagina %26% goes here but check text for bleeding from vaginal injuries, vaginal diseases, vaginal tumors, etc %28%index under proper VAGINA term%29%%A%
% 209.58/209.78 |- skos__hiddenLabel mesh__D014592 Uterine Hemorrhages
% 209.58/209.78 |- skos__altLabel mesh__D014592 Hemorrhage, Uterine
% 209.58/209.78 |- skos__broader mesh__D014592smesh__D014591
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D014592 sjn
% 209.58/209.78 |- rdf__type mesh__D014592sskos__Concept
% 209.58/209.78 |- skos__hiddenLabel mesh__D014592 Bleeding, Uterine
% 209.58/209.78 |- skos__broader mesh__D014592smesh__D006470
% 209.58/209.78 |- skos__altLabel mesh__D014592 Uterine Bleeding
% 209.58/209.78 |- mesh__recordMaintainer mesh__D014592 lkt
% 209.58/209.78 |- skos__related mesh__D014592smesh__D008796
% 209.58/209.78 |- skos__scopeNote mesh__D014592
% 209.58/209.78 Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.%A%
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D014592 2006
% 209.58/209.78 |- skos__related mesh__D014592smesh__D008595
% 209.58/209.78 |- mesh__recordOriginator mesh__D014592 NLM
% 209.58/209.78 |- mesh__dateCreated mesh__D014592 1999-01-01
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D008555 2006
% 209.58/209.78 |- skos__prefLabel mesh__D008555 Melitten
% 209.58/209.78 |- mesh__historyNote mesh__D008555
% 209.58/209.78 91%28%75%29%; was see under BEE VENOMS 1978-90; was see under VENOMS 1975-77%A%
% 209.58/209.78 |- mesh__dateEstablished mesh__D008555 1991-01-01
% 209.58/209.78 |- skos__annotation mesh__D008555
% 209.58/209.78 a bee venom; /antag permitted but consider also ANTIVENINS%A%
% 209.58/209.78 |- skos__scopeNote mesh__D008555
% 209.58/209.78 Basic polypeptide from the venom of the honey bee %28%Apis mellifera%29%; it contains 62 amino acids, has cytolytic properties, causes contracture of muscle, releases histamine and disrupts surface tension, probably due to lysis of cell and mitochondrial membranes. Synonyms: melittin; melliten.%A%
% 209.58/209.78 |- mesh__recordOriginator mesh__D008555 NLM
% 209.58/209.78 |- mesh__dateRevised mesh__D008555 2005-06-30
% 209.58/209.78 |- rdf__type mesh__D008555sskos__Concept
% 209.58/209.78 |- skos__altLabel mesh__D008555 Melittin
% 209.58/209.78 |- mesh__recordMaintainer mesh__D008555 ssb
% 209.58/209.78 |- skos__broader mesh__D008555smesh__D001514
% 209.58/209.78 |- skos__altLabel mesh__D008555 Mellitin
% 209.58/209.78 |- skos__historyNote mesh__D008555 Peptides %28%1973-1974%29%
% 209.58/209.78 |- skos__historyNote mesh__D008555 Bees %28%1973-1974%29%
% 209.58/209.78 |- skos__historyNote mesh__D008555 Venoms %28%1973-1974%29%
% 209.58/209.78 |- mesh__dateCreated mesh__D008555 1974-11-19
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D008555
% 209.58/209.78 91; was see under BEE VENOMS 1978-90; was see under VENOMS 1975-77%A%
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D008555 sjn
% 209.58/209.78 |- skos__historyNote mesh__D000572
% 209.58/209.78 Voluntary Health Agencies %28%1966-1974%29%
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D000572 PLS
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 1999
% 209.58/209.78 |- skos__hiddenLabel mesh__D000572 Association, American Heart
% 209.58/209.78 |- mesh__dateEstablished mesh__D000572 1991-01-01
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 2003
% 209.58/209.78 |- mesh__recordOriginator mesh__D000572 NLM
% 209.58/209.78 |- skos__annotation mesh__D000572
% 209.58/209.78 add UNITED STATES or specific state %28%NIM%29%: DF: AMERICAN HEART ASSOC CATALOG: use NAF entry%A%
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 1995
% 209.58/209.78 |- skos__historyNote mesh__D000572
% 209.58/209.78 Cardiovascular Diseases %28%1966-1974%29%
% 209.58/209.78 |- mesh__dateCreated mesh__D000572 1999-01-01
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 2004
% 209.58/209.78 |- skos__historyNote mesh__D000572 Heart Diseases %28%1966-1974%29%
% 209.58/209.78 |- skos__hiddenLabel mesh__D000572 Heart Associations, American
% 209.58/209.78 |- skos__hiddenLabel mesh__D000572 Heart Association, American
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 2000
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 2005
% 209.58/209.78 |- mesh__dateRevised mesh__D000572 1994-05-12
% 209.58/209.78 |- skos__prefLabel mesh__D000572 American Heart Association
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 1996
% 209.58/209.78 |- skos__scopeNote mesh__D000572
% 209.58/209.78 A voluntary organization concerned with the prevention and treatment of heart and vascular diseases.%A%
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 2001
% 209.58/209.78 |- mesh__historyNote mesh__D000572
% 209.58/209.78 91%28%75%29%; was see under VOLUNTARY HEALTH AGENCIES 1975-90
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 2006
% 209.58/209.78 |- skos__hiddenLabel mesh__D000572 Associations, American Heart
% 209.58/209.78 |- skos__hiddenLabel mesh__D000572 American Heart Associations
% 209.58/209.78 |- rdf__type mesh__D000572sskos__Concept
% 209.58/209.78 |- skos__historyNote mesh__D000572 Societies, Medical %28%1966-1974%29%
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 1997
% 209.58/209.78 |- mesh__onlineNote mesh__D000572
% 209.58/209.78 search VOLUNTARY HEALTH AGENCIES 1967-74
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 2002
% 209.58/209.78 |- skos__broader mesh__D000572smesh__D014837
% 209.58/209.78 |- mesh__recordMaintainer mesh__D000572 TGC
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D000572
% 209.58/209.78 91; was see under VOLUNTARY HEALTH AGENCIES 1975-90
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000572 1998
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018983 2003
% 209.58/209.78 |- rdf__type mesh__D018983sskos__Concept
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018983 2006
% 209.58/209.78 |- skos__hiddenLabel mesh__D018983 DNA Footprint
% 209.58/209.78 |- skos__hiddenLabel mesh__D018983 DNA Footprints
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D018983 96
% 209.58/209.78 |- skos__broader mesh__D018983smesh__D005821
% 209.58/209.78 |- skos__scopeNote mesh__D018983
% 209.58/209.78 A method for determining the sequence specificity of DNA-binding proteins. DNA footprinting utilizes a DNA damaging agent %28%either a chemical reagent or a nuclease%29% which cleaves DNA at every base pair. DNA cleavage is inhibited where the ligand binds to DNA. %28%from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%
% 209.58/209.78 |- mesh__historyNote mesh__D018983 96
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018983 2004
% 209.58/209.78 |- skos__broader mesh__D018983smesh__D023282
% 209.58/209.78 |- mesh__dateCreated mesh__D018983 1995-05-24
% 209.58/209.78 |- mesh__dateRevised mesh__D018983 2000-06-22
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018983 2001
% 209.58/209.78 |- skos__hiddenLabel mesh__D018983 Footprinting, DNA
% 209.58/209.78 |- mesh__dateEstablished mesh__D018983 1996-01-01
% 209.58/209.78 |- skos__hiddenLabel mesh__D018983 DNA Footprintings
% 209.58/209.78 |- skos__hiddenLabel mesh__D018983 Footprint, DNA
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018983 2002
% 209.58/209.78 |- skos__prefLabel mesh__D018983 DNA Footprinting
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018983 2005
% 209.58/209.78 |- skos__annotation mesh__D018983 DNA FINGERPRINTING is available
% 209.58/209.78 |- skos__hiddenLabel mesh__D018983 Footprintings, DNA
% 209.58/209.78 |- mesh__dateRevised mesh__D018185 1994-05-12
% 209.58/209.78 |- skos__broader mesh__D018185smesh__D018184
% 209.58/209.78 |- skos__annotation mesh__D018185
% 209.58/209.78 caused by a member of the Paramyxoviridae family; GEN or unspecified; prefer specifics%A%
% 209.58/209.78 |- mesh__recordOriginator mesh__D018185 AGS
% 209.58/209.78 |- mesh__historyNote mesh__D018185 94
% 209.58/209.78 |- mesh__dateCreated mesh__D018185 1993-06-04
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 2002
% 209.58/209.78 |- mesh__dateEstablished mesh__D018185 1994-01-01
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 1996
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 2003
% 209.58/209.78 |- skos__prefLabel mesh__D018185 Morbillivirus Infections
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D018185 PLS
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 1998
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 2005
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 1997
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 2004
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 2000
% 209.58/209.78 |- skos__hiddenLabel mesh__D018185 Infection, Morbillivirus
% 209.58/209.78 |- skos__scopeNote mesh__D018185
% 209.58/209.78 Infections with viruses of the genus MORBILLIVIRUS, family PARAMYXOVIRIDAE. Infections mainly cause acute disease in their hosts, although in some cases infection is persistent and leads to degenerative conditions.%A%
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 1999
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 2006
% 209.58/209.78 |- skos__altLabel mesh__D018185 Infections, Morbillivirus
% 209.58/209.78 |- mesh__recordMaintainer mesh__D018185 AGS
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D018185 94
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 2001
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D018185 1995
% 209.58/209.78 |- rdf__type mesh__D018185sskos__Concept
% 209.58/209.78 |- skos__hiddenLabel mesh__D018185 Morbillivirus Infection
% 209.58/209.78 |- mesh__historyNote mesh__D004963 75; was see under ESTRANES 1973-74
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 2006
% 209.58/209.78 |- skos__hiddenLabel mesh__D004963 19 Norandrostenes
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 1994
% 209.58/209.78 |- mesh__dateRevised mesh__D004963 1993-06-03
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 1999
% 209.58/209.78 |- mesh__recordMaintainer mesh__D004963 PLS
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 1995
% 209.58/209.78 |- skos__scopeNote mesh__D004963
% 209.58/209.78 Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds.%A%
% 209.58/209.78 |- skos__broader mesh__D004963smesh__D004962
% 209.58/209.78 |- mesh__dateCreated mesh__D004963 1999-01-01
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D004963 75; was see under ESTRANES 1973-74
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 2000
% 209.58/209.78 |- skos__annotation mesh__D004963 do not confuse with ESTRANES
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D004963 PLS
% 209.58/209.78 |- rdf__type mesh__D004963sskos__Concept
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 2003
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 2001
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 1996
% 209.58/209.78 |- skos__prefLabel mesh__D004963 Estrenes
% 209.58/209.78 |- mesh__recordOriginator mesh__D004963 NLM
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 2004
% 209.58/209.78 |- skos__altLabel mesh__D004963 19-Norandrostenes
% 209.58/209.78 |- skos__historyNote mesh__D004963 Estranes %28%1968-1974%29%
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 2002
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 1997
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 2005
% 209.58/209.78 |- mesh__dateEstablished mesh__D004963 1975-09-01
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004963 1998
% 209.58/209.78 |- mesh__onlineNote mesh__D004963 search ESTRANES 1973-74
% 209.58/209.78 |- skos__broader mesh__D002791Q000737smesh__D002791
% 209.58/209.78 |- mesh__preferredCombination mesh__D002791Q000737smesh__D002784Q000737
% 209.58/209.78 |- rdf__type mesh__D002791Q000737smesh__CompoundConcept
% 209.58/209.78 |- skos__annotation mesh__D004165 caused by Corynebacterium diphtheriae
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 2004
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 1997
% 209.58/209.78 |- skos__prefLabel mesh__D004165 Diphtheria
% 209.58/209.78 |- skos__broader mesh__D004165smesh__D003354
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 2002
% 209.58/209.78 |- skos__hiddenLabel mesh__D004165 Diphtherias
% 209.58/209.78 |- rdf__type mesh__D004165sskos__Concept
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 2005
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 1998
% 209.58/209.78 |- skos__scopeNote mesh__D004165
% 209.58/209.78 A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.%A%
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 2006
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 1999
% 209.58/209.78 |- mesh__dateRevised mesh__D004165 1995-05-25
% 209.58/209.78 |- mesh__recordMaintainer mesh__D004165 PLS
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 2000
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 2003
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 1996
% 209.58/209.78 |- mesh__dateCreated mesh__D004165 1999-01-01
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D004165 2001
% 209.58/209.78 |- mesh__recordOriginator mesh__D004165 NLM
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D004165 PLS
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 C4bC3bINA Cofactor
% 209.58/209.78 |- mesh__recordOriginator mesh__D050716 lkt
% 209.58/209.78 |- skos__altLabel mesh__D050716 Complement C3b-C4b Inactivator Cofactor
% 209.58/209.78 |- skos__altLabel mesh__D050716 Complement Component 4b-Binding Protein
% 209.58/209.78 |- mesh__historyNote mesh__D050716 2006
% 209.58/209.78 |- skos__historyNote mesh__D050716
% 209.58/209.78 Complement Inactivator Proteins %28%1981-2005%29%
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 C4b Binding Protein
% 209.58/209.78 |- skos__altLabel mesh__D050716 C4b-C3b Inactivator Cofactor
% 209.58/209.78 |- skos__broader mesh__D050716smesh__D003169
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 Complement C3b C4b Inactivator Cofactor
% 209.58/209.78 |- mesh__dateEstablished mesh__D050716 2006-01-01
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 Protein, Complement C4b-Binding
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 Complement C4b Binding Protein
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 Complement Component 4b Binding Protein
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D050716 2006
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D050716 sjn
% 209.58/209.78 |- skos__prefLabel mesh__D050716 Complement C4b-Binding Protein
% 209.58/209.78 |- skos__altLabel mesh__D050716 Complement 4b Binding Protein
% 209.58/209.78 |- skos__altLabel mesh__D050716 C4b-Binding Protein
% 209.58/209.78 |- mesh__dateCreated mesh__D050716 2005-06-30
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 Protein, C4b-Binding
% 209.58/209.78 |- skos__scopeNote mesh__D050716
% 209.58/209.78 A serum protein that regulates the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It binds as a cofactor to COMPLEMENT FACTOR I which then hydrolyzes the COMPLEMENT C4B in the CLASSICAL PATHWAY C3 CONVERTASE %28%C4bC2a%29%.%A%
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 C4b-Binding Protein, Complement
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D050716 2006
% 209.58/209.78 |- mesh__recordMaintainer mesh__D050716 lkt
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 C4b C3b Inactivator Cofactor
% 209.58/209.78 |- skos__hiddenLabel mesh__D050716 Cofactor, C4b-C3b Inactivator
% 209.58/209.78 |- skos__altLabel mesh__D050716 C4bC3bINA-Cofactor
% 209.58/209.78 |- rdf__type mesh__D050716sskos__Concept
% 209.58/209.78 |- mesh__recordMaintainer mesh__D014593 lkt
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D014593 67
% 209.58/209.78 |- skos__annotation mesh__D014593 check tags FEMALE and PREGNANCY
% 209.58/209.78 |- skos__altLabel mesh__D014593 Uterine Atony
% 209.58/209.78 |- skos__hiddenLabel mesh__D014593 Inertia, Uterine
% 209.58/209.78 |- mesh__recordOriginator mesh__D014593 NLM
% 209.58/209.78 |- skos__broader mesh__D014593smesh__D004420
% 209.58/209.78 |- mesh__historyNote mesh__D014593 67%28%64%29%
% 209.58/209.78 |- mesh__dateEstablished mesh__D014593 1967-01-01
% 209.58/209.78 |- mesh__dateRevised mesh__D014593 2005-06-30
% 209.58/209.78 |- rdf__type mesh__D014593sskos__Concept
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D014593 2006
% 209.58/209.78 |- skos__prefLabel mesh__D014593 Uterine Inertia
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D014593 sjn
% 209.58/209.78 |- mesh__dateCreated mesh__D014593 1999-01-01
% 209.58/209.78 |- skos__scopeNote mesh__D014593
% 209.58/209.78 Failure of the UTERUS to contract with normal strength, duration, and intervals during childbirth %28%LABOR, OBSTETRIC%29%. It is also called uterine atony.%A%
% 209.58/209.78 |- skos__hiddenLabel mesh__D014593 Atony, Uterine
% 209.58/209.78 |- skos__broader mesh__D019308Q000031smesh__D019308
% 209.58/209.78 |- mesh__preferredCombination mesh__D019308Q000031smesh__D010169
% 209.58/209.78 |- rdf__type mesh__D019308Q000031smesh__CompoundConcept
% 209.58/209.78 |- skos__altLabel mesh__D008556 Rosenthal-Melkerson Syndrome
% 209.58/209.78 |- skos__hiddenLabel mesh__D008556 Melkersson Rosenthal Syndrome
% 209.58/209.78 |- skos__altLabel mesh__D008556 Cheilitis Granulomatosa
% 209.58/209.78 |- skos__altLabel mesh__D008556 Syndrome, Melkerson Rosenthal
% 209.58/209.78 |- skos__hiddenLabel mesh__D008556
% 209.58/209.78 Granulomatous Cheilitis, Miescher-Melkersson-Rosenthal
% 209.58/209.78 |- skos__altLabel mesh__D008556
% 209.58/209.78 Cheilitis Granulomatosa, Facial Neuropathy, Orofacial Edema
% 209.58/209.78 |- mesh__dateRevised mesh__D008556 2001-07-25
% 209.58/209.78 |- skos__altLabel mesh__D008556 Melkersson Syndrome
% 209.58/209.78 |- mesh__recordOriginator mesh__D008556 NLM
% 209.58/209.78 |- skos__hiddenLabel mesh__D008556 Rosenthal Melkerson Syndrome
% 209.58/209.78 |- skos__altLabel mesh__D008556
% 209.58/209.78 Facial Neuropathy, Orofacial Edema, Cheilitis Granulomatosa
% 209.58/209.78 |- mesh__publicMeSHNote mesh__D008556 64
% 209.58/209.78 |- skos__altLabel mesh__D008556
% 209.58/209.78 Miescher-Melkersson-Rosenthal Granulomatous Cheilitis
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D008556 2005
% 209.58/209.78 |- skos__broader mesh__D008556smesh__D009059
% 209.58/209.78 |- skos__hiddenLabel mesh__D008556 Rosenthal Melkersson Syndrome
% 209.58/209.78 |- rdf__type mesh__D008556sskos__Concept
% 209.58/209.78 |- skos__altLabel mesh__D008556
% 209.58/209.78 Orofacial Edema, Facial Neuropathy, Cheilitis Granulomatosa
% 209.58/209.78 |- mesh__recordMaintainer mesh__D008556 ags
% 209.58/209.78 |- mesh__historyNote mesh__D008556 64%28%63%29%
% 209.58/209.78 |- mesh__dateCreated mesh__D008556 1999-01-01
% 209.58/209.78 |- skos__hiddenLabel mesh__D008556 Melkerson Rosenthal Syndrome
% 209.58/209.78 |- skos__altLabel mesh__D008556 Macrocheilia, Facial Palsy, Edema
% 209.58/209.78 |- mesh__dateEstablished mesh__D008556 1964-01-01
% 209.58/209.78 |- skos__hiddenLabel mesh__D008556
% 209.58/209.78 Cheilitis, Miescher-Melkersson-Rosenthal Granulomatous
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D008556 2004
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D008556 sjn
% 209.58/209.78 |- skos__altLabel mesh__D008556 Melkerson-Rosenthal Syndrome
% 209.58/209.78 |- skos__broader mesh__D008556smesh__D005155
% 209.58/209.78 |- skos__hiddenLabel mesh__D008556 Melkersson Rosenthal Miescher Syndrome
% 209.58/209.78 |- skos__altLabel mesh__D008556 Melkersson-Rosenthal-Miescher Syndrome
% 209.58/209.78 |- skos__prefLabel mesh__D008556 Melkersson-Rosenthal Syndrome
% 209.58/209.78 |- skos__altLabel mesh__D008556
% 209.58/209.78 Facial Neuropathy, Cheilitis Granulomatosa, Orofacial Edema
% 209.58/209.78 |- skos__hiddenLabel mesh__D008556
% 209.58/209.78 Miescher Melkersson Rosenthal Granulomatous Cheilitis
% 209.58/209.78 |- skos__scopeNote mesh__D008556
% 209.58/209.78 An idiopathic syndrome characterized by one or more of the following; recurrent orofacial swelling, relapsing facial paralysis, and fissured tongue %28%lingua plicata%29%. The onset is usually in childhood and relapses are common. Cheilitis granulomatosa is a monosymptomatic variant of this condition. %28%Dermatol Clin 1996 Apr;14%28%2%29%:371-9; Magalini %26% Magalini, Dictionary of Medical Syndromes, 4th ed, p531%29%%A%
% 209.58/209.78 |- skos__altLabel mesh__D008556
% 209.58/209.78 Orofacial Edema, Cheilitis Granulomatosa, Facial Neuropathy
% 209.58/209.78 |- skos__altLabel mesh__D008556 Rosenthal-Melkersson Syndrome
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D008556 2003
% 209.58/209.78 |- skos__altLabel mesh__D008556
% 209.58/209.78 Cheilitis Granulomatosa, Orofacial Edema, Facial Neuropathy
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D008556 2002
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D008556 2006
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 2001
% 209.58/209.78 |- skos__broader mesh__D000573smesh__D012954
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 2005
% 209.58/209.78 |- mesh__recordOriginator mesh__D000573 EC
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 2002
% 209.58/209.78 |- skos__annotation mesh__D000573
% 209.58/209.78 add UNITED STATES %28%NIM%29%; DF: AHA CATALOG: use NAF entry%A%
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 2006
% 209.58/209.78 |- rdf__type mesh__D000573sskos__Concept
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 1997
% 209.58/209.78 |- skos__prefLabel mesh__D000573 American Hospital Association
% 209.58/209.78 |- mesh__recordAuthorizer mesh__D000573 PLS
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 1998
% 209.58/209.78 |- skos__altLabel mesh__D000573 Association, American Hospital
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 1999
% 209.58/209.78 |- mesh__dateCreated mesh__D000573 1977-05-05
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 2003
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 2000
% 209.58/209.78 |- mesh__dateRevised mesh__D000573 1996-06-10
% 209.58/209.78 |- mesh__activeMeSHYear mesh__D000573 2004
% 209.58/209.78 |- mesh__dateEstablished mesh__D000573 1978-01-01
% 209.58/209.78 |- skos__scopeNote mesh__D000573
% 209.58/209.78 A professional society in the United States whose membership is composed of hospitals.%A%
% 209.58/209.78 |- mesh__historyNote mesh__D000573 78
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D000573 78
% 209.58/209.79 |- mesh__recordMaintainer mesh__D000573 KEV
% 209.58/209.79 |- skos__altLabel mesh__D018984 T-Cell Epitope
% 209.58/209.79 |- mesh__dateCreated mesh__D018984 1995-05-24
% 209.58/209.79 |- skos__altLabel mesh__D018984 T-Lymphocyte Epitopes
% 209.58/209.79 |- skos__prefLabel mesh__D018984 Epitopes, T-Lymphocyte
% 209.58/209.79 |- mesh__recordOriginator mesh__D018984 AGS
% 209.58/209.79 |- skos__hiddenLabel mesh__D018984 T Lymphocyte Epitopes
% 209.58/209.79 |- skos__hiddenLabel mesh__D018984 Epitope, T-Cell
% 209.58/209.79 |- skos__historyNote mesh__D018984 Epitopes %28%1983-1995%29%
% 209.58/209.79 |- skos__annotation mesh__D018984
% 209.58/209.79 sites on antigens recognized by T-lymphocytes; DF: note short X ref%A%
% 209.58/209.79 |- skos__hiddenLabel mesh__D018984 Epitope, T-Lymphocyte
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D018984 sjn
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D018984 96
% 209.58/209.79 |- rdf__type mesh__D018984sskos__Concept
% 209.58/209.79 |- skos__scopeNote mesh__D018984
% 209.58/209.79 Antigenic determinants recognized and bound by the T-cell receptor. Epitopes recognized by the T-cell receptor are often located in the inner, unexposed side of the antigen, and become accessible to the T-cell receptors after proteolytic processing of the antigen.%A%
% 209.58/209.79 |- skos__broader mesh__D018984smesh__D000939
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018984 2006
% 209.58/209.79 |- mesh__recordMaintainer mesh__D018984 ssb
% 209.58/209.79 |- skos__hiddenLabel mesh__D018984 Epitopes, T-Cell
% 209.58/209.79 |- skos__altLabel mesh__D018984 T-Cell Epitopes
% 209.58/209.79 |- skos__hiddenLabel mesh__D018984 T Cell Epitopes
% 209.58/209.79 |- mesh__dateEstablished mesh__D018984 1996-01-01
% 209.58/209.79 |- skos__altLabel mesh__D018984 T-Lymphocyte Epitope
% 209.58/209.79 |- skos__hiddenLabel mesh__D018984 T Lymphocyte Epitope
% 209.58/209.79 |- mesh__historyNote mesh__D018984 96
% 209.58/209.79 |- skos__hiddenLabel mesh__D018984 Epitopes, T Lymphocyte
% 209.58/209.79 |- mesh__dateRevised mesh__D018984 2005-06-30
% 209.58/209.79 |- skos__hiddenLabel mesh__D018984 T Cell Epitope
% 209.58/209.79 |- rdf__type mesh__D018186sskos__Concept
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018186 2005
% 209.58/209.79 |- skos__hiddenLabel mesh__D018186 Infection, Pneumovirus
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D018186 94
% 209.58/209.79 |- mesh__dateCreated mesh__D018186 1993-06-04
% 209.58/209.79 |- mesh__recordMaintainer mesh__D018186 sjn
% 209.58/209.79 |- skos__annotation mesh__D018186
% 209.58/209.79 caused by a RESPIROVIRUS; GEN or unspecified
% 209.58/209.79 |- mesh__historyNote mesh__D018186 94
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018186 2004
% 209.58/209.79 |- mesh__dateEstablished mesh__D018186 1994-01-01
% 209.58/209.79 |- skos__scopeNote mesh__D018186
% 209.58/209.79 Infections with viruses of the genus PNEUMOVIRUS, family PARAMYXOVIRIDAE. This includes RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, an important cause of respiratory disease in humans.%A%
% 209.58/209.79 |- skos__hiddenLabel mesh__D018186 Pneumovirus Infection
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018186 2003
% 209.58/209.79 |- mesh__dateRevised mesh__D018186 2001-08-03
% 209.58/209.79 |- skos__broader mesh__D018186smesh__D018184
% 209.58/209.79 |- skos__prefLabel mesh__D018186 Pneumovirus Infections
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D018186 sjn
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018186 2006
% 209.58/209.79 |- mesh__recordOriginator mesh__D018186 AGS
% 209.58/209.79 |- skos__altLabel mesh__D018186 Infections, Pneumovirus
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018186 2002
% 209.58/209.79 |- skos__scopeNote mesh__D004964
% 209.58/209.79 A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3-beta, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol.%A%
% 209.58/209.79 |- skos__broader mesh__D004964smesh__D045166
% 209.58/209.79 |- mesh__dateCreated mesh__D004964 1999-01-01
% 209.58/209.79 |- skos__prefLabel mesh__D004964 Estriol
% 209.58/209.79 |- mesh__dateRevised mesh__D004964 2005-06-30
% 209.58/209.79 |- rdf__type mesh__D004964sskos__Concept
% 209.58/209.79 |- skos__altLabel mesh__D004964 16-Hydroxyestradiol
% 209.58/209.79 |- skos__hiddenLabel mesh__D004964 16 Epiestriol
% 209.58/209.79 |- mesh__recordMaintainer mesh__D004964 exl
% 209.58/209.79 |- skos__hiddenLabel mesh__D004964 17 Epiestriol
% 209.58/209.79 |- skos__hiddenLabel mesh__D004964 16 Hydroxyestradiol
% 209.58/209.79 |- skos__hiddenLabel mesh__D004964 16,17 Epiestriol
% 209.58/209.79 |- skos__altLabel mesh__D004964 16-alpha-Hydroxy-Estradiol
% 209.58/209.79 |- mesh__recordOriginator mesh__D004964 NLM
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D004964 2006
% 209.58/209.79 |- skos__hiddenLabel mesh__D004964 16 alpha Hydroxy Estradiol
% 209.58/209.79 |- skos__broader mesh__D004964smesh__D004963
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D004964 sjn
% 209.58/209.79 |- mesh__recordOriginator mesh__D004166 NLM
% 209.58/209.79 |- skos__scopeNote mesh__D004166
% 209.58/209.79 An antitoxin produced against the toxin of CORYNEBACTERIUM DIPHTHERIAE that is used for the treatment of DIPHTHERIA.%A%
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D004166 sjn
% 209.58/209.79 |- rdf__type mesh__D004166sskos__Concept
% 209.58/209.79 |- skos__prefLabel mesh__D004166 Diphtheria Antitoxin
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D004166 2006
% 209.58/209.79 |- mesh__dateCreated mesh__D004166 1999-01-01
% 209.58/209.79 |- mesh__recordMaintainer mesh__D004166 ssb
% 209.58/209.79 |- skos__broader mesh__D004166smesh__D000992
% 209.58/209.79 |- mesh__dateRevised mesh__D004166 2005-06-30
% 209.58/209.79 |- skos__hiddenLabel mesh__D004166 Antitoxin, Diphtheria
% 209.58/209.79 |- mesh__dateEstablished mesh__D050717 2006-01-01
% 209.58/209.79 |- mesh__dateCreated mesh__D050717 2005-06-30
% 209.58/209.79 |- skos__hiddenLabel mesh__D050717 Retinoblastoma Like Protein 2
% 209.58/209.79 |- skos__altLabel mesh__D050717 Retinoblastoma Like Protein p130
% 209.58/209.79 |- skos__altLabel mesh__D050717 RBL2 Protein
% 209.58/209.79 |- mesh__historyNote mesh__D050717 2006%28%1994%29%
% 209.58/209.79 |- mesh__recordOriginator mesh__D050717 DRC
% 209.58/209.79 |- skos__scopeNote mesh__D050717
% 209.58/209.79 A negative regulator of the CELL CYCLE that undergoes PHOSPHORYLATION by CYCLIN-DEPENDENT KINASES. RBL2 contains a conserved pocket region that binds E2F4 TRANSCRIPTION FACTOR and E2F5 TRANSCRIPTION FACTOR. RBL2 also interacts with viral ONCOPROTEINS such as POLYOMAVIRUS TUMOR ANTIGENS; ADENOVIRUS E1A PROTEINS; and PAPILLOMAVIRUS E7 PROTEINS.%A%
% 209.58/209.79 |- mesh__recordMaintainer mesh__D050717 DRC
% 209.58/209.79 |- skos__broader mesh__D050717smesh__D009687
% 209.58/209.79 |- skos__broader mesh__D050717smesh__D010750
% 209.58/209.79 |- skos__broader mesh__D050717smesh__D025521
% 209.58/209.79 |- skos__altLabel mesh__D050717 Retinoblastoma-Like Protein 2
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D050717
% 209.58/209.79 2006; RETINOBLASTOMA-LIKE PROTEIN P130 was indexed under PROTEIN 2004-2005, under ADAPTOR PROTEINS 2004, under PHOSPHOPROTEINS 1996-2004, %26% under PROTEINS 1994-1995%A%
% 209.58/209.79 |- skos__hiddenLabel mesh__D050717 p130, Retinoblastoma-Like Protein
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D050717 2006
% 209.58/209.79 |- skos__prefLabel mesh__D050717 Retinoblastoma-Like Protein p130
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D050717 sjn
% 209.58/209.79 |- rdf__type mesh__D050717sskos__Concept
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Uterus Cancers
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Cancer, Uterine
% 209.58/209.79 |- skos__broader mesh__D014594smesh__D005833
% 209.58/209.79 |- skos__annotation mesh__D014594
% 209.58/209.79 fibroma = LEIOMYOMA %28%IM%29% + UTERINE NEOPLASMS %28%IM%29%; coord IM with histol type of neopl %28%IM%29%; UTERINE CERVICAL NEOPLASMS %26% ENDOMETRIAL NEOPLASMS are available%A%
% 209.58/209.79 |- skos__altLabel mesh__D014594 Neoplasms, Uterine
% 209.58/209.79 |- skos__altLabel mesh__D014594 Uterus Neoplasms
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D014594 sjn
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Uterine Neoplasm
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Neoplasm, Uterus
% 209.58/209.79 |- skos__scopeNote mesh__D014594 Tumors or cancer of the UTERUS.
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Uterus Neoplasm
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Uterine Cancers
% 209.58/209.79 |- skos__altLabel mesh__D014594 Uterine Cancer
% 209.58/209.79 |- skos__altLabel mesh__D014594 Neoplasms, Uterus
% 209.58/209.79 |- mesh__dateRevised mesh__D014594 2005-07-01
% 209.58/209.79 |- skos__altLabel mesh__D014594 Uterus Cancer
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Cancers, Uterus
% 209.58/209.79 |- mesh__recordOriginator mesh__D014594 NLM
% 209.58/209.79 |- skos__altLabel mesh__D014594 Cancer of the Uterus
% 209.58/209.79 |- skos__prefLabel mesh__D014594 Uterine Neoplasms
% 209.58/209.79 |- skos__broader mesh__D014594smesh__D014591
% 209.58/209.79 |- mesh__dateCreated mesh__D014594 1999-01-01
% 209.58/209.79 |- mesh__recordMaintainer mesh__D014594 sjn
% 209.58/209.79 |- rdf__type mesh__D014594sskos__Concept
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Cancer, Uterus
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Neoplasm, Uterine
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D014594 2006
% 209.58/209.79 |- skos__hiddenLabel mesh__D014594 Cancers, Uterine
% 209.58/209.79 |- skos__hiddenLabel mesh__D008557 Melorheostoses
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 2002
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 1999
% 209.58/209.79 |- skos__prefLabel mesh__D008557 Melorheostosis
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 2005
% 209.58/209.79 |- mesh__recordMaintainer mesh__D008557 TGC
% 209.58/209.79 |- skos__scopeNote mesh__D008557
% 209.58/209.79 A form of osteosclerosis or hyperostosis extending in a linear track through one of the long bones of an extremity, and consisting of proliferated ivory-like new bone. %22%Melo-%22% is from the Greek, limb and %22%-rheostosis%22% refers to streaks %28%rheo- from the Greek, flow%29%, in the bones. %28%Dorland, 27th ed%29%%A%
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 1996
% 209.58/209.79 |- skos__annotation mesh__D008557 a form of osteosclerosis
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 2006
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 2000
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 1997
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 1994
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 2003
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 2001
% 209.58/209.79 |- mesh__dateCreated mesh__D008557 1999-01-01
% 209.58/209.79 |- mesh__dateRevised mesh__D008557 1993-06-02
% 209.58/209.79 |- rdf__type mesh__D008557sskos__Concept
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 1995
% 209.58/209.79 |- mesh__recordOriginator mesh__D008557 NLM
% 209.58/209.79 |- skos__broader mesh__D008557smesh__D010026
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 2004
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008557 1998
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D008557 PLS
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 1996
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 2006
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 2000
% 209.58/209.79 |- rdf__type mesh__D000574sskos__Concept
% 209.58/209.79 |- skos__annotation mesh__D000574
% 209.58/209.79 add UNITED STATES %28%NIM%29%; DF: AMA CATALOG: use NAF entry%A%
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D000574 66
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 1997
% 209.58/209.79 |- mesh__historyNote mesh__D000574 66
% 209.58/209.79 |- mesh__dateRevised mesh__D000574 1992-03-25
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 2001
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 1998
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 1993
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 2002
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 1994
% 209.58/209.79 |- skos__prefLabel mesh__D000574 American Medical Association
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 1999
% 209.58/209.79 |- skos__scopeNote mesh__D000574
% 209.58/209.79 Professional society representing the field of medicine.%A%
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 2003
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 1995
% 209.58/209.79 |- mesh__recordMaintainer mesh__D000574 TAP
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D000574 PLS
% 209.58/209.79 |- skos__hiddenLabel mesh__D000574 Medical Association, American
% 209.58/209.79 |- skos__hiddenLabel mesh__D000574 Association, American Medical
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 2004
% 209.58/209.79 |- mesh__dateCreated mesh__D000574 1999-01-01
% 209.58/209.79 |- mesh__recordOriginator mesh__D000574 NLM
% 209.58/209.79 |- skos__broader mesh__D000574smesh__D012955
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000574 2005
% 209.58/209.79 |- mesh__dateEstablished mesh__D000574 1966-01-01
% 209.58/209.79 |- mesh__dateEstablished mesh__D018985 1996-01-01
% 209.58/209.79 |- skos__hiddenLabel mesh__D018985 Epitope, B-Lymphocyte
% 209.58/209.79 |- mesh__dateRevised mesh__D018985 2005-06-30
% 209.58/209.79 |- skos__historyNote mesh__D018985 Epitopes %28%1987-1995%29%
% 209.58/209.79 |- skos__hiddenLabel mesh__D018985 B Cell Epitope
% 209.58/209.79 |- skos__altLabel mesh__D018985 B-Lymphocyte Epitopes
% 209.58/209.79 |- skos__hiddenLabel mesh__D018985 B Lymphocyte Epitope
% 209.58/209.79 |- mesh__recordOriginator mesh__D018985 AGS
% 209.58/209.79 |- mesh__dateCreated mesh__D018985 1995-06-08
% 209.58/209.79 |- skos__altLabel mesh__D018985 B-Cell Epitopes
% 209.58/209.79 |- rdf__type mesh__D018985sskos__Concept
% 209.58/209.79 |- skos__broader mesh__D018985smesh__D000939
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018985 2006
% 209.58/209.79 |- skos__hiddenLabel mesh__D018985 Epitopes, B-Cell
% 209.58/209.79 |- skos__hiddenLabel mesh__D018985 B Lymphocyte Epitopes
% 209.58/209.79 |- skos__hiddenLabel mesh__D018985 Epitopes, B Lymphocyte
% 209.58/209.79 |- mesh__historyNote mesh__D018985 96
% 209.58/209.79 |- skos__hiddenLabel mesh__D018985 Epitope, B-Cell
% 209.58/209.79 |- skos__altLabel mesh__D018985 B-Cell Epitope
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D018985 sjn
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D018985 96
% 209.58/209.79 |- skos__scopeNote mesh__D018985
% 209.58/209.79 Antigenic determinants recognized and bound by the B-cell receptor. Epitopes recognized by the B-cell receptor are located on the surface of the antigen.%A%
% 209.58/209.79 |- skos__annotation mesh__D018985
% 209.58/209.79 sites on antigens recognized by B-lymphocytes; DF: note short X ref%A%
% 209.58/209.79 |- mesh__recordMaintainer mesh__D018985 ssb
% 209.58/209.79 |- skos__altLabel mesh__D018985 B-Lymphocyte Epitope
% 209.58/209.79 |- skos__hiddenLabel mesh__D018985 B Cell Epitopes
% 209.58/209.79 |- skos__prefLabel mesh__D018985 Epitopes, B-Lymphocyte
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 1994
% 209.58/209.79 |- skos__scopeNote mesh__D018187
% 209.58/209.79 A psychological theory based on dimensions or categories used by a given person in describing or explaining the personality and behavior of others or of himself. The basic idea is that different people will use consistently different categories. The theory was formulated in the fifties by George Kelly. Two tests devised by him are the role construct repertory test and the repertory grid test. %28%From Stuart Sutherland, The International Dictionary of Psychology, 1989%29%%A%
% 209.58/209.79 |- skos__hiddenLabel mesh__D018187 Theories, Personal Construct
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 2002
% 209.58/209.79 |- mesh__historyNote mesh__D018187 94
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 1997
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 2004
% 209.58/209.79 |- skos__hiddenLabel mesh__D018187 Construct Theories, Personal
% 209.58/209.79 |- skos__hiddenLabel mesh__D018187 Theory, Personal Construct
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D018187 94
% 209.58/209.79 |- skos__hiddenLabel mesh__D018187 Construct Theory, Personal
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 1996
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 2003
% 209.58/209.79 |- mesh__dateCreated mesh__D018187 1993-06-02
% 209.58/209.79 |- skos__annotation mesh__D018187
% 209.58/209.79 no qualif; includes personal construct, personal construct method, personal construct organization, etc.; for personal construct ther, coord IM with PSYCHOTHERAPY %28%IM%29%%A%
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 2006
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 2001
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 1999
% 209.58/209.79 |- mesh__dateEstablished mesh__D018187 1994-01-01
% 209.58/209.79 |- skos__broader mesh__D018187smesh__D011582
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 2000
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 1995
% 209.58/209.79 |- skos__hiddenLabel mesh__D018187 Personal Construct Theories
% 209.58/209.79 |- rdf__type mesh__D018187sskos__Concept
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 1998
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D018187 2005
% 209.58/209.79 |- skos__prefLabel mesh__D018187 Personal Construct Theory
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D004965 2006
% 209.58/209.79 |- skos__related mesh__D004965smesh__D004967
% 209.58/209.79 |- skos__broader mesh__D004965smesh__D020847
% 209.58/209.79 |- mesh__recordMaintainer mesh__D004965 lkt
% 209.58/209.79 |- skos__prefLabel mesh__D004965 Estrogen Antagonists
% 209.58/209.79 |- mesh__dateRevised mesh__D004965 2003-07-09
% 209.58/209.79 |- rdf__type mesh__D004965sskos__Concept
% 209.58/209.79 |- skos__historyNote mesh__D004965 specific estrogen %28%1966-1977%29%
% 209.58/209.79 |- skos__hiddenLabel mesh__D004965 Antagonists, Estrogen
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D004965 78
% 209.58/209.79 |- mesh__recordOriginator mesh__D004965 RLS
% 209.58/209.79 |- mesh__dateCreated mesh__D004965 1999-11-08
% 209.58/209.79 |- skos__related mesh__D004965smesh__D020847
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D004965 2004
% 209.58/209.79 |- skos__scopeNote mesh__D004965
% 209.58/209.79 Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.%A%
% 209.58/209.79 |- mesh__dateEstablished mesh__D004965 1978-01-01
% 209.58/209.79 |- skos__historyNote mesh__D004965 Estrogens %28%1966-1977%29%
% 209.58/209.79 |- mesh__historyNote mesh__D004965 78
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D004965 2005
% 209.58/209.79 |- skos__annotation mesh__D004965
% 209.58/209.79 DF: ESTROGEN ANTAG; do not confuse with ANTIESTROGENS see ESTROGEN RECEPT MODULATORS%A%
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D004965 sjn
% 209.58/209.79 |- skos__historyNote mesh__D037341 Mycotoxins %28%1992-1997%29%
% 209.58/209.79 |- mesh__dateCreated mesh__D037341 2002-07-03
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D037341 2003
% 209.58/209.79 |- rdf__type mesh__D037341sskos__Concept
% 209.58/209.79 |- mesh__dateEstablished mesh__D037341 2003-01-01
% 209.58/209.79 |- mesh__historyNote mesh__D037341 2003
% 209.58/209.79 |- skos__scopeNote mesh__D037341
% 209.58/209.79 A group of MYCOTOXINS found in CORN contaminated with FUSARIUM fungus. They are chains of about 20 carbons with acidic ester, acetylamino and sometimes other substituents. They inhibit ceramide synthetase conversion of SPHINGOLIPIDS to CERAMIDES.%A%
% 209.58/209.79 |- mesh__recordOriginator mesh__D037341 ssb
% 209.58/209.79 |- mesh__recordMaintainer mesh__D037341 ssb
% 209.58/209.79 |- skos__broader mesh__D037341smesh__D009183
% 209.58/209.79 |- skos__historyNote mesh__D037341 Carboxylic Acids %28%1992-2002%29%
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D037341 sjn
% 209.58/209.79 |- skos__prefLabel mesh__D037341 Fumonisins
% 209.58/209.79 |- mesh__dateRevised mesh__D037341 2005-06-30
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D037341 2006
% 209.58/209.79 |- skos__broader mesh__D037341smesh__D000473
% 209.58/209.79 |- mesh__dateCreated mesh__D004167 1999-01-01
% 209.58/209.79 |- mesh__dateRevised mesh__D004167 2005-07-20
% 209.58/209.79 |- skos__annotation mesh__D004167
% 209.58/209.79 /antag permitted but consider also DIPHTHERIA ANTITOXIN
% 209.58/209.79 |- skos__scopeNote mesh__D004167
% 209.58/209.79 An ADP-ribosylating EXOTOXIN produced by CORYNEBACTERIUM DIPHTHERIAE that causes the signs and symptoms of DIPHTHERIA. It can be broken into two unequal domains: the smaller, catalytic A domain is the lethal moiety and contains mono ADPribose transferase which transfers ADP RIBOSE to PEPTIDE ELONGATION FACTOR 2 thereby inhibiting protein synthesis; and the larger B domain that is needed for entry into cells.%A%
% 209.58/209.79 |- mesh__recordMaintainer mesh__D004167 ags
% 209.58/209.79 |- skos__altLabel mesh__D004167 Toxin, Corynebacterium Diphtheriae
% 209.58/209.79 |- skos__altLabel mesh__D004167 Corynebacterium Diphtheriae Toxin
% 209.58/209.79 |- skos__prefLabel mesh__D004167 Diphtheria Toxin
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D004167 2006A
% 209.58/209.79 |- rdf__type mesh__D004167sskos__Concept
% 209.58/209.79 |- mesh__recordOriginator mesh__D004167 NLM
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D004167 2006
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D004167 ags
% 209.58/209.79 |- skos__broader mesh__D004167smesh__D001427
% 209.58/209.79 |- skos__broader mesh__D004167smesh__D036002
% 209.58/209.79 |- skos__broader mesh__D009650smesh__D009654
% 209.58/209.79 |- rdf__type mesh__D009650sskos__Concept
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 2003
% 209.58/209.79 |- mesh__dateEstablished mesh__D009650 1974-01-01
% 209.58/209.79 |- skos__scopeNote mesh__D009650
% 209.58/209.79 Pregnanes which have undergone ring contractions or are lacking carbon-18 or carbon-19. Unsaturation in the steroid ring system is not included.%A%
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 1998
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 2000
% 209.58/209.79 |- skos__annotation mesh__D009650 do not confuse with NORPREGNENES
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D009650 74
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 2004
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 1999
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 1994
% 209.58/209.79 |- mesh__historyNote mesh__D009650 74
% 209.58/209.79 |- mesh__dateCreated mesh__D009650 1999-01-01
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 2001
% 209.58/209.79 |- mesh__recordMaintainer mesh__D009650 PLS
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 1995
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 2005
% 209.58/209.79 |- mesh__recordOriginator mesh__D009650 NLM
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 2002
% 209.58/209.79 |- skos__prefLabel mesh__D009650 Norpregnanes
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D009650 PLS
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 2006
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 1996
% 209.58/209.79 |- mesh__dateRevised mesh__D009650 1993-06-03
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D009650 1997
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D023321 2001
% 209.58/209.79 |- mesh__recordMaintainer mesh__D023321 ssb
% 209.58/209.79 |- skos__hiddenLabel mesh__D023321 Vaccines, Poliovirus
% 209.58/209.79 |- skos__prefLabel mesh__D023321 Poliovirus Vaccines
% 209.58/209.79 |- mesh__recordOriginator mesh__D023321 ags
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D023321 2006
% 209.58/209.79 |- skos__scopeNote mesh__D023321
% 209.58/209.79 Vaccines used to prevent POLIOMYELITIS. They include inactivated %28%POLIOVIRUS VACCINE, INACTIVATED%29% and oral vaccines %28%POLIOVIRUS VACCINE, ORAL%29%.%A%
% 209.58/209.79 |- skos__broader mesh__D023321smesh__D014765
% 209.58/209.79 |- mesh__historyNote mesh__D023321 2001
% 209.58/209.79 |- rdf__type mesh__D023321sskos__Concept
% 209.58/209.79 |- mesh__dateRevised mesh__D023321 2005-06-30
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D023321 sjn
% 209.58/209.79 |- mesh__dateEstablished mesh__D023321 2001-01-01
% 209.58/209.79 |- mesh__dateCreated mesh__D023321 2000-06-22
% 209.58/209.79 |- skos__scopeNote mesh__D050718
% 209.58/209.79 An endogenous serine protease inhibitor %28%SERPINS%29%. It is a 105-kDA plasma glycoprotein, encoded by C1NH gene and produced primarily by the liver and monocytes. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from hereditary ANGIONEUROTIC EDEMA.%A%
% 209.58/209.79 |- skos__hiddenLabel mesh__D050718 C1 Inhibitor Protein
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D050718 sjn
% 209.58/209.79 |- skos__broader mesh__D050718smesh__D003174
% 209.58/209.79 |- skos__altLabel mesh__D050718 C1-INH Protein
% 209.58/209.79 |- mesh__dateEstablished mesh__D050718 2006-01-01
% 209.58/209.79 |- skos__altLabel mesh__D050718 Complement C1-Inhibitor Protein
% 209.58/209.79 |- mesh__dateCreated mesh__D050718 2005-06-30
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D050718 2006
% 209.58/209.79 |- skos__altLabel mesh__D050718 C1-Inhibitor Protein
% 209.58/209.79 |- skos__altLabel mesh__D050718 Plasma Protease C1 Inhibitor
% 209.58/209.79 |- skos__prefLabel mesh__D050718 Complement C1 Inhibitor Protein
% 209.58/209.79 |- skos__hiddenLabel mesh__D050718 C1 INH Protein
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D050718 2006
% 209.58/209.79 |- mesh__recordMaintainer mesh__D050718 lkt
% 209.58/209.79 |- skos__historyNote mesh__D050718
% 209.58/209.79 Complement C1 Inactivator Proteins %28%1970-2005%29%
% 209.58/209.79 |- skos__hiddenLabel mesh__D050718 Protein, Complement C1-Inhibitor
% 209.58/209.79 |- mesh__historyNote mesh__D050718 2006
% 209.58/209.79 |- rdf__type mesh__D050718sskos__Concept
% 209.58/209.79 |- skos__hiddenLabel mesh__D050718 Protein, C1-INH
% 209.58/209.79 |- mesh__recordOriginator mesh__D050718 lkt
% 209.58/209.79 |- skos__annotation mesh__D050718
% 209.58/209.79 do not confuse with COMPLEMENT C1 INACTIVATOR PROTEINS
% 209.58/209.79 |- skos__hiddenLabel mesh__D050718 Protein, C1-Inhibitor
% 209.58/209.79 |- skos__prefLabel mesh__D014595 Uterine Perforation
% 209.58/209.79 |- skos__hiddenLabel mesh__D014595 Perforation, Uterine
% 209.58/209.79 |- skos__broader mesh__D014595smesh__D014597
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D014595 sjn
% 209.58/209.79 |- skos__scopeNote mesh__D014595
% 209.58/209.79 A hole or break through the wall of the UTERUS, usually made by the placement of an instrument or INTRAUTERINE DEVICES.%A%
% 209.58/209.79 |- mesh__dateEstablished mesh__D014595 1991-01-01
% 209.58/209.79 |- mesh__dateCreated mesh__D014595 1974-11-11
% 209.58/209.79 |- rdf__type mesh__D014595sskos__Concept
% 209.58/209.79 |- mesh__historyNote mesh__D014595
% 209.58/209.79 91%28%75%29%; was see under UTERINE RUPTURE 1975-90
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D014595 2006
% 209.58/209.79 |- skos__hiddenLabel mesh__D014595 Perforations, Uterine
% 209.58/209.79 |- mesh__recordOriginator mesh__D014595 NLM
% 209.58/209.79 |- mesh__recordMaintainer mesh__D014595 lkt
% 209.58/209.79 |- skos__hiddenLabel mesh__D014595 Uterine Perforations
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D014595
% 209.58/209.79 91; was see under UTERINE RUPTURE 1975-90
% 209.58/209.79 |- mesh__dateRevised mesh__D014595 2005-06-30
% 209.58/209.79 |- skos__altLabel mesh__D008558 Phenylalanine Mustard
% 209.58/209.79 |- skos__prefLabel mesh__D008558 Melphalan
% 209.58/209.79 |- mesh__dateRevised mesh__D008558 2005-06-30
% 209.58/209.79 |- mesh__recordOriginator mesh__D008558 NLM
% 209.58/209.79 |- mesh__recordMaintainer mesh__D008558 ssb
% 209.58/209.79 |- skos__altLabel mesh__D008558
% 209.58/209.79 4-%28%Bis%28%2-chloroethyl%29%amino%29%phenylalanine
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D008558 2006
% 209.58/209.79 |- skos__hiddenLabel mesh__D008558 Mustard, Phenylalanine
% 209.58/209.79 |- skos__scopeNote mesh__D008558
% 209.58/209.79 An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.%A%
% 209.58/209.79 |- mesh__dateCreated mesh__D008558 1999-01-01
% 209.58/209.79 |- skos__broader mesh__D008558smesh__D010649
% 209.58/209.79 |- skos__altLabel mesh__D008558 L-PAM
% 209.58/209.79 |- rdf__type mesh__D008558sskos__Concept
% 209.58/209.79 |- mesh__publicMeSHNote mesh__D008558
% 209.58/209.79 PEPTICHEMIO was see under NITROGEN MUSTARD COMPOUNDS 1975-80%A%
% 209.58/209.79 |- mesh__recordAuthorizer mesh__D008558 sjn
% 209.58/209.79 |- skos__altLabel mesh__D008558 Sarcolysine
% 209.58/209.79 |- skos__altLabel mesh__D008558 Merphalan
% 209.58/209.79 |- skos__broader mesh__D008558smesh__D009588
% 209.58/209.79 |- skos__hiddenLabel mesh__D000575 Nurses%27% Association, American
% 209.58/209.79 |- mesh__recordMaintainer mesh__D000575 TAP
% 209.58/209.79 |- skos__prefLabel mesh__D000575 American Nurses%27% Association
% 209.58/209.79 |- mesh__recordOriginator mesh__D000575 NLM
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000575 1997
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000575 2002
% 209.58/209.79 |- mesh__dateRevised mesh__D000575 1992-03-25
% 209.58/209.79 |- mesh__activeMeSHYear mesh__D000575 2006
% 209.58/209.79 |- rdf__type mesh__D000575sskos__Concept
% 209.58/209.80 |- skos__scopeNote mesh__D000575
% 209.58/209.80 Professional society representing the field of nursing.%A%
% 209.58/209.80 |- mesh__historyNote mesh__D000575 67%28%65%29%
% 209.58/209.80 |- mesh__activeMeSHYear mesh__D000575 2001
% 209.58/209.80 |- mesh__activeMeSHYear mesh__D000575 1996
% 209.58/209.80 |- mesh__activeMeSHYear mesh__D000575 1995
% 209.58/209.80 |- skos__hiddenLabel mesh__D000575 Associations, American Nurses%27%
% 209.58/209.80 |- skos__broader mesh__D000575smesh__D012956
% 209.58/209.80 |- skos__annotation mesh__D000575
% 209.58/209.80 add UNITED STATES %28%NIM%29%; DF: ANA CATALOG: use NAF entry%A%
% 209.58/209.80 |- skos__hiddenLabel mesh__D000575 Association, American Nurses%27%
% 209.58/209.80 |- mesh__activeMeSHYear mesh__D000575 2005
% 209.58/209.80 |- skos__hiddenLabel mesh__D000575 American Nurses%27% Associations
% 209.58/209.80 |- mesh__dateCreated mesh__D000575 1999-01-01
% 209.58/209.80 |- mesh__activeMeSHYear mesh__D000575 2000
% 209.58/209.80 |- mesh__activeMeSHYear mesh__D000575 1994
% 209.58/209.80 |- mesh__recordAuthorizer mesh__D000575 PLS
% 209.58/209.80 |- mesh__activeMeSHYear mesh__D000575 2004
% 209.58/209.80 |- mesh__activeMeSHYear mesh__D000575 1999
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D000575 67
% 209.65/209.80 |- skos__hiddenLabel mesh__D000575 American Nurses Association
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D000575 1993
% 209.65/209.80 |- mesh__dateEstablished mesh__D000575 1967-01-01
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D000575 2003
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D000575 1998
% 209.65/209.80 |- skos__hiddenLabel mesh__D000575 Nurses%27% Associations, American
% 209.65/209.80 |- mesh__recordOriginator mesh__D019280 JLS
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019280 2006
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Syndrome, BOR
% 209.65/209.80 |- skos__broader mesh__D019280smesh__D000015
% 209.65/209.80 |- skos__altLabel mesh__D019280 BOR Syndrome
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Syndrome, Branchio-Oculo-Facial
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Branchio Otorenal Syndrome
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Dysplasias, Branchio-Otorenal
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019280 2003
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Branchio-Oculo-Facial Syndromes
% 209.65/209.80 |- rdf__type mesh__D019280sskos__Concept
% 209.65/209.80 |- skos__broader mesh__D019280smesh__D025063
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019280 2002
% 209.65/209.80 |- skos__historyNote mesh__D019280
% 209.65/209.80 Chromosome Abnormalities %28%1966-1996%29%
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019280 2004
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Syndromes, BOR
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Syndrome, Branchio-Otorenal
% 209.65/209.80 |- mesh__dateCreated mesh__D019280 1996-06-10
% 209.65/209.80 |- skos__altLabel mesh__D019280 Branchio-Otorenal Syndrome
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Branchio-Otorenal Syndromes
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Syndromes, Branchio-Otorenal
% 209.65/209.80 |- skos__historyNote mesh__D019280
% 209.65/209.80 Abnormalities, Multiple %28%1966-1996%29%
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D019280 97
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D019280 sjn
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Syndromes, Branchio-Oto-Renal
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Syndromes, Branchio-Oculo-Facial
% 209.65/209.80 |- mesh__dateRevised mesh__D019280 2001-07-25
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 BOR Syndromes
% 209.65/209.80 |- skos__annotation mesh__D019280
% 209.65/209.80 multiple abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: note short X ref%A%
% 209.65/209.80 |- mesh__recordMaintainer mesh__D019280 nns
% 209.65/209.80 |- mesh__dateEstablished mesh__D019280 1997-01-01
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Branchio Oculo Facial Syndrome
% 209.65/209.80 |- skos__scopeNote mesh__D019280
% 209.65/209.80 An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to Mondini type cochlear defect and stapes fixation. %28%Jablonski%27%s Dictionary of Syndromes %26% Eponymic Diseases, 2d ed%29%%A%
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Dysplasia, Branchio-Otorenal
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Branchio Otorenal Dysplasia
% 209.65/209.80 |- skos__prefLabel mesh__D019280 Branchio-Oto-Renal Syndrome
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019280 2005
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Branchio-Oto-Renal Syndromes
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Branchio Oto Renal Syndrome
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Syndrome, Branchio-Oto-Renal
% 209.65/209.80 |- mesh__historyNote mesh__D019280 97
% 209.65/209.80 |- skos__hiddenLabel mesh__D019280 Branchio-Otorenal Dysplasias
% 209.65/209.80 |- skos__altLabel mesh__D019280 Branchio-Otorenal Dysplasia
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D005260 sjn
% 209.65/209.80 |- mesh__historyNote mesh__D005260 1966; for FEMALES use WOMEN 1978-2005
% 209.65/209.80 |- skos__annotation mesh__D005260
% 209.65/209.80 check tag only for female organs, diseases, physiol processes, genetics, etc.; do not confuse with WOMEN as a social, cultural, political, economic force; Manual 18.9+, 34.12; 35.6.2 CATALOG: do not use: for indexers only%A%
% 209.65/209.80 |- skos__prefLabel mesh__D005260 Female
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D005260 2006
% 209.65/209.80 |- mesh__recordOriginator mesh__D005260 NLM
% 209.65/209.80 |- mesh__dateRevised mesh__D005260 2005-06-30
% 209.65/209.80 |- mesh__dateCreated mesh__D005260 1999-01-01
% 209.65/209.80 |- mesh__recordMaintainer mesh__D005260 ags
% 209.65/209.80 |- skos__altLabel mesh__D005260 Females
% 209.65/209.80 |- skos__hiddenLabel mesh__D018986 Motor Vehicle
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D018986 sjn
% 209.65/209.80 |- skos__broader mesh__D018986smesh__D014186
% 209.65/209.80 |- skos__scopeNote mesh__D018986
% 209.65/209.80 AUTOMOBILES, trucks, buses, or similar engine-driven conveyances. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%
% 209.65/209.80 |- mesh__dateCreated mesh__D018986 1995-06-20
% 209.65/209.80 |- skos__related mesh__D018986smesh__D000063
% 209.65/209.80 |- skos__historyNote mesh__D018986 Transportation %28%1966-1995%29%
% 209.65/209.80 |- skos__hiddenLabel mesh__D018986 Vehicle, Motor
% 209.65/209.80 |- mesh__dateEstablished mesh__D018986 1996-01-01
% 209.65/209.80 |- mesh__dateRevised mesh__D018986 2005-06-30
% 209.65/209.80 |- skos__historyNote mesh__D018986 specific vehicles %28%1966-1995%29%
% 209.65/209.80 |- mesh__recordOriginator mesh__D018986 JLS
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D018986 96
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018986 2006
% 209.65/209.80 |- rdf__type mesh__D018986sskos__Concept
% 209.65/209.80 |- skos__prefLabel mesh__D018986 Motor Vehicles
% 209.65/209.80 |- mesh__recordMaintainer mesh__D018986 ssb
% 209.65/209.80 |- mesh__historyNote mesh__D018986 96
% 209.65/209.80 |- skos__hiddenLabel mesh__D018986 Truck
% 209.65/209.80 |- skos__altLabel mesh__D018986 Vehicles, Motor
% 209.65/209.80 |- skos__annotation mesh__D018986
% 209.65/209.80 general or unspecified; prefer specific indentions
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 2001
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 1996
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 2003
% 209.65/209.80 |- skos__annotation mesh__D018188 caused by a picornavirus
% 209.65/209.80 |- skos__scopeNote mesh__D018188
% 209.65/209.80 Infections caused by viruses of the genus CARDIOVIRUS, family PICORNAVIRIDAE.%A%
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 2000
% 209.65/209.80 |- skos__hiddenLabel mesh__D018188 Infection, Cardiovirus
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 1999
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 2006
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 1995
% 209.65/209.80 |- rdf__type mesh__D018188sskos__Concept
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 1998
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 2005
% 209.65/209.80 |- skos__prefLabel mesh__D018188 Cardiovirus Infections
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 2002
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 1994
% 209.65/209.80 |- skos__hiddenLabel mesh__D018188 Cardiovirus Infection
% 209.65/209.80 |- skos__broader mesh__D018188smesh__D010850
% 209.65/209.80 |- mesh__dateCreated mesh__D018188 1993-06-04
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D018188 94
% 209.65/209.80 |- mesh__historyNote mesh__D018188 94
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 1997
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018188 2004
% 209.65/209.80 |- mesh__dateEstablished mesh__D018188 1994-01-01
% 209.65/209.80 |- skos__altLabel mesh__D018188 Infections, Cardiovirus
% 209.65/209.80 |- mesh__recordMaintainer mesh__D004966 exl
% 209.65/209.80 |- skos__altLabel mesh__D004966 Conjugated Estrogens
% 209.65/209.80 |- skos__altLabel mesh__D004966 Wyeth Brand of Estrogens, Conjugated
% 209.65/209.80 |- skos__altLabel mesh__D004966 Almirall Brand of Estrogens, Conjugated
% 209.65/209.80 |- mesh__recordOriginator mesh__D004966 NLM
% 209.65/209.80 |- skos__altLabel mesh__D004966 Climopax
% 209.65/209.80 |- skos__altLabel mesh__D004966 Climarest
% 209.65/209.80 |- skos__hiddenLabel mesh__D004966 Equine Estrogens, Conjugated
% 209.65/209.80 |- skos__hiddenLabel mesh__D004966 Conjugated Estrogenic Hormones
% 209.65/209.80 |- skos__altLabel mesh__D004966 Transannon
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D004966 sjn
% 209.65/209.80 |- skos__altLabel mesh__D004966 Estrogenic Substances, Conjugated
% 209.65/209.80 |- skos__scopeNote mesh__D004966
% 209.65/209.80 A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate %28%52-62%25%%29% and equilin sulfate %28%22-30%25%%29% with a total of the two between 80-88%25%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.%A%
% 209.65/209.80 |- skos__altLabel mesh__D004966 Trianon Brand of Estrogens, Conjugated
% 209.65/209.80 |- skos__altLabel mesh__D004966 Solvay Brand of Estrogens, Conjugated
% 209.65/209.80 |- skos__altLabel mesh__D004966 Progens
% 209.65/209.80 |- skos__altLabel mesh__D004966 Oestrofeminal
% 209.65/209.80 |- skos__prefLabel mesh__D004966 Estrogens, Conjugated %28%USP%29%
% 209.65/209.80 |- skos__altLabel mesh__D004966 ASTA Medica Brand of Estrogens, Conjugated
% 209.65/209.80 |- skos__altLabel mesh__D004966 Estrogenic Hormones, Conjugated
% 209.65/209.80 |- skos__altLabel mesh__D004966 Duramed Brand of Estrogens, Conjugated
% 209.65/209.80 |- mesh__historyNote mesh__D004966
% 209.65/209.80 2004 %28%1973%29%; for CENESTIN use ESTROGENS, CONJUGATED %28%NM%29% 1999-2002%A%
% 209.65/209.80 |- skos__altLabel mesh__D004966 Prelestrin
% 209.65/209.80 |- skos__altLabel mesh__D004966 Femavit
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D004966 2006
% 209.65/209.80 |- mesh__dateCreated mesh__D004966 1999-01-01
% 209.65/209.80 |- skos__altLabel mesh__D004966 Estrogens, Conjugated
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D004966
% 209.65/209.80 2004; see ESTROGENS, CONJUGATED 1994-2003, see ESTROGENIC SUBSTANCES, CONJUGATED 1973-1993; CENESTIN was indexed under ESTROGENS, CONJUGATED 1999-2002; PRESOMEN was indexed under ESTROGENIC SUBSTANCES, CONJUGATED 1987-1998; for PREMARIN see PREMARIN 1991-1993, see ESTROGENIC SUBSTANCES, CONJUGATED 1975-1990%A%
% 209.65/209.80 |- mesh__dateRevised mesh__D004966 2005-06-30
% 209.65/209.80 |- skos__broader mesh__D004966smesh__D045166
% 209.65/209.80 |- rdf__type mesh__D004966sskos__Concept
% 209.65/209.80 |- skos__hiddenLabel mesh__D004966 Conjugated Estrogenic Substances
% 209.65/209.80 |- skos__annotation mesh__D004966
% 209.65/209.80 do not confuse with ESTRADIOL CONGENERS
% 209.65/209.80 |- skos__hiddenLabel mesh__D037342 Pertussis Toxin, IAP
% 209.65/209.80 |- skos__hiddenLabel mesh__D037342 Islets Activating Protein
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D037342 ags
% 209.65/209.80 |- skos__broader mesh__D037342smesh__D036002
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D037342 2006
% 209.65/209.80 |- skos__altLabel mesh__D037342 IAP Pertussis Toxin
% 209.65/209.80 |- skos__historyNote mesh__D037342
% 209.65/209.80 Virulence Factors, Bordetella %28%1977-2002%29%
% 209.65/209.80 |- skos__hiddenLabel mesh__D037342 Histamine Sensitizing Factor
% 209.65/209.80 |- skos__altLabel mesh__D037342 Pertussigen
% 209.65/209.80 |- skos__broader mesh__D037342smesh__D010566
% 209.65/209.80 |- skos__hiddenLabel mesh__D037342 Toxin, IAP Pertussis
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D037342
% 209.65/209.80 2003; see PERTUSSIS TOXINS 1986-2002; for PERTUSSIGEN, ISLET-ACTIVATING PROTEIN, IAP PERTUSSIS TOXIN, and HISTAMINE-SENSITIZING FACTOR see PERTUSSIS TOXINS 1986-2002%A%
% 209.65/209.80 |- mesh__recordMaintainer mesh__D037342 ags
% 209.65/209.80 |- rdf__type mesh__D037342sskos__Concept
% 209.65/209.80 |- mesh__historyNote mesh__D037342
% 209.65/209.80 2003; use VIRULENCE FACTORS, BORDETELLA 1986-2002; for PERTUSSIGEN, ISLET-ACTIVATING PROTEIN, IAP PERTUSSIS TOXIN, and HISTAMINE-SENSITIZING FACTOR use VIRULENCE FACTORS, BORDETELLA 1986-2002%A%
% 209.65/209.80 |- mesh__dateRevised mesh__D037342 2005-07-20
% 209.65/209.80 |- skos__hiddenLabel mesh__D037342 Lymphocytosis Promoting Factor
% 209.65/209.80 |- skos__altLabel mesh__D037342 Islet-Activating Protein
% 209.65/209.80 |- skos__prefLabel mesh__D037342 Pertussis Toxin
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D037342 2006A
% 209.65/209.80 |- skos__altLabel mesh__D037342 Lymphocytosis-Promoting Factor
% 209.65/209.80 |- skos__hiddenLabel mesh__D037342 Islet Activating Protein
% 209.65/209.80 |- mesh__dateEstablished mesh__D037342 2003-01-01
% 209.65/209.80 |- mesh__recordOriginator mesh__D037342 nns
% 209.65/209.80 |- mesh__dateCreated mesh__D037342 2002-07-03
% 209.65/209.80 |- skos__scopeNote mesh__D037342
% 209.65/209.80 One of the virulence factors produced by BORDETELLA PERTUSSIS. It is a multimeric protein composed of five subunits S1 - S5. S1 contains mono ADPribose transferase activity.%A%
% 209.65/209.80 |- skos__hiddenLabel mesh__D037342 Toxin, Pertussis
% 209.65/209.80 |- skos__altLabel mesh__D037342 Islets-Activating Protein
% 209.65/209.80 |- skos__altLabel mesh__D037342 Histamine-Sensitizing Factor
% 209.65/209.80 |- skos__prefLabel mesh__D004168 Diphtheria Toxoid
% 209.65/209.80 |- skos__altLabel mesh__D004168 Diphtheria Vaccine
% 209.65/209.80 |- skos__hiddenLabel mesh__D004168 Vaccine, Diphtheria
% 209.65/209.80 |- skos__scopeNote mesh__D004168
% 209.65/209.80 The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; %28%DTP%29%; or with tetanus toxoid alone %28%DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use%29%. Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment. %28%From Dorland, 28th ed%29%%A%
% 209.65/209.80 |- rdf__type mesh__D004168sskos__Concept
% 209.65/209.80 |- skos__hiddenLabel mesh__D004168 Toxoid, Diphtheria
% 209.65/209.80 |- skos__related mesh__D004168smesh__D015721
% 209.65/209.80 |- mesh__dateRevised mesh__D004168 2005-06-30
% 209.65/209.80 |- skos__broader mesh__D004168smesh__D014121
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D004168 2006
% 209.65/209.80 |- mesh__recordOriginator mesh__D004168 NLM
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D004168 sjn
% 209.65/209.80 |- mesh__dateCreated mesh__D004168 1999-01-01
% 209.65/209.80 |- mesh__recordMaintainer mesh__D004168 ssb
% 209.65/209.80 |- mesh__dateEstablished mesh__D009651 1975-09-01
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 1998
% 209.65/209.80 |- mesh__onlineNote mesh__D009651 search NORPREGNANES 1974
% 209.65/209.80 |- skos__prefLabel mesh__D009651 Norpregnatrienes
% 209.65/209.80 |- mesh__dateRevised mesh__D009651 1993-06-03
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 2004
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 1994
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 1999
% 209.65/209.80 |- mesh__dateCreated mesh__D009651 1999-01-01
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 1995
% 209.65/209.80 |- skos__historyNote mesh__D009651 Norpregnanes %28%1974%29%
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 2005
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 2000
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D009651
% 209.65/209.80 75; was see under NORPREGNANES 1974
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 2006
% 209.65/209.80 |- skos__scopeNote mesh__D009651
% 209.65/209.80 Pregnatrienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.%A%
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 1996
% 209.65/209.80 |- mesh__historyNote mesh__D009651 75; was see under NORPREGNANES 1974
% 209.65/209.80 |- skos__broader mesh__D009651smesh__D009650
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 2001
% 209.65/209.80 |- mesh__recordMaintainer mesh__D009651 PLS
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 1997
% 209.65/209.80 |- mesh__recordOriginator mesh__D009651 NLM
% 209.65/209.80 |- rdf__type mesh__D009651sskos__Concept
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 2002
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D009651 PLS
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D009651 2003
% 209.65/209.80 |- skos__hiddenLabel mesh__D050719 p130 Crk Associated Substrate
% 209.65/209.80 |- skos__altLabel mesh__D050719 p130Cas Protein
% 209.65/209.80 |- skos__hiddenLabel mesh__D050719 Substrate, p130 Crk-Associated
% 209.65/209.80 |- skos__hiddenLabel mesh__D050719 Cas Protein, p130
% 209.65/209.80 |- skos__altLabel mesh__D050719 p130 Crk-Associated Substrate
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D050719
% 209.65/209.80 2006; CRK-ASSOCIATED SUBSTRATE was indexed under PROTEINS 2004-2005%A%
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D050719 2006
% 209.65/209.80 |- skos__hiddenLabel mesh__D050719 Crk Associated Substrate
% 209.65/209.80 |- mesh__dateEstablished mesh__D050719 2006-01-01
% 209.65/209.80 |- skos__altLabel mesh__D050719 p130 Cas Protein
% 209.65/209.80 |- skos__altLabel mesh__D050719
% 209.65/209.80 Breast Cancer Anti-Estrogen Resistance 1 Protein
% 209.65/209.80 |- rdf__type mesh__D050719sskos__Concept
% 209.65/209.80 |- skos__hiddenLabel mesh__D050719 Crk Associated Substrate Protein
% 209.65/209.80 |- skos__altLabel mesh__D050719 Crk-Associated Substrate
% 209.65/209.80 |- mesh__recordMaintainer mesh__D050719 DRC
% 209.65/209.80 |- skos__altLabel mesh__D050719 BCAR1 Protein
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D050719 sjn
% 209.65/209.80 |- mesh__dateCreated mesh__D050719 2005-06-30
% 209.65/209.80 |- skos__hiddenLabel mesh__D050719 Crk-Associated Substrate, p130
% 209.65/209.80 |- skos__scopeNote mesh__D050719
% 209.65/209.80 Crk-associated substrate was originally identified as a highly phosphorylated 130 kDa protein that associates with ONCOGENE PROTEIN CRK and ONCOGENE PROTEIN SRC. It is a signal transducing adaptor protein that undergoes tyrosine PHOSPHORYLATION in signaling pathways that regulate CELL MIGRATION and CELL PROLIFERATION.%A%
% 209.65/209.80 |- skos__broader mesh__D050719smesh__D048868
% 209.65/209.80 |- skos__hiddenLabel mesh__D050719 Substrate Protein, Crk-Associated
% 209.65/209.80 |- skos__prefLabel mesh__D050719 Crk-Associated Substrate Protein
% 209.65/209.80 |- mesh__historyNote mesh__D050719 2006%28%2004%29%
% 209.65/209.80 |- mesh__recordOriginator mesh__D050719 DRC
% 209.65/209.80 |- skos__broader mesh__D050719smesh__D010750
% 209.65/209.80 |- skos__hiddenLabel mesh__D050719
% 209.65/209.80 Breast Cancer Anti Estrogen Resistance 1 Protein
% 209.65/209.80 |- skos__altLabel mesh__D050719 CKRAS Protein
% 209.65/209.80 |- mesh__recordMaintainer mesh__D014596 lkt
% 209.65/209.80 |- skos__broader mesh__D014596smesh__D014591
% 209.65/209.80 |- mesh__dateCreated mesh__D014596 1999-01-01
% 209.65/209.80 |- rdf__type mesh__D014596sskos__Concept
% 209.65/209.80 |- mesh__recordOriginator mesh__D014596 NLM
% 209.65/209.80 |- skos__hiddenLabel mesh__D014596 Vaginal Prolapses
% 209.65/209.80 |- skos__hiddenLabel mesh__D014596 Prolapses, Vaginal
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D014596 2006
% 209.65/209.80 |- mesh__dateRevised mesh__D014596 2005-06-30
% 209.65/209.80 |- skos__hiddenLabel mesh__D014596 Uterine Prolapses
% 209.65/209.80 |- skos__prefLabel mesh__D014596 Uterine Prolapse
% 209.65/209.80 |- skos__scopeNote mesh__D014596
% 209.65/209.80 Downward displacement of the UTERUS. It is classified in various degrees: in the first degree the UTERINE CERVIX is within the vaginal orifice; in the second degree the cervix is outside the orifice; in the third degree the entire uterus is outside the orifice.%A%
% 209.65/209.80 |- skos__hiddenLabel mesh__D014596 Prolapse, Uterine
% 209.65/209.80 |- skos__annotation mesh__D014596 do not confuse with UTERINE INVERSION
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D014596 sjn
% 209.65/209.80 |- skos__hiddenLabel mesh__D014596 Prolapse, Vaginal
% 209.65/209.80 |- skos__hiddenLabel mesh__D014596 Prolapses, Uterine
% 209.65/209.80 |- mesh__onlineNote mesh__D008559 use MEMANTINE to search D 145 1976-83
% 209.65/209.80 |- skos__altLabel mesh__D008559 1-Amino-3,5-dimethyladamantane
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D008559 sjn
% 209.65/209.80 |- skos__altLabel mesh__D008559 Merz Brand of Memantine Hydrochloride
% 209.65/209.80 |- skos__altLabel mesh__D008559 D145
% 209.65/209.80 |- skos__altLabel mesh__D008559 Lundbeck Brand of Memantine Hydrochloride
% 209.65/209.80 |- mesh__dateCreated mesh__D008559 1975-07-23
% 209.65/209.80 |- mesh__recordMaintainer mesh__D008559 CCR
% 209.65/209.80 |- mesh__recordOriginator mesh__D008559 SH
% 209.65/209.80 |- mesh__historyNote mesh__D008559
% 209.65/209.80 91%28%84%29%; was see under AMANTADINE 1984-90; was D 145 see under AMANTADINE 1976-83%A%
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D008559 2006
% 209.65/209.80 |- skos__historyNote mesh__D008559
% 209.65/209.80 Amantadine %28%1974%29%/analogs %26% derivatives %28%1975%29%
% 209.65/209.80 |- mesh__dateRevised mesh__D008559 2005-06-30
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D008559
% 209.65/209.80 91; was see under AMANTADINE 1984-90; was D 145 see under AMANTADINE 1976-83%A%
% 209.65/209.80 |- skos__hiddenLabel mesh__D008559 D 145
% 209.65/209.80 |- skos__prefLabel mesh__D008559 Memantine
% 209.65/209.80 |- rdf__type mesh__D008559sskos__Concept
% 209.65/209.80 |- skos__altLabel mesh__D008559 Memantin
% 209.65/209.80 |- skos__scopeNote mesh__D008559
% 209.65/209.80 AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.%A%
% 209.65/209.80 |- skos__broader mesh__D008559smesh__D000547
% 209.65/209.80 |- mesh__dateEstablished mesh__D008559 1991-01-01
% 209.65/209.80 |- skos__altLabel mesh__D008559 1,3-Dimethyl-5-aminoadamantane
% 209.65/209.80 |- skos__annotation mesh__D000576 naturally radioactive; IM
% 209.65/209.80 |- skos__broader mesh__D000576smesh__D019216
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D000576 sjn
% 209.65/209.80 |- rdf__type mesh__D000576sskos__Concept
% 209.65/209.80 |- skos__broader mesh__D000576smesh__D008671
% 209.65/209.80 |- mesh__dateCreated mesh__D000576 1999-01-01
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D000576 2006
% 209.65/209.80 |- mesh__dateRevised mesh__D000576 2005-06-30
% 209.65/209.80 |- skos__prefLabel mesh__D000576 Americium
% 209.65/209.80 |- skos__scopeNote mesh__D000576
% 209.65/209.80 Americium. A completely man-made radioactive actinide with atomic symbol Am, atomic number 95, and atomic weight 243. Its valence can range from +3 to +6. Because of its nonmagnetic ground state, it is an excellent superconductor. It is also used in bone mineral analysis and as a radiation source for radiotherapy.%A%
% 209.65/209.80 |- mesh__recordMaintainer mesh__D000576 jmp
% 209.65/209.80 |- mesh__recordOriginator mesh__D000576 NLM
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019281 1998
% 209.65/209.80 |- skos__scopeNote mesh__D019281
% 209.65/209.80 The process by which two molecules of the same chemical composition form a condensation product or polymer.%A%
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019281 2001
% 209.65/209.80 |- mesh__recordOriginator mesh__D019281 TPW
% 209.65/209.80 |- skos__broader mesh__D019281smesh__D002627
% 209.65/209.80 |- mesh__dateEstablished mesh__D019281 1997-01-01
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D019281 SJN
% 209.65/209.80 |- mesh__historyNote mesh__D019281 97
% 209.65/209.80 |- skos__prefLabel mesh__D019281 Dimerization
% 209.65/209.80 |- skos__annotation mesh__D019281
% 209.65/209.80 NIM; no qualif; coord with substance processed %28%IM or NIM%29%%A%
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019281 2000
% 209.65/209.80 |- mesh__dateCreated mesh__D019281 1996-06-10
% 209.65/209.80 |- mesh__recordMaintainer mesh__D019281 PXP
% 209.65/209.80 |- rdf__type mesh__D019281sskos__Concept
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019281 2004
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D019281 97
% 209.65/209.80 |- skos__hiddenLabel mesh__D019281 Dimerizations
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019281 2006
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019281 2003
% 209.65/209.80 |- skos__broader mesh__D019281smesh__D008660
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019281 1999
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019281 2005
% 209.65/209.80 |- mesh__dateRevised mesh__D019281 1997-06-20
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D019281 2002
% 209.65/209.80 |- skos__prefLabel mesh__D005261
% 209.65/209.80 Female Genital Diseases and Pregnancy Complications
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D005261 2006
% 209.65/209.80 |- mesh__historyNote mesh__D005261 98; use explode 1979-97
% 209.65/209.80 |- mesh__dateCreated mesh__D005261 1999-01-01
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D005261 2005
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D005261 2002
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D005261 2004
% 209.65/209.80 |- mesh__dateEstablished mesh__D005261 1998-01-01
% 209.65/209.80 |- skos__annotation mesh__D005261
% 209.65/209.80 not used for indexing CATALOG: do not use
% 209.65/209.80 |- rdf__type mesh__D005261sskos__Concept
% 209.65/209.80 |- mesh__runningHead mesh__D005261
% 209.65/209.80 C13 - DISEASES-FEMALE GENITAL AND PREGNANCY COMPLICATIONS%A%
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D005261 2001
% 209.65/209.80 |- mesh__recordMaintainer mesh__D005261 MSR
% 209.65/209.80 |- mesh__recordOriginator mesh__D005261 NLM
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D005261 2003
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D005261 2000
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D005261 SJN
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D005261 98
% 209.65/209.80 |- mesh__dateRevised mesh__D005261 1998-06-10
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D005261 1999
% 209.65/209.80 |- skos__scopeNote mesh__D018987
% 209.65/209.80 Any of the ducts which transport saliva. Salivary ducts include the parotid duct, the major and minor sublingual ducts, and the submandibular duct.%A%
% 209.65/209.80 |- skos__hiddenLabel mesh__D018987 Whartons Duct
% 209.65/209.80 |- skos__hiddenLabel mesh__D018987 Stensen Duct
% 209.65/209.80 |- mesh__recordOriginator mesh__D018987 PXP
% 209.65/209.80 |- mesh__dateRevised mesh__D018987 2003-07-09
% 209.65/209.80 |- skos__historyNote mesh__D018987 Salivary Glands %28%1966-1995%29%
% 209.65/209.80 |- skos__prefLabel mesh__D018987 Salivary Ducts
% 209.65/209.80 |- skos__hiddenLabel mesh__D018987 Wharton Duct
% 209.65/209.80 |- mesh__recordAuthorizer mesh__D018987 sjn
% 209.65/209.80 |- skos__hiddenLabel mesh__D018987 Ducts, Salivary
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018987 2004
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018987 2006
% 209.65/209.80 |- rdf__type mesh__D018987sskos__Concept
% 209.65/209.80 |- skos__hiddenLabel mesh__D018987 Duct, Wharton%27%s
% 209.65/209.80 |- skos__broader mesh__D018987smesh__D012469
% 209.65/209.80 |- skos__hiddenLabel mesh__D018987 Stensens Duct
% 209.65/209.80 |- mesh__dateCreated mesh__D018987 1995-05-24
% 209.65/209.80 |- skos__hiddenLabel mesh__D018987 Duct, Salivary
% 209.65/209.80 |- mesh__activeMeSHYear mesh__D018987 2005
% 209.65/209.80 |- skos__hiddenLabel mesh__D018987 Salivary Duct
% 209.65/209.80 |- mesh__dateEstablished mesh__D018987 1996-01-01
% 209.65/209.80 |- mesh__historyNote mesh__D018987 96
% 209.65/209.80 |- mesh__recordMaintainer mesh__D018987 lkt
% 209.65/209.80 |- mesh__publicMeSHNote mesh__D018987 96
% 209.65/209.80 |- skos__annotation mesh__D018987
% 209.65/209.80 dis of salivary ducts: coord IM with SALIVARY GLAND DISEASES %28%IM%29%; dis of ducts of a specific salivary gland: coord IM with specific salivary gland disease %28%IM%29% or specific salivary gland %28%IM%29% and SALIVARY GLAND DISEASES %28%IM%29%; /radiogr = SIALOGRAPHY %26% do not add SALIVARY DUCTS unless particularly discussed%A%
% 209.65/209.80 |- skos__hiddenLabel mesh__D018987 Duct, Stensen%27%s
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D018189 94
% 209.65/209.81 |- skos__altLabel mesh__D018189 Immunomagnetic Purging
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Immunomagnetic Bead Techniques
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Purging, Immunomagnetic
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018189 2006
% 209.65/209.81 |- mesh__dateEstablished mesh__D018189 1994-01-01
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Separation, Immunomagnetic
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Separation, Immunomagnetic Cell
% 209.65/209.81 |- rdf__type mesh__D018189sskos__Concept
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Immunomagnetic Separations
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018189 2001
% 209.65/209.81 |- skos__broader mesh__D018189smesh__D002469
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018189 2005
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Bead Techniques, Immunomagnetic
% 209.65/209.81 |- skos__historyNote mesh__D018189 Cell Separation %28%1983-1993%29%
% 209.65/209.81 |- skos__altLabel mesh__D018189 Immunomagnetic Bead Technique
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Immunomagnetic Cell Separations
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Immunomagnetic Purgings
% 209.65/209.81 |- skos__scopeNote mesh__D018189
% 209.65/209.81 A cell-separation technique where magnetizable microspheres or beads are first coated with monoclonal antibody, allowed to search and bind to target cells, and are then selectively removed when passed through a magnetic field. Among other applications, the technique is commonly used to remove tumor cells from the marrow %28%BONE MARROW PURGING%29% of patients who are to undergo autologous bone marrow transplantation.%A%
% 209.65/209.81 |- mesh__historyNote mesh__D018189 94
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Separations, Immunomagnetic
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Cell Separations, Immunomagnetic
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018189 2004
% 209.65/209.81 |- mesh__recordOriginator mesh__D018189 AGS
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D018189 sjn
% 209.65/209.81 |- mesh__recordMaintainer mesh__D018189 nns
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Bead Technique, Immunomagnetic
% 209.65/209.81 |- mesh__dateRevised mesh__D018189 2000-06-22
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018189 2002
% 209.65/209.81 |- skos__altLabel mesh__D018189 Immunomagnetic Cell Separation
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Separations, Immunomagnetic Cell
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Purgings, Immunomagnetic
% 209.65/209.81 |- skos__prefLabel mesh__D018189 Immunomagnetic Separation
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018189 2003
% 209.65/209.81 |- skos__related mesh__D018189smesh__D016465
% 209.65/209.81 |- skos__hiddenLabel mesh__D018189 Cell Separation, Immunomagnetic
% 209.65/209.81 |- mesh__dateCreated mesh__D018189 1993-06-04
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004967 2004
% 209.65/209.81 |- mesh__historyNote mesh__D004967
% 209.65/209.81 1963; /therapeutic use was ESTROGENS, THERAPEUTIC 1965
% 209.65/209.81 |- skos__related mesh__D004967smesh__D020847
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004967 2005
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D004967
% 209.65/209.81 1963; /therapeutic use was ESTROGENS, THERAPEUTIC 1965
% 209.65/209.81 |- skos__annotation mesh__D004967
% 209.65/209.81 /defic: consider also HYPOGONADISM %26% other gonadal disorders in Cat C19; for antagonists consider ANTIESTROGENS or ESTROGEN ANTAGONISTS%A%
% 209.65/209.81 |- mesh__recordOriginator mesh__D004967 NLM
% 209.65/209.81 |- skos__prefLabel mesh__D004967 Estrogens
% 209.65/209.81 |- skos__altLabel mesh__D004967 Estrogen
% 209.65/209.81 |- skos__altLabel mesh__D004967 Estrogenic Agents
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004967 2006
% 209.65/209.81 |- mesh__dateCreated mesh__D004967 1999-01-01
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D004967 sjn
% 209.65/209.81 |- mesh__recordMaintainer mesh__D004967 lkt
% 209.65/209.81 |- rdf__type mesh__D004967sskos__Concept
% 209.65/209.81 |- mesh__dateRevised mesh__D004967 2003-07-09
% 209.65/209.81 |- skos__scopeNote mesh__D004967
% 209.65/209.81 Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.%A%
% 209.65/209.81 |- skos__altLabel mesh__D004967 Estrogenic Compounds
% 209.65/209.81 |- skos__hiddenLabel mesh__D004967 Agents, Estrogenic
% 209.65/209.81 |- skos__related mesh__D004967smesh__D011960
% 209.65/209.81 |- skos__broader mesh__D004967smesh__D006728
% 209.65/209.81 |- skos__related mesh__D004967smesh__D004965
% 209.65/209.81 |- skos__hiddenLabel mesh__D004967 Compounds, Estrogenic
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 2006
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 1999
% 209.65/209.81 |- skos__related mesh__D004169smesh__D013031
% 209.65/209.81 |- mesh__recordOriginator mesh__D004169 NLM
% 209.65/209.81 |- skos__prefLabel mesh__D004169 Diphyllobothriasis
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 2004
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 1997
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 2005
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 1998
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 2001
% 209.65/209.81 |- skos__historyNote mesh__D004169 Cestode Infections %28%1966-1967%29%
% 209.65/209.81 |- mesh__dateCreated mesh__D004169 1999-01-01
% 209.65/209.81 |- mesh__recordMaintainer mesh__D004169 JLS
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 2003
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 1996
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D004169 68
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 2000
% 209.65/209.81 |- mesh__dateRevised mesh__D004169 1993-06-04
% 209.65/209.81 |- mesh__dateEstablished mesh__D004169 1968-01-01
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 1995
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D004169 PLS
% 209.65/209.81 |- rdf__type mesh__D004169sskos__Concept
% 209.65/209.81 |- skos__scopeNote mesh__D004169
% 209.65/209.81 Infection with tapeworms of the genus Diphyllobothrium.%A%
% 209.65/209.81 |- skos__hiddenLabel mesh__D004169 Diphyllobothriases
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 2002
% 209.65/209.81 |- skos__annotation mesh__D004169
% 209.65/209.81 tapeworm infect; consider also SPARGANOSIS %28%infection at larval stage%29%%A%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004169 1994
% 209.65/209.81 |- mesh__historyNote mesh__D004169 68
% 209.65/209.81 |- skos__broader mesh__D004169smesh__D002590
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 2000
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 2005
% 209.65/209.81 |- skos__broader mesh__D009652smesh__D009650
% 209.65/209.81 |- mesh__dateCreated mesh__D009652 1999-01-01
% 209.65/209.81 |- rdf__type mesh__D009652sskos__Concept
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D009652
% 209.65/209.81 75; was see under NORPREGNANES 1974
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 1995
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 2004
% 209.65/209.81 |- skos__annotation mesh__D009652 do not confuse with NORPREGNANES
% 209.65/209.81 |- mesh__recordOriginator mesh__D009652 NLM
% 209.65/209.81 |- mesh__dateRevised mesh__D009652 1993-06-03
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 1994
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 2003
% 209.65/209.81 |- mesh__onlineNote mesh__D009652 search NORPREGNANES 1974
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 1999
% 209.65/209.81 |- mesh__recordMaintainer mesh__D009652 PLS
% 209.65/209.81 |- skos__historyNote mesh__D009652 Norpregnanes %28%1974%29%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 2002
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 1998
% 209.65/209.81 |- skos__prefLabel mesh__D009652 Norpregnenes
% 209.65/209.81 |- skos__scopeNote mesh__D009652
% 209.65/209.81 Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..%A%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 1997
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 2006
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 2001
% 209.65/209.81 |- mesh__historyNote mesh__D009652 75; was see under NORPREGNANES 1974
% 209.65/209.81 |- mesh__dateEstablished mesh__D009652 1975-09-01
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D009652 PLS
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009652 1996
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D014597 2006
% 209.65/209.81 |- skos__broader mesh__D014597smesh__D014591
% 209.65/209.81 |- mesh__recordMaintainer mesh__D014597 lkt
% 209.65/209.81 |- skos__hiddenLabel mesh__D014597 Uterine Ruptures
% 209.65/209.81 |- skos__annotation mesh__D014597
% 209.65/209.81 spontaneous or traumatic but do not coordinate with RUPTURE or RUPTURE, SPONTANEOUS%A%
% 209.65/209.81 |- mesh__recordOriginator mesh__D014597 NLM
% 209.65/209.81 |- skos__scopeNote mesh__D014597
% 209.65/209.81 A complete separation or tear in the wall of the UTERUS with or without expulsion of the FETUS. It may be due to injuries, multiple pregnancies, large fetus, previous scarring, or obstruction.%A%
% 209.65/209.81 |- skos__broader mesh__D014597smesh__D012421
% 209.65/209.81 |- mesh__dateRevised mesh__D014597 2005-06-30
% 209.65/209.81 |- skos__broader mesh__D014597smesh__D007744
% 209.65/209.81 |- skos__hiddenLabel mesh__D014597 Ruptures, Uterine
% 209.65/209.81 |- skos__prefLabel mesh__D014597 Uterine Rupture
% 209.65/209.81 |- mesh__dateCreated mesh__D014597 1999-01-01
% 209.65/209.81 |- skos__hiddenLabel mesh__D014597 Rupture, Uterine
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D014597 sjn
% 209.65/209.81 |- rdf__type mesh__D014597sskos__Concept
% 209.65/209.81 |- rdf__type mesh__D000577sskos__Concept
% 209.65/209.81 |- mesh__recordOriginator mesh__D000577 NLM
% 209.65/209.81 |- skos__broader mesh__D000577smesh__D009930
% 209.65/209.81 |- mesh__dateCreated mesh__D000577 1999-01-01
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 2006
% 209.65/209.81 |- mesh__recordMaintainer mesh__D000577 TGC
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 2002
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 2005
% 209.65/209.81 |- mesh__dateRevised mesh__D000577 1995-03-16
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 1999
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 2001
% 209.65/209.81 |- skos__prefLabel mesh__D000577 Amides
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 2004
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 1998
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 2000
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D000577 PLS
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 2003
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 1997
% 209.65/209.81 |- skos__scopeNote mesh__D000577
% 209.65/209.81 Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D000577 1996
% 209.65/209.81 |- skos__broader mesh__D019282smesh__D008659
% 209.65/209.81 |- skos__related mesh__D019282smesh__D002100
% 209.65/209.81 |- skos__scopeNote mesh__D019282
% 209.65/209.81 Any disease marked especially by progressive emaciation and weakness. %28%Dorland, 28th ed, p490%29%%A%
% 209.65/209.81 |- mesh__historyNote mesh__D019282 97
% 209.65/209.81 |- mesh__dateRevised mesh__D019282 1997-06-20
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D019282 2004
% 209.65/209.81 |- skos__hiddenLabel mesh__D019282 Wasting Syndromes
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D019282 2002
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D019282 2003
% 209.65/209.81 |- rdf__type mesh__D019282sskos__Concept
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D019282 2006
% 209.65/209.81 |- skos__altLabel mesh__D019282 Wasting Disease
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D019282 2001
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D019282 SJN
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D019282 2005
% 209.65/209.81 |- mesh__recordOriginator mesh__D019282 AGS
% 209.65/209.81 |- mesh__dateEstablished mesh__D019282 1997-01-01
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D019282 2000
% 209.65/209.81 |- skos__hiddenLabel mesh__D019282 Wasting Diseases
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D019282 1999
% 209.65/209.81 |- mesh__dateCreated mesh__D019282 1996-06-10
% 209.65/209.81 |- mesh__recordMaintainer mesh__D019282 TGC
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D019282 97
% 209.65/209.81 |- skos__broader mesh__D019282smesh__D009748
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D019282 1998
% 209.65/209.81 |- skos__annotation mesh__D019282
% 209.65/209.81 do not confuse with CACHEXIA: do not make diagnoses, use words of text; HIV WASTING SYNDROME is also available%A%
% 209.65/209.81 |- skos__prefLabel mesh__D019282 Wasting Syndrome
% 209.65/209.81 |- skos__prefLabel mesh__D005262 Feminization
% 209.65/209.81 |- rdf__type mesh__D005262sskos__Concept
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D005262 72
% 209.65/209.81 |- skos__hiddenLabel mesh__D005262 Feminizations
% 209.65/209.81 |- skos__scopeNote mesh__D005262
% 209.65/209.81 Development of female secondary SEX CHARACTERISTICS in the MALE. It is due to the effects of estrogenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.%A%
% 209.65/209.81 |- mesh__historyNote mesh__D005262 72%28%67%29%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D005262 2006
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D005262 sjn
% 209.65/209.81 |- skos__broader mesh__D005262smesh__D012816
% 209.65/209.81 |- mesh__dateCreated mesh__D005262 1999-01-01
% 209.65/209.81 |- skos__historyNote mesh__D005262 Sex Characteristics %28%1966%29%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D005262 2005
% 209.65/209.81 |- mesh__dateRevised mesh__D005262 2004-07-07
% 209.65/209.81 |- mesh__recordMaintainer mesh__D005262 lkt
% 209.65/209.81 |- mesh__dateEstablished mesh__D005262 1972-01-01
% 209.65/209.81 |- mesh__recordOriginator mesh__D005262 NLM
% 209.65/209.81 |- skos__annotation mesh__D005262 check the tag MALE
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 2004
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 2000
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 2006
% 209.65/209.81 |- rdf__type mesh__D018988sskos__Concept
% 209.65/209.81 |- mesh__dateCreated mesh__D018988 1995-06-29
% 209.65/209.81 |- skos__annotation mesh__D018988
% 209.65/209.81 %22%passage of viable bact from the gastrointest tract to extra-intest sites%22%; coord IM with specific bact /physiol %28%IM%29%%A%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 2003
% 209.65/209.81 |- skos__historyNote mesh__D018988 Cell Movement %28%1972-1995%29%
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D018988 96
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 1997
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 2005
% 209.65/209.81 |- mesh__historyNote mesh__D018988 96
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 1999
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 1996
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 1998
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 2002
% 209.65/209.81 |- skos__broader mesh__D018988smesh__D018407
% 209.65/209.81 |- skos__prefLabel mesh__D018988 Bacterial Translocation
% 209.65/209.81 |- skos__scopeNote mesh__D018988
% 209.65/209.81 The passage of viable bacteria from the gastrointestinal tract to extra-intestinal sites, such as the mesenteric lymph node complex, liver, spleen, kidney, and blood. Factors that promote bacterial translocation include overgrowth with gram-negative enteric bacilli, impaired host immune defenses, and injury to the intestinal mucosa resulting in increased intestinal permeability. These mechanisms can act in concert to promote synergistically the systemic spread of indigenous translocating bacteria to cause lethal sepsis.%A%
% 209.65/209.81 |- skos__altLabel mesh__D018988 Translocation, Bacterial
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D018988 2001
% 209.65/209.81 |- mesh__dateEstablished mesh__D018988 1996-01-01
% 209.65/209.81 |- skos__hiddenLabel mesh__D004968 Nonsteroidal Estrogens
% 209.65/209.81 |- skos__broader mesh__D004968smesh__D004967
% 209.65/209.81 |- skos__historyNote mesh__D004968 Estrogens %28%1966-1974%29%
% 209.65/209.81 |- mesh__dateRevised mesh__D004968 2003-07-09
% 209.65/209.81 |- mesh__recordMaintainer mesh__D004968 lkt
% 209.65/209.81 |- skos__hiddenLabel mesh__D004968 Estrogens, Non Steroidal
% 209.65/209.81 |- skos__scopeNote mesh__D004968
% 209.65/209.81 Non-steroidal compounds with estrogenic activity.
% 209.65/209.81 |- mesh__dateEstablished mesh__D004968 1975-09-01
% 209.65/209.81 |- skos__altLabel mesh__D004968 Estrogens, Nonsteroidal
% 209.65/209.81 |- mesh__historyNote mesh__D004968 75
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004968 2006
% 209.65/209.81 |- mesh__recordOriginator mesh__D004968 NLM
% 209.65/209.81 |- skos__prefLabel mesh__D004968 Estrogens, Non-Steroidal
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D004968 75
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004968 2005
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D004968 sjn
% 209.65/209.81 |- rdf__type mesh__D004968sskos__Concept
% 209.65/209.81 |- skos__hiddenLabel mesh__D004968 Non-Steroidal Estrogens
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D004968 2004
% 209.65/209.81 |- mesh__dateCreated mesh__D004968 1974-11-11
% 209.65/209.81 |- mesh__dateCreated mesh__D009653 1974-11-11
% 209.65/209.81 |- skos__historyNote mesh__D009653 Progesterone %28%1974%29%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 2001
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 1994
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 2003
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D009653 PLS
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 2000
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 1999
% 209.65/209.81 |- skos__prefLabel mesh__D009653 Norprogesterones
% 209.65/209.81 |- mesh__dateEstablished mesh__D009653 1991-01-01
% 209.65/209.81 |- skos__scopeNote mesh__D009653
% 209.65/209.81 Progesterones which have undergone ring contraction or which are lacking carbon 18 or 19.%A%
% 209.65/209.81 |- mesh__recordOriginator mesh__D009653 NLM
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 1998
% 209.65/209.81 |- mesh__dateRevised mesh__D009653 1993-06-03
% 209.65/209.81 |- skos__broader mesh__D009653smesh__D009652
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 1997
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 2006
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D009653
% 209.65/209.81 91; was see under NORPREGNENES 1975-90
% 209.65/209.81 |- mesh__recordMaintainer mesh__D009653 PLS
% 209.65/209.81 |- skos__historyNote mesh__D009653 Norpregnanes %28%1974%29%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 1996
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 2005
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 2002
% 209.65/209.81 |- rdf__type mesh__D009653sskos__Concept
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 1995
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D009653 2004
% 209.65/209.81 |- mesh__historyNote mesh__D009653
% 209.65/209.81 91%28%75%29%; was see under NORPREGNENES 1975-90
% 209.65/209.81 |- skos__prefLabel mesh__D001670
% 209.65/209.81 Biochemical Phenomena, Metabolism, and Nutrition
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D001670 1999
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D001670 2005
% 209.65/209.81 |- mesh__onlineNote mesh__D001670
% 209.65/209.81 pre-explosion = BIOCHEM PHENOM METAB %28%PX%29%
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D001670 1998
% 209.65/209.81 |- skos__altLabel mesh__D001670
% 209.65/209.81 Metabolism, Nutrition, and Biochemical Phenomena
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D001670 2002
% 209.65/209.81 |- mesh__recordOriginator mesh__D001670 NLM
% 209.65/209.81 |- mesh__historyNote mesh__D001670 98; use pre-explosion
% 209.65/209.81 |- mesh__recordMaintainer mesh__D001670 TGC
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D001670 98
% 209.65/209.81 |- rdf__type mesh__D001670sskos__Concept
% 209.65/209.81 |- mesh__runningHead mesh__D001670
% 209.65/209.81 G6 - BIOCHEMICAL PHENOMENA, METABOLISM, AND NUTRITION
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D001670 2004
% 209.65/209.81 |- mesh__dateRevised mesh__D001670 1997-06-27
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D001670 2001
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D001670 2003
% 209.65/209.81 |- skos__annotation mesh__D001670
% 209.65/209.81 not used for indexing CATALOG: do not use
% 209.65/209.81 |- mesh__recordAuthorizer mesh__D001670 SJN
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D001670 2006
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D001670 2000
% 209.65/209.81 |- mesh__dateCreated mesh__D001670 1999-01-01
% 209.65/209.81 |- mesh__dateEstablished mesh__D001670 1998-01-01
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D014598 2004
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D014598 2002
% 209.65/209.81 |- mesh__activeMeSHYear mesh__D014598 2006
% 209.65/209.81 |- skos__altLabel mesh__D014598 Blastokinin
% 209.65/209.81 |- mesh__publicMeSHNote mesh__D014598
% 209.65/209.81 91; was see under GLYCOPROTEINS 1975-90
% 209.74/209.92 |- mesh__recordMaintainer mesh__D014598 KEV
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D014598 1996
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D014598 1998
% 209.74/209.92 |- mesh__dateEstablished mesh__D014598 1991-01-01
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D014598 1997
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D014598 2000
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D014598 1999
% 209.74/209.92 |- mesh__historyNote mesh__D014598
% 209.74/209.92 91%28%75%29%; was see under GLYCOPROTEINS 1975-90
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D014598 2001
% 209.74/209.92 |- skos__scopeNote mesh__D014598
% 209.74/209.92 A protein fraction of pregnant uterine fluid which can induce and regulate blastocystic development. Blastokinin is thought to be similar or identical to uteroglobin. Presence in uterine fluid regulated by progesterone.%A%
% 209.74/209.92 |- skos__annotation mesh__D014598
% 209.74/209.92 a glycoprotein in pregnant uterine fluid; /biosyn /physiol permitted%A%
% 209.74/209.92 |- skos__prefLabel mesh__D014598 Uteroglobin
% 209.74/209.92 |- mesh__recordOriginator mesh__D014598 NLM
% 209.74/209.92 |- mesh__dateRevised mesh__D014598 1995-05-22
% 209.74/209.92 |- mesh__dateCreated mesh__D014598 1974-11-19
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D014598 2003
% 209.74/209.92 |- skos__broader mesh__D014598smesh__D006023
% 209.74/209.92 |- skos__historyNote mesh__D014598 Glycoproteins %28%1971-1974%29%
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D014598 2005
% 209.74/209.92 |- rdf__type mesh__D014598sskos__Concept
% 209.74/209.92 |- mesh__recordAuthorizer mesh__D014598 PLS
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 2005
% 209.74/209.92 |- mesh__recordMaintainer mesh__D000578 TGC
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 2000
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 1999
% 209.74/209.92 |- mesh__dateRevised mesh__D000578 1992-05-07
% 209.74/209.92 |- mesh__recordAuthorizer mesh__D000578 PLS
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 1994
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 2004
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 1998
% 209.74/209.92 |- skos__prefLabel mesh__D000578 Amidines
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 1993
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 2003
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 1997
% 209.74/209.92 |- mesh__recordOriginator mesh__D000578 NLM
% 209.74/209.92 |- mesh__activeMeSHYear mesh__D000578 1996
% 209.74/209.93 |- rdf__type mesh__D000578sskos__Concept
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D000578 2002
% 209.74/209.93 |- skos__broader mesh__D000578smesh__D009930
% 209.74/209.93 |- mesh__dateCreated mesh__D000578 1999-01-01
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D000578 2006
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D000578 2001
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D000578 1995
% 209.74/209.93 |- mesh__historyNote mesh__D019283 97
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D019283 2005
% 209.74/209.93 |- mesh__dateEstablished mesh__D019283 1997-01-01
% 209.74/209.93 |- mesh__dateCreated mesh__D019283 1996-06-10
% 209.74/209.93 |- mesh__dateRevised mesh__D019283 2004-07-07
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D019283 97
% 209.74/209.93 |- mesh__recordOriginator mesh__D019283 JLS
% 209.74/209.93 |- rdf__type mesh__D019283sskos__Concept
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D019283 2006
% 209.74/209.93 |- skos__broader mesh__D019283smesh__D010195
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D019283 sjn
% 209.74/209.93 |- skos__altLabel mesh__D019283 Necrotizing Pancreatitis, Acute
% 209.74/209.93 |- skos__prefLabel mesh__D019283 Pancreatitis, Acute Necrotizing
% 209.74/209.93 |- skos__altLabel mesh__D019283 Acute Necrotizing Pancreatitis
% 209.74/209.93 |- skos__scopeNote mesh__D019283
% 209.74/209.93 A severe form of acute INFLAMMATION of the PANCREAS characterized by one or more areas of NECROSIS in the pancreas with varying degree of involvement of the surrounding tissues or organ systems. Massive pancreatic necrosis may lead to DIABETES MELLITUS, and malabsorption.%A%
% 209.74/209.93 |- mesh__recordMaintainer mesh__D019283 lkt
% 209.74/209.93 |- skos__historyNote mesh__D019283 Pancreatitis %28%1990-1996%29%
% 209.74/209.93 |- skos__hiddenLabel mesh__D005263 Artery, Femoral
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 1995
% 209.74/209.93 |- mesh__dateRevised mesh__D005263 1992-05-15
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D005263 PLS
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 2001
% 209.74/209.93 |- mesh__recordOriginator mesh__D005263 NLM
% 209.74/209.93 |- skos__hiddenLabel mesh__D005263 Femoral Arteries
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 2000
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 1994
% 209.74/209.93 |- mesh__recordMaintainer mesh__D005263 TAP
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 1993
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 1999
% 209.74/209.93 |- skos__broader mesh__D005263smesh__D001158
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 2006
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 1998
% 209.74/209.93 |- mesh__dateCreated mesh__D005263 1999-01-01
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 2005
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 1997
% 209.74/209.93 |- skos__hiddenLabel mesh__D005263 Arteries, Femoral
% 209.74/209.93 |- skos__prefLabel mesh__D005263 Femoral Artery
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 2004
% 209.74/209.93 |- rdf__type mesh__D005263sskos__Concept
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 2002
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 1996
% 209.74/209.93 |- skos__scopeNote mesh__D005263
% 209.74/209.93 The main artery of the thigh, a continuation of the external iliac artery.%A%
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005263 2003
% 209.74/209.93 |- skos__altLabel mesh__D043382 FAPY-DNA Glycosylase
% 209.74/209.93 |- skos__historyNote mesh__D043382 N-Glycosyl Hydrolases %28%1981-2003%29%
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D043382 2005
% 209.74/209.93 |- mesh__recordMaintainer mesh__D043382 jmp
% 209.74/209.93 |- mesh__dateCreated mesh__D043382 2003-07-09
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D043382 2006
% 209.74/209.93 |- mesh__recordOriginator mesh__D043382 AKE
% 209.74/209.93 |- mesh__historyNote mesh__D043382
% 209.74/209.93 2004; use DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE %28%NM%29% 1981-2003%A%
% 209.74/209.93 |- skos__hiddenLabel mesh__D043382 DNA Formamidopyrimidine Glycosylase
% 209.74/209.93 |- skos__hiddenLabel mesh__D043382 FAPY DNA Glycosylase
% 209.74/209.93 |- mesh__dateEstablished mesh__D043382 2004-01-01
% 209.74/209.93 |- rdf__type mesh__D043382sskos__Concept
% 209.74/209.93 |- skos__prefLabel mesh__D043382 DNA-Formamidopyrimidine Glycosylase
% 209.74/209.93 |- skos__scopeNote mesh__D043382
% 209.74/209.93 A DNA repair enzyme that is an N-glycosyl hydrolase with specificity for DNA-containing ring-opened N%28%7%29%-methylguanine residues.%A%
% 209.74/209.93 |- skos__altLabel mesh__D043382 Formamidopyrimidine-DNA Glycosylase
% 209.74/209.93 |- skos__related mesh__D043382smesh__D004260
% 209.74/209.93 |- skos__broader mesh__D043382smesh__D045647
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D043382 sjn
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D043382
% 209.74/209.93 2004; DNA-FORMAIDOPYRIMIDINE GLYCOSYLASE was indexed under N-GLYCOSYL HYDROLASES 1981-2003%A%
% 209.74/209.93 |- skos__hiddenLabel mesh__D043382 Formamidopyrimidine DNA Glycosylase
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D043382 2004
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 2006
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 2002
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 1997
% 209.74/209.93 |- mesh__historyNote mesh__D009654 68
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 2005
% 209.74/209.93 |- skos__scopeNote mesh__D009654
% 209.74/209.93 Steroids which have undergone contraction in ring size or reduction in side chains.%A%
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 2001
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 1996
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 1995
% 209.74/209.93 |- mesh__dateCreated mesh__D009654 1999-01-01
% 209.74/209.93 |- rdf__type mesh__D009654sskos__Concept
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 2004
% 209.74/209.93 |- skos__broader mesh__D009654smesh__D013256
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D009654 PLS
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 1994
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 2000
% 209.74/209.93 |- mesh__dateEstablished mesh__D009654 1968-01-01
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 2003
% 209.74/209.93 |- skos__prefLabel mesh__D009654 Norsteroids
% 209.74/209.93 |- mesh__dateRevised mesh__D009654 1993-06-03
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 1999
% 209.74/209.93 |- mesh__recordOriginator mesh__D009654 NLM
% 209.74/209.93 |- mesh__recordMaintainer mesh__D009654 PLS
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D009654 68
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009654 1998
% 209.74/209.93 |- skos__prefLabel mesh__D001671 Biochemistry
% 209.74/209.93 |- mesh__recordMaintainer mesh__D001671 jls
% 209.74/209.93 |- rdf__type mesh__D001671sskos__Concept
% 209.74/209.93 |- skos__broader mesh__D001671smesh__D001690
% 209.74/209.93 |- skos__broader mesh__D001671smesh__D002621
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001671 2004
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001671 2002
% 209.74/209.93 |- mesh__recordOriginator mesh__D001671 NLM
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D001671 sjn
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001671 2003
% 209.74/209.93 |- mesh__dateRevised mesh__D001671 2001-07-25
% 209.74/209.93 |- mesh__dateCreated mesh__D001671 1999-01-01
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001671 2006
% 209.74/209.93 |- skos__annotation mesh__D001671
% 209.74/209.93 SPEC only: do not use as NIM coord for chemistry of biol matter%A%
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001671 2005
% 209.74/209.93 |- skos__annotation mesh__D014599
% 209.74/209.93 /blood supply: consider PLACENTAL CIRCULATION; /surg: consider HYSTERECTOMY or HYSTEROTOMY; inflammation = ENDOMETRITIS%A%
% 209.74/209.93 |- mesh__recordOriginator mesh__D014599 NLM
% 209.74/209.93 |- mesh__recordMaintainer mesh__D014599 lkt
% 209.74/209.93 |- skos__broader mesh__D014599smesh__D005836
% 209.74/209.93 |- skos__related mesh__D014599smesh__D007044
% 209.74/209.93 |- mesh__dateCreated mesh__D014599 1999-01-01
% 209.74/209.93 |- skos__prefLabel mesh__D014599 Uterus
% 209.74/209.93 |- skos__related mesh__D014599smesh__D015907
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D014599 sjn
% 209.74/209.93 |- mesh__considerAlso mesh__D014599 consider also terms at HYSTER-
% 209.74/209.93 |- skos__related mesh__D014599smesh__D007047
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D014599 2003
% 209.74/209.93 |- mesh__dateRevised mesh__D014599 2002-07-03
% 209.74/209.93 |- rdf__type mesh__D014599sskos__Concept
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D014599 2005
% 209.74/209.93 |- skos__scopeNote mesh__D014599
% 209.74/209.93 The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus %28%the body%29% which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI %28%the neck%29% opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.%A%
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D014599 2004
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D014599 2006
% 209.74/209.93 |- skos__altLabel mesh__D014599 Uteri
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D000579 2004
% 209.74/209.93 |- mesh__historyNote mesh__D000579 74%28%73%29%
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D000579 sjn
% 209.74/209.93 |- skos__scopeNote mesh__D000579
% 209.74/209.93 Enzymes of a subclass of TRANSFERASES that catalyze the transfer of an amidino group from donor to acceptor. EC 2.1.4.%A%
% 209.74/209.93 |- skos__prefLabel mesh__D000579 Amidinotransferases
% 209.74/209.93 |- mesh__dateEstablished mesh__D000579 1974-01-01
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D000579 74
% 209.74/209.93 |- rdf__type mesh__D000579sskos__Concept
% 209.74/209.93 |- skos__broader mesh__D000579smesh__D019875
% 209.74/209.93 |- mesh__recordMaintainer mesh__D000579 ssb
% 209.74/209.93 |- mesh__dateCreated mesh__D000579 1999-01-01
% 209.74/209.93 |- mesh__dateRevised mesh__D000579 2003-07-09
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D000579 2006
% 209.74/209.93 |- skos__altLabel mesh__D000579 Transamidinases
% 209.74/209.93 |- mesh__recordOriginator mesh__D000579 NLM
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D000579 2005
% 209.74/209.93 |- mesh__historyNote mesh__D019284
% 209.74/209.93 97; was THAPSIGARGIN %28%NM%29% 1979-96
% 209.74/209.93 |- mesh__onlineNote mesh__D019284
% 209.74/209.93 use THAPSIGARGIN %28%NM%29% to search THAPSIGARGIN 1980-96
% 209.74/209.93 |- rdf__type mesh__D019284sskos__Concept
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D019284 2006
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D019284
% 209.74/209.93 97; THAPSIGARGIN was indexed under TERPENES 1979-96
% 209.74/209.93 |- skos__historyNote mesh__D019284 Terpenes %28%1979-1996%29%
% 209.74/209.93 |- mesh__dateEstablished mesh__D019284 1997-01-01
% 209.74/209.93 |- mesh__recordMaintainer mesh__D019284 ssb
% 209.74/209.93 |- mesh__dateCreated mesh__D019284 1996-06-10
% 209.74/209.93 |- mesh__dateRevised mesh__D019284 2003-07-09
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D019284 sjn
% 209.74/209.93 |- skos__scopeNote mesh__D019284
% 209.74/209.93 A potent skin irritating sesquiterpene lactone isolated from the roots of Thapsia garganica L. %28%Apiaceae%29%. It also acts as a non-phorbol-ester-type tumor promoter which discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca%28%2+%29%-ATPase. %28%Biochem Pharmacol 1987;36%28%5%29%:621-6; Proc Natl Acad Sci USA 1991;88%28%16%29%:7096-100%29%%A%
% 209.74/209.93 |- mesh__recordOriginator mesh__D019284 ADP
% 209.74/209.93 |- skos__broader mesh__D019284smesh__D012717
% 209.74/209.93 |- skos__prefLabel mesh__D019284 Thapsigargin
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D019284 2005
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D019284 2004
% 209.74/209.93 |- mesh__dateCreated mesh__D005264 1999-01-01
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D005264 sjn
% 209.74/209.93 |- skos__hiddenLabel mesh__D005264 Fractures, Femoral
% 209.74/209.93 |- skos__scopeNote mesh__D005264 Fractures of the femur.
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005264 2006
% 209.74/209.93 |- skos__broader mesh__D005264smesh__D007869
% 209.74/209.93 |- mesh__recordOriginator mesh__D005264 NLM
% 209.74/209.93 |- mesh__dateRevised mesh__D005264 2005-06-30
% 209.74/209.93 |- mesh__recordMaintainer mesh__D005264 ssb
% 209.74/209.93 |- skos__annotation mesh__D005264
% 209.74/209.93 of femoral shaft only; see X refs %26% note at HIP FRACTURES%A%
% 209.74/209.93 |- skos__hiddenLabel mesh__D005264 Femoral Fracture
% 209.74/209.93 |- skos__broader mesh__D005264smesh__D050723
% 209.74/209.93 |- skos__hiddenLabel mesh__D005264 Fracture, Femoral
% 209.74/209.93 |- skos__prefLabel mesh__D005264 Femoral Fractures
% 209.74/209.93 |- rdf__type mesh__D005264sskos__Concept
% 209.74/209.93 |- skos__altLabel mesh__D043383 SAH Hydrolase
% 209.74/209.93 |- skos__broader mesh__D043383smesh__D006867
% 209.74/209.93 |- rdf__type mesh__D043383sskos__Concept
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D043383
% 209.74/209.93 2004; ADENOSYLHOMOCYSTEINASE was indexed under HYDROLASES 1976-2003%A%
% 209.74/209.93 |- skos__hiddenLabel mesh__D043383 Hydrolase, S-adenosylhomocysteine
% 209.74/209.93 |- skos__historyNote mesh__D043383 Hydrolases %28%1976-2003%29%
% 209.74/209.93 |- skos__hiddenLabel mesh__D043383 S adenosylhomocysteine Hydrolase
% 209.74/209.93 |- skos__scopeNote mesh__D043383
% 209.74/209.93 An enzyme which catalyzes the catabolism of S-ADENOSYLHOMOCYSTEINE to ADENOSINE and HOMOCYSTEINE. It may play a role in regulating the concentration of intracellular adenosylhomocysteine.%A%
% 209.74/209.93 |- skos__altLabel mesh__D043383 S-adenosylhomocysteine Hydrolase
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D043383 2004
% 209.74/209.93 |- mesh__dateEstablished mesh__D043383 2004-01-01
% 209.74/209.93 |- mesh__historyNote mesh__D043383
% 209.74/209.93 2004; use ADENOSYLHOMOCYSTEINASE %28%NM%29% 1980-2003
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D043383 2005
% 209.74/209.93 |- skos__prefLabel mesh__D043383 Adenosylhomocysteinase
% 209.74/209.93 |- skos__altLabel mesh__D043383 S-adenosylhomocysteine Synthase
% 209.74/209.93 |- mesh__dateCreated mesh__D043383 2003-07-09
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D043383 2006
% 209.74/209.93 |- skos__hiddenLabel mesh__D043383 S adenosylhomocysteine Synthase
% 209.74/209.93 |- mesh__historyNote mesh__D051017 2006
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D051017 2006
% 209.74/209.93 |- skos__altLabel mesh__D051017 Programmed Cell Death Proteins
% 209.74/209.93 |- mesh__dateEstablished mesh__D051017 2006-01-01
% 209.74/209.93 |- mesh__dateCreated mesh__D051017 2005-06-30
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D051017 2006
% 209.74/209.93 |- rdf__type mesh__D051017sskos__Concept
% 209.74/209.93 |- mesh__recordOriginator mesh__D051017 DRC
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D051017 sjn
% 209.74/209.93 |- skos__altLabel mesh__D051017 Pro-Apoptotic Proteins
% 209.74/209.93 |- skos__altLabel mesh__D051017 Survival Factors %28%Apoptosis%29%
% 209.74/209.93 |- mesh__recordMaintainer mesh__D051017 DRC
% 209.74/209.93 |- skos__altLabel mesh__D051017 Anti-Apoptotic Proteins
% 209.74/209.93 |- skos__altLabel mesh__D051017 Death Factors %28%Apoptosis%29%
% 209.74/209.93 |- skos__scopeNote mesh__D051017
% 209.74/209.93 A large group of proteins that control APOPTOSIS. This family of proteins includes many ONCOGENE PROTEINS as well as a wide variety of classes of INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS such as CASPASES.%A%
% 209.74/209.93 |- skos__broader mesh__D051017smesh__D047908
% 209.74/209.93 |- skos__hiddenLabel mesh__D051017 Regulatory Proteins, Apoptosis
% 209.74/209.93 |- skos__prefLabel mesh__D051017 Apoptosis Regulatory Proteins
% 209.74/209.93 |- skos__altLabel mesh__D009655 para-Octopamine
% 209.74/209.93 |- mesh__onlineNote mesh__D009655
% 209.74/209.93 use OCTOPAMINE to search NORSYNEPHRINE 1966-90
% 209.74/209.93 |- skos__prefLabel mesh__D009655 Octopamine
% 209.74/209.93 |- mesh__recordOriginator mesh__D009655 NLM
% 209.74/209.93 |- mesh__historyNote mesh__D009655 91; NORSYNEPHRINE was heading 1963-90
% 209.74/209.93 |- skos__altLabel mesh__D009655 Norsynephrine
% 209.74/209.93 |- mesh__dateCreated mesh__D009655 1999-01-01
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D009655 sjn
% 209.74/209.93 |- rdf__type mesh__D009655sskos__Concept
% 209.74/209.93 |- skos__altLabel mesh__D009655 Norsympatol
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D009655
% 209.74/209.93 91; NORSYNEPHRINE was heading 1963-90
% 209.74/209.93 |- skos__altLabel mesh__D009655 4-Octopamine
% 209.74/209.93 |- mesh__dateRevised mesh__D009655 2005-06-30
% 209.74/209.93 |- skos__broader mesh__D009655smesh__D010627
% 209.74/209.93 |- skos__altLabel mesh__D009655 p-Octopamine
% 209.74/209.93 |- mesh__recordMaintainer mesh__D009655 ssb
% 209.74/209.93 |- skos__scopeNote mesh__D009655
% 209.74/209.93 An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D%28%-%29% form is more potent than the L%28%+%29% form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.%A%
% 209.74/209.93 |- skos__altLabel mesh__D009655
% 209.74/209.93 alpha-%28%Aminoethyl%29%-4-hydroxybenzenemethanol
% 209.74/209.93 |- skos__broader mesh__D009655smesh__D014439
% 209.74/209.93 |- skos__broader mesh__D009655smesh__D004983
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009655 2006
% 209.74/209.93 |- mesh__dateEstablished mesh__D001672 1973-01-01
% 209.74/209.93 |- mesh__historyNote mesh__D001672 73%28%72%29%
% 209.74/209.93 |- skos__related mesh__D001672smesh__D008422
% 209.74/209.93 |- rdf__type mesh__D001672sskos__Concept
% 209.74/209.93 |- mesh__recordMaintainer mesh__D001672 nns
% 209.74/209.93 |- skos__hiddenLabel mesh__D001672 Materials, Biocompatible
% 209.74/209.93 |- mesh__dateCreated mesh__D001672 1999-01-01
% 209.74/209.93 |- skos__scopeNote mesh__D001672
% 209.74/209.93 Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function.%A%
% 209.74/209.93 |- skos__prefLabel mesh__D001672 Biocompatible Materials
% 209.74/209.93 |- mesh__dateRevised mesh__D001672 2005-06-30
% 209.74/209.93 |- skos__hiddenLabel mesh__D001672 Materials, Hemocompatible
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001672 2006
% 209.74/209.93 |- skos__historyNote mesh__D001672 Prosthesis %28%1966-1971%29%
% 209.74/209.93 |- skos__broader mesh__D001672smesh__D001697
% 209.74/209.93 |- skos__altLabel mesh__D001672 Biomaterials
% 209.74/209.93 |- skos__related mesh__D001672smesh__D040761
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D001672 sjn
% 209.74/209.93 |- mesh__recordOriginator mesh__D001672 NLM
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D001672 73
% 209.74/209.93 |- skos__broader mesh__D005265smesh__D006620
% 209.74/209.93 |- skos__altLabel mesh__D005265 Femur Neck Fractures
% 209.74/209.93 |- mesh__dateCreated mesh__D005265 1999-01-01
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D005265 2006
% 209.74/209.93 |- skos__hiddenLabel mesh__D005265 Femur Neck Fracture
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D005265 sjn
% 209.74/209.93 |- skos__prefLabel mesh__D005265 Femoral Neck Fractures
% 209.74/209.93 |- skos__hiddenLabel mesh__D005265 Femoral Neck Fracture
% 209.74/209.93 |- skos__scopeNote mesh__D005265
% 209.74/209.93 Fractures of the short, constricted portion of the thigh bone between the femur head and the trochanters. It excludes intertrochanteric fractures which are HIP FRACTURES.%A%
% 209.74/209.93 |- mesh__recordOriginator mesh__D005265 NLM
% 209.74/209.93 |- rdf__type mesh__D005265sskos__Concept
% 209.74/209.93 |- mesh__dateRevised mesh__D005265 2005-06-30
% 209.74/209.93 |- mesh__recordMaintainer mesh__D005265 ssb
% 209.74/209.93 |- skos__broader mesh__D043384smesh__D045727
% 209.74/209.93 |- skos__broader mesh__D043384smesh__D000626
% 209.74/209.93 |- skos__altLabel mesh__D043384 Angiotensinase A
% 209.74/209.93 |- skos__scopeNote mesh__D043384
% 209.74/209.93 A ZINC-dependent membrane-bound aminopeptidase that catalyzes the N-terminal peptide cleavage of GLUTAMATE %28%and to a lesser extent ASPARTATE%29%. The enzyme appears to play a role in the catabolic pathway of the RENIN-ANGIOTENSIN SYSTEM.%A%
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D043384
% 209.74/209.93 2004; GLUTAMYL AMINOPEPTIDASE was indexed under AMINOPEPTIDASES 1981-2003 %26% ASPARTIC ACID 1978-1980%A%
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D043384 2004
% 209.74/209.93 |- skos__hiddenLabel mesh__D043384 Aminopeptidase, Aspartyl
% 209.74/209.93 |- skos__historyNote mesh__D043384 Aspartic Acid %28%1978-1980%29%
% 209.74/209.93 |- skos__altLabel mesh__D043384 Aspartyl Aminopeptidase
% 209.74/209.93 |- skos__altLabel mesh__D043384 Aspartate Aminopeptidase
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D043384 2005
% 209.74/209.93 |- skos__prefLabel mesh__D043384 Glutamyl Aminopeptidase
% 209.74/209.93 |- skos__historyNote mesh__D043384 Aminopeptidases %28%1981-2003%29%
% 209.74/209.93 |- mesh__dateCreated mesh__D043384 2003-07-09
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D043384 2006
% 209.74/209.93 |- skos__hiddenLabel mesh__D043384 Aminopeptidase, Glutamyl
% 209.74/209.93 |- skos__hiddenLabel mesh__D043384 Aminopeptidase, Aspartate
% 209.74/209.93 |- mesh__dateEstablished mesh__D043384 2004-01-01
% 209.74/209.93 |- rdf__type mesh__D043384sskos__Concept
% 209.74/209.93 |- mesh__historyNote mesh__D043384
% 209.74/209.93 2004; use GLUTAMYL AMINPEPTIDASE %28%NM%29% 1980-2003
% 209.74/209.93 |- skos__altLabel mesh__D043384 Aminopeptidase A
% 209.74/209.93 |- mesh__historyNote mesh__D051816 2006%28%1991%29%
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D051816
% 209.74/209.93 2006; TRISTETRAPROLIN was indexed under DNA-BINDING PROTEINS 2001-2005, %26% under IMMEDIATE-EARLY PROTEINS 1991-2005, %26% under PROTEINS 1998-2000%A%
% 209.74/209.93 |- mesh__dateRevised mesh__D051816 2005-07-21
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D051816 2006C
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D051816 ags
% 209.74/209.93 |- skos__broader mesh__D051816smesh__D004268
% 209.74/209.93 |- skos__broader mesh__D051816smesh__D017874
% 209.74/209.93 |- skos__hiddenLabel mesh__D051816 G0 G1 Switch Regulatory Protein 24
% 209.74/209.93 |- skos__prefLabel mesh__D051816 Tristetraprolin
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D051816 2006B
% 209.74/209.93 |- skos__altLabel mesh__D051816 G0-G1 Switch Regulatory Protein 24
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D051816 2006
% 209.74/209.93 |- skos__broader mesh__D051816smesh__D014157
% 209.74/209.93 |- mesh__dateEstablished mesh__D051816 2006-01-01
% 209.74/209.93 |- mesh__recordMaintainer mesh__D051816 ags
% 209.74/209.93 |- rdf__type mesh__D051816sskos__Concept
% 209.74/209.93 |- skos__scopeNote mesh__D051816
% 209.74/209.93 A ZINC FINGER MOTIF containing transcription factor that was originally identified as one of the IMMEDIATE-EARLY PROTEINS. It shuttles between the CYTOPLASM and the CELL NUCLEUS and is involved in destabilization of mRNAs for TUMOR NECROSIS FACTOR-ALPHA.%A%
% 209.74/209.93 |- skos__altLabel mesh__D051816 Tristetraprolin Protein
% 209.74/209.93 |- skos__altLabel mesh__D051816 Zinc Finger Protein 36
% 209.74/209.93 |- mesh__recordOriginator mesh__D051816 DRC
% 209.74/209.93 |- mesh__dateCreated mesh__D051816 2005-06-30
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D051816 2006A
% 209.74/209.93 |- skos__hiddenLabel mesh__D015693 HIV 3%27% orf Protein
% 209.74/209.93 |- skos__scopeNote mesh__D015693
% 209.74/209.93 Products of the HIV nef gene %28%formerly 3%27%-orf gene%29%. The products trans-suppress viral replication and function as negative regulators of transcription. nef stands for negative factor.%A%
% 209.74/209.93 |- mesh__dateCreated mesh__D015693 1989-10-20
% 209.74/209.93 |- skos__altLabel mesh__D015693 nef Gene Products
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D015693
% 209.74/209.93 91; was see under VIRAL REGULATORY PROTEINS 1990
% 209.74/209.93 |- mesh__dateRevised mesh__D015693 2005-06-30
% 209.74/209.93 |- skos__broader mesh__D015693smesh__D015520
% 209.74/209.93 |- skos__hiddenLabel mesh__D015693 Product, nef Gene
% 209.74/209.93 |- skos__hiddenLabel mesh__D015693 3%27% orf Protein
% 209.74/209.93 |- skos__hiddenLabel mesh__D015693 HIV F Protein
% 209.74/209.93 |- mesh__recordMaintainer mesh__D015693 SYSTEM
% 209.74/209.93 |- skos__historyNote mesh__D015693 Viral Proteins %28%1987-1988%29%
% 209.74/209.93 |- skos__hiddenLabel mesh__D015693 Protein, 3%27%-orf
% 209.74/209.93 |- skos__prefLabel mesh__D015693 Gene Products, nef
% 209.74/209.93 |- mesh__recordOriginator mesh__D015693 AGS
% 209.74/209.93 |- rdf__type mesh__D015693sskos__Concept
% 209.74/209.93 |- skos__hiddenLabel mesh__D015693 nef Gene Product
% 209.74/209.93 |- skos__altLabel mesh__D015693 Gene Product, nef
% 209.74/209.93 |- skos__annotation mesh__D015693
% 209.74/209.93 nef stands for %22%negative factor%22%; IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%
% 209.74/209.93 |- skos__hiddenLabel mesh__D015693 Protein, nef
% 209.74/209.93 |- skos__historyNote mesh__D015693 Retroviridae Proteins %28%1987-1989%29%
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D015693 sjn
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D015693 2006
% 209.74/209.93 |- skos__hiddenLabel mesh__D015693 Protein, HIV-F
% 209.74/209.93 |- mesh__dateEstablished mesh__D015693 1991-01-01
% 209.74/209.93 |- skos__hiddenLabel mesh__D015693 Protein, HIV-3%27%-orf
% 209.74/209.93 |- mesh__historyNote mesh__D015693
% 209.74/209.93 91%28%90%29%; was see under VIRAL REGULATORY PROTEINS 1990
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 2001
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 1997
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 1994
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 2003
% 209.74/209.93 |- skos__prefLabel mesh__D009656 North America
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 1995
% 209.74/209.93 |- rdf__type mesh__D009656sskos__Concept
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 2004
% 209.74/209.93 |- mesh__dateRevised mesh__D009656 1993-06-03
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 1998
% 209.74/209.93 |- skos__broader mesh__D009656smesh__D000569
% 209.74/209.93 |- mesh__recordOriginator mesh__D009656 NLM
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 2002
% 209.74/209.93 |- skos__annotation mesh__D009656 includes Mexico
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 1999
% 209.74/209.93 |- mesh__recordMaintainer mesh__D009656 PLS
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 2005
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 1996
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D009656 PLS
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 2000
% 209.74/209.93 |- mesh__dateCreated mesh__D009656 1999-01-01
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D009656 2006
% 209.74/209.93 |- rdf__type mesh__D001673sskos__Concept
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001673 2003
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D001673 sjn
% 209.74/209.93 |- mesh__dateCreated mesh__D001673 1999-01-01
% 209.74/209.93 |- mesh__recordOriginator mesh__D001673 NLM
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001673 2004
% 209.74/209.93 |- mesh__historyNote mesh__D001673
% 209.74/209.93 78%28%69%29%; was see under SANITARY ENGINEERING 1975-77
% 209.74/209.93 |- skos__hiddenLabel mesh__D001673 Bioremediations
% 209.74/209.93 |- skos__broader mesh__D001673smesh__D012498
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001673 2005
% 209.74/209.93 |- skos__historyNote mesh__D001673 Biophysics %28%1966-1968%29%
% 209.74/209.93 |- skos__historyNote mesh__D001673 appropriate material
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001673 2001
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001673 2006
% 209.74/209.93 |- mesh__recordMaintainer mesh__D001673 jmp
% 209.74/209.93 |- skos__hiddenLabel mesh__D001673 Biodegradations
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D001673
% 209.74/209.93 78; was see under SANITARY ENGINEERING 1975-77
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D001673 2002
% 209.74/209.93 |- skos__historyNote mesh__D001673 Sanitary Engineering %28%1966-1968%29%
% 209.74/209.93 |- skos__prefLabel mesh__D001673 Biodegradation
% 209.74/209.93 |- skos__scopeNote mesh__D001673
% 209.74/209.93 The series of processes by which living organisms degrade pollutant chemicals, organic wastes, pesticides, and implantable materials.%A%
% 209.74/209.93 |- mesh__dateRevised mesh__D001673 2000-06-22
% 209.74/209.93 |- mesh__dateEstablished mesh__D001673 1978-01-01
% 209.74/209.93 |- skos__annotation mesh__D001673
% 209.74/209.93 NIM when specific substance is IM; do not confuse with BIOTRANSFORMATION: see note there%A%
% 209.74/209.93 |- skos__broader mesh__D001673smesh__D001686
% 209.74/209.93 |- mesh__historyNote mesh__D019286
% 209.74/209.93 97; was ENDOPEPTIDASE K %28%NM%29% 1979-96
% 209.74/209.93 |- skos__historyNote mesh__D019286
% 209.74/209.93 Peptide Peptidohydrolases %28%1979-1987%29%
% 209.74/209.93 |- skos__hiddenLabel mesh__D019286 Proteinase, Tritirachium Alkaline
% 209.74/209.93 |- skos__altLabel mesh__D019286 Tritirachium Alkaline Proteinase
% 209.74/209.93 |- mesh__recordAuthorizer mesh__D019286 sjn
% 209.74/209.93 |- skos__scopeNote mesh__D019286
% 209.74/209.93 An enzyme that catalyzes the hydrolysis of keratin, and of other proteins with subtilisin-like specificity. It hydrolyses peptide amides. Endopeptidase K is from the mold Tritirachium album Limber. %28%Enzyme Nomenclature, 1992%29% EC 3.4.21.64.%A%
% 209.74/209.93 |- skos__altLabel mesh__D019286 Proteinase K
% 209.74/209.93 |- skos__altLabel mesh__D019286 Protease K
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D019286 2004
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D019286 2005
% 209.74/209.93 |- mesh__recordOriginator mesh__D019286 TPW
% 209.74/209.93 |- skos__prefLabel mesh__D019286 Endopeptidase K
% 209.74/209.93 |- rdf__type mesh__D019286sskos__Concept
% 209.74/209.93 |- mesh__activeMeSHYear mesh__D019286 2006
% 209.74/209.93 |- mesh__onlineNote mesh__D019286
% 209.74/209.93 use ENDOPEPTIDASE K %28%NM%29% to search ENDOPEPTIDASE K 1980-96%A%
% 209.74/209.93 |- skos__broader mesh__D019286smesh__D012697
% 209.74/209.93 |- mesh__dateEstablished mesh__D019286 1997-01-01
% 209.74/209.93 |- mesh__publicMeSHNote mesh__D019286
% 209.74/209.93 97; ENDOPEPTIDASE K was indexed under SERINE PROTEINASES 1988-96 %26% PEPTIDE PEPTIDOHYDROLASES 1979-87%A%
% 209.74/209.93 |- skos__hiddenLabel mesh__D019286 Alkaline Proteinase, Tritirachium
% 209.74/209.93 |- mesh__dateRevised mesh__D019286 2003-07-09
% 209.74/209.93 |- skos__historyNote mesh__D019286 Serine Proteinases %28%1988-1996%29%
% 209.74/209.94 |- mesh__dateCreated mesh__D019286 1996-06-10
% 209.74/209.94 |- mesh__recordMaintainer mesh__D019286 ssb
% 209.74/209.94 |- skos__hiddenLabel mesh__D005266 Neoplasm, Femoral
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 2003
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 2001
% 209.74/209.94 |- mesh__dateRevised mesh__D005266 1995-06-08
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 1997
% 209.74/209.94 |- mesh__recordOriginator mesh__D005266 NLM
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 2004
% 209.74/209.94 |- skos__broader mesh__D005266smesh__D001859
% 209.74/209.94 |- rdf__type mesh__D005266sskos__Concept
% 209.74/209.94 |- skos__hiddenLabel mesh__D005266 Neoplasms, Femoral
% 209.74/209.94 |- skos__hiddenLabel mesh__D005266 Femoral Neoplasm
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 2002
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 1998
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 2005
% 209.74/209.94 |- skos__prefLabel mesh__D005266 Femoral Neoplasms
% 209.74/209.94 |- skos__annotation mesh__D005266
% 209.74/209.94 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific FEMUR HEAD or FEMUR NECK %28%NIM%29% as merely locational + histol type of neopl %28%IM%29%%A%
% 209.74/209.94 |- mesh__dateCreated mesh__D005266 1999-01-01
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 1999
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D005266 PLS
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 2006
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 2000
% 209.74/209.94 |- mesh__recordMaintainer mesh__D005266 KEV
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005266 1996
% 209.74/209.94 |- skos__altLabel mesh__D010400 Medical Brand of Penicillin G Potassium
% 209.74/209.94 |- skos__altLabel mesh__D010400 CSL Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__altLabel mesh__D010400 Ern Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__altLabel mesh__D010400 Benzylpenicillin
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D010400 sjn
% 209.74/209.94 |- mesh__recordOriginator mesh__D010400 NLM
% 209.74/209.94 |- skos__altLabel mesh__D010400 Medical Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__prefLabel mesh__D010400 Penicillin G
% 209.74/209.94 |- skos__altLabel mesh__D010400 Bioniche Brand of Penicillin G Sodium
% 209.74/209.94 |- rdf__type mesh__D010400sskos__Concept
% 209.74/209.94 |- mesh__recordMaintainer mesh__D010400 lkw
% 209.74/209.94 |- skos__altLabel mesh__D010400 Sodium Benzylpenicillin
% 209.74/209.94 |- skos__altLabel mesh__D010400 Vangard Brand of Penicillin G Potassium
% 209.74/209.94 |- skos__altLabel mesh__D010400 Ortega Brand of Penicillin G Potassium
% 209.74/209.94 |- skos__altLabel mesh__D010400 Antibioticos Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__scopeNote mesh__D010400
% 209.74/209.94 A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.%A%
% 209.74/209.94 |- skos__altLabel mesh__D010400 Parmed Brand of Penicillin G Potassium
% 209.74/209.94 |- skos__altLabel mesh__D010400 CEPA Brand of Penicillin G Sodium
% 209.74/209.94 |- mesh__dateCreated mesh__D010400 1999-01-01
% 209.74/209.94 |- skos__altLabel mesh__D010400 Sodium Penicillin
% 209.74/209.94 |- skos__altLabel mesh__D010400 Jenapharm Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__annotation mesh__D010400 GEN or unspecified; prefer specifics
% 209.74/209.94 |- skos__broader mesh__D010400smesh__D010406
% 209.74/209.94 |- skos__altLabel mesh__D010400 Lakeside Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__altLabel mesh__D010400 Normon Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__altLabel mesh__D010400 Unicilina
% 209.74/209.94 |- skos__altLabel mesh__D010400 Pfizer Brand of Penicillin G Potassium
% 209.74/209.94 |- skos__altLabel mesh__D010400 Llorente Brand of Penicillin G Sodium
% 209.74/209.94 |- mesh__dateRevised mesh__D010400 2005-06-30
% 209.74/209.94 |- skos__altLabel mesh__D010400
% 209.74/209.94 Gr%C3%%BC%nenthal Brand of Penicillin G Potassium
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D010400 2006
% 209.74/209.94 |- skos__altLabel mesh__D010400 Clonmel Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__altLabel mesh__D010400 Britannia Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__altLabel mesh__D010400 UCB Brand of Penicillin G Sodium
% 209.74/209.94 |- skos__altLabel mesh__D010400 Benzylpenicillin Potassium
% 209.74/209.94 |- skos__altLabel mesh__D051817 Early Response Factor Berg36
% 209.74/209.94 |- mesh__dateCreated mesh__D051817 2005-06-30
% 209.74/209.94 |- skos__broader mesh__D051817smesh__D004268
% 209.74/209.94 |- skos__broader mesh__D051817smesh__D017874
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D051817
% 209.74/209.94 2006; BUTYRATE RESPONSE FACTOR 1 was indexed under DNA-BINDING PROTEINS 2001-2005, %26% under IMMEDIATE-EARLY PROTEINS 1991-2005, %26% under PROTEINS 1998-2000%A%
% 209.74/209.94 |- skos__scopeNote mesh__D051817
% 209.74/209.94 A ZINC FINGER MOTIF containing immediate early protein that is closely related to TRISTETRAPROLIN. It interacts with and helps destabilize VASCULAR ENDOTHELIAL GROWTH FACTOR mRNA.%A%
% 209.74/209.94 |- mesh__historyNote mesh__D051817 2006%28%1991%29%
% 209.74/209.94 |- skos__prefLabel mesh__D051817 Butyrate Response Factor 1
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D051817 2006
% 209.74/209.94 |- rdf__type mesh__D051817sskos__Concept
% 209.74/209.94 |- mesh__recordMaintainer mesh__D051817 DRC
% 209.74/209.94 |- mesh__recordOriginator mesh__D051817 DRC
% 209.74/209.94 |- skos__broader mesh__D051817smesh__D016601
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D051817 sjn
% 209.74/209.94 |- mesh__dateEstablished mesh__D051817 2006-01-01
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 art trs Gene Protein, HIV
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 Products, rev Gene
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 HIV Transactivator Protein
% 209.74/209.94 |- skos__prefLabel mesh__D015694 Gene Products, rev
% 209.74/209.94 |- skos__historyNote mesh__D015694 Retroviridae Proteins %28%1986-1989%29%
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 Protein, HIV Trans-Activator
% 209.74/209.94 |- mesh__historyNote mesh__D015694
% 209.74/209.94 91%28%90%29%; was see under TRANS-ACTIVATORS 1990
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 Product, rev Gene
% 209.74/209.94 |- mesh__recordMaintainer mesh__D015694 SYSTEM
% 209.74/209.94 |- mesh__dateCreated mesh__D015694 1989-07-06
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 HIV trs art Gene Protein
% 209.74/209.94 |- skos__altLabel mesh__D015694 Gene Product, rev
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D015694
% 209.74/209.94 91; was see under TRANS-ACTIVATORS 1990
% 209.74/209.94 |- rdf__type mesh__D015694sskos__Concept
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 rev Gene Product
% 209.74/209.94 |- skos__altLabel mesh__D015694 rev Gene Products
% 209.74/209.94 |- mesh__dateRevised mesh__D015694 2005-06-30
% 209.74/209.94 |- skos__historyNote mesh__D015694 Viral Proteins %28%1986-1989%29%
% 209.74/209.94 |- skos__altLabel mesh__D015694 Transactivator Protein, HIV
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 trs art Gene Protein, HIV
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 Trans Activator Protein, HIV
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 HIV Trans-Activator Protein
% 209.74/209.94 |- skos__altLabel mesh__D015694 HIV art-trs Gene Protein
% 209.74/209.94 |- skos__scopeNote mesh__D015694
% 209.74/209.94 Trans-acting nuclear proteins whose functional expression are required for HIV viral replication. Specifically, the rev gene products are required for processing and translation of the HIV gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence %28%CAR%29% in env, also known as the rev-responsive element %28%RRE%29%, is responsive to the rev gene product. rev is short for regulator of virion.%A%
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D015694 2006
% 209.74/209.94 |- mesh__recordOriginator mesh__D015694 AGS
% 209.74/209.94 |- mesh__dateEstablished mesh__D015694 1991-01-01
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 Protein, rev
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 HIV art trs Gene Protein
% 209.74/209.94 |- skos__hiddenLabel mesh__D015694 Protein, HIV Transactivator
% 209.74/209.94 |- skos__altLabel mesh__D015694 art-trs Gene Protein, HIV
% 209.74/209.94 |- skos__altLabel mesh__D015694 HIV trs-art Gene Protein
% 209.74/209.94 |- skos__annotation mesh__D015694
% 209.74/209.94 Rev stands for %22%regulator of virion%22%; IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%
% 209.74/209.94 |- skos__broader mesh__D015694smesh__D015534
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D015694 sjn
% 209.74/209.94 |- mesh__dateEstablished mesh__D048070 2005-01-01
% 209.74/209.94 |- skos__broader mesh__D048070smesh__D005315
% 209.74/209.94 |- mesh__recordOriginator mesh__D048070 lkt
% 209.74/209.94 |- mesh__dateRevised mesh__D048070 2005-06-30
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D048070
% 209.74/209.94 2005; see PLACENTA INSUFFICIENCY 1998-2004
% 209.74/209.94 |- skos__altLabel mesh__D048070 Malnutrition, Fetal
% 209.74/209.94 |- skos__historyNote mesh__D048070 Fetal Diseases %28%1965-1981%29%
% 209.74/209.94 |- skos__hiddenLabel mesh__D048070 Fetal Nutrition Disorder
% 209.74/209.94 |- skos__altLabel mesh__D048070 Nutrition Disorders, Fetal
% 209.74/209.94 |- mesh__dateCreated mesh__D048070 2004-07-07
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D048070 sjn
% 209.74/209.94 |- mesh__recordMaintainer mesh__D048070 lkt
% 209.74/209.94 |- skos__scopeNote mesh__D048070
% 209.74/209.94 Disorders caused by nutritional imbalance, either overnutrition or undernutrition, in the FETUS in utero.%A%
% 209.74/209.94 |- skos__historyNote mesh__D048070
% 209.74/209.94 Placental Insufficiency %28%1982-2004%29%
% 209.74/209.94 |- skos__prefLabel mesh__D048070 Fetal Nutrition Disorders
% 209.74/209.94 |- skos__hiddenLabel mesh__D048070 Nutrition Disorder, Fetal
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D048070 2006
% 209.74/209.94 |- skos__broader mesh__D048070smesh__D044342
% 209.74/209.94 |- rdf__type mesh__D048070sskos__Concept
% 209.74/209.94 |- mesh__historyNote mesh__D048070
% 209.74/209.94 2005; use PLACENTA INSUFFICIENCY 1998-2004
% 209.74/209.94 |- mesh__dateRevised mesh__D009657 1997-06-20
% 209.74/209.94 |- skos__broader mesh__D009657smesh__D015144
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009657 2000
% 209.74/209.94 |- rdf__type mesh__D009657sskos__Concept
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009657 2004
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009657 1998
% 209.74/209.94 |- skos__prefLabel mesh__D009657 North Carolina
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009657 2001
% 209.74/209.94 |- skos__broader mesh__D009657smesh__D001061
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009657 1999
% 209.74/209.94 |- mesh__recordMaintainer mesh__D009657 PXP
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009657 2005
% 209.74/209.94 |- mesh__recordOriginator mesh__D009657 NLM
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009657 2002
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D009657 SJN
% 209.74/209.94 |- mesh__dateCreated mesh__D009657 1999-01-01
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009657 2006
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009657 2003
% 209.74/209.94 |- skos__broader mesh__D001674smesh__D011211
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Biological Energy Source
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Energy Sources, Biologic
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D001674 2006
% 209.74/209.94 |- mesh__dateRevised mesh__D001674 2005-06-30
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D001674 74
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Sources, Bioelectric Energy
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Power Source, Bioelectric
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Bioelectric Energy Source
% 209.74/209.94 |- skos__annotation mesh__D001674
% 209.74/209.94 includes biofuels, ionic concentration cells, biogalvanic cells, etc.%A%
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Energy Source, Bioelectric
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Bioelectric Power Source
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Energy Source, Biologic
% 209.74/209.94 |- mesh__recordMaintainer mesh__D001674 ags
% 209.74/209.94 |- mesh__historyNote mesh__D001674 74
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Sources, Bioelectric Power
% 209.74/209.94 |- mesh__recordOriginator mesh__D001674 NLM
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D001674 sjn
% 209.74/209.94 |- rdf__type mesh__D001674sskos__Concept
% 209.74/209.94 |- skos__altLabel mesh__D001674 Biologic Energy Source
% 209.74/209.94 |- skos__scopeNote mesh__D001674
% 209.74/209.94 Implantable devices which convert biological energy %28%chemical energy of the metabolism of continuously regenerating body fluids or mechanical energy of periodic movements%29% to electrical energy. The sources include biogalvanic cells, biofuel cells, and ionic concentration cells.%A%
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Sources, Biological Energy
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Source, Bioelectric Energy
% 209.74/209.94 |- mesh__dateEstablished mesh__D001674 1974-01-01
% 209.74/209.94 |- skos__altLabel mesh__D001674 Energy Source, Biological
% 209.74/209.94 |- mesh__dateCreated mesh__D001674 1999-01-01
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Sources, Biologic Energy
% 209.74/209.94 |- skos__altLabel mesh__D001674 Energy Sources, Biological
% 209.74/209.94 |- skos__altLabel mesh__D001674 Biological Energy Sources
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Energy Sources, Bioelectric
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Bioelectric Power Sources
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Biologic Energy Sources
% 209.74/209.94 |- skos__prefLabel mesh__D001674 Bioelectric Energy Sources
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Source, Biologic Energy
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Source, Bioelectric Power
% 209.74/209.94 |- skos__hiddenLabel mesh__D001674 Source, Biological Energy
% 209.74/209.94 |- mesh__recordMaintainer mesh__D020030 ssb
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D020030 sjn
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D020030 99
% 209.74/209.94 |- mesh__dateEstablished mesh__D020030 1999-01-01
% 209.74/209.94 |- mesh__dateRevised mesh__D020030 2005-06-30
% 209.74/209.94 |- skos__broader mesh__D020030smesh__D045504
% 209.74/209.94 |- skos__scopeNote mesh__D020030
% 209.74/209.94 A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. %28%Adv Pharmacol 1995;34:361-81%29%%A%
% 209.74/209.94 |- skos__historyNote mesh__D020030 Nitric Oxide %28%1990-1998%29%
% 209.74/209.94 |- skos__prefLabel mesh__D020030 Nitric Oxide Donors
% 209.74/209.94 |- skos__related mesh__D020030smesh__D009569
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D020030 2006
% 209.74/209.94 |- rdf__type mesh__D020030sskos__Concept
% 209.74/209.94 |- skos__hiddenLabel mesh__D020030 Donors, Nitric Oxide
% 209.74/209.94 |- skos__hiddenLabel mesh__D020030 Oxide Donors, Nitric
% 209.74/209.94 |- mesh__recordOriginator mesh__D020030 ADP
% 209.74/209.94 |- mesh__historyNote mesh__D020030 99
% 209.74/209.94 |- skos__broader mesh__D020030smesh__D002317
% 209.74/209.94 |- mesh__dateCreated mesh__D020030 1998-06-10
% 209.74/209.94 |- skos__historyNote mesh__D019287 Zinc %28%1979-1993%29%
% 209.74/209.94 |- skos__historyNote mesh__D019287 Sulfates %28%1979-1996%29%
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D019287
% 209.74/209.94 97; ZINC SULFATE was indexed under ZINC COMPOUNDS 1994-96, SULFATES 1979-96, %26% ZINC 1979-93%A%
% 209.74/209.94 |- skos__scopeNote mesh__D019287
% 209.74/209.94 A compound given in the treatment of conditions associated with zinc deficiency such as acrodermatitis enteropathica. Externally, zinc sulfate is used as an astringent in lotions and eye drops. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A%
% 209.74/209.94 |- mesh__recordMaintainer mesh__D019287 WXM
% 209.74/209.94 |- skos__broader mesh__D019287smesh__D017967
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D019287 2004
% 209.74/209.94 |- mesh__onlineNote mesh__D019287
% 209.74/209.94 use ZINC SULFATE %28%NM%29% to search ZINC SULFATE 1980-96
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D019287 2003
% 209.74/209.94 |- mesh__dateEstablished mesh__D019287 1997-01-01
% 209.74/209.94 |- mesh__dateCreated mesh__D019287 1996-06-10
% 209.74/209.94 |- mesh__dateRevised mesh__D019287 2001-07-25
% 209.74/209.94 |- skos__hiddenLabel mesh__D019287 Sulfate, Zinc
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D019287 sjn
% 209.74/209.94 |- skos__prefLabel mesh__D019287 Zinc Sulfate
% 209.74/209.94 |- skos__historyNote mesh__D019287 Zinc Compounds %28%1994-1996%29%
% 209.74/209.94 |- rdf__type mesh__D019287sskos__Concept
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D019287 2006
% 209.74/209.94 |- mesh__recordOriginator mesh__D019287 ADP
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D019287 2002
% 209.74/209.94 |- skos__broader mesh__D019287smesh__D013431
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D019287 2005
% 209.74/209.94 |- mesh__historyNote mesh__D019287
% 209.74/209.94 97; was ZINC SULFATE %28%NM%29% 1979-96
% 209.74/209.94 |- skos__scopeNote mesh__D038441
% 209.74/209.94 A diet typical of the Mediterranean region characterized by a pattern high in fruits and vegetables, cereals and bread, potatoes, poultry, beans, nuts, olive oil and fish while low in red meat and dairy and moderate in alcohol consumption.%A%
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D038441 2003
% 209.74/209.94 |- mesh__dateCreated mesh__D038441 2002-07-03
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D038441 2004
% 209.74/209.94 |- skos__altLabel mesh__D038441 Mediterranean Diet
% 209.74/209.94 |- skos__prefLabel mesh__D038441 Diet, Mediterranean
% 209.74/209.94 |- mesh__dateEstablished mesh__D038441 2003-01-01
% 209.74/209.94 |- mesh__historyNote mesh__D038441 2003
% 209.74/209.94 |- skos__annotation mesh__D038441 coord with specific disease or edible
% 209.74/209.94 |- skos__broader mesh__D038441smesh__D004032
% 209.74/209.94 |- skos__hiddenLabel mesh__D038441 Mediterranean Diets
% 209.74/209.94 |- rdf__type mesh__D038441sskos__Concept
% 209.74/209.94 |- skos__historyNote mesh__D038441 Diet %28%1984-2002%29%
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D038441 2005
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D038441 2003
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D038441 2006
% 209.74/209.94 |- skos__hiddenLabel mesh__D038441 Diets, Mediterranean
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005267 2004
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D005267 sjn
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005267 2000
% 209.74/209.94 |- skos__annotation mesh__D005267
% 209.74/209.94 dis = FEMORAL NEUROPATHY; neopl = FEMORAL NEUROPATHY %28%IM%29% + PERIPHERAL NERVOUS SYSTEM NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; posterior femoral cutaneous nerve: index under PERIPHERAL NERVES%A%
% 209.74/209.94 |- skos__hiddenLabel mesh__D005267 Femoral Nerves
% 209.74/209.94 |- rdf__type mesh__D005267sskos__Concept
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005267 2001
% 209.74/209.94 |- mesh__recordOriginator mesh__D005267 NLM
% 209.74/209.94 |- skos__prefLabel mesh__D005267 Femoral Nerve
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005267 2005
% 209.74/209.94 |- mesh__dateRevised mesh__D005267 1999-11-05
% 209.74/209.94 |- skos__broader mesh__D005267smesh__D008160
% 209.74/209.94 |- mesh__dateCreated mesh__D005267 1999-01-01
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005267 2006
% 209.74/209.94 |- skos__scopeNote mesh__D005267
% 209.74/209.94 A nerve originating in the lumbar spinal cord %28%usually L2 to L4%29% and traveling through the lumbar plexus to provide motor innervation to extensors of the thigh and sensory innervation to parts of the thigh, lower leg, and foot, and to the hip and knee joints.%A%
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005267 2002
% 209.74/209.94 |- mesh__recordMaintainer mesh__D005267 KEV
% 209.74/209.94 |- skos__hiddenLabel mesh__D005267 Nerve, Femoral
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D005267 2003
% 209.74/209.94 |- skos__hiddenLabel mesh__D005267 Nerves, Femoral
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401 Bicillin LA
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401 Penicillin, Benzathine
% 209.74/209.94 |- skos__altLabel mesh__D010401 Bayer Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- mesh__dateCreated mesh__D010401 1999-01-01
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D010401
% 209.74/209.94 91; was see under PENICILLIN G 1985-90; was heading 1963-84%A%
% 209.74/209.94 |- skos__altLabel mesh__D010401 Penicillin G Benzathine
% 209.74/209.94 |- mesh__historyNote mesh__D010401
% 209.74/209.94 91%28%85%29%63; was see under PENICILLIN G 1985-90; was heading 1963-84%A%
% 209.74/209.94 |- skos__altLabel mesh__D010401 Bicillin L-A
% 209.74/209.94 |- skos__altLabel mesh__D010401 Roerig Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__altLabel mesh__D010401
% 209.74/209.94 Jenapharm Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401 Benzatina, Provipen
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D010401 2005
% 209.74/209.94 |- skos__altLabel mesh__D010401
% 209.74/209.94 I Farmacologia Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401
% 209.74/209.94 Benzylp%C3%%A9%nicilline Panpharma, Benzathine
% 209.74/209.94 |- rdf__type mesh__D010401sskos__Concept
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401 Benzathine, Penicillin G
% 209.74/209.94 |- skos__altLabel mesh__D010401 Wyeth Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- mesh__recordOriginator mesh__D010401 NLM
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D010401 2006
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401 G Benzathine, Penicillin
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401 Benzathine Penicillin G
% 209.74/209.94 |- skos__altLabel mesh__D010401
% 209.74/209.94 Sabater Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- mesh__dateRevised mesh__D010401 2004-07-07
% 209.74/209.94 |- mesh__dateEstablished mesh__D010401 1991-01-01
% 209.74/209.94 |- skos__scopeNote mesh__D010401
% 209.74/209.94 Semisynthetic antibiotic prepared by combining the sodium salt of penicillin G with N,N%27%-dibenzylethylenediamine.%A%
% 209.74/209.94 |- skos__altLabel mesh__D010401 CSL Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__altLabel mesh__D010401 Roger Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__prefLabel mesh__D010401 Penicillin G, Benzathine
% 209.74/209.94 |- skos__altLabel mesh__D010401
% 209.74/209.94 Pharmacia Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__altLabel mesh__D010401 Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__altLabel mesh__D010401
% 209.74/209.94 Wassermann Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__broader mesh__D010401smesh__D010400
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401 Bicillin L A
% 209.74/209.94 |- skos__altLabel mesh__D010401 Specia Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401
% 209.74/209.94 Panpharma, Benzathine Benzylp%C3%%A9%nicilline
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401 Retard, Peniroger
% 209.74/209.94 |- skos__altLabel mesh__D010401
% 209.74/209.94 Yamanouchi Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- mesh__recordMaintainer mesh__D010401 ssb
% 209.74/209.94 |- skos__altLabel mesh__D010401 Benzathine Penicillin
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D010401 sjn
% 209.74/209.94 |- skos__altLabel mesh__D010401
% 209.74/209.94 Panpharma Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__hiddenLabel mesh__D010401 Benzylpenicillin, Benzathine
% 209.74/209.94 |- skos__altLabel mesh__D010401
% 209.74/209.94 Antibioticos Brand of Benzathine Benzylpenicillin
% 209.74/209.94 |- skos__altLabel mesh__D051818 Activator 1 Protein, 40 kDa Subunit
% 209.74/209.94 |- skos__broader mesh__D051818smesh__D004268
% 209.74/209.94 |- skos__altLabel mesh__D051818 Activator 1 Protein, 36 kDa Subunit
% 209.74/209.94 |- mesh__recordOriginator mesh__D051818 DRC
% 209.74/209.94 |- mesh__recordMaintainer mesh__D051818 ags
% 209.74/209.94 |- skos__altLabel mesh__D051818 Activator 1 p40
% 209.74/209.94 |- skos__altLabel mesh__D051818 Activator 1 Protein
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D051818 2006
% 209.74/209.94 |- mesh__dateEstablished mesh__D051818 2006-01-01
% 209.74/209.94 |- mesh__dateRevised mesh__D051818 2005-07-13
% 209.74/209.94 |- rdf__type mesh__D051818sskos__Concept
% 209.74/209.94 |- mesh__dateCreated mesh__D051818 2005-06-30
% 209.74/209.94 |- skos__altLabel mesh__D051818 Activator 1 Protein, 38 kDa Subunit
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D051818 2006A
% 209.74/209.94 |- skos__altLabel mesh__D051818 Activator 1 Protein, 145 kDa Subunit
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D051818 ags
% 209.74/209.94 |- mesh__historyNote mesh__D051818 2006%28%1992%29%
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D051818
% 209.74/209.94 2006; REPLICATION FACTOR C was indexed under DNA-BINDING PROTEINS 1992-2005%A%
% 209.74/209.94 |- skos__altLabel mesh__D051818 Activator 1 Protein, 37 kDa Subunit
% 209.74/209.94 |- skos__scopeNote mesh__D051818
% 209.74/209.94 A DNA-binding protein that consists of 5 polypeptides and plays an essential role in DNA REPLICATION in eukaryotes. It binds DNA PRIMER-template junctions and recruits PROLIFERATING CELL NUCLEAR ANTIGEN and DNA POLYMERASES to the site of DNA synthesis.%A%
% 209.74/209.94 |- skos__prefLabel mesh__D051818 Replication Factor C
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009658 2002
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D009658 SJN
% 209.74/209.94 |- mesh__recordOriginator mesh__D009658 NLM
% 209.74/209.94 |- skos__broader mesh__D009658smesh__D015146
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009658 2005
% 209.74/209.94 |- mesh__dateCreated mesh__D009658 1999-01-01
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009658 2006
% 209.74/209.94 |- skos__prefLabel mesh__D009658 North Dakota
% 209.74/209.94 |- mesh__dateRevised mesh__D009658 1997-06-20
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009658 2000
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009658 2003
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009658 2001
% 209.74/209.94 |- rdf__type mesh__D009658sskos__Concept
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009658 2004
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009658 1998
% 209.74/209.94 |- mesh__recordMaintainer mesh__D009658 PXP
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D009658 1999
% 209.74/209.94 |- mesh__recordMaintainer mesh__D001675 jls
% 209.74/209.94 |- skos__prefLabel mesh__D001675 Bioethics
% 209.74/209.94 |- skos__related mesh__D001675smesh__D004992
% 209.74/209.94 |- skos__annotation mesh__D001675
% 209.74/209.94 SPEC only; for issues in bioethics use BIOETHICAL ISSUES or its specifics; ETHICISTS is also available%A%
% 209.74/209.94 |- mesh__dateEstablished mesh__D001675 1978-01-01
% 209.74/209.94 |- rdf__type mesh__D001675sskos__Concept
% 209.74/209.94 |- mesh__dateRevised mesh__D001675 2003-07-09
% 209.74/209.94 |- skos__broader mesh__D001675smesh__D004989
% 209.74/209.94 |- skos__related mesh__D001675smesh__D026822
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D001675 2004
% 209.74/209.94 |- mesh__recordOriginator mesh__D001675 EC
% 209.74/209.94 |- mesh__historyNote mesh__D001675 78
% 209.74/209.94 |- skos__hiddenLabel mesh__D001675 Ethics, Biomedical
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D001675 78
% 209.74/209.94 |- skos__scopeNote mesh__D001675
% 209.74/209.94 A branch of applied ethics that studies the value implications of practices and developments in life sciences, medicine, and health care.%A%
% 209.74/209.94 |- mesh__dateCreated mesh__D001675 1977-04-22
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D001675 sjn
% 209.74/209.94 |- skos__hiddenLabel mesh__D001675 Ethics, Health Care
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D001675 2005
% 209.74/209.94 |- skos__historyNote mesh__D001675 Ethics, Medical %28%1966-1977%29%
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D001675 2006
% 209.74/209.94 |- rdf__type mesh__D006360sskos__Concept
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Heat Shock Protein Chlamydomonas
% 209.74/209.94 |- skos__prefLabel mesh__D006360 Heat-Shock Proteins
% 209.74/209.94 |- skos__scopeNote mesh__D006360
% 209.74/209.94 Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions.%A%
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Proteins, Heat-Shock
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Protein 34, Stress
% 209.74/209.94 |- mesh__publicMeSHNote mesh__D006360 84
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Heat Shock Proteins
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Chlamydomonas, Heat-Shock Protein
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Proteins, Stress
% 209.74/209.94 |- skos__related mesh__D006360smesh__D018832
% 209.74/209.94 |- mesh__dateEstablished mesh__D006360 1984-01-01
% 209.74/209.94 |- skos__altLabel mesh__D006360 Heat-Shock Protein
% 209.74/209.94 |- mesh__dateRevised mesh__D006360 2005-06-30
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Heat Shock Protein
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Protein 27, Heat-Shock
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D006360 2006
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Heat Shock Protein 27
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Protein, Heat-Shock
% 209.74/209.94 |- skos__historyNote mesh__D006360 Proteins %28%1966-1983%29%
% 209.74/209.94 |- skos__historyNote mesh__D006360 Heat %28%1966-1983%29%
% 209.74/209.94 |- mesh__dateCreated mesh__D006360 1983-06-16
% 209.74/209.94 |- skos__altLabel mesh__D006360 Stress Proteins
% 209.74/209.94 |- mesh__recordMaintainer mesh__D006360 SYSTEM
% 209.74/209.94 |- mesh__historyNote mesh__D006360 84
% 209.74/209.94 |- skos__broader mesh__D006360smesh__D011506
% 209.74/209.94 |- skos__hiddenLabel mesh__D006360 Protein 71, Stress
% 209.74/209.94 |- mesh__recordOriginator mesh__D006360 RLS
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D006360 sjn
% 209.74/209.94 |- skos__annotation mesh__D006360
% 209.74/209.94 /biosyn /drug eff /physiol /ultrastruct permitted; do not use /analogs%A%
% 209.74/209.94 |- skos__broader mesh__D020031smesh__D014412
% 209.74/209.94 |- mesh__historyNote mesh__D020031 99
% 209.74/209.94 |- skos__altLabel mesh__D020031 Infections, EBV
% 209.74/209.94 |- mesh__dateCreated mesh__D020031 1998-06-10
% 209.74/209.94 |- skos__altLabel mesh__D020031 Herpesvirus 4 Infections, Human
% 209.74/209.94 |- mesh__recordAuthorizer mesh__D020031 sjn
% 209.74/209.94 |- mesh__activeMeSHYear mesh__D020031 2006
% 209.74/209.95 |- mesh__recordMaintainer mesh__D020031 ags
% 209.74/209.95 |- mesh__dateEstablished mesh__D020031 1999-01-01
% 209.74/209.95 |- rdf__type mesh__D020031sskos__Concept
% 209.74/209.95 |- skos__broader mesh__D020031smesh__D006566
% 209.74/209.95 |- mesh__dateRevised mesh__D020031 2005-06-30
% 209.74/209.95 |- skos__hiddenLabel mesh__D020031 EBV Infection
% 209.74/209.95 |- skos__scopeNote mesh__D020031
% 209.74/209.95 Infection with human herpesvirus 4 %28%HERPESVIRUS 4, HUMAN%29%; which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA %28%African type%29%, INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia %28%LEUKOPLAKIA, HAIRY%29%.%A%
% 209.74/209.95 |- skos__prefLabel mesh__D020031 Epstein-Barr Virus Infections
% 209.74/209.95 |- skos__hiddenLabel mesh__D020031 Virus Infections, Epstein-Barr
% 209.74/209.95 |- skos__altLabel mesh__D020031 Infections, Epstein-Barr Virus
% 209.74/209.95 |- skos__altLabel mesh__D020031 EBV Infections
% 209.74/209.95 |- skos__altLabel mesh__D020031 Human Herpesvirus 4 Infections
% 209.74/209.95 |- skos__historyNote mesh__D020031
% 209.74/209.95 Herpesviridae Infections %28%1970-1998%29%
% 209.74/209.95 |- skos__altLabel mesh__D020031 Human Herpes Virus 4 Infections
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D020031 99
% 209.74/209.95 |- skos__hiddenLabel mesh__D020031 Epstein Barr Virus Infections
% 209.74/209.95 |- mesh__recordOriginator mesh__D020031 AGS
% 209.74/209.95 |- skos__altLabel mesh__D019288 KSHV
% 209.74/209.95 |- skos__prefLabel mesh__D019288 Herpesvirus 8, Human
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019288 2002
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288
% 209.74/209.95 Kaposi%27%s Sarcoma Associated Herpesvirus
% 209.74/209.95 |- skos__altLabel mesh__D019288 HHV-8
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019288 2004
% 209.74/209.95 |- skos__altLabel mesh__D019288 Herpesvirus, Kaposi%27%s Sarcoma-Associated
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288
% 209.74/209.95 Herpesviruses, Kaposi%27%s Sarcoma-Associated
% 209.74/209.95 |- skos__scopeNote mesh__D019288
% 209.74/209.95 A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, isolated from patients with AIDS-related and %22%classical%22% Kaposi sarcoma.%A%
% 209.74/209.95 |- skos__altLabel mesh__D019288 Kaposi Sarcoma-Associated Herpesvirus
% 209.74/209.95 |- mesh__recordOriginator mesh__D019288 AGS
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019288 2003
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288 Herpesvirus, Kaposi Sarcoma Associated
% 209.74/209.95 |- skos__altLabel mesh__D019288 Human herpesvirus 8
% 209.74/209.95 |- skos__broader mesh__D019288smesh__D018144
% 209.74/209.95 |- rdf__type mesh__D019288sskos__Concept
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288
% 209.74/209.95 Herpesvirus, Kaposi%27%s Sarcoma Associated
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288 Kaposis Sarcoma-Associated Herpesvirus
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019288 2006
% 209.74/209.95 |- mesh__recordMaintainer mesh__D019288 ags
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288
% 209.74/209.95 Sarcoma-Associated Herpesviruses, Kaposi%27%s
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288 Sarcoma-Associated Herpesvirus, Kaposi
% 209.74/209.95 |- skos__altLabel mesh__D019288 Herpesvirus, Kaposi Sarcoma-Associated
% 209.74/209.95 |- mesh__historyNote mesh__D019288 2002%28%1997%29%
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288 Herpesvirus, Kaposis Sarcoma-Associated
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288
% 209.74/209.95 Kaposi%27%s Sarcoma-Associated Herpesviruses
% 209.74/209.95 |- skos__hiddenLabel mesh__D019288 Kaposi Sarcoma Associated Herpesvirus
% 209.74/209.95 |- mesh__dateEstablished mesh__D019288 1997-01-01
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019288 2005
% 209.74/209.95 |- mesh__dateCreated mesh__D019288 1996-06-10
% 209.74/209.95 |- mesh__dateRevised mesh__D019288 2001-07-25
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D019288 sjn
% 209.74/209.95 |- skos__altLabel mesh__D019288 Kaposi%27%s Sarcoma-Associated Herpesvirus
% 209.74/209.95 |- skos__annotation mesh__D019288
% 209.74/209.95 infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% or KAPOSI SARCOMA if so specified by author%A%
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D019288
% 209.74/209.95 2002; see HERPESVIRUS, KAPOSI SARCOMA-ASSOCIATED 1998-2001, see HERPESVIRUS, KAPOSI%27%S SARCOMA-ASSOCIATED 1997; KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS was KAPOSI%27%S SARCOMA-ASSOCIATED HERPESVIRUS 1997%A%
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 2005
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D005268 PLS
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 2004
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 1996
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 2000
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 2003
% 209.74/209.95 |- skos__hiddenLabel mesh__D005268 Vein, Femoral
% 209.74/209.95 |- skos__hiddenLabel mesh__D005268 Veins, Femoral
% 209.74/209.95 |- rdf__type mesh__D005268sskos__Concept
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 1995
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 2002
% 209.74/209.95 |- skos__scopeNote mesh__D005268
% 209.74/209.95 The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein.%A%
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 1993
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 1994
% 209.74/209.95 |- skos__broader mesh__D005268smesh__D014680
% 209.74/209.95 |- skos__prefLabel mesh__D005268 Femoral Vein
% 209.74/209.95 |- skos__hiddenLabel mesh__D005268 Femoral Veins
% 209.74/209.95 |- mesh__recordOriginator mesh__D005268 NLM
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 1999
% 209.74/209.95 |- mesh__recordMaintainer mesh__D005268 TAP
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 2006
% 209.74/209.95 |- mesh__dateRevised mesh__D005268 1992-05-15
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 2001
% 209.74/209.95 |- mesh__dateCreated mesh__D005268 1999-01-01
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 1998
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005268 1997
% 209.74/209.95 |- skos__altLabel mesh__D024422 Aneugenic Agents
% 209.74/209.95 |- skos__hiddenLabel mesh__D024422 Polyploidy Inducing Agents
% 209.74/209.95 |- skos__hiddenLabel mesh__D024422 Aneuploidy Inducing Agents
% 209.74/209.95 |- skos__scopeNote mesh__D024422
% 209.74/209.95 Agents which affect CELL DIVISION and the MITOTIC SPINDLE APPARATUS resulting in the loss or gain of whole CHROMOSOMES, thereby inducing an ANEUPLOIDY.%A%
% 209.74/209.95 |- skos__broader mesh__D024422smesh__D009153
% 209.74/209.95 |- skos__historyNote mesh__D024422 Aneuploidy %28%1989-2001%29%
% 209.74/209.95 |- skos__hiddenLabel mesh__D024422 Agents, Polyploidy-Inducing
% 209.74/209.95 |- skos__historyNote mesh__D024422 Mutagens %28%1988-2001%29%
% 209.74/209.95 |- skos__hiddenLabel mesh__D024422 Agents, Aneugenic
% 209.74/209.95 |- mesh__dateCreated mesh__D024422 2001-07-25
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D024422 2004
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D024422 2002
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D024422 2005
% 209.74/209.95 |- mesh__historyNote mesh__D024422 2002
% 209.74/209.95 |- skos__related mesh__D024422smesh__D000782
% 209.74/209.95 |- skos__altLabel mesh__D024422 Aneuploidy-Inducing Agents
% 209.74/209.95 |- mesh__dateRevised mesh__D024422 2003-07-09
% 209.74/209.95 |- mesh__dateEstablished mesh__D024422 2002-01-01
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D024422 2006
% 209.74/209.95 |- skos__prefLabel mesh__D024422 Aneugens
% 209.74/209.95 |- skos__hiddenLabel mesh__D024422 Agents, Aneuploidy-Inducing
% 209.74/209.95 |- rdf__type mesh__D024422sskos__Concept
% 209.74/209.95 |- rdf__type mesh__D010402sskos__Concept
% 209.74/209.95 |- skos__hiddenLabel mesh__D010402 Procaine, Penicillin G
% 209.74/209.95 |- skos__hiddenLabel mesh__D010402 Penicillin, Procaine
% 209.74/209.95 |- skos__broader mesh__D010402smesh__D011343
% 209.74/209.95 |- skos__hiddenLabel mesh__D010402 Procaine Penicillin G
% 209.74/209.95 |- skos__altLabel mesh__D010402 Benzylpenicillin Procaine
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D010402
% 209.74/209.95 91; was see under PENICILLIN G 1985-90; was heading 1963-84%A%
% 209.74/209.95 |- skos__broader mesh__D010402smesh__D010400
% 209.74/209.95 |- mesh__dateEstablished mesh__D010402 1991-01-01
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D010402 2005
% 209.74/209.95 |- skos__altLabel mesh__D010402 Penicillin G Procaine
% 209.74/209.95 |- skos__altLabel mesh__D010402 Procaine Penicillin
% 209.74/209.95 |- skos__hiddenLabel mesh__D010402 Procaine, Benzylpenicillin
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D010402 sjn
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D010402 2006
% 209.74/209.95 |- mesh__recordOriginator mesh__D010402 NLM
% 209.74/209.95 |- mesh__historyNote mesh__D010402
% 209.74/209.95 91%28%85%29%63; was see under PENICILLIN G 1985-90; was heading 1963-84%A%
% 209.74/209.95 |- skos__scopeNote mesh__D010402
% 209.74/209.95 Semisynthetic antibiotic prepared by combining penicillin G with PROCAINE.%A%
% 209.74/209.95 |- skos__hiddenLabel mesh__D010402 G Procaine, Penicillin
% 209.74/209.95 |- skos__prefLabel mesh__D010402 Penicillin G, Procaine
% 209.74/209.95 |- mesh__dateCreated mesh__D010402 1999-01-01
% 209.74/209.95 |- mesh__dateRevised mesh__D010402 2004-07-07
% 209.74/209.95 |- mesh__recordMaintainer mesh__D010402 ssb
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D051819 2006
% 209.74/209.95 |- mesh__historyNote mesh__D051819 2006%28%1992%29%
% 209.74/209.95 |- mesh__recordOriginator mesh__D051819 DRC
% 209.74/209.95 |- skos__scopeNote mesh__D051819
% 209.74/209.95 A ubiquitously expressed sequence-specific transcriptional repressor that is normally the target of signaling by NOTCH PROTEINS.%A%
% 209.74/209.95 |- skos__hiddenLabel mesh__D051819
% 209.74/209.95 Immunoglobulin J Recombination Signal Sequence Binding Protein
% 209.74/209.95 |- skos__altLabel mesh__D051819 RBP-Jkappa Protein
% 209.74/209.95 |- rdf__type mesh__D051819sskos__Concept
% 209.74/209.95 |- skos__hiddenLabel mesh__D051819 RBP Jkappa Protein
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D051819 sjn
% 209.74/209.95 |- skos__hiddenLabel mesh__D051819 C Promotor Binding Factor 1
% 209.74/209.95 |- mesh__dateEstablished mesh__D051819 2006-01-01
% 209.74/209.95 |- skos__altLabel mesh__D051819 Recombination Binding Protein J
% 209.74/209.95 |- mesh__dateCreated mesh__D051819 2005-06-30
% 209.74/209.95 |- skos__broader mesh__D051819smesh__D009687
% 209.74/209.95 |- skos__broader mesh__D051819smesh__D014157
% 209.74/209.95 |- skos__prefLabel mesh__D051819
% 209.74/209.95 Immunoglobulin J Recombination Signal Sequence-Binding Protein
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D051819
% 209.74/209.95 2006; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS 1992-2005%A%
% 209.74/209.95 |- mesh__recordMaintainer mesh__D051819 DRC
% 209.74/209.95 |- skos__broader mesh__D051819smesh__D004268
% 209.74/209.95 |- skos__altLabel mesh__D051819 C-Promotor-Binding Factor 1
% 209.74/209.95 |- mesh__dateEstablished mesh__D015696 1991-01-01
% 209.74/209.95 |- skos__altLabel mesh__D015696 Gene Product, tat
% 209.74/209.95 |- skos__hiddenLabel mesh__D015696 Trans Acting Transcription Factor, HIV
% 209.74/209.95 |- skos__hiddenLabel mesh__D015696 Products, tat Gene
% 209.74/209.95 |- skos__historyNote mesh__D015696 Transcription Factors %28%1988-1989%29%
% 209.74/209.95 |- skos__altLabel mesh__D015696 tat Gene Products
% 209.74/209.95 |- skos__broader mesh__D015696smesh__D015534
% 209.74/209.95 |- rdf__type mesh__D015696sskos__Concept
% 209.74/209.95 |- skos__hiddenLabel mesh__D015696 tat Gene Product
% 209.74/209.95 |- mesh__dateCreated mesh__D015696 1989-07-07
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D015696 sjn
% 209.74/209.95 |- skos__scopeNote mesh__D015696
% 209.74/209.95 Trans-acting transcription factors. Nuclear proteins whose expression is required for HIV viral replication. The tat protein stimulates HIV-LTR-driven RNA synthesis for both viral regulatory and viral structural proteins. tat stands for trans-activation of transcription.%A%
% 209.74/209.95 |- skos__annotation mesh__D015696
% 209.74/209.95 Tat stands for %22%trans-activation of transcription%22%; IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%
% 209.74/209.95 |- skos__hiddenLabel mesh__D015696 Product, tat Gene
% 209.74/209.95 |- mesh__recordOriginator mesh__D015696 AGS
% 209.74/209.95 |- skos__hiddenLabel mesh__D015696 Protein, tat
% 209.74/209.95 |- skos__prefLabel mesh__D015696 Gene Products, tat
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D015696 2006
% 209.74/209.95 |- skos__hiddenLabel mesh__D015696 Protein, HIV tat
% 209.74/209.95 |- mesh__recordMaintainer mesh__D015696 SYSTEM
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D015696
% 209.74/209.95 91; was see under TRANS-ACTIVATORS 1990
% 209.74/209.95 |- mesh__dateRevised mesh__D015696 2005-06-30
% 209.74/209.95 |- mesh__historyNote mesh__D015696
% 209.74/209.95 91%28%90%29%; was see under TRANS-ACTIVATORS 1990
% 209.74/209.95 |- skos__hiddenLabel mesh__D015696 tat Protein, HIV
% 209.74/209.95 |- skos__broader mesh__D009659smesh__D001267
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 1996
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 2006
% 209.74/209.95 |- mesh__dateCreated mesh__D009659 1986-04-02
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 1997
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 2002
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 1994
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 2003
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 1995
% 209.74/209.95 |- mesh__recordOriginator mesh__D009659 RC
% 209.74/209.95 |- mesh__dateEstablished mesh__D009659 1987-01-01
% 209.74/209.95 |- rdf__type mesh__D009659sskos__Concept
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 2004
% 209.74/209.95 |- mesh__historyNote mesh__D009659 87
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 1998
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D009659 PLS
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 2000
% 209.74/209.95 |- skos__annotation mesh__D009659 no qualif
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 1999
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 2001
% 209.74/209.95 |- skos__prefLabel mesh__D009659 North Sea
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 1993
% 209.74/209.95 |- mesh__recordMaintainer mesh__D009659 TGC
% 209.74/209.95 |- mesh__dateRevised mesh__D009659 1992-05-15
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D009659 2005
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D001676 2006
% 209.74/209.95 |- skos__broader mesh__D001676smesh__D026441
% 209.74/209.95 |- mesh__recordMaintainer mesh__D001676 sjn
% 209.74/209.95 |- skos__broader mesh__D001676smesh__D011613
% 209.74/209.95 |- rdf__type mesh__D001676sskos__Concept
% 209.74/209.95 |- skos__altLabel mesh__D001676 Psychophysiologic Feedback
% 209.74/209.95 |- skos__prefLabel mesh__D001676 Biofeedback %28%Psychology%29%
% 209.74/209.95 |- skos__broader mesh__D001676smesh__D001521
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D001676 77
% 209.74/209.95 |- mesh__dateRevised mesh__D001676 2004-07-13
% 209.74/209.95 |- skos__hiddenLabel mesh__D001676 Biofeedbacks %28%Psychology%29%
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D001676 sjn
% 209.74/209.95 |- mesh__recordOriginator mesh__D001676 EC
% 209.74/209.95 |- mesh__historyNote mesh__D001676 77
% 209.74/209.95 |- mesh__dateEstablished mesh__D001676 1977-01-01
% 209.74/209.95 |- skos__altLabel mesh__D001676 Biofeedback
% 209.74/209.95 |- skos__scopeNote mesh__D001676
% 209.74/209.95 Process by which a person uses biofeedback information to gain voluntary control over processes or functions which are primarily under autonomic control. It is used in experimental or treatment settings with human subjects. %28%From APA Thesaurus of Psychological Terms, 8th ed%29%%A%
% 209.74/209.95 |- skos__altLabel mesh__D001676 Feedback, Psychophysiologic
% 209.74/209.95 |- mesh__dateCreated mesh__D001676 1976-04-16
% 209.74/209.95 |- skos__altLabel mesh__D001676 Feedback, Psychophysiological
% 209.74/209.95 |- skos__broader mesh__D001676smesh__D011603
% 209.74/209.95 |- skos__annotation mesh__D001676
% 209.74/209.95 differentiate from FEEDBACK as a physiol concept %28%G%29% %26% as an information concept %28%L%29%; DF: BIOFEEDBACK%A%
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D001676 2005
% 209.74/209.95 |- skos__historyNote mesh__D001676 Feedback %28%1966-1976%29%
% 209.74/209.95 |- skos__annotation mesh__D020830 DF: RAC1 PROTEIN
% 209.74/209.95 |- skos__prefLabel mesh__D020830 rac1 GTP-Binding Protein
% 209.74/209.95 |- skos__hiddenLabel mesh__D020830 TC 25 GTP Binding Protein
% 209.74/209.95 |- skos__hiddenLabel mesh__D020830 GTP-Binding Protein, TC-25
% 209.74/209.95 |- mesh__dateCreated mesh__D020830 1999-11-03
% 209.74/209.95 |- mesh__dateRevised mesh__D020830 2005-06-30
% 209.74/209.95 |- skos__hiddenLabel mesh__D020830
% 209.74/209.95 ras Related C3 Botulinum Toxin Substrate 1
% 209.74/209.95 |- skos__historyNote mesh__D020830 G-Proteins %28%1991-1999%29%
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D020830
% 209.74/209.95 2000; RAC1 GENE PRODUCT was indexed under G-PROTEINS 1991-1999 %26% PROTEINS 1989-1990%A%
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D020830 sjn
% 209.74/209.95 |- skos__altLabel mesh__D020830 TC-25 GTP-Binding Protein
% 209.74/209.95 |- skos__broader mesh__D020830smesh__D020744
% 209.74/209.95 |- skos__altLabel mesh__D020830 ras-Related C3 Botulinum Toxin Substrate 1
% 209.74/209.95 |- rdf__type mesh__D020830sskos__Concept
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020830 2006
% 209.74/209.95 |- mesh__recordOriginator mesh__D020830 jmp
% 209.74/209.95 |- skos__hiddenLabel mesh__D020830 rac1 GTP Binding Protein
% 209.74/209.95 |- skos__hiddenLabel mesh__D020830 GTP-Binding Protein, rac1
% 209.74/209.95 |- mesh__dateEstablished mesh__D020830 2000-01-01
% 209.74/209.95 |- mesh__historyNote mesh__D020830
% 209.74/209.95 2000; for RAC1 GENE PRODUCT use RAC GTP-BINDING PROTEINS %28%NM%29% 1989-1999%A%
% 209.74/209.95 |- skos__altLabel mesh__D020830 rac1 Protein
% 209.74/209.95 |- mesh__recordMaintainer mesh__D020830 jmp
% 209.74/209.95 |- skos__scopeNote mesh__D020830
% 209.74/209.95 A rac GTP-binding protein involved in regulating actin filaments at the plasma membrane. It controls the development of filopodia and lamellipodia in cells and thereby influences cellular motility and adhesion. It is also involved in activation of NADPH OXIDASE. This enzyme was formerly listed as EC 3.6.1.47.%A%
% 209.74/209.95 |- skos__broader mesh__D006361smesh__D004780
% 209.74/209.95 |- mesh__recordOriginator mesh__D006361 NLM
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 1996
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 2003
% 209.74/209.95 |- skos__scopeNote mesh__D006361
% 209.74/209.95 The application of heat to raise the temperature of the environment, ambient or local, or the systems for accomplishing this effect. It is distinguished from HEAT, the physical property and principle of physics.%A%
% 209.74/209.95 |- rdf__type mesh__D006361sskos__Concept
% 209.74/209.95 |- skos__annotation mesh__D006361
% 209.74/209.95 the environment: differentiate from HEAT, the principle of physics; /adv eff permitted but do not confuse with HEAT /adv eff%A%
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 2002
% 209.74/209.95 |- skos__prefLabel mesh__D006361 Heating
% 209.74/209.95 |- mesh__dateCreated mesh__D006361 1999-01-01
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 1999
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 2006
% 209.74/209.95 |- mesh__dateRevised mesh__D006361 1995-05-18
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 2001
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D006361 PLS
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 1998
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 2000
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 2005
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 1997
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006361 2004
% 209.74/209.95 |- mesh__recordMaintainer mesh__D006361 TGC
% 209.74/209.95 |- skos__broader mesh__D020032smesh__D001597
% 209.74/209.95 |- skos__prefLabel mesh__D020032 Tyrphostins
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020032 2003
% 209.74/209.95 |- mesh__dateCreated mesh__D020032 1998-06-11
% 209.74/209.95 |- skos__historyNote mesh__D020032 Benzylidene Compounds %28%1989-1998%29%
% 209.74/209.95 |- mesh__historyNote mesh__D020032 99
% 209.74/209.95 |- skos__historyNote mesh__D020032
% 209.74/209.95 Protein-Tyrosine Kinase/antagonists %26% inhibitors %28%1989-1998%29%
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020032 2002
% 209.74/209.95 |- skos__scopeNote mesh__D020032
% 209.74/209.95 A family of synthetic protein tyrosine kinase inhibitors. They selectively inhibit receptor autophosphorylation and are used to study receptor function.%A%
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D020032 99
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020032 1999
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020032 2006
% 209.74/209.95 |- rdf__type mesh__D020032sskos__Concept
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020032 2001
% 209.74/209.95 |- skos__historyNote mesh__D020032 Nitriles %28%1989-1998%29%
% 209.74/209.95 |- skos__broader mesh__D020032smesh__D009570
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020032 2005
% 209.74/209.95 |- skos__broader mesh__D020032smesh__D011810
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020032 2000
% 209.74/209.95 |- mesh__dateEstablished mesh__D020032 1999-01-01
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020032 2004
% 209.74/209.95 |- skos__prefLabel mesh__D019289 Pyruvic Acid
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 2000
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 1997
% 209.74/209.95 |- rdf__type mesh__D019289sskos__Concept
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 2006
% 209.74/209.95 |- skos__historyNote mesh__D019289 Pyruvates %28%1981-1996%29%
% 209.74/209.95 |- mesh__dateCreated mesh__D019289 1996-06-10
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D019289
% 209.74/209.95 97; PYRUVIC ACID was indexed under PYRUVATES 1981-96
% 209.74/209.95 |- mesh__historyNote mesh__D019289
% 209.74/209.95 97; was PYRUVIC ACID %28%NM%29% 1981-96
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 2005
% 209.74/209.95 |- skos__scopeNote mesh__D019289
% 209.74/209.95 An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. %28%From Stedman, 26th ed%29%%A%
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 2002
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 1999
% 209.74/209.95 |- skos__annotation mesh__D019289
% 209.74/209.95 do not confuse X ref PYRUVATE with PYRUVATES
% 209.74/209.95 |- skos__broader mesh__D019289smesh__D011773
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 2004
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 1998
% 209.74/209.95 |- mesh__onlineNote mesh__D019289
% 209.74/209.95 use PYRUVIC ACID %28%NM%29% to search PYRUVIC ACID 1981-96
% 209.74/209.95 |- skos__hiddenLabel mesh__D019289 Acid, Pyruvic
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 2001
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D019289 2003
% 209.74/209.95 |- mesh__dateEstablished mesh__D019289 1997-01-01
% 209.74/209.95 |- mesh__dateRevised mesh__D005269 2005-06-30
% 209.74/209.95 |- mesh__recordMaintainer mesh__D005269 ags
% 209.74/209.95 |- skos__annotation mesh__D005269
% 209.74/209.95 fractures: FEMORAL FRACTURES %26% FEMORAL NECK FRACTURES are available but see note under HIP FRACTURES; do not index under FEMUR when THIGH is meant: see note there%A%
% 209.74/209.95 |- rdf__type mesh__D005269sskos__Concept
% 209.74/209.95 |- skos__hiddenLabel mesh__D005269 Trochanters
% 209.74/209.95 |- skos__prefLabel mesh__D005269 Femur
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D005269 2006
% 209.74/209.95 |- mesh__dateCreated mesh__D005269 1999-01-01
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D005269 sjn
% 209.74/209.95 |- skos__hiddenLabel mesh__D005269 Femurs
% 209.74/209.95 |- skos__scopeNote mesh__D005269
% 209.74/209.95 The longest and largest bone of the skeleton, it is situated between the hip and the knee.%A%
% 209.74/209.95 |- skos__broader mesh__D005269smesh__D007867
% 209.74/209.95 |- mesh__recordOriginator mesh__D005269 NLM
% 209.74/209.95 |- skos__hiddenLabel mesh__D010403 Resistances, Penicillin
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D010403 64
% 209.74/209.95 |- mesh__recordMaintainer mesh__D010403 ssb
% 209.74/209.95 |- skos__scopeNote mesh__D010403
% 209.74/209.95 Nonsusceptibility of an organism to the action of penicillins.%A%
% 209.74/209.95 |- mesh__dateRevised mesh__D010403 2003-07-09
% 209.74/209.95 |- skos__hiddenLabel mesh__D010403 Penicillin Resistances
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D010403 2005
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D010403 2006
% 209.74/209.95 |- mesh__dateEstablished mesh__D010403 1964-01-01
% 209.74/209.95 |- skos__broader mesh__D010403smesh__D018440
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D010403 2004
% 209.74/209.95 |- skos__prefLabel mesh__D010403 Penicillin Resistance
% 209.74/209.95 |- skos__hiddenLabel mesh__D010403 Resistance, Penicillin
% 209.74/209.95 |- mesh__dateCreated mesh__D010403 1999-01-01
% 209.74/209.95 |- mesh__historyNote mesh__D010403 64
% 209.74/209.95 |- rdf__type mesh__D010403sskos__Concept
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D010403 sjn
% 209.74/209.95 |- mesh__recordOriginator mesh__D010403 NLM
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020831 2004
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020831 2005
% 209.74/209.95 |- mesh__historyNote mesh__D020831 2000
% 209.74/209.95 |- skos__historyNote mesh__D020831 Acupuncture Therapy %28%1989-1999%29%
% 209.74/209.95 |- rdf__type mesh__D020831sskos__Concept
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020831 2006
% 209.74/209.95 |- skos__broader mesh__D020831smesh__D015670
% 209.74/209.95 |- skos__prefLabel mesh__D020831 Acupuncture, Ear
% 209.74/209.95 |- skos__altLabel mesh__D020831 Auricular Acupuncture
% 209.74/209.95 |- skos__hiddenLabel mesh__D020831 Auricular Acupunctures
% 209.74/209.95 |- skos__hiddenLabel mesh__D020831 Acupunctures, Ear
% 209.74/209.95 |- skos__altLabel mesh__D020831 Ear Acupuncture
% 209.74/209.95 |- mesh__dateCreated mesh__D020831 1999-11-03
% 209.74/209.95 |- skos__hiddenLabel mesh__D020831 Ear Acupunctures
% 209.74/209.95 |- mesh__dateEstablished mesh__D020831 2000-01-01
% 209.74/209.95 |- mesh__dateRevised mesh__D020831 2002-07-02
% 209.74/209.95 |- skos__historyNote mesh__D020831 Acupuncture %28%1972-1990%29%
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D020831 sjn
% 209.74/209.95 |- mesh__recordOriginator mesh__D020831 ags
% 209.74/209.95 |- skos__scopeNote mesh__D020831
% 209.74/209.95 Acupuncture therapy by inserting needles in the ear. It is used to control pain and for treating various ailments.%A%
% 209.74/209.95 |- mesh__recordMaintainer mesh__D020831 ags
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020831 2003
% 209.74/209.95 |- skos__hiddenLabel mesh__D020831 Acupunctures, Auricular
% 209.74/209.95 |- skos__altLabel mesh__D020831 Acupuncture, Auricular
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D020831 2000
% 209.74/209.95 |- rdf__type mesh__D006362sskos__Concept
% 209.74/209.95 |- skos__hiddenLabel mesh__D006362 mu Chain Disease
% 209.74/209.95 |- skos__prefLabel mesh__D006362 Heavy Chain Disease
% 209.74/209.95 |- skos__related mesh__D006362smesh__D007143
% 209.74/209.95 |- skos__hiddenLabel mesh__D006362 Franklins Disease
% 209.74/209.95 |- skos__altLabel mesh__D006362 Franklin%27%s Disease
% 209.74/209.95 |- skos__hiddenLabel mesh__D006362 Heavy Chain Diseases
% 209.74/209.95 |- mesh__dateEstablished mesh__D006362 1966-01-01
% 209.74/209.95 |- mesh__dateRevised mesh__D006362 2005-07-01
% 209.74/209.95 |- skos__hiddenLabel mesh__D006362 gamma Chain Disease
% 209.74/209.95 |- mesh__recordOriginator mesh__D006362 NLM
% 209.74/209.95 |- skos__broader mesh__D006362smesh__D008232
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D006362 66
% 209.74/209.95 |- mesh__dateCreated mesh__D006362 1999-01-01
% 209.74/209.95 |- skos__scopeNote mesh__D006362
% 209.74/209.95 A disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. The amino acid sequences of the N-%28%amino-%29% terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross-links to the light chains. The defect arises through faulty coupling of the variable %28%V%29% and constant %28%C%29% region genes.%A%
% 209.74/209.95 |- skos__hiddenLabel mesh__D006362 mu-Chain Diseases
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D006362 2006
% 209.74/209.95 |- skos__broader mesh__D006362smesh__D010265
% 209.74/209.95 |- mesh__recordAuthorizer mesh__D006362 sjn
% 209.74/209.95 |- mesh__historyNote mesh__D006362 66%28%64%29%
% 209.74/209.95 |- skos__altLabel mesh__D006362 Franklin Disease
% 209.74/209.95 |- skos__annotation mesh__D006362
% 209.74/209.95 specify the immunoglobulin fragment coord NIM, as gamma chain dis = HEAVY CHAIN DISEASE %28%IM%29% + IMMUNOGLOBULIN GAMMA-CHAINS %28%NIM%29%; ALPHA-CHAIN DISEASE see IMMUNOPROLIFERATIVE SMALL INTESTINAL DISEASE is available%A%
% 209.74/209.95 |- skos__hiddenLabel mesh__D006362 gamma-Chain Diseases
% 209.74/209.95 |- mesh__recordMaintainer mesh__D006362 sjn
% 209.74/209.95 |- mesh__dateEstablished mesh__D020033 1999-01-01
% 209.74/209.95 |- skos__prefLabel mesh__D020033 Protein Isoforms
% 209.74/209.95 |- mesh__publicMeSHNote mesh__D020033 99
% 209.74/209.95 |- rdf__type mesh__D020033sskos__Concept
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020033 2006
% 209.74/209.95 |- skos__altLabel mesh__D020033 Isoforms
% 209.74/209.95 |- skos__scopeNote mesh__D020033
% 209.74/209.95 Different forms of a protein that may be produced from different genes, or from the same gene by alternative splicing.%A%
% 209.74/209.95 |- mesh__recordOriginator mesh__D020033 NNS
% 209.74/209.95 |- skos__hiddenLabel mesh__D020033 Isoforms, Protein
% 209.74/209.95 |- mesh__historyNote mesh__D020033 99
% 209.74/209.95 |- mesh__dateRevised mesh__D020033 2001-07-25
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020033 2005
% 209.74/209.95 |- mesh__activeMeSHYear mesh__D020033 2002
% 209.74/209.95 |- skos__annotation mesh__D020033
% 209.74/209.95 IM general only; coord NIM with specific protein %28%IM%29%; for enzymes use ISOENZYMES%A%
% 209.74/209.95 |- mesh__dateCreated mesh__D020033 1998-06-10
% 209.74/209.96 |- skos__broader mesh__D020033smesh__D011506
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020033 2004
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D020033 sjn
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020033 2003
% 209.74/209.96 |- mesh__recordMaintainer mesh__D020033 nns
% 209.74/209.96 |- mesh__historyNote mesh__D016790 92
% 209.74/209.96 |- skos__prefLabel mesh__D016790 Plasmodium knowlesi
% 209.74/209.96 |- mesh__recordMaintainer mesh__D016790 ags
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D016790 sjn
% 209.74/209.96 |- mesh__dateRevised mesh__D016790 2003-07-09
% 209.74/209.96 |- skos__annotation mesh__D016790
% 209.74/209.96 in monkeys; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D016790 92
% 209.74/209.96 |- mesh__recordOriginator mesh__D016790 PXP
% 209.74/209.96 |- mesh__dateCreated mesh__D016790 1991-05-02
% 209.74/209.96 |- skos__scopeNote mesh__D016790
% 209.74/209.96 A protozoan parasite from Southeast Asia that causes monkey malaria. It is naturally acquired by man in Malaysia and can also be transmitted experimentally to humans.%A%
% 209.74/209.96 |- mesh__dateEstablished mesh__D016790 1992-01-01
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D016790 2006
% 209.74/209.96 |- skos__historyNote mesh__D016790 Plasmodium %28%1966-1991%29%
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D016790 2004
% 209.74/209.96 |- skos__broader mesh__D016790smesh__D010961
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D016790 2005
% 209.74/209.96 |- rdf__type mesh__D016790sskos__Concept
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 1995
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 1998
% 209.74/209.96 |- skos__scopeNote mesh__D002770
% 209.74/209.96 Unsaturated derivatives of cholane with methyl groups at C-10 and C-13 and a branched five-carbon chain at C-17. They must have at least one double bond in the ring system.%A%
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 1994
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 2002
% 209.74/209.96 |- skos__historyNote mesh__D002770 Cholanes %28%1968-1974%29%
% 209.74/209.96 |- skos__broader mesh__D002770smesh__D002757
% 209.74/209.96 |- mesh__recordMaintainer mesh__D002770 PLS
% 209.74/209.96 |- skos__prefLabel mesh__D002770 Cholenes
% 209.74/209.96 |- rdf__type mesh__D002770sskos__Concept
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 2004
% 209.74/209.96 |- mesh__onlineNote mesh__D002770 search CHOLANES 1973-74
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 1997
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 2003
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D002770 PLS
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 2001
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 1996
% 209.74/209.96 |- mesh__dateRevised mesh__D002770 1993-06-03
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 2006
% 209.74/209.96 |- skos__annotation mesh__D002770
% 209.74/209.96 do not confuse with CHOLANES or CHOLINE; includes choladienes, cholatrienes%A%
% 209.74/209.96 |- mesh__historyNote mesh__D002770 75; was see under CHOLANES 1973-74
% 209.74/209.96 |- mesh__recordOriginator mesh__D002770 NLM
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 1999
% 209.74/209.96 |- mesh__dateCreated mesh__D002770 1999-01-01
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 2005
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002770 2000
% 209.74/209.96 |- mesh__dateEstablished mesh__D002770 1975-01-01
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D002770 75; was see under CHOLANES 1973-74
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D010404 2006
% 209.74/209.96 |- skos__hiddenLabel mesh__D010404 Penicillin Berromycin
% 209.74/209.96 |- skos__hiddenLabel mesh__D010404 Penicillin Beromycin
% 209.74/209.96 |- skos__altLabel mesh__D010404 Phenoxymethylpenicillin
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D010404 sjn
% 209.74/209.96 |- mesh__onlineNote mesh__D010404
% 209.74/209.96 use PENICILLIN V to search PENICILLIN, PHENOXYMETHYL 1966-91; use PENICILLIN V/AA to search PROPICILLIN 1966-84 %28%as Prov 1966-72%29%%A%
% 209.74/209.96 |- mesh__dateCreated mesh__D010404 1999-01-01
% 209.74/209.96 |- mesh__dateRevised mesh__D010404 2004-07-07
% 209.74/209.96 |- skos__hiddenLabel mesh__D010404 V Cillin K
% 209.74/209.96 |- mesh__recordOriginator mesh__D010404 NLM
% 209.74/209.96 |- skos__altLabel mesh__D010404 Beromycin, Penicillin
% 209.74/209.96 |- rdf__type mesh__D010404sskos__Concept
% 209.74/209.96 |- skos__altLabel mesh__D010404 Penicillin, Phenoxymethyl
% 209.74/209.96 |- skos__altLabel mesh__D010404 Fenoxymethylpenicillin
% 209.74/209.96 |- skos__hiddenLabel mesh__D010404 Phenoxymethyl Penicillin
% 209.74/209.96 |- mesh__recordMaintainer mesh__D010404 ssb
% 209.74/209.96 |- skos__altLabel mesh__D010404 Berromycin, Penicillin
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D010404
% 209.74/209.96 92; was PENICILLIN, PHENOXYMETHYL 1963-91; PENICILLIN V was see PENICILLIN, PHENOXYMETHYL 1963-91; PROPICILLIN was heading 1973-84%A%
% 209.74/209.96 |- skos__hiddenLabel mesh__D010404 Sodium, Penicillin V
% 209.74/209.96 |- skos__hiddenLabel mesh__D010404 Potassium, Penicillin V
% 209.74/209.96 |- skos__hiddenLabel mesh__D010404 VCillin K
% 209.74/209.96 |- skos__scopeNote mesh__D010404
% 209.74/209.96 A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms.%A%
% 209.74/209.96 |- mesh__historyNote mesh__D010404
% 209.74/209.96 92; was PENICILLIN, PHENOXYMETHYL 1963-91; PENICILLIN V was see PENICILLIN, PHENOXYMETHYL 1963-91; PROPICILLIN was heading 1964-84 %28%Prov 1964-72%29%%A%
% 209.74/209.96 |- skos__hiddenLabel mesh__D010404 V Sodium, Penicillin
% 209.74/209.96 |- skos__altLabel mesh__D010404 Penicillin VK
% 209.74/209.96 |- skos__prefLabel mesh__D010404 Penicillin V
% 209.74/209.96 |- skos__broader mesh__D010404smesh__D010406
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D010404 2005
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D015698 2006
% 209.74/209.96 |- skos__altLabel mesh__D015698 Genome Library
% 209.74/209.96 |- skos__hiddenLabel mesh__D015698 Library, Genome
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D015698 sjn
% 209.74/209.96 |- mesh__recordOriginator mesh__D015698 PXP
% 209.74/209.96 |- mesh__recordMaintainer mesh__D015698 NLM
% 209.74/209.96 |- skos__related mesh__D015698smesh__D018244
% 209.74/209.96 |- mesh__dateRevised mesh__D015698 2002-07-03
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D015698 2003
% 209.74/209.96 |- skos__hiddenLabel mesh__D015698 Library, Genomic
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D015698 2005
% 209.74/209.96 |- skos__related mesh__D015698smesh__D004274
% 209.74/209.96 |- skos__hiddenLabel mesh__D015698 Genomic Libraries
% 209.74/209.96 |- mesh__dateEstablished mesh__D015698 1990-01-01
% 209.74/209.96 |- mesh__dateCreated mesh__D015698 1989-06-06
% 209.74/209.96 |- skos__annotation mesh__D015698
% 209.74/209.96 a form of gene library containing complete DNA seq; no qualif%A%
% 209.74/209.96 |- skos__hiddenLabel mesh__D015698 Genome Libraries
% 209.74/209.96 |- skos__scopeNote mesh__D015698
% 209.74/209.96 A form of GENE LIBRARY containing the complete DNA sequences present in the genome of a given organism. It contrasts with a cDNA library which contains only sequences utilized in protein coding %28%lacking introns%29%.%A%
% 209.74/209.96 |- skos__prefLabel mesh__D015698 Genomic Library
% 209.74/209.96 |- skos__broader mesh__D015698smesh__D015723
% 209.74/209.96 |- skos__broader mesh__D015698smesh__D016678
% 209.74/209.96 |- skos__historyNote mesh__D015698 Cloning, Molecular %28%1980-1989%29%
% 209.74/209.96 |- rdf__type mesh__D015698sskos__Concept
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D015698 90
% 209.74/209.96 |- skos__related mesh__D015698smesh__D016045
% 209.74/209.96 |- mesh__historyNote mesh__D015698 90
% 209.74/209.96 |- skos__historyNote mesh__D015698
% 209.74/209.96 Nucleic Acid Hybridization %28%1980-1989%29%
% 209.74/209.96 |- skos__hiddenLabel mesh__D015698 Libraries, Genomic
% 209.74/209.96 |- skos__historyNote mesh__D015698
% 209.74/209.96 Molecular Sequence Data %28%1988-1989%29%
% 209.74/209.96 |- skos__historyNote mesh__D015698 Base Sequence %28%1980-1989%29%
% 209.74/209.96 |- skos__hiddenLabel mesh__D015698 Libraries, Genome
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D015698 2004
% 209.74/209.96 |- mesh__dateCreated mesh__D001678 1999-01-01
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D001678 2006
% 209.74/209.96 |- mesh__recordOriginator mesh__D001678 NLM
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D001678 sjn
% 209.74/209.96 |- skos__hiddenLabel mesh__D001678 Biogeneses
% 209.74/209.96 |- rdf__type mesh__D001678sskos__Concept
% 209.74/209.96 |- skos__altLabel mesh__D001678 Origin of Life
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D001678 2005
% 209.74/209.96 |- skos__annotation mesh__D001678
% 209.74/209.96 see scope note; not for biogenesis of substances, organs, cells or subcellular elements%A%
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D001678 2004
% 209.74/209.96 |- skos__prefLabel mesh__D001678 Biogenesis
% 209.74/209.96 |- skos__hiddenLabel mesh__D001678 Life Origin
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D001678 2003
% 209.74/209.96 |- skos__scopeNote mesh__D001678
% 209.74/209.96 The origin of life. It includes studies of the potential basis for life in organic compounds but excludes studies of the development of altered forms of life through mutation and natural selection, which is EVOLUTION.%A%
% 209.74/209.96 |- mesh__recordMaintainer mesh__D001678 hjn
% 209.74/209.96 |- skos__broader mesh__D001678smesh__D001686
% 209.74/209.96 |- mesh__dateRevised mesh__D001678 2002-07-02
% 209.74/209.96 |- skos__hiddenLabel mesh__D001678 Life Origins
% 209.74/209.96 |- skos__broader mesh__D001921Q000736smesh__D001921
% 209.74/209.96 |- mesh__preferredCombination mesh__D001921Q000736smesh__D004453
% 209.74/209.96 |- rdf__type mesh__D001921Q000736smesh__CompoundConcept
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D020832 sjn
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020832 2006
% 209.74/209.96 |- mesh__dateRevised mesh__D020832 2004-07-07
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D020832 2000
% 209.74/209.96 |- mesh__recordMaintainer mesh__D020832 nns
% 209.74/209.96 |- skos__hiddenLabel mesh__D020832 Hands, EF
% 209.74/209.96 |- skos__scopeNote mesh__D020832
% 209.74/209.96 Calcium-binding motifs composed of two helixes %28%E and F%29% joined by a loop. Calcium is bound by the loop region. These motifs are found in many proteins that are regulated by calcium.%A%
% 209.74/209.96 |- skos__hiddenLabel mesh__D020832 EF Hand
% 209.74/209.96 |- skos__altLabel mesh__D020832 EF Hands
% 209.74/209.96 |- skos__hiddenLabel mesh__D020832 Motif, EF Hand
% 209.74/209.96 |- mesh__dateEstablished mesh__D020832 2000-01-01
% 209.74/209.96 |- skos__prefLabel mesh__D020832 EF Hand Motifs
% 209.74/209.96 |- mesh__dateCreated mesh__D020832 1999-11-03
% 209.74/209.96 |- skos__broader mesh__D020832smesh__D018257
% 209.74/209.96 |- skos__hiddenLabel mesh__D020832 EF Hand Motif
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020832 2005
% 209.74/209.96 |- mesh__recordOriginator mesh__D020832 nns
% 209.74/209.96 |- mesh__historyNote mesh__D020832 2000
% 209.74/209.96 |- rdf__type mesh__D020832sskos__Concept
% 209.74/209.96 |- skos__hiddenLabel mesh__D020832 Hand, EF
% 209.74/209.96 |- skos__hiddenLabel mesh__D020832 Motifs, EF Hand
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 1999
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 2006
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 2002
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 1998
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 2005
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 2001
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 1997
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 2004
% 209.74/209.96 |- skos__prefLabel mesh__D006363 Hebrides
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D006363 PLS
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 2000
% 209.74/209.96 |- skos__broader mesh__D006363smesh__D006113
% 209.74/209.96 |- skos__annotation mesh__D006363 a group of islands west of Scotland
% 209.74/209.96 |- skos__scopeNote mesh__D006363
% 209.74/209.96 A group of islands in the Atlantic Ocean west of Scotland, comprising the Outer Hebrides and the Inner Hebrides. They were the scene of frequent incursions of Scandinavian settlers from the 6th century A.D. They were ceded to Scotland by Norway in the 13th century. The origin of the name is uncertain. It is suggested that it is the result of a miscopying of the Roman name Ebudae or Hebudae with ri for u. %28%From Webster%27%s New Geographical Dictionary, 1988, p496 %26% Room, Brewer%27%s Dictionary of Names, 1992, p235%29%%A%
% 209.74/209.96 |- mesh__recordMaintainer mesh__D006363 TGC
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 1996
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006363 2003
% 209.74/209.96 |- rdf__type mesh__D006363sskos__Concept
% 209.74/209.96 |- mesh__recordOriginator mesh__D006363 NLM
% 209.74/209.96 |- mesh__dateRevised mesh__D006363 1995-02-17
% 209.74/209.96 |- mesh__dateCreated mesh__D006363 1999-01-01
% 209.74/209.96 |- skos__scopeNote mesh__D020034
% 209.74/209.96 Synthetic organosiloxane gels that are formed from synthetic polymers of silicone oxide with organic sidechains %28%polydimethylsiloxane%29% by lengthening the polymer chains. Unlike silicone elastomers, they are not treated with amorphous silica. They are used as fillers in breast implants.%A%
% 209.74/209.96 |- skos__broader mesh__D020034smesh__D012828
% 209.74/209.96 |- mesh__dateRevised mesh__D020034 2004-07-07
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020034 2005
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D020034 sjn
% 209.74/209.96 |- mesh__dateEstablished mesh__D020034 1999-01-01
% 209.74/209.96 |- skos__related mesh__D020034smesh__D018427
% 209.74/209.96 |- mesh__recordOriginator mesh__D020034 ADP
% 209.74/209.96 |- skos__hiddenLabel mesh__D020034 Gels, Silicone
% 209.74/209.96 |- mesh__dateCreated mesh__D020034 1998-06-11
% 209.74/209.96 |- skos__historyNote mesh__D020034 Silicones %28%1970-1998%29%
% 209.74/209.96 |- mesh__recordMaintainer mesh__D020034 jmp
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D020034 99
% 209.74/209.96 |- mesh__historyNote mesh__D020034 99
% 209.74/209.96 |- skos__prefLabel mesh__D020034 Silicone Gels
% 209.74/209.96 |- rdf__type mesh__D020034sskos__Concept
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020034 2006
% 209.74/209.96 |- skos__annotation mesh__D020034
% 209.74/209.96 silicones in breast implants probably goes here unless specified as elastomers %28%SILICONE ELASTOMERS%29%; for prosthetic implants do not use /ther use%A%
% 209.74/209.96 |- skos__historyNote mesh__D020034 Silicone Elastomers %28%1973-1998%29%
% 209.74/209.96 |- rdf__type mesh__D044482sskos__Concept
% 209.74/209.96 |- mesh__dateRevised mesh__D044482 2004-07-07
% 209.74/209.96 |- mesh__recordOriginator mesh__D044482 ssb
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D044482 sjn
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D044482 2004
% 209.74/209.96 |- skos__prefLabel mesh__D044482 Benzeneacetamides
% 209.74/209.96 |- mesh__dateEstablished mesh__D044482 2004-01-01
% 209.74/209.96 |- skos__altLabel mesh__D044482 2-Phenylacetamides
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D044482 2005
% 209.74/209.96 |- skos__broader mesh__D044482smesh__D001555
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D044482 2006
% 209.74/209.96 |- mesh__dateCreated mesh__D044482 2003-07-09
% 209.74/209.96 |- mesh__historyNote mesh__D044482 2004
% 209.74/209.96 |- skos__scopeNote mesh__D044482
% 209.74/209.96 Compounds based on benzeneacetamide, that are similar in structure to ACETANILIDES.%A%
% 209.74/209.96 |- mesh__recordMaintainer mesh__D044482 ssb
% 209.74/209.96 |- skos__related mesh__D044482smesh__D000083
% 209.74/209.96 |- skos__broader mesh__D044482smesh__D000081
% 209.74/209.96 |- mesh__dateRevised mesh__D016791 2003-07-09
% 209.74/209.96 |- skos__prefLabel mesh__D016791 Piroplasmia
% 209.74/209.96 |- mesh__recordOriginator mesh__D016791 PXP
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D016791 2006
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D016791 2004
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D016791 sjn
% 209.74/209.96 |- skos__broader mesh__D016791smesh__D016782
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D016791 92
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D016791 2005
% 209.74/209.96 |- mesh__dateCreated mesh__D016791 1991-05-02
% 209.74/209.96 |- rdf__type mesh__D016791sskos__Concept
% 209.74/209.96 |- mesh__dateEstablished mesh__D016791 1992-01-01
% 209.74/209.96 |- skos__annotation mesh__D016791
% 209.74/209.96 a subclass of tick-borne protozoa: do not confuse with order PIROPLASMIDA%A%
% 209.74/209.96 |- skos__scopeNote mesh__D016791
% 209.74/209.96 A subclass of heteroxenous parasitic protozoa usually transmitted by ticks. Its organisms are rod-shaped or amoeboid with conoid, oocysts, spores, and pseudocysts absent. Locomotion is by body flexion, gliding, or, in sexual stages, by large axopodium-like organelles.%A%
% 209.74/209.96 |- mesh__historyNote mesh__D016791 92
% 209.74/209.96 |- mesh__recordMaintainer mesh__D016791 ags
% 209.74/209.96 |- skos__related mesh__D052116smesh__D012794
% 209.74/209.96 |- mesh__historyNote mesh__D052116
% 209.74/209.96 2006%28%1980%29%; use SIALIC ACIDS %26% MUCOPROTEINS 1976-1979
% 209.74/209.96 |- skos__scopeNote mesh__D052116
% 209.74/209.96 A subcategory of mucins that contain SIALIC ACID.
% 209.74/209.96 |- mesh__dateCreated mesh__D052116 2005-06-30
% 209.74/209.96 |- skos__altLabel mesh__D052116 Sialomucin
% 209.74/209.96 |- skos__altLabel mesh__D052116 Endothelial-Specific Sialomucin
% 209.74/209.96 |- skos__hiddenLabel mesh__D052116 Sialomucin, Endothelial-Specific
% 209.74/209.96 |- skos__prefLabel mesh__D052116 Sialomucins
% 209.74/209.96 |- mesh__recordOriginator mesh__D052116 jmp
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D052116 2006
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D052116 sjn
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D052116
% 209.74/209.96 2006; SIALOMUCINS was indexed under MUCINS 1982-2005, under SIALIC ACIDS, %26% under MUCOPROTEINS 1976-1981%A%
% 209.74/209.96 |- mesh__recordMaintainer mesh__D052116 jmp
% 209.74/209.96 |- skos__altLabel mesh__D052116 Endomucin
% 209.74/209.96 |- skos__broader mesh__D052116smesh__D009077
% 209.74/209.96 |- mesh__dateEstablished mesh__D052116 2006-01-01
% 209.74/209.96 |- rdf__type mesh__D052116sskos__Concept
% 209.74/209.96 |- skos__hiddenLabel mesh__D052116 Endothelial Specific Sialomucin
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D002771 PLS
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 2001
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 2003
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 1997
% 209.74/209.96 |- mesh__recordOriginator mesh__D002771 NLM
% 209.74/209.96 |- skos__scopeNote mesh__D002771
% 209.74/209.96 An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.%A%
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 2000
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 1996
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 2006
% 209.74/209.96 |- skos__hiddenLabel mesh__D002771 Choleras
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 2005
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 1999
% 209.74/209.96 |- mesh__dateCreated mesh__D002771 1999-01-01
% 209.74/209.96 |- mesh__recordMaintainer mesh__D002771 PLS
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 2002
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 1998
% 209.74/209.96 |- skos__annotation mesh__D002771 caused by Vibrio cholerae
% 209.74/209.96 |- mesh__dateRevised mesh__D002771 1995-05-25
% 209.74/209.96 |- rdf__type mesh__D002771sskos__Concept
% 209.74/209.96 |- skos__broader mesh__D002771smesh__D014735
% 209.74/209.96 |- skos__prefLabel mesh__D002771 Cholera
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D002771 2004
% 209.74/209.96 |- skos__hiddenLabel mesh__D010405 AER I beta Lactamase
% 209.74/209.96 |- mesh__historyNote mesh__D010405
% 209.74/209.96 84%28%79%29%63; was see under BETA-LACTAMASES 1979-83
% 209.74/209.96 |- skos__prefLabel mesh__D010405 Penicillinase
% 209.74/209.96 |- mesh__dateCreated mesh__D010405 1999-01-01
% 209.74/209.96 |- rdf__type mesh__D010405sskos__Concept
% 209.74/209.96 |- mesh__dateEstablished mesh__D010405 1984-01-01
% 209.74/209.96 |- skos__broader mesh__D010405smesh__D001618
% 209.74/209.96 |- skos__hiddenLabel mesh__D010405 beta-Lactamase, AER-I
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D010405
% 209.74/209.96 84,63-78; was see under BETA-LACTAMASES 1979-83
% 209.74/209.96 |- skos__scopeNote mesh__D010405
% 209.74/209.96 A beta-lactamase preferentially cleaving penicillins. %28%Dorland, 28th ed%29% EC 3.5.2.-.%A%
% 209.74/209.96 |- skos__hiddenLabel mesh__D010405 gamma Penicillinase
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D010405 sjn
% 209.74/209.96 |- skos__hiddenLabel mesh__D010405 Lactamase III, beta
% 209.74/209.96 |- mesh__recordOriginator mesh__D010405 NLM
% 209.74/209.96 |- mesh__dateRevised mesh__D010405 2003-07-09
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D010405 2005
% 209.74/209.96 |- mesh__recordMaintainer mesh__D010405 ssb
% 209.74/209.96 |- skos__hiddenLabel mesh__D010405 Lactamase RP4, beta
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D010405 2006
% 209.74/209.96 |- skos__hiddenLabel mesh__D010405 beta Lactamase I
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D010405 2004
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D015699 2006
% 209.74/209.96 |- skos__hiddenLabel mesh__D015699 HTLV III gp120
% 209.74/209.96 |- skos__hiddenLabel mesh__D015699 gp120, HTLV-III
% 209.74/209.96 |- mesh__dateEstablished mesh__D015699 1990-01-01
% 209.74/209.96 |- skos__related mesh__D015699smesh__D015717
% 209.74/209.96 |- mesh__recordOriginator mesh__D015699 AGS
% 209.74/209.96 |- skos__prefLabel mesh__D015699 HIV Envelope Protein gp120
% 209.74/209.96 |- mesh__historyNote mesh__D015699 90
% 209.74/209.96 |- skos__altLabel mesh__D015699 gp120 Envelope Glycoprotein, HIV
% 209.74/209.96 |- skos__altLabel mesh__D015699 HTLV-III gp120
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D015699 sjn
% 209.74/209.96 |- skos__altLabel mesh__D015699 env Protein gp120, HIV
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D015699 90
% 209.74/209.96 |- skos__altLabel mesh__D015699 HIV Envelope Glycoprotein gp120
% 209.74/209.96 |- skos__broader mesh__D015699smesh__D015686
% 209.74/209.96 |- rdf__type mesh__D015699sskos__Concept
% 209.74/209.96 |- skos__historyNote mesh__D015699
% 209.74/209.96 Viral Envelope Proteins %28%1983-1989%29%
% 209.74/209.96 |- skos__altLabel mesh__D015699 gp120%28%HIV%29%
% 209.74/209.96 |- skos__scopeNote mesh__D015699
% 209.74/209.96 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV.%A%
% 209.74/209.96 |- skos__broader mesh__D015699smesh__D015488
% 209.74/209.96 |- skos__annotation mesh__D015699
% 209.74/209.96 IM; despite X refs, coord with HIV-1 or HIV-2 %28%IM%29%; /drug eff /ultrastruct permitted; DF: GP120%A%
% 209.74/209.96 |- skos__altLabel mesh__D015699 Envelope Glycoprotein gp120, HIV
% 209.74/209.96 |- mesh__recordMaintainer mesh__D015699 ssb
% 209.74/209.96 |- mesh__dateRevised mesh__D015699 2005-06-30
% 209.74/209.96 |- skos__historyNote mesh__D015699 Retroviridae Proteins %28%1986-1989%29%
% 209.74/209.96 |- mesh__dateCreated mesh__D015699 1989-06-19
% 209.74/209.96 |- skos__hiddenLabel mesh__D015699 HIV 2 Envelope Protein gp120
% 209.74/209.96 |- skos__hiddenLabel mesh__D015699 HIV 1 Envelope Protein gp120
% 209.74/209.96 |- skos__annotation mesh__D001679
% 209.74/209.96 GEN or unspecified: prefer specific biogenic amine group term or specific biogenic amine indented under each%A%
% 209.74/209.96 |- skos__broader mesh__D001679smesh__D000588
% 209.74/209.96 |- skos__hiddenLabel mesh__D001679 Amine, Biogenic
% 209.74/209.96 |- skos__altLabel mesh__D001679 Biogenic Amine
% 209.74/209.96 |- skos__historyNote mesh__D001679 Amines %28%1966-1970%29%
% 209.74/209.96 |- skos__prefLabel mesh__D001679 Biogenic Amines
% 209.74/209.96 |- mesh__historyNote mesh__D001679 73%28%71%29%
% 209.74/209.96 |- mesh__dateRevised mesh__D001679 2005-06-30
% 209.74/209.96 |- mesh__dateEstablished mesh__D001679 1973-01-01
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D001679 73
% 209.74/209.96 |- mesh__recordOriginator mesh__D001679 NLM
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D001679 sjn
% 209.74/209.96 |- skos__altLabel mesh__D001679 Amines, Biogenic
% 209.74/209.96 |- mesh__dateCreated mesh__D001679 1999-01-01
% 209.74/209.96 |- skos__related mesh__D001679smesh__D017982
% 209.74/209.96 |- skos__scopeNote mesh__D001679
% 209.74/209.96 A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects %28%e.g., histamine, serotonin, epinephrine, tyramine%29%. Those derived from aromatic amino acids, and also their synthetic analogs %28%e.g., amphetamine%29%, are of use in pharmacology.%A%
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D001679 2006
% 209.74/209.96 |- mesh__recordMaintainer mesh__D001679 ssb
% 209.74/209.96 |- rdf__type mesh__D001679sskos__Concept
% 209.74/209.96 |- skos__broader mesh__D001921Q000737smesh__D001921
% 209.74/209.96 |- mesh__preferredCombination mesh__D001921Q000737smesh__D001923
% 209.74/209.96 |- rdf__type mesh__D001921Q000737smesh__CompoundConcept
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020833 2003
% 209.74/209.96 |- skos__hiddenLabel mesh__D020833 Injury, Diffuse Axonal
% 209.74/209.96 |- skos__hiddenLabel mesh__D020833 Axonal Injuries, Diffuse
% 209.74/209.96 |- rdf__type mesh__D020833sskos__Concept
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020833 2002
% 209.74/209.96 |- skos__prefLabel mesh__D020833 Diffuse Axonal Injury
% 209.74/209.96 |- skos__historyNote mesh__D020833 Brain Injuries %28%1982-1999%29%
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D020833 2000
% 209.74/209.96 |- mesh__historyNote mesh__D020833 2000
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020833 2006
% 209.74/209.96 |- skos__hiddenLabel mesh__D020833 DAIs %28%Diffuse Axonal Injury%29%
% 209.74/209.96 |- skos__scopeNote mesh__D020833
% 209.74/209.96 A relatively common sequela of blunt head injury, characterized by a global disruption of axons throughout the brain. Associated clinical features may include NEUROBEHAVIORAL MANIFESTATIONS; PERSISTENT VEGETATIVE STATE; DEMENTIA; and other disorders.%A%
% 209.74/209.96 |- skos__hiddenLabel mesh__D020833 Diffuse Axonal Injuries
% 209.74/209.96 |- skos__broader mesh__D020833smesh__D001930
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020833 2005
% 209.74/209.96 |- skos__hiddenLabel mesh__D020833 Injuries, Diffuse Axonal
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020833 2001
% 209.74/209.96 |- mesh__dateCreated mesh__D020833 1999-11-08
% 209.74/209.96 |- mesh__dateEstablished mesh__D020833 2000-01-01
% 209.74/209.96 |- skos__altLabel mesh__D020833 Axonal Injury, Diffuse
% 209.74/209.96 |- skos__altLabel mesh__D020833 DAI %28%Diffuse Axonal Injury%29%
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020833 2000
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020833 2004
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006364 2005
% 209.74/209.96 |- skos__hiddenLabel mesh__D006364 Hedgehog
% 209.74/209.96 |- mesh__historyNote mesh__D006364 72
% 209.74/209.96 |- mesh__dateEstablished mesh__D006364 1972-01-01
% 209.74/209.96 |- mesh__recordAuthorizer mesh__D006364 sjn
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006364 2004
% 209.74/209.96 |- skos__broader mesh__D006364smesh__D007312
% 209.74/209.96 |- skos__prefLabel mesh__D006364 Hedgehogs
% 209.74/209.96 |- skos__scopeNote mesh__D006364
% 209.74/209.96 The family Erinaceidae, in the order INSECTIVORA. Most are true hedgehogs possessing a coat of spines and a very short tail. Those members of the family found in Southeast Asia %28%moonrats or gymnures%29% have normal body hair and a long tail.%A%
% 209.74/209.96 |- rdf__type mesh__D006364sskos__Concept
% 209.74/209.96 |- mesh__recordMaintainer mesh__D006364 ags
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D006364 72
% 209.74/209.96 |- skos__altLabel mesh__D006364 Erinaceidae
% 209.74/209.96 |- mesh__dateRevised mesh__D006364 2003-07-09
% 209.74/209.96 |- skos__historyNote mesh__D006364 Insectivora %28%1966-1971%29%
% 209.74/209.96 |- mesh__dateCreated mesh__D006364 1999-01-01
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D006364 2006
% 209.74/209.96 |- mesh__recordOriginator mesh__D006364 NLM
% 209.74/209.96 |- skos__broader mesh__D020035smesh__D004798
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020035 2006
% 209.74/209.96 |- skos__annotation mesh__D020035
% 209.74/209.96 IM GEN only; coord NIM with specific enzyme %28%IM%29%
% 209.74/209.96 |- mesh__dateEstablished mesh__D020035 1999-01-01
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020035 2005
% 209.74/209.96 |- skos__scopeNote mesh__D020035
% 209.74/209.96 Catalytically active enzymes that are formed by the combination of an apoenzyme %28%APOENZYMES%29% and its appropriate cofactors and prosthetic groups.%A%
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D020035 2004
% 209.74/209.96 |- mesh__dateRevised mesh__D020035 2003-07-09
% 209.74/209.96 |- mesh__historyNote mesh__D020035 99; use COENZYMES 1996-98
% 209.74/209.96 |- skos__prefLabel mesh__D020035 Holoenzymes
% 209.74/209.96 |- rdf__type mesh__D020035sskos__Concept
% 209.74/209.96 |- skos__historyNote mesh__D020035 Coenzymes %28%1966-1998%29%
% 209.74/209.96 |- mesh__dateCreated mesh__D020035 1998-06-10
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D020035 99; see COENZYMES 1996-98
% 209.74/209.96 |- skos__scopeNote mesh__D044483
% 209.74/209.96 The growth of INTESTINAL POLYPS. Growth processes include neoplastic %28%ADENOMA and CARCINOMA%29% and non-neoplastic %28%hyperplastic, mucosal, inflammatory, and other polyps%29%.%A%
% 209.74/209.96 |- skos__historyNote mesh__D044483 Polyps %28%1966-1973%29%
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D044483 2004
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D044483 2005
% 209.74/209.96 |- skos__prefLabel mesh__D044483 Intestinal Polyposis
% 209.74/209.96 |- mesh__publicMeSHNote mesh__D044483
% 209.74/209.96 2004; see INTESTINAL POLYPS 1996-2003; for CRONKHITE-CANADA SYNDROME see CHURG-STRAUSS SYNDROME 1992-1995%A%
% 209.74/209.96 |- mesh__activeMeSHYear mesh__D044483 2006
% 209.74/209.96 |- mesh__dateCreated mesh__D044483 2003-07-09
% 209.74/209.96 |- skos__broader mesh__D044483smesh__D007410
% 209.74/209.96 |- skos__hiddenLabel mesh__D044483 Polyposis, Intestinal
% 209.74/209.96 |- mesh__dateEstablished mesh__D044483 2004-01-01
% 209.74/209.96 |- rdf__type mesh__D044483sskos__Concept
% 209.74/209.96 |- skos__annotation mesh__D044483
% 209.74/209.96 INTESTINAL POLYPS is also available; familial: consider also ADENOMATOUS POLYPOSIS COLI%A%
% 209.74/209.96 |- skos__historyNote mesh__D044483 Intestinal Polyps %28%1973-2003%29%
% 209.74/209.96 |- mesh__historyNote mesh__D044483
% 209.74/209.96 2004; use INTESTINAL POLYPS 1996-2003; for CRONKHITE-CANADA SYNDROME use CHURG-STRAUSS SYNDROME 1992-1995%A%
% 209.74/209.97 |- skos__broader mesh__D016792smesh__D016791
% 209.74/209.97 |- skos__annotation mesh__D016792
% 209.74/209.97 an order of tick-borne protozoa: do not confuse with subclass PIROPLASMIA%A%
% 209.74/209.97 |- mesh__dateRevised mesh__D016792 2003-07-09
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D016792 2005
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D016792 2006
% 209.74/209.97 |- skos__prefLabel mesh__D016792 Piroplasmida
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D016792 2004
% 209.74/209.97 |- mesh__recordOriginator mesh__D016792 PXP
% 209.74/209.97 |- mesh__dateCreated mesh__D016792 1991-05-02
% 209.74/209.97 |- rdf__type mesh__D016792sskos__Concept
% 209.74/209.97 |- mesh__recordMaintainer mesh__D016792 ags
% 209.74/209.97 |- skos__scopeNote mesh__D016792
% 209.74/209.97 An order of protozoa comprising heteroxenous tick-borne blood parasites. Representative genera include BABESIA, Dactylosoma, and THEILERIA.%A%
% 209.74/209.97 |- mesh__historyNote mesh__D016792 92
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D016792 sjn
% 209.74/209.97 |- mesh__dateEstablished mesh__D016792 1992-01-01
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D016792 92
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D052117 sjn
% 209.74/209.97 |- mesh__recordMaintainer mesh__D052117 ssb
% 209.74/209.97 |- skos__hiddenLabel mesh__D052117 1,3 Dioxindans
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D052117 2006
% 209.74/209.97 |- skos__altLabel mesh__D052117 Methylenedioxybenzenes
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D052117 2006
% 209.74/209.97 |- skos__altLabel mesh__D052117 1,3-Dioxindans
% 209.74/209.97 |- skos__broader mesh__D052117smesh__D006574
% 209.74/209.97 |- mesh__recordOriginator mesh__D052117 ssb
% 209.74/209.97 |- rdf__type mesh__D052117sskos__Concept
% 209.74/209.97 |- skos__historyNote mesh__D052117 Dioxoles %28%1970-2005%29%
% 209.74/209.97 |- skos__broader mesh__D052117smesh__D004149
% 209.74/209.97 |- mesh__dateCreated mesh__D052117 2005-06-30
% 209.74/209.97 |- skos__hiddenLabel mesh__D052117 1,3 Dioxaindans
% 209.74/209.97 |- skos__altLabel mesh__D052117 1,3-Dioxaindans
% 209.74/209.97 |- mesh__historyNote mesh__D052117 2006
% 209.74/209.97 |- mesh__dateEstablished mesh__D052117 2006-01-01
% 209.74/209.97 |- skos__prefLabel mesh__D052117 Benzodioxoles
% 209.74/209.97 |- skos__scopeNote mesh__D052117
% 209.74/209.97 Compounds based on benzene fused to oxole. They can be formed from methylated CATECHOLS such as EUGENOL.%A%
% 209.74/209.97 |- skos__historyNote mesh__D002772 Bacterial Proteins %28%1966-1977%29%
% 209.74/209.97 |- skos__prefLabel mesh__D002772 Cholera Toxin
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002772 2006
% 209.74/209.97 |- mesh__historyNote mesh__D002772 78
% 209.74/209.97 |- skos__altLabel mesh__D002772 Choleragen
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D002772 sjn
% 209.74/209.97 |- skos__altLabel mesh__D002772 Cholera Exotoxin
% 209.74/209.97 |- skos__annotation mesh__D002772
% 209.74/209.97 /antag permitted but consider also ANTITOXINS
% 209.74/209.97 |- mesh__recordMaintainer mesh__D002772 ssb
% 209.74/209.97 |- skos__broader mesh__D002772smesh__D036002
% 209.74/209.97 |- skos__broader mesh__D002772smesh__D001427
% 209.74/209.97 |- mesh__dateRevised mesh__D002772 2005-06-30
% 209.74/209.97 |- skos__hiddenLabel mesh__D002772 Toxin, Cholera
% 209.74/209.97 |- skos__historyNote mesh__D002772 Enterotoxins %28%1966-1977%29%
% 209.74/209.97 |- skos__altLabel mesh__D002772 Cholera Toxin B Subunit
% 209.74/209.97 |- skos__historyNote mesh__D002772 Bacterial Toxins %28%1977%29%
% 209.74/209.97 |- skos__altLabel mesh__D002772 Cholera Toxin Protomer B
% 209.74/209.97 |- skos__hiddenLabel mesh__D002772 Exotoxin, Cholera
% 209.74/209.97 |- rdf__type mesh__D002772sskos__Concept
% 209.74/209.97 |- skos__historyNote mesh__D002772 Toxins %28%1966-1967%29%
% 209.74/209.97 |- skos__scopeNote mesh__D002772
% 209.74/209.97 An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy %28%H%29% or A subunit and the B protomer which consists of 5 light %28%L%29% or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO%28%ADP-RIBOSE%29% TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells, and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells.%A%
% 209.74/209.97 |- mesh__dateCreated mesh__D002772 1977-04-22
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D002772 78
% 209.74/209.97 |- skos__hiddenLabel mesh__D002772 Enterotoxin CT, Cholera
% 209.74/209.97 |- skos__broader mesh__D002772smesh__D004768
% 209.74/209.97 |- skos__altLabel mesh__D002772 Cholera Toxin A Subunit
% 209.74/209.97 |- skos__altLabel mesh__D002772 Cholera Enterotoxin CT
% 209.74/209.97 |- skos__hiddenLabel mesh__D002772 CT, Cholera Enterotoxin
% 209.74/209.97 |- mesh__recordOriginator mesh__D002772 SH
% 209.74/209.97 |- mesh__dateEstablished mesh__D002772 1978-01-01
% 209.74/209.97 |- skos__hiddenLabel mesh__D010406 Penicillin Antibiotics
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D010406 2006
% 209.74/209.97 |- skos__scopeNote mesh__D010406
% 209.74/209.97 A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. %28%Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1065%29%%A%
% 209.74/209.97 |- skos__broader mesh__D010406smesh__D047090
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D010406 2005
% 209.74/209.97 |- mesh__historyNote mesh__D010406
% 209.74/209.97 75; was PENICILLIN 1963-74; /adv eff-pois-tox was PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84%A%
% 209.74/209.97 |- rdf__type mesh__D010406sskos__Concept
% 209.74/209.97 |- skos__altLabel mesh__D010406 Antibiotics, Penicillin
% 209.74/209.97 |- mesh__dateRevised mesh__D010406 2004-07-07
% 209.74/209.97 |- skos__broader mesh__D010406smesh__D019086
% 209.74/209.97 |- skos__annotation mesh__D010406 check text for a specific if possible
% 209.74/209.97 |- skos__prefLabel mesh__D010406 Penicillins
% 209.74/209.97 |- mesh__recordMaintainer mesh__D010406 ssb
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D010406
% 209.74/209.97 75; was PENICILLIN 1963-74; /adverse effects /poisoning /toxicity were PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84%A%
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D010406 sjn
% 209.74/209.97 |- mesh__onlineNote mesh__D010406
% 209.74/209.97 use PENICILLINS to search PENICILLIN 1966-74 %26% HETACILLIN 1974-84%A%
% 209.74/209.97 |- mesh__recordOriginator mesh__D010406 NLM
% 209.74/209.97 |- mesh__dateCreated mesh__D010406 1999-01-01
% 209.74/209.97 |- mesh__historyNote mesh__D020834 2000
% 209.74/209.97 |- skos__related mesh__D020834smesh__D019448
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020834 2006
% 209.74/209.97 |- skos__prefLabel mesh__D020834 Ethnopharmacology
% 209.74/209.97 |- skos__broader mesh__D020834smesh__D008519
% 209.74/209.97 |- skos__scopeNote mesh__D020834
% 209.74/209.97 The study of the actions and properties of medicinal agents, often derived from PLANTS, indigenous to populations or ETHNIC GROUPS.%A%
% 209.74/209.97 |- skos__annotation mesh__D020834
% 209.74/209.97 specialty; coordinate with geographic term or ethnic group if pertinent; coordinate NIM with specific drug or plant %28%IM%29% for ethnopharmacologic aspects of the drug or plant%A%
% 209.74/209.97 |- skos__historyNote mesh__D020834 Pharmacology %28%1983-1999%29%
% 209.74/209.97 |- skos__historyNote mesh__D020834 Medicine, Traditional %28%1979-1999%29%
% 209.74/209.97 |- skos__broader mesh__D020834smesh__D010600
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D020834 2000
% 209.74/209.97 |- mesh__dateEstablished mesh__D020834 2000-01-01
% 209.74/209.97 |- mesh__dateRevised mesh__D020834 2005-06-30
% 209.74/209.97 |- mesh__recordOriginator mesh__D020834 ags
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D020834 sjn
% 209.74/209.97 |- skos__related mesh__D020834smesh__D010944
% 209.74/209.97 |- skos__related mesh__D020834smesh__D010598
% 209.74/209.97 |- mesh__recordMaintainer mesh__D020834 ssb
% 209.74/209.97 |- mesh__dateCreated mesh__D020834 1999-11-08
% 209.74/209.97 |- rdf__type mesh__D020834sskos__Concept
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006365 2003
% 209.74/209.97 |- skos__related mesh__D006365smesh__D013628
% 209.74/209.97 |- skos__broader mesh__D006365smesh__D005528
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006365 2004
% 209.74/209.97 |- skos__hiddenLabel mesh__D006365 Heels
% 209.74/209.97 |- mesh__recordOriginator mesh__D006365 NLM
% 209.74/209.97 |- mesh__dateCreated mesh__D006365 1999-01-01
% 209.74/209.97 |- rdf__type mesh__D006365sskos__Concept
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D006365 sjn
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006365 2005
% 209.74/209.97 |- skos__related mesh__D006365smesh__D000125
% 209.74/209.97 |- skos__annotation mesh__D006365 primates only
% 209.74/209.97 |- mesh__dateRevised mesh__D006365 2002-07-03
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006365 2006
% 209.74/209.97 |- skos__related mesh__D006365smesh__D002111
% 209.74/209.97 |- skos__prefLabel mesh__D006365 Heel
% 209.74/209.97 |- mesh__recordMaintainer mesh__D006365 PLS
% 209.74/209.97 |- skos__broader mesh__D020036smesh__D001203
% 209.74/209.97 |- skos__related mesh__D020036smesh__D001758
% 209.74/209.97 |- mesh__dateCreated mesh__D020036 1998-06-10
% 209.74/209.97 |- mesh__historyNote mesh__D020036 99
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D020036 sjn
% 209.74/209.97 |- mesh__recordMaintainer mesh__D020036 SYSTEM
% 209.74/209.97 |- mesh__dateEstablished mesh__D020036 1999-01-01
% 209.74/209.97 |- mesh__recordOriginator mesh__D020036 AGS
% 209.74/209.97 |- skos__related mesh__D020036smesh__D002912
% 209.74/209.97 |- rdf__type mesh__D020036sskos__Concept
% 209.74/209.97 |- mesh__dateRevised mesh__D020036 2005-06-30
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D020036 99
% 209.74/209.97 |- skos__prefLabel mesh__D020036 Onygenales
% 209.74/209.97 |- skos__scopeNote mesh__D020036
% 209.74/209.97 An order of fungi in the phylum ASCOMYCOTA containing many medically important species. There are four families and mitosporic %28%anamorphic%29% forms are prominent.%A%
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020036 2006
% 209.74/209.97 |- skos__prefLabel mesh__D016793 Babesia bovis
% 209.74/209.97 |- skos__annotation mesh__D016793
% 209.74/209.97 infection = BABESIOSIS %28%IM%29% + CATTLE DISEASES %28%IM%29% + check tags ANIMALS %26% CATTLE%A%
% 209.74/209.97 |- mesh__dateEstablished mesh__D016793 1992-01-01
% 209.74/209.97 |- mesh__dateRevised mesh__D016793 2003-07-30
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D016793 92
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D016793 2006
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D016793 sjn
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D016793 2004
% 209.74/209.97 |- skos__scopeNote mesh__D016793
% 209.74/209.97 A species of protozoa that is a cause of bovine babesiosis. Ticks of the genera Boophilus, Rhipicephalus, and IXODES are the chief vectors.%A%
% 209.74/209.97 |- skos__historyNote mesh__D016793 Babesia %28%1975-1991%29%
% 209.74/209.97 |- mesh__recordOriginator mesh__D016793 PXP
% 209.74/209.97 |- mesh__historyNote mesh__D016793 92
% 209.74/209.97 |- mesh__recordMaintainer mesh__D016793 ags
% 209.74/209.97 |- rdf__type mesh__D016793sskos__Concept
% 209.74/209.97 |- mesh__dateCreated mesh__D016793 1991-05-02
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D016793 2005
% 209.74/209.97 |- skos__broader mesh__D016793smesh__D001403
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D052118 2006
% 209.74/209.97 |- rdf__type mesh__D052118sskos__Concept
% 209.74/209.97 |- skos__scopeNote mesh__D052118
% 209.74/209.97 An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. In PLATELETS and T-LYMPHOCYTES it may play a role in the cellular degranulation process.%A%
% 209.74/209.97 |- mesh__dateEstablished mesh__D052118 2006-01-01
% 209.74/209.97 |- mesh__recordOriginator mesh__D052118 jmp
% 209.74/209.97 |- skos__altLabel mesh__D052118 Antigens, CD107a
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D052118 sjn
% 209.74/209.97 |- skos__broader mesh__D052118smesh__D051907
% 209.74/209.97 |- mesh__recordMaintainer mesh__D052118 jmp
% 209.74/209.97 |- mesh__historyNote mesh__D052118 2006%28%1986%29%
% 209.74/209.97 |- skos__altLabel mesh__D052118 CD107a Antigens
% 209.74/209.97 |- skos__altLabel mesh__D052118 CD107a Antigen
% 209.74/209.97 |- skos__altLabel mesh__D052118 LAMP1 Protein
% 209.74/209.97 |- skos__altLabel mesh__D052118 LAMPA Protein
% 209.74/209.97 |- skos__prefLabel mesh__D052118 Lysosomal-Associated Membrane Protein 1
% 209.74/209.97 |- skos__broader mesh__D052118smesh__D015703
% 209.74/209.97 |- mesh__dateCreated mesh__D052118 2005-06-30
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D052118
% 209.74/209.97 2006; CD107A ANTIGEN was indexed under ANTIGENS, CD 1986-2005%A%
% 209.74/209.97 |- skos__hiddenLabel mesh__D052118 Lysosomal Associated Membrane Protein 1
% 209.74/209.97 |- skos__altLabel mesh__D052118 LGP120 Protein
% 209.74/209.97 |- skos__broader mesh__D052118smesh__D010980
% 209.74/209.97 |- mesh__dateCreated mesh__D029910 2001-07-25
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D029910 2002
% 209.74/209.97 |- skos__prefLabel mesh__D029910 Trigonella
% 209.74/209.97 |- skos__altLabel mesh__D029910 Fenugreek
% 209.74/209.97 |- mesh__historyNote mesh__D029910 2002
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D029910 2004
% 209.74/209.97 |- skos__annotation mesh__D029910
% 209.74/209.97 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D029910 2002
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D029910 2003
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D029910 2006
% 209.74/209.97 |- mesh__dateEstablished mesh__D029910 2002-01-01
% 209.74/209.97 |- skos__altLabel mesh__D029910 Poenumgraecum
% 209.74/209.97 |- skos__scopeNote mesh__D029910 A plant genus of the family FABACEAE.
% 209.74/209.97 |- skos__altLabel mesh__D029910 Foenumgraecum
% 209.74/209.97 |- rdf__type mesh__D029910sskos__Concept
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D029910 2005
% 209.74/209.97 |- skos__broader mesh__D029910smesh__D007887
% 209.74/209.97 |- mesh__recordOriginator mesh__D010407 NLM
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D010407 sjn
% 209.74/209.97 |- rdf__type mesh__D010407sskos__Concept
% 209.74/209.97 |- skos__scopeNote mesh__D010407
% 209.74/209.97 A mitosporic Trichocomaceae fungal genus that develops fruiting organs resembling a broom. When identified, teleomorphs include Eupenicillium and TALAROMYCES. Several species %28%but especially PENICILLIUM CHRYSOGENUM%29% are sources of the antibiotic penicillin.%A%
% 209.74/209.97 |- skos__prefLabel mesh__D010407 Penicillium
% 209.74/209.97 |- mesh__dateCreated mesh__D010407 1999-01-01
% 209.74/209.97 |- mesh__recordMaintainer mesh__D010407 SYSTEM
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D010407 2006
% 209.74/209.97 |- mesh__dateRevised mesh__D010407 2005-06-30
% 209.74/209.97 |- skos__broader mesh__D010407smesh__D003904
% 209.74/209.97 |- mesh__historyNote mesh__D020835
% 209.74/209.97 2000; for KAMPO %26% KANPO use MEDICINE, CHINESE TRADITIONAL 1994-1999%A%
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D020835 sjn
% 209.74/209.97 |- skos__altLabel mesh__D020835 Kampo Medicine
% 209.74/209.97 |- mesh__dateEstablished mesh__D020835 2000-01-01
% 209.74/209.97 |- skos__altLabel mesh__D020835 Kanpo
% 209.74/209.97 |- skos__broader mesh__D020835smesh__D008518
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020835 2004
% 209.74/209.97 |- mesh__recordMaintainer mesh__D020835 ssb
% 209.74/209.97 |- skos__hiddenLabel mesh__D020835 Medicine, Kanpo
% 209.74/209.97 |- skos__altLabel mesh__D020835 Kanpo Medicine
% 209.74/209.97 |- skos__broader mesh__D020835smesh__D008519
% 209.74/209.97 |- skos__prefLabel mesh__D020835 Medicine, Kampo
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020835 2003
% 209.74/209.97 |- skos__annotation mesh__D020835
% 209.74/209.97 coord with DRUGS, CHINESE HERBAL or MATERIA MEDICA if pertinent; MEDICINE, CHINESE TRADITIONAL is also available%A%
% 209.74/209.97 |- rdf__type mesh__D020835sskos__Concept
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D020835
% 209.74/209.97 2000; for KAMPO %26% KAMPO use MEDICINE, CHINESE TRADITIONAL 1994-1999%A%
% 209.74/209.97 |- skos__altLabel mesh__D020835 Kampo
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020835 2006
% 209.74/209.97 |- skos__scopeNote mesh__D020835
% 209.74/209.97 System of herbal medicine practiced in Japan by both herbalists and practitioners of modern medicine. Kampo originated in China and is based on Chinese herbal medicine %28%MEDICINE, CHINESE TRADITIONAL%29%.%A%
% 209.74/209.97 |- mesh__dateRevised mesh__D020835 2001-07-25
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020835 2002
% 209.74/209.97 |- mesh__dateCreated mesh__D020835 1999-11-03
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020835 2005
% 209.74/209.97 |- skos__related mesh__D020835smesh__D008516
% 209.74/209.97 |- skos__historyNote mesh__D020835
% 209.74/209.97 Medicine, Chinese Traditional %28%1994-1999%29%
% 209.74/209.97 |- mesh__recordOriginator mesh__D020835 ags
% 209.74/209.97 |- mesh__dateEstablished mesh__D006366 1968-01-01
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006366 2004
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006366 2001
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D006366 68
% 209.74/209.97 |- skos__prefLabel mesh__D006366 Heinz Bodies
% 209.74/209.97 |- skos__broader mesh__D006366smesh__D004908
% 209.74/209.97 |- skos__hiddenLabel mesh__D006366 Bodies, Heinz
% 209.74/209.97 |- mesh__dateCreated mesh__D006366 1999-01-01
% 209.74/209.97 |- rdf__type mesh__D006366sskos__Concept
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006366 2005
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006366 2002
% 209.74/209.97 |- mesh__recordOriginator mesh__D006366 NLM
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006366 2006
% 209.74/209.97 |- mesh__dateRevised mesh__D006366 2000-06-22
% 209.74/209.97 |- mesh__historyNote mesh__D006366 68%28%63%29%
% 209.74/209.97 |- skos__scopeNote mesh__D006366
% 209.74/209.97 Abnormal intracellular inclusions, composed of denatured hemoglobin, found on the membrane of red blood cells. They are seen in thalassemias, enzymopathies, hemoglobinopathies, and after splenectomy.%A%
% 209.74/209.97 |- mesh__recordMaintainer mesh__D006366 KEV
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D006366 sjn
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006366 2003
% 209.74/209.97 |- skos__prefLabel mesh__D020037 Sordariales
% 209.74/209.97 |- mesh__dateRevised mesh__D020037 2005-06-30
% 209.74/209.97 |- mesh__historyNote mesh__D020037 99
% 209.74/209.97 |- skos__scopeNote mesh__D020037
% 209.74/209.97 An order of fungi in the phylum ASCOMYCOTA that includes many valuable experimental organisms. There are eight families and very few anamorphic forms.%A%
% 209.74/209.97 |- skos__broader mesh__D020037smesh__D001203
% 209.74/209.97 |- mesh__recordOriginator mesh__D020037 AGS
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D020037 99
% 209.74/209.97 |- mesh__dateCreated mesh__D020037 1998-06-11
% 209.74/209.97 |- rdf__type mesh__D020037sskos__Concept
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D020037 sjn
% 209.74/209.97 |- mesh__recordMaintainer mesh__D020037 SYSTEM
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020037 2006
% 209.74/209.97 |- mesh__dateEstablished mesh__D020037 1999-01-01
% 209.74/209.97 |- skos__scopeNote mesh__D011500
% 209.74/209.97 Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.%A%
% 209.74/209.97 |- skos__historyNote mesh__D011500 Proteins/biosynthesis %28%1966-1987%29%
% 209.74/209.97 |- mesh__historyNote mesh__D011500 88
% 209.74/209.97 |- mesh__dateCreated mesh__D011500 1987-04-09
% 209.74/209.97 |- skos__broader mesh__D011500smesh__D004791
% 209.74/209.97 |- mesh__recordMaintainer mesh__D011500 jls
% 209.74/209.97 |- mesh__recordOriginator mesh__D011500 RLS
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D011500 2006
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D011500 2004
% 209.74/209.97 |- skos__annotation mesh__D011500 enzyme inhib; DF: PROTEIN SYN INHIB
% 209.74/209.97 |- rdf__type mesh__D011500sskos__Concept
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D011500 2005A
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D011500 2005
% 209.74/209.97 |- skos__prefLabel mesh__D011500 Protein Synthesis Inhibitors
% 209.74/209.97 |- mesh__dateRevised mesh__D011500 2004-07-30
% 209.74/209.97 |- skos__hiddenLabel mesh__D011500 Inhibitors, Protein Synthesis
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D011500 jls
% 209.74/209.97 |- mesh__dateEstablished mesh__D011500 1988-01-01
% 209.74/209.97 |- skos__altLabel mesh__D011500 Protein Synthesis Antagonists
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D011500 88
% 209.74/209.97 |- skos__hiddenLabel mesh__D011500 Antagonists, Protein Synthesis
% 209.74/209.97 |- skos__scopeNote mesh__D016794
% 209.74/209.97 A genus of tick-borne protozoa parasitic in the lymphocytes, erythrocytes, and endothelial cells of mammals. Its organisms multiply asexually and then invade erythrocytes, where they undergo no further reproduction until ingested by a transmitting tick.%A%
% 209.74/209.97 |- mesh__dateCreated mesh__D016794 1991-05-02
% 209.74/209.97 |- mesh__historyNote mesh__D016794 92
% 209.74/209.97 |- rdf__type mesh__D016794sskos__Concept
% 209.74/209.97 |- mesh__recordOriginator mesh__D016794 PXP
% 209.74/209.97 |- mesh__dateEstablished mesh__D016794 1992-01-01
% 209.74/209.97 |- mesh__recordMaintainer mesh__D016794 ags
% 209.74/209.97 |- mesh__dateRevised mesh__D016794 2003-07-09
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D016794 92
% 209.74/209.97 |- skos__prefLabel mesh__D016794 Theileria
% 209.74/209.97 |- skos__annotation mesh__D016794
% 209.74/209.97 a tick-borne protozoon; infection = THEILERIASIS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D016794 2005
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D016794 sjn
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D016794 2006
% 209.74/209.97 |- skos__historyNote mesh__D016794 Sporozoea %28%1966-1991%29%
% 209.74/209.97 |- skos__broader mesh__D016794smesh__D016792
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D016794 2004
% 209.74/209.97 |- skos__hiddenLabel mesh__D052119 Lysosomal Associated Membrane Protein 2
% 209.74/209.97 |- skos__altLabel mesh__D052119 LAMP2 Protein
% 209.74/209.97 |- skos__altLabel mesh__D052119 CD107b Antigens
% 209.74/209.97 |- mesh__recordMaintainer mesh__D052119 jmp
% 209.74/209.97 |- skos__prefLabel mesh__D052119 Lysosomal-Associated Membrane Protein 2
% 209.74/209.97 |- mesh__dateCreated mesh__D052119 2005-06-30
% 209.74/209.97 |- rdf__type mesh__D052119sskos__Concept
% 209.74/209.97 |- skos__broader mesh__D052119smesh__D015703
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D052119
% 209.74/209.97 2006; ANTIGENS CD107B was indexed under ANTIGENS, CD 2003-2005, %26% under MEMBRANE GLYCOPROTEINS 1986-2002%A%
% 209.74/209.97 |- mesh__historyNote mesh__D052119 2006%28%1986%29%
% 209.74/209.97 |- skos__altLabel mesh__D052119 Antigens, CD107b
% 209.74/209.97 |- skos__altLabel mesh__D052119 LGP110 Protein
% 209.74/209.97 |- mesh__recordOriginator mesh__D052119 jmp
% 209.74/209.97 |- skos__scopeNote mesh__D052119
% 209.74/209.97 An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. Loss of expression of lysosomal-associated membrane protein 2 is associated with GLYCOGEN STORAGE DISEASE TYPE IIB.%A%
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D052119 sjn
% 209.74/209.97 |- skos__altLabel mesh__D052119 LGP-B Protein
% 209.74/209.97 |- skos__hiddenLabel mesh__D052119 LGP B Protein
% 209.74/209.97 |- mesh__dateEstablished mesh__D052119 2006-01-01
% 209.74/209.97 |- skos__broader mesh__D052119smesh__D051907
% 209.74/209.97 |- skos__altLabel mesh__D052119 CD107b Antigen
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D052119 2006
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 1994
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D002774 75; was see under CHOLESTENES 1974
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 1999
% 209.74/209.97 |- mesh__dateEstablished mesh__D002774 1975-01-01
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 1995
% 209.74/209.97 |- skos__annotation mesh__D002774 do not confuse with CHOLESTADIENOLS
% 209.74/209.97 |- skos__prefLabel mesh__D002774 Cholestadienes
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 2003
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D002774 PLS
% 209.74/209.97 |- mesh__historyNote mesh__D002774 75; was see under CHOLESTENES 1974
% 209.74/209.97 |- rdf__type mesh__D002774sskos__Concept
% 209.74/209.97 |- mesh__recordMaintainer mesh__D002774 PLS
% 209.74/209.97 |- skos__broader mesh__D002774smesh__D002782
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 1996
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 2004
% 209.74/209.97 |- skos__historyNote mesh__D002774 Cholestenes %28%1973-1974%29%
% 209.74/209.97 |- mesh__dateCreated mesh__D002774 1999-01-01
% 209.74/209.97 |- skos__scopeNote mesh__D002774
% 209.74/209.97 Cholene derivatives with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. They must have two double bonds in the ring system.%A%
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 2000
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 1997
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 2005
% 209.74/209.97 |- mesh__onlineNote mesh__D002774 search CHOLESTENES 1974
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 2001
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 1998
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 2006
% 209.74/209.97 |- mesh__dateRevised mesh__D002774 1993-06-03
% 209.74/209.97 |- mesh__recordOriginator mesh__D002774 NLM
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D002774 2002
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D029911 2002
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D029911 2003
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D029911 2006
% 209.74/209.97 |- mesh__recordMaintainer mesh__D029911 ssb
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D029911 sjn
% 209.74/209.97 |- rdf__type mesh__D029911sskos__Concept
% 209.74/209.97 |- mesh__dateEstablished mesh__D029911 2002-01-01
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D029911 2005
% 209.74/209.97 |- skos__annotation mesh__D029911
% 209.74/209.97 CAT%27%S CLAW is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.74/209.97 |- mesh__dateCreated mesh__D029911 2001-07-25
% 209.74/209.97 |- skos__broader mesh__D029911smesh__D007887
% 209.74/209.97 |- skos__scopeNote mesh__D029911
% 209.74/209.97 A plant genus of the family FABACEAE. The common name of %22%Bird-Of-Paradise%22% is also used for other plants such as Heliconia %28%HELICONIACEAE%29% and Strelitzia %28%STRELITZIACEAE%29% and some birds. The common name of %22%Cat%27%s-Claw%22% is more often used with UNCARIA. The common name of %22%Pernambuco%22% also refers to a state in Brazil. Furanoditerpenoid lactones and caesalpin are produced by members of this genus.%A%
% 209.74/209.97 |- mesh__historyNote mesh__D029911 2002
% 209.74/209.97 |- skos__prefLabel mesh__D029911 Caesalpinia
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D029911 2004
% 209.74/209.97 |- mesh__dateRevised mesh__D029911 2002-07-02
% 209.74/209.97 |- mesh__recordOriginator mesh__D029911 ssb
% 209.74/209.97 |- mesh__dateEstablished mesh__D010408 1991-01-01
% 209.74/209.97 |- mesh__historyNote mesh__D010408 91%28%72%29%
% 209.74/209.97 |- skos__scopeNote mesh__D010408
% 209.74/209.97 A mitosporic fungal species used in the production of penicillin.%A%
% 209.74/209.97 |- mesh__dateRevised mesh__D010408 2005-06-30
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D010408 91; see PENICILLIUM 1972-90
% 209.74/209.97 |- mesh__dateCreated mesh__D010408 1999-01-01
% 209.74/209.97 |- mesh__recordOriginator mesh__D010408 NLM
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D010408 2006
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D010408 sjn
% 209.74/209.97 |- mesh__recordMaintainer mesh__D010408 SYSTEM
% 209.74/209.97 |- skos__altLabel mesh__D010408 Penicillium notatum
% 209.74/209.97 |- skos__prefLabel mesh__D010408 Penicillium chrysogenum
% 209.74/209.97 |- skos__historyNote mesh__D010408 Penicillium %28%1966-1971%29%
% 209.74/209.97 |- skos__broader mesh__D010408smesh__D010407
% 209.74/209.97 |- rdf__type mesh__D010408sskos__Concept
% 209.74/209.97 |- mesh__dateEstablished mesh__D020836 2000-01-01
% 209.74/209.97 |- mesh__historyNote mesh__D020836
% 209.74/209.97 2000; use PROTEIN CONFORMATION %28%1993-1999%29%
% 209.74/209.97 |- mesh__recordMaintainer mesh__D020836 jmp
% 209.74/209.97 |- skos__related mesh__D020836smesh__D046912
% 209.74/209.97 |- mesh__dateCreated mesh__D020836 1999-11-04
% 209.74/209.97 |- skos__broader mesh__D020836smesh__D011487
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D020836 sjn
% 209.74/209.97 |- skos__hiddenLabel mesh__D020836 Protein Structures, Quaternary
% 209.74/209.97 |- rdf__type mesh__D020836sskos__Concept
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020836 2006
% 209.74/209.97 |- mesh__recordOriginator mesh__D020836 nns
% 209.74/209.97 |- skos__altLabel mesh__D020836 Quaternary Protein Structure
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D020836 2005
% 209.74/209.97 |- skos__scopeNote mesh__D020836
% 209.74/209.97 The characteristic 3-dimensional shape and arrangement of multimeric proteins %28%aggregates of more than one polypeptide chain%29%.%A%
% 209.74/209.97 |- skos__historyNote mesh__D020836
% 209.74/209.97 Macromolecular Protein Complexes %28%1966-1999%29%
% 209.74/209.97 |- skos__historyNote mesh__D020836 Protein Conformation %28%1972-1999%29%
% 209.74/209.97 |- mesh__dateRevised mesh__D020836 2004-07-07
% 209.74/209.97 |- skos__hiddenLabel mesh__D020836 Quaternary Protein Structures
% 209.74/209.97 |- mesh__publicMeSHNote mesh__D020836
% 209.74/209.97 2000; see PROTEIN CONFORMATION %28%1993-1999%29%
% 209.74/209.97 |- skos__annotation mesh__D020836
% 209.74/209.97 for multimeric proteins; for the 3-dimensional shape of a single polypeptide chain use PROTEIN CONFORMATION%A%
% 209.74/209.97 |- skos__prefLabel mesh__D020836 Protein Structure, Quaternary
% 209.74/209.97 |- skos__scopeNote mesh__D006367
% 209.74/209.97 The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks %28%one of several pseudonyms%29%. These cells are used for VIRUS CULTIVATION and antitumor drug screening assays.%A%
% 209.74/209.97 |- skos__hiddenLabel mesh__D006367 Hela Cell
% 209.74/209.97 |- skos__hiddenLabel mesh__D006367 Cell, Hela
% 209.74/209.97 |- mesh__recordAuthorizer mesh__D006367 sjn
% 209.74/209.97 |- mesh__activeMeSHYear mesh__D006367 2006
% 209.74/209.97 |- skos__broader mesh__D006367smesh__D004847
% 209.74/209.98 |- skos__broader mesh__D006367smesh__D045744
% 209.74/209.98 |- mesh__dateRevised mesh__D006367 2005-07-01
% 209.74/209.98 |- skos__annotation mesh__D006367
% 209.74/209.98 almost always NIM with no subheadings; check HUMAN; do not routinely add UTERINE CERVICAL NEOPLASMS%A%
% 209.74/209.98 |- mesh__historyNote mesh__D006367 68%28%65%29%
% 209.74/209.98 |- mesh__dateEstablished mesh__D006367 1968-01-01
% 209.74/209.98 |- skos__prefLabel mesh__D006367 Hela Cells
% 209.74/209.98 |- skos__hiddenLabel mesh__D006367 Cells, Hela
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D006367 68
% 209.74/209.98 |- mesh__recordMaintainer mesh__D006367 sjn
% 209.74/209.98 |- mesh__dateCreated mesh__D006367 1999-01-01
% 209.74/209.98 |- rdf__type mesh__D006367sskos__Concept
% 209.74/209.98 |- mesh__recordOriginator mesh__D006367 NLM
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Leader, Spliced
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Leader Sequences, Spliced
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D020038 2004
% 209.74/209.98 |- skos__historyNote mesh__D020038 RNA, Messenger %28%1983-1995%29%
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Sequence, SL2
% 209.74/209.98 |- mesh__dateEstablished mesh__D020038 1999-01-01
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Sequences, Spliced Leader
% 209.74/209.98 |- skos__altLabel mesh__D020038 Spliced Leader Sequences
% 209.74/209.98 |- skos__prefLabel mesh__D020038 RNA, Spliced Leader
% 209.74/209.98 |- skos__altLabel mesh__D020038 Spliced Leader
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D020038 99
% 209.74/209.98 |- skos__altLabel mesh__D020038 SL RNA
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Leader Sequences, Trans-Spliced
% 209.74/209.98 |- mesh__dateCreated mesh__D020038 1998-06-11
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Sequence, SL1
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Sequence, SL4
% 209.74/209.98 |- skos__related mesh__D020038smesh__D020040
% 209.74/209.98 |- rdf__type mesh__D020038sskos__Concept
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D020038 2002
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Sequences, Trans-Spliced Leader
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D020038 2005
% 209.74/209.98 |- mesh__historyNote mesh__D020038 99
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Trans Spliced Leader Sequences
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Sequence, SL3
% 209.74/209.98 |- skos__broader mesh__D020038smesh__D022661
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D020038 2006
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Leader RNA, Spliced
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D020038 2003
% 209.74/209.98 |- mesh__dateRevised mesh__D020038 2000-06-22
% 209.74/209.98 |- skos__altLabel mesh__D020038 Spliced Leader RNA
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D020038 2001
% 209.74/209.98 |- skos__annotation mesh__D020038
% 209.74/209.98 do not confuse with LEADER SEQUENCES, MRNA see 5%27% UNTRANSLATED REGION%A%
% 209.74/209.98 |- skos__scopeNote mesh__D020038
% 209.74/209.98 The small RNAs which provide spliced leader sequences, SL1, SL2, SL3, SL4 and SL5 %28%short sequences which are joined to the 5%27% ends of pre-mRNAs by TRANS-SPLICING%29%. They are found primarily in primitive eukaryotes %28%protozoans and nematodes%29%.%A%
% 209.74/209.98 |- skos__hiddenLabel mesh__D020038 Sequence, SL5
% 209.74/209.98 |- skos__historyNote mesh__D020038 Signal Peptides %28%1987-1998%29%
% 209.74/209.98 |- skos__hiddenLabel mesh__D025521 Proteins, Tumor Suppressor
% 209.74/209.98 |- skos__scopeNote mesh__D025521
% 209.74/209.98 Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.%A%
% 209.74/209.98 |- mesh__recordMaintainer mesh__D025521 SYSTEM
% 209.74/209.98 |- skos__hiddenLabel mesh__D025521 Proteins, Metastasis Suppressor
% 209.74/209.98 |- mesh__dateRevised mesh__D025521 2005-06-30
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D025521 sjn
% 209.74/209.98 |- mesh__dateEstablished mesh__D025521 2002-01-01
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D025521 2002
% 209.74/209.98 |- mesh__recordOriginator mesh__D025521 nns
% 209.74/209.98 |- skos__prefLabel mesh__D025521 Tumor Suppressor Proteins
% 209.74/209.98 |- rdf__type mesh__D025521sskos__Concept
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D025521 2006
% 209.74/209.98 |- skos__broader mesh__D025521smesh__D009363
% 209.74/209.98 |- mesh__dateCreated mesh__D025521 2001-07-25
% 209.74/209.98 |- skos__hiddenLabel mesh__D025521 Proteins, Growth Suppressor
% 209.74/209.98 |- skos__related mesh__D025521smesh__D016147
% 209.74/209.98 |- mesh__historyNote mesh__D025521 2002
% 209.74/209.98 |- rdf__type mesh__D002775sskos__Concept
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 2000
% 209.74/209.98 |- mesh__dateEstablished mesh__D002775 1974-01-01
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 1996
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 2004
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 2001
% 209.74/209.98 |- mesh__dateCreated mesh__D002775 1999-01-01
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 1997
% 209.74/209.98 |- mesh__dateRevised mesh__D002775 1993-06-03
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 2005
% 209.74/209.98 |- mesh__recordOriginator mesh__D002775 NLM
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 2002
% 209.74/209.98 |- skos__prefLabel mesh__D002775 Cholestadienols
% 209.74/209.98 |- skos__broader mesh__D002775smesh__D002774
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 1998
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 2006
% 209.74/209.98 |- mesh__historyNote mesh__D002775 74
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 1994
% 209.74/209.98 |- skos__annotation mesh__D002775 do not confuse with CHOLESTADIENES
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 1999
% 209.74/209.98 |- mesh__recordMaintainer mesh__D002775 PLS
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 1995
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D002775 74
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D002775 PLS
% 209.74/209.98 |- skos__scopeNote mesh__D002775
% 209.74/209.98 Cholestadiene derivatives containing a hydroxy group anywhere in the molecule.%A%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002775 2003
% 209.74/209.98 |- mesh__dateRevised mesh__D029912 2002-07-02
% 209.74/209.98 |- rdf__type mesh__D029912sskos__Concept
% 209.74/209.98 |- mesh__dateEstablished mesh__D029912 2002-01-01
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D029912 2005
% 209.74/209.98 |- skos__broader mesh__D029912smesh__D007887
% 209.74/209.98 |- skos__scopeNote mesh__D029912
% 209.74/209.98 A plant genus of the family FABACEAE. Members contain ABRIN.%A%
% 209.74/209.98 |- mesh__recordMaintainer mesh__D029912 ssb
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D029912 sjn
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D029912 2004
% 209.74/209.98 |- mesh__dateCreated mesh__D029912 2001-07-25
% 209.74/209.98 |- skos__annotation mesh__D029912
% 209.74/209.98 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.74/209.98 |- mesh__recordOriginator mesh__D029912 ssb
% 209.74/209.98 |- skos__prefLabel mesh__D029912 Abrus
% 209.74/209.98 |- skos__altLabel mesh__D029912 Precatory Bean Plant
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D029912 2002
% 209.74/209.98 |- mesh__historyNote mesh__D029912 2002
% 209.74/209.98 |- skos__altLabel mesh__D029912 Bean Plant, Precatory
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D029912 2003
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D029912 2006
% 209.74/209.98 |- skos__hiddenLabel mesh__D010409 Penile Disease
% 209.74/209.98 |- skos__prefLabel mesh__D010409 Penile Diseases
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D010409 2002
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D010409 1999
% 209.74/209.98 |- mesh__dateEstablished mesh__D010409 1966-01-01
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D010409 2004
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D010409 2001
% 209.74/209.98 |- skos__hiddenLabel mesh__D010409 Disease, Penile
% 209.74/209.98 |- mesh__dateCreated mesh__D010409 1999-01-01
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D010409 66
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D010409 2006
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D010409 2003
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D010409 SJN
% 209.74/209.98 |- mesh__recordMaintainer mesh__D010409 NDW
% 209.74/209.98 |- skos__hiddenLabel mesh__D010409 Penis Disease
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D010409 2005
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D010409 2000
% 209.74/209.98 |- mesh__dateRevised mesh__D010409 1998-06-10
% 209.74/209.98 |- skos__hiddenLabel mesh__D010409 Diseases, Penis
% 209.74/209.98 |- skos__hiddenLabel mesh__D010409 Disease, Penis
% 209.74/209.98 |- mesh__historyNote mesh__D010409 66
% 209.74/209.98 |- mesh__recordOriginator mesh__D010409 NLM
% 209.74/209.98 |- rdf__type mesh__D010409sskos__Concept
% 209.74/209.98 |- skos__altLabel mesh__D010409 Penis Diseases
% 209.74/209.98 |- skos__hiddenLabel mesh__D010409 Diseases, Penile
% 209.74/209.98 |- skos__annotation mesh__D010409
% 209.74/209.98 inflamm dis = BALANITIS; penile fract: index under PENIS /inj %28%IM%29% + RUPTURE %28%NIM%29%%A%
% 209.74/209.98 |- skos__broader mesh__D010409smesh__D005832
% 209.74/209.98 |- skos__historyNote mesh__D007460 Amides %28%1972-1974%29%
% 209.74/209.98 |- skos__broader mesh__D007460smesh__D019807
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D007460 2002
% 209.74/209.98 |- skos__broader mesh__D007460smesh__D000081
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D007460 2006
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D007460
% 209.74/209.98 91; was see under IODOACETATES 1975-90
% 209.74/209.98 |- mesh__recordMaintainer mesh__D007460 adp
% 209.74/209.98 |- mesh__dateEstablished mesh__D007460 1991-01-01
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D007460 2003
% 209.74/209.98 |- mesh__dateRevised mesh__D007460 1999-11-03
% 209.74/209.98 |- mesh__recordOriginator mesh__D007460 NLM
% 209.74/209.98 |- rdf__type mesh__D007460sskos__Concept
% 209.74/209.98 |- mesh__historyNote mesh__D007460
% 209.74/209.98 91%28%75%29%; was see under IODOACETATES 1975-90
% 209.74/209.98 |- skos__historyNote mesh__D007460 Iodoacetates %28%1969-1974%29%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D007460 2000
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D007460 2004
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D007460 sjn
% 209.74/209.98 |- mesh__dateCreated mesh__D007460 1974-11-19
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D007460 2001
% 209.74/209.98 |- skos__prefLabel mesh__D007460 Iodoacetamide
% 209.74/209.98 |- skos__scopeNote mesh__D007460
% 209.74/209.98 An alkylating sulfhydryl reagent. Its actions are similar to those of iodoacetate.%A%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D007460 2005
% 209.74/209.98 |- skos__historyNote mesh__D020837 Fungal Proteins %28%1992-1999%29%
% 209.74/209.98 |- skos__prefLabel mesh__D020837 SOS1 Protein
% 209.74/209.98 |- skos__scopeNote mesh__D020837
% 209.74/209.98 A mammalian homolog of the DROSOPHILA SON OF SEVENLESS PROTEIN. It is a guanine nucleotide exchange factor for RAS PROTEINS.%A%
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D020837
% 209.74/209.98 2000; SOS1 PROTEIN was indexed under REPRESSOR PROTEINS 1993-1999; MSOS1 PROTEIN was indexed under PROTEINS 1993-1999%A%
% 209.74/209.98 |- skos__altLabel mesh__D020837 Son of Sevenless Homolog 1
% 209.74/209.98 |- skos__broader mesh__D020837smesh__D020664
% 209.74/209.98 |- rdf__type mesh__D020837sskos__Concept
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D020837 2006
% 209.74/209.98 |- mesh__dateEstablished mesh__D020837 2000-01-01
% 209.74/209.98 |- mesh__dateCreated mesh__D020837 1999-11-03
% 209.74/209.98 |- mesh__dateRevised mesh__D020837 2005-06-30
% 209.74/209.98 |- mesh__historyNote mesh__D020837
% 209.74/209.98 2000; use SOS1 PROTEIN %28%NM%29% 1992-1999; for MSOS1 PROTEIN use GUANINE NUCLEOTIDE EXCHANGE FACTORS %28%NM%29% 1996-1999%A%
% 209.74/209.98 |- skos__historyNote mesh__D020837 Membrane Proteins %28%1992-1999%29%
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D020837 sjn
% 209.74/209.98 |- skos__historyNote mesh__D020837 Repressor Proteins %28%1992-1999%29%
% 209.74/209.98 |- mesh__recordMaintainer mesh__D020837 ags
% 209.74/209.98 |- mesh__recordOriginator mesh__D020837 jmp
% 209.74/209.98 |- skos__altLabel mesh__D020837 mSOS1 Protein
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D006368 2006
% 209.74/209.98 |- skos__prefLabel mesh__D006368 Helianthus
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D006368 2002
% 209.74/209.98 |- mesh__recordOriginator mesh__D006368 NLM
% 209.74/209.98 |- skos__annotation mesh__D006368
% 209.74/209.98 for sunflower seeds coord IM with SEEDS %28%IM%29%; do not confuse X ref JERUSALEM ARTICHOKE with plain artichoke %28%index probably VEGETABLES%29%%A%
% 209.74/209.98 |- skos__hiddenLabel mesh__D006368 Artichoke, Jerusalem
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D006368 2003
% 209.74/209.98 |- mesh__dateRevised mesh__D006368 1998-06-10
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D006368 SJN
% 209.74/209.98 |- skos__broader mesh__D006368smesh__D000821
% 209.74/209.98 |- mesh__recordMaintainer mesh__D006368 NNS
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D006368 2004
% 209.74/209.98 |- skos__hiddenLabel mesh__D006368 Sunflowers
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D006368 2000
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D006368 2001
% 209.74/209.98 |- mesh__dateCreated mesh__D006368 1999-01-01
% 209.74/209.98 |- rdf__type mesh__D006368sskos__Concept
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D006368 2005
% 209.74/209.98 |- skos__broader mesh__D006368smesh__D019659
% 209.74/209.98 |- skos__scopeNote mesh__D006368
% 209.74/209.98 A genus of tall, erect American herbs of the Compositae. The seeds yield oil and are used as food and animal feed; the roots of Helianthus tuberosum %28%Jerusalem artichoke%29% are edible.%A%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D006368 1999
% 209.74/209.98 |- skos__historyNote mesh__D017090 Orthodontic Appliances %28%1969-1992%29%
% 209.74/209.98 |- mesh__historyNote mesh__D017090 93
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 2001
% 209.74/209.98 |- skos__scopeNote mesh__D017090
% 209.74/209.98 Rigid or flexible appliances that overlay the occlusal surfaces of the teeth. They are used to treat clenching and bruxism and their sequelae, and to provide temporary relief from muscle or temporomandibular joint pain.%A%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 2004
% 209.74/209.98 |- mesh__recordMaintainer mesh__D017090 JLS
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 2000
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 2006
% 209.74/209.98 |- skos__altLabel mesh__D017090 Splints, Occlusal
% 209.74/209.98 |- mesh__dateRevised mesh__D017090 1996-06-21
% 209.74/209.98 |- mesh__dateCreated mesh__D017090 1992-05-22
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 2003
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 1997
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D017090 93
% 209.74/209.98 |- skos__prefLabel mesh__D017090 Occlusal Splints
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 2005
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 1999
% 209.74/209.98 |- skos__hiddenLabel mesh__D017090 Occlusal Splint
% 209.74/209.98 |- rdf__type mesh__D017090sskos__Concept
% 209.74/209.98 |- mesh__recordOriginator mesh__D017090 MXR
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D017090 PLS
% 209.74/209.98 |- mesh__dateEstablished mesh__D017090 1993-01-01
% 209.74/209.98 |- skos__annotation mesh__D017090
% 209.74/209.98 rigid or flexible splint used in orthodontics %26% treatment of clenching %26% bruxism%A%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 1998
% 209.74/209.98 |- skos__hiddenLabel mesh__D017090 Splint, Occlusal
% 209.74/209.98 |- skos__broader mesh__D017090smesh__D009967
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D017090 2002
% 209.74/209.98 |- mesh__dateEstablished mesh__D025522 2002-01-01
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D025522 2004
% 209.74/209.98 |- skos__hiddenLabel mesh__D025522 Phage, N4
% 209.74/209.98 |- skos__broader mesh__D025522smesh__D017902
% 209.74/209.98 |- skos__altLabel mesh__D025522 Enterobacteria phage N4
% 209.74/209.98 |- skos__scopeNote mesh__D025522
% 209.74/209.98 A species with unassigned genus in the family PODOVIRIDAE.%A%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D025522 2005
% 209.74/209.98 |- rdf__type mesh__D025522sskos__Concept
% 209.74/209.98 |- skos__altLabel mesh__D025522 Phage N4
% 209.74/209.98 |- skos__prefLabel mesh__D025522 Bacteriophage N4
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D025522 2006
% 209.74/209.98 |- skos__hiddenLabel mesh__D025522 Phages, N4
% 209.74/209.98 |- skos__hiddenLabel mesh__D025522 N4 Phages
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D025522 2002
% 209.74/209.98 |- skos__broader mesh__D025522smesh__D003090
% 209.74/209.98 |- skos__historyNote mesh__D025522 Coliphages %28%1977-1993%29%
% 209.74/209.98 |- skos__altLabel mesh__D025522 Coliphage N4
% 209.74/209.98 |- mesh__historyNote mesh__D025522 2002; use PODOVIRIDAE 1994-2001
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D025522 2002; see PODOVIRIDAE 1994-2001
% 209.74/209.98 |- skos__altLabel mesh__D025522 N4 Phage
% 209.74/209.98 |- mesh__dateCreated mesh__D025522 2001-07-25
% 209.74/209.98 |- skos__historyNote mesh__D025522 Podoviridae %28%1993-2001%29%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D025522 2003
% 209.74/209.98 |- skos__historyNote mesh__D003070 Ribonucleosides %28%1971-1978%29%
% 209.74/209.98 |- mesh__recordMaintainer mesh__D003070 JRT
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 2005
% 209.74/209.98 |- mesh__historyNote mesh__D003070
% 209.74/209.98 90%28%79%29%; was see under RIBONUCLEOSIDES 1979-89
% 209.74/209.98 |- skos__historyNote mesh__D003070 Azepines %28%1966-1978%29%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 2000
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 1999
% 209.74/209.98 |- skos__historyNote mesh__D003070 Nucleosides %28%1966-1970%29%
% 209.74/209.98 |- rdf__type mesh__D003070sskos__Concept
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 2004
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 1998
% 209.74/209.98 |- mesh__recordOriginator mesh__D003070 SH
% 209.74/209.98 |- mesh__dateRevised mesh__D003070 1995-06-08
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 2003
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D003070
% 209.74/209.98 90; was see under RIBONUCLEOSIDES 1979-89
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 1997
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D003070 PLS
% 209.74/209.98 |- skos__annotation mesh__D003070
% 209.74/209.98 an enzyme inhib %26% antineoplastic antibiotic
% 209.74/209.98 |- skos__prefLabel mesh__D003070 Coformycin
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 1996
% 209.74/209.98 |- mesh__dateEstablished mesh__D003070 1990-01-01
% 209.74/209.98 |- skos__broader mesh__D003070smesh__D005573
% 209.74/209.98 |- mesh__dateCreated mesh__D003070 1977-12-08
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 2002
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 2006
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D003070 2001
% 209.74/209.98 |- skos__scopeNote mesh__D003070
% 209.74/209.98 A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.%A%
% 209.74/209.98 |- skos__annotation mesh__D011502 consider also KWASHIORKOR
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D011502
% 209.74/209.98 92; was PROTEIN-CALORIE MALNUTRITION 1974-91
% 209.74/209.98 |- mesh__dateCreated mesh__D011502 1999-01-01
% 209.74/209.98 |- skos__historyNote mesh__D011502 Nutrition Disorders %28%1966-1971%29%
% 209.74/209.98 |- mesh__recordMaintainer mesh__D011502 nns
% 209.74/209.98 |- skos__hiddenLabel mesh__D011502 Malnutrition, Protein-Energy
% 209.74/209.98 |- skos__hiddenLabel mesh__D011502 Malnutritions, Protein-Energy
% 209.74/209.98 |- skos__prefLabel mesh__D011502 Protein-Energy Malnutrition
% 209.74/209.98 |- skos__related mesh__D011502smesh__D004614
% 209.74/209.98 |- skos__historyNote mesh__D011502
% 209.74/209.98 Infant Nutrition Disorders %28%1966-1971%29%
% 209.74/209.98 |- mesh__dateRevised mesh__D011502 2004-07-07
% 209.74/209.98 |- skos__scopeNote mesh__D011502
% 209.74/209.98 The lack of sufficient energy or protein to meet the body%27%s metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses.%A%
% 209.74/209.98 |- mesh__historyNote mesh__D011502
% 209.74/209.98 92; was PROTEIN-CALORIE MALNUTRITION 1972-91 %28%Prov 1972-73%29%%A%
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D011502 sjn
% 209.74/209.98 |- mesh__onlineNote mesh__D011502
% 209.74/209.98 use PROTEIN-ENERGY MALNUTRITION to search PROTEIN-CALORIE MALNUTRITION 1972-91 %28%as Prov 1972-73%29%%A%
% 209.74/209.98 |- skos__altLabel mesh__D011502 Protein-Calorie Malnutrition
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D011502 2006
% 209.74/209.98 |- skos__hiddenLabel mesh__D011502 Protein Calorie Malnutrition
% 209.74/209.98 |- rdf__type mesh__D011502sskos__Concept
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D011502 2005
% 209.74/209.98 |- mesh__recordOriginator mesh__D011502 NLM
% 209.74/209.98 |- skos__hiddenLabel mesh__D011502 Protein Energy Malnutrition
% 209.74/209.98 |- skos__broader mesh__D011502smesh__D011488
% 209.74/209.98 |- mesh__dateEstablished mesh__D011502 1974-01-01
% 209.74/209.98 |- skos__hiddenLabel mesh__D011502 Malnutrition, Protein-Calorie
% 209.74/209.98 |- skos__altLabel mesh__D049970 Ophthalmopathy, Thyroid-Associated
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Congestive Ophthalmopathies
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D049970 sjn
% 209.74/209.98 |- mesh__recordMaintainer mesh__D049970 lkt
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Infiltrative
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Congestive
% 209.74/209.98 |- skos__altLabel mesh__D049970 Thyroid-Associated Ophthalmopathy
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D049970 2006
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Dysthyroid
% 209.74/209.98 |- skos__altLabel mesh__D049970 Edematous Ophthalmopathy
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Infiltrative Ophthalmopathy
% 209.74/209.98 |- skos__scopeNote mesh__D049970
% 209.74/209.98 An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive %28%inflammation of the orbital connective tissue%29%, myopathic %28%swelling and dysfunction of the extraocular muscles%29%, and mixed congestive-myopathic ophthalmopathy.%A%
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Edematous Ophthalmopathies
% 209.74/209.98 |- mesh__dateEstablished mesh__D049970 2006-01-01
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Dysthyroid Ophthalmopathies
% 209.74/209.98 |- skos__historyNote mesh__D049970 Graves Disease %28%1987-2005%29%
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Thyroid Associated Ophthalmopathy
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Myopathic
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Infiltrative Ophthalmopathies
% 209.74/209.98 |- skos__altLabel mesh__D049970 Ophthalmopathies, Thyroid-Associated
% 209.74/209.98 |- skos__altLabel mesh__D049970 Dysthyroid Ophthalmopathy
% 209.74/209.98 |- mesh__dateCreated mesh__D049970 2005-06-30
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Congestive
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Myopathic
% 209.74/209.98 |- skos__altLabel mesh__D049970 Thyroid-Associated Ophthalmopathies
% 209.74/209.98 |- skos__broader mesh__D049970smesh__D006111
% 209.74/209.98 |- skos__prefLabel mesh__D049970 Graves Ophthalmopathy
% 209.74/209.98 |- skos__altLabel mesh__D049970 Ophthalmopathy, Infiltrative
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Graves
% 209.74/209.98 |- mesh__historyNote mesh__D049970 2006; use GRAVES DISEASE 1997-2005
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Thyroid Associated Ophthalmopathies
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Dysthyroid
% 209.74/209.98 |- skos__broader mesh__D049970smesh__D015785
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Myopathic Ophthalmopathies
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Edematous
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D049970
% 209.74/209.98 2006; see GRAVES%27% DISEASE 1997-2005
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Thyroid Associated
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Thyroid Associated
% 209.74/209.98 |- mesh__recordOriginator mesh__D049970 lkt
% 209.74/209.98 |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Edematous
% 209.74/209.98 |- rdf__type mesh__D049970sskos__Concept
% 209.74/209.98 |- mesh__recordAuthorizer mesh__D016796 sjn
% 209.74/209.98 |- skos__broader mesh__D016796smesh__D016794
% 209.74/209.98 |- mesh__historyNote mesh__D016796 92
% 209.74/209.98 |- mesh__recordOriginator mesh__D016796 PXP
% 209.74/209.98 |- mesh__dateRevised mesh__D016796 2003-07-30
% 209.74/209.98 |- rdf__type mesh__D016796sskos__Concept
% 209.74/209.98 |- skos__prefLabel mesh__D016796 Theileria annulata
% 209.74/209.98 |- mesh__dateEstablished mesh__D016796 1992-01-01
% 209.74/209.98 |- skos__scopeNote mesh__D016796
% 209.74/209.98 A protozoan parasite causing tropical theileriasis in cattle. It is transmitted by ticks of the Hyalomma genus.%A%
% 209.74/209.98 |- skos__annotation mesh__D016796
% 209.74/209.98 a tick-borne protozoon; infection: coord IM with THEILERIASIS %28%IM%29% + check tags ANIMALS %26% CATTLE but not also CATTLE DISEASES; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D016796 92
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D016796 2004
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D016796 2006
% 209.74/209.98 |- mesh__recordMaintainer mesh__D016796 sjn
% 209.74/209.98 |- mesh__dateCreated mesh__D016796 1991-05-02
% 209.74/209.98 |- skos__historyNote mesh__D016796 Sporozoea %28%1966-1991%29%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D016796 2005
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002776 2003
% 209.74/209.98 |- mesh__dateEstablished mesh__D002776 1968-01-01
% 209.74/209.98 |- mesh__dateCreated mesh__D002776 1999-01-01
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002776 2001
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002776 1997
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002776 2004
% 209.74/209.98 |- mesh__recordOriginator mesh__D002776 NLM
% 209.74/209.98 |- mesh__dateRevised mesh__D002776 1993-06-03
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002776 2002
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002776 1998
% 209.74/209.98 |- skos__scopeNote mesh__D002776
% 209.74/209.98 Derivatives of the saturated steroid cholestane with methyl groups at C-18 and C-19 and an iso-octyl side chain at C-17.%A%
% 209.74/209.98 |- mesh__activeMeSHYear mesh__D002776 2005
% 209.74/209.98 |- mesh__publicMeSHNote mesh__D002776 68
% 209.84/209.98 |- mesh__activeMeSHYear mesh__D002776 1999
% 209.84/209.98 |- mesh__activeMeSHYear mesh__D002776 2006
% 209.84/209.98 |- mesh__recordAuthorizer mesh__D002776 PLS
% 209.84/209.98 |- skos__annotation mesh__D002776 do not confuse with CHOLESTENES
% 209.84/209.98 |- mesh__activeMeSHYear mesh__D002776 1994
% 209.84/209.98 |- mesh__historyNote mesh__D002776 68
% 209.84/209.98 |- skos__prefLabel mesh__D002776 Cholestanes
% 209.84/209.98 |- mesh__recordMaintainer mesh__D002776 PLS
% 209.84/209.98 |- skos__broader mesh__D002776smesh__D013256
% 209.84/209.98 |- mesh__activeMeSHYear mesh__D002776 2000
% 209.84/209.98 |- mesh__activeMeSHYear mesh__D002776 1995
% 209.84/209.98 |- mesh__activeMeSHYear mesh__D002776 1996
% 209.84/209.98 |- rdf__type mesh__D002776sskos__Concept
% 209.84/209.98 |- mesh__publicMeSHNote mesh__D007461
% 209.84/209.98 63; SODIUM IODOACETATE was indexed under IODOACETATES 1988-98; IODOACETATE was indexed under IODOACETATES 1980-98%A%
% 209.84/209.98 |- mesh__activeMeSHYear mesh__D007461 2001
% 209.84/209.98 |- mesh__dateCreated mesh__D007461 1999-01-01
% 209.84/209.98 |- mesh__historyNote mesh__D007461
% 209.84/209.98 63; for SODIUM IODOACETATE use IODOACETATES %28%NM%29% 1988-98; for IODOACETATE use IODOACETATES %28%NM%29% 1980-98%A%
% 209.84/209.98 |- mesh__recordMaintainer mesh__D007461 adp
% 209.84/209.98 |- mesh__activeMeSHYear mesh__D007461 2002
% 209.84/209.98 |- skos__broader mesh__D007461smesh__D019807
% 209.84/209.98 |- mesh__activeMeSHYear mesh__D007461 2003
% 209.84/209.98 |- skos__prefLabel mesh__D007461 Iodoacetates
% 209.84/209.98 |- rdf__type mesh__D007461sskos__Concept
% 209.84/209.98 |- skos__hiddenLabel mesh__D007461 Iodoacetate, Sodium
% 209.84/209.98 |- skos__broader mesh__D007461smesh__D000085
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007461 2004
% 209.84/209.99 |- mesh__dateRevised mesh__D007461 1999-11-03
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007461 2005
% 209.84/209.99 |- mesh__recordOriginator mesh__D007461 NLM
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007461 2000
% 209.84/209.99 |- skos__scopeNote mesh__D007461
% 209.84/209.99 Iodinated derivatives of acetic acid. Iodoacetates are commonly used as alkylating sulfhydryl reagents and enzyme inhibitors in biochemical research.%A%
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D007461 sjn
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007461 2006
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D020838 2005
% 209.84/209.99 |- rdf__type mesh__D020838sskos__Concept
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D020838 2006
% 209.84/209.99 |- mesh__dateEstablished mesh__D020838 2000-01-01
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D020838 2000
% 209.84/209.99 |- mesh__dateRevised mesh__D020838 2002-07-03
% 209.84/209.99 |- skos__prefLabel mesh__D020838 Calendula
% 209.84/209.99 |- skos__scopeNote mesh__D020838
% 209.84/209.99 A plant genus of the family ASTERACEAE. Members contain CAROTENOIDS, essential oils %28%OILS, VOLATILE%29%, flavonoids, mucilage, SAPONINS, and STEROLS. The plants are used both topically and internally. The common name of Marigold is also used for TAGETES.%A%
% 209.84/209.99 |- skos__historyNote mesh__D020838 Plants, Medicinal %28%1970-1999%29%
% 209.84/209.99 |- skos__broader mesh__D020838smesh__D019659
% 209.84/209.99 |- skos__annotation mesh__D020838
% 209.84/209.99 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D020838 2003
% 209.84/209.99 |- mesh__recordOriginator mesh__D020838 ags
% 209.84/209.99 |- mesh__recordMaintainer mesh__D020838 ssb
% 209.84/209.99 |- mesh__dateCreated mesh__D020838 1999-11-03
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D020838 sjn
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D020838 2004
% 209.84/209.99 |- mesh__historyNote mesh__D020838 2000
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D006369 86
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D006369 2006
% 209.84/209.99 |- mesh__dateEstablished mesh__D006369 1986-01-01
% 209.84/209.99 |- mesh__recordOriginator mesh__D006369 EC
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D006369 2004
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D006369 2005
% 209.84/209.99 |- mesh__dateCreated mesh__D006369 1985-03-11
% 209.84/209.99 |- skos__broader mesh__D006369smesh__D017183
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D006369 sjn
% 209.84/209.99 |- skos__scopeNote mesh__D006369
% 209.84/209.99 A superfamily of parasitic nematodes which were formerly considered a part of TRICHOSTRONGYLOIDEA. It includes the following genera: Heligmosomum, NEMATOSPIROIDES, and NIPPOSTRONGYLUS. The hosts are rodents.%A%
% 209.84/209.99 |- mesh__recordMaintainer mesh__D006369 ags
% 209.84/209.99 |- mesh__dateRevised mesh__D006369 2003-07-09
% 209.84/209.99 |- skos__annotation mesh__D006369
% 209.84/209.99 a superfamily of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 209.84/209.99 |- rdf__type mesh__D006369sskos__Concept
% 209.84/209.99 |- mesh__historyNote mesh__D006369 86
% 209.84/209.99 |- skos__prefLabel mesh__D006369 Heligmosomatoidea
% 209.84/209.99 |- mesh__dateEstablished mesh__D017091 1993-01-01
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017091 2006
% 209.84/209.99 |- mesh__recordMaintainer mesh__D017091 lkt
% 209.84/209.99 |- skos__altLabel mesh__D017091 Ischemic Colitis
% 209.84/209.99 |- mesh__dateCreated mesh__D017091 1992-05-07
% 209.84/209.99 |- skos__broader mesh__D017091smesh__D003092
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017091 2005
% 209.84/209.99 |- rdf__type mesh__D017091sskos__Concept
% 209.84/209.99 |- mesh__dateRevised mesh__D017091 2003-07-09
% 209.84/209.99 |- skos__broader mesh__D017091smesh__D007511
% 209.84/209.99 |- mesh__recordOriginator mesh__D017091 TGC
% 209.84/209.99 |- skos__historyNote mesh__D017091 Colitis %28%1967-1992%29%
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D017091 sjn
% 209.84/209.99 |- skos__historyNote mesh__D017091 Ischemia %28%1967-1992%29%
% 209.84/209.99 |- mesh__historyNote mesh__D017091 93
% 209.84/209.99 |- skos__prefLabel mesh__D017091 Colitis, Ischemic
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017091 2004
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D017091 93
% 209.84/209.99 |- skos__scopeNote mesh__D017091
% 209.84/209.99 Inflammation of the COLON due to colonic ISCHEMIA resulting from alterations in systemic circulation or local vasculature.%A%
% 209.84/209.99 |- skos__prefLabel mesh__D025523 Bacteriophage HK022
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D025523 2006
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D025523
% 209.84/209.99 2002; see BACTERIOPHAGE LAMBDA 1994-2001
% 209.84/209.99 |- mesh__dateCreated mesh__D025523 2001-07-25
% 209.84/209.99 |- mesh__historyNote mesh__D025523
% 209.84/209.99 2002; use BACTERIOPHAGE LAMBDA 1994-2001
% 209.84/209.99 |- skos__historyNote mesh__D025523 Bacteriophage lambda %28%1990-2001%29%
% 209.84/209.99 |- skos__hiddenLabel mesh__D025523 HK022, Bacteriophage
% 209.84/209.99 |- skos__scopeNote mesh__D025523
% 209.84/209.99 A tentative species in the genus lambda-like Viruses, family SIPHOVIRIDAE.%A%
% 209.84/209.99 |- skos__historyNote mesh__D025523 Coliphages %28%1976-2001%29%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D025523 2003
% 209.84/209.99 |- skos__altLabel mesh__D025523 Enterobacteria phage HK022
% 209.84/209.99 |- skos__hiddenLabel mesh__D025523 HK022, Enterobacteria phage
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D025523 2004
% 209.84/209.99 |- skos__broader mesh__D025523smesh__D017906
% 209.84/209.99 |- mesh__dateEstablished mesh__D025523 2002-01-01
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D025523 2005
% 209.84/209.99 |- skos__broader mesh__D025523smesh__D003090
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D025523 2002
% 209.84/209.99 |- rdf__type mesh__D025523sskos__Concept
% 209.84/209.99 |- rdf__type mesh__D003071sskos__Concept
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003071 2004
% 209.84/209.99 |- mesh__dateCreated mesh__D003071 1999-01-01
% 209.84/209.99 |- skos__broader mesh__D003071smesh__D008606
% 209.84/209.99 |- mesh__recordMaintainer mesh__D003071 jrf
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003071 2003
% 209.84/209.99 |- skos__prefLabel mesh__D003071 Cognition
% 209.84/209.99 |- mesh__dateRevised mesh__D003071 2002-07-03
% 209.84/209.99 |- skos__scopeNote mesh__D003071
% 209.84/209.99 Intellectual or mental process whereby an organism becomes aware of or obtains knowledge.%A%
% 209.84/209.99 |- mesh__recordOriginator mesh__D003071 NLM
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003071 2006
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D003071 sjn
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003071 2005
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011503 2006A
% 209.84/209.99 |- skos__scopeNote mesh__D011503
% 209.84/209.99 Transglutaminases catalyze cross-linking of proteins at a GLUTAMINE in one chain with LYSINE in another chain. They include keratinocyte transglutaminase %28%TGM1 or TGK%29%, tissue transglutaminase %28%TGM2 or TGC%29%, plasma transglutaminase involved with coagulation %28%FACTOR XIII and FACTOR XIIIa%29%, hair follicle transglutaminase, and prostate transglutaminase. Although structures differ, they share an active site %28%YGQCW%29% and strict CALCIUM dependence.%A%
% 209.84/209.99 |- mesh__dateEstablished mesh__D011503 1986-01-01
% 209.84/209.99 |- skos__hiddenLabel mesh__D011503
% 209.84/209.99 Gamma-Glutamyltransferases, Glutaminyl-Peptide
% 209.84/209.99 |- skos__historyNote mesh__D011503 Acyltransferases %28%1966-1985%29%
% 209.84/209.99 |- mesh__historyNote mesh__D011503 2002%28%1986%29%
% 209.84/209.99 |- mesh__recordOriginator mesh__D011503 RLS
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011503 2006B
% 209.84/209.99 |- skos__hiddenLabel mesh__D011503
% 209.84/209.99 Protein Glutamine gamma Glutamyltransferases
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011503 2005
% 209.84/209.99 |- mesh__recordMaintainer mesh__D011503 ags
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D011503
% 209.84/209.99 2002; see PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 1986-2002; for TRANSGLUTAMINASES see TRANSGLUTAMINASES 1986-2002%A%
% 209.84/209.99 |- mesh__dateCreated mesh__D011503 1985-04-24
% 209.84/209.99 |- mesh__dateRevised mesh__D011503 2005-08-02
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011503 2006
% 209.84/209.99 |- skos__altLabel mesh__D011503
% 209.84/209.99 Glutaminyl-Peptide Gamma-Glutamyltransferases
% 209.84/209.99 |- skos__prefLabel mesh__D011503 Transglutaminases
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011503 2004
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D011503 ags
% 209.84/209.99 |- skos__broader mesh__D011503smesh__D019881
% 209.84/209.99 |- rdf__type mesh__D011503sskos__Concept
% 209.84/209.99 |- skos__annotation mesh__D011503
% 209.84/209.99 distinguish X refs GLUTAMINYL-PEPTIDE GAMMA-GLUTAMYLTRANSFERASES and TRANSGLUTAMINASES from GAMMA-GLUTAMYL TRANSPEPTIDASE which is involved with glutathione metabolism; PLASMA TRANSGLUTAMINASE see FACTOR XIIIA is also available%A%
% 209.84/209.99 |- skos__hiddenLabel mesh__D011503
% 209.84/209.99 Glutaminyl Peptide Gamma Glutamyltransferases
% 209.84/209.99 |- skos__altLabel mesh__D011503
% 209.84/209.99 Protein-Glutamine gamma-Glutamyltransferases
% 209.84/209.99 |- skos__hiddenLabel mesh__D011503
% 209.84/209.99 gamma-Glutamyltransferases, Protein-Glutamine
% 209.84/209.99 |- skos__prefLabel mesh__D049971 Thiazides
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D049971 2006
% 209.84/209.99 |- mesh__recordMaintainer mesh__D049971 ssb
% 209.84/209.99 |- rdf__type mesh__D049971sskos__Concept
% 209.84/209.99 |- mesh__historyNote mesh__D049971 2006
% 209.84/209.99 |- mesh__dateEstablished mesh__D049971 2006-01-01
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D049971 sjn
% 209.84/209.99 |- skos__historyNote mesh__D049971 Benzothiadiazines %28%1963-2005%29%
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D049971 2006
% 209.84/209.99 |- skos__scopeNote mesh__D049971
% 209.84/209.99 Heterocyclic compounds with SULFUR and NITROGEN in the ring. This term commonly refers to the BENZOTHIADIAZINES that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS.%A%
% 209.84/209.99 |- mesh__recordOriginator mesh__D049971 ssb
% 209.84/209.99 |- skos__broader mesh__D049971smesh__D013457
% 209.84/209.99 |- mesh__dateCreated mesh__D049971 2005-06-30
% 209.84/209.99 |- skos__broader mesh__D016797smesh__D016794
% 209.84/209.99 |- mesh__recordOriginator mesh__D016797 PXP
% 209.84/209.99 |- rdf__type mesh__D016797sskos__Concept
% 209.84/209.99 |- mesh__historyNote mesh__D016797 92
% 209.84/209.99 |- mesh__dateRevised mesh__D016797 2003-07-30
% 209.84/209.99 |- mesh__dateCreated mesh__D016797 1991-05-02
% 209.84/209.99 |- mesh__recordMaintainer mesh__D016797 sjn
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D016797 sjn
% 209.84/209.99 |- skos__prefLabel mesh__D016797 Theileria parva
% 209.84/209.99 |- skos__annotation mesh__D016797
% 209.84/209.99 a tick-borne protozoon; infection: coord IM with THEILERIASIS %28%IM%29% + check tags ANIMALS %26% CATTLE but not also CATTLE DISEASES; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D016797 2004
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D016797 2006
% 209.84/209.99 |- mesh__dateEstablished mesh__D016797 1992-01-01
% 209.84/209.99 |- skos__scopeNote mesh__D016797
% 209.84/209.99 A protozoan parasite that is the etiologic agent of East Coast fever %28%THEILERIASIS%29%. Transmission is by ticks of the Physicephalus and Hyalomma genera.%A%
% 209.84/209.99 |- skos__historyNote mesh__D016797 Sporozoea %28%1966-1991%29%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D016797 2005
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D016797 92
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 2004
% 209.84/209.99 |- mesh__recordMaintainer mesh__D002777 PLS
% 209.84/209.99 |- mesh__historyNote mesh__D002777 78
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 2000
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 1998
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 2005
% 209.84/209.99 |- skos__altLabel mesh__D002777 Hydroxycholestanes
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 2001
% 209.84/209.99 |- skos__altLabel mesh__D002777 Bile Alcohols
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 1999
% 209.84/209.99 |- skos__scopeNote mesh__D002777
% 209.84/209.99 Cholestanes substituted in any position with one or more hydroxy groups. They are found in feces and bile. In contrast to bile acids and salts, they are not reabsorbed.%A%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 2006
% 209.84/209.99 |- skos__historyNote mesh__D002777 Sterols %28%1966-1977%29%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 1994
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 2002
% 209.84/209.99 |- mesh__recordOriginator mesh__D002777 RLS
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D002777 78
% 209.84/209.99 |- skos__historyNote mesh__D002777 Cholestanes %28%1968-1977%29%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 1995
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 1996
% 209.84/209.99 |- mesh__dateCreated mesh__D002777 1977-04-15
% 209.84/209.99 |- rdf__type mesh__D002777sskos__Concept
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 2003
% 209.84/209.99 |- skos__prefLabel mesh__D002777 Cholestanols
% 209.84/209.99 |- mesh__dateRevised mesh__D002777 1993-06-02
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D002777 PLS
% 209.84/209.99 |- skos__annotation mesh__D002777
% 209.84/209.99 do not confuse with CHOLESTANOL; beta-cholestanol = BETA-CHOLESTANOL see CHOLESTANOL%A%
% 209.84/209.99 |- skos__hiddenLabel mesh__D002777 Alcohols, Bile
% 209.84/209.99 |- skos__broader mesh__D002777smesh__D002776
% 209.84/209.99 |- mesh__dateEstablished mesh__D002777 1978-01-01
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D002777 1997
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 2002
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D007462 PLS
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 2006
% 209.84/209.99 |- mesh__recordOriginator mesh__D007462 NLM
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 1998
% 209.84/209.99 |- skos__broader mesh__D007462smesh__D001555
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 2001
% 209.84/209.99 |- skos__prefLabel mesh__D007462 Iodobenzenes
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 1997
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 2000
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 2005
% 209.84/209.99 |- skos__broader mesh__D007462smesh__D006847
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 2004
% 209.84/209.99 |- mesh__historyNote mesh__D007462 73%28%72%29%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 1996
% 209.84/209.99 |- rdf__type mesh__D007462sskos__Concept
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 1995
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 2003
% 209.84/209.99 |- mesh__dateRevised mesh__D007462 1992-05-19
% 209.84/209.99 |- skos__historyNote mesh__D007462 Benzene Derivatives %28%1968-1971%29%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 1994
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D007462 73
% 209.84/209.99 |- mesh__dateEstablished mesh__D007462 1973-01-01
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 1993
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D007462 1999
% 209.84/209.99 |- mesh__dateCreated mesh__D007462 1999-01-01
% 209.84/209.99 |- mesh__recordMaintainer mesh__D007462 TAP
% 209.84/209.99 |- skos__broader mesh__D020839smesh__D020664
% 209.84/209.99 |- skos__annotation mesh__D020839
% 209.84/209.99 SON OF SEVENLESS PROTEINS is also available
% 209.84/209.99 |- skos__altLabel mesh__D020839 Drosophila SOS Protein
% 209.84/209.99 |- mesh__dateRevised mesh__D020839 2005-06-30
% 209.84/209.99 |- skos__altLabel mesh__D020839 Drosophila Son of Sevenless Protein
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D020839 sjn
% 209.84/209.99 |- skos__historyNote mesh__D020839 Membrane Proteins %28%1992-1999%29%
% 209.84/209.99 |- skos__hiddenLabel mesh__D020839 Protein, Drosophila SOS
% 209.84/209.99 |- skos__altLabel mesh__D020839 SOS Protein
% 209.84/209.99 |- mesh__recordMaintainer mesh__D020839 jmp
% 209.84/209.99 |- skos__scopeNote mesh__D020839
% 209.84/209.99 A guanine nucleotide exchange factor from DROSOPHILA. Sevenless refers to genetic mutations in DROSOPHILA that cause loss of the R7 photoreceptor which is required to see UV light.%A%
% 209.84/209.99 |- mesh__recordOriginator mesh__D020839 jmp
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D020839
% 209.84/209.99 2000; SOS PROTEIN was indexed under MEMBRANE PROTEINS 1995-1999%A%
% 209.84/209.99 |- mesh__historyNote mesh__D020839
% 209.84/209.99 2000; for SOS PROTEIN use SON OF SEVENLESS PROTEINS 1995-1999%A%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D020839 2006
% 209.84/209.99 |- rdf__type mesh__D020839sskos__Concept
% 209.84/209.99 |- skos__prefLabel mesh__D020839 Son of Sevenless Protein, Drosophila
% 209.84/209.99 |- skos__hiddenLabel mesh__D020839 SOS Protein, Drosophila
% 209.84/209.99 |- mesh__dateCreated mesh__D020839 1999-11-03
% 209.84/209.99 |- mesh__dateEstablished mesh__D020839 2000-01-01
% 209.84/209.99 |- mesh__historyNote mesh__D017890 94
% 209.84/209.99 |- skos__scopeNote mesh__D017890
% 209.84/209.99 The spontaneous transplantation of splenic tissue to unusual sites after open splenic trauma, e.g., after automobile accidents, gunshot or stab wounds. The splenic pulp implants appear as red-blue nodules on the peritoneum, omentum, and mesentery, morphologically similar to multifocal pelvic endometriosis. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 2001
% 209.84/209.99 |- skos__broader mesh__D017890smesh__D013161
% 209.84/209.99 |- mesh__dateEstablished mesh__D017890 1994-01-01
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 2000
% 209.84/209.99 |- skos__historyNote mesh__D017890 Splenic Diseases %28%1966-1993%29%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 1999
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D017890 PLS
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 1997
% 209.84/209.99 |- mesh__dateCreated mesh__D017890 1993-02-16
% 209.84/209.99 |- skos__historyNote mesh__D017890 Splenic Rupture %28%1966-1993%29%
% 209.84/209.99 |- skos__historyNote mesh__D017890 Spleen %28%1966-1993%29%
% 209.84/209.99 |- rdf__type mesh__D017890sskos__Concept
% 209.84/209.99 |- skos__prefLabel mesh__D017890 Splenosis
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 2006
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 1998
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 2002
% 209.84/209.99 |- skos__hiddenLabel mesh__D017890 Splenoses
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 2004
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 1996
% 209.84/209.99 |- mesh__recordMaintainer mesh__D017890 TAP
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D017890 94
% 209.84/209.99 |- skos__annotation mesh__D017890
% 209.84/209.99 spontaneous intra-abdom transpl of spleen tissue to other tissue, usually after trauma%A%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 2005
% 209.84/209.99 |- mesh__dateRevised mesh__D017890 1995-06-08
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017890 2003
% 209.84/209.99 |- mesh__recordOriginator mesh__D017890 TGC
% 209.84/209.99 |- mesh__dateRevised mesh__D031561 2003-07-09
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D031561 2003
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D031561 2006
% 209.84/209.99 |- mesh__dateCreated mesh__D031561 2002-07-03
% 209.84/209.99 |- skos__scopeNote mesh__D031561
% 209.84/209.99 A plant genus of the family LYTHRACEAE that contains ALKALOIDS.%A%
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D031561 2004
% 209.84/209.99 |- mesh__recordMaintainer mesh__D031561 ssb
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D031561 2005
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D031561 sjn
% 209.84/209.99 |- mesh__historyNote mesh__D031561 2003
% 209.84/209.99 |- skos__prefLabel mesh__D031561 Lythrum
% 209.84/209.99 |- mesh__recordOriginator mesh__D031561 ssb
% 209.84/209.99 |- mesh__dateEstablished mesh__D031561 2003-01-01
% 209.84/209.99 |- rdf__type mesh__D031561sskos__Concept
% 209.84/209.99 |- skos__annotation mesh__D031561
% 209.84/209.99 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.84/209.99 |- skos__altLabel mesh__D031561 Loosestrife
% 209.84/209.99 |- skos__broader mesh__D031561smesh__D029561
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017092 2005
% 209.84/209.99 |- rdf__type mesh__D017092sskos__Concept
% 209.84/209.99 |- mesh__dateCreated mesh__D017092 1992-05-22
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Porphyrias, Congenital Erythropoietic
% 209.84/209.99 |- skos__broader mesh__D017092smesh__D011164
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Porphyria, Congenital Erythropoietic
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D017092 93
% 209.84/209.99 |- mesh__dateEstablished mesh__D017092 1993-01-01
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Erythropoietic Porphyrias, Congenital
% 209.84/209.99 |- skos__altLabel mesh__D017092 Gunther Disease
% 209.84/209.99 |- mesh__recordMaintainer mesh__D017092 lkt
% 209.84/209.99 |- mesh__dateRevised mesh__D017092 2004-07-15
% 209.84/209.99 |- skos__annotation mesh__D017092
% 209.84/209.99 do not confuse with PROTOPORPHYRIA, ERYTHROPOIETIC or PORPHYRIA, HEPATOERYTHROPOIETIC%A%
% 209.84/209.99 |- skos__broader mesh__D017092smesh__D012873
% 209.84/209.99 |- skos__prefLabel mesh__D017092 Porphyria, Erythropoietic
% 209.84/209.99 |- skos__broader mesh__D017092smesh__D008661
% 209.84/209.99 |- mesh__historyNote mesh__D017092 93
% 209.84/209.99 |- skos__historyNote mesh__D017092 Porphyria %28%1966-1992%29%
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Disease, Gunther%27%s
% 209.84/209.99 |- skos__altLabel mesh__D017092 Porphyria, Erythropoietic, Congenital
% 209.84/209.99 |- skos__altLabel mesh__D017092 Gunther%27%s Disease
% 209.84/209.99 |- mesh__recordOriginator mesh__D017092 PXP
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Erythropoietic Porphyrias
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Erythropoietic Porphyria, Congenital
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Porphyrias, Erythropoietic
% 209.84/209.99 |- skos__scopeNote mesh__D017092
% 209.84/209.99 An autosomal recessive porphyria that is due to a deficiency of UROPORPHYRINOGEN III SYNTHASE in the BONE MARROW; also known as congenital erythropoietic porphyria. This disease is characterized by SPLENOMEGALY; ANEMIA; photosensitivity; cutaneous lesions; accumulation of hydroxymethylbilane; and increased excretion of UROPORPHYRINS and COPROPORPHYRINS.%A%
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Disease, Gunther
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D017092 sjn
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D017092 2006
% 209.84/209.99 |- skos__altLabel mesh__D017092 Congenital Erythropoietic Porphyria
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Congenital Erythropoietic Porphyrias
% 209.84/209.99 |- skos__hiddenLabel mesh__D017092 Gunthers Disease
% 209.84/209.99 |- skos__altLabel mesh__D017092 Erythropoietic Porphyria
% 209.84/209.99 |- mesh__dateEstablished mesh__D003870 1991-01-01
% 209.84/209.99 |- skos__annotation mesh__D003870
% 209.84/209.99 infestation: coord IM with TICK INFESTATIONS %28%IM%29%
% 209.84/209.99 |- skos__historyNote mesh__D003870 Ticks %28%1966-1972%29%
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D003870 sjn
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D003870 91; was see under TICKS 1973-90
% 209.84/209.99 |- rdf__type mesh__D003870sskos__Concept
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003870 2004
% 209.84/209.99 |- mesh__recordOriginator mesh__D003870 NLM
% 209.84/209.99 |- mesh__historyNote mesh__D003870
% 209.84/209.99 91%28%73%29%; was see under TICKS 1973-90
% 209.84/209.99 |- skos__scopeNote mesh__D003870
% 209.84/209.99 A widely distributed genus of TICKS, in the family IXODIDAE, including a number that infest humans and other mammals. Several are vectors of diseases such as TULAREMIA; ROCKY MOUNTAIN SPOTTED FEVER; COLORADO TICK FEVER; and ANAPLASMOSIS.%A%
% 209.84/209.99 |- mesh__dateRevised mesh__D003870 2003-07-09
% 209.84/209.99 |- mesh__dateCreated mesh__D003870 1999-01-01
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003870 2006
% 209.84/209.99 |- mesh__recordMaintainer mesh__D003870 ags
% 209.84/209.99 |- skos__prefLabel mesh__D003870 Dermacentor
% 209.84/209.99 |- skos__broader mesh__D003870smesh__D026863
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003870 2005
% 209.84/209.99 |- mesh__historyNote mesh__D003072 69
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D003072 PLS
% 209.84/209.99 |- skos__prefLabel mesh__D003072 Cognition Disorders
% 209.84/209.99 |- skos__historyNote mesh__D003072 Cognition %28%1966-1968%29%
% 209.84/209.99 |- mesh__recordOriginator mesh__D003072 NLM
% 209.84/209.99 |- skos__broader mesh__D003072smesh__D019965
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003072 2006
% 209.84/209.99 |- mesh__dateEstablished mesh__D003072 1969-01-01
% 209.84/209.99 |- skos__hiddenLabel mesh__D003072 Disorders, Cognition
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003072 2002
% 209.84/209.99 |- skos__scopeNote mesh__D003072
% 209.84/209.99 Disturbances in the mental process related to thinking, reasoning, and judgment.%A%
% 209.84/209.99 |- skos__historyNote mesh__D003072 specific disorder
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003072 2005
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003072 1999
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003072 2001
% 209.84/209.99 |- rdf__type mesh__D003072sskos__Concept
% 209.84/209.99 |- skos__hiddenLabel mesh__D003072 Disorder, Cognition
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003072 2004
% 209.84/209.99 |- mesh__dateCreated mesh__D003072 1999-01-01
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003072 2000
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003072 1998
% 209.84/209.99 |- mesh__dateRevised mesh__D003072 1997-09-12
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D003072 2003
% 209.84/209.99 |- mesh__recordMaintainer mesh__D003072 SJN
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D003072 69
% 209.84/209.99 |- skos__related mesh__D011504smesh__D008231
% 209.84/209.99 |- mesh__dateRevised mesh__D011504 2005-07-18
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504 Enteropathy, Protein-Losing
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504
% 209.84/209.99 Idiopathic Hypercatabolic Hypoproteinemias
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504
% 209.84/209.99 Hypoproteinemias, Idiopathic Hypercatabolic
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504
% 209.84/209.99 Hypercatabolic Hypoproteinemias, Idiopathic
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011504 2005
% 209.84/209.99 |- mesh__recordMaintainer mesh__D011504 ags
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011504 2006A
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504
% 209.84/209.99 Hypoproteinemia, Idiopathic Hypercatabolic
% 209.84/209.99 |- skos__prefLabel mesh__D011504 Protein-Losing Enteropathies
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504 Exudative Enteropathy
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011504 2006
% 209.84/209.99 |- mesh__dateEstablished mesh__D011504 1966-01-01
% 209.84/209.99 |- skos__related mesh__D011504smesh__D000361
% 209.84/209.99 |- mesh__dateCreated mesh__D011504 1999-01-01
% 209.84/209.99 |- mesh__historyNote mesh__D011504 66
% 209.84/209.99 |- mesh__recordOriginator mesh__D011504 NLM
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011504 2006B
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011504 2004
% 209.84/209.99 |- mesh__recordAuthorizer mesh__D011504 ags
% 209.84/209.99 |- rdf__type mesh__D011504sskos__Concept
% 209.84/209.99 |- skos__scopeNote mesh__D011504
% 209.84/209.99 Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIA; WHIPPLE%27%S DISEASE; and NEOPLASMS of the SMALL INTESTINE.%A%
% 209.84/209.99 |- skos__altLabel mesh__D011504 Protein-Losing Enteropathy
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D011504 2005A
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504 Protein Losing Enteropathies
% 209.84/209.99 |- skos__broader mesh__D011504smesh__D007410
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504
% 209.84/209.99 Hypercatabolic Hypoproteinemia, Idiopathic
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504 Enteropathies, Protein-Losing
% 209.84/209.99 |- skos__related mesh__D011504smesh__D007019
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504 Exudative Enteropathies
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504 Enteropathies, Exudative
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D011504 66
% 209.84/209.99 |- skos__hiddenLabel mesh__D011504 Protein Losing Enteropathy
% 209.84/209.99 |- skos__altLabel mesh__D011504 Enteropathy, Exudative
% 209.84/209.99 |- mesh__publicMeSHNote mesh__D016798 92; CILIATA was heading 1963-91
% 209.84/209.99 |- mesh__activeMeSHYear mesh__D016798 2004
% 209.84/209.99 |- skos__annotation mesh__D016798
% 209.84/209.99 infection = CILIOPHORA INFECTIONS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 209.84/210.00 |- skos__broader mesh__D016798smesh__D011527
% 209.84/210.00 |- mesh__dateRevised mesh__D016798 2003-07-09
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D016798 2006
% 209.84/210.00 |- mesh__historyNote mesh__D016798 92; CILIATA was heading 1963-91
% 209.84/210.00 |- skos__prefLabel mesh__D016798 Ciliophora
% 209.84/210.00 |- mesh__recordMaintainer mesh__D016798 ags
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D016798 2005
% 209.84/210.00 |- mesh__dateCreated mesh__D016798 1991-05-02
% 209.84/210.00 |- mesh__onlineNote mesh__D016798
% 209.84/210.00 use CILIOPHORA to search CILIATA 1966-91
% 209.84/210.00 |- skos__scopeNote mesh__D016798
% 209.84/210.00 A phylum of protozoa characterized by the presence of cilia at some time during the life cycle. It comprises three classes: KINETOFRAGMINOPHOREA; OLIGOHYMENOPHOREA; and POLYMENOPHOREA.%A%
% 209.84/210.00 |- rdf__type mesh__D016798sskos__Concept
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D016798 sjn
% 209.84/210.00 |- mesh__recordOriginator mesh__D016798 PXP
% 209.84/210.00 |- mesh__dateEstablished mesh__D016798 1992-01-01
% 209.84/210.00 |- skos__historyNote mesh__D016798 Protozoa %28%1975-1991%29%
% 209.84/210.00 |- skos__broader mesh__D005343Q000037smesh__D005343
% 209.84/210.00 |- mesh__preferredCombination mesh__D005343Q000037smesh__D000933
% 209.84/210.00 |- rdf__type mesh__D005343Q000037smesh__CompoundConcept
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 2004
% 209.84/210.00 |- skos__broader mesh__D002778smesh__D002776
% 209.84/210.00 |- mesh__dateCreated mesh__D002778 1974-11-11
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 1996
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 2003
% 209.84/210.00 |- skos__scopeNote mesh__D002778
% 209.84/210.00 CHOLESTANES substituted with any number of keto groups.%A%
% 209.84/210.00 |- mesh__dateEstablished mesh__D002778 1991-01-01
% 209.84/210.00 |- skos__historyNote mesh__D002778 Cholestanes %28%1968-1974%29%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 2002
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D002778
% 209.84/210.00 91; was see under CHOLESTANES 1975-90
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 1995
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 2001
% 209.84/210.00 |- mesh__dateRevised mesh__D002778 1993-06-03
% 209.84/210.00 |- skos__prefLabel mesh__D002778 Cholestanones
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 1999
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 1994
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 2006
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 2000
% 209.84/210.00 |- skos__annotation mesh__D002778
% 209.84/210.00 do not confuse with CHOLESTENONES; includes cholestanediones, cholestanetriones%A%
% 209.84/210.00 |- mesh__historyNote mesh__D002778
% 209.84/210.00 91%28%75%29%; was see under CHOLESTANES 1975-90
% 209.84/210.00 |- mesh__recordOriginator mesh__D002778 NLM
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 1998
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 2005
% 209.84/210.00 |- mesh__recordMaintainer mesh__D002778 PLS
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D002778 PLS
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002778 1997
% 209.84/210.00 |- rdf__type mesh__D002778sskos__Concept
% 209.84/210.00 |- skos__broader mesh__D001769Q000201smesh__D001769
% 209.84/210.00 |- mesh__preferredCombination mesh__D001769Q000201smesh__D004798Q000097
% 209.84/210.00 |- rdf__type mesh__D001769Q000201smesh__CompoundConcept
% 209.84/210.00 |- skos__broader mesh__D007463smesh__D001565
% 209.84/210.00 |- skos__scopeNote mesh__D007463
% 209.84/210.00 Benzoic acid esters or salts substituted with one or more iodine atoms.%A%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007463 2005
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007463 2002
% 209.84/210.00 |- mesh__dateEstablished mesh__D007463 1974-01-01
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007463 2004
% 209.84/210.00 |- mesh__dateRevised mesh__D007463 1998-06-10
% 209.84/210.00 |- rdf__type mesh__D007463sskos__Concept
% 209.84/210.00 |- mesh__recordOriginator mesh__D007463 NLM
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007463 2001
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D007463 74
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007463 2003
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007463 2000
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D007463 SJN
% 209.84/210.00 |- mesh__recordMaintainer mesh__D007463 ADP
% 209.84/210.00 |- mesh__dateCreated mesh__D007463 1999-01-01
% 209.84/210.00 |- mesh__historyNote mesh__D007463 74%28%72%29%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007463 1999
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007463 2006
% 209.84/210.00 |- skos__historyNote mesh__D007463 Benzoates %28%1966-1971%29%
% 209.84/210.00 |- skos__prefLabel mesh__D007463 Iodobenzoates
% 209.84/210.00 |- mesh__recordMaintainer mesh__D045582 SYSTEM
% 209.84/210.00 |- skos__historyNote mesh__D045582 Mollicutes %28%1995-2003%29%
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D045582 2004
% 209.84/210.00 |- skos__broader mesh__D045582smesh__D000129
% 209.84/210.00 |- skos__historyNote mesh__D045582 Mycoplasma %28%1996-1998%29%
% 209.84/210.00 |- mesh__dateEstablished mesh__D045582 2004-01-01
% 209.84/210.00 |- skos__prefLabel mesh__D045582 Phytoplasma
% 209.84/210.00 |- skos__scopeNote mesh__D045582
% 209.84/210.00 A genus of minute bacteria in the family ACHOLEPLASMATACEAE that inhabit phloem sieve elements of infected PLANTS and cause symptoms such as yellowing, phyllody, and witches%27% brooms. Organisms lack a CELL WALL and thus are similar to MYCOPLASMA in animals. They are transmitted by over 100 species of INSECTS especially leafhoppers, planthoppers, and PSYLLIDS.%A%
% 209.84/210.00 |- mesh__dateCreated mesh__D045582 2003-07-09
% 209.84/210.00 |- mesh__recordOriginator mesh__D045582 ags
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D045582 sjn
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D045582 2006
% 209.84/210.00 |- rdf__type mesh__D045582sskos__Concept
% 209.84/210.00 |- mesh__dateRevised mesh__D045582 2005-06-30
% 209.84/210.00 |- mesh__historyNote mesh__D045582 2004
% 209.84/210.00 |- skos__altLabel mesh__D017891 Epidemiology, Pharmaceutical
% 209.84/210.00 |- skos__historyNote mesh__D017891 Epidemiologic Methods %28%1985-1993%29%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017891 2002
% 209.84/210.00 |- skos__broader mesh__D017891smesh__D004813
% 209.84/210.00 |- skos__prefLabel mesh__D017891 Pharmacoepidemiology
% 209.84/210.00 |- skos__scopeNote mesh__D017891
% 209.84/210.00 The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. %28%Pharmacoepidemiol Drug Saf 1992;1%28%1%29%; J Pharmacoepidemiol 1990;1%28%1%29%%29%%A%
% 209.84/210.00 |- skos__hiddenLabel mesh__D017891 Epidemiologies, Pharmaceutical
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D017891 94
% 209.84/210.00 |- mesh__recordMaintainer mesh__D017891 jls
% 209.84/210.00 |- mesh__dateCreated mesh__D017891 1993-02-16
% 209.84/210.00 |- rdf__type mesh__D017891sskos__Concept
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017891 2006
% 209.84/210.00 |- skos__altLabel mesh__D017891 Pharmaceutical Epidemiology
% 209.84/210.00 |- skos__hiddenLabel mesh__D017891 Pharmaceutical Epidemiologies
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017891 2004
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D017891 sjn
% 209.84/210.00 |- mesh__recordOriginator mesh__D017891 TGC
% 209.84/210.00 |- mesh__dateEstablished mesh__D017891 1994-01-01
% 209.84/210.00 |- skos__historyNote mesh__D017891 Pharmacology %28%1984-1993%29%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017891 2005
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017891 2003
% 209.84/210.00 |- mesh__historyNote mesh__D017891 94
% 209.84/210.00 |- skos__broader mesh__D017891smesh__D010600
% 209.84/210.00 |- skos__historyNote mesh__D017891 Epidemiology %28%1984-1993%29%
% 209.84/210.00 |- mesh__dateRevised mesh__D017891 2001-07-25
% 209.84/210.00 |- skos__annotation mesh__D017891
% 209.84/210.00 SPEC: SPEC qualif; DF: PHARMACOEPIDEMIOL
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D031562 2004
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D031562 2005
% 209.84/210.00 |- skos__prefLabel mesh__D031562 Cuphea
% 209.84/210.00 |- mesh__historyNote mesh__D031562 2003
% 209.84/210.00 |- skos__broader mesh__D031562smesh__D029561
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D031562 2003
% 209.84/210.00 |- skos__scopeNote mesh__D031562
% 209.84/210.00 A plant genus of the family LYTHRACEAE. Members contain lauric acid and cuphiin.%A%
% 209.84/210.00 |- rdf__type mesh__D031562sskos__Concept
% 209.84/210.00 |- skos__annotation mesh__D031562
% 209.84/210.00 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.84/210.00 |- mesh__dateCreated mesh__D031562 2002-07-03
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D031562 2003
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D031562 2006
% 209.84/210.00 |- mesh__dateEstablished mesh__D031562 2003-01-01
% 209.84/210.00 |- skos__broader mesh__D017093smesh__D048550
% 209.84/210.00 |- mesh__recordOriginator mesh__D017093 TGC
% 209.84/210.00 |- rdf__type mesh__D017093sskos__Concept
% 209.84/210.00 |- mesh__historyNote mesh__D017093
% 209.84/210.00 1993; for FULMINATING HEPATIC FAILURE; HEPATIC FAILURE, FULMINANT; and LIVER FAILURE, FULMINANT use HEPATIC ENCEPHALOPATHY 1993-1999%A%
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D017093 sjn
% 209.84/210.00 |- mesh__dateCreated mesh__D017093 1992-05-22
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D017093
% 209.84/210.00 1993; for FULMINATING HEPATIC FAILURE; HEPATIC FAILURE, FULMINANT; and LIVER FAILURE, FULMINANT see HEPATIC ENCEPHALOPATHY 1993-1999%A%
% 209.84/210.00 |- skos__historyNote mesh__D017093 Hepatic Encephalopathy %28%1967-1992%29%
% 209.84/210.00 |- skos__historyNote mesh__D017093 Liver Diseases %28%1966-1992%29%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017093 2005
% 209.84/210.00 |- skos__annotation mesh__D017093
% 209.84/210.00 if coma is present, index under HEPATIC ENCEPHALOPATHY; LIVER FAILURE, ACUTE is also available%A%
% 209.84/210.00 |- skos__prefLabel mesh__D017093 Liver Failure
% 209.84/210.00 |- mesh__recordMaintainer mesh__D017093 lkt
% 209.84/210.00 |- skos__scopeNote mesh__D017093
% 209.84/210.00 Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTIC DEHYDROGENASE; and albumin/globulin ratio. %28%Blakiston%27%s Gould Medical Dictionary, 4th ed%29%%A%
% 209.84/210.00 |- mesh__dateEstablished mesh__D017093 1993-01-01
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017093 2006
% 209.84/210.00 |- skos__altLabel mesh__D017093 Hepatic Failure
% 209.84/210.00 |- mesh__dateRevised mesh__D017093 2004-07-07
% 209.84/210.00 |- rdf__type mesh__D003871sskos__Concept
% 209.84/210.00 |- skos__hiddenLabel mesh__D003871 Sulfate, Dermatan
% 209.84/210.00 |- skos__hiddenLabel mesh__D003871 beta Heparin
% 209.84/210.00 |- skos__broader mesh__D003871smesh__D002807
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D003871 sjn
% 209.84/210.00 |- skos__prefLabel mesh__D003871 Dermatan Sulfate
% 209.84/210.00 |- skos__altLabel mesh__D003871 Chondroitin Sulfate B
% 209.84/210.00 |- mesh__recordMaintainer mesh__D003871 ssb
% 209.84/210.00 |- mesh__dateCreated mesh__D003871 1999-01-01
% 209.84/210.00 |- skos__altLabel mesh__D003871 beta-Heparin
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003871 2006
% 209.84/210.00 |- skos__hiddenLabel mesh__D003871 Sulfate B, Chondroitin
% 209.84/210.00 |- mesh__dateRevised mesh__D003871 2004-07-07
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003871 2005
% 209.84/210.00 |- mesh__recordOriginator mesh__D003871 NLM
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D003871 91; see CHONDROITIN 1975-90
% 209.84/210.00 |- mesh__historyNote mesh__D003871 91%28%75%29%
% 209.84/210.00 |- mesh__dateEstablished mesh__D003871 1991-01-01
% 209.84/210.00 |- skos__scopeNote mesh__D003871
% 209.84/210.00 A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A %28%see CHONDROITIN SULFATES%29% by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. %28%from Merck, 12th ed%29%%A%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 2006
% 209.84/210.00 |- mesh__dateEstablished mesh__D003073 1969-01-01
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1994
% 209.84/210.00 |- mesh__historyNote mesh__D003073 69
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D003073 PLS
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 2005
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1993
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1999
% 209.84/210.00 |- mesh__recordOriginator mesh__D003073 NLM
% 209.84/210.00 |- mesh__dateRevised mesh__D003073 1989-04-28
% 209.84/210.00 |- rdf__type mesh__D003073sskos__Concept
% 209.84/210.00 |- skos__scopeNote mesh__D003073
% 209.84/210.00 Motivational state produced by inconsistencies between simultaneously held cognitions or between a cognition and behavior; e.g., smoking enjoyment and believing smoking is harmful are dissonant.%A%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 2004
% 209.84/210.00 |- mesh__dateCreated mesh__D003073 1999-01-01
% 209.84/210.00 |- mesh__recordMaintainer mesh__D003073 TGC
% 209.84/210.00 |- skos__prefLabel mesh__D003073 Cognitive Dissonance
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1991
% 209.84/210.00 |- skos__historyNote mesh__D003073 Motivation %28%1966-1968%29%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1992
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1998
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 2002
% 209.84/210.00 |- skos__hiddenLabel mesh__D003073 Dissonance, Cognitive
% 209.84/210.00 |- skos__hiddenLabel mesh__D003073 Dissonances, Cognitive
% 209.84/210.00 |- skos__hiddenLabel mesh__D003073 Cognitive Dissonances
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 2003
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1997
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1990
% 209.84/210.00 |- skos__annotation mesh__D003073 no qualif
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 2001
% 209.84/210.00 |- skos__broader mesh__D003073smesh__D003071
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D003073 69
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1996
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 2000
% 209.84/210.00 |- skos__historyNote mesh__D003073 Cognition %28%1966-1968%29%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003073 1995
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D011505 2006
% 209.84/210.00 |- mesh__recordMaintainer mesh__D011505 ssb
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D011505 2004
% 209.84/210.00 |- rdf__type mesh__D011505sskos__Concept
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D011505 86
% 209.84/210.00 |- skos__altLabel mesh__D011505 Tyrosine-Specific Protein Kinase
% 209.84/210.00 |- skos__hiddenLabel mesh__D011505 Protein Tyrosine Kinase
% 209.84/210.00 |- skos__hiddenLabel mesh__D011505 Kinase, Tyrosine Protein
% 209.84/210.00 |- skos__historyNote mesh__D011505 Protein Kinases %28%1973-1985%29%
% 209.84/210.00 |- skos__hiddenLabel mesh__D011505 Kinase, Tyrosine
% 209.84/210.00 |- skos__prefLabel mesh__D011505 Protein-Tyrosine Kinase
% 209.84/210.00 |- skos__hiddenLabel mesh__D011505 Tyrosine Specific Protein Kinase
% 209.84/210.00 |- skos__hiddenLabel mesh__D011505 Kinase, Tyrosine-Specific Protein
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D011505 sjn
% 209.84/210.00 |- mesh__dateRevised mesh__D011505 2003-07-09
% 209.84/210.00 |- mesh__dateEstablished mesh__D011505 1986-01-01
% 209.84/210.00 |- mesh__recordOriginator mesh__D011505 RLS
% 209.84/210.00 |- skos__related mesh__D011505smesh__D015688
% 209.84/210.00 |- skos__altLabel mesh__D011505 Tyrosylprotein Kinase
% 209.84/210.00 |- skos__broader mesh__D011505smesh__D011494
% 209.84/210.00 |- skos__historyNote mesh__D011505 Phosphotransferases %28%1966-1972%29%
% 209.84/210.00 |- skos__hiddenLabel mesh__D011505 Protein Kinase, Tyrosine-Specific
% 209.84/210.00 |- mesh__dateCreated mesh__D011505 1985-04-25
% 209.84/210.00 |- skos__hiddenLabel mesh__D011505 Kinase, Protein-Tyrosine
% 209.84/210.00 |- skos__related mesh__D011505smesh__D018909
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D011505 2005
% 209.84/210.00 |- skos__scopeNote mesh__D011505
% 209.84/210.00 An enzyme that catalyzes the phosphorylation of tyrosine residues in proteins with ATP or other nucleotides as phosphate donors. EC 2.7.1.112.%A%
% 209.84/210.00 |- skos__altLabel mesh__D011505 Tyrosine Protein Kinase
% 209.84/210.00 |- skos__altLabel mesh__D011505 Tyrosine Kinase
% 209.84/210.00 |- skos__hiddenLabel mesh__D011505 Kinase, Tyrosylprotein
% 209.84/210.00 |- mesh__historyNote mesh__D011505 86
% 209.84/210.00 |- mesh__historyNote mesh__D016799
% 209.84/210.00 92; SUCTORIA was see CILIATA 1985-91, was heading 1963-84%A%
% 209.84/210.00 |- mesh__dateEstablished mesh__D016799 1992-01-01
% 209.84/210.00 |- mesh__recordMaintainer mesh__D016799 ags
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D016799 2005
% 209.84/210.00 |- mesh__onlineNote mesh__D016799
% 209.84/210.00 use CILIOPHORA to search SUCTORIA 1966-91
% 209.84/210.00 |- skos__scopeNote mesh__D016799
% 209.84/210.00 A class of ciliate protozoa. Prominent cytopharyngeal apparatus is characteristic of this class as is only a slight distinction between oral and somatic cilia.%A%
% 209.84/210.00 |- rdf__type mesh__D016799sskos__Concept
% 209.84/210.00 |- skos__annotation mesh__D016799
% 209.84/210.00 a class of CILIOPHORA %28%formerly CILIATA%29%
% 209.84/210.00 |- mesh__recordOriginator mesh__D016799 PXP
% 209.84/210.00 |- skos__broader mesh__D016799smesh__D016798
% 209.84/210.00 |- mesh__dateCreated mesh__D016799 1991-05-02
% 209.84/210.00 |- skos__prefLabel mesh__D016799 Kinetofragminophorea
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D016799 sjn
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D016799 2004
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D016799
% 209.84/210.00 92; SUCTORIA was see CILIATA 1985-91, was heading 1963-84%A%
% 209.84/210.00 |- mesh__dateRevised mesh__D016799 2003-07-09
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D016799 2006
% 209.84/210.00 |- mesh__dateRevised mesh__D002779 2003-07-09
% 209.84/210.00 |- skos__related mesh__D002779smesh__D041781
% 209.84/210.00 |- skos__hiddenLabel mesh__D002779 Obstruction, Bile Duct
% 209.84/210.00 |- skos__hiddenLabel mesh__D002779 Duct Obstruction, Bile
% 209.84/210.00 |- mesh__historyNote mesh__D002779 1972 %28%1969%29%
% 209.84/210.00 |- skos__hiddenLabel mesh__D002779 Cholestases
% 209.84/210.00 |- skos__altLabel mesh__D002779 Biliary Stasis
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002779 2006
% 209.84/210.00 |- skos__altLabel mesh__D002779 Bile Duct Obstruction
% 209.84/210.00 |- mesh__dateCreated mesh__D002779 1999-01-01
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D002779 1972
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002779 2005
% 209.84/210.00 |- skos__prefLabel mesh__D002779 Cholestasis
% 209.84/210.00 |- skos__broader mesh__D002779smesh__D001649
% 209.84/210.00 |- rdf__type mesh__D002779sskos__Concept
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D002779 2004
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D002779 sjn
% 209.84/210.00 |- skos__scopeNote mesh__D002779
% 209.84/210.00 Impairment of bile flow due to obstruction in small bile ducts %28%INTRAHEPATIC CHOLESTASIS%29% or obstruction in large bile ducts %28%EXTRAHEPATIC CHOLESTASIS%29%.%A%
% 209.84/210.00 |- skos__hiddenLabel mesh__D002779 Stases, Biliary
% 209.84/210.00 |- skos__hiddenLabel mesh__D002779 Duct Obstructions, Bile
% 209.84/210.00 |- skos__hiddenLabel mesh__D002779 Obstructions, Bile Duct
% 209.84/210.00 |- skos__hiddenLabel mesh__D002779 Bile Duct Obstructions
% 209.84/210.00 |- mesh__recordMaintainer mesh__D002779 lkt
% 209.84/210.00 |- skos__hiddenLabel mesh__D002779 Stasis, Biliary
% 209.84/210.00 |- mesh__dateEstablished mesh__D002779 1972-01-01
% 209.84/210.00 |- skos__hiddenLabel mesh__D002779 Biliary Stases
% 209.84/210.00 |- mesh__recordOriginator mesh__D002779 NLM
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007464 2003
% 209.84/210.00 |- mesh__dateRevised mesh__D007464 2000-06-22
% 209.84/210.00 |- skos__broader mesh__D007464smesh__D015125
% 209.84/210.00 |- skos__hiddenLabel mesh__D007464 Entero Septol
% 209.84/210.00 |- skos__altLabel mesh__D007464 Chloroiodoquine
% 209.84/210.00 |- mesh__dateEstablished mesh__D007464 1963-01-01
% 209.84/210.00 |- mesh__historyNote mesh__D007464
% 209.84/210.00 93; was IODOCHLORHYDROXYQUIN 1963-92 %28%see under HYDROXYQUINOLINES 1983-90%29%; CLIOQUINOL was see IODOCHLORHYDROXYQUIN 1976-92%A%
% 209.84/210.00 |- mesh__onlineNote mesh__D007464
% 209.84/210.00 use CLIOQUINOL to search IODOCHLORHYDROXYQUIN 1966-92
% 209.84/210.00 |- mesh__recordMaintainer mesh__D007464 TWD
% 209.84/210.00 |- skos__hiddenLabel mesh__D007464 EnteroSeptol
% 209.84/210.00 |- mesh__dateCreated mesh__D007464 1999-01-01
% 209.84/210.00 |- skos__prefLabel mesh__D007464 Clioquinol
% 209.84/210.00 |- skos__hiddenLabel mesh__D007464 EnteroVioform
% 209.84/210.00 |- skos__scopeNote mesh__D007464
% 209.84/210.00 A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.%A%
% 209.84/210.00 |- skos__hiddenLabel mesh__D007464 5 Chloro 7 iodo 8 quinolinol
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D007464
% 209.84/210.00 93; was IODOCHLORHYDROXYQUIN 1963-92 %28%see under HYDROXYQUINOLINES 1983-90%29%; CLIOQUINOL was see IODOCHLORHYDROXYQUIN 1976-92%A%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007464 2006
% 209.84/210.00 |- skos__hiddenLabel mesh__D007464 Entero Vioform
% 209.84/210.00 |- skos__altLabel mesh__D007464 Iodochloroxyquinoline
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007464 2002
% 209.84/210.00 |- mesh__recordOriginator mesh__D007464 NLM
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007464 2005
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007464 2001
% 209.84/210.00 |- skos__altLabel mesh__D007464 5-Chloro-7-iodo-8-quinolinol
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D007464 2004
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D007464 sjn
% 209.84/210.00 |- skos__altLabel mesh__D007464 Iodochlorhydroxyquin
% 209.84/210.00 |- rdf__type mesh__D007464sskos__Concept
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 2006
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 1998
% 209.84/210.00 |- skos__annotation mesh__D017892
% 209.84/210.00 inorganic; GEN or unspecified; prefer specifics; DF: OSMIUM CPDS%A%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 2004
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 1996
% 209.84/210.00 |- skos__hiddenLabel mesh__D017892 Compounds, Osmium
% 209.84/210.00 |- skos__prefLabel mesh__D017892 Osmium Compounds
% 209.84/210.00 |- skos__broader mesh__D017892smesh__D007287
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 2005
% 209.84/210.00 |- mesh__dateCreated mesh__D017892 1993-06-21
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 2002
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 2003
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D017892 94
% 209.84/210.00 |- skos__scopeNote mesh__D017892
% 209.84/210.00 Inorganic compounds that contain osmium as an integral part of the molecule.%A%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 1995
% 209.84/210.00 |- mesh__historyNote mesh__D017892 94
% 209.84/210.00 |- mesh__dateEstablished mesh__D017892 1994-01-01
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 1994
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 2001
% 209.84/210.00 |- skos__historyNote mesh__D017892 Osmium %28%1966-1993%29%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 1999
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 2000
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017892 1997
% 209.84/210.00 |- rdf__type mesh__D017892sskos__Concept
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D031563 2004
% 209.84/210.00 |- mesh__dateEstablished mesh__D031563 2003-01-01
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D031563 2005
% 209.84/210.00 |- mesh__historyNote mesh__D031563 2003
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D031563 2003
% 209.84/210.00 |- skos__broader mesh__D031563smesh__D029561
% 209.84/210.00 |- rdf__type mesh__D031563sskos__Concept
% 209.84/210.00 |- skos__prefLabel mesh__D031563 Lagerstroemia
% 209.84/210.00 |- skos__annotation mesh__D031563
% 209.84/210.00 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.84/210.00 |- mesh__dateCreated mesh__D031563 2002-07-03
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D031563 2003
% 209.84/210.00 |- skos__scopeNote mesh__D031563
% 209.84/210.00 A plant genus of the family LYTHRACEAE. Members contain lagertannin and have hypoglycemic effects.%A%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D031563 2006
% 209.84/210.00 |- skos__historyNote mesh__D017094 Porphyria %28%1966-1992%29%
% 209.84/210.00 |- skos__broader mesh__D017094smesh__D012873
% 209.84/210.00 |- mesh__historyNote mesh__D017094 2005 %28%1993%29%
% 209.84/210.00 |- skos__annotation mesh__D017094
% 209.84/210.00 do not confuse with PORPHYRIA, ERYTHROHEPATIC
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017094 2005
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D017094 sjn
% 209.84/210.00 |- skos__altLabel mesh__D017094 Hepatic Porphyria
% 209.84/210.00 |- mesh__dateCreated mesh__D017094 1992-05-22
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D017094 2006
% 209.84/210.00 |- skos__broader mesh__D017094smesh__D008107
% 209.84/210.00 |- mesh__dateRevised mesh__D017094 2004-07-07
% 209.84/210.00 |- mesh__publicMeSHNote mesh__D017094
% 209.84/210.00 2005; see PORPHYRIA, HEPATIC 1993-2004
% 209.84/210.00 |- skos__broader mesh__D017094smesh__D008661
% 209.84/210.00 |- skos__hiddenLabel mesh__D017094 Hepatic Porphyrias
% 209.84/210.00 |- skos__altLabel mesh__D017094 Porphyria, Hepatic
% 209.84/210.00 |- mesh__recordMaintainer mesh__D017094 lkt
% 209.84/210.00 |- skos__broader mesh__D017094smesh__D011164
% 209.84/210.00 |- mesh__recordOriginator mesh__D017094 PXP
% 209.84/210.00 |- rdf__type mesh__D017094sskos__Concept
% 209.84/210.00 |- skos__prefLabel mesh__D017094 Porphyrias, Hepatic
% 209.84/210.00 |- mesh__dateEstablished mesh__D017094 1993-01-01
% 209.84/210.00 |- skos__scopeNote mesh__D017094
% 209.84/210.00 A group of metabolic diseases due to deficiency of one of a number of LIVER enzymes in the biosynthetic pathway of HEME. They are characterized by the accumulation and increased excretion of PORPHYRINS or its precursors. Clinical features include neurological symptoms %28%PORPHYRIA, ACUTE INTERMITTENT%29%, cutaneous lesions due to photosensitivity %28%PORPHYRIA CUTANEA TARDA%29%, or both %28%HEREDITARY COPROPORPHYRIA%29%. Hepatic porphyrias can be hereditary or acquired as a result of toxicity to the hepatic tissues.%A%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 2000
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 2006
% 209.84/210.00 |- mesh__recordOriginator mesh__D003872 NLM
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D003872 PLS
% 209.84/210.00 |- mesh__recordMaintainer mesh__D003872 TAP
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 1997
% 209.84/210.00 |- mesh__dateRevised mesh__D003872 1993-06-02
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 2005
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 2002
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 1996
% 209.84/210.00 |- skos__prefLabel mesh__D003872 Dermatitis
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 1999
% 209.84/210.00 |- skos__scopeNote mesh__D003872 Any inflammation of the skin.
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 1995
% 209.84/210.00 |- rdf__type mesh__D003872sskos__Concept
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 1998
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 2004
% 209.84/210.00 |- skos__hiddenLabel mesh__D003872 Dermatitides
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 2001
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 1994
% 209.84/210.00 |- skos__broader mesh__D003872smesh__D012871
% 209.84/210.00 |- skos__annotation mesh__D003872
% 209.84/210.00 any skin inflamm; /chem ind = DERMATITIS MEDICAMENTOSA see DRUG ERUPTIONS or DERMATITIS, CONTACT%A%
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003872 2003
% 209.84/210.00 |- mesh__dateCreated mesh__D003872 1999-01-01
% 209.84/210.00 |- skos__scopeNote mesh__D003074
% 209.84/210.00 Solitary, round, circumscribed shadows found in the lungs in x-ray examinations. Common causes are tuberculosis, neoplasms, cysts, or vascular anomalies. %28%Stedman, 25th ed%29%%A%
% 209.84/210.00 |- mesh__dateCreated mesh__D003074 1999-01-01
% 209.84/210.00 |- skos__hiddenLabel mesh__D003074 Lesion, Pulmonary Coin
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003074 2006
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003074 1998
% 209.84/210.00 |- mesh__dateRevised mesh__D003074 1996-06-10
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003074 2001
% 209.84/210.00 |- mesh__dateEstablished mesh__D003074 1965-01-01
% 209.84/210.00 |- skos__broader mesh__D003074smesh__D008175
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003074 2003
% 209.84/210.00 |- skos__altLabel mesh__D003074 Nodules, Solitary Pulmonary
% 209.84/210.00 |- mesh__recordAuthorizer mesh__D003074 PLS
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003074 1999
% 209.84/210.00 |- rdf__type mesh__D003074sskos__Concept
% 209.84/210.00 |- skos__altLabel mesh__D003074 Pulmonary Nodule, Solitary
% 209.84/210.00 |- skos__altLabel mesh__D003074 Coin Lesions, Pulmonary
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003074 2004
% 209.84/210.00 |- skos__altLabel mesh__D003074 Pulmonary Coin Lesion
% 209.84/210.00 |- mesh__historyNote mesh__D003074 65
% 209.84/210.00 |- skos__altLabel mesh__D003074 Pulmonary Nodules, Solitary
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003074 2002
% 209.84/210.00 |- skos__altLabel mesh__D003074 Nodule, Solitary Pulmonary
% 209.84/210.00 |- skos__altLabel mesh__D003074 Solitary Pulmonary Nodule
% 209.84/210.00 |- mesh__activeMeSHYear mesh__D003074 1997
% 209.84/210.00 |- skos__prefLabel mesh__D003074 Coin Lesion, Pulmonary
% 209.84/210.00 |- mesh__recordMaintainer mesh__D003074 TPW
% 209.84/210.00 |- mesh__recordOriginator mesh__D003074 NLM
% 209.84/210.01 |- skos__altLabel mesh__D003074 Solitary Pulmonary Nodules
% 209.84/210.01 |- skos__altLabel mesh__D003074 Pulmonary Coin Lesions
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D003074 65
% 209.84/210.01 |- skos__hiddenLabel mesh__D003074 Lesions, Pulmonary Coin
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003074 2000
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003074 2005
% 209.84/210.01 |- skos__annotation mesh__D003074
% 209.84/210.01 if neopl, coord IM with LUNG NEOPLASMS %28%NIM%29%; if non-neopl, do not coord with LUNG DISEASES; DF: COIN LESION PULM%A%
% 209.84/210.01 |- skos__broader mesh__D003074smesh__D008171
% 209.84/210.01 |- skos__altLabel mesh__D011506 Gene Proteins
% 209.84/210.01 |- mesh__recordOriginator mesh__D011506 NLM
% 209.84/210.01 |- skos__related mesh__D011506smesh__D000595
% 209.84/210.01 |- mesh__historyNote mesh__D011506
% 209.84/210.01 /metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64%A%
% 209.84/210.01 |- skos__related mesh__D011506smesh__D001798
% 209.84/210.01 |- skos__hiddenLabel mesh__D011506 Proteins, Gene
% 209.84/210.01 |- skos__broader mesh__D011506smesh__D000602
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D011506
% 209.84/210.01 /metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64%A%
% 209.84/210.01 |- skos__related mesh__D011506smesh__D011487
% 209.84/210.01 |- skos__hiddenLabel mesh__D011506 Protein Gene Products
% 209.84/210.01 |- skos__annotation mesh__D011506
% 209.84/210.01 general only; prefer specific protein or specific precoordinated protein group terms such as EYE PROTEINS, BACTERIAL PROTEINS, DIETARY PROTEINS, etc.; primary protein structure = AMINO ACID SEQUENCE; protein structure referring to protein architecture = PROTEIN CONFORMATION or its specifics: PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; or PROTEIN STRUCTURE, QUATERNARY%A%
% 209.84/210.01 |- skos__scopeNote mesh__D011506
% 209.84/210.01 Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.%A%
% 209.84/210.01 |- mesh__onlineNote mesh__D011506 pre-explosion = PROTEINS %28%PX%29%
% 209.84/210.01 |- skos__prefLabel mesh__D011506 Proteins
% 209.84/210.01 |- mesh__dateRevised mesh__D011506 2005-07-27
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D011506 2006
% 209.84/210.01 |- mesh__recordMaintainer mesh__D011506 ags
% 209.84/210.01 |- mesh__dateCreated mesh__D011506 1999-01-01
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D011506 2006A
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D011506 ags
% 209.84/210.01 |- rdf__type mesh__D011506sskos__Concept
% 209.84/210.01 |- mesh__recordOriginator mesh__D007465 NLM
% 209.84/210.01 |- mesh__recordMaintainer mesh__D007465 jls
% 209.84/210.01 |- skos__annotation mesh__D007465
% 209.84/210.01 for radiolabeled cpd coord IM with IODINE RADIOISOTOPES %28%NIM%29%%A%
% 209.84/210.01 |- mesh__historyNote mesh__D007465
% 209.84/210.01 66; RADIO-HIPPURAN was see under IUDOHIPPURIC ACID 1966-77; HIPPURAN was see IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65%A%
% 209.84/210.01 |- skos__hiddenLabel mesh__D007465 o-Iodohippurate, Sodium
% 209.84/210.01 |- skos__hiddenLabel mesh__D007465 Sodium o Iodohippurate
% 209.84/210.01 |- skos__hiddenLabel mesh__D007465 RadioHippuran
% 209.84/210.01 |- skos__hiddenLabel mesh__D007465 I OIH
% 209.84/210.01 |- skos__hiddenLabel mesh__D007465 Iodohippurate, Sodium
% 209.84/210.01 |- mesh__dateCreated mesh__D007465 1999-01-01
% 209.84/210.01 |- skos__prefLabel mesh__D007465 Iodohippuric Acid
% 209.84/210.01 |- mesh__dateRevised mesh__D007465 2004-07-28
% 209.84/210.01 |- mesh__dateEstablished mesh__D007465 1966-01-01
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007465 2006
% 209.84/210.01 |- skos__hiddenLabel mesh__D007465 Acid, Iodohippuric
% 209.84/210.01 |- skos__altLabel mesh__D007465 ortho-Iodohippurate
% 209.84/210.01 |- skos__hiddenLabel mesh__D007465 Radio Hippuran
% 209.84/210.01 |- skos__altLabel mesh__D007465 Iodobenzoylglycine
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007465 2005A
% 209.84/210.01 |- skos__altLabel mesh__D007465 I-OIH
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007465 2005
% 209.84/210.01 |- mesh__onlineNote mesh__D007465
% 209.84/210.01 use IODOHIPPURIC ACID to search RADIO-HIPPURAN %26% HIPPURAN 1966-77%A%
% 209.84/210.01 |- skos__broader mesh__D007465smesh__D006626
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D007465
% 209.84/210.01 66; HIPPURAN was see under IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65%A%
% 209.84/210.01 |- skos__altLabel mesh__D007465 Orthoiodohippurate
% 209.84/210.01 |- skos__hiddenLabel mesh__D007465 ortho Iodohippurate
% 209.84/210.01 |- skos__altLabel mesh__D007465 I-Hippuran
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D007465 jls
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007465 2004
% 209.84/210.01 |- skos__scopeNote mesh__D007465
% 209.84/210.01 An iodine-containing compound used in pyelography as a radiopaque medium. If labeled with radioiodine, it can be used for studies of renal function.%A%
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007465 2002
% 209.84/210.01 |- skos__altLabel mesh__D007465 Sodium o-Iodohippurate
% 209.84/210.01 |- rdf__type mesh__D007465sskos__Concept
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007465 2003
% 209.84/210.01 |- skos__hiddenLabel mesh__D007465 I Hippuran
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007465 2001
% 209.84/210.01 |- skos__broader mesh__D007465smesh__D001549
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D045584 2004
% 209.84/210.01 |- mesh__dateEstablished mesh__D045584 2004-01-01
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D045584 2005
% 209.84/210.01 |- mesh__dateCreated mesh__D045584 2003-07-09
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D045584 2006
% 209.84/210.01 |- mesh__historyNote mesh__D045584 2004
% 209.84/210.01 |- skos__hiddenLabel mesh__D045584 Positioning, Chromosome
% 209.84/210.01 |- rdf__type mesh__D045584sskos__Concept
% 209.84/210.01 |- skos__related mesh__D045584smesh__D042581
% 209.84/210.01 |- skos__prefLabel mesh__D045584 Chromosome Positioning
% 209.84/210.01 |- skos__scopeNote mesh__D045584
% 209.84/210.01 The mechanisms of eukaryotic CELLS that place or keep the CHROMOSOMES in a particular SUBNUCLEAR SPACE.%A%
% 209.84/210.01 |- skos__broader mesh__D045584smesh__D002451
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D045584 2004
% 209.84/210.01 |- skos__hiddenLabel mesh__D017893 Photopheresis, Extracorporeal
% 209.84/210.01 |- rdf__type mesh__D017893sskos__Concept
% 209.84/210.01 |- mesh__recordOriginator mesh__D017893 TGC
% 209.84/210.01 |- skos__altLabel mesh__D017893 Extracorporeal Photopheresis
% 209.84/210.01 |- skos__broader mesh__D017893smesh__D005112
% 209.84/210.01 |- skos__historyNote mesh__D017893 Photochemotherapy %28%1984-1993%29%
% 209.84/210.01 |- skos__historyNote mesh__D017893 Methoxsalen %28%1986-1993%29%
% 209.84/210.01 |- skos__annotation mesh__D017893 a form of PUVA ther
% 209.84/210.01 |- mesh__historyNote mesh__D017893 94
% 209.84/210.01 |- mesh__dateRevised mesh__D017893 2005-06-30
% 209.84/210.01 |- skos__historyNote mesh__D017893 PUVA Therapy %28%1984-1993%29%
% 209.84/210.01 |- skos__hiddenLabel mesh__D017893 Extracorporeal Photochemotherapies
% 209.84/210.01 |- skos__broader mesh__D017893smesh__D011701
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D017893 94
% 209.84/210.01 |- skos__scopeNote mesh__D017893
% 209.84/210.01 A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen %28%METHOXSALEN%29% and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases.%A%
% 209.84/210.01 |- skos__altLabel mesh__D017893 Photochemotherapy, Extracorporeal
% 209.84/210.01 |- skos__altLabel mesh__D017893 Extracorporeal Photochemotherapy
% 209.84/210.01 |- skos__prefLabel mesh__D017893 Photopheresis
% 209.84/210.01 |- mesh__dateEstablished mesh__D017893 1994-01-01
% 209.84/210.01 |- mesh__dateCreated mesh__D017893 1993-02-16
% 209.84/210.01 |- skos__hiddenLabel mesh__D017893 Photochemotherapies, Extracorporeal
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D017893 2006
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D017893 sjn
% 209.84/210.01 |- mesh__recordMaintainer mesh__D017893 lkt
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D031564 2003
% 209.84/210.01 |- rdf__type mesh__D031564sskos__Concept
% 209.84/210.01 |- skos__annotation mesh__D031564
% 209.84/210.01 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.84/210.01 |- mesh__dateEstablished mesh__D031564 2003-01-01
% 209.84/210.01 |- mesh__historyNote mesh__D031564 2003
% 209.84/210.01 |- skos__altLabel mesh__D031564 Henna Plant
% 209.84/210.01 |- skos__scopeNote mesh__D031564
% 209.84/210.01 A plant genus of the family LYTHRACEAE that is the source of henna and has cytotoxic activity.%A%
% 209.84/210.01 |- skos__broader mesh__D031564smesh__D029561
% 209.84/210.01 |- skos__prefLabel mesh__D031564 Lawsonia Plant
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D031564 2003
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D031564 2006
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D031564 2004
% 209.84/210.01 |- mesh__dateCreated mesh__D031564 2002-07-03
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D031564 2005
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D017095 93
% 209.84/210.01 |- mesh__recordMaintainer mesh__D017095 lkt
% 209.84/210.01 |- skos__hiddenLabel mesh__D017095 Failure, Renal
% 209.84/210.01 |- mesh__dateEstablished mesh__D017095 1993-01-01
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D017095 2006
% 209.84/210.01 |- mesh__dateRevised mesh__D017095 2005-06-30
% 209.84/210.01 |- mesh__dateCreated mesh__D017095 1992-05-20
% 209.84/210.01 |- skos__historyNote mesh__D017095 Kidney Failure, Acute %28%1966-1992%29%
% 209.84/210.01 |- skos__hiddenLabel mesh__D017095 Failures, Kidney
% 209.84/210.01 |- skos__hiddenLabel mesh__D017095 Kidney Failures
% 209.84/210.01 |- skos__altLabel mesh__D017095 Renal Failure
% 209.84/210.01 |- skos__hiddenLabel mesh__D017095 Renal Failures
% 209.84/210.01 |- rdf__type mesh__D017095sskos__Concept
% 209.84/210.01 |- skos__hiddenLabel mesh__D017095 Failures, Renal
% 209.84/210.01 |- skos__hiddenLabel mesh__D017095 Failure, Kidney
% 209.84/210.01 |- mesh__recordOriginator mesh__D017095 TGC
% 209.84/210.01 |- skos__annotation mesh__D017095
% 209.84/210.01 for renal failure unspecified as %22%acute%22% %28%KIDNEY FAILURE, ACUTE%29% or %22%chronic%22% %28%KIDNEY FAILURE, CHRONIC%29% but check text for clues at those annotations; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; and RENAL INSUFFICIENCY are also available%A%
% 209.84/210.01 |- skos__scopeNote mesh__D017095
% 209.84/210.01 A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal failure, either acute %28%KIDNEY FAILURE, ACUTE%29% or chronic %28%KIDNEY FAILURE, CHRONIC%29%, requires HEMODIALYSIS.%A%
% 209.84/210.01 |- mesh__historyNote mesh__D017095 93
% 209.84/210.01 |- skos__broader mesh__D017095smesh__D051437
% 209.84/210.01 |- skos__historyNote mesh__D017095 Kidney Diseases %28%1966-1992%29%
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D017095 sjn
% 209.84/210.01 |- skos__historyNote mesh__D017095
% 209.84/210.01 Kidney Failure, Chronic %28%1966-1992%29%
% 209.84/210.01 |- skos__prefLabel mesh__D017095 Kidney Failure
% 209.84/210.01 |- skos__altLabel mesh__D003873 Dermatitis Exfoliativa
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 2001
% 209.84/210.01 |- skos__hiddenLabel mesh__D003873 Dermatitides, Exfoliative
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 2005
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 1993
% 209.84/210.01 |- skos__scopeNote mesh__D003873
% 209.84/210.01 The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder %28%e.g., atopic dermatitis, psoriasis, etc.%29%, or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. %28%From Dorland, 27th ed%29%%A%
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 1996
% 209.84/210.01 |- mesh__dateRevised mesh__D003873 1992-05-20
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 2000
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D003873
% 209.84/210.01 93; was DERMATITIS EXFOLIATIVA 1963-92; ERYTHRODERMA was heading 1963-92%A%
% 209.84/210.01 |- skos__altLabel mesh__D003873 Erythroderma
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 1999
% 209.84/210.01 |- mesh__recordOriginator mesh__D003873 NLM
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D003873 PLS
% 209.84/210.01 |- mesh__recordMaintainer mesh__D003873 PLS
% 209.84/210.01 |- skos__broader mesh__D003873smesh__D003872
% 209.84/210.01 |- skos__prefLabel mesh__D003873 Dermatitis, Exfoliative
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 1995
% 209.84/210.01 |- rdf__type mesh__D003873sskos__Concept
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 1998
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 2004
% 209.84/210.01 |- skos__broader mesh__D003873smesh__D017443
% 209.84/210.01 |- mesh__historyNote mesh__D003873
% 209.84/210.01 93; was DERMATITIS EXFOLIATIVA 1963-92; ERYTHRODERMA was heading 1963-92%A%
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 2002
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 1994
% 209.84/210.01 |- skos__hiddenLabel mesh__D003873 Exfoliative Dermatitis
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 2003
% 209.84/210.01 |- mesh__dateCreated mesh__D003873 1999-01-01
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 2006
% 209.84/210.01 |- skos__hiddenLabel mesh__D003873 Exfoliative Dermatitides
% 209.84/210.01 |- mesh__onlineNote mesh__D003873
% 209.84/210.01 use DERMATITIS, EXFOLIATIVE to search DERMATITIS EXFOLIATIVA %26% ERYTHRODERMA 1966-92%A%
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003873 1997
% 209.84/210.01 |- skos__hiddenLabel mesh__D003873 Erythrodermas
% 209.84/210.01 |- skos__hiddenLabel mesh__D003075 Coital Frequencies
% 209.84/210.01 |- skos__hiddenLabel mesh__D003075 Intercourse, First
% 209.84/210.01 |- skos__prefLabel mesh__D003075 Coitus
% 209.84/210.01 |- skos__altLabel mesh__D003075 Sexual Intercourse
% 209.84/210.01 |- rdf__type mesh__D003075sskos__Concept
% 209.84/210.01 |- skos__broader mesh__D003075smesh__D012725
% 209.84/210.01 |- mesh__recordMaintainer mesh__D003075 sjn
% 209.84/210.01 |- skos__hiddenLabel mesh__D003075 First Intercourses
% 209.84/210.01 |- skos__scopeNote mesh__D003075
% 209.84/210.01 The sexual union of a male and a female, a term used for human only.%A%
% 209.84/210.01 |- mesh__dateRevised mesh__D003075 2004-07-13
% 209.84/210.01 |- skos__hiddenLabel mesh__D003075 Intercourse, Sexual
% 209.84/210.01 |- skos__hiddenLabel mesh__D003075 Frequencies, Coital
% 209.84/210.01 |- skos__broader mesh__D003075smesh__D012098
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003075 2005
% 209.84/210.01 |- skos__hiddenLabel mesh__D003075 Intercourses, First
% 209.84/210.01 |- skos__hiddenLabel mesh__D003075 Frequency, Coital
% 209.84/210.01 |- mesh__dateCreated mesh__D003075 1999-01-01
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D003075 2006
% 209.84/210.01 |- mesh__recordOriginator mesh__D003075 NLM
% 209.84/210.01 |- skos__annotation mesh__D003075
% 209.84/210.01 human only: animal = COPULATION; for anal or oral sex index under SEX BEHAVIOR%A%
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D003075 sjn
% 209.84/210.01 |- skos__hiddenLabel mesh__D011507 Proteinurias
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D011507 2003
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D011507 sjn
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D011507 2005
% 209.84/210.01 |- skos__scopeNote mesh__D011507
% 209.84/210.01 The presence of proteins in the urine, an indicator of KIDNEY DISEASES.%A%
% 209.84/210.01 |- mesh__recordMaintainer mesh__D011507 lkt
% 209.84/210.01 |- rdf__type mesh__D011507sskos__Concept
% 209.84/210.01 |- mesh__recordOriginator mesh__D011507 NLM
% 209.84/210.01 |- skos__annotation mesh__D011507
% 209.84/210.01 EPH %28%Edema, Proteinuria, Hypertension%29% = GESTOSIS, EPH %26% do not index under PROTEINURIA unless it is particularly discussed%A%
% 209.84/210.01 |- skos__broader mesh__D011507smesh__D014570
% 209.84/210.01 |- skos__prefLabel mesh__D011507 Proteinuria
% 209.84/210.01 |- mesh__dateCreated mesh__D011507 1999-01-01
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D011507 2004
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D011507 2006
% 209.84/210.01 |- mesh__dateRevised mesh__D011507 2002-07-03
% 209.84/210.01 |- skos__broader mesh__D001415Q000293smesh__D001415
% 209.84/210.01 |- mesh__preferredCombination mesh__D001415Q000293smesh__D019567
% 209.84/210.01 |- rdf__type mesh__D001415Q000293smesh__CompoundConcept
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D007466 91; was see under IODINE 1975-90
% 209.84/210.01 |- mesh__recordMaintainer mesh__D007466 ssb
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007466 2005
% 209.84/210.01 |- mesh__dateCreated mesh__D007466 1974-11-19
% 209.84/210.01 |- skos__related mesh__D007466smesh__D000891
% 209.84/210.01 |- skos__annotation mesh__D007466
% 209.84/210.01 an iodophor is a complex of iodine %26% a non-ionic surface-active agent; D25-26 qualif%A%
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007466 2006
% 209.84/210.01 |- mesh__recordOriginator mesh__D007466 NLM
% 209.84/210.01 |- skos__scopeNote mesh__D007466
% 209.84/210.01 Complexes of iodine and non-ionic surface-active agent acting as carrier and solubilizing agent for the iodine in water. Iodophors usually enhance bactericidal activity of iodine, reduce vapor pressure and odor, minimize staining, and allow wide dilution with water. %28%From Merck Index, 11th ed%29%%A%
% 209.84/210.01 |- mesh__dateRevised mesh__D007466 2003-07-09
% 209.84/210.01 |- mesh__dateEstablished mesh__D007466 1991-01-01
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D007466 sjn
% 209.84/210.01 |- mesh__historyNote mesh__D007466
% 209.84/210.01 91%28%75%29%; was see under IODINE 1975-90
% 209.84/210.01 |- skos__hiddenLabel mesh__D007466 Iodine, Tamed
% 209.84/210.01 |- skos__prefLabel mesh__D007466 Iodophors
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D007466 2004
% 209.84/210.01 |- skos__altLabel mesh__D007466 Tamed Iodine
% 209.84/210.01 |- rdf__type mesh__D007466sskos__Concept
% 209.84/210.01 |- skos__historyNote mesh__D007466 Iodine %28%1971-1974%29%
% 209.84/210.01 |- skos__broader mesh__D007466smesh__D013501
% 209.84/210.01 |- mesh__dateCreated mesh__D045585 2003-07-09
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D045585 2006
% 209.84/210.01 |- skos__altLabel mesh__D045585 Fen1 Protein
% 209.84/210.01 |- skos__prefLabel mesh__D045585 Flap Endonucleases
% 209.84/210.01 |- rdf__type mesh__D045585sskos__Concept
% 209.84/210.01 |- mesh__dateEstablished mesh__D045585 2004-01-01
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D045585
% 209.84/210.01 2004; FLAP ENDONUCLEASES was indexed under ENDODEOYRIBONUCLEASES 1994-2003; FEN1 PROTEIN was indexed under EXODEOXYRIBNUCLEASES 1997-2003; RTH-1 NUCLEASE was indexed under EXODEOXYRIBNUCLEASES 1996-2003%A%
% 209.84/210.01 |- skos__hiddenLabel mesh__D045585 RAD2 Homolog 1 Nuclease
% 209.84/210.01 |- mesh__recordOriginator mesh__D045585 jmp
% 209.84/210.01 |- skos__altLabel mesh__D045585 FEN-1
% 209.84/210.01 |- skos__hiddenLabel mesh__D045585 Nuclease, RTH-1
% 209.84/210.01 |- skos__hiddenLabel mesh__D045585 Flap Endonuclease 1
% 209.84/210.01 |- mesh__recordMaintainer mesh__D045585 jmp
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D045585 sjn
% 209.84/210.01 |- skos__scopeNote mesh__D045585
% 209.84/210.01 Endonucleases that remove 5%27% DNA sequences from a DNA structure called a DNA flap. The DNA flap structure occurs in double-stranded DNA containing a single-stranded break where the 5%27% portion of the downstream strand is too long and overlaps the 3%27% end of the upstream strand. Flap endonucleases cleave the downstream strand of the overlap flap structure precisely after the first base-paired nucleotide, creating a ligatable nick.%A%
% 209.84/210.01 |- skos__hiddenLabel mesh__D045585 RTH 1 Nuclease
% 209.84/210.01 |- mesh__historyNote mesh__D045585
% 209.84/210.01 2004; use FLAP ENDONUCLEASES %28%NM%29% 1994-2003; for FEN1 PROTEIN use EXODEOXYRIBONUCLEASE V 1997-2003; for RTH-1 NUCLEASE use EXODEOXYRIBONUCLEASE V 1996-2003%A%
% 209.84/210.01 |- skos__altLabel mesh__D045585 RTH-1 Nuclease
% 209.84/210.01 |- skos__historyNote mesh__D045585 Endodeoxyribonucleases %28%1994-2003%29%
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D045585 2004
% 209.84/210.01 |- skos__hiddenLabel mesh__D045585 Endonuclease-1, Flap
% 209.84/210.01 |- skos__hiddenLabel mesh__D045585 Endonucleases, Flap
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D045585 2005
% 209.84/210.01 |- skos__altLabel mesh__D045585 RAD2 Homolog-1 Nuclease
% 209.84/210.01 |- skos__broader mesh__D045585smesh__D004706
% 209.84/210.01 |- skos__broader mesh__D011574Q000266smesh__D011574
% 209.84/210.01 |- mesh__preferredCombination mesh__D011574Q000266smesh__D011572Q000266
% 209.84/210.01 |- rdf__type mesh__D011574Q000266smesh__CompoundConcept
% 209.84/210.01 |- skos__prefLabel mesh__D012600 Scoliosis
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 2002
% 209.84/210.01 |- mesh__recordMaintainer mesh__D012600 TGC
% 209.84/210.01 |- skos__broader mesh__D012600smesh__D013121
% 209.84/210.01 |- skos__scopeNote mesh__D012600
% 209.84/210.01 An appreciable lateral deviation in the normally straight vertical line of the spine. %28%Dorland, 27th ed%29%%A%
% 209.84/210.01 |- mesh__recordOriginator mesh__D012600 NLM
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 1995
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 2001
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 1999
% 209.84/210.01 |- mesh__recordAuthorizer mesh__D012600 PLS
% 209.84/210.01 |- mesh__dateCreated mesh__D012600 1999-01-01
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 2006
% 209.84/210.01 |- mesh__dateRevised mesh__D012600 1994-04-11
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 1997
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 2000
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 1998
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 2004
% 209.84/210.01 |- skos__hiddenLabel mesh__D012600 Scolioses
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 1996
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 2005
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D012600 2003
% 209.84/210.01 |- rdf__type mesh__D012600sskos__Concept
% 209.84/210.01 |- skos__annotation mesh__D012600 a type of spinal curvature
% 209.84/210.01 |- skos__broader mesh__D031565smesh__D029561
% 209.84/210.01 |- rdf__type mesh__D031565sskos__Concept
% 209.84/210.01 |- skos__scopeNote mesh__D031565
% 209.84/210.01 A plant genus of the family LYTHRACEAE. Members contain woodfordins.%A%
% 209.84/210.01 |- skos__prefLabel mesh__D031565 Woodfordia
% 209.84/210.01 |- skos__annotation mesh__D031565
% 209.84/210.01 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.84/210.01 |- mesh__dateCreated mesh__D031565 2002-07-03
% 209.84/210.01 |- mesh__dateEstablished mesh__D031565 2003-01-01
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D031565 2005
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D031565 2003
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D031565 2003
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D031565 2006
% 209.84/210.01 |- mesh__historyNote mesh__D031565 2003
% 209.84/210.01 |- mesh__activeMeSHYear mesh__D031565 2004
% 209.84/210.01 |- mesh__publicMeSHNote mesh__D017096 1993
% 209.87/210.01 |- skos__altLabel mesh__D017096 Transmissible Spongiform Encephalopathies
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Spongiform Encephalopathy, Transmissible
% 209.87/210.01 |- skos__scopeNote mesh__D017096
% 209.87/210.01 A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. %28%From Proc Natl Acad Sci USA 1998 Nov 10;95%28%23%29%:13363-83%29%%A%
% 209.87/210.01 |- mesh__dateCreated mesh__D017096 1992-05-22
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Encephalopathy, Transmissible Spongiform
% 209.87/210.01 |- skos__prefLabel mesh__D017096 Prion Diseases
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Disorder, Prion-Induced
% 209.87/210.01 |- mesh__historyNote mesh__D017096 1993
% 209.87/210.01 |- skos__broader mesh__D017096smesh__D002494
% 209.87/210.01 |- skos__altLabel mesh__D017096 Transmissible Dementias
% 209.87/210.01 |- rdf__type mesh__D017096sskos__Concept
% 209.87/210.01 |- skos__altLabel mesh__D017096 Prion-Induced Disorder
% 209.87/210.01 |- mesh__dateEstablished mesh__D017096 1993-01-01
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Prion-Induced Disorders
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Prion Protein Disease
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Dementia, Transmissible
% 209.87/210.01 |- skos__altLabel mesh__D017096 Dementias, Transmissible
% 209.87/210.01 |- skos__altLabel mesh__D017096 Prion Protein Diseases
% 209.87/210.01 |- skos__historyNote mesh__D017096 Slow Virus Diseases %28%1966-1992%29%
% 209.87/210.01 |- mesh__recordAuthorizer mesh__D017096 ags
% 209.87/210.01 |- mesh__recordMaintainer mesh__D017096 ags
% 209.87/210.01 |- skos__annotation mesh__D017096 GEN or unspecified: prefer specifics
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Transmissible Dementia
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Prion Disease
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Disorders, Prion-Induced
% 209.87/210.01 |- skos__altLabel mesh__D017096
% 209.87/210.01 Inherited Human Transmissible Spongiform Encephalopathies
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D017096 2005
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D017096 2006A
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096
% 209.87/210.01 Encephalopathies, Transmissible Spongiform
% 209.87/210.01 |- skos__altLabel mesh__D017096 Encephalopathies, Spongiform, Transmissible
% 209.87/210.01 |- mesh__recordOriginator mesh__D017096 AGS
% 209.87/210.01 |- mesh__dateRevised mesh__D017096 2005-07-13
% 209.87/210.01 |- skos__broader mesh__D017096smesh__D019636
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Transmissible Spongiform Encephalopathy
% 209.87/210.01 |- skos__hiddenLabel mesh__D017096 Prion Induced Disorder
% 209.87/210.01 |- skos__altLabel mesh__D017096 Spongiform Encephalopathies, Transmissible
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D017096 2006
% 209.87/210.01 |- skos__hiddenLabel mesh__D003874 Disease, Duhring%27%s
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 1993
% 209.87/210.01 |- skos__scopeNote mesh__D003874
% 209.87/210.01 Rare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis.%A%
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 1998
% 209.87/210.01 |- skos__hiddenLabel mesh__D003874 Disease, Duhring
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 2000
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 1994
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 1999
% 209.87/210.01 |- skos__altLabel mesh__D003874 Duhring%27%s Disease
% 209.87/210.01 |- mesh__recordAuthorizer mesh__D003874 PLS
% 209.87/210.01 |- skos__broader mesh__D003874smesh__D003872
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 2003
% 209.87/210.01 |- skos__broader mesh__D003874smesh__D001327
% 209.87/210.01 |- rdf__type mesh__D003874sskos__Concept
% 209.87/210.01 |- mesh__dateCreated mesh__D003874 1999-01-01
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 2001
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 1995
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 2004
% 209.87/210.01 |- skos__broader mesh__D003874smesh__D012872
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 2002
% 209.87/210.01 |- mesh__dateRevised mesh__D003874 1992-05-20
% 209.87/210.01 |- mesh__recordOriginator mesh__D003874 NLM
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 2005
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 1996
% 209.87/210.01 |- skos__altLabel mesh__D003874 Duhring Disease
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 2006
% 209.87/210.01 |- skos__annotation mesh__D003874
% 209.87/210.01 a bullous skin dis: nothing to do with herpes
% 209.87/210.01 |- skos__prefLabel mesh__D003874 Dermatitis Herpetiformis
% 209.87/210.01 |- mesh__recordMaintainer mesh__D003874 PLS
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003874 1997
% 209.87/210.01 |- skos__hiddenLabel mesh__D003874 Duhrings Disease
% 209.87/210.01 |- skos__broader mesh__D003076smesh__D003075
% 209.87/210.01 |- skos__scopeNote mesh__D003076
% 209.87/210.01 A contraceptive method whereby coitus is purposely interrupted in order to prevent EJACULATION of SEMEN into the VAGINA.%A%
% 209.87/210.01 |- mesh__recordMaintainer mesh__D003076 lkt
% 209.87/210.01 |- mesh__recordOriginator mesh__D003076 NLM
% 209.87/210.01 |- mesh__activeMeSHYear mesh__D003076 2006
% 209.87/210.01 |- mesh__recordAuthorizer mesh__D003076 sjn
% 209.87/210.01 |- mesh__dateEstablished mesh__D003076 1975-09-01
% 209.87/210.01 |- skos__historyNote mesh__D003076 Contraception %28%1966-1974%29%
% 209.87/210.01 |- skos__hiddenLabel mesh__D003076 Interruptus, Coitus
% 209.87/210.01 |- skos__broader mesh__D003076smesh__D003267
% 209.87/210.01 |- mesh__publicMeSHNote mesh__D003076 75
% 209.87/210.01 |- mesh__dateCreated mesh__D003076 1974-11-19
% 209.87/210.01 |- skos__prefLabel mesh__D003076 Coitus Interruptus
% 209.87/210.01 |- mesh__dateRevised mesh__D003076 2005-06-30
% 209.87/210.01 |- rdf__type mesh__D003076sskos__Concept
% 209.87/210.01 |- mesh__historyNote mesh__D003076 75
% 209.87/210.01 |- skos__historyNote mesh__D003076 Coitus %28%1966-1974%29%
% 209.87/210.01 |- mesh__publicMeSHNote mesh__D011508
% 209.87/210.01 91; was see under PROTEOGLYCANS 1977-90; was see under MUCOPOLYSACCHARIDES 1976%A%
% 209.87/210.01 |- rdf__type mesh__D011508sskos__Concept
% 209.87/210.01 |- skos__historyNote mesh__D011508 Mucoproteins %28%1973-1974%29%
% 209.87/210.01 |- skos__hiddenLabel mesh__D011508 Sulfates, Proteochondroitin
% 209.87/210.01 |- skos__scopeNote mesh__D011508
% 209.87/210.01 Proteoglycans found in cartilage. They consist of several chondroitin sulfate molecules linked to protein%28%s%29% by neutral sugar linkage regions.%A%
% 209.87/210.01 |- mesh__dateCreated mesh__D011508 1975-07-25
% 209.87/210.01 |- mesh__recordMaintainer mesh__D011508 SYSTEM
% 209.87/210.01 |- mesh__recordOriginator mesh__D011508 RLS
% 209.87/210.01 |- mesh__recordAuthorizer mesh__D011508 sjn
% 209.87/210.01 |- mesh__dateRevised mesh__D011508 2005-06-30
% 209.87/210.01 |- skos__hiddenLabel mesh__D011508 Sulfate Proteoglycan, Chondroitin
% 209.87/210.01 |- skos__hiddenLabel mesh__D011508 Proteoglycan, Chondroitin Sulfate
% 209.87/210.01 |- mesh__historyNote mesh__D011508
% 209.87/210.01 91%28%76%29%; was see under PROTEOGLYCANS 1977-90; was see under MUCOPOLYSACCHARIDES 1976%A%
% 209.87/210.02 |- skos__hiddenLabel mesh__D011508 Sulfate, Proteochondroitin
% 209.87/210.02 |- skos__broader mesh__D011508smesh__D011509
% 209.87/210.02 |- skos__historyNote mesh__D011508 Chondroitin %28%1973-1974%29%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D011508 2006
% 209.87/210.02 |- skos__prefLabel mesh__D011508 Proteochondroitin Sulfates
% 209.87/210.02 |- mesh__dateEstablished mesh__D011508 1991-01-01
% 209.87/210.02 |- mesh__recordMaintainer mesh__D007467 SYSTEM
% 209.87/210.02 |- skos__historyNote mesh__D007467 Iodine %28%1966-1967%29%
% 209.87/210.02 |- skos__broader mesh__D007467smesh__D011506
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D007467 2006
% 209.87/210.02 |- skos__related mesh__D007467smesh__D012711
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D007467 72
% 209.87/210.02 |- skos__historyNote mesh__D007467 Proteins %28%1966-1967%29%
% 209.87/210.02 |- mesh__dateRevised mesh__D007467 2005-06-30
% 209.87/210.02 |- skos__prefLabel mesh__D007467 Iodoproteins
% 209.87/210.02 |- mesh__dateEstablished mesh__D007467 1972-01-01
% 209.87/210.02 |- mesh__recordOriginator mesh__D007467 NLM
% 209.87/210.02 |- rdf__type mesh__D007467sskos__Concept
% 209.87/210.02 |- mesh__dateCreated mesh__D007467 1999-01-01
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D007467 sjn
% 209.87/210.02 |- mesh__historyNote mesh__D007467 72%28%68%29%
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Nuclear Inclusion
% 209.87/210.02 |- rdf__type mesh__D045586sskos__Concept
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Intranuclear Inclusion Body
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Inclusions, Intranuclear
% 209.87/210.02 |- mesh__historyNote mesh__D045586 2004
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Nuclear Inclusion Body
% 209.87/210.02 |- skos__historyNote mesh__D045586
% 209.87/210.02 Inclusion Bodies or specifics %28%1965-2003%29%
% 209.87/210.02 |- skos__broader mesh__D045586smesh__D002479
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Intranuclear Inclusion
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D045586 2004
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Inclusion, Nuclear
% 209.87/210.02 |- skos__prefLabel mesh__D045586 Intranuclear Inclusion Bodies
% 209.87/210.02 |- skos__related mesh__D045586smesh__D007181
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D045586 2004
% 209.87/210.02 |- mesh__dateEstablished mesh__D045586 2004-01-01
% 209.87/210.02 |- skos__altLabel mesh__D045586 Nuclear Inclusions
% 209.87/210.02 |- skos__altLabel mesh__D045586 Inclusion Bodies, Intranuclear
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Inclusion Bodies, Nuclear
% 209.87/210.02 |- skos__altLabel mesh__D045586 Intranuclear Inclusions
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D045586 2005
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Inclusion Body, Intranuclear
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Inclusion, Intranuclear
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Inclusions, Nuclear
% 209.87/210.02 |- skos__altLabel mesh__D045586 Nuclear Inclusion Bodies
% 209.87/210.02 |- mesh__dateCreated mesh__D045586 2003-07-09
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D045586 2006
% 209.87/210.02 |- skos__hiddenLabel mesh__D045586 Inclusion Body, Nuclear
% 209.87/210.02 |- skos__scopeNote mesh__D045586
% 209.87/210.02 Circumscribed masses of foreign or metabolically inactive materials, within the CELL NUCLEUS. Some are VIRAL INCLUSION BODIES.%A%
% 209.87/210.02 |- skos__altLabel mesh__D012601 Roche Brand of Scopolamine Hydrobromide
% 209.87/210.02 |- skos__altLabel mesh__D012601
% 209.87/210.02 Novartis Consumer Health Brand of Scopolamine
% 209.87/210.02 |- skos__broader mesh__D012601smesh__D014326
% 209.87/210.02 |- skos__broader mesh__D012601smesh__D001533
% 209.87/210.02 |- skos__hiddenLabel mesh__D012601 Hydrobromide, Scopolamine
% 209.87/210.02 |- skos__scopeNote mesh__D012601
% 209.87/210.02 An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic.%A%
% 209.87/210.02 |- skos__altLabel mesh__D012601 Hamilton Brand of Scopolamine Hydrobromide
% 209.87/210.02 |- skos__altLabel mesh__D012601 Hyoscine
% 209.87/210.02 |- mesh__recordMaintainer mesh__D012601 wdj
% 209.87/210.02 |- skos__altLabel mesh__D012601 Renaudin Brand of Scopolamine Hydrobromide
% 209.87/210.02 |- mesh__dateCreated mesh__D012601 1999-01-01
% 209.87/210.02 |- skos__prefLabel mesh__D012601 Scopolamine
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D012601 2006
% 209.87/210.02 |- mesh__recordOriginator mesh__D012601 NLM
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D012601 2006B
% 209.87/210.02 |- skos__altLabel mesh__D012601 Alcon Brand of Scopolamine Hydrobromide
% 209.87/210.02 |- skos__hiddenLabel mesh__D012601 Transderm V
% 209.87/210.02 |- skos__altLabel mesh__D012601 Cooper Brand of Scopolamine Hydrobromide
% 209.87/210.02 |- skos__altLabel mesh__D012601 Transderm-V
% 209.87/210.02 |- skos__altLabel mesh__D012601 Hope Brand of Scopolamine
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D012601 wdj
% 209.87/210.02 |- rdf__type mesh__D012601sskos__Concept
% 209.87/210.02 |- skos__altLabel mesh__D012601 Inibisa Brand of Scopolamine Hydrobromide
% 209.87/210.02 |- mesh__dateRevised mesh__D012601 2005-07-22
% 209.87/210.02 |- skos__altLabel mesh__D012601 Scopoderm TTS
% 209.87/210.02 |- skos__altLabel mesh__D012601 Novartis Brand of Scopolamine
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D012601 2006A
% 209.87/210.02 |- skos__hiddenLabel mesh__D017895 Compounds, Manganese
% 209.87/210.02 |- skos__annotation mesh__D017895
% 209.87/210.02 inorganic; GEN or unspecified; prefer specifics; DF: MANGANESE CPDS%A%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017895 2005
% 209.87/210.02 |- mesh__dateEstablished mesh__D017895 1994-01-01
% 209.87/210.02 |- mesh__dateCreated mesh__D017895 1993-06-21
% 209.87/210.02 |- mesh__recordOriginator mesh__D017895 TPW
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D017895 94
% 209.87/210.02 |- mesh__dateRevised mesh__D017895 1999-11-03
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017895 2003
% 209.87/210.02 |- skos__scopeNote mesh__D017895
% 209.87/210.02 Inorganic chemicals that contain manganese as an integral part of the molecule.%A%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017895 2006
% 209.87/210.02 |- rdf__type mesh__D017895sskos__Concept
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017895 2000
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017895 2004
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D017895 sjn
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017895 2001
% 209.87/210.02 |- skos__historyNote mesh__D017895 Manganese %28%1966-1993%29%
% 209.87/210.02 |- skos__prefLabel mesh__D017895 Manganese Compounds
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017895 2002
% 209.87/210.02 |- mesh__historyNote mesh__D017895 94
% 209.87/210.02 |- skos__broader mesh__D017895smesh__D007287
% 209.87/210.02 |- mesh__recordMaintainer mesh__D017895 tpw
% 209.87/210.02 |- mesh__historyNote mesh__D031566 2003
% 209.87/210.02 |- skos__annotation mesh__D031566
% 209.87/210.02 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.87/210.02 |- skos__broader mesh__D031566smesh__D029562
% 209.87/210.02 |- skos__scopeNote mesh__D031566
% 209.87/210.02 A plant genus of the family MAGNOLIACEAE. The germacranolide sesquiterpene lactones costunolide, parthenolide, and costunolide diepoxide have been isolated from the leaves. Bark contains honokiol and magnolol. Parts are an ingredient of Banxia Houpo Tang.%A%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D031566 2005
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D031566 2003
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D031566 2003
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D031566 2006
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D031566 2004
% 209.87/210.02 |- mesh__dateEstablished mesh__D031566 2003-01-01
% 209.87/210.02 |- skos__altLabel mesh__D031566 Sweet Bay
% 209.87/210.02 |- skos__prefLabel mesh__D031566 Magnolia
% 209.87/210.02 |- rdf__type mesh__D031566sskos__Concept
% 209.87/210.02 |- mesh__dateCreated mesh__D031566 2002-07-02
% 209.87/210.02 |- skos__altLabel mesh__D031566 Bay, Sweet
% 209.87/210.02 |- skos__altLabel mesh__D050720 Retinoblastoma Like Protein p107
% 209.87/210.02 |- skos__altLabel mesh__D050720 p107 Tumor Suppressor Protein
% 209.87/210.02 |- mesh__dateEstablished mesh__D050720 2006-01-01
% 209.87/210.02 |- skos__broader mesh__D050720smesh__D010750
% 209.87/210.02 |- skos__altLabel mesh__D050720 Retinoblastoma-Like Protein 1
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D050720 sjn
% 209.87/210.02 |- skos__prefLabel mesh__D050720 Retinoblastoma-Like Protein p107
% 209.87/210.02 |- skos__broader mesh__D050720smesh__D009687
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D050720
% 209.87/210.02 2006; RETINOBLASTOMA-LIKE PROTEIN P107 was indexed under NUCLEAR PROTEINS 1995-2005 %26% under PROTEINS 1991-1994%A%
% 209.87/210.02 |- mesh__historyNote mesh__D050720 2006%28%1991%29%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D050720 2006
% 209.87/210.02 |- skos__hiddenLabel mesh__D050720 Retinoblastoma Like Protein 1
% 209.87/210.02 |- rdf__type mesh__D050720sskos__Concept
% 209.87/210.02 |- skos__hiddenLabel mesh__D050720 p107, Retinoblastoma-Like Protein
% 209.87/210.02 |- mesh__recordOriginator mesh__D050720 DRC
% 209.87/210.02 |- mesh__dateCreated mesh__D050720 2005-06-30
% 209.87/210.02 |- skos__broader mesh__D050720smesh__D025521
% 209.87/210.02 |- skos__scopeNote mesh__D050720
% 209.87/210.02 A negative regulator of the CELL CYCLE that undergoes PHOSPHORYLATION by CYCLIN-DEPENDENT KINASES. It contains a conserved pocket region that binds E2F4 TRANSCRIPTION FACTOR and interacts with viral ONCOPROTEINS such as POLYOMAVIRUS TUMOR ANTIGENS; ADENOVIRUS E1A PROTEINS; and PAPILLOMAVIRUS E7 PROTEINS.%A%
% 209.87/210.02 |- mesh__recordMaintainer mesh__D050720 DRC
% 209.87/210.02 |- skos__altLabel mesh__D050720 RBL1 Protein
% 209.87/210.02 |- skos__hiddenLabel mesh__D017097 Resistance, Electrical
% 209.87/210.02 |- skos__altLabel mesh__D017097 Biolectric Impedance
% 209.87/210.02 |- skos__hiddenLabel mesh__D017097 Resistances, Ohmic
% 209.87/210.02 |- skos__hiddenLabel mesh__D017097 Impedance, Bioelectrical
% 209.87/210.02 |- mesh__dateEstablished mesh__D017097 1993-01-01
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017097 2006
% 209.87/210.02 |- skos__broader mesh__D017097smesh__D004553
% 209.87/210.02 |- skos__altLabel mesh__D017097 Impedance
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017097 2002
% 209.87/210.02 |- skos__scopeNote mesh__D017097
% 209.87/210.02 The resistance to the flow of either alternating or direct electrical current.%A%
% 209.87/210.02 |- skos__historyNote mesh__D017097 Electrophysiology %28%1966-1967%29%
% 209.87/210.02 |- skos__historyNote mesh__D017097 Electric Conductivity %28%1968-1992%29%
% 209.87/210.02 |- skos__hiddenLabel mesh__D017097 Resistance, Electric
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017097 2005
% 209.87/210.02 |- mesh__dateCreated mesh__D017097 1992-05-08
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D017097 sjn
% 209.87/210.02 |- mesh__recordOriginator mesh__D017097 TGC
% 209.87/210.02 |- rdf__type mesh__D017097sskos__Concept
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D017097 93
% 209.87/210.02 |- skos__annotation mesh__D017097
% 209.87/210.02 NIM; bioelectric impedance anal of body composition: coord with BODY COMPOSITION%A%
% 209.87/210.02 |- skos__altLabel mesh__D017097 Electrical Impedance
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017097 2004
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017097 2001
% 209.87/210.02 |- skos__hiddenLabel mesh__D017097 Impedance, Biolectric
% 209.87/210.02 |- mesh__historyNote mesh__D017097 93
% 209.87/210.02 |- skos__hiddenLabel mesh__D017097 Resistance, Ohmic
% 209.87/210.02 |- skos__hiddenLabel mesh__D017097 Ohmic Resistances
% 209.87/210.02 |- skos__prefLabel mesh__D017097 Electric Impedance
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017097 2000
% 209.87/210.02 |- mesh__dateRevised mesh__D017097 1999-11-03
% 209.87/210.02 |- skos__hiddenLabel mesh__D017097 Impedance, Electrical
% 209.87/210.02 |- skos__altLabel mesh__D017097 Electrical Resistance
% 209.87/210.02 |- mesh__recordMaintainer mesh__D017097 KEV
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D017097 2003
% 209.87/210.02 |- skos__hiddenLabel mesh__D017097 Impedance, Electric
% 209.87/210.02 |- skos__hiddenLabel mesh__D003875 Eruptions, Drug
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 1994
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 1999
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D003875
% 209.87/210.02 93; was DERMATITIS MEDICAMENTOSA 1963-92; DRUG ERUPTIONS was see DERMATITIS MEDICAMENTOSA 1975-92, was see under DERMATITIS MEDICAMENTOSA 1971-74%A%
% 209.87/210.02 |- mesh__recordMaintainer mesh__D003875 PLS
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 2003
% 209.87/210.02 |- mesh__dateRevised mesh__D003875 1992-05-14
% 209.87/210.02 |- skos__broader mesh__D003875smesh__D003872
% 209.87/210.02 |- rdf__type mesh__D003875sskos__Concept
% 209.87/210.02 |- mesh__dateCreated mesh__D003875 1999-01-01
% 209.87/210.02 |- skos__hiddenLabel mesh__D003875 Eruption, Drug
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 1995
% 209.87/210.02 |- skos__annotation mesh__D003875
% 209.87/210.02 for any skin dis caused by ther agent whether prescribed by MD or not, or through any route of admin%A%
% 209.87/210.02 |- skos__broader mesh__D003875smesh__D004342
% 209.87/210.02 |- skos__scopeNote mesh__D003875
% 209.87/210.02 Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.%A%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 2004
% 209.87/210.02 |- skos__broader mesh__D003875smesh__D004362
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 2000
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 2005
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D003875 PLS
% 209.87/210.02 |- mesh__onlineNote mesh__D003875
% 209.87/210.02 use DRUG ERUPTIONS to search DERMATITIS MEDICAMENTOSA 1966-92%A%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 1996
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 2001
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 2006
% 209.87/210.02 |- skos__altLabel mesh__D003875 Dermatitis Medicamentosa
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 1997
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 2002
% 209.87/210.02 |- skos__altLabel mesh__D003875 Dermatitis, Adverse Drug Reaction
% 209.87/210.02 |- skos__prefLabel mesh__D003875 Drug Eruptions
% 209.87/210.02 |- skos__hiddenLabel mesh__D003875 Drug Eruption
% 209.87/210.02 |- mesh__recordOriginator mesh__D003875 NLM
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 1993
% 209.87/210.02 |- mesh__historyNote mesh__D003875
% 209.87/210.02 93; was DERMATITIS MEDICAMENTOSA 1963-92; DRUG ERUPTIONS was see DERMATITIS MEDICAMENTOSA 1975-92, was see under DERMATITIS MEDICAMENTOSA 1971-74%A%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003875 1998
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003077 2005
% 209.87/210.02 |- skos__annotation mesh__D003077 a coal residue used as fuel
% 209.87/210.02 |- mesh__historyNote mesh__D003077
% 209.87/210.02 91%28%75%29%; was see under COAL 1975-90; was in Cat J only 1975-81%A%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003077 2006
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003077 1998
% 209.87/210.02 |- skos__scopeNote mesh__D003077
% 209.87/210.02 A residue of coal, left after dry %28%destructive%29% distillation, used as a fuel.%A%
% 209.87/210.02 |- mesh__dateCreated mesh__D003077 1999-01-01
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003077 2002
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003077 2003
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003077 1999
% 209.87/210.02 |- mesh__recordMaintainer mesh__D003077 JLS
% 209.87/210.02 |- skos__prefLabel mesh__D003077 Coke
% 209.87/210.02 |- mesh__recordOriginator mesh__D003077 NLM
% 209.87/210.02 |- rdf__type mesh__D003077sskos__Concept
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003077 2004
% 209.87/210.02 |- mesh__dateRevised mesh__D003077 1997-06-20
% 209.87/210.02 |- skos__broader mesh__D003077smesh__D003031
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D003077
% 209.87/210.02 91; was see under COAL 1975-90; was in Cat J only 1975-81%A%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003077 2000
% 209.87/210.02 |- skos__hiddenLabel mesh__D003077 Cokes
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D003077 SJN
% 209.87/210.02 |- mesh__onlineNote mesh__D003077 search COAL 1968-74
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D003077 2001
% 209.87/210.02 |- mesh__dateEstablished mesh__D003077 1991-01-01
% 209.87/210.02 |- mesh__recordOriginator mesh__D011509 NLM
% 209.87/210.02 |- mesh__recordMaintainer mesh__D011509 SYSTEM
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D011509
% 209.87/210.02 77; was see under MUCOPOLYSACCHARIDES 1975-76; PROTEOCHONDROITIN SULFATES was see under MUCOPOLYSACCHARIDES 1976%A%
% 209.87/210.02 |- skos__altLabel mesh__D011509 Proteoglycan
% 209.87/210.02 |- mesh__dateEstablished mesh__D011509 1977-01-01
% 209.87/210.02 |- mesh__dateCreated mesh__D011509 1999-01-01
% 209.87/210.02 |- skos__annotation mesh__D011509 polysaccharides
% 209.87/210.02 |- mesh__onlineNote mesh__D011509 search MUCOPOLYSACCHARIDES 1973-74
% 209.87/210.02 |- skos__prefLabel mesh__D011509 Proteoglycans
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D011509 2006
% 209.87/210.02 |- skos__historyNote mesh__D011509 Mucopolysaccharides %28%1966-1974%29%
% 209.87/210.02 |- skos__broader mesh__D011509smesh__D006023
% 209.87/210.02 |- skos__scopeNote mesh__D011509
% 209.87/210.02 Glycoproteins which have a very high polysaccharide content.%A%
% 209.87/210.02 |- skos__broader mesh__D011509smesh__D011134
% 209.87/210.02 |- mesh__historyNote mesh__D011509
% 209.87/210.02 77%28%75%29%; was see under MUCOPOLYSACCHARIDES 1975-76
% 209.87/210.02 |- rdf__type mesh__D011509sskos__Concept
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D011509 sjn
% 209.87/210.02 |- mesh__dateRevised mesh__D011509 2005-06-30
% 209.87/210.02 |- mesh__historyNote mesh__D008560 79
% 209.87/210.02 |- skos__scopeNote mesh__D008560
% 209.87/210.02 The motion of phospholipid molecules within the lipid bilayer, dependent on the classes of phospholipids present, their fatty acid composition and degree of unsaturation of the acyl chains, the cholesterol concentration, and temperature.%A%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 2003
% 209.87/210.02 |- skos__hiddenLabel mesh__D008560 Fluidities, Bilayer
% 209.87/210.02 |- mesh__recordMaintainer mesh__D008560 TAP
% 209.87/210.02 |- skos__prefLabel mesh__D008560 Membrane Fluidity
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 1993
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 1998
% 209.87/210.02 |- mesh__recordOriginator mesh__D008560 VDK
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 2004
% 209.87/210.02 |- mesh__dateRevised mesh__D008560 1992-05-15
% 209.87/210.02 |- skos__historyNote mesh__D008560 Membranes %28%1966-1976%29%
% 209.87/210.02 |- skos__historyNote mesh__D008560 Cell Membrane %28%1966-1978%29%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 1994
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D008560 PLS
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D008560 79
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 1999
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 2000
% 209.87/210.02 |- skos__broader mesh__D008560smesh__D001669
% 209.87/210.02 |- skos__hiddenLabel mesh__D008560 Fluidity, Membrane
% 209.87/210.02 |- mesh__dateCreated mesh__D008560 1978-05-19
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 2005
% 209.87/210.02 |- skos__hiddenLabel mesh__D008560 Fluidities, Membrane
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 1995
% 209.87/210.02 |- skos__historyNote mesh__D008560 Phospholipids %28%1966-1976%29%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 2001
% 209.87/210.02 |- skos__historyNote mesh__D008560 Lipids %28%1966-1976%29%
% 209.87/210.02 |- skos__hiddenLabel mesh__D008560 Bilayer Fluidities
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 2006
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 1996
% 209.87/210.02 |- skos__altLabel mesh__D008560 Bilayer Fluidity
% 209.87/210.02 |- skos__hiddenLabel mesh__D008560 Membrane Fluidities
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 2002
% 209.87/210.02 |- skos__historyNote mesh__D008560 Membrane Lipids %28%1977-1978%29%
% 209.87/210.02 |- mesh__dateEstablished mesh__D008560 1979-01-01
% 209.87/210.02 |- skos__annotation mesh__D008560 IM; permitted with artif membranes
% 209.87/210.02 |- skos__hiddenLabel mesh__D008560 Fluidity, Bilayer
% 209.87/210.02 |- rdf__type mesh__D008560sskos__Concept
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D008560 1997
% 209.87/210.02 |- mesh__dateRevised mesh__D007468 2001-07-25
% 209.87/210.02 |- skos__altLabel mesh__D007468 Cardiotrast
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D007468 2004
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D007468 sjn
% 209.87/210.02 |- rdf__type mesh__D007468sskos__Concept
% 209.87/210.02 |- mesh__dateCreated mesh__D007468 1999-01-01
% 209.87/210.02 |- skos__altLabel mesh__D007468 Diodone
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D007468 2002
% 209.87/210.02 |- skos__altLabel mesh__D007468 Kardiotrast
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D007468 2005
% 209.87/210.02 |- skos__prefLabel mesh__D007468 Iodopyracet
% 209.87/210.02 |- skos__scopeNote mesh__D007468
% 209.87/210.02 An ionic monomeric contrast medium that was formerly used for a variety of diagnostic procedures. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p706%29%%A%
% 209.87/210.02 |- mesh__recordMaintainer mesh__D007468 ssb
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D007468 2006
% 209.87/210.02 |- skos__broader mesh__D007468smesh__D007469
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D007468 2003
% 209.87/210.02 |- mesh__recordOriginator mesh__D007468 NLM
% 209.87/210.02 |- skos__annotation mesh__D007468 D25-26 qualif
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 2005
% 209.87/210.02 |- skos__prefLabel mesh__D018190 Lymphatic Vessel Tumors
% 209.87/210.02 |- skos__broader mesh__D018190smesh__D009370
% 209.87/210.02 |- mesh__recordAuthorizer mesh__D018190 PLS
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 2001
% 209.87/210.02 |- skos__annotation mesh__D018190
% 209.87/210.02 neoplasms composed of lymphatic tissue, not located in lymphatic tissue: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord with precoord organ/neopl term; restricted use: Manual 24.2.2.5%A%
% 209.87/210.02 |- mesh__recordMaintainer mesh__D018190 KEV
% 209.87/210.02 |- skos__hiddenLabel mesh__D018190 Tumor, Lymphatic Vessel
% 209.87/210.02 |- skos__hiddenLabel mesh__D018190 Lymphatic Vessel Tumor
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 2000
% 209.87/210.02 |- skos__hiddenLabel mesh__D018190 Tumors, Lymphatic Vessel
% 209.87/210.02 |- mesh__publicMeSHNote mesh__D018190 94
% 209.87/210.02 |- mesh__historyNote mesh__D018190 94
% 209.87/210.02 |- mesh__dateEstablished mesh__D018190 1994-01-01
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 1997
% 209.87/210.02 |- mesh__recordOriginator mesh__D018190 PLS
% 209.87/210.02 |- mesh__dateRevised mesh__D018190 1995-06-08
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 1999
% 209.87/210.02 |- skos__scopeNote mesh__D018190
% 209.87/210.02 Neoplasms composed of lymphoid tissue, a lattice work of reticular tissue the interspaces of which contain lymphocytes. The concept does not refer to neoplasms located in lymphatic vessels.%A%
% 209.87/210.02 |- skos__historyNote mesh__D018190 Lymphoma %28%1970-1993%29%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 2004
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 1996
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 2006
% 209.87/210.02 |- mesh__dateCreated mesh__D018190 1993-06-24
% 209.87/210.02 |- skos__historyNote mesh__D018190 Lymphatic Metastasis %28%1980-1989%29%
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 1998
% 209.87/210.02 |- rdf__type mesh__D018190sskos__Concept
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 2003
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D018190 2002
% 209.87/210.02 |- rdf__type mesh__D004170sskos__Concept
% 209.87/210.02 |- mesh__recordOriginator mesh__D004170 NLM
% 209.87/210.02 |- mesh__activeMeSHYear mesh__D004170 2005
% 209.88/210.02 |- mesh__dateRevised mesh__D004170 2003-07-09
% 209.88/210.02 |- mesh__dateCreated mesh__D004170 1999-01-01
% 209.88/210.02 |- mesh__recordAuthorizer mesh__D004170 sjn
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D004170 2006
% 209.88/210.02 |- mesh__recordMaintainer mesh__D004170 ags
% 209.88/210.02 |- skos__broader mesh__D004170smesh__D002589
% 209.88/210.02 |- skos__scopeNote mesh__D004170
% 209.88/210.02 A genus of tapeworm containing several species which occurs in the intestine of fish, birds, and mammals including man. Infection in humans is usually by eating uncooked fish. The larval stage is known as SPARGANUM.%A%
% 209.88/210.02 |- skos__prefLabel mesh__D004170 Diphyllobothrium
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D004170 2004
% 209.88/210.02 |- skos__annotation mesh__D004170
% 209.88/210.02 infection = DIPHYLLOBOTHRIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 1997
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 2006
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 2001
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 1998
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 2004
% 209.88/210.02 |- mesh__recordAuthorizer mesh__D012602 PLS
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 1996
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 2005
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 2000
% 209.88/210.02 |- mesh__recordMaintainer mesh__D012602 TAP
% 209.88/210.02 |- rdf__type mesh__D012602sskos__Concept
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 2003
% 209.88/210.02 |- mesh__historyNote mesh__D012602
% 209.88/210.02 78%28%75%29%; was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74%A%
% 209.88/210.02 |- mesh__dateEstablished mesh__D012602 1978-01-01
% 209.88/210.02 |- mesh__dateRevised mesh__D012602 1992-05-20
% 209.88/210.02 |- mesh__onlineNote mesh__D012602
% 209.88/210.02 search SCOPOLAMINE 1966-74 %26% TROPANES 1969-74
% 209.88/210.02 |- skos__broader mesh__D012602smesh__D012601
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 2002
% 209.88/210.02 |- skos__historyNote mesh__D012602 Tropanes %28%1966-1974%29%
% 209.88/210.02 |- skos__scopeNote mesh__D012602
% 209.88/210.02 Analogs or derivatives of scopolamine.
% 209.88/210.02 |- skos__hiddenLabel mesh__D012602 Derivatives, Scopolamine
% 209.88/210.02 |- skos__historyNote mesh__D012602 Scopolamine %28%1966-1974%29%
% 209.88/210.02 |- skos__prefLabel mesh__D012602 Scopolamine Derivatives
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 1995
% 209.88/210.02 |- mesh__recordOriginator mesh__D012602 NLM
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 1993
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 1999
% 209.88/210.02 |- mesh__publicMeSHNote mesh__D012602
% 209.88/210.02 78; was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74; BUTYLSCOPOLAMMONIUM BROMIDE was see under SCOPOLAMINE 1976-77%A%
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D012602 1994
% 209.88/210.02 |- mesh__dateCreated mesh__D012602 1999-01-01
% 209.88/210.02 |- mesh__publicMeSHNote mesh__D031567 2003
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D031567 2003
% 209.88/210.02 |- skos__prefLabel mesh__D031567 Liriodendron
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D031567 2006
% 209.88/210.02 |- mesh__activeMeSHYear mesh__D031567 2004
% 209.88/210.02 |- skos__broader mesh__D031567smesh__D029562
% 209.88/210.02 |- skos__altLabel mesh__D031567 Yellow Poplar
% 209.88/210.02 |- mesh__historyNote mesh__D031567 2003
% 209.88/210.02 |- rdf__type mesh__D031567sskos__Concept
% 209.88/210.02 |- skos__altLabel mesh__D031567 Tulip Tree
% 209.88/210.03 |- skos__annotation mesh__D031567
% 209.88/210.03 X ref YELLOW POPLAR: POPLAR, TRUE see POPULUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.88/210.03 |- skos__altLabel mesh__D031567 Poplar, Yellow
% 209.88/210.03 |- skos__scopeNote mesh__D031567
% 209.88/210.03 A plant genus of the family MAGNOLIACEAE. Members include hardwood trees of eastern North America with distinct large tuliplike flowers.%A%
% 209.88/210.03 |- mesh__dateCreated mesh__D031567 2002-07-03
% 209.88/210.03 |- mesh__dateEstablished mesh__D031567 2003-01-01
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D031567 2005
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D050721 sjn
% 209.88/210.03 |- skos__hiddenLabel mesh__D050721 c-cbl, Proto-Oncogene Proteins
% 209.88/210.03 |- mesh__dateEstablished mesh__D050721 2006-01-01
% 209.88/210.03 |- mesh__historyNote mesh__D050721 2006%28%1991%29%
% 209.88/210.03 |- skos__prefLabel mesh__D050721 Proto-Oncogene Proteins c-cbl
% 209.88/210.03 |- skos__broader mesh__D050721smesh__D044767
% 209.88/210.03 |- mesh__recordMaintainer mesh__D050721 DRC
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D050721
% 209.88/210.03 2006; PROTO-ONCOGENE PROTEINS C-CBL was indexed under UBIQUITIN-PROTEIN LIGASES 2005, %26% under LIGASES %26% PROTO-ONCOGENE PROTEINS 1991-2005%A%
% 209.88/210.03 |- mesh__dateCreated mesh__D050721 2005-06-30
% 209.88/210.03 |- skos__scopeNote mesh__D050721
% 209.88/210.03 Proto-oncogene proteins that negatively regulate RECEPTOR PROTEIN-TYROSINE KINASE signaling. It is a UBIQUITIN-PROTEIN LIGASE and the cellular homologue of ONCOGENE PROTEIN V-CBL.%A%
% 209.88/210.03 |- skos__hiddenLabel mesh__D050721 c-cbl, Proto-Oncogene Protein
% 209.88/210.03 |- skos__hiddenLabel mesh__D050721 Proteins c-cbl, Proto-Oncogene
% 209.88/210.03 |- skos__altLabel mesh__D050721 Proto-Oncogene Protein c-cbl
% 209.88/210.03 |- skos__altLabel mesh__D050721 CBL E3 Ubiquitin Protein Ligase
% 209.88/210.03 |- skos__hiddenLabel mesh__D050721 Proto-Oncogene Protein, cbl
% 209.88/210.03 |- mesh__recordOriginator mesh__D050721 DRC
% 209.88/210.03 |- skos__altLabel mesh__D050721 cbl Proto-Oncogene Protein
% 209.88/210.03 |- skos__broader mesh__D050721smesh__D011518
% 209.88/210.03 |- skos__hiddenLabel mesh__D050721 Proto Oncogene Proteins c cbl
% 209.88/210.03 |- skos__hiddenLabel mesh__D050721 c cbl Proto Oncogene Protein
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D050721 2006
% 209.88/210.03 |- rdf__type mesh__D050721sskos__Concept
% 209.88/210.03 |- skos__hiddenLabel mesh__D050721 Proto-Oncogene Protein, c-cbl
% 209.88/210.03 |- skos__hiddenLabel mesh__D050721 Proto Oncogene Protein c cbl
% 209.88/210.03 |- skos__altLabel mesh__D050721 c-cbl Proto-Oncogene Protein
% 209.88/210.03 |- skos__hiddenLabel mesh__D050721 cbl Proto Oncogene Protein
% 209.88/210.03 |- skos__altLabel mesh__D050721 c-cbl Protein
% 209.88/210.03 |- skos__annotation mesh__D017098 DF: IGA DEFIC
% 209.88/210.03 |- skos__hiddenLabel mesh__D017098 IgA Deficiencies
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017098 2005
% 209.88/210.03 |- mesh__dateCreated mesh__D017098 1992-05-20
% 209.88/210.03 |- skos__prefLabel mesh__D017098 IgA Deficiency
% 209.88/210.03 |- skos__historyNote mesh__D017098 IgA/deficiency %28%1971-1992%29%
% 209.88/210.03 |- skos__broader mesh__D017098smesh__D004406
% 209.88/210.03 |- skos__scopeNote mesh__D017098
% 209.88/210.03 A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN A.%A%
% 209.88/210.03 |- mesh__dateRevised mesh__D017098 2001-08-03
% 209.88/210.03 |- rdf__type mesh__D017098sskos__Concept
% 209.88/210.03 |- mesh__dateEstablished mesh__D017098 1993-01-01
% 209.88/210.03 |- skos__historyNote mesh__D017098 Dysgammaglobulinemia %28%1975-1992%29%
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017098 2002
% 209.88/210.03 |- skos__hiddenLabel mesh__D017098 Deficiencies, IgA
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017098 2004
% 209.88/210.03 |- mesh__historyNote mesh__D017098 93
% 209.88/210.03 |- skos__altLabel mesh__D017098 Deficiency, IgA
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D017098 sjn
% 209.88/210.03 |- mesh__recordOriginator mesh__D017098 TGC
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017098 2003
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D017098 93
% 209.88/210.03 |- mesh__recordMaintainer mesh__D017098 sjn
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017098 2006
% 209.88/210.03 |- skos__altLabel mesh__D003876 Neurodermatitis, Atopic
% 209.88/210.03 |- skos__broader mesh__D003876smesh__D006969
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Atopic Neurodermatitis
% 209.88/210.03 |- mesh__dateCreated mesh__D003876 1999-01-01
% 209.88/210.03 |- rdf__type mesh__D003876sskos__Concept
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Neurodermatitides, Atopic
% 209.88/210.03 |- mesh__dateRevised mesh__D003876 2001-07-25
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Atopic Dermatitis
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Dermatitides, Atopic
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003876 2003
% 209.88/210.03 |- skos__broader mesh__D003876smesh__D012873
% 209.88/210.03 |- skos__altLabel mesh__D003876 Neurodermatitis, Disseminated
% 209.88/210.03 |- skos__broader mesh__D003876smesh__D017443
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D003876 sjn
% 209.88/210.03 |- skos__broader mesh__D003876smesh__D003872
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003876 2004
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Atopic Neurodermatitides
% 209.88/210.03 |- skos__annotation mesh__D003876 a type of immediate hypersensitivity
% 209.88/210.03 |- skos__altLabel mesh__D003876 Eczema, Atopic
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003876 2005
% 209.88/210.03 |- skos__prefLabel mesh__D003876 Dermatitis, Atopic
% 209.88/210.03 |- skos__scopeNote mesh__D003876
% 209.88/210.03 A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin %28%IgE%29%, with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.%A%
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Neurodermatitides, Disseminated
% 209.88/210.03 |- mesh__recordOriginator mesh__D003876 NLM
% 209.88/210.03 |- mesh__recordMaintainer mesh__D003876 nns
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003876 2002
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Disseminated Neurodermatitides
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003876 2006
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Atopic Eczema
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Atopic Dermatitides
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Infantile Eczema
% 209.88/210.03 |- skos__hiddenLabel mesh__D003876 Disseminated Neurodermatitis
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D003078 sjn
% 209.88/210.03 |- skos__scopeNote mesh__D003078
% 209.88/210.03 A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever %28%PERIODIC DISEASE%29%.%A%
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003078 2002
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003078 2006
% 209.88/210.03 |- mesh__dateRevised mesh__D003078 2001-07-25
% 209.88/210.03 |- mesh__recordMaintainer mesh__D003078 CCR
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003078 2005
% 209.88/210.03 |- mesh__dateCreated mesh__D003078 1999-01-01
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003078 2004
% 209.88/210.03 |- skos__broader mesh__D003078smesh__D000470
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003078 2003
% 209.88/210.03 |- rdf__type mesh__D003078sskos__Concept
% 209.88/210.03 |- mesh__recordOriginator mesh__D003078 NLM
% 209.88/210.03 |- skos__prefLabel mesh__D003078 Colchicine
% 209.88/210.03 |- skos__related mesh__D008561smesh__D023581
% 209.88/210.03 |- skos__hiddenLabel mesh__D008561 Membrane Fusions
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D008561 2005
% 209.88/210.03 |- skos__scopeNote mesh__D008561
% 209.88/210.03 The adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes.%A%
% 209.88/210.03 |- skos__prefLabel mesh__D008561 Membrane Fusion
% 209.88/210.03 |- mesh__historyNote mesh__D008561 82
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D008561 2002
% 209.88/210.03 |- skos__hiddenLabel mesh__D008561 Fusion, Membrane
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D008561 2006
% 209.88/210.03 |- skos__historyNote mesh__D008561 Cell Fusion %28%1971-1981%29%
% 209.88/210.03 |- mesh__dateEstablished mesh__D008561 1982-01-01
% 209.88/210.03 |- rdf__type mesh__D008561sskos__Concept
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D008561 82
% 209.88/210.03 |- mesh__recordMaintainer mesh__D008561 nns
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D008561 sjn
% 209.88/210.03 |- skos__hiddenLabel mesh__D008561 Fusions, Membrane
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D008561 2003
% 209.88/210.03 |- skos__historyNote mesh__D008561 Cell Membrane %28%1966-1981%29%
% 209.88/210.03 |- skos__broader mesh__D008561smesh__D002468
% 209.88/210.03 |- mesh__dateCreated mesh__D008561 1981-05-20
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D008561 2004
% 209.88/210.03 |- mesh__recordOriginator mesh__D008561 AEP
% 209.88/210.03 |- mesh__dateRevised mesh__D008561 2001-07-25
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 2000
% 209.88/210.03 |- rdf__type mesh__D007469sskos__Concept
% 209.88/210.03 |- mesh__dateCreated mesh__D007469 1999-01-01
% 209.88/210.03 |- skos__annotation mesh__D007469 contrast media; D25-26 qualif
% 209.88/210.03 |- mesh__dateRevised mesh__D007469 1995-06-08
% 209.88/210.03 |- mesh__recordMaintainer mesh__D007469 JRT
% 209.88/210.03 |- skos__broader mesh__D007469smesh__D011728
% 209.88/210.03 |- skos__scopeNote mesh__D007469
% 209.88/210.03 Iodinated pyridine derivatives that are often used as contrast media.%A%
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 1998
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 2001
% 209.88/210.03 |- mesh__recordOriginator mesh__D007469 NLM
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 2005
% 209.88/210.03 |- skos__historyNote mesh__D007469 Contrast Media %28%1966-1967%29%
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 1999
% 209.88/210.03 |- mesh__dateEstablished mesh__D007469 1968-01-01
% 209.88/210.03 |- mesh__historyNote mesh__D007469 68
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 2006
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 2002
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 1996
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 2003
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D007469
% 209.88/210.03 68; PROPYLIODONE was see under CONTRAST MEDIA 1963-74
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D007469 PLS
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 1997
% 209.88/210.03 |- skos__prefLabel mesh__D007469 Iodopyridones
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D007469 2004
% 209.88/210.03 |- mesh__dateCreated mesh__D018191 1993-06-24
% 209.88/210.03 |- skos__hiddenLabel mesh__D018191 Cystic Lymphangiomas
% 209.88/210.03 |- skos__annotation mesh__D018191
% 209.88/210.03 coord IM with precoord organ/neopl term %28%IM%29%
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D018191 sjn
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D018191 2002
% 209.88/210.03 |- skos__broader mesh__D018191smesh__D008202
% 209.88/210.03 |- skos__hiddenLabel mesh__D018191 Cystic Hygromas
% 209.88/210.03 |- mesh__historyNote mesh__D018191 94
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D018191 2001
% 209.88/210.03 |- mesh__recordOriginator mesh__D018191 PLS
% 209.88/210.03 |- skos__hiddenLabel mesh__D018191 Lymphangiomas, Cystic
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D018191 2004
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D018191 2000
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D018191 2006
% 209.88/210.03 |- skos__hiddenLabel mesh__D018191 Hygromas
% 209.88/210.03 |- rdf__type mesh__D018191sskos__Concept
% 209.88/210.03 |- skos__hiddenLabel mesh__D018191 Hygromas, Cystic
% 209.88/210.03 |- skos__hiddenLabel mesh__D018191 Cystic Lymphangioma
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D018191 94
% 209.88/210.03 |- skos__altLabel mesh__D018191 Hygroma, Cystic
% 209.88/210.03 |- skos__prefLabel mesh__D018191 Lymphangioma, Cystic
% 209.88/210.03 |- mesh__dateRevised mesh__D018191 1999-11-03
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D018191 2003
% 209.88/210.03 |- mesh__dateEstablished mesh__D018191 1994-01-01
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D018191 2005
% 209.88/210.03 |- skos__historyNote mesh__D018191 Lymphangioma %28%1966-1993%29%
% 209.88/210.03 |- skos__scopeNote mesh__D018191
% 209.88/210.03 A cystic growth originating from lymphatic tissue. It is usually found in the neck, axilla, or groin.%A%
% 209.88/210.03 |- skos__altLabel mesh__D018191 Hygroma
% 209.88/210.03 |- mesh__recordMaintainer mesh__D018191 KEV
% 209.88/210.03 |- skos__hiddenLabel mesh__D018191 Cystic Hygroma
% 209.88/210.03 |- skos__hiddenLabel mesh__D004171 Diploids
% 209.88/210.03 |- mesh__dateCreated mesh__D004171 1999-01-01
% 209.88/210.03 |- skos__hiddenLabel mesh__D004171 Cells, Diploid
% 209.88/210.03 |- mesh__dateEstablished mesh__D004171 1968-01-01
% 209.88/210.03 |- skos__annotation mesh__D004171 no qualif
% 209.88/210.03 |- rdf__type mesh__D004171sskos__Concept
% 209.88/210.03 |- skos__hiddenLabel mesh__D004171 Cell, Diploid
% 209.88/210.03 |- mesh__recordOriginator mesh__D004171 NLM
% 209.88/210.03 |- mesh__historyNote mesh__D004171 68
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D004171 2006
% 209.88/210.03 |- mesh__dateRevised mesh__D004171 2003-07-09
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D004171 sjn
% 209.88/210.03 |- skos__broader mesh__D004171smesh__D011003
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D004171 2005
% 209.88/210.03 |- skos__altLabel mesh__D004171 Diploid
% 209.88/210.03 |- skos__historyNote mesh__D004171 Chromosomes %28%1966-1967%29%
% 209.88/210.03 |- mesh__recordMaintainer mesh__D004171 nns
% 209.88/210.03 |- skos__hiddenLabel mesh__D004171 Diploidies
% 209.88/210.03 |- skos__scopeNote mesh__D004171
% 209.88/210.03 The chromosomal constitution of cells, in which each type of CHROMOSOME is represented twice. Symbol: 2N or 2X.%A%
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D004171 2004
% 209.88/210.03 |- skos__hiddenLabel mesh__D004171 Diploid Cells
% 209.88/210.03 |- skos__prefLabel mesh__D004171 Diploidy
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D004171 68
% 209.88/210.03 |- skos__scopeNote mesh__D012603
% 209.88/210.03 Plant growth factor derived from the root of Scopolia carniolica or Scopolia japonica.%A%
% 209.88/210.03 |- rdf__type mesh__D012603sskos__Concept
% 209.88/210.03 |- mesh__recordOriginator mesh__D012603 NLM
% 209.88/210.03 |- mesh__dateEstablished mesh__D012603 1991-01-01
% 209.88/210.03 |- skos__broader mesh__D012603smesh__D014468
% 209.88/210.03 |- mesh__dateRevised mesh__D012603 2005-06-30
% 209.88/210.03 |- skos__hiddenLabel mesh__D012603 Acid, Chrysotropic
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D012603
% 209.88/210.03 91; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76%A%
% 209.88/210.03 |- mesh__dateCreated mesh__D012603 1974-11-19
% 209.88/210.03 |- skos__prefLabel mesh__D012603 Scopoletin
% 209.88/210.03 |- skos__altLabel mesh__D012603 Gelseminic Acid
% 209.88/210.03 |- skos__altLabel mesh__D012603 Methylesculetin
% 209.88/210.03 |- skos__hiddenLabel mesh__D012603 Acid, Gelseminic
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D012603 2006
% 209.88/210.03 |- skos__altLabel mesh__D012603 Chrysotropic Acid
% 209.88/210.03 |- skos__historyNote mesh__D012603 Bioflavonoids %28%1972-1974%29%
% 209.88/210.03 |- mesh__historyNote mesh__D012603
% 209.88/210.03 91%28%75%29%; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76%A%
% 209.88/210.03 |- mesh__recordMaintainer mesh__D012603 ssb
% 209.88/210.03 |- skos__historyNote mesh__D012603 Coumarins %28%1969-1974%29%
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D012603 sjn
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D050722
% 209.88/210.03 2006; ONCOGENE PROTEIN V-CBL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2005, %26% under RETROVIRIDAE PROTEINS 1989%A%
% 209.88/210.03 |- skos__altLabel mesh__D050722 v-cbl Protein
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D050722 2006A
% 209.88/210.03 |- mesh__historyNote mesh__D050722 2006%28%1989%29%
% 209.88/210.03 |- mesh__recordOriginator mesh__D050722 DRC
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 70Z Cbl Protein
% 209.88/210.03 |- skos__scopeNote mesh__D050722
% 209.88/210.03 An oncoprotein from the Cas NS-1 murine retrovirus that induces pre- B-CELL LYMPHOMA and MYELOID LEUKEMIAS. v-cbl protein is a tyrosine-phosphorylated, truncated form of its cellular homologue, PROTO-ONCOGENE PROTEIN C-CBL.%A%
% 209.88/210.03 |- skos__altLabel mesh__D050722 cbl Oncogene Protein
% 209.88/210.03 |- skos__altLabel mesh__D050722 Casitas B-Lineage Lymphoma Protein
% 209.88/210.03 |- mesh__dateEstablished mesh__D050722 2006-01-01
% 209.88/210.03 |- skos__altLabel mesh__D050722 Oncogene Protein 70Z-Cbl
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 cbl, Oncogene Protein
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 Oncogene Protein, cbl
% 209.88/210.03 |- mesh__dateCreated mesh__D050722 2005-06-30
% 209.88/210.03 |- skos__altLabel mesh__D050722 v-cbl Oncogene Protein
% 209.88/210.03 |- mesh__recordMaintainer mesh__D050722 ags
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 v-cbl, Oncogene Protein
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D050722 2006
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 Oncogene Protein, v-cbl
% 209.88/210.03 |- skos__prefLabel mesh__D050722 Oncogene Protein v-cbl
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 v cbl Oncogene Protein
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 Oncogene Protein 70Z Cbl
% 209.88/210.03 |- mesh__dateRevised mesh__D050722 2005-07-12
% 209.88/210.03 |- skos__broader mesh__D050722smesh__D015682
% 209.88/210.03 |- rdf__type mesh__D050722sskos__Concept
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 Oncogene Protein v cbl
% 209.88/210.03 |- skos__altLabel mesh__D050722 Oncogene Protein cbl
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D050722 ags
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 70Z-Cbl, Oncogene Protein
% 209.88/210.03 |- skos__hiddenLabel mesh__D050722 Casitas B Lineage Lymphoma Protein
% 209.88/210.03 |- mesh__recordMaintainer mesh__D017099 sjn
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D017099 sjn
% 209.88/210.03 |- skos__annotation mesh__D017099 DF: IGG DEFIC
% 209.88/210.03 |- mesh__recordOriginator mesh__D017099 TGC
% 209.88/210.03 |- skos__prefLabel mesh__D017099 IgG Deficiency
% 209.88/210.03 |- skos__scopeNote mesh__D017099
% 209.88/210.03 A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN G.%A%
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017099 2004
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D017099 93
% 209.88/210.03 |- mesh__historyNote mesh__D017099 93
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017099 2003
% 209.88/210.03 |- skos__hiddenLabel mesh__D017099 IgG Deficiencies
% 209.88/210.03 |- mesh__dateRevised mesh__D017099 2001-08-07
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017099 2006
% 209.88/210.03 |- mesh__dateEstablished mesh__D017099 1993-01-01
% 209.88/210.03 |- mesh__dateCreated mesh__D017099 1992-05-20
% 209.88/210.03 |- skos__altLabel mesh__D017099 Deficiency, IgG
% 209.88/210.03 |- skos__broader mesh__D017099smesh__D004406
% 209.88/210.03 |- skos__historyNote mesh__D017099 IgG/deficiency %28%1973-1992%29%
% 209.88/210.03 |- skos__hiddenLabel mesh__D017099 Deficiencies, IgG
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017099 2005
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D017099 2002
% 209.88/210.03 |- skos__historyNote mesh__D017099 IgG %28%1971-1972%29%
% 209.88/210.03 |- rdf__type mesh__D017099sskos__Concept
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 2004
% 209.88/210.03 |- skos__hiddenLabel mesh__D003877 Contact Eczema
% 209.88/210.03 |- skos__hiddenLabel mesh__D003877 Hypersensitivities, Contact
% 209.88/210.03 |- mesh__recordOriginator mesh__D003877 NLM
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 2002
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 2005
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 1997
% 209.88/210.03 |- skos__hiddenLabel mesh__D003877 Contact Dermatitides
% 209.88/210.03 |- skos__altLabel mesh__D003877 Eczema, Contact
% 209.88/210.03 |- skos__hiddenLabel mesh__D003877 Dermatitides, Contact
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 2006
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 1998
% 209.88/210.03 |- skos__hiddenLabel mesh__D003877 Contact Hypersensitivity
% 209.88/210.03 |- skos__altLabel mesh__D003877 Dermatitis Venenata
% 209.88/210.03 |- skos__scopeNote mesh__D003877
% 209.88/210.03 A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.%A%
% 209.88/210.03 |- skos__hiddenLabel mesh__D003877 Contact Hypersensitivities
% 209.88/210.03 |- skos__altLabel mesh__D003877 Contact Dermatitis
% 209.88/210.03 |- rdf__type mesh__D003877sskos__Concept
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 1999
% 209.88/210.03 |- mesh__dateCreated mesh__D003877 1999-01-01
% 209.88/210.03 |- mesh__dateRevised mesh__D003877 1996-06-10
% 209.88/210.03 |- skos__prefLabel mesh__D003877 Dermatitis, Contact
% 209.88/210.03 |- skos__annotation mesh__D003877
% 209.88/210.03 unspecified as allergic or non-allergic but DERMATITIS, ALLERGIC CONTACT is available%A%
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 2000
% 209.88/210.03 |- skos__hiddenLabel mesh__D003877 Contact Sensitivities
% 209.88/210.03 |- skos__altLabel mesh__D003877 Sensitivity, Contact
% 209.88/210.03 |- skos__hiddenLabel mesh__D003877 Contact Sensitivity
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 2003
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D003877 PLS
% 209.88/210.03 |- skos__broader mesh__D003877smesh__D017443
% 209.88/210.03 |- skos__related mesh__D003877smesh__D009783
% 209.88/210.03 |- mesh__recordMaintainer mesh__D003877 TGC
% 209.88/210.03 |- skos__hiddenLabel mesh__D003877 Sensitivities, Contact
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003877 2001
% 209.88/210.03 |- skos__broader mesh__D003877smesh__D003872
% 209.88/210.03 |- skos__annotation mesh__D003079
% 209.88/210.03 COLCHICINE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.88/210.03 |- mesh__historyNote mesh__D003079
% 209.88/210.03 91%28%86%29%63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%
% 209.88/210.03 |- mesh__recordOriginator mesh__D003079 NLM
% 209.88/210.03 |- skos__altLabel mesh__D003079 Crocus, Autumn
% 209.88/210.03 |- mesh__dateEstablished mesh__D003079 1991-01-01
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003079 2006
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D003079 sjn
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003079 2002
% 209.88/210.03 |- skos__altLabel mesh__D003079 Meadow Saffron
% 209.88/210.03 |- skos__broader mesh__D003079smesh__D019668
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003079 2005
% 209.88/210.03 |- mesh__dateCreated mesh__D003079 1999-01-01
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003079 2004
% 209.88/210.03 |- skos__prefLabel mesh__D003079 Colchicum
% 209.88/210.03 |- skos__altLabel mesh__D003079 Autumn Crocus
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D003079 2003
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D003079
% 209.88/210.03 91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%
% 209.88/210.03 |- rdf__type mesh__D003079sskos__Concept
% 209.88/210.03 |- skos__scopeNote mesh__D003079
% 209.88/210.03 A genus of poisonous, liliaceous plants. The roots %28%corms%29% of Colchicum autumnale, the fall crocus or meadow saffron, yield COLCHICINE, which is used as a biochemical tool and to treat gout. Other members of this genus yield saffron dye, flavoring agents, and aromatics.%A%
% 209.88/210.03 |- skos__related mesh__D003079smesh__D003078
% 209.88/210.03 |- skos__altLabel mesh__D003079 Fall Crocus
% 209.88/210.03 |- mesh__dateRevised mesh__D003079 2001-07-25
% 209.88/210.03 |- mesh__recordMaintainer mesh__D003079 ssb
% 209.88/210.03 |- skos__hiddenLabel mesh__D008562 Glycoproteins, Surface
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D008562 2006
% 209.88/210.03 |- mesh__dateCreated mesh__D008562 1987-05-05
% 209.88/210.03 |- mesh__dateRevised mesh__D008562 2005-06-30
% 209.88/210.03 |- skos__altLabel mesh__D008562 Surface Glycoproteins
% 209.88/210.03 |- skos__hiddenLabel mesh__D008562 Glycoprotein, Membrane
% 209.88/210.03 |- skos__historyNote mesh__D008562 Membrane Proteins %28%1977-1987%29%
% 209.88/210.03 |- skos__hiddenLabel mesh__D008562 Glycoproteins, Membrane
% 209.88/210.03 |- rdf__type mesh__D008562sskos__Concept
% 209.88/210.03 |- skos__hiddenLabel mesh__D008562 Surface Glycoproteins, Cell
% 209.88/210.03 |- skos__hiddenLabel mesh__D008562 Glycoprotein, Cell Surface
% 209.88/210.03 |- skos__hiddenLabel mesh__D008562 Surface Glycoprotein, Cell
% 209.88/210.03 |- skos__prefLabel mesh__D008562 Membrane Glycoproteins
% 209.88/210.03 |- skos__scopeNote mesh__D008562
% 209.88/210.03 Glycoproteins found on the membrane or surface of cells.%A%
% 209.88/210.03 |- mesh__historyNote mesh__D008562 88
% 209.88/210.03 |- mesh__dateEstablished mesh__D008562 1988-01-01
% 209.88/210.03 |- mesh__recordMaintainer mesh__D008562 SYSTEM
% 209.88/210.03 |- skos__altLabel mesh__D008562 Membrane Glycoprotein
% 209.88/210.03 |- mesh__recordOriginator mesh__D008562 RR
% 209.88/210.03 |- skos__altLabel mesh__D008562 Cell Surface Glycoprotein
% 209.88/210.03 |- skos__historyNote mesh__D008562 Glycoproteins %28%1966-1987%29%
% 209.88/210.03 |- skos__altLabel mesh__D008562 Cell Surface Glycoproteins
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D008562 sjn
% 209.88/210.03 |- skos__broader mesh__D008562smesh__D006023
% 209.88/210.03 |- skos__hiddenLabel mesh__D008562 Glycoproteins, Cell Surface
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D008562 88
% 209.88/210.03 |- skos__altLabel mesh__D008562 Surface Glycoprotein
% 209.88/210.03 |- skos__broader mesh__D008562smesh__D008565
% 209.88/210.03 |- skos__hiddenLabel mesh__D008562 Glycoprotein, Surface
% 209.88/210.03 |- mesh__recordMaintainer mesh__D032661 SYSTEM
% 209.88/210.03 |- mesh__dateRevised mesh__D032661 2005-06-30
% 209.88/210.03 |- skos__scopeNote mesh__D032661
% 209.88/210.03 A genus of ascomycetous fungi %28%ASCOMYCOTA%29%, family Clavicipitaceae, order HYPOCREALES, that grows by infecting insect larvae or mature insects with spores that germinate often before the cocoon is formed.%A%
% 209.88/210.03 |- mesh__dateEstablished mesh__D032661 2003-01-01
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D032661 sjn
% 209.88/210.03 |- skos__historyNote mesh__D032661 Ascomycota %28%1968-2002%29%
% 209.88/210.03 |- skos__prefLabel mesh__D032661 Cordyceps
% 209.88/210.03 |- rdf__type mesh__D032661sskos__Concept
% 209.88/210.03 |- mesh__historyNote mesh__D032661 2003
% 209.88/210.03 |- mesh__dateCreated mesh__D032661 2002-07-03
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D032661 2003
% 209.88/210.03 |- skos__broader mesh__D032661smesh__D006999
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D032661 2006
% 209.88/210.03 |- mesh__recordOriginator mesh__D032661 ags
% 209.88/210.03 |- mesh__publicMeSHNote mesh__D018192
% 209.88/210.03 2006; see LYMPHANGIOMYOMATOSIS 1994-2005
% 209.88/210.03 |- skos__broader mesh__D018192smesh__D008203
% 209.88/210.03 |- mesh__activeMeSHYear mesh__D018192 2006
% 209.88/210.03 |- mesh__dateRevised mesh__D018192 2005-06-30
% 209.88/210.03 |- skos__hiddenLabel mesh__D018192 Lymphangiomyomatoses
% 209.88/210.03 |- rdf__type mesh__D018192sskos__Concept
% 209.88/210.03 |- mesh__historyNote mesh__D018192 2006 %28%1994%29%
% 209.88/210.03 |- skos__scopeNote mesh__D018192
% 209.88/210.03 A disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath %28%DYSPNEA%29%.%A%
% 209.88/210.03 |- mesh__dateCreated mesh__D018192 1993-06-24
% 209.88/210.03 |- skos__altLabel mesh__D018192 Lymphangiomyomatosis
% 209.88/210.03 |- mesh__recordAuthorizer mesh__D018192 sjn
% 209.88/210.04 |- skos__prefLabel mesh__D018192 Lymphangioleiomyomatosis
% 209.88/210.04 |- skos__hiddenLabel mesh__D018192 Lymphangioleiomyomatoses
% 209.88/210.04 |- skos__annotation mesh__D018192
% 209.88/210.04 differentiate from LYMPHANGIOMYOMA; coordinate IM with precoordinated organ/neoplasm terms %28%IM%29% if relevant%A%
% 209.88/210.04 |- skos__historyNote mesh__D018192 Lymphangioma %28%1968-1993%29%
% 209.88/210.04 |- mesh__dateEstablished mesh__D018192 1994-01-01
% 209.88/210.04 |- mesh__recordOriginator mesh__D018192 PLS
% 209.88/210.04 |- mesh__recordMaintainer mesh__D018192 lkt
% 209.88/210.04 |- skos__broader mesh__D004970smesh__D015068
% 209.88/210.04 |- mesh__dateRevised mesh__D004970 2005-06-30
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D004970 2006
% 209.88/210.04 |- skos__altLabel mesh__D004970 Hauck Brand of Estrone
% 209.88/210.04 |- mesh__recordMaintainer mesh__D004970 CCR
% 209.88/210.04 |- skos__altLabel mesh__D004970 Vortech Brand of Estrone
% 209.88/210.04 |- skos__broader mesh__D004970smesh__D045166
% 209.88/210.04 |- skos__broader mesh__D004970smesh__D004963
% 209.88/210.04 |- mesh__recordOriginator mesh__D004970 NLM
% 209.88/210.04 |- rdf__type mesh__D004970sskos__Concept
% 209.88/210.04 |- skos__scopeNote mesh__D004970
% 209.88/210.04 An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.%A%
% 209.88/210.04 |- mesh__dateCreated mesh__D004970 1999-01-01
% 209.88/210.04 |- skos__altLabel mesh__D004970 Hyrex Brand of Estrone
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D004970 sjn
% 209.88/210.04 |- skos__prefLabel mesh__D004970 Estrone
% 209.88/210.04 |- skos__broader mesh__D004172smesh__D014786
% 209.88/210.04 |- rdf__type mesh__D004172sskos__Concept
% 209.88/210.04 |- mesh__recordMaintainer mesh__D004172 nns
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Horizontal Diplopias
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Diplopias, Refractive
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Diplopias
% 209.88/210.04 |- skos__scopeNote mesh__D004172
% 209.88/210.04 A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.%A%
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Polyopsias
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Unilateral Diplopias
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Vertical Diplopia
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Diplopias, Unilateral
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Monocular Diplopia
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D004172 2006
% 209.88/210.04 |- skos__altLabel mesh__D004172 Double Vision
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Diplopias, Monocular
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Diplopias, Intermittent
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D004172 2005
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Diplopias, Cortical
% 209.88/210.04 |- skos__altLabel mesh__D004172 Diplopia, Monocular
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Refractive Diplopias
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Intermittent Diplopia
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Unilateral Diplopia
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Cortical Diplopia
% 209.88/210.04 |- mesh__recordOriginator mesh__D004172 NLM
% 209.88/210.04 |- mesh__dateRevised mesh__D004172 2004-07-07
% 209.88/210.04 |- skos__prefLabel mesh__D004172 Diplopia
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Monocular Diplopias
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D004172 sjn
% 209.88/210.04 |- mesh__dateCreated mesh__D004172 1999-01-01
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Diplopias, Horizontal
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Vision, Double
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Refractive Diplopia
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Vertical Diplopias
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Intermittent Diplopias
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Diplopias, Vertical
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Cortical Diplopias
% 209.88/210.04 |- skos__hiddenLabel mesh__D004172 Horizontal Diplopia
% 209.88/210.04 |- rdf__type mesh__D012604sskos__Concept
% 209.88/210.04 |- skos__hiddenLabel mesh__D012604 beta Scorpion Toxin
% 209.88/210.04 |- skos__hiddenLabel mesh__D012604 Toxin, gamma-Scorpion
% 209.88/210.04 |- skos__historyNote mesh__D012604 Scorpions %28%1966-1977%29%
% 209.88/210.04 |- skos__hiddenLabel mesh__D012604 Venoms, Scorpion
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D012604 78
% 209.88/210.04 |- skos__hiddenLabel mesh__D012604 Toxin, alpha-Scorpion
% 209.88/210.04 |- skos__scopeNote mesh__D012604
% 209.88/210.04 Venoms from animals of the order Scorpionida of the class Arachnida. They contain neuro- and hemotoxins, enzymes, and various other factors that may release acetylcholine and catecholamines from nerve endings. Of the several protein toxins that have been characterized, most are immunogenic.%A%
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D012604 sjn
% 209.88/210.04 |- skos__altLabel mesh__D012604 Scorpion Venom
% 209.88/210.04 |- mesh__historyNote mesh__D012604 78
% 209.88/210.04 |- skos__prefLabel mesh__D012604 Scorpion Venoms
% 209.88/210.04 |- skos__hiddenLabel mesh__D012604 Venom, Scorpion
% 209.88/210.04 |- skos__broader mesh__D012604smesh__D001180
% 209.88/210.04 |- skos__annotation mesh__D012604
% 209.88/210.04 /antag permitted but consider also ANTIVENINS; /enzymol permitted%A%
% 209.88/210.04 |- skos__hiddenLabel mesh__D012604 Toxin, beta-Scorpion
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D012604 2006
% 209.88/210.04 |- skos__hiddenLabel mesh__D012604 alpha Scorpion Toxin
% 209.88/210.04 |- mesh__dateRevised mesh__D012604 2005-06-30
% 209.88/210.04 |- mesh__dateEstablished mesh__D012604 1978-01-01
% 209.88/210.04 |- mesh__recordOriginator mesh__D012604 SH
% 209.88/210.04 |- skos__historyNote mesh__D012604 Venoms %28%1966-1977%29%
% 209.88/210.04 |- mesh__dateCreated mesh__D012604 1977-04-22
% 209.88/210.04 |- mesh__recordMaintainer mesh__D012604 ssb
% 209.88/210.04 |- skos__hiddenLabel mesh__D012604 gamma Scorpion Toxin
% 209.88/210.04 |- mesh__historyNote mesh__D017898 94
% 209.88/210.04 |- mesh__dateRevised mesh__D017898 1996-06-10
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 1997
% 209.88/210.04 |- skos__hiddenLabel mesh__D017898 Tobamoviruses
% 209.88/210.04 |- skos__scopeNote mesh__D017898
% 209.88/210.04 A genus of plant viruses in which the virion is a rigid filament. Transmission is by mechanical inoculation or seed. The type species is TOBACCO MOSAIC VIRUS.%A%
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 1999
% 209.88/210.04 |- mesh__dateEstablished mesh__D017898 1994-01-01
% 209.88/210.04 |- mesh__recordOriginator mesh__D017898 AGS
% 209.88/210.04 |- mesh__dateCreated mesh__D017898 1993-06-04
% 209.88/210.04 |- skos__prefLabel mesh__D017898 Tobamovirus
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 2002
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 1998
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 2004
% 209.88/210.04 |- rdf__type mesh__D017898sskos__Concept
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 2001
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 2006
% 209.88/210.04 |- skos__annotation mesh__D017898
% 209.88/210.04 a genus of mosaic viruses of which TOBACCO MOSAIC VIRUS is the type species; from TOBAcco MOsaic virus; coord IM with specific plant /virol %28%IM or NIM%29%%A%
% 209.88/210.04 |- skos__historyNote mesh__D017898 RNA Viruses %28%1990-1993%29%
% 209.88/210.04 |- skos__historyNote mesh__D017898 Plant Viruses %28%1990-1993%29%
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 2003
% 209.88/210.04 |- mesh__recordMaintainer mesh__D017898 AGS
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D017898 94
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D017898 PLS
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 2000
% 209.88/210.04 |- skos__broader mesh__D017898smesh__D009029
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017898 2005
% 209.88/210.04 |- mesh__recordOriginator mesh__D050723 ssb
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D050723 2006
% 209.88/210.04 |- mesh__recordMaintainer mesh__D050723 ssb
% 209.88/210.04 |- skos__scopeNote mesh__D050723 Breaks in bones.
% 209.88/210.04 |- skos__hiddenLabel mesh__D050723 Broken Bone
% 209.88/210.04 |- skos__hiddenLabel mesh__D050723 Bones, Broken
% 209.88/210.04 |- rdf__type mesh__D050723sskos__Concept
% 209.88/210.04 |- mesh__historyNote mesh__D050723 2006
% 209.88/210.04 |- skos__annotation mesh__D050723
% 209.88/210.04 coord IM with specific bone /inj %28%IM%29% but note many precoordinated Bone/Fracture terms and many specific types of fractures%A%
% 209.88/210.04 |- skos__prefLabel mesh__D050723 Fractures, Bone
% 209.88/210.04 |- skos__altLabel mesh__D050723 Broken Bones
% 209.88/210.04 |- mesh__dateEstablished mesh__D050723 2006-01-01
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D050723 sjn
% 209.88/210.04 |- skos__hiddenLabel mesh__D050723 Bone, Broken
% 209.88/210.04 |- skos__hiddenLabel mesh__D050723 Bone Fracture
% 209.88/210.04 |- mesh__dateCreated mesh__D050723 2005-06-30
% 209.88/210.04 |- skos__hiddenLabel mesh__D050723 Fracture, Bone
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D050723 2006
% 209.88/210.04 |- skos__altLabel mesh__D050723 Bone Fractures
% 209.88/210.04 |- skos__broader mesh__D050723smesh__D014947
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D003878 2005
% 209.88/210.04 |- mesh__dateRevised mesh__D003878 2003-07-09
% 209.88/210.04 |- skos__scopeNote mesh__D003878
% 209.88/210.04 The study of the patterns of ridges of the skin of the fingers, palms, toes, and soles.%A%
% 209.88/210.04 |- mesh__historyNote mesh__D003878
% 209.88/210.04 66; FINGERPRINTS was see under DERMATOGLYPHICS 1966-78, was heading 1963-65; PLANTAR PRINTS was see under DERMATOGLYPHICS 1966-78%A%
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D003878 2006
% 209.88/210.04 |- mesh__recordMaintainer mesh__D003878 lkt
% 209.88/210.04 |- mesh__recordOriginator mesh__D003878 NLM
% 209.88/210.04 |- mesh__onlineNote mesh__D003878
% 209.88/210.04 use DERMATOGLYPHICS to search FINGERPRINTS %26% PLANTAR PRINTS 1966-78%A%
% 209.88/210.04 |- skos__hiddenLabel mesh__D003878 Print, Plantar
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D003878
% 209.88/210.04 66; FINGERPRINTS was see under DERMATOGLYPHICS 1966-78, was heading 1963-65; PLANTAR PRINTS was see under DERMATOGLYPHICS 1966-78%A%
% 209.88/210.04 |- mesh__dateCreated mesh__D003878 1999-01-01
% 209.88/210.04 |- rdf__type mesh__D003878sskos__Concept
% 209.88/210.04 |- skos__hiddenLabel mesh__D003878 Dermatoglyphic
% 209.88/210.04 |- skos__hiddenLabel mesh__D003878 Plantar Print
% 209.88/210.04 |- skos__broader mesh__D003878smesh__D008919
% 209.88/210.04 |- skos__prefLabel mesh__D003878 Dermatoglyphics
% 209.88/210.04 |- skos__broader mesh__D003878smesh__D005554
% 209.88/210.04 |- skos__hiddenLabel mesh__D003878 Prints, Plantar
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D003878 2004
% 209.88/210.04 |- skos__hiddenLabel mesh__D003878 Fingerprint
% 209.88/210.04 |- mesh__dateEstablished mesh__D003878 1966-01-01
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D003878 sjn
% 209.88/210.04 |- skos__prefLabel mesh__D008563 Membrane Lipids
% 209.88/210.04 |- skos__historyNote mesh__D008563 Lipids %28%1966-1976%29%
% 209.88/210.04 |- skos__scopeNote mesh__D008563
% 209.88/210.04 Lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation.%A%
% 209.88/210.04 |- skos__broader mesh__D008563smesh__D008055
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D008563 sjn
% 209.88/210.04 |- skos__altLabel mesh__D008563 Cell Membrane Lipids
% 209.88/210.04 |- skos__historyNote mesh__D008563 Membranes %28%1968-1976%29%
% 209.88/210.04 |- skos__hiddenLabel mesh__D008563 Lipids, Membrane
% 209.88/210.04 |- mesh__dateRevised mesh__D008563 2003-07-09
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008563 2006
% 209.88/210.04 |- mesh__historyNote mesh__D008563 77
% 209.88/210.04 |- skos__hiddenLabel mesh__D008563 Membrane Lipids, Cell
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008563 2005
% 209.88/210.04 |- skos__annotation mesh__D008563 /biosyn /physiol permitted
% 209.88/210.04 |- rdf__type mesh__D008563sskos__Concept
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008563 2004
% 209.88/210.04 |- skos__historyNote mesh__D008563 Cell Membrane %28%1966-1976%29%
% 209.88/210.04 |- skos__historyNote mesh__D008563 Phospholipids %28%1966-1976%29%
% 209.88/210.04 |- mesh__dateCreated mesh__D008563 1976-04-27
% 209.88/210.04 |- skos__hiddenLabel mesh__D008563 Lipids, Cell Membrane
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D008563 77
% 209.88/210.04 |- mesh__recordOriginator mesh__D008563 RLS
% 209.88/210.04 |- mesh__dateEstablished mesh__D008563 1977-01-01
% 209.88/210.04 |- mesh__recordMaintainer mesh__D008563 ssb
% 209.88/210.04 |- skos__hiddenLabel mesh__D000580 C.I. 20470
% 209.88/210.04 |- skos__scopeNote mesh__D000580
% 209.88/210.04 A dye used to stain proteins in electrophoretic techniques. It is used interchangeably with its acid form.%A%
% 209.88/210.04 |- mesh__dateCreated mesh__D000580 1975-07-23
% 209.88/210.04 |- skos__hiddenLabel mesh__D000580 Black, Amido
% 209.88/210.04 |- skos__prefLabel mesh__D000580 Amido Black
% 209.88/210.04 |- skos__hiddenLabel mesh__D000580 C.I.20470
% 209.88/210.04 |- mesh__recordOriginator mesh__D000580 SH
% 209.88/210.04 |- skos__broader mesh__D000580smesh__D001391
% 209.88/210.04 |- skos__broader mesh__D000580smesh__D009282
% 209.88/210.04 |- mesh__recordMaintainer mesh__D000580 NLM
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D000580
% 209.88/210.04 91; was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, %26% C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93%A%
% 209.88/210.04 |- mesh__dateRevised mesh__D000580 2005-07-06
% 209.88/210.04 |- mesh__dateEstablished mesh__D000580 1991-01-01
% 209.88/210.04 |- mesh__onlineNote mesh__D000580
% 209.88/210.04 use AMIDO BLACK to search ACID BLACK 1, NAPHTHOL BLUE BLACK, %26% C.I. ACID BLACK 1 1976-93%A%
% 209.88/210.04 |- skos__historyNote mesh__D000580 Azo Compounds %28%1969-1975%29%
% 209.88/210.04 |- skos__historyNote mesh__D000580 Naphthalenesulfonates %28%1974-1975%29%
% 209.88/210.04 |- mesh__historyNote mesh__D000580
% 209.88/210.04 91%28%76%29%; was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, %26% C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93%A%
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D000580 NLM
% 209.88/210.04 |- skos__historyNote mesh__D000580 Nitrobenzenes %28%1974-1975%29%
% 209.88/210.04 |- skos__annotation mesh__D000580 D25-26 qualif
% 209.88/210.04 |- rdf__type mesh__D000580sskos__Concept
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D000580 2006
% 209.88/210.04 |- skos__broader mesh__D014835Q000295smesh__D014835
% 209.88/210.04 |- mesh__preferredCombination mesh__D014835Q000295smesh__D009330
% 209.88/210.04 |- rdf__type mesh__D014835Q000295smesh__CompoundConcept
% 209.88/210.04 |- skos__hiddenLabel mesh__D018991 Folch PI Proteolipid Protein
% 209.88/210.04 |- skos__altLabel mesh__D018991 Folch-Lees Protein
% 209.88/210.04 |- mesh__onlineNote mesh__D018991
% 209.88/210.04 use MYELIN PROTEOLIPID PROTEIN %28%NM%29% to search FOLCH-PI PROTEOLIPID PROTEIN 1981-95%A%
% 209.88/210.04 |- skos__altLabel mesh__D018991 Proteolipid Protein, Myelin
% 209.88/210.04 |- skos__historyNote mesh__D018991 Myelin Proteins %28%1979-1995%29%
% 209.88/210.04 |- skos__prefLabel mesh__D018991 Myelin Proteolipid Protein
% 209.88/210.04 |- skos__hiddenLabel mesh__D018991 Proteolipid Protein, Folch-PI
% 209.88/210.04 |- skos__altLabel mesh__D018991 Myelin PLP
% 209.88/210.04 |- rdf__type mesh__D018991sskos__Concept
% 209.88/210.04 |- mesh__recordOriginator mesh__D018991 TPW
% 209.88/210.04 |- skos__broader mesh__D018991smesh__D009185
% 209.88/210.04 |- skos__related mesh__D018991smesh__D020371
% 209.88/210.04 |- skos__hiddenLabel mesh__D018991 Protein, Folch-PI Proteolipid
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D018991 2006
% 209.88/210.04 |- mesh__dateEstablished mesh__D018991 1996-01-01
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D018991 sjn
% 209.88/210.04 |- skos__altLabel mesh__D018991 Folch-PI Proteolipid Protein
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D018991 2004
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D018991 2005
% 209.88/210.04 |- skos__annotation mesh__D018991
% 209.88/210.04 /biosyn /drug eff /physiol /ultrastruct permitted
% 209.88/210.04 |- mesh__historyNote mesh__D018991
% 209.88/210.04 96; was FOLCH-PI PROTEOLIPID PROTEIN %28%NM%29% 1979-95
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D018991
% 209.88/210.04 96; FOLCH-PI PROTEOLIPID PROTEIN was indexed under MYELIN PROTEINS 1979-95%A%
% 209.88/210.04 |- mesh__dateCreated mesh__D018991 1995-06-05
% 209.88/210.04 |- skos__hiddenLabel mesh__D018991 Protein, Myelin Proteolipid
% 209.88/210.04 |- skos__hiddenLabel mesh__D018991 PLP, Myelin
% 209.88/210.04 |- skos__scopeNote mesh__D018991
% 209.88/210.04 A myelin protein that is the major component of the organic solvent extractable lipoprotein complexes of whole brain. It has been the subject of much study because of its unusual physical properties. It remains soluble in chloroform even after essentially all of its bound lipids have been removed. %28%From Siegel et al., Basic Neurochemistry, 4th ed, p122%29%%A%
% 209.88/210.04 |- skos__hiddenLabel mesh__D018991 Folch Lees Protein
% 209.88/210.04 |- mesh__recordMaintainer mesh__D018991 ssb
% 209.88/210.04 |- skos__broader mesh__D018991smesh__D011510
% 209.88/210.04 |- mesh__dateRevised mesh__D018991 2003-07-09
% 209.88/210.04 |- skos__hiddenLabel mesh__D018991 Protein, Folch-Lees
% 209.88/210.04 |- skos__broader mesh__D012701Q000037smesh__D012701
% 209.88/210.04 |- mesh__preferredCombination mesh__D012701Q000037smesh__D012702
% 209.88/210.04 |- rdf__type mesh__D012701Q000037smesh__CompoundConcept
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D018193 2005
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D018193 98
% 209.88/210.04 |- rdf__type mesh__D018193sskos__Concept
% 209.88/210.04 |- skos__historyNote mesh__D018193 specific neoplasm %28%1966-1997%29%
% 209.88/210.04 |- skos__prefLabel mesh__D018193 Neoplasms, Complex and Mixed
% 209.88/210.04 |- mesh__historyNote mesh__D018193 98; use explode 1994-97
% 209.88/210.04 |- skos__altLabel mesh__D018193 Complex and Mixed Neoplasms
% 209.88/210.04 |- skos__broader mesh__D018193smesh__D009370
% 209.88/210.04 |- skos__annotation mesh__D018193
% 209.88/210.04 neopl composed of more than one type of neopl tissue; indexing policy: Manual section 24; also TN Suppl: Tumor Key for human %26% corresponding vet tumors %28%does not contain exper tumors%29%; TN 135: correct use of tissue type terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; DF: NEOPL COMPLEX MIXED%A%
% 209.88/210.04 |- mesh__dateRevised mesh__D018193 2004-07-13
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D018193 sjn
% 209.88/210.04 |- mesh__dateEstablished mesh__D018193 1998-01-01
% 209.88/210.04 |- mesh__recordOriginator mesh__D018193 PLS
% 209.88/210.04 |- mesh__dateCreated mesh__D018193 1993-08-26
% 209.88/210.04 |- skos__scopeNote mesh__D018193
% 209.88/210.04 Neoplasms composed of more than one type of neoplastic tissue.%A%
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D018193 2006
% 209.88/210.04 |- mesh__recordMaintainer mesh__D018193 sjn
% 209.88/210.04 |- mesh__dateCreated mesh__D004971 1999-01-01
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D004971 sjn
% 209.88/210.04 |- skos__broader mesh__D004971smesh__D030762
% 209.88/210.04 |- mesh__recordMaintainer mesh__D004971 lkt
% 209.88/210.04 |- skos__annotation mesh__D004971 non-primate mammals only
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D004971 2006
% 209.88/210.04 |- mesh__dateRevised mesh__D004971 2004-07-07
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D004971 2005
% 209.88/210.04 |- skos__scopeNote mesh__D004971
% 209.88/210.04 The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.%A%
% 209.88/210.04 |- rdf__type mesh__D004971sskos__Concept
% 209.88/210.04 |- skos__prefLabel mesh__D004971 Estrus
% 209.88/210.04 |- mesh__recordOriginator mesh__D004971 NLM
% 209.88/210.04 |- mesh__dateEstablished mesh__D004173 1991-01-01
% 209.88/210.04 |- mesh__recordOriginator mesh__D004173 NLM
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D004173 2005
% 209.88/210.04 |- mesh__recordMaintainer mesh__D004173 sjn
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D004173 sjn
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D004173
% 209.88/210.04 91; was see under RODENTIA 1982-90; was KANGAROO RATS see under RODENTS 1975-81%A%
% 209.88/210.04 |- skos__broader mesh__D004173smesh__D012377
% 209.88/210.04 |- skos__altLabel mesh__D004173 Rats, Kangaroo
% 209.88/210.04 |- mesh__dateRevised mesh__D004173 2004-07-13
% 209.88/210.04 |- skos__hiddenLabel mesh__D004173 Rat, Kangaroo
% 209.88/210.04 |- mesh__onlineNote mesh__D004173
% 209.88/210.04 use DIPODOMYS to search KANGAROO RATS 1975-81
% 209.88/210.04 |- skos__altLabel mesh__D004173 Kangaroo Rats
% 209.88/210.04 |- skos__scopeNote mesh__D004173
% 209.88/210.04 A genus of the family Heteromyidae which contains 22 species. Their physiology is adapted for the conservation of water, and they seldom drink water. They are found in arid or desert habitats and travel by hopping on their hind limbs.%A%
% 209.88/210.04 |- rdf__type mesh__D004173sskos__Concept
% 209.88/210.04 |- skos__prefLabel mesh__D004173 Dipodomys
% 209.88/210.04 |- skos__hiddenLabel mesh__D004173 Kangaroo Rat
% 209.88/210.04 |- mesh__dateCreated mesh__D004173 1974-12-12
% 209.88/210.04 |- skos__annotation mesh__D004173
% 209.88/210.04 do not confuse X ref KANGAROO RATS with rat kangaroos %28% = MACROPODIDAE%29%; NIM when exper animal: no qualif; when IM, qualif permitted; do not check tag RATS%A%
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D004173 2006
% 209.88/210.04 |- mesh__historyNote mesh__D004173
% 209.88/210.04 91%28%82%29%; was see under RODENTIA 1982-90; was KANGAROO RATS see under RODENTS 1975-81%A%
% 209.88/210.04 |- skos__annotation mesh__D012605
% 209.88/210.04 /microbiol /parasitol /virol permitted; scorpion sting: coord NIM with ARACHNIDISM %28%IM%29%; several genera: Androctonus, Buthus, Centruoides, Leiurus, Nebo, Tityus%A%
% 209.88/210.04 |- skos__prefLabel mesh__D012605 Scorpions
% 209.88/210.04 |- mesh__dateCreated mesh__D012605 1999-01-01
% 209.88/210.04 |- skos__broader mesh__D012605smesh__D001097
% 209.88/210.04 |- skos__scopeNote mesh__D012605
% 209.88/210.04 Arthropods of the order Scorpiones, of which 1500 to 2000 species have been described. The most common live in tropical or subtropical areas. They are nocturnal and feed principally on insects and other arthropods. They are large arachnids but do not attack man spontaneously. They have a venomous sting. Their medical significance varies considerably and is dependent on their habits and venom potency rather than on their size. At most, the sting is equivalent to that of a hornet but certain species possess a highly toxic venom potentially fatal to humans. %28%From Dorland, 27th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973, p417; Barnes, Invertebrate Zoology, 5th ed, p503%29%%A%
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D012605 2005A
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D012605 2005
% 209.88/210.04 |- mesh__dateRevised mesh__D012605 2004-08-02
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D012605 2006
% 209.88/210.04 |- mesh__recordOriginator mesh__D012605 NLM
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D012605 2004
% 209.88/210.04 |- mesh__recordMaintainer mesh__D012605 jls
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D012605 jls
% 209.88/210.04 |- rdf__type mesh__D012605sskos__Concept
% 209.88/210.04 |- skos__scopeNote mesh__D017899
% 209.88/210.04 An order comprising three families of tailed bacteriophages: MYOVIRIDAE; PODOVIRIDAE; and SIPHOVIRIDAE.%A%
% 209.88/210.04 |- skos__annotation mesh__D017899
% 209.88/210.04 an order of tailed %28%caudo-%29% bacteriophages
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017899 2004
% 209.88/210.04 |- skos__broader mesh__D017899smesh__D001435
% 209.88/210.04 |- rdf__type mesh__D017899sskos__Concept
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D017899 94
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017899 2006
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017899 2003
% 209.88/210.04 |- mesh__dateEstablished mesh__D017899 1994-01-01
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017899 2005
% 209.88/210.04 |- mesh__dateRevised mesh__D017899 2001-07-25
% 209.88/210.04 |- skos__prefLabel mesh__D017899 Caudovirales
% 209.88/210.04 |- skos__broader mesh__D017899smesh__D004267
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D017899 sjn
% 209.88/210.04 |- mesh__historyNote mesh__D017899 94
% 209.88/210.04 |- mesh__recordOriginator mesh__D017899 AGS
% 209.88/210.04 |- mesh__dateCreated mesh__D017899 1993-06-04
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D017899 2002
% 209.88/210.04 |- mesh__recordMaintainer mesh__D017899 mdb
% 209.88/210.04 |- mesh__dateCreated mesh__D050724 2005-06-30
% 209.88/210.04 |- rdf__type mesh__D050724sskos__Concept
% 209.88/210.04 |- skos__hiddenLabel mesh__D050724 Fracture, Cartilage
% 209.88/210.04 |- skos__broader mesh__D050724smesh__D014947
% 209.88/210.04 |- mesh__recordMaintainer mesh__D050724 ssb
% 209.88/210.04 |- skos__scopeNote mesh__D050724 Breaks in CARTILAGE.
% 209.88/210.04 |- skos__altLabel mesh__D050724 Cartilage Fractures
% 209.88/210.04 |- skos__historyNote mesh__D050724 Fractures, Bone %28%1963-2005%29%
% 209.88/210.04 |- mesh__historyNote mesh__D050724 2006
% 209.88/210.04 |- skos__hiddenLabel mesh__D050724 Cartilage Fracture
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D050724 2006
% 209.88/210.04 |- mesh__dateEstablished mesh__D050724 2006-01-01
% 209.88/210.04 |- skos__annotation mesh__D050724
% 209.88/210.04 coordinate IM with specific type of cartilage /inj %28%IM%29%
% 209.88/210.04 |- mesh__recordOriginator mesh__D050724 ssb
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D050724 sjn
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D050724 2006
% 209.88/210.04 |- skos__prefLabel mesh__D050724 Fractures, Cartilage
% 209.88/210.04 |- skos__altLabel mesh__D003879 Agent, Dermatologic
% 209.88/210.04 |- skos__hiddenLabel mesh__D003879 Dermatological Agent
% 209.88/210.04 |- mesh__historyNote mesh__D003879 67
% 209.88/210.04 |- skos__altLabel mesh__D003879 Dermatological Agents
% 209.88/210.04 |- mesh__recordMaintainer mesh__D003879 sjn
% 209.88/210.04 |- skos__altLabel mesh__D003879 Dermatologic Agent
% 209.88/210.04 |- skos__hiddenLabel mesh__D003879 Agents, Dermatological
% 209.88/210.04 |- mesh__dateCreated mesh__D003879 1999-01-01
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D003879 sjn
% 209.88/210.04 |- skos__broader mesh__D003879smesh__D045506
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D003879 2006
% 209.88/210.04 |- skos__annotation mesh__D003879
% 209.88/210.04 GEN or unspecified; prefer specifics; consider also SKIN /drug eff %26% SKIN DISEASES /drug ther; DF: DERMATOL AGENTS%A%
% 209.88/210.04 |- skos__prefLabel mesh__D003879 Dermatologic Agents
% 209.88/210.04 |- skos__altLabel mesh__D003879 Agent, Dermatological
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D003879 2006A
% 209.88/210.04 |- skos__altLabel mesh__D003879 Agents, Dermatologic
% 209.88/210.04 |- mesh__dateEstablished mesh__D003879 1967-01-01
% 209.88/210.04 |- mesh__recordOriginator mesh__D003879 NLM
% 209.88/210.04 |- mesh__dateRevised mesh__D003879 2005-08-15
% 209.88/210.04 |- rdf__type mesh__D003879sskos__Concept
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D003879 67
% 209.88/210.04 |- skos__related mesh__D003879smesh__D000891
% 209.88/210.04 |- skos__scopeNote mesh__D003879
% 209.88/210.04 Drugs used to treat or prevent skin disorders or for the routine care of skin.%A%
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 1994
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 1999
% 209.88/210.04 |- skos__prefLabel mesh__D008564 Membrane Potentials
% 209.88/210.04 |- skos__broader mesh__D008564smesh__D004594
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 2001
% 209.88/210.04 |- skos__broader mesh__D008564smesh__D001693
% 209.88/210.04 |- skos__hiddenLabel mesh__D008564 Potentials, Transmembrane
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 2003
% 209.88/210.04 |- skos__altLabel mesh__D008564 Resting Potentials
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 1995
% 209.88/210.04 |- skos__hiddenLabel mesh__D008564 Potential, Membrane
% 209.88/210.04 |- skos__broader mesh__D008564smesh__D009424
% 209.88/210.04 |- skos__annotation mesh__D008564
% 209.88/210.04 NIM; coord with organ /physiol %28%IM%29%
% 209.88/210.04 |- mesh__dateEstablished mesh__D008564 1968-01-01
% 209.88/210.04 |- skos__hiddenLabel mesh__D008564 Transmembrane Potential
% 209.88/210.04 |- skos__hiddenLabel mesh__D008564 Potential, Transmembrane
% 209.88/210.04 |- mesh__historyNote mesh__D008564 68%28%67%29%
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 2002
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 2004
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 1996
% 209.88/210.04 |- skos__scopeNote mesh__D008564
% 209.88/210.04 Ratio of inside versus outside concentration of potassium, sodium, chloride and other ions in diffusible tissues or cells. Also called transmembrane and resting potentials, they are measured by recording electrophysiologic responses in voltage-dependent ionic channels of %28%e.g.%29% nerve, muscle and blood cells as well as artificial membranes.%A%
% 209.88/210.04 |- mesh__recordMaintainer mesh__D008564 TAP
% 209.88/210.04 |- skos__broader mesh__D008564smesh__D001703
% 209.88/210.04 |- mesh__recordOriginator mesh__D008564 NLM
% 209.88/210.04 |- mesh__publicMeSHNote mesh__D008564 68
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 2005
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 1997
% 209.88/210.04 |- skos__hiddenLabel mesh__D008564 Potential, Resting
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D008564 PLS
% 209.88/210.04 |- skos__hiddenLabel mesh__D008564 Resting Potential
% 209.88/210.04 |- skos__altLabel mesh__D008564 Transmembrane Potentials
% 209.88/210.04 |- skos__hiddenLabel mesh__D008564 Potentials, Resting
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 1993
% 209.88/210.04 |- skos__hiddenLabel mesh__D008564 Potentials, Membrane
% 209.88/210.04 |- mesh__dateCreated mesh__D008564 1999-01-01
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 2006
% 209.88/210.04 |- rdf__type mesh__D008564sskos__Concept
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 1998
% 209.88/210.04 |- skos__historyNote mesh__D008564 Electrophysiology %28%1966%29%
% 209.88/210.04 |- mesh__dateRevised mesh__D008564 1992-05-15
% 209.88/210.04 |- skos__hiddenLabel mesh__D008564 Membrane Potential
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D008564 2000
% 209.88/210.04 |- mesh__recordAuthorizer mesh__D000581 sjn
% 209.88/210.04 |- mesh__activeMeSHYear mesh__D000581 2004
% 209.88/210.04 |- mesh__recordMaintainer mesh__D000581 ssb
% 209.88/210.04 |- mesh__dateRevised mesh__D000581 2003-07-09
% 209.88/210.04 |- skos__broader mesh__D000581smesh__D006867
% 209.88/210.05 |- mesh__dateCreated mesh__D000581 1999-01-01
% 209.88/210.05 |- rdf__type mesh__D000581sskos__Concept
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D000581 2006
% 209.88/210.05 |- skos__altLabel mesh__D000581 Amidases
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D000581 2005
% 209.88/210.05 |- skos__prefLabel mesh__D000581 Amidohydrolases
% 209.88/210.05 |- mesh__recordOriginator mesh__D000581 NLM
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 2006
% 209.88/210.05 |- skos__prefLabel mesh__D018992 Myelin-Associated Glycoprotein
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 2004
% 209.88/210.05 |- skos__altLabel mesh__D018992 MAG Protein
% 209.88/210.05 |- skos__altLabel mesh__D018992 Pleural Glycoproteins
% 209.88/210.05 |- skos__scopeNote mesh__D018992
% 209.88/210.05 A myelin protein found in the periaxonal membrane of both the central and peripheral nervous systems myelin sheaths. It has a structure that is similar to members of the Ig superfamily that participate in cell adhesion. %28%From Siegel et al., Basic Neurochemistry, 5th ed, p132%29%%A%
% 209.88/210.05 |- skos__annotation mesh__D018992
% 209.88/210.05 /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A%
% 209.88/210.05 |- skos__hiddenLabel mesh__D018992 Glycoproteins, Pleural
% 209.88/210.05 |- mesh__historyNote mesh__D018992
% 209.88/210.05 96; was PLEURAL GLYCOPROTEINS %28%NM%29% 1982-95
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 2005
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 2001
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 1999
% 209.88/210.05 |- skos__hiddenLabel mesh__D018992
% 209.88/210.05 Large Myelin Associated Glycoprotein Isoform
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 2003
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D018992
% 209.88/210.05 96; PLEURAL GLYCOPROTEINS was indexed under MYELIN PROTEINS 1982-95%A%
% 209.88/210.05 |- mesh__dateCreated mesh__D018992 1995-06-05
% 209.88/210.05 |- skos__altLabel mesh__D018992
% 209.88/210.05 Large Myelin-Associated Glycoprotein Isoform
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 1997
% 209.88/210.05 |- skos__broader mesh__D018992smesh__D008562
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 2000
% 209.88/210.05 |- skos__hiddenLabel mesh__D018992 Glycoprotein, Myelin-Associated
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 1998
% 209.88/210.05 |- skos__hiddenLabel mesh__D018992 Myelin Associated Glycoprotein
% 209.88/210.05 |- skos__hiddenLabel mesh__D018992 L MAG
% 209.88/210.05 |- skos__broader mesh__D018992smesh__D009185
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 1996
% 209.88/210.05 |- skos__hiddenLabel mesh__D018992 S MAG
% 209.88/210.05 |- skos__altLabel mesh__D018992 S-MAG
% 209.88/210.05 |- mesh__dateEstablished mesh__D018992 1996-01-01
% 209.88/210.05 |- skos__hiddenLabel mesh__D018992
% 209.88/210.05 Small Myelin Associated Glycoprotein Isoform
% 209.88/210.05 |- skos__hiddenLabel mesh__D018992 Protein, MAG
% 209.88/210.05 |- skos__historyNote mesh__D018992 Myelin Proteins %28%1982-1995%29%
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018992 2002
% 209.88/210.05 |- mesh__onlineNote mesh__D018992
% 209.88/210.05 use MYELIN-ASSOCIATED GLYCOPROTEIN %28%NM%29% to search PLEURAL GLYCOPROTEINS 1982-95%A%
% 209.88/210.05 |- rdf__type mesh__D018992sskos__Concept
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D018194 PLS
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 1999
% 209.88/210.05 |- skos__historyNote mesh__D018194 Endometriosis %28%1975-1993%29%
% 209.88/210.05 |- skos__scopeNote mesh__D018194
% 209.88/210.05 A benign neoplasm of muscle %28%usually smooth muscle%29% with glandular elements. It occurs most frequently in the uterus and uterine ligaments. %28%Stedman, 25th ed%29%%A%
% 209.88/210.05 |- mesh__dateEstablished mesh__D018194 1994-01-01
% 209.88/210.05 |- rdf__type mesh__D018194sskos__Concept
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 2000
% 209.88/210.05 |- skos__annotation mesh__D018194
% 209.88/210.05 /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D018194 94
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 2001
% 209.88/210.05 |- mesh__historyNote mesh__D018194 94
% 209.88/210.05 |- skos__broader mesh__D018194smesh__D018193
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 2003
% 209.88/210.05 |- mesh__recordMaintainer mesh__D018194 KEV
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 1996
% 209.88/210.05 |- skos__hiddenLabel mesh__D018194 Adenomyomas
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 2005
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 2004
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 1998
% 209.88/210.05 |- skos__prefLabel mesh__D018194 Adenomyoma
% 209.88/210.05 |- mesh__recordOriginator mesh__D018194 PLS
% 209.88/210.05 |- mesh__dateCreated mesh__D018194 1993-06-24
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 1997
% 209.88/210.05 |- mesh__dateRevised mesh__D018194 1995-06-08
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 2002
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018194 2006
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004972 2003
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D004972 91; was see under BREEDING 1975-90
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004972 2006
% 209.88/210.05 |- skos__annotation mesh__D004972 animal only
% 209.88/210.05 |- mesh__historyNote mesh__D004972
% 209.88/210.05 91%28%75%29%; was see under BREEDING 1975-90
% 209.88/210.05 |- mesh__recordOriginator mesh__D004972 NLM
% 209.88/210.05 |- mesh__dateCreated mesh__D004972 1974-11-19
% 209.88/210.05 |- skos__hiddenLabel mesh__D004972 Detection, Estrus
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D004972 sjn
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004972 2005
% 209.88/210.05 |- mesh__recordMaintainer mesh__D004972 lkt
% 209.88/210.05 |- skos__broader mesh__D004972smesh__D001947
% 209.88/210.05 |- skos__hiddenLabel mesh__D004972 Estrus Detections
% 209.88/210.05 |- skos__prefLabel mesh__D004972 Estrus Detection
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004972 2002
% 209.88/210.05 |- rdf__type mesh__D004972sskos__Concept
% 209.88/210.05 |- mesh__dateEstablished mesh__D004972 1991-01-01
% 209.88/210.05 |- mesh__dateRevised mesh__D004972 2001-07-25
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004972 2004
% 209.88/210.05 |- skos__hiddenLabel mesh__D004972 Detections, Estrus
% 209.88/210.05 |- skos__scopeNote mesh__D004972
% 209.88/210.05 Methods for recognizing the state of ESTRUS.
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004174 2004
% 209.88/210.05 |- mesh__historyNote mesh__D004174
% 209.88/210.05 91%28%76%29%; was see under MORPHINANS 1976-90
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004174 2002
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004174 2003
% 209.88/210.05 |- mesh__recordOriginator mesh__D004174 SH
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D004174 sjn
% 209.88/210.05 |- rdf__type mesh__D004174sskos__Concept
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004174 2001
% 209.88/210.05 |- skos__historyNote mesh__D004174 Morphinans %28%1973-1975%29%
% 209.88/210.05 |- skos__prefLabel mesh__D004174 Diprenorphine
% 209.88/210.05 |- skos__broader mesh__D004174smesh__D009019
% 209.88/210.05 |- skos__hiddenLabel mesh__D004174 Hydrochloride, Diprenorphine
% 209.88/210.05 |- mesh__dateCreated mesh__D004174 1975-07-23
% 209.88/210.05 |- skos__scopeNote mesh__D004174
% 209.88/210.05 A narcotic antagonist similar in action to NALOXONE. It is used to remobilize animals after ETORPHINE neuroleptanalgesia and is considered a specific antagonist to etorphine.%A%
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D004174
% 209.88/210.05 91; was see under MORPHINANS 1976-90
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004174 2006
% 209.88/210.05 |- skos__historyNote mesh__D004174 Cyclopropanes %28%1973-1975%29%
% 209.88/210.05 |- mesh__dateRevised mesh__D004174 2000-06-22
% 209.88/210.05 |- mesh__recordMaintainer mesh__D004174 TWD
% 209.88/210.05 |- mesh__dateEstablished mesh__D004174 1991-01-01
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004174 2005
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 1996
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 2005
% 209.88/210.05 |- mesh__recordOriginator mesh__D012606 NLM
% 209.88/210.05 |- mesh__recordMaintainer mesh__D012606 KEV
% 209.88/210.05 |- skos__broader mesh__D012606smesh__D006113
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 1999
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 2003
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 1997
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 2006
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 2001
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 2004
% 209.88/210.05 |- rdf__type mesh__D012606sskos__Concept
% 209.88/210.05 |- skos__prefLabel mesh__D012606 Scotland
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 2002
% 209.88/210.05 |- mesh__dateRevised mesh__D012606 1995-05-23
% 209.88/210.05 |- mesh__dateCreated mesh__D012606 1999-01-01
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D012606 PLS
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 1998
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012606 2000
% 209.88/210.05 |- skos__broader mesh__D050725smesh__D009856
% 209.88/210.05 |- mesh__recordMaintainer mesh__D050725 ags
% 209.88/210.05 |- skos__altLabel mesh__D050725 E7 Oncogene Proteins
% 209.88/210.05 |- skos__prefLabel mesh__D050725 Papillomavirus E7 Proteins
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D050725 2006
% 209.88/210.05 |- rdf__type mesh__D050725sskos__Concept
% 209.88/210.05 |- mesh__dateEstablished mesh__D050725 2006-01-01
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D050725 2006A
% 209.88/210.05 |- mesh__dateCreated mesh__D050725 2005-06-30
% 209.88/210.05 |- skos__hiddenLabel mesh__D050725 E7 Proteins, Papillomavirus
% 209.88/210.05 |- skos__hiddenLabel mesh__D050725 Oncogene Proteins, E7
% 209.88/210.05 |- skos__scopeNote mesh__D050725
% 209.88/210.05 ONCOGENE PROTEINS from PAPILLOMAVIRUS that deregulate the CELL CYCLE of infected cells and lead to NEOPLASTIC CELL TRANSFORMATION. Papillomavirus E7 proteins have been shown to interact with various regulators of the cell cycle including RETINOBLASTOMA PROTEIN and certain cyclin-dependent kinase inhibitors.%A%
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D050725 ags
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D050725 2006
% 209.88/210.05 |- mesh__dateRevised mesh__D050725 2005-07-12
% 209.88/210.05 |- mesh__historyNote mesh__D050725 2006
% 209.88/210.05 |- skos__altLabel mesh__D050725 Oncogene Protein E7, Papillomavirus
% 209.88/210.05 |- mesh__recordOriginator mesh__D050725 DRC
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Proteins, Cell Surface
% 209.88/210.05 |- rdf__type mesh__D008565sskos__Concept
% 209.88/210.05 |- skos__historyNote mesh__D008565 Proteins %28%1966-1976%29%
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Proteins, Surface
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Protein, Integral Membrane
% 209.88/210.05 |- skos__altLabel mesh__D008565 Membrane Protein
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Membrane Associated Proteins
% 209.88/210.05 |- mesh__dateRevised mesh__D008565 2005-06-30
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Membrane Proteins, Integral
% 209.88/210.05 |- skos__annotation mesh__D008565
% 209.88/210.05 /biosyn /drug eff /physiol /ultrastruct permitted
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Proteins, Cell Membrane
% 209.88/210.05 |- mesh__recordOriginator mesh__D008565 RLS
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D008565 77
% 209.88/210.05 |- mesh__dateCreated mesh__D008565 1976-04-27
% 209.88/210.05 |- mesh__dateEstablished mesh__D008565 1977-01-01
% 209.88/210.05 |- skos__scopeNote mesh__D008565
% 209.88/210.05 Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.%A%
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Membrane Protein, Integral
% 209.88/210.05 |- skos__altLabel mesh__D008565 Membrane-Associated Proteins
% 209.88/210.05 |- skos__prefLabel mesh__D008565 Membrane Proteins
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Protein, Membrane
% 209.88/210.05 |- skos__broader mesh__D008565smesh__D011506
% 209.88/210.05 |- skos__historyNote mesh__D008565 Cell Membranes %28%1966-1976%29%
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Proteins, Integral Membrane
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D008565 2006
% 209.88/210.05 |- skos__historyNote mesh__D008565 Membranes %28%1968-1976%29%
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Proteins, Membrane-Associated
% 209.88/210.05 |- skos__altLabel mesh__D008565 Surface Proteins
% 209.88/210.05 |- skos__hiddenLabel mesh__D008565 Proteins, Membrane
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D008565 sjn
% 209.88/210.05 |- skos__altLabel mesh__D008565 Integral Membrane Protein
% 209.88/210.05 |- mesh__historyNote mesh__D008565 77
% 209.88/210.05 |- mesh__recordMaintainer mesh__D008565 SYSTEM
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D000582 2004
% 209.88/210.05 |- skos__historyNote mesh__D000582 Pyrophosphoric Acids %28%1974%29%
% 209.88/210.05 |- mesh__recordOriginator mesh__D000582 NLM
% 209.88/210.05 |- skos__hiddenLabel mesh__D000582
% 209.88/210.05 Amidotransferase, Phosphoribosyl Pyrophosphate
% 209.88/210.05 |- mesh__dateRevised mesh__D000582 2003-07-09
% 209.88/210.05 |- mesh__dateEstablished mesh__D000582 1991-01-01
% 209.88/210.05 |- skos__historyNote mesh__D000582 Pentosyltransferases %28%1974%29%
% 209.88/210.05 |- rdf__type mesh__D000582sskos__Concept
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D000582 sjn
% 209.88/210.05 |- skos__hiddenLabel mesh__D000582 Glutamine Amidophosphoribosyltransferase
% 209.88/210.05 |- mesh__dateCreated mesh__D000582 1974-11-19
% 209.88/210.05 |- skos__historyNote mesh__D000582 Pentosephosphates %28%1974%29%
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D000582 2006
% 209.88/210.05 |- skos__altLabel mesh__D000582
% 209.88/210.05 Phosphoribosyldiphosphate 5-Amidotransferase
% 209.88/210.05 |- skos__historyNote mesh__D000582 Glutamine %28%1974%29%
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D000582 2005
% 209.88/210.05 |- skos__hiddenLabel mesh__D000582
% 209.88/210.05 Pyrophosphate Amidotransferase, Phosphoribosyl
% 209.88/210.05 |- mesh__recordMaintainer mesh__D000582 ssb
% 209.88/210.05 |- skos__altLabel mesh__D000582
% 209.88/210.05 Glutamine Phosphoribosyl Pyrophosphate Amidotransferase
% 209.88/210.05 |- skos__altLabel mesh__D000582
% 209.88/210.05 Phosphoribosyl Pyrophosphate Amidotransferase
% 209.88/210.05 |- mesh__historyNote mesh__D000582
% 209.88/210.05 91%28%75%29%; was see under PENTOSYLTRANSFERASES 1975-90
% 209.88/210.05 |- skos__scopeNote mesh__D000582
% 209.88/210.05 An enzyme, involved in the early steps of purine nucleotide biosynthesis, that catalyzes the formation of 5-phosphoribosylamine from glutamine and phosphoribosylpyrophosphate. EC 2.4.2.14.%A%
% 209.88/210.05 |- skos__hiddenLabel mesh__D000582
% 209.88/210.05 Phosphoribosyldiphosphate 5 Amidotransferase
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D000582
% 209.88/210.05 91; was see under PENTOSYLTRANSFERASES 1975-90
% 209.88/210.05 |- skos__altLabel mesh__D000582 Glutamine-Amidophosphoribosyltransferase
% 209.88/210.05 |- skos__broader mesh__D000582smesh__D010430
% 209.88/210.05 |- skos__hiddenLabel mesh__D000582
% 209.88/210.05 5-Amidotransferase, Phosphoribosyldiphosphate
% 209.88/210.05 |- skos__prefLabel mesh__D000582 Amidophosphoribosyltransferase
% 209.88/210.05 |- skos__hiddenLabel mesh__D018993 Zero, Myelin Protein
% 209.88/210.05 |- skos__altLabel mesh__D018993 Myelin Protein Zero
% 209.88/210.05 |- skos__broader mesh__D018993smesh__D006023
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D018993 sjn
% 209.88/210.05 |- mesh__dateCreated mesh__D018993 1995-06-05
% 209.88/210.05 |- skos__historyNote mesh__D018993 Myelin Proteins %28%1981-1995%29%
% 209.88/210.05 |- skos__altLabel mesh__D018993 P0 Glycoprotein
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D018993
% 209.88/210.05 96; PROTEIN ZERO, PERIPHERAL NERVE MYELIN was indexed under MYELIN PROTEINS 1981-95%A%
% 209.88/210.05 |- skos__hiddenLabel mesh__D018993 Protein Zero, Myelin
% 209.88/210.05 |- mesh__historyNote mesh__D018993
% 209.88/210.05 96; was PROTEIN ZERO, PERIPHERAL NERVE MYELIN %28%NM%29% 1981-95%A%
% 209.88/210.05 |- skos__hiddenLabel mesh__D018993 Protein, Myelin P0
% 209.88/210.05 |- skos__altLabel mesh__D018993 Protein Zero, Peripheral Nerve Myelin
% 209.88/210.05 |- mesh__dateRevised mesh__D018993 2005-06-30
% 209.88/210.05 |- mesh__recordMaintainer mesh__D018993 ssb
% 209.88/210.05 |- skos__scopeNote mesh__D018993
% 209.88/210.05 A protein that accounts for more than half of the peripheral nervous system myelin protein. The extracellular domain of this protein is believed to engage in adhesive interactions and thus hold the myelin membrane compact. It can behave as a homophilic adhesion molecule through interactions with its extracellular domains. %28%From J Cell Biol 1994;126%28%4%29%:1089-97%29%%A%
% 209.88/210.05 |- skos__hiddenLabel mesh__D018993 P0 Protein, Myelin
% 209.88/210.05 |- skos__altLabel mesh__D018993 P0 Protein
% 209.88/210.05 |- skos__hiddenLabel mesh__D018993 Glycoprotein, P0
% 209.88/210.05 |- skos__prefLabel mesh__D018993 Myelin P0 Protein
% 209.88/210.05 |- skos__annotation mesh__D018993
% 209.88/210.05 0 in P0 is the digit, not the letter O; /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A%
% 209.88/210.05 |- skos__broader mesh__D018993smesh__D009185
% 209.88/210.05 |- mesh__dateEstablished mesh__D018993 1996-01-01
% 209.88/210.05 |- mesh__recordOriginator mesh__D018993 TPW
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018993 2006
% 209.88/210.05 |- rdf__type mesh__D018993sskos__Concept
% 209.88/210.05 |- skos__related mesh__D018993smesh__D002607
% 209.88/210.05 |- mesh__onlineNote mesh__D018993
% 209.88/210.05 use MYELIN P0 PROTEIN %28%NM%29% to search PROTEIN ZERO, PERIPHERAL NERVE MYELIN 1981-95%A%
% 209.88/210.05 |- skos__hiddenLabel mesh__D018993 Protein, P0
% 209.88/210.05 |- skos__broader mesh__D018993smesh__D015816
% 209.88/210.05 |- skos__broader mesh__D000990Q000172smesh__D000990
% 209.88/210.05 |- mesh__preferredCombination mesh__D000990Q000172smesh__D020152
% 209.88/210.05 |- rdf__type mesh__D000990Q000172smesh__CompoundConcept
% 209.88/210.05 |- skos__historyNote mesh__D018195
% 209.88/210.05 Neoplasms, Germ Cell and Embryonal %28%1977-1993%29%
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 2002
% 209.88/210.05 |- skos__hiddenLabel mesh__D018195 Adenosarcomas
% 209.88/210.05 |- skos__scopeNote mesh__D018195
% 209.88/210.05 A malignant neoplasm arising simultaneously or consecutively in mesodermal tissue and glandular epithelium of the same part. %28%Stedman, 25th ed%29%%A%
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D018195 PLS
% 209.88/210.05 |- skos__annotation mesh__D018195
% 209.88/210.05 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 209.88/210.05 |- mesh__historyNote mesh__D018195 94
% 209.88/210.05 |- mesh__recordMaintainer mesh__D018195 KEV
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 2003
% 209.88/210.05 |- mesh__dateEstablished mesh__D018195 1994-01-01
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 1996
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 2000
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 2005
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 2004
% 209.88/210.05 |- mesh__recordOriginator mesh__D018195 PLS
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 1998
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 1997
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 2001
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D018195 94
% 209.88/210.05 |- mesh__dateRevised mesh__D018195 1995-06-08
% 209.88/210.05 |- skos__broader mesh__D018195smesh__D018193
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 2006
% 209.88/210.05 |- mesh__dateCreated mesh__D018195 1993-06-25
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D018195 1999
% 209.88/210.05 |- skos__historyNote mesh__D018195 Nephroblastoma %28%1966-1993%29%
% 209.88/210.05 |- rdf__type mesh__D018195sskos__Concept
% 209.88/210.05 |- skos__prefLabel mesh__D018195 Adenosarcoma
% 209.88/210.05 |- skos__broader mesh__D018195smesh__D012509
% 209.88/210.05 |- mesh__dateCreated mesh__D004973 1974-11-11
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D004973 76; was see under ESTRUS 1975
% 209.88/210.05 |- skos__hiddenLabel mesh__D004973 Synchronization, Estrus
% 209.88/210.05 |- skos__scopeNote mesh__D004973
% 209.88/210.05 Occurrence or induction of ESTRUS in all of the females in a group at the same time, applies only to non-primate mammals with ESTROUS CYCLE.%A%
% 209.88/210.05 |- rdf__type mesh__D004973sskos__Concept
% 209.88/210.05 |- skos__hiddenLabel mesh__D004973 Synchronizations, Estrus
% 209.88/210.05 |- skos__hiddenLabel mesh__D004973 Estrus Synchronizations
% 209.88/210.05 |- skos__prefLabel mesh__D004973 Estrus Synchronization
% 209.88/210.05 |- mesh__recordOriginator mesh__D004973 NLM
% 209.88/210.05 |- mesh__recordMaintainer mesh__D004973 lkt
% 209.88/210.05 |- skos__historyNote mesh__D004973 Estrus %28%1966-1974%29%
% 209.88/210.05 |- mesh__historyNote mesh__D004973
% 209.88/210.05 76%28%75%29%; was see under ESTRUS 1975
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D004973 sjn
% 209.88/210.05 |- skos__broader mesh__D004973smesh__D004971
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004973 2006
% 209.88/210.05 |- skos__broader mesh__D004973smesh__D001947
% 209.88/210.05 |- skos__annotation mesh__D004973 non-primate mammals only
% 209.88/210.05 |- mesh__dateRevised mesh__D004973 2004-07-07
% 209.88/210.05 |- mesh__dateEstablished mesh__D004973 1976-01-01
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004973 2005
% 209.88/210.05 |- skos__altLabel mesh__D051020 bcl-Xlong Protein
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl XS Protein
% 209.88/210.05 |- mesh__historyNote mesh__D051020 2006%28%1993%29%
% 209.88/210.05 |- mesh__recordOriginator mesh__D051020 DRC
% 209.88/210.05 |- skos__altLabel mesh__D051020 bcl2L1 Protein
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl Xlong Protein
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D051020 2006A
% 209.88/210.05 |- mesh__dateEstablished mesh__D051020 2006-01-01
% 209.88/210.05 |- rdf__type mesh__D051020sskos__Concept
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl Xbeta Protein
% 209.88/210.05 |- skos__prefLabel mesh__D051020 bcl-X Protein
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl Xshort Protein
% 209.88/210.05 |- skos__altLabel mesh__D051020 bcl-Xa Protein
% 209.88/210.05 |- skos__altLabel mesh__D051020 bcl-Xb Protein
% 209.88/210.05 |- skos__altLabel mesh__D051020 bcl-X%28%S%29% Protein
% 209.88/210.05 |- skos__altLabel mesh__D051020 bcl-x%28%beta%29% Protein
% 209.88/210.05 |- skos__altLabel mesh__D051020 bcl2-Like 1 Protein
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl Xa Protein
% 209.88/210.05 |- mesh__recordMaintainer mesh__D051020 ags
% 209.88/210.05 |- skos__altLabel mesh__D051020 bcl-Xshort Protein
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl Xb Protein
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D051020 ags
% 209.88/210.05 |- mesh__dateRevised mesh__D051020 2005-07-08
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D051020
% 209.88/210.05 2006; BCL-X PROTEIN was indexed under PROTO-ONCOGENE PROTEINS 1993-2004, %26% under PROTO-ONCOGENE PROTEINS C-BCL-2 2005%A%
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl2 Like 1 Protein
% 209.88/210.05 |- skos__altLabel mesh__D051020 bcl-X%28%L%29% Protein
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl X Protein
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D051020 2006
% 209.88/210.05 |- skos__scopeNote mesh__D051020
% 209.88/210.05 A member of the bcl-2 protein family that plays a role in the regulation of APOPTOSIS. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the BCL2L1 mRNA and are referred to as Bcl-XS and Bcl-XL.%A%
% 209.88/210.05 |- mesh__dateCreated mesh__D051020 2005-06-30
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl XL Protein
% 209.88/210.05 |- skos__annotation mesh__D051020
% 209.88/210.05 Don%27%t confuse with the closely related BCL2-ASSOCIATED X PROTEIN%A%
% 209.88/210.05 |- skos__hiddenLabel mesh__D051020 bcl Xalpha Protein
% 209.88/210.05 |- skos__broader mesh__D051020smesh__D019253
% 209.88/210.05 |- skos__prefLabel mesh__D004175 Diptera
% 209.88/210.05 |- mesh__recordMaintainer mesh__D004175 ags
% 209.88/210.05 |- skos__altLabel mesh__D004175 Flies, True
% 209.88/210.05 |- mesh__dateRevised mesh__D004175 2005-07-18
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D004175 ags
% 209.88/210.05 |- skos__broader mesh__D004175smesh__D007313
% 209.88/210.05 |- rdf__type mesh__D004175sskos__Concept
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004175 2006A
% 209.88/210.05 |- mesh__historyNote mesh__D004175
% 209.88/210.05 81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74%A%
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D004175
% 209.88/210.05 81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74; MIDGES %28%either MIDGES, BITING see CERATOPOGONIDAE or MIDGES, NONBITING see CHIRONOMIDAE as of 1981%29% was see under DIPTERA 1975-80; CERATOPOGONIDAE was see CULICOIDES 1975-80; CULICOIDES %28%see CERATOPOGONIDAE as of 1981%29% was heading 1963-80%A%
% 209.88/210.05 |- skos__scopeNote mesh__D004175
% 209.88/210.05 An order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, Sarcophagidae, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots %28%see LARVA%29%.%A%
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004175 2005
% 209.88/210.05 |- mesh__onlineNote mesh__D004175 use DIPTERA to search FLIES 1966-80
% 209.88/210.05 |- mesh__recordOriginator mesh__D004175 NLM
% 209.88/210.05 |- skos__altLabel mesh__D004175 Flies
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D004175 2006
% 209.88/210.05 |- skos__annotation mesh__D004175
% 209.88/210.05 do not use /drug eff for insecticides; index caddisfly, dragonfly, mayfly %26% stonefly under INSECTS; FIREFLIES see BEETLES is available, sawfly %26% ichneumon fly under HYMENOPTERA; infestation by fly maggots = MYIASIS%A%
% 209.88/210.05 |- mesh__dateCreated mesh__D004175 1999-01-01
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012607 2003
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Altitudinal
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Central Scotoma
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012607 2006
% 209.88/210.05 |- skos__prefLabel mesh__D012607 Scotoma
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Bjerrum
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Paracecal Scotoma
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Centrocecal Scotoma
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Altitudinal Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Paracentral Scotoma
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Paracecal
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Ring Scotomas
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012607 2005
% 209.88/210.05 |- skos__broader mesh__D012607smesh__D014786
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Peripheral Scotoma
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Ring Scotoma
% 209.88/210.05 |- rdf__type mesh__D012607sskos__Concept
% 209.88/210.05 |- skos__annotation mesh__D012607
% 209.88/210.05 differentiate from physiol blind spot %28% = BLIND SPOT%29%
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Scintillating
% 209.88/210.05 |- mesh__dateRevised mesh__D012607 2001-07-25
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Sector Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Arcuate Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scintillating Scotoma
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Central Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Peripheral Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Centrocecal Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Sector Scotoma
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Peripheral
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Bjerrum Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Arcuate Scotoma
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Arcuate
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Centrocecal
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Central
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Ring
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Sector
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012607 2004
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D012607 sjn
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scintillating Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Scotomas, Paracentral
% 209.88/210.05 |- mesh__recordOriginator mesh__D012607 NLM
% 209.88/210.05 |- mesh__dateCreated mesh__D012607 1999-01-01
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Bjerrum Scotoma
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Paracecal Scotomas
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Altitudinal Scotoma
% 209.88/210.05 |- mesh__activeMeSHYear mesh__D012607 2002
% 209.88/210.05 |- skos__hiddenLabel mesh__D012607 Paracentral Scotomas
% 209.88/210.05 |- mesh__recordMaintainer mesh__D012607 mdb
% 209.88/210.05 |- skos__scopeNote mesh__D012607
% 209.88/210.05 A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES %28%e.g., RETINAL DISEASES and GLAUCOMA%29%; OPTIC NERVE DISEASES, and other conditions.%A%
% 209.88/210.05 |- skos__related mesh__D008566smesh__D002462
% 209.88/210.05 |- skos__related mesh__D008566smesh__D002473
% 209.88/210.05 |- mesh__recordAuthorizer mesh__D008566 sjn
% 209.88/210.05 |- mesh__dateCreated mesh__D008566 1999-01-01
% 209.88/210.05 |- skos__related mesh__D008566smesh__D007425
% 209.88/210.05 |- mesh__publicMeSHNote mesh__D008566 68
% 209.88/210.05 |- skos__related mesh__D008566smesh__D013583
% 209.88/210.05 |- skos__related mesh__D008566smesh__D008563
% 209.88/210.05 |- skos__annotation mesh__D008566
% 209.88/210.05 general; prefer specifics; almost never IM
% 209.88/210.05 |- skos__related mesh__D008566smesh__D008565
% 209.88/210.05 |- skos__hiddenLabel mesh__D008566 Tissues, Membrane
% 209.88/210.05 |- skos__hiddenLabel mesh__D008566 Membrane
% 209.88/210.05 |- mesh__recordOriginator mesh__D008566 NLM
% 209.88/210.05 |- skos__hiddenLabel mesh__D008566 Membrane Tissues
% 209.88/210.05 |- mesh__dateRevised mesh__D008566 2005-06-30
% 209.88/210.06 |- skos__related mesh__D008566smesh__D009441
% 209.88/210.06 |- skos__related mesh__D008566smesh__D009685
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D008566 2006
% 209.88/210.06 |- mesh__historyNote mesh__D008566 68%28%66%29%
% 209.88/210.06 |- skos__broader mesh__D008566smesh__D014024
% 209.88/210.06 |- skos__scopeNote mesh__D008566
% 209.88/210.06 Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.%A%
% 209.88/210.06 |- skos__prefLabel mesh__D008566 Membranes
% 209.88/210.06 |- skos__altLabel mesh__D008566 Membrane Tissue
% 209.88/210.06 |- mesh__recordMaintainer mesh__D008566 lkt
% 209.88/210.06 |- rdf__type mesh__D008566sskos__Concept
% 209.88/210.06 |- skos__hiddenLabel mesh__D008566 Tissue, Membrane
% 209.88/210.06 |- mesh__dateEstablished mesh__D008566 1968-01-01
% 209.88/210.06 |- skos__altLabel mesh__D000583 Mead Johnson Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__hiddenLabel mesh__D000583
% 209.88/210.06 Bristol Myers Squibb Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__altLabel mesh__D000583 Collins Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__altLabel mesh__D000583 Lemery Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__altLabel mesh__D000583 Amiklin
% 209.88/210.06 |- skos__altLabel mesh__D000583 Apothecon Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__altLabel mesh__D000583 Biclin
% 209.88/210.06 |- skos__altLabel mesh__D000583 Fustery Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__altLabel mesh__D000583 Cryopharma Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__hiddenLabel mesh__D000583 BBK 8
% 209.88/210.06 |- skos__historyNote mesh__D000583 Kanamycin %28%1973-1974%29%
% 209.88/210.06 |- mesh__dateEstablished mesh__D000583 1987-01-01
% 209.88/210.06 |- mesh__historyNote mesh__D000583
% 209.88/210.06 87%28%75%29%; was see under KANAMYCIN 1975-86
% 209.88/210.06 |- mesh__recordMaintainer mesh__D000583 CCR
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D000583 2006
% 209.88/210.06 |- mesh__dateCreated mesh__D000583 1974-11-19
% 209.88/210.06 |- skos__altLabel mesh__D000583 Grossmann Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__hiddenLabel mesh__D000583 Medical, Amikacina
% 209.88/210.06 |- skos__historyNote mesh__D000583 Aminobutyric Acids %28%1973-1974%29%
% 209.88/210.06 |- skos__hiddenLabel mesh__D000583 BB K 8
% 209.88/210.06 |- rdf__type mesh__D000583sskos__Concept
% 209.88/210.06 |- skos__altLabel mesh__D000583 Norman Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__altLabel mesh__D000583 Son%27%s Brand of Amikacin Sulfate
% 209.88/210.06 |- mesh__dateRevised mesh__D000583 2005-06-30
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D000583 sjn
% 209.88/210.06 |- skos__altLabel mesh__D000583 Rovi Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__altLabel mesh__D000583 Galen Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__hiddenLabel mesh__D000583 Normon, Amikacina
% 209.88/210.06 |- skos__broader mesh__D000583smesh__D007612
% 209.88/210.06 |- mesh__recordOriginator mesh__D000583 NLM
% 209.88/210.06 |- skos__altLabel mesh__D000583 Amukin
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D000583
% 209.88/210.06 87; was see under KANAMYCIN 1975-86
% 209.88/210.06 |- skos__prefLabel mesh__D000583 Amikacin
% 209.88/210.06 |- skos__altLabel mesh__D000583
% 209.88/210.06 Bristol-Myers Squibb Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__altLabel mesh__D000583 Medical Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__altLabel mesh__D000583 Pisa Brand of Amikacin Sulfate
% 209.88/210.06 |- skos__scopeNote mesh__D000583
% 209.88/210.06 A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.%A%
% 209.88/210.06 |- skos__altLabel mesh__D000583 BB-K 8
% 209.88/210.06 |- skos__hiddenLabel mesh__D000583 BBK8
% 209.88/210.06 |- skos__altLabel mesh__D000583 Biklin
% 209.88/210.06 |- skos__hiddenLabel mesh__D000583 BB K8
% 209.88/210.06 |- skos__hiddenLabel mesh__D000583 Sulfate, Amikacin
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D013700 2002
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Arteritides, Giant Cell
% 209.88/210.06 |- skos__altLabel mesh__D013700 Horton Disease
% 209.88/210.06 |- skos__prefLabel mesh__D013700 Temporal Arteritis
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D013700 2003
% 209.88/210.06 |- skos__altLabel mesh__D013700 Horton%27%s Giant Cell Arteritis
% 209.88/210.06 |- skos__broader mesh__D013700smesh__D017445
% 209.88/210.06 |- skos__altLabel mesh__D013700 Giant Cell Arteritis
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Disease, Horton%27%s
% 209.88/210.06 |- skos__altLabel mesh__D013700 Aortitis, Giant Cell
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D013700 2006
% 209.88/210.06 |- mesh__recordOriginator mesh__D013700 NLM
% 209.88/210.06 |- skos__altLabel mesh__D013700 Giant Cell Aortitis, Horton%27%s
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Disease, Horton
% 209.88/210.06 |- skos__altLabel mesh__D013700 Arteritis, Temporal
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Arteritis, Cranial
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Juvenile Temporal Arteritides
% 209.88/210.06 |- skos__broader mesh__D013700smesh__D020293
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D013700 2001
% 209.88/210.06 |- skos__altLabel mesh__D013700 Giant Cell Arteritis, Horton
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Arteritis, Juvenile Temporal
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Arteritides, Cranial
% 209.88/210.06 |- skos__altLabel mesh__D013700 Horton%27%s Disease
% 209.88/210.06 |- mesh__recordMaintainer mesh__D013700 KEV
% 209.88/210.06 |- skos__altLabel mesh__D013700 Giant Cell Aortic Arteritis
% 209.88/210.06 |- skos__altLabel mesh__D013700 Arteritis, Giant Cell, Horton
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D013700 2005
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D013700 sjn
% 209.88/210.06 |- skos__related mesh__D013700smesh__D011111
% 209.88/210.06 |- skos__altLabel mesh__D013700 Arteritis, Giant Cell, Horton%27%s
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Aortitides, Giant Cell
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Hortons Disease
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D013700 2000
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Temporal Arteritis, Juvenile
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Temporal Arteritides
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Arteritides, Juvenile Temporal
% 209.88/210.06 |- mesh__dateRevised mesh__D013700 1999-11-08
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Cranial Arteritides
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Giant Cell Aortitides
% 209.88/210.06 |- skos__altLabel mesh__D013700 Horton Giant Cell Arteritis
% 209.88/210.06 |- skos__altLabel mesh__D013700 Cranial Arteritis
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Temporal Arteritides, Juvenile
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Arteritis, Giant Cell
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Arteritides, Temporal
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D013700 2004
% 209.88/210.06 |- skos__altLabel mesh__D013700 Giant Cell Aortitis
% 209.88/210.06 |- skos__hiddenLabel mesh__D013700 Giant Cell Arteritides
% 209.88/210.06 |- skos__scopeNote mesh__D013700
% 209.88/210.06 A systemic autoimmune vasculitis occurring primarily in people over the age of 50. Pathologic features include a necrotizing panarteritis including granulomas and giant cells. There is a predilection for involvement of central nervous system blood vessels and the most frequent neurologic complication is an OPTIC NEUROPATHY, ISCHEMIC. Large blood vessels may become involved, including the aorta. Clinical manifestations may include myalgias, weight loss, headache, visual loss, necrosis of the skin or tongue, and chest discomfort. Superficial scalp arteries may become tender and enlarged. A related condition, juvenile temporal arteritis, tends to occur in the first or second decade of life. %28%From Adams et al., Principles of Neurology, 6th ed, p856%29%%A%
% 209.88/210.06 |- rdf__type mesh__D013700sskos__Concept
% 209.88/210.06 |- skos__broader mesh__D013700smesh__D001167
% 209.88/210.06 |- mesh__dateCreated mesh__D013700 1999-01-01
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D018994
% 209.88/210.06 1996; for MYOSIN LIGHT CHAIN see MYOSINS 1982-1995; for MYOSIN ALKALI LIGHT CHAINS see MYOSINS 1990-1995%A%
% 209.88/210.06 |- skos__scopeNote mesh__D018994
% 209.88/210.06 The smaller subunits of MYOSINS that bind near the head groups of MYOSIN HEAVY CHAINS. The myosin light chains have a molecular weight of about 20 KDa and there are usually one essential and one regulatory pair of light chains associated with each heavy chain. Many myosin light chains that bind calcium are considered %22%calmodulin-like%22% proteins.%A%
% 209.88/210.06 |- mesh__historyNote mesh__D018994
% 209.88/210.06 1996; for MYOSIN LIGHT CHAIN use MYOSINS 1982-1995; for MYOSIN ALKALI LIGHT CHAINS use MYOSINS 1990-1995%A%
% 209.88/210.06 |- skos__broader mesh__D018994smesh__D002135
% 209.88/210.06 |- skos__altLabel mesh__D018994 Myosin Alkali Light Chains
% 209.88/210.06 |- mesh__recordOriginator mesh__D018994 TPW
% 209.88/210.06 |- mesh__recordMaintainer mesh__D018994 DRC
% 209.88/210.06 |- skos__historyNote mesh__D018994 Myosin %28%1969-1995%29%
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D018994 sjn
% 209.88/210.06 |- skos__altLabel mesh__D018994 Myosin Regulatory Light Chains
% 209.88/210.06 |- skos__prefLabel mesh__D018994 Myosin Light Chains
% 209.88/210.06 |- skos__hiddenLabel mesh__D018994 Light Chain, Myosin
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018994 2006
% 209.88/210.06 |- mesh__dateCreated mesh__D018994 1995-06-05
% 209.88/210.06 |- rdf__type mesh__D018994sskos__Concept
% 209.88/210.06 |- skos__altLabel mesh__D018994 Myosin Essential Light Chain
% 209.88/210.06 |- mesh__dateRevised mesh__D018994 2005-06-30
% 209.88/210.06 |- skos__broader mesh__D018994smesh__D009218
% 209.88/210.06 |- skos__altLabel mesh__D018994 Myosin Alkali Light Chain
% 209.88/210.06 |- skos__hiddenLabel mesh__D018994 Light Chains, Myosin
% 209.88/210.06 |- mesh__dateEstablished mesh__D018994 1996-01-01
% 209.88/210.06 |- skos__altLabel mesh__D018994 Myosin Light Chain
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 1996
% 209.88/210.06 |- skos__scopeNote mesh__D018196
% 209.88/210.06 A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.%A%
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D018196 94
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 2001
% 209.88/210.06 |- skos__annotation mesh__D018196
% 209.88/210.06 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with organ/neopl term %28%IM%29%%A%
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 2005
% 209.88/210.06 |- mesh__dateCreated mesh__D018196 1993-06-25
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 2004
% 209.88/210.06 |- mesh__recordOriginator mesh__D018196 PLS
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 1998
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 1997
% 209.88/210.06 |- mesh__dateRevised mesh__D018196 1995-06-08
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 2006
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 1999
% 209.88/210.06 |- skos__hiddenLabel mesh__D018196 Adenosquamous Carcinoma
% 209.88/210.06 |- skos__historyNote mesh__D018196
% 209.88/210.06 Carcinoma, Squamous Cell %28%1968-1993%29%
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 2002
% 209.88/210.06 |- rdf__type mesh__D018196sskos__Concept
% 209.88/210.06 |- mesh__dateEstablished mesh__D018196 1994-01-01
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D018196 PLS
% 209.88/210.06 |- skos__prefLabel mesh__D018196 Carcinoma, Adenosquamous
% 209.88/210.06 |- skos__hiddenLabel mesh__D018196 Adenosquamous Carcinomas
% 209.88/210.06 |- skos__historyNote mesh__D018196 Adenocarcinoma %28%1968-1993%29%
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 2000
% 209.88/210.06 |- skos__broader mesh__D018196smesh__D018193
% 209.88/210.06 |- skos__broader mesh__D018196smesh__D002277
% 209.88/210.06 |- mesh__historyNote mesh__D018196 94
% 209.88/210.06 |- skos__hiddenLabel mesh__D018196 Carcinomas, Adenosquamous
% 209.88/210.06 |- mesh__recordMaintainer mesh__D018196 KEV
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018196 2003
% 209.88/210.06 |- mesh__historyNote mesh__D004974
% 209.88/210.06 91%28%80%29%; was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79%A%
% 209.88/210.06 |- rdf__type mesh__D004974sskos__Concept
% 209.88/210.06 |- mesh__recordOriginator mesh__D004974 RLS
% 209.88/210.06 |- mesh__onlineNote mesh__D004974
% 209.88/210.06 use ETAZOLATE to search SQ 20009 1976-79
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D004974
% 209.88/210.06 91; was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79%A%
% 209.88/210.06 |- skos__historyNote mesh__D004974 Hydrazines %28%1973-1975%29%
% 209.88/210.06 |- skos__prefLabel mesh__D004974 Etazolate
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D004974 2004
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D004974 2002
% 209.88/210.06 |- skos__historyNote mesh__D004974 Pyrazoles %28%1973-1975%29%
% 209.88/210.06 |- mesh__dateEstablished mesh__D004974 1991-01-01
% 209.88/210.06 |- skos__scopeNote mesh__D004974
% 209.88/210.06 A potent phosphodiesterase inhibitor proposed as an antipsychotic agent.%A%
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D004974 2003
% 209.88/210.06 |- mesh__dateRevised mesh__D004974 2000-06-21
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D004974 2006
% 209.88/210.06 |- skos__historyNote mesh__D004974 Nicotinic Acids %28%1975%29%
% 209.88/210.06 |- skos__hiddenLabel mesh__D004974 SQ20009
% 209.88/210.06 |- skos__hiddenLabel mesh__D004974 SQ 20009
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D004974 2001
% 209.88/210.06 |- mesh__dateCreated mesh__D004974 1975-07-25
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D004974 2005
% 209.88/210.06 |- skos__historyNote mesh__D004974 Pyridines %28%1973-1974%29%
% 209.88/210.06 |- skos__broader mesh__D004974smesh__D009539
% 209.88/210.06 |- skos__hiddenLabel mesh__D004974 Hydrochloride, Etazolate
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D004974 sjn
% 209.88/210.06 |- mesh__recordMaintainer mesh__D004974 jmp
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D004176 sjn
% 209.88/210.06 |- skos__broader mesh__D004176smesh__D011743
% 209.88/210.06 |- skos__altLabel mesh__D004176 Curantyl
% 209.88/210.06 |- skos__altLabel mesh__D004176 Belmac Brand of Dipyridamole
% 209.88/210.06 |- skos__altLabel mesh__D004176 Ashbourne Brand of Dipyridamole
% 209.88/210.06 |- rdf__type mesh__D004176sskos__Concept
% 209.88/210.06 |- mesh__dateEstablished mesh__D004176 1966-01-01
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D004176 66; was PERSANTIN 1963-65
% 209.88/210.06 |- skos__prefLabel mesh__D004176 Dipyridamole
% 209.88/210.06 |- skos__altLabel mesh__D004176 IPRAD Brand of Dipyridamole
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D004176 2006
% 209.88/210.06 |- skos__altLabel mesh__D004176 Novopharm Brand of Dipyridamole
% 209.88/210.06 |- skos__altLabel mesh__D004176 Apotex Brand of Dipyridamole
% 209.88/210.06 |- mesh__historyNote mesh__D004176 66; was PERSANTIN 1963-65
% 209.88/210.06 |- skos__altLabel mesh__D004176 Boehringer Ingelheim Brand of Dipyridamole
% 209.88/210.06 |- skos__altLabel mesh__D004176 Persantin
% 209.88/210.06 |- mesh__dateRevised mesh__D004176 2005-06-30
% 209.88/210.06 |- mesh__dateCreated mesh__D004176 1999-01-01
% 209.88/210.06 |- skos__altLabel mesh__D004176 Dipyramidole
% 209.88/210.06 |- skos__altLabel mesh__D004176 Kurantil
% 209.88/210.06 |- skos__hiddenLabel mesh__D004176 Berlin Chemie Brand of Dipyridamole
% 209.88/210.06 |- skos__scopeNote mesh__D004176
% 209.88/210.06 A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. %28%From AMA Drug Evaluations Annual, 1994, p752%29%%A%
% 209.88/210.06 |- mesh__recordMaintainer mesh__D004176 exl
% 209.88/210.06 |- mesh__recordOriginator mesh__D004176 NLM
% 209.88/210.06 |- skos__altLabel mesh__D004176 Berlin-Chemie Brand of Dipyridamole
% 209.88/210.06 |- rdf__type mesh__D012608sskos__Concept
% 209.88/210.06 |- skos__related mesh__D012608smesh__D017096
% 209.88/210.06 |- skos__broader mesh__D012608smesh__D017096
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D012608 2001
% 209.88/210.06 |- skos__related mesh__D012608smesh__D011328
% 209.88/210.06 |- mesh__recordOriginator mesh__D012608 NLM
% 209.88/210.06 |- skos__annotation mesh__D012608
% 209.88/210.06 a prion dis; usually animal: check tag ANIMAL; if in sheep, coord IM with SHEEP %28%NIM%29% but do not index under SHEEP DISEASES; if in goats, coord IM with GOAT DISEASES %28%IM%29% %26% GOATS %28%NIM%29%%A%
% 209.88/210.06 |- mesh__dateEstablished mesh__D012608 1968-01-01
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D012608 68
% 209.88/210.06 |- mesh__dateCreated mesh__D012608 1999-01-01
% 209.88/210.06 |- skos__related mesh__D012608smesh__D018620
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D012608 2000
% 209.88/210.06 |- mesh__dateRevised mesh__D012608 1999-11-08
% 209.88/210.06 |- skos__altLabel mesh__D012608 Rida
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D012608 sjn
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D012608 2004
% 209.88/210.06 |- mesh__recordMaintainer mesh__D012608 KEV
% 209.88/210.06 |- skos__prefLabel mesh__D012608 Scrapie
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D012608 2006
% 209.88/210.06 |- skos__scopeNote mesh__D012608
% 209.88/210.06 A fatal disease of the nervous system in sheep and goats, characterized by pruritus, debility, and locomotor incoordination. It is caused by proteinaceous infectious particles called PRIONS.%A%
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D012608 2003
% 209.88/210.06 |- skos__broader mesh__D012608smesh__D012757
% 209.88/210.06 |- mesh__historyNote mesh__D012608 68%28%66%29%
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D012608 2002
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D012608 2005
% 209.88/210.06 |- skos__prefLabel mesh__D050727 Benzaldehyde Dehydrogenase %28%NADP+%29%
% 209.88/210.06 |- skos__altLabel mesh__D050727 NADP-Linked Benzaldehyde Dehydrogenase
% 209.88/210.06 |- mesh__historyNote mesh__D050727
% 209.88/210.06 2006%28%1980%29%; use ALDEHYDE OXIDOREDUCTASES 1978-1979
% 209.88/210.06 |- mesh__recordOriginator mesh__D050727 AKE
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D050727 2006
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D050727
% 209.88/210.06 2006; BENZALDEHYDE DEHYDROGENASE %28%NADP+%29% was indexed under ALDEHYDE OXIDOREDUCTASES 1978-2005%A%
% 209.88/210.06 |- skos__hiddenLabel mesh__D050727 Benzaldehyde Dehydrogenase, NADP-Linked
% 209.88/210.06 |- skos__hiddenLabel mesh__D050727 NADP Linked Benzaldehyde Dehydrogenase
% 209.88/210.06 |- skos__hiddenLabel mesh__D050727 Dehydrogenase, NADP-Linked Benzaldehyde
% 209.88/210.06 |- mesh__dateEstablished mesh__D050727 2006-01-01
% 209.88/210.06 |- rdf__type mesh__D050727sskos__Concept
% 209.88/210.06 |- skos__altLabel mesh__D050727 Benzaldehyde Dehydrogenase %28%NADP%29%
% 209.88/210.06 |- skos__broader mesh__D050727smesh__D000445
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D050727 sjn
% 209.88/210.06 |- skos__scopeNote mesh__D050727
% 209.88/210.06 An NADP+ dependent enzyme that catalyzes the oxidation of BENZALDEHYDE to BENZOIC ACID. It also plays a role in the degradation of TOLUENE and XYLENE.%A%
% 209.88/210.06 |- mesh__recordMaintainer mesh__D050727 AKE
% 209.88/210.06 |- mesh__dateCreated mesh__D050727 2005-06-30
% 209.88/210.06 |- skos__prefLabel mesh__D008567 Membranes, Artificial
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D008567 68
% 209.88/210.06 |- mesh__recordMaintainer mesh__D008567 nns
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D008567 2005
% 209.88/210.06 |- skos__broader mesh__D008567smesh__D001697
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D008567 2006
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D008567 sjn
% 209.88/210.06 |- mesh__dateEstablished mesh__D008567 1968-01-01
% 209.88/210.06 |- mesh__dateRevised mesh__D008567 2004-07-07
% 209.88/210.06 |- skos__altLabel mesh__D008567 Artificial Membranes
% 209.88/210.06 |- skos__hiddenLabel mesh__D008567 Artificial Membrane
% 209.88/210.06 |- skos__scopeNote mesh__D008567
% 209.88/210.06 Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis %28%RENAL DIALYSIS%29%, monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION.%A%
% 209.88/210.06 |- skos__broader mesh__D008567smesh__D040761
% 209.88/210.06 |- mesh__dateCreated mesh__D008567 1999-01-01
% 209.88/210.06 |- mesh__recordOriginator mesh__D008567 NLM
% 209.88/210.06 |- rdf__type mesh__D008567sskos__Concept
% 209.88/210.06 |- skos__hiddenLabel mesh__D008567 Membrane, Artificial
% 209.88/210.06 |- mesh__historyNote mesh__D008567 68%28%66%29%
% 209.88/210.06 |- skos__altLabel mesh__D000584 Amrad Brand of Amiloride Hydrochloride
% 209.88/210.06 |- skos__hiddenLabel mesh__D000584 Hydrochloride, Amiloride
% 209.88/210.06 |- rdf__type mesh__D000584sskos__Concept
% 209.88/210.06 |- skos__prefLabel mesh__D000584 Amiloride
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D000584 2006
% 209.88/210.06 |- mesh__dateRevised mesh__D000584 2005-06-30
% 209.88/210.06 |- skos__hiddenLabel mesh__D000584 Anhydrous Amiloride Hydrochloride
% 209.88/210.06 |- skos__altLabel mesh__D000584 Modamide
% 209.88/210.06 |- skos__altLabel mesh__D000584 Douglas Brand of Amiloride Hydrochloride
% 209.88/210.06 |- skos__altLabel mesh__D000584
% 209.88/210.06 Cahill May Roberts Brand of Amiloride Hydrochloride
% 209.88/210.06 |- skos__broader mesh__D000584smesh__D011719
% 209.88/210.06 |- skos__historyNote mesh__D000584 Diuretics %28%1966-1971%29%
% 209.88/210.06 |- skos__altLabel mesh__D000584
% 209.88/210.06 Trommsdorff Brand of Amiloride Hydrochloride
% 209.88/210.06 |- skos__altLabel mesh__D000584 Merck Brand of Amiloride Hydrochloride
% 209.88/210.06 |- mesh__dateCreated mesh__D000584 1999-01-01
% 209.88/210.06 |- mesh__dateEstablished mesh__D000584 1986-01-01
% 209.88/210.06 |- mesh__historyNote mesh__D000584
% 209.88/210.06 86%28%72%29%; was see under PYRAZINES 1975-85, was Prov 1972-74%A%
% 209.88/210.06 |- skos__hiddenLabel mesh__D000584 Trom, Amiduret
% 209.88/210.06 |- skos__altLabel mesh__D000584 Berolina Brand of Amiloride Hydrochloride
% 209.88/210.06 |- mesh__recordOriginator mesh__D000584 NLM
% 209.88/210.06 |- mesh__recordMaintainer mesh__D000584 ssb
% 209.88/210.06 |- skos__altLabel mesh__D000584 Alphapharm Brand of Amiloride Hydrochloride
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D000584
% 209.88/210.06 86; was see under PYRAZINES 1975-85
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D000584 sjn
% 209.88/210.06 |- skos__hiddenLabel mesh__D000584 Hydrochloride, Anhydrous Amiloride
% 209.88/210.06 |- skos__altLabel mesh__D000584
% 209.88/210.06 Merck Sharp %26% Dohme Brand of Amiloride Hydrochloride
% 209.88/210.06 |- skos__scopeNote mesh__D000584
% 209.88/210.06 A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p705%29%%A%
% 209.88/210.06 |- skos__historyNote mesh__D000584 Pyrazines %28%1966-1971%29%
% 209.88/210.06 |- mesh__recordOriginator mesh__D027721 ssb
% 209.88/210.06 |- mesh__dateRevised mesh__D027721 2002-07-02
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D027721 2003
% 209.88/210.06 |- mesh__historyNote mesh__D027721 2002
% 209.88/210.06 |- skos__prefLabel mesh__D027721 Amaranthus
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D027721 2006
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D027721 sjn
% 209.88/210.06 |- mesh__recordMaintainer mesh__D027721 ssb
% 209.88/210.06 |- skos__scopeNote mesh__D027721
% 209.88/210.06 A plant genus, in the family AMARANTHACEAE, best known as a source of high-protein grain crops and of Red Dye No. 2 %28%AMARANTH DYE%29%. Tumbleweed sometimes refers to Amaranthus but more often refers to SALSOLA.%A%
% 209.88/210.06 |- skos__historyNote mesh__D027721 Amaranth Dye %28%1988-2001%29%
% 209.88/210.06 |- skos__broader mesh__D027721smesh__D027703
% 209.88/210.06 |- mesh__dateEstablished mesh__D027721 2002-01-01
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D027721 2005
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D027721 2002
% 209.88/210.06 |- skos__historyNote mesh__D027721 Phytotherapy %28%1981-2001%29%
% 209.88/210.06 |- mesh__dateCreated mesh__D027721 2001-07-25
% 209.88/210.06 |- rdf__type mesh__D027721sskos__Concept
% 209.88/210.06 |- skos__annotation mesh__D027721
% 209.88/210.06 X ref REDROOT PIGWEED: REDROOT see SANGUINARIA is also available; AMARANTH DYE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.88/210.06 |- skos__altLabel mesh__D027721 Amaranth Plant
% 209.88/210.06 |- skos__historyNote mesh__D027721 Cereals %28%1980-2001%29%
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D027721 2004
% 209.88/210.06 |- skos__hiddenLabel mesh__D013701 Temporal Bones
% 209.88/210.06 |- skos__hiddenLabel mesh__D013701 Bone, Temporal
% 209.88/210.06 |- skos__related mesh__D013701smesh__D007758
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D013701 NLM
% 209.88/210.06 |- skos__broader mesh__D013701smesh__D012886
% 209.88/210.06 |- mesh__recordOriginator mesh__D013701 NLM
% 209.88/210.06 |- skos__prefLabel mesh__D013701 Temporal Bone
% 209.88/210.06 |- mesh__recordMaintainer mesh__D013701 NLM
% 209.88/210.06 |- mesh__dateCreated mesh__D013701 1999-01-01
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D013701 2006
% 209.88/210.06 |- mesh__dateRevised mesh__D013701 2005-07-06
% 209.88/210.06 |- rdf__type mesh__D013701sskos__Concept
% 209.88/210.06 |- skos__hiddenLabel mesh__D013701 Bones, Temporal
% 209.88/210.06 |- skos__annotation mesh__D013701
% 209.88/210.06 fractures: coord TEMPORAL BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with SKULL NEOPLASMS %28%IM%29%%A%
% 209.88/210.06 |- skos__prefLabel mesh__D018995 Myosin Heavy Chains
% 209.88/210.06 |- mesh__dateRevised mesh__D018995 2005-06-30
% 209.88/210.06 |- mesh__dateEstablished mesh__D018995 1996-01-01
% 209.88/210.06 |- skos__hiddenLabel mesh__D018995 Heavy Chains, Myosin
% 209.88/210.06 |- skos__historyNote mesh__D018995 Myosin %28%1971-1995%29%
% 209.88/210.06 |- skos__scopeNote mesh__D018995
% 209.88/210.06 The larger subunits of MYOSINS. The heavy chains have a molecular weight of about 230 kDa and each heavy chain is usually associated with a dissimilar pair of MYOSIN LIGHT CHAINS.%A%
% 209.88/210.06 |- mesh__recordOriginator mesh__D018995 TPW
% 209.88/210.06 |- mesh__dateCreated mesh__D018995 1995-06-05
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018995 2006
% 209.88/210.06 |- rdf__type mesh__D018995sskos__Concept
% 209.88/210.06 |- mesh__recordMaintainer mesh__D018995 DRC
% 209.88/210.06 |- skos__broader mesh__D018995smesh__D009218
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D018995 sjn
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D018995
% 209.88/210.06 1996; for MYOSIN HEAVY CHAIN see MYOSINS 1982-1995
% 209.88/210.06 |- skos__altLabel mesh__D018995 Myosin Heavy Chain
% 209.88/210.06 |- skos__hiddenLabel mesh__D018995 Heavy Chain, Myosin
% 209.88/210.06 |- mesh__historyNote mesh__D018995
% 209.88/210.06 1996; for MYOSIN HEAVY CHAIN use MYOSINS 1982-1995
% 209.88/210.06 |- mesh__dateCreated mesh__D051820 2005-06-30
% 209.88/210.06 |- mesh__historyNote mesh__D051820 2006
% 209.88/210.06 |- skos__hiddenLabel mesh__D051820 Transcription Factors, LEF
% 209.88/210.06 |- mesh__recordMaintainer mesh__D051820 DRC
% 209.88/210.06 |- skos__hiddenLabel mesh__D051820 Transcription Factors, TCF
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D051820 2006
% 209.88/210.06 |- skos__broader mesh__D051820smesh__D004268
% 209.88/210.06 |- skos__broader mesh__D051820smesh__D014157
% 209.88/210.06 |- rdf__type mesh__D051820sskos__Concept
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D051820 2006
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D051820 sjn
% 209.88/210.06 |- skos__altLabel mesh__D051820 Lymphoid Enhancer Factors
% 209.88/210.06 |- mesh__dateEstablished mesh__D051820 2006-01-01
% 209.88/210.06 |- skos__altLabel mesh__D051820 LEF Transcription Factors
% 209.88/210.06 |- skos__altLabel mesh__D051820 T-Cell Factors
% 209.88/210.06 |- skos__scopeNote mesh__D051820
% 209.88/210.06 A family of DNA-binding proteins that are primarily expressed in T-LYMPHOCYTES. They interact with BETA CATENIN and serve as transcriptional activators and repressors in a variety of developmental processes.%A%
% 209.88/210.06 |- skos__broader mesh__D051820smesh__D006609
% 209.88/210.06 |- skos__hiddenLabel mesh__D051820 T Cell Factors
% 209.88/210.06 |- skos__prefLabel mesh__D051820 TCF Transcription Factors
% 209.88/210.06 |- mesh__recordOriginator mesh__D051820 DRC
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 1997
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 1998
% 209.88/210.06 |- mesh__recordOriginator mesh__D018197 PLS
% 209.88/210.06 |- mesh__dateRevised mesh__D018197 1995-06-08
% 209.88/210.06 |- skos__broader mesh__D018197smesh__D018193
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 2006
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 1999
% 209.88/210.06 |- mesh__publicMeSHNote mesh__D018197 94
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 2001
% 209.88/210.06 |- skos__scopeNote mesh__D018197
% 209.88/210.06 A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. %28%Stedman, 25th ed%29%%A%
% 209.88/210.06 |- rdf__type mesh__D018197sskos__Concept
% 209.88/210.06 |- mesh__dateCreated mesh__D018197 1993-06-25
% 209.88/210.06 |- skos__historyNote mesh__D018197
% 209.88/210.06 Carcinoma, Hepatocellular %28%1966-1993%29%
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 2002
% 209.88/210.06 |- mesh__recordMaintainer mesh__D018197 KEV
% 209.88/210.06 |- mesh__historyNote mesh__D018197 94
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 2003
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D018197 PLS
% 209.88/210.06 |- mesh__dateEstablished mesh__D018197 1994-01-01
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 1996
% 209.88/210.06 |- skos__prefLabel mesh__D018197 Hepatoblastoma
% 209.88/210.06 |- skos__hiddenLabel mesh__D018197 Hepatoblastomas
% 209.88/210.06 |- skos__annotation mesh__D018197
% 209.88/210.06 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with LIVER NEOPLASMS %28%IM%29%%A%
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 2004
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 2005
% 209.88/210.06 |- mesh__activeMeSHYear mesh__D018197 2000
% 209.88/210.06 |- mesh__recordMaintainer mesh__D004975 CCR
% 209.88/210.06 |- skos__hiddenLabel mesh__D004975 Monohydrate, Ethacridine
% 209.88/210.06 |- skos__historyNote mesh__D004975 Diamines %28%1973-1974%29%
% 209.88/210.06 |- rdf__type mesh__D004975sskos__Concept
% 209.88/210.06 |- skos__hiddenLabel mesh__D004975 Monohydrate Ethacridine Lactate
% 209.88/210.06 |- skos__altLabel mesh__D004975 Fresenius Brand of Ethacridine Lactate
% 209.88/210.06 |- mesh__recordOriginator mesh__D004975 NLM
% 209.88/210.06 |- skos__altLabel mesh__D004975 Chinosol Brand of Ethacridine Lactate
% 209.88/210.06 |- skos__altLabel mesh__D004975 Acrinol
% 209.88/210.06 |- mesh__recordAuthorizer mesh__D004975 sjn
% 209.88/210.06 |- skos__prefLabel mesh__D004975 Ethacridine
% 209.88/210.07 |- skos__hiddenLabel mesh__D004975
% 209.88/210.07 Cassella med Brand of Ethacridine Lactate
% 209.88/210.07 |- skos__altLabel mesh__D004975 2,5-Diamino-7-ethoxyacridine
% 209.88/210.07 |- skos__hiddenLabel mesh__D004975 2,5 Diamino 7 ethoxyacridine
% 209.88/210.07 |- mesh__dateCreated mesh__D004975 1974-11-11
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004975 2006
% 209.88/210.07 |- skos__altLabel mesh__D004975 Neo Chinosol
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D004975
% 209.88/210.07 91; was see under ACRIDINES 1975-90
% 209.88/210.07 |- mesh__dateRevised mesh__D004975 2005-06-30
% 209.88/210.07 |- skos__historyNote mesh__D004975 Lactates %28%1968-1974%29%
% 209.88/210.07 |- skos__altLabel mesh__D004975 Cassella-med Brand of Ethacridine Lactate
% 209.88/210.07 |- skos__scopeNote mesh__D004975
% 209.88/210.07 A topically applied anti-infective agent.
% 209.88/210.07 |- mesh__dateEstablished mesh__D004975 1991-01-01
% 209.88/210.07 |- skos__historyNote mesh__D004975 Acridines %28%1968-1974%29%
% 209.88/210.07 |- mesh__historyNote mesh__D004975
% 209.88/210.07 91%28%75%29%; was see under ACRIDINES 1975-90
% 209.88/210.07 |- skos__hiddenLabel mesh__D004975 Lactate, Ethacridine
% 209.88/210.07 |- skos__broader mesh__D004975smesh__D000609
% 209.88/210.07 |- skos__altLabel mesh__D004177 Metamizole
% 209.88/210.07 |- mesh__dateRevised mesh__D004177 2005-06-30
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004177 2006
% 209.88/210.07 |- mesh__historyNote mesh__D004177
% 209.88/210.07 91%28%75%29%; was see under AMINOPYRINE 1975-90
% 209.88/210.07 |- skos__altLabel mesh__D004177 Methamizole
% 209.88/210.07 |- mesh__dateCreated mesh__D004177 1974-11-19
% 209.88/210.07 |- skos__historyNote mesh__D004177 Antipyrine %28%1972-1974%29%
% 209.88/210.07 |- skos__hiddenLabel mesh__D004177 Methanesulfonate, Noramidopyrine
% 209.88/210.07 |- skos__altLabel mesh__D004177 Dipyronium
% 209.88/210.07 |- skos__broader mesh__D004177smesh__D000632
% 209.88/210.07 |- skos__annotation mesh__D004177
% 209.88/210.07 a non-steroidal anti-inflamm agent; do not confuse with DIPYRINE see AMINOPYRINE, also an non-steroidal anti-inflamm agent%A%
% 209.88/210.07 |- mesh__recordOriginator mesh__D004177 NLM
% 209.88/210.07 |- skos__scopeNote mesh__D004177
% 209.88/210.07 A drug that has analgesic, anti-inflammatory, and antipyretic properties. It is the sodium sulfonate of AMINOPYRINE. Because of the risk of serious adverse effects its use is justified only in serious situations where no alternative is available or suitable. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p13%29%%A%
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D004177 sjn
% 209.88/210.07 |- skos__hiddenLabel mesh__D004177 Methanesulfonate Sodium, Noramidopyrine
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D004177
% 209.88/210.07 91; was see under AMINOPYRINE 1975-90
% 209.88/210.07 |- skos__historyNote mesh__D004177 Methanesulfonates %28%1974%29%
% 209.88/210.07 |- skos__altLabel mesh__D004177 Noramidopyrine Methanesulfonate Sodium
% 209.88/210.07 |- skos__altLabel mesh__D004177 Methampyrone
% 209.88/210.07 |- skos__altLabel mesh__D004177 Metamizol
% 209.88/210.07 |- skos__prefLabel mesh__D004177 Dipyrone
% 209.88/210.07 |- rdf__type mesh__D004177sskos__Concept
% 209.88/210.07 |- mesh__dateEstablished mesh__D004177 1991-01-01
% 209.88/210.07 |- skos__altLabel mesh__D004177 Novamidazophen
% 209.88/210.07 |- mesh__recordMaintainer mesh__D004177 ssb
% 209.88/210.07 |- rdf__type mesh__D009660sskos__Concept
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 1998
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 2000
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 1994
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 2003
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 1999
% 209.88/210.07 |- mesh__recordMaintainer mesh__D009660 PLS
% 209.88/210.07 |- mesh__dateCreated mesh__D009660 1999-01-01
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 2001
% 209.88/210.07 |- skos__prefLabel mesh__D009660 Northern Ireland
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 1995
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 2004
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D009660 PLS
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 2002
% 209.88/210.07 |- mesh__recordOriginator mesh__D009660 NLM
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 1996
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 2005
% 209.88/210.07 |- mesh__dateRevised mesh__D009660 1993-06-03
% 209.88/210.07 |- skos__annotation mesh__D009660
% 209.88/210.07 capital, Belfast; differentiate from IRELAND %28%Irish Free State, Eire%29%%A%
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 1997
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009660 2006
% 209.88/210.07 |- skos__broader mesh__D009660smesh__D006113
% 209.88/210.07 |- skos__scopeNote mesh__D050728
% 209.88/210.07 An NAD+ dependent enzyme that catalyzes the oxidation of betain aldehyde to BETAINE.%A%
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D050728 sjn
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D050728
% 209.88/210.07 2006; BETAINE-ALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1979-2005, %26% under NAD, OXIDOREDUCTASES %26% ALDEHYDES 1972-1978%A%
% 209.88/210.07 |- skos__prefLabel mesh__D050728 Betaine-Aldehyde Dehydrogenase
% 209.88/210.07 |- skos__hiddenLabel mesh__D050728 Aldehyde Oxidase, Betaine
% 209.88/210.07 |- skos__hiddenLabel mesh__D050728 Oxidase, Betaine Aldehyde
% 209.88/210.07 |- mesh__dateCreated mesh__D050728 2005-06-30
% 209.88/210.07 |- skos__hiddenLabel mesh__D050728 Dehydrogenase, Betaine Aldehyde
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D050728 2006
% 209.88/210.07 |- skos__hiddenLabel mesh__D050728 Dehydrogenase, Betaine-Aldehyde
% 209.88/210.07 |- mesh__recordOriginator mesh__D050728 AKE
% 209.88/210.07 |- skos__altLabel mesh__D050728 Betaine Aldehyde Dehydrogenase
% 209.88/210.07 |- rdf__type mesh__D050728sskos__Concept
% 209.88/210.07 |- skos__hiddenLabel mesh__D050728 Aldehyde Dehydrogenase, Betaine
% 209.88/210.07 |- skos__altLabel mesh__D050728 Betaine Aldehyde Oxidase
% 209.88/210.07 |- skos__altLabel mesh__D050728 Glycine Betaine Aldehyde Dehydrogenase
% 209.88/210.07 |- mesh__recordMaintainer mesh__D050728 AKE
% 209.88/210.07 |- mesh__historyNote mesh__D050728
% 209.88/210.07 2006%28%1980%29%; use ALDEHYDE OXIDOREDUCTASES 1979, %26% OXIDOREDUCTASES %26% ALDEHYDES 1972-1978%A%
% 209.88/210.07 |- mesh__dateEstablished mesh__D050728 2006-01-01
% 209.88/210.07 |- skos__broader mesh__D050728smesh__D000445
% 209.88/210.07 |- mesh__dateRevised mesh__D008568 2005-06-30
% 209.88/210.07 |- skos__prefLabel mesh__D008568 Memory
% 209.88/210.07 |- skos__annotation mesh__D008568 human %26% animal
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D008568 2006
% 209.88/210.07 |- mesh__recordMaintainer mesh__D008568 jls
% 209.88/210.07 |- mesh__dateCreated mesh__D008568 1999-01-01
% 209.88/210.07 |- skos__scopeNote mesh__D008568
% 209.88/210.07 Complex mental function having four distinct phases: %28%1%29% memorizing or learning, %28%2%29% retention, %28%3%29% recall, and %28%4%29% recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.%A%
% 209.88/210.07 |- rdf__type mesh__D008568sskos__Concept
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D008568 sjn
% 209.88/210.07 |- skos__broader mesh__D008568smesh__D007858
% 209.88/210.07 |- mesh__recordOriginator mesh__D008568 NLM
% 209.88/210.07 |- skos__annotation mesh__D000585 D25-26 qualif
% 209.88/210.07 |- skos__altLabel mesh__D000585 Beutlich Brand of Aminacrine Hydrochloride
% 209.88/210.07 |- mesh__dateCreated mesh__D000585 1979-02-28
% 209.88/210.07 |- skos__altLabel mesh__D000585 Aminoacridine Hydrochloride
% 209.88/210.07 |- skos__altLabel mesh__D000585 Acridinamine
% 209.88/210.07 |- mesh__dateEstablished mesh__D000585 1991-01-01
% 209.88/210.07 |- skos__historyNote mesh__D000585 Acridines %28%1966-1979%29%
% 209.88/210.07 |- skos__scopeNote mesh__D000585
% 209.88/210.07 A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator.%A%
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D000585 sjn
% 209.88/210.07 |- mesh__recordOriginator mesh__D000585 SH
% 209.88/210.07 |- mesh__dateRevised mesh__D000585 2004-07-07
% 209.88/210.07 |- skos__hiddenLabel mesh__D000585 Hydrochloride, Aminoacridine
% 209.88/210.07 |- mesh__historyNote mesh__D000585
% 209.88/210.07 91%28%80%29%; was see under AMINOACRIDINES 1980-90
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D000585 2005
% 209.88/210.07 |- skos__altLabel mesh__D000585 Sigma Brand of Aminacrine Hydrochloride
% 209.88/210.07 |- rdf__type mesh__D000585sskos__Concept
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D000585
% 209.88/210.07 91; was see under AMINOACRIDINES 1980-90
% 209.88/210.07 |- skos__hiddenLabel mesh__D000585 Hydrochloride, Aminacrine
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D000585 2006
% 209.88/210.07 |- skos__prefLabel mesh__D000585 Aminacrine
% 209.88/210.07 |- skos__hiddenLabel mesh__D000585 9 Aminoacridine
% 209.88/210.07 |- mesh__recordMaintainer mesh__D000585 mdb
% 209.88/210.07 |- skos__altLabel mesh__D000585 Aminoacridine
% 209.88/210.07 |- skos__broader mesh__D000585smesh__D000609
% 209.88/210.07 |- skos__altLabel mesh__D000585 9-Aminoacridine
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290 Nu Pharm Brand of Megestrol Acetate
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D019290 97
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290 Lin Megestrol
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290 LinMegestrol
% 209.88/210.07 |- skos__altLabel mesh__D019290 Lemery Brand of Megestrol Acetate
% 209.88/210.07 |- skos__altLabel mesh__D019290 Bristol-Myers Brand of Megestrol Acetate
% 209.88/210.07 |- mesh__recordMaintainer mesh__D019290 CCR
% 209.88/210.07 |- mesh__recordOriginator mesh__D019290 TPW
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290
% 209.88/210.07 Bristol Myers Squibb Brand of Megestrol Acetate
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290 Bristol Myers Brand of Megestrol Acetate
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D019290 sjn
% 209.88/210.07 |- rdf__type mesh__D019290sskos__Concept
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290 Nu Megestrol
% 209.88/210.07 |- skos__altLabel mesh__D019290 Megestat
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290 Acetate, Megestrol
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290 Apo Megestrol
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D019290 2006
% 209.88/210.07 |- mesh__dateEstablished mesh__D019290 1997-01-01
% 209.88/210.07 |- skos__altLabel mesh__D019290 Apotex Brand of Megestrol Acetate
% 209.88/210.07 |- skos__scopeNote mesh__D019290
% 209.88/210.07 Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. %28%From Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A%
% 209.88/210.07 |- skos__altLabel mesh__D019290 Megostat
% 209.88/210.07 |- skos__altLabel mesh__D019290 Nu-Pharm Brand of Megestrol Acetate
% 209.88/210.07 |- mesh__dateCreated mesh__D019290 1996-06-10
% 209.88/210.07 |- mesh__historyNote mesh__D019290 97;
% 209.88/210.07 |- mesh__dateRevised mesh__D019290 2005-06-30
% 209.88/210.07 |- skos__altLabel mesh__D019290 Madaus Brand of Megestrol Acetate
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290 ApoMegestrol
% 209.88/210.07 |- skos__prefLabel mesh__D019290 Megestrol Acetate
% 209.88/210.07 |- skos__altLabel mesh__D019290 Prasfarma Brand of Megestrol Acetate
% 209.88/210.07 |- skos__hiddenLabel mesh__D019290 NuMegestrol
% 209.88/210.07 |- skos__broader mesh__D019290smesh__D008535
% 209.88/210.07 |- skos__altLabel mesh__D019290 Linson Pharma Brand of Megestrol Acetate
% 209.88/210.07 |- skos__altLabel mesh__D019290 Squibb Brand of Megestrol Acetate
% 209.88/210.07 |- skos__historyNote mesh__D019290
% 209.88/210.07 Megestrol/analogs %26% derivatives %28%1980-1996%29%
% 209.88/210.07 |- skos__altLabel mesh__D019290
% 209.88/210.07 Bristol-Myers Squibb Brand of Megestrol Acetate
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D027722 2003
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D027722 2006
% 209.88/210.07 |- skos__prefLabel mesh__D027722 Convolvulaceae
% 209.88/210.07 |- mesh__dateEstablished mesh__D027722 2002-01-01
% 209.88/210.07 |- skos__scopeNote mesh__D027722
% 209.88/210.07 The morning glory family of flowering plants, of the order Solanales, which includes about 50 genera and at least 1,400 species. Leaves are alternate and flowers are funnel-shaped. Most are twining and erect herbs, with a few woody vines, trees, and shrubs.%A%
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D027722 2005
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D027722 2002
% 209.88/210.07 |- mesh__historyNote mesh__D027722 2002
% 209.88/210.07 |- mesh__recordMaintainer mesh__D027722 ssb
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D027722 sjn
% 209.88/210.07 |- rdf__type mesh__D027722sskos__Concept
% 209.88/210.07 |- mesh__dateRevised mesh__D027722 2002-07-03
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D027722 2004
% 209.88/210.07 |- skos__broader mesh__D027722smesh__D019684
% 209.88/210.07 |- skos__annotation mesh__D027722
% 209.88/210.07 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.88/210.07 |- mesh__recordOriginator mesh__D027722 ssb
% 209.88/210.07 |- mesh__dateCreated mesh__D027722 2001-07-25
% 209.88/210.07 |- skos__hiddenLabel mesh__D005270 Head, Femur
% 209.88/210.07 |- skos__broader mesh__D005270smesh__D005269
% 209.88/210.07 |- rdf__type mesh__D005270sskos__Concept
% 209.88/210.07 |- mesh__recordOriginator mesh__D005270 NLM
% 209.88/210.07 |- skos__hiddenLabel mesh__D005270 Femur Heads
% 209.88/210.07 |- mesh__dateCreated mesh__D005270 1999-01-01
% 209.88/210.07 |- mesh__dateRevised mesh__D005270 2005-06-30
% 209.88/210.07 |- skos__hiddenLabel mesh__D005270 Heads, Femur
% 209.88/210.07 |- skos__scopeNote mesh__D005270
% 209.88/210.07 The hemispheric articular surface at the upper extremity of the thigh bone. %28%Stedman, 26th ed%29%%A%
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D005270 2006
% 209.88/210.07 |- mesh__recordMaintainer mesh__D005270 ags
% 209.88/210.07 |- skos__annotation mesh__D005270
% 209.88/210.07 fract = FEMUR HEAD /inj %28%IM%29% + HIP FRACTURES %28%IM%29%; avascular or aseptic necrosis of hip goes under FEMUR HEAD NECROSIS%A%
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D005270 sjn
% 209.88/210.07 |- skos__prefLabel mesh__D005270 Femur Head
% 209.88/210.07 |- skos__scopeNote mesh__D013702
% 209.88/210.07 Lower lateral part of the cerebral hemisphere.
% 209.88/210.07 |- mesh__dateRevised mesh__D013702 1998-06-11
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D013702 2002
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D013702 1999
% 209.88/210.07 |- skos__hiddenLabel mesh__D013702 Temporal Lobes
% 209.88/210.07 |- mesh__dateCreated mesh__D013702 1999-01-01
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D013702 2006
% 209.88/210.07 |- rdf__type mesh__D013702sskos__Concept
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D013702 2004
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D013702 2005
% 209.88/210.07 |- mesh__recordMaintainer mesh__D013702 TPW
% 209.88/210.07 |- skos__hiddenLabel mesh__D013702 Lobe, Temporal
% 209.88/210.07 |- skos__annotation mesh__D013702
% 209.88/210.07 dis: coord IM with BRAIN DISEASES %28%IM%29%; neopl: coord IM with BRAIN NEOPLASMS %28%IM%29%%A%
% 209.88/210.07 |- mesh__recordOriginator mesh__D013702 NLM
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D013702 2001
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D013702 2003
% 209.88/210.07 |- skos__hiddenLabel mesh__D013702 Lobes, Temporal
% 209.88/210.07 |- skos__prefLabel mesh__D013702 Temporal Lobe
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D013702 2000
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D013702 SJN
% 209.88/210.07 |- skos__hiddenLabel mesh__D013702 Area, Wernicke
% 209.88/210.07 |- skos__broader mesh__D013702smesh__D002540
% 209.88/210.07 |- skos__annotation mesh__D018996
% 209.88/210.07 /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A%
% 209.88/210.07 |- skos__hiddenLabel mesh__D018996 P2 Protein, Myelin
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 2003
% 209.88/210.07 |- mesh__dateCreated mesh__D018996 1995-06-08
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 2006
% 209.88/210.07 |- rdf__type mesh__D018996sskos__Concept
% 209.88/210.07 |- skos__altLabel mesh__D018996 Myelin Basic Protein P2
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 1998
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 2000
% 209.88/210.07 |- skos__hiddenLabel mesh__D018996 Protein, P2
% 209.88/210.07 |- skos__altLabel mesh__D018996 P2 Protein
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 2004
% 209.88/210.07 |- mesh__dateEstablished mesh__D018996 1996-01-01
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 2001
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 1996
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 1999
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D018996
% 209.88/210.07 96; MYELIN P2 PROTEINS was indexed under ENCEPHALITOGENIC BASIC PROTEINS 1982-95 %26% MYELIN PROTEINS 1980-81%A%
% 209.88/210.07 |- skos__broader mesh__D018996smesh__D004676
% 209.88/210.07 |- skos__scopeNote mesh__D018996
% 209.88/210.07 A positively charged protein found in peripheral nervous system myelin. Sensitive immunological techniques have demonstrated that P2 is expressed in small amounts of central nervous system myelin sheaths of some species. It is an antigen for experimental allergic neuritis %28%NEURITIS, EXPERIMENTAL ALLERGIC%29%, the peripheral nervous system counterpart of experimental allergic encephalomyelitis. %28%From Siegel et al., Basic Neurochemistry, 5th ed, p133%29%%A%
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 2002
% 209.88/210.07 |- skos__hiddenLabel mesh__D018996 Protein, Myelin P2
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 1997
% 209.88/210.07 |- skos__historyNote mesh__D018996 Myelin Basic Proteins %28%1982-1995%29%
% 209.88/210.07 |- mesh__historyNote mesh__D018996
% 209.88/210.07 96; was MYELIN P2 PROTEINS %28%NM%29% 1980-95
% 209.88/210.07 |- skos__historyNote mesh__D018996 Myelin Proteins %28%1980-1981%29%
% 209.88/210.07 |- skos__prefLabel mesh__D018996 Myelin P2 Protein
% 209.88/210.07 |- mesh__onlineNote mesh__D018996
% 209.88/210.07 use MYELIN P2 PROTEIN %28%NM%29% to search MYELIN P2 PROTEINS 1980-95%A%
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018996 2005
% 209.88/210.07 |- mesh__historyNote mesh__D051821 2006%28%1991%29%
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D051821 2006
% 209.88/210.07 |- skos__prefLabel mesh__D051821 Lymphoid Enhancer-Binding Factor 1
% 209.88/210.07 |- mesh__dateCreated mesh__D051821 2005-06-30
% 209.88/210.07 |- rdf__type mesh__D051821sskos__Concept
% 209.88/210.07 |- skos__altLabel mesh__D051821 LEF-1 Transcription Factor
% 209.88/210.07 |- mesh__recordMaintainer mesh__D051821 DRC
% 209.88/210.07 |- skos__scopeNote mesh__D051821
% 209.88/210.07 A T-cell factor that plays an essential role in EMBRYONIC DEVELOPMENT.%A%
% 209.88/210.07 |- skos__hiddenLabel mesh__D051821 LEF 1 Transcription Factor
% 209.88/210.07 |- skos__broader mesh__D051821smesh__D051820
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D051821
% 209.88/210.07 2006; LYMPHOID ENHANCER-BINDING FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1995-2005, %26% under NUCLEAR PROTEINS 1991-1994%A%
% 209.88/210.07 |- skos__hiddenLabel mesh__D051821 Transcription Factor, LEF-1
% 209.88/210.07 |- mesh__recordOriginator mesh__D051821 DRC
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D051821 sjn
% 209.88/210.07 |- skos__hiddenLabel mesh__D051821 Lymphoid Enhancer Binding Factor 1
% 209.88/210.07 |- mesh__dateEstablished mesh__D051821 2006-01-01
% 209.88/210.07 |- mesh__recordOriginator mesh__D018198 PLS
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 2000
% 209.88/210.07 |- mesh__dateRevised mesh__D018198 1995-06-08
% 209.88/210.07 |- skos__historyNote mesh__D018198
% 209.88/210.07 Neoplasms, Germ Cell and Embryonal %28%1966-1993%29%
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 2003
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 1996
% 209.88/210.07 |- skos__broader mesh__D018198smesh__D018193
% 209.88/210.07 |- skos__scopeNote mesh__D018198
% 209.88/210.07 A malignant tumor composed of more than one type of neoplastic tissue. %28%Dorland, 27th ed%29%%A%
% 209.88/210.07 |- skos__annotation mesh__D018198
% 209.88/210.07 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with organ/neopl term %28%IM%29%%A%
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 2006
% 209.88/210.07 |- skos__historyNote mesh__D018198 Adenoma, Pleomorphic %28%1966-1993%29%
% 209.88/210.07 |- skos__hiddenLabel mesh__D018198 Tumors, Malignant Mixed
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 1999
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 2002
% 209.88/210.07 |- rdf__type mesh__D018198sskos__Concept
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 2005
% 209.88/210.07 |- skos__hiddenLabel mesh__D018198 Malignant Mixed Tumor
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 1998
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D018198 94
% 209.88/210.07 |- mesh__recordMaintainer mesh__D018198 KEV
% 209.88/210.07 |- skos__hiddenLabel mesh__D018198 Tumor, Malignant Mixed
% 209.88/210.07 |- mesh__dateCreated mesh__D018198 1993-06-25
% 209.88/210.07 |- skos__hiddenLabel mesh__D018198 Malignant Mixed Tumors
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D018198 PLS
% 209.88/210.07 |- skos__hiddenLabel mesh__D018198 Mixed Tumors, Malignant
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 2004
% 209.88/210.07 |- skos__prefLabel mesh__D018198 Mixed Tumor, Malignant
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 2001
% 209.88/210.07 |- mesh__historyNote mesh__D018198 94
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D018198 1997
% 209.88/210.07 |- mesh__dateEstablished mesh__D018198 1994-01-01
% 209.88/210.07 |- mesh__recordOriginator mesh__D004976 NLM
% 209.88/210.07 |- skos__altLabel mesh__D004976 Etacrynic Acid
% 209.88/210.07 |- skos__altLabel mesh__D004976 Ethacrinic Acid
% 209.88/210.07 |- mesh__recordMaintainer mesh__D004976 exl
% 209.88/210.07 |- skos__hiddenLabel mesh__D004976 Acid, Etacrynic
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D004976 sjn
% 209.88/210.07 |- skos__hiddenLabel mesh__D004976 Acid, Ethacrynic
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D004976 66
% 209.88/210.07 |- skos__prefLabel mesh__D004976 Ethacrynic Acid
% 209.88/210.07 |- skos__hiddenLabel mesh__D004976 Sodium, Ethacrynate
% 209.88/210.07 |- mesh__dateEstablished mesh__D004976 1966-01-01
% 209.88/210.07 |- mesh__dateCreated mesh__D004976 1999-01-01
% 209.88/210.07 |- mesh__dateRevised mesh__D004976 2005-06-30
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004976 2006
% 209.88/210.07 |- skos__broader mesh__D004976smesh__D010642
% 209.88/210.07 |- skos__altLabel mesh__D004976 Ethacrynic Acid, Sodium Salt
% 209.88/210.07 |- skos__scopeNote mesh__D004976
% 209.88/210.07 A compound that inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. This compound has been classified as a loop or high ceiling diuretic.%A%
% 209.88/210.07 |- skos__hiddenLabel mesh__D004976 Acid, Ethacrinic
% 209.88/210.07 |- mesh__historyNote mesh__D004976 66%28%63%29%
% 209.88/210.07 |- rdf__type mesh__D004976sskos__Concept
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D051023
% 209.88/210.07 2006; BID PROTEIN was indexed under CARRIER PROTEINS 1996-2005%A%
% 209.88/210.07 |- rdf__type mesh__D051023sskos__Concept
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D051023 ags
% 209.88/210.07 |- skos__scopeNote mesh__D051023
% 209.88/210.07 A member of the Bcl-2 protein family that reversibly binds MEMBRANES. It is a pro-apoptotic protein that is activated by caspase cleavage.%A%
% 209.88/210.07 |- mesh__dateEstablished mesh__D051023 2006-01-01
% 209.88/210.07 |- skos__altLabel mesh__D051023 Bid Protein
% 209.88/210.07 |- mesh__recordMaintainer mesh__D051023 ags
% 209.88/210.07 |- mesh__dateRevised mesh__D051023 2005-07-11
% 209.88/210.07 |- mesh__recordOriginator mesh__D051023 DRC
% 209.88/210.07 |- mesh__historyNote mesh__D051023 2006%28%1996%29%
% 209.88/210.07 |- mesh__dateCreated mesh__D051023 2005-06-30
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D051023 2006A
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D051023 2006
% 209.88/210.07 |- skos__altLabel mesh__D051023 Truncated Bid Protein
% 209.88/210.07 |- skos__prefLabel mesh__D051023
% 209.88/210.07 BH3 Interacting Domain Death Agonist Protein
% 209.88/210.07 |- skos__broader mesh__D051023smesh__D019253
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 2002
% 209.88/210.07 |- skos__scopeNote mesh__D004178
% 209.88/210.07 A contact herbicide used also to produce desiccation and defoliation. %28%From Merck Index, 11th ed%29%%A%
% 209.88/210.07 |- mesh__recordMaintainer mesh__D004178 JRT
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 2003
% 209.88/210.07 |- mesh__dateCreated mesh__D004178 1999-01-01
% 209.88/210.07 |- mesh__dateRevised mesh__D004178 1995-06-08
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 1996
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 2004
% 209.88/210.07 |- mesh__historyNote mesh__D004178
% 209.88/210.07 91%28%71%29%; was see under PYRIDINIUM COMPOUNDS 1971-90
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 1997
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 2000
% 209.88/210.07 |- skos__hiddenLabel mesh__D004178 Dibromide, Diquat
% 209.88/210.07 |- mesh__recordOriginator mesh__D004178 NLM
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 2001
% 209.88/210.07 |- skos__historyNote mesh__D004178 Pyridinium Compounds %28%1968-1970%29%
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D004178 PLS
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D004178
% 209.88/210.07 91; was see under PYRIDINIUM COMPOUNDS 1971-90
% 209.88/210.07 |- rdf__type mesh__D004178sskos__Concept
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 2005
% 209.88/210.07 |- skos__broader mesh__D004178smesh__D011726
% 209.88/210.07 |- skos__historyNote mesh__D004178 Herbicides %28%1966-1970%29%
% 209.88/210.07 |- mesh__dateEstablished mesh__D004178 1991-01-01
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 1998
% 209.88/210.07 |- skos__prefLabel mesh__D004178 Diquat
% 209.88/210.07 |- skos__annotation mesh__D004178 an herbicide
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 2006
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D004178 1999
% 209.88/210.07 |- skos__altLabel mesh__D009661 Paxtibi
% 209.88/210.07 |- mesh__dateCreated mesh__D009661 1999-01-01
% 209.88/210.07 |- skos__altLabel mesh__D009661 Dista Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- skos__prefLabel mesh__D009661 Nortriptyline
% 209.88/210.07 |- skos__altLabel mesh__D009661
% 209.88/210.07 Reig Jofre Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- skos__altLabel mesh__D009661 Allegron
% 209.88/210.07 |- mesh__dateRevised mesh__D009661 2005-07-07
% 209.88/210.07 |- skos__hiddenLabel mesh__D009661
% 209.88/210.07 Nu Pharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- skos__altLabel mesh__D009661 Desitriptyline
% 209.88/210.07 |- skos__hiddenLabel mesh__D009661 Nu Nortriptyline
% 209.88/210.07 |- skos__hiddenLabel mesh__D009661 Apo Nortriptyline
% 209.88/210.07 |- skos__hiddenLabel mesh__D009661 Gen Nortriptyline
% 209.88/210.07 |- skos__altLabel mesh__D009661
% 209.88/210.07 Genpharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- mesh__recordAuthorizer mesh__D009661 ags
% 209.88/210.07 |- skos__broader mesh__D009661smesh__D003986
% 209.88/210.07 |- skos__altLabel mesh__D009661 Lilly Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- skos__altLabel mesh__D009661 Apotex Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- skos__altLabel mesh__D009661
% 209.88/210.07 Lundbeck Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- skos__hiddenLabel mesh__D009661 ratio Nortriptyline
% 209.88/210.07 |- skos__hiddenLabel mesh__D009661 PMS Nortriptyline
% 209.88/210.07 |- mesh__historyNote mesh__D009661 68%28%65%29%
% 209.88/210.07 |- skos__hiddenLabel mesh__D009661 Novo Nortriptyline
% 209.88/210.07 |- mesh__dateEstablished mesh__D009661 1968-01-01
% 209.88/210.07 |- skos__altLabel mesh__D009661 Desmethylamitriptylin
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009661 2006
% 209.88/210.07 |- skos__altLabel mesh__D009661
% 209.88/210.07 Ratiopharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D009661 2006A
% 209.88/210.07 |- skos__altLabel mesh__D009661
% 209.88/210.07 Nu-Pharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- skos__altLabel mesh__D009661
% 209.88/210.07 Novopharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- rdf__type mesh__D009661sskos__Concept
% 209.88/210.07 |- mesh__recordOriginator mesh__D009661 NLM
% 209.88/210.07 |- skos__altLabel mesh__D009661
% 209.88/210.07 Pharmascience Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- skos__hiddenLabel mesh__D009661 Hydrochloride, Nortriptyline
% 209.88/210.07 |- skos__scopeNote mesh__D009661
% 209.88/210.07 A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.%A%
% 209.88/210.07 |- skos__altLabel mesh__D009661
% 209.88/210.07 Mallinckrodt Brand of Nortriptyline Hydrochloride
% 209.88/210.07 |- mesh__recordMaintainer mesh__D009661 ags
% 209.88/210.07 |- mesh__publicMeSHNote mesh__D009661 68
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D008569 2005
% 209.88/210.07 |- mesh__dateRevised mesh__D008569 1999-12-06
% 209.88/210.07 |- skos__hiddenLabel mesh__D008569 Memory Losses
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D008569 2000
% 209.88/210.07 |- skos__broader mesh__D008569smesh__D019954
% 209.88/210.07 |- mesh__dateEstablished mesh__D008569 1969-01-01
% 209.88/210.07 |- mesh__historyNote mesh__D008569 1969
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D008569 2000A
% 209.88/210.07 |- skos__hiddenLabel mesh__D008569 Cognitive Retention Disorders
% 209.88/210.07 |- mesh__dateCreated mesh__D008569 1999-01-01
% 209.88/210.07 |- skos__hiddenLabel mesh__D008569 Deficit, Memory
% 209.88/210.07 |- skos__hiddenLabel mesh__D008569 Memory Deficit
% 209.88/210.07 |- mesh__recordOriginator mesh__D008569 NLM
% 209.88/210.07 |- skos__hiddenLabel mesh__D008569 Semantic Memory Disorders
% 209.88/210.07 |- skos__hiddenLabel mesh__D008569 Memory Disorders, Semantic
% 209.88/210.07 |- skos__historyNote mesh__D008569 Memory %28%1966-1968%29%
% 209.88/210.07 |- skos__hiddenLabel mesh__D008569 Spatial Memory Disorders
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D008569 2004
% 209.88/210.07 |- skos__hiddenLabel mesh__D008569 Memory Disorders, Spatial
% 209.88/210.07 |- mesh__activeMeSHYear mesh__D008569 2002
% 209.88/210.08 |- skos__hiddenLabel mesh__D008569 Cognitive Retention Disorder
% 209.88/210.08 |- skos__altLabel mesh__D008569 Retention Disorders, Cognitive
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D008569 2003
% 209.88/210.08 |- skos__hiddenLabel mesh__D008569 Retention Disorder, Cognitive
% 209.88/210.08 |- skos__altLabel mesh__D008569 Semantic Memory Disorder
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D008569 ags
% 209.88/210.08 |- skos__hiddenLabel mesh__D008569 Memory Disorders, Age Related
% 209.88/210.08 |- mesh__recordMaintainer mesh__D008569 ags
% 209.88/210.08 |- skos__altLabel mesh__D008569 Spatial Memory Disorder
% 209.88/210.08 |- skos__hiddenLabel mesh__D008569 Deficits, Memory
% 209.88/210.08 |- skos__prefLabel mesh__D008569 Memory Disorders
% 209.88/210.08 |- skos__hiddenLabel mesh__D008569 Memory Disorder, Age-Related
% 209.88/210.08 |- skos__historyNote mesh__D008569 Deja Vu %28%1968%29%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D008569 2006
% 209.88/210.08 |- skos__scopeNote mesh__D008569
% 209.88/210.08 Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM %28%see also ALCOHOL AMNESTIC DISORDER%29%; SCHIZOPHRENIA; and other conditions.%A%
% 209.88/210.08 |- skos__altLabel mesh__D008569 Memory Disorders, Age-Related
% 209.88/210.08 |- skos__historyNote mesh__D008569 Amnesia %28%1966-1968%29%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D008569 2001
% 209.88/210.08 |- rdf__type mesh__D008569sskos__Concept
% 209.88/210.08 |- skos__hiddenLabel mesh__D008569 Age-Related Memory Disorder
% 209.88/210.08 |- skos__hiddenLabel mesh__D008569 Memory Disorder
% 209.88/210.08 |- skos__hiddenLabel mesh__D008569 Age Related Memory Disorders
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D008569 1969
% 209.88/210.08 |- skos__broader mesh__D007106Q000627smesh__D007106
% 209.88/210.08 |- mesh__preferredCombination mesh__D007106Q000627smesh__D007116
% 209.88/210.08 |- rdf__type mesh__D007106Q000627smesh__CompoundConcept
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D000586 2003
% 209.88/210.08 |- mesh__dateCreated mesh__D000586 1999-01-01
% 209.88/210.08 |- skos__historyNote mesh__D000586 Chemistry, Organic %28%1966-1970%29%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D000586 2004
% 209.88/210.08 |- skos__broader mesh__D000586smesh__D002625
% 209.88/210.08 |- mesh__recordOriginator mesh__D000586 NLM
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D000586 2005
% 209.88/210.08 |- skos__annotation mesh__D000586
% 209.88/210.08 almost never IM; enzymatic amination: coord NIM with TRANSAMINASES %28%IM%29% + substrate %28%NIM%29% or specific transaminase %28%IM%29%%A%
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D000586 sjn
% 209.88/210.08 |- rdf__type mesh__D000586sskos__Concept
% 209.88/210.08 |- skos__hiddenLabel mesh__D000586 Aminations
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D000586 2006
% 209.88/210.08 |- skos__prefLabel mesh__D000586 Amination
% 209.88/210.08 |- skos__broader mesh__D000586smesh__D008660
% 209.88/210.08 |- skos__scopeNote mesh__D000586
% 209.88/210.08 The creation of an amine. It can be produced by the addition of an amino group to an organic compound or reduction of a nitro group.%A%
% 209.88/210.08 |- mesh__dateEstablished mesh__D000586 1974-01-01
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D000586 2001
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D000586 74
% 209.88/210.08 |- mesh__historyNote mesh__D000586 74%28%71%29%
% 209.88/210.08 |- skos__related mesh__D000586smesh__D003641
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D000586 2002
% 209.88/210.08 |- mesh__dateRevised mesh__D000586 2000-06-21
% 209.88/210.08 |- mesh__recordMaintainer mesh__D000586 adp
% 209.88/210.08 |- skos__hiddenLabel mesh__D019291 Base, Cranial
% 209.88/210.08 |- mesh__recordOriginator mesh__D019291 TGC
% 209.88/210.08 |- skos__altLabel mesh__D019291 Basicranium
% 209.88/210.08 |- skos__altLabel mesh__D019291 Basis cranii
% 209.88/210.08 |- skos__altLabel mesh__D019291 Cranial Base
% 209.88/210.08 |- skos__broader mesh__D019291smesh__D006257
% 209.88/210.08 |- mesh__historyNote mesh__D019291 97
% 209.88/210.08 |- mesh__dateEstablished mesh__D019291 1997-01-01
% 209.88/210.08 |- mesh__dateCreated mesh__D019291 1996-06-10
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D019291 97
% 209.88/210.08 |- skos__annotation mesh__D019291
% 209.88/210.08 GEN: prefer specifics; NIM when merely locational; neopl = SKULL BASE NEOPLASMS%A%
% 209.88/210.08 |- rdf__type mesh__D019291sskos__Concept
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019291 2004
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019291 2006
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D019291 sjn
% 209.88/210.08 |- skos__altLabel mesh__D019291 Base of Skull
% 209.88/210.08 |- mesh__dateRevised mesh__D019291 2002-07-02
% 209.88/210.08 |- skos__prefLabel mesh__D019291 Skull Base
% 209.88/210.08 |- skos__scopeNote mesh__D019291
% 209.88/210.08 The inferior region of the skull consisting of an internal %28%cerebral%29%, and an external %28%basilar%29% surface.%A%
% 209.88/210.08 |- skos__broader mesh__D019291smesh__D012886
% 209.88/210.08 |- skos__historyNote mesh__D019291 Skull %28%1966-1996%29%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019291 2003
% 209.88/210.08 |- mesh__recordMaintainer mesh__D019291 ags
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019291 2005
% 209.88/210.08 |- skos__hiddenLabel mesh__D019291 Base, Skull
% 209.88/210.08 |- skos__related mesh__D027723smesh__D027742
% 209.88/210.08 |- skos__annotation mesh__D027723
% 209.88/210.08 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D027723 2006
% 209.88/210.08 |- skos__altLabel mesh__D027723 Pseudo-Yam
% 209.88/210.08 |- mesh__recordOriginator mesh__D027723 ssb
% 209.88/210.08 |- skos__scopeNote mesh__D027723
% 209.88/210.08 A plant species of the genus IPOMOEA, family CONVOLVULACEAE. Some cultivars are sweet and edible whereas bitter varieties are a source of SAPONINS. This sweet potato is sometimes referred to as a yam %28%DIOSCOREA%29%.%A%
% 209.88/210.08 |- mesh__historyNote mesh__D027723 2002; use Solanaceae 1998-2001
% 209.88/210.08 |- rdf__type mesh__D027723sskos__Concept
% 209.88/210.08 |- mesh__recordMaintainer mesh__D027723 ssb
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D027723 2003
% 209.88/210.08 |- mesh__dateEstablished mesh__D027723 2002-01-01
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D027723 2002; see Solanaceae 1998-2001
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D027723 2004
% 209.88/210.08 |- skos__prefLabel mesh__D027723 Ipomoea batatas
% 209.88/210.08 |- skos__altLabel mesh__D027723 Yam, Pseudo
% 209.88/210.08 |- skos__historyNote mesh__D027723 Solanaceae %28%1998-2001%29%
% 209.88/210.08 |- skos__broader mesh__D027723smesh__D027741
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D027723 sjn
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D027723 2005
% 209.88/210.08 |- mesh__dateRevised mesh__D027723 2002-07-03
% 209.88/210.08 |- mesh__dateCreated mesh__D027723 2001-07-25
% 209.88/210.08 |- rdf__type mesh__D005271sskos__Concept
% 209.88/210.08 |- skos__altLabel mesh__D005271 Avascular Necrosis of Femur Head
% 209.88/210.08 |- mesh__dateCreated mesh__D005271 1999-01-01
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D005271 2004
% 209.88/210.08 |- mesh__dateEstablished mesh__D005271 1973-01-01
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D005271 sjn
% 209.88/210.08 |- skos__altLabel mesh__D005271 Necrosis, Aseptic, of Femur Head
% 209.88/210.08 |- skos__scopeNote mesh__D005271
% 209.88/210.08 Aseptic or avascular necrosis of the femoral head. The major types are idiopathic %28%primary%29%, as a complication of fractures or dislocations, and LEGG-PERTHES DISEASE.%A%
% 209.88/210.08 |- skos__historyNote mesh__D005271 Femur Head %28%1966-1972%29%
% 209.88/210.08 |- skos__hiddenLabel mesh__D005271 Head Necrosis, Femur
% 209.88/210.08 |- skos__historyNote mesh__D005271 Bone Diseases %28%1966-1972%29%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D005271 2005
% 209.88/210.08 |- skos__hiddenLabel mesh__D005271 Necrosis, Femur Head
% 209.88/210.08 |- mesh__historyNote mesh__D005271 73
% 209.88/210.08 |- skos__broader mesh__D005271smesh__D010020
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D005271 2000
% 209.88/210.08 |- mesh__recordOriginator mesh__D005271 NLM
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D005271 2006
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D005271
% 209.88/210.08 73; LEGG-PERTHES DISEASE was see under OSTEOCHONDRITIS 1963-78%A%
% 209.88/210.08 |- skos__prefLabel mesh__D005271 Femur Head Necrosis
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D005271 2001
% 209.88/210.08 |- skos__historyNote mesh__D005271 Necrosis %28%1966-1972%29%
% 209.88/210.08 |- mesh__recordMaintainer mesh__D005271 TGC
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D005271 2002
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D005271 2003
% 209.88/210.08 |- mesh__dateRevised mesh__D005271 1999-11-03
% 209.88/210.08 |- skos__hiddenLabel mesh__D005271 Femur Head Necroses
% 209.88/210.08 |- skos__scopeNote mesh__D046688
% 209.88/210.08 Number of deaths of children between one year of age to 12 years of age in a given population.%A%
% 209.88/210.08 |- mesh__recordMaintainer mesh__D046688 lkt
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D046688 sjn
% 209.88/210.08 |- skos__hiddenLabel mesh__D046688 Child Mortalities
% 209.88/210.08 |- skos__broader mesh__D046688smesh__D009026
% 209.88/210.08 |- mesh__dateCreated mesh__D046688 2004-07-07
% 209.88/210.08 |- skos__altLabel mesh__D046688 Mortality, Child
% 209.88/210.08 |- skos__annotation mesh__D046688
% 209.88/210.08 a statistical concept; check the tag CHILD, PRESCHOOL or CHILD%A%
% 209.88/210.08 |- skos__prefLabel mesh__D046688 Child Mortality
% 209.88/210.08 |- mesh__dateEstablished mesh__D046688 2005-01-01
% 209.88/210.08 |- rdf__type mesh__D046688sskos__Concept
% 209.88/210.08 |- mesh__recordOriginator mesh__D046688 lkt
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D046688 2005
% 209.88/210.08 |- skos__historyNote mesh__D046688 Infant Mortality %28%1980-2004%29%
% 209.88/210.08 |- skos__hiddenLabel mesh__D046688 Mortalities, Child
% 209.88/210.08 |- mesh__historyNote mesh__D046688 2005; use INFANT MORTALITY 1980-2004
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D046688
% 209.88/210.08 2005; see INFANT MORTALITY 1980-2004
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D046688 2006
% 209.88/210.08 |- skos__historyNote mesh__D046688 Mortality %28%1966-2004%29%
% 209.88/210.08 |- skos__historyNote mesh__D013703 Muscles %28%1966-1979%29%
% 209.88/210.08 |- rdf__type mesh__D013703sskos__Concept
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D013703 2004
% 209.88/210.08 |- mesh__recordOriginator mesh__D013703 SMH
% 209.88/210.08 |- skos__historyNote mesh__D013703 Facial Muscles %28%1966-1979%29%
% 209.88/210.08 |- mesh__recordMaintainer mesh__D013703 nns
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D013703 2005
% 209.88/210.08 |- skos__scopeNote mesh__D013703
% 209.88/210.08 A masticatory muscle whose action is closing the jaws; its posterior portion retracts the mandible.%A%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D013703 2003
% 209.88/210.08 |- skos__hiddenLabel mesh__D013703 Temporal Muscles
% 209.88/210.08 |- skos__historyNote mesh__D013703 Masticatory Muscles %28%1966-1979%29%
% 209.88/210.08 |- mesh__historyNote mesh__D013703
% 209.88/210.08 91%28%80%29%; was see under MASTICATORY MUSCLES 1980-90
% 209.88/210.08 |- skos__hiddenLabel mesh__D013703 Muscles, Temporal
% 209.88/210.08 |- mesh__dateRevised mesh__D013703 2001-07-25
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D013703 sjn
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D013703
% 209.88/210.08 91; was see under MASTICATORY MUSCLES 1980-90
% 209.88/210.08 |- skos__prefLabel mesh__D013703 Temporal Muscle
% 209.88/210.08 |- mesh__dateEstablished mesh__D013703 1991-01-01
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D013703 2002
% 209.88/210.08 |- mesh__dateCreated mesh__D013703 1979-03-12
% 209.88/210.08 |- skos__broader mesh__D013703smesh__D008410
% 209.88/210.08 |- skos__annotation mesh__D013703
% 209.88/210.08 /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%
% 209.88/210.08 |- skos__hiddenLabel mesh__D013703 Muscle, Temporal
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D013703 2006
% 209.88/210.08 |- skos__altLabel mesh__D018997 HCG, beta Subunit
% 209.88/210.08 |- skos__altLabel mesh__D018997 HCG-beta
% 209.88/210.08 |- skos__prefLabel mesh__D018997
% 209.88/210.08 Chorionic Gonadotropin, beta Subunit, Human
% 209.88/210.08 |- skos__altLabel mesh__D018997
% 209.88/210.08 Chorionic Gonadotropin, beta Polypeptide, Human
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D018997 sjn
% 209.88/210.08 |- skos__broader mesh__D018997smesh__D015415
% 209.88/210.08 |- skos__historyNote mesh__D018997
% 209.88/210.08 Gonadotropins, Chorionic %28%1977-1995%29%
% 209.88/210.08 |- skos__altLabel mesh__D018997 Chorionic Gonadotropin, beta Chain, Human
% 209.88/210.08 |- skos__historyNote mesh__D018997 Peptide Fragments %28%1977-1995%29%
% 209.88/210.08 |- mesh__recordMaintainer mesh__D018997 ssb
% 209.88/210.08 |- mesh__onlineNote mesh__D018997
% 209.88/210.08 use CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN %28%NM%29% to search HCG-BETA 1978-95%A%
% 209.88/210.08 |- mesh__historyNote mesh__D018997 96; was HCG-BETA %28%NM%29% 1977-95
% 209.88/210.08 |- skos__broader mesh__D018997smesh__D014408
% 209.88/210.08 |- skos__hiddenLabel mesh__D018997 HCG beta
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D018997
% 209.88/210.08 96; HCG-BETA was indexed under GONADOTROPINS, CHORIONIC %26% PEPTIDE FRAGMENTS 1977-95%A%
% 209.88/210.08 |- mesh__dateEstablished mesh__D018997 1996-01-01
% 209.88/210.08 |- mesh__dateRevised mesh__D018997 2005-06-30
% 209.88/210.08 |- skos__altLabel mesh__D018997 Human Chorionic Gonadotropin, beta Subunit
% 209.88/210.08 |- skos__broader mesh__D018997smesh__D006063
% 209.88/210.08 |- skos__scopeNote mesh__D018997
% 209.88/210.08 The beta subunit of human CHORIONIC GONADOTROPIN. Its structure is similar to the beta subunit of LUTEINIZING HORMONE, except for the additional 30 amino acids at the carboxy end with the associated carbohydrate residues. HCG-beta is used as a diagnostic marker for early detection of pregnancy, spontaneous abortion %28%ABORTION, SPONTANEOUS%29%; ECTOPIC PREGNANCY; HYDATIDIFORM MOLE; CHORIOCARCINOMA; or DOWN SYNDROME.%A%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018997 2006
% 209.88/210.08 |- rdf__type mesh__D018997sskos__Concept
% 209.88/210.08 |- mesh__recordOriginator mesh__D018997 TPW
% 209.88/210.08 |- mesh__dateCreated mesh__D018997 1995-06-05
% 209.88/210.08 |- skos__broader mesh__D051822smesh__D051820
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D051822 2006
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D051822 sjn
% 209.88/210.08 |- skos__scopeNote mesh__D051822
% 209.88/210.08 A TCF transcription factor that was originally identified as a DNA-binding protein that interacts with the ENHANCERS of T-CELL RECEPTOR ALPHA GENES. It is a plays a role in T-LYMPHOCYTE development.%A%
% 209.88/210.08 |- rdf__type mesh__D051822sskos__Concept
% 209.88/210.08 |- mesh__recordOriginator mesh__D051822 DRC
% 209.88/210.08 |- skos__hiddenLabel mesh__D051822 TCF 1 Transcription Factor
% 209.88/210.08 |- skos__prefLabel mesh__D051822 T Cell Transcription Factor 1
% 209.88/210.08 |- skos__altLabel mesh__D051822 T Cell Factor 1
% 209.88/210.08 |- skos__hiddenLabel mesh__D051822 Transcription Factor, TCF-1
% 209.88/210.08 |- mesh__historyNote mesh__D051822 2006%28%1991%29%
% 209.88/210.08 |- mesh__dateEstablished mesh__D051822 2006-01-01
% 209.88/210.08 |- mesh__dateCreated mesh__D051822 2005-06-30
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D051822
% 209.88/210.08 2006; T CELL FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1995-2005, %26% under NUCLEAR PROTEINS 1991-1994%A%
% 209.88/210.08 |- mesh__recordMaintainer mesh__D051822 DRC
% 209.88/210.08 |- skos__altLabel mesh__D051822 TCF-1 Transcription Factor
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D018199 PLS
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 1996
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 2001
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 2006
% 209.88/210.08 |- mesh__dateEstablished mesh__D018199 1994-01-01
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 1999
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 2000
% 209.88/210.08 |- skos__hiddenLabel mesh__D018199 Tumors, Mesodermal Mixed
% 209.88/210.08 |- skos__hiddenLabel mesh__D018199 Tumor, Mesodermal Mixed
% 209.88/210.08 |- skos__hiddenLabel mesh__D018199 Mesodermal Mixed Tumor
% 209.88/210.08 |- rdf__type mesh__D018199sskos__Concept
% 209.88/210.08 |- skos__historyNote mesh__D018199
% 209.88/210.08 Neoplasms, Germ Cell and Embryonal %28%1968-1993%29%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 2005
% 209.88/210.08 |- skos__broader mesh__D018199smesh__D012509
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 1998
% 209.88/210.08 |- skos__broader mesh__D018199smesh__D018193
% 209.88/210.08 |- mesh__recordMaintainer mesh__D018199 KEV
% 209.88/210.08 |- skos__prefLabel mesh__D018199 Mixed Tumor, Mesodermal
% 209.88/210.08 |- skos__scopeNote mesh__D018199
% 209.88/210.08 A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20%25% of patients. %28%Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1702%29%%A%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 2002
% 209.88/210.08 |- skos__annotation mesh__D018199
% 209.88/210.08 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably UTERINE NEOPLASMS %28%IM%29%%A%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 2004
% 209.88/210.08 |- mesh__historyNote mesh__D018199 94
% 209.88/210.08 |- skos__hiddenLabel mesh__D018199 Mixed Tumors, Mesodermal
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 1997
% 209.88/210.08 |- mesh__recordOriginator mesh__D018199 PLS
% 209.88/210.08 |- skos__hiddenLabel mesh__D018199 Mesodermal Mixed Tumors
% 209.88/210.08 |- mesh__dateRevised mesh__D018199 1995-06-08
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D018199 94
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D018199 2003
% 209.88/210.08 |- mesh__dateCreated mesh__D018199 1993-06-25
% 209.88/210.08 |- skos__altLabel mesh__D004977 EMB-Fatol
% 209.88/210.08 |- skos__altLabel mesh__D004977 Llorente Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- skos__altLabel mesh__D004977 Lederle Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- mesh__recordMaintainer mesh__D004977 CCR
% 209.88/210.08 |- skos__altLabel mesh__D004977 SERB Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- skos__prefLabel mesh__D004977 Ethambutol
% 209.88/210.08 |- mesh__recordOriginator mesh__D004977 NLM
% 209.88/210.08 |- skos__hiddenLabel mesh__D004977 EMB Fatol
% 209.88/210.08 |- skos__hiddenLabel mesh__D004977 Llorente, Etambutol
% 209.88/210.08 |- skos__altLabel mesh__D004977 AHP Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D004977 sjn
% 209.88/210.08 |- skos__hiddenLabel mesh__D004977 EMB Hefa
% 209.88/210.08 |- skos__altLabel mesh__D004977 Miambutol
% 209.88/210.08 |- skos__altLabel mesh__D004977 Riemser Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D004977 2006
% 209.88/210.08 |- mesh__dateEstablished mesh__D004977 1968-01-01
% 209.88/210.08 |- mesh__dateCreated mesh__D004977 1999-01-01
% 209.88/210.08 |- skos__altLabel mesh__D004977 Genopharm Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- skos__altLabel mesh__D004977 Fatol Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- skos__broader mesh__D004977smesh__D005029
% 209.88/210.08 |- skos__altLabel mesh__D004977 Wyeth Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- skos__altLabel mesh__D004977 Elan Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- skos__hiddenLabel mesh__D004977 Hydrochloride, Ethambutol
% 209.88/210.08 |- skos__altLabel mesh__D004977 ICN Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D004977 68
% 209.88/210.08 |- skos__scopeNote mesh__D004977
% 209.88/210.08 An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, p863%29%%A%
% 209.88/210.08 |- mesh__historyNote mesh__D004977 68%28%63%29%
% 209.88/210.08 |- rdf__type mesh__D004977sskos__Concept
% 209.88/210.08 |- mesh__dateRevised mesh__D004977 2005-06-30
% 209.88/210.08 |- skos__altLabel mesh__D004977 Sanavita Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- skos__altLabel mesh__D004977
% 209.88/210.08 Wernigerode Brand of Ethambutol Hydrochloride
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 II, Cardiotoxin
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 I, Cardiotoxin
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D004179 sjn
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 Gamma, Cobra Toxin
% 209.88/210.08 |- skos__broader mesh__D004179smesh__D003040
% 209.88/210.08 |- skos__historyNote mesh__D004179 Proteins %28%1966-1977%29%
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D004179
% 209.88/210.08 91; was see under COBRA VENOMS 1978-90
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D004179 2006
% 209.88/210.08 |- mesh__dateEstablished mesh__D004179 1991-01-01
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 Cardiotoxin, Cobra
% 209.88/210.08 |- mesh__recordMaintainer mesh__D004179 ssb
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 Elapid Cardiotoxins
% 209.88/210.08 |- skos__annotation mesh__D004179
% 209.88/210.08 proteins in cobra venom; /antag permitted but consider also ANTIVENINS%A%
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 Factors, Direct Lytic
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 4, Cardiotoxin VII
% 209.88/210.08 |- skos__scopeNote mesh__D004179
% 209.88/210.08 Most abundant proteins in cobra %28%Naja of the Elapids%29% venom; basic polypeptides of 57 to 62 amino acids with four disulfide bonds and a molecular weight of less than 7000; causes skeletal and cardiac muscle contracture, interferes with neuromuscular and ganglionic transmission, depolarizes nerve, muscle and blood cell membranes, thus causing hemolysis. Synonyms: cobramine A; cobramine B; cobra cytotoxin; gamma toxin; membrane-active polypeptide.%A%
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 VII 4, Cardiotoxin
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 Basic Polypeptide, Cardiotoxin-Like
% 209.88/210.08 |- skos__altLabel mesh__D004179 Cardiotoxin
% 209.88/210.08 |- skos__historyNote mesh__D004179 Snakes %28%1966-1974%29%
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 Polypeptide, Cardiotoxin-Like Basic
% 209.88/210.08 |- skos__altLabel mesh__D004179 Cardiotoxin-Like Basic Polypeptide
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 VII2, Cardiotoxin
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 Toxin Gamma, Cobra
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 Lytic Factors, Direct
% 209.88/210.08 |- skos__hiddenLabel mesh__D004179 Cardiotoxin Like Basic Polypeptide
% 209.88/210.08 |- mesh__dateRevised mesh__D004179 2005-06-30
% 209.88/210.08 |- mesh__recordOriginator mesh__D004179 SH
% 209.88/210.08 |- skos__altLabel mesh__D004179 Cobra Cardiotoxin
% 209.88/210.08 |- mesh__dateCreated mesh__D004179 1977-04-27
% 209.88/210.08 |- skos__historyNote mesh__D004179 Snake Venoms %28%1975-1977%29%
% 209.88/210.08 |- skos__historyNote mesh__D004179 Peptides %28%1966-1977%29%
% 209.88/210.08 |- skos__prefLabel mesh__D004179 Direct Lytic Factors
% 209.88/210.08 |- mesh__historyNote mesh__D004179
% 209.88/210.08 91%28%78%29%; was see under COBRA VENOMS 1978-90
% 209.88/210.08 |- rdf__type mesh__D004179sskos__Concept
% 209.88/210.08 |- skos__historyNote mesh__D004179 Venoms %28%1966-1974%29%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 2001
% 209.88/210.08 |- mesh__dateRevised mesh__D009662 1992-05-19
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 2005
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 1996
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D009662 PLS
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 2002
% 209.88/210.08 |- skos__prefLabel mesh__D009662 Nortropanes
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 2006
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 1997
% 209.88/210.08 |- mesh__recordOriginator mesh__D009662 NLM
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 1993
% 209.88/210.08 |- rdf__type mesh__D009662sskos__Concept
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 1998
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 1994
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 2003
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 1999
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 2000
% 209.88/210.08 |- mesh__dateCreated mesh__D009662 1999-01-01
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 1995
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D009662 2004
% 209.88/210.08 |- mesh__recordMaintainer mesh__D009662 TAP
% 209.88/210.08 |- skos__broader mesh__D009662smesh__D014326
% 209.88/210.08 |- mesh__dateCreated mesh__D033761 2002-07-03
% 209.88/210.08 |- rdf__type mesh__D033761sskos__Concept
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D033761 2003
% 209.88/210.08 |- skos__annotation mesh__D033761
% 209.88/210.08 sporulation: coord organism /physiol %28%IM%29% + SPORES, PROTOZOAN %28%NIM%29%; Manual 23.31%A%
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D033761 sjn
% 209.88/210.08 |- mesh__historyNote mesh__D033761 2003
% 209.88/210.08 |- mesh__recordMaintainer mesh__D033761 sjn
% 209.88/210.08 |- skos__prefLabel mesh__D033761 Spores, Protozoan
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D033761 2006
% 209.88/210.08 |- mesh__recordOriginator mesh__D033761 ags
% 209.88/210.08 |- skos__broader mesh__D033761smesh__D013170
% 209.88/210.08 |- mesh__dateRevised mesh__D033761 2005-07-01
% 209.88/210.08 |- mesh__dateEstablished mesh__D033761 2003-01-01
% 209.88/210.08 |- skos__scopeNote mesh__D033761
% 209.88/210.08 A vegetative stage in the life cycle of sporozoan PROTOZOA. It is characteristic of members of the phyla APICOMPLEXA and MICROSPORIDIA.%A%
% 209.88/210.08 |- skos__altLabel mesh__D000587 Secondary Amine Oxidoreductases
% 209.88/210.08 |- skos__broader mesh__D000587smesh__D010088
% 209.88/210.08 |- mesh__recordMaintainer mesh__D000587 jmp
% 209.88/210.08 |- mesh__recordOriginator mesh__D000587 NLM
% 209.88/210.08 |- skos__scopeNote mesh__D000587
% 209.88/210.08 Enzymes catalyzing the dehydrogenation of secondary amines, introducing a C=N double bond as the primary reaction. In some cases this is later hydrolyzed.%A%
% 209.88/210.08 |- mesh__recordAuthorizer mesh__D000587 sjn
% 209.88/210.08 |- rdf__type mesh__D000587sskos__Concept
% 209.88/210.08 |- skos__historyNote mesh__D000587 Oxidoreductases %28%1966-1974%29%
% 209.88/210.08 |- mesh__dateEstablished mesh__D000587 1975-01-01
% 209.88/210.08 |- skos__hiddenLabel mesh__D000587 Oxidoreductases, Secondary Amine
% 209.88/210.08 |- skos__altLabel mesh__D000587 Amine Oxidoreductases, Secondary Amine
% 209.88/210.08 |- skos__annotation mesh__D000587
% 209.88/210.08 do not confuse with OXIDOREDUCTASES ACTING ON CH-NH2 GROUP DONORS%A%
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D000587 2006
% 209.88/210.08 |- skos__prefLabel mesh__D000587
% 209.88/210.08 Oxidoreductases Acting on CH-NH Group Donors
% 209.88/210.08 |- skos__hiddenLabel mesh__D000587
% 209.88/210.08 Oxidoreductases Acting on CH NH Group Donors
% 209.88/210.08 |- mesh__historyNote mesh__D000587 2006%28%1975%29%
% 209.88/210.08 |- mesh__dateRevised mesh__D000587 2005-06-30
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D000587
% 209.88/210.08 2006; see AMINE OXIDOREDUCTASES 1975-2005
% 209.88/210.08 |- mesh__dateCreated mesh__D000587 1999-01-01
% 209.88/210.08 |- skos__hiddenLabel mesh__D000587 Amine Oxidoreductases, Secondary
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019292 2002
% 209.88/210.08 |- skos__annotation mesh__D019292
% 209.88/210.08 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific histol type of neopl %28%IM%29%%A%
% 209.88/210.08 |- skos__prefLabel mesh__D019292 Skull Base Neoplasms
% 209.88/210.08 |- mesh__historyNote mesh__D019292 97
% 209.88/210.08 |- skos__altLabel mesh__D019292 Neoplasms, Skull Base
% 209.88/210.08 |- skos__hiddenLabel mesh__D019292 Skull Base Neoplasm
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019292 2001
% 209.88/210.08 |- mesh__dateRevised mesh__D019292 2000-06-22
% 209.88/210.08 |- skos__broader mesh__D019292smesh__D012888
% 209.88/210.08 |- rdf__type mesh__D019292sskos__Concept
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019292 2004
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019292 2006
% 209.88/210.08 |- mesh__dateEstablished mesh__D019292 1997-01-01
% 209.88/210.08 |- mesh__dateCreated mesh__D019292 1996-06-10
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019292 2003
% 209.88/210.08 |- mesh__publicMeSHNote mesh__D019292 97
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D019292 2005
% 209.88/210.08 |- skos__historyNote mesh__D019292 Skull Neoplasms %28%1966-1996%29%
% 209.88/210.08 |- skos__scopeNote mesh__D019292
% 209.88/210.08 Neoplasms of the base of the skull specifically, differentiated from neoplasms of unspecified sites or bones of the skull %28%SKULL NEOPLASMS%29%.%A%
% 209.88/210.08 |- skos__hiddenLabel mesh__D019292 Neoplasm, Skull Base
% 209.88/210.08 |- mesh__dateRevised mesh__D027724 2005-07-06
% 209.88/210.08 |- mesh__recordMaintainer mesh__D027724 ags
% 209.88/210.08 |- skos__historyNote mesh__D027724
% 209.88/210.08 Reproduction Techniques %28%1989-2001%29%
% 209.88/210.08 |- skos__hiddenLabel mesh__D027724 Technics, Assisted Reproductive
% 209.88/210.08 |- skos__historyNote mesh__D027724 Fertilization in Vitro %28%1989-2001%29%
% 209.88/210.08 |- skos__hiddenLabel mesh__D027724 Technic, Assisted Reproductive
% 209.88/210.08 |- skos__hiddenLabel mesh__D027724 Assisted Reproductive Technologies
% 209.88/210.08 |- skos__altLabel mesh__D027724 Assisted Reproductive Technics
% 209.88/210.08 |- skos__altLabel mesh__D027724 Assisted Reproductive Techniques
% 209.88/210.08 |- mesh__activeMeSHYear mesh__D027724 2006
% 209.88/210.08 |- skos__hiddenLabel mesh__D027724 Assisted Reproductive Technic
% 209.88/210.08 |- skos__broader mesh__D027724smesh__D012099
% 209.88/210.08 |- skos__hiddenLabel mesh__D027724 Technology, Assisted Reproductive
% 209.88/210.08 |- skos__hiddenLabel mesh__D027724 Reproductive Technics, Assisted
% 209.88/210.08 |- skos__hiddenLabel mesh__D027724 Assisted Reproductive Technology
% 209.88/210.08 |- mesh__recordOriginator mesh__D027724 lkt
% 209.88/210.08 |- rdf__type mesh__D027724sskos__Concept
% 209.88/210.08 |- skos__prefLabel mesh__D027724 Reproductive Techniques, Assisted
% 209.88/210.08 |- skos__hiddenLabel mesh__D027724 Reproductive Technologies, Assisted
% 209.88/210.08 |- skos__hiddenLabel mesh__D027724 Assisted Reproductive Technique
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D027724 2002
% 209.88/210.09 |- skos__hiddenLabel mesh__D027724 Technique, Assisted Reproductive
% 209.88/210.09 |- mesh__dateEstablished mesh__D027724 2002-01-01
% 209.88/210.09 |- skos__hiddenLabel mesh__D027724 Reproductive Technique, Assisted
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D027724 sjn
% 209.88/210.09 |- skos__hiddenLabel mesh__D027724 Techniques, Assisted Reproductive
% 209.88/210.09 |- skos__hiddenLabel mesh__D027724 Technologies, Assisted Reproductive
% 209.88/210.09 |- skos__annotation mesh__D027724
% 209.88/210.09 usually for humans; may be used for animals if specified; otherwise use BREEDING or its specifics; REPRODUCTIVE TECHNIQUES is also available%A%
% 209.88/210.09 |- skos__scopeNote mesh__D027724
% 209.88/210.09 Clinical and laboratory techniques used to enhance fertility in humans and animals.%A%
% 209.88/210.09 |- skos__hiddenLabel mesh__D027724 Reproductive Technic, Assisted
% 209.88/210.09 |- mesh__dateCreated mesh__D027724 2001-07-25
% 209.88/210.09 |- mesh__historyNote mesh__D027724 2002
% 209.88/210.09 |- skos__prefLabel mesh__D005272 Femur Neck
% 209.88/210.09 |- skos__annotation mesh__D005272 fract = FEMORAL NECK FRACTURES
% 209.88/210.09 |- skos__hiddenLabel mesh__D005272 Neck, Femur
% 209.88/210.09 |- skos__hiddenLabel mesh__D005272 Necks, Femur
% 209.88/210.09 |- mesh__recordMaintainer mesh__D005272 ags
% 209.88/210.09 |- rdf__type mesh__D005272sskos__Concept
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D005272 sjn
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D005272 2006
% 209.88/210.09 |- skos__hiddenLabel mesh__D005272 Femur Necks
% 209.88/210.09 |- skos__broader mesh__D005272smesh__D005269
% 209.88/210.09 |- mesh__dateCreated mesh__D005272 1999-01-01
% 209.88/210.09 |- mesh__recordOriginator mesh__D005272 NLM
% 209.88/210.09 |- mesh__dateRevised mesh__D005272 2005-06-30
% 209.88/210.09 |- skos__hiddenLabel mesh__D046689 Fetal Mortality, Late
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D046689 2006
% 209.88/210.09 |- skos__historyNote mesh__D046689 Fetal Death %28%1966-2004%29%
% 209.88/210.09 |- skos__hiddenLabel mesh__D046689 Fetal Mortalities, Late
% 209.88/210.09 |- mesh__dateCreated mesh__D046689 2004-07-07
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D046689 2005
% 209.88/210.09 |- skos__hiddenLabel mesh__D046689 Mortality, Late Fetal
% 209.88/210.09 |- mesh__recordOriginator mesh__D046689 lkt
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D046689 2005
% 209.88/210.09 |- skos__broader mesh__D046689smesh__D009026
% 209.88/210.09 |- skos__hiddenLabel mesh__D046689 Late Fetal Mortalities
% 209.88/210.09 |- skos__scopeNote mesh__D046689
% 209.88/210.09 Number of fetal deaths with stated or presumed gestation of 20 weeks or more in a given population. Late fetal mortality is death after of 28 weeks or more.%A%
% 209.88/210.09 |- skos__prefLabel mesh__D046689 Fetal Mortality
% 209.88/210.09 |- skos__annotation mesh__D046689
% 209.88/210.09 do not confuse with FETAL DEATH, a non-statistical concept%A%
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D046689 sjn
% 209.88/210.09 |- skos__hiddenLabel mesh__D046689 Mortalities, Late Fetal
% 209.88/210.09 |- mesh__recordMaintainer mesh__D046689 lkt
% 209.88/210.09 |- mesh__dateEstablished mesh__D046689 2005-01-01
% 209.88/210.09 |- skos__altLabel mesh__D046689 Mortality, Fetal
% 209.88/210.09 |- skos__hiddenLabel mesh__D046689 Fetal Mortalities
% 209.88/210.09 |- skos__hiddenLabel mesh__D046689 Mortalities, Fetal
% 209.88/210.09 |- rdf__type mesh__D046689sskos__Concept
% 209.88/210.09 |- mesh__historyNote mesh__D046689 2005
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013704 2005
% 209.88/210.09 |- skos__prefLabel mesh__D013704 Temporomandibular Joint
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013704 2003
% 209.88/210.09 |- skos__hiddenLabel mesh__D013704 Joint, Temporomandibular
% 209.88/210.09 |- skos__broader mesh__D013704smesh__D007596
% 209.88/210.09 |- skos__broader mesh__D013704smesh__D013284
% 209.88/210.09 |- mesh__recordOriginator mesh__D013704 NLM
% 209.88/210.09 |- skos__altLabel mesh__D013704 TMJ
% 209.88/210.09 |- mesh__recordMaintainer mesh__D013704 ags
% 209.88/210.09 |- skos__scopeNote mesh__D013704
% 209.88/210.09 An articulation between the condyle of the mandible and the articular tubercle of the temporal bone.%A%
% 209.88/210.09 |- mesh__dateRevised mesh__D013704 2001-07-25
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D013704 sjn
% 209.88/210.09 |- mesh__dateCreated mesh__D013704 1999-01-01
% 209.88/210.09 |- skos__hiddenLabel mesh__D013704 Temporomandibular Joints
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013704 2006
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013704 2002
% 209.88/210.09 |- skos__related mesh__D013704smesh__D016302
% 209.88/210.09 |- rdf__type mesh__D013704sskos__Concept
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013704 2004
% 209.88/210.09 |- skos__hiddenLabel mesh__D013704 Joints, Temporomandibular
% 209.88/210.09 |- mesh__recordOriginator mesh__D018998 TPW
% 209.88/210.09 |- mesh__dateEstablished mesh__D018998 1996-01-01
% 209.88/210.09 |- skos__altLabel mesh__D018998 WGA-HRP
% 209.88/210.09 |- skos__historyNote mesh__D018998 Wheat Germ Agglutinins %28%1987-1995%29%
% 209.88/210.09 |- mesh__dateRevised mesh__D018998 2005-06-30
% 209.88/210.09 |- skos__annotation mesh__D018998 DF: note short X ref
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D018998 2006
% 209.88/210.09 |- skos__broader mesh__D018998smesh__D014909
% 209.88/210.09 |- mesh__onlineNote mesh__D018998
% 209.88/210.09 use WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE %28%NM%29% to search WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE 1986-95%A%
% 209.88/210.09 |- rdf__type mesh__D018998sskos__Concept
% 209.88/210.09 |- skos__historyNote mesh__D018998 Horseradish Peroxidase %28%1986-1995%29%
% 209.88/210.09 |- skos__hiddenLabel mesh__D018998
% 209.88/210.09 Wheat Germ Agglutinin Horseradish Peroxidase Conjugate
% 209.88/210.09 |- mesh__dateCreated mesh__D018998 1995-06-05
% 209.88/210.09 |- skos__prefLabel mesh__D018998
% 209.88/210.09 Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate
% 209.88/210.09 |- mesh__recordMaintainer mesh__D018998 ssb
% 209.88/210.09 |- skos__broader mesh__D018998smesh__D006735
% 209.88/210.09 |- mesh__historyNote mesh__D018998
% 209.88/210.09 96; was WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE %28%NM%29% 1986-95%A%
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D018998 sjn
% 209.88/210.09 |- skos__scopeNote mesh__D018998
% 209.88/210.09 The lectin wheatgerm agglutinin conjugated to the enzyme HORSERADISH PEROXIDASE. It is widely used for tracing neural pathways.%A%
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D018998
% 209.88/210.09 96; WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE was indexed under HORSERADISH PEROXIDASE 1986-95, WHEAT GERM AGGLUTININS 1987-95, %26% LECTINS 1986%A%
% 209.88/210.09 |- skos__historyNote mesh__D018998 Lectins %28%1986%29%
% 209.88/210.09 |- skos__hiddenLabel mesh__D004978 MER 25
% 209.88/210.09 |- skos__prefLabel mesh__D004978 Ethamoxytriphetol
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D004978 2006
% 209.88/210.09 |- mesh__historyNote mesh__D004978
% 209.88/210.09 91%28%75%29%; was see under ALCOHOL, ETHYL 1975-90
% 209.88/210.09 |- skos__scopeNote mesh__D004978 A non-steroidal estrogen antagonist.
% 209.88/210.09 |- mesh__dateEstablished mesh__D004978 1991-01-01
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D004978
% 209.88/210.09 91; was see under ALCOHOL, ETHYL 1975-90
% 209.88/210.09 |- mesh__recordMaintainer mesh__D004978 CCR
% 209.88/210.09 |- skos__historyNote mesh__D004978 Diethylamines %28%1974%29%
% 209.88/210.09 |- rdf__type mesh__D004978sskos__Concept
% 209.88/210.09 |- skos__hiddenLabel mesh__D004978 MER25
% 209.88/210.09 |- skos__historyNote mesh__D004978 Alcohol, Ethyl %28%1969-1974%29%
% 209.88/210.09 |- skos__broader mesh__D004978smesh__D000431
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D004978 2003
% 209.88/210.09 |- mesh__recordOriginator mesh__D004978 NLM
% 209.88/210.09 |- mesh__dateRevised mesh__D004978 2000-06-22
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D004978 2001
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D004978 2004
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D004978 sjn
% 209.88/210.09 |- skos__historyNote mesh__D004978 Phenyl Ethers %28%1974%29%
% 209.88/210.09 |- mesh__dateCreated mesh__D004978 1974-11-11
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D004978 2002
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D004978 2005
% 209.88/210.09 |- skos__broader mesh__D051025smesh__D010750
% 209.88/210.09 |- skos__altLabel mesh__D051025 bcl2-Antagonist of Cell Death Protein
% 209.88/210.09 |- skos__altLabel mesh__D051025 Bad Protein
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D051025 2006
% 209.88/210.09 |- mesh__dateCreated mesh__D051025 2005-06-30
% 209.88/210.09 |- mesh__recordMaintainer mesh__D051025 DRC
% 209.88/210.09 |- skos__broader mesh__D051025smesh__D019253
% 209.88/210.09 |- skos__scopeNote mesh__D051025
% 209.88/210.09 A pro-apoptotic protein and member of the Bcl-2 protein family that is regulated by PHOSPHORYLATION. Unphosphorylated Bad protein inhibits the activity of BCL-XL PROTEIN.%A%
% 209.88/210.09 |- rdf__type mesh__D051025sskos__Concept
% 209.88/210.09 |- skos__hiddenLabel mesh__D051025 Death Protein, bcl-Associated
% 209.88/210.09 |- mesh__dateEstablished mesh__D051025 2006-01-01
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D051025
% 209.88/210.09 2006; BAD PROTEIN was indexed under CARRIER PROTEINS 1995-2005%A%
% 209.88/210.09 |- skos__prefLabel mesh__D051025 bcl-Associated Death Protein
% 209.88/210.09 |- skos__hiddenLabel mesh__D051025 bcl2 Antagonist of Cell Death Protein
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D051025 sjn
% 209.88/210.09 |- skos__hiddenLabel mesh__D051025 bcl Associated Death Protein
% 209.88/210.09 |- mesh__recordOriginator mesh__D051025 DRC
% 209.88/210.09 |- mesh__historyNote mesh__D051025 2006%28%1995%29%
% 209.88/210.09 |- mesh__onlineNote mesh__D009663
% 209.88/210.09 use NORWALK VIRUS to search NORWALK AGENT 1982-93
% 209.88/210.09 |- mesh__dateEstablished mesh__D009663 1982-01-01
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009663 2006
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D009663 94; was NORWALK AGENT 1982-93
% 209.88/210.09 |- mesh__historyNote mesh__D009663 94; was NORWALK AGENT 1982-93
% 209.88/210.09 |- skos__annotation mesh__D009663
% 209.88/210.09 infection: coord IM with CALICIVIRIDAE INFECTIONS %28%IM%29% + probably GASTROENTERITIS %28%IM%29%%A%
% 209.88/210.09 |- rdf__type mesh__D009663sskos__Concept
% 209.88/210.09 |- skos__scopeNote mesh__D009663
% 209.88/210.09 The type species in the genus NOROVIRUS, first isolated in 1968 from the stools of school children in Norwalk, Ohio, who were suffering from GASTROENTERITIS. The virions are non-enveloped spherical particles containing a single protein. Multiple strains are named after the places where outbreaks have occurred.%A%
% 209.88/210.09 |- mesh__dateRevised mesh__D009663 2003-07-09
% 209.88/210.09 |- skos__broader mesh__D009663smesh__D029322
% 209.88/210.09 |- mesh__recordMaintainer mesh__D009663 ags
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D009663 sjn
% 209.88/210.09 |- mesh__dateCreated mesh__D009663 1981-05-20
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009663 2004
% 209.88/210.09 |- skos__prefLabel mesh__D009663 Norwalk virus
% 209.88/210.09 |- skos__altLabel mesh__D009663 Norwalk Agent
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009663 2005
% 209.88/210.09 |- mesh__recordOriginator mesh__D009663 RC
% 209.88/210.09 |- skos__historyNote mesh__D009663 Gastroenteritis %28%1966-1981%29%
% 209.88/210.09 |- mesh__dateCreated mesh__D001680 1999-01-01
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001680 2006
% 209.88/210.09 |- mesh__recordMaintainer mesh__D001680 jls
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001680 2002
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001680 2005
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D001680 sjn
% 209.88/210.09 |- mesh__recordOriginator mesh__D001680 NLM
% 209.88/210.09 |- mesh__dateRevised mesh__D001680 1999-11-09
% 209.88/210.09 |- skos__prefLabel mesh__D001680 Biography
% 209.88/210.09 |- skos__scopeNote mesh__D001680
% 209.88/210.09 A written account of a person%27%s life and the branch of literature concerned with the lives of people. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A%
% 209.88/210.09 |- skos__altLabel mesh__D001680 Biographies
% 209.88/210.09 |- rdf__type mesh__D001680sskos__Concept
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001680 2001
% 209.88/210.09 |- skos__annotation mesh__D001680
% 209.88/210.09 biog as a subject, not for biogs of persons: Manual 32.10; do not confuse with Publication Type BIOGRAPHY %28%Manual 17.17+%29%; IM; no qualif; memoirs as a subject go here or under AUTOBIOGRAPHY if pertinent; DF: BIOG or BIOGR%A%
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001680 2004
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001680 2000
% 209.88/210.09 |- skos__related mesh__D001680smesh__D001325
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001680 2003
% 209.88/210.09 |- skos__broader mesh__D001680smesh__D008091
% 209.88/210.09 |- mesh__recordMaintainer mesh__D000588 TPW
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 2005
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 1998
% 209.88/210.09 |- skos__broader mesh__D000588smesh__D009930
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 2004
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 1997
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 2003
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 1996
% 209.88/210.09 |- mesh__dateRevised mesh__D000588 1995-03-16
% 209.88/210.09 |- mesh__recordOriginator mesh__D000588 NLM
% 209.88/210.09 |- rdf__type mesh__D000588sskos__Concept
% 209.88/210.09 |- skos__prefLabel mesh__D000588 Amines
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 2002
% 209.88/210.09 |- mesh__dateCreated mesh__D000588 1999-01-01
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 2001
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D000588 PLS
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 2006
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 2000
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D000588 1999
% 209.88/210.09 |- skos__scopeNote mesh__D000588
% 209.88/210.09 A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%
% 209.88/210.09 |- skos__broader mesh__D006761Q000295smesh__D006761
% 209.88/210.09 |- mesh__preferredCombination mesh__D006761Q000295smesh__D004865
% 209.88/210.09 |- rdf__type mesh__D006761Q000295smesh__CompoundConcept
% 209.88/210.09 |- rdf__type mesh__D005273sskos__Concept
% 209.88/210.09 |- skos__historyNote mesh__D005273 Carbamates %28%1974-1976%29%
% 209.88/210.09 |- skos__prefLabel mesh__D005273 Fenbendazole
% 209.88/210.09 |- mesh__dateCreated mesh__D005273 1976-04-16
% 209.88/210.09 |- mesh__dateRevised mesh__D005273 2005-06-30
% 209.88/210.09 |- mesh__historyNote mesh__D005273
% 209.88/210.09 91%28%77%29%; was see under BENZIMIDAZOLES 1977-90
% 209.88/210.09 |- skos__scopeNote mesh__D005273
% 209.88/210.09 Antinematodal benzimidazole used in veterinary medicine.%A%
% 209.88/210.09 |- mesh__dateEstablished mesh__D005273 1991-01-01
% 209.88/210.09 |- skos__historyNote mesh__D005273 Benzimidazoles %28%1974-1976%29%
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D005273 2006
% 209.88/210.09 |- skos__broader mesh__D005273smesh__D001562
% 209.88/210.09 |- skos__altLabel mesh__D005273 Phenbendasol
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D005273
% 209.88/210.09 91; was see under BENZIMIDAZOLES 1977-90
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D005273 sjn
% 209.88/210.09 |- mesh__recordMaintainer mesh__D005273 exl
% 209.88/210.09 |- skos__broader mesh__D005273smesh__D002219
% 209.88/210.09 |- skos__historyNote mesh__D005273 Sulfides %28%1974%29%
% 209.88/210.09 |- mesh__recordOriginator mesh__D005273 SH
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 1999
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 2000
% 209.88/210.09 |- mesh__recordOriginator mesh__D013705 RC
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Temporomandibular Joint Disorder
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Joint Disease, Temporomandibular
% 209.88/210.09 |- skos__altLabel mesh__D013705 TMJ Diseases
% 209.88/210.09 |- skos__annotation mesh__D013705
% 209.88/210.09 GEN or unspecified; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME is also available; DF: TMJ DIS%A%
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D013705
% 209.88/210.09 97; was TEMPOROMANDIBULAR JOINT DISEASES 1982-96
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 1998
% 209.88/210.09 |- skos__altLabel mesh__D013705 TMJ Disorders
% 209.88/210.09 |- rdf__type mesh__D013705sskos__Concept
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Disorders, TMJ
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Joint Diseases, Temporomandibular
% 209.88/210.09 |- skos__broader mesh__D013705smesh__D017271
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Disease, TMJ
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 2004
% 209.88/210.09 |- mesh__dateCreated mesh__D013705 1981-02-24
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Disorder, Temporomandibular
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Disorder, TMJ
% 209.88/210.09 |- mesh__recordMaintainer mesh__D013705 TGC
% 209.88/210.09 |- mesh__dateRevised mesh__D013705 1996-06-10
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Diseases, Temporomandibular Joint
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D013705 PLS
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Temporomandibular Disorder
% 209.88/210.09 |- mesh__dateEstablished mesh__D013705 1982-01-01
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Diseases, TMJ
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Disorders, Temporomandibular Joint
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 2003
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 TMJ Disease
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Temporomandibular Joint Disease
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 2002
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 2006
% 209.88/210.09 |- skos__prefLabel mesh__D013705 Temporomandibular Joint Disorders
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Joint Disorders, Temporomandibular
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 TMJ Disorder
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Joint Disorder, Temporomandibular
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Disorders, Temporomandibular
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Disorder, Temporomandibular Joint
% 209.88/210.09 |- skos__scopeNote mesh__D013705
% 209.88/210.09 A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. %28%From Thoma%27%s Oral Pathology, 6th ed, pp577-600%29%%A%
% 209.88/210.09 |- skos__historyNote mesh__D013705 Joint Diseases %28%1966-1981%29%
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 1997
% 209.88/210.09 |- skos__hiddenLabel mesh__D013705 Disease, Temporomandibular Joint
% 209.88/210.09 |- skos__altLabel mesh__D013705 Temporomandibular Joint Diseases
% 209.88/210.09 |- mesh__historyNote mesh__D013705
% 209.88/210.09 97; was TEMPOROMANDIBULAR JOINT DISEASES 1982-96
% 209.88/210.09 |- skos__broader mesh__D013705smesh__D007592
% 209.88/210.09 |- skos__historyNote mesh__D013705
% 209.88/210.09 Temporomandibular Joint %28%1966-1981%29%
% 209.88/210.09 |- skos__broader mesh__D013705smesh__D009057
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 2001
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D013705 2005
% 209.88/210.09 |- skos__altLabel mesh__D013705 Temporomandibular Disorders
% 209.88/210.09 |- skos__hiddenLabel mesh__D018999 Toxin, CTX
% 209.88/210.09 |- rdf__type mesh__D018999sskos__Concept
% 209.88/210.09 |- mesh__dateCreated mesh__D018999 1995-05-24
% 209.88/210.09 |- mesh__recordOriginator mesh__D018999 TPW
% 209.88/210.09 |- mesh__dateEstablished mesh__D018999 1996-01-01
% 209.88/210.09 |- mesh__dateRevised mesh__D018999 2005-06-30
% 209.88/210.09 |- skos__prefLabel mesh__D018999 Charybdotoxin
% 209.88/210.09 |- skos__historyNote mesh__D018999 Scorpion Venoms %28%1984-1995%29%
% 209.88/210.09 |- skos__scopeNote mesh__D018999
% 209.88/210.09 A 37-amino acid residue peptide isolated from the scorpion Leiurus quinquestriatus hebraeus. It is a neurotoxin that inhibits calcium activated potassium channels.%A%
% 209.88/210.09 |- skos__hiddenLabel mesh__D018999 Toxin, Quinquestriatus
% 209.88/210.09 |- skos__broader mesh__D018999smesh__D012604
% 209.88/210.09 |- mesh__recordMaintainer mesh__D018999 ssb
% 209.88/210.09 |- skos__broader mesh__D018999smesh__D010455
% 209.88/210.09 |- mesh__historyNote mesh__D018999
% 209.88/210.09 96; was QUINQUESTRIATUS TOXIN %28%NM%29% 1984-95
% 209.88/210.09 |- mesh__onlineNote mesh__D018999
% 209.88/210.09 use CHARYBDOTOXIN %28%NM%29% to search QUINQUESTRIATUS TOXIN 1984-95%A%
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D018999 sjn
% 209.88/210.09 |- skos__altLabel mesh__D018999 Quinquestriatus Toxin
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D018999
% 209.88/210.09 96; QUINQUESTRIATUS TOXIN was indexed under SCORPION VENOMS 1984-95%A%
% 209.88/210.09 |- skos__altLabel mesh__D018999 CTX Toxin
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D018999 2006
% 209.88/210.09 |- skos__altLabel mesh__D018999 ChTX
% 209.88/210.09 |- skos__altLabel mesh__D004979 Sanofi Synthelabo Brand of Ethamsylate
% 209.88/210.09 |- mesh__dateEstablished mesh__D004979 1991-01-01
% 209.88/210.09 |- rdf__type mesh__D004979sskos__Concept
% 209.88/210.09 |- skos__broader mesh__D004979smesh__D001557
% 209.88/210.09 |- skos__altLabel mesh__D004979 Esteve Brand of Ethamsylate
% 209.88/210.09 |- skos__historyNote mesh__D004979 Hydroquinones %28%1974%29%
% 209.88/210.09 |- mesh__dateCreated mesh__D004979 1974-11-19
% 209.88/210.09 |- skos__altLabel mesh__D004979 Allphar Brand of Ethamsylate
% 209.88/210.09 |- skos__altLabel mesh__D004979 Cyclonamine
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D004979
% 209.88/210.09 91; was see under BENZENESULFONATES 1975-90
% 209.88/210.09 |- mesh__dateRevised mesh__D004979 2005-06-30
% 209.88/210.09 |- mesh__recordMaintainer mesh__D004979 CCR
% 209.88/210.09 |- skos__altLabel mesh__D004979 Etamsylate
% 209.88/210.09 |- skos__historyNote mesh__D004979 Benzenesulfonates %28%1974%29%
% 209.88/210.09 |- skos__altLabel mesh__D004979 Dicynene
% 209.88/210.09 |- skos__scopeNote mesh__D004979
% 209.88/210.09 Benzenesulfonate derivative used as a systemic hemostatic.%A%
% 209.88/210.09 |- mesh__recordOriginator mesh__D004979 NLM
% 209.88/210.09 |- skos__altLabel mesh__D004979 OM Brand of Ethamsylate
% 209.88/210.09 |- mesh__historyNote mesh__D004979
% 209.88/210.09 91%28%75%29%; was see under BENZENESULFONATES 1975-90
% 209.88/210.09 |- skos__prefLabel mesh__D004979 Ethamsylate
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D004979 2006
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D004979 sjn
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026
% 209.88/210.09 Formyltransferase, Phosphoribosylglycinamide
% 209.88/210.09 |- mesh__dateCreated mesh__D051026 2005-06-30
% 209.88/210.09 |- mesh__dateEstablished mesh__D051026 2006-01-01
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D051026 sjn
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026
% 209.88/210.09 Transformylase, 5%27%-Phosphoribosylglycinamide
% 209.88/210.09 |- skos__altLabel mesh__D051026
% 209.88/210.09 2-Amino-N-Ribosylacetamide 5%27%-Phosphate Transformylase
% 209.88/210.09 |- skos__altLabel mesh__D051026 GARTFase
% 209.88/210.09 |- skos__scopeNote mesh__D051026
% 209.88/210.09 An enzyme that catalyzes the transfer of a formyl group from N10-formyltetrahydrofolate to N1-%28%5-phospho-D-ribosyl%29%glycinamide to yield N2-formyl-N1-%28%5-phospho-D-ribosyl%29%glycinamide and TETRAHYDROFOLATE. It plays a role in the de novo PURINE biosynthetic pathway.%A%
% 209.88/210.09 |- skos__altLabel mesh__D051026 GAR Transformylase
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026
% 209.88/210.09 Transformylase, 2-Amino-N-Ribosylacetamide 5%27%-Phosphate
% 209.88/210.09 |- mesh__recordMaintainer mesh__D051026 AKE
% 209.88/210.09 |- skos__altLabel mesh__D051026 Glycinamide Ribonucleotide Transformylase
% 209.88/210.09 |- skos__prefLabel mesh__D051026
% 209.88/210.09 Phosphoribosylglycinamide Formyltransferase
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D051026 2006
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026 Transformylase, GAR
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026
% 209.88/210.09 Ribonucleotide Transformylase, Glycinamide
% 209.88/210.09 |- skos__altLabel mesh__D051026 Glycinamideribotide Transformylase
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026 Formyltransferase, GAR
% 209.88/210.09 |- skos__altLabel mesh__D051026
% 209.88/210.09 5%27%-Phosphoribosylglycinamide Transformylase
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026
% 209.88/210.09 5%27%-Phosphate Transformylase, 2-Amino-N-Ribosylacetamide
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026
% 209.88/210.09 5%27% Phosphoribosylglycinamide Transformylase
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026
% 209.88/210.09 2 Amino N Ribosylacetamide 5%27% Phosphate Transformylase
% 209.88/210.09 |- skos__altLabel mesh__D051026 GAR Formyltransferase
% 209.88/210.09 |- skos__broader mesh__D051026smesh__D019877
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026
% 209.88/210.09 Transformylase, Glycinamide Ribonucleotide
% 209.88/210.09 |- mesh__historyNote mesh__D051026
% 209.88/210.09 2006%28%1980%29%; use ACYLTRANSFERASES 1979, GLYCINE 1974-1979, FORMIC ACIDS 1974-1979, PENTOSEPHOSPHATES 1974-1975, RIBOSEMONOPHOSPHATES 1975-1979, %26% TRANSFERASES 1974-1978%A%
% 209.88/210.09 |- rdf__type mesh__D051026sskos__Concept
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D051026
% 209.88/210.09 2006; PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1998-2005, ACYLTRANSFERASES 1979-1997, GLYCINE 1974-1980, FORMIC ACIDS 1974-1982, GLYCINE 1980-1982, PENTOSEPHOSPHATES 1974-1975, RIBOSEMONOPHOSPHATES 1975-1980, %26% under TRANSFERASES 1974-1978%A%
% 209.88/210.09 |- skos__hiddenLabel mesh__D051026 Transformylase, Glycinamideribotide
% 209.88/210.09 |- mesh__recordOriginator mesh__D051026 AKE
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 1997
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 2002
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 1996
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 2006
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D009664 PLS
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 1995
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 2001
% 209.88/210.09 |- mesh__dateCreated mesh__D009664 1999-01-01
% 209.88/210.09 |- rdf__type mesh__D009664sskos__Concept
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 2000
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 2005
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 1994
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 2004
% 209.88/210.09 |- skos__broader mesh__D009664smesh__D012537
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 1999
% 209.88/210.09 |- skos__prefLabel mesh__D009664 Norway
% 209.88/210.09 |- mesh__dateRevised mesh__D009664 1993-06-03
% 209.88/210.09 |- mesh__recordMaintainer mesh__D009664 PLS
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 2003
% 209.88/210.09 |- mesh__recordOriginator mesh__D009664 NLM
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D009664 1998
% 209.88/210.09 |- skos__altLabel mesh__D001681 Assay, Biological
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D001681 PLS
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 2005
% 209.88/210.09 |- skos__prefLabel mesh__D001681 Biological Assay
% 209.88/210.09 |- skos__hiddenLabel mesh__D001681 Assay, Biologic
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 2000
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 1995
% 209.88/210.09 |- skos__annotation mesh__D001681
% 209.88/210.09 assays using living-matter intermediate; check text: not all %22%bioassays%22% are MeSH term BIOLOGICAL ASSAY; Manual 22.27; DF: BIOL ASSAY%A%
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 1998
% 209.88/210.09 |- skos__broader mesh__D001681smesh__D008919
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 1994
% 209.88/210.09 |- rdf__type mesh__D001681sskos__Concept
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 2002
% 209.88/210.09 |- skos__altLabel mesh__D001681 Bioassay
% 209.88/210.09 |- mesh__recordOriginator mesh__D001681 NLM
% 209.88/210.09 |- skos__altLabel mesh__D001681 Assays, Biological
% 209.88/210.09 |- mesh__recordMaintainer mesh__D001681 TAP
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 2004
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 1997
% 209.88/210.09 |- skos__altLabel mesh__D001681 Biologic Assay
% 209.88/210.09 |- skos__hiddenLabel mesh__D001681 Biological Assays
% 209.88/210.09 |- skos__altLabel mesh__D001681 Biologic Assays
% 209.88/210.09 |- mesh__dateRevised mesh__D001681 1992-03-25
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 2003
% 209.88/210.09 |- skos__hiddenLabel mesh__D001681 Bioassays
% 209.88/210.09 |- skos__scopeNote mesh__D001681
% 209.88/210.09 A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc.%A%
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 1996
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 1993
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 2001
% 209.88/210.09 |- mesh__dateCreated mesh__D001681 1999-01-01
% 209.88/210.09 |- skos__hiddenLabel mesh__D001681 Assays, Biologic
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 2006
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D001681 1999
% 209.88/210.09 |- mesh__activeMeSHYear mesh__D019294 2005
% 209.88/210.09 |- skos__prefLabel mesh__D019294 Xanthomatosis, Cerebrotendinous
% 209.88/210.09 |- mesh__dateEstablished mesh__D019294 1997-01-01
% 209.88/210.09 |- skos__historyNote mesh__D019294 Xanthomatosis %28%1968-1996%29%
% 209.88/210.09 |- skos__altLabel mesh__D019294 Van Bogaert-Scherer-Epstein Disease
% 209.88/210.09 |- mesh__dateRevised mesh__D019294 2001-07-25
% 209.88/210.09 |- mesh__dateCreated mesh__D019294 1996-06-10
% 209.88/210.09 |- skos__broader mesh__D019294smesh__D008052
% 209.88/210.09 |- mesh__publicMeSHNote mesh__D019294 97
% 209.88/210.09 |- mesh__recordMaintainer mesh__D019294 nns
% 209.88/210.09 |- skos__hiddenLabel mesh__D019294 Cerebrotendinous Xanthomatoses
% 209.88/210.09 |- skos__hiddenLabel mesh__D019294 Disease, Van Bogaert-Scherer-Epstein
% 209.88/210.09 |- mesh__recordAuthorizer mesh__D019294 sjn
% 209.88/210.09 |- mesh__historyNote mesh__D019294 97
% 209.88/210.09 |- skos__broader mesh__D019294smesh__D014973
% 209.88/210.10 |- skos__hiddenLabel mesh__D019294 Bogaert-Scherer-Epstein Disease, Van
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D019294 2004
% 209.88/210.10 |- skos__annotation mesh__D019294 a lipid storage dis
% 209.88/210.10 |- skos__hiddenLabel mesh__D019294 Van Bogaert Scherer Epstein Disease
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D019294 2002
% 209.88/210.10 |- skos__scopeNote mesh__D019294
% 209.88/210.10 A lipid storage disease, inherited as an autosomal recessive trait, characterized by xanthomas of the tendons, the white matter of the brain, and the lungs, and by spasticity, ataxia, pyramidal paresis, mental retardation, dementia, early cataracts, and atherosclerosis. It is associated with elevated plasma and tissue levels of cholestanol and defective bile synthesis, with the deposition of cholestanol in the central nervous system and myelin of peripheral nerves. The lesions contain cholesterol and dehydrocholesterol. %28%Dorland, 28th ed%29%%A%
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D019294 2003
% 209.88/210.10 |- skos__hiddenLabel mesh__D019294 Xanthomatoses, Cerebrotendinous
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D019294 2006
% 209.88/210.10 |- rdf__type mesh__D019294sskos__Concept
% 209.88/210.10 |- skos__hiddenLabel mesh__D019294 Cerebrotendinous Xanthomatosis
% 209.88/210.10 |- mesh__recordOriginator mesh__D019294 TGC
% 209.88/210.10 |- skos__broader mesh__D013706smesh__D009209
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 2002
% 209.88/210.10 |- skos__hiddenLabel mesh__D013706 Joint Syndrome, Temporomandibular
% 209.88/210.10 |- skos__altLabel mesh__D013706
% 209.88/210.10 Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint
% 209.88/210.10 |- mesh__historyNote mesh__D013706
% 209.88/210.10 97; was TEMPOROMANDIBULAR JOINT SYNDROME 1973-96, was COSTEN%27%S SYNDROME 1966-72; COSTEN%27%S SYNDROME was see TEMPOROMANDIBULAR JOINT SYNDROME 1973-96%A%
% 209.88/210.10 |- skos__hiddenLabel mesh__D013706 Costens Syndrome
% 209.88/210.10 |- mesh__dateRevised mesh__D013706 1996-06-13
% 209.88/210.10 |- skos__hiddenLabel mesh__D013706 Costen Syndrome
% 209.88/210.10 |- mesh__dateCreated mesh__D013706 1999-01-01
% 209.88/210.10 |- skos__prefLabel mesh__D013706
% 209.88/210.10 Temporomandibular Joint Dysfunction Syndrome
% 209.88/210.10 |- skos__broader mesh__D013706smesh__D013705
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 1998
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D013706 PLS
% 209.88/210.10 |- mesh__onlineNote mesh__D013706
% 209.88/210.10 use TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME to search TEMPOROMANDIBULAR JOINT SYNDROME 1973-96 %26% COSTEN%27%S SYNDROME 1966-96%A%
% 209.88/210.10 |- skos__hiddenLabel mesh__D013706 Syndrome, TMJ
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 2005
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 1999
% 209.88/210.10 |- mesh__recordMaintainer mesh__D013706 TGC
% 209.88/210.10 |- skos__scopeNote mesh__D013706
% 209.88/210.10 A symptom complex consisting of pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. The symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are uncertain but include occlusal dysharmony and psychophysiologic factors.%A%
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D013706
% 209.88/210.10 97; was TEMPOROMANDIBULAR JOINT SYNDROME 1973-96, was COSTEN%27%S SYNDROME 1966-72; COSTEN%27%S SYNDROME was see TEMPOROMANDIBULAR JOINT SYNDROME 1973-96%A%
% 209.88/210.10 |- skos__annotation mesh__D013706 DF: note short X ref TMJ SYNDROME
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 2003
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 1997
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 2006
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 2000
% 209.88/210.10 |- skos__altLabel mesh__D013706 Costen%27%s Syndrome
% 209.88/210.10 |- rdf__type mesh__D013706sskos__Concept
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 2004
% 209.88/210.10 |- skos__altLabel mesh__D013706 TMJ Syndrome
% 209.88/210.10 |- skos__hiddenLabel mesh__D013706 Syndrome, Costen%27%s
% 209.88/210.10 |- skos__hiddenLabel mesh__D013706 Syndrome, Temporomandibular Joint
% 209.88/210.10 |- mesh__recordOriginator mesh__D013706 NLM
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D013706 2001
% 209.88/210.10 |- mesh__dateEstablished mesh__D013706 1973-01-01
% 209.88/210.10 |- skos__altLabel mesh__D013706 Temporomandibular Joint Syndrome
% 209.88/210.10 |- skos__broader mesh__D005384Q000293smesh__D005384
% 209.88/210.10 |- mesh__preferredCombination mesh__D005384Q000293smesh__D005383
% 209.88/210.10 |- rdf__type mesh__D005384Q000293smesh__CompoundConcept
% 209.88/210.10 |- skos__hiddenLabel mesh__D051027
% 209.88/210.10 Formyltransferase, Phosphoribosylaminoimidazolecarboxamide
% 209.88/210.10 |- skos__scopeNote mesh__D051027
% 209.88/210.10 An enzyme that catalyzes the conversion of aminoimidazole-4-carboxamide ribonucleotide to 5-formyl-aminoimidazole-4-carboxamide ribonucleotide in the PURINE de novo synthesis pathway. It requires the cofactor N%28%10%29%-FORMYLTETRAHYDROFOLATE as the formyl donor.%A%
% 209.88/210.10 |- mesh__recordOriginator mesh__D051027 AKE
% 209.88/210.10 |- skos__hiddenLabel mesh__D051027 Transformylase, AICAR
% 209.88/210.10 |- mesh__historyNote mesh__D051027
% 209.88/210.10 2006%28%1980%29%; use FORMIC ACIDS 1974-1980, AMINOIMIDAZOLE CARBOXAMIDE 1979-1980, IMIDAZOLES 1974-1979, PENTOSEPHOSPHATES 1974-1979, TRANSFERASES 1974-1979%A%
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D051027 2006A
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D051027 2006
% 209.88/210.10 |- skos__hiddenLabel mesh__D051027
% 209.88/210.10 Ribonucleotide Transformylase, Aminoimidazolecarboxamide
% 209.88/210.10 |- mesh__recordMaintainer mesh__D051027 ags
% 209.88/210.10 |- skos__hiddenLabel mesh__D051027 Formyltransferase, AICAR
% 209.88/210.10 |- mesh__dateCreated mesh__D051027 2005-06-30
% 209.88/210.10 |- mesh__dateEstablished mesh__D051027 2006-01-01
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D051027 ags
% 209.88/210.10 |- skos__hiddenLabel mesh__D051027
% 209.88/210.10 Transformylase, Aminoimidazolecarboxamide Ribonucleotide
% 209.88/210.10 |- skos__altLabel mesh__D051027 AICAR Formyltransferase
% 209.88/210.10 |- skos__broader mesh__D051027smesh__D019877
% 209.88/210.10 |- mesh__dateRevised mesh__D051027 2005-07-14
% 209.88/210.10 |- skos__altLabel mesh__D051027 AICARTFase
% 209.88/210.10 |- skos__altLabel mesh__D051027
% 209.88/210.10 Aminoimidazolecarboxamide Ribonucleotide Transformylase
% 209.88/210.10 |- rdf__type mesh__D051027sskos__Concept
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D051027
% 209.88/210.10 2006; PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1998-2005, ACYLTRANSFERASES 1980-1997, FORMIC ACIDS 1974-1980, AMINOIMIDAZOLE CARBOXAMIDE 1979-1980, IMIDAZOLES 1974-1979, PENTOSEPHOSPHATES 1974-1979, TRANSFERASES 1974-1979%A%
% 209.88/210.10 |- skos__altLabel mesh__D051027 AICAR Transformylase
% 209.88/210.10 |- skos__prefLabel mesh__D051027
% 209.88/210.10 Phosphoribosylaminoimidazolecarboxamide Formyltransferase
% 209.88/210.10 |- skos__broader mesh__D009665smesh__D007546
% 209.88/210.10 |- mesh__recordMaintainer mesh__D009665 lkw
% 209.88/210.10 |- skos__altLabel mesh__D009665 Dreluso Brand of Noscapine Hydrochloride
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009665 2006
% 209.88/210.10 |- mesh__recordOriginator mesh__D009665 NLM
% 209.88/210.10 |- skos__prefLabel mesh__D009665 Noscapine
% 209.88/210.10 |- skos__hiddenLabel mesh__D009665 Tropfen, Capval
% 209.88/210.10 |- skos__hiddenLabel mesh__D009665 Hydrogen Embonate, Noscapine
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009665 2005
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D009665 sjn
% 209.88/210.10 |- skos__hiddenLabel mesh__D009665 Noscapine Dreluso Brand
% 209.88/210.10 |- mesh__dateCreated mesh__D009665 1999-01-01
% 209.88/210.10 |- skos__hiddenLabel mesh__D009665 Embonate, Noscapine Hydrogen
% 209.88/210.10 |- rdf__type mesh__D009665sskos__Concept
% 209.88/210.10 |- skos__altLabel mesh__D009665 Byk Brand of Noscapine Hydrochloride
% 209.88/210.10 |- mesh__dateRevised mesh__D009665 2004-07-07
% 209.88/210.10 |- skos__altLabel mesh__D009665 Dreluso Brand of Noscapine
% 209.88/210.10 |- skos__altLabel mesh__D009665 Berna Brand of Noscapine Hydrochloride
% 209.88/210.10 |- skos__hiddenLabel mesh__D009665 Hydrochloride, Noscapine
% 209.88/210.10 |- skos__altLabel mesh__D009665 Boots Brand of Noscapine Hydrochloride
% 209.88/210.10 |- skos__hiddenLabel mesh__D009665 prikkelhoest, Librochin
% 209.88/210.10 |- skos__broader mesh__D009665smesh__D009892
% 209.88/210.10 |- skos__scopeNote mesh__D009665
% 209.88/210.10 A naturally occurring opium alkaloid that is a centrally acting antitussive agent.%A%
% 209.88/210.10 |- skos__altLabel mesh__D009665 Narcotine
% 209.88/210.10 |- skos__historyNote mesh__D001682 Pharmacology %28%1966-1969%29%
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Biological Availabilities
% 209.88/210.10 |- skos__scopeNote mesh__D001682
% 209.88/210.10 The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.%A%
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Equivalencies, Availability
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Availabilities, Physiologic
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Availabilities, Biologic
% 209.88/210.10 |- skos__prefLabel mesh__D001682 Biological Availability
% 209.88/210.10 |- skos__altLabel mesh__D001682 Availability, Physiologic
% 209.88/210.10 |- mesh__onlineNote mesh__D001682
% 209.88/210.10 use BIOLOGICAL AVAILABILITY to search AVAILABILITY EQUIVALENCY 1980-86, BIOLOGIC AVAILABILITY %26% PHYSIOLOGIC AVAILABILITY 1975-79, %26% BIOPHARMACEUTICS 1970-74%A%
% 209.88/210.10 |- mesh__dateRevised mesh__D001682 2004-07-07
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Physiologic Availabilities
% 209.88/210.10 |- skos__altLabel mesh__D001682 Availability, Biologic
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Bioavailabilities
% 209.88/210.10 |- skos__altLabel mesh__D001682 Biologic Availability
% 209.88/210.10 |- skos__altLabel mesh__D001682 Bioavailability
% 209.88/210.10 |- mesh__historyNote mesh__D001682
% 209.88/210.10 79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86%A%
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D001682
% 209.88/210.10 79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; AVAILABILITY EQUIVALENCY %26% PHYSIOLOGIC AVAILABILITY were see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOLOGICAL AVAILABILITY 1980-86%A%
% 209.88/210.10 |- mesh__dateCreated mesh__D001682 1999-01-01
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D001682 2006
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Availability Equivalencies
% 209.88/210.10 |- skos__historyNote mesh__D001682 Drug Compounding %28%1966-1969%29%
% 209.88/210.10 |- skos__historyNote mesh__D001682 Biopharmaceutics %28%1966-1974%29%
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Biologic Availabilities
% 209.88/210.10 |- skos__annotation mesh__D001682
% 209.88/210.10 NIM with specific drug /pharmacokin %28%IM%29%; no qualif; DF: BIOL AVAILABILITY%A%
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D001682 2005
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Equivalency, Availability
% 209.88/210.10 |- skos__altLabel mesh__D001682 Availability, Biological
% 209.88/210.10 |- skos__broader mesh__D001682smesh__D010599
% 209.88/210.10 |- skos__hiddenLabel mesh__D001682 Availabilities, Biological
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D001682 sjn
% 209.88/210.10 |- mesh__recordOriginator mesh__D001682 NLM
% 209.88/210.10 |- mesh__dateEstablished mesh__D001682 1979-01-01
% 209.88/210.10 |- skos__historyNote mesh__D001682 Drugs %28%1966-1969%29%
% 209.88/210.10 |- mesh__recordMaintainer mesh__D001682 ssb
% 209.88/210.10 |- rdf__type mesh__D001682sskos__Concept
% 209.88/210.10 |- skos__altLabel mesh__D001682 Physiologic Availability
% 209.88/210.10 |- mesh__historyNote mesh__D028021
% 209.88/210.10 2002; use SODIUM-POTASSIUM-CHLORIDE COTRANSPORTERS 1984-2001%A%
% 209.88/210.10 |- mesh__dateRevised mesh__D028021 2005-06-30
% 209.88/210.10 |- skos__historyNote mesh__D028021 Carrier Proteins %28%1984-2001%29%
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D028021 sjn
% 209.88/210.10 |- rdf__type mesh__D028021sskos__Concept
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D028021
% 209.88/210.10 2002; SODIUM, POTASSIUM, CHLORIDE-COTRANSPORTER was indexed under CARRIER PROTEINS 1984-2001%A%
% 209.88/210.10 |- mesh__recordOriginator mesh__D028021 jmp
% 209.88/210.10 |- skos__altLabel mesh__D028021 Sodium-Potassium-Chloride Cotransporter
% 209.88/210.10 |- mesh__dateCreated mesh__D028021 2001-07-25
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 Sodium Potassium Chloride Cotransporter
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 Na K Cl Transporter
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D028021 2006
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 Cotransporter, NaCl-KCl
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 Na K Cl Symporter
% 209.88/210.10 |- skos__altLabel mesh__D028021 NaCl-KCl Cotransporter
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 Sodium Potassium Chloride Cotransporters
% 209.88/210.10 |- skos__altLabel mesh__D028021
% 209.88/210.10 Na%28%+%29%, K%28%+%29%, Cl%28%-%29%-Cotransporter
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021
% 209.88/210.10 Cotransporters, Sodium-Potassium-Chloride
% 209.88/210.10 |- skos__altLabel mesh__D028021 Na-K-Cl-Symporter
% 209.88/210.10 |- skos__prefLabel mesh__D028021 Sodium-Potassium-Chloride Symporters
% 209.88/210.10 |- skos__altLabel mesh__D028021 Sodium-Potassium-Chloride Cotransporters
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 NaCl KCl Cotransporter
% 209.88/210.10 |- skos__altLabel mesh__D028021 Sodium, Potassium, Chloride-Cotransporter
% 209.88/210.10 |- skos__broader mesh__D028021smesh__D027981
% 209.88/210.10 |- skos__scopeNote mesh__D028021
% 209.88/210.10 A subclass of symporters that specifically transport SODIUM CHLORIDE and POTASSIUM CHLORIDE across cellular membranes in a tightly coupled process.%A%
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 Cotransporter, Sodium-Potassium-Chloride
% 209.88/210.10 |- mesh__recordMaintainer mesh__D028021 SYSTEM
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 Sodium Potassium Chloride Symporters
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 Symporters, Sodium-Potassium-Chloride
% 209.88/210.10 |- skos__altLabel mesh__D028021 NaK2Cl Symporter
% 209.88/210.10 |- mesh__dateEstablished mesh__D028021 2002-01-01
% 209.88/210.10 |- skos__hiddenLabel mesh__D028021 Symporter, NaK2Cl
% 209.88/210.10 |- skos__altLabel mesh__D028021 Na-K-Cl-Transporter
% 209.88/210.10 |- skos__prefLabel mesh__D014001 Tin
% 209.88/210.10 |- mesh__recordOriginator mesh__D014001 NLM
% 209.88/210.10 |- skos__annotation mesh__D014001
% 209.88/210.10 Sn-118; Sn-112, 114-117, 119, 122, 124 = TIN %28%IM%29% + ISOTOPES %28%NIM%29%; Sn-108-111, 113, 120, 121, 123, 125-128 = TIN RADIOISOTOPES %28%IM%29%%A%
% 209.88/210.10 |- skos__broader mesh__D014001smesh__D019216
% 209.88/210.10 |- skos__related mesh__D014001smesh__D009947
% 209.88/210.10 |- skos__altLabel mesh__D014001 Stannum
% 209.88/210.10 |- mesh__dateCreated mesh__D014001 1999-01-01
% 209.88/210.10 |- mesh__recordMaintainer mesh__D014001 ssb
% 209.88/210.10 |- skos__scopeNote mesh__D014001
% 209.88/210.10 A trace element that is required in bone formation. It has the atomic symbol Sn, atomic number 50, and atomic weight 118.71.%A%
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D014001 2006
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D014001 sjn
% 209.88/210.10 |- mesh__dateRevised mesh__D014001 2005-06-30
% 209.88/210.10 |- rdf__type mesh__D014001sskos__Concept
% 209.88/210.10 |- skos__related mesh__D014001smesh__D014004
% 209.88/210.10 |- mesh__dateCreated mesh__D019295 1996-06-13
% 209.88/210.10 |- skos__broader mesh__D019295smesh__D001695
% 209.88/210.10 |- skos__related mesh__D019295smesh__D008490
% 209.88/210.10 |- skos__altLabel mesh__D019295 Molecular Biology, Computational
% 209.88/210.10 |- mesh__recordMaintainer mesh__D019295 jls
% 209.88/210.10 |- skos__scopeNote mesh__D019295
% 209.88/210.10 A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories applicable to MOLECULAR BIOLOGY and areas of computer-based techniques for solving biological problems including manipulation of models and datasets.%A%
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D019295 2003
% 209.88/210.10 |- mesh__dateRevised mesh__D019295 2002-07-02
% 209.88/210.10 |- skos__annotation mesh__D019295
% 209.88/210.10 SPEC; SPEC qualif; coord IM with specific biol spec %28%IM%29%; DF: COMPUTATIONAL BIOL%A%
% 209.88/210.10 |- mesh__historyNote mesh__D019295 97
% 209.88/210.10 |- skos__altLabel mesh__D019295 Biology, Computational
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D019295 2005
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D019295 2004
% 209.88/210.10 |- mesh__dateEstablished mesh__D019295 1997-01-01
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D019295 97
% 209.88/210.10 |- mesh__recordOriginator mesh__D019295 JLS
% 209.88/210.10 |- skos__historyNote mesh__D019295 Molecular Biology %28%1992-1996%29%
% 209.88/210.10 |- rdf__type mesh__D019295sskos__Concept
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D019295 2006
% 209.88/210.10 |- skos__altLabel mesh__D019295 Bioinformatics
% 209.88/210.10 |- skos__prefLabel mesh__D019295 Computational Biology
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D019295 sjn
% 209.88/210.10 |- skos__hiddenLabel mesh__D052120
% 209.88/210.10 X Linked Vacuolar Cardiomyopathy and Myopathy
% 209.88/210.10 |- mesh__dateEstablished mesh__D052120 2006-01-01
% 209.88/210.10 |- mesh__dateCreated mesh__D052120 2005-06-30
% 209.88/210.10 |- mesh__historyNote mesh__D052120 2006
% 209.88/210.10 |- mesh__dateRevised mesh__D052120 2005-07-19
% 209.88/210.10 |- skos__altLabel mesh__D052120
% 209.88/210.10 Vacuolar Cardiomyopathy and Myopathy, X-linked
% 209.88/210.10 |- skos__broader mesh__D052120smesh__D009202
% 209.88/210.10 |- skos__broader mesh__D052120smesh__D040181
% 209.88/210.10 |- skos__prefLabel mesh__D052120 Glycogen Storage Disease Type IIb
% 209.88/210.10 |- skos__hiddenLabel mesh__D052120
% 209.88/210.10 Vacuolar Cardiomyopathy and Myopathy, X linked
% 209.88/210.10 |- skos__altLabel mesh__D052120 Danon Disease
% 209.88/210.10 |- rdf__type mesh__D052120sskos__Concept
% 209.88/210.10 |- skos__altLabel mesh__D052120
% 209.88/210.10 X-Linked Vacuolar Cardiomyopathy and Myopathy
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D052120 ags
% 209.88/210.10 |- mesh__recordMaintainer mesh__D052120 ags
% 209.88/210.10 |- skos__hiddenLabel mesh__D052120 Disease, Danon
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D052120 2006A
% 209.88/210.10 |- skos__scopeNote mesh__D052120
% 209.88/210.10 An X-linked dominant multisystem disorder resulting in cardiomyopathy, myopathy and MENTAL RETARDATION. It is caused by mutation in the gene encoding LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2.%A%
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D052120 2006
% 209.88/210.10 |- skos__broader mesh__D052120smesh__D006008
% 209.88/210.10 |- mesh__recordOriginator mesh__D052120 jmp
% 209.88/210.10 |- skos__broader mesh__D052120smesh__D038901
% 209.88/210.10 |- skos__altLabel mesh__D052120 Glycogen Storage Disease IIb
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D052120 2006
% 209.88/210.10 |- skos__hiddenLabel mesh__D005275 Hydrochloride, Fendiline
% 209.88/210.10 |- mesh__historyNote mesh__D005275
% 209.88/210.10 91%28%80%29%; was see under PHENETHYLAMINES 1980-90
% 209.88/210.10 |- mesh__dateCreated mesh__D005275 1979-03-01
% 209.88/210.10 |- skos__altLabel mesh__D005275 Celltech Brand of Fendiline Hydrochloride
% 209.88/210.10 |- skos__prefLabel mesh__D005275 Fendiline
% 209.88/210.10 |- skos__broader mesh__D005275smesh__D010627
% 209.88/210.10 |- skos__altLabel mesh__D005275 Senzit
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D005275 sjn
% 209.88/210.10 |- mesh__recordOriginator mesh__D005275 SH
% 209.88/210.10 |- rdf__type mesh__D005275sskos__Concept
% 209.88/210.10 |- mesh__recordMaintainer mesh__D005275 CCR
% 209.88/210.10 |- mesh__dateRevised mesh__D005275 2005-06-30
% 209.88/210.10 |- skos__altLabel mesh__D005275 Fendilin
% 209.88/210.10 |- skos__historyNote mesh__D005275 Phenethylamines %28%1966-1979%29%
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D005275
% 209.88/210.10 91; was see under PHENETHYLAMINES 1980-90
% 209.88/210.10 |- mesh__dateEstablished mesh__D005275 1991-01-01
% 209.88/210.10 |- skos__scopeNote mesh__D005275
% 209.88/210.10 Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.%A%
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D005275 2006
% 209.88/210.10 |- skos__broader mesh__D016572Q000031smesh__D016572
% 209.88/210.10 |- mesh__preferredCombination mesh__D016572Q000031smesh__D003524
% 209.88/210.10 |- rdf__type mesh__D016572Q000031smesh__CompoundConcept
% 209.88/210.10 |- mesh__recordMaintainer mesh__D051028 ags
% 209.88/210.10 |- rdf__type mesh__D051028sskos__Concept
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform omega
% 209.88/210.10 |- mesh__dateCreated mesh__D051028 2005-07-06
% 209.88/210.10 |- skos__scopeNote mesh__D051028
% 209.88/210.10 A member of the Bcl-2 protein family and homologous partner of C-BCL-2 PROTO-ONCOGENE PROTEIN. It regulates the release of CYTOCHROME C and APOPTOSIS INDUCING FACTOR from the MITOCHONDRIA. Several isoforms of BCL2-associated X protein occur due to ALTERNATIVE SPLICING of the mRNA for this protein.%A%
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform delta
% 209.88/210.10 |- skos__altLabel mesh__D051028 Bax-delta Protein
% 209.88/210.10 |- skos__altLabel mesh__D051028 Bax-beta Protein
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D051028
% 209.88/210.10 2006; BCL2-ASSOCIATED X-PROTEIN was indexed under PROTO-ONCOGENE PROTEINS C-BCL-2 1993-2005%A%
% 209.88/210.10 |- mesh__recordOriginator mesh__D051028 DRC
% 209.88/210.10 |- skos__altLabel mesh__D051028 Bax-alpha Protein
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 bcl 2 Associated X Protein
% 209.88/210.10 |- skos__altLabel mesh__D051028 bcl2-Associated X Protein
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 Bax omega Protein
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform sigma
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform beta
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 Protein, bcl-2-Associated X
% 209.88/210.10 |- mesh__dateRevised mesh__D051028 2005-07-08
% 209.88/210.10 |- mesh__dateEstablished mesh__D051028 2006-01-01
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 X Protein, bcl-2-Associated
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform alpha
% 209.88/210.10 |- skos__altLabel mesh__D051028 Bax Protein
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D051028 2006A
% 209.88/210.10 |- skos__annotation mesh__D051028
% 209.88/210.10 Don%27%t confuse with the closely related BCL-X PROTEIN
% 209.88/210.10 |- skos__broader mesh__D051028smesh__D019253
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 Bax delta Protein
% 209.88/210.10 |- skos__altLabel mesh__D051028 Bax-sigma Protein
% 209.88/210.10 |- skos__altLabel mesh__D051028 Bax-omega Protein
% 209.88/210.10 |- skos__altLabel mesh__D051028 Bax Apoptosis Regulator Protein
% 209.88/210.10 |- skos__prefLabel mesh__D051028 bcl-2-Associated X Protein
% 209.88/210.10 |- mesh__historyNote mesh__D051028 2006%28%1993%29%
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 Bax alpha Protein
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D051028 2006
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 Bax beta Protein
% 209.88/210.10 |- skos__hiddenLabel mesh__D051028 Bax sigma Protein
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D051028 ags
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009666 1999
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009666 2004
% 209.88/210.10 |- skos__prefLabel mesh__D009666 Nose
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009666 2000
% 209.88/210.10 |- mesh__dateRevised mesh__D009666 1997-06-20
% 209.88/210.10 |- skos__hiddenLabel mesh__D009666 Noses
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009666 1998
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009666 2003
% 209.88/210.10 |- mesh__recordMaintainer mesh__D009666 TPW
% 209.88/210.10 |- mesh__considerAlso mesh__D009666
% 209.88/210.10 consider also terms at NAS- and RHIN-
% 209.88/210.10 |- skos__scopeNote mesh__D009666
% 209.88/210.10 A specialized structure that serves as an organ of the sense of smell as well as part of the respiratory system; the term includes both the external nose and the nasal cavity.%A%
% 209.88/210.10 |- skos__annotation mesh__D009666
% 209.88/210.10 %22%nose%22% unspecified as NASAL BONE or NASAL CAVITY; /abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; /secret = NASAL MUCOSA /secret; /surg: consider also RHINOPLASTY%A%
% 209.88/210.10 |- skos__broader mesh__D009666smesh__D012137
% 209.88/210.10 |- mesh__recordOriginator mesh__D009666 NLM
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009666 2006
% 209.88/210.10 |- skos__broader mesh__D009666smesh__D012679
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009666 2002
% 209.88/210.10 |- skos__related mesh__D009666smesh__D012225
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009666 2005
% 209.88/210.10 |- mesh__dateCreated mesh__D009666 1999-01-01
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D009666 2001
% 209.88/210.10 |- skos__broader mesh__D009666smesh__D005145
% 209.88/210.10 |- rdf__type mesh__D009666sskos__Concept
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D009666 SJN
% 209.88/210.10 |- skos__altLabel mesh__D001683 Biological Pacemakers
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Biologic Clocks
% 209.88/210.10 |- skos__altLabel mesh__D001683 Biologic Clock
% 209.88/210.10 |- skos__altLabel mesh__D001683 Oscillators, Endogenous
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Biologic Pacemaker
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Biologic Oscillators
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Oscillators, Biologic
% 209.88/210.10 |- mesh__dateRevised mesh__D001683 2003-07-22
% 209.88/210.10 |- skos__altLabel mesh__D001683 Clocks, Biological
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Clock, Biological
% 209.88/210.10 |- skos__altLabel mesh__D001683 Pacemaker, Biologic
% 209.88/210.10 |- skos__altLabel mesh__D001683 Pacemakers, Biologic
% 209.88/210.10 |- skos__altLabel mesh__D001683 Clock, Biologic
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D001683 2005
% 209.88/210.10 |- skos__annotation mesh__D001683 IM; DF: BIOL CLOCKS
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Clocks, Biologic
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Biological Clock
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Endogenous Oscillator
% 209.88/210.10 |- skos__altLabel mesh__D001683 Biologic Oscillator
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D001683 2006
% 209.88/210.10 |- skos__scopeNote mesh__D001683
% 209.88/210.10 The physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioral phenomena in plants and animals.%A%
% 209.88/210.10 |- mesh__recordMaintainer mesh__D001683 ags
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D001683 sjn
% 209.88/210.10 |- skos__altLabel mesh__D001683 Biological Oscillators
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D001683 67
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Oscillator, Biological
% 209.88/210.10 |- mesh__recordOriginator mesh__D001683 NLM
% 209.88/210.10 |- rdf__type mesh__D001683sskos__Concept
% 209.88/210.10 |- skos__prefLabel mesh__D001683 Biological Clocks
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Pacemaker, Biological
% 209.88/210.10 |- mesh__dateEstablished mesh__D001683 1967-01-01
% 209.88/210.10 |- skos__altLabel mesh__D001683 Oscillator, Biologic
% 209.88/210.10 |- skos__related mesh__D001683smesh__D020178
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Oscillator, Endogenous
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Biological Oscillator
% 209.88/210.10 |- skos__altLabel mesh__D001683 Pacemakers, Biological
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Endogenous Oscillators
% 209.88/210.10 |- skos__related mesh__D001683smesh__D002940
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Biologic Pacemakers
% 209.88/210.10 |- skos__hiddenLabel mesh__D001683 Biological Pacemaker
% 209.88/210.10 |- mesh__historyNote mesh__D001683 67%28%64%29%
% 209.88/210.10 |- skos__broader mesh__D001683smesh__D002909
% 209.88/210.10 |- mesh__dateCreated mesh__D001683 1999-01-01
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D001683 2004
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Laser Therapies, Low-Level
% 209.88/210.10 |- mesh__recordMaintainer mesh__D028022 lkt
% 209.88/210.10 |- skos__altLabel mesh__D028022 Low-Level Laser Therapy
% 209.88/210.10 |- skos__altLabel mesh__D028022 Laser Therapy, Low-Power
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Irradiation, Low-Power Laser
% 209.88/210.10 |- skos__altLabel mesh__D028022 Low-Power Laser Therapy
% 209.88/210.10 |- skos__annotation mesh__D028022
% 209.88/210.10 coord IM with disease /radiother %28%IM%29%
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Biostimulation, Laser
% 209.88/210.10 |- skos__broader mesh__D028022smesh__D010789
% 209.88/210.10 |- mesh__historyNote mesh__D028022 2002
% 209.88/210.10 |- skos__scopeNote mesh__D028022
% 209.88/210.10 Treatment using irradiation with light at low power intensities and with wavelengths in the range 540nm-830nm. The effects are thought to be mediated by a photochemical reaction that alters CELL MEMBRANE PERMEABILITY, leading to increased mRNA synthesis and CELL PROLIFERATION. The effects are not due to heat, as in LASER SURGERY. Low-level laser therapy has been used in general medicine, veterinary medicine, and dentistry for a wide variety of conditions, but most frequently for wound healing and pain control.%A%
% 209.88/210.10 |- skos__altLabel mesh__D028022 Laser Irradiation, Low-Power
% 209.88/210.10 |- mesh__recordOriginator mesh__D028022 ags
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Low Power Laser Therapy
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Laser Therapy, Low Level
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D028022 2002
% 209.88/210.10 |- skos__altLabel mesh__D028022 Laser Biostimulation
% 209.88/210.10 |- skos__prefLabel mesh__D028022 Laser Therapy, Low-Level
% 209.88/210.10 |- mesh__dateRevised mesh__D028022 2005-06-30
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Low Power Laser Irradiation
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Laser Therapy, Low Power
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Laser Therapies, Low-Power
% 209.88/210.10 |- skos__historyNote mesh__D028022
% 209.88/210.10 specific disease/radiotherapy %28%1985-2001%29%
% 209.88/210.10 |- mesh__recordAuthorizer mesh__D028022 sjn
% 209.88/210.10 |- mesh__dateCreated mesh__D028022 2001-07-25
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Low-Power Laser Therapies
% 209.88/210.10 |- skos__historyNote mesh__D028022 Lasers/therapeutic use %28%1983-2001%29%
% 209.88/210.10 |- mesh__dateEstablished mesh__D028022 2002-01-01
% 209.88/210.10 |- skos__altLabel mesh__D028022 LLLT
% 209.88/210.10 |- rdf__type mesh__D028022sskos__Concept
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Low-Level Laser Therapies
% 209.88/210.10 |- skos__altLabel mesh__D028022 Low-Power Laser Irradiation
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Low Level Laser Therapy
% 209.88/210.10 |- skos__hiddenLabel mesh__D028022 Laser Irradiation, Low Power
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D028022 2006
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D014800 1995
% 209.88/210.10 |- skos__hiddenLabel mesh__D014800 Cobalt Chromium Molybdenum Alloy
% 209.88/210.10 |- skos__prefLabel mesh__D014800 Vitallium
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D014800 1999
% 209.88/210.10 |- skos__annotation mesh__D014800
% 209.88/210.10 used for dentures %26% other non-dent prosthesis; D25-26 qualif%A%
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D014800 2005
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D014800 2000
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D014800 1996
% 209.88/210.10 |- skos__broader mesh__D014800smesh__D002858
% 209.88/210.10 |- mesh__dateRevised mesh__D014800 1993-06-04
% 209.88/210.10 |- skos__scopeNote mesh__D014800
% 209.88/210.10 An alloy of 60%25% cobalt, 20%25% chromium, 5%25% molybdenum, and traces of other substances. It is used in dentures, certain surgical appliances, prostheses, implants, and instruments.%A%
% 209.88/210.10 |- mesh__publicMeSHNote mesh__D014800
% 209.88/210.10 91,63-64; was see under CHROMIUM ALLOYS 1982-90; was see under CHROMIUM-COBALT ALLOYS 1965-81; was heading 1963-64%A%
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D014800 2006
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D014800 2001
% 209.88/210.10 |- mesh__activeMeSHYear mesh__D014800 1997
% 209.88/210.10 |- mesh__dateCreated mesh__D014800 1999-01-01
% 209.88/210.10 |- mesh__onlineNote mesh__D014800
% 209.88/210.10 use CHROMIUM ALLOYS to search VITALLIUM 1966-74
% 209.88/210.11 |- mesh__historyNote mesh__D014800
% 209.88/210.11 91%28%75%29%63-64; was see under CHROMIUM ALLOYS 1982-90; was see under CHROMIUM-COBALT ALLOYS 1965-81; was heading 1963-64%A%
% 209.88/210.11 |- mesh__recordMaintainer mesh__D014800 TPW
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D014800 2003
% 209.88/210.11 |- mesh__recordAuthorizer mesh__D014800 PLS
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D014800 2004
% 209.88/210.11 |- skos__hiddenLabel mesh__D014800 Alloy, Cobalt-Chromium-Molybdenum
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D014800 1994
% 209.88/210.11 |- rdf__type mesh__D014800sskos__Concept
% 209.88/210.11 |- mesh__recordOriginator mesh__D014800 NLM
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D014800 2002
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D014800 1998
% 209.88/210.11 |- mesh__dateEstablished mesh__D014800 1991-01-01
% 209.88/210.11 |- skos__scopeNote mesh__D014002
% 209.88/210.11 Inorganic fluorides of tin. They include both stannic fluoride %28%tin tetrafluoride%29% and stannous fluoride %28%tin difluoride%29%. The latter is used in the prevention of dental caries.%A%
% 209.88/210.11 |- skos__hiddenLabel mesh__D014002 Fluorides, Tin
% 209.88/210.11 |- skos__historyNote mesh__D014002 Fluorides %28%1966-1976%29%
% 209.88/210.11 |- skos__hiddenLabel mesh__D014002 Tetrafluoride, Tin
% 209.88/210.11 |- skos__altLabel mesh__D014002 Young Dental Brand of Tin Difluoride
% 209.88/210.11 |- mesh__recordOriginator mesh__D014002 RLS
% 209.88/210.11 |- skos__altLabel mesh__D014002 Stannic Fluoride
% 209.88/210.11 |- skos__historyNote mesh__D014002 Fluorides, Topical %28%1966-1976%29%
% 209.88/210.11 |- skos__prefLabel mesh__D014002 Tin Fluorides
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D014002 2006
% 209.88/210.11 |- skos__broader mesh__D014002smesh__D017971
% 209.88/210.11 |- skos__altLabel mesh__D014002 Omnii Brand 1 of Tin Difluoride
% 209.88/210.11 |- skos__altLabel mesh__D014002 Stannous Fluoride
% 209.88/210.11 |- skos__historyNote mesh__D014002 Tin %28%1966-1976%29%
% 209.88/210.11 |- skos__hiddenLabel mesh__D014002 Difluoride, Tin
% 209.88/210.11 |- skos__annotation mesh__D014002
% 209.88/210.11 X ref STANNOUS FLUORIDE used in dent caries prev
% 209.88/210.11 |- skos__altLabel mesh__D014002 Colgate Brand of Tin Difluoride
% 209.88/210.11 |- mesh__publicMeSHNote mesh__D014002
% 209.88/210.11 91; was see under FLUORIDES 1977-90
% 209.88/210.11 |- skos__broader mesh__D014002smesh__D002327
% 209.88/210.11 |- mesh__historyNote mesh__D014002
% 209.88/210.11 91%28%77%29%; was see under FLUORIDES 1977-90
% 209.88/210.11 |- skos__altLabel mesh__D014002 Ortho Brand of Tin Difluoride
% 209.88/210.11 |- skos__altLabel mesh__D014002 Omnii Brand 2 of Tin Difluoride
% 209.88/210.11 |- mesh__dateEstablished mesh__D014002 1991-01-01
% 209.88/210.11 |- mesh__dateCreated mesh__D014002 1976-04-16
% 209.88/210.11 |- rdf__type mesh__D014002sskos__Concept
% 209.88/210.11 |- skos__altLabel mesh__D014002 McGloin Brand of Tin Difluoride
% 209.88/210.11 |- mesh__recordAuthorizer mesh__D014002 sjn
% 209.88/210.11 |- mesh__dateRevised mesh__D014002 2005-06-30
% 209.88/210.11 |- skos__hiddenLabel mesh__D014002 Fluoride, Stannous
% 209.88/210.11 |- skos__altLabel mesh__D014002 Palisades Brand of Tin Difluoride
% 209.88/210.11 |- skos__broader mesh__D014002smesh__D005459
% 209.88/210.11 |- skos__hiddenLabel mesh__D014002 Fluoride, Stannic
% 209.88/210.11 |- mesh__recordMaintainer mesh__D014002 lkw
% 209.88/210.11 |- skos__historyNote mesh__D019296 Carbon Dioxide %28%1966-1996%29%
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D019296 2002
% 209.88/210.11 |- skos__scopeNote mesh__D019296
% 209.88/210.11 Continuous recording of the carbon dioxide content of expired air.%A%
% 209.88/210.11 |- mesh__recordAuthorizer mesh__D019296 sjn
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D019296 2003
% 209.88/210.11 |- skos__broader mesh__D019296smesh__D012129
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D019296 2000
% 209.88/210.11 |- skos__annotation mesh__D019296 DF: CAPNOGR
% 209.88/210.11 |- mesh__historyNote mesh__D019296 97
% 209.88/210.11 |- mesh__dateRevised mesh__D019296 1999-11-03
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D019296 2005
% 209.88/210.11 |- mesh__recordMaintainer mesh__D019296 KEV
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D019296 2004
% 209.88/210.11 |- mesh__recordOriginator mesh__D019296 TGC
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D019296 2001
% 209.88/210.11 |- rdf__type mesh__D019296sskos__Concept
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D019296 2006
% 209.88/210.11 |- skos__prefLabel mesh__D019296 Capnography
% 209.88/210.11 |- skos__hiddenLabel mesh__D019296 Capnographies
% 209.88/210.11 |- mesh__dateEstablished mesh__D019296 1997-01-01
% 209.88/210.11 |- mesh__dateCreated mesh__D019296 1996-06-10
% 209.88/210.11 |- mesh__publicMeSHNote mesh__D019296 97
% 209.88/210.11 |- mesh__dateRevised mesh__D005276 1997-06-20
% 209.88/210.11 |- mesh__activeMeSHYear mesh__D005276 2003
% 209.88/210.11 |- mesh__recordMaintainer mesh__D005276 PXP
% 209.88/210.11 |- mesh__recordOriginator mesh__D005276 NLM
% 209.88/210.11 |- mesh__historyNote mesh__D005276 97; was FENESTRATION 1966-96
% 209.88/210.11 |- skos__broader mesh__D005276smesh__D013506
% 209.88/210.11 |- mesh__publicMeSHNote mesh__D005276 97; was FENESTRATION 1963-96
% 209.88/210.11 |- skos__hiddenLabel mesh__D005276 Fenestrations, Labyrinth
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D005276 2004
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D005276 2002
% 209.97/210.11 |- skos__hiddenLabel mesh__D005276 Labyrinth Fenestrations
% 209.97/210.11 |- rdf__type mesh__D005276sskos__Concept
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D005276 1998
% 209.97/210.11 |- skos__prefLabel mesh__D005276 Fenestration, Labyrinth
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D005276 2005
% 209.97/210.11 |- skos__hiddenLabel mesh__D005276 Labyrinth Fenestration
% 209.97/210.11 |- skos__scopeNote mesh__D005276
% 209.97/210.11 The surgical creation of a new opening in the labyrinth of the ear for the restoration of hearing in cases of OTOSCLEROSIS. %28%Dorland, 27th ed%29%%A%
% 209.97/210.11 |- mesh__dateCreated mesh__D005276 1999-01-01
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D005276 2000
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D005276 1999
% 209.97/210.11 |- skos__annotation mesh__D005276
% 209.97/210.11 to cure otosclerosis; do not use /util except by MeSH definition%A%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D005276 2006
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D005276 SJN
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D005276 2001
% 209.97/210.11 |- mesh__onlineNote mesh__D005276
% 209.97/210.11 use FENESTRATION, LABYRINTH to search FENESTRATION 1966-96%A%
% 209.97/210.11 |- mesh__historyNote mesh__D013708 73; was TENDON INJURY 1963-72
% 209.97/210.11 |- rdf__type mesh__D013708sskos__Concept
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013708 2004
% 209.97/210.11 |- mesh__recordMaintainer mesh__D013708 TPW
% 209.97/210.11 |- mesh__dateRevised mesh__D013708 1997-06-20
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013708 2000
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D013708 SJN
% 209.97/210.11 |- mesh__dateEstablished mesh__D013708 1973-01-01
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D013708 73; was TENDON INJURY 1963-72
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013708 2001
% 209.97/210.11 |- skos__scopeNote mesh__D013708
% 209.97/210.11 Injuries to the fibrous cords of connective tissue which attach muscles to bones or other structures.%A%
% 209.97/210.11 |- skos__hiddenLabel mesh__D013708 Tendon Injury
% 209.97/210.11 |- mesh__recordOriginator mesh__D013708 NLM
% 209.97/210.11 |- skos__broader mesh__D013708smesh__D014947
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013708 2002
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013708 1998
% 209.97/210.11 |- mesh__onlineNote mesh__D013708
% 209.97/210.11 use TENDON INJURIES to search TENDON INJURY 1966-72
% 209.97/210.11 |- mesh__dateCreated mesh__D013708 1999-01-01
% 209.97/210.11 |- skos__hiddenLabel mesh__D013708 Injury, Tendon
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013708 2005
% 209.97/210.11 |- skos__altLabel mesh__D013708 Injuries, Tendon
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013708 1999
% 209.97/210.11 |- skos__prefLabel mesh__D013708 Tendon Injuries
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013708 2003
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013708 2006
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D010410 sjn
% 209.97/210.11 |- skos__scopeNote mesh__D010410
% 209.97/210.11 The state of the PENIS when the erectile tissue becomes filled or swollen %28%tumid%29% with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions.%A%
% 209.97/210.11 |- skos__historyNote mesh__D010410 Penis %28%1966-1985%29%
% 209.97/210.11 |- mesh__dateCreated mesh__D010410 1985-06-06
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D010410 2005
% 209.97/210.11 |- skos__hiddenLabel mesh__D010410 Erection, Penile
% 209.97/210.11 |- rdf__type mesh__D010410sskos__Concept
% 209.97/210.11 |- skos__hiddenLabel mesh__D010410 Tumescence, Nocturnal Penile
% 209.97/210.11 |- mesh__recordOriginator mesh__D010410 EC
% 209.97/210.11 |- mesh__recordMaintainer mesh__D010410 lkt
% 209.97/210.11 |- skos__prefLabel mesh__D010410 Penile Erection
% 209.97/210.11 |- mesh__historyNote mesh__D010410 86
% 209.97/210.11 |- mesh__dateEstablished mesh__D010410 1986-01-01
% 209.97/210.11 |- skos__hiddenLabel mesh__D010410 Penile Tumescence, Nocturnal
% 209.97/210.11 |- mesh__dateRevised mesh__D010410 2004-07-07
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D010410 86
% 209.97/210.11 |- skos__altLabel mesh__D010410 Tumescence, Penile
% 209.97/210.11 |- skos__broader mesh__D010410smesh__D012098
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D010410 2006
% 209.97/210.11 |- skos__hiddenLabel mesh__D009667 Acquired Nose Deformities
% 209.97/210.11 |- skos__hiddenLabel mesh__D009667 Deformities, Acquired Nose
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 1998
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 2003
% 209.97/210.11 |- skos__broader mesh__D009667smesh__D009668
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 2001
% 209.97/210.11 |- mesh__recordMaintainer mesh__D009667 TGC
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D009667 PLS
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D009667 78; was NOSE DEFORMITIES 1968-77
% 209.97/210.11 |- skos__prefLabel mesh__D009667 Nose Deformities, Acquired
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 1997
% 209.97/210.11 |- skos__hiddenLabel mesh__D009667 Acquired Nose Deformity
% 209.97/210.11 |- skos__scopeNote mesh__D009667
% 209.97/210.11 Deformities of the nose acquired after birth from injury or disease.%A%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 2000
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 2006
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 1996
% 209.97/210.11 |- skos__hiddenLabel mesh__D009667 Deformity, Acquired Nose
% 209.97/210.11 |- mesh__historyNote mesh__D009667 78; was NOSE DEFORMITIES 1968-77
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 1995
% 209.97/210.11 |- mesh__dateRevised mesh__D009667 1992-05-15
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 2005
% 209.97/210.11 |- mesh__recordOriginator mesh__D009667 NLM
% 209.97/210.11 |- mesh__dateCreated mesh__D009667 1999-01-01
% 209.97/210.11 |- skos__annotation mesh__D009667
% 209.97/210.11 = deformities acquired from inj or dis; congenital deformities = NOSE /abnorm %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 1994
% 209.97/210.11 |- rdf__type mesh__D009667sskos__Concept
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 1999
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 2004
% 209.97/210.11 |- mesh__onlineNote mesh__D009667
% 209.97/210.11 use NOSE DEFORMITIES, ACQUIRED to search NOSE DEFORMITIES 1968-77%A%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 2002
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D009667 1993
% 209.97/210.11 |- skos__hiddenLabel mesh__D009667 Nose Deformity, Acquired
% 209.97/210.11 |- mesh__recordOriginator mesh__D001684 SMH
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 2002
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 1997
% 209.97/210.11 |- skos__altLabel mesh__D001684 Xenograft Dressings
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressings, Homograft
% 209.97/210.11 |- skos__altLabel mesh__D001684 Allograft Dressings
% 209.97/210.11 |- mesh__dateRevised mesh__D001684 1992-03-25
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Amniotic Membrane Dressing
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressing, Xenograft
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Pig Skin Dressing
% 209.97/210.11 |- skos__altLabel mesh__D001684 Dressing, Biological
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressing, Heterograft
% 209.97/210.11 |- skos__altLabel mesh__D001684 Biologic Dressing
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 2001
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Xenograft Dressings, Porcine
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 1996
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Xenograft Dressing, Porcine
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressings, Heterograft
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressings, Biologic
% 209.97/210.11 |- skos__altLabel mesh__D001684 Dressings, Biological
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 2006
% 209.97/210.11 |- rdf__type mesh__D001684sskos__Concept
% 209.97/210.11 |- skos__prefLabel mesh__D001684 Biological Dressings
% 209.97/210.11 |- mesh__dateCreated mesh__D001684 1977-03-01
% 209.97/210.11 |- skos__broader mesh__D001684smesh__D001458
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Biologic Dressings
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 1995
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 2000
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Allograft Dressing
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressings, Xenograft
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressing, Homograft
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 1993
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressings, Allograft
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 2005
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressing, Amniotic Membrane
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressings, Porcine Xenograft
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 1999
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 1994
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressing, Allograft
% 209.97/210.11 |- mesh__recordMaintainer mesh__D001684 TAP
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Heterograft Dressing
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Xenograft Dressing
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressing, Porcine Xenograft
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 2004
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D001684 91; was see under BANDAGES 1978-90
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Homograft Dressing
% 209.97/210.11 |- mesh__dateEstablished mesh__D001684 1991-01-01
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 1998
% 209.97/210.11 |- skos__annotation mesh__D001684
% 209.97/210.11 %22%human or animal tissue used as temporary wound covering%22%; do not specify source unless especially discussed %26% do not coord with TRANSPLANTATION, HETEROLOGOUS; note X refs below; DF: BIOL DRESSINGS%A%
% 209.97/210.11 |- skos__historyNote mesh__D001684 Skin/transplantation %28%1966-1977%29%
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressing, Biologic
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressings, Amniotic Membrane
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Porcine Xenograft Dressing
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Biological Dressing
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D001684 PLS
% 209.97/210.11 |- skos__altLabel mesh__D001684 Pig Skin Dressings
% 209.97/210.11 |- skos__scopeNote mesh__D001684
% 209.97/210.11 Human or animal tissue used as temporary wound coverings.%A%
% 209.97/210.11 |- skos__historyNote mesh__D001684 Bandages %28%1966-1977%29%
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressing, Pig Skin
% 209.97/210.11 |- mesh__historyNote mesh__D001684
% 209.97/210.11 91%28%78%29%; was see under BANDAGES 1978-90
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D001684 2003
% 209.97/210.11 |- skos__hiddenLabel mesh__D001684 Dressings, Pig Skin
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D028023 2004
% 209.97/210.11 |- skos__altLabel mesh__D028023 Pijiguao
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D028023 2002
% 209.97/210.11 |- skos__broader mesh__D028023smesh__D019684
% 209.97/210.11 |- skos__scopeNote mesh__D028023
% 209.97/210.11 The palm family of order Arecales, subclass Arecidae, class Liliopsida.%A%
% 209.97/210.11 |- skos__annotation mesh__D028023
% 209.97/210.11 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.97/210.11 |- mesh__dateEstablished mesh__D028023 2002-01-01
% 209.97/210.11 |- mesh__historyNote mesh__D028023 2002
% 209.97/210.11 |- rdf__type mesh__D028023sskos__Concept
% 209.97/210.11 |- mesh__recordOriginator mesh__D028023 ssb
% 209.97/210.11 |- skos__altLabel mesh__D028023 Peach Palm
% 209.97/210.11 |- mesh__recordMaintainer mesh__D028023 ssb
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D028023 2006
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D028023 sjn
% 209.97/210.11 |- mesh__dateRevised mesh__D028023 2003-07-09
% 209.97/210.11 |- skos__prefLabel mesh__D028023 Arecaceae
% 209.97/210.11 |- skos__altLabel mesh__D028023 Pejibaye
% 209.97/210.11 |- mesh__dateCreated mesh__D028023 2001-07-25
% 209.97/210.11 |- skos__altLabel mesh__D028023 Palm, Peach
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D028023 2005
% 209.97/210.11 |- skos__related mesh__D020040smesh__D020038
% 209.97/210.11 |- skos__prefLabel mesh__D020040 Trans-Splicing
% 209.97/210.11 |- skos__altLabel mesh__D020040 Trans Splicing
% 209.97/210.11 |- skos__altLabel mesh__D020040 Trans RNA Splicing
% 209.97/210.11 |- skos__altLabel mesh__D020040 RNA Trans-Splicing
% 209.97/210.11 |- mesh__recordOriginator mesh__D020040 NNS
% 209.97/210.11 |- skos__broader mesh__D020040smesh__D012326
% 209.97/210.11 |- skos__hiddenLabel mesh__D020040 RNA Trans Splicing
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D020040 99
% 209.97/210.11 |- skos__scopeNote mesh__D020040
% 209.97/210.11 The joining of RNA from two different genes. One type of trans-splicing is the %22%spliced leader%22% type %28%primarily found in protozoans such as trypanosomes and in lower invertebrates such as nematodes%29% which results in the addition of a capped, noncoding, spliced leader sequence to the 5%27% end of mRNAs. Another type of trans-splicing is the %22%discontinuous group II introns%22% type %28%found in plant/algal chloroplasts and plant mitochondria%29% which results in the joining of two independently transcribed coding sequences. Both are mechanistically similar to conventional nuclear pre-mRNA cis-splicing. Mammalian cells are also capable of trans-splicing.%A%
% 209.97/210.11 |- skos__hiddenLabel mesh__D020040 Trans-Splicings, RNA
% 209.97/210.11 |- mesh__dateEstablished mesh__D020040 1999-01-01
% 209.97/210.11 |- skos__historyNote mesh__D020040 RNA Splicing %28%1982-1998%29%
% 209.97/210.11 |- skos__hiddenLabel mesh__D020040 Splicing, Trans
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D020040 2005
% 209.97/210.11 |- mesh__recordMaintainer mesh__D020040 ags
% 209.97/210.11 |- skos__hiddenLabel mesh__D020040 RNA Splicing, Trans
% 209.97/210.11 |- mesh__dateCreated mesh__D020040 1998-06-11
% 209.97/210.11 |- mesh__dateRevised mesh__D020040 2005-07-28
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D020040 2006
% 209.97/210.11 |- rdf__type mesh__D020040sskos__Concept
% 209.97/210.11 |- mesh__historyNote mesh__D020040 99
% 209.97/210.11 |- skos__annotation mesh__D020040
% 209.97/210.11 note category: a physiol process taking place within the cell nucleus; do not confuse with DNA, RECOMBINANT; CLONING, MOLECULAR; or GENETIC ENGINEERING%A%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D020040 2006A
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D020040 ags
% 209.97/210.11 |- skos__altLabel mesh__D014801 All-Trans-Retinol
% 209.97/210.11 |- mesh__dateRevised mesh__D014801 2005-06-30
% 209.97/210.11 |- mesh__recordOriginator mesh__D014801 NLM
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014801 2006
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D014801 sjn
% 209.97/210.11 |- mesh__dateCreated mesh__D014801 1999-01-01
% 209.97/210.11 |- mesh__onlineNote mesh__D014801
% 209.97/210.11 use VITAMIN A to search RETINOL 1969-76
% 209.97/210.11 |- skos__prefLabel mesh__D014801 Vitamin A
% 209.97/210.11 |- skos__broader mesh__D014801smesh__D012176
% 209.97/210.11 |- mesh__recordMaintainer mesh__D014801 ssb
% 209.97/210.11 |- skos__scopeNote mesh__D014801
% 209.97/210.11 Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of CAROTENOIDS found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.%A%
% 209.97/210.11 |- skos__altLabel mesh__D014801 Vitamin A1
% 209.97/210.11 |- skos__annotation mesh__D014801
% 209.97/210.11 /ther use: coordinate disease with /drug ther, not /diet ther%A%
% 209.97/210.11 |- rdf__type mesh__D014801sskos__Concept
% 209.97/210.11 |- skos__hiddenLabel mesh__D014801 All Trans Retinol
% 209.97/210.11 |- skos__altLabel mesh__D014801
% 209.97/210.11 3,7-dimethyl-9-%28%2,6,6-trimethyl-1-cyclohexen-1-yl%29%-2,4,6,8-nonatetraen-1-ol, %28%all-E%29%-Isomer
% 209.97/210.11 |- mesh__historyNote mesh__D014801
% 209.97/210.11 RETINOL was see under VITAMIN A 1971-76, was see VITAMIN A 1969-70%A%
% 209.97/210.11 |- skos__hiddenLabel mesh__D014003 Polyphosphates, Stannous
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 2003
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 1997
% 209.97/210.11 |- skos__prefLabel mesh__D014003 Tin Polyphosphates
% 209.97/210.11 |- skos__hiddenLabel mesh__D014003 Pyrophosphates, Stannous
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 2005
% 209.97/210.11 |- skos__hiddenLabel mesh__D014003 Pyrophosphates, Tin
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 1999
% 209.97/210.11 |- mesh__recordMaintainer mesh__D014003 TPW
% 209.97/210.11 |- skos__historyNote mesh__D014003 Tin %28%1966-1976%29%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 1996
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 1995
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D014003
% 209.97/210.11 91; was see under POLYPHOSPHATES 1978-90; was see under PHOSPHATES 1977%A%
% 209.97/210.11 |- mesh__dateCreated mesh__D014003 1976-04-16
% 209.97/210.11 |- mesh__dateRevised mesh__D014003 1993-06-03
% 209.97/210.11 |- mesh__recordOriginator mesh__D014003 RLS
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 1998
% 209.97/210.11 |- rdf__type mesh__D014003sskos__Concept
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D014003 PLS
% 209.97/210.11 |- skos__hiddenLabel mesh__D014003 Polyphosphates, Tin
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 2002
% 209.97/210.11 |- mesh__dateEstablished mesh__D014003 1991-01-01
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 1994
% 209.97/210.11 |- skos__scopeNote mesh__D014003
% 209.97/210.11 Poly or pyrophosphates of tin. In conjunction with radioactive technetium these compounds are used as bone-scanning agents and in scintigraphy to diagnose myocardial and cerebral infarction.%A%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 2001
% 209.97/210.11 |- skos__broader mesh__D014003smesh__D011122
% 209.97/210.11 |- mesh__historyNote mesh__D014003
% 209.97/210.11 91%28%77%29%; was see under POLYPHOSPHATES 1978-90; was see under PHOSPHATES 1977%A%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 2004
% 209.97/210.11 |- skos__historyNote mesh__D014003 Phosphates %28%1966-1976%29%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 2000
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D014003 2006
% 209.97/210.11 |- skos__historyNote mesh__D014003 Pyrophosphates %28%1966-1976%29%
% 209.97/210.11 |- skos__broader mesh__D014003smesh__D017971
% 209.97/210.11 |- mesh__dateEstablished mesh__D019297 1997-01-01
% 209.97/210.11 |- skos__broader mesh__D019297smesh__D004140
% 209.97/210.11 |- mesh__historyNote mesh__D019297
% 209.97/210.11 97; was 2,4-DINITROPHENOL %28%NM%29% 1980-96
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D019297 2006
% 209.97/210.11 |- rdf__type mesh__D019297sskos__Concept
% 209.97/210.11 |- mesh__dateCreated mesh__D019297 1996-06-10
% 209.97/210.11 |- skos__annotation mesh__D019297 DF: note short X ref
% 209.97/210.11 |- mesh__dateRevised mesh__D019297 2005-07-06
% 209.97/210.11 |- skos__hiddenLabel mesh__D019297 2,4 Dinitrophenol
% 209.97/210.11 |- skos__altLabel mesh__D019297 2,4-DNP
% 209.97/210.11 |- mesh__onlineNote mesh__D019297
% 209.97/210.11 use 2,4-DINITROPHENOL %28%NM%29% to search 2,4-DINITROPHENOL 1980-96%A%
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D019297
% 209.97/210.11 97; 2,4-DINITROPHENOL was indexed under DINITROPHENOLS 1980-96%A%
% 209.97/210.11 |- mesh__recordOriginator mesh__D019297 ADP
% 209.97/210.11 |- mesh__recordMaintainer mesh__D019297 NLM
% 209.97/210.11 |- skos__prefLabel mesh__D019297 2,4-Dinitrophenol
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D019297 NLM
% 209.97/210.11 |- skos__scopeNote mesh__D019297
% 209.97/210.11 A toxic dye, chemically related to trinitrophenol %28%picric acid%29%, used in biochemical studies of oxidative processes where it uncouples oxidative phosphorylation. It is also used as a metabolic stimulant. %28%Stedman, 26th ed%29%%A%
% 209.97/210.11 |- skos__historyNote mesh__D019297 Dinitrophenols %28%1980-1996%29%
% 209.97/210.11 |- mesh__historyNote mesh__D005277 72%28%66%29%
% 209.97/210.11 |- mesh__dateEstablished mesh__D005277 1972-01-01
% 209.97/210.11 |- skos__hiddenLabel mesh__D005277 Fenfluramine, R Isomer
% 209.97/210.11 |- mesh__recordOriginator mesh__D005277 NLM
% 209.97/210.11 |- rdf__type mesh__D005277sskos__Concept
% 209.97/210.11 |- mesh__dateRevised mesh__D005277 2005-06-30
% 209.97/210.11 |- skos__hiddenLabel mesh__D005277 Fenfluramine Hydrochloride, R Isomer
% 209.97/210.11 |- mesh__recordMaintainer mesh__D005277 CCR
% 209.97/210.11 |- skos__prefLabel mesh__D005277 Fenfluramine
% 209.97/210.11 |- skos__broader mesh__D005277smesh__D010627
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D005277 72
% 209.97/210.11 |- mesh__dateCreated mesh__D005277 1999-01-01
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D005277 2006
% 209.97/210.11 |- skos__hiddenLabel mesh__D005277 Hydrochloride, Fenfluramine
% 209.97/210.11 |- skos__altLabel mesh__D005277 Robins Brand of Fenfluramine Hydrochloride
% 209.97/210.11 |- skos__scopeNote mesh__D005277
% 209.97/210.11 A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release.%A%
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D005277 sjn
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013709 1999
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013709 2004
% 209.97/210.11 |- mesh__historyNote mesh__D013709 73%28%69%29%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013709 2006
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013709 1998
% 209.97/210.11 |- mesh__dateRevised mesh__D013709 1997-06-20
% 209.97/210.11 |- skos__hiddenLabel mesh__D013709 Transfer, Tendon
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013709 2003
% 209.97/210.11 |- skos__prefLabel mesh__D013709 Tendon Transfer
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013709 2002
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013709 2005
% 209.97/210.11 |- rdf__type mesh__D013709sskos__Concept
% 209.97/210.11 |- mesh__recordAuthorizer mesh__D013709 SJN
% 209.97/210.11 |- mesh__publicMeSHNote mesh__D013709 73
% 209.97/210.11 |- mesh__dateCreated mesh__D013709 1999-01-01
% 209.97/210.11 |- skos__hiddenLabel mesh__D013709 Transfers, Tendon
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013709 2001
% 209.97/210.11 |- mesh__recordMaintainer mesh__D013709 PXP
% 209.97/210.11 |- skos__annotation mesh__D013709
% 209.97/210.11 do not use /util except by MeSH definition; do not confuse with TENDONS /transpl%A%
% 209.97/210.11 |- mesh__dateEstablished mesh__D013709 1973-01-01
% 209.97/210.11 |- skos__broader mesh__D013709smesh__D019637
% 209.97/210.11 |- skos__historyNote mesh__D013709 Tendons/surgery %28%1966-1968%29%
% 209.97/210.11 |- mesh__activeMeSHYear mesh__D013709 2000
% 209.97/210.11 |- mesh__recordOriginator mesh__D013709 NLM
% 209.97/210.12 |- skos__scopeNote mesh__D013709
% 209.97/210.12 Surgical procedure by which a tendon is incised at its insertion and placed at an anatomical site distant from the original insertion. The tendon remains attached at the point of origin and takes over the function of a muscle inactivated by trauma or disease.%A%
% 209.97/210.12 |- skos__hiddenLabel mesh__D013709 Tendon Transfers
% 209.97/210.12 |- skos__hiddenLabel mesh__D010411 Fibrous Cavernitides
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 2001
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 2003
% 209.97/210.12 |- skos__hiddenLabel mesh__D010411 Fibrous Cavernitis
% 209.97/210.12 |- skos__hiddenLabel mesh__D010411 Cavernitides, Fibrous
% 209.97/210.12 |- skos__altLabel mesh__D010411 Peyronie Disease
% 209.97/210.12 |- mesh__dateRevised mesh__D010411 1993-06-02
% 209.97/210.12 |- rdf__type mesh__D010411sskos__Concept
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 2000
% 209.97/210.12 |- mesh__recordOriginator mesh__D010411 NLM
% 209.97/210.12 |- skos__hiddenLabel mesh__D010411 Penile Indurations
% 209.97/210.12 |- skos__broader mesh__D010411smesh__D010409
% 209.97/210.12 |- skos__annotation mesh__D010411 hardening of the corpora cavernosa
% 209.97/210.12 |- skos__hiddenLabel mesh__D010411 Peyronies Disease
% 209.97/210.12 |- mesh__dateCreated mesh__D010411 1999-01-01
% 209.97/210.12 |- skos__prefLabel mesh__D010411 Penile Induration
% 209.97/210.12 |- skos__hiddenLabel mesh__D010411 Induration, Penile
% 209.97/210.12 |- skos__altLabel mesh__D010411 Peyronie%27%s Disease
% 209.97/210.12 |- skos__hiddenLabel mesh__D010411 Indurations, Penile
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 1995
% 209.97/210.12 |- skos__scopeNote mesh__D010411
% 209.97/210.12 A disease of unknown etiology in which there are plaques or strands of dense fibrous tissue causing induration of the corpora cavernosa of the penis. The condition produces a painful deformity and is sometimes seen in cases of DUPUYTREN%27%S CONTRACTURE.%A%
% 209.97/210.12 |- skos__hiddenLabel mesh__D010411 Disease, Peyronie
% 209.97/210.12 |- skos__broader mesh__D010411smesh__D003240
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 2002
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 1999
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 1994
% 209.97/210.12 |- skos__hiddenLabel mesh__D010411 Disease, Peyronie%27%s
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 1997
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D010411 PLS
% 209.97/210.12 |- skos__altLabel mesh__D010411 Cavernitis, Fibrous
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 2006
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 1998
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 2004
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 1996
% 209.97/210.12 |- mesh__recordMaintainer mesh__D010411 TAP
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010411 2005
% 209.97/210.12 |- mesh__recordOriginator mesh__D009668 NLM
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 1996
% 209.97/210.12 |- skos__hiddenLabel mesh__D009668 Nose Disease
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D009668 66
% 209.97/210.12 |- skos__broader mesh__D009668smesh__D012140
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D009668 PLS
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 2005
% 209.97/210.12 |- mesh__dateCreated mesh__D009668 1999-01-01
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 1997
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 1994
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 2000
% 209.97/210.12 |- skos__broader mesh__D009668smesh__D010038
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 2006
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 2001
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 1995
% 209.97/210.12 |- mesh__dateRevised mesh__D009668 1990-03-22
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 2003
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 1998
% 209.97/210.12 |- mesh__dateEstablished mesh__D009668 1966-01-01
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 1992
% 209.97/210.12 |- rdf__type mesh__D009668sskos__Concept
% 209.97/210.12 |- mesh__historyNote mesh__D009668 66
% 209.97/210.12 |- skos__scopeNote mesh__D009668
% 209.97/210.12 Disorders of the nose, general or unspecified.
% 209.97/210.12 |- skos__hiddenLabel mesh__D009668 Diseases, Nose
% 209.97/210.12 |- skos__annotation mesh__D009668 inflamm dis = RHINITIS
% 209.97/210.12 |- skos__prefLabel mesh__D009668 Nose Diseases
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 1999
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 2004
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 1993
% 209.97/210.12 |- mesh__recordMaintainer mesh__D009668 TGC
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 2002
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009668 1991
% 209.97/210.12 |- skos__hiddenLabel mesh__D009668 Disease, Nose
% 209.97/210.12 |- skos__scopeNote mesh__D001685
% 209.97/210.12 Compounds made by living organisms that contribute to or influence a phenomenon or process. They have biological or physiological activities.%A%
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001685 2006
% 209.97/210.12 |- skos__hiddenLabel mesh__D001685 Biologic Factor
% 209.97/210.12 |- skos__altLabel mesh__D001685 Biologic Factors
% 209.97/210.12 |- mesh__dateRevised mesh__D001685 2005-06-30
% 209.97/210.12 |- mesh__recordMaintainer mesh__D001685 ssb
% 209.97/210.12 |- skos__prefLabel mesh__D001685 Biological Factors
% 209.97/210.12 |- skos__altLabel mesh__D001685 Biological Factor
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D001685 89
% 209.97/210.12 |- skos__altLabel mesh__D001685 Factor, Biologic
% 209.97/210.12 |- mesh__dateEstablished mesh__D001685 1989-01-01
% 209.97/210.12 |- rdf__type mesh__D001685sskos__Concept
% 209.97/210.12 |- skos__altLabel mesh__D001685 Factors, Biological
% 209.97/210.12 |- skos__altLabel mesh__D001685 Factor, Biological
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D001685 sjn
% 209.97/210.12 |- mesh__historyNote mesh__D001685 89; was Non-MeSH before 1989
% 209.97/210.12 |- mesh__dateCreated mesh__D001685 1999-01-01
% 209.97/210.12 |- mesh__recordOriginator mesh__D001685 NLM
% 209.97/210.12 |- mesh__runningHead mesh__D001685 D23 - BIOLOGICAL FACTORS
% 209.97/210.12 |- skos__annotation mesh__D001685
% 209.97/210.12 differentiate from BIOLOGICAL PRODUCTS; DF: BIOL FACTORS
% 209.97/210.12 |- skos__hiddenLabel mesh__D001685 Factors, Biologic
% 209.97/210.12 |- skos__hiddenLabel mesh__D034061 Thrombocytopoieses
% 209.97/210.12 |- skos__prefLabel mesh__D034061 Thrombopoiesis
% 209.97/210.12 |- skos__altLabel mesh__D034061 Thrombocytopoiesis
% 209.97/210.12 |- mesh__dateRevised mesh__D034061 2003-07-09
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D034061 2005
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D034061 2003
% 209.97/210.12 |- skos__hiddenLabel mesh__D034061 Megakaryocytopoieses
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D034061 2006
% 209.97/210.12 |- mesh__dateEstablished mesh__D034061 2003-01-01
% 209.97/210.12 |- skos__broader mesh__D034061smesh__D006410
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D034061 2004
% 209.97/210.12 |- skos__hiddenLabel mesh__D034061 Thrombopoieses
% 209.97/210.12 |- mesh__dateCreated mesh__D034061 2002-07-03
% 209.97/210.12 |- mesh__historyNote mesh__D034061 2003
% 209.97/210.12 |- skos__historyNote mesh__D034061 Blood Platelets %28%1965-2002%29%
% 209.97/210.12 |- rdf__type mesh__D034061sskos__Concept
% 209.97/210.12 |- skos__historyNote mesh__D034061 Hematopoiesis %28%1965-2002%29%
% 209.97/210.12 |- skos__scopeNote mesh__D034061
% 209.97/210.12 The process of generating thrombocytes %28%BLOOD PLATELETS%29% from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via the MEGAKARYOCYTES. The humoral factor with thrombopoiesis-stimulating activity is designated THROMBOPOIETIN.%A%
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D006370
% 209.97/210.12 91; was see under PHOTOTHERAPY 1986-90; was see under PHYSICAL THERAPY 1975-85; was see under SUNLIGHT 1966-74%A%
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D006370 sjn
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D006370 2006
% 209.97/210.12 |- skos__scopeNote mesh__D006370
% 209.97/210.12 The treatment of disease by exposing the body to the sun%27%s rays; the therapeutic use of sunbathing. %28%From Dorland, 27th ed%29%%A%
% 209.97/210.12 |- skos__annotation mesh__D006370
% 209.97/210.12 note X ref; do not use /util except by MeSH definition
% 209.97/210.12 |- mesh__recordOriginator mesh__D006370 NLM
% 209.97/210.12 |- skos__broader mesh__D006370smesh__D010789
% 209.97/210.12 |- rdf__type mesh__D006370sskos__Concept
% 209.97/210.12 |- mesh__dateCreated mesh__D006370 1999-01-01
% 209.97/210.12 |- mesh__dateRevised mesh__D006370 2005-06-30
% 209.97/210.12 |- mesh__recordMaintainer mesh__D006370 lkt
% 209.97/210.12 |- mesh__historyNote mesh__D006370
% 209.97/210.12 91%28%75%29%; was see under PHOTOTHERAPY 1986-90; was see under PHYSICAL THERAPY 1975-85; was see under SUNLIGHT 1963-74%A%
% 209.97/210.12 |- skos__prefLabel mesh__D006370 Heliotherapy
% 209.97/210.12 |- mesh__onlineNote mesh__D006370
% 209.97/210.12 use SUNLIGHT to search HELIOTHERAPY 1966-74
% 209.97/210.12 |- mesh__dateEstablished mesh__D006370 1991-01-01
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D028024 2004
% 209.97/210.12 |- skos__scopeNote mesh__D028024
% 209.97/210.12 A plant genus in the family ARECACEAE, order Arecales, subclass Arecidae. The fruit or the extract %28%Permixon%29% is used for PROSTATIC HYPERPLASIA.%A%
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D028024 2002
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D028024 2002
% 209.97/210.12 |- skos__altLabel mesh__D028024 Serenoa serrulata
% 209.97/210.12 |- skos__annotation mesh__D028024
% 209.97/210.12 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.97/210.12 |- skos__historyNote mesh__D028024 Plants, Medicinal %28%1969-2001%29%
% 209.97/210.12 |- skos__prefLabel mesh__D028024 Serenoa
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D028024 2005
% 209.97/210.12 |- rdf__type mesh__D028024sskos__Concept
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D028024 2006
% 209.97/210.12 |- skos__altLabel mesh__D028024 Sabal
% 209.97/210.12 |- skos__altLabel mesh__D028024 Sabal serrulata
% 209.97/210.12 |- skos__broader mesh__D028024smesh__D028023
% 209.97/210.12 |- mesh__historyNote mesh__D028024 2002
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D028024 2003
% 209.97/210.12 |- mesh__dateCreated mesh__D028024 2001-07-25
% 209.97/210.12 |- mesh__dateEstablished mesh__D028024 2002-01-01
% 209.97/210.12 |- skos__related mesh__D014802smesh__D014985
% 209.97/210.12 |- skos__altLabel mesh__D014802 Deficiency, Vitamin A
% 209.97/210.12 |- skos__hiddenLabel mesh__D014802 Vitamin A Deficiencies
% 209.97/210.12 |- skos__prefLabel mesh__D014802 Vitamin A Deficiency
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014802 2006
% 209.97/210.12 |- mesh__recordOriginator mesh__D014802 NLM
% 209.97/210.12 |- skos__hiddenLabel mesh__D014802 Deficiencies, Vitamin A
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014802 2004
% 209.97/210.12 |- skos__related mesh__D014802smesh__D009755
% 209.97/210.12 |- skos__broader mesh__D014802smesh__D001361
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D014802 sjn
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014802 2005
% 209.97/210.12 |- mesh__dateCreated mesh__D014802 1999-01-01
% 209.97/210.12 |- mesh__recordMaintainer mesh__D014802 lkt
% 209.97/210.12 |- skos__scopeNote mesh__D014802
% 209.97/210.12 A nutritional condition produced by a deficiency of VITAMIN A in the diet, characterized by NIGHT BLINDNESS and other ocular manifestations such as dryness of the conjunctiva and later of the cornea %28%XEROPHTHALMIA%29%. Vitamin A deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin A-rich foods. In the United States it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption. %28%From Cecil Textbook of Medicine, 19th ed, p1179%29%%A%
% 209.97/210.12 |- skos__annotation mesh__D014802 DF: VITAMIN A DEFIC
% 209.97/210.12 |- mesh__dateRevised mesh__D014802 2003-07-09
% 209.97/210.12 |- rdf__type mesh__D014802sskos__Concept
% 209.97/210.12 |- mesh__recordMaintainer mesh__D014004 TPW
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 2000
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 1996
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 1995
% 209.97/210.12 |- skos__broader mesh__D014004smesh__D011868
% 209.97/210.12 |- skos__scopeNote mesh__D014004
% 209.97/210.12 Unstable isotopes of tin that decay or disintegrate emitting radiation. Sn atoms with atomic weights 108-111, 113, 120-121, 123 and 125-128 are tin radioisotopes.%A%
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 1998
% 209.97/210.12 |- rdf__type mesh__D014004sskos__Concept
% 209.97/210.12 |- mesh__historyNote mesh__D014004 88
% 209.97/210.12 |- skos__historyNote mesh__D014004 Radioisotopes %28%1966-1987%29%
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 1994
% 209.97/210.12 |- skos__hiddenLabel mesh__D014004 Radioisotopes, Tin
% 209.97/210.12 |- skos__annotation mesh__D014004
% 209.97/210.12 Sn-108-111, 113, 120-121, 123, 125-128; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%
% 209.97/210.12 |- mesh__dateCreated mesh__D014004 1987-04-08
% 209.97/210.12 |- mesh__dateRevised mesh__D014004 1993-06-03
% 209.97/210.12 |- mesh__recordOriginator mesh__D014004 RLS
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 2004
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D014004 PLS
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 2002
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 2006
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 2003
% 209.97/210.12 |- mesh__dateEstablished mesh__D014004 1988-01-01
% 209.97/210.12 |- skos__prefLabel mesh__D014004 Tin Radioisotopes
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 2001
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 1997
% 209.97/210.12 |- skos__historyNote mesh__D014004 Tin %28%1966-1987%29%
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 2005
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D014004 88
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D014004 1999
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D019298 2006
% 209.97/210.12 |- rdf__type mesh__D019298sskos__Concept
% 209.97/210.12 |- skos__historyNote mesh__D019298 Glucosephosphates %28%1981-1996%29%
% 209.97/210.12 |- mesh__dateEstablished mesh__D019298 1997-01-01
% 209.97/210.12 |- skos__broader mesh__D019298smesh__D005958
% 209.97/210.12 |- skos__prefLabel mesh__D019298 Glucose-6-Phosphate
% 209.97/210.12 |- mesh__dateCreated mesh__D019298 1996-06-10
% 209.97/210.12 |- mesh__recordMaintainer mesh__D019298 ssb
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D019298 sjn
% 209.97/210.12 |- skos__hiddenLabel mesh__D019298 Glucose 6 Phosphate
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D019298 2005
% 209.97/210.12 |- mesh__onlineNote mesh__D019298
% 209.97/210.12 use GLUCOSE-6-PHOSPHATE %28%NM%29% to search GLUCOSE-6-PHOSPHATE 1981-96%A%
% 209.97/210.12 |- mesh__dateRevised mesh__D019298 2004-07-07
% 209.97/210.12 |- mesh__historyNote mesh__D019298
% 209.97/210.12 97; was GLUCOSE-6-PHOSPHATE %28%NM%29% 1981-96
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D019298
% 209.97/210.12 97; GLUCOSE-6-PHOSPHATE was indexed under GLUCOSEPHOSPHATES 1981-96%A%
% 209.97/210.12 |- skos__scopeNote mesh__D019298
% 209.97/210.12 An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. %28%Stedman, 26th ed%29%%A%
% 209.97/210.12 |- mesh__recordOriginator mesh__D019298 ADP
% 209.97/210.12 |- skos__broader mesh__D005278smesh__D009946
% 209.97/210.12 |- skos__altLabel mesh__D005278 Metathion
% 209.97/210.12 |- mesh__dateCreated mesh__D005278 1999-01-01
% 209.97/210.12 |- mesh__dateEstablished mesh__D005278 1974-01-01
% 209.97/210.12 |- skos__annotation mesh__D005278 TN 111 for eff on insects
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D005278 2006
% 209.97/210.12 |- skos__scopeNote mesh__D005278
% 209.97/210.12 An organothiophosphate cholinesterase inhibitor that is used as an insecticide.%A%
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D005278 74
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D005278 sjn
% 209.97/210.12 |- mesh__historyNote mesh__D005278 74%28%72%29%
% 209.97/210.12 |- skos__historyNote mesh__D005278 Insecticides %28%1966-1971%29%
% 209.97/210.12 |- skos__prefLabel mesh__D005278 Fenitrothion
% 209.97/210.12 |- mesh__recordOriginator mesh__D005278 NLM
% 209.97/210.12 |- skos__hiddenLabel mesh__D005278 1050, Agria
% 209.97/210.12 |- mesh__dateRevised mesh__D005278 2005-06-30
% 209.97/210.12 |- skos__altLabel mesh__D005278 Sumithione
% 209.97/210.12 |- mesh__recordMaintainer mesh__D005278 ssb
% 209.97/210.12 |- rdf__type mesh__D005278sskos__Concept
% 209.97/210.12 |- mesh__dateCreated mesh__D010412 1999-01-01
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010412 2002
% 209.97/210.12 |- skos__broader mesh__D010412smesh__D010409
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Cancers, Penile
% 209.97/210.12 |- skos__scopeNote mesh__D010412
% 209.97/210.12 Cancers or tumors of the PENIS or of its component tissues.%A%
% 209.97/210.12 |- skos__altLabel mesh__D010412 Penile Cancer
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Cancer, Penis
% 209.97/210.12 |- mesh__dateRevised mesh__D010412 1999-11-08
% 209.97/210.12 |- skos__altLabel mesh__D010412 Penis Neoplasms
% 209.97/210.12 |- skos__altLabel mesh__D010412 Penis Cancer
% 209.97/210.12 |- mesh__recordMaintainer mesh__D010412 adp
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010412 2006
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010412 2001
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010412 2004
% 209.97/210.12 |- skos__broader mesh__D010412smesh__D005834
% 209.97/210.12 |- skos__altLabel mesh__D010412 Neoplasms, Penile
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010412 2005
% 209.97/210.12 |- mesh__recordOriginator mesh__D010412 NLM
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D010412 sjn
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010412 2000
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Penile Neoplasm
% 209.97/210.12 |- skos__altLabel mesh__D010412 Cancer of the Penis
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Cancers, Penis
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D010412 2003
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Penile Cancers
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Cancer, Penile
% 209.97/210.12 |- rdf__type mesh__D010412sskos__Concept
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Penis Cancers
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Neoplasm, Penile
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Neoplasm, Penis
% 209.97/210.12 |- skos__annotation mesh__D010412
% 209.97/210.12 coord IM with histol type of neopl %28%IM%29%
% 209.97/210.12 |- skos__hiddenLabel mesh__D010412 Penis Neoplasm
% 209.97/210.12 |- skos__prefLabel mesh__D010412 Penile Neoplasms
% 209.97/210.12 |- skos__altLabel mesh__D010412 Neoplasms, Penis
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009669 2005
% 209.97/210.12 |- mesh__dateCreated mesh__D009669 1999-01-01
% 209.97/210.12 |- mesh__recordMaintainer mesh__D009669 nns
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009669 2002
% 209.97/210.12 |- skos__hiddenLabel mesh__D009669 Cancer, Nose
% 209.97/210.12 |- skos__scopeNote mesh__D009669 Tumors or cancer of the NOSE.
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009669 2006
% 209.97/210.12 |- mesh__recordOriginator mesh__D009669 NLM
% 209.97/210.12 |- skos__annotation mesh__D009669
% 209.97/210.12 soft or bony tissue; coord IM with specific site in nose %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 209.97/210.12 |- mesh__dateRevised mesh__D009669 2000-06-22
% 209.97/210.12 |- skos__hiddenLabel mesh__D009669 Nose Cancers
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D009669 sjn
% 209.97/210.12 |- skos__broader mesh__D009669smesh__D012142
% 209.97/210.12 |- skos__hiddenLabel mesh__D009669 Nose Neoplasm
% 209.97/210.12 |- skos__broader mesh__D009669smesh__D010039
% 209.97/210.12 |- skos__altLabel mesh__D009669 Cancer of the Nose
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009669 2003
% 209.97/210.12 |- skos__altLabel mesh__D009669 Neoplasms, Nose
% 209.97/210.12 |- rdf__type mesh__D009669sskos__Concept
% 209.97/210.12 |- skos__broader mesh__D009669smesh__D012888
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009669 2004
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D009669 2001
% 209.97/210.12 |- skos__hiddenLabel mesh__D009669 Cancers, Nose
% 209.97/210.12 |- skos__altLabel mesh__D009669 Nose Cancer
% 209.97/210.12 |- skos__broader mesh__D009669smesh__D009668
% 209.97/210.12 |- skos__hiddenLabel mesh__D009669 Neoplasm, Nose
% 209.97/210.12 |- skos__prefLabel mesh__D009669 Nose Neoplasms
% 209.97/210.12 |- mesh__recordOriginator mesh__D001686 NLM
% 209.97/210.12 |- rdf__type mesh__D001686sskos__Concept
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D001686 98
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001686 2003
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D001686 SJN
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001686 2000
% 209.97/210.12 |- mesh__dateCreated mesh__D001686 1999-01-01
% 209.97/210.12 |- skos__scopeNote mesh__D001686
% 209.97/210.12 Biological functions and activities at the organic and molecular levels in humans, animals, microorganisms, and plants. For biochemical and metabolic processes, BIOCHEMICAL PHENOMENA is available.%A%
% 209.97/210.12 |- mesh__dateRevised mesh__D001686 1997-06-20
% 209.97/210.12 |- mesh__dateEstablished mesh__D001686 1998-01-01
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001686 2004
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001686 2001
% 209.97/210.12 |- skos__altLabel mesh__D001686 Biologic Phenomena
% 209.97/210.12 |- skos__broader mesh__D001686smesh__D001687
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001686 2005
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001686 1998
% 209.97/210.12 |- skos__hiddenLabel mesh__D001686 Phenomena, Biologic
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001686 2002
% 209.97/210.12 |- skos__annotation mesh__D001686
% 209.97/210.12 GEN or unspecified; prefer specifics; BIOCHEMICAL PHENOMENA is also available%A%
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001686 2006
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D001686 1999
% 209.97/210.12 |- mesh__historyNote mesh__D001686 98; use explode 1970-97
% 209.97/210.12 |- skos__prefLabel mesh__D001686 Biological Phenomena
% 209.97/210.12 |- skos__altLabel mesh__D001686 Phenomena, Biological
% 209.97/210.12 |- mesh__recordMaintainer mesh__D001686 TGC
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D034062 2005
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D034062 2003
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D034062 2006
% 209.97/210.12 |- skos__broader mesh__D034062smesh__D017096
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D034062 2004
% 209.97/210.12 |- skos__hiddenLabel mesh__D034062 Insomnias, Fatal Familial
% 209.97/210.12 |- skos__prefLabel mesh__D034062 Insomnia, Fatal Familial
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D034062 2003; see PRION DISEASES 1993-2002
% 209.97/210.12 |- skos__broader mesh__D034062smesh__D007319
% 209.97/210.12 |- mesh__historyNote mesh__D034062 2003; use PRION DISEASES 1993-2002
% 209.97/210.12 |- skos__hiddenLabel mesh__D034062 Fatal Familial Insomnias
% 209.97/210.12 |- skos__scopeNote mesh__D034062
% 209.97/210.12 An autosomal dominant disorder characterized by degeneration of the THALAMUS and progressive insomnia. It is caused by a mutation in the prion protein %28%PRIONS%29%.%A%
% 209.97/210.12 |- mesh__dateEstablished mesh__D034062 2003-01-01
% 209.97/210.12 |- skos__historyNote mesh__D034062 Prion Diseases %28%1992-2002%29%
% 209.97/210.12 |- rdf__type mesh__D034062sskos__Concept
% 209.97/210.12 |- skos__altLabel mesh__D034062 Fatal Familial Insomnia
% 209.97/210.12 |- skos__historyNote mesh__D034062
% 209.97/210.12 Sleep Initiation and Maintenance Disorders %28%1986-1992%29%
% 209.97/210.12 |- mesh__dateCreated mesh__D034062 2002-07-03
% 209.97/210.12 |- skos__historyNote mesh__D020840 Kallikreins %28%1983-1999%29%
% 209.97/210.12 |- skos__altLabel mesh__D020840 hK2 Kallikrein
% 209.97/210.12 |- skos__altLabel mesh__D020840 Kallikrein 2
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikreins, Human Glandular
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D020840 2006
% 209.97/210.12 |- skos__altLabel mesh__D020840 Pancreatic Kallikrein
% 209.97/210.12 |- skos__altLabel mesh__D020840 Glandular Kallikrein
% 209.97/210.12 |- mesh__historyNote mesh__D020840
% 209.97/210.12 2000; use TISSUE KALLIKREIN %28%NM%29% 1983-1999
% 209.97/210.12 |- rdf__type mesh__D020840sskos__Concept
% 209.97/210.12 |- skos__prefLabel mesh__D020840 Tissue Kallikreins
% 209.97/210.12 |- mesh__recordMaintainer mesh__D020840 ssb
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D020840 sjn
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikrein, Glandular
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Glandular Kallikrein 1
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D020840
% 209.97/210.12 2000; TISSUE KALLIKREIN was indexed under KALLIKREIN 1983-1999 %26% PEPTIDE PEPTIDOHYDROLASES 1982-1983%A%
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikrein, hK2
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikrein, Prostate Specific
% 209.97/210.12 |- mesh__dateEstablished mesh__D020840 2000-01-01
% 209.97/210.12 |- skos__broader mesh__D020840smesh__D014408
% 209.97/210.12 |- skos__altLabel mesh__D020840 hK1 Kallikrein
% 209.97/210.12 |- skos__altLabel mesh__D020840 Human Glandular Kallikreins
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 1, Kallikrein
% 209.97/210.12 |- skos__annotation mesh__D020840
% 209.97/210.12 do not confuse PROSTATE SPECIFIC KALLIKREIN with PROSTATE SPECIFIC ANTIGEN%A%
% 209.97/210.12 |- skos__broader mesh__D020840smesh__D007610
% 209.97/210.12 |- mesh__dateRevised mesh__D020840 2005-06-30
% 209.97/210.12 |- skos__altLabel mesh__D020840 Glandular Kallikrein-1
% 209.97/210.12 |- skos__scopeNote mesh__D020840
% 209.97/210.12 A family of trypsin-like SERINE ENDOPEPTIDASES that are expressed in a variety of cell types including human prostate epithelial cells. They are formed from tissue prokallikrein by action with TRYPSIN. They are highly similar to PROSTATE-SPECIFIC ANTIGEN. EC 3.4.21.35.%A%
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikrein-1, Glandular
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikrein, hK1
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikrein, Tissue
% 209.97/210.12 |- skos__altLabel mesh__D020840 Prostate Specific Kallikrein
% 209.97/210.12 |- mesh__recordOriginator mesh__D020840 adp
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikrein, Urinary
% 209.97/210.12 |- skos__altLabel mesh__D020840 Tissue Kallikrein
% 209.97/210.12 |- skos__altLabel mesh__D020840 Kallikrein 1
% 209.97/210.12 |- skos__altLabel mesh__D020840 Urinary Kallikrein
% 209.97/210.12 |- skos__historyNote mesh__D020840 Endopeptidases %28%1982-1983%29%
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 2, Kallikrein
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Specific Kallikrein, Prostate
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikrein, Pancreatic
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Kallikreins, Tissue
% 209.97/210.12 |- skos__hiddenLabel mesh__D020840 Glandular Kallikreins, Human
% 209.97/210.12 |- mesh__dateCreated mesh__D020840 1999-11-09
% 209.97/210.12 |- skos__altLabel mesh__D047788 Revolutionary War
% 209.97/210.12 |- skos__hiddenLabel mesh__D047788 American Revolution, 1775 1783
% 209.97/210.12 |- mesh__dateEstablished mesh__D047788 2005-01-01
% 209.97/210.12 |- mesh__dateCreated mesh__D047788 2004-07-07
% 209.97/210.12 |- mesh__publicMeSHNote mesh__D047788 2005
% 209.97/210.12 |- skos__broader mesh__D047788smesh__D049671
% 209.97/210.12 |- mesh__historyNote mesh__D047788 2005
% 209.97/210.12 |- mesh__recordOriginator mesh__D047788 jls
% 209.97/210.12 |- skos__hiddenLabel mesh__D047788 War, Revolutionary
% 209.97/210.12 |- mesh__recordMaintainer mesh__D047788 jls
% 209.97/210.12 |- mesh__recordAuthorizer mesh__D047788 sjn
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D047788 2005
% 209.97/210.12 |- skos__altLabel mesh__D047788 American Revolution, 1775-1783
% 209.97/210.12 |- skos__hiddenLabel mesh__D047788 Revolution, American
% 209.97/210.12 |- skos__scopeNote mesh__D047788
% 209.97/210.12 Armed conflict that resulted in separation of American colonies from Britain and established the United States of America.%A%
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D047788 2006
% 209.97/210.12 |- rdf__type mesh__D047788sskos__Concept
% 209.97/210.12 |- skos__hiddenLabel mesh__D047788 Revolutions, American
% 209.97/210.12 |- skos__prefLabel mesh__D047788 American Revolution
% 209.97/210.12 |- skos__altLabel mesh__D047788 American War of Independence
% 209.97/210.12 |- skos__hiddenLabel mesh__D047788 American Revolutions
% 209.97/210.12 |- mesh__dateRevised mesh__D006371 1993-06-04
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D006371 1998
% 209.97/210.12 |- mesh__activeMeSHYear mesh__D006371 2003
% 209.97/210.12 |- mesh__recordMaintainer mesh__D006371 TPW
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 1994
% 209.97/210.13 |- rdf__type mesh__D006371sskos__Concept
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 2000
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 1999
% 209.97/210.13 |- mesh__dateCreated mesh__D006371 1999-01-01
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 2004
% 209.97/210.13 |- skos__prefLabel mesh__D006371 Helium
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 1995
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 2001
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 2005
% 209.97/210.13 |- skos__annotation mesh__D006371
% 209.97/210.13 a rare gas; He-4; He-3 = HELIUM %28%IM%29% + ISOTOPES %28%NIM%29%; He-5, 6, 8 = HELIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 1996
% 209.97/210.13 |- skos__broader mesh__D006371smesh__D005741
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 2002
% 209.97/210.13 |- mesh__recordOriginator mesh__D006371 NLM
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 2006
% 209.97/210.13 |- skos__scopeNote mesh__D006371
% 209.97/210.13 Helium. A noble gas with the atomic symbol He, atomic number 2, and atomic weight 4.003. It is a colorless, odorless, tasteless gas that is not combustible and does not support combustion. It was first detected in the sun and is now obtained from natural gas. Medically it is used as a diluent for other gases, being especially useful with oxygen in the treatment of certain cases of respiratory obstruction, and as a vehicle for general anesthetics. %28%Dorland, 27th ed%29%%A%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006371 1997
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D006371 PLS
% 209.97/210.13 |- rdf__type mesh__D020042sskos__Concept
% 209.97/210.13 |- skos__scopeNote mesh__D020042
% 209.97/210.13 Development of lesions in the lymph node characterized by infiltration of the cortex or paracortex by large collections of proliferating histiocytes and complete or, more often, incomplete necrosis of lymphoid tissue.%A%
% 209.97/210.13 |- skos__altLabel mesh__D020042 Lymphadenitis, Histiocytic Necrotizing
% 209.97/210.13 |- skos__altLabel mesh__D020042 Kikuchi-Fujimoto Disease
% 209.97/210.13 |- skos__hiddenLabel mesh__D020042 Disease, Kikuchi
% 209.97/210.13 |- mesh__historyNote mesh__D020042 99
% 209.97/210.13 |- mesh__dateCreated mesh__D020042 1998-06-10
% 209.97/210.13 |- skos__hiddenLabel mesh__D020042 Disease, Kikuchi-Fujimoto
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020042 2003
% 209.97/210.13 |- skos__hiddenLabel mesh__D020042 Disease, Kikuchi%27%s
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D020042 99
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020042 2000
% 209.97/210.13 |- skos__broader mesh__D020042smesh__D008199
% 209.97/210.13 |- skos__hiddenLabel mesh__D020042 Necrotizing Lymphadenitis, Histiocytic
% 209.97/210.13 |- mesh__dateEstablished mesh__D020042 1999-01-01
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020042 2004
% 209.97/210.13 |- skos__prefLabel mesh__D020042 Histiocytic Necrotizing Lymphadenitis
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020042 2001
% 209.97/210.13 |- skos__altLabel mesh__D020042 Kikuchi Disease
% 209.97/210.13 |- skos__hiddenLabel mesh__D020042 Kikuchi Fujimoto Disease
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020042 2005
% 209.97/210.13 |- skos__altLabel mesh__D020042 Kikuchi%27%s Disease
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020042 2002
% 209.97/210.13 |- skos__historyNote mesh__D020042 Lymphadenitis %28%1983-1998%29%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020042 1999
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020042 2006
% 209.97/210.13 |- skos__hiddenLabel mesh__D020042 Kikuchis Disease
% 209.97/210.13 |- skos__altLabel mesh__D014803 Neurobion
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014803 2006
% 209.97/210.13 |- skos__scopeNote mesh__D014803
% 209.97/210.13 A group of water-soluble vitamins, some of which are COENZYMES.%A%
% 209.97/210.13 |- mesh__dateCreated mesh__D014803 1999-01-01
% 209.97/210.13 |- mesh__dateRevised mesh__D014803 2005-06-30
% 209.97/210.13 |- skos__prefLabel mesh__D014803 Vitamin B Complex
% 209.97/210.13 |- rdf__type mesh__D014803sskos__Concept
% 209.97/210.13 |- skos__annotation mesh__D014803
% 209.97/210.13 GEN or unspecified B vitamins; prefer specific vitamin B; /defic = VITAMIN B DEFICIENCY or PELLAGRA; /ther use: coord disease with /drug ther, not /diet ther%A%
% 209.97/210.13 |- mesh__recordOriginator mesh__D014803 NLM
% 209.97/210.13 |- mesh__recordMaintainer mesh__D014803 ssb
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D014803 sjn
% 209.97/210.13 |- skos__altLabel mesh__D014803 B Vitamins
% 209.97/210.13 |- skos__broader mesh__D014803smesh__D014815
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 2000
% 209.97/210.13 |- skos__hiddenLabel mesh__D014005 Epidermophytoses
% 209.97/210.13 |- mesh__dateCreated mesh__D014005 1999-01-01
% 209.97/210.13 |- rdf__type mesh__D014005sskos__Concept
% 209.97/210.13 |- mesh__recordOriginator mesh__D014005 NLM
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 2001
% 209.97/210.13 |- skos__scopeNote mesh__D014005
% 209.97/210.13 A general term describing various dermatophytoses. Specific types include TINEA CAPITIS %28%ringworm of the scalp%29%, TINEA FAVOSA %28%of scalp and skin%29%, TINEA PEDIS %28%athlete%27%s foot%29%, and tinea unguium %28%see ONYCHOMYCOSIS, ringworm of the nails%29%. %28%Dorland, 27th ed%29%%A%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 2003
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 2005
% 209.97/210.13 |- skos__annotation mesh__D014005
% 209.97/210.13 the disease ringworm: do not confuse with TAENIA, tapeworm; GEN or unspecified: prefer specifics%A%
% 209.97/210.13 |- skos__broader mesh__D014005smesh__D003881
% 209.97/210.13 |- mesh__dateRevised mesh__D014005 1996-06-10
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 2004
% 209.97/210.13 |- skos__prefLabel mesh__D014005 Tinea
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D014005 PLS
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 2002
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 2006
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 1998
% 209.97/210.13 |- skos__hiddenLabel mesh__D014005 Trichophytoses
% 209.97/210.13 |- skos__hiddenLabel mesh__D014005 Tineas
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 1997
% 209.97/210.13 |- mesh__recordMaintainer mesh__D014005 TGC
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014005 1999
% 209.97/210.13 |- skos__altLabel mesh__D014005 Ringworm
% 209.97/210.13 |- skos__broader mesh__D008214Q000637smesh__D008214
% 209.97/210.13 |- mesh__preferredCombination mesh__D008214Q000637smesh__D017710
% 209.97/210.13 |- rdf__type mesh__D008214Q000637smesh__CompoundConcept
% 209.97/210.13 |- mesh__historyNote mesh__D019299 97
% 209.97/210.13 |- skos__historyNote mesh__D019299
% 209.97/210.13 specific disease/surgery %28%1966-1996%29%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 2003
% 209.97/210.13 |- mesh__dateEstablished mesh__D019299 1997-01-01
% 209.97/210.13 |- skos__prefLabel mesh__D019299 Decompression, Surgical
% 209.97/210.13 |- mesh__dateCreated mesh__D019299 1996-06-10
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 1997
% 209.97/210.13 |- skos__scopeNote mesh__D019299
% 209.97/210.13 A surgical operation for the relief of pressure in a body compartment or on a body part. %28%From Dorland, 28th ed%29%%A%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 2006
% 209.97/210.13 |- rdf__type mesh__D019299sskos__Concept
% 209.97/210.13 |- skos__hiddenLabel mesh__D019299 Surgical Decompressions
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 2002
% 209.97/210.13 |- skos__broader mesh__D019299smesh__D013514
% 209.97/210.13 |- skos__hiddenLabel mesh__D019299 Decompressions, Surgical
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 2005
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 1999
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 2004
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 2001
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 1998
% 209.97/210.13 |- skos__altLabel mesh__D019299 Surgical Decompression
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D019299 97
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D019299 2000
% 209.97/210.13 |- skos__annotation mesh__D019299
% 209.97/210.13 do not use /util except by MeSH definition
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D005279
% 209.97/210.13 91; was see under PHENYLPROPIONATES 1975-90
% 209.97/210.13 |- skos__historyNote mesh__D005279 Ethers %28%1972%29%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D005279 2006
% 209.97/210.13 |- skos__historyNote mesh__D005279 Propionates %28%1972-1974%29%
% 209.97/210.13 |- skos__hiddenLabel mesh__D005279 Calcium, Fenoprofen
% 209.97/210.13 |- skos__prefLabel mesh__D005279 Fenoprofen
% 209.97/210.13 |- skos__historyNote mesh__D005279
% 209.97/210.13 Anti-Inflammatory Agents %28%1972-1974%29%
% 209.97/210.13 |- skos__broader mesh__D005279smesh__D010666
% 209.97/210.13 |- mesh__recordMaintainer mesh__D005279 exl
% 209.97/210.13 |- skos__historyNote mesh__D005279 Phenols %28%1973%29%
% 209.97/210.13 |- skos__scopeNote mesh__D005279
% 209.97/210.13 An anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to ASPIRIN, but causes less gastrointestinal bleeding.%A%
% 209.97/210.13 |- mesh__historyNote mesh__D005279
% 209.97/210.13 91%28%75%29%; was see under PHENYLPROPIONATES 1975-90
% 209.97/210.13 |- skos__historyNote mesh__D005279 Phenyl Ethers %28%1974%29%
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D005279 sjn
% 209.97/210.13 |- skos__altLabel mesh__D005279 Fenoprofen Dihydrate, Calcium Salt
% 209.97/210.13 |- rdf__type mesh__D005279sskos__Concept
% 209.97/210.13 |- mesh__dateEstablished mesh__D005279 1991-01-01
% 209.97/210.13 |- mesh__dateCreated mesh__D005279 1974-11-11
% 209.97/210.13 |- mesh__recordOriginator mesh__D005279 NLM
% 209.97/210.13 |- mesh__dateRevised mesh__D005279 2005-06-30
% 209.97/210.13 |- mesh__recordMaintainer mesh__D010413 mdb
% 209.97/210.13 |- skos__prefLabel mesh__D010413 Penis
% 209.97/210.13 |- skos__broader mesh__D010413smesh__D005837
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010413 2006
% 209.97/210.13 |- skos__scopeNote mesh__D010413
% 209.97/210.13 The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra.%A%
% 209.97/210.13 |- skos__related mesh__D010413smesh__D002944
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010413 2004
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010413 2005
% 209.97/210.13 |- mesh__considerAlso mesh__D010413 consider also terms at PENILE
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010413 2003
% 209.97/210.13 |- rdf__type mesh__D010413sskos__Concept
% 209.97/210.13 |- mesh__recordOriginator mesh__D010413 NLM
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D010413 sjn
% 209.97/210.13 |- mesh__dateCreated mesh__D010413 1999-01-01
% 209.97/210.13 |- skos__annotation mesh__D010413
% 209.97/210.13 inflammation = BALANITIS; penile fract: index under PENIS /inj %28%IM%29% + RUPTURE %28%NIM%29%%A%
% 209.97/210.13 |- mesh__dateRevised mesh__D010413 2002-07-03
% 209.97/210.13 |- skos__scopeNote mesh__D034861
% 209.97/210.13 The outer margins of the ABDOMEN, extending from the osteocartilaginous thoracic cage to the PELVIS. Though its major part is muscular, the abdominal wall consists of at least seven layers: the SKIN, subcutaneous fat, deep FASCIA; ABDOMINAL MUSCLES, transversalis fascia, extraperitoneal fat, and the parietal PERITONEUM.%A%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D034861 2005
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D034861
% 209.97/210.13 2003; see ABDOMINAL MUSCLES 1966-1992
% 209.97/210.13 |- skos__hiddenLabel mesh__D034861 Wall, Abdominal
% 209.97/210.13 |- mesh__dateEstablished mesh__D034861 2003-01-01
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D034861 2006
% 209.97/210.13 |- skos__broader mesh__D034861smesh__D000005
% 209.97/210.13 |- mesh__historyNote mesh__D034861 2003; use ABDOMINAL MUSCLES 1966-1992
% 209.97/210.13 |- mesh__dateCreated mesh__D034861 2002-07-02
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D034861 2003
% 209.97/210.13 |- skos__related mesh__D034861smesh__D000009
% 209.97/210.13 |- rdf__type mesh__D034861sskos__Concept
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D034861 2004
% 209.97/210.13 |- skos__prefLabel mesh__D034861 Abdominal Wall
% 209.97/210.13 |- skos__historyNote mesh__D034861 Abdominal Muscles %28%1965-2002%29%
% 209.97/210.13 |- rdf__type mesh__D001687sskos__Concept
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D001687 SJN
% 209.97/210.13 |- skos__altLabel mesh__D001687
% 209.97/210.13 Biologic Phenomena, Cell Phenomena, and Immunity
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001687 2000
% 209.97/210.13 |- mesh__dateCreated mesh__D001687 1999-01-01
% 209.97/210.13 |- mesh__dateEstablished mesh__D001687 1998-01-01
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001687 2003
% 209.97/210.13 |- mesh__recordMaintainer mesh__D001687 TGC
% 209.97/210.13 |- skos__prefLabel mesh__D001687
% 209.97/210.13 Biological Phenomena, Cell Phenomena, and Immunity
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001687 2001
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001687 2004
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001687 1998
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001687 2002
% 209.97/210.13 |- mesh__historyNote mesh__D001687 98; use explode
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001687 2005
% 209.97/210.13 |- mesh__runningHead mesh__D001687
% 209.97/210.13 G4 - BIOLOGIC, CYTOLOGIC, AND IMMUNOLOGIC PHENOMENA
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001687 1999
% 209.97/210.13 |- skos__annotation mesh__D001687
% 209.97/210.13 not used for indexing CATALOG: do not use
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001687 2006
% 209.97/210.13 |- mesh__dateRevised mesh__D001687 1997-06-27
% 209.97/210.13 |- skos__altLabel mesh__D001687
% 209.97/210.13 Immunity, Biological Phenomena, and Cell Phenomena
% 209.97/210.13 |- mesh__recordOriginator mesh__D001687 NLM
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D001687 98
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D047789 jls
% 209.97/210.13 |- mesh__dateRevised mesh__D047789 2004-08-03
% 209.97/210.13 |- mesh__recordOriginator mesh__D047789 jls
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 1939-1945 World War
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 War, 1939-1945 World
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 War II, World
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 2nd World Wars
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D047789 2005
% 209.97/210.13 |- mesh__dateEstablished mesh__D047789 2005-01-01
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 War, Second World
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 World War, 1939 1945
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 War, 2nd World
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 World Wars, 2nd
% 209.97/210.13 |- mesh__historyNote mesh__D047789 2005
% 209.97/210.13 |- skos__scopeNote mesh__D047789
% 209.97/210.13 Global conflict involving countries of Europe, Africa, Asia, and North America that occurred between 1939 and 1945.%A%
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 World Wars, Second
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D047789 2006
% 209.97/210.13 |- skos__prefLabel mesh__D047789 World War II
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 World War, 2nd
% 209.97/210.13 |- mesh__recordMaintainer mesh__D047789 jls
% 209.97/210.13 |- rdf__type mesh__D047789sskos__Concept
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 Wars, 2nd World
% 209.97/210.13 |- skos__altLabel mesh__D047789 World War, 1939-1945
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 Wars, Second World
% 209.97/210.13 |- skos__broader mesh__D047789smesh__D049673
% 209.97/210.13 |- skos__altLabel mesh__D047789 2nd World War
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 World War, Second
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D047789 2005A
% 209.97/210.13 |- skos__altLabel mesh__D047789 Second World War
% 209.97/210.13 |- mesh__dateCreated mesh__D047789 2004-07-07
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D047789 2005
% 209.97/210.13 |- skos__hiddenLabel mesh__D047789 Second World Wars
% 209.97/210.13 |- skos__historyNote mesh__D006372 Snails %28%1966-1974%29%
% 209.97/210.13 |- skos__scopeNote mesh__D006372
% 209.97/210.13 A genus of chiefly Eurasian and African land snails including the principal edible snails as well as several pests of cultivated plants.%A%
% 209.97/210.13 |- skos__annotation mesh__D006372
% 209.97/210.13 /microbiol /parasitol /virol permitted; DF: HELIX
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D006372 78; was see under SNAILS 1975-77
% 209.97/210.13 |- mesh__historyNote mesh__D006372
% 209.97/210.13 78%28%75%29%; was see under SNAILS 1975-77
% 209.97/210.13 |- mesh__recordMaintainer mesh__D006372 ags
% 209.97/210.13 |- mesh__dateRevised mesh__D006372 2005-06-30
% 209.97/210.13 |- mesh__dateEstablished mesh__D006372 1978-01-01
% 209.97/210.13 |- mesh__dateCreated mesh__D006372 1974-12-12
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006372 2006
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D006372 sjn
% 209.97/210.13 |- skos__broader mesh__D006372smesh__D012908
% 209.97/210.13 |- mesh__recordOriginator mesh__D006372 NLM
% 209.97/210.13 |- rdf__type mesh__D006372sskos__Concept
% 209.97/210.13 |- skos__prefLabel mesh__D006372 Helix %28%Snails%29%
% 209.97/210.13 |- skos__hiddenLabel mesh__D020043 Essential Gene
% 209.97/210.13 |- skos__broader mesh__D020043smesh__D005796
% 209.97/210.13 |- skos__scopeNote mesh__D020043
% 209.97/210.13 Those genes found in an organism which are necessary for its viability and normal function.%A%
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D020043 99
% 209.97/210.13 |- skos__prefLabel mesh__D020043 Genes, Essential
% 209.97/210.13 |- skos__hiddenLabel mesh__D020043 Essential Genes
% 209.97/210.13 |- mesh__historyNote mesh__D020043 99
% 209.97/210.13 |- mesh__recordMaintainer mesh__D020043 nns
% 209.97/210.13 |- skos__hiddenLabel mesh__D020043 Gene, Essential
% 209.97/210.13 |- mesh__dateCreated mesh__D020043 1998-06-10
% 209.97/210.13 |- mesh__recordOriginator mesh__D020043 NDW
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D020043 sjn
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020043 2006
% 209.97/210.13 |- mesh__dateEstablished mesh__D020043 1999-01-01
% 209.97/210.13 |- rdf__type mesh__D020043sskos__Concept
% 209.97/210.13 |- mesh__dateRevised mesh__D020043 2005-06-30
% 209.97/210.13 |- skos__annotation mesh__D020043 coord NIM with specific genes
% 209.97/210.13 |- mesh__dateCreated mesh__D014804 1999-01-01
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014804 2005
% 209.97/210.13 |- skos__broader mesh__D014804smesh__D001361
% 209.97/210.13 |- mesh__recordOriginator mesh__D014804 NLM
% 209.97/210.13 |- mesh__recordMaintainer mesh__D014804 lkt
% 209.97/210.13 |- skos__related mesh__D014804smesh__D010383
% 209.97/210.13 |- skos__hiddenLabel mesh__D014804 Vitamin B Deficiencies
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D014804 sjn
% 209.97/210.13 |- rdf__type mesh__D014804sskos__Concept
% 209.97/210.13 |- skos__altLabel mesh__D014804 Deficiency, Vitamin B
% 209.97/210.13 |- mesh__dateRevised mesh__D014804 2003-07-09
% 209.97/210.13 |- skos__prefLabel mesh__D014804 Vitamin B Deficiency
% 209.97/210.13 |- skos__hiddenLabel mesh__D014804 Deficiencies, Vitamin B
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014804 2006
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014804 2004
% 209.97/210.13 |- skos__prefLabel mesh__D014006 Tinea Capitis
% 209.97/210.13 |- mesh__dateRevised mesh__D014006 1992-05-22
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 2003
% 209.97/210.13 |- skos__annotation mesh__D014006
% 209.97/210.13 ringworm of the scalp; do not coord with SCALP or SCALP DERMATOSES%A%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 2000
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 2005
% 209.97/210.13 |- skos__scopeNote mesh__D014006
% 209.97/210.13 Ringworm of the scalp caused by species of Microsporum and Trichophyton, which may occasionally involve the eyebrows and eyelashes. %28%Dorland, 27th ed%29%%A%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 2004
% 209.97/210.13 |- mesh__recordOriginator mesh__D014006 NLM
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 2001
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 2006
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 1996
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 1998
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 1997
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 1994
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 1999
% 209.97/210.13 |- skos__broader mesh__D014006smesh__D012536
% 209.97/210.13 |- skos__broader mesh__D014006smesh__D014005
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 1993
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D014006 PLS
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 2002
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D014006 1995
% 209.97/210.13 |- mesh__dateCreated mesh__D014006 1999-01-01
% 209.97/210.13 |- rdf__type mesh__D014006sskos__Concept
% 209.97/210.13 |- mesh__recordMaintainer mesh__D014006 MXR
% 209.97/210.13 |- skos__broader mesh__D019346Q000031smesh__D019346
% 209.97/210.13 |- mesh__preferredCombination mesh__D019346Q000031smesh__D000085
% 209.97/210.13 |- rdf__type mesh__D019346Q000031smesh__CompoundConcept
% 209.97/210.13 |- mesh__dateCreated mesh__D002780 1979-05-29
% 209.97/210.13 |- skos__historyNote mesh__D002780 Cholestasis %28%1966-1979%29%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D002780 2004
% 209.97/210.13 |- skos__hiddenLabel mesh__D002780 Intrahepatic Cholestases
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D002780 2006
% 209.97/210.13 |- skos__hiddenLabel mesh__D002780 Intrahepatic Biliary Stasis
% 209.97/210.13 |- skos__altLabel mesh__D002780 Intrahepatic Cholestasis
% 209.97/210.13 |- skos__altLabel mesh__D002780 Bile Duct Obstruction, Intrahepatic
% 209.97/210.13 |- mesh__dateEstablished mesh__D002780 1980-01-01
% 209.97/210.13 |- skos__prefLabel mesh__D002780 Cholestasis, Intrahepatic
% 209.97/210.13 |- skos__altLabel mesh__D002780 Biliary Stasis, Intrahepatic
% 209.97/210.13 |- skos__scopeNote mesh__D002780
% 209.97/210.13 Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC%29%.%A%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D002780 2006A
% 209.97/210.13 |- skos__hiddenLabel mesh__D002780 Intrahepatic Biliary Stases
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D002780 ags
% 209.97/210.13 |- mesh__dateRevised mesh__D002780 2005-07-18
% 209.97/210.13 |- skos__broader mesh__D002780smesh__D002779
% 209.97/210.13 |- skos__historyNote mesh__D002780 Liver %28%1966-1979%29%
% 209.97/210.13 |- mesh__recordOriginator mesh__D002780 SMH
% 209.97/210.13 |- skos__broader mesh__D002780smesh__D008107
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D002780 80
% 209.97/210.13 |- mesh__recordMaintainer mesh__D002780 ags
% 209.97/210.13 |- rdf__type mesh__D002780sskos__Concept
% 209.97/210.13 |- skos__historyNote mesh__D002780
% 209.97/210.13 Bile Ducts, Intrahepatic %28%1966-1979%29%
% 209.97/210.13 |- skos__hiddenLabel mesh__D002780 Biliary Stases, Intrahepatic
% 209.97/210.13 |- mesh__historyNote mesh__D002780 80
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D002780 2005
% 209.97/210.13 |- skos__hiddenLabel mesh__D002780 Cholestases, Intrahepatic
% 209.97/210.13 |- skos__related mesh__D002780smesh__D041781
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010414 2005
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010414 2001
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010414 1999
% 209.97/210.13 |- mesh__recordMaintainer mesh__D010414 PXP
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010414 2003
% 209.97/210.13 |- skos__broader mesh__D010414smesh__D001061
% 209.97/210.13 |- skos__broader mesh__D010414smesh__D008873
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010414 2006
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D010414 SJN
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010414 2002
% 209.97/210.13 |- mesh__recordOriginator mesh__D010414 NLM
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010414 2004
% 209.97/210.13 |- skos__broader mesh__D010414smesh__D006114
% 209.97/210.13 |- mesh__dateCreated mesh__D010414 1999-01-01
% 209.97/210.13 |- rdf__type mesh__D010414sskos__Concept
% 209.97/210.13 |- skos__prefLabel mesh__D010414 Pennsylvania
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010414 2000
% 209.97/210.13 |- skos__annotation mesh__D010414 PHILADELPHIA is also available
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D010414 1998
% 209.97/210.13 |- mesh__dateRevised mesh__D010414 1997-06-20
% 209.97/210.13 |- skos__altLabel mesh__D001688 Biologic Products
% 209.97/210.13 |- skos__annotation mesh__D001688
% 209.97/210.13 manufactured products: differentiate from BIOLOGICAL FACTORS, natural substances; includes sera, vaccines, antitoxins, tissue %26% hormonal prep; /ther use of sera, vaccines %26% antitoxins: coord with disease /ther, not /drug ther; /ther use of tissue %26% hormonal prep: coord with disease /ther, not /drug ther; DF: BIOL PRODUCTS%A%
% 209.97/210.13 |- mesh__recordOriginator mesh__D001688 NLM
% 209.97/210.13 |- skos__hiddenLabel mesh__D001688 Products, Natural
% 209.97/210.13 |- mesh__dateRevised mesh__D001688 2005-11-09
% 209.97/210.13 |- skos__altLabel mesh__D001688 Biologics
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D001688
% 209.97/210.13 1963; for NATURAL PRODUCTS see BIOLOGICAL FACTORS 2000-2005%A%
% 209.97/210.13 |- mesh__historyNote mesh__D001688
% 209.97/210.13 1963; for NATURAL PRODUCTS also use BIOLOGICAL FACTORS 2000-2005%A%
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001688 2006A
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D001688 2006
% 209.97/210.13 |- skos__prefLabel mesh__D001688 Biological Products
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D001688 ags
% 209.97/210.13 |- skos__broader mesh__D001688smesh__D045424
% 209.97/210.13 |- rdf__type mesh__D001688sskos__Concept
% 209.97/210.13 |- skos__scopeNote mesh__D001688
% 209.97/210.13 Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease %28%as vaccines or pollen extracts%29%. Biological products are differentiated from BIOLOGICAL FACTORS in that the latter are compounds with biological or physiological activity made by living organisms. %28%From Webster%27%s 3d ed%29%%A%
% 209.97/210.13 |- mesh__recordMaintainer mesh__D001688 ags
% 209.97/210.13 |- skos__altLabel mesh__D001688 Products, Biological
% 209.97/210.13 |- mesh__dateCreated mesh__D001688 1999-01-01
% 209.97/210.13 |- skos__hiddenLabel mesh__D001688 Products, Biologic
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020842 2006
% 209.97/210.13 |- skos__scopeNote mesh__D020842
% 209.97/210.13 A peptidohydrolytic enzyme that is formed from PREKALLIKREIN by FACTOR XIIA. It activates FACTOR XII; FACTOR VII; and PLASMINOGEN. It is selective for both ARGININE and to a lesser extent LYSINE bonds. EC 3.4.21.34.%A%
% 209.97/210.13 |- skos__hiddenLabel mesh__D020842 Kallikrein, Plasma
% 209.97/210.13 |- skos__altLabel mesh__D020842 Serum Kallikrein
% 209.97/210.13 |- mesh__dateRevised mesh__D020842 2003-07-09
% 209.97/210.13 |- skos__prefLabel mesh__D020842 Plasma Kallikrein
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D020842 2000
% 209.97/210.13 |- skos__altLabel mesh__D020842 Kininogenin
% 209.97/210.13 |- mesh__dateEstablished mesh__D020842 2000-01-01
% 209.97/210.13 |- mesh__recordMaintainer mesh__D020842 ssb
% 209.97/210.13 |- skos__historyNote mesh__D020842 Kallikreins %28%1965-1999%29%
% 209.97/210.13 |- skos__altLabel mesh__D020842 Kallikrein I
% 209.97/210.13 |- mesh__recordOriginator mesh__D020842 adp
% 209.97/210.13 |- mesh__historyNote mesh__D020842 2000
% 209.97/210.13 |- mesh__dateCreated mesh__D020842 1999-11-08
% 209.97/210.13 |- rdf__type mesh__D020842sskos__Concept
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D020842 sjn
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020842 2004
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D020842 2005
% 209.97/210.13 |- skos__broader mesh__D020842smesh__D007610
% 209.97/210.13 |- skos__hiddenLabel mesh__D020842 Kallikrein, Serum
% 209.97/210.13 |- mesh__recordAuthorizer mesh__D006373 sjn
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006373 2004
% 209.97/210.13 |- mesh__onlineNote mesh__D006373
% 209.97/210.13 use HELMINTHIASIS to search NEMATOMORPHA INFECTIONS 1975-91%A%
% 209.97/210.13 |- rdf__type mesh__D006373sskos__Concept
% 209.97/210.13 |- skos__related mesh__D006373smesh__D000871
% 209.97/210.13 |- mesh__publicMeSHNote mesh__D006373
% 209.97/210.13 NEMATOMORPHA INFECTIONS was heading 1991, see under HELMINTHIASIS 1975-90%A%
% 209.97/210.13 |- skos__annotation mesh__D006373
% 209.97/210.13 GEN; infections in the intestines: coord IM with INTESTINAL DISEASES, PARASITIC %28%IM%29%%A%
% 209.97/210.13 |- mesh__recordOriginator mesh__D006373 NLM
% 209.97/210.13 |- skos__scopeNote mesh__D006373
% 209.97/210.13 Infestation with parasitic worms of the helminth class.%A%
% 209.97/210.13 |- skos__altLabel mesh__D006373 Nematomorpha Infections
% 209.97/210.13 |- mesh__historyNote mesh__D006373
% 209.97/210.13 NEMATOMORPHA INFECTIONS was heading 1975-91 %28%see under HELMINTHIASIS 1975-90%29%%A%
% 209.97/210.13 |- skos__broader mesh__D006373smesh__D010272
% 209.97/210.13 |- mesh__activeMeSHYear mesh__D006373 2006
% 209.97/210.13 |- mesh__dateRevised mesh__D006373 2003-07-09
% 209.97/210.13 |- mesh__recordMaintainer mesh__D006373 lkt
% 209.97/210.13 |- skos__hiddenLabel mesh__D006373 Nematomorpha Infection
% 209.97/210.13 |- skos__prefLabel mesh__D006373 Helminthiasis
% 209.97/210.13 |- mesh__dateCreated mesh__D006373 1999-01-01
% 209.97/210.13 |- skos__hiddenLabel mesh__D006373 Infection, Nematomorpha
% 209.97/210.13 |- skos__hiddenLabel mesh__D006373 Helminthiases
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D006373 2005
% 209.97/210.14 |- skos__annotation mesh__D014805
% 209.97/210.14 ther use: coordinate disease with /drug ther, not /diet ther%A%
% 209.97/210.14 |- skos__prefLabel mesh__D014805 Vitamin B 12
% 209.97/210.14 |- rdf__type mesh__D014805sskos__Concept
% 209.97/210.14 |- skos__hiddenLabel mesh__D014805 B12, Vitamin
% 209.97/210.14 |- skos__altLabel mesh__D014805 Cobalamin
% 209.97/210.14 |- mesh__dateRevised mesh__D014805 2005-06-30
% 209.97/210.14 |- mesh__recordOriginator mesh__D014805 NLM
% 209.97/210.14 |- skos__related mesh__D014805smesh__D012546
% 209.97/210.14 |- mesh__recordMaintainer mesh__D014805 ssb
% 209.97/210.14 |- skos__broader mesh__D014805smesh__D045728
% 209.97/210.14 |- skos__hiddenLabel mesh__D014805 B 12, Vitamin
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D014805 sjn
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014805 2006
% 209.97/210.14 |- skos__scopeNote mesh__D014805
% 209.97/210.14 A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues.%A%
% 209.97/210.14 |- skos__altLabel mesh__D014805 Vitamin B12
% 209.97/210.14 |- mesh__dateCreated mesh__D014805 1999-01-01
% 209.97/210.14 |- skos__altLabel mesh__D014805 Cyanocobalamin
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 1995
% 209.97/210.14 |- mesh__dateRevised mesh__D014007 1993-06-03
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 2000
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 2003
% 209.97/210.14 |- mesh__recordOriginator mesh__D014007 NLM
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 1996
% 209.97/210.14 |- skos__annotation mesh__D014007
% 209.97/210.14 ringworm of the scalp; caused by Trichophyton schoenleini%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 2001
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 2005
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 2004
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 1998
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 1997
% 209.97/210.14 |- mesh__recordMaintainer mesh__D014007 TAP
% 209.97/210.14 |- skos__scopeNote mesh__D014007
% 209.97/210.14 A disease of the scalp that may affect the glabrous skin and the nails and is recognized by the concave sulfur-yellow crusts that form around loose, wiry hairs. Atrophy ensues, leaving a smooth, glossy, thin, paper-white patch. This type of disease is rare in the United States and more frequently seen in the Middle East, Africa, Southeastern Europe, and other countries bordering the Mediterranean Sea. %28%Arnold, Odom, and James, Andrew%27%s Diseases of the Skin, 8th ed, p319%29%%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 2006
% 209.97/210.14 |- skos__altLabel mesh__D014007 Favus
% 209.97/210.14 |- skos__broader mesh__D014007smesh__D014006
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 1999
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D014007 PLS
% 209.97/210.14 |- mesh__dateCreated mesh__D014007 1999-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 2002
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014007 1994
% 209.97/210.14 |- rdf__type mesh__D014007sskos__Concept
% 209.97/210.14 |- skos__prefLabel mesh__D014007 Tinea Favosa
% 209.97/210.14 |- mesh__recordOriginator mesh__D002781 NLM
% 209.97/210.14 |- rdf__type mesh__D002781sskos__Concept
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002781 2004
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002781 2000
% 209.97/210.14 |- mesh__recordMaintainer mesh__D002781 KEV
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002781 2003
% 209.97/210.14 |- skos__hiddenLabel mesh__D002781 Cholesteatomas
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002781 2006
% 209.97/210.14 |- skos__scopeNote mesh__D002781
% 209.97/210.14 A non-neoplastic keratinizing mass with stratified squamous epithelium, frequently occurring in the meninges, central nervous system, bones of the skull, and most commonly in the middle ear and mastoid region.%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002781 2002
% 209.97/210.14 |- mesh__dateRevised mesh__D002781 1999-11-03
% 209.97/210.14 |- mesh__dateCreated mesh__D002781 1999-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002781 2005
% 209.97/210.14 |- skos__broader mesh__D002781smesh__D007642
% 209.97/210.14 |- skos__prefLabel mesh__D002781 Cholesteatoma
% 209.97/210.14 |- skos__annotation mesh__D002781
% 209.97/210.14 non-neoplastic: coord IM with organ/dis %28%IM%29% but CHOLESTEATOMA, MIDDLE EAR is available%A%
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D002781 sjn
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002781 2001
% 209.97/210.14 |- skos__broader mesh__D010415smesh__D007182
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 2004
% 209.97/210.14 |- mesh__dateCreated mesh__D010415 1999-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 2001
% 209.97/210.14 |- rdf__type mesh__D010415sskos__Concept
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 2002
% 209.97/210.14 |- mesh__recordOriginator mesh__D010415 NLM
% 209.97/210.14 |- skos__hiddenLabel mesh__D010415 Pension
% 209.97/210.14 |- mesh__recordMaintainer mesh__D010415 PLS
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 1994
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D010415 PLS
% 209.97/210.14 |- skos__altLabel mesh__D010415 Retirement Benefits
% 209.97/210.14 |- skos__hiddenLabel mesh__D010415 Retirement Benefit
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 1998
% 209.97/210.14 |- skos__prefLabel mesh__D010415 Pensions
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 1995
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 1993
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 1996
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 2005
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 1999
% 209.97/210.14 |- skos__hiddenLabel mesh__D010415 Benefit, Retirement
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 2003
% 209.97/210.14 |- skos__hiddenLabel mesh__D010415 Benefits, Retirement
% 209.97/210.14 |- mesh__dateRevised mesh__D010415 1992-05-15
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 1997
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 2006
% 209.97/210.14 |- skos__scopeNote mesh__D010415
% 209.97/210.14 Fixed sums paid regularly to individuals.
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010415 2000
% 209.97/210.14 |- rdf__type mesh__D015100sskos__Concept
% 209.97/210.14 |- skos__historyNote mesh__D015100 Biphenyl Compounds %28%1970-1974%29%
% 209.97/210.14 |- mesh__recordMaintainer mesh__D015100 CCR
% 209.97/210.14 |- mesh__dateCreated mesh__D015100 1974-11-19
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015100 2005
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D015100
% 209.97/210.14 91; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76%A%
% 209.97/210.14 |- skos__historyNote mesh__D015100 Phenylenediamines %28%1974%29%
% 209.97/210.14 |- skos__hiddenLabel mesh__D015100 Diaminobenzidine, 3,3%27%
% 209.97/210.14 |- mesh__dateRevised mesh__D015100 2000-06-22
% 209.97/210.14 |- skos__altLabel mesh__D015100 3,3-Diaminobenzidine
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015100 2003
% 209.97/210.14 |- skos__hiddenLabel mesh__D015100 Diaminobenzidine, 3,3
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015100 2006
% 209.97/210.14 |- skos__broader mesh__D015100smesh__D001713
% 209.97/210.14 |- skos__altLabel mesh__D015100 3,3%27% Diaminobenzidine
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015100 2004
% 209.97/210.14 |- skos__prefLabel mesh__D015100 3,3%27%-Diaminobenzidine
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015100 2001
% 209.97/210.14 |- mesh__recordOriginator mesh__D015100 NLM
% 209.97/210.14 |- skos__altLabel mesh__D015100 3,3 Diaminobenzidine
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D015100 sjn
% 209.97/210.14 |- mesh__historyNote mesh__D015100
% 209.97/210.14 91%28%75%29%; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015100 2002
% 209.97/210.14 |- mesh__dateEstablished mesh__D015100 1991-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 2005
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 1997
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 1992
% 209.97/210.14 |- skos__prefLabel mesh__D001689 Biological Psychiatry
% 209.97/210.14 |- skos__annotation mesh__D001689
% 209.97/210.14 SPEC only: SPEC qualif; DF: BIOL PSYCHIATRY
% 209.97/210.14 |- mesh__dateRevised mesh__D001689 1991-08-23
% 209.97/210.14 |- mesh__historyNote mesh__D001689 84
% 209.97/210.14 |- skos__hiddenLabel mesh__D001689 Psychiatry, Biologic
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 2004
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 1996
% 209.97/210.14 |- skos__historyNote mesh__D001689 Psychiatry %28%1966-1983%29%
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D001689 PLS
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 2003
% 209.97/210.14 |- skos__altLabel mesh__D001689 Psychiatry, Biological
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 2002
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 1995
% 209.97/210.14 |- mesh__recordOriginator mesh__D001689 EC
% 209.97/210.14 |- skos__altLabel mesh__D001689 Biologic Psychiatry
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 2001
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 1999
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D001689 84
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 1994
% 209.97/210.14 |- mesh__recordMaintainer mesh__D001689 TGC
% 209.97/210.14 |- mesh__dateEstablished mesh__D001689 1984-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 2006
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 2000
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 1998
% 209.97/210.14 |- skos__scopeNote mesh__D001689
% 209.97/210.14 An interdisciplinary science concerned with studies of the biological bases of behavior - biochemical, genetic, physiological, and neurological - and applying these to the understanding and treatment of mental illness.%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D001689 1993
% 209.97/210.14 |- mesh__dateCreated mesh__D001689 1983-06-10
% 209.97/210.14 |- skos__broader mesh__D001689smesh__D011570
% 209.97/210.14 |- rdf__type mesh__D001689sskos__Concept
% 209.97/210.14 |- mesh__dateCreated mesh__D020843 1999-11-08
% 209.97/210.14 |- mesh__dateRevised mesh__D020843 2002-07-03
% 209.97/210.14 |- mesh__dateEstablished mesh__D020843 2000-01-01
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D020843 sjn
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020843 2003
% 209.97/210.14 |- mesh__recordOriginator mesh__D020843 ags
% 209.97/210.14 |- skos__broader mesh__D020843smesh__D019659
% 209.97/210.14 |- mesh__historyNote mesh__D020843 2000
% 209.97/210.14 |- skos__historyNote mesh__D020843 Plants, Medicinal %28%1965-1999%29%
% 209.97/210.14 |- rdf__type mesh__D020843sskos__Concept
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020843 2004
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020843 2005
% 209.97/210.14 |- skos__scopeNote mesh__D020843
% 209.97/210.14 Common name for several daisy-like plants %28%MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM%29% native to Europe and Western Asia, now naturalized in the United States and Australia.%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020843 2006
% 209.97/210.14 |- skos__altLabel mesh__D020843 Camomile
% 209.97/210.14 |- skos__annotation mesh__D020843
% 209.97/210.14 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D020843
% 209.97/210.14 2000; CHAMOMILE was indexed under FLAVONES 1989-1999 %26% OILS, VOLATILE 1981-1999%A%
% 209.97/210.14 |- mesh__recordMaintainer mesh__D020843 ssb
% 209.97/210.14 |- skos__prefLabel mesh__D020843 Chamomile
% 209.97/210.14 |- rdf__type mesh__D006374sskos__Concept
% 209.97/210.14 |- mesh__historyNote mesh__D006374 98; use explode 1975-97
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D006374 98
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D006374 sjn
% 209.97/210.14 |- skos__broader mesh__D006374smesh__D006373
% 209.97/210.14 |- skos__scopeNote mesh__D006374
% 209.97/210.14 Infestation of animals with parasitic worms of the helminth class. The infestation may be experimental or veterinary.%A%
% 209.97/210.14 |- skos__hiddenLabel mesh__D006374 Helminthiases, Animal
% 209.97/210.14 |- mesh__recordOriginator mesh__D006374 NLM
% 209.97/210.14 |- skos__prefLabel mesh__D006374 Helminthiasis, Animal
% 209.97/210.14 |- skos__historyNote mesh__D006374
% 209.97/210.14 Helminthiasis/veterinary %28%1966-1997%29%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D006374 2006
% 209.97/210.14 |- mesh__recordMaintainer mesh__D006374 ags
% 209.97/210.14 |- skos__broader mesh__D006374smesh__D010273
% 209.97/210.14 |- mesh__dateCreated mesh__D006374 1999-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D006374 2005
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D006374 2004
% 209.97/210.14 |- skos__annotation mesh__D006374
% 209.97/210.14 exper or vet; GEN or unspecified; prefer specifics; don%27%t forget to check tag ANIMALS%A%
% 209.97/210.14 |- mesh__dateEstablished mesh__D006374 1998-01-01
% 209.97/210.14 |- skos__hiddenLabel mesh__D006374 Animal Helminthiasis
% 209.97/210.14 |- mesh__dateRevised mesh__D006374 2003-07-30
% 209.97/210.14 |- skos__hiddenLabel mesh__D006374 Animal Helminthiases
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020045 2005
% 209.97/210.14 |- skos__broader mesh__D020045smesh__D004141
% 209.97/210.14 |- mesh__dateCreated mesh__D020045 1998-06-10
% 209.97/210.14 |- mesh__dateRevised mesh__D020045 2003-07-09
% 209.97/210.14 |- skos__annotation mesh__D020045
% 209.97/210.14 infection: coord IM with PROTOZOAN INFECTIONS %28%IM%29%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020045 2004
% 209.97/210.14 |- skos__prefLabel mesh__D020045 Pfiesteria piscicida
% 209.97/210.14 |- mesh__dateEstablished mesh__D020045 1999-01-01
% 209.97/210.14 |- skos__scopeNote mesh__D020045
% 209.97/210.14 A dinoflagellate with a life cycle that includes numerous flagellated, amoeboid, and encysted stages. Both the flagellated and amoeboid forms produce toxins which cause open wounds on fish. Pfiesteria piscicida feeds on tissue sloughed from these wounds, as well as on bacteria and algae. It is found in Atlantic estuaries of the United States.%A%
% 209.97/210.14 |- skos__historyNote mesh__D020045 Dinoflagellida %28%1998%29%
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D020045 99
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020045 2006
% 209.97/210.14 |- rdf__type mesh__D020045sskos__Concept
% 209.97/210.14 |- mesh__historyNote mesh__D020045 99
% 209.97/210.14 |- skos__annotation mesh__D014806
% 209.97/210.14 coord IM with specific B 12 vitamin /defic %28%IM%29%; DF: VITAMIN B 12 DEFIC%A%
% 209.97/210.14 |- skos__altLabel mesh__D014806 Deficiency, Vitamin B 12
% 209.97/210.14 |- rdf__type mesh__D014806sskos__Concept
% 209.97/210.14 |- mesh__dateRevised mesh__D014806 2003-07-09
% 209.97/210.14 |- skos__scopeNote mesh__D014806
% 209.97/210.14 A nutritional condition produced by a deficiency of VITAMIN B 12 in the diet, characterized by megaloblastic anemia. Since vitamin B 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin B 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. %28%From Cecil Textbook of Medicine, 19th ed, p848%29%%A%
% 209.97/210.14 |- skos__broader mesh__D014806smesh__D014804
% 209.97/210.14 |- skos__prefLabel mesh__D014806 Vitamin B 12 Deficiency
% 209.97/210.14 |- mesh__dateCreated mesh__D014806 1999-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014806 2005
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014806 2006
% 209.97/210.14 |- mesh__recordOriginator mesh__D014806 NLM
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014806 2004
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D014806 sjn
% 209.97/210.14 |- skos__hiddenLabel mesh__D014806 Deficiencies, Vitamin B12
% 209.97/210.14 |- skos__hiddenLabel mesh__D014806 Vitamin B12 Deficiencies
% 209.97/210.14 |- skos__altLabel mesh__D014806 Deficiency, Vitamin B12
% 209.97/210.14 |- mesh__recordMaintainer mesh__D014806 lkt
% 209.97/210.14 |- skos__altLabel mesh__D014806 Vitamin B12 Deficiency
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014008 2005
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014008 2004
% 209.97/210.14 |- mesh__recordMaintainer mesh__D014008 KEV
% 209.97/210.14 |- skos__altLabel mesh__D014008 Athlete%27%s Foot
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014008 2002
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D014008 sjn
% 209.97/210.14 |- skos__annotation mesh__D014008
% 209.97/210.14 do not coord with FOOT or FOOT DERMATOSES
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014008 2006
% 209.97/210.14 |- skos__broader mesh__D014008smesh__D005533
% 209.97/210.14 |- mesh__dateCreated mesh__D014008 1999-01-01
% 209.97/210.14 |- rdf__type mesh__D014008sskos__Concept
% 209.97/210.14 |- skos__hiddenLabel mesh__D014008 Athlete Foot
% 209.97/210.14 |- skos__broader mesh__D014008smesh__D014005
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014008 2000
% 209.97/210.14 |- mesh__dateRevised mesh__D014008 1999-11-08
% 209.97/210.14 |- mesh__recordOriginator mesh__D014008 NLM
% 209.97/210.14 |- skos__prefLabel mesh__D014008 Tinea Pedis
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014008 2001
% 209.97/210.14 |- skos__scopeNote mesh__D014008
% 209.97/210.14 Dermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014008 2003
% 209.97/210.14 |- skos__hiddenLabel mesh__D014008 Athletes Foot
% 209.97/210.14 |- skos__broader mesh__D014008smesh__D011537
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 2003
% 209.97/210.14 |- skos__historyNote mesh__D002782 Cholestanes %28%1968-1972%29%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 1997
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D002782 PLS
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 2001
% 209.97/210.14 |- mesh__dateRevised mesh__D002782 1993-06-03
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 2006
% 209.97/210.14 |- mesh__recordOriginator mesh__D002782 NLM
% 209.97/210.14 |- skos__annotation mesh__D002782
% 209.97/210.14 do not confuse with CHOLESTANES; includes cholestatrienes%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 1996
% 209.97/210.14 |- mesh__historyNote mesh__D002782 73
% 209.97/210.14 |- skos__scopeNote mesh__D002782
% 209.97/210.14 Steroids with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. Members include compounds with any degree of unsaturation; however, CHOLESTADIENES is available for derivatives containing two double bonds.%A%
% 209.97/210.14 |- mesh__dateCreated mesh__D002782 1999-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 2005
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 2000
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 1999
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 1998
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 1995
% 209.97/210.14 |- mesh__dateEstablished mesh__D002782 1973-01-01
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D002782 73
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 2002
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 1994
% 209.97/210.14 |- skos__broader mesh__D002782smesh__D002776
% 209.97/210.14 |- skos__prefLabel mesh__D002782 Cholestenes
% 209.97/210.14 |- rdf__type mesh__D002782sskos__Concept
% 209.97/210.14 |- mesh__recordMaintainer mesh__D002782 PLS
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D002782 2004
% 209.97/210.14 |- skos__broader mesh__D010416smesh__D002733
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010416 2005
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010416 2003
% 209.97/210.14 |- skos__scopeNote mesh__D010416
% 209.97/210.14 An insecticide and herbicide that has also been used as a wood preservative. Pentachlorphenol is a widespread environmental pollutant. Both chronic and acute pentachlorophenol poisoning are medical concerns. The range of its biological actions is still being actively explored, but it is clearly a potent enzyme inhibitor and has been used as such as an experimental tool.%A%
% 209.97/210.14 |- skos__historyNote mesh__D010416 Herbicides %28%1966-1970%29%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010416 2006
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D010416
% 209.97/210.14 91; was see under CHLOROPHENOLS 1977-90; was see under PHENOLS 1971-76%A%
% 209.97/210.14 |- mesh__dateEstablished mesh__D010416 1991-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010416 2001
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010416 2004
% 209.97/210.14 |- mesh__historyNote mesh__D010416
% 209.97/210.14 91%28%71%29%; was see under CHLOROPHENOLS 1977-90; was see under PHENOLS 1971-76%A%
% 209.97/210.14 |- mesh__dateCreated mesh__D010416 1999-01-01
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D010416 sjn
% 209.97/210.14 |- mesh__recordMaintainer mesh__D010416 CCR
% 209.97/210.14 |- mesh__recordOriginator mesh__D010416 NLM
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D010416 2002
% 209.97/210.14 |- mesh__dateRevised mesh__D010416 2000-06-22
% 209.97/210.14 |- skos__historyNote mesh__D010416 Phenols %28%1966-1970%29%
% 209.97/210.14 |- rdf__type mesh__D010416sskos__Concept
% 209.97/210.14 |- skos__hiddenLabel mesh__D010416 Pentachlorophenate, Sodium
% 209.97/210.14 |- skos__prefLabel mesh__D010416 Pentachlorophenol
% 209.97/210.14 |- skos__altLabel mesh__D029121 Metapneumovirus, Avian
% 209.97/210.14 |- skos__annotation mesh__D029121
% 209.97/210.14 infection: coord IM with PARAMYXOVIRIDAE INFECTIONS %28%IM%29%
% 209.97/210.14 |- skos__broader mesh__D029121smesh__D018099
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D029121
% 209.97/210.14 2002; for RHINOTRACHEITIS VIRUS, TURKEY see PNEUMOVIRUS 1994-2001%A%
% 209.97/210.14 |- mesh__recordOriginator mesh__D029121 ags
% 209.97/210.14 |- skos__altLabel mesh__D029121 Turkey rhinotracheitis virus
% 209.97/210.14 |- skos__altLabel mesh__D029121 Pneumovirus, Avian
% 209.97/210.14 |- skos__scopeNote mesh__D029121
% 209.97/210.14 A genus of the subfamily PNEUMOVIRINAE, containing two members: Turkey rhinotracheitis virus and a human Metapneumovirus. Virions lack HEMAGGLUTININ and NEURAMINIDASE.%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D029121 2006
% 209.97/210.14 |- mesh__historyNote mesh__D029121
% 209.97/210.14 2002; for RHINOTRACHEITIS VIRUS, TURKEY use PNEUMOVIRUS 1994-2001%A%
% 209.97/210.14 |- mesh__dateEstablished mesh__D029121 2002-01-01
% 209.97/210.14 |- skos__altLabel mesh__D029121 Human Metapneumovirus
% 209.97/210.14 |- skos__altLabel mesh__D029121 Rhinotracheitis Virus, Turkey
% 209.97/210.14 |- mesh__dateRevised mesh__D029121 2004-07-13
% 209.97/210.14 |- skos__hiddenLabel mesh__D029121 Metapneumoviruses
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D029121 2005
% 209.97/210.14 |- mesh__recordMaintainer mesh__D029121 sjn
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D029121 sjn
% 209.97/210.14 |- mesh__dateCreated mesh__D029121 2001-07-25
% 209.97/210.14 |- rdf__type mesh__D029121sskos__Concept
% 209.97/210.14 |- skos__prefLabel mesh__D029121 Metapneumovirus
% 209.97/210.14 |- skos__altLabel mesh__D029121 Avian Metapneumovirus
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015101 2005
% 209.97/210.14 |- mesh__dateCreated mesh__D015101 1976-04-21
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015101 2002
% 209.97/210.14 |- mesh__dateRevised mesh__D015101 2000-06-22
% 209.97/210.14 |- skos__scopeNote mesh__D015101
% 209.97/210.14 A material used in the manufacture of azo dyes that is toxic to skin and carcinogenic in several species.%A%
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015101 2003
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015101 2006
% 209.97/210.14 |- skos__hiddenLabel mesh__D015101 3,3%27% Dichlorobenzidine
% 209.97/210.14 |- skos__hiddenLabel mesh__D015101 3,3 Dichlorobenzidine
% 209.97/210.14 |- mesh__recordMaintainer mesh__D015101 CCR
% 209.97/210.14 |- skos__historyNote mesh__D015101 Biphenyl Compounds %28%1969-1974%29%
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D015101
% 209.97/210.14 91; was see under BENZIDINES 1977-90
% 209.97/210.14 |- skos__prefLabel mesh__D015101 3,3%27%-Dichlorobenzidine
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015101 2004
% 209.97/210.14 |- skos__historyNote mesh__D015101 Aniline Compounds %28%1969-1974%29%
% 209.97/210.14 |- mesh__historyNote mesh__D015101
% 209.97/210.14 91%28%77%29%; was see under BENZIDINES 1977-90
% 209.97/210.14 |- skos__altLabel mesh__D015101 3,3-Dichlorobenzidine
% 209.97/210.14 |- mesh__recordOriginator mesh__D015101 SH
% 209.97/210.14 |- mesh__dateEstablished mesh__D015101 1991-01-01
% 209.97/210.14 |- skos__broader mesh__D015101smesh__D001713
% 209.97/210.14 |- rdf__type mesh__D015101sskos__Concept
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D015101 2001
% 209.97/210.14 |- skos__historyNote mesh__D015101 Benzidines/AA %28%1975-1976%29%
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D015101 sjn
% 209.97/210.14 |- skos__scopeNote mesh__D020844
% 209.97/210.14 Perennial herb Symphytum officinale, in the family Boraginaceae, used topically for wound healing. It contains ALLANTOIN, carotene, essential oils %28%OILS, VOLATILE%29%; GLYCOSIDES; mucilage, resin, SAPONINS; TANNINS; triterpenoids, VITAMIN B12, and ZINC. Comfrey also contains PYRROLIZIDINE ALKALOIDS and is hepatotoxic if ingested.%A%
% 209.97/210.14 |- mesh__recordMaintainer mesh__D020844 ssb
% 209.97/210.14 |- mesh__dateEstablished mesh__D020844 2000-01-01
% 209.97/210.14 |- mesh__dateCreated mesh__D020844 1999-11-04
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020844 2003
% 209.97/210.14 |- skos__historyNote mesh__D020844 Plants, Medicinal %28%1967-1999%29%
% 209.97/210.14 |- mesh__historyNote mesh__D020844 2000
% 209.97/210.14 |- rdf__type mesh__D020844sskos__Concept
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020844 2004
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020844 2005
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D020844 sjn
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020844 2006
% 209.97/210.14 |- mesh__recordOriginator mesh__D020844 ags
% 209.97/210.14 |- skos__prefLabel mesh__D020844 Comfrey
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D020844 2000
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D020844 2002
% 209.97/210.14 |- skos__altLabel mesh__D020844 Symphytum officinale
% 209.97/210.14 |- mesh__dateRevised mesh__D020844 2001-07-25
% 209.97/210.14 |- skos__broader mesh__D020844smesh__D028082
% 209.97/210.14 |- mesh__dateCreated mesh__D006375 1974-12-12
% 209.97/210.14 |- skos__broader mesh__D006375smesh__D003904
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D006375 2006
% 209.97/210.14 |- mesh__recordMaintainer mesh__D006375 SYSTEM
% 209.97/210.14 |- mesh__dateRevised mesh__D006375 2005-06-30
% 209.97/210.14 |- mesh__historyNote mesh__D006375 91%28%75%29%
% 209.97/210.14 |- mesh__dateEstablished mesh__D006375 1991-01-01
% 209.97/210.14 |- rdf__type mesh__D006375sskos__Concept
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D006375 sjn
% 209.97/210.14 |- skos__prefLabel mesh__D006375 Helminthosporium
% 209.97/210.14 |- skos__scopeNote mesh__D006375
% 209.97/210.14 A mitosporic fungal genus including both saprophytes and plant parasites.%A%
% 209.97/210.14 |- mesh__recordOriginator mesh__D006375 NLM
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D006375
% 209.97/210.14 91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85
% 209.97/210.14 |- rdf__type mesh__D014807sskos__Concept
% 209.97/210.14 |- skos__prefLabel mesh__D014807 Vitamin D
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D014807 sjn
% 209.97/210.14 |- skos__scopeNote mesh__D014807
% 209.97/210.14 A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.%A%
% 209.97/210.14 |- mesh__dateCreated mesh__D014807 1999-01-01
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014807 2006
% 209.97/210.14 |- skos__related mesh__D014807smesh__D018167
% 209.97/210.14 |- mesh__recordMaintainer mesh__D014807 ssb
% 209.97/210.14 |- skos__annotation mesh__D014807
% 209.97/210.14 /defic = VITAMIN D DEFICIENCY or RICKETS; /ther use: coordinate disease with /drug ther, not /diet ther%A%
% 209.97/210.14 |- skos__broader mesh__D014807smesh__D012632
% 209.97/210.14 |- mesh__dateRevised mesh__D014807 2005-06-30
% 209.97/210.14 |- mesh__recordOriginator mesh__D014807 NLM
% 209.97/210.14 |- skos__broader mesh__D006321Q000201smesh__D006321
% 209.97/210.14 |- mesh__preferredCombination mesh__D006321Q000201smesh__D009206Q000201
% 209.97/210.14 |- rdf__type mesh__D006321Q000201smesh__CompoundConcept
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014009 2006
% 209.97/210.14 |- mesh__historyNote mesh__D014009
% 209.97/210.14 93; was TINEA UNGUIUM 1963-92; ONYCHOMYCOSIS was see TINEA UNGUIUM 1963-92%A%
% 209.97/210.14 |- mesh__onlineNote mesh__D014009
% 209.97/210.14 use ONYCHOMYCOSIS to search TINEA UNGUIUM 1966-92
% 209.97/210.14 |- skos__prefLabel mesh__D014009 Onychomycosis
% 209.97/210.14 |- mesh__dateCreated mesh__D014009 1999-01-01
% 209.97/210.14 |- rdf__type mesh__D014009sskos__Concept
% 209.97/210.14 |- mesh__publicMeSHNote mesh__D014009
% 209.97/210.14 93; was TINEA UNGUIUM 1963-92; ONYCHOMYCOSIS was see TINEA UNGUIUM 1963-92%A%
% 209.97/210.14 |- skos__broader mesh__D014009smesh__D014005
% 209.97/210.14 |- mesh__dateRevised mesh__D014009 2001-07-25
% 209.97/210.14 |- skos__altLabel mesh__D014009 Tinea Unguium
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014009 2002
% 209.97/210.14 |- mesh__recordAuthorizer mesh__D014009 sjn
% 209.97/210.14 |- skos__annotation mesh__D014009
% 209.97/210.14 ringworm of the nails; do not coord with NAILS; specify FOOT DERMATOSES %28%NIM%29% or HAND DERMATOSES %28%NIM%29%%A%
% 209.97/210.14 |- skos__scopeNote mesh__D014009
% 209.97/210.14 A fungal infection of the nail plate, usually caused by a species of Epidermophyton, Microsporum, or Trichophyton, and producing opaque, white, thickened, friable, and brittle nails. %28%Dorland, 27th ed%29%%A%
% 209.97/210.14 |- skos__hiddenLabel mesh__D014009 Onychomycoses
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014009 2003
% 209.97/210.14 |- mesh__recordMaintainer mesh__D014009 lkt
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014009 2005
% 209.97/210.14 |- mesh__recordOriginator mesh__D014009 NLM
% 209.97/210.14 |- mesh__activeMeSHYear mesh__D014009 2004
% 209.97/210.14 |- skos__broader mesh__D014009smesh__D009260
% 209.97/210.15 |- skos__scopeNote mesh__D002783
% 209.97/210.15 CHOLESTENES with one or more double bonds and substituted by any number of keto groups.%A%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 2002
% 209.97/210.15 |- mesh__recordMaintainer mesh__D002783 PLS
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 1995
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 1998
% 209.97/210.15 |- mesh__dateCreated mesh__D002783 1974-11-11
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 1994
% 209.97/210.15 |- mesh__historyNote mesh__D002783
% 209.97/210.15 91%28%75%29%; was see under CHOLESTENES 1975-90
% 209.97/210.15 |- skos__prefLabel mesh__D002783 Cholestenones
% 209.97/210.15 |- skos__annotation mesh__D002783
% 209.97/210.15 do not confuse with CHOLESTANONES; includes cholestenediones, cholestenetriones%A%
% 209.97/210.15 |- rdf__type mesh__D002783sskos__Concept
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 2004
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D002783 PLS
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 2001
% 209.97/210.15 |- mesh__dateRevised mesh__D002783 1993-06-03
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D002783
% 209.97/210.15 91; was see under CHOLESTENES 1975-90
% 209.97/210.15 |- mesh__recordOriginator mesh__D002783 NLM
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 2003
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 1997
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 2000
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 2006
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 1996
% 209.97/210.15 |- skos__broader mesh__D002783smesh__D002782
% 209.97/210.15 |- mesh__dateEstablished mesh__D002783 1991-01-01
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 2005
% 209.97/210.15 |- skos__historyNote mesh__D002783 Cholestenes %28%1973-1974%29%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002783 1999
% 209.97/210.15 |- mesh__recordOriginator mesh__D010417 NLM
% 209.97/210.15 |- skos__altLabel mesh__D010417
% 209.97/210.15 Alpharma Brand of Pentaerythritol Tetranitrate
% 209.97/210.15 |- skos__scopeNote mesh__D010417
% 209.97/210.15 A vasodilator with general properties similar to NITROGLYCERIN but with a more prolonged duration of action. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1025%29%%A%
% 209.97/210.15 |- skos__hiddenLabel mesh__D010417 Tetranitrate, Pentaerythritol
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D010417 2006
% 209.97/210.15 |- skos__broader mesh__D010417smesh__D011409
% 209.97/210.15 |- skos__altLabel mesh__D010417 Pentalog
% 209.97/210.15 |- skos__altLabel mesh__D010417
% 209.97/210.15 Parke Davis Brand of Pentaerythritol Tetranitrate
% 209.97/210.15 |- mesh__dateCreated mesh__D010417 1999-01-01
% 209.97/210.15 |- skos__altLabel mesh__D010417
% 209.97/210.15 Ravensberg Brand of Pentaerythritol Tetranitrate
% 209.97/210.15 |- rdf__type mesh__D010417sskos__Concept
% 209.97/210.15 |- skos__altLabel mesh__D010417
% 209.97/210.15 Vanguard Brand of Pentaerythritol Tetranitrate
% 209.97/210.15 |- mesh__recordMaintainer mesh__D010417 lkw
% 209.97/210.15 |- skos__altLabel mesh__D010417 Dexo Brand of Pentaerythritol Tetranitrate
% 209.97/210.15 |- mesh__dateRevised mesh__D010417 2005-06-30
% 209.97/210.15 |- skos__prefLabel mesh__D010417 Pentaerythritol Tetranitrate
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D010417 sjn
% 209.97/210.15 |- skos__hiddenLabel mesh__D029122 pneumonia viruses, Murine
% 209.97/210.15 |- skos__altLabel mesh__D029122 Pneumonia Virus of Mice
% 209.97/210.15 |- skos__prefLabel mesh__D029122 Murine pneumonia virus
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029122 2006
% 209.97/210.15 |- mesh__dateEstablished mesh__D029122 2002-01-01
% 209.97/210.15 |- skos__historyNote mesh__D029122 Paramyxoviridae %28%1974-1993%29%
% 209.97/210.15 |- skos__hiddenLabel mesh__D029122 pneumonia virus, Murine
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029122 2005
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029122 2002
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029122 2004
% 209.97/210.15 |- skos__broader mesh__D029122smesh__D018111
% 209.97/210.15 |- rdf__type mesh__D029122sskos__Concept
% 209.97/210.15 |- skos__annotation mesh__D029122
% 209.97/210.15 infection: coord IM with PNEUMOVIRUS INFECTIONS; index also PNEUMONIA, VIRAL if pertinent%A%
% 209.97/210.15 |- skos__scopeNote mesh__D029122
% 209.97/210.15 A species of the genus PNEUMOVIRUS causing pneumonia in mice.%A%
% 209.97/210.15 |- skos__hiddenLabel mesh__D029122 Mice Pneumonia Virus
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029122 2003
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D029122 2002; see PNEUMOVIRUS 1994-2001
% 209.97/210.15 |- skos__historyNote mesh__D029122 Orthomyxoviridae %28%1967-1973%29%
% 209.97/210.15 |- skos__hiddenLabel mesh__D029122 Murine pneumonia viruses
% 209.97/210.15 |- mesh__historyNote mesh__D029122 2002; use PNEUMOVIRUS 1994-2001
% 209.97/210.15 |- skos__hiddenLabel mesh__D029122 Mice Pneumonia Viruses
% 209.97/210.15 |- skos__historyNote mesh__D029122 Pneumovirus %28%1994-2001%29%
% 209.97/210.15 |- mesh__dateCreated mesh__D029122 2001-07-25
% 209.97/210.15 |- mesh__dateEstablished mesh__D015900 1990-01-01
% 209.97/210.15 |- rdf__type mesh__D015900sskos__Concept
% 209.97/210.15 |- skos__altLabel mesh__D015900 Radiography, Dual Energy Scanned Projection
% 209.97/210.15 |- mesh__historyNote mesh__D015900 90
% 209.97/210.15 |- skos__prefLabel mesh__D015900
% 209.97/210.15 Radiography, Dual-Energy Scanned Projection
% 209.97/210.15 |- mesh__recordMaintainer mesh__D015900 jls
% 209.97/210.15 |- skos__altLabel mesh__D015900 Dual Energy Scanned Projection Radiography
% 209.97/210.15 |- skos__annotation mesh__D015900
% 209.97/210.15 do not use /util except by MeSH definition; DF: D SCAN RADIOGR%A%
% 209.97/210.15 |- mesh__dateCreated mesh__D015900 1989-05-16
% 209.97/210.15 |- skos__altLabel mesh__D015900 Dual-Energy Scanned Projection Radiography
% 209.97/210.15 |- skos__altLabel mesh__D015900
% 209.97/210.15 Digital Scanned Projection Radiography, Dual-Energy
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D015900 90
% 209.97/210.15 |- skos__historyNote mesh__D015900 Subtraction Technique %28%1981-1989%29%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015900 2005
% 209.97/210.15 |- skos__altLabel mesh__D015900
% 209.97/210.15 Digital Scan Projection Radiography, Dual Energy
% 209.97/210.15 |- mesh__dateRevised mesh__D015900 2004-07-07
% 209.97/210.15 |- skos__historyNote mesh__D015900
% 209.97/210.15 Radiographic Image Enhancement %28%1983-1989%29%
% 209.97/210.15 |- skos__altLabel mesh__D015900
% 209.97/210.15 Digital Scan Projection Radiography, Dual-Energy
% 209.97/210.15 |- skos__broader mesh__D015900smesh__D011856
% 209.97/210.15 |- skos__altLabel mesh__D015900
% 209.97/210.15 Digital Scanned Projection Radiography, Dual Energy
% 209.97/210.15 |- mesh__recordOriginator mesh__D015900 PLS
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015900 2006
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D015900 sjn
% 209.97/210.15 |- skos__scopeNote mesh__D015900
% 209.97/210.15 A method of producing a high-quality scan by digitizing and subtracting the images produced by high- and low-energy x-rays.%A%
% 209.97/210.15 |- skos__broader mesh__D015900smesh__D013382
% 209.97/210.15 |- skos__broader mesh__D015900smesh__D007089
% 209.97/210.15 |- skos__altLabel mesh__D015102 DOPAC
% 209.97/210.15 |- mesh__dateRevised mesh__D015102 2005-06-30
% 209.97/210.15 |- skos__historyNote mesh__D015102 Catechols %28%1972-1974%29%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015102 2006
% 209.97/210.15 |- skos__hiddenLabel mesh__D015102 3,4 Dihydroxyphenylacetic Acid
% 209.97/210.15 |- skos__historyNote mesh__D015102 Phenylacetates %28%1972-1974%29%
% 209.97/210.15 |- skos__scopeNote mesh__D015102 A deaminated metabolite of LEVODOPA.
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D015102 sjn
% 209.97/210.15 |- skos__altLabel mesh__D015102 Homoprotocatechuic Acid
% 209.97/210.15 |- mesh__onlineNote mesh__D015102
% 209.97/210.15 use 3,4-DIHYDROXYPHENYLACETIC ACID to search DOPACETIC ACID 1975-93%A%
% 209.97/210.15 |- mesh__recordMaintainer mesh__D015102 ssb
% 209.97/210.15 |- skos__broader mesh__D015102smesh__D010648
% 209.97/210.15 |- mesh__historyNote mesh__D015102
% 209.97/210.15 91%28%75%29%; was see under PHENYLACETATES 1975-90; DOPACETIC ACID was see 3,4-DIHYDROXYPHENYLACETIC ACID 1975-93%A%
% 209.97/210.15 |- rdf__type mesh__D015102sskos__Concept
% 209.97/210.15 |- mesh__dateCreated mesh__D015102 1974-11-19
% 209.97/210.15 |- mesh__recordOriginator mesh__D015102 NLM
% 209.97/210.15 |- skos__prefLabel mesh__D015102 3,4-Dihydroxyphenylacetic Acid
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D015102
% 209.97/210.15 91; was see under PHENYLACETATES 1975-90; DOPACETIC ACID was see 3,4-DIHYDROXYPHENYLACETIC ACID 1975-93%A%
% 209.97/210.15 |- mesh__dateEstablished mesh__D015102 1991-01-01
% 209.97/210.15 |- mesh__recordMaintainer mesh__D020845 ssb
% 209.97/210.15 |- mesh__recordOriginator mesh__D020845 adp
% 209.97/210.15 |- skos__historyNote mesh__D020845 Receptors, Estrogen %28%1996-1999%29%
% 209.97/210.15 |- skos__scopeNote mesh__D020845
% 209.97/210.15 A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. %28%Horm Res 1997;48:155-63%29%%A%
% 209.97/210.15 |- mesh__dateCreated mesh__D020845 1999-11-08
% 209.97/210.15 |- mesh__dateEstablished mesh__D020845 2000-01-01
% 209.97/210.15 |- skos__altLabel mesh__D020845 SERM
% 209.97/210.15 |- skos__broader mesh__D020845smesh__D020847
% 209.97/210.15 |- skos__altLabel mesh__D020845 Estrogen Receptor Modulator, Selective
% 209.97/210.15 |- skos__annotation mesh__D020845
% 209.97/210.15 do not confuse with ESTROGEN RECEPTOR MODULATORS
% 209.97/210.15 |- rdf__type mesh__D020845sskos__Concept
% 209.97/210.15 |- skos__altLabel mesh__D020845 Estrogen Receptor Modulators, Selective
% 209.97/210.15 |- skos__related mesh__D020845smesh__D050071
% 209.97/210.15 |- mesh__historyNote mesh__D020845 2000
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020845 2006
% 209.97/210.15 |- skos__altLabel mesh__D020845 Selective Estrogen Receptor Modulator
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D020845 2000
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D020845 sjn
% 209.97/210.15 |- skos__prefLabel mesh__D020845 Selective Estrogen Receptor Modulators
% 209.97/210.15 |- skos__altLabel mesh__D020845 SERMs
% 209.97/210.15 |- mesh__dateRevised mesh__D020845 2005-06-30
% 209.97/210.15 |- skos__scopeNote mesh__D006376
% 209.97/210.15 Commonly known as parasitic worms, this group includes the ACANTHOCEPHALA; NEMATODA; and PLATYHELMINTHS. Some authors consider certain species of LEECHES that can become temporarily parasitic as helminths.%A%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D006376 2005
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D006376 ASCHELMINTHES was heading 1976-85
% 209.97/210.15 |- mesh__recordOriginator mesh__D006376 NLM
% 209.97/210.15 |- mesh__dateCreated mesh__D006376 1999-01-01
% 209.97/210.15 |- mesh__recordMaintainer mesh__D006376 ags
% 209.97/210.15 |- skos__broader mesh__D006376smesh__D007448
% 209.97/210.15 |- skos__prefLabel mesh__D006376 Helminths
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D006376 2004
% 209.97/210.15 |- skos__altLabel mesh__D006376 Worms, Parasitic
% 209.97/210.15 |- mesh__historyNote mesh__D006376 ASCHELMINTHES was heading 1976-85
% 209.97/210.15 |- skos__altLabel mesh__D006376 Parasitic Worms
% 209.97/210.15 |- rdf__type mesh__D006376sskos__Concept
% 209.97/210.15 |- mesh__onlineNote mesh__D006376
% 209.97/210.15 use HELMINTHS to search ASCHELMINTHES 1976-85
% 209.97/210.15 |- skos__annotation mesh__D006376
% 209.97/210.15 GEN or unspecified; prefer specifics; infection = HELMINTHIASIS; coord with specific precoord helminth terms %28%e.g., ANTIGENS, HELMINTH%29% if pertinent%A%
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D006376 sjn
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D006376 2006
% 209.97/210.15 |- mesh__dateRevised mesh__D006376 2003-07-09
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020047 2003
% 209.97/210.15 |- skos__broader mesh__D020047smesh__D012002
% 209.97/210.15 |- mesh__dateCreated mesh__D020047 1998-06-11
% 209.97/210.15 |- skos__hiddenLabel mesh__D020047 Rectoceles
% 209.97/210.15 |- skos__prefLabel mesh__D020047 Rectocele
% 209.97/210.15 |- rdf__type mesh__D020047sskos__Concept
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020047 1999
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020047 2002
% 209.97/210.15 |- skos__altLabel mesh__D020047 Proctocele
% 209.97/210.15 |- skos__hiddenLabel mesh__D020047 Proctoceles
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D020047 99
% 209.97/210.15 |- mesh__historyNote mesh__D020047 99
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020047 2006
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020047 2001
% 209.97/210.15 |- skos__historyNote mesh__D020047 Rectal Diseases %28%1966-1998%29%
% 209.97/210.15 |- mesh__dateEstablished mesh__D020047 1999-01-01
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020047 2005
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020047 2000
% 209.97/210.15 |- skos__scopeNote mesh__D020047
% 209.97/210.15 A hernial protrusion of part of the rectum into the vagina. %28%Dorland, 28th ed%29%%A%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020047 2004
% 209.97/210.15 |- skos__hiddenLabel mesh__D014808 Vitamin D Deficiencies
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D014808 2006
% 209.97/210.15 |- skos__broader mesh__D014808smesh__D001361
% 209.97/210.15 |- skos__hiddenLabel mesh__D014808 Deficiencies, Vitamin D
% 209.97/210.15 |- skos__altLabel mesh__D014808 Deficiency, Vitamin D
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D014808 2004
% 209.97/210.15 |- skos__annotation mesh__D014808 DF: VITAMIN D DEFIC
% 209.97/210.15 |- mesh__recordOriginator mesh__D014808 NLM
% 209.97/210.15 |- mesh__recordMaintainer mesh__D014808 lkt
% 209.97/210.15 |- mesh__dateRevised mesh__D014808 2003-07-09
% 209.97/210.15 |- skos__prefLabel mesh__D014808 Vitamin D Deficiency
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D014808 sjn
% 209.97/210.15 |- skos__scopeNote mesh__D014808
% 209.97/210.15 A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. %28%From Cecil Textbook of Medicine, 19th ed, p1406%29%%A%
% 209.97/210.15 |- rdf__type mesh__D014808sskos__Concept
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D014808 2005
% 209.97/210.15 |- skos__related mesh__D014808smesh__D012279
% 209.97/210.15 |- mesh__dateCreated mesh__D014808 1999-01-01
% 209.97/210.15 |- skos__related mesh__D011510smesh__D008074
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D011510 77
% 209.97/210.15 |- mesh__historyNote mesh__D011510 77
% 209.97/210.15 |- skos__prefLabel mesh__D011510 Proteolipids
% 209.97/210.15 |- skos__broader mesh__D011510smesh__D008563
% 209.97/210.15 |- mesh__recordMaintainer mesh__D011510 SYSTEM
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D011510 2006
% 209.97/210.15 |- mesh__recordOriginator mesh__D011510 RLS
% 209.97/210.15 |- mesh__dateCreated mesh__D011510 1976-05-19
% 209.97/210.15 |- mesh__dateEstablished mesh__D011510 1977-01-01
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D011510 sjn
% 209.97/210.15 |- rdf__type mesh__D011510sskos__Concept
% 209.97/210.15 |- skos__annotation mesh__D011510 do not confuse with LIPOPROTEINS
% 209.97/210.15 |- skos__scopeNote mesh__D011510
% 209.97/210.15 Protein-lipid combinations abundant in brain tissue, but also present in a wide variety of animal and plant tissues. In contrast to lipoproteins, they are insoluble in water, but soluble in a chloroform-methanol mixture. The protein moiety has a high content of hydrophobic amino acids. The associated lipids consist of a mixture of GLYCEROPHOSPHATES; CEREBROSIDES; and SULFOGLYCOSPHINGOLIPIDS; while lipoproteins contain PHOSPHOLIPIDS; CHOLESTEROL; and TRIGLYCERIDES.%A%
% 209.97/210.15 |- mesh__dateRevised mesh__D011510 2005-06-30
% 209.97/210.15 |- skos__historyNote mesh__D011510 Lipoproteins %28%1966-1976%29%
% 209.97/210.15 |- skos__historyNote mesh__D011510 specific lipoprotein%28%1966-1976%29%
% 209.97/210.15 |- skos__broader mesh__D011510smesh__D011506
% 209.97/210.15 |- rdf__type mesh__D002784sskos__Concept
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002784 2004
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D002784
% 209.97/210.15 /blood was BLOOD CHOLESTEROL 1963-67
% 209.97/210.15 |- skos__annotation mesh__D002784
% 209.97/210.15 GEN or unspecified; prefer specifics; /biosyn /physiol permitted; /blood: consider also HYPERCHOLESTEROLEMIA %26% specifics; cholesterol granuloma = CHOLESTEROL + GRANULOMA, FOREIGN-BODY%A%
% 209.97/210.15 |- skos__broader mesh__D002784smesh__D013261
% 209.97/210.15 |- mesh__onlineNote mesh__D002784
% 209.97/210.15 use CHOLESTEROL to search BLOOD CHOLESTEROL 1966-67
% 209.97/210.15 |- skos__related mesh__D002784smesh__D006937
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002784 2006
% 209.97/210.15 |- skos__related mesh__D002784smesh__D017700
% 209.97/210.15 |- mesh__recordMaintainer mesh__D002784 ssb
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D002784 sjn
% 209.97/210.15 |- skos__prefLabel mesh__D002784 Cholesterol
% 209.97/210.15 |- skos__broader mesh__D002784smesh__D002782
% 209.97/210.15 |- mesh__dateCreated mesh__D002784 1999-01-01
% 209.97/210.15 |- mesh__historyNote mesh__D002784 /blood was BLOOD CHOLESTEROL 1963-67
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D002784 2005
% 209.97/210.15 |- mesh__recordOriginator mesh__D002784 NLM
% 209.97/210.15 |- skos__scopeNote mesh__D002784
% 209.97/210.15 The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.%A%
% 209.97/210.15 |- mesh__dateRevised mesh__D002784 2003-07-09
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029921 2003
% 209.97/210.15 |- mesh__dateCreated mesh__D029921 2001-07-25
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029921 2006A
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D029921 2002
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029921 2006
% 209.97/210.15 |- skos__annotation mesh__D029921
% 209.97/210.15 note X ref RED CLOVER: CLOVER see MEDICAGO; BUSH CLOVER see LESPEDEZA; and SWEET CLOVER see MELILOTUS are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.97/210.15 |- rdf__type mesh__D029921sskos__Concept
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029921 2002
% 209.97/210.15 |- skos__altLabel mesh__D029921 Red clover
% 209.97/210.15 |- mesh__historyNote mesh__D029921 2002
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029921 2005
% 209.97/210.15 |- skos__scopeNote mesh__D029921 A plant genus of the family FABACEAE.
% 209.97/210.15 |- mesh__recordOriginator mesh__D029921 ssb
% 209.97/210.15 |- skos__altLabel mesh__D029921 Clover, Red
% 209.97/210.15 |- skos__broader mesh__D029921smesh__D007887
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D029921 2004
% 209.97/210.15 |- skos__prefLabel mesh__D029921 Trifolium
% 209.97/210.15 |- mesh__dateRevised mesh__D029921 2005-07-19
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D029921 ags
% 209.97/210.15 |- mesh__dateEstablished mesh__D029921 2002-01-01
% 209.97/210.15 |- mesh__recordMaintainer mesh__D029921 ags
% 209.97/210.15 |- mesh__dateEstablished mesh__D010418 1973-01-01
% 209.97/210.15 |- skos__altLabel mesh__D010418 Gastrin Pentapeptide
% 209.97/210.15 |- rdf__type mesh__D010418sskos__Concept
% 209.97/210.15 |- skos__broader mesh__D010418smesh__D005755
% 209.97/210.15 |- skos__broader mesh__D010418smesh__D009842
% 209.97/210.15 |- mesh__recordMaintainer mesh__D010418 ssb
% 209.97/210.15 |- skos__hiddenLabel mesh__D010418 Pentapeptide, Gastrin
% 209.97/210.15 |- skos__historyNote mesh__D010418
% 209.97/210.15 Gastrointestinal Hormones %28%1966-1971%29%
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D010418 sjn
% 209.97/210.15 |- mesh__recordOriginator mesh__D010418 NLM
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D010418 2004
% 209.97/210.15 |- skos__prefLabel mesh__D010418 Pentagastrin
% 209.97/210.15 |- mesh__dateCreated mesh__D010418 1999-01-01
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D010418 2006
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D010418 73
% 209.97/210.15 |- skos__historyNote mesh__D010418 Peptides %28%1966-1971%29%
% 209.97/210.15 |- mesh__historyNote mesh__D010418 73%28%72%29%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D010418 2003
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D010418 2002
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D010418 2005
% 209.97/210.15 |- skos__related mesh__D010418smesh__D005765
% 209.97/210.15 |- skos__scopeNote mesh__D010418
% 209.97/210.15 A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid.%A%
% 209.97/210.15 |- mesh__dateRevised mesh__D010418 2001-07-25
% 209.97/210.15 |- skos__scopeNote mesh__D015901
% 209.97/210.15 A method of delineating blood vessels by subtracting a tissue background image from an image of tissue plus intravascular contrast material that attenuates the X-ray photons. The background image is determined from a digitized image taken a few moments before injection of the contrast material. The resulting angiogram is a high-contrast image of the vessel. This subtraction technique allows extraction of a high-intensity signal from the superimposed background information. The image is thus the result of the differential absorption of X-rays by different tissues.%A%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015901 1999
% 209.97/210.15 |- skos__broader mesh__D015901smesh__D013382
% 209.97/210.15 |- skos__historyNote mesh__D015901 Subtraction Technique %28%1980-1989%29%
% 209.97/210.15 |- skos__broader mesh__D015901smesh__D011856
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015901 2005
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015901 2000
% 209.97/210.15 |- mesh__recordMaintainer mesh__D015901 PXP
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D015901 90
% 209.97/210.15 |- skos__historyNote mesh__D015901 Angiography %28%1980-1989%29%
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D015901 SJN
% 209.97/210.15 |- mesh__recordOriginator mesh__D015901 PLS
% 209.97/210.15 |- skos__altLabel mesh__D015901 Subtraction Angiography, Digital
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015901 2006
% 209.97/210.15 |- mesh__historyNote mesh__D015901 90
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015901 2001
% 209.97/210.15 |- mesh__dateRevised mesh__D015901 1997-06-20
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015901 2003
% 209.97/210.15 |- skos__altLabel mesh__D015901 Digital Subtraction Angiography
% 209.97/210.15 |- rdf__type mesh__D015901sskos__Concept
% 209.97/210.15 |- skos__annotation mesh__D015901
% 209.97/210.15 /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: DS ANGIOGR%A%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015901 2004
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015901 1998
% 209.97/210.15 |- skos__prefLabel mesh__D015901 Angiography, Digital Subtraction
% 209.97/210.15 |- mesh__dateEstablished mesh__D015901 1990-01-01
% 209.97/210.15 |- mesh__dateCreated mesh__D015901 1989-05-15
% 209.97/210.15 |- skos__broader mesh__D015901smesh__D000792
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015901 2002
% 209.97/210.15 |- rdf__type mesh__D048088sskos__Concept
% 209.97/210.15 |- mesh__dateCreated mesh__D048088 2004-07-07
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D048088 2005
% 209.97/210.15 |- skos__annotation mesh__D048088 general; prefer specifics
% 209.97/210.15 |- mesh__recordOriginator mesh__D048088 jls
% 209.97/210.15 |- skos__historyNote mesh__D048088 Information Systems %28%1979-2004%29%
% 209.97/210.15 |- skos__scopeNote mesh__D048088
% 209.97/210.15 The field of information science concerned with the analysis and dissemination of data through the application of computers.%A%
% 209.97/210.15 |- skos__prefLabel mesh__D048088 Informatics
% 209.97/210.15 |- mesh__historyNote mesh__D048088 2005
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D048088 2005
% 209.97/210.15 |- mesh__dateEstablished mesh__D048088 2005-01-01
% 209.97/210.15 |- skos__broader mesh__D048088smesh__D007254
% 209.97/210.15 |- mesh__recordMaintainer mesh__D048088 jls
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D048088 sjn
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D048088 2006
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015103 2005
% 209.97/210.15 |- mesh__recordMaintainer mesh__D015103 CCR
% 209.97/210.15 |- rdf__type mesh__D015103sskos__Concept
% 209.97/210.15 |- skos__historyNote mesh__D015103 Serine %28%1971-1974%29%
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D015103
% 209.97/210.15 97; was 3,4-DIHYDROXYPHENYLSERINE 1975-96 %28%see under SERINE 1975-90%29%; DOPS was see DIHYDROXYPHENYLSERINE 1975-96%A%
% 209.97/210.15 |- skos__hiddenLabel mesh__D015103 erythro 3,4 Dihydroxyphenylserine
% 209.97/210.15 |- skos__altLabel mesh__D015103 DL-threo-3,4-Dihydroxyphenylserine
% 209.97/210.15 |- mesh__dateRevised mesh__D015103 2000-06-22
% 209.97/210.15 |- skos__prefLabel mesh__D015103 Droxidopa
% 209.97/210.15 |- skos__altLabel mesh__D015103 threo-DOPS
% 209.97/210.15 |- mesh__dateCreated mesh__D015103 1974-11-27
% 209.97/210.15 |- skos__broader mesh__D015103smesh__D009638
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D015103 sjn
% 209.97/210.15 |- skos__hiddenLabel mesh__D015103 DL threo 3,4 Dihydroxyphenylserine
% 209.97/210.15 |- skos__historyNote mesh__D015103 Catechols %28%1971-1974%29%
% 209.97/210.15 |- mesh__historyNote mesh__D015103
% 209.97/210.15 97; was 3,4-DIHYDROXYPHENYLSERINE 1975-96 %28%see under SERINE 1975-90%29%; DOPS was see DIHYDROXYPHENYLSERINE 1975-96%A%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015103 2002
% 209.97/210.15 |- skos__broader mesh__D015103smesh__D012694
% 209.97/210.15 |- mesh__dateEstablished mesh__D015103 1991-01-01
% 209.97/210.15 |- skos__scopeNote mesh__D015103
% 209.97/210.15 A precursor of noradrenaline that is used in the treatment of parkinsonism. The racemic form %28%DL-threo-3,4-dihydroxyphenylserine%29% has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in Parkinson%27%s disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease. Administration of DL-threo-3,4-dihydroxyphenylserine has been claimed to result in an improvement in this phenomenon but controlled studies have failed to demonstrate improvement. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A%
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015103 2004
% 209.97/210.15 |- mesh__onlineNote mesh__D015103 use DROXIDOPA to search DOPS 1975-96
% 209.97/210.15 |- skos__hiddenLabel mesh__D015103 threo DOPS
% 209.97/210.15 |- skos__hiddenLabel mesh__D015103 3,4 threo DOPS
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015103 2001
% 209.97/210.15 |- skos__altLabel mesh__D015103 3,4-threo-DOPS
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015103 2006
% 209.97/210.15 |- skos__hiddenLabel mesh__D015103 3,4 Dihydroxyphenylserine
% 209.97/210.15 |- mesh__recordOriginator mesh__D015103 NLM
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D015103 2003
% 209.97/210.15 |- mesh__dateEstablished mesh__D020846 2000-01-01
% 209.97/210.15 |- skos__altLabel mesh__D020846 cdc42 Protein, Yeast
% 209.97/210.15 |- mesh__dateCreated mesh__D020846 1999-11-03
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D020846 sjn
% 209.97/210.15 |- mesh__historyNote mesh__D020846
% 209.97/210.15 2002%28%2000%29%; use CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE %28%NM%29% 1991-1999%A%
% 209.97/210.15 |- skos__annotation mesh__D020846
% 209.97/210.15 CDC42 GTP-BINDING PROTEIN is also available
% 209.97/210.15 |- mesh__dateRevised mesh__D020846 2005-06-30
% 209.97/210.15 |- rdf__type mesh__D020846sskos__Concept
% 209.97/210.15 |- mesh__recordOriginator mesh__D020846 jmp
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D020846 2006
% 209.97/210.15 |- skos__hiddenLabel mesh__D020846 cdc42 GTP Binding Protein, Yeast
% 209.97/210.15 |- skos__hiddenLabel mesh__D020846
% 209.97/210.15 cdc42 GTP Binding Protein, Saccharomyces cerevisiae
% 209.97/210.15 |- skos__broader mesh__D020846smesh__D029701
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D020846
% 209.97/210.15 2002; CDC42 PROTEIN, FUNGAL %28%now CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE%29% was indexed under CELL CYCLE PROTEINS %26% G-PROTEINS 1996-1999 %26% FUNGAL PROTEINS 1991-1995%A%
% 209.97/210.15 |- skos__broader mesh__D020846smesh__D020741
% 209.97/210.15 |- mesh__recordMaintainer mesh__D020846 jmp
% 209.97/210.15 |- skos__scopeNote mesh__D020846
% 209.97/210.15 A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS from SACCHAROMYCES CEREVISIAE. It is involved in morphological events related to the cell cycle. This enzyme was formerly listed as EC 3.6.1.47.%A%
% 209.97/210.15 |- skos__historyNote mesh__D020846 G-Proteins %28%1996-1999%29%
% 209.97/210.15 |- skos__hiddenLabel mesh__D020846 Yeast cdc42 Protein
% 209.97/210.15 |- skos__prefLabel mesh__D020846
% 209.97/210.15 cdc42 GTP-Binding Protein, Saccharomyces cerevisiae
% 209.97/210.15 |- skos__broader mesh__D020846smesh__D020764
% 209.97/210.15 |- skos__historyNote mesh__D020846 Cell Cycle Proteins %28%1996-1999%29%
% 209.97/210.15 |- skos__altLabel mesh__D006377 T-Lymphocytes, Helper
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 T-Lymphocyte, Helper-Inducer
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 Helper-Inducer T-Cell
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 T-Lymphocyte, Inducer
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 T-Cell, Helper
% 209.97/210.15 |- mesh__dateCreated mesh__D006377 1982-04-29
% 209.97/210.15 |- skos__related mesh__D006377smesh__D008211
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 Helper-Inducer T-Lymphocyte
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 Helper T Cells
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 Helper Cell
% 209.97/210.15 |- mesh__dateEstablished mesh__D006377 1983-01-01
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 T Lymphocytes, Inducer
% 209.97/210.15 |- mesh__historyNote mesh__D006377
% 209.97/210.15 93; was HELPER CELLS 1983-92; was see T-LYMPHOCYTES 1979-82; was see LYMPHOCYTE COOPERATION 1978%A%
% 209.97/210.15 |- skos__altLabel mesh__D006377 T-Cells, Helper-Inducer
% 209.97/210.15 |- skos__related mesh__D006377smesh__D007376
% 209.97/210.15 |- skos__scopeNote mesh__D006377
% 209.97/210.15 Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes %28%either T or B%29% to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions.%A%
% 209.97/210.15 |- skos__altLabel mesh__D006377 Inducer Cells
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 T-Lymphocyte, Helper
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 Inducer T-Lymphocytes
% 209.97/210.15 |- skos__broader mesh__D006377smesh__D015496
% 209.97/210.15 |- mesh__activeMeSHYear mesh__D006377 2006
% 209.97/210.15 |- mesh__onlineNote mesh__D006377
% 209.97/210.15 use T-LYMPHOCYTES, HELPER-INDUCER to search HELPER CELLS 1983-92; use T-LYMPHOCYTES 1979-82 %26% LYMPHOCYTE COOPERATION 1978%A%
% 209.97/210.15 |- skos__historyNote mesh__D006377 T-Lymphocytes %28%1973-1982%29%
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 Inducer Cell
% 209.97/210.15 |- mesh__recordOriginator mesh__D006377 SAG
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 T Cells, Helper Inducer
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 Helper-Inducer T-Cells
% 209.97/210.15 |- skos__historyNote mesh__D006377 Antibody Formation %28%1972-1973%29%
% 209.97/210.15 |- mesh__publicMeSHNote mesh__D006377
% 209.97/210.15 93; was HELPER CELLS 1983-92; was see T-LYMPHOCYTES 1979-82; was see LYMPHOCYTE COOPERATION 1978%A%
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 Inducer T-Lymphocyte
% 209.97/210.15 |- mesh__recordMaintainer mesh__D006377 ags
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 Helper T-Lymphocyte
% 209.97/210.15 |- mesh__dateRevised mesh__D006377 2005-06-30
% 209.97/210.15 |- skos__hiddenLabel mesh__D006377 T-Cell, Helper-Inducer
% 209.97/210.15 |- mesh__recordAuthorizer mesh__D006377 sjn
% 209.97/210.16 |- skos__hiddenLabel mesh__D006377 Helper T-Cell
% 209.97/210.16 |- rdf__type mesh__D006377sskos__Concept
% 209.97/210.16 |- skos__altLabel mesh__D006377 Helper-Inducer T-Lymphocytes
% 209.97/210.16 |- skos__hiddenLabel mesh__D006377 Helper T-Lymphocytes
% 209.97/210.16 |- skos__annotation mesh__D006377
% 209.97/210.16 subpopulations: coordinate IM with T-LYMPHOCYTE SUBSETS %28%IM%29%%A%
% 209.97/210.16 |- skos__hiddenLabel mesh__D006377 T-Cells, Helper
% 209.97/210.16 |- skos__hiddenLabel mesh__D006377 Helper Inducer T Lymphocytes
% 209.97/210.16 |- skos__hiddenLabel mesh__D006377 T Lymphocytes, Helper
% 209.97/210.16 |- skos__altLabel mesh__D006377 Helper T-Cells
% 209.97/210.16 |- skos__prefLabel mesh__D006377 T-Lymphocytes, Helper-Inducer
% 209.97/210.16 |- skos__altLabel mesh__D006377 T-Lymphocytes, Inducer
% 209.97/210.16 |- skos__hiddenLabel mesh__D006377 T Lymphocytes, Helper Inducer
% 209.97/210.16 |- skos__altLabel mesh__D006377 Helper Cells
% 209.97/210.16 |- skos__historyNote mesh__D020048 Cockroaches %28%1965-1998%29%
% 209.97/210.16 |- skos__scopeNote mesh__D020048
% 209.97/210.16 A family of insects, in the order Dictyoptera %28%COCKROACHES%29%, including genera Blattella, Parcoblatta, and Symploce.%A%
% 209.97/210.16 |- rdf__type mesh__D020048sskos__Concept
% 209.97/210.16 |- skos__prefLabel mesh__D020048 Blattellidae
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D020048 99
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D020048 2006
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D020048 2005
% 209.97/210.16 |- skos__broader mesh__D020048smesh__D003058
% 209.97/210.16 |- mesh__dateCreated mesh__D020048 1998-06-10
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D020048 2004
% 209.97/210.16 |- mesh__dateRevised mesh__D020048 2003-07-09
% 209.97/210.16 |- mesh__historyNote mesh__D020048 99
% 209.97/210.16 |- mesh__dateEstablished mesh__D020048 1999-01-01
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 25 HCC Binding Protein
% 209.97/210.16 |- mesh__recordOriginator mesh__D014809 RLS
% 209.97/210.16 |- skos__scopeNote mesh__D014809
% 209.97/210.16 An alpha-globulin found in the plasma of man and other vertebrates. It is apparently synthesized in the liver and carries vitamin D and its metabolites through the circulation and mediates the response of tissue. It is also known as group-specific component %28%Gc%29%. Gc subtypes are used to determine specific phenotypes and gene frequencies. These data are employed in the classification of population groups, paternity investigations, and in forensic medicine.%A%
% 209.97/210.16 |- skos__altLabel mesh__D014809 Group-Specific Component Globulin
% 209.97/210.16 |- mesh__dateRevised mesh__D014809 2004-07-07
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 Globulin, Vitamin D-Binding
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 Component Globulin, Group-Specific
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809
% 209.97/210.16 25 Hydroxycholecalciferol Binding Protein
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 Globulin, Gc
% 209.97/210.16 |- mesh__recordMaintainer mesh__D014809 jmp
% 209.97/210.16 |- mesh__historyNote mesh__D014809 85
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 Group Specific Component Globulin
% 209.97/210.16 |- rdf__type mesh__D014809sskos__Concept
% 209.97/210.16 |- skos__historyNote mesh__D014809 Proteins %28%1966-1971%29%
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 Globulin, Group-Specific Component
% 209.97/210.16 |- skos__historyNote mesh__D014809 Vitamin D %28%1966-1984%29%
% 209.97/210.16 |- skos__altLabel mesh__D014809 Gc Globulin
% 209.97/210.16 |- skos__historyNote mesh__D014809 Carrier Proteins %28%1971-1984%29%
% 209.97/210.16 |- skos__altLabel mesh__D014809 25-Hydroxyvitamin D-Binding Protein
% 209.97/210.16 |- skos__prefLabel mesh__D014809 Vitamin D-Binding Protein
% 209.97/210.16 |- mesh__dateEstablished mesh__D014809 1985-01-01
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 Vitamin D Binding Globulin
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 25 Hydroxyvitamin D Binding Protein
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 Vitamin D Binding Protein
% 209.97/210.16 |- mesh__dateCreated mesh__D014809 1984-05-30
% 209.97/210.16 |- skos__hiddenLabel mesh__D014809 Calciferol Binding Protein
% 209.97/210.16 |- skos__historyNote mesh__D014809 Alpha Globulins %28%1966-1984%29%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D014809 2005
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D014809 sjn
% 209.97/210.16 |- skos__altLabel mesh__D014809 Transcalciferin
% 209.97/210.16 |- skos__altLabel mesh__D014809 Vitamin D-Binding Globulin
% 209.97/210.16 |- skos__altLabel mesh__D014809 Calciferol-Binding Protein
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D014809 2006
% 209.97/210.16 |- skos__altLabel mesh__D014809 25-Hydroxycholecalciferol-Binding Protein
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D014809 85
% 209.97/210.16 |- skos__broader mesh__D014809smesh__D002352
% 209.97/210.16 |- skos__altLabel mesh__D014809 25-HCC-Binding Protein
% 209.97/210.16 |- rdf__type mesh__D011511sskos__Concept
% 209.97/210.16 |- skos__scopeNote mesh__D011511
% 209.97/210.16 A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.%A%
% 209.97/210.16 |- skos__broader mesh__D011511smesh__D004755
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D011511 sjn
% 209.97/210.16 |- mesh__dateCreated mesh__D011511 1999-01-01
% 209.97/210.16 |- mesh__dateRevised mesh__D011511 2005-06-30
% 209.97/210.16 |- skos__annotation mesh__D011511 GEN; infection = PROTEUS INFECTIONS
% 209.97/210.16 |- mesh__recordOriginator mesh__D011511 NLM
% 209.97/210.16 |- skos__prefLabel mesh__D011511 Proteus
% 209.97/210.16 |- mesh__recordMaintainer mesh__D011511 SYSTEM
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D011511 2006
% 209.97/210.16 |- skos__prefLabel mesh__D002785 Sterol O-Acyltransferase
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D002785 sjn
% 209.97/210.16 |- skos__hiddenLabel mesh__D002785 Sterol O Acyltransferase
% 209.97/210.16 |- skos__hiddenLabel mesh__D002785 Esterifying Enzyme, Cholesterol
% 209.97/210.16 |- skos__scopeNote mesh__D002785
% 209.97/210.16 An enzyme that catalyzes the formation of cholesterol esters by the direct transfer of the fatty acid group from a fatty acyl CoA derivative. This enzyme has been found in the adrenal gland, gonads, liver, intestinal mucosa, and aorta of many mammalian species. EC 2.3.1.26.%A%
% 209.97/210.16 |- rdf__type mesh__D002785sskos__Concept
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D002785 2004
% 209.97/210.16 |- skos__hiddenLabel mesh__D002785 Enzyme, Cholesterol Esterifying
% 209.97/210.16 |- skos__altLabel mesh__D002785 Acyl-CoA-Cholesterol Acyltransferase
% 209.97/210.16 |- skos__hiddenLabel mesh__D002785 Acyl CoA Cholesterol Acyltransferase
% 209.97/210.16 |- skos__hiddenLabel mesh__D002785 Acyltransferase, Cholesterol
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D002785
% 209.97/210.16 98; see CHOLESTEROL ACYLTRANSFERASE 1985-97; see ACYLTRANSFERASES 1976-84%A%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D002785 2005
% 209.97/210.16 |- mesh__historyNote mesh__D002785 98%28%76%29%
% 209.97/210.16 |- skos__altLabel mesh__D002785 Cholesterol Esterifying Enzyme
% 209.97/210.16 |- mesh__recordOriginator mesh__D002785 RLS
% 209.97/210.16 |- skos__historyNote mesh__D002785 Cholesterol %28%1973-1975%29%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D002785 2006
% 209.97/210.16 |- mesh__recordMaintainer mesh__D002785 ssb
% 209.97/210.16 |- skos__broader mesh__D002785smesh__D000217
% 209.97/210.16 |- skos__historyNote mesh__D002785 Coenzyme A %28%1973-1975%29%
% 209.97/210.16 |- skos__hiddenLabel mesh__D002785 O-Acyltransferase, Sterol
% 209.97/210.16 |- mesh__dateEstablished mesh__D002785 1985-01-01
% 209.97/210.16 |- skos__historyNote mesh__D002785 Acyltransferases %28%1973-1975%29%
% 209.97/210.16 |- skos__altLabel mesh__D002785 Cholesterol Acyltransferase
% 209.97/210.16 |- mesh__dateCreated mesh__D002785 1975-07-25
% 209.97/210.16 |- mesh__dateRevised mesh__D002785 2003-07-09
% 209.97/210.16 |- skos__hiddenLabel mesh__D002785 Acyltransferase, Acyl-CoA-Cholesterol
% 209.97/210.16 |- mesh__dateEstablished mesh__D035161 2003-01-01
% 209.97/210.16 |- rdf__type mesh__D035161sskos__Concept
% 209.97/210.16 |- skos__broader mesh__D035161smesh__D019684
% 209.97/210.16 |- skos__scopeNote mesh__D035161
% 209.97/210.16 A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida of tropical trees.%A%
% 209.97/210.16 |- skos__prefLabel mesh__D035161 Bombacaceae
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D035161 2003
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D035161 2005
% 209.97/210.16 |- mesh__historyNote mesh__D035161 2003
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D035161 2003
% 209.97/210.16 |- skos__altLabel mesh__D035161 Balsa
% 209.97/210.16 |- skos__annotation mesh__D035161
% 209.97/210.16 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.97/210.16 |- skos__altLabel mesh__D035161 Durian
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D035161 2006
% 209.97/210.16 |- mesh__dateCreated mesh__D035161 2002-07-02
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D035161 2004
% 209.97/210.16 |- skos__prefLabel mesh__D010419 Pentamidine
% 209.97/210.16 |- mesh__dateEstablished mesh__D010419 1990-01-01
% 209.97/210.16 |- mesh__recordMaintainer mesh__D010419 lkw
% 209.97/210.16 |- mesh__historyNote mesh__D010419
% 209.97/210.16 90%28%75%29%; was see under AMIDINES 1975-89
% 209.97/210.16 |- skos__altLabel mesh__D010419 Sicor Brand of Pentamidine Isethionate
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D010419 2006
% 209.97/210.16 |- skos__altLabel mesh__D010419 Pentamidin
% 209.97/210.16 |- skos__historyNote mesh__D010419 Amidines %28%1972-1974%29%
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D010419 90; was see under AMIDINES 1975-89
% 209.97/210.16 |- mesh__dateRevised mesh__D010419 2005-06-30
% 209.97/210.16 |- mesh__dateCreated mesh__D010419 1974-11-19
% 209.97/210.16 |- skos__altLabel mesh__D010419
% 209.97/210.16 American Pharmaceutical Partners Brand 2 of Pentamidine Isethionate
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D010419 sjn
% 209.97/210.16 |- mesh__recordOriginator mesh__D010419 NLM
% 209.97/210.16 |- skos__historyNote mesh__D010419 Phenyl Ethers %28%1974%29%
% 209.97/210.16 |- skos__altLabel mesh__D010419
% 209.97/210.16 Rh%C3%%B4%ne-Poulenc Rorer Brand of Pentamidine Isethionate
% 209.97/210.16 |- skos__altLabel mesh__D010419
% 209.97/210.16 American Pharmaceutical Partners Brand 1 of Pentamidine Isethionate
% 209.97/210.16 |- rdf__type mesh__D010419sskos__Concept
% 209.97/210.16 |- skos__scopeNote mesh__D010419
% 209.97/210.16 Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.%A%
% 209.97/210.16 |- skos__altLabel mesh__D010419
% 209.97/210.16 GlaxoSmithKline Brand of Pentamidine Isethionate
% 209.97/210.16 |- skos__broader mesh__D010419smesh__D001550
% 209.97/210.16 |- skos__altLabel mesh__D010419 JHC Brand of Pentamidine Isethionate
% 209.97/210.16 |- skos__altLabel mesh__D010419 Aventis Brand of Pentamidine Isethionate
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D007470 2005
% 209.97/210.16 |- skos__broader mesh__D007470smesh__D014443
% 209.97/210.16 |- skos__historyNote mesh__D007470 Tyrosine %28%1966-1967%29%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D007470 2006
% 209.97/210.16 |- mesh__historyNote mesh__D007470 72%28%68%29%
% 209.97/210.16 |- skos__prefLabel mesh__D007470 Monoiodotyrosine
% 209.97/210.16 |- mesh__dateEstablished mesh__D007470 1972-01-01
% 209.97/210.16 |- mesh__dateCreated mesh__D007470 1999-01-01
% 209.97/210.16 |- mesh__recordOriginator mesh__D007470 NLM
% 209.97/210.16 |- mesh__recordMaintainer mesh__D007470 nns
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D007470 2003
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D007470 sjn
% 209.97/210.16 |- skos__altLabel mesh__D007470 Iodotyrosine
% 209.97/210.16 |- rdf__type mesh__D007470sskos__Concept
% 209.97/210.16 |- skos__broader mesh__D007470smesh__D013963
% 209.97/210.16 |- skos__historyNote mesh__D007470 Thyroid Hormones %28%1966-1967%29%
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D007470 72
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D007470 2004
% 209.97/210.16 |- mesh__dateRevised mesh__D007470 2001-07-25
% 209.97/210.16 |- skos__scopeNote mesh__D007470
% 209.97/210.16 A product from the iodination of tyrosine. In the biosynthesis of thyroid hormones %28%THYROXINE and TRIIODOTHYRONINE%29%, tyrosine is first iodized to monoiodotyrosine.%A%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D007470 2002
% 209.97/210.16 |- skos__altLabel mesh__D021141 Technics, Nucleic Acid Amplification
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Techniques, DNA Amplification
% 209.97/210.16 |- rdf__type mesh__D021141sskos__Concept
% 209.97/210.16 |- skos__altLabel mesh__D021141 RNA Amplification Technics
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Technics, RNA Amplification
% 209.97/210.16 |- mesh__recordOriginator mesh__D021141 jmp
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D021141 2005A
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D021141 2004
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 DNA Amplification Technic
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Techniques, RNA Amplification
% 209.97/210.16 |- mesh__dateRevised mesh__D021141 2004-07-29
% 209.97/210.16 |- skos__altLabel mesh__D021141 Amplification Technics, Nucleic Acid
% 209.97/210.16 |- skos__historyNote mesh__D021141 Gene Amplification %28%1980-2000%29%
% 209.97/210.16 |- skos__broader mesh__D021141smesh__D005821
% 209.97/210.16 |- skos__altLabel mesh__D021141 Techniques, Nucleic Acid Amplification
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Amplification Technique, RNA
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Amplification Technics, DNA
% 209.97/210.16 |- skos__prefLabel mesh__D021141 Nucleic Acid Amplification Techniques
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Amplification Techniques, DNA
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D021141 2003
% 209.97/210.16 |- mesh__recordMaintainer mesh__D021141 jls
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Technic, DNA Amplification
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D021141 2002
% 209.97/210.16 |- skos__altLabel mesh__D021141 DNA Amplification Technics
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Technique, RNA Amplification
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Technique, DNA Amplification
% 209.97/210.16 |- skos__altLabel mesh__D021141 Amplification Techniques, Nucleic Acid
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 RNA Amplification Technic
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 DNA Amplification Technique
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D021141 2001
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Amplification Technic, DNA
% 209.97/210.16 |- mesh__dateCreated mesh__D021141 2000-06-21
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Technic, RNA Amplification
% 209.97/210.16 |- mesh__historyNote mesh__D021141 2001
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D021141 2006
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D021141 2001
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Amplification Techniques, RNA
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Amplification Technic, RNA
% 209.97/210.16 |- skos__altLabel mesh__D021141 Nucleic Acid Amplification Technics
% 209.97/210.16 |- skos__scopeNote mesh__D021141
% 209.97/210.16 Laboratory techniques that involve the in-vitro synthesis of many copies of DNA or RNA from one original template.%A%
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Amplification Technique, DNA
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 RNA Amplification Technique
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Amplification Technics, RNA
% 209.97/210.16 |- mesh__dateEstablished mesh__D021141 2001-01-01
% 209.97/210.16 |- skos__hiddenLabel mesh__D021141 Technics, DNA Amplification
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D021141 jls
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D021141 2005
% 209.97/210.16 |- skos__historyNote mesh__D015902
% 209.97/210.16 Radionuclide Imaging/instrumentation %28%1966-1989%29%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015902 2005
% 209.97/210.16 |- skos__historyNote mesh__D015902 Radiometry %28%1966-1972%29%
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Cameras, Nuclear
% 209.97/210.16 |- skos__altLabel mesh__D015902 Scintillation Cameras
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D015902 90
% 209.97/210.16 |- skos__historyNote mesh__D015902 Scintillation Counting %28%1979-1989%29%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015902 2002
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Nuclear Camera
% 209.97/210.16 |- mesh__recordOriginator mesh__D015902 PLS
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015902 2006
% 209.97/210.16 |- skos__prefLabel mesh__D015902 Gamma Cameras
% 209.97/210.16 |- skos__broader mesh__D015902smesh__D004864
% 209.97/210.16 |- skos__scopeNote mesh__D015902
% 209.97/210.16 Electronic instruments that produce photographs or cathode-ray tube images of the gamma-ray emissions from organs containing radionuclide tracers.%A%
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Cameras, Scintillation
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Cameras, Gamma
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015902 2003
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Scinti-Camera
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Camera, Gamma
% 209.97/210.16 |- skos__annotation mesh__D015902
% 209.97/210.16 do not use /util except by MeSH definition
% 209.97/210.16 |- rdf__type mesh__D015902sskos__Concept
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015902 2000
% 209.97/210.16 |- mesh__recordMaintainer mesh__D015902 PXP
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Scinti Cameras
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Camera, Scintillation
% 209.97/210.16 |- skos__altLabel mesh__D015902 Scinti-Cameras
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Gamma Camera
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D015902 SJN
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015902 2004
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015902 1998
% 209.97/210.16 |- mesh__historyNote mesh__D015902 90
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015902 2001
% 209.97/210.16 |- mesh__dateRevised mesh__D015902 1997-06-20
% 209.97/210.16 |- mesh__dateEstablished mesh__D015902 1990-01-01
% 209.97/210.16 |- mesh__dateCreated mesh__D015902 1989-05-15
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Camera, Nuclear
% 209.97/210.16 |- skos__hiddenLabel mesh__D015902 Scintillation Camera
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015902 1999
% 209.97/210.16 |- skos__altLabel mesh__D015902 Nuclear Cameras
% 209.97/210.16 |- skos__broader mesh__D048089smesh__D018410
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D048089 2005
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D048089 sjn
% 209.97/210.16 |- skos__broader mesh__D048089smesh__D048090
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D048089 2005
% 209.97/210.16 |- skos__altLabel mesh__D048089 Enzootic Calf Pneumonia
% 209.97/210.16 |- skos__prefLabel mesh__D048089 Pneumonia of Calves, Enzootic
% 209.97/210.16 |- skos__hiddenLabel mesh__D048089 Pneumonia, Enzootic Calf
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D048089 2006
% 209.97/210.16 |- skos__scopeNote mesh__D048089
% 209.97/210.16 Chronic endemic respiratory disease of dairy calves and an important component of bovine respiratory disease complex. It primarily affects calves up to six months of age and the etiology is multifactorial. Stress plus a primary viral infection is followed by a secondary bacterial infection. The latter is most commonly associated with PASTEURELLA MULTOCIDA producing a purulent BRONCHOPNEUMONIA. Sometimes present are MANNHEIMIA HAEMOLYTICA; HAEMOPHILUS SOMNUS and mycoplasma species.%A%
% 209.97/210.16 |- skos__hiddenLabel mesh__D048089 Enzootic Calf Pneumonias
% 209.97/210.16 |- skos__hiddenLabel mesh__D048089 Pneumonias, Enzootic Calf
% 209.97/210.16 |- skos__altLabel mesh__D048089 Enzootic Pneumonia of Calves
% 209.97/210.16 |- mesh__historyNote mesh__D048089 2005
% 209.97/210.16 |- skos__annotation mesh__D048089
% 209.97/210.16 infection: coordinate IM with PASTEURELLA MULTOCIDA %28%IM%29%, MANNHEIMIA HAEMOLYTICA %28%IM%29% or HAEMOPHILUS SOMNUS %28%IM%29% only if particularly discussed; check the tag CATTLE%A%
% 209.97/210.16 |- skos__hiddenLabel mesh__D048089 Calf Pneumonia, Enzootic
% 209.97/210.16 |- mesh__recordOriginator mesh__D048089 ags
% 209.97/210.16 |- rdf__type mesh__D048089sskos__Concept
% 209.97/210.16 |- mesh__recordMaintainer mesh__D048089 ags
% 209.97/210.16 |- mesh__dateCreated mesh__D048089 2004-07-07
% 209.97/210.16 |- mesh__dateEstablished mesh__D048089 2005-01-01
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D015104
% 209.97/210.16 91; was see under AMPHETAMINES 1977-90
% 209.97/210.16 |- skos__historyNote mesh__D015104 Amphetamine %28%1973-1976%29%
% 209.97/210.16 |- mesh__dateRevised mesh__D015104 2000-06-22
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015104 2001
% 209.97/210.16 |- mesh__dateCreated mesh__D015104 1976-04-13
% 209.97/210.16 |- skos__scopeNote mesh__D015104
% 209.97/210.16 An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.%A%
% 209.97/210.16 |- skos__hiddenLabel mesh__D015104 3,4 Methylenedioxyamphetamine
% 209.97/210.16 |- skos__historyNote mesh__D015104 Methyl Ethers %28%1973%29%
% 209.97/210.16 |- skos__historyNote mesh__D015104 Dioxoles %28%1974-1975%29%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015104 2004
% 209.97/210.16 |- mesh__historyNote mesh__D015104
% 209.97/210.16 91%28%77%29%; was see under AMPHETAMINES 1977-90
% 209.97/210.16 |- mesh__recordMaintainer mesh__D015104 CCR
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015104 2006
% 209.97/210.16 |- mesh__dateEstablished mesh__D015104 1991-01-01
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015104 2003
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015104 2005
% 209.97/210.16 |- mesh__recordOriginator mesh__D015104 SH
% 209.97/210.16 |- skos__prefLabel mesh__D015104 3,4-Methylenedioxyamphetamine
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D015104 sjn
% 209.97/210.16 |- rdf__type mesh__D015104sskos__Concept
% 209.97/210.16 |- skos__broader mesh__D015104smesh__D000662
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D015104 2002
% 209.97/210.16 |- rdf__type mesh__D020847sskos__Concept
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D020847 2006
% 209.97/210.16 |- skos__related mesh__D020847smesh__D004965
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D020847
% 209.97/210.16 2000; see ESTROGEN ANTAGONISTS 1978-1999
% 209.97/210.16 |- skos__hiddenLabel mesh__D020847 Receptor Modulator, Estrogen
% 209.97/210.16 |- skos__hiddenLabel mesh__D020847 Modulator, Estrogen Receptor
% 209.97/210.16 |- skos__hiddenLabel mesh__D020847 Modulators, Estrogen Receptor
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D020847 2005
% 209.97/210.16 |- mesh__recordMaintainer mesh__D020847 lkt
% 209.97/210.16 |- mesh__dateCreated mesh__D020847 1999-11-03
% 209.97/210.16 |- skos__altLabel mesh__D020847 Antiestrogen
% 209.97/210.16 |- skos__annotation mesh__D020847
% 209.97/210.16 do not confuse with SELECTIVE ESTROGEN RECEPTOR MODULATORS%A%
% 209.97/210.16 |- skos__prefLabel mesh__D020847 Estrogen Receptor Modulators
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D020847 sjn
% 209.97/210.16 |- skos__broader mesh__D020847smesh__D006727
% 209.97/210.16 |- mesh__recordOriginator mesh__D020847 adp
% 209.97/210.16 |- skos__related mesh__D020847smesh__D004967
% 209.97/210.16 |- skos__hiddenLabel mesh__D020847 Receptor Modulators, Estrogen
% 209.97/210.16 |- skos__altLabel mesh__D020847 Estrogen Receptor Modulator
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D020847 2004
% 209.97/210.16 |- skos__altLabel mesh__D020847 Antiestrogens
% 209.97/210.16 |- mesh__dateEstablished mesh__D020847 2000-01-01
% 209.97/210.16 |- mesh__dateRevised mesh__D020847 2003-07-09
% 209.97/210.16 |- mesh__historyNote mesh__D020847
% 209.97/210.16 2000; use ESTROGEN ANTAGONISTS 1978-1999
% 209.97/210.16 |- skos__scopeNote mesh__D020847
% 209.97/210.16 Substances that possess antiestrogenic actions but can also produce estrogenic effects as well. They act as complete or partial agonist or as antagonist. They can be either steroidal or nonsteroidal in structure.%A%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 1998
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 2000
% 209.97/210.16 |- skos__hiddenLabel mesh__D006378 Virus, Helper
% 209.97/210.16 |- skos__scopeNote mesh__D006378
% 209.97/210.16 Viruses which enable defective viruses to replicate or to form a protein coat by complementing the missing gene function of the defective %28%satellite%29% virus. Helper and satellite may be of the same or different genus.%A%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 2004
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 2001
% 209.97/210.16 |- skos__annotation mesh__D006378
% 209.97/210.16 enable defective viruses to replicate or to form a protein coat; coord IM with specific virus %28%IM%29%%A%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 1999
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D006378 PLS
% 209.97/210.16 |- rdf__type mesh__D006378sskos__Concept
% 209.97/210.16 |- mesh__dateEstablished mesh__D006378 1973-01-01
% 209.97/210.16 |- skos__hiddenLabel mesh__D006378 Viruses, Helper
% 209.97/210.16 |- mesh__historyNote mesh__D006378
% 209.97/210.16 75; was HELPER VIRUS 1967-74 %28%Prov 1967-72%29%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 1996
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 2005
% 209.97/210.16 |- skos__hiddenLabel mesh__D006378 Helper Virus
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 2002
% 209.97/210.16 |- mesh__dateCreated mesh__D006378 1999-01-01
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D006378 75; was HELPER VIRUS 1973-74
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 1997
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 1994
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 2006
% 209.97/210.16 |- mesh__dateRevised mesh__D006378 1993-06-04
% 209.97/210.16 |- mesh__recordOriginator mesh__D006378 NLM
% 209.97/210.16 |- skos__related mesh__D006378smesh__D012526
% 209.97/210.16 |- skos__broader mesh__D006378smesh__D014780
% 209.97/210.16 |- skos__historyNote mesh__D006378 specific virus %28%1966%29%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 1995
% 209.97/210.16 |- mesh__onlineNote mesh__D006378
% 209.97/210.16 use HELPER VIRUSES to search HELPER VIRUS 1967-74 %28%as Prov 1967-72%29%%A%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D006378 2003
% 209.97/210.16 |- skos__prefLabel mesh__D006378 Helper Viruses
% 209.97/210.16 |- mesh__recordMaintainer mesh__D006378 AGS
% 209.97/210.16 |- mesh__dateCreated mesh__D020049 1998-06-10
% 209.97/210.16 |- rdf__type mesh__D020049sskos__Concept
% 209.97/210.16 |- skos__historyNote mesh__D020049 Insects %28%1966-1998%29%
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D020049 2005
% 209.97/210.16 |- skos__broader mesh__D020049smesh__D007313
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D020049 2006
% 209.97/210.16 |- skos__altLabel mesh__D020049 Termites
% 209.97/210.16 |- mesh__dateEstablished mesh__D020049 1999-01-01
% 209.97/210.16 |- skos__scopeNote mesh__D020049
% 209.97/210.16 An order of insects, restricted mostly to the tropics, containing at least eight families. A few species occur in temperate regions of North America.%A%
% 209.97/210.16 |- skos__prefLabel mesh__D020049 Isoptera
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D020049 2004
% 209.97/210.16 |- mesh__dateRevised mesh__D020049 2003-07-09
% 209.97/210.16 |- mesh__historyNote mesh__D020049 99
% 209.97/210.16 |- skos__annotation mesh__D020049
% 209.97/210.16 do not use /drug eff for insecticides: TN 111
% 209.97/210.16 |- mesh__publicMeSHNote mesh__D020049 99
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 2001
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 1998
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 2005
% 209.97/210.16 |- skos__related mesh__D003080smesh__D005627
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 2002
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 1999
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 2006
% 209.97/210.16 |- skos__broader mesh__D003080smesh__D013696
% 209.97/210.16 |- skos__related mesh__D003080smesh__D007102
% 209.97/210.16 |- skos__prefLabel mesh__D003080 Cold
% 209.97/210.16 |- mesh__recordOriginator mesh__D003080 NLM
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 1995
% 209.97/210.16 |- mesh__considerAlso mesh__D003080 consider also terms at CRYO-
% 209.97/210.16 |- skos__related mesh__D003080smesh__D015925
% 209.97/210.16 |- rdf__type mesh__D003080sskos__Concept
% 209.97/210.16 |- mesh__recordAuthorizer mesh__D003080 PLS
% 209.97/210.16 |- skos__annotation mesh__D003080
% 209.97/210.16 cooling of organs during surg goes under HYPOTHERMIA, INDUCED%A%
% 209.97/210.16 |- skos__related mesh__D003080smesh__D017679
% 209.97/210.16 |- mesh__dateRevised mesh__D003080 1994-05-24
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 1996
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 2003
% 209.97/210.16 |- skos__related mesh__D003080smesh__D007036
% 209.97/210.16 |- mesh__recordMaintainer mesh__D003080 TGC
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 2000
% 209.97/210.16 |- skos__related mesh__D003080smesh__D007035
% 209.97/210.16 |- skos__related mesh__D003080smesh__D003452
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 1997
% 209.97/210.16 |- mesh__dateCreated mesh__D003080 1999-01-01
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D003080 2004
% 209.97/210.16 |- skos__related mesh__D003080smesh__D012768
% 209.97/210.16 |- skos__scopeNote mesh__D003080
% 209.97/210.16 An absence of warmth or heat or a temperature notably below an accustomed norm.%A%
% 209.97/210.16 |- skos__related mesh__D003080smesh__D012034
% 209.97/210.16 |- mesh__dateRevised mesh__D011512 1996-06-10
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D011512 1998
% 209.97/210.16 |- mesh__activeMeSHYear mesh__D011512 2000
% 209.97/210.16 |- mesh__dateCreated mesh__D011512 1999-01-01
% 209.97/210.16 |- skos__hiddenLabel mesh__D011512 Infection, Proteus
% 209.97/210.16 |- skos__altLabel mesh__D011512 Infections, Proteus
% 209.97/210.16 |- skos__hiddenLabel mesh__D011512 Proteus Infection
% 209.97/210.16 |- mesh__recordMaintainer mesh__D011512 TGC
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D011512 2002
% 209.97/210.17 |- skos__broader mesh__D011512smesh__D004756
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D011512 2006
% 209.97/210.17 |- mesh__recordOriginator mesh__D011512 NLM
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D011512 2004
% 209.97/210.17 |- skos__scopeNote mesh__D011512
% 209.97/210.17 Infections with bacteria of the genus PROTEUS.
% 209.97/210.17 |- rdf__type mesh__D011512sskos__Concept
% 209.97/210.17 |- skos__prefLabel mesh__D011512 Proteus Infections
% 209.97/210.17 |- skos__annotation mesh__D011512
% 209.97/210.17 gram-neg bact infect; GEN; coord IM with various species %28%IM%29%%A%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D011512 2005
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D011512 1999
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D011512 PLS
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D011512 2001
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D011512 2003
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D011512 1997
% 209.97/210.17 |- rdf__type mesh__D002786sskos__Concept
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D002786
% 209.97/210.17 2003; see CHOLESTEROL MONOOXYGENASE 1997-2002, see CHOLESTEROL DESMOLASE 1988-1996, see OXIDOREDUCTASES 1975-1987%A%
% 209.97/210.17 |- mesh__dateCreated mesh__D002786 1974-11-19
% 209.97/210.17 |- mesh__historyNote mesh__D002786 2003 %28%1975%29%
% 209.97/210.17 |- skos__altLabel mesh__D002786 Cytochrome P450scc
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D002786 2005
% 209.97/210.17 |- skos__altLabel mesh__D002786 Cytochrome P-450 CYP11A1
% 209.97/210.17 |- mesh__dateRevised mesh__D002786 2005-07-11
% 209.97/210.17 |- skos__broader mesh__D002786smesh__D013250
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D002786 2006
% 209.97/210.17 |- mesh__recordOriginator mesh__D002786 NLM
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D002786 2006A
% 209.97/210.17 |- skos__prefLabel mesh__D002786 Cholesterol Side-Chain Cleavage Enzyme
% 209.97/210.17 |- skos__hiddenLabel mesh__D002786 Cholesterol Side Chain Cleavage Enzyme
% 209.97/210.17 |- skos__altLabel mesh__D002786 CYP11A1
% 209.97/210.17 |- skos__hiddenLabel mesh__D002786 Cytochrome P 450 CYP11A1
% 209.97/210.17 |- skos__scopeNote mesh__D002786
% 209.97/210.17 A mitochondrial cytochrome P450 enzyme that catalyzes the side-chain cleavage of C27 cholesterol to C21 pregnenolone in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP11A1 gene, catalyzes the breakage between C20 and C22 which is the initial and rate-limiting step in the biosynthesis of various gonadal and adrenal steroid hormones.%A%
% 209.97/210.17 |- skos__altLabel mesh__D002786 Cytochrome P450 11A1
% 209.97/210.17 |- skos__historyNote mesh__D002786 Oxidoreductases %28%1971-1974%29%
% 209.97/210.17 |- skos__altLabel mesh__D002786 Cholesterol Desmolase
% 209.97/210.17 |- skos__historyNote mesh__D002786 Multienzyme Complexes %28%1973-1974%29%
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D002786 ags
% 209.97/210.17 |- skos__historyNote mesh__D002786 Cholesterol %28%1971-1974%29%
% 209.97/210.17 |- skos__altLabel mesh__D002786 Cytochrome P-450%28%scc%29%
% 209.97/210.17 |- mesh__dateEstablished mesh__D002786 1988-01-01
% 209.97/210.17 |- mesh__recordMaintainer mesh__D002786 ags
% 209.97/210.17 |- skos__altLabel mesh__D002786 CYP 11A1
% 209.97/210.17 |- skos__broader mesh__D002786smesh__D009097
% 209.97/210.17 |- skos__hiddenLabel mesh__D002786 20,22 Desmolase
% 209.97/210.17 |- skos__altLabel mesh__D002786 20,22-Desmolase
% 209.97/210.17 |- skos__altLabel mesh__D002786
% 209.97/210.17 Cholesterol Monooxygenase %28%Side-Chain-Cleaving%29%
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D035162 2003
% 209.97/210.17 |- mesh__dateCreated mesh__D035162 2002-07-02
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035162 2005
% 209.97/210.17 |- skos__broader mesh__D035162smesh__D035161
% 209.97/210.17 |- skos__prefLabel mesh__D035162 Adansonia
% 209.97/210.17 |- skos__scopeNote mesh__D035162
% 209.97/210.17 A plant genus of the family BOMBACACEAE that is used for FOOD and MEDICINE, TRADITIONAL.%A%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035162 2003
% 209.97/210.17 |- skos__annotation mesh__D035162
% 209.97/210.17 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.97/210.17 |- mesh__dateEstablished mesh__D035162 2003-01-01
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035162 2006
% 209.97/210.17 |- skos__altLabel mesh__D035162 Baobab
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035162 2004
% 209.97/210.17 |- rdf__type mesh__D035162sskos__Concept
% 209.97/210.17 |- mesh__historyNote mesh__D035162 2003
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007471 2006
% 209.97/210.17 |- mesh__dateCreated mesh__D007471 1974-11-19
% 209.97/210.17 |- skos__historyNote mesh__D007471 Amides %28%1966-1974%29%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007471 2002
% 209.97/210.17 |- mesh__dateEstablished mesh__D007471 1991-01-01
% 209.97/210.17 |- skos__historyNote mesh__D007471 Glycolates %28%1966-1974%29%
% 209.97/210.17 |- skos__annotation mesh__D007471 D25-26 qualif
% 209.97/210.17 |- mesh__historyNote mesh__D007471
% 209.97/210.17 91%28%75%29%; was see under IODOBENZOATES 1975-90
% 209.97/210.17 |- skos__broader mesh__D007471smesh__D014283
% 209.97/210.17 |- skos__prefLabel mesh__D007471 Ioglycamic Acid
% 209.97/210.17 |- mesh__recordMaintainer mesh__D007471 CCR
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007471 2003
% 209.97/210.17 |- mesh__dateRevised mesh__D007471 2000-06-21
% 209.97/210.17 |- rdf__type mesh__D007471sskos__Concept
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007471 2004
% 209.97/210.17 |- skos__hiddenLabel mesh__D007471 Acid, Ioglycamic
% 209.97/210.17 |- mesh__recordOriginator mesh__D007471 NLM
% 209.97/210.17 |- skos__historyNote mesh__D007471 Iodobenzoates %28%1974%29%
% 209.97/210.17 |- skos__historyNote mesh__D007471 Benzoates %28%1966-1973%29%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007471 2005
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D007471 sjn
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D007471
% 209.97/210.17 91; was see under IODOBENZOATES 1975-90
% 209.97/210.17 |- skos__scopeNote mesh__D007471
% 209.97/210.17 A radiopaque medium. It is a mixture of its meglumine and sodium salts and is used to visualize the biliary tract.%A%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007471 2001
% 209.97/210.17 |- mesh__recordMaintainer mesh__D048888 ags
% 209.97/210.17 |- mesh__recordOriginator mesh__D048888 ags
% 209.97/210.17 |- skos__broader mesh__D048888smesh__D001517
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D048888 2005
% 209.97/210.17 |- skos__altLabel mesh__D048888 Firefly
% 209.97/210.17 |- mesh__dateEstablished mesh__D048888 2005-01-01
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D048888 2006
% 209.97/210.17 |- rdf__type mesh__D048888sskos__Concept
% 209.97/210.17 |- mesh__historyNote mesh__D048888 2005; use BEETLES 1993-2004
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D048888 sjn
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D048888 2005; see BEETLES 1993-2004
% 209.97/210.17 |- skos__historyNote mesh__D048888 Beetles %28%1965-2004%29%
% 209.97/210.17 |- mesh__dateCreated mesh__D048888 2004-07-15
% 209.97/210.17 |- skos__prefLabel mesh__D048888 Fireflies
% 209.97/210.17 |- skos__altLabel mesh__D048888 Lampyridae
% 209.97/210.17 |- skos__scopeNote mesh__D048888
% 209.97/210.17 The family Lampyidae, which are bioluminescent BEETLES. They contain FIREFLY LUCIFERIN and LUCIFERASES. Oxidation of firefly luciferin results in luminescence.%A%
% 209.97/210.17 |- skos__historyNote mesh__D015903 Photogrammetry %28%1974-1989%29%
% 209.97/210.17 |- skos__hiddenLabel mesh__D015903 Photograph, Moire
% 209.97/210.17 |- mesh__dateRevised mesh__D015903 2001-08-13
% 209.97/210.17 |- skos__hiddenLabel mesh__D015903 Pattern, Moire
% 209.97/210.17 |- mesh__recordOriginator mesh__D015903 PLS
% 209.97/210.17 |- mesh__dateCreated mesh__D015903 1989-05-15
% 209.97/210.17 |- skos__historyNote mesh__D015903 Interferometry %28%1977-1989%29%
% 209.97/210.17 |- skos__broader mesh__D015903smesh__D010780
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D015903 2006
% 209.97/210.17 |- skos__hiddenLabel mesh__D015903 Photographs, Moire
% 209.97/210.17 |- mesh__historyNote mesh__D015903 90
% 209.97/210.17 |- skos__annotation mesh__D015903
% 209.97/210.17 in titles %26% translations spell moir%C3%%A9%; DF: MOIRE TOPOGR
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D015903 2004
% 209.97/210.17 |- skos__hiddenLabel mesh__D015903 Moire Photograph
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D015903 2005
% 209.97/210.17 |- skos__hiddenLabel mesh__D015903 Patterns, Moire
% 209.97/210.17 |- rdf__type mesh__D015903sskos__Concept
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D015903 2003
% 209.97/210.17 |- mesh__dateEstablished mesh__D015903 1990-01-01
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D015903 sjn
% 209.97/210.17 |- skos__broader mesh__D015903smesh__D007368
% 209.97/210.17 |- skos__scopeNote mesh__D015903
% 209.97/210.17 A method of three-dimensional morphometry in which contour maps are produced from the overlapping interference fringes created when an object is illuminated by beams of coherent light issuing from two different point sources.%A%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D015903 2002
% 209.97/210.17 |- skos__hiddenLabel mesh__D015903 Moire Pattern
% 209.97/210.17 |- skos__prefLabel mesh__D015903 Moire Topography
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D015903 90
% 209.97/210.17 |- mesh__recordMaintainer mesh__D015903 jls
% 209.97/210.17 |- skos__altLabel mesh__D015903 Topography, Moire
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D015105 2004
% 209.97/210.17 |- mesh__onlineNote mesh__D015105
% 209.97/210.17 use 3%27%,5%27%-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE to search 3%27%,5%27%-CYCLIC AMP PHOSPHODIESTERASE 1975-93%A%
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105 3,5 Cyclic AMP 5 Nucleotidohydrolase
% 209.97/210.17 |- rdf__type mesh__D015105sskos__Concept
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105 3%27%,5%27% Nucleotide Phosphodiesterase
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 3%27%,5%27% Cyclic AMP 5%27% Nucleotidohydrolase
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 Phosphodiesterase, 3%27%,5%27%-Cyclic Nucleotide
% 209.97/210.17 |- mesh__dateEstablished mesh__D015105 1978-01-01
% 209.97/210.17 |- mesh__historyNote mesh__D015105
% 209.97/210.17 94; was 3%27%,5%27%-CYCLIC AMP PHOSPHODIESTERASE 1975-93 %28%see under PHOSPHODIESTERASES 1975-77%29%%A%
% 209.97/210.17 |- skos__altLabel mesh__D015105 3%27%,5%27%-Cyclic AMP Phosphodiesterase
% 209.97/210.17 |- mesh__dateRevised mesh__D015105 2003-07-09
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 Phosphodiesterase, 3%27%,5%27%-Cyclic AMP
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 AMP 5%27%-Nucleotidohydrolase, 3%27%,5%27%-Cyclic
% 209.97/210.17 |- skos__altLabel mesh__D015105
% 209.97/210.17 3%27%,5%27%-Cyclic AMP 5%27%-Nucleotidohydrolase
% 209.97/210.17 |- skos__scopeNote mesh__D015105
% 209.97/210.17 An enzyme that catalyzes the hydrolysis of cyclic AMP to form adenosine 5%27%-phosphate. The enzyme is widely distributed in animal tissue and controls the level of intracellular cyclic AMP. Also acts on 3%27%,5%27%-cyclic IMP and 3%27%,5%27%-cyclic GMP. EC 3.1.4.17.%A%
% 209.97/210.17 |- mesh__dateCreated mesh__D015105 1974-11-11
% 209.97/210.17 |- skos__altLabel mesh__D015105 CAMP Phosphodiesterase
% 209.97/210.17 |- skos__prefLabel mesh__D015105
% 209.97/210.17 3%27%,5%27%-Cyclic-Nucleotide Phosphodiesterase
% 209.97/210.17 |- skos__historyNote mesh__D015105 Phosphodiesterases %28%1973-1974%29%
% 209.97/210.17 |- skos__broader mesh__D015105smesh__D010727
% 209.97/210.17 |- mesh__recordOriginator mesh__D015105 NLM
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 AMP Phosphodiesterase, 3%27%,5%27%-Cyclic
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105 AMP Phosphodiesterase, 3,5-Cyclic
% 209.97/210.17 |- skos__altLabel mesh__D015105
% 209.97/210.17 3%27%,5%27%-Cyclic Nucleotide Phosphodiesterase
% 209.97/210.17 |- skos__altLabel mesh__D015105 3%27%,5%27% Cyclic AMP Phosphodiesterase
% 209.97/210.17 |- mesh__recordMaintainer mesh__D015105 ssb
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105 Phosphodiesterase, CAMP
% 209.97/210.17 |- skos__annotation mesh__D015105
% 209.97/210.17 regulation: consider also CALMODULIN; DF: 3 5 CYCL NPD
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D015105 2005
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D015105 sjn
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105 5-Nucleotidohydrolase, 3,5-Cyclic AMP
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 Phosphodiesterase, 3%27%,5%27%-Cyclic-Nucleotide
% 209.97/210.17 |- skos__historyNote mesh__D015105
% 209.97/210.17 Adenosine Cyclic Monophosphate %28%1973-1974%29%
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105 AMP 5-Nucleotidohydrolase, 3,5-Cyclic
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 Nucleotide Phosphodiesterase, 3%27%,5%27%-Cyclic
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 Phosphodiesterase, 3%27%,5%27%-Cyclic-AMP
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 Phosphodiesterase, 3%27%,5%27%-Nucleotide
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105 Calmodulin Dependent Phosphodiesterase
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D015105 2006
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 5%27%-Nucleotidohydrolase, 3%27%,5%27%-Cyclic AMP
% 209.97/210.17 |- skos__altLabel mesh__D015105 3,5-Cyclic AMP 5-Nucleotidohydrolase
% 209.97/210.17 |- skos__altLabel mesh__D015105 3%27%,5%27%-Nucleotide Phosphodiesterase
% 209.97/210.17 |- skos__altLabel mesh__D015105 3%27%,5%27%-Cyclic-AMP Phosphodiesterase
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105
% 209.97/210.17 3%27%,5%27% Cyclic Nucleotide Phosphodiesterase
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105 Phosphodiesterase, 3,5-Cyclic AMP
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D015105
% 209.97/210.17 94; was 3%27%,5%27%-CYCLIC AMP PHOSPHODIESTERASE 1975-93 %28%see under PHOSPHODIESTERASES 1975-77%29%%A%
% 209.97/210.17 |- skos__hiddenLabel mesh__D015105 3,5 Cyclic AMP Phosphodiesterase
% 209.97/210.17 |- skos__altLabel mesh__D015105 3,5-Cyclic AMP Phosphodiesterase
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 alpha 1 Chimaerin
% 209.97/210.17 |- mesh__recordOriginator mesh__D020848 jmp
% 209.97/210.17 |- skos__broader mesh__D020848smesh__D020740
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D020848 2005
% 209.97/210.17 |- skos__altLabel mesh__D020848 rhoGAP2 Protein
% 209.97/210.17 |- skos__altLabel mesh__D020848 alpha-1 Chimaerin
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 Chimaerin, alpha-2
% 209.97/210.17 |- mesh__historyNote mesh__D020848
% 209.97/210.17 2000; use CHIMERIN 1 %28%NM%29% 1990-1999; for ALPHA1-CHIMAERIN use GTPASE-ACTIVATING PROTEINS %28%NM%29% 1996-1999%A%
% 209.97/210.17 |- skos__altLabel mesh__D020848 alpha-2 Chimaerin
% 209.97/210.17 |- skos__altLabel mesh__D020848 alpha-Chimerin
% 209.97/210.17 |- skos__altLabel mesh__D020848 alpha-Chimaerin
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 alpha Chimaerin
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 alpha 1 Chimerin
% 209.97/210.17 |- skos__altLabel mesh__D020848 arhGAP2 Protein
% 209.97/210.17 |- mesh__recordMaintainer mesh__D020848 jmp
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 Chimerin, alpha-2
% 209.97/210.17 |- skos__altLabel mesh__D020848 alpha-1 Chimerin
% 209.97/210.17 |- mesh__dateRevised mesh__D020848 2004-07-07
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 n Chimaerin
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 alpha 2 Chimaerin
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D020848
% 209.97/210.17 2000; N-CHIMAERIN %28%now CHIMERIN 1%29% was indexed under NERVE TISSUE PROTEINS 1990-1999; ALPHA1-CHIMAERIN was indexed under PROTEINS 1996-1999%A%
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 alpha1 Chimaerin
% 209.97/210.17 |- skos__altLabel mesh__D020848 n-Chimaerin
% 209.97/210.17 |- mesh__dateCreated mesh__D020848 1999-11-03
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 alpha 2 Chimerin
% 209.97/210.17 |- mesh__dateEstablished mesh__D020848 2000-01-01
% 209.97/210.17 |- skos__historyNote mesh__D020848 Nerve Tissue Proteins %28%1991-1999%29%
% 209.97/210.17 |- skos__altLabel mesh__D020848 n-Chimerin
% 209.97/210.17 |- skos__prefLabel mesh__D020848 Chimerin 1
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D020848 sjn
% 209.97/210.17 |- rdf__type mesh__D020848sskos__Concept
% 209.97/210.17 |- skos__scopeNote mesh__D020848
% 209.97/210.17 A GTPase activating protein that is specific for RAC GTP-BINDING PROTEINS. It is expressed primarily in the brain and may be involved in signal transduction. The alternatively spliced form of CHIMERIN 1 %28%alpha-2 Chimerin%29% contains an additional src homology domain and is expressed in both the brain and testes.%A%
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 Chimerin, alpha-1
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D020848 2006
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 alpha Chimerin
% 209.97/210.17 |- skos__hiddenLabel mesh__D020848 Chimaerin, alpha-1
% 209.97/210.17 |- skos__altLabel mesh__D020848 alpha1-Chimaerin
% 209.97/210.17 |- skos__altLabel mesh__D020848 Chimaerin 1
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D006379 2005
% 209.97/210.17 |- mesh__recordOriginator mesh__D006379 NLM
% 209.97/210.17 |- mesh__dateEstablished mesh__D006379 1979-01-01
% 209.97/210.17 |- skos__annotation mesh__D006379 no qualif
% 209.97/210.17 |- mesh__dateCreated mesh__D006379 1974-11-19
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D006379 2006
% 209.97/210.17 |- skos__hiddenLabel mesh__D006379 Behavior, Helping
% 209.97/210.17 |- skos__hiddenLabel mesh__D006379 Helping Behaviors
% 209.97/210.17 |- skos__prefLabel mesh__D006379 Helping Behavior
% 209.97/210.17 |- mesh__recordMaintainer mesh__D006379 JLS
% 209.97/210.17 |- mesh__historyNote mesh__D006379
% 209.97/210.17 79%28%75%29%; was see under SOCIAL BEHAVIOR 1975-78
% 209.97/210.17 |- skos__hiddenLabel mesh__D006379 Behaviors, Helping
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D006379 2003
% 209.97/210.17 |- mesh__dateRevised mesh__D006379 2002-07-02
% 209.97/210.17 |- skos__scopeNote mesh__D006379
% 209.97/210.17 Behaviors associated with the giving of assistance or aid to individuals.%A%
% 209.97/210.17 |- skos__historyNote mesh__D006379
% 209.97/210.17 Interpersonal Relations %28%1969-1974%29%
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D006379
% 209.97/210.17 79; was see under SOCIAL BEHAVIOR 1975-78
% 209.97/210.17 |- skos__broader mesh__D006379smesh__D012919
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D006379 2004
% 209.97/210.17 |- skos__historyNote mesh__D006379 Social Behavior %28%1969-1974%29%
% 209.97/210.17 |- rdf__type mesh__D006379sskos__Concept
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D006379 sjn
% 209.97/210.17 |- skos__historyNote mesh__D006379 specific interpersonal relations heading
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 2000
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 1994
% 209.97/210.17 |- skos__hiddenLabel mesh__D003081 Cold Climates
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 1999
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 2006
% 209.97/210.17 |- skos__hiddenLabel mesh__D003081 Polar Region
% 209.97/210.17 |- skos__broader mesh__D003081smesh__D002980
% 209.97/210.17 |- skos__hiddenLabel mesh__D003081 Climates, Cold
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 2001
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 1995
% 209.97/210.17 |- rdf__type mesh__D003081sskos__Concept
% 209.97/210.17 |- skos__hiddenLabel mesh__D003081 Region, Polar
% 209.97/210.17 |- skos__hiddenLabel mesh__D003081 Regions, Polar
% 209.97/210.17 |- skos__prefLabel mesh__D003081 Cold Climate
% 209.97/210.17 |- mesh__onlineNote mesh__D003081
% 209.97/210.17 use COLD CLIMATE to search POLAR REGIONS 1966-77
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 2002
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 1996
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 2003
% 209.97/210.17 |- mesh__recordOriginator mesh__D003081 NLM
% 209.97/210.17 |- skos__hiddenLabel mesh__D003081 Climate, Cold
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 1997
% 209.97/210.17 |- mesh__dateCreated mesh__D003081 1999-01-01
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 2004
% 209.97/210.17 |- mesh__dateRevised mesh__D003081 1992-05-18
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D003081 PLS
% 209.97/210.17 |- mesh__recordMaintainer mesh__D003081 TAP
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 1993
% 209.97/210.17 |- mesh__historyNote mesh__D003081
% 209.97/210.17 POLAR REGIONS was see under COLD CLIMATE 1963-77
% 209.97/210.17 |- skos__annotation mesh__D003081
% 209.97/210.17 specify for Polar Region cold climate ARCTIC REGIONS or ANTARCTIC REGIONS if pertinent; specify other geog for cold climate if pertinent%A%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 1998
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D003081 2005
% 209.97/210.17 |- skos__annotation mesh__D011513
% 209.97/210.17 infection: coord IM with PROTEUS INFECTIONS %28%IM%29%
% 209.97/210.17 |- skos__broader mesh__D011513smesh__D011511
% 209.97/210.17 |- mesh__recordOriginator mesh__D011513 NLM
% 209.97/210.17 |- mesh__dateEstablished mesh__D011513 1974-01-01
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D011513 2006
% 209.97/210.17 |- rdf__type mesh__D011513sskos__Concept
% 209.97/210.17 |- mesh__recordMaintainer mesh__D011513 SYSTEM
% 209.97/210.17 |- mesh__historyNote mesh__D011513 74%28%72%29%
% 209.97/210.17 |- skos__prefLabel mesh__D011513 Proteus mirabilis
% 209.97/210.17 |- mesh__dateCreated mesh__D011513 1999-01-01
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D011513 sjn
% 209.97/210.17 |- skos__scopeNote mesh__D011513
% 209.97/210.17 A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.%A%
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D011513 74
% 209.97/210.17 |- mesh__dateRevised mesh__D011513 2005-06-30
% 209.97/210.17 |- skos__historyNote mesh__D011513 Proteus %28%1966-1971%29%
% 209.97/210.17 |- skos__prefLabel mesh__D035961 Alismatidae
% 209.97/210.17 |- mesh__dateEstablished mesh__D035961 2003-01-01
% 209.97/210.17 |- rdf__type mesh__D035961sskos__Concept
% 209.97/210.17 |- mesh__dateCreated mesh__D035961 2002-07-02
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035961 2005
% 209.97/210.17 |- skos__scopeNote mesh__D035961
% 209.97/210.17 A plant subclass of the class Liliopsida %28%monocotyledons%29% in the Chronquist classification system. This is equivalent to the Alismatales order in the APG classification system. It is a primitive group of more or less aquatic plants.%A%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035961 2006
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D035961 2003
% 209.97/210.17 |- skos__annotation mesh__D035961
% 209.97/210.17 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035961 2003
% 209.97/210.17 |- skos__broader mesh__D035961smesh__D019684
% 209.97/210.17 |- skos__altLabel mesh__D035961 Alismatales
% 209.97/210.17 |- mesh__historyNote mesh__D035961 2003
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035961 2004
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Steroid Esterase, Lipoidal
% 209.97/210.17 |- skos__altLabel mesh__D002787 Sterol Ester Acylhydrolase
% 209.97/210.17 |- mesh__dateCreated mesh__D002787 1974-11-19
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Hydrolase, 15-Ketosteryl Oleate
% 209.97/210.17 |- skos__altLabel mesh__D002787 Hormone-Sensitive Lipase
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D002787 2004
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D002787 sjn
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Lipase, Acylcholesterol
% 209.97/210.17 |- skos__altLabel mesh__D002787 Cholesterylester Hydrolase
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Lipase, Hormone-Sensitive
% 209.97/210.17 |- skos__altLabel mesh__D002787 Acylcholesterol Lipase
% 209.97/210.17 |- mesh__recordOriginator mesh__D002787 NLM
% 209.97/210.17 |- skos__altLabel mesh__D002787 Cholesterol Ester Hydrolase
% 209.97/210.17 |- skos__historyNote mesh__D002787 Cholesterol %28%1973-1974%29%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D002787 2005
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Hydrolase, Cholesteryl Oleate
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Hydrolase, Cholesterol Ester
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 15 Ketosteryl Oleate Hydrolase
% 209.97/210.17 |- skos__altLabel mesh__D002787 Steroid Hormone Esterase
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Esterase, Lipoidal Steroid
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Esterase, Cholesterol
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Acylhydrolase, Sterol Ester
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D002787 2006
% 209.97/210.17 |- mesh__historyNote mesh__D002787
% 209.97/210.17 91%28%75%29%; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A%
% 209.97/210.17 |- skos__altLabel mesh__D002787 Lipoidal Steroid Esterase
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Hydrolase, Cholesterylester
% 209.97/210.17 |- skos__broader mesh__D002787smesh__D002265
% 209.97/210.17 |- skos__scopeNote mesh__D002787
% 209.97/210.17 An enzyme that catalyzes the hydrolysis of cholesterol and some other sterol esters, to liberate cholesterol plus a fatty acid anion. EC 3.1.1.13.%A%
% 209.97/210.17 |- mesh__recordMaintainer mesh__D002787 ssb
% 209.97/210.17 |- skos__altLabel mesh__D002787 Cholesteryl Oleate Hydrolase
% 209.97/210.17 |- mesh__dateEstablished mesh__D002787 1991-01-01
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Esterase, Steroid Hormone
% 209.97/210.17 |- mesh__dateRevised mesh__D002787 2003-07-09
% 209.97/210.17 |- rdf__type mesh__D002787sskos__Concept
% 209.97/210.17 |- skos__prefLabel mesh__D002787 Cholesterol Esterase
% 209.97/210.17 |- skos__historyNote mesh__D002787 Esterases %28%1973-1974%29%
% 209.97/210.17 |- skos__hiddenLabel mesh__D002787 Hormone Sensitive Lipase
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D002787
% 209.97/210.17 91; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A%
% 209.97/210.17 |- skos__altLabel mesh__D035163 Salmalia malabaricum
% 209.97/210.17 |- skos__scopeNote mesh__D035163
% 209.97/210.17 A plant genus of the family BOMBACACEAE. The fine silky hairs covering the seeds have been used like kapok %28%CEIBA%29% for floatation, stuffing, and insulation.%A%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035163 2004
% 209.97/210.17 |- mesh__dateCreated mesh__D035163 2002-07-02
% 209.97/210.17 |- mesh__dateEstablished mesh__D035163 2003-01-01
% 209.97/210.17 |- skos__broader mesh__D035163smesh__D035161
% 209.97/210.17 |- skos__prefLabel mesh__D035163 Bombax
% 209.97/210.17 |- rdf__type mesh__D035163sskos__Concept
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D035163 2003
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035163 2005
% 209.97/210.17 |- skos__annotation mesh__D035163
% 209.97/210.17 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035163 2003
% 209.97/210.17 |- mesh__historyNote mesh__D035163 2003
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D035163 2006
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D021941 sjn
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D021941 2004
% 209.97/210.17 |- mesh__recordOriginator mesh__D021941 nns
% 209.97/210.17 |- rdf__type mesh__D021941sskos__Concept
% 209.97/210.17 |- skos__broader mesh__D021941smesh__D003034
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D021941 2006
% 209.97/210.17 |- skos__broader mesh__D021941smesh__D018699
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D021941 2005
% 209.97/210.17 |- skos__prefLabel mesh__D021941 Caveolae
% 209.97/210.17 |- skos__broader mesh__D021941smesh__D021962
% 209.97/210.17 |- mesh__recordMaintainer mesh__D021941 nns
% 209.97/210.17 |- skos__related mesh__D021941smesh__D022461
% 209.97/210.17 |- skos__hiddenLabel mesh__D021941 Caveolas
% 209.97/210.17 |- mesh__dateCreated mesh__D021941 2000-06-27
% 209.97/210.17 |- mesh__historyNote mesh__D021941 2001
% 209.97/210.17 |- skos__scopeNote mesh__D021941
% 209.97/210.17 Endocytic/exocytic CELL MEMBRANE STRUCTURES rich in glycosphingolipids, cholesterol, and lipid-anchored membrane proteins that function in ENDOCYTOSIS %28%potocytosis%29%, transcytosis, and SIGNAL TRANSDUCTION. Caveolae assume various shapes from open pits to closed vesicles. Caveolar coats are composed of CAVEOLINS.%A%
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D021941 2001
% 209.97/210.17 |- skos__historyNote mesh__D021941 Cell Membrane %28%1971-2000%29%
% 209.97/210.17 |- mesh__dateRevised mesh__D021941 2003-07-09
% 209.97/210.17 |- mesh__dateEstablished mesh__D021941 2001-01-01
% 209.97/210.17 |- skos__altLabel mesh__D021941 Caveola
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007472 2003
% 209.97/210.17 |- rdf__type mesh__D007472sskos__Concept
% 209.97/210.17 |- mesh__recordOriginator mesh__D007472 RLS
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007472 2004
% 209.97/210.17 |- mesh__recordAuthorizer mesh__D007472 sjn
% 209.97/210.17 |- mesh__dateRevised mesh__D007472 2001-07-25
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007472 2005
% 209.97/210.17 |- mesh__historyNote mesh__D007472 87
% 209.97/210.17 |- skos__broader mesh__D007472smesh__D014283
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007472 2002
% 209.97/210.17 |- mesh__dateCreated mesh__D007472 1986-06-03
% 209.97/210.17 |- mesh__activeMeSHYear mesh__D007472 2006
% 209.97/210.17 |- mesh__dateEstablished mesh__D007472 1987-01-01
% 209.97/210.17 |- mesh__recordMaintainer mesh__D007472 jmp
% 209.97/210.17 |- skos__historyNote mesh__D007472 Triiodobenzoic Acids %28%1972-1986%29%
% 209.97/210.17 |- mesh__publicMeSHNote mesh__D007472 87
% 209.97/210.17 |- skos__altLabel mesh__D007472 Iohexol 350
% 209.97/210.17 |- skos__prefLabel mesh__D007472 Iohexol
% 209.97/210.17 |- skos__scopeNote mesh__D007472
% 209.97/210.17 An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.%A%
% 209.97/210.17 |- skos__historyNote mesh__D048889 Beetles %28%1965-2004%29%
% 209.97/210.17 |- skos__prefLabel mesh__D048889 Weevils
% 209.97/210.17 |- mesh__dateCreated mesh__D048889 2004-07-07
% 209.97/210.17 |- rdf__type mesh__D048889sskos__Concept
% 209.97/210.17 |- skos__historyNote mesh__D048889 Coleoptera %28%1974-2004%29%
% 209.97/210.17 |- mesh__recordOriginator mesh__D048889 ags
% 209.97/210.17 |- mesh__dateEstablished mesh__D048889 2005-01-01
% 209.97/210.17 |- skos__broader mesh__D048889smesh__D001517
% 209.97/210.18 |- mesh__publicMeSHNote mesh__D048889 2005
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D048889 2005
% 209.97/210.18 |- skos__scopeNote mesh__D048889
% 209.97/210.18 BEETLES in the family Curculionidae and the largest family in the order COLEOPTERA. They have a markedly convex shape and many are considered pests.%A%
% 209.97/210.18 |- mesh__recordMaintainer mesh__D048889 ags
% 209.97/210.18 |- mesh__historyNote mesh__D048889 2005
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D048889 2006
% 209.97/210.18 |- mesh__recordAuthorizer mesh__D048889 sjn
% 209.97/210.18 |- skos__altLabel mesh__D048889 Curculionidae
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Bilio Pancreatic Bypass
% 209.97/210.18 |- mesh__dateCreated mesh__D015904 1989-05-15
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Bypasses, Bilio Pancreatic
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D015904 2003
% 209.97/210.18 |- skos__altLabel mesh__D015904 Bilio-Pancreatic Diversion
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Pancreatic Diversions, Bilio
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Bilio-Pancreatic Bypasses
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Pancreatic Diversion, Bilio
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Biliopancreatic Bypasses
% 209.97/210.18 |- skos__annotation mesh__D015904
% 209.97/210.18 do not use /util except by MeSH definition
% 209.97/210.18 |- skos__altLabel mesh__D015904 Biliopancreatic Bypass
% 209.97/210.18 |- skos__historyNote mesh__D015904 Jejunoileal Bypass %28%1987-1989%29%
% 209.97/210.18 |- skos__historyNote mesh__D015904 Duodenum/surgery %28%1977-1986%29%
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Bypasses, Biliopancreatic
% 209.97/210.18 |- skos__altLabel mesh__D015904 Bilio Pancreatic Bypasses
% 209.97/210.18 |- skos__historyNote mesh__D015904 Jejunum/surgery %28%1977-1986%29%
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D015904 2004
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Bypass, Bilio-Pancreatic
% 209.97/210.18 |- mesh__historyNote mesh__D015904 90
% 209.97/210.18 |- mesh__recordOriginator mesh__D015904 PLS
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D015904 2005
% 209.97/210.18 |- mesh__dateRevised mesh__D015904 2002-10-23
% 209.97/210.18 |- skos__prefLabel mesh__D015904 Biliopancreatic Diversion
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Diversions, Bilio-Pancreatic
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Pancreatic Bypasses, Bilio
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Diversions, Bilio Pancreatic
% 209.97/210.18 |- skos__historyNote mesh__D015904 Obesity/therapy %28%1977-1989%29%
% 209.97/210.18 |- mesh__recordMaintainer mesh__D015904 sjn
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Bilio-Pancreatic Diversions
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Diversion, Bilio-Pancreatic
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Diversions, Biliopancreatic
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D015904 2006
% 209.97/210.18 |- skos__altLabel mesh__D015904 Bilio-Pancreatic Bypass
% 209.97/210.18 |- skos__broader mesh__D015904smesh__D013505
% 209.97/210.18 |- skos__historyNote mesh__D015904
% 209.97/210.18 Obesity, Morbid/therapy %28%1987-1989%29%
% 209.97/210.18 |- skos__scopeNote mesh__D015904
% 209.97/210.18 A surgical procedure which diverts pancreatobiliary secretions via the duodenum and the jejunum into the colon, the remaining small intestine being anastomosed to the stomach after antrectomy. The procedure produces less diarrhea than does jejunoileal bypass.%A%
% 209.97/210.18 |- mesh__recordAuthorizer mesh__D015904 sjn
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D015904 2003A
% 209.97/210.18 |- mesh__publicMeSHNote mesh__D015904 90
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Bypass, Biliopancreatic
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Bilio Pancreatic Diversion
% 209.97/210.18 |- skos__altLabel mesh__D015904 Bilio Pancreatic Diversions
% 209.97/210.18 |- skos__broader mesh__D015904smesh__D001662
% 209.97/210.18 |- rdf__type mesh__D015904sskos__Concept
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Bypasses, Bilio-Pancreatic
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Diversion, Bilio Pancreatic
% 209.97/210.18 |- mesh__dateEstablished mesh__D015904 1990-01-01
% 209.97/210.18 |- skos__historyNote mesh__D015904 Gastric Bypass %28%1989%29%
% 209.97/210.18 |- skos__hiddenLabel mesh__D015904 Biliopancreatic Diversions
% 209.97/210.18 |- mesh__onlineNote mesh__D015106
% 209.97/210.18 use 3%27%,5%27%-CYCLIC-GMP PHOSPHODIESTERASE to search 3%27%,5%27%-CYCLIC GMP PHOSPHODIESTERASE 1978-93%A%
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D015106 2005
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106
% 209.97/210.18 Phosphodiesterase, 3%27%,5%27%-Cyclic-GMP
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106
% 209.97/210.18 GMP Phosphodiesterase, 3%27%,5%27%-Cyclic
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106
% 209.97/210.18 3%27%,5%27% Cyclic GMP 5%27% Nucleotidohydrolase
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D015106 2004
% 209.97/210.18 |- mesh__recordMaintainer mesh__D015106 ssb
% 209.97/210.18 |- mesh__historyNote mesh__D015106
% 209.97/210.18 94; was 3%27%,5%27%-CYCLIC GMP PHOSPHODIESTERASE 1978-93
% 209.97/210.18 |- skos__prefLabel mesh__D015106 3%27%,5%27%-Cyclic-GMP Phosphodiesterase
% 209.97/210.18 |- mesh__recordOriginator mesh__D015106 RLS
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106 GMP Phosphodiesterase, 3,5-Cyclic
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D015106 2006
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106 5-Nucleotidohydrolase, 3,5-Cyclic GMP
% 209.97/210.18 |- skos__altLabel mesh__D015106 3,5-Cyclic GMP Phosphodiesterase
% 209.97/210.18 |- mesh__dateEstablished mesh__D015106 1978-01-01
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106 3,5 Cyclic GMP 5 Nucleotidohydrolase
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106 Phosphodiesterase, 3,5-Cyclic GMP
% 209.97/210.18 |- skos__broader mesh__D015106smesh__D010727
% 209.97/210.18 |- skos__historyNote mesh__D015106 Phosphodiesterases %28%1972-1977%29%
% 209.97/210.18 |- mesh__recordAuthorizer mesh__D015106 sjn
% 209.97/210.18 |- skos__annotation mesh__D015106 DF: CYCL GMP PHOSPHODIESTERASE
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106 3,5 Cyclic GMP Phosphodiesterase
% 209.97/210.18 |- rdf__type mesh__D015106sskos__Concept
% 209.97/210.18 |- skos__altLabel mesh__D015106 3%27%,5%27%-Cyclic GMP Phosphodiesterase
% 209.97/210.18 |- skos__historyNote mesh__D015106
% 209.97/210.18 Guanosine Cyclic Monophosphate %28%1971-1977%29%
% 209.97/210.18 |- mesh__dateRevised mesh__D015106 2003-07-09
% 209.97/210.18 |- skos__scopeNote mesh__D015106
% 209.97/210.18 An enzyme that catalyzes the hydrolysis of cyclic GMP to yield guanosine-5%27%-phosphate. EC 3.1.4.35.%A%
% 209.97/210.18 |- mesh__publicMeSHNote mesh__D015106
% 209.97/210.18 94; was 3%27%,5%27%-CYCLIC GMP PHOSPHODIESTERASE 1978-93
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106 GMP 5-Nucleotidohydrolase, 3,5-Cyclic
% 209.97/210.18 |- skos__altLabel mesh__D015106 3,5-Cyclic GMP 5-Nucleotidohydrolase
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106
% 209.97/210.18 GMP 5%27%-Nucleotidohydrolase, 3%27%,5%27%-Cyclic
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106 3%27%,5%27% Cyclic GMP Phosphodiesterase
% 209.97/210.18 |- skos__altLabel mesh__D015106
% 209.97/210.18 3%27%,5%27%-Cyclic GMP 5%27%-Nucleotidohydrolase
% 209.97/210.18 |- mesh__dateCreated mesh__D015106 1977-05-20
% 209.97/210.18 |- skos__hiddenLabel mesh__D015106
% 209.97/210.18 Phosphodiesterase, 3%27%,5%27%-Cyclic GMP
% 209.97/210.18 |- mesh__dateEstablished mesh__D020849 2000-01-01
% 209.97/210.18 |- skos__altLabel mesh__D020849 Keoxifene
% 209.97/210.18 |- mesh__historyNote mesh__D020849
% 209.97/210.18 2000; use RALOXIFENE %28%NM%29% 1983-1999
% 209.97/210.18 |- mesh__dateCreated mesh__D020849 1999-11-03
% 209.97/210.18 |- mesh__recordAuthorizer mesh__D020849 sjn
% 209.97/210.18 |- mesh__dateRevised mesh__D020849 2005-06-30
% 209.97/210.18 |- skos__hiddenLabel mesh__D020849 139481, LY
% 209.97/210.18 |- mesh__publicMeSHNote mesh__D020849
% 209.97/210.18 2000; LY 139481 %28%now RALOXIFENE%29% was indexed under PIPERIDINES 1983-1999%A%
% 209.97/210.18 |- skos__altLabel mesh__D020849 LY 139481
% 209.97/210.18 |- skos__altLabel mesh__D020849 LY 156758
% 209.97/210.18 |- skos__hiddenLabel mesh__D020849 Hydrochloride, Keoxifene
% 209.97/210.18 |- skos__historyNote mesh__D020849 Piperidines %28%1983-1999%29%
% 209.97/210.18 |- skos__hiddenLabel mesh__D020849 LY156758
% 209.97/210.18 |- skos__prefLabel mesh__D020849 Raloxifene
% 209.97/210.18 |- skos__hiddenLabel mesh__D020849 LY139481
% 209.97/210.18 |- skos__broader mesh__D020849smesh__D013629
% 209.97/210.18 |- rdf__type mesh__D020849sskos__Concept
% 209.97/210.18 |- skos__scopeNote mesh__D020849
% 209.97/210.18 A second generation selective estrogen receptor modulator %28%SERM%29% used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.%A%
% 209.97/210.18 |- mesh__recordOriginator mesh__D020849 adp
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D020849 2006
% 209.97/210.18 |- mesh__recordMaintainer mesh__D020849 ssb
% 209.97/210.18 |- skos__hiddenLabel mesh__D020849 156758, LY
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 2004
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 2006
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 1996
% 209.97/210.18 |- skos__prefLabel mesh__D003880 Dermatology
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 2002
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 1998
% 209.97/210.18 |- mesh__recordOriginator mesh__D003880 NLM
% 209.97/210.18 |- skos__scopeNote mesh__D003880
% 209.97/210.18 A medical specialty concerned with the skin, its structure, functions, diseases, and treatment.%A%
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 1997
% 209.97/210.18 |- skos__related mesh__D003880smesh__D012871
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 1999
% 209.97/210.18 |- mesh__dateRevised mesh__D003880 1994-02-08
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 1995
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 2000
% 209.97/210.18 |- rdf__type mesh__D003880sskos__Concept
% 209.97/210.18 |- skos__annotation mesh__D003880 SPEC: SPEC qualif; DF: DERMATOL
% 209.97/210.18 |- mesh__recordAuthorizer mesh__D003880 PLS
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 2003
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 2001
% 209.97/210.18 |- mesh__recordMaintainer mesh__D003880 TGC
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003880 2005
% 209.97/210.18 |- mesh__dateCreated mesh__D003880 1999-01-01
% 209.97/210.18 |- skos__broader mesh__D003880smesh__D013040
% 209.97/210.18 |- mesh__recordOriginator mesh__D003082 NLM
% 209.97/210.18 |- skos__annotation mesh__D003082
% 209.97/210.18 do not use /util except by MeSH definition
% 209.97/210.18 |- skos__scopeNote mesh__D003082
% 209.97/210.18 Excision of a portion of the colon or of the whole colon. %28%Dorland, 28th ed%29%%A%
% 209.97/210.18 |- skos__prefLabel mesh__D003082 Colectomy
% 209.97/210.18 |- mesh__publicMeSHNote mesh__D003082 65
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003082 2002
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003082 2006
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003082 1999
% 209.97/210.18 |- mesh__historyNote mesh__D003082 65
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003082 2001
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003082 2005
% 209.97/210.18 |- mesh__activeMeSHYear mesh__D003082 1998
% 209.97/210.18 |- skos__hiddenLabel mesh__D003082 Colectomies
% 209.97/210.18 |- mesh__dateCreated mesh__D003082 1999-01-01
% 210.03/210.18 |- mesh__dateRevised mesh__D003082 1997-06-20
% 210.03/210.18 |- rdf__type mesh__D003082sskos__Concept
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003082 2000
% 210.03/210.18 |- mesh__dateEstablished mesh__D003082 1965-01-01
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003082 2004
% 210.03/210.18 |- mesh__recordMaintainer mesh__D003082 PXP
% 210.03/210.18 |- mesh__recordAuthorizer mesh__D003082 SJN
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003082 2003
% 210.03/210.18 |- skos__broader mesh__D003082smesh__D013505
% 210.03/210.18 |- mesh__publicMeSHNote mesh__D011514 74
% 210.03/210.18 |- skos__scopeNote mesh__D011514
% 210.03/210.18 A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in soil, fecal matter, and sewage. It is an opportunistic pathogen and causes cystitis and pyelonephritis.%A%
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D011514 2006
% 210.03/210.18 |- mesh__dateRevised mesh__D011514 2005-06-30
% 210.03/210.18 |- skos__historyNote mesh__D011514 Proteus %28%1966-1971%29%
% 210.03/210.18 |- skos__annotation mesh__D011514
% 210.03/210.18 infection: coord IM with PROTEUS INFECTIONS %28%IM%29%
% 210.03/210.18 |- rdf__type mesh__D011514sskos__Concept
% 210.03/210.18 |- skos__broader mesh__D011514smesh__D011511
% 210.03/210.18 |- mesh__recordMaintainer mesh__D011514 SYSTEM
% 210.03/210.18 |- mesh__recordOriginator mesh__D011514 NLM
% 210.03/210.18 |- mesh__dateCreated mesh__D011514 1999-01-01
% 210.03/210.18 |- mesh__dateEstablished mesh__D011514 1974-01-01
% 210.03/210.18 |- mesh__historyNote mesh__D011514 74%28%72%29%
% 210.03/210.18 |- skos__prefLabel mesh__D011514 Proteus vulgaris
% 210.03/210.18 |- mesh__recordAuthorizer mesh__D011514 sjn
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D035962 2006
% 210.03/210.18 |- mesh__publicMeSHNote mesh__D035962 2003
% 210.03/210.18 |- skos__annotation mesh__D035962
% 210.03/210.18 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.03/210.18 |- mesh__historyNote mesh__D035962 2003
% 210.03/210.18 |- skos__broader mesh__D035962smesh__D035961
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D035962 2003
% 210.03/210.18 |- mesh__dateEstablished mesh__D035962 2003-01-01
% 210.03/210.18 |- mesh__dateCreated mesh__D035962 2002-07-03
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D035962 2004
% 210.03/210.18 |- skos__prefLabel mesh__D035962 Zosteraceae
% 210.03/210.18 |- skos__scopeNote mesh__D035962
% 210.03/210.18 A plant family of the order Najadales, subclass ALISMATIDAE, class Liliopsida %28%monocotyledons%29%. This is a group of perennial aquatic herbs with basal leaves.%A%
% 210.03/210.18 |- rdf__type mesh__D035962sskos__Concept
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D035962 2005
% 210.03/210.18 |- skos__hiddenLabel mesh__D002788 Esters, Cholesteryl
% 210.03/210.18 |- mesh__recordMaintainer mesh__D002788 ssb
% 210.03/210.18 |- mesh__historyNote mesh__D002788
% 210.03/210.18 78%28%76%29%; was see under CHOLESTEROL 1976-77
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D002788 2006
% 210.03/210.18 |- skos__historyNote mesh__D002788 Cholesterol %28%1966-1977%29%
% 210.03/210.18 |- skos__broader mesh__D002788smesh__D002784
% 210.03/210.18 |- skos__prefLabel mesh__D002788 Cholesterol Esters
% 210.03/210.18 |- mesh__dateCreated mesh__D002788 1975-07-25
% 210.03/210.18 |- skos__hiddenLabel mesh__D002788 Esters, Cholesterol
% 210.03/210.18 |- skos__scopeNote mesh__D002788
% 210.03/210.18 Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.%A%
% 210.03/210.18 |- rdf__type mesh__D002788sskos__Concept
% 210.03/210.18 |- mesh__dateRevised mesh__D002788 2003-07-09
% 210.03/210.18 |- mesh__recordAuthorizer mesh__D002788 sjn
% 210.03/210.18 |- skos__altLabel mesh__D002788 Cholesteryl Esters
% 210.03/210.18 |- mesh__dateEstablished mesh__D002788 1978-01-01
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D002788 2004
% 210.03/210.18 |- skos__historyNote mesh__D002788 Esters %28%1968-1977%29%
% 210.03/210.18 |- mesh__publicMeSHNote mesh__D002788
% 210.03/210.18 78; was see under CHOLESTEROL 1976-77
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D002788 2005
% 210.03/210.18 |- mesh__recordOriginator mesh__D002788 RLS
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D035164 2004
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D035164 2006
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D035164 2003
% 210.03/210.18 |- skos__broader mesh__D035164smesh__D035161
% 210.03/210.18 |- skos__annotation mesh__D035164
% 210.03/210.18 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D035164 2005
% 210.03/210.18 |- skos__scopeNote mesh__D035164
% 210.03/210.18 A plant genus of the family BOMBACACEAE. The fine silky hairs covering the seeds have been used for floatation, stuffing, and insulation.%A%
% 210.03/210.18 |- skos__prefLabel mesh__D035164 Ceiba
% 210.03/210.18 |- mesh__dateCreated mesh__D035164 2002-07-03
% 210.03/210.18 |- mesh__dateEstablished mesh__D035164 2003-01-01
% 210.03/210.18 |- skos__altLabel mesh__D035164 Kapok Tree
% 210.03/210.18 |- rdf__type mesh__D035164sskos__Concept
% 210.03/210.18 |- mesh__historyNote mesh__D035164 2003
% 210.03/210.18 |- mesh__publicMeSHNote mesh__D035164 2003
% 210.03/210.18 |- skos__hiddenLabel mesh__D007473 Channels, Ionic
% 210.03/210.18 |- mesh__dateCreated mesh__D007473 1978-05-19
% 210.03/210.18 |- mesh__publicMeSHNote mesh__D007473 79
% 210.03/210.18 |- mesh__recordMaintainer mesh__D007473 SYSTEM
% 210.03/210.18 |- skos__altLabel mesh__D007473 Ionic Channel
% 210.03/210.18 |- skos__historyNote mesh__D007473 Cell Membrane %28%1966-1978%29%
% 210.03/210.18 |- skos__related mesh__D007473smesh__D015640
% 210.03/210.18 |- skos__hiddenLabel mesh__D007473 Channel, Ionic
% 210.03/210.18 |- skos__broader mesh__D007473smesh__D026901
% 210.03/210.18 |- skos__historyNote mesh__D007473 Electric Conductivity %28%1968-1978%29%
% 210.03/210.18 |- mesh__recordOriginator mesh__D007473 VDK
% 210.03/210.18 |- skos__prefLabel mesh__D007473 Ion Channels
% 210.03/210.18 |- mesh__recordAuthorizer mesh__D007473 sjn
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D007473 2006
% 210.03/210.18 |- mesh__historyNote mesh__D007473 79
% 210.03/210.18 |- skos__altLabel mesh__D007473 Ion Channel
% 210.03/210.18 |- skos__altLabel mesh__D007473 Ionic Channels
% 210.03/210.18 |- skos__hiddenLabel mesh__D007473 Channels, Ion
% 210.03/210.18 |- skos__annotation mesh__D007473
% 210.03/210.18 IM; GEN: prefer specifics; coord IM with specific ion /metab %28%IM%29%; for disorders caused by dysfunction %28%channelopathy%29% use /physiopathology%A%
% 210.03/210.18 |- skos__altLabel mesh__D007473 Membrane Channels
% 210.03/210.18 |- skos__historyNote mesh__D007473 Membrane Potentials %28%1967-1978%29%
% 210.03/210.18 |- skos__related mesh__D007473smesh__D016623
% 210.03/210.18 |- skos__broader mesh__D007473smesh__D008562
% 210.03/210.18 |- skos__scopeNote mesh__D007473
% 210.03/210.18 Gated, ion-selective glycoproteins that traverse membranes. The stimulus for channel gating can be a membrane potential, drug, transmitter, cytoplasmic messenger, or a mechanical deformation. Ion channels which are integral parts of ionotropic neurotransmitter receptors are not included.%A%
% 210.03/210.18 |- skos__hiddenLabel mesh__D007473 Channel, Ion
% 210.03/210.18 |- rdf__type mesh__D007473sskos__Concept
% 210.03/210.18 |- skos__hiddenLabel mesh__D007473 Channel, Membrane
% 210.03/210.18 |- mesh__dateEstablished mesh__D007473 1979-01-01
% 210.03/210.18 |- skos__altLabel mesh__D007473 Membrane Channel
% 210.03/210.18 |- mesh__dateRevised mesh__D007473 2005-06-30
% 210.03/210.18 |- skos__hiddenLabel mesh__D007473 Channels, Membrane
% 210.03/210.18 |- skos__historyNote mesh__D015905 Implants, Artificial %28%1987-1989%29%
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015905 2002
% 210.03/210.18 |- skos__historyNote mesh__D015905 Balloon Dilatation %28%1988-1989%29%
% 210.03/210.18 |- skos__annotation mesh__D015905
% 210.03/210.18 note category: an inflatable device; do not confuse with digestive gases; used in ther of morbid obesity: note XR %26% do not coord with OBESITY, MORBID unless particularly discussed%A%
% 210.03/210.18 |- skos__historyNote mesh__D015905
% 210.03/210.18 Intubation, Gastrointestinal %28%1974-1979%29%
% 210.03/210.18 |- mesh__dateCreated mesh__D015905 1989-05-15
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015905 1998
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Bubble, Gastric
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015905 2003
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015905 1999
% 210.03/210.18 |- mesh__dateRevised mesh__D015905 1997-06-20
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Balloons, Gastric
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Gastric Bubble, Garren-Edwards
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015905 2004
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015905 2000
% 210.03/210.18 |- mesh__recordOriginator mesh__D015905 PLS
% 210.03/210.18 |- skos__broader mesh__D015905smesh__D004864
% 210.03/210.18 |- skos__historyNote mesh__D015905 Dilatation %28%1980-1987%29%
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Balloon, Ballobes
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015905 2005
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Gastric Balloons
% 210.03/210.18 |- skos__prefLabel mesh__D015905 Gastric Balloon
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Bubbles, Gastric
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Garren Edwards Gastric Bubble
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015905 2001
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015905 2006
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Gastric Bubbles
% 210.03/210.18 |- skos__historyNote mesh__D015905 Obesity %28%1977-1987%29%
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Balloon, Gastric
% 210.03/210.18 |- skos__altLabel mesh__D015905 Gastric Bubble
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Ballobes Balloons
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Bubble, Garren-Edwards Gastric
% 210.03/210.18 |- mesh__dateEstablished mesh__D015905 1990-01-01
% 210.03/210.18 |- skos__scopeNote mesh__D015905
% 210.03/210.18 An inflatable device implanted in the stomach as an adjunct to therapy of morbid obesity. Specific types include the silicone Garren-Edwards Gastric Bubble %28%GEGB%29%, approved by the FDA in 1985, and the Ballobes Balloon.%A%
% 210.03/210.18 |- mesh__historyNote mesh__D015905
% 210.03/210.18 98; was GASTRIC BUBBLE 1990-97; GASTRIC BALLOON was see GASTRIC BUBBLE 1990-97%A%
% 210.03/210.18 |- skos__hiddenLabel mesh__D015905 Balloons, Ballobes
% 210.03/210.18 |- mesh__recordMaintainer mesh__D015905 PXP
% 210.03/210.18 |- mesh__publicMeSHNote mesh__D015905
% 210.03/210.18 98; was GASTRIC BUBBLE 1990-97; GASTRIC BALLOON was see GASTRIC BUBBLE 1990-97%A%
% 210.03/210.18 |- rdf__type mesh__D015905sskos__Concept
% 210.03/210.18 |- mesh__recordAuthorizer mesh__D015905 SJN
% 210.03/210.18 |- skos__historyNote mesh__D015905 Obesity, Morbid %28%1987-1989%29%
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015107 2003
% 210.03/210.18 |- skos__hiddenLabel mesh__D015107 1,4 Butanolide
% 210.03/210.18 |- skos__altLabel mesh__D015107 Furanone, tetrahydro-2-
% 210.03/210.18 |- mesh__recordMaintainer mesh__D015107 ssb
% 210.03/210.18 |- skos__altLabel mesh__D015107 4-Hydroxybutyric Acid Lactone
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015107 2005
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015107 2004
% 210.03/210.18 |- mesh__dateCreated mesh__D015107 1975-07-23
% 210.03/210.18 |- skos__altLabel mesh__D015107 1,4-Butanolide
% 210.03/210.18 |- mesh__recordOriginator mesh__D015107 RLS
% 210.03/210.18 |- mesh__recordAuthorizer mesh__D015107 sjn
% 210.03/210.18 |- skos__hiddenLabel mesh__D015107 4 Butyrolactone
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D015107 2006
% 210.03/210.18 |- skos__altLabel mesh__D015107 Dihydro-2%28%3H%29%-furanone
% 210.03/210.18 |- rdf__type mesh__D015107sskos__Concept
% 210.03/210.18 |- mesh__historyNote mesh__D015107
% 210.03/210.18 91%28%77%29%; was see under FURANS 1977-90; was GAMMA BUTYROLACTONE see under FURANS 1976%A%
% 210.03/210.18 |- skos__scopeNote mesh__D015107
% 210.03/210.18 One of the FURANS with a carbonyl thereby forming a cyclic lactone. It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate. It is also used as a pharmacological agent and solvent.%A%
% 210.03/210.18 |- mesh__dateEstablished mesh__D015107 1991-01-01
% 210.03/210.18 |- skos__hiddenLabel mesh__D015107 Lactone, 4-Hydroxybutyric Acid
% 210.03/210.18 |- mesh__dateRevised mesh__D015107 2002-07-02
% 210.03/210.18 |- skos__historyNote mesh__D015107 Lactones %28%1969-1975%29%
% 210.03/210.18 |- skos__historyNote mesh__D015107 Furans %28%1969-1975%29%
% 210.03/210.18 |- skos__altLabel mesh__D015107 gamma-Butyrolactone
% 210.03/210.18 |- skos__hiddenLabel mesh__D015107 gamma Butyrolactone
% 210.03/210.18 |- mesh__onlineNote mesh__D015107
% 210.03/210.18 use 4-BUTYROLACTONE to search GAMMA BUTYROLACTONE 1976
% 210.03/210.18 |- skos__hiddenLabel mesh__D015107 4 Hydroxybutyric Acid Lactone
% 210.03/210.18 |- skos__prefLabel mesh__D015107 4-Butyrolactone
% 210.03/210.18 |- skos__broader mesh__D015107smesh__D005663
% 210.03/210.18 |- skos__broader mesh__D015107smesh__D007783
% 210.03/210.18 |- skos__hiddenLabel mesh__D015107 Furanone, tetrahydro 2
% 210.03/210.18 |- mesh__publicMeSHNote mesh__D015107
% 210.03/210.18 91; was see under FURANS 1977-90; was GAMMA BUTYROLACTONE see under FURANS 1976%A%
% 210.03/210.18 |- mesh__recordAuthorizer mesh__D003881 PLS
% 210.03/210.18 |- skos__hiddenLabel mesh__D003881 Skin Disease, Fungal
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 2001
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 1996
% 210.03/210.18 |- skos__hiddenLabel mesh__D003881 Fungal Skin Disease
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 1998
% 210.03/210.18 |- skos__altLabel mesh__D003881 Dermatomycosis
% 210.03/210.18 |- mesh__historyNote mesh__D003881 77; was DERMATOMYCOSIS 1963-76
% 210.03/210.18 |- skos__altLabel mesh__D003881 Skin Diseases, Fungal
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 1997
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 1994
% 210.03/210.18 |- skos__annotation mesh__D003881
% 210.03/210.18 fungus dis of skin; coord IM with specific fungus or fungal dis %28%IM%29%%A%
% 210.03/210.18 |- mesh__onlineNote mesh__D003881
% 210.03/210.18 use DERMATOMYCOSES to search DERMATOMYCOSIS 1966-76
% 210.03/210.18 |- mesh__dateRevised mesh__D003881 1993-06-02
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 1999
% 210.03/210.18 |- skos__altLabel mesh__D003881 Dermatophytoses
% 210.03/210.18 |- skos__prefLabel mesh__D003881 Dermatomycoses
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 2002
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 1995
% 210.03/210.18 |- rdf__type mesh__D003881sskos__Concept
% 210.03/210.18 |- skos__broader mesh__D003881smesh__D012874
% 210.03/210.18 |- mesh__recordOriginator mesh__D003881 NLM
% 210.03/210.18 |- mesh__recordMaintainer mesh__D003881 TAP
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 2003
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 2005
% 210.03/210.18 |- mesh__dateCreated mesh__D003881 1999-01-01
% 210.03/210.18 |- mesh__publicMeSHNote mesh__D003881 77; was DERMATOMYCOSIS 1963-76
% 210.03/210.18 |- skos__broader mesh__D003881smesh__D009181
% 210.03/210.18 |- skos__scopeNote mesh__D003881
% 210.03/210.18 Superficial infections of the skin or its appendages by any of various fungi.%A%
% 210.03/210.18 |- skos__altLabel mesh__D003881 Fungal Skin Diseases
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 2004
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 2006
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D003881 2000
% 210.03/210.18 |- skos__altLabel mesh__D011515 Fatol Brand of Prothionamide
% 210.03/210.18 |- mesh__activeMeSHYear mesh__D011515 2006
% 210.03/210.18 |- rdf__type mesh__D011515sskos__Concept
% 210.03/210.18 |- skos__broader mesh__D011515smesh__D007539
% 210.03/210.18 |- mesh__historyNote mesh__D011515
% 210.03/210.18 91%28%75%29%; was see under ISONICOTINIC ACIDS 1975-90
% 210.03/210.18 |- mesh__recordAuthorizer mesh__D011515 sjn
% 210.03/210.18 |- skos__prefLabel mesh__D011515 Prothionamide
% 210.03/210.18 |- mesh__dateRevised mesh__D011515 2005-06-30
% 210.03/210.18 |- skos__altLabel mesh__D011515 Sanavita Brand of Prothionamide
% 210.03/210.18 |- skos__historyNote mesh__D011515 Isonicotinic Acids %28%1970-1974%29%
% 210.03/210.18 |- skos__altLabel mesh__D011515 Wernigerode Brand of Prothionamide
% 210.03/210.18 |- mesh__dateCreated mesh__D011515 1974-11-19
% 210.03/210.18 |- mesh__recordMaintainer mesh__D011515 lkw
% 210.03/210.18 |- mesh__publicMeSHNote mesh__D011515
% 210.03/210.18 91; was see under ISONICOTINIC ACIDS 1975-90
% 210.03/210.18 |- mesh__recordOriginator mesh__D011515 NLM
% 210.03/210.18 |- mesh__dateEstablished mesh__D011515 1991-01-01
% 210.03/210.18 |- skos__altLabel mesh__D011515 Protionamide
% 210.03/210.18 |- skos__historyNote mesh__D011515 Sulfides %28%1972-1974%29%
% 210.03/210.18 |- skos__scopeNote mesh__D011515
% 210.03/210.18 Antitubercular agent similar in action and side effects to ETHIONAMIDE. It is used mostly in combination with other agents.%A%
% 210.03/210.18 |- rdf__type mesh__D016200sskos__Concept
% 210.03/210.18 |- mesh__dateCreated mesh__D016200 1990-06-17
% 210.03/210.18 |- skos__hiddenLabel mesh__D016200 Histone H1 Kinase, Growth Associated
% 210.03/210.18 |- skos__hiddenLabel mesh__D016200 Mitosis Promoting Factor
% 210.03/210.18 |- skos__altLabel mesh__D016200 M Phase-Promoting Factor
% 210.03/210.18 |- skos__broader mesh__D016200smesh__D018844
% 210.03/210.18 |- mesh__recordAuthorizer mesh__D016200 sjn
% 210.03/210.18 |- skos__altLabel mesh__D016200 Histone H1 Kinase, Growth-Associated
% 210.03/210.18 |- skos__broader mesh__D016200smesh__D006133
% 210.03/210.18 |- skos__hiddenLabel mesh__D016200 M Phase Promoting Factor
% 210.03/210.18 |- skos__related mesh__D016200smesh__D016213
% 210.03/210.19 |- mesh__historyNote mesh__D016200
% 210.03/210.19 91; HISTONE H1 KINASE, M-PHASE-SPECIFIC was HISTONE H1 KINASE, M PHASE-SPECIFIC 1991-93%A%
% 210.03/210.19 |- skos__historyNote mesh__D016200 Growth Substances %28%1979-1990%29%
% 210.03/210.19 |- mesh__recordOriginator mesh__D016200 AGS
% 210.03/210.19 |- skos__hiddenLabel mesh__D016200 Maturation Promoting Factor
% 210.03/210.19 |- mesh__recordMaintainer mesh__D016200 ssb
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D016200 2006
% 210.03/210.19 |- skos__hiddenLabel mesh__D016200 Histone H1 Kinase, M Phase Specific
% 210.03/210.19 |- skos__annotation mesh__D016200
% 210.03/210.19 a protein kinase; /drug eff permitted; DF: MPF
% 210.03/210.19 |- skos__altLabel mesh__D016200 Mitosis-Promoting Factor
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D016200
% 210.03/210.19 91; HISTONE H1 KINASE, M-PHASE-SPECIFIC was HISTONE H1 KINASE, M PHASE-SPECIFIC 1991-93%A%
% 210.03/210.19 |- mesh__dateRevised mesh__D016200 2005-06-30
% 210.03/210.19 |- skos__scopeNote mesh__D016200
% 210.03/210.19 Protein kinase that drives both the mitotic and meiotic cycles in all eukaryotic organisms. In meiosis it induces immature oocytes to undergo meiotic maturation. In mitosis it has a role in the G2/M phase transition. Once activated by CYCLINS; MPF directly phosphorylates some of the proteins involved in nuclear envelope breakdown, chromosome condensation, spindle assembly, and the degradation of cyclins. The catalytic subunit of MPF is PROTEIN P34CDC2.%A%
% 210.03/210.19 |- skos__altLabel mesh__D016200 Histone H1 Kinase, M-Phase-Specific
% 210.03/210.19 |- skos__prefLabel mesh__D016200 Maturation-Promoting Factor
% 210.03/210.19 |- mesh__dateEstablished mesh__D016200 1991-01-01
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D002789
% 210.03/210.19 91; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90%A%
% 210.03/210.19 |- skos__hiddenLabel mesh__D002789 Oxidase, Cholesterol
% 210.03/210.19 |- mesh__recordOriginator mesh__D002789 RLS
% 210.03/210.19 |- rdf__type mesh__D002789sskos__Concept
% 210.03/210.19 |- mesh__dateRevised mesh__D002789 2003-07-09
% 210.03/210.19 |- mesh__dateCreated mesh__D002789 1977-04-15
% 210.03/210.19 |- mesh__recordMaintainer mesh__D002789 ssb
% 210.03/210.19 |- skos__prefLabel mesh__D002789 Cholesterol Oxidase
% 210.03/210.19 |- mesh__dateEstablished mesh__D002789 1991-01-01
% 210.03/210.19 |- skos__historyNote mesh__D002789
% 210.03/210.19 Hydroxysteroid Dehydrogenases %28%1966-1977%29%
% 210.03/210.19 |- skos__historyNote mesh__D002789 Cholesterol %28%1966-1977%29%
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D002789 2004
% 210.03/210.19 |- mesh__historyNote mesh__D002789
% 210.03/210.19 91%28%78%29%; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90%A%
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D002789 sjn
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D002789 2005
% 210.03/210.19 |- skos__scopeNote mesh__D002789
% 210.03/210.19 An enzyme that catalyzes the oxidation of cholesterol in the presence of molecular oxygen to 4-cholesten-3-one and hydrogen peroxide. The enzyme is not specific for cholesterol, but will also oxidize other 3-hydroxysteroids. EC 1.1.3.6.%A%
% 210.03/210.19 |- skos__broader mesh__D002789smesh__D015096
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D002789 2006
% 210.03/210.19 |- mesh__dateEstablished mesh__D035165 2003-01-01
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D035165 2006
% 210.03/210.19 |- mesh__historyNote mesh__D035165 2003
% 210.03/210.19 |- skos__broader mesh__D035165smesh__D014157
% 210.03/210.19 |- mesh__dateRevised mesh__D035165 2005-06-30
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D035165 sjn
% 210.03/210.19 |- skos__broader mesh__D035165smesh__D004268
% 210.03/210.19 |- rdf__type mesh__D035165sskos__Concept
% 210.03/210.19 |- mesh__recordOriginator mesh__D035165 jmp
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D035165 2003
% 210.03/210.19 |- mesh__recordMaintainer mesh__D035165 ags
% 210.03/210.19 |- skos__altLabel mesh__D035165 General Transcription Factors
% 210.03/210.19 |- mesh__dateCreated mesh__D035165 2002-07-03
% 210.03/210.19 |- skos__scopeNote mesh__D035165
% 210.03/210.19 Transcription factors that form transcription initiation complexes on DNA, bind to specific DNA-DIRECTED RNA POLYMERASES and are required to initiate transcription. Although their binding may be localized to distinct sequence and structural motifs within the DNA they are considered non-specific with regard to the specific gene being transcribed.%A%
% 210.03/210.19 |- skos__prefLabel mesh__D035165 Transcription Factors, General
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 1996
% 210.03/210.19 |- rdf__type mesh__D007474sskos__Concept
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D007474 ags
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 1995
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 2003
% 210.03/210.19 |- skos__prefLabel mesh__D007474 Ion Exchange
% 210.03/210.19 |- mesh__recordMaintainer mesh__D007474 ags
% 210.03/210.19 |- skos__scopeNote mesh__D007474
% 210.03/210.19 Reversible chemical reaction between a solid, often one of the ION EXCHANGE RESINS, and a fluid whereby ions may be exchanged from one substance to another. This technique is used in water purification, in research, and in industry.%A%
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 1994
% 210.03/210.19 |- skos__annotation mesh__D007474
% 210.03/210.19 a physicochem process: do not confuse with ION TRANSPORT, which takes place in biol systems; NIM; no qualif%A%
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 2006A
% 210.03/210.19 |- mesh__dateCreated mesh__D007474 1999-01-01
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 1993
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 1999
% 210.03/210.19 |- skos__broader mesh__D007474smesh__D002627
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 2002
% 210.03/210.19 |- skos__hiddenLabel mesh__D007474 Exchange, Ion
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 2006
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 1998
% 210.03/210.19 |- mesh__recordOriginator mesh__D007474 NLM
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 2001
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 1997
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 2000
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 2005
% 210.03/210.19 |- mesh__dateRevised mesh__D007474 2005-07-18
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007474 2004
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D015906 SJN
% 210.03/210.19 |- mesh__dateCreated mesh__D015906 1989-05-15
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015906 1998
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015906 2002
% 210.03/210.19 |- skos__altLabel mesh__D015906 Angioplasty, Coronary Balloon
% 210.03/210.19 |- skos__altLabel mesh__D015906 Coronary Angioplasty, Transluminal Balloon
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015906 2003
% 210.03/210.19 |- skos__prefLabel mesh__D015906
% 210.03/210.19 Angioplasty, Transluminal, Percutaneous Coronary
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015906 1999
% 210.03/210.19 |- skos__scopeNote mesh__D015906
% 210.03/210.19 Dilatation of an occluded coronary artery %28%or arteries%29% by means of a balloon catheter to restore myocardial blood supply.%A%
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015906 2004
% 210.03/210.19 |- mesh__dateRevised mesh__D015906 1997-06-20
% 210.03/210.19 |- mesh__historyNote mesh__D015906 90
% 210.03/210.19 |- mesh__recordOriginator mesh__D015906 PLS
% 210.03/210.19 |- skos__historyNote mesh__D015906 Dilatation %28%1978-1981%29%
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015906 2005
% 210.03/210.19 |- skos__hiddenLabel mesh__D015906 Angioplasties, Coronary Balloon
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015906 2000
% 210.03/210.19 |- skos__broader mesh__D015906smesh__D000800
% 210.03/210.19 |- skos__historyNote mesh__D015906
% 210.03/210.19 Angioplasty, Transluminal %28%1982-1989%29%
% 210.03/210.19 |- skos__annotation mesh__D015906
% 210.03/210.19 coord IM with disease /ther %28%IM%29%, not /surg; do not use /util except by MeSH definition; if laser, coord IM with ANGIOPLASTY, BALLOON, LASER-ASSISTED %28%IM%29%; DF: note short X ref%A%
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D015906 90
% 210.03/210.19 |- skos__altLabel mesh__D015906 PTCA
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015906 2006
% 210.03/210.19 |- skos__hiddenLabel mesh__D015906 Balloon Angioplasties, Coronary
% 210.03/210.19 |- skos__hiddenLabel mesh__D015906 Balloon Angioplasty, Coronary
% 210.03/210.19 |- skos__historyNote mesh__D015906 Heart Catheterization %28%1976-1981%29%
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015906 2001
% 210.03/210.19 |- skos__historyNote mesh__D015906 Coronary Vessels %28%1978-1989%29%
% 210.03/210.19 |- mesh__dateEstablished mesh__D015906 1990-01-01
% 210.03/210.19 |- skos__broader mesh__D015906smesh__D009204
% 210.03/210.19 |- skos__historyNote mesh__D015906 Coronary Disease %28%1980-1989%29%
% 210.03/210.19 |- rdf__type mesh__D015906sskos__Concept
% 210.03/210.19 |- skos__altLabel mesh__D015906
% 210.03/210.19 Percutaneous Transluminal Coronary Angioplasty
% 210.03/210.19 |- skos__altLabel mesh__D015906 Angioplasty, Balloon, Coronary
% 210.03/210.19 |- skos__altLabel mesh__D015906 Balloon Dilatation, Coronary Artery
% 210.03/210.19 |- mesh__recordMaintainer mesh__D015906 PXP
% 210.03/210.19 |- skos__altLabel mesh__D015906 Transluminal Coronary Balloon Dilatation
% 210.03/210.19 |- skos__hiddenLabel mesh__D015906 Coronary Balloon Angioplasty
% 210.03/210.19 |- skos__hiddenLabel mesh__D015906 Coronary Balloon Angioplasties
% 210.03/210.19 |- skos__broader mesh__D011453Q000031smesh__D011453
% 210.03/210.19 |- mesh__preferredCombination mesh__D011453Q000031smesh__D011465
% 210.03/210.19 |- rdf__type mesh__D011453Q000031smesh__CompoundConcept
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015108 2004
% 210.03/210.19 |- skos__hiddenLabel mesh__D015108 4 Hydroxyaminoquinoline N oxide
% 210.03/210.19 |- skos__broader mesh__D015108smesh__D003497
% 210.03/210.19 |- skos__scopeNote mesh__D015108
% 210.03/210.19 A potent mutagen and carcinogen. It is a reduction product of 4-NITROQUINOLINE-1-OXIDE. It binds with nucleic acids and inactivates both bacteria and bacteriophage.%A%
% 210.03/210.19 |- skos__historyNote mesh__D015108 Cyclic N-Oxides %28%1972-1974%29%
% 210.03/210.19 |- mesh__dateRevised mesh__D015108 2000-06-22
% 210.03/210.19 |- skos__hiddenLabel mesh__D015108 4 Hydroxyaminoquinoline 1 oxide
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015108 2006
% 210.03/210.19 |- mesh__dateCreated mesh__D015108 1974-11-14
% 210.03/210.19 |- mesh__recordMaintainer mesh__D015108 CCR
% 210.03/210.19 |- rdf__type mesh__D015108sskos__Concept
% 210.03/210.19 |- mesh__dateEstablished mesh__D015108 1991-01-01
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015108 2002
% 210.03/210.19 |- skos__historyNote mesh__D015108 Hydroxylamines %28%1974%29%
% 210.03/210.19 |- skos__prefLabel mesh__D015108 4-Hydroxyaminoquinoline-1-oxide
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D015108 sjn
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D015108
% 210.03/210.19 91; was see under AMINOQUINOLINES 1975-90
% 210.03/210.19 |- mesh__historyNote mesh__D015108
% 210.03/210.19 91%28%75%29%; was see under AMINOQUINOLINES 1975-90
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015108 2003
% 210.03/210.19 |- skos__broader mesh__D015108smesh__D006898
% 210.03/210.19 |- skos__historyNote mesh__D015108 Quinolines %28%1972-1974%29%
% 210.03/210.19 |- skos__broader mesh__D015108smesh__D000634
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015108 2001
% 210.03/210.19 |- skos__annotation mesh__D015108 D25-26 qualif
% 210.03/210.19 |- skos__altLabel mesh__D015108 4-Hydroxyaminoquinoline-N-oxide
% 210.03/210.19 |- mesh__recordOriginator mesh__D015108 NLM
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015108 2005
% 210.03/210.19 |- skos__broader mesh__D003882smesh__D012871
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003882 2003
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Dermatomyositides, Childhood Type
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Dermatomyositides, Adult Type
% 210.03/210.19 |- skos__broader mesh__D003882smesh__D017285
% 210.03/210.19 |- mesh__dateCreated mesh__D003882 1999-01-01
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Dermatopolymyositides
% 210.03/210.19 |- skos__annotation mesh__D003882
% 210.03/210.19 coord IM with PARANEOPLASTIC SYNDROMES %28%IM%29% if pertinent
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003882 2006
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Adult Type Dermatomyositis
% 210.03/210.19 |- skos__prefLabel mesh__D003882 Dermatomyositis
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003882 2002
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003882 2005
% 210.03/210.19 |- mesh__dateRevised mesh__D003882 1999-11-03
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Childhood Type Dermatomyositis
% 210.03/210.19 |- skos__altLabel mesh__D003882 Dermatopolymyositis
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Polymyositis Dermatomyositis
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Dermatomyositides
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Polymyositis-Dermatomyositides
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D003882 sjn
% 210.03/210.19 |- skos__broader mesh__D003882smesh__D009220
% 210.03/210.19 |- mesh__recordMaintainer mesh__D003882 KEV
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003882 2001
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Childhood Type Dermatomyositides
% 210.03/210.19 |- skos__hiddenLabel mesh__D003882 Adult Type Dermatomyositides
% 210.03/210.19 |- skos__scopeNote mesh__D003882
% 210.03/210.19 A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash %28%or less often an exfoliative dermatitis%29% involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. %28%From Adams et al., Principles of Neurology, 6th ed, pp1405-6%29%%A%
% 210.03/210.19 |- rdf__type mesh__D003882sskos__Concept
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003882 2004
% 210.03/210.19 |- skos__altLabel mesh__D003882 Polymyositis-Dermatomyositis
% 210.03/210.19 |- skos__broader mesh__D003882smesh__D003240
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003882 2000
% 210.03/210.19 |- mesh__recordOriginator mesh__D003882 NLM
% 210.03/210.19 |- mesh__historyNote mesh__D003084
% 210.03/210.19 91%28%75%29%; was see under POLYAMINES 1975-90
% 210.03/210.19 |- mesh__dateRevised mesh__D003084 2004-07-07
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D003084
% 210.03/210.19 91; was see under POLYAMINES 1975-90
% 210.03/210.19 |- skos__altLabel mesh__D003084 Colestipol HCl
% 210.03/210.19 |- skos__broader mesh__D003084smesh__D011073
% 210.03/210.19 |- mesh__recordMaintainer mesh__D003084 jmp
% 210.03/210.19 |- skos__historyNote mesh__D003084 Polymers %28%1971-1974%29%
% 210.03/210.19 |- skos__broader mesh__D003084smesh__D011108
% 210.03/210.19 |- skos__prefLabel mesh__D003084 Colestipol
% 210.03/210.19 |- mesh__dateCreated mesh__D003084 1974-11-27
% 210.03/210.19 |- skos__historyNote mesh__D003084 Polyamines %28%1972-1974%29%
% 210.03/210.19 |- skos__hiddenLabel mesh__D003084 U 26,597 A
% 210.03/210.19 |- skos__scopeNote mesh__D003084
% 210.03/210.19 Highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic. It may also may reduce triglyceride levels.%A%
% 210.03/210.19 |- mesh__dateEstablished mesh__D003084 1991-01-01
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D003084 sjn
% 210.03/210.19 |- mesh__recordOriginator mesh__D003084 NLM
% 210.03/210.19 |- skos__historyNote mesh__D003084 Ethers, Cyclic %28%1972-1974%29%
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003084 2006
% 210.03/210.19 |- skos__hiddenLabel mesh__D003084 Hydrochloride, Colestipol
% 210.03/210.19 |- skos__hiddenLabel mesh__D003084 HCl, Colestipol
% 210.03/210.19 |- rdf__type mesh__D003084sskos__Concept
% 210.03/210.19 |- skos__hiddenLabel mesh__D003084 U26,597 A
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003084 2005
% 210.03/210.19 |- rdf__type mesh__D011516sskos__Concept
% 210.03/210.19 |- skos__altLabel mesh__D011516 Blood Coagulation Factor II
% 210.03/210.19 |- skos__altLabel mesh__D011516 Differentiation Reversal Factor
% 210.03/210.19 |- mesh__recordMaintainer mesh__D011516 ssb
% 210.03/210.19 |- skos__hiddenLabel mesh__D011516 II, Coagulation Factor
% 210.03/210.19 |- skos__related mesh__D011516smesh__D003029
% 210.03/210.19 |- skos__broader mesh__D011516smesh__D004792
% 210.03/210.19 |- skos__altLabel mesh__D011516 Factor II
% 210.03/210.19 |- skos__hiddenLabel mesh__D011516 Factor II, Coagulation
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D011516 sjn
% 210.03/210.19 |- skos__prefLabel mesh__D011516 Prothrombin
% 210.03/210.19 |- skos__hiddenLabel mesh__D011516 Factor, Differentiation Reversal
% 210.03/210.19 |- skos__annotation mesh__D011516
% 210.03/210.19 a blood coag factor; an enzyme precursor
% 210.03/210.19 |- mesh__dateRevised mesh__D011516 2005-06-30
% 210.03/210.19 |- skos__scopeNote mesh__D011516
% 210.03/210.19 A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia.%A%
% 210.03/210.19 |- skos__broader mesh__D011516smesh__D001779
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D011516 2006
% 210.03/210.19 |- mesh__dateCreated mesh__D011516 1999-01-01
% 210.03/210.19 |- mesh__recordOriginator mesh__D011516 NLM
% 210.03/210.19 |- skos__altLabel mesh__D011516 Coagulation Factor II
% 210.03/210.19 |- skos__prefLabel mesh__D016201 Receptors, Lymphocyte Homing
% 210.03/210.19 |- mesh__historyNote mesh__D016201
% 210.03/210.19 91; ANTIGENS, CD44, CD44 ANTIGENS %26% PgP-1 ANTIGEN were see RECEPTORS, LYMPHOCYTE HOMING 1991-93;ANTIGENS, CD44 was ANTIGEN, CD44 see RECEPTORS, LYMPHOCYTE HOMING 1991-92; CD44 ANTIGENS was CD44 ANTIGEN see RECEPTORS, LYMPHOCYTE HOMING 1991-92%A%
% 210.03/210.19 |- skos__hiddenLabel mesh__D016201 Antigen Family, Hermes
% 210.03/210.19 |- skos__annotation mesh__D016201 DF: RECEPT LYMPHOCYTE HOMING
% 210.03/210.19 |- skos__broader mesh__D016201smesh__D015815
% 210.03/210.19 |- skos__broader mesh__D016201smesh__D011971
% 210.03/210.19 |- skos__hiddenLabel mesh__D016201 Homing Receptors, Lymphocyte
% 210.03/210.19 |- skos__scopeNote mesh__D016201
% 210.03/210.19 Cell surface glycoproteins on lymphocytes and other leukocytes that mediate adhesion to specialized blood vessels called high endothelial venules. Several different classes of lymphocyte homing receptors have been identified, and they appear to target different surface molecules %28%addressins%29% on high endothelial venules in different tissues. The adhesion plays a crucial role in the trafficking of lymphocytes.%A%
% 210.03/210.19 |- skos__altLabel mesh__D016201 Homing Receptor, Lymph Node
% 210.03/210.19 |- skos__altLabel mesh__D016201 Lymph Node Homing Receptor
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D016201 2006
% 210.03/210.19 |- skos__historyNote mesh__D016201 Cell Adhesion Molecules %28%1990%29%
% 210.03/210.19 |- mesh__dateRevised mesh__D016201 2005-06-30
% 210.03/210.19 |- skos__altLabel mesh__D016201 Receptor, Lymph Node Homing
% 210.03/210.19 |- skos__hiddenLabel mesh__D016201 Receptors, T-Cell Homing
% 210.03/210.19 |- mesh__dateCreated mesh__D016201 1990-04-24
% 210.03/210.19 |- mesh__recordOriginator mesh__D016201 RLS
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D016201
% 210.03/210.19 91; ANTIGENS, CD44, CD44 ANTIGENS %26% PgP-1 ANTIGENSwere see RECEPTORS, LYMPHOCYTE HOMING 1991-93; ANTIGENS, CD44 was ANTIGEN, CD44 see RECEPTORS, LYMPHOCYTE HOMING 1991-92; CD44 ANTIGENS was CD44 ANTIGEN see RECEPTORS, LYMPHOCYTE HOMING 1991-92%A%
% 210.03/210.19 |- skos__altLabel mesh__D016201 Lymphocyte Homing Receptors
% 210.03/210.19 |- rdf__type mesh__D016201sskos__Concept
% 210.03/210.19 |- skos__historyNote mesh__D016201 Antigens, CD %28%1990%29%
% 210.03/210.19 |- skos__hiddenLabel mesh__D016201 Homing Receptors, T Cell
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D016201 sjn
% 210.03/210.19 |- skos__historyNote mesh__D016201
% 210.03/210.19 Antigens, Differentiation %28%1988-1990%29%
% 210.03/210.19 |- skos__hiddenLabel mesh__D016201 T-Cell Homing Receptors
% 210.03/210.19 |- mesh__dateEstablished mesh__D016201 1991-01-01
% 210.03/210.19 |- mesh__onlineNote mesh__D016201
% 210.03/210.19 use RECEPTORS, LYMPHOCYTE HOMING to search ANTIGENS, CD44, CD44 ANTIGENS %26% PgP-1 ANTIGEN 1991-93 %26% ANTIGEN, CD44 %26% CD44 ANTIGEN 1991-92%A%
% 210.03/210.19 |- skos__broader mesh__D016201smesh__D015703
% 210.03/210.19 |- mesh__recordMaintainer mesh__D016201 ssb
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D035964 2006
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D035964 2003
% 210.03/210.19 |- skos__broader mesh__D035964smesh__D006573
% 210.03/210.19 |- mesh__recordMaintainer mesh__D035964 ssb
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D035964 sjn
% 210.03/210.19 |- mesh__dateRevised mesh__D035964 2004-07-07
% 210.03/210.19 |- skos__prefLabel mesh__D035964 Oxocins
% 210.03/210.19 |- rdf__type mesh__D035964sskos__Concept
% 210.03/210.19 |- skos__altLabel mesh__D035964 Oxocenes
% 210.03/210.19 |- skos__scopeNote mesh__D035964
% 210.03/210.19 Compounds based on an 8-membered heterocyclic ring including an oxygen. They can be considered medium ring ethers.%A%
% 210.03/210.19 |- mesh__recordOriginator mesh__D035964 ssb
% 210.03/210.19 |- mesh__historyNote mesh__D035964 2003
% 210.03/210.19 |- mesh__dateEstablished mesh__D035964 2003-01-01
% 210.03/210.19 |- mesh__dateCreated mesh__D035964 2002-07-03
% 210.03/210.19 |- skos__broader mesh__D035964smesh__D004988
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D035964 2005
% 210.03/210.19 |- mesh__dateCreated mesh__D007475 1999-01-01
% 210.03/210.19 |- skos__hiddenLabel mesh__D007475 Resins, Ion Exchange
% 210.03/210.19 |- skos__annotation mesh__D007475 D25-26 qualif
% 210.03/210.19 |- skos__scopeNote mesh__D007475
% 210.03/210.19 High molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions %28%ION EXCHANGE%29% with either cations or anions.%A%
% 210.03/210.19 |- skos__broader mesh__D007475smesh__D019995
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007475 2006
% 210.03/210.19 |- skos__related mesh__D007475smesh__D002852
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007475 2005
% 210.03/210.19 |- mesh__dateRevised mesh__D007475 2003-07-09
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D007475 2004
% 210.03/210.19 |- mesh__recordMaintainer mesh__D007475 ssb
% 210.03/210.19 |- rdf__type mesh__D007475sskos__Concept
% 210.03/210.19 |- skos__hiddenLabel mesh__D007475 Exchange Resins, Ion
% 210.03/210.19 |- mesh__recordOriginator mesh__D007475 NLM
% 210.03/210.19 |- skos__prefLabel mesh__D007475 Ion Exchange Resins
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D007475 sjn
% 210.03/210.19 |- skos__broader mesh__D015907smesh__D004724
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D015907 sjn
% 210.03/210.19 |- skos__related mesh__D015907smesh__D007047
% 210.03/210.19 |- skos__altLabel mesh__D015907 Uteroscopy
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D015907 90; was see ENDOSCOPY 1979-89
% 210.03/210.19 |- skos__prefLabel mesh__D015907 Hysteroscopy
% 210.03/210.19 |- mesh__recordMaintainer mesh__D015907 KEV
% 210.03/210.19 |- skos__scopeNote mesh__D015907
% 210.03/210.19 Endoscopic examination, therapy or surgery of the interior of the uterus.%A%
% 210.03/210.19 |- skos__altLabel mesh__D015907 Surgical Procedures, Hysteroscopic
% 210.03/210.19 |- mesh__dateRevised mesh__D015907 2002-07-03
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015907 2005
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Surgeries, Hysteroscopic
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Uteroscopies
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Uterine Endoscopies
% 210.03/210.19 |- skos__broader mesh__D015907smesh__D013509
% 210.03/210.19 |- skos__broader mesh__D015907smesh__D003944
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Surgical Procedure, Hysteroscopic
% 210.03/210.19 |- skos__altLabel mesh__D015907 Surgery, Hysteroscopic
% 210.03/210.19 |- skos__altLabel mesh__D015907 Endoscopy, Uterine
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015907 2003
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Procedures, Hysteroscopic Surgical
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015907 2006
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Hysteroscopies
% 210.03/210.19 |- mesh__historyNote mesh__D015907 90; was see ENDOSCOPY 1979-89
% 210.03/210.19 |- mesh__dateCreated mesh__D015907 1989-10-04
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Hysteroscopic Surgical Procedure
% 210.03/210.19 |- skos__historyNote mesh__D015907 Endoscopy %28%1966-1989%29%
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Endoscopies, Uterine
% 210.03/210.19 |- skos__broader mesh__D015907smesh__D013513
% 210.03/210.19 |- skos__altLabel mesh__D015907 Hysteroscopic Surgery
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015907 2004
% 210.03/210.19 |- mesh__recordOriginator mesh__D015907 AGS
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Hysteroscopic Surgeries
% 210.03/210.19 |- rdf__type mesh__D015907sskos__Concept
% 210.03/210.19 |- skos__altLabel mesh__D015907 Uterine Endoscopy
% 210.03/210.19 |- mesh__dateEstablished mesh__D015907 1990-01-01
% 210.03/210.19 |- skos__hiddenLabel mesh__D015907 Procedure, Hysteroscopic Surgical
% 210.03/210.19 |- mesh__onlineNote mesh__D015907
% 210.03/210.19 use ENDOSCOPY to search HYSTEROSCOPY 1979-89
% 210.03/210.19 |- skos__hiddenLabel mesh__D015109 Hydroxylase, p-Hydroxybenzoate
% 210.03/210.19 |- skos__historyNote mesh__D015109 Hydroxylases %28%1971-1974%29%
% 210.03/210.19 |- mesh__dateEstablished mesh__D015109 1991-01-01
% 210.03/210.19 |- skos__broader mesh__D015109smesh__D006899
% 210.03/210.19 |- skos__scopeNote mesh__D015109
% 210.03/210.19 A flavoprotein that catalyzes the synthesis of protocatechuic acid from 4-hydroxybenzoate in the presence of molecular oxygen. EC 1.14.13.2.%A%
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D015109
% 210.03/210.19 91; was see under HYDROXYLASES 1975-90
% 210.03/210.19 |- skos__altLabel mesh__D015109 p-Hydroxybenzoate Hydroxylase
% 210.03/210.19 |- mesh__recordOriginator mesh__D015109 NLM
% 210.03/210.19 |- skos__hiddenLabel mesh__D015109 4 Hydroxybenzoate 3 Monooxygenase
% 210.03/210.19 |- mesh__dateRevised mesh__D015109 2004-07-07
% 210.03/210.19 |- skos__hiddenLabel mesh__D015109 p Hydroxybenzoate Hydroxylase
% 210.03/210.19 |- skos__historyNote mesh__D015109 Phenols %28%1971-1974%29%
% 210.03/210.19 |- skos__prefLabel mesh__D015109 4-Hydroxybenzoate-3-Monooxygenase
% 210.03/210.19 |- skos__hiddenLabel mesh__D015109 para Hydroxybenzoate Hydroxylase
% 210.03/210.19 |- mesh__historyNote mesh__D015109
% 210.03/210.19 91%28%75%29%; was see under HYDROXYLASES 1975-90
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015109 2005
% 210.03/210.19 |- mesh__recordMaintainer mesh__D015109 ssb
% 210.03/210.19 |- mesh__dateCreated mesh__D015109 1974-11-19
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D015109 2006
% 210.03/210.19 |- skos__altLabel mesh__D015109 para-Hydroxybenzoate Hydroxylase
% 210.03/210.19 |- skos__historyNote mesh__D015109 Benzoates %28%1971-1974%29%
% 210.03/210.19 |- rdf__type mesh__D015109sskos__Concept
% 210.03/210.19 |- skos__hiddenLabel mesh__D015109 Hydroxylase, para-Hydroxybenzoate
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D015109 sjn
% 210.03/210.19 |- skos__scopeNote mesh__D003883
% 210.03/210.19 A family of ascomycetous fungi, order Onygenales, characterized by smooth ascospores. The two genera in the family are Arthroderma and Ctenomyces. Several well-known anamorphic forms are parasitic upon the skin.%A%
% 210.03/210.19 |- skos__related mesh__D003883smesh__D008864
% 210.03/210.19 |- skos__prefLabel mesh__D003883 Arthrodermataceae
% 210.03/210.19 |- mesh__historyNote mesh__D003883
% 210.03/210.19 99; for ARTHRODERMA use ASCOMYCOTA 1975-98; for NANNIZZIA use MICROSPORUM 1975-98%A%
% 210.03/210.19 |- mesh__recordOriginator mesh__D003883 NLM
% 210.03/210.19 |- skos__altLabel mesh__D003883 Dermatophytes
% 210.03/210.19 |- mesh__recordMaintainer mesh__D003883 SYSTEM
% 210.03/210.19 |- skos__broader mesh__D003883smesh__D020036
% 210.03/210.19 |- skos__related mesh__D003883smesh__D004821
% 210.03/210.19 |- rdf__type mesh__D003883sskos__Concept
% 210.03/210.19 |- mesh__dateRevised mesh__D003883 2005-06-30
% 210.03/210.19 |- skos__altLabel mesh__D003883 Cutaneous Fungus
% 210.03/210.19 |- skos__related mesh__D003883smesh__D014249
% 210.03/210.19 |- skos__altLabel mesh__D003883 Dermatomyces
% 210.03/210.19 |- mesh__publicMeSHNote mesh__D003883
% 210.03/210.19 99; see DERMATOPHYTES 1963-98; for ARTHRODERMA see ASCOMYCOTA 1975-98; for NANNIZZIA see MICROSPORUM 1975-98%A%
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D003883 sjn
% 210.03/210.19 |- skos__altLabel mesh__D003883 Cutaneous Fungi
% 210.03/210.19 |- mesh__dateCreated mesh__D003883 1999-01-01
% 210.03/210.19 |- skos__annotation mesh__D003883 infection = DERMATOMYCOSES
% 210.03/210.19 |- skos__altLabel mesh__D003883 Arthroderma
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003883 2006
% 210.03/210.19 |- skos__annotation mesh__D003085
% 210.03/210.19 coord IM with organ/diseases %28%IM%29%, as renal colic = COLIC %28%IM%29% + KIDNEY DISEASES %28%IM%29%, biliary colic = COLIC %28%IM%29% + BILIARY TRACT DISEASES or specific %28%IM%29%%A%
% 210.03/210.19 |- skos__hiddenLabel mesh__D003085 Colic, Infantile
% 210.03/210.19 |- skos__broader mesh__D003085smesh__D015746
% 210.03/210.19 |- skos__altLabel mesh__D003085 Colicky Pain
% 210.03/210.19 |- skos__prefLabel mesh__D003085 Colic
% 210.03/210.19 |- skos__hiddenLabel mesh__D003085 Pain, Colicky
% 210.03/210.19 |- skos__scopeNote mesh__D003085
% 210.03/210.19 A clinical syndrome with intermittent abdominal pain characterized by sudden onset and cessation. It is usually associated with obstruction of the INTESTINES; of the CYSTIC DUCT; or of the URINARY TRACT.%A%
% 210.03/210.19 |- skos__hiddenLabel mesh__D003085 Cramps, Abdominal
% 210.03/210.19 |- skos__hiddenLabel mesh__D003085 Abdominal Cramp
% 210.03/210.19 |- mesh__recordMaintainer mesh__D003085 lkt
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003085 2006
% 210.03/210.19 |- skos__hiddenLabel mesh__D003085 Cramp, Abdominal
% 210.03/210.19 |- mesh__dateRevised mesh__D003085 2003-07-09
% 210.03/210.19 |- mesh__dateCreated mesh__D003085 1999-01-01
% 210.03/210.19 |- rdf__type mesh__D003085sskos__Concept
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003085 2005
% 210.03/210.19 |- mesh__recordOriginator mesh__D003085 NLM
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D003085 2004
% 210.03/210.19 |- mesh__recordAuthorizer mesh__D003085 sjn
% 210.03/210.19 |- skos__related mesh__D011517smesh__D001777
% 210.03/210.19 |- skos__scopeNote mesh__D011517
% 210.03/210.19 Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.%A%
% 210.03/210.19 |- skos__hiddenLabel mesh__D011517 Prothrombin Times
% 210.03/210.19 |- mesh__recordMaintainer mesh__D011517 nns
% 210.03/210.19 |- skos__altLabel mesh__D011517 Russell Viper Venom Time
% 210.03/210.19 |- skos__broader mesh__D011517smesh__D045122
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D011517 2005
% 210.03/210.19 |- skos__prefLabel mesh__D011517 Prothrombin Time
% 210.03/210.19 |- mesh__recordOriginator mesh__D011517 NLM
% 210.03/210.19 |- skos__altLabel mesh__D011517 Russells Viper Venom Time
% 210.03/210.19 |- mesh__activeMeSHYear mesh__D011517 2006
% 210.03/210.20 |- mesh__dateCreated mesh__D011517 1999-01-01
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D011517 2004
% 210.03/210.20 |- skos__hiddenLabel mesh__D011517 Test, Quick
% 210.03/210.20 |- rdf__type mesh__D011517sskos__Concept
% 210.03/210.20 |- skos__broader mesh__D011517smesh__D001780
% 210.03/210.20 |- skos__hiddenLabel mesh__D011517 Time, Prothrombin
% 210.03/210.20 |- skos__hiddenLabel mesh__D011517 Times, Prothrombin
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D011517 sjn
% 210.03/210.20 |- mesh__dateRevised mesh__D011517 2003-07-09
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D016202 2003
% 210.03/210.20 |- skos__hiddenLabel mesh__D016202 N Methyl D aspartate
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D016202 2006
% 210.03/210.20 |- skos__historyNote mesh__D016202 Convulsants %28%1975-1990%29%
% 210.03/210.20 |- mesh__historyNote mesh__D016202 91
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D016202 2004
% 210.03/210.20 |- rdf__type mesh__D016202sskos__Concept
% 210.03/210.20 |- mesh__recordMaintainer mesh__D016202 nns
% 210.03/210.20 |- skos__broader mesh__D016202smesh__D001224
% 210.03/210.20 |- skos__hiddenLabel mesh__D016202 N Methylaspartate
% 210.03/210.20 |- skos__hiddenLabel mesh__D016202 Acid, N-Methyl-D-aspartic
% 210.03/210.20 |- skos__hiddenLabel mesh__D016202 N Methyl D aspartic Acid
% 210.03/210.20 |- mesh__dateEstablished mesh__D016202 1991-01-01
% 210.03/210.20 |- mesh__dateRevised mesh__D016202 2001-07-25
% 210.03/210.20 |- mesh__recordOriginator mesh__D016202 RLS
% 210.03/210.20 |- skos__altLabel mesh__D016202 NMDA
% 210.03/210.20 |- skos__related mesh__D016202smesh__D016194
% 210.03/210.20 |- skos__annotation mesh__D016202
% 210.03/210.20 a glutamate agonist; /biosyn /physiol permitted; DF: note short X ref%A%
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D016202 2005
% 210.03/210.20 |- mesh__dateCreated mesh__D016202 1990-06-29
% 210.03/210.20 |- skos__prefLabel mesh__D016202 N-Methylaspartate
% 210.03/210.20 |- skos__scopeNote mesh__D016202
% 210.03/210.20 An amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors %28%RECEPTORS, NMDA%29%.%A%
% 210.03/210.20 |- skos__altLabel mesh__D016202 N-Methyl-D-aspartate
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D016202 2002
% 210.03/210.20 |- skos__historyNote mesh__D016202 Aspartic Acid %28%1966-1990%29%
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D016202 sjn
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D016202 91
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D007476 2006
% 210.03/210.20 |- mesh__dateRevised mesh__D007476 2005-06-30
% 210.03/210.20 |- mesh__historyNote mesh__D007476 76
% 210.03/210.20 |- skos__historyNote mesh__D007476 Uncoupling Agents %28%1972-1975%29%
% 210.03/210.20 |- skos__historyNote mesh__D007476 Antibiotics %28%1966-1975%29%
% 210.03/210.20 |- mesh__recordMaintainer mesh__D007476 ssb
% 210.03/210.20 |- skos__prefLabel mesh__D007476 Ionophores
% 210.03/210.20 |- mesh__dateCreated mesh__D007476 1975-07-25
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D007476 sjn
% 210.03/210.20 |- skos__historyNote mesh__D007476 Biological Transport %28%1966-1975%29%
% 210.03/210.20 |- rdf__type mesh__D007476sskos__Concept
% 210.03/210.20 |- skos__broader mesh__D007476smesh__D049990
% 210.03/210.20 |- mesh__dateEstablished mesh__D007476 1976-01-01
% 210.03/210.20 |- skos__broader mesh__D007476smesh__D020313
% 210.03/210.20 |- skos__related mesh__D007476smesh__D002463
% 210.03/210.20 |- skos__scopeNote mesh__D007476
% 210.03/210.20 Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes.%A%
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D007476 76
% 210.03/210.20 |- mesh__recordOriginator mesh__D007476 RLS
% 210.03/210.20 |- skos__annotation mesh__D015908
% 210.03/210.20 a type of assisted circulation; do not use /util except by MeSH definition%A%
% 210.03/210.20 |- mesh__recordMaintainer mesh__D015908 PLS
% 210.03/210.20 |- skos__related mesh__D015908smesh__D006353
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 1997
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 2005
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 1991
% 210.03/210.20 |- mesh__recordOriginator mesh__D015908 PLS
% 210.03/210.20 |- skos__historyNote mesh__D015908
% 210.03/210.20 Intra-Aortic Balloon Pumping %28%1977-1989%29%
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 2003
% 210.03/210.20 |- skos__historyNote mesh__D015908 Heart-Assist Devices %28%1986-1989%29%
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 2006
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 2000
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 2004
% 210.03/210.20 |- skos__hiddenLabel mesh__D015908 External Counterpulsation
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 1994
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 2001
% 210.03/210.20 |- skos__scopeNote mesh__D015908
% 210.03/210.20 A technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. It may be achieved by intra-aortic balloon, or by implanting a special pumping device in the chest, or externally by applying a negative pressure to the lower extremities during cardiac systole.%A%
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D015908 PLS
% 210.03/210.20 |- skos__historyNote mesh__D015908 Blood Pressure %28%1966-1989%29%
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 1998
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 1992
% 210.03/210.20 |- mesh__dateEstablished mesh__D015908 1990-01-01
% 210.03/210.20 |- rdf__type mesh__D015908sskos__Concept
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 1995
% 210.03/210.20 |- skos__prefLabel mesh__D015908 Counterpulsation
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 2002
% 210.03/210.20 |- skos__broader mesh__D015908smesh__D001243
% 210.03/210.20 |- skos__historyNote mesh__D015908 Assisted Circulation %28%1967-1989%29%
% 210.03/210.20 |- skos__hiddenLabel mesh__D015908 Counterpulsation, Diastolic
% 210.03/210.20 |- mesh__historyNote mesh__D015908 90
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D015908 90
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 1996
% 210.03/210.20 |- mesh__dateRevised mesh__D015908 1990-02-16
% 210.03/210.20 |- mesh__dateCreated mesh__D015908 1989-05-15
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 1999
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D015908 1993
% 210.03/210.20 |- skos__altLabel mesh__D040301 Fetal Liver Kinase-1
% 210.03/210.20 |- skos__hiddenLabel mesh__D040301 Flk-1, VEGF Receptor
% 210.03/210.20 |- skos__hiddenLabel mesh__D040301 VEGF Receptor Flk 1
% 210.03/210.20 |- mesh__dateCreated mesh__D040301 2002-07-03
% 210.03/210.20 |- skos__hiddenLabel mesh__D040301
% 210.03/210.20 Vascular Endothelial Growth Factor Receptor 2
% 210.03/210.20 |- skos__altLabel mesh__D040301 Kinase Insert Domain Receptor
% 210.03/210.20 |- skos__altLabel mesh__D040301 VEGFR-2
% 210.03/210.20 |- mesh__recordOriginator mesh__D040301 MDJ
% 210.03/210.20 |- mesh__historyNote mesh__D040301
% 210.03/210.20 2003; for FETAL LIVER KINASE-1, KDR TYROSINE KINASE, FLK-1 RECEPTOR TYROSINE KINASE %26% FLK-1 PROTEIN use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR 1993-2002; for VEGFR-2 use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR 1996-2002%A%
% 210.03/210.20 |- skos__altLabel mesh__D040301 Flk-1 Receptor Tyrosine Kinase
% 210.03/210.20 |- skos__altLabel mesh__D040301 Flk-1 Protein
% 210.03/210.20 |- skos__hiddenLabel mesh__D040301 Flk 1 Receptor Tyrosine Kinase
% 210.03/210.20 |- skos__broader mesh__D040301smesh__D040262
% 210.03/210.20 |- skos__hiddenLabel mesh__D040301 Fetal Liver Kinase 1
% 210.03/210.20 |- skos__altLabel mesh__D040301 KDR Tyrosine Kinase
% 210.03/210.20 |- skos__altLabel mesh__D040301 VEGF Receptor KDR
% 210.03/210.20 |- skos__hiddenLabel mesh__D040301 Flk 1 Protein
% 210.03/210.20 |- mesh__recordMaintainer mesh__D040301 jmp
% 210.03/210.20 |- skos__scopeNote mesh__D040301
% 210.03/210.20 A 200-230-kDa tyrosine kinase receptor for vascular endothelial growth factors found primarily in endothelial and hematopoietic cells and their precursors. VEGFR-2 is important for vascular and hematopoietic development, and mediates almost all endothelial cell responses to VEGF.%A%
% 210.03/210.20 |- skos__hiddenLabel mesh__D040301 Tyrosine Kinase, KDR
% 210.03/210.20 |- rdf__type mesh__D040301sskos__Concept
% 210.03/210.20 |- skos__historyNote mesh__D040301
% 210.03/210.20 Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 210.03/210.20 |- skos__historyNote mesh__D040301 Protein-Tyrosine Kinase %28%1993%29%
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D040301 sjn
% 210.03/210.20 |- mesh__dateRevised mesh__D040301 2005-06-30
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D040301
% 210.03/210.20 2003; VEGFR-2 was indexed under RECEPTORS, PROTEIN-TYROSINE KINASES 1996-2002%A%
% 210.03/210.20 |- skos__hiddenLabel mesh__D040301 KDR, VEGF Receptor
% 210.03/210.20 |- mesh__dateEstablished mesh__D040301 2003-01-01
% 210.03/210.20 |- skos__prefLabel mesh__D040301
% 210.03/210.20 Vascular Endothelial Growth Factor Receptor-2
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D040301 2006
% 210.03/210.20 |- skos__altLabel mesh__D040301 VEGF Receptor Flk-1
% 210.03/210.20 |- skos__historyNote mesh__D040301
% 210.03/210.20 Receptors, Growth Factor %28%1993-2002%29%
% 210.03/210.20 |- mesh__historyNote mesh__D012610
% 210.03/210.20 91%28%75%29%; was see under MYIASIS 1975-90
% 210.03/210.20 |- mesh__dateEstablished mesh__D012610 1991-01-01
% 210.03/210.20 |- skos__annotation mesh__D012610
% 210.03/210.20 caused by Cochliomyia hominivorax %28% = DIPTERA%29%
% 210.03/210.20 |- mesh__dateRevised mesh__D012610 2005-06-30
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D012610 sjn
% 210.03/210.20 |- skos__hiddenLabel mesh__D012610 Screw Worm Infections
% 210.03/210.20 |- skos__hiddenLabel mesh__D012610 Infections, Screw Worm
% 210.03/210.20 |- skos__prefLabel mesh__D012610 Screw Worm Infection
% 210.03/210.20 |- skos__altLabel mesh__D012610 Infection, Screw Worm
% 210.03/210.20 |- mesh__onlineNote mesh__D012610 search MYIASIS 1968-74
% 210.03/210.20 |- mesh__recordMaintainer mesh__D012610 ags
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D012610 91; was see under MYIASIS 1975-90
% 210.03/210.20 |- mesh__recordOriginator mesh__D012610 NLM
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012610 2006
% 210.03/210.20 |- skos__scopeNote mesh__D012610
% 210.03/210.20 Infection with larvae of the blow fly Cochliomyia hominivorax %28%Callitroga americanum%29%, a common cause of disease in livestock in the southern and southwestern U.S.A.%A%
% 210.03/210.20 |- mesh__dateCreated mesh__D012610 1999-01-01
% 210.03/210.20 |- rdf__type mesh__D012610sskos__Concept
% 210.03/210.20 |- skos__broader mesh__D012610smesh__D009198
% 210.03/210.20 |- rdf__type mesh__D003884sskos__Concept
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003884 2004
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003884 2006A
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003884 2001
% 210.03/210.20 |- skos__prefLabel mesh__D003884 Dermoid Cyst
% 210.03/210.20 |- skos__broader mesh__D003884smesh__D003560
% 210.03/210.20 |- skos__hiddenLabel mesh__D003884 Dermoids
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003884 2003
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D003884 DERMOID was heading 1968-80
% 210.03/210.20 |- mesh__dateCreated mesh__D003884 1999-01-01
% 210.03/210.20 |- mesh__historyNote mesh__D003884 DERMOID was heading 1968-80
% 210.03/210.20 |- skos__broader mesh__D003884smesh__D009373
% 210.03/210.20 |- skos__scopeNote mesh__D003884
% 210.03/210.20 A tumor consisting of displaced ectodermal structures along the lines of embryonic fusion, the wall being formed of epithelium-lined connective tissue, including skin appendages, and containing keratin, sebum, and hair. %28%Stedman, 25th ed%29%%A%
% 210.03/210.20 |- skos__hiddenLabel mesh__D003884 Cysts, Dermoid
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003884 2000
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003884 2006
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D003884 ags
% 210.03/210.20 |- mesh__dateRevised mesh__D003884 2005-07-12
% 210.03/210.20 |- skos__hiddenLabel mesh__D003884 Dermoid Cysts
% 210.03/210.20 |- mesh__recordOriginator mesh__D003884 NLM
% 210.03/210.20 |- skos__altLabel mesh__D003884 Dermoid
% 210.03/210.20 |- mesh__onlineNote mesh__D003884
% 210.03/210.20 use DERMOID CYST to search DERMOID 1968-80
% 210.03/210.20 |- skos__annotation mesh__D003884
% 210.03/210.20 neoplastic; coord IM with precoord organ/neopl term %28%IM%29%
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003884 2005
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003884 2002
% 210.03/210.20 |- mesh__recordMaintainer mesh__D003884 ags
% 210.03/210.20 |- skos__hiddenLabel mesh__D003884 Cyst, Dermoid
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Factor, Colicin
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Factor, Bacteriocin
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Plasmid, Bacteriocin
% 210.03/210.20 |- skos__scopeNote mesh__D003086
% 210.03/210.20 Plasmids encoding bacterial exotoxins %28%BACTERIOCINS%29%.
% 210.03/210.20 |- mesh__recordOriginator mesh__D003086 AEP
% 210.03/210.20 |- mesh__recordMaintainer mesh__D003086 nns
% 210.03/210.20 |- skos__historyNote mesh__D003086
% 210.03/210.20 Extrachromosomal Inheritance %28%1968-1977%29%
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Bacteriocin Plasmid
% 210.03/210.20 |- mesh__dateRevised mesh__D003086 2003-07-25
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Plasmid, Colicin
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Factors, Bacteriocin
% 210.03/210.20 |- skos__altLabel mesh__D003086 Colicin Factors
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D003086 sjn
% 210.03/210.20 |- skos__altLabel mesh__D003086 Bacteriocin Factors
% 210.03/210.20 |- skos__historyNote mesh__D003086 Plasmids %28%1975-1977%29%
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Factor, Col
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Col Factor
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003086 2005
% 210.03/210.20 |- mesh__historyNote mesh__D003086 2004%28%1978%29%
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Plasmids, Colicin
% 210.03/210.20 |- skos__prefLabel mesh__D003086 Bacteriocin Plasmids
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Factors, Colicin
% 210.03/210.20 |- skos__broader mesh__D003086smesh__D010957
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003086 2006
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D003086
% 210.03/210.20 2004; see COLICIN FACTORS 1991-2003, see PLASMIDS 1978-1990%A%
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Colicin Plasmid
% 210.03/210.20 |- rdf__type mesh__D003086sskos__Concept
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Factors, Col
% 210.03/210.20 |- mesh__dateEstablished mesh__D003086 1991-01-01
% 210.03/210.20 |- mesh__dateCreated mesh__D003086 1977-05-09
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Bacteriocin Factor
% 210.03/210.20 |- skos__historyNote mesh__D003086 Colicins %28%1966-1977%29%
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Colicin Factor
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003086 2004
% 210.03/210.20 |- skos__altLabel mesh__D003086 Col Factors
% 210.03/210.20 |- skos__hiddenLabel mesh__D003086 Plasmids, Bacteriocin
% 210.03/210.20 |- mesh__dateCreated mesh__D011518 1985-04-25
% 210.03/210.20 |- skos__hiddenLabel mesh__D011518 Proto-Oncogene Proteins, Cellular
% 210.03/210.20 |- skos__scopeNote mesh__D011518
% 210.03/210.20 Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity.%A%
% 210.03/210.20 |- skos__broader mesh__D011518smesh__D015513
% 210.03/210.20 |- skos__hiddenLabel mesh__D011518 c onc Proteins
% 210.03/210.20 |- skos__hiddenLabel mesh__D011518 Cellular Proto-Oncogene Products
% 210.03/210.20 |- mesh__dateEstablished mesh__D011518 1986-01-01
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D011518
% 210.03/210.20 91; was PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D011518 sjn
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D011518 2006
% 210.03/210.20 |- mesh__recordOriginator mesh__D011518 RLS
% 210.03/210.20 |- skos__prefLabel mesh__D011518 Proto-Oncogene Proteins
% 210.03/210.20 |- mesh__dateRevised mesh__D011518 2005-06-30
% 210.03/210.20 |- skos__altLabel mesh__D011518 Cellular Proto-Oncogene Proteins
% 210.03/210.20 |- skos__hiddenLabel mesh__D011518 Cellular Proto Oncogene Proteins
% 210.03/210.20 |- skos__historyNote mesh__D011518 Proteins %28%1966-1985%29%
% 210.03/210.20 |- mesh__recordMaintainer mesh__D011518 DRC
% 210.03/210.20 |- rdf__type mesh__D011518sskos__Concept
% 210.03/210.20 |- skos__historyNote mesh__D011518 Oncogenes %28%1983-1985%29%
% 210.03/210.20 |- mesh__onlineNote mesh__D011518
% 210.03/210.20 use PROTO-ONCOGENE PROTEINS to search PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90%A%
% 210.03/210.20 |- skos__historyNote mesh__D011518 Cell Differentiation %28%1966-1985%29%
% 210.03/210.20 |- skos__altLabel mesh__D011518 Proto Oncogene Proteins, Cellular
% 210.03/210.20 |- mesh__historyNote mesh__D011518
% 210.03/210.20 91; was PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90
% 210.03/210.20 |- skos__hiddenLabel mesh__D011518 Proto Oncogene Products, Cellular
% 210.03/210.20 |- skos__historyNote mesh__D011518
% 210.03/210.20 Gene Expression Regulation %28%1981-1985%29%
% 210.03/210.20 |- skos__annotation mesh__D011518
% 210.03/210.20 GEN or unspecified; prefer specifics; /drug eff /ultrastruct permitted; DF: note short X ref%A%
% 210.03/210.20 |- skos__hiddenLabel mesh__D011518 Proto Oncogene Proteins
% 210.03/210.20 |- skos__altLabel mesh__D011518 c-onc Proteins
% 210.03/210.20 |- skos__altLabel mesh__D011518 Proto-Oncogene Products, Cellular
% 210.03/210.20 |- rdf__type mesh__D049188sskos__Concept
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D049188 2006
% 210.03/210.20 |- skos__broader mesh__D049188smesh__D011248
% 210.03/210.20 |- mesh__historyNote mesh__D049188
% 210.03/210.20 2005; use PRENATAL EXPOSURE DELAYED EFFECTS 1991-2004
% 210.03/210.20 |- mesh__dateCreated mesh__D049188 2004-07-07
% 210.03/210.20 |- skos__historyNote mesh__D049188 Pregnancy %28%1976-2004%29%
% 210.03/210.20 |- mesh__dateRevised mesh__D049188 2005-06-30
% 210.03/210.20 |- mesh__recordMaintainer mesh__D049188 lkt
% 210.03/210.20 |- skos__prefLabel mesh__D049188 Prenatal Injuries
% 210.03/210.20 |- skos__historyNote mesh__D049188
% 210.03/210.20 Prenatal Exposure Delayed Effects %28%1977-2004%29%
% 210.03/210.20 |- skos__hiddenLabel mesh__D049188 Prenatal Injury
% 210.03/210.20 |- skos__hiddenLabel mesh__D049188 Injury, Prenatal
% 210.03/210.20 |- skos__annotation mesh__D049188
% 210.03/210.20 for any damage to the EMBRYO or FETUS; not limited to traumatic injuries%A%
% 210.03/210.20 |- skos__scopeNote mesh__D049188
% 210.03/210.20 Damages to the EMBRYO or the FETUS before BIRTH. Damages can be caused by any factors including biological, chemical, or physical.%A%
% 210.03/210.20 |- mesh__recordOriginator mesh__D049188 lkt
% 210.03/210.20 |- mesh__dateEstablished mesh__D049188 2005-01-01
% 210.03/210.20 |- skos__altLabel mesh__D049188 Injuries, Prenatal
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D049188
% 210.03/210.20 2005; see PRENATAL EXPOSURE DELAYED EFFECTS 1991-2004
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D049188 sjn
% 210.03/210.20 |- skos__broader mesh__D016203smesh__D042846
% 210.03/210.20 |- skos__altLabel mesh__D016203 cdk1 Kinase
% 210.03/210.20 |- skos__altLabel mesh__D016203 Protein p34cdc2
% 210.03/210.20 |- skos__hiddenLabel mesh__D016203 Cyclin Dependent Kinase 1
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D016203 2006
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D016203 sjn
% 210.03/210.20 |- mesh__recordMaintainer mesh__D016203 ssb
% 210.03/210.20 |- skos__prefLabel mesh__D016203 CDC2 Protein Kinase
% 210.03/210.20 |- mesh__dateCreated mesh__D016203 1990-06-19
% 210.03/210.20 |- skos__broader mesh__D016203smesh__D010750
% 210.03/210.20 |- skos__altLabel mesh__D016203 Cyclin-Dependent Kinase 1
% 210.03/210.20 |- mesh__historyNote mesh__D016203 2004%28%1991%29%
% 210.03/210.20 |- skos__altLabel mesh__D016203 Cdk1 Protein Kinase
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D016203
% 210.03/210.20 2004; see PROTEIN P34CDC2 1991-2003
% 210.03/210.20 |- skos__altLabel mesh__D016203 Histone Kinase p34%28%cdc2%29%
% 210.03/210.20 |- skos__hiddenLabel mesh__D016203 Protein Kinase, Cdk1
% 210.03/210.20 |- rdf__type mesh__D016203sskos__Concept
% 210.03/210.20 |- skos__hiddenLabel mesh__D016203 p34cdc2, Protein
% 210.03/210.20 |- skos__broader mesh__D016203smesh__D016200
% 210.03/210.20 |- skos__scopeNote mesh__D016203
% 210.03/210.20 Phosphoprotein with protein kinase activity that functions in the G2/M phase transition of the CELL CYCLE. It is the catalytic subunit of the MATURATION-PROMOTING FACTOR and complexes with both CYCLIN A and CYCLIN B in mammalian cells. The maximal activity of cyclin-dependent kinase 1 is achieved when it is fully dephosphorylated.%A%
% 210.03/210.20 |- skos__altLabel mesh__D016203 cdc2+ Protein
% 210.03/210.20 |- mesh__dateRevised mesh__D016203 2005-06-30
% 210.03/210.20 |- mesh__recordOriginator mesh__D016203 AGS
% 210.03/210.20 |- mesh__dateEstablished mesh__D016203 1991-01-01
% 210.03/210.20 |- skos__historyNote mesh__D016203 Phosphoproteins %28%1987-1990%29%
% 210.03/210.20 |- skos__hiddenLabel mesh__D016203 Protein Kinase, CDC2
% 210.03/210.20 |- skos__broader mesh__D007477smesh__D004573
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D007477 2004
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D007477 2002
% 210.03/210.20 |- mesh__recordMaintainer mesh__D007477 adp
% 210.03/210.20 |- rdf__type mesh__D007477sskos__Concept
% 210.03/210.20 |- skos__annotation mesh__D007477
% 210.03/210.20 avoid: too general; GEN; ionization chamber: index under RADIOMETRY /instrum%A%
% 210.03/210.20 |- mesh__dateRevised mesh__D007477 2000-06-22
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D007477 2003
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D007477 2001
% 210.03/210.20 |- mesh__recordOriginator mesh__D007477 NLM
% 210.03/210.20 |- skos__prefLabel mesh__D007477 Ions
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D007477 sjn
% 210.03/210.20 |- mesh__dateCreated mesh__D007477 1999-01-01
% 210.03/210.20 |- skos__scopeNote mesh__D007477
% 210.03/210.20 An atom or group of atoms that have a positive or negative electric charge due to a gain %28%negative charge%29% or loss %28%positive charge%29% of one or more electrons. Atoms with a positive charge are known as CATIONS; those with a negative charge are ANIONS.%A%
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D007477 2006
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D007477 2005
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1989
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1992
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1999
% 210.03/210.20 |- skos__broader mesh__D012611smesh__D005837
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 2005
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1996
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1993
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 2002
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1990
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 2006
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1997
% 210.03/210.20 |- mesh__dateCreated mesh__D012611 1999-01-01
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 2003
% 210.03/210.20 |- rdf__type mesh__D012611sskos__Concept
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 2000
% 210.03/210.20 |- skos__hiddenLabel mesh__D012611 Scrotums
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1994
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 2004
% 210.03/210.20 |- skos__prefLabel mesh__D012611 Scrotum
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1991
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 2001
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1998
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D012611 1995
% 210.03/210.20 |- skos__scopeNote mesh__D003885
% 210.03/210.20 Specific substances elaborated by plants, microorganisms or animals that cause damage to the skin; they may be proteins or other specific factors or substances; constituents of spider, jellyfish or other venoms cause dermonecrosis and certain bacteria synthesize dermolytic agents.%A%
% 210.03/210.20 |- skos__historyNote mesh__D003885 specific skin heading %28%1966-1977%29%
% 210.03/210.20 |- mesh__dateRevised mesh__D003885 2005-06-30
% 210.03/210.20 |- skos__annotation mesh__D003885
% 210.03/210.20 /antag permitted but consider also ANTITOXINS; coord IM with source of dermotoxin %28%IM or NIM%29%; do not use for dermatoxicity of various chemicals %26% drugs %28% = SKIN /drug eff or skin dis heading /chem ind + Cat D term /adv eff-pois-tox%29%%A%
% 210.03/210.20 |- mesh__recordOriginator mesh__D003885 SH
% 210.03/210.20 |- skos__historyNote mesh__D003885 Skin %28%1966-1977%29%
% 210.03/210.20 |- skos__altLabel mesh__D003885 Dermatotoxins
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D003885 sjn
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003885 2006
% 210.03/210.20 |- skos__broader mesh__D003885smesh__D009676
% 210.03/210.20 |- mesh__recordMaintainer mesh__D003885 ssb
% 210.03/210.20 |- mesh__dateEstablished mesh__D003885 1978-01-01
% 210.03/210.20 |- mesh__historyNote mesh__D003885 78
% 210.03/210.20 |- skos__prefLabel mesh__D003885 Dermotoxins
% 210.03/210.20 |- skos__historyNote mesh__D003885 Toxins %28%1966-1977%29%
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D003885 78
% 210.03/210.20 |- rdf__type mesh__D003885sskos__Concept
% 210.03/210.20 |- mesh__dateCreated mesh__D003885 1977-04-22
% 210.03/210.20 |- rdf__type mesh__D036261sskos__Concept
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D036261 sjn
% 210.03/210.20 |- mesh__historyNote mesh__D036261
% 210.03/210.20 2003; use RECEPTOR, EPHB6 %28%NM%29% 1996-2002
% 210.03/210.20 |- skos__historyNote mesh__D036261 Membrane Proteins %28%1996-2002%29%
% 210.03/210.20 |- mesh__dateRevised mesh__D036261 2005-06-30
% 210.03/210.20 |- skos__altLabel mesh__D036261 Mep Protein
% 210.03/210.20 |- skos__prefLabel mesh__D036261 Receptor, EphB6
% 210.03/210.20 |- mesh__dateEstablished mesh__D036261 2003-01-01
% 210.03/210.20 |- skos__broader mesh__D036261smesh__D036081
% 210.03/210.20 |- skos__hiddenLabel mesh__D036261 EphB6, Ephrin Receptor
% 210.03/210.20 |- skos__altLabel mesh__D036261 Ephrin Receptor EphB6
% 210.03/210.20 |- skos__scopeNote mesh__D036261
% 210.03/210.20 An eph family receptor found primarily in BRAIN and THYMUS. The EphB6 receptor is unusual in that its tyrosine kinase domain shares little homology with other members of this class. The unusual tyrosine kinase domain of this receptor appears to result in its lack of tyrosine kinase activity.%A%
% 210.03/210.20 |- skos__altLabel mesh__D036261 EphB6 Receptor
% 210.03/210.20 |- mesh__dateCreated mesh__D036261 2002-07-03
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D036261 2006
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D036261
% 210.03/210.20 2003; MEP PROTEIN %28%now RECEPTOR, EPHB6%29% was indexed under MEMBRANE PROTEINS 1996-2002, EPHB6 RECEPTOR was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2001-2002%A%
% 210.03/210.20 |- mesh__recordMaintainer mesh__D036261 jmp
% 210.03/210.20 |- skos__historyNote mesh__D036261
% 210.03/210.20 Receptor Protein-Tyrosine Kinases %28%2001-2002%29%
% 210.03/210.20 |- skos__hiddenLabel mesh__D036261 Receptor EphB6, Ephrin
% 210.03/210.20 |- mesh__recordOriginator mesh__D036261 jmp
% 210.03/210.20 |- mesh__recordMaintainer mesh__D003087 SYSTEM
% 210.03/210.20 |- skos__broader mesh__D003087smesh__D001426
% 210.03/210.20 |- skos__altLabel mesh__D003087 Colicin E
% 210.03/210.20 |- skos__hiddenLabel mesh__D003087 Colicin K K235
% 210.03/210.20 |- mesh__dateRevised mesh__D003087 2005-06-30
% 210.03/210.20 |- mesh__dateCreated mesh__D003087 1999-01-01
% 210.03/210.20 |- skos__prefLabel mesh__D003087 Colicins
% 210.03/210.20 |- skos__broader mesh__D003087smesh__D029968
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D003087 2006
% 210.03/210.20 |- mesh__dateEstablished mesh__D003087 1966-01-01
% 210.03/210.20 |- mesh__recordOriginator mesh__D003087 NLM
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D003087 sjn
% 210.03/210.20 |- rdf__type mesh__D003087sskos__Concept
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D003087 66
% 210.03/210.20 |- skos__scopeNote mesh__D003087
% 210.03/210.20 Bacteriocins elaborated by strains of Escherichia coli and related species. They are proteins or protein-lipopolysaccharide complexes lethal to other strains of the same species.%A%
% 210.03/210.20 |- skos__altLabel mesh__D003087 Colicines
% 210.03/210.20 |- mesh__historyNote mesh__D003087 66%28%65%29%
% 210.03/210.20 |- mesh__recordMaintainer mesh__D011519 nns
% 210.03/210.20 |- skos__scopeNote mesh__D011519
% 210.03/210.20 Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc.%A%
% 210.03/210.20 |- skos__broader mesh__D011519smesh__D009857
% 210.03/210.20 |- skos__prefLabel mesh__D011519 Proto-Oncogenes
% 210.03/210.20 |- skos__hiddenLabel mesh__D011519 Proto Oncogene
% 210.03/210.20 |- skos__altLabel mesh__D011519 Proto-Oncogene
% 210.03/210.20 |- skos__hiddenLabel mesh__D011519 Proto Oncogenes
% 210.03/210.20 |- mesh__dateCreated mesh__D011519 1985-03-20
% 210.03/210.20 |- skos__annotation mesh__D011519
% 210.03/210.20 %22%normal cellular genes homologous to viral oncogenes%22%
% 210.03/210.20 |- mesh__recordOriginator mesh__D011519 AEP
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D011519 2006
% 210.03/210.20 |- mesh__historyNote mesh__D011519 86; was see ONCOGENES 1983-85
% 210.03/210.20 |- mesh__recordAuthorizer mesh__D011519 sjn
% 210.03/210.20 |- mesh__dateEstablished mesh__D011519 1986-01-01
% 210.03/210.20 |- skos__historyNote mesh__D011519 Genes %28%1966-1977%29%
% 210.03/210.20 |- mesh__dateRevised mesh__D011519 2005-06-30
% 210.03/210.20 |- rdf__type mesh__D011519sskos__Concept
% 210.03/210.20 |- skos__historyNote mesh__D011519 Genes, Viral %28%1978-1982%29%
% 210.03/210.20 |- mesh__onlineNote mesh__D011519 search ONCOGENES 1983-85
% 210.03/210.20 |- mesh__publicMeSHNote mesh__D011519 86; was see ONCOGENES 1983-85
% 210.03/210.20 |- skos__historyNote mesh__D011519 Oncogenes %28%1983-1985%29%
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D008570 2005
% 210.03/210.20 |- mesh__activeMeSHYear mesh__D008570 2001
% 210.03/210.20 |- skos__altLabel mesh__D008570 Memory, Shortterm
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D008570 69
% 210.03/210.21 |- skos__prefLabel mesh__D008570 Memory, Short-Term
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008570 1997
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Immediate Memory
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008570 2006
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Memories, Immediate
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Immediate Recalls
% 210.03/210.21 |- skos__historyNote mesh__D008570 Memory %28%1966-1968%29%
% 210.03/210.21 |- mesh__dateRevised mesh__D008570 1995-06-08
% 210.03/210.21 |- mesh__dateEstablished mesh__D008570 1969-01-01
% 210.03/210.21 |- mesh__dateCreated mesh__D008570 1999-01-01
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Memory, Short Term
% 210.03/210.21 |- skos__broader mesh__D008570smesh__D008568
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008570 2002
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008570 2003
% 210.03/210.21 |- skos__scopeNote mesh__D008570
% 210.03/210.21 Temporary storage of information for a few seconds to hours, as opposed to long-term memory which refers to material stored for days, years, or a lifetime.%A%
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Memories, Shortterm
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Shortterm Memories
% 210.03/210.21 |- mesh__historyNote mesh__D008570
% 210.03/210.21 69; IMMEDIATE RECALL was see under MEMORY, SHORT-TERM 1969-78%A%
% 210.03/210.21 |- mesh__onlineNote mesh__D008570
% 210.03/210.21 use MEMORY, SHORT-TERM to search IMMEDIATE RECALL 1969-78%A%
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Recall, Immediate
% 210.03/210.21 |- mesh__recordMaintainer mesh__D008570 RAZ
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Short-Term Memories
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008570 1998
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Shortterm Memory
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008570 2004
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Recalls, Immediate
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Memories, Short-Term
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Immediate Memories
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008570 1999
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008570 2000
% 210.03/210.21 |- skos__hiddenLabel mesh__D008570 Short-Term Memory
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D008570 PLS
% 210.03/210.21 |- rdf__type mesh__D008570sskos__Concept
% 210.03/210.21 |- skos__altLabel mesh__D008570 Memory, Immediate
% 210.03/210.21 |- mesh__recordOriginator mesh__D008570 NLM
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008570 1996
% 210.03/210.21 |- skos__historyNote mesh__D022241 Viral Vaccines %28%1964-2000%29%
% 210.03/210.21 |- skos__hiddenLabel mesh__D022241 Vaccines, Parainfluenza
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D022241 2006
% 210.03/210.21 |- mesh__dateRevised mesh__D022241 2005-06-30
% 210.03/210.21 |- rdf__type mesh__D022241sskos__Concept
% 210.03/210.21 |- skos__scopeNote mesh__D022241
% 210.03/210.21 Vaccines or candidate vaccines used to prevent infection with parainfluenza viruses in humans and animals.%A%
% 210.03/210.21 |- mesh__recordOriginator mesh__D022241 ags
% 210.03/210.21 |- mesh__dateCreated mesh__D022241 2000-06-22
% 210.03/210.21 |- skos__broader mesh__D022241smesh__D014765
% 210.03/210.21 |- mesh__historyNote mesh__D022241 2001
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D022241 sjn
% 210.03/210.21 |- skos__annotation mesh__D022241
% 210.03/210.21 coord IM with specific parainfluenza virus /immunol %28%IM%29%
% 210.03/210.21 |- mesh__dateEstablished mesh__D022241 2001-01-01
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D022241 2001
% 210.03/210.21 |- mesh__recordMaintainer mesh__D022241 ssb
% 210.03/210.21 |- skos__prefLabel mesh__D022241 Parainfluenza Vaccines
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007478 2003
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D007478 sjn
% 210.03/210.21 |- skos__scopeNote mesh__D007478
% 210.03/210.21 Therapeutic introduction of ions of soluble salts into tissues by means of electric current. In medical literature it is commonly used to indicate the process of increasing the penetration of drugs into surface tissues by the application of electric current. It has nothing to do with ION EXCHANGE; AIR IONIZATION nor PHONOPHORESIS, none of which requires current.%A%
% 210.03/210.21 |- skos__hiddenLabel mesh__D007478 Iontophoreses
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007478 2004
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007478 2002
% 210.03/210.21 |- rdf__type mesh__D007478sskos__Concept
% 210.03/210.21 |- mesh__dateCreated mesh__D007478 1999-01-01
% 210.03/210.21 |- mesh__recordMaintainer mesh__D007478 mdb
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007478 2005
% 210.03/210.21 |- skos__broader mesh__D007478smesh__D004333
% 210.03/210.21 |- skos__prefLabel mesh__D007478 Iontophoresis
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007478 2006
% 210.03/210.21 |- skos__broader mesh__D007478smesh__D004586
% 210.03/210.21 |- mesh__dateRevised mesh__D007478 2001-07-25
% 210.03/210.21 |- mesh__recordOriginator mesh__D007478 NLM
% 210.03/210.21 |- mesh__recordOriginator mesh__D004180 NLM
% 210.03/210.21 |- mesh__dateRevised mesh__D004180 1997-06-20
% 210.03/210.21 |- skos__annotation mesh__D004180 DF: DIRECT SERV COSTS
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004180 2000
% 210.03/210.21 |- rdf__type mesh__D004180sskos__Concept
% 210.03/210.21 |- skos__scopeNote mesh__D004180
% 210.03/210.21 Costs which are directly identifiable with a particular service.%A%
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004180 2005
% 210.03/210.21 |- skos__hiddenLabel mesh__D004180 Cost, Direct Service
% 210.03/210.21 |- skos__broader mesh__D004180smesh__D017048
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D004180
% 210.03/210.21 91; was see under COSTS AND COST ANALYSIS 1975-90
% 210.03/210.21 |- mesh__onlineNote mesh__D004180 search COSTS AND COST ANALYSIS 1968-74
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004180 1998
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D004180 SJN
% 210.03/210.21 |- mesh__dateCreated mesh__D004180 1999-01-01
% 210.03/210.21 |- skos__prefLabel mesh__D004180 Direct Service Costs
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004180 2001
% 210.03/210.21 |- skos__hiddenLabel mesh__D004180 Service Cost, Direct
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004180 2006
% 210.03/210.21 |- mesh__historyNote mesh__D004180
% 210.03/210.21 91%28%75%29%; was see under COSTS AND COST ANALYSIS 1975-90
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004180 1999
% 210.03/210.21 |- skos__altLabel mesh__D004180 Costs, Direct Service
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004180 2002
% 210.03/210.21 |- skos__hiddenLabel mesh__D004180 Direct Service Cost
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004180 2003
% 210.03/210.21 |- mesh__recordMaintainer mesh__D004180 TPW
% 210.03/210.21 |- mesh__dateEstablished mesh__D004180 1991-01-01
% 210.03/210.21 |- skos__altLabel mesh__D004180 Service Costs, Direct
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004180 2004
% 210.03/210.21 |- mesh__recordMaintainer mesh__D012612 ags
% 210.03/210.21 |- mesh__recordOriginator mesh__D012612 NLM
% 210.03/210.21 |- skos__prefLabel mesh__D012612 Scrub Typhus
% 210.03/210.21 |- skos__altLabel mesh__D012612 Tsutsugamushi Fever
% 210.03/210.21 |- skos__hiddenLabel mesh__D012612 Tsutsugamushi Diseases
% 210.03/210.21 |- skos__scopeNote mesh__D012612
% 210.03/210.21 An acute infectious disease caused by ORIENTIA TSUTSUGAMUSHI. It is limited to eastern and southeastern Asia, India, northern Australia, and the adjacent islands. Characteristics include the formation of a primary cutaneous lesion at the site of the bite of an infected mite, fever lasting about two weeks, and a maculopapular rash.%A%
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D012612
% 210.03/210.21 TSUTSUGAMUSHI DISEASE was TSUTSUGAMUSHI see SCRUB TYPHUS 1963-91%A%
% 210.03/210.21 |- skos__hiddenLabel mesh__D012612 Fever, Tsutsugamushi
% 210.03/210.21 |- skos__annotation mesh__D012612 caused by ORIENTIA TSUTSUGAMUSHI
% 210.03/210.21 |- skos__altLabel mesh__D012612 Tsutsugamushi Disease
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012612 2006
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D012612 sjn
% 210.03/210.21 |- mesh__onlineNote mesh__D012612
% 210.03/210.21 use SCRUB TYPHUS to search TSUTSUGAMUSHI 1966-91
% 210.03/210.21 |- skos__hiddenLabel mesh__D012612 Fevers, Tsutsugamushi
% 210.03/210.21 |- skos__hiddenLabel mesh__D012612 Disease, Tsutsugamushi
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012612 2004
% 210.03/210.21 |- rdf__type mesh__D012612sskos__Concept
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012612 2005
% 210.03/210.21 |- mesh__dateCreated mesh__D012612 1999-01-01
% 210.03/210.21 |- skos__broader mesh__D012612smesh__D012288
% 210.03/210.21 |- skos__hiddenLabel mesh__D012612 Diseases, Tsutsugamushi
% 210.03/210.21 |- mesh__dateRevised mesh__D012612 2003-07-09
% 210.03/210.21 |- mesh__historyNote mesh__D012612
% 210.03/210.21 TSUTSUGAMUSHI DISEASE was TSUTSUGAMUSHI see SCRUB TYPHUS 1963-91%A%
% 210.03/210.21 |- skos__hiddenLabel mesh__D012612 Tsutsugamushi Fevers
% 210.03/210.21 |- skos__altLabel mesh__D012612 Typhus, Scrub
% 210.03/210.21 |- mesh__recordMaintainer mesh__D003886 lkt
% 210.03/210.21 |- mesh__recordOriginator mesh__D003886 NLM
% 210.03/210.21 |- mesh__historyNote mesh__D003886 2006 %28%1964%29%
% 210.03/210.21 |- skos__scopeNote mesh__D003886
% 210.03/210.21 A layer of the cornea. It is the basal lamina of the CORNEAL ENDOTHELIUM %28%from which it is secreted%29% separating it from the CORNEAL STROMA. It is a homogeneous structure composed of fine collagenous filaments, and slowly increases in thickness with age.%A%
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003886 2006
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Membrane, Descemet
% 210.03/210.21 |- skos__altLabel mesh__D003886 Lamina Elastica Posterior
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Elastica Posterior, Lamina
% 210.03/210.21 |- skos__broader mesh__D003886smesh__D003315
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Lamina Elastica Posteriors
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D003886
% 210.03/210.21 2006; see DESCEMENT%27%S MEMBRANE 1964-2005
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Membrane, Descemet%27%s
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Descemet Membranes
% 210.03/210.21 |- mesh__dateRevised mesh__D003886 2005-06-30
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Elastica Posteriors, Lamina
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Descemets Membrane
% 210.03/210.21 |- skos__broader mesh__D003886smesh__D001485
% 210.03/210.21 |- skos__altLabel mesh__D003886 Descemet%27%s Membrane
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D003886 sjn
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Membranes, Descemet
% 210.03/210.21 |- mesh__dateCreated mesh__D003886 1999-01-01
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Posterior, Lamina Elastica
% 210.03/210.21 |- rdf__type mesh__D003886sskos__Concept
% 210.03/210.21 |- skos__hiddenLabel mesh__D003886 Posteriors, Lamina Elastica
% 210.03/210.21 |- mesh__dateEstablished mesh__D003886 1974-01-01
% 210.03/210.21 |- skos__prefLabel mesh__D003886 Descemet Membrane
% 210.03/210.21 |- skos__scopeNote mesh__D036262
% 210.03/210.21 The study, based on direct observation, use of statistical records, interviews, or experimental methods, of actual practices or the actual impact of practices or policies.%A%
% 210.03/210.21 |- skos__related mesh__D036262smesh__D003625
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D036262 2005
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D036262 2003
% 210.03/210.21 |- mesh__dateEstablished mesh__D036262 2003-01-01
% 210.03/210.21 |- mesh__historyNote mesh__D036262 2003
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D036262 2006
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D036262 2004
% 210.03/210.21 |- skos__prefLabel mesh__D036262 Empirical Research
% 210.03/210.21 |- rdf__type mesh__D036262sskos__Concept
% 210.03/210.21 |- mesh__dateCreated mesh__D036262 2002-07-03
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D036262 2003
% 210.03/210.21 |- skos__broader mesh__D036262smesh__D012106
% 210.03/210.21 |- skos__hiddenLabel mesh__D036262 Research, Empirical
% 210.03/210.21 |- mesh__dateRevised mesh__D003088 2004-07-07
% 210.03/210.21 |- skos__hiddenLabel mesh__D003088 Bobwhites
% 210.03/210.21 |- skos__hiddenLabel mesh__D003088 Bob White
% 210.03/210.21 |- rdf__type mesh__D003088sskos__Concept
% 210.03/210.21 |- skos__altLabel mesh__D003088 Colinis
% 210.03/210.21 |- skos__scopeNote mesh__D003088
% 210.03/210.21 A genus of QUAIL, in the family Odontophoridae, comprised of at least four different species of bobwhites.%A%
% 210.03/210.21 |- skos__altLabel mesh__D003088 Bobwhite
% 210.03/210.21 |- mesh__dateEstablished mesh__D003088 1991-01-01
% 210.03/210.21 |- skos__broader mesh__D003088smesh__D011784
% 210.03/210.21 |- mesh__historyNote mesh__D003088
% 210.03/210.21 91%28%75%29%; was see under QUAIL 1975-90; BOBWHITE was BOB-WHITE 1975-94%A%
% 210.03/210.21 |- skos__altLabel mesh__D003088 Bob-White
% 210.03/210.21 |- mesh__recordMaintainer mesh__D003088 ags
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003088 2005
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D003088
% 210.03/210.21 91; was see under QUAIL 1975-90; BOBWHITE was BOB-WHITE 1975-94%A%
% 210.03/210.21 |- skos__prefLabel mesh__D003088 Colinus
% 210.03/210.21 |- skos__annotation mesh__D003088
% 210.03/210.21 diseases: coord IM with BIRD DISEASES %28%IM%29%
% 210.03/210.21 |- skos__hiddenLabel mesh__D003088 Bob-Whites
% 210.03/210.21 |- mesh__recordOriginator mesh__D003088 NLM
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003088 2006
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D003088 sjn
% 210.03/210.21 |- mesh__dateCreated mesh__D003088 1974-11-19
% 210.03/210.21 |- skos__historyNote mesh__D008571 Male %28%1966-1979%29%
% 210.03/210.21 |- skos__broader mesh__D008571smesh__D009272
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D008571 80
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008571 2006
% 210.03/210.21 |- mesh__recordMaintainer mesh__D008571 ags
% 210.03/210.21 |- skos__prefLabel mesh__D008571 Men
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D008571 sjn
% 210.03/210.21 |- mesh__dateCreated mesh__D008571 1979-04-27
% 210.03/210.21 |- mesh__recordOriginator mesh__D008571 SMH
% 210.03/210.21 |- skos__annotation mesh__D008571
% 210.03/210.21 for men only as a cultural, social, sociological, political, economic force; do not confuse with the check tag MALE; when indexing MEN, check the tags HUMANS %26% MALE; Manual 18.9.6, 34.12%A%
% 210.03/210.21 |- rdf__type mesh__D008571sskos__Concept
% 210.03/210.21 |- mesh__historyNote mesh__D008571 80
% 210.03/210.21 |- mesh__dateEstablished mesh__D008571 1980-01-01
% 210.03/210.21 |- skos__scopeNote mesh__D008571
% 210.03/210.21 Human adult males as cultural, psychological, sociological, political, and economic entities.%A%
% 210.03/210.21 |- mesh__dateRevised mesh__D008571 2005-06-30
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D022242 2006
% 210.03/210.21 |- skos__scopeNote mesh__D022242
% 210.03/210.21 Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.%A%
% 210.03/210.21 |- mesh__historyNote mesh__D022242
% 210.03/210.21 2001; use PNEUMOCOCCAL VACCINES %28%NM%29% to search PNEUMOVAX 1978-2000%A%
% 210.03/210.21 |- skos__broader mesh__D022242smesh__D022541
% 210.03/210.21 |- skos__prefLabel mesh__D022242 Pneumococcal Vaccines
% 210.03/210.21 |- rdf__type mesh__D022242sskos__Concept
% 210.03/210.21 |- skos__hiddenLabel mesh__D022242 Vaccines, Pneumococcal
% 210.03/210.21 |- mesh__dateEstablished mesh__D022242 2001-01-01
% 210.03/210.21 |- skos__hiddenLabel mesh__D022242 Vaccine, Pneumococcal Polysaccharide
% 210.03/210.21 |- mesh__dateRevised mesh__D022242 2005-06-30
% 210.03/210.21 |- mesh__recordMaintainer mesh__D022242 ags
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D022242
% 210.03/210.21 2001; PNEUMOVAX %28%now PNEUMOCOCCAL VACCINES%29% was indexed under BACTERIAL VACCINES 1983-2000 %26% POLYSACCHARIDES, BACTERIAL 1978-1982%A%
% 210.03/210.21 |- skos__hiddenLabel mesh__D022242 Pnu Imune Vaccine
% 210.03/210.21 |- mesh__dateCreated mesh__D022242 2000-06-22
% 210.03/210.21 |- mesh__recordOriginator mesh__D022242 ags
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D022242 sjn
% 210.03/210.21 |- skos__historyNote mesh__D022242 Bacterial Vaccines %28%1965-2000%29%
% 210.03/210.21 |- skos__hiddenLabel mesh__D022242 Polysaccharide Vaccine, Pneumococcal
% 210.03/210.21 |- skos__hiddenLabel mesh__D022242 PnuImune Vaccine
% 210.03/210.21 |- skos__hiddenLabel mesh__D016205 Rat, Rice
% 210.03/210.21 |- rdf__type mesh__D016205sskos__Concept
% 210.03/210.21 |- skos__hiddenLabel mesh__D016205 Rice Rats
% 210.03/210.21 |- skos__historyNote mesh__D016205 Rodentia %28%1966-1981%29%
% 210.03/210.21 |- skos__hiddenLabel mesh__D016205 Cotton Rat
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D016205
% 210.03/210.21 2006; see HESPEROMYINAE 1991-2005; for NEOTOMA, SIGMODON, and RATS, COTTON see CRICETIDAE 1982-1990%A%
% 210.03/210.21 |- mesh__historyNote mesh__D016205
% 210.03/210.21 2006 %28%1991%29%; for NEOTOMA, SIGMODON, and RATS, COTTON use ARVICOLINAE 1982-1990%A%
% 210.03/210.21 |- skos__altLabel mesh__D016205 Hesperomyinae
% 210.03/210.21 |- skos__historyNote mesh__D016205 Microtinae %28%1982-1990%29%
% 210.03/210.21 |- skos__broader mesh__D016205smesh__D009115
% 210.03/210.21 |- mesh__recordOriginator mesh__D016205 PXP
% 210.03/210.21 |- skos__scopeNote mesh__D016205
% 210.03/210.21 A subfamily of the family MURIDAE comprised of 69 genera. New World mice and rats are included in this subfamily.%A%
% 210.03/210.21 |- mesh__dateRevised mesh__D016205 2005-06-30
% 210.03/210.21 |- skos__hiddenLabel mesh__D016205 Rat, Cotton
% 210.03/210.21 |- skos__hiddenLabel mesh__D016205 Cotton Rats
% 210.03/210.21 |- skos__annotation mesh__D016205
% 210.03/210.21 for entry term RATS, RICE and other species commonly called %22%rats%22% but taxonomically SIGMODONTINAE, do not use the check tag RATS.%A%
% 210.03/210.21 |- mesh__dateCreated mesh__D016205 1990-06-06
% 210.03/210.21 |- skos__hiddenLabel mesh__D016205 Rice Rat
% 210.03/210.21 |- mesh__dateEstablished mesh__D016205 1991-01-01
% 210.03/210.21 |- mesh__recordMaintainer mesh__D016205 ags
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D016205 2006
% 210.03/210.21 |- skos__historyNote mesh__D016205 Rats %28%1966-1981%29%
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D016205 sjn
% 210.03/210.21 |- skos__altLabel mesh__D016205 Hesperomyines
% 210.03/210.21 |- skos__prefLabel mesh__D016205 Sigmodontinae
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D046690
% 210.03/210.21 2005; for ELECTRICAL STIMULATION OF THE BRAIN see ELECTRIC STIMULATION 1997-2003%A%
% 210.03/210.21 |- skos__hiddenLabel mesh__D046690 Brain Stimulations, Deep
% 210.03/210.21 |- mesh__dateEstablished mesh__D046690 2005-01-01
% 210.03/210.21 |- skos__scopeNote mesh__D046690
% 210.03/210.21 Therapy for MOVEMENT DISORDERS, especially PARKINSON DISEASE, that applies electricity via stereotactic implantation of ELECTRODES in specific areas of the BRAIN such as the THALAMUS. The electrodes are attached to a neurostimulator placed subcutaneously.%A%
% 210.03/210.21 |- skos__historyNote mesh__D046690
% 210.03/210.21 Electric Stimulation Therapy %28%1973-2004%29%
% 210.03/210.21 |- skos__prefLabel mesh__D046690 Deep Brain Stimulation
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D046690 sjn
% 210.03/210.21 |- mesh__historyNote mesh__D046690
% 210.03/210.21 2005; for ELECTRICAL STIMULATION OF THE BRAIN use ELECTRIC STIMULATION 1997-2003%A%
% 210.03/210.21 |- mesh__dateRevised mesh__D046690 2005-06-30
% 210.03/210.21 |- skos__hiddenLabel mesh__D046690 Deep Brain Stimulations
% 210.03/210.21 |- mesh__recordOriginator mesh__D046690 ags
% 210.03/210.21 |- skos__historyNote mesh__D046690 Electric Stimulation %28%1973-2004%29%
% 210.03/210.21 |- skos__annotation mesh__D046690 coord with disease /ther
% 210.03/210.21 |- skos__altLabel mesh__D046690 Brain Stimulation, Deep
% 210.03/210.21 |- skos__related mesh__D046690smesh__D004558
% 210.03/210.21 |- mesh__dateCreated mesh__D046690 2004-07-07
% 210.03/210.21 |- skos__broader mesh__D046690smesh__D013514
% 210.03/210.21 |- rdf__type mesh__D046690sskos__Concept
% 210.03/210.21 |- skos__hiddenLabel mesh__D046690 Stimulations, Deep Brain
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D046690 2006
% 210.03/210.21 |- skos__hiddenLabel mesh__D046690 Stimulation, Deep Brain
% 210.03/210.21 |- mesh__recordMaintainer mesh__D046690 lkt
% 210.03/210.21 |- skos__broader mesh__D046690smesh__D004599
% 210.03/210.21 |- skos__historyNote mesh__D007479
% 210.03/210.21 Iothalamic Acid/analogs %26% derivatives %28%1975-1986%29%
% 210.03/210.21 |- skos__historyNote mesh__D007479 Iothalamic Acid %28%1968-1974%29%
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007479 2004
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007479 2001
% 210.03/210.21 |- mesh__dateEstablished mesh__D007479 1987-01-01
% 210.03/210.21 |- skos__hiddenLabel mesh__D007479 B15,000
% 210.03/210.21 |- rdf__type mesh__D007479sskos__Concept
% 210.03/210.21 |- skos__hiddenLabel mesh__D007479 B 15000
% 210.03/210.21 |- skos__broader mesh__D007479smesh__D014283
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D007479 sjn
% 210.03/210.21 |- skos__prefLabel mesh__D007479 Iopamidol
% 210.03/210.21 |- mesh__recordMaintainer mesh__D007479 CCR
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D007479 87
% 210.03/210.21 |- skos__altLabel mesh__D007479 B-15000
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007479 2005
% 210.03/210.21 |- skos__hiddenLabel mesh__D007479 B15000
% 210.03/210.21 |- skos__altLabel mesh__D007479 Jopamidol
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007479 2002
% 210.03/210.21 |- skos__scopeNote mesh__D007479
% 210.03/210.21 A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures.%A%
% 210.03/210.21 |- mesh__historyNote mesh__D007479 87
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007479 2006
% 210.03/210.21 |- skos__hiddenLabel mesh__D007479 B 15,000
% 210.03/210.21 |- mesh__dateRevised mesh__D007479 2000-06-21
% 210.03/210.21 |- mesh__dateCreated mesh__D007479 1986-06-02
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D007479 2003
% 210.03/210.21 |- mesh__recordOriginator mesh__D007479 RLS
% 210.03/210.21 |- skos__broader mesh__D004181smesh__D012013
% 210.03/210.21 |- skos__annotation mesh__D004181
% 210.03/210.21 IM for directories as a subject; do not confuse with Publication Type DIRECTORY; for directories %26% lists of members of societies %26% acad, etc. index under specialty %28%IM%29% + SOCIETIES or other specific corporate heading %28%IM%29% + geog %28%NIM%29% + DIRECTORY %28%PT%29%; no qualif; policy: Manual 33.13%A%
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004181 2006
% 210.03/210.21 |- skos__scopeNote mesh__D004181
% 210.03/210.21 Lists of persons or organizations, systematically arranged, usually in alphabetic or classed order, giving address, affiliations, etc., for individuals, and giving address, officers, functions, and similar data for organizations. %28%ALA Glossary of Library and Information Science, 1983%29%%A%
% 210.03/210.21 |- skos__prefLabel mesh__D004181 Directories
% 210.03/210.21 |- mesh__dateRevised mesh__D004181 1999-11-03
% 210.03/210.21 |- mesh__recordMaintainer mesh__D004181 kle
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004181 2003
% 210.03/210.21 |- mesh__recordOriginator mesh__D004181 NLM
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004181 2000
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D004181 sjn
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004181 2004
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004181 2001
% 210.03/210.21 |- rdf__type mesh__D004181sskos__Concept
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004181 2005
% 210.03/210.21 |- mesh__dateCreated mesh__D004181 1999-01-01
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D004181 2002
% 210.03/210.21 |- mesh__historyNote mesh__D012613
% 210.03/210.21 91%28%75%29%; was see under ART 1975-90
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 1995
% 210.03/210.21 |- mesh__dateEstablished mesh__D012613 1991-01-01
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D012613 PLS
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 1993
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 1999
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 1994
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 1997
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 2002
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 1998
% 210.03/210.21 |- mesh__recordMaintainer mesh__D012613 TAP
% 210.03/210.21 |- skos__prefLabel mesh__D012613 Sculpture
% 210.03/210.21 |- mesh__recordOriginator mesh__D012613 NLM
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 1996
% 210.03/210.21 |- mesh__onlineNote mesh__D012613 search ART 1966-74
% 210.03/210.21 |- skos__hiddenLabel mesh__D012613 Sculptures
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 2006
% 210.03/210.21 |- mesh__dateRevised mesh__D012613 1992-05-18
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 2004
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D012613 91; was see under ART 1975-90
% 210.03/210.21 |- rdf__type mesh__D012613sskos__Concept
% 210.03/210.21 |- skos__broader mesh__D012613smesh__D001154
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 2005
% 210.03/210.21 |- mesh__dateCreated mesh__D012613 1999-01-01
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 2001
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 2003
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D012613 2000
% 210.03/210.21 |- skos__altLabel mesh__D003887 Psychologic Desensitization
% 210.03/210.21 |- mesh__recordOriginator mesh__D003887 NLM
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 2002
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 2004
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 1996
% 210.03/210.21 |- mesh__dateEstablished mesh__D003887 1991-01-01
% 210.03/210.21 |- mesh__historyNote mesh__D003887
% 210.03/210.21 95; was DESENSITIZATION %28%PSYCHOLOGY%29% 1975-94 %28%see under BEHAVIOR THERAPY 1975-90%29%%A%
% 210.03/210.21 |- skos__altLabel mesh__D003887 Desensitization, Psychological
% 210.03/210.21 |- skos__altLabel mesh__D003887 Psychological Desensitization
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 2005
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 1997
% 210.03/210.21 |- skos__prefLabel mesh__D003887 Desensitization, Psychologic
% 210.03/210.21 |- skos__scopeNote mesh__D003887
% 210.03/210.21 A behavior therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli.%A%
% 210.03/210.21 |- skos__broader mesh__D003887smesh__D001521
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 2006
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 1998
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 2000
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D003887 PLS
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D003887
% 210.03/210.21 95; was DESENSITIZATION %28%PSYCHOLOGY%29% 1975-94 %28%see under BEHAVIOR THERAPY 1975-90%29%%A%
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 1999
% 210.03/210.21 |- mesh__dateCreated mesh__D003887 1999-01-01
% 210.03/210.21 |- mesh__onlineNote mesh__D003887
% 210.03/210.21 use DESENSITIZATION, PSYCHOLOGIC to search DESENSITIZATION %28%PSYCHOLOGY%29% 1975-94; use BEHAVIOR THERAPY 1969-74%A%
% 210.03/210.21 |- skos__altLabel mesh__D003887 Desensitization %28%Psychology%29%
% 210.03/210.21 |- mesh__recordMaintainer mesh__D003887 TGC
% 210.03/210.21 |- skos__annotation mesh__D003887
% 210.03/210.21 a behavior ther technique; DF: DESENSITIZATION PSYCHOL
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 2001
% 210.03/210.21 |- mesh__dateRevised mesh__D003887 1995-05-31
% 210.03/210.21 |- rdf__type mesh__D003887sskos__Concept
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003887 2003
% 210.03/210.21 |- skos__hiddenLabel mesh__D003887 Desensitizations %28%Psychology%29%
% 210.03/210.21 |- rdf__type mesh__D003089sskos__Concept
% 210.03/210.21 |- skos__hiddenLabel mesh__D003089 B, Colipase
% 210.03/210.21 |- skos__hiddenLabel mesh__D003089 A, Colipase
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D003089 sjn
% 210.03/210.21 |- mesh__dateEstablished mesh__D003089 1991-01-01
% 210.03/210.21 |- mesh__historyNote mesh__D003089
% 210.03/210.21 91%28%76%29%; was see under PROTEINS 1976-90
% 210.03/210.21 |- skos__broader mesh__D003089smesh__D011506
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D003089 91; was see under PROTEINS 1976-90
% 210.03/210.21 |- skos__prefLabel mesh__D003089 Colipases
% 210.03/210.21 |- mesh__recordMaintainer mesh__D003089 SYSTEM
% 210.03/210.21 |- skos__historyNote mesh__D003089 Proteins %28%1974-1975%29%
% 210.03/210.21 |- skos__annotation mesh__D003089
% 210.03/210.21 a protein: not an enzyme despite -ase; /biosyn /physiol permitted%A%
% 210.03/210.21 |- skos__scopeNote mesh__D003089
% 210.03/210.21 Colipase I and II, consisting of 94-95 and 84-85 amino acid residues, respectively, have been isolated from porcine pancreas. Their role is to prevent the inhibitory effect of bile salts on the lipase-catalyzed intraduodenal hydrolysis of dietary long-chain triglycerides.%A%
% 210.03/210.21 |- mesh__dateRevised mesh__D003089 2005-06-30
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D003089 2006
% 210.03/210.21 |- mesh__dateCreated mesh__D003089 1975-07-23
% 210.03/210.21 |- mesh__recordOriginator mesh__D003089 RLS
% 210.03/210.21 |- skos__historyNote mesh__D003089 Lipase %28%1974-1975%29%
% 210.03/210.21 |- mesh__recordOriginator mesh__D008572 NLM
% 210.03/210.21 |- mesh__dateCreated mesh__D008572 1999-01-01
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008572 2006
% 210.03/210.21 |- mesh__dateEstablished mesh__D008572 1973-01-01
% 210.03/210.21 |- skos__prefLabel mesh__D008572 Menarche
% 210.03/210.21 |- skos__historyNote mesh__D008572 Puberty %28%1966-1968%29%
% 210.03/210.21 |- mesh__dateRevised mesh__D008572 2004-07-07
% 210.03/210.21 |- rdf__type mesh__D008572sskos__Concept
% 210.03/210.21 |- skos__scopeNote mesh__D008572
% 210.03/210.21 The first MENSTRUAL CYCLE marked by the initiation of MENSTRUATION.%A%
% 210.03/210.21 |- mesh__recordMaintainer mesh__D008572 lkt
% 210.03/210.21 |- mesh__historyNote mesh__D008572 73%28%69%29%
% 210.03/210.21 |- mesh__recordAuthorizer mesh__D008572 sjn
% 210.03/210.21 |- mesh__publicMeSHNote mesh__D008572 73
% 210.03/210.21 |- skos__historyNote mesh__D008572 Menstruation %28%1966-1968%29%
% 210.03/210.21 |- skos__broader mesh__D008572smesh__D011627
% 210.03/210.21 |- mesh__activeMeSHYear mesh__D008572 2005
% 210.03/210.22 |- mesh__recordOriginator mesh__D022243 ags
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D022243 2001
% 210.03/210.22 |- skos__scopeNote mesh__D022243
% 210.03/210.22 Vaccines or candidate vaccines used to prevent infection with ROTAVIRUS.%A%
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D022243 sjn
% 210.03/210.22 |- rdf__type mesh__D022243sskos__Concept
% 210.03/210.22 |- skos__historyNote mesh__D022243 Viral Vaccines %28%1979-2000%29%
% 210.03/210.22 |- mesh__recordMaintainer mesh__D022243 ssb
% 210.03/210.22 |- mesh__dateEstablished mesh__D022243 2001-01-01
% 210.03/210.22 |- skos__prefLabel mesh__D022243 Rotavirus Vaccines
% 210.03/210.22 |- mesh__dateCreated mesh__D022243 2000-06-22
% 210.03/210.22 |- mesh__dateRevised mesh__D022243 2005-06-30
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D022243 2006
% 210.03/210.22 |- skos__broader mesh__D022243smesh__D014765
% 210.03/210.22 |- mesh__historyNote mesh__D022243 2001
% 210.03/210.22 |- skos__hiddenLabel mesh__D022243 Vaccines, Rotavirus
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D016206 sjn
% 210.03/210.22 |- mesh__recordMaintainer mesh__D016206 jls
% 210.03/210.22 |- skos__annotation mesh__D016206
% 210.03/210.22 collections of bibliographic refs: differentiate from DATABASES, FACTUAL, collections of facts%A%
% 210.03/210.22 |- mesh__dateCreated mesh__D016206 1990-08-14
% 210.03/210.22 |- skos__broader mesh__D016206smesh__D019992
% 210.03/210.22 |- skos__hiddenLabel mesh__D016206 Database, Bibliographic
% 210.03/210.22 |- mesh__dateEstablished mesh__D016206 1991-01-01
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D016206
% 210.03/210.22 91; DATABASES was see INFORMATION SYSTEMS 1982-90
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D016206 2006
% 210.03/210.22 |- mesh__dateRevised mesh__D016206 2004-07-07
% 210.03/210.22 |- skos__historyNote mesh__D016206 Bibliography %28%1966-1990%29%
% 210.03/210.22 |- skos__prefLabel mesh__D016206 Databases, Bibliographic
% 210.03/210.22 |- skos__broader mesh__D016206smesh__D001634
% 210.03/210.22 |- skos__hiddenLabel mesh__D016206 Bibliographic Databases
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D016206 2005
% 210.03/210.22 |- skos__historyNote mesh__D016206 Information Systems %28%1966-1981%29%
% 210.03/210.22 |- skos__hiddenLabel mesh__D016206 Bibliographic Database
% 210.03/210.22 |- skos__scopeNote mesh__D016206
% 210.03/210.22 Extensive collections, reputedly complete, of references and citations to books, articles, publications, etc., generally on a single subject or specialized subject area. Databases can operate through automated files, libraries, or computer disks. The concept should be differentiated from DATABASES, FACTUAL which is used for collections of data and facts apart from bibliographic references to them.%A%
% 210.03/210.22 |- mesh__historyNote mesh__D016206
% 210.03/210.22 91; DATABASES was see INFORMATION SYSTEMS 1982-90
% 210.03/210.22 |- mesh__recordOriginator mesh__D016206 TGC
% 210.03/210.22 |- rdf__type mesh__D016206sskos__Concept
% 210.03/210.22 |- mesh__onlineNote mesh__D016206
% 210.03/210.22 use INFORMATION SYSTEMS to search DATABASES 1982-90
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 2000
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 1996
% 210.03/210.22 |- mesh__dateRevised mesh__D004980 1992-05-19
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 2004
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 2001
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 1998
% 210.03/210.22 |- mesh__recordMaintainer mesh__D004980 TAP
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 2006
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D004980 PLS
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 1997
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 1994
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D004980 73
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 1999
% 210.03/210.22 |- skos__historyNote mesh__D004980 Alkanes %28%1966-1972%29%
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 1993
% 210.03/210.22 |- mesh__dateEstablished mesh__D004980 1973-01-01
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 1995
% 210.03/210.22 |- skos__broader mesh__D004980smesh__D000473
% 210.03/210.22 |- mesh__recordOriginator mesh__D004980 NLM
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 2002
% 210.03/210.22 |- rdf__type mesh__D004980sskos__Concept
% 210.03/210.22 |- skos__prefLabel mesh__D004980 Ethane
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 2003
% 210.03/210.22 |- mesh__dateCreated mesh__D004980 1999-01-01
% 210.03/210.22 |- mesh__historyNote mesh__D004980 73
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004980 2005
% 210.03/210.22 |- skos__broader mesh__D011453Q000037smesh__D011453
% 210.03/210.22 |- mesh__preferredCombination mesh__D011453Q000037smesh__D011448
% 210.03/210.22 |- rdf__type mesh__D011453Q000037smesh__CompoundConcept
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D004182
% 210.03/210.22 91; was see under FILARIOIDEA 1975-90
% 210.03/210.22 |- mesh__onlineNote mesh__D004182 search FILARIOIDEA 1966-74
% 210.03/210.22 |- skos__prefLabel mesh__D004182 Dirofilaria
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004182 2004
% 210.03/210.22 |- rdf__type mesh__D004182sskos__Concept
% 210.03/210.22 |- mesh__dateEstablished mesh__D004182 1991-01-01
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004182 2005
% 210.03/210.22 |- mesh__historyNote mesh__D004182
% 210.03/210.22 91%28%75%29%; was see under FILARIOIDEA 1975-90
% 210.03/210.22 |- mesh__recordOriginator mesh__D004182 NLM
% 210.03/210.22 |- mesh__dateRevised mesh__D004182 2003-07-09
% 210.03/210.22 |- skos__annotation mesh__D004182
% 210.03/210.22 infection = DIROFILARIASIS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%
% 210.03/210.22 |- mesh__dateCreated mesh__D004182 1999-01-01
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D004182 sjn
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004182 2006
% 210.03/210.22 |- skos__scopeNote mesh__D004182
% 210.03/210.22 A genus of filarial nematodes. Various immature species have been found to infect the eyes or subcutaneous tissue in humans.%A%
% 210.03/210.22 |- skos__broader mesh__D004182smesh__D005370
% 210.03/210.22 |- mesh__recordMaintainer mesh__D004182 ags
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D012614 2006
% 210.03/210.22 |- skos__hiddenLabel mesh__D012614 Scurvies
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D012614 2004
% 210.03/210.22 |- rdf__type mesh__D012614sskos__Concept
% 210.03/210.22 |- skos__related mesh__D012614smesh__D001206
% 210.03/210.22 |- mesh__dateCreated mesh__D012614 1999-01-01
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D012614 sjn
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D012614 2005
% 210.03/210.22 |- mesh__dateRevised mesh__D012614 2003-07-09
% 210.03/210.22 |- skos__broader mesh__D012614smesh__D020141
% 210.03/210.22 |- skos__altLabel mesh__D012614 Scorbutus
% 210.03/210.22 |- mesh__recordMaintainer mesh__D012614 lkt
% 210.03/210.22 |- mesh__recordOriginator mesh__D012614 NLM
% 210.03/210.22 |- skos__scopeNote mesh__D012614
% 210.03/210.22 A condition due to deficiency of ASCORBIC ACID %28%vitamin C%29% in the diet and marked by weakness, anemia, spongy gums, a tendency to mucocutaneous hemorrhages and a brawny induration of the muscles of the calves and legs. %28%Dorland, 27th ed%29%%A%
% 210.03/210.22 |- skos__broader mesh__D012614smesh__D001206
% 210.03/210.22 |- skos__prefLabel mesh__D012614 Scurvy
% 210.03/210.22 |- skos__hiddenLabel mesh__D003888 Allergen Immunotherapies
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003888 2005
% 210.03/210.22 |- mesh__historyNote mesh__D003888
% 210.03/210.22 80; was DESENSITIZATION 1963-79 %28%Prov 1963-64%29%
% 210.03/210.22 |- skos__hiddenLabel mesh__D003888 Immunotherapies, Allergen
% 210.03/210.22 |- mesh__recordOriginator mesh__D003888 NLM
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003888 2002
% 210.03/210.22 |- skos__hiddenLabel mesh__D003888 Hyposensitization Therapies
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003888 2006
% 210.03/210.22 |- mesh__recordMaintainer mesh__D003888 sjn
% 210.03/210.22 |- mesh__dateRevised mesh__D003888 2001-08-07
% 210.03/210.22 |- skos__scopeNote mesh__D003888
% 210.03/210.22 Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity.%A%
% 210.03/210.22 |- skos__prefLabel mesh__D003888 Desensitization, Immunologic
% 210.03/210.22 |- mesh__dateEstablished mesh__D003888 1965-01-01
% 210.03/210.22 |- skos__annotation mesh__D003888
% 210.03/210.22 do not use /util except by MeSH definition; DF: DESENSITIZATION IMMUNOL%A%
% 210.03/210.22 |- mesh__dateCreated mesh__D003888 1999-01-01
% 210.03/210.22 |- skos__broader mesh__D003888smesh__D007165
% 210.03/210.22 |- rdf__type mesh__D003888sskos__Concept
% 210.03/210.22 |- skos__altLabel mesh__D003888 Immunotherapy, Allergen
% 210.03/210.22 |- skos__altLabel mesh__D003888 Immunologic Desensitization
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003888 2003
% 210.03/210.22 |- skos__altLabel mesh__D003888 Hyposensitization Therapy
% 210.03/210.22 |- mesh__onlineNote mesh__D003888
% 210.03/210.22 use DESENSITIZATION, IMMUNOLOGIC to search DESENSITIZATION 1966-79%A%
% 210.03/210.22 |- skos__altLabel mesh__D003888 Therapy, Hyposensitization
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D003888 sjn
% 210.03/210.22 |- skos__hiddenLabel mesh__D003888 Desensitizations, Immunologic
% 210.03/210.22 |- skos__hiddenLabel mesh__D003888 Immunologic Desensitizations
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003888 2004
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D003888 80; was DESENSITIZATION 1965-79
% 210.03/210.22 |- skos__hiddenLabel mesh__D003888 Therapies, Hyposensitization
% 210.03/210.22 |- rdf__type mesh__D008573sskos__Concept
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D008573 sjn
% 210.03/210.22 |- skos__broader mesh__D008573smesh__D008671
% 210.03/210.22 |- mesh__recordOriginator mesh__D008573 NLM
% 210.03/210.22 |- mesh__dateRevised mesh__D008573 2005-06-30
% 210.03/210.22 |- skos__annotation mesh__D008573 man-made radioactive element; IM
% 210.03/210.22 |- skos__prefLabel mesh__D008573 Mendelevium
% 210.03/210.22 |- mesh__recordMaintainer mesh__D008573 jmp
% 210.03/210.22 |- mesh__dateCreated mesh__D008573 1999-01-01
% 210.03/210.22 |- skos__broader mesh__D008573smesh__D019216
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D008573 2006
% 210.03/210.22 |- skos__scopeNote mesh__D008573
% 210.03/210.22 Mendelevium. A man-made radioactive element of the actinide family with atomic symbol Md, atomic number 101, and atomic weight 258.%A%
% 210.03/210.22 |- skos__hiddenLabel mesh__D000590 Ketones, Peptide Chloromethyl
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000590 2003
% 210.03/210.22 |- mesh__recordMaintainer mesh__D000590 KEV
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000590 2005
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000590 2004
% 210.03/210.22 |- skos__historyNote mesh__D000590 Peptides %28%1966-1976%29%
% 210.03/210.22 |- mesh__historyNote mesh__D000590 77
% 210.03/210.22 |- rdf__type mesh__D000590sskos__Concept
% 210.03/210.22 |- skos__prefLabel mesh__D000590 Amino Acid Chloromethyl Ketones
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D000590
% 210.03/210.22 77; TOSYLLYSINE CHLOROMETHYL KETONE was see under LYSINE 1975-76; TOSYLPHENYLALANYL CHLOROMETHYL KETONE was see under PHENYLALANINE 1975-76%A%
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000590 2006
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000590 2000
% 210.03/210.22 |- skos__altLabel mesh__D000590 Peptide Chloromethyl Ketones
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000590 2001
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D000590 sjn
% 210.03/210.22 |- mesh__dateEstablished mesh__D000590 1977-01-01
% 210.03/210.22 |- mesh__dateRevised mesh__D000590 1999-11-09
% 210.03/210.22 |- mesh__dateCreated mesh__D000590 1976-05-19
% 210.03/210.22 |- skos__scopeNote mesh__D000590
% 210.03/210.22 Inhibitors of SERINE ENDOPEPTIDASES and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process.%A%
% 210.03/210.22 |- mesh__recordOriginator mesh__D000590 RLS
% 210.03/210.22 |- skos__historyNote mesh__D000590 specific amino acid %28%1966-1976%29%
% 210.03/210.22 |- skos__broader mesh__D000590smesh__D000596
% 210.03/210.22 |- skos__hiddenLabel mesh__D000590 Chloromethyl Ketones, Peptide
% 210.03/210.22 |- skos__annotation mesh__D000590 serine proteinase inhib; DF: AACK
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000590 2002
% 210.03/210.22 |- skos__historyNote mesh__D016207 Biological Products %28%1976-1988%29%
% 210.03/210.22 |- mesh__dateEstablished mesh__D016207 1991-01-01
% 210.03/210.22 |- mesh__historyNote mesh__D016207 91
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D016207 91
% 210.03/210.22 |- skos__broader mesh__D016207smesh__D036341
% 210.03/210.22 |- mesh__recordOriginator mesh__D016207 AGS
% 210.03/210.22 |- skos__prefLabel mesh__D016207 Cytokines
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D016207 2006
% 210.03/210.22 |- mesh__dateRevised mesh__D016207 2005-06-30
% 210.03/210.22 |- rdf__type mesh__D016207sskos__Concept
% 210.03/210.22 |- skos__historyNote mesh__D016207 Biological Factors %28%1989-1990%29%
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D016207 sjn
% 210.03/210.22 |- mesh__recordMaintainer mesh__D016207 ssb
% 210.03/210.22 |- skos__scopeNote mesh__D016207
% 210.03/210.22 Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.%A%
% 210.03/210.22 |- mesh__dateCreated mesh__D016207 1990-04-24
% 210.03/210.22 |- skos__broader mesh__D019811Q000031smesh__D019811
% 210.03/210.22 |- mesh__preferredCombination mesh__D019811Q000031smesh__D006898
% 210.03/210.22 |- rdf__type mesh__D019811Q000031smesh__CompoundConcept
% 210.03/210.22 |- skos__hiddenLabel mesh__D004981 Deaminase, Ethanolamine
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D004981
% 210.03/210.22 91; was see under AMMONIA-LYASES 1975-90
% 210.03/210.22 |- skos__hiddenLabel mesh__D004981 Ethanolamine Ammonia Lyase
% 210.03/210.22 |- rdf__type mesh__D004981sskos__Concept
% 210.03/210.22 |- mesh__dateCreated mesh__D004981 1974-11-19
% 210.03/210.22 |- mesh__dateEstablished mesh__D004981 1991-01-01
% 210.03/210.22 |- mesh__dateRevised mesh__D004981 2003-07-09
% 210.03/210.22 |- mesh__recordMaintainer mesh__D004981 ssb
% 210.03/210.22 |- skos__prefLabel mesh__D004981 Ethanolamine Ammonia-Lyase
% 210.03/210.22 |- skos__broader mesh__D004981smesh__D000642
% 210.03/210.22 |- skos__scopeNote mesh__D004981
% 210.03/210.22 An enzyme that catalyzes the deamination of ethanolamine to acetaldehyde. EC 4.3.1.7.%A%
% 210.03/210.22 |- skos__altLabel mesh__D004981 Ethanolamine Deaminase
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004981 2005
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004981 2004
% 210.03/210.22 |- mesh__historyNote mesh__D004981
% 210.03/210.22 91%28%75%29%; was see under AMMONIA-LYASES 1975-90
% 210.03/210.22 |- skos__historyNote mesh__D004981 Ammonia-Lyases %28%1973-1974%29%
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004981 2006
% 210.03/210.22 |- skos__hiddenLabel mesh__D004981 Ammonia-Lyase, Ethanolamine
% 210.03/210.22 |- skos__historyNote mesh__D004981 Ethanolamines %28%1973-1974%29%
% 210.03/210.22 |- mesh__recordOriginator mesh__D004981 NLM
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D004981 sjn
% 210.03/210.22 |- skos__altLabel mesh__D004183 Dog Heartworm
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004183 2006
% 210.03/210.22 |- mesh__recordOriginator mesh__D004183 NLM
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D004183 sjn
% 210.03/210.22 |- mesh__dateRevised mesh__D004183 2003-07-09
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004183 2005
% 210.03/210.22 |- skos__scopeNote mesh__D004183
% 210.03/210.22 A filarial parasite primarily of dogs but occurring also in foxes, wolves, and humans. The parasite is transmitted by mosquitoes.%A%
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004183 2004
% 210.03/210.22 |- mesh__historyNote mesh__D004183
% 210.03/210.22 91%28%75%29%; was see under FILARIOIDEA 1975-90
% 210.03/210.22 |- mesh__recordMaintainer mesh__D004183 ags
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D004183
% 210.03/210.22 91; was see under FILARIOIDEA 1975-90
% 210.03/210.22 |- skos__annotation mesh__D004183
% 210.03/210.22 infection = DIROFILARIASIS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%
% 210.03/210.22 |- skos__broader mesh__D004183smesh__D004182
% 210.03/210.22 |- rdf__type mesh__D004183sskos__Concept
% 210.03/210.22 |- skos__prefLabel mesh__D004183 Dirofilaria immitis
% 210.03/210.22 |- mesh__dateEstablished mesh__D004183 1991-01-01
% 210.03/210.22 |- mesh__dateCreated mesh__D004183 1974-12-12
% 210.03/210.22 |- rdf__type mesh__D012615sskos__Concept
% 210.03/210.22 |- skos__scopeNote mesh__D012615
% 210.03/210.22 The order Actiniaria, in the class ANTHOZOA, comprised of large, solitary polyps. All species are carnivorous.%A%
% 210.03/210.22 |- mesh__recordOriginator mesh__D012615 NLM
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D012615 2005
% 210.03/210.22 |- mesh__dateRevised mesh__D012615 2003-07-09
% 210.03/210.22 |- skos__altLabel mesh__D012615 Actiniaria
% 210.03/210.22 |- mesh__dateCreated mesh__D012615 1974-12-12
% 210.03/210.22 |- skos__broader mesh__D012615smesh__D037421
% 210.03/210.22 |- skos__prefLabel mesh__D012615 Sea Anemones
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D012615 sjn
% 210.03/210.22 |- mesh__recordMaintainer mesh__D012615 ags
% 210.03/210.22 |- mesh__dateEstablished mesh__D012615 1991-01-01
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D012615
% 210.03/210.22 91; was see under COELENTERATA 1975-90
% 210.03/210.22 |- mesh__historyNote mesh__D012615
% 210.03/210.22 91%28%75%29%; was see under COELENTERATA 1975-90
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D012615 2006
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D012615 2004
% 210.03/210.22 |- skos__hiddenLabel mesh__D017300 Dihydrate Pipecuronium Dibromide
% 210.03/210.22 |- mesh__dateEstablished mesh__D017300 1993-01-01
% 210.03/210.22 |- mesh__dateRevised mesh__D017300 2003-07-09
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D017300 2006
% 210.03/210.22 |- mesh__dateCreated mesh__D017300 1992-05-19
% 210.03/210.22 |- skos__broader mesh__D017300smesh__D010879
% 210.03/210.22 |- skos__altLabel mesh__D017300 Pipecurium
% 210.03/210.22 |- skos__scopeNote mesh__D017300
% 210.03/210.22 A piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent %28%NEUROMUSCULAR NONDEPOLARIZING AGENTS%29%. It is used as a muscle relaxant during ANESTHESIA and surgical procedures.%A%
% 210.03/210.22 |- skos__hiddenLabel mesh__D017300 RGH1106
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D017300 2004
% 210.03/210.22 |- skos__hiddenLabel mesh__D017300 Bromide, Pipecurium
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D017300
% 210.03/210.22 93; PIPECURIUM was indexed under PIPERAZINES %26% ANDROSTANES 1980-92 %26% STEROIDS 1979-80%A%
% 210.03/210.22 |- skos__historyNote mesh__D017300 Piperazines %28%1980-1992%29%
% 210.03/210.22 |- skos__hiddenLabel mesh__D017300 Bromide, Pipecuronium
% 210.03/210.22 |- mesh__historyNote mesh__D017300 93; was PIPECURIUM %28%NM%29% 1979-92
% 210.03/210.22 |- rdf__type mesh__D017300sskos__Concept
% 210.03/210.22 |- skos__prefLabel mesh__D017300 Pipecuronium
% 210.03/210.22 |- skos__historyNote mesh__D017300
% 210.03/210.22 5-Androstane-3,17-diol/analogs %26% derivatives %28%1980-1992%29%
% 210.03/210.22 |- skos__altLabel mesh__D017300 Pipecurium Bromide
% 210.03/210.22 |- mesh__recordOriginator mesh__D017300 TPW
% 210.03/210.22 |- skos__hiddenLabel mesh__D017300 RGH 1106
% 210.03/210.22 |- mesh__onlineNote mesh__D017300
% 210.03/210.22 use PIPECURONIUM %28%NM%29% to search PIPECURIUM 1979-92
% 210.03/210.22 |- skos__hiddenLabel mesh__D017300 Dibromide Pipecuronium
% 210.03/210.22 |- mesh__recordMaintainer mesh__D017300 lkt
% 210.03/210.22 |- skos__historyNote mesh__D017300 Steroids %28%1979-1980%29%
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D017300 2005
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D017300 sjn
% 210.03/210.22 |- skos__hiddenLabel mesh__D017300 Dibromide, Dihydrate Pipecuronium
% 210.03/210.22 |- mesh__dateRevised mesh__D003889 1999-11-03
% 210.03/210.22 |- skos__hiddenLabel mesh__D003889 Desert Climates
% 210.03/210.22 |- mesh__dateCreated mesh__D003889 1999-01-01
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D003889 sjn
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003889 2000
% 210.03/210.22 |- rdf__type mesh__D003889sskos__Concept
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003889 2003
% 210.03/210.22 |- skos__scopeNote mesh__D003889
% 210.03/210.22 A type of climate characterized by insufficient moisture to support appreciable plant life. It is a climate of extreme aridity, usually of extreme heat, and of negligible rainfall. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003889 2001
% 210.03/210.22 |- skos__annotation mesh__D003889 specify geog if pertinent
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003889 2004
% 210.03/210.22 |- mesh__recordMaintainer mesh__D003889 kle
% 210.03/210.22 |- mesh__recordOriginator mesh__D003889 NLM
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003889 2002
% 210.03/210.22 |- skos__hiddenLabel mesh__D003889 Climates, Desert
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003889 2005
% 210.03/210.22 |- skos__prefLabel mesh__D003889 Desert Climate
% 210.03/210.22 |- skos__broader mesh__D003889smesh__D002980
% 210.03/210.22 |- skos__hiddenLabel mesh__D003889 Climate, Desert
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D003889 2006
% 210.03/210.22 |- mesh__historyNote mesh__D008574 94; was MENGO VIRUS 1973-93
% 210.03/210.22 |- mesh__dateRevised mesh__D008574 2001-08-07
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D008574 2004
% 210.03/210.22 |- skos__annotation mesh__D008574
% 210.03/210.22 a strain of ENCEPHALOMYOCARDITIS VIRUS; Mengo is in Uganda; infection: coord IM with CARDIOVIRUS INFECTIONS %28%IM%29%%A%
% 210.03/210.22 |- mesh__onlineNote mesh__D008574
% 210.03/210.22 use MENGOVIRUS to search MENGO VIRUS 1973-93
% 210.03/210.22 |- skos__hiddenLabel mesh__D008574 Virus, Mengo
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D008574 sjn
% 210.03/210.22 |- skos__altLabel mesh__D008574 Mengo Virus
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D008574 2005
% 210.03/210.22 |- mesh__dateCreated mesh__D008574 1999-01-01
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D008574 2006
% 210.03/210.22 |- mesh__recordOriginator mesh__D008574 NLM
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D008574 94; was MENGO VIRUS 1973-93
% 210.03/210.22 |- skos__historyNote mesh__D008574
% 210.03/210.22 Encephalomyocarditis Viruses %28%1966-1972%29%
% 210.03/210.22 |- skos__scopeNote mesh__D008574
% 210.03/210.22 A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, isolated from rodents and lagomorphs and occasionally causing febrile illness in man.%A%
% 210.03/210.22 |- skos__broader mesh__D008574smesh__D004686
% 210.03/210.22 |- skos__prefLabel mesh__D008574 Mengovirus
% 210.03/210.22 |- mesh__dateEstablished mesh__D008574 1973-01-01
% 210.03/210.22 |- mesh__recordMaintainer mesh__D008574 sjn
% 210.03/210.22 |- rdf__type mesh__D008574sskos__Concept
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D008574 2002
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D008574 2003
% 210.03/210.22 |- skos__hiddenLabel mesh__D000591 Isomerases, Amino Acid
% 210.03/210.22 |- skos__prefLabel mesh__D000591 Amino Acid Isomerases
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D000591 74
% 210.03/210.22 |- mesh__recordMaintainer mesh__D000591 ssb
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000591 2004
% 210.03/210.22 |- mesh__dateRevised mesh__D000591 2003-07-09
% 210.03/210.22 |- skos__historyNote mesh__D000591 specific amino acid %28%1966-1971%29%
% 210.03/210.22 |- mesh__dateCreated mesh__D000591 1999-01-01
% 210.03/210.22 |- mesh__historyNote mesh__D000591 74%28%72%29%
% 210.03/210.22 |- skos__hiddenLabel mesh__D000591 Racemases, Amino Acid
% 210.03/210.22 |- skos__broader mesh__D000591smesh__D019998
% 210.03/210.22 |- rdf__type mesh__D000591sskos__Concept
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000591 2006
% 210.03/210.22 |- mesh__dateEstablished mesh__D000591 1974-01-01
% 210.03/210.22 |- skos__hiddenLabel mesh__D000591 Acid Isomerases, Amino
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D000591 2005
% 210.03/210.22 |- mesh__recordOriginator mesh__D000591 NLM
% 210.03/210.22 |- skos__scopeNote mesh__D000591
% 210.03/210.22 Enzymes that catalyze either the racemization or epimerization of chiral centers within amino acids or derivatives. EC 5.1.1.%A%
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D000591 sjn
% 210.03/210.22 |- skos__hiddenLabel mesh__D000591 Acid Racemases, Amino
% 210.03/210.22 |- skos__historyNote mesh__D000591 Isomerases %28%1966-1971%29%
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D016208 1991
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Factual Data Banks
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Data Base, Factual
% 210.03/210.22 |- mesh__recordMaintainer mesh__D016208 jls
% 210.03/210.22 |- mesh__recordOriginator mesh__D016208 TGC
% 210.03/210.22 |- skos__altLabel mesh__D016208 Databanks, Factual
% 210.03/210.22 |- mesh__dateRevised mesh__D016208 2004-07-07
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Factual Data Bases
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Factual Databanks
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Factual Data Base
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Data Bank, Factual
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D016208 sjn
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Factual Data Bank
% 210.03/210.22 |- mesh__dateCreated mesh__D016208 1990-05-07
% 210.03/210.22 |- skos__historyNote mesh__D016208 Information Systems %28%1966-1990%29%
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Database, Factual
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D016208 2005
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Databank, Factual
% 210.03/210.22 |- skos__scopeNote mesh__D016208
% 210.03/210.22 Extensive collections, reputedly complete, of facts and data garnered from material of a specialized subject area and made available for analysis and application. The collection can be automated by various contemporary methods for retrieval. The concept should be differentiated from DATABASES, BIBLIOGRAPHIC which is restricted to collections of bibliographic references.%A%
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D016208 2006
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Factual Databases
% 210.03/210.22 |- mesh__dateEstablished mesh__D016208 1991-01-01
% 210.03/210.22 |- skos__altLabel mesh__D016208 Data Banks, Factual
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Factual Database
% 210.03/210.22 |- rdf__type mesh__D016208sskos__Concept
% 210.03/210.22 |- skos__hiddenLabel mesh__D016208 Factual Databank
% 210.03/210.22 |- mesh__historyNote mesh__D016208 1991
% 210.03/210.22 |- skos__broader mesh__D016208smesh__D019992
% 210.03/210.22 |- skos__prefLabel mesh__D016208 Databases, Factual
% 210.03/210.22 |- skos__altLabel mesh__D016208 Data Bases, Factual
% 210.03/210.22 |- skos__broader mesh__D009206Q000637smesh__D009206
% 210.03/210.22 |- mesh__preferredCombination mesh__D009206Q000637smesh__D016027
% 210.03/210.22 |- rdf__type mesh__D009206Q000637smesh__CompoundConcept
% 210.03/210.22 |- rdf__type mesh__D004982sskos__Concept
% 210.03/210.22 |- mesh__recordOriginator mesh__D004982 RLS
% 210.03/210.22 |- mesh__dateEstablished mesh__D004982 1991-01-01
% 210.03/210.22 |- mesh__dateRevised mesh__D004982 2003-07-09
% 210.03/210.22 |- skos__historyNote mesh__D004982 Amino Alcohols %28%1966-1972%29%
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D004982 sjn
% 210.03/210.22 |- skos__historyNote mesh__D004982 Ethanolamines %28%1973-1978%29%
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D004982
% 210.03/210.22 91; was see under PHOSPHOTRANSFERASES 1979-90
% 210.03/210.22 |- skos__altLabel mesh__D004982
% 210.03/210.22 sn-1,2-Diacylglycerol Ethanolaminephosphotransferase
% 210.03/210.22 |- skos__altLabel mesh__D004982 Phosphoethanolaminetransferase
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004982 2005
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004982 2004
% 210.03/210.22 |- mesh__historyNote mesh__D004982
% 210.03/210.22 91%28%79%29%; was see under PHOSPHOTRANSFERASES 1979-90
% 210.03/210.22 |- mesh__recordMaintainer mesh__D004982 ssb
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004982 2006
% 210.03/210.22 |- skos__prefLabel mesh__D004982 Ethanolaminephosphotransferase
% 210.03/210.22 |- skos__scopeNote mesh__D004982
% 210.03/210.22 An enzyme that catalyzes reversibly the transfer of phosphoethanolamine from CDP-ethanolamine to diacylglycerol to yield phosphatidylethanolamine %28%cephalin%29% and CMP. The enzyme is found in the endoplasmic reticulum. EC 2.7.8.1.%A%
% 210.03/210.22 |- skos__hiddenLabel mesh__D004982
% 210.03/210.22 Ethanolaminephosphotransferase, sn-1,2-Diacylglycerol
% 210.03/210.22 |- skos__historyNote mesh__D004982 Phosphotransferases %28%1966-1978%29%
% 210.03/210.22 |- skos__hiddenLabel mesh__D004982
% 210.03/210.22 sn 1,2 Diacylglycerol Ethanolaminephosphotransferase
% 210.03/210.22 |- mesh__dateCreated mesh__D004982 1978-03-08
% 210.03/210.22 |- skos__broader mesh__D004982smesh__D017855
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004184 2005
% 210.03/210.22 |- mesh__activeMeSHYear mesh__D004184 2004
% 210.03/210.22 |- skos__prefLabel mesh__D004184 Dirofilariasis
% 210.03/210.22 |- skos__historyNote mesh__D004184 Filariasis %28%1966-1967%29%
% 210.03/210.22 |- mesh__historyNote mesh__D004184 68
% 210.03/210.22 |- mesh__publicMeSHNote mesh__D004184 68
% 210.03/210.22 |- skos__broader mesh__D004184smesh__D005368
% 210.03/210.22 |- mesh__recordOriginator mesh__D004184 NLM
% 210.03/210.22 |- skos__hiddenLabel mesh__D004184 Disease, Heartworm
% 210.03/210.22 |- mesh__recordAuthorizer mesh__D004184 sjn
% 210.03/210.23 |- mesh__dateCreated mesh__D004184 1999-01-01
% 210.03/210.23 |- mesh__recordMaintainer mesh__D004184 ags
% 210.03/210.23 |- skos__altLabel mesh__D004184 Heartworm Disease
% 210.03/210.23 |- skos__hiddenLabel mesh__D004184 Dirofilariases
% 210.03/210.23 |- mesh__dateEstablished mesh__D004184 1968-01-01
% 210.03/210.23 |- skos__broader mesh__D004184smesh__D006374
% 210.03/210.23 |- rdf__type mesh__D004184sskos__Concept
% 210.03/210.23 |- skos__annotation mesh__D004184
% 210.03/210.23 usually in animals, espec dogs; coord IM with precoord animal/dis term %28%IM%29% + specific animal %28%NIM%29%; check also tag ANIMALS; drug ther: consider FILARICIDES%A%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004184 2006
% 210.03/210.23 |- mesh__dateRevised mesh__D004184 2003-07-30
% 210.03/210.23 |- skos__scopeNote mesh__D004184
% 210.03/210.23 Infection with nematodes of the genus DIROFILARIA, usually in animals, especially dogs, but occasionally in man.%A%
% 210.03/210.23 |- skos__prefLabel mesh__D012616 Sea Cucumbers
% 210.03/210.23 |- skos__altLabel mesh__D012616 Holothuroidea
% 210.03/210.23 |- mesh__dateEstablished mesh__D012616 1991-01-01
% 210.03/210.23 |- mesh__recordOriginator mesh__D012616 AEP
% 210.03/210.23 |- mesh__historyNote mesh__D012616
% 210.03/210.23 91%28%78%29%; was see under ECHINODERMATA 1978-90
% 210.03/210.23 |- skos__scopeNote mesh__D012616
% 210.03/210.23 A class of Echinodermata characterized by long, slender bodies.%A%
% 210.03/210.23 |- mesh__recordMaintainer mesh__D012616 ags
% 210.03/210.23 |- skos__annotation mesh__D012616 note specifics
% 210.03/210.23 |- skos__historyNote mesh__D012616 Echinodermata %28%1966-1977%29%
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D012616
% 210.03/210.23 91; was see under ECHINODERMATA 1978-90
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D012616 2005
% 210.03/210.23 |- mesh__dateRevised mesh__D012616 2004-07-07
% 210.03/210.23 |- skos__broader mesh__D012616smesh__D004447
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D012616 2006
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D012616 sjn
% 210.03/210.23 |- mesh__dateCreated mesh__D012616 1977-03-01
% 210.03/210.23 |- rdf__type mesh__D012616sskos__Concept
% 210.03/210.23 |- skos__altLabel mesh__D017301 Calcium Magnesium ATPase
% 210.03/210.23 |- mesh__recordMaintainer mesh__D017301 ssb
% 210.03/210.23 |- skos__scopeNote mesh__D017301
% 210.03/210.23 An enzyme that catalyzes the hydrolysis of ATP and is activated by millimolar concentrations of either Ca%28%2+%29% or Mg%28%2+%29%. Unlike CA%28%2+%29%-TRANSPORTING ATPASE it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. %28%Prog Biophys Mol Biol 1988;52%28%1%29%:1%29%. A subgroup of EC 3.6.1.3.%A%
% 210.03/210.23 |- skos__altLabel mesh__D017301 Adenosinetriphosphatase, Calcium, Magnesium
% 210.03/210.23 |- skos__altLabel mesh__D017301 Ca2+-Mg2+ ATPase
% 210.03/210.23 |- mesh__onlineNote mesh__D017301
% 210.03/210.23 use CA%28%2+%29% MG%28%2+%29%-ATPASE %28%NM%29% to search CALCIUM MAGNESIUM ATPASE 1979-92, ADENOSINE TRIPHOSPHATASE, MAGNESIUM, MAGNESIUM ATPASE %26% ATPASE, MAGNESIUM 1986-92, %26% MAGNESIUM ADENOSINE TRIPHOSPHATASE 1989-92%A%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D017301 2006
% 210.03/210.23 |- skos__altLabel mesh__D017301 Ca Mg-ATPase
% 210.03/210.23 |- skos__hiddenLabel mesh__D017301 Magnesium Adenosine Triphosphatase
% 210.03/210.23 |- skos__altLabel mesh__D017301 Magnesium ATPase
% 210.03/210.23 |- mesh__dateEstablished mesh__D017301 1993-01-01
% 210.03/210.23 |- skos__altLabel mesh__D017301 ATPase, Calcium Magnesium
% 210.03/210.23 |- skos__altLabel mesh__D017301 Calcium Magnesium Adenosinetriphosphatase
% 210.03/210.23 |- skos__hiddenLabel mesh__D017301 Ca Mg ATPase
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D017301
% 210.03/210.23 93; ADENOSINE TRIPHOSPHATASE, MAGNESIUM was heading 1986-92; CALCIUM MAGNESIUM ATPASE was indexed under ADENOSINE TRIPHOSPHATASE, CALCIUM %26% ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92, ADENOSINE TRIPHOSPHATASE 1981-92, %26% MAGNESIUM 1979-80; MAGNESIUM ADENOSINE TRIPHOSPHATASE was see ADENOSINE TRIPHOSPHATASE 1989-92; MAGNESIUM ATPASE %26% ATPASE, MAGNESIUM were see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92%A%
% 210.03/210.23 |- skos__altLabel mesh__D017301 Adenosinetriphosphatase, Magnesium
% 210.03/210.23 |- skos__historyNote mesh__D017301 Magnesium %28%1979-1980%29%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D017301 2005
% 210.03/210.23 |- skos__altLabel mesh__D017301 Mg2+-ATPase
% 210.03/210.23 |- skos__hiddenLabel mesh__D017301 ATPase, Mg2+-Dependent
% 210.03/210.23 |- skos__historyNote mesh__D017301
% 210.03/210.23 Ca%28%2+%29%-Transporting ATPase %28%1986-1992%29%
% 210.03/210.23 |- skos__altLabel mesh__D017301
% 210.03/210.23 Adenosine Triphosphatase, Calcium, Magnesium
% 210.03/210.23 |- skos__prefLabel mesh__D017301 Ca%28%2+%29% Mg%28%2+%29%-ATPase
% 210.03/210.23 |- skos__hiddenLabel mesh__D017301
% 210.03/210.23 Adenosinetriphosphatase, Calcium Magnesium
% 210.03/210.23 |- skos__related mesh__D017301smesh__D000252
% 210.03/210.23 |- mesh__dateRevised mesh__D017301 2003-07-09
% 210.03/210.23 |- skos__annotation mesh__D017301 DF: CA MG ATPASE
% 210.03/210.23 |- skos__hiddenLabel mesh__D017301 Mg2+ ATPase
% 210.03/210.23 |- skos__hiddenLabel mesh__D017301 Mg2+ Dependent ATPase
% 210.03/210.23 |- skos__hiddenLabel mesh__D017301 ATPase, Ca2+-Mg2+
% 210.03/210.23 |- skos__broader mesh__D017301smesh__D000251
% 210.03/210.23 |- skos__historyNote mesh__D017301
% 210.03/210.23 Adenosine Triphosphatase, Magnesium %28%1986-1992%29%
% 210.03/210.23 |- skos__altLabel mesh__D017301 Calcium Magnesium Adenosine Triphosphatase
% 210.03/210.23 |- mesh__recordOriginator mesh__D017301 TPW
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D017301 sjn
% 210.03/210.23 |- skos__altLabel mesh__D017301 ATPase, Magnesium
% 210.03/210.23 |- rdf__type mesh__D017301sskos__Concept
% 210.03/210.23 |- skos__altLabel mesh__D017301 Mg2+-Dependent ATPase
% 210.03/210.23 |- skos__historyNote mesh__D017301
% 210.03/210.23 Adenosinetriphosphatase %28%1981-1985%29%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D017301 2004
% 210.03/210.23 |- skos__altLabel mesh__D017301 Adenosine Triphosphatase, Magnesium
% 210.03/210.23 |- skos__altLabel mesh__D017301 Magnesium Adenosinetriphosphatase
% 210.03/210.23 |- mesh__dateCreated mesh__D017301 1992-06-29
% 210.03/210.23 |- mesh__historyNote mesh__D017301
% 210.03/210.23 93; ADENOSINE TRIPHOSPHATASE, MAGNESIUM was heading 1986-92; CALCIUM MAGNESIUM ATPASE was NM 1979-92; MAGNESIUM ADENOSINE TRIPHOSPHATASE was see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1989-92; MAGNESIUM ATPASE %26% ATPASE, MAGNESIUM were see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92%A%
% 210.03/210.23 |- skos__hiddenLabel mesh__D017301 Ca2+ Mg2+ ATPase
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008575 2005
% 210.03/210.23 |- mesh__dateRevised mesh__D008575 2001-08-13
% 210.03/210.23 |- rdf__type mesh__D008575sskos__Concept
% 210.03/210.23 |- skos__hiddenLabel mesh__D008575 Disease, Meniere
% 210.03/210.23 |- skos__altLabel mesh__D008575 Meniere%27%s Syndrome
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008575 2004
% 210.03/210.23 |- skos__prefLabel mesh__D008575 Meniere%27%s Disease
% 210.03/210.23 |- skos__scopeNote mesh__D008575
% 210.03/210.23 A disease of the inner ear characterized by vertigo, tinnitus, and fluctuating hearing loss often accompanied by fullness in the affected ear. ENDOLYMPHATIC HYDROPS %28%swelling of the endolymph-containing structures%29% is the main pathologic finding.%A%
% 210.03/210.23 |- skos__hiddenLabel mesh__D008575 Menieres Syndrome
% 210.03/210.23 |- mesh__dateCreated mesh__D008575 1999-01-01
% 210.03/210.23 |- skos__hiddenLabel mesh__D008575 Syndrome, Meniere%27%s
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008575 2003
% 210.03/210.23 |- skos__broader mesh__D008575smesh__D018159
% 210.03/210.23 |- skos__hiddenLabel mesh__D008575 Meniere Syndrome
% 210.03/210.23 |- skos__hiddenLabel mesh__D008575 Menieres Disease
% 210.03/210.23 |- skos__hiddenLabel mesh__D008575 Disease, Meniere%27%s
% 210.03/210.23 |- skos__hiddenLabel mesh__D008575 Aural Vertigo
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008575 2002
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D008575 sjn
% 210.03/210.23 |- mesh__recordMaintainer mesh__D008575 jls
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008575 2006
% 210.03/210.23 |- skos__altLabel mesh__D008575 Meniere Disease
% 210.03/210.23 |- skos__annotation mesh__D008575
% 210.03/210.23 an inner ear dis; spell with one accent %28%Meni%C3%%A8%re%27%s%29% in translations; note see related%A%
% 210.03/210.23 |- skos__related mesh__D008575smesh__D018159
% 210.03/210.23 |- mesh__recordOriginator mesh__D008575 NLM
% 210.03/210.23 |- skos__altLabel mesh__D000592 Inborn Errors, Amino Acid Metabolism
% 210.03/210.23 |- skos__altLabel mesh__D000592 Amino Acidopathies, Inborn
% 210.03/210.23 |- mesh__recordOriginator mesh__D000592 NLM
% 210.03/210.23 |- skos__hiddenLabel mesh__D000592 Inborn Amino Acidopathy
% 210.03/210.23 |- skos__annotation mesh__D000592
% 210.03/210.23 coord IM with specific amino acid /metab %28%IM%29%; DF: AA METAB INBORN ERR%A%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D000592 2004
% 210.03/210.23 |- mesh__historyNote mesh__D000592
% 210.03/210.23 1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D000592 sjn
% 210.03/210.23 |- skos__scopeNote mesh__D000592
% 210.03/210.23 Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances %28%e.g., ACIDOSIS%29% and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life.%A%
% 210.03/210.23 |- skos__hiddenLabel mesh__D000592 Inborn Amino Acidopathies
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D000592 2003
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D000592
% 210.03/210.23 1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964
% 210.03/210.23 |- mesh__dateCreated mesh__D000592 1999-01-01
% 210.03/210.23 |- rdf__type mesh__D000592sskos__Concept
% 210.03/210.23 |- skos__hiddenLabel mesh__D000592 Congenital Amino Acidopathy
% 210.03/210.23 |- skos__altLabel mesh__D000592 Amino Acid Metabolism Disorders, Inborn
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D000592 2006
% 210.03/210.23 |- skos__altLabel mesh__D000592 Amino Acid Metabolism, Inborn Error
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D000592 2005
% 210.03/210.23 |- skos__altLabel mesh__D000592 Congenital Amino Acidopathies
% 210.03/210.23 |- mesh__dateRevised mesh__D000592 2001-07-25
% 210.03/210.23 |- skos__broader mesh__D000592smesh__D008661
% 210.03/210.23 |- mesh__recordMaintainer mesh__D000592 nns
% 210.03/210.23 |- skos__altLabel mesh__D000592 Inherited Errors of Amino Acid Metabolism
% 210.03/210.23 |- skos__hiddenLabel mesh__D000592 Amino Acidopathy, Congenital
% 210.03/210.23 |- skos__hiddenLabel mesh__D000592 Amino Acidopathy, Inborn
% 210.03/210.23 |- skos__altLabel mesh__D000592 Amino Acidopathies, Congenital
% 210.03/210.23 |- skos__prefLabel mesh__D000592 Amino Acid Metabolism, Inborn Errors
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D000592 2002
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Anionic Neutrophil Activating Peptide
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Activation Factor, Neutrophil
% 210.03/210.23 |- mesh__dateCreated mesh__D016209 1990-04-24
% 210.03/210.23 |- skos__altLabel mesh__D016209 Chemotactic Factor, Neutrophil
% 210.03/210.23 |- mesh__recordMaintainer mesh__D016209 ssb
% 210.03/210.23 |- skos__scopeNote mesh__D016209
% 210.03/210.23 A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. IL-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.%A%
% 210.03/210.23 |- skos__altLabel mesh__D016209 Chemotactic Factor, Macrophage-Derived
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Activating Peptide, Neutrophil
% 210.03/210.23 |- mesh__recordOriginator mesh__D016209 AGS
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209
% 210.03/210.23 Peptides, Fibroblast-Derived Neutrophil-Activating
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Neutrophil-Activating Peptide, Anionic
% 210.03/210.23 |- skos__broader mesh__D016209smesh__D007378
% 210.03/210.23 |- skos__altLabel mesh__D016209 Neutrophil Activating Peptide
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Chemotactic Factor, Macrophage Derived
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Neutrophil Chemotactic Factor
% 210.03/210.23 |- skos__altLabel mesh__D016209 Neutrophil Activation Factor
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Macrophage-Derived Chemotactic Factor
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Interleukin 8
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D016209 91
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D016209 2006
% 210.03/210.23 |- skos__related mesh__D016209smesh__D018375
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209
% 210.03/210.23 Monocyte-Derived Neutrophil-Activating Peptide
% 210.03/210.23 |- skos__broader mesh__D016209smesh__D018925
% 210.03/210.23 |- skos__altLabel mesh__D016209
% 210.03/210.23 Neutrophil-Activating Peptide, Monocyte-Derived
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209
% 210.03/210.23 Chemotactic Peptide-Interleukin-8, Granulocyte
% 210.03/210.23 |- mesh__dateEstablished mesh__D016209 1991-01-01
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209
% 210.03/210.23 Granulocyte Chemotactic Peptide Interleukin 8
% 210.03/210.23 |- skos__altLabel mesh__D016209
% 210.03/210.23 Monocyte-Derived Neutrophil Chemotactic Factor
% 210.03/210.23 |- mesh__historyNote mesh__D016209 91
% 210.03/210.23 |- skos__historyNote mesh__D016209 Interleukins %28%1988-1990%29%
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209
% 210.03/210.23 Lymphocyte-Derived Neutrophil-Activating Peptide
% 210.03/210.23 |- skos__altLabel mesh__D016209 Neutrophil Activation Peptide
% 210.03/210.23 |- skos__altLabel mesh__D016209 Anionic Neutrophil-Activating Peptide
% 210.03/210.23 |- rdf__type mesh__D016209sskos__Concept
% 210.03/210.23 |- skos__altLabel mesh__D016209
% 210.03/210.23 Chemotactic Factor, Neutrophil, Monocyte-Derived
% 210.03/210.23 |- skos__altLabel mesh__D016209 Leukocyte Adhesion Inhibitor
% 210.03/210.23 |- skos__altLabel mesh__D016209 GCP-IL-8
% 210.03/210.23 |- mesh__dateRevised mesh__D016209 2005-06-30
% 210.03/210.23 |- skos__annotation mesh__D016209 DF: IL 8 or IL8
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209
% 210.03/210.23 Neutrophil Activating Peptides, Fibroblast Derived
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Activation Peptide, Neutrophil
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209
% 210.03/210.23 Neutrophil Activating Peptide, Monocyte Derived
% 210.03/210.23 |- skos__altLabel mesh__D016209 IL8
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209
% 210.03/210.23 Neutrophil Activating Peptide, Lymphocyte Derived
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D016209 sjn
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209
% 210.03/210.23 Fibroblast-Derived Neutrophil-Activating Peptides
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Peptide, Anionic Neutrophil-Activating
% 210.03/210.23 |- skos__altLabel mesh__D016209
% 210.03/210.23 Neutrophil-Activating Peptide, Lymphocyte-Derived
% 210.03/210.23 |- skos__altLabel mesh__D016209
% 210.03/210.23 Granulocyte Chemotactic Peptide-Interleukin-8
% 210.03/210.23 |- skos__altLabel mesh__D016209 IL-8
% 210.03/210.23 |- skos__prefLabel mesh__D016209 Interleukin-8
% 210.03/210.23 |- skos__hiddenLabel mesh__D016209 Adhesion Inhibitor, Leukocyte
% 210.03/210.23 |- skos__broader mesh__D006621Q000293smesh__D006621
% 210.03/210.23 |- mesh__preferredCombination mesh__D006621Q000293smesh__D025981
% 210.03/210.23 |- rdf__type mesh__D006621Q000293smesh__CompoundConcept
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004983 2005
% 210.03/210.23 |- mesh__dateRevised mesh__D004983 2001-07-25
% 210.03/210.23 |- mesh__recordMaintainer mesh__D004983 mdb
% 210.03/210.23 |- skos__annotation mesh__D004983 ETHANOLAMINE is also available
% 210.03/210.23 |- skos__prefLabel mesh__D004983 Ethanolamines
% 210.03/210.23 |- rdf__type mesh__D004983sskos__Concept
% 210.03/210.23 |- mesh__historyNote mesh__D004983 73
% 210.03/210.23 |- skos__scopeNote mesh__D004983
% 210.03/210.23 AMINO ALCOHOLS containing the ETHANOLAMINE; %28%-NH2CH2CHOH%29% group and its derivatives.%A%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004983 2004
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D004983 73
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D004983 sjn
% 210.03/210.23 |- skos__broader mesh__D004983smesh__D000605
% 210.03/210.23 |- mesh__recordOriginator mesh__D004983 NLM
% 210.03/210.23 |- skos__broader mesh__D004983smesh__D000431
% 210.03/210.23 |- mesh__dateEstablished mesh__D004983 1973-01-01
% 210.03/210.23 |- mesh__dateCreated mesh__D004983 1999-01-01
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004983 2003
% 210.03/210.23 |- skos__historyNote mesh__D004983 Amino Alcohols %28%1966-1972%29%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004983 2006
% 210.03/210.23 |- skos__altLabel mesh__D004983 Aminoethanols
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004983 2002
% 210.03/210.23 |- skos__related mesh__D004185smesh__D014729
% 210.03/210.23 |- skos__prefLabel mesh__D004185 Disability Evaluation
% 210.03/210.23 |- rdf__type mesh__D004185sskos__Concept
% 210.03/210.23 |- mesh__dateRevised mesh__D004185 1997-06-20
% 210.03/210.23 |- mesh__recordMaintainer mesh__D004185 PXP
% 210.03/210.23 |- skos__annotation mesh__D004185 no qualif
% 210.03/210.23 |- skos__hiddenLabel mesh__D004185 Evaluation, Disability
% 210.03/210.23 |- skos__hiddenLabel mesh__D004185 Disability Evaluations
% 210.03/210.23 |- skos__scopeNote mesh__D004185
% 210.03/210.23 Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen%27%s compensation benefits.%A%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004185 2006
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D004185 SJN
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004185 2002
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004185 1999
% 210.03/210.23 |- mesh__recordOriginator mesh__D004185 NLM
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004185 2005
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004185 2001
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004185 1998
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004185 2004
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004185 2000
% 210.03/210.23 |- skos__hiddenLabel mesh__D004185 Evaluations, Disability
% 210.03/210.23 |- skos__broader mesh__D004185smesh__D019937
% 210.03/210.23 |- mesh__dateCreated mesh__D004185 1999-01-01
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004185 2003
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D012617 sjn
% 210.03/210.23 |- skos__altLabel mesh__D012617 Clypeasteroida
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D012617 72
% 210.03/210.23 |- mesh__recordMaintainer mesh__D012617 ags
% 210.03/210.23 |- skos__historyNote mesh__D012617 Echinodermata %28%1966-1971%29%
% 210.03/210.23 |- skos__altLabel mesh__D012617 Sand Dollars
% 210.03/210.23 |- skos__annotation mesh__D012617
% 210.03/210.23 general; prefer specifics; sea urchin eggs = OVUM %28%IM%29% + SEA URCHINS %28%NIM%29% if merely test organism%A%
% 210.03/210.23 |- skos__altLabel mesh__D012617 Echinoidea
% 210.03/210.23 |- mesh__dateCreated mesh__D012617 1999-01-01
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D012617 2005
% 210.03/210.23 |- mesh__dateRevised mesh__D012617 2004-07-07
% 210.03/210.23 |- mesh__dateEstablished mesh__D012617 1972-01-01
% 210.03/210.23 |- skos__prefLabel mesh__D012617 Sea Urchins
% 210.03/210.23 |- skos__broader mesh__D012617smesh__D004447
% 210.03/210.23 |- mesh__recordOriginator mesh__D012617 NLM
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D012617 2006
% 210.03/210.23 |- rdf__type mesh__D012617sskos__Concept
% 210.03/210.23 |- mesh__historyNote mesh__D012617 72
% 210.03/210.23 |- skos__scopeNote mesh__D012617
% 210.03/210.23 Somewhat flattened, globular echinoderms, having thin, brittle shells of calcareous plates. They are useful models for studying FERTILIZATION and EMBRYO DEVELOPMENT.%A%
% 210.03/210.23 |- skos__broader mesh__D017302smesh__D002135
% 210.03/210.23 |- mesh__recordOriginator mesh__D017302 AGS
% 210.03/210.23 |- skos__altLabel mesh__D017302 Calpactin
% 210.03/210.23 |- skos__prefLabel mesh__D017302 Annexins
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D017302
% 210.03/210.23 1993; ANNEXIN XI was indexed under CALCIUM-BINDING PROTEINS 1992; ANNEXIN IX %26% ANNEXIN X were indexed under CALCIUM-BINDING PROTEINS 1990-1992; VASCULAR ANTICOAGULANT %28%ENDOGENOUS%29% was indexed under PEPTIDES 1988-1992; PLACENTAL ANTICOAGULANT PROTEINS was indexed under PREGNANCY PROTEINS 1987-1992; LIPOCORTINS was indexed under CALCIUM-BINDING PROTEINS 1985-1992; CALPACTIN %26% CALCIMEDINS were indexed under CALCIUM-BINDING PROTEINS 1984-1992; CALELECTRIN was indexed under CALCIUM-BINDING PROTEINS 1982-1992; CHROMOBINDINS was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1986-2004%A%
% 210.03/210.23 |- mesh__dateEstablished mesh__D017302 1993-01-01
% 210.03/210.23 |- skos__altLabel mesh__D017302 Lipocortins
% 210.03/210.23 |- skos__historyNote mesh__D017302
% 210.03/210.23 Calcium-Binding Proteins %28%1984-1992%29%
% 210.03/210.23 |- skos__altLabel mesh__D017302 Calcimedins
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D017302 2006
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D017302 sjn
% 210.03/210.23 |- skos__altLabel mesh__D017302 Annexin X
% 210.03/210.23 |- skos__altLabel mesh__D017302 Annexin VIII
% 210.03/210.23 |- skos__altLabel mesh__D017302 Annexin IX
% 210.03/210.23 |- mesh__dateCreated mesh__D017302 1992-05-07
% 210.03/210.23 |- mesh__historyNote mesh__D017302 1993
% 210.03/210.23 |- skos__altLabel mesh__D017302 Annexin XI
% 210.03/210.23 |- skos__scopeNote mesh__D017302
% 210.03/210.23 Family of calcium- and phospholipid-binding proteins which are structurally related and exhibit immunological cross-reactivity. Each member contains four homologous 70-kDa repeats. The annexins are differentially distributed in vertebrate tissues %28%and lower eukaryotes%29% and appear to be involved in MEMBRANE FUSION and SIGNAL TRANSDUCTION.%A%
% 210.03/210.23 |- skos__altLabel mesh__D017302 Lipocortin
% 210.03/210.23 |- mesh__recordMaintainer mesh__D017302 SYSTEM
% 210.03/210.23 |- rdf__type mesh__D017302sskos__Concept
% 210.03/210.23 |- mesh__dateRevised mesh__D017302 2005-06-30
% 210.03/210.23 |- skos__altLabel mesh__D017302 Calelectrin
% 210.03/210.23 |- skos__altLabel mesh__D050736 crk Oncogene Protein
% 210.03/210.23 |- skos__hiddenLabel mesh__D050736 Oncogene Protein, v-crk
% 210.03/210.23 |- mesh__historyNote mesh__D050736 2006%28%1989%29%
% 210.03/210.23 |- skos__hiddenLabel mesh__D050736 Oncogene Protein v crk
% 210.03/210.23 |- mesh__dateEstablished mesh__D050736 2006-01-01
% 210.03/210.23 |- skos__prefLabel mesh__D050736 Oncogene Protein v-crk
% 210.03/210.23 |- skos__altLabel mesh__D050736 v-crk Protein
% 210.03/210.23 |- mesh__recordMaintainer mesh__D050736 DRC
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D050736 sjn
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D050736 2006
% 210.03/210.23 |- rdf__type mesh__D050736sskos__Concept
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D050736
% 210.03/210.23 2006; ONCOGENE PROTEIN V-CRK was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-2005%A%
% 210.03/210.23 |- skos__altLabel mesh__D050736 Oncogene Protein crk
% 210.03/210.23 |- skos__broader mesh__D050736smesh__D015682
% 210.03/210.23 |- skos__altLabel mesh__D050736 CT10 Regulator of Kinase Oncogene Protein
% 210.03/210.23 |- mesh__dateCreated mesh__D050736 2005-06-30
% 210.03/210.23 |- skos__hiddenLabel mesh__D050736 v-crk, Oncogene Protein
% 210.03/210.23 |- skos__hiddenLabel mesh__D050736 crk, Oncogene Protein
% 210.03/210.23 |- skos__scopeNote mesh__D050736
% 210.03/210.23 A signal transducing adaptor protein that is encoded by the crk ONCOGENE from TYPE C AVIAN RETROVIRUSES. It contains SRC HOMOLOGY DOMAINS and is closely related to its cellular homolog, PROTO-ONCOGENE PROTEIN C-CRK.%A%
% 210.03/210.23 |- skos__altLabel mesh__D050736 v-crk Oncogene Protein
% 210.03/210.23 |- skos__hiddenLabel mesh__D050736 v crk Oncogene Protein
% 210.03/210.23 |- skos__hiddenLabel mesh__D050736 Oncogene Protein, crk
% 210.03/210.23 |- mesh__recordOriginator mesh__D050736 DRC
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 1995
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 2001
% 210.03/210.23 |- skos__broader mesh__D008576smesh__D001158
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 2003
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 1994
% 210.03/210.23 |- mesh__dateCreated mesh__D008576 1999-01-01
% 210.03/210.23 |- mesh__recordOriginator mesh__D008576 NLM
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 2000
% 210.03/210.23 |- skos__hiddenLabel mesh__D008576 Arteries, Meningeal
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 1999
% 210.03/210.23 |- skos__hiddenLabel mesh__D008576 Artery, Meningeal
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 1993
% 210.03/210.23 |- skos__scopeNote mesh__D008576 Arteries which supply the dura mater.
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 1998
% 210.03/210.23 |- mesh__dateRevised mesh__D008576 1992-05-15
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 2006
% 210.03/210.23 |- skos__prefLabel mesh__D008576 Meningeal Arteries
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D008576 PLS
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 2005
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 1997
% 210.03/210.23 |- mesh__recordMaintainer mesh__D008576 TAP
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 2002
% 210.03/210.23 |- skos__hiddenLabel mesh__D008576 Meningeal Artery
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 1996
% 210.03/210.23 |- rdf__type mesh__D008576sskos__Concept
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D008576 2004
% 210.03/210.23 |- skos__altLabel mesh__D000593 Naphthylamidases
% 210.03/210.23 |- rdf__type mesh__D000593sskos__Concept
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D000593 2006
% 210.03/210.23 |- skos__altLabel mesh__D000593 Arylamidases
% 210.03/210.23 |- mesh__dateEstablished mesh__D000593 1974-01-01
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D000593 2005
% 210.03/210.23 |- mesh__historyNote mesh__D000593 74
% 210.03/210.23 |- mesh__recordOriginator mesh__D000593 NLM
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D000593 sjn
% 210.03/210.23 |- skos__broader mesh__D000593smesh__D000626
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D000593 2004
% 210.03/210.23 |- skos__prefLabel mesh__D000593 Amino Acid Naphthylamidases
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D000593 74
% 210.03/210.23 |- mesh__dateRevised mesh__D000593 2003-07-09
% 210.03/210.23 |- mesh__recordMaintainer mesh__D000593 ssb
% 210.03/210.23 |- mesh__dateCreated mesh__D000593 1999-01-01
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D041401 2006
% 210.03/210.23 |- mesh__historyNote mesh__D041401 2003
% 210.03/210.23 |- mesh__recordOriginator mesh__D041401 ags
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D041401 2003
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D041401 sjn
% 210.03/210.23 |- mesh__recordMaintainer mesh__D041401 SYSTEM
% 210.03/210.23 |- mesh__dateRevised mesh__D041401 2005-06-30
% 210.03/210.23 |- skos__prefLabel mesh__D041401 Leptospira interrogans serovar pomona
% 210.03/210.23 |- skos__broader mesh__D041401smesh__D007921
% 210.03/210.23 |- mesh__dateCreated mesh__D041401 2002-07-03
% 210.03/210.23 |- skos__historyNote mesh__D041401 Leptospira interrogans %28%1976-2002%29%
% 210.03/210.23 |- rdf__type mesh__D041401sskos__Concept
% 210.03/210.23 |- skos__scopeNote mesh__D041401
% 210.03/210.23 A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary hosts include CATTLE and SWINE.%A%
% 210.03/210.23 |- mesh__dateEstablished mesh__D041401 2003-01-01
% 210.03/210.23 |- skos__annotation mesh__D041401
% 210.03/210.23 do not confuse with the seroGROUP pomona, sometimes termed Leptospira pomona %28%index LEPTOSPIRA INTERROGANS%29%; infection: coord IM with probably LEPTOSPIROSIS %28%IM%29%%A%
% 210.03/210.23 |- skos__scopeNote mesh__D013710
% 210.03/210.23 Fibrous bands or cords of CONNECTIVE TISSUE at the ends of MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures.%A%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D013710 2002
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D013710 2005
% 210.03/210.23 |- mesh__dateCreated mesh__D013710 1999-01-01
% 210.03/210.23 |- skos__prefLabel mesh__D013710 Tendons
% 210.03/210.23 |- mesh__historyNote mesh__D013710
% 210.03/210.23 /transplantation was TENDON TRANSPLANTATION 1963-65
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D013710 sjn
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D013710 2006
% 210.03/210.23 |- mesh__recordMaintainer mesh__D013710 nns
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D013710 2003
% 210.03/210.23 |- rdf__type mesh__D013710sskos__Concept
% 210.03/210.23 |- mesh__dateRevised mesh__D013710 2001-07-25
% 210.03/210.23 |- skos__annotation mesh__D013710
% 210.03/210.23 tendon rupt = TENDON INJURIES %28%IM%29% + RUPTURE %28%NIM%29%; /surg: consider TENDON TRANSFER; /transpl permitted: do not confuse with TENDON TRANSFER; for specifically located tendons coord IM with general area of tendon, not a bone term, as metacarpal tendon: TENDONS %28%IM%29% + HAND or FINGERS %28%IM%29%, not METACARPUS; %22%false tendons%22% of heart = PURKINJE FIBERS %28%see note there%29%; tendon reflex = REFLEX, TENDON see REFLEX, STRETCH%A%
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D013710 2004
% 210.03/210.23 |- skos__broader mesh__D013710smesh__D009141
% 210.03/210.23 |- skos__related mesh__D013710smesh__D013709
% 210.03/210.23 |- skos__hiddenLabel mesh__D013710 Tendon
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D013710
% 210.03/210.23 /transplantation was TENDON TRANSPLANTATION 1963-65
% 210.03/210.23 |- mesh__recordOriginator mesh__D013710 NLM
% 210.03/210.23 |- skos__scopeNote mesh__D004984
% 210.03/210.23 A sedative and hypnotic that has been used in the short-term management of INSOMNIA. Its use has been superseded by other drugs.%A%
% 210.03/210.23 |- rdf__type mesh__D004984sskos__Concept
% 210.03/210.23 |- skos__altLabel mesh__D004984 Ethchlorvinol
% 210.03/210.23 |- skos__broader mesh__D004984smesh__D002728
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004984 2004
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D004984 66
% 210.03/210.23 |- mesh__dateCreated mesh__D004984 1999-01-01
% 210.03/210.23 |- mesh__dateEstablished mesh__D004984 1966-01-01
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004984 2006
% 210.03/210.23 |- mesh__historyNote mesh__D004984 66%28%63%29%
% 210.03/210.23 |- skos__prefLabel mesh__D004984 Ethchlorvynol
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D004984 sjn
% 210.03/210.23 |- mesh__recordOriginator mesh__D004984 NLM
% 210.03/210.23 |- mesh__recordMaintainer mesh__D004984 ssb
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004984 2005
% 210.03/210.23 |- skos__altLabel mesh__D004984 Ethchlorovynol
% 210.03/210.23 |- mesh__dateRevised mesh__D004984 2003-07-09
% 210.03/210.23 |- mesh__dateEstablished mesh__D004186 1974-01-01
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004186 2006
% 210.03/210.23 |- mesh__dateRevised mesh__D004186 2003-07-09
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004186 2005
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D004186 2004
% 210.03/210.23 |- mesh__historyNote mesh__D004186 74
% 210.03/210.23 |- mesh__publicMeSHNote mesh__D004186 74
% 210.03/210.23 |- mesh__dateCreated mesh__D004186 1999-01-01
% 210.03/210.23 |- skos__broader mesh__D004186smesh__D006026
% 210.03/210.23 |- mesh__recordMaintainer mesh__D004186 ssb
% 210.03/210.23 |- mesh__recordOriginator mesh__D004186 NLM
% 210.03/210.23 |- skos__prefLabel mesh__D004186 Disaccharidases
% 210.03/210.23 |- mesh__recordAuthorizer mesh__D004186 sjn
% 210.03/210.23 |- rdf__type mesh__D004186sskos__Concept
% 210.03/210.23 |- mesh__activeMeSHYear mesh__D012618 2005
% 210.03/210.23 |- skos__broader mesh__D012618smesh__D013106
% 210.03/210.23 |- skos__related mesh__D012618smesh__D009542
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Histiocytoses, Sea Blue
% 210.03/210.24 |- mesh__dateCreated mesh__D012618 1983-05-31
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D012618 2003
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D012618 2006
% 210.03/210.24 |- skos__broader mesh__D012618smesh__D015616
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Histiocytoses, Sea-Blue
% 210.03/210.24 |- skos__altLabel mesh__D012618 Histiocyte Syndromes, Sea Blue
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Sea Blue Histiocyte Syndrome
% 210.03/210.24 |- skos__historyNote mesh__D012618 Histiocytes %28%1966-1983%29%
% 210.03/210.24 |- mesh__dateRevised mesh__D012618 2001-07-25
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Sea-Blue Histiocytosis
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D012618 2004
% 210.03/210.24 |- rdf__type mesh__D012618sskos__Concept
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Histiocyte Syndrome, Sea-Blue
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D012618 2002
% 210.03/210.24 |- mesh__recordMaintainer mesh__D012618 nns
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D012618 84
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D012618 sjn
% 210.03/210.24 |- skos__altLabel mesh__D012618 Sea Blue Histiocytosis
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Sea-Blue Histiocytoses
% 210.03/210.24 |- mesh__historyNote mesh__D012618 84
% 210.03/210.24 |- skos__altLabel mesh__D012618 Histiocytosis, Sea-Blue
% 210.03/210.24 |- mesh__dateEstablished mesh__D012618 1984-01-01
% 210.03/210.24 |- mesh__recordOriginator mesh__D012618 VDK
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Syndromes, Sea-Blue Histiocyte
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Syndrome, Sea-Blue Histiocyte
% 210.03/210.24 |- skos__scopeNote mesh__D012618
% 210.03/210.24 Rare disorder consisting of splenomegaly, mild purpura secondary to thrombocytopenia, and occasionally, hepatic cirrhosis associated with the appearance of numerous histiocytes in the spleen and bone marrow which stain a sea-blue color.%A%
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Histiocyte Syndromes, Sea-Blue
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Sea-Blue Histiocyte Syndromes
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Histiocytosis, Sea Blue
% 210.03/210.24 |- skos__altLabel mesh__D012618 Histiocyte Syndrome, Sea Blue
% 210.03/210.24 |- skos__prefLabel mesh__D012618 Sea-Blue Histiocyte Syndrome
% 210.03/210.24 |- skos__hiddenLabel mesh__D012618 Sea Blue Histiocytoses
% 210.03/210.24 |- skos__altLabel mesh__D050737 c-crk Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c-crk, Proto-Oncogene Proteins
% 210.03/210.24 |- skos__altLabel mesh__D050737 CT10 Regulator of Kinase Protein
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D050737 sjn
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Crk 2 Protein
% 210.03/210.24 |- skos__altLabel mesh__D050737 CRKI Protein
% 210.03/210.24 |- mesh__dateCreated mesh__D050737 2005-06-30
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Proteins, crk
% 210.03/210.24 |- skos__scopeNote mesh__D050737
% 210.03/210.24 Signal transducing adaptor proteins that contain SRC HOMOLOGY DOMAINS and play a role in CYTOSKELETON reorganization. c-crk protein is closely related to ONCOGENE PROTEIN V-CRK and includes several alternatively spliced isoforms.%A%
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto Oncogene Protein c crk 3
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto Oncogene Protein c crk
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proteins c-crk, Proto-Oncogene
% 210.03/210.24 |- mesh__historyNote mesh__D050737 2006%28%1990%29%
% 210.03/210.24 |- skos__broader mesh__D050737smesh__D048868
% 210.03/210.24 |- skos__altLabel mesh__D050737 c-crkI Protein
% 210.03/210.24 |- skos__altLabel mesh__D050737 Proto-Oncogene Protein c-crk
% 210.03/210.24 |- skos__altLabel mesh__D050737 Crk-2 Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 crk Proto Oncogene Proteins
% 210.03/210.24 |- skos__altLabel mesh__D050737 CrkII Adapter Protein
% 210.03/210.24 |- skos__prefLabel mesh__D050737 Proto-Oncogene Proteins c-crk
% 210.03/210.24 |- skos__altLabel mesh__D050737 CRKII Protein
% 210.03/210.24 |- skos__altLabel mesh__D050737 crk Proto-Oncogene Proteins
% 210.03/210.24 |- skos__altLabel mesh__D050737 c-crk-3 Proto-Oncogene Protein
% 210.03/210.24 |- skos__broader mesh__D050737smesh__D011518
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto Oncogene Protein c crk 2
% 210.03/210.24 |- mesh__dateEstablished mesh__D050737 2006-01-01
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c-crk-1, Proto-Oncogene Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c-crk-2, Proto-Oncogene Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Protein, c-crk-3
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Proteins, c-crk
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c-crk-3, Proto-Oncogene Protein
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D050737 2006
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c CrkIII Protein
% 210.03/210.24 |- skos__altLabel mesh__D050737 c-crk Proto-Oncogene Proteins
% 210.03/210.24 |- skos__altLabel mesh__D050737 CrkIII Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c-crk, Proto-Oncogene Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c crk 3 Proto Oncogene Protein
% 210.03/210.24 |- mesh__recordMaintainer mesh__D050737 DRC
% 210.03/210.24 |- mesh__recordOriginator mesh__D050737 DRC
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto Oncogene Proteins c crk
% 210.03/210.24 |- skos__altLabel mesh__D050737 c-CrkII Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Adapter Protein, CrkII
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Crk 1 Protein
% 210.03/210.24 |- skos__altLabel mesh__D050737 c-CrkIII Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Protein, c-crk-I
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c CrkII Protein
% 210.03/210.24 |- skos__altLabel mesh__D050737 c-crk-I Proto-Oncogene Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto Oncogene Protein c crk 1
% 210.03/210.24 |- skos__altLabel mesh__D050737 c-crk-2 Proto-Oncogene Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c crk 2 Proto Oncogene Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c crk I Proto Oncogene Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Protein, c-crk-2
% 210.03/210.24 |- rdf__type mesh__D050737sskos__Concept
% 210.03/210.24 |- skos__hiddenLabel mesh__D050737 c crk Proto Oncogene Proteins
% 210.03/210.24 |- skos__altLabel mesh__D050737 Crk-1 Protein
% 210.03/210.24 |- skos__altLabel mesh__D050737 Crk3 Protein
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D050737
% 210.03/210.24 2006; PROTO-ONCOGENE PROTEIN C-CRK was indexed under PROTO-ONCOGENE PROTEINS 1990-2005%A%
% 210.03/210.24 |- skos__broader mesh__D008577smesh__D016543
% 210.03/210.24 |- mesh__recordOriginator mesh__D008577 VDK
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm, Malignant
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D008577 2003
% 210.03/210.24 |- mesh__dateRevised mesh__D008577 2001-07-25
% 210.03/210.24 |- mesh__dateEstablished mesh__D008577 1978-01-01
% 210.03/210.24 |- skos__historyNote mesh__D008577 Brain Neoplasms %28%1966-1977%29%
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Leptomeningeal Neoplasm
% 210.03/210.24 |- mesh__recordMaintainer mesh__D008577 nns
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Cancers, Meningeal
% 210.03/210.24 |- skos__scopeNote mesh__D008577
% 210.03/210.24 Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.%A%
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm, Intracranial
% 210.03/210.24 |- skos__altLabel mesh__D008577 Meningeal Neoplasms, Intracranial
% 210.03/210.24 |- skos__altLabel mesh__D008577 Neoplasms, Leptomeningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasm, Leptomeningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasms, Intracranial Meningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasm, Benign Meningeal
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D008577 2004
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasm, Malignant Meningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasms, Spinal Meningeal
% 210.03/210.24 |- skos__altLabel mesh__D008577 Meningeal Tumors
% 210.03/210.24 |- rdf__type mesh__D008577sskos__Concept
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Tumor, Meningeal
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D008577 2005
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Meningeal Cancers
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm, Benign
% 210.03/210.24 |- skos__annotation mesh__D008577
% 210.03/210.24 coord IM with histol type of neopl %28%IM%29%; for intracranial or spinal meningioma, see note on MENINGIOMA; intradural extramedullary neopl do not go here: index under SPINAL CORD NEOPLASMS %26% do not try to locate %22%intradural%22% or %22%extramedullary%22%; meningeal leukemia does not go here: index under MENINGES /pathol %28%IM%29% + LEUKEMIC INFILTRATION %28%IM%29% %28%see note there%29% + specific type of leukemia %28%IM%29% if relevant%A%
% 210.03/210.24 |- skos__historyNote mesh__D008577 Neoplasms %28%1966-1977%29%
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Tumors, Meningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasms, Spinal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Intracranial Meningeal Neoplasm
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D008577 78
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Cancer, Meningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasm, Spinal Meningeal
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D008577 2006
% 210.03/210.24 |- mesh__dateCreated mesh__D008577 1977-04-27
% 210.03/210.24 |- skos__altLabel mesh__D008577 Neoplasms, Meningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasms, Malignant Meningeal
% 210.03/210.24 |- skos__altLabel mesh__D008577 Meningeal Cancer
% 210.03/210.24 |- mesh__historyNote mesh__D008577 78
% 210.03/210.24 |- skos__prefLabel mesh__D008577 Meningeal Neoplasms
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Meningeal Tumor
% 210.03/210.24 |- skos__altLabel mesh__D008577 Meningeal Neoplasms, Malignant
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasm, Intracranial Meningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm, Spinal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasms, Benign Meningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Spinal Meningeal Neoplasm
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Malignant Meningeal Neoplasm
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Benign Meningeal Neoplasm
% 210.03/210.24 |- skos__altLabel mesh__D008577 Meningeal Neoplasms, Benign
% 210.03/210.24 |- skos__historyNote mesh__D008577 Meninges %28%1966-1977%29%
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D008577 2002
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D008577 sjn
% 210.03/210.24 |- skos__hiddenLabel mesh__D008577 Neoplasm, Meningeal
% 210.03/210.24 |- skos__hiddenLabel mesh__D000594 Oxidoreductases, Amino Acid
% 210.03/210.24 |- mesh__dateRevised mesh__D000594 2005-06-30
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D000594
% 210.03/210.24 74; was AMINOACID OXIDOREDUCTASES 1964-73
% 210.03/210.24 |- mesh__historyNote mesh__D000594
% 210.03/210.24 74; was AMINOACID OXIDOREDUCTASES 1964-73
% 210.03/210.24 |- mesh__recordMaintainer mesh__D000594 jmp
% 210.03/210.24 |- skos__prefLabel mesh__D000594 Amino Acid Oxidoreductases
% 210.03/210.24 |- mesh__dateEstablished mesh__D000594 1964-01-01
% 210.03/210.24 |- skos__scopeNote mesh__D000594
% 210.03/210.24 A class of enzymes that catalyze oxidation-reduction reactions of amino acids. EC 1.4.-.%A%
% 210.03/210.24 |- mesh__onlineNote mesh__D000594
% 210.03/210.24 use AMINO ACID OXIDOREDUCTASES to search AMINOACID OXIDOREDUCTASES 1966-73%A%
% 210.03/210.24 |- mesh__recordOriginator mesh__D000594 NLM
% 210.03/210.24 |- skos__broader mesh__D000594smesh__D050891
% 210.03/210.24 |- mesh__dateCreated mesh__D000594 1999-01-01
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D000594 sjn
% 210.03/210.24 |- rdf__type mesh__D000594sskos__Concept
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D000594 2006
% 210.03/210.24 |- skos__hiddenLabel mesh__D000594 Acid Oxidoreductases, Amino
% 210.03/210.24 |- skos__hiddenLabel mesh__D013711 Tendon, Paraarticular
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D013711 2006
% 210.03/210.24 |- mesh__dateRevised mesh__D013711 2001-07-25
% 210.03/210.24 |- skos__prefLabel mesh__D013711 Tendons, Para-Articular
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D013711 2003
% 210.03/210.24 |- rdf__type mesh__D013711sskos__Concept
% 210.03/210.24 |- mesh__historyNote mesh__D013711 65
% 210.03/210.24 |- skos__hiddenLabel mesh__D013711 Tendon, Para-Articular
% 210.03/210.24 |- mesh__recordOriginator mesh__D013711 NLM
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D013711 2004
% 210.03/210.24 |- skos__hiddenLabel mesh__D013711 Paraarticular Tendon
% 210.03/210.24 |- skos__hiddenLabel mesh__D013711 Tendons, Para Articular
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D013711 2002
% 210.03/210.24 |- skos__hiddenLabel mesh__D013711 Paraarticular Tendons
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D013711 65
% 210.03/210.24 |- mesh__recordMaintainer mesh__D013711 nns
% 210.03/210.24 |- skos__altLabel mesh__D013711 Tendons, Paraarticular
% 210.03/210.24 |- skos__hiddenLabel mesh__D013711 Para-Articular Tendon
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D013711 sjn
% 210.03/210.24 |- skos__hiddenLabel mesh__D013711 Para-Articular Tendons
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D013711 2005
% 210.03/210.24 |- mesh__dateEstablished mesh__D013711 1965-01-01
% 210.03/210.24 |- mesh__dateCreated mesh__D013711 1999-01-01
% 210.03/210.24 |- skos__broader mesh__D013711smesh__D013710
% 210.03/210.24 |- skos__hiddenLabel mesh__D004985 epsilon ATP
% 210.03/210.24 |- skos__prefLabel mesh__D004985 Ethenoadenosine Triphosphate
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 1997
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 2003
% 210.03/210.24 |- mesh__historyNote mesh__D004985
% 210.03/210.24 91%28%75%29%; was see under ADENOSINE TRIPHOSPHATE 1975-90
% 210.03/210.24 |- mesh__dateEstablished mesh__D004985 1991-01-01
% 210.03/210.24 |- mesh__dateRevised mesh__D004985 1992-05-19
% 210.03/210.24 |- mesh__recordOriginator mesh__D004985 NLM
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 1993
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 2000
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 2006
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D004985
% 210.03/210.24 91; was see under ADENOSINE TRIPHOSPHATE 1975-90
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 1996
% 210.03/210.24 |- skos__annotation mesh__D004985 %22%a fluorescent analog of ATP%22%
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 1999
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D004985 PLS
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 2005
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 1995
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 2002
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 1998
% 210.03/210.24 |- rdf__type mesh__D004985sskos__Concept
% 210.03/210.24 |- skos__broader mesh__D004985smesh__D000255
% 210.03/210.24 |- skos__historyNote mesh__D004985 Adenosine Triphosphate %28%1972-1974%29%
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 1994
% 210.03/210.24 |- mesh__recordMaintainer mesh__D004985 TGC
% 210.03/210.24 |- skos__hiddenLabel mesh__D004985 Triphosphate, Ethenoadenosine
% 210.03/210.24 |- skos__scopeNote mesh__D004985
% 210.03/210.24 1,N-6-Ethenoadenosine triphosphate. A fluorescent analog of adenosine triphosphate.%A%
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 2004
% 210.03/210.24 |- skos__historyNote mesh__D004985 Imidazoles %28%1972-1974%29%
% 210.03/210.24 |- mesh__dateCreated mesh__D004985 1974-11-19
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004985 2001
% 210.03/210.24 |- skos__prefLabel mesh__D037361 Adenylate Cyclase Toxin
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Bordetella Ac-Hly
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D037361
% 210.03/210.24 2003; see PERTUSSIS TOXINS 1986-2002; CYCLOLYSIN was indexed under BACTERIAL PROTEINS and PROTEIN PRECURSORS 1989-2002%A%
% 210.03/210.24 |- skos__altLabel mesh__D037361 cyaA Toxin
% 210.03/210.24 |- skos__scopeNote mesh__D037361
% 210.03/210.24 One of the virulence factors produced by virulent BORDETELLA organisms. It is a bifunctional protein with both ADENYLATE CYCLASE and hemolysin components.%A%
% 210.03/210.24 |- skos__altLabel mesh__D037361 Cyclolysin
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Ac Hly, Bordetella
% 210.03/210.24 |- skos__altLabel mesh__D037361 cyaA Protein, Bordetella
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D037361 sjn
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Toxin, cyaA
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Cyclase Toxin, Adenylate
% 210.03/210.24 |- skos__altLabel mesh__D037361 Adenylate Cyclase-Hemolysin
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Bordetella AC Toxin
% 210.03/210.24 |- mesh__recordMaintainer mesh__D037361 ssb
% 210.03/210.24 |- skos__altLabel mesh__D037361 Ac-Hly, Bordetella
% 210.03/210.24 |- skos__broader mesh__D037361smesh__D000262
% 210.03/210.24 |- skos__altLabel mesh__D037361 AC Toxin, Bordetella
% 210.03/210.24 |- mesh__dateCreated mesh__D037361 2002-07-02
% 210.03/210.24 |- skos__altLabel mesh__D037361
% 210.03/210.24 Adenylate Cyclase-Haemolysin Bifunctional Protein, B. pertussis
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Cyclase-Hemolysin, Adenylate
% 210.03/210.24 |- skos__altLabel mesh__D037361 Bordetella Adenylate Cyclase Toxin
% 210.03/210.24 |- mesh__dateRevised mesh__D037361 2005-06-30
% 210.03/210.24 |- mesh__dateEstablished mesh__D037361 2003-01-01
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Adenylate Cyclase Hemolysin
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D037361 2006
% 210.03/210.24 |- mesh__recordOriginator mesh__D037361 nns
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Toxin, Adenylate Cyclase
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361
% 210.03/210.24 Pertussis Adenylate Cyclase Haemolysin Bifunctional Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Protein, Bordetella cyaA
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Toxin, Bordetella AC
% 210.03/210.24 |- skos__broader mesh__D037361smesh__D010566
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361 Bordetella cyaA Protein
% 210.03/210.24 |- skos__hiddenLabel mesh__D037361
% 210.03/210.24 Adenylate Cyclase Haemolysin Bifunctional Protein, B. pertussis
% 210.03/210.24 |- skos__historyNote mesh__D037361
% 210.03/210.24 Virulence Factors, Bordetella %28%1984-2002%29%
% 210.03/210.24 |- skos__altLabel mesh__D037361
% 210.03/210.24 Pertussis Adenylate Cyclase-Haemolysin Bifunctional Protein
% 210.03/210.24 |- rdf__type mesh__D037361sskos__Concept
% 210.03/210.24 |- skos__altLabel mesh__D037361 cyaA Gene Product, Bordetella
% 210.03/210.24 |- mesh__historyNote mesh__D037361
% 210.03/210.24 2003; use VIRULENCE FACTORS, BORDETELLA 1986-2002; for CYCLOLYSIN use ADENYLATE CYCLASE TOXIN %28%NM%29% 1989-2002%A%
% 210.03/210.24 |- skos__broader mesh__D004187smesh__D009844
% 210.03/210.24 |- rdf__type mesh__D004187sskos__Concept
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004187 2006
% 210.03/210.24 |- mesh__recordOriginator mesh__D004187 NLM
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D004187 sjn
% 210.03/210.24 |- mesh__dateRevised mesh__D004187 2004-07-07
% 210.03/210.24 |- mesh__dateCreated mesh__D004187 1999-01-01
% 210.03/210.24 |- skos__prefLabel mesh__D004187 Disaccharides
% 210.03/210.24 |- skos__scopeNote mesh__D004187
% 210.03/210.24 Oligosaccharides containing two monosaccharide units linked by a glycosidic bond.%A%
% 210.03/210.24 |- skos__annotation mesh__D004187 GEN; prefer specifics
% 210.03/210.24 |- mesh__recordMaintainer mesh__D004187 ssb
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D004187 2005
% 210.03/210.24 |- mesh__recordMaintainer mesh__D009670 ags
% 210.03/210.24 |- mesh__dateEstablished mesh__D009670 1991-01-01
% 210.03/210.24 |- mesh__dateCreated mesh__D009670 1981-05-19
% 210.03/210.24 |- mesh__dateRevised mesh__D009670 2005-06-30
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D009670
% 210.03/210.24 92; was NOSEMA CUNICULI 1982-91 %28%see under SPOROZOA 1982-90%29%; ENCEPHALITOZOON CUNICULI was see NOSEMA CUNICULI 1982-91%A%
% 210.03/210.24 |- skos__historyNote mesh__D009670 Protozoa %28%1966-1981%29%
% 210.03/210.24 |- skos__prefLabel mesh__D009670 Encephalitozoon cuniculi
% 210.03/210.24 |- skos__scopeNote mesh__D009670
% 210.03/210.24 A species of parasitic FUNGI. This intracellular parasite is found in the BRAIN; HEART; and KIDNEYS of several MAMMALS. Transmission is probably by ingestion of the spores %28%SPORES, FUNGAL%29%.%A%
% 210.03/210.24 |- skos__historyNote mesh__D009670 Sporozoa %28%1966-1981%29%
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D009670 2006
% 210.03/210.24 |- skos__altLabel mesh__D009670 Nosema cuniculi
% 210.03/210.24 |- mesh__historyNote mesh__D009670
% 210.03/210.24 92; was NOSEMA CUNICULI 1982-91 %28%see under SPOROZOA 1982-90%29%; ENCEPHALITOZOON CUNICULI was see NOSEMA CUNICULI 1982-91%A%
% 210.03/210.24 |- skos__annotation mesh__D009670
% 210.03/210.24 infection: coordinate IM with ENCEPHALITOZOONOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%
% 210.03/210.24 |- skos__broader mesh__D009670smesh__D016819
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D009670 sjn
% 210.03/210.24 |- rdf__type mesh__D009670sskos__Concept
% 210.03/210.24 |- mesh__recordOriginator mesh__D009670 EC
% 210.03/210.24 |- mesh__onlineNote mesh__D009670
% 210.03/210.24 use ENCEPHALITOZOON CUNICULI to search NOSEMA CUNICULI 1982-91%A%
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D023341 2003
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D023341 2001; see SHIVERING 1977-2000
% 210.03/210.24 |- skos__related mesh__D023341smesh__D012768
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D023341 2006
% 210.03/210.24 |- rdf__type mesh__D023341sskos__Concept
% 210.03/210.24 |- skos__scopeNote mesh__D023341
% 210.03/210.24 The sudden sensation of being cold. It may be accompanied by SHIVERING.%A%
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D023341 2005
% 210.03/210.24 |- skos__broader mesh__D023341smesh__D012816
% 210.03/210.24 |- mesh__dateCreated mesh__D023341 2000-06-22
% 210.03/210.24 |- mesh__dateEstablished mesh__D023341 2001-01-01
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D023341 2002
% 210.03/210.24 |- mesh__historyNote mesh__D023341 2001; use SHIVERING 1977-2000
% 210.03/210.24 |- skos__prefLabel mesh__D023341 Chills
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D023341 2004
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D023341 2001
% 210.03/210.24 |- skos__historyNote mesh__D023341 Shivering %28%1977-2000%29%
% 210.03/210.24 |- rdf__type mesh__D017304sskos__Concept
% 210.03/210.24 |- mesh__historyNote mesh__D017304 2005%28%1984%29%
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D017304 sjn
% 210.03/210.24 |- skos__altLabel mesh__D017304 Annexin V
% 210.03/210.24 |- skos__altLabel mesh__D017304 Endonexin II
% 210.03/210.24 |- mesh__recordOriginator mesh__D017304 AGS
% 210.03/210.24 |- skos__altLabel mesh__D017304 Lipocortin-V
% 210.03/210.24 |- skos__altLabel mesh__D017304 Anchorin CII
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D017304
% 210.03/210.24 2005; ANNEXIN V was indexed under CALCIUM-BINDING PROTEINS and PREGNANCY PROTEINS 1984-1992; ANNEXIN A5 was indexed under ANNEXINS 2003-2004 %26% under ANNEXIN V 2004%A%
% 210.03/210.24 |- skos__prefLabel mesh__D017304 Annexin A5
% 210.03/210.24 |- skos__historyNote mesh__D017304
% 210.03/210.24 Calcium-Binding Proteins %28%1984-1992%29%
% 210.03/210.24 |- mesh__dateRevised mesh__D017304 2004-07-13
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D017304 2006
% 210.03/210.24 |- skos__scopeNote mesh__D017304
% 210.03/210.24 A protein of the annexin family isolated from human PLACENTA and other tissues. It inhibits cytosolic PHOSPHOLIPASE A2, and displays anticoagulant activity.%A%
% 210.03/210.24 |- mesh__dateCreated mesh__D017304 1992-05-07
% 210.03/210.24 |- skos__altLabel mesh__D017304 Placental Anticoagulant Protein I
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D017304 2005
% 210.03/210.24 |- mesh__recordMaintainer mesh__D017304 sjn
% 210.03/210.24 |- skos__altLabel mesh__D017304 Lipocortin V
% 210.03/210.24 |- skos__altLabel mesh__D017304 Calphobindin I
% 210.03/210.24 |- skos__broader mesh__D017304smesh__D017302
% 210.03/210.24 |- mesh__dateEstablished mesh__D017304 1993-01-01
% 210.03/210.24 |- skos__historyNote mesh__D017304 Pregnancy Proteins %28%1984-1992%29%
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D050738 2006
% 210.03/210.24 |- skos__hiddenLabel mesh__D050738 Infection, Mesomycetozoea
% 210.03/210.24 |- mesh__dateCreated mesh__D050738 2005-06-30
% 210.03/210.24 |- mesh__recordMaintainer mesh__D050738 ags
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D050738 2006
% 210.03/210.24 |- skos__hiddenLabel mesh__D050738 Mesomycetozoea Infection
% 210.03/210.24 |- rdf__type mesh__D050738sskos__Concept
% 210.03/210.24 |- skos__prefLabel mesh__D050738 Mesomycetozoea Infections
% 210.03/210.24 |- skos__broader mesh__D050738smesh__D010272
% 210.03/210.24 |- mesh__historyNote mesh__D050738 2006
% 210.03/210.24 |- skos__scopeNote mesh__D050738
% 210.03/210.24 Infections by MESOMYCETOZOEA, general or unspecified.
% 210.03/210.24 |- skos__hiddenLabel mesh__D050738 Infections, Mesomycetozoea
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D050738 sjn
% 210.03/210.24 |- mesh__recordOriginator mesh__D050738 ags
% 210.03/210.24 |- mesh__dateEstablished mesh__D050738 2006-01-01
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D008578 2005
% 210.03/210.24 |- rdf__type mesh__D008578sskos__Concept
% 210.03/210.24 |- mesh__dateRevised mesh__D008578 2002-07-03
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D008578 2004
% 210.03/210.24 |- skos__broader mesh__D008578smesh__D002490
% 210.03/210.24 |- skos__prefLabel mesh__D008578 Meninges
% 210.03/210.24 |- skos__annotation mesh__D008578
% 210.03/210.24 inflammation = MENINGITIS %26% its specifics
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D008578 sjn
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D008578 2003
% 210.03/210.24 |- mesh__dateCreated mesh__D008578 1999-01-01
% 210.03/210.24 |- mesh__recordOriginator mesh__D008578 NLM
% 210.03/210.24 |- mesh__recordMaintainer mesh__D008578 mdb
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D008578 2006
% 210.03/210.24 |- mesh__recordOriginator mesh__D000595 NLM
% 210.03/210.24 |- skos__altLabel mesh__D000595 Amino Acid Sequences
% 210.03/210.24 |- skos__altLabel mesh__D000595 Protein Structure, Primary
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D000595 sjn
% 210.03/210.24 |- skos__hiddenLabel mesh__D000595 Protein Structures, Primary
% 210.03/210.24 |- skos__broader mesh__D000595smesh__D015394
% 210.03/210.24 |- mesh__dateEstablished mesh__D000595 1966-01-01
% 210.03/210.24 |- skos__hiddenLabel mesh__D000595 Structure, Primary Protein
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D000595 2003
% 210.03/210.24 |- mesh__dateCreated mesh__D000595 1999-01-01
% 210.03/210.24 |- mesh__dateRevised mesh__D000595 2002-07-02
% 210.03/210.24 |- mesh__historyNote mesh__D000595 66
% 210.03/210.24 |- mesh__recordMaintainer mesh__D000595 nns
% 210.03/210.24 |- skos__altLabel mesh__D000595 Sequence, Amino Acid
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D000595 2004
% 210.03/210.24 |- skos__scopeNote mesh__D000595
% 210.03/210.24 The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.%A%
% 210.03/210.24 |- skos__altLabel mesh__D000595 Sequences, Amino Acid
% 210.03/210.24 |- skos__broader mesh__D000595smesh__D008969
% 210.03/210.24 |- skos__hiddenLabel mesh__D000595 Primary Protein Structure
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D000595 2005
% 210.03/210.24 |- skos__hiddenLabel mesh__D000595 Primary Protein Structures
% 210.03/210.24 |- skos__prefLabel mesh__D000595 Amino Acid Sequence
% 210.03/210.24 |- skos__hiddenLabel mesh__D000595 Structures, Primary Protein
% 210.03/210.24 |- rdf__type mesh__D000595sskos__Concept
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D000595 2006
% 210.03/210.24 |- skos__annotation mesh__D000595
% 210.03/210.24 IM general; coord NIM with specific protein or peptide; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: AMINO ACID SEQ or AA SEQ; use this heading when protein structure refers to the sequence of a protein; for covalent bonds to other molecules we have MOLECULAR STRUCTURE; when protein structure refers to protein architecture use PROTEIN CONFORMATION or its specifics%A%
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D000595 66
% 210.03/210.24 |- mesh__dateEstablished mesh__D005280 1986-01-01
% 210.03/210.24 |- mesh__recordMaintainer mesh__D005280 exl
% 210.03/210.24 |- skos__scopeNote mesh__D005280
% 210.03/210.24 An adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.%A%
% 210.03/210.24 |- mesh__recordOriginator mesh__D005280 NLM
% 210.03/210.24 |- skos__historyNote mesh__D005280 Orciprenaline %28%1973-1974%29%
% 210.03/210.24 |- skos__hiddenLabel mesh__D005280 Th1165a
% 210.03/210.24 |- skos__prefLabel mesh__D005280 Fenoterol
% 210.03/210.24 |- skos__hiddenLabel mesh__D005280 Th 1165a
% 210.03/210.24 |- mesh__dateRevised mesh__D005280 2005-06-30
% 210.03/210.24 |- skos__altLabel mesh__D005280 p-Hydroxyphenylorciprenaline
% 210.03/210.24 |- rdf__type mesh__D005280sskos__Concept
% 210.03/210.24 |- skos__altLabel mesh__D005280 Berotec
% 210.03/210.24 |- skos__hiddenLabel mesh__D005280 Hydrochloride, Fenoterol
% 210.03/210.24 |- mesh__dateCreated mesh__D005280 1974-11-19
% 210.03/210.24 |- mesh__publicMeSHNote mesh__D005280
% 210.03/210.24 86; was see under ETHANOLAMINES 1975-85
% 210.03/210.24 |- mesh__historyNote mesh__D005280
% 210.03/210.24 86%28%75%29%; was see under ETHANOLAMINES 1975-85
% 210.03/210.24 |- skos__broader mesh__D005280smesh__D009921
% 210.03/210.24 |- skos__altLabel mesh__D005280 p-Hydroxyphenyl-orciprenaline
% 210.03/210.24 |- mesh__activeMeSHYear mesh__D005280 2006
% 210.03/210.24 |- mesh__recordAuthorizer mesh__D005280 sjn
% 210.03/210.24 |- skos__altLabel mesh__D005280 Phenoterol
% 210.03/210.24 |- skos__hiddenLabel mesh__D005280 p Hydroxyphenylorciprenaline
% 210.03/210.24 |- skos__historyNote mesh__D005280 Phenols %28%1973-1974%29%
% 210.03/210.24 |- skos__hiddenLabel mesh__D005280 p Hydroxyphenyl orciprenaline
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D013712 sjn
% 210.03/210.25 |- skos__historyNote mesh__D013712 Beetles %28%1966-1971%29%
% 210.03/210.25 |- skos__prefLabel mesh__D013712 Tenebrio
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D013712 72
% 210.03/210.25 |- skos__broader mesh__D013712smesh__D001517
% 210.03/210.25 |- mesh__dateEstablished mesh__D013712 1972-01-01
% 210.03/210.25 |- mesh__recordOriginator mesh__D013712 NLM
% 210.03/210.25 |- skos__scopeNote mesh__D013712
% 210.03/210.25 A genus of beetles which infests grain products. Its larva is called mealworm.%A%
% 210.03/210.25 |- mesh__recordMaintainer mesh__D013712 ags
% 210.03/210.25 |- mesh__historyNote mesh__D013712 72
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D013712 2005
% 210.03/210.25 |- skos__altLabel mesh__D013712 Mealworm
% 210.03/210.25 |- mesh__dateCreated mesh__D013712 1999-01-01
% 210.03/210.25 |- mesh__dateRevised mesh__D013712 2004-07-07
% 210.03/210.25 |- skos__annotation mesh__D013712
% 210.03/210.25 beetle; /microbiol /parasitol /virol permitted
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D013712 2006
% 210.03/210.25 |- rdf__type mesh__D013712sskos__Concept
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004986 2006
% 210.03/210.25 |- skos__broader mesh__D004986smesh__D005019
% 210.03/210.25 |- mesh__dateRevised mesh__D004986 2000-06-22
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004986 2001
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D004986
% 210.03/210.25 91,63-64; was see under ETHYL ETHERS 1974-90; was see under ETHYL ETHER 1965-73; was heading 1963-64%A%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004986 2005
% 210.03/210.25 |- skos__scopeNote mesh__D004986
% 210.03/210.25 A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.%A%
% 210.03/210.25 |- skos__altLabel mesh__D004986 Ether
% 210.03/210.25 |- mesh__historyNote mesh__D004986
% 210.03/210.25 91%28%75%29%63-64; was see under ETHYL ETHERS 1974-90; was see under ETHYL ETHER 1965-73; was heading 1963-64%A%
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D004986 sjn
% 210.03/210.25 |- mesh__recordOriginator mesh__D004986 NLM
% 210.03/210.25 |- rdf__type mesh__D004986sskos__Concept
% 210.03/210.25 |- mesh__onlineNote mesh__D004986
% 210.03/210.25 use ETHYL ETHERS to search ETHER, ETHYL 1966-74
% 210.03/210.25 |- skos__hiddenLabel mesh__D004986 Ether, Diethyl
% 210.03/210.25 |- skos__altLabel mesh__D004986 Ethyl Ether
% 210.03/210.25 |- skos__prefLabel mesh__D004986 Ether, Ethyl
% 210.03/210.25 |- skos__altLabel mesh__D004986 Diethyl Ether
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004986 2004
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004986 2002
% 210.03/210.25 |- mesh__dateCreated mesh__D004986 1999-01-01
% 210.03/210.25 |- mesh__recordMaintainer mesh__D004986 CCR
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004986 2003
% 210.03/210.25 |- mesh__dateEstablished mesh__D004986 1991-01-01
% 210.03/210.25 |- mesh__dateRevised mesh__D051033 2005-07-27
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D051033 2006C
% 210.03/210.25 |- skos__prefLabel mesh__D051033 Apoptosis Inducing Factor
% 210.03/210.25 |- skos__altLabel mesh__D051033 AIF Apoptosis Regulatory Protein
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D051033 ags
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D051033 2006B
% 210.03/210.25 |- mesh__recordMaintainer mesh__D051033 ags
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D051033 2006D
% 210.03/210.25 |- skos__altLabel mesh__D051033 Mitochondrial Apoptosis-Inducing Factor
% 210.03/210.25 |- skos__broader mesh__D051033smesh__D009247
% 210.03/210.25 |- skos__hiddenLabel mesh__D051033 Apoptosis-Inducing Factor, Mitochondrial
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D051033 2006
% 210.03/210.25 |- skos__hiddenLabel mesh__D051033 Mitochondrial Apoptosis Inducing Factor
% 210.03/210.25 |- mesh__historyNote mesh__D051033 2006%28%1999%29%
% 210.03/210.25 |- mesh__dateCreated mesh__D051033 2005-06-30
% 210.03/210.25 |- mesh__recordOriginator mesh__D051033 DRC
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D051033
% 210.03/210.25 2006; APOPTOSIS INDUCING FACTOR was indexed under FLAVOPROTEINS %26% MEMBRANE PROTEINS 1999-2005%A%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D051033 2006A
% 210.03/210.25 |- skos__annotation mesh__D051033
% 210.03/210.25 INHIBITOR OF APOPTOSIS PROTEINS is also available
% 210.03/210.25 |- skos__altLabel mesh__D051033 Apoptosis-Inducing Factor
% 210.03/210.25 |- skos__broader mesh__D051033smesh__D005420
% 210.03/210.25 |- rdf__type mesh__D051033sskos__Concept
% 210.03/210.25 |- mesh__dateEstablished mesh__D051033 2006-01-01
% 210.03/210.25 |- skos__broader mesh__D051033smesh__D051017
% 210.03/210.25 |- skos__scopeNote mesh__D051033
% 210.03/210.25 A flavoprotein that functions as a powerful antioxidant in the MITOCHONDRIA and promotes APOPTOSIS when released from the mitochondria. In mammalian cells AIF is released in response to pro-apoptotic protein members of the bcl-2 protein family. It translocates to the CELL NUCLEUS and binds DNA to stimulate CASPASE-independent CHROMATIN condensation.%A%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004188 1999
% 210.03/210.25 |- skos__hiddenLabel mesh__D004188 Disarticulations
% 210.03/210.25 |- skos__historyNote mesh__D004188 Amputation %28%1966-1971%29%
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D004188 72
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004188 2003
% 210.03/210.25 |- mesh__dateCreated mesh__D004188 1999-01-01
% 210.03/210.25 |- skos__prefLabel mesh__D004188 Disarticulation
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004188 2000
% 210.03/210.25 |- skos__scopeNote mesh__D004188
% 210.03/210.25 Amputation or separation at a joint. %28%Dorland, 28th ed%29%%A%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004188 2004
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004188 2001
% 210.03/210.25 |- mesh__recordOriginator mesh__D004188 NLM
% 210.03/210.25 |- skos__broader mesh__D004188smesh__D000671
% 210.03/210.25 |- mesh__recordMaintainer mesh__D004188 PXP
% 210.03/210.25 |- mesh__dateEstablished mesh__D004188 1972-01-01
% 210.03/210.25 |- mesh__dateRevised mesh__D004188 1997-06-20
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004188 2005
% 210.03/210.25 |- mesh__historyNote mesh__D004188 72
% 210.03/210.25 |- rdf__type mesh__D004188sskos__Concept
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004188 1998
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004188 2002
% 210.03/210.25 |- skos__annotation mesh__D004188
% 210.03/210.25 %22%amputation or separation at a joint%22%; do not use /util except by MeSH definition%A%
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D004188 SJN
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004188 2006
% 210.03/210.25 |- mesh__recordMaintainer mesh__D009671 ssb
% 210.03/210.25 |- mesh__dateCreated mesh__D009671 1999-01-01
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009671 2006
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009671 2005
% 210.03/210.25 |- skos__related mesh__D009671smesh__D011781
% 210.03/210.25 |- rdf__type mesh__D009671sskos__Concept
% 210.03/210.25 |- skos__prefLabel mesh__D009671 Nostrums
% 210.03/210.25 |- skos__broader mesh__D009671smesh__D004364
% 210.03/210.25 |- mesh__dateRevised mesh__D009671 2003-07-09
% 210.03/210.25 |- mesh__recordOriginator mesh__D009671 NLM
% 210.03/210.25 |- skos__annotation mesh__D009671
% 210.03/210.25 do not confuse with DRUGS, NON-PRESCRIPTION
% 210.03/210.25 |- skos__scopeNote mesh__D009671
% 210.03/210.25 Medicines whose effectiveness is unproven and whose ingredients are often secret.%A%
% 210.03/210.25 |- skos__related mesh__D009671smesh__D008519
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D009671 sjn
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009671 2004
% 210.03/210.25 |- skos__altLabel mesh__D017305 Lipocortin 1
% 210.03/210.25 |- mesh__dateEstablished mesh__D017305 1993-01-01
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D017305
% 210.03/210.25 2005; see ANNEXIN I 1993-2004; LIPOCORTIN 1 was indexed under CALCIUM-BINDING PROTEINS 1985-1992, ANNEXIN I %26% CALPACTIN II were indexed under CALCIUM-BINDING PROTEINS 1984-1992, ANNEXIN A1 was indexed under ANNEXIN I 2004; RENOCORTIN was indexed under GLYCOPROTEINS 1986-2004 %26% under PROTEINS 1983-1985; CHROMOBINDIN 9 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1986-2004%A%
% 210.03/210.25 |- skos__altLabel mesh__D017305 Lipocortin I
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D017305 sjn
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D017305 2006
% 210.03/210.25 |- skos__altLabel mesh__D017305 Annexin I
% 210.03/210.25 |- skos__altLabel mesh__D017305 Renocortin
% 210.03/210.25 |- skos__prefLabel mesh__D017305 Annexin A1
% 210.03/210.25 |- mesh__recordOriginator mesh__D017305 AGS
% 210.03/210.25 |- mesh__dateCreated mesh__D017305 1992-05-07
% 210.03/210.25 |- skos__altLabel mesh__D017305 Calpactin II
% 210.03/210.25 |- mesh__recordMaintainer mesh__D017305 jmp
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D017305 2005
% 210.03/210.25 |- skos__broader mesh__D017305smesh__D017302
% 210.03/210.25 |- skos__scopeNote mesh__D017305
% 210.03/210.25 Protein of the annexin family exhibiting lipid interaction and steroid-inducibility.%A%
% 210.03/210.25 |- skos__historyNote mesh__D017305
% 210.03/210.25 Calcium-Binding Proteins %28%1984-1992%29%
% 210.03/210.25 |- rdf__type mesh__D017305sskos__Concept
% 210.03/210.25 |- mesh__historyNote mesh__D017305
% 210.03/210.25 2005%28%1993%29%; for LIPOCORTIN I use ANNEXINS %28%NM%29% 1985-1992, for ANNEXIN I %26% CALPACTIN II use ANNEXINS %28%NM%29% 1984-1992%A%
% 210.03/210.25 |- mesh__dateRevised mesh__D017305 2004-07-07
% 210.03/210.25 |- skos__altLabel mesh__D017305 Chromobindin 9
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Meningotheliomatous
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Transitional Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Intraventricular Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Hemangiopericytic
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Spinal
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Microcystic Meningiomas
% 210.03/210.25 |- rdf__type mesh__D008579sskos__Concept
% 210.03/210.25 |- mesh__recordMaintainer mesh__D008579 ags
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Hemangiopericytic Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Olfactory Groove
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Benign
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Intraorbital Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Spinal
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Intracranial Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Spinal Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningotheliomatous Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Fibrous Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Convexity Meningiomas, Cerebral
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Intraorbital
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Olfactory Groove
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Posterior Fossa
% 210.03/210.25 |- skos__prefLabel mesh__D008579 Meningioma
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Hemangioblastic
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Multiple
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Benign
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Multiple Meningioma
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Parasagittal
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomatoses
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Xanthomatous
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Clear Cell
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Cerebral Convexity
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Fibrous
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Angioblastic
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Angiomatous Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Angiomatous
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Meningotheliomatous
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Cerebral Convexity
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Microcystic
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Malignant Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Fibrous
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D008579 2006
% 210.03/210.25 |- mesh__recordOriginator mesh__D008579 NLM
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Psammomatous
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Microcystic
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Sphenoid Wing Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Papillary
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Transitional
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Papillary
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Wing Meningioma, Sphenoid
% 210.03/210.25 |- skos__altLabel mesh__D008579 Meningiomatosis
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Sphenoid Wing
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Psammomatous
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Secretory
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Benign Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Posterior Fossa Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Parasagittal
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Angiomatous
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Malignant
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Multiple Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Intraventricular
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Xanthomatous Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Secretory Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Clear Cell Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Papillary Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Groove Meningiomas, Olfactory
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Intracranial
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Angioblastic Meningiomas
% 210.03/210.25 |- skos__broader mesh__D008579smesh__D008577
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Olfactory Groove Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Parasagittal Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Xanthomatous
% 210.03/210.25 |- skos__scopeNote mesh__D008579
% 210.03/210.25 A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7%29%%A%
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Malignant
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Convexity Meningioma, Cerebral
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Hemangioblastic
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Intraventricular
% 210.03/210.25 |- mesh__dateCreated mesh__D008579 1999-01-01
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Intraorbital
% 210.03/210.25 |- skos__broader mesh__D008579smesh__D009380
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Wing Meningiomas, Sphenoid
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Hemangiopericytic
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D008579 sjn
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Psammomatous Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Posterior Fossa
% 210.03/210.25 |- skos__annotation mesh__D008579
% 210.03/210.25 benign or malignant; coord IM with MENINGEAL NEOPLASMS %28%IM%29% but not with BRAIN NEOPLASMS nor SPINAL CORD NEOPLASMS for intracranial or spinal meningioma unless site is particularly discussed%A%
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Secretory
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Angioblastic
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Cerebral Convexity Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Transitional
% 210.03/210.25 |- skos__broader mesh__D008579smesh__D009383
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Clear Cell
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Hemangioblastic Meningiomas
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningioma, Intracranial
% 210.03/210.25 |- mesh__dateRevised mesh__D008579 2005-06-30
% 210.03/210.25 |- skos__hiddenLabel mesh__D008579 Meningiomas, Sphenoid Wing
% 210.03/210.25 |- mesh__historyNote mesh__D000596
% 210.03/210.25 /metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64%A%
% 210.03/210.25 |- skos__broader mesh__D000596smesh__D000602
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000596 2003
% 210.03/210.25 |- mesh__dateCreated mesh__D000596 1999-01-01
% 210.03/210.25 |- skos__related mesh__D000596smesh__D017459
% 210.03/210.25 |- mesh__recordOriginator mesh__D000596 NLM
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000596 2004
% 210.03/210.25 |- mesh__dateRevised mesh__D000596 1997-06-20
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000596 2000
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000596 2005
% 210.03/210.25 |- skos__scopeNote mesh__D000596
% 210.03/210.25 Organic compounds that generally contain an amino %28%-NH2%29% and a carboxyl %28%-COOH%29% group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.%A%
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D000596 SJN
% 210.03/210.25 |- mesh__onlineNote mesh__D000596 pre-explosion = AMINO ACIDS %28%PX%29%
% 210.03/210.25 |- rdf__type mesh__D000596sskos__Concept
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000596 2001
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000596 2006
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000596 1998
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000596 2002
% 210.03/210.25 |- mesh__recordMaintainer mesh__D000596 TGC
% 210.03/210.25 |- skos__annotation mesh__D000596
% 210.03/210.25 /urine permitted but consider also AMINOACIDURIA, RENAL
% 210.03/210.25 |- skos__prefLabel mesh__D000596 Amino Acids
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000596 1999
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D000596
% 210.03/210.25 /metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64%A%
% 210.03/210.25 |- skos__hiddenLabel mesh__D000596 Acids, Amino
% 210.03/210.25 |- skos__broader mesh__D005753Q000557smesh__D005753
% 210.03/210.25 |- rdf__type mesh__D005753Q000557smesh__CompoundConcept
% 210.03/210.25 |- skos__hiddenLabel mesh__D013713 Bristol Myers Squibb Brand of Teniposide
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D013713 2006
% 210.03/210.25 |- skos__broader mesh__D013713smesh__D005960
% 210.03/210.25 |- skos__hiddenLabel mesh__D013713 VM26
% 210.03/210.25 |- rdf__type mesh__D013713sskos__Concept
% 210.03/210.25 |- mesh__recordOriginator mesh__D013713 SH
% 210.03/210.25 |- skos__hiddenLabel mesh__D013713 NSC 122819
% 210.03/210.25 |- skos__historyNote mesh__D013713 Podophyllotoxin %28%1973-1974%29%
% 210.03/210.25 |- skos__altLabel mesh__D013713
% 210.03/210.25 Demethyl Epipodophyllotoxin Thenylidine Glucoside
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D013713 sjn
% 210.03/210.25 |- mesh__recordMaintainer mesh__D013713 CCR
% 210.03/210.25 |- skos__hiddenLabel mesh__D013713 Bristol Myers Brand of Teniposide
% 210.03/210.25 |- mesh__dateEstablished mesh__D013713 1991-01-01
% 210.03/210.25 |- mesh__historyNote mesh__D013713
% 210.03/210.25 91%28%81%29%; was see under PODOPHYLLOTOXIN 1981-90; was VM 26 see under PODOPHYLLOTOXIN 1976-80%A%
% 210.03/210.25 |- skos__historyNote mesh__D013713 Glycosides %28%1973-1974%29%
% 210.03/210.25 |- skos__altLabel mesh__D013713 Bristol-Myers Brand of Teniposide
% 210.03/210.25 |- mesh__dateCreated mesh__D013713 1975-07-25
% 210.03/210.25 |- skos__scopeNote mesh__D013713
% 210.03/210.25 A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent cells from entering into the mitotic phase of the cell cycle, and lead to cell death. Teniposide acts primarily in the G2 and S phases of the cycle.%A%
% 210.03/210.25 |- skos__hiddenLabel mesh__D013713 NSC122819
% 210.03/210.25 |- skos__altLabel mesh__D013713 Bristol-Myers Squibb Brand of Teniposide
% 210.03/210.25 |- mesh__onlineNote mesh__D013713 use TENIPOSIDE to search VM 26 1976-80
% 210.03/210.25 |- skos__historyNote mesh__D013713 Glucosides %28%1975%29%
% 210.03/210.25 |- skos__prefLabel mesh__D013713 Teniposide
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D013713
% 210.03/210.25 91; was see under PODOPHYLLOTOXIN 1981-90; was VM 26 see under PODOPHYLLOTOXIN 1976-80%A%
% 210.03/210.25 |- skos__hiddenLabel mesh__D013713 VM 26
% 210.03/210.25 |- mesh__dateRevised mesh__D013713 2005-06-30
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D004987 SJN
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004987 2001
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004987 1999
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004987 2006
% 210.03/210.25 |- mesh__recordOriginator mesh__D004987 NLM
% 210.03/210.25 |- mesh__dateRevised mesh__D004987 1997-06-20
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004987 2000
% 210.03/210.25 |- skos__annotation mesh__D004987
% 210.03/210.25 do not confuse with ETHER see ETHER, ETHYL
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D004987
% 210.03/210.25 ETHOGLUCID was see under ALKYLATING AGENTS 1967-74
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004987 1998
% 210.03/210.25 |- rdf__type mesh__D004987sskos__Concept
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004987 2005
% 210.03/210.25 |- skos__broader mesh__D004987smesh__D009930
% 210.03/210.25 |- skos__prefLabel mesh__D004987 Ethers
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004987 2002
% 210.03/210.25 |- mesh__dateCreated mesh__D004987 1999-01-01
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004987 2004
% 210.03/210.25 |- mesh__recordMaintainer mesh__D004987 TGC
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004987 2003
% 210.03/210.25 |- skos__altLabel mesh__D051034 IAP2 Protein
% 210.03/210.25 |- skos__altLabel mesh__D051034 IAP1 Protein
% 210.03/210.25 |- skos__altLabel mesh__D051034
% 210.03/210.25 Baculoviral Inhibitor Of Apoptosis Repeat Proteins
% 210.03/210.25 |- skos__altLabel mesh__D051034 cIAP1 Protein
% 210.03/210.25 |- mesh__recordOriginator mesh__D051034 DRC
% 210.03/210.25 |- skos__prefLabel mesh__D051034 Inhibitor of Apoptosis Proteins
% 210.03/210.25 |- skos__altLabel mesh__D051034 c-IAP2 Protein
% 210.03/210.25 |- skos__altLabel mesh__D051034 IAP Protein %28%Apoptosis%29%
% 210.03/210.25 |- mesh__dateEstablished mesh__D051034 2006-01-01
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D051034 2006
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D051034
% 210.03/210.25 2006; INHIBITOR OF APOPTOSIS PROTEINS was indexed under PROTEINS 1997-2005%A%
% 210.03/210.25 |- skos__annotation mesh__D051034
% 210.03/210.25 APOPTOSIS REGULATORY PROTEINS is also available
% 210.03/210.25 |- skos__hiddenLabel mesh__D051034 Apoptosis Proteins Inhibitor
% 210.03/210.25 |- skos__altLabel mesh__D051034 Inhibitor-Of-Apoptosis Protein
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D051034 ags
% 210.03/210.25 |- mesh__dateRevised mesh__D051034 2005-07-11
% 210.03/210.25 |- rdf__type mesh__D051034sskos__Concept
% 210.03/210.25 |- mesh__historyNote mesh__D051034 2006%28%1997%29%
% 210.03/210.25 |- skos__altLabel mesh__D051034 c-IAP1 Protein
% 210.03/210.25 |- skos__broader mesh__D051034smesh__D051017
% 210.03/210.25 |- mesh__dateCreated mesh__D051034 2005-06-30
% 210.03/210.25 |- skos__hiddenLabel mesh__D051034 Inhibitor Of Apoptosis Protein
% 210.03/210.25 |- skos__scopeNote mesh__D051034
% 210.03/210.25 A conserved class of proteins that control APOPTOSIS in both VERTEBRATES and INVERTEBRATES. IAP proteins interact with and inhibit CASPASES, and they function as ANTI-APOPTOTIC PROTEINS. The protein class is defined by an approximately 80-amino acid motif called the baculoviral inhibitor of apoptosis repeat.%A%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D051034 2006A
% 210.03/210.25 |- mesh__recordMaintainer mesh__D051034 ags
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004189 2004
% 210.03/210.25 |- mesh__recordMaintainer mesh__D004189 kle
% 210.03/210.25 |- skos__prefLabel mesh__D004189 Disaster Planning
% 210.03/210.25 |- mesh__historyNote mesh__D004189 78
% 210.03/210.25 |- skos__hiddenLabel mesh__D004189 Planning, Disaster
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004189 2002
% 210.03/210.25 |- mesh__recordOriginator mesh__D004189 EC
% 210.03/210.25 |- mesh__dateEstablished mesh__D004189 1978-01-01
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004189 2005
% 210.03/210.25 |- rdf__type mesh__D004189sskos__Concept
% 210.03/210.25 |- skos__annotation mesh__D004189
% 210.03/210.25 specify disaster %28%IM%29% if pertinent; specify geog if pertinent%A%
% 210.03/210.25 |- skos__hiddenLabel mesh__D004189 Plannings, Disaster
% 210.03/210.25 |- mesh__dateRevised mesh__D004189 1999-11-03
% 210.03/210.25 |- skos__broader mesh__D004189smesh__D004190
% 210.03/210.25 |- mesh__dateCreated mesh__D004189 1977-05-05
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004189 2006
% 210.03/210.25 |- skos__scopeNote mesh__D004189
% 210.03/210.25 Procedures outlined for the care of casualties and the maintenance of services in disasters.%A%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004189 2000
% 210.03/210.25 |- skos__historyNote mesh__D004189 Disasters %28%1966-1977%29%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004189 2003
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D004189 2001
% 210.03/210.25 |- skos__hiddenLabel mesh__D004189 Disaster Plannings
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D004189 78
% 210.03/210.25 |- skos__related mesh__D004189smesh__D002959
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D004189 sjn
% 210.03/210.25 |- skos__hiddenLabel mesh__D009672 Notochords
% 210.03/210.25 |- skos__annotation mesh__D009672 read MeSH definition
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 2002
% 210.03/210.25 |- mesh__recordMaintainer mesh__D009672 NLM
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 1996
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 2005
% 210.03/210.25 |- skos__prefLabel mesh__D009672 Notochord
% 210.03/210.25 |- mesh__dateCreated mesh__D009672 1977-12-05
% 210.03/210.25 |- skos__historyNote mesh__D009672 Chick Embryo %28%1966-1978%29%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 2006
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 1997
% 210.03/210.25 |- mesh__historyNote mesh__D009672
% 210.03/210.25 91%28%79%29%; was see under EMBRYO 1979-90
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 1992
% 210.03/210.25 |- mesh__dateEstablished mesh__D009672 1991-01-01
% 210.03/210.25 |- skos__broader mesh__D009672smesh__D004622
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 1993
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D009672 91; was see under EMBRYO 1979-90
% 210.03/210.25 |- rdf__type mesh__D009672sskos__Concept
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 1998
% 210.03/210.25 |- mesh__dateRevised mesh__D009672 1990-04-13
% 210.03/210.25 |- skos__historyNote mesh__D009672 Embryo %28%1966-1978%29%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 2000
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 1991
% 210.03/210.25 |- skos__scopeNote mesh__D009672
% 210.03/210.25 The rod-shaped body, composed of cells derived from the mesoblast and defining the primitive axis of the embryo. In lower vertebrates, it persists throughout life as the main axial support of the body, but in higher vertebrates it is replaced by the vertebral column.%A%
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 1994
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 2003
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 1999
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 2004
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 1995
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D009672 2001
% 210.03/210.25 |- mesh__recordOriginator mesh__D009672 AEP
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D009672 PLS
% 210.03/210.25 |- mesh__dateCreated mesh__D017306 1992-05-07
% 210.03/210.25 |- skos__historyNote mesh__D017306
% 210.03/210.25 Calcium-Binding Proteins %28%1984-1992%29%
% 210.03/210.25 |- skos__altLabel mesh__D017306 Capactin I Heavy Chain
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D017306 2005
% 210.03/210.25 |- skos__altLabel mesh__D017306 Annexin II, P90 Complex
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D017306 2006B
% 210.03/210.25 |- mesh__recordAuthorizer mesh__D017306 ags
% 210.03/210.25 |- skos__broader mesh__D017306smesh__D017302
% 210.03/210.25 |- mesh__dateEstablished mesh__D017306 1993-01-01
% 210.03/210.25 |- rdf__type mesh__D017306sskos__Concept
% 210.03/210.25 |- mesh__historyNote mesh__D017306
% 210.03/210.25 2005%28%1993%29% for ANNEXIN II %26% CALPACTIN I use ANNEXINS 1984-1992%A%
% 210.03/210.25 |- mesh__dateRevised mesh__D017306 2005-07-22
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D017306 2006A
% 210.03/210.25 |- skos__hiddenLabel mesh__D017306 P36 Annexin II
% 210.03/210.25 |- skos__altLabel mesh__D017306 Annexin II, P36
% 210.03/210.25 |- skos__altLabel mesh__D017306 Annexin II
% 210.03/210.25 |- mesh__recordMaintainer mesh__D017306 ags
% 210.03/210.25 |- skos__altLabel mesh__D017306 Lipocortin II
% 210.03/210.25 |- skos__scopeNote mesh__D017306
% 210.03/210.25 A member of the annexin family that is a substrate for a tyrosine kinase, ONCOGENE PROTEIN PP60%28%V-SRC%29%. Annexin A2 occurs as a 36-KDa monomer and in a 90-KDa complex containing two subunits of annexin A2 and two subunits of S100 FAMILY PROTEIN P11. The monomeric form of annexin A2 was formerly referred to as calpactin I heavy chain.%A%
% 210.03/210.25 |- mesh__recordOriginator mesh__D017306 AGS
% 210.03/210.25 |- mesh__publicMeSHNote mesh__D017306
% 210.03/210.25 2005; use ANNEXIN II 1993-2004; ANNEXIN II %26% CALPACTIN I were indexed under CALCIUM-BINDING PROTEINS 1984-1992, ANNEXIN A2 was indexed under ANNEXIN II 2004%A%
% 210.03/210.25 |- skos__altLabel mesh__D017306 Calpactin I
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D017306 2006
% 210.03/210.25 |- skos__prefLabel mesh__D017306 Annexin A2
% 210.03/210.25 |- skos__scopeNote mesh__D000597
% 210.03/210.25 Amino acids which have a branched carbon chain.
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000597 2005
% 210.03/210.25 |- mesh__activeMeSHYear mesh__D000597 1997
% 210.03/210.25 |- mesh__historyNote mesh__D000597 79
% 210.03/210.26 |- mesh__dateRevised mesh__D000597 1992-05-07
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 2002
% 210.03/210.26 |- mesh__recordOriginator mesh__D000597 RLS
% 210.03/210.26 |- rdf__type mesh__D000597sskos__Concept
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D000597 79
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 2006
% 210.03/210.26 |- mesh__dateEstablished mesh__D000597 1979-01-01
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D000597 PLS
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 1998
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 1993
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 1994
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 1999
% 210.03/210.26 |- skos__broader mesh__D000597smesh__D000596
% 210.03/210.26 |- mesh__recordMaintainer mesh__D000597 TAP
% 210.03/210.26 |- mesh__dateCreated mesh__D000597 1978-05-16
% 210.03/210.26 |- skos__prefLabel mesh__D000597 Amino Acids, Branched-Chain
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 1995
% 210.03/210.26 |- skos__historyNote mesh__D000597 Amino Acids %28%1966-1978%29%
% 210.03/210.26 |- skos__hiddenLabel mesh__D000597 Acids, Branched-Chain Amino
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 2003
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 2000
% 210.03/210.26 |- skos__altLabel mesh__D000597 Amino Acids, Branched Chain
% 210.03/210.26 |- skos__hiddenLabel mesh__D000597 Branched-Chain Amino Acids
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 2004
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 1996
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000597 2001
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013714 2005
% 210.03/210.26 |- mesh__recordMaintainer mesh__D013714 PXP
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013714 2001
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013714 2003
% 210.03/210.26 |- mesh__recordOriginator mesh__D013714 NLM
% 210.03/210.26 |- mesh__dateRevised mesh__D013714 1997-06-20
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013714 2000
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D013714 SJN
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013714 2002
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013714 1999
% 210.03/210.26 |- skos__prefLabel mesh__D013714 Tennessee
% 210.03/210.26 |- mesh__dateCreated mesh__D013714 1999-01-01
% 210.03/210.26 |- skos__broader mesh__D013714smesh__D001061
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013714 2006
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013714 1998
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013714 2004
% 210.03/210.26 |- rdf__type mesh__D013714sskos__Concept
% 210.03/210.26 |- skos__broader mesh__D004988smesh__D004987
% 210.03/210.26 |- skos__scopeNote mesh__D004988
% 210.03/210.26 Compounds of the general formula R-O-R arranged in a ring or crown formation.%A%
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D004988 2006
% 210.03/210.26 |- mesh__recordMaintainer mesh__D004988 ssb
% 210.03/210.26 |- rdf__type mesh__D004988sskos__Concept
% 210.03/210.26 |- mesh__dateCreated mesh__D004988 1999-01-01
% 210.03/210.26 |- skos__hiddenLabel mesh__D004988 Cyclic Ethers
% 210.03/210.26 |- skos__broader mesh__D004988smesh__D047028
% 210.03/210.26 |- skos__prefLabel mesh__D004988 Ethers, Cyclic
% 210.03/210.26 |- mesh__recordOriginator mesh__D004988 NLM
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D004988 sjn
% 210.03/210.26 |- mesh__dateRevised mesh__D004988 2004-07-07
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D004988 2005
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D009673
% 210.03/210.26 91; was see under SALAMANDRIDAE 1981-90
% 210.03/210.26 |- skos__scopeNote mesh__D009673
% 210.03/210.26 A species of newt in the Salamandridae family in which the larvae transform into terrestrial eft stage and later into an aquatic adult. They occur from Canada to southern United States. Viridescens refers to the greenish color often found in this species.%A%
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D009673 2006
% 210.03/210.26 |- skos__hiddenLabel mesh__D009673 viridescens, Triturus
% 210.03/210.26 |- skos__hiddenLabel mesh__D009673 viridescens, Diemictylus
% 210.03/210.26 |- mesh__dateEstablished mesh__D009673 1991-01-01
% 210.03/210.26 |- skos__altLabel mesh__D009673 Triturus viridescens
% 210.03/210.26 |- skos__altLabel mesh__D009673 Diemictylus viridescens
% 210.03/210.26 |- mesh__dateCreated mesh__D009673 1980-05-12
% 210.03/210.26 |- skos__hiddenLabel mesh__D009673 viridescens, Notophthalmus
% 210.03/210.26 |- rdf__type mesh__D009673sskos__Concept
% 210.03/210.26 |- skos__historyNote mesh__D009673 Salamandridae %28%1975-1980%29%
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D009673 sjn
% 210.03/210.26 |- skos__hiddenLabel mesh__D009673 Newts, Red-Spotted
% 210.03/210.26 |- mesh__dateRevised mesh__D009673 2003-07-09
% 210.03/210.26 |- mesh__recordMaintainer mesh__D009673 ags
% 210.03/210.26 |- mesh__historyNote mesh__D009673
% 210.03/210.26 91%28%81%29%; was see under SALAMANDRIDAE 1981-90
% 210.03/210.26 |- skos__historyNote mesh__D009673 Urodela %28%1966-1974%29%
% 210.03/210.26 |- mesh__recordOriginator mesh__D009673 EC
% 210.03/210.26 |- skos__prefLabel mesh__D009673 Notophthalmus viridescens
% 210.03/210.26 |- skos__hiddenLabel mesh__D009673 Red-Spotted Newts
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D009673 2004
% 210.03/210.26 |- skos__annotation mesh__D009673
% 210.03/210.26 a species of newt; NIM as exper animal: no qualif; when IM, qualif permitted%A%
% 210.03/210.26 |- skos__broader mesh__D009673smesh__D019185
% 210.03/210.26 |- skos__hiddenLabel mesh__D009673 Red-Spotted Newt
% 210.03/210.26 |- skos__hiddenLabel mesh__D009673 Newt, Red Spotted
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D009673 2005
% 210.03/210.26 |- skos__hiddenLabel mesh__D001690 Life Science
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D001690 sjn
% 210.03/210.26 |- mesh__recordMaintainer mesh__D001690 jls
% 210.03/210.26 |- skos__altLabel mesh__D001690 Sciences, Biological
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D001690
% 210.03/210.26 91; BIOLOGICAL SCIENCES was see BIOLOGY 1990
% 210.03/210.26 |- mesh__runningHead mesh__D001690 G1 - BIOLOGICAL SCIENCES
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D001690 2003
% 210.03/210.26 |- mesh__onlineNote mesh__D001690
% 210.03/210.26 use BIOLOGY to search BIOLOGICAL SCIENCES 1975-90
% 210.03/210.26 |- skos__prefLabel mesh__D001690 Biological Sciences
% 210.03/210.26 |- mesh__historyNote mesh__D001690
% 210.03/210.26 91; was BIOLOGICAL SCIENCES %28%NON MESH%29% 1975-90; BIOLOGICAL SCIENCES was see BIOLOGY 1990%A%
% 210.03/210.26 |- mesh__recordOriginator mesh__D001690 NLM
% 210.03/210.26 |- skos__hiddenLabel mesh__D001690 Science, Life
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D001690 2005
% 210.03/210.26 |- skos__hiddenLabel mesh__D001690 Science, Biologic
% 210.03/210.26 |- mesh__dateEstablished mesh__D001690 1991-01-01
% 210.03/210.26 |- skos__scopeNote mesh__D001690
% 210.03/210.26 All of the divisions of the natural sciences dealing with the various aspects of the phenomena of life and vital processes. The concept includes anatomy and physiology, biochemistry and biophysics, and the biology of animals, plants, and microorganisms. It should be differentiated from BIOLOGY, one of its subdivisions, concerned specifically with the origin and life processes of living organisms.%A%
% 210.03/210.26 |- skos__annotation mesh__D001690
% 210.03/210.26 SPEC; SPEC qualif; do not confuse with BIOLOGY; DF: BIOL SCIENCES%A%
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D001690 2004
% 210.03/210.26 |- skos__altLabel mesh__D001690 Biological Science
% 210.03/210.26 |- skos__hiddenLabel mesh__D001690 Sciences, Biologic
% 210.03/210.26 |- skos__hiddenLabel mesh__D001690 Biologic Science
% 210.03/210.26 |- mesh__dateCreated mesh__D001690 1999-01-01
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D001690 2006
% 210.03/210.26 |- mesh__dateRevised mesh__D001690 2001-07-25
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D001690 2002
% 210.03/210.26 |- skos__altLabel mesh__D001690 Life Sciences
% 210.03/210.26 |- skos__historyNote mesh__D001690 Biology %28%1975-1990%29%
% 210.03/210.26 |- skos__hiddenLabel mesh__D001690 Sciences, Life
% 210.03/210.26 |- skos__altLabel mesh__D001690 Biologic Sciences
% 210.03/210.26 |- rdf__type mesh__D001690sskos__Concept
% 210.03/210.26 |- skos__altLabel mesh__D001690 Science, Biological
% 210.03/210.26 |- skos__scopeNote mesh__D017307
% 210.03/210.26 A selective beta-1-adrenergic partial agonist. Because it is a partial agonist it acts like an agonist when sympathetic activity is low and as an antagonist when sympathetic activity is high. It reduces myocardial ischemia and improves ventricular function in patients with mild to moderate heart failure. In patients with severe heart failure it has been shown to produce benefits in systolic and diastolic function.%A%
% 210.03/210.26 |- skos__broader mesh__D017307smesh__D011412
% 210.03/210.26 |- mesh__onlineNote mesh__D017307
% 210.03/210.26 use XAMOTEROL %28%NM%29% to search XAMOTEROL 1984-92
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D017307 2006
% 210.03/210.26 |- skos__prefLabel mesh__D017307 Xamoterol
% 210.03/210.26 |- mesh__dateRevised mesh__D017307 2005-06-30
% 210.03/210.26 |- skos__broader mesh__D017307smesh__D050198
% 210.03/210.26 |- skos__historyNote mesh__D017307 Propanolamines %28%1984-1992%29%
% 210.03/210.26 |- rdf__type mesh__D017307sskos__Concept
% 210.03/210.26 |- skos__hiddenLabel mesh__D017307 Monohydrochloride, Xamoterol
% 210.03/210.26 |- skos__hiddenLabel mesh__D017307 ICI118587
% 210.03/210.26 |- skos__hiddenLabel mesh__D017307 Fumarate, Xamoterol
% 210.03/210.26 |- skos__hiddenLabel mesh__D017307 Monohydrobromide, Xamoterol
% 210.03/210.26 |- mesh__dateEstablished mesh__D017307 1993-01-01
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D017307 sjn
% 210.03/210.26 |- mesh__recordMaintainer mesh__D017307 ssb
% 210.03/210.26 |- skos__hiddenLabel mesh__D017307 ICI 118587
% 210.03/210.26 |- skos__hiddenLabel mesh__D017307 Hemifumarate, Xamoterol
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D017307
% 210.03/210.26 93; XAMOTEROL was indexed under PROPANOLAMINES 1984-92
% 210.03/210.26 |- mesh__recordOriginator mesh__D017307 TPW
% 210.03/210.26 |- mesh__dateCreated mesh__D017307 1992-05-22
% 210.03/210.26 |- skos__broader mesh__D017307smesh__D009025
% 210.03/210.26 |- mesh__historyNote mesh__D017307 93; was XAMOTEROL %28%NM%29% 1984-92
% 210.03/210.26 |- mesh__recordMaintainer mesh__D000598 ADP
% 210.03/210.26 |- skos__prefLabel mesh__D000598 Amino Acids, Cyclic
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D000598 98
% 210.03/210.26 |- rdf__type mesh__D000598sskos__Concept
% 210.03/210.26 |- skos__hiddenLabel mesh__D000598 Acids, Cyclic Amino
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000598 2002
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000598 2005
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000598 1998
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000598 2006
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000598 1999
% 210.03/210.26 |- mesh__recordOriginator mesh__D000598 NLM
% 210.03/210.26 |- skos__annotation mesh__D000598
% 210.03/210.26 GEN; prefer specifics; used for mapping supplementary chemicals%A%
% 210.03/210.26 |- skos__broader mesh__D000598smesh__D000596
% 210.03/210.26 |- mesh__dateCreated mesh__D000598 1999-01-01
% 210.03/210.26 |- skos__altLabel mesh__D000598 Cyclic Amino Acids
% 210.03/210.26 |- skos__scopeNote mesh__D000598
% 210.03/210.26 A class of amino acids characterized by a closed ring structure.%A%
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000598 2000
% 210.03/210.26 |- mesh__dateRevised mesh__D000598 1997-06-26
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000598 2003
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D000598 SJN
% 210.03/210.26 |- mesh__dateEstablished mesh__D000598 1998-01-01
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000598 2001
% 210.03/210.26 |- mesh__historyNote mesh__D000598 98; use explode 1967-97
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000598 2004
% 210.03/210.26 |- mesh__dateEstablished mesh__D005283 1966-01-01
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D005283 2002
% 210.03/210.26 |- mesh__recordMaintainer mesh__D005283 CCR
% 210.03/210.26 |- skos__altLabel mesh__D005283 Phentanyl
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D005283 2003
% 210.03/210.26 |- skos__prefLabel mesh__D005283 Fentanyl
% 210.03/210.26 |- rdf__type mesh__D005283sskos__Concept
% 210.03/210.26 |- mesh__dateCreated mesh__D005283 1999-01-01
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D005283 2004
% 210.03/210.26 |- skos__hiddenLabel mesh__D005283 Citrate, Fentanyl
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D005283 sjn
% 210.03/210.26 |- skos__broader mesh__D005283smesh__D010880
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D005283 66
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D005283 2005
% 210.03/210.26 |- skos__scopeNote mesh__D005283
% 210.03/210.26 A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1078%29%%A%
% 210.03/210.26 |- mesh__recordOriginator mesh__D005283 NLM
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D005283 2006
% 210.03/210.26 |- mesh__historyNote mesh__D005283 66
% 210.03/210.26 |- mesh__dateRevised mesh__D005283 2001-07-25
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 2002
% 210.03/210.26 |- skos__prefLabel mesh__D013715 Tennis
% 210.03/210.26 |- mesh__dateEstablished mesh__D013715 1990-01-01
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D013715 90; was see under SPORTS 1976-89
% 210.03/210.26 |- mesh__recordOriginator mesh__D013715 JW
% 210.03/210.26 |- skos__broader mesh__D013715smesh__D015865
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 1999
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D013715 PLS
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 1997
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 2006
% 210.03/210.26 |- skos__historyNote mesh__D013715 Sports %28%1966-1975%29%
% 210.03/210.26 |- mesh__historyNote mesh__D013715
% 210.03/210.26 90%28%76%29%; was see under SPORTS 1976-89
% 210.03/210.26 |- skos__annotation mesh__D013715
% 210.03/210.26 /inj: coord IM with specific inj %28%IM%29%; /physiol permitted%A%
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 2001
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 1998
% 210.03/210.26 |- mesh__recordMaintainer mesh__D013715 TGC
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 2004
% 210.03/210.26 |- rdf__type mesh__D013715sskos__Concept
% 210.03/210.26 |- skos__scopeNote mesh__D013715
% 210.03/210.26 A game played by two or four players with rackets and an elastic ball on a level court divided by a low net.%A%
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 2000
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 2005
% 210.03/210.26 |- mesh__dateCreated mesh__D013715 1975-07-21
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013715 2003
% 210.03/210.26 |- mesh__dateRevised mesh__D013715 1996-06-10
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Moral Policies
% 210.03/210.26 |- rdf__type mesh__D004989sskos__Concept
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Laws, Natural
% 210.03/210.26 |- mesh__dateCreated mesh__D004989 1999-01-01
% 210.03/210.26 |- skos__scopeNote mesh__D004989
% 210.03/210.26 The philosophy or code pertaining to what is ideal in human character and conduct. Also, the field of study dealing with the principles of morality.%A%
% 210.03/210.26 |- skos__broader mesh__D004989smesh__D017530
% 210.03/210.26 |- skos__broader mesh__D004989smesh__D006809
% 210.03/210.26 |- mesh__recordMaintainer mesh__D004989 sjn
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Issue, Ethical
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Policy, Moral
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Ethics, Situational
% 210.03/210.26 |- mesh__dateRevised mesh__D004989 2004-07-13
% 210.03/210.26 |- skos__prefLabel mesh__D004989 Ethics
% 210.03/210.26 |- skos__broader mesh__D004989smesh__D009014
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Policies, Moral
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Law, Natural
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Natural Laws
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Issues, Ethical
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D004989 2005
% 210.03/210.26 |- mesh__recordOriginator mesh__D004989 NLM
% 210.03/210.26 |- skos__broader mesh__D004989smesh__D010684
% 210.03/210.26 |- skos__hiddenLabel mesh__D004989 Ethical Issue
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D004989 sjn
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D004989 2006
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D051036 sjn
% 210.03/210.26 |- skos__scopeNote mesh__D051036
% 210.03/210.26 A major class of calcium activated potassium channels whose members are voltage-dependent. MaxiK channels are activated by either membrane depolarization or an increase in intracellular Ca%28%2+%29%. They are key regulators of calcium and electrical signaling in a variety of tissues.%A%
% 210.03/210.26 |- rdf__type mesh__D051036sskos__Concept
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D051036
% 210.03/210.26 2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, %26% under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2002-2005%A%
% 210.03/210.26 |- skos__hiddenLabel mesh__D051036 Maxi K Channels
% 210.03/210.26 |- mesh__historyNote mesh__D051036 2006%28%2993%29%
% 210.03/210.26 |- skos__altLabel mesh__D051036 Maxi-K Channels
% 210.03/210.26 |- skos__broader mesh__D051036smesh__D024681
% 210.03/210.26 |- skos__prefLabel mesh__D051036
% 210.03/210.26 Large-Conductance Calcium-Activated Potassium Channels
% 210.03/210.26 |- mesh__dateCreated mesh__D051036 2005-06-30
% 210.03/210.26 |- mesh__recordOriginator mesh__D051036 DRC
% 210.03/210.26 |- mesh__recordMaintainer mesh__D051036 DRC
% 210.03/210.26 |- skos__altLabel mesh__D051036 BK Channels
% 210.03/210.26 |- skos__hiddenLabel mesh__D051036
% 210.03/210.26 Large Conductance Calcium Activated Potassium Channels
% 210.03/210.26 |- skos__altLabel mesh__D051036 MaxiK Channels
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D051036 2006
% 210.03/210.26 |- mesh__dateEstablished mesh__D051036 2006-01-01
% 210.03/210.26 |- skos__altLabel mesh__D051036 Big K Channels
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D009674 2003
% 210.03/210.26 |- mesh__dateCreated mesh__D009674 1999-01-01
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D009674 2004
% 210.03/210.26 |- skos__annotation mesh__D009674 a province of eastern Canada
% 210.03/210.26 |- mesh__recordMaintainer mesh__D009674 mdb
% 210.03/210.26 |- mesh__dateRevised mesh__D009674 2001-07-25
% 210.03/210.26 |- skos__broader mesh__D009674smesh__D002170
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D009674 2005
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D009674 2002
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D009674 2006
% 210.03/210.26 |- mesh__recordOriginator mesh__D009674 NLM
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D009674 sjn
% 210.03/210.26 |- skos__scopeNote mesh__D009674
% 210.03/210.26 A province of eastern Canada, one of the Maritime Provinces with NEW BRUNSWICK; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND. Its capital is Halifax. The territory was granted in 1621 by James I to the Scotsman Sir William Alexander and was called Nova Scotia, the Latin for New Scotland. The territory had earlier belonged to the French, under the name of Acadia. %28%From Webster%27%s New Geographical Dictionary, 1988, p871 %26% Room, Brewer%27%s Dictionary of Names, 1992, p384%29%%A%
% 210.03/210.26 |- skos__prefLabel mesh__D009674 Nova Scotia
% 210.03/210.26 |- rdf__type mesh__D009674sskos__Concept
% 210.03/210.26 |- skos__scopeNote mesh__D001691
% 210.03/210.26 Treatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.%A%
% 210.03/210.26 |- skos__altLabel mesh__D001691 Therapy, Biological
% 210.03/210.26 |- mesh__historyNote mesh__D001691 98; use explode 1976-97
% 210.03/210.26 |- skos__hiddenLabel mesh__D001691 Biological Therapies
% 210.03/210.26 |- skos__altLabel mesh__D001691 Biologic Therapy
% 210.03/210.26 |- mesh__dateCreated mesh__D001691 1999-01-01
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D001691 2006
% 210.03/210.26 |- mesh__dateEstablished mesh__D001691 1998-01-01
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D001691 sjn
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D001691 98
% 210.03/210.26 |- mesh__recordOriginator mesh__D001691 NLM
% 210.03/210.26 |- skos__hiddenLabel mesh__D001691 Biologic Therapies
% 210.03/210.26 |- skos__hiddenLabel mesh__D001691 Therapy, Biologic
% 210.03/210.26 |- mesh__recordMaintainer mesh__D001691 lkt
% 210.03/210.26 |- rdf__type mesh__D001691sskos__Concept
% 210.03/210.26 |- skos__broader mesh__D001691smesh__D013812
% 210.03/210.26 |- skos__annotation mesh__D001691
% 210.03/210.26 general or unspecified; prefer specifics; DF: BIOL THER
% 210.03/210.26 |- skos__prefLabel mesh__D001691 Biological Therapy
% 210.03/210.26 |- mesh__dateRevised mesh__D001691 2005-06-30
% 210.03/210.26 |- skos__hiddenLabel mesh__D001691 Therapies, Biologic
% 210.03/210.26 |- skos__hiddenLabel mesh__D001691 Therapies, Biological
% 210.03/210.26 |- skos__hiddenLabel mesh__D017308 Acid, Etodolic
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D017308 ags
% 210.03/210.26 |- skos__hiddenLabel mesh__D017308 AY 24236
% 210.03/210.26 |- mesh__recordOriginator mesh__D017308 TPW
% 210.03/210.26 |- skos__historyNote mesh__D017308 Indoleacetic Acids %28%1976-1992%29%
% 210.03/210.26 |- rdf__type mesh__D017308sskos__Concept
% 210.03/210.26 |- mesh__dateCreated mesh__D017308 1992-05-08
% 210.03/210.26 |- skos__hiddenLabel mesh__D017308 AY 24,236
% 210.03/210.26 |- skos__hiddenLabel mesh__D017308 AY24,236
% 210.03/210.26 |- skos__prefLabel mesh__D017308 Etodolac
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D017308 2006A
% 210.03/210.26 |- mesh__recordMaintainer mesh__D017308 ags
% 210.03/210.26 |- skos__scopeNote mesh__D017308
% 210.03/210.26 A nonsteroidal anti-inflammatory agent with potent analgesic and antiarthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ankylosing SPONDYLITIS; and in the alleviation of postoperative pain %28%PAIN, POSTOPERATIVE%29%.%A%
% 210.03/210.26 |- skos__altLabel mesh__D017308 AY-24236
% 210.03/210.26 |- mesh__onlineNote mesh__D017308
% 210.03/210.26 use ETODOLAC %28%NM%29% to search ETODOLAC 1980-92
% 210.03/210.26 |- skos__hiddenLabel mesh__D017308 AY24236
% 210.03/210.26 |- mesh__dateEstablished mesh__D017308 1993-01-01
% 210.03/210.26 |- skos__altLabel mesh__D017308 Etodolic Acid
% 210.03/210.26 |- mesh__historyNote mesh__D017308 93; was ETODOLAC %28%NM%29% 1976-92
% 210.03/210.26 |- mesh__dateRevised mesh__D017308 2005-07-22
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D017308
% 210.03/210.26 93; ETODOLAC was indexed under INDOLEACETIC ACIDS 1989-92 %26% 1976-79 %26% ACETIC ACIDS 1976-88%A%
% 210.03/210.26 |- skos__historyNote mesh__D017308 Acetic Acids %28%1976-1988%29%
% 210.03/210.26 |- skos__broader mesh__D017308smesh__D007210
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D017308 2006
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D014010 2002
% 210.03/210.26 |- mesh__dateRevised mesh__D014010 1998-06-11
% 210.03/210.26 |- skos__scopeNote mesh__D014010
% 210.03/210.26 A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions, and is caused by Pityrosporon orbiculare. %28%Dorland, 27th ed%29%%A%
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D014010 2005
% 210.03/210.26 |- skos__annotation mesh__D014010
% 210.03/210.26 caused by PITYROSPORUM ORBICULARE see MALASSEZIA
% 210.03/210.26 |- mesh__recordMaintainer mesh__D014010 AGS
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D014010 2003
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D014010 2006
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D014010 2004
% 210.03/210.26 |- mesh__recordOriginator mesh__D014010 NLM
% 210.03/210.26 |- mesh__dateCreated mesh__D014010 1999-01-01
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D014010 1999
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D014010 SJN
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D014010 2000
% 210.03/210.26 |- skos__prefLabel mesh__D014010 Tinea Versicolor
% 210.03/210.26 |- skos__broader mesh__D014010smesh__D003881
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D014010 2001
% 210.03/210.26 |- rdf__type mesh__D014010sskos__Concept
% 210.03/210.26 |- skos__altLabel mesh__D014010 Pityriasis Versicolor
% 210.03/210.26 |- skos__altLabel mesh__D000599 Dibasic Amino Acids
% 210.03/210.26 |- mesh__dateRevised mesh__D000599 1992-05-07
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 2001
% 210.03/210.26 |- mesh__dateEstablished mesh__D000599 1974-01-01
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 1993
% 210.03/210.26 |- skos__altLabel mesh__D000599 Amino Acids, Dibasic
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 2006
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 1999
% 210.03/210.26 |- mesh__historyNote mesh__D000599 74
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 2002
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 1994
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D000599 PLS
% 210.03/210.26 |- skos__broader mesh__D000599smesh__D000596
% 210.03/210.26 |- mesh__dateCreated mesh__D000599 1999-01-01
% 210.03/210.26 |- skos__hiddenLabel mesh__D000599 Acids, Diamino Amino
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 2003
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 1996
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 1995
% 210.03/210.26 |- skos__prefLabel mesh__D000599 Amino Acids, Diamino
% 210.03/210.26 |- skos__hiddenLabel mesh__D000599 Acids, Dibasic Amino
% 210.03/210.26 |- mesh__recordMaintainer mesh__D000599 TAP
% 210.03/210.26 |- mesh__recordOriginator mesh__D000599 NLM
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 2004
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 1997
% 210.03/210.26 |- skos__altLabel mesh__D000599 Diamino Amino Acids
% 210.03/210.26 |- rdf__type mesh__D000599sskos__Concept
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 2000
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D000599
% 210.03/210.26 74; DIAMINOPIMELIC ACID was see under PIMELIC ACIDS 1975-79%A%
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 2005
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D000599 1998
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D005284 sjn
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D005284 74
% 210.03/210.26 |- skos__prefLabel mesh__D005284 Fenthion
% 210.03/210.26 |- skos__annotation mesh__D005284 TN 111 for eff on insects
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D005284 2006
% 210.03/210.26 |- skos__broader mesh__D005284smesh__D009946
% 210.03/210.26 |- skos__historyNote mesh__D005284 Insecticides %28%1966-1971%29%
% 210.03/210.26 |- mesh__recordOriginator mesh__D005284 NLM
% 210.03/210.26 |- skos__scopeNote mesh__D005284
% 210.03/210.26 Potent cholinesterase inhibitor used as an insecticide and acaricide.%A%
% 210.03/210.26 |- mesh__dateCreated mesh__D005284 1999-01-01
% 210.03/210.26 |- mesh__dateRevised mesh__D005284 2005-06-30
% 210.03/210.26 |- mesh__historyNote mesh__D005284 74%28%72%29%
% 210.03/210.26 |- mesh__dateEstablished mesh__D005284 1974-01-01
% 210.03/210.26 |- rdf__type mesh__D005284sskos__Concept
% 210.03/210.26 |- mesh__recordMaintainer mesh__D005284 ssb
% 210.03/210.26 |- skos__hiddenLabel mesh__D013716 Humeral Epicondylitides, Lateral
% 210.03/210.26 |- skos__historyNote mesh__D013716 Elbow %28%1966-1981%29%
% 210.03/210.26 |- skos__altLabel mesh__D013716 Epicondylitis, Lateral Humeral
% 210.03/210.26 |- mesh__publicMeSHNote mesh__D013716 82
% 210.03/210.26 |- mesh__recordAuthorizer mesh__D013716 sjn
% 210.03/210.26 |- skos__broader mesh__D013716smesh__D009140
% 210.03/210.26 |- skos__historyNote mesh__D013716 Sports Medicine %28%1966-1967%29%
% 210.03/210.26 |- mesh__historyNote mesh__D013716 82
% 210.03/210.26 |- skos__scopeNote mesh__D013716
% 210.03/210.26 A condition characterized by pain in or near the lateral humeral epicondyle or in the forearm extensor muscle mass as a result of unusual strain. It occurs in tennis players as well as housewives, artisans, and violinists.%A%
% 210.03/210.26 |- skos__hiddenLabel mesh__D013716 Epicondylitides, Lateral Humeral
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013716 2006
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013716 2002
% 210.03/210.26 |- skos__hiddenLabel mesh__D013716 Lateral Humeral Epicondylitides
% 210.03/210.26 |- mesh__dateRevised mesh__D013716 1999-11-03
% 210.03/210.26 |- mesh__dateEstablished mesh__D013716 1982-01-01
% 210.03/210.26 |- skos__annotation mesh__D013716
% 210.03/210.26 in %22%housewives, artisans %26% violinists%22% as well as in tennis players; do not coord with TENNIS %28%NIM%29% unless the sport is particularly discussed; do not coord with ATHLETIC INJURIES %28%IM%29% unless tennis elbow is discussed as an athletic inj%A%
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013716 2004
% 210.03/210.26 |- rdf__type mesh__D013716sskos__Concept
% 210.03/210.26 |- skos__hiddenLabel mesh__D013716 Tennis Elbows
% 210.03/210.26 |- mesh__recordMaintainer mesh__D013716 jls
% 210.03/210.26 |- skos__historyNote mesh__D013716 Tendinitis %28%1966-1981%29%
% 210.03/210.26 |- mesh__dateCreated mesh__D013716 1981-03-02
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013716 2005
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013716 2003
% 210.03/210.26 |- skos__broader mesh__D013716smesh__D001134
% 210.03/210.26 |- skos__historyNote mesh__D013716 Elbow Joint %28%1966-1981%29%
% 210.03/210.26 |- skos__prefLabel mesh__D013716 Tennis Elbow
% 210.03/210.26 |- skos__historyNote mesh__D013716 Sports %28%1966-1975%29%
% 210.03/210.26 |- skos__historyNote mesh__D013716 Tennis %28%1976-1981%29%
% 210.03/210.26 |- mesh__recordOriginator mesh__D013716 RC
% 210.03/210.26 |- mesh__activeMeSHYear mesh__D013716 2001
% 210.03/210.27 |- skos__historyNote mesh__D013716 Athletic Injuries %28%1968-1981%29%
% 210.03/210.27 |- skos__hiddenLabel mesh__D013716 Elbows, Tennis
% 210.03/210.27 |- skos__hiddenLabel mesh__D013716 Elbow, Tennis
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D013716 2000
% 210.03/210.27 |- skos__hiddenLabel mesh__D013716 Lateral Humeral Epicondylitis
% 210.03/210.27 |- skos__hiddenLabel mesh__D013716 Humeral Epicondylitis, Lateral
% 210.03/210.27 |- skos__hiddenLabel mesh__D018401 Size, Sample
% 210.03/210.27 |- mesh__historyNote mesh__D018401 95
% 210.03/210.27 |- mesh__dateCreated mesh__D018401 1994-02-28
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D018401 2005
% 210.03/210.27 |- skos__annotation mesh__D018401
% 210.03/210.27 NIM with specific population or circumstances sampled %28%IM%29%; no qualif; not restricted to epidemiology%A%
% 210.03/210.27 |- skos__broader mesh__D018401smesh__D015340
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D018401 2003
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D018401 2006
% 210.03/210.27 |- skos__broader mesh__D018401smesh__D012107
% 210.03/210.27 |- mesh__recordOriginator mesh__D018401 TGC
% 210.03/210.27 |- skos__hiddenLabel mesh__D018401 Sample Sizes
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D018401 2004
% 210.03/210.27 |- mesh__recordMaintainer mesh__D018401 ags
% 210.03/210.27 |- rdf__type mesh__D018401sskos__Concept
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D018401 2002
% 210.03/210.27 |- mesh__dateRevised mesh__D018401 2001-07-25
% 210.03/210.27 |- mesh__dateEstablished mesh__D018401 1995-01-01
% 210.03/210.27 |- skos__prefLabel mesh__D018401 Sample Size
% 210.03/210.27 |- mesh__publicMeSHNote mesh__D018401 95
% 210.03/210.27 |- mesh__recordAuthorizer mesh__D018401 sjn
% 210.03/210.27 |- skos__scopeNote mesh__D018401
% 210.03/210.27 The number of units %28%persons, animals, patients, specified circumstances, etc.%29% in a population to be studied. The sample size should be big enough to have a high likelihood of detecting a true difference between two groups. %28%From Wassertheil-Smoller, Biostatistics and Epidemiology, 1990, p95%29%%A%
% 210.03/210.27 |- skos__hiddenLabel mesh__D018401 Sizes, Sample
% 210.03/210.27 |- rdf__type mesh__D051037sskos__Concept
% 210.03/210.27 |- mesh__dateEstablished mesh__D051037 2006-01-01
% 210.03/210.27 |- skos__broader mesh__D051037smesh__D051036
% 210.03/210.27 |- skos__scopeNote mesh__D051037
% 210.03/210.27 The pore-forming subunits of large-conductance calcium-activated potassium channels. They form tetramers in CELL MEMBRANES.%A%
% 210.03/210.27 |- mesh__recordAuthorizer mesh__D051037 sjn
% 210.03/210.27 |- skos__prefLabel mesh__D051037
% 210.03/210.27 Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
% 210.03/210.27 |- mesh__publicMeSHNote mesh__D051037
% 210.03/210.27 2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, %26% under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2002-2005%A%
% 210.03/210.27 |- skos__altLabel mesh__D051037 MaxiK Channel alpha Subunit
% 210.03/210.27 |- mesh__recordOriginator mesh__D051037 DRC
% 210.03/210.27 |- skos__hiddenLabel mesh__D051037
% 210.03/210.27 Large Conductance Calcium Activated Potassium Channel alpha Subunits
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D051037 2006
% 210.03/210.27 |- skos__hiddenLabel mesh__D051037
% 210.03/210.27 Large Conductance Calcium Activated Potassium Channels, alpha Subunit
% 210.03/210.27 |- mesh__dateCreated mesh__D051037 2005-06-30
% 210.03/210.27 |- mesh__historyNote mesh__D051037 2006%28%1993%29%
% 210.03/210.27 |- skos__altLabel mesh__D051037
% 210.03/210.27 Large-Conductance Calcium-Activated Potassium Channels, alpha Subunit
% 210.03/210.27 |- mesh__recordMaintainer mesh__D051037 DRC
% 210.03/210.27 |- skos__hiddenLabel mesh__D009675 Sodium, Novobiocin
% 210.03/210.27 |- skos__hiddenLabel mesh__D009675 Calcium, Novobiocin
% 210.03/210.27 |- mesh__dateCreated mesh__D009675 1999-01-01
% 210.03/210.27 |- mesh__recordAuthorizer mesh__D009675 sjn
% 210.03/210.27 |- skos__prefLabel mesh__D009675 Novobiocin
% 210.03/210.27 |- skos__altLabel mesh__D009675 Streptonivicin
% 210.03/210.27 |- skos__altLabel mesh__D009675 Crystallinic Acid
% 210.03/210.27 |- skos__altLabel mesh__D009675 Novobiocin, Monosodium Salt
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D009675 2006
% 210.03/210.27 |- skos__hiddenLabel mesh__D009675 Monosodium Salt Novobiocin
% 210.03/210.27 |- skos__scopeNote mesh__D009675
% 210.03/210.27 An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase %28%ATPase%29% activity. %28%From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189%29%%A%
% 210.03/210.27 |- mesh__dateRevised mesh__D009675 2005-06-30
% 210.03/210.27 |- rdf__type mesh__D009675sskos__Concept
% 210.03/210.27 |- mesh__recordMaintainer mesh__D009675 ssb
% 210.03/210.27 |- mesh__recordOriginator mesh__D009675 NLM
% 210.03/210.27 |- skos__broader mesh__D009675smesh__D049933
% 210.03/210.27 |- skos__broader mesh__D009675smesh__D006027
% 210.03/210.27 |- skos__related mesh__D001692smesh__D009079
% 210.03/210.27 |- skos__altLabel mesh__D001692 Biologic Transport
% 210.03/210.27 |- skos__altLabel mesh__D001692 Transport, Biological
% 210.03/210.27 |- skos__related mesh__D001692smesh__D026901
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D001692 2004
% 210.03/210.27 |- skos__prefLabel mesh__D001692 Biological Transport
% 210.03/210.27 |- skos__hiddenLabel mesh__D001692 Transport, Biologic
% 210.03/210.27 |- skos__related mesh__D001692smesh__D004058
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D001692 2003
% 210.03/210.27 |- skos__related mesh__D001692smesh__D018892
% 210.03/210.27 |- mesh__historyNote mesh__D001692 66%28%64%29%
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D001692 2006
% 210.03/210.27 |- skos__broader mesh__D001692smesh__D008660
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D001692 2002
% 210.03/210.27 |- mesh__recordMaintainer mesh__D001692 jmp
% 210.03/210.27 |- mesh__dateCreated mesh__D001692 1999-01-01
% 210.03/210.27 |- mesh__dateEstablished mesh__D001692 1966-01-01
% 210.03/210.27 |- mesh__activeMeSHYear mesh__D001692 2005
% 210.03/210.27 |- mesh__publicMeSHNote mesh__D001692 66
% 210.03/210.27 |- mesh__recordAuthorizer mesh__D001692 sjn
% 210.03/210.27 |- skos__related mesh__D001692smesh__D008431
% 210.03/210.27 |- mesh__recordOriginator mesh__D001692 NLM
% 210.03/210.27 |- skos__annotation mesh__D001692
% 210.03/210.27 almost never IM; coord NIM with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%; DF: BIOL TRANSPORT%A%
% 210.03/210.27 |- mesh__dateRevised mesh__D001692 2001-07-25
% 210.03/210.27 |- rdf__type mesh__D001692sskos__Concept
% 210.03/210.27 |- skos__scopeNote mesh__D001692
% 210.03/210.27 The movement of materials %28%including biochemical substances and drugs%29% through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.%A%
% 210.03/210.27 |- skos__related mesh__D001692smesh__D002463
% 210.03/210.27 |- skos__altLabel mesh__D014011 Fasigin
% 210.03/210.27 |- mesh__publicMeSHNote mesh__D014011
% 210.03/210.27 91; was see under NITROIMIDAZOLES 1975-90
% 210.03/210.27 |- skos__prefLabel mesh__D014011 Tinidazole
% 210.03/210.27 |- skos__scopeNote mesh__D014011
% 210.03/210.27 A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections.%A%
% 210.03/210.27 |- mesh__dateEstablished mesh__D014011 1991-01-01
% 210.03/210.27 |- mesh__dateCreated mesh__D014011 1974-11-19
% 210.03/210.27 |- mesh__historyNote mesh__D014011
% 210.03/210.27 91%28%75%29%; was see under NITROIMIDAZOLES 1975-90
% 210.03/210.27 |- skos__hiddenLabel mesh__D014011 CP12574
% 210.03/210.27 |- skos__altLabel mesh__D014011 Pierre Fabre Brand of Tinidazole
% 210.03/210.27 |- skos__altLabel mesh__D014011 Teofarma Brand of Tinidazole
% 210.13/210.27 |- skos__altLabel mesh__D014011 Farmasierra Brand of Tinidazole
% 210.13/210.27 |- skos__hiddenLabel mesh__D014011 CP12,574
% 210.13/210.27 |- skos__broader mesh__D014011smesh__D009593
% 210.13/210.27 |- rdf__type mesh__D014011sskos__Concept
% 210.13/210.27 |- skos__altLabel mesh__D014011 Simplotan
% 210.13/210.27 |- skos__altLabel mesh__D014011 Pfizer Brand of Tinidazole
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D014011 sjn
% 210.13/210.27 |- skos__historyNote mesh__D014011 Nitroimidazoles %28%1971-1974%29%
% 210.13/210.27 |- skos__historyNote mesh__D014011 Sulfones %28%1971-1974%29%
% 210.13/210.27 |- mesh__dateRevised mesh__D014011 2005-06-30
% 210.13/210.27 |- skos__altLabel mesh__D014011 Fasigyne
% 210.13/210.27 |- skos__altLabel mesh__D014011 Fasygin
% 210.13/210.27 |- mesh__recordMaintainer mesh__D014011 ssb
% 210.13/210.27 |- skos__hiddenLabel mesh__D014011 CP 12,574
% 210.13/210.27 |- skos__altLabel mesh__D014011 CP-12574
% 210.13/210.27 |- skos__hiddenLabel mesh__D014011 CP 12574
% 210.13/210.27 |- mesh__recordOriginator mesh__D014011 NLM
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D014011 2006
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D005285 2006
% 210.13/210.27 |- mesh__dateCreated mesh__D005285 1999-01-01
% 210.13/210.27 |- skos__prefLabel mesh__D005285 Fermentation
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D005285 sjn
% 210.13/210.27 |- skos__broader mesh__D005285smesh__D001669
% 210.13/210.27 |- skos__broader mesh__D005285smesh__D050260
% 210.13/210.27 |- mesh__recordOriginator mesh__D005285 NLM
% 210.13/210.27 |- rdf__type mesh__D005285sskos__Concept
% 210.13/210.27 |- skos__scopeNote mesh__D005285
% 210.13/210.27 Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID.%A%
% 210.13/210.27 |- mesh__recordMaintainer mesh__D005285 lkt
% 210.13/210.27 |- mesh__dateRevised mesh__D005285 2005-06-30
% 210.13/210.27 |- skos__hiddenLabel mesh__D005285 Fermentations
% 210.13/210.27 |- skos__prefLabel mesh__D013717 Tenosynovitis
% 210.13/210.27 |- mesh__dateRevised mesh__D013717 2005-06-30
% 210.13/210.27 |- mesh__recordOriginator mesh__D013717 NLM
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D013717 2006
% 210.13/210.27 |- skos__annotation mesh__D013717
% 210.13/210.27 inflamm of a tendon sheath: do not confuse with TENDINITIS %28%inflamm of tendon%29% or SYNOVITIS %28%inflamm of synovial membrane%29%; do not confuse X ref DE QUERVAIN DISEASE with de Quervain%27%s dis of thyroid %28% = DE QUERVAIN THYROIDITIS see THYROIDITIS, SUBACUTE%29%%A%
% 210.13/210.27 |- skos__hiddenLabel mesh__D013717 Disease, De Quervain
% 210.13/210.27 |- rdf__type mesh__D013717sskos__Concept
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D013717 sjn
% 210.13/210.27 |- skos__scopeNote mesh__D013717
% 210.13/210.27 Inflammation of a tendon sheath. Causes include trauma, tendon stress, bacterial disease %28%gonorrhea, tuberculosis%29%, rheumatic disease, and gout. Common sites are the shoulder capsule, hip capsule, hamstring muscles, and Achilles tendon. The tendon sheaths become inflamed and painful, and accumulate fluid. Joint mobility is usually reduced. Friction rubs may be felt or heard %28%with a stethoscope%29% on movement. Calcium deposits may occur in the tendon and its sheath, leading to opacities on radiographs of the affected area. %28%Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A%
% 210.13/210.27 |- skos__hiddenLabel mesh__D013717 Quervain Disease, De
% 210.13/210.27 |- skos__hiddenLabel mesh__D013717 Tenosynovitides
% 210.13/210.27 |- mesh__dateCreated mesh__D013717 1999-01-01
% 210.13/210.27 |- mesh__recordMaintainer mesh__D013717 ags
% 210.13/210.27 |- skos__broader mesh__D013717smesh__D052256
% 210.13/210.27 |- skos__annotation mesh__D018402
% 210.13/210.27 a genus of moth; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D018402 sjn
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D018402 2006
% 210.13/210.27 |- skos__historyNote mesh__D018402 Moths %28%1975-1994%29%
% 210.13/210.27 |- skos__broader mesh__D018402smesh__D009036
% 210.13/210.27 |- skos__historyNote mesh__D018402 Lepidoptera %28%1975-1994%29%
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D018402 2004
% 210.13/210.27 |- mesh__recordMaintainer mesh__D018402 ags
% 210.13/210.27 |- rdf__type mesh__D018402sskos__Concept
% 210.13/210.27 |- skos__altLabel mesh__D018402 Manduca sexta
% 210.13/210.27 |- skos__historyNote mesh__D018402 Insects %28%1967-1974%29%
% 210.13/210.27 |- mesh__dateCreated mesh__D018402 1994-01-25
% 210.13/210.27 |- skos__prefLabel mesh__D018402 Manduca
% 210.13/210.27 |- mesh__recordOriginator mesh__D018402 PXP
% 210.13/210.27 |- mesh__historyNote mesh__D018402 95
% 210.13/210.27 |- mesh__dateEstablished mesh__D018402 1995-01-01
% 210.13/210.27 |- skos__scopeNote mesh__D018402
% 210.13/210.27 A genus of sphinx or hawk moths of the family Sphingidae. These insects are used in molecular biology studies during all stages of their life cycle.%A%
% 210.13/210.27 |- mesh__dateRevised mesh__D018402 2003-07-09
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D018402 2005
% 210.13/210.27 |- mesh__publicMeSHNote mesh__D018402 95
% 210.13/210.27 |- skos__altLabel mesh__D051836 COUP-TF Proteins
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D051836 2006
% 210.13/210.27 |- skos__broader mesh__D051836smesh__D004268
% 210.13/210.27 |- skos__broader mesh__D051836smesh__D011987
% 210.13/210.27 |- mesh__recordOriginator mesh__D051836 DRC
% 210.13/210.27 |- rdf__type mesh__D051836sskos__Concept
% 210.13/210.27 |- skos__altLabel mesh__D051836
% 210.13/210.27 Chicken Ovalbumin Upstream Promoter-Transcription Factors
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D051836 sjn
% 210.13/210.27 |- mesh__dateEstablished mesh__D051836 2006-01-01
% 210.13/210.27 |- skos__hiddenLabel mesh__D051836 Transcription Factors, COUP
% 210.13/210.27 |- mesh__recordMaintainer mesh__D051836 DRC
% 210.13/210.27 |- mesh__historyNote mesh__D051836 2006%28%1991%29%
% 210.13/210.27 |- skos__prefLabel mesh__D051836 COUP Transcription Factors
% 210.13/210.27 |- skos__hiddenLabel mesh__D051836
% 210.13/210.27 Chicken Ovalbumin Upstream Promoter Transcription Factors
% 210.13/210.27 |- mesh__dateCreated mesh__D051836 2005-06-30
% 210.13/210.27 |- skos__scopeNote mesh__D051836
% 210.13/210.27 A sub-family of steroid receptor transcription factors with specificity for a variety of DNA sequences related to AGGTCA. They can heterodimerize with a variety of factors including RETINOIC ACID RECEPTORS; THYROID HORMONE RECEPTORS; and VITAMIN D RECEPTORS.%A%
% 210.13/210.27 |- skos__hiddenLabel mesh__D051836 COUP TF Proteins
% 210.13/210.27 |- mesh__publicMeSHNote mesh__D051836
% 210.13/210.27 2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS %26% RECEPTORS, STEROID %26% TRANSCRIPTION FACTORS 1991-2005, %26% under REPRESSOR PROTEINS 1991-2004%A%
% 210.13/210.27 |- mesh__recordMaintainer mesh__D051038 DRC
% 210.13/210.27 |- skos__broader mesh__D051038smesh__D051036
% 210.13/210.27 |- rdf__type mesh__D051038sskos__Concept
% 210.13/210.27 |- mesh__recordOriginator mesh__D051038 DRC
% 210.13/210.27 |- skos__altLabel mesh__D051038 MaxiK Channel beta Subunits
% 210.13/210.27 |- skos__hiddenLabel mesh__D051038
% 210.13/210.27 Large Conductance Calcium Activated Potassium Channels, beta Subunits
% 210.13/210.27 |- skos__scopeNote mesh__D051038
% 210.13/210.27 The regulatory subunits of large-conductance calcium-activated potassium channels.%A%
% 210.13/210.27 |- skos__prefLabel mesh__D051038
% 210.13/210.27 Large-Conductance Calcium-Activated Potassium Channel beta Subunits
% 210.13/210.27 |- mesh__dateEstablished mesh__D051038 2006-01-01
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D051038 sjn
% 210.13/210.27 |- mesh__dateCreated mesh__D051038 2005-06-30
% 210.13/210.27 |- mesh__historyNote mesh__D051038 2006%28%1993%29%
% 210.13/210.27 |- mesh__publicMeSHNote mesh__D051038
% 210.13/210.27 2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL BETA SUBUNITS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, %26% under POTASSIUM CHANNELS, CALCIUM ACTIVATED 2002-2005%A%
% 210.13/210.27 |- skos__altLabel mesh__D051038
% 210.13/210.27 Large-Conductance Calcium-Activated Potassium Channels, beta Subunits
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D051038 2006
% 210.13/210.27 |- skos__hiddenLabel mesh__D051038
% 210.13/210.27 Large Conductance Calcium Activated Potassium Channel beta Subunits
% 210.13/210.27 |- rdf__type mesh__D009676sskos__Concept
% 210.13/210.27 |- mesh__historyNote mesh__D009676 98; use explode 1974-97
% 210.13/210.27 |- skos__prefLabel mesh__D009676 Noxae
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D009676 2004
% 210.13/210.27 |- skos__scopeNote mesh__D009676
% 210.13/210.27 Agents capable of exerting a harmful effect on the body.%A%
% 210.13/210.27 |- mesh__dateRevised mesh__D009676 2003-07-09
% 210.13/210.27 |- mesh__recordOriginator mesh__D009676 NLM
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D009676 sjn
% 210.13/210.27 |- mesh__dateEstablished mesh__D009676 1998-01-01
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D009676 2006
% 210.13/210.27 |- skos__annotation mesh__D009676 GEN or unspecified; prefer specifics
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D009676 2005
% 210.13/210.27 |- skos__broader mesh__D009676smesh__D004786
% 210.13/210.27 |- mesh__publicMeSHNote mesh__D009676 98
% 210.13/210.27 |- mesh__dateCreated mesh__D009676 1999-01-01
% 210.13/210.27 |- mesh__recordMaintainer mesh__D009676 ssb
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D001693 2004
% 210.13/210.27 |- mesh__recordOriginator mesh__D001693 NLM
% 210.13/210.27 |- skos__hiddenLabel mesh__D001693 Transport, Active
% 210.13/210.27 |- mesh__dateRevised mesh__D001693 2001-07-25
% 210.13/210.27 |- skos__hiddenLabel mesh__D001693 Transport, Active Biologic
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D001693 2003
% 210.13/210.27 |- mesh__historyNote mesh__D001693 66
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D001693 2006
% 210.13/210.27 |- skos__altLabel mesh__D001693 Biologic Transport, Active
% 210.13/210.27 |- skos__broader mesh__D001693smesh__D001692
% 210.13/210.27 |- mesh__dateCreated mesh__D001693 1999-01-01
% 210.13/210.27 |- mesh__recordMaintainer mesh__D001693 jmp
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D001693 2005
% 210.13/210.27 |- mesh__publicMeSHNote mesh__D001693 66
% 210.13/210.27 |- skos__annotation mesh__D001693
% 210.13/210.27 almost never IM; coord with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%; DF: BIOL TRANSPORT ACTIVE%A%
% 210.13/210.27 |- skos__hiddenLabel mesh__D001693 Transport, Uphill
% 210.13/210.27 |- rdf__type mesh__D001693sskos__Concept
% 210.13/210.27 |- skos__scopeNote mesh__D001693
% 210.13/210.27 The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.%A%
% 210.13/210.27 |- skos__altLabel mesh__D001693 Transport, Active Biological
% 210.13/210.27 |- skos__prefLabel mesh__D001693 Biological Transport, Active
% 210.13/210.27 |- skos__hiddenLabel mesh__D001693 Active Biologic Transport
% 210.13/210.27 |- skos__altLabel mesh__D001693 Active Transport
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D001693 2002
% 210.13/210.27 |- mesh__dateEstablished mesh__D001693 1966-01-01
% 210.13/210.27 |- skos__related mesh__D001693smesh__D016623
% 210.13/210.27 |- skos__altLabel mesh__D001693 Uphill Transport
% 210.13/210.27 |- skos__altLabel mesh__D001693 Active Biological Transport
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D001693 sjn
% 210.13/210.27 |- skos__scopeNote mesh__D042501
% 210.13/210.27 Intercellular signaling peptides and proteins that regulate the proliferation of new blood vessels under normal physiological conditions %28%ANGIOGENESIS, PHYSIOLOGICAL%29%. Aberrant expression of angiogenic proteins during disease states such as tumorigenesis can also result in PATHOLOGICAL ANGIOGENESIS.%A%
% 210.13/210.27 |- skos__prefLabel mesh__D042501 Angiogenic Proteins
% 210.13/210.27 |- skos__broader mesh__D042501smesh__D036341
% 210.13/210.27 |- rdf__type mesh__D042501sskos__Concept
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D042501 sjn
% 210.13/210.27 |- mesh__recordMaintainer mesh__D042501 ssb
% 210.13/210.27 |- mesh__publicMeSHNote mesh__D042501 2004
% 210.13/210.27 |- mesh__dateCreated mesh__D042501 2003-07-09
% 210.13/210.27 |- mesh__dateEstablished mesh__D042501 2004-01-01
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D042501 2006
% 210.13/210.27 |- mesh__dateRevised mesh__D042501 2005-06-30
% 210.13/210.27 |- skos__historyNote mesh__D042501
% 210.13/210.27 Angiogenesis Modulating Agents %28%1973-2003%29%
% 210.13/210.27 |- mesh__historyNote mesh__D042501 2004
% 210.13/210.27 |- mesh__recordOriginator mesh__D042501 jmp
% 210.13/210.27 |- rdf__type mesh__D014810sskos__Concept
% 210.13/210.27 |- skos__broader mesh__D014810smesh__D001578
% 210.13/210.27 |- mesh__recordMaintainer mesh__D014810 ssb
% 210.13/210.27 |- skos__scopeNote mesh__D014810
% 210.13/210.27 A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.%A%
% 210.13/210.27 |- skos__prefLabel mesh__D014810 Vitamin E
% 210.13/210.27 |- skos__annotation mesh__D014810
% 210.13/210.27 /ther use: coordinate disease with /drug ther, not /diet ther%A%
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D014810 2006
% 210.13/210.27 |- mesh__dateCreated mesh__D014810 1999-01-01
% 210.13/210.27 |- mesh__dateRevised mesh__D014810 2005-06-30
% 210.13/210.27 |- mesh__recordOriginator mesh__D014810 NLM
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D014810 sjn
% 210.13/210.27 |- skos__broader mesh__D014012smesh__D006311
% 210.13/210.27 |- mesh__dateRevised mesh__D014012 2004-07-07
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012
% 210.13/210.27 Spontaneous Oto Acoustic Emission Tinnitus
% 210.13/210.27 |- mesh__recordOriginator mesh__D014012 NLM
% 210.13/210.27 |- rdf__type mesh__D014012sskos__Concept
% 210.13/210.27 |- skos__altLabel mesh__D014012 Tensor Palatini Induced Tinnitus
% 210.13/210.27 |- skos__altLabel mesh__D014012 Tinnitus, Leudet%27%s
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Induced Tinnitus, Noise
% 210.13/210.27 |- skos__altLabel mesh__D014012 Ringing-Buzzing-Tinnitus
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Subjective Tinnitus
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Tinnitus, Vascular Origin
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Clicking Tinnitus
% 210.13/210.27 |- skos__altLabel mesh__D014012 Vascular Origin Tinnitus
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D014012 2005
% 210.13/210.27 |- skos__scopeNote mesh__D014012
% 210.13/210.27 A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.%A%
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Ringing Buzzing Tinnitus
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Tinnitus, Pulsatile
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012
% 210.13/210.27 Tinnitus, Spontaneous Oto Acoustic Emission
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Tinnitus, Leudets
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D014012 sjn
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Leudet Tinnitus
% 210.13/210.27 |- skos__altLabel mesh__D014012 Tensor Tympani Induced Tinnitus
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D014012 2006
% 210.13/210.27 |- skos__altLabel mesh__D014012 Spontaneous Oto-Acoustic Emission Tinnitus
% 210.13/210.27 |- mesh__recordMaintainer mesh__D014012 lkt
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Noise Induced Tinnitus
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Leudet%27%s Tinnitus
% 210.13/210.27 |- skos__prefLabel mesh__D014012 Tinnitus
% 210.13/210.27 |- skos__hiddenLabel mesh__D014012 Objective Tinnitus
% 210.13/210.27 |- mesh__dateCreated mesh__D014012 1999-01-01
% 210.13/210.27 |- mesh__dateRevised mesh__D005286 2005-06-30
% 210.13/210.27 |- mesh__recordMaintainer mesh__D005286 jmp
% 210.13/210.27 |- skos__scopeNote mesh__D005286
% 210.13/210.27 Fermium. A man-made radioactive actinide with atomic symbol Fm, atomic number 100, and atomic weight 257. Its known isotopes range from 244-254 and 256-258. Its valence can be +2 or +3. Like einsteinium, it was discovered in 1952 in the debris from a thermonuclear explosion.%A%
% 210.13/210.27 |- rdf__type mesh__D005286sskos__Concept
% 210.13/210.27 |- skos__broader mesh__D005286smesh__D019216
% 210.13/210.27 |- skos__annotation mesh__D005286 man-made radioactive element; IM
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D005286 sjn
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D005286 2006
% 210.13/210.27 |- skos__prefLabel mesh__D005286 Fermium
% 210.13/210.27 |- mesh__dateCreated mesh__D005286 1999-01-01
% 210.13/210.27 |- mesh__recordOriginator mesh__D005286 NLM
% 210.13/210.27 |- skos__broader mesh__D005286smesh__D008671
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D013718 2006
% 210.13/210.27 |- skos__historyNote mesh__D013718 Elasticity %28%1967-1976%29%
% 210.13/210.27 |- skos__hiddenLabel mesh__D013718 Strength, Tensile
% 210.13/210.27 |- rdf__type mesh__D013718sskos__Concept
% 210.13/210.27 |- skos__historyNote mesh__D013718 Biomechanics %28%1968-1976%29%
% 210.13/210.27 |- mesh__recordOriginator mesh__D013718 VDK
% 210.13/210.27 |- mesh__dateEstablished mesh__D013718 1977-01-01
% 210.13/210.27 |- mesh__recordMaintainer mesh__D013718 lkt
% 210.13/210.27 |- skos__broader mesh__D013718smesh__D019563
% 210.13/210.27 |- skos__broader mesh__D013718smesh__D001696
% 210.13/210.27 |- skos__annotation mesh__D013718
% 210.13/210.27 NIM; do not confuse with COMPRESSIVE STRENGTH
% 210.13/210.27 |- mesh__historyNote mesh__D013718 77
% 210.13/210.27 |- skos__scopeNote mesh__D013718
% 210.13/210.27 The maximum stress a material subjected to a stretching load can withstand without tearing. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed, p2001%29%%A%
% 210.13/210.27 |- mesh__dateCreated mesh__D013718 1976-04-16
% 210.13/210.27 |- mesh__dateRevised mesh__D013718 2004-07-07
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D013718 2005
% 210.13/210.27 |- skos__prefLabel mesh__D013718 Tensile Strength
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D013718 sjn
% 210.13/210.27 |- mesh__publicMeSHNote mesh__D013718 77
% 210.13/210.27 |- skos__hiddenLabel mesh__D013718 Strengths, Tensile
% 210.13/210.27 |- skos__historyNote mesh__D013718 Stress, Mechanical %28%1973-1976%29%
% 210.13/210.27 |- skos__hiddenLabel mesh__D013718 Tensile Strengths
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D010420 1998
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D010420 SJN
% 210.13/210.27 |- skos__prefLabel mesh__D010420 Pentanes
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D010420 2006
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D010420 1999
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D010420 2002
% 210.13/210.27 |- skos__scopeNote mesh__D010420
% 210.13/210.27 Five-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives.%A%
% 210.13/210.27 |- mesh__recordOriginator mesh__D010420 RLS
% 210.13/210.27 |- mesh__dateEstablished mesh__D010420 1978-01-01
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D010420 2003
% 210.13/210.27 |- mesh__recordMaintainer mesh__D010420 TGC
% 210.13/210.27 |- skos__historyNote mesh__D010420 Hydrocarbons %28%1966-1977%29%
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D010420 2004
% 210.13/210.27 |- mesh__dateCreated mesh__D010420 1977-05-20
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D010420 2000
% 210.13/210.27 |- skos__broader mesh__D010420smesh__D000473
% 210.13/210.27 |- rdf__type mesh__D010420sskos__Concept
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D010420 2001
% 210.13/210.27 |- mesh__historyNote mesh__D010420 78
% 210.13/210.27 |- mesh__dateRevised mesh__D010420 1997-06-20
% 210.13/210.27 |- skos__historyNote mesh__D010420 Alkanes %28%1966-1977%29%
% 210.13/210.27 |- skos__annotation mesh__D010420 CYCLOPENTANES is also available
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D010420 2005
% 210.13/210.27 |- mesh__publicMeSHNote mesh__D010420 78
% 210.13/210.27 |- skos__broader mesh__D051837smesh__D051836
% 210.13/210.27 |- mesh__recordMaintainer mesh__D051837 ags
% 210.13/210.27 |- rdf__type mesh__D051837sskos__Concept
% 210.13/210.27 |- skos__prefLabel mesh__D051837 COUP Transcription Factor II
% 210.13/210.27 |- mesh__recordOriginator mesh__D051837 DRC
% 210.13/210.27 |- mesh__recordAuthorizer mesh__D051837 ags
% 210.13/210.27 |- skos__altLabel mesh__D051837 ApoAI Regulatory Protein-1
% 210.13/210.27 |- skos__hiddenLabel mesh__D051837
% 210.13/210.27 Chicken Ovalbumin Upstream Promoter Transcription Factor II
% 210.13/210.27 |- mesh__dateEstablished mesh__D051837 2006-01-01
% 210.13/210.27 |- skos__hiddenLabel mesh__D051837 ApoAI Regulatory Protein 1
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D051837 2006A
% 210.13/210.27 |- skos__broader mesh__D051837smesh__D012097
% 210.13/210.27 |- skos__scopeNote mesh__D051837
% 210.13/210.27 A COUP transcription factor that plays a role as a negative regulator of GENETIC TRANSCRIPTION that competes with other hormone receptors for the common response element AGGTCA. It can also stimulate transcription of genes involved in the METABOLISM of GLUCOSE and CHOLESTEROL.%A%
% 210.13/210.27 |- mesh__dateRevised mesh__D051837 2005-08-03
% 210.13/210.27 |- mesh__activeMeSHYear mesh__D051837 2006
% 210.13/210.27 |- mesh__historyNote mesh__D051837 2006%28%1991%29%
% 210.13/210.27 |- mesh__dateCreated mesh__D051837 2005-06-30
% 210.13/210.27 |- mesh__publicMeSHNote mesh__D051837
% 210.13/210.27 2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTOR II was indexed under DNA-BINDING PROTEINS %26% RECEPTORS, STEROID %26% TRANSCRIPTION FACTORS 1991-2005, %26% under REPRESSOR PROTEINS 1991-2004%A%
% 210.13/210.27 |- skos__altLabel mesh__D051837 COUP-TFII Protein
% 210.13/210.27 |- skos__hiddenLabel mesh__D051837 COUP TFII Protein
% 210.13/210.27 |- skos__altLabel mesh__D051837 Apolipoprotein AI Regulatory Protein 1
% 210.13/210.27 |- skos__altLabel mesh__D051837
% 210.13/210.27 Chicken Ovalbumin Upstream Promoter-Transcription Factor II
% 210.13/210.27 |- rdf__type mesh__D051039sskos__Concept
% 210.13/210.27 |- skos__annotation mesh__D051039
% 210.13/210.27 diseases: coordinate IM with MONKEY DISEASES %28%IM%29%
% 210.13/210.27 |- skos__hiddenLabel mesh__D051039 Golden Tamarin
% 210.13/210.27 |- skos__historyNote mesh__D051039 Callitrichidae %28%1977-2005%29%
% 210.13/210.27 |- skos__altLabel mesh__D051039 Leontideus
% 210.13/210.27 |- skos__prefLabel mesh__D051039 Leontopithecus
% 210.13/210.27 |- mesh__historyNote mesh__D051039 2006; use CALLITRICHIDAE 1990-2005
% 210.13/210.27 |- mesh__recordOriginator mesh__D051039 ags
% 210.13/210.27 |- skos__hiddenLabel mesh__D051039 Golden Tamarins
% 210.13/210.27 |- skos__hiddenLabel mesh__D051039 Tamarins, Golden
% 210.13/210.27 |- skos__scopeNote mesh__D051039
% 210.13/210.27 The genus of lion tamarins in the family CALLITRICHIDAE. The common name refers to the mane on the shoulders.%A%
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D051039 2006; see CALLITRICHINAE 1990-2005
% 210.13/210.28 |- skos__hiddenLabel mesh__D051039 Tamarins, Lion
% 210.13/210.28 |- skos__hiddenLabel mesh__D051039 Lion Tamarins
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D051039 2006
% 210.13/210.28 |- skos__altLabel mesh__D051039 Tamarin, Golden
% 210.13/210.28 |- mesh__recordMaintainer mesh__D051039 ags
% 210.13/210.28 |- skos__broader mesh__D051039smesh__D002143
% 210.13/210.28 |- mesh__dateEstablished mesh__D051039 2006-01-01
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D051039 sjn
% 210.13/210.28 |- mesh__dateCreated mesh__D051039 2005-06-30
% 210.13/210.28 |- skos__hiddenLabel mesh__D051039 Lion Tamarin
% 210.13/210.28 |- skos__altLabel mesh__D051039 Tamarin, Lion
% 210.13/210.28 |- skos__scopeNote mesh__D048090
% 210.13/210.28 A multifactorial disease of CATTLE resulting from complex interactions between environmental factors, host factors, and pathogens. The environmental factors act as stressors adversely affecting the IMMUNE SYSTEM and other host defenses and enhancing transmission of infecting agents.%A%
% 210.13/210.28 |- mesh__recordMaintainer mesh__D048090 ags
% 210.13/210.28 |- mesh__recordOriginator mesh__D048090 ags
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D048090 sjn
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D048090 2005
% 210.13/210.28 |- mesh__dateEstablished mesh__D048090 2005-01-01
% 210.13/210.28 |- rdf__type mesh__D048090sskos__Concept
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D048090 2006
% 210.13/210.28 |- mesh__dateCreated mesh__D048090 2004-07-19
% 210.13/210.28 |- skos__prefLabel mesh__D048090 Bovine Respiratory Disease Complex
% 210.13/210.28 |- skos__broader mesh__D048090smesh__D002418
% 210.13/210.28 |- mesh__historyNote mesh__D048090 2005
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D048090 2005
% 210.13/210.28 |- skos__broader mesh__D048090smesh__D012141
% 210.13/210.28 |- skos__historyNote mesh__D048090
% 210.13/210.28 Respiratory Tract Infections %28%1972-2004%29%
% 210.13/210.28 |- mesh__dateCreated mesh__D009677 1975-07-21
% 210.13/210.28 |- mesh__recordOriginator mesh__D009677 SH
% 210.13/210.28 |- mesh__dateEstablished mesh__D009677 1991-01-01
% 210.13/210.28 |- mesh__dateRevised mesh__D009677 2000-06-22
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009677 2003
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D009677 91; was see under THIOUREA 1976-90
% 210.13/210.28 |- skos__broader mesh__D009677smesh__D013890
% 210.13/210.28 |- skos__historyNote mesh__D009677
% 210.13/210.28 Thiourea %28%1974%29% /analogs %26% derivatives %28%1975%29%
% 210.13/210.28 |- skos__altLabel mesh__D009677 Noxytiolin
% 210.13/210.28 |- skos__prefLabel mesh__D009677 Noxythiolin
% 210.13/210.28 |- skos__altLabel mesh__D009677 Noxitiolin
% 210.13/210.28 |- skos__hiddenLabel mesh__D009677 NoxyflexS
% 210.13/210.28 |- skos__hiddenLabel mesh__D009677 Noxyflex S
% 210.13/210.28 |- skos__altLabel mesh__D009677
% 210.13/210.28 N-Methyl-N%27%%27%-%28%hydroxymethyl%29%thiourea
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009677 2006
% 210.13/210.28 |- skos__scopeNote mesh__D009677
% 210.13/210.28 Local antibacterial that probably acts by releasing formaldehyde in aqueous solutions. It is used for irrigation of infected body cavities - bladder, peritoneum, etc. and as a spray for burns.%A%
% 210.13/210.28 |- skos__altLabel mesh__D009677 Noxitiolinum
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009677 2005
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D009677 sjn
% 210.13/210.28 |- skos__historyNote mesh__D009677
% 210.13/210.28 Alcohol, Methyl %28%1974%29% /analogs %26% derivatives %28%1975%29%
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009677 2002
% 210.13/210.28 |- mesh__historyNote mesh__D009677
% 210.13/210.28 91%28%76%29%; was see under THIOUREA 1976-90
% 210.13/210.28 |- mesh__recordMaintainer mesh__D009677 CCR
% 210.13/210.28 |- rdf__type mesh__D009677sskos__Concept
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009677 2004
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009677 2001
% 210.13/210.28 |- mesh__dateCreated mesh__D001694 1999-01-01
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001694 2005
% 210.13/210.28 |- skos__broader mesh__D001694smesh__D014857
% 210.13/210.28 |- mesh__recordMaintainer mesh__D001694 ags
% 210.13/210.28 |- skos__annotation mesh__D001694 DF: BIOL WARFARE
% 210.13/210.28 |- skos__altLabel mesh__D001694 Warfare, Bacterial
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001694 2002
% 210.13/210.28 |- rdf__type mesh__D001694sskos__Concept
% 210.13/210.28 |- mesh__historyNote mesh__D001694
% 210.13/210.28 BACTERIAL WARFARE was see under BIOLOGICAL WARFARE 1963-78%A%
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D001694 sjn
% 210.13/210.28 |- skos__altLabel mesh__D001694 Warfare, Biological
% 210.13/210.28 |- skos__hiddenLabel mesh__D001694 Warfare, Biologic
% 210.13/210.28 |- mesh__recordOriginator mesh__D001694 NLM
% 210.13/210.28 |- mesh__onlineNote mesh__D001694
% 210.13/210.28 use BIOLOGICAL WARFARE to search BACTERIAL WARFARE 1966-78%A%
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001694 2004
% 210.13/210.28 |- skos__prefLabel mesh__D001694 Biological Warfare
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001694 2001
% 210.13/210.28 |- skos__scopeNote mesh__D001694
% 210.13/210.28 Warfare involving the use of living organisms or their products as disease etiologic agents against people, animals, or plants.%A%
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001694 2003
% 210.13/210.28 |- skos__related mesh__D001694smesh__D014754
% 210.13/210.28 |- skos__altLabel mesh__D001694 Biologic Warfare
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001694 2006
% 210.13/210.28 |- mesh__dateRevised mesh__D001694 2000-06-22
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D042502 2004
% 210.13/210.28 |- mesh__dateRevised mesh__D042502 2005-06-30
% 210.13/210.28 |- mesh__dateCreated mesh__D042502 2003-07-09
% 210.13/210.28 |- skos__scopeNote mesh__D042502
% 210.13/210.28 A genus of chemoorganotrophic, gram negative rods, in the family ALCALIGENACEAE. They are pathogenic parasites of HORSES.%A%
% 210.13/210.28 |- mesh__historyNote mesh__D042502 2004
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D042502 2006
% 210.13/210.28 |- skos__prefLabel mesh__D042502 Taylorella
% 210.13/210.28 |- mesh__recordMaintainer mesh__D042502 SYSTEM
% 210.13/210.28 |- skos__broader mesh__D042502smesh__D042401
% 210.13/210.28 |- mesh__recordOriginator mesh__D042502 ags
% 210.13/210.28 |- skos__annotation mesh__D042502
% 210.13/210.28 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D042502 sjn
% 210.13/210.28 |- mesh__dateEstablished mesh__D042502 2004-01-01
% 210.13/210.28 |- rdf__type mesh__D042502sskos__Concept
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D020050
% 210.13/210.28 99; for MANTIDS %26% PRAYING MANTIS see ORTHOPTERA 1986-98
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D020050 2005
% 210.13/210.28 |- skos__altLabel mesh__D020050 Mantids
% 210.13/210.28 |- skos__annotation mesh__D020050
% 210.13/210.28 do not use /drug eff for insecticides: TN 111
% 210.13/210.28 |- mesh__dateCreated mesh__D020050 1998-06-10
% 210.13/210.28 |- skos__scopeNote mesh__D020050
% 210.13/210.28 An order of insects, comprising a single family %28%Mantidae%29%, restricted almost entirely to the tropics. Only one species, the praying mantis %28%Mantis religiosa%29%, is found in temperate habitats.%A%
% 210.13/210.28 |- mesh__dateRevised mesh__D020050 2003-07-09
% 210.13/210.28 |- mesh__historyNote mesh__D020050
% 210.13/210.28 99; for MANTIDS %26% PRAYING MANTIS use ORTHOPTERA 1986-98
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D020050 2004
% 210.13/210.28 |- skos__historyNote mesh__D020050 Orthoptera %28%1981-1998%29%
% 210.13/210.28 |- skos__historyNote mesh__D020050 Insects %28%1966-1998%29%
% 210.13/210.28 |- skos__prefLabel mesh__D020050 Mantodea
% 210.13/210.28 |- rdf__type mesh__D020050sskos__Concept
% 210.13/210.28 |- skos__broader mesh__D020050smesh__D007313
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D020050 2006
% 210.13/210.28 |- mesh__dateEstablished mesh__D020050 1999-01-01
% 210.13/210.28 |- mesh__recordOriginator mesh__D014811 NLM
% 210.13/210.28 |- skos__annotation mesh__D014811 DF: VITAMIN E DEFIC
% 210.13/210.28 |- mesh__dateRevised mesh__D014811 2003-07-09
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D014811 2005
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D014811 sjn
% 210.13/210.28 |- mesh__recordMaintainer mesh__D014811 lkt
% 210.13/210.28 |- skos__hiddenLabel mesh__D014811 Deficiencies, Vitamin E
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D014811 2006
% 210.13/210.28 |- mesh__dateCreated mesh__D014811 1999-01-01
% 210.13/210.28 |- skos__prefLabel mesh__D014811 Vitamin E Deficiency
% 210.13/210.28 |- skos__hiddenLabel mesh__D014811 Vitamin E Deficiencies
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D014811 2004
% 210.13/210.28 |- skos__broader mesh__D014811smesh__D001361
% 210.13/210.28 |- rdf__type mesh__D014811sskos__Concept
% 210.13/210.28 |- skos__scopeNote mesh__D014811
% 210.13/210.28 A nutritional condition produced by a deficiency of VITAMIN E in the diet, characterized by posterior column and spinocerebellar tract abnormalities, areflexia, ophthalmoplegia, and disturbances of gait, proprioception, and vibration. In premature infants vitamin E deficiency is associated with hemolytic anemia, thrombocytosis, edema, intraventricular hemorrhage, and increasing risk of retrolental fibroplasia and bronchopulmonary dysplasia. An apparent inborn error of vitamin E metabolism, named familial isolated vitamin E deficiency, has recently been identified. %28%Cecil Textbook of Medicine, 19th ed, p1181%29%%A%
% 210.13/210.28 |- skos__altLabel mesh__D014811 Deficiency, Vitamin E
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D014013 2006
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D014013 2003
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D014013 sjn
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D014013 2005
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D014013 2002
% 210.13/210.28 |- skos__historyNote mesh__D014013 Benzenesulfonates %28%1974%29%
% 210.13/210.28 |- skos__annotation mesh__D014013 D25-26 qualif
% 210.13/210.28 |- mesh__recordMaintainer mesh__D014013 CCR
% 210.13/210.28 |- mesh__dateEstablished mesh__D014013 1991-01-01
% 210.13/210.28 |- mesh__recordOriginator mesh__D014013 NLM
% 210.13/210.28 |- mesh__historyNote mesh__D014013
% 210.13/210.28 91%28%75%29%; was see under BENZENESULFONATES 1975-90
% 210.13/210.28 |- rdf__type mesh__D014013sskos__Concept
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D014013 2001
% 210.13/210.28 |- mesh__dateRevised mesh__D014013 2000-06-22
% 210.13/210.28 |- skos__scopeNote mesh__D014013
% 210.13/210.28 A colorimetric reagent for iron, manganese, titanium, molybdenum, and complexes of zirconium. %28%From Merck Index, 11th ed%29%%A%
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D014013
% 210.13/210.28 91; was see under BENZENESULFONATES 1975-90
% 210.13/210.28 |- skos__historyNote mesh__D014013 Catechols %28%1974%29%
% 210.13/210.28 |- skos__broader mesh__D014013smesh__D002396
% 210.13/210.28 |- skos__prefLabel mesh__D014013 Tiron
% 210.13/210.28 |- skos__broader mesh__D014013smesh__D001557
% 210.13/210.28 |- mesh__dateCreated mesh__D014013 1974-11-19
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D014013 2004
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D038461 2005
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D038461
% 210.13/210.28 2003; PROTEIN-PROLINE KINASE %28%now PROLINE-DIRECTED PROTEIN KINASES%29% was indexed under PROTEIN-SERINE-THREONINE KINASES 1994-2002 %26% under PROTEIN KINASES 1990-1993%A%
% 210.13/210.28 |- skos__hiddenLabel mesh__D038461 Proline Directed Protein Kinases
% 210.13/210.28 |- skos__hiddenLabel mesh__D038461 Kinase, Protein-Proline
% 210.13/210.28 |- skos__scopeNote mesh__D038461
% 210.13/210.28 A subclass of protein serine-threonine kinases that phosphorylate proteins on a SERINE or THREONINE residue that is immediately preceding a PROLINE residue.%A%
% 210.13/210.28 |- skos__hiddenLabel mesh__D038461 Kinases, Proline-Directed Protein
% 210.13/210.28 |- skos__hiddenLabel mesh__D038461 Protein Kinase, Proline-Directed
% 210.13/210.28 |- skos__hiddenLabel mesh__D038461 Protein Proline Kinase
% 210.13/210.28 |- skos__broader mesh__D038461smesh__D017346
% 210.13/210.28 |- skos__prefLabel mesh__D038461 Proline-Directed Protein Kinases
% 210.13/210.28 |- skos__altLabel mesh__D038461 Protein-Proline Kinase
% 210.13/210.28 |- skos__historyNote mesh__D038461 Protein Kinases %28%1990-1993%29%
% 210.13/210.28 |- rdf__type mesh__D038461sskos__Concept
% 210.13/210.28 |- skos__hiddenLabel mesh__D038461 Proline Directed Protein Kinase
% 210.13/210.28 |- skos__hiddenLabel mesh__D038461 Protein Kinases, Proline-Directed
% 210.13/210.28 |- skos__altLabel mesh__D038461 PDPK Enzymes
% 210.13/210.28 |- mesh__dateRevised mesh__D038461 2003-07-09
% 210.13/210.28 |- mesh__dateEstablished mesh__D038461 2003-01-01
% 210.13/210.28 |- skos__hiddenLabel mesh__D038461 Kinase, Proline-Directed Protein
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D038461 2006
% 210.13/210.28 |- mesh__historyNote mesh__D038461
% 210.13/210.28 2003; use PROLINE-DIRECTED PROTEIN KINASES %28%NM%29% 1990-2002%A%
% 210.13/210.28 |- mesh__dateCreated mesh__D038461 2002-07-03
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D038461 2004
% 210.13/210.28 |- skos__altLabel mesh__D038461 Proline-Directed Protein Kinase
% 210.13/210.28 |- skos__historyNote mesh__D038461
% 210.13/210.28 Protein-Serine-Threonine Kinases %28%1994-2002%29%
% 210.13/210.28 |- skos__broader mesh__D005287smesh__D050862
% 210.13/210.28 |- skos__hiddenLabel mesh__D005287 Iron Sulfur Protein Reductase
% 210.13/210.28 |- rdf__type mesh__D005287sskos__Concept
% 210.13/210.28 |- skos__scopeNote mesh__D005287
% 210.13/210.28 An enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4.%A%
% 210.13/210.28 |- mesh__recordOriginator mesh__D005287 NLM
% 210.13/210.28 |- skos__hiddenLabel mesh__D005287 Protein Reductase, Iron-Sulfur
% 210.13/210.28 |- mesh__dateCreated mesh__D005287 1974-11-19
% 210.13/210.28 |- mesh__dateRevised mesh__D005287 2005-06-30
% 210.13/210.28 |- skos__historyNote mesh__D005287 NADH, NADPH Oxidoreductases %28%1974%29%
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D005287 2006
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D005287
% 210.13/210.28 91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90
% 210.13/210.28 |- skos__hiddenLabel mesh__D005287 Reductase, Iron-Sulfur Protein
% 210.13/210.28 |- skos__hiddenLabel mesh__D005287 Reductase, Adrenodoxin
% 210.13/210.28 |- skos__prefLabel mesh__D005287 Ferredoxin-NADP Reductase
% 210.13/210.28 |- mesh__recordMaintainer mesh__D005287 AKE
% 210.13/210.28 |- skos__historyNote mesh__D005287 Ferredoxins %28%1974%29%
% 210.13/210.28 |- mesh__dateEstablished mesh__D005287 1991-01-01
% 210.13/210.28 |- skos__hiddenLabel mesh__D005287 Reductase, NADPH-Ferredoxin
% 210.13/210.28 |- skos__hiddenLabel mesh__D005287 NADPH Ferredoxin Reductase
% 210.13/210.28 |- mesh__historyNote mesh__D005287
% 210.13/210.28 91%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-90%A%
% 210.13/210.28 |- skos__altLabel mesh__D005287 Adrenodoxin Reductase
% 210.13/210.28 |- skos__altLabel mesh__D005287 NADPH-Ferredoxin Reductase
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D005287 sjn
% 210.13/210.28 |- skos__hiddenLabel mesh__D005287 Reductase, Ferredoxin-NADP
% 210.13/210.28 |- skos__altLabel mesh__D005287 Iron-Sulfur Protein Reductase
% 210.13/210.28 |- skos__hiddenLabel mesh__D005287 Ferredoxin NADP Reductase
% 210.13/210.28 |- skos__scopeNote mesh__D013719
% 210.13/210.28 Tensor muscle of the tympanic membrane that draws the handle of the malleus medialward and tenses the tympanic membrane. %28%Stedman, 25th ed%29%%A%
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D013719 sjn
% 210.13/210.28 |- skos__hiddenLabel mesh__D013719 Tympanus, Tensor
% 210.13/210.28 |- mesh__dateCreated mesh__D013719 1999-01-01
% 210.13/210.28 |- skos__annotation mesh__D013719
% 210.13/210.28 /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%
% 210.13/210.28 |- mesh__recordMaintainer mesh__D013719 nns
% 210.13/210.28 |- skos__broader mesh__D013719smesh__D018482
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D013719 2005
% 210.13/210.28 |- skos__prefLabel mesh__D013719 Tensor Tympani
% 210.13/210.28 |- skos__broader mesh__D013719smesh__D004432
% 210.13/210.28 |- skos__hiddenLabel mesh__D013719 Tensor Tympanus
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D013719 2003
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D013719 2006
% 210.13/210.28 |- mesh__dateRevised mesh__D013719 2001-07-25
% 210.13/210.28 |- skos__hiddenLabel mesh__D013719 Tympani, Tensor
% 210.13/210.28 |- mesh__recordOriginator mesh__D013719 NLM
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D013719 2004
% 210.13/210.28 |- rdf__type mesh__D013719sskos__Concept
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D013719
% 210.13/210.28 91; was see under TYMPANIC MEMBRANE 1963-90
% 210.13/210.28 |- mesh__historyNote mesh__D013719
% 210.13/210.28 91%28%63%29%; was see under TYMPANIC MEMBRANE 1963-90
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D013719 2002
% 210.13/210.28 |- mesh__dateEstablished mesh__D013719 1991-01-01
% 210.13/210.28 |- skos__broader mesh__D018404smesh__D002875
% 210.13/210.28 |- mesh__historyNote mesh__D018404 95
% 210.13/210.28 |- mesh__dateEstablished mesh__D018404 1995-01-01
% 210.13/210.28 |- mesh__recordMaintainer mesh__D018404 nns
% 210.13/210.28 |- skos__historyNote mesh__D018404 Chromosome Aberrations %28%1966-1994%29%
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D018404 2005
% 210.13/210.28 |- mesh__recordOriginator mesh__D018404 PXP
% 210.13/210.28 |- skos__historyNote mesh__D018404 specific chromosome %28%1966-1994%29%
% 210.13/210.28 |- skos__broader mesh__D018404smesh__D002869
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D018404 2006
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D018404 2003
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D018404 95
% 210.13/210.28 |- mesh__dateRevised mesh__D018404 2002-07-03
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D018404 sjn
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D018404 2004
% 210.13/210.28 |- rdf__type mesh__D018404sskos__Concept
% 210.13/210.28 |- skos__hiddenLabel mesh__D018404 Isochromosome
% 210.13/210.28 |- skos__prefLabel mesh__D018404 Isochromosomes
% 210.13/210.28 |- skos__annotation mesh__D018404 note category
% 210.13/210.28 |- skos__scopeNote mesh__D018404
% 210.13/210.28 Metacentric chromosomes produced during MEIOSIS or MITOSIS when the CENTROMERE splits transversely instead of longitudinally. The chromosomes produced by this abnormal division are one chromosome having the two long arms of the original chromosome, but no short arms, and the other chromosome consisting of the two short arms and no long arms. Each of these isochromosomes constitutes a simultaneous duplication and deletion.%A%
% 210.13/210.28 |- mesh__dateCreated mesh__D018404 1994-01-25
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D010421 2005
% 210.13/210.28 |- skos__broader mesh__D010421smesh__D014631
% 210.13/210.28 |- skos__prefLabel mesh__D010421 Pentanoic Acids
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D010421 sjn
% 210.13/210.28 |- mesh__recordOriginator mesh__D010421 NLM
% 210.13/210.28 |- mesh__recordMaintainer mesh__D010421 ssb
% 210.13/210.28 |- mesh__dateRevised mesh__D010421 2003-07-09
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D010421 2006
% 210.13/210.28 |- mesh__dateEstablished mesh__D010421 1991-01-01
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D010421 2004
% 210.13/210.28 |- mesh__historyNote mesh__D010421
% 210.13/210.28 91%28%75%29%; was see under VALERATES 1975-90
% 210.13/210.28 |- mesh__onlineNote mesh__D010421 search VALERATES 1966-74
% 210.13/210.28 |- skos__hiddenLabel mesh__D010421 Acids, Pentanoic
% 210.13/210.28 |- rdf__type mesh__D010421sskos__Concept
% 210.13/210.28 |- mesh__dateCreated mesh__D010421 1999-01-01
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D010421
% 210.13/210.28 91; was see under VALERATES 1975-90
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D051838
% 210.13/210.28 2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTOR I was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A%
% 210.13/210.28 |- skos__broader mesh__D051838smesh__D051836
% 210.13/210.28 |- mesh__recordMaintainer mesh__D051838 DRC
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D051838 2006
% 210.13/210.28 |- skos__scopeNote mesh__D051838
% 210.13/210.28 A COUP transcription factor that was originally identified as a homodimer that binds to a direct repeat regulatory element in the chicken albumin PROMOTOR. It is a transcription factor that plays an important role in EMBRYONIC DEVELOPMENT of the CENTRAL NERVOUS SYSTEM.%A%
% 210.13/210.28 |- mesh__dateEstablished mesh__D051838 2006-01-01
% 210.13/210.28 |- rdf__type mesh__D051838sskos__Concept
% 210.13/210.28 |- mesh__dateCreated mesh__D051838 2005-06-30
% 210.13/210.28 |- mesh__recordOriginator mesh__D051838 DRC
% 210.13/210.28 |- skos__hiddenLabel mesh__D051838 COUP TFI Protein
% 210.13/210.28 |- skos__altLabel mesh__D051838 COUP-TFI Protein
% 210.13/210.28 |- skos__hiddenLabel mesh__D051838
% 210.13/210.28 Chicken Ovalbumin Upstream Promoter Transcription Factor I
% 210.13/210.28 |- skos__altLabel mesh__D051838
% 210.13/210.28 Chicken Ovalbumin Upstream Promoter-Transcription Factor I
% 210.13/210.28 |- skos__prefLabel mesh__D051838 COUP Transcription Factor I
% 210.13/210.28 |- skos__hiddenLabel mesh__D051838 ErbA Related Protein 3
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D051838 sjn
% 210.13/210.28 |- mesh__historyNote mesh__D051838 2006%28%1989%29%
% 210.13/210.28 |- skos__altLabel mesh__D051838 ErbA-Related Protein-3
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D048091 2005
% 210.13/210.28 |- skos__altLabel mesh__D048091 Regeneration, Guided Tissue
% 210.13/210.28 |- skos__broader mesh__D048091smesh__D019651
% 210.13/210.28 |- skos__hiddenLabel mesh__D048091 Tissue Regeneration, Guided
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D048091 2006
% 210.13/210.28 |- mesh__dateCreated mesh__D048091 2004-07-07
% 210.13/210.28 |- skos__prefLabel mesh__D048091 Guided Tissue Regeneration
% 210.13/210.28 |- rdf__type mesh__D048091sskos__Concept
% 210.13/210.28 |- mesh__dateEstablished mesh__D048091 2005-01-01
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D048091 2005
% 210.13/210.28 |- mesh__dateRevised mesh__D048091 2005-07-12
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D048091 ags
% 210.13/210.28 |- skos__related mesh__D048091smesh__D023822
% 210.13/210.28 |- skos__scopeNote mesh__D048091
% 210.13/210.28 Procedures for enhancing and directing tissue repair and renewal processes, such as BONE REGENERATION; NERVE REGENERATION; etc. They involve surgically implanting growth conducive tracks or conduits at the damaged site to stimulate and control of the location of cell repopulation. The tracks or conduits are made from synthetic and/or natural materials and may include support cells and induction factors for CELL GROWTH PROCESSES; or CELL MIGRATION.%A%
% 210.13/210.28 |- mesh__recordMaintainer mesh__D048091 ags
% 210.13/210.28 |- mesh__recordOriginator mesh__D048091 nns
% 210.13/210.28 |- skos__historyNote mesh__D048091
% 210.13/210.28 Guided Tissue Regeneration, Periodontal %28%1992-2004%29%
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D048091 2006A
% 210.13/210.28 |- mesh__historyNote mesh__D048091 2005
% 210.13/210.28 |- skos__related mesh__D048091smesh__D012038
% 210.13/210.28 |- skos__related mesh__D009678smesh__D011850
% 210.13/210.28 |- mesh__historyNote mesh__D009678
% 210.13/210.28 82; was ATOMIC ENERGY %28%Cat H heading only%29% 1963-81
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 2006
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D009678 82; was ATOMIC ENERGY 1963-81
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 1996
% 210.13/210.28 |- mesh__dateRevised mesh__D009678 1994-05-31
% 210.13/210.28 |- skos__prefLabel mesh__D009678 Nuclear Energy
% 210.13/210.28 |- skos__broader mesh__D009678smesh__D009686
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 2002
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 1995
% 210.13/210.28 |- skos__hiddenLabel mesh__D009678 Energy, Atomic
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 2005
% 210.13/210.28 |- mesh__dateCreated mesh__D009678 1999-01-01
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 2001
% 210.13/210.28 |- skos__scopeNote mesh__D009678
% 210.13/210.28 Energy released by nuclear fission or nuclear fusion.
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D009678 PLS
% 210.13/210.28 |- rdf__type mesh__D009678sskos__Concept
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 1999
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 2004
% 210.13/210.28 |- skos__altLabel mesh__D009678 Atomic Energy
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 2000
% 210.13/210.28 |- skos__broader mesh__D009678smesh__D004736
% 210.13/210.28 |- mesh__onlineNote mesh__D009678
% 210.13/210.28 use NUCLEAR ENERGY to search ATOMIC ENERGY 1966-81 %28%as Cat H heading%29%%A%
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 1998
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 2003
% 210.13/210.28 |- skos__annotation mesh__D009678
% 210.13/210.28 nuclear power plants: see note %26% X ref at POWER PLANTS
% 210.13/210.28 |- skos__hiddenLabel mesh__D009678 Energy, Nuclear
% 210.13/210.28 |- mesh__recordMaintainer mesh__D009678 TGC
% 210.13/210.28 |- skos__related mesh__D009678smesh__D011835
% 210.13/210.28 |- mesh__recordOriginator mesh__D009678 NLM
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D009678 1997
% 210.13/210.28 |- mesh__recordMaintainer mesh__D001695 hjn
% 210.13/210.28 |- rdf__type mesh__D001695sskos__Concept
% 210.13/210.28 |- skos__broader mesh__D001695smesh__D001690
% 210.13/210.28 |- skos__prefLabel mesh__D001695 Biology
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001695 2004
% 210.13/210.28 |- mesh__dateRevised mesh__D001695 2002-07-02
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D001695 sjn
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001695 2003
% 210.13/210.28 |- mesh__recordOriginator mesh__D001695 NLM
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001695 2006
% 210.13/210.28 |- skos__annotation mesh__D001695
% 210.13/210.28 SPEC; do not confuse with BIOLOGICAL SCIENCES which includes all the life sciences; DF: BIOL%A%
% 210.13/210.28 |- mesh__dateCreated mesh__D001695 1999-01-01
% 210.13/210.28 |- skos__scopeNote mesh__D001695
% 210.13/210.28 One of the biological sciences concerned with the origin, structure, development, growth, function, genetics, and reproduction of animals, plants, and microorganisms.%A%
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D001695 2005
% 210.13/210.28 |- skos__prefLabel mesh__D006380 Helplessness, Learned
% 210.13/210.28 |- mesh__publicMeSHNote mesh__D006380 83
% 210.13/210.28 |- skos__altLabel mesh__D006380 Learned Helplessness
% 210.13/210.28 |- mesh__recordMaintainer mesh__D006380 sjn
% 210.13/210.28 |- skos__broader mesh__D006380smesh__D003674
% 210.13/210.28 |- mesh__dateCreated mesh__D006380 1982-04-28
% 210.13/210.28 |- rdf__type mesh__D006380sskos__Concept
% 210.13/210.28 |- mesh__dateEstablished mesh__D006380 1983-01-01
% 210.13/210.28 |- mesh__dateRevised mesh__D006380 2004-07-13
% 210.13/210.28 |- skos__broader mesh__D006380smesh__D007858
% 210.13/210.28 |- skos__annotation mesh__D006380 no qualif
% 210.13/210.28 |- mesh__historyNote mesh__D006380 83
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D006380 2006
% 210.13/210.28 |- skos__scopeNote mesh__D006380
% 210.13/210.28 Learned expectation that one%27%s responses are independent of reward and, hence, do not predict or control the occurrence of rewards. Learned helplessness derives from a history, experimentally induced or naturally occurring, of having received punishment/aversive stimulation regardless of responses made. Such circumstances result in an impaired ability to learn. Used for human or animal populations. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A%
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D006380 sjn
% 210.13/210.28 |- mesh__recordOriginator mesh__D006380 EC
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D006380 2005
% 210.13/210.28 |- skos__hiddenLabel mesh__D020051 B, Arylsulfatase
% 210.13/210.28 |- mesh__recordMaintainer mesh__D020051 ssb
% 210.13/210.28 |- mesh__recordAuthorizer mesh__D020051 sjn
% 210.13/210.28 |- skos__altLabel mesh__D020051 N-Acetylgalactosamine 4-Sulfatase
% 210.13/210.28 |- skos__hiddenLabel mesh__D020051
% 210.13/210.28 Sulphatase, N-Acetylgalactosamine-4-sulphate
% 210.13/210.28 |- skos__hiddenLabel mesh__D020051 B2, Arylsulfatase
% 210.13/210.28 |- skos__hiddenLabel mesh__D020051 4-Sulfatase, N-Acetylgalactosamine
% 210.13/210.28 |- mesh__dateEstablished mesh__D020051 1999-01-01
% 210.13/210.28 |- mesh__dateRevised mesh__D020051 2003-07-09
% 210.13/210.28 |- skos__altLabel mesh__D020051 N-Acetylgalactosamine-4-sulfate Sulfatase
% 210.13/210.28 |- mesh__activeMeSHYear mesh__D020051 2004
% 210.13/210.28 |- skos__scopeNote mesh__D020051
% 210.13/210.28 An arylsulfatase that catalyzes the hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine 4-sulfate units of chondroitin sulfate and dermatan sulfate. A deficiency of this enzyme is responsible for the inherited lysosomal disease, Maroteaux-Lamy syndrome %28%MUCOPOLYSACCHARIDOSIS VI%29%. EC 3.1.6.12.%A%
% 210.13/210.28 |- skos__altLabel mesh__D020051 Arylsulfatase B
% 210.13/210.28 |- skos__hiddenLabel mesh__D020051
% 210.13/210.28 N Acetylgalactosamine 4 sulfate Sulfatase
% 210.13/210.28 |- skos__altLabel mesh__D020051 N-Acetylgalactosamine-4-sulphate Sulphatase
% 210.13/210.28 |- skos__broader mesh__D020051smesh__D001192
% 210.13/210.28 |- skos__hiddenLabel mesh__D020051
% 210.13/210.28 N Acetylgalactosamine 4 sulphate Sulphatase
% 210.13/210.28 |- mesh__historyNote mesh__D020051
% 210.13/210.28 99; for ARYLSULFATASE B use CHONDRO-4-SULFATASE 1975-98; use N-ACETYLGALACTOSAMINE-4-SULFATASE %28%NM%29% 1988-98%A%
% 210.13/210.28 |- skos__historyNote mesh__D020051 Sulfatases %28%1988-1998%29%
% 210.14/210.28 |- mesh__dateCreated mesh__D020051 1998-06-10
% 210.14/210.28 |- rdf__type mesh__D020051sskos__Concept
% 210.14/210.28 |- mesh__recordOriginator mesh__D020051 ADP
% 210.14/210.28 |- mesh__activeMeSHYear mesh__D020051 2006
% 210.14/210.28 |- skos__broader mesh__D020051smesh__D002811
% 210.14/210.28 |- skos__hiddenLabel mesh__D020051 N Acetylgalactosamine 4 Sulfatase
% 210.14/210.28 |- skos__hiddenLabel mesh__D020051 B1, Arylsulfatase
% 210.14/210.28 |- skos__prefLabel mesh__D020051 N-Acetylgalactosamine-4-Sulfatase
% 210.14/210.28 |- mesh__activeMeSHYear mesh__D020051 2005
% 210.14/210.28 |- skos__hiddenLabel mesh__D020051
% 210.14/210.28 Sulfatase, N-Acetylgalactosamine-4-sulfate
% 210.14/210.28 |- mesh__publicMeSHNote mesh__D020051
% 210.14/210.28 99; for ARYLSULFATASE B see CHONDRO-4-SULFATASE 1975-98; N-ACETYLGALACTOSAMINE-4-SULFATE SULFATASE %28%now N-ACETYLGALACTOSAMINE-4-SULFATASE%29% was indexed under SULFATASES 1988-98%A%
% 210.14/210.28 |- mesh__dateCreated mesh__D014812 1999-01-01
% 210.14/210.28 |- mesh__dateRevised mesh__D014812 2005-06-30
% 210.14/210.28 |- skos__broader mesh__D014812smesh__D009285
% 210.14/210.28 |- mesh__recordOriginator mesh__D014812 NLM
% 210.14/210.28 |- rdf__type mesh__D014812sskos__Concept
% 210.14/210.28 |- skos__prefLabel mesh__D014812 Vitamin K
% 210.14/210.28 |- mesh__recordAuthorizer mesh__D014812 sjn
% 210.14/210.28 |- skos__broader mesh__D014812smesh__D010836
% 210.14/210.28 |- skos__scopeNote mesh__D014812
% 210.14/210.28 A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 %28%VITAMIN K 1%29% derived from plants, VITAMIN K 2 %28%menaquinone%29% from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 %28%menadione%29%. Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.%A%
% 210.14/210.28 |- mesh__recordMaintainer mesh__D014812 ssb
% 210.14/210.28 |- skos__annotation mesh__D014812
% 210.14/210.28 /ther use: coordinate disease with /drug ther, not /diet ther%A%
% 210.14/210.28 |- mesh__activeMeSHYear mesh__D014812 2006
% 210.14/210.28 |- mesh__historyNote mesh__D014014 65%28%63%29%
% 210.14/210.29 |- mesh__dateRevised mesh__D014014 2000-06-21
% 210.14/210.29 |- mesh__recordMaintainer mesh__D014014 nns
% 210.14/210.29 |- skos__annotation mesh__D014014
% 210.14/210.29 IM; coord with specific substance used as adhesive if pertinent %28%IM%29%; D25-26 qualif%A%
% 210.14/210.29 |- skos__hiddenLabel mesh__D014014 Adhesives, Tissue
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D014014 sjn
% 210.14/210.29 |- rdf__type mesh__D014014sskos__Concept
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D014014 65
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014014 2002
% 210.14/210.29 |- mesh__dateCreated mesh__D014014 1999-01-01
% 210.14/210.29 |- skos__related mesh__D014014smesh__D001843
% 210.14/210.29 |- skos__hiddenLabel mesh__D014014 Adhesive, Tissue
% 210.14/210.29 |- skos__broader mesh__D014014smesh__D001697
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014014 2004
% 210.14/210.29 |- mesh__recordOriginator mesh__D014014 NLM
% 210.14/210.29 |- skos__hiddenLabel mesh__D014014 Tissue Adhesive
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014014 2001
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014014 2006
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014014 2003
% 210.14/210.29 |- mesh__dateEstablished mesh__D014014 1965-01-01
% 210.14/210.29 |- skos__scopeNote mesh__D014014
% 210.14/210.29 Substances used to cause adherence of tissue to tissue or tissue to non-tissue surfaces, as for prostheses.%A%
% 210.14/210.29 |- skos__prefLabel mesh__D014014 Tissue Adhesives
% 210.14/210.29 |- skos__broader mesh__D014014smesh__D013523
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014014 2005
% 210.14/210.29 |- rdf__type mesh__D005288sskos__Concept
% 210.14/210.29 |- skos__altLabel mesh__D005288 Ferredoxin
% 210.14/210.29 |- mesh__historyNote mesh__D005288 66%28%64%29%
% 210.14/210.29 |- mesh__dateCreated mesh__D005288 1999-01-01
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D005288 sjn
% 210.14/210.29 |- skos__hiddenLabel mesh__D005288 III, Ferredoxin
% 210.14/210.29 |- skos__scopeNote mesh__D005288
% 210.14/210.29 Iron-containing proteins that transfer electrons, usually at a low potential, to flavoproteins; the iron is not present as in heme. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D005288 2006
% 210.14/210.29 |- mesh__dateEstablished mesh__D005288 1966-01-01
% 210.14/210.29 |- skos__annotation mesh__D005288
% 210.14/210.29 bact %26% plant proteins; /drug eff /ultrastruct permitted
% 210.14/210.29 |- skos__broader mesh__D005288smesh__D007506
% 210.14/210.29 |- mesh__recordOriginator mesh__D005288 NLM
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D005288 66
% 210.14/210.29 |- skos__prefLabel mesh__D005288 Ferredoxins
% 210.14/210.29 |- mesh__dateRevised mesh__D005288 2005-06-30
% 210.14/210.29 |- mesh__recordMaintainer mesh__D005288 SYSTEM
% 210.14/210.29 |- skos__broader mesh__D005288smesh__D010940
% 210.14/210.29 |- skos__broader mesh__D005288smesh__D001426
% 210.14/210.29 |- skos__broader mesh__D004798Q000037smesh__D004798
% 210.14/210.29 |- mesh__preferredCombination mesh__D004798Q000037smesh__D004791
% 210.14/210.29 |- rdf__type mesh__D004798Q000037smesh__CompoundConcept
% 210.14/210.29 |- mesh__dateEstablished mesh__D024442 2002-01-01
% 210.14/210.29 |- mesh__recordMaintainer mesh__D024442 ags
% 210.14/210.29 |- skos__hiddenLabel mesh__D024442 Mitochondrial Aspartate Aminotransferase
% 210.14/210.29 |- skos__prefLabel mesh__D024442 Aspartate Aminotransferase, Mitochondrial
% 210.14/210.29 |- skos__broader mesh__D024442smesh__D001219
% 210.14/210.29 |- skos__annotation mesh__D024442
% 210.14/210.29 ASPARTATE AMINOTRANSFERASE, CYTOPLASMIC is also available%A%
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D024442 2004
% 210.14/210.29 |- skos__historyNote mesh__D024442
% 210.14/210.29 Aspartate Aminotransferases %28%1968-2001%29%
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D024442 ags
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D024442 2002
% 210.14/210.29 |- mesh__dateRevised mesh__D024442 2005-07-08
% 210.14/210.29 |- skos__hiddenLabel mesh__D024442 Oxaloacetate Transaminase-2, Glutamate
% 210.14/210.29 |- skos__hiddenLabel mesh__D024442
% 210.14/210.29 Aminotransferase, Mitochondrial Aspartate
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D024442 2006A
% 210.14/210.29 |- mesh__recordOriginator mesh__D024442 jmp
% 210.14/210.29 |- mesh__dateCreated mesh__D024442 2001-07-25
% 210.14/210.29 |- mesh__historyNote mesh__D024442 2002
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D024442 2006
% 210.14/210.29 |- skos__hiddenLabel mesh__D024442 Transaminase-2, Glutamate Oxaloacetate
% 210.14/210.29 |- skos__scopeNote mesh__D024442
% 210.14/210.29 An aspartate aminotransferase found in MITOCHONDRIA.
% 210.14/210.29 |- skos__altLabel mesh__D024442 Glutamate Oxaloacetate Transaminase-2
% 210.14/210.29 |- rdf__type mesh__D024442sskos__Concept
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D024442 2005
% 210.14/210.29 |- skos__hiddenLabel mesh__D024442 Glutamate Oxaloacetate Transaminase 2
% 210.14/210.29 |- skos__hiddenLabel mesh__D010422 Ketones, Methyl Propyl
% 210.14/210.29 |- skos__broader mesh__D010422smesh__D007659
% 210.14/210.29 |- skos__hiddenLabel mesh__D010422 Ketones, Diethyl
% 210.14/210.29 |- mesh__historyNote mesh__D010422
% 210.14/210.29 91%28%75%29%; was see under KETONES 1975-90
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010422 2001
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010422 2006
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D010422 sjn
% 210.14/210.29 |- skos__scopeNote mesh__D010422
% 210.14/210.29 5-carbon straight-chain or branched-chain ketones.
% 210.14/210.29 |- skos__prefLabel mesh__D010422 Pentanones
% 210.14/210.29 |- mesh__recordOriginator mesh__D010422 NLM
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010422 2004
% 210.14/210.29 |- mesh__dateCreated mesh__D010422 1974-11-11
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010422 2005
% 210.14/210.29 |- skos__hiddenLabel mesh__D010422 Propyl Ketones, Methyl
% 210.14/210.29 |- mesh__dateEstablished mesh__D010422 1991-01-01
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010422 2003
% 210.14/210.29 |- mesh__recordMaintainer mesh__D010422 CCR
% 210.14/210.29 |- skos__historyNote mesh__D010422 Ketones %28%1966-1974%29%
% 210.14/210.29 |- rdf__type mesh__D010422sskos__Concept
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010422 2002
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D010422 91; was see under KETONES 1975-90
% 210.14/210.29 |- mesh__dateRevised mesh__D010422 2000-06-22
% 210.14/210.29 |- rdf__type mesh__D051839sskos__Concept
% 210.14/210.29 |- skos__hiddenLabel mesh__D051839 Nuclear Factor I X
% 210.14/210.29 |- skos__hiddenLabel mesh__D051839 Nuclear Factor I C
% 210.14/210.29 |- skos__scopeNote mesh__D051839
% 210.14/210.29 Transcription factors that were originally identified as site-specific DNA-binding proteins essential for DNA REPLICATION by ADENOVIRUSES. They play important roles in MAMMARY GLAND function and development.%A%
% 210.14/210.29 |- skos__hiddenLabel mesh__D051839 Transcription Factors, NFI
% 210.14/210.29 |- skos__hiddenLabel mesh__D051839 Nuclear Factor 1
% 210.14/210.29 |- skos__altLabel mesh__D051839 Nuclear Factor-1
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D051839 sjn
% 210.14/210.29 |- mesh__historyNote mesh__D051839 2006%28%1984%29%
% 210.14/210.29 |- skos__hiddenLabel mesh__D051839 Nuclear Factor I B
% 210.14/210.29 |- mesh__recordOriginator mesh__D051839 DRC
% 210.14/210.29 |- mesh__recordMaintainer mesh__D051839 DRC
% 210.14/210.29 |- skos__hiddenLabel mesh__D051839 TGGCA Binding Protein
% 210.14/210.29 |- mesh__dateEstablished mesh__D051839 2006-01-01
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D051839
% 210.14/210.29 2006; NFI TRANSCRIPTION FACTORS was indexed under TRANSCRIPTION FACTORS 1984-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2005, %26% under DNA-BINDING PROTEINS 1986-2004%A%
% 210.14/210.29 |- skos__altLabel mesh__D051839 CAAT Box Transcription Factor
% 210.14/210.29 |- mesh__dateCreated mesh__D051839 2005-06-30
% 210.14/210.29 |- skos__altLabel mesh__D051839 Nuclear Factor I
% 210.14/210.29 |- skos__prefLabel mesh__D051839 NFI Transcription Factors
% 210.14/210.29 |- skos__broader mesh__D051839smesh__D004268
% 210.14/210.29 |- skos__altLabel mesh__D051839 TGGCA-Binding Protein
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D051839 2006
% 210.14/210.29 |- skos__broader mesh__D051839smesh__D014157
% 210.14/210.29 |- skos__hiddenLabel mesh__D051839 Nuclear Factor I A
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D009679 2005
% 210.14/210.29 |- mesh__historyNote mesh__D009679
% 210.14/210.29 91%28%75%29%; was see under FAMILY 1975-90
% 210.14/210.29 |- mesh__dateCreated mesh__D009679 1974-11-11
% 210.14/210.29 |- mesh__onlineNote mesh__D009679
% 210.14/210.29 use FAMILY to search DAUGHTERS 1991, SIBLINGS 1991, SONS 1980-91%A%
% 210.14/210.29 |- mesh__recordOriginator mesh__D009679 NLM
% 210.14/210.29 |- rdf__type mesh__D009679sskos__Concept
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D009679 sjn
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D009679 2004
% 210.14/210.29 |- mesh__dateRevised mesh__D009679 2002-07-03
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D009679 91; was see under FAMILY 1975-90
% 210.14/210.29 |- skos__prefLabel mesh__D009679 Nuclear Family
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D009679 2003
% 210.14/210.29 |- skos__hiddenLabel mesh__D009679 Family, Nuclear
% 210.14/210.29 |- mesh__recordMaintainer mesh__D009679 hjn
% 210.14/210.29 |- skos__hiddenLabel mesh__D009679 Son
% 210.14/210.29 |- mesh__dateEstablished mesh__D009679 1991-01-01
% 210.14/210.29 |- skos__annotation mesh__D009679
% 210.14/210.29 parents %26% children: does not include grandparents
% 210.14/210.29 |- skos__broader mesh__D009679smesh__D005190
% 210.14/210.29 |- skos__hiddenLabel mesh__D009679 Families, Nuclear
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D009679 2006
% 210.14/210.29 |- skos__hiddenLabel mesh__D009679 Nuclear Families
% 210.14/210.29 |- skos__hiddenLabel mesh__D009679 Daughter
% 210.14/210.29 |- skos__scopeNote mesh__D009679
% 210.14/210.29 A family composed of spouses and their children.
% 210.14/210.29 |- mesh__recordOriginator mesh__D001696 NLM
% 210.14/210.29 |- rdf__type mesh__D001696sskos__Concept
% 210.14/210.29 |- mesh__dateEstablished mesh__D001696 1968-01-01
% 210.14/210.29 |- mesh__recordMaintainer mesh__D001696 nns
% 210.14/210.29 |- skos__prefLabel mesh__D001696 Biomechanics
% 210.14/210.29 |- mesh__dateRevised mesh__D001696 2003-07-09
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D001696 2004
% 210.14/210.29 |- mesh__dateCreated mesh__D001696 1999-01-01
% 210.14/210.29 |- skos__broader mesh__D001696smesh__D001703
% 210.14/210.29 |- skos__annotation mesh__D001696 usually NIM
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D001696 2005
% 210.14/210.29 |- skos__scopeNote mesh__D001696
% 210.14/210.29 The study of the application of mechanical laws and the action of forces to living structures.%A%
% 210.14/210.29 |- skos__historyNote mesh__D001696 Biophysics %28%1966-1967%29%
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D001696 68
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D001696 2006
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D001696 sjn
% 210.14/210.29 |- mesh__historyNote mesh__D001696 68
% 210.14/210.29 |- skos__scopeNote mesh__D006381
% 210.14/210.29 An international agreement of the World Medical Association which offers guidelines for conducting experiments using human subjects. It was adopted in 1962 and revised by the 18th World Medical Assembly at Helsinki, Finland in 1964. Subsequent revisions were made in 1975, 1983, 1989, and 1996. %28%From Encyclopedia of Bioethics, rev ed, 1995%29%%A%
% 210.14/210.29 |- mesh__dateRevised mesh__D006381 2004-07-13
% 210.14/210.29 |- skos__prefLabel mesh__D006381 Helsinki Declaration
% 210.14/210.29 |- rdf__type mesh__D006381sskos__Concept
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D006381 sjn
% 210.14/210.29 |- skos__hiddenLabel mesh__D006381 Declaration, Helsinki
% 210.14/210.29 |- mesh__dateCreated mesh__D006381 1999-01-01
% 210.14/210.29 |- skos__related mesh__D006381smesh__D006805
% 210.14/210.29 |- mesh__onlineNote mesh__D006381 search ETHICS, MEDICAL 1969-74
% 210.14/210.29 |- skos__altLabel mesh__D006381 Declaration of Helsinki
% 210.14/210.29 |- mesh__recordMaintainer mesh__D006381 sjn
% 210.14/210.29 |- skos__broader mesh__D006381smesh__D032984
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006381 2005
% 210.14/210.29 |- mesh__recordOriginator mesh__D006381 NLM
% 210.14/210.29 |- skos__hiddenLabel mesh__D006381 Helsinki Declarations
% 210.14/210.29 |- mesh__dateEstablished mesh__D006381 1991-01-01
% 210.14/210.29 |- skos__broader mesh__D006381smesh__D032781
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006381 2006
% 210.14/210.29 |- mesh__historyNote mesh__D006381
% 210.14/210.29 91%28%75%29%; was see under ETHICS, MEDICAL 1975-90
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D006381
% 210.14/210.29 91; was see under ETHICS, MEDICAL 1975-90
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014813 2004
% 210.14/210.29 |- skos__broader mesh__D014813smesh__D001361
% 210.14/210.29 |- rdf__type mesh__D014813sskos__Concept
% 210.14/210.29 |- skos__broader mesh__D014813smesh__D001778
% 210.14/210.29 |- skos__hiddenLabel mesh__D014813 Vitamin K Deficiencies
% 210.14/210.29 |- skos__broader mesh__D014813smesh__D006474
% 210.14/210.29 |- skos__scopeNote mesh__D014813
% 210.14/210.29 A nutritional condition produced by a deficiency of VITAMIN K in the diet, characterized by an increased tendency to hemorrhage %28%HEMORRHAGIC DISORDERS%29%. Such bleeding episodes may be particularly severe in newborn infants. %28%From Cecil Textbook of Medicine, 19th ed, p1182%29%%A%
% 210.14/210.29 |- skos__annotation mesh__D014813 DF: VITAMIN K DEFIC
% 210.14/210.29 |- mesh__dateRevised mesh__D014813 2003-07-09
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014813 2005
% 210.14/210.29 |- mesh__recordOriginator mesh__D014813 NLM
% 210.14/210.29 |- skos__altLabel mesh__D014813 Deficiency, Vitamin K
% 210.14/210.29 |- mesh__recordMaintainer mesh__D014813 lkt
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014813 2006
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D014813 sjn
% 210.14/210.29 |- skos__hiddenLabel mesh__D014813 Deficiencies, Vitamin K
% 210.14/210.29 |- mesh__dateCreated mesh__D014813 1999-01-01
% 210.14/210.29 |- skos__prefLabel mesh__D014813 Vitamin K Deficiency
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 1994
% 210.14/210.29 |- mesh__recordOriginator mesh__D014015 NLM
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 2001
% 210.14/210.29 |- skos__annotation mesh__D014015
% 210.14/210.29 GEN or unspecified for tissues or organs: prefer specifics; coord IM with specific organ or tissue %28%IM%29%%A%
% 210.14/210.29 |- mesh__dateCreated mesh__D014015 1999-01-01
% 210.14/210.29 |- mesh__recordMaintainer mesh__D014015 PLS
% 210.14/210.29 |- skos__hiddenLabel mesh__D014015 Tissue Bank
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 2004
% 210.14/210.29 |- skos__scopeNote mesh__D014015
% 210.14/210.29 Centers for acquiring, characterizing, and storing organs or tissue for future use.%A%
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 2000
% 210.14/210.29 |- skos__hiddenLabel mesh__D014015 Banking, Tissue
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 2006
% 210.14/210.29 |- mesh__dateRevised mesh__D014015 1993-11-29
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 2003
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 2005
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 1997
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 1999
% 210.14/210.29 |- skos__hiddenLabel mesh__D014015 Banks, Tissue
% 210.14/210.29 |- skos__prefLabel mesh__D014015 Tissue Banks
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 1996
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 1995
% 210.14/210.29 |- rdf__type mesh__D014015sskos__Concept
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D014015 PLS
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 2002
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014015 1998
% 210.14/210.29 |- skos__hiddenLabel mesh__D014015 Bank, Tissue
% 210.14/210.29 |- skos__broader mesh__D014015smesh__D018070
% 210.14/210.29 |- mesh__dateCreated mesh__D005289 1974-12-12
% 210.14/210.29 |- skos__altLabel mesh__D005289 European Polecats
% 210.14/210.29 |- skos__hiddenLabel mesh__D005289 Polecat, Domestic
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D005289 2006
% 210.14/210.29 |- mesh__dateRevised mesh__D005289 2004-07-07
% 210.14/210.29 |- skos__hiddenLabel mesh__D005289 Domestic Polecat
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D005289 sjn
% 210.14/210.29 |- mesh__historyNote mesh__D005289
% 210.14/210.29 91%28%75%29%; was see under CARNIVORA 1975-90
% 210.14/210.29 |- skos__broader mesh__D005289smesh__D045969
% 210.14/210.29 |- mesh__recordMaintainer mesh__D005289 ags
% 210.14/210.29 |- skos__scopeNote mesh__D005289
% 210.14/210.29 Semidomesticated variety of European polecat much used for hunting RODENTS and/or RABBITS and as a laboratory animal. It is in the subfamily Mustelinae, family MUSTELIDAE.%A%
% 210.14/210.29 |- skos__hiddenLabel mesh__D005289 Polecats, Domestic
% 210.14/210.29 |- mesh__recordOriginator mesh__D005289 NLM
% 210.14/210.29 |- mesh__dateEstablished mesh__D005289 1991-01-01
% 210.14/210.29 |- skos__hiddenLabel mesh__D005289 Polecats, European
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D005289
% 210.14/210.29 91; was see under CARNIVORA 1975-90
% 210.14/210.29 |- skos__hiddenLabel mesh__D005289 Ferret
% 210.14/210.29 |- rdf__type mesh__D005289sskos__Concept
% 210.14/210.29 |- skos__altLabel mesh__D005289 Mustela putorius furo
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D005289 2005
% 210.14/210.29 |- skos__prefLabel mesh__D005289 Ferrets
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D024443 2004
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D024443 ags
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D024443 2002
% 210.14/210.29 |- skos__annotation mesh__D024443
% 210.14/210.29 ASPARTATE AMINOTRANSFERASE, MITOCHONDRIAL is also available%A%
% 210.14/210.29 |- skos__hiddenLabel mesh__D024443 Oxaloacetate-Transaminase-1, Glutamate
% 210.14/210.29 |- mesh__dateRevised mesh__D024443 2005-07-08
% 210.14/210.29 |- skos__historyNote mesh__D024443
% 210.14/210.29 Aspartate Aminotransferases %28%1972-2001%29%
% 210.14/210.29 |- skos__altLabel mesh__D024443 Glutamate Oxaloacetate-Transaminase-1
% 210.14/210.29 |- skos__scopeNote mesh__D024443
% 210.14/210.29 An aspartate aminotransferase found in the CYTOPLASM.
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D024443 2006
% 210.14/210.29 |- skos__broader mesh__D024443smesh__D001219
% 210.14/210.29 |- skos__hiddenLabel mesh__D024443 Cytoplasmic Aspartate Aminotransferase
% 210.14/210.29 |- rdf__type mesh__D024443sskos__Concept
% 210.14/210.29 |- skos__prefLabel mesh__D024443 Aspartate Aminotransferase, Cytoplasmic
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D024443 2005
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D024443 2006A
% 210.14/210.29 |- mesh__recordOriginator mesh__D024443 jmp
% 210.14/210.29 |- mesh__dateCreated mesh__D024443 2001-07-25
% 210.14/210.29 |- mesh__historyNote mesh__D024443 2002
% 210.14/210.29 |- skos__hiddenLabel mesh__D024443 Aminotransferase, Cytoplasmic Aspartate
% 210.14/210.29 |- mesh__dateEstablished mesh__D024443 2002-01-01
% 210.14/210.29 |- mesh__recordMaintainer mesh__D024443 ags
% 210.14/210.29 |- mesh__dateCreated mesh__D018406 1994-01-25
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D018406 1999
% 210.14/210.29 |- skos__altLabel mesh__D018406 Physiology, Viral
% 210.14/210.29 |- mesh__recordMaintainer mesh__D018406 NNS
% 210.14/210.29 |- skos__hiddenLabel mesh__D018406 Viral Physiologies
% 210.14/210.29 |- skos__historyNote mesh__D018406 Viruses/physiology %28%1966-1997%29%
% 210.14/210.29 |- mesh__dateRevised mesh__D018406 1998-06-11
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D018406 SJN
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D018406 2002
% 210.14/210.29 |- skos__annotation mesh__D018406
% 210.14/210.29 GEN or unspecified; prefer specifics; DF: VIRAL PHYSIOL
% 210.14/210.29 |- mesh__recordOriginator mesh__D018406 PXP
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D018406 2004
% 210.14/210.29 |- mesh__dateEstablished mesh__D018406 1998-01-01
% 210.14/210.29 |- skos__related mesh__D018406smesh__D005827
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D018406 2001
% 210.14/210.29 |- skos__scopeNote mesh__D018406
% 210.14/210.29 Biological processes and activities of viruses.
% 210.14/210.29 |- skos__related mesh__D018406smesh__D008827
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D018406 2006
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D018406 98
% 210.14/210.29 |- mesh__historyNote mesh__D018406 98; use explode 1995-97
% 210.14/210.29 |- skos__prefLabel mesh__D018406 Viral Physiology
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D018406 2003
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D018406 2000
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D018406 2005
% 210.14/210.29 |- skos__broader mesh__D018406smesh__D008827
% 210.14/210.29 |- rdf__type mesh__D018406sskos__Concept
% 210.14/210.29 |- skos__hiddenLabel mesh__D018406 Physiologies, Viral
% 210.14/210.29 |- skos__hiddenLabel mesh__D010423 Hydrochloride, Pentazocine
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010423 2002
% 210.14/210.29 |- mesh__recordMaintainer mesh__D010423 TWD
% 210.14/210.29 |- skos__prefLabel mesh__D010423 Pentazocine
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010423 2006
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010423 2004
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010423 2005
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010423 2001
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D010423 2003
% 210.14/210.29 |- skos__broader mesh__D010423smesh__D001575
% 210.14/210.29 |- skos__scopeNote mesh__D010423
% 210.14/210.29 The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. %28%From AMA Drug Evaluations Annual, 1991, p97%29%%A%
% 210.14/210.29 |- rdf__type mesh__D010423sskos__Concept
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D010423 sjn
% 210.14/210.29 |- mesh__recordOriginator mesh__D010423 NLM
% 210.14/210.29 |- mesh__dateRevised mesh__D010423 2000-06-22
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D010423 66
% 210.14/210.29 |- mesh__dateEstablished mesh__D010423 1966-01-01
% 210.14/210.29 |- mesh__dateCreated mesh__D010423 1999-01-01
% 210.14/210.29 |- mesh__historyNote mesh__D010423 66%28%64%29%
% 210.14/210.29 |- skos__hiddenLabel mesh__D010423 Lactate, Pentazocine
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D001697 2003
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D001697 sjn
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D001697 2004
% 210.14/210.29 |- mesh__recordOriginator mesh__D001697 NLM
% 210.14/210.29 |- mesh__dateCreated mesh__D001697 1999-01-01
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D001697 98
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D001697 2005
% 210.14/210.29 |- skos__scopeNote mesh__D001697
% 210.14/210.29 Substances used in biomedicine or dentistry predominantly for their physical, as opposed to chemical, properties.%A%
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D001697 2001
% 210.14/210.29 |- skos__prefLabel mesh__D001697 Biomedical and Dental Materials
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D001697 2006
% 210.14/210.29 |- mesh__recordMaintainer mesh__D001697 jls
% 210.14/210.29 |- mesh__dateEstablished mesh__D001697 1998-01-01
% 210.14/210.29 |- skos__annotation mesh__D001697
% 210.14/210.29 GEN; prefer specifics; used for mapping supplementary chemicals%A%
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D001697 2002
% 210.14/210.29 |- mesh__historyNote mesh__D001697 98; use explode 1974-97
% 210.14/210.29 |- rdf__type mesh__D001697sskos__Concept
% 210.14/210.29 |- mesh__runningHead mesh__D001697 D25 - BIOMEDICAL AND DENTAL MATERIALS
% 210.14/210.29 |- mesh__dateRevised mesh__D001697 2000-06-22
% 210.14/210.29 |- skos__historyNote mesh__D006382 Hemagglutination %28%1966-1969%29%
% 210.14/210.29 |- rdf__type mesh__D006382sskos__Concept
% 210.14/210.29 |- skos__hiddenLabel mesh__D006382 Hemadsorptions
% 210.14/210.29 |- skos__scopeNote mesh__D006382
% 210.14/210.29 A phenomenon manifested by an agent or substance adhering to or being adsorbed on the surface of a red blood cell, as tuberculin can be adsorbed on red blood cells under certain conditions. %28%Stedman, 25th ed%29%%A%
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006382 1999
% 210.14/210.29 |- mesh__dateCreated mesh__D006382 1999-01-01
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006382 2004
% 210.14/210.29 |- mesh__dateEstablished mesh__D006382 1972-01-01
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006382 2000
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006382 2005
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006382 2001
% 210.14/210.29 |- skos__annotation mesh__D006382
% 210.14/210.29 do not confuse with HEMOSORPTION see HEMOPERFUSION
% 210.14/210.29 |- skos__prefLabel mesh__D006382 Hemadsorption
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006382 2006
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D006382 72
% 210.14/210.29 |- mesh__historyNote mesh__D006382 72%28%70%29%
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006382 2002
% 210.14/210.29 |- skos__broader mesh__D006382smesh__D008827
% 210.14/210.29 |- mesh__recordOriginator mesh__D006382 NLM
% 210.14/210.29 |- mesh__recordMaintainer mesh__D006382 TGC
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006382 1998
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D006382 SJN
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D006382 2003
% 210.14/210.29 |- mesh__dateRevised mesh__D006382 1997-06-20
% 210.14/210.29 |- mesh__dateCreated mesh__D014814 1976-04-13
% 210.14/210.29 |- mesh__recordMaintainer mesh__D014814 ssb
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D014814 sjn
% 210.14/210.29 |- mesh__historyNote mesh__D014814
% 210.14/210.29 91%28%77%29%; was see under VITAMINS 1977-90
% 210.14/210.29 |- skos__hiddenLabel mesh__D014814 Chloride, Methylmethioninesulfonium
% 210.14/210.29 |- skos__historyNote mesh__D014814 Vitamins %28%1973-1976%29%
% 210.14/210.29 |- skos__scopeNote mesh__D014814
% 210.14/210.29 A vitamin found in green vegetables. It is used in the treatment of peptic ulcers, colitis, and gastritis and has an effect on secretory, acid-forming, and enzymatic functions of the intestinal tract.%A%
% 210.14/210.29 |- skos__historyNote mesh__D014814 Methionine %28%1973-1976%29%
% 210.14/210.29 |- skos__hiddenLabel mesh__D014814 Methylsulfonium Chloride, Methionine
% 210.14/210.29 |- skos__altLabel mesh__D014814 Methionine Methylsulfonium Chloride
% 210.14/210.29 |- rdf__type mesh__D014814sskos__Concept
% 210.14/210.29 |- skos__broader mesh__D014814smesh__D008715
% 210.14/210.29 |- skos__hiddenLabel mesh__D014814 Chloride, Methionine Methylsulfonium
% 210.14/210.29 |- skos__annotation mesh__D014814
% 210.14/210.29 /ther use: coordinate disease with /drug ther, not /diet ther%A%
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D014814 91; was see under VITAMINS 1977-90
% 210.14/210.29 |- skos__hiddenLabel mesh__D014814 S Methylmethionine
% 210.14/210.29 |- skos__prefLabel mesh__D014814 Vitamin U
% 210.14/210.29 |- mesh__dateEstablished mesh__D014814 1991-01-01
% 210.14/210.29 |- skos__altLabel mesh__D014814 Methylmethioninesulfonium Chloride
% 210.14/210.29 |- mesh__recordOriginator mesh__D014814 RLS
% 210.14/210.29 |- mesh__dateRevised mesh__D014814 2005-06-30
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014814 2006
% 210.14/210.29 |- mesh__historyNote mesh__D014016 72%28%68%29%
% 210.14/210.29 |- mesh__dateCreated mesh__D014016 1999-01-01
% 210.14/210.29 |- skos__annotation mesh__D014016 DF: TISSUE CONDITIONING
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014016 2004
% 210.14/210.29 |- mesh__recordAuthorizer mesh__D014016 PLS
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014016 2002
% 210.14/210.29 |- skos__altLabel mesh__D014016 Conditioning, Dental Tissue
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014016 2006
% 210.14/210.29 |- mesh__publicMeSHNote mesh__D014016 72
% 210.14/210.29 |- skos__altLabel mesh__D014016 Tissue Conditioning, Dental
% 210.14/210.29 |- mesh__recordOriginator mesh__D014016 NLM
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014016 2003
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014016 2001
% 210.14/210.29 |- skos__prefLabel mesh__D014016 Tissue Conditioning %28%Dental%29%
% 210.14/210.29 |- mesh__activeMeSHYear mesh__D014016 2005
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014016 1997
% 210.14/210.30 |- skos__scopeNote mesh__D014016
% 210.14/210.30 The use of a treatment material %28%tissue conditioner%29% to re-establish tone and health to irritated oral soft tissue, usually applied to the edentulous alveolar ridge.%A%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014016 1999
% 210.14/210.30 |- mesh__recordMaintainer mesh__D014016 TAP
% 210.14/210.30 |- skos__altLabel mesh__D014016 Dental Tissue Conditioning
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014016 2000
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014016 1993
% 210.14/210.30 |- skos__historyNote mesh__D014016 Prosthodontics %28%1966-1967%29%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014016 1996
% 210.14/210.30 |- mesh__dateEstablished mesh__D014016 1972-01-01
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014016 1995
% 210.14/210.30 |- rdf__type mesh__D014016sskos__Concept
% 210.14/210.30 |- skos__hiddenLabel mesh__D014016 Conditioning, Tissue %28%Dental%29%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014016 1998
% 210.14/210.30 |- skos__hiddenLabel mesh__D014016 Conditionings, Tissue %28%Dental%29%
% 210.14/210.30 |- skos__hiddenLabel mesh__D014016 Tissue Conditionings %28%Dental%29%
% 210.14/210.30 |- mesh__dateRevised mesh__D014016 1992-05-18
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014016 1994
% 210.14/210.30 |- skos__broader mesh__D014016smesh__D011476
% 210.14/210.30 |- skos__historyNote mesh__D014016 Periodontics %28%1966-1967%29%
% 210.14/210.30 |- mesh__dateCreated mesh__D030481 2001-07-25
% 210.14/210.30 |- skos__prefLabel mesh__D030481 Pyruvate Dehydrogenase %28%Lipoamide%29%
% 210.14/210.30 |- skos__historyNote mesh__D030481
% 210.14/210.30 Pyruvate Dehydrogenase Complex %28%1983-2001%29%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D030481 2006
% 210.14/210.30 |- skos__broader mesh__D030481smesh__D007658
% 210.14/210.30 |- skos__scopeNote mesh__D030481
% 210.14/210.30 The E1 component of the multienzyme PYRUVATE DEHYDROGENASE COMPLEX. It is composed of 2 alpha subunits %28%pyruvate dehydrogenase E1 alpha subunit%29% and 2 beta subunits %28%pyruvate dehydrogenase E1 beta subunit%29%.%A%
% 210.14/210.30 |- mesh__dateEstablished mesh__D030481 2002-01-01
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D030481 sjn
% 210.14/210.30 |- mesh__recordOriginator mesh__D030481 nns
% 210.14/210.30 |- mesh__dateRevised mesh__D030481 2005-06-30
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D030481
% 210.14/210.30 2002; PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29% was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1983-2001%A%
% 210.14/210.30 |- skos__altLabel mesh__D030481 Pyruvate Dehydrogenase-E1
% 210.14/210.30 |- skos__altLabel mesh__D030481 Pyruvate Decarboxylase %28%Lipoamide%29%
% 210.14/210.30 |- mesh__recordMaintainer mesh__D030481 jmp
% 210.14/210.30 |- skos__broader mesh__D030481smesh__D011768
% 210.14/210.30 |- mesh__historyNote mesh__D030481
% 210.14/210.30 2002; use PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29% %28%NM%29% 1983-2001%A%
% 210.14/210.30 |- skos__hiddenLabel mesh__D030481 Pyruvate Dehydrogenase E1
% 210.14/210.30 |- skos__altLabel mesh__D030481 Pyruvate Dehydrogenase Component E1
% 210.14/210.30 |- rdf__type mesh__D030481sskos__Concept
% 210.14/210.30 |- skos__altLabel mesh__D002790 CYP 7A
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D002790 2005
% 210.14/210.30 |- mesh__historyNote mesh__D002790 2003 %28%1975%29%
% 210.14/210.30 |- skos__prefLabel mesh__D002790 Cholesterol 7-alpha-Hydroxylase
% 210.14/210.30 |- skos__broader mesh__D002790smesh__D013250
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D002790 2006
% 210.14/210.30 |- mesh__dateCreated mesh__D002790 1974-11-19
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D002790 sjn
% 210.14/210.30 |- skos__altLabel mesh__D002790 Cholesterol 7alpha-Hydroxylase
% 210.14/210.30 |- skos__altLabel mesh__D002790 Cytochrome P-450 CYP7
% 210.14/210.30 |- skos__hiddenLabel mesh__D002790 Cholesterol 7alpha Hydroxylase
% 210.14/210.30 |- skos__altLabel mesh__D002790 CYP7
% 210.14/210.30 |- mesh__dateRevised mesh__D002790 2004-07-07
% 210.14/210.30 |- mesh__recordOriginator mesh__D002790 NLM
% 210.14/210.30 |- skos__altLabel mesh__D002790 Cholesterol 7-alpha-Monooxygenase
% 210.14/210.30 |- skos__hiddenLabel mesh__D002790 Cholesterol 7 alpha Hydroxylase
% 210.14/210.30 |- skos__altLabel mesh__D002790 Cytochrome P450 7
% 210.14/210.30 |- skos__scopeNote mesh__D002790
% 210.14/210.30 A membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS.%A%
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D002790
% 210.14/210.30 2003; see CHOLESTEROL 7 ALPHA-MONOOXYGENASE 1997-2002, see CHOLESTEROL-7-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1975-1990%A%
% 210.14/210.30 |- skos__hiddenLabel mesh__D002790 Cholesterol 7 alpha Monooxygenase
% 210.14/210.30 |- skos__historyNote mesh__D002790 Steroid Hydroxylases %28%1974%29%
% 210.14/210.30 |- mesh__recordMaintainer mesh__D002790 ssb
% 210.14/210.30 |- mesh__dateEstablished mesh__D002790 1991-01-01
% 210.14/210.30 |- skos__altLabel mesh__D002790 CYP 7
% 210.14/210.30 |- skos__altLabel mesh__D002790 CYP7A
% 210.14/210.30 |- skos__historyNote mesh__D002790 Cholesterol %28%1974%29%
% 210.14/210.30 |- skos__hiddenLabel mesh__D002790 Cholesterol 7 Hydroxylase
% 210.14/210.30 |- rdf__type mesh__D002790sskos__Concept
% 210.14/210.30 |- skos__hiddenLabel mesh__D002790 Cytochrome P 450 CYP7
% 210.14/210.30 |- skos__altLabel mesh__D002790 Cholesterol-7-Hydroxylase
% 210.14/210.30 |- skos__hiddenLabel mesh__D018407 Bacterial Physiologies
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018407 1999
% 210.14/210.30 |- mesh__recordMaintainer mesh__D018407 NNS
% 210.14/210.30 |- skos__annotation mesh__D018407
% 210.14/210.30 GEN or unspecified; prefer specifics; DF: BACT PHYSIOL
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D018407 SJN
% 210.14/210.30 |- skos__altLabel mesh__D018407 Physiology, Bacterial
% 210.14/210.30 |- mesh__recordOriginator mesh__D018407 PXP
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018407 2002
% 210.14/210.30 |- mesh__dateEstablished mesh__D018407 1998-01-01
% 210.14/210.30 |- skos__scopeNote mesh__D018407
% 210.14/210.30 Physiological processes and activities of bacteria.
% 210.14/210.30 |- skos__related mesh__D018407smesh__D005827
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D018407 98
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018407 2001
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018407 2004
% 210.14/210.30 |- skos__related mesh__D018407smesh__D008827
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018407 2000
% 210.14/210.30 |- skos__prefLabel mesh__D018407 Bacterial Physiology
% 210.14/210.30 |- mesh__historyNote mesh__D018407 98; use explode 1995-97
% 210.14/210.30 |- rdf__type mesh__D018407sskos__Concept
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018407 2003
% 210.14/210.30 |- skos__broader mesh__D018407smesh__D008827
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018407 2006
% 210.14/210.30 |- skos__historyNote mesh__D018407 Bacteria/physiology %28%1966-1997%29%
% 210.14/210.30 |- skos__hiddenLabel mesh__D018407 Physiologies, Bacterial
% 210.14/210.30 |- mesh__dateRevised mesh__D018407 1998-06-10
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018407 2005
% 210.14/210.30 |- mesh__dateCreated mesh__D018407 1994-01-25
% 210.14/210.30 |- skos__broader mesh__D010424smesh__D001463
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D010424 2005
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D010424 sjn
% 210.14/210.30 |- mesh__recordOriginator mesh__D010424 NLM
% 210.14/210.30 |- skos__altLabel mesh__D010424 Pentobarbital, Monosodium Salt
% 210.14/210.30 |- rdf__type mesh__D010424sskos__Concept
% 210.14/210.30 |- mesh__dateCreated mesh__D010424 1999-01-01
% 210.14/210.30 |- skos__scopeNote mesh__D010424
% 210.14/210.30 A short-acting barbiturate that is effective as a sedative and hypnotic %28%but not as an anti-anxiety%29% agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. %28%From AMA Drug Evaluations Annual, 1994, p236%29%%A%
% 210.14/210.30 |- skos__altLabel mesh__D010424 Pentobarbitone
% 210.14/210.30 |- mesh__dateRevised mesh__D010424 2003-07-09
% 210.14/210.30 |- mesh__recordMaintainer mesh__D010424 ssb
% 210.14/210.30 |- skos__altLabel mesh__D010424 Mebubarbital
% 210.14/210.30 |- skos__altLabel mesh__D010424 Ethaminal
% 210.14/210.30 |- skos__hiddenLabel mesh__D010424 Monosodium Salt Pentobarbital
% 210.14/210.30 |- skos__prefLabel mesh__D010424 Pentobarbital
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D010424 2006
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D010424 2004
% 210.14/210.30 |- skos__altLabel mesh__D001698 Engineering, Biomedical
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D001698 2003
% 210.14/210.30 |- skos__annotation mesh__D001698
% 210.14/210.30 SPEC: SPEC qualif; DF: BIOMED ENGINEERING
% 210.14/210.30 |- mesh__recordOriginator mesh__D001698 NLM
% 210.14/210.30 |- mesh__dateEstablished mesh__D001698 1968-01-01
% 210.14/210.30 |- mesh__dateCreated mesh__D001698 1999-01-01
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D001698 2000
% 210.14/210.30 |- skos__related mesh__D001698smesh__D008491
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D001698 2004
% 210.14/210.30 |- mesh__historyNote mesh__D001698 68
% 210.14/210.30 |- skos__scopeNote mesh__D001698
% 210.14/210.30 Application of principles and practices of engineering science to biomedical research and health care.%A%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D001698 2001
% 210.14/210.30 |- mesh__recordMaintainer mesh__D001698 jls
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D001698 2005
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D001698 68
% 210.14/210.30 |- mesh__dateRevised mesh__D001698 1999-11-03
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D001698 2002
% 210.14/210.30 |- skos__broader mesh__D001698smesh__D004738
% 210.14/210.30 |- skos__altLabel mesh__D001698 Engineering, Clinical
% 210.14/210.30 |- skos__broader mesh__D001698smesh__D006281
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D001698 2006
% 210.14/210.30 |- rdf__type mesh__D001698sskos__Concept
% 210.14/210.30 |- skos__prefLabel mesh__D001698 Biomedical Engineering
% 210.14/210.30 |- skos__related mesh__D001698smesh__D004582
% 210.14/210.30 |- skos__related mesh__D001698smesh__D020811
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D001698 sjn
% 210.14/210.30 |- skos__broader mesh__D020852smesh__D020806
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D020852 2004
% 210.14/210.30 |- mesh__historyNote mesh__D020852 2000
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Encephalopathies, Lyme Disease
% 210.14/210.30 |- skos__altLabel mesh__D020852 Meningoencephalitis, Lyme
% 210.14/210.30 |- mesh__dateRevised mesh__D020852 2005-07-08
% 210.14/210.30 |- skos__scopeNote mesh__D020852
% 210.14/210.30 Nervous system infections caused by tick-borne spirochetes of the BORRELIA BURGDORFERI GROUP. The disease may affect elements of the central or peripheral nervous system in isolation or in combination. Common clinical manifestations include a lymphocytic meningitis, cranial neuropathy %28%most often a facial neuropathy%29%, POLYRADICULOPATHY, and a mild loss of memory and other cognitive functions. Less often more extensive inflammation involving the central nervous system %28%encephalomyelitis%29% may occur. In the peripheral nervous system, B. burgdorferi infection is associated with mononeuritis multiplex and polyradiculoneuritis. %28%From J Neurol Sci 1998 Jan 8;153%28%2%29%:182-91%29%%A%
% 210.14/210.30 |- skos__altLabel mesh__D020852 Lyme Disease Encephalopathy
% 210.14/210.30 |- skos__historyNote mesh__D020852 Lyme Disease %28%1984-1999%29%
% 210.14/210.30 |- skos__altLabel mesh__D020852 Lyme Disease, Central Nervous System
% 210.14/210.30 |- skos__prefLabel mesh__D020852 Lyme Neuroborreliosis
% 210.14/210.30 |- skos__altLabel mesh__D020852 Lyme Borreliosis, Nervous System
% 210.14/210.30 |- mesh__recordMaintainer mesh__D020852 ags
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Lyme Polyradiculopathies
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D020852 ags
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Polyradiculopathies, Lyme
% 210.14/210.30 |- skos__annotation mesh__D020852
% 210.14/210.30 coord IM with Borrelia %28%IM%29% + specific site/dis term %28%IM%29% if pertinent%A%
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Polyradiculitis, Lyme
% 210.14/210.30 |- skos__historyNote mesh__D020852
% 210.14/210.30 Encephalitis, Tick-Borne %28%1979-1983%29%
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Borrelia burgdorferi Neuroborreliosis
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Lyme Polyradiculitides
% 210.14/210.30 |- skos__altLabel mesh__D020852 Lyme Disease, Nervous System
% 210.14/210.30 |- rdf__type mesh__D020852sskos__Concept
% 210.14/210.30 |- skos__altLabel mesh__D020852 Nervous System Lyme Disease
% 210.14/210.30 |- mesh__recordOriginator mesh__D020852 KEV
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D020852 2005
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Neuroborreliosis, Lyme
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Lyme Disease Encephalopathies
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Meningoradiculitis, Lyme
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D020852 2002
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D020852 2006A
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Neuroborrelioses, Borrelia burgdorferi
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D020852 2000
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D020852 2006
% 210.14/210.30 |- mesh__dateEstablished mesh__D020852 2000-01-01
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D020852 2003
% 210.14/210.30 |- skos__altLabel mesh__D020852 Nervous System Lyme Borreliosis
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Polyradiculitides, Lyme
% 210.14/210.30 |- mesh__dateCreated mesh__D020852 1999-11-03
% 210.14/210.30 |- skos__altLabel mesh__D020852 Neuroborreliosis, Borrelia burgdorferi
% 210.14/210.30 |- skos__altLabel mesh__D020852 Mononeuritis Multiplex, Lyme Disease
% 210.14/210.30 |- skos__broader mesh__D020852smesh__D008193
% 210.14/210.30 |- skos__hiddenLabel mesh__D020852 Polyradiculopathy, Lyme
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006383 2005
% 210.14/210.30 |- skos__hiddenLabel mesh__D006383 Inhibition Test, Hemadsorption
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006383 2002
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006383 2006
% 210.14/210.30 |- mesh__historyNote mesh__D006383 73%28%63%29%
% 210.14/210.30 |- mesh__recordOriginator mesh__D006383 NLM
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D006383 SJN
% 210.14/210.30 |- skos__hiddenLabel mesh__D006383 Tests, Hemadsorption Inhibition
% 210.14/210.30 |- mesh__dateRevised mesh__D006383 1997-06-20
% 210.14/210.30 |- skos__hiddenLabel mesh__D006383 Test, Hemadsorption Inhibition
% 210.14/210.30 |- skos__hiddenLabel mesh__D006383 Hemadsorption Inhibition Test
% 210.14/210.30 |- mesh__recordMaintainer mesh__D006383 PXP
% 210.14/210.30 |- skos__annotation mesh__D006383 NIM
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006383 1998
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006383 2003
% 210.14/210.30 |- skos__prefLabel mesh__D006383 Hemadsorption Inhibition Tests
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006383 2000
% 210.14/210.30 |- rdf__type mesh__D006383sskos__Concept
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006383 1999
% 210.14/210.30 |- mesh__dateCreated mesh__D006383 1999-01-01
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006383 2004
% 210.14/210.30 |- skos__hiddenLabel mesh__D006383 Inhibition Tests, Hemadsorption
% 210.14/210.30 |- mesh__dateEstablished mesh__D006383 1973-01-01
% 210.14/210.30 |- skos__broader mesh__D006383smesh__D012698
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006383 2001
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D006383 73
% 210.14/210.30 |- skos__annotation mesh__D014815
% 210.14/210.30 deficiency = AVITAMINOSIS but prefer specific precoordinated vitamin deficiency terms %28%avitaminosis A = VITAMIN A DEFICIENCY etc%29%; ther use: coordinate disease term with /drug ther, not /diet ther%A%
% 210.14/210.30 |- mesh__recordOriginator mesh__D014815 NLM
% 210.14/210.30 |- skos__scopeNote mesh__D014815
% 210.14/210.30 A general term for a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body. They may be water-soluble or fat-soluble. %28%Dorland, 28th ed%29%%A%
% 210.14/210.30 |- rdf__type mesh__D014815sskos__Concept
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014815 2006A
% 210.14/210.30 |- mesh__recordMaintainer mesh__D014815 ags
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D014815 ags
% 210.14/210.30 |- mesh__dateRevised mesh__D014815 2005-07-08
% 210.14/210.30 |- skos__broader mesh__D014815smesh__D018977
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014815 2006
% 210.14/210.30 |- skos__prefLabel mesh__D014815 Vitamins
% 210.14/210.30 |- mesh__dateCreated mesh__D014815 1999-01-01
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D019500 sjn
% 210.14/210.30 |- skos__scopeNote mesh__D019500
% 210.14/210.30 Works containing informational articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. %28%From The ALA Glossary of Library and Information Science, 1983%29%%A%
% 210.14/210.30 |- skos__altLabel mesh__D019500 Encyclopedias %28%PT%29%
% 210.14/210.30 |- skos__broader mesh__D019500smesh__D052180
% 210.14/210.30 |- mesh__dateCreated mesh__D019500 1996-06-21
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D019500 2006
% 210.14/210.30 |- mesh__recordOriginator mesh__D019500 TGC
% 210.14/210.30 |- mesh__dateRevised mesh__D019500 2005-06-30
% 210.14/210.30 |- mesh__historyNote mesh__D019500 1997
% 210.14/210.30 |- mesh__dateEstablished mesh__D019500 1997-01-01
% 210.14/210.30 |- skos__prefLabel mesh__D019500 Encyclopedias %5B%Publication Type%5D%
% 210.14/210.30 |- mesh__recordMaintainer mesh__D019500 jls
% 210.14/210.30 |- skos__annotation mesh__D019500
% 210.14/210.30 publication type only; for encyclopedias as a subject, index under main heading ENCYCLOPEDIAS%A%
% 210.14/210.30 |- rdf__type mesh__D019500sskos__Concept
% 210.14/210.30 |- skos__related mesh__D002791smesh__D006938
% 210.14/210.30 |- skos__broader mesh__D002791smesh__D002784
% 210.14/210.30 |- skos__scopeNote mesh__D002791
% 210.14/210.30 Cholesterol present in food, especially in animal products.%A%
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D002791 73
% 210.14/210.30 |- mesh__recordMaintainer mesh__D002791 ssb
% 210.14/210.30 |- mesh__historyNote mesh__D002791 73
% 210.14/210.30 |- skos__related mesh__D002791smesh__D006937
% 210.14/210.30 |- skos__altLabel mesh__D002791 Dietary Cholesterol
% 210.14/210.30 |- skos__historyNote mesh__D002791 Dietary Fats %28%1966-1972%29%
% 210.14/210.30 |- mesh__dateRevised mesh__D002791 2003-07-09
% 210.14/210.30 |- skos__broader mesh__D002791smesh__D004041
% 210.14/210.30 |- skos__prefLabel mesh__D002791 Cholesterol, Dietary
% 210.14/210.30 |- rdf__type mesh__D002791sskos__Concept
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D002791 2005
% 210.14/210.30 |- skos__historyNote mesh__D002791 Cholesterol %28%1966-1972%29%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D002791 2004
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D002791 sjn
% 210.14/210.30 |- mesh__dateEstablished mesh__D002791 1973-01-01
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D002791 2006
% 210.14/210.30 |- mesh__dateCreated mesh__D002791 1999-01-01
% 210.14/210.30 |- skos__annotation mesh__D002791
% 210.14/210.30 /adv eff: coord with disease /etiol, not /chem ind
% 210.14/210.30 |- mesh__recordOriginator mesh__D002791 NLM
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D018408 sjn
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018408 2004
% 210.14/210.30 |- mesh__dateRevised mesh__D018408 2000-06-22
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Techniques, Voltage-Clamp
% 210.14/210.30 |- mesh__recordOriginator mesh__D018408 PXP
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Technics, Patch-Clamp
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Technique, Voltage-Clamp
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D018408 95
% 210.14/210.30 |- mesh__historyNote mesh__D018408 95
% 210.14/210.30 |- mesh__dateEstablished mesh__D018408 1995-01-01
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Technic, Voltage-Clamp
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Voltage Clamp Techniques
% 210.14/210.30 |- skos__historyNote mesh__D018408 Electrophysiology %28%1975-1994%29%
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Voltage-Clamp Technic
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Voltage Clamp Technics
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Whole Cell Recording
% 210.14/210.30 |- mesh__dateCreated mesh__D018408 1994-01-25
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Technique, Patch-Clamp
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018408 2001
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Recording, Whole-Cell
% 210.14/210.30 |- rdf__type mesh__D018408sskos__Concept
% 210.14/210.30 |- skos__annotation mesh__D018408
% 210.14/210.30 a cytol technique for removing a tiny patch of plasma membrane; NIM%A%
% 210.14/210.30 |- skos__prefLabel mesh__D018408 Patch-Clamp Techniques
% 210.14/210.30 |- skos__historyNote mesh__D018408 Ion Channels %28%1978-1994%29%
% 210.14/210.30 |- skos__altLabel mesh__D018408 Patch-Clamp Technics
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Technics, Voltage-Clamp
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018408 2005
% 210.14/210.30 |- skos__broader mesh__D018408smesh__D003584
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Recordings, Whole-Cell
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Technic, Patch-Clamp
% 210.14/210.30 |- skos__altLabel mesh__D018408 Voltage-Clamp Technics
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018408 2002
% 210.14/210.30 |- skos__historyNote mesh__D018408 Membrane Potentials %28%1975-1994%29%
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Patch Clamp Techniques
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Patch-Clamp Technique
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Whole-Cell Recordings
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018408 2006
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Patch-Clamp Technic
% 210.14/210.30 |- skos__scopeNote mesh__D018408
% 210.14/210.30 An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.%A%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D018408 2003
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Patch Clamp Technics
% 210.14/210.30 |- mesh__recordMaintainer mesh__D018408 TGC
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Voltage-Clamp Technique
% 210.14/210.30 |- skos__hiddenLabel mesh__D018408 Techniques, Patch-Clamp
% 210.14/210.30 |- rdf__type mesh__D010425sskos__Concept
% 210.14/210.30 |- skos__hiddenLabel mesh__D010425 Tartrate, Pentolinium
% 210.14/210.30 |- mesh__dateRevised mesh__D010425 2001-07-25
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D010425 sjn
% 210.14/210.30 |- skos__prefLabel mesh__D010425 Pentolinium Tartrate
% 210.14/210.30 |- mesh__dateCreated mesh__D010425 1999-01-01
% 210.14/210.30 |- mesh__recordMaintainer mesh__D010425 CCR
% 210.14/210.30 |- mesh__recordOriginator mesh__D010425 NLM
% 210.14/210.30 |- skos__altLabel mesh__D010425 Pentolonium Tartrate
% 210.14/210.30 |- skos__broader mesh__D010425smesh__D011759
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D010425 2006
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D010425 2002
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D010425 2004
% 210.14/210.30 |- skos__scopeNote mesh__D010425
% 210.14/210.30 A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension.%A%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D010425 2005
% 210.14/210.30 |- skos__hiddenLabel mesh__D010425 Tartrate, Pentolonium
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D010425 2003
% 210.14/210.30 |- skos__broader mesh__D009666Q000557smesh__D009666
% 210.14/210.30 |- mesh__preferredCombination mesh__D009666Q000557smesh__D009297Q000557
% 210.14/210.30 |- rdf__type mesh__D009666Q000557smesh__CompoundConcept
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D015110
% 210.14/210.30 77; PHENPROCOUMON was see under COUMARINS 1975-76
% 210.14/210.30 |- mesh__recordMaintainer mesh__D015110 ssb
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D015110 2006
% 210.14/210.30 |- skos__prefLabel mesh__D015110 4-Hydroxycoumarins
% 210.14/210.30 |- mesh__historyNote mesh__D015110 77
% 210.14/210.30 |- mesh__recordOriginator mesh__D015110 SH
% 210.14/210.30 |- mesh__dateRevised mesh__D015110 2005-06-30
% 210.14/210.30 |- skos__scopeNote mesh__D015110
% 210.14/210.30 Substances found in many plants, containing the 4-hydroxycoumarin radical. They interfere with vitamin K and the blood clotting mechanism, are tightly protein-bound, inhibit mitochondrial and microsomal enzymes, and are used as oral anticoagulants.%A%
% 210.14/210.30 |- rdf__type mesh__D015110sskos__Concept
% 210.14/210.30 |- mesh__dateCreated mesh__D015110 1976-04-13
% 210.14/210.30 |- skos__hiddenLabel mesh__D015110 4 Hydroxycoumarins
% 210.14/210.30 |- skos__annotation mesh__D015110 /biosyn permitted if by plant
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D015110 sjn
% 210.14/210.30 |- mesh__dateEstablished mesh__D015110 1977-01-01
% 210.14/210.30 |- skos__historyNote mesh__D015110 Coumarins %28%1972-1976%29%
% 210.14/210.30 |- skos__broader mesh__D015110smesh__D003374
% 210.14/210.30 |- skos__broader mesh__D001699smesh__D013223
% 210.14/210.30 |- mesh__dateRevised mesh__D001699 2005-06-30
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D001699 2006
% 210.14/210.30 |- rdf__type mesh__D001699sskos__Concept
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D001699 sjn
% 210.14/210.30 |- skos__prefLabel mesh__D001699 Biometry
% 210.14/210.30 |- mesh__recordOriginator mesh__D001699 NLM
% 210.14/210.30 |- mesh__recordMaintainer mesh__D001699 nns
% 210.14/210.30 |- skos__scopeNote mesh__D001699
% 210.14/210.30 The use of statistical methods to analyze biological observations and phenomena.%A%
% 210.14/210.30 |- skos__broader mesh__D001699smesh__D015991
% 210.14/210.30 |- mesh__dateCreated mesh__D001699 1999-01-01
% 210.14/210.30 |- skos__altLabel mesh__D001699 Biostatistics
% 210.14/210.30 |- skos__altLabel mesh__D001699 Biometrics
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 1997
% 210.14/210.30 |- mesh__dateRevised mesh__D006384 1992-05-15
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 2001
% 210.14/210.30 |- skos__prefLabel mesh__D006384 Hemagglutination
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 1993
% 210.14/210.30 |- skos__broader mesh__D006384smesh__D000371
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 2002
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 1998
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 2003
% 210.14/210.30 |- mesh__recordOriginator mesh__D006384 NLM
% 210.14/210.30 |- mesh__recordMaintainer mesh__D006384 TAP
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 1994
% 210.14/210.30 |- rdf__type mesh__D006384sskos__Concept
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 1999
% 210.14/210.30 |- mesh__dateCreated mesh__D006384 1999-01-01
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 2004
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D006384 PLS
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 1995
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 2005
% 210.14/210.30 |- skos__annotation mesh__D006384
% 210.14/210.30 intravascular hemagglutination = ERYTHROCYTE AGGREGATION, INTRAVASCULAR%A%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 2000
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 1996
% 210.14/210.30 |- skos__hiddenLabel mesh__D006384 Hemagglutinations
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D006384 2006
% 210.14/210.30 |- skos__hiddenLabel mesh__D014816 Duct, Vitelline
% 210.14/210.30 |- skos__hiddenLabel mesh__D014816 Vitelline Ducts
% 210.14/210.30 |- skos__hiddenLabel mesh__D014816 Ducts, Vitelline
% 210.14/210.30 |- mesh__historyNote mesh__D014816 79; was VITELLINE DUCTS 1963-78
% 210.14/210.30 |- skos__hiddenLabel mesh__D014816 Omphalomesenteric Ducts
% 210.14/210.30 |- skos__altLabel mesh__D014816 Omphalomesenteric Duct
% 210.14/210.30 |- skos__hiddenLabel mesh__D014816 Ducts, Omphalomesenteric
% 210.14/210.30 |- mesh__onlineNote mesh__D014816
% 210.14/210.30 use VITELLINE DUCT to search VITELLINE DUCTS 1966-78
% 210.14/210.30 |- skos__hiddenLabel mesh__D014816 Duct, Omphalomesenteric
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014816 2006
% 210.14/210.30 |- mesh__publicMeSHNote mesh__D014816 79; was VITELLINE DUCTS 1963-78
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014816 2004
% 210.14/210.30 |- mesh__dateCreated mesh__D014816 1999-01-01
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014816 2005
% 210.14/210.30 |- mesh__recordOriginator mesh__D014816 NLM
% 210.14/210.30 |- skos__broader mesh__D014816smesh__D004622
% 210.14/210.30 |- mesh__recordMaintainer mesh__D014816 lkt
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D014816 sjn
% 210.14/210.30 |- skos__scopeNote mesh__D014816
% 210.14/210.30 The narrow tube connecting the YOLK SAC with the midgut of the EMBRYO; persistence of all or part of it in post-fetal life produces abnormalities, of which the commonest is MECKEL DIVERTICULUM.%A%
% 210.14/210.30 |- skos__related mesh__D014816smesh__D008467
% 210.14/210.30 |- rdf__type mesh__D014816sskos__Concept
% 210.14/210.30 |- skos__prefLabel mesh__D014816 Vitelline Duct
% 210.14/210.30 |- mesh__dateRevised mesh__D014816 2003-07-09
% 210.14/210.30 |- skos__annotation mesh__D014018
% 210.14/210.30 distrib of drugs or chem in organs %26% tissues; GEN only: not a substitute for organ /metab or organ /chem; never IM; coord NIM with substance /pharmacokin %28%IM%29% or /metab %28%IM%29%%A%
% 210.14/210.30 |- skos__scopeNote mesh__D014018
% 210.14/210.30 Accumulation of a drug or chemical substance in various organs %28%including those not relevant to its pharmacologic or therapeutic action%29%. This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios.%A%
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014018 2005
% 210.14/210.30 |- mesh__recordAuthorizer mesh__D014018 sjn
% 210.14/210.30 |- mesh__dateRevised mesh__D014018 2004-07-07
% 210.14/210.30 |- skos__broader mesh__D014018smesh__D010599
% 210.14/210.30 |- skos__prefLabel mesh__D014018 Tissue Distribution
% 210.14/210.30 |- mesh__activeMeSHYear mesh__D014018 2006
% 210.14/210.30 |- mesh__dateEstablished mesh__D014018 1978-01-01
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D014018 78
% 210.14/210.31 |- skos__historyNote mesh__D014018 Organ Specificity %28%1966-1977%29%
% 210.14/210.31 |- mesh__recordMaintainer mesh__D014018 ssb
% 210.14/210.31 |- rdf__type mesh__D014018sskos__Concept
% 210.14/210.31 |- skos__hiddenLabel mesh__D014018 Distributions, Tissue
% 210.14/210.31 |- skos__hiddenLabel mesh__D014018 Distribution, Tissue
% 210.14/210.31 |- skos__hiddenLabel mesh__D014018 Tissue Distributions
% 210.14/210.31 |- skos__broader mesh__D014018smesh__D008660
% 210.14/210.31 |- mesh__historyNote mesh__D014018 78
% 210.14/210.31 |- mesh__recordOriginator mesh__D014018 VDK
% 210.14/210.31 |- mesh__dateCreated mesh__D014018 1977-04-27
% 210.14/210.31 |- skos__prefLabel mesh__D002792 Cholestyramine
% 210.14/210.31 |- mesh__recordOriginator mesh__D002792 NLM
% 210.14/210.31 |- mesh__historyNote mesh__D002792 66%28%64%29%
% 210.14/210.31 |- skos__scopeNote mesh__D002792
% 210.14/210.31 A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium as Cl%28%-%29% anion. It exchanges chloride ions with bile salts, thus decreasing their concentration and that of cholesterol. It is used as a hypocholesteremic in diarrhea and biliary obstruction, and as an antipruritic.%A%
% 210.14/210.31 |- skos__hiddenLabel mesh__D002792 Resin, Cholestyramine
% 210.14/210.31 |- rdf__type mesh__D002792sskos__Concept
% 210.14/210.31 |- skos__broader mesh__D002792smesh__D011137
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D002792 66
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D002792 2005
% 210.14/210.31 |- mesh__recordMaintainer mesh__D002792 jmp
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D002792 2006
% 210.14/210.31 |- mesh__dateCreated mesh__D002792 1999-01-01
% 210.14/210.31 |- skos__altLabel mesh__D002792 Colestyramin
% 210.14/210.31 |- skos__altLabel mesh__D002792 Cholestyramine Resin
% 210.14/210.31 |- skos__altLabel mesh__D002792 Colestyramine
% 210.14/210.31 |- mesh__dateEstablished mesh__D002792 1966-01-01
% 210.14/210.31 |- mesh__dateRevised mesh__D002792 2004-07-07
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D002792 sjn
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 2001
% 210.14/210.31 |- skos__altLabel mesh__D018409 Injuries, Foot
% 210.14/210.31 |- mesh__dateEstablished mesh__D018409 1995-01-01
% 210.14/210.31 |- rdf__type mesh__D018409sskos__Concept
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 2003
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 2006
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 2000
% 210.14/210.31 |- skos__prefLabel mesh__D018409 Foot Injuries
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 2005
% 210.14/210.31 |- skos__scopeNote mesh__D018409
% 210.14/210.31 General or unspecified injuries involving the foot.
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 1997
% 210.14/210.31 |- mesh__dateCreated mesh__D018409 1994-06-28
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 1996
% 210.14/210.31 |- mesh__onlineNote mesh__D018409
% 210.14/210.31 use FOOT INJURIES to search FOOT/injuries 1966-94
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D018409 95; was FOOT/injuries 1966-94
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 1999
% 210.14/210.31 |- skos__broader mesh__D018409smesh__D007869
% 210.14/210.31 |- skos__annotation mesh__D018409
% 210.14/210.31 GEN or unspecified; consider also /inj with specific sites of foot%A%
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 1998
% 210.14/210.31 |- mesh__historyNote mesh__D018409 95; was FOOT/injuries 1966-94
% 210.14/210.31 |- skos__hiddenLabel mesh__D018409 Injury, Foot
% 210.14/210.31 |- skos__historyNote mesh__D018409 Foot/injuries %28%1966-1994%29%
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 1995
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 2002
% 210.14/210.31 |- skos__hiddenLabel mesh__D018409 Foot Injury
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D018409 2004
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Sulfate, Xylan
% 210.14/210.31 |- skos__altLabel mesh__D010426 HOE-946
% 210.14/210.31 |- skos__prefLabel mesh__D010426 Pentosan Sulfuric Polyester
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D010426 sjn
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 SP 54
% 210.14/210.31 |- skos__altLabel mesh__D010426 BAY-946
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 SP54, Xylan
% 210.14/210.31 |- skos__historyNote mesh__D010426 Polysaccharides %28%1970-1974%29%
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Sulfuric Polyester, Pentosane
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Xylan, Polysulfated
% 210.14/210.31 |- skos__historyNote mesh__D010426 Sulfuric Acids %28%1972-1974%29%
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D010426
% 210.14/210.31 1991; see POLYSACCHARIDES 1975-1990
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 946, HOE-BAY
% 210.14/210.31 |- mesh__dateCreated mesh__D010426 1974-11-19
% 210.14/210.31 |- skos__altLabel mesh__D010426 Pentosan Polysulfate Sodium
% 210.14/210.31 |- skos__altLabel mesh__D010426 Polysulfated Xylan
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 PZ 68
% 210.14/210.31 |- mesh__dateRevised mesh__D010426 2005-06-30
% 210.14/210.31 |- skos__altLabel mesh__D010426 Polypentose Sulfate
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 54, Tavan SP
% 210.14/210.31 |- skos__altLabel mesh__D010426 PZ68
% 210.14/210.31 |- skos__altLabel mesh__D010426 HOE-BAY 946
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 SP 54, Tavan
% 210.14/210.31 |- skos__altLabel mesh__D010426 Xylan Sulfate
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D010426 2006
% 210.14/210.31 |- mesh__recordMaintainer mesh__D010426 ssb
% 210.14/210.31 |- skos__altLabel mesh__D010426 Pentosane Sulfuric Polyester
% 210.14/210.31 |- mesh__dateEstablished mesh__D010426 1991-01-01
% 210.14/210.31 |- mesh__recordOriginator mesh__D010426 NLM
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Polyester, Pentosane Sulfuric
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Polyester, Pentosan Sulfuric
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Sulfuric Polyester, Pentosan
% 210.14/210.31 |- skos__broader mesh__D010426smesh__D011134
% 210.14/210.31 |- skos__scopeNote mesh__D010426
% 210.14/210.31 A sulfated pentosyl polysaccharide with heparin-like properties.%A%
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Polysulfate, Pentosan
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Sulfate, Polypentose
% 210.14/210.31 |- rdf__type mesh__D010426sskos__Concept
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 HOE BAY 946
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Sodium, Pentosan Polysulphate
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 HOE 946
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Sodium, Pentosan Polysulfate
% 210.14/210.31 |- mesh__historyNote mesh__D010426 1991%28%1975%29%
% 210.14/210.31 |- skos__broader mesh__D010426smesh__D013464
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 SP54
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 BAY 946
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Polysulfate Sodium, Pentosan
% 210.14/210.31 |- skos__hiddenLabel mesh__D010426 Polysulphate Sodium, Pentosan
% 210.14/210.31 |- skos__hiddenLabel mesh__D015111 Dioxygenase, 4-Hydroxyphenylpyruvate
% 210.14/210.31 |- mesh__recordMaintainer mesh__D015111 ags
% 210.14/210.31 |- skos__prefLabel mesh__D015111 4-Hydroxyphenylpyruvate Dioxygenase
% 210.14/210.31 |- skos__scopeNote mesh__D015111
% 210.14/210.31 An enzyme that catalyzes the conversion of 4-hydroxyphenylpyruvate plus oxygen to homogentisic acid and carbon dioxide. EC 1.13.11.27.%A%
% 210.14/210.31 |- skos__altLabel mesh__D015111 P-Hydroxyphenylpyruvate Oxidase
% 210.14/210.31 |- skos__hiddenLabel mesh__D015111 Hydroxylase, para-Hydroxyphenylpyruvate
% 210.14/210.31 |- mesh__dateCreated mesh__D015111 1974-11-19
% 210.14/210.31 |- skos__historyNote mesh__D015111 Phenylpyruvic Acids %28%1974%29%
% 210.14/210.31 |- skos__hiddenLabel mesh__D015111 P Hydroxyphenylpyruvate Hydroxylase
% 210.14/210.31 |- skos__altLabel mesh__D015111 para-Hydroxyphenylpyruvate Hydroxylase
% 210.14/210.31 |- mesh__recordOriginator mesh__D015111 NLM
% 210.14/210.31 |- rdf__type mesh__D015111sskos__Concept
% 210.14/210.31 |- skos__altLabel mesh__D015111 P-Hydroxyphenylpyruvate Hydroxylase
% 210.14/210.31 |- mesh__dateEstablished mesh__D015111 1991-01-01
% 210.14/210.31 |- mesh__historyNote mesh__D015111
% 210.14/210.31 91%28%75%29%; was see under OXYGENASES 1975-90
% 210.14/210.31 |- skos__hiddenLabel mesh__D015111 Hydroxylase, P-Hydroxyphenylpyruvate
% 210.14/210.31 |- mesh__dateRevised mesh__D015111 2005-06-30
% 210.14/210.31 |- skos__historyNote mesh__D015111 Oxygenases %28%1974%29%
% 210.14/210.31 |- skos__hiddenLabel mesh__D015111 P Hydroxyphenylpyruvate Oxidase
% 210.14/210.31 |- skos__altLabel mesh__D015111 para-Hydroxyphenylpyruvate Oxidase
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D015111
% 210.14/210.31 91; was see under OXYGENASES 1975-90
% 210.14/210.31 |- skos__hiddenLabel mesh__D015111 para Hydroxyphenylpyruvate Hydroxylase
% 210.14/210.31 |- skos__broader mesh__D015111smesh__D049308
% 210.14/210.31 |- skos__hiddenLabel mesh__D015111 Oxidase, para-Hydroxyphenylpyruvate
% 210.14/210.31 |- skos__hiddenLabel mesh__D015111 Oxidase, P-Hydroxyphenylpyruvate
% 210.14/210.31 |- skos__hiddenLabel mesh__D015111 para Hydroxyphenylpyruvate Oxidase
% 210.14/210.31 |- skos__annotation mesh__D015111
% 210.14/210.31 /defic: consider also TYROSINE /blood %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A%
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D015111 sjn
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D015111 2006
% 210.14/210.31 |- skos__annotation mesh__D006385 NIM
% 210.14/210.31 |- skos__prefLabel mesh__D006385 Hemagglutination Inhibition Tests
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D006385 2002
% 210.14/210.31 |- mesh__recordMaintainer mesh__D006385 PXP
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D006385 2006
% 210.14/210.31 |- skos__broader mesh__D006385smesh__D012698
% 210.14/210.31 |- skos__hiddenLabel mesh__D006385 Tests, Hemagglutination Inhibition
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D006385 2001
% 210.14/210.31 |- mesh__dateCreated mesh__D006385 1999-01-01
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D006385 2000
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D006385 2005
% 210.14/210.31 |- skos__scopeNote mesh__D006385
% 210.14/210.31 Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.%A%
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D006385 SJN
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D006385 2004
% 210.14/210.31 |- mesh__dateRevised mesh__D006385 1997-06-20
% 210.14/210.31 |- skos__altLabel mesh__D006385 Hemagglutination Inhibition Test
% 210.14/210.31 |- skos__hiddenLabel mesh__D006385 Test, Hemagglutination Inhibition
% 210.14/210.31 |- skos__hiddenLabel mesh__D006385 Inhibition Test, Hemagglutination
% 210.14/210.31 |- skos__hiddenLabel mesh__D006385 Inhibition Tests, Hemagglutination
% 210.14/210.31 |- rdf__type mesh__D006385sskos__Concept
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D006385 1999
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D006385 2003
% 210.14/210.31 |- mesh__recordOriginator mesh__D006385 NLM
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D006385 1998
% 210.14/210.31 |- mesh__dateEstablished mesh__D014817 1973-01-01
% 210.14/210.31 |- skos__hiddenLabel mesh__D014817 Membranes, Vitelline
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1994
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1997
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1992
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D014817 PLS
% 210.14/210.31 |- mesh__recordMaintainer mesh__D014817 TGC
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 2006
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1998
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 2002
% 210.14/210.31 |- skos__scopeNote mesh__D014817 The plasma membrane of the egg.
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 2004
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1996
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1990
% 210.14/210.31 |- mesh__dateCreated mesh__D014817 1999-01-01
% 210.14/210.31 |- mesh__historyNote mesh__D014817 73%28%63%29%
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 2005
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 2003
% 210.14/210.31 |- skos__broader mesh__D014817smesh__D010063
% 210.14/210.31 |- mesh__dateRevised mesh__D014817 1989-04-06
% 210.14/210.31 |- rdf__type mesh__D014817sskos__Concept
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 2001
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D014817 73
% 210.14/210.31 |- skos__prefLabel mesh__D014817 Vitelline Membrane
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 2000
% 210.14/210.31 |- mesh__recordOriginator mesh__D014817 NLM
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1991
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1995
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1993
% 210.14/210.31 |- skos__hiddenLabel mesh__D014817 Membrane, Vitelline
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014817 1999
% 210.14/210.31 |- skos__hiddenLabel mesh__D014817 Vitelline Membranes
% 210.14/210.31 |- skos__broader mesh__D013340Q000193smesh__D013340
% 210.14/210.31 |- mesh__preferredCombination mesh__D013340Q000193smesh__D004516
% 210.14/210.31 |- rdf__type mesh__D013340Q000193smesh__CompoundConcept
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Donor, Organ
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D014019 jls
% 210.14/210.31 |- skos__related mesh__D014019smesh__D019520
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Donor, Ovum
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Tissue Donor
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D014019 67
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Donor
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014019 2006
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014019 2003A
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Donors, Tissue
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Donors, Ovum
% 210.14/210.31 |- mesh__dateCreated mesh__D014019 1999-01-01
% 210.14/210.31 |- mesh__historyNote mesh__D014019 67%28%64%29%
% 210.14/210.31 |- rdf__type mesh__D014019sskos__Concept
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Semen Donor
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014019 2005A
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Donor, Semen
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Donors, Semen
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Organ Donor
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Donors, Organ
% 210.14/210.31 |- skos__scopeNote mesh__D014019
% 210.14/210.31 Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients.%A%
% 210.14/210.31 |- mesh__dateEstablished mesh__D014019 1967-01-01
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Donor, Tissue
% 210.14/210.31 |- skos__broader mesh__D014019smesh__D009272
% 210.14/210.31 |- mesh__recordOriginator mesh__D014019 NLM
% 210.14/210.31 |- skos__prefLabel mesh__D014019 Tissue Donors
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014019 2003
% 210.14/210.31 |- skos__annotation mesh__D014019
% 210.14/210.31 semen or sperm donors: coord IM with SEMEN %28%IM%29% or SPERMATOZOA %28%IM%29%; consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS %28%husband%29% %28%IM%29% or INSEMINATION, ARTIFICIAL, HETEROLOGOUS %28%non-husband%29% %28%IM%29%%A%
% 210.14/210.31 |- skos__related mesh__D014019smesh__D033001
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014019 2005
% 210.14/210.31 |- mesh__dateRevised mesh__D014019 2004-08-02
% 210.14/210.31 |- mesh__recordMaintainer mesh__D014019 jls
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D014019 2004
% 210.14/210.31 |- skos__hiddenLabel mesh__D014019 Ovum Donor
% 210.14/210.31 |- mesh__recordMaintainer mesh__D019502 jls
% 210.14/210.31 |- mesh__recordOriginator mesh__D019502 TGC
% 210.14/210.31 |- mesh__dateRevised mesh__D019502 2005-06-30
% 210.14/210.31 |- mesh__historyNote mesh__D019502 1997
% 210.14/210.31 |- skos__altLabel mesh__D019502 Ephemera
% 210.14/210.31 |- skos__altLabel mesh__D019502 Ephemera %28%PT%29%
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D019502 2006
% 210.14/210.31 |- mesh__dateEstablished mesh__D019502 1997-01-01
% 210.14/210.31 |- rdf__type mesh__D019502sskos__Concept
% 210.14/210.31 |- skos__annotation mesh__D019502
% 210.14/210.31 publication type only; for ephemera as a subject, index under main heading for specific type of ephemeron such as ADVERTISING; CORRESPONDENCE; PAMPHLETS; etc.%A%
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D019502 sjn
% 210.14/210.31 |- mesh__dateCreated mesh__D019502 1996-06-21
% 210.14/210.31 |- skos__scopeNote mesh__D019502
% 210.14/210.31 Works consisting of transient everyday items, usually printed on paper, that are produced for a specific limited use and then often thrown away. %28%From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed %26% The ALA Glossary of Library and Information Science, 1983%29%%A%
% 210.14/210.31 |- skos__broader mesh__D019502smesh__D052180
% 210.14/210.31 |- skos__prefLabel mesh__D019502 Ephemera %5B%Publication Type%5D%
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D052138 sjn
% 210.14/210.31 |- skos__hiddenLabel mesh__D052138 Gene, Neoplasm
% 210.14/210.31 |- mesh__historyNote mesh__D052138
% 210.14/210.31 2006; for CANCER GENES use ONCOGENES 1985-2005
% 210.14/210.31 |- mesh__dateCreated mesh__D052138 2005-06-30
% 210.14/210.31 |- skos__scopeNote mesh__D052138
% 210.14/210.31 Genes whose abnormal expression, or MUTATION are associated with the development, growth, or progression of NEOPLASMS.%A%
% 210.14/210.31 |- skos__related mesh__D052138smesh__D009363
% 210.14/210.31 |- mesh__recordOriginator mesh__D052138 nns
% 210.14/210.31 |- skos__annotation mesh__D052138
% 210.14/210.31 general; prefer specifics; coordinate with specific neoplasm terms /genet; do not confuse with ONCOGENES%A%
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D052138 2006
% 210.14/210.31 |- skos__hiddenLabel mesh__D052138 Gene, Cancer
% 210.14/210.31 |- rdf__type mesh__D052138sskos__Concept
% 210.14/210.31 |- skos__hiddenLabel mesh__D052138 Genes, Cancer
% 210.14/210.31 |- skos__prefLabel mesh__D052138 Genes, Neoplasm
% 210.14/210.31 |- skos__altLabel mesh__D052138 Neoplasm Genes
% 210.14/210.31 |- skos__hiddenLabel mesh__D052138 Cancer Gene
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D052138
% 210.14/210.31 2006; for CANCER GENES see ONCOGENES 1985-2005
% 210.14/210.31 |- mesh__recordMaintainer mesh__D052138 nns
% 210.14/210.31 |- skos__broader mesh__D052138smesh__D005796
% 210.14/210.31 |- skos__hiddenLabel mesh__D052138 Neoplasm Gene
% 210.14/210.31 |- mesh__dateEstablished mesh__D052138 2006-01-01
% 210.14/210.31 |- skos__broader mesh__D002793smesh__D002757
% 210.14/210.31 |- mesh__onlineNote mesh__D002793
% 210.14/210.31 use CHOLIC ACIDS to search CHOLIC ACID 1973-74 %28%as Prov 1973%29%; use BILE ACIDS AND SALTS 1966-72%A%
% 210.14/210.31 |- mesh__dateCreated mesh__D002793 1999-01-01
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D002793 2005
% 210.14/210.31 |- mesh__dateRevised mesh__D002793 1999-11-03
% 210.14/210.31 |- mesh__recordMaintainer mesh__D002793 adp
% 210.14/210.31 |- skos__scopeNote mesh__D002793
% 210.14/210.31 The 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics.%A%
% 210.14/210.31 |- skos__altLabel mesh__D002793 Cholalic Acids
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D002793 sjn
% 210.14/210.31 |- skos__historyNote mesh__D002793 Bile Acids and Salts %28%1966-1972%29%
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D002793 2001
% 210.14/210.31 |- skos__annotation mesh__D002793
% 210.14/210.31 cholic acid glycine conjugate = GLYCOCHOLIC ACID; cholic acid taurine conjugate = TAUROCHOLIC ACID; CHOLIC ACID is also available%A%
% 210.14/210.31 |- skos__hiddenLabel mesh__D002793 Acids, Cholic
% 210.14/210.31 |- mesh__recordOriginator mesh__D002793 NLM
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D002793 2004
% 210.14/210.31 |- rdf__type mesh__D002793sskos__Concept
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D002793 2000
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D002793
% 210.14/210.31 75; was CHOLIC ACID 1974, was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73%A%
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D002793 2003
% 210.14/210.31 |- mesh__historyNote mesh__D002793
% 210.14/210.31 75; was CHOLIC ACID 1973-74 %28%Prov 1973%29%, was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73%A%
% 210.14/210.31 |- skos__prefLabel mesh__D002793 Cholic Acids
% 210.14/210.31 |- mesh__dateEstablished mesh__D002793 1974-01-01
% 210.14/210.31 |- skos__broader mesh__D002793smesh__D001647
% 210.14/210.31 |- skos__hiddenLabel mesh__D002793 Acids, Cholalic
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D002793 2006
% 210.14/210.31 |- mesh__activeMeSHYear mesh__D002793 2002
% 210.14/210.31 |- mesh__publicMeSHNote mesh__D010427
% 210.14/210.31 2006; see PENTOSEPHOSPHATE PATHWAY 1985-2005
% 210.14/210.31 |- skos__altLabel mesh__D010427 Pentose Phosphate Shunt
% 210.14/210.31 |- skos__hiddenLabel mesh__D010427 Shunts, Pentosephosphate
% 210.14/210.31 |- mesh__dateCreated mesh__D010427 1984-05-29
% 210.14/210.31 |- skos__altLabel mesh__D010427 Pentose-Phosphate Pathway
% 210.14/210.31 |- skos__hiddenLabel mesh__D010427 Pathways, Pentose-Phosphate
% 210.14/210.31 |- mesh__recordAuthorizer mesh__D010427 sjn
% 210.14/210.31 |- skos__altLabel mesh__D010427 Pentosephosphate Pathway
% 210.14/210.31 |- skos__prefLabel mesh__D010427 Pentose Phosphate Pathway
% 210.14/210.31 |- mesh__dateEstablished mesh__D010427 1985-01-01
% 210.14/210.31 |- skos__hiddenLabel mesh__D010427 Shunts, Hexose Monophosphate
% 210.14/210.31 |- mesh__recordMaintainer mesh__D010427 lkt
% 210.14/210.31 |- skos__scopeNote mesh__D010427
% 210.14/210.31 An oxidative decarboxylation process that converts GLUCOSE-6-PHOSPHATE to D-ribose-5-phosphate via 6-phosphogluconate. The pentose product is used in the biosynthesis of NUCLEIC ACIDS. The generated energy is stored in the form of NADPH. This pathway is prominent in tissues which are active in the synthesis of FATTY ACIDS and STEROIDS.%A%
% 210.14/210.31 |- skos__hiddenLabel mesh__D010427 Hexose Monophosphate Shunts
% 210.14/210.31 |- skos__altLabel mesh__D010427 Pentose Shunt
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pathway, Pentosephosphate
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pentose Phosphate Shunts
% 210.17/210.31 |- skos__broader mesh__D010427smesh__D050260
% 210.17/210.31 |- skos__historyNote mesh__D010427 Hexosephosphates %28%1966-1984%29%
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pentosephosphate Shunts
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D010427 2006
% 210.17/210.31 |- mesh__dateRevised mesh__D010427 2005-06-30
% 210.17/210.31 |- mesh__recordOriginator mesh__D010427 VDK
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pentosephosphate Pathways
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Shunts, Pentose Phosphate
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Shunt, Pentose Phosphate
% 210.17/210.31 |- mesh__historyNote mesh__D010427 2006 %28%1985%29%
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Shunt, Pentosephosphate
% 210.17/210.31 |- skos__altLabel mesh__D010427 Pentosephosphate Shunt
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pathways, Pentose Phosphate
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pathway, Pentose Phosphate
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pentose Phosphate Pathways
% 210.17/210.31 |- rdf__type mesh__D010427sskos__Concept
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pathway, Pentose-Phosphate
% 210.17/210.31 |- skos__broader mesh__D010427smesh__D004734
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pentose Shunts
% 210.17/210.31 |- skos__historyNote mesh__D010427 Pentosephosphates %28%1966-1984%29%
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pathways, Pentosephosphate
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Shunt, Hexose Monophosphate
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Shunts, Pentose
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Shunt, Pentose
% 210.17/210.31 |- skos__altLabel mesh__D010427 Hexose Monophosphate Shunt
% 210.17/210.31 |- skos__hiddenLabel mesh__D010427 Pentose-Phosphate Pathways
% 210.17/210.31 |- mesh__publicMeSHNote mesh__D015112
% 210.17/210.31 91; was see under NITROQUINOLINES 1975-90
% 210.17/210.31 |- skos__historyNote mesh__D015112 Quinolines %28%1970-1974%29%
% 210.17/210.31 |- skos__historyNote mesh__D015112 Nitro Compounds %28%1972-1974%29%
% 210.17/210.31 |- skos__scopeNote mesh__D015112
% 210.17/210.31 A potent mutagen and carcinogen. This compound and its metabolite 4-HYDROXYAMINOQUINOLINE-1-OXIDE bind to nucleic acids. It inactivates bacteria but not bacteriophage.%A%
% 210.17/210.31 |- mesh__dateCreated mesh__D015112 1974-11-14
% 210.17/210.31 |- mesh__dateRevised mesh__D015112 2000-06-22
% 210.17/210.31 |- mesh__dateEstablished mesh__D015112 1991-01-01
% 210.17/210.31 |- skos__broader mesh__D015112smesh__D003497
% 210.17/210.31 |- skos__hiddenLabel mesh__D015112 4 Nitroquinoline N oxide
% 210.17/210.31 |- mesh__recordAuthorizer mesh__D015112 sjn
% 210.17/210.31 |- mesh__recordMaintainer mesh__D015112 CCR
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D015112 2005
% 210.17/210.31 |- skos__hiddenLabel mesh__D015112 4 Nitroquinoline 1 oxide
% 210.17/210.31 |- skos__broader mesh__D015112smesh__D009600
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D015112 2003
% 210.17/210.31 |- mesh__historyNote mesh__D015112
% 210.17/210.31 91%28%75%29%; was see under NITROQUINOLINES 1975-90
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D015112 2006
% 210.17/210.31 |- mesh__recordOriginator mesh__D015112 NLM
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D015112 2004
% 210.17/210.31 |- skos__altLabel mesh__D015112 4-Nitroquinoline-N-oxide
% 210.17/210.31 |- skos__prefLabel mesh__D015112 4-Nitroquinoline-1-oxide
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D015112 2001
% 210.17/210.31 |- skos__historyNote mesh__D015112 Cyclic N-Oxides %28%1972-1974%29%
% 210.17/210.31 |- rdf__type mesh__D015112sskos__Concept
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D015112 2002
% 210.17/210.31 |- skos__annotation mesh__D015112 D25-26 qualif
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D006386 2006
% 210.17/210.31 |- mesh__recordOriginator mesh__D006386 NLM
% 210.17/210.31 |- mesh__historyNote mesh__D006386 66
% 210.17/210.31 |- skos__scopeNote mesh__D006386
% 210.17/210.31 Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. %28%From Stedman, 26th ed%29%%A%
% 210.17/210.31 |- mesh__dateCreated mesh__D006386 1999-01-01
% 210.17/210.31 |- mesh__publicMeSHNote mesh__D006386 66
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D006386 2005
% 210.17/210.31 |- skos__annotation mesh__D006386 NIM
% 210.17/210.31 |- skos__hiddenLabel mesh__D006386 Hemagglutination Test
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D006386 2002
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D006386 2004
% 210.17/210.31 |- mesh__recordMaintainer mesh__D006386 PXP
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D006386 2001
% 210.17/210.31 |- mesh__dateEstablished mesh__D006386 1966-01-01
% 210.17/210.31 |- rdf__type mesh__D006386sskos__Concept
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D006386 1999
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D006386 2003
% 210.17/210.31 |- skos__hiddenLabel mesh__D006386 Test, Hemagglutination
% 210.17/210.31 |- skos__hiddenLabel mesh__D006386 Tests, Hemagglutination
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D006386 2000
% 210.17/210.31 |- mesh__recordAuthorizer mesh__D006386 SJN
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D006386 1998
% 210.17/210.31 |- mesh__dateRevised mesh__D006386 1997-06-20
% 210.17/210.31 |- skos__broader mesh__D006386smesh__D000372
% 210.17/210.31 |- skos__prefLabel mesh__D006386 Hemagglutination Tests
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D014818 2006
% 210.17/210.31 |- skos__hiddenLabel mesh__D014818 Vitellogeneses
% 210.17/210.31 |- mesh__publicMeSHNote mesh__D014818 84
% 210.17/210.31 |- mesh__recordAuthorizer mesh__D014818 sjn
% 210.17/210.31 |- skos__scopeNote mesh__D014818
% 210.17/210.31 The active production and accumulation of VITELLINS %28%egg yolk proteins%29% in the non-mammalian OOCYTES from circulating precursors, VITELLOGENINS. Vitellogenesis usually begins after the first MEIOSIS and is regulated by estrogenic hormones.%A%
% 210.17/210.31 |- mesh__recordMaintainer mesh__D014818 lkt
% 210.17/210.31 |- mesh__dateRevised mesh__D014818 2004-07-07
% 210.17/210.31 |- mesh__historyNote mesh__D014818 84
% 210.17/210.31 |- mesh__dateEstablished mesh__D014818 1984-01-01
% 210.17/210.31 |- mesh__dateCreated mesh__D014818 1983-06-06
% 210.17/210.31 |- rdf__type mesh__D014818sskos__Concept
% 210.17/210.31 |- mesh__recordOriginator mesh__D014818 EC
% 210.17/210.31 |- skos__broader mesh__D014818smesh__D009866
% 210.17/210.31 |- skos__prefLabel mesh__D014818 Vitellogenesis
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D014818 2005
% 210.17/210.31 |- mesh__activeMeSHYear mesh__D011520 2005
% 210.17/210.31 |- skos__scopeNote mesh__D011520
% 210.17/210.31 An enzyme that catalyzes the oxidation of protocatechuate to 3-carboxy-cis-cis-muconate in the presence of molecular oxygen. It contains ferric ion. EC 1.13.11.3.%A%
% 210.17/210.31 |- mesh__historyNote mesh__D011520
% 210.17/210.31 91%28%75%29%; was see under OXYGENASES 1975-90
% 210.17/210.31 |- mesh__dateCreated mesh__D011520 1974-11-19
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D011520 2006
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D011520 sjn
% 210.17/210.32 |- mesh__dateEstablished mesh__D011520 1991-01-01
% 210.17/210.32 |- mesh__recordOriginator mesh__D011520 NLM
% 210.17/210.32 |- mesh__recordMaintainer mesh__D011520 ssb
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D011520
% 210.17/210.32 91; was see under OXYGENASES 1975-90
% 210.17/210.32 |- skos__historyNote mesh__D011520 Oxygenases %28%1972-1974%29%
% 210.17/210.32 |- rdf__type mesh__D011520sskos__Concept
% 210.17/210.32 |- skos__hiddenLabel mesh__D011520 Protocatechuate 3,4 Dioxygenase
% 210.17/210.32 |- skos__broader mesh__D011520smesh__D008084
% 210.17/210.32 |- skos__historyNote mesh__D011520 Benzoates %28%1972-1974%29%
% 210.17/210.32 |- mesh__dateRevised mesh__D011520 2004-07-07
% 210.17/210.32 |- skos__prefLabel mesh__D011520 Protocatechuate-3,4-Dioxygenase
% 210.17/210.32 |- mesh__dateCreated mesh__D052139 2005-06-30
% 210.17/210.32 |- skos__scopeNote mesh__D052139
% 210.17/210.32 Intracellular signaling peptides and proteins that bind to CALCIUM. They undergo allosteric changes when bound to CALCIUM that affects their interaction with other signal-transducing molecules. They differ from CALCIUM-SENSING RECEPTORS which sense extracellular calcium levels.%A%
% 210.17/210.32 |- skos__hiddenLabel mesh__D052139 Intracellular Calcium Sensing Proteins
% 210.17/210.32 |- skos__hiddenLabel mesh__D052139 Peptides, Intracellular Calcium-Sensing
% 210.17/210.32 |- skos__hiddenLabel mesh__D052139 Calcium Sensing Peptides, Intracellular
% 210.17/210.32 |- skos__prefLabel mesh__D052139 Intracellular Calcium-Sensing Proteins
% 210.17/210.32 |- mesh__historyNote mesh__D052139 2006
% 210.17/210.32 |- skos__related mesh__D052139smesh__D044169
% 210.17/210.32 |- skos__hiddenLabel mesh__D052139 Intracellular Calcium Sensing Peptides
% 210.17/210.32 |- mesh__recordOriginator mesh__D052139 jmp
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D052139 sjn
% 210.17/210.32 |- mesh__dateEstablished mesh__D052139 2006-01-01
% 210.17/210.32 |- skos__altLabel mesh__D052139 Calcium-Sensing Proteins, Intracellular
% 210.17/210.32 |- skos__hiddenLabel mesh__D052139 Calcium Sensing Proteins, Intracellular
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D052139 2006
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D052139 2006
% 210.17/210.32 |- mesh__recordMaintainer mesh__D052139 jmp
% 210.17/210.32 |- skos__broader mesh__D052139smesh__D002135
% 210.17/210.32 |- skos__broader mesh__D052139smesh__D047908
% 210.17/210.32 |- skos__altLabel mesh__D052139 Calcium-Sensing Peptides, Intracellular
% 210.17/210.32 |- rdf__type mesh__D052139sskos__Concept
% 210.17/210.32 |- skos__annotation mesh__D002794 /biosyn /physiol permitted
% 210.17/210.32 |- skos__hiddenLabel mesh__D002794 O-Sulfate, Choline
% 210.17/210.32 |- skos__hiddenLabel mesh__D002794 Bitartrate, Choline
% 210.17/210.32 |- skos__altLabel mesh__D002794 2-Hydroxy-N,N,N-trimethylethanaminium
% 210.17/210.32 |- skos__broader mesh__D002794smesh__D050337
% 210.17/210.32 |- skos__altLabel mesh__D002794 Vidine
% 210.17/210.32 |- skos__hiddenLabel mesh__D002794 Citrate, Choline
% 210.17/210.32 |- rdf__type mesh__D002794sskos__Concept
% 210.17/210.32 |- skos__prefLabel mesh__D002794 Choline
% 210.17/210.32 |- skos__scopeNote mesh__D002794
% 210.17/210.32 A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism.%A%
% 210.17/210.32 |- skos__altLabel mesh__D002794 Fagine
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D002794 sjn
% 210.17/210.32 |- mesh__recordMaintainer mesh__D002794 ssb
% 210.17/210.32 |- skos__broader mesh__D002794smesh__D004983
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D002794 2006
% 210.17/210.32 |- skos__hiddenLabel mesh__D002794 Chloride, Choline
% 210.17/210.32 |- skos__broader mesh__D002794smesh__D000644
% 210.17/210.32 |- mesh__dateRevised mesh__D002794 2005-06-30
% 210.17/210.32 |- mesh__recordOriginator mesh__D002794 NLM
% 210.17/210.32 |- mesh__dateCreated mesh__D002794 1999-01-01
% 210.17/210.32 |- skos__hiddenLabel mesh__D002794 Choline O Sulfate
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D010428 2006
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D010428 sjn
% 210.17/210.32 |- mesh__dateCreated mesh__D010428 1999-01-01
% 210.17/210.32 |- mesh__recordOriginator mesh__D010428 NLM
% 210.17/210.32 |- skos__broader mesh__D010428smesh__D013403
% 210.17/210.32 |- rdf__type mesh__D010428sskos__Concept
% 210.17/210.32 |- mesh__dateRevised mesh__D010428 2005-07-01
% 210.17/210.32 |- skos__prefLabel mesh__D010428 Pentosephosphates
% 210.17/210.32 |- mesh__recordMaintainer mesh__D010428 sjn
% 210.17/210.32 |- skos__annotation mesh__D010428
% 210.17/210.32 /metab: consider also PENTOSE PHOSPHATE PATHWAY
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 1992
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 1999
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 2000
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D015911 90
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 1996
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 1993
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 2005
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D015911 PLS
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 2001
% 210.17/210.32 |- mesh__recordMaintainer mesh__D015911 TGC
% 210.17/210.32 |- skos__related mesh__D015911smesh__D012597
% 210.17/210.32 |- skos__prefLabel mesh__D015911 Sclerotherapy
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 1997
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 2006
% 210.17/210.32 |- mesh__historyNote mesh__D015911 90
% 210.17/210.32 |- skos__broader mesh__D015911smesh__D004358
% 210.17/210.32 |- mesh__recordOriginator mesh__D015911 PLS
% 210.17/210.32 |- skos__scopeNote mesh__D015911
% 210.17/210.32 Treatment of varicose veins, hemorrhoids, gastric and esophageal varices, and peptic ulcer hemorrhage by injection or infusion of chemical agents which cause localized thrombosis and eventual fibrosis and obliteration of the vessels.%A%
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 2003
% 210.17/210.32 |- skos__annotation mesh__D015911
% 210.17/210.32 coord IM with dis /ther %28%IM%29%, not /drug ther
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 1994
% 210.17/210.32 |- mesh__dateCreated mesh__D015911 1989-05-16
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 2002
% 210.17/210.32 |- skos__historyNote mesh__D015911 Sclerosing Solutions %28%1966-1989%29%
% 210.17/210.32 |- skos__hiddenLabel mesh__D015911 Sclerotherapies
% 210.17/210.32 |- mesh__dateEstablished mesh__D015911 1990-01-01
% 210.17/210.32 |- rdf__type mesh__D015911sskos__Concept
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 2004
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 1998
% 210.17/210.32 |- mesh__dateRevised mesh__D015911 1991-06-20
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015911 1995
% 210.17/210.32 |- mesh__historyNote mesh__D015113
% 210.17/210.32 98%28%75%29%; was 5-ANDROSTANE-3,17-DIOL 1975-97; see ANDROSTANOLS 1980-90; was ANDROSTANEDIOL see ANDROSTANES 1975-79%A%
% 210.17/210.32 |- skos__hiddenLabel mesh__D015113 Androstane 3,17 diol
% 210.17/210.32 |- skos__broader mesh__D015113smesh__D045165
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015113 2005
% 210.17/210.32 |- skos__altLabel mesh__D015113 5alpha-Androstane-3beta,17alpha-diol
% 210.17/210.32 |- skos__broader mesh__D015113smesh__D000732
% 210.17/210.32 |- skos__scopeNote mesh__D015113
% 210.17/210.32 The unspecified form of the steroid, normally a major metabolite of TESTOSTERONE with androgenic activity. It has been implicated as a regulator of gonadotropin secretion.%A%
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015113 2006
% 210.17/210.32 |- skos__hiddenLabel mesh__D015113 5alpha Androstane 3beta,17alpha diol
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D015113 sjn
% 210.17/210.32 |- mesh__onlineNote mesh__D015113
% 210.17/210.32 use 5-ANDROSTANE-3,17-DIOL to search ANDROSTANEDIOL 1975-79%A%
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D015113 2004
% 210.17/210.32 |- skos__hiddenLabel mesh__D015113 5 alpha Androstane 3 beta,17 beta diol
% 210.17/210.32 |- mesh__dateRevised mesh__D015113 2003-07-09
% 210.17/210.32 |- skos__historyNote mesh__D015113 Hydroxysteroids %28%1973-1974%29%
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D015113
% 210.17/210.32 98; was 5-ANDROSTANE-3,17-DIOL 1975-97; 91; see ANDROSTANOLS 1980-90; was ANDROSTANEDIOL see ANDROSTANES 1975-79%A%
% 210.17/210.32 |- skos__historyNote mesh__D015113 Androstanes %28%1973-1975%29%
% 210.17/210.32 |- skos__prefLabel mesh__D015113 Androstane-3,17-diol
% 210.17/210.32 |- skos__hiddenLabel mesh__D015113 5 alpha Androstane 3alpha,17 beta diol
% 210.17/210.32 |- skos__altLabel mesh__D015113 5 Androstane 3,17 diol
% 210.17/210.32 |- skos__hiddenLabel mesh__D015113 5 alpha Androstane 3 beta,17 alpha diol
% 210.17/210.32 |- rdf__type mesh__D015113sskos__Concept
% 210.17/210.32 |- skos__altLabel mesh__D015113 5-Androstane-3,17-diol
% 210.17/210.32 |- mesh__recordOriginator mesh__D015113 NLM
% 210.17/210.32 |- skos__altLabel mesh__D015113 5 alpha-Androstane-3alpha,17 beta-diol
% 210.17/210.32 |- mesh__dateCreated mesh__D015113 1974-11-11
% 210.17/210.32 |- skos__hiddenLabel mesh__D015113 5 alpha Androstane 3 alpha,17 beta diol
% 210.17/210.32 |- skos__hiddenLabel mesh__D015113 5 beta Androstane 3 alpha,17 beta diol
% 210.17/210.32 |- mesh__recordMaintainer mesh__D015113 lkt
% 210.17/210.32 |- mesh__dateEstablished mesh__D015113 1991-01-01
% 210.17/210.32 |- skos__related mesh__D020856smesh__D001482
% 210.17/210.32 |- mesh__dateRevised mesh__D020856 2002-07-02
% 210.17/210.32 |- skos__historyNote mesh__D020856 Base Sequence %28%1980-1999%29%
% 210.17/210.32 |- skos__hiddenLabel mesh__D020856 Region, AT Rich
% 210.17/210.32 |- skos__broader mesh__D020856smesh__D001483
% 210.17/210.32 |- skos__historyNote mesh__D020856 Adenine %28%1971-1987%29%
% 210.17/210.32 |- skos__related mesh__D020856smesh__D020862
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D020856 2000
% 210.17/210.32 |- skos__hiddenLabel mesh__D020856 Regions, AT Rich
% 210.17/210.32 |- mesh__recordMaintainer mesh__D020856 nns
% 210.17/210.32 |- skos__hiddenLabel mesh__D020856 Sequences, AT Rich
% 210.17/210.32 |- mesh__dateEstablished mesh__D020856 2000-01-01
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020856 2003
% 210.17/210.32 |- skos__hiddenLabel mesh__D020856 Sequence, AT Rich
% 210.17/210.32 |- skos__prefLabel mesh__D020856 AT Rich Sequence
% 210.17/210.32 |- mesh__historyNote mesh__D020856 2000
% 210.17/210.32 |- rdf__type mesh__D020856sskos__Concept
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020856 2004
% 210.17/210.32 |- skos__altLabel mesh__D020856 AT Rich Region
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020856 2005
% 210.17/210.32 |- mesh__dateCreated mesh__D020856 1999-11-03
% 210.17/210.32 |- skos__scopeNote mesh__D020856
% 210.17/210.32 A nucleic acid sequence that contains an above average number of ADENINE and THYMINE bases.%A%
% 210.17/210.32 |- skos__hiddenLabel mesh__D020856 AT Rich Sequences
% 210.17/210.32 |- mesh__recordOriginator mesh__D020856 nns
% 210.17/210.32 |- skos__hiddenLabel mesh__D020856 AT Rich Regions
% 210.17/210.32 |- skos__historyNote mesh__D020856 Thymine %28%1971-1987%29%
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D020856 sjn
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020856 2006
% 210.17/210.32 |- skos__hiddenLabel mesh__D039561 Initiation Factor-4E, Eukaryotic
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D039561
% 210.17/210.32 2003; EIF-4E %28%now EUKARYOTIC INITIATION FACTOR-4E%29% was indexed under PEPTIDE INITIATION FACTORS 1986-2002%A%
% 210.17/210.32 |- skos__altLabel mesh__D039561 Peptide Initiation Factor EIF-4E
% 210.17/210.32 |- skos__altLabel mesh__D039561 Eukaryotic Peptide Initiation Factor-4E
% 210.17/210.32 |- skos__scopeNote mesh__D039561
% 210.17/210.32 A peptide initiation factor that binds specifically to the 5%27% MRNA CAP STRUCTURE of MRNA in the CYTOPLASM. It is a component of the trimeric complex EIF4F.%A%
% 210.17/210.32 |- rdf__type mesh__D039561sskos__Concept
% 210.17/210.32 |- skos__broader mesh__D039561smesh__D039381
% 210.17/210.32 |- skos__prefLabel mesh__D039561 Eukaryotic Initiation Factor-4E
% 210.17/210.32 |- skos__altLabel mesh__D039561 EIF4E
% 210.17/210.32 |- mesh__historyNote mesh__D039561
% 210.17/210.32 2003; use EUKARYOTIC INITIATION FACTOR-4E %28%NM%29% 1986-2002
% 210.17/210.32 |- skos__broader mesh__D039561smesh__D039562
% 210.17/210.32 |- skos__hiddenLabel mesh__D039561 Factor-4E, Eukaryotic Initiation
% 210.17/210.32 |- skos__hiddenLabel mesh__D039561 EIF 4E
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D039561 2006
% 210.17/210.32 |- mesh__dateCreated mesh__D039561 2002-07-03
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D039561 2004
% 210.17/210.32 |- skos__hiddenLabel mesh__D039561 Eukaryotic Peptide Initiation Factor 4E
% 210.17/210.32 |- mesh__dateEstablished mesh__D039561 2003-01-01
% 210.17/210.32 |- skos__altLabel mesh__D039561 EIF-4E
% 210.17/210.32 |- skos__historyNote mesh__D039561
% 210.17/210.32 Peptide Initiation Factors %28%1986-2002%29%
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D039561 2005
% 210.17/210.32 |- skos__altLabel mesh__D039561 CDC33 Gene Product
% 210.17/210.32 |- skos__hiddenLabel mesh__D039561 Eukaryotic Initiation Factor 4E
% 210.17/210.32 |- skos__hiddenLabel mesh__D039561 Peptide Initiation Factor EIF 4E
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D039561 2003
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 2004
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 2000
% 210.17/210.32 |- skos__broader mesh__D006387smesh__D018406
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 1999
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 2003
% 210.17/210.32 |- rdf__type mesh__D006387sskos__Concept
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 1998
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D006387 PLS
% 210.17/210.32 |- skos__prefLabel mesh__D006387 Hemagglutination, Viral
% 210.17/210.32 |- mesh__historyNote mesh__D006387 70
% 210.17/210.32 |- skos__hiddenLabel mesh__D006387 Viral Hemagglutination
% 210.17/210.32 |- mesh__recordOriginator mesh__D006387 NLM
% 210.17/210.32 |- skos__hiddenLabel mesh__D006387 Hemagglutinations, Viral
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 1997
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 2006
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 2002
% 210.17/210.32 |- mesh__dateEstablished mesh__D006387 1970-01-01
% 210.17/210.32 |- mesh__dateRevised mesh__D006387 1994-02-08
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 1996
% 210.17/210.32 |- skos__hiddenLabel mesh__D006387 Viral Hemagglutinations
% 210.17/210.32 |- mesh__recordMaintainer mesh__D006387 PXP
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 2005
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 1995
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D006387 2001
% 210.17/210.32 |- skos__historyNote mesh__D006387 Hemagglutination %28%1966-1969%29%
% 210.17/210.32 |- mesh__dateCreated mesh__D006387 1999-01-01
% 210.17/210.32 |- skos__scopeNote mesh__D006387
% 210.17/210.32 Agglutination of erythrocytes by a virus.
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D006387 70
% 210.17/210.32 |- mesh__dateEstablished mesh__D020058 1999-01-01
% 210.17/210.32 |- skos__annotation mesh__D020058 STYRENES is also available
% 210.17/210.32 |- skos__scopeNote mesh__D020058
% 210.17/210.32 A colorless, toxic liquid with a strong aromatic odor. It is used to make rubbers, polymers and copolymers, and polystyrene plastics.%A%
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020058 2006
% 210.17/210.32 |- skos__prefLabel mesh__D020058 Styrene
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020058 2002
% 210.17/210.32 |- skos__altLabel mesh__D020058 Vinylbenzene
% 210.17/210.32 |- skos__historyNote mesh__D020058 Styrenes %28%1981-1998%29%
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020058 2005
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020058 2001
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020058 2004
% 210.17/210.32 |- mesh__historyNote mesh__D020058 99; use STYRENE %28%NM%29% 1981-98
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020058 2000
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020058 2003
% 210.17/210.32 |- skos__broader mesh__D020058smesh__D013343
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D020058 1999
% 210.17/210.32 |- skos__hiddenLabel mesh__D020058 Monomer, Styrene
% 210.17/210.32 |- rdf__type mesh__D020058sskos__Concept
% 210.17/210.32 |- mesh__dateCreated mesh__D020058 1998-06-11
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D020058
% 210.17/210.32 99; STYRENE was indexed under STYRENES 1981-98
% 210.17/210.32 |- skos__altLabel mesh__D020058 Styrol
% 210.17/210.32 |- skos__altLabel mesh__D020058 Styrene Monomer
% 210.17/210.32 |- skos__historyNote mesh__D014819 Lipoproteins %28%1972-1974%29%
% 210.17/210.32 |- skos__historyNote mesh__D014819 Egg Proteins %28%1973-1974%29%
% 210.17/210.32 |- skos__historyNote mesh__D014819 Phosphoproteins %28%1973-1974%29%
% 210.17/210.32 |- mesh__dateEstablished mesh__D014819 1986-01-01
% 210.17/210.32 |- mesh__recordOriginator mesh__D014819 NLM
% 210.17/210.32 |- skos__broader mesh__D014819smesh__D019476
% 210.17/210.32 |- rdf__type mesh__D014819sskos__Concept
% 210.17/210.32 |- skos__scopeNote mesh__D014819
% 210.17/210.32 Phospholipoglycoproteins produced in the fat body of egg-laying animals such as non-mammalian VERTEBRATES; ARTHROPODS; and others. Vitellogenins are secreted into the HEMOLYMPH, and taken into the OOCYTES by receptor-mediated ENDOCYTOSIS to form the major yolk proteins, VITELLINS. Vitellogenin production is under the regulation of steroid hormones, such as ESTRADIOL and JUVENILE HORMONES in insects.%A%
% 210.17/210.32 |- skos__broader mesh__D014819smesh__D047048
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D014819 sjn
% 210.17/210.32 |- mesh__historyNote mesh__D014819
% 210.17/210.32 2005 %28%1986%29%; use LIPOPROTEINS 1975-1985; for YOLK PROTEIN 2, DROSOPHILA use EGG PROTEINS 1990-2004%A%
% 210.17/210.32 |- mesh__recordMaintainer mesh__D014819 sjn
% 210.17/210.32 |- skos__prefLabel mesh__D014819 Vitellogenins
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D014819 2005
% 210.17/210.32 |- mesh__dateCreated mesh__D014819 1974-11-11
% 210.17/210.32 |- mesh__dateRevised mesh__D014819 2004-07-13
% 210.17/210.32 |- skos__broader mesh__D014819smesh__D008074
% 210.17/210.32 |- skos__broader mesh__D014819smesh__D010750
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D014819
% 210.17/210.32 2005; see VITELLOGENIN 1986-2004; see LIPOPROTEINS 1975-1985; for YOLK PROTEIN 2, DROSOPHILA see EGG PROTEINS 1990-2004%A%
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D014819 2006
% 210.17/210.32 |- skos__altLabel mesh__D014819 Vitellogenin
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D025541 2004
% 210.17/210.32 |- mesh__dateRevised mesh__D025541 2003-07-09
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D025541 2006
% 210.17/210.32 |- rdf__type mesh__D025541sskos__Concept
% 210.17/210.32 |- mesh__dateEstablished mesh__D025541 2002-01-01
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D025541
% 210.17/210.32 2002; see BACTERIOCHLOROPHYLLS 1991-2001; see CHLOROPHYLL 1983-1990%A%
% 210.17/210.32 |- skos__broader mesh__D025541smesh__D001429
% 210.17/210.32 |- skos__scopeNote mesh__D025541
% 210.17/210.32 A specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.%A%
% 210.17/210.32 |- skos__prefLabel mesh__D025541 Bacteriochlorophyll A
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D025541 2005
% 210.17/210.32 |- skos__historyNote mesh__D025541 Bacteriochlorophylls %28%1982-2001%29%
% 210.17/210.32 |- mesh__dateCreated mesh__D025541 2001-07-25
% 210.17/210.32 |- mesh__historyNote mesh__D025541
% 210.17/210.32 2002; use BACTERIOCHLOROPHYLLS 1983-2001
% 210.17/210.32 |- skos__prefLabel mesh__D019504 Eulogies %5B%Publication Type%5D%
% 210.17/210.32 |- skos__annotation mesh__D019504
% 210.17/210.32 publication type only; do not confuse with Publication Type FUNERAL SERMONS for eulogies delivered at funeral services%A%
% 210.17/210.32 |- skos__altLabel mesh__D019504 Eulogies %28%PT%29%
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D019504 sjn
% 210.17/210.32 |- mesh__dateCreated mesh__D019504 1996-06-21
% 210.17/210.32 |- skos__broader mesh__D019504smesh__D052180
% 210.17/210.32 |- skos__scopeNote mesh__D019504
% 210.17/210.32 Works consisting of speeches or writings in praise of a person or thing, especially a set oration in honor of a deceased person. They differ from FUNERAL SERMONS %5B%PUBLICATION TYPE%5D% which are delivered at ceremonies for the deceased prior to their burial or cremation. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%
% 210.17/210.32 |- mesh__recordMaintainer mesh__D019504 jls
% 210.17/210.32 |- skos__altLabel mesh__D019504 Eulogies
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D019504 2006
% 210.17/210.32 |- mesh__recordOriginator mesh__D019504 TGC
% 210.17/210.32 |- mesh__dateRevised mesh__D019504 2005-06-30
% 210.17/210.32 |- mesh__historyNote mesh__D019504 1997
% 210.17/210.32 |- mesh__dateEstablished mesh__D019504 1997-01-01
% 210.17/210.32 |- rdf__type mesh__D019504sskos__Concept
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D011521
% 210.17/210.32 91; was see under CHLOROPHYLL 1975-90
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D011521 sjn
% 210.17/210.32 |- mesh__dateCreated mesh__D011521 1974-11-19
% 210.17/210.32 |- skos__altLabel mesh__D011521 Monovinyl Protochlorophyllide
% 210.17/210.32 |- skos__altLabel mesh__D011521 MV-PChlide
% 210.17/210.32 |- mesh__dateRevised mesh__D011521 2005-06-30
% 210.17/210.32 |- mesh__dateEstablished mesh__D011521 1991-01-01
% 210.17/210.32 |- skos__historyNote mesh__D011521 Porphyrins %28%1972-1974%29%
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D011521 2006
% 210.17/210.32 |- mesh__recordOriginator mesh__D011521 NLM
% 210.17/210.32 |- mesh__recordMaintainer mesh__D011521 ssb
% 210.17/210.32 |- skos__hiddenLabel mesh__D011521 MV PChlide
% 210.17/210.32 |- skos__broader mesh__D011521smesh__D002734
% 210.17/210.32 |- rdf__type mesh__D011521sskos__Concept
% 210.17/210.32 |- skos__annotation mesh__D011521 a chlorophyll
% 210.17/210.32 |- mesh__historyNote mesh__D011521
% 210.17/210.32 91%28%75%29%; was see under CHLOROPHYLL 1975-90
% 210.17/210.32 |- skos__historyNote mesh__D011521 Chlorophyll %28%1972-1974%29%
% 210.17/210.32 |- skos__scopeNote mesh__D011521
% 210.17/210.32 A photo-active pigment localized in prolamellar bodies occurring within the proplastids of dark-grown bean leaves. In the process of photoconversion, the highly fluorescent protochlorophyllide is converted to chlorophyll.%A%
% 210.17/210.32 |- skos__prefLabel mesh__D011521 Protochlorophyllide
% 210.17/210.32 |- skos__hiddenLabel mesh__D011521 Protochlorophyllide, Monovinyl
% 210.17/210.32 |- skos__hiddenLabel mesh__D011521 A, Protochlorophyllide
% 210.17/210.32 |- mesh__dateCreated mesh__D002795 1974-11-19
% 210.17/210.32 |- skos__scopeNote mesh__D002795
% 210.17/210.32 An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6.%A%
% 210.17/210.32 |- skos__historyNote mesh__D002795 Choline %28%1966-1974%29%
% 210.17/210.32 |- mesh__recordOriginator mesh__D002795 NLM
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D002795 2006
% 210.17/210.32 |- mesh__dateEstablished mesh__D002795 1978-01-01
% 210.17/210.32 |- skos__prefLabel mesh__D002795 Choline O-Acetyltransferase
% 210.17/210.32 |- skos__altLabel mesh__D002795 Choline Acetyltransferase
% 210.17/210.32 |- skos__hiddenLabel mesh__D002795 O-Acetyltransferase, Choline
% 210.17/210.32 |- skos__hiddenLabel mesh__D002795 Choline O Acetyltransferase
% 210.17/210.32 |- skos__historyNote mesh__D002795 Acetyltransferases %28%1973-1974%29%
% 210.17/210.32 |- mesh__historyNote mesh__D002795 98%28%75%29%
% 210.17/210.32 |- skos__hiddenLabel mesh__D002795 Acetylase, Choline
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D002795 2005
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D002795
% 210.17/210.32 98; see CHOLINE ACETYLTRANSFERASE 1978-97; see ACETYLTRANSFERASES 1975-77%A%
% 210.17/210.32 |- mesh__dateRevised mesh__D002795 2003-07-09
% 210.17/210.32 |- skos__historyNote mesh__D002795 Transferases %28%1966-1972%29%
% 210.17/210.32 |- skos__hiddenLabel mesh__D002795 Acetyltransferase, Choline
% 210.17/210.32 |- skos__broader mesh__D002795smesh__D000123
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D002795 sjn
% 210.17/210.32 |- mesh__activeMeSHYear mesh__D002795 2004
% 210.17/210.32 |- rdf__type mesh__D002795sskos__Concept
% 210.17/210.32 |- mesh__recordMaintainer mesh__D002795 ssb
% 210.17/210.32 |- skos__altLabel mesh__D002795 Choline Acetylase
% 210.17/210.32 |- rdf__type mesh__D043603sskos__Concept
% 210.17/210.32 |- skos__broader mesh__D043603smesh__D045643
% 210.17/210.32 |- skos__hiddenLabel mesh__D043603 Endonuclease, Apurine-Apyrimidine
% 210.17/210.32 |- mesh__dateCreated mesh__D043603 2003-07-09
% 210.17/210.32 |- skos__hiddenLabel mesh__D043603 DNA Endonuclease, Apurinic
% 210.17/210.32 |- skos__altLabel mesh__D043603 Apurinic DNA Endonuclease
% 210.17/210.32 |- mesh__publicMeSHNote mesh__D043603
% 210.17/210.32 2004; DNA-%28%APURINIC OR APYRIMIDINIC SITE%29% LYASE was indexed under CARBON-OXYGEN LYASES 1996-2003, DEOXYRIBONUCLEASES 1978-1982, ENDODEOXYRIBONUCLEASES 1983-1995, ENDONUCLEASES 1978-1982 %26% LYASES 1978-1980%A%
% 210.17/210.32 |- mesh__dateEstablished mesh__D043603 2004-01-01
% 210.17/210.32 |- mesh__recordAuthorizer mesh__D043603 sjn
% 210.17/210.32 |- skos__scopeNote mesh__D043603
% 210.17/210.32 A DNA repair enzyme that catalyses the excision of ribose residues at apurinic and apyrimidinic DNA sites that can result from the action of DNA GLYCOSYLASES. The enzyme catalyzes a beta-elimination reaction in which the C-O-P bond 3%27% to the apurinic or apyrimidinic site in DNA is broken, leaving a 3%27%-terminal unsaturated sugar and a product with a terminal 5%27%-phosphate. This enzyme was previously listed under EC 3.1.25.2.%A%
% 210.17/210.32 |- skos__broader mesh__D043603smesh__D019757
% 210.17/210.32 |- mesh__historyNote mesh__D043603
% 210.17/210.32 2004; use DNA-%28%APURINIC OR APYRIMIDINIC SITE%29% LYASE %28%NM%29% 1980-2003%A%
% 210.17/210.32 |- skos__historyNote mesh__D043603 Carbon-Oxygen Lyases %28%1978-2003%29%
% 210.17/210.32 |- skos__hiddenLabel mesh__D043603 Endonuclease, Apurinic
% 210.17/210.32 |- skos__altLabel mesh__D043603
% 210.17/210.32 Endodeoxyribonuclease %28%Apurinic or Apyrimidinic%29%
% 210.17/210.32 |- skos__hiddenLabel mesh__D043603 Apurine Apyrimidine Endonuclease
% 210.17/210.32 |- skos__altLabel mesh__D043603 AP Lyase
% 210.18/210.32 |- skos__hiddenLabel mesh__D043603 Endonuclease, Apurinic DNA
% 210.18/210.32 |- mesh__recordOriginator mesh__D043603 AKE
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D043603 2004
% 210.18/210.32 |- skos__hiddenLabel mesh__D043603 Endonuclease, AP
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D043603 2005
% 210.18/210.32 |- skos__altLabel mesh__D043603 AP Endonuclease
% 210.18/210.32 |- mesh__recordMaintainer mesh__D043603 jmp
% 210.18/210.32 |- skos__altLabel mesh__D043603 Apurinic Endonuclease
% 210.18/210.32 |- skos__prefLabel mesh__D043603
% 210.18/210.32 DNA-%28%Apurinic or Apyrimidinic Site%29% Lyase
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D043603 2006
% 210.18/210.32 |- skos__altLabel mesh__D043603 DNA Lyase %28%Apurinic or Apyrimidinic%29%
% 210.18/210.32 |- skos__altLabel mesh__D043603 Apurine-Apyrimidine Endonuclease
% 210.18/210.32 |- mesh__dateCreated mesh__D010429 1999-01-01
% 210.18/210.32 |- mesh__dateRevised mesh__D010429 2004-07-07
% 210.18/210.32 |- skos__prefLabel mesh__D010429 Pentoses
% 210.18/210.32 |- rdf__type mesh__D010429sskos__Concept
% 210.18/210.32 |- mesh__recordAuthorizer mesh__D010429 sjn
% 210.18/210.32 |- mesh__recordOriginator mesh__D010429 NLM
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D010429 2005
% 210.18/210.32 |- skos__scopeNote mesh__D010429
% 210.18/210.32 A class of carbohydrates that contains five carbon atoms.%A%
% 210.18/210.32 |- mesh__recordMaintainer mesh__D010429 ssb
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D010429 2006
% 210.18/210.32 |- skos__broader mesh__D010429smesh__D009005
% 210.18/210.32 |- skos__annotation mesh__D010429 monosaccharides; GEN; prefer specifics
% 210.18/210.32 |- skos__hiddenLabel mesh__D007480 Acid, Iopanoic
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D007480 2005
% 210.18/210.32 |- skos__hiddenLabel mesh__D007480 Acid, Iodopanoic
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D007480 2002
% 210.18/210.32 |- skos__altLabel mesh__D007480 Iodopanoic Acid
% 210.18/210.32 |- skos__annotation mesh__D007480 D25-26 qualif
% 210.18/210.32 |- rdf__type mesh__D007480sskos__Concept
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D007480 2004
% 210.18/210.32 |- mesh__recordOriginator mesh__D007480 NLM
% 210.18/210.32 |- mesh__recordAuthorizer mesh__D007480 sjn
% 210.18/210.32 |- skos__scopeNote mesh__D007480
% 210.18/210.32 Radiopaque medium used as diagnostic aid.
% 210.18/210.32 |- mesh__dateRevised mesh__D007480 2000-06-21
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D007480 2001
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D007480 2003
% 210.18/210.32 |- mesh__dateCreated mesh__D007480 1999-01-01
% 210.18/210.32 |- skos__broader mesh__D007480smesh__D007462
% 210.18/210.32 |- skos__prefLabel mesh__D007480 Iopanoic Acid
% 210.18/210.32 |- mesh__recordMaintainer mesh__D007480 CCR
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D007480 2006
% 210.18/210.32 |- skos__hiddenLabel mesh__D015912 Therapies, Thrombolytic
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D015912 1993
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D015912 1996
% 210.18/210.32 |- skos__historyNote mesh__D015912 Fibrinolysis %28%1966-1989%29%
% 210.18/210.32 |- mesh__activeMeSHYear mesh__D015912 2000
% 210.18/210.32 |- skos__prefLabel mesh__D015912 Thrombolytic Therapy
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 2004
% 210.18/210.33 |- skos__historyNote mesh__D015912 Fibrinolytic Agents %28%1966-1989%29%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 1992
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 1999
% 210.18/210.33 |- skos__hiddenLabel mesh__D015912 Thrombolyses, Therapeutic
% 210.18/210.33 |- skos__altLabel mesh__D015912 Therapeutic Thrombolysis
% 210.18/210.33 |- mesh__historyNote mesh__D015912 90
% 210.18/210.33 |- skos__hiddenLabel mesh__D015912 Therapeutic Thrombolyses
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 1991
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 2003
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 1995
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 1998
% 210.18/210.33 |- rdf__type mesh__D015912sskos__Concept
% 210.18/210.33 |- skos__altLabel mesh__D015912 Therapy, Thrombolytic
% 210.18/210.33 |- skos__historyNote mesh__D015912
% 210.18/210.33 Thrombosis/drug therapy %28%1966-1989%29%
% 210.18/210.33 |- skos__broader mesh__D015912smesh__D004358
% 210.18/210.33 |- skos__hiddenLabel mesh__D015912 Fibrinolytic Therapies
% 210.18/210.33 |- skos__hiddenLabel mesh__D015912 Thrombolytic Therapies
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 2002
% 210.18/210.33 |- mesh__dateCreated mesh__D015912 1989-09-06
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D015912 90
% 210.18/210.33 |- skos__altLabel mesh__D015912 Thrombolysis, Therapeutic
% 210.18/210.33 |- skos__annotation mesh__D015912
% 210.18/210.33 coord IM with specific thrombolytic agents /ther use %28%IM%29% if specified + dis /drug ther %28%IM%29%%A%
% 210.18/210.33 |- mesh__dateEstablished mesh__D015912 1990-01-01
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 2006
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 1994
% 210.18/210.33 |- skos__altLabel mesh__D015912 Fibrinolytic Therapy
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 1990
% 210.18/210.33 |- skos__altLabel mesh__D015912 Therapy, Fibrinolytic
% 210.18/210.33 |- skos__historyNote mesh__D015912
% 210.18/210.33 Thromboembolism/drug therapy %28%1966-1989%29%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 2005
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 1997
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015912 2001
% 210.18/210.33 |- skos__hiddenLabel mesh__D015912 Therapies, Fibrinolytic
% 210.18/210.33 |- skos__scopeNote mesh__D015912
% 210.18/210.33 Use of infusions of fibrinolytic agents to destroy or dissolve thrombi in blood vessels or bypass grafts.%A%
% 210.18/210.33 |- rdf__type mesh__D015114sskos__Concept
% 210.18/210.33 |- skos__hiddenLabel mesh__D015114 delta 5 Androstene 3 beta,17 beta Diol
% 210.18/210.33 |- skos__hiddenLabel mesh__D015114 Androst 5 ene 3,17 diol
% 210.18/210.33 |- skos__altLabel mesh__D015114 Delta 5-Androstenediol
% 210.18/210.33 |- skos__hiddenLabel mesh__D015114 Androst 5 ene 3 beta,17 beta Diol
% 210.18/210.33 |- skos__altLabel mesh__D015114 5-Androstene-3,17-diol
% 210.18/210.33 |- skos__altLabel mesh__D015114 5-Androstene-3beta-17beta-Diol
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015114 2006A
% 210.18/210.33 |- mesh__dateRevised mesh__D015114 2005-07-11
% 210.18/210.33 |- mesh__recordMaintainer mesh__D015114 ags
% 210.18/210.33 |- skos__prefLabel mesh__D015114 Androstenediol
% 210.18/210.33 |- mesh__historyNote mesh__D015114
% 210.18/210.33 2004 %28%1976%29%; use 5-ANDROSTENE-3,17-DIOL 1991-1997, use ANDROSTENEDIOLS 1976-1990%A%
% 210.18/210.33 |- skos__hiddenLabel mesh__D015114 Delta 5 Androstenediol
% 210.18/210.33 |- skos__altLabel mesh__D015114 Parke Davis Brand of Androstenediol
% 210.18/210.33 |- mesh__dateCreated mesh__D015114 1975-07-18
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D015114 ags
% 210.18/210.33 |- mesh__dateEstablished mesh__D015114 1991-01-01
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015114 2004
% 210.18/210.33 |- skos__altLabel mesh__D015114 delta 5-Androstene-3 beta,17 beta-Diol
% 210.18/210.33 |- skos__altLabel mesh__D015114 Hermaphrodiol
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015114 2006
% 210.18/210.33 |- skos__broader mesh__D015114smesh__D000734
% 210.18/210.33 |- mesh__recordOriginator mesh__D015114 RLS
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D015114
% 210.18/210.33 2004; see ANDROST-5-ENE-3 BETA,17 BETA-DIOL 1998-2003, see 5-ANDROSTENE-3,17-DIOL 1991-1997, see ANDROSTENEDIOLS 1976-1990%A%
% 210.18/210.33 |- skos__scopeNote mesh__D015114
% 210.18/210.33 An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group %28%17-HYDROXYSTEROID DEHYDROGENASES%29%, is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group %28%3-HYDROXYSTEROID DEHYDROGENASES%29%.%A%
% 210.18/210.33 |- skos__historyNote mesh__D015114 Androstenediols %28%1975%29%
% 210.18/210.33 |- skos__hiddenLabel mesh__D015114 5 Androstene 3beta 17beta Diol
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015114 2005
% 210.18/210.33 |- skos__hiddenLabel mesh__D015114 5 Androstene 3,17 diol
% 210.18/210.33 |- skos__altLabel mesh__D015114 Androst-5-ene-3,17-diol
% 210.18/210.33 |- skos__broader mesh__D015114smesh__D045165
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015114 2006B
% 210.18/210.33 |- skos__altLabel mesh__D015114 Androst-5-ene-3 beta,17 beta-Diol
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020857 2003
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020857 2002
% 210.18/210.33 |- rdf__type mesh__D020857sskos__Concept
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020857 2006
% 210.18/210.33 |- mesh__historyNote mesh__D020857 2000
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020857 2005
% 210.18/210.33 |- skos__historyNote mesh__D020857
% 210.18/210.33 Foot Deformities, Acquired %28%1979-1996%29%
% 210.18/210.33 |- skos__prefLabel mesh__D020857 Hallux Limitus
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D020857 2000
% 210.18/210.33 |- skos__broader mesh__D020857smesh__D007592
% 210.18/210.33 |- mesh__dateCreated mesh__D020857 1999-11-03
% 210.18/210.33 |- skos__historyNote mesh__D020857 Foot Diseases %28%1997%29%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020857 2001
% 210.18/210.33 |- skos__hiddenLabel mesh__D020857 Limitus, Hallux
% 210.18/210.33 |- mesh__dateEstablished mesh__D020857 2000-01-01
% 210.18/210.33 |- skos__historyNote mesh__D020857 Foot Deformities %28%1998-1999%29%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020857 2000
% 210.18/210.33 |- skos__scopeNote mesh__D020857
% 210.18/210.33 A bony proliferation and articular degeneration of the first METATARSOPHALANGEAL JOINT that is characterized by pain and a progressive decrease in the dorsiflexion range of motion.%A%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020857 2004
% 210.18/210.33 |- skos__broader mesh__D020857smesh__D005531
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D039562 2006A
% 210.18/210.33 |- mesh__dateEstablished mesh__D039562 2003-01-01
% 210.18/210.33 |- mesh__recordOriginator mesh__D039562 jmp
% 210.18/210.33 |- skos__altLabel mesh__D039562 EIF-4F
% 210.18/210.33 |- mesh__dateCreated mesh__D039562 2002-07-03
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D039562 2006
% 210.18/210.33 |- mesh__historyNote mesh__D039562
% 210.18/210.33 2003; use EUKARYOTIC INITIATION FACTOR-4F %28%NM%29% 1983-2003
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D039562 2004
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D039562
% 210.18/210.33 2003; EIF-4F %28%now EUKARYOTIC INITIATION FACTOR-4F%29% was indexed under PEPTIDE INITIATION FACTORS 1983-2003%A%
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D039562 ags
% 210.18/210.33 |- skos__prefLabel mesh__D039562 Eukaryotic Initiation Factor-4F
% 210.18/210.33 |- mesh__recordMaintainer mesh__D039562 ags
% 210.18/210.33 |- skos__hiddenLabel mesh__D039562 EIF 4F
% 210.18/210.33 |- skos__altLabel mesh__D039562 Peptide Initiation Factor EIF-4F
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D039562 2005
% 210.18/210.33 |- skos__hiddenLabel mesh__D039562 Peptide Initiation Factor EIF 4F
% 210.18/210.33 |- skos__broader mesh__D039562smesh__D039381
% 210.18/210.33 |- skos__altLabel mesh__D039562 EIF4F
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D039562 2003
% 210.18/210.33 |- skos__scopeNote mesh__D039562
% 210.18/210.33 A trimeric peptide initiation factor complex that associates with the 5%27% MRNA CAP STRUCTURE of RNA and plays an essential role in MRNA TRANSLATION. It is composed of EUKAYROTIC INITIATION FACTOR-4A; EUKARYOTIC INITIATION FACTOR-4E; and EUKAYROTIC INITIATION FACTOR-4G.%A%
% 210.18/210.33 |- skos__hiddenLabel mesh__D039562 Protein Initiation Factor EIF 4F
% 210.18/210.33 |- skos__historyNote mesh__D039562
% 210.18/210.33 Peptide Initiation Factors %28%1983-2002%29%
% 210.18/210.33 |- skos__altLabel mesh__D039562 Eukaryotic Initiation Factor-%28%iso%29%4F
% 210.18/210.33 |- skos__hiddenLabel mesh__D039562 Initiation Factor-4F, Eukaryotic
% 210.18/210.33 |- skos__hiddenLabel mesh__D039562 Eukaryotic Initiation Factor 4F
% 210.18/210.33 |- mesh__dateRevised mesh__D039562 2005-07-13
% 210.18/210.33 |- skos__broader mesh__D039562smesh__D039642
% 210.18/210.33 |- rdf__type mesh__D039562sskos__Concept
% 210.18/210.33 |- skos__altLabel mesh__D039562 EIF4F Translation Initiation Complex
% 210.18/210.33 |- skos__altLabel mesh__D039562 Protein Initiation Factor EIF-4F
% 210.18/210.33 |- rdf__type mesh__D006388sskos__Concept
% 210.18/210.33 |- mesh__recordMaintainer mesh__D006388 ssb
% 210.18/210.33 |- mesh__dateRevised mesh__D006388 2005-06-30
% 210.18/210.33 |- skos__prefLabel mesh__D006388 Hemagglutinins
% 210.18/210.33 |- mesh__onlineNote mesh__D006388 search ANTIBODIES 1966-74
% 210.18/210.33 |- skos__historyNote mesh__D006388 Antibodies %28%1966-1974%29%
% 210.18/210.33 |- mesh__historyNote mesh__D006388
% 210.18/210.33 81%28%75%29%; was see under AGGLUTININS 1975-80, was see under ANTIBODIES 1968-74, was see ANTIBODIES 1963-67%A%
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D006388 sjn
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D006388 2006
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D006388
% 210.18/210.33 81; was see under AGGLUTININS 1975-80, was indexed under ANTIBODIES 1963-74.%A%
% 210.18/210.33 |- skos__broader mesh__D006388smesh__D000373
% 210.18/210.33 |- mesh__dateCreated mesh__D006388 1999-01-01
% 210.18/210.33 |- mesh__recordOriginator mesh__D006388 NLM
% 210.18/210.33 |- skos__annotation mesh__D006388
% 210.18/210.33 restrict to erythrocytes: leukoagglutinins are indexed under AGGLUTININS %28%IM%29% + LEUKOCYTES or specific with /immunol %28%IM%29%%A%
% 210.18/210.33 |- skos__scopeNote mesh__D006388
% 210.18/210.33 Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc.%A%
% 210.18/210.33 |- skos__altLabel mesh__D006388 Hemagglutinin
% 210.18/210.33 |- mesh__dateEstablished mesh__D006388 1981-01-01
% 210.18/210.33 |- skos__scopeNote mesh__D020059
% 210.18/210.33 An aspartic endopeptidase of the hydrolase class that is similar to cathepsin D but has a slightly broader specificity. EC 3.4.23.34.%A%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020059 2004
% 210.18/210.33 |- skos__altLabel mesh__D020059 Slow Moving Proteinase
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D020059 sjn
% 210.18/210.33 |- skos__altLabel mesh__D020059 Erythrocyte Membrane Aspartic Proteinase
% 210.18/210.33 |- skos__broader mesh__D020059smesh__D002403
% 210.18/210.33 |- skos__prefLabel mesh__D020059 Cathepsin E
% 210.18/210.33 |- mesh__dateEstablished mesh__D020059 1999-01-01
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D020059
% 210.18/210.33 99; CATHEPSIN E %26% ERYTHROCYTE MEMBRANE ASPARTIC PROTEINASE were indexed under CATHEPSINS 1980-98%A%
% 210.18/210.33 |- mesh__recordMaintainer mesh__D020059 ssb
% 210.18/210.33 |- mesh__recordOriginator mesh__D020059 ADP
% 210.18/210.33 |- skos__broader mesh__D020059smesh__D016282
% 210.18/210.33 |- rdf__type mesh__D020059sskos__Concept
% 210.18/210.33 |- skos__historyNote mesh__D020059 Cathepsins %28%1980-1998%29%
% 210.18/210.33 |- skos__hiddenLabel mesh__D020059 E, Cathepsin
% 210.18/210.33 |- skos__hiddenLabel mesh__D020059 Proteinase, Slow Moving
% 210.18/210.33 |- mesh__dateRevised mesh__D020059 2003-07-09
% 210.18/210.33 |- skos__related mesh__D020059smesh__D002402
% 210.18/210.33 |- skos__hiddenLabel mesh__D020059 Moving Proteinase, Slow
% 210.18/210.33 |- mesh__dateCreated mesh__D020059 1998-06-10
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020059 2006
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D020059 2005
% 210.18/210.33 |- mesh__historyNote mesh__D020059
% 210.18/210.33 99; use CATHEPSIN E %28%NM%29% 1980-98
% 210.18/210.33 |- mesh__historyNote mesh__D025542 2002
% 210.18/210.33 |- mesh__dateCreated mesh__D025542 2001-07-25
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D025542 2002
% 210.18/210.33 |- skos__scopeNote mesh__D025542
% 210.18/210.33 A protein found most abundantly in the nervous system. Defects or deficiencies in this protein are associated with NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome. Mutations in the gene %28%GENE, NEUROFIBROMATOSIS 1%29% affect two known functions: regulation of ras-GTPase and tumor suppression.%A%
% 210.18/210.33 |- skos__historyNote mesh__D025542 Nerve Tissue Proteins %28%1995-2001%29%
% 210.18/210.33 |- skos__historyNote mesh__D025542 Proteins %28%1990-1999%29%
% 210.18/210.33 |- skos__related mesh__D025542smesh__D016514
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D025542 2006
% 210.18/210.33 |- rdf__type mesh__D025542sskos__Concept
% 210.18/210.33 |- mesh__recordMaintainer mesh__D025542 jls
% 210.18/210.33 |- mesh__dateEstablished mesh__D025542 2002-01-01
% 210.18/210.33 |- skos__prefLabel mesh__D025542 Neurofibromin 1
% 210.18/210.33 |- skos__altLabel mesh__D025542 Neurofibromin
% 210.18/210.33 |- skos__altLabel mesh__D025542 NF-1 Protein
% 210.18/210.33 |- skos__altLabel mesh__D025542 NF1 GRP
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D025542 2005A
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D025542 jls
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D025542 2005
% 210.18/210.33 |- mesh__recordOriginator mesh__D025542 nns
% 210.18/210.33 |- mesh__dateRevised mesh__D025542 2004-07-29
% 210.18/210.33 |- skos__altLabel mesh__D025542 Neurofibromatosis Type 1 Protein
% 210.18/210.33 |- skos__altLabel mesh__D025542 NF1 Protein
% 210.18/210.33 |- skos__altLabel mesh__D025542 NF1-GAP-Related Protein
% 210.18/210.33 |- skos__related mesh__D025542smesh__D009456
% 210.18/210.33 |- skos__altLabel mesh__D025542 Neurofibromatosis Type 1 Gene Product
% 210.18/210.33 |- skos__hiddenLabel mesh__D025542 NF 1 Protein
% 210.18/210.33 |- skos__broader mesh__D025542smesh__D020703
% 210.18/210.33 |- skos__hiddenLabel mesh__D025542 NF1 GAP Related Protein
% 210.18/210.33 |- skos__broader mesh__D025542smesh__D025521
% 210.18/210.33 |- skos__hiddenLabel mesh__D003090 Coliphage
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 2002
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 1993
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 1998
% 210.18/210.33 |- skos__annotation mesh__D003090 GEN or unspecified; prefer specifics
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 2005
% 210.18/210.33 |- mesh__recordMaintainer mesh__D003090 AGS
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 1994
% 210.18/210.33 |- skos__hiddenLabel mesh__D003090 Phage, Escherichia coli
% 210.18/210.33 |- mesh__recordOriginator mesh__D003090 NLM
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 1999
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 2006
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D003090 PLS
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 1995
% 210.18/210.33 |- skos__scopeNote mesh__D003090
% 210.18/210.33 Viruses whose host is Escherichia coli.
% 210.18/210.33 |- skos__hiddenLabel mesh__D003090 Phages, Escherichia coli
% 210.18/210.33 |- rdf__type mesh__D003090sskos__Concept
% 210.18/210.33 |- mesh__dateRevised mesh__D003090 1992-05-07
% 210.18/210.33 |- skos__hiddenLabel mesh__D003090 Escherichia coli Phage
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 2000
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 1996
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 2003
% 210.18/210.33 |- skos__broader mesh__D003090smesh__D001435
% 210.18/210.33 |- skos__altLabel mesh__D003090 Escherichia coli Phages
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 2001
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 1997
% 210.18/210.33 |- skos__prefLabel mesh__D003090 Coliphages
% 210.18/210.33 |- mesh__dateCreated mesh__D003090 1999-01-01
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D003090 2004
% 210.18/210.33 |- mesh__dateEstablished mesh__D019505 1997-01-01
% 210.18/210.33 |- skos__broader mesh__D019505smesh__D019504
% 210.18/210.33 |- skos__altLabel mesh__D019505 Funeral Sermons
% 210.18/210.33 |- skos__scopeNote mesh__D019505
% 210.18/210.33 Works consisting of sermons delivered at ceremonies for a dead person prior to burial or cremation. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%
% 210.18/210.33 |- skos__annotation mesh__D019505
% 210.18/210.33 publication type only; for funeral sermons as a subject, index under main heading FUNERAL RITES%A%
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D019505 sjn
% 210.18/210.33 |- skos__prefLabel mesh__D019505 Funeral Sermons %5B%Publication Type%5D%
% 210.18/210.33 |- mesh__dateCreated mesh__D019505 1996-06-21
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D019505 2006
% 210.18/210.33 |- mesh__recordMaintainer mesh__D019505 jls
% 210.18/210.33 |- rdf__type mesh__D019505sskos__Concept
% 210.18/210.33 |- skos__altLabel mesh__D019505 Funeral Sermons %28%PT%29%
% 210.18/210.33 |- mesh__recordOriginator mesh__D019505 TGC
% 210.18/210.33 |- mesh__dateRevised mesh__D019505 2005-06-30
% 210.18/210.33 |- mesh__historyNote mesh__D019505 1997
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 2002
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 1994
% 210.18/210.33 |- skos__broader mesh__D011522smesh__D002414
% 210.18/210.33 |- skos__hiddenLabel mesh__D011522 Ion, Hydrogen
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 2006
% 210.18/210.33 |- skos__prefLabel mesh__D011522 Protons
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D011522 PLS
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 1998
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 2003
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 1995
% 210.18/210.33 |- rdf__type mesh__D011522sskos__Concept
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 2000
% 210.18/210.33 |- skos__hiddenLabel mesh__D011522 Ions, Hydrogen
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 1999
% 210.18/210.33 |- mesh__dateCreated mesh__D011522 1999-01-01
% 210.18/210.33 |- mesh__recordMaintainer mesh__D011522 TPW
% 210.18/210.33 |- skos__scopeNote mesh__D011522
% 210.18/210.33 Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion.%A%
% 210.18/210.33 |- mesh__dateEstablished mesh__D011522 1966-01-01
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 2004
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 1996
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 2001
% 210.18/210.33 |- mesh__recordOriginator mesh__D011522 NLM
% 210.18/210.33 |- mesh__historyNote mesh__D011522 66
% 210.18/210.33 |- mesh__dateRevised mesh__D011522 1993-06-02
% 210.18/210.33 |- skos__broader mesh__D011522smesh__D006859
% 210.18/210.33 |- skos__annotation mesh__D011522 elementary particles; IM
% 210.18/210.33 |- skos__broader mesh__D011522smesh__D004601
% 210.18/210.33 |- skos__hiddenLabel mesh__D011522 Hydrogen Ion
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D011522 66
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 1997
% 210.18/210.33 |- skos__altLabel mesh__D011522 Hydrogen Ions
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D011522 2005
% 210.18/210.33 |- skos__hiddenLabel mesh__D011522 Proton
% 210.18/210.33 |- mesh__recordMaintainer mesh__D049990 ssb
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D049990 2006
% 210.18/210.33 |- mesh__dateCreated mesh__D049990 2005-06-30
% 210.18/210.33 |- skos__hiddenLabel mesh__D049990 Modulators, Membrane Transport
% 210.18/210.33 |- skos__prefLabel mesh__D049990 Membrane Transport Modulators
% 210.18/210.33 |- mesh__dateEstablished mesh__D049990 2006-01-01
% 210.18/210.33 |- skos__altLabel mesh__D049990 Membrane Transport Protein Modulators
% 210.18/210.33 |- skos__broader mesh__D049990smesh__D045504
% 210.18/210.33 |- skos__historyNote mesh__D049990
% 210.18/210.33 Membrane Transport Proteins %28%2002-2005%29%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D049990 2006
% 210.18/210.33 |- mesh__recordOriginator mesh__D049990 ssb
% 210.18/210.33 |- skos__annotation mesh__D049990 general; prefer specifics
% 210.18/210.33 |- skos__hiddenLabel mesh__D049990 Transport Modulators, Membrane
% 210.18/210.33 |- skos__scopeNote mesh__D049990
% 210.18/210.33 Agents that affect ION PUMPS; ION CHANNELS; ABC TRANSPORTERS; and other MEMBRANE TRANSPORT PROTEINS.%A%
% 210.18/210.33 |- mesh__historyNote mesh__D049990 2006
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D049990 sjn
% 210.18/210.33 |- rdf__type mesh__D049990sskos__Concept
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D002796 2006
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D002796 sjn
% 210.18/210.33 |- mesh__dateCreated mesh__D002796 1999-01-01
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D002796 2005
% 210.18/210.33 |- skos__hiddenLabel mesh__D002796 Deficiencies, Choline
% 210.18/210.33 |- mesh__recordOriginator mesh__D002796 NLM
% 210.18/210.33 |- skos__scopeNote mesh__D002796
% 210.18/210.33 A condition produced by a deficiency of CHOLINE in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline %28%included in the B vitamin complex%29% and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions. %28%From Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A%
% 210.18/210.33 |- mesh__dateRevised mesh__D002796 2003-07-09
% 210.18/210.33 |- skos__prefLabel mesh__D002796 Choline Deficiency
% 210.18/210.33 |- mesh__dateEstablished mesh__D002796 1967-01-01
% 210.18/210.33 |- mesh__historyNote mesh__D002796 67%28%64%29%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D002796 2004
% 210.18/210.33 |- rdf__type mesh__D002796sskos__Concept
% 210.18/210.33 |- skos__hiddenLabel mesh__D002796 Choline Deficiencies
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D002796 67
% 210.18/210.33 |- skos__broader mesh__D002796smesh__D014804
% 210.18/210.33 |- skos__annotation mesh__D002796
% 210.18/210.33 a vitamin B defic in animals; DF: CHOLINE DEFIC
% 210.18/210.33 |- mesh__recordMaintainer mesh__D002796 lkt
% 210.18/210.33 |- skos__altLabel mesh__D002796 Deficiency, Choline
% 210.18/210.33 |- skos__historyNote mesh__D043604
% 210.18/210.33 Paraganglioma, Extra-Adrenal %28%1970-2003%29%
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D043604 2004
% 210.18/210.33 |- skos__prefLabel mesh__D043604 Glomus Tympanicum Tumor
% 210.18/210.33 |- mesh__historyNote mesh__D043604 2004
% 210.18/210.33 |- mesh__dateEstablished mesh__D043604 2004-01-01
% 210.18/210.33 |- skos__historyNote mesh__D043604 Glomus Tumor %28%1974-2003%29%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D043604 2004
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D043604 2005
% 210.18/210.33 |- skos__hiddenLabel mesh__D043604 Tumor, Glomus Tympanicum
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D043604 2006
% 210.18/210.33 |- rdf__type mesh__D043604sskos__Concept
% 210.18/210.33 |- skos__hiddenLabel mesh__D043604 Glomus Tympanicum Tumors
% 210.18/210.33 |- skos__scopeNote mesh__D043604
% 210.18/210.33 A rare PARAGANGLIOMA involving the GLOMUS TYMPANICUM, a collection of chemoreceptor tissue adjacent to the TYMPANIC CAVITY. It can cause TINNITUS and conductive hearing loss %28%HEARING LOSS, CONDUCTIVE%29%.%A%
% 210.18/210.33 |- mesh__dateCreated mesh__D043604 2003-07-09
% 210.18/210.33 |- skos__hiddenLabel mesh__D043604 Tumors, Glomus Tympanicum
% 210.18/210.33 |- skos__annotation mesh__D043604 coord IM with EAR NEOPLASMS %28%IM%29%
% 210.18/210.33 |- skos__broader mesh__D043604smesh__D010236
% 210.18/210.33 |- mesh__recordMaintainer mesh__D007481 CCR
% 210.18/210.33 |- rdf__type mesh__D007481sskos__Concept
% 210.18/210.33 |- mesh__historyNote mesh__D007481
% 210.18/210.33 91%28%75%29%; was see under IODOBENZENES 1975-90
% 210.18/210.33 |- mesh__dateCreated mesh__D007481 1974-11-19
% 210.18/210.33 |- skos__scopeNote mesh__D007481
% 210.18/210.33 A mixture of isomers used as contrast medium, mainly for brain and spinal cord visualization.%A%
% 210.18/210.33 |- skos__altLabel mesh__D007481 Iodophendylate
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D007481 2004
% 210.18/210.33 |- skos__historyNote mesh__D007481 Iodobenzenes %28%1973-1974%29%
% 210.18/210.33 |- skos__historyNote mesh__D007481 Benzene %28%1966-1967%29%
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D007481
% 210.18/210.33 91; was see under IODOBENZENES 1975-90
% 210.18/210.33 |- skos__altLabel mesh__D007481 Myodil
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D007481 2002
% 210.18/210.33 |- skos__annotation mesh__D007481 D25-26 qualif
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D007481 2003
% 210.18/210.33 |- mesh__dateEstablished mesh__D007481 1991-01-01
% 210.18/210.33 |- skos__altLabel mesh__D007481 Pantopaque
% 210.18/210.33 |- mesh__dateRevised mesh__D007481 2000-06-22
% 210.18/210.33 |- skos__altLabel mesh__D007481 Isophendylate
% 210.18/210.33 |- mesh__recordOriginator mesh__D007481 NLM
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D007481 sjn
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D007481 2006
% 210.18/210.33 |- skos__prefLabel mesh__D007481 Iophendylate
% 210.18/210.33 |- skos__historyNote mesh__D007481 Benzene Derivatives %28%1968-1972%29%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D007481 2001
% 210.18/210.33 |- skos__broader mesh__D007481smesh__D007462
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D007481 2005
% 210.18/210.33 |- skos__historyNote mesh__D007481 Fatty Acids %28%1966-1974%29%
% 210.18/210.33 |- skos__altLabel mesh__D007481 Iofendylate
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 2003
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 1994
% 210.18/210.33 |- rdf__type mesh__D015913sskos__Concept
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 2004
% 210.18/210.33 |- mesh__dateRevised mesh__D015913 1990-03-22
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 1998
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 1995
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 2002
% 210.18/210.33 |- mesh__dateCreated mesh__D015913 1989-10-03
% 210.18/210.33 |- mesh__dateEstablished mesh__D015913 1990-01-01
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 1992
% 210.18/210.33 |- skos__hiddenLabel mesh__D015913 Therapies, Chelation
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 1999
% 210.18/210.33 |- skos__historyNote mesh__D015913
% 210.18/210.33 Chelating Agents/therapeutic use %28%1966-1989%29%
% 210.18/210.33 |- skos__prefLabel mesh__D015913 Chelation Therapy
% 210.18/210.33 |- skos__altLabel mesh__D015913 Therapy, Chelation
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 1996
% 210.18/210.33 |- skos__annotation mesh__D015913
% 210.18/210.33 coord IM with specific chelating agent /ther use %28%IM%29% + metal being chelated with no qualif%A%
% 210.18/210.33 |- skos__hiddenLabel mesh__D015913 Chelation Therapies
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 1993
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 2005
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 2000
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D015913 90
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 1997
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 1991
% 210.18/210.33 |- skos__broader mesh__D015913smesh__D004358
% 210.18/210.33 |- skos__scopeNote mesh__D015913
% 210.18/210.33 Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.%A%
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 2006
% 210.18/210.33 |- mesh__recordAuthorizer mesh__D015913 PLS
% 210.18/210.33 |- mesh__recordOriginator mesh__D015913 PLS
% 210.18/210.33 |- mesh__historyNote mesh__D015913 90
% 210.18/210.33 |- mesh__recordMaintainer mesh__D015913 TGC
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015913 2001
% 210.18/210.33 |- mesh__publicMeSHNote mesh__D015115
% 210.18/210.33 78; was see under TRYPTAMINES 1975-77
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015115 2002
% 210.18/210.33 |- skos__prefLabel mesh__D015115 5,6-Dihydroxytryptamine
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015115 2004
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015115 2001
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015115 2006
% 210.18/210.33 |- skos__altLabel mesh__D015115 3-%28%2-Aminoethyl%29%indole-5,6-diol
% 210.18/210.33 |- skos__broader mesh__D015115smesh__D004102
% 210.18/210.33 |- mesh__activeMeSHYear mesh__D015115 2003
% 210.18/210.33 |- mesh__recordOriginator mesh__D015115 NLM
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015115 2005
% 210.18/210.34 |- skos__hiddenLabel mesh__D015115 5,6 Dihydroxytryptamine
% 210.18/210.34 |- mesh__dateEstablished mesh__D015115 1978-01-01
% 210.18/210.34 |- rdf__type mesh__D015115sskos__Concept
% 210.18/210.34 |- skos__historyNote mesh__D015115 Tryptamines %28%1966-1974%29%
% 210.18/210.34 |- skos__scopeNote mesh__D015115
% 210.18/210.34 Tryptamine substituted with two hydroxyl groups in positions 5 and 6. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacologic research.%A%
% 210.18/210.34 |- mesh__recordMaintainer mesh__D015115 TWD
% 210.18/210.34 |- mesh__historyNote mesh__D015115
% 210.18/210.34 78%28%75%29%; was see under TRYPTAMINES 1975-77
% 210.18/210.34 |- mesh__dateRevised mesh__D015115 2000-06-22
% 210.18/210.34 |- mesh__dateCreated mesh__D015115 1974-11-27
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D015115 sjn
% 210.18/210.34 |- skos__hiddenLabel mesh__D020858 Retrieval, Organ
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D020858 2005
% 210.18/210.34 |- mesh__recordOriginator mesh__D020858 nns
% 210.18/210.34 |- skos__broader mesh__D020858smesh__D013514
% 210.18/210.34 |- skos__annotation mesh__D020858 sperm collection goes here
% 210.18/210.34 |- skos__hiddenLabel mesh__D020858 Retrievals, Organ
% 210.18/210.34 |- skos__related mesh__D020858smesh__D009926
% 210.18/210.34 |- skos__related mesh__D020858smesh__D009927
% 210.18/210.34 |- skos__broader mesh__D020858smesh__D013048
% 210.18/210.34 |- mesh__dateRevised mesh__D020858 2004-07-07
% 210.18/210.34 |- mesh__dateEstablished mesh__D020858 2000-01-01
% 210.18/210.34 |- mesh__recordMaintainer mesh__D020858 lkt
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D020858
% 210.18/210.34 2005; see TISSUE HARVESTING 2000-2004
% 210.18/210.34 |- skos__hiddenLabel mesh__D020858 Organ Retrievals
% 210.18/210.34 |- mesh__historyNote mesh__D020858 2005 %28%2000%29%
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D020858 sjn
% 210.18/210.34 |- mesh__dateCreated mesh__D020858 1999-11-03
% 210.18/210.34 |- skos__prefLabel mesh__D020858 Tissue and Organ Harvesting
% 210.18/210.34 |- skos__related mesh__D020858smesh__D001793
% 210.18/210.34 |- skos__related mesh__D020858smesh__D012662
% 210.18/210.34 |- skos__hiddenLabel mesh__D020858 Organ Harvestings
% 210.18/210.34 |- skos__scopeNote mesh__D020858
% 210.18/210.34 The procedure of removing TISSUES, organs, or specimens from DONORS for reuse, such as TRANSPLANTATION.%A%
% 210.18/210.34 |- skos__related mesh__D020858smesh__D014021
% 210.18/210.34 |- rdf__type mesh__D020858sskos__Concept
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D020858 2006
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D039563 2006
% 210.18/210.34 |- mesh__dateEstablished mesh__D039563 2003-01-01
% 210.18/210.34 |- skos__scopeNote mesh__D039563
% 210.18/210.34 A class of non-sedating drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early %28%first generation%29% antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment.%A%
% 210.18/210.34 |- skos__historyNote mesh__D039563
% 210.18/210.34 Histamine H1 Antagonists %28%1982-2002%29%
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D039563 2005
% 210.18/210.34 |- mesh__dateCreated mesh__D039563 2002-07-02
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D039563 2004
% 210.18/210.34 |- mesh__historyNote mesh__D039563 2003
% 210.18/210.34 |- skos__hiddenLabel mesh__D039563 Non-Sedating H1 Antihistamines
% 210.18/210.34 |- skos__hiddenLabel mesh__D039563 Histamine H1 Antagonists, Non Sedating
% 210.18/210.34 |- skos__hiddenLabel mesh__D039563 H1 Antihistamines, Non Sedating
% 210.18/210.34 |- skos__altLabel mesh__D039563 H1 Antihistamines, Non-Sedating
% 210.18/210.34 |- skos__hiddenLabel mesh__D039563 Antihistamines, Second Generation
% 210.18/210.34 |- skos__altLabel mesh__D039563 Second Generation H1 Antagonists
% 210.18/210.34 |- skos__altLabel mesh__D039563 Second Generation Antihistamines
% 210.18/210.34 |- skos__prefLabel mesh__D039563 Histamine H1 Antagonists, Non-Sedating
% 210.18/210.34 |- skos__broader mesh__D039563smesh__D006634
% 210.18/210.34 |- skos__historyNote mesh__D039563 Benzhydryl Compounds %28%1982-2002%29%
% 210.18/210.34 |- mesh__dateRevised mesh__D039563 2003-07-09
% 210.18/210.34 |- rdf__type mesh__D039563sskos__Concept
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D039563 2003
% 210.18/210.34 |- mesh__recordMaintainer mesh__D006389 ssb
% 210.18/210.34 |- mesh__recordOriginator mesh__D006389 NLM
% 210.18/210.34 |- skos__prefLabel mesh__D006389 Hemagglutinins, Viral
% 210.18/210.34 |- skos__broader mesh__D006389smesh__D000956
% 210.18/210.34 |- skos__broader mesh__D006389smesh__D014759
% 210.18/210.34 |- skos__historyNote mesh__D006389 Antigens %28%1966%29%
% 210.18/210.34 |- mesh__dateCreated mesh__D006389 1999-01-01
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D006389 2006
% 210.18/210.34 |- mesh__dateEstablished mesh__D006389 1972-01-01
% 210.18/210.34 |- mesh__dateRevised mesh__D006389 2005-06-30
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D006389 sjn
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D006389 72; was see under ANTIGENS 1968-71
% 210.18/210.34 |- skos__hiddenLabel mesh__D006389 Viral Hemagglutinins
% 210.18/210.34 |- mesh__historyNote mesh__D006389
% 210.18/210.34 72%28%67%29%; was see under ANTIGENS 1968-71
% 210.18/210.34 |- rdf__type mesh__D006389sskos__Concept
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D025543 2005
% 210.18/210.34 |- mesh__dateEstablished mesh__D025543 2002-01-01
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D025543 2002; see INOVIRUS 1994-2001
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D025543 2002
% 210.18/210.34 |- skos__prefLabel mesh__D025543 Bacteriophage IKe
% 210.18/210.34 |- skos__historyNote mesh__D025543 Coliphages %28%1976-1996%29%
% 210.18/210.34 |- skos__broader mesh__D025543smesh__D017912
% 210.18/210.34 |- skos__hiddenLabel mesh__D025543 Phages, IKe
% 210.18/210.34 |- mesh__dateCreated mesh__D025543 2001-07-25
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D025543 2004
% 210.18/210.34 |- mesh__historyNote mesh__D025543 2002; use INOVIRUS 1994-2001
% 210.18/210.34 |- skos__altLabel mesh__D025543 Enterobacteria phage IKe
% 210.18/210.34 |- skos__annotation mesh__D025543 coord with specific bacterium /virol
% 210.18/210.34 |- skos__scopeNote mesh__D025543
% 210.18/210.34 A species of filamentous phage in the genus INOVIRUS, family INOVIRIDAE. They are specific for enterobacteria that contain an IncN plasmid.%A%
% 210.18/210.34 |- skos__historyNote mesh__D025543 Inovirus %28%1993-2001%29%
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D025543 2003
% 210.18/210.34 |- skos__altLabel mesh__D025543 Phage IKe
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D025543 2006
% 210.18/210.34 |- skos__altLabel mesh__D025543 IKe Phage
% 210.18/210.34 |- rdf__type mesh__D025543sskos__Concept
% 210.18/210.34 |- skos__hiddenLabel mesh__D025543 IKe Phages
% 210.18/210.34 |- skos__hiddenLabel mesh__D025543 Phage, IKe
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003091 2005
% 210.18/210.34 |- skos__hiddenLabel mesh__D003091 Sulfate, Colistin
% 210.18/210.34 |- skos__altLabel mesh__D003091 Colisticin
% 210.18/210.34 |- skos__broader mesh__D003091smesh__D011113
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003091 2006
% 210.18/210.34 |- skos__scopeNote mesh__D003091
% 210.18/210.34 Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 %28%or Colistins A, B, and C%29% which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.%A%
% 210.18/210.34 |- mesh__recordMaintainer mesh__D003091 ssb
% 210.18/210.34 |- rdf__type mesh__D003091sskos__Concept
% 210.18/210.34 |- mesh__dateRevised mesh__D003091 2004-07-07
% 210.18/210.34 |- mesh__recordOriginator mesh__D003091 NLM
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D003091 sjn
% 210.18/210.34 |- mesh__dateCreated mesh__D003091 1999-01-01
% 210.18/210.34 |- skos__altLabel mesh__D003091 Polymyxin E
% 210.18/210.34 |- skos__hiddenLabel mesh__D003091 Sulfomethate, Colistin
% 210.18/210.34 |- skos__prefLabel mesh__D003091 Colistin
% 210.18/210.34 |- skos__altLabel mesh__D003091 Colimycin
% 210.18/210.34 |- mesh__historyNote mesh__D011523 66%28%64%29%
% 210.18/210.34 |- skos__broader mesh__D011523smesh__D002477
% 210.18/210.34 |- skos__prefLabel mesh__D011523 Protoplasts
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 2001
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 2006
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 2000
% 210.18/210.34 |- mesh__dateEstablished mesh__D011523 1966-01-01
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 2004
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 1995
% 210.18/210.34 |- skos__annotation mesh__D011523 A 11 qualif
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 2005
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 1993
% 210.18/210.34 |- rdf__type mesh__D011523sskos__Concept
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 2003
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 1999
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 1994
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D011523 NLM
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 1992
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 1997
% 210.18/210.34 |- mesh__dateRevised mesh__D011523 1990-05-26
% 210.18/210.34 |- skos__hiddenLabel mesh__D011523 Protoplast
% 210.18/210.34 |- mesh__dateCreated mesh__D011523 1999-01-01
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 1998
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 2002
% 210.18/210.34 |- mesh__recordMaintainer mesh__D011523 PLS
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 1996
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011523 1991
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D011523 66
% 210.18/210.34 |- mesh__recordOriginator mesh__D011523 NLM
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D002797 2006
% 210.18/210.34 |- skos__hiddenLabel mesh__D002797 Choline Transphosphatase, ATP
% 210.18/210.34 |- skos__hiddenLabel mesh__D002797 Transphosphatase, ATP Choline
% 210.18/210.34 |- skos__altLabel mesh__D002797 ATP Choline Transphosphatase
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D002797
% 210.18/210.34 91; was see under PHOSPHOTRANSFERASES, ATP 1976-90
% 210.18/210.34 |- mesh__recordMaintainer mesh__D002797 ssb
% 210.18/210.34 |- skos__altLabel mesh__D002797 Choline Phosphokinase
% 210.18/210.34 |- mesh__historyNote mesh__D002797
% 210.18/210.34 91%28%76%29%; was see under PHOSPHOTRANSFERASES, ATP 1976-90
% 210.18/210.34 |- mesh__dateRevised mesh__D002797 2003-07-09
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D002797 sjn
% 210.18/210.34 |- skos__hiddenLabel mesh__D002797 Phosphokinase, Choline
% 210.18/210.34 |- mesh__dateEstablished mesh__D002797 1991-01-01
% 210.18/210.34 |- skos__scopeNote mesh__D002797
% 210.18/210.34 An enzyme that is active in the first step of choline phosphoglyceride %28%lecithin%29% biosynthesis by catalyzing the phosphorylation of choline to phosphorylcholine in the presence of ATP. Ethanolamine and its methyl and ethyl derivatives can also act as acceptors. EC 2.7.1.32.%A%
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D002797 2004
% 210.18/210.34 |- rdf__type mesh__D002797sskos__Concept
% 210.18/210.34 |- skos__historyNote mesh__D002797 Choline %28%1974-1975%29%
% 210.18/210.34 |- mesh__dateCreated mesh__D002797 1975-07-18
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D002797 2005
% 210.18/210.34 |- skos__prefLabel mesh__D002797 Choline Kinase
% 210.18/210.34 |- skos__historyNote mesh__D002797
% 210.18/210.34 Phosphotransferases, ATP %28%1974-1975%29%
% 210.18/210.34 |- skos__hiddenLabel mesh__D002797 Kinase, Choline
% 210.18/210.34 |- skos__broader mesh__D002797smesh__D017853
% 210.18/210.34 |- mesh__recordOriginator mesh__D002797 RLS
% 210.18/210.34 |- mesh__dateRevised mesh__D007482 2004-07-07
% 210.18/210.34 |- rdf__type mesh__D007482sskos__Concept
% 210.18/210.34 |- skos__hiddenLabel mesh__D007482 Iotalamate, Meglumine
% 210.18/210.34 |- mesh__recordOriginator mesh__D007482 NLM
% 210.18/210.34 |- mesh__onlineNote mesh__D007482
% 210.18/210.34 use IOTHALAMATE MEGLUMINE to search MEGLUMINE IOTHALAMATE 1975-81%A%
% 210.18/210.34 |- skos__hiddenLabel mesh__D007482 Meglumine, Iotalamate
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D007482 sjn
% 210.18/210.34 |- skos__scopeNote mesh__D007482
% 210.18/210.34 A radiopaque medium used for urography, angiography, venography, and myelography. It is highly viscous and binds to plasma proteins.%A%
% 210.18/210.34 |- skos__prefLabel mesh__D007482 Iothalamate Meglumine
% 210.18/210.34 |- skos__altLabel mesh__D007482 Iotalamate Meglumine
% 210.18/210.34 |- skos__altLabel mesh__D007482 Methylglucamine Iotalamate
% 210.18/210.34 |- skos__hiddenLabel mesh__D007482 Iothalamate, Meglumine
% 210.18/210.34 |- skos__historyNote mesh__D007482 Adipic Acids %28%1966-1977%29%
% 210.18/210.34 |- skos__altLabel mesh__D007482 Iothalamic Acid Methylglucamine
% 210.18/210.34 |- mesh__recordMaintainer mesh__D007482 ssb
% 210.18/210.34 |- skos__historyNote mesh__D007482 Iothalamic Acid %28%1966-1977%29%
% 210.18/210.34 |- skos__altLabel mesh__D007482 Methylglucamine Iothalamate
% 210.18/210.34 |- mesh__dateEstablished mesh__D007482 1978-01-01
% 210.18/210.34 |- skos__altLabel mesh__D007482 Iothalamic Acid Meglumine
% 210.18/210.34 |- skos__hiddenLabel mesh__D007482 Meglumine, Iothalamate
% 210.18/210.34 |- skos__altLabel mesh__D007482 Meglumine Iothalamate
% 210.18/210.34 |- mesh__dateCreated mesh__D007482 1974-11-19
% 210.18/210.34 |- skos__hiddenLabel mesh__D007482 Methylglucamine, Iothalamic Acid
% 210.18/210.34 |- skos__broader mesh__D007482smesh__D008536
% 210.18/210.34 |- mesh__historyNote mesh__D007482
% 210.18/210.34 82; was MEGLUMINE IOTHALAMATE 1978-81, was MEGLUMINE IOTHALAMATE see under IOTHALAMIC ACID 1975-77%A%
% 210.18/210.34 |- skos__historyNote mesh__D007482 Sorbitol %28%1966-1977%29%
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D007482 2005
% 210.18/210.34 |- skos__hiddenLabel mesh__D007482 Iothalamate, Methylglucamine
% 210.18/210.34 |- skos__broader mesh__D007482smesh__D014283
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D007482
% 210.18/210.34 82; was MEGLUMINE IOTHALAMATE 1978-81, was MEGLUMINE IOTHALAMATE see under IOTHALAMIC ACID 1975-77%A%
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D007482 2006
% 210.18/210.34 |- skos__hiddenLabel mesh__D007482 Meglumine, Iothalamic Acid
% 210.18/210.34 |- skos__hiddenLabel mesh__D007482 Iotalamate, Methylglucamine
% 210.18/210.34 |- skos__altLabel mesh__D007482 Meglumine Iotalamate
% 210.18/210.34 |- rdf__type mesh__D015914sskos__Concept
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015914 2004
% 210.18/210.34 |- mesh__dateCreated mesh__D015914 1989-07-19
% 210.18/210.34 |- skos__hiddenLabel mesh__D015914
% 210.18/210.34 Hormone Replacement Therapy, Post Menopausal
% 210.18/210.34 |- mesh__historyNote mesh__D015914 90
% 210.18/210.34 |- skos__hiddenLabel mesh__D015914 Replacements, Estrogen
% 210.18/210.34 |- mesh__dateEstablished mesh__D015914 1990-01-01
% 210.18/210.34 |- skos__scopeNote mesh__D015914
% 210.18/210.34 The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.%A%
% 210.18/210.34 |- mesh__dateRevised mesh__D015914 2002-07-03
% 210.18/210.34 |- skos__historyNote mesh__D015914
% 210.18/210.34 Estrogenic Substances, Conjugated %28%1966-1989%29%
% 210.18/210.34 |- skos__hiddenLabel mesh__D015914 Estrogen Replacement Therapies
% 210.18/210.34 |- skos__historyNote mesh__D015914 Estrogens, Synthetic %28%1975-1989%29%
% 210.18/210.34 |- skos__altLabel mesh__D015914 Replacement, Estrogen
% 210.18/210.34 |- skos__altLabel mesh__D015914 Estrogen Progestin Combination Therapy
% 210.18/210.34 |- skos__altLabel mesh__D015914
% 210.18/210.34 Hormone Replacement Therapy, Post-Menopausal
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015914 2005
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D015914 90
% 210.18/210.34 |- skos__prefLabel mesh__D015914 Estrogen Replacement Therapy
% 210.18/210.34 |- skos__historyNote mesh__D015914 Estrogens %28%1966-1989%29%
% 210.18/210.34 |- skos__hiddenLabel mesh__D015914 Replacement Therapies, Estrogen
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015914 2006
% 210.18/210.34 |- skos__historyNote mesh__D015914 Menopause %28%1966-1989%29%
% 210.18/210.34 |- skos__annotation mesh__D015914
% 210.18/210.34 coord IM with specific estrogen %28%IM or NIM%29% and also specific progestational agent %28%IM or NIM%29% if pertinent; check tag FEMALE; DF: ESTROGEN REPLACE%A%
% 210.18/210.34 |- mesh__recordOriginator mesh__D015914 PLS
% 210.18/210.34 |- skos__hiddenLabel mesh__D015914 Therapies, Estrogen Replacement
% 210.18/210.34 |- skos__altLabel mesh__D015914 Replacement Therapy, Estrogen
% 210.18/210.34 |- skos__broader mesh__D015914smesh__D020249
% 210.18/210.34 |- skos__altLabel mesh__D015914 Therapy, Estrogen Replacement
% 210.18/210.34 |- mesh__recordMaintainer mesh__D015914 lkt
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015914 2003
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D015914 sjn
% 210.18/210.34 |- skos__hiddenLabel mesh__D015914 Estrogen Replacements
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015116 2003
% 210.18/210.34 |- skos__hiddenLabel mesh__D015116 5,7 Dihydroxytryptamine
% 210.18/210.34 |- skos__hiddenLabel mesh__D015116
% 210.18/210.34 Sulfate, 5,7-Dihydroxytryptamine Creatine
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015116 2005
% 210.18/210.34 |- mesh__dateCreated mesh__D015116 1977-04-27
% 210.18/210.34 |- skos__altLabel mesh__D015116 3-%28%2-Aminoethyl%29%-1H-indole-5,7-diol
% 210.18/210.34 |- mesh__recordOriginator mesh__D015116 SH
% 210.18/210.34 |- skos__hiddenLabel mesh__D015116 5,7 Dihydroxytryptamine Creatine Sulfate
% 210.18/210.34 |- mesh__recordMaintainer mesh__D015116 TWD
% 210.18/210.34 |- skos__prefLabel mesh__D015116 5,7-Dihydroxytryptamine
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D015116 sjn
% 210.18/210.34 |- rdf__type mesh__D015116sskos__Concept
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015116 2002
% 210.18/210.34 |- skos__historyNote mesh__D015116 Tryptamines %28%1966-1977%29%
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015116 2001
% 210.18/210.34 |- mesh__dateRevised mesh__D015116 2000-06-22
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D015116
% 210.18/210.34 91; was see under DIHYDROXYTRYPTAMINES 1978-90
% 210.18/210.34 |- skos__hiddenLabel mesh__D015116
% 210.18/210.34 Creatine Sulfate, 5,7-Dihydroxytryptamine
% 210.18/210.34 |- mesh__historyNote mesh__D015116
% 210.18/210.34 91%28%78%29%; was see under DIHYDROXYTRYPTAMINES 1978-90
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015116 2004
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D015116 2006
% 210.18/210.34 |- skos__broader mesh__D015116smesh__D004102
% 210.18/210.34 |- skos__scopeNote mesh__D015116
% 210.18/210.34 Tryptamine substituted with two hydroxyl groups in positions 5 and 7. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacology as a tool.%A%
% 210.18/210.34 |- mesh__dateEstablished mesh__D015116 1991-01-01
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D039564 2006
% 210.18/210.34 |- mesh__historyNote mesh__D039564
% 210.18/210.34 2003; use INTEGRIN ALPHAV %28%NM%29% 1994-2002
% 210.18/210.34 |- skos__broader mesh__D039564smesh__D039001
% 210.18/210.34 |- skos__altLabel mesh__D039564 alphav Integrin
% 210.18/210.34 |- skos__broader mesh__D039564smesh__D015703
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D039564 sjn
% 210.18/210.34 |- skos__hiddenLabel mesh__D039564 alphaV, Integrin
% 210.18/210.34 |- mesh__dateEstablished mesh__D039564 2003-01-01
% 210.18/210.34 |- skos__altLabel mesh__D039564 CD51 Antigen
% 210.18/210.34 |- skos__historyNote mesh__D039564 Antigens, CD %28%1994-2002%29%
% 210.18/210.34 |- mesh__recordOriginator mesh__D039564 MDJ
% 210.18/210.34 |- mesh__dateRevised mesh__D039564 2005-06-30
% 210.18/210.34 |- skos__altLabel mesh__D039564 Integrin alpha V
% 210.18/210.34 |- skos__altLabel mesh__D039564 CD51 Antigens
% 210.18/210.34 |- skos__altLabel mesh__D039564 Antigens, CD51
% 210.18/210.34 |- skos__annotation mesh__D039564
% 210.18/210.34 %22%V%22% in alphaV is the letter not the roman numeral
% 210.18/210.34 |- skos__prefLabel mesh__D039564 Integrin alphaV
% 210.18/210.34 |- mesh__recordMaintainer mesh__D039564 ssb
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D039564
% 210.18/210.34 2003; INTEGRIN ALPHAV was indexed under ANTIGENS, CD 1994-2002%A%
% 210.18/210.34 |- skos__altLabel mesh__D039564 alpha%28%V%29% Integrin
% 210.18/210.34 |- rdf__type mesh__D039564sskos__Concept
% 210.18/210.34 |- mesh__dateCreated mesh__D039564 2002-07-03
% 210.18/210.34 |- skos__hiddenLabel mesh__D039564 Integrin, alphav
% 210.18/210.34 |- skos__scopeNote mesh__D039564
% 210.18/210.34 An alpha integrin with a molecular weight of 160-kDa that is found in a variety of cell types. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds. Integrin alphaV can combine with several different beta subunits to form heterodimers that generally bind to RGD sequence-containing extracellular matrix proteins.%A%
% 210.18/210.34 |- skos__hiddenLabel mesh__D039564 alpha V, Integrin
% 210.18/210.34 |- skos__hiddenLabel mesh__D039564 Antigen, CD51
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D020859 2000
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D020859 2001
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D020859 2004
% 210.18/210.34 |- mesh__dateEstablished mesh__D020859 2000-01-01
% 210.18/210.34 |- skos__broader mesh__D020859smesh__D005531
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D020859 2000
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D020859 2003
% 210.18/210.34 |- skos__hiddenLabel mesh__D020859 Rigidus, Hallux
% 210.18/210.34 |- rdf__type mesh__D020859sskos__Concept
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D020859 2006
% 210.18/210.34 |- mesh__historyNote mesh__D020859 2000
% 210.18/210.34 |- skos__historyNote mesh__D020859
% 210.18/210.34 Metatarsophalangeal Joint %28%1983-1999%29%
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D020859 2002
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D020859 2005
% 210.18/210.34 |- skos__broader mesh__D020859smesh__D007592
% 210.18/210.34 |- skos__prefLabel mesh__D020859 Hallux Rigidus
% 210.18/210.34 |- skos__scopeNote mesh__D020859
% 210.18/210.34 A condition caused by degenerative arthritis %28%see OSTEOARTHRITIS%29% of the METATARSOPHALANGEAL JOINT of the great toe and characterized by pain and limited dorsiflexion, but relatively unrestricted plantar flexion.%A%
% 210.18/210.34 |- mesh__dateCreated mesh__D020859 1999-11-03
% 210.18/210.34 |- skos__altLabel mesh__D031581 Ayahuasca
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D031581 2005
% 210.18/210.34 |- skos__broader mesh__D031581smesh__D029581
% 210.18/210.34 |- mesh__historyNote mesh__D031581 2003
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D031581 2006
% 210.18/210.34 |- mesh__dateEstablished mesh__D031581 2003-01-01
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D031581 2003
% 210.18/210.34 |- mesh__dateCreated mesh__D031581 2002-07-02
% 210.18/210.34 |- skos__prefLabel mesh__D031581 Banisteriopsis
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D031581 2003
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D031581 2004
% 210.18/210.34 |- skos__scopeNote mesh__D031581
% 210.18/210.34 A plant genus of the family MALPIGHIACEAE which includes an Amazonian psychoactive plant that contains the beta-carboline harmine and N,N-dimethyltryptamine.%A%
% 210.18/210.34 |- rdf__type mesh__D031581sskos__Concept
% 210.18/210.34 |- skos__annotation mesh__D031581
% 210.18/210.34 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 2005
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 2004
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 2002
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 2006
% 210.18/210.34 |- mesh__dateEstablished mesh__D003890 1977-01-01
% 210.18/210.34 |- skos__broader mesh__D003890smesh__D002623
% 210.18/210.34 |- skos__annotation mesh__D003890
% 210.18/210.34 note category; differentiate from DEHYDRATION, a disease state%A%
% 210.18/210.34 |- skos__prefLabel mesh__D003890 Desiccation
% 210.18/210.34 |- skos__related mesh__D003890smesh__D005612
% 210.18/210.34 |- skos__altLabel mesh__D003890 Dessication
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 1996
% 210.18/210.34 |- skos__broader mesh__D003890smesh__D002627
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 1998
% 210.18/210.34 |- mesh__dateCreated mesh__D003890 1976-05-19
% 210.18/210.34 |- mesh__historyNote mesh__D003890 77
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 2000
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 1997
% 210.18/210.34 |- skos__scopeNote mesh__D003890
% 210.18/210.34 Removal of moisture from a substance %28%chemical, food, tissue, etc.%29%.%A%
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D003890 PLS
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 2001
% 210.18/210.34 |- mesh__recordOriginator mesh__D003890 VDK
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 1999
% 210.18/210.34 |- mesh__dateRevised mesh__D003890 1994-05-12
% 210.18/210.34 |- mesh__recordMaintainer mesh__D003890 TGC
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 1995
% 210.18/210.34 |- rdf__type mesh__D003890sskos__Concept
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003890 2003
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D003890 77
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D003092 sjn
% 210.18/210.34 |- rdf__type mesh__D003092sskos__Concept
% 210.18/210.34 |- mesh__dateRevised mesh__D003092 2004-07-07
% 210.18/210.34 |- skos__annotation mesh__D003092
% 210.18/210.34 general; note specifics; ENTEROCOLITIS is also available
% 210.18/210.34 |- skos__broader mesh__D003092smesh__D003108
% 210.18/210.34 |- mesh__dateCreated mesh__D003092 1999-01-01
% 210.18/210.34 |- skos__prefLabel mesh__D003092 Colitis
% 210.18/210.34 |- mesh__recordMaintainer mesh__D003092 lkt
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003092 2005
% 210.18/210.34 |- skos__broader mesh__D003092smesh__D005759
% 210.18/210.34 |- skos__hiddenLabel mesh__D003092 Colitides
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D003092 2006
% 210.18/210.34 |- skos__scopeNote mesh__D003092
% 210.18/210.34 Inflammation of the COLON section of the large intestine %28%INTESTINE, LARGE%29%, usually with symptoms such as DIARRHEA %28%often with blood and mucus%29%, ABDOMINAL PAIN, and FEVER.%A%
% 210.18/210.34 |- mesh__recordOriginator mesh__D003092 NLM
% 210.18/210.34 |- skos__historyNote mesh__D011524 Porphyrins %28%1968-1974%29%
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D011524
% 210.18/210.34 91; was see under PORPHYRINS 1975-90
% 210.18/210.34 |- mesh__dateRevised mesh__D011524 2005-06-30
% 210.18/210.34 |- mesh__historyNote mesh__D011524
% 210.18/210.34 91%28%75%29%; was see under PORPHYRINS 1975-90
% 210.18/210.34 |- mesh__recordOriginator mesh__D011524 NLM
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D011524 2006
% 210.18/210.34 |- skos__scopeNote mesh__D011524
% 210.18/210.34 Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.%A%
% 210.18/210.34 |- mesh__dateEstablished mesh__D011524 1991-01-01
% 210.18/210.34 |- rdf__type mesh__D011524sskos__Concept
% 210.18/210.34 |- skos__annotation mesh__D011524 porphyrins
% 210.18/210.34 |- mesh__dateCreated mesh__D011524 1974-11-19
% 210.18/210.34 |- skos__broader mesh__D011524smesh__D011166
% 210.18/210.34 |- mesh__recordMaintainer mesh__D011524 ssb
% 210.18/210.34 |- skos__prefLabel mesh__D011524 Protoporphyrins
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D011524 sjn
% 210.18/210.34 |- skos__annotation mesh__D049992 coordinate with DIURETICS if pertinent
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D049992 2006
% 210.18/210.34 |- skos__hiddenLabel mesh__D049992 Chloride Cotransporters, Sodium
% 210.18/210.34 |- skos__hiddenLabel mesh__D049992 Cotransporter, Sodium-Chloride
% 210.18/210.34 |- skos__hiddenLabel mesh__D049992 Sodium Chloride Cotransporter
% 210.18/210.34 |- skos__hiddenLabel mesh__D049992 Symporters, Sodium Chloride
% 210.18/210.34 |- skos__hiddenLabel mesh__D049992 Na Cl Symporters
% 210.18/210.34 |- skos__altLabel mesh__D049992 Sodium Chloride Cotransporters
% 210.18/210.34 |- mesh__dateEstablished mesh__D049992 2006-01-01
% 210.18/210.34 |- skos__hiddenLabel mesh__D049992 Sodium Chloride Transporter
% 210.18/210.34 |- mesh__activeMeSHYear mesh__D049992 2006
% 210.18/210.34 |- skos__altLabel mesh__D049992 Na-Cl-Symporters
% 210.18/210.34 |- skos__scopeNote mesh__D049992
% 210.18/210.34 A subclass of symporters found in KIDNEY TUBULES, DISTAL that are the major pathway for salt resorption. Inhibition of these symporters by BENZOTHIADIAZINES is the basis of action of some DIURETICS.%A%
% 210.18/210.34 |- mesh__recordAuthorizer mesh__D049992 sjn
% 210.18/210.34 |- skos__hiddenLabel mesh__D049992 Cotransporters, Sodium Chloride
% 210.18/210.34 |- skos__hiddenLabel mesh__D049992 Chloride Symporters, Sodium
% 210.18/210.34 |- skos__prefLabel mesh__D049992 Sodium Chloride Symporters
% 210.18/210.34 |- mesh__recordMaintainer mesh__D049992 ssb
% 210.18/210.34 |- skos__hiddenLabel mesh__D049992 Transporter, Sodium-Chloride
% 210.18/210.34 |- mesh__historyNote mesh__D049992
% 210.18/210.34 2006%28%1984%29%; for SODIUM-CHLORIDE COTRANSPORTER use SYMPORTERS %28%NM%29%%A%
% 210.18/210.34 |- skos__broader mesh__D049992smesh__D027981
% 210.18/210.34 |- rdf__type mesh__D049992sskos__Concept
% 210.18/210.34 |- skos__altLabel mesh__D049992 Sodium-Chloride Transporter
% 210.18/210.34 |- mesh__recordOriginator mesh__D049992 ssb
% 210.18/210.34 |- mesh__dateCreated mesh__D049992 2005-06-30
% 210.18/210.34 |- skos__altLabel mesh__D049992 Sodium-Chloride Cotransporter
% 210.18/210.34 |- mesh__dateCreated mesh__D002798 1974-11-19
% 210.18/210.34 |- skos__altLabel mesh__D002798 Cholinephosphotransferase
% 210.18/210.34 |- mesh__recordMaintainer mesh__D002798 ssb
% 210.18/210.34 |- skos__hiddenLabel mesh__D002798 Transferase, Phosphorylcholine-Glyceride
% 210.18/210.34 |- skos__altLabel mesh__D002798
% 210.18/210.34 CDP-Choline 1,2-Diglyceride Choline Phosphotransferase
% 210.18/210.34 |- skos__historyNote mesh__D002798 Cytosine Nucleotides %28%1973-1974%29%
% 210.18/210.34 |- skos__altLabel mesh__D002798 CDP-Diacylglycerol Synthase
% 210.18/210.34 |- skos__altLabel mesh__D002798 Phosphocholinetransferase
% 210.18/210.34 |- mesh__publicMeSHNote mesh__D002798
% 210.18/210.34 1994; see CHOLINEPHOSPHOTRANSFERASE 1975-93; 1-ALKYL-2-ACETYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE was indexed under DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE 1994-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE see PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993%A%
% 210.18/210.34 |- skos__hiddenLabel mesh__D002798
% 210.18/210.34 Choline Phosphotransferase, Diacylglycerol-CDP
% 210.18/210.34 |- skos__altLabel mesh__D002798 Phosphorylcholineglyceride Transferase
% 210.18/210.34 |- skos__hiddenLabel mesh__D002798
% 210.18/210.34 CDP Choline 1,2 Diglyceride Choline Phosphotransferase
% 210.18/210.34 |- skos__hiddenLabel mesh__D002798
% 210.18/210.34 Cholinephosphotransferase, Diacylglycerol
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798
% 210.18/210.35 Cholinephosphotransferase, 1-alkyl-2-Acetylglycerol
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798 Cholinephosphotransferase, CDP-Choline
% 210.18/210.35 |- skos__altLabel mesh__D002798 CDP-Choline Cholinephosphotransferase
% 210.18/210.35 |- mesh__historyNote mesh__D002798
% 210.18/210.35 1994%28%1975%29%; use CHOLINEPHOSPHOTRANSFERASE 1975-93; for 1-ALKYL-2-ACETOGLYCEROL CHOLINEPHOSPHOTRANSFERASE use DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE %28%NM%29% 1987-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE use PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993%A%
% 210.18/210.35 |- skos__broader mesh__D002798smesh__D017855
% 210.18/210.35 |- mesh__dateRevised mesh__D002798 2003-07-09
% 210.18/210.35 |- skos__scopeNote mesh__D002798
% 210.18/210.35 An enzyme that catalyzes the synthesis of phosphatidylcholines from CDPcholine and 1,2-diacylglycerols. EC 2.7.8.2.%A%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002798 2006
% 210.18/210.35 |- skos__altLabel mesh__D002798
% 210.18/210.35 Diacylglycerol-CDP Choline Phosphotransferase
% 210.18/210.35 |- skos__prefLabel mesh__D002798 Diacylglycerol Cholinephosphotransferase
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798 Phosphocholinetransferase, PAF
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798 Phosphorylcholine Glyceride Transferase
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798
% 210.18/210.35 Phosphotransferase, Diacylglycerol-CDP Choline
% 210.18/210.35 |- skos__historyNote mesh__D002798 Choline %28%1973-1974%29%
% 210.18/210.35 |- rdf__type mesh__D002798sskos__Concept
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002798 2005
% 210.18/210.35 |- skos__altLabel mesh__D002798 Phosphorylcholine-Glyceride Transferase
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798 CDP Diacylglycerol Synthase
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D002798 sjn
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798 Transferase, Phosphorylcholineglyceride
% 210.18/210.35 |- mesh__dateEstablished mesh__D002798 1991-01-01
% 210.18/210.35 |- skos__historyNote mesh__D002798 Glycerides %28%1973-1974%29%
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798 CDP Choline Cholinephosphotransferase
% 210.18/210.35 |- mesh__recordOriginator mesh__D002798 NLM
% 210.18/210.35 |- skos__historyNote mesh__D002798 Phosphotransferases %28%1973-1974%29%
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798 Synthase, CDP-Diacylglycerol
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002798 2004
% 210.18/210.35 |- skos__altLabel mesh__D002798
% 210.18/210.35 1-alkyl-2-Acetylglycerol Cholinephosphotransferase
% 210.18/210.35 |- skos__hiddenLabel mesh__D002798
% 210.18/210.35 Diacylglycerol CDP Choline Phosphotransferase
% 210.18/210.35 |- skos__altLabel mesh__D002798 PAF Phosphocholinetransferase
% 210.18/210.35 |- skos__hiddenLabel mesh__D007483 Acid, Methalamic
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007483 2004
% 210.18/210.35 |- mesh__historyNote mesh__D007483 66%28%63%29%
% 210.18/210.35 |- skos__hiddenLabel mesh__D007483 AngioConray
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D007483 66
% 210.18/210.35 |- skos__hiddenLabel mesh__D007483 Acid, Iotalamic
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D007483 sjn
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007483 2005
% 210.18/210.35 |- mesh__recordOriginator mesh__D007483 NLM
% 210.18/210.35 |- skos__altLabel mesh__D007483 Iotalamic Acid
% 210.18/210.35 |- skos__prefLabel mesh__D007483 Iothalamic Acid
% 210.18/210.35 |- skos__altLabel mesh__D007483 Methalamic Acid
% 210.18/210.35 |- skos__hiddenLabel mesh__D007483 Acid, Iothalamic
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007483 2001
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007483 2006
% 210.18/210.35 |- skos__altLabel mesh__D007483 Iothalamic Acid, Monosodium Salt
% 210.18/210.35 |- skos__scopeNote mesh__D007483
% 210.18/210.35 A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine %28%IOTHALAMATE MEGLUMINE%29% salts.%A%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007483 2002
% 210.18/210.35 |- skos__hiddenLabel mesh__D007483 Iothalamate, Sodium
% 210.18/210.35 |- skos__annotation mesh__D007483 D25-26 qualif
% 210.18/210.35 |- mesh__dateEstablished mesh__D007483 1966-01-01
% 210.18/210.35 |- skos__hiddenLabel mesh__D007483 Angio Conray
% 210.18/210.35 |- mesh__recordMaintainer mesh__D007483 CCR
% 210.18/210.35 |- skos__broader mesh__D007483smesh__D014283
% 210.18/210.35 |- rdf__type mesh__D007483sskos__Concept
% 210.18/210.35 |- mesh__dateCreated mesh__D007483 1999-01-01
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007483 2003
% 210.18/210.35 |- mesh__dateRevised mesh__D007483 2000-06-21
% 210.18/210.35 |- skos__hiddenLabel mesh__D015915 CPM Therapies
% 210.18/210.35 |- skos__broader mesh__D015915smesh__D005081
% 210.18/210.35 |- skos__scopeNote mesh__D015915
% 210.18/210.35 Movement of a body part initiated and maintained by a mechanical or electrical device to restore normal range of motion to joints, muscles, or tendons after surgery, prosthesis implantation, contracture flexion, or long immobilization.%A%
% 210.18/210.35 |- skos__altLabel mesh__D015915 Passive Motion Therapy, Continuous
% 210.18/210.35 |- skos__prefLabel mesh__D015915 Motion Therapy, Continuous Passive
% 210.18/210.35 |- rdf__type mesh__D015915sskos__Concept
% 210.18/210.35 |- mesh__dateEstablished mesh__D015915 1990-01-01
% 210.18/210.35 |- skos__annotation mesh__D015915
% 210.18/210.35 a type of exercise ther; do not use /util except by MeSH definition%A%
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D015915 sjn
% 210.18/210.35 |- skos__altLabel mesh__D015915 Movement Therapy, Continuous Passive
% 210.18/210.35 |- skos__historyNote mesh__D015915 Physical Therapy %28%1966-1989%29%
% 210.18/210.35 |- skos__historyNote mesh__D015915
% 210.18/210.35 Manipulation, Orthopedic %28%1966-1977%29%
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D015915 90
% 210.18/210.35 |- mesh__recordMaintainer mesh__D015915 lkt
% 210.18/210.35 |- skos__historyNote mesh__D015915 Movement %28%1966-1989%29%
% 210.18/210.35 |- skos__altLabel mesh__D015915 Continuous Passive Movement Therapy
% 210.18/210.35 |- skos__altLabel mesh__D015915 Continuous Passive Motion Therapy
% 210.18/210.35 |- skos__altLabel mesh__D015915 CPM Therapy
% 210.18/210.35 |- mesh__recordOriginator mesh__D015915 PLS
% 210.18/210.35 |- skos__historyNote mesh__D015915 Exercise Therapy %28%1972-1989%29%
% 210.18/210.35 |- mesh__dateCreated mesh__D015915 1989-05-15
% 210.18/210.35 |- skos__altLabel mesh__D015915 Passive Movement Therapy, Continuous
% 210.18/210.35 |- mesh__dateRevised mesh__D015915 2005-06-30
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D015915 2006
% 210.18/210.35 |- skos__hiddenLabel mesh__D015915 Therapy, CPM
% 210.18/210.35 |- skos__hiddenLabel mesh__D015915 Therapies, CPM
% 210.18/210.35 |- mesh__historyNote mesh__D015915 90
% 210.18/210.35 |- mesh__recordOriginator mesh__D015117 NLM
% 210.18/210.35 |- skos__altLabel mesh__D015117 5,8,11,14 Eicosatetraynoic Acid
% 210.18/210.35 |- rdf__type mesh__D015117sskos__Concept
% 210.18/210.35 |- mesh__dateRevised mesh__D015117 2003-07-09
% 210.18/210.35 |- skos__historyNote mesh__D015117
% 210.18/210.35 Fatty Acids, Unsaturated %28%1973-1974%29%
% 210.18/210.35 |- skos__broader mesh__D015117smesh__D015777
% 210.18/210.35 |- skos__scopeNote mesh__D015117
% 210.18/210.35 A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E%28%2%29% and F%28%2a%29%.%A%
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D015117
% 210.18/210.35 91; was see under FATTY ACIDS, UNSATURATED 1975-90
% 210.18/210.35 |- skos__hiddenLabel mesh__D015117 Ro 3 1428
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D015117 sjn
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D015117 2004
% 210.18/210.35 |- skos__prefLabel mesh__D015117 5,8,11,14-Eicosatetraynoic Acid
% 210.18/210.35 |- mesh__recordMaintainer mesh__D015117 ssb
% 210.18/210.35 |- skos__altLabel mesh__D015117 ETYA
% 210.18/210.35 |- mesh__dateCreated mesh__D015117 1974-11-19
% 210.18/210.35 |- skos__hiddenLabel mesh__D015117 Ro 31428
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D015117 2006
% 210.18/210.35 |- mesh__dateEstablished mesh__D015117 1991-01-01
% 210.18/210.35 |- mesh__historyNote mesh__D015117
% 210.18/210.35 91%28%75%29%; was see under FATTY ACIDS, UNSATURATED 1975-90
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D015117 2005
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D031582 2003
% 210.18/210.35 |- skos__scopeNote mesh__D031582
% 210.18/210.35 A plant genus of the family MALPIGHIACEAE. G. glauca is the source of %27%Galphimia glauca extract%27% and contains %27%galphimine B%27% and tetragalloylquinic acid.%A%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D031582 2003
% 210.18/210.35 |- skos__prefLabel mesh__D031582 Galphimia
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D031582 2004
% 210.18/210.35 |- skos__broader mesh__D031582smesh__D029581
% 210.18/210.35 |- rdf__type mesh__D031582sskos__Concept
% 210.18/210.35 |- skos__annotation mesh__D031582
% 210.18/210.35 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.18/210.35 |- mesh__dateEstablished mesh__D031582 2003-01-01
% 210.18/210.35 |- mesh__dateCreated mesh__D031582 2002-07-03
% 210.18/210.35 |- mesh__historyNote mesh__D031582 2003
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D031582 2005
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D031582 2006
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D003891 2006
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D003891 sjn
% 210.18/210.35 |- skos__prefLabel mesh__D003891 Desipramine
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D003891 65
% 210.18/210.35 |- skos__hiddenLabel mesh__D003891 Hydrochloride, Desipramine
% 210.18/210.35 |- skos__hiddenLabel mesh__D003891
% 210.18/210.35 Rh%C3%%B4%ne Poulenc Rorer Brand of Desipramine Hydrochloride
% 210.18/210.35 |- skos__altLabel mesh__D003891 Temmler Brand of Desipramine Hydrochloride
% 210.18/210.35 |- skos__altLabel mesh__D003891
% 210.18/210.35 Rh%C3%%B4%ne-Poulenc Rorer Brand of Desipramine Hydrochloride
% 210.18/210.35 |- mesh__recordOriginator mesh__D003891 NLM
% 210.18/210.35 |- mesh__historyNote mesh__D003891 65%28%63%29%
% 210.18/210.35 |- skos__hiddenLabel mesh__D003891
% 210.18/210.35 Nu Pharm Brand of Desipramine Hydrochloride
% 210.18/210.35 |- skos__altLabel mesh__D003891 Pertrofran
% 210.18/210.35 |- skos__altLabel mesh__D003891 Aventis Brand of Desipramine Hydrochloride
% 210.18/210.35 |- rdf__type mesh__D003891sskos__Concept
% 210.18/210.35 |- skos__altLabel mesh__D003891
% 210.18/210.35 Ratiopharm Brand of Desipramine Hydrochloride
% 210.18/210.35 |- mesh__dateEstablished mesh__D003891 1965-01-01
% 210.18/210.35 |- mesh__recordMaintainer mesh__D003891 exl
% 210.18/210.35 |- skos__altLabel mesh__D003891 Pertofran
% 210.18/210.35 |- skos__altLabel mesh__D003891 Novartis Brand of Desipramine Hydrochloride
% 210.18/210.35 |- mesh__dateCreated mesh__D003891 1999-01-01
% 210.18/210.35 |- skos__broader mesh__D003891smesh__D003984
% 210.18/210.35 |- skos__altLabel mesh__D003891 Desmethylimipramine
% 210.18/210.35 |- skos__altLabel mesh__D003891 Demethylimipramine
% 210.18/210.35 |- skos__scopeNote mesh__D003891
% 210.18/210.35 A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.%A%
% 210.18/210.35 |- skos__altLabel mesh__D003891 Apotex Brand of Desipramine Hydrochloride
% 210.18/210.35 |- skos__altLabel mesh__D003891
% 210.18/210.35 Pharmascience Brand of Desipramine Hydrochloride
% 210.18/210.35 |- skos__altLabel mesh__D003891 Nu-Pharm Brand of Desipramine Hydrochloride
% 210.18/210.35 |- skos__altLabel mesh__D003891
% 210.18/210.35 Aventis Behring Brand of Desipramine Hydrochloride
% 210.18/210.35 |- mesh__dateRevised mesh__D003891 2005-06-30
% 210.18/210.35 |- skos__altLabel mesh__D003891
% 210.18/210.35 Novopharm Brand of Desipramine Hydrochloride
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D003093 2004
% 210.18/210.35 |- mesh__recordOriginator mesh__D003093 NLM
% 210.18/210.35 |- mesh__dateCreated mesh__D003093 1999-01-01
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D003093 sjn
% 210.18/210.35 |- skos__broader mesh__D003093smesh__D003092
% 210.18/210.35 |- skos__scopeNote mesh__D003093
% 210.18/210.35 Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.%A%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D003093 2005
% 210.18/210.35 |- mesh__dateRevised mesh__D003093 2003-07-09
% 210.18/210.35 |- skos__broader mesh__D003093smesh__D015212
% 210.18/210.35 |- skos__prefLabel mesh__D003093 Colitis, Ulcerative
% 210.18/210.35 |- skos__annotation mesh__D003093
% 210.18/210.35 usually chronic so do not coord with CHRONIC DISEASE
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D003093 2006
% 210.18/210.35 |- skos__altLabel mesh__D003093 Ulcerative Colitis
% 210.18/210.35 |- mesh__recordMaintainer mesh__D003093 lkt
% 210.18/210.35 |- rdf__type mesh__D003093sskos__Concept
% 210.18/210.35 |- mesh__recordOriginator mesh__D019508 TGC
% 210.18/210.35 |- mesh__dateEstablished mesh__D019508 1997-01-01
% 210.18/210.35 |- mesh__dateCreated mesh__D019508 1996-06-21
% 210.18/210.35 |- mesh__recordMaintainer mesh__D019508 jls
% 210.18/210.35 |- mesh__dateRevised mesh__D019508 2005-06-30
% 210.18/210.35 |- skos__altLabel mesh__D019508 Guidebooks
% 210.18/210.35 |- skos__annotation mesh__D019508
% 210.18/210.35 publication type only; handbooks for travelers
% 210.18/210.35 |- skos__broader mesh__D019508smesh__D052180
% 210.18/210.35 |- skos__altLabel mesh__D019508 Guidebooks %28%PT%29%
% 210.18/210.35 |- rdf__type mesh__D019508sskos__Concept
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D019508 2006
% 210.18/210.35 |- skos__prefLabel mesh__D019508 Guidebooks %5B%Publication Type%5D%
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D019508 sjn
% 210.18/210.35 |- mesh__historyNote mesh__D019508 1997
% 210.18/210.35 |- skos__scopeNote mesh__D019508
% 210.18/210.35 Works consisting of publications for travelers that give information about a city, region, or country, or similar handbooks about buildings, museums, etc. %28%The ALA Glossary of Library and Information Science, 1983%29%%A%
% 210.18/210.35 |- mesh__recordMaintainer mesh__D011525 SYSTEM
% 210.18/210.35 |- skos__annotation mesh__D011525
% 210.18/210.35 infection: coordinate IM with INFECTION %28%IM%29%
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D011525 80
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D011525 sjn
% 210.18/210.35 |- mesh__recordOriginator mesh__D011525 AEP
% 210.18/210.35 |- skos__broader mesh__D011525smesh__D000460
% 210.18/210.35 |- skos__historyNote mesh__D011525 Algae, Green %28%1970-1979%29%
% 210.18/210.35 |- mesh__dateRevised mesh__D011525 2005-06-30
% 210.18/210.35 |- mesh__dateEstablished mesh__D011525 1980-01-01
% 210.18/210.35 |- skos__prefLabel mesh__D011525 Prototheca
% 210.18/210.35 |- skos__historyNote mesh__D011525 Algae %28%1966-1979%29%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D011525 2006
% 210.18/210.35 |- mesh__dateCreated mesh__D011525 1978-12-21
% 210.18/210.35 |- mesh__historyNote mesh__D011525 80
% 210.18/210.35 |- skos__scopeNote mesh__D011525
% 210.18/210.35 A genus of achlorophyllic algae in the family Chlorellaceae, and closely related to CHLORELLA. It is found in decayed matter; WATER; SEWAGE; and SOIL; and produces cutaneous and disseminated infections in various VERTEBRATES including humans.%A%
% 210.18/210.35 |- rdf__type mesh__D011525sskos__Concept
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D049993 2006
% 210.18/210.35 |- skos__hiddenLabel mesh__D049993 Diuretics, Benzothiadiazine
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D049993
% 210.18/210.35 2006; for THIAZIDE DIURETICS use THIAZIDE DIURETICS 1976-2005%A%
% 210.18/210.35 |- skos__scopeNote mesh__D049993
% 210.18/210.35 Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.%A%
% 210.18/210.35 |- skos__broader mesh__D049993smesh__D049990
% 210.18/210.35 |- skos__annotation mesh__D049993 coordinate with DIURETICS if pertinent
% 210.18/210.35 |- skos__altLabel mesh__D049993 Thiazide Diuretics
% 210.18/210.35 |- skos__prefLabel mesh__D049993 Sodium Chloride Symporter Inhibitors
% 210.18/210.35 |- rdf__type mesh__D049993sskos__Concept
% 210.18/210.35 |- mesh__dateCreated mesh__D049993 2005-06-30
% 210.18/210.35 |- skos__altLabel mesh__D049993 Benzothiadiazine Diuretics
% 210.18/210.35 |- skos__hiddenLabel mesh__D049993 Diuretics, Potassium Depleting
% 210.18/210.35 |- mesh__dateEstablished mesh__D049993 2006-01-01
% 210.18/210.35 |- mesh__recordOriginator mesh__D049993 ssb
% 210.18/210.35 |- mesh__historyNote mesh__D049993 2006
% 210.18/210.35 |- skos__altLabel mesh__D049993 Sodium Chloride Cotransporter Inhibitors
% 210.18/210.35 |- skos__altLabel mesh__D049993
% 210.18/210.35 Thiazide Sensitive NaCl Cotransporter Inhibitors
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D049993 sjn
% 210.18/210.35 |- mesh__recordMaintainer mesh__D049993 ssb
% 210.18/210.35 |- skos__altLabel mesh__D016210 Methapharma Brand of Methacholine Chloride
% 210.18/210.35 |- skos__hiddenLabel mesh__D016210 Acetyl beta methylcholine
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D016210 sjn
% 210.18/210.35 |- mesh__dateEstablished mesh__D016210 1991-01-01
% 210.18/210.35 |- skos__prefLabel mesh__D016210 Methacholine Chloride
% 210.18/210.35 |- skos__broader mesh__D016210smesh__D008688
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D016210 91
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D016210 2006
% 210.18/210.35 |- skos__altLabel mesh__D016210
% 210.18/210.35 2-%28%Acetyloxy%29%-N,N,N-trimethyl-1-propanaminium Chloride
% 210.18/210.35 |- skos__altLabel mesh__D016210 Acetyl-2-methylcholine Chloride
% 210.18/210.35 |- mesh__historyNote mesh__D016210 91
% 210.18/210.35 |- skos__scopeNote mesh__D016210
% 210.18/210.35 A quaternary ammonium parasympathomimetic agent with the muscarinic actions of ACETYLCHOLINE. It is hydrolyzed by ACETYLCHOLINESTERASE at a considerably slower rate than ACETYLCHOLINE and is more resistant to hydrolysis by nonspecific CHOLINESTERASES so that its actions are more prolonged. It is used as a parasympathomimetic bronchoconstrictor agent and as a diagnostic aid for bronchial asthma. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1116%29%%A%
% 210.18/210.35 |- skos__altLabel mesh__D016210 Roche Brand of Methacholine Chloride
% 210.18/210.35 |- rdf__type mesh__D016210sskos__Concept
% 210.18/210.35 |- skos__hiddenLabel mesh__D016210 Chloride, Methacholine
% 210.18/210.35 |- skos__altLabel mesh__D016210 Mecholine
% 210.18/210.35 |- skos__hiddenLabel mesh__D016210 Acetyl 2 methylcholine Chloride
% 210.18/210.35 |- mesh__dateRevised mesh__D016210 2005-06-30
% 210.18/210.35 |- skos__altLabel mesh__D016210 Lindopharm Brand of Methacholine Chloride
% 210.18/210.35 |- skos__historyNote mesh__D016210 Methacholine Compounds %28%1966-1990%29%
% 210.18/210.35 |- mesh__dateCreated mesh__D016210 1990-04-24
% 210.18/210.35 |- mesh__recordMaintainer mesh__D016210 ssb
% 210.18/210.35 |- mesh__recordOriginator mesh__D016210 RLS
% 210.18/210.35 |- skos__altLabel mesh__D016210 Acetyl-beta-methacholine Chloride
% 210.18/210.35 |- skos__hiddenLabel mesh__D016210 Acetyl beta methacholine Chloride
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 2006
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 1999
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D002799 77
% 210.18/210.35 |- skos__hiddenLabel mesh__D002799 Fibers, Cholinergic
% 210.18/210.35 |- skos__prefLabel mesh__D002799 Cholinergic Fibers
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 1994
% 210.18/210.35 |- mesh__historyNote mesh__D002799 77
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D002799 PLS
% 210.18/210.35 |- mesh__recordOriginator mesh__D002799 MM
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 2003
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 1995
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 1996
% 210.18/210.35 |- rdf__type mesh__D002799sskos__Concept
% 210.18/210.35 |- skos__scopeNote mesh__D002799
% 210.18/210.35 Nerve fibers liberating acetylcholine at the synapse after an impulse.%A%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 2000
% 210.18/210.35 |- skos__broader mesh__D002799smesh__D009412
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 2004
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 1997
% 210.18/210.35 |- skos__hiddenLabel mesh__D002799 Fiber, Cholinergic
% 210.18/210.35 |- skos__historyNote mesh__D002799
% 210.18/210.35 Parasympathetic Nervous System %28%1966-1976%29%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 2001
% 210.18/210.35 |- mesh__dateRevised mesh__D002799 1993-06-18
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 2005
% 210.18/210.35 |- mesh__recordMaintainer mesh__D002799 RAZ
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 1998
% 210.18/210.35 |- skos__hiddenLabel mesh__D002799 Cholinergic Fiber
% 210.18/210.35 |- mesh__dateCreated mesh__D002799 1976-04-27
% 210.18/210.35 |- mesh__dateEstablished mesh__D002799 1977-01-01
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D002799 2002
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D043607 2004
% 210.18/210.35 |- mesh__recordOriginator mesh__D043607 lkt
% 210.18/210.35 |- skos__altLabel mesh__D043607
% 210.18/210.35 NADPH-Dependent 20 alpha-Hydroxysteroid Oxidoreductase
% 210.18/210.35 |- skos__altLabel mesh__D043607 20-alpha-HSD
% 210.18/210.35 |- skos__hiddenLabel mesh__D043607
% 210.18/210.35 NADPH Dependent 20 alpha Hydroxysteroid Oxidoreductase
% 210.18/210.35 |- mesh__dateCreated mesh__D043607 2003-07-09
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D043607 2006
% 210.18/210.35 |- skos__scopeNote mesh__D043607
% 210.18/210.35 An enzymes that catalyzes the reversible reduction-oxidation reaction of 20-alpha-hydroxysteroids, such as from PROGESTERONE to 20-ALPHA-DIHYDROPROGESTERONE.%A%
% 210.18/210.35 |- skos__historyNote mesh__D043607
% 210.18/210.35 Hydroxysteroid Dehydrogenases %28%1965-1977%29%
% 210.18/210.35 |- mesh__recordMaintainer mesh__D043607 lkt
% 210.18/210.35 |- rdf__type mesh__D043607sskos__Concept
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D043607
% 210.18/210.35 2004; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE was indexed under 20-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1982-2003%A%
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D043607 sjn
% 210.18/210.35 |- skos__hiddenLabel mesh__D043607
% 210.18/210.35 17 beta, 20 alpha Hydroxysteroid Dehydrogenase
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D043607 2005
% 210.18/210.35 |- skos__hiddenLabel mesh__D043607 20 alpha Hydroxysteroid Dehydrogenase
% 210.18/210.35 |- skos__broader mesh__D043607smesh__D015089
% 210.18/210.35 |- skos__altLabel mesh__D043607 20 alpha-Hydroxysteroid Dehydrogenase
% 210.18/210.35 |- mesh__dateEstablished mesh__D043607 2004-01-01
% 210.18/210.35 |- mesh__historyNote mesh__D043607
% 210.18/210.35 2004; use 20-ALPHA-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1982-2003%A%
% 210.18/210.35 |- skos__historyNote mesh__D043607
% 210.18/210.35 20-Hydroxysteroid Dehydrogenases %28%1978-2003%29%
% 210.18/210.35 |- skos__hiddenLabel mesh__D043607 20 alpha HSD
% 210.18/210.35 |- skos__prefLabel mesh__D043607 20-alpha-Hydroxysteroid Dehydrogenase
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007484 2002
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007484 2006
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D007484 SJN
% 210.18/210.35 |- skos__prefLabel mesh__D007484 Iowa
% 210.18/210.35 |- mesh__dateRevised mesh__D007484 1997-06-20
% 210.18/210.35 |- rdf__type mesh__D007484sskos__Concept
% 210.18/210.35 |- mesh__dateCreated mesh__D007484 1999-01-01
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007484 2003
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007484 2000
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007484 2004
% 210.18/210.35 |- mesh__recordOriginator mesh__D007484 NLM
% 210.18/210.35 |- skos__broader mesh__D007484smesh__D015146
% 210.18/210.35 |- mesh__recordMaintainer mesh__D007484 PXP
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007484 1998
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007484 2001
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007484 2005
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D007484 1999
% 210.18/210.35 |- skos__broader mesh__D015916smesh__D004322
% 210.18/210.35 |- rdf__type mesh__D015916sskos__Concept
% 210.18/210.35 |- mesh__dateEstablished mesh__D015916 1990-01-01
% 210.18/210.35 |- mesh__dateRevised mesh__D015916 2005-06-30
% 210.18/210.35 |- skos__hiddenLabel mesh__D015916 Postural Respiratory Drainage
% 210.18/210.35 |- skos__hiddenLabel mesh__D015916 Drainage, Postural Respiratory
% 210.18/210.35 |- skos__prefLabel mesh__D015916 Drainage, Postural
% 210.18/210.35 |- skos__altLabel mesh__D015916 Postural Drainage
% 210.18/210.35 |- mesh__historyNote mesh__D015916 90
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D015916 90
% 210.18/210.35 |- skos__hiddenLabel mesh__D015916 Drainages, Postural Respiratory
% 210.18/210.35 |- skos__broader mesh__D015916smesh__D012138
% 210.18/210.35 |- skos__altLabel mesh__D015916 Respiratory Drainage, Postural
% 210.18/210.35 |- skos__annotation mesh__D015916
% 210.18/210.35 ther drainage of %22%copious mucus secretion%22% in bronchopulm dis%A%
% 210.18/210.35 |- skos__broader mesh__D015916smesh__D026241
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D015916 sjn
% 210.18/210.35 |- mesh__recordOriginator mesh__D015916 PLS
% 210.18/210.35 |- skos__hiddenLabel mesh__D015916 Postural Respiratory Drainages
% 210.18/210.35 |- mesh__recordMaintainer mesh__D015916 lkt
% 210.18/210.35 |- mesh__dateCreated mesh__D015916 1989-05-15
% 210.18/210.35 |- skos__hiddenLabel mesh__D015916 Respiratory Drainages, Postural
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D015916 2006
% 210.18/210.35 |- skos__historyNote mesh__D015916 Posture %28%1966-1989%29%
% 210.18/210.35 |- skos__scopeNote mesh__D015916
% 210.18/210.35 Therapeutic drainage in bronchopulmonary diseases in which there is copious mucus secretion, such as chronic bronchitis, bronchiectasis, pulmonary abscess, or cystic fibrosis. The patient is placed with head downward, so that the trachea is inclined downward and below the affected area. It may be done in 15- to 20-minute sessions or by having the patient sleep in a head-down position. The therapy may be used in conjunction with forced expiration, bronchodilator agents, or expectorants.%A%
% 210.18/210.35 |- skos__historyNote mesh__D015916 Drainage %28%1966-1989%29%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D015118 2005
% 210.18/210.35 |- rdf__type mesh__D015118sskos__Concept
% 210.18/210.35 |- skos__altLabel mesh__D015118 5,8,11,14,17-Eicosapentaenoic Acid
% 210.18/210.35 |- skos__prefLabel mesh__D015118 Eicosapentaenoic Acid
% 210.18/210.35 |- skos__hiddenLabel mesh__D015118 omega 3 Eicosapentaenoic Acid
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D015118
% 210.18/210.35 1986; see 5,8,11,14,17-EICOSAPENTAENOIC ACID 1986-2003
% 210.18/210.35 |- mesh__recordOriginator mesh__D015118 RLS
% 210.18/210.35 |- mesh__dateCreated mesh__D015118 1985-06-05
% 210.18/210.35 |- skos__broader mesh__D015118smesh__D015777
% 210.18/210.35 |- mesh__dateRevised mesh__D015118 2003-07-09
% 210.18/210.35 |- skos__broader mesh__D015118smesh__D015525
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D015118 sjn
% 210.18/210.35 |- mesh__recordMaintainer mesh__D015118 jmp
% 210.18/210.35 |- skos__scopeNote mesh__D015118
% 210.18/210.35 Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.%A%
% 210.18/210.35 |- skos__altLabel mesh__D015118 5,8,11,14,17-Icosapentaenoic Acid
% 210.18/210.35 |- mesh__dateEstablished mesh__D015118 1986-01-01
% 210.18/210.35 |- skos__altLabel mesh__D015118 omega-3-Eicosapentaenoic Acid
% 210.18/210.35 |- mesh__historyNote mesh__D015118 2003%28%1986%29%;
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D015118 2004
% 210.18/210.35 |- skos__altLabel mesh__D015118 Timnodonic Acid
% 210.18/210.35 |- skos__historyNote mesh__D015118
% 210.18/210.35 Fatty Acids, Unsaturated %28%1973-1985%29%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D015118 2006
% 210.18/210.35 |- skos__historyNote mesh__D015118 Fatty Acids %28%1966-1972%29%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D031583 2003
% 210.18/210.35 |- mesh__dateCreated mesh__D031583 2002-07-02
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D031583 2004
% 210.18/210.35 |- skos__prefLabel mesh__D031583 Althaea
% 210.18/210.35 |- rdf__type mesh__D031583sskos__Concept
% 210.18/210.35 |- skos__broader mesh__D031583smesh__D019660
% 210.18/210.35 |- skos__annotation mesh__D031583
% 210.18/210.35 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D031583 2005
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D031583 2006
% 210.18/210.35 |- skos__scopeNote mesh__D031583
% 210.18/210.35 A plant genus of the family MALVACEAE known for mucilaginous roots. The common names of hollyhock and mallow are also used for other genera of MALVACEAE.%A%
% 210.18/210.35 |- mesh__dateEstablished mesh__D031583 2003-01-01
% 210.18/210.35 |- skos__altLabel mesh__D031583 Marshmallow
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D031583 2003
% 210.18/210.35 |- mesh__historyNote mesh__D031583 2003
% 210.18/210.35 |- skos__altLabel mesh__D031583 Mallow, Marsh
% 210.18/210.35 |- mesh__dateCreated mesh__D003892 1974-11-19
% 210.18/210.35 |- skos__hiddenLabel mesh__D003892 C, Desacetyllanatoside
% 210.18/210.35 |- mesh__historyNote mesh__D003892
% 210.18/210.35 91%28%75%29%; was see under LANATOSIDES 1975-90
% 210.18/210.35 |- skos__prefLabel mesh__D003892 Deslanoside
% 210.18/210.35 |- rdf__type mesh__D003892sskos__Concept
% 210.18/210.35 |- skos__historyNote mesh__D003892 Lanatosides %28%1969-1974%29%
% 210.18/210.35 |- skos__scopeNote mesh__D003892
% 210.18/210.35 Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis lanata.%A%
% 210.18/210.35 |- skos__hiddenLabel mesh__D003892 C, Deslanatoside
% 210.18/210.35 |- skos__altLabel mesh__D003892 Deslanatoside C
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D003892 2005
% 210.18/210.35 |- mesh__publicMeSHNote mesh__D003892
% 210.18/210.35 91; was see under LANATOSIDES 1975-90
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D003892 sjn
% 210.18/210.35 |- skos__hiddenLabel mesh__D003892 C, Desacetyldigilanide
% 210.18/210.35 |- skos__altLabel mesh__D003892 Desacetyldigilanide C
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D003892 2006
% 210.18/210.35 |- mesh__dateRevised mesh__D003892 2004-07-07
% 210.18/210.35 |- skos__hiddenLabel mesh__D003892 Cedilanid D
% 210.18/210.35 |- skos__altLabel mesh__D003892 Desacetyllanatoside C
% 210.18/210.35 |- skos__altLabel mesh__D003892 Desacetyl Lanatoside
% 210.18/210.35 |- skos__hiddenLabel mesh__D003892 CedilanidD
% 210.18/210.35 |- mesh__recordOriginator mesh__D003892 NLM
% 210.18/210.35 |- mesh__dateEstablished mesh__D003892 1991-01-01
% 210.18/210.35 |- mesh__recordMaintainer mesh__D003892 ssb
% 210.18/210.35 |- skos__broader mesh__D003892smesh__D007799
% 210.18/210.35 |- skos__hiddenLabel mesh__D003892 Lanatoside, Desacetyl
% 210.18/210.35 |- mesh__dateCreated mesh__D003094 1999-01-01
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D003094 2005
% 210.18/210.35 |- rdf__type mesh__D003094sskos__Concept
% 210.18/210.35 |- mesh__dateRevised mesh__D003094 2005-07-29
% 210.18/210.35 |- skos__scopeNote mesh__D003094
% 210.18/210.35 A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones %28%BONE AND BONES%29% and teeth %28%TOOTH%29%.%A%
% 210.18/210.35 |- mesh__recordMaintainer mesh__D003094 ags
% 210.18/210.35 |- mesh__activeMeSHYear mesh__D003094 2006B
% 210.18/210.35 |- mesh__recordAuthorizer mesh__D003094 ags
% 210.18/210.35 |- skos__hiddenLabel mesh__D003094 alpha Collagen
% 210.18/210.35 |- skos__hiddenLabel mesh__D003094 Collagen Hemostat, Microfibril
% 210.18/210.36 |- skos__broader mesh__D003094smesh__D016326
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003094 2006A
% 210.18/210.36 |- mesh__recordOriginator mesh__D003094 NLM
% 210.18/210.36 |- skos__annotation mesh__D003094
% 210.18/210.36 GEN; prefer specifics; precusor = PROCOLLAGEN; do not confuse X ref MICROFIBRIL COLLAGEN HEMOSTAT with FIBRILLAR COLLAGENS%A%
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003094 2006
% 210.18/210.36 |- skos__prefLabel mesh__D003094 Collagen
% 210.18/210.36 |- skos__broader mesh__D003094smesh__D001704
% 210.18/210.36 |- skos__altLabel mesh__D003094 Collagenfleece
% 210.18/210.36 |- rdf__type mesh__D019509sskos__Concept
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D019509 sjn
% 210.18/210.36 |- skos__annotation mesh__D019509
% 210.18/210.36 CATALOG: do not use for current materials
% 210.18/210.36 |- skos__scopeNote mesh__D019509
% 210.18/210.36 Works such as books on herbs or plants usually describing their medicinal value. %28%Random House Unabridged Dictionary, 2d ed%29%%A%
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D019509 2006
% 210.18/210.36 |- mesh__historyNote mesh__D019509 1997
% 210.18/210.36 |- mesh__dateEstablished mesh__D019509 1997-01-01
% 210.18/210.36 |- skos__prefLabel mesh__D019509 Herbals %5B%Publication Type%5D%
% 210.18/210.36 |- skos__altLabel mesh__D019509 Herbals %28%PT%29%
% 210.18/210.36 |- mesh__recordOriginator mesh__D019509 TGC
% 210.18/210.36 |- skos__broader mesh__D019509smesh__D019539
% 210.18/210.36 |- mesh__recordMaintainer mesh__D019509 jls
% 210.18/210.36 |- mesh__dateRevised mesh__D019509 2005-06-30
% 210.18/210.36 |- mesh__dateCreated mesh__D019509 1996-06-21
% 210.18/210.36 |- mesh__historyNote mesh__D011526
% 210.18/210.36 91%28%80%29%; was see under VERATRUM ALKALOIDS 1981-90; PROTOVERATRINE A was see under CEVANES 1975-79, was Prov 1966-74; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1966-68; CRYPTENAMINE was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74%A%
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D011526 2001
% 210.18/210.36 |- skos__altLabel mesh__D011526 Neoprotoveratrin
% 210.18/210.36 |- mesh__onlineNote mesh__D011526
% 210.18/210.36 use PROTOVERATRINES to search PROTOVERATRINE A 1966-75; use PROTOVERATRINES to search PROTOVERATRINE A DERIVATIVES 1978-80, use CEVANES 1969-77; use VERATRUM to search PROTOVERATRINE 1966-68; use PROTOVERATRINES to search CRYPTENAMINE 1975-79, use VERATRUM 1966-74%A%
% 210.18/210.36 |- skos__altLabel mesh__D011526 Protoveratrine A
% 210.18/210.36 |- skos__prefLabel mesh__D011526 Protoveratrines
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D011526
% 210.18/210.36 91; was see under VERATRUM ALKALOIDS 1981-90; PROTOVERATRINE A was see under CEVANES 1975-79, was Prov 1966-74; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1966-68; CRYPTENAMINE was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74%A%
% 210.18/210.36 |- skos__broader mesh__D011526smesh__D002595
% 210.18/210.36 |- mesh__dateRevised mesh__D011526 2000-06-21
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D011526 sjn
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D011526 2006
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D011526 2002
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D011526 2004
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D011526 2005
% 210.18/210.36 |- rdf__type mesh__D011526sskos__Concept
% 210.18/210.36 |- mesh__recordOriginator mesh__D011526 NLM
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D011526 2003
% 210.18/210.36 |- skos__scopeNote mesh__D011526
% 210.18/210.36 Mixtures of closely related hypotensive alkaloids from Veratrum album %28%Liliaceae%29%. They have been used in the treatment of hypertension but have largely been replaced by drugs with fewer adverse effects.%A%
% 210.18/210.36 |- mesh__dateEstablished mesh__D011526 1991-01-01
% 210.18/210.36 |- mesh__dateCreated mesh__D011526 1999-01-01
% 210.18/210.36 |- mesh__recordMaintainer mesh__D011526 TWD
% 210.18/210.36 |- skos__hiddenLabel mesh__D049994
% 210.18/210.36 Bumetanide Sensitive Na K Cl Transporter Inhibitors
% 210.18/210.36 |- skos__altLabel mesh__D049994
% 210.18/210.36 Bumetanide Sensitive Na-K-Cl-Transporter Inhibitors
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D049994 sjn
% 210.18/210.36 |- skos__altLabel mesh__D049994
% 210.18/210.36 Sodium Potassium Chloride Cotransporter Inhibitors
% 210.18/210.36 |- mesh__recordMaintainer mesh__D049994 ssb
% 210.18/210.36 |- rdf__type mesh__D049994sskos__Concept
% 210.18/210.36 |- skos__hiddenLabel mesh__D049994 Inhibitors, Na-K-CL Symporter
% 210.18/210.36 |- skos__hiddenLabel mesh__D049994 Symporter Inhibitors, Na-K-CL
% 210.18/210.36 |- skos__hiddenLabel mesh__D049994 Diuretics, High Ceiling
% 210.18/210.36 |- skos__broader mesh__D049994smesh__D049990
% 210.18/210.36 |- skos__scopeNote mesh__D049994
% 210.18/210.36 Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. Excess use is associated with HYPOKALEMIA and HYPERGLYCEMIA.%A%
% 210.18/210.36 |- skos__annotation mesh__D049994 coordinate with DIURETICS if pertinent
% 210.18/210.36 |- skos__prefLabel mesh__D049994
% 210.18/210.36 Sodium Potassium Chloride Symporter Inhibitors
% 210.18/210.36 |- skos__hiddenLabel mesh__D049994 Diuretics, Loop
% 210.18/210.36 |- skos__hiddenLabel mesh__D049994 Na K CL Symporter Inhibitors
% 210.18/210.36 |- mesh__recordOriginator mesh__D049994 ssb
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D049994 2006
% 210.18/210.36 |- mesh__dateCreated mesh__D049994 2005-06-30
% 210.18/210.36 |- skos__hiddenLabel mesh__D049994 Ceiling Diuretics, High
% 210.18/210.36 |- skos__historyNote mesh__D049994
% 210.18/210.36 Sodium-Potassium-Chloride Symporters %28%2002-2005%29%
% 210.18/210.36 |- mesh__dateEstablished mesh__D049994 2006-01-01
% 210.18/210.36 |- skos__altLabel mesh__D049994 Na-K-CL Symporter Inhibitors
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D049994 2006
% 210.18/210.36 |- mesh__historyNote mesh__D049994 2006
% 210.18/210.36 |- skos__broader mesh__D052119Q000172smesh__D052119
% 210.18/210.36 |- mesh__preferredCombination mesh__D052119Q000172smesh__D052120
% 210.18/210.36 |- rdf__type mesh__D052119Q000172smesh__CompoundConcept
% 210.18/210.36 |- skos__broader mesh__D016211smesh__D015291
% 210.18/210.36 |- skos__hiddenLabel mesh__D016211
% 210.18/210.36 Epidermal Growth Factor Related Transforming Growth Factor
% 210.18/210.36 |- mesh__dateRevised mesh__D016211 2005-06-30
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D016211 2006
% 210.18/210.36 |- skos__annotation mesh__D016211
% 210.18/210.36 /drug eff permitted; DF: note short X ref
% 210.18/210.36 |- skos__altLabel mesh__D016211 TGFalpha
% 210.18/210.36 |- skos__altLabel mesh__D016211
% 210.18/210.36 Epidermal Growth Factor-Related Transforming Growth Factor
% 210.18/210.36 |- skos__historyNote mesh__D016211 Peptides %28%1983-1988%29%
% 210.18/210.36 |- skos__historyNote mesh__D016211
% 210.18/210.36 Transforming Growth Factors %28%1989-1990%29%
% 210.18/210.36 |- mesh__dateCreated mesh__D016211 1990-06-29
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D016211 sjn
% 210.18/210.36 |- skos__altLabel mesh__D016211 TGF-alpha
% 210.18/210.36 |- mesh__historyNote mesh__D016211
% 210.18/210.36 91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-ALPHA was see TRANSFORMING GROWTH FACTORS 1989-90%A%
% 210.18/210.36 |- mesh__dateEstablished mesh__D016211 1991-01-01
% 210.18/210.36 |- skos__scopeNote mesh__D016211
% 210.18/210.36 Factor isolated in a variety of tissues including epithelium, and maternal decidua. It is closely related to EPIDERMAL GROWTH FACTOR and binds to the EGF receptor. TGF-alpha acts synergistically with TGF-beta in inducing phenotypic transformation, but its physiological role is unknown.%A%
% 210.18/210.36 |- rdf__type mesh__D016211sskos__Concept
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D016211
% 210.18/210.36 91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-ALPHA was see TRANSFORMING GROWTH FACTORS 1989-90%A%
% 210.18/210.36 |- mesh__recordOriginator mesh__D016211 AGS
% 210.18/210.36 |- mesh__onlineNote mesh__D016211
% 210.18/210.36 use TRANSFORMING GROWTH FACTORS to search TRANSFORMING GROWTH FACTOR ALPHA %26% TGF-ALPHA 1989-90%A%
% 210.18/210.36 |- mesh__recordMaintainer mesh__D016211 ssb
% 210.18/210.36 |- skos__prefLabel mesh__D016211 Transforming Growth Factor alpha
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D007485
% 210.18/210.36 87; IOXAGLATE MEGLUMINE was IOXAGLATE, MEGLUMINE 1987-93; IOXAGLATE SODIUM was IOXAGLATE, SODIUM 1987-93%A%
% 210.18/210.36 |- mesh__recordMaintainer mesh__D007485 ssb
% 210.18/210.36 |- mesh__dateRevised mesh__D007485 2001-07-25
% 210.18/210.36 |- skos__broader mesh__D007485smesh__D014283
% 210.18/210.36 |- rdf__type mesh__D007485sskos__Concept
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D007485 2002
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D007485 2003
% 210.18/210.36 |- skos__scopeNote mesh__D007485
% 210.18/210.36 A low-osmolar, ionic contrast medium used in various radiographic procedures.%A%
% 210.18/210.36 |- skos__historyNote mesh__D007485 Triiodobenzoic Acids %28%1972-1986%29%
% 210.18/210.36 |- skos__historyNote mesh__D007485 Benzoates %28%1966-1971%29%
% 210.18/210.36 |- skos__altLabel mesh__D007485 Methylglucamine Ioxaglate
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D007485 2004
% 210.18/210.36 |- mesh__dateEstablished mesh__D007485 1987-01-01
% 210.18/210.36 |- skos__altLabel mesh__D007485 Ioxaglic Acid Monosodium Salt
% 210.18/210.36 |- skos__prefLabel mesh__D007485 Ioxaglic Acid
% 210.18/210.36 |- skos__hiddenLabel mesh__D007485 Meglumine, Ioxaglate
% 210.18/210.36 |- skos__hiddenLabel mesh__D007485 Ioxaglate, Methylglucamine
% 210.18/210.36 |- mesh__recordOriginator mesh__D007485 RLS
% 210.18/210.36 |- skos__altLabel mesh__D007485 P286 %28%Contrast Media%29%
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D007485 2005
% 210.18/210.36 |- mesh__historyNote mesh__D007485
% 210.18/210.36 87; IOXAGLATE MEGLUMINE was IOXAGLATE, MEGLUMINE 1987-93; IOXAGLATE SODIUM was IOXAGLATE, SODIUM 1987-93%A%
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D007485 sjn
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D007485 2006
% 210.18/210.36 |- mesh__dateCreated mesh__D007485 1986-06-16
% 210.18/210.36 |- skos__historyNote mesh__D015917 Penis/surgery %28%1966-1989%29%
% 210.18/210.36 |- skos__hiddenLabel mesh__D015917 Implants, Penile
% 210.18/210.36 |- skos__hiddenLabel mesh__D015917 Implant, Penile
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015917 1998
% 210.18/210.36 |- mesh__recordOriginator mesh__D015917 PLS
% 210.18/210.36 |- mesh__dateCreated mesh__D015917 1989-05-15
% 210.18/210.36 |- skos__related mesh__D015917smesh__D019935
% 210.18/210.36 |- skos__hiddenLabel mesh__D015917 Prostheses, Penis
% 210.18/210.36 |- skos__historyNote mesh__D015917 Impotence %28%1966-1989%29%
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015917 2006
% 210.18/210.36 |- mesh__onlineNote mesh__D015917
% 210.18/210.36 use PENILE PROSTHESIS to search PROSTHESIS, PENILE 1990
% 210.18/210.36 |- skos__hiddenLabel mesh__D015917 Penile Prostheses
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015917 2001
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015917 2004
% 210.18/210.36 |- skos__altLabel mesh__D015917 Prosthesis, Penile
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015917 2000
% 210.18/210.36 |- mesh__historyNote mesh__D015917
% 210.18/210.36 90; PROSTHESIS, PENILE was see PENILE PROSTHESIS 1990
% 210.18/210.36 |- mesh__recordMaintainer mesh__D015917 PXP
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D015917
% 210.18/210.36 90; PROSTHESIS, PENILE was see PENILE PROSTHESIS 1990
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015917 2005
% 210.18/210.36 |- skos__hiddenLabel mesh__D015917 Prosthesis, Penis
% 210.18/210.36 |- skos__hiddenLabel mesh__D015917 Penis Prostheses
% 210.18/210.36 |- skos__hiddenLabel mesh__D015917 Penile Implants
% 210.18/210.36 |- skos__altLabel mesh__D015917 Penile Implant
% 210.18/210.36 |- rdf__type mesh__D015917sskos__Concept
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015917 2003
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D015917 SJN
% 210.18/210.36 |- skos__altLabel mesh__D015917 Penis, Artificial
% 210.18/210.36 |- skos__broader mesh__D015917smesh__D019736
% 210.18/210.36 |- skos__scopeNote mesh__D015917
% 210.18/210.36 Rigid, semi-rigid, or inflatable cylindric hydraulic devices, with either combined or separate reservoir and pumping systems, implanted for the surgical treatment of organic impotence.%A%
% 210.18/210.36 |- skos__historyNote mesh__D015917 Prosthesis %28%1966-1989%29%
% 210.18/210.36 |- skos__prefLabel mesh__D015917 Penile Prosthesis
% 210.18/210.36 |- skos__altLabel mesh__D015917 Penis Prosthesis
% 210.18/210.36 |- mesh__dateRevised mesh__D015917 1997-06-20
% 210.18/210.36 |- skos__hiddenLabel mesh__D015917 Prostheses, Penile
% 210.18/210.36 |- mesh__dateEstablished mesh__D015917 1990-01-01
% 210.18/210.36 |- skos__altLabel mesh__D015917 Artificial Penis
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015917 1999
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015917 2002
% 210.18/210.36 |- mesh__dateRevised mesh__D015119 2000-06-21
% 210.18/210.36 |- mesh__dateEstablished mesh__D015119 1991-01-01
% 210.18/210.36 |- rdf__type mesh__D015119sskos__Concept
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015119 2001
% 210.18/210.36 |- skos__historyNote mesh__D015119 Aminocaproic Acids %28%1966-1976%29%
% 210.18/210.36 |- skos__scopeNote mesh__D015119
% 210.18/210.36 An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.%A%
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D015119
% 210.18/210.36 91; was see under AMINOCAPROIC ACIDS 1977-90; EPSILON-AMINOCAPROIC ACID was see AMINOCAPROIC ACIDS 1975-76, was see AMINOCAPROIC ACID 1964-74%A%
% 210.18/210.36 |- mesh__historyNote mesh__D015119
% 210.18/210.36 91%28%77%29%; was see under AMINOCAPROIC ACIDS 1977-90; EPSILON-AMINOCAPROIC ACID was see AMINOCAPROIC ACIDS 1975-76, was see AMINOCAPROIC ACID 1964-74%A%
% 210.18/210.36 |- skos__hiddenLabel mesh__D015119 Acid, 6-Aminocaproic
% 210.18/210.36 |- skos__hiddenLabel mesh__D015119 Acid, 6-Aminohexanoic
% 210.18/210.36 |- mesh__dateCreated mesh__D015119 1976-05-19
% 210.18/210.36 |- skos__broader mesh__D015119smesh__D000614
% 210.18/210.36 |- skos__altLabel mesh__D015119 6-Aminohexanoic Acid
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015119 2003
% 210.18/210.36 |- skos__hiddenLabel mesh__D015119 Acid, epsilon-Aminocaproic
% 210.18/210.36 |- mesh__recordMaintainer mesh__D015119 CCR
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015119 2002
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015119 2005
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015119 2004
% 210.18/210.36 |- skos__hiddenLabel mesh__D015119 6 Aminocaproic Acid
% 210.18/210.36 |- skos__hiddenLabel mesh__D015119 6 Aminohexanoic Acid
% 210.18/210.36 |- skos__hiddenLabel mesh__D015119 CY 116
% 210.18/210.36 |- skos__altLabel mesh__D015119 epsilon-Aminocaproic Acid
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D015119 sjn
% 210.18/210.36 |- mesh__recordOriginator mesh__D015119 RLS
% 210.18/210.36 |- skos__prefLabel mesh__D015119 6-Aminocaproic Acid
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015119 2006
% 210.18/210.36 |- mesh__onlineNote mesh__D015119
% 210.18/210.36 use AMINOCAPROIC ACIDS to search EPSILON-AMINOCAPROIC ACID 1966-76%A%
% 210.18/210.36 |- skos__hiddenLabel mesh__D015119 epsilon Aminocaproic Acid
% 210.18/210.36 |- skos__hiddenLabel mesh__D015119 CY116
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D031584 2003
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D031584 2004
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D031584 2005
% 210.18/210.36 |- mesh__dateCreated mesh__D031584 2002-07-03
% 210.18/210.36 |- skos__prefLabel mesh__D031584 Hibiscus
% 210.18/210.36 |- skos__altLabel mesh__D031584 Kenaf
% 210.18/210.36 |- mesh__historyNote mesh__D031584 2003
% 210.18/210.36 |- skos__broader mesh__D031584smesh__D019660
% 210.18/210.36 |- skos__annotation mesh__D031584
% 210.18/210.36 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D031584 2003
% 210.18/210.36 |- rdf__type mesh__D031584sskos__Concept
% 210.18/210.36 |- skos__scopeNote mesh__D031584
% 210.18/210.36 A plant genus of the family MALVACEAE. Members contain LIGNANS. H. cannabinus is a source of textile fiber %28%TEXTILES%29%.%A%
% 210.18/210.36 |- mesh__dateEstablished mesh__D031584 2003-01-01
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D031584 2006
% 210.18/210.36 |- mesh__recordMaintainer mesh__D003893 jmp
% 210.18/210.36 |- skos__historyNote mesh__D003893
% 210.18/210.36 Intermediate Filament Proteins %28%1983-1984%29%
% 210.18/210.36 |- rdf__type mesh__D003893sskos__Concept
% 210.18/210.36 |- skos__annotation mesh__D003893
% 210.18/210.36 an intermediate filament protein; /biosyn /physiol permitted%A%
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003893 2005
% 210.18/210.36 |- mesh__dateEstablished mesh__D003893 1985-01-01
% 210.18/210.36 |- skos__scopeNote mesh__D003893
% 210.18/210.36 An intermediate filament protein found predominantly in smooth, skeletal, and cardiac muscle cells. Localized at the Z line. MW 50,000 to 55,000 is species dependent.%A%
% 210.18/210.36 |- skos__altLabel mesh__D003893 Skeletin
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003893 2006
% 210.18/210.36 |- mesh__dateRevised mesh__D003893 2004-07-07
% 210.18/210.36 |- mesh__dateCreated mesh__D003893 1984-04-06
% 210.18/210.36 |- skos__broader mesh__D003893smesh__D007381
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D003893 sjn
% 210.18/210.36 |- skos__prefLabel mesh__D003893 Desmin
% 210.18/210.36 |- skos__historyNote mesh__D003893 Muscle Proteins %28%1966-1982%29%
% 210.18/210.36 |- mesh__historyNote mesh__D003893 85
% 210.18/210.36 |- mesh__recordOriginator mesh__D003893 RLS
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D003893 85
% 210.18/210.36 |- skos__scopeNote mesh__D003095
% 210.18/210.36 Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that %22%collagen%22% was equivalent to %22%connective tissue%22%, but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term %22%collagen diseases%22% now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. %28%From Cecil Textbook of Medicine, 19th ed, p1494%29%%A%
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003095 2001
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003095 2003
% 210.18/210.36 |- skos__hiddenLabel mesh__D003095 Collagen Disease
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003095 2000
% 210.18/210.36 |- skos__hiddenLabel mesh__D003095 Disease, Collagen
% 210.18/210.36 |- mesh__recordMaintainer mesh__D003095 KEV
% 210.18/210.36 |- skos__hiddenLabel mesh__D003095 Diseases, Collagen
% 210.18/210.36 |- skos__broader mesh__D003095smesh__D003240
% 210.18/210.36 |- skos__annotation mesh__D003095 GEN or unspecified; prefer specifics
% 210.18/210.36 |- mesh__dateRevised mesh__D003095 1999-11-03
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003095 2006
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D003095 sjn
% 210.18/210.36 |- mesh__dateCreated mesh__D003095 1999-01-01
% 210.18/210.36 |- mesh__recordOriginator mesh__D003095 NLM
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003095 2005
% 210.18/210.36 |- rdf__type mesh__D003095sskos__Concept
% 210.18/210.36 |- skos__prefLabel mesh__D003095 Collagen Diseases
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003095 2002
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003095 2004
% 210.18/210.36 |- skos__annotation mesh__D011527
% 210.18/210.36 GEN; avoid: prefer specifics; infection = PROTOZOAN INFECTIONS; /drug eff: consider also ANTIPROTOZOAL AGENTS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 210.18/210.36 |- mesh__dateRevised mesh__D011527 2003-07-09
% 210.18/210.36 |- mesh__recordOriginator mesh__D011527 NLM
% 210.18/210.36 |- skos__broader mesh__D011527smesh__D007448
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D011527 2005
% 210.18/210.36 |- mesh__recordMaintainer mesh__D011527 ags
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D011527 2006
% 210.18/210.36 |- mesh__dateCreated mesh__D011527 1999-01-01
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D011527 2004
% 210.18/210.36 |- rdf__type mesh__D011527sskos__Concept
% 210.18/210.36 |- skos__prefLabel mesh__D011527 Protozoa
% 210.18/210.36 |- skos__scopeNote mesh__D011527
% 210.18/210.36 A subkingdom consisting of unicellular organisms that are the simplest in the animal kingdom. Most are free living. They range in size from submicroscopic to macroscopic. Protozoa are divided into seven phyla: SARCOMASTIGOPHORA; Labyrinthomorpha, APICOMPLEXA; MICROSPORA; Ascetospora, Myxozoa, and CILIOPHORA.%A%
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D011527 sjn
% 210.18/210.36 |- skos__altLabel mesh__D011527 Protozoans
% 210.18/210.36 |- skos__related mesh__D011527smesh__D000981
% 210.18/210.36 |- skos__hiddenLabel mesh__D016212 Growth Factor, Milk
% 210.18/210.36 |- skos__altLabel mesh__D016212 Platelet Transforming Growth Factor
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D016212 2006
% 210.18/210.36 |- mesh__recordMaintainer mesh__D016212 ssb
% 210.18/210.36 |- skos__broader mesh__D016212smesh__D015291
% 210.18/210.36 |- skos__altLabel mesh__D016212 TGF-beta
% 210.18/210.36 |- skos__hiddenLabel mesh__D016212 Factor, Milk Growth
% 210.18/210.36 |- skos__altLabel mesh__D016212 Milk Growth Factor
% 210.18/210.36 |- skos__altLabel mesh__D016212 Bone-Derived Transforming Growth Factor
% 210.18/210.36 |- mesh__dateRevised mesh__D016212 2005-06-30
% 210.18/210.36 |- mesh__dateEstablished mesh__D016212 1991-01-01
% 210.18/210.36 |- rdf__type mesh__D016212sskos__Concept
% 210.18/210.36 |- skos__historyNote mesh__D016212 Peptides %28%1983-1988%29%
% 210.18/210.36 |- skos__historyNote mesh__D016212
% 210.18/210.36 Transforming Growth Factors %28%1989-1990%29%
% 210.18/210.36 |- mesh__historyNote mesh__D016212
% 210.18/210.36 91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-BETA was see TRANSFORMING GROWTH FACTORS 1989-90%A%
% 210.18/210.36 |- mesh__onlineNote mesh__D016212
% 210.18/210.36 use TRANSFORMING GROWTH FACTORS to search TRANSFORMING GROWTH FACTOR BETA %26% TGF-BETA 1989-90%A%
% 210.18/210.36 |- mesh__dateCreated mesh__D016212 1990-06-29
% 210.18/210.36 |- skos__altLabel mesh__D016212 TGFbeta
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D016212 sjn
% 210.18/210.36 |- skos__hiddenLabel mesh__D016212 Bone Derived Transforming Growth Factor
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D016212
% 210.18/210.36 91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-BETA was see TRANSFORMING GROWTH FACTORS 1989-90%A%
% 210.18/210.36 |- skos__broader mesh__D016212smesh__D006133
% 210.18/210.36 |- skos__prefLabel mesh__D016212 Transforming Growth Factor beta
% 210.18/210.36 |- skos__scopeNote mesh__D016212
% 210.18/210.36 A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 %28%TGF-beta1.2%29% or of TGF-beta2 and 3 %28%TGF-beta2.3%29% have been isolated. The TGF-beta proteins are synthesized as precursor proteins.%A%
% 210.18/210.36 |- mesh__recordOriginator mesh__D016212 AGS
% 210.18/210.36 |- skos__scopeNote mesh__D007486
% 210.18/210.36 A syrup made from the dried rhizomes of two different species, CEPHAELIS ipecacuanha and C. acuminata. They contain EMETINE, cephaeline, psychotrine and other ISOQUINOLINES. Ipecac syrup is used widely as an emetic acting both locally on the gastric mucosa and centrally on the chemoreceptor trigger zone.%A%
% 210.18/210.36 |- mesh__recordMaintainer mesh__D007486 ssb
% 210.18/210.36 |- mesh__dateCreated mesh__D007486 1999-01-01
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D007486 2006
% 210.18/210.36 |- skos__altLabel mesh__D007486 Syrup of Ipecac
% 210.18/210.36 |- skos__altLabel mesh__D007486 Ipecac %28%Syrup%29%
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D007486 sjn
% 210.18/210.36 |- mesh__recordOriginator mesh__D007486 NLM
% 210.18/210.36 |- skos__broader mesh__D007486smesh__D010936
% 210.18/210.36 |- skos__related mesh__D007486smesh__D028503
% 210.18/210.36 |- skos__related mesh__D007486smesh__D004640
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D007486
% 210.18/210.36 99; see IPECAC %28%SYRUP%29% 1995-98; see IPECAC 1963-94
% 210.18/210.36 |- rdf__type mesh__D007486sskos__Concept
% 210.18/210.36 |- mesh__historyNote mesh__D007486 99%28%63%29%
% 210.18/210.36 |- mesh__dateRevised mesh__D007486 2005-06-30
% 210.18/210.36 |- skos__hiddenLabel mesh__D007486 Ipecac Syrup
% 210.18/210.36 |- skos__prefLabel mesh__D007486 Ipecac
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Pumps, Implantable Infusion
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Perfusion Pump, Implantable
% 210.18/210.36 |- skos__scopeNote mesh__D015918
% 210.18/210.36 Implanted fluid propulsion systems with self-contained power source for providing long-term controlled-rate delivery of drugs such as chemotherapeutic agents or analgesics. Delivery rate may be externally controlled or osmotically or peristatically controlled with the aid of transcutaneous monitoring.%A%
% 210.18/210.36 |- skos__altLabel mesh__D015918
% 210.18/210.36 Implantable Medication Systems, Programmable
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Implantable Perfusion Pump
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015918 2004
% 210.18/210.36 |- mesh__historyNote mesh__D015918 90
% 210.18/210.36 |- skos__altLabel mesh__D015918
% 210.18/210.36 Systems, Programmable Implantable Medication
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Pumps, Implantable Perfusion
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015918 2005
% 210.18/210.36 |- mesh__dateEstablished mesh__D015918 1990-01-01
% 210.18/210.36 |- skos__altLabel mesh__D015918 Programmable Implantable Medication Systems
% 210.18/210.36 |- rdf__type mesh__D015918sskos__Concept
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015918 2000
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D015918 jls
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D015918 90
% 210.18/210.36 |- skos__altLabel mesh__D015918 Drug Delivery Systems, Implantable
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Implantable Infusion Pump
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015918 2006
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Peristaltic Pump, Implantable
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015918 2001
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Implantable Peristaltic Pump
% 210.18/210.36 |- skos__historyNote mesh__D015918 Infusion Pumps %28%1987-1989%29%
% 210.18/210.36 |- mesh__recordMaintainer mesh__D015918 jls
% 210.18/210.36 |- mesh__dateCreated mesh__D015918 1989-05-15
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Pump, Implantable Peristaltic
% 210.18/210.36 |- mesh__dateRevised mesh__D015918 2004-07-30
% 210.18/210.36 |- skos__broader mesh__D015918smesh__D007260
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Infusion Pump, Implantable
% 210.18/210.36 |- skos__prefLabel mesh__D015918 Infusion Pumps, Implantable
% 210.18/210.36 |- skos__altLabel mesh__D015918 Perfusion Pumps, Implantable
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Implantable Perfusion Pumps
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Implantable Peristaltic Pumps
% 210.18/210.36 |- skos__historyNote mesh__D015918 Infusions, Parenteral %28%1975-1986%29%
% 210.18/210.36 |- skos__related mesh__D015918smesh__D004343
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015918 2005A
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Pump, Implantable Perfusion
% 210.18/210.36 |- skos__historyNote mesh__D015918 Drug Implants %28%1977-1989%29%
% 210.18/210.36 |- mesh__recordOriginator mesh__D015918 PLS
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015918 2002
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Pumps, Implantable Peristaltic
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D015918 2003
% 210.18/210.36 |- skos__hiddenLabel mesh__D015918 Pump, Implantable Infusion
% 210.18/210.36 |- skos__altLabel mesh__D015918 Implantable Infusion Pumps
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D031585 2006
% 210.18/210.36 |- skos__prefLabel mesh__D031585 Melia
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D031585 2003
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D031585 2004
% 210.18/210.36 |- skos__scopeNote mesh__D031585
% 210.18/210.36 A plant genus of the family MELIACEAE. Members contain meliavolkinin, melianin C and limonoids.%A%
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D031585 2005
% 210.18/210.36 |- mesh__dateCreated mesh__D031585 2002-07-03
% 210.18/210.36 |- skos__annotation mesh__D031585
% 210.18/210.36 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.18/210.36 |- skos__broader mesh__D031585smesh__D029582
% 210.18/210.36 |- mesh__historyNote mesh__D031585 2003
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D031585 2003
% 210.18/210.36 |- rdf__type mesh__D031585sskos__Concept
% 210.18/210.36 |- mesh__dateEstablished mesh__D031585 2003-01-01
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003894 2006A
% 210.18/210.36 |- skos__altLabel mesh__D003894 Apo-Desmopressin
% 210.18/210.36 |- skos__altLabel mesh__D003894 1-Deamino-8-D-arginine Vasopressin
% 210.18/210.36 |- skos__hiddenLabel mesh__D003894 Vasopressin, 1-Deamino-8-D-arginine
% 210.18/210.36 |- mesh__dateEstablished mesh__D003894 1986-01-01
% 210.18/210.36 |- mesh__onlineNote mesh__D003894
% 210.18/210.36 use DESMOPRESSIN to search DEAMINO ARGININE VASOPRESSIN 1975-78%A%
% 210.18/210.36 |- skos__hiddenLabel mesh__D003894 Arginine Vasopressin, Deamino
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003894 2006
% 210.18/210.36 |- skos__altLabel mesh__D003894 Vasopressin, Deamino Arginine
% 210.18/210.36 |- mesh__dateCreated mesh__D003894 1974-11-19
% 210.18/210.36 |- skos__historyNote mesh__D003894 Arginine %28%1966-1974%29%
% 210.18/210.36 |- skos__altLabel mesh__D003894 1-Desamino-8-arginine Vasopressin
% 210.18/210.36 |- skos__prefLabel mesh__D003894 Deamino Arginine Vasopressin
% 210.18/210.36 |- skos__historyNote mesh__D003894 Vasopressins %28%1966-1974%29%
% 210.18/210.36 |- skos__altLabel mesh__D003894 Desmotabs
% 210.18/210.36 |- skos__altLabel mesh__D003894 Octostim
% 210.18/210.36 |- skos__altLabel mesh__D003894 Desmospray
% 210.18/210.36 |- skos__altLabel mesh__D003894 Octim
% 210.18/210.36 |- skos__scopeNote mesh__D003894
% 210.18/210.36 A synthetic analog of the pituitary hormone, ARGIPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.%A%
% 210.18/210.36 |- skos__hiddenLabel mesh__D003894 Monoacetate, Desmopressin
% 210.18/210.36 |- mesh__recordAuthorizer mesh__D003894 ags
% 210.18/210.36 |- skos__broader mesh__D003894smesh__D001127
% 210.18/210.36 |- skos__hiddenLabel mesh__D003894 Ferring, Desmopressine
% 210.18/210.36 |- skos__altLabel mesh__D003894 Desmogalen
% 210.18/210.36 |- skos__altLabel mesh__D003894 Stimate
% 210.18/210.36 |- skos__altLabel mesh__D003894 Nocutil
% 210.18/210.36 |- mesh__recordMaintainer mesh__D003894 ags
% 210.18/210.36 |- skos__hiddenLabel mesh__D003894 Monoacetate, Trihydrate Desmopressin
% 210.18/210.36 |- skos__hiddenLabel mesh__D003894 ApoDesmopressin
% 210.18/210.36 |- mesh__historyNote mesh__D003894
% 210.18/210.36 86%28%79%29%; was see under ARGIPRESSIN 1979-85; was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78%A%
% 210.18/210.36 |- mesh__recordOriginator mesh__D003894 NLM
% 210.18/210.36 |- skos__altLabel mesh__D003894 Desmopressine Ferring
% 210.18/210.36 |- rdf__type mesh__D003894sskos__Concept
% 210.18/210.36 |- skos__hiddenLabel mesh__D003894 Vasopressin, 1-Desamino-8-arginine
% 210.18/210.36 |- skos__altLabel mesh__D003894 Desmopressin Monoacetate, Trihydrate
% 210.18/210.36 |- skos__altLabel mesh__D003894 Minurin
% 210.18/210.36 |- mesh__publicMeSHNote mesh__D003894
% 210.18/210.36 86; was see under ARGIPRESSIN 1979-85; was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78%A%
% 210.18/210.36 |- skos__hiddenLabel mesh__D003894 Trihydrate Desmopressin Monoacetate
% 210.18/210.36 |- mesh__dateRevised mesh__D003894 2005-08-03
% 210.18/210.36 |- skos__hiddenLabel mesh__D003894 Acetate, Desmopressin
% 210.18/210.36 |- skos__annotation mesh__D003096
% 210.18/210.36 a method of surg ther of tuberc; do not use /util except by MeSH definition%A%
% 210.18/210.36 |- mesh__recordOriginator mesh__D003096 NLM
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003096 1999
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003096 2006
% 210.18/210.36 |- skos__prefLabel mesh__D003096 Collapse Therapy
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003096 2002
% 210.18/210.36 |- skos__hiddenLabel mesh__D003096 Therapies, Collapse
% 210.18/210.36 |- skos__broader mesh__D003096smesh__D013510
% 210.18/210.36 |- mesh__dateCreated mesh__D003096 1999-01-01
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003096 1998
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003096 2005
% 210.18/210.36 |- rdf__type mesh__D003096sskos__Concept
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003096 2001
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003096 2004
% 210.18/210.36 |- skos__hiddenLabel mesh__D003096 Collapse Therapies
% 210.18/210.36 |- mesh__activeMeSHYear mesh__D003096 2000
% 210.18/210.36 |- mesh__dateRevised mesh__D003096 1997-06-20
% 210.18/210.37 |- skos__scopeNote mesh__D003096
% 210.18/210.37 Surgical treatment of pulmonary tuberculosis whereby the lung is totally or partially, temporarily or permanently, immobilized. The procedure was based on the popular concept that collapsing the affected portion of a tuberculous lung allowed the infected area to rest and thereby recover. At the beginning of the 20th century artificially induced pneumothorax %28%PNEUMOTHORAX, ARTIFICIAL%29% was popular. Later a variety of other techniques was used to encourage collapse of the infected portion of the lung: unilateral phrenic nerve division, PNEUMONOLYSIS, pneumoperitoneum %28%PNEUMOPERITONEUM, ARTIFICIAL%29%, and THORACOPLASTY. Collapse therapy has declined since the advent of antitubercular chemotherapy. %28%Stedman, 25th ed; from Sabiston Jr, Textbook of Surgery, 14th ed, p1733-4%29%%A%
% 210.18/210.37 |- mesh__recordMaintainer mesh__D003096 PXP
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003096 2003
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D003096 SJN
% 210.18/210.37 |- skos__altLabel mesh__D003096 Therapy, Collapse
% 210.18/210.37 |- skos__broader mesh__D044702smesh__D012143
% 210.18/210.37 |- skos__hiddenLabel mesh__D044702 Phenomenon, Respiratory Physiologic
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D044702 2004
% 210.18/210.37 |- skos__hiddenLabel mesh__D044702 Phenomena, Respiratory Physiological
% 210.18/210.37 |- skos__hiddenLabel mesh__D044702 Physiological Phenomena, Respiratory
% 210.18/210.37 |- skos__altLabel mesh__D044702 Respiratory Physiological Phenomenon
% 210.18/210.37 |- mesh__historyNote mesh__D044702 2004
% 210.18/210.37 |- skos__hiddenLabel mesh__D044702 Physiological Phenomenon, Respiratory
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D044702 2004
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D044702 2005
% 210.18/210.37 |- skos__annotation mesh__D044702 not used for indexing or cataloging
% 210.18/210.37 |- skos__prefLabel mesh__D044702 Respiratory Physiologic Phenomena
% 210.18/210.37 |- skos__hiddenLabel mesh__D044702 Physiologic Phenomenon, Respiratory
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D044702 2006
% 210.18/210.37 |- rdf__type mesh__D044702sskos__Concept
% 210.18/210.37 |- skos__altLabel mesh__D044702 Respiratory Physiologic Phenomenon
% 210.18/210.37 |- mesh__dateEstablished mesh__D044702 2004-01-01
% 210.18/210.37 |- skos__hiddenLabel mesh__D044702 Phenomena, Respiratory Physiologic
% 210.18/210.37 |- skos__altLabel mesh__D044702 Respiratory Physiological Phenomena
% 210.18/210.37 |- mesh__dateCreated mesh__D044702 2003-07-09
% 210.18/210.37 |- skos__scopeNote mesh__D044702
% 210.18/210.37 Observable or measurable characteristics of the RESPIRATORY SYSTEM.%A%
% 210.18/210.37 |- skos__hiddenLabel mesh__D044702 Physiologic Phenomena, Respiratory
% 210.18/210.37 |- skos__hiddenLabel mesh__D044702 Phenomenon, Respiratory Physiological
% 210.18/210.37 |- skos__annotation mesh__D011528
% 210.18/210.37 GEN; prefer specifics; /drug ther: consider also ANTIPROTOZOAL AGENTS%A%
% 210.18/210.37 |- skos__hiddenLabel mesh__D011528 Histomoniases
% 210.18/210.37 |- skos__hiddenLabel mesh__D011528 Protozoan Infection
% 210.18/210.37 |- skos__hiddenLabel mesh__D011528 Infection, Protozoan
% 210.18/210.37 |- mesh__recordMaintainer mesh__D011528 TGC
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011528 2005
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011528 2003
% 210.18/210.37 |- skos__altLabel mesh__D011528 Infections, Protozoan
% 210.18/210.37 |- skos__scopeNote mesh__D011528
% 210.18/210.37 Infections with unicellular organisms of the subkingdom PROTOZOA.%A%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011528 2006
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011528 2000
% 210.18/210.37 |- mesh__dateCreated mesh__D011528 1999-01-01
% 210.18/210.37 |- mesh__recordOriginator mesh__D011528 NLM
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011528 2004
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011528 1998
% 210.18/210.37 |- rdf__type mesh__D011528sskos__Concept
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011528 1999
% 210.18/210.37 |- mesh__dateRevised mesh__D011528 1997-06-20
% 210.18/210.37 |- skos__prefLabel mesh__D011528 Protozoan Infections
% 210.18/210.37 |- mesh__onlineNote mesh__D011528
% 210.18/210.37 use PROTOZOAN INFECTIONS to search HISTOMONIASIS 1968-85
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011528 2001
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D011528 HISTOMONIASIS was heading 1968-85
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D011528 SJN
% 210.18/210.37 |- skos__related mesh__D011528smesh__D000981
% 210.18/210.37 |- mesh__historyNote mesh__D011528 HISTOMONIASIS was heading 1968-85
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011528 2002
% 210.18/210.37 |- skos__broader mesh__D011528smesh__D010272
% 210.18/210.37 |- skos__annotation mesh__D016213
% 210.18/210.37 regulatory proteins; growth substances; do not confuse with the nuclear protein cyclin %28%PCNA or Proliferating Cell Nuclear Antigen%29%; note specifics%A%
% 210.18/210.37 |- skos__scopeNote mesh__D016213
% 210.18/210.37 Regulatory proteins that function in the cell cycle to activate maturation promoting factor. They complex with p34cdc2 %28%PROTEIN P34CDC2%29%, the catalytic subunit of MATURATION-PROMOTING FACTOR, and modulate its protein kinase activity. Cyclins themselves have no enzymatic activity.%A%
% 210.18/210.37 |- skos__broader mesh__D016213smesh__D006133
% 210.18/210.37 |- rdf__type mesh__D016213sskos__Concept
% 210.18/210.37 |- skos__historyNote mesh__D016213 Invertebrate Hormones %28%1987-1990%29%
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D016213 sjn
% 210.18/210.37 |- mesh__dateEstablished mesh__D016213 1991-01-01
% 210.18/210.37 |- skos__broader mesh__D016213smesh__D018797
% 210.18/210.37 |- skos__altLabel mesh__D016213 Cyclin
% 210.18/210.37 |- mesh__recordOriginator mesh__D016213 AGS
% 210.18/210.37 |- mesh__recordMaintainer mesh__D016213 ssb
% 210.18/210.37 |- mesh__onlineNote mesh__D016213 use CYCLINS to search CYCLIN 1991-2
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D016213 93; was CYCLIN 1991-2
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D016213 2006
% 210.18/210.37 |- mesh__historyNote mesh__D016213 93; was CYCLIN 1991-2
% 210.18/210.37 |- skos__prefLabel mesh__D016213 Cyclins
% 210.18/210.37 |- skos__related mesh__D016213smesh__D016200
% 210.18/210.37 |- mesh__dateRevised mesh__D016213 2005-06-30
% 210.18/210.37 |- mesh__dateCreated mesh__D016213 1990-06-17
% 210.18/210.37 |- skos__hiddenLabel mesh__D007487 Sodium, Ipodate
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D007487 2005
% 210.18/210.37 |- skos__hiddenLabel mesh__D007487 SoluBiloptin
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D007487 2002
% 210.18/210.37 |- skos__hiddenLabel mesh__D007487 Ipodate, Sodium
% 210.18/210.37 |- skos__altLabel mesh__D007487 Iopodate
% 210.18/210.37 |- skos__broader mesh__D007487smesh__D007462
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D007487 2004
% 210.18/210.37 |- rdf__type mesh__D007487sskos__Concept
% 210.18/210.37 |- skos__altLabel mesh__D007487 Sodium Iopodate
% 210.18/210.37 |- mesh__recordMaintainer mesh__D007487 ssb
% 210.18/210.37 |- skos__hiddenLabel mesh__D007487 Iopodate, Calcium
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D007487 2003
% 210.18/210.37 |- skos__hiddenLabel mesh__D007487 Iopodate, Sodium
% 210.18/210.37 |- skos__prefLabel mesh__D007487 Ipodate
% 210.18/210.37 |- mesh__recordOriginator mesh__D007487 NLM
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D007487 sjn
% 210.18/210.37 |- skos__annotation mesh__D007487 D25-26 qualif
% 210.18/210.37 |- skos__altLabel mesh__D007487 Calcium Iopodate
% 210.18/210.37 |- mesh__dateRevised mesh__D007487 2001-07-25
% 210.18/210.37 |- skos__scopeNote mesh__D007487
% 210.18/210.37 Ionic monomeric contrast media. Usually the sodium or calcium salts are used for examination of the gall bladder and biliary tract. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p704%29%%A%
% 210.18/210.37 |- skos__hiddenLabel mesh__D007487 Solu Biloptin
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D007487 2006
% 210.18/210.37 |- skos__altLabel mesh__D007487 Sodium Ipodate
% 210.18/210.37 |- skos__hiddenLabel mesh__D007487 Ipodate, Calcium
% 210.18/210.37 |- mesh__dateCreated mesh__D007487 1999-01-01
% 210.18/210.37 |- skos__prefLabel mesh__D015919 Ventilators, Negative-Pressure
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 2003
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 2002
% 210.18/210.37 |- skos__broader mesh__D015919smesh__D012122
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Negative-Pressure Respirators
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 2006
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Respirators, Negative Pressure
% 210.18/210.37 |- mesh__dateEstablished mesh__D015919 1990-01-01
% 210.18/210.37 |- skos__altLabel mesh__D015919 Pulmonary Ventilators, Negative-Pressure
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Negative Pressure Pulmonary Ventilator
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 1994
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Ventilators, Negative Pressure
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D015919 90
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 2001
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 2005
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Pulmonary Ventilator, Negative Pressure
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Pulmonary Ventilators, Negative Pressure
% 210.18/210.37 |- skos__altLabel mesh__D015919 Negative-Pressure Pulmonary Ventilators
% 210.18/210.37 |- skos__altLabel mesh__D015919 Respirators, Negative-Pressure
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Negative-Pressure Respirator
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 1997
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 2000
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Respirator, Negative-Pressure
% 210.18/210.37 |- mesh__recordOriginator mesh__D015919 PLS
% 210.18/210.37 |- skos__altLabel mesh__D015919 Respirators, Pulmonary, Negative-Pressure
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Negative-Pressure Ventilator
% 210.18/210.37 |- skos__scopeNote mesh__D015919
% 210.18/210.37 Body ventilators that assist ventilation by applying intermittent subatmospheric pressure around the thorax, abdomen, or airway and periodically expand the chest wall and inflate the lungs. They are relatively simple to operate and do not require tracheostomy. These devices include the tank ventilators %28%%22%iron lung%22%%29%, Portalung, Pneumowrap, and chest cuirass %28%%22%tortoise shell%22%%29%.%A%
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Ventilator, Tank
% 210.18/210.37 |- skos__altLabel mesh__D015919 Negative-Pressure Pulmonary Ventilator
% 210.18/210.37 |- skos__historyNote mesh__D015919
% 210.18/210.37 Respiration, Artificial %28%1966-1989%29%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 1993
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 1996
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Tank Ventilator
% 210.18/210.37 |- skos__historyNote mesh__D015919
% 210.18/210.37 Ventilators, Mechanical %28%1966-1989%29%
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Negative Pressure Ventilators
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 1999
% 210.18/210.37 |- skos__altLabel mesh__D015919 Ventilator, Negative-Pressure Pulmonary
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Negative Pressure Pulmonary Ventilators
% 210.18/210.37 |- skos__altLabel mesh__D015919 Ventilators, Pulmonary, Negative-Pressure
% 210.18/210.37 |- mesh__recordMaintainer mesh__D015919 PLS
% 210.18/210.37 |- mesh__historyNote mesh__D015919 90
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Ventilators, Negative-Pressure Pulmonary
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Ventilator, Negative Pressure Pulmonary
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Ventilator, Negative-Pressure
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 2004
% 210.18/210.37 |- skos__altLabel mesh__D015919 Negative-Pressure Ventilators
% 210.18/210.37 |- skos__altLabel mesh__D015919 Pulmonary Ventilator, Negative-Pressure
% 210.18/210.37 |- skos__hiddenLabel mesh__D015919 Ventilators, Tank
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 1995
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D015919 1998
% 210.18/210.37 |- mesh__dateCreated mesh__D015919 1989-05-16
% 210.18/210.37 |- rdf__type mesh__D015919sskos__Concept
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D015919 PLS
% 210.18/210.37 |- mesh__dateRevised mesh__D015919 1992-05-18
% 210.18/210.37 |- skos__hiddenLabel mesh__D012621 Seasonal Variations
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 1995
% 210.18/210.37 |- mesh__recordMaintainer mesh__D012621 TGC
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 1992
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 1999
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 2002
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 2005
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 1996
% 210.18/210.37 |- skos__hiddenLabel mesh__D012621 Variation, Seasonal
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 1993
% 210.18/210.37 |- skos__broader mesh__D012621smesh__D004777
% 210.18/210.37 |- skos__hiddenLabel mesh__D012621 Season
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 2006
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 1997
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 2000
% 210.18/210.37 |- mesh__dateCreated mesh__D012621 1999-01-01
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 2003
% 210.18/210.37 |- skos__broader mesh__D012621smesh__D010507
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D012621 PLS
% 210.18/210.37 |- rdf__type mesh__D012621sskos__Concept
% 210.18/210.37 |- mesh__recordOriginator mesh__D012621 NLM
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 2001
% 210.18/210.37 |- mesh__dateRevised mesh__D012621 1991-01-09
% 210.18/210.37 |- skos__prefLabel mesh__D012621 Seasons
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 1994
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 2004
% 210.18/210.37 |- skos__hiddenLabel mesh__D012621 Variations, Seasonal
% 210.18/210.37 |- skos__annotation mesh__D012621 no qualif
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012621 1998
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D031586 2003
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D031586 2004
% 210.18/210.37 |- skos__altLabel mesh__D031586 Chinaberry Tree
% 210.18/210.37 |- mesh__dateEstablished mesh__D031586 2003-01-01
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D031586 2005
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D031586 2003
% 210.18/210.37 |- rdf__type mesh__D031586sskos__Concept
% 210.18/210.37 |- skos__scopeNote mesh__D031586
% 210.18/210.37 A plant species of the genus MELIA, family MELIACEAE, which is toxic to insects. The name is very similar to Melia azadirachta %28%AZADIRACHTA%29%.%A%
% 210.18/210.37 |- mesh__recordOriginator mesh__D031586 ssb
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D031586 ags
% 210.18/210.37 |- skos__prefLabel mesh__D031586 Melia azedarach
% 210.18/210.37 |- mesh__dateCreated mesh__D031586 2002-07-03
% 210.18/210.37 |- mesh__recordMaintainer mesh__D031586 ags
% 210.18/210.37 |- mesh__historyNote mesh__D031586 2003
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D031586 2006A
% 210.18/210.37 |- skos__annotation mesh__D031586
% 210.18/210.37 MELIA AZEDARACH see AZADIRACHTA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.18/210.37 |- skos__broader mesh__D031586smesh__D031585
% 210.18/210.37 |- mesh__dateRevised mesh__D031586 2005-07-18
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D031586 2006
% 210.18/210.37 |- skos__scopeNote mesh__D003895
% 210.18/210.37 4-%28%4-Amino-4-carboxybutyl%29%-1-%28%5-amino-5-carboxypentyl%29%-3,5-bis%28%3-amino-3-carboxypropyl%29%pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring.%A%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 1995
% 210.18/210.37 |- rdf__type mesh__D003895sskos__Concept
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 2004
% 210.18/210.37 |- skos__historyNote mesh__D003895 Pyridinium Compounds %28%1970-1974%29%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 1998
% 210.18/210.37 |- skos__broader mesh__D003895smesh__D011726
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 1994
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 2003
% 210.18/210.37 |- skos__prefLabel mesh__D003895 Desmosine
% 210.18/210.37 |- skos__historyNote mesh__D003895 Amino Acids %28%1972-1974%29%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 2001
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 2006
% 210.18/210.37 |- mesh__dateCreated mesh__D003895 1974-11-19
% 210.18/210.37 |- skos__broader mesh__D003895smesh__D000598
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 1997
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 2000
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 2005
% 210.18/210.37 |- mesh__recordOriginator mesh__D003895 NLM
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D003895 PLS
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 1993
% 210.18/210.37 |- mesh__dateRevised mesh__D003895 1992-05-13
% 210.18/210.37 |- mesh__recordMaintainer mesh__D003895 TAP
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 1996
% 210.18/210.37 |- mesh__dateEstablished mesh__D003895 1991-01-01
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D003895
% 210.18/210.37 91; was see under AMINO ACIDS 1975-90
% 210.18/210.37 |- mesh__historyNote mesh__D003895
% 210.18/210.37 91%28%75%29%; was see under AMINO ACIDS 1975-90
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 1999
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003895 2002
% 210.18/210.37 |- mesh__dateEstablished mesh__D044703 2004-01-01
% 210.18/210.37 |- skos__hiddenLabel mesh__D044703 Respiratory Physiological Processes
% 210.18/210.37 |- skos__hiddenLabel mesh__D044703 Process, Respiratory Physiological
% 210.18/210.37 |- skos__hiddenLabel mesh__D044703 Physiologic Processes, Respiratory
% 210.18/210.37 |- skos__hiddenLabel mesh__D044703 Processes, Respiratory Physiological
% 210.18/210.37 |- skos__prefLabel mesh__D044703 Respiratory Physiologic Processes
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D044703 2004
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D044703 2005
% 210.18/210.37 |- skos__hiddenLabel mesh__D044703 Processes, Respiratory Physiologic
% 210.18/210.37 |- skos__scopeNote mesh__D044703
% 210.18/210.37 Biological actions and events that support the functions of the RESPIRATORY SYSTEM.%A%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D044703 2006
% 210.18/210.37 |- rdf__type mesh__D044703sskos__Concept
% 210.18/210.37 |- mesh__historyNote mesh__D044703 2004
% 210.18/210.37 |- mesh__dateCreated mesh__D044703 2003-07-09
% 210.18/210.37 |- skos__annotation mesh__D044703 not used for indexing or cataloging
% 210.18/210.37 |- skos__hiddenLabel mesh__D044703 Physiological Processes, Respiratory
% 210.18/210.37 |- skos__broader mesh__D044703smesh__D012143
% 210.18/210.37 |- skos__hiddenLabel mesh__D044703 Physiological Process, Respiratory
% 210.18/210.37 |- skos__altLabel mesh__D044703 Respiratory Physiological Process
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D044703 2004
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003097 2006
% 210.18/210.37 |- mesh__historyNote mesh__D003097 66%28%64%29%
% 210.18/210.37 |- skos__annotation mesh__D003097
% 210.18/210.37 a naturally occurring physiol phenomenon: not for restoration of funct by surg; not restricted to coronary vessels; do not confuse with NEOVASCULARIZATION, PHYSIOLOGIC: see MeSH scope notes; DF: COLLATERAL CIRC%A%
% 210.18/210.37 |- skos__hiddenLabel mesh__D003097 Collateral Circulations, Blood
% 210.18/210.37 |- skos__hiddenLabel mesh__D003097 Collateral Blood Circulations
% 210.18/210.37 |- skos__altLabel mesh__D003097 Collateral Blood Circulation
% 210.18/210.37 |- mesh__dateRevised mesh__D003097 2003-07-09
% 210.18/210.37 |- mesh__dateCreated mesh__D003097 1999-01-01
% 210.18/210.37 |- rdf__type mesh__D003097sskos__Concept
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003097 2005
% 210.18/210.37 |- skos__hiddenLabel mesh__D003097 Blood Collateral Circulation
% 210.18/210.37 |- skos__hiddenLabel mesh__D003097 Collateral Circulations
% 210.18/210.37 |- skos__scopeNote mesh__D003097
% 210.18/210.37 Maintenance of blood flow to an organ despite obstruction of a principal vessel. Blood flow is maintained through small vessels.%A%
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D003097 sjn
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D003097 2004
% 210.18/210.37 |- mesh__recordMaintainer mesh__D003097 nns
% 210.18/210.37 |- mesh__recordOriginator mesh__D003097 NLM
% 210.18/210.37 |- skos__hiddenLabel mesh__D003097 Circulation, Blood Collateral
% 210.18/210.37 |- mesh__dateEstablished mesh__D003097 1966-01-01
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D003097 66
% 210.18/210.37 |- skos__broader mesh__D003097smesh__D001775
% 210.18/210.37 |- skos__altLabel mesh__D003097 Collateral Circulation, Blood
% 210.18/210.37 |- skos__prefLabel mesh__D003097 Collateral Circulation
% 210.18/210.37 |- skos__altLabel mesh__D003097 Circulation, Collateral
% 210.18/210.37 |- skos__related mesh__D003097smesh__D018919
% 210.18/210.37 |- skos__hiddenLabel mesh__D003097 Circulation, Collateral Blood
% 210.18/210.37 |- skos__altLabel mesh__D003097 Blood Circulation, Collateral
% 210.18/210.37 |- skos__prefLabel mesh__D011529 Protozoan Infections, Animal
% 210.18/210.37 |- mesh__dateCreated mesh__D011529 1999-01-01
% 210.18/210.37 |- mesh__recordMaintainer mesh__D011529 ags
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011529 2004
% 210.18/210.37 |- skos__broader mesh__D011529smesh__D011528
% 210.18/210.37 |- mesh__dateEstablished mesh__D011529 1998-01-01
% 210.18/210.37 |- skos__hiddenLabel mesh__D011529 Animal Protozoan Infections
% 210.18/210.37 |- skos__hiddenLabel mesh__D011529 Animal Protozoan Infection
% 210.18/210.37 |- skos__annotation mesh__D011529
% 210.18/210.37 exper or vet; GEN or unspecified; prefer specific indentions or specific protozoan infect /vet; don%27%t forget to check tag ANIMALS; DF: PROTOZOAN INFECT ANIMAL%A%
% 210.18/210.37 |- rdf__type mesh__D011529sskos__Concept
% 210.18/210.37 |- skos__broader mesh__D011529smesh__D010273
% 210.18/210.37 |- skos__historyNote mesh__D011529
% 210.18/210.37 Protozoan Infections/veterinary %28%1966-1997%29%
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D011529 sjn
% 210.18/210.37 |- mesh__dateRevised mesh__D011529 2003-07-30
% 210.18/210.37 |- skos__scopeNote mesh__D011529
% 210.18/210.37 Infections with unicellular organisms of the subkingdom PROTOZOA. The infections may be experimental or veterinary.%A%
% 210.18/210.37 |- skos__hiddenLabel mesh__D011529 Protozoan Infection, Animal
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011529 2005
% 210.18/210.37 |- skos__hiddenLabel mesh__D011529 Infections, Animal Protozoan
% 210.18/210.37 |- mesh__recordOriginator mesh__D011529 NLM
% 210.18/210.37 |- mesh__historyNote mesh__D011529 98; use explode 1971-97
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D011529 98
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D011529 2006
% 210.18/210.37 |- skos__hiddenLabel mesh__D011529 Infection, Animal Protozoan
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D008580 2002
% 210.18/210.37 |- skos__hiddenLabel mesh__D008580 Syndrome, Dupre
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D008580 sjn
% 210.18/210.37 |- skos__hiddenLabel mesh__D008580 Meningisms
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D008580 2004
% 210.18/210.37 |- skos__hiddenLabel mesh__D008580 Meningitis-Like Reactions
% 210.18/210.37 |- skos__altLabel mesh__D008580 Meningismus
% 210.18/210.37 |- skos__hiddenLabel mesh__D008580 Reaction, Meningitis-Like
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D008580 2003
% 210.18/210.37 |- mesh__recordMaintainer mesh__D008580 KEV
% 210.18/210.37 |- skos__altLabel mesh__D008580 Pseudomeningitis
% 210.18/210.37 |- skos__hiddenLabel mesh__D008580 Reactions, Meningitis-Like
% 210.18/210.37 |- mesh__dateRevised mesh__D008580 1999-11-04
% 210.18/210.37 |- skos__altLabel mesh__D008580 Dupre Syndrome
% 210.18/210.37 |- mesh__recordOriginator mesh__D008580 NLM
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D008580 2001
% 210.18/210.37 |- skos__hiddenLabel mesh__D008580 Meningitis Like Reaction
% 210.18/210.37 |- skos__altLabel mesh__D008580 Meningitis-Like Reaction
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D008580 2006
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D008580 2000
% 210.18/210.37 |- skos__altLabel mesh__D008580 Dupre%27%s Syndrome
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D008580 2005
% 210.18/210.37 |- skos__scopeNote mesh__D008580
% 210.18/210.37 A condition characterized by neck stiffness, headache, and other symptoms suggestive of meningeal irritation, but without actual inflammation of the meninges %28%MENINGITIS%29%. Spinal fluid pressure may be elevated but spinal fluid is normal. %28%DeJong, The Neurologic Examination, 4th ed, p673%29%%A%
% 210.18/210.37 |- skos__hiddenLabel mesh__D008580 Dupres Syndrome
% 210.18/210.37 |- mesh__dateCreated mesh__D008580 1999-01-01
% 210.18/210.37 |- skos__hiddenLabel mesh__D008580 Syndrome, Dupre%27%s
% 210.18/210.37 |- skos__broader mesh__D008580smesh__D009461
% 210.18/210.37 |- rdf__type mesh__D008580sskos__Concept
% 210.18/210.37 |- skos__prefLabel mesh__D008580 Meningism
% 210.18/210.37 |- skos__hiddenLabel mesh__D008580 Pseudomeningitides
% 210.18/210.37 |- skos__broader mesh__D019426Q000037smesh__D019426
% 210.18/210.37 |- mesh__preferredCombination mesh__D019426Q000037smesh__D019429
% 210.18/210.37 |- rdf__type mesh__D019426Q000037smesh__CompoundConcept
% 210.18/210.37 |- mesh__dateRevised mesh__D007488 2004-07-07
% 210.18/210.37 |- skos__broader mesh__D007488smesh__D007211
% 210.18/210.37 |- skos__historyNote mesh__D007488 Antidepressive Agents %28%1966-1971%29%
% 210.18/210.37 |- skos__historyNote mesh__D007488 Indoles %28%1966-1971%29%
% 210.18/210.37 |- mesh__dateEstablished mesh__D007488 1991-01-01
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D007488 2006
% 210.18/210.37 |- skos__scopeNote mesh__D007488
% 210.18/210.37 A tricyclic antidepressant that has actions and uses similar to those of AMITRIPTYLINE, but has only weak antimuscarinic and sedative effects. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p257%29%%A%
% 210.18/210.37 |- mesh__dateCreated mesh__D007488 1999-01-01
% 210.18/210.37 |- skos__prefLabel mesh__D007488 Iprindole
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D007488 2005
% 210.18/210.37 |- mesh__recordMaintainer mesh__D007488 ssb
% 210.18/210.37 |- mesh__historyNote mesh__D007488
% 210.18/210.37 91%28%72%29%; was see under INDOLES 1972-90
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D007488 91; was see under INDOLES 1972-90
% 210.18/210.37 |- mesh__recordOriginator mesh__D007488 NLM
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D007488 sjn
% 210.18/210.37 |- rdf__type mesh__D007488sskos__Concept
% 210.18/210.37 |- skos__broader mesh__D007488smesh__D034242
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D004190 sjn
% 210.18/210.37 |- mesh__recordOriginator mesh__D004190 NLM
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D004190 2006
% 210.18/210.37 |- skos__broader mesh__D004190smesh__D004777
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D004190 2005
% 210.18/210.37 |- skos__hiddenLabel mesh__D004190 Disaster
% 210.18/210.37 |- mesh__dateCreated mesh__D004190 1999-01-01
% 210.18/210.37 |- skos__prefLabel mesh__D004190 Disasters
% 210.18/210.37 |- skos__related mesh__D004190smesh__D012066
% 210.18/210.37 |- mesh__dateRevised mesh__D004190 2004-07-07
% 210.18/210.37 |- skos__related mesh__D004190smesh__D047852
% 210.18/210.37 |- rdf__type mesh__D004190sskos__Concept
% 210.18/210.37 |- mesh__recordMaintainer mesh__D004190 jls
% 210.18/210.37 |- mesh__dateEstablished mesh__D012622 1970-01-01
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012622 2006
% 210.18/210.37 |- mesh__recordOriginator mesh__D012622 NLM
% 210.18/210.37 |- skos__scopeNote mesh__D012622
% 210.18/210.37 Restraining belts fastened to the frame of automobiles, aircraft, or other vehicles, and strapped around the person occupying the seat in the car or plane, intended to prevent the person from being thrown forward or out of the vehicle in case of sudden deceleration.%A%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012622 2001
% 210.18/210.37 |- mesh__dateCreated mesh__D012622 1999-01-01
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012622 2003
% 210.18/210.37 |- rdf__type mesh__D012622sskos__Concept
% 210.18/210.37 |- mesh__historyNote mesh__D012622 70
% 210.18/210.37 |- skos__hiddenLabel mesh__D012622 Belt, Seat
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D012622 70
% 210.18/210.37 |- mesh__recordAuthorizer mesh__D012622 SJN
% 210.18/210.37 |- skos__historyNote mesh__D012622 Accidents, Traffic %28%1966-1969%29%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012622 2004
% 210.18/210.37 |- skos__hiddenLabel mesh__D012622 Seat Belt
% 210.18/210.37 |- skos__historyNote mesh__D012622 Accident Prevention %28%1966-1969%29%
% 210.18/210.37 |- skos__broader mesh__D012622smesh__D011482
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012622 1998
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012622 2002
% 210.18/210.37 |- skos__historyNote mesh__D012622 Automobiles %28%1966-1969%29%
% 210.18/210.37 |- skos__hiddenLabel mesh__D012622 Belts, Seat
% 210.18/210.37 |- mesh__dateRevised mesh__D012622 1997-06-20
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012622 1999
% 210.18/210.37 |- skos__prefLabel mesh__D012622 Seat Belts
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012622 2005
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D012622 2000
% 210.18/210.37 |- skos__related mesh__D012622smesh__D017278
% 210.18/210.37 |- mesh__recordMaintainer mesh__D012622 PXP
% 210.18/210.37 |- mesh__historyNote mesh__D031587 2003
% 210.18/210.37 |- skos__prefLabel mesh__D031587 Cedrela
% 210.18/210.37 |- mesh__dateEstablished mesh__D031587 2003-01-01
% 210.18/210.37 |- skos__scopeNote mesh__D031587
% 210.18/210.37 A plant genus of the family MELIACEAE. Members contain cedrelanolide.%A%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D031587 2006
% 210.18/210.37 |- mesh__publicMeSHNote mesh__D031587 2003
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D031587 2004
% 210.18/210.37 |- skos__annotation mesh__D031587
% 210.18/210.37 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D031587 2005
% 210.18/210.37 |- skos__broader mesh__D031587smesh__D029582
% 210.18/210.37 |- mesh__activeMeSHYear mesh__D031587 2003
% 210.18/210.37 |- rdf__type mesh__D031587sskos__Concept
% 210.18/210.37 |- mesh__dateCreated mesh__D031587 2002-07-03
% 210.18/210.37 |- skos__hiddenLabel mesh__D050741 Common Porpoises
% 210.18/210.37 |- mesh__dateCreated mesh__D050741 2005-06-30
% 210.18/210.37 |- skos__historyNote mesh__D050741 Porpoises %28%1998-2005%29%
% 210.18/210.37 |- skos__hiddenLabel mesh__D050741 Porpoise, Common
% 210.18/210.37 |- skos__hiddenLabel mesh__D050741 Porpoises, Harbour
% 210.18/210.37 |- skos__altLabel mesh__D050741 Harbour Porpoise
% 210.18/210.38 |- skos__hiddenLabel mesh__D050741 Porpoise, Harbor
% 210.18/210.38 |- mesh__recordMaintainer mesh__D050741 ags
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D050741 2006; see PORPOISES 1998-2005
% 210.18/210.38 |- skos__scopeNote mesh__D050741
% 210.18/210.38 A genus of PORPOISES, in the family Phocoenidae, comprised of several species. They frequent coastal waters, bays, estuaries, and the mouths of large rivers.%A%
% 210.18/210.38 |- skos__hiddenLabel mesh__D050741 Harbour Porpoises
% 210.18/210.38 |- skos__altLabel mesh__D050741 Common Porpoise
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D050741 2006
% 210.18/210.38 |- rdf__type mesh__D050741sskos__Concept
% 210.18/210.38 |- skos__hiddenLabel mesh__D050741 Porpoise, Harbour
% 210.18/210.38 |- skos__altLabel mesh__D050741 Harbor Porpoise
% 210.18/210.38 |- skos__broader mesh__D050741smesh__D019576
% 210.18/210.38 |- skos__prefLabel mesh__D050741 Phocoena
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D050741 sjn
% 210.18/210.38 |- skos__hiddenLabel mesh__D050741 Porpoises, Harbor
% 210.18/210.38 |- mesh__dateEstablished mesh__D050741 2006-01-01
% 210.18/210.38 |- skos__hiddenLabel mesh__D050741 Porpoises, Common
% 210.18/210.38 |- skos__historyNote mesh__D050741 Dolphins %28%1968-1997%29%
% 210.18/210.38 |- skos__hiddenLabel mesh__D050741 Harbor Porpoises
% 210.18/210.38 |- mesh__historyNote mesh__D050741 2006; use PORPOISES 1998-2005
% 210.18/210.38 |- mesh__recordOriginator mesh__D050741 ags
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003896 2006
% 210.18/210.38 |- mesh__recordOriginator mesh__D003896 NLM
% 210.18/210.38 |- skos__historyNote mesh__D003896 Cell Membrane %28%1966-1971%29%
% 210.18/210.38 |- skos__hiddenLabel mesh__D003896 Desmosome
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003896 2005
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D003896 72
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003896 2002
% 210.18/210.38 |- mesh__historyNote mesh__D003896 72
% 210.18/210.38 |- skos__annotation mesh__D003896
% 210.18/210.38 A 11 qualif except /cytol; /genet permitted
% 210.18/210.38 |- mesh__dateRevised mesh__D003896 2000-06-22
% 210.18/210.38 |- mesh__recordMaintainer mesh__D003896 TGC
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D003896 sjn
% 210.18/210.38 |- rdf__type mesh__D003896sskos__Concept
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003896 2004
% 210.18/210.38 |- skos__prefLabel mesh__D003896 Desmosomes
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003896 2001
% 210.18/210.38 |- mesh__dateEstablished mesh__D003896 1972-01-01
% 210.18/210.38 |- skos__scopeNote mesh__D003896
% 210.18/210.38 A type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely apposed. It consists of a circular region of each membrane together with associated intracellular microfilaments and an intercellular material which may include, for example, mucopolysaccharides. %28%From Glick, Glossary of Biochemistry and Molecular Biology, 1990; Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%
% 210.18/210.38 |- skos__broader mesh__D003896smesh__D007365
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003896 2003
% 210.18/210.38 |- mesh__dateCreated mesh__D003896 1999-01-01
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 2001
% 210.18/210.38 |- skos__prefLabel mesh__D003098 Collective Bargaining
% 210.18/210.38 |- skos__hiddenLabel mesh__D003098 Bargaining, Collective
% 210.18/210.38 |- mesh__dateRevised mesh__D003098 1993-09-16
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 1996
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 2003
% 210.18/210.38 |- mesh__dateEstablished mesh__D003098 1971-01-01
% 210.18/210.38 |- mesh__historyNote mesh__D003098 71
% 210.18/210.38 |- skos__broader mesh__D003098smesh__D007750
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D003098 NLM
% 210.18/210.38 |- rdf__type mesh__D003098sskos__Concept
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 1997
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 2004
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 2002
% 210.18/210.38 |- skos__historyNote mesh__D003098 Labor Unions %28%1966-1970%29%
% 210.18/210.38 |- mesh__recordMaintainer mesh__D003098 PLS
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D003098 71
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 1995
% 210.18/210.38 |- skos__scopeNote mesh__D003098
% 210.18/210.38 The process of negotiation between representatives of an employee organization, association or union, and representatives of the employer.%A%
% 210.18/210.38 |- skos__hiddenLabel mesh__D003098 Collective Bargainings
% 210.18/210.38 |- skos__hiddenLabel mesh__D003098 Bargainings, Collective
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 1998
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 2005
% 210.18/210.38 |- skos__broader mesh__D003098smesh__D010559
% 210.18/210.38 |- mesh__recordOriginator mesh__D003098 NLM
% 210.18/210.38 |- mesh__dateCreated mesh__D003098 1999-01-01
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 2000
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 1999
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003098 2006
% 210.18/210.38 |- skos__scopeNote mesh__D044704
% 210.18/210.38 An isoform of DNA that occurs in an environment rich in SODIUM and POTASSIUM ions. It is a right-handed helix with 11 base pairs per turn, a pitch of 0.256 nm per base pair and a helical diameter of 2.3 nm.%A%
% 210.18/210.38 |- skos__altLabel mesh__D044704 A-DNA
% 210.18/210.38 |- skos__prefLabel mesh__D044704 DNA, A-Form
% 210.18/210.38 |- skos__related mesh__D044704smesh__D043542
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D044704 2006
% 210.18/210.38 |- rdf__type mesh__D044704sskos__Concept
% 210.18/210.38 |- skos__historyNote mesh__D044704 DNA %28%1985-2003%29%
% 210.18/210.38 |- mesh__dateEstablished mesh__D044704 2004-01-01
% 210.18/210.38 |- skos__related mesh__D044704smesh__D009690
% 210.18/210.38 |- mesh__dateCreated mesh__D044704 2003-07-09
% 210.18/210.38 |- skos__hiddenLabel mesh__D044704 DNA, A Form
% 210.18/210.38 |- skos__broader mesh__D044704smesh__D004247
% 210.18/210.38 |- skos__related mesh__D044704smesh__D044705
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D044704 2004; see DNA 1986-2003
% 210.18/210.38 |- skos__hiddenLabel mesh__D044704 A-Form DNA
% 210.18/210.38 |- mesh__historyNote mesh__D044704 2004; use DNA 1986-2003
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D044704 2004
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D044704 2005
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008581 2006
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008581 2005
% 210.18/210.38 |- mesh__dateRevised mesh__D008581 1999-11-03
% 210.18/210.38 |- mesh__dateCreated mesh__D008581 1999-01-01
% 210.18/210.38 |- rdf__type mesh__D008581sskos__Concept
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008581 2002
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D008581 sjn
% 210.18/210.38 |- skos__annotation mesh__D008581
% 210.18/210.38 GEN: prefer specifics; for pachymeningitis %28%DURA MATER%29% or leptomeningitis %28%ARACHNOIDITIS or PIA MATER%29% do not specify meninx unless particularly discussed; purulent, suppurative or pyogenic: do not coord with SUPPURATION %28%NIM%29% unless particularly discussed%A%
% 210.18/210.38 |- skos__broader mesh__D008581smesh__D002494
% 210.18/210.38 |- skos__broader mesh__D008581smesh__D002493
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008581 2004
% 210.18/210.38 |- mesh__recordOriginator mesh__D008581 NLM
% 210.18/210.38 |- skos__scopeNote mesh__D008581
% 210.18/210.38 Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections %28%viral, bacterial, and fungal%29% are the most common causes of this condition, but subarachnoid hemorrhage %28%HEMORRHAGES, SUBARACHNOID%29%, chemical irritation %28%chemical MENINGITIS%29%, granulomatous conditions, neoplastic conditions %28%e.g., carcinomatous meningitis%29%, and other inflammatory conditions may produce this syndrome. %28%From Joynt, Clinical Neurology, 1994, Ch24, p6%29%%A%
% 210.18/210.38 |- mesh__recordMaintainer mesh__D008581 KEV
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008581 2001
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008581 2003
% 210.18/210.38 |- skos__related mesh__D008581smesh__D013353
% 210.18/210.38 |- skos__hiddenLabel mesh__D008581 Pachymeningitides
% 210.18/210.38 |- skos__hiddenLabel mesh__D008581 Meningitides
% 210.18/210.38 |- skos__prefLabel mesh__D008581 Meningitis
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008581 2000
% 210.18/210.38 |- skos__hiddenLabel mesh__D016215 Macrophage Activating Factors
% 210.18/210.38 |- skos__prefLabel mesh__D016215 Macrophage-Activating Factors
% 210.18/210.38 |- mesh__dateRevised mesh__D016215 2005-06-30
% 210.18/210.38 |- skos__scopeNote mesh__D016215
% 210.18/210.38 Factors secreted by stimulated lymphocytes that prime macrophages to become nonspecifically cytotoxic to tumors. They also modulate the expression of macrophage cell surface Ia antigens. One MAF is interferon-gamma %28%INTERFERON TYPE II%29%. Other factors antigenically distinct from IFN-gamma have also been identified.%A%
% 210.18/210.38 |- skos__annotation mesh__D016215
% 210.18/210.38 a lymphokine; /biosyn /drug eff /physiol /ultrastruct permitted; DF: MAF%A%
% 210.18/210.38 |- skos__hiddenLabel mesh__D016215 Factors, Macrophage-Activating
% 210.18/210.38 |- mesh__recordOriginator mesh__D016215 AGS
% 210.18/210.38 |- mesh__historyNote mesh__D016215 91
% 210.18/210.38 |- mesh__dateEstablished mesh__D016215 1991-01-01
% 210.18/210.38 |- skos__historyNote mesh__D016215 Lymphokines %28%1976-1990%29%
% 210.18/210.38 |- mesh__dateCreated mesh__D016215 1990-04-24
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D016215 91
% 210.18/210.38 |- mesh__recordMaintainer mesh__D016215 ssb
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016215 2006
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D016215 sjn
% 210.18/210.38 |- skos__broader mesh__D016215smesh__D008222
% 210.18/210.38 |- rdf__type mesh__D016215sskos__Concept
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004191 1998
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004191 2006
% 210.18/210.38 |- mesh__dateCreated mesh__D004191 1999-01-01
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004191 1999
% 210.18/210.38 |- mesh__runningHead mesh__D004191
% 210.18/210.38 F4 - BEHAVIORAL DISCIPLINES AND ACTIVITIES
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004191 2000
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D004191 98
% 210.18/210.38 |- mesh__recordOriginator mesh__D004191 NLM
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004191 2003
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D004191 SJN
% 210.18/210.38 |- mesh__dateRevised mesh__D004191 1997-06-26
% 210.18/210.38 |- mesh__recordMaintainer mesh__D004191 TGC
% 210.18/210.38 |- skos__scopeNote mesh__D004191
% 210.18/210.38 The specialties in psychiatry and psychology, their diagnostic techniques and tests, their therapeutic methods, and psychiatric and psychological services.%A%
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004191 2001
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004191 2004
% 210.18/210.38 |- skos__annotation mesh__D004191
% 210.18/210.38 not used for indexing CATALOG: do not use
% 210.18/210.38 |- skos__prefLabel mesh__D004191 Behavioral Disciplines and Activities
% 210.18/210.38 |- rdf__type mesh__D004191sskos__Concept
% 210.18/210.38 |- mesh__historyNote mesh__D004191 98; use explode
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004191 2002
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004191 2005
% 210.18/210.38 |- mesh__dateEstablished mesh__D004191 1998-01-01
% 210.18/210.38 |- skos__related mesh__D012623smesh__D013790
% 210.18/210.38 |- mesh__dateRevised mesh__D012623 2004-07-07
% 210.18/210.38 |- rdf__type mesh__D012623sskos__Concept
% 210.18/210.38 |- mesh__historyNote mesh__D012623 74%28%69%29%
% 210.18/210.38 |- skos__prefLabel mesh__D012623 Seawater
% 210.18/210.38 |- skos__broader mesh__D012623smesh__D014867
% 210.18/210.38 |- mesh__recordOriginator mesh__D012623 NLM
% 210.18/210.38 |- skos__hiddenLabel mesh__D012623 Water, Sea
% 210.18/210.38 |- skos__altLabel mesh__D012623 Sea Water
% 210.18/210.38 |- skos__historyNote mesh__D012623 Water %28%1966-1968%29%
% 210.18/210.38 |- skos__scopeNote mesh__D012623
% 210.18/210.38 The SALINE water of OCEANS AND SEAS that provides habitat for marine organisms.%A%
% 210.18/210.38 |- skos__related mesh__D012623smesh__D019015
% 210.18/210.38 |- skos__hiddenLabel mesh__D012623 Sea Waters
% 210.18/210.38 |- mesh__recordMaintainer mesh__D012623 ssb
% 210.18/210.38 |- skos__hiddenLabel mesh__D012623 Seawaters
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D012623 2005
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D012623 sjn
% 210.18/210.38 |- skos__hiddenLabel mesh__D012623 Waters, Sea
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D012623 2006
% 210.18/210.38 |- mesh__dateEstablished mesh__D012623 1974-01-01
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D012623 74
% 210.18/210.38 |- mesh__dateCreated mesh__D012623 1999-01-01
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003897 2005
% 210.18/210.38 |- skos__historyNote mesh__D003897 Sterols %28%1966-1971%29%
% 210.18/210.38 |- mesh__dateEstablished mesh__D003897 1974-01-01
% 210.18/210.38 |- mesh__historyNote mesh__D003897
% 210.18/210.38 74%28%72%29%; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66%A%
% 210.18/210.38 |- mesh__recordOriginator mesh__D003897 NLM
% 210.18/210.38 |- skos__altLabel mesh__D003897 Demosterol
% 210.18/210.38 |- rdf__type mesh__D003897sskos__Concept
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003897 2004
% 210.18/210.38 |- skos__broader mesh__D003897smesh__D002775
% 210.18/210.38 |- mesh__onlineNote mesh__D003897
% 210.18/210.38 search DEHYDROCHOLESTEROL under CHOLECALCIFEROLS 1966
% 210.18/210.38 |- skos__altLabel mesh__D003897 24-Dehydrocholesterol
% 210.18/210.38 |- skos__broader mesh__D003897smesh__D003684
% 210.18/210.38 |- skos__prefLabel mesh__D003897 Desmosterol
% 210.18/210.38 |- mesh__dateCreated mesh__D003897 1999-01-01
% 210.18/210.38 |- mesh__dateRevised mesh__D003897 2003-07-09
% 210.18/210.38 |- skos__hiddenLabel mesh__D003897 24 Dehydrocholesterol
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003897 2006
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D003897 sjn
% 210.18/210.38 |- skos__scopeNote mesh__D003897
% 210.18/210.38 An intermediate in the synthesis of cholesterol.
% 210.18/210.38 |- mesh__recordMaintainer mesh__D003897 ssb
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D003897
% 210.18/210.38 74; DEHYDROCHOLESTEROL was see under VITAMIN D3 1963-66
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 2003
% 210.18/210.38 |- mesh__recordOriginator mesh__D003099 NLM
% 210.18/210.38 |- skos__scopeNote mesh__D003099
% 210.18/210.38 Test designed to identify students suitable for admission into a graduate or undergraduate curriculum.%A%
% 210.18/210.38 |- skos__hiddenLabel mesh__D003099 College Admission Tests
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 2000
% 210.18/210.38 |- mesh__dateEstablished mesh__D003099 1991-01-01
% 210.18/210.38 |- rdf__type mesh__D003099sskos__Concept
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 2004
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 1997
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 1994
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 2001
% 210.18/210.38 |- skos__prefLabel mesh__D003099 College Admission Test
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D003099 PLS
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 1995
% 210.18/210.38 |- skos__hiddenLabel mesh__D003099 Test, College Admission
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 1998
% 210.18/210.38 |- mesh__dateRevised mesh__D003099 1992-05-07
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 2005
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D003099
% 210.18/210.38 91; was see under EDUCATIONAL MEASUREMENT 1975-90
% 210.18/210.38 |- skos__hiddenLabel mesh__D003099 Admission Tests, College
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 2002
% 210.18/210.38 |- mesh__dateCreated mesh__D003099 1999-01-01
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 2006
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 1999
% 210.18/210.38 |- mesh__historyNote mesh__D003099
% 210.18/210.38 91%28%75%29%; was see under EDUCATIONAL MEASUREMENT 1975-90
% 210.18/210.38 |- skos__broader mesh__D003099smesh__D004521
% 210.18/210.38 |- mesh__onlineNote mesh__D003099 search EDUCATIONAL MEASUREMENT 1966-74
% 210.18/210.38 |- mesh__recordMaintainer mesh__D003099 TGC
% 210.18/210.38 |- skos__hiddenLabel mesh__D003099 Tests, College Admission
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 1993
% 210.18/210.38 |- skos__hiddenLabel mesh__D003099 Admission Test, College
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003099 1996
% 210.18/210.38 |- rdf__type mesh__D044705sskos__Concept
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D044705 2006A
% 210.18/210.38 |- mesh__dateCreated mesh__D044705 2003-07-09
% 210.18/210.38 |- skos__broader mesh__D044705smesh__D004247
% 210.18/210.38 |- mesh__historyNote mesh__D044705 2004
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D044705 ags
% 210.18/210.38 |- skos__hiddenLabel mesh__D044705 C-Form DNA
% 210.18/210.38 |- mesh__dateEstablished mesh__D044705 2004-01-01
% 210.18/210.38 |- skos__related mesh__D044705smesh__D043542
% 210.18/210.38 |- skos__hiddenLabel mesh__D044705 DNA, C Form
% 210.18/210.38 |- mesh__recordOriginator mesh__D044705 jmp
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D044705 2004
% 210.18/210.38 |- skos__related mesh__D044705smesh__D009690
% 210.18/210.38 |- mesh__recordMaintainer mesh__D044705 ags
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D044705 2005
% 210.18/210.38 |- skos__historyNote mesh__D044705 DNA %28%1986-2003%29%
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D044705 2004
% 210.18/210.38 |- mesh__dateRevised mesh__D044705 2005-07-13
% 210.18/210.38 |- skos__scopeNote mesh__D044705
% 210.18/210.38 An isoform of DNA that occurs under experimental conditions. It is a right-handed helix that is less compact than the B-form of DNA.%A%
% 210.18/210.38 |- skos__related mesh__D044705smesh__D044704
% 210.18/210.38 |- skos__related mesh__D044705smesh__D018076
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D044705 2006
% 210.18/210.38 |- skos__prefLabel mesh__D044705 DNA, C-Form
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008582 2001
% 210.18/210.38 |- skos__altLabel mesh__D008582 Aseptic Meningitis
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008582 2005
% 210.18/210.38 |- skos__annotation mesh__D008582
% 210.18/210.38 coord IM with specific cause %28%IM%29% if pertinent
% 210.18/210.38 |- mesh__recordMaintainer mesh__D008582 ags
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D008582 1991; see MENINGITIS 1977-1990
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008582 2000
% 210.18/210.38 |- rdf__type mesh__D008582sskos__Concept
% 210.18/210.38 |- skos__broader mesh__D008582smesh__D008587
% 210.18/210.38 |- mesh__historyNote mesh__D008582 1991%28%1977%29%
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008582 2000B
% 210.18/210.38 |- skos__scopeNote mesh__D008582
% 210.18/210.38 A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. %28%From Adams et al., Principles of Neurology, 6th ed, p745%29%%A%
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008582 2004
% 210.18/210.38 |- skos__broader mesh__D008582smesh__D008581
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008582 2000A
% 210.18/210.38 |- mesh__dateRevised mesh__D008582 1999-12-06
% 210.18/210.38 |- mesh__dateEstablished mesh__D008582 1991-01-01
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008582 2002
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D008582 ags
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008582 2003
% 210.18/210.38 |- mesh__recordOriginator mesh__D008582 MM
% 210.18/210.38 |- skos__prefLabel mesh__D008582 Meningitis, Aseptic
% 210.18/210.38 |- skos__historyNote mesh__D008582 Meningitis %28%1966-1976%29%
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D008582 2006
% 210.18/210.38 |- mesh__dateCreated mesh__D008582 1976-04-27
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016216 2000
% 210.18/210.38 |- skos__altLabel mesh__D016216 Diagnosis, Prenatal Ultrasonic
% 210.18/210.38 |- skos__altLabel mesh__D016216 Diagnosis, Ultrasonic Prenatal
% 210.18/210.38 |- skos__historyNote mesh__D016216
% 210.18/210.38 Ultrasonics/diagnostic use %28%1968-1984%29%
% 210.18/210.38 |- mesh__recordMaintainer mesh__D016216 PXP
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D016216 91
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016216 2006
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016216 2001
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016216 2003
% 210.18/210.38 |- skos__altLabel mesh__D016216 Ultrasonic Diagnosis, Prenatal
% 210.18/210.38 |- skos__hiddenLabel mesh__D016216 Ultrasonic Prenatal Diagnoses
% 210.18/210.38 |- skos__hiddenLabel mesh__D016216 Prenatal Ultrasonic Diagnoses
% 210.18/210.38 |- skos__historyNote mesh__D016216 Ultrasonography %28%1985-1990%29%
% 210.18/210.38 |- skos__altLabel mesh__D016216 Ultrasonic Prenatal Diagnosis
% 210.18/210.38 |- mesh__dateEstablished mesh__D016216 1991-01-01
% 210.18/210.38 |- skos__hiddenLabel mesh__D016216 Ultrasonic Diagnoses, Prenatal
% 210.18/210.38 |- skos__historyNote mesh__D016216 Prenatal Diagnosis %28%1973-1990%29%
% 210.18/210.38 |- skos__prefLabel mesh__D016216 Ultrasonography, Prenatal
% 210.18/210.38 |- skos__broader mesh__D016216smesh__D014463
% 210.18/210.38 |- mesh__historyNote mesh__D016216 91
% 210.18/210.38 |- skos__hiddenLabel mesh__D016216 Diagnoses, Prenatal Ultrasonic
% 210.18/210.38 |- skos__altLabel mesh__D016216 Prenatal Diagnosis, Ultrasonic
% 210.18/210.38 |- skos__altLabel mesh__D016216 Prenatal Ultrasonic Diagnosis
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016216 2002
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016216 2004
% 210.18/210.38 |- skos__altLabel mesh__D016216 Prenatal Ultrasonography
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D016216 SJN
% 210.18/210.38 |- skos__annotation mesh__D016216
% 210.18/210.38 coord IM with specific fetal anat, physiol or other clin feature %28%IM%29%; if on mother, coord IM with specific maternal aspect %28%IM%29%; check tags FEMALE %26% PREGNANCY; DF: ULTRASONOGR PRENATAL%A%
% 210.18/210.38 |- skos__hiddenLabel mesh__D016216 Diagnoses, Ultrasonic Prenatal
% 210.18/210.38 |- mesh__recordOriginator mesh__D016216 TGC
% 210.18/210.38 |- rdf__type mesh__D016216sskos__Concept
% 210.18/210.38 |- skos__hiddenLabel mesh__D016216 Prenatal Diagnoses, Ultrasonic
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016216 1998
% 210.18/210.38 |- skos__broader mesh__D016216smesh__D011296
% 210.18/210.38 |- skos__scopeNote mesh__D016216
% 210.18/210.38 The visualization of tissues during pregnancy through recording of the echoes of ultrasonic waves directed into the body. The procedure may be applied with reference to the mother or the fetus and with reference to organs or the detection of maternal or fetal disease.%A%
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016216 1999
% 210.18/210.38 |- skos__altLabel mesh__D016216 Ultrasonography, Fetal
% 210.18/210.38 |- mesh__dateRevised mesh__D016216 1997-06-20
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D016216 2005
% 210.18/210.38 |- mesh__dateCreated mesh__D016216 1990-05-07
% 210.18/210.38 |- rdf__type mesh__D032681sskos__Concept
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D032681 2003
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D032681 2005
% 210.18/210.38 |- skos__historyNote mesh__D032681 Karyotyping %28%1996-2002%29%
% 210.18/210.38 |- mesh__dateCreated mesh__D032681 2002-07-03
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D032681 2006
% 210.18/210.38 |- mesh__historyNote mesh__D032681 2003
% 210.18/210.38 |- skos__hiddenLabel mesh__D032681 Spectral Karyotypings
% 210.18/210.38 |- skos__scopeNote mesh__D032681
% 210.18/210.38 The simultaneous identification of all chromosomes from a cell by fluorescence in situ hybridization %28%IN SITU HYBRIDIZATION, FLUORESCENCE%29% with chromosome-specific florescent probes that are discerned by their different emission spectra.%A%
% 210.18/210.38 |- skos__broader mesh__D032681smesh__D020223
% 210.18/210.38 |- skos__altLabel mesh__D032681 Karyotyping, Spectral
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D032681 2003
% 210.18/210.38 |- mesh__dateEstablished mesh__D032681 2003-01-01
% 210.18/210.38 |- skos__hiddenLabel mesh__D032681 Karyotypings, Spectral
% 210.18/210.38 |- skos__broader mesh__D032681smesh__D007621
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D032681 2004
% 210.18/210.38 |- skos__prefLabel mesh__D032681 Spectral Karyotyping
% 210.18/210.38 |- skos__altLabel mesh__D004990 Dental Ethics
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004990 2001
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004990 2005
% 210.18/210.38 |- skos__annotation mesh__D004990
% 210.18/210.38 specify geog if pertinent; DF: ETHICS DENT
% 210.18/210.38 |- skos__hiddenLabel mesh__D004990 Dental Ethic
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004990 2000
% 210.18/210.38 |- skos__hiddenLabel mesh__D004990 Ethic, Dental
% 210.18/210.38 |- skos__broader mesh__D004990smesh__D010685
% 210.18/210.38 |- skos__prefLabel mesh__D004990 Ethics, Dental
% 210.18/210.38 |- rdf__type mesh__D004990sskos__Concept
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D004990 sjn
% 210.18/210.38 |- mesh__recordOriginator mesh__D004990 NLM
% 210.18/210.38 |- skos__broader mesh__D004990smesh__D004995
% 210.18/210.38 |- mesh__recordMaintainer mesh__D004990 adp
% 210.18/210.38 |- skos__scopeNote mesh__D004990
% 210.18/210.38 The principles of proper professional conduct concerning the rights and duties of the dentist, relations with patients and fellow practitioners, as well as actions of the dentist in patient care and interpersonal relations with patient families. %28%From Stedman, 25th ed%29%%A%
% 210.18/210.38 |- mesh__dateRevised mesh__D004990 1999-11-08
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004990 2004
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004990 2002
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004990 2006
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004990 2003
% 210.18/210.38 |- mesh__dateCreated mesh__D004990 1999-01-01
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004192 2002
% 210.18/210.38 |- skos__hiddenLabel mesh__D004192 Discriminations %28%Psychology%29%
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004192 1999
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004192 2003
% 210.18/210.38 |- mesh__dateEstablished mesh__D004192 1966-01-01
% 210.18/210.38 |- skos__broader mesh__D004192smesh__D010465
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004192 2004
% 210.18/210.38 |- rdf__type mesh__D004192sskos__Concept
% 210.18/210.38 |- mesh__dateRevised mesh__D004192 1998-06-10
% 210.18/210.38 |- mesh__onlineNote mesh__D004192
% 210.18/210.38 use DISCRIMINATION %28%PSYCHOLOGY%29% to search DISCRIMINATION 1966-77%A%
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004192 2000
% 210.18/210.38 |- mesh__recordOriginator mesh__D004192 NLM
% 210.18/210.38 |- skos__prefLabel mesh__D004192 Discrimination %28%Psychology%29%
% 210.18/210.38 |- skos__annotation mesh__D004192
% 210.18/210.38 not for racial, religious, sex or social discrimination %28% = PREJUDICE%29%; DF: DISCRIMINATION%A%
% 210.18/210.38 |- skos__altLabel mesh__D004192 Discrimination
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D004192 SJN
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D004192 78; was DISCRIMINATION 1966-77
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004192 2005
% 210.18/210.38 |- skos__scopeNote mesh__D004192
% 210.18/210.38 Differential response to different stimuli.
% 210.18/210.38 |- mesh__historyNote mesh__D004192 78; was DISCRIMINATION 1966-77
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004192 2001
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D004192 2006
% 210.18/210.38 |- mesh__dateCreated mesh__D004192 1999-01-01
% 210.18/210.38 |- mesh__recordMaintainer mesh__D004192 JLS
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D012624 2006
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D012624 sjn
% 210.18/210.38 |- skos__prefLabel mesh__D012624 Seaweed
% 210.18/210.38 |- mesh__dateRevised mesh__D012624 2005-06-30
% 210.18/210.38 |- rdf__type mesh__D012624sskos__Concept
% 210.18/210.38 |- mesh__dateCreated mesh__D012624 1999-01-01
% 210.18/210.38 |- skos__broader mesh__D012624smesh__D000456
% 210.18/210.38 |- mesh__recordOriginator mesh__D012624 NLM
% 210.18/210.38 |- mesh__recordMaintainer mesh__D012624 SYSTEM
% 210.18/210.38 |- skos__scopeNote mesh__D012624
% 210.18/210.38 Marine ALGAE widely distributed in the ocean, occurring from the tide level to considerable depths, free-floating %28%planktonic%29% or anchored to the substratum %28%benthic%29%. They lack a specialized vascular system but take up fluids, nutrients, and gases directly from the water. They contain CHLOROPHYLL and are photosynthetic, but some also contain other light-absorbing pigments. Many are of economic importance as FOOD, fertilizer, AGAR, potash, or source of IODINE.%A%
% 210.18/210.38 |- skos__hiddenLabel mesh__D012624 Seaweeds
% 210.18/210.38 |- skos__annotation mesh__D012624 coord with specific alga if pertinent
% 210.18/210.38 |- skos__related mesh__D012624smesh__D002351
% 210.18/210.38 |- skos__altLabel mesh__D050743 Pyruvate Ferredoxin Oxidoreductase
% 210.18/210.38 |- skos__hiddenLabel mesh__D050743 Oxidoreductase, Pyruvate
% 210.18/210.38 |- mesh__publicMeSHNote mesh__D050743
% 210.18/210.38 2006; PYRUVATE SYNTHASE was indexed under KETONE OXIDOREDUCTASES 1975-2005, under FERREDOXINS 1972-1979, under ACETYL COENZYME A 1974-1978, under PYRUVATES 1970-1982, %26% under COENZYME A %26% CARBOXY-LYASES 1970-1974%A%
% 210.18/210.38 |- skos__hiddenLabel mesh__D050743 Synthase, Pyruvate
% 210.18/210.38 |- skos__hiddenLabel mesh__D050743 Ferredoxin Oxidoreductase, Pyruvate
% 210.18/210.38 |- mesh__historyNote mesh__D050743
% 210.18/210.38 2006%28%1980%29%; use KETONE OXIDOREDUCTASES 1975-1979, FERREDOXINS 1972-1979, ACETYL COENZYME A 1974-1978, PYRUVATES 1970-1979, %26% COENZYME A %26% CARBOXY-LYASES 1970-1974%A%
% 210.18/210.38 |- mesh__dateEstablished mesh__D050743 2006-01-01
% 210.18/210.38 |- skos__altLabel mesh__D050743 Pyruvate-Ferredoxin Oxidoreductase
% 210.18/210.38 |- mesh__recordAuthorizer mesh__D050743 sjn
% 210.18/210.38 |- skos__scopeNote mesh__D050743
% 210.18/210.38 A ferredoxin-containing enzyme that catalyzes the COENZYME A-dependent oxidative decarboxylation of PYRUVATE to acetyl-COENZYME A and CARBON DIOXIDE.%A%
% 210.18/210.38 |- skos__altLabel mesh__D050743 Pyruvate Oxidoreductase
% 210.18/210.38 |- mesh__recordMaintainer mesh__D050743 AKE
% 210.18/210.38 |- skos__altLabel mesh__D050743 Pyruvate Synthetase
% 210.18/210.38 |- skos__hiddenLabel mesh__D050743 Synthetase, Pyruvate
% 210.18/210.38 |- mesh__recordOriginator mesh__D050743 AKE
% 210.18/210.38 |- mesh__dateCreated mesh__D050743 2005-06-30
% 210.18/210.38 |- skos__hiddenLabel mesh__D050743 Oxidoreductase, Pyruvate-Ferredoxin
% 210.18/210.38 |- skos__hiddenLabel mesh__D050743 Oxidoreductase, Pyruvate Ferredoxin
% 210.18/210.38 |- skos__prefLabel mesh__D050743 Pyruvate Synthase
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D050743 2006
% 210.18/210.38 |- rdf__type mesh__D050743sskos__Concept
% 210.18/210.38 |- skos__broader mesh__D050743smesh__D007658
% 210.18/210.38 |- mesh__activeMeSHYear mesh__D003898 2006
% 210.18/210.39 |- mesh__recordOriginator mesh__D003898 NLM
% 210.18/210.39 |- skos__altLabel mesh__D003898 Bayer Brand of Desonide
% 210.18/210.39 |- skos__altLabel mesh__D003898 Owen Brand of Desonide
% 210.18/210.39 |- skos__altLabel mesh__D003898 CS Brand of Desonide
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D003898
% 210.18/210.39 91; was see under PREGNADIENETRIOLS 1975-90; PREDNACINOLONE was PREDNACINOLON 1975-94; HYDROXYPREDNISOLONACETONIDE was see DESONIDE 1975-95%A%
% 210.18/210.39 |- skos__altLabel mesh__D003898 Locatop
% 210.18/210.39 |- skos__historyNote mesh__D003898 Acetals %28%1974%29%
% 210.18/210.39 |- skos__scopeNote mesh__D003898
% 210.18/210.39 A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.%A%
% 210.18/210.39 |- mesh__dateEstablished mesh__D003898 1991-01-01
% 210.18/210.39 |- skos__prefLabel mesh__D003898 Desonide
% 210.18/210.39 |- skos__altLabel mesh__D003898 Alcon Brand of Desonide
% 210.18/210.39 |- rdf__type mesh__D003898sskos__Concept
% 210.18/210.39 |- mesh__recordMaintainer mesh__D003898 exl
% 210.18/210.39 |- skos__altLabel mesh__D003898 Desocort
% 210.18/210.39 |- skos__hiddenLabel mesh__D003898 Clay Park Brand of Desonide
% 210.18/210.39 |- skos__historyNote mesh__D003898 Pregnadienetriols %28%1974%29%
% 210.18/210.39 |- skos__annotation mesh__D003898 D25-26 qualif
% 210.18/210.39 |- skos__broader mesh__D003898smesh__D011246
% 210.18/210.39 |- skos__altLabel mesh__D003898 Galderma Brand of Desonide
% 210.18/210.39 |- skos__altLabel mesh__D003898 Clay-Park Brand of Desonide
% 210.18/210.39 |- skos__altLabel mesh__D003898 Prednacinolone
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D003898 sjn
% 210.18/210.39 |- mesh__dateRevised mesh__D003898 2005-06-30
% 210.18/210.39 |- mesh__dateCreated mesh__D003898 1974-11-19
% 210.18/210.39 |- skos__historyNote mesh__D003898 Ketosteroids %28%1974%29%
% 210.18/210.39 |- skos__altLabel mesh__D003898 Pierre Fabre Brand of Desonide
% 210.18/210.39 |- mesh__historyNote mesh__D003898
% 210.18/210.39 91%28%75%29%; was see under PREGNADIENETRIOLS 1975-90; PREDNACINOLONE was PREDNACINOLON 1975-94; HYDROXYPREDNISOLONACETONIDE was see DESONIDE 1975-95%A%
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Hemophilus Meningitis
% 210.18/210.39 |- skos__annotation mesh__D008583
% 210.18/210.39 coord IM with Haemophilus species if available
% 210.18/210.39 |- rdf__type mesh__D008583sskos__Concept
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Haemophilus Meningitides
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Meningitides, Haemophilus aphrophilus
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Hemophilus Meningitides
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D008583 ags
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Haemophilus aphrophilus Meningitides
% 210.18/210.39 |- skos__broader mesh__D008583smesh__D016920
% 210.18/210.39 |- skos__altLabel mesh__D008583 Meningitis, Hemophilus influenzae, Type B
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Haemophilus aphrophilus Meningitis
% 210.18/210.39 |- mesh__recordOriginator mesh__D008583 NLM
% 210.18/210.39 |- skos__altLabel mesh__D008583 Meningitis, Hemophilus influenzae Type F
% 210.18/210.39 |- skos__altLabel mesh__D008583 Type B Haemophilus influenzae Meningitis
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008583 2006A
% 210.18/210.39 |- skos__altLabel mesh__D008583 Meningitis, Hemophilus
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008583 2004
% 210.18/210.39 |- mesh__dateRevised mesh__D008583 2005-07-29
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Meningitides, Haemophilus parainfluenzae
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 HiB Meninigitis
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008583 2005
% 210.18/210.39 |- mesh__dateCreated mesh__D008583 1999-01-01
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Haemophilus Meningitis
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Meningitides, Hemophilus
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Haemophilus parainfluenzae Meningitis
% 210.18/210.39 |- skos__altLabel mesh__D008583 Meninigitis, HiB
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Haemophilus parainfluenzae Meningitides
% 210.18/210.39 |- skos__hiddenLabel mesh__D008583 Meningitides, Haemophilus
% 210.18/210.39 |- skos__altLabel mesh__D008583 Hemophilus influenzae Meningitis Type B
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008583 2006
% 210.18/210.39 |- skos__scopeNote mesh__D008583
% 210.18/210.39 BACTERIAL INFECTIONS of the nervous system caused by HAEMOPHILUS organisms, and marked by prominent inflammation of the meninges. HAEMOPHILUS INFLUENZAE TYPE B is the most common causative organism. The condition primarily affects children under 6 years of age but may occur in adults. Clinical manifestations include fever; nuchal rigidity; PHOTOPHOBIA; SEIZURES; HEARING LOSS, SENSORINEURAL; COMA; and cerebrovascular thrombosis. The organism tends to enter the central nervous system following infections of adjacent structures, including the middle ear %28%see also OTITIS MEDIA%29%, sinuses, and pharynx. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp396-7%29%%A%
% 210.18/210.39 |- skos__altLabel mesh__D008583 Type B Hemophilus influenzae Meningitis
% 210.18/210.39 |- skos__prefLabel mesh__D008583 Meningitis, Haemophilus
% 210.18/210.39 |- skos__broader mesh__D008583smesh__D006192
% 210.18/210.39 |- mesh__recordMaintainer mesh__D008583 ags
% 210.18/210.39 |- skos__altLabel mesh__D016217 Mammography, Ultrasonic
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D016217 91
% 210.18/210.39 |- skos__broader mesh__D016217smesh__D003944
% 210.18/210.39 |- skos__historyNote mesh__D016217 Breast Neoplasms %28%1966-1990%29%
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D016217 2001
% 210.18/210.39 |- skos__altLabel mesh__D016217 Mammography, Ultrasound
% 210.18/210.39 |- skos__hiddenLabel mesh__D016217 Mammary Ultrasonographies
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D016217 2005
% 210.18/210.39 |- mesh__dateCreated mesh__D016217 1990-05-07
% 210.18/210.39 |- skos__hiddenLabel mesh__D016217 Breast Ultrasonographies
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D016217 2002
% 210.18/210.39 |- skos__historyNote mesh__D016217 Ultrasonography %28%1985-1990%29%
% 210.18/210.39 |- skos__annotation mesh__D016217
% 210.18/210.39 check tag usually FEMALE; DF: ULTRASONOGR MAMMARY
% 210.18/210.39 |- mesh__dateEstablished mesh__D016217 1991-01-01
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D016217 SJN
% 210.18/210.39 |- skos__hiddenLabel mesh__D016217 Ultrasound Mammographies
% 210.18/210.39 |- skos__hiddenLabel mesh__D016217 Mammographies, Ultrasound
% 210.18/210.39 |- skos__altLabel mesh__D016217 Ultrasonic Mammography
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D016217 2006
% 210.18/210.39 |- mesh__recordOriginator mesh__D016217 TGC
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D016217 2003
% 210.18/210.39 |- skos__broader mesh__D016217smesh__D014463
% 210.18/210.39 |- mesh__historyNote mesh__D016217 91
% 210.18/210.39 |- skos__hiddenLabel mesh__D016217 Mammographies, Ultrasonic
% 210.18/210.39 |- skos__hiddenLabel mesh__D016217 Ultrasonographies, Mammary
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D016217 2004
% 210.18/210.39 |- skos__hiddenLabel mesh__D016217 Ultrasonographies, Breast
% 210.18/210.39 |- skos__altLabel mesh__D016217 Ultrasonography, Breast
% 210.18/210.39 |- skos__hiddenLabel mesh__D016217 Ultrasonic Mammographies
% 210.18/210.39 |- rdf__type mesh__D016217sskos__Concept
% 210.18/210.39 |- skos__altLabel mesh__D016217 Mammary Ultrasonography
% 210.18/210.39 |- skos__scopeNote mesh__D016217
% 210.18/210.39 Use of ultrasound for imaging the breast. The most frequent application is the diagnosis of neoplasms of the female breast.%A%
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D016217 1998
% 210.18/210.39 |- mesh__dateRevised mesh__D016217 1997-06-20
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D016217 2000
% 210.18/210.39 |- skos__prefLabel mesh__D016217 Ultrasonography, Mammary
% 210.18/210.39 |- skos__historyNote mesh__D016217
% 210.18/210.39 Ultrasonics/diagnostic use %28%1968-1984%29%
% 210.18/210.39 |- mesh__recordMaintainer mesh__D016217 PXP
% 210.18/210.39 |- skos__altLabel mesh__D016217 Breast Ultrasonography
% 210.18/210.39 |- skos__altLabel mesh__D016217 Ultrasound Mammography
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D016217 1999
% 210.18/210.39 |- mesh__recordMaintainer mesh__D004991 sjn
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Facility Ethic, Health
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Organizational Ethic
% 210.18/210.39 |- mesh__recordOriginator mesh__D004991 EC
% 210.18/210.39 |- skos__scopeNote mesh__D004991
% 210.18/210.39 The moral and ethical obligations or responsibilities of institutions.%A%
% 210.18/210.39 |- mesh__dateEstablished mesh__D004991 1991-01-01
% 210.18/210.39 |- mesh__dateRevised mesh__D004991 2003-07-25
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Obligation, Institutional
% 210.18/210.39 |- skos__prefLabel mesh__D004991 Ethics, Institutional
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Institutional Obligation
% 210.18/210.39 |- rdf__type mesh__D004991sskos__Concept
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Institutional Ethic
% 210.18/210.39 |- mesh__dateCreated mesh__D004991 1977-04-22
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Obligations, Institutional
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Facility Ethics, Health
% 210.18/210.39 |- skos__annotation mesh__D004991
% 210.18/210.39 coord IM with type of institution %28%IM%29%; specify geog if pertinent%A%
% 210.18/210.39 |- skos__altLabel mesh__D004991 Health Facility Ethics
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Ethic, Hospital
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Ethic, Organizational
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004991 2005
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Ethic, Institutional
% 210.18/210.39 |- skos__related mesh__D004991smesh__D040861
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Health Facility Ethic
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004991 2004
% 210.18/210.39 |- skos__altLabel mesh__D004991 Institutional Ethics
% 210.18/210.39 |- skos__altLabel mesh__D004991 Hospital Ethics
% 210.18/210.39 |- mesh__historyNote mesh__D004991
% 210.18/210.39 91%28%Aug 77%29%; was see under ETHICS 1977-90
% 210.18/210.39 |- skos__broader mesh__D004991smesh__D004989
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D004991 sjn
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004991 2006
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D004991
% 210.18/210.39 91; was see under ETHICS Aug 1977-90
% 210.18/210.39 |- skos__altLabel mesh__D004991 Organizational Ethics
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Hospital Ethic
% 210.18/210.39 |- skos__hiddenLabel mesh__D004991 Ethic, Health Facility
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 2000
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 1996
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 2004
% 210.18/210.39 |- rdf__type mesh__D004193sskos__Concept
% 210.18/210.39 |- skos__scopeNote mesh__D004193
% 210.18/210.39 Learning that is manifested in the ability to respond differentially to various stimuli.%A%
% 210.18/210.39 |- skos__prefLabel mesh__D004193 Discrimination Learning
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 2001
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 1997
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 2005
% 210.18/210.39 |- mesh__recordMaintainer mesh__D004193 TAP
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 1993
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 2002
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 1998
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 2006
% 210.18/210.39 |- mesh__dateCreated mesh__D004193 1999-01-01
% 210.18/210.39 |- skos__broader mesh__D004193smesh__D007858
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 1994
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 1999
% 210.18/210.39 |- skos__hiddenLabel mesh__D004193 Learnings, Discrimination
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 1995
% 210.18/210.39 |- mesh__dateRevised mesh__D004193 1992-05-14
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004193 2003
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D004193 PLS
% 210.18/210.39 |- skos__hiddenLabel mesh__D004193 Learning, Discrimination
% 210.18/210.39 |- skos__hiddenLabel mesh__D004193 Discrimination Learnings
% 210.18/210.39 |- mesh__recordOriginator mesh__D004193 NLM
% 210.18/210.39 |- skos__hiddenLabel mesh__D012625 Gland Diseases, Sebaceous
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012625 2004
% 210.18/210.39 |- skos__hiddenLabel mesh__D012625 Gland Disease, Sebaceous
% 210.18/210.39 |- mesh__dateCreated mesh__D012625 1999-01-01
% 210.18/210.39 |- rdf__type mesh__D012625sskos__Concept
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012625 2005
% 210.18/210.39 |- skos__historyNote mesh__D012625 Sebaceous Glands %28%1966-1997%29%
% 210.18/210.39 |- mesh__historyNote mesh__D012625 98; use explode 1976-97
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012625 2003
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D012625 sjn
% 210.18/210.39 |- skos__annotation mesh__D012625
% 210.18/210.39 GEN or unspecified; prefer specifics; DF: SEBACEOUS GLAND DIS%A%
% 210.18/210.39 |- skos__hiddenLabel mesh__D012625 Sebaceous Gland Disease
% 210.18/210.39 |- skos__prefLabel mesh__D012625 Sebaceous Gland Diseases
% 210.18/210.39 |- skos__broader mesh__D012625smesh__D012871
% 210.18/210.39 |- skos__hiddenLabel mesh__D012625 Disease, Sebaceous Gland
% 210.18/210.39 |- mesh__dateEstablished mesh__D012625 1998-01-01
% 210.18/210.39 |- skos__hiddenLabel mesh__D012625 Diseases, Sebaceous Gland
% 210.18/210.39 |- skos__historyNote mesh__D012625
% 210.18/210.39 Skin Appendage Diseases %28%1966-1997%29%
% 210.18/210.39 |- mesh__dateRevised mesh__D012625 2001-07-25
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012625 2002
% 210.18/210.39 |- mesh__recordMaintainer mesh__D012625 lkt
% 210.18/210.39 |- skos__scopeNote mesh__D012625
% 210.18/210.39 Diseases of the sebaceous glands such as sebaceous hyperplasia and sebaceous cell carcinoma %28%SEBACEOUS GLAND NEOPLASMS%29%.%A%
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012625 2006
% 210.18/210.39 |- mesh__recordOriginator mesh__D012625 NLM
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D012625 98
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D017310 2005
% 210.18/210.39 |- skos__altLabel mesh__D017310 Annexin VII
% 210.18/210.39 |- mesh__recordMaintainer mesh__D017310 jmp
% 210.18/210.39 |- skos__altLabel mesh__D017310 Synexin
% 210.18/210.39 |- rdf__type mesh__D017310sskos__Concept
% 210.18/210.39 |- skos__historyNote mesh__D017310 Proteins %28%1978-1992%29%
% 210.18/210.39 |- skos__prefLabel mesh__D017310 Annexin A7
% 210.18/210.39 |- mesh__dateRevised mesh__D017310 2004-07-07
% 210.18/210.39 |- skos__broader mesh__D017310smesh__D017302
% 210.18/210.39 |- skos__scopeNote mesh__D017310
% 210.18/210.39 An annexin family member that plays a role in MEMBRANE FUSION and signaling via VOLTAGE-DEPENDENT CALCIUM CHANNELS.%A%
% 210.18/210.39 |- mesh__dateEstablished mesh__D017310 1993-01-01
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D017310 2006
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D017310 sjn
% 210.18/210.39 |- mesh__historyNote mesh__D017310 2005%28%1978%29%
% 210.18/210.39 |- mesh__dateCreated mesh__D017310 1992-05-07
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D017310
% 210.18/210.39 2005; see ANNEXIN VII 1993-2004; SYNEXIN was indexed under PROTEINS 1978-1992; ANNEXIN A7 was indexed under ANNEXIN VIII 2004%A%
% 210.18/210.39 |- mesh__recordOriginator mesh__D017310 AGS
% 210.18/210.39 |- skos__scopeNote mesh__D050744
% 210.18/210.39 An enzyme that catalyzes the oxidation of 5,6-dihydrouracil to URACIL using NAD as a cofactor. This enzyme also plays a role in the catabolism of the antimetabolite 5-FLUOROURACIL.%A%
% 210.18/210.39 |- skos__hiddenLabel mesh__D050744 Dehydrogenase, Dihydrouracil
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D050744 ags
% 210.18/210.39 |- skos__prefLabel mesh__D050744 Dihydrouracil Dehydrogenase %28%NAD+%29%
% 210.18/210.39 |- skos__altLabel mesh__D050744 Dihydrothymine Dehydrogenase %28%NAD%29%
% 210.18/210.39 |- mesh__dateEstablished mesh__D050744 2006-01-01
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D050744 2006A
% 210.18/210.39 |- skos__broader mesh__D050744smesh__D044925
% 210.18/210.39 |- mesh__dateRevised mesh__D050744 2005-07-11
% 210.18/210.39 |- skos__altLabel mesh__D050744 Dihydrouracil Dehydrogenase
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D050744
% 210.18/210.39 2006; DIHYDROURACIL DEHYDROGENASE %28%NAD+%29% was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, OXIDOREDUCTASES 1983-2003, %26% URACIL 1970-1982%A%
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D050744 2006
% 210.18/210.39 |- skos__altLabel mesh__D050744 Dihydrouracil Dehydrogenase %28%NAD%29%
% 210.18/210.39 |- mesh__recordMaintainer mesh__D050744 ags
% 210.18/210.39 |- skos__historyNote mesh__D050744
% 210.18/210.39 Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.18/210.39 |- rdf__type mesh__D050744sskos__Concept
% 210.18/210.39 |- mesh__historyNote mesh__D050744 2006%28%1970%29%
% 210.18/210.39 |- mesh__dateCreated mesh__D050744 2005-06-30
% 210.18/210.39 |- skos__historyNote mesh__D050744 Oxidoreductases %28%1983-2003%29%
% 210.18/210.39 |- mesh__recordOriginator mesh__D050744 AKE
% 210.18/210.39 |- skos__broader mesh__D003899smesh__D011244
% 210.18/210.39 |- skos__prefLabel mesh__D003899 Desoximetasone
% 210.18/210.39 |- skos__altLabel mesh__D003899 Medicis Brand of Desoximetasone
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D003899 sjn
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D003899
% 210.18/210.39 91; was see under DEXAMETHASONE 1979-90
% 210.18/210.39 |- skos__historyNote mesh__D003899 Steroids, Fluorinated %28%1974%29%
% 210.18/210.39 |- mesh__dateRevised mesh__D003899 2005-06-30
% 210.18/210.39 |- skos__altLabel mesh__D003899 Optipharma Brand of Desoximetasone
% 210.18/210.39 |- skos__hiddenLabel mesh__D003899 A41304
% 210.18/210.39 |- skos__scopeNote mesh__D003899
% 210.18/210.39 A topical anti-inflammatory glucocorticoid used in DERMATOSES, skin allergies, PSORIASIS, etc.%A%
% 210.18/210.39 |- skos__hiddenLabel mesh__D003899 17 Desoxymethasone
% 210.18/210.39 |- rdf__type mesh__D003899sskos__Concept
% 210.18/210.39 |- mesh__recordMaintainer mesh__D003899 exl
% 210.18/210.39 |- skos__historyNote mesh__D003899 Dexamethasone %28%1966-1978%29%
% 210.18/210.39 |- mesh__historyNote mesh__D003899
% 210.18/210.39 91%28%79%29%; was see under DEXAMETHASONE 1979-90
% 210.18/210.39 |- skos__altLabel mesh__D003899 Stiefel Brand of Desoximetasone
% 210.18/210.39 |- skos__altLabel mesh__D003899 17-Desoxymethasone
% 210.18/210.39 |- skos__altLabel mesh__D003899 Aventis Brand of Desoximetasone
% 210.18/210.39 |- mesh__dateEstablished mesh__D003899 1991-01-01
% 210.18/210.39 |- skos__historyNote mesh__D003899 Pregnadienediols %28%1974%29%
% 210.18/210.39 |- skos__altLabel mesh__D003899 Deoxydexamethasone
% 210.18/210.39 |- mesh__recordOriginator mesh__D003899 SH
% 210.18/210.39 |- skos__altLabel mesh__D003899 Hoechst Brand of Desoximetasone
% 210.18/210.39 |- skos__altLabel mesh__D003899 Flubason
% 210.18/210.39 |- skos__altLabel mesh__D003899 Bipharma Brand of Desoximetasone
% 210.18/210.39 |- mesh__dateCreated mesh__D003899 1977-12-08
% 210.18/210.39 |- skos__hiddenLabel mesh__D003899 A 41304
% 210.18/210.39 |- skos__altLabel mesh__D003899 Abbott Brand of Desoximetasone
% 210.18/210.39 |- skos__broader mesh__D003899smesh__D003907
% 210.18/210.39 |- skos__altLabel mesh__D003899 Desoxymethasone
% 210.18/210.39 |- skos__altLabel mesh__D003899 Dermik Brand of Desoximetasone
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D003899 2006
% 210.18/210.39 |- rdf__type mesh__D044707sskos__Concept
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D044707 2005
% 210.18/210.39 |- skos__hiddenLabel mesh__D044707 Sciences, Forensic
% 210.18/210.39 |- skos__scopeNote mesh__D044707
% 210.18/210.39 Disciplines that apply sciences to law. Forensic sciences include a wide range of disciplines, such as TOXICOLOGY; FORENSIC ANTHROPOLOGY; FORENSIC MEDICINE; FORENSIC DENTISTRY; and others.%A%
% 210.18/210.39 |- skos__broader mesh__D044707smesh__D003418
% 210.18/210.39 |- mesh__dateEstablished mesh__D044707 2004-01-01
% 210.18/210.39 |- skos__hiddenLabel mesh__D044707 Science, Forensic
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D044707 2004
% 210.18/210.39 |- skos__historyNote mesh__D044707 Forensic Medicine %28%1965-2003%29%
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D044707 2004
% 210.18/210.39 |- mesh__historyNote mesh__D044707 2004
% 210.18/210.39 |- skos__hiddenLabel mesh__D044707 Forensic Science
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D044707 2006
% 210.18/210.39 |- mesh__dateCreated mesh__D044707 2003-07-09
% 210.18/210.39 |- skos__prefLabel mesh__D044707 Forensic Sciences
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008584 2003
% 210.18/210.39 |- skos__broader mesh__D008584smesh__D016920
% 210.18/210.39 |- skos__broader mesh__D008584smesh__D008088
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Meningitides, Listeria monocytogenes
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Listeria Meningitis
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008584 2005A
% 210.18/210.39 |- mesh__recordMaintainer mesh__D008584 jls
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008584 2004
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Cerebritis, Listeria
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Meningoencephalitides, Listeria
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Listeria Meningoencephalitides
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Cerebritides, Listeria
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008584 2000
% 210.18/210.39 |- skos__scopeNote mesh__D008584
% 210.18/210.39 Inflammation of the meninges caused by LISTERIA MONOCYTOGENES infection, usually occurring in individuals under the age of 3 years or over the age of 50 years. It may occur at any age in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES. Clinical manifestations include FEVER, altered mentation, HEADACHE, meningeal signs, focal neurologic signs, and SEIZURES. %28%From Medicine 1998 Sep;77%28%5%29%:313-36%29%%A%
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Meningitis, Listeria monocytogenes
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Meningitides, Listeria
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008584 2005
% 210.18/210.39 |- mesh__recordOriginator mesh__D008584 NLM
% 210.18/210.39 |- mesh__dateCreated mesh__D008584 1999-01-01
% 210.18/210.39 |- skos__altLabel mesh__D008584 Listeria monocytogenes Meningitis
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008584 2001
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008584 2006
% 210.18/210.39 |- skos__prefLabel mesh__D008584 Meningitis, Listeria
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Listeria Meningitides
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D008584 2002
% 210.18/210.39 |- skos__annotation mesh__D008584
% 210.18/210.39 do not coord with LISTERIA MONOCYTOGENES unless organism is particularly discussed%A%
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Listeria monocytogenes Meningitides
% 210.18/210.39 |- skos__altLabel mesh__D008584 Listeria Meningoencephalitis
% 210.18/210.39 |- mesh__dateRevised mesh__D008584 2004-07-28
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D008584 jls
% 210.18/210.39 |- rdf__type mesh__D008584sskos__Concept
% 210.18/210.39 |- skos__hiddenLabel mesh__D008584 Listeria Cerebritides
% 210.18/210.39 |- mesh__recordOriginator mesh__D004992 NLM
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D004992 sjn
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004992 2002
% 210.18/210.39 |- skos__related mesh__D004992smesh__D001675
% 210.18/210.39 |- skos__broader mesh__D004992smesh__D010686
% 210.18/210.39 |- skos__prefLabel mesh__D004992 Ethics, Medical
% 210.18/210.39 |- rdf__type mesh__D004992sskos__Concept
% 210.18/210.39 |- skos__altLabel mesh__D004992 Medical Ethics
% 210.18/210.39 |- skos__broader mesh__D004992smesh__D004995
% 210.18/210.39 |- mesh__dateCreated mesh__D004992 1999-01-01
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004992 2003
% 210.18/210.39 |- mesh__recordMaintainer mesh__D004992 tjk
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004992 2005
% 210.18/210.39 |- skos__scopeNote mesh__D004992
% 210.18/210.39 The principles of proper professional conduct concerning the rights and duties of the physician, relations with patients and fellow practitioners, as well as actions of the physician in patient care and interpersonal relations with patient families. %28%From Stedman, 25th ed%29%%A%
% 210.18/210.39 |- skos__annotation mesh__D004992
% 210.18/210.39 restrict to ethics in relation to the physician; ETHICS, CLINICAL is available for ethics in relation to patient care; BIOETHICS and BIOETHICAL ISSUES are also available; specify geog if pertinent; DF: ETHICS MED%A%
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004992 2004
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004992 2006
% 210.18/210.39 |- mesh__dateRevised mesh__D004992 2001-07-25
% 210.18/210.39 |- mesh__recordMaintainer mesh__D004194 nns
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004194 2005
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D004194 sjn
% 210.18/210.39 |- mesh__recordOriginator mesh__D004194 NLM
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004194 2006
% 210.18/210.39 |- mesh__dateCreated mesh__D004194 1999-01-01
% 210.18/210.39 |- mesh__dateRevised mesh__D004194 2001-07-25
% 210.18/210.39 |- skos__annotation mesh__D004194
% 210.18/210.39 GEN only as a physiol, pathol, philosophical concept, opposite %22%health%22%; Manual 23.5+; /transm = DISEASE TRANSMISSION but consider COMMUNICABLE DISEASES as probably better or DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL or DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; /vet = VETERINARY MEDICINE or ANIMAL DISEASES; /econ permitted but consider also economic aspects of disease as ECONOMICS, MEDICAL; /psychol permitted but consider also psychogenic origin of disease as PSYCHOPHYSIOLOGIC DISORDERS; use remaining qualif discreetly%A%
% 210.18/210.39 |- skos__scopeNote mesh__D004194
% 210.18/210.39 A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.%A%
% 210.18/210.39 |- skos__hiddenLabel mesh__D004194 Diseases
% 210.18/210.39 |- skos__prefLabel mesh__D004194 Disease
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004194 2002
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004194 2003
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D004194 2004
% 210.18/210.39 |- rdf__type mesh__D004194sskos__Concept
% 210.18/210.39 |- skos__broader mesh__D004194smesh__D010335
% 210.18/210.39 |- mesh__dateRevised mesh__D012626 2001-07-25
% 210.18/210.39 |- mesh__recordMaintainer mesh__D012626 lkt
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012626 2002
% 210.18/210.39 |- mesh__historyNote mesh__D012626 68
% 210.18/210.39 |- skos__broader mesh__D012626smesh__D012625
% 210.18/210.39 |- mesh__recordOriginator mesh__D012626 NLM
% 210.18/210.39 |- skos__broader mesh__D012626smesh__D012878
% 210.18/210.39 |- skos__altLabel mesh__D012626 Neoplasms, Sebaceous Gland
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D012626 68
% 210.18/210.39 |- skos__hiddenLabel mesh__D012626 Neoplasm, Sebaceous Gland
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012626 2006
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012626 2004
% 210.18/210.39 |- rdf__type mesh__D012626sskos__Concept
% 210.18/210.39 |- skos__annotation mesh__D012626
% 210.18/210.39 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%
% 210.18/210.39 |- skos__prefLabel mesh__D012626 Sebaceous Gland Neoplasms
% 210.18/210.39 |- mesh__dateCreated mesh__D012626 1999-01-01
% 210.18/210.39 |- skos__historyNote mesh__D012626 Sebaceous Glands %28%1966-1967%29%
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D012626 sjn
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012626 2005
% 210.18/210.39 |- skos__historyNote mesh__D012626 Skin Neoplasms %28%1966-1967%29%
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D012626 2003
% 210.18/210.39 |- skos__hiddenLabel mesh__D012626 Sebaceous Gland Neoplasm
% 210.18/210.39 |- mesh__dateEstablished mesh__D012626 1968-01-01
% 210.18/210.39 |- skos__hiddenLabel mesh__D045002 3 alpha Hydroxysteroid Oxidoreductase
% 210.18/210.39 |- skos__hiddenLabel mesh__D045002 Oxidoreductase, 3 alpha-Hydroxysteroid
% 210.18/210.39 |- skos__altLabel mesh__D045002 5-DP-3 alpha-HSO
% 210.18/210.39 |- skos__altLabel mesh__D045002
% 210.18/210.39 5 alpha-3 alpha-Hydroxysteroid Dehydrogenase
% 210.18/210.39 |- skos__altLabel mesh__D045002
% 210.18/210.39 3alpha-Hydroxysteroid Dehydrogenase %28%B-specific%29%
% 210.18/210.39 |- skos__altLabel mesh__D045002 3 alpha-Hydroxysteroid Dehydrogenase
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D045002 sjn
% 210.18/210.39 |- mesh__recordOriginator mesh__D045002 AKE
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D045002 2004
% 210.18/210.39 |- skos__broader mesh__D045002smesh__D015096
% 210.18/210.39 |- skos__altLabel mesh__D045002 3 alpha-Hydroxysteroid Oxidoreductase
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D045002 2005
% 210.18/210.39 |- skos__hiddenLabel mesh__D045002
% 210.18/210.39 NADPH 5 alpha Dihydroprogesterone 3 alpha Hydroxysteroid Oxidoreductase
% 210.18/210.39 |- mesh__dateCreated mesh__D045002 2003-07-09
% 210.18/210.39 |- skos__altLabel mesh__D045002
% 210.18/210.39 3 alpha-Hydroxysteroid Dehydrogenase %28%B-Specific%29%
% 210.18/210.39 |- rdf__type mesh__D045002sskos__Concept
% 210.18/210.39 |- mesh__historyNote mesh__D045002
% 210.18/210.39 2004; use 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE %28%B-SPECIFIC%29% %28%NM%29% 1979-2003%A%
% 210.18/210.39 |- mesh__recordMaintainer mesh__D045002 jmp
% 210.18/210.39 |- mesh__activeMeSHYear mesh__D045002 2006
% 210.18/210.39 |- skos__hiddenLabel mesh__D045002 Dehydrogenase, 3 alpha-Hydroxysteroid
% 210.18/210.39 |- skos__altLabel mesh__D045002
% 210.18/210.39 NADPH-5 alpha-Dihydroprogesterone 3 alpha-Hydroxysteroid Oxidoreductase
% 210.18/210.39 |- skos__hiddenLabel mesh__D045002 3 alpha Hydroxysteroid Dehydrogenase
% 210.18/210.39 |- mesh__dateEstablished mesh__D045002 2004-01-01
% 210.18/210.39 |- skos__historyNote mesh__D045002
% 210.18/210.39 3-Hydroxysteroid Dehydrogenases %28%1979-2003%29%
% 210.18/210.39 |- skos__prefLabel mesh__D045002
% 210.18/210.39 3-alpha-Hydroxysteroid Dehydrogenase %28%B-Specific%29%
% 210.18/210.39 |- skos__scopeNote mesh__D045002
% 210.18/210.39 A 3-hydroxysteroid dehydrogenase which catalyzes the reversible reduction of the active androgen, DIHYDROTESTOSTERONE to 5 ALPHA-ANDROSTANE-3 ALPHA,17 BETA-DIOL. It also has activity towards other 3-alpha-hydroxysteroids and on 9-, 11- and 15- hydroxyprostaglandins. The enzyme is B-specific in reference to the orientation of reduced NAD or NADPH.%A%
% 210.18/210.39 |- skos__hiddenLabel mesh__D045002
% 210.18/210.39 5 alpha Dihydroprogesterone 3 alpha Hydroxysteroid Oxidoreductase
% 210.18/210.39 |- mesh__publicMeSHNote mesh__D045002
% 210.18/210.39 2004; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE %28%B-SPECIFIC%29% was indexed under 3-HYDROXYSTEROID DEHYDROGENASES 1979-2003; 5 ALPHA-DIHYDROPROGESTERONE 3 ALPHA-HYDROSTEROID OXIDOREDUCTASE was indexed under 3-HYDROXYSTEROID DEHYDROGENASES 1981-2003%A%
% 210.18/210.39 |- mesh__onlineNote mesh__D017311
% 210.18/210.39 use AMLODIPINE %28%NM%29% to search AMLODIPINE 1986-92
% 210.18/210.39 |- mesh__recordAuthorizer mesh__D017311 sjn
% 210.18/210.39 |- skos__altLabel mesh__D017311 Mack Brand of Amlodipine Besilate
% 210.18/210.39 |- rdf__type mesh__D017311sskos__Concept
% 210.18/210.39 |- skos__altLabel mesh__D017311 Amlor
% 210.18/210.39 |- mesh__historyNote mesh__D017311 93; was AMLODIPINE %28%NM%29% 1986-92
% 210.18/210.39 |- skos__altLabel mesh__D017311 Almirall Brand of Amlodipine Besilate
% 210.18/210.39 |- mesh__recordMaintainer mesh__D017311 mdb
% 210.18/210.39 |- skos__hiddenLabel mesh__D017311 Besylate, Amlodipine
% 210.18/210.39 |- skos__scopeNote mesh__D017311
% 210.18/210.39 A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension.%A%
% 210.18/210.39 |- mesh__dateRevised mesh__D017311 2004-07-07
% 210.18/210.39 |- skos__hiddenLabel mesh__D017311 Maleate, Amlodipine
% 210.18/210.39 |- skos__historyNote mesh__D017311
% 210.18/210.39 Nifedipine/analogs %26% derivatives %28%1986-1992%29%
% 210.18/210.39 |- skos__altLabel mesh__D017311 Amlodipine Maleate %28%1:1%29%
% 210.18/210.40 |- mesh__recordOriginator mesh__D017311 TPW
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D017311 2006
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D017311
% 210.18/210.40 93; AMLODIPINE was indexed under NIFEDIPINE/analogs %26% derivatives 1986-92%A%
% 210.18/210.40 |- mesh__dateCreated mesh__D017311 1992-05-07
% 210.18/210.40 |- skos__prefLabel mesh__D017311 Amlodipine
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D017311 2005
% 210.18/210.40 |- skos__altLabel mesh__D017311 Pfizer Brand of Amlodipine Besilate
% 210.18/210.40 |- skos__altLabel mesh__D017311 Istin
% 210.18/210.40 |- mesh__dateEstablished mesh__D017311 1993-01-01
% 210.18/210.40 |- skos__broader mesh__D017311smesh__D004095
% 210.18/210.40 |- skos__historyNote mesh__D050745 Oxidoreductases %28%1980-2005%29%
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D050745 sjn
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D050745
% 210.18/210.40 2006; ENOYL-%28%ACYL-CARRIER-PROTEIN%29% REDUCTASE %28%NADPH%29% was indexed under OXIDOREDUCTASES 1980-2005%A%
% 210.18/210.40 |- mesh__dateEstablished mesh__D050745 2006-01-01
% 210.18/210.40 |- skos__altLabel mesh__D050745
% 210.18/210.40 Enoyl-%28%Acyl-Carrier-Protein%29%reductase %28%NADPH%29%
% 210.18/210.40 |- mesh__recordMaintainer mesh__D050745 AKE
% 210.18/210.40 |- skos__altLabel mesh__D050745 Acyl-ACP Dehydrogenase
% 210.18/210.40 |- mesh__dateCreated mesh__D050745 2005-06-30
% 210.18/210.40 |- skos__scopeNote mesh__D050745
% 210.18/210.40 An enzyme that catalyzes the oxidation of acyl-%5B%acyl-carrier protein%5D% to trans-2,3-dehydroacyl-%5B%acyl-carrier protein%5D% in the fatty acid biosynthesis pathway. It has a preference for acyl derivatives with carbon chain length from 4 to 16.%A%
% 210.18/210.40 |- skos__prefLabel mesh__D050745
% 210.18/210.40 Enoyl-%28%Acyl-Carrier Protein%29% Reductase %28%NADPH, B-Specific%29%
% 210.18/210.40 |- mesh__recordOriginator mesh__D050745 AKE
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D050745 2006
% 210.18/210.40 |- skos__hiddenLabel mesh__D050745 Dehydrogenase, Acyl-ACP
% 210.18/210.40 |- rdf__type mesh__D050745sskos__Concept
% 210.18/210.40 |- skos__hiddenLabel mesh__D050745 Acyl ACP Dehydrogenase
% 210.18/210.40 |- mesh__historyNote mesh__D050745 2006%28%1980%29%
% 210.18/210.40 |- skos__broader mesh__D050745smesh__D044925
% 210.18/210.40 |- skos__broader mesh__D020001Q000031smesh__D020001
% 210.18/210.40 |- mesh__preferredCombination mesh__D020001Q000031smesh__D000440
% 210.18/210.40 |- rdf__type mesh__D020001Q000031smesh__CompoundConcept
% 210.18/210.40 |- skos__related mesh__D044708smesh__D043864
% 210.18/210.40 |- mesh__recordMaintainer mesh__D044708 ssb
% 210.18/210.40 |- skos__related mesh__D044708smesh__D020080
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D044708 2004
% 210.18/210.40 |- mesh__dateRevised mesh__D044708 2004-07-07
% 210.18/210.40 |- skos__broader mesh__D044708smesh__D004247
% 210.18/210.40 |- skos__annotation mesh__D044708
% 210.18/210.40 coord with specific DNA source; DNA, CATENATED is also available%A%
% 210.18/210.40 |- mesh__historyNote mesh__D044708 2004
% 210.18/210.40 |- mesh__recordOriginator mesh__D044708 ssb
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D044708 2006
% 210.18/210.40 |- mesh__dateCreated mesh__D044708 2003-07-09
% 210.18/210.40 |- skos__altLabel mesh__D044708 DNA, Concatemers
% 210.18/210.40 |- mesh__dateEstablished mesh__D044708 2004-01-01
% 210.18/210.40 |- rdf__type mesh__D044708sskos__Concept
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D044708 2005
% 210.18/210.40 |- skos__prefLabel mesh__D044708 DNA, Concatenated
% 210.18/210.40 |- skos__altLabel mesh__D044708 Concatenated DNA
% 210.18/210.40 |- skos__scopeNote mesh__D044708
% 210.18/210.40 Head to tail array of covalently joined DNA sequences generated by concatenation. Concatenated DNA is attached end to end in contrast to CATENATED DNA which is attached loop to loop.%A%
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D044708 sjn
% 210.18/210.40 |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup B
% 210.18/210.40 |- skos__altLabel mesh__D008585 Serogroup W-135, Meningococcal Meningitis
% 210.18/210.40 |- mesh__recordMaintainer mesh__D008585 sjn
% 210.18/210.40 |- skos__prefLabel mesh__D008585 Meningitis, Meningococcal
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008585 2005
% 210.18/210.40 |- skos__annotation mesh__D008585
% 210.18/210.40 do not coord with NEISSERIA MENINGITIDIS unless organism is particularly discussed but coord with specific serogroup %28%IM%29% if given%A%
% 210.18/210.40 |- mesh__dateCreated mesh__D008585 1999-01-01
% 210.18/210.40 |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup C
% 210.18/210.40 |- skos__broader mesh__D008585smesh__D008589
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008585 2006
% 210.18/210.40 |- skos__altLabel mesh__D008585 Serogroup Y, Meningococcal Meningitis
% 210.18/210.40 |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup W135
% 210.18/210.40 |- mesh__dateRevised mesh__D008585 2002-10-18
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008585 2003A
% 210.18/210.40 |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup W-135
% 210.18/210.40 |- skos__altLabel mesh__D008585 Meningitis, Meningococcal, Serogroup W135
% 210.18/210.40 |- skos__altLabel mesh__D008585 Meningitis, Meningococcic
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D008585
% 210.18/210.40 1978; see MENINGITIS, MENINGOCOCCIC 1963-1977
% 210.18/210.40 |- skos__hiddenLabel mesh__D008585 Meningococcal Meningitis
% 210.18/210.40 |- skos__scopeNote mesh__D008585
% 210.18/210.40 A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. %28%From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10%28%1%29%:13-8%29%%A%
% 210.18/210.40 |- skos__hiddenLabel mesh__D008585
% 210.18/210.40 Meningococcal Meningitis, Serogroup W 135
% 210.18/210.40 |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup A
% 210.18/210.40 |- skos__altLabel mesh__D008585 Serogroup W135, Meningococcal Meningitis
% 210.18/210.40 |- skos__altLabel mesh__D008585 Serogroup A Meningococcal Meningitis
% 210.18/210.40 |- rdf__type mesh__D008585sskos__Concept
% 210.18/210.40 |- skos__altLabel mesh__D008585 Serogroup C Meningococcal Meningitis
% 210.18/210.40 |- mesh__historyNote mesh__D008585 1978%28%1963%29%
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D008585 sjn
% 210.18/210.40 |- skos__altLabel mesh__D008585 Serogroup B Meningococcal Meningitis
% 210.18/210.40 |- skos__broader mesh__D008585smesh__D016920
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008585 2003
% 210.18/210.40 |- skos__hiddenLabel mesh__D008585
% 210.18/210.40 Serogroup W 135, Meningococcal Meningitis
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008585 2004
% 210.18/210.40 |- mesh__recordOriginator mesh__D008585 NLM
% 210.18/210.40 |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup Y
% 210.18/210.40 |- skos__hiddenLabel mesh__D016219 Adoptive Cellular Immunotherapies
% 210.18/210.40 |- skos__hiddenLabel mesh__D016219 Adoptive Immunotherapies
% 210.18/210.40 |- mesh__recordMaintainer mesh__D016219 TGC
% 210.18/210.40 |- skos__altLabel mesh__D016219 Cellular Immunotherapy, Adoptive
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D016219 2003
% 210.18/210.40 |- rdf__type mesh__D016219sskos__Concept
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D016219 2006
% 210.18/210.40 |- skos__annotation mesh__D016219
% 210.18/210.40 IM; do not use /util except by MeSH definition
% 210.18/210.40 |- mesh__recordOriginator mesh__D016219 AGS
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D016219 2000
% 210.18/210.40 |- skos__historyNote mesh__D016219 Immunization, Passive %28%1983-1990%29%
% 210.18/210.40 |- skos__scopeNote mesh__D016219
% 210.18/210.40 Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer %28%LAK%29% cells and tumor-infiltrating lymphocytes %28%TIL%29%. This is usually considered a form of passive immunotherapy. %28%From DeVita, et al., Cancer, 1993, pp.305-7, 314%29%%A%
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D016219 2005
% 210.18/210.40 |- mesh__dateRevised mesh__D016219 1997-06-20
% 210.18/210.40 |- skos__altLabel mesh__D016219 Adoptive Cellular Immunotherapy
% 210.18/210.40 |- skos__altLabel mesh__D016219 Immunotherapy, Adoptive Cellular
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D016219 91
% 210.18/210.40 |- skos__hiddenLabel mesh__D016219 Cellular Immunotherapies, Adoptive
% 210.18/210.40 |- mesh__dateEstablished mesh__D016219 1991-01-01
% 210.18/210.40 |- skos__hiddenLabel mesh__D016219 Immunotherapies, Adoptive Cellular
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D016219 SJN
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D016219 1999
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D016219 2002
% 210.18/210.40 |- mesh__historyNote mesh__D016219 91
% 210.18/210.40 |- skos__altLabel mesh__D016219 Adoptive Immunotherapy
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D016219 2004
% 210.18/210.40 |- mesh__dateCreated mesh__D016219 1990-06-06
% 210.18/210.40 |- skos__broader mesh__D016219smesh__D019264
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D016219 1998
% 210.18/210.40 |- skos__hiddenLabel mesh__D016219 Immunotherapies, Adoptive
% 210.18/210.40 |- skos__prefLabel mesh__D016219 Immunotherapy, Adoptive
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D016219 2001
% 210.18/210.40 |- skos__broader mesh__D009206Q000648smesh__D009206
% 210.18/210.40 |- rdf__type mesh__D009206Q000648smesh__CompoundConcept
% 210.18/210.40 |- mesh__dateCreated mesh__D004993 1999-01-01
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004993 2001
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004993 2005
% 210.18/210.40 |- skos__altLabel mesh__D004993 Nursing Ethics
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004993 2004
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004993 2006
% 210.18/210.40 |- skos__hiddenLabel mesh__D004993 Nursing Ethic
% 210.18/210.40 |- skos__scopeNote mesh__D004993
% 210.18/210.40 The principles of proper professional conduct concerning the rights and duties of nurses themselves, their patients, and their fellow practitioners, as well as their actions in the care of patients and in relations with their families.%A%
% 210.18/210.40 |- skos__broader mesh__D004993smesh__D010687
% 210.18/210.40 |- skos__hiddenLabel mesh__D004993 Ethic, Nursing
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004993 2002
% 210.18/210.40 |- mesh__recordOriginator mesh__D004993 NLM
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D004993 sjn
% 210.18/210.40 |- skos__prefLabel mesh__D004993 Ethics, Nursing
% 210.18/210.40 |- mesh__recordMaintainer mesh__D004993 kle
% 210.18/210.40 |- skos__annotation mesh__D004993
% 210.18/210.40 specify geog if pertinent; DF: ETHICS NURS
% 210.18/210.40 |- mesh__dateRevised mesh__D004993 1999-11-03
% 210.18/210.40 |- rdf__type mesh__D004993sskos__Concept
% 210.18/210.40 |- skos__broader mesh__D004993smesh__D004995
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004993 2000
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004993 2003
% 210.18/210.40 |- rdf__type mesh__D051040sskos__Concept
% 210.18/210.40 |- skos__hiddenLabel mesh__D051040 3, Synaptobrevin
% 210.18/210.40 |- mesh__dateEstablished mesh__D051040 2006-01-01
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D051040
% 210.18/210.40 2006; CELLUBREVIN %28%now VESICLE-ASSOCIATED MEMBRANE PROTEIN 3%29% was indexed under MEMBRANE PROTEINS 1993-2005%A%
% 210.18/210.40 |- skos__broader mesh__D051040smesh__D050683
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D051040 2006
% 210.18/210.40 |- mesh__recordOriginator mesh__D051040 nns
% 210.18/210.40 |- skos__altLabel mesh__D051040 Synaptobrevin 3
% 210.18/210.40 |- skos__hiddenLabel mesh__D051040 Vesicle Associated Membrane Protein 3
% 210.18/210.40 |- skos__prefLabel mesh__D051040 Vesicle-Associated Membrane Protein 3
% 210.18/210.40 |- skos__historyNote mesh__D051040 Membrane Proteins %28%1997-2005%29%
% 210.18/210.40 |- skos__altLabel mesh__D051040 VAMP3
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D051040 sjn
% 210.18/210.40 |- mesh__recordMaintainer mesh__D051040 nns
% 210.18/210.40 |- skos__historyNote mesh__D051040
% 210.18/210.40 Vesicular Transport Proteins %28%1997-2005%29%
% 210.18/210.40 |- skos__scopeNote mesh__D051040
% 210.18/210.40 A member of the vesicle associated membrane protein family. It has a broad tissue distribution and is involved in MEMBRANE FUSION events of the endocytic pathways.%A%
% 210.18/210.40 |- mesh__dateCreated mesh__D051040 2005-06-30
% 210.18/210.40 |- skos__altLabel mesh__D051040 Cellubrevin
% 210.18/210.40 |- mesh__historyNote mesh__D051040 2006 %28%1993%29%
% 210.18/210.40 |- rdf__type mesh__D004195sskos__Concept
% 210.18/210.40 |- mesh__dateCreated mesh__D004195 1999-01-01
% 210.18/210.40 |- skos__prefLabel mesh__D004195 Disease Models, Animal
% 210.18/210.40 |- mesh__historyNote mesh__D004195 70
% 210.18/210.40 |- skos__broader mesh__D004195smesh__D023421
% 210.18/210.40 |- skos__related mesh__D004195smesh__D000830
% 210.18/210.40 |- skos__annotation mesh__D004195
% 210.18/210.40 not a routine coordinate with experimental animal diseases: index only when the text indicates a disease model; when the model is the point of the article, coordinate IM with the specific disease %28%IM%29% + specific animal %28%IM%29% if pertinent%A%
% 210.18/210.40 |- skos__broader mesh__D004195smesh__D000820
% 210.18/210.40 |- skos__scopeNote mesh__D004195
% 210.18/210.40 Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.%A%
% 210.18/210.40 |- skos__historyNote mesh__D004195 Models, Biological %28%1968-1969%29%
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004195 2006
% 210.18/210.40 |- skos__broader mesh__D004195smesh__D008954
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D004195 sjn
% 210.18/210.40 |- mesh__recordOriginator mesh__D004195 NLM
% 210.18/210.40 |- mesh__recordMaintainer mesh__D004195 sjn
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004195 2005
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D004195 70
% 210.18/210.40 |- skos__hiddenLabel mesh__D004195 Disease Model, Animal
% 210.18/210.40 |- skos__hiddenLabel mesh__D004195 Animal Disease Model
% 210.18/210.40 |- skos__hiddenLabel mesh__D004195 Animal Disease Models
% 210.18/210.40 |- mesh__dateRevised mesh__D004195 2004-07-13
% 210.18/210.40 |- skos__historyNote mesh__D004195 Animal Diseases %28%1966-1969%29%
% 210.18/210.40 |- mesh__dateEstablished mesh__D004195 1970-01-01
% 210.18/210.40 |- skos__hiddenLabel mesh__D012627 Gland, Sebaceous
% 210.18/210.40 |- skos__prefLabel mesh__D012627 Sebaceous Glands
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D012627 2006
% 210.18/210.40 |- mesh__recordMaintainer mesh__D012627 nns
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D012627 2004
% 210.18/210.40 |- skos__scopeNote mesh__D012627
% 210.18/210.40 Small, sacculated organs found within the DERMIS. Each gland has a single duct that emerges from a cluster of oval alveoli. Each alveolus consists of a transparent BASEMENT MEMBRANE enclosing epithelial cells. The ducts from most sebaceous glands open into a HAIR FOLLICLE, but some open on the general surface of the SKIN. Sebaceous glands secrete SEBUM.%A%
% 210.18/210.40 |- skos__broader mesh__D012627smesh__D012867
% 210.18/210.40 |- skos__broader mesh__D012627smesh__D005088
% 210.18/210.40 |- rdf__type mesh__D012627sskos__Concept
% 210.18/210.40 |- skos__hiddenLabel mesh__D012627 Sebaceous Gland
% 210.18/210.40 |- mesh__dateCreated mesh__D012627 1999-01-01
% 210.18/210.40 |- mesh__recordOriginator mesh__D012627 NLM
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D012627 2005
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D012627 2003
% 210.18/210.40 |- mesh__dateRevised mesh__D012627 2002-07-03
% 210.18/210.40 |- skos__hiddenLabel mesh__D012627 Glands, Sebaceous
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D012627 sjn
% 210.18/210.40 |- skos__broader mesh__D006932Q000151smesh__D006932
% 210.18/210.40 |- mesh__preferredCombination mesh__D006932Q000151smesh__D006933
% 210.18/210.40 |- rdf__type mesh__D006932Q000151smesh__CompoundConcept
% 210.18/210.40 |- rdf__type mesh__D017312sskos__Concept
% 210.18/210.40 |- skos__prefLabel mesh__D017312 Toremifene
% 210.18/210.40 |- skos__hiddenLabel mesh__D017312 Citrate, Toremifene
% 210.18/210.40 |- mesh__recordOriginator mesh__D017312 TPW
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D017312 sjn
% 210.18/210.40 |- mesh__historyNote mesh__D017312 93; was TOREMIFENE %28%NM%29% 1985-92
% 210.18/210.40 |- mesh__dateEstablished mesh__D017312 1993-01-01
% 210.18/210.40 |- skos__altLabel mesh__D017312 Toremifene Citrate %28%1:1%29%
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D017312 2006
% 210.18/210.40 |- skos__historyNote mesh__D017312
% 210.18/210.40 Tamoxifen/analogs %26% derivatives %28%1985-1992%29%
% 210.18/210.40 |- skos__broader mesh__D017312smesh__D013629
% 210.18/210.40 |- skos__scopeNote mesh__D017312
% 210.18/210.40 A first generation selective estrogen receptor modulator %28%SERM%29%. Like TAMOXIFEN, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.%A%
% 210.18/210.40 |- skos__hiddenLabel mesh__D017312 FC 1157a
% 210.18/210.40 |- mesh__recordMaintainer mesh__D017312 ssb
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D017312
% 210.18/210.40 93; TOREMIFENE was indexed under TAMOXIFEN/analogs %26% derivatives 1985-92%A%
% 210.18/210.40 |- mesh__dateRevised mesh__D017312 2005-06-30
% 210.18/210.40 |- mesh__dateCreated mesh__D017312 1992-05-20
% 210.18/210.40 |- skos__hiddenLabel mesh__D017312 FC1157a
% 210.18/210.40 |- mesh__onlineNote mesh__D017312
% 210.18/210.40 use TOREMIFENE %28%NM%29% to search TOREMIFENE 1985-92
% 210.18/210.40 |- mesh__recordMaintainer mesh__D050746 AKE
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D050746
% 210.18/210.40 2006; DIHYDRODIPICOLINATE REDUCTASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1982-2003, and under PICOLINIC ACIDS 1974-1981%A%
% 210.18/210.40 |- skos__hiddenLabel mesh__D050746 Acid Reductase, Dihydrodipicolinic
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D050746 sjn
% 210.18/210.40 |- mesh__dateEstablished mesh__D050746 2006-01-01
% 210.18/210.40 |- skos__prefLabel mesh__D050746 Dihydrodipicolinate Reductase
% 210.18/210.40 |- skos__historyNote mesh__D050746
% 210.18/210.40 Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.18/210.40 |- skos__hiddenLabel mesh__D050746 Reductase, Dihydrodipicolinic Acid
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D050746 2006
% 210.18/210.40 |- skos__hiddenLabel mesh__D050746 Reductase, Dihydrodipicolinate
% 210.18/210.40 |- mesh__dateCreated mesh__D050746 2005-06-30
% 210.18/210.40 |- mesh__historyNote mesh__D050746 2006%28%1974%29%
% 210.18/210.40 |- rdf__type mesh__D050746sskos__Concept
% 210.18/210.40 |- mesh__recordOriginator mesh__D050746 AKE
% 210.18/210.40 |- skos__broader mesh__D050746smesh__D044925
% 210.18/210.40 |- skos__historyNote mesh__D050746 Picolinic Acids %28%1974-1981%29%
% 210.18/210.40 |- skos__altLabel mesh__D050746 Dihydrodipicolinic Acid Reductase
% 210.18/210.40 |- skos__historyNote mesh__D050746 Oxidoreductases %28%1982-2003%29%
% 210.18/210.40 |- skos__scopeNote mesh__D050746
% 210.18/210.40 An enzyme that catalyzes the oxidation of 2,3,4,5-tetrahydrodipicolinate to 2,3-dihydrodipicolinate using NAD%28%P%29%+ as a cofactor. It is found in BACTERIA and higher plants involved in the biosynthesis of DIAMINOPIMELIC ACID and LYSINE.%A%
% 210.18/210.40 |- skos__broader mesh__D044709smesh__D044707
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D044709 sjn
% 210.18/210.40 |- mesh__recordOriginator mesh__D044709 lkt
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D044709 2006
% 210.18/210.40 |- skos__related mesh__D044709smesh__D014948
% 210.18/210.40 |- mesh__historyNote mesh__D044709
% 210.18/210.40 2004; for BALLISTICS, WOUND see WOUNDS, GUNSHOT 1987-2003%A%
% 210.18/210.40 |- skos__hiddenLabel mesh__D044709 Ballistics, Forensic
% 210.18/210.40 |- mesh__dateCreated mesh__D044709 2003-07-09
% 210.18/210.40 |- skos__hiddenLabel mesh__D044709 Ballistic, Forensic
% 210.18/210.40 |- rdf__type mesh__D044709sskos__Concept
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D044709 2005
% 210.18/210.40 |- skos__hiddenLabel mesh__D044709 Wound Ballistics
% 210.18/210.40 |- skos__historyNote mesh__D044709 Wounds, Gunshot %28%1966-2003%29%
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D044709
% 210.18/210.40 2004; for BALLISTICS, WOUND use WOUNDS, GUNSHOT 1987-2003%A%
% 210.18/210.40 |- skos__hiddenLabel mesh__D044709 Forensic Ballistic
% 210.18/210.40 |- skos__scopeNote mesh__D044709
% 210.18/210.40 The science of studying projectiles in motion, BALLISTICS, being applied to law. Ballistics on firearm projectiles, such as bullets, include the study of what happens inside the weapon, during the flight of the projectile, and when the projectile strikes the target, such as body tissue.%A%
% 210.18/210.40 |- mesh__recordMaintainer mesh__D044709 lkt
% 210.18/210.40 |- mesh__dateEstablished mesh__D044709 2004-01-01
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D044709 2004
% 210.18/210.40 |- skos__prefLabel mesh__D044709 Forensic Ballistics
% 210.18/210.40 |- skos__altLabel mesh__D008586 Meningitis, Streptococcus pneumoniae
% 210.18/210.40 |- skos__hiddenLabel mesh__D008586 Streptococcus pneumoniae Meningitides
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008586 2006
% 210.18/210.40 |- skos__hiddenLabel mesh__D008586 Pneumococcal Meningitides
% 210.18/210.40 |- mesh__recordOriginator mesh__D008586 NLM
% 210.18/210.40 |- skos__scopeNote mesh__D008586
% 210.18/210.40 An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease %28%ANEMIA, SICKLE CELL%29%; skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits %28%notably DEAFNESS%29%; and COMA. %28%From Miller et al., Merritt%27%s Textbook of Neurology, 9th ed, p111%29%%A%
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008586 2001
% 210.18/210.40 |- rdf__type mesh__D008586sskos__Concept
% 210.18/210.40 |- skos__hiddenLabel mesh__D008586 Streptococcus pneumoniae Meningitis
% 210.18/210.40 |- skos__hiddenLabel mesh__D008586 Meningitis, Experimental Pneumococcal
% 210.18/210.40 |- skos__hiddenLabel mesh__D008586 Pneumococcal Meningitis
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008586 2002
% 210.18/210.40 |- skos__broader mesh__D008586smesh__D016920
% 210.18/210.40 |- skos__hiddenLabel mesh__D008586 Experimental Pneumococcal Meningitides
% 210.18/210.40 |- skos__hiddenLabel mesh__D008586 Pneumococcal Meningitis, Experimental
% 210.18/210.40 |- skos__hiddenLabel mesh__D008586 Pneumococcal Meningitides, Experimental
% 210.18/210.40 |- skos__prefLabel mesh__D008586 Meningitis, Pneumococcal
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008586 2003
% 210.18/210.40 |- skos__annotation mesh__D008586
% 210.18/210.40 do not coord with STREPTOCOCCUS PNEUMONIAE unless organism is particularly discussed%A%
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008586 2004
% 210.18/210.40 |- mesh__dateRevised mesh__D008586 1999-11-03
% 210.18/210.40 |- mesh__recordMaintainer mesh__D008586 KEV
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D008586 sjn
% 210.18/210.40 |- skos__altLabel mesh__D008586 Meningitis, Pneumococcal, Experimental
% 210.18/210.40 |- skos__hiddenLabel mesh__D008586 Meningitides, Streptococcus pneumoniae
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008586 2005
% 210.18/210.40 |- mesh__dateCreated mesh__D008586 1999-01-01
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D008586 2000
% 210.18/210.40 |- skos__broader mesh__D008586smesh__D011008
% 210.18/210.40 |- mesh__dateRevised mesh__D013720 2005-06-30
% 210.18/210.40 |- mesh__historyNote mesh__D013720
% 210.18/210.40 91%28%75%29%; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%A%
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D013720
% 210.18/210.40 91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90
% 210.18/210.40 |- rdf__type mesh__D013720sskos__Concept
% 210.18/210.40 |- mesh__recordMaintainer mesh__D013720 ssb
% 210.18/210.40 |- mesh__dateEstablished mesh__D013720 1991-01-01
% 210.18/210.40 |- skos__prefLabel mesh__D013720 Tenuazonic Acid
% 210.18/210.40 |- skos__annotation mesh__D013720 an antineoplastic antibiotic
% 210.18/210.40 |- mesh__recordOriginator mesh__D013720 NLM
% 210.18/210.40 |- mesh__dateCreated mesh__D013720 1974-11-19
% 210.18/210.40 |- skos__broader mesh__D013720smesh__D009183
% 210.18/210.40 |- skos__historyNote mesh__D013720 Pyrrolidinones %28%1971-1974%29%
% 210.18/210.40 |- skos__scopeNote mesh__D013720
% 210.18/210.40 3-Acetyl-5-sec-butyl-4-hydroxy-3-pyrrolin-2-one. A metabolite found in a strain of the fungus Alternaria tenuis Auct. which functions as an antibiotic with antiviral and antineoplastic properties, and may also act as a mycotoxin.%A%
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D013720 sjn
% 210.18/210.40 |- skos__hiddenLabel mesh__D013720 Acid, Tenuazonic
% 210.18/210.40 |- skos__broader mesh__D013720smesh__D011760
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D013720 2006
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004994 2006
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004994 2000
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D004994
% 210.18/210.40 68; was ETHICS, PHARMACEUTICAL 1963-67
% 210.18/210.40 |- skos__annotation mesh__D004994
% 210.18/210.40 specify geog if pertinent; DF: ETHICS PHARM
% 210.18/210.40 |- skos__hiddenLabel mesh__D004994 Ethic, Pharmaceutic
% 210.18/210.40 |- skos__altLabel mesh__D004994 Ethics, Pharmaceutic
% 210.18/210.40 |- skos__scopeNote mesh__D004994
% 210.18/210.40 The principles of proper professional conduct concerning the rights and duties of the pharmacist, relations with patients and fellow practitioners, as well as actions of the pharmacist in health care and interpersonal relations with patient families. %28%From Stedman, 25th ed%29%%A%
% 210.18/210.40 |- mesh__dateEstablished mesh__D004994 1968-01-01
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004994 2001
% 210.18/210.40 |- skos__prefLabel mesh__D004994 Ethics, Pharmacy
% 210.18/210.40 |- skos__hiddenLabel mesh__D004994 Pharmaceutic Ethic
% 210.18/210.40 |- mesh__recordMaintainer mesh__D004994 adp
% 210.18/210.40 |- skos__altLabel mesh__D004994 Pharmacy Ethics
% 210.18/210.40 |- mesh__historyNote mesh__D004994
% 210.18/210.40 68; was ETHICS, PHARMACEUTICAL 1963-67
% 210.18/210.40 |- skos__hiddenLabel mesh__D004994 Pharmaceutical Ethic
% 210.18/210.40 |- skos__altLabel mesh__D004994 Ethics, Pharmaceutical
% 210.18/210.40 |- rdf__type mesh__D004994sskos__Concept
% 210.18/210.40 |- mesh__dateRevised mesh__D004994 1999-11-08
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004994 2002
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D004994 sjn
% 210.18/210.40 |- mesh__recordOriginator mesh__D004994 NLM
% 210.18/210.40 |- skos__broader mesh__D004994smesh__D004995
% 210.18/210.40 |- mesh__dateCreated mesh__D004994 1999-01-01
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004994 2003
% 210.18/210.40 |- skos__hiddenLabel mesh__D004994 Ethic, Pharmacy
% 210.18/210.40 |- skos__hiddenLabel mesh__D004994 Ethic, Pharmaceutical
% 210.18/210.40 |- skos__altLabel mesh__D004994 Pharmaceutical Ethics
% 210.18/210.40 |- skos__altLabel mesh__D004994 Pharmaceutic Ethics
% 210.18/210.40 |- skos__hiddenLabel mesh__D004994 Pharmacy Ethic
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004994 2005
% 210.18/210.40 |- mesh__onlineNote mesh__D004994
% 210.18/210.40 use ETHICS, PHARMACY to search ETHICS, PHARMACEUTICAL 1966-67%A%
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004994 2004
% 210.18/210.40 |- mesh__dateRevised mesh__D045802 2005-06-30
% 210.18/210.40 |- skos__broader mesh__D045802smesh__D009174
% 210.18/210.40 |- mesh__recordMaintainer mesh__D045802 SYSTEM
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D045802 2004
% 210.18/210.40 |- skos__scopeNote mesh__D045802
% 210.18/210.40 A species of gram-negative bacteria originally isolated from the LUNGS; TRACHEA; and NASAL CAVITY of SHEEP. It causes chronic interstitial pneumonia %28%PNEUMONIA, MYCOPLASMA%29% in both SHEEP and GOATS.%A%
% 210.18/210.40 |- skos__annotation mesh__D045802
% 210.18/210.40 infection: coord IM with PNEUMONIA, MYCOPLASMA/vet %28%IM%29%
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D045802 sjn
% 210.18/210.40 |- rdf__type mesh__D045802sskos__Concept
% 210.18/210.40 |- mesh__historyNote mesh__D045802 2004
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D045802 2006
% 210.18/210.40 |- mesh__recordOriginator mesh__D045802 ags
% 210.18/210.40 |- mesh__dateEstablished mesh__D045802 2004-01-01
% 210.18/210.40 |- skos__historyNote mesh__D045802 Mycoplasma %28%1975-2003%29%
% 210.18/210.40 |- mesh__dateCreated mesh__D045802 2003-07-09
% 210.18/210.40 |- skos__prefLabel mesh__D045802 Mycoplasma ovipneumoniae
% 210.18/210.40 |- skos__hiddenLabel mesh__D004196 Outbreak, Disease
% 210.18/210.40 |- mesh__historyNote mesh__D004196 68%28%66%29%
% 210.18/210.40 |- skos__altLabel mesh__D004196 Outbreaks
% 210.18/210.40 |- skos__annotation mesh__D004196
% 210.18/210.40 IM; coord IM with specific dis /epidemiol %28%IM%29% %26% specify geog%A%
% 210.18/210.40 |- mesh__dateEstablished mesh__D004196 1968-01-01
% 210.18/210.40 |- skos__hiddenLabel mesh__D004196 Disease Outbreak
% 210.18/210.40 |- skos__scopeNote mesh__D004196
% 210.18/210.40 Sudden increase in the incidence of a disease. The concept includes epidemics and pandemics.%A%
% 210.18/210.40 |- skos__hiddenLabel mesh__D004196 Pandemic
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D004196 ags
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004196 2006
% 210.18/210.40 |- skos__hiddenLabel mesh__D004196 Outbreaks, Disease
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004196 2006A
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004196 2005
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004196 2002
% 210.18/210.40 |- skos__related mesh__D004196smesh__D003141
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004196 2004
% 210.18/210.40 |- mesh__recordMaintainer mesh__D004196 ags
% 210.18/210.40 |- skos__hiddenLabel mesh__D004196 Epidemic
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004196 2001
% 210.18/210.40 |- mesh__recordOriginator mesh__D004196 NLM
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004196 2003
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D004196 68
% 210.18/210.40 |- mesh__dateRevised mesh__D004196 2005-11-10
% 210.18/210.40 |- rdf__type mesh__D004196sskos__Concept
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D004196 2000
% 210.18/210.40 |- skos__prefLabel mesh__D004196 Disease Outbreaks
% 210.18/210.40 |- mesh__dateCreated mesh__D004196 1999-01-01
% 210.18/210.40 |- skos__broader mesh__D004196smesh__D011634
% 210.18/210.40 |- skos__broader mesh__D013587Q000151smesh__D013587
% 210.18/210.40 |- mesh__preferredCombination mesh__D013587Q000151smesh__D013590
% 210.18/210.40 |- rdf__type mesh__D013587Q000151smesh__CompoundConcept
% 210.18/210.40 |- skos__hiddenLabel mesh__D012628 Seborrheic Dermatitides
% 210.18/210.40 |- mesh__dateCreated mesh__D012628 1999-01-01
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D012628 2005
% 210.18/210.40 |- skos__broader mesh__D012628smesh__D003872
% 210.18/210.40 |- mesh__publicMeSHNote mesh__D012628 93; was SEBORRHEA 1963-92
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D012628 2003
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D012628 2006
% 210.18/210.40 |- mesh__dateRevised mesh__D012628 2001-07-25
% 210.18/210.40 |- mesh__recordAuthorizer mesh__D012628 sjn
% 210.18/210.40 |- skos__prefLabel mesh__D012628 Dermatitis, Seborrheic
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D012628 2002
% 210.18/210.40 |- mesh__activeMeSHYear mesh__D012628 2004
% 210.18/210.40 |- rdf__type mesh__D012628sskos__Concept
% 210.18/210.40 |- skos__broader mesh__D012628smesh__D017444
% 210.18/210.40 |- skos__broader mesh__D012628smesh__D012625
% 210.18/210.40 |- skos__hiddenLabel mesh__D012628 Seborrheic Dermatitis
% 210.18/210.40 |- skos__scopeNote mesh__D012628
% 210.18/210.40 A chronic inflammatory disease of the skin of unknown etiology. It is characterized by moderate erythema, dry, moist, or greasy scaling, and yellow crusted patches on various areas, especially the scalp. On the scalp, it generally appears first as small patches of scales, progressing to involve the entire scalp with exfoliation of excessive amounts of dry scales %28%dandruff%29%.%A%
% 210.18/210.41 |- skos__hiddenLabel mesh__D012628 Dermatitides, Seborrheic
% 210.18/210.41 |- mesh__onlineNote mesh__D012628
% 210.18/210.41 use DERMATITIS, SEBORRHEIC to search SEBORRHEA 1966-92
% 210.18/210.41 |- skos__broader mesh__D012628smesh__D017443
% 210.18/210.41 |- mesh__recordMaintainer mesh__D012628 lkt
% 210.18/210.41 |- mesh__recordOriginator mesh__D012628 NLM
% 210.18/210.41 |- skos__altLabel mesh__D012628 Seborrhea
% 210.18/210.41 |- mesh__historyNote mesh__D012628 93; was SEBORRHEA 1963-92
% 210.18/210.41 |- mesh__recordMaintainer mesh__D017313 ssb
% 210.18/210.41 |- skos__altLabel mesh__D017313 N-%28%4-Hydroxyphenyl%29%retinamide
% 210.18/210.41 |- skos__altLabel mesh__D017313 4-HPR
% 210.18/210.41 |- mesh__dateRevised mesh__D017313 2005-06-30
% 210.18/210.41 |- skos__scopeNote mesh__D017313
% 210.18/210.41 A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.%A%
% 210.18/210.41 |- skos__historyNote mesh__D017313
% 210.18/210.41 Tretinoin/analogs %26% derivatives %28%1979-1992%29%
% 210.18/210.41 |- mesh__publicMeSHNote mesh__D017313
% 210.18/210.41 93; FENRETINIDE was indexed under TRETINOIN/analogs %26% derivatives 1979-92%A%
% 210.18/210.41 |- mesh__historyNote mesh__D017313
% 210.18/210.41 93; was FENRETINIDE %28%NM%29% 1979-92
% 210.18/210.41 |- skos__altLabel mesh__D017313 Fenretinimide
% 210.18/210.41 |- skos__hiddenLabel mesh__D017313 MCNR1967
% 210.18/210.41 |- mesh__recordOriginator mesh__D017313 TPW
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D017313 2006
% 210.18/210.41 |- mesh__dateCreated mesh__D017313 1992-05-19
% 210.18/210.41 |- skos__hiddenLabel mesh__D017313 MCN R 1967
% 210.18/210.41 |- skos__hiddenLabel mesh__D017313 Fenretinide, 13 cis Isomer
% 210.18/210.41 |- skos__hiddenLabel mesh__D017313 13-cis-Isomer Fenretinide
% 210.18/210.41 |- skos__prefLabel mesh__D017313 Fenretinide
% 210.18/210.41 |- mesh__recordAuthorizer mesh__D017313 sjn
% 210.18/210.41 |- skos__broader mesh__D017313smesh__D012176
% 210.18/210.41 |- mesh__dateEstablished mesh__D017313 1993-01-01
% 210.18/210.41 |- skos__hiddenLabel mesh__D017313 4 Hydroxyphenylretinamide
% 210.18/210.41 |- mesh__onlineNote mesh__D017313
% 210.18/210.41 use FENRETINIDE %28%NM%29% to search FENRETINIDE 1979-92
% 210.18/210.41 |- rdf__type mesh__D017313sskos__Concept
% 210.18/210.41 |- skos__altLabel mesh__D017313 4-Hydroxyphenylretinamide
% 210.18/210.41 |- skos__broader mesh__D008587smesh__D014777
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D008587 2002
% 210.18/210.41 |- mesh__dateRevised mesh__D008587 2001-08-03
% 210.18/210.41 |- mesh__recordMaintainer mesh__D008587 sjn
% 210.18/210.41 |- skos__altLabel mesh__D008587 Viral Meningitis
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D008587 2006
% 210.18/210.41 |- mesh__recordAuthorizer mesh__D008587 sjn
% 210.18/210.41 |- skos__scopeNote mesh__D008587
% 210.18/210.41 Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp1-3%29%%A%
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D008587 2005
% 210.18/210.41 |- skos__hiddenLabel mesh__D008587 Meningitides, Viral
% 210.18/210.41 |- mesh__recordOriginator mesh__D008587 NLM
% 210.18/210.41 |- skos__broader mesh__D008587smesh__D008581
% 210.18/210.41 |- rdf__type mesh__D008587sskos__Concept
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D008587 2004
% 210.18/210.41 |- skos__annotation mesh__D008587
% 210.18/210.41 coord IM with specific virus dis %28%IM%29%
% 210.18/210.41 |- skos__prefLabel mesh__D008587 Meningitis, Viral
% 210.18/210.41 |- skos__hiddenLabel mesh__D008587 Viral Meningitides
% 210.18/210.41 |- skos__broader mesh__D008587smesh__D020805
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D008587 2003
% 210.18/210.41 |- mesh__dateCreated mesh__D008587 1999-01-01
% 210.18/210.41 |- skos__broader mesh__D027741smesh__D027722
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D027741 2002
% 210.18/210.41 |- mesh__dateCreated mesh__D027741 2001-07-25
% 210.18/210.41 |- skos__annotation mesh__D027741
% 210.18/210.41 for morning glory check whether it is IPOMOEA or CONVOLVULUS; specify Plant Components; for /Chem crd with D tree compound and/or Preparation; for therap. coordinate with Food or Toxicity or Diseases and PHYTOTHERAPY%A%
% 210.18/210.41 |- rdf__type mesh__D027741sskos__Concept
% 210.18/210.41 |- skos__prefLabel mesh__D027741 Ipomoea
% 210.18/210.41 |- mesh__publicMeSHNote mesh__D027741 2002
% 210.18/210.41 |- skos__scopeNote mesh__D027741
% 210.18/210.41 A plant genus in the family CONVOLVULACEAE best known for morning glories %28%a common name also used with CONVOLVULUS%29% and sweet potato.%A%
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D027741 2003
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D027741 2005
% 210.18/210.41 |- mesh__dateEstablished mesh__D027741 2002-01-01
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D027741 2004
% 210.18/210.41 |- skos__related mesh__D027741smesh__D027742
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D027741 2006
% 210.18/210.41 |- mesh__historyNote mesh__D027741 2002
% 210.18/210.41 |- skos__annotation mesh__D013721
% 210.18/210.41 a chemosterilant %26% alkylating antineoplastic
% 210.18/210.41 |- skos__historyNote mesh__D013721 Chemosterilants %28%1966-1971%29%
% 210.18/210.41 |- mesh__dateCreated mesh__D013721 1999-01-01
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D013721 2006
% 210.18/210.41 |- rdf__type mesh__D013721sskos__Concept
% 210.18/210.41 |- mesh__dateEstablished mesh__D013721 1991-01-01
% 210.18/210.41 |- mesh__activeMeSHYear mesh__D013721 2003
% 210.18/210.41 |- mesh__recordOriginator mesh__D013721 NLM
% 210.18/210.41 |- mesh__historyNote mesh__D013721
% 210.18/210.41 96; was TEPA 1972-95 %28%see under AZIRINES 1972-90%29%
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013721 2002
% 210.27/210.41 |- skos__prefLabel mesh__D013721 Triethylenephosphoramide
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013721 2004
% 210.27/210.41 |- skos__altLabel mesh__D013721 TEPA
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D013721
% 210.27/210.41 96; was TEPA 1972-95 %28%see under AZIRINES 1972-90%29%
% 210.27/210.41 |- skos__broader mesh__D013721smesh__D001388
% 210.27/210.41 |- mesh__recordMaintainer mesh__D013721 jmp
% 210.27/210.41 |- skos__scopeNote mesh__D013721
% 210.27/210.41 An insect chemosterilant and an antineoplastic agent.
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D013721 sjn
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013721 2000
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013721 2005
% 210.27/210.41 |- mesh__dateRevised mesh__D013721 1999-11-03
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013721 2001
% 210.27/210.41 |- skos__historyNote mesh__D013721 Azirines %28%1968-1971%29%
% 210.27/210.41 |- skos__altLabel mesh__D051840
% 210.27/210.41 Nuclease Sensitive Element Binding Protein 1
% 210.27/210.41 |- skos__prefLabel mesh__D051840 Y-Box-Binding Protein 1
% 210.27/210.41 |- mesh__dateEstablished mesh__D051840 2006-01-01
% 210.27/210.41 |- skos__hiddenLabel mesh__D051840 Y Box Binding Protein YB 1
% 210.27/210.41 |- skos__altLabel mesh__D051840 Y-Box Protein-1
% 210.27/210.41 |- skos__hiddenLabel mesh__D051840 Y Box Binding Protein 1
% 210.27/210.41 |- mesh__historyNote mesh__D051840 2006%28%1984%29%
% 210.27/210.41 |- mesh__recordOriginator mesh__D051840 DRC
% 210.27/210.41 |- mesh__dateCreated mesh__D051840 2005-06-30
% 210.27/210.41 |- skos__altLabel mesh__D051840 NSEP1 Transcription Factor
% 210.27/210.41 |- rdf__type mesh__D051840sskos__Concept
% 210.27/210.41 |- skos__hiddenLabel mesh__D051840 Y Box Protein 1
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D051840 2006
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D051840 sjn
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D051840
% 210.27/210.41 2006; Y-BOX-BINDING PROTEIN 1 was indexed under TRANSCRIPTION FACTORS 1984-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2005, %26% under DNA-BINDING PROTEINS 1986-2004%A%
% 210.27/210.41 |- mesh__recordMaintainer mesh__D051840 DRC
% 210.27/210.41 |- skos__broader mesh__D051840smesh__D022762
% 210.27/210.41 |- skos__altLabel mesh__D051840 DNA Binding Protein B
% 210.27/210.41 |- skos__hiddenLabel mesh__D051840 Transcription Factor, NSEP1
% 210.27/210.41 |- skos__scopeNote mesh__D051840
% 210.27/210.41 Y-box-binding protein 1 was originally identified as a DNA-binding protein that interacts with Y-box PROMOTER REGIONS of MHC CLASS II GENES. It is a highly conserved transcription factor that regulates expression of a wide variety of GENES.%A%
% 210.27/210.41 |- skos__altLabel mesh__D051840 Y-Box Binding Protein YB-1
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D004995 sjn
% 210.27/210.41 |- skos__historyNote mesh__D004995 Ethics %28%1966-1967%29%
% 210.27/210.41 |- mesh__historyNote mesh__D004995 68
% 210.27/210.41 |- mesh__recordOriginator mesh__D004995 NLM
% 210.27/210.41 |- mesh__dateCreated mesh__D004995 1999-01-01
% 210.27/210.41 |- skos__prefLabel mesh__D004995 Ethics, Professional
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D004995 2003
% 210.27/210.41 |- mesh__recordMaintainer mesh__D004995 jrf
% 210.27/210.41 |- skos__scopeNote mesh__D004995
% 210.27/210.41 The principles of proper conduct concerning the rights and duties of the professional, relations with patients or consumers and fellow practitioners, as well as actions of the professional and interpersonal relations with patient or consumer families. %28%From Stedman, 25th ed%29%%A%
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D004995 2006
% 210.27/210.41 |- skos__annotation mesh__D004995 specify geog if pertinent
% 210.27/210.41 |- skos__hiddenLabel mesh__D004995 Ethic, Professional
% 210.27/210.41 |- skos__broader mesh__D004995smesh__D004989
% 210.27/210.41 |- skos__related mesh__D004995smesh__D028743
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D004995 2002
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D004995 2005
% 210.27/210.41 |- mesh__dateRevised mesh__D004995 2001-07-25
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D004995 68
% 210.27/210.41 |- rdf__type mesh__D004995sskos__Concept
% 210.27/210.41 |- mesh__dateEstablished mesh__D004995 1968-01-01
% 210.27/210.41 |- skos__hiddenLabel mesh__D004995 Professional Ethic
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D004995 2004
% 210.27/210.41 |- skos__altLabel mesh__D004995 Professional Ethics
% 210.27/210.41 |- skos__hiddenLabel mesh__D051042
% 210.27/210.41 Formimino L Glutamate Tetrahydrofolate 5 Formiminotransferase
% 210.27/210.41 |- rdf__type mesh__D051042sskos__Concept
% 210.27/210.41 |- mesh__recordMaintainer mesh__D051042 ags
% 210.27/210.41 |- mesh__recordOriginator mesh__D051042 AKE
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D051042
% 210.27/210.41 2006; GLUTAMATE FORMIMIDOYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1980-2005, FORMIMINOGLUTAMIC ACID 1977-1980, TRANSFERASES 1975-1997, GLUTAMATES 1975-1977, %26% under FORMIC ACIDS %26% IMINES 1975-1976%A%
% 210.27/210.41 |- skos__scopeNote mesh__D051042
% 210.27/210.41 A PYRIDOXAL PHOSPHATE-containing enzyme that catalyzes the transfer of a formyl group from L-GLUTAMATE to N-formimidoyl-L-glutamate and TETRAHYDROFOLATE. This enzyme may also catalyze formyl transfer from 5-formyltetrahydrofolate to L-GLUTAMATE. This enzyme was formerly categorized as EC 2.1.2.6.%A%
% 210.27/210.41 |- skos__hiddenLabel mesh__D051042 Transferase, Formimino
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D051042 ags
% 210.27/210.41 |- skos__altLabel mesh__D051042 Formimino Transferase
% 210.27/210.41 |- mesh__dateCreated mesh__D051042 2005-06-30
% 210.27/210.41 |- skos__hiddenLabel mesh__D051042 Formiminotransferase, Glutamate
% 210.27/210.41 |- skos__hiddenLabel mesh__D051042 Formyltransferase, Glutamate
% 210.27/210.41 |- skos__hiddenLabel mesh__D051042 Formimidoyltransferase, Glutamate
% 210.27/210.41 |- skos__altLabel mesh__D051042
% 210.27/210.41 Formimino-L-Glutamate Tetrahydrofolate 5-Formiminotransferase
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D051042 2006
% 210.27/210.41 |- skos__hiddenLabel mesh__D051042
% 210.27/210.41 Tetrahydrofolate 5-Formiminotransferase, Formimino-L-Glutamate
% 210.27/210.41 |- skos__hiddenLabel mesh__D051042
% 210.27/210.41 5-Formiminotransferase, Formimino-L-Glutamate Tetrahydrofolate
% 210.27/210.41 |- skos__prefLabel mesh__D051042 Glutamate Formimidoyltransferase
% 210.27/210.41 |- skos__hiddenLabel mesh__D051042 Transferase, Formiminotetrahydrofolate
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D051042 2006A
% 210.27/210.41 |- mesh__dateRevised mesh__D051042 2005-07-14
% 210.27/210.41 |- skos__altLabel mesh__D051042 Glutamate Formiminotransferase
% 210.27/210.41 |- skos__altLabel mesh__D051042 Glutamate Formyltransferase
% 210.27/210.41 |- mesh__historyNote mesh__D051042
% 210.27/210.41 2006%28%1980%29%; use FORMIMINOGLUTAMIC ACID 1977-1980, TRANSFERASES 1975-1997, GLUTAMATES 1975-1977, FORMIC ACIDS %26% IMINES 1975-1976%A%
% 210.27/210.41 |- mesh__dateEstablished mesh__D051042 2006-01-01
% 210.27/210.41 |- skos__broader mesh__D051042smesh__D019877
% 210.27/210.41 |- skos__altLabel mesh__D051042 Formiminotetrahydrofolate Transferase
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D045803 sjn
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D045803 2004
% 210.27/210.41 |- mesh__historyNote mesh__D045803 2004
% 210.27/210.41 |- skos__scopeNote mesh__D045803
% 210.27/210.41 A species of gram-negative bacteria highly pathogenic to RATS and MICE. It is the primary cause of murine respiratory mycoplasmosis.%A%
% 210.27/210.41 |- skos__historyNote mesh__D045803 Mycoplasma %28%1965-2003%29%
% 210.27/210.41 |- mesh__recordOriginator mesh__D045803 ags
% 210.27/210.41 |- skos__broader mesh__D045803smesh__D009174
% 210.27/210.41 |- skos__annotation mesh__D045803
% 210.27/210.41 infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%
% 210.27/210.41 |- mesh__dateRevised mesh__D045803 2005-06-30
% 210.27/210.41 |- mesh__dateEstablished mesh__D045803 2004-01-01
% 210.27/210.41 |- mesh__recordMaintainer mesh__D045803 SYSTEM
% 210.27/210.41 |- rdf__type mesh__D045803sskos__Concept
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D045803 2006
% 210.27/210.41 |- mesh__dateCreated mesh__D045803 2003-07-09
% 210.27/210.41 |- skos__prefLabel mesh__D045803 Mycoplasma pulmonis
% 210.27/210.41 |- skos__prefLabel mesh__D004197 Disease Reservoirs
% 210.27/210.41 |- skos__annotation mesh__D004197
% 210.27/210.41 IM; note category; differentiate from DISEASE VECTORS %28%B1 %26% B2%29%: reservoirs can be animate or inanimate %28%like swamps, housedust, etc.%29%%A%
% 210.27/210.41 |- skos__related mesh__D004197smesh__D002353
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D004197 sjn
% 210.27/210.41 |- mesh__dateEstablished mesh__D004197 1967-01-01
% 210.27/210.41 |- mesh__recordOriginator mesh__D004197 NLM
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D004197 67
% 210.27/210.41 |- skos__hiddenLabel mesh__D004197 Reservoir, Disease
% 210.27/210.41 |- skos__scopeNote mesh__D004197
% 210.27/210.41 Animate or inanimate sources which harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs should be distinguished from vectors and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks.%A%
% 210.27/210.41 |- skos__broader mesh__D004197smesh__D011634
% 210.27/210.41 |- mesh__recordMaintainer mesh__D004197 ags
% 210.27/210.41 |- mesh__historyNote mesh__D004197 67%28%65%29%
% 210.27/210.41 |- rdf__type mesh__D004197sskos__Concept
% 210.27/210.41 |- skos__hiddenLabel mesh__D004197 Disease Reservoir
% 210.27/210.41 |- mesh__dateCreated mesh__D004197 1999-01-01
% 210.27/210.41 |- skos__related mesh__D004197smesh__D004199
% 210.27/210.41 |- mesh__dateRevised mesh__D004197 2005-06-30
% 210.27/210.41 |- skos__hiddenLabel mesh__D004197 Reservoirs, Disease
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D004197 2006
% 210.27/210.41 |- mesh__dateCreated mesh__D012629 1999-01-01
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D012629 2003
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D012629 2006
% 210.27/210.41 |- mesh__recordOriginator mesh__D012629 NLM
% 210.27/210.41 |- skos__prefLabel mesh__D012629 Sebum
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D012629 2000
% 210.27/210.41 |- skos__scopeNote mesh__D012629
% 210.27/210.41 The oily substance secreted by SEBACEOUS GLANDS. It is composed of KERATIN, fat, and cellular debris.%A%
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D012629 2004
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D012629 2001
% 210.27/210.41 |- rdf__type mesh__D012629sskos__Concept
% 210.27/210.41 |- mesh__dateRevised mesh__D012629 1999-11-03
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D012629 2002
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D012629 sjn
% 210.27/210.41 |- skos__hiddenLabel mesh__D012629 Sebums
% 210.27/210.41 |- mesh__recordMaintainer mesh__D012629 KEV
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D012629 2005
% 210.27/210.41 |- skos__broader mesh__D012629smesh__D012634
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1992
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1999
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 2001
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 2004
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D009680 74
% 210.27/210.41 |- skos__prefLabel mesh__D009680 Nuclear Fission
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1995
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1998
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 2000
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 2003
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1991
% 210.27/210.41 |- mesh__dateRevised mesh__D009680 1989-06-14
% 210.27/210.41 |- mesh__recordOriginator mesh__D009680 NLM
% 210.27/210.41 |- mesh__historyNote mesh__D009680
% 210.27/210.41 74%28%71%29%; was in Cat H only 1971-81
% 210.27/210.41 |- skos__scopeNote mesh__D009680
% 210.27/210.41 Nuclear reaction in which the nucleus of a heavy atom such as uranium or plutonium is split into two approximately equal parts by a neutron, charged particle, or photon.%A%
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1994
% 210.27/210.41 |- mesh__recordMaintainer mesh__D009680 TGC
% 210.27/210.41 |- mesh__dateCreated mesh__D009680 1999-01-01
% 210.27/210.41 |- skos__hiddenLabel mesh__D009680 Fission, Nuclear
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 2006
% 210.27/210.41 |- skos__hiddenLabel mesh__D009680 Nuclear Fissions
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D009680 PLS
% 210.27/210.41 |- mesh__dateEstablished mesh__D009680 1974-01-01
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1997
% 210.27/210.41 |- skos__broader mesh__D009680smesh__D009678
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 2002
% 210.27/210.41 |- skos__hiddenLabel mesh__D009680 Fissions, Nuclear
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1990
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 2005
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1993
% 210.27/210.41 |- skos__annotation mesh__D009680
% 210.27/210.41 no qualif; do not confuse with NUCLEAR FUSION
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D009680 1996
% 210.27/210.41 |- skos__historyNote mesh__D009680 Nuclear Energy %28%1966-1970%29%
% 210.27/210.41 |- rdf__type mesh__D009680sskos__Concept
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D017314 2006
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D017314 sjn
% 210.27/210.41 |- skos__prefLabel mesh__D017314 Annexin A4
% 210.27/210.41 |- mesh__dateCreated mesh__D017314 1992-05-07
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D017314
% 210.27/210.41 1993; ANNEXIN IV were indexed under PREGNANCY PROTEINS 1987-1992; LIPOCORTIN IV was indexed under CALCIUM-BINDING PROTEINS 1982-1992; ANNEXIN A4 was indexed under ANNEXIN IV 2004%A%
% 210.27/210.41 |- skos__scopeNote mesh__D017314
% 210.27/210.41 Protein of the annexin family originally isolated from the electric organ of the electric ray Torpedo marmorata. It has been found in a wide range of mammalian tissue where it is localized to the apical membrane of polarized EPITHELIAL CELLS.%A%
% 210.27/210.41 |- skos__historyNote mesh__D017314
% 210.27/210.41 Calcium-Binding Proteins %28%1982-1992%29%
% 210.27/210.41 |- skos__hiddenLabel mesh__D017314 Calelectrin 32 kDa
% 210.27/210.41 |- mesh__dateRevised mesh__D017314 2004-07-07
% 210.27/210.41 |- skos__hiddenLabel mesh__D017314 32-kDa, Calelectrin
% 210.27/210.41 |- mesh__recordMaintainer mesh__D017314 jmp
% 210.27/210.41 |- rdf__type mesh__D017314sskos__Concept
% 210.27/210.41 |- skos__altLabel mesh__D017314 Annexin IV
% 210.27/210.41 |- skos__altLabel mesh__D017314 Calelectrin 32-kDa
% 210.27/210.41 |- mesh__historyNote mesh__D017314
% 210.27/210.41 2005%28%1993%29%; for ANNEXIN IV use ANNEXINS 1987-1992
% 210.27/210.41 |- skos__altLabel mesh__D017314 Placental Anticoagulant Protein II
% 210.27/210.41 |- skos__altLabel mesh__D017314 Lipocortin IV
% 210.27/210.41 |- mesh__recordOriginator mesh__D017314 AGS
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D017314 2005
% 210.27/210.41 |- skos__broader mesh__D017314smesh__D017302
% 210.27/210.41 |- mesh__dateEstablished mesh__D017314 1993-01-01
% 210.27/210.41 |- skos__altLabel mesh__D008588 Herniation of Meninges
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Herniation, Meningeal
% 210.27/210.41 |- mesh__recordMaintainer mesh__D008588 KEV
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D008588 2006
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Meningoceles, Acquired
% 210.27/210.41 |- skos__broader mesh__D008588smesh__D009436
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Traumatic Meningoceles
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Meninges Herniations
% 210.27/210.41 |- skos__prefLabel mesh__D008588 Meningocele
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D008588 2005
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Meningoceles, Rudimentary
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D008588 2002
% 210.27/210.41 |- skos__scopeNote mesh__D008588
% 210.27/210.41 A congenital or acquired protrusion of the meninges, unaccompanied by neural tissue, through a bony defect in the skull or vertebral column.%A%
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Rudimentary Meningoceles
% 210.27/210.41 |- mesh__dateRevised mesh__D008588 1999-11-03
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D008588 sjn
% 210.27/210.41 |- rdf__type mesh__D008588sskos__Concept
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D008588 2004
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D008588 2001
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Meningocele, Rudimentary
% 210.27/210.41 |- skos__altLabel mesh__D008588 Meningeal Herniation
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Acquired Meningoceles
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Meningeal Herniations
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Meningocele, Acquired
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D008588 2003
% 210.27/210.41 |- skos__annotation mesh__D008588
% 210.27/210.41 meningoencephalocele: coord IM with ENCEPHALOCELE %28%IM%29%
% 210.27/210.41 |- mesh__dateCreated mesh__D008588 1999-01-01
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Herniations, Meningeal
% 210.27/210.41 |- mesh__recordOriginator mesh__D008588 NLM
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D008588 2000
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Meninges Herniation
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Meningoceles, Traumatic
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Traumatic Meningocele
% 210.27/210.41 |- skos__hiddenLabel mesh__D008588 Meningoceles
% 210.27/210.41 |- rdf__type mesh__D027742sskos__Concept
% 210.27/210.41 |- skos__historyNote mesh__D027742 Liliaceae %28%1998-2001%29%
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D027742 2002; see Liliaceae 1998-2001
% 210.27/210.41 |- skos__broader mesh__D027742smesh__D027743
% 210.27/210.41 |- skos__annotation mesh__D027742
% 210.27/210.41 do not confuse X ref YAM with PSEUDO-YAM see IPOMOEA BATATAS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.27/210.41 |- mesh__historyNote mesh__D027742 2002; use Liliaceae 1998-2001
% 210.27/210.41 |- mesh__dateCreated mesh__D027742 2001-07-25
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D027742 ags
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D027742 2006A
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D027742 2005
% 210.27/210.41 |- mesh__recordOriginator mesh__D027742 ssb
% 210.27/210.41 |- mesh__dateEstablished mesh__D027742 2002-01-01
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D027742 2006
% 210.27/210.41 |- skos__scopeNote mesh__D027742
% 210.27/210.41 A plant genus best known for edible underground tubers. Yam may also refer to a moist variety of sweet potato, IPOMOEA BATATAS.%A%
% 210.27/210.41 |- skos__related mesh__D027742smesh__D027741
% 210.27/210.41 |- mesh__recordMaintainer mesh__D027742 ags
% 210.27/210.41 |- mesh__dateRevised mesh__D027742 2005-07-27
% 210.27/210.41 |- skos__prefLabel mesh__D027742 Dioscorea
% 210.27/210.41 |- mesh__recordOriginator mesh__D005290 NLM
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D005290 2004
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D005290 SJN
% 210.27/210.41 |- rdf__type mesh__D005290sskos__Concept
% 210.27/210.41 |- skos__broader mesh__D005290smesh__D017614
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D005290 2001
% 210.27/210.41 |- mesh__dateRevised mesh__D005290 1997-06-20
% 210.27/210.41 |- mesh__onlineNote mesh__D005290
% 210.27/210.41 use IRON to search FERRIC AND FERROUS COMPOUNDS 1966-74
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D005290 2003
% 210.27/210.41 |- skos__scopeNote mesh__D005290
% 210.27/210.41 Inorganic or organic compounds containing trivalent iron.%A%
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D005290 2000
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D005290
% 210.27/210.41 87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74%A%
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D005290 2006
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D005290 1999
% 210.27/210.41 |- mesh__recordMaintainer mesh__D005290 ADP
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D005290 2005
% 210.27/210.41 |- skos__prefLabel mesh__D005290 Ferric Compounds
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D005290 1998
% 210.27/210.41 |- skos__historyNote mesh__D005290 Iron %28%1966-1974%29%
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D005290 2002
% 210.27/210.41 |- mesh__historyNote mesh__D005290
% 210.27/210.41 87%28%75%29%; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74%A%
% 210.27/210.41 |- skos__hiddenLabel mesh__D005290 Compounds, Ferric
% 210.27/210.41 |- mesh__dateEstablished mesh__D005290 1987-01-01
% 210.27/210.41 |- skos__broader mesh__D005290smesh__D009942
% 210.27/210.41 |- skos__annotation mesh__D005290
% 210.27/210.41 = iron%28%III%29% or Fe%28%III%29%, as Fe2O3, FeCl3; iron%28%II%29% or Fe%28%II%29% = FERROUS COMPOUNDS; hematinics; DF: FERRIC CPDS%A%
% 210.27/210.41 |- mesh__dateCreated mesh__D005290 1975-02-04
% 210.27/210.41 |- skos__related mesh__D005290smesh__D007501
% 210.27/210.41 |- skos__historyNote mesh__D013722 Snakes %28%1966-1972%29%
% 210.27/210.41 |- skos__historyNote mesh__D013722 Oligopeptides %28%1973-1974%29%
% 210.27/210.41 |- mesh__dateEstablished mesh__D013722 1991-01-01
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013722 2003
% 210.27/210.41 |- skos__altLabel mesh__D013722 Nonapeptide-Converting Enzyme Inhibitor
% 210.27/210.41 |- mesh__dateRevised mesh__D013722 2001-07-25
% 210.27/210.41 |- skos__hiddenLabel mesh__D013722 Nonapeptide Converting Enzyme Inhibitor
% 210.27/210.41 |- skos__hiddenLabel mesh__D013722 Enzyme Inhibitor, Nonapeptide-Converting
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013722 2004
% 210.27/210.41 |- skos__scopeNote mesh__D013722
% 210.27/210.41 A synthetic nonapeptide %28%Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro%29% which is identical to the peptide from the venom of the snake, Bothrops jararaca. It inhibits kininase II and ANGIOTENSIN I and has been proposed as an antihypertensive agent.%A%
% 210.27/210.41 |- mesh__historyNote mesh__D013722
% 210.27/210.41 91%28%81%29%; was see under OLIGOPEPTIDES 1981-90, was SQ 20881 see under OLIGOPEPTIDES 1975-80; SQ 20881 was see TEPROTIDE 1981-93; NONAPEPTIDE CONVERTING-ENZYME INHIBITOR was %28%NM%29% 1975-93%A%
% 210.27/210.41 |- mesh__onlineNote mesh__D013722
% 210.27/210.41 use TEPROTIDE to search SQ 20881 1975-93; use TEPROTIDE %28%NM%29% to search NONAPEPTIDE CONVERTING-ENZYME INHIBITOR 1980-93%A%
% 210.27/210.41 |- mesh__recordMaintainer mesh__D013722 ssb
% 210.27/210.41 |- skos__altLabel mesh__D013722 BPP-9a
% 210.27/210.41 |- skos__broader mesh__D013722smesh__D009842
% 210.27/210.41 |- skos__hiddenLabel mesh__D013722 Bradykinin Potentiating Peptide 9a
% 210.27/210.41 |- mesh__recordOriginator mesh__D013722 NLM
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013722 2002
% 210.27/210.41 |- skos__historyNote mesh__D013722 Peptides %28%1966-1972%29%
% 210.27/210.41 |- mesh__dateCreated mesh__D013722 1974-11-19
% 210.27/210.41 |- mesh__publicMeSHNote mesh__D013722
% 210.27/210.41 91; was see under OLIGOPEPTIDES 1981-90, was SQ 20881 see under OLIGOPEPTIDES 1975-80; SQ 20881 was see TEPROTIDE 1981-93; NONAPEPTIDE CONVERTING-ENZYME INHIBITOR was indexed under OLIGOPEPTIDES 1975-93%A%
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013722 2005
% 210.27/210.41 |- skos__hiddenLabel mesh__D013722 Peptide 9a, Bradykinin-Potentiating
% 210.27/210.41 |- skos__prefLabel mesh__D013722 Teprotide
% 210.27/210.41 |- mesh__recordAuthorizer mesh__D013722 sjn
% 210.27/210.41 |- rdf__type mesh__D013722sskos__Concept
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D013722 2006
% 210.27/210.41 |- skos__altLabel mesh__D013722 Bradykinin-Potentiating Peptide 9a
% 210.27/210.41 |- mesh__recordMaintainer mesh__D051841 DRC
% 210.27/210.41 |- mesh__recordOriginator mesh__D051841 DRC
% 210.27/210.41 |- skos__scopeNote mesh__D051841
% 210.27/210.41 A transcription factor that takes part in the NF-kappa-B complex by interacting with NF-KAPPA B P50 SUBUNIT or NF-KAPPA B P52 SUBUNIT. It regulates GENETIC TRANSCRIPTION that is involved in immune and inflammatory responses.%A%
% 210.27/210.41 |- mesh__dateEstablished mesh__D051841 2006-01-01
% 210.27/210.41 |- mesh__historyNote mesh__D051841 2006%28%1992%29%
% 210.27/210.41 |- skos__hiddenLabel mesh__D051841 Rel Protein, Inhibitory
% 210.27/210.41 |- mesh__activeMeSHYear mesh__D051841 2006
% 210.27/210.41 |- rdf__type mesh__D051841sskos__Concept
% 210.27/210.41 |- skos__prefLabel mesh__D051841 Transcription Factor RelB
% 210.27/210.41 |- skos__altLabel mesh__D051841 Inhibitory Rel Protein
% 210.27/210.41 |- skos__broader mesh__D051841smesh__D016328
% 210.27/210.41 |- skos__altLabel mesh__D051841 Rel-Related Protein
% 210.27/210.41 |- mesh__dateCreated mesh__D051841 2005-06-30
% 210.27/210.42 |- skos__altLabel mesh__D051841
% 210.27/210.42 v-Rel Reticuloendotheliosis Viral Oncogene Homolog B
% 210.27/210.42 |- skos__hiddenLabel mesh__D051841 RelB, Transcription Factor
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D051841
% 210.27/210.42 2006; TRANSCRIPTION FACTOR RELB was indexed under PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A%
% 210.27/210.42 |- skos__hiddenLabel mesh__D051841
% 210.27/210.42 v Rel Reticuloendotheliosis Viral Oncogene Homolog B
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D051841 sjn
% 210.27/210.42 |- skos__hiddenLabel mesh__D051841 Rel Related Protein
% 210.27/210.42 |- mesh__dateRevised mesh__D004996 2000-06-22
% 210.27/210.42 |- skos__hiddenLabel mesh__D004996 Bromide, Homidium
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004996 2001
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004996 2006
% 210.27/210.42 |- mesh__historyNote mesh__D004996 74%28%72%29%
% 210.27/210.42 |- skos__historyNote mesh__D004996 Antiviral Agents %28%1966-1971%29%
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D004996 sjn
% 210.27/210.42 |- mesh__recordOriginator mesh__D004996 NLM
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004996 2005
% 210.27/210.42 |- skos__prefLabel mesh__D004996 Ethidium
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D004996 74
% 210.27/210.42 |- rdf__type mesh__D004996sskos__Concept
% 210.27/210.42 |- skos__historyNote mesh__D004996 Antiprotozoal Agents %28%1966-1971%29%
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004996 2002
% 210.27/210.42 |- skos__hiddenLabel mesh__D004996 Bromide, Ethidium
% 210.27/210.42 |- skos__altLabel mesh__D004996 Homidium Bromide
% 210.27/210.42 |- mesh__recordMaintainer mesh__D004996 TWD
% 210.27/210.42 |- skos__historyNote mesh__D004996 Phenanthridines %28%1969-1971%29%
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004996 2004
% 210.27/210.42 |- skos__scopeNote mesh__D004996
% 210.27/210.42 A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.%A%
% 210.27/210.42 |- skos__broader mesh__D004996smesh__D010617
% 210.27/210.42 |- skos__historyNote mesh__D004996 appropriate enzyme/AI %28%1968-1971%29%
% 210.27/210.42 |- mesh__dateEstablished mesh__D004996 1974-01-01
% 210.27/210.42 |- mesh__dateCreated mesh__D004996 1999-01-01
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004996 2003
% 210.27/210.42 |- skos__broader mesh__D004198smesh__D001824
% 210.27/210.42 |- mesh__dateRevised mesh__D004198 2004-07-07
% 210.27/210.42 |- skos__hiddenLabel mesh__D004198 Susceptibilities, Disease
% 210.27/210.42 |- skos__hiddenLabel mesh__D004198 Disease Susceptibilities
% 210.27/210.42 |- mesh__historyNote mesh__D004198 81; was DIATHESIS 1963-80
% 210.27/210.42 |- skos__annotation mesh__D004198 IM GEN only
% 210.27/210.42 |- mesh__recordMaintainer mesh__D004198 nns
% 210.27/210.42 |- rdf__type mesh__D004198sskos__Concept
% 210.27/210.42 |- mesh__dateCreated mesh__D004198 1999-01-01
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D004198 sjn
% 210.27/210.42 |- mesh__recordOriginator mesh__D004198 NLM
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004198 2006
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D004198 81; was DIATHESIS 1963-80
% 210.27/210.42 |- skos__broader mesh__D004198smesh__D020969
% 210.27/210.42 |- mesh__onlineNote mesh__D004198
% 210.27/210.42 use DISEASE SUSCEPTIBILITY to search DIATHESIS 1966-80
% 210.27/210.42 |- skos__scopeNote mesh__D004198
% 210.27/210.42 A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.%A%
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004198 2005
% 210.27/210.42 |- skos__hiddenLabel mesh__D004198 Diatheses
% 210.27/210.42 |- skos__altLabel mesh__D004198 Diathesis
% 210.27/210.42 |- skos__prefLabel mesh__D004198 Disease Susceptibility
% 210.27/210.42 |- skos__altLabel mesh__D004198 Susceptibility, Disease
% 210.27/210.42 |- skos__annotation mesh__D045804
% 210.27/210.42 infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D045804 sjn
% 210.27/210.42 |- mesh__recordMaintainer mesh__D045804 SYSTEM
% 210.27/210.42 |- mesh__historyNote mesh__D045804 2004
% 210.27/210.42 |- mesh__recordOriginator mesh__D045804 ags
% 210.27/210.42 |- rdf__type mesh__D045804sskos__Concept
% 210.27/210.42 |- skos__scopeNote mesh__D045804
% 210.27/210.42 A species of gram-negative bacteria strongly implicated in oral infection, PERIODONTAL DISEASES, eye and ear disorders, and SEPTIC ARTHRITIS.%A%
% 210.27/210.42 |- skos__broader mesh__D045804smesh__D009174
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D045804 2006
% 210.27/210.42 |- mesh__dateRevised mesh__D045804 2005-06-30
% 210.27/210.42 |- mesh__dateEstablished mesh__D045804 2004-01-01
% 210.27/210.42 |- mesh__dateCreated mesh__D045804 2003-07-09
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D045804 2004
% 210.27/210.42 |- skos__prefLabel mesh__D045804 Mycoplasma salivarium
% 210.27/210.42 |- skos__historyNote mesh__D045804 Mycoplasma %28%1962-2003%29%
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 2004
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 1995
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 1998
% 210.27/210.42 |- skos__annotation mesh__D009681
% 210.27/210.42 no qualif; do not confuse with NUCLEAR FISSION
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 2003
% 210.27/210.42 |- mesh__recordMaintainer mesh__D009681 NLM
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D009681
% 210.27/210.42 91; was see under NUCLEAR ENERGY 1982-90; was see under ATOMIC ENERGY 1975-81; was in Cat H only 1971-81%A%
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 1994
% 210.27/210.42 |- mesh__dateCreated mesh__D009681 1999-01-01
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 2001
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 2006
% 210.27/210.42 |- skos__prefLabel mesh__D009681 Nuclear Fusion
% 210.27/210.42 |- mesh__onlineNote mesh__D009681
% 210.27/210.42 use NUCLEAR ENERGY to search NUCLEAR FUSION 1971-74 %28%as Prov%29%%A%
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 1997
% 210.27/210.42 |- skos__broader mesh__D009681smesh__D009678
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 2000
% 210.27/210.42 |- mesh__historyNote mesh__D009681
% 210.27/210.42 91%28%71%29%; was see under NUCLEAR ENERGY 1982-90; was see under ATOMIC ENERGY 1975-81; was Prov 1971-74; was in Cat H only 1971-81%A%
% 210.27/210.42 |- mesh__recordOriginator mesh__D009681 NLM
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 1991
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 2005
% 210.27/210.42 |- skos__hiddenLabel mesh__D009681 Nuclear Fusions
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 1993
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 1996
% 210.27/210.42 |- rdf__type mesh__D009681sskos__Concept
% 210.27/210.42 |- skos__historyNote mesh__D009681 Nuclear Energy %28%1966-1970%29%
% 210.27/210.42 |- skos__scopeNote mesh__D009681
% 210.27/210.42 Thermonuclear reaction in which the nuclei of an element of low atomic weight unite under extremely high temperature and pressure to form a nucleus of a heavier atom.%A%
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 1992
% 210.27/210.42 |- mesh__dateRevised mesh__D009681 1990-06-04
% 210.27/210.42 |- skos__hiddenLabel mesh__D009681 Fusion, Nuclear
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D009681 PLS
% 210.27/210.42 |- skos__hiddenLabel mesh__D009681 Fusions, Nuclear
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 1999
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009681 2002
% 210.27/210.42 |- mesh__dateEstablished mesh__D009681 1991-01-01
% 210.27/210.42 |- skos__altLabel mesh__D017315 Ro-31-2848
% 210.27/210.42 |- mesh__historyNote mesh__D017315 93; was CILAZAPRIL %28%NM%29% 1984-92
% 210.27/210.42 |- mesh__dateEstablished mesh__D017315 1993-01-01
% 210.27/210.42 |- skos__broader mesh__D017315smesh__D011724
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D017315
% 210.27/210.42 93; CILAZAPRIL was indexed under PYRIDAZINES 1984-92
% 210.27/210.42 |- skos__hiddenLabel mesh__D017315 Hydrate, Cilazapril
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D017315 sjn
% 210.27/210.42 |- rdf__type mesh__D017315sskos__Concept
% 210.27/210.42 |- skos__prefLabel mesh__D017315 Cilazapril
% 210.27/210.42 |- skos__hiddenLabel mesh__D017315 Ro 31 2848
% 210.27/210.42 |- mesh__dateRevised mesh__D017315 2001-07-25
% 210.27/210.42 |- mesh__recordMaintainer mesh__D017315 ssb
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D017315 2005
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D017315 2002
% 210.27/210.42 |- skos__scopeNote mesh__D017315
% 210.27/210.42 One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS %28%ACE inhibitors%29% used for hypertension. It is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat.%A%
% 210.27/210.42 |- skos__historyNote mesh__D017315 Pyridazines %28%1984-1992%29%
% 210.27/210.42 |- skos__hiddenLabel mesh__D017315 Ro 312848
% 210.27/210.42 |- mesh__onlineNote mesh__D017315
% 210.27/210.42 use CILAZAPRIL %28%NM%29% to search CILAZAPRIL 1984-92
% 210.27/210.42 |- skos__hiddenLabel mesh__D017315 Ro312848
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D017315 2006
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D017315 2003
% 210.27/210.42 |- mesh__recordOriginator mesh__D017315 TPW
% 210.27/210.42 |- mesh__dateCreated mesh__D017315 1992-05-07
% 210.27/210.42 |- skos__hiddenLabel mesh__D017315 Monohydrobromide, Cilazapril
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D017315 2004
% 210.27/210.42 |- rdf__type mesh__D008589sskos__Concept
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D008589 2004
% 210.27/210.42 |- mesh__recordOriginator mesh__D008589 NLM
% 210.27/210.42 |- skos__hiddenLabel mesh__D008589 Meningococcal Infection
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D008589 2003
% 210.27/210.42 |- mesh__dateCreated mesh__D008589 1999-01-01
% 210.27/210.42 |- skos__prefLabel mesh__D008589 Meningococcal Infections
% 210.27/210.42 |- skos__altLabel mesh__D008589 Infections, Meningococcal
% 210.27/210.42 |- skos__annotation mesh__D008589
% 210.27/210.42 MENINGITIS, MENINGOCOCCAL is also available; coord IM with specific Neisseria meningitidis serogroup %28%IM%29% if given; DF: MENINGOCOCCAL INFECT%A%
% 210.27/210.42 |- mesh__recordMaintainer mesh__D008589 ags
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D008589 2006
% 210.27/210.42 |- mesh__dateRevised mesh__D008589 2002-07-03
% 210.27/210.42 |- skos__broader mesh__D008589smesh__D016870
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D008589 2005
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D008589 sjn
% 210.27/210.42 |- skos__scopeNote mesh__D008589
% 210.27/210.42 Infections with bacteria of the species NEISSERIA MENINGITIDIS.%A%
% 210.27/210.42 |- skos__hiddenLabel mesh__D008589 Infection, Meningococcal
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D027743 2005
% 210.27/210.42 |- skos__broader mesh__D027743smesh__D019684
% 210.27/210.42 |- mesh__dateRevised mesh__D027743 2003-07-09
% 210.27/210.42 |- skos__scopeNote mesh__D027743
% 210.27/210.42 The yam plant family, of the order Liliales, has thick roots or tubers and net-veined, heart-shaped leaves that sometimes are lobed.%A%
% 210.27/210.42 |- rdf__type mesh__D027743sskos__Concept
% 210.27/210.42 |- mesh__dateCreated mesh__D027743 2001-07-25
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D027743 2002
% 210.27/210.42 |- mesh__historyNote mesh__D027743 2002
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D027743 2004
% 210.27/210.42 |- mesh__recordOriginator mesh__D027743 ssb
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D027743 sjn
% 210.27/210.42 |- mesh__recordMaintainer mesh__D027743 ssb
% 210.27/210.42 |- skos__prefLabel mesh__D027743 Dioscoreaceae
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D027743 2006
% 210.27/210.42 |- mesh__dateEstablished mesh__D027743 2002-01-01
% 210.27/210.42 |- skos__annotation mesh__D027743
% 210.27/210.42 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.27/210.42 |- skos__broader mesh__D004364Q000493smesh__D004364
% 210.27/210.42 |- mesh__preferredCombination mesh__D004364Q000493smesh__D010599
% 210.27/210.42 |- rdf__type mesh__D004364Q000493smesh__CompoundConcept
% 210.27/210.42 |- mesh__recordOriginator mesh__D005291 NLM
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005291 2006
% 210.27/210.42 |- mesh__dateEstablished mesh__D005291 1991-01-01
% 210.27/210.42 |- skos__historyNote mesh__D005291 Peptides, Cyclic %28%1973-1974%29%
% 210.27/210.42 |- mesh__dateRevised mesh__D005291 2005-06-30
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D005291
% 210.27/210.42 91; was see under HYDROXAMIC ACIDS 1975-90
% 210.27/210.42 |- mesh__recordMaintainer mesh__D005291 ssb
% 210.27/210.42 |- skos__prefLabel mesh__D005291 Ferrichrome
% 210.27/210.42 |- mesh__historyNote mesh__D005291
% 210.27/210.42 91%28%75%29%; was see under HYDROXAMIC ACIDS 1975-90
% 210.27/210.42 |- skos__historyNote mesh__D005291 Iron Chelates %28%1972-1974%29%
% 210.27/210.42 |- rdf__type mesh__D005291sskos__Concept
% 210.27/210.42 |- skos__broader mesh__D005291smesh__D010456
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D005291 sjn
% 210.27/210.42 |- skos__historyNote mesh__D005291 Hydroxamic Acids %28%1972-1974%29%
% 210.27/210.42 |- skos__broader mesh__D005291smesh__D006877
% 210.27/210.42 |- mesh__dateCreated mesh__D005291 1974-11-19
% 210.27/210.42 |- skos__scopeNote mesh__D005291
% 210.27/210.42 A cyclic peptide consisting of three residues of delta-N-hydroxy-delta-N-acetylornithine. It acts as an iron transport agent in Ustilago sphaerogena.%A%
% 210.27/210.42 |- skos__broader mesh__D013723smesh__D009676
% 210.27/210.42 |- mesh__dateEstablished mesh__D013723 1975-09-01
% 210.27/210.42 |- skos__altLabel mesh__D013723 Embryotoxins
% 210.27/210.42 |- skos__historyNote mesh__D013723
% 210.27/210.42 Abnormalities, Drug-Induced %28%1966-1974%29%
% 210.27/210.42 |- skos__annotation mesh__D013723
% 210.27/210.42 be careful: %22%teratogenic effect%22% of a drug or chem is probably ABNORMALITIES, DRUG-INDUCED + drug or chem named %28%with required qualif%29% %26% not TERATOGENS%A%
% 210.27/210.42 |- skos__related mesh__D013723smesh__D000014
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D013723 sjn
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D013723 2005
% 210.27/210.42 |- mesh__historyNote mesh__D013723 75
% 210.27/210.42 |- mesh__dateCreated mesh__D013723 1999-01-01
% 210.27/210.42 |- rdf__type mesh__D013723sskos__Concept
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D013723 2006
% 210.27/210.42 |- mesh__dateRevised mesh__D013723 2003-07-09
% 210.27/210.42 |- skos__prefLabel mesh__D013723 Teratogens
% 210.27/210.42 |- mesh__recordMaintainer mesh__D013723 ssb
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D013723 2004
% 210.27/210.42 |- skos__scopeNote mesh__D013723
% 210.27/210.42 An agent that causes the production of physical defects in the developing embryo.%A%
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D013723 75
% 210.27/210.42 |- mesh__recordOriginator mesh__D013723 NLM
% 210.27/210.42 |- skos__broader mesh__D051842smesh__D047908
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D051842 sjn
% 210.27/210.42 |- mesh__recordMaintainer mesh__D051842 DRC
% 210.27/210.42 |- mesh__dateCreated mesh__D051842 2005-06-30
% 210.27/210.42 |- skos__broader mesh__D051842smesh__D009419
% 210.27/210.42 |- skos__prefLabel mesh__D051842 Olfactory Marker Protein
% 210.27/210.42 |- rdf__type mesh__D051842sskos__Concept
% 210.27/210.42 |- mesh__historyNote mesh__D051842 2006%28%1982%29%
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D051842 2006
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D051842
% 210.27/210.42 2006; OLFACTORY MARKER PROTEIN was indexed under NERVE TISSUE PROTEINS 1982-2005%A%
% 210.27/210.42 |- mesh__dateEstablished mesh__D051842 2006-01-01
% 210.27/210.42 |- mesh__recordOriginator mesh__D051842 DRC
% 210.27/210.42 |- skos__scopeNote mesh__D051842
% 210.27/210.42 A ubiquitous, cytoplasmic protein found in mature OLFACTORY RECEPTOR NEURONS of all VERTEBRATES. It is a modulator of the olfactory SIGNAL TRANSDUCTION PATHWAY.%A%
% 210.27/210.42 |- skos__altLabel mesh__D004997 Jenapharm Brand of Ethinyl Estradiol
% 210.27/210.42 |- skos__altLabel mesh__D004997 Ethinyloestradiol
% 210.27/210.42 |- rdf__type mesh__D004997sskos__Concept
% 210.27/210.42 |- mesh__recordMaintainer mesh__D004997 CCR
% 210.27/210.42 |- skos__altLabel mesh__D004997 Schering-Plough Brand of Ethinyl Estradiol
% 210.27/210.42 |- skos__hiddenLabel mesh__D004997 Jenapharm, Ethinylestradiol
% 210.27/210.42 |- skos__hiddenLabel mesh__D004997 Ethinyl Oestradiol Effik
% 210.27/210.42 |- mesh__dateCreated mesh__D004997 1999-01-01
% 210.27/210.42 |- skos__prefLabel mesh__D004997 Ethinyl Estradiol
% 210.27/210.42 |- skos__broader mesh__D004997smesh__D042782
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D004997 sjn
% 210.27/210.42 |- skos__hiddenLabel mesh__D004997 Estradiol, Ethinyl
% 210.27/210.42 |- skos__hiddenLabel mesh__D004997 Estradiol, Ethynyl
% 210.27/210.42 |- mesh__recordOriginator mesh__D004997 NLM
% 210.27/210.42 |- skos__broader mesh__D004997smesh__D009651
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004997 2006
% 210.27/210.42 |- skos__altLabel mesh__D004997 Effik Brand of Ethinyl Estradiol
% 210.27/210.42 |- skos__scopeNote mesh__D004997
% 210.27/210.42 A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.%A%
% 210.27/210.42 |- skos__altLabel mesh__D004997 Schering Brand of Ethinyl Estradiol
% 210.27/210.42 |- skos__altLabel mesh__D004997 Organon Brand of Ethinyl Estradiol
% 210.27/210.42 |- mesh__dateRevised mesh__D004997 2005-06-30
% 210.27/210.42 |- skos__hiddenLabel mesh__D004997 Hemihydrate, Ethinyl Estradiol
% 210.27/210.42 |- skos__altLabel mesh__D004997 Ethynyl Estradiol
% 210.27/210.42 |- mesh__recordMaintainer mesh__D045805 SYSTEM
% 210.27/210.42 |- mesh__dateRevised mesh__D045805 2005-06-30
% 210.27/210.42 |- rdf__type mesh__D045805sskos__Concept
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D045805 2006
% 210.27/210.42 |- skos__scopeNote mesh__D045805
% 210.27/210.42 A species of gram-negative bacteria pathogenic to CHICKENS; TURKEYS, and guinea fowls. It causes disease in a wide variety of organs and tissues including JOINTS, tendon sheaths and the RESPIRATORY TRACT.%A%
% 210.27/210.42 |- mesh__dateCreated mesh__D045805 2003-07-09
% 210.27/210.42 |- skos__prefLabel mesh__D045805 Mycoplasma synoviae
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D045805 2004
% 210.27/210.42 |- skos__broader mesh__D045805smesh__D009174
% 210.27/210.42 |- skos__historyNote mesh__D045805 Mycoplasma %28%1965-2003%29%
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D045805 sjn
% 210.27/210.42 |- skos__annotation mesh__D045805
% 210.27/210.42 infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%
% 210.27/210.42 |- mesh__recordOriginator mesh__D045805 ags
% 210.27/210.42 |- mesh__historyNote mesh__D045805 2004
% 210.27/210.42 |- mesh__dateEstablished mesh__D045805 2004-01-01
% 210.27/210.42 |- mesh__dateCreated mesh__D004199 1999-01-01
% 210.27/210.42 |- skos__scopeNote mesh__D004199
% 210.27/210.42 Invertebrates or non-human vertebrates which transmit infective organisms from one host to another.%A%
% 210.27/210.42 |- skos__hiddenLabel mesh__D004199 Vector, Disease
% 210.27/210.42 |- skos__hiddenLabel mesh__D004199 Disease Vector
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004199 2004
% 210.27/210.42 |- mesh__dateRevised mesh__D004199 1998-06-10
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D004199 SJN
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004199 2002
% 210.27/210.42 |- mesh__recordMaintainer mesh__D004199 JLS
% 210.27/210.42 |- skos__prefLabel mesh__D004199 Disease Vectors
% 210.27/210.42 |- rdf__type mesh__D004199sskos__Concept
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004199 2005
% 210.27/210.42 |- skos__broader mesh__D004199smesh__D018562
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004199 2000
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004199 2006
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004199 2001
% 210.27/210.42 |- mesh__historyNote mesh__D004199 67%28%65%29%
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004199 1999
% 210.27/210.42 |- mesh__recordOriginator mesh__D004199 NLM
% 210.27/210.42 |- skos__hiddenLabel mesh__D004199 Vectors, Disease
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D004199 2003
% 210.27/210.42 |- mesh__dateEstablished mesh__D004199 1967-01-01
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D004199 67
% 210.27/210.42 |- skos__prefLabel mesh__D009682 Magnetic Resonance Spectroscopy
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009682 2006
% 210.27/210.42 |- mesh__dateRevised mesh__D009682 2000-06-22
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D009682 sjn
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009682 2005
% 210.27/210.42 |- mesh__historyNote mesh__D009682 66%28%65%29%
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D009682 66
% 210.27/210.42 |- rdf__type mesh__D009682sskos__Concept
% 210.27/210.42 |- mesh__recordMaintainer mesh__D009682 nns
% 210.27/210.42 |- skos__hiddenLabel mesh__D009682 Spectroscopy, MR
% 210.27/210.42 |- skos__hiddenLabel mesh__D009682 Resonance, Nuclear Magnetic
% 210.27/210.42 |- skos__hiddenLabel mesh__D009682 NMR Spectroscopies
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009682 2002
% 210.27/210.42 |- skos__altLabel mesh__D009682 MR Spectroscopy
% 210.27/210.42 |- mesh__dateEstablished mesh__D009682 1966-01-01
% 210.27/210.42 |- skos__hiddenLabel mesh__D009682 Magnetic Resonance, Nuclear
% 210.27/210.42 |- skos__broader mesh__D009682smesh__D013057
% 210.27/210.42 |- skos__hiddenLabel mesh__D009682 Resonance Spectroscopy, Magnetic
% 210.27/210.42 |- skos__related mesh__D009682smesh__D008279
% 210.27/210.42 |- skos__broader mesh__D009682smesh__D009686
% 210.27/210.42 |- skos__hiddenLabel mesh__D009682 Spectroscopies, NMR
% 210.27/210.42 |- skos__altLabel mesh__D009682 NMR Spectroscopy
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009682 2004
% 210.27/210.42 |- skos__altLabel mesh__D009682 NMR Spectroscopy, In Vivo
% 210.27/210.42 |- skos__hiddenLabel mesh__D009682 Magnetic Resonance Spectroscopies
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009682 2001
% 210.27/210.42 |- skos__altLabel mesh__D009682 Spectroscopy, Magnetic Resonance
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D009682 2003
% 210.27/210.42 |- skos__altLabel mesh__D009682 Spectroscopy, NMR
% 210.27/210.42 |- skos__annotation mesh__D009682
% 210.27/210.42 index under element or isotope used in performing the NMR spectroscopy only if discussed %28%probably NIM%29%; do not confuse with MAGNETIC RESONANCE IMAGING: check text; coord with disease, organ or tissue using pertinent qualifs; for diag use coord with disease /diag %28%not /radiogr nor /radionuclide%29%; DF: NMR%A%
% 210.27/210.42 |- mesh__dateCreated mesh__D009682 1999-01-01
% 210.27/210.42 |- skos__hiddenLabel mesh__D009682 Resonance, Magnetic
% 210.27/210.42 |- skos__scopeNote mesh__D009682
% 210.27/210.42 Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography %28%MAGNETIC RESONANCE IMAGING%29%.%A%
% 210.27/210.42 |- mesh__recordOriginator mesh__D009682 NLM
% 210.27/210.42 |- skos__broader mesh__D007862Q000172smesh__D007862
% 210.27/210.42 |- mesh__preferredCombination mesh__D007862Q000172smesh__D007863
% 210.27/210.42 |- rdf__type mesh__D007862Q000172smesh__CompoundConcept
% 210.27/210.42 |- mesh__dateRevised mesh__D017316 2005-06-30
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D017316 2006
% 210.27/210.42 |- skos__hiddenLabel mesh__D017316 CGS 16949A
% 210.27/210.42 |- mesh__dateCreated mesh__D017316 1992-05-19
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D017316
% 210.27/210.42 93; CGS 16949A was indexed under IMIDAZOLES %26% NITRILES 1988-92%A%
% 210.27/210.42 |- skos__historyNote mesh__D017316 Imidazoles %28%1988-1992%29%
% 210.27/210.42 |- mesh__historyNote mesh__D017316 93; was CGS 16949A %28%NM%29% 1988-92
% 210.27/210.42 |- skos__scopeNote mesh__D017316
% 210.27/210.42 A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.%A%
% 210.27/210.42 |- skos__broader mesh__D017316smesh__D009570
% 210.27/210.42 |- skos__broader mesh__D017316smesh__D007093
% 210.27/210.42 |- skos__prefLabel mesh__D017316 Fadrozole
% 210.27/210.42 |- mesh__onlineNote mesh__D017316
% 210.27/210.42 use FADROZOLE %28%NM%29% to search CGS 16949A 1988-92
% 210.27/210.42 |- skos__hiddenLabel mesh__D017316 Hydrochloride, Fadrozole
% 210.27/210.42 |- mesh__dateEstablished mesh__D017316 1993-01-01
% 210.27/210.42 |- skos__altLabel mesh__D017316 Fadrozole Hydrochloride
% 210.27/210.42 |- rdf__type mesh__D017316sskos__Concept
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D017316 sjn
% 210.27/210.42 |- mesh__recordMaintainer mesh__D017316 ssb
% 210.27/210.42 |- skos__hiddenLabel mesh__D017316 CGS16949A
% 210.27/210.42 |- skos__historyNote mesh__D017316 Nitriles %28%1988-1992%29%
% 210.27/210.42 |- mesh__recordOriginator mesh__D017316 TPW
% 210.27/210.42 |- skos__hiddenLabel mesh__D017316 Monohydrochloride, Fadrozole
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D033781 2003
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D033781
% 210.27/210.42 2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002
% 210.27/210.42 |- mesh__dateEstablished mesh__D033781 2003-01-01
% 210.27/210.42 |- skos__altLabel mesh__D033781 SLC25A6 Protein
% 210.27/210.42 |- skos__altLabel mesh__D033781 ANT-3 Transport Protein
% 210.27/210.42 |- skos__broader mesh__D033781smesh__D000226
% 210.27/210.42 |- skos__scopeNote mesh__D033781
% 210.27/210.42 A subtype of mitochondrial ADP, ATP translocase found primarily in the LIVER.%A%
% 210.27/210.42 |- skos__altLabel mesh__D033781
% 210.27/210.42 Solute Carrier Family 25 %28%Mitochondrial Carrier; Adenine Nucleotide Translocator%29%, Member 6
% 210.27/210.42 |- mesh__historyNote mesh__D033781
% 210.27/210.42 2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002
% 210.27/210.42 |- skos__historyNote mesh__D033781
% 210.27/210.42 Mitochondrial ADP, ATP Translocases %28%1999-2002%29%
% 210.27/210.42 |- mesh__dateCreated mesh__D033781 2002-07-02
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D033781 2006
% 210.27/210.42 |- skos__hiddenLabel mesh__D033781 Transport Protein, ANT3
% 210.27/210.42 |- skos__prefLabel mesh__D033781 Adenine Nucleotide Translocator 3
% 210.27/210.42 |- skos__hiddenLabel mesh__D033781 Transport Protein, ANT-3
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D033781 2005
% 210.27/210.42 |- skos__altLabel mesh__D033781 ANT3 Transport Protein
% 210.27/210.42 |- skos__altLabel mesh__D033781 ADP,ATP Carrier Protein, Liver Isoform T2
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D033781 2004
% 210.27/210.42 |- skos__hiddenLabel mesh__D033781 ANT 3 Transport Protein
% 210.27/210.42 |- rdf__type mesh__D033781sskos__Concept
% 210.27/210.42 |- rdf__type mesh__D027744sskos__Concept
% 210.27/210.42 |- skos__annotation mesh__D027744
% 210.27/210.42 do not confuse with bryony = BRYONIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D027744 2002
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D027744 2002
% 210.27/210.42 |- skos__scopeNote mesh__D027744
% 210.27/210.42 A plant genus of the DIOSCOREACEAE plant family.
% 210.27/210.42 |- skos__historyNote mesh__D027744 Plants, Medicinal %28%1968-2001%29%
% 210.27/210.42 |- skos__altLabel mesh__D027744 Black Bryony
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D027744 2004
% 210.27/210.42 |- mesh__dateCreated mesh__D027744 2001-07-25
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D027744 2003
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D027744 2006
% 210.27/210.42 |- mesh__historyNote mesh__D027744 2002
% 210.27/210.42 |- mesh__dateEstablished mesh__D027744 2002-01-01
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D027744 2005
% 210.27/210.42 |- skos__broader mesh__D027744smesh__D027743
% 210.27/210.42 |- skos__altLabel mesh__D027744 Bryony, Black
% 210.27/210.42 |- skos__prefLabel mesh__D027744 Tamus
% 210.27/210.42 |- skos__broader mesh__D004364Q000494smesh__D004364
% 210.27/210.42 |- mesh__preferredCombination mesh__D004364Q000494smesh__D010600
% 210.27/210.42 |- rdf__type mesh__D004364Q000494smesh__CompoundConcept
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 2002
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D005292 66
% 210.27/210.42 |- mesh__dateEstablished mesh__D005292 1966-01-01
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 2005
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 1998
% 210.27/210.42 |- mesh__dateRevised mesh__D005292 1993-06-01
% 210.27/210.42 |- skos__broader mesh__D005292smesh__D003486
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 1994
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 2006
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 1999
% 210.27/210.42 |- skos__broader mesh__D005292smesh__D005290
% 210.27/210.42 |- skos__scopeNote mesh__D005292
% 210.27/210.42 Inorganic salts of the hypothetical acid, H3Fe%28%CN%29%6.
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 1995
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 2000
% 210.27/210.42 |- mesh__recordOriginator mesh__D005292 NLM
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 2003
% 210.27/210.42 |- mesh__recordMaintainer mesh__D005292 TPW
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 1996
% 210.27/210.42 |- mesh__historyNote mesh__D005292 66
% 210.27/210.42 |- skos__annotation mesh__D005292 do not confuse with FERROCYANIDES
% 210.27/210.42 |- skos__prefLabel mesh__D005292 Ferricyanides
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 2001
% 210.27/210.42 |- rdf__type mesh__D005292sskos__Concept
% 210.27/210.42 |- mesh__dateCreated mesh__D005292 1999-01-01
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 2004
% 210.27/210.42 |- mesh__activeMeSHYear mesh__D005292 1997
% 210.27/210.42 |- mesh__recordAuthorizer mesh__D005292 PLS
% 210.27/210.42 |- mesh__publicMeSHNote mesh__D013724
% 210.27/210.42 82; was TERATOID TUMOR 1963-81; TERATOMA, CYSTIC %26% TERATOMA, MATURE were see DERMOID CYST 1985-93; DYSEMBRYOMA was heading 1963-84%A%
% 210.27/210.42 |- mesh__onlineNote mesh__D013724
% 210.27/210.42 use TERATOMA to search TERATOID TUMOR 1966-81 %26% DYSEMBRYOMA 1966-84; use DERMOID CYST to search TERATOMA, CYSTIC %26% TERATOMA, MATURE 1985-93%A%
% 210.27/210.42 |- skos__altLabel mesh__D013724 Dysembryoma
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 1998
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 2005
% 210.27/210.43 |- mesh__recordMaintainer mesh__D013724 KEV
% 210.27/210.43 |- mesh__dateRevised mesh__D013724 1995-06-08
% 210.27/210.43 |- mesh__recordOriginator mesh__D013724 NLM
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Teratomas, Mature
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 2002
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 1999
% 210.27/210.43 |- mesh__dateCreated mesh__D013724 1999-01-01
% 210.27/210.43 |- rdf__type mesh__D013724sskos__Concept
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 2006
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Cystic Teratomas
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 1996
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D013724 PLS
% 210.27/210.43 |- skos__broader mesh__D013724smesh__D009373
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Teratoid Tumors
% 210.27/210.43 |- skos__altLabel mesh__D013724 Teratoid Tumor
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 2003
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 2000
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Teratomas
% 210.27/210.43 |- skos__altLabel mesh__D013724 Teratoma, Cystic
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 1997
% 210.27/210.43 |- mesh__historyNote mesh__D013724
% 210.27/210.43 82; was TERATOID TUMOR 1963-81; TERATOMA, CYSTIC %26% TERATOMA, MATURE were see DERMOID CYST 1985-93; DYSEMBRYOMA was heading 1963-84%A%
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Mature Teratoma
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Dysembryomas
% 210.27/210.43 |- skos__altLabel mesh__D013724 Teratoma, Mature
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 2004
% 210.27/210.43 |- skos__annotation mesh__D013724
% 210.27/210.43 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Teratomas, Cystic
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013724 2001
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Tumor, Teratoid
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Cystic Teratoma
% 210.27/210.43 |- skos__prefLabel mesh__D013724 Teratoma
% 210.27/210.43 |- skos__scopeNote mesh__D013724
% 210.27/210.43 A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They may be solid or cystic and are classified histologically as mature, immature, and malignant. %28%From Dorland, 27th ed %26% DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1642%29%%A%
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Tumors, Teratoid
% 210.27/210.43 |- skos__hiddenLabel mesh__D013724 Mature Teratomas
% 210.27/210.43 |- mesh__dateEstablished mesh__D051843 2006-01-01
% 210.27/210.43 |- skos__scopeNote mesh__D051843
% 210.27/210.43 A family of homologous proteins of low MOLECULAR WEIGHT that are predominately expressed in the BRAIN and that have been implicated in a variety of human diseases. They were originally isolated from CHOLINERGIC FIBERS of TORPEDO.%A%
% 210.27/210.43 |- skos__broader mesh__D051843smesh__D009419
% 210.27/210.43 |- rdf__type mesh__D051843sskos__Concept
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D051843 sjn
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D051843 2006
% 210.27/210.43 |- mesh__recordMaintainer mesh__D051843 DRC
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D051843
% 210.27/210.43 2006; SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A%
% 210.27/210.43 |- mesh__historyNote mesh__D051843 2006%28%1988%29%
% 210.27/210.43 |- skos__prefLabel mesh__D051843 Synucleins
% 210.27/210.43 |- mesh__dateCreated mesh__D051843 2005-06-30
% 210.27/210.43 |- mesh__recordOriginator mesh__D051843 DRC
% 210.27/210.43 |- skos__altLabel mesh__D051843 Synuclein
% 210.27/210.43 |- rdf__type mesh__D004998sskos__Concept
% 210.27/210.43 |- skos__altLabel mesh__D004998 Ethiodized Oil %28%Injection%29%
% 210.27/210.43 |- skos__altLabel mesh__D004998 Ethiodized Oils
% 210.27/210.43 |- skos__scopeNote mesh__D004998
% 210.27/210.43 Ethyl ester of iodinated fatty acid of poppyseed oil. It contains 37%25% organically bound iodine and has been used as a diagnostic aid %28%radiopaque medium%29% and as an antineoplastic agent when part of the iodine is 131-I. %28%From Merck Index, 11th ed%29%%A%
% 210.27/210.43 |- skos__broader mesh__D004998smesh__D007459
% 210.27/210.43 |- skos__hiddenLabel mesh__D004998 Oil, Ethiodized
% 210.27/210.43 |- mesh__dateCreated mesh__D004998 1999-01-01
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D004998 sjn
% 210.27/210.43 |- mesh__recordOriginator mesh__D004998 NLM
% 210.27/210.43 |- mesh__onlineNote mesh__D004998
% 210.27/210.43 use ETHIODIZED OIL to search ETHIODIZED OILS 1978-93 %26% ETHIODOL 1966-93 %28%as Prov 1966-72%29%; use ETHIODIZED OIL %28%NM%29% to search ETHIODIZED POPPY SEED OIL 1991-93%A%
% 210.27/210.43 |- mesh__recordMaintainer mesh__D004998 ssb
% 210.27/210.43 |- mesh__dateEstablished mesh__D004998 1973-01-01
% 210.27/210.43 |- skos__prefLabel mesh__D004998 Ethiodized Oil
% 210.27/210.43 |- skos__annotation mesh__D004998 contrast media; D25-26 qualif
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D004998
% 210.27/210.43 94; was ETHIODIZED OILS 1978-93, was ETHIODOL 1973-77; ETHIODOL was see ETHIODIZED OILS 1978-93; ETHIODIZED POPPY SEED OIL was indexed under ETHIODIZED OILS 1991-93%A%
% 210.27/210.43 |- mesh__historyNote mesh__D004998
% 210.27/210.43 94; was ETHIODIZED OILS 1978-93, was ETHIODOL 1964-77 %28%Prov 1964-72%29%; ETHIODOL was see ETHIODIZED OILS 1978-93; ETHIODIZED POPPY SEED OIL was %28%NM%29% 1991-93%A%
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D004998 2006
% 210.27/210.43 |- skos__hiddenLabel mesh__D004998 Oils, Ethiodized
% 210.27/210.43 |- mesh__dateRevised mesh__D004998 2005-06-30
% 210.27/210.43 |- skos__related mesh__D009683smesh__D011868
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009683 2005
% 210.27/210.43 |- rdf__type mesh__D009683sskos__Concept
% 210.27/210.43 |- skos__altLabel mesh__D009683 Atomic Medicine
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009683 2000
% 210.27/210.43 |- skos__historyNote mesh__D009683 Radiation Injuries %28%1966%29%
% 210.27/210.43 |- skos__altLabel mesh__D009683 Medicine, Nuclear
% 210.27/210.43 |- skos__prefLabel mesh__D009683 Nuclear Medicine
% 210.27/210.43 |- mesh__recordOriginator mesh__D009683 NLM
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009683 1999
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009683 2004
% 210.27/210.43 |- mesh__dateEstablished mesh__D009683 1967-01-01
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009683 2002
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D009683 SJN
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009683 1998
% 210.27/210.43 |- skos__altLabel mesh__D009683 Medicine, Atomic
% 210.27/210.43 |- skos__altLabel mesh__D009683 Nuclear Radiology
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009683 2003
% 210.27/210.43 |- mesh__recordMaintainer mesh__D009683 PXP
% 210.27/210.43 |- mesh__historyNote mesh__D009683 67
% 210.27/210.43 |- skos__historyNote mesh__D009683 Radioisotopes %28%1966%29%
% 210.27/210.43 |- skos__historyNote mesh__D009683 Nuclear Energy %28%1966%29%
% 210.27/210.43 |- mesh__dateCreated mesh__D009683 1999-01-01
% 210.27/210.43 |- mesh__dateRevised mesh__D009683 1997-06-20
% 210.27/210.43 |- skos__annotation mesh__D009683 SPEC: SPEC qualif; DF: NUCLEAR MED
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009683 2006
% 210.27/210.43 |- skos__broader mesh__D009683smesh__D011871
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D009683 67
% 210.27/210.43 |- skos__historyNote mesh__D009683 Nuclear Warfare %28%1966%29%
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009683 2001
% 210.27/210.43 |- skos__scopeNote mesh__D009683
% 210.27/210.43 A specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds in a pharmaceutical form.%A%
% 210.27/210.43 |- skos__altLabel mesh__D017317 Calphobindin II
% 210.27/210.43 |- skos__altLabel mesh__D017317 Calcimedin 67-kDa
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D017317 2005
% 210.27/210.43 |- mesh__recordMaintainer mesh__D017317 jmp
% 210.27/210.43 |- skos__hiddenLabel mesh__D017317
% 210.27/210.43 Calcium and Phospholipid Binding Protein p68
% 210.27/210.43 |- skos__hiddenLabel mesh__D017317 Calelectrin 67 kDa
% 210.27/210.43 |- skos__broader mesh__D017317smesh__D017302
% 210.27/210.43 |- skos__historyNote mesh__D017317
% 210.27/210.43 Calcium-Binding Proteins %28%1984-1992%29%
% 210.27/210.43 |- skos__altLabel mesh__D017317 Annexin VI
% 210.27/210.43 |- rdf__type mesh__D017317sskos__Concept
% 210.27/210.43 |- skos__hiddenLabel mesh__D017317 Calcimedin 67 kDa
% 210.27/210.43 |- mesh__dateRevised mesh__D017317 2004-07-07
% 210.27/210.43 |- mesh__historyNote mesh__D017317 2005%28%1987%29%
% 210.27/210.43 |- mesh__dateEstablished mesh__D017317 1993-01-01
% 210.27/210.43 |- skos__altLabel mesh__D017317 Lipocortin VI
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D017317 sjn
% 210.27/210.43 |- skos__scopeNote mesh__D017317
% 210.27/210.43 Protein of the annexin family with a probable role in exocytotic and endocytotic membrane events.%A%
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D017317 2006
% 210.27/210.43 |- skos__prefLabel mesh__D017317 Annexin A6
% 210.27/210.43 |- skos__altLabel mesh__D017317
% 210.27/210.43 Calcium and Phospholipid-Binding Protein p68
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D017317
% 210.27/210.43 2005; ANNEXIN VI was indexed under CALCIUM-BINDING PROTEINS 1990-1992; CALPHOBINDIN II was indexed under PREGNANCY PROTEINS 1987-1992; CALCIUM AND PHOSPHOLIPID-BINDING PROTEIN P68 was indexed under BINDING PROTEINS %26% CALCIUM 1979-1980; CALCIUM-BINDING PROTEINS 1981-2004 %26% ANNEXIN VI 2004%A%
% 210.27/210.43 |- mesh__recordOriginator mesh__D017317 AGS
% 210.27/210.43 |- skos__altLabel mesh__D017317 Calelectrin 67-kDa
% 210.27/210.43 |- mesh__dateCreated mesh__D017317 1992-05-07
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D005293 2006
% 210.27/210.43 |- skos__scopeNote mesh__D005293
% 210.27/210.43 An iron-containing protein complex that is formed by a combination of ferric iron with the protein APOFERRITIN.%A%
% 210.27/210.43 |- skos__broader mesh__D005293smesh__D033862
% 210.27/210.43 |- mesh__recordMaintainer mesh__D005293 jmp
% 210.27/210.43 |- mesh__dateRevised mesh__D005293 2002-07-03
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D005293 2003
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D005293 sjn
% 210.27/210.43 |- skos__prefLabel mesh__D005293 Ferritin
% 210.27/210.43 |- mesh__dateCreated mesh__D005293 1999-01-01
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D005293 2004
% 210.27/210.43 |- rdf__type mesh__D005293sskos__Concept
% 210.27/210.43 |- mesh__recordOriginator mesh__D005293 NLM
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D005293 2005
% 210.27/210.43 |- mesh__recordMaintainer mesh__D013725 jmp
% 210.27/210.43 |- skos__scopeNote mesh__D013725
% 210.27/210.43 Terbium. An element of the rare earth family of metals. It has the atomic symbol Tb, atomic number 65, and atomic weight 158.92.%A%
% 210.27/210.43 |- skos__prefLabel mesh__D013725 Terbium
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013725 2006
% 210.27/210.43 |- rdf__type mesh__D013725sskos__Concept
% 210.27/210.43 |- mesh__recordOriginator mesh__D013725 NLM
% 210.27/210.43 |- mesh__dateCreated mesh__D013725 1999-01-01
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013725 2004
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013725 2005
% 210.27/210.43 |- mesh__dateRevised mesh__D013725 2001-07-25
% 210.27/210.43 |- skos__broader mesh__D013725smesh__D028581
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013725 2003
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D013725 sjn
% 210.27/210.43 |- skos__annotation mesh__D013725
% 210.27/210.43 a rare earth metal; Tb-159; Tb-147-158, 160-164 = TERBIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013725 2002
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 2000
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 1998
% 210.27/210.43 |- mesh__historyNote mesh__D018410 95
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 1997
% 210.27/210.43 |- mesh__dateEstablished mesh__D018410 1995-01-01
% 210.27/210.43 |- skos__broader mesh__D018410smesh__D011014
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D018410 95
% 210.27/210.43 |- skos__hiddenLabel mesh__D018410 Pneumonias, Bacterial
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 1996
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 2006
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 2002
% 210.27/210.43 |- skos__broader mesh__D018410smesh__D001424
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 2005
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 2004
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 1995
% 210.27/210.43 |- rdf__type mesh__D018410sskos__Concept
% 210.27/210.43 |- skos__altLabel mesh__D018410 Bacterial Pneumonia
% 210.27/210.43 |- skos__scopeNote mesh__D018410
% 210.27/210.43 Pneumonia caused by various species of bacteria. Bacterial pneumonia commonly results from bronchogenic spread of infection following microaspiration of secretions. The largest category of this disease arises from community-acquired pneumonias.%A%
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 2003
% 210.27/210.43 |- skos__annotation mesh__D018410
% 210.27/210.43 GEN or unspecified; prefer specifics; coord IM with specific bact infect %28%IM%29%; DF: PNEUMONIA BACT%A%
% 210.27/210.43 |- mesh__dateCreated mesh__D018410 1994-01-25
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 2001
% 210.27/210.43 |- skos__hiddenLabel mesh__D018410 Bacterial Pneumonias
% 210.27/210.43 |- skos__prefLabel mesh__D018410 Pneumonia, Bacterial
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018410 1999
% 210.27/210.43 |- mesh__historyNote mesh__D051844 2006%28%1988%29%
% 210.27/210.43 |- skos__prefLabel mesh__D051844 alpha-Synuclein
% 210.27/210.43 |- rdf__type mesh__D051844sskos__Concept
% 210.27/210.43 |- skos__scopeNote mesh__D051844
% 210.27/210.43 A synuclein that is a major component of LEWY BODIES that plays a role in neurodegeneration and neuroprotection.%A%
% 210.27/210.43 |- mesh__recordOriginator mesh__D051844 DRC
% 210.27/210.43 |- mesh__dateEstablished mesh__D051844 2006-01-01
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D051844
% 210.27/210.43 2006; ALPHA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A%
% 210.27/210.43 |- skos__hiddenLabel mesh__D051844 Non AB Component of AD Amyloid Protein
% 210.27/210.43 |- mesh__recordMaintainer mesh__D051844 DRC
% 210.27/210.43 |- skos__broader mesh__D051844smesh__D051843
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D051844 sjn
% 210.27/210.43 |- skos__altLabel mesh__D051844 Non-AB Component of AD Amyloid Protein
% 210.27/210.43 |- skos__hiddenLabel mesh__D051844 alpha Synuclein
% 210.27/210.43 |- mesh__dateCreated mesh__D051844 2005-06-30
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D051844 2006
% 210.27/210.43 |- rdf__type mesh__D004999sskos__Concept
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 Amifostine Lilly Brand
% 210.27/210.43 |- mesh__historyNote mesh__D004999
% 210.27/210.43 94; was ETHIOFOS 1985-93 %28%see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1985-90%29%; was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-84%A%
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D004999 2006
% 210.27/210.43 |- skos__altLabel mesh__D004999 Schering-Plough Brand of Amifostine
% 210.27/210.43 |- skos__altLabel mesh__D004999 Essex Brand of Amifostine
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 Disodium Salt, Amifostine
% 210.27/210.43 |- skos__altLabel mesh__D004999 Gammaphos
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999
% 210.27/210.43 Acid, Aminopropylaminoethylthiophosphoric
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 Amifostine Schering-Plough Brand
% 210.27/210.43 |- skos__historyNote mesh__D004999
% 210.27/210.43 Organothiophosphorus Compounds %28%1972-1976%29%
% 210.27/210.43 |- skos__annotation mesh__D004999 D25-26 qualif
% 210.27/210.43 |- skos__historyNote mesh__D004999 Diamines %28%1974-1976%29%
% 210.27/210.43 |- mesh__dateEstablished mesh__D004999 1991-01-01
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 Schering Plough Brand of Amifostine
% 210.27/210.43 |- skos__altLabel mesh__D004999 Ethiofos
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 WR 2721
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 NSC296961
% 210.27/210.43 |- skos__altLabel mesh__D004999
% 210.27/210.43 S-%28%N-%28%3-Aminopropyl%29%-2-aminoethyl%29%thiophosphoric Acid
% 210.27/210.43 |- skos__altLabel mesh__D004999 US Bioscience Brand of Amifostine
% 210.27/210.43 |- skos__scopeNote mesh__D004999
% 210.27/210.43 A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.%A%
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D004999
% 210.27/210.43 94; was ETHIOFOS 1985-93 %28%see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1985-90%29%; was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-84%A%
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 Amifostine Essex Brand
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 YM08310
% 210.27/210.43 |- mesh__dateRevised mesh__D004999 2005-06-30
% 210.27/210.43 |- skos__prefLabel mesh__D004999 Amifostine
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 Salt, Amifostine Disodium
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 YM 08310
% 210.27/210.43 |- skos__altLabel mesh__D004999 APAETP
% 210.27/210.43 |- skos__altLabel mesh__D004999 Aminopropylaminoethylthiophosphoric Acid
% 210.27/210.43 |- skos__altLabel mesh__D004999 Alza Brand of Amifostine
% 210.27/210.43 |- mesh__recordMaintainer mesh__D004999 ssb
% 210.27/210.43 |- skos__altLabel mesh__D004999 Lilly Brand of Amifostine
% 210.27/210.43 |- mesh__onlineNote mesh__D004999
% 210.27/210.43 use AMIFOSTINE to search ETHIOFOS 1985-93 %26% WR 2721 1977-84%A%
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 Monohydrochloride, Amifostine
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 Monohydrate, Amifostine
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 Amifostine Alza Brand
% 210.27/210.43 |- skos__altLabel mesh__D004999 Aminopropyl Aminoethylthiophosphate
% 210.27/210.43 |- mesh__dateCreated mesh__D004999 1976-04-13
% 210.27/210.43 |- mesh__recordOriginator mesh__D004999 SH
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 NSC 296961
% 210.27/210.43 |- skos__broader mesh__D004999smesh__D009946
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D004999 sjn
% 210.27/210.43 |- skos__hiddenLabel mesh__D004999 WR2721
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 Acetyl CoA Glutamate N Acetyltransferase
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 N-Acetyltransferase, Amino-Acid
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 Amino Acid N Acetyltransferase
% 210.27/210.43 |- skos__altLabel mesh__D051046 Amino-Acid Acetyltransferase
% 210.27/210.43 |- mesh__recordOriginator mesh__D051046 AKE
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 N Acetylglutamate Synthetase
% 210.27/210.43 |- skos__altLabel mesh__D051046 N-Acetyl-L-Glutamate Synthetase
% 210.27/210.43 |- skos__altLabel mesh__D051046 N-Acetylglutamate Synthetase
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 Synthetase, N-Acetyl-L-Glutamate
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 N Acetyl L Glutamate Synthetase
% 210.27/210.43 |- rdf__type mesh__D051046sskos__Concept
% 210.27/210.43 |- skos__altLabel mesh__D051046
% 210.27/210.43 Acetyl Coenzyme A Glutamate N-Acetyltransferase
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 Acetyltransferase, Amino-Acid
% 210.27/210.43 |- mesh__dateCreated mesh__D051046 2005-06-30
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046
% 210.27/210.43 Acetyl Coenzyme A Glutamate N Acetyltransferase
% 210.27/210.43 |- skos__altLabel mesh__D051046 Acetyl CoA Glutamate N-Acetyltransferase
% 210.27/210.43 |- skos__altLabel mesh__D051046 Amino Acid Acetyltransferase
% 210.27/210.43 |- mesh__historyNote mesh__D051046
% 210.27/210.43 2006%28%1980%29%; use ACETYLTRANSFERASES, ACETYL COENZYME A %26% GLUTAMATES 1973-1979%A%
% 210.27/210.43 |- skos__prefLabel mesh__D051046 Amino-Acid N-Acetyltransferase
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 Acetyltransferase, Amino Acid
% 210.27/210.43 |- skos__broader mesh__D051046smesh__D000123
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 N Acetylglutamate Synthase
% 210.27/210.43 |- skos__scopeNote mesh__D051046
% 210.27/210.43 A mitochondrial matrix enzyme that catalyzes the synthesis of L-GLUTAMATE to N-acetyl-L-glutamate in the presence of ACETYL-COA.%A%
% 210.27/210.43 |- mesh__recordMaintainer mesh__D051046 AKE
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 Acid Acetyltransferase, Amino
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 Synthetase, N-Acetylglutamate
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D051046
% 210.27/210.43 2006; AMINO-ACID N-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, %26% under ACETYL COENZYME A %26% GLUTAMATES 1973-1980%A%
% 210.27/210.43 |- mesh__dateEstablished mesh__D051046 2006-01-01
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D051046 2006
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D051046 sjn
% 210.27/210.43 |- skos__hiddenLabel mesh__D051046 Synthase, N-Acetylglutamate
% 210.27/210.43 |- skos__altLabel mesh__D051046 N-Acetylglutamate Synthase
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 1993
% 210.27/210.43 |- mesh__dateCreated mesh__D009684 1981-05-19
% 210.27/210.43 |- rdf__type mesh__D009684sskos__Concept
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 2000
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 1998
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 2003
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 1994
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 1999
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 2004
% 210.27/210.43 |- skos__prefLabel mesh__D009684 Nuclear Medicine Department, Hospital
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 2001
% 210.27/210.43 |- mesh__historyNote mesh__D009684
% 210.27/210.43 91%28%82%29%; was see under HOSPITAL DEPARTMENTS 1982-90
% 210.27/210.43 |- skos__altLabel mesh__D009684 Hospital Nuclear Medicine Department
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 1995
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D009684 PLS
% 210.27/210.43 |- skos__scopeNote mesh__D009684
% 210.27/210.43 Hospital department responsible for the administration and management of nuclear medicine services.%A%
% 210.27/210.43 |- skos__altLabel mesh__D009684 Nuclear Medicine Departments, Hospital
% 210.27/210.43 |- skos__historyNote mesh__D009684 Nuclear Medicine %28%1967-1981%29%
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 2002
% 210.27/210.43 |- skos__annotation mesh__D009684
% 210.27/210.43 restrict to radioisotope diag %26% ther serv: do not confuse with RADIOLOGY DEPARTMENT, HOSPITAL %28%x-ray %26% radiocobalt only%29%; DF: NUCLEAR MED DEP%A%
% 210.27/210.43 |- skos__historyNote mesh__D009684 Hospital Departments %28%1968-1981%29%
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D009684
% 210.27/210.43 91; was see under HOSPITAL DEPARTMENTS 1982-90
% 210.27/210.43 |- mesh__recordMaintainer mesh__D009684 TGC
% 210.27/210.43 |- skos__broader mesh__D009684smesh__D006748
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 2005
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 1996
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 2006
% 210.27/210.43 |- mesh__recordOriginator mesh__D009684 EC
% 210.27/210.43 |- skos__altLabel mesh__D009684 Hospital Nuclear Medicine Departments
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D009684 1997
% 210.27/210.43 |- mesh__dateEstablished mesh__D009684 1991-01-01
% 210.27/210.43 |- mesh__dateRevised mesh__D009684 1992-05-15
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D017318 2006
% 210.27/210.43 |- skos__broader mesh__D017318smesh__D017302
% 210.27/210.43 |- skos__scopeNote mesh__D017318
% 210.27/210.43 A protein of the annexin family that catalyzes the conversion of 1-D-inositol 1,2-cyclic phosphate and water to 1-D-myo-inositol 1-phosphate.%A%
% 210.27/210.43 |- skos__altLabel mesh__D017318 Annexin III
% 210.27/210.43 |- skos__prefLabel mesh__D017318 Annexin A3
% 210.27/210.43 |- mesh__recordMaintainer mesh__D017318 jmp
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D017318 2005
% 210.27/210.43 |- rdf__type mesh__D017318sskos__Concept
% 210.27/210.43 |- skos__altLabel mesh__D017318 Lipocortin III
% 210.27/210.43 |- skos__historyNote mesh__D017318
% 210.27/210.43 Calcium-Binding Proteins %28%1991-1992%29%
% 210.27/210.43 |- mesh__dateRevised mesh__D017318 2004-07-07
% 210.27/210.43 |- mesh__historyNote mesh__D017318 2005%28%1991%29%
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D017318
% 210.27/210.43 2005; ANNEXIN III was indexed under CALCIUM-BINDING PROTEINS 1991-1992; ANNEXIN A3 was indexed under ANNEXIN III 2004%A%
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D017318 sjn
% 210.27/210.43 |- skos__broader mesh__D017318smesh__D010727
% 210.27/210.43 |- mesh__dateEstablished mesh__D017318 1993-01-01
% 210.27/210.43 |- mesh__recordOriginator mesh__D017318 AGS
% 210.27/210.43 |- skos__altLabel mesh__D017318 Placental Anticoagulant Protein III
% 210.27/210.43 |- skos__altLabel mesh__D017318 Calcimedin 35 alpha
% 210.27/210.43 |- mesh__dateCreated mesh__D017318 1992-05-07
% 210.27/210.43 |- mesh__dateRevised mesh__D014020 2005-06-30
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D014020 2006
% 210.27/210.43 |- mesh__recordOriginator mesh__D014020 NLM
% 210.27/210.43 |- mesh__recordMaintainer mesh__D014020 ssb
% 210.27/210.43 |- rdf__type mesh__D014020sskos__Concept
% 210.27/210.43 |- skos__prefLabel mesh__D014020 Tissue Extracts
% 210.27/210.43 |- skos__broader mesh__D014020smesh__D045424
% 210.27/210.43 |- skos__scopeNote mesh__D014020
% 210.27/210.43 Preparations made from animal tissues or organs %28%ANIMAL STRUCTURES%29%. They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions.%A%
% 210.27/210.43 |- mesh__dateCreated mesh__D014020 1999-01-01
% 210.27/210.43 |- skos__annotation mesh__D014020
% 210.27/210.43 not for chemical substances %22%extracted%22% from tissues %28%= specific chemical + organ or tissue /chem%29%%A%
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D014020 sjn
% 210.27/210.43 |- skos__hiddenLabel mesh__D014020 Extracts, Tissue
% 210.27/210.43 |- mesh__historyNote mesh__D005294
% 210.27/210.43 91%28%77%29%; was see under LYASES 1977-90
% 210.27/210.43 |- skos__altLabel mesh__D005294 Porphyrin-Metal Chelatase
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D005294 91; was see under LYASES 1977-90
% 210.27/210.43 |- skos__hiddenLabel mesh__D005294 Synthetase, Heme
% 210.27/210.43 |- skos__altLabel mesh__D005294 Heme Synthetase
% 210.27/210.43 |- rdf__type mesh__D005294sskos__Concept
% 210.27/210.43 |- mesh__dateEstablished mesh__D005294 1991-01-01
% 210.27/210.43 |- skos__broader mesh__D005294smesh__D008190
% 210.27/210.43 |- skos__hiddenLabel mesh__D005294 Protoheme Ferro Lyase
% 210.27/210.43 |- skos__historyNote mesh__D005294 Lyases %28%1966-1976%29%
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D005294 2005
% 210.27/210.43 |- mesh__dateCreated mesh__D005294 1976-04-27
% 210.27/210.43 |- skos__hiddenLabel mesh__D005294 Chelatase, Zinc
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D005294 2005A
% 210.27/210.43 |- skos__hiddenLabel mesh__D005294 Porphyrin Metal Chelatase
% 210.27/210.43 |- skos__hiddenLabel mesh__D005294 Chelatase, Porphyrin-Metal
% 210.27/210.43 |- skos__hiddenLabel mesh__D005294 Ferro-Lyase, Protoheme
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D005294 2006
% 210.27/210.43 |- skos__altLabel mesh__D005294 Protoheme Ferro-Lyase
% 210.27/210.43 |- skos__historyNote mesh__D005294 Protoporphyrins %28%1975-1976%29%
% 210.27/210.43 |- skos__scopeNote mesh__D005294
% 210.27/210.43 A mitochondrial enzyme found in a wide variety of cells and tissues. It is the final enzyme in the 8-enzyme biosynthetic pathway of HEME. Ferrochelatase catalyzes ferrous insertion into protoporphyrin IX to form protoheme or heme. Deficiency in this enzyme results in ERYTHROPOIETIC PROTOPORPHYRIA.%A%
% 210.27/210.43 |- mesh__recordMaintainer mesh__D005294 sjn
% 210.27/210.43 |- skos__historyNote mesh__D005294 Porphyrins %28%1966-1976%29%
% 210.27/210.43 |- mesh__recordOriginator mesh__D005294 RLS
% 210.27/210.43 |- skos__prefLabel mesh__D005294 Ferrochelatase
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D005294 sjn
% 210.27/210.43 |- skos__historyNote mesh__D005294 Iron %28%1966-1976%29%
% 210.27/210.43 |- mesh__dateRevised mesh__D005294 2004-10-20
% 210.27/210.43 |- mesh__recordAuthorizer mesh__D013726 sjn
% 210.27/210.43 |- mesh__recordMaintainer mesh__D013726 CCR
% 210.27/210.43 |- skos__hiddenLabel mesh__D013726 KWD2019
% 210.27/210.43 |- skos__altLabel mesh__D013726 Butalitab
% 210.27/210.43 |- skos__altLabel mesh__D013726 Novartis Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726 Aliud Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__hiddenLabel mesh__D013726 Terbutalin ratiopharm
% 210.27/210.43 |- skos__altLabel mesh__D013726 Lagap Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__hiddenLabel mesh__D013726 KWD 2019
% 210.27/210.43 |- skos__altLabel mesh__D013726 Estedi Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726 Terbasmin
% 210.27/210.43 |- skos__altLabel mesh__D013726 Dermapharm Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726 Bricanyl SA
% 210.27/210.43 |- skos__altLabel mesh__D013726 Hexal Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726 Alpharma Brand of Terbutaline Sulfate
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D013726 2006
% 210.27/210.43 |- rdf__type mesh__D013726sskos__Concept
% 210.27/210.43 |- skos__scopeNote mesh__D013726
% 210.27/210.43 A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.%A%
% 210.27/210.43 |- skos__altLabel mesh__D013726 Lindopharm Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726 Fatol Brand of Terbutaline Sulfate
% 210.27/210.43 |- mesh__dateCreated mesh__D013726 1999-01-01
% 210.27/210.43 |- skos__hiddenLabel mesh__D013726
% 210.27/210.43 ct Arzneimittel Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726 Hoechst Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726
% 210.27/210.43 ct-Arzneimittel Brand of Terbutaline Sulfate
% 210.27/210.43 |- mesh__dateRevised mesh__D013726 2005-06-30
% 210.27/210.43 |- skos__altLabel mesh__D013726 Stadapharm Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726 Kendrick Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726 ratiopharm Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__prefLabel mesh__D013726 Terbutaline
% 210.27/210.43 |- skos__altLabel mesh__D013726 Azupharma Brand of Terbutaline Sulfate
% 210.27/210.43 |- skos__altLabel mesh__D013726 pharma-stern Brand of Terbutaline Sulfate
% 210.27/210.43 |- mesh__recordOriginator mesh__D013726 NLM
% 210.27/210.43 |- skos__altLabel mesh__D013726 AstraZeneca Brand of Terbutaline Sulfate
% 210.27/210.43 |- mesh__dateEstablished mesh__D013726 1974-01-01
% 210.27/210.43 |- skos__broader mesh__D013726smesh__D004983
% 210.27/210.43 |- mesh__historyNote mesh__D013726 74
% 210.27/210.43 |- mesh__publicMeSHNote mesh__D013726 74
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018411 2006
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018411 2005
% 210.27/210.43 |- mesh__activeMeSHYear mesh__D018411 2004
% 210.27/210.43 |- skos__annotation mesh__D018411
% 210.27/210.43 a genus of moths; /microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111%A%
% 210.27/210.43 |- rdf__type mesh__D018411sskos__Concept
% 210.27/210.43 |- mesh__dateEstablished mesh__D018411 1995-01-01
% 210.27/210.43 |- mesh__dateCreated mesh__D018411 1994-01-25
% 210.27/210.44 |- skos__historyNote mesh__D018411 Moths %28%1975-1994%29%
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D018411 95
% 210.27/210.44 |- skos__historyNote mesh__D018411 Lepidoptera %28%1975-1990%29%
% 210.27/210.44 |- skos__scopeNote mesh__D018411
% 210.27/210.44 A genus of owlet moths of the family Noctuidae. These insects are used in molecular biology studies during all stages of their life cycle.%A%
% 210.27/210.44 |- mesh__historyNote mesh__D018411 95
% 210.27/210.44 |- mesh__dateRevised mesh__D018411 2003-07-09
% 210.27/210.44 |- skos__broader mesh__D018411smesh__D009036
% 210.27/210.44 |- skos__prefLabel mesh__D018411 Spodoptera
% 210.27/210.44 |- skos__historyNote mesh__D018411 Insects %28%1966-1974%29%
% 210.27/210.44 |- mesh__recordOriginator mesh__D051845 DRC
% 210.27/210.44 |- skos__broader mesh__D051845smesh__D051843
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D051845 sjn
% 210.27/210.44 |- skos__altLabel mesh__D051845 Synoretin
% 210.27/210.44 |- mesh__dateCreated mesh__D051845 2005-06-30
% 210.27/210.44 |- mesh__dateEstablished mesh__D051845 2006-01-01
% 210.27/210.44 |- skos__scopeNote mesh__D051845
% 210.27/210.44 A homolog of ALPHA-SYNUCLEIN that plays a role in neurofilament network integrity. It is overexpressed in a variety of human NEOPLASMS and may be involved in modulating AXON architecture during EMBRYONIC DEVELOPMENT and in the adult. Gamma-Synuclein may also activate SIGNAL TRANSDUCTION PATHWAYS associated with ETS-DOMAIN PROTEIN ELK-1.%A%
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D051845
% 210.27/210.44 2006; GAMMA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A%
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D051845 2006
% 210.27/210.44 |- skos__hiddenLabel mesh__D051845 gamma Synuclein
% 210.27/210.44 |- rdf__type mesh__D051845sskos__Concept
% 210.27/210.44 |- mesh__historyNote mesh__D051845 2006%28%1988%29%
% 210.27/210.44 |- skos__prefLabel mesh__D051845 gamma-Synuclein
% 210.27/210.44 |- mesh__recordMaintainer mesh__D051845 DRC
% 210.27/210.44 |- skos__altLabel mesh__D051845 Persyn
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047 Acetyltransferase, Dihydrolipoamide
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047 S-Acetyltransferase, Dihydrolipoamide
% 210.27/210.44 |- skos__altLabel mesh__D051047 Lipoate Acetyltransferase
% 210.27/210.44 |- rdf__type mesh__D051047sskos__Concept
% 210.27/210.44 |- skos__altLabel mesh__D051047 Dihydrolipoyl Transacetylase
% 210.27/210.44 |- skos__altLabel mesh__D051047 Dihydrolipoamide Acetyltransferase
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047 Dihydrolipoamide S Acetyltransferase
% 210.27/210.44 |- mesh__dateEstablished mesh__D051047 2006-01-01
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D051047 sjn
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047
% 210.27/210.44 Dihydrolipoyllysine Residue Acetyltransferase
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047
% 210.27/210.44 Acetyltransferase, Dihydrolipoyllysine-Residue
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047 Acetyltransferase, Dihydrolipoyl
% 210.27/210.44 |- skos__altLabel mesh__D051047 Dihydrolipoyl Acetyltransferase
% 210.27/210.44 |- skos__altLabel mesh__D051047 Dihydrolipoamide S-Acetyltransferase
% 210.27/210.44 |- skos__broader mesh__D051047smesh__D011768
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D051047
% 210.27/210.44 2006; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1968-2005, under ACETYLTRANSFERASES 1968-1973, under LIPOIC ACID 1968-1982; PYRUVATE DEHYDROGENASE COMPLEX E2 was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1994-2005%A%
% 210.27/210.44 |- mesh__historyNote mesh__D051047
% 210.27/210.44 2006%28%1980%29%; use PYRUVATE DEHYDROGENASE COMPLEX, ACETYLTRANSFERASES %26% under LIPOIC ACID 1968-1979%A%
% 210.27/210.44 |- mesh__recordOriginator mesh__D051047 AKE
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047
% 210.27/210.44 Acetyl CoA Dihydrolipoamide S Acetyltransferase
% 210.27/210.44 |- skos__altLabel mesh__D051047 Pyruvate Dehydrogenase Complex E2
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047
% 210.27/210.44 S-Acetyltransferase, Acetyl-CoA-Dihydrolipoamide
% 210.27/210.44 |- skos__broader mesh__D051047smesh__D000123
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047 Acetyltransferase, Lipoate
% 210.27/210.44 |- skos__scopeNote mesh__D051047
% 210.27/210.44 An enzyme that catalyzes the acetyltransferase reaction using ACETYL CoA as an acetyl donor and dihydrolipoamide as acceptor to produce COENZYME A %28%CoA%29% and S-acetyldihydrolipoamide. It forms the %28%E2%29% subunit of the PYRUVATE DEHYDROGENASE COMPLEX.%A%
% 210.27/210.44 |- mesh__recordMaintainer mesh__D051047 AKE
% 210.27/210.44 |- mesh__dateCreated mesh__D051047 2005-06-30
% 210.27/210.44 |- skos__altLabel mesh__D051047
% 210.27/210.44 Acetyl-CoA-Dihydrolipoamide S-Acetyltransferase
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D051047 2006
% 210.27/210.44 |- skos__prefLabel mesh__D051047
% 210.27/210.44 Dihydrolipoyllysine-Residue Acetyltransferase
% 210.27/210.44 |- skos__hiddenLabel mesh__D051047 Transacetylase, Dihydrolipoyl
% 210.27/210.44 |- skos__prefLabel mesh__D045808 Refusal to Participate
% 210.27/210.44 |- skos__hiddenLabel mesh__D045808 Participate, Refusal to
% 210.27/210.44 |- mesh__dateEstablished mesh__D045808 2004-01-01
% 210.27/210.44 |- skos__scopeNote mesh__D045808
% 210.27/210.44 Refusal to take part in activities or procedures that are requested or expected of an individual. This may include refusal by HEALTH PERSONNEL to participate in specific medical procedures or refusal by PATIENTS or members of the public to take part in CLINICAL TRIALS or health promotion programs.%A%
% 210.27/210.44 |- skos__related mesh__D045808smesh__D016312
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D045808 2005
% 210.27/210.44 |- mesh__recordMaintainer mesh__D045808 jls
% 210.27/210.44 |- mesh__recordOriginator mesh__D045808 jls
% 210.27/210.44 |- skos__broader mesh__D045808smesh__D034462
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D045808 sjn
% 210.27/210.44 |- skos__related mesh__D045808smesh__D010358
% 210.27/210.44 |- mesh__historyNote mesh__D045808 2004; use DISSENT AND DISPUTES 2003
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D045808 2004
% 210.27/210.44 |- mesh__dateCreated mesh__D045808 2003-07-22
% 210.27/210.44 |- skos__related mesh__D045808smesh__D003242
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D045808
% 210.27/210.44 2004; see DISSENT AND DISPUTES 2003
% 210.27/210.44 |- rdf__type mesh__D045808sskos__Concept
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D045808 2006
% 210.27/210.44 |- skos__related mesh__D045808smesh__D016079
% 210.27/210.44 |- skos__hiddenLabel mesh__D009685 Membrane, Nuclear
% 210.27/210.44 |- mesh__dateCreated mesh__D009685 1976-05-19
% 210.27/210.44 |- mesh__dateRevised mesh__D009685 2003-07-09
% 210.27/210.44 |- skos__hiddenLabel mesh__D009685 Nuclear Membranes
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009685 2004
% 210.27/210.44 |- skos__hiddenLabel mesh__D009685 Membranes, Nuclear
% 210.27/210.44 |- mesh__historyNote mesh__D009685 2001
% 210.27/210.44 |- skos__hiddenLabel mesh__D009685 Envelopes, Nuclear
% 210.27/210.44 |- skos__historyNote mesh__D009685 Cell Membrane %28%1966-1976%29%
% 210.27/210.44 |- mesh__recordOriginator mesh__D009685 VDK
% 210.27/210.44 |- skos__hiddenLabel mesh__D009685 Envelope, Nuclear
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009685 2005
% 210.27/210.44 |- skos__altLabel mesh__D009685 Nuclear Membrane
% 210.27/210.44 |- skos__broader mesh__D009685smesh__D007425
% 210.27/210.44 |- skos__scopeNote mesh__D009685
% 210.27/210.44 The membrane system of the CELL NUCLEUS that surrounds the nucleoplasm. It consists of two concentric membranes separated by the perinuclear space. The structures of the envelope where it opens to the cytoplasm are called the nuclear pores %28%NUCLEAR PORE%29%.%A%
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009685 2006
% 210.27/210.44 |- skos__historyNote mesh__D009685 Membranes %28%1968-1976%29%
% 210.27/210.44 |- skos__broader mesh__D009685smesh__D021961
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D009685
% 210.27/210.44 2001; for NUCLEAR ENVELOPE see NUCLEAR MEMBRANE 1977-2000%A%
% 210.27/210.44 |- skos__broader mesh__D009685smesh__D022003
% 210.27/210.44 |- skos__historyNote mesh__D009685 Cell Nucleus %28%1966-1976%29%
% 210.27/210.44 |- skos__hiddenLabel mesh__D009685 Nuclear Envelopes
% 210.27/210.44 |- rdf__type mesh__D009685sskos__Concept
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D009685 sjn
% 210.27/210.44 |- mesh__recordMaintainer mesh__D009685 nns
% 210.27/210.44 |- mesh__dateEstablished mesh__D009685 1977-01-01
% 210.27/210.44 |- skos__prefLabel mesh__D009685 Nuclear Envelope
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D017319 sjn
% 210.27/210.44 |- skos__related mesh__D017319smesh__D010778
% 210.27/210.44 |- skos__broader mesh__D017319smesh__D003879
% 210.27/210.44 |- mesh__recordMaintainer mesh__D017319 ssb
% 210.27/210.44 |- mesh__historyNote mesh__D017319 93
% 210.27/210.44 |- skos__hiddenLabel mesh__D017319 Agents, Photosensitizing
% 210.27/210.44 |- skos__related mesh__D017319smesh__D011701
% 210.27/210.44 |- skos__annotation mesh__D017319
% 210.27/210.44 GEN or unspecified; prefer specifics; D25-26 qualif
% 210.27/210.44 |- mesh__recordOriginator mesh__D017319 TPW
% 210.27/210.44 |- mesh__dateCreated mesh__D017319 1992-05-22
% 210.27/210.44 |- skos__altLabel mesh__D017319 Photosensitizers
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D017319 2006
% 210.27/210.44 |- skos__related mesh__D017319smesh__D006414
% 210.27/210.44 |- mesh__dateRevised mesh__D017319 2005-06-30
% 210.27/210.44 |- skos__broader mesh__D017319smesh__D011838
% 210.27/210.44 |- rdf__type mesh__D017319sskos__Concept
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D017319 93
% 210.27/210.44 |- skos__scopeNote mesh__D017319
% 210.27/210.44 Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.%A%
% 210.27/210.44 |- skos__prefLabel mesh__D017319 Photosensitizing Agents
% 210.27/210.44 |- mesh__dateEstablished mesh__D017319 1993-01-01
% 210.27/210.44 |- skos__altLabel mesh__D028041 Hydrocotyle asiatica
% 210.27/210.44 |- mesh__dateCreated mesh__D028041 2001-07-25
% 210.27/210.44 |- mesh__recordMaintainer mesh__D028041 ags
% 210.27/210.44 |- skos__historyNote mesh__D028041 Plants, Medicinal %28%1967-2001%29%
% 210.27/210.44 |- skos__altLabel mesh__D028041 Hydrocotyle
% 210.27/210.44 |- skos__annotation mesh__D028041
% 210.27/210.44 for Cola or Kola see COLA, for Bitter Kola check if COLA or GARCINIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.27/210.44 |- mesh__dateEstablished mesh__D028041 2002-01-01
% 210.27/210.44 |- skos__scopeNote mesh__D028041
% 210.27/210.44 A plant of the family APIACEAE which is the source of asiatic acid and asiaticoside. Centella asiatica %28%L.%29% Urb. = Hydrocotyle asiatica L. is known for effect on peripheral circulation.%A%
% 210.27/210.44 |- skos__altLabel mesh__D028041 Gotu kola
% 210.27/210.44 |- skos__broader mesh__D028041smesh__D019661
% 210.27/210.44 |- rdf__type mesh__D028041sskos__Concept
% 210.27/210.44 |- skos__altLabel mesh__D028041 Mandukaparni
% 210.27/210.44 |- mesh__historyNote mesh__D028041 2002
% 210.27/210.44 |- skos__prefLabel mesh__D028041 Centella
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D028041 2002
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D028041 2006
% 210.27/210.44 |- mesh__recordOriginator mesh__D028041 ssb
% 210.27/210.44 |- mesh__dateRevised mesh__D028041 2005-06-30
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D028041 sjn
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014021 2006
% 210.27/210.44 |- skos__scopeNote mesh__D014021
% 210.27/210.44 The process by which a tissue or aggregate of cells is kept alive outside of the organism from which it was derived %28%i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism%29%.%A%
% 210.27/210.44 |- skos__prefLabel mesh__D014021 Tissue Preservation
% 210.27/210.44 |- mesh__dateCreated mesh__D014021 1999-01-01
% 210.27/210.44 |- skos__annotation mesh__D014021
% 210.27/210.44 GEN: prefer specifics; cryopreservation of tissue: coord specific tissue heading %28%no qualif%29% + CRYOPRESERVATION; ORGAN PRESERVATION is also available%A%
% 210.27/210.44 |- mesh__recordMaintainer mesh__D014021 NLM
% 210.27/210.44 |- skos__broader mesh__D014021smesh__D011309
% 210.27/210.44 |- mesh__dateRevised mesh__D014021 2004-07-20
% 210.27/210.44 |- mesh__historyNote mesh__D014021 67
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D014021 NLM
% 210.27/210.44 |- mesh__dateEstablished mesh__D014021 1967-01-01
% 210.27/210.44 |- rdf__type mesh__D014021sskos__Concept
% 210.27/210.44 |- skos__broader mesh__D014021smesh__D016591
% 210.27/210.44 |- skos__related mesh__D014021smesh__D020858
% 210.27/210.44 |- skos__historyNote mesh__D014021 Tissue Banks %28%1966%29%
% 210.27/210.44 |- skos__hiddenLabel mesh__D014021 Preservation, Tissue
% 210.27/210.44 |- mesh__recordOriginator mesh__D014021 NLM
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014021 2005
% 210.27/210.44 |- skos__hiddenLabel mesh__D014021 Tissue Preservations
% 210.27/210.44 |- skos__hiddenLabel mesh__D014021 Preservations, Tissue
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D014021 67
% 210.27/210.44 |- mesh__dateRevised mesh__D000001 2003-07-30
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D000001 2004
% 210.27/210.44 |- mesh__dateCreated mesh__D000001 1974-11-19
% 210.27/210.44 |- skos__altLabel mesh__D000001 A23187
% 210.27/210.44 |- mesh__historyNote mesh__D000001
% 210.27/210.44 91%28%75%29%; was A 23187 1975-90 %28%see under ANTIBIOTICS 1975-83%29%%A%
% 210.27/210.44 |- mesh__recordMaintainer mesh__D000001 SYSTEM
% 210.27/210.44 |- skos__historyNote mesh__D000001 Carboxylic Acids %28%1973-1974%29%
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D000001 2006
% 210.27/210.44 |- mesh__recordOriginator mesh__D000001 NLM
% 210.27/210.44 |- skos__broader mesh__D000001smesh__D001583
% 210.27/210.44 |- skos__scopeNote mesh__D000001
% 210.27/210.44 An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.%A%
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D000001 2005
% 210.27/210.44 |- skos__altLabel mesh__D000001 Antibiotic A23187
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D000001
% 210.27/210.44 91; was A 23187 1975-90 %28%see under ANTIBIOTICS 1975-83%29%
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D000001 NLM
% 210.27/210.44 |- mesh__onlineNote mesh__D000001
% 210.27/210.44 use CALCIMYCIN to search A 23187 1975-90
% 210.27/210.44 |- skos__historyNote mesh__D000001 Antibiotics %28%1973-1974%29%
% 210.27/210.44 |- skos__hiddenLabel mesh__D000001 A 23187
% 210.27/210.44 |- rdf__type mesh__D000001sskos__Concept
% 210.27/210.44 |- skos__hiddenLabel mesh__D000001 A23187, Antibiotic
% 210.27/210.44 |- mesh__dateEstablished mesh__D000001 1984-01-01
% 210.27/210.44 |- skos__prefLabel mesh__D000001 Calcimycin
% 210.27/210.44 |- mesh__recordMaintainer mesh__D052140 ags
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D052140 sjn
% 210.27/210.44 |- skos__historyNote mesh__D052140 Papillomavirus, Human %28%1994-2005%29%
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D052140 2006
% 210.27/210.44 |- mesh__recordOriginator mesh__D052140 ags
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D052140 2006
% 210.27/210.44 |- skos__historyNote mesh__D052140 Papillomavirus %28%1983-1993%29%
% 210.27/210.44 |- skos__altLabel mesh__D052140 Human papillomavirus type 11
% 210.27/210.44 |- skos__hiddenLabel mesh__D052140 HPV 11
% 210.27/210.44 |- skos__altLabel mesh__D052140 HPV-11
% 210.27/210.44 |- skos__prefLabel mesh__D052140 Human papillomavirus 11
% 210.27/210.44 |- skos__hiddenLabel mesh__D052140 papillomavirus 11, Human
% 210.27/210.44 |- mesh__dateEstablished mesh__D052140 2006-01-01
% 210.27/210.44 |- skos__broader mesh__D052140smesh__D018145
% 210.27/210.44 |- mesh__historyNote mesh__D052140 2006
% 210.27/210.44 |- mesh__dateCreated mesh__D052140 2005-06-30
% 210.27/210.44 |- skos__scopeNote mesh__D052140
% 210.27/210.44 A type of HUMAN PAPILLOMAVIRUS causing recurrent respiratory PAPILLOMATOSIS; GENITAL WARTS; and other neoplasms.%A%
% 210.27/210.44 |- skos__annotation mesh__D052140
% 210.27/210.44 infection: coordinate IM with GENITAL WARTS %28%IM%29% or PAPILLOMAVIRUS INFECTIONS %28%IM%29% + PAPILLOMATOSIS %28%IM%29% or other neoplasms term %28%IM%29% if pertinent%A%
% 210.27/210.44 |- rdf__type mesh__D052140sskos__Concept
% 210.27/210.44 |- mesh__dateCreated mesh__D005295 1999-01-01
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D005295 2004
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D005295 SJN
% 210.27/210.44 |- rdf__type mesh__D005295sskos__Concept
% 210.27/210.44 |- mesh__dateRevised mesh__D005295 1997-06-20
% 210.27/210.44 |- skos__scopeNote mesh__D005295
% 210.27/210.44 Inorganic salts of the hypothetical acid ferrocyanic acid %28%H4Fe%28%CN%29%6%29%.%A%
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D005295 66
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D005295 2005
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D005295 1998
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D005295 2000
% 210.27/210.44 |- skos__broader mesh__D005295smesh__D003486
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D005295 2006
% 210.27/210.44 |- mesh__recordOriginator mesh__D005295 NLM
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D005295 1999
% 210.27/210.44 |- mesh__historyNote mesh__D005295 66
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D005295 2001
% 210.27/210.44 |- skos__prefLabel mesh__D005295 Ferrocyanides
% 210.27/210.44 |- skos__broader mesh__D005295smesh__D005296
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D005295 2002
% 210.27/210.44 |- mesh__recordMaintainer mesh__D005295 TGC
% 210.27/210.44 |- skos__annotation mesh__D005295 do not confuse with FERRICYANIDES
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D005295 2003
% 210.27/210.44 |- skos__scopeNote mesh__D013727
% 210.27/210.44 Medical and nursing care of patients in the terminal stage of an illness.%A%
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D013727 2004
% 210.27/210.44 |- mesh__dateCreated mesh__D013727 1999-01-01
% 210.27/210.44 |- skos__related mesh__D013727smesh__D032722
% 210.27/210.44 |- skos__prefLabel mesh__D013727 Terminal Care
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D013727 2005
% 210.27/210.44 |- mesh__recordOriginator mesh__D013727 NLM
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D013727 2003
% 210.27/210.44 |- skos__related mesh__D013727smesh__D017051
% 210.27/210.44 |- skos__hiddenLabel mesh__D013727 Care, Terminal
% 210.27/210.44 |- skos__annotation mesh__D013727
% 210.27/210.44 med %26% nurs care for the patient: TERMINALLY ILL refers to the patient; also available is HOSPICE CARE %28%palliative %26% supportive care for the patient %26% family%29%%A%
% 210.27/210.44 |- mesh__recordMaintainer mesh__D013727 jrf
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D013727 sjn
% 210.27/210.44 |- mesh__historyNote mesh__D013727 68%28%64%29%
% 210.27/210.44 |- skos__related mesh__D013727smesh__D010166
% 210.27/210.44 |- skos__related mesh__D013727smesh__D008020
% 210.27/210.44 |- mesh__dateEstablished mesh__D013727 1968-01-01
% 210.27/210.44 |- mesh__dateRevised mesh__D013727 2002-07-03
% 210.27/210.44 |- skos__broader mesh__D013727smesh__D005791
% 210.27/210.44 |- rdf__type mesh__D013727sskos__Concept
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D013727 2006
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D013727 68
% 210.27/210.44 |- skos__broader mesh__D051846smesh__D051843
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D051846
% 210.27/210.44 2006; BETA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A%
% 210.27/210.44 |- mesh__recordMaintainer mesh__D051846 DRC
% 210.27/210.44 |- mesh__dateEstablished mesh__D051846 2006-01-01
% 210.27/210.44 |- skos__prefLabel mesh__D051846 beta-Synuclein
% 210.27/210.44 |- skos__altLabel mesh__D051846 Phosphoneuroprotein 14
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D051846 sjn
% 210.27/210.44 |- skos__hiddenLabel mesh__D051846 beta Synuclein
% 210.27/210.44 |- mesh__dateCreated mesh__D051846 2005-06-30
% 210.27/210.44 |- mesh__recordOriginator mesh__D051846 DRC
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D051846 2006
% 210.27/210.44 |- rdf__type mesh__D051846sskos__Concept
% 210.27/210.44 |- mesh__historyNote mesh__D051846 2006%28%1988%29%
% 210.27/210.44 |- skos__scopeNote mesh__D051846
% 210.27/210.44 A synuclein that is closely related to ALPHA-SYNUCLEIN. It may play a neuroprotective role against some of the toxic effects of aggregated ALPHA-SYNUCLEIN.%A%
% 210.27/210.44 |- skos__altLabel mesh__D051048
% 210.27/210.44 Palmitoyl-CoA-sn-1,2-Diacylglycerol Acyltransferase
% 210.27/210.44 |- mesh__dateCreated mesh__D051048 2005-06-30
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048
% 210.27/210.44 Acyltransferase, Palmitoyl-Coenzyme A-sn-1,2-Diacylglycerol
% 210.27/210.44 |- skos__altLabel mesh__D051048 Diacylglycerol O-Acyltransferase 1
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048 Acyltransferase, Diacylglycerol
% 210.27/210.44 |- skos__altLabel mesh__D051048 DAGAT Enzyme
% 210.27/210.44 |- mesh__historyNote mesh__D051048
% 210.27/210.44 2006%28%1980%29%; use ACETYLTRANSFERASES 1973-1979, %26% GLYCERIDES 1973-1975%A%
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D051048 2006A
% 210.27/210.44 |- skos__broader mesh__D051048smesh__D000217
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048 Diacylglycerol O Acyltransferase 1
% 210.27/210.44 |- mesh__recordMaintainer mesh__D051048 ags
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048 Acyltransferase 1, Diglyceride
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048 O-Acyltransferase, Diacylglycerol
% 210.27/210.44 |- mesh__dateEstablished mesh__D051048 2006-01-01
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D051048 2006
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048 O-Acyltransferase 1, Diacylglycerol
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048
% 210.27/210.44 A-sn-1,2-Diacylglycerol Acyltransferase, Palmitoyl-Coenzyme
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048
% 210.27/210.44 Palmitoyl CoA sn 1,2 Diacylglycerol Acyltransferase
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048
% 210.27/210.44 Palmitoyl Coenzyme A sn 1,2 Diacylglycerol Acyltransferase
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048
% 210.27/210.44 Acyltransferase, Palmitoyl-CoA-sn-1,2-Diacylglycerol
% 210.27/210.44 |- skos__altLabel mesh__D051048
% 210.27/210.44 Acyl-Coenzyme A Diacyl-glycerol Acyltransferase
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048 Diacylglycerol O Acyltransferase
% 210.27/210.44 |- mesh__dateRevised mesh__D051048 2005-07-13
% 210.27/210.44 |- skos__altLabel mesh__D051048 Diacylglycerol Acyltransferase
% 210.27/210.44 |- mesh__recordOriginator mesh__D051048 AKE
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D051048 ags
% 210.27/210.44 |- rdf__type mesh__D051048sskos__Concept
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048
% 210.27/210.44 Acyl Coenzyme A Diacyl glycerol Acyltransferase
% 210.27/210.44 |- skos__altLabel mesh__D051048
% 210.27/210.44 Palmitoyl-Coenzyme A-sn-1,2-Diacylglycerol Acyltransferase
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D051048
% 210.27/210.44 2006; DIACYLGLYCEROL O-ACYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, %26% GLYCERIDES 1973-1975%A%
% 210.27/210.44 |- skos__hiddenLabel mesh__D051048 Acyltransferase, Diglyceride
% 210.27/210.44 |- skos__altLabel mesh__D051048 Diglyceride Acyltransferase
% 210.27/210.44 |- skos__scopeNote mesh__D051048
% 210.27/210.44 An enzyme that catalyses the last step of the TRIACYLGLYCEROL synthesis reaction in which diacylglycerol is covalently joined to LONG-CHAIN ACYL COA to form triglyceride. It was formerly categorized as EC 2.3.1.124.%A%
% 210.27/210.44 |- skos__prefLabel mesh__D051048 Diacylglycerol O-Acyltransferase
% 210.27/210.44 |- skos__broader mesh__D045809smesh__D012940
% 210.27/210.44 |- skos__related mesh__D045809smesh__D006806
% 210.27/210.44 |- mesh__dateEstablished mesh__D045809 2004-01-01
% 210.27/210.44 |- skos__hiddenLabel mesh__D045809 Human Rights Abuse
% 210.27/210.44 |- skos__related mesh__D045809smesh__D014858
% 210.27/210.44 |- skos__hiddenLabel mesh__D045809 Abuse, Human Rights
% 210.27/210.44 |- skos__scopeNote mesh__D045809
% 210.27/210.44 Deliberate maltreatment of groups of humans beings including violations of generally-accepted fundamental rights as stated by the Universal Declaration of Human Rights, adopted and proclaimed by the United Nations General Assembly resolution 217 A %28%III%29% of 10 December 1948.%A%
% 210.27/210.44 |- skos__historyNote mesh__D045809 Human Rights %28%1973-2003%29%
% 210.27/210.44 |- rdf__type mesh__D045809sskos__Concept
% 210.27/210.44 |- mesh__dateCreated mesh__D045809 2003-07-09
% 210.27/210.44 |- skos__prefLabel mesh__D045809 Human Rights Abuses
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D045809 2006
% 210.27/210.44 |- mesh__dateRevised mesh__D045809 2004-07-13
% 210.27/210.44 |- skos__hiddenLabel mesh__D045809 Rights Abuse, Human
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D045809 2005
% 210.27/210.44 |- skos__related mesh__D045809smesh__D014104
% 210.27/210.44 |- mesh__recordMaintainer mesh__D045809 sjn
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D045809 sjn
% 210.27/210.44 |- skos__hiddenLabel mesh__D045809 Rights Abuses, Human
% 210.27/210.44 |- mesh__historyNote mesh__D045809 2004
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D045809 2004
% 210.27/210.44 |- mesh__recordOriginator mesh__D045809 jls
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D009686 NLM
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 2005
% 210.27/210.44 |- skos__hiddenLabel mesh__D009686 Nuclear Physic
% 210.27/210.44 |- skos__annotation mesh__D009686 SPEC: SPEC qualif
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1996
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 2002
% 210.27/210.44 |- mesh__recordOriginator mesh__D009686 NLM
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 2006
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1992
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1997
% 210.27/210.44 |- skos__broader mesh__D009686smesh__D010825
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1993
% 210.27/210.44 |- mesh__recordMaintainer mesh__D009686 CAB
% 210.27/210.44 |- rdf__type mesh__D009686sskos__Concept
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1998
% 210.27/210.44 |- skos__prefLabel mesh__D009686 Nuclear Physics
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1990
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 2003
% 210.27/210.44 |- skos__hiddenLabel mesh__D009686 Physic, Nuclear
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 2000
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1999
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1994
% 210.27/210.44 |- mesh__dateRevised mesh__D009686 1976-05-12
% 210.27/210.44 |- mesh__dateCreated mesh__D009686 1999-01-01
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1991
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 2004
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1989
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 1995
% 210.27/210.44 |- skos__hiddenLabel mesh__D009686 Physics, Nuclear
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D009686 2001
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D028042 2004
% 210.27/210.44 |- skos__broader mesh__D028042smesh__D019661
% 210.27/210.44 |- skos__historyNote mesh__D028042 Anise %28%2001-2002%29%
% 210.27/210.44 |- skos__prefLabel mesh__D028042 Pimpinella
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D028042 2005
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D028042 sjn
% 210.27/210.44 |- rdf__type mesh__D028042sskos__Concept
% 210.27/210.44 |- mesh__dateEstablished mesh__D028042 2002-01-01
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D028042 2006
% 210.27/210.44 |- skos__annotation mesh__D028042
% 210.27/210.44 distinguish from Star Anise %28%ILLICIUM%29%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D028042
% 210.27/210.44 2003; see ANISE 2001-2002, see APIACEAE 1988-2001
% 210.27/210.44 |- mesh__dateRevised mesh__D028042 2002-07-02
% 210.27/210.44 |- mesh__recordMaintainer mesh__D028042 ssb
% 210.27/210.44 |- mesh__recordOriginator mesh__D028042 ssb
% 210.27/210.44 |- skos__scopeNote mesh__D028042
% 210.27/210.44 A plant genus in the family APIACEAE %28%Umbelliferae%29% that is used in SPICES and is a source of anethole.%A%
% 210.27/210.44 |- mesh__historyNote mesh__D028042 2003; use APIACEAE 1998-2001
% 210.27/210.44 |- mesh__dateCreated mesh__D028042 2001-07-25
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D028042 2003
% 210.27/210.44 |- skos__scopeNote mesh__D014820
% 210.27/210.44 A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.%A%
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 2005
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 1998
% 210.27/210.44 |- mesh__recordOriginator mesh__D014820 NLM
% 210.27/210.44 |- mesh__recordMaintainer mesh__D014820 TGC
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D014820 PLS
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 1997
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 2004
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 2002
% 210.27/210.44 |- skos__broader mesh__D014820smesh__D017496
% 210.27/210.44 |- skos__prefLabel mesh__D014820 Vitiligo
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 2003
% 210.27/210.44 |- skos__annotation mesh__D014820 macular depigmentation
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 1996
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 1995
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 2001
% 210.27/210.44 |- mesh__dateRevised mesh__D014820 1993-06-03
% 210.27/210.44 |- mesh__dateCreated mesh__D014820 1999-01-01
% 210.27/210.44 |- rdf__type mesh__D014820sskos__Concept
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 1994
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 2000
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 1999
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014820 2006
% 210.27/210.44 |- skos__hiddenLabel mesh__D014022 Viability, Organ
% 210.27/210.44 |- mesh__recordOriginator mesh__D014022 NLM
% 210.27/210.44 |- mesh__dateCreated mesh__D014022 1999-01-01
% 210.27/210.44 |- mesh__historyNote mesh__D014022
% 210.27/210.44 76%28%71%29%; was see under CYTOLOGY 1975
% 210.27/210.44 |- mesh__dateRevised mesh__D014022 2004-07-07
% 210.27/210.44 |- skos__hiddenLabel mesh__D014022 Viability, Tissue
% 210.27/210.44 |- skos__historyNote mesh__D014022 Tissue Preservation %28%1966-1970%29%
% 210.27/210.44 |- skos__historyNote mesh__D014022 Tissue Culture %28%1966-1970%29%
% 210.27/210.44 |- mesh__recordMaintainer mesh__D014022 nns
% 210.27/210.44 |- rdf__type mesh__D014022sskos__Concept
% 210.27/210.44 |- skos__historyNote mesh__D014022 specific organ or tissue
% 210.27/210.44 |- skos__hiddenLabel mesh__D014022 Survival, Tissue
% 210.27/210.44 |- skos__historyNote mesh__D014022
% 210.27/210.44 Preservation, Biological %28%1966-1970%29%
% 210.27/210.44 |- skos__broader mesh__D014022smesh__D001686
% 210.27/210.44 |- mesh__recordAuthorizer mesh__D014022 sjn
% 210.27/210.44 |- mesh__activeMeSHYear mesh__D014022 2005
% 210.27/210.44 |- skos__prefLabel mesh__D014022 Tissue Survival
% 210.27/210.44 |- mesh__publicMeSHNote mesh__D014022 76; was see under CYTOLOGY 1975
% 210.27/210.44 |- skos__scopeNote mesh__D014022
% 210.27/210.44 The span of viability of a tissue or an organ.
% 210.27/210.44 |- skos__hiddenLabel mesh__D014022 Survival, Organ
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014022 2006
% 210.27/210.45 |- skos__historyNote mesh__D014022 Transplantation %28%1966-1970%29%
% 210.27/210.45 |- mesh__dateEstablished mesh__D014022 1976-01-01
% 210.27/210.45 |- skos__broader mesh__D000800smesh__D017130
% 210.27/210.45 |- skos__hiddenLabel mesh__D000800 Transluminal Arterial Dilatation
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D000800
% 210.27/210.45 93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92%A%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000800 1999
% 210.27/210.45 |- mesh__dateRevised mesh__D000800 1997-06-20
% 210.27/210.45 |- skos__annotation mesh__D000800
% 210.27/210.45 coord IM with disease /ther %28%IM%29%, not /surg
% 210.27/210.45 |- skos__hiddenLabel mesh__D000800 Angioplasty, Percutaneous Transluminal
% 210.27/210.45 |- skos__scopeNote mesh__D000800
% 210.27/210.45 Use of a balloon catheter for dilatation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of balloon dilatation in coronary arteries, ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY is available.%A%
% 210.27/210.45 |- mesh__dateCreated mesh__D000800 1981-02-23
% 210.27/210.45 |- skos__altLabel mesh__D000800 Dilatation, Transluminal Arterial
% 210.27/210.45 |- mesh__recordMaintainer mesh__D000800 PXP
% 210.27/210.45 |- skos__hiddenLabel mesh__D000800 Transluminal Angioplasty
% 210.27/210.45 |- skos__hiddenLabel mesh__D000800 Dilatations, Transluminal Arterial
% 210.27/210.45 |- skos__altLabel mesh__D000800 Balloon Angioplasty
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000800 2000
% 210.27/210.45 |- skos__historyNote mesh__D000800
% 210.27/210.45 specific arterial occlusive disease %28%1966-1981%29%
% 210.27/210.45 |- mesh__recordOriginator mesh__D000800 SMH
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000800 2005
% 210.27/210.45 |- mesh__dateEstablished mesh__D000800 1982-01-01
% 210.27/210.45 |- skos__altLabel mesh__D000800 Percutaneous Transluminal Angioplasty
% 210.27/210.45 |- skos__altLabel mesh__D000800 Angioplasty, Transluminal
% 210.27/210.45 |- mesh__onlineNote mesh__D000800
% 210.27/210.45 use ANGIOPLASTY, BALLOON to search ANGIOPLASTY, TRANSLUMINAL 1982-92%A%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000800 2001
% 210.27/210.45 |- skos__broader mesh__D000800smesh__D001451
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000800 2006
% 210.27/210.45 |- skos__historyNote mesh__D000800
% 210.27/210.45 Arterial Occlusive Diseases %28%1973-1981%29%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000800 2003
% 210.27/210.45 |- rdf__type mesh__D000800sskos__Concept
% 210.27/210.45 |- skos__hiddenLabel mesh__D000800 Transluminal Angioplasty, Percutaneous
% 210.27/210.45 |- skos__historyNote mesh__D000800 Dilatation %28%1968-1981%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D000800 Arterial Dilatations, Transluminal
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000800 2002
% 210.27/210.45 |- skos__historyNote mesh__D000800 Catheterization %28%1966-1981%29%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000800 1998
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000800 2004
% 210.27/210.45 |- skos__prefLabel mesh__D000800 Angioplasty, Balloon
% 210.27/210.45 |- mesh__historyNote mesh__D000800
% 210.27/210.45 93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92%A%
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D000800 SJN
% 210.27/210.45 |- skos__hiddenLabel mesh__D000800 Transluminal Arterial Dilatations
% 210.27/210.45 |- skos__historyNote mesh__D000800 Heart Catheterization %28%1976-1981%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D000800 Arterial Dilatation, Transluminal
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D000002
% 210.27/210.45 96; was ABATE 1972-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%29%%A%
% 210.27/210.45 |- mesh__dateEstablished mesh__D000002 1991-01-01
% 210.27/210.45 |- skos__broader mesh__D000002smesh__D009946
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D000002 sjn
% 210.27/210.45 |- mesh__recordMaintainer mesh__D000002 ssb
% 210.27/210.45 |- mesh__historyNote mesh__D000002
% 210.27/210.45 96; was ABATE 1972-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%29%%A%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000002 2006
% 210.27/210.45 |- skos__annotation mesh__D000002 TN 111 for eff on insects
% 210.27/210.45 |- skos__historyNote mesh__D000002 Insecticides %28%1966-1971%29%
% 210.27/210.45 |- mesh__dateCreated mesh__D000002 1999-01-01
% 210.27/210.45 |- mesh__recordOriginator mesh__D000002 NLM
% 210.27/210.45 |- mesh__dateRevised mesh__D000002 2005-06-30
% 210.27/210.45 |- rdf__type mesh__D000002sskos__Concept
% 210.27/210.45 |- skos__prefLabel mesh__D000002 Temefos
% 210.27/210.45 |- skos__scopeNote mesh__D000002 An organothiophosphate insecticide.
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005296 2004
% 210.27/210.45 |- skos__broader mesh__D005296smesh__D009942
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D005296 SJN
% 210.27/210.45 |- mesh__dateEstablished mesh__D005296 1987-01-01
% 210.27/210.45 |- mesh__dateRevised mesh__D005296 1997-06-20
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005296 2003
% 210.27/210.45 |- rdf__type mesh__D005296sskos__Concept
% 210.27/210.45 |- mesh__historyNote mesh__D005296
% 210.27/210.45 87%28%75%29%; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74%A%
% 210.27/210.45 |- mesh__recordMaintainer mesh__D005296 ADP
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005296 2002
% 210.27/210.45 |- skos__historyNote mesh__D005296 Iron %28%1966-1974%29%
% 210.27/210.45 |- skos__scopeNote mesh__D005296
% 210.27/210.45 Inorganic or organic compounds that contain divalent iron.%A%
% 210.27/210.45 |- skos__related mesh__D005296smesh__D007501
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005296 2006
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005296 1999
% 210.27/210.45 |- mesh__onlineNote mesh__D005296
% 210.27/210.45 use IRON to search FERRIC AND FERROUS COMPOUNDS 1966-74
% 210.27/210.45 |- skos__annotation mesh__D005296
% 210.27/210.45 = iron%28%II%29% or Fe%28%II%29%, as FeO, FeCl2; iron%28%III%29% or Fe%28%III%29% = FERRIC COMPOUNDS; DF: FERROUS CPDS%A%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005296 2001
% 210.27/210.45 |- skos__hiddenLabel mesh__D005296 Compounds, Ferrous
% 210.27/210.45 |- mesh__recordOriginator mesh__D005296 NLM
% 210.27/210.45 |- skos__broader mesh__D005296smesh__D017614
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D005296
% 210.27/210.45 87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1964-74%A%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005296 2000
% 210.27/210.45 |- mesh__dateCreated mesh__D005296 1975-02-04
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005296 2005
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005296 1998
% 210.27/210.45 |- skos__prefLabel mesh__D005296 Ferrous Compounds
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Regions, Transcriptional Terminator
% 210.27/210.45 |- skos__historyNote mesh__D013728 Genes, Regulator %28%1968-1984%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Terminator Regions, Transcriptional
% 210.27/210.45 |- mesh__historyNote mesh__D013728
% 210.27/210.45 91%28%85%29%; was see under GENES, REGULATOR 1985-90
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Transcriptional Terminator Region
% 210.27/210.45 |- mesh__dateRevised mesh__D013728 2005-06-30
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Region, Terminator %28%Genetics%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Regions, Terminator %28%Genetics%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Terminator Region
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Region, Transcriptional Terminator
% 210.27/210.45 |- mesh__recordMaintainer mesh__D013728 nns
% 210.27/210.45 |- skos__historyNote mesh__D013728 Genes %28%1966-1967%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Regions, Terminator
% 210.27/210.45 |- mesh__dateEstablished mesh__D013728 1991-01-01
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Terminator Sequences
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Region, Terminator
% 210.27/210.45 |- skos__altLabel mesh__D013728 Terminator Sequence
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Terminator Region, Transcriptional
% 210.27/210.45 |- skos__altLabel mesh__D013728 Transcriptional Terminator Regions
% 210.27/210.45 |- skos__altLabel mesh__D013728 Terminator Regions
% 210.27/210.45 |- skos__annotation mesh__D013728 DF: TERMINATOR REGIONS
% 210.27/210.45 |- skos__scopeNote mesh__D013728
% 210.27/210.45 DNA sequences which signal the termination of transcription.%A%
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Sequence, Terminator
% 210.27/210.45 |- skos__prefLabel mesh__D013728 Terminator Regions %28%Genetics%29%
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D013728 sjn
% 210.27/210.45 |- skos__historyNote mesh__D013728 Transcription, Genetic %28%1973-1984%29%
% 210.27/210.45 |- mesh__recordOriginator mesh__D013728 AEP
% 210.27/210.45 |- rdf__type mesh__D013728sskos__Concept
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D013728 2006
% 210.27/210.45 |- skos__historyNote mesh__D013728
% 210.27/210.45 Gene Expression Regulation %28%1981-1984%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Sequences, Terminator
% 210.27/210.45 |- skos__broader mesh__D013728smesh__D012045
% 210.27/210.45 |- mesh__dateCreated mesh__D013728 1984-04-05
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D013728
% 210.27/210.45 91; was see under GENES, REGULATOR 1985-90
% 210.27/210.45 |- skos__broader mesh__D013728smesh__D050436
% 210.27/210.45 |- skos__hiddenLabel mesh__D013728 Terminator Region %28%Genetics%29%
% 210.27/210.45 |- rdf__type mesh__D018413sskos__Concept
% 210.27/210.45 |- skos__prefLabel mesh__D018413 Bartonella quintana
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D018413 96; was ROCHALIMAEA QUINTANA 1995
% 210.27/210.45 |- skos__historyNote mesh__D018413 Rickettsia %28%1966-1989%29%
% 210.27/210.45 |- mesh__dateEstablished mesh__D018413 1995-01-01
% 210.27/210.45 |- skos__annotation mesh__D018413 infection = TRENCH FEVER
% 210.27/210.45 |- skos__altLabel mesh__D018413 Rochalimaea quintana
% 210.27/210.45 |- mesh__dateCreated mesh__D018413 1994-01-25
% 210.27/210.45 |- mesh__historyNote mesh__D018413 96; was ROCHALIMAEA QUINTANA 1995
% 210.27/210.45 |- skos__scopeNote mesh__D018413
% 210.27/210.45 A species of gram-negative bacteria in which man is the primary host and the human body louse, Pediculus humanus, the principal vector. It is the etiological agent of TRENCH FEVER.%A%
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D018413 sjn
% 210.27/210.45 |- skos__historyNote mesh__D018413 Rickettsiaceae %28%1990-1994%29%
% 210.27/210.45 |- mesh__recordOriginator mesh__D018413 PXP
% 210.27/210.45 |- skos__altLabel mesh__D018413 Rickettsia quintana
% 210.27/210.45 |- mesh__recordMaintainer mesh__D018413 SYSTEM
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D018413 2006
% 210.27/210.45 |- mesh__dateRevised mesh__D018413 2005-06-30
% 210.27/210.45 |- skos__broader mesh__D018413smesh__D001473
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D010430 2005
% 210.27/210.45 |- mesh__recordMaintainer mesh__D010430 ssb
% 210.27/210.45 |- mesh__dateCreated mesh__D010430 1999-01-01
% 210.27/210.45 |- mesh__historyNote mesh__D010430 72
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D010430 sjn
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D010430 2006
% 210.27/210.45 |- mesh__dateRevised mesh__D010430 2003-07-09
% 210.27/210.45 |- mesh__recordOriginator mesh__D010430 NLM
% 210.27/210.45 |- skos__prefLabel mesh__D010430 Pentosyltransferases
% 210.27/210.45 |- skos__historyNote mesh__D010430 Transferases %28%1966-1971%29%
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D010430 72
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D010430 2004
% 210.27/210.45 |- skos__broader mesh__D010430smesh__D016695
% 210.27/210.45 |- rdf__type mesh__D010430sskos__Concept
% 210.27/210.45 |- skos__scopeNote mesh__D010430
% 210.27/210.45 Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another. %28%Dorland, 28th ed%29% EC 2.4.2.%A%
% 210.27/210.45 |- mesh__dateEstablished mesh__D010430 1972-01-01
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D051847
% 210.27/210.45 2006; LITHOSTATHINE was indexed under CALCIUM-BINDING PROTEINS %26% NERVE TISSUE PROTEINS 1982-2005%A%
% 210.27/210.45 |- skos__altLabel mesh__D051847 Lithostatin
% 210.27/210.45 |- skos__broader mesh__D051847smesh__D011506
% 210.27/210.45 |- mesh__recordMaintainer mesh__D051847 DRC
% 210.27/210.45 |- mesh__dateEstablished mesh__D051847 2006-01-01
% 210.27/210.45 |- skos__hiddenLabel mesh__D051847
% 210.27/210.45 Regenerating Islet Derived 1 alpha Protein
% 210.27/210.45 |- mesh__recordOriginator mesh__D051847 DRC
% 210.27/210.45 |- skos__hiddenLabel mesh__D051847
% 210.27/210.45 Regenerating Islet Derived 1 beta Protein
% 210.27/210.45 |- skos__altLabel mesh__D051847 Pancreatic Thread Protein
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D051847 2006
% 210.27/210.45 |- mesh__historyNote mesh__D051847 2006%28%1982%29%
% 210.27/210.45 |- rdf__type mesh__D051847sskos__Concept
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D051847 sjn
% 210.27/210.45 |- skos__altLabel mesh__D051847 Pancreatic Stone Protein
% 210.27/210.45 |- mesh__dateCreated mesh__D051847 2005-06-30
% 210.27/210.45 |- skos__scopeNote mesh__D051847
% 210.27/210.45 The proteinaceous component of the pancreatic stone in patients with PANCREATITIS.%A%
% 210.27/210.45 |- skos__prefLabel mesh__D051847 Lithostathine
% 210.27/210.45 |- skos__hiddenLabel mesh__D051049 Synthetase, Ceramide
% 210.27/210.45 |- mesh__recordMaintainer mesh__D051049 AKE
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D051049 2006
% 210.27/210.45 |- mesh__dateCreated mesh__D051049 2005-06-30
% 210.27/210.45 |- skos__prefLabel mesh__D051049 Sphingosine N-Acyltransferase
% 210.27/210.45 |- skos__hiddenLabel mesh__D051049
% 210.27/210.45 Fatty Acyl CoA Sphingosine Acyltransferase
% 210.27/210.45 |- skos__broader mesh__D051049smesh__D000217
% 210.27/210.45 |- skos__altLabel mesh__D051049
% 210.27/210.45 Fatty Acyl-CoA - Sphingosine Acyltransferase
% 210.27/210.45 |- rdf__type mesh__D051049sskos__Concept
% 210.27/210.45 |- mesh__dateEstablished mesh__D051049 2006-01-01
% 210.27/210.45 |- skos__hiddenLabel mesh__D051049 Sphingosine N Acyltransferase
% 210.27/210.45 |- mesh__historyNote mesh__D051049 2006%28%1985%29%
% 210.27/210.45 |- skos__altLabel mesh__D051049 Ceramide Synthetase
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D051049
% 210.27/210.45 2006; SPHINGOSINE N-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1985-2005%A%
% 210.27/210.45 |- skos__hiddenLabel mesh__D051049 N-Acyltransferase, Sphingosine
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D051049 sjn
% 210.27/210.45 |- skos__hiddenLabel mesh__D051049 Acyltransferase, Sphingosine
% 210.27/210.45 |- mesh__recordOriginator mesh__D051049 AKE
% 210.27/210.45 |- skos__scopeNote mesh__D051049
% 210.27/210.45 An enzyme that catalyzes the acyltransferase of SPHINGOSINE to N-acylsphingosine using acyl-COENZYME A as donor and COENZYME A as acceptor. The enzyme is mainly localized in the MITOCHONDRIA.%A%
% 210.27/210.45 |- skos__altLabel mesh__D051049 Sphingosine Acyltransferase
% 210.27/210.45 |- skos__annotation mesh__D009687
% 210.27/210.45 proteins in the cell nucleus: do not confuse with NUCLEOPROTEINS %28%proteins conjugated with nucleic acids%29%%A%
% 210.27/210.45 |- mesh__recordMaintainer mesh__D009687 SYSTEM
% 210.27/210.45 |- skos__broader mesh__D009687smesh__D011506
% 210.27/210.45 |- mesh__dateRevised mesh__D009687 2005-06-30
% 210.27/210.45 |- skos__historyNote mesh__D009687 Nucleoproteins %28%1966-1987%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D009687 Proteins, Nucleolar
% 210.27/210.45 |- rdf__type mesh__D009687sskos__Concept
% 210.27/210.45 |- skos__prefLabel mesh__D009687 Nuclear Proteins
% 210.27/210.45 |- skos__hiddenLabel mesh__D009687 Proteins, Nuclear
% 210.27/210.45 |- mesh__historyNote mesh__D009687 88
% 210.27/210.45 |- skos__hiddenLabel mesh__D009687 Protein, Nuclear
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D009687 sjn
% 210.27/210.45 |- skos__scopeNote mesh__D009687
% 210.27/210.45 Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.%A%
% 210.27/210.45 |- mesh__recordOriginator mesh__D009687 RLS
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D009687 88
% 210.27/210.45 |- skos__historyNote mesh__D009687 Proteins %28%1966-1987%29%
% 210.27/210.45 |- mesh__dateEstablished mesh__D009687 1988-01-01
% 210.27/210.45 |- mesh__dateCreated mesh__D009687 1987-04-03
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D009687 2006
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014821 1998
% 210.27/210.45 |- skos__annotation mesh__D014821
% 210.27/210.45 do not use /util except by MeSH definition
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014821 2006
% 210.27/210.45 |- mesh__recordOriginator mesh__D014821 RC
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014821 2005
% 210.27/210.45 |- mesh__dateEstablished mesh__D014821 1984-01-01
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014821 2002
% 210.27/210.45 |- mesh__dateCreated mesh__D014821 1983-02-09
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014821 2004
% 210.27/210.45 |- skos__hiddenLabel mesh__D014821 Vitrectomies
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014821 2001
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D014821 84
% 210.27/210.45 |- mesh__recordMaintainer mesh__D014821 PXP
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014821 2003
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D014821 SJN
% 210.27/210.45 |- rdf__type mesh__D014821sskos__Concept
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014821 2000
% 210.27/210.45 |- skos__prefLabel mesh__D014821 Vitrectomy
% 210.27/210.45 |- skos__historyNote mesh__D014821 Vitreous Body/surgery %28%1966-1983%29%
% 210.27/210.45 |- skos__scopeNote mesh__D014821
% 210.27/210.45 Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.%A%
% 210.27/210.45 |- mesh__dateRevised mesh__D014821 1997-06-20
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014821 1999
% 210.27/210.45 |- skos__broader mesh__D014821smesh__D013508
% 210.27/210.45 |- mesh__historyNote mesh__D014821 84
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D014023 sjn
% 210.27/210.45 |- skos__hiddenLabel mesh__D014023 Stimulators, Biogenic
% 210.27/210.45 |- mesh__recordMaintainer mesh__D014023 ssb
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014023 2005
% 210.27/210.45 |- skos__broader mesh__D014023smesh__D009945
% 210.27/210.45 |- skos__altLabel mesh__D014023 Therapy, Tissue
% 210.27/210.45 |- skos__altLabel mesh__D014023 Therapy, Cell
% 210.27/210.45 |- mesh__recordOriginator mesh__D014023 NLM
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014023 2003
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014023 2006
% 210.27/210.45 |- skos__prefLabel mesh__D014023 Tissue Therapy
% 210.27/210.45 |- skos__hiddenLabel mesh__D014023 Biogenic Stimulator
% 210.27/210.45 |- skos__scopeNote mesh__D014023
% 210.27/210.45 Historically, tissue transplantation, especially of refrigerated tissue %28%after Filatov%29%. It was theorized that nonspecific substances, capable of initiating restorative processes, formed in tissues when refrigerated. Cell therapy %28%after Niehans%29% refers to implantation of tissue by injection. Originally this involved fresh cells but later frozen or lyophilized cells.%A%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014023 2004
% 210.27/210.45 |- mesh__dateCreated mesh__D014023 1999-01-01
% 210.27/210.45 |- skos__hiddenLabel mesh__D014023 Stimulator, Biogenic
% 210.27/210.45 |- skos__annotation mesh__D014023
% 210.27/210.45 historical; for contemporary cell or tissue therapy prefer CELL TRANSPLANTATION or TISSUE TRANSPLANTATION%A%
% 210.27/210.45 |- mesh__dateRevised mesh__D014023 2001-07-25
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D014023 2002
% 210.27/210.45 |- rdf__type mesh__D014023sskos__Concept
% 210.27/210.45 |- mesh__dateRevised mesh__D000801 2003-07-09
% 210.27/210.45 |- mesh__historyNote mesh__D000801
% 210.27/210.45 91%28%81%29%; was see under METASTRONGYLOIDEA 1981-90
% 210.27/210.45 |- skos__annotation mesh__D000801
% 210.27/210.45 a genus of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 210.27/210.45 |- rdf__type mesh__D000801sskos__Concept
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000801 2004
% 210.27/210.45 |- mesh__recordOriginator mesh__D000801 AEP
% 210.27/210.45 |- mesh__dateCreated mesh__D000801 1980-03-28
% 210.27/210.45 |- skos__prefLabel mesh__D000801 Angiostrongylus
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000801 2006
% 210.27/210.45 |- skos__scopeNote mesh__D000801
% 210.27/210.45 A genus of parasitic nematodes of the superfamily METASTRONGYLOIDEA. Two species, ANGIOSTRONGYLUS CANTONENSIS and A. vasorum, infest the lungs of rats and dogs, respectively. A. cantonensis is transmissible to man where it causes frequently fatal infection of the central nervous system.%A%
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D000801
% 210.27/210.45 91; was see under METASTRONGYLOIDEA 1981-90
% 210.27/210.45 |- mesh__recordMaintainer mesh__D000801 ags
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D000801 sjn
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000801 2005
% 210.27/210.45 |- skos__historyNote mesh__D000801 Metastrongyloidea %28%1966-1980%29%
% 210.27/210.45 |- skos__broader mesh__D000801smesh__D008681
% 210.27/210.45 |- mesh__dateEstablished mesh__D000801 1991-01-01
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000003 2000
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000003 2005
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000003 2001
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000003 2006
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000003 2002
% 210.27/210.45 |- skos__broader mesh__D000003smesh__D008462
% 210.27/210.45 |- skos__prefLabel mesh__D000003 Abattoirs
% 210.27/210.45 |- mesh__dateCreated mesh__D000003 1999-01-01
% 210.27/210.45 |- mesh__recordMaintainer mesh__D000003 JLS
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D000003 SJN
% 210.27/210.45 |- skos__hiddenLabel mesh__D000003 Slaughterhouse
% 210.27/210.45 |- mesh__dateRevised mesh__D000003 1997-06-20
% 210.27/210.45 |- rdf__type mesh__D000003sskos__Concept
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000003 1998
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000003 2003
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000003 1999
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D000003 2004
% 210.27/210.45 |- skos__hiddenLabel mesh__D000003 Abattoir
% 210.27/210.45 |- skos__scopeNote mesh__D000003
% 210.27/210.45 Places where animals are slaughtered and dressed for market.%A%
% 210.27/210.45 |- mesh__recordOriginator mesh__D000003 NLM
% 210.27/210.45 |- skos__altLabel mesh__D000003 Slaughterhouses
% 210.27/210.45 |- skos__broader mesh__D005297smesh__D014227
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005297 2003
% 210.27/210.45 |- rdf__type mesh__D005297sskos__Concept
% 210.27/210.45 |- mesh__recordMaintainer mesh__D005297 CCR
% 210.27/210.45 |- mesh__historyNote mesh__D005297
% 210.27/210.45 91%28%76%29%; was see under TRIAZINES 1976-90
% 210.27/210.45 |- mesh__dateEstablished mesh__D005297 1991-01-01
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005297 2006
% 210.27/210.45 |- mesh__dateCreated mesh__D005297 1975-07-25
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D005297
% 210.27/210.45 91; was see under TRIAZINES 1976-90
% 210.27/210.45 |- mesh__recordOriginator mesh__D005297 RLS
% 210.27/210.45 |- mesh__dateRevised mesh__D005297 2000-06-22
% 210.27/210.45 |- skos__scopeNote mesh__D005297
% 210.27/210.45 A ferroin compound that forms a stable magenta-colored solution with the ferrous ion. The complex has an absorption peak at 562 nm and is used as a reagent and indicator for iron.%A%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005297 2005
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D005297 sjn
% 210.27/210.45 |- skos__historyNote mesh__D005297 Benzenesulfonates %28%1974-1975%29%
% 210.27/210.45 |- skos__historyNote mesh__D005297 Pyridines %28%1972-1975%29%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005297 2002
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005297 2004
% 210.27/210.45 |- skos__annotation mesh__D005297 D25-26 qualif
% 210.27/210.45 |- skos__prefLabel mesh__D005297 Ferrozine
% 210.27/210.45 |- skos__historyNote mesh__D005297 Triazines %28%1972-1975%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D005297 Monosodium Salt Ferrozine
% 210.27/210.45 |- skos__broader mesh__D005297smesh__D001557
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D005297 2001
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D013729 sjn
% 210.27/210.45 |- skos__scopeNote mesh__D013729
% 210.27/210.45 A class of compounds composed of repeating 5-carbon units of HEMITERPENES.%A%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D013729 2005
% 210.27/210.45 |- mesh__dateRevised mesh__D013729 2003-07-09
% 210.27/210.45 |- mesh__dateCreated mesh__D013729 1999-01-01
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D013729 2006
% 210.27/210.45 |- skos__prefLabel mesh__D013729 Terpenes
% 210.27/210.45 |- rdf__type mesh__D013729sskos__Concept
% 210.27/210.45 |- mesh__recordOriginator mesh__D013729 NLM
% 210.27/210.45 |- skos__altLabel mesh__D013729 Terpenoids
% 210.27/210.45 |- mesh__recordMaintainer mesh__D013729 ssb
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D013729 2004
% 210.27/210.45 |- skos__broader mesh__D013729smesh__D006838
% 210.27/210.45 |- skos__altLabel mesh__D018414 T8 Cells
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 Lymphocytes, CD8-Positive
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 T8 Lymphocyte
% 210.27/210.45 |- mesh__recordOriginator mesh__D018414 AGS
% 210.27/210.45 |- skos__scopeNote mesh__D018414
% 210.27/210.45 A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes %28%T-LYMPHOCYTES, CYTOTOXIC%29% and suppressor T-lymphocytes %28%T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR%29%.%A%
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 CD8-Positive T-Lymphocyte
% 210.27/210.45 |- skos__related mesh__D018414smesh__D016827
% 210.27/210.45 |- skos__historyNote mesh__D018414 T-Lymphocytes %28%1982-1994%29%
% 210.27/210.45 |- skos__altLabel mesh__D018414 CD8-Positive Lymphocytes
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 T8 Cell
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 Lymphocyte, T8
% 210.27/210.45 |- skos__historyNote mesh__D018414 T-Lymphocyte Subsets %28%1991-1994%29%
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 Lymphocytes, T8
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 CD8 Positive T Lymphocytes
% 210.27/210.45 |- mesh__historyNote mesh__D018414 95
% 210.27/210.45 |- skos__broader mesh__D018414smesh__D013601
% 210.27/210.45 |- mesh__recordMaintainer mesh__D018414 jmp
% 210.27/210.45 |- mesh__dateEstablished mesh__D018414 1995-01-01
% 210.27/210.45 |- mesh__dateRevised mesh__D018414 2003-07-09
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D018414 2005
% 210.27/210.45 |- skos__altLabel mesh__D018414 T8 Lymphocytes
% 210.27/210.45 |- skos__prefLabel mesh__D018414 CD8-Positive T-Lymphocytes
% 210.27/210.45 |- skos__related mesh__D018414smesh__D016516
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D018414 95
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 T-Lymphocyte, CD8-Positive
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 Lymphocyte, CD8-Positive
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D018414 sjn
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D018414 2006
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 Cells, T8
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 T-Lymphocytes, CD8-Positive
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D018414 2004
% 210.27/210.45 |- skos__annotation mesh__D018414
% 210.27/210.45 A 11 qualif; a subpopulation of regulatory T-lymphocytes; subpopulations: coord IM with T-LYMPHOCYTE SUBSETS %28%IM%29%; count: coord IM with LYMPHOCYTE COUNT %28%NIM%29%; DF: note short X ref%A%
% 210.27/210.45 |- mesh__dateCreated mesh__D018414 1994-05-23
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 Cell, T8
% 210.27/210.45 |- rdf__type mesh__D018414sskos__Concept
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 CD8 Positive Lymphocytes
% 210.27/210.45 |- skos__hiddenLabel mesh__D018414 CD8-Positive Lymphocyte
% 210.27/210.45 |- skos__hiddenLabel mesh__D010431 BL191
% 210.27/210.45 |- mesh__dateEstablished mesh__D010431 1991-01-01
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D010431 2004
% 210.27/210.45 |- skos__hiddenLabel mesh__D010431 BL 191
% 210.27/210.45 |- skos__historyNote mesh__D010431 Xanthines %28%1972-1976%29%
% 210.27/210.45 |- skos__broader mesh__D010431smesh__D013805
% 210.27/210.45 |- rdf__type mesh__D010431sskos__Concept
% 210.27/210.45 |- skos__prefLabel mesh__D010431 Pentoxifylline
% 210.27/210.45 |- mesh__recordOriginator mesh__D010431 SH
% 210.27/210.45 |- mesh__historyNote mesh__D010431 91%28%77%29%
% 210.27/210.45 |- mesh__recordMaintainer mesh__D010431 ssb
% 210.27/210.45 |- mesh__recordAuthorizer mesh__D010431 sjn
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D010431 91; see THEOBROMINE 1977-90
% 210.27/210.45 |- skos__altLabel mesh__D010431 Oxpentifylline
% 210.27/210.45 |- skos__scopeNote mesh__D010431
% 210.27/210.45 A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production.%A%
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D010431 2005
% 210.27/210.45 |- mesh__dateCreated mesh__D010431 1976-04-16
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D010431 2006
% 210.27/210.45 |- mesh__dateRevised mesh__D010431 2003-07-09
% 210.27/210.45 |- skos__related mesh__D009688smesh__D047852
% 210.27/210.45 |- mesh__publicMeSHNote mesh__D009688 68
% 210.27/210.45 |- skos__hiddenLabel mesh__D009688 Reactors, Nuclear
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D009688 2006
% 210.27/210.45 |- mesh__recordMaintainer mesh__D009688 jls
% 210.27/210.45 |- skos__broader mesh__D009688smesh__D011210
% 210.27/210.45 |- skos__broader mesh__D009688smesh__D009686
% 210.27/210.45 |- mesh__activeMeSHYear mesh__D009688 2005
% 210.27/210.45 |- mesh__dateCreated mesh__D009688 1999-01-01
% 210.27/210.45 |- skos__annotation mesh__D009688
% 210.27/210.45 RADIONUCLIDE GENERATORS is also available; nuclear power plants does not go here: see note %26% X ref at POWER PLANTS%A%
% 210.27/210.45 |- skos__hiddenLabel mesh__D009688 Reactor, Nuclear
% 210.27/210.45 |- mesh__dateEstablished mesh__D009688 1968-01-01
% 210.27/210.45 |- rdf__type mesh__D009688sskos__Concept
% 210.27/210.45 |- mesh__historyNote mesh__D009688 68%28%64%29%
% 210.27/210.45 |- mesh__dateRevised mesh__D009688 2004-07-07
% 210.27/210.45 |- skos__related mesh__D009688smesh__D018788
% 210.27/210.45 |- skos__hiddenLabel mesh__D009688 Nuclear Reactor
% 210.27/210.45 |- skos__scopeNote mesh__D009688
% 210.27/210.45 Devices containing fissionable material in sufficient quantity and so arranged as to be capable of maintaining a controlled, self-sustaining nuclear fission chain reaction. They are also known as atomic piles, atomic reactors, fission reactors, and nuclear piles, although such names are deprecated. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 210.27/210.45 |- mesh__recordOriginator mesh__D009688 NLM
% 210.27/210.46 |- skos__prefLabel mesh__D009688 Nuclear Reactors
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D009688 sjn
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D034081 2005
% 210.27/210.46 |- skos__broader mesh__D034081smesh__D000820
% 210.27/210.46 |- skos__prefLabel mesh__D034081 Wasting Disease, Chronic
% 210.27/210.46 |- skos__historyNote mesh__D034081 Prion Diseases %28%1993-2002%29%
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D034081 2003
% 210.27/210.46 |- skos__altLabel mesh__D034081 Chronic Wasting Disease
% 210.27/210.46 |- rdf__type mesh__D034081sskos__Concept
% 210.27/210.46 |- skos__scopeNote mesh__D034081
% 210.27/210.46 A transmissible spongiform encephalopathy %28%prion disease%29% of DEER and elk characterized by chronic weight loss leading to death. It is thought to spread by direct contact between animals or through environmental contamination with the prion protein %28%PRIONS%29%.%A%
% 210.27/210.46 |- mesh__historyNote mesh__D034081 2003
% 210.27/210.46 |- skos__broader mesh__D034081smesh__D017096
% 210.27/210.46 |- mesh__dateCreated mesh__D034081 2002-07-03
% 210.27/210.46 |- skos__historyNote mesh__D034081 Wasting Syndrome %28%1999-2002%29%
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D034081 2006
% 210.27/210.46 |- mesh__dateEstablished mesh__D034081 2003-01-01
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D034081 2004
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D034081 2003
% 210.27/210.46 |- mesh__dateCreated mesh__D028044 2001-07-25
% 210.27/210.46 |- skos__annotation mesh__D028044
% 210.27/210.46 do not confuse with PHOSPHATE TRANSPORT PROTEINS
% 210.27/210.46 |- mesh__dateEstablished mesh__D028044 2002-01-01
% 210.27/210.46 |- skos__scopeNote mesh__D028044
% 210.27/210.46 Proteins that bind to and are involved in the metabolism of phosphate ions.%A%
% 210.27/210.46 |- rdf__type mesh__D028044sskos__Concept
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D028044 2006
% 210.27/210.46 |- mesh__historyNote mesh__D028044
% 210.27/210.46 2002; use PHOSPHATE-BINDING PROTEINS %28%NM%29% 1980-2001
% 210.27/210.46 |- skos__prefLabel mesh__D028044 Phosphate-Binding Proteins
% 210.27/210.46 |- skos__historyNote mesh__D028044 Carrier Proteins %28%1980-2001%29%
% 210.27/210.46 |- skos__hiddenLabel mesh__D028044 Phosphate Binding Proteins
% 210.27/210.46 |- skos__broader mesh__D028044smesh__D002352
% 210.27/210.46 |- mesh__dateRevised mesh__D028044 2005-06-30
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D028044 sjn
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D028044
% 210.27/210.46 2002; PHOSPHATE-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2001%A%
% 210.27/210.46 |- mesh__recordMaintainer mesh__D028044 SYSTEM
% 210.27/210.46 |- mesh__recordOriginator mesh__D028044 jmp
% 210.27/210.46 |- skos__annotation mesh__D006390
% 210.27/210.46 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 2005
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 1997
% 210.27/210.46 |- mesh__recordOriginator mesh__D006390 NLM
% 210.27/210.46 |- skos__scopeNote mesh__D006390
% 210.27/210.46 A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy %28%between benign hemangiomas and conventional angiosarcomas%29%. They affect men and women about equally and rarely develop in childhood. %28%From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866%29%%A%
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 1996
% 210.27/210.46 |- skos__prefLabel mesh__D006390 Hemangioendothelioma
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 2002
% 210.27/210.46 |- rdf__type mesh__D006390sskos__Concept
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 2004
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 1999
% 210.27/210.46 |- skos__hiddenLabel mesh__D006390 Hemangioendotheliomas
% 210.27/210.46 |- mesh__recordMaintainer mesh__D006390 KEV
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 2003
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 1998
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D006390 PLS
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 2001
% 210.27/210.46 |- mesh__dateCreated mesh__D006390 1999-01-01
% 210.27/210.46 |- skos__broader mesh__D006390smesh__D006391
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 2006
% 210.27/210.46 |- mesh__dateRevised mesh__D006390 1995-06-08
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006390 2000
% 210.27/210.46 |- mesh__historyNote mesh__D020061 99
% 210.27/210.46 |- skos__annotation mesh__D020061
% 210.27/210.46 do not use /drug eff for insecticides: TN 111
% 210.27/210.46 |- mesh__dateEstablished mesh__D020061 1999-01-01
% 210.27/210.46 |- mesh__dateRevised mesh__D020061 2003-07-09
% 210.27/210.46 |- skos__prefLabel mesh__D020061 Phthirus
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D020061 2004
% 210.27/210.46 |- mesh__dateCreated mesh__D020061 1998-06-10
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D020061 99
% 210.27/210.46 |- skos__altLabel mesh__D020061 Crab Lice
% 210.27/210.46 |- skos__scopeNote mesh__D020061
% 210.27/210.46 Lice of the genus Phthirus, family Pediculidae. Phthirus pubis, the crab louse, is usually acquired by sexual contact or contact with infected objects. It is found most frequently in the pubic hair, but also on eyebrows, eyelashes, or on the axillary hairs.%A%
% 210.27/210.46 |- rdf__type mesh__D020061sskos__Concept
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D020061 2006
% 210.27/210.46 |- skos__broader mesh__D020061smesh__D000854
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D020061 2005
% 210.27/210.46 |- skos__historyNote mesh__D020061 Lice %28%1965-1998%29%
% 210.27/210.46 |- skos__hiddenLabel mesh__D014822 Body, Vitreous
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014822 2006
% 210.27/210.46 |- skos__annotation mesh__D014822
% 210.27/210.46 /surg: consider also VITRECTOMY; VITREOUS DETACHMENT is available; opacities, muscae volitantes %26% other dis are indexed VITREOUS BODY %28%IM%29% and EYE DISEASES %28%IM%29%%A%
% 210.27/210.46 |- mesh__dateCreated mesh__D014822 1999-01-01
% 210.27/210.46 |- mesh__dateRevised mesh__D014822 1999-11-03
% 210.27/210.46 |- skos__prefLabel mesh__D014822 Vitreous Body
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014822 2003
% 210.27/210.46 |- skos__related mesh__D014822smesh__D014821
% 210.27/210.46 |- mesh__recordOriginator mesh__D014822 NLM
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014822 2002
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014822 2004
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D014822 sjn
% 210.27/210.46 |- skos__hiddenLabel mesh__D014822 Vitreous Bodies
% 210.27/210.46 |- rdf__type mesh__D014822sskos__Concept
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014822 2000
% 210.27/210.46 |- skos__broader mesh__D014822smesh__D005123
% 210.27/210.46 |- skos__scopeNote mesh__D014822
% 210.27/210.46 The transparent, semigelatinous substance that fills the cavity behind the crystalline lens of the EYE and in front of the RETINA. It is contained in a thin hyoid membrane and forms about four fifths of the optic globe.%A%
% 210.27/210.46 |- skos__hiddenLabel mesh__D014822 Bodies, Vitreous
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014822 2005
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014822 2001
% 210.27/210.46 |- mesh__recordMaintainer mesh__D014822 KEV
% 210.27/210.46 |- mesh__runningHead mesh__D014024 A10 - ANATOMY-TISSUES
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014024 2005
% 210.27/210.46 |- skos__scopeNote mesh__D014024
% 210.27/210.46 Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.%A%
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D014024 sjn
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014024 2006
% 210.27/210.46 |- mesh__recordMaintainer mesh__D014024 lkt
% 210.27/210.46 |- mesh__dateEstablished mesh__D014024 1998-01-01
% 210.27/210.46 |- mesh__dateCreated mesh__D014024 1999-01-01
% 210.27/210.46 |- mesh__dateRevised mesh__D014024 2004-07-07
% 210.27/210.46 |- mesh__recordOriginator mesh__D014024 NLM
% 210.27/210.46 |- skos__hiddenLabel mesh__D014024 Tissue
% 210.27/210.46 |- skos__annotation mesh__D014024 not used for indexing
% 210.27/210.46 |- skos__prefLabel mesh__D014024 Tissues
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D014024 98
% 210.27/210.46 |- rdf__type mesh__D014024sskos__Concept
% 210.27/210.46 |- skos__historyNote mesh__D014024
% 210.27/210.46 specific organ/anatomy %26% histology %28%1967-1997%29%
% 210.27/210.46 |- mesh__historyNote mesh__D014024 98; use explode 1967-97
% 210.27/210.46 |- skos__historyNote mesh__D014024
% 210.27/210.46 specific tissue/anatomy %26% histology %28%1967-1997%29%
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D000802 sjn
% 210.27/210.46 |- skos__altLabel mesh__D000802 5-Valine-Angiotensin II Amide
% 210.27/210.46 |- skos__altLabel mesh__D000802 1-Asparagine-5-valine Angiotensin II
% 210.27/210.46 |- skos__broader mesh__D000802smesh__D000804
% 210.27/210.46 |- rdf__type mesh__D000802sskos__Concept
% 210.27/210.46 |- mesh__dateCreated mesh__D000802 1999-01-01
% 210.27/210.46 |- skos__prefLabel mesh__D000802 Angiotensin Amide
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000802 2006
% 210.27/210.46 |- skos__hiddenLabel mesh__D000802 Amide, Angiotensin
% 210.27/210.46 |- mesh__historyNote mesh__D000802
% 210.27/210.46 91%28%75%29%66-73; was see under ANGIOTENSIN II/analogs %26% derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73%A%
% 210.27/210.46 |- mesh__onlineNote mesh__D000802 search ANGIOTENSIN II 1966-74
% 210.27/210.46 |- skos__hiddenLabel mesh__D000802 Amide, 5-Valine-Angiotensin II
% 210.27/210.46 |- skos__historyNote mesh__D000802 Angiotensin II %28%1966-1974%29%
% 210.27/210.46 |- skos__hiddenLabel mesh__D000802 5 Valine Angiotensin II Amide
% 210.27/210.46 |- mesh__recordMaintainer mesh__D000802 ssb
% 210.27/210.46 |- mesh__recordOriginator mesh__D000802 NLM
% 210.27/210.46 |- mesh__dateRevised mesh__D000802 2005-06-30
% 210.27/210.46 |- skos__altLabel mesh__D000802 Angiotensinamide
% 210.27/210.46 |- skos__hiddenLabel mesh__D000802 1 Asparagine 5 valine Angiotensin II
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D000802
% 210.27/210.46 91,66-73; was see under ANGIOTENSIN II/analogs %26% derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73%A%
% 210.27/210.46 |- mesh__dateEstablished mesh__D000802 1966-01-01
% 210.27/210.46 |- skos__scopeNote mesh__D000802
% 210.27/210.46 The octapeptide amide of bovine angiotensin II used to increase blood pressure by vasoconstriction.%A%
% 210.27/210.46 |- skos__hiddenLabel mesh__D000802 Angiotensin II, 1-Asparagine-5-valine
% 210.27/210.46 |- skos__broader mesh__D005121Q000002smesh__D005121
% 210.27/210.46 |- mesh__preferredCombination mesh__D005121Q000002smesh__D017880
% 210.27/210.46 |- rdf__type mesh__D005121Q000002smesh__CompoundConcept
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000004 2001
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000004 2005
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D000004 sjn
% 210.27/210.46 |- skos__broader mesh__D000004smesh__D009275
% 210.27/210.46 |- skos__prefLabel mesh__D000004 Abbreviations
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000004 2002
% 210.27/210.46 |- mesh__dateRevised mesh__D000004 1999-11-03
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000004 2006
% 210.27/210.46 |- mesh__dateCreated mesh__D000004 1999-01-01
% 210.27/210.46 |- mesh__recordMaintainer mesh__D000004 kle
% 210.27/210.46 |- skos__hiddenLabel mesh__D000004 Abbreviation
% 210.27/210.46 |- rdf__type mesh__D000004sskos__Concept
% 210.27/210.46 |- skos__annotation mesh__D000004 includes acronyms; IM; no qualif
% 210.27/210.46 |- skos__scopeNote mesh__D000004
% 210.27/210.46 Shortened forms of written words or phrases used for brevity.%A%
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000004 2003
% 210.27/210.46 |- mesh__recordOriginator mesh__D000004 NLM
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000004 2000
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000004 2004
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Surveys, World Fertility
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Fertility, Marital
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D005298 2006
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Fertility, Natural
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Fertility Surveys, World
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D005298 2002
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Determinants, Fertility
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D005298 sjn
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D005298 2005
% 210.27/210.46 |- skos__altLabel mesh__D005298 Fecundity
% 210.27/210.46 |- skos__prefLabel mesh__D005298 Fertility
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D005298 2001
% 210.27/210.46 |- skos__related mesh__D005298smesh__D007246
% 210.27/210.46 |- mesh__dateRevised mesh__D005298 2000-06-22
% 210.27/210.46 |- mesh__dateCreated mesh__D005298 1999-01-01
% 210.27/210.46 |- skos__altLabel mesh__D005298 Below Replacement Fertility
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 World Fertility Surveys
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Preference, Fertility
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Fertility Incentive
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Preferences, Fertility
% 210.27/210.46 |- mesh__recordOriginator mesh__D005298 NLM
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Fertility Survey, World
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D005298 2004
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Survey, World Fertility
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D005298 2003
% 210.27/210.46 |- skos__scopeNote mesh__D005298
% 210.27/210.46 The capacity to conceive or to induce conception. It may refer to either the male or female.%A%
% 210.27/210.46 |- rdf__type mesh__D005298sskos__Concept
% 210.27/210.46 |- mesh__recordMaintainer mesh__D005298 jls
% 210.27/210.46 |- skos__annotation mesh__D005298
% 210.27/210.46 IM for human, other mammals, birds %26% fish, NIM for animals lower than fish, plants %26% micro-organisms; /drug eff: consider also FERTILITY AGENTS%A%
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Fertility Determinant
% 210.27/210.46 |- skos__altLabel mesh__D005298 Fecundability
% 210.27/210.46 |- skos__broader mesh__D005298smesh__D012098
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Fertility, Differential
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Determinant, Fertility
% 210.27/210.46 |- skos__hiddenLabel mesh__D005298 Fertility Preference
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 1996
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 2003
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 1993
% 210.27/210.46 |- mesh__dateEstablished mesh__D010432 1991-01-01
% 210.27/210.46 |- skos__scopeNote mesh__D010432
% 210.27/210.46 5-Hydroxymethyl-6-methyl- 2,4-%28%1H,3H%29%-pyrimidinedione. Uracil derivative used in combination with toxic antibiotics to lessen their toxicity; also to stimulate leukopoiesis and immunity. Synonyms: pentoksil; hydroxymethylmethyluracil.%A%
% 210.27/210.46 |- mesh__historyNote mesh__D010432
% 210.27/210.46 91%28%80%29%; was see under URACIL 1980-90
% 210.27/210.46 |- mesh__recordMaintainer mesh__D010432 TAP
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 1997
% 210.27/210.46 |- rdf__type mesh__D010432sskos__Concept
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 2004
% 210.27/210.46 |- mesh__recordOriginator mesh__D010432 SH
% 210.27/210.46 |- skos__prefLabel mesh__D010432 Pentoxyl
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 2002
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D010432 91; was see under URACIL 1980-90
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D010432 PLS
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 1994
% 210.27/210.46 |- skos__altLabel mesh__D010432 Pentoxil
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 1998
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 2005
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 2000
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 1995
% 210.27/210.46 |- mesh__dateRevised mesh__D010432 1992-05-19
% 210.27/210.46 |- mesh__dateCreated mesh__D010432 1979-03-02
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 1999
% 210.27/210.46 |- skos__historyNote mesh__D010432
% 210.27/210.46 Uracil %28%1966-1974%29% /AA %28%1975-1979%29%
% 210.27/210.46 |- skos__broader mesh__D010432smesh__D014498
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 2006
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D010432 2001
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D009689 2006
% 210.27/210.46 |- mesh__recordOriginator mesh__D009689 NLM
% 210.27/210.46 |- skos__altLabel mesh__D009689 Atomic Warfare
% 210.27/210.46 |- skos__scopeNote mesh__D009689
% 210.27/210.46 Warfare involving the use of nuclear weapons.
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D009689 2005
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D009689 sjn
% 210.27/210.46 |- skos__broader mesh__D009689smesh__D014857
% 210.27/210.46 |- mesh__dateCreated mesh__D009689 1999-01-01
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Weapon, Nuclear
% 210.27/210.46 |- rdf__type mesh__D009689sskos__Concept
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D009689 82; was ATOMIC WARFARE 1963-81
% 210.27/210.46 |- skos__prefLabel mesh__D009689 Nuclear Warfare
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Testings, Nuclear Weapons
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D009689 2004
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Nuclear Weapon
% 210.27/210.46 |- mesh__historyNote mesh__D009689 82; was ATOMIC WARFARE 1963-81
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Warfare, Nuclear
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Weapons Testings, Nuclear
% 210.27/210.46 |- mesh__dateRevised mesh__D009689 2003-07-09
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Testing, Nuclear Weapons
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Nuclear Weapons Testings
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Weapons, Nuclear
% 210.27/210.46 |- mesh__onlineNote mesh__D009689
% 210.27/210.46 use NUCLEAR WARFARE to search ATOMIC WARFARE 1966-81
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Warfare, Atomic
% 210.27/210.46 |- mesh__recordMaintainer mesh__D009689 ags
% 210.27/210.46 |- skos__related mesh__D009689smesh__D011847
% 210.27/210.46 |- skos__hiddenLabel mesh__D009689 Weapons Testing, Nuclear
% 210.27/210.46 |- skos__historyNote mesh__D020860 Subtilisins %28%1973-1999%29%
% 210.27/210.46 |- mesh__dateCreated mesh__D020860 1999-11-03
% 210.27/210.46 |- skos__historyNote mesh__D020860 Endopeptidases %28%1966-1972%29%
% 210.27/210.46 |- skos__broader mesh__D020860smesh__D013381
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D020860 2005
% 210.27/210.46 |- mesh__dateRevised mesh__D020860 2003-07-09
% 210.27/210.46 |- rdf__type mesh__D020860sskos__Concept
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D020860 2000
% 210.27/210.46 |- mesh__dateEstablished mesh__D020860 2000-01-01
% 210.27/210.46 |- skos__prefLabel mesh__D020860 Subtilisin
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D020860 2006
% 210.27/210.46 |- mesh__historyNote mesh__D020860 2000
% 210.27/210.46 |- skos__scopeNote mesh__D020860
% 210.27/210.46 A serine endopeptidase isolated from Bacillus subtilis. It hydrolyzes proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. It also hydrolyzes peptide amides. %28%From Enzyme Nomenclature, 1992%29% EC 3.4.21.62.%A%
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D020860 2004
% 210.27/210.46 |- skos__annotation mesh__D020860 SUBTILISINS is also available
% 210.27/210.46 |- skos__hiddenLabel mesh__D006391 Histiocytoid Hemangioma
% 210.27/210.46 |- rdf__type mesh__D006391sskos__Concept
% 210.27/210.46 |- skos__related mesh__D006391smesh__D018219
% 210.27/210.46 |- skos__prefLabel mesh__D006391 Hemangioma
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D006391 sjn
% 210.27/210.46 |- skos__hiddenLabel mesh__D006391 Hemangiomas
% 210.27/210.46 |- mesh__recordMaintainer mesh__D006391 ags
% 210.27/210.46 |- skos__altLabel mesh__D006391 Chorangioma
% 210.27/210.46 |- skos__hiddenLabel mesh__D006391 Hemangiomas, Histiocytoid
% 210.27/210.46 |- skos__broader mesh__D006391smesh__D009383
% 210.27/210.46 |- mesh__dateCreated mesh__D006391 1999-01-01
% 210.27/210.46 |- mesh__recordOriginator mesh__D006391 NLM
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D006391 2006
% 210.27/210.46 |- skos__hiddenLabel mesh__D006391 Chorangiomas
% 210.27/210.46 |- skos__annotation mesh__D006391
% 210.27/210.46 coordinate IM with pre-coordinated organ/neopl term %28%IM%29%; CENTRAL NERVOUS SYSTEM VENOUS ANGIOMA; PULMONARY SCLEROSING HEMANGIOMA; and LYMPHANGIOMA is also available%A%
% 210.27/210.46 |- skos__hiddenLabel mesh__D006391 Histiocytoid Hemangiomas
% 210.27/210.46 |- skos__related mesh__D006391smesh__D047868
% 210.27/210.46 |- skos__hiddenLabel mesh__D006391 Angiomas
% 210.27/210.46 |- skos__hiddenLabel mesh__D006391 Intramuscular Hemangiomas
% 210.27/210.46 |- skos__scopeNote mesh__D006391
% 210.27/210.46 A benign tumor, made up of an overgrowth of BLOOD VESSELS. It is extremely common, occurring mostly in infancy and childhood. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. About 75%25% are present at birth, and about 60%25% occur in the head and neck area. %28%from Stedman, 25th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1355%29%%A%
% 210.27/210.46 |- skos__hiddenLabel mesh__D006391 Hemangiomas, Intramuscular
% 210.27/210.46 |- skos__hiddenLabel mesh__D006391 Intramuscular Hemangioma
% 210.27/210.46 |- skos__altLabel mesh__D006391 Angioma
% 210.27/210.46 |- mesh__dateRevised mesh__D006391 2005-06-30
% 210.27/210.46 |- skos__broader mesh__D020062smesh__D006430
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D020062 2004
% 210.27/210.46 |- skos__scopeNote mesh__D020062
% 210.27/210.46 A suborder of HEMIPTERA, called true bugs, characterized by the possession of two pairs of wings. It includes the medically important families CIMICIDAE and REDUVIIDAE. %28%From Dorland, 28th ed%29%%A%
% 210.27/210.46 |- skos__historyNote mesh__D020062 Hemiptera %28%1973-1998%29%
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D020062 99
% 210.27/210.46 |- skos__prefLabel mesh__D020062 Heteroptera
% 210.27/210.46 |- rdf__type mesh__D020062sskos__Concept
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D020062 2006
% 210.27/210.46 |- mesh__historyNote mesh__D020062 99
% 210.27/210.46 |- mesh__dateEstablished mesh__D020062 1999-01-01
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D020062 2005
% 210.27/210.46 |- skos__historyNote mesh__D020062 Insects %28%1965-1974%29%
% 210.27/210.46 |- skos__annotation mesh__D020062
% 210.27/210.46 do not use /drug eff for insecticides: TN 111
% 210.27/210.46 |- mesh__dateCreated mesh__D020062 1998-06-10
% 210.27/210.46 |- mesh__dateRevised mesh__D020062 2003-07-09
% 210.27/210.46 |- skos__prefLabel mesh__D014823 Vitreous Hemorrhage
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014823 2001
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014823 2004
% 210.27/210.46 |- skos__hiddenLabel mesh__D014823 Vitreous Hemorrhages
% 210.27/210.46 |- skos__historyNote mesh__D014823 Vitreous Body %28%1966-1986%29%
% 210.27/210.46 |- mesh__dateRevised mesh__D014823 1999-11-03
% 210.27/210.46 |- rdf__type mesh__D014823sskos__Concept
% 210.27/210.46 |- skos__scopeNote mesh__D014823 Hemorrhage into the VITREOUS BODY.
% 210.27/210.46 |- skos__broader mesh__D014823smesh__D005130
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014823 2002
% 210.27/210.46 |- mesh__recordOriginator mesh__D014823 RC
% 210.27/210.46 |- skos__historyNote mesh__D014823 Hemorrhage %28%1966-1986%29%
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014823 2005
% 210.27/210.46 |- skos__altLabel mesh__D014823 Hemorrhage, Vitreous
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D014823 sjn
% 210.27/210.46 |- mesh__dateCreated mesh__D014823 1986-04-08
% 210.27/210.46 |- mesh__dateEstablished mesh__D014823 1987-01-01
% 210.27/210.46 |- mesh__recordMaintainer mesh__D014823 KEV
% 210.27/210.46 |- mesh__historyNote mesh__D014823 87
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014823 2006
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014823 2000
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D014823 87
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014823 2003
% 210.27/210.46 |- rdf__type mesh__D014025sskos__Concept
% 210.27/210.46 |- mesh__recordOriginator mesh__D014025 NLM
% 210.27/210.46 |- mesh__dateCreated mesh__D014025 1999-01-01
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014025 2004
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014025 2006
% 210.27/210.46 |- skos__annotation mesh__D014025
% 210.27/210.46 Ti-48; Ti-46, 47, 49, 50 = TITANIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Ti-43-45, 51 = TITANIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D014025 sjn
% 210.27/210.46 |- mesh__dateRevised mesh__D014025 2001-07-25
% 210.27/210.46 |- skos__prefLabel mesh__D014025 Titanium
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014025 2003
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014025 2005
% 210.27/210.46 |- skos__broader mesh__D014025smesh__D019565
% 210.27/210.46 |- mesh__recordMaintainer mesh__D014025 jmp
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D014025 2002
% 210.27/210.46 |- skos__broader mesh__D014025smesh__D028561
% 210.27/210.46 |- skos__scopeNote mesh__D014025
% 210.27/210.46 A dark-gray, metallic element of widespread distribution but occurring in small amounts; atomic number, 22; atomic weight, 47.90; symbol, Ti; specific gravity, 4.5; used for fixation of fractures. %28%Dorland, 28th ed%29%%A%
% 210.27/210.46 |- skos__prefLabel mesh__D000803 Angiotensin I
% 210.27/210.46 |- skos__hiddenLabel mesh__D000803 I, Angiotensin
% 210.27/210.46 |- skos__scopeNote mesh__D000803
% 210.27/210.46 The decapeptide precursor of ANGIOTENSIN II, generated by the action of renin on angiotensinogen. It has limited pharmacologic activity.%A%
% 210.27/210.46 |- mesh__dateRevised mesh__D000803 2005-06-30
% 210.27/210.46 |- rdf__type mesh__D000803sskos__Concept
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D000803
% 210.27/210.46 87; was see under ANGIOTENSINS 1978-86
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D000803 sjn
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000803 2006
% 210.27/210.46 |- skos__historyNote mesh__D000803 Angiotensin II %28%1966-1977%29%
% 210.27/210.46 |- mesh__dateCreated mesh__D000803 1977-06-09
% 210.27/210.46 |- skos__broader mesh__D000803smesh__D000809
% 210.27/210.46 |- mesh__recordMaintainer mesh__D000803 ssb
% 210.27/210.46 |- mesh__historyNote mesh__D000803
% 210.27/210.46 87%28%78%29%; was see under ANGIOTENSINS 1978-86
% 210.27/210.46 |- skos__annotation mesh__D000803
% 210.27/210.46 a neurotransmitter; /biosyn /physiol permitted
% 210.27/210.46 |- mesh__dateEstablished mesh__D000803 1987-01-01
% 210.27/210.46 |- mesh__recordOriginator mesh__D000803 SH
% 210.27/210.46 |- skos__broader mesh__D000005smesh__D001829
% 210.27/210.46 |- rdf__type mesh__D000005sskos__Concept
% 210.27/210.46 |- mesh__recordMaintainer mesh__D000005 ags
% 210.27/210.46 |- mesh__recordOriginator mesh__D000005 NLM
% 210.27/210.46 |- mesh__dateRevised mesh__D000005 2002-07-02
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000005 2003
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000005 2004
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D000005 sjn
% 210.27/210.46 |- skos__prefLabel mesh__D000005 Abdomen
% 210.27/210.46 |- skos__hiddenLabel mesh__D000005 Abdomens
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000005 2005
% 210.27/210.46 |- skos__scopeNote mesh__D000005
% 210.27/210.46 That portion of the body that lies between the THORAX and the PELVIS.%A%
% 210.27/210.46 |- skos__annotation mesh__D000005
% 210.27/210.46 GEN: prefer specifics; abdom muscles = ABDOMINAL MUSCLES but RECTUS ABDOMINIS is available; abdominal pain = ABDOMINAL PAIN; abrupt dis requiring emerg surg = ABDOMEN, ACUTE%A%
% 210.27/210.46 |- mesh__dateCreated mesh__D000005 1999-01-01
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D000005 2006
% 210.27/210.46 |- mesh__dateCreated mesh__D005299 1999-01-01
% 210.27/210.46 |- skos__historyNote mesh__D005299 Gonadotropins %28%1966-1972%29%
% 210.27/210.46 |- mesh__dateEstablished mesh__D005299 1973-01-01
% 210.27/210.46 |- mesh__recordMaintainer mesh__D005299 ssb
% 210.27/210.46 |- skos__scopeNote mesh__D005299
% 210.27/210.46 Drugs used to increase fertility or to treat infertility.%A%
% 210.27/210.46 |- skos__hiddenLabel mesh__D005299 Drugs, Fertility
% 210.27/210.46 |- skos__altLabel mesh__D005299 Infertility Drugs
% 210.27/210.46 |- skos__broader mesh__D005299smesh__D012102
% 210.27/210.46 |- skos__historyNote mesh__D005299 Ovulation/drug effects %28%1966-1972%29%
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D005299 sjn
% 210.27/210.46 |- skos__altLabel mesh__D005299 Fertility Drugs
% 210.27/210.46 |- skos__hiddenLabel mesh__D005299 Agents, Infertility
% 210.27/210.46 |- rdf__type mesh__D005299sskos__Concept
% 210.27/210.46 |- mesh__historyNote mesh__D005299 73
% 210.27/210.46 |- skos__altLabel mesh__D005299 Infertility Agents
% 210.27/210.46 |- skos__prefLabel mesh__D005299 Fertility Agents
% 210.27/210.46 |- mesh__recordOriginator mesh__D005299 NLM
% 210.27/210.46 |- skos__hiddenLabel mesh__D005299 Drugs, Infertility
% 210.27/210.46 |- skos__historyNote mesh__D005299 Fertility/drug effects %28%1966-1972%29%
% 210.27/210.46 |- mesh__dateRevised mesh__D005299 2005-06-30
% 210.27/210.46 |- mesh__activeMeSHYear mesh__D005299 2006
% 210.27/210.46 |- skos__hiddenLabel mesh__D005299 Agents, Fertility
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D005299 73
% 210.27/210.46 |- skos__annotation mesh__D005299 consider also FERTILITY /drug eff
% 210.27/210.46 |- mesh__historyNote mesh__D018416 96; was ROCHALIMAEA HENSELAE 1995
% 210.27/210.46 |- skos__broader mesh__D018416smesh__D001473
% 210.27/210.46 |- skos__altLabel mesh__D018416 Rochalimaea henselae
% 210.27/210.46 |- mesh__recordMaintainer mesh__D018416 SYSTEM
% 210.27/210.46 |- mesh__recordAuthorizer mesh__D018416 sjn
% 210.27/210.46 |- mesh__publicMeSHNote mesh__D018416 96; was ROCHALIMAEA HENSELAE 1995
% 210.27/210.46 |- skos__historyNote mesh__D018416 Rickettsiaceae %28%1992-1994%29%
% 210.27/210.46 |- rdf__type mesh__D018416sskos__Concept
% 210.27/210.46 |- skos__historyNote mesh__D018416 Rickettsieae %28%1992-1994%29%
% 210.27/210.46 |- mesh__dateCreated mesh__D018416 1994-01-25
% 210.27/210.46 |- skos__prefLabel mesh__D018416 Bartonella henselae
% 210.27/210.46 |- mesh__dateRevised mesh__D018416 2005-06-30
% 210.27/210.46 |- mesh__dateEstablished mesh__D018416 1995-01-01
% 210.27/210.46 |- mesh__recordOriginator mesh__D018416 PXP
% 210.27/210.47 |- skos__scopeNote mesh__D018416
% 210.27/210.47 A species of gram-negative bacteria that is the etiologic agent of bacillary angiomatosis %28%ANGIOMATOSIS, BACILLARY%29%. This organism can also be a cause of CAT-SCRATCH DISEASE in immunocompetent patients.%A%
% 210.27/210.47 |- skos__annotation mesh__D018416
% 210.27/210.47 infection = ANGIOMATOSIS, BACILLARY or CAT-SCRATCH DISEASE %28%see note there%29%: check text%A%
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D018416 2006
% 210.27/210.47 |- rdf__type mesh__D010433sskos__Concept
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D010433 2004
% 210.27/210.47 |- skos__altLabel mesh__D010433 Korazol
% 210.27/210.47 |- skos__altLabel mesh__D010433 Corazole
% 210.27/210.47 |- skos__altLabel mesh__D010433 Metrazole
% 210.27/210.47 |- skos__broader mesh__D010433smesh__D001381
% 210.27/210.47 |- skos__altLabel mesh__D010433 Pentylenetetrazol
% 210.27/210.47 |- skos__altLabel mesh__D010433 Corazol
% 210.27/210.47 |- mesh__dateCreated mesh__D010433 1999-01-01
% 210.27/210.47 |- skos__scopeNote mesh__D010433
% 210.27/210.47 A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.%A%
% 210.27/210.47 |- skos__altLabel mesh__D010433 Korazole
% 210.27/210.47 |- mesh__dateRevised mesh__D010433 2001-08-03
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D010433 2005
% 210.27/210.47 |- skos__altLabel mesh__D010433 Leptazole
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D010433 sjn
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D010433 2002
% 210.27/210.47 |- mesh__recordOriginator mesh__D010433 NLM
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D010433 2006
% 210.27/210.47 |- skos__altLabel mesh__D010433 Pentetrazole
% 210.27/210.47 |- mesh__recordMaintainer mesh__D010433 sjn
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D010433 2003
% 210.27/210.47 |- skos__altLabel mesh__D010433 Pentamethylenetetrazole
% 210.27/210.47 |- skos__prefLabel mesh__D010433 Pentylenetetrazole
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D034881 2006
% 210.27/210.47 |- mesh__historyNote mesh__D034881 2003
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D034881 2003
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D034881 2005
% 210.27/210.47 |- skos__broader mesh__D034881smesh__D009685
% 210.27/210.47 |- rdf__type mesh__D034881sskos__Concept
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D034881 2004
% 210.27/210.47 |- mesh__dateRevised mesh__D034881 2003-07-09
% 210.27/210.47 |- skos__prefLabel mesh__D034881 Nuclear Lamina
% 210.27/210.47 |- mesh__dateEstablished mesh__D034881 2003-01-01
% 210.27/210.47 |- skos__hiddenLabel mesh__D034881 Nuclear Laminas
% 210.27/210.47 |- skos__broader mesh__D034881smesh__D015530
% 210.27/210.47 |- skos__scopeNote mesh__D034881
% 210.27/210.47 A lattice of fibrils which covers the entire inner surface of the nuclear envelope and interlinks nuclear pores %28%NUCLEAR PORE%29%.%A%
% 210.27/210.47 |- skos__hiddenLabel mesh__D034881 Lamina, Nuclear
% 210.27/210.47 |- mesh__dateCreated mesh__D034881 2002-07-03
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006392 2002
% 210.27/210.47 |- skos__broader mesh__D006392smesh__D020141
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006392 2003
% 210.27/210.47 |- skos__broader mesh__D006392smesh__D006391
% 210.27/210.47 |- mesh__dateCreated mesh__D006392 1999-01-01
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D006392 SJN
% 210.27/210.47 |- skos__annotation mesh__D006392
% 210.27/210.47 /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 210.27/210.47 |- skos__hiddenLabel mesh__D006392 Cavernous Hemangioma
% 210.27/210.47 |- skos__hiddenLabel mesh__D006392 Angiomas, Cavernous
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006392 2006
% 210.27/210.47 |- skos__hiddenLabel mesh__D006392 Cavernous Angioma
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006392 2001
% 210.27/210.47 |- skos__prefLabel mesh__D006392 Hemangioma, Cavernous
% 210.27/210.47 |- skos__scopeNote mesh__D006392
% 210.27/210.47 A vascular tumor preponderantly composed of large dilated blood vessels, often containing large amounts of blood, occurring in the skin, subcutaneously, or both, and also in many viscera, particularly the liver, spleen, pancreas, and sometimes the brain. The typical superficial lesions are bright to dark red in color; deep lesions have a blue color. A cavernous hemangioma in the skin extends more deeply than a capillary hemangioma and is less likely to regress spontaneously. %28%Dorland, 27th ed; from Stedman, 25th ed%29%%A%
% 210.27/210.47 |- skos__hiddenLabel mesh__D006392 Hemangiomas, Cavernous
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006392 2005
% 210.27/210.47 |- skos__hiddenLabel mesh__D006392 Cavernous Angiomas
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006392 2000
% 210.27/210.47 |- mesh__recordOriginator mesh__D006392 NLM
% 210.27/210.47 |- mesh__dateRevised mesh__D006392 1998-06-10
% 210.27/210.47 |- skos__hiddenLabel mesh__D006392 Cavernous Hemangiomas
% 210.27/210.47 |- rdf__type mesh__D006392sskos__Concept
% 210.27/210.47 |- mesh__recordMaintainer mesh__D006392 NNS
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006392 2004
% 210.27/210.47 |- skos__altLabel mesh__D006392 Angioma, Cavernous
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006392 1999
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D020063 99
% 210.27/210.47 |- mesh__dateCreated mesh__D020063 1998-06-10
% 210.27/210.47 |- rdf__type mesh__D020063sskos__Concept
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020063 2006
% 210.27/210.47 |- skos__broader mesh__D020063smesh__D020062
% 210.27/210.47 |- skos__prefLabel mesh__D020063 Cimicidae
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020063 2005
% 210.27/210.47 |- skos__scopeNote mesh__D020063
% 210.27/210.47 A family of wingless, blood-sucking insects of the suborder HETEROPTERA, including the bedbugs and related forms. Cimex %28%BEDBUGS%29%, Heamatosiphon, and Oeciacus are medically important genera. %28%From Dorland, 28th ed%29%%A%
% 210.27/210.47 |- skos__annotation mesh__D020063
% 210.27/210.47 do not use /drug eff for insecticides: TN 111
% 210.27/210.47 |- skos__historyNote mesh__D020063 Hemiptera %28%1986-1998%29%
% 210.27/210.47 |- mesh__historyNote mesh__D020063 99
% 210.27/210.47 |- mesh__dateEstablished mesh__D020063 1999-01-01
% 210.27/210.47 |- mesh__dateRevised mesh__D020063 2003-07-09
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020063 2004
% 210.27/210.47 |- mesh__recordMaintainer mesh__D014824 jrf
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D014824 sjn
% 210.27/210.47 |- skos__broader mesh__D014824smesh__D032761
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014824 2005
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014824 2006
% 210.27/210.47 |- mesh__dateCreated mesh__D014824 1999-01-01
% 210.27/210.47 |- mesh__dateRevised mesh__D014824 2002-07-03
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014824 2003
% 210.27/210.47 |- skos__related mesh__D014824smesh__D000827
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014824 2004
% 210.27/210.47 |- skos__hiddenLabel mesh__D014824 Vivisections
% 210.27/210.47 |- skos__scopeNote mesh__D014824
% 210.27/210.47 The cutting of or surgical operation on a living animal, usually for physiological or pathological investigation. %28%from Merriam-Webster%27%s Collegiate Dict, 10th ed%29%%A%
% 210.27/210.47 |- mesh__recordOriginator mesh__D014824 NLM
% 210.27/210.47 |- skos__prefLabel mesh__D014824 Vivisection
% 210.27/210.47 |- rdf__type mesh__D014824sskos__Concept
% 210.27/210.47 |- mesh__dateCreated mesh__D014026 1999-01-01
% 210.27/210.47 |- skos__prefLabel mesh__D014026 Tobacco
% 210.27/210.47 |- skos__altLabel mesh__D014026 Nicotiana
% 210.27/210.47 |- skos__related mesh__D014026smesh__D014029
% 210.27/210.47 |- mesh__recordOriginator mesh__D014026 NLM
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014026 2006
% 210.27/210.47 |- skos__related mesh__D014026smesh__D012907
% 210.27/210.47 |- skos__annotation mesh__D014026
% 210.27/210.47 as plant %26% for smoking %28% = SMOKING%29%, sniffing %28% = SNUFF see TOBACCO, SMOKELESS%29% %26% chewing %28% = CHEWING TOBACCO see TOBACCO, SMOKELESS%29%; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.27/210.47 |- skos__scopeNote mesh__D014026
% 210.27/210.47 A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; its dried leaves are used for SMOKING.%A%
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014026 2005
% 210.27/210.47 |- mesh__recordMaintainer mesh__D014026 ssb
% 210.27/210.47 |- skos__broader mesh__D014026smesh__D019657
% 210.27/210.47 |- mesh__dateRevised mesh__D014026 2004-07-07
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D014026 sjn
% 210.27/210.47 |- rdf__type mesh__D014026sskos__Concept
% 210.27/210.47 |- skos__related mesh__D014026smesh__D009538
% 210.27/210.47 |- rdf__type mesh__D000804sskos__Concept
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000804 2006
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D000804
% 210.27/210.47 1974; see ANGIOTENSIN 1971-1973, see ANGIOTENSIN 1967-1970; ANGIOTENSIN was heading 1964-1978, was HYPERTENSIN 1963 %28%HYPERTENSIN see ANGIOTENSIN 1964-1965, see ANGIOTENSIN AMIDE 1966-1973%29%; ANGIOTENSIN II, ILE%28%5%29%- was indexed under ANGIOTENSIN II 1981-1999, and ISOLEUCINE 1975-1981%A%
% 210.27/210.47 |- skos__broader mesh__D000804smesh__D000809
% 210.27/210.47 |- mesh__historyNote mesh__D000804
% 210.27/210.47 1974%28%1963%29%; for ANGIOTENSIN II, ILE%28%5%29%- use ANGIOTENSIN II %28%NM%29% 1974-1999%A%
% 210.27/210.47 |- mesh__recordOriginator mesh__D000804 NLM
% 210.27/210.47 |- skos__hiddenLabel mesh__D000804 5 L Isoleucine Angiotensin II
% 210.27/210.47 |- skos__altLabel mesh__D000804 5-L-Isoleucine Angiotensin II
% 210.27/210.47 |- mesh__dateRevised mesh__D000804 2005-06-30
% 210.27/210.47 |- skos__altLabel mesh__D000804 Isoleucine%28%5%29%-Angiotensin
% 210.27/210.47 |- skos__altLabel mesh__D000804 ANG-%28%1-8%29%Octapeptide
% 210.27/210.47 |- skos__related mesh__D000804smesh__D012084
% 210.27/210.47 |- skos__hiddenLabel mesh__D000804 II, 5-L-Isoleucine Angiotensin
% 210.27/210.47 |- skos__altLabel mesh__D000804 Valyl%28%5%29%-Angiotensin II
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D000804 sjn
% 210.27/210.47 |- skos__prefLabel mesh__D000804 Angiotensin II
% 210.27/210.47 |- mesh__dateCreated mesh__D000804 1999-01-01
% 210.27/210.47 |- skos__altLabel mesh__D000804 Angiotensin II, Isoleucine%28%5%29%-
% 210.27/210.47 |- skos__altLabel mesh__D000804 Isoleucyl%28%5%29%-Angiotensin II
% 210.27/210.47 |- skos__altLabel mesh__D000804 Angiotensin-%28%1-8%29% Octapeptide
% 210.27/210.47 |- skos__hiddenLabel mesh__D000804 Angiotensin II, 5-L-Isoleucine
% 210.27/210.47 |- skos__scopeNote mesh__D000804
% 210.27/210.47 The active form of angiotensin. An octapeptide found in blood, it is synthesized from ANGIOTENSIN I and quickly destroyed. Angiotensin II causes profound vasoconstriction with a resulting increase in blood pressure. It differs among species by the amino acid in position 5. The human form has ISOLEUCINE in this position. The clinically and experimentally used bovine form has VALINE in position 5. Medically useful antagonism is obtained with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.%A%
% 210.27/210.47 |- skos__altLabel mesh__D000804 Angiotensin II, Valine%28%5%29%-
% 210.27/210.47 |- mesh__recordMaintainer mesh__D000804 ssb
% 210.27/210.47 |- skos__scopeNote mesh__D000006
% 210.27/210.47 A clinical syndrome with acute abdominal pain that is severe, localized, and rapid onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases.%A%
% 210.27/210.47 |- skos__hiddenLabel mesh__D000006 Acute Abdomens
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000006 2004
% 210.27/210.47 |- mesh__recordOriginator mesh__D000006 NLM
% 210.27/210.47 |- mesh__dateRevised mesh__D000006 2003-07-09
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000006 2005
% 210.27/210.47 |- skos__broader mesh__D000006smesh__D015746
% 210.27/210.47 |- skos__hiddenLabel mesh__D000006 Abdomens, Acute
% 210.27/210.47 |- skos__prefLabel mesh__D000006 Abdomen, Acute
% 210.27/210.47 |- mesh__dateCreated mesh__D000006 1999-01-01
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000006 2006
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D000006 sjn
% 210.27/210.47 |- skos__hiddenLabel mesh__D000006 Acute Abdomen
% 210.27/210.47 |- mesh__recordMaintainer mesh__D000006 lkt
% 210.27/210.47 |- rdf__type mesh__D000006sskos__Concept
% 210.27/210.47 |- mesh__historyNote mesh__D046108 2005
% 210.27/210.47 |- skos__hiddenLabel mesh__D046108 Bird, Kiwi
% 210.27/210.47 |- mesh__recordOriginator mesh__D046108 ags
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D046108 2006
% 210.27/210.47 |- skos__scopeNote mesh__D046108
% 210.27/210.47 A superorder of large, mostly flightless birds, named for their distinctive PALATE morphology. It includes the orders Apterygiformes, Casuriiformes, Dinornithiformes, RHEIFORMES; STRUTHIONIFORMES and Tinamiformes.%A%
% 210.27/210.47 |- rdf__type mesh__D046108sskos__Concept
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D046108 2005
% 210.27/210.47 |- skos__hiddenLabel mesh__D046108 Ratite
% 210.27/210.47 |- mesh__dateCreated mesh__D046108 2004-07-07
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D046108 sjn
% 210.27/210.47 |- mesh__recordMaintainer mesh__D046108 ags
% 210.27/210.47 |- skos__prefLabel mesh__D046108 Palaeognathae
% 210.27/210.47 |- skos__broader mesh__D046108smesh__D001717
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D046108
% 210.27/210.47 2005; for KIWI BIRD see RATITES 2002-2004; for RATITES see RATITES 1999-2004%A%
% 210.27/210.47 |- mesh__dateEstablished mesh__D046108 2005-01-01
% 210.27/210.47 |- skos__historyNote mesh__D018417
% 210.27/210.47 T-Lymphocytes, Helper-Inducer %28%1985-1994%29%
% 210.27/210.47 |- skos__annotation mesh__D018417
% 210.27/210.47 helper-inducer T-lymphocytes: h stands for %22%helper%22%; A 11 qualif%A%
% 210.27/210.47 |- skos__hiddenLabel mesh__D018417 Th1 Cell
% 210.27/210.47 |- skos__scopeNote mesh__D018417
% 210.27/210.47 Subset of helper-inducer T-lymphocytes which synthesize and secrete interleukin-2, gamma-interferon, and interleukin-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions.%A%
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D018417 2004
% 210.27/210.47 |- skos__hiddenLabel mesh__D018417 Cell, Th1
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D018417 2006
% 210.27/210.47 |- mesh__dateRevised mesh__D018417 2003-07-09
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D018417 95
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D018417 2005
% 210.27/210.47 |- skos__historyNote mesh__D018417 T-Lymphocyte Subsets %28%1991-1994%29%
% 210.27/210.47 |- mesh__historyNote mesh__D018417 95
% 210.27/210.47 |- rdf__type mesh__D018417sskos__Concept
% 210.27/210.47 |- mesh__dateCreated mesh__D018417 1994-05-12
% 210.27/210.47 |- skos__prefLabel mesh__D018417 Th1 Cells
% 210.27/210.47 |- skos__broader mesh__D018417smesh__D006377
% 210.27/210.47 |- mesh__dateEstablished mesh__D018417 1995-01-01
% 210.27/210.47 |- skos__hiddenLabel mesh__D018417 Cells, Th1
% 210.27/210.47 |- skos__scopeNote mesh__D010434
% 210.27/210.47 Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice.%A%
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D010434 2004
% 210.27/210.47 |- mesh__recordOriginator mesh__D010434 NLM
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D010434 2005
% 210.27/210.47 |- rdf__type mesh__D010434sskos__Concept
% 210.27/210.47 |- skos__broader mesh__D010434smesh__D016282
% 210.27/210.47 |- mesh__historyNote mesh__D010434 91; was PEPSIN 1964-90
% 210.27/210.47 |- mesh__recordMaintainer mesh__D010434 ssb
% 210.27/210.47 |- mesh__onlineNote mesh__D010434 use PEPSIN A to search PEPSIN 1966-90
% 210.27/210.47 |- skos__prefLabel mesh__D010434 Pepsin A
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D010434 91; was PEPSIN 1964-90
% 210.27/210.47 |- skos__annotation mesh__D010434 /biosyn /physiol permitted
% 210.27/210.47 |- mesh__dateCreated mesh__D010434 1999-01-01
% 210.27/210.47 |- mesh__dateRevised mesh__D010434 2003-07-09
% 210.27/210.47 |- skos__altLabel mesh__D010434 Pepsin
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D010434 2006
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D010434 sjn
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D034882
% 210.27/210.47 2003; LAMINS was indexed under Nuclear Proteins 1988-2002, NUCLEOPROTEINS 1980-1987%A%
% 210.27/210.47 |- mesh__recordMaintainer mesh__D034882 SYSTEM
% 210.27/210.47 |- skos__prefLabel mesh__D034882 Lamins
% 210.27/210.47 |- rdf__type mesh__D034882sskos__Concept
% 210.27/210.47 |- mesh__recordOriginator mesh__D034882 jmp
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D034882 sjn
% 210.27/210.47 |- mesh__dateCreated mesh__D034882 2002-07-03
% 210.27/210.47 |- skos__scopeNote mesh__D034882
% 210.27/210.47 Nuclear matrix proteins that are structural components of the NUCLEAR LAMINA. They are found in most multicellular organisms.%A%
% 210.27/210.47 |- mesh__dateRevised mesh__D034882 2005-06-30
% 210.27/210.47 |- skos__related mesh__D034882smesh__D034881
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D034882 2006
% 210.27/210.47 |- mesh__dateEstablished mesh__D034882 2003-01-01
% 210.27/210.47 |- skos__broader mesh__D034882smesh__D034521
% 210.27/210.47 |- mesh__historyNote mesh__D034882 2003; use LAMINS %28%NM%29% 1980-2002
% 210.27/210.47 |- skos__annotation mesh__D034882 see SCR for organism-specific lamins
% 210.27/210.47 |- skos__scopeNote mesh__D020862
% 210.27/210.47 A nucleic acid sequence that contains an above average number of GUANINE and CYTOSINE bases.%A%
% 210.27/210.47 |- skos__hiddenLabel mesh__D020862 Region, GC Rich
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020862 2005
% 210.27/210.47 |- mesh__historyNote mesh__D020862 2000
% 210.27/210.47 |- mesh__recordOriginator mesh__D020862 nns
% 210.27/210.47 |- skos__related mesh__D020862smesh__D020856
% 210.27/210.47 |- skos__hiddenLabel mesh__D020862 Regions, GC Rich
% 210.27/210.47 |- skos__prefLabel mesh__D020862 GC Rich Sequence
% 210.27/210.47 |- skos__historyNote mesh__D020862
% 210.27/210.47 Dinucleoside Phosphates %28%1989-1999%29%
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D020862 2000
% 210.27/210.47 |- mesh__dateRevised mesh__D020862 2002-07-03
% 210.27/210.47 |- skos__historyNote mesh__D020862 CpG Islands %28%1996-1999%29%
% 210.27/210.47 |- skos__hiddenLabel mesh__D020862 GC Rich Regions
% 210.27/210.47 |- skos__historyNote mesh__D020862 Base Sequence %28%1989-1999%29%
% 210.27/210.47 |- skos__broader mesh__D020862smesh__D001483
% 210.27/210.47 |- skos__hiddenLabel mesh__D020862 Sequences, GC Rich
% 210.27/210.47 |- mesh__dateEstablished mesh__D020862 2000-01-01
% 210.27/210.47 |- skos__altLabel mesh__D020862 GC Rich Region
% 210.27/210.47 |- mesh__dateCreated mesh__D020862 1999-11-03
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D020862 sjn
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020862 2004
% 210.27/210.47 |- skos__related mesh__D020862smesh__D032085
% 210.27/210.47 |- skos__hiddenLabel mesh__D020862 GC Rich Sequences
% 210.27/210.47 |- rdf__type mesh__D020862sskos__Concept
% 210.27/210.47 |- mesh__recordMaintainer mesh__D020862 nns
% 210.27/210.47 |- skos__hiddenLabel mesh__D020862 Sequence, GC Rich
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020862 2003
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020862 2006
% 210.27/210.47 |- skos__related mesh__D020862smesh__D001482
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 2002
% 210.27/210.47 |- mesh__recordOriginator mesh__D006393 NLM
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 2005
% 210.27/210.47 |- skos__hiddenLabel mesh__D006393 Hemangiopericytomas
% 210.27/210.47 |- skos__prefLabel mesh__D006393 Hemangiopericytoma
% 210.27/210.47 |- skos__broader mesh__D006393smesh__D009383
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 1996
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 2006
% 210.27/210.47 |- mesh__dateRevised mesh__D006393 1995-06-08
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D006393 PLS
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 1997
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 2000
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 2003
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 1998
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 2001
% 210.27/210.47 |- rdf__type mesh__D006393sskos__Concept
% 210.27/210.47 |- skos__annotation mesh__D006393
% 210.27/210.47 benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 210.27/210.47 |- mesh__dateCreated mesh__D006393 1999-01-01
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 2004
% 210.27/210.47 |- skos__scopeNote mesh__D006393
% 210.27/210.47 A tumor composed of spindle cells with a rich vascular network, which apparently arises from pericytes, cells of smooth muscle origin that lie around small vessels. Benign and malignant hemangiopericytomas exist, and the rarity of these lesions has led to considerable confusion in distinguishing between benign and malignant variants. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1364%29%%A%
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D006393 1999
% 210.27/210.47 |- mesh__recordMaintainer mesh__D006393 KEV
% 210.27/210.47 |- mesh__historyNote mesh__D020064 99; use TRIATOMINAE 1979-98
% 210.27/210.47 |- rdf__type mesh__D020064sskos__Concept
% 210.27/210.47 |- mesh__dateCreated mesh__D020064 1998-06-11
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020064 2006
% 210.27/210.47 |- mesh__dateEstablished mesh__D020064 1999-01-01
% 210.27/210.47 |- skos__broader mesh__D020064smesh__D020062
% 210.27/210.47 |- skos__historyNote mesh__D020064 Triatominae %28%1979-1998%29%
% 210.27/210.47 |- skos__scopeNote mesh__D020064
% 210.27/210.47 A family of winged insects of the suborder HETEROPTERA, called assassin bugs, because most prey on other insects. However one subfamily, TRIATOMINAE, attacks humans and other vertebrates and transmits Chagas disease.%A%
% 210.27/210.47 |- skos__prefLabel mesh__D020064 Reduviidae
% 210.27/210.47 |- skos__annotation mesh__D020064
% 210.27/210.47 do not use /drug eff for insecticides: TN 111
% 210.27/210.47 |- mesh__dateRevised mesh__D020064 2003-07-09
% 210.27/210.47 |- skos__altLabel mesh__D020064 Assassin Bugs
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020064 2004
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D020064 99; see TRIATOMINAE 1979-98
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D020064 2005
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 1999
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 2005
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 2002
% 210.27/210.47 |- mesh__recordOriginator mesh__D014825 NLM
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 1996
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 2006
% 210.27/210.47 |- mesh__dateCreated mesh__D014825 1999-01-01
% 210.27/210.47 |- skos__prefLabel mesh__D014825 Vocabulary
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 1997
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 2003
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 2000
% 210.27/210.47 |- skos__scopeNote mesh__D014825
% 210.27/210.47 The sum or the stock of words used by a language, a group, or an individual. %28%From Webster, 3d ed%29%%A%
% 210.27/210.47 |- mesh__recordMaintainer mesh__D014825 TGC
% 210.27/210.47 |- skos__annotation mesh__D014825
% 210.27/210.47 a person%27%s stock of words; do not use for nomenclature %28% = NOMENCLATURE%29% or for THESAURUS see VOCABULARY, CONTROLLED; no qualif%A%
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 2004
% 210.27/210.47 |- mesh__dateRevised mesh__D014825 1994-12-27
% 210.27/210.47 |- skos__broader mesh__D014825smesh__D008037
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 2001
% 210.27/210.47 |- rdf__type mesh__D014825sskos__Concept
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D014825 PLS
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014825 1998
% 210.27/210.47 |- skos__hiddenLabel mesh__D014825 Vocabularies
% 210.27/210.47 |- mesh__dateRevised mesh__D014027 1996-06-10
% 210.27/210.47 |- skos__hiddenLabel mesh__D014027 Mosaic Viruses, Tobacco
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 2005
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 1997
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 1999
% 210.27/210.47 |- skos__hiddenLabel mesh__D014027 Viruses, Tobacco Mosaic
% 210.27/210.47 |- skos__hiddenLabel mesh__D014027 Tobacco Mosaic Viruses
% 210.27/210.47 |- rdf__type mesh__D014027sskos__Concept
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D014027 PLS
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 2002
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 1998
% 210.27/210.47 |- skos__scopeNote mesh__D014027
% 210.27/210.47 The type species of TOBAMOVIRUS which causes mosaic disease of tobacco. Transmission occurs by mechanical inoculation.%A%
% 210.27/210.47 |- mesh__recordOriginator mesh__D014027 NLM
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 2001
% 210.27/210.47 |- skos__hiddenLabel mesh__D014027 Mosaic Virus, Tobacco
% 210.27/210.47 |- skos__broader mesh__D014027smesh__D017898
% 210.27/210.47 |- skos__annotation mesh__D014027
% 210.27/210.47 a species of plant virus; coord IM with TOBACCO /virol %28%IM or NIM%29%%A%
% 210.27/210.47 |- mesh__dateCreated mesh__D014027 1999-01-01
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 2004
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 2000
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 2006
% 210.27/210.47 |- skos__prefLabel mesh__D014027 Tobacco Mosaic Virus
% 210.27/210.47 |- mesh__recordMaintainer mesh__D014027 AGS
% 210.27/210.47 |- skos__hiddenLabel mesh__D014027 Virus, Tobacco Mosaic
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D014027 2003
% 210.27/210.47 |- mesh__recordOriginator mesh__D000805 RLS
% 210.27/210.47 |- skos__hiddenLabel mesh__D000805 Angiotensin II, Des-Asp
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D000805
% 210.27/210.47 91; was see under ANGIOTENSIN II 1977-90
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D000805 sjn
% 210.27/210.47 |- skos__broader mesh__D000805smesh__D000809
% 210.27/210.47 |- skos__annotation mesh__D000805
% 210.27/210.47 a neurotransmitter; comparison with angiotensin II: see MeSH definition; /biosyn /physiol permitted%A%
% 210.27/210.47 |- skos__altLabel mesh__D000805 Des-Aspartyl-Angiotensin II
% 210.27/210.47 |- skos__scopeNote mesh__D000805
% 210.27/210.47 A heptapeptide formed by the enzymatic hydrolysis of ANGIOTENSIN II. It has greater activity than angiotensin II for stimulating aldosterone synthesis and in the release of prostaglandins but only 20%25% of the pressor activity.%A%
% 210.27/210.47 |- skos__historyNote mesh__D000805 Angiotensin II %28%1966-1976%29%
% 210.27/210.47 |- skos__hiddenLabel mesh__D000805 Des Asp Angiotensin II
% 210.27/210.47 |- skos__prefLabel mesh__D000805 Angiotensin III
% 210.27/210.47 |- mesh__recordMaintainer mesh__D000805 ssb
% 210.27/210.47 |- mesh__dateCreated mesh__D000805 1976-05-19
% 210.27/210.47 |- mesh__historyNote mesh__D000805
% 210.27/210.47 91%28%77%29%; was see under ANGIOTENSIN II 1977-90
% 210.27/210.47 |- skos__hiddenLabel mesh__D000805 Des Aspartyl Angiotensin II
% 210.27/210.47 |- rdf__type mesh__D000805sskos__Concept
% 210.27/210.47 |- skos__altLabel mesh__D000805 Des-Asp Angiotensin II
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000805 2006
% 210.27/210.47 |- mesh__dateRevised mesh__D000805 2005-06-30
% 210.27/210.47 |- mesh__dateEstablished mesh__D000805 1991-01-01
% 210.27/210.47 |- skos__prefLabel mesh__D019510 DNA Fragmentation
% 210.27/210.47 |- skos__broader mesh__D019510smesh__D004249
% 210.27/210.47 |- skos__annotation mesh__D019510
% 210.27/210.47 do not confuse with DNA DAMAGE which includes by drugs or radiation; coord IM with specific DNA %28%IM%29%%A%
% 210.27/210.47 |- skos__scopeNote mesh__D019510
% 210.27/210.47 Endonucleolytic cleavage %28%cutting both strands%29% of genomic DNA into fragments at internucleosomal sites. DNA fragmentation along with chromatin condensation are considered the hallmarks of APOPTOSIS.%A%
% 210.27/210.47 |- mesh__dateCreated mesh__D019510 1996-06-13
% 210.27/210.47 |- skos__broader mesh__D019510smesh__D017209
% 210.27/210.47 |- mesh__recordOriginator mesh__D019510 AGS
% 210.27/210.47 |- skos__hiddenLabel mesh__D019510 Fragmentation, Internucleosomal DNA
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D019510 2006
% 210.27/210.47 |- skos__historyNote mesh__D019510 DNA %28%1966-1996%29%
% 210.27/210.47 |- mesh__recordMaintainer mesh__D019510 nns
% 210.27/210.47 |- skos__related mesh__D019510smesh__D020287
% 210.27/210.47 |- skos__hiddenLabel mesh__D019510 DNA Fragmentation, Internucleosomal
% 210.27/210.47 |- skos__hiddenLabel mesh__D019510 Fragmentation, DNA
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D019510 2005
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D019510 2004
% 210.27/210.47 |- mesh__publicMeSHNote mesh__D019510 97
% 210.27/210.47 |- rdf__type mesh__D019510sskos__Concept
% 210.27/210.47 |- mesh__historyNote mesh__D019510 97
% 210.27/210.47 |- mesh__dateEstablished mesh__D019510 1997-01-01
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D019510 sjn
% 210.27/210.47 |- skos__historyNote mesh__D019510 DNA Damage %28%1987-1996%29%
% 210.27/210.47 |- mesh__dateRevised mesh__D019510 2003-07-09
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 2000
% 210.27/210.47 |- skos__annotation mesh__D000007
% 210.27/210.47 general term for inj of organs in the abdom cavity; prefer specific organs /inj%A%
% 210.27/210.47 |- rdf__type mesh__D000007sskos__Concept
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 2005
% 210.27/210.47 |- skos__hiddenLabel mesh__D000007 Injury, Abdominal
% 210.27/210.47 |- skos__scopeNote mesh__D000007
% 210.27/210.47 General or unspecified injuries involving organs in the abdominal cavity.%A%
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 1995
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 2004
% 210.27/210.47 |- skos__hiddenLabel mesh__D000007 Abdominal Injury
% 210.27/210.47 |- mesh__dateRevised mesh__D000007 1991-06-21
% 210.27/210.47 |- skos__broader mesh__D000007smesh__D014947
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 1999
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 1994
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 2003
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 1998
% 210.27/210.47 |- mesh__dateCreated mesh__D000007 1999-01-01
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 1993
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 2002
% 210.27/210.47 |- mesh__recordAuthorizer mesh__D000007 PLS
% 210.27/210.47 |- mesh__recordMaintainer mesh__D000007 PXP
% 210.27/210.47 |- skos__prefLabel mesh__D000007 Abdominal Injuries
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 1997
% 210.27/210.47 |- mesh__recordOriginator mesh__D000007 NLM
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 1992
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 2001
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 1996
% 210.27/210.47 |- skos__altLabel mesh__D000007 Injuries, Abdominal
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D000007 2006
% 210.27/210.47 |- mesh__activeMeSHYear mesh__D046109 2005
% 210.27/210.47 |- skos__historyNote mesh__D046109 Songbirds %28%1998-2004%29%
% 210.27/210.47 |- mesh__dateEstablished mesh__D046109 2005-01-01
% 210.27/210.47 |- mesh__dateCreated mesh__D046109 2004-07-07
% 210.27/210.47 |- mesh__recordOriginator mesh__D046109 ags
% 210.27/210.48 |- mesh__recordMaintainer mesh__D046109 ags
% 210.27/210.48 |- skos__historyNote mesh__D046109 Birds %28%1968-1997%29%
% 210.27/210.48 |- skos__broader mesh__D046109smesh__D001717
% 210.27/210.48 |- skos__scopeNote mesh__D046109
% 210.27/210.48 A widely distributed order of perching BIRDS, including more than half of all bird species.%A%
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D046109 sjn
% 210.27/210.48 |- skos__prefLabel mesh__D046109 Passeriformes
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D046109 2005; see SONGBIRDS 1999-2004
% 210.27/210.48 |- mesh__historyNote mesh__D046109 2005; use SONGBIRDS 1999-2004
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D046109 2006
% 210.27/210.48 |- rdf__type mesh__D046109sskos__Concept
% 210.27/210.48 |- skos__annotation mesh__D018418
% 210.27/210.48 helper-inducer T-lymphocytes: h stands for %22%helper%22%; A 11 qualif%A%
% 210.27/210.48 |- skos__historyNote mesh__D018418
% 210.27/210.48 T-Lymphocytes, Helper-Inducer %28%1985-1994%29%
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D018418 2004
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D018418 95
% 210.27/210.48 |- skos__hiddenLabel mesh__D018418 Th2 Cell
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D018418 2006
% 210.27/210.48 |- rdf__type mesh__D018418sskos__Concept
% 210.27/210.48 |- mesh__historyNote mesh__D018418 95
% 210.27/210.48 |- mesh__dateRevised mesh__D018418 2003-07-09
% 210.27/210.48 |- mesh__dateCreated mesh__D018418 1994-06-03
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D018418 2005
% 210.27/210.48 |- skos__scopeNote mesh__D018418
% 210.27/210.48 Subset of helper-inducer T-lymphocytes which synthesize and secrete the interleukins IL-4, IL-5, IL-6, and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses.%A%
% 210.27/210.48 |- skos__broader mesh__D018418smesh__D006377
% 210.27/210.48 |- skos__hiddenLabel mesh__D018418 Cells, Th2
% 210.27/210.48 |- skos__hiddenLabel mesh__D018418 Cell, Th2
% 210.27/210.48 |- skos__historyNote mesh__D018418 T-Lymphocytes %28%1980-1981%29%
% 210.27/210.48 |- skos__historyNote mesh__D018418 T-Lymphocyte Subsets %28%1989-1994%29%
% 210.27/210.48 |- mesh__dateEstablished mesh__D018418 1995-01-01
% 210.27/210.48 |- skos__prefLabel mesh__D018418 Th2 Cells
% 210.27/210.48 |- skos__historyNote mesh__D010435 Enzyme Precursors %28%1966-1971%29%
% 210.27/210.48 |- rdf__type mesh__D010435sskos__Concept
% 210.27/210.48 |- mesh__historyNote mesh__D010435 99%28%72%29%
% 210.27/210.48 |- skos__annotation mesh__D010435
% 210.27/210.48 do not confuse with PEPSINOGEN see PEPSINOGEN A
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D010435 sjn
% 210.27/210.48 |- skos__historyNote mesh__D010435 Pepsinogen %28%1972-1998%29%
% 210.27/210.48 |- mesh__recordOriginator mesh__D010435 NLM
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D010435 99; see Pepsinogen 1972-98
% 210.27/210.48 |- skos__broader mesh__D010435smesh__D004792
% 210.27/210.48 |- mesh__dateCreated mesh__D010435 1999-01-01
% 210.27/210.48 |- skos__historyNote mesh__D010435 Pepsin %28%1966-1971%29%
% 210.27/210.48 |- mesh__dateEstablished mesh__D010435 1972-01-01
% 210.27/210.48 |- mesh__dateRevised mesh__D010435 2003-07-09
% 210.27/210.48 |- skos__prefLabel mesh__D010435 Pepsinogens
% 210.27/210.48 |- skos__scopeNote mesh__D010435
% 210.27/210.48 Proenzymes secreted by chief cells, mucous neck cells, and pyloric gland cells, which are converted into pepsin in the presence of gastric acid or pepsin itself. %28%Dorland, 28th ed%29% In humans there are 2 related pepsinogen systems: PEPSINOGEN A %28%formerly pepsinogen I or pepsinogen%29% and PEPSINOGEN C %28%formerly pepsinogen II or progastricsin%29%. Pepsinogen B is the name of a pepsinogen from pigs.%A%
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010435 2006
% 210.27/210.48 |- mesh__recordMaintainer mesh__D010435 ssb
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010435 2004
% 210.27/210.48 |- skos__related mesh__D010435smesh__D005750
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010435 2005
% 210.27/210.48 |- skos__hiddenLabel mesh__D015120 6 Aminonicotinamide
% 210.27/210.48 |- skos__broader mesh__D015120smesh__D009536
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D015120
% 210.27/210.48 91; was see under NICOTINAMIDE 1976-90
% 210.27/210.48 |- mesh__dateCreated mesh__D015120 1975-07-21
% 210.27/210.48 |- skos__historyNote mesh__D015120 Amines %28%1972-1975%29%
% 210.27/210.48 |- skos__prefLabel mesh__D015120 6-Aminonicotinamide
% 210.27/210.48 |- mesh__dateRevised mesh__D015120 2005-06-30
% 210.27/210.48 |- rdf__type mesh__D015120sskos__Concept
% 210.27/210.48 |- mesh__recordMaintainer mesh__D015120 ssb
% 210.27/210.48 |- mesh__recordOriginator mesh__D015120 RLS
% 210.27/210.48 |- mesh__historyNote mesh__D015120
% 210.27/210.48 91%28%76%29%; was see under NICOTINAMIDE 1976-90
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D015120 sjn
% 210.27/210.48 |- skos__historyNote mesh__D015120
% 210.27/210.48 Nicotinamide %28%1968-1974%29% /analogs %26% derivatives %28%1975%29%
% 210.27/210.48 |- mesh__dateEstablished mesh__D015120 1991-01-01
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D015120 2006
% 210.27/210.48 |- skos__scopeNote mesh__D015120
% 210.27/210.48 A vitamin antagonist which has teratogenic effects.
% 210.27/210.48 |- skos__hiddenLabel mesh__D001100 Inflammations, Arachnoid Membrane
% 210.27/210.48 |- rdf__type mesh__D001100sskos__Concept
% 210.27/210.48 |- skos__historyNote mesh__D001100 Brain Diseases %28%1966%29%
% 210.27/210.48 |- mesh__dateRevised mesh__D001100 1999-11-23
% 210.27/210.48 |- mesh__dateCreated mesh__D001100 1999-01-01
% 210.27/210.48 |- mesh__historyNote mesh__D001100 1967
% 210.27/210.48 |- skos__hiddenLabel mesh__D001100 Arachnoiditides
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D001100 2002
% 210.27/210.48 |- skos__historyNote mesh__D001100 Meningitis %28%1966%29%
% 210.27/210.48 |- skos__broader mesh__D001100smesh__D008581
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D001100 2004
% 210.27/210.48 |- mesh__dateEstablished mesh__D001100 1967-01-01
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D001100 2000A
% 210.27/210.48 |- mesh__recordMaintainer mesh__D001100 ags
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D001100 ags
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D001100 2003
% 210.27/210.48 |- skos__altLabel mesh__D001100 Inflammation, Arachnoid Membrane
% 210.27/210.48 |- skos__altLabel mesh__D001100 Arachnoid Membrane Inflammation
% 210.27/210.48 |- mesh__recordOriginator mesh__D001100 NLM
% 210.27/210.48 |- skos__prefLabel mesh__D001100 Arachnoiditis
% 210.27/210.48 |- skos__scopeNote mesh__D001100
% 210.27/210.48 Acute or chronic inflammation of the arachnoid membrane of the meninges most often involving the spinal cord or base of the brain. This term generally refers to a persistent inflammatory process characterized by thickening of the ARACHNOID membrane and dural adhesions. Associated conditions include prior surgery, infections, trauma, SUBARACHNOID HEMORRHAGE, and chemical irritation. Clinical features vary with the site of inflammation, but include cranial neuropathies, radiculopathies, and myelopathies. %28%From Joynt, Clinical Neurology, 1997, Ch48, p25%29%%A%
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D001100 2001
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D001100 2006
% 210.27/210.48 |- skos__hiddenLabel mesh__D001100 Arachnoid Membrane Inflammations
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D001100 1967
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D001100 2000
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D001100 2005
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D020863 2001
% 210.27/210.48 |- skos__altLabel mesh__D020863 Suprasellar Cyst
% 210.27/210.48 |- skos__hiddenLabel mesh__D020863 Cleft Cysts, Rathke%27%s
% 210.27/210.48 |- skos__altLabel mesh__D020863 Rathke%27%s Cleft Cysts
% 210.27/210.48 |- skos__scopeNote mesh__D020863
% 210.27/210.48 Congenital or acquired cysts of the brain, spinal cord, or meninges which may remain stable in size or undergo progressive enlargement.%A%
% 210.27/210.48 |- skos__hiddenLabel mesh__D020863 Cysts, Rathke Cleft
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D020863 2000
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D020863 2004
% 210.27/210.48 |- skos__hiddenLabel mesh__D020863 Cysts, Suprasellar
% 210.27/210.48 |- rdf__type mesh__D020863sskos__Concept
% 210.27/210.48 |- skos__broader mesh__D020863smesh__D009421
% 210.27/210.48 |- skos__hiddenLabel mesh__D020863 Cyst, Suprasellar
% 210.27/210.48 |- mesh__dateEstablished mesh__D020863 2000-01-01
% 210.27/210.48 |- skos__broader mesh__D020863smesh__D016543
% 210.27/210.48 |- skos__hiddenLabel mesh__D020863 Rathkes Cleft Cysts
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D020863 2003
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D020863 2006
% 210.27/210.48 |- skos__prefLabel mesh__D020863 Central Nervous System Cysts
% 210.27/210.48 |- skos__altLabel mesh__D020863 Cysts, Central Nervous System
% 210.27/210.48 |- skos__annotation mesh__D020863 coord with organ neopl site
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D020863 2005
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D020863
% 210.27/210.48 2000; for SUPRASELLAR CYST see CRANIOPHARYNGIOMA 1966-1999%A%
% 210.27/210.48 |- mesh__historyNote mesh__D020863
% 210.27/210.48 2000; for SUPRASELLAR CYST use CRANIOPHARYNGIOMA 1966-1999%A%
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D020863 2002
% 210.27/210.48 |- skos__hiddenLabel mesh__D020863 Suprasellar Cysts
% 210.27/210.48 |- mesh__dateCreated mesh__D020863 1999-11-03
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 2001
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 2006
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 1996
% 210.27/210.48 |- mesh__dateRevised mesh__D006394 1995-06-08
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D006394 86; was ANGIOSARCOMA 1963-85
% 210.27/210.48 |- skos__hiddenLabel mesh__D006394 Angiosarcomas
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 2002
% 210.27/210.48 |- skos__prefLabel mesh__D006394 Hemangiosarcoma
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 1997
% 210.27/210.48 |- mesh__recordOriginator mesh__D006394 NLM
% 210.27/210.48 |- skos__broader mesh__D006394smesh__D009383
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 2003
% 210.27/210.48 |- skos__hiddenLabel mesh__D006394 Hemangiosarcomas
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 1998
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D006394 PLS
% 210.27/210.48 |- rdf__type mesh__D006394sskos__Concept
% 210.27/210.48 |- mesh__dateCreated mesh__D006394 1999-01-01
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 2004
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 1999
% 210.27/210.48 |- skos__altLabel mesh__D006394 Angiosarcoma
% 210.27/210.48 |- skos__broader mesh__D006394smesh__D012509
% 210.27/210.48 |- mesh__recordMaintainer mesh__D006394 KEV
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 2000
% 210.27/210.48 |- skos__scopeNote mesh__D006394
% 210.27/210.48 A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. %28%Stedman, 25th ed%29%%A%
% 210.27/210.48 |- mesh__historyNote mesh__D006394 86; was ANGIOSARCOMA 1963-85
% 210.27/210.48 |- mesh__onlineNote mesh__D006394
% 210.27/210.48 use HEMANGIOSARCOMA to search ANGIOSARCOMA 1966-85
% 210.27/210.48 |- skos__annotation mesh__D006394
% 210.27/210.48 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D006394 2005
% 210.27/210.48 |- mesh__dateRevised mesh__D020065 2004-07-07
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D020065 sjn
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D020065 99
% 210.27/210.48 |- skos__scopeNote mesh__D020065
% 210.27/210.48 A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation %28%HYPOXEMIA%29% in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension %28%HYPERTENSION, PORTAL%29%.%A%
% 210.27/210.48 |- mesh__dateEstablished mesh__D020065 1999-01-01
% 210.27/210.48 |- skos__hiddenLabel mesh__D020065 Syndromes, Hepatopulmonary
% 210.27/210.48 |- skos__hiddenLabel mesh__D020065 Syndrome, Hepato-Pulmonary
% 210.27/210.48 |- skos__broader mesh__D020065smesh__D008107
% 210.27/210.48 |- mesh__recordMaintainer mesh__D020065 lkt
% 210.27/210.48 |- skos__hiddenLabel mesh__D020065 Hepato Pulmonary Syndrome
% 210.27/210.48 |- mesh__dateCreated mesh__D020065 1998-06-10
% 210.27/210.48 |- mesh__recordOriginator mesh__D020065 NDW
% 210.27/210.48 |- skos__hiddenLabel mesh__D020065 Syndromes, Hepato-Pulmonary
% 210.27/210.48 |- skos__prefLabel mesh__D020065 Hepatopulmonary Syndrome
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D020065 2005
% 210.27/210.48 |- skos__historyNote mesh__D020065 Liver Diseases %28%1982-1998%29%
% 210.27/210.48 |- skos__hiddenLabel mesh__D020065 Hepato-Pulmonary Syndromes
% 210.27/210.48 |- skos__altLabel mesh__D020065 Hepato-Pulmonary Syndrome
% 210.27/210.48 |- mesh__historyNote mesh__D020065 99
% 210.27/210.48 |- skos__hiddenLabel mesh__D020065 Syndrome, Hepatopulmonary
% 210.27/210.48 |- rdf__type mesh__D020065sskos__Concept
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D020065 2006
% 210.27/210.48 |- skos__hiddenLabel mesh__D020065 Hepatopulmonary Syndromes
% 210.27/210.48 |- skos__altLabel mesh__D014826 Vocal Cord Paresis
% 210.27/210.48 |- skos__altLabel mesh__D014826 Unilateral Paralysis, Vocal Cord
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014826 2000
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014826 2006
% 210.27/210.48 |- skos__broader mesh__D014826smesh__D020421
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D014826 ags
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Laryngeal Paralyses
% 210.27/210.48 |- skos__broader mesh__D014826smesh__D010243
% 210.27/210.48 |- skos__scopeNote mesh__D014826
% 210.27/210.48 Paralysis of one or both vocal cords, which produces hoarseness or aphonia. This condition may be caused by diseases of the medulla %28%e.g., LATERAL MEDULLARY SYNDROME;%29%, VAGUS NERVE; or recurrent laryngeal nerve. Neuromuscular junction diseases and local myopathic processes may also affect vocal cord function. %28%Adams et al., Principles of Neurology, 6th ed, p1380%29%%A%
% 210.27/210.48 |- mesh__dateCreated mesh__D014826 1999-01-01
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Paralyses, Laryngeal
% 210.27/210.48 |- rdf__type mesh__D014826sskos__Concept
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Paralyses, Vocal Cord
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Vocal Fold Palsies
% 210.27/210.48 |- skos__altLabel mesh__D014826 Vocal Cord Palsy
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Palsy, Vocal Cord
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Vocal Cord Paralyses
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014826 2001
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Paresis, Vocal Cord
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Paralysis, Laryngeal
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Vocal Cord Pareses
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Pareses, Vocal Cord
% 210.27/210.48 |- skos__prefLabel mesh__D014826 Vocal Cord Paralysis
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Paralysis, Vocal Cord
% 210.27/210.48 |- skos__altLabel mesh__D014826 Total Vocal Cord Paralysis
% 210.27/210.48 |- skos__broader mesh__D014826smesh__D007818
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Palsies, Vocal Fold
% 210.27/210.48 |- mesh__recordMaintainer mesh__D014826 ags
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Palsy, Vocal Fold
% 210.27/210.48 |- skos__altLabel mesh__D014826 Recurrent Laryngeal Nerve Palsy
% 210.27/210.48 |- skos__annotation mesh__D014826
% 210.27/210.48 coord with RECURRENT LARYNGEAL NERVE if pertinent
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Vocal Cord Palsies
% 210.27/210.48 |- skos__altLabel mesh__D014826 Vocal Cord Paralysis, Unilateral
% 210.27/210.48 |- skos__altLabel mesh__D014826 Vocal Fold Palsy
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014826 2003
% 210.27/210.48 |- skos__altLabel mesh__D014826 Unilateral Vocal Cord Paralysis
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014826 2002
% 210.27/210.48 |- skos__hiddenLabel mesh__D014826 Palsies, Vocal Cord
% 210.27/210.48 |- mesh__recordOriginator mesh__D014826 NLM
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014826 2006A
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014826 2004
% 210.27/210.48 |- mesh__dateRevised mesh__D014826 2005-07-18
% 210.27/210.48 |- skos__altLabel mesh__D014826 Paralysis, Vocal Cord, Unilateral
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014826 2005
% 210.27/210.48 |- skos__broader mesh__D014028smesh__D012906
% 210.27/210.48 |- skos__altLabel mesh__D014028 Air Pollution, Tobacco Smoke
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 2000
% 210.27/210.48 |- skos__scopeNote mesh__D014028
% 210.27/210.48 Contamination of the air by tobacco smoke.
% 210.27/210.48 |- skos__historyNote mesh__D014028 Air Pollution %28%1972-1981%29%
% 210.27/210.48 |- rdf__type mesh__D014028sskos__Concept
% 210.27/210.48 |- mesh__recordMaintainer mesh__D014028 TGC
% 210.27/210.48 |- mesh__dateCreated mesh__D014028 1981-05-19
% 210.27/210.48 |- skos__historyNote mesh__D014028 Ventilation %28%1972-1981%29%
% 210.27/210.48 |- skos__altLabel mesh__D014028 Environmental Tobacco Smoke Pollution
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 1998
% 210.27/210.48 |- mesh__recordOriginator mesh__D014028 EC
% 210.27/210.48 |- mesh__dateRevised mesh__D014028 1996-06-10
% 210.27/210.48 |- skos__historyNote mesh__D014028 Environmental Exposure %28%1972-1981%29%
% 210.27/210.48 |- mesh__dateEstablished mesh__D014028 1982-01-01
% 210.27/210.48 |- skos__annotation mesh__D014028
% 210.27/210.48 note X ref PASSIVE SMOKING; disease caused by passive smoking = disease /etiol, not /chem ind%A%
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D014028 82
% 210.27/210.48 |- mesh__historyNote mesh__D014028 82
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 2004
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D014028 PLS
% 210.27/210.48 |- skos__hiddenLabel mesh__D014028 Smoke Pollution, Tobacco
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 2002
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 2006
% 210.27/210.48 |- skos__altLabel mesh__D014028 Environmental Pollution, Tobacco Smoke
% 210.27/210.48 |- skos__hiddenLabel mesh__D014028 Pollution, Tobacco Smoke
% 210.27/210.48 |- skos__historyNote mesh__D014028 Smoking %28%1972-1981%29%
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 2003
% 210.27/210.48 |- skos__historyNote mesh__D014028
% 210.27/210.48 Air Pollutants, Environmental %28%1975-1981%29%
% 210.27/210.48 |- skos__historyNote mesh__D014028 Smoke %28%1972-1981%29%
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 2001
% 210.27/210.48 |- skos__altLabel mesh__D014028 Passive Smoking
% 210.27/210.48 |- skos__prefLabel mesh__D014028 Tobacco Smoke Pollution
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 2005
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 1997
% 210.27/210.48 |- skos__historyNote mesh__D014028 Air Pollutants %28%1975-1981%29%
% 210.27/210.48 |- skos__altLabel mesh__D014028 Environmental Smoke Pollution, Tobacco
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D014028 1999
% 210.27/210.48 |- skos__hiddenLabel mesh__D000806
% 210.27/210.48 Enzyme Inhibitors, Angiotensin-Converting
% 210.27/210.48 |- skos__altLabel mesh__D000806 Kininase II Inhibitors
% 210.27/210.48 |- skos__prefLabel mesh__D000806 Angiotensin-Converting Enzyme Inhibitors
% 210.27/210.48 |- mesh__dateEstablished mesh__D000806 1988-01-01
% 210.27/210.48 |- skos__hiddenLabel mesh__D000806
% 210.27/210.48 Angiotensin I Converting Enzyme Inhibitors
% 210.27/210.48 |- skos__broader mesh__D000806smesh__D011480
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D000806
% 210.27/210.48 88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93%A%
% 210.27/210.48 |- skos__hiddenLabel mesh__D000806
% 210.27/210.48 Antagonists, Angiotensin Converting Enzyme
% 210.27/210.48 |- skos__altLabel mesh__D000806 Angiotensin-Converting Enzyme Antagonists
% 210.27/210.48 |- mesh__recordOriginator mesh__D000806 RLS
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D000806 sjn
% 210.27/210.48 |- skos__annotation mesh__D000806
% 210.27/210.48 protease inhib %26% antihypertensives; DF: ACE INHIB
% 210.27/210.48 |- skos__historyNote mesh__D000806
% 210.27/210.48 Kininase II/antagonists %26% inhibitors %28%1973-1987%29%
% 210.27/210.48 |- skos__hiddenLabel mesh__D000806
% 210.27/210.48 Angiotensin Converting Enzyme Antagonists
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000806 2005
% 210.27/210.48 |- skos__altLabel mesh__D000806 Kininase II Antagonists
% 210.27/210.48 |- rdf__type mesh__D000806sskos__Concept
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000806 2004
% 210.27/210.48 |- skos__hiddenLabel mesh__D000806 Angiotensin Converting Enzyme Inhibitors
% 210.27/210.48 |- mesh__onlineNote mesh__D000806
% 210.27/210.48 use TEPROTIDE to search ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR 1991-93%A%
% 210.27/210.48 |- skos__hiddenLabel mesh__D000806
% 210.27/210.48 Enzyme Antagonists, Angiotensin-Converting
% 210.27/210.48 |- mesh__recordMaintainer mesh__D000806 ssb
% 210.27/210.48 |- mesh__historyNote mesh__D000806
% 210.27/210.48 88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93%A%
% 210.27/210.48 |- skos__hiddenLabel mesh__D000806
% 210.27/210.48 Inhibitors, Angiotensin Converting Enzyme
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000806 2006
% 210.27/210.48 |- skos__altLabel mesh__D000806 Inhibitors, Kininase II
% 210.27/210.48 |- skos__altLabel mesh__D000806 Antagonists, Kininase II
% 210.27/210.48 |- skos__altLabel mesh__D000806 ACE Inhibitors
% 210.27/210.48 |- skos__altLabel mesh__D000806 Inhibitors, Angiotensin-Converting Enzyme
% 210.27/210.48 |- skos__altLabel mesh__D000806 Antagonists, Angiotensin-Converting Enzyme
% 210.27/210.48 |- skos__historyNote mesh__D000806
% 210.27/210.48 Enzymes/antagonists %26% inhibitors %28%1968-1974%29%
% 210.27/210.48 |- skos__altLabel mesh__D000806 Inhibitors, ACE
% 210.27/210.48 |- skos__historyNote mesh__D000806 Enzyme Inhibitors %28%1975-1987%29%
% 210.27/210.48 |- mesh__dateCreated mesh__D000806 1987-05-04
% 210.27/210.48 |- skos__scopeNote mesh__D000806
% 210.27/210.48 A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.%A%
% 210.27/210.48 |- skos__altLabel mesh__D000806 Angiotensin I-Converting Enzyme Inhibitors
% 210.27/210.48 |- mesh__dateRevised mesh__D000806 2003-07-09
% 210.27/210.48 |- skos__hiddenLabel mesh__D000008 Neoplasms, Abdominal
% 210.27/210.48 |- mesh__recordOriginator mesh__D000008 NLM
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 2001
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 2004
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 2000
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 1999
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 2003
% 210.27/210.48 |- skos__hiddenLabel mesh__D000008 Neoplasm, Abdominal
% 210.27/210.48 |- mesh__dateCreated mesh__D000008 1999-01-01
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 1998
% 210.27/210.48 |- mesh__dateRevised mesh__D000008 1995-06-08
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 1997
% 210.27/210.48 |- skos__annotation mesh__D000008
% 210.27/210.48 general term for neopl of organs in the abdom cavity; prefer specific organ/neopl terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl if given %28%IM%29%%A%
% 210.27/210.48 |- mesh__recordMaintainer mesh__D000008 KEV
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 1996
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 2006
% 210.27/210.48 |- skos__broader mesh__D000008smesh__D009371
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 2002
% 210.27/210.48 |- skos__hiddenLabel mesh__D000008 Abdominal Neoplasm
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D000008 PLS
% 210.27/210.48 |- skos__prefLabel mesh__D000008 Abdominal Neoplasms
% 210.27/210.48 |- rdf__type mesh__D000008sskos__Concept
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D000008 2005
% 210.27/210.48 |- skos__historyNote mesh__D046908 Peptide Biosynthesis %28%1976-2004%29%
% 210.27/210.48 |- skos__hiddenLabel mesh__D046908
% 210.27/210.48 Peptide Biosynthesis, Nucleic Acid Independent
% 210.27/210.48 |- mesh__recordOriginator mesh__D046908 nns
% 210.27/210.48 |- skos__annotation mesh__D046908
% 210.27/210.48 coordinate with specific peptide /biosyn if pertinent
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D046908 2005
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D046908 2005
% 210.27/210.48 |- mesh__historyNote mesh__D046908 2005
% 210.27/210.48 |- skos__hiddenLabel mesh__D046908 Biosynthesis, Extra-Ribosomal Peptide
% 210.27/210.48 |- skos__hiddenLabel mesh__D046908 Non-Ribosomal Peptide Biosynthesis
% 210.27/210.48 |- skos__broader mesh__D046908smesh__D010452
% 210.27/210.48 |- skos__hiddenLabel mesh__D046908 Peptide Biosynthesis, Extraribosomal
% 210.27/210.48 |- skos__hiddenLabel mesh__D046908
% 210.27/210.48 Nucleic Acid Independent Peptide Biosynthesis
% 210.27/210.48 |- skos__altLabel mesh__D046908 Peptide Biosynthesis, Non-Ribosomal
% 210.27/210.48 |- skos__prefLabel mesh__D046908
% 210.27/210.48 Peptide Biosynthesis, Nucleic Acid-Independent
% 210.27/210.48 |- skos__altLabel mesh__D046908
% 210.27/210.48 Nucleic Acid-Independent Peptide Biosynthesis
% 210.27/210.48 |- skos__hiddenLabel mesh__D046908 Extra-Ribosomal Peptide Biosynthesis
% 210.27/210.48 |- skos__altLabel mesh__D046908 Extraribosomal Peptide Biosynthesis
% 210.27/210.48 |- skos__altLabel mesh__D046908 Peptide Biosynthesis, Extra-Ribosomal
% 210.27/210.48 |- mesh__dateEstablished mesh__D046908 2005-01-01
% 210.27/210.48 |- mesh__dateCreated mesh__D046908 2004-07-07
% 210.27/210.48 |- skos__hiddenLabel mesh__D046908 Peptide Biosynthesis, Non Ribosomal
% 210.27/210.48 |- skos__hiddenLabel mesh__D046908 Peptide Biosynthesis, Extra Ribosomal
% 210.27/210.48 |- skos__historyNote mesh__D046908
% 210.27/210.48 specific peptide/biosynthesis %28%1969-2004%29%
% 210.27/210.48 |- skos__altLabel mesh__D046908 Nonribosomal Peptide Biosynthesis
% 210.27/210.48 |- rdf__type mesh__D046908sskos__Concept
% 210.27/210.48 |- skos__hiddenLabel mesh__D046908 Peptide Biosynthesis, Nonribosomal
% 210.27/210.48 |- mesh__recordMaintainer mesh__D046908 nns
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D046908 2006
% 210.27/210.48 |- skos__scopeNote mesh__D046908
% 210.27/210.48 The enzymatic synthesis of PEPTIDES without an RNA template by processes that do not use the ribosomal apparatus %28%RIBOSOMES%29%.%A%
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D046908 sjn
% 210.27/210.48 |- skos__annotation mesh__D018419
% 210.27/210.48 animal only, not man; GEN or unspecified; prefer specifics; coord IM with specific dis /vet %28%IM%29%; for abnormalities or injuries, index under specific primate heading /abnorm or /inj; don%27%t forget also PRIMATES %28%NIM%29% if no specific primate is indexed; also check tag ANIMALS; DF: PRIMATE DIS%A%
% 210.27/210.48 |- mesh__dateEstablished mesh__D018419 1995-01-01
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D018419 2006
% 210.27/210.48 |- rdf__type mesh__D018419sskos__Concept
% 210.27/210.48 |- skos__prefLabel mesh__D018419 Primate Diseases
% 210.27/210.48 |- mesh__historyNote mesh__D018419 95
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D018419 2005
% 210.27/210.48 |- skos__scopeNote mesh__D018419
% 210.27/210.48 Diseases of animals within the order PRIMATES. This term includes diseases of Haplorhini and Strepsirhini.%A%
% 210.27/210.48 |- skos__hiddenLabel mesh__D018419 Diseases, Primate
% 210.27/210.48 |- mesh__dateCreated mesh__D018419 1994-01-25
% 210.27/210.48 |- mesh__dateRevised mesh__D018419 2003-07-30
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D018419 95
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D018419 sjn
% 210.27/210.48 |- skos__broader mesh__D018419smesh__D000820
% 210.27/210.48 |- skos__hiddenLabel mesh__D018419 Primate Disease
% 210.27/210.48 |- skos__hiddenLabel mesh__D018419 Disease, Primate
% 210.27/210.48 |- mesh__recordOriginator mesh__D018419 PXP
% 210.27/210.48 |- mesh__recordMaintainer mesh__D018419 ags
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D018419 2004
% 210.27/210.48 |- mesh__recordAuthorizer mesh__D010436 PLS
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010436 1999
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010436 2006
% 210.27/210.48 |- mesh__recordMaintainer mesh__D010436 JRT
% 210.27/210.48 |- skos__historyNote mesh__D010436 Oligopeptides %28%1973-1974%29%
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010436 1997
% 210.27/210.48 |- mesh__publicMeSHNote mesh__D010436
% 210.27/210.48 91; was see under OLIGOPEPTIDES 1975-90
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010436 2001
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010436 2004
% 210.27/210.48 |- mesh__historyNote mesh__D010436
% 210.27/210.48 91%28%75%29%; was see under OLIGOPEPTIDES 1975-90
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010436 1998
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010436 2000
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010436 2005
% 210.27/210.48 |- mesh__activeMeSHYear mesh__D010436 1996
% 210.27/210.48 |- rdf__type mesh__D010436sskos__Concept
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D010436 2003
% 210.27/210.49 |- skos__scopeNote mesh__D010436
% 210.27/210.49 N-acylated oligopeptides isolated from culture filtrates of Actinomycetes, which act specifically to inhibit acid proteases such as pepsin and renin.%A%
% 210.27/210.49 |- mesh__recordOriginator mesh__D010436 NLM
% 210.27/210.49 |- mesh__dateRevised mesh__D010436 1995-06-08
% 210.27/210.49 |- skos__prefLabel mesh__D010436 Pepstatins
% 210.27/210.49 |- mesh__dateEstablished mesh__D010436 1991-01-01
% 210.27/210.49 |- skos__annotation mesh__D010436 protease inhib
% 210.27/210.49 |- mesh__dateCreated mesh__D010436 1974-11-19
% 210.27/210.49 |- skos__broader mesh__D010436smesh__D009842
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D010436 2002
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029141 2004
% 210.27/210.49 |- skos__broader mesh__D029141smesh__D012209
% 210.27/210.49 |- skos__altLabel mesh__D029141 Egtved virus
% 210.27/210.49 |- skos__hiddenLabel mesh__D029141 Novirhabdoviruses
% 210.27/210.49 |- skos__annotation mesh__D029141
% 210.27/210.49 infection: coord IM with RHABDOVIRIDAE INFECTIONS %28%IM%29%
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029141 2002
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029141 2005
% 210.27/210.49 |- skos__scopeNote mesh__D029141
% 210.27/210.49 A genus in the family RHABDOVIRIDAE, infecting numerous species of fish with broad geographic distribution. The type species is INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS.%A%
% 210.27/210.49 |- skos__hiddenLabel mesh__D029141 rhabdovirus, Hirame
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D029141 2002
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029141 2006
% 210.27/210.49 |- skos__altLabel mesh__D029141 Hemorrhagic Septicemia Virus, Viral
% 210.27/210.49 |- mesh__dateCreated mesh__D029141 2001-07-25
% 210.27/210.49 |- skos__prefLabel mesh__D029141 Novirhabdovirus
% 210.27/210.49 |- mesh__historyNote mesh__D029141 2002
% 210.27/210.49 |- rdf__type mesh__D029141sskos__Concept
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029141 2003
% 210.27/210.49 |- mesh__dateEstablished mesh__D029141 2002-01-01
% 210.27/210.49 |- skos__hiddenLabel mesh__D015121 F1 alpha, 6-Ketoprostaglandin
% 210.27/210.49 |- mesh__historyNote mesh__D015121 82
% 210.27/210.49 |- rdf__type mesh__D015121sskos__Concept
% 210.27/210.49 |- skos__hiddenLabel mesh__D015121 alpha, 6-Ketoprostaglandin F1
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D015121 82
% 210.27/210.49 |- skos__broader mesh__D015121smesh__D005229
% 210.27/210.49 |- skos__altLabel mesh__D015121 6-Oxo-PGF1 alpha
% 210.27/210.49 |- skos__historyNote mesh__D015121 Prostaglandins F %28%1975-1981%29%
% 210.27/210.49 |- skos__altLabel mesh__D015121 6 Ketoprostaglandin F1 alpha
% 210.27/210.49 |- skos__hiddenLabel mesh__D015121 alpha, 6-Oxo-PGF1
% 210.27/210.49 |- skos__hiddenLabel mesh__D015121 alpha, 6-Oxoprostaglandin F1
% 210.27/210.49 |- skos__hiddenLabel mesh__D015121 6 Oxoprostaglandin F1 alpha
% 210.27/210.49 |- mesh__dateEstablished mesh__D015121 1982-01-01
% 210.27/210.49 |- skos__broader mesh__D015121smesh__D011460
% 210.27/210.49 |- mesh__dateRevised mesh__D015121 2005-06-30
% 210.27/210.49 |- skos__hiddenLabel mesh__D015121 alpha, 6-Keto-PGF1
% 210.27/210.49 |- skos__hiddenLabel mesh__D015121 6 Keto PGF1 alpha
% 210.27/210.49 |- mesh__recordOriginator mesh__D015121 RLS
% 210.27/210.49 |- skos__prefLabel mesh__D015121 6-Ketoprostaglandin F1 alpha
% 210.27/210.49 |- skos__altLabel mesh__D015121 6-Oxoprostaglandin F1 alpha
% 210.27/210.49 |- skos__altLabel mesh__D015121 6-Keto-PGF1 alpha
% 210.27/210.49 |- mesh__recordMaintainer mesh__D015121 ssb
% 210.27/210.49 |- skos__hiddenLabel mesh__D015121 6 Oxo PGF1 alpha
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D015121 2006
% 210.27/210.49 |- skos__historyNote mesh__D015121 Prostaglandins %28%1966-1974%29%
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D015121 sjn
% 210.27/210.49 |- skos__annotation mesh__D015121
% 210.27/210.49 a prostaglandin F; /biosyn /physiol permitted; DF: note short X ref%A%
% 210.27/210.49 |- skos__hiddenLabel mesh__D015121 F1 alpha, 6-Oxoprostaglandin
% 210.27/210.49 |- mesh__dateCreated mesh__D015121 1981-05-12
% 210.27/210.49 |- skos__scopeNote mesh__D015121
% 210.27/210.49 The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.%A%
% 210.27/210.49 |- mesh__dateEstablished mesh__D001101 1991-01-01
% 210.27/210.49 |- mesh__onlineNote mesh__D001101
% 210.27/210.49 use ARBAPROSTIL to search 15-METHYLPROSTAGLANDIN E2 METHYL ESTER %26% METHYLDINOPROSTONE 1980-93%A%
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D001101 sjn
% 210.27/210.49 |- skos__hiddenLabel mesh__D001101 15 Methylprostaglandin E2
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D001101 2006
% 210.27/210.49 |- mesh__dateCreated mesh__D001101 1979-05-23
% 210.27/210.49 |- skos__hiddenLabel mesh__D001101 U42842
% 210.27/210.49 |- skos__hiddenLabel mesh__D001101 U 42842
% 210.27/210.49 |- skos__altLabel mesh__D001101 15-Methylprostaglandin E2
% 210.27/210.49 |- mesh__dateRevised mesh__D001101 2005-06-30
% 210.27/210.49 |- skos__historyNote mesh__D001101 Prostaglandins, Synthetic %28%1977%29%
% 210.27/210.49 |- skos__prefLabel mesh__D001101 Arbaprostil
% 210.27/210.49 |- skos__broader mesh__D001101smesh__D011459
% 210.27/210.49 |- skos__historyNote mesh__D001101
% 210.27/210.49 Prostaglandins E, Synthetic %28%1978-1979%29%
% 210.27/210.49 |- mesh__recordMaintainer mesh__D001101 ssb
% 210.27/210.49 |- rdf__type mesh__D001101sskos__Concept
% 210.27/210.49 |- skos__historyNote mesh__D001101 Prostaglandins %28%1966-1974%29%
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D001101
% 210.27/210.49 91; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER %26% METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93%A%
% 210.27/210.49 |- mesh__historyNote mesh__D001101
% 210.27/210.49 91%28%80%29%; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER %26% METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93%A%
% 210.27/210.49 |- mesh__recordOriginator mesh__D001101 RLS
% 210.27/210.49 |- skos__historyNote mesh__D001101 Prostaglandins E %28%1975-1977%29%
% 210.27/210.49 |- skos__scopeNote mesh__D001101
% 210.27/210.49 A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and can inhibit the growth of experimental tumors.%A%
% 210.27/210.49 |- skos__scopeNote mesh__D020864
% 210.27/210.49 CALCIUM CHANNELS that are concentrated in neural tissue. Omega toxins inhibit the actions of these channels by altering their voltage dependence.%A%
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 Calcium Channels, Neural-Type
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 N Type Calcium Channels
% 210.27/210.49 |- mesh__dateCreated mesh__D020864 1999-11-03
% 210.27/210.49 |- rdf__type mesh__D020864sskos__Concept
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 Channels, N-Type Calcium
% 210.27/210.49 |- skos__altLabel mesh__D020864 N-Type VDCC
% 210.27/210.49 |- mesh__dateEstablished mesh__D020864 2000-01-01
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 N Type Calcium Channel
% 210.27/210.49 |- skos__altLabel mesh__D020864 N-Type Calcium Channel
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D020864 sjn
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D020864 2006
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 Neural Type Calcium Channels
% 210.27/210.49 |- mesh__recordOriginator mesh__D020864 adp
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 VDCC, N-Type
% 210.27/210.49 |- mesh__dateRevised mesh__D020864 2005-06-30
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 N Type VDCC
% 210.27/210.49 |- mesh__historyNote mesh__D020864 2000
% 210.27/210.49 |- skos__annotation mesh__D020864 DF: VDCC N
% 210.27/210.49 |- skos__prefLabel mesh__D020864 Calcium Channels, N-Type
% 210.27/210.49 |- skos__historyNote mesh__D020864 Calcium Channels %28%1990-1999%29%
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 Channel, N-Type Calcium
% 210.27/210.49 |- skos__altLabel mesh__D020864 N-Type Voltage-Dependent Calcium Channels
% 210.27/210.49 |- skos__broader mesh__D020864smesh__D015220
% 210.27/210.49 |- skos__altLabel mesh__D020864 N-Type Calcium Channels
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 Channels, Neural-Type Calcium
% 210.27/210.49 |- skos__altLabel mesh__D020864 Neural-Type Calcium Channels
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 Calcium Channel, N-Type
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864
% 210.27/210.49 N Type Voltage Dependent Calcium Channels
% 210.27/210.49 |- skos__hiddenLabel mesh__D020864 Calcium Channels, N Type
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D020864 2000
% 210.27/210.49 |- mesh__recordMaintainer mesh__D020864 SYSTEM
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D006395 2003
% 210.27/210.49 |- skos__hiddenLabel mesh__D006395 Hemarthroses
% 210.27/210.49 |- skos__broader mesh__D006395smesh__D007592
% 210.27/210.49 |- skos__broader mesh__D006395smesh__D006470
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D006395 2000
% 210.27/210.49 |- rdf__type mesh__D006395sskos__Concept
% 210.27/210.49 |- mesh__dateCreated mesh__D006395 1999-01-01
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D006395 2004
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D006395 67
% 210.27/210.49 |- skos__prefLabel mesh__D006395 Hemarthrosis
% 210.27/210.49 |- mesh__recordMaintainer mesh__D006395 KEV
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D006395 sjn
% 210.27/210.49 |- mesh__dateRevised mesh__D006395 1999-11-03
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D006395 2001
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D006395 2005
% 210.27/210.49 |- mesh__historyNote mesh__D006395 67%28%64%29%
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D006395 2002
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D006395 2006
% 210.27/210.49 |- mesh__dateEstablished mesh__D006395 1967-01-01
% 210.27/210.49 |- mesh__recordOriginator mesh__D006395 NLM
% 210.27/210.49 |- skos__scopeNote mesh__D006395
% 210.27/210.49 Bleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia.%A%
% 210.27/210.49 |- mesh__historyNote mesh__D020066
% 210.27/210.49 99; use PLASMODIUM FALCIPARUM MEROZOITE PRECURSOR SURFACE COAT PROTEIN %28%NM%29% 1987-98%A%
% 210.27/210.49 |- skos__altLabel mesh__D020066 MSA1
% 210.27/210.49 |- skos__prefLabel mesh__D020066 Merozoite Surface Protein 1
% 210.27/210.49 |- mesh__dateCreated mesh__D020066 1998-06-10
% 210.27/210.49 |- skos__scopeNote mesh__D020066
% 210.27/210.49 A surface protein found on Plasmodium species which induces a T-cell response. The antigen is polymorphic, sharing amino acid sequence homology among PLASMODIUM FALCIPARUM; PLASMODIUM CHABAUDI; PLASMODIUM VIVAX; and PLASMODIUM YOELII.%A%
% 210.27/210.49 |- mesh__recordMaintainer mesh__D020066 ssb
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D020066
% 210.27/210.49 99; PLASMODIUM FALCIPARUM MEROZOITE PRECURSOR SURFACE COAT PROTEIN %28%now MEROZOITE SURFACE PROTEIN 1%29% was indexed under PROTOZOAN PROTEINS 1990-98 and ANTIGENS, PROTOZOAN 1987-89%A%
% 210.27/210.49 |- skos__altLabel mesh__D020066 MSP1
% 210.27/210.49 |- skos__altLabel mesh__D020066 MSA-1
% 210.27/210.49 |- skos__altLabel mesh__D020066 Merozoite Surface Protein-1
% 210.27/210.49 |- skos__altLabel mesh__D020066 PFM-PSCP
% 210.27/210.49 |- skos__altLabel mesh__D020066 MSA-1 Protein
% 210.27/210.49 |- mesh__dateRevised mesh__D020066 2005-06-30
% 210.27/210.49 |- skos__altLabel mesh__D020066 Major Merozoite Surface Protein Precursor
% 210.27/210.49 |- mesh__recordOriginator mesh__D020066 NDW
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D020066 sjn
% 210.27/210.49 |- rdf__type mesh__D020066sskos__Concept
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D020066 2006
% 210.27/210.49 |- skos__altLabel mesh__D020066 PMMSA
% 210.27/210.49 |- skos__hiddenLabel mesh__D020066 P. vivax MSP1
% 210.27/210.49 |- mesh__dateEstablished mesh__D020066 1999-01-01
% 210.27/210.49 |- skos__broader mesh__D020066smesh__D015800
% 210.27/210.49 |- skos__historyNote mesh__D020066 Antigens, Protozoan %28%1985-1989%29%
% 210.27/210.49 |- skos__hiddenLabel mesh__D020066 MSA 1 Protein
% 210.27/210.49 |- skos__altLabel mesh__D020066
% 210.27/210.49 Plasmodium falciparum Merozoite Precursor Surface Coat Protein
% 210.27/210.49 |- skos__annotation mesh__D020066
% 210.27/210.49 coord IM with specific PLASMODIUM species
% 210.27/210.49 |- skos__altLabel mesh__D020066 MSP-1
% 210.27/210.49 |- skos__historyNote mesh__D020066 Protozoan Proteins %28%1990-1998%29%
% 210.27/210.49 |- skos__altLabel mesh__D020066 Merozoite Surface Antigen 1
% 210.27/210.49 |- skos__broader mesh__D020066smesh__D000953
% 210.27/210.49 |- skos__hiddenLabel mesh__D020066 Surface Protein-1, Merozoite
% 210.27/210.49 |- skos__hiddenLabel mesh__D020066 Protein, MSA1
% 210.27/210.49 |- skos__hiddenLabel mesh__D020066 Protein, MSA-1
% 210.27/210.49 |- skos__altLabel mesh__D020066 MSA1 Protein
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 1999
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D014827 PLS
% 210.27/210.49 |- skos__annotation mesh__D014827 inflammation = LARYNGITIS
% 210.27/210.49 |- mesh__recordMaintainer mesh__D014827 TGC
% 210.27/210.49 |- skos__hiddenLabel mesh__D014827 Folds, Vocal
% 210.27/210.49 |- skos__hiddenLabel mesh__D014827 Vocal Cord
% 210.27/210.49 |- mesh__dateRevised mesh__D014827 1991-01-08
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 2002
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 1994
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 1997
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 1992
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 2006
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 1998
% 210.27/210.49 |- skos__prefLabel mesh__D014827 Vocal Cords
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 2004
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 1996
% 210.27/210.49 |- mesh__dateCreated mesh__D014827 1999-01-01
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 2005
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 2001
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 2003
% 210.27/210.49 |- skos__hiddenLabel mesh__D014827 Cords, Vocal
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 2000
% 210.27/210.49 |- skos__hiddenLabel mesh__D014827 Cord, Vocal
% 210.27/210.49 |- mesh__recordOriginator mesh__D014827 NLM
% 210.27/210.49 |- rdf__type mesh__D014827sskos__Concept
% 210.27/210.49 |- skos__scopeNote mesh__D014827
% 210.27/210.49 The folds of mucous membrane along either wall of the larynx from the angle between the laminae of the thyroid cartilage to the vocal process of the arytenoid cartilage.%A%
% 210.27/210.49 |- skos__altLabel mesh__D014827 Vocal Fold
% 210.27/210.49 |- skos__hiddenLabel mesh__D014827 Fold, Vocal
% 210.27/210.49 |- skos__hiddenLabel mesh__D014827 Vocal Folds
% 210.27/210.49 |- skos__broader mesh__D014827smesh__D005931
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 1995
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014827 1993
% 210.27/210.49 |- skos__hiddenLabel mesh__D014029 Nicotine Use Disorders
% 210.27/210.49 |- rdf__type mesh__D014029sskos__Concept
% 210.27/210.49 |- skos__annotation mesh__D014029
% 210.27/210.49 includes cigarettes, cigars, chewing tobacco %26% snuff; a psychiatric diag: do not confuse with SMOKING /adv eff; note X ref NICOTINE DEPENDENCE: do not coord with NICOTINE unless nicotine is substantially discussed as a chemical%A%
% 210.27/210.49 |- skos__hiddenLabel mesh__D014029 Disorder, Nicotine Use
% 210.27/210.49 |- mesh__dateRevised mesh__D014029 1999-11-03
% 210.27/210.49 |- skos__historyNote mesh__D014029 Smoking %28%1966-1980%29%
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D014029 81
% 210.27/210.49 |- mesh__recordOriginator mesh__D014029 EC
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D014029 sjn
% 210.27/210.49 |- skos__hiddenLabel mesh__D014029 Dependence, Tobacco
% 210.27/210.49 |- skos__hiddenLabel mesh__D014029 Dependence, Nicotine
% 210.27/210.49 |- skos__prefLabel mesh__D014029 Tobacco Use Disorder
% 210.27/210.49 |- skos__hiddenLabel mesh__D014029 Use Disorder, Nicotine
% 210.27/210.49 |- skos__hiddenLabel mesh__D014029 Tobacco Use Disorders
% 210.27/210.49 |- mesh__historyNote mesh__D014029 81
% 210.27/210.49 |- mesh__recordMaintainer mesh__D014029 adp
% 210.27/210.49 |- skos__broader mesh__D014029smesh__D019966
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014029 2002
% 210.27/210.49 |- mesh__dateCreated mesh__D014029 1980-05-21
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014029 2004
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014029 2001
% 210.27/210.49 |- mesh__dateEstablished mesh__D014029 1981-01-01
% 210.27/210.49 |- skos__hiddenLabel mesh__D014029 Tobacco Dependences
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014029 2003
% 210.27/210.49 |- skos__altLabel mesh__D014029 Tobacco-Use Disorder
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014029 2006
% 210.27/210.49 |- skos__related mesh__D014029smesh__D016540
% 210.27/210.49 |- skos__hiddenLabel mesh__D014029 Disorder, Tobacco-Use
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014029 2000
% 210.27/210.49 |- skos__scopeNote mesh__D014029
% 210.27/210.49 Tobacco used to the detriment of a person%27%s health or social functioning. Tobacco dependence is included.%A%
% 210.27/210.49 |- skos__hiddenLabel mesh__D014029 Disorder, Tobacco Use
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D014029 2005
% 210.27/210.49 |- skos__broader mesh__D019512smesh__D020751
% 210.27/210.49 |- skos__historyNote mesh__D019512 Alcoholism %28%1966-1996%29%
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D019512 2005
% 210.27/210.49 |- mesh__dateCreated mesh__D019512 1996-06-19
% 210.27/210.49 |- rdf__type mesh__D019512sskos__Concept
% 210.27/210.49 |- skos__annotation mesh__D019512
% 210.27/210.49 usually chronic so do not coord with CHRONIC DISEASE
% 210.27/210.49 |- mesh__historyNote mesh__D019512 97
% 210.27/210.49 |- mesh__dateEstablished mesh__D019512 1997-01-01
% 210.27/210.49 |- skos__historyNote mesh__D019512 Pancreatitis %28%1966-1996%29%
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D019512 97
% 210.27/210.49 |- skos__broader mesh__D019512smesh__D010195
% 210.27/210.49 |- mesh__dateRevised mesh__D019512 2004-07-07
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D019512 sjn
% 210.27/210.49 |- skos__scopeNote mesh__D019512
% 210.27/210.49 Acute or chronic INFLAMMATION of the PANCREAS due to excessive ALCOHOL DRINKING. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.%A%
% 210.27/210.49 |- skos__altLabel mesh__D019512 Alcoholic Pancreatitis
% 210.27/210.49 |- mesh__recordOriginator mesh__D019512 PXP
% 210.27/210.49 |- skos__prefLabel mesh__D019512 Pancreatitis, Alcoholic
% 210.27/210.49 |- mesh__recordMaintainer mesh__D019512 lkt
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D019512 2006
% 210.27/210.49 |- mesh__onlineNote mesh__D000009
% 210.27/210.49 use ABDOMINAL MUSCLES to search ABDOMINAL WALL 1966-92
% 210.27/210.49 |- skos__broader mesh__D000009smesh__D018482
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D000009 93; was ABDOMINAL WALL 1963-92
% 210.27/210.49 |- skos__related mesh__D000009smesh__D034861
% 210.27/210.49 |- mesh__recordMaintainer mesh__D000009 ags
% 210.27/210.49 |- skos__hiddenLabel mesh__D000009 Abdominal Muscle
% 210.27/210.49 |- skos__prefLabel mesh__D000009 Abdominal Muscles
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D000009 2006
% 210.27/210.49 |- skos__hiddenLabel mesh__D000009 Muscle, Abdominal
% 210.27/210.49 |- mesh__recordOriginator mesh__D000009 NLM
% 210.27/210.49 |- rdf__type mesh__D000009sskos__Concept
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D000009 2005
% 210.27/210.49 |- mesh__dateRevised mesh__D000009 2002-07-02
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D000009 2004
% 210.27/210.49 |- skos__scopeNote mesh__D000009
% 210.27/210.49 Muscles forming the ABDOMINAL WALL including RECTUS ABDOMINIS, external and internal oblique muscles, transversus abdominis, and quadratus abdominis. %28%from Stedman, 25th ed%29%%A%
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D000009 sjn
% 210.27/210.49 |- skos__annotation mesh__D000009
% 210.27/210.49 RECTUS ABDOMINIS is available; hernia = HERNIA, VENTRAL; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%
% 210.27/210.49 |- mesh__historyNote mesh__D000009 93; was ABDOMINAL WALL 1966-92
% 210.27/210.49 |- skos__hiddenLabel mesh__D000009 Muscles, Abdominal
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D000009 2003
% 210.27/210.49 |- mesh__dateCreated mesh__D000009 1999-01-01
% 210.27/210.49 |- mesh__dateRevised mesh__D010437 2003-07-09
% 210.27/210.49 |- skos__hiddenLabel mesh__D010437 Ulcers, Gastroduodenal
% 210.27/210.49 |- skos__broader mesh__D010437smesh__D013272
% 210.27/210.49 |- skos__altLabel mesh__D010437 Gastroduodenal Ulcer
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D010437 2006
% 210.27/210.49 |- skos__broader mesh__D010437smesh__D004378
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D010437 2004
% 210.27/210.49 |- mesh__recordMaintainer mesh__D010437 lkt
% 210.27/210.49 |- skos__hiddenLabel mesh__D010437 Ulcer, Marginal
% 210.27/210.49 |- skos__scopeNote mesh__D010437
% 210.27/210.49 Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs %28%NSAIDS%29%.%A%
% 210.27/210.49 |- skos__hiddenLabel mesh__D010437 Ulcers, Marginal
% 210.27/210.49 |- skos__hiddenLabel mesh__D010437 Peptic Ulcers
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D010437 2005
% 210.27/210.49 |- rdf__type mesh__D010437sskos__Concept
% 210.27/210.49 |- skos__hiddenLabel mesh__D010437 Ulcers, Peptic
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D010437
% 210.27/210.49 MARGINAL ULCER was heading 1964-96 %28%see under PEPTIC ULCER 1964-90%29%%A%
% 210.27/210.49 |- skos__related mesh__D010437smesh__D015043
% 210.27/210.49 |- skos__related mesh__D010437smesh__D005743
% 210.27/210.49 |- skos__related mesh__D010437smesh__D010438
% 210.27/210.49 |- skos__annotation mesh__D010437
% 210.27/210.49 GEN: prefer STOMACH ULCER or DUODENAL ULCER but note GASTRODUODENAL ULCER = PEPTIC ULCER; stress ulcer: coord with STRESS or STRESS, PSYCHOLOGICAL %28%IM or NIM%29%%A%
% 210.27/210.49 |- skos__hiddenLabel mesh__D010437 Marginal Ulcers
% 210.27/210.49 |- skos__hiddenLabel mesh__D010437 Gastroduodenal Ulcers
% 210.27/210.49 |- skos__hiddenLabel mesh__D010437 Ulcer, Gastroduodenal
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D010437 sjn
% 210.27/210.49 |- skos__prefLabel mesh__D010437 Peptic Ulcer
% 210.27/210.49 |- mesh__historyNote mesh__D010437
% 210.27/210.49 MARGINAL ULCER was heading 1964-96 %28%see under PEPTIC ULCER 1964-90%29%%A%
% 210.27/210.49 |- mesh__dateCreated mesh__D010437 1999-01-01
% 210.27/210.49 |- skos__broader mesh__D010437smesh__D005767
% 210.27/210.49 |- mesh__recordOriginator mesh__D010437 NLM
% 210.27/210.49 |- skos__related mesh__D010437smesh__D000897
% 210.27/210.49 |- skos__hiddenLabel mesh__D010437 Ulcer, Peptic
% 210.27/210.49 |- mesh__historyNote mesh__D029142 2002
% 210.27/210.49 |- skos__prefLabel mesh__D029142 Infectious hematopoietic necrosis virus
% 210.27/210.49 |- skos__scopeNote mesh__D029142
% 210.27/210.49 The type species of NOVIRHABDOVIRUS, in the family RHABDOVIRIDAE. It is a major pathogen of TROUT and SALMON.%A%
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029142 2005
% 210.27/210.49 |- skos__broader mesh__D029142smesh__D029141
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D029142 2002
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029142 2006
% 210.27/210.49 |- skos__annotation mesh__D029142
% 210.27/210.49 do not confuse with INFECTIOUS HYPODERMAL AND HEMATOPOIETIC NECROSIS VIRUS see DENSOVIRINAE; infection: coord IM with RHABDOVIRIDAE INFECTIONS %28%IM%29%%A%
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029142 2002
% 210.27/210.49 |- skos__historyNote mesh__D029142 RNA Viruses %28%1973-1975%29%
% 210.27/210.49 |- skos__altLabel mesh__D029142 IHNV
% 210.27/210.49 |- rdf__type mesh__D029142sskos__Concept
% 210.27/210.49 |- mesh__dateEstablished mesh__D029142 2002-01-01
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029142 2003
% 210.27/210.49 |- skos__historyNote mesh__D029142 Rhabdoviridae %28%1981-2001%29%
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D029142 2004
% 210.27/210.49 |- mesh__dateCreated mesh__D029142 2001-07-25
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D015920 2006
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D015920 sjn
% 210.27/210.49 |- skos__broader mesh__D015920smesh__D004864
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D015920 2005
% 210.27/210.49 |- mesh__dateCreated mesh__D015920 1989-05-15
% 210.27/210.49 |- skos__historyNote mesh__D015920
% 210.27/210.49 Air Pollutants, Occupational %28%1975-1989%29%
% 210.27/210.49 |- skos__hiddenLabel mesh__D015920 Scavengers, Anesthetic Gas
% 210.27/210.49 |- mesh__publicMeSHNote mesh__D015920 90
% 210.27/210.49 |- mesh__historyNote mesh__D015920 90
% 210.27/210.49 |- mesh__recordOriginator mesh__D015920 PLS
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D015920 2004
% 210.27/210.49 |- skos__hiddenLabel mesh__D015920 Scavengers, Gas
% 210.27/210.49 |- skos__hiddenLabel mesh__D015920 Gas Scavenger
% 210.27/210.49 |- skos__hiddenLabel mesh__D015920 Anesthetic Gas Scavenger
% 210.27/210.49 |- skos__hiddenLabel mesh__D015920 Gas Scavenger, Anesthetic
% 210.27/210.49 |- skos__hiddenLabel mesh__D015920 Scavenger, Gas
% 210.27/210.49 |- skos__prefLabel mesh__D015920 Gas Scavengers
% 210.27/210.49 |- skos__hiddenLabel mesh__D015920 Gas Scavengers, Anesthetic
% 210.27/210.49 |- rdf__type mesh__D015920sskos__Concept
% 210.27/210.49 |- skos__scopeNote mesh__D015920
% 210.27/210.49 Apparatus for removing exhaled or leaked anesthetic gases or other volatile agents, thus reducing the exposure of operating room personnel to such agents, as well as preventing the buildup of potentially explosive mixtures in operating rooms or laboratories.%A%
% 210.27/210.49 |- mesh__recordMaintainer mesh__D015920 lkt
% 210.27/210.49 |- mesh__dateRevised mesh__D015920 2003-07-09
% 210.27/210.49 |- skos__historyNote mesh__D015920 Air Pollutants %28%1972-1983%29%
% 210.27/210.49 |- skos__historyNote mesh__D015920 Anesthesia, Inhalation %28%1972-1989%29%
% 210.27/210.49 |- skos__historyNote mesh__D015920 Operating Rooms %28%1977-1989%29%
% 210.27/210.49 |- mesh__dateEstablished mesh__D015920 1990-01-01
% 210.27/210.49 |- skos__hiddenLabel mesh__D015920 Scavenger, Anesthetic Gas
% 210.27/210.49 |- skos__annotation mesh__D015920
% 210.27/210.49 note category %26% cross refs or read MeSH definition
% 210.27/210.49 |- skos__altLabel mesh__D015122 GlaxoSmithKline Brand of 6-Mercaptopurine
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122 Puri Nethol
% 210.27/210.49 |- rdf__type mesh__D015122sskos__Concept
% 210.27/210.49 |- mesh__historyNote mesh__D015122
% 210.27/210.49 85; was MERCAPTOPURINE 1963-84; ARABINOSYL-6-MERCAPTOPURINE was heading 1975-91 %28%see under 6-MERCAPTOPURINE 1975-90%29%%A%
% 210.27/210.49 |- mesh__recordAuthorizer mesh__D015122 sjn
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122 6 Thiohypoxanthine
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122 6 Thiopurine
% 210.27/210.49 |- skos__prefLabel mesh__D015122 6-Mercaptopurine
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122 Wellcome Brand of 6 Mercaptopurine
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122
% 210.27/210.49 GlaxoSmithKline Brand of 6 Mercaptopurine
% 210.27/210.49 |- skos__broader mesh__D015122smesh__D011687
% 210.27/210.49 |- skos__altLabel mesh__D015122 6-Thiopurine
% 210.27/210.49 |- skos__altLabel mesh__D015122 Puri-Nethol
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122 BW 57 323H
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122 6 Mercaptopurine Monohydrate
% 210.27/210.49 |- mesh__recordMaintainer mesh__D015122 CCR
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122 BW 57323H
% 210.27/210.49 |- skos__broader mesh__D015122smesh__D013438
% 210.27/210.49 |- skos__scopeNote mesh__D015122
% 210.27/210.49 An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.%A%
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122 Glaxo Wellcome Brand of 6 Mercaptopurine
% 210.27/210.49 |- mesh__onlineNote mesh__D015122
% 210.27/210.49 use 6-MERCAPTOPURINE to search MERCAPTOPURINE 1966-84 %26% ARABINOSYL-6-MERCAPTOPURINE 1975-91%A%
% 210.27/210.49 |- skos__altLabel mesh__D015122 Mercaptopurine
% 210.27/210.49 |- mesh__recordOriginator mesh__D015122 NLM
% 210.27/210.49 |- skos__hiddenLabel mesh__D015122 6 Mercaptopurine
% 210.27/210.49 |- mesh__activeMeSHYear mesh__D015122 2006
% 210.27/210.49 |- skos__altLabel mesh__D015122 1,7-Dihydro-6H-purine-6-thione
% 210.27/210.50 |- skos__altLabel mesh__D015122 Glaxo Wellcome Brand of 6-Mercaptopurine
% 210.27/210.50 |- skos__altLabel mesh__D015122 Wellcome Brand of 6-Mercaptopurine
% 210.27/210.50 |- skos__altLabel mesh__D015122 6-Thiohypoxanthine
% 210.27/210.50 |- mesh__publicMeSHNote mesh__D015122
% 210.27/210.50 85; was MERCAPTOPURINE 1963-84; ARABINOSYL-6-MERCAPTOPURINE was heading 1991, was see under 6-MERCAPTOPURINE 1975-90%A%
% 210.27/210.50 |- mesh__dateCreated mesh__D015122 1999-01-01
% 210.27/210.50 |- mesh__dateRevised mesh__D015122 2005-06-30
% 210.27/210.50 |- skos__historyNote mesh__D001900 Massachusetts %28%1966-1969%29%
% 210.27/210.50 |- mesh__dateEstablished mesh__D001900 1970-01-01
% 210.27/210.50 |- rdf__type mesh__D001900sskos__Concept
% 210.27/210.50 |- mesh__recordOriginator mesh__D001900 NLM
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001900 2004
% 210.27/210.50 |- skos__prefLabel mesh__D001900 Boston
% 210.27/210.50 |- mesh__recordMaintainer mesh__D001900 PXP
% 210.27/210.50 |- mesh__historyNote mesh__D001900 70
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001900 2006
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001900 2003
% 210.27/210.50 |- skos__broader mesh__D001900smesh__D008404
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001900 1999
% 210.27/210.50 |- mesh__dateRevised mesh__D001900 1997-06-20
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001900 2002
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001900 2005
% 210.27/210.50 |- skos__broader mesh__D001900smesh__D002947
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001900 1998
% 210.27/210.50 |- mesh__dateCreated mesh__D001900 1999-01-01
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001900 2001
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001900 2000
% 210.27/210.50 |- mesh__recordAuthorizer mesh__D001900 SJN
% 210.27/210.50 |- skos__hiddenLabel mesh__D001102 Infections, Arbovirus
% 210.27/210.50 |- mesh__dateRevised mesh__D001102 2004-07-13
% 210.27/210.50 |- skos__hiddenLabel mesh__D001102 Infection, Arbovirus
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001102 2006
% 210.27/210.50 |- skos__hiddenLabel mesh__D001102 Arbovirus Infection
% 210.27/210.50 |- mesh__historyNote mesh__D001102 65; was ARBORVIRUS INFECTIONS 1963-64
% 210.27/210.50 |- mesh__recordOriginator mesh__D001102 NLM
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D001102 2005
% 210.27/210.50 |- mesh__recordAuthorizer mesh__D001102 sjn
% 210.27/210.50 |- rdf__type mesh__D001102sskos__Concept
% 210.27/210.50 |- skos__scopeNote mesh__D001102
% 210.27/210.50 Infections caused by arthropod-borne viruses, general or unspecified.%A%
% 210.27/210.50 |- skos__broader mesh__D001102smesh__D014777
% 210.27/210.50 |- skos__prefLabel mesh__D001102 Arbovirus Infections
% 210.27/210.50 |- mesh__dateCreated mesh__D001102 1999-01-01
% 210.27/210.50 |- mesh__recordMaintainer mesh__D001102 sjn
% 210.27/210.50 |- mesh__dateEstablished mesh__D001102 1965-01-01
% 210.27/210.50 |- mesh__publicMeSHNote mesh__D001102
% 210.27/210.50 65; was ARBORVIRUS INFECTIONS 1963-64
% 210.27/210.50 |- skos__annotation mesh__D001102
% 210.27/210.50 GEN; consider also 2 major groups, BUNYAVIRUS INFECTIONS %26% TOGAVIRUS INFECTIONS or specifics%A%
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865 P Type VDCC
% 210.27/210.50 |- skos__altLabel mesh__D020865 Purkinje-Type Calcium Channels
% 210.27/210.50 |- skos__historyNote mesh__D020865 Calcium Channels %28%1991-1999%29%
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865 Calcium Channels, P Type
% 210.27/210.50 |- rdf__type mesh__D020865sskos__Concept
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865 Channels, Purkinje-Type Calcium
% 210.27/210.50 |- skos__altLabel mesh__D020865 P-Type Calcium Channels
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865 Channel, P-Type Calcium
% 210.27/210.50 |- skos__altLabel mesh__D020865 P-Type Calcium Channel
% 210.27/210.50 |- mesh__activeMeSHYear mesh__D020865 2006
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865 VDCC, P-Type
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865 Calcium Channels, Purkinje-Type
% 210.27/210.50 |- skos__altLabel mesh__D020865 P-Type Voltage-Dependent Calcium Channels
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865 Purkinje Type Calcium Channels
% 210.27/210.50 |- mesh__recordOriginator mesh__D020865 adp
% 210.27/210.50 |- mesh__recordMaintainer mesh__D020865 SYSTEM
% 210.27/210.50 |- mesh__publicMeSHNote mesh__D020865
% 210.27/210.50 2000; P-TYPE VDCC was indexed under CALCIUM CHANNELS 1999%A%
% 210.27/210.50 |- skos__scopeNote mesh__D020865
% 210.27/210.50 CALCIUM CHANNELS located within the PURKINJE CELLS of the cerebellum. They are involved in stimulation-secretion coupling of neurons.%A%
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865 Calcium Channel, P-Type
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865
% 210.27/210.50 P Type Voltage Dependent Calcium Channels
% 210.27/210.50 |- mesh__dateCreated mesh__D020865 1999-11-08
% 210.27/210.50 |- mesh__dateEstablished mesh__D020865 2000-01-01
% 210.27/210.50 |- mesh__recordAuthorizer mesh__D020865 sjn
% 210.27/210.50 |- skos__prefLabel mesh__D020865 Calcium Channels, P-Type
% 210.27/210.50 |- skos__hiddenLabel mesh__D020865 P Type Calcium Channels
% 210.27/210.50 |- skos__annotation mesh__D020865 DF: VDCC P
% 210.35/210.50 |- skos__altLabel mesh__D020865 P-Type VDCC
% 210.35/210.50 |- mesh__dateRevised mesh__D020865 2005-06-30
% 210.35/210.50 |- skos__hiddenLabel mesh__D020865 P Type Calcium Channel
% 210.35/210.50 |- skos__hiddenLabel mesh__D020865 Channels, P-Type Calcium
% 210.35/210.50 |- skos__broader mesh__D020865smesh__D020864
% 210.35/210.50 |- mesh__historyNote mesh__D020865
% 210.35/210.50 2000; for P-TYPE VDCC use VOLTAGE-DEPENDENT CALCIUM CHANNEL %28%P-Q TYPE%29% %28%NM%29% 1999%A%
% 210.35/210.50 |- skos__broader mesh__D006396smesh__D006471
% 210.35/210.50 |- rdf__type mesh__D006396sskos__Concept
% 210.35/210.50 |- mesh__dateCreated mesh__D006396 1999-01-01
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D006396 2004
% 210.35/210.50 |- skos__broader mesh__D006396smesh__D014839
% 210.35/210.50 |- mesh__recordMaintainer mesh__D006396 lkt
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D006396 2005
% 210.35/210.50 |- mesh__dateRevised mesh__D006396 2003-07-09
% 210.35/210.50 |- skos__scopeNote mesh__D006396
% 210.35/210.50 Vomiting of blood that is either fresh bright red, or older %22%coffee-ground%22% in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.%A%
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D006396 2006
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D006396 sjn
% 210.35/210.50 |- skos__prefLabel mesh__D006396 Hematemesis
% 210.35/210.50 |- skos__hiddenLabel mesh__D006396 Hematemeses
% 210.35/210.50 |- mesh__recordOriginator mesh__D006396 NLM
% 210.35/210.50 |- mesh__dateCreated mesh__D014828 1999-01-01
% 210.35/210.50 |- skos__altLabel mesh__D014828 Animal Vocalization
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D014828 2005
% 210.35/210.50 |- mesh__recordOriginator mesh__D014828 NLM
% 210.35/210.50 |- skos__prefLabel mesh__D014828 Vocalization, Animal
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D014828 2003
% 210.35/210.50 |- skos__hiddenLabel mesh__D014828 Animal Vocalizations
% 210.35/210.50 |- skos__historyNote mesh__D014828 Communication %28%1966-1967%29%
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D014828 sjn
% 210.35/210.50 |- mesh__recordMaintainer mesh__D014828 JLS
% 210.35/210.50 |- skos__scopeNote mesh__D014828
% 210.35/210.50 Vocal sounds used in animal communication.
% 210.35/210.50 |- rdf__type mesh__D014828sskos__Concept
% 210.35/210.50 |- mesh__dateRevised mesh__D014828 2002-07-02
% 210.35/210.50 |- mesh__historyNote mesh__D014828 68
% 210.35/210.50 |- skos__historyNote mesh__D014828 Voice %28%1966-1967%29%
% 210.35/210.50 |- mesh__dateEstablished mesh__D014828 1968-01-01
% 210.35/210.50 |- skos__broader mesh__D014828smesh__D000819
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D014828 2006
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D014828 68
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D014828 2004
% 210.35/210.50 |- skos__hiddenLabel mesh__D014828 Vocalizations, Animal
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D019513 2002
% 210.35/210.50 |- skos__annotation mesh__D019513
% 210.35/210.50 polit, econ %26% social equality of women to men
% 210.35/210.50 |- skos__hiddenLabel mesh__D019513 Ethics, Feminist
% 210.35/210.50 |- mesh__historyNote mesh__D019513 97; was see WOMEN%27%S RIGHTS 1994-96
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D019513 2003
% 210.35/210.50 |- skos__prefLabel mesh__D019513 Feminism
% 210.35/210.50 |- mesh__dateCreated mesh__D019513 1996-06-10
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D019513
% 210.35/210.50 97; was see WOMEN%27%S RIGHTS 1994-96
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D019513 1999
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D019513 2001
% 210.35/210.50 |- skos__hiddenLabel mesh__D019513 Ethic, Feminist
% 210.35/210.50 |- mesh__dateEstablished mesh__D019513 1997-01-01
% 210.35/210.50 |- skos__hiddenLabel mesh__D019513 Feminist Ethic
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D019513 1998
% 210.35/210.50 |- mesh__dateRevised mesh__D019513 1997-06-20
% 210.35/210.50 |- skos__historyNote mesh__D019513 Women%27%s Rights %28%1977-1996%29%
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D019513 SJN
% 210.35/210.50 |- mesh__recordMaintainer mesh__D019513 JLS
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D019513 2000
% 210.35/210.50 |- skos__broader mesh__D019513smesh__D006808
% 210.35/210.50 |- skos__scopeNote mesh__D019513
% 210.35/210.50 The theory of the political, economic, and social equality of the sexes and organized activity on behalf of women%27%s rights and interests. %28%Webster New Collegiate Dictionary, 1981%29%%A%
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D019513 2006
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D019513 2005
% 210.35/210.50 |- rdf__type mesh__D019513sskos__Concept
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D019513 2004
% 210.35/210.50 |- mesh__recordOriginator mesh__D019513 JLS
% 210.35/210.50 |- mesh__onlineNote mesh__D019513
% 210.35/210.50 use WOMEN%27%S RIGHTS to search FEMINISM 1994-96
% 210.35/210.50 |- mesh__dateCreated mesh__D000808 1974-11-19
% 210.35/210.50 |- mesh__recordMaintainer mesh__D000808 JRT
% 210.35/210.50 |- skos__historyNote mesh__D000808 Protein Precursors %28%1971-1974%29%
% 210.35/210.50 |- skos__altLabel mesh__D000808 Renin-Substrate
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 2004
% 210.35/210.50 |- skos__scopeNote mesh__D000808
% 210.35/210.50 An alpha-globulin of which a fragment of 14 amino acids is converted by renin to angiotensin I, the inactive precursor of angiotensin II. It is a member of the serpin superfamily.%A%
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 2001
% 210.35/210.50 |- skos__hiddenLabel mesh__D000808 Renin Substrate
% 210.35/210.50 |- skos__hiddenLabel mesh__D000808 Tetradecapeptide, Renin Substrate
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 2003
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 1997
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D000808
% 210.35/210.50 87; was see under ANGIOTENSINS 1975-86
% 210.35/210.50 |- rdf__type mesh__D000808sskos__Concept
% 210.35/210.50 |- skos__annotation mesh__D000808
% 210.35/210.50 a serpin %26% angiotensin II precursor; /biosyn /drug eff /physiol /ultrastruct permitted%A%
% 210.35/210.50 |- skos__historyNote mesh__D000808 Alpha Globulins %28%1968-1974%29%
% 210.35/210.50 |- mesh__dateEstablished mesh__D000808 1987-01-01
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 2000
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 2006
% 210.35/210.50 |- skos__broader mesh__D000808smesh__D015843
% 210.35/210.50 |- mesh__recordOriginator mesh__D000808 NLM
% 210.35/210.50 |- skos__historyNote mesh__D000808 Angiotensin II %28%1968-1974%29%
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 1996
% 210.35/210.50 |- mesh__dateRevised mesh__D000808 1995-06-08
% 210.35/210.50 |- skos__broader mesh__D000808smesh__D011498
% 210.35/210.50 |- skos__broader mesh__D000808smesh__D000809
% 210.35/210.50 |- skos__prefLabel mesh__D000808 Angiotensinogen
% 210.35/210.50 |- skos__altLabel mesh__D000808 Hypertensinogen
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 2005
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 1999
% 210.35/210.50 |- mesh__historyNote mesh__D000808
% 210.35/210.50 87%28%75%29%; was see under ANGIOTENSINS 1975-86
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 2002
% 210.35/210.50 |- skos__altLabel mesh__D000808 Proangiotensin
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D000808 PLS
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D000808 1998
% 210.35/210.50 |- mesh__recordMaintainer mesh__D011530 lkw
% 210.35/210.50 |- skos__broader mesh__D011530smesh__D003986
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D011530 sjn
% 210.35/210.50 |- mesh__dateRevised mesh__D011530 2005-06-30
% 210.35/210.50 |- skos__historyNote mesh__D011530 Propylamines %28%1969-1974%29%
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D011530 2006
% 210.35/210.50 |- mesh__dateCreated mesh__D011530 1974-11-19
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D011530
% 210.35/210.50 91; was see under DIBENZOCYCLOHEPTENES 1975-90
% 210.35/210.50 |- mesh__dateEstablished mesh__D011530 1991-01-01
% 210.35/210.50 |- skos__altLabel mesh__D011530
% 210.35/210.50 Odyssey Brand of Protriptyline Hydrochloride
% 210.35/210.50 |- mesh__recordOriginator mesh__D011530 NLM
% 210.35/210.50 |- skos__historyNote mesh__D011530 Dibenzocycloheptenes %28%1969-1974%29%
% 210.35/210.50 |- skos__scopeNote mesh__D011530
% 210.35/210.50 Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation.%A%
% 210.35/210.50 |- skos__hiddenLabel mesh__D011530 Hydrochloride, Protriptyline
% 210.35/210.50 |- skos__prefLabel mesh__D011530 Protriptyline
% 210.35/210.50 |- rdf__type mesh__D011530sskos__Concept
% 210.35/210.50 |- mesh__historyNote mesh__D011530
% 210.35/210.50 91%28%75%29%; was see under DIBENZOCYCLOHEPTENES 1975-90
% 210.35/210.50 |- skos__prefLabel mesh__D029941 Fish Proteins
% 210.35/210.50 |- mesh__dateRevised mesh__D029941 2005-06-30
% 210.35/210.50 |- mesh__dateEstablished mesh__D029941 2002-01-01
% 210.35/210.50 |- mesh__historyNote mesh__D029941 2002
% 210.35/210.50 |- mesh__dateCreated mesh__D029941 2001-07-25
% 210.35/210.50 |- mesh__recordOriginator mesh__D029941 jmp
% 210.35/210.50 |- skos__related mesh__D029941smesh__D005399
% 210.35/210.50 |- mesh__recordMaintainer mesh__D029941 DRC
% 210.35/210.50 |- skos__broader mesh__D029941smesh__D011506
% 210.35/210.50 |- skos__annotation mesh__D029941
% 210.35/210.50 coorrd IM with specific protein %28%IM%29% + specific fish %28%IM%29%%A%
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D029941 2002
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D029941 2006
% 210.35/210.50 |- skos__scopeNote mesh__D029941
% 210.35/210.50 Proteins obtained from species of fish %28%FISHES%29%.
% 210.35/210.50 |- rdf__type mesh__D029941sskos__Concept
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D029941 sjn
% 210.35/210.50 |- mesh__dateRevised mesh__D010438 2003-07-09
% 210.35/210.50 |- skos__annotation mesh__D010438
% 210.35/210.50 coord IM with STOMACH ULCER %28%IM%29% or DUODENAL ULCER %28%IM%29% if appropriate%A%
% 210.35/210.50 |- skos__prefLabel mesh__D010438 Peptic Ulcer Hemorrhage
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D010438 2006
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D010438 sjn
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D010438 2004
% 210.35/210.50 |- mesh__recordOriginator mesh__D010438 NLM
% 210.35/210.50 |- rdf__type mesh__D010438sskos__Concept
% 210.35/210.50 |- skos__scopeNote mesh__D010438
% 210.35/210.50 Bleeding from a PEPTIC ULCER that can be located in any segment of the GASTROINTESTINAL TRACT.%A%
% 210.35/210.50 |- mesh__dateCreated mesh__D010438 1999-01-01
% 210.35/210.50 |- skos__hiddenLabel mesh__D010438 Peptic Ulcer Hemorrhages
% 210.35/210.50 |- skos__hiddenLabel mesh__D010438 Ulcer Hemorrhage, Peptic
% 210.35/210.50 |- skos__related mesh__D010438smesh__D010437
% 210.35/210.50 |- skos__broader mesh__D010438smesh__D006471
% 210.35/210.50 |- mesh__recordMaintainer mesh__D010438 lkt
% 210.35/210.50 |- skos__altLabel mesh__D010438 Hemorrhage, Peptic Ulcer
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D010438 2005
% 210.35/210.50 |- mesh__dateCreated mesh__D015921 1989-05-26
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D015921 sjn
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015921 2002
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D015921
% 210.35/210.50 90; DENTAL PROSTHESIS, SURGICAL was see DENTAL IMPLANTATION 1975-89%A%
% 210.35/210.50 |- skos__related mesh__D015921smesh__D003757
% 210.35/210.50 |- skos__related mesh__D015921smesh__D014093
% 210.35/210.50 |- skos__altLabel mesh__D015921 Prosthesis, Surgical Dental
% 210.35/210.50 |- skos__prefLabel mesh__D015921 Dental Implants
% 210.35/210.50 |- mesh__historyNote mesh__D015921
% 210.35/210.50 90; DENTAL PROSTHESIS, SURGICAL was see DENTAL IMPLANTATION 1975-89%A%
% 210.35/210.50 |- skos__altLabel mesh__D015921 Dental Implant
% 210.35/210.50 |- skos__altLabel mesh__D015921 Implant, Dental
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015921 2006
% 210.35/210.50 |- skos__altLabel mesh__D015921 Prostheses, Surgical Dental
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015921 2001
% 210.35/210.50 |- mesh__dateRevised mesh__D015921 1999-11-03
% 210.35/210.50 |- mesh__recordOriginator mesh__D015921 PLS
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015921 2005
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015921 2000
% 210.35/210.50 |- skos__annotation mesh__D015921 DF: DENT IMPLANTS
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015921 2004
% 210.35/210.50 |- skos__broader mesh__D015921smesh__D017266
% 210.35/210.50 |- rdf__type mesh__D015921sskos__Concept
% 210.35/210.50 |- skos__altLabel mesh__D015921 Implants, Dental
% 210.35/210.50 |- mesh__recordMaintainer mesh__D015921 jls
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015921 2003
% 210.35/210.50 |- skos__scopeNote mesh__D015921
% 210.35/210.50 Biocompatible materials placed into %28%endosseous%29% or onto %28%subperiosteal%29% the jawbone to support a crown, bridge, or artificial tooth, or to stabilize a diseased tooth.%A%
% 210.35/210.50 |- mesh__onlineNote mesh__D015921
% 210.35/210.50 use DENTAL IMPLANTATION to search DENTAL PROSTHESIS, SURGICAL 1975-89%A%
% 210.35/210.50 |- mesh__dateEstablished mesh__D015921 1990-01-01
% 210.35/210.50 |- skos__altLabel mesh__D015921 Dental Prosthesis, Surgical
% 210.35/210.50 |- skos__altLabel mesh__D015921 Surgical Dental Prostheses
% 210.35/210.50 |- skos__broader mesh__D015921smesh__D003764
% 210.35/210.50 |- skos__historyNote mesh__D015921 Dental Implantation %28%1966-1989%29%
% 210.35/210.50 |- skos__broader mesh__D015921smesh__D019736
% 210.35/210.50 |- skos__altLabel mesh__D015921 Surgical Dental Prosthesis
% 210.35/210.50 |- skos__altLabel mesh__D015123 Anti-BaPDE
% 210.35/210.50 |- skos__historyNote mesh__D015123 Benzopyrenes %28%1966-1986%29%
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 2002
% 210.35/210.50 |- skos__altLabel mesh__D015123
% 210.35/210.50 7,8-Dihydroxy-9,10-Epoxy-7,8,9,10-Tetrahydrobenzo%28%a%29%pyrene
% 210.35/210.50 |- mesh__dateRevised mesh__D015123 1995-06-16
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 1998
% 210.35/210.50 |- mesh__recordMaintainer mesh__D015123 JRT
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 2005
% 210.35/210.50 |- mesh__historyNote mesh__D015123
% 210.35/210.50 91%28%87%29%; was see under DIHYDROXYDIHYDROBENZOPYRENES 1987-90%A%
% 210.35/210.50 |- skos__altLabel mesh__D015123
% 210.35/210.50 Benzo%28%a%29%pyrene 7,8-Dihydrodiol 9,10-Epoxide
% 210.35/210.50 |- mesh__recordOriginator mesh__D015123 RLS
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 1996
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 2003
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 1999
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 2006
% 210.35/210.50 |- mesh__dateCreated mesh__D015123 1986-04-09
% 210.35/210.50 |- skos__altLabel mesh__D015123 7,8-BaP-9,10-Diol Epoxide
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D015123
% 210.35/210.50 91; was see under DIHYDROXYDIHYDROBENZOPYRENES 1987-90
% 210.35/210.50 |- skos__altLabel mesh__D015123 Benzo%28%a%29%pyrene-7,8-diol 9,10-Epoxide
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D015123 PLS
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 1997
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 2004
% 210.35/210.50 |- skos__altLabel mesh__D015123 BPDE
% 210.35/210.50 |- skos__broader mesh__D015123smesh__D004101
% 210.35/210.50 |- skos__prefLabel mesh__D015123
% 210.35/210.50 7,8-Dihydro-7,8-dihydroxybenzo%28%a%29%pyrene 9,10-oxide
% 210.35/210.50 |- skos__annotation mesh__D015123
% 210.35/210.50 a carcinogen %26% mutagen; D25-26 qualif; DF: 7 8 DDBP
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 2000
% 210.35/210.50 |- skos__hiddenLabel mesh__D015123 Anti BaPDE
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D015123 2001
% 210.35/210.50 |- rdf__type mesh__D015123sskos__Concept
% 210.35/210.50 |- mesh__dateEstablished mesh__D015123 1991-01-01
% 210.35/210.50 |- skos__scopeNote mesh__D015123
% 210.35/210.50 7,8,8a,9a-Tetrahydrobenzo%28%10,11%29%chryseno %28%3,4-b%29%oxirene-7,8-diol. A benzopyrene derivative with carcinogenic and mutagenic activity.%A%
% 210.35/210.50 |- skos__broader mesh__D001901smesh__D001695
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001901 2006
% 210.35/210.50 |- mesh__recordMaintainer mesh__D001901 jls
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001901 2003
% 210.35/210.50 |- skos__annotation mesh__D001901 SPEC: SPEC qualif
% 210.35/210.50 |- skos__hiddenLabel mesh__D001901 Botanies
% 210.35/210.50 |- skos__related mesh__D001901smesh__D010944
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D001901 sjn
% 210.35/210.50 |- mesh__recordOriginator mesh__D001901 NLM
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001901 2005
% 210.35/210.50 |- mesh__dateCreated mesh__D001901 1999-01-01
% 210.35/210.50 |- skos__prefLabel mesh__D001901 Botany
% 210.35/210.50 |- skos__related mesh__D001901smesh__D019448
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001901 2002
% 210.35/210.50 |- rdf__type mesh__D001901sskos__Concept
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001901 2004
% 210.35/210.50 |- mesh__dateRevised mesh__D001901 2001-07-25
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001103 2005
% 210.35/210.50 |- skos__hiddenLabel mesh__D001103 Arthropod Borne Viruses
% 210.35/210.50 |- skos__hiddenLabel mesh__D001103 Virus, Arthropod-Borne
% 210.35/210.50 |- skos__related mesh__D001103smesh__D001116
% 210.35/210.50 |- skos__hiddenLabel mesh__D001103 Arbovirus
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001103 2006
% 210.35/210.50 |- skos__related mesh__D001103smesh__D014035
% 210.35/210.50 |- skos__hiddenLabel mesh__D001103 Arthropod-Borne Virus
% 210.35/210.50 |- mesh__dateCreated mesh__D001103 1999-01-01
% 210.35/210.50 |- mesh__dateEstablished mesh__D001103 1965-01-01
% 210.35/210.50 |- skos__scopeNote mesh__D001103
% 210.35/210.50 Arthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; TOGAVIRIDAE; and FLAVIVIRIDAE. %28%From Dictionary of Microbiology and Molecular Biology, 2nd ed%29%%A%
% 210.35/210.50 |- skos__broader mesh__D001103smesh__D014780
% 210.35/210.50 |- skos__related mesh__D001103smesh__D012087
% 210.35/210.50 |- skos__annotation mesh__D001103
% 210.35/210.50 GEN; from ARthropod-BOrne; infection = ARBOVIRUS INFECTIONS%A%
% 210.35/210.50 |- rdf__type mesh__D001103sskos__Concept
% 210.35/210.50 |- mesh__dateRevised mesh__D001103 2001-07-25
% 210.35/210.50 |- skos__prefLabel mesh__D001103 Arboviruses
% 210.35/210.50 |- skos__related mesh__D001103smesh__D018067
% 210.35/210.50 |- skos__altLabel mesh__D001103 Arthropod-Borne Viruses
% 210.35/210.50 |- mesh__recordOriginator mesh__D001103 NLM
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001103 2003
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D001103
% 210.35/210.50 75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80%A%
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D001103 sjn
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001103 2004
% 210.35/210.50 |- mesh__historyNote mesh__D001103
% 210.35/210.50 75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80%A%
% 210.35/210.50 |- skos__related mesh__D001103smesh__D002043
% 210.35/210.50 |- mesh__recordMaintainer mesh__D001103 mdb
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D001103 2002
% 210.35/210.50 |- mesh__onlineNote mesh__D001103
% 210.35/210.50 use ARBOVIRUSES to search ARBOVIRUS 1966-74
% 210.35/210.50 |- skos__hiddenLabel mesh__D001103 Viruses, Arthropod-Borne
% 210.35/210.50 |- mesh__dateRevised mesh__D020866 2005-06-30
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D020866 2006
% 210.35/210.50 |- skos__altLabel mesh__D020866 Conus geographus Toxin
% 210.35/210.50 |- skos__scopeNote mesh__D020866
% 210.35/210.50 A neurotoxic peptide, which is a cleavage product %28%VIa%29% of the omega-Conotoxin precursor protein contained in venom from the marine snail, CONUS geographus. It is an antagonist of CALCIUM CHANNELS, N-TYPE.%A%
% 210.35/210.50 |- mesh__historyNote mesh__D020866
% 210.35/210.50 2000; use OMEGA-CONOTOXIN GVIA %28%NM%29% 1984-1999
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 geographus Toxin, Conus
% 210.35/210.50 |- skos__altLabel mesh__D020866 Conus geographus Toxin GVIA
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 toxin, omega-Conus geographus
% 210.35/210.50 |- skos__altLabel mesh__D020866 omega-Conus geographus toxin
% 210.35/210.50 |- skos__altLabel mesh__D020866 omega-CgTX GVIA
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 Toxin, Conus geographus
% 210.35/210.50 |- mesh__recordMaintainer mesh__D020866 ssb
% 210.35/210.50 |- mesh__dateEstablished mesh__D020866 2000-01-01
% 210.35/210.50 |- skos__altLabel mesh__D020866 omega-CgTX
% 210.35/210.50 |- skos__historyNote mesh__D020866 Peptides %28%1994-1999%29%
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 omega CgTX
% 210.35/210.50 |- skos__historyNote mesh__D020866 Mollusk Venoms %28%1984-1993%29%
% 210.35/210.50 |- mesh__recordOriginator mesh__D020866 adp
% 210.35/210.50 |- skos__broader mesh__D020866smesh__D020960
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 geographus toxin, omega-Conus
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 omega Conus geographus toxin
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 omega Conotoxin GVIA
% 210.35/210.50 |- skos__prefLabel mesh__D020866 omega-Conotoxin GVIA
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D020866 sjn
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 omega CgTX GVIA
% 210.35/210.50 |- mesh__dateCreated mesh__D020866 1999-11-03
% 210.35/210.50 |- rdf__type mesh__D020866sskos__Concept
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D020866
% 210.35/210.50 2000; CONUS GEOGRAPHUS TOXIN %28%now OMEGA-CONOTOXIN GVIA%29% was indexed under PEPTIDES 1994-1999 %26% MOLLUSK VENOMS 1984-1993%A%
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 GVIA, omega-CgTX
% 210.35/210.50 |- skos__hiddenLabel mesh__D020866 GVIA, omega-Conotoxin
% 210.35/210.50 |- skos__scopeNote mesh__D006397
% 210.35/210.50 Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias.%A%
% 210.35/210.50 |- skos__hiddenLabel mesh__D006397 Agents, Hematopoietic
% 210.35/210.50 |- rdf__type mesh__D006397sskos__Concept
% 210.35/210.50 |- skos__broader mesh__D006397smesh__D006401
% 210.35/210.50 |- mesh__recordOriginator mesh__D006397 NLM
% 210.35/210.50 |- mesh__publicMeSHNote mesh__D006397 75
% 210.35/210.50 |- skos__historyNote mesh__D006397 Anemia/drug therapy %28%1966-1974%29%
% 210.35/210.50 |- mesh__historyNote mesh__D006397 75
% 210.35/210.50 |- mesh__recordMaintainer mesh__D006397 ssb
% 210.35/210.50 |- mesh__dateEstablished mesh__D006397 1975-09-01
% 210.35/210.50 |- mesh__activeMeSHYear mesh__D006397 2006
% 210.35/210.50 |- skos__altLabel mesh__D006397 Hematopoietic Agents
% 210.35/210.50 |- mesh__dateRevised mesh__D006397 2005-06-30
% 210.35/210.50 |- mesh__dateCreated mesh__D006397 1999-01-01
% 210.35/210.50 |- skos__prefLabel mesh__D006397 Hematinics
% 210.35/210.50 |- mesh__recordAuthorizer mesh__D006397 sjn
% 210.35/210.50 |- mesh__recordMaintainer mesh__D020068 SYSTEM
% 210.35/210.50 |- skos__prefLabel mesh__D020068 Zygosaccharomyces
% 210.35/210.51 |- rdf__type mesh__D020068sskos__Concept
% 210.35/210.51 |- mesh__dateCreated mesh__D020068 1998-06-11
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D020068 2006
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D020068 sjn
% 210.35/210.51 |- mesh__dateRevised mesh__D020068 2005-06-30
% 210.35/210.51 |- mesh__historyNote mesh__D020068 99
% 210.35/210.51 |- mesh__recordOriginator mesh__D020068 AGS
% 210.35/210.51 |- mesh__dateEstablished mesh__D020068 1999-01-01
% 210.35/210.51 |- skos__scopeNote mesh__D020068
% 210.35/210.51 A genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES.%A%
% 210.35/210.51 |- skos__historyNote mesh__D020068 Saccharomyces %28%1973-1985%29%
% 210.35/210.51 |- skos__historyNote mesh__D020068 Saccharomycetales %28%1986-1998%29%
% 210.35/210.51 |- skos__broader mesh__D020068smesh__D004718
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D020068 99
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 2001
% 210.35/210.51 |- skos__altLabel mesh__D014829 Education, Vocational
% 210.35/210.51 |- skos__hiddenLabel mesh__D014829 Vocational Educations
% 210.35/210.51 |- rdf__type mesh__D014829sskos__Concept
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 1995
% 210.35/210.51 |- mesh__dateRevised mesh__D014829 1992-05-18
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 2000
% 210.35/210.51 |- mesh__recordOriginator mesh__D014829 NLM
% 210.35/210.51 |- skos__prefLabel mesh__D014829 Vocational Education
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 1999
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 1994
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 1993
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 1998
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 1997
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 2006
% 210.35/210.51 |- mesh__recordMaintainer mesh__D014829 TGC
% 210.35/210.51 |- skos__broader mesh__D014829smesh__D004505
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 2002
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D014829 PLS
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 1996
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 2005
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 2004
% 210.35/210.51 |- skos__hiddenLabel mesh__D014829 Educations, Vocational
% 210.35/210.51 |- skos__scopeNote mesh__D014829
% 210.35/210.51 Education for specific trades or occupations.
% 210.35/210.51 |- mesh__dateCreated mesh__D014829 1999-01-01
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D014829 2003
% 210.35/210.51 |- mesh__dateEstablished mesh__D019514 1997-01-01
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D019514 sjn
% 210.35/210.51 |- mesh__dateCreated mesh__D019514 1996-06-21
% 210.35/210.51 |- skos__prefLabel mesh__D019514 Instruction %5B%Publication Type%5D%
% 210.35/210.51 |- skos__broader mesh__D019514smesh__D052180
% 210.35/210.51 |- skos__altLabel mesh__D019514 Instruction %28%Pub Type%29%
% 210.35/210.51 |- skos__scopeNote mesh__D019514
% 210.35/210.51 Works consisting of nonfiction films and video designed to teach, instruct, or train. %28%From Moving Image Materials: Genre Terms, 1988%29%%A%
% 210.35/210.51 |- skos__altLabel mesh__D019514 Instruction
% 210.35/210.51 |- mesh__dateRevised mesh__D019514 2005-06-30
% 210.35/210.51 |- skos__annotation mesh__D019514
% 210.35/210.51 publication type only; restrict to instruction by motion pictures %26% video, not by lectures, classroom or printed matter; used for historical materials only CATALOG: do not use for current materials%A%
% 210.35/210.51 |- mesh__recordMaintainer mesh__D019514 jls
% 210.35/210.51 |- mesh__recordOriginator mesh__D019514 TGC
% 210.35/210.51 |- mesh__historyNote mesh__D019514 1997
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D019514 2006
% 210.35/210.51 |- rdf__type mesh__D019514sskos__Concept
% 210.35/210.51 |- skos__altLabel mesh__D019514 Instruction %28%PT%29%
% 210.35/210.51 |- rdf__type mesh__D000809sskos__Concept
% 210.35/210.51 |- mesh__recordMaintainer mesh__D000809 ssb
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D000809 2006
% 210.35/210.51 |- skos__historyNote mesh__D000809 Angiotensin II %28%1966-1977%29%
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D000809 sjn
% 210.35/210.51 |- skos__broader mesh__D000809smesh__D009479
% 210.35/210.51 |- mesh__dateEstablished mesh__D000809 1964-01-01
% 210.35/210.51 |- skos__scopeNote mesh__D000809
% 210.35/210.51 Oligopeptides ranging in size from angiotensin precursors with 14 amino acids to the active vasoconstrictor angiotensin II with 8 amino acids, or their analogs or derivatives. The amino acid content varies with the species and changes in that content produce antagonistic or inactive compounds.%A%
% 210.35/210.51 |- skos__related mesh__D000809smesh__D011945
% 210.35/210.51 |- skos__broader mesh__D000809smesh__D009842
% 210.35/210.51 |- skos__prefLabel mesh__D000809 Angiotensins
% 210.35/210.51 |- skos__altLabel mesh__D000809 Angiotensin
% 210.35/210.51 |- skos__related mesh__D000809smesh__D012084
% 210.35/210.51 |- skos__historyNote mesh__D000809 Angiotensin III %28%1977%29%
% 210.35/210.51 |- mesh__dateCreated mesh__D000809 1999-01-01
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D000809
% 210.35/210.51 1978; for ANGIOTENSIN see ANGIOTENSIN II 1978-1999
% 210.35/210.51 |- skos__broader mesh__D000809smesh__D012898
% 210.35/210.51 |- mesh__historyNote mesh__D000809
% 210.35/210.51 1978; for ANGIOTENSIN use ANGIOTENSIN II 1978-1999
% 210.35/210.51 |- mesh__dateRevised mesh__D000809 2005-06-30
% 210.35/210.51 |- mesh__recordOriginator mesh__D000809 NLM
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D011531 2006
% 210.35/210.51 |- skos__prefLabel mesh__D011531 Proventriculus
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D011531 68
% 210.35/210.51 |- skos__historyNote mesh__D011531 Poultry %28%1966-1967%29%
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D011531 sjn
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D011531 2003
% 210.35/210.51 |- mesh__dateEstablished mesh__D011531 1968-01-01
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D011531 2000
% 210.35/210.51 |- skos__historyNote mesh__D011531 Birds %28%1966-1967%29%
% 210.35/210.51 |- mesh__historyNote mesh__D011531 68
% 210.35/210.51 |- skos__annotation mesh__D011531
% 210.35/210.51 avian only; non-avian: use DIGESTIVE SYSTEM; dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet %28%IM%29% + histol type %28%IM%29%%A%
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D011531 2004
% 210.35/210.51 |- mesh__recordMaintainer mesh__D011531 KEV
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D011531 2001
% 210.35/210.51 |- skos__historyNote mesh__D011531 Stomach %28%1966-1967%29%
% 210.35/210.51 |- mesh__dateRevised mesh__D011531 1999-11-03
% 210.35/210.51 |- rdf__type mesh__D011531sskos__Concept
% 210.35/210.51 |- mesh__dateCreated mesh__D011531 1999-01-01
% 210.35/210.51 |- skos__scopeNote mesh__D011531
% 210.35/210.51 A thin-walled, glandular stomach found in birds. It precedes the gizzard.%A%
% 210.35/210.51 |- mesh__recordOriginator mesh__D011531 NLM
% 210.35/210.51 |- skos__broader mesh__D011531smesh__D013278
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D011531 2005
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D011531 2002
% 210.35/210.51 |- skos__hiddenLabel mesh__D035181 TATA Box Binding Protein
% 210.35/210.51 |- skos__altLabel mesh__D035181 TATA-Binding Protein
% 210.35/210.51 |- mesh__dateEstablished mesh__D035181 2003-01-01
% 210.35/210.51 |- skos__hiddenLabel mesh__D035181 RNA Polymerase II TATA Binding Protein
% 210.35/210.51 |- skos__hiddenLabel mesh__D035181 TATA Binding Protein
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D035181 2006
% 210.35/210.51 |- skos__altLabel mesh__D035181 TATA-Box-Binding Protein
% 210.35/210.51 |- skos__prefLabel mesh__D035181 TATA-Box Binding Protein
% 210.35/210.51 |- skos__historyNote mesh__D035181 DNA-Binding Proteins %28%1992-2002%29%
% 210.35/210.51 |- skos__scopeNote mesh__D035181
% 210.35/210.51 A general transcription factor that plays a major role in the activation of eukaryotic genes transcribed by RNA POLYMERASES. It binds specifically to the TATA BOX promoter element, which lies close to the position of transcription initiation in RNA transcribed by RNA POLYMERASE II. Although considered a principal component of TRANSCRIPTION FACTOR TFIID it also takes part in general transcription factor complexes involved in RNA POLYMERASE I and RNA POLYMERASE III transcription.%A%
% 210.35/210.51 |- skos__broader mesh__D035181smesh__D035362
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D035181
% 210.35/210.51 2003; TATA-BOX BINDING PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2002%A%
% 210.35/210.51 |- mesh__historyNote mesh__D035181
% 210.35/210.51 2003; use TATA-BOX BINDING PROTEIN %28%NM%29% 1992-2002
% 210.35/210.51 |- mesh__recordMaintainer mesh__D035181 ags
% 210.35/210.51 |- skos__altLabel mesh__D035181 Transcription Factor TBP
% 210.35/210.51 |- mesh__dateRevised mesh__D035181 2005-06-30
% 210.35/210.51 |- skos__altLabel mesh__D035181 RNA Polymerase II TATA-Binding Protein
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D035181 sjn
% 210.35/210.51 |- skos__historyNote mesh__D035181 Transcription Factors %28%1992-2002%29%
% 210.35/210.51 |- mesh__recordOriginator mesh__D035181 jmp
% 210.35/210.51 |- mesh__dateCreated mesh__D035181 2002-07-03
% 210.35/210.51 |- skos__broader mesh__D035181smesh__D035165
% 210.35/210.51 |- rdf__type mesh__D035181sskos__Concept
% 210.35/210.51 |- mesh__recordMaintainer mesh__D010439 lkt
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D010439 2004
% 210.35/210.51 |- skos__hiddenLabel mesh__D010439 Peptic Ulcer Perforations
% 210.35/210.51 |- skos__hiddenLabel mesh__D010439 Ulcer Perforation, Peptic
% 210.35/210.51 |- rdf__type mesh__D010439sskos__Concept
% 210.35/210.51 |- mesh__dateCreated mesh__D010439 1999-01-01
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D010439 sjn
% 210.35/210.51 |- skos__annotation mesh__D010439
% 210.35/210.51 coord IM with STOMACH ULCER /compl %28%IM%29% or DUODENAL ULCER /compl %28%IM%29% if pertinent%A%
% 210.35/210.51 |- skos__hiddenLabel mesh__D010439 Perforations, Peptic Ulcer
% 210.35/210.51 |- skos__hiddenLabel mesh__D010439 Ulcer Perforations, Peptic
% 210.35/210.51 |- mesh__recordOriginator mesh__D010439 NLM
% 210.35/210.51 |- skos__hiddenLabel mesh__D010439 Perforation, Peptic Ulcer
% 210.35/210.51 |- skos__scopeNote mesh__D010439
% 210.35/210.51 Penetration of a PEPTIC ULCER through the wall of DUODENUM or STOMACH allowing the leakage of luminal contents into the PERITONEAL CAVITY.%A%
% 210.35/210.51 |- skos__broader mesh__D010439smesh__D010437
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D010439 2005
% 210.35/210.51 |- mesh__dateRevised mesh__D010439 2003-07-09
% 210.35/210.51 |- skos__prefLabel mesh__D010439 Peptic Ulcer Perforation
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D010439 2006
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D007490 2002
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D007490 2005
% 210.35/210.51 |- skos__prefLabel mesh__D007490 Iproniazid
% 210.35/210.51 |- rdf__type mesh__D007490sskos__Concept
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D007490 sjn
% 210.35/210.51 |- mesh__recordOriginator mesh__D007490 NLM
% 210.35/210.51 |- skos__scopeNote mesh__D007490
% 210.35/210.51 An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity.%A%
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D007490 2001
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D007490 2004
% 210.35/210.51 |- skos__broader mesh__D007490smesh__D006834
% 210.35/210.51 |- mesh__dateRevised mesh__D007490 2000-06-22
% 210.35/210.51 |- mesh__dateCreated mesh__D007490 1999-01-01
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D007490 2003
% 210.35/210.51 |- skos__broader mesh__D007490smesh__D007539
% 210.35/210.51 |- mesh__recordMaintainer mesh__D007490 CCR
% 210.35/210.51 |- skos__altLabel mesh__D007490 Iprazid
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D007490 2006
% 210.35/210.51 |- rdf__type mesh__D021161sskos__Concept
% 210.35/210.51 |- skos__broader mesh__D021161smesh__D021141
% 210.35/210.51 |- skos__altLabel mesh__D021161 Nucleic Acid Sequence-Based Amplification
% 210.35/210.51 |- skos__scopeNote mesh__D021161
% 210.35/210.51 An isothermal in-vitro nucleotide amplification process. The process involves the concomitant action of a RNA-DIRECTED DNA POLYMERASE, a ribonuclease %28%RIBONUCLEASES%29%, and DNA-DIRECTED RNA POLYMERASES to synthesize large quantities of sequence-specific RNA and DNA molecules.%A%
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161
% 210.35/210.51 Nucleic Acid Sequence Based Amplification
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161 Self-Sustained Sequence Replications
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D021161 sjn
% 210.35/210.51 |- mesh__dateEstablished mesh__D021161 2001-01-01
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161 Replications, Self-Sustained Sequence
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D021161 2001
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D021161 2004
% 210.35/210.51 |- mesh__dateRevised mesh__D021161 2002-07-03
% 210.35/210.51 |- skos__annotation mesh__D021161 DF:NASBA
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161 Replication, Self-Sustained Sequence
% 210.35/210.51 |- mesh__dateCreated mesh__D021161 2000-06-21
% 210.35/210.51 |- mesh__recordOriginator mesh__D021161 jmp
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D021161 2003
% 210.35/210.51 |- skos__altLabel mesh__D021161 NASBA Analysis
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161 NASBA Analyses
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161 Analysis, NASBA
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D021161 2006
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161 Self Sustained Sequence Replication
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161 Sequence Replications, Self-Sustained
% 210.35/210.51 |- mesh__recordMaintainer mesh__D021161 sjn
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161 Sequence Replication, Self-Sustained
% 210.35/210.51 |- skos__hiddenLabel mesh__D021161 Analyses, NASBA
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D021161 2005
% 210.35/210.51 |- skos__prefLabel mesh__D021161 Self-Sustained Sequence Replication
% 210.35/210.51 |- mesh__historyNote mesh__D021161 2001
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D015922 2006
% 210.35/210.51 |- skos__broader mesh__D015922smesh__D003172
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D015922 2006; see COMPLEMENT 1Q 1990-2005
% 210.35/210.51 |- skos__altLabel mesh__D015922 C1q Complement
% 210.35/210.51 |- mesh__recordMaintainer mesh__D015922 lkt
% 210.35/210.51 |- skos__historyNote mesh__D015922 Complement 1 %28%1980-1989%29%
% 210.35/210.51 |- skos__prefLabel mesh__D015922 Complement C1q
% 210.35/210.51 |- skos__hiddenLabel mesh__D015922 C1q, Complement
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D015922 sjn
% 210.35/210.51 |- rdf__type mesh__D015922sskos__Concept
% 210.35/210.51 |- mesh__recordOriginator mesh__D015922 AGS
% 210.35/210.51 |- mesh__historyNote mesh__D015922 2006 %28%1990%29%
% 210.35/210.51 |- mesh__dateEstablished mesh__D015922 1990-01-01
% 210.35/210.51 |- skos__hiddenLabel mesh__D015922 Complement, C1q
% 210.35/210.51 |- skos__altLabel mesh__D015922 Complement Component 1q
% 210.35/210.51 |- skos__scopeNote mesh__D015922
% 210.35/210.51 A subcomponent of complement C1, composed of six copies of three polypeptide chains %28%A, B, and C%29%, each encoded by a separate gene %28%C1QA; C1QB; C1QC%29%. This complex is arranged in nine subunits %28%six disulfide-linked dimers of A and B, and three disulfide-linked homodimers of C%29%. C1q has binding sites for antibodies %28%the heavy chain of IMMUNOGLOBULIN G or IMMUNOGLOBULIN M%29%. The interaction of C1q and immunoglobulin activates the two proenzymes COMPLEMENT C1R and COMPLEMENT C1S, thus initiating the cascade of COMPLEMENT ACTIVATION via the CLASSICAL COMPLEMENT PATHWAY.%A%
% 210.35/210.51 |- skos__altLabel mesh__D015922 Complement 1q
% 210.35/210.51 |- mesh__dateCreated mesh__D015922 1989-05-25
% 210.35/210.51 |- mesh__dateRevised mesh__D015922 2005-06-30
% 210.35/210.51 |- skos__hiddenLabel mesh__D015922 Component 1q, Complement
% 210.35/210.51 |- skos__historyNote mesh__D015922
% 210.35/210.51 Complement Activating Enzymes %28%1979-1989%29%
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124
% 210.35/210.51 8 Bromo Cyclic Adenosine Monophosphate, Monosodium Salt
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D015124 2006
% 210.35/210.51 |- skos__prefLabel mesh__D015124 8-Bromo Cyclic Adenosine Monophosphate
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124 8 Bromo cAMP
% 210.35/210.51 |- skos__historyNote mesh__D015124 Adenine Nucleotides %28%1966-1968%29%
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124 Cyclic AMP, 8-Br
% 210.35/210.51 |- mesh__recordMaintainer mesh__D015124 ssb
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124 8 Bromo Cyclic AMP
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124 8 Br Cyclic AMP
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D015124 2004
% 210.35/210.51 |- mesh__dateRevised mesh__D015124 2001-07-25
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124
% 210.35/210.51 8 Bromo Cyclic Adenosine Monophosphate, Sodium Salt
% 210.35/210.51 |- rdf__type mesh__D015124sskos__Concept
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D015124 2002
% 210.35/210.51 |- mesh__recordOriginator mesh__D015124 RLS
% 210.35/210.51 |- mesh__dateEstablished mesh__D015124 1984-01-01
% 210.35/210.51 |- skos__broader mesh__D015124smesh__D000242
% 210.35/210.51 |- skos__altLabel mesh__D015124 8-Bromo Cyclic AMP
% 210.35/210.51 |- mesh__dateCreated mesh__D015124 1983-05-31
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124 8 Bromo Cyclic Adenosine Monophosphate
% 210.35/210.51 |- skos__altLabel mesh__D015124
% 210.35/210.51 8-Bromoadenosine 3%27%,5%27%-Cyclic Monophosphate
% 210.35/210.51 |- skos__annotation mesh__D015124 DF: BR CAMP
% 210.35/210.51 |- skos__altLabel mesh__D015124 8-Bromo-cAMP
% 210.35/210.51 |- mesh__historyNote mesh__D015124 84
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124 Cyclic AMP, 8-Bromo
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D015124 sjn
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124 AMP, Br Cycl
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D015124 84
% 210.35/210.51 |- skos__altLabel mesh__D015124 Br Cycl AMP
% 210.35/210.51 |- skos__altLabel mesh__D015124 8-Br Cyclic AMP
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D015124 2005
% 210.35/210.51 |- skos__historyNote mesh__D015124
% 210.35/210.51 Adenosine Cyclic Monophosphate %28%1968-1983%29%
% 210.35/210.51 |- skos__scopeNote mesh__D015124
% 210.35/210.51 A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.%A%
% 210.35/210.51 |- skos__hiddenLabel mesh__D015124
% 210.35/210.51 8 Bromoadenosine 3%27%,5%27% Cyclic Monophosphate
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D015124 2003
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001902 2005
% 210.35/210.51 |- mesh__dateRevised mesh__D001902 1997-06-20
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001902 1998
% 210.35/210.51 |- mesh__dateCreated mesh__D001902 1999-01-01
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001902 2002
% 210.35/210.51 |- skos__annotation mesh__D001902
% 210.35/210.51 a republic in southern Africa; X ref BECHUANALAND was its former name; X ref KALAHARI refers to the desert %26% region%A%
% 210.35/210.51 |- skos__altLabel mesh__D001902 Bechuanaland
% 210.35/210.51 |- skos__broader mesh__D001902smesh__D000353
% 210.35/210.51 |- skos__scopeNote mesh__D001902
% 210.35/210.51 A republic in southern Africa, between NAMIBIA and ZAMBIA. It was formerly called Bechuanaland. Its capital is Gaborone. The Kalahari Desert is in the west and southwest. Botswana was organized as a British protectorate in 1885 and became independent in 1966. The name comes from bo, the prefix for abstract nouns + Tswana, the people themselves. Bechuana in its earlier name is the English corruption of Botswana. %28%From Webster%27%s New Geographical Dictionary, 1988, p185 %26% Room, Brewer%27%s Dictionary of Names, 1992, p74%29%%A%
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001902 2001
% 210.35/210.51 |- mesh__recordMaintainer mesh__D001902 TGC
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001902 2000
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D001902 SJN
% 210.35/210.51 |- rdf__type mesh__D001902sskos__Concept
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001902 2004
% 210.35/210.51 |- mesh__recordOriginator mesh__D001902 NLM
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001902 2006
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001902 2003
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001902 1999
% 210.35/210.51 |- skos__prefLabel mesh__D001902 Botswana
% 210.35/210.51 |- mesh__dateCreated mesh__D001104 1999-01-01
% 210.35/210.51 |- mesh__historyNote mesh__D001104
% 210.35/210.51 91%28%75%29%; was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75%A%
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001104 2005
% 210.35/210.51 |- mesh__dateEstablished mesh__D001104 1991-01-01
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D001104 2006
% 210.35/210.51 |- rdf__type mesh__D001104sskos__Concept
% 210.35/210.51 |- mesh__recordOriginator mesh__D001104 NLM
% 210.35/210.51 |- mesh__onlineNote mesh__D001104 search PLANTS, MEDICINAL 1966-74
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D001104 sjn
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D001104
% 210.35/210.51 91; was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75%A%
% 210.35/210.51 |- mesh__recordMaintainer mesh__D001104 ssb
% 210.35/210.51 |- mesh__dateRevised mesh__D001104 2004-07-07
% 210.35/210.51 |- skos__prefLabel mesh__D001104 Arbutin
% 210.35/210.51 |- skos__broader mesh__D001104smesh__D005960
% 210.35/210.51 |- mesh__dateCreated mesh__D020867 1999-11-08
% 210.35/210.51 |- skos__prefLabel mesh__D020867 omega-Agatoxin IVA
% 210.35/210.51 |- mesh__dateEstablished mesh__D020867 2000-01-01
% 210.35/210.51 |- skos__broader mesh__D020867smesh__D013111
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D020867 sjn
% 210.35/210.51 |- mesh__historyNote mesh__D020867
% 210.35/210.51 2000; use OMEGA-AGATOXIN IVA %28%NM%29% 1992-1999
% 210.35/210.51 |- skos__historyNote mesh__D020867 Spider Venoms %28%1992-1999%29%
% 210.35/210.51 |- mesh__dateRevised mesh__D020867 2005-06-30
% 210.35/210.51 |- rdf__type mesh__D020867sskos__Concept
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D020867
% 210.35/210.51 2000; OMEGA-AGATOXIN IVA was indexed under SPIDER VENOMS 1992-1999%A%
% 210.35/210.51 |- skos__hiddenLabel mesh__D020867 omega Agatoxin IVA
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D020867 2006
% 210.35/210.51 |- skos__hiddenLabel mesh__D020867 omega Aga IVA
% 210.35/210.51 |- skos__altLabel mesh__D020867 omega-Aga-IVA
% 210.35/210.51 |- mesh__recordMaintainer mesh__D020867 ssb
% 210.35/210.51 |- skos__broader mesh__D020867smesh__D019476
% 210.35/210.51 |- skos__scopeNote mesh__D020867
% 210.35/210.51 A neuropeptide toxin from the venom of the funnel web spider, Agelenopsis aperta. It inhibits CALCIUM CHANNELS, P-TYPE by altering the voltage-dependent gating so that very large depolarizations are needed for channel opening. It also inhibits CALCIUM CHANNELS, Q-TYPE.%A%
% 210.35/210.51 |- skos__hiddenLabel mesh__D020867 IVA, omega-Agatoxin
% 210.35/210.51 |- mesh__recordOriginator mesh__D020867 adp
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D006398 2003
% 210.35/210.51 |- rdf__type mesh__D006398sskos__Concept
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D006398 2000
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D006398 sjn
% 210.35/210.51 |- skos__broader mesh__D006398smesh__D005832
% 210.35/210.51 |- skos__scopeNote mesh__D006398
% 210.35/210.51 Hemorrhage into a canal or cavity of the body, especially into the tunica vaginalis testis.%A%
% 210.35/210.51 |- mesh__dateRevised mesh__D006398 1999-11-03
% 210.35/210.51 |- mesh__recordMaintainer mesh__D006398 KEV
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D006398 2006
% 210.35/210.51 |- mesh__recordOriginator mesh__D006398 NLM
% 210.35/210.51 |- skos__hiddenLabel mesh__D006398 Hematoceles
% 210.35/210.51 |- skos__broader mesh__D006398smesh__D006470
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D006398 2005
% 210.35/210.51 |- skos__prefLabel mesh__D006398 Hematocele
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D006398 2002
% 210.35/210.51 |- mesh__dateCreated mesh__D006398 1999-01-01
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D006398 2004
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D006398 2001
% 210.35/210.51 |- skos__scopeNote mesh__D020069
% 210.35/210.51 Unilateral or bilateral pain of the shoulder. It is often caused by physical activities such as work or sports participation, but may also be pathologic in origin.%A%
% 210.35/210.51 |- mesh__recordMaintainer mesh__D020069 KEV
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D020069 2004
% 210.35/210.51 |- skos__broader mesh__D020069smesh__D010146
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D020069 2003
% 210.35/210.51 |- skos__hiddenLabel mesh__D020069 Pain, Shoulder
% 210.35/210.51 |- mesh__dateEstablished mesh__D020069 1999-01-01
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D020069 2002
% 210.35/210.51 |- rdf__type mesh__D020069sskos__Concept
% 210.35/210.51 |- mesh__dateCreated mesh__D020069 1998-06-11
% 210.35/210.51 |- mesh__dateRevised mesh__D020069 1999-11-08
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D020069 99
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D020069 2001
% 210.35/210.51 |- mesh__recordOriginator mesh__D020069 NDW
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D020069 2006
% 210.35/210.51 |- skos__prefLabel mesh__D020069 Shoulder Pain
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D020069 2000
% 210.35/210.51 |- skos__hiddenLabel mesh__D020069 Shoulder Pains
% 210.35/210.51 |- skos__hiddenLabel mesh__D020069 Pains, Shoulder
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D020069 2005
% 210.35/210.51 |- skos__historyNote mesh__D020069 Pain %28%1966-1998%29%
% 210.35/210.51 |- mesh__historyNote mesh__D020069 99
% 210.35/210.51 |- skos__broader mesh__D020069smesh__D018771
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D020069 sjn
% 210.35/210.51 |- mesh__dateEstablished mesh__D011532 1991-01-01
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D011532 sjn
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D011532 2006
% 210.35/210.51 |- mesh__dateRevised mesh__D011532 2005-06-30
% 210.35/210.51 |- rdf__type mesh__D011532sskos__Concept
% 210.35/210.51 |- skos__scopeNote mesh__D011532
% 210.35/210.51 Gram-negative rods isolated from human urine and feces.%A%
% 210.35/210.51 |- mesh__historyNote mesh__D011532
% 210.35/210.51 91%28%75%29%; was see under ENTEROBACTERIACEAE 1975-90; was see under PROTEUS 1975-89; PROTEUS INCONSTANS was see PROVIDENCIA 1978-91%A%
% 210.35/210.51 |- mesh__dateCreated mesh__D011532 1999-01-01
% 210.35/210.51 |- mesh__recordOriginator mesh__D011532 NLM
% 210.35/210.51 |- skos__prefLabel mesh__D011532 Providencia
% 210.35/210.51 |- skos__broader mesh__D011532smesh__D004755
% 210.35/210.51 |- skos__annotation mesh__D011532
% 210.35/210.51 infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%
% 210.35/210.51 |- mesh__recordMaintainer mesh__D011532 SYSTEM
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D011532
% 210.35/210.51 91; was see under ENTEROBACTERIACEAE 1975-90; was see under PROTEUS 1975-89; PROTEUS INCONSTANS was see PROVIDENCIA 1978-91%A%
% 210.35/210.51 |- mesh__onlineNote mesh__D011532
% 210.35/210.51 use PROVIDENCIA to search PROTEUS INCONSTANS 1978-91; use PROTEUS to search PROVIDENCIA 1974%A%
% 210.35/210.51 |- skos__altLabel mesh__D035182 TBP-Related Factor
% 210.35/210.51 |- skos__altLabel mesh__D035182 TBP-Like Protein %28%TLP%29%
% 210.35/210.51 |- mesh__dateRevised mesh__D035182 2005-06-30
% 210.35/210.51 |- skos__scopeNote mesh__D035182
% 210.35/210.51 A class of proteins related in structure and function to TATA-BOX BINDING PROTEIN that can take the place of TATA-BOX BINDING PROTEIN in the transcription initiation complex. They are found in most multicellular organisms and may be involved in tissue-specific promoter regulation. They bind to DNA and interact with TATA-BINDING PROTEIN ASSOCIATED FACTORS, however they may lack specificity for the TATA-BOX.%A%
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D035182 sjn
% 210.35/210.51 |- mesh__recordOriginator mesh__D035182 jmp
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D035182
% 210.35/210.51 2003; TBP-RELATED FACTOR %28%now TATA-BOX BINDING PROTEIN-LIKE PROTEINS%29% was indexed under TRANSCRIPTION FACTORS %26% DNA-BINDING PROTEINS 1993-2002%A%
% 210.35/210.51 |- mesh__dateCreated mesh__D035182 2002-07-03
% 210.35/210.51 |- skos__historyNote mesh__D035182 DNA-Binding Proteins %28%1993-2002%29%
% 210.35/210.51 |- mesh__dateEstablished mesh__D035182 2003-01-01
% 210.35/210.51 |- skos__hiddenLabel mesh__D035182 TLP, TBP-Like
% 210.35/210.51 |- skos__hiddenLabel mesh__D035182 TBP Like TLP
% 210.35/210.51 |- mesh__recordMaintainer mesh__D035182 ags
% 210.35/210.51 |- skos__hiddenLabel mesh__D035182 TATA Binding Protein Related Factor
% 210.35/210.51 |- skos__broader mesh__D035182smesh__D035165
% 210.35/210.51 |- rdf__type mesh__D035182sskos__Concept
% 210.35/210.51 |- skos__hiddenLabel mesh__D035182 TATA Box Binding Protein Like Proteins
% 210.35/210.51 |- skos__altLabel mesh__D035182 TATA-Binding Protein-Related Factors
% 210.35/210.51 |- skos__prefLabel mesh__D035182 TATA Box Binding Protein-Like Proteins
% 210.35/210.51 |- skos__historyNote mesh__D035182 Transcription Factors %28%1993-2002%29%
% 210.35/210.51 |- skos__altLabel mesh__D035182 TBP-Like TLP
% 210.35/210.51 |- mesh__historyNote mesh__D035182
% 210.35/210.51 2003; use TATA-BOX BINDING PROTEIN-LIKE PROTEINS %28%NM%29% 1993-2002%A%
% 210.35/210.51 |- skos__hiddenLabel mesh__D035182 TBP Related Factor
% 210.35/210.51 |- skos__hiddenLabel mesh__D035182 TATA Binding Protein Related Factors
% 210.35/210.51 |- skos__altLabel mesh__D035182 TATA-Binding Protein-Related Factor
% 210.35/210.51 |- skos__annotation mesh__D035182
% 210.35/210.51 X ref TBP-RELATED FACTOR: see SCR for organism-specific TBP-related factors%A%
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D035182 2006
% 210.35/210.51 |- mesh__dateRevised mesh__D007491 2005-06-30
% 210.35/210.51 |- rdf__type mesh__D007491sskos__Concept
% 210.35/210.51 |- mesh__recordMaintainer mesh__D007491 ssb
% 210.35/210.51 |- skos__scopeNote mesh__D007491
% 210.35/210.51 An antihistomonal agent with low toxicity. It also promotes growth and feed utilization in poultry.%A%
% 210.35/210.51 |- mesh__dateCreated mesh__D007491 1974-11-19
% 210.35/210.51 |- mesh__dateEstablished mesh__D007491 1991-01-01
% 210.35/210.51 |- skos__historyNote mesh__D007491 Imidazoles %28%1966-1973%29%
% 210.35/210.51 |- mesh__historyNote mesh__D007491
% 210.35/210.51 91%28%75%29%; was see under NITROIMIDAZOLES 1975-90
% 210.35/210.51 |- mesh__publicMeSHNote mesh__D007491
% 210.35/210.51 91; was see under NITROIMIDAZOLES 1975-90
% 210.35/210.51 |- skos__prefLabel mesh__D007491 Ipronidazole
% 210.35/210.51 |- mesh__recordAuthorizer mesh__D007491 sjn
% 210.35/210.51 |- mesh__recordOriginator mesh__D007491 NLM
% 210.35/210.51 |- skos__broader mesh__D007491smesh__D009593
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D007491 2006
% 210.35/210.51 |- skos__historyNote mesh__D007491 Nitroimidazoles %28%1974%29%
% 210.35/210.51 |- mesh__activeMeSHYear mesh__D015923 2006
% 210.35/210.51 |- skos__altLabel mesh__D015923 C1r Complement
% 210.35/210.51 |- mesh__historyNote mesh__D015923 2006 %28%1990%29%
% 210.35/210.51 |- mesh__dateRevised mesh__D015923 2005-06-30
% 210.35/210.51 |- skos__broader mesh__D015923smesh__D003172
% 210.35/210.51 |- rdf__type mesh__D015923sskos__Concept
% 210.35/210.51 |- mesh__dateEstablished mesh__D015923 1990-01-01
% 210.35/210.51 |- skos__scopeNote mesh__D015923
% 210.35/210.51 A 80-kDa subcomponent of complement C1, existing as a SERINE PROTEASE proenzyme in the intact complement C1 complex. When COMPLEMENT C1Q is bound to antibodies, the changed tertiary structure causes autolytic activation of complement C1r which is cleaved into two chains, A %28%heavy%29% and B %28%light, the serine protease%29%, connected by disulfide bonds. The activated C1r serine protease, in turn, activates COMPLEMENT C1S proenzyme by cleaving the Arg426-Ile427 bond. No fragment is released when either C1r or C1s is cleaved.%A%
% 210.35/210.51 |- mesh__dateCreated mesh__D015923 1989-05-25
% 210.35/210.51 |- skos__altLabel mesh__D015923 Complement Component 1r
% 210.35/210.51 |- mesh__recordOriginator mesh__D015923 AGS
% 210.35/210.51 |- skos__historyNote mesh__D015923
% 210.35/210.51 Complement Activating Enzymes %28%1979-1989%29%
% 210.35/210.51 |- skos__historyNote mesh__D015923 Complement 1 %28%1979-1989%29%
% 210.35/210.52 |- skos__altLabel mesh__D015923 Complement 1r
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D015923 sjn
% 210.35/210.52 |- mesh__recordMaintainer mesh__D015923 lkt
% 210.35/210.52 |- skos__hiddenLabel mesh__D015923 Complement, C1r
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D015923 2006; see COMPLEMENT 1R 1990-2005
% 210.35/210.52 |- skos__hiddenLabel mesh__D015923 Component 1r, Complement
% 210.35/210.52 |- skos__hiddenLabel mesh__D015923 C1r, Complement
% 210.35/210.52 |- skos__prefLabel mesh__D015923 Complement C1r
% 210.35/210.52 |- skos__broader mesh__D015923smesh__D003166
% 210.35/210.52 |- skos__historyNote mesh__D015923 Enzyme Precursors %28%1979-1982%29%
% 210.35/210.52 |- skos__altLabel mesh__D015125 Riemser Brand of Oxyquinoline Sulfate
% 210.35/210.52 |- skos__hiddenLabel mesh__D015125 8 Hydroxyquinoline
% 210.35/210.52 |- skos__scopeNote mesh__D015125
% 210.35/210.52 An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.%A%
% 210.35/210.52 |- skos__hiddenLabel mesh__D015125 Sulfate, 8-Hydroxyquinoline
% 210.35/210.52 |- skos__broader mesh__D015125smesh__D006912
% 210.35/210.52 |- skos__hiddenLabel mesh__D015125 8 Hydroxyquinoline Sulfate
% 210.35/210.52 |- mesh__dateCreated mesh__D015125 1974-11-19
% 210.35/210.52 |- mesh__historyNote mesh__D015125
% 210.35/210.52 92; was 8-HYDROXYQUINOLINE 1975-91 %28%see under HYDROXYQUINOLINES 1975-90%29%; OXYQUINOLINE was see 8-HYDROXYQUINOLINE 1975-91%A%
% 210.35/210.52 |- skos__altLabel mesh__D015125 8-Oxyquinoline
% 210.35/210.52 |- rdf__type mesh__D015125sskos__Concept
% 210.35/210.52 |- skos__annotation mesh__D015125 DF: note short X ref
% 210.35/210.52 |- skos__hiddenLabel mesh__D015125 8 Oxyquinoline
% 210.35/210.52 |- skos__altLabel mesh__D015125
% 210.35/210.52 Chinosol Brand of Oxyquinoline Potassium Sulfate %28%2:1%29%
% 210.35/210.52 |- skos__prefLabel mesh__D015125 Oxyquinoline
% 210.35/210.52 |- skos__altLabel mesh__D015125 8-Hydroxyquinoline
% 210.35/210.52 |- mesh__recordOriginator mesh__D015125 NLM
% 210.35/210.52 |- skos__altLabel mesh__D015125 Oxyquinol
% 210.35/210.52 |- mesh__dateEstablished mesh__D015125 1991-01-01
% 210.35/210.52 |- skos__altLabel mesh__D015125 8-Hydroxyquinoline Sulfate
% 210.35/210.52 |- mesh__recordMaintainer mesh__D015125 lkw
% 210.35/210.52 |- skos__historyNote mesh__D015125 Quinolines %28%1971-1974%29%
% 210.35/210.52 |- mesh__dateRevised mesh__D015125 2005-06-30
% 210.35/210.52 |- skos__hiddenLabel mesh__D015125 8 Quinolinol
% 210.35/210.52 |- skos__hiddenLabel mesh__D015125 Sulfate, Oxyquinoline
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D015125
% 210.35/210.52 92; was 8-HYDROXYQUINOLINE 1975-91 %28%see under HYDROXYQUINOLINES 1975-90%29%; OXYQUINOLINE was see 8-HYDROXYQUINOLINE 1975-91%A%
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015125 2006
% 210.35/210.52 |- skos__altLabel mesh__D015125 Tendem Brand of Oxyquinoline Sulfate
% 210.35/210.52 |- skos__altLabel mesh__D015125 Oxine
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D015125 sjn
% 210.35/210.52 |- skos__altLabel mesh__D015125 8-Quinolinol
% 210.35/210.52 |- mesh__onlineNote mesh__D015125
% 210.35/210.52 use OXYQUINOLINE to search 8-HYDROXYQUINOLINE 1975-91
% 210.35/210.52 |- skos__historyNote mesh__D001903 Infant Nutrition %28%1966-1974%29%
% 210.35/210.52 |- skos__hiddenLabel mesh__D001903 Bottlefeedings
% 210.35/210.52 |- skos__scopeNote mesh__D001903
% 210.35/210.52 Use of nursing bottles for feeding. Applies to humans and animals.%A%
% 210.35/210.52 |- skos__broader mesh__D001903smesh__D007227
% 210.35/210.52 |- rdf__type mesh__D001903sskos__Concept
% 210.35/210.52 |- mesh__dateCreated mesh__D001903 1974-11-19
% 210.35/210.52 |- mesh__recordMaintainer mesh__D001903 TAP
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001903 2004
% 210.35/210.52 |- skos__broader mesh__D001903smesh__D005248
% 210.35/210.52 |- skos__altLabel mesh__D001903 Bottlefeeding
% 210.35/210.52 |- mesh__dateEstablished mesh__D001903 1975-09-01
% 210.35/210.52 |- mesh__historyNote mesh__D001903 75
% 210.35/210.52 |- skos__hiddenLabel mesh__D001903 Bottle Feedings
% 210.35/210.52 |- skos__hiddenLabel mesh__D001903 Feeding, Bottle
% 210.35/210.52 |- skos__annotation mesh__D001903 human %26% animal
% 210.35/210.52 |- skos__prefLabel mesh__D001903 Bottle Feeding
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001903 2006
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001903 2003
% 210.35/210.52 |- mesh__dateRevised mesh__D001903 2002-07-02
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001903 2005
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D001903 sjn
% 210.35/210.52 |- mesh__recordOriginator mesh__D001903 NLM
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D001903 75
% 210.35/210.52 |- skos__hiddenLabel mesh__D001903 Feedings, Bottle
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D001105
% 210.35/210.52 98; see ARCHAEOBACTERIA 1992-97, see ARCHAEBACTERIA 1991, see BACTERIA 1981-90; ARCHAEA was see ARCHAEOBACTERIA 1995-97%A%
% 210.35/210.52 |- skos__prefLabel mesh__D001105 Archaea
% 210.35/210.52 |- skos__scopeNote mesh__D001105
% 210.35/210.52 One of the three domains of life %28%the others being BACTERIA and Eukarya%29%, formerly called Archaebacteria under the taxon Bacteria, but now considered separate and distinct. They are characterized by: %28%1%29% the presence of characteristic tRNAs and ribosomal RNAs; %28%2%29% the absence of peptidoglycan cell walls; %28%3%29% the presence of ether-linked lipids built from branched-chain subunits; and %28%4%29% their occurrence in unusual habitats. While archaea resemble bacteria in morphology and genomic organization, they resemble eukarya in their method of genomic replication. The domain contains at least four kingdoms: CRENARCHAEOTA; EURYARCHAEOTA; NANOARCHAEOTA; and KORARCHAEOTA.%A%
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001105 2006
% 210.35/210.52 |- rdf__type mesh__D001105sskos__Concept
% 210.35/210.52 |- skos__altLabel mesh__D001105 Archaeobacteria
% 210.35/210.52 |- skos__historyNote mesh__D001105 Bacteria %28%1966-1980%29%
% 210.35/210.52 |- mesh__dateRevised mesh__D001105 2005-06-30
% 210.35/210.52 |- mesh__runningHead mesh__D001105 B7 - ORGANISMS-ARCHAEA
% 210.35/210.52 |- mesh__dateCreated mesh__D001105 1980-04-02
% 210.35/210.52 |- skos__altLabel mesh__D001105 Archaebacteria
% 210.35/210.52 |- skos__altLabel mesh__D001105 Archaeon
% 210.35/210.52 |- mesh__historyNote mesh__D001105
% 210.35/210.52 98%28%81%29%; ARCHAEA was see ARCHAEOBACTERIA 1995-97
% 210.35/210.52 |- mesh__recordMaintainer mesh__D001105 ags
% 210.35/210.52 |- skos__annotation mesh__D001105
% 210.35/210.52 in taxonomy, one of the 3 domains of life along with BACTERIA %26% Eucarya%A%
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D001105 sjn
% 210.35/210.52 |- skos__altLabel mesh__D001105 Archebacteria
% 210.35/210.52 |- mesh__recordOriginator mesh__D001105 AEP
% 210.35/210.52 |- mesh__dateEstablished mesh__D001105 1991-01-01
% 210.35/210.52 |- skos__related mesh__D020868smesh__D019175
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D020868 2005
% 210.35/210.52 |- skos__scopeNote mesh__D020868
% 210.35/210.52 Interruption or suppression of the expression of a gene at transcriptional or translational levels.%A%
% 210.35/210.52 |- skos__historyNote mesh__D020868
% 210.35/210.52 Gene Expression Regulation %28%1981-1999%29%
% 210.35/210.52 |- mesh__dateCreated mesh__D020868 1999-11-03
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D020868 2004
% 210.35/210.52 |- mesh__historyNote mesh__D020868 2000
% 210.35/210.52 |- rdf__type mesh__D020868sskos__Concept
% 210.35/210.52 |- mesh__recordOriginator mesh__D020868 nns
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D020868 2006
% 210.35/210.52 |- skos__altLabel mesh__D020868 Gene Inactivation
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D020868 sjn
% 210.35/210.52 |- skos__hiddenLabel mesh__D020868 Silencing, Gene
% 210.35/210.52 |- skos__broader mesh__D020868smesh__D005786
% 210.35/210.52 |- mesh__dateRevised mesh__D020868 2003-07-09
% 210.35/210.52 |- skos__related mesh__D020868smesh__D044127
% 210.35/210.52 |- skos__prefLabel mesh__D020868 Gene Silencing
% 210.35/210.52 |- skos__hiddenLabel mesh__D020868 Inactivation, Gene
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D020868 2000
% 210.35/210.52 |- mesh__recordMaintainer mesh__D020868 nns
% 210.35/210.52 |- mesh__dateEstablished mesh__D020868 2000-01-01
% 210.35/210.52 |- mesh__dateCreated mesh__D006399 1977-11-25
% 210.35/210.52 |- skos__prefLabel mesh__D006399 Hematocolpos
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D006399 2006
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D006399 79
% 210.35/210.52 |- skos__broader mesh__D006399smesh__D014623
% 210.35/210.52 |- mesh__recordMaintainer mesh__D006399 lkt
% 210.35/210.52 |- skos__historyNote mesh__D006399 Vagina/abnormalities %28%1966-1978%29%
% 210.35/210.52 |- skos__scopeNote mesh__D006399
% 210.35/210.52 A blood-filled VAGINA that is obstructed.
% 210.35/210.52 |- mesh__dateRevised mesh__D006399 2005-06-30
% 210.35/210.52 |- skos__historyNote mesh__D006399 Vaginal Diseases %28%1966-1978%29%
% 210.35/210.52 |- mesh__historyNote mesh__D006399 79
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D006399 sjn
% 210.35/210.52 |- mesh__recordOriginator mesh__D006399 SMH
% 210.35/210.52 |- rdf__type mesh__D006399sskos__Concept
% 210.35/210.52 |- mesh__dateEstablished mesh__D006399 1979-01-01
% 210.35/210.52 |- skos__hiddenLabel mesh__D019516 Closure, Orthodontic Space
% 210.35/210.52 |- skos__hiddenLabel mesh__D019516 Orthodontic Space Closures
% 210.35/210.52 |- skos__hiddenLabel mesh__D019516 Space Closures, Orthodontic
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 2006
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 2003
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 2000
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 2004
% 210.35/210.52 |- rdf__type mesh__D019516sskos__Concept
% 210.35/210.52 |- skos__scopeNote mesh__D019516
% 210.35/210.52 Therapeutic closure of spaces caused by the extraction of teeth, the congenital absence of teeth, or the excessive space between teeth.%A%
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 2001
% 210.35/210.52 |- mesh__historyNote mesh__D019516 97
% 210.35/210.52 |- skos__prefLabel mesh__D019516 Orthodontic Space Closure
% 210.35/210.52 |- mesh__dateEstablished mesh__D019516 1997-01-01
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D019516 97
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 1998
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 2002
% 210.35/210.52 |- mesh__dateCreated mesh__D019516 1996-06-24
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 1999
% 210.35/210.52 |- skos__altLabel mesh__D019516 Space Closure, Orthodontic
% 210.35/210.52 |- skos__broader mesh__D019516smesh__D009971
% 210.35/210.52 |- skos__hiddenLabel mesh__D019516 Closures, Orthodontic Space
% 210.35/210.52 |- skos__historyNote mesh__D019516 Tooth Movement %28%1993-1996%29%
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 1997
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019516 2005
% 210.35/210.52 |- skos__related mesh__D011533smesh__D016254
% 210.35/210.52 |- skos__scopeNote mesh__D011533
% 210.35/210.52 Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology.%A%
% 210.35/210.52 |- skos__related mesh__D011533smesh__D020077
% 210.35/210.52 |- rdf__type mesh__D011533sskos__Concept
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D011533 2004
% 210.35/210.52 |- skos__related mesh__D011533smesh__D016662
% 210.35/210.52 |- mesh__dateCreated mesh__D011533 1987-05-09
% 210.35/210.52 |- skos__historyNote mesh__D011533
% 210.35/210.52 Oncogenic Viruses or specific %28%1971-1976%29%
% 210.35/210.52 |- skos__annotation mesh__D011533
% 210.35/210.52 coord IM with specific virus %28%IM%29%
% 210.35/210.52 |- mesh__historyNote mesh__D011533 88
% 210.35/210.52 |- skos__related mesh__D011533smesh__D039002
% 210.35/210.52 |- mesh__dateRevised mesh__D011533 2002-07-03
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D011533 sjn
% 210.35/210.52 |- skos__altLabel mesh__D011533 Provirus
% 210.35/210.52 |- skos__broader mesh__D011533smesh__D014780
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D011533 2005
% 210.35/210.52 |- mesh__recordOriginator mesh__D011533 SCD
% 210.35/210.52 |- mesh__dateEstablished mesh__D011533 1988-01-01
% 210.35/210.52 |- skos__historyNote mesh__D011533
% 210.35/210.52 Retroviridae or specific %28%1977-1987%29%
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D011533 2006
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D011533 88
% 210.35/210.52 |- mesh__recordMaintainer mesh__D011533 ags
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D011533 2003
% 210.35/210.52 |- skos__prefLabel mesh__D011533 Proviruses
% 210.35/210.52 |- rdf__type mesh__D035981sskos__Concept
% 210.35/210.52 |- skos__altLabel mesh__D035981 Ivy, English
% 210.35/210.52 |- mesh__dateEstablished mesh__D035981 2003-01-01
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D035981 2006
% 210.35/210.52 |- skos__scopeNote mesh__D035981
% 210.35/210.52 A plant genus of the family ARALIACEAE. Members contain hederin %28%olean-12-ene%29% type TRITERPENES.%A%
% 210.35/210.52 |- skos__annotation mesh__D035981
% 210.35/210.52 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.35/210.52 |- skos__prefLabel mesh__D035981 Hedera
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D035981 2005
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D035981 2003
% 210.35/210.52 |- mesh__historyNote mesh__D035981 2003
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D035981 2004
% 210.35/210.52 |- mesh__dateCreated mesh__D035981 2002-07-03
% 210.35/210.52 |- skos__broader mesh__D035981smesh__D027481
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D035981 2003
% 210.35/210.52 |- skos__hiddenLabel mesh__D021961 Structures, Cell Membrane
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D021961 ags
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D021961 2001
% 210.35/210.52 |- mesh__dateCreated mesh__D021961 2000-07-05
% 210.35/210.52 |- skos__prefLabel mesh__D021961 Cell Membrane Structures
% 210.35/210.52 |- mesh__recordMaintainer mesh__D021961 nns
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D021961 2001
% 210.35/210.52 |- skos__hiddenLabel mesh__D021961 Structure, Cell Membrane
% 210.35/210.52 |- skos__hiddenLabel mesh__D021961 Membrane Structure, Cell
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D021961 2002
% 210.35/210.52 |- skos__hiddenLabel mesh__D021961 Cell Membrane Structure
% 210.35/210.52 |- skos__hiddenLabel mesh__D021961 Membrane Structures, Cell
% 210.35/210.52 |- mesh__historyNote mesh__D021961 2001
% 210.35/210.52 |- rdf__type mesh__D021961sskos__Concept
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D021961 2005
% 210.35/210.52 |- skos__annotation mesh__D021961 GEN: avoid; prefer specifics
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D021961 2003
% 210.35/210.52 |- mesh__recordOriginator mesh__D021961 nns
% 210.35/210.52 |- skos__scopeNote mesh__D021961
% 210.35/210.52 Structures which are part of the CELL MEMBRANE or have cell membrane as a major part of their structure.%A%
% 210.35/210.52 |- skos__broader mesh__D021961smesh__D002462
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D021961 2006
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D021961 2004
% 210.35/210.52 |- mesh__dateEstablished mesh__D021961 2001-01-01
% 210.35/210.52 |- skos__prefLabel mesh__D007492 Iran
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 1996
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 1993
% 210.35/210.52 |- mesh__dateRevised mesh__D007492 1992-05-20
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 2001
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 2003
% 210.35/210.52 |- mesh__dateCreated mesh__D007492 1999-01-01
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 2000
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 1999
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 2006
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 1995
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 1998
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 2005
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 1994
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D007492 PLS
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 2002
% 210.35/210.52 |- skos__broader mesh__D007492smesh__D008877
% 210.35/210.52 |- rdf__type mesh__D007492sskos__Concept
% 210.35/210.52 |- mesh__recordMaintainer mesh__D007492 PLS
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 1997
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D007492 2004
% 210.35/210.52 |- mesh__recordOriginator mesh__D007492 NLM
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015924 2001
% 210.35/210.52 |- skos__annotation mesh__D015924
% 210.35/210.52 measurement must be continuous; often in telemetric monitoring; do not use as a substitute for use of a sphygmomanometer for the usual blood pressure reading %28% = BLOOD PRESSURE DETERMINATION /instrum%29%%A%
% 210.35/210.52 |- skos__altLabel mesh__D015924 Monitors, Blood Pressure
% 210.35/210.52 |- rdf__type mesh__D015924sskos__Concept
% 210.35/210.52 |- mesh__dateRevised mesh__D015924 1997-06-20
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015924 2004
% 210.35/210.52 |- mesh__dateEstablished mesh__D015924 1990-01-01
% 210.35/210.52 |- skos__hiddenLabel mesh__D015924 Continuous Sphygmomanometers
% 210.35/210.52 |- mesh__historyNote mesh__D015924 90
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015924 1998
% 210.35/210.52 |- skos__hiddenLabel mesh__D015924 Blood Pressure Monitor
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015924 1999
% 210.35/210.52 |- skos__hiddenLabel mesh__D015924 Pressure Monitor, Blood
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015924 2002
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D015924 90
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015924 2005
% 210.35/210.52 |- mesh__dateCreated mesh__D015924 1989-05-26
% 210.35/210.52 |- skos__historyNote mesh__D015924
% 210.35/210.52 Blood Pressure Determination/instrumentation %28%1970-1989%29%
% 210.35/210.52 |- skos__hiddenLabel mesh__D015924 Sphygmomanometer, Continuous
% 210.35/210.52 |- skos__scopeNote mesh__D015924
% 210.35/210.52 Devices for continuously measuring and displaying the arterial blood pressure.%A%
% 210.35/210.52 |- skos__broader mesh__D015924smesh__D019722
% 210.35/210.52 |- skos__altLabel mesh__D015924 Sphygmomanometers, Continuous
% 210.35/210.52 |- skos__prefLabel mesh__D015924 Blood Pressure Monitors
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015924 2006
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015924 2000
% 210.35/210.52 |- mesh__recordOriginator mesh__D015924 PLS
% 210.35/210.52 |- skos__hiddenLabel mesh__D015924 Continuous Sphygmomanometer
% 210.35/210.52 |- skos__historyNote mesh__D015924
% 210.35/210.52 Monitoring, Physiologic/instrumentation %28%1970-1989%29%
% 210.35/210.52 |- mesh__recordMaintainer mesh__D015924 PXP
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015924 2003
% 210.35/210.52 |- skos__hiddenLabel mesh__D015924 Monitor, Blood Pressure
% 210.35/210.52 |- skos__hiddenLabel mesh__D015924 Pressure Monitors, Blood
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D015924 SJN
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015126 2006
% 210.35/210.52 |- skos__historyNote mesh__D015126
% 210.35/210.52 Fatty Acids, Unsaturated %28%1973-1974%29%
% 210.35/210.52 |- skos__hiddenLabel mesh__D015126 Linolenic Acid, Homo-gamma
% 210.35/210.52 |- skos__hiddenLabel mesh__D015126 Acid, Dihomo-gamma-Linolenic
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015126 2005
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D015126
% 210.35/210.52 91; was see under FATTY ACIDS, UNSATURATED 1975-90
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D015126 sjn
% 210.35/210.52 |- mesh__historyNote mesh__D015126
% 210.35/210.52 91%28%75%29%; was see under FATTY ACIDS, UNSATURATED 1975-90
% 210.35/210.52 |- skos__hiddenLabel mesh__D015126 Dihomo gamma Linolenic Acid
% 210.35/210.52 |- skos__altLabel mesh__D015126 8,11,14 Eicosatrienoic Acid
% 210.35/210.52 |- mesh__recordMaintainer mesh__D015126 ssb
% 210.35/210.52 |- skos__prefLabel mesh__D015126 8,11,14-Eicosatrienoic Acid
% 210.35/210.52 |- skos__hiddenLabel mesh__D015126 Acid, Homo-gamma Linolenic
% 210.35/210.52 |- skos__hiddenLabel mesh__D015126 Acid, Dihomogammalinolenic
% 210.35/210.52 |- skos__hiddenLabel mesh__D015126 Ro 121989
% 210.35/210.52 |- skos__hiddenLabel mesh__D015126 Homo gamma Linolenic Acid
% 210.35/210.52 |- rdf__type mesh__D015126sskos__Concept
% 210.35/210.52 |- skos__altLabel mesh__D015126 Dihomogammalinolenic Acid
% 210.35/210.52 |- mesh__dateRevised mesh__D015126 2003-07-09
% 210.35/210.52 |- mesh__dateCreated mesh__D015126 1974-11-19
% 210.35/210.52 |- skos__scopeNote mesh__D015126
% 210.35/210.52 A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5.%A%
% 210.35/210.52 |- skos__broader mesh__D015126smesh__D015777
% 210.35/210.52 |- mesh__recordOriginator mesh__D015126 NLM
% 210.35/210.52 |- skos__hiddenLabel mesh__D015126 Ro 12 1989
% 210.35/210.52 |- skos__altLabel mesh__D015126 DHLA
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D015126 2004
% 210.35/210.52 |- mesh__dateEstablished mesh__D015126 1991-01-01
% 210.35/210.52 |- skos__altLabel mesh__D015126 Dihomo-gamma-Linolenic Acid
% 210.35/210.52 |- skos__scopeNote mesh__D001904
% 210.35/210.52 Antiserum given therapeutically in BOTULISM.
% 210.35/210.52 |- mesh__dateRevised mesh__D001904 2005-06-30
% 210.35/210.52 |- skos__historyNote mesh__D001904 Antitoxins %28%1966-1971%29%
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D001904 73
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D001904 sjn
% 210.35/210.52 |- mesh__recordOriginator mesh__D001904 NLM
% 210.35/210.52 |- skos__broader mesh__D001904smesh__D000992
% 210.35/210.52 |- rdf__type mesh__D001904sskos__Concept
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001904 2006
% 210.35/210.52 |- mesh__dateCreated mesh__D001904 1999-01-01
% 210.35/210.52 |- mesh__recordMaintainer mesh__D001904 ssb
% 210.35/210.52 |- skos__prefLabel mesh__D001904 Botulinum Antitoxin
% 210.35/210.52 |- skos__hiddenLabel mesh__D001904 Antitoxin, Botulinum
% 210.35/210.52 |- mesh__historyNote mesh__D001904 73%28%72%29%
% 210.35/210.52 |- mesh__dateEstablished mesh__D001904 1973-01-01
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 2000
% 210.35/210.52 |- mesh__recordOriginator mesh__D001106 NLM
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 2003
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 1997
% 210.35/210.52 |- skos__related mesh__D001106smesh__D010162
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 2001
% 210.35/210.52 |- skos__annotation mesh__D001106
% 210.35/210.52 IM; SPEC; SPEC qualif; pre-Columbian: nothing later; DF: ARCHAEOL%A%
% 210.35/210.52 |- skos__broader mesh__D001106smesh__D000884
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 2004
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 1998
% 210.35/210.52 |- mesh__recordMaintainer mesh__D001106 JLS
% 210.35/210.52 |- mesh__dateRevised mesh__D001106 1993-06-04
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D001106 PLS
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 2002
% 210.35/210.52 |- mesh__dateCreated mesh__D001106 1999-01-01
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 2005
% 210.35/210.52 |- skos__altLabel mesh__D001106 Archeology
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 1999
% 210.35/210.52 |- skos__prefLabel mesh__D001106 Archaeology
% 210.35/210.52 |- rdf__type mesh__D001106sskos__Concept
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 1994
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 2006
% 210.35/210.52 |- skos__scopeNote mesh__D001106
% 210.35/210.52 The scientific study of past societies through artifacts, fossils, etc.%A%
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 1995
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D001106 1996
% 210.35/210.52 |- skos__annotation mesh__D020869
% 210.35/210.52 do not confuse with DNA PROFILING see DNA FINGERPRINTING %28%determining the uniqueness of the DNA sequence of an individual%29%%A%
% 210.35/210.52 |- skos__scopeNote mesh__D020869
% 210.35/210.52 The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.%A%
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Profilings, Gene Expression
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Transcript Expression Analyses
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Differential Displays, mRNA
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Analyses, Transcript Expression
% 210.35/210.52 |- mesh__recordMaintainer mesh__D020869 nns
% 210.35/210.52 |- mesh__dateEstablished mesh__D020869 2000-01-01
% 210.35/210.52 |- skos__prefLabel mesh__D020869 Gene Expression Profiling
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D020869 2004
% 210.35/210.52 |- skos__altLabel mesh__D020869 Transcript Expression Analysis
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 mRNA Differential Displays
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Gene Expression Profilings
% 210.35/210.52 |- mesh__dateRevised mesh__D020869 2003-07-09
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Analysis, Transcript Expression
% 210.35/210.52 |- rdf__type mesh__D020869sskos__Concept
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D020869 2006
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Monitoring, Gene Expression
% 210.35/210.52 |- skos__related mesh__D020869smesh__D015870
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Profiling, Gene Expression
% 210.35/210.52 |- mesh__historyNote mesh__D020869 2000
% 210.35/210.52 |- skos__altLabel mesh__D020869 Gene Expression Pattern Analysis
% 210.35/210.52 |- skos__related mesh__D020869smesh__D020411
% 210.35/210.52 |- skos__altLabel mesh__D020869 Gene Expression Monitoring
% 210.35/210.52 |- mesh__recordOriginator mesh__D020869 nns
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Gene Expression Monitorings
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Differential Display, mRNA
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D020869 2005
% 210.35/210.52 |- skos__broader mesh__D020869smesh__D005821
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Monitorings, Gene Expression
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D020869 2000
% 210.35/210.52 |- mesh__dateCreated mesh__D020869 1999-11-03
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D020869 sjn
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Displays, mRNA Differential
% 210.35/210.52 |- skos__hiddenLabel mesh__D020869 Display, mRNA Differential
% 210.35/210.52 |- mesh__recordMaintainer mesh__D047208 ags
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D047208 ags
% 210.35/210.52 |- skos__hiddenLabel mesh__D047208 Neurotoxin, RNS2
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D047208 2006A
% 210.35/210.52 |- skos__broader mesh__D047208smesh__D047091
% 210.35/210.52 |- skos__hiddenLabel mesh__D047208 Eosinophil Derived Neurotoxin
% 210.35/210.52 |- skos__hiddenLabel mesh__D047208 Neurotoxin, Eosinophil-Derived
% 210.35/210.52 |- skos__altLabel mesh__D047208 Eosinophil Protein X
% 210.35/210.52 |- skos__altLabel mesh__D047208 Serum Eosinophil Protein X
% 210.35/210.52 |- mesh__historyNote mesh__D047208 2005%28%1989%29%
% 210.35/210.52 |- mesh__dateCreated mesh__D047208 2004-07-07
% 210.35/210.52 |- mesh__dateRevised mesh__D047208 2005-07-08
% 210.35/210.52 |- skos__historyNote mesh__D047208 Ribonucleases %28%1989-2004%29%
% 210.35/210.52 |- skos__broader mesh__D047208smesh__D004722
% 210.35/210.52 |- skos__altLabel mesh__D047208 RNS2 Neurotoxin
% 210.35/210.52 |- mesh__publicMeSHNote mesh__D047208
% 210.35/210.52 2005; EOSINOPHIL-DERIVED NEUROTOXIN was indexed under RIBONUCLEASES 1989-2004%A%
% 210.35/210.52 |- skos__scopeNote mesh__D047208
% 210.35/210.52 A 19-kDa cationic peptide found in EOSINOPHIL granules. Eosinophil-derived neurotoxin is a RIBONUCLEASE and may play a role as an endogenous antiviral agent.%A%
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D047208 2006
% 210.35/210.52 |- rdf__type mesh__D047208sskos__Concept
% 210.35/210.52 |- mesh__recordOriginator mesh__D047208 jmp
% 210.35/210.52 |- skos__prefLabel mesh__D047208 Eosinophil-Derived Neurotoxin
% 210.35/210.52 |- mesh__dateEstablished mesh__D047208 2005-01-01
% 210.35/210.52 |- skos__altLabel mesh__D047208 s-EPX
% 210.35/210.52 |- mesh__dateCreated mesh__D019517 1996-06-21
% 210.35/210.52 |- skos__scopeNote mesh__D019517
% 210.35/210.52 Work consisting of untitled raw motion picture and video footage which has not been edited or assembled into a finished work. %28%From: Moving Image Materials: Genre Terms, 1988%29%%A%
% 210.35/210.52 |- rdf__type mesh__D019517sskos__Concept
% 210.35/210.52 |- mesh__recordMaintainer mesh__D019517 jls
% 210.35/210.52 |- mesh__dateRevised mesh__D019517 2005-06-30
% 210.35/210.52 |- mesh__recordOriginator mesh__D019517 TGC
% 210.35/210.52 |- mesh__historyNote mesh__D019517 1997
% 210.35/210.52 |- skos__annotation mesh__D019517
% 210.35/210.52 publication type only; unedited raw motion picture or video footage; used for historical materials only; CATALOG: do not use for current materials%A%
% 210.35/210.52 |- skos__broader mesh__D019517smesh__D052180
% 210.35/210.52 |- skos__prefLabel mesh__D019517 Unedited Footage %5B%Publication Type%5D%
% 210.35/210.52 |- mesh__dateEstablished mesh__D019517 1997-01-01
% 210.35/210.52 |- skos__altLabel mesh__D019517 Unedited Footage %28%PT%29%
% 210.35/210.52 |- skos__altLabel mesh__D019517 Unedited Footage
% 210.35/210.52 |- mesh__recordAuthorizer mesh__D019517 sjn
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D019517 2006
% 210.35/210.52 |- skos__altLabel mesh__D019517 Outtakes
% 210.35/210.52 |- skos__broader mesh__D021962smesh__D021961
% 210.35/210.52 |- skos__scopeNote mesh__D021962
% 210.35/210.52 Detergent-insoluble CELL MEMBRANE components. They are enriched in SPHINGOLIPIDS and CHOLESTEROL and clustered with glycosyl-phosphatidylinositol %28%GPI%29%-anchored proteins.%A%
% 210.35/210.52 |- mesh__recordOriginator mesh__D021962 nns
% 210.35/210.52 |- mesh__activeMeSHYear mesh__D021962 2006
% 210.35/210.53 |- skos__historyNote mesh__D021962 Cell Membrane %28%1981-2000%29%
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D021962 2001
% 210.35/210.53 |- skos__hiddenLabel mesh__D021962 Sphingolipid Microdomain
% 210.35/210.53 |- skos__hiddenLabel mesh__D021962 Microdomain, Membrane
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D021962 2005
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D021962 sjn
% 210.35/210.53 |- skos__prefLabel mesh__D021962 Membrane Microdomains
% 210.35/210.53 |- skos__altLabel mesh__D021962 Lipid Rafts, Cell Membrane
% 210.35/210.53 |- mesh__dateCreated mesh__D021962 2000-06-22
% 210.35/210.53 |- skos__hiddenLabel mesh__D021962 Sphingolipid-Cholesterol Raft
% 210.35/210.53 |- skos__altLabel mesh__D021962 Sphingolipid Microdomains
% 210.35/210.53 |- mesh__recordMaintainer mesh__D021962 jmp
% 210.35/210.53 |- mesh__dateRevised mesh__D021962 2004-07-07
% 210.35/210.53 |- mesh__historyNote mesh__D021962 2001
% 210.35/210.53 |- skos__hiddenLabel mesh__D021962 Microdomains, Sphingolipid
% 210.35/210.53 |- mesh__dateEstablished mesh__D021962 2001-01-01
% 210.35/210.53 |- skos__hiddenLabel mesh__D021962 Microdomains, Membrane
% 210.35/210.53 |- skos__hiddenLabel mesh__D021962 Sphingolipid Cholesterol Rafts
% 210.35/210.53 |- skos__hiddenLabel mesh__D021962 Membrane Microdomain
% 210.35/210.53 |- skos__hiddenLabel mesh__D021962 Microdomain, Sphingolipid
% 210.35/210.53 |- rdf__type mesh__D021962sskos__Concept
% 210.35/210.53 |- skos__altLabel mesh__D021962 Sphingolipid-Cholesterol Rafts
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 1999
% 210.35/210.53 |- mesh__recordOriginator mesh__D007493 NLM
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 2006
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 1995
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 1998
% 210.35/210.53 |- mesh__dateRevised mesh__D007493 1992-05-20
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 2001
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 2005
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 1994
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 2000
% 210.35/210.53 |- skos__broader mesh__D007493smesh__D008877
% 210.35/210.53 |- rdf__type mesh__D007493sskos__Concept
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 1997
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 2004
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 1996
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 1993
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D007493 PLS
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 2003
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007493 2002
% 210.35/210.53 |- mesh__dateCreated mesh__D007493 1999-01-01
% 210.35/210.53 |- skos__prefLabel mesh__D007493 Iraq
% 210.35/210.53 |- mesh__recordMaintainer mesh__D007493 PLS
% 210.35/210.53 |- skos__annotation mesh__D015925
% 210.35/210.53 %22%preservation of cells, tissue, organs or embryos by freezing%22%; cryopreserv of organs or tissue: coord IM with specific organ or tissue heading %28%IM with no qualif%29%%A%
% 210.35/210.53 |- mesh__dateCreated mesh__D015925 1989-05-26
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D015925 sjn
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D015925 2005
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D015925 90
% 210.35/210.53 |- skos__broader mesh__D015925smesh__D011309
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D015925 2006
% 210.35/210.53 |- mesh__historyNote mesh__D015925 90
% 210.35/210.53 |- mesh__recordOriginator mesh__D015925 PLS
% 210.35/210.53 |- skos__prefLabel mesh__D015925 Cryopreservation
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D015925 2003
% 210.35/210.53 |- mesh__dateRevised mesh__D015925 2001-07-25
% 210.35/210.53 |- skos__hiddenLabel mesh__D015925 Suspension, Cryonic
% 210.35/210.53 |- skos__hiddenLabel mesh__D015925 Suspensions, Cryonic
% 210.35/210.53 |- skos__hiddenLabel mesh__D015925 Cryonic Suspensions
% 210.35/210.53 |- skos__historyNote mesh__D015925
% 210.35/210.53 Preservation, Biological %28%1975-1989%29%
% 210.35/210.53 |- mesh__recordMaintainer mesh__D015925 nns
% 210.35/210.53 |- skos__historyNote mesh__D015925 Freezing %28%1966-1989%29%
% 210.35/210.53 |- skos__altLabel mesh__D015925 Cryofixation
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D015925 2004
% 210.35/210.53 |- rdf__type mesh__D015925sskos__Concept
% 210.35/210.53 |- skos__scopeNote mesh__D015925
% 210.35/210.53 Preservation of cells, tissues, organs, or embryos by freezing. In histological preparations, cryopreservation or cryofixation is used to maintain the existing form, structure, and chemical composition of all the constituent elements of the specimens.%A%
% 210.35/210.53 |- skos__broader mesh__D015925smesh__D014021
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D015925 2002
% 210.35/210.53 |- mesh__dateEstablished mesh__D015925 1990-01-01
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D015127
% 210.35/210.53 85; was see under BENZANTHRACENES 1975-84
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D015127 2005
% 210.35/210.53 |- skos__altLabel mesh__D015127 7,12-Dimethylbenzanthracene
% 210.35/210.53 |- skos__broader mesh__D015127smesh__D001551
% 210.35/210.53 |- skos__altLabel mesh__D015127 DMBA
% 210.35/210.53 |- mesh__recordOriginator mesh__D015127 RLS
% 210.35/210.53 |- rdf__type mesh__D015127sskos__Concept
% 210.35/210.53 |- mesh__historyNote mesh__D015127
% 210.35/210.53 85%28%75%29%; was see under BENZANTHRACENES 1975-84
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D015127 sjn
% 210.35/210.53 |- skos__hiddenLabel mesh__D015127 7,12 Dimethylbenzanthracene
% 210.35/210.53 |- mesh__dateEstablished mesh__D015127 1985-01-01
% 210.35/210.53 |- mesh__recordMaintainer mesh__D015127 ssb
% 210.35/210.53 |- skos__annotation mesh__D015127
% 210.35/210.53 a carcinogen; D25-26 qualif; DF: note short X ref
% 210.35/210.53 |- skos__historyNote mesh__D015127 Benzanthracenes %28%1966-1974%29%
% 210.35/210.53 |- mesh__dateCreated mesh__D015127 1974-10-24
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D015127 2006
% 210.35/210.53 |- skos__prefLabel mesh__D015127 9,10-Dimethyl-1,2-benzanthracene
% 210.35/210.53 |- skos__scopeNote mesh__D015127
% 210.35/210.53 7,12-Dimethylbenzanthracene. Polycyclic aromatic hydrocarbon found in tobacco smoke that is a potent carcinogen.%A%
% 210.35/210.53 |- mesh__dateRevised mesh__D015127 2004-07-07
% 210.35/210.53 |- skos__historyNote mesh__D001905 Clostridium Botulinum %28%1966-1968%29%
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D001905 78; was BOTULINUM TOXIN 1972-77
% 210.35/210.53 |- skos__related mesh__D001905smesh__D001906
% 210.35/210.53 |- rdf__type mesh__D001905sskos__Concept
% 210.35/210.53 |- mesh__dateRevised mesh__D001905 2005-06-30
% 210.35/210.53 |- skos__hiddenLabel mesh__D001905 Toxins, Clostridium botulinum
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001905 2006
% 210.35/210.53 |- mesh__dateCreated mesh__D001905 1999-01-01
% 210.35/210.53 |- mesh__historyNote mesh__D001905
% 210.35/210.53 78; was BOTULINUM TOXIN 1969-77 %28%Prov 1969-71%29%
% 210.35/210.53 |- mesh__onlineNote mesh__D001905
% 210.35/210.53 use BOTULINUM TOXINS to search BOTULINUM TOXIN 1969-77 %28%as Prov 1969-71%29%%A%
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D001905 sjn
% 210.35/210.53 |- mesh__recordOriginator mesh__D001905 NLM
% 210.35/210.53 |- skos__hiddenLabel mesh__D001905 botulinum Toxins, Clostridium
% 210.35/210.53 |- skos__altLabel mesh__D001905 Botulin
% 210.35/210.53 |- skos__altLabel mesh__D001905 Botulinum Toxin
% 210.35/210.53 |- skos__scopeNote mesh__D001905
% 210.35/210.53 Proteins synthesized as a single chain of %7E%150 kDa with 35%25% sequence identity to TETANUS TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. They have neuro-, entero-, and hemotoxic properties, are immunogenic, and include the most potent poisons known. The most commonly used apparently blocks release of ACETYLCHOLINE at cholinergic SYNAPSES.%A%
% 210.35/210.53 |- skos__hiddenLabel mesh__D001905 Toxins, Botulinum
% 210.35/210.53 |- skos__historyNote mesh__D001905 Toxins %28%1966-1968%29%
% 210.35/210.53 |- mesh__dateEstablished mesh__D001905 1972-01-01
% 210.35/210.53 |- skos__altLabel mesh__D001905 Clostridium botulinum Toxins
% 210.35/210.53 |- skos__broader mesh__D001905smesh__D001426
% 210.35/210.53 |- mesh__recordMaintainer mesh__D001905 ssb
% 210.35/210.53 |- skos__annotation mesh__D001905
% 210.35/210.53 /antag permitted but consider also BOTULINUM ANTITOXIN
% 210.35/210.53 |- skos__prefLabel mesh__D001905 Botulinum Toxins
% 210.35/210.53 |- skos__hiddenLabel mesh__D001905 Toxin, Botulinum
% 210.35/210.53 |- skos__broader mesh__D001905smesh__D001427
% 210.35/210.53 |- skos__broader mesh__D019800Q000031smesh__D019800
% 210.35/210.53 |- mesh__preferredCombination mesh__D019800Q000031smesh__D010636
% 210.35/210.53 |- rdf__type mesh__D019800Q000031smesh__CompoundConcept
% 210.35/210.53 |- skos__hiddenLabel mesh__D001107 Ramp
% 210.35/210.53 |- skos__scopeNote mesh__D001107
% 210.35/210.53 Designs for approaching areas inside or outside facilities.%A%
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001107 2004
% 210.35/210.53 |- skos__hiddenLabel mesh__D001107 Architectural Barriers
% 210.35/210.53 |- mesh__recordMaintainer mesh__D001107 TPW
% 210.35/210.53 |- skos__hiddenLabel mesh__D001107 Accesses, Facility
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001107 1998
% 210.35/210.53 |- skos__hiddenLabel mesh__D001107 Architectural Barrier
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001107 2000
% 210.35/210.53 |- mesh__historyNote mesh__D001107
% 210.35/210.53 91%28%Aug 77%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A%
% 210.35/210.53 |- skos__hiddenLabel mesh__D001107 Barrier, Architectural
% 210.35/210.53 |- skos__hiddenLabel mesh__D001107 Access, Facility
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001107 2005
% 210.35/210.53 |- skos__altLabel mesh__D001107 Accessibility, Architectural
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001107 1999
% 210.35/210.53 |- skos__hiddenLabel mesh__D001107 Facility Accesses
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001107 2001
% 210.35/210.53 |- skos__annotation mesh__D001107
% 210.35/210.53 for approaching inside or outside areas; DF: note short X ref%A%
% 210.35/210.53 |- rdf__type mesh__D001107sskos__Concept
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001107 2006
% 210.35/210.53 |- mesh__dateRevised mesh__D001107 1997-06-20
% 210.35/210.53 |- skos__historyNote mesh__D001107 Architecture %28%1966-Jul 1977%29%
% 210.35/210.53 |- mesh__dateEstablished mesh__D001107 1991-01-01
% 210.35/210.53 |- mesh__recordOriginator mesh__D001107 EC
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001107 2002
% 210.35/210.53 |- mesh__dateCreated mesh__D001107 1977-05-05
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D001107 SJN
% 210.35/210.53 |- skos__broader mesh__D001107smesh__D005160
% 210.35/210.53 |- skos__prefLabel mesh__D001107 Architectural Accessibility
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001107 2003
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D001107
% 210.35/210.53 91; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A%
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D047209 2006
% 210.35/210.53 |- skos__historyNote mesh__D047209 Peroxides %28%1997-2004%29%
% 210.35/210.53 |- rdf__type mesh__D047209sskos__Concept
% 210.35/210.53 |- mesh__dateEstablished mesh__D047209 2005-01-01
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D047209 sjn
% 210.35/210.53 |- skos__scopeNote mesh__D047209
% 210.35/210.53 A 66-kDa peroxidase found in EOSINOPHIL granules. Eosinophil peroxidase is a cationic protein with a pI of 10.8 and is comprised of a heavy chain subunit and a light chain subunit. It possesses cytotoxic activity towards BACTERIA and other organisms, which is attributed to its peroxidase activity.%A%
% 210.35/210.53 |- mesh__dateCreated mesh__D047209 2004-07-07
% 210.35/210.53 |- mesh__historyNote mesh__D047209 2005%28%1997%29%
% 210.35/210.53 |- skos__broader mesh__D047209smesh__D047091
% 210.35/210.53 |- mesh__dateRevised mesh__D047209 2005-06-30
% 210.35/210.53 |- skos__hiddenLabel mesh__D047209 Peroxidase, Eosinophil
% 210.35/210.53 |- mesh__recordMaintainer mesh__D047209 ssb
% 210.35/210.53 |- skos__prefLabel mesh__D047209 Eosinophil Peroxidase
% 210.35/210.53 |- mesh__recordOriginator mesh__D047209 jmp
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D047209
% 210.35/210.53 2005; EOSINOPHIL PEROXIDASE was indexed under PEROXIDES 1997-2004%A%
% 210.35/210.53 |- skos__broader mesh__D047209smesh__D010544
% 210.35/210.53 |- skos__hiddenLabel mesh__D019518 Period, Postcibal
% 210.35/210.53 |- rdf__type mesh__D019518sskos__Concept
% 210.35/210.53 |- mesh__historyNote mesh__D019518 97
% 210.35/210.53 |- skos__prefLabel mesh__D019518 Postprandial Period
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D019518 2006
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D019518 2004
% 210.35/210.53 |- skos__hiddenLabel mesh__D019518 Postcibal Periods
% 210.35/210.53 |- mesh__recordMaintainer mesh__D019518 lkt
% 210.35/210.53 |- mesh__recordOriginator mesh__D019518 JLS
% 210.35/210.53 |- skos__hiddenLabel mesh__D019518 Periods, Postprandial
% 210.35/210.53 |- mesh__dateRevised mesh__D019518 2003-07-09
% 210.35/210.53 |- skos__broader mesh__D019518smesh__D004068
% 210.35/210.53 |- skos__historyNote mesh__D019518 Eating %28%1966-1996%29%
% 210.35/210.53 |- skos__scopeNote mesh__D019518
% 210.35/210.53 The time frame after a meal or FOOD INTAKE.
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D019518 97
% 210.35/210.53 |- mesh__dateEstablished mesh__D019518 1997-01-01
% 210.35/210.53 |- skos__historyNote mesh__D019518 Food %28%1966-1996%29%
% 210.35/210.53 |- skos__hiddenLabel mesh__D019518 Postprandial Periods
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D019518 sjn
% 210.35/210.53 |- skos__altLabel mesh__D019518 Postcibal Period
% 210.35/210.53 |- skos__hiddenLabel mesh__D019518 Period, Postprandial
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D019518 2005
% 210.35/210.53 |- skos__hiddenLabel mesh__D019518 Periods, Postcibal
% 210.35/210.53 |- mesh__dateCreated mesh__D019518 1996-06-13
% 210.35/210.53 |- skos__hiddenLabel mesh__D011535 Belly Syndrome, Prune
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011535 2005
% 210.35/210.53 |- skos__hiddenLabel mesh__D011535 Belly Syndromes, Prune
% 210.35/210.53 |- skos__annotation mesh__D011535
% 210.35/210.53 a syndrome of multiple abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 210.35/210.53 |- rdf__type mesh__D011535sskos__Concept
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011535 2003
% 210.35/210.53 |- skos__historyNote mesh__D011535 Cryptorchism %28%1966-1981%29%
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D011535 sjn
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D011535 82
% 210.35/210.53 |- skos__hiddenLabel mesh__D011535 Prune-Belly Syndromes
% 210.35/210.53 |- mesh__recordOriginator mesh__D011535 AEP
% 210.35/210.53 |- skos__historyNote mesh__D011535
% 210.35/210.53 Abnormalities, Multiple %28%1968-1981%29%
% 210.35/210.53 |- skos__hiddenLabel mesh__D011535 Syndromes, Prune Belly
% 210.35/210.53 |- skos__broader mesh__D011535smesh__D000015
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011535 2002
% 210.35/210.53 |- mesh__recordMaintainer mesh__D011535 kle
% 210.35/210.53 |- skos__prefLabel mesh__D011535 Prune Belly Syndrome
% 210.35/210.53 |- skos__hiddenLabel mesh__D011535 Syndrome, Prune-Belly
% 210.35/210.53 |- mesh__historyNote mesh__D011535 82
% 210.35/210.53 |- skos__hiddenLabel mesh__D011535 Syndromes, Prune-Belly
% 210.35/210.53 |- skos__historyNote mesh__D011535 Abdominal Wall/AB %28%1966-1981%29%
% 210.35/210.53 |- skos__hiddenLabel mesh__D011535 Prune Belly Syndromes
% 210.35/210.53 |- skos__altLabel mesh__D011535 Prune-Belly Syndrome
% 210.35/210.53 |- skos__hiddenLabel mesh__D011535 Syndrome, Prune Belly
% 210.35/210.53 |- skos__scopeNote mesh__D011535
% 210.35/210.53 A syndrome characterized by abdominal wall musculature deficiency, cryptorchism, and urinary tract abnormalities. The syndrome derives its name from its characteristic distended abdomen with wrinkled skin.%A%
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011535 2001
% 210.35/210.53 |- mesh__dateRevised mesh__D011535 1999-11-03
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011535 2006
% 210.35/210.53 |- mesh__dateEstablished mesh__D011535 1982-01-01
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011535 2000
% 210.35/210.53 |- skos__historyNote mesh__D011535 Urogenital System/AB %28%1966-1981%29%
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011535 2004
% 210.35/210.53 |- mesh__dateCreated mesh__D011535 1981-02-23
% 210.35/210.53 |- skos__prefLabel mesh__D016220 Fibroblast Growth Factor 1
% 210.35/210.53 |- mesh__dateEstablished mesh__D016220 1991-01-01
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D016220 2006A
% 210.35/210.53 |- skos__altLabel mesh__D016220
% 210.35/210.53 Heparin-Binding Fibroblast Growth Factor Class I
% 210.35/210.53 |- skos__altLabel mesh__D016220 Fibroblast Growth Factor, Acidic
% 210.35/210.53 |- skos__altLabel mesh__D016220 Heparin-Binding Growth Factor, Class I
% 210.35/210.53 |- skos__scopeNote mesh__D016220
% 210.35/210.53 A 17-kDa single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. It binds to HEPARIN, which potentiates its biological activity and protects it from proteolysis. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages, and also has chemotactic and mitogenic activities. It was originally named acidic fibroblast growth factor based upon its chemical properties and to distinguish it from basic fibroblast growth factor %28%FIBROBLAST GROWTH FACTOR 2%29%.%A%
% 210.35/210.53 |- skos__altLabel mesh__D016220 Class I Heparin-Binding Growth Factor
% 210.35/210.53 |- mesh__dateRevised mesh__D016220 2005-07-07
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D016220 2006
% 210.35/210.53 |- skos__altLabel mesh__D016220 HBGF-1
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D016220 ags
% 210.35/210.53 |- mesh__recordMaintainer mesh__D016220 ags
% 210.35/210.53 |- skos__broader mesh__D016220smesh__D042501
% 210.35/210.53 |- rdf__type mesh__D016220sskos__Concept
% 210.35/210.53 |- skos__historyNote mesh__D016220
% 210.35/210.53 Fibroblast Growth Factor %28%1984-1990%29%
% 210.35/210.53 |- skos__annotation mesh__D016220 DF: FGF1
% 210.35/210.53 |- skos__altLabel mesh__D016220 Fibroblast Growth Factor-1
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D016220
% 210.35/210.53 2002; FIBROBLAST GROWTH FACTOR-1 was indexed under FIBROBLAST GROWTH FACTOR ACIDIC 2001, FIBROBLAST GROWTH FACTOR 2000-2001 %26% under FIBROBLAST GROWTH FACTOR, BASIC 1998-2000%A%
% 210.35/210.53 |- skos__altLabel mesh__D016220 Acidic Fibroblast Growth Factor
% 210.35/210.53 |- skos__hiddenLabel mesh__D016220 Heparin Binding Growth Factor, Class I
% 210.35/210.53 |- skos__historyNote mesh__D016220 Growth Substances %28%1974-1983%29%
% 210.35/210.53 |- skos__altLabel mesh__D016220 FGF-1
% 210.35/210.53 |- mesh__dateCreated mesh__D016220 1990-07-05
% 210.35/210.53 |- mesh__recordOriginator mesh__D016220 RLS
% 210.35/210.53 |- skos__altLabel mesh__D016220 FGF1
% 210.35/210.53 |- skos__broader mesh__D016220smesh__D005346
% 210.35/210.53 |- mesh__historyNote mesh__D016220
% 210.35/210.53 2002%28%1991%29%; for FIBROBLAST GROWTH FACTOR-1 use FIBROBLAST GROWTH FACTOR 1%28%NM%29% 1998-2001%A%
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D002200 2006
% 210.35/210.53 |- skos__scopeNote mesh__D002200
% 210.35/210.53 The vascular resistance to the flow of BLOOD through the CAPILLARIES portions of the peripheral vascular bed.%A%
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D002200 2005
% 210.35/210.53 |- mesh__recordMaintainer mesh__D002200 nns
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D002200
% 210.35/210.53 91,63-85; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85%A%
% 210.35/210.53 |- rdf__type mesh__D002200sskos__Concept
% 210.35/210.53 |- skos__hiddenLabel mesh__D002200 Resistances, Capillary
% 210.35/210.53 |- mesh__dateEstablished mesh__D002200 1991-01-01
% 210.35/210.53 |- skos__prefLabel mesh__D002200 Capillary Resistance
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D002200 sjn
% 210.35/210.53 |- mesh__recordOriginator mesh__D002200 NLM
% 210.35/210.53 |- mesh__dateCreated mesh__D002200 1999-01-01
% 210.35/210.53 |- skos__hiddenLabel mesh__D002200 Resistance, Capillary
% 210.35/210.53 |- skos__hiddenLabel mesh__D002200 Capillary Resistances
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D002200 2004
% 210.35/210.53 |- skos__broader mesh__D002200smesh__D014655
% 210.35/210.53 |- mesh__historyNote mesh__D002200
% 210.35/210.53 91%28%86%29%63; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85%A%
% 210.35/210.53 |- mesh__dateRevised mesh__D002200 2003-07-09
% 210.35/210.53 |- skos__altLabel mesh__D007494 Irish Free State
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 1994
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 1999
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 2006
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 1995
% 210.35/210.53 |- skos__prefLabel mesh__D007494 Ireland
% 210.35/210.53 |- skos__altLabel mesh__D007494 Ireland, Republic of
% 210.35/210.53 |- skos__altLabel mesh__D007494 Eire
% 210.35/210.53 |- mesh__dateRevised mesh__D007494 1993-06-02
% 210.35/210.53 |- mesh__recordMaintainer mesh__D007494 TGC
% 210.35/210.53 |- skos__annotation mesh__D007494
% 210.35/210.53 capital, Dublin; differentiate from NORTHERN IRELAND
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 2000
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 1996
% 210.35/210.53 |- mesh__dateCreated mesh__D007494 1999-01-01
% 210.35/210.53 |- skos__broader mesh__D007494smesh__D005060
% 210.35/210.53 |- rdf__type mesh__D007494sskos__Concept
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 2003
% 210.35/210.53 |- mesh__recordOriginator mesh__D007494 NLM
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 1997
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 2004
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 2001
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D007494 PLS
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 2002
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 1998
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D007494 2005
% 210.35/210.53 |- skos__broader mesh__D015926smesh__D000706
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D015926 2006
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D015926 2006A
% 210.35/210.53 |- skos__historyNote mesh__D015926 Anaphylatoxins %28%1977-1989%29%
% 210.35/210.53 |- skos__altLabel mesh__D015926 Complement 3a
% 210.35/210.53 |- mesh__recordMaintainer mesh__D015926 ags
% 210.35/210.53 |- skos__historyNote mesh__D015926 Complement 3 %28%1975-1989%29%
% 210.35/210.53 |- mesh__historyNote mesh__D015926 2006 %28%1990%29%
% 210.35/210.53 |- mesh__recordOriginator mesh__D015926 AGS
% 210.35/210.53 |- skos__hiddenLabel mesh__D015926 Complement, C3a
% 210.35/210.53 |- skos__broader mesh__D015926smesh__D003176
% 210.35/210.53 |- skos__hiddenLabel mesh__D015926 C3a, Complement
% 210.35/210.53 |- rdf__type mesh__D015926sskos__Concept
% 210.35/210.53 |- skos__altLabel mesh__D015926 Complement Component 3a
% 210.35/210.53 |- skos__hiddenLabel mesh__D015926 Component 3a, Complement
% 210.35/210.53 |- mesh__dateRevised mesh__D015926 2005-07-11
% 210.35/210.53 |- skos__scopeNote mesh__D015926
% 210.35/210.53 The smaller fragment generated from the cleavage of complement C3 by C3 CONVERTASE. C3a, a 77-amino acid peptide, is a mediator of local inflammatory process. It induces smooth MUSCLE CONTRACTION, and HISTAMINE RELEASE from MAST CELLS and LEUKOCYTES. C3a is considered an anaphylatoxin along with COMPLEMENT C4A; COMPLEMENT C5A; and COMPLEMENT C5A, DES-ARGININE.%A%
% 210.35/210.53 |- skos__historyNote mesh__D015926 Complement %28%1967-1976%29%
% 210.35/210.53 |- mesh__dateEstablished mesh__D015926 1990-01-01
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D015926 ags
% 210.35/210.53 |- mesh__dateCreated mesh__D015926 1989-07-14
% 210.35/210.53 |- mesh__publicMeSHNote mesh__D015926 2006; see COMPLEMENT 3A 1990-2005
% 210.35/210.53 |- skos__altLabel mesh__D015926 C3a Complement
% 210.35/210.53 |- skos__prefLabel mesh__D015926 Complement C3a
% 210.35/210.53 |- skos__scopeNote mesh__D001906
% 210.35/210.53 A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS %28%including respiratory paralysis%29%, blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes %28%e.g., food-borne, infant, wound, and others%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p1208%29%%A%
% 210.35/210.53 |- skos__broader mesh__D001906smesh__D020511
% 210.35/210.53 |- skos__altLabel mesh__D001906 Toxico-Infectious Botulism
% 210.35/210.53 |- mesh__recordMaintainer mesh__D001906 ags
% 210.35/210.53 |- skos__broader mesh__D001906smesh__D005517
% 210.35/210.53 |- skos__broader mesh__D001906smesh__D020258
% 210.35/210.53 |- skos__related mesh__D001906smesh__D001905
% 210.35/210.53 |- skos__prefLabel mesh__D001906 Botulism
% 210.35/210.53 |- skos__broader mesh__D001906smesh__D003015
% 210.35/210.53 |- mesh__dateRevised mesh__D001906 2004-07-07
% 210.35/210.53 |- skos__hiddenLabel mesh__D001906 Infantile Botulism
% 210.35/210.53 |- skos__altLabel mesh__D001906 Botulism, Toxico-Infectious
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001906 2005
% 210.35/210.53 |- skos__annotation mesh__D001906
% 210.35/210.53 coordinate IM with specific Clostridium botulinum type %28%IM%29% if pertinent%A%
% 210.35/210.53 |- rdf__type mesh__D001906sskos__Concept
% 210.35/210.53 |- skos__hiddenLabel mesh__D001906 Botulism, Toxico Infectious
% 210.35/210.53 |- skos__hiddenLabel mesh__D001906 Toxico Infectious Botulism
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001906 2006
% 210.35/210.53 |- mesh__recordOriginator mesh__D001906 NLM
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D001906 sjn
% 210.35/210.53 |- mesh__dateCreated mesh__D001906 1999-01-01
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 2004
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1991
% 210.35/210.53 |- mesh__dateCreated mesh__D001108 1999-01-01
% 210.35/210.53 |- skos__annotation mesh__D001108 SPEC: SPEC qualif
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1996
% 210.35/210.53 |- skos__related mesh__D001108smesh__D006275
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 2003
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1990
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 2002
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1995
% 210.35/210.53 |- mesh__recordMaintainer mesh__D001108 TGC
% 210.35/210.53 |- skos__broader mesh__D001108smesh__D013676
% 210.35/210.53 |- skos__prefLabel mesh__D001108 Architecture
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1999
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 2001
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D001108 PLS
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1994
% 210.35/210.53 |- rdf__type mesh__D001108sskos__Concept
% 210.35/210.53 |- mesh__recordOriginator mesh__D001108 NLM
% 210.35/210.53 |- skos__hiddenLabel mesh__D001108 Architectures
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 2006
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 2000
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1993
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1998
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1997
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 2005
% 210.35/210.53 |- mesh__dateRevised mesh__D001108 1989-06-13
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D001108 1992
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D019519 sjn
% 210.35/210.53 |- skos__broader mesh__D019519smesh__D019502
% 210.35/210.53 |- skos__scopeNote mesh__D019519
% 210.35/210.53 Works consisting of single or multi-sheet notices made to attract attention to events, activities, causes, goods, or services. They are for posting, usually in a public place and are chiefly pictorial. They are intended to make an immediate impression from a distance. Posters do not include poster presentations at conferences and meetings. %28%From Thesaurus for Graphic Materials II: Genre and Physical Characteristic Headings, 1995%29%%A%
% 210.35/210.53 |- mesh__historyNote mesh__D019519 1997
% 210.35/210.53 |- skos__annotation mesh__D019519
% 210.35/210.53 publication type only; not for poster presentations at meetings; Publication Types ADVERTISEMENTS %26% BROADSIDES are also available%A%
% 210.35/210.53 |- rdf__type mesh__D019519sskos__Concept
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D019519 2006
% 210.35/210.53 |- mesh__dateEstablished mesh__D019519 1997-01-01
% 210.35/210.53 |- mesh__recordOriginator mesh__D019519 TGC
% 210.35/210.53 |- skos__prefLabel mesh__D019519 Posters %5B%Publication Type%5D%
% 210.35/210.53 |- skos__altLabel mesh__D019519 Posters
% 210.35/210.53 |- skos__altLabel mesh__D019519 Posters %28%PT%29%
% 210.35/210.53 |- mesh__dateCreated mesh__D019519 1996-06-21
% 210.35/210.53 |- mesh__recordMaintainer mesh__D019519 jls
% 210.35/210.53 |- mesh__dateRevised mesh__D019519 2005-06-30
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 2000
% 210.35/210.53 |- mesh__dateCreated mesh__D011536 1999-01-01
% 210.35/210.53 |- mesh__dateRevised mesh__D011536 1993-06-02
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 1998
% 210.35/210.53 |- mesh__recordMaintainer mesh__D011536 TAP
% 210.35/210.53 |- skos__prefLabel mesh__D011536 Prurigo
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 1996
% 210.35/210.53 |- skos__annotation mesh__D011536 itchy skin eruptions
% 210.35/210.53 |- skos__scopeNote mesh__D011536
% 210.35/210.53 A name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. %28%From Dorland, 27th ed%29%%A%
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 2002
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 2006
% 210.35/210.53 |- skos__broader mesh__D011536smesh__D012871
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 2004
% 210.35/210.53 |- mesh__recordOriginator mesh__D011536 NLM
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 1995
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 2005
% 210.35/210.53 |- mesh__recordAuthorizer mesh__D011536 PLS
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 1999
% 210.35/210.53 |- rdf__type mesh__D011536sskos__Concept
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 2001
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 2003
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 1994
% 210.35/210.53 |- mesh__activeMeSHYear mesh__D011536 1997
% 210.35/210.53 |- skos__altLabel mesh__D016221 Festschrift
% 210.35/210.54 |- skos__altLabel mesh__D016221 Festschrift %28%PT%29%
% 210.35/210.54 |- skos__altLabel mesh__D016221 Festschriften
% 210.35/210.54 |- skos__altLabel mesh__D016221 Festschriften %28%PT%29%
% 210.35/210.54 |- mesh__dateEstablished mesh__D016221 1996-01-01
% 210.35/210.54 |- skos__broader mesh__D016221smesh__D016456
% 210.35/210.54 |- rdf__type mesh__D016221sskos__Concept
% 210.35/210.54 |- skos__historyNote mesh__D016221 Historical Biography %28%1966-1990%29%
% 210.35/210.54 |- mesh__historyNote mesh__D016221 1991
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D016221 sjn
% 210.35/210.54 |- mesh__recordOriginator mesh__D016221 TGC
% 210.35/210.54 |- skos__broader mesh__D016221smesh__D016424
% 210.35/210.54 |- skos__prefLabel mesh__D016221 Festschrift %5B%Publication Type%5D%
% 210.35/210.54 |- mesh__recordMaintainer mesh__D016221 jls
% 210.35/210.54 |- skos__annotation mesh__D016221
% 210.35/210.54 publication type only; check appropriate century tags; Manual 32.18.8%A%
% 210.35/210.54 |- skos__scopeNote mesh__D016221
% 210.35/210.54 Work consisting of a collection of essays or other writings contributed by students, teachers, colleagues, and admirers to honor a scholar, physician, or other scientist on a special occasion noting an event of importance in his or her life.%A%
% 210.35/210.54 |- skos__broader mesh__D016221smesh__D020470
% 210.35/210.54 |- skos__historyNote mesh__D016221 Current Biog-Obit %28%1966-1990%29%
% 210.35/210.54 |- mesh__dateRevised mesh__D016221 2005-06-30
% 210.35/210.54 |- mesh__dateCreated mesh__D016221 1995-06-23
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D016221 2006
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 2000
% 210.35/210.54 |- mesh__recordMaintainer mesh__D002201 PLS
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 2005
% 210.35/210.54 |- skos__broader mesh__D002201smesh__D005102
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 1997
% 210.35/210.54 |- skos__hiddenLabel mesh__D002201 Expenditure, Capital
% 210.35/210.54 |- mesh__historyNote mesh__D002201
% 210.35/210.54 91%28%Aug 77%29%; was see under ECONOMICS 1977-90
% 210.35/210.54 |- rdf__type mesh__D002201sskos__Concept
% 210.35/210.54 |- mesh__dateEstablished mesh__D002201 1991-01-01
% 210.35/210.54 |- skos__prefLabel mesh__D002201 Capital Expenditures
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 2002
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 1996
% 210.35/210.54 |- mesh__recordOriginator mesh__D002201 EC
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 2004
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 1999
% 210.35/210.54 |- skos__hiddenLabel mesh__D002201 Capital Expenditure
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 1995
% 210.35/210.54 |- mesh__dateCreated mesh__D002201 1977-05-12
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 2003
% 210.35/210.54 |- mesh__dateRevised mesh__D002201 1993-09-16
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 1998
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D002201
% 210.35/210.54 91; was see under ECONOMICS Aug 1977-90
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 2001
% 210.35/210.54 |- skos__annotation mesh__D002201 not restricted to health care; NIM
% 210.35/210.54 |- skos__scopeNote mesh__D002201
% 210.35/210.54 Those funds disbursed for facilities and equipment, particularly those related to the delivery of health care.%A%
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002201 2006
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D002201 NLM
% 210.35/210.54 |- skos__hiddenLabel mesh__D002201 Expenditures, Capital
% 210.35/210.54 |- skos__broader mesh__D007495smesh__D019216
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007495 2002
% 210.35/210.54 |- mesh__dateCreated mesh__D007495 1999-01-01
% 210.35/210.54 |- skos__broader mesh__D007495smesh__D028561
% 210.35/210.54 |- rdf__type mesh__D007495sskos__Concept
% 210.35/210.54 |- skos__prefLabel mesh__D007495 Iridium
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007495 2003
% 210.35/210.54 |- skos__related mesh__D007495smesh__D007496
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007495 2004
% 210.35/210.54 |- skos__annotation mesh__D007495
% 210.35/210.54 Ir-193; Ir-191 = IRIDIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Ir-182-190, 192, 194-198 = IRIDIUM RADIOISOTOPES %28%IM%29%%A%
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D007495 sjn
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007495 2005
% 210.35/210.54 |- mesh__recordOriginator mesh__D007495 NLM
% 210.35/210.54 |- mesh__recordMaintainer mesh__D007495 jmp
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007495 2006
% 210.35/210.54 |- skos__scopeNote mesh__D007495
% 210.35/210.54 A metallic element with the atomic symbol Ir, atomic number 77, and atomic weight 192.22.%A%
% 210.35/210.54 |- mesh__dateRevised mesh__D007495 2001-07-25
% 210.35/210.54 |- mesh__historyNote mesh__D015927
% 210.35/210.54 91%28%90%29%; was see under SKIN TESTS 1990
% 210.35/210.54 |- skos__broader mesh__D015927smesh__D007428
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D015927 91; was see under SKIN TESTS 1990
% 210.35/210.54 |- skos__altLabel mesh__D015927 Skin Test Endpoint Titration
% 210.35/210.54 |- mesh__dateRevised mesh__D015927 2002-07-03
% 210.35/210.54 |- mesh__recordOriginator mesh__D015927 PLS
% 210.35/210.54 |- skos__prefLabel mesh__D015927 Skin Test End-Point Titration
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015927 2006
% 210.35/210.54 |- skos__annotation mesh__D015927
% 210.35/210.54 a type of intradermal allergy test; DF: STEPT
% 210.35/210.54 |- mesh__dateCreated mesh__D015927 1989-05-16
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015927 2004
% 210.35/210.54 |- skos__altLabel mesh__D015927 Serial Dilution Endpoint Titration
% 210.35/210.54 |- skos__broader mesh__D015927smesh__D017186
% 210.35/210.54 |- skos__scopeNote mesh__D015927
% 210.35/210.54 A quantitative form of intradermal testing for the relative allergenicity of a substance. It is used to determine the amount of an allergen that will be tolerated in immunotherapy.%A%
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015927 2005
% 210.35/210.54 |- skos__historyNote mesh__D015927 Skin Tests %28%1975-1989%29%
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015927 2003
% 210.35/210.54 |- rdf__type mesh__D015927sskos__Concept
% 210.35/210.54 |- skos__hiddenLabel mesh__D015927 Serial Dilution End Point Titration
% 210.35/210.54 |- skos__hiddenLabel mesh__D015927 Skin Test End Point Titration
% 210.35/210.54 |- skos__altLabel mesh__D015927 Serial Dilution End-Point Titration
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D015927 sjn
% 210.35/210.54 |- mesh__dateEstablished mesh__D015927 1991-01-01
% 210.35/210.54 |- skos__broader mesh__D015927smesh__D009500
% 210.35/210.54 |- skos__hiddenLabel mesh__D015927 Titration Skin Test, End Point
% 210.35/210.54 |- mesh__recordMaintainer mesh__D015927 lkt
% 210.35/210.54 |- skos__altLabel mesh__D015927 Titration Skin Test, End-Point
% 210.35/210.54 |- skos__altLabel mesh__D015927 Titration Skin Test, Endpoint
% 210.35/210.54 |- mesh__recordMaintainer mesh__D001907 ags
% 210.35/210.54 |- skos__hiddenLabel mesh__D001907 Fever, Mediterranean Spotted
% 210.35/210.54 |- skos__annotation mesh__D001907 caused by RICKETTSIA CONORII
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D001907
% 210.35/210.54 87; was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64%A%
% 210.35/210.54 |- mesh__recordOriginator mesh__D001907 NLM
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D001907 sjn
% 210.35/210.54 |- mesh__historyNote mesh__D001907
% 210.35/210.54 87%28%75%29%; was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64%A%
% 210.35/210.54 |- skos__hiddenLabel mesh__D001907 Boutonneuse Fevers
% 210.35/210.54 |- skos__scopeNote mesh__D001907
% 210.35/210.54 A febrile disease of the Mediterranean area, the Crimea, Africa, and India, caused by infection with RICKETTSIA CONORII.%A%
% 210.35/210.54 |- skos__hiddenLabel mesh__D001907 Spotted Fever, Mediterranean
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001907 2005
% 210.35/210.54 |- skos__altLabel mesh__D001907 Mediterranean Spotted Fever
% 210.35/210.54 |- mesh__dateEstablished mesh__D001907 1987-01-01
% 210.35/210.54 |- rdf__type mesh__D001907sskos__Concept
% 210.35/210.54 |- skos__broader mesh__D001907smesh__D017282
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001907 2004
% 210.35/210.54 |- skos__hiddenLabel mesh__D001907 Fever, Boutonneuse
% 210.35/210.54 |- skos__broader mesh__D001907smesh__D012282
% 210.35/210.54 |- skos__hiddenLabel mesh__D001907 Fevers, Boutonneuse
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001907 2006
% 210.35/210.54 |- mesh__dateCreated mesh__D001907 1999-01-01
% 210.35/210.54 |- mesh__onlineNote mesh__D001907 search RICKETTSIAL INFECTIONS 1966-74
% 210.35/210.54 |- mesh__dateRevised mesh__D001907 2003-07-09
% 210.35/210.54 |- skos__prefLabel mesh__D001907 Boutonneuse Fever
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D001109 sjn
% 210.35/210.54 |- skos__hiddenLabel mesh__D001109 Archive
% 210.35/210.54 |- skos__broader mesh__D001109smesh__D007253
% 210.35/210.54 |- skos__prefLabel mesh__D001109 Archives
% 210.35/210.54 |- skos__broader mesh__D001109smesh__D006664
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001109 2006
% 210.35/210.54 |- rdf__type mesh__D001109sskos__Concept
% 210.35/210.54 |- mesh__dateRevised mesh__D001109 2005-06-30
% 210.35/210.54 |- skos__annotation mesh__D001109
% 210.35/210.54 restricted use; note category; archives of clinical or other biological specimens = BIOLOGICAL SPECIMEN BANKS or specifics; for %22%medical archives%22% do not coordinate with MEDICINE; note PICTURE ARCHIVING, RADIOLOGIC see RADIOLOGY INFORMATION SYSTEMS is available%A%
% 210.35/210.54 |- mesh__recordMaintainer mesh__D001109 ags
% 210.35/210.54 |- mesh__dateCreated mesh__D001109 1999-01-01
% 210.35/210.54 |- mesh__recordOriginator mesh__D001109 NLM
% 210.35/210.54 |- skos__broader mesh__D003920Q000150smesh__D003920
% 210.35/210.54 |- mesh__preferredCombination mesh__D003920Q000150smesh__D048909
% 210.35/210.54 |- rdf__type mesh__D003920Q000150smesh__CompoundConcept
% 210.35/210.54 |- mesh__recordOriginator mesh__D011537 NLM
% 210.35/210.54 |- mesh__dateRevised mesh__D011537 1999-11-03
% 210.35/210.54 |- skos__altLabel mesh__D011537 Itching
% 210.35/210.54 |- skos__scopeNote mesh__D011537
% 210.35/210.54 An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.%A%
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011537 2006
% 210.35/210.54 |- skos__prefLabel mesh__D011537 Pruritus
% 210.35/210.54 |- mesh__recordMaintainer mesh__D011537 KEV
% 210.35/210.54 |- skos__broader mesh__D011537smesh__D012871
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011537 2001
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011537 2004
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011537 2000
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011537 2005
% 210.35/210.54 |- skos__broader mesh__D011537smesh__D012877
% 210.35/210.54 |- rdf__type mesh__D011537sskos__Concept
% 210.35/210.54 |- skos__altLabel mesh__D011537 Pruritis
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011537 2003
% 210.35/210.54 |- mesh__dateCreated mesh__D011537 1999-01-01
% 210.35/210.54 |- skos__annotation mesh__D011537
% 210.35/210.54 /drug ther: consider also ANTIPRURITICS
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D011537 sjn
% 210.35/210.54 |- skos__related mesh__D011537smesh__D000982
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011537 2002
% 210.35/210.54 |- skos__altLabel mesh__D016222 Fibroblast Growth Factor-2
% 210.35/210.54 |- rdf__type mesh__D016222sskos__Concept
% 210.35/210.54 |- mesh__recordMaintainer mesh__D016222 ags
% 210.35/210.54 |- skos__historyNote mesh__D016222 Growth Substances %28%1974-1983%29%
% 210.35/210.54 |- skos__broader mesh__D016222smesh__D042501
% 210.35/210.54 |- skos__altLabel mesh__D016222 FGF2
% 210.35/210.54 |- mesh__recordOriginator mesh__D016222 RLS
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D016222
% 210.35/210.54 2001; FIBROBLAST GROWTH FACTOR-2 was indexed under FIBROBLAST GROWTH FACTOR, BASIC 1996-2001 %26% under FIBROBLAST GROWTH FACTOR 1995; PROSTATROPIN was indexed under NERVE TISSUE PROTEINS 1986-2001%A%
% 210.35/210.54 |- skos__broader mesh__D016222smesh__D005346
% 210.35/210.54 |- skos__altLabel mesh__D016222 FGF-2
% 210.35/210.54 |- skos__altLabel mesh__D016222 Prostate Epithelial Cell Growth Factor
% 210.35/210.54 |- skos__altLabel mesh__D016222 Basic Fibroblast Growth Factor
% 210.35/210.54 |- mesh__historyNote mesh__D016222
% 210.35/210.54 2001%28%1991%29%; for FIBROBLAST GROWTH FACTOR-2 use FIBROBLAST GROWTH FACTOR 2 %28%NM%29% 1995; for PROSTATROPIN use FIBROBLAST GROWTH FACTOR 2 %28%NM%29% 1986-2001%A%
% 210.35/210.54 |- mesh__dateRevised mesh__D016222 2005-07-07
% 210.35/210.54 |- mesh__dateCreated mesh__D016222 1990-06-28
% 210.35/210.54 |- skos__altLabel mesh__D016222 Prostatropin
% 210.35/210.54 |- skos__hiddenLabel mesh__D016222 FGF 2
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D016222 2006A
% 210.35/210.54 |- mesh__dateEstablished mesh__D016222 1991-01-01
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D016222 2006
% 210.35/210.54 |- skos__altLabel mesh__D016222 HBGF-2
% 210.35/210.54 |- skos__prefLabel mesh__D016222 Fibroblast Growth Factor 2
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D016222 ags
% 210.35/210.54 |- skos__scopeNote mesh__D016222
% 210.35/210.54 A single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. Several different forms of the human protein exist ranging from 18-24 kDa in size due to the use of alternative start sites within the fgf-2 gene. It has a 55 percent amino acid residue identity to FIBROBLAST GROWTH FACTOR 1 and has potent heparin-binding activity. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages. It was originally named basic fibroblast growth factor based upon its chemical properties and to distinguish it from acidic fibroblast growth factor %28%FIBROBLAST GROWTH FACTOR 1%29%.%A%
% 210.35/210.54 |- skos__altLabel mesh__D016222 Class II Heparin-Binding Growth Factor
% 210.35/210.54 |- skos__altLabel mesh__D016222 Heparin-Binding Growth Factor Class II
% 210.35/210.54 |- skos__annotation mesh__D016222 DF: FGFB
% 210.35/210.54 |- skos__altLabel mesh__D016222 Fibroblast Growth Factor, Basic
% 210.35/210.54 |- skos__historyNote mesh__D016222
% 210.35/210.54 Fibroblast Growth Factor %28%1984-1990%29%
% 210.35/210.54 |- mesh__dateCreated mesh__D002202 1979-05-29
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002202 2004
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D002202
% 210.35/210.54 91; was see under FINANCIAL MANAGEMENT 1980-90
% 210.35/210.54 |- skos__historyNote mesh__D002202 Financial Management %28%1978-1979%29%
% 210.35/210.54 |- mesh__dateEstablished mesh__D002202 1991-01-01
% 210.35/210.54 |- skos__hiddenLabel mesh__D002202 Capital Funding
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D002202 sjn
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002202 2001
% 210.35/210.54 |- skos__prefLabel mesh__D002202 Capital Financing
% 210.35/210.54 |- mesh__dateRevised mesh__D002202 1999-11-03
% 210.35/210.54 |- mesh__recordMaintainer mesh__D002202 ags
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002202 2003
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002202 2000
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002202 2006
% 210.35/210.54 |- skos__hiddenLabel mesh__D002202 Capital Financings
% 210.35/210.54 |- skos__altLabel mesh__D002202 Financing, Capital
% 210.35/210.54 |- mesh__recordOriginator mesh__D002202 EC
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002202 2005
% 210.35/210.54 |- mesh__historyNote mesh__D002202
% 210.35/210.54 91%28%80%29%; was see under FINANCIAL MANAGEMENT 1980-90
% 210.35/210.54 |- skos__broader mesh__D002202smesh__D005376
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002202 2002
% 210.35/210.54 |- skos__scopeNote mesh__D002202
% 210.35/210.54 Institutional funding for facilities and for equipment which becomes a part of the assets of the institution.%A%
% 210.35/210.54 |- skos__hiddenLabel mesh__D002202 Capital Fundings
% 210.35/210.54 |- skos__altLabel mesh__D002202 Funding, Capital
% 210.35/210.54 |- rdf__type mesh__D002202sskos__Concept
% 210.35/210.54 |- mesh__recordOriginator mesh__D007496 RLS
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 1997
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 2000
% 210.35/210.54 |- mesh__dateCreated mesh__D007496 1987-04-08
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 2004
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 1998
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 2001
% 210.35/210.54 |- skos__annotation mesh__D007496
% 210.35/210.54 Ir-182-190, 192, 194-198; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 2005
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 1994
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D007496 PLS
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 1999
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 2002
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 2006
% 210.35/210.54 |- skos__hiddenLabel mesh__D007496 Radioisotopes, Iridium
% 210.35/210.54 |- skos__broader mesh__D007496smesh__D011868
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 1995
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D007496 88
% 210.35/210.54 |- skos__prefLabel mesh__D007496 Iridium Radioisotopes
% 210.35/210.54 |- skos__historyNote mesh__D007496 Iridium %28%1966-1987%29%
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 1996
% 210.35/210.54 |- mesh__recordMaintainer mesh__D007496 TPW
% 210.35/210.54 |- rdf__type mesh__D007496sskos__Concept
% 210.35/210.54 |- skos__historyNote mesh__D007496 Radioisotopes %28%1966-1987%29%
% 210.35/210.54 |- mesh__historyNote mesh__D007496 88
% 210.35/210.54 |- mesh__dateEstablished mesh__D007496 1988-01-01
% 210.35/210.54 |- skos__scopeNote mesh__D007496
% 210.35/210.54 Unstable isotopes of iridium that decay or disintegrate emitting radiation. Ir atoms with atomic weights 182-190, 192, and 194-198 are radioactive iridium isotopes.%A%
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D007496 2003
% 210.35/210.54 |- mesh__dateRevised mesh__D007496 1993-06-02
% 210.35/210.54 |- skos__broader mesh__D015928smesh__D001521
% 210.35/210.54 |- mesh__recordOriginator mesh__D015928 PLS
% 210.35/210.54 |- skos__altLabel mesh__D015928 Therapy, Cognition
% 210.35/210.54 |- skos__historyNote mesh__D015928 Behavior Therapy %28%1967-1989%29%
% 210.35/210.54 |- skos__prefLabel mesh__D015928 Cognitive Therapy
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 2001
% 210.35/210.54 |- skos__altLabel mesh__D015928 Behavior Therapy, Cognitive
% 210.35/210.54 |- mesh__recordMaintainer mesh__D015928 TGC
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D015928 90
% 210.35/210.54 |- skos__altLabel mesh__D015928 Psychotherapy, Cognitive
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 1996
% 210.35/210.54 |- skos__hiddenLabel mesh__D015928 Therapies, Cognitive Behavior
% 210.35/210.54 |- skos__hiddenLabel mesh__D015928 Therapies, Cognitive
% 210.35/210.54 |- rdf__type mesh__D015928sskos__Concept
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 2003
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D015928 PLS
% 210.35/210.54 |- skos__hiddenLabel mesh__D015928 Psychotherapies, Cognitive
% 210.35/210.54 |- skos__annotation mesh__D015928
% 210.35/210.54 a psychother technique; DF: COGNITIVE THER
% 210.35/210.54 |- mesh__dateEstablished mesh__D015928 1990-01-01
% 210.35/210.54 |- skos__hiddenLabel mesh__D015928 Therapies, Cognition
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 2002
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 1997
% 210.35/210.54 |- skos__hiddenLabel mesh__D015928 Cognitive Psychotherapies
% 210.35/210.54 |- skos__altLabel mesh__D015928 Therapy, Cognitive
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 2004
% 210.35/210.54 |- mesh__historyNote mesh__D015928 90
% 210.35/210.54 |- mesh__dateCreated mesh__D015928 1989-05-15
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 1998
% 210.35/210.54 |- skos__altLabel mesh__D015928 Cognitive Psychotherapy
% 210.35/210.54 |- skos__historyNote mesh__D015928 Cognition %28%1967-1989%29%
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 2005
% 210.35/210.54 |- skos__hiddenLabel mesh__D015928 Behavior Therapies, Cognitive
% 210.35/210.54 |- skos__altLabel mesh__D015928 Cognitive Behavior Therapy
% 210.35/210.54 |- skos__hiddenLabel mesh__D015928 Cognition Therapies
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 1999
% 210.35/210.54 |- skos__scopeNote mesh__D015928
% 210.35/210.54 A direct form of psychotherapy based on the interpretation of situations %28%cognitive structure of experiences%29% that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior. The therapy uses behavioral and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behavior.%A%
% 210.35/210.54 |- skos__altLabel mesh__D015928 Therapy, Cognitive Behavior
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 2006
% 210.35/210.54 |- skos__hiddenLabel mesh__D015928 Cognitive Behavior Therapies
% 210.35/210.54 |- skos__hiddenLabel mesh__D015928 Cognitive Therapies
% 210.35/210.54 |- skos__altLabel mesh__D015928 Cognition Therapy
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D015928 2000
% 210.35/210.54 |- mesh__dateRevised mesh__D015928 1995-05-31
% 210.35/210.54 |- skos__historyNote mesh__D040321
% 210.35/210.54 Receptors, Growth Factor %28%1995-2002%29%
% 210.35/210.54 |- rdf__type mesh__D040321sskos__Concept
% 210.35/210.54 |- mesh__recordOriginator mesh__D040321 MDJ
% 210.35/210.54 |- skos__altLabel mesh__D040321 VEGFR-3
% 210.35/210.54 |- skos__historyNote mesh__D040321
% 210.35/210.54 Receptors, Cell Surface %28%1994-2000%29%
% 210.35/210.54 |- mesh__dateRevised mesh__D040321 2005-06-30
% 210.35/210.54 |- mesh__dateEstablished mesh__D040321 2003-01-01
% 210.35/210.54 |- mesh__recordMaintainer mesh__D040321 jmp
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D040321 2006
% 210.35/210.54 |- skos__historyNote mesh__D040321
% 210.35/210.54 Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 210.35/210.54 |- skos__prefLabel mesh__D040321
% 210.35/210.54 Vascular Endothelial Growth Factor Receptor-3
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D040321
% 210.35/210.54 2003; FLT4 PROTEIN %28%now VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-2002, RECEPTORS, CELL SURFACE 1994-2000 %26% RECEPTORS, GROWTH FACTOR 1995-2002%A%
% 210.35/210.54 |- skos__altLabel mesh__D040321 FLT4 Protein
% 210.35/210.54 |- mesh__historyNote mesh__D040321
% 210.35/210.54 2003; use VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3 %28%NM%29% 1994-2002%A%
% 210.35/210.54 |- skos__hiddenLabel mesh__D040321 Flt 4
% 210.35/210.54 |- skos__hiddenLabel mesh__D040321
% 210.35/210.54 Vascular Endothelial Growth Factor Receptor 3
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D040321 sjn
% 210.35/210.54 |- skos__altLabel mesh__D040321 Flt-4
% 210.35/210.54 |- skos__broader mesh__D040321smesh__D040262
% 210.35/210.54 |- skos__scopeNote mesh__D040321
% 210.35/210.54 A vascular endothelial cell growth factor receptor whose expression is restricted primarily to adult lymphatic endothelium. VEGFR-3 preferentially binds the vascular endothelial growth factor C and vascular endothelial growth factor D and may be involved in the control of lymphangiogenesis.%A%
% 210.35/210.54 |- mesh__dateCreated mesh__D040321 2002-07-03
% 210.35/210.54 |- skos__hiddenLabel mesh__D001908 Bovine Pestiviruses
% 210.35/210.54 |- mesh__dateEstablished mesh__D001908 1991-01-01
% 210.35/210.54 |- mesh__recordMaintainer mesh__D001908 ags
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001908 2006A
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001908 2005
% 210.35/210.54 |- skos__altLabel mesh__D001908 Diarrhea Virus, Bovine Viral
% 210.35/210.54 |- skos__scopeNote mesh__D001908
% 210.35/210.54 A group of viruses in the genus PESTIVIRUS, causing diarrhea, fever, oral ulcerations, hemorrhagic syndrome, and various necrotic lesions among cattle and other domestic animals. The two species %28%genotypes%29%, BVDV-1 and BVDV-2 , exhibit antigenic and pathological differences. The historical designation, BVDV, consisted of both %28%then unrecognized%29% genotypes.%A%
% 210.35/210.54 |- mesh__historyNote mesh__D001908 2002 %28%1975%29%
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D001908
% 210.35/210.54 2002; see DIARRHEA VIRUS, BOVINE VIRAL 1994-2001, see BOVINE DIARRHEA VIRUS 1991-1993, see PESTIVIRUSES 1981-1990, see RNA VIRUSES 1975-1980%A%
% 210.35/210.54 |- skos__hiddenLabel mesh__D001908 Diarrhea Viruses, Bovine
% 210.35/210.54 |- mesh__dateRevised mesh__D001908 2005-07-08
% 210.35/210.54 |- skos__altLabel mesh__D001908 Bovine Viral Diarrhea Viruses
% 210.35/210.54 |- skos__annotation mesh__D001908
% 210.35/210.54 historical only: prefer specifics; infection = BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE or HEMORRHAGIC SYNDROME, BOVINE%A%
% 210.35/210.54 |- mesh__recordOriginator mesh__D001908 NLM
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001908 2004
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D001908 ags
% 210.35/210.54 |- skos__altLabel mesh__D001908 Bovine Diarrhea Virus
% 210.35/210.54 |- rdf__type mesh__D001908sskos__Concept
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001908 2003
% 210.35/210.54 |- skos__prefLabel mesh__D001908 Diarrhea Viruses, Bovine Viral
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001908 2002
% 210.35/210.54 |- skos__hiddenLabel mesh__D001908 Diarrhea Virus, Bovine
% 210.35/210.54 |- skos__hiddenLabel mesh__D001908 Viruses, Bovine Diarrhea
% 210.35/210.54 |- skos__hiddenLabel mesh__D001908 Pestiviruses, Bovine
% 210.35/210.54 |- skos__altLabel mesh__D001908 Bovine Pestivirus
% 210.35/210.54 |- skos__hiddenLabel mesh__D001908 Bovine Diarrhea Viruses
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D001908 2006
% 210.35/210.54 |- mesh__dateCreated mesh__D001908 1974-12-12
% 210.35/210.54 |- skos__hiddenLabel mesh__D001908 Virus, Bovine Diarrhea
% 210.35/210.54 |- skos__broader mesh__D001908smesh__D010576
% 210.35/210.54 |- skos__broader mesh__D005333Q000254smesh__D005333
% 210.35/210.54 |- mesh__preferredCombination mesh__D005333Q000254smesh__D047109
% 210.35/210.54 |- rdf__type mesh__D005333Q000254smesh__CompoundConcept
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011538 2006
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011538 2002
% 210.35/210.54 |- skos__prefLabel mesh__D011538 Pruritus Ani
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011538 2004
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011538 2005
% 210.35/210.54 |- rdf__type mesh__D011538sskos__Concept
% 210.35/210.54 |- mesh__recordOriginator mesh__D011538 NLM
% 210.35/210.54 |- skos__annotation mesh__D011538 note spelling: -itus, not -itis
% 210.35/210.54 |- mesh__dateRevised mesh__D011538 1999-11-03
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011538 2003
% 210.35/210.54 |- mesh__recordMaintainer mesh__D011538 TPW
% 210.35/210.54 |- mesh__dateCreated mesh__D011538 1999-01-01
% 210.35/210.54 |- skos__broader mesh__D011538smesh__D001004
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011538 2001
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D011538 2000
% 210.35/210.54 |- skos__scopeNote mesh__D011538
% 210.35/210.54 Intense chronic itching in the anal area.
% 210.35/210.54 |- skos__broader mesh__D011538smesh__D011537
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D011538 sjn
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Psychiatric Will
% 210.35/210.54 |- skos__prefLabel mesh__D016223 Advance Directives
% 210.35/210.54 |- skos__broader mesh__D016223smesh__D032722
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Directive, Advance
% 210.35/210.54 |- mesh__recordAuthorizer mesh__D016223 sjn
% 210.35/210.54 |- rdf__type mesh__D016223sskos__Concept
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Directives, Advance
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Wills, Psychiatric
% 210.35/210.54 |- mesh__publicMeSHNote mesh__D016223 1991
% 210.35/210.54 |- mesh__recordOriginator mesh__D016223 TGC
% 210.35/210.54 |- mesh__dateCreated mesh__D016223 1990-06-01
% 210.35/210.54 |- mesh__dateEstablished mesh__D016223 1991-01-01
% 210.35/210.54 |- skos__related mesh__D016223smesh__D016414
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Contracts, Ulysses
% 210.35/210.54 |- skos__altLabel mesh__D016223 Ulysses Contracts
% 210.35/210.54 |- skos__altLabel mesh__D016223 Healthcare Power of Attorney
% 210.35/210.54 |- mesh__dateRevised mesh__D016223 2002-07-02
% 210.35/210.54 |- skos__broader mesh__D016223smesh__D007603
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Contract, Ulysses
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D016223 2005
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Ulysses Contract
% 210.35/210.54 |- mesh__recordMaintainer mesh__D016223 jrf
% 210.35/210.54 |- skos__historyNote mesh__D016223 Wills %28%1966-1990%29%
% 210.35/210.54 |- skos__related mesh__D016223smesh__D024362
% 210.35/210.54 |- skos__related mesh__D016223smesh__D012297
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Will, Psychiatric
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Attorney Medical Power
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Advance Directive
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D016223 2003
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D016223 2006
% 210.35/210.54 |- skos__scopeNote mesh__D016223
% 210.35/210.54 Declarations by patients, made in advance of a situation in which they may be incompetent to decide about their own care, stating their treatment preferences or authorizing a third party to make decisions for them. %28%Bioethics Thesaurus%29%%A%
% 210.35/210.54 |- skos__hiddenLabel mesh__D016223 Attorney Healthcare Power
% 210.35/210.54 |- skos__historyNote mesh__D016223 Right to Die %28%1987-1990%29%
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D016223 2004
% 210.35/210.54 |- mesh__historyNote mesh__D016223 1991
% 210.35/210.54 |- skos__hiddenLabel mesh__D002203 Punishment, Capital
% 210.35/210.54 |- skos__hiddenLabel mesh__D002203 Penalty, Death
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002203 2003
% 210.35/210.54 |- skos__prefLabel mesh__D002203 Capital Punishment
% 210.35/210.54 |- skos__hiddenLabel mesh__D002203 Electrocutions, Judicial
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002203 1998
% 210.35/210.54 |- mesh__dateRevised mesh__D002203 1997-06-20
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002203 2006
% 210.35/210.54 |- skos__annotation mesh__D002203
% 210.35/210.54 X ref ELECTROCUTION, JUDICIAL: do not index also under the electricity aspect unless particularly discussed%A%
% 210.35/210.54 |- skos__broader mesh__D002203smesh__D012926
% 210.35/210.54 |- skos__hiddenLabel mesh__D002203 Penalties, Death
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002203 2001
% 210.35/210.54 |- mesh__recordOriginator mesh__D002203 NLM
% 210.35/210.54 |- mesh__recordMaintainer mesh__D002203 TGC
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002203 2005
% 210.35/210.54 |- skos__altLabel mesh__D002203 Death Penalty
% 210.35/210.54 |- skos__hiddenLabel mesh__D002203 Punishments, Capital
% 210.35/210.54 |- mesh__activeMeSHYear mesh__D002203 2000
% 210.35/210.54 |- rdf__type mesh__D002203sskos__Concept
% 210.35/210.54 |- skos__hiddenLabel mesh__D002203 Capital Punishments
% 210.35/210.55 |- skos__scopeNote mesh__D002203
% 210.35/210.55 The use of the death penalty for certain crimes.
% 210.35/210.55 |- skos__hiddenLabel mesh__D002203 Death Penalties
% 210.35/210.55 |- mesh__dateCreated mesh__D002203 1999-01-01
% 210.35/210.55 |- skos__hiddenLabel mesh__D002203 Judicial Electrocutions
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002203 2004
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002203 2002
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002203 1999
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D002203 SJN
% 210.35/210.55 |- skos__hiddenLabel mesh__D002203 Judicial Electrocution
% 210.35/210.55 |- skos__annotation mesh__D007497
% 210.35/210.55 infection in insects: coord IM with specific insect /virol %28%IM%29%; infection in vertebrates: coord IM with DNA VIRUS INFECTIONS %28%IM%29%%A%
% 210.35/210.55 |- mesh__dateEstablished mesh__D007497 1978-01-01
% 210.35/210.55 |- skos__historyNote mesh__D007497 DNA Viruses %28%1966-1977%29%
% 210.35/210.55 |- mesh__dateCreated mesh__D007497 1977-05-04
% 210.35/210.55 |- mesh__historyNote mesh__D007497 1981 %28%1978%29%
% 210.35/210.55 |- skos__hiddenLabel mesh__D007497
% 210.35/210.55 Deoxyriboviruses, Icosahedral Cytoplasmic
% 210.35/210.55 |- skos__hiddenLabel mesh__D007497
% 210.35/210.55 Cytoplasmic Deoxyriboviruses, Icosahedral
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D007497
% 210.35/210.55 1981; see IRIDOVIRUSES 1978-80; for GOLDFISH VIRUSES see GOLDFISH VIRUS 1-LIKE VIRUSES 1997-2001, see IRIDOVIRIDAE 1994-96, see IRIDOVIRUSES 1978-80%A%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007497 2005
% 210.35/210.55 |- skos__prefLabel mesh__D007497 Iridoviridae
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D007497 sjn
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007497 2006
% 210.35/210.55 |- skos__hiddenLabel mesh__D007497 Chloriridoviruses
% 210.35/210.55 |- skos__scopeNote mesh__D007497
% 210.35/210.55 A family of large icosahedral DNA viruses infecting insects and poikilothermic vertebrates. Genera include IRIDOVIRUS; RANAVIRUS; Chloriridovirus, and Lymphocystivirus.%A%
% 210.35/210.55 |- mesh__recordOriginator mesh__D007497 AEP
% 210.35/210.55 |- skos__hiddenLabel mesh__D007497 Viruses, Goldfish
% 210.35/210.55 |- skos__broader mesh__D007497smesh__D004267
% 210.35/210.55 |- mesh__dateRevised mesh__D007497 2001-07-25
% 210.35/210.55 |- mesh__recordMaintainer mesh__D007497 ags
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007497 2002
% 210.35/210.55 |- rdf__type mesh__D007497sskos__Concept
% 210.35/210.55 |- skos__historyNote mesh__D007497 Insect Viruses %28%1966-1977%29%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007497 2003
% 210.35/210.55 |- skos__hiddenLabel mesh__D007497 Lymphocystiviruses
% 210.35/210.55 |- skos__hiddenLabel mesh__D007497 Goldfish Virus
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007497 2004
% 210.35/210.55 |- skos__altLabel mesh__D007497 Icosahedral Cytoplasmic Deoxyriboviruses
% 210.35/210.55 |- skos__prefLabel mesh__D001909 Leukemia Virus, Bovine
% 210.35/210.55 |- mesh__historyNote mesh__D001909
% 210.35/210.55 94; was BOVINE LEUKEMIA VIRUS 1977-93 %28%see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977%29%; was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76%A%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D001909 2002
% 210.35/210.55 |- skos__broader mesh__D001909smesh__D017977
% 210.35/210.55 |- skos__hiddenLabel mesh__D001909 Leukemia Virus, Cattle
% 210.35/210.55 |- skos__hiddenLabel mesh__D001909 Virus, Cattle Leukemia
% 210.35/210.55 |- skos__altLabel mesh__D001909 Bovine Leukemia Virus
% 210.35/210.55 |- skos__scopeNote mesh__D001909
% 210.35/210.55 The type species of DELTARETROVIRUS that causes a form of bovine lymphosarcoma %28%ENZOOTIC BOVINE LEUKOSIS%29% or persistent lymphocytosis.%A%
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D001909
% 210.35/210.55 94; was BOVINE LEUKEMIA VIRUS 1977-93 %28%see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977%29%; was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76%A%
% 210.35/210.55 |- mesh__dateRevised mesh__D001909 2001-08-03
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D001909 2004
% 210.35/210.55 |- skos__altLabel mesh__D001909 Cattle Leukemia Virus
% 210.35/210.55 |- skos__annotation mesh__D001909
% 210.35/210.55 a species of the genus DELTARETROVIRUS; infection = ENZOOTIC BOVINE LEUKOSIS%A%
% 210.35/210.55 |- rdf__type mesh__D001909sskos__Concept
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D001909 2003
% 210.35/210.55 |- mesh__recordMaintainer mesh__D001909 sjn
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D001909 2006
% 210.35/210.55 |- mesh__dateCreated mesh__D001909 1974-12-12
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D001909 sjn
% 210.35/210.55 |- mesh__recordOriginator mesh__D001909 NLM
% 210.35/210.55 |- mesh__dateEstablished mesh__D001909 1991-01-01
% 210.35/210.55 |- mesh__onlineNote mesh__D001909
% 210.35/210.55 use LEUKEMIA VIRUS, BOVINE to search BOVINE LEUKEMIA VIRUS 1977-93 %26% CATTLE LEUKEMIA VIRUS 1975-76%A%
% 210.35/210.55 |- skos__altLabel mesh__D001909 BLV
% 210.35/210.55 |- skos__hiddenLabel mesh__D001909 Virus, Bovine Leukemia
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D001909 2005
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012631 2006
% 210.35/210.55 |- skos__scopeNote mesh__D012631
% 210.35/210.55 A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity.%A%
% 210.35/210.55 |- mesh__recordOriginator mesh__D012631 NLM
% 210.35/210.55 |- skos__altLabel mesh__D012631 Flynn Brand of Secobarbital Sodium
% 210.35/210.55 |- mesh__dateCreated mesh__D012631 1999-01-01
% 210.35/210.55 |- mesh__recordMaintainer mesh__D012631 CCR
% 210.35/210.55 |- mesh__dateRevised mesh__D012631 2005-06-30
% 210.35/210.55 |- skos__altLabel mesh__D012631 Meballymal
% 210.35/210.55 |- rdf__type mesh__D012631sskos__Concept
% 210.35/210.55 |- skos__altLabel mesh__D012631 Quinalbarbitone
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D012631 sjn
% 210.35/210.55 |- skos__broader mesh__D012631smesh__D001463
% 210.35/210.55 |- skos__altLabel mesh__D012631 Vangard Brand of Secobarbital Sodium
% 210.35/210.55 |- skos__hiddenLabel mesh__D012631 Sodium, Secobarbital
% 210.35/210.55 |- skos__prefLabel mesh__D012631 Secobarbital
% 210.35/210.55 |- skos__altLabel mesh__D012631 Ranbaxy Brand of Secobarbital Sodium
% 210.35/210.55 |- mesh__recordMaintainer mesh__D036281 jls
% 210.35/210.55 |- mesh__historyNote mesh__D036281 2003
% 210.35/210.55 |- skos__scopeNote mesh__D036281
% 210.35/210.55 Research into the cause, transmission, amelioration, elimination, or enhancement of inherited disorders and traits.%A%
% 210.35/210.55 |- skos__broader mesh__D036281smesh__D005823
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D036281 2006
% 210.35/210.55 |- mesh__dateEstablished mesh__D036281 2003-01-01
% 210.35/210.55 |- mesh__dateCreated mesh__D036281 2002-07-03
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D036281 2004
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D036281 jls
% 210.35/210.55 |- mesh__dateRevised mesh__D036281 2002-10-31
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D036281 2005
% 210.35/210.55 |- skos__annotation mesh__D036281
% 210.35/210.55 genetic research as a field or the progress or status of genetic research; do not add routinely for specific research studies in genetics%A%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D036281 2003
% 210.35/210.55 |- skos__altLabel mesh__D036281 Research, Genetic
% 210.35/210.55 |- mesh__recordOriginator mesh__D036281 hjn
% 210.35/210.55 |- skos__prefLabel mesh__D036281 Genetic Research
% 210.35/210.55 |- skos__broader mesh__D036281smesh__D035843
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D036281 2003A
% 210.35/210.55 |- rdf__type mesh__D036281sskos__Concept
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D036281 2003
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D011539 2006
% 210.35/210.55 |- mesh__dateCreated mesh__D011539 1999-01-01
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D011539 2002
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D011539 2004
% 210.35/210.55 |- skos__broader mesh__D011539smesh__D011537
% 210.35/210.55 |- skos__scopeNote mesh__D011539
% 210.35/210.55 Intense itching of the external female genitals.
% 210.35/210.55 |- rdf__type mesh__D011539sskos__Concept
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D011539 sjn
% 210.35/210.55 |- skos__prefLabel mesh__D011539 Pruritus Vulvae
% 210.35/210.55 |- mesh__recordMaintainer mesh__D011539 PLS
% 210.35/210.55 |- skos__broader mesh__D011539smesh__D014845
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D011539 2000
% 210.35/210.55 |- mesh__recordOriginator mesh__D011539 NLM
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D011539 2005
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D011539 2001
% 210.35/210.55 |- mesh__dateRevised mesh__D011539 1999-11-03
% 210.35/210.55 |- skos__annotation mesh__D011539 note spelling: -itus, not -itis
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D011539 2003
% 210.35/210.55 |- skos__broader mesh__D008590smesh__D004660
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008590 2001
% 210.35/210.55 |- skos__annotation mesh__D008590
% 210.35/210.55 coord IM with precoord or specific infection term %28%IM%29% or other cause %28%IM%29%; DF: MENINGOENCEPH%A%
% 210.35/210.55 |- skos__scopeNote mesh__D008590
% 210.35/210.55 An inflammatory process involving the brain %28%ENCEPHALITIS%29% and meninges %28%MENINGITIS%29%, most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.%A%
% 210.35/210.55 |- rdf__type mesh__D008590sskos__Concept
% 210.35/210.55 |- mesh__recordOriginator mesh__D008590 NLM
% 210.35/210.55 |- skos__broader mesh__D008590smesh__D008581
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008590 2002
% 210.35/210.55 |- skos__altLabel mesh__D008590 Cerebromeningitis
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008590 2003
% 210.35/210.55 |- skos__hiddenLabel mesh__D008590 Cerebromeningitides
% 210.35/210.55 |- mesh__recordMaintainer mesh__D008590 KEV
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008590 2005
% 210.35/210.55 |- mesh__dateRevised mesh__D008590 1999-11-03
% 210.35/210.55 |- skos__prefLabel mesh__D008590 Meningoencephalitis
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008590 2004
% 210.35/210.55 |- skos__hiddenLabel mesh__D008590 Meningoencephalitides
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008590 2000
% 210.35/210.55 |- skos__broader mesh__D008590smesh__D002494
% 210.35/210.55 |- skos__hiddenLabel mesh__D008590 Encephalomeningitides
% 210.35/210.55 |- mesh__dateCreated mesh__D008590 1999-01-01
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D008590 sjn
% 210.35/210.55 |- skos__altLabel mesh__D008590 Encephalomeningitis
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008590 2006
% 210.35/210.55 |- mesh__recordMaintainer mesh__D022261 ssb
% 210.35/210.55 |- mesh__dateEstablished mesh__D022261 2001-01-01
% 210.35/210.55 |- mesh__recordOriginator mesh__D022261 ags
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D022261 sjn
% 210.35/210.55 |- skos__prefLabel mesh__D022261 Respiratory Syncytial Virus Vaccines
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D022261 2006
% 210.35/210.55 |- skos__scopeNote mesh__D022261
% 210.35/210.55 Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.%A%
% 210.35/210.55 |- skos__hiddenLabel mesh__D022261 Vaccines, RSV
% 210.35/210.55 |- mesh__dateCreated mesh__D022261 2000-06-22
% 210.35/210.55 |- skos__altLabel mesh__D022261 RSV Vaccines
% 210.35/210.55 |- skos__broader mesh__D022261smesh__D014765
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D022261 2001
% 210.35/210.55 |- mesh__historyNote mesh__D022261 2001
% 210.35/210.55 |- mesh__dateRevised mesh__D022261 2005-06-30
% 210.35/210.55 |- rdf__type mesh__D022261sskos__Concept
% 210.35/210.55 |- skos__historyNote mesh__D022261 Viral Vaccines %28%1966-2000%29%
% 210.35/210.55 |- mesh__historyNote mesh__D016224
% 210.35/210.55 91; was see RIGHT TO DIE 1987-90; was see WILLS 1977-86
% 210.35/210.55 |- mesh__recordMaintainer mesh__D016224 jls
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D016224 sjn
% 210.35/210.55 |- skos__broader mesh__D016224smesh__D016223
% 210.35/210.55 |- mesh__recordOriginator mesh__D016224 TGC
% 210.35/210.55 |- skos__hiddenLabel mesh__D016224 Living Will
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016224 2005
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D016224
% 210.35/210.55 91; was see RIGHT TO DIE 1987-90; was see WILLS 1977-86
% 210.35/210.55 |- skos__broader mesh__D016224smesh__D014918
% 210.35/210.55 |- skos__related mesh__D016224smesh__D012297
% 210.35/210.55 |- skos__prefLabel mesh__D016224 Living Wills
% 210.35/210.55 |- skos__historyNote mesh__D016224 Wills %28%1977-1986%29%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016224 2006
% 210.35/210.55 |- mesh__dateRevised mesh__D016224 2003-07-09
% 210.35/210.55 |- skos__hiddenLabel mesh__D016224 Will, Living
% 210.35/210.55 |- skos__scopeNote mesh__D016224
% 210.35/210.55 Written, witnessed declarations in which persons request that if they become disabled beyond reasonable expectation of recovery, they be allowed to die rather than be kept alive by extraordinary means. %28%Bioethics Thesaurus%29%%A%
% 210.35/210.55 |- skos__hiddenLabel mesh__D016224 Wills, Living
% 210.35/210.55 |- mesh__dateCreated mesh__D016224 1990-08-03
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016224 2004
% 210.35/210.55 |- skos__historyNote mesh__D016224 Right to Die %28%1987-1990%29%
% 210.35/210.55 |- rdf__type mesh__D016224sskos__Concept
% 210.35/210.55 |- mesh__onlineNote mesh__D016224
% 210.35/210.55 use RIGHT TO DIE to search LIVING WILLS 1987-90; use WILLS to search LIVING WILLS 1977-86%A%
% 210.35/210.55 |- mesh__dateEstablished mesh__D016224 1991-01-01
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D002204
% 210.35/210.55 91; was see under FEES AND CHARGES Aug 1977-90
% 210.35/210.55 |- mesh__dateRevised mesh__D002204 1997-06-20
% 210.35/210.55 |- skos__hiddenLabel mesh__D002204 Fees, Capitation
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002204 1998
% 210.35/210.55 |- skos__altLabel mesh__D002204 Fee, Capitation
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002204 2003
% 210.35/210.55 |- mesh__recordMaintainer mesh__D002204 JLS
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002204 2001
% 210.35/210.55 |- mesh__historyNote mesh__D002204
% 210.35/210.55 91%28%Aug 77%29%; was see under FEES AND CHARGES 1977-90
% 210.35/210.55 |- skos__scopeNote mesh__D002204
% 210.35/210.55 A method of payment for health services in which an individual or institutional provider is paid a fixed, per capita amount without regard to the actual number or nature of services provided to each patient.%A%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002204 2006
% 210.35/210.55 |- skos__hiddenLabel mesh__D002204 Capitation Fees
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002204 2000
% 210.35/210.55 |- rdf__type mesh__D002204sskos__Concept
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002204 2005
% 210.35/210.55 |- mesh__dateCreated mesh__D002204 1977-05-05
% 210.35/210.55 |- skos__prefLabel mesh__D002204 Capitation Fee
% 210.35/210.55 |- skos__broader mesh__D002204smesh__D005249
% 210.35/210.55 |- skos__annotation mesh__D002204
% 210.35/210.55 %22%capitation%22% refers to %22%a fixed per capita amt without regard to no. or nature of serv provided%22%%A%
% 210.35/210.55 |- mesh__dateEstablished mesh__D002204 1991-01-01
% 210.35/210.55 |- mesh__recordOriginator mesh__D002204 EC
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D002204 SJN
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002204 2002
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002204 1999
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002204 2004
% 210.35/210.55 |- skos__scopeNote mesh__D007498
% 210.35/210.55 The most anterior portion of the uveal layer, separating the anterior chamber from the posterior. It consists of two layers - the stroma and the pigmented epithelium. Color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium.%A%
% 210.35/210.55 |- rdf__type mesh__D007498sskos__Concept
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007498 2003
% 210.35/210.55 |- mesh__recordMaintainer mesh__D007498 ags
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007498 2002
% 210.35/210.55 |- skos__prefLabel mesh__D007498 Iris
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007498 2006
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007498 2001
% 210.35/210.55 |- skos__broader mesh__D007498smesh__D014602
% 210.35/210.55 |- mesh__dateCreated mesh__D007498 1999-01-01
% 210.35/210.55 |- skos__annotation mesh__D007498
% 210.35/210.55 inflammation = IRITIS but note IRIDOCYCLITIS is also available; color = EYE COLOR; /blood supply consider also CILIARY ARTERIES; pigmented epithelium of iris: coord IRIS with PIGMENT EPITHELIUM OF EYE%A%
% 210.35/210.55 |- mesh__dateRevised mesh__D007498 1999-11-03
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007498 2005
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D007498 sjn
% 210.35/210.55 |- mesh__recordOriginator mesh__D007498 NLM
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007498 2000
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007498 2004
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 2005
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 2001
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 1996
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D012632 68
% 210.35/210.55 |- mesh__historyNote mesh__D012632 68
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 2006
% 210.35/210.55 |- mesh__dateEstablished mesh__D012632 1968-01-01
% 210.35/210.55 |- mesh__dateCreated mesh__D012632 1999-01-01
% 210.35/210.55 |- skos__scopeNote mesh__D012632
% 210.35/210.55 Steroids in which fission of one or more ring structures and concomitant addition of a hydrogen atom at each terminal group has occurred.%A%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 1997
% 210.35/210.55 |- skos__broader mesh__D012632smesh__D013256
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 2003
% 210.35/210.55 |- skos__prefLabel mesh__D012632 Secosteroids
% 210.35/210.55 |- rdf__type mesh__D012632sskos__Concept
% 210.35/210.55 |- mesh__dateRevised mesh__D012632 1993-06-03
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 2002
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 2004
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 1994
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 1998
% 210.35/210.55 |- mesh__recordMaintainer mesh__D012632 PLS
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 1995
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 2000
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012632 1999
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D012632 PLS
% 210.35/210.55 |- mesh__recordOriginator mesh__D012632 NLM
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D008591
% 210.35/210.55 78; was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77%A%
% 210.35/210.55 |- skos__scopeNote mesh__D008591
% 210.35/210.55 Congenital, or rarely acquired, herniation of meningeal and spinal cord tissue through a bony defect in the vertebral column. The majority of these defects occur in the lumbosacral region. Clinical features include PARAPLEGIA, loss of sensation in the lower body, and incontinence. This condition may be associated with the ARNOLD-CHIARI MALFORMATION and HYDROCEPHALUS. %28%From Joynt, Clinical Neurology, 1992, Ch55, pp35-6%29%%A%
% 210.35/210.55 |- skos__hiddenLabel mesh__D008591 Myeloceles
% 210.35/210.55 |- skos__hiddenLabel mesh__D008591 Meningomyeloceles
% 210.35/210.55 |- skos__altLabel mesh__D008591 Myelomeningocele
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008591 2006
% 210.35/210.55 |- skos__hiddenLabel mesh__D008591 Acquired Myelomeningocele
% 210.35/210.55 |- skos__hiddenLabel mesh__D008591 Myelomeningoceles
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008591 2002
% 210.35/210.55 |- mesh__dateCreated mesh__D008591 1999-01-01
% 210.35/210.55 |- mesh__dateRevised mesh__D008591 1999-11-03
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D008591 sjn
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008591 2005
% 210.35/210.55 |- mesh__dateEstablished mesh__D008591 1978-01-01
% 210.35/210.55 |- mesh__onlineNote mesh__D008591
% 210.35/210.55 search SPINA BIFIDA 1966-74; use SPINA BIFIDA to search MYELOCELE 1966-77%A%
% 210.35/210.55 |- rdf__type mesh__D008591sskos__Concept
% 210.35/210.55 |- skos__prefLabel mesh__D008591 Meningomyelocele
% 210.35/210.55 |- skos__hiddenLabel mesh__D008591 Myelomeningoceles, Acquired
% 210.35/210.55 |- skos__hiddenLabel mesh__D008591 Acquired Meningomyeloceles
% 210.35/210.55 |- mesh__recordMaintainer mesh__D008591 KEV
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008591 2001
% 210.35/210.55 |- mesh__recordOriginator mesh__D008591 NLM
% 210.35/210.55 |- skos__altLabel mesh__D008591 Myelomeningocele, Acquired
% 210.35/210.55 |- mesh__historyNote mesh__D008591
% 210.35/210.55 78%28%75%29%; was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77%A%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008591 2004
% 210.35/210.55 |- skos__hiddenLabel mesh__D008591 Meningomyelocele, Acquired
% 210.35/210.55 |- skos__historyNote mesh__D008591 Spina Bifida %28%1966-1974%29%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008591 2000
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008591 2003
% 210.35/210.55 |- skos__hiddenLabel mesh__D008591 Meningomyeloceles, Acquired
% 210.35/210.55 |- skos__hiddenLabel mesh__D008591 Acquired Myelomeningoceles
% 210.35/210.55 |- skos__broader mesh__D008591smesh__D009436
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 1994
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 2005
% 210.35/210.55 |- mesh__dateEstablished mesh__D002205 1991-01-01
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D002205 PLS
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 1995
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 1996
% 210.35/210.55 |- skos__hiddenLabel mesh__D002205 Syndrome, Caplan%27%s
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D002205
% 210.35/210.55 91,63-83; was see under PNEUMOCONIOSIS 1984-90; was heading 1963-83%A%
% 210.35/210.55 |- skos__annotation mesh__D002205
% 210.35/210.55 %22%pneumoconiosis assoc with rheum arthritis%22%; do not coord with OCCUPATIONAL DISEASES%A%
% 210.35/210.55 |- mesh__dateCreated mesh__D002205 1999-01-01
% 210.35/210.55 |- skos__prefLabel mesh__D002205 Caplan%27%s Syndrome
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 2006
% 210.35/210.55 |- mesh__recordMaintainer mesh__D002205 TGC
% 210.35/210.55 |- skos__scopeNote mesh__D002205
% 210.35/210.55 Pneumoconiosis associated with rheumatoid arthritis.
% 210.35/210.55 |- mesh__historyNote mesh__D002205
% 210.35/210.55 91%28%84%29%63; was see under PNEUMOCONIOSIS 1984-90; was heading 1963-83%A%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 1997
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 2000
% 210.35/210.55 |- rdf__type mesh__D002205sskos__Concept
% 210.35/210.55 |- mesh__recordOriginator mesh__D002205 NLM
% 210.35/210.55 |- skos__broader mesh__D002205smesh__D011009
% 210.35/210.55 |- skos__broader mesh__D002205smesh__D001172
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 1998
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 2001
% 210.35/210.55 |- mesh__dateRevised mesh__D002205 1993-03-03
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 2003
% 210.35/210.55 |- skos__hiddenLabel mesh__D002205 Caplans Syndrome
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 1999
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 2002
% 210.35/210.55 |- skos__hiddenLabel mesh__D002205 Caplan Syndrome
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D002205 2004
% 210.35/210.55 |- mesh__dateCreated mesh__D007499 1980-04-07
% 210.35/210.55 |- mesh__dateEstablished mesh__D007499 1981-01-01
% 210.35/210.55 |- skos__broader mesh__D007499smesh__D014603
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 2000
% 210.35/210.55 |- skos__prefLabel mesh__D007499 Iris Diseases
% 210.35/210.55 |- mesh__dateRevised mesh__D007499 1993-06-03
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 1994
% 210.35/210.55 |- skos__scopeNote mesh__D007499
% 210.35/210.55 Diseases, dysfunctions, or disorders of or located in the iris.%A%
% 210.35/210.55 |- mesh__recordMaintainer mesh__D007499 PLS
% 210.35/210.55 |- skos__historyNote mesh__D007499 Uveal Diseases %28%1966-1980%29%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 1999
% 210.35/210.55 |- skos__hiddenLabel mesh__D007499 Disease, Iris
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 2006
% 210.35/210.55 |- mesh__historyNote mesh__D007499 81
% 210.35/210.55 |- skos__historyNote mesh__D007499 Iris %28%1966-1980%29%
% 210.35/210.55 |- skos__hiddenLabel mesh__D007499 Iris Disease
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 1998
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 2005
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D007499 81
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 2002
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 1997
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 2004
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 2001
% 210.35/210.55 |- rdf__type mesh__D007499sskos__Concept
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 1996
% 210.35/210.55 |- mesh__recordOriginator mesh__D007499 RC
% 210.35/210.55 |- skos__hiddenLabel mesh__D007499 Diseases, Iris
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 1995
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D007499 2003
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D007499 PLS
% 210.35/210.55 |- skos__broader mesh__D005947Q000652smesh__D005947
% 210.35/210.55 |- mesh__preferredCombination mesh__D005947Q000652smesh__D006029
% 210.35/210.55 |- rdf__type mesh__D005947Q000652smesh__CompoundConcept
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D012633 2006
% 210.35/210.55 |- skos__broader mesh__D012633smesh__D036361
% 210.35/210.55 |- mesh__dateCreated mesh__D012633 1999-01-01
% 210.35/210.55 |- skos__hiddenLabel mesh__D012633 Pig Secretin Maleate
% 210.35/210.55 |- mesh__recordOriginator mesh__D012633 NLM
% 210.35/210.55 |- rdf__type mesh__D012633sskos__Concept
% 210.35/210.55 |- skos__broader mesh__D012633smesh__D005768
% 210.35/210.55 |- skos__hiddenLabel mesh__D012633 Pig Secretin
% 210.35/210.55 |- skos__prefLabel mesh__D012633 Secretin
% 210.35/210.55 |- mesh__recordMaintainer mesh__D012633 ssb
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D012633 sjn
% 210.35/210.55 |- skos__hiddenLabel mesh__D012633 Pig Secretin Citrate
% 210.35/210.55 |- mesh__dateRevised mesh__D012633 2005-06-30
% 210.35/210.55 |- skos__broader mesh__D012633smesh__D009479
% 210.35/210.55 |- skos__hiddenLabel mesh__D012633 Pig Secretin Sulfate
% 210.35/210.55 |- skos__scopeNote mesh__D012633
% 210.35/210.55 A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. %28%USAN and the USP Dictionary of Drug Names, 1994, p597%29%%A%
% 210.35/210.55 |- skos__hiddenLabel mesh__D012633 Pig Secretin Pentacetate
% 210.35/210.55 |- skos__broader mesh__D008592smesh__D007719
% 210.35/210.55 |- skos__altLabel mesh__D008592 Lateral Menisci
% 210.35/210.55 |- mesh__dateCreated mesh__D008592 1999-01-01
% 210.35/210.55 |- mesh__dateRevised mesh__D008592 2005-06-30
% 210.35/210.55 |- skos__hiddenLabel mesh__D008592 Lateral Meniscus
% 210.35/210.55 |- mesh__historyNote mesh__D008592 87; was SEMILUNAR CARTILAGES 1963-86
% 210.35/210.55 |- rdf__type mesh__D008592sskos__Concept
% 210.35/210.55 |- mesh__recordMaintainer mesh__D008592 ags
% 210.35/210.55 |- skos__hiddenLabel mesh__D008592 Medial Meniscus
% 210.35/210.55 |- skos__hiddenLabel mesh__D008592 Meniscus, Lateral
% 210.35/210.55 |- skos__hiddenLabel mesh__D008592 Meniscus, Medial
% 210.35/210.55 |- skos__hiddenLabel mesh__D008592 Meniscus, Tibial
% 210.35/210.55 |- mesh__publicMeSHNote mesh__D008592
% 210.35/210.55 87; was SEMILUNAR CARTILAGES 1963-86
% 210.35/210.55 |- skos__altLabel mesh__D008592 Menisci, Medial
% 210.35/210.55 |- mesh__recordAuthorizer mesh__D008592 sjn
% 210.35/210.55 |- skos__hiddenLabel mesh__D008592 Cartilages, Semilunar
% 210.35/210.55 |- skos__scopeNote mesh__D008592
% 210.35/210.55 The interarticular fibrocartilages of the superior surface of the tibia.%A%
% 210.35/210.55 |- mesh__onlineNote mesh__D008592
% 210.35/210.55 use MENISCI, TIBIAL to search SEMILUNAR CARTILAGES 1966-86%A%
% 210.35/210.55 |- skos__hiddenLabel mesh__D008592 Semilunar Cartilage
% 210.35/210.55 |- skos__altLabel mesh__D008592 Tibial Menisci
% 210.35/210.55 |- skos__altLabel mesh__D008592 Semilunar Cartilages
% 210.35/210.55 |- skos__broader mesh__D008592smesh__D051445
% 210.35/210.55 |- skos__hiddenLabel mesh__D008592 Cartilage, Semilunar
% 210.35/210.55 |- skos__prefLabel mesh__D008592 Menisci, Tibial
% 210.35/210.55 |- skos__hiddenLabel mesh__D008592 Tibial Meniscus
% 210.35/210.55 |- mesh__recordOriginator mesh__D008592 NLM
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D008592 2006
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016226 1997
% 210.35/210.55 |- skos__historyNote mesh__D016226 Phosphorus %28%1966-1990%29%
% 210.35/210.55 |- skos__prefLabel mesh__D016226 Phosphorus, Dietary
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016226 2004
% 210.35/210.55 |- mesh__historyNote mesh__D016226 91
% 210.35/210.55 |- rdf__type mesh__D016226sskos__Concept
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016226 1994
% 210.35/210.55 |- mesh__dateCreated mesh__D016226 1990-05-07
% 210.35/210.55 |- skos__broader mesh__D016226smesh__D017553
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016226 2000
% 210.35/210.55 |- mesh__recordOriginator mesh__D016226 RLS
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016226 1995
% 210.35/210.55 |- mesh__dateEstablished mesh__D016226 1991-01-01
% 210.35/210.55 |- skos__annotation mesh__D016226
% 210.35/210.55 /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther%A%
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016226 2001
% 210.35/210.55 |- skos__altLabel mesh__D016226 Dietary Phosphorus
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016226 1998
% 210.35/210.55 |- mesh__dateRevised mesh__D016226 1993-06-02
% 210.35/210.55 |- mesh__activeMeSHYear mesh__D016226 2005
% 210.35/210.56 |- mesh__recordMaintainer mesh__D016226 TPW
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D016226 91
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016226 2002
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016226 1999
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016226 1996
% 210.35/210.56 |- skos__scopeNote mesh__D016226
% 210.35/210.56 Phosphorus used in foods or obtained from food. This element is a major intracellular component which plays an important role in many biochemical pathways relating to normal physiological functions. High concentrations of dietary phosphorus can cause nephrocalcinosis which is associated with impaired kidney function. Low concentrations of dietary phosphorus cause an increase in calcitriol in the blood and osteoporosis.%A%
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016226 2006
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016226 2003
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D016226 PLS
% 210.35/210.56 |- mesh__dateCreated mesh__D002206 1981-05-20
% 210.35/210.56 |- skos__prefLabel mesh__D002206 Capnocytophaga
% 210.35/210.56 |- skos__historyNote mesh__D002206 Bacteroides %28%1975-1981%29%
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D002206 2006
% 210.35/210.56 |- skos__scopeNote mesh__D002206
% 210.35/210.56 A gram-negative gliding bacterium isolated from the oral cavity. It is a pathogen often causing PERIODONTITIS.%A%
% 210.35/210.56 |- skos__broader mesh__D002206smesh__D041965
% 210.35/210.56 |- mesh__dateRevised mesh__D002206 2005-06-30
% 210.35/210.56 |- rdf__type mesh__D002206sskos__Concept
% 210.35/210.56 |- mesh__historyNote mesh__D002206
% 210.35/210.56 91%28%82%29%; was see under CYTOPHAGACEAE 1982-90
% 210.35/210.56 |- mesh__recordMaintainer mesh__D002206 SYSTEM
% 210.35/210.56 |- skos__annotation mesh__D002206
% 210.35/210.56 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 210.35/210.56 |- mesh__recordOriginator mesh__D002206 RC
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D002206
% 210.35/210.56 91; was see under CYTOPHAGACEAE 1982-90
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D002206 sjn
% 210.35/210.56 |- skos__broader mesh__D002206smesh__D006092
% 210.35/210.56 |- skos__historyNote mesh__D002206 Cytophagaceae %28%1975-1981%29%
% 210.35/210.56 |- mesh__dateEstablished mesh__D002206 1991-01-01
% 210.35/210.56 |- skos__hiddenLabel mesh__D048308
% 210.35/210.56 Cytokine Suppressive Anti inflammatory Drug Binding Protein
% 210.35/210.56 |- skos__altLabel mesh__D048308 SAPK2a
% 210.35/210.56 |- skos__altLabel mesh__D048308 MAPK14
% 210.35/210.56 |- skos__altLabel mesh__D048308 Kinase CSBP
% 210.35/210.56 |- skos__hiddenLabel mesh__D048308 MAP Kinase, p38alpha
% 210.35/210.56 |- skos__hiddenLabel mesh__D048308 MAX Interacting Protein 2
% 210.35/210.56 |- skos__altLabel mesh__D048308 p38alpha MAP Kinase
% 210.35/210.56 |- skos__altLabel mesh__D048308 Mxi2 Protein
% 210.35/210.56 |- skos__altLabel mesh__D048308 CSAID-Binding Protein
% 210.35/210.56 |- skos__hiddenLabel mesh__D048308 Stress activated protein kinase 2a
% 210.35/210.56 |- skos__hiddenLabel mesh__D048308 Mitogen Activated Protein Kinase 14
% 210.35/210.56 |- skos__altLabel mesh__D048308 p38alpha Mitogen-Activated Protein Kinase
% 210.35/210.56 |- skos__hiddenLabel mesh__D048308 MAPK14 Mitogen Activated Protein Kinase
% 210.35/210.56 |- skos__historyNote mesh__D048308
% 210.35/210.56 Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1995-1999%29%
% 210.35/210.56 |- mesh__historyNote mesh__D048308 2005%28%1994%29%
% 210.35/210.56 |- skos__scopeNote mesh__D048308
% 210.35/210.56 A 38-kDa mitogen-activated protein kinase that is abundantly expressed in a broad variety of cell types. It is involved in the regulation of cellular stress responses as well as the control of proliferation and survival of many cell types. The kinase activity of the enzyme is inhibited by the pyridinyl-imidazole compound SB 203580.%A%
% 210.35/210.56 |- skos__hiddenLabel mesh__D048308
% 210.35/210.56 p38alpha Mitogen Activated Protein Kinase
% 210.35/210.56 |- skos__prefLabel mesh__D048308 Mitogen-Activated Protein Kinase 14
% 210.35/210.56 |- mesh__dateEstablished mesh__D048308 2005-01-01
% 210.35/210.56 |- skos__hiddenLabel mesh__D048308 CSBP, Kinase
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D048308 2005
% 210.35/210.56 |- mesh__recordOriginator mesh__D048308 jmp
% 210.35/210.56 |- skos__altLabel mesh__D048308
% 210.35/210.56 Cytokine Suppressive Anti-inflammatory Drug Binding Protein
% 210.35/210.56 |- rdf__type mesh__D048308sskos__Concept
% 210.35/210.56 |- skos__historyNote mesh__D048308
% 210.35/210.56 Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D048308
% 210.35/210.56 2005; MITOGEN-ACTIVATED PROTEIN KINASE 14 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2002-2004; CSAID-BINDING PROTEIN %26% KINASE CSBP were indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004; MXI2 PROTEIN was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000%A%
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D048308 sjn
% 210.35/210.56 |- skos__broader mesh__D048308smesh__D048051
% 210.35/210.56 |- skos__altLabel mesh__D048308 p38alphaMAPK
% 210.35/210.56 |- skos__hiddenLabel mesh__D048308 CSAID Binding Protein
% 210.35/210.56 |- mesh__dateCreated mesh__D048308 2004-07-07
% 210.35/210.56 |- skos__altLabel mesh__D048308 Stress-activated protein kinase 2a
% 210.35/210.56 |- skos__altLabel mesh__D048308 MAX-Interacting Protein 2
% 210.35/210.56 |- skos__altLabel mesh__D048308 MAPK14 Mitogen-Activated Protein Kinase
% 210.35/210.56 |- mesh__recordMaintainer mesh__D048308 jmp
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D048308 2006
% 210.35/210.56 |- skos__historyNote mesh__D012634 specific secretions %28%1966-1997%29%
% 210.35/210.56 |- skos__prefLabel mesh__D012634 Bodily Secretions
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012634 2002
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012634 1998
% 210.35/210.56 |- skos__hiddenLabel mesh__D012634 Bodily Secretion
% 210.35/210.56 |- mesh__dateRevised mesh__D012634 1997-06-20
% 210.35/210.56 |- skos__altLabel mesh__D012634 Secretions
% 210.35/210.56 |- skos__hiddenLabel mesh__D012634 Secretion
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012634 1999
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012634 2005
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012634 2000
% 210.35/210.56 |- mesh__recordMaintainer mesh__D012634 TGC
% 210.35/210.56 |- mesh__dateEstablished mesh__D012634 1998-01-01
% 210.35/210.56 |- skos__scopeNote mesh__D012634
% 210.35/210.56 Endogenous substances produced through the activity of intact cells of glands, tissues, or organs. They do not include hormones or enzymes.%A%
% 210.35/210.56 |- skos__historyNote mesh__D012634
% 210.35/210.56 specific organ/secretion %28%1966-1997%29%
% 210.35/210.56 |- mesh__recordOriginator mesh__D012634 NLM
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012634 2006
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012634 2001
% 210.35/210.56 |- mesh__dateCreated mesh__D012634 1999-01-01
% 210.35/210.56 |- mesh__historyNote mesh__D012634 98; use explode 1967-97
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D012634 98
% 210.35/210.56 |- skos__hiddenLabel mesh__D012634 Secretion, Bodily
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012634 2003
% 210.35/210.56 |- skos__annotation mesh__D012634
% 210.35/210.56 avoid: too general; prefer specific secretion or Cat A %26% D terms with /secret%A%
% 210.35/210.56 |- skos__hiddenLabel mesh__D012634 Secretions, Bodily
% 210.35/210.56 |- skos__broader mesh__D012634smesh__D005441
% 210.35/210.56 |- rdf__type mesh__D012634sskos__Concept
% 210.35/210.56 |- skos__historyNote mesh__D012634
% 210.35/210.56 specific substance/secretion %28%1966-1997%29%
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012634 2004
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D012634 SJN
% 210.35/210.56 |- rdf__type mesh__D050753sskos__Concept
% 210.35/210.56 |- skos__hiddenLabel mesh__D050753 Enoyl-ACP Reductase, NADH-Dependent
% 210.35/210.56 |- skos__hiddenLabel mesh__D050753 Reductase, NADH-Enoyl ACP
% 210.35/210.56 |- skos__prefLabel mesh__D050753
% 210.35/210.56 Enoyl-%28%Acyl-Carrier-Protein%29% Reductase %28%NADH%29%
% 210.35/210.56 |- skos__altLabel mesh__D050753 NADH-Enoyl ACP Reductase
% 210.35/210.56 |- skos__historyNote mesh__D050753 Acyl Carrier Protein %28%1978-1983%29%
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D050753 sjn
% 210.35/210.56 |- skos__hiddenLabel mesh__D050753 Reductase, NADH-Dependent Enoyl-ACP
% 210.35/210.56 |- skos__altLabel mesh__D050753
% 210.35/210.56 Enoyl%28%Acyl-Carrier-Protein%29% Reductase %28%NADH%29%
% 210.35/210.56 |- mesh__dateEstablished mesh__D050753 2006-01-01
% 210.35/210.56 |- skos__altLabel mesh__D050753 NADH-Dependent Enoyl-ACP Reductase
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D050753
% 210.35/210.56 2006; ENOYL-%5B%ACYL-CARRIER-PROTEIN%5D% REDUCTASE %28%NADH%29% was indexed under OXIDOREDUCTASES 1984-2005, under ACYL CARRIER PROTEIN 1978-1983, under CARRIER PROTEINS 1972-1979, and under PROTEINS 1970-1972%A%
% 210.35/210.56 |- skos__historyNote mesh__D050753 Proteins %28%1970-1972%29%
% 210.35/210.56 |- skos__historyNote mesh__D050753 Carrier Proteins %28%1972-1979%29%
% 210.35/210.56 |- skos__hiddenLabel mesh__D050753 NADH Enoyl ACP Reductase
% 210.35/210.56 |- mesh__recordMaintainer mesh__D050753 AKE
% 210.35/210.56 |- skos__scopeNote mesh__D050753
% 210.35/210.56 An NAD-dependent enzyme that catalyzes the oxidation of acyl-%5B%acyl-carrier protein%5D% to trans-2,3-dehydroacyl-%5B%acyl-carrier protein%5D%. It has a preference for acyl groups with a carbon chain length between 4 to 16.%A%
% 210.35/210.56 |- mesh__dateCreated mesh__D050753 2005-06-30
% 210.35/210.56 |- mesh__historyNote mesh__D050753 2006%28%1970%29%
% 210.35/210.56 |- skos__broader mesh__D050753smesh__D044925
% 210.35/210.56 |- mesh__recordOriginator mesh__D050753 AKE
% 210.35/210.56 |- skos__historyNote mesh__D050753 Oxidoreductases %28%1984-2005%29%
% 210.35/210.56 |- skos__hiddenLabel mesh__D050753 ACP Reductase, NADH-Enoyl
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D050753 2006
% 210.35/210.56 |- skos__hiddenLabel mesh__D050753 NADH Dependent Enoyl ACP Reductase
% 210.35/210.56 |- skos__altLabel mesh__D008593 Change of Life, Female
% 210.35/210.56 |- skos__related mesh__D008593smesh__D017698
% 210.35/210.56 |- skos__broader mesh__D008593smesh__D002979
% 210.35/210.56 |- mesh__recordOriginator mesh__D008593 NLM
% 210.35/210.56 |- skos__annotation mesh__D008593
% 210.35/210.56 PERIMENOPAUSE; PREMENOPAUSE; and POSTMENOPAUSE are available%A%
% 210.35/210.56 |- mesh__dateRevised mesh__D008593 2004-07-07
% 210.35/210.56 |- mesh__recordMaintainer mesh__D008593 lkt
% 210.35/210.56 |- skos__related mesh__D008593smesh__D015663
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D008593 2006
% 210.35/210.56 |- skos__prefLabel mesh__D008593 Menopause
% 210.35/210.56 |- mesh__dateCreated mesh__D008593 1999-01-01
% 210.35/210.56 |- skos__related mesh__D008593smesh__D015914
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D008593 2005
% 210.35/210.56 |- skos__scopeNote mesh__D008593
% 210.35/210.56 The last menstrual period. Permanent cessation of menses %28%MENSTRUATION%29% is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.%A%
% 210.35/210.56 |- rdf__type mesh__D008593sskos__Concept
% 210.35/210.56 |- skos__related mesh__D008593smesh__D019584
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D008593 sjn
% 210.35/210.56 |- skos__related mesh__D008593smesh__D017697
% 210.35/210.56 |- mesh__historyNote mesh__D016227 91
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016227 2004
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016227 2006
% 210.35/210.56 |- mesh__recordMaintainer mesh__D016227 ssb
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D016227 91
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D016227 sjn
% 210.35/210.56 |- skos__altLabel mesh__D016227 o-Benzoquinones
% 210.35/210.56 |- skos__altLabel mesh__D016227 p-Benzoquinones
% 210.35/210.56 |- skos__historyNote mesh__D016227 Quinones %28%1966-1990%29%
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016227 2005
% 210.35/210.56 |- mesh__dateRevised mesh__D016227 2003-07-09
% 210.35/210.56 |- rdf__type mesh__D016227sskos__Concept
% 210.35/210.56 |- skos__prefLabel mesh__D016227 Benzoquinones
% 210.35/210.56 |- skos__altLabel mesh__D016227 Benzodiones
% 210.35/210.56 |- mesh__recordOriginator mesh__D016227 RLS
% 210.35/210.56 |- mesh__dateCreated mesh__D016227 1990-05-07
% 210.35/210.56 |- skos__broader mesh__D016227smesh__D011809
% 210.35/210.56 |- skos__scopeNote mesh__D016227
% 210.35/210.56 Benzene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.%A%
% 210.35/210.56 |- mesh__dateEstablished mesh__D016227 1991-01-01
% 210.35/210.56 |- skos__broader mesh__D002207smesh__D010456
% 210.35/210.56 |- skos__hiddenLabel mesh__D002207 Sulfate, Capreomycin
% 210.35/210.56 |- skos__altLabel mesh__D002207 Elan Brand of Capreomycin Disulfate
% 210.35/210.56 |- mesh__dateRevised mesh__D002207 2004-07-07
% 210.35/210.56 |- skos__scopeNote mesh__D002207
% 210.35/210.56 Cyclic peptide antibiotic similar to VIOMYCIN. It is produced by Streptomyces capreolus.%A%
% 210.35/210.56 |- skos__altLabel mesh__D002207 Capastat
% 210.35/210.56 |- mesh__recordOriginator mesh__D002207 NLM
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D002207 sjn
% 210.35/210.56 |- mesh__historyNote mesh__D002207
% 210.35/210.56 96; was CAPREOMYCIN 1972-95 %28%Prov 1972-73%29%; CAPROMYCIN was see CAPREOMYCIN 1978-93%A%
% 210.35/210.56 |- skos__prefLabel mesh__D002207 Capreomycin Sulfate
% 210.35/210.56 |- mesh__dateEstablished mesh__D002207 1974-01-01
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D002207 2005
% 210.35/210.56 |- mesh__onlineNote mesh__D002207
% 210.35/210.56 use CAPREOMYCIN SULFATE to search CAPROMYCIN 1978-93
% 210.35/210.56 |- mesh__recordMaintainer mesh__D002207 ssb
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D002207
% 210.35/210.56 96; was CAPREOMYCIN 1974-95; CAPROMYCIN was see CAPREOMYCIN 1978-93%A%
% 210.35/210.56 |- mesh__dateCreated mesh__D002207 1999-01-01
% 210.35/210.56 |- skos__historyNote mesh__D002207 Antitubercular Agents %28%1966-1971%29%
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D002207 2006
% 210.35/210.56 |- skos__altLabel mesh__D002207 Dista Brand of Capreomycin Disulfate
% 210.35/210.56 |- skos__altLabel mesh__D002207 Capromycin
% 210.35/210.56 |- rdf__type mesh__D002207sskos__Concept
% 210.35/210.56 |- skos__altLabel mesh__D002207 Lilly Brand of Capreomycin Disulfate
% 210.35/210.56 |- skos__hiddenLabel mesh__D048309 Short-Tailed Opossums
% 210.35/210.56 |- skos__scopeNote mesh__D048309
% 210.35/210.56 A genus of short-tailed OPOSSUMS in the family Didelphidae found in South American, chiefly Brazil. They are opossums least well-adapted to arboreal life.%A%
% 210.35/210.56 |- skos__hiddenLabel mesh__D048309 Short-Tailed Opossum
% 210.35/210.56 |- mesh__recordMaintainer mesh__D048309 jls
% 210.35/210.56 |- skos__historyNote mesh__D048309 Opossums %28%1969-2004%29%
% 210.35/210.56 |- mesh__historyNote mesh__D048309 2005; use OPOSSUMS 1995-2004
% 210.35/210.56 |- skos__broader mesh__D048309smesh__D009893
% 210.35/210.56 |- skos__prefLabel mesh__D048309 Monodelphis
% 210.35/210.56 |- skos__hiddenLabel mesh__D048309 Opossum, Short-Tailed
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D048309 jls
% 210.35/210.56 |- skos__hiddenLabel mesh__D048309 Opossums, Short Tailed
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D048309 2005; see OPOSSUMS 1995-2004
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D048309 2005A
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D048309 2005
% 210.35/210.56 |- rdf__type mesh__D048309sskos__Concept
% 210.35/210.56 |- skos__altLabel mesh__D048309 Opossums, Short-Tailed
% 210.35/210.56 |- mesh__dateCreated mesh__D048309 2004-07-07
% 210.35/210.56 |- mesh__dateRevised mesh__D048309 2004-07-28
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D048309 2006
% 210.35/210.56 |- mesh__dateEstablished mesh__D048309 2005-01-01
% 210.35/210.56 |- mesh__recordOriginator mesh__D048309 ags
% 210.35/210.56 |- mesh__recordMaintainer mesh__D012635 nns
% 210.35/210.56 |- mesh__dateCreated mesh__D012635 1975-07-25
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D012635 sjn
% 210.35/210.56 |- mesh__recordOriginator mesh__D012635 SH
% 210.35/210.56 |- mesh__historyNote mesh__D012635
% 210.35/210.56 91%28%76%29%; was see under IMMUNOGLOBULIN FRAGMENTS 1976-90
% 210.35/210.56 |- skos__historyNote mesh__D012635 Colostrum %28%1973-1975%29%
% 210.35/210.56 |- mesh__dateRevised mesh__D012635 2005-06-30
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012635 2006
% 210.35/210.56 |- skos__historyNote mesh__D012635
% 210.35/210.56 Immunoglobulin Fragments %28%1973-1975%29%
% 210.35/210.56 |- skos__prefLabel mesh__D012635 Secretory Component
% 210.35/210.56 |- rdf__type mesh__D012635sskos__Concept
% 210.35/210.56 |- skos__altLabel mesh__D012635 Secretory Piece
% 210.35/210.56 |- skos__scopeNote mesh__D012635
% 210.35/210.56 The extracellular moiety of the POLYMERIC IMMUNOGLOBULIN RECEPTOR found alone or complexed with IGA or IGM, in a variety of external secretions %28%tears, bile, colostrum.%29% Secretory component is derived by proteolytic cleavage of the receptor during transcytosis. When immunoglobulins IgA and IgM are bound to the receptor, during their transcytosis secretory component becomes covalently attached to them generating SECRETORY IMMUNOGLOBULIN A or secretory IMMUNOGLOBULIN M.%A%
% 210.35/210.56 |- skos__historyNote mesh__D012635 IgA %28%1973-1975%29%
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D012635
% 210.35/210.56 91; was see under IMMUNOGLOBULIN FRAGMENTS 1976-90
% 210.35/210.56 |- mesh__dateEstablished mesh__D012635 1991-01-01
% 210.35/210.56 |- skos__broader mesh__D012635smesh__D050440
% 210.35/210.56 |- skos__broader mesh__D012635smesh__D007071
% 210.35/210.56 |- skos__broader mesh__D017320smesh__D011480
% 210.35/210.56 |- mesh__historyNote mesh__D017320 93
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D017320 2004
% 210.35/210.56 |- mesh__dateRevised mesh__D017320 2003-07-09
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D017320 2005
% 210.35/210.56 |- skos__annotation mesh__D017320 DF: HIV PROTEASE INHIB
% 210.35/210.56 |- skos__scopeNote mesh__D017320
% 210.35/210.56 Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly.%A%
% 210.35/210.56 |- mesh__dateCreated mesh__D017320 1992-05-20
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D017320 93
% 210.35/210.56 |- rdf__type mesh__D017320sskos__Concept
% 210.35/210.56 |- skos__hiddenLabel mesh__D017320 Inhibitors, HIV Protease
% 210.35/210.56 |- skos__broader mesh__D017320smesh__D019380
% 210.35/210.56 |- mesh__recordMaintainer mesh__D017320 ssb
% 210.35/210.56 |- skos__historyNote mesh__D017320 Antiviral Agents %28%1990-1992%29%
% 210.35/210.56 |- skos__historyNote mesh__D017320
% 210.35/210.56 HIV Protease/antagonists %26% inhibitors %28%1990-1992%29%
% 210.35/210.56 |- skos__prefLabel mesh__D017320 HIV Protease Inhibitors
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D017320 sjn
% 210.35/210.56 |- skos__hiddenLabel mesh__D017320 Protease Inhibitors, HIV
% 210.35/210.56 |- mesh__dateEstablished mesh__D017320 1993-01-01
% 210.35/210.56 |- mesh__recordOriginator mesh__D017320 AGS
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D017320 2006
% 210.35/210.56 |- skos__related mesh__D003300smesh__D002570
% 210.35/210.56 |- skos__related mesh__D003300smesh__D003301
% 210.35/210.56 |- skos__annotation mesh__D003300
% 210.35/210.56 Cu-63; Cu-65 = COPPER %28%IM%29% + ISOTOPES %28%NIM%29%; Cu-58-62, 64, 66-68 = COPPER RADIOISOTOPES %28%IM%29%%A%
% 210.35/210.56 |- mesh__dateRevised mesh__D003300 2005-06-30
% 210.35/210.56 |- rdf__type mesh__D003300sskos__Concept
% 210.35/210.56 |- mesh__recordOriginator mesh__D003300 NLM
% 210.35/210.56 |- skos__broader mesh__D003300smesh__D019216
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D003300 sjn
% 210.35/210.56 |- skos__hiddenLabel mesh__D003300 Copper Level, Serum
% 210.35/210.56 |- mesh__recordMaintainer mesh__D003300 ssb
% 210.35/210.56 |- skos__hiddenLabel mesh__D003300 Level, Serum Copper
% 210.35/210.56 |- mesh__dateCreated mesh__D003300 1999-01-01
% 210.35/210.56 |- skos__broader mesh__D003300smesh__D028561
% 210.35/210.56 |- skos__prefLabel mesh__D003300 Copper
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003300 2006
% 210.35/210.56 |- skos__scopeNote mesh__D003300
% 210.35/210.56 A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.%A%
% 210.35/210.56 |- skos__related mesh__D008594smesh__D016649
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D008594 sjn
% 210.35/210.56 |- skos__scopeNote mesh__D008594
% 210.35/210.56 The premature cessation of menses %28%MENSTRUATION%29% when the last menstrual period occurs in a woman under the age of 40. It is due to the depletion of OVARIAN FOLLICLES. Premature MENOPAUSE can be caused by diseases; OVARIECTOMY; RADIATION; chemicals; and chromosomal abnormalities.%A%
% 210.35/210.56 |- skos__broader mesh__D008594smesh__D010049
% 210.35/210.56 |- mesh__dateRevised mesh__D008594 2004-07-07
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D008594 2006
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D008594
% 210.35/210.56 91; was see under MENOPAUSE 1975-90
% 210.35/210.56 |- mesh__recordOriginator mesh__D008594 NLM
% 210.35/210.56 |- skos__hiddenLabel mesh__D008594 Premature Menopause
% 210.35/210.56 |- rdf__type mesh__D008594sskos__Concept
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D008594 2005
% 210.35/210.56 |- skos__prefLabel mesh__D008594 Menopause, Premature
% 210.35/210.56 |- mesh__recordMaintainer mesh__D008594 lkt
% 210.35/210.56 |- skos__broader mesh__D008594smesh__D008593
% 210.35/210.56 |- mesh__dateEstablished mesh__D008594 1991-01-01
% 210.35/210.56 |- mesh__dateCreated mesh__D008594 1974-11-11
% 210.35/210.56 |- mesh__historyNote mesh__D008594
% 210.35/210.56 91%28%75%29%; was see under MENOPAUSE 1975-90
% 210.35/210.56 |- skos__altLabel mesh__D016228 ECDGF
% 210.35/210.56 |- mesh__recordOriginator mesh__D016228 RLS
% 210.35/210.56 |- skos__altLabel mesh__D016228 Endothelial Growth Factor
% 210.35/210.56 |- skos__broader mesh__D016228smesh__D036341
% 210.35/210.56 |- mesh__dateRevised mesh__D016228 2005-07-13
% 210.35/210.56 |- skos__hiddenLabel mesh__D016228 Endothelial Cell Derived Growth Factors
% 210.35/210.56 |- skos__hiddenLabel mesh__D016228 alpha Endothelial Growth Factor
% 210.35/210.56 |- rdf__type mesh__D016228sskos__Concept
% 210.35/210.56 |- skos__historyNote mesh__D016228 Growth Substances %28%1966-1983%29%
% 210.35/210.56 |- skos__annotation mesh__D016228
% 210.35/210.56 do not confuse with EGF; %28%EPIDERMAL GROWTH FACTOR%29%
% 210.35/210.56 |- skos__related mesh__D016228smesh__D042461
% 210.35/210.56 |- skos__hiddenLabel mesh__D016228 Growth Factor, alpha-Endothelial
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D016228 91
% 210.35/210.56 |- skos__altLabel mesh__D016228 Endo-GF
% 210.35/210.56 |- skos__altLabel mesh__D016228 Endothelial Growth Factor Polypeptides
% 210.35/210.56 |- skos__historyNote mesh__D016228
% 210.35/210.56 Fibroblast Growth Factor %28%1984-1990%29%
% 210.35/210.56 |- skos__hiddenLabel mesh__D016228 Growth Factors, Endothelial
% 210.35/210.56 |- skos__hiddenLabel mesh__D016228 beta Endothelial Growth Factor
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D016228 ags
% 210.35/210.56 |- mesh__dateCreated mesh__D016228 1990-05-30
% 210.35/210.56 |- skos__prefLabel mesh__D016228 Endothelial Growth Factors
% 210.35/210.56 |- mesh__recordMaintainer mesh__D016228 ags
% 210.35/210.56 |- mesh__dateEstablished mesh__D016228 1991-01-01
% 210.35/210.56 |- mesh__historyNote mesh__D016228 91
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016228 2006A
% 210.35/210.56 |- skos__scopeNote mesh__D016228
% 210.35/210.56 These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences.%A%
% 210.35/210.56 |- skos__hiddenLabel mesh__D016228 Growth Factor, beta-Endothelial
% 210.35/210.56 |- skos__hiddenLabel mesh__D016228 Growth Factor, Endothelial
% 210.35/210.56 |- skos__altLabel mesh__D016228 Endothelial Cell-Derived Growth Factors
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D016228 2006
% 210.35/210.56 |- skos__prefLabel mesh__D002208 Caproates
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D002208 2004
% 210.35/210.56 |- skos__broader mesh__D002208smesh__D005232
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D002208 sjn
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D002208 2005
% 210.35/210.56 |- mesh__recordOriginator mesh__D002208 NLM
% 210.35/210.56 |- mesh__dateRevised mesh__D002208 2003-07-09
% 210.35/210.56 |- mesh__dateCreated mesh__D002208 1999-01-01
% 210.35/210.56 |- skos__broader mesh__D002208smesh__D000144
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D002208 2006
% 210.35/210.56 |- skos__altLabel mesh__D002208 Hexanoates
% 210.35/210.56 |- rdf__type mesh__D002208sskos__Concept
% 210.35/210.56 |- mesh__recordMaintainer mesh__D002208 ssb
% 210.35/210.56 |- mesh__dateEstablished mesh__D012636 1968-01-01
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 2002
% 210.35/210.56 |- mesh__recordOriginator mesh__D012636 NLM
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 1995
% 210.35/210.56 |- mesh__recordMaintainer mesh__D012636 TAP
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 1993
% 210.35/210.56 |- skos__broader mesh__D012636smesh__D008660
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 1999
% 210.35/210.56 |- skos__prefLabel mesh__D012636 Secretory Rate
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 1994
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 1997
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D012636 68
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 2001
% 210.35/210.56 |- skos__annotation mesh__D012636
% 210.35/210.56 NIM; restrict to secretion of endogenous substances %28%see MeSH definition%29%%A%
% 210.35/210.56 |- skos__hiddenLabel mesh__D012636 Secretory Rates
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 1998
% 210.35/210.56 |- skos__hiddenLabel mesh__D012636 Rates, Secretory
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 2006
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 2000
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 1996
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 2004
% 210.35/210.56 |- mesh__dateRevised mesh__D012636 1992-05-18
% 210.35/210.56 |- skos__scopeNote mesh__D012636
% 210.35/210.56 The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa.%A%
% 210.35/210.56 |- mesh__historyNote mesh__D012636 68%28%66%29%
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D012636 PLS
% 210.35/210.56 |- mesh__dateCreated mesh__D012636 1999-01-01
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 2005
% 210.35/210.56 |- rdf__type mesh__D012636sskos__Concept
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D012636 2003
% 210.35/210.56 |- skos__hiddenLabel mesh__D012636 Rate, Secretory
% 210.35/210.56 |- mesh__dateEstablished mesh__D017321 1993-01-01
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D017321 2003
% 210.35/210.56 |- skos__historyNote mesh__D017321 Drug Evaluation %28%1980-1992%29%
% 210.35/210.56 |- skos__altLabel mesh__D017321 Evaluation Studies, FDA Phase 1
% 210.35/210.56 |- skos__prefLabel mesh__D017321 Clinical Trials, Phase I
% 210.35/210.56 |- rdf__type mesh__D017321sskos__Concept
% 210.35/210.56 |- skos__altLabel mesh__D017321 Clinical Trials, Phase 1
% 210.35/210.56 |- skos__altLabel mesh__D017321 Drug Evaluation, FDA Phase 1
% 210.35/210.56 |- mesh__recordMaintainer mesh__D017321 tjk
% 210.35/210.56 |- mesh__dateCreated mesh__D017321 1992-05-13
% 210.35/210.56 |- skos__broader mesh__D017321smesh__D002986
% 210.35/210.56 |- skos__scopeNote mesh__D017321
% 210.35/210.56 Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range %28%if appropriate%29%. These tests also are used to determine pharmacologic and pharmacokinetic properties %28%toxicity, metabolism, absorption, elimination, and preferred route of administration%29%. They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.%A%
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D017321
% 210.35/210.56 93; DRUG EVALUATION, FDA PHASE I was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE I was EVALUATION STUDIES, DRUG, FDA PHASE I see DRUG EVALUATION 1982-92%A%
% 210.35/210.56 |- skos__annotation mesh__D017321
% 210.35/210.56 trial lasts about a year; for U.S. %26% foreign studies; for I/II clin trials, index under CLINICAL TRIALS, PHASE I + CLINICAL TRIALS, PHASE II; IM for articles %26% books about phase I clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE I; DF: CLIN TRIALS PHASE I%A%
% 210.35/210.56 |- skos__historyNote mesh__D017321 Clinical Trials %28%1980-1992%29%
% 210.35/210.56 |- mesh__recordOriginator mesh__D017321 TPW
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D017321 2006
% 210.35/210.56 |- skos__related mesh__D017321smesh__D033281
% 210.35/210.56 |- skos__altLabel mesh__D017321 Phase I Clinical Trials
% 210.35/210.56 |- mesh__dateRevised mesh__D017321 2002-07-03
% 210.35/210.56 |- mesh__onlineNote mesh__D017321
% 210.35/210.56 use DRUG EVALUATION to search DRUG EVALUATION, FDA PHASE I 1980-92 %26% EVALUATION STUDIES, DRUG, FDA PHASE I 1982-92%A%
% 210.35/210.56 |- skos__altLabel mesh__D017321 Phase 1 Clinical Trials
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D017321 2005
% 210.35/210.56 |- mesh__historyNote mesh__D017321
% 210.35/210.56 93; DRUG EVALUATION, FDA PHASE I was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE I was EVALUATION STUDIES, DRUG, FDA PHASE I see DRUG EVALUATION 1982-92%A%
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D017321 2004
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D017321 sjn
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 2003
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 1997
% 210.35/210.56 |- mesh__dateEstablished mesh__D003301 1988-01-01
% 210.35/210.56 |- mesh__dateCreated mesh__D003301 1987-04-06
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 2006
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 1996
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 2002
% 210.35/210.56 |- mesh__historyNote mesh__D003301 88
% 210.35/210.56 |- skos__scopeNote mesh__D003301
% 210.35/210.56 Unstable isotopes of copper that decay or disintegrate emitting radiation. Cu atoms with atomic weights 58-62, 64, and 66-68 are radioactive copper isotopes.%A%
% 210.35/210.56 |- skos__annotation mesh__D003301
% 210.35/210.56 Cu-58-62, 64, 66-68; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 1999
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 2005
% 210.35/210.56 |- skos__historyNote mesh__D003301 Copper %28%1966-1987%29%
% 210.35/210.56 |- skos__historyNote mesh__D003301 Radioisotopes %28%1966-1987%29%
% 210.35/210.56 |- skos__prefLabel mesh__D003301 Copper Radioisotopes
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 1995
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 1998
% 210.35/210.56 |- mesh__dateRevised mesh__D003301 1993-06-01
% 210.35/210.56 |- rdf__type mesh__D003301sskos__Concept
% 210.35/210.56 |- skos__broader mesh__D003301smesh__D011868
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D003301 PLS
% 210.35/210.56 |- mesh__publicMeSHNote mesh__D003301 88
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 1994
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 2001
% 210.35/210.56 |- mesh__recordMaintainer mesh__D003301 TPW
% 210.35/210.56 |- mesh__recordOriginator mesh__D003301 RLS
% 210.35/210.56 |- skos__hiddenLabel mesh__D003301 Radioisotopes, Copper
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 2004
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D003301 2000
% 210.35/210.56 |- mesh__dateRevised mesh__D008595 2005-06-30
% 210.35/210.56 |- mesh__dateCreated mesh__D008595 1999-01-01
% 210.35/210.56 |- skos__prefLabel mesh__D008595 Menorrhagia
% 210.35/210.56 |- skos__scopeNote mesh__D008595
% 210.35/210.56 Excessive uterine bleeding during MENSTRUATION.
% 210.35/210.56 |- mesh__recordMaintainer mesh__D008595 lkt
% 210.35/210.56 |- mesh__activeMeSHYear mesh__D008595 2006
% 210.35/210.56 |- skos__broader mesh__D008595smesh__D008599
% 210.35/210.56 |- mesh__recordAuthorizer mesh__D008595 sjn
% 210.35/210.56 |- skos__annotation mesh__D008595 do not confuse with METRORRHAGIA
% 210.35/210.57 |- rdf__type mesh__D008595sskos__Concept
% 210.35/210.57 |- skos__broader mesh__D008595smesh__D014592
% 210.35/210.57 |- skos__altLabel mesh__D008595 Hypermenorrhea
% 210.35/210.57 |- mesh__recordOriginator mesh__D008595 NLM
% 210.35/210.57 |- mesh__dateRevised mesh__D016229 2004-07-07
% 210.35/210.57 |- skos__hiddenLabel mesh__D016229 AD-AP, Amyloid
% 210.35/210.57 |- skos__hiddenLabel mesh__D016229 Alzheimer beta Protein
% 210.35/210.57 |- skos__altLabel mesh__D016229 beta-Amyloid Protein
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D016229 2006
% 210.35/210.57 |- skos__annotation mesh__D016229
% 210.35/210.57 /biosyn /drug eff /physiol /ultrastruct permitted
% 210.35/210.57 |- mesh__recordOriginator mesh__D016229 RLS
% 210.35/210.57 |- rdf__type mesh__D016229sskos__Concept
% 210.35/210.57 |- mesh__recordMaintainer mesh__D016229 nns
% 210.35/210.57 |- skos__hiddenLabel mesh__D016229 Amyloid beta Protein
% 210.35/210.57 |- skos__altLabel mesh__D016229
% 210.35/210.57 Amyloid Fibril Protein %28%Alzheimer%27%s%29%
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D016229 sjn
% 210.35/210.57 |- skos__prefLabel mesh__D016229 Amyloid beta-Protein
% 210.35/210.57 |- mesh__dateCreated mesh__D016229 1990-06-17
% 210.35/210.57 |- skos__hiddenLabel mesh__D016229 Amyloid AD AP
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D016229 2005
% 210.35/210.57 |- skos__hiddenLabel mesh__D016229 beta-Protein, Alzheimer
% 210.35/210.57 |- skos__altLabel mesh__D016229 ABP %28%Alzheimer%27%s%29%
% 210.35/210.57 |- skos__related mesh__D016229smesh__D016657
% 210.35/210.57 |- skos__hiddenLabel mesh__D016229 beta-Protein, Amyloid
% 210.35/210.57 |- skos__broader mesh__D016229smesh__D000682
% 210.35/210.57 |- skos__altLabel mesh__D016229 Amyloid AD-AP
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D016229 91
% 210.35/210.57 |- skos__altLabel mesh__D016229 Alzheimer beta-Protein
% 210.35/210.57 |- mesh__dateEstablished mesh__D016229 1991-01-01
% 210.35/210.57 |- skos__scopeNote mesh__D016229
% 210.35/210.57 A 4-kDa protein, 39-43 amino acids long, expressed by a gene located on chromosome 21. It is the major protein subunit of the vascular and plaque amyloid filaments in individuals with Alzheimer%27%s disease and in aged individuals with trisomy 21 %28%DOWN SYNDROME%29%. The protein is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.%A%
% 210.35/210.57 |- skos__hiddenLabel mesh__D016229 Protein A4, Amyloid
% 210.35/210.57 |- skos__altLabel mesh__D016229 Amyloid Protein A4
% 210.35/210.57 |- skos__hiddenLabel mesh__D016229 Protein, beta-Amyloid
% 210.35/210.57 |- skos__historyNote mesh__D016229 Amyloid %28%1966-1990%29%
% 210.35/210.57 |- mesh__historyNote mesh__D016229 91
% 210.35/210.57 |- skos__hiddenLabel mesh__D016229 beta Amyloid Protein
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D002209 2005
% 210.35/210.57 |- mesh__historyNote mesh__D002209
% 210.35/210.57 91%28%75%29%; was see under AZEPINES 1975-90
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D002209 2004
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D002209 91; was see under AZEPINES 1975-90
% 210.35/210.57 |- skos__broader mesh__D002209smesh__D007769
% 210.35/210.57 |- mesh__recordMaintainer mesh__D002209 CCR
% 210.35/210.57 |- skos__hiddenLabel mesh__D002209 Lactam, Aminocaproic
% 210.35/210.57 |- skos__broader mesh__D002209smesh__D001381
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D002209 2003
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D002209 2002
% 210.35/210.57 |- skos__altLabel mesh__D002209 Aminocaproic Lactam
% 210.35/210.57 |- mesh__dateCreated mesh__D002209 1974-11-19
% 210.35/210.57 |- skos__altLabel mesh__D002209 Hexahydro-2H-Azepin-2-One
% 210.35/210.57 |- skos__scopeNote mesh__D002209
% 210.35/210.57 Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation.%A%
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D002209 2001
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D002209 sjn
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D002209 2006
% 210.35/210.57 |- mesh__recordOriginator mesh__D002209 NLM
% 210.35/210.57 |- skos__hiddenLabel mesh__D002209 Hexahydro 2H Azepin 2 One
% 210.35/210.57 |- mesh__dateRevised mesh__D002209 2000-06-21
% 210.35/210.57 |- skos__historyNote mesh__D002209 Azepines %28%1968-1974%29%
% 210.35/210.57 |- skos__prefLabel mesh__D002209 Caprolactam
% 210.35/210.57 |- mesh__dateEstablished mesh__D002209 1991-01-01
% 210.35/210.57 |- rdf__type mesh__D002209sskos__Concept
% 210.35/210.57 |- rdf__type mesh__D051050sskos__Concept
% 210.35/210.57 |- mesh__dateEstablished mesh__D051050 2006-01-01
% 210.35/210.57 |- skos__hiddenLabel mesh__D051050 Acetyltransferase, Serine
% 210.35/210.57 |- skos__altLabel mesh__D051050 L-Serine O-Acetyltransferase
% 210.35/210.57 |- mesh__dateCreated mesh__D051050 2005-06-30
% 210.35/210.57 |- mesh__historyNote mesh__D051050
% 210.35/210.57 2006%28%1980%29%; use ACETYLTRANSFERASES %26% ACETYL COENZYME A 1973-1979, SERINE 1970-1979, %26% ACYLTRANSFERASES 1970-1973%A%
% 210.35/210.57 |- skos__hiddenLabel mesh__D051050 O-Acetyltransferase, L-Serine
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D051050 sjn
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D051050 2006
% 210.35/210.57 |- skos__hiddenLabel mesh__D051050 O-Acetyltransferase, Serine
% 210.35/210.57 |- skos__altLabel mesh__D051050 Serine Transacetylase
% 210.35/210.57 |- skos__altLabel mesh__D051050 Serine Acetyltransferase
% 210.35/210.57 |- skos__broader mesh__D051050smesh__D000123
% 210.35/210.57 |- skos__hiddenLabel mesh__D051050 Transacetylase, Serine
% 210.35/210.57 |- skos__hiddenLabel mesh__D051050 L Serine O Acetyltransferase
% 210.35/210.57 |- mesh__recordMaintainer mesh__D051050 AKE
% 210.35/210.57 |- mesh__recordOriginator mesh__D051050 AKE
% 210.35/210.57 |- skos__scopeNote mesh__D051050
% 210.35/210.57 An enzyme that catalyzes the conversion of L-SERINE to COENZYME A and O-acetyl-L-serine, using ACETYL-COA as a donor.%A%
% 210.35/210.57 |- skos__hiddenLabel mesh__D051050 Serine O Acetyltransferase
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D051050
% 210.35/210.57 2006; SERINE O-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, under ACETYL COENZYME A 1973-1980, under SERINE 1970-1980, %26% under ACYLTRANSFERASES 1970-1973%A%
% 210.35/210.57 |- skos__prefLabel mesh__D051050 Serine O-Acetyltransferase
% 210.35/210.57 |- skos__broader mesh__D012637smesh__D009934
% 210.35/210.57 |- mesh__historyNote mesh__D012637 78
% 210.35/210.57 |- skos__annotation mesh__D012637 med or non-med contexts
% 210.35/210.57 |- mesh__recordOriginator mesh__D012637 EC
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D012637 2006
% 210.35/210.57 |- skos__hiddenLabel mesh__D012637 Security Measure
% 210.35/210.57 |- skos__scopeNote mesh__D012637
% 210.35/210.57 Regulations to assure protection of property and equipment.%A%
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D012637 78
% 210.35/210.57 |- skos__hiddenLabel mesh__D012637 Security, National
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D012637 2004
% 210.35/210.57 |- mesh__recordMaintainer mesh__D012637 tjk
% 210.35/210.57 |- rdf__type mesh__D012637sskos__Concept
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D012637 2005
% 210.35/210.57 |- mesh__dateRevised mesh__D012637 2002-07-03
% 210.35/210.57 |- skos__hiddenLabel mesh__D012637 Measures, Security
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D012637 2003
% 210.35/210.57 |- skos__prefLabel mesh__D012637 Security Measures
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D012637 sjn
% 210.35/210.57 |- mesh__dateEstablished mesh__D012637 1978-01-01
% 210.35/210.57 |- skos__hiddenLabel mesh__D012637 Measure, Security
% 210.35/210.57 |- mesh__dateCreated mesh__D012637 1977-05-12
% 210.35/210.57 |- mesh__dateRevised mesh__D017322 2001-07-25
% 210.35/210.57 |- skos__prefLabel mesh__D017322 Clinical Trials, Phase II
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D017322 2002
% 210.35/210.57 |- mesh__dateEstablished mesh__D017322 1993-01-01
% 210.35/210.57 |- skos__scopeNote mesh__D017322
% 210.35/210.57 Studies that are usually controlled to assess the effectiveness and dosage %28%if appropriate%29% of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.%A%
% 210.35/210.57 |- skos__altLabel mesh__D017322 Phase 2 Clinical Trials
% 210.35/210.57 |- skos__historyNote mesh__D017322 Clinical Trials %28%1980-1992%29%
% 210.35/210.57 |- mesh__onlineNote mesh__D017322
% 210.35/210.57 use DRUG EVALUATION to search DRUG EVALUATION, FDA PHASE II 1980-92 %26% EVALUATION STUDIES, DRUG, FDA PHASE II 1982-92%A%
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D017322 2006
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D017322 sjn
% 210.35/210.57 |- skos__altLabel mesh__D017322 Evaluation Studies, FDA Phase 2
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D017322 2005
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D017322 2004
% 210.35/210.57 |- mesh__recordMaintainer mesh__D017322 ags
% 210.35/210.57 |- skos__altLabel mesh__D017322 Drug Evaluation, FDA Phase 2
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D017322 2003
% 210.35/210.57 |- skos__altLabel mesh__D017322 Clinical Trials, Phase 2
% 210.35/210.57 |- mesh__historyNote mesh__D017322
% 210.35/210.57 93; DRUG EVALUATION, FDA PHASE II was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE II was EVALUATION STUDIES, DRUG, FDA PHASE II see DRUG EVALUATION 1982-92%A%
% 210.35/210.57 |- rdf__type mesh__D017322sskos__Concept
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D017322
% 210.35/210.57 93; DRUG EVALUATION, FDA PHASE II was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE II was EVALUATION STUDIES, DRUG, FDA PHASE II see DRUG EVALUATION 1982-92%A%
% 210.35/210.57 |- mesh__dateCreated mesh__D017322 1992-05-13
% 210.35/210.57 |- skos__historyNote mesh__D017322 Drug Evaluation %28%1980-1992%29%
% 210.35/210.57 |- mesh__recordOriginator mesh__D017322 TPW
% 210.35/210.57 |- skos__broader mesh__D017322smesh__D002986
% 210.35/210.57 |- skos__altLabel mesh__D017322 Phase II Clinical Trials
% 210.35/210.57 |- skos__annotation mesh__D017322
% 210.35/210.57 trial lasts about 2 years; for U.S. %26% foreign studies; for I/II clin trials, index under CLINICAL TRIALS, PHASE I + CLINICAL TRIALS, PHASE II, for II/III clin trials, index under CLINICAL TRIALS, PHASE II + CLINICAL TRIALS, PHASE III; IM for articles %26% books about phase II clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE II; DF: CLIN TRIALS PHASE II%A%
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D050756 2006A
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756 CIP KIP CDKI Proteins
% 210.35/210.57 |- skos__altLabel mesh__D050756 INK4 CKI Proteins
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756 CDKI Proteins, CIP-KIP
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D050756 2006
% 210.35/210.57 |- mesh__recordOriginator mesh__D050756 DRC
% 210.35/210.57 |- skos__broader mesh__D050756smesh__D025521
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756 Inhibitor Proteins, Cyclin-Kinase
% 210.35/210.57 |- skos__altLabel mesh__D050756 CIP-KIP CDKI Proteins
% 210.35/210.57 |- mesh__recordMaintainer mesh__D050756 ags
% 210.35/210.57 |- skos__altLabel mesh__D050756 CIP-KIP CKI Proteins
% 210.35/210.57 |- rdf__type mesh__D050756sskos__Concept
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756 CKI Proteins, INK4
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756 CIP KIP CKI Proteins
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756
% 210.35/210.57 Inhibitors of Cyclin Dependent Kinase 4 Proteins
% 210.35/210.57 |- mesh__dateCreated mesh__D050756 2005-06-30
% 210.35/210.57 |- skos__altLabel mesh__D050756 CKI Proteins
% 210.35/210.57 |- skos__prefLabel mesh__D050756 Cyclin-Dependent Kinase Inhibitor Proteins
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756 CKI Proteins, CIP-KIP
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756
% 210.35/210.57 CIP KIP Cyclin Dependent Kinase Inhibitors
% 210.35/210.57 |- skos__altLabel mesh__D050756
% 210.35/210.57 Inhibitors of Cyclin-Dependent Kinase 4 Proteins
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756
% 210.35/210.57 Cyclin Dependent Kinase Inhibitor Proteins
% 210.35/210.57 |- skos__scopeNote mesh__D050756
% 210.35/210.57 A group of cell cycle proteins that negatively regulate the activity of CYCLIN/CYCLIN-DEPENDENT KINASE complexes. They inhibit CELL CYCLE progression and help control CELL PROLIFERATION following GENOTOXIC STRESS as well as during CELL DIFFERENTIATION.%A%
% 210.35/210.57 |- skos__altLabel mesh__D050756 Cyclin-Kinase Inhibitor Proteins
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756 INK4 Cyclin Dependent Kinase Inhibitors
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756 Cyclin Kinase Inhibitor Proteins
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D050756 ags
% 210.35/210.57 |- mesh__dateRevised mesh__D050756 2005-07-07
% 210.35/210.57 |- skos__altLabel mesh__D050756 INK4 CDKI Proteins
% 210.35/210.57 |- mesh__historyNote mesh__D050756 2006
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D050756 2006
% 210.35/210.57 |- skos__hiddenLabel mesh__D050756 CDKI Proteins, INK4
% 210.35/210.57 |- skos__altLabel mesh__D050756 CDKI Proteins
% 210.35/210.57 |- skos__broader mesh__D050756smesh__D018797
% 210.35/210.57 |- mesh__dateEstablished mesh__D050756 2006-01-01
% 210.35/210.57 |- mesh__dateRevised mesh__D003302 2005-06-30
% 210.35/210.57 |- skos__scopeNote mesh__D003302
% 210.35/210.57 A genus of black-spored basidiomycetous fungi of the family Coprinaceae, order Agaricales; some species are edible.%A%
% 210.35/210.57 |- mesh__recordOriginator mesh__D003302 NLM
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D003302
% 210.35/210.57 91; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A%
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D003302 sjn
% 210.35/210.57 |- mesh__historyNote mesh__D003302
% 210.35/210.57 91%28%75%29%; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A%
% 210.35/210.57 |- rdf__type mesh__D003302sskos__Concept
% 210.35/210.57 |- skos__prefLabel mesh__D003302 Coprinus
% 210.35/210.57 |- mesh__dateEstablished mesh__D003302 1991-01-01
% 210.35/210.57 |- mesh__recordMaintainer mesh__D003302 SYSTEM
% 210.35/210.57 |- skos__broader mesh__D003302smesh__D000363
% 210.35/210.57 |- mesh__dateCreated mesh__D003302 1974-12-12
% 210.35/210.57 |- skos__annotation mesh__D003302 a basidiomycete
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D003302 2006
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 CP90033
% 210.35/210.57 |- skos__altLabel mesh__D008596 Menopur
% 210.35/210.57 |- skos__altLabel mesh__D008596 Gonadotropins, Human Menopausal
% 210.35/210.57 |- mesh__historyNote mesh__D008596 73
% 210.35/210.57 |- skos__historyNote mesh__D008596
% 210.35/210.57 Gonadotropins, Pituitary %28%1966-1972%29%
% 210.35/210.57 |- mesh__dateEstablished mesh__D008596 1973-01-01
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 Menotropins Lepori Brand
% 210.35/210.57 |- mesh__dateCreated mesh__D008596 1999-01-01
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 CP 89044
% 210.35/210.57 |- skos__altLabel mesh__D008596 Organon Brand of Menotropins
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D008596 2006
% 210.35/210.57 |- skos__broader mesh__D008596smesh__D001688
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 Menotropins Serono Brand
% 210.35/210.57 |- skos__altLabel mesh__D008596 Organon Teknika Brand of Menotropins
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 Human Menopausal Gonadotropins
% 210.35/210.57 |- skos__altLabel mesh__D008596 Fustery Brand of Menotropins
% 210.35/210.57 |- skos__altLabel mesh__D008596 Lepori Brand of Menotropins
% 210.35/210.57 |- skos__related mesh__D008596smesh__D011967
% 210.35/210.57 |- skos__altLabel mesh__D008596 Ferring Brand of Menotropins
% 210.35/210.57 |- rdf__type mesh__D008596sskos__Concept
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 Lepori, HMG
% 210.35/210.57 |- skos__altLabel mesh__D008596 HMG Ferring
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 Pergonal 500
% 210.35/210.57 |- skos__scopeNote mesh__D008596
% 210.35/210.57 Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations.%A%
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 CP89044
% 210.35/210.57 |- skos__altLabel mesh__D008596 Menotrophin
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D008596 73
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D008596 sjn
% 210.35/210.57 |- skos__prefLabel mesh__D008596 Menotropins
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 Menotropins Organon Brand
% 210.35/210.57 |- mesh__dateRevised mesh__D008596 2005-06-30
% 210.35/210.57 |- skos__broader mesh__D008596smesh__D006065
% 210.35/210.57 |- skos__altLabel mesh__D008596 Serono Brand of Menotropins
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 CP 90033
% 210.35/210.57 |- mesh__recordOriginator mesh__D008596 NLM
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 Menotropins Fustery Brand
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 Menotropins Ferring Brand
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 ORG31338
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 Pergonal500
% 210.35/210.57 |- skos__hiddenLabel mesh__D008596 ORG 31338
% 210.35/210.57 |- mesh__recordMaintainer mesh__D008596 lkt
% 210.35/210.57 |- skos__broader mesh__D007239Q000517smesh__D007239
% 210.35/210.57 |- mesh__preferredCombination mesh__D007239Q000517smesh__D017053
% 210.35/210.57 |- rdf__type mesh__D007239Q000517smesh__CompoundConcept
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D013730 PLS
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 1998
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 2004
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 2000
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 1997
% 210.35/210.57 |- skos__hiddenLabel mesh__D013730 Compounds, Triphenyl
% 210.35/210.57 |- skos__prefLabel mesh__D013730 Terphenyl Compounds
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 2003
% 210.35/210.57 |- skos__historyNote mesh__D013730 Benzene Derivatives %28%1973-1974%29%
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D013730 75
% 210.35/210.57 |- mesh__dateCreated mesh__D013730 1974-11-11
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 1996
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 1995
% 210.35/210.57 |- mesh__dateRevised mesh__D013730 1992-05-20
% 210.35/210.57 |- mesh__recordOriginator mesh__D013730 NLM
% 210.35/210.57 |- skos__broader mesh__D013730smesh__D001555
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 2006
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 1994
% 210.35/210.57 |- skos__annotation mesh__D013730 DF: TERPHENYL CPDS
% 210.35/210.57 |- skos__hiddenLabel mesh__D013730 Compounds, Terphenyl
% 210.35/210.57 |- mesh__dateEstablished mesh__D013730 1975-09-01
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 2002
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 1999
% 210.35/210.57 |- mesh__historyNote mesh__D013730 75
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 2005
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 1993
% 210.35/210.57 |- mesh__recordMaintainer mesh__D013730 TGC
% 210.35/210.57 |- skos__scopeNote mesh__D013730
% 210.35/210.57 Compounds consisting of benzene rings linked to each other in either ortho, meta or para positions. Permitted are any substitutions, but ring fusion to any of the benzene rings is not allowed.%A%
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013730 2001
% 210.35/210.57 |- rdf__type mesh__D013730sskos__Concept
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D051051 2006
% 210.35/210.57 |- skos__hiddenLabel mesh__D051051 CoA-ACP Transacylase, Acetyl
% 210.35/210.57 |- skos__altLabel mesh__D051051
% 210.35/210.57 Acetyl Coenzyme A-Acyl Carrier Protein Transacylase
% 210.35/210.57 |- mesh__historyNote mesh__D051051
% 210.35/210.57 2006%28%1980%29%; use ACETYLTRANSFERASES 1970-1979, CARRIER PROTEINS 1973-1978, ACYL CARRIER PROTEIN 1978-1979, ACYLTRANSFERASES 1970-1973, ACETYL COENZYME A 1978-1979, %26% ACYLTRANSFERASES %26% PROTEINS 1970-1973%A%
% 210.35/210.57 |- skos__hiddenLabel mesh__D051051 Acetyl CoA ACP Transacylase
% 210.35/210.57 |- skos__hiddenLabel mesh__D051051 Acyl Carrier Protein S Acetyltransferase
% 210.35/210.57 |- skos__hiddenLabel mesh__D051051
% 210.35/210.57 S-Acetyltransferase, Acyl-Carrier Protein
% 210.35/210.57 |- mesh__recordMaintainer mesh__D051051 ags
% 210.35/210.57 |- skos__broader mesh__D051051smesh__D000123
% 210.35/210.57 |- skos__hiddenLabel mesh__D051051 Acetyl CoA Transacylase
% 210.35/210.57 |- skos__hiddenLabel mesh__D051051
% 210.35/210.57 Acetyl Coenzyme A Acyl Carrier Protein Transacylase
% 210.35/210.57 |- skos__altLabel mesh__D051051 Acetyl CoA-ACP Transacylase
% 210.35/210.57 |- mesh__dateEstablished mesh__D051051 2006-01-01
% 210.35/210.57 |- skos__altLabel mesh__D051051
% 210.35/210.57 %28%Acyl-Carrier-Protein%29% S-Acetyltransferase
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D051051 2006A
% 210.35/210.57 |- skos__scopeNote mesh__D051051
% 210.35/210.57 A enzyme that catalyzes the transfer of acetyl groups from ACETYL CoA to acyl-carrier protein to form COENZYME A and acetyl-acyl-carrier protein.%A%
% 210.35/210.57 |- rdf__type mesh__D051051sskos__Concept
% 210.35/210.57 |- mesh__dateCreated mesh__D051051 2005-06-30
% 210.35/210.57 |- skos__hiddenLabel mesh__D051051 Transacylase, Acetyl CoA-ACP
% 210.35/210.57 |- skos__prefLabel mesh__D051051 Acyl-Carrier Protein S-Acetyltransferase
% 210.35/210.57 |- skos__altLabel mesh__D051051
% 210.35/210.57 %28%Acyl-Carrier-Protein%29% Acetyltransferase
% 210.35/210.57 |- skos__hiddenLabel mesh__D051051
% 210.35/210.57 Protein S-Acetyltransferase, Acyl-Carrier
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D051051 ags
% 210.35/210.57 |- mesh__dateRevised mesh__D051051 2005-07-07
% 210.35/210.57 |- skos__altLabel mesh__D051051 Acetyl-CoA Transacylase
% 210.35/210.57 |- mesh__recordOriginator mesh__D051051 AKE
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D051051
% 210.35/210.57 2006; %28%ACYL-CARRIER-PROTEIN%29% S-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1970-2005, under CARRIER PROTEINS 1973-1978, ACYL CARRIER PROTEIN 1978-1982, ACYLTRANSFERASES 1970-1973, ACETYL COENZYME A 1978-1982, %26% under ACYLTRANSFERASES %26% PROTEINS 1970-1973%A%
% 210.35/210.57 |- skos__hiddenLabel mesh__D051051 Transacylase, Acetyl-CoA
% 210.35/210.57 |- mesh__dateRevised mesh__D017323 2005-06-30
% 210.35/210.57 |- mesh__dateCreated mesh__D017323 1992-05-20
% 210.35/210.57 |- mesh__recordOriginator mesh__D017323 TPW
% 210.35/210.57 |- skos__scopeNote mesh__D017323
% 210.35/210.57 The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy %28%HEMATOPORPHYRIN PHOTORADIATION%29%; to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of photodynamic therapy in the United States.%A%
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D017323 2006
% 210.35/210.57 |- skos__related mesh__D017323smesh__D006414
% 210.35/210.57 |- skos__altLabel mesh__D017323 DHP Ether
% 210.35/210.57 |- skos__historyNote mesh__D017323 Hematoporphyrins %28%1985-1992%29%
% 210.35/210.57 |- mesh__recordMaintainer mesh__D017323 ssb
% 210.35/210.57 |- mesh__dateEstablished mesh__D017323 1993-01-01
% 210.35/210.57 |- skos__broader mesh__D017323smesh__D017324
% 210.35/210.57 |- skos__altLabel mesh__D017323 Dihematoporphyrin Ester
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D017323 sjn
% 210.35/210.57 |- mesh__onlineNote mesh__D017323
% 210.35/210.57 use DIHEMATOPORPHYRIN ETHER %28%NM%29% to search DIHEMATOPORPHYRIN ETHER 1985-92%A%
% 210.35/210.57 |- rdf__type mesh__D017323sskos__Concept
% 210.35/210.57 |- skos__hiddenLabel mesh__D017323 Ether, Dihematoporphyrin
% 210.35/210.57 |- mesh__historyNote mesh__D017323
% 210.35/210.57 93; was DIHEMATOPORPHYRIN ETHER %28%NM%29% 1985-92
% 210.35/210.57 |- skos__prefLabel mesh__D017323 Dihematoporphyrin Ether
% 210.35/210.57 |- skos__altLabel mesh__D017323 Porfimer
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D017323
% 210.35/210.57 93; DIHEMATOPORPHYRIN ETHER was indexed under HEMATOPORPHYRINS 1985-92%A%
% 210.35/210.57 |- skos__broader mesh__D003303smesh__D001526
% 210.35/210.57 |- rdf__type mesh__D003303sskos__Concept
% 210.35/210.57 |- mesh__dateRevised mesh__D003303 2002-07-03
% 210.35/210.57 |- skos__historyNote mesh__D003303 Feces %28%1966-1969%29%
% 210.35/210.57 |- mesh__dateEstablished mesh__D003303 1970-01-01
% 210.35/210.57 |- mesh__recordMaintainer mesh__D003303 KEV
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D003303 2004
% 210.35/210.57 |- mesh__recordOriginator mesh__D003303 NLM
% 210.35/210.57 |- skos__broader mesh__D003303smesh__D012817
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D003303 2003
% 210.35/210.57 |- skos__scopeNote mesh__D003303 Eating of excrement.
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D003303 2006
% 210.35/210.57 |- mesh__dateCreated mesh__D003303 1999-01-01
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D003303 sjn
% 210.35/210.57 |- mesh__historyNote mesh__D003303 70
% 210.35/210.57 |- skos__prefLabel mesh__D003303 Coprophagia
% 210.35/210.57 |- skos__broader mesh__D003303smesh__D001068
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D003303 70
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D003303 2005
% 210.35/210.57 |- skos__annotation mesh__D003303 human %26% animal
% 210.35/210.57 |- mesh__dateRevised mesh__D008597 2005-07-27
% 210.35/210.57 |- skos__hiddenLabel mesh__D008597 Ovarian Cycles
% 210.35/210.57 |- skos__hiddenLabel mesh__D008597 Endometrial Cycles
% 210.35/210.57 |- mesh__historyNote mesh__D008597 85
% 210.35/210.57 |- mesh__recordMaintainer mesh__D008597 ags
% 210.35/210.57 |- skos__hiddenLabel mesh__D008597 Cycle, Ovarian
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D008597 ags
% 210.35/210.57 |- mesh__recordOriginator mesh__D008597 EC
% 210.35/210.57 |- skos__hiddenLabel mesh__D008597 Cycle, Endometrial
% 210.35/210.57 |- skos__annotation mesh__D008597
% 210.35/210.57 human %26% other primates only; for non-primates use ESTROUS CYCLE; do not confuse with MENSTRUATION%A%
% 210.35/210.57 |- mesh__dateEstablished mesh__D008597 1985-01-01
% 210.35/210.57 |- skos__hiddenLabel mesh__D008597 Cycles, Endometrial
% 210.35/210.57 |- skos__historyNote mesh__D008597 Menstruation %28%1966-1984%29%
% 210.35/210.57 |- skos__broader mesh__D008597smesh__D012098
% 210.35/210.57 |- skos__hiddenLabel mesh__D008597 Cycles, Menstrual
% 210.35/210.57 |- skos__scopeNote mesh__D008597
% 210.35/210.57 The period from onset of one menstrual bleeding %28%MENSTRUATION%29% to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.%A%
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D008597 2005
% 210.35/210.57 |- skos__hiddenLabel mesh__D008597 Cycle, Menstrual
% 210.35/210.57 |- skos__related mesh__D008597smesh__D030762
% 210.35/210.57 |- skos__hiddenLabel mesh__D008597 Menstrual Cycles
% 210.35/210.57 |- skos__hiddenLabel mesh__D008597 Cycles, Ovarian
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D008597 2006
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D008597 2006A
% 210.35/210.57 |- mesh__dateCreated mesh__D008597 1984-05-31
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D008597 85
% 210.35/210.57 |- skos__prefLabel mesh__D008597 Menstrual Cycle
% 210.35/210.57 |- rdf__type mesh__D008597sskos__Concept
% 210.35/210.57 |- mesh__dateCreated mesh__D013731 1999-01-01
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013731 2003
% 210.35/210.57 |- mesh__dateEstablished mesh__D013731 1968-01-01
% 210.35/210.57 |- skos__broader mesh__D013731smesh__D013037
% 210.35/210.57 |- skos__hiddenLabel mesh__D013731 Territorialities
% 210.35/210.57 |- skos__prefLabel mesh__D013731 Territoriality
% 210.35/210.57 |- skos__scopeNote mesh__D013731
% 210.35/210.57 Behavior in defense of an area against another individual or individuals primarily of the same species.%A%
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013731 2006
% 210.35/210.57 |- skos__annotation mesh__D013731 no qualif
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D013731 68
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013731 2005
% 210.35/210.57 |- mesh__recordOriginator mesh__D013731 NLM
% 210.35/210.57 |- mesh__recordMaintainer mesh__D013731 TGC
% 210.35/210.57 |- skos__historyNote mesh__D013731 Behavior, Animal %28%1966-1967%29%
% 210.35/210.57 |- rdf__type mesh__D013731sskos__Concept
% 210.35/210.57 |- mesh__dateRevised mesh__D013731 2002-07-03
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D013731 2004
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D013731 sjn
% 210.35/210.57 |- mesh__historyNote mesh__D013731 68
% 210.35/210.57 |- mesh__dateCreated mesh__D012639 1999-01-01
% 210.35/210.57 |- rdf__type mesh__D012639sskos__Concept
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D012639 2005
% 210.35/210.57 |- skos__altLabel mesh__D012639 Plant Zygotes
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D012639 2003
% 210.35/210.57 |- skos__broader mesh__D012639smesh__D005638
% 210.35/210.57 |- skos__related mesh__D012639smesh__D009754
% 210.35/210.57 |- skos__hiddenLabel mesh__D012639 Plant Zygote
% 210.35/210.57 |- mesh__onlineNote mesh__D012639
% 210.35/210.57 use EMBRYO, PLANT to search EMBRYOS, PLANT 1986-94
% 210.35/210.57 |- mesh__dateRevised mesh__D012639 2002-07-03
% 210.35/210.57 |- skos__annotation mesh__D012639
% 210.35/210.57 IM GEN or unspecified; for seed of specific plants, coord IM with plant %28%IM%29%, as sunflower seeds = SEEDS %28%IM%29% + HELIANTHUS %28%IM%29%; coord probably IM in genetics %26% space physiol, NIM in pharmacognosy, with specific plant %28%IM or NIM%29%%A%
% 210.35/210.57 |- mesh__historyNote mesh__D012639
% 210.35/210.57 63; EMBRYO, PLANT was EMBRYOS, PLANT see SEEDS 1986-94
% 210.35/210.57 |- skos__hiddenLabel mesh__D012639 Embryo, Plant
% 210.35/210.57 |- mesh__publicMeSHNote mesh__D012639
% 210.35/210.57 63; EMBRYO, PLANT was EMBRYOS, PLANT see SEEDS 1986-94
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D012639 sjn
% 210.35/210.57 |- skos__prefLabel mesh__D012639 Seeds
% 210.35/210.57 |- skos__altLabel mesh__D012639 Zygotes, Plant
% 210.35/210.57 |- skos__hiddenLabel mesh__D012639 Plant Embryo
% 210.35/210.57 |- skos__scopeNote mesh__D012639
% 210.35/210.57 The encapsulated embryos of flowering plants. They are used as is or for animal feed because of the high content of concentrated nutrients like starches, proteins, and fats. Rapeseed, cottonseed, and sunflower seed are also produced for the oils %28%fats%29% they yield.%A%
% 210.35/210.57 |- skos__altLabel mesh__D012639 Plant Embryos
% 210.35/210.57 |- skos__hiddenLabel mesh__D012639 Seed
% 210.35/210.57 |- skos__altLabel mesh__D012639 Embryos, Plant
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D012639 2006
% 210.35/210.57 |- skos__hiddenLabel mesh__D012639 Zygote, Plant
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D012639 2004
% 210.35/210.57 |- skos__broader mesh__D012639smesh__D005502
% 210.35/210.57 |- mesh__recordMaintainer mesh__D012639 JLS
% 210.35/210.57 |- mesh__recordOriginator mesh__D012639 NLM
% 210.35/210.57 |- mesh__dateEstablished mesh__D009690 1972-01-01
% 210.35/210.57 |- mesh__historyNote mesh__D009690 72
% 210.35/210.57 |- mesh__activeMeSHYear mesh__D009690 2006
% 210.35/210.57 |- skos__hiddenLabel mesh__D009690 Conformation, Nucleic Acid
% 210.35/210.57 |- mesh__recordOriginator mesh__D009690 NLM
% 210.35/210.57 |- rdf__type mesh__D009690sskos__Concept
% 210.35/210.57 |- mesh__recordAuthorizer mesh__D009690 sjn
% 210.35/210.57 |- skos__historyNote mesh__D009690 Nucleic Acids %28%1966-1971%29%
% 210.35/210.58 |- mesh__dateRevised mesh__D009690 2004-07-07
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D009690 72
% 210.35/210.58 |- skos__related mesh__D009690smesh__D018807
% 210.35/210.58 |- skos__prefLabel mesh__D009690 Nucleic Acid Conformation
% 210.35/210.58 |- skos__broader mesh__D009690smesh__D008968
% 210.35/210.58 |- mesh__dateCreated mesh__D009690 1999-01-01
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009690 2005
% 210.35/210.58 |- skos__annotation mesh__D009690 coord with DNA or RNA or specific
% 210.35/210.58 |- skos__hiddenLabel mesh__D009690 Conformations, Nucleic Acid
% 210.35/210.58 |- skos__hiddenLabel mesh__D009690 Nucleic Acid Conformations
% 210.35/210.58 |- skos__scopeNote mesh__D009690
% 210.35/210.58 The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape.%A%
% 210.35/210.58 |- mesh__recordMaintainer mesh__D009690 nns
% 210.35/210.58 |- mesh__recordOriginator mesh__D023361 jls
% 210.35/210.58 |- skos__related mesh__D023361smesh__D016430
% 210.35/210.58 |- mesh__recordMaintainer mesh__D023361 ags
% 210.35/210.58 |- skos__altLabel mesh__D023361 Validation Studies %5B%PT%5D%
% 210.35/210.58 |- mesh__historyNote mesh__D023361 2001
% 210.35/210.58 |- skos__scopeNote mesh__D023361
% 210.35/210.58 Works consisting of research using processes by which the reliability and relevance of a procedure for a specific purpose are established.%A%
% 210.35/210.58 |- skos__prefLabel mesh__D023361
% 210.35/210.58 Validation Studies %5B%Publication Type%5D%
% 210.35/210.58 |- mesh__dateRevised mesh__D023361 2005-08-03
% 210.35/210.58 |- skos__altLabel mesh__D023361 Validation Studies %28%Pub Type%29%
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D023361 2006A
% 210.35/210.58 |- skos__broader mesh__D023361smesh__D052182
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D023361 2006
% 210.35/210.58 |- skos__annotation mesh__D023361
% 210.35/210.58 publication type only; CATALOG: do not use
% 210.35/210.58 |- mesh__dateCreated mesh__D023361 2000-06-22
% 210.35/210.58 |- rdf__type mesh__D023361sskos__Concept
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D023361 ags
% 210.35/210.58 |- mesh__dateEstablished mesh__D023361 2001-01-01
% 210.35/210.58 |- mesh__dateEstablished mesh__D017324 1993-01-01
% 210.35/210.58 |- skos__prefLabel mesh__D017324 Hematoporphyrin Derivative
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D017324 2006
% 210.35/210.58 |- skos__broader mesh__D017324smesh__D006415
% 210.35/210.58 |- skos__related mesh__D017324smesh__D006414
% 210.35/210.58 |- skos__altLabel mesh__D017324 Hematoporphyrin D
% 210.35/210.58 |- skos__altLabel mesh__D017324 Hematoporphyrin YHPD
% 210.35/210.58 |- mesh__recordMaintainer mesh__D017324 ssb
% 210.35/210.58 |- mesh__historyNote mesh__D017324
% 210.35/210.58 93; was HEMATOPORPHYRIN D %28%NM%29% 1981-92
% 210.35/210.58 |- mesh__dateRevised mesh__D017324 2005-06-30
% 210.35/210.58 |- mesh__dateCreated mesh__D017324 1992-05-20
% 210.35/210.58 |- skos__historyNote mesh__D017324 Hematoporphyrins %28%1980-1992%29%
% 210.35/210.58 |- skos__hiddenLabel mesh__D017324 YHPD, Hematoporphyrin
% 210.35/210.58 |- skos__annotation mesh__D017324 DF: note short X ref
% 210.35/210.58 |- mesh__onlineNote mesh__D017324
% 210.35/210.58 use HEMATOPORPHYRIN DERIVATIVE %28%NM%29% to search HEMATOPORPHYRIN D 1981-92%A%
% 210.35/210.58 |- rdf__type mesh__D017324sskos__Concept
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D017324
% 210.35/210.58 93; HEMATOPORPHYRIN D was indexed under HEMATOPORPHYRINS 1981-92%A%
% 210.35/210.58 |- mesh__recordOriginator mesh__D017324 TPW
% 210.35/210.58 |- skos__scopeNote mesh__D017324
% 210.35/210.58 A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors %28%HEMATOPORPHYRIN PHOTORADIATION%29%. A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER.%A%
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D017324 sjn
% 210.35/210.58 |- skos__historyNote mesh__D003304 Carboxy-Lyases %28%1972-1974%29%
% 210.35/210.58 |- mesh__recordMaintainer mesh__D003304 jmp
% 210.35/210.58 |- skos__broader mesh__D003304smesh__D044925
% 210.35/210.58 |- skos__historyNote mesh__D003304 Coproporphyrins %28%1975%29%
% 210.35/210.58 |- skos__altLabel mesh__D003304 Coproporphyrinogenase
% 210.35/210.58 |- skos__altLabel mesh__D003304 Coproporphyrinogen III Oxidases
% 210.35/210.58 |- mesh__dateEstablished mesh__D003304 1991-01-01
% 210.35/210.58 |- skos__historyNote mesh__D003304 Oxidoreductases %28%1975%29%
% 210.35/210.58 |- mesh__dateCreated mesh__D003304 1975-07-25
% 210.35/210.58 |- skos__hiddenLabel mesh__D003304 Oxidases, Coproporphyrinogen III
% 210.35/210.58 |- mesh__recordOriginator mesh__D003304 RLS
% 210.35/210.58 |- mesh__historyNote mesh__D003304
% 210.35/210.58 91%28%76%29%; was see under OXIDOREDUCTASES 1976-90
% 210.35/210.58 |- mesh__dateRevised mesh__D003304 2005-06-30
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D003304 sjn
% 210.35/210.58 |- skos__scopeNote mesh__D003304
% 210.35/210.58 An enzyme that catalyzes the oxidative decarboxylation of coproporphyrinogen III to protoporphyrinogen IX by the conversion of two propionate groups to two vinyl groups. It is the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by CPO gene. Mutations of CPO gene result in HEREDITARY COPROPORPHYRIA.%A%
% 210.35/210.58 |- skos__historyNote mesh__D003304 Porphyrins %28%1972-1974%29%
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D003304
% 210.35/210.58 91; was see under OXIDOREDUCTASES 1976-90
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D003304 2006
% 210.35/210.58 |- skos__hiddenLabel mesh__D003304 Oxidase, Coproporphyrinogen
% 210.35/210.58 |- skos__prefLabel mesh__D003304 Coproporphyrinogen Oxidase
% 210.35/210.58 |- rdf__type mesh__D003304sskos__Concept
% 210.35/210.58 |- skos__hiddenLabel mesh__D003304 III Oxidases, Coproporphyrinogen
% 210.35/210.58 |- skos__prefLabel mesh__D008598 Menstruation
% 210.35/210.58 |- mesh__dateRevised mesh__D008598 2004-07-07
% 210.35/210.58 |- skos__broader mesh__D008598smesh__D008597
% 210.35/210.58 |- skos__related mesh__D008598smesh__D008600
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008598 2005
% 210.35/210.58 |- skos__hiddenLabel mesh__D008598 Menstruations
% 210.35/210.58 |- mesh__dateCreated mesh__D008598 1999-01-01
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D008598 sjn
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008598 2006
% 210.35/210.58 |- skos__annotation mesh__D008598
% 210.35/210.58 human %26% other primates only; non-primates = ESTRUS; do not confuse with MENSTRUAL CYCLE%A%
% 210.35/210.58 |- skos__related mesh__D008598smesh__D011293
% 210.35/210.58 |- mesh__recordOriginator mesh__D008598 NLM
% 210.35/210.58 |- rdf__type mesh__D008598sskos__Concept
% 210.35/210.58 |- skos__scopeNote mesh__D008598
% 210.35/210.58 The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.%A%
% 210.35/210.58 |- mesh__recordMaintainer mesh__D008598 lkt
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 2001
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 1996
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D013732 PLS
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 2003
% 210.35/210.58 |- skos__hiddenLabel mesh__D013732 Questionnaires, Test Anxiety
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D013732
% 210.35/210.58 91; was see under PERSONALITY INVENTORY 1975-90
% 210.35/210.58 |- skos__hiddenLabel mesh__D013732 Test Anxiety Scales
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 2000
% 210.35/210.58 |- skos__broader mesh__D013732smesh__D010555
% 210.35/210.58 |- skos__hiddenLabel mesh__D013732 Scale, Test Anxiety
% 210.35/210.58 |- mesh__dateEstablished mesh__D013732 1991-01-01
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 1995
% 210.35/210.58 |- skos__hiddenLabel mesh__D013732 Test Anxiety Questionnaires
% 210.35/210.58 |- skos__hiddenLabel mesh__D013732 Scales, Test Anxiety
% 210.35/210.58 |- mesh__recordOriginator mesh__D013732 NLM
% 210.35/210.58 |- mesh__historyNote mesh__D013732
% 210.35/210.58 91%28%75%29%; was see under PERSONALITY INVENTORY 1975-90
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 1999
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 1994
% 210.35/210.58 |- mesh__dateRevised mesh__D013732 1992-05-18
% 210.35/210.58 |- skos__scopeNote mesh__D013732
% 210.35/210.58 A self-reporting test consisting of items concerning fear and worry about taking tests and physiological activity, such as heart rate, sweating, etc., before, during, and after tests.%A%
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 2006
% 210.35/210.58 |- skos__altLabel mesh__D013732 Test Anxiety Questionnaire
% 210.35/210.58 |- rdf__type mesh__D013732sskos__Concept
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 1998
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 1993
% 210.35/210.58 |- mesh__recordMaintainer mesh__D013732 TAP
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 2005
% 210.35/210.58 |- skos__hiddenLabel mesh__D013732 Questionnaire, Test Anxiety
% 210.35/210.58 |- skos__prefLabel mesh__D013732 Test Anxiety Scale
% 210.35/210.58 |- mesh__onlineNote mesh__D013732 search PERSONALITY INVENTORY 1968-74
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 1997
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 2002
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013732 2004
% 210.35/210.58 |- mesh__dateCreated mesh__D013732 1999-01-01
% 210.35/210.58 |- skos__hiddenLabel mesh__D009691 Denaturations, Nucleic Acid
% 210.35/210.58 |- skos__hiddenLabel mesh__D009691 Denaturation, Nucleic Acid
% 210.35/210.58 |- skos__related mesh__D009691smesh__D020871
% 210.35/210.58 |- mesh__dateEstablished mesh__D009691 1970-01-01
% 210.35/210.58 |- mesh__recordMaintainer mesh__D009691 nns
% 210.35/210.58 |- rdf__type mesh__D009691sskos__Concept
% 210.35/210.58 |- skos__broader mesh__D009691smesh__D001669
% 210.35/210.58 |- skos__hiddenLabel mesh__D009691 Acid Denaturation, Nucleic
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D009691 70
% 210.35/210.58 |- skos__annotation mesh__D009691
% 210.35/210.58 IM general only; coord NIM with DNA or RNA or specific %28%IM%29%%A%
% 210.35/210.58 |- mesh__historyNote mesh__D009691 70%28%67%29%
% 210.35/210.58 |- mesh__dateRevised mesh__D009691 2003-07-09
% 210.35/210.58 |- mesh__recordOriginator mesh__D009691 NLM
% 210.35/210.58 |- skos__hiddenLabel mesh__D009691 Acid Denaturations, Nucleic
% 210.35/210.58 |- mesh__dateCreated mesh__D009691 1999-01-01
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D009691 sjn
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009691 2005
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009691 2004
% 210.35/210.58 |- skos__hiddenLabel mesh__D009691 Nucleic Acid Denaturations
% 210.35/210.58 |- skos__prefLabel mesh__D009691 Nucleic Acid Denaturation
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009691 2006
% 210.35/210.58 |- skos__scopeNote mesh__D009691
% 210.35/210.58 Disorganization of secondary structures of nucleic acids through cleavage of hydrogen bonds and hydrophobic linkages. Denatured DNA appears to be a single-stranded flexible structure. The effects of denaturation on RNA are similar though less pronounced and largely reversible.%A%
% 210.35/210.58 |- skos__altLabel mesh__D023362 Evaluation Studies %28%Pub Type%29%
% 210.35/210.58 |- mesh__historyNote mesh__D023362 2001
% 210.35/210.58 |- skos__scopeNote mesh__D023362
% 210.35/210.58 Works consisting of studies determining the effectiveness or utility of processes, personnel, and equipment.%A%
% 210.35/210.58 |- skos__prefLabel mesh__D023362
% 210.35/210.58 Evaluation Studies %5B%Publication Type%5D%
% 210.35/210.58 |- mesh__recordMaintainer mesh__D023362 jls
% 210.35/210.58 |- skos__broader mesh__D023362smesh__D052182
% 210.35/210.58 |- skos__related mesh__D023362smesh__D023361
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D023362 sjn
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D023362 2006
% 210.35/210.58 |- rdf__type mesh__D023362sskos__Concept
% 210.35/210.58 |- skos__altLabel mesh__D023362 Evaluation Studies %5B%PT%5D%
% 210.35/210.58 |- mesh__dateCreated mesh__D023362 2000-06-22
% 210.35/210.58 |- skos__annotation mesh__D023362
% 210.35/210.58 publication type only; evaluation studies as a subject are indexed under the main heading EVALUATION STUDIES%A%
% 210.35/210.58 |- mesh__dateRevised mesh__D023362 2005-06-30
% 210.35/210.58 |- mesh__dateEstablished mesh__D023362 2001-01-01
% 210.35/210.58 |- mesh__recordOriginator mesh__D023362 jls
% 210.35/210.58 |- skos__related mesh__D023362smesh__D016430
% 210.35/210.58 |- skos__scopeNote mesh__D017325
% 210.35/210.58 Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.%A%
% 210.35/210.58 |- skos__hiddenLabel mesh__D017325 Vaccine, Hepatitis B
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D017325 sjn
% 210.35/210.58 |- skos__hiddenLabel mesh__D017325 Vaccines, Hepatitis B
% 210.35/210.58 |- mesh__dateEstablished mesh__D017325 1993-01-01
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D017325
% 210.35/210.58 93; HEPATITIS B VACCINE was indexed under VIRAL HEPATITIS VACCINES 1985-92 %26% VIRAL VACCINES 1982-84%A%
% 210.35/210.58 |- rdf__type mesh__D017325sskos__Concept
% 210.35/210.58 |- mesh__onlineNote mesh__D017325
% 210.35/210.58 use HEPATITIS B VACCINES %28%NM%29% to search HEPATITIS B VACCINE 1982-92%A%
% 210.35/210.58 |- mesh__recordMaintainer mesh__D017325 ssb
% 210.35/210.58 |- mesh__dateRevised mesh__D017325 2005-06-30
% 210.35/210.58 |- mesh__dateCreated mesh__D017325 1992-05-20
% 210.35/210.58 |- skos__altLabel mesh__D017325 Hepatitis B Vaccine
% 210.35/210.58 |- mesh__historyNote mesh__D017325
% 210.35/210.58 93; was HEPATITIS B VACCINE %28%NM%29% 1982-92
% 210.35/210.58 |- skos__historyNote mesh__D017325 Viral Vaccines %28%1982-1984%29%
% 210.35/210.58 |- skos__historyNote mesh__D017325
% 210.35/210.58 Viral Hepatitis Vaccines %28%1985-1992%29%
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D017325 2006
% 210.35/210.58 |- mesh__recordOriginator mesh__D017325 AGS
% 210.35/210.58 |- skos__prefLabel mesh__D017325 Hepatitis B Vaccines
% 210.35/210.58 |- skos__broader mesh__D017325smesh__D014761
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D050759 2006A
% 210.35/210.58 |- skos__broader mesh__D050759smesh__D050756
% 210.35/210.58 |- skos__hiddenLabel mesh__D050759 Cyclin Dependent Kinase Inhibitor p21
% 210.35/210.58 |- skos__altLabel mesh__D050759 Cdk2 Inhibitor Protein
% 210.35/210.58 |- skos__hiddenLabel mesh__D050759 CDK2 Associated Protein 20 kDa
% 210.35/210.58 |- skos__altLabel mesh__D050759 CDKN1 Protein
% 210.35/210.58 |- skos__altLabel mesh__D050759 Cell Cycle Regulator p21
% 210.35/210.58 |- mesh__recordOriginator mesh__D050759 DRC
% 210.35/210.58 |- skos__hiddenLabel mesh__D050759
% 210.35/210.58 Cyclin Dependent Kinase Inhibitor 1A Protein
% 210.35/210.58 |- skos__altLabel mesh__D050759
% 210.35/210.58 Cyclin-Dependent Kinase Inhibitor 1A Protein
% 210.35/210.58 |- skos__altLabel mesh__D050759 Cyclin Kinase Inhibitor p21
% 210.35/210.58 |- mesh__dateCreated mesh__D050759 2005-06-30
% 210.35/210.58 |- skos__altLabel mesh__D050759 p21 Cyclin Kinase Inhibitor
% 210.35/210.58 |- skos__altLabel mesh__D050759 CDKN1A Protein
% 210.35/210.58 |- mesh__dateRevised mesh__D050759 2005-07-12
% 210.35/210.58 |- mesh__historyNote mesh__D050759 2006%28%1993%29%
% 210.35/210.58 |- skos__altLabel mesh__D050759 p21 Cell Cycle Regulator
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D050759 2006
% 210.35/210.58 |- skos__hiddenLabel mesh__D050759
% 210.35/210.58 Senescent Cell Derived Inhibitor Protein 1
% 210.35/210.58 |- skos__altLabel mesh__D050759 CDK2-Associated Protein 20 kDa
% 210.35/210.58 |- skos__prefLabel mesh__D050759 Cyclin-Dependent Kinase Inhibitor p21
% 210.35/210.58 |- mesh__recordMaintainer mesh__D050759 ags
% 210.35/210.58 |- rdf__type mesh__D050759sskos__Concept
% 210.35/210.58 |- skos__hiddenLabel mesh__D050759 Cdk Interacting Protein 1
% 210.35/210.58 |- skos__scopeNote mesh__D050759
% 210.35/210.58 A cyclin-dependent kinase inhibitor that mediates TUMOR SUPRESSOR PROTEIN P53-dependent CELL CYCLE arrest. p21 interacts with a range of CYCLIN-DEPENDENT KINASES and associates with PROLIFERATING CELL NUCLEAR ANTIGEN and CASPASE 3.%A%
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D050759 ags
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D050759
% 210.35/210.58 2006; CYCLIN-DEPENDENT KINASE INHIBITOR P21 was indexed under CYCLINS 1993-2005, %26% under CELL CYCLE PROTEINS 2005%A%
% 210.35/210.58 |- skos__altLabel mesh__D050759 Senescent Cell-Derived Inhibitor Protein 1
% 210.35/210.58 |- mesh__dateEstablished mesh__D050759 2006-01-01
% 210.35/210.58 |- skos__altLabel mesh__D050759 Cdk-Interacting Protein 1
% 210.35/210.58 |- mesh__dateEstablished mesh__D003305 1991-01-01
% 210.35/210.58 |- mesh__dateCreated mesh__D003305 1975-07-25
% 210.35/210.58 |- mesh__historyNote mesh__D003305
% 210.35/210.58 91%28%76%29%; was see under PORPHYRINOGENS 1976-90
% 210.35/210.58 |- skos__scopeNote mesh__D003305
% 210.35/210.58 Porphyrinogens which are intermediates in the heme biosynthesis. They have four methyl and four propionic acid side chains attached to the pyrrole rings. Coproporphyrinogens I and III are formed in the presence of uroporphyrinogen decarboxylase from the corresponding uroporphyrinogen. They can yield coproporphyrins by autooxidation or protoporphyrin by oxidative decarboxylation.%A%
% 210.35/210.58 |- skos__historyNote mesh__D003305 Porphyrins %28%1971-1974%29%
% 210.35/210.58 |- mesh__recordMaintainer mesh__D003305 ssb
% 210.35/210.58 |- skos__prefLabel mesh__D003305 Coproporphyrinogens
% 210.35/210.58 |- mesh__recordOriginator mesh__D003305 RLS
% 210.35/210.58 |- skos__annotation mesh__D003305 intermediates in heme biosyn
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D003305 2006
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D003305
% 210.35/210.58 91; was see under PORPHYRINOGENS 1976-90
% 210.35/210.58 |- mesh__dateRevised mesh__D003305 2005-06-30
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D003305 sjn
% 210.35/210.58 |- rdf__type mesh__D003305sskos__Concept
% 210.35/210.58 |- skos__broader mesh__D003305smesh__D011165
% 210.35/210.58 |- skos__historyNote mesh__D003305 Porphyrinogens %28%1975%29%
% 210.35/210.58 |- rdf__type mesh__D008599sskos__Concept
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008599 2000
% 210.35/210.58 |- skos__annotation mesh__D008599
% 210.35/210.58 human only; GEN or unspecified: prefer specifics; note X refs%A%
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Disorder, Menstruation
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Retrograde Menstruation
% 210.35/210.58 |- skos__prefLabel mesh__D008599 Menstruation Disturbances
% 210.35/210.58 |- mesh__recordOriginator mesh__D008599 NLM
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008599 2004
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Disturbances, Menstruation
% 210.35/210.58 |- mesh__dateCreated mesh__D008599 1999-01-01
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D008599 ags
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Retrograde Menstruations
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D008599
% 210.35/210.58 2000; see MENSTRUATION DISORDERS 1963-1999; for HYPOMENORRHEA, POLYMENORRHEA %26% MENSTRUATION, RETROGRADE see MENSTRUATION DISORDERS 1975-1985%A%
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Menstruations, Retrograde
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008599 2003
% 210.35/210.58 |- skos__scopeNote mesh__D008599
% 210.35/210.58 Variations of menstruation which may be indicative of disease.%A%
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Disorders, Menstruation
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Polymenorrheas
% 210.35/210.58 |- mesh__historyNote mesh__D008599 2000%28%1963%29%
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008599 2002
% 210.35/210.58 |- mesh__recordMaintainer mesh__D008599 ags
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Disturbance, Menstruation
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008599 2000A
% 210.35/210.58 |- skos__broader mesh__D008599smesh__D010335
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008599 2006
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008599 2001
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Menstruation Disorder
% 210.35/210.58 |- mesh__dateRevised mesh__D008599 1999-12-06
% 210.35/210.58 |- skos__altLabel mesh__D008599 Menstruation Disorders
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D008599 2005
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Hypomenorrheas
% 210.35/210.58 |- skos__hiddenLabel mesh__D008599 Menstruation Disturbance
% 210.35/210.58 |- skos__hiddenLabel mesh__D013733 Disease, Testicular
% 210.35/210.58 |- mesh__dateEstablished mesh__D013733 1966-01-01
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D013733 66
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D013733 sjn
% 210.35/210.58 |- skos__broader mesh__D013733smesh__D005832
% 210.35/210.58 |- skos__prefLabel mesh__D013733 Testicular Diseases
% 210.35/210.58 |- mesh__dateCreated mesh__D013733 1999-01-01
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013733 2006
% 210.35/210.58 |- skos__hiddenLabel mesh__D013733 Diseases, Testicular
% 210.35/210.58 |- rdf__type mesh__D013733sskos__Concept
% 210.35/210.58 |- mesh__dateRevised mesh__D013733 2005-06-30
% 210.35/210.58 |- skos__broader mesh__D013733smesh__D006058
% 210.35/210.58 |- skos__annotation mesh__D013733 inflammatory disease = ORCHITIS
% 210.35/210.58 |- mesh__historyNote mesh__D013733 66
% 210.35/210.58 |- skos__scopeNote mesh__D013733 Pathological processes of the TESTIS.
% 210.35/210.58 |- skos__hiddenLabel mesh__D013733 Testicular Disease
% 210.35/210.58 |- mesh__recordOriginator mesh__D013733 NLM
% 210.35/210.58 |- mesh__recordMaintainer mesh__D013733 lkt
% 210.35/210.58 |- skos__historyNote mesh__D009692 specific DNA %28%1966-1979%29%
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009692 2006
% 210.35/210.58 |- skos__historyNote mesh__D009692 Recombination, Genetic %28%1968-1979%29%
% 210.35/210.58 |- skos__historyNote mesh__D009692 specific RNA %28%1966-1979%29%
% 210.35/210.58 |- skos__altLabel mesh__D009692 Heteroduplexes, Nucleic Acid
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009692 2002
% 210.35/210.58 |- skos__historyNote mesh__D009692 RNA %28%1966-1979%29%
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D009692 SJN
% 210.35/210.58 |- skos__hiddenLabel mesh__D009692 DNA, Heteroduplex
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009692 2005
% 210.35/210.58 |- skos__annotation mesh__D009692
% 210.35/210.58 coord with specific DNA or RNA or both %28%IM%29%
% 210.35/210.58 |- mesh__recordMaintainer mesh__D009692 NDW
% 210.35/210.58 |- mesh__recordOriginator mesh__D009692 RLS
% 210.35/210.58 |- rdf__type mesh__D009692sskos__Concept
% 210.35/210.58 |- skos__scopeNote mesh__D009692
% 210.35/210.58 Double-stranded nucleic acid molecules %28%DNA-DNA or DNA-RNA%29% which contain regions of nucleotide mismatches %28%non-complementary%29%. In vivo, these heteroduplexes can result from mutation or genetic recombination; in vitro, they are formed by nucleic acid hybridization. Electron microscopic analysis of the resulting heteroduplexes facilitates the mapping of regions of base sequence homology of nucleic acids.%A%
% 210.35/210.58 |- skos__related mesh__D009692smesh__D020180
% 210.35/210.58 |- skos__historyNote mesh__D009692 Base Sequence %28%1971-1979%29%
% 210.35/210.58 |- skos__related mesh__D009692smesh__D020137
% 210.35/210.58 |- mesh__dateEstablished mesh__D009692 1980-01-01
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009692 1999
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009692 2001
% 210.35/210.58 |- mesh__historyNote mesh__D009692 80
% 210.35/210.58 |- skos__historyNote mesh__D009692
% 210.35/210.58 Nucleic Acid Hybridization %28%1971-1979%29%
% 210.35/210.58 |- skos__prefLabel mesh__D009692 Nucleic Acid Heteroduplexes
% 210.35/210.58 |- skos__hiddenLabel mesh__D009692 Acid Heteroduplexes, Nucleic
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009692 2004
% 210.35/210.58 |- mesh__dateCreated mesh__D009692 1979-05-23
% 210.35/210.58 |- skos__historyNote mesh__D009692 DNA %28%1966-1979%29%
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009692 2000
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D009692 2003
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D009692 80
% 210.35/210.58 |- mesh__dateRevised mesh__D009692 1998-06-10
% 210.35/210.58 |- skos__broader mesh__D009692smesh__D009696
% 210.35/210.58 |- skos__historyNote mesh__D009692 Mutation %28%1966-1979%29%
% 210.35/210.58 |- skos__altLabel mesh__D017326 Evaluation Studies, FDA Phase 3
% 210.35/210.58 |- mesh__recordOriginator mesh__D017326 TPW
% 210.35/210.58 |- skos__broader mesh__D017326smesh__D002986
% 210.35/210.58 |- skos__altLabel mesh__D017326 Phase III Clinical Trials
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D017326 2005
% 210.35/210.58 |- skos__altLabel mesh__D017326 Clinical Trials, Phase 3
% 210.35/210.58 |- skos__altLabel mesh__D017326 Drug Evaluation, FDA Phase 3
% 210.35/210.58 |- mesh__dateEstablished mesh__D017326 1993-01-01
% 210.35/210.58 |- skos__historyNote mesh__D017326 Clinical Trials %28%1980-1992%29%
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D017326 2006
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D017326 sjn
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D017326 2003
% 210.35/210.58 |- skos__annotation mesh__D017326
% 210.35/210.58 trial lasts about 3 years; for U.S. %26% foreign studies; for II/III clin trials, index under CLINICAL TRIALS, PHASE II + CLINICAL TRIALS, PHASE III; IM for articles %26% books about phase III clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE III; DF: CLIN TRIALS PAHSE III%A%
% 210.35/210.58 |- mesh__onlineNote mesh__D017326
% 210.35/210.58 use CLINICAL TRIALS to search DRUG EVALUATION, FDA PHASE III 1980-92 %26% EVALUATION STUDIES, FDA PHASE III 1982-92%A%
% 210.35/210.58 |- mesh__dateCreated mesh__D017326 1992-05-13
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D017326 2004
% 210.35/210.58 |- skos__scopeNote mesh__D017326
% 210.35/210.58 Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.%A%
% 210.35/210.58 |- skos__altLabel mesh__D017326 Phase 3 Clinical Trials
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D017326
% 210.35/210.58 93; DRUG EVALUATION, FDA PHASE III was see CLINICAL TRIALS 1980-92; EVALUATION STUDIES, FDA PHASE III was see CLINICAL TRIALS 1982-92%A%
% 210.35/210.58 |- mesh__recordMaintainer mesh__D017326 ags
% 210.35/210.58 |- mesh__historyNote mesh__D017326
% 210.35/210.58 93; DRUG EVALUATION, FDA PHASE III was see CLINICAL TRIALS 1980-92; EVALUATION STUDIES, FDA PHASE III was see CLINICAL TRIALS 1982-92%A%
% 210.35/210.58 |- skos__altLabel mesh__D017326 Drug Evaluation, FDA Phase III
% 210.35/210.58 |- mesh__dateRevised mesh__D017326 2001-07-25
% 210.35/210.58 |- skos__prefLabel mesh__D017326 Clinical Trials, Phase III
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D017326 2002
% 210.35/210.58 |- rdf__type mesh__D017326sskos__Concept
% 210.35/210.58 |- mesh__dateRevised mesh__D003306 2005-06-30
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D003306 sjn
% 210.35/210.58 |- mesh__historyNote mesh__D003306
% 210.35/210.58 91%28%75%29%; was see under PORPHYRINS 1975-90
% 210.35/210.58 |- skos__broader mesh__D003306smesh__D011166
% 210.35/210.58 |- skos__scopeNote mesh__D003306
% 210.35/210.58 Porphyrins with four methyl and four propionic acid side chains attached to the pyrrole rings. Elevated levels of Coproporphyrin III in the urine and feces are major findings in patients with HEREDITARY COPROPORPHYRIA.%A%
% 210.35/210.58 |- mesh__recordMaintainer mesh__D003306 ssb
% 210.35/210.58 |- mesh__dateEstablished mesh__D003306 1991-01-01
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D003306 2006
% 210.35/210.58 |- skos__prefLabel mesh__D003306 Coproporphyrins
% 210.35/210.58 |- rdf__type mesh__D003306sskos__Concept
% 210.35/210.58 |- skos__historyNote mesh__D003306 Porphyrins %28%1969-1974%29%
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D003306
% 210.35/210.58 91; was see under PORPHYRINS 1975-90
% 210.35/210.58 |- mesh__recordOriginator mesh__D003306 NLM
% 210.35/210.58 |- mesh__dateCreated mesh__D003306 1974-11-19
% 210.35/210.58 |- skos__broader mesh__D003080Q000627smesh__D003080
% 210.35/210.58 |- mesh__preferredCombination mesh__D003080Q000627smesh__D017679
% 210.35/210.58 |- rdf__type mesh__D003080Q000627smesh__CompoundConcept
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D049408 2006
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D049408 sjn
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D049408 2005
% 210.35/210.58 |- skos__broader mesh__D049408smesh__D007202
% 210.35/210.58 |- skos__historyNote mesh__D049408
% 210.35/210.58 Luminescent Measurements %28%1964-2004%29%
% 210.35/210.58 |- mesh__historyNote mesh__D049408 2005
% 210.35/210.58 |- skos__scopeNote mesh__D049408
% 210.35/210.58 Compound such as LUMINESCENT PROTEINS that cause or emit light %28%PHYSICAL LUMINESCENCE%29%.%A%
% 210.35/210.58 |- skos__prefLabel mesh__D049408 Luminescent Agents
% 210.35/210.58 |- skos__related mesh__D049408smesh__D005456
% 210.35/210.58 |- mesh__recordMaintainer mesh__D049408 ssb
% 210.35/210.58 |- skos__related mesh__D049408smesh__D002863
% 210.35/210.58 |- mesh__dateEstablished mesh__D049408 2005-01-01
% 210.35/210.58 |- mesh__recordOriginator mesh__D049408 ssb
% 210.35/210.58 |- mesh__dateCreated mesh__D049408 2004-07-07
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D049408 2005
% 210.35/210.58 |- skos__hiddenLabel mesh__D049408 Agents, Phosphorescent
% 210.35/210.58 |- rdf__type mesh__D049408sskos__Concept
% 210.35/210.58 |- skos__hiddenLabel mesh__D049408 Agents, Luminescent
% 210.35/210.58 |- skos__altLabel mesh__D013734 Androgen-Insensitivity Syndrome, Complete
% 210.35/210.58 |- mesh__historyNote mesh__D013734 2002%28%1968%29%
% 210.35/210.58 |- skos__hiddenLabel mesh__D013734 Androgen Insensitivity Syndrome
% 210.35/210.58 |- mesh__recordOriginator mesh__D013734 NLM
% 210.35/210.58 |- mesh__recordMaintainer mesh__D013734 lkt
% 210.35/210.58 |- skos__broader mesh__D013734smesh__D011545
% 210.35/210.58 |- skos__hiddenLabel mesh__D013734
% 210.35/210.58 Androgen Insensitivity Syndrome, Complete
% 210.35/210.58 |- skos__hiddenLabel mesh__D013734
% 210.35/210.58 Androgen-Insensitivity Syndromes, Partial
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D013734
% 210.35/210.58 2002; see TESTICULAR FEMINIZATION %28%1970-2001%29%
% 210.35/210.58 |- mesh__dateCreated mesh__D013734 1999-01-01
% 210.35/210.58 |- mesh__recordAuthorizer mesh__D013734 sjn
% 210.35/210.58 |- skos__scopeNote mesh__D013734
% 210.35/210.58 A familial form of PSEUDOHERMAPHRODITISM transmitted as an X-linked recessive trait. These patients have a karyotype of 46,XY with end-organ resistance to androgen due to mutations in the androgen receptor %28%RECEPTORS, ANDROGEN%29% gene. Severity of the defect in receptor quantity or quality correlates with their phenotypes. In these genetic males, the phenotypic spectrum ranges from those with normal female external genitalia, through those with genital ambiguity as in Reifenstein Syndrome, to that of a normal male with INFERTILITY.%A%
% 210.35/210.58 |- mesh__activeMeSHYear mesh__D013734 2006
% 210.35/210.58 |- rdf__type mesh__D013734sskos__Concept
% 210.35/210.58 |- skos__annotation mesh__D013734 check the tag MALE
% 210.35/210.58 |- skos__hiddenLabel mesh__D013734 Androgen Insensitivity Syndrome, Partial
% 210.35/210.58 |- skos__prefLabel mesh__D013734 Androgen-Insensitivity Syndrome
% 210.35/210.58 |- mesh__dateEstablished mesh__D013734 1970-01-01
% 210.35/210.58 |- skos__hiddenLabel mesh__D013734 Reifensteins Syndrome
% 210.35/210.58 |- skos__altLabel mesh__D013734 Reifenstein%27%s Syndrome
% 210.35/210.58 |- skos__broader mesh__D013734smesh__D040181
% 210.35/210.58 |- skos__altLabel mesh__D013734 Androgen-Insensitivity Syndrome, Partial
% 210.35/210.58 |- skos__historyNote mesh__D013734
% 210.35/210.58 Sex Differentiation Disorders %28%1966-1967%29%
% 210.35/210.58 |- mesh__dateRevised mesh__D013734 2005-06-30
% 210.35/210.58 |- rdf__type mesh__D046110sskos__Concept
% 210.35/210.58 |- skos__hiddenLabel mesh__D046110 Hypertension, Pregnancy Transient
% 210.35/210.58 |- skos__hiddenLabel mesh__D046110 Pregnancy Transient Hypertension
% 210.35/210.58 |- mesh__publicMeSHNote mesh__D046110 2005
% 210.35/210.58 |- skos__broader mesh__D046110smesh__D011248
% 210.35/210.58 |- skos__hiddenLabel mesh__D046110 Hypertension, Gestational
% 210.35/210.58 |- skos__historyNote mesh__D046110 Hypertension %28%1970-2004%29%
% 210.35/210.58 |- skos__hiddenLabel mesh__D046110 Pregnancy-Induced Hypertension
% 210.35/210.58 |- skos__hiddenLabel mesh__D046110 Hypertension, Pregnancy Induced
% 210.35/210.58 |- mesh__historyNote mesh__D046110 2005
% 210.35/210.58 |- skos__historyNote mesh__D046110
% 210.35/210.58 Pregnancy Complications, Cardiovascular %28%1970-2004%29%
% 210.35/210.59 |- skos__scopeNote mesh__D046110
% 210.35/210.59 A condition in pregnant women with elevated systolic %28%%3E%140 mm Hg%29% and diastolic %28%%3E%90 mm Hg%29% blood pressure on at least two occasions 6 h apart. HYPERTENSION complicates 8-10%25% of all pregnancies, generally after 20 weeks of gestation. Gestational hypertension can be divided into several broad categories according to the complexity and associated symptoms, such as EDEMA; PROTEINURIA; SEIZURES; abnormalities in BLOOD COAGULATION and liver functions.%A%
% 210.35/210.59 |- mesh__recordOriginator mesh__D046110 lkt
% 210.35/210.59 |- skos__altLabel mesh__D046110 Gestational Hypertension
% 210.35/210.59 |- mesh__recordAuthorizer mesh__D046110 sjn
% 210.35/210.59 |- mesh__recordMaintainer mesh__D046110 lkt
% 210.35/210.59 |- skos__annotation mesh__D046110 check tags FEMALE %26% PREGNANCY
% 210.35/210.59 |- mesh__dateRevised mesh__D046110 2005-06-30
% 210.35/210.59 |- mesh__dateCreated mesh__D046110 2004-07-07
% 210.35/210.59 |- mesh__dateEstablished mesh__D046110 2005-01-01
% 210.35/210.59 |- mesh__activeMeSHYear mesh__D046110 2006
% 210.35/210.59 |- skos__broader mesh__D046110smesh__D006973
% 210.35/210.59 |- skos__prefLabel mesh__D046110 Hypertension, Pregnancy-Induced
% 210.35/210.59 |- skos__prefLabel mesh__D009693 Nucleic Acid Hybridization
% 210.35/210.59 |- mesh__activeMeSHYear mesh__D009693 2000
% 210.35/210.59 |- skos__hiddenLabel mesh__D009693 Acid Hybridization, Nucleic
% 210.35/210.59 |- mesh__activeMeSHYear mesh__D009693 2005
% 210.35/210.59 |- mesh__recordOriginator mesh__D009693 NLM
% 210.35/210.59 |- mesh__recordAuthorizer mesh__D009693 jls
% 210.35/210.59 |- skos__hiddenLabel mesh__D009693 Hybridizations, Genomic
% 210.35/210.59 |- mesh__activeMeSHYear mesh__D009693 2005A
% 210.35/210.59 |- rdf__type mesh__D009693sskos__Concept
% 210.35/210.59 |- skos__hiddenLabel mesh__D009693 Hybridization, Genomic
% 210.35/210.59 |- skos__hiddenLabel mesh__D009693 Acid Hybridizations, Nucleic
% 210.35/210.59 |- skos__annotation mesh__D009693
% 210.35/210.59 IM general only; coord NIM with DNA or RNA or specific %28%IM%29%; IN SITU HYBRIDIZATION %26% IN SITU HYBRIDIZATION, FLUORESCENCE are available%A%
% 210.35/210.59 |- skos__historyNote mesh__D009693 RNA %28%1966-1970%29%
% 210.35/210.59 |- skos__historyNote mesh__D009693 DNA %28%1966-1970%29%
% 210.35/210.59 |- mesh__activeMeSHYear mesh__D009693 1999
% 210.35/210.59 |- mesh__dateEstablished mesh__D009693 1972-01-01
% 210.35/210.59 |- mesh__activeMeSHYear mesh__D009693 2002
% 210.45/210.59 |- mesh__historyNote mesh__D009693 72%28%71%29%
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009693 2004
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009693 1998
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D009693 72
% 210.45/210.59 |- skos__hiddenLabel mesh__D009693 Hybridizations, Nucleic Acid
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009693 2003
% 210.45/210.59 |- skos__hiddenLabel mesh__D009693 Genomic Hybridizations
% 210.45/210.59 |- skos__hiddenLabel mesh__D009693 Nucleic Acid Hybridizations
% 210.45/210.59 |- mesh__recordMaintainer mesh__D009693 jls
% 210.45/210.59 |- mesh__dateCreated mesh__D009693 1999-01-01
% 210.45/210.59 |- skos__broader mesh__D009693smesh__D001669
% 210.45/210.59 |- skos__hiddenLabel mesh__D009693 Hybridization, Nucleic Acid
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009693 2001
% 210.45/210.59 |- skos__scopeNote mesh__D009693
% 210.45/210.59 Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. %28%Kendrew, Encyclopedia of Molecular Biology, 1994, p503%29%%A%
% 210.45/210.59 |- skos__broader mesh__D009693smesh__D005821
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009693 2006
% 210.45/210.59 |- skos__related mesh__D009693smesh__D015139
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009693 1997
% 210.45/210.59 |- mesh__dateRevised mesh__D009693 2004-07-29
% 210.45/210.59 |- skos__altLabel mesh__D017327 Evaluation Studies, FDA Phase 4
% 210.45/210.59 |- skos__altLabel mesh__D017327 Clinical Trials, Phase 4
% 210.45/210.59 |- skos__altLabel mesh__D017327 Phase IV Clinical Trials
% 210.45/210.59 |- mesh__recordMaintainer mesh__D017327 ssb
% 210.45/210.59 |- mesh__dateRevised mesh__D017327 2005-06-30
% 210.45/210.59 |- skos__historyNote mesh__D017327 Clinical Trials %28%1980-1992%29%
% 210.45/210.59 |- mesh__recordOriginator mesh__D017327 TPW
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D017327 2006
% 210.45/210.59 |- skos__broader mesh__D017327smesh__D002986
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D017327
% 210.45/210.59 93; DRUG EVALUATION, FDA PHASE IV was see CLINICAL TRIALS 1981-92; EVALUATION STUDIES, FDA PHASE IV was see CLINICAL TRIALS 1982-92%A%
% 210.45/210.59 |- mesh__historyNote mesh__D017327
% 210.45/210.59 93; DRUG EVALUATION, FDA PHASE IV was see CLINICAL TRIALS 1981-92; EVALUATION STUDIES, FDA PHASE IV was see CLINICAL TRIALS 1982-92%A%
% 210.45/210.59 |- skos__prefLabel mesh__D017327 Clinical Trials, Phase IV
% 210.45/210.59 |- mesh__onlineNote mesh__D017327
% 210.45/210.59 use CLINICAL TRIALS to search DRUG EVALUATION, FDA PHASE IV 1980-92 %26% EVALUATION STUDIES, FDA PHASE IV 1981-92%A%
% 210.45/210.59 |- mesh__dateEstablished mesh__D017327 1993-01-01
% 210.45/210.59 |- skos__annotation mesh__D017327
% 210.45/210.59 for U.S. %26% foreign studies; IM for articles %26% books about phase IV clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE IV; DF: CLIN TRIALS PHASE IV%A%
% 210.45/210.59 |- skos__scopeNote mesh__D017327
% 210.45/210.59 Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.%A%
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D017327 sjn
% 210.45/210.59 |- skos__related mesh__D017327smesh__D004362
% 210.45/210.59 |- rdf__type mesh__D017327sskos__Concept
% 210.45/210.59 |- mesh__dateCreated mesh__D017327 1992-05-13
% 210.45/210.59 |- skos__altLabel mesh__D017327 Drug Evaluation, FDA Phase IV
% 210.45/210.59 |- skos__broader mesh__D017327smesh__D011358
% 210.45/210.59 |- skos__altLabel mesh__D017327 Drug Evaluation, FDA Phase 4
% 210.45/210.59 |- skos__altLabel mesh__D017327 Phase 4 Clinical Trials
% 210.45/210.59 |- skos__prefLabel mesh__D003307 Copulation
% 210.45/210.59 |- mesh__recordOriginator mesh__D003307 NLM
% 210.45/210.59 |- mesh__recordMaintainer mesh__D003307 lkt
% 210.45/210.59 |- skos__scopeNote mesh__D003307
% 210.45/210.59 Sexual union of a male and a female in non-human species.%A%
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003307 2005
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D003307 sjn
% 210.45/210.59 |- skos__annotation mesh__D003307 animal only: for human, use COITUS
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D003307 75
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003307 2006
% 210.45/210.59 |- mesh__dateRevised mesh__D003307 2004-07-07
% 210.45/210.59 |- mesh__dateCreated mesh__D003307 1974-11-11
% 210.45/210.59 |- rdf__type mesh__D003307sskos__Concept
% 210.45/210.59 |- skos__hiddenLabel mesh__D003307 Copulations
% 210.45/210.59 |- skos__historyNote mesh__D003307 Coitus %28%1966-1974%29%
% 210.45/210.59 |- mesh__historyNote mesh__D003307 75
% 210.45/210.59 |- mesh__dateEstablished mesh__D003307 1975-09-01
% 210.45/210.59 |- skos__broader mesh__D003307smesh__D012726
% 210.45/210.59 |- mesh__recordMaintainer mesh__D049409 ags
% 210.45/210.59 |- skos__scopeNote mesh__D049409
% 210.45/210.59 Luciferases from FIREFLIES, usually Photinus, that oxidizes FIREFLY LUCIFERIN to cause emission of PHOTONS.%A%
% 210.45/210.59 |- skos__broader mesh__D049409smesh__D008156
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D049409 ags
% 210.45/210.59 |- skos__hiddenLabel mesh__D049409 Firefly Luciferases
% 210.45/210.59 |- mesh__dateCreated mesh__D049409 2004-07-07
% 210.45/210.59 |- rdf__type mesh__D049409sskos__Concept
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D049409 2005
% 210.45/210.59 |- mesh__recordOriginator mesh__D049409 ssb
% 210.45/210.59 |- mesh__dateRevised mesh__D049409 2005-07-14
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D049409 2006A
% 210.45/210.59 |- skos__prefLabel mesh__D049409 Luciferases, Firefly
% 210.45/210.59 |- mesh__historyNote mesh__D049409 2005
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D049409 2006
% 210.45/210.59 |- skos__historyNote mesh__D049409 Luciferases %28%1965-2004%29%
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D049409 2005
% 210.45/210.59 |- mesh__dateEstablished mesh__D049409 2005-01-01
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D013735 2006
% 210.45/210.59 |- rdf__type mesh__D013735sskos__Concept
% 210.45/210.59 |- mesh__dateRevised mesh__D013735 2003-07-09
% 210.45/210.59 |- skos__broader mesh__D013735smesh__D042341
% 210.45/210.59 |- mesh__dateCreated mesh__D013735 1974-11-11
% 210.45/210.59 |- skos__prefLabel mesh__D013735 Testicular Hormones
% 210.45/210.59 |- mesh__recordMaintainer mesh__D013735 lkt
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D013735 2004
% 210.45/210.59 |- skos__annotation mesh__D013735 /biosyn /physiol permitted
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D013735 75
% 210.45/210.59 |- mesh__recordOriginator mesh__D013735 NLM
% 210.45/210.59 |- mesh__dateEstablished mesh__D013735 1975-09-01
% 210.45/210.59 |- skos__hiddenLabel mesh__D013735 Hormones, Testicular
% 210.45/210.59 |- skos__scopeNote mesh__D013735 Hormones produced in the testis.
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D013735 sjn
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D013735 2005
% 210.45/210.59 |- skos__historyNote mesh__D013735 Sex Hormones %28%1966-1974%29%
% 210.45/210.59 |- mesh__historyNote mesh__D013735 75
% 210.45/210.59 |- mesh__dateCreated mesh__D018420 1994-06-03
% 210.45/210.59 |- skos__hiddenLabel mesh__D018420 Diseases, Pongidae
% 210.45/210.59 |- mesh__recordMaintainer mesh__D018420 jls
% 210.45/210.59 |- rdf__type mesh__D018420sskos__Concept
% 210.45/210.59 |- skos__broader mesh__D018420smesh__D018419
% 210.45/210.59 |- skos__hiddenLabel mesh__D018420 Diseases, Ape
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D018420 2005A
% 210.45/210.59 |- mesh__dateRevised mesh__D018420 2004-08-03
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D018420 95
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D018420 jls
% 210.45/210.59 |- skos__altLabel mesh__D018420 Pongidae Diseases
% 210.45/210.59 |- skos__hiddenLabel mesh__D018420 Disease, Pongidae
% 210.45/210.59 |- skos__scopeNote mesh__D018420
% 210.45/210.59 Diseases of chimpanzees, gorillas, and orangutans.
% 210.45/210.59 |- skos__hiddenLabel mesh__D018420 Disease, Ape
% 210.45/210.59 |- skos__hiddenLabel mesh__D018420 Ape Disease
% 210.45/210.59 |- mesh__historyNote mesh__D018420 95
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D018420 2005
% 210.45/210.59 |- skos__hiddenLabel mesh__D018420 Pongidae Disease
% 210.45/210.59 |- mesh__dateEstablished mesh__D018420 1995-01-01
% 210.45/210.59 |- skos__annotation mesh__D018420
% 210.45/210.59 coordinate IM with specific ape %28%IM%29% or with HOMINIDAE %28%NIM%29% if ape is not specified + specific disease /vet; DF: APE DIS%A%
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D018420 2006
% 210.45/210.59 |- mesh__recordOriginator mesh__D018420 PXP
% 210.45/210.59 |- skos__prefLabel mesh__D018420 Ape Diseases
% 210.45/210.59 |- mesh__dateRevised mesh__D004400 2005-06-30
% 210.45/210.59 |- mesh__historyNote mesh__D004400
% 210.45/210.59 91%28%80%29%; was see under THEOPHYLLINE 1980-90
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D004400 2006
% 210.45/210.59 |- mesh__recordMaintainer mesh__D004400 exl
% 210.45/210.59 |- skos__scopeNote mesh__D004400
% 210.45/210.59 A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis.%A%
% 210.45/210.59 |- skos__broader mesh__D004400smesh__D013806
% 210.45/210.59 |- mesh__dateEstablished mesh__D004400 1991-01-01
% 210.45/210.59 |- skos__prefLabel mesh__D004400 Dyphylline
% 210.45/210.59 |- skos__altLabel mesh__D004400 Major Brand of Dyphylline
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D004400
% 210.45/210.59 91; was see under THEOPHYLLINE 1980-90
% 210.45/210.59 |- skos__altLabel mesh__D004400 Diphylline
% 210.45/210.59 |- rdf__type mesh__D004400sskos__Concept
% 210.45/210.59 |- mesh__dateCreated mesh__D004400 1979-05-30
% 210.45/210.59 |- skos__altLabel mesh__D004400 Wallace Brand of Dyphylline
% 210.45/210.59 |- skos__altLabel mesh__D004400 Savage Brand of Dyphylline
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D004400 sjn
% 210.45/210.59 |- skos__historyNote mesh__D004400
% 210.45/210.59 Theophylline %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 210.45/210.59 |- skos__altLabel mesh__D004400 Lunsco Brand of Dyphylline
% 210.45/210.59 |- skos__altLabel mesh__D004400 Dihydroxypropyltheophylline
% 210.45/210.59 |- mesh__recordOriginator mesh__D004400 SH
% 210.45/210.59 |- skos__altLabel mesh__D004400 Hauck Brand of Dyphylline
% 210.45/210.59 |- skos__altLabel mesh__D004400 Diprophylline
% 210.45/210.59 |- skos__hiddenLabel mesh__D051056 Inactivating Agents, Complement
% 210.45/210.59 |- skos__annotation mesh__D051056
% 210.45/210.59 do not confuse with COMPLEMENT INACTIVATOR PROTEINS
% 210.45/210.59 |- mesh__dateCreated mesh__D051056 2005-06-30
% 210.45/210.59 |- skos__scopeNote mesh__D051056
% 210.45/210.59 Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host.%A%
% 210.45/210.59 |- skos__prefLabel mesh__D051056 Complement Inactivating Agents
% 210.45/210.59 |- mesh__historyNote mesh__D051056 2006
% 210.45/210.59 |- skos__hiddenLabel mesh__D051056 Inhibiting Agents, Complement
% 210.45/210.59 |- skos__hiddenLabel mesh__D051056 Agents, Complement Inhibiting
% 210.45/210.59 |- skos__hiddenLabel mesh__D051056 Agents, Complement Inactivating
% 210.45/210.59 |- skos__broader mesh__D051056smesh__D007166
% 210.45/210.59 |- skos__historyNote mesh__D051056
% 210.45/210.59 Complement System Proteins %28%1975-2005%29%
% 210.45/210.59 |- skos__altLabel mesh__D051056 Complement Inhibiting Agents
% 210.45/210.59 |- mesh__recordOriginator mesh__D051056 lkt
% 210.45/210.59 |- mesh__dateEstablished mesh__D051056 2006-01-01
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D051056 2006
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D051056 2006
% 210.45/210.59 |- mesh__recordMaintainer mesh__D051056 lkt
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D051056 sjn
% 210.45/210.59 |- rdf__type mesh__D051056sskos__Concept
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 2004
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 1995
% 210.45/210.59 |- skos__hiddenLabel mesh__D009694 Acid Precursors, Nucleic
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 1998
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 2001
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 2003
% 210.45/210.59 |- skos__hiddenLabel mesh__D009694 Precursors, Nucleic Acid
% 210.45/210.59 |- mesh__dateRevised mesh__D009694 1992-05-19
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D009694 75
% 210.45/210.59 |- mesh__dateEstablished mesh__D009694 1975-09-01
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 1994
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 2000
% 210.45/210.59 |- skos__annotation mesh__D009694
% 210.45/210.59 IM; coord with DNA or RNA or specific %28%IM%29%; /drug eff /ultrastruct permitted%A%
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 2006
% 210.45/210.59 |- mesh__recordMaintainer mesh__D009694 TGC
% 210.45/210.59 |- skos__broader mesh__D009694smesh__D009706
% 210.45/210.59 |- mesh__recordOriginator mesh__D009694 NLM
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 1997
% 210.45/210.59 |- skos__historyNote mesh__D009694 Nucleic Acids %28%1968-1974%29%
% 210.45/210.59 |- mesh__dateCreated mesh__D009694 1974-11-11
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 2005
% 210.45/210.59 |- mesh__historyNote mesh__D009694 75
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D009694 PLS
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 1993
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 1996
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 2002
% 210.45/210.59 |- rdf__type mesh__D009694sskos__Concept
% 210.45/210.59 |- skos__prefLabel mesh__D009694 Nucleic Acid Precursors
% 210.45/210.59 |- skos__scopeNote mesh__D009694
% 210.45/210.59 Use for nucleic acid precursors in general or for which there is no specific heading.%A%
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D009694 1999
% 210.45/210.59 |- skos__hiddenLabel mesh__D017328
% 210.45/210.59 Bristol Myers Squibb Brand of Fosinopril Sodium
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D017328 sjn
% 210.45/210.59 |- skos__broader mesh__D017328smesh__D011392
% 210.45/210.59 |- skos__altLabel mesh__D017328
% 210.45/210.59 Merck Lipha Sant%C3%%A9% Brand of Fosinopril
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D017328
% 210.45/210.59 93; FOSENOPRIL was indexed under PROLINE/analogs %26% derivatives 1985-92%A%
% 210.45/210.59 |- skos__altLabel mesh__D017328 Fosenopril
% 210.45/210.59 |- skos__altLabel mesh__D017328 Esteve Brand of Fosinopril Sodium
% 210.45/210.59 |- mesh__dateEstablished mesh__D017328 1993-01-01
% 210.45/210.59 |- skos__altLabel mesh__D017328 Tensocardil
% 210.45/210.59 |- skos__hiddenLabel mesh__D017328 Sodium, Fosinopril
% 210.45/210.59 |- mesh__recordOriginator mesh__D017328 TPW
% 210.45/210.59 |- skos__hiddenLabel mesh__D017328 SQ28555
% 210.45/210.59 |- skos__altLabel mesh__D017328 Newace
% 210.45/210.59 |- mesh__onlineNote mesh__D017328
% 210.45/210.59 use FOSINOPRIL %28%NM%29% to search FOSENOPRIL 1985-92
% 210.45/210.59 |- skos__hiddenLabel mesh__D017328 SQ 28,555
% 210.45/210.59 |- skos__altLabel mesh__D017328
% 210.45/210.59 Fosinopril, %28%1%28%S*%28%R*%29%%29%,2 alpha,4 beta%29%-Isomer
% 210.45/210.59 |- skos__altLabel mesh__D017328 Squibb Brand of Fosinopril Sodium
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D017328 2006
% 210.45/210.59 |- skos__prefLabel mesh__D017328 Fosinopril
% 210.45/210.59 |- skos__hiddenLabel mesh__D017328 SQ 28555
% 210.45/210.59 |- skos__altLabel mesh__D017328 Fositens
% 210.45/210.59 |- skos__altLabel mesh__D017328 Staril
% 210.45/210.59 |- mesh__recordMaintainer mesh__D017328 CCR
% 210.45/210.59 |- skos__broader mesh__D017328smesh__D009943
% 210.45/210.59 |- skos__altLabel mesh__D017328 SQ-28555
% 210.45/210.59 |- mesh__dateRevised mesh__D017328 2005-06-30
% 210.45/210.59 |- mesh__dateCreated mesh__D017328 1992-05-20
% 210.45/210.59 |- skos__historyNote mesh__D017328
% 210.45/210.59 Proline/analogs %26% derivatives %28%1985-1992%29%
% 210.45/210.59 |- skos__scopeNote mesh__D017328
% 210.45/210.59 A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat.%A%
% 210.45/210.59 |- skos__altLabel mesh__D017328 Fosinorm
% 210.45/210.59 |- rdf__type mesh__D017328sskos__Concept
% 210.45/210.59 |- skos__altLabel mesh__D017328
% 210.45/210.59 Bristol-Myers Squibb Brand of Fosinopril Sodium
% 210.45/210.59 |- skos__hiddenLabel mesh__D017328 SQ28,555
% 210.45/210.59 |- mesh__historyNote mesh__D017328 93; was FOSENOPRIL %28%NM%29% 1985-92
% 210.45/210.59 |- skos__altLabel mesh__D017328 Ferrer Brand of Fosinopril Sodium
% 210.45/210.59 |- skos__altLabel mesh__D017328 Schwarz Brand of Fosinopril Sodium
% 210.45/210.59 |- skos__altLabel mesh__D017328 Sanol Brand of Fosinopril Sodium
% 210.45/210.59 |- skos__hiddenLabel mesh__D003308 Processes, Duplicating
% 210.45/210.59 |- skos__broader mesh__D003308smesh__D007254
% 210.45/210.59 |- rdf__type mesh__D003308sskos__Concept
% 210.45/210.59 |- skos__hiddenLabel mesh__D003308 Processes, Copying
% 210.45/210.59 |- mesh__recordMaintainer mesh__D003308 PXP
% 210.45/210.59 |- skos__altLabel mesh__D003308 Copying Process
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003308 2000
% 210.45/210.59 |- mesh__dateCreated mesh__D003308 1999-01-01
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003308 2003
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D003308 SJN
% 210.45/210.59 |- skos__hiddenLabel mesh__D003308 Process, Copying
% 210.45/210.59 |- skos__scopeNote mesh__D003308
% 210.45/210.59 Reproduction of data in a new location or other destination, leaving the source data unchanged, although the physical form of the result may differ from that of the source.%A%
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003308 2001
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003308 2004
% 210.45/210.59 |- mesh__recordOriginator mesh__D003308 NLM
% 210.45/210.59 |- skos__altLabel mesh__D003308 Duplicating Process
% 210.45/210.59 |- mesh__dateRevised mesh__D003308 1997-06-20
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003308 2002
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003308 2005
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003308 1998
% 210.45/210.59 |- skos__altLabel mesh__D003308 Duplicating Processes
% 210.45/210.59 |- skos__prefLabel mesh__D003308 Copying Processes
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003308 2006
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D003308 1999
% 210.45/210.59 |- skos__hiddenLabel mesh__D003308 Process, Duplicating
% 210.45/210.59 |- skos__broader mesh__D014030smesh__D014026
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D014030 2006
% 210.45/210.59 |- mesh__dateRevised mesh__D014030 2001-07-25
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D014030 2002
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D014030 2004
% 210.45/210.59 |- skos__altLabel mesh__D014030 Chewing Tobacco
% 210.45/210.59 |- mesh__recordOriginator mesh__D014030 NLM
% 210.45/210.59 |- mesh__recordMaintainer mesh__D014030 ssb
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D014030 2005
% 210.45/210.59 |- skos__scopeNote mesh__D014030
% 210.45/210.59 The powdered leaves of Nicotiana tabacum which are either inhaled through the nose, chewed, or stored in cheek pouches. It includes any product of tobacco that is not smoked.%A%
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D014030 2003
% 210.45/210.59 |- skos__prefLabel mesh__D014030 Tobacco, Smokeless
% 210.45/210.59 |- mesh__dateEstablished mesh__D014030 1991-01-01
% 210.45/210.59 |- mesh__historyNote mesh__D014030
% 210.45/210.59 91%28%86%29%; was see under TOBACCO 1986-90; was SNUFF see under TOBACCO 1963-85%A%
% 210.45/210.59 |- skos__altLabel mesh__D014030 Smokeless Tobacco
% 210.45/210.59 |- rdf__type mesh__D014030sskos__Concept
% 210.45/210.59 |- mesh__dateCreated mesh__D014030 1999-01-01
% 210.45/210.59 |- skos__annotation mesh__D014030 D25-26 qualif
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D014030 sjn
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D014030
% 210.45/210.59 91; was see under TOBACCO 1986-90; was SNUFF see under TOBACCO 1963-85%A%
% 210.45/210.59 |- mesh__onlineNote mesh__D014030
% 210.45/210.59 to search SNUFF use TOBACCO, SMOKELESS 1975-85 %26% TOBACCO 1966-74%A%
% 210.45/210.59 |- skos__annotation mesh__D000010
% 210.45/210.59 neopl = ABDUCENS NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Nerve, Abducens
% 210.45/210.59 |- skos__altLabel mesh__D000010 Sixth Cranial Nerve
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D000010 2000
% 210.45/210.59 |- mesh__onlineNote mesh__D000010
% 210.45/210.59 use ABDUCENS NERVE to search ABDUCENT NERVE 1966-76
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Sixth Cranial Nerves
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Nerve VI, Cranial
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Cranial Nerves, Sixth
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D000010 2003
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 VI, Cranial Nerve
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Nerve, Abducent
% 210.45/210.59 |- mesh__dateCreated mesh__D000010 1999-01-01
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Abducens Nerves
% 210.45/210.59 |- skos__prefLabel mesh__D000010 Abducens Nerve
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D000010 77; was ABDUCENT NERVE 1963-76
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Cranial Nerve, Sixth
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D000010 2006
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Nerves, Sixth Cranial
% 210.45/210.59 |- mesh__historyNote mesh__D000010 77; was ABDUCENT NERVE 1963-76
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D000010 2002
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Nerve, Sixth Cranial
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Cranial Nerve VIs
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D000010 2005
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Nerves, Abducens
% 210.45/210.59 |- mesh__dateRevised mesh__D000010 1999-11-03
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D000010 sjn
% 210.45/210.59 |- rdf__type mesh__D000010sskos__Concept
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Nerves, Abducent
% 210.45/210.59 |- skos__broader mesh__D000010smesh__D003391
% 210.45/210.59 |- mesh__recordOriginator mesh__D000010 NLM
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Nerve VIs, Cranial
% 210.45/210.59 |- skos__altLabel mesh__D000010 Abducent Nerve
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D000010 2001
% 210.45/210.59 |- skos__altLabel mesh__D000010 Cranial Nerve VI
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 VIs, Cranial Nerve
% 210.45/210.59 |- mesh__recordMaintainer mesh__D000010 KEV
% 210.45/210.59 |- skos__scopeNote mesh__D000010
% 210.45/210.59 The 6th cranial nerve. The abducens nerve originates in the abducens nucleus of the pons and sends motor fibers to the lateral rectus muscles of the eye. Damage to the nerve or its nucleus disrupts horizontal eye movement control.%A%
% 210.45/210.59 |- skos__hiddenLabel mesh__D000010 Abducent Nerves
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D000010 2004
% 210.45/210.59 |- mesh__dateEstablished mesh__D046910 2005-01-01
% 210.45/210.59 |- skos__scopeNote mesh__D046910
% 210.45/210.59 The period in the MENSTRUAL CYCLE that is optimal for FERTILIZATION of the OVUM and yielding PREGNANCY. The duration of fertile period depends on the life span of male GAMETES within the female reproductive tract and the time of OVULATION. It usually begins a few days before ovulation and ends on the day of ovulation.%A%
% 210.45/210.59 |- skos__historyNote mesh__D046910 Menstruation %28%1980-2004%29%
% 210.45/210.59 |- mesh__dateCreated mesh__D046910 2004-07-07
% 210.45/210.59 |- skos__prefLabel mesh__D046910 Fertile Period
% 210.45/210.59 |- mesh__historyNote mesh__D046910 2005; use MENSTRUATION 1980-2004
% 210.45/210.59 |- mesh__recordOriginator mesh__D046910 lkt
% 210.45/210.59 |- skos__historyNote mesh__D046910 Fertility %28%1971-2004%29%
% 210.45/210.59 |- mesh__recordAuthorizer mesh__D046910 sjn
% 210.45/210.59 |- mesh__publicMeSHNote mesh__D046910 2005; see MENSTRUATION 1980-2004
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D046910 2005
% 210.45/210.59 |- rdf__type mesh__D046910sskos__Concept
% 210.45/210.59 |- skos__related mesh__D046910smesh__D012252
% 210.45/210.59 |- mesh__recordMaintainer mesh__D046910 lkt
% 210.45/210.59 |- skos__broader mesh__D046910smesh__D008597
% 210.45/210.59 |- mesh__activeMeSHYear mesh__D046910 2006
% 210.45/210.59 |- skos__broader mesh__D013736smesh__D005834
% 210.45/210.59 |- mesh__onlineNote mesh__D013736
% 210.45/210.59 use TESTICULAR NEOPLASMS to search RETE CELL TUMOR 1966-83%A%
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Cancers, Testis
% 210.45/210.59 |- skos__altLabel mesh__D013736 Testis Cancer
% 210.45/210.59 |- mesh__historyNote mesh__D013736 RETE CELL TUMOR was heading 1963-83
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Tumors, Rete Cell
% 210.45/210.59 |- skos__altLabel mesh__D013736 Cancer of the Testis
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Rete Cell Tumors
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Tumor, Rete Cell
% 210.45/210.59 |- skos__prefLabel mesh__D013736 Testicular Neoplasms
% 210.45/210.59 |- skos__related mesh__D013736smesh__D018237
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Testis Cancers
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Cancer, Testicular
% 210.45/210.59 |- mesh__dateRevised mesh__D013736 2005-06-30
% 210.45/210.59 |- skos__altLabel mesh__D013736 Testis Neoplasms
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Testicular Neoplasm
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Testicular Cancers
% 210.45/210.59 |- mesh__recordMaintainer mesh__D013736 lkt
% 210.45/210.59 |- skos__broader mesh__D013736smesh__D013733
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Neoplasm, Testicular
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Cancers, Testicular
% 210.45/210.59 |- skos__altLabel mesh__D013736 Neoplasms, Testis
% 210.45/210.59 |- skos__scopeNote mesh__D013736
% 210.45/210.59 Tumors or cancer of the TESTIS. Germ cell tumors %28%GERMINOMA%29% of the testis constitute 95%25% of all testicular neoplasms.%A%
% 210.45/210.59 |- skos__hiddenLabel mesh__D013736 Testis Neoplasm
% 210.45/210.60 |- mesh__recordOriginator mesh__D013736 NLM
% 210.45/210.60 |- mesh__dateCreated mesh__D013736 1999-01-01
% 210.45/210.60 |- skos__hiddenLabel mesh__D013736 Neoplasm, Testis
% 210.45/210.60 |- skos__altLabel mesh__D013736 Neoplasms, Testicular
% 210.45/210.60 |- skos__annotation mesh__D013736
% 210.45/210.60 coord IM with histol type of neopl %28%IM%29%
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D013736 2006
% 210.45/210.60 |- mesh__publicMeSHNote mesh__D013736
% 210.45/210.60 RETE CELL TUMOR was heading 1963-83
% 210.45/210.60 |- rdf__type mesh__D013736sskos__Concept
% 210.45/210.60 |- skos__hiddenLabel mesh__D013736 Cancer, Testis
% 210.45/210.60 |- skos__altLabel mesh__D013736 Testicular Cancer
% 210.45/210.60 |- skos__broader mesh__D013736smesh__D004701
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D013736 sjn
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D018421 2006
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D018421 2001
% 210.45/210.60 |- skos__broader mesh__D018421smesh__D006348
% 210.45/210.60 |- skos__related mesh__D018421smesh__D019739
% 210.45/210.60 |- mesh__recordOriginator mesh__D018421 PXP
% 210.45/210.60 |- skos__scopeNote mesh__D018421
% 210.45/210.60 An operation that uses stimulated latissimus dorsi muscle %28%SKELETAL MUSCLE VENTRICLE%29% to assist cardiac function. The latissimus dorsi muscle is mobilized from the chest wall and moved into the thorax through the bed of the resected 2nd or 3rd rib. The muscle is then wrapped around the left and right ventricles and stimulated to contract during cardiac systole by means of an implanted burst-stimulator. %28%Stedman, 26th ed%29%%A%
% 210.45/210.60 |- skos__altLabel mesh__D018421 Dynamic Cardiomyoplasty
% 210.45/210.60 |- skos__prefLabel mesh__D018421 Cardiomyoplasty
% 210.45/210.60 |- skos__altLabel mesh__D018421 Cardiomyoplasty, Dynamic
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D018421 2005
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D018421 2004
% 210.45/210.60 |- mesh__recordMaintainer mesh__D018421 PXP
% 210.45/210.60 |- mesh__dateRevised mesh__D018421 1997-06-20
% 210.45/210.60 |- skos__annotation mesh__D018421
% 210.45/210.60 a technique in heart surg using autol skeletal muscle
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D018421 2000
% 210.45/210.60 |- rdf__type mesh__D018421sskos__Concept
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D018421 SJN
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D018421 2003
% 210.45/210.60 |- mesh__dateEstablished mesh__D018421 1995-01-01
% 210.45/210.60 |- mesh__publicMeSHNote mesh__D018421 95
% 210.45/210.60 |- skos__hiddenLabel mesh__D018421 Dynamic Cardiomyoplasties
% 210.45/210.60 |- skos__hiddenLabel mesh__D018421 Cardiomyoplasties, Dynamic
% 210.45/210.60 |- skos__historyNote mesh__D018421 Heart Surgery %28%1987-1994%29%
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D018421 2002
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D018421 1999
% 210.45/210.60 |- mesh__dateCreated mesh__D018421 1994-06-03
% 210.45/210.60 |- skos__hiddenLabel mesh__D018421 Cardiomyoplasties
% 210.45/210.60 |- mesh__historyNote mesh__D018421 95
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D018421 1998
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Spastic Dysarthrias
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Mixed Dysarthrias
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Dysarthrias
% 210.45/210.60 |- mesh__publicMeSHNote mesh__D004401
% 210.45/210.60 91; was see under SPEECH DISORDERS 1963-90
% 210.45/210.60 |- mesh__recordOriginator mesh__D004401 RC
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D004401 2001
% 210.45/210.60 |- skos__historyNote mesh__D004401 Speech Disorders %28%1966-1978%29%
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Flaccid Dysarthrias
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D004401 2006A
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D004401 2006
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Guttural Dysarthria
% 210.45/210.60 |- skos__scopeNote mesh__D004401
% 210.45/210.60 Disorders of speech articulation caused by imperfect coordination of pharynx, larynx, tongue, or face muscles. This may result from CRANIAL NERVE DISEASES; NEUROMUSCULAR DISEASES; CEREBELLAR DISEASES; BASAL GANGLIA DISEASES; BRAIN STEM diseases; or diseases of the corticobulbar tracts %28%see PYRAMIDAL TRACTS%29%. The cortical language centers are intact in this condition. %28%From Adams et al., Principles of Neurology, 6th ed, p489%29%%A%
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D004401 2000
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Dysarthrias, Guttural
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D004401 jls
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Mixed Dysarthria
% 210.45/210.60 |- skos__prefLabel mesh__D004401 Dysarthria
% 210.45/210.60 |- mesh__historyNote mesh__D004401
% 210.45/210.60 91%28%75%29%; was see under SPEECH DISORDERS 1963-90
% 210.45/210.60 |- mesh__dateEstablished mesh__D004401 1991-01-01
% 210.45/210.60 |- mesh__dateRevised mesh__D004401 2005-07-30
% 210.45/210.60 |- skos__altLabel mesh__D004401 Dysarthosis
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D004401 2005
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D004401 2004
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Dysarthrias, Flaccid
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Scanning Dysarthria
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Spastic Dysarthria
% 210.45/210.60 |- rdf__type mesh__D004401sskos__Concept
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Dysarthrias, Mixed
% 210.45/210.60 |- mesh__dateCreated mesh__D004401 1978-05-17
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D004401 2002
% 210.45/210.60 |- mesh__recordMaintainer mesh__D004401 jls
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Scanning Dysarthrias
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D004401 2003
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D004401 2003A
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Dysarthrias, Scanning
% 210.45/210.60 |- mesh__onlineNote mesh__D004401
% 210.45/210.60 use SPEECH DISORDERS to search DYSARTHRIA 1966-74
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Dysarthoses
% 210.45/210.60 |- skos__broader mesh__D004401smesh__D001184
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Guttural Dysarthrias
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Flaccid Dysarthria
% 210.45/210.60 |- skos__hiddenLabel mesh__D004401 Dysarthrias, Spastic
% 210.45/210.60 |- skos__altLabel mesh__D051057 RAC-PK Protein
% 210.45/210.60 |- skos__broader mesh__D051057smesh__D017346
% 210.45/210.60 |- skos__altLabel mesh__D051057 Proto-Oncogene Protein Akt
% 210.45/210.60 |- skos__scopeNote mesh__D051057
% 210.45/210.60 A protein-serine-threonine kinase that is activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. It plays a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells.%A%
% 210.45/210.60 |- mesh__dateCreated mesh__D051057 2005-06-30
% 210.45/210.60 |- skos__altLabel mesh__D051057 Protein Kinase B alpha
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proteins c-akt1, Proto-Oncogene
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D051057 2006
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D051057 sjn
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Related to A and C Protein
% 210.45/210.60 |- skos__altLabel mesh__D051057 Akt-beta Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Rac PK alpha Protein
% 210.45/210.60 |- skos__broader mesh__D051057smesh__D047908
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 c-akt, Proto-Oncogene Proteins
% 210.45/210.60 |- skos__altLabel mesh__D051057 Akt-gamma Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proto Oncogene Proteins c akt3
% 210.45/210.60 |- skos__altLabel mesh__D051057 Rac Protein Kinase
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 RAC PK Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proto Oncogene Proteins c akt2
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Protein, akt Proto-Oncogene
% 210.45/210.60 |- mesh__recordOriginator mesh__D051057 DRC
% 210.45/210.60 |- rdf__type mesh__D051057sskos__Concept
% 210.45/210.60 |- skos__altLabel mesh__D051057 Protein Kinase B gamma
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Akt, Proto-Oncogene Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Protein, c-akt Proto-Oncogene
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proteins c-akt2, Proto-Oncogene
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proteins c-akt3, Proto-Oncogene
% 210.45/210.60 |- mesh__historyNote mesh__D051057 2006%28%1987%29%
% 210.45/210.60 |- skos__prefLabel mesh__D051057 Proto-Oncogene Proteins c-akt
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Akt beta Protein
% 210.45/210.60 |- skos__altLabel mesh__D051057 AKT3 Protein Kinase
% 210.45/210.60 |- skos__altLabel mesh__D051057 Rac-PK beta Protein
% 210.45/210.60 |- skos__altLabel mesh__D051057 Rac-PK alpha Protein
% 210.45/210.60 |- skos__altLabel mesh__D051057 Protein Kinase B
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 akt Proto Oncogene Protein
% 210.45/210.60 |- skos__broader mesh__D051057smesh__D011518
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proto Oncogene Proteins c akt1
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proto Oncogene Protein RAC
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proto Oncogene Protein Akt
% 210.45/210.60 |- skos__altLabel mesh__D051057 Proto-Oncogene Protein RAC
% 210.45/210.60 |- skos__altLabel mesh__D051057 Protein-Serine-Threonine Kinase %28%Rac%29%
% 210.45/210.60 |- skos__altLabel mesh__D051057 AKT1 Protein Kinase
% 210.45/210.60 |- skos__altLabel mesh__D051057 akt Proto-Oncogene Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 alpha Protein, Rac-PK
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proto-Oncogene Protein, akt
% 210.45/210.60 |- mesh__publicMeSHNote mesh__D051057
% 210.45/210.60 2006; PROTO-ONCOGENE PROTEINS C-AKT was indexed under PROTEIN-SERINE-THREONINE KINASES %26% PROTO-ONCOGENE PROTEINS 1987-2005%A%
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proto Oncogene Proteins c akt
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 c akt Proto Oncogene Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 c-akt3, Proto-Oncogene Proteins
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 RAC, Proto-Oncogene Protein
% 210.45/210.60 |- skos__altLabel mesh__D051057 Protein Kinase B beta
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 c-akt2, Proto-Oncogene Proteins
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Proto-Oncogene Protein, c-akt
% 210.45/210.60 |- skos__altLabel mesh__D051057 c-akt Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Akt gamma Protein
% 210.45/210.60 |- skos__altLabel mesh__D051057 Related to A and C-Protein
% 210.45/210.60 |- mesh__dateEstablished mesh__D051057 2006-01-01
% 210.45/210.60 |- skos__altLabel mesh__D051057 Akt-alpha Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Akt alpha Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 c-akt1, Proto-Oncogene Proteins
% 210.45/210.60 |- mesh__recordMaintainer mesh__D051057 DRC
% 210.45/210.60 |- skos__altLabel mesh__D051057 AKT2 Protein Kinase
% 210.45/210.60 |- skos__altLabel mesh__D051057 c-akt Proto-Oncogene Protein
% 210.45/210.60 |- skos__hiddenLabel mesh__D051057 Rac PK beta Protein
% 210.45/210.60 |- mesh__publicMeSHNote mesh__D009695
% 210.45/210.60 78; was see under NUCLEIC ACIDS 1975-77
% 210.45/210.60 |- skos__hiddenLabel mesh__D009695 Renaturations, Nucleic Acid
% 210.45/210.60 |- skos__hiddenLabel mesh__D009695 Acid Renaturation, Nucleic
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 2003
% 210.45/210.60 |- skos__hiddenLabel mesh__D009695 Nucleic Acid Renaturations
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 1994
% 210.45/210.60 |- mesh__dateCreated mesh__D009695 1999-01-01
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 2006
% 210.45/210.60 |- mesh__recordMaintainer mesh__D009695 TGC
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 1997
% 210.45/210.60 |- skos__broader mesh__D009695smesh__D001669
% 210.45/210.60 |- skos__historyNote mesh__D009695 Nucleic Acids %28%1966-1970%29%
% 210.45/210.60 |- mesh__dateRevised mesh__D009695 1992-05-15
% 210.45/210.60 |- skos__hiddenLabel mesh__D009695 Renaturation, Nucleic Acid
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 2001
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 2005
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 1993
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 2000
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 1996
% 210.45/210.60 |- mesh__dateEstablished mesh__D009695 1978-01-01
% 210.45/210.60 |- rdf__type mesh__D009695sskos__Concept
% 210.45/210.60 |- mesh__recordOriginator mesh__D009695 NLM
% 210.45/210.60 |- skos__historyNote mesh__D009695 RNA %28%1966-1970%29%
% 210.45/210.60 |- skos__historyNote mesh__D009695 DNA %28%1966-1970%29%
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 1999
% 210.45/210.60 |- skos__hiddenLabel mesh__D009695 Acid Renaturations, Nucleic
% 210.45/210.60 |- skos__scopeNote mesh__D009695
% 210.45/210.60 The reformation of all, or part of, the native conformation of a nucleic acid molecule after the molecule has undergone denaturation.%A%
% 210.45/210.60 |- skos__prefLabel mesh__D009695 Nucleic Acid Renaturation
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 2004
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D009695 PLS
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 1995
% 210.45/210.60 |- skos__annotation mesh__D009695
% 210.45/210.60 IM general only; coord NIM with DNA or RNA or specific %28%IM%29%%A%
% 210.45/210.60 |- mesh__historyNote mesh__D009695
% 210.45/210.60 78%28%71%29%; was see under NUCLEIC ACIDS 1975-77
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 2002
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D009695 1998
% 210.45/210.60 |- skos__altLabel mesh__D017329 LHRH, Tryptophyl%28%6%29%-
% 210.45/210.60 |- skos__hiddenLabel mesh__D017329 CL118532
% 210.45/210.60 |- mesh__publicMeSHNote mesh__D017329
% 210.45/210.60 1993; TRIPTORELIN was indexed under GONADORELIN/analogs %26% derivatives 1978-1992%A%
% 210.45/210.60 |- skos__altLabel mesh__D017329 LHRH, Trp%28%6%29%-
% 210.45/210.60 |- skos__historyNote mesh__D017329
% 210.45/210.60 Gonadorelin/analogs %26% derivatives %28%1978-1992%29%
% 210.45/210.60 |- mesh__dateEstablished mesh__D017329 1993-01-01
% 210.45/210.60 |- skos__hiddenLabel mesh__D017329 AY 25650
% 210.45/210.60 |- mesh__recordOriginator mesh__D017329 TPW
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D017329 2004
% 210.45/210.60 |- skos__altLabel mesh__D017329 GnRH, Trp%28%6%29%-
% 210.45/210.60 |- mesh__dateCreated mesh__D017329 1992-05-22
% 210.45/210.60 |- skos__broader mesh__D017329smesh__D007987
% 210.45/210.60 |- skos__hiddenLabel mesh__D017329 AY25650
% 210.45/210.60 |- skos__altLabel mesh__D017329
% 210.45/210.60 6-D-Tryptophan-Luteinizing Hormone-Releasing Factor %28%Pig%29%
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D017329 2003
% 210.45/210.60 |- skos__prefLabel mesh__D017329 Triptorelin
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D017329 2006
% 210.45/210.60 |- rdf__type mesh__D017329sskos__Concept
% 210.45/210.60 |- skos__hiddenLabel mesh__D017329 CL 118532
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D017329 2002
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D017329 2005
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D017329 sjn
% 210.45/210.60 |- skos__scopeNote mesh__D017329
% 210.45/210.60 A long-acting GONADORELIN analog agonist. It has been used in the treatment of prostatic cancer, ovarian cancer, precocious puberty, endometriosis, and to induce ovulation for in vitro fertilization.%A%
% 210.45/210.60 |- mesh__historyNote mesh__D017329
% 210.45/210.60 1993; use TRIPTORELIN %28%NM%29% 1980-1992; for LHRH, TRP%28%6%29%- use TRIPTORELIN %28%NM%29% 1995-1999%A%
% 210.45/210.60 |- skos__altLabel mesh__D017329 D-Trp-6-LH-RH
% 210.45/210.60 |- mesh__dateRevised mesh__D017329 2001-07-25
% 210.45/210.60 |- mesh__recordMaintainer mesh__D017329 ssb
% 210.45/210.60 |- mesh__dateCreated mesh__D003309 1999-01-01
% 210.45/210.60 |- mesh__dateRevised mesh__D003309 1999-11-03
% 210.45/210.60 |- skos__hiddenLabel mesh__D003309 Copyrights
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D003309 2003
% 210.45/210.60 |- skos__broader mesh__D003309smesh__D018973
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D003309 2004
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D003309 2000
% 210.45/210.60 |- skos__broader mesh__D003309smesh__D011643
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D003309 2005
% 210.45/210.60 |- skos__annotation mesh__D003309 specify geog
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D003309 2001
% 210.45/210.60 |- mesh__recordOriginator mesh__D003309 NLM
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D003309 2006
% 210.45/210.60 |- skos__prefLabel mesh__D003309 Copyright
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D003309 sjn
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D003309 2002
% 210.45/210.60 |- rdf__type mesh__D003309sskos__Concept
% 210.45/210.60 |- mesh__recordMaintainer mesh__D003309 kle
% 210.45/210.60 |- skos__scopeNote mesh__D003309
% 210.45/210.60 The exclusive right, granted by law for a certain number of years, to make and dispose of copies of a literary, musical or artistic work. In the United States the copyright is granted for the life of the author plus 50 years. In the case of a joint work, it is for the life of the last joint author to die, plus 50 years. In either case the copyright runs until the end of the calendar year 50 years after the author%27%s death. %28%Random House College Dictionary, rev ed; Strong, W.S.: The Copyright Book: a Practical Guide, 1981%29%%A%
% 210.45/210.60 |- skos__historyNote mesh__D014031 Glycosides %28%1966-1973%29%
% 210.45/210.60 |- skos__historyNote mesh__D014031 Aminoglycosides %28%1974%29%
% 210.45/210.60 |- skos__hiddenLabel mesh__D014031 Sulfate, Tobramycin
% 210.45/210.60 |- mesh__dateCreated mesh__D014031 1974-11-11
% 210.45/210.60 |- mesh__historyNote mesh__D014031
% 210.45/210.60 84%28%75%29%; was see under ANTIBIOTICS 1975-83
% 210.45/210.60 |- rdf__type mesh__D014031sskos__Concept
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D014031 sjn
% 210.45/210.60 |- mesh__dateEstablished mesh__D014031 1984-01-01
% 210.45/210.60 |- skos__historyNote mesh__D014031 Antibiotics %28%1966-1974%29%
% 210.45/210.60 |- skos__altLabel mesh__D014031 Nebramycin Factor 6
% 210.45/210.60 |- mesh__dateRevised mesh__D014031 2004-07-07
% 210.45/210.60 |- skos__prefLabel mesh__D014031 Tobramycin
% 210.45/210.60 |- mesh__recordOriginator mesh__D014031 NLM
% 210.45/210.60 |- skos__scopeNote mesh__D014031
% 210.45/210.60 An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10%25% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.%A%
% 210.45/210.60 |- mesh__recordMaintainer mesh__D014031 ssb
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D014031 2006
% 210.45/210.60 |- skos__broader mesh__D014031smesh__D009328
% 210.45/210.60 |- skos__altLabel mesh__D014031 Nebicin
% 210.45/210.60 |- mesh__publicMeSHNote mesh__D014031
% 210.45/210.60 84; was see under ANTIBIOTICS 1975-83
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D014031 2005
% 210.45/210.60 |- skos__annotation mesh__D000011
% 210.45/210.60 infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29%%A%
% 210.45/210.60 |- skos__hiddenLabel mesh__D000011 Virus, Abelson Leukemia
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D000011 2006
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D000011 2006B
% 210.45/210.60 |- mesh__publicMeSHNote mesh__D000011
% 210.45/210.60 2002; see ABELSON LEUKEMIA VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1980-1990%A%
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D000011 ags
% 210.45/210.60 |- skos__hiddenLabel mesh__D000011 Leukemia Virus, Abelson
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D000011 2005
% 210.45/210.60 |- mesh__dateEstablished mesh__D000011 1991-01-01
% 210.45/210.60 |- skos__altLabel mesh__D000011 Abelson Leukemia Virus
% 210.45/210.60 |- rdf__type mesh__D000011sskos__Concept
% 210.45/210.60 |- skos__broader mesh__D000011smesh__D009052
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D000011 2006A
% 210.45/210.60 |- skos__prefLabel mesh__D000011 Abelson murine leukemia virus
% 210.45/210.60 |- mesh__dateRevised mesh__D000011 2005-07-28
% 210.45/210.60 |- mesh__dateCreated mesh__D000011 1979-04-16
% 210.45/210.60 |- mesh__historyNote mesh__D000011 2002 %28%1980%29%
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D000011 2004
% 210.45/210.60 |- mesh__recordMaintainer mesh__D000011 ags
% 210.45/210.60 |- skos__scopeNote mesh__D000011
% 210.45/210.60 A replication-defective strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with FRIEND MURINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; or RAUSCHER VIRUS.%A%
% 210.45/210.60 |- mesh__recordOriginator mesh__D000011 AEP
% 210.45/210.60 |- skos__historyNote mesh__D000011 Mouse Leukemia Viruses %28%1966-1979%29%
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D000011 2003
% 210.45/210.60 |- mesh__recordOriginator mesh__D046911 jmp
% 210.45/210.60 |- mesh__dateEstablished mesh__D046911 2005-01-01
% 210.45/210.60 |- mesh__historyNote mesh__D046911 2005
% 210.45/210.60 |- skos__hiddenLabel mesh__D046911 Compounds, Macromolecular
% 210.45/210.60 |- skos__altLabel mesh__D046911 Macromolecular Compounds and Complexes
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D046911 2005
% 210.45/210.60 |- rdf__type mesh__D046911sskos__Concept
% 210.45/210.60 |- mesh__publicMeSHNote mesh__D046911
% 210.45/210.60 2005; see MACROMOLECULAR SYSTEMS 1966-2004
% 210.45/210.60 |- skos__hiddenLabel mesh__D046911 Complexes, Macromolecular
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D046911 2006
% 210.45/210.60 |- skos__annotation mesh__D046911
% 210.45/210.60 general only; do not use as a routine coordinate with specific macromolecular substances%A%
% 210.45/210.60 |- mesh__recordAuthorizer mesh__D046911 sjn
% 210.45/210.60 |- mesh__recordMaintainer mesh__D046911 jmp
% 210.45/210.60 |- mesh__runningHead mesh__D046911 D5 - MACROMOLECULAR SUBSTANCES
% 210.45/210.60 |- skos__prefLabel mesh__D046911 Macromolecular Substances
% 210.45/210.60 |- skos__hiddenLabel mesh__D046911 Substances, Macromolecular
% 210.45/210.60 |- skos__scopeNote mesh__D046911
% 210.45/210.60 Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kD in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure.%A%
% 210.45/210.60 |- mesh__dateCreated mesh__D046911 2004-07-07
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D013737 2006
% 210.45/210.60 |- rdf__type mesh__D013737sskos__Concept
% 210.45/210.60 |- mesh__dateCreated mesh__D013737 1999-01-01
% 210.45/210.60 |- mesh__recordOriginator mesh__D013737 NLM
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D013737 2004
% 210.45/210.60 |- skos__related mesh__D013737smesh__D009919
% 210.45/210.60 |- mesh__recordMaintainer mesh__D013737 lkt
% 210.45/210.60 |- mesh__activeMeSHYear mesh__D013737 2005
% 210.46/210.60 |- mesh__recordAuthorizer mesh__D013737 sjn
% 210.46/210.60 |- skos__prefLabel mesh__D013737 Testis
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D013737 2003
% 210.46/210.60 |- skos__altLabel mesh__D013737 Testicles
% 210.46/210.60 |- skos__annotation mesh__D013737
% 210.46/210.60 torsion = SPERMATIC CORD TORSION; inflammation = ORCHITIS; /abnorm: agenesis or dysgenesis: coord TESTIS /abnorm %28%IM%29% with GONADAL DYSGENESIS %28%IM%29%; /cytol: consider also LEYDIG CELLS; /surg is probably ORCHIECTOMY; excision = ORCHIECTOMY%A%
% 210.46/210.60 |- skos__broader mesh__D013737smesh__D005837
% 210.46/210.60 |- mesh__dateRevised mesh__D013737 2002-07-03
% 210.46/210.60 |- mesh__considerAlso mesh__D013737 consider also terms at ORCHI-
% 210.46/210.60 |- skos__scopeNote mesh__D013737
% 210.46/210.60 The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells %28%SPERMATOGENESIS%29% and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.%A%
% 210.46/210.60 |- skos__broader mesh__D013737smesh__D006066
% 210.46/210.60 |- skos__hiddenLabel mesh__D013737 Testicle
% 210.46/210.60 |- skos__altLabel mesh__D013737 Testes
% 210.46/210.60 |- skos__altLabel mesh__D051856 FANC Proteins
% 210.46/210.60 |- mesh__recordMaintainer mesh__D051856 DRC
% 210.46/210.60 |- skos__broader mesh__D051856smesh__D011506
% 210.46/210.60 |- skos__scopeNote mesh__D051856
% 210.46/210.60 A diverse group of proteins whose genetic MUTATIONS have been associated with the chromosomal instability syndrome FANCONI ANEMIA. Many of these proteins play important roles in protecting CELLS against OXIDATIVE STRESS.%A%
% 210.46/210.60 |- mesh__recordAuthorizer mesh__D051856 sjn
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D051856 2006
% 210.46/210.60 |- mesh__dateCreated mesh__D051856 2005-06-30
% 210.46/210.60 |- skos__prefLabel mesh__D051856
% 210.46/210.60 Fanconi Anemia Complementation Group Proteins
% 210.46/210.60 |- rdf__type mesh__D051856sskos__Concept
% 210.46/210.60 |- skos__annotation mesh__D051856 general; prefer specifics
% 210.46/210.60 |- mesh__recordOriginator mesh__D051856 DRC
% 210.46/210.60 |- mesh__dateEstablished mesh__D051856 2006-01-01
% 210.46/210.60 |- mesh__historyNote mesh__D051856 2006%28%1993%29%
% 210.46/210.60 |- skos__altLabel mesh__D051856 Fanconi Anemia Proteins
% 210.46/210.60 |- mesh__publicMeSHNote mesh__D051856
% 210.46/210.60 2006; FANCONI ANEMIA PROTEINS was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% CELL CYCLE PROTEINS 1993-2005%A%
% 210.46/210.60 |- skos__broader mesh__D004402smesh__D001342
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D004402 2003
% 210.46/210.60 |- skos__altLabel mesh__D004402 Riley-Day Syndrome
% 210.46/210.60 |- mesh__recordOriginator mesh__D004402 NLM
% 210.46/210.60 |- skos__broader mesh__D004402smesh__D009477
% 210.46/210.60 |- mesh__dateRevised mesh__D004402 2001-07-25
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D004402 2006
% 210.46/210.60 |- mesh__recordAuthorizer mesh__D004402 sjn
% 210.46/210.60 |- skos__altLabel mesh__D004402
% 210.46/210.60 Type 3 Hereditary Sensory Neuropathy, Dominant
% 210.46/210.60 |- skos__altLabel mesh__D004402
% 210.46/210.60 HSAN %28%Hereditary Sensory and Autonomic Neuropathy%29% Type III
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D004402 2002
% 210.46/210.60 |- mesh__historyNote mesh__D004402 81; was AUTONOMIC DYSFUNCTION 1963-80
% 210.46/210.60 |- skos__altLabel mesh__D004402
% 210.46/210.60 Hereditary-Sensory and Autonomic Neuropathy Type III
% 210.46/210.60 |- skos__altLabel mesh__D004402
% 210.46/210.60 Hereditary Sensory Neuropathy, Dominant, Type III
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D004402 2005
% 210.46/210.60 |- skos__annotation mesh__D004402
% 210.46/210.60 do not confuse with DYSAUTONOMIA see AUTONOMIC NERVOUS SYSTEM DISEASES%A%
% 210.46/210.60 |- skos__hiddenLabel mesh__D004402 Syndrome, Riley-Day
% 210.46/210.60 |- rdf__type mesh__D004402sskos__Concept
% 210.46/210.60 |- mesh__onlineNote mesh__D004402
% 210.46/210.60 use DYSAUTONOMIA, FAMILIAL to search AUTONOMIC DYSFUNCTION 1966-80%A%
% 210.46/210.60 |- skos__altLabel mesh__D004402
% 210.46/210.60 Type III Hereditary Sensory Neuropathy, Dominant
% 210.46/210.60 |- skos__altLabel mesh__D004402 HSAN Type III
% 210.46/210.60 |- skos__altLabel mesh__D004402
% 210.46/210.60 Neuropathy, Hereditary and Autonomic, Type III
% 210.46/210.60 |- skos__scopeNote mesh__D004402
% 210.46/210.60 An autosomal disorder of the peripheral and autonomic nervous systems limited to individuals of Ashkenazic Jewish descent. Clinical manifestations are present at birth and include diminished lacrimation, defective thermoregulation, orthostatic hypotension %28%HYPOTENSION, ORTHOSTATIC%29%, fixed pupils, excessive SWEATING, loss of pain and temperature sensation, and absent reflexes. Pathologic features include reduced numbers of small diameter peripheral nerve fibers and autonomic ganglion neurons. %28%From Adams et al., Principles of Neurology, 6th ed, p1348; Nat Genet 1993;4%28%2%29%:160-4%29%%A%
% 210.46/210.60 |- skos__altLabel mesh__D004402
% 210.46/210.60 Dominant Hereditary Sensory Neuropathy, Type III
% 210.46/210.60 |- skos__hiddenLabel mesh__D004402 Familial Dysautonomia
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D004402 2004
% 210.46/210.60 |- skos__altLabel mesh__D004402
% 210.46/210.60 Hereditary Sensory Neuropathy, Type 3, Dominant
% 210.46/210.60 |- mesh__recordMaintainer mesh__D004402 nns
% 210.46/210.60 |- mesh__dateCreated mesh__D004402 1999-01-01
% 210.46/210.60 |- mesh__publicMeSHNote mesh__D004402
% 210.46/210.60 81; was AUTONOMIC DYSFUNCTION 1963-80
% 210.46/210.60 |- skos__altLabel mesh__D004402
% 210.46/210.60 Hereditary Sensory Neuropathy, Dominant, Type 3
% 210.46/210.60 |- skos__hiddenLabel mesh__D004402 Riley Day Syndrome
% 210.46/210.60 |- skos__prefLabel mesh__D004402 Dysautonomia, Familial
% 210.46/210.60 |- mesh__recordOriginator mesh__D051058 DRC
% 210.46/210.60 |- skos__broader mesh__D051058smesh__D017346
% 210.46/210.60 |- skos__altLabel mesh__D051058 akt-Oncogene Protein
% 210.46/210.60 |- skos__hiddenLabel mesh__D051058 Oncogene Protein v akt
% 210.46/210.60 |- skos__hiddenLabel mesh__D051058 v-akt, Oncogene Protein
% 210.46/210.60 |- skos__altLabel mesh__D051058 v-akt Kinase Transforming Protein
% 210.46/210.60 |- skos__hiddenLabel mesh__D051058 v akt Kinase Transforming Protein
% 210.46/210.60 |- mesh__dateEstablished mesh__D051058 2006-01-01
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D051058 2006
% 210.46/210.60 |- mesh__recordAuthorizer mesh__D051058 sjn
% 210.46/210.60 |- skos__altLabel mesh__D051058 Oncogene Protein akt
% 210.46/210.60 |- skos__hiddenLabel mesh__D051058 akt, Oncogene Protein
% 210.46/210.60 |- skos__hiddenLabel mesh__D051058 akt Oncogene Protein
% 210.46/210.60 |- skos__altLabel mesh__D051058 v-akt Protein
% 210.46/210.60 |- mesh__publicMeSHNote mesh__D051058
% 210.46/210.60 2006; ONCOGENE PROTEIN V-AKT was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2005, %26% under RETROVIRIDAE PROTEINS 1987-1989%A%
% 210.46/210.60 |- mesh__dateCreated mesh__D051058 2005-06-30
% 210.46/210.60 |- skos__broader mesh__D051058smesh__D015682
% 210.46/210.60 |- rdf__type mesh__D051058sskos__Concept
% 210.46/210.60 |- mesh__historyNote mesh__D051058 2006%28%1987%29%
% 210.46/210.60 |- skos__scopeNote mesh__D051058
% 210.46/210.60 A viral oncoprotein originally isolated from a murine T CELL LYMPHOMA infected with the acutely transforming retrovirus AKT8. v-akt protein is the viral homologue of PROTO-ONCOGENE PROTEINS C-AKT.%A%
% 210.46/210.60 |- skos__prefLabel mesh__D051058 Oncogene Protein v-akt
% 210.46/210.60 |- mesh__recordMaintainer mesh__D051058 DRC
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D009696 2002
% 210.46/210.60 |- skos__broader mesh__D009696smesh__D009706
% 210.46/210.60 |- mesh__recordOriginator mesh__D009696 NLM
% 210.46/210.60 |- skos__hiddenLabel mesh__D009696 Acids, Nucleic
% 210.46/210.60 |- mesh__activeMeSHYear mesh__D009696 2005
% 210.46/210.60 |- mesh__recordAuthorizer mesh__D009696 sjn
% 210.46/210.61 |- skos__annotation mesh__D009696
% 210.46/210.61 GEN: prefer RNA %26% DNA whether Priority 1, 2 or 3 article;%A%
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D009696 2006
% 210.46/210.61 |- skos__scopeNote mesh__D009696
% 210.46/210.61 High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages.%A%
% 210.46/210.61 |- rdf__type mesh__D009696sskos__Concept
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D009696 2000
% 210.46/210.61 |- skos__prefLabel mesh__D009696 Nucleic Acids
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D009696 2003
% 210.46/210.61 |- mesh__recordMaintainer mesh__D009696 jmp
% 210.46/210.61 |- mesh__dateCreated mesh__D009696 1999-01-01
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D009696 2004
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D009696 2001
% 210.46/210.61 |- mesh__dateRevised mesh__D009696 1999-11-03
% 210.46/210.61 |- mesh__recordOriginator mesh__D042521 ags
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D042521 sjn
% 210.46/210.61 |- rdf__type mesh__D042521sskos__Concept
% 210.46/210.61 |- mesh__dateCreated mesh__D042521 2003-07-09
% 210.46/210.61 |- mesh__publicMeSHNote mesh__D042521 2004
% 210.46/210.61 |- skos__broader mesh__D042521smesh__D016946
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D042521 2006
% 210.46/210.61 |- mesh__dateEstablished mesh__D042521 2004-01-01
% 210.46/210.61 |- mesh__dateRevised mesh__D042521 2005-06-30
% 210.46/210.61 |- skos__broader mesh__D042521smesh__D020562
% 210.46/210.61 |- skos__prefLabel mesh__D042521 Burkholderiaceae
% 210.46/210.61 |- mesh__historyNote mesh__D042521 2004
% 210.46/210.61 |- mesh__recordMaintainer mesh__D042521 SYSTEM
% 210.46/210.61 |- skos__scopeNote mesh__D042521
% 210.46/210.61 A family of gram negative, aerobic, non-sporeforming, rod-shaped bacteria.%A%
% 210.46/210.61 |- mesh__recordOriginator mesh__D014830 NLM
% 210.46/210.61 |- skos__annotation mesh__D014830
% 210.46/210.61 consider also APTITUDE or APTITUDE TESTS
% 210.46/210.61 |- skos__broader mesh__D014830smesh__D011588
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 1997
% 210.46/210.61 |- skos__scopeNote mesh__D014830
% 210.46/210.61 Systematic efforts to assist individuals in selecting an occupation or suitable employment on the basis of aptitude, education, etc.%A%
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 2005
% 210.46/210.61 |- skos__prefLabel mesh__D014830 Vocational Guidance
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 2002
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 2004
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 2001
% 210.46/210.61 |- skos__hiddenLabel mesh__D014830 Counseling, Career
% 210.46/210.61 |- mesh__dateCreated mesh__D014830 1999-01-01
% 210.46/210.61 |- mesh__recordMaintainer mesh__D014830 JLS
% 210.46/210.61 |- mesh__dateRevised mesh__D014830 1996-06-10
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 2003
% 210.46/210.61 |- rdf__type mesh__D014830sskos__Concept
% 210.46/210.61 |- skos__hiddenLabel mesh__D014830 Guidance, Vocational
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 2000
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 1999
% 210.46/210.61 |- skos__broader mesh__D014830smesh__D011590
% 210.46/210.61 |- skos__altLabel mesh__D014830 Career Counseling
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D014830 PLS
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 1998
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014830 2006
% 210.46/210.61 |- skos__altLabel mesh__D014032 Ecarazine
% 210.46/210.61 |- rdf__type mesh__D014032sskos__Concept
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014032 2001
% 210.46/210.61 |- mesh__onlineNote mesh__D014032
% 210.46/210.61 use TODRALAZINE to search BINAZINE 1975-79
% 210.46/210.61 |- mesh__dateEstablished mesh__D014032 1991-01-01
% 210.46/210.61 |- mesh__recordMaintainer mesh__D014032 CCR
% 210.46/210.61 |- skos__altLabel mesh__D014032 Binazin
% 210.46/210.61 |- skos__historyNote mesh__D014032 Heterocyclic Compounds %28%1971-1974%29%
% 210.46/210.61 |- mesh__dateRevised mesh__D014032 2000-06-21
% 210.46/210.61 |- mesh__historyNote mesh__D014032
% 210.46/210.61 91%28%80%29%; was see under HYDRAZINES 1980-90; was BINAZINE see under HYDRAZINES 1975-79%A%
% 210.46/210.61 |- skos__prefLabel mesh__D014032 Todralazine
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D014032 sjn
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014032 2006
% 210.46/210.61 |- skos__broader mesh__D014032smesh__D010793
% 210.46/210.61 |- skos__scopeNote mesh__D014032
% 210.46/210.61 An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects.%A%
% 210.46/210.61 |- mesh__dateCreated mesh__D014032 1974-11-19
% 210.46/210.61 |- mesh__publicMeSHNote mesh__D014032
% 210.46/210.61 91; was see under HYDRAZINES 1980-90; was BINAZINE see under HYDRAZINES 1975-79%A%
% 210.46/210.61 |- skos__altLabel mesh__D014032 Todrazoline
% 210.46/210.61 |- skos__historyNote mesh__D014032 Hydrazines %28%1971-1974%29%
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014032 2005
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014032 2004
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014032 2002
% 210.46/210.61 |- skos__broader mesh__D014032smesh__D006834
% 210.46/210.61 |- skos__historyNote mesh__D014032 Carboxylic Acids %28%1972-1974%29%
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D014032 2003
% 210.46/210.61 |- mesh__recordOriginator mesh__D014032 NLM
% 210.46/210.61 |- mesh__recordOriginator mesh__D000810 NLM
% 210.46/210.61 |- mesh__recordMaintainer mesh__D000810 AGS
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000810 2002
% 210.46/210.61 |- rdf__type mesh__D000810sskos__Concept
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000810 2005
% 210.46/210.61 |- skos__prefLabel mesh__D000810 Angola
% 210.46/210.61 |- skos__annotation mesh__D000810 a republic in southern Africa
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000810 2003
% 210.46/210.61 |- skos__broader mesh__D000810smesh__D000353
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000810 2006
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000810 1998
% 210.46/210.61 |- skos__scopeNote mesh__D000810
% 210.46/210.61 A republic in southern Africa, southwest of DEMOCRATIC REPUBLIC OF THE CONGO and west of ZAMBIA. Its capital is Luanda. It was formerly a Portuguese overseas province called Portuguese West Africa, having been reached by Portuguese sailors in 1483, with Portuguese rule established in 1575. Its status was changed from colony to overseas province in 1951 and it received its independence in 1975. Angola is named for N%27%gola, a native ruler there in the 16th century. %28%From Webster%27%s New Geographical Dictionary, 1988, p51 %26% Room, Brewer%27%s Dictionary of Names, 1992, p23%29%%A%
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000810 2004
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D000810 SJN
% 210.46/210.61 |- mesh__dateCreated mesh__D000810 1999-01-01
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000810 1999
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000810 2000
% 210.46/210.61 |- mesh__dateRevised mesh__D000810 1997-06-20
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000810 2001
% 210.46/210.61 |- mesh__recordMaintainer mesh__D000012 lkt
% 210.46/210.61 |- skos__prefLabel mesh__D000012 Abetalipoproteinemia
% 210.46/210.61 |- rdf__type mesh__D000012sskos__Concept
% 210.46/210.61 |- mesh__historyNote mesh__D000012 1966%28%1964%29%
% 210.46/210.61 |- skos__hiddenLabel mesh__D000012 Diseases, Betalipoprotein Deficiency
% 210.46/210.61 |- skos__hiddenLabel mesh__D000012 Disease, Betalipoprotein Deficiency
% 210.46/210.61 |- skos__broader mesh__D000012smesh__D020739
% 210.46/210.61 |- skos__altLabel mesh__D000012
% 210.46/210.61 Deficiency Disease, Microsomal Triglyceride Transfer Protein
% 210.46/210.61 |- skos__altLabel mesh__D000012 Apolipoprotein B Deficiency Disease
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D000012 sjn
% 210.46/210.61 |- mesh__dateRevised mesh__D000012 2005-06-30
% 210.46/210.61 |- mesh__publicMeSHNote mesh__D000012 1966
% 210.46/210.61 |- skos__altLabel mesh__D000012 Bassen-Kornzweig Disease
% 210.46/210.61 |- skos__hiddenLabel mesh__D000012 Bassen Kornzweig Syndrome
% 210.46/210.61 |- skos__broader mesh__D000012smesh__D007009
% 210.46/210.61 |- skos__hiddenLabel mesh__D000012 Diseases, Bassen-Kornzweig
% 210.46/210.61 |- skos__hiddenLabel mesh__D000012 Bassen-Kornzweig Diseases
% 210.46/210.61 |- mesh__recordOriginator mesh__D000012 NLM
% 210.46/210.61 |- skos__broader mesh__D000012smesh__D001796
% 210.46/210.61 |- skos__hiddenLabel mesh__D000012 Bassen Kornzweig Disease
% 210.46/210.61 |- skos__hiddenLabel mesh__D000012 Betalipoprotein Deficiency Diseases
% 210.46/210.61 |- skos__annotation mesh__D000012
% 210.46/210.61 do not confuse with HYPOBETALIPOPROTEINEMIA
% 210.46/210.61 |- skos__altLabel mesh__D000012 Deficiency Disease, Betalipoprotein
% 210.46/210.61 |- skos__scopeNote mesh__D000012
% 210.46/210.61 A disorder of lipid metabolism inherited as an autosomal recessive trait characterized by the near absence of APOLIPOPROTEINS B and apoB-containing lipoproteins in plasma. Microsomal triglyceride transfer protein is deficient or absent in enterocytes. Clinical and laboratory findings include acanthocytosis, hypocholesterolemia, peripheral neuropathy, posterior column degeneration, ataxia, and steatorrhea. Intellectual abilities may also be impaired. %28%Menkes, Textbook of Child Neurology, 5th ed, p118; Curr Opin Lipidol 1994 Apr;5%28%2%29%:81-6%29%%A%
% 210.46/210.61 |- mesh__dateCreated mesh__D000012 1999-01-01
% 210.46/210.61 |- mesh__dateEstablished mesh__D000012 1966-01-01
% 210.46/210.61 |- skos__hiddenLabel mesh__D000012 Deficiency Diseases, Betalipoprotein
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D000012 2006
% 210.46/210.61 |- skos__altLabel mesh__D000012
% 210.46/210.61 Microsomal Triglyceride Transfer Protein Deficiency Disease
% 210.46/210.61 |- skos__altLabel mesh__D000012 Betalipoprotein Deficiency Disease
% 210.46/210.61 |- skos__altLabel mesh__D000012 Bassen-Kornzweig Syndrome
% 210.46/210.61 |- skos__altLabel mesh__D000012 Deficiency Disease, Apolipoprotein B
% 210.46/210.61 |- skos__hiddenLabel mesh__D000012 Abetalipoproteinemias
% 210.46/210.61 |- skos__related mesh__D000012smesh__D001055
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D046912 sjn
% 210.46/210.61 |- mesh__dateRevised mesh__D046912 2005-06-30
% 210.46/210.61 |- skos__altLabel mesh__D046912 Macromolecular Protein Complexes
% 210.46/210.61 |- skos__annotation mesh__D046912
% 210.46/210.61 general only; do not use as a routine coordinate with specific multiprotein complexes; MULTIENZYME COMPLEXES is also available%A%
% 210.46/210.61 |- mesh__dateEstablished mesh__D046912 2005-01-01
% 210.46/210.61 |- mesh__publicMeSHNote mesh__D046912
% 210.46/210.61 2005; see MACROMOLECULAR SYSTEMS 1966-2004
% 210.46/210.61 |- skos__historyNote mesh__D046912
% 210.46/210.61 Macromolecular Substances %28%1966-2004%29%
% 210.46/210.61 |- mesh__recordMaintainer mesh__D046912 SYSTEM
% 210.46/210.61 |- skos__scopeNote mesh__D046912
% 210.46/210.61 Macromolecular complexes formed from the association of defined protein subunits.%A%
% 210.46/210.61 |- mesh__historyNote mesh__D046912
% 210.46/210.61 2005; use MACROMOLECULAR SUBSTANCES 1966-2004
% 210.46/210.61 |- skos__broader mesh__D046912smesh__D046911
% 210.46/210.61 |- rdf__type mesh__D046912sskos__Concept
% 210.46/210.61 |- mesh__dateCreated mesh__D046912 2004-07-07
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D046912 2006
% 210.46/210.61 |- skos__hiddenLabel mesh__D046912 Complexes, Macromolecular Protein
% 210.46/210.61 |- skos__prefLabel mesh__D046912 Multiprotein Complexes
% 210.46/210.61 |- skos__hiddenLabel mesh__D046912 Protein Complexes, Macromolecular
% 210.46/210.61 |- skos__hiddenLabel mesh__D046912 Complexes, Multiprotein
% 210.46/210.61 |- mesh__recordOriginator mesh__D046912 jmp
% 210.46/210.61 |- mesh__historyNote mesh__D013738 73%28%64%29%
% 210.46/210.61 |- mesh__publicMeSHNote mesh__D013738 73
% 210.46/210.61 |- mesh__dateRevised mesh__D013738 2005-06-30
% 210.46/210.61 |- mesh__dateEstablished mesh__D013738 1973-01-01
% 210.46/210.61 |- skos__altLabel mesh__D013738 1-Dehydrotestolactone
% 210.46/210.61 |- mesh__recordOriginator mesh__D013738 NLM
% 210.46/210.61 |- skos__broader mesh__D013738smesh__D000730
% 210.46/210.61 |- skos__broader mesh__D013738smesh__D006718
% 210.46/210.61 |- skos__altLabel mesh__D013738 delta%28%1%29%-Testolactone
% 210.46/210.61 |- skos__scopeNote mesh__D013738
% 210.46/210.61 An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.%A%
% 210.46/210.61 |- skos__altLabel mesh__D013738 Bristol-Myers Squibb Brand of Testolactone
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D013738 sjn
% 210.46/210.61 |- mesh__recordMaintainer mesh__D013738 CCR
% 210.46/210.61 |- skos__hiddenLabel mesh__D013738 1 Dehydrotestolactone
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D013738 2006
% 210.46/210.61 |- rdf__type mesh__D013738sskos__Concept
% 210.46/210.61 |- mesh__dateCreated mesh__D013738 1999-01-01
% 210.46/210.61 |- skos__prefLabel mesh__D013738 Testolactone
% 210.46/210.61 |- skos__hiddenLabel mesh__D013738
% 210.46/210.61 Bristol Myers Squibb Brand of Testolactone
% 210.46/210.61 |- mesh__dateRevised mesh__D010440 2000-06-22
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D010440 2005
% 210.46/210.61 |- mesh__recordMaintainer mesh__D010440 CCR
% 210.46/210.61 |- mesh__recordOriginator mesh__D010440 NLM
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D010440 2004
% 210.46/210.61 |- mesh__dateCreated mesh__D010440 1974-11-19
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D010440 2002
% 210.46/210.61 |- skos__historyNote mesh__D010440 Peptides %28%1974%29%
% 210.46/210.61 |- rdf__type mesh__D010440sskos__Concept
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D010440 2003
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D010440 2001
% 210.46/210.61 |- mesh__historyNote mesh__D010440
% 210.46/210.61 91%28%75%29%; was see under MELPHALAN 1981-90; was see under NITROGEN MUSTARD COMPOUNDS 1975-80%A%
% 210.46/210.61 |- skos__broader mesh__D010440smesh__D008558
% 210.46/210.61 |- mesh__dateEstablished mesh__D010440 1991-01-01
% 210.46/210.61 |- skos__scopeNote mesh__D010440
% 210.46/210.61 A mixture of six synthetic oligopeptides, each containing MELPHALAN. It is used as a broad-spectrum antineoplastic due to its alkylating and antimetabolic actions but, is toxic to bone marrow, gastrointestinal system and vasculature.%A%
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D010440 2006
% 210.46/210.61 |- skos__broader mesh__D010440smesh__D009842
% 210.46/210.61 |- skos__prefLabel mesh__D010440 Peptichemio
% 210.46/210.61 |- mesh__publicMeSHNote mesh__D010440
% 210.46/210.61 91; was see under MELPHALAN 1981-90; was see under NITROGEN MUSTARD COMPOUNDS 1975-80%A%
% 210.46/210.61 |- skos__historyNote mesh__D010440 Nitrogen Mustard Compounds %28%1974%29%
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D010440 sjn
% 210.46/210.61 |- skos__hiddenLabel mesh__D051857 Transcription Factor, Otx1
% 210.46/210.61 |- skos__broader mesh__D051857smesh__D014157
% 210.46/210.61 |- skos__hiddenLabel mesh__D051857 Transcription Factor, Otx2
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D051857 2006
% 210.46/210.61 |- mesh__recordMaintainer mesh__D051857 DRC
% 210.46/210.61 |- rdf__type mesh__D051857sskos__Concept
% 210.46/210.61 |- skos__hiddenLabel mesh__D051857 Transcription Factors, Otx
% 210.46/210.61 |- mesh__recordOriginator mesh__D051857 DRC
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D051857 sjn
% 210.46/210.61 |- skos__altLabel mesh__D051857 Homeobox Protein OTX2
% 210.46/210.61 |- skos__hiddenLabel mesh__D051857 Homeodomain Proteins, Otx
% 210.46/210.61 |- skos__altLabel mesh__D051857 Otx Homeodomain Proteins
% 210.46/210.61 |- skos__altLabel mesh__D051857 Orthodenticle Homolog Homeodomain Proteins
% 210.46/210.61 |- mesh__dateCreated mesh__D051857 2005-06-30
% 210.46/210.61 |- skos__prefLabel mesh__D051857 Otx Transcription Factors
% 210.46/210.61 |- skos__hiddenLabel mesh__D051857 OTX1, Homeobox Protein
% 210.46/210.61 |- mesh__publicMeSHNote mesh__D051857
% 210.46/210.61 2006; OTX TRANSCRIPTION FACTORS was indexed under HOMEODOMAIN PROTEINS 2000-2005%A%
% 210.46/210.61 |- skos__altLabel mesh__D051857 Homeobox Protein OTX1
% 210.46/210.61 |- mesh__historyNote mesh__D051857 2006%28%2000%29%
% 210.46/210.61 |- skos__scopeNote mesh__D051857
% 210.46/210.61 A family of VERTEBRATE homeodomain proteins that share homology with orthodenticle protein, Drosophila. They regulate GENETIC TRANSCRIPTION and play an important role in EMBRYONIC DEVELOPMENT of the BRAIN.%A%
% 210.46/210.61 |- skos__hiddenLabel mesh__D051857 OTX2, Homeobox Protein
% 210.46/210.61 |- skos__broader mesh__D051857smesh__D018398
% 210.46/210.61 |- mesh__dateEstablished mesh__D051857 2006-01-01
% 210.46/210.61 |- mesh__recordMaintainer mesh__D004403 ags
% 210.46/210.61 |- skos__prefLabel mesh__D004403 Dysentery
% 210.46/210.61 |- skos__hiddenLabel mesh__D004403 Diarrheal Disease, Infectious
% 210.46/210.61 |- mesh__recordOriginator mesh__D004403 NLM
% 210.46/210.61 |- rdf__type mesh__D004403sskos__Concept
% 210.46/210.61 |- skos__scopeNote mesh__D004403
% 210.46/210.61 Acute inflammation of the intestine associated with infectious DIARRHEA of various etiologies, generally acquired by eating contaminated food containing TOXINS, BIOLOGICAL derived from BACTERIA; PROTOZOA; or other microorganisms. Dysentery is characterized initially by watery FECES then by bloody mucoid stools. It is often associated with ABDOMINAL PAIN; FEVER; and DEHYDRATION.%A%
% 210.46/210.61 |- mesh__dateRevised mesh__D004403 2005-07-08
% 210.46/210.61 |- skos__broader mesh__D004403smesh__D005759
% 210.46/210.61 |- skos__hiddenLabel mesh__D004403 Infectious Diarrheal Diseases
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D004403 ags
% 210.46/210.61 |- mesh__dateCreated mesh__D004403 1999-01-01
% 210.46/210.61 |- skos__altLabel mesh__D004403 Infectious Diarrheal Disease
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D004403 2006
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D004403 2006A
% 210.46/210.61 |- skos__broader mesh__D004403smesh__D007410
% 210.46/210.61 |- mesh__recordMaintainer mesh__D051059 DRC
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D051059 2006
% 210.46/210.61 |- skos__prefLabel mesh__D051059 PTEN Phosphohydrolase
% 210.46/210.61 |- mesh__publicMeSHNote mesh__D051059
% 210.46/210.61 2006; PTEN PROTEIN was indexed under PROTEIN-TYROSINE-PHOSPHATASES 1997-1998, under TUMOR SUPPRESSOR PROTEINS 1997-2005, %26% under PHOSPHORIC MONOESTER HYDROLASES 1999-2005%A%
% 210.46/210.61 |- skos__scopeNote mesh__D051059
% 210.46/210.61 A lipid phosphatase that acts on phosphatidylinositol-3,4,5-trisphosphate to regulate various SIGNAL TRANSDUCTION PATHWAYS. It modulates CELL GROWTH PROCESSES; CELL MIGRATION; and APOPTOSIS. Mutations in PTEN are associated with COWDEN DISEASE and PROTEUS SYNDROME as well as NEOPLASTIC CELL TRANSFORMATION.%A%
% 210.46/210.61 |- skos__altLabel mesh__D051059
% 210.46/210.61 Phosphatase and Tensin Homologue on Chromosome Ten Protein
% 210.46/210.61 |- rdf__type mesh__D051059sskos__Concept
% 210.46/210.61 |- skos__broader mesh__D051059smesh__D010744
% 210.46/210.61 |- mesh__dateEstablished mesh__D051059 2006-01-01
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D051059 sjn
% 210.46/210.61 |- skos__altLabel mesh__D051059 PTEN Protein
% 210.46/210.61 |- skos__hiddenLabel mesh__D051059 Phosphatase, PTEN
% 210.46/210.61 |- skos__altLabel mesh__D051059
% 210.46/210.61 Mutated In Multiple Advanced Cancers 1 Protein
% 210.46/210.61 |- skos__altLabel mesh__D051059 PTEN Phosphatase
% 210.46/210.61 |- mesh__historyNote mesh__D051059 2006%28%1997%29%
% 210.46/210.61 |- skos__hiddenLabel mesh__D051059 Phosphohydrolase, PTEN
% 210.46/210.61 |- skos__broader mesh__D051059smesh__D047908
% 210.46/210.61 |- mesh__dateCreated mesh__D051059 2005-06-30
% 210.46/210.61 |- mesh__recordOriginator mesh__D051059 DRC
% 210.46/210.61 |- skos__altLabel mesh__D051059 MMAC1 Protein
% 210.46/210.61 |- skos__broader mesh__D051059smesh__D025521
% 210.46/210.61 |- skos__altLabel mesh__D009697 Nucleolar Organizer
% 210.46/210.61 |- skos__prefLabel mesh__D009697 Nucleolus Organizer Region
% 210.46/210.61 |- skos__historyNote mesh__D009697 Chromosomes %28%1966-1979%29%
% 210.46/210.61 |- mesh__dateRevised mesh__D009697 2005-06-30
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D009697 2006
% 210.46/210.61 |- skos__hiddenLabel mesh__D009697 Nucleolus Organizer Regions
% 210.46/210.61 |- mesh__historyNote mesh__D009697 80
% 210.46/210.61 |- skos__hiddenLabel mesh__D009697 Organizer Region, Nucleolus
% 210.46/210.61 |- skos__hiddenLabel mesh__D009697 Nucleolar Organizers
% 210.46/210.61 |- rdf__type mesh__D009697sskos__Concept
% 210.46/210.61 |- skos__hiddenLabel mesh__D009697 Region, Nucleolus Organizer
% 210.46/210.61 |- skos__hiddenLabel mesh__D009697 Organizers, Nucleolar
% 210.46/210.61 |- mesh__recordAuthorizer mesh__D009697 sjn
% 210.46/210.61 |- mesh__recordMaintainer mesh__D009697 nns
% 210.46/210.61 |- skos__scopeNote mesh__D009697
% 210.46/210.61 The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA.%A%
% 210.46/210.61 |- skos__hiddenLabel mesh__D009697 Organizer, Nucleolar
% 210.46/210.61 |- mesh__dateEstablished mesh__D009697 1980-01-01
% 210.46/210.61 |- mesh__dateCreated mesh__D009697 1979-05-25
% 210.46/210.61 |- skos__hiddenLabel mesh__D009697 Organizer Regions, Nucleolus
% 210.46/210.61 |- skos__historyNote mesh__D009697 Cell Nucleolus %28%1966-1979%29%
% 210.46/210.61 |- skos__historyNote mesh__D009697 Chromosomes, Human %28%1978-1979%29%
% 210.46/210.61 |- mesh__publicMeSHNote mesh__D009697 80
% 210.46/210.61 |- mesh__recordOriginator mesh__D009697 VDK
% 210.46/210.61 |- skos__broader mesh__D009697smesh__D040481
% 210.46/210.61 |- skos__broader mesh__D009697smesh__D022004
% 210.46/210.61 |- skos__hiddenLabel mesh__D009697 Regions, Nucleolus Organizer
% 210.46/210.61 |- skos__historyNote mesh__D009697
% 210.46/210.61 specific human chromosome %28%1968-1979%29%
% 210.46/210.61 |- skos__altLabel mesh__D042522 Gene Replication Timing
% 210.46/210.61 |- skos__broader mesh__D042522smesh__D004261
% 210.46/210.61 |- mesh__historyNote mesh__D042522 2004
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D042522 2006
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 Timings, Chromosome Replication
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 DNA Replication Timings
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 Timing, DNA Replication
% 210.46/210.61 |- mesh__activeMeSHYear mesh__D042522 2005
% 210.46/210.61 |- skos__altLabel mesh__D042522 DNA Replication Pattern, Temporal
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 Replication Timing, DNA
% 210.46/210.61 |- skos__historyNote mesh__D042522 DNA Replication %28%1968-2003%29%
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 Replication Timing, Chromosome
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 Replication Timings, DNA
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 Replication Timings, Chromosome
% 210.46/210.61 |- skos__related mesh__D042522smesh__D016196
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 Timing, Chromosome Replication
% 210.46/210.61 |- skos__scopeNote mesh__D042522
% 210.46/210.61 The temporal order in which the DNA of the GENOME is replicated.%A%
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 Replication Timing, Gene
% 210.46/210.61 |- skos__hiddenLabel mesh__D042522 Timing, Gene Replication
% 210.46/210.61 |- skos__altLabel mesh__D042522 DNA Replication Order, Temporal
% 210.47/210.61 |- mesh__dateEstablished mesh__D042522 2004-01-01
% 210.47/210.61 |- skos__altLabel mesh__D042522 Chromosome Replication Pattern, Temporal
% 210.47/210.61 |- skos__hiddenLabel mesh__D042522 Chromosome Replication Timings
% 210.47/210.61 |- skos__hiddenLabel mesh__D042522 Timings, DNA Replication
% 210.47/210.61 |- rdf__type mesh__D042522sskos__Concept
% 210.47/210.61 |- skos__hiddenLabel mesh__D042522 Timings, Gene Replication
% 210.47/210.61 |- skos__altLabel mesh__D042522 Chromosome Replication Timing
% 210.47/210.61 |- skos__altLabel mesh__D042522 Gene Replication Pattern, Temporal
% 210.47/210.61 |- skos__hiddenLabel mesh__D042522 Replication Timings, Gene
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D042522 2004
% 210.47/210.61 |- skos__hiddenLabel mesh__D042522 Gene Replication Timings
% 210.47/210.61 |- mesh__dateCreated mesh__D042522 2003-07-09
% 210.47/210.61 |- skos__prefLabel mesh__D042522 DNA Replication Timing
% 210.47/210.61 |- mesh__publicMeSHNote mesh__D042522 2004
% 210.47/210.61 |- skos__prefLabel mesh__D020070 Cervical Ripening
% 210.47/210.61 |- mesh__dateCreated mesh__D020070 1998-06-10
% 210.47/210.61 |- skos__hiddenLabel mesh__D020070 Cervical Ripenings
% 210.47/210.61 |- skos__broader mesh__D020070smesh__D007743
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D020070 2005
% 210.47/210.61 |- skos__historyNote mesh__D020070 Cervix Uteri %28%1976-1998%29%
% 210.47/210.61 |- rdf__type mesh__D020070sskos__Concept
% 210.47/210.61 |- skos__hiddenLabel mesh__D020070 Ripenings, Cervical
% 210.47/210.61 |- skos__scopeNote mesh__D020070
% 210.47/210.61 A change in the CERVIX UTERI with respect to its readiness to relax. The cervix normally becomes softer, more flexible, more distensible, and shorter in the final weeks of PREGNANCY. These cervical changes can also be chemically induced %28%LABOR, INDUCED%29%.%A%
% 210.47/210.61 |- mesh__historyNote mesh__D020070 99
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D020070 2006
% 210.47/210.61 |- mesh__recordAuthorizer mesh__D020070 sjn
% 210.47/210.61 |- mesh__recordOriginator mesh__D020070 NDW
% 210.47/210.61 |- mesh__dateRevised mesh__D020070 2004-07-07
% 210.47/210.61 |- mesh__dateEstablished mesh__D020070 1999-01-01
% 210.47/210.61 |- mesh__recordMaintainer mesh__D020070 lkt
% 210.47/210.61 |- skos__hiddenLabel mesh__D020070 Ripening, Cervical
% 210.47/210.61 |- mesh__publicMeSHNote mesh__D020070 99
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D014831 2004
% 210.47/210.61 |- skos__annotation mesh__D014831
% 210.47/210.61 human only: for animal use VOCALIZATION, ANIMAL
% 210.47/210.61 |- skos__prefLabel mesh__D014831 Voice
% 210.47/210.61 |- mesh__recordMaintainer mesh__D014831 nns
% 210.47/210.61 |- mesh__dateCreated mesh__D014831 1999-01-01
% 210.47/210.61 |- skos__related mesh__D014831smesh__D013060
% 210.47/210.61 |- rdf__type mesh__D014831sskos__Concept
% 210.47/210.61 |- mesh__dateRevised mesh__D014831 2003-07-09
% 210.47/210.61 |- skos__broader mesh__D014831smesh__D044702
% 210.47/210.61 |- mesh__recordOriginator mesh__D014831 NLM
% 210.47/210.61 |- mesh__recordAuthorizer mesh__D014831 sjn
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D014831 2006
% 210.47/210.61 |- skos__hiddenLabel mesh__D014831 Voices
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D014831 2005
% 210.47/210.61 |- skos__related mesh__D014831smesh__D010699
% 210.47/210.61 |- skos__scopeNote mesh__D014831
% 210.47/210.61 The sounds produced by humans by the passage of air through the LARYNX and over the VOCAL CORDS, and then modified by the resonance organs, the NASOPHARYNX, and the MOUTH.%A%
% 210.47/210.61 |- mesh__dateRevised mesh__D014033 2005-06-30
% 210.47/210.61 |- skos__hiddenLabel mesh__D014033 Toe Interphalangeal Joints
% 210.47/210.61 |- skos__hiddenLabel mesh__D014033 Toe Interphalangeal Joint
% 210.47/210.61 |- mesh__recordMaintainer mesh__D014033 ags
% 210.47/210.61 |- rdf__type mesh__D014033sskos__Concept
% 210.47/210.61 |- skos__prefLabel mesh__D014033 Toe Joint
% 210.47/210.61 |- skos__scopeNote mesh__D014033
% 210.47/210.61 The articulation between the head of one phalanx and the base of the one distal to it, in each toe.%A%
% 210.47/210.61 |- skos__hiddenLabel mesh__D014033 Foot Interphalangeal Joint
% 210.47/210.61 |- mesh__publicMeSHNote mesh__D014033 65
% 210.47/210.61 |- skos__broader mesh__D014033smesh__D033023
% 210.47/210.61 |- mesh__recordOriginator mesh__D014033 NLM
% 210.47/210.61 |- skos__hiddenLabel mesh__D014033 Foot Interphalangeal Joints
% 210.47/210.61 |- skos__hiddenLabel mesh__D014033 Joint, Toe
% 210.47/210.61 |- skos__hiddenLabel mesh__D014033 Joints, Toe
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D014033 2006
% 210.47/210.61 |- mesh__historyNote mesh__D014033 65
% 210.47/210.61 |- mesh__dateCreated mesh__D014033 1999-01-01
% 210.47/210.61 |- skos__altLabel mesh__D014033 Interphalangeal Joint of Foot
% 210.47/210.61 |- mesh__recordAuthorizer mesh__D014033 sjn
% 210.47/210.61 |- skos__annotation mesh__D014033
% 210.47/210.61 restrict to humans and other vertebrates; differentiate from TOES%A%
% 210.47/210.61 |- skos__altLabel mesh__D014033 Interphalangeal Joint of Toe
% 210.47/210.61 |- mesh__dateEstablished mesh__D014033 1965-01-01
% 210.47/210.61 |- skos__hiddenLabel mesh__D014033 Toe Joints
% 210.47/210.61 |- mesh__dateRevised mesh__D000811 2003-07-09
% 210.47/210.61 |- mesh__historyNote mesh__D000811 72
% 210.47/210.61 |- mesh__dateEstablished mesh__D000811 1972-01-01
% 210.47/210.61 |- mesh__dateCreated mesh__D000811 1999-01-01
% 210.47/210.61 |- mesh__recordOriginator mesh__D000811 NLM
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D000811 2004
% 210.47/210.61 |- rdf__type mesh__D000811sskos__Concept
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D000811 2006
% 210.47/210.61 |- mesh__recordAuthorizer mesh__D000811 sjn
% 210.47/210.61 |- mesh__recordMaintainer mesh__D000811 ags
% 210.47/210.61 |- skos__prefLabel mesh__D000811 Anguilla
% 210.47/210.61 |- skos__broader mesh__D000811smesh__D004524
% 210.47/210.61 |- skos__historyNote mesh__D000811 Eels %28%1966-1971%29%
% 210.47/210.61 |- mesh__publicMeSHNote mesh__D000811 72
% 210.47/210.61 |- skos__hiddenLabel mesh__D000811 Anguillas
% 210.47/210.61 |- mesh__activeMeSHYear mesh__D000811 2005
% 210.47/210.62 |- skos__annotation mesh__D000811
% 210.47/210.62 eel; NIM when exper animal: no qualif; when IM, qualif permitted%A%
% 210.47/210.62 |- mesh__onlineNote mesh__D000013
% 210.47/210.62 pre-explosion = ABNORMALITIES %28%PX%29%
% 210.47/210.62 |- skos__altLabel mesh__D000013 Birth Defects
% 210.47/210.62 |- skos__hiddenLabel mesh__D000013 Abnormality
% 210.47/210.62 |- skos__altLabel mesh__D000013 Deformities
% 210.47/210.62 |- skos__altLabel mesh__D000013 Defects, Congenital
% 210.47/210.62 |- skos__altLabel mesh__D000013 Abnormalities, Congenital
% 210.47/210.62 |- skos__hiddenLabel mesh__D000013 Deformity
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000013 2004
% 210.47/210.62 |- skos__broader mesh__D000013smesh__D009358
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000013 2002
% 210.47/210.62 |- skos__altLabel mesh__D000013 Congenital Defects
% 210.47/210.62 |- mesh__dateRevised mesh__D000013 2000-06-22
% 210.47/210.62 |- skos__hiddenLabel mesh__D000013 Abnormality, Congenital
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000013 2003
% 210.47/210.62 |- mesh__dateCreated mesh__D000013 1999-01-01
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D000013 sjn
% 210.47/210.62 |- skos__hiddenLabel mesh__D000013 Defect, Birth
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000013 2006
% 210.47/210.62 |- skos__prefLabel mesh__D000013 Abnormalities
% 210.47/210.62 |- mesh__recordOriginator mesh__D000013 NLM
% 210.47/210.62 |- skos__hiddenLabel mesh__D000013 Defects, Birth
% 210.47/210.62 |- skos__hiddenLabel mesh__D000013 Birth Defect
% 210.47/210.62 |- skos__hiddenLabel mesh__D000013 Congenital Abnormality
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000013 2001
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000013 2005
% 210.47/210.62 |- rdf__type mesh__D000013sskos__Concept
% 210.47/210.62 |- skos__hiddenLabel mesh__D000013 Defect, Congenital
% 210.47/210.62 |- skos__hiddenLabel mesh__D000013 Congenital Defect
% 210.47/210.62 |- mesh__recordMaintainer mesh__D000013 jls
% 210.47/210.62 |- skos__annotation mesh__D000013
% 210.47/210.62 GEN only: prefer /abnorm: Manual 19.7+, 19.8.1; do not use /compl /congen %26% do not coord with INFANT, NEWBORN, DISEASES; policy: Manual 23.20+; TN 109: relation to /congen %26% INFANT, NEWBORN, DISEASES%A%
% 210.47/210.62 |- skos__altLabel mesh__D000013 Congenital Abnormalities
% 210.47/210.62 |- skos__scopeNote mesh__D000013
% 210.47/210.62 Congenital malformations of organs or parts.
% 210.47/210.62 |- mesh__dateRevised mesh__D038481 2005-07-12
% 210.47/210.62 |- mesh__recordOriginator mesh__D038481 lkt
% 210.47/210.62 |- mesh__historyNote mesh__D038481 2003
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D038481 2005
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D038481 2006A
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D038481 2006
% 210.47/210.62 |- skos__prefLabel mesh__D038481 Anterior Temporal Lobectomy
% 210.47/210.62 |- skos__hiddenLabel mesh__D038481 Lobectomy, Anterior Temporal
% 210.47/210.62 |- mesh__recordMaintainer mesh__D038481 ags
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D038481 2003
% 210.47/210.62 |- skos__broader mesh__D038481smesh__D019635
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D038481 2003
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D038481 2004
% 210.47/210.62 |- mesh__dateCreated mesh__D038481 2002-07-02
% 210.47/210.62 |- skos__scopeNote mesh__D038481
% 210.47/210.62 A neurosurgical procedure that removes the anterior TEMPORAL LOBE including the medial temporal structures of CEREBRAL CORTEX; AMYGDALA; HIPPOCAMPUS; and the adjacent PARAHIPPOCAMPAL GYRUS. This procedure is generally used for the treatment of intractable temporal epilepsy %28%EPILEPSY, TEMPORAL LOBE%29%.%A%
% 210.47/210.62 |- skos__related mesh__D038481smesh__D004833
% 210.47/210.62 |- skos__historyNote mesh__D038481
% 210.47/210.62 Epilepsy, Temporal Lobe %28%1965-2002%29%
% 210.47/210.62 |- rdf__type mesh__D038481sskos__Concept
% 210.47/210.62 |- mesh__dateEstablished mesh__D038481 2003-01-01
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D038481 ags
% 210.47/210.62 |- mesh__recordMaintainer mesh__D046913 ssb
% 210.47/210.62 |- skos__annotation mesh__D046913
% 210.47/210.62 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D046913 sjn
% 210.47/210.62 |- mesh__historyNote mesh__D046913 2005
% 210.47/210.62 |- rdf__type mesh__D046913sskos__Concept
% 210.47/210.62 |- skos__scopeNote mesh__D046913
% 210.47/210.62 A plant species of the family FABACEAE used to study GENETICS because it is DIPLOID, self fertile, has a small genome, and short generation time.%A%
% 210.47/210.62 |- skos__prefLabel mesh__D046913 Medicago truncatula
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D046913 2006
% 210.47/210.62 |- mesh__dateEstablished mesh__D046913 2005-01-01
% 210.47/210.62 |- mesh__dateCreated mesh__D046913 2004-07-07
% 210.47/210.62 |- mesh__recordOriginator mesh__D046913 ssb
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D046913 2005
% 210.47/210.62 |- skos__historyNote mesh__D046913 Medicago %28%1992-2004%29%
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D046913 2005
% 210.47/210.62 |- skos__broader mesh__D046913smesh__D029902
% 210.47/210.62 |- skos__altLabel mesh__D013739 Ortho Brand of Testosterone
% 210.47/210.62 |- skos__prefLabel mesh__D013739 Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 Dr. Kade Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 CEPA Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 Solvay Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 17-beta-Hydroxy-8 alpha-4-Androsten-3-one
% 210.47/210.62 |- skos__annotation mesh__D013739
% 210.47/210.62 TESTOSTERONE PROPIONATE is also available
% 210.47/210.62 |- mesh__recordMaintainer mesh__D013739 ags
% 210.47/210.62 |- skos__altLabel mesh__D013739 Ulmer Brand of Testosterone
% 210.47/210.62 |- skos__hiddenLabel mesh__D013739 8 Isotestosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 Paladin Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739
% 210.47/210.62 Auxilium Pharmaceuticals Inc. Brand of Testosterone
% 210.47/210.62 |- skos__broader mesh__D013739smesh__D000737
% 210.47/210.62 |- mesh__historyNote mesh__D013739
% 210.47/210.62 1963; for SUSTANON use TESTOSTERONE %28%NM%29% 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965%A%
% 210.47/210.62 |- skos__altLabel mesh__D013739 Unimed Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 SmithKline Beecham Brand of Testosterone
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D013739 2006
% 210.47/210.62 |- rdf__type mesh__D013739sskos__Concept
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D013739
% 210.47/210.62 1963; SUSTANON was indexed under TESTOSTERONE/AA 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965%A%
% 210.47/210.62 |- mesh__dateCreated mesh__D013739 1999-01-01
% 210.47/210.62 |- skos__scopeNote mesh__D013739
% 210.47/210.62 A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.%A%
% 210.47/210.62 |- skos__altLabel mesh__D013739 Bartor Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 Watson Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 Ferring Brand of Testosterone
% 210.47/210.62 |- mesh__recordOriginator mesh__D013739 NLM
% 210.47/210.62 |- mesh__dateRevised mesh__D013739 2005-07-27
% 210.47/210.62 |- skos__hiddenLabel mesh__D013739
% 210.47/210.62 17 beta Hydroxy 8 alpha 4 Androsten 3 one
% 210.47/210.62 |- skos__altLabel mesh__D013739 AstraZeneca Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 17-beta-Hydroxy-4-Androsten-3-one
% 210.47/210.62 |- skos__broader mesh__D013739smesh__D045165
% 210.47/210.62 |- skos__altLabel mesh__D013739 Schering Brand of Testosterone
% 210.47/210.62 |- skos__hiddenLabel mesh__D013739 17 beta Hydroxy 4 Androsten 3 one
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D013739 ags
% 210.47/210.62 |- skos__altLabel mesh__D013739 Faulding Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 Pasadena Brand of Testosterone
% 210.47/210.62 |- skos__altLabel mesh__D013739 GlaxoSmithKline Brand of Testosterone
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D013739 2006A
% 210.47/210.62 |- skos__altLabel mesh__D013739 Hauck Brand of Testosterone
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D024461 sjn
% 210.47/210.62 |- skos__altLabel mesh__D024461 Myosin I
% 210.47/210.62 |- mesh__dateRevised mesh__D024461 2005-06-30
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D024461
% 210.47/210.62 2002; for MYOSIN IA %26% MYOSIN IB see MYOSIN 1988-2001
% 210.47/210.62 |- skos__prefLabel mesh__D024461 Myosin Type I
% 210.47/210.62 |- mesh__recordMaintainer mesh__D024461 DRC
% 210.47/210.62 |- skos__scopeNote mesh__D024461
% 210.47/210.62 A subclass of myosins found generally associated with actin-rich membrane structures such as filopodia. Members of the myosin type I family are ubiquitously expressed in eukaryotes. The heavy chains of myosin type I lack coiled-coil forming sequences in their tails and therefore do not dimerize.%A%
% 210.47/210.62 |- mesh__dateCreated mesh__D024461 2001-07-25
% 210.47/210.62 |- mesh__dateEstablished mesh__D024461 2002-01-01
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D024461 2006
% 210.47/210.62 |- skos__broader mesh__D024461smesh__D009218
% 210.47/210.62 |- rdf__type mesh__D024461sskos__Concept
% 210.47/210.62 |- mesh__historyNote mesh__D024461
% 210.47/210.62 2002; for MYOSIN IA %26% MYOSIN IB use MYOSINS 1988-2001
% 210.47/210.62 |- skos__historyNote mesh__D024461 Myosins %28%1987-2001%29%
% 210.47/210.62 |- mesh__recordOriginator mesh__D024461 jmp
% 210.47/210.62 |- skos__altLabel mesh__D018424 Middle Ear Cholesteatoma
% 210.47/210.62 |- mesh__historyNote mesh__D018424 95
% 210.47/210.62 |- skos__prefLabel mesh__D018424 Cholesteatoma, Middle Ear
% 210.47/210.62 |- mesh__dateEstablished mesh__D018424 1995-01-01
% 210.47/210.62 |- skos__broader mesh__D018424smesh__D002781
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D018424 2000
% 210.47/210.62 |- skos__historyNote mesh__D018424 Ear, Middle %28%1966-1994%29%
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D018424 2006
% 210.47/210.62 |- skos__hiddenLabel mesh__D018424 Middle Ear Cholesteatomas
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D018424 95
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D018424 2005
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D018424 sjn
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D018424 2004
% 210.47/210.62 |- skos__broader mesh__D018424smesh__D004427
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D018424 2002
% 210.47/210.62 |- mesh__recordOriginator mesh__D018424 PXP
% 210.47/210.62 |- rdf__type mesh__D018424sskos__Concept
% 210.47/210.62 |- skos__scopeNote mesh__D018424
% 210.47/210.62 Cholesteatoma of the middle ear, usually associated with chronic infection, and commonly affecting the tympanum, epitympanum, and antrum.%A%
% 210.47/210.62 |- mesh__recordMaintainer mesh__D018424 KEV
% 210.47/210.62 |- mesh__dateRevised mesh__D018424 1999-11-03
% 210.47/210.62 |- mesh__dateCreated mesh__D018424 1994-06-03
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D018424 2003
% 210.47/210.62 |- skos__historyNote mesh__D018424 Ear Diseases %28%1966-1994%29%
% 210.47/210.62 |- skos__hiddenLabel mesh__D018424 Cholesteatomas, Middle Ear
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D018424 2001
% 210.47/210.62 |- skos__historyNote mesh__D018424 Cholesteatoma %28%1966-1994%29%
% 210.47/210.62 |- mesh__dateRevised mesh__D010441 2004-07-30
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D010441
% 210.47/210.62 2005; see PEPTIDE CHAIN ELONGATION 1973-2004
% 210.47/210.62 |- mesh__recordMaintainer mesh__D010441 jls
% 210.47/210.62 |- skos__prefLabel mesh__D010441 Peptide Chain Elongation, Translational
% 210.47/210.62 |- skos__related mesh__D010441smesh__D010458
% 210.47/210.62 |- skos__altLabel mesh__D010441 Chain Elongation, Peptide, Translational
% 210.47/210.62 |- rdf__type mesh__D010441sskos__Concept
% 210.47/210.62 |- mesh__recordOriginator mesh__D010441 NLM
% 210.47/210.62 |- skos__related mesh__D010441smesh__D010445
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D010441 2005
% 210.47/210.62 |- mesh__historyNote mesh__D010441 2005%28%1971%29%
% 210.47/210.62 |- skos__historyNote mesh__D010441 Peptides/biosynthesis %28%1966-1970%29%
% 210.47/210.62 |- mesh__dateEstablished mesh__D010441 1973-01-01
% 210.47/210.62 |- mesh__dateCreated mesh__D010441 1999-01-01
% 210.47/210.62 |- skos__related mesh__D010441smesh__D011500
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D010441 2006
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D010441 jls
% 210.47/210.62 |- skos__altLabel mesh__D010441 Translational Peptide Chain Elongation
% 210.47/210.62 |- skos__broader mesh__D010441smesh__D014176
% 210.47/210.62 |- skos__altLabel mesh__D010441 Protein Chain Elongation, Translational
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D010441 2005A
% 210.47/210.62 |- skos__annotation mesh__D010441
% 210.47/210.62 coordinate with specific peptide; for protein biosynthesis on the ribosome only; for non-ribosomal biosynthesis use PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%A%
% 210.47/210.62 |- skos__scopeNote mesh__D010441
% 210.47/210.62 A process of GENETIC TRANSLATION, when an amino acid is transferred from its cognate TRANSFER RNA to the lengthening chain of PEPTIDES.%A%
% 210.47/210.62 |- mesh__dateCreated mesh__D051858 2005-06-30
% 210.47/210.62 |- skos__scopeNote mesh__D051858
% 210.47/210.62 A subclass of winged helix DNA-binding proteins that share homology with their founding member fork head protein, Drosophila.%A%
% 210.47/210.62 |- mesh__recordOriginator mesh__D051858 DRC
% 210.47/210.62 |- skos__altLabel mesh__D051858 Fox Transcription Factors
% 210.47/210.62 |- skos__altLabel mesh__D051858 Forkhead Box Transcription Factors
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D051858 2006
% 210.47/210.62 |- skos__hiddenLabel mesh__D051858 Transcription Factors, Fox
% 210.47/210.62 |- mesh__historyNote mesh__D051858 2006%28%1989%29%
% 210.47/210.62 |- rdf__type mesh__D051858sskos__Concept
% 210.47/210.62 |- skos__hiddenLabel mesh__D051858 Transcription Factors, Forkhead
% 210.47/210.62 |- mesh__recordMaintainer mesh__D051858 DRC
% 210.47/210.62 |- mesh__dateEstablished mesh__D051858 2006-01-01
% 210.47/210.62 |- skos__altLabel mesh__D051858 Forkhead Proteins
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D051858
% 210.47/210.62 2006; FORKHEAD TRANSCRIPTION FACTORS was indexed under NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A%
% 210.47/210.62 |- skos__altLabel mesh__D051858 Forkhead Box Proteins
% 210.47/210.62 |- skos__broader mesh__D051858smesh__D051540
% 210.47/210.62 |- skos__prefLabel mesh__D051858 Forkhead Transcription Factors
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D051858 sjn
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Intestinal Entamoebiasis
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Amoebic Dysenteries
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Amebic Dysenteries
% 210.47/210.62 |- skos__broader mesh__D004404smesh__D000562
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D004404 2006
% 210.47/210.62 |- mesh__recordOriginator mesh__D004404 NLM
% 210.47/210.62 |- skos__broader mesh__D004404smesh__D007411
% 210.47/210.62 |- rdf__type mesh__D004404sskos__Concept
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Dysenteries, Amebic
% 210.47/210.62 |- skos__scopeNote mesh__D004404
% 210.47/210.62 DYSENTERY caused by intestinal PROTOZOA infection, chiefly with ENTAMOEBA HISTOLYTICA. This condition may be associated with amebic infection of the LIVER and other distant sites.%A%
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Intestinal Amebiases
% 210.47/210.62 |- mesh__recordMaintainer mesh__D004404 lkt
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D004404 sjn
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Entamoebiases, Intestinal
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Dysenteries, Amoebic
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D004404 2005
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Amebic Colitis
% 210.47/210.62 |- skos__broader mesh__D004404smesh__D004403
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Colitides, Amoebic
% 210.47/210.62 |- skos__altLabel mesh__D004404 Intestinal Amebiasis
% 210.47/210.62 |- skos__altLabel mesh__D004404 Colitis, Amebic
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Amebic Colitides
% 210.47/210.62 |- skos__altLabel mesh__D004404 Intestinal Amoebiasis
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Colitides, Amebic
% 210.47/210.62 |- mesh__dateCreated mesh__D004404 1999-01-01
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Colitis, Amoebic
% 210.47/210.62 |- skos__altLabel mesh__D004404 Amoebic Colitis
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Dysentery, Amoebic
% 210.47/210.62 |- mesh__dateRevised mesh__D004404 2004-07-07
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Intestinal Entamoebiases
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Intestinal Amoebiases
% 210.47/210.62 |- skos__prefLabel mesh__D004404 Dysentery, Amebic
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Amoebic Colitides
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Amoebiases, Intestinal
% 210.47/210.62 |- skos__altLabel mesh__D004404 Amebic Dysentery
% 210.47/210.62 |- skos__hiddenLabel mesh__D004404 Amebiases, Intestinal
% 210.47/210.62 |- skos__altLabel mesh__D004404 Amoebic Dysentery
% 210.47/210.62 |- skos__altLabel mesh__D004404 Amoebiasis, Intestinal
% 210.47/210.62 |- skos__altLabel mesh__D004404 Amebiasis, Intestinal
% 210.47/210.62 |- rdf__type mesh__D009698sskos__Concept
% 210.47/210.62 |- mesh__dateCreated mesh__D009698 1999-01-01
% 210.47/210.62 |- skos__scopeNote mesh__D009698
% 210.47/210.62 Proteins conjugated with nucleic acids.
% 210.47/210.62 |- skos__prefLabel mesh__D009698 Nucleoproteins
% 210.47/210.62 |- skos__altLabel mesh__D009698 Nucleoprotein
% 210.47/210.62 |- skos__broader mesh__D009698smesh__D011506
% 210.47/210.62 |- mesh__dateRevised mesh__D009698 2005-06-30
% 210.47/210.62 |- skos__annotation mesh__D009698
% 210.47/210.62 proteins conjugated with nucleic acids: do not confuse with NUCLEAR PROTEINS %28%proteins in the cell nucleus%29%%A%
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D009698 2006
% 210.47/210.62 |- mesh__recordOriginator mesh__D009698 NLM
% 210.47/210.62 |- mesh__recordMaintainer mesh__D009698 SYSTEM
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D009698 sjn
% 210.47/210.62 |- rdf__type mesh__D020071sskos__Concept
% 210.47/210.62 |- mesh__recordMaintainer mesh__D020071 nns
% 210.47/210.62 |- skos__prefLabel mesh__D020071 Interspersed Repetitive Sequences
% 210.47/210.62 |- skos__altLabel mesh__D020071 Elements, Mobile Genetic
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Gene, Jumping
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Repetitive Sequence, Dispersed
% 210.47/210.62 |- mesh__recordOriginator mesh__D020071 NNS
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Element, Mobile Genetic
% 210.47/210.62 |- skos__annotation mesh__D020071
% 210.47/210.62 GEN: prefer specifics - DNA TRANSPOSABLE ELEMENTS or RETROELEMENTS or its indentions%A%
% 210.47/210.62 |- skos__historyNote mesh__D020071
% 210.47/210.62 DNA Transposable Elements %28%1980-1998%29%
% 210.47/210.62 |- skos__broader mesh__D020071smesh__D012091
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D020071 sjn
% 210.47/210.62 |- skos__altLabel mesh__D020071 Interspersed Repetitive Elements
% 210.47/210.62 |- skos__related mesh__D020071smesh__D016254
% 210.47/210.62 |- mesh__dateCreated mesh__D020071 1998-06-10
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Repetitive Elements, Interspersed
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Sequence, Dispersed Repetitive
% 210.47/210.62 |- skos__altLabel mesh__D020071 Dispersed Repetitive Sequences
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Element, Interspersed Repetitive
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Sequences, Interspersed Repetitive
% 210.47/210.62 |- skos__altLabel mesh__D020071 Repetitive Sequences, Interspersed
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D020071 2006
% 210.47/210.62 |- mesh__dateEstablished mesh__D020071 1999-01-01
% 210.47/210.62 |- skos__scopeNote mesh__D020071
% 210.47/210.62 Copies of transposable elements interspersed throughout the genome, some of which are still active and often referred to as %22%jumping genes%22%. There are two classes of interspersed repetitive elements. Class I elements %28%or RETROELEMENTS - such as retrotransposons, retroviruses, LONG INTERSPERSED NUCLEOTIDE ELEMENTS and SHORT INTERSPERSED NUCLEOTIDE ELEMENTS%29% transpose via reverse transcription of an RNA intermediate. Class II elements %28%or DNA TRANSPOSABLE ELEMENTS - such as transposons, Tn elements, insertion sequence elements and mobile gene cassettes of bacterial integrons%29% transpose directly from one site in the DNA to another.%A%
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Sequence, Interspersed Repetitive
% 210.47/210.62 |- skos__altLabel mesh__D020071 Jumping Genes
% 210.47/210.62 |- skos__historyNote mesh__D020071
% 210.47/210.62 Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.47/210.62 |- skos__altLabel mesh__D020071 Repetitive Sequences, Dispersed
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Repetitive Sequence, Interspersed
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Sequences, Dispersed Repetitive
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Interspersed Repetitive Element
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Jumping Gene
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D020071
% 210.47/210.62 99; for MOBILE GENETIC ELEMENTS see DNA INSERTION ELEMENTS 1986-98; for SELFISH DNA see DNA %28%1983-2003%29%%A%
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Dispersed Repetitive Sequence
% 210.47/210.62 |- mesh__dateRevised mesh__D020071 2005-06-30
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Genetic Element, Mobile
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Elements, Interspersed Repetitive
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Interspersed Repetitive Sequence
% 210.47/210.62 |- skos__altLabel mesh__D020071 Genetic Elements, Mobile
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Mobile Genetic Element
% 210.47/210.62 |- skos__broader mesh__D020071smesh__D040481
% 210.47/210.62 |- mesh__historyNote mesh__D020071
% 210.47/210.62 99; for MOBILE GENETIC ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1986-98; for SELFISH DNA use DNA %28%1983-2003%29%%A%
% 210.47/210.62 |- skos__hiddenLabel mesh__D020071 Repetitive Element, Interspersed
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonias, Flaccid
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Flaccid Dysphonias
% 210.47/210.62 |- mesh__dateRevised mesh__D014832 2001-07-25
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonia, Flaccid
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Fatigues, Voice
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Pseudobulbar Dysphonia, Spastic
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D014832 2004
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonias, Spastic
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonias, Hyperkinetic
% 210.47/210.62 |- skos__annotation mesh__D014832 available also is HOARSENESS
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Neurologic Voice Disorders
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Voice Disorders, Neurologic
% 210.47/210.62 |- skos__scopeNote mesh__D014832
% 210.47/210.62 Disorders of voice pitch, loudness, or quality. Dysphonia refers to impaired utterance of sounds by the vocal folds.%A%
% 210.47/210.62 |- mesh__dateEstablished mesh__D014832 1979-01-01
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D014832 1979
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonia, Spastic
% 210.47/210.62 |- mesh__recordMaintainer mesh__D014832 nns
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonia, Hyperkinetic
% 210.47/210.62 |- skos__prefLabel mesh__D014832 Voice Disorders
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D014832 2005
% 210.47/210.62 |- skos__altLabel mesh__D014832 Neurologic Adducter Spastic Dysphonia
% 210.47/210.62 |- mesh__dateCreated mesh__D014832 1978-05-22
% 210.47/210.62 |- skos__broader mesh__D014832smesh__D007818
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Voice Disorder
% 210.47/210.62 |- mesh__recordOriginator mesh__D014832 RC
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D014832 sjn
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonia, Organic Tremor
% 210.47/210.62 |- skos__altLabel mesh__D014832 Neurologic Voice Disorder
% 210.47/210.62 |- mesh__historyNote mesh__D014832 1979
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D014832 2006
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Tremor Dysphonia, Organic
% 210.47/210.62 |- skos__altLabel mesh__D014832 Phonation Disorders
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Disturbance, Voice
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonias, Spastic Pseudobulbar
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Tremor Dysphonias, Organic
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Spastic Dysphonias
% 210.47/210.62 |- rdf__type mesh__D014832sskos__Concept
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Organic Tremor Dysphonias
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D014832 2002
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Hyperkinetic Dysphonias
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonias, Organic Tremor
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Phonation Disorder
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Dysphonia, Spastic Pseudobulbar
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Spastic Pseudobulbar Dysphonias
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D014832 2003
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Voice Fatigues
% 210.47/210.62 |- skos__broader mesh__D014832smesh__D009461
% 210.47/210.62 |- skos__historyNote mesh__D014832 Voice %28%1966-1978%29%
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Pseudobulbar Dysphonias, Spastic
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Fatigue, Voice
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Disturbances, Voice
% 210.47/210.62 |- skos__hiddenLabel mesh__D014832 Voice Disturbances
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D014034 sjn
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D014034 2005
% 210.47/210.62 |- skos__broader mesh__D014034smesh__D005545
% 210.47/210.62 |- skos__annotation mesh__D014034
% 210.47/210.62 TN 117: use for human %26% other vertebrates; TN 238: differentiation from TOE JOINT %26% indexing instructions; NIM when merely locational as in FOOT DERMATOSES %28%IM%29%%A%
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D014034 2006
% 210.47/210.62 |- mesh__dateRevised mesh__D014034 2004-07-13
% 210.47/210.62 |- skos__prefLabel mesh__D014034 Toes
% 210.47/210.62 |- mesh__recordOriginator mesh__D014034 NLM
% 210.47/210.62 |- mesh__dateCreated mesh__D014034 1999-01-01
% 210.47/210.62 |- mesh__recordMaintainer mesh__D014034 sjn
% 210.47/210.62 |- skos__hiddenLabel mesh__D014034 Toe
% 210.47/210.62 |- rdf__type mesh__D014034sskos__Concept
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000812 2002
% 210.47/210.62 |- mesh__recordMaintainer mesh__D000812 adp
% 210.47/210.62 |- skos__broader mesh__D000812smesh__D009930
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000812 2001
% 210.47/210.62 |- mesh__dateCreated mesh__D000812 1999-01-01
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000812 2004
% 210.47/210.62 |- rdf__type mesh__D000812sskos__Concept
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000812 2006
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000812 2003
% 210.47/210.62 |- skos__scopeNote mesh__D000812
% 210.47/210.62 Chemical compounds derived from acids by the elimination of a molecule of water.%A%
% 210.47/210.62 |- mesh__recordOriginator mesh__D000812 NLM
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000812 2005
% 210.47/210.62 |- mesh__dateRevised mesh__D000812 2000-06-21
% 210.47/210.62 |- mesh__historyNote mesh__D000812 66
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D000812 sjn
% 210.47/210.62 |- skos__prefLabel mesh__D000812 Anhydrides
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D000812 66
% 210.47/210.62 |- mesh__dateEstablished mesh__D000812 1966-01-01
% 210.47/210.62 |- mesh__dateCreated mesh__D000014 1999-01-01
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000014 2001
% 210.47/210.62 |- skos__related mesh__D000014smesh__D013723
% 210.47/210.62 |- skos__scopeNote mesh__D000014
% 210.47/210.62 Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.%A%
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000014 2004
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000014 2002
% 210.47/210.62 |- skos__hiddenLabel mesh__D000014 Drug-Induced Abnormality
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000014 2005
% 210.47/210.62 |- skos__hiddenLabel mesh__D000014 Abnormality, Drug-Induced
% 210.47/210.62 |- mesh__historyNote mesh__D000014 64
% 210.47/210.62 |- skos__broader mesh__D000014smesh__D000013
% 210.47/210.62 |- skos__hiddenLabel mesh__D000014 Abnormalities, Drug Induced
% 210.47/210.62 |- skos__altLabel mesh__D000014 Drug-Induced Abnormalities
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000014 2006
% 210.47/210.62 |- skos__hiddenLabel mesh__D000014 Drug Induced Abnormalities
% 210.47/210.62 |- mesh__publicMeSHNote mesh__D000014 64
% 210.47/210.62 |- skos__annotation mesh__D000014
% 210.47/210.62 IM; do not use /chem ind /compl /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific chem /adv eff-pois-tox %28%IM%29% + specific organ /abnorm or specific abnorm /chem ind %28%IM%29%; Manual 23.20.3%A%
% 210.47/210.62 |- skos__prefLabel mesh__D000014 Abnormalities, Drug-Induced
% 210.47/210.62 |- mesh__recordMaintainer mesh__D000014 kle
% 210.47/210.62 |- mesh__dateRevised mesh__D000014 1999-11-03
% 210.47/210.62 |- mesh__recordAuthorizer mesh__D000014 sjn
% 210.47/210.62 |- rdf__type mesh__D000014sskos__Concept
% 210.47/210.62 |- mesh__activeMeSHYear mesh__D000014 2000
% 210.47/210.63 |- mesh__dateEstablished mesh__D000014 1964-01-01
% 210.47/210.63 |- mesh__recordOriginator mesh__D000014 NLM
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000014 2003
% 210.47/210.63 |- rdf__type mesh__D046914sskos__Concept
% 210.47/210.63 |- skos__altLabel mesh__D046914 Coumarouna odorata
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D046914 2006
% 210.47/210.63 |- skos__prefLabel mesh__D046914 Dipteryx
% 210.47/210.63 |- mesh__dateCreated mesh__D046914 2004-07-07
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D046914 2005
% 210.47/210.63 |- skos__broader mesh__D046914smesh__D007887
% 210.47/210.63 |- mesh__recordOriginator mesh__D046914 ssb
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D046914 2005
% 210.47/210.63 |- mesh__recordMaintainer mesh__D046914 ssb
% 210.47/210.63 |- skos__historyNote mesh__D046914 Fabaceae %28%1995-2004%29%
% 210.47/210.63 |- skos__altLabel mesh__D046914 Tonka Bean
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D046914 sjn
% 210.47/210.63 |- skos__scopeNote mesh__D046914
% 210.47/210.63 A plant genus of the family FABACEAE. Members contain COUMARINS.%A%
% 210.47/210.63 |- skos__annotation mesh__D046914
% 210.47/210.63 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.47/210.63 |- mesh__historyNote mesh__D046914 2005
% 210.47/210.63 |- mesh__dateEstablished mesh__D046914 2005-01-01
% 210.47/210.63 |- skos__historyNote mesh__D024462 Myosins %28%1973-2001%29%
% 210.47/210.63 |- skos__historyNote mesh__D024462 Muscle Proteins %28%1965-1972%29%
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D024462 2006
% 210.47/210.63 |- mesh__recordOriginator mesh__D024462 jmp
% 210.47/210.63 |- skos__broader mesh__D024462smesh__D009218
% 210.47/210.63 |- rdf__type mesh__D024462sskos__Concept
% 210.47/210.63 |- mesh__dateEstablished mesh__D024462 2002-01-01
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D024462 sjn
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D024462
% 210.47/210.63 2002; for MYOSIN II see MYOSIN 1983-2001
% 210.47/210.63 |- mesh__historyNote mesh__D024462
% 210.47/210.63 2002; for MYOSIN II use MYOSINS 1983-2001
% 210.47/210.63 |- mesh__recordMaintainer mesh__D024462 DRC
% 210.47/210.63 |- skos__scopeNote mesh__D024462
% 210.47/210.63 The subfamily of myosin proteins that are commonly found in muscle fibers. Myosin II is also involved a diverse array of cellular functions including cell division, transport within the GOLGI APPARATUS, and maintaining MICROVILLI structure.%A%
% 210.47/210.63 |- mesh__dateRevised mesh__D024462 2005-06-30
% 210.47/210.63 |- skos__altLabel mesh__D024462 Myosin II
% 210.47/210.63 |- skos__prefLabel mesh__D024462 Myosin Type II
% 210.47/210.63 |- mesh__dateCreated mesh__D024462 2001-07-25
% 210.47/210.63 |- skos__annotation mesh__D024462 GEN or unspecified; prefer specifics
% 210.47/210.63 |- skos__related mesh__D010442smesh__D010448
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D010442 jls
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D010442 2005A
% 210.47/210.63 |- rdf__type mesh__D010442sskos__Concept
% 210.47/210.63 |- skos__altLabel mesh__D010442 Protein Chain Initiation, Translational
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D010442
% 210.47/210.63 2005; see PEPTIDE CHAIN INITIATION 1973-2004
% 210.47/210.63 |- mesh__recordMaintainer mesh__D010442 jls
% 210.47/210.63 |- skos__scopeNote mesh__D010442
% 210.47/210.63 A process of GENETIC TRANSLATION whereby the formation of a peptide chain is started. It includes assembly of the RIBOSOME components, the MESSENGER RNA coding for the polypeptide to be made, INITIATOR TRNA, and PEPTIDE INITIATION FACTORS; and placement of the first amino acid in the peptide chain. The details and components of this process are unique for prokaryotic protein biosynthesis and eukaryotic protein biosynthesis.%A%
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D010442 2005
% 210.47/210.63 |- skos__prefLabel mesh__D010442 Peptide Chain Initiation, Translational
% 210.47/210.63 |- mesh__dateCreated mesh__D010442 1999-01-01
% 210.47/210.63 |- skos__related mesh__D010442smesh__D018387
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D010442 2006
% 210.47/210.63 |- skos__altLabel mesh__D010442 Translational Peptide Chain Initiation
% 210.47/210.63 |- skos__broader mesh__D010442smesh__D014176
% 210.47/210.63 |- skos__annotation mesh__D010442
% 210.47/210.63 coordinate with specific peptide; for protein biosynthesis on the ribosome only; for non-ribosomal biosynthesis use PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%A%
% 210.47/210.63 |- mesh__dateRevised mesh__D010442 2004-07-30
% 210.47/210.63 |- mesh__recordOriginator mesh__D010442 NLM
% 210.47/210.63 |- mesh__historyNote mesh__D010442 73%28%71%29%
% 210.47/210.63 |- skos__historyNote mesh__D010442 Peptides/biosynthesis %28%1966-1970%29%
% 210.47/210.63 |- mesh__dateEstablished mesh__D010442 1973-01-01
% 210.47/210.63 |- skos__related mesh__D010442smesh__D011500
% 210.47/210.63 |- skos__altLabel mesh__D010442 Chain Initiation, Peptide, Translational
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D051859 sjn
% 210.47/210.63 |- mesh__historyNote mesh__D051859 2006%28%1985%29%
% 210.47/210.63 |- rdf__type mesh__D051859sskos__Concept
% 210.47/210.63 |- mesh__dateCreated mesh__D051859 2005-06-30
% 210.47/210.63 |- skos__altLabel mesh__D051859 Neuroendocrine Peptide 7B2
% 210.47/210.63 |- skos__prefLabel mesh__D051859 Neuroendocrine Secretory Protein 7B2
% 210.47/210.63 |- skos__hiddenLabel mesh__D051859 7B2, Pituitary Protein
% 210.47/210.63 |- skos__altLabel mesh__D051859 Neuroendocrine Protein 7B2
% 210.47/210.63 |- skos__altLabel mesh__D051859 Secretory Granule Endocrine Protein I
% 210.47/210.63 |- skos__hiddenLabel mesh__D051859 7B2, Neuroendocrine Protein
% 210.47/210.63 |- skos__broader mesh__D051859smesh__D009419
% 210.47/210.63 |- skos__hiddenLabel mesh__D051859 7B2, Neuroendocrine Peptide
% 210.47/210.63 |- skos__hiddenLabel mesh__D051859 7B2, Neuroendocrine Chaperone
% 210.47/210.63 |- skos__altLabel mesh__D051859 Pituitary Protein 7B2
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D051859
% 210.47/210.63 2006; NEUROENDOCRINE SECRETORY PROTEIN 7B2 was indexed under NERVE TISSUE PROTEINS %26% PITUITARY HORMONES 1985-2005%A%
% 210.47/210.63 |- mesh__dateEstablished mesh__D051859 2006-01-01
% 210.47/210.63 |- skos__altLabel mesh__D051859 Secretogranin V
% 210.47/210.63 |- mesh__recordMaintainer mesh__D051859 DRC
% 210.47/210.63 |- skos__scopeNote mesh__D051859
% 210.47/210.63 An acidic protein found in the NEUROENDOCRINE SYSTEM that functions as a molecular chaperone for PROPROTEIN CONVERTASE 2.%A%
% 210.47/210.63 |- skos__altLabel mesh__D051859 Secretory Granule Protein 7B2
% 210.47/210.63 |- skos__altLabel mesh__D051859 Neuroendocrine Chaperone 7B2
% 210.47/210.63 |- skos__broader mesh__D051859smesh__D018832
% 210.47/210.63 |- mesh__recordOriginator mesh__D051859 DRC
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D051859 2006
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D004405 2006
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella dysenteriae
% 210.47/210.63 |- mesh__recordOriginator mesh__D004405 NLM
% 210.47/210.63 |- skos__broader mesh__D004405smesh__D004403
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shiga bacillus Dysentery
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 dysenteriae Dysentery, Shigella
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella sonnei
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 flexneri Dysenteries, Shigella
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella flexneri
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shigella boydii Dysentery
% 210.47/210.63 |- skos__broader mesh__D004405smesh__D004756
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D004405 sjn
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shigella flexneri Dysentery
% 210.47/210.63 |- rdf__type mesh__D004405sskos__Concept
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shigella Dysenteries
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shigella flexneri Dysenteries
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Dysentery, Shigella
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D004405 2004
% 210.47/210.63 |- skos__scopeNote mesh__D004405
% 210.47/210.63 DYSENTERY caused by gram-negative rod-shaped enteric bacteria %28%ENTEROBACTERIACEAE%29%, most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE %28%severest%29%; Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI %28%mildest%29%.%A%
% 210.47/210.63 |- skos__altLabel mesh__D004405 Dysentery, Shiga bacillus
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 boydii Dysentery, Shigella
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 flexneri Dysentery, Shigella
% 210.47/210.63 |- mesh__dateRevised mesh__D004405 2003-07-09
% 210.47/210.63 |- skos__altLabel mesh__D004405 Dysentery, Shigella dysenteriae type 1
% 210.47/210.63 |- mesh__recordMaintainer mesh__D004405 lkt
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shigella dysenteriae Dysentery
% 210.47/210.63 |- mesh__dateCreated mesh__D004405 1999-01-01
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shigella dysenteriae Dysenteries
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shigella sonnei Dysentery
% 210.47/210.63 |- skos__altLabel mesh__D004405 Shigella Dysentery
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 dysenteriae Dysenteries, Shigella
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella boydii
% 210.47/210.63 |- skos__annotation mesh__D004405
% 210.47/210.63 coord IM with specific organism %28%IM%29% if pertinent
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 sonnei Dysentery, Shigella
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shigella boydii Dysenteries
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D004405 2005
% 210.47/210.63 |- skos__prefLabel mesh__D004405 Dysentery, Bacillary
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 boydii Dysenteries, Shigella
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Shigella sonnei Dysenteries
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 sonnei Dysenteries, Shigella
% 210.47/210.63 |- skos__hiddenLabel mesh__D004405 Bacillary Dysentery
% 210.47/210.63 |- skos__hiddenLabel mesh__D009699 Hydrolases, Nucleoside
% 210.47/210.63 |- skos__hiddenLabel mesh__D009699 Hydrolases, Nitrogen-linked Glycoside
% 210.47/210.63 |- skos__altLabel mesh__D009699 Hydrolases, N-Glycosyl
% 210.47/210.63 |- mesh__dateCreated mesh__D009699 1999-01-01
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D009699 sjn
% 210.47/210.63 |- skos__altLabel mesh__D009699 Nitrogen-linked Glycoside Hydrolases
% 210.47/210.63 |- mesh__recordMaintainer mesh__D009699 ags
% 210.47/210.63 |- skos__prefLabel mesh__D009699 N-Glycosyl Hydrolases
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D009699 2004
% 210.47/210.63 |- skos__scopeNote mesh__D009699
% 210.47/210.63 A class of enzymes involved in the hydrolysis of the N-glycosidic bond of nitrogen-linked sugars.%A%
% 210.47/210.63 |- skos__broader mesh__D009699smesh__D006026
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D009699 2005
% 210.47/210.63 |- skos__altLabel mesh__D009699 Nucleoside Hydrolases
% 210.47/210.63 |- skos__hiddenLabel mesh__D009699 N Glycosyl Hydrolases
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D009699 2006
% 210.47/210.63 |- skos__altLabel mesh__D009699 Glycoside Hydrolases, Nitrogen-linked
% 210.47/210.63 |- mesh__historyNote mesh__D009699 2003%28%1966%29%
% 210.47/210.63 |- skos__hiddenLabel mesh__D009699 Nitrogen linked Glycoside Hydrolases
% 210.47/210.63 |- skos__hiddenLabel mesh__D009699 Hydrolases, N Glycosyl
% 210.47/210.63 |- mesh__dateRevised mesh__D009699 2003-07-09
% 210.47/210.63 |- rdf__type mesh__D009699sskos__Concept
% 210.47/210.63 |- skos__hiddenLabel mesh__D009699 Glycoside Hydrolases, Nitrogen linked
% 210.47/210.63 |- mesh__recordOriginator mesh__D009699 NLM
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D009699 2003; see NUCLEOSIDASES 1966-2002
% 210.47/210.63 |- skos__broader mesh__D020072smesh__D001487
% 210.47/210.63 |- skos__prefLabel mesh__D020072 Polyporales
% 210.47/210.63 |- mesh__dateRevised mesh__D020072 2005-06-30
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D020072 2005; see APHYLLPHORALES 1999-2004
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D020072 sjn
% 210.47/210.63 |- mesh__historyNote mesh__D020072 2005 %28%1999%29%
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D020072 2006
% 210.47/210.63 |- rdf__type mesh__D020072sskos__Concept
% 210.47/210.63 |- skos__altLabel mesh__D020072 Aphyllophorales
% 210.47/210.63 |- mesh__dateEstablished mesh__D020072 1999-01-01
% 210.47/210.63 |- mesh__recordOriginator mesh__D020072 AGS
% 210.47/210.63 |- mesh__dateCreated mesh__D020072 1998-06-10
% 210.47/210.63 |- skos__scopeNote mesh__D020072
% 210.47/210.63 An order of fungi in the phylum BASIDIOMYCOTA having macroscopic basidiocarps. The members are characterized by their saprophytic activities as decomposers, particularly in the degradation of CELLULOSE and LIGNIN. A large number of species in the order have been used medicinally. %28%From Alexopoulos, Introductory Mycology, 4th ed, pp504-68%29%%A%
% 210.47/210.63 |- mesh__recordMaintainer mesh__D020072 ags
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D014833 91; was see under VOICE 1979-90
% 210.47/210.63 |- skos__historyNote mesh__D014833 Voice %28%1966-1978%29%
% 210.47/210.63 |- skos__related mesh__D014833smesh__D010699
% 210.47/210.63 |- mesh__historyNote mesh__D014833
% 210.47/210.63 91%28%79%29%; was see under VOICE 1979-90
% 210.47/210.63 |- skos__hiddenLabel mesh__D014833 Quality, Voice
% 210.47/210.63 |- mesh__recordMaintainer mesh__D014833 nns
% 210.47/210.63 |- mesh__dateEstablished mesh__D014833 1991-01-01
% 210.47/210.63 |- mesh__dateRevised mesh__D014833 2003-07-09
% 210.47/210.63 |- skos__hiddenLabel mesh__D014833 Voice Qualities
% 210.47/210.63 |- mesh__dateCreated mesh__D014833 1978-05-22
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014833 2006
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D014833 sjn
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014833 2005
% 210.47/210.63 |- skos__scopeNote mesh__D014833
% 210.47/210.63 That component of SPEECH which gives the primary distinction to a given speaker%27%s VOICE when pitch and loudness are excluded. It involves both phonatory and resonatory characteristics. Some of the descriptions of voice quality are harshness, breathiness and nasality.%A%
% 210.47/210.63 |- mesh__recordOriginator mesh__D014833 RC
% 210.47/210.63 |- skos__hiddenLabel mesh__D014833 Qualities, Voice
% 210.47/210.63 |- skos__related mesh__D014833smesh__D006685
% 210.47/210.63 |- skos__broader mesh__D014833smesh__D014831
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014833 2004
% 210.47/210.63 |- rdf__type mesh__D014833sskos__Concept
% 210.47/210.63 |- skos__prefLabel mesh__D014833 Voice Quality
% 210.47/210.63 |- skos__altLabel mesh__D014035 Togaviruses
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 2000
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 1998
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D014035 PLS
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 2004
% 210.47/210.63 |- mesh__recordMaintainer mesh__D014035 AGS
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 2001
% 210.47/210.63 |- skos__hiddenLabel mesh__D014035 Togavirus
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 1996
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D014035
% 210.47/210.63 81; was TOGAVIRUSES see ARBOVIRUSES 1978-80
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 1999
% 210.47/210.63 |- skos__broader mesh__D014035smesh__D012328
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 2002
% 210.47/210.63 |- skos__prefLabel mesh__D014035 Togaviridae
% 210.47/210.63 |- skos__historyNote mesh__D014035 Arboviruses %28%1966-1980%29%
% 210.47/210.63 |- mesh__onlineNote mesh__D014035
% 210.47/210.63 use ARBOVIRUSES to search TOGAVIRUSES 1978-80
% 210.47/210.63 |- skos__annotation mesh__D014035
% 210.47/210.63 %22%a family of RNA viruses, mainly arboviruses%22%; infection = TOGAVIRIDAE INFECTIONS%A%
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 1997
% 210.47/210.63 |- rdf__type mesh__D014035sskos__Concept
% 210.47/210.63 |- mesh__dateCreated mesh__D014035 1980-05-22
% 210.47/210.63 |- mesh__recordOriginator mesh__D014035 RC
% 210.47/210.63 |- skos__scopeNote mesh__D014035
% 210.47/210.63 A family of RNA viruses, mainly arboviruses, consisting of two genera: ALPHAVIRUS %28%group A arboviruses%29%, and RUBIVIRUS. Virions are spherical, 60-70 nm in diameter, with a lipoprotein envelope tightly applied to the icosahedral nucleocapsid.%A%
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 2005
% 210.47/210.63 |- mesh__dateRevised mesh__D014035 1993-06-04
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 1994
% 210.47/210.63 |- mesh__dateEstablished mesh__D014035 1981-01-01
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 2003
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 1995
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D014035 2006
% 210.47/210.63 |- mesh__historyNote mesh__D014035
% 210.47/210.63 81; was TOGAVIRUSES see ARBOVIRUSES 1978-80
% 210.47/210.63 |- mesh__recordMaintainer mesh__D000813 TGC
% 210.47/210.63 |- mesh__recordOriginator mesh__D000813 NLM
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 2006
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 2003
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 1997
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D000813 PLS
% 210.47/210.63 |- skos__prefLabel mesh__D000813 Anilides
% 210.47/210.63 |- skos__broader mesh__D000813smesh__D000577
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 2005
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 1999
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 1996
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 2002
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 1993
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 1998
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 2001
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 1995
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 2000
% 210.47/210.63 |- mesh__dateRevised mesh__D000813 1992-05-07
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 1994
% 210.47/210.63 |- mesh__dateCreated mesh__D000813 1999-01-01
% 210.47/210.63 |- rdf__type mesh__D000813sskos__Concept
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000813 2004
% 210.47/210.63 |- skos__altLabel mesh__D000015 Multiple Abnormalities
% 210.47/210.63 |- mesh__dateEstablished mesh__D000015 1968-01-01
% 210.47/210.63 |- mesh__recordMaintainer mesh__D000015 KEV
% 210.47/210.63 |- skos__prefLabel mesh__D000015 Abnormalities, Multiple
% 210.47/210.63 |- skos__historyNote mesh__D000015 Abnormalities %28%1966-1967%29%
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000015 2002
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000015 2004
% 210.47/210.63 |- mesh__dateRevised mesh__D000015 1999-11-08
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000015 2005
% 210.47/210.63 |- skos__broader mesh__D000015smesh__D000013
% 210.47/210.63 |- skos__annotation mesh__D000015
% 210.47/210.63 IM; do not use /compl /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific abnorm %28%IM%29%; Manual 23.20.2%A%
% 210.47/210.63 |- skos__related mesh__D000015smesh__D008607
% 210.47/210.63 |- mesh__historyNote mesh__D000015 68
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000015 2006
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D000015 sjn
% 210.47/210.63 |- rdf__type mesh__D000015sskos__Concept
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D000015 68
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000015 2000
% 210.47/210.63 |- mesh__recordOriginator mesh__D000015 NLM
% 210.47/210.63 |- mesh__dateCreated mesh__D000015 1999-01-01
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000015 2001
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D000015 2003
% 210.47/210.63 |- rdf__type mesh__D046915sskos__Concept
% 210.47/210.63 |- skos__altLabel mesh__D046915 Penicillin-Binding Protein
% 210.47/210.63 |- skos__broader mesh__D046915smesh__D001426
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 2b
% 210.47/210.63 |- skos__related mesh__D046915smesh__D006602
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Protein 1b, Penicillin-Binding
% 210.47/210.63 |- skos__historyNote mesh__D046915 Bacterial Proteins %28%1978-2004%29%
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Synthetase, Peptidoglycan
% 210.47/210.63 |- skos__related mesh__D046915smesh__D002267
% 210.47/210.63 |- mesh__dateRevised mesh__D046915 2005-06-30
% 210.47/210.63 |- mesh__historyNote mesh__D046915 2005 %28%1978%29%;
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 4
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 1b
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 7
% 210.47/210.63 |- mesh__recordOriginator mesh__D046915 jmp
% 210.47/210.63 |- skos__historyNote mesh__D046915 Peptidyltransferase %28%1978-2004%29%
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 3
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 6
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D046915
% 210.47/210.63 2005; PENICILLIN-BINDING PROTEINS was indexed under HEXOSYLTRANSFERASES 1999-2004, under BACTERIAL PROTEINS, MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; CARRIER PROTEINS, %26% PEPTIDYLTRANSFERASE 1978-2004%A%
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Proteins
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Proteins, Penicillin-Binding
% 210.47/210.63 |- mesh__recordMaintainer mesh__D046915 SYSTEM
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein
% 210.47/210.63 |- mesh__dateCreated mesh__D046915 2004-07-08
% 210.47/210.63 |- skos__prefLabel mesh__D046915 Penicillin-Binding Proteins
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D046915 2006
% 210.47/210.63 |- skos__related mesh__D046915smesh__D010458
% 210.47/210.63 |- mesh__dateEstablished mesh__D046915 2005-01-01
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 2
% 210.47/210.63 |- skos__altLabel mesh__D046915 Penicillin-Binding Protein-2a
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Protein 1A, Penicillin-Binding
% 210.47/210.63 |- skos__historyNote mesh__D046915
% 210.47/210.63 Muramoylpentapeptide Carboxypeptidase %28%1978-2004%29%
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 5
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D046915 sjn
% 210.47/210.63 |- skos__scopeNote mesh__D046915
% 210.47/210.63 Bacterial proteins that share the property of binding irreversibly to PENICILLINS and other ANTIBACTERIAL AGENTS derived from LACTAMS. The penicillin-binding proteins are primarily enzymes involved in CELL WALL biosynthesis including MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; PEPTIDE SYNTHASES; TRANSPEPTIDASES; and HEXOSYLTRANSFERASES.%A%
% 210.47/210.63 |- skos__historyNote mesh__D046915 Carrier Proteins %28%1978-2004%29%
% 210.47/210.63 |- skos__broader mesh__D046915smesh__D004798
% 210.47/210.63 |- skos__historyNote mesh__D046915 Hexosyltransferases %28%1999-2004%29%
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 1
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 2a
% 210.47/210.63 |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 1A
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D018426 sjn
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D018426 2006
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D018426 2003
% 210.47/210.63 |- skos__prefLabel mesh__D018426 SEER Program
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D018426 2004
% 210.47/210.63 |- skos__hiddenLabel mesh__D018426 Program, SEER
% 210.47/210.63 |- mesh__recordMaintainer mesh__D018426 jls
% 210.47/210.63 |- rdf__type mesh__D018426sskos__Concept
% 210.47/210.63 |- skos__altLabel mesh__D018426
% 210.47/210.63 SEER Program %28%National Cancer Institute %28%U.S.%29%%29%
% 210.47/210.63 |- mesh__recordOriginator mesh__D018426 TGC
% 210.47/210.63 |- skos__broader mesh__D018426smesh__D012042
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D018426 2002
% 210.47/210.63 |- skos__annotation mesh__D018426
% 210.47/210.63 a cancer surveillance program of Nat Cancer Inst; X ref explains acronym; IM CATALOG: use NAF entry%A%
% 210.47/210.63 |- mesh__dateRevised mesh__D018426 2001-07-25
% 210.47/210.63 |- mesh__historyNote mesh__D018426 95
% 210.47/210.63 |- skos__scopeNote mesh__D018426
% 210.47/210.63 A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results %28%SEER%29% Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. %28%From National Cancer Institute, NIH Publication No. 91-3074, October 1990%29%%A%
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D018426 2005
% 210.47/210.63 |- mesh__dateEstablished mesh__D018426 1995-01-01
% 210.47/210.63 |- mesh__dateCreated mesh__D018426 1994-02-28
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D018426 95
% 210.47/210.63 |- skos__altLabel mesh__D018426
% 210.47/210.63 Surveillance, Epidemiology, and End Results Program
% 210.47/210.63 |- mesh__dateEstablished mesh__D010443 1973-01-01
% 210.47/210.63 |- rdf__type mesh__D010443sskos__Concept
% 210.47/210.63 |- skos__altLabel mesh__D010443 Translational Peptide Chain Termination
% 210.47/210.63 |- mesh__dateRevised mesh__D010443 2004-07-07
% 210.47/210.63 |- skos__altLabel mesh__D010443 Chain Termination, Peptide, Translational
% 210.47/210.63 |- mesh__dateCreated mesh__D010443 1999-01-01
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D010443 sjn
% 210.47/210.63 |- skos__scopeNote mesh__D010443
% 210.47/210.63 A process of GENETIC TRANSLATION whereby the last amino acid is added to a lengthening polypeptide. This termination is signaled from the MESSENGER RNA, by one of three termination codons %28%CODON, TERMINATOR%29% that immediately follows the last amino acid-specifying CODON.%A%
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D010443 2005
% 210.47/210.63 |- mesh__recordOriginator mesh__D010443 NLM
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D010443
% 210.47/210.63 2005; see PEPTIDE CHAIN TERMINATION 1973-2004
% 210.47/210.63 |- skos__broader mesh__D010443smesh__D014176
% 210.47/210.63 |- skos__prefLabel mesh__D010443 Peptide Chain Termination, Translational
% 210.47/210.63 |- skos__related mesh__D010443smesh__D010454
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D010443 2006
% 210.47/210.63 |- skos__annotation mesh__D010443
% 210.47/210.63 coordinate with specific peptide; for protein biosynthesis on the ribosome only; for non-ribosomal biosynthesis use PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%A%
% 210.47/210.63 |- skos__altLabel mesh__D010443 Protein Chain Termination, Translational
% 210.47/210.63 |- mesh__recordMaintainer mesh__D010443 nns
% 210.47/210.63 |- skos__historyNote mesh__D010443 Peptides/biosynthesis %28%1966-1970%29%
% 210.47/210.63 |- mesh__historyNote mesh__D010443 2005%28%1971%29%
% 210.47/210.63 |- skos__related mesh__D010443smesh__D018388
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D004406 2004
% 210.47/210.63 |- skos__broader mesh__D004406smesh__D007153
% 210.47/210.63 |- skos__historyNote mesh__D004406 Immunity %28%1966-1970%29%
% 210.47/210.63 |- skos__scopeNote mesh__D004406
% 210.47/210.63 An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins.%A%
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D004406
% 210.47/210.63 78; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77%A%
% 210.47/210.63 |- skos__broader mesh__D004406smesh__D001796
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D004406 2006
% 210.47/210.63 |- skos__prefLabel mesh__D004406 Dysgammaglobulinemia
% 210.47/210.63 |- skos__hiddenLabel mesh__D004406 Dysgammaglobulinemias
% 210.47/210.63 |- mesh__recordMaintainer mesh__D004406 lkt
% 210.47/210.63 |- rdf__type mesh__D004406sskos__Concept
% 210.47/210.63 |- mesh__dateRevised mesh__D004406 2003-07-09
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D004406 2005
% 210.47/210.63 |- mesh__recordOriginator mesh__D004406 NLM
% 210.47/210.63 |- mesh__historyNote mesh__D004406
% 210.47/210.63 78%28%75%29%; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77%A%
% 210.47/210.63 |- mesh__dateEstablished mesh__D004406 1978-01-01
% 210.47/210.63 |- skos__historyNote mesh__D004406
% 210.47/210.63 Immunologic Deficiency Syndromes %28%1968-1974%29%
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D004406 sjn
% 210.47/210.63 |- mesh__onlineNote mesh__D004406
% 210.47/210.63 search IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-74
% 210.47/210.63 |- skos__annotation mesh__D004406
% 210.47/210.63 coord IM with specific immunoglobulin /defic %28%IM%29% but note IGA DEFICIENCY and IGG DEFICIENCY are available; AGAMMAGLOBULINEMIA is also available%A%
% 210.47/210.63 |- mesh__dateCreated mesh__D004406 1999-01-01
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Degradation, mRNA
% 210.47/210.63 |- skos__related mesh__D020871smesh__D009691
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Degradation, RNA
% 210.47/210.63 |- mesh__dateRevised mesh__D020871 2005-07-29
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D020871 2005
% 210.47/210.63 |- mesh__dateEstablished mesh__D020871 2000-01-01
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Decay, mRNA
% 210.47/210.63 |- skos__prefLabel mesh__D020871 RNA Stability
% 210.47/210.63 |- rdf__type mesh__D020871sskos__Concept
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Transcript Degradation, mRNA
% 210.47/210.63 |- skos__annotation mesh__D020871 coord with specific RNA if pertinent
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D020871 2006A
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Stability, mRNA
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Instability, mRNA
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D020871 2006
% 210.47/210.63 |- skos__altLabel mesh__D020871 mRNA Transcript Degradation
% 210.47/210.63 |- skos__broader mesh__D020871smesh__D001669
% 210.47/210.63 |- skos__scopeNote mesh__D020871
% 210.47/210.63 The extent to which an RNA molecule retains its structural integrity and resists degradation by RNASE, and base-catalyzed HYDROLYSIS, under changing in vivo or in vitro conditions.%A%
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Stability, RNA
% 210.47/210.63 |- mesh__activeMeSHYear mesh__D020871 2004
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Decay, RNA
% 210.47/210.63 |- mesh__historyNote mesh__D020871 2000
% 210.47/210.63 |- mesh__recordAuthorizer mesh__D020871 ags
% 210.47/210.63 |- mesh__dateCreated mesh__D020871 1999-11-03
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Instability, RNA
% 210.47/210.63 |- mesh__recordOriginator mesh__D020871 nns
% 210.47/210.63 |- mesh__recordMaintainer mesh__D020871 ags
% 210.47/210.63 |- skos__hiddenLabel mesh__D020871 Degradation, mRNA Transcript
% 210.47/210.63 |- mesh__publicMeSHNote mesh__D020871 2000
% 210.47/210.63 |- skos__broader mesh__D020073smesh__D011247
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D020073 99
% 210.47/210.64 |- skos__hiddenLabel mesh__D020073 Nulligravidities
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D020073 2006
% 210.47/210.64 |- rdf__type mesh__D020073sskos__Concept
% 210.47/210.64 |- skos__hiddenLabel mesh__D020073 Multigravidities
% 210.47/210.64 |- mesh__recordOriginator mesh__D020073 NDW
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D020073 sjn
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D020073 2005
% 210.47/210.64 |- skos__broader mesh__D020073smesh__D017584
% 210.47/210.64 |- skos__historyNote mesh__D020073 Pregnancy %28%1966-1998%29%
% 210.47/210.64 |- skos__related mesh__D020073smesh__D010298
% 210.47/210.64 |- skos__prefLabel mesh__D020073 Gravidity
% 210.47/210.64 |- mesh__historyNote mesh__D020073 99
% 210.47/210.64 |- skos__hiddenLabel mesh__D020073 Gravidities
% 210.47/210.64 |- skos__hiddenLabel mesh__D020073 Primigravidities
% 210.47/210.64 |- mesh__dateRevised mesh__D020073 2004-07-07
% 210.47/210.64 |- mesh__recordMaintainer mesh__D020073 lkt
% 210.47/210.64 |- mesh__dateEstablished mesh__D020073 1999-01-01
% 210.47/210.64 |- skos__annotation mesh__D020073
% 210.47/210.64 human %26% animal; do not confuse with PARITY
% 210.47/210.64 |- skos__scopeNote mesh__D020073
% 210.47/210.64 The number of pregnancies, complete or incomplete, experienced by a female. It is different from PARITY, which is the number of offspring borne. %28%From Stedman, 26th ed%29%%A%
% 210.47/210.64 |- mesh__dateCreated mesh__D020073 1998-06-10
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1992
% 210.47/210.64 |- skos__hiddenLabel mesh__D014834 Training, Voice
% 210.47/210.64 |- skos__hiddenLabel mesh__D014834 Trainings, Voice
% 210.47/210.64 |- skos__hiddenLabel mesh__D014834 Voice Trainings
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1999
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 2000
% 210.47/210.64 |- skos__broader mesh__D014834smesh__D012049
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1996
% 210.47/210.64 |- skos__annotation mesh__D014834 no qualif
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1991
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1993
% 210.47/210.64 |- skos__prefLabel mesh__D014834 Voice Training
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 2005
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D014834 PLS
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 2001
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1997
% 210.47/210.64 |- mesh__dateCreated mesh__D014834 1999-01-01
% 210.47/210.64 |- mesh__recordMaintainer mesh__D014834 TGC
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 2006
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 2003
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1994
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1990
% 210.47/210.64 |- mesh__dateRevised mesh__D014834 1989-05-16
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 2002
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 2004
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1998
% 210.47/210.64 |- mesh__recordOriginator mesh__D014834 NLM
% 210.47/210.64 |- rdf__type mesh__D014834sskos__Concept
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014834 1995
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 1999
% 210.47/210.64 |- mesh__dateCreated mesh__D014036 1980-05-13
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 1996
% 210.47/210.64 |- mesh__historyNote mesh__D014036 94; was TOGAVIRUS INFECTIONS 1981-93
% 210.47/210.64 |- mesh__onlineNote mesh__D014036
% 210.47/210.64 use TOGAVIRIDAE INFECTIONS to search TOGAVIRUS INFECTIONS 1981-93%A%
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 2000
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 1997
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D014036 PLS
% 210.47/210.64 |- rdf__type mesh__D014036sskos__Concept
% 210.47/210.64 |- skos__hiddenLabel mesh__D014036 Togavirus Infection
% 210.47/210.64 |- skos__altLabel mesh__D014036 Togavirus Infections
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D014036
% 210.47/210.64 94; was TOGAVIRUS INFECTIONS 1981-93
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 2001
% 210.47/210.64 |- skos__hiddenLabel mesh__D014036 Infection, Togaviridae
% 210.47/210.64 |- mesh__recordOriginator mesh__D014036 RC
% 210.47/210.64 |- skos__hiddenLabel mesh__D014036 Infection, Togavirus
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 1994
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 2005
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 2002
% 210.47/210.64 |- skos__prefLabel mesh__D014036 Togaviridae Infections
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 1995
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 2006
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 2003
% 210.47/210.64 |- skos__broader mesh__D014036smesh__D012327
% 210.47/210.64 |- skos__historyNote mesh__D014036 Arbovirus Infections %28%1966-1980%29%
% 210.47/210.64 |- skos__hiddenLabel mesh__D014036 Togaviridae Infection
% 210.47/210.64 |- skos__altLabel mesh__D014036 Infections, Togavirus
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 1998
% 210.47/210.64 |- skos__scopeNote mesh__D014036
% 210.47/210.64 Virus diseases caused by the TOGAVIRIDAE.
% 210.47/210.64 |- mesh__dateRevised mesh__D014036 1993-06-04
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014036 2004
% 210.47/210.64 |- skos__annotation mesh__D014036 GEN or unspecified; prefer specifics
% 210.47/210.64 |- mesh__dateEstablished mesh__D014036 1981-01-01
% 210.47/210.64 |- skos__altLabel mesh__D014036 Infections, Togaviridae
% 210.47/210.64 |- mesh__recordMaintainer mesh__D014036 AGS
% 210.47/210.64 |- skos__annotation mesh__D000814 DF: ANILINE CPDS
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 2005
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 1999
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 1996
% 210.47/210.64 |- skos__prefLabel mesh__D000814 Aniline Compounds
% 210.47/210.64 |- mesh__recordOriginator mesh__D000814 NLM
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 1993
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 1998
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D000814 PLS
% 210.47/210.64 |- skos__broader mesh__D000814smesh__D000588
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 1995
% 210.47/210.64 |- skos__altLabel mesh__D000814 Phenylamines
% 210.47/210.64 |- mesh__dateRevised mesh__D000814 1992-05-07
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 2002
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 1994
% 210.47/210.64 |- mesh__dateCreated mesh__D000814 1999-01-01
% 210.47/210.64 |- rdf__type mesh__D000814sskos__Concept
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 2004
% 210.47/210.64 |- mesh__recordMaintainer mesh__D000814 TGC
% 210.47/210.64 |- skos__hiddenLabel mesh__D000814 Compounds, Aniline
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 2001
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 2006
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 2003
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 1997
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000814 2000
% 210.47/210.64 |- mesh__recordMaintainer mesh__D000016 kle
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000016 2004
% 210.47/210.64 |- skos__hiddenLabel mesh__D000016 Abnormality, Radiation-Induced
% 210.47/210.64 |- mesh__dateRevised mesh__D000016 1999-11-03
% 210.47/210.64 |- skos__hiddenLabel mesh__D000016 Abnormalities, Radiation Induced
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000016 2001
% 210.47/210.64 |- mesh__recordOriginator mesh__D000016 AEP
% 210.47/210.64 |- skos__prefLabel mesh__D000016 Abnormalities, Radiation-Induced
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000016 2005
% 210.47/210.64 |- mesh__dateEstablished mesh__D000016 1979-01-01
% 210.47/210.64 |- skos__broader mesh__D000016smesh__D000013
% 210.47/210.64 |- skos__historyNote mesh__D000016 Radiation Injuries %28%1966-1978%29%
% 210.47/210.64 |- skos__hiddenLabel mesh__D000016 Radiation-Induced Abnormality
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000016 2002
% 210.47/210.64 |- skos__historyNote mesh__D000016 Abnormalities %28%1966-1978%29%
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000016 2006
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D000016 79
% 210.47/210.64 |- rdf__type mesh__D000016sskos__Concept
% 210.47/210.64 |- skos__annotation mesh__D000016
% 210.47/210.64 IM; do not use /compl /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific abnorm %28%IM%29%%A%
% 210.47/210.64 |- skos__hiddenLabel mesh__D000016 Radiation Induced Abnormalities
% 210.47/210.64 |- skos__scopeNote mesh__D000016
% 210.47/210.64 Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation.%A%
% 210.47/210.64 |- skos__broader mesh__D000016smesh__D011832
% 210.47/210.64 |- mesh__dateCreated mesh__D000016 1978-03-20
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000016 2003
% 210.47/210.64 |- mesh__historyNote mesh__D000016 79
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D000016 sjn
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000016 2000
% 210.47/210.64 |- skos__altLabel mesh__D000016 Radiation-Induced Abnormalities
% 210.47/210.64 |- skos__altLabel mesh__D018427 Breast Prosthesis, Internal
% 210.47/210.64 |- mesh__recordOriginator mesh__D018427 TGC
% 210.47/210.64 |- skos__hiddenLabel mesh__D018427 Internal Breast Prosthesis
% 210.47/210.64 |- mesh__dateEstablished mesh__D018427 1995-01-01
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D018427 2002
% 210.47/210.64 |- skos__hiddenLabel mesh__D018427 Breast Implant
% 210.47/210.64 |- skos__hiddenLabel mesh__D018427 Prostheses, Internal Breast
% 210.47/210.64 |- skos__historyNote mesh__D018427 Implants, Artificial %28%1971-1994%29%
% 210.47/210.64 |- mesh__dateCreated mesh__D018427 1994-04-21
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D018427 1999
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D018427 95
% 210.47/210.64 |- skos__historyNote mesh__D018427 Silicones %28%1967-1994%29%
% 210.47/210.64 |- skos__prefLabel mesh__D018427 Breast Implants
% 210.47/210.64 |- mesh__recordMaintainer mesh__D018427 ADP
% 210.47/210.64 |- mesh__historyNote mesh__D018427 95
% 210.47/210.64 |- skos__hiddenLabel mesh__D018427 Implant, Breast
% 210.47/210.64 |- skos__hiddenLabel mesh__D018427 Internal Breast Prostheses
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D018427 2005
% 210.47/210.64 |- skos__altLabel mesh__D018427 Implants, Breast
% 210.47/210.64 |- mesh__dateRevised mesh__D018427 1998-06-10
% 210.47/210.64 |- skos__related mesh__D018427smesh__D019928
% 210.47/210.64 |- skos__scopeNote mesh__D018427
% 210.47/210.64 Implants used to reconstruct and/or cosmetically enhance the female breast. They have an outer shell or envelope of silicone elastomer and are filled with either saline or silicone gel. The outer shell may be either smooth or textured.%A%
% 210.47/210.64 |- skos__hiddenLabel mesh__D018427 Breast Prostheses, Internal
% 210.47/210.64 |- skos__related mesh__D018427smesh__D012826
% 210.47/210.64 |- skos__hiddenLabel mesh__D018427 Prosthesis, Internal Breast
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D018427 2006
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D018427 2003
% 210.47/210.64 |- skos__broader mesh__D018427smesh__D019736
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D018427 2000
% 210.47/210.64 |- skos__related mesh__D018427smesh__D020034
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D018427 SJN
% 210.47/210.64 |- skos__annotation mesh__D018427
% 210.47/210.64 IM; coord with implant material %28%IM or NIM%29%
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D018427 2004
% 210.47/210.64 |- skos__historyNote mesh__D018427 Prosthesis %28%1967-1994%29%
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D018427 2001
% 210.47/210.64 |- rdf__type mesh__D018427sskos__Concept
% 210.47/210.64 |- skos__altLabel mesh__D010444 Elongation Factor Tu
% 210.47/210.64 |- mesh__recordOriginator mesh__D010444 RLS
% 210.47/210.64 |- skos__hiddenLabel mesh__D010444 EF Tu
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D010444 2005
% 210.47/210.64 |- skos__historyNote mesh__D010444 Bacterial Proteins %28%1966-1972%29%
% 210.47/210.64 |- skos__hiddenLabel mesh__D010444 Factor Tu, Elongation
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D010444 86
% 210.47/210.64 |- skos__historyNote mesh__D010444
% 210.47/210.64 Peptide Elongation Factors %28%1973-1985%29%
% 210.47/210.64 |- skos__hiddenLabel mesh__D010444 eEF Tu
% 210.47/210.64 |- skos__altLabel mesh__D010444 EF-Tu
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D010444 2006
% 210.47/210.64 |- skos__prefLabel mesh__D010444 Peptide Elongation Factor Tu
% 210.47/210.64 |- mesh__dateRevised mesh__D010444 2003-07-09
% 210.47/210.64 |- mesh__dateCreated mesh__D010444 1985-06-06
% 210.47/210.64 |- mesh__historyNote mesh__D010444 86
% 210.47/210.64 |- skos__historyNote mesh__D010444 Peptides %28%1966-1972%29%
% 210.47/210.64 |- skos__altLabel mesh__D010444 Protein Synthesis Elongation Factor Tu
% 210.47/210.64 |- skos__broader mesh__D010444smesh__D020963
% 210.47/210.64 |- skos__scopeNote mesh__D010444
% 210.47/210.64 A protein found in bacteria and eukaryotic mitochondria which delivers aminoacyl-tRNA%27%s to the A site of the ribosome. The aminoacyl-tRNA is first bound to a complex of elongation factor Tu containing a molecule of bound GTP. The resulting complex is then bound to the 70S initiation complex. Simultaneously the GTP is hydrolyzed and a Tu-GDP complex is released from the 70S ribosome. The Tu-GTP complex is regenerated from the Tu-GDP complex by the Ts elongation factor and GTP. EC 3.6.1.-.%A%
% 210.47/210.64 |- skos__annotation mesh__D010444 DF: EFTU
% 210.47/210.64 |- rdf__type mesh__D010444sskos__Concept
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D010444 2004
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D010444 sjn
% 210.47/210.64 |- skos__historyNote mesh__D010444 Proteins %28%1966-1972%29%
% 210.47/210.64 |- mesh__recordMaintainer mesh__D010444 ssb
% 210.47/210.64 |- mesh__dateEstablished mesh__D010444 1986-01-01
% 210.47/210.64 |- mesh__recordMaintainer mesh__D004407 mdb
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D004407 2004
% 210.47/210.64 |- mesh__recordOriginator mesh__D004407 NLM
% 210.47/210.64 |- skos__scopeNote mesh__D004407
% 210.47/210.64 A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16%25% of all germ cell tumors but are rare before the age of 10, although nearly 50%25% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. %28%Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1646%29%%A%
% 210.47/210.64 |- mesh__onlineNote mesh__D004407
% 210.47/210.64 use DYSGERMINOMA to search DISGERMINOMA 1966-78
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D004407 sjn
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D004407 2005
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D004407 79; was DISGERMINOMA 1963-78
% 210.47/210.64 |- skos__hiddenLabel mesh__D004407 Dysgerminomas
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D004407 2006
% 210.47/210.64 |- mesh__dateCreated mesh__D004407 1999-01-01
% 210.47/210.64 |- skos__altLabel mesh__D004407 Disgerminoma
% 210.47/210.64 |- rdf__type mesh__D004407sskos__Concept
% 210.47/210.64 |- mesh__historyNote mesh__D004407 79; was DISGERMINOMA 1963-78
% 210.47/210.64 |- mesh__dateRevised mesh__D004407 2003-07-09
% 210.47/210.64 |- skos__hiddenLabel mesh__D004407 Disgerminomas
% 210.47/210.64 |- skos__prefLabel mesh__D004407 Dysgerminoma
% 210.47/210.64 |- skos__broader mesh__D004407smesh__D018237
% 210.47/210.64 |- skos__annotation mesh__D004407
% 210.47/210.64 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably OVARIAN NEOPLASMS %28%IM%29%%A%
% 210.47/210.64 |- mesh__dateEstablished mesh__D020074 1999-01-01
% 210.47/210.64 |- skos__historyNote mesh__D020074 Agaricales %28%1978-1998%29%
% 210.47/210.64 |- skos__historyNote mesh__D020074 Basidiomycota %28%1966-1993%29%
% 210.47/210.64 |- mesh__recordOriginator mesh__D020074 AGS
% 210.47/210.64 |- skos__prefLabel mesh__D020074 Lentinula
% 210.47/210.64 |- mesh__dateCreated mesh__D020074 1998-06-10
% 210.47/210.64 |- skos__broader mesh__D020074smesh__D011124
% 210.47/210.64 |- skos__historyNote mesh__D020074 Polyporaceae %28%1985-1998%29%
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D020074
% 210.47/210.64 2005; see LENTINUS 1999-2004, see POLYPORACEAE 1986-98
% 210.47/210.64 |- mesh__dateRevised mesh__D020074 2005-06-30
% 210.47/210.64 |- skos__scopeNote mesh__D020074
% 210.47/210.64 A genus of fungi of the family Tricholomataceae, order AGARICALES. The commonly known SHIITAKE MUSHROOMS are Lentinula edodes %28%also seen as Lentinus edodes%29%.%A%
% 210.47/210.64 |- mesh__recordMaintainer mesh__D020074 SYSTEM
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D020074 sjn
% 210.47/210.64 |- skos__altLabel mesh__D020074 Lentinus
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D020074 2006
% 210.47/210.64 |- rdf__type mesh__D020074sskos__Concept
% 210.47/210.64 |- mesh__historyNote mesh__D020074
% 210.47/210.64 2005 %28%1999%29%; use POLYPORACEAE 1986-98
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 1996
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 2002
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 1993
% 210.47/210.64 |- mesh__recordOriginator mesh__D014835 NLM
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 2005
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 1997
% 210.47/210.64 |- mesh__dateCreated mesh__D014835 1999-01-01
% 210.47/210.64 |- skos__historyNote mesh__D014835 Gases %28%1966-1970%29%
% 210.47/210.64 |- skos__historyNote mesh__D014835 Chemistry, Physical %28%1966-1970%29%
% 210.47/210.64 |- skos__prefLabel mesh__D014835 Volatilization
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 2006
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 2000
% 210.47/210.64 |- skos__hiddenLabel mesh__D014835 Volatilizations
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 2003
% 210.47/210.64 |- mesh__dateEstablished mesh__D014835 1974-01-01
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D014835 74
% 210.47/210.64 |- skos__hiddenLabel mesh__D014835 Vaporizations
% 210.47/210.64 |- mesh__recordMaintainer mesh__D014835 TAP
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 1994
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D014835 PLS
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 2001
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 2004
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 1998
% 210.47/210.64 |- skos__historyNote mesh__D014835 appropriate chemical heading
% 210.47/210.64 |- skos__annotation mesh__D014835 NIM
% 210.47/210.64 |- rdf__type mesh__D014835sskos__Concept
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 1995
% 210.47/210.64 |- skos__broader mesh__D014835smesh__D002627
% 210.47/210.64 |- mesh__dateRevised mesh__D014835 1992-05-18
% 210.47/210.64 |- mesh__historyNote mesh__D014835 74%28%71%29%
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014835 1999
% 210.47/210.64 |- mesh__recordOriginator mesh__D014037 NLM
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 2001
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D014037 PLS
% 210.47/210.64 |- mesh__dateRevised mesh__D014037 1995-02-21
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 2000
% 210.47/210.64 |- skos__prefLabel mesh__D014037 Togo
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 2004
% 210.47/210.64 |- skos__broader mesh__D014037smesh__D000354
% 210.47/210.64 |- skos__scopeNote mesh__D014037
% 210.47/210.64 A republic in western Africa, lying between GHANA on its west and BENIN on its east. Its capital is Lome. Togo was the eastern part of the German protectorate of Togoland from 1884 until it was captured by Anglo-French forces in 1914. It became an autonomous republic within the French Union in 1956, achieving independence in 1960. The country probably derives its name from Lake Togo, to %28%water%29% + go %28%edge or shore%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p1216 %26% Room, Brewer%27%s Dictionary of Names, 1992, p548%29%%A%
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 2006
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 1997
% 210.47/210.64 |- mesh__dateCreated mesh__D014037 1999-01-01
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 1999
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 2003
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 2005
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 1996
% 210.47/210.64 |- mesh__recordMaintainer mesh__D014037 TGC
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 1998
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D014037 2002
% 210.47/210.64 |- skos__annotation mesh__D014037 a republic in western Africa
% 210.47/210.64 |- rdf__type mesh__D014037sskos__Concept
% 210.47/210.64 |- skos__scopeNote mesh__D000815
% 210.47/210.64 A drug-metabolizing, cytochrome P-450 enzyme which catalyzes the hydroxylation of aniline to hydroxyaniline in the presence of reduced flavoprotein and molecular oxygen. EC 1.14.14.-.%A%
% 210.47/210.64 |- skos__historyNote mesh__D000815 Hydroxylases %28%1973-1974%29%
% 210.47/210.64 |- mesh__recordMaintainer mesh__D000815 ssb
% 210.47/210.64 |- skos__historyNote mesh__D000815 Aniline Compounds %28%1973-1974%29%
% 210.47/210.64 |- skos__hiddenLabel mesh__D000815 Hydroxylase, Aniline
% 210.47/210.64 |- mesh__dateRevised mesh__D000815 2004-07-07
% 210.47/210.64 |- mesh__dateCreated mesh__D000815 1974-11-11
% 210.47/210.64 |- skos__prefLabel mesh__D000815 Aniline Hydroxylase
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000815 2005
% 210.47/210.64 |- skos__broader mesh__D000815smesh__D001189
% 210.47/210.64 |- mesh__recordOriginator mesh__D000815 NLM
% 210.47/210.64 |- mesh__dateEstablished mesh__D000815 1991-01-01
% 210.47/210.64 |- skos__annotation mesh__D000815 a cytochrome P-450 enzyme
% 210.47/210.64 |- rdf__type mesh__D000815sskos__Concept
% 210.47/210.64 |- mesh__historyNote mesh__D000815
% 210.47/210.64 91%28%75%29%; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76%A%
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000815 2006
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D000815
% 210.47/210.64 91; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76%A%
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D000815 sjn
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D019520 2006
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D019520 2000
% 210.47/210.64 |- mesh__dateCreated mesh__D019520 1996-06-10
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D019520 2003A
% 210.47/210.64 |- skos__prefLabel mesh__D019520 Living Donors
% 210.47/210.64 |- rdf__type mesh__D019520sskos__Concept
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D019520 2003
% 210.47/210.64 |- mesh__historyNote mesh__D019520 97
% 210.47/210.64 |- skos__hiddenLabel mesh__D019520 Living Donor
% 210.47/210.64 |- mesh__recordOriginator mesh__D019520 JLS
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D019520 2001
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D019520 2004
% 210.47/210.64 |- mesh__dateEstablished mesh__D019520 1997-01-01
% 210.47/210.64 |- skos__annotation mesh__D019520
% 210.47/210.64 coord IM with precoord organ/transpl heading %28%IM%29% or specific organ or tissue /transpl %28%IM%29% if precoord transpl heading is not in MeSH%A%
% 210.47/210.64 |- skos__historyNote mesh__D019520 Tissue Donors %28%1990-1996%29%
% 210.47/210.64 |- skos__hiddenLabel mesh__D019520 Donor, Living
% 210.47/210.64 |- mesh__dateRevised mesh__D019520 2002-10-31
% 210.47/210.64 |- skos__broader mesh__D019520smesh__D014019
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D019520 97
% 210.47/210.64 |- skos__scopeNote mesh__D019520
% 210.47/210.64 Non-cadaveric providers of organs for transplant to related or non-related recipients.%A%
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D019520 1999
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D019520 2002
% 210.47/210.64 |- mesh__recordMaintainer mesh__D019520 jls
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D019520 2005
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D019520 jls
% 210.47/210.64 |- skos__altLabel mesh__D019520 Donors, Living
% 210.47/210.64 |- skos__prefLabel mesh__D000017 ABO Blood-Group System
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D000017 2006
% 210.47/210.64 |- skos__altLabel mesh__D000017 ABH Blood Group
% 210.47/210.64 |- rdf__type mesh__D000017sskos__Concept
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 ABO Factor
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 ABO Blood-Group Systems
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 Factor, ABO
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 H Blood Groups
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D000017 sjn
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D000017 76; was ABO FACTORS 1963-75
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 Factors, ABO
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 Blood-Group Systems, ABO
% 210.47/210.64 |- skos__scopeNote mesh__D000017
% 210.47/210.64 The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane.%A%
% 210.47/210.64 |- mesh__dateRevised mesh__D000017 2005-06-30
% 210.47/210.64 |- mesh__recordMaintainer mesh__D000017 ssb
% 210.47/210.64 |- skos__altLabel mesh__D000017 H Blood Group
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 Blood Groups, ABH
% 210.47/210.64 |- skos__annotation mesh__D000017
% 210.47/210.64 IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 Blood Group, ABH
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 Blood-Group System, ABO
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 Blood Group, H
% 210.47/210.64 |- mesh__historyNote mesh__D000017 76; was ABO FACTORS 1963-75
% 210.47/210.64 |- mesh__recordOriginator mesh__D000017 SH
% 210.47/210.64 |- mesh__onlineNote mesh__D000017
% 210.47/210.64 use ABO BLOOD-GROUP SYSTEM to search ABO FACTORS 1966-75
% 210.47/210.64 |- mesh__dateEstablished mesh__D000017 1976-01-01
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 Blood Groups, H
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 ABH Blood Groups
% 210.47/210.64 |- skos__broader mesh__D000017smesh__D001789
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 Systems, ABO Blood-Group
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 System, ABO Blood-Group
% 210.47/210.64 |- skos__altLabel mesh__D000017 H Blood Group System
% 210.47/210.64 |- mesh__dateCreated mesh__D000017 1975-07-25
% 210.47/210.64 |- skos__hiddenLabel mesh__D000017 ABO Blood Group System
% 210.47/210.64 |- mesh__historyNote mesh__D005500 67%28%65%29%
% 210.47/210.64 |- skos__broader mesh__D005500smesh__D008137
% 210.47/210.64 |- mesh__recordOriginator mesh__D005500 NLM
% 210.47/210.64 |- rdf__type mesh__D005500sskos__Concept
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D005500 2005
% 210.47/210.64 |- mesh__dateEstablished mesh__D005500 1967-01-01
% 210.47/210.64 |- skos__hiddenLabel mesh__D005500 Study, Follow-Up
% 210.47/210.64 |- mesh__dateCreated mesh__D005500 1999-01-01
% 210.47/210.64 |- skos__hiddenLabel mesh__D005500 Studies, Followup
% 210.47/210.64 |- mesh__activeMeSHYear mesh__D005500 2006
% 210.47/210.64 |- skos__hiddenLabel mesh__D005500 Followup Study
% 210.47/210.64 |- mesh__recordMaintainer mesh__D005500 jls
% 210.47/210.64 |- skos__altLabel mesh__D005500 Followup Studies
% 210.47/210.64 |- skos__hiddenLabel mesh__D005500 Studies, Follow-Up
% 210.47/210.64 |- skos__scopeNote mesh__D005500
% 210.47/210.64 Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.%A%
% 210.47/210.64 |- skos__annotation mesh__D005500
% 210.47/210.64 IM General only; coord NIM with specific disease %28%IM%29%; specify geography if pertinent; usually epidemiologic in concept; relation to age tag: Manual 18.5.13%A%
% 210.47/210.64 |- skos__prefLabel mesh__D005500 Follow-Up Studies
% 210.47/210.64 |- skos__hiddenLabel mesh__D005500 Follow-Up Study
% 210.47/210.64 |- mesh__dateRevised mesh__D005500 2004-07-07
% 210.47/210.64 |- mesh__publicMeSHNote mesh__D005500 67
% 210.47/210.64 |- skos__hiddenLabel mesh__D005500 Study, Followup
% 210.47/210.64 |- skos__broader mesh__D005500smesh__D015331
% 210.47/210.64 |- mesh__recordAuthorizer mesh__D005500 sjn
% 210.47/210.64 |- skos__hiddenLabel mesh__D005500 Follow Up Studies
% 210.47/210.64 |- skos__prefLabel mesh__D052156 SELEX Aptamer Technique
% 210.47/210.64 |- mesh__recordMaintainer mesh__D052156 ssb
% 210.47/210.64 |- skos__hiddenLabel mesh__D052156 Aptamer Technique, SELEX
% 210.47/210.64 |- mesh__historyNote mesh__D052156 2006
% 210.47/210.64 |- skos__hiddenLabel mesh__D052156 Technique, SELEX Aptamer
% 210.47/210.64 |- rdf__type mesh__D052156sskos__Concept
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D052156 sjn
% 210.47/210.65 |- skos__hiddenLabel mesh__D052156 Techniques, SELEX Aptamer
% 210.47/210.65 |- mesh__dateEstablished mesh__D052156 2006-01-01
% 210.47/210.65 |- skos__scopeNote mesh__D052156
% 210.47/210.65 A method of generating a large library of randomized nucleotides and selecting NUCLEOTIDE APTAMERS by iterative rounds of in vitro selection. A modified procedure substitutes AMINO ACIDS in place of NUCLEOTIDES to make PEPTIDE APTAMERS.%A%
% 210.47/210.65 |- skos__hiddenLabel mesh__D052156 Aptamer Techniques, SELEX
% 210.47/210.65 |- mesh__dateCreated mesh__D052156 2005-06-30
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D052156 2006
% 210.47/210.65 |- mesh__recordOriginator mesh__D052156 ssb
% 210.47/210.65 |- skos__hiddenLabel mesh__D052156 SELEX Aptamer Techniques
% 210.47/210.65 |- skos__altLabel mesh__D052156
% 210.47/210.65 Systematic Evolution of Ligands by Eponential Enrichment
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D052156 2006
% 210.47/210.65 |- skos__broader mesh__D052156smesh__D020650
% 210.47/210.65 |- skos__broader mesh__D006225Q000293smesh__D006225
% 210.47/210.65 |- mesh__preferredCombination mesh__D006225Q000293smesh__D006230
% 210.47/210.65 |- rdf__type mesh__D006225Q000293smesh__CompoundConcept
% 210.47/210.65 |- mesh__historyNote mesh__D018428 95
% 210.47/210.65 |- mesh__dateEstablished mesh__D018428 1995-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D018428 2005
% 210.47/210.65 |- mesh__recordOriginator mesh__D018428 PXP
% 210.47/210.65 |- mesh__dateRevised mesh__D018428 2003-07-09
% 210.47/210.65 |- mesh__dateCreated mesh__D018428 1994-06-03
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D018428 2006
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D018428 95
% 210.47/210.65 |- skos__prefLabel mesh__D018428 Drosophilidae
% 210.47/210.65 |- skos__annotation mesh__D018428
% 210.47/210.65 a family of Diptera; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D018428 sjn
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D018428 2004
% 210.47/210.65 |- skos__broader mesh__D018428smesh__D004175
% 210.47/210.65 |- rdf__type mesh__D018428sskos__Concept
% 210.47/210.65 |- skos__scopeNote mesh__D018428
% 210.47/210.65 A family of the order DIPTERA. These flies are generally found around decaying vegetation and fruit. Several species, because of their short life span, giant salivary gland chromosomes, and ease of culturing, have been used extensively in studies of heredity.%A%
% 210.47/210.65 |- mesh__recordMaintainer mesh__D018428 ags
% 210.47/210.65 |- skos__prefLabel mesh__D010445 Peptide Elongation Factors
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D010445 sjn
% 210.47/210.65 |- skos__annotation mesh__D010445
% 210.47/210.65 /drug eff /biosyn /physiol /ultrastruct permitted
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D010445 2006
% 210.47/210.65 |- mesh__recordOriginator mesh__D010445 NLM
% 210.47/210.65 |- skos__hiddenLabel mesh__D010445 Elongation Factors, Peptide
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D010445 73
% 210.47/210.65 |- mesh__dateEstablished mesh__D010445 1973-01-01
% 210.47/210.65 |- skos__historyNote mesh__D010445 Peptides %28%1966-1972%29%
% 210.47/210.65 |- skos__hiddenLabel mesh__D010445 Factor, Elongation
% 210.47/210.65 |- skos__historyNote mesh__D010445 Bacterial Proteins %28%1966-1972%29%
% 210.47/210.65 |- rdf__type mesh__D010445sskos__Concept
% 210.47/210.65 |- skos__hiddenLabel mesh__D010445 Factors, Peptide Elongation
% 210.47/210.65 |- mesh__recordMaintainer mesh__D010445 SYSTEM
% 210.47/210.65 |- skos__historyNote mesh__D010445 Proteins %28%1966-1972%29%
% 210.47/210.65 |- skos__scopeNote mesh__D010445
% 210.47/210.65 Protein factors uniquely required during the elongation phase of protein synthesis.%A%
% 210.47/210.65 |- mesh__dateRevised mesh__D010445 2005-06-30
% 210.47/210.65 |- mesh__dateCreated mesh__D010445 1999-01-01
% 210.47/210.65 |- mesh__historyNote mesh__D010445 73
% 210.47/210.65 |- skos__broader mesh__D010445smesh__D012269
% 210.47/210.65 |- mesh__dateEstablished mesh__D004408 1991-01-01
% 210.47/210.65 |- skos__scopeNote mesh__D004408
% 210.47/210.65 A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.%A%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004408 2001
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004408 2000A
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004408 2005
% 210.47/210.65 |- skos__hiddenLabel mesh__D004408 Dysgeusias
% 210.47/210.65 |- mesh__historyNote mesh__D004408 1991%28%1975%29%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004408 2002
% 210.47/210.65 |- mesh__dateRevised mesh__D004408 1999-12-02
% 210.47/210.65 |- mesh__recordMaintainer mesh__D004408 ags
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004408 2006
% 210.47/210.65 |- skos__broader mesh__D004408smesh__D013651
% 210.47/210.65 |- mesh__recordOriginator mesh__D004408 NLM
% 210.47/210.65 |- mesh__dateCreated mesh__D004408 1999-01-01
% 210.47/210.65 |- rdf__type mesh__D004408sskos__Concept
% 210.47/210.65 |- skos__altLabel mesh__D004408 Parageusia
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D004408 ags
% 210.47/210.65 |- skos__annotation mesh__D004408
% 210.47/210.65 do not confuse with AGEUSIA, loss of sense of taste
% 210.47/210.65 |- skos__hiddenLabel mesh__D004408 Distorted Taste
% 210.47/210.65 |- skos__hiddenLabel mesh__D004408 Parageusias
% 210.47/210.65 |- skos__altLabel mesh__D004408 Taste, Distorted
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004408 2003
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D004408
% 210.47/210.65 1991; see TASTE DISORDERS 1975-1990
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004408 2000
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004408 2004
% 210.47/210.65 |- skos__prefLabel mesh__D004408 Dysgeusia
% 210.47/210.65 |- skos__hiddenLabel mesh__D004408 Altered Taste
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 1996
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 2005
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 1998
% 210.47/210.65 |- skos__scopeNote mesh__D001110
% 210.47/210.65 The Arctic Ocean and the lands in it and adjacent to it. It includes Point Barrow, Alaska, most of the Franklin District in Canada, two thirds of Greenland, Svalbard, Franz Josef Land, Lapland, Novaya Zemlya, and Northern Siberia. %28%Webster%27%s New Geographical Dictionary, 1988, p66%29%%A%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 2004
% 210.47/210.65 |- mesh__dateRevised mesh__D001110 1995-02-17
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 1997
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 2006
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 2000
% 210.47/210.65 |- skos__broader mesh__D001110smesh__D005842
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 1999
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 2001
% 210.47/210.65 |- mesh__dateCreated mesh__D001110 1999-01-01
% 210.47/210.65 |- mesh__recordOriginator mesh__D001110 NLM
% 210.47/210.65 |- rdf__type mesh__D001110sskos__Concept
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D001110 PLS
% 210.47/210.65 |- mesh__recordMaintainer mesh__D001110 TGC
% 210.47/210.65 |- skos__prefLabel mesh__D001110 Arctic Regions
% 210.47/210.65 |- skos__annotation mesh__D001110
% 210.47/210.65 note spelling: ARCTIC: neither spelled nor pronounced %22%artic%22%%A%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 2002
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001110 2003
% 210.47/210.65 |- mesh__historyNote mesh__D020075 99
% 210.47/210.65 |- skos__historyNote mesh__D020075 Basidiomycota %28%1978-1998%29%
% 210.47/210.65 |- mesh__dateEstablished mesh__D020075 1999-01-01
% 210.47/210.65 |- skos__broader mesh__D020075smesh__D011124
% 210.47/210.65 |- mesh__recordMaintainer mesh__D020075 SYSTEM
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D020075 99
% 210.47/210.65 |- mesh__recordOriginator mesh__D020075 AGS
% 210.47/210.65 |- mesh__dateCreated mesh__D020075 1998-06-10
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D020075 2006
% 210.47/210.65 |- rdf__type mesh__D020075sskos__Concept
% 210.47/210.65 |- mesh__dateRevised mesh__D020075 2005-06-30
% 210.47/210.65 |- skos__prefLabel mesh__D020075 Phanerochaete
% 210.47/210.65 |- skos__scopeNote mesh__D020075
% 210.47/210.65 A genus of fungi in the family Corticiaceae, order Stereales, that degrades lignin. The white-rot fungus Phanerochaete chrysosporium is a frequently used species in research.%A%
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D020075 sjn
% 210.47/210.65 |- skos__broader mesh__D014836smesh__D008606
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 2003
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 2004
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 1998
% 210.47/210.65 |- rdf__type mesh__D014836sskos__Concept
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 2002
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 1999
% 210.47/210.65 |- mesh__dateRevised mesh__D014836 1995-05-23
% 210.47/210.65 |- mesh__recordOriginator mesh__D014836 NLM
% 210.47/210.65 |- mesh__recordMaintainer mesh__D014836 KEV
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 1996
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 2000
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 2005
% 210.47/210.65 |- mesh__dateCreated mesh__D014836 1999-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 1997
% 210.47/210.65 |- skos__prefLabel mesh__D014836 Volition
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 2006
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D014836 PLS
% 210.47/210.65 |- skos__scopeNote mesh__D014836
% 210.47/210.65 Voluntary activity without external compulsion.
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014836 2001
% 210.47/210.65 |- skos__altLabel mesh__D014836 Will
% 210.47/210.65 |- skos__annotation mesh__D014038
% 210.47/210.65 includes bed pans, urinals, commodes, etc.
% 210.47/210.65 |- mesh__dateEstablished mesh__D014038 1977-01-01
% 210.47/210.65 |- skos__hiddenLabel mesh__D014038 Facility, Toilet
% 210.47/210.65 |- skos__broader mesh__D014038smesh__D012498
% 210.47/210.65 |- skos__scopeNote mesh__D014038
% 210.47/210.65 Facilities provided for human excretion, often with accompanying handwashing facilities.%A%
% 210.47/210.65 |- mesh__recordOriginator mesh__D014038 NLM
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D014038 sjn
% 210.47/210.65 |- mesh__onlineNote mesh__D014038
% 210.47/210.65 use TOILET FACILITIES to search LATRINES 1966-76
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014038 2006
% 210.47/210.65 |- mesh__dateCreated mesh__D014038 1999-01-01
% 210.47/210.65 |- skos__broader mesh__D014038smesh__D011633
% 210.47/210.65 |- mesh__dateRevised mesh__D014038 2004-07-13
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014038 2005
% 210.47/210.65 |- skos__prefLabel mesh__D014038 Toilet Facilities
% 210.47/210.65 |- mesh__recordMaintainer mesh__D014038 sjn
% 210.47/210.65 |- skos__hiddenLabel mesh__D014038 Latrine
% 210.47/210.65 |- rdf__type mesh__D014038sskos__Concept
% 210.47/210.65 |- skos__hiddenLabel mesh__D014038 Facilities, Toilet
% 210.47/210.65 |- skos__hiddenLabel mesh__D014038 Toilet Facility
% 210.47/210.65 |- mesh__historyNote mesh__D014038 77; was LATRINES 1963-76
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D014038 77; was LATRINES 1963-76
% 210.47/210.65 |- mesh__recordOriginator mesh__D000816 SH
% 210.47/210.65 |- mesh__dateCreated mesh__D000816 1975-07-21
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D000816 sjn
% 210.47/210.65 |- skos__broader mesh__D000816smesh__D009588
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000816 2003
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000816 2001
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000816 2005
% 210.47/210.65 |- skos__altLabel mesh__D000816 N,N-Di%28%2-Chloroethyl%29%aniline
% 210.47/210.65 |- skos__altLabel mesh__D000816 N,N-bis%28%2-chloroethyl%29%aniline
% 210.47/210.65 |- mesh__historyNote mesh__D000816
% 210.47/210.65 91%28%76%29%; was see under NITROGEN MUSTARD COMPOUNDS 1976-90; LYMPHOCHIN %26% LYMPHOQUIN were see ANILINE MUSTARD 1976-95%A%
% 210.47/210.65 |- mesh__dateEstablished mesh__D000816 1991-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000816 2004
% 210.47/210.65 |- rdf__type mesh__D000816sskos__Concept
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000816 2006
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D000816
% 210.47/210.65 91; was see under NITROGEN MUSTARD COMPOUNDS 1976-90; LYMPHOCHIN %26% LYMPHOQUIN were see ANILINE MUSTARD 1976-95%A%
% 210.47/210.65 |- skos__historyNote mesh__D000816
% 210.47/210.65 Nitrogen Mustard Compounds %28%1970-1975%29%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000816 2002
% 210.47/210.65 |- mesh__recordMaintainer mesh__D000816 jmp
% 210.47/210.65 |- skos__prefLabel mesh__D000816 Aniline Mustard
% 210.47/210.65 |- mesh__dateRevised mesh__D000816 2000-06-21
% 210.47/210.65 |- skos__scopeNote mesh__D000816 Alkylating anti-neoplastic agent.
% 210.47/210.65 |- skos__historyNote mesh__D000816 Aniline Compounds %28%1970-1975%29%
% 210.47/210.65 |- skos__hiddenLabel mesh__D000816 Mustard, Aniline
% 210.47/210.65 |- mesh__recordOriginator mesh__D019521 JLS
% 210.47/210.65 |- rdf__type mesh__D019521sskos__Concept
% 210.47/210.65 |- mesh__historyNote mesh__D019521 97
% 210.47/210.65 |- skos__prefLabel mesh__D019521 Body Patterning
% 210.47/210.65 |- skos__scopeNote mesh__D019521
% 210.47/210.65 The processes occurring in early development that direct morphogenesis. They specify the body plan ensuring that cells will proceed to differentiate, grow, and diversify in size and shape at the correct relative positions. Included are axial patterning, segmentation, compartment specification, limb position, organ boundary patterning, blood vessel patterning, etc.%A%
% 210.47/210.65 |- skos__altLabel mesh__D019521 Body Pattern Specification
% 210.47/210.65 |- mesh__dateRevised mesh__D019521 2004-07-07
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Formation, Embryonic Pattern
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Specification, Body Pattern
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Development Polarity
% 210.47/210.65 |- mesh__recordMaintainer mesh__D019521 lkt
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Pattern Formation, Body
% 210.47/210.65 |- skos__historyNote mesh__D019521 Morphogenesis %28%1986-1996%29%
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Embryonic Pattern Formations
% 210.47/210.65 |- skos__altLabel mesh__D019521 Body Pattern Formation
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Pattern Formation, Embryonic
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Pattern Specification, Body
% 210.47/210.65 |- mesh__dateEstablished mesh__D019521 1997-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D019521 2005
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Specification, Embryonic Pattern
% 210.47/210.65 |- skos__altLabel mesh__D019521 Embryonic Pattern Specification
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Patterning, Body
% 210.47/210.65 |- skos__broader mesh__D019521smesh__D009024
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D019521 2006
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D019521 97
% 210.47/210.65 |- mesh__dateCreated mesh__D019521 1996-06-13
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Patterning, Axial %28%Embryology%29%
% 210.47/210.65 |- skos__hiddenLabel mesh__D019521 Pattern Specification, Embryonic
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D019521 sjn
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D000018 PLS
% 210.47/210.65 |- mesh__dateCreated mesh__D000018 1999-01-01
% 210.47/210.65 |- skos__broader mesh__D000018smesh__D013279
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 2003
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 1996
% 210.47/210.65 |- mesh__dateEstablished mesh__D000018 1968-01-01
% 210.47/210.65 |- skos__annotation mesh__D000018
% 210.47/210.65 a ruminant%27%s 4th stomach; dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet %28%IM%29% + histol type /vet %28%IM%29%; ulcer: coord IM with STOMACH ULCER /vet %28%IM%29%%A%
% 210.47/210.65 |- mesh__recordMaintainer mesh__D000018 TGC
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 2004
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 1997
% 210.47/210.65 |- mesh__historyNote mesh__D000018 68
% 210.47/210.65 |- skos__scopeNote mesh__D000018
% 210.47/210.65 The fourth stomach of ruminating animals. It is also called the %22%true%22% stomach. It is an elongated pear-shaped sac lying on the floor of the abdomen, on the right-hand side, and roughly between the seventh and twelfth ribs. It leads to the beginning of the small intestine. %28%From Black%27%s Veterinary Dictionary, 17th ed%29%%A%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 2000
% 210.47/210.65 |- mesh__recordOriginator mesh__D000018 NLM
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 2005
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 1998
% 210.47/210.65 |- skos__historyNote mesh__D000018 Stomach %28%1966-1967%29%
% 210.47/210.65 |- skos__prefLabel mesh__D000018 Abomasum
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 2001
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 2006
% 210.47/210.65 |- mesh__dateRevised mesh__D000018 1995-05-18
% 210.47/210.65 |- skos__hiddenLabel mesh__D000018 Abomasums
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 1999
% 210.47/210.65 |- rdf__type mesh__D000018sskos__Concept
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D000018 68
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D000018 2002
% 210.47/210.65 |- skos__prefLabel mesh__D052157 Aptamers, Nucleotide
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D052157 2006
% 210.47/210.65 |- skos__altLabel mesh__D052157 Nucleotide Aptamers
% 210.47/210.65 |- skos__scopeNote mesh__D052157
% 210.47/210.65 Nucleotide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity.%A%
% 210.47/210.65 |- mesh__recordMaintainer mesh__D052157 ssb
% 210.47/210.65 |- mesh__recordOriginator mesh__D052157 ssb
% 210.47/210.65 |- skos__hiddenLabel mesh__D052157 Ligands, RNA Oligonucleotide
% 210.47/210.65 |- mesh__historyNote mesh__D052157 2006
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D052157 2006
% 210.47/210.65 |- mesh__dateEstablished mesh__D052157 2006-01-01
% 210.47/210.65 |- skos__hiddenLabel mesh__D052157 RNA Oligonucleotide Ligands
% 210.47/210.65 |- skos__hiddenLabel mesh__D052157 DNA Oligonucleotide Ligands
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D052157 sjn
% 210.47/210.65 |- skos__broader mesh__D052157smesh__D009841
% 210.47/210.65 |- skos__hiddenLabel mesh__D052157 Ligands, DNA Oligonucleotide
% 210.47/210.65 |- rdf__type mesh__D052157sskos__Concept
% 210.47/210.65 |- mesh__dateCreated mesh__D052157 2005-06-30
% 210.47/210.65 |- mesh__recordMaintainer mesh__D018429 ags
% 210.47/210.65 |- skos__prefLabel mesh__D018429 Glossinidae
% 210.47/210.65 |- mesh__historyNote mesh__D018429 95
% 210.47/210.65 |- skos__annotation mesh__D018429
% 210.47/210.65 a family of Diptera occurring only in Africa; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%
% 210.47/210.65 |- mesh__recordOriginator mesh__D018429 PXP
% 210.47/210.65 |- mesh__dateCreated mesh__D018429 1994-06-03
% 210.47/210.65 |- mesh__dateEstablished mesh__D018429 1995-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D018429 2005
% 210.47/210.65 |- skos__scopeNote mesh__D018429
% 210.47/210.65 A family of the order DIPTERA that includes the TSETSE FLIES. These flies occur only in Africa.%A%
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D018429 95
% 210.47/210.65 |- mesh__dateRevised mesh__D018429 2003-07-09
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D018429 sjn
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D018429 2006
% 210.47/210.65 |- rdf__type mesh__D018429sskos__Concept
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D018429 2004
% 210.47/210.65 |- skos__broader mesh__D018429smesh__D004175
% 210.47/210.65 |- mesh__dateRevised mesh__D010446 1998-06-10
% 210.47/210.65 |- mesh__historyNote mesh__D010446 74
% 210.47/210.65 |- mesh__dateCreated mesh__D010446 1999-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D010446 2001
% 210.47/210.65 |- skos__hiddenLabel mesh__D010446 Fragments, Peptide
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D010446 1999
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D010446 2006
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D010446 2000
% 210.47/210.65 |- skos__prefLabel mesh__D010446 Peptide Fragments
% 210.47/210.65 |- skos__scopeNote mesh__D010446
% 210.47/210.65 Partial proteins formed by partial hydrolysis of complete proteins.%A%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D010446 2004
% 210.47/210.65 |- skos__broader mesh__D010446smesh__D010455
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D010446 2005
% 210.47/210.65 |- mesh__recordOriginator mesh__D010446 NLM
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D010446 74
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D010446 2003
% 210.47/210.65 |- mesh__dateEstablished mesh__D010446 1974-01-01
% 210.47/210.65 |- rdf__type mesh__D010446sskos__Concept
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D010446 SJN
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D010446 2002
% 210.47/210.65 |- mesh__recordMaintainer mesh__D010446 ADP
% 210.47/210.65 |- skos__broader mesh__D014566Q000530smesh__D014566
% 210.47/210.65 |- mesh__preferredCombination mesh__D014566Q000530smesh__D014567
% 210.47/210.65 |- rdf__type mesh__D014566Q000530smesh__CompoundConcept
% 210.47/210.65 |- rdf__type mesh__D004409sskos__Concept
% 210.47/210.65 |- mesh__recordMaintainer mesh__D004409 nns
% 210.47/210.65 |- mesh__dateCreated mesh__D004409 1976-05-19
% 210.47/210.65 |- mesh__recordOriginator mesh__D004409 MM
% 210.47/210.65 |- mesh__dateEstablished mesh__D004409 1977-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004409 2003
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Dyskinesias, Lingual-Facial-Buccal
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Dyskinesia, Drug Induced
% 210.47/210.65 |- skos__altLabel mesh__D004409 Medication-Induced Dyskinesia
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004409 2004
% 210.47/210.65 |- skos__historyNote mesh__D004409 Movement Disorders %28%1966-1976%29%
% 210.47/210.65 |- skos__related mesh__D004409smesh__D017109
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Orofacial Dyskinesias
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Dyskinesias, Medication-Induced
% 210.47/210.65 |- skos__scopeNote mesh__D004409
% 210.47/210.65 Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents %28%see ANTIPSYCHOTIC AGENTS%29%. %28%Adams et al., Principles of Neurology, 6th ed, p1199%29%%A%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004409 2002
% 210.47/210.65 |- skos__altLabel mesh__D004409 Orofacial Dyskinesia
% 210.47/210.65 |- skos__prefLabel mesh__D004409 Dyskinesia, Drug-Induced
% 210.47/210.65 |- mesh__dateRevised mesh__D004409 2001-07-25
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Drug-Induced Dyskinesia
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Medication Induced Dyskinesia
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Dyskinesia, Orofacial
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004409 2005
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Dyskinesia, Medication Induced
% 210.47/210.65 |- mesh__historyNote mesh__D004409 77
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D004409 77
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D004409 sjn
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Dyskinesia, Lingual-Facial-Buccal
% 210.47/210.65 |- skos__broader mesh__D004409smesh__D020258
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Lingual-Facial-Buccal Dyskinesias
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Dyskinesias, Drug-Induced
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D004409 2006
% 210.47/210.65 |- skos__annotation mesh__D004409
% 210.47/210.65 do not confuse with AKATHISIA, DRUG-INDUCED which shows %22%anxiety, restlessness %26% agitation%22%%A%
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Lingual Facial Buccal Dyskinesia
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Medication-Induced Dyskinesias
% 210.47/210.65 |- skos__hiddenLabel mesh__D004409 Drug-Induced Dyskinesias
% 210.47/210.65 |- skos__hiddenLabel mesh__D001111 Nucleus, Arcuate
% 210.47/210.65 |- mesh__dateEstablished mesh__D001111 1983-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 2001
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 2004
% 210.47/210.65 |- skos__altLabel mesh__D001111 Infundibular Nucleus
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 1997
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 2000
% 210.47/210.65 |- skos__hiddenLabel mesh__D001111 Nucleus, Infundibular
% 210.47/210.65 |- skos__historyNote mesh__D001111 Hypothalamus %28%1966-1982%29%
% 210.47/210.65 |- mesh__recordMaintainer mesh__D001111 TAP
% 210.47/210.65 |- mesh__dateRevised mesh__D001111 1992-03-25
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 2003
% 210.47/210.65 |- skos__broader mesh__D001111smesh__D007033
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 1993
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 1996
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 2006
% 210.47/210.65 |- skos__prefLabel mesh__D001111 Arcuate Nucleus
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 1999
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 2002
% 210.47/210.65 |- mesh__historyNote mesh__D001111 83
% 210.47/210.65 |- mesh__dateCreated mesh__D001111 1982-04-23
% 210.47/210.65 |- mesh__recordOriginator mesh__D001111 RC
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 1995
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D001111 PLS
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 2005
% 210.47/210.65 |- skos__scopeNote mesh__D001111
% 210.47/210.65 A nucleus located in the middle hypothalamus in the most ventral part of the third ventricle near the entrance of the infundibular recess. Its small cells are in close contact with the ependyma.%A%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 1998
% 210.47/210.65 |- skos__annotation mesh__D001111 in the HYPOTHALAMUS, MIDDLE
% 210.47/210.65 |- rdf__type mesh__D001111sskos__Concept
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D001111 1994
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D001111 83
% 210.47/210.65 |- mesh__publicMeSHNote mesh__D020076 99
% 210.47/210.65 |- mesh__recordMaintainer mesh__D020076 ags
% 210.47/210.65 |- mesh__historyNote mesh__D020076 99
% 210.47/210.65 |- skos__broader mesh__D020076smesh__D000363
% 210.47/210.65 |- skos__altLabel mesh__D020076 Pleurotus ostreatus
% 210.47/210.65 |- mesh__dateRevised mesh__D020076 2005-06-30
% 210.47/210.65 |- skos__prefLabel mesh__D020076 Pleurotus
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D020076 sjn
% 210.47/210.65 |- skos__historyNote mesh__D020076 Basidiomycota %28%1966-1998%29%
% 210.47/210.65 |- mesh__recordOriginator mesh__D020076 AGS
% 210.47/210.65 |- skos__historyNote mesh__D020076 Polyporaceae %28%1988-1998%29%
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D020076 2006
% 210.47/210.65 |- rdf__type mesh__D020076sskos__Concept
% 210.47/210.65 |- skos__scopeNote mesh__D020076
% 210.47/210.65 A genus of basidiomycetous fungi, family POLYPORACEAE, order POLYPORALES, that grows on logs or tree stumps in shelflike layers. The species P. ostreatus, the oyster mushroom, is a choice edible species and is the most frequently encountered member of the genus in eastern North America. %28%Alexopoulos et al., Introductory Mycology, 4th ed, p531%29%%A%
% 210.47/210.65 |- mesh__dateEstablished mesh__D020076 1999-01-01
% 210.47/210.65 |- mesh__dateCreated mesh__D020076 1998-06-10
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014837 2004
% 210.47/210.65 |- rdf__type mesh__D014837sskos__Concept
% 210.47/210.65 |- skos__hiddenLabel mesh__D014837 Agency, Voluntary Health
% 210.47/210.65 |- skos__prefLabel mesh__D014837 Voluntary Health Agencies
% 210.47/210.65 |- skos__hiddenLabel mesh__D014837 Voluntary Health Agency
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014837 2001
% 210.47/210.65 |- mesh__dateRevised mesh__D014837 1999-11-03
% 210.47/210.65 |- skos__hiddenLabel mesh__D014837 Agencies, Voluntary Health
% 210.47/210.65 |- skos__annotation mesh__D014837
% 210.47/210.65 IM; coord with specific pertinent med specialty %28%IM%29%; TN 174: definition %26% use%A%
% 210.47/210.65 |- skos__hiddenLabel mesh__D014837 Health Agencies, Voluntary
% 210.47/210.65 |- mesh__recordMaintainer mesh__D014837 kle
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014837 2005
% 210.47/210.65 |- skos__scopeNote mesh__D014837
% 210.47/210.65 Non-profit organizations concerned with various aspects of health, e.g., education, promotion, treatment, services, etc.%A%
% 210.47/210.65 |- mesh__dateCreated mesh__D014837 1999-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014837 2002
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014837 2006
% 210.47/210.65 |- mesh__recordAuthorizer mesh__D014837 sjn
% 210.47/210.65 |- skos__hiddenLabel mesh__D014837 Health Agency, Voluntary
% 210.47/210.65 |- mesh__recordOriginator mesh__D014837 NLM
% 210.47/210.65 |- skos__broader mesh__D014837smesh__D009939
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014837 2003
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014837 2000
% 210.47/210.65 |- skos__altLabel mesh__D014837 PPFA
% 210.47/210.65 |- mesh__dateCreated mesh__D014039 1999-01-01
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014039 1999
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014039 2003
% 210.47/210.65 |- mesh__activeMeSHYear mesh__D014039 1993
% 210.47/210.66 |- skos__hiddenLabel mesh__D014039 Toilet Trainings
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 2005
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 1996
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 1995
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 1998
% 210.47/210.66 |- mesh__dateRevised mesh__D014039 1989-05-16
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 1992
% 210.47/210.66 |- mesh__dateEstablished mesh__D014039 1968-01-01
% 210.47/210.66 |- mesh__recordMaintainer mesh__D014039 TGC
% 210.47/210.66 |- rdf__type mesh__D014039sskos__Concept
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 1994
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D014039 68
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 2002
% 210.47/210.66 |- skos__scopeNote mesh__D014039
% 210.47/210.66 Conditioning to defecate and urinate in culturally acceptable places.%A%
% 210.47/210.66 |- skos__historyNote mesh__D014039 Child Care %28%1966-1967%29%
% 210.47/210.66 |- skos__broader mesh__D014039smesh__D002668
% 210.47/210.66 |- mesh__recordOriginator mesh__D014039 NLM
% 210.47/210.66 |- skos__hiddenLabel mesh__D014039 Training, Toilet
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 2001
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D014039 PLS
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 1991
% 210.47/210.66 |- mesh__historyNote mesh__D014039 68
% 210.47/210.66 |- skos__hiddenLabel mesh__D014039 Trainings, Toilet
% 210.47/210.66 |- skos__annotation mesh__D014039 no qualif
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 2004
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 2006
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 2000
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 1997
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014039 1990
% 210.47/210.66 |- skos__prefLabel mesh__D014039 Toilet Training
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 2005
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D000817 PLS
% 210.47/210.66 |- skos__broader mesh__D000817smesh__D009282
% 210.47/210.66 |- rdf__type mesh__D000817sskos__Concept
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 2004
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 1996
% 210.47/210.66 |- skos__scopeNote mesh__D000817
% 210.47/210.66 A class of organic compounds which contain an anilino %28%phenylamino%29% group linked to a salt or ester of naphthalenesulfonic acid. They are frequently used as fluorescent dyes and sulfhydryl reagents.%A%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 2002
% 210.47/210.66 |- skos__prefLabel mesh__D000817 Anilino Naphthalenesulfonates
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 2006
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 1998
% 210.47/210.66 |- mesh__recordOriginator mesh__D000817 NLM
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 1997
% 210.47/210.66 |- skos__hiddenLabel mesh__D000817 Naphthalenesulfonates, Anilino
% 210.47/210.66 |- mesh__historyNote mesh__D000817 74
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D000817 74
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 1999
% 210.47/210.66 |- mesh__recordMaintainer mesh__D000817 TPW
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 1994
% 210.47/210.66 |- skos__broader mesh__D000817smesh__D000814
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 2000
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 2001
% 210.47/210.66 |- mesh__dateCreated mesh__D000817 1999-01-01
% 210.47/210.66 |- mesh__dateEstablished mesh__D000817 1974-01-01
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 1995
% 210.47/210.66 |- mesh__dateRevised mesh__D000817 1993-06-04
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000817 2003
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 2006
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 2001
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 2005
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 2004
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D019522 97
% 210.47/210.66 |- skos__hiddenLabel mesh__D019522 Vaginal Discharges
% 210.47/210.66 |- skos__broader mesh__D019522smesh__D014623
% 210.47/210.66 |- rdf__type mesh__D019522sskos__Concept
% 210.47/210.66 |- mesh__historyNote mesh__D019522 97
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 2000
% 210.47/210.66 |- skos__scopeNote mesh__D019522
% 210.47/210.66 A common gynecologic disorder characterized by an abnormal, nonbloody discharge from the genital tract.%A%
% 210.47/210.66 |- skos__hiddenLabel mesh__D019522 Discharge, Vaginal
% 210.47/210.66 |- mesh__dateEstablished mesh__D019522 1997-01-01
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 2003
% 210.47/210.66 |- skos__historyNote mesh__D019522 Vagina/secretion %28%1966-1996%29%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 1999
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 2002
% 210.47/210.66 |- skos__hiddenLabel mesh__D019522 Discharges, Vaginal
% 210.47/210.66 |- skos__prefLabel mesh__D019522 Vaginal Discharge
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 1998
% 210.47/210.66 |- skos__annotation mesh__D019522
% 210.47/210.66 note category; nonbloody; IM; coord with cause of discharge %28%IM%29%%A%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019522 1997
% 210.47/210.66 |- skos__historyNote mesh__D019522 Vaginal Diseases %28%1966-1996%29%
% 210.47/210.66 |- mesh__dateCreated mesh__D019522 1996-06-13
% 210.47/210.66 |- skos__related mesh__D000019smesh__D010120
% 210.47/210.66 |- mesh__recordOriginator mesh__D000019 NLM
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000019 2006
% 210.47/210.66 |- mesh__dateRevised mesh__D000019 2005-06-30
% 210.47/210.66 |- skos__historyNote mesh__D000019 Abortion, Induced %28%1970-1974%29%
% 210.47/210.66 |- rdf__type mesh__D000019sskos__Concept
% 210.47/210.66 |- skos__altLabel mesh__D000019 Contraceptive Agents, Postconception
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D000019 75
% 210.47/210.66 |- skos__prefLabel mesh__D000019 Abortifacient Agents
% 210.47/210.66 |- skos__hiddenLabel mesh__D000019 Agents, Postconception Contraceptive
% 210.47/210.66 |- skos__altLabel mesh__D000019 Abortifacients
% 210.47/210.66 |- skos__scopeNote mesh__D000019
% 210.47/210.66 Chemical substances that interrupt pregnancy after implantation.%A%
% 210.47/210.66 |- skos__broader mesh__D000019smesh__D012102
% 210.47/210.66 |- mesh__recordMaintainer mesh__D000019 ssb
% 210.47/210.66 |- mesh__historyNote mesh__D000019 75
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D000019 sjn
% 210.47/210.66 |- skos__hiddenLabel mesh__D000019 Postconception Contraceptive Agents
% 210.47/210.66 |- mesh__dateCreated mesh__D000019 1999-01-01
% 210.47/210.66 |- mesh__dateEstablished mesh__D000019 1975-01-01
% 210.47/210.66 |- skos__annotation mesh__D000019
% 210.47/210.66 do not use /ther use for use of abortifacients as abortifacients%A%
% 210.47/210.66 |- skos__hiddenLabel mesh__D000019 Agents, Abortifacient
% 210.47/210.66 |- mesh__dateRevised mesh__D005502 2002-06-26
% 210.47/210.66 |- skos__broader mesh__D005502smesh__D019602
% 210.47/210.66 |- mesh__recordMaintainer mesh__D005502 ssb
% 210.47/210.66 |- skos__scopeNote mesh__D005502
% 210.47/210.66 Anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat. %28%Dorland, 27th ed%29%%A%
% 210.47/210.66 |- skos__related mesh__D005502smesh__D004032
% 210.47/210.66 |- skos__hiddenLabel mesh__D005502 Foods
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D005502 sjn
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D005502 2003
% 210.47/210.66 |- rdf__type mesh__D005502sskos__Concept
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D005502 2005
% 210.47/210.66 |- skos__related mesh__D005502smesh__D010945
% 210.47/210.66 |- mesh__dateCreated mesh__D005502 1999-01-01
% 210.47/210.66 |- mesh__recordOriginator mesh__D005502 NLM
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D005502 2004
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D005502 2006
% 210.47/210.66 |- skos__annotation mesh__D005502
% 210.47/210.66 /adv eff = probably FOOD HYPERSENSITIVITY or FOOD POISONING; /rad eff = probably FOOD IRRADIATION or FOOD CONTAMINATION, RADIOACTIVE; Manual 31.5-31.12; food consumption = FOOD or EATING or FOOD SUPPLY; food for animals = ANIMAL FEED; refeeding after starvation goes here; microbes found in food: consider FOOD MICROBIOLOGY %28%IM%29% + specific microbe %28%IM%29%; parasites found in food: consider FOOD PARASITOLOGY %28%IM%29% + specific parasite %28%IM%29%; differentiation from DIET %26% NUTRITION: see note under NUTRITION %26% Manual 31.5%A%
% 210.47/210.66 |- skos__prefLabel mesh__D005502 Food
% 210.47/210.66 |- mesh__dateCreated mesh__D052158 2005-06-30
% 210.47/210.66 |- mesh__recordOriginator mesh__D052158 ssb
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D052158 2006
% 210.47/210.66 |- skos__prefLabel mesh__D052158 Aptamers, Peptide
% 210.47/210.66 |- skos__altLabel mesh__D052158 Peptide Aptamers
% 210.47/210.66 |- skos__scopeNote mesh__D052158
% 210.47/210.66 Peptide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity.%A%
% 210.47/210.66 |- rdf__type mesh__D052158sskos__Concept
% 210.47/210.66 |- mesh__recordMaintainer mesh__D052158 ssb
% 210.47/210.66 |- skos__broader mesh__D052158smesh__D010455
% 210.47/210.66 |- mesh__historyNote mesh__D052158 2006
% 210.47/210.66 |- mesh__dateEstablished mesh__D052158 2006-01-01
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D052158 sjn
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D052158 2006
% 210.47/210.66 |- skos__prefLabel mesh__D010447 Peptide Hydrolases
% 210.47/210.66 |- skos__broader mesh__D010447smesh__D006867
% 210.47/210.66 |- skos__altLabel mesh__D010447 Esteroproteases
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D010447 2006
% 210.47/210.66 |- mesh__historyNote mesh__D010447
% 210.47/210.66 1966; for PROTEINASES use ENDOPEPTIDASES 1979-2000; for PROTEASES use ENDOPEPTIDASES 1987-2004%A%
% 210.47/210.66 |- skos__altLabel mesh__D010447 Peptidases
% 210.47/210.66 |- skos__altLabel mesh__D010447 Proteinases
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D010447 2005
% 210.47/210.66 |- mesh__recordMaintainer mesh__D010447 jmp
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D010447
% 210.47/210.66 1966; for PROTEINASES see ENDOPEPTIDASES 1979-2004; for PROTEASES see ENDOPEPTIDASES 1987-2004%A%
% 210.47/210.66 |- rdf__type mesh__D010447sskos__Concept
% 210.47/210.66 |- skos__scopeNote mesh__D010447
% 210.47/210.66 Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES.%A%
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D010447 sjn
% 210.47/210.66 |- mesh__dateRevised mesh__D010447 2004-07-07
% 210.47/210.66 |- skos__altLabel mesh__D010447 Proteases
% 210.47/210.66 |- mesh__recordOriginator mesh__D010447 NLM
% 210.47/210.66 |- skos__altLabel mesh__D010447 Proteolytic Enzymes
% 210.47/210.66 |- mesh__dateCreated mesh__D010447 1999-01-01
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1993
% 210.47/210.66 |- skos__hiddenLabel mesh__D015930 Dietary Record
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 2006
% 210.47/210.66 |- skos__hiddenLabel mesh__D015930 Food Diary
% 210.47/210.66 |- skos__hiddenLabel mesh__D015930 Records, Diet
% 210.47/210.66 |- skos__altLabel mesh__D015930 Food Diaries
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1998
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 2001
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D015930 90
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1992
% 210.47/210.66 |- skos__altLabel mesh__D015930 Dietary Records
% 210.47/210.66 |- skos__scopeNote mesh__D015930
% 210.47/210.66 Records of nutrient intake over a specific period of time, usually kept by the patient.%A%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 2005
% 210.47/210.66 |- skos__broader mesh__D015930smesh__D011996
% 210.47/210.66 |- skos__annotation mesh__D015930
% 210.47/210.66 record of food intake usually kept by patient; no qualif
% 210.47/210.66 |- mesh__dateCreated mesh__D015930 1989-05-15
% 210.47/210.66 |- skos__historyNote mesh__D015930 Diet %28%1966-1989%29%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1997
% 210.47/210.66 |- skos__hiddenLabel mesh__D015930 Record, Diet
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 2000
% 210.47/210.66 |- skos__hiddenLabel mesh__D015930 Diary, Food
% 210.47/210.66 |- mesh__historyNote mesh__D015930 90
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1991
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 2004
% 210.47/210.66 |- skos__prefLabel mesh__D015930 Diet Records
% 210.47/210.66 |- skos__hiddenLabel mesh__D015930 Diet Record
% 210.47/210.66 |- skos__hiddenLabel mesh__D015930 Diaries, Food
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1996
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1995
% 210.47/210.66 |- skos__hiddenLabel mesh__D015930 Record, Dietary
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1990
% 210.47/210.66 |- skos__historyNote mesh__D015930 Nutrition Surveys %28%1971-1989%29%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 2003
% 210.47/210.66 |- rdf__type mesh__D015930sskos__Concept
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1994
% 210.47/210.66 |- mesh__dateEstablished mesh__D015930 1990-01-01
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 1999
% 210.47/210.66 |- skos__hiddenLabel mesh__D015930 Records, Dietary
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D015930 2002
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D001910
% 210.47/210.66 94; was BOVINE PAPILLOMATOSIS VIRUS 1975-93 %28%see under PAPILLOMAVIRUSES 1978-90, see under PAPILLOMA VIRUSES 1975-77%29%%A%
% 210.47/210.66 |- mesh__recordOriginator mesh__D001910 NLM
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D001910 sjn
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Papillomaviruses, Bovine
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 papillomatosis viruses, Bovine
% 210.47/210.66 |- skos__altLabel mesh__D001910 Bovine Wart Virus
% 210.47/210.66 |- skos__altLabel mesh__D001910 Papilloma Virus, Bovine
% 210.47/210.66 |- skos__altLabel mesh__D001910 Bovine Papular Dermatitis Virus
% 210.47/210.66 |- mesh__historyNote mesh__D001910
% 210.47/210.66 94; was BOVINE PAPILLOMATOSIS VIRUS 1975-93 %28%see under PAPILLOMAVIRUSES 1978-90, see under PAPILLOMA VIRUSES 1975-77%29%%A%
% 210.47/210.66 |- skos__scopeNote mesh__D001910
% 210.47/210.66 A species of PAPILLOMAVIRUS producing large numbers of WARTS on calves. Connective tissue proliferation is an important component of the warts.%A%
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Bovine papillomatosis viruses
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Wart Viruses, Bovine
% 210.47/210.66 |- skos__altLabel mesh__D001910 Bovine papillomatosis virus
% 210.47/210.66 |- mesh__recordMaintainer mesh__D001910 ags
% 210.47/210.66 |- rdf__type mesh__D001910sskos__Concept
% 210.47/210.66 |- skos__prefLabel mesh__D001910 Papillomavirus, Bovine
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Bovine Papilloma Virus
% 210.47/210.66 |- skos__broader mesh__D001910smesh__D010213
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Bovine Papillomavirus
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001910 2005
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Bovine Wart Viruses
% 210.47/210.66 |- mesh__dateEstablished mesh__D001910 1991-01-01
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Bovine Papillomaviruses
% 210.47/210.66 |- mesh__dateRevised mesh__D001910 2003-07-09
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Wart Virus, Bovine
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Papilloma Viruses, Bovine
% 210.47/210.66 |- mesh__dateCreated mesh__D001910 1974-12-12
% 210.47/210.66 |- skos__hiddenLabel mesh__D001910 Bovine Papilloma Viruses
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001910 2006
% 210.47/210.66 |- skos__annotation mesh__D001910
% 210.47/210.66 infection: coord IM with PAPILLOMAVIRUS INFECTIONS %28%IM%29%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001910 2004
% 210.47/210.66 |- mesh__onlineNote mesh__D001910
% 210.47/210.66 use PAPILLOMAVIRUS, BOVINE to search BOVINE PAPILLOMATOSIS VIRUS 1975-93%A%
% 210.47/210.66 |- skos__prefLabel mesh__D001112 Arcus Senilis
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001112 2003
% 210.47/210.66 |- skos__annotation mesh__D001112
% 210.47/210.66 cholesterol or hyalin deposits in cornea causing opacity; frequent in those over 50%A%
% 210.47/210.66 |- mesh__recordMaintainer mesh__D001112 TPW
% 210.47/210.66 |- skos__scopeNote mesh__D001112
% 210.47/210.66 A corneal disease in which there is a deposition of phospholipid and cholesterol in the corneal stroma and anterior sclera.%A%
% 210.47/210.66 |- mesh__recordOriginator mesh__D001112 NLM
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001112 2001
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001112 2006
% 210.47/210.66 |- skos__hiddenLabel mesh__D001112 Arcus, Corneal
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001112 1999
% 210.47/210.66 |- mesh__historyNote mesh__D001112
% 210.47/210.66 91%28%64%29%; was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89%A%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001112 2000
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001112 2005
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D001112
% 210.47/210.66 91; was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89%A%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001112 1998
% 210.47/210.66 |- skos__altLabel mesh__D001112 Corneal Arcus
% 210.47/210.66 |- rdf__type mesh__D001112sskos__Concept
% 210.47/210.66 |- mesh__dateCreated mesh__D001112 1999-01-01
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001112 2002
% 210.47/210.66 |- mesh__dateEstablished mesh__D001112 1991-01-01
% 210.47/210.66 |- mesh__dateRevised mesh__D001112 1997-06-20
% 210.47/210.66 |- skos__broader mesh__D001112smesh__D003318
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D001112 2004
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D001112 SJN
% 210.47/210.66 |- skos__altLabel mesh__D020875 D-Ala2-NMe-Phe4-Gly-ol Enkephalin
% 210.47/210.66 |- skos__altLabel mesh__D020875 DAMGE
% 210.47/210.66 |- skos__altLabel mesh__D020875
% 210.47/210.66 Ala%28%2%29%-MePhe%28%4%29%-Gly-ol%28%5%29% Enkephalin
% 210.47/210.66 |- skos__hiddenLabel mesh__D020875 RX 783006
% 210.47/210.66 |- skos__altLabel mesh__D020875 DAMGO
% 210.47/210.66 |- skos__hiddenLabel mesh__D020875 2 Ala 4 MePhe 5 Gly Enkephalin
% 210.47/210.66 |- skos__hiddenLabel mesh__D020875 Enkephalin, D-Ala2-NMe-Phe4-Gly-ol
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D020875
% 210.47/210.66 2000; ENKEPHALIN, ALA%28%2%29%-MEPHE%28%4%29%-GLY%28%5%29%- was indexed under ENKEPHALINS 1981-1999%A%
% 210.47/210.66 |- skos__hiddenLabel mesh__D020875 D Ala2 NMe Phe4 Gly ol Enkephalin
% 210.47/210.66 |- skos__broader mesh__D020875smesh__D004745
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D020875 sjn
% 210.47/210.66 |- mesh__recordMaintainer mesh__D020875 ssb
% 210.47/210.66 |- skos__altLabel mesh__D020875
% 210.47/210.66 Enkephalin, alanyl%28%2%29%-methylphenylalanyl%28%4%29%-glycine%28%5%29%-
% 210.47/210.66 |- skos__altLabel mesh__D020875 DAGOL
% 210.47/210.66 |- mesh__recordOriginator mesh__D020875 adp
% 210.47/210.66 |- mesh__dateCreated mesh__D020875 1999-11-08
% 210.47/210.66 |- mesh__dateRevised mesh__D020875 2005-06-30
% 210.47/210.66 |- skos__altLabel mesh__D020875
% 210.47/210.66 D-Ala%28%2%29%-MePhe%28%4%29%-Gly-ol%28%5%29% Enkephalin
% 210.47/210.66 |- skos__altLabel mesh__D020875 2-Ala-4-MePhe-5-Gly-Enkephalin
% 210.47/210.66 |- mesh__historyNote mesh__D020875
% 210.47/210.66 2000; use ENKEPHALIN, ALA%28%2%29%-MEPHE%28%4%29%-GLY%28%5%29%- %28%NM%29% 1981-1999%A%
% 210.47/210.66 |- rdf__type mesh__D020875sskos__Concept
% 210.47/210.66 |- skos__scopeNote mesh__D020875
% 210.47/210.66 An enkephalin analog that selectively binds to the MU OPIOID RECEPTOR. It is used as a model for drug permeability experiments.%A%
% 210.47/210.66 |- skos__altLabel mesh__D020875 Tyr-Ala-Gly-%28%NMe%29%Phe-Gly-ol
% 210.47/210.66 |- skos__altLabel mesh__D020875 DAGO
% 210.47/210.66 |- mesh__dateEstablished mesh__D020875 2000-01-01
% 210.47/210.66 |- skos__prefLabel mesh__D020875
% 210.47/210.66 Enkephalin, Ala%28%2%29%-MePhe%28%4%29%-Gly%28%5%29%-
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D020875 2006
% 210.47/210.66 |- skos__historyNote mesh__D020875 Enkephalins %28%1981-1999%29%
% 210.47/210.66 |- mesh__dateEstablished mesh__D020077 1999-01-01
% 210.47/210.66 |- skos__related mesh__D020077smesh__D011533
% 210.47/210.66 |- skos__hiddenLabel mesh__D020077 Retrovirus, Endogenous
% 210.47/210.66 |- skos__hiddenLabel mesh__D020077 Endogenous Retrovirus, Human
% 210.47/210.66 |- mesh__dateCreated mesh__D020077 1998-06-10
% 210.47/210.66 |- skos__hiddenLabel mesh__D020077 Retrovirus, Human Endogenous
% 210.47/210.66 |- skos__prefLabel mesh__D020077 Endogenous Retroviruses
% 210.47/210.66 |- skos__hiddenLabel mesh__D020077 Retroviruses, Human Endogenous
% 210.47/210.66 |- skos__altLabel mesh__D020077 ERVs
% 210.47/210.66 |- mesh__historyNote mesh__D020077 99
% 210.47/210.66 |- rdf__type mesh__D020077sskos__Concept
% 210.47/210.66 |- skos__historyNote mesh__D020077 Retroelements %28%1995-1998%29%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D020077 2006
% 210.47/210.66 |- skos__hiddenLabel mesh__D020077 Endogenous Retroviruses, Human
% 210.47/210.66 |- mesh__dateRevised mesh__D020077 2005-06-30
% 210.47/210.66 |- skos__scopeNote mesh__D020077
% 210.47/210.66 Retroviruses that have integrated into the germline %28%PROVIRUSES%29% that have lost infectious capability but retained the capability to transpose.%A%
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D020077 sjn
% 210.47/210.66 |- skos__hiddenLabel mesh__D020077 Human Endogenous Retrovirus
% 210.47/210.66 |- skos__hiddenLabel mesh__D020077 Endogenous Retrovirus
% 210.47/210.66 |- skos__altLabel mesh__D020077 Retroviruses, Endogenous
% 210.47/210.66 |- mesh__recordOriginator mesh__D020077 NNS
% 210.47/210.66 |- mesh__recordMaintainer mesh__D020077 nns
% 210.47/210.66 |- skos__altLabel mesh__D020077 HERVs
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D020077 99
% 210.47/210.66 |- skos__broader mesh__D020077smesh__D018626
% 210.47/210.66 |- skos__broader mesh__D020077smesh__D012190
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014838 2004
% 210.47/210.66 |- skos__prefLabel mesh__D014838 Voluntary Workers
% 210.47/210.66 |- mesh__recordOriginator mesh__D014838 NLM
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D014838 sjn
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D014838 68
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014838 2005
% 210.47/210.66 |- skos__scopeNote mesh__D014838 Persons who donate their services.
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014838 2003
% 210.47/210.66 |- skos__broader mesh__D014838smesh__D009272
% 210.47/210.66 |- rdf__type mesh__D014838sskos__Concept
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014838 2002
% 210.47/210.66 |- mesh__historyNote mesh__D014838 68
% 210.47/210.66 |- mesh__recordMaintainer mesh__D014838 hjn
% 210.47/210.66 |- skos__hiddenLabel mesh__D014838 Voluntary Worker
% 210.47/210.66 |- mesh__dateEstablished mesh__D014838 1968-01-01
% 210.47/210.66 |- skos__historyNote mesh__D014838 specific service %28%1966-1967%29%
% 210.47/210.66 |- skos__hiddenLabel mesh__D014838 Personnel, Untrained
% 210.47/210.66 |- skos__hiddenLabel mesh__D014838 Workers, Voluntary
% 210.47/210.66 |- skos__altLabel mesh__D014838 Volunteer Workers
% 210.47/210.66 |- skos__hiddenLabel mesh__D014838 Worker, Voluntary
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D014838 2006
% 210.47/210.66 |- mesh__dateRevised mesh__D014838 2001-07-25
% 210.47/210.66 |- mesh__dateCreated mesh__D014838 1999-01-01
% 210.47/210.66 |- mesh__dateRevised mesh__D019523 2005-06-30
% 210.47/210.66 |- rdf__type mesh__D019523sskos__Concept
% 210.47/210.66 |- mesh__dateCreated mesh__D019523 1996-06-21
% 210.47/210.66 |- mesh__recordOriginator mesh__D019523 TGC
% 210.47/210.66 |- mesh__historyNote mesh__D019523 1997
% 210.47/210.66 |- skos__scopeNote mesh__D019523
% 210.47/210.66 Works consisting of discourses for the purpose of religious instruction or exhortation, especially one based on a text of Scripture and delivered by a member of the clergy, as part of a religious service. %28%From: Random House Unabridged Dictionary, 2d ed%29%%A%
% 210.47/210.66 |- mesh__recordMaintainer mesh__D019523 jls
% 210.47/210.66 |- skos__annotation mesh__D019523
% 210.47/210.66 publication type only; do not confuse with Publication Type FUNERAL SERMONS which is restricted to funeral ceremonies%A%
% 210.47/210.66 |- skos__prefLabel mesh__D019523 Sermons %5B%Publication Type%5D%
% 210.47/210.66 |- skos__altLabel mesh__D019523 Sermons
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D019523 sjn
% 210.47/210.66 |- mesh__dateEstablished mesh__D019523 1997-01-01
% 210.47/210.66 |- skos__broader mesh__D019523smesh__D019484
% 210.47/210.66 |- skos__altLabel mesh__D019523 Sermons %28%PT%29%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D019523 2006
% 210.47/210.66 |- skos__annotation mesh__D000818
% 210.47/210.66 NIM as check tag; Manual 18.7+, 22.33; relation to /vet: Manual 19.8.81%A%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000818 2006
% 210.47/210.66 |- skos__prefLabel mesh__D000818 Animals
% 210.47/210.66 |- mesh__recordOriginator mesh__D000818 CAB
% 210.47/210.66 |- mesh__recordMaintainer mesh__D000818 ags
% 210.47/210.66 |- mesh__historyNote mesh__D000818
% 210.47/210.66 2004 %28%1974%29%; was check tag only %28%not a descriptor%29% 1974-2003%A%
% 210.47/210.66 |- mesh__dateCreated mesh__D000818 1975-07-25
% 210.47/210.66 |- mesh__dateRevised mesh__D000818 2003-07-09
% 210.47/210.66 |- mesh__dateEstablished mesh__D000818 1976-01-01
% 210.47/210.66 |- mesh__runningHead mesh__D000818 B1 - ORGANISMS-ANIMALS
% 210.47/210.66 |- skos__scopeNote mesh__D000818
% 210.47/210.66 Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain Eukarya.%A%
% 210.47/210.66 |- skos__altLabel mesh__D000818 Animalia
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D000818 sjn
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000818 2005
% 210.47/210.66 |- skos__altLabel mesh__D000818 Animal
% 210.47/210.66 |- rdf__type mesh__D000818sskos__Concept
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D000818 2004
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D000818 2004
% 210.47/210.66 |- rdf__type mesh__D011540sskos__Concept
% 210.47/210.66 |- skos__scopeNote mesh__D011540
% 210.47/210.66 The reaction of potassium ferrocyanide with ferric iron to yield a dark blue precipitate at the sites of the ferric iron. Used to determine ferric iron in tissues, particularly in the diagnosis of disorders of iron metabolism.%A%
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D011540 2003
% 210.47/210.66 |- mesh__recordMaintainer mesh__D011540 MXR
% 210.47/210.66 |- mesh__recordOriginator mesh__D011540 SMH
% 210.47/210.66 |- skos__historyNote mesh__D011540 Dyes %28%1966-1978%29%
% 210.47/210.66 |- skos__broader mesh__D011540smesh__D013194
% 210.47/210.66 |- skos__hiddenLabel mesh__D011540 Reactions, Ferrocyanide
% 210.47/210.66 |- skos__hiddenLabel mesh__D011540 Prussian Blue Reactions
% 210.47/210.66 |- mesh__dateEstablished mesh__D011540 1991-01-01
% 210.47/210.66 |- skos__hiddenLabel mesh__D011540 Reaction, Ferrocyanide
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D011540
% 210.47/210.66 91; was see under HISTOCYTOCHEMISTRY 1979-90
% 210.47/210.66 |- skos__altLabel mesh__D011540 Ferrocyanide Reaction
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D011540 2006
% 210.47/210.66 |- mesh__historyNote mesh__D011540
% 210.47/210.66 91%28%79%29%; was see under HISTOCYTOCHEMISTRY 1979-90
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D011540 2002
% 210.47/210.66 |- skos__hiddenLabel mesh__D011540 Blue Reactions, Prussian
% 210.47/210.66 |- mesh__dateRevised mesh__D011540 2000-06-22
% 210.47/210.66 |- mesh__dateCreated mesh__D011540 1978-04-28
% 210.47/210.66 |- skos__annotation mesh__D011540 NIM; no qualif
% 210.47/210.66 |- skos__broader mesh__D011540smesh__D006651
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D011540 2005
% 210.47/210.66 |- skos__hiddenLabel mesh__D011540 Reactions, Prussian Blue
% 210.47/210.66 |- skos__prefLabel mesh__D011540 Prussian Blue Reaction
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D011540 2001
% 210.47/210.66 |- skos__historyNote mesh__D011540 Ferrocyanides %28%1966-1978%29%
% 210.47/210.66 |- skos__hiddenLabel mesh__D011540 Ferrocyanide Reactions
% 210.47/210.66 |- skos__hiddenLabel mesh__D011540 Reaction, Prussian Blue
% 210.47/210.66 |- skos__hiddenLabel mesh__D011540 Blue Reaction, Prussian
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D011540 2004
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D011540 sjn
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D005503 2006
% 210.47/210.66 |- mesh__dateRevised mesh__D005503 2003-07-09
% 210.47/210.66 |- mesh__dateCreated mesh__D005503 1999-01-01
% 210.47/210.66 |- mesh__recordMaintainer mesh__D005503 ssb
% 210.47/210.66 |- mesh__recordOriginator mesh__D005503 NLM
% 210.47/210.66 |- skos__scopeNote mesh__D005503
% 210.47/210.66 Substances which are of little or no nutritive value, but are used in the processing or storage of foods or animal feed, especially in the developed countries; includes ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS %28%both plain and LOCAL%29%; VEHICLES; EXCIPIENTS and other similarly used substances. Many of the same substances are PHARMACEUTIC AIDS when added to pharmaceuticals rather than to foods.%A%
% 210.47/210.66 |- skos__related mesh__D005503smesh__D010592
% 210.47/210.66 |- skos__hiddenLabel mesh__D005503 Additives, Food
% 210.47/210.66 |- skos__prefLabel mesh__D005503 Food Additives
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D005503 2005
% 210.47/210.66 |- skos__hiddenLabel mesh__D005503 Food Additive
% 210.47/210.66 |- skos__broader mesh__D005503smesh__D005502
% 210.47/210.66 |- skos__hiddenLabel mesh__D005503 Additive, Food
% 210.47/210.66 |- skos__broader mesh__D005503smesh__D020313
% 210.47/210.66 |- mesh__activeMeSHYear mesh__D005503 2004
% 210.47/210.66 |- rdf__type mesh__D005503sskos__Concept
% 210.47/210.66 |- skos__annotation mesh__D005503 D25-26 qualif
% 210.47/210.66 |- mesh__recordAuthorizer mesh__D005503 sjn
% 210.47/210.66 |- skos__prefLabel mesh__D052159 Frasier Syndrome
% 210.47/210.66 |- skos__broader mesh__D052159smesh__D014564
% 210.47/210.66 |- mesh__publicMeSHNote mesh__D052159
% 210.47/210.66 2006; see DENYS-DRASH SYNDROME 2002-2005
% 210.47/210.66 |- mesh__historyNote mesh__D052159
% 210.47/210.66 2006; use DENYS-DRASH SYNDROME 2002-2005
% 210.47/210.67 |- mesh__recordMaintainer mesh__D052159 lkt
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D052159 sjn
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D052159 2006
% 210.47/210.67 |- mesh__dateEstablished mesh__D052159 2006-01-01
% 210.47/210.67 |- mesh__dateCreated mesh__D052159 2005-06-30
% 210.47/210.67 |- skos__scopeNote mesh__D052159
% 210.47/210.67 A syndrome characterized by CHRONIC KIDNEY FAILURE and GONADAL DYSGENESIS in phenotypic females with karyotype of 46,XY or 46,XX. It is caused by donor splice-site mutations of Wilms tumor suppressor gene %28%GENES, WILMS TUMOR%29% on chromosome 11.%A%
% 210.47/210.67 |- rdf__type mesh__D052159sskos__Concept
% 210.47/210.67 |- skos__hiddenLabel mesh__D052159 Syndrome, Frasier
% 210.47/210.67 |- mesh__recordOriginator mesh__D052159 lkt
% 210.47/210.67 |- skos__prefLabel mesh__D010448 Peptide Initiation Factors
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D010448 sjn
% 210.47/210.67 |- skos__hiddenLabel mesh__D010448 Initiation Factors, Peptide
% 210.47/210.67 |- skos__altLabel mesh__D010448 Initiation Factor
% 210.47/210.67 |- rdf__type mesh__D010448sskos__Concept
% 210.47/210.67 |- skos__related mesh__D010448smesh__D010442
% 210.47/210.67 |- skos__altLabel mesh__D010448 Initiation Factors
% 210.47/210.67 |- mesh__historyNote mesh__D010448 73
% 210.47/210.67 |- mesh__recordOriginator mesh__D010448 NLM
% 210.47/210.67 |- skos__broader mesh__D010448smesh__D012269
% 210.47/210.67 |- skos__historyNote mesh__D010448 Proteins %28%1966-1972%29%
% 210.47/210.67 |- skos__historyNote mesh__D010448 Peptides %28%1966-1972%29%
% 210.47/210.67 |- skos__annotation mesh__D010448 GEN or unspecified; prefer specifics
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D010448 73
% 210.47/210.67 |- mesh__dateCreated mesh__D010448 1999-01-01
% 210.47/210.67 |- mesh__dateEstablished mesh__D010448 1973-01-01
% 210.47/210.67 |- mesh__recordMaintainer mesh__D010448 SYSTEM
% 210.47/210.67 |- skos__scopeNote mesh__D010448
% 210.47/210.67 Protein factors uniquely required during the initiation phase of protein synthesis in GENETIC TRANSLATION.%A%
% 210.47/210.67 |- skos__hiddenLabel mesh__D010448 Factors, Peptide Initiation
% 210.47/210.67 |- mesh__dateRevised mesh__D010448 2005-06-30
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D010448 2006
% 210.47/210.67 |- skos__historyNote mesh__D010448 Bacterial Proteins %28%1966-1972%29%
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D015931 90
% 210.47/210.67 |- skos__altLabel mesh__D015931 Infant, Newborn, Intensive Care
% 210.47/210.67 |- skos__hiddenLabel mesh__D015931 Care, Neonatal Intensive
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D015931 2005
% 210.47/210.67 |- mesh__dateCreated mesh__D015931 1989-05-15
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D015931 sjn
% 210.47/210.67 |- skos__broader mesh__D015931smesh__D007224
% 210.47/210.67 |- mesh__recordOriginator mesh__D015931 PLS
% 210.47/210.67 |- skos__historyNote mesh__D015931 Infant Care %28%1966-1989%29%
% 210.47/210.67 |- skos__prefLabel mesh__D015931 Intensive Care, Neonatal
% 210.47/210.67 |- mesh__recordMaintainer mesh__D015931 sjn
% 210.47/210.67 |- mesh__dateRevised mesh__D015931 2004-07-13
% 210.47/210.67 |- skos__broader mesh__D015931smesh__D017055
% 210.47/210.67 |- rdf__type mesh__D015931sskos__Concept
% 210.47/210.67 |- mesh__dateEstablished mesh__D015931 1990-01-01
% 210.47/210.67 |- mesh__historyNote mesh__D015931 90
% 210.47/210.67 |- skos__historyNote mesh__D015931 Intensive Care Units %28%1966-1981%29%
% 210.47/210.67 |- skos__altLabel mesh__D015931 Neonatal Intensive Care
% 210.47/210.67 |- skos__historyNote mesh__D015931 Infant, Newborn %28%1966-1989%29%
% 210.47/210.67 |- skos__annotation mesh__D015931
% 210.47/210.67 check also tags HUMANS %26% INFANT, NEWBORN
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D015931 2006
% 210.47/210.67 |- skos__scopeNote mesh__D015931
% 210.47/210.67 Continuous care and monitoring of newborn infants with life-threatening conditions, in any setting.%A%
% 210.47/210.67 |- skos__historyNote mesh__D015931
% 210.47/210.67 Intensive Care Units, Neonatal %28%1982-1989%29%
% 210.47/210.67 |- skos__hiddenLabel mesh__D001911 mamillitis viruses, Bovine
% 210.47/210.67 |- skos__altLabel mesh__D001911 Bovine Ulcerative Mammillitis Virus
% 210.47/210.67 |- skos__altLabel mesh__D001911 Bovine mamillitis virus
% 210.47/210.67 |- skos__altLabel mesh__D001911 Bovine herpesvirus 2
% 210.47/210.67 |- skos__broader mesh__D001911smesh__D018139
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D001911 sjn
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001911 2002
% 210.47/210.67 |- mesh__recordOriginator mesh__D001911 NLM
% 210.47/210.67 |- skos__altLabel mesh__D001911 Herpes Mammillitis Virus, Bovine
% 210.47/210.67 |- mesh__onlineNote mesh__D001911
% 210.47/210.67 use HERPESVIRUS 2, BOVINE to search BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93; search ALLERTON VIRUS INFECTIONS under LUMPY SKIN DISEASE 1970-76%A%
% 210.47/210.67 |- skos__hiddenLabel mesh__D001911 mamillitis virus, Bovine
% 210.47/210.67 |- rdf__type mesh__D001911sskos__Concept
% 210.47/210.67 |- mesh__recordMaintainer mesh__D001911 ags
% 210.47/210.67 |- skos__altLabel mesh__D001911 Bovine Herpes Mammillitis Virus
% 210.47/210.67 |- mesh__dateEstablished mesh__D001911 1991-01-01
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001911 2005
% 210.47/210.67 |- skos__scopeNote mesh__D001911
% 210.47/210.67 A species of SIMPLEXVIRUS causing mammillitis in cattle in Great Britain and South Africa.%A%
% 210.47/210.67 |- skos__prefLabel mesh__D001911 Herpesvirus 2, Bovine
% 210.47/210.67 |- skos__altLabel mesh__D001911 Ulcerative Mammillitis Virus, Bovine
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001911 2003
% 210.47/210.67 |- skos__altLabel mesh__D001911 BHM Virus
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001911 2006
% 210.47/210.67 |- mesh__dateCreated mesh__D001911 1974-12-12
% 210.47/210.67 |- skos__altLabel mesh__D001911 Herpesvirus 2 %28%alpha%29%, Bovine
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001911 2004
% 210.47/210.67 |- mesh__dateRevised mesh__D001911 2001-07-25
% 210.47/210.67 |- skos__altLabel mesh__D001911 Allerton Virus
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D001911
% 210.47/210.67 94; was BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76%A%
% 210.47/210.67 |- skos__hiddenLabel mesh__D001911 Bovine mamillitis viruses
% 210.47/210.67 |- skos__annotation mesh__D001911
% 210.47/210.67 do not confuse with HERPESVIRUS 1, BOVINE; infection: coord IM with HERPES SIMPLEX %28%IM%29%%A%
% 210.47/210.67 |- mesh__historyNote mesh__D001911
% 210.47/210.67 94; was BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76%A%
% 210.47/210.67 |- mesh__recordMaintainer mesh__D001113 kle
% 210.47/210.67 |- skos__altLabel mesh__D001113 Area Health Education Center
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001113 2005
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001113 2002
% 210.47/210.67 |- rdf__type mesh__D001113sskos__Concept
% 210.47/210.67 |- skos__broader mesh__D001113smesh__D012576
% 210.47/210.67 |- mesh__historyNote mesh__D001113
% 210.47/210.67 91%28%75%29%; was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90%A%
% 210.47/210.67 |- mesh__dateRevised mesh__D001113 1999-11-03
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001113 2004
% 210.47/210.67 |- mesh__dateEstablished mesh__D001113 1991-01-01
% 210.47/210.67 |- mesh__recordOriginator mesh__D001113 NLM
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001113 2001
% 210.47/210.67 |- mesh__dateCreated mesh__D001113 1974-11-11
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D001113 sjn
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001113 2003
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D001113
% 210.47/210.67 91; was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90
% 210.47/210.67 |- skos__prefLabel mesh__D001113 Area Health Education Centers
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001113 2000
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001113 2006
% 210.47/210.67 |- skos__annotation mesh__D001113 specify geog if pertinent; DF: AHEC
% 210.47/210.67 |- skos__scopeNote mesh__D001113
% 210.47/210.67 Education centers authorized by the Comprehensive Health Manpower Training Act, 1971, for the training of health personnel in areas where health needs are the greatest. May be used for centers other than those established by the United States act.%A%
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020078 2006
% 210.47/210.67 |- rdf__type mesh__D020078sskos__Concept
% 210.47/210.67 |- skos__hiddenLabel mesh__D020078 Neurogenic Inflammations
% 210.47/210.67 |- mesh__dateEstablished mesh__D020078 1999-01-01
% 210.47/210.67 |- skos__broader mesh__D020078smesh__D007249
% 210.47/210.67 |- mesh__recordMaintainer mesh__D020078 KEV
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020078 2003
% 210.47/210.67 |- mesh__dateCreated mesh__D020078 1998-06-10
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D020078 99
% 210.47/210.67 |- skos__prefLabel mesh__D020078 Neurogenic Inflammation
% 210.47/210.67 |- skos__broader mesh__D020078smesh__D009461
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020078 2000
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020078 2004
% 210.47/210.67 |- mesh__dateRevised mesh__D020078 1999-11-03
% 210.47/210.67 |- skos__scopeNote mesh__D020078
% 210.47/210.67 Inflammation caused by an injurious stimulus of peripheral neurons and resulting in release of neuropeptides which affect vascular permeability and help initiate proinflammatory and immune reactions at the site of injury.%A%
% 210.47/210.67 |- skos__hiddenLabel mesh__D020078 Inflammations, Neurogenic
% 210.47/210.67 |- skos__hiddenLabel mesh__D020078 Inflammation, Neurogenic
% 210.47/210.67 |- skos__historyNote mesh__D020078 Inflammation %28%1967-1998%29%
% 210.47/210.67 |- mesh__historyNote mesh__D020078 99
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020078 2001
% 210.47/210.67 |- skos__related mesh__D020078smesh__D015213
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020078 2005
% 210.47/210.67 |- mesh__recordOriginator mesh__D020078 NDW
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020078 2002
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D020078 sjn
% 210.47/210.67 |- skos__altLabel mesh__D014839 Emesis
% 210.47/210.67 |- rdf__type mesh__D014839sskos__Concept
% 210.47/210.67 |- skos__annotation mesh__D014839
% 210.47/210.67 /chem ind: EMETICS is also available; /drug ther: ANTIEMETICS is also available%A%
% 210.47/210.67 |- mesh__recordMaintainer mesh__D014839 lkt
% 210.47/210.67 |- skos__related mesh__D014839smesh__D004639
% 210.47/210.67 |- skos__prefLabel mesh__D014839 Vomiting
% 210.47/210.67 |- mesh__recordOriginator mesh__D014839 NLM
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D014839 sjn
% 210.47/210.67 |- mesh__dateRevised mesh__D014839 2003-07-09
% 210.47/210.67 |- skos__related mesh__D014839smesh__D000932
% 210.47/210.67 |- skos__broader mesh__D014839smesh__D012817
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D014839 2006
% 210.47/210.67 |- mesh__dateCreated mesh__D014839 1999-01-01
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D014839 2004
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D014839 2005
% 210.47/210.67 |- skos__scopeNote mesh__D014839
% 210.47/210.67 The forcible expulsion of the contents of the STOMACH through the MOUTH.%A%
% 210.47/210.67 |- skos__altLabel mesh__D025561 Pf1 Phage
% 210.47/210.67 |- skos__broader mesh__D025561smesh__D017912
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D025561 2003
% 210.47/210.67 |- skos__broader mesh__D025561smesh__D017105
% 210.47/210.67 |- skos__historyNote mesh__D025561 Inovirus %28%1993-2001%29%
% 210.47/210.67 |- skos__hiddenLabel mesh__D025561 Pf1 Phages
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D025561 2005
% 210.47/210.67 |- skos__hiddenLabel mesh__D025561 Phage, Pf1
% 210.47/210.67 |- skos__altLabel mesh__D025561 Phage Pf1
% 210.47/210.67 |- mesh__recordMaintainer mesh__D025561 ags
% 210.47/210.67 |- skos__hiddenLabel mesh__D025561 Phages, Pf1
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D025561 2004
% 210.47/210.67 |- rdf__type mesh__D025561sskos__Concept
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D025561 sjn
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D025561 2006
% 210.47/210.67 |- skos__annotation mesh__D025561 coord with specific Pseudomonas /virol
% 210.47/210.67 |- skos__historyNote mesh__D025561 Bacteriophages %28%1980-1993%29%
% 210.47/210.67 |- mesh__dateCreated mesh__D025561 2001-07-25
% 210.47/210.67 |- mesh__dateEstablished mesh__D025561 2002-01-01
% 210.47/210.67 |- mesh__historyNote mesh__D025561 2002; use INOVIRUS 1994-2001
% 210.47/210.67 |- skos__prefLabel mesh__D025561 Bacteriophage Pf1
% 210.47/210.67 |- mesh__dateRevised mesh__D025561 2002-07-02
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D025561 2002; see INOVIRUS 1994-2001
% 210.47/210.67 |- skos__scopeNote mesh__D025561
% 210.47/210.67 A species of filamentous Pseudomonas phage in the genus INOVIRUS, family INOVIRIDAE.%A%
% 210.47/210.67 |- mesh__recordOriginator mesh__D025561 ags
% 210.47/210.67 |- skos__altLabel mesh__D025561 Pseudomonas phage Pf1
% 210.47/210.67 |- mesh__dateRevised mesh__D000819 2003-07-30
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D000819 sjn
% 210.47/210.67 |- skos__prefLabel mesh__D000819 Animal Communication
% 210.47/210.67 |- rdf__type mesh__D000819sskos__Concept
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D000819 2006
% 210.47/210.67 |- skos__related mesh__D000819smesh__D010675
% 210.47/210.67 |- mesh__recordMaintainer mesh__D000819 ags
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D000819 2005
% 210.47/210.67 |- skos__related mesh__D000819smesh__D014828
% 210.47/210.67 |- mesh__historyNote mesh__D000819 68
% 210.47/210.67 |- skos__broader mesh__D000819smesh__D001522
% 210.47/210.67 |- skos__hiddenLabel mesh__D000819 Communication, Animal
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D000819 68
% 210.47/210.67 |- skos__historyNote mesh__D000819 Communication %28%1966-1967%29%
% 210.47/210.67 |- mesh__dateEstablished mesh__D000819 1968-01-01
% 210.47/210.67 |- skos__scopeNote mesh__D000819
% 210.47/210.67 Communication between animals involving the giving off by one individual of some chemical or physical signal, that, on being received by another, influences its behavior.%A%
% 210.47/210.67 |- skos__hiddenLabel mesh__D000819 Animal Communications
% 210.47/210.67 |- skos__hiddenLabel mesh__D000819 Communications, Animal
% 210.47/210.67 |- mesh__dateCreated mesh__D000819 1999-01-01
% 210.47/210.67 |- mesh__recordOriginator mesh__D000819 NLM
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D000819 2004
% 210.47/210.67 |- skos__annotation mesh__D000819
% 210.47/210.67 no qualif; do not forget also to check tag ANIMALS
% 210.47/210.67 |- skos__altLabel mesh__D011541 Allescheria
% 210.47/210.67 |- mesh__historyNote mesh__D011541
% 210.47/210.67 91%28%86%29%; was see under ASCOMYCETES 1986-90; MONOSPORIUM was heading 1963-85%A%
% 210.47/210.67 |- skos__altLabel mesh__D011541 Petriellidium
% 210.47/210.67 |- mesh__dateEstablished mesh__D011541 1991-01-01
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D011541 sjn
% 210.47/210.67 |- mesh__dateCreated mesh__D011541 1985-02-07
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D011541 2006
% 210.47/210.67 |- skos__annotation mesh__D011541
% 210.47/210.67 infection: coord IM with probably MADUROMYCOSIS or other mycosis %28%IM%29%%A%
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D011541
% 210.47/210.67 91; was see under ASCOMYCETES 1986-90; MONOSPORIUM was heading 1963-85%A%
% 210.47/210.67 |- mesh__recordMaintainer mesh__D011541 SYSTEM
% 210.47/210.67 |- skos__historyNote mesh__D011541 Ascomycetes %28%1966-1985%29%
% 210.47/210.67 |- mesh__recordOriginator mesh__D011541 RC
% 210.47/210.67 |- skos__historyNote mesh__D011541 Maduromycosis %28%1966-1985%29%
% 210.47/210.67 |- skos__scopeNote mesh__D011541
% 210.47/210.67 Ascomycetous fungi, family Microascaceae, order Microascales, commonly found in the soil. They are causative agents of mycetoma, maduromycosis, and other infections in humans.%A%
% 210.47/210.67 |- mesh__dateRevised mesh__D011541 2005-06-30
% 210.47/210.67 |- skos__prefLabel mesh__D011541 Pseudallescheria
% 210.47/210.67 |- rdf__type mesh__D011541sskos__Concept
% 210.47/210.67 |- mesh__onlineNote mesh__D011541
% 210.47/210.67 use PSEUDALLESCHERIA to search MONOSPORIUM 1966-85
% 210.47/210.67 |- skos__historyNote mesh__D011541 Mycoses %28%1966-1985%29%
% 210.47/210.67 |- skos__broader mesh__D011541smesh__D001203
% 210.47/210.67 |- skos__hiddenLabel mesh__D005504 Food Analyses
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005504 2002
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005504 2006
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005504 1999
% 210.47/210.67 |- mesh__dateRevised mesh__D005504 1997-06-20
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005504 2005
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005504 1998
% 210.47/210.67 |- skos__broader mesh__D005504smesh__D008919
% 210.47/210.67 |- skos__broader mesh__D005504smesh__D005524
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005504 2001
% 210.47/210.67 |- mesh__recordMaintainer mesh__D005504 JLS
% 210.47/210.67 |- skos__prefLabel mesh__D005504 Food Analysis
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005504 2000
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D005504 SJN
% 210.47/210.67 |- skos__altLabel mesh__D005504 Analysis, Food
% 210.47/210.67 |- rdf__type mesh__D005504sskos__Concept
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005504 2004
% 210.47/210.67 |- skos__hiddenLabel mesh__D005504 Analyses, Food
% 210.47/210.67 |- skos__annotation mesh__D005504
% 210.47/210.67 GEN only; prefer /anal with specific food item in Cat J2
% 210.47/210.67 |- mesh__dateCreated mesh__D005504 1999-01-01
% 210.47/210.67 |- mesh__recordOriginator mesh__D005504 NLM
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005504 2003
% 210.47/210.67 |- mesh__historyNote mesh__D010449 87
% 210.47/210.67 |- skos__hiddenLabel mesh__D010449 Fingerprint, Protein
% 210.47/210.67 |- mesh__recordMaintainer mesh__D010449 nns
% 210.47/210.67 |- skos__broader mesh__D010449smesh__D004590
% 210.47/210.67 |- skos__broader mesh__D010449smesh__D002854
% 210.47/210.67 |- skos__hiddenLabel mesh__D010449 Fingerprint, Peptide
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D010449 sjn
% 210.47/210.67 |- mesh__recordOriginator mesh__D010449 VDK
% 210.47/210.67 |- mesh__dateRevised mesh__D010449 2004-07-07
% 210.47/210.67 |- skos__altLabel mesh__D010449 Peptide Fingerprinting
% 210.47/210.67 |- skos__related mesh__D010449smesh__D010446
% 210.47/210.67 |- skos__hiddenLabel mesh__D010449 Mapping, Peptide
% 210.47/210.67 |- skos__altLabel mesh__D010449 Fingerprints, Protein
% 210.47/210.67 |- skos__broader mesh__D010449smesh__D002623
% 210.47/210.67 |- skos__hiddenLabel mesh__D010449 Peptide Fingerprint
% 210.47/210.67 |- skos__historyNote mesh__D010449 Chromatography, Paper %28%1966-1986%29%
% 210.47/210.67 |- skos__hiddenLabel mesh__D010449 Peptide Fingerprints
% 210.47/210.67 |- skos__hiddenLabel mesh__D010449 Protein Fingerprints
% 210.47/210.67 |- skos__hiddenLabel mesh__D010449 Fingerprinting, Peptide
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D010449 2006
% 210.47/210.67 |- skos__scopeNote mesh__D010449
% 210.47/210.67 Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases.%A%
% 210.47/210.67 |- skos__hiddenLabel mesh__D010449 Protein Fingerprint
% 210.47/210.67 |- skos__hiddenLabel mesh__D010449 Fingerprinting, Protein
% 210.47/210.67 |- skos__altLabel mesh__D010449 Protein Fingerprinting
% 210.47/210.67 |- skos__prefLabel mesh__D010449 Peptide Mapping
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D010449 2005
% 210.47/210.67 |- mesh__dateCreated mesh__D010449 1986-06-24
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D010449 87
% 210.47/210.67 |- rdf__type mesh__D010449sskos__Concept
% 210.47/210.67 |- skos__historyNote mesh__D010449 Electrophoresis, Paper %28%1973-1986%29%
% 210.47/210.67 |- skos__broader mesh__D010449smesh__D020539
% 210.47/210.67 |- mesh__dateEstablished mesh__D010449 1987-01-01
% 210.47/210.67 |- skos__hiddenLabel mesh__D015932 C3c Fragment, Complement
% 210.47/210.67 |- skos__altLabel mesh__D015932 Complement Component 3c
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D015932 2006; see COMPLEMENT 3C 1990-2005
% 210.47/210.67 |- skos__hiddenLabel mesh__D015932 Component 3c, Complement
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D015932 2006
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D015932 sjn
% 210.47/210.67 |- skos__historyNote mesh__D015932 Complement 3 %28%1974-1989%29%
% 210.47/210.67 |- skos__prefLabel mesh__D015932 Complement C3c
% 210.47/210.67 |- mesh__recordMaintainer mesh__D015932 lkt
% 210.47/210.67 |- skos__hiddenLabel mesh__D015932 Complement, C3c
% 210.47/210.67 |- skos__broader mesh__D015932smesh__D003179
% 210.47/210.67 |- skos__scopeNote mesh__D015932
% 210.47/210.67 A 206-amino-acid fragment in the alpha chain %28%672-1663%29% of C3b. It is generated when C3b is inactivated %28%iC3b%29% and its alpha chain is cleaved by COMPLEMENT FACTOR I into C3c %28%749-954%29%, and C3dg %28%955-1303%29% in the presence COMPLEMENT FACTOR H.%A%
% 210.47/210.67 |- skos__altLabel mesh__D015932 Complement C3c Fragment
% 210.47/210.67 |- mesh__recordOriginator mesh__D015932 AGS
% 210.47/210.67 |- mesh__dateEstablished mesh__D015932 1990-01-01
% 210.47/210.67 |- rdf__type mesh__D015932sskos__Concept
% 210.47/210.67 |- skos__hiddenLabel mesh__D015932 C3c, Complement
% 210.47/210.67 |- mesh__historyNote mesh__D015932 2006 %28%1990%29%
% 210.47/210.67 |- skos__altLabel mesh__D015932 C3c Complement
% 210.47/210.67 |- mesh__dateRevised mesh__D015932 2005-06-30
% 210.47/210.67 |- skos__hiddenLabel mesh__D015932 Fragment, Complement C3c
% 210.47/210.67 |- skos__altLabel mesh__D015932 Complement 3c
% 210.47/210.67 |- mesh__dateCreated mesh__D015932 1989-05-25
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001912 2002
% 210.47/210.67 |- skos__scopeNote mesh__D001912
% 210.47/210.67 Acute disease of cattle caused by the bovine viral diarrhea viruses %28%DIARRHEA VIRUSES, BOVINE VIRAL%29%. Often mouth ulcerations are the only sign but fever, diarrhea, drop in milk yield, and loss of appetite are also seen. Severity of clinical disease varies and is strain dependent. Outbreaks are characterized by low morbidity and high mortality.%A%
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001912 2005
% 210.47/210.67 |- skos__prefLabel mesh__D001912 Bovine Virus Diarrhea-Mucosal Disease
% 210.47/210.67 |- mesh__historyNote mesh__D001912
% 210.47/210.67 91%28%72%29%; was see under CATTLE DISEASES 1972-90
% 210.47/210.67 |- skos__altLabel mesh__D001912 Mucosal Disease, Bovine Viral Diarrhea
% 210.47/210.67 |- mesh__dateRevised mesh__D001912 2001-07-25
% 210.47/210.67 |- mesh__dateCreated mesh__D001912 1999-01-01
% 210.47/210.67 |- skos__altLabel mesh__D001912 Bovine Virus Diarrhea Mucosal Disease
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D001912
% 210.47/210.67 91; was see under CATTLE DISEASES 1972-90
% 210.47/210.67 |- rdf__type mesh__D001912sskos__Concept
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D001912 sjn
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001912 2004
% 210.47/210.67 |- skos__broader mesh__D001912smesh__D018182
% 210.47/210.67 |- skos__historyNote mesh__D001912 Cattle Diseases %28%1966-1971%29%
% 210.47/210.67 |- skos__historyNote mesh__D001912
% 210.47/210.67 Virus Diseases/veterinary %28%1966-1971%29%
% 210.47/210.67 |- skos__annotation mesh__D001912 DF: BVD DIS
% 210.47/210.67 |- mesh__recordOriginator mesh__D001912 NLM
% 210.47/210.67 |- mesh__recordMaintainer mesh__D001912 ags
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001912 2006
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001912 2003
% 210.47/210.67 |- mesh__dateEstablished mesh__D001912 1991-01-01
% 210.47/210.67 |- skos__broader mesh__D001912smesh__D002418
% 210.47/210.67 |- rdf__type mesh__D001114sskos__Concept
% 210.47/210.67 |- mesh__dateRevised mesh__D001114 2005-07-27
% 210.47/210.67 |- mesh__dateCreated mesh__D001114 1999-01-01
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001114 2006A
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001114 2004
% 210.47/210.67 |- mesh__dateEstablished mesh__D001114 1991-01-01
% 210.47/210.67 |- skos__prefLabel mesh__D001114 Areca
% 210.47/210.67 |- skos__annotation mesh__D001114
% 210.47/210.67 Betel may go here or under PIPER BETLE; %27%catechu%27% may go here or under ACACIA CATECHU see ACACIA; check text; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001114 2003
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D001114 ags
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001114 2006
% 210.47/210.67 |- mesh__recordMaintainer mesh__D001114 ags
% 210.47/210.67 |- mesh__historyNote mesh__D001114
% 210.47/210.67 91%28%86%29%63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%
% 210.47/210.67 |- skos__broader mesh__D001114smesh__D028023
% 210.47/210.67 |- mesh__recordOriginator mesh__D001114 NLM
% 210.47/210.67 |- skos__scopeNote mesh__D001114
% 210.47/210.67 A plant genus of the family ARECACEAE. Members contain ARECOLINE and CATECHIN. The leaves and nuts have been used as masticatories, stimulants, and astringents in traditional medicine. The common name of betel is also used for PIPER BETLE. The common name of catechu is sometimes used for ACACIA CATECHU.%A%
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D001114 2005
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D001114
% 210.47/210.67 91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Long Terminal Repeats
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Sequence, R Repetitive
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repeat Sequences, Terminal
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repeats, Terminal
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Sequence, Terminal Repeat
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020079 2005
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Sequences, Flanking Repeat
% 210.47/210.67 |- skos__altLabel mesh__D020079 Flanking Repeat Sequences
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Sequences, Terminal Repeat
% 210.47/210.67 |- skos__altLabel mesh__D020079 Terminal Repeat
% 210.47/210.67 |- mesh__dateRevised mesh__D020079 2002-07-03
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 R Repetitive Sequences
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Terminal Repeat, Long
% 210.47/210.67 |- skos__prefLabel mesh__D020079 Terminal Repeat Sequences
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repeat, Terminal
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repeat, Long Terminal
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020079 2004
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repeats, Long Terminal
% 210.47/210.67 |- rdf__type mesh__D020079sskos__Concept
% 210.47/210.67 |- mesh__publicMeSHNote mesh__D020079
% 210.47/210.67 99; for DELTA ELEMENTS see DNA INSERTION ELEMENTS 1988-98; for INVERTED TERMINAL REPEAT see REPETITIVE SEQUENCE, NUCLEIC ACID 1988-98; for LONG TERMINAL REPEAT, TERMINAL REPEAT %26% R REPETITIVE SEQUENCE see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repeat Sequence, Terminal
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Terminal Repeats, Long
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Terminal Repeats
% 210.47/210.67 |- skos__broader mesh__D020079smesh__D012091
% 210.47/210.67 |- skos__scopeNote mesh__D020079
% 210.47/210.67 Nucleotide sequences repeated on both the 5%27% and 3%27% ends of a sequence under consideration. For example, the hallmarks of a transposon are that it is flanked by inverted repeats on each end and the inverted repeats are flanked by direct repeats. The Delta element of Ty retrotransposons and LTRs %28%long terminal repeats%29% are examples of this concept.%A%
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020079 2003
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Sequence, Flanking Repeat
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repetitive Sequences, R
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Delta Element
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repetitive Sequence, R
% 210.47/210.67 |- mesh__historyNote mesh__D020079
% 210.47/210.67 99; for DELTA ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1988-98; for INVERTED TERMINAL REPEAT use REPETITIVE SEQUENCE, NUCLEIC ACID 1988-98; for LONG TERMINAL REPEAT, TERMINAL REPEAT %26% R REPETITIVE SEQUENCE use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Terminal Repeat Sequence
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Element, Delta
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repeat Sequences, Flanking
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Sequences, R Repetitive
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Flanking Repeat Sequence
% 210.47/210.67 |- skos__historyNote mesh__D020079
% 210.47/210.67 Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Repeat Sequence, Flanking
% 210.47/210.67 |- skos__annotation mesh__D020079 DF: TERMINAL REPEAT SEQ
% 210.47/210.67 |- skos__hiddenLabel mesh__D020079 Elements, Delta
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D020079 2006
% 210.47/210.67 |- mesh__dateCreated mesh__D020079 1998-06-11
% 210.47/210.67 |- mesh__dateEstablished mesh__D020079 1999-01-01
% 210.47/210.67 |- skos__prefLabel mesh__D019525 Price Lists %5B%Publication Type%5D%
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D019525 sjn
% 210.47/210.67 |- skos__altLabel mesh__D019525 Price Lists
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D019525 2006
% 210.47/210.67 |- skos__annotation mesh__D019525 publication type only
% 210.47/210.67 |- rdf__type mesh__D019525sskos__Concept
% 210.47/210.67 |- skos__altLabel mesh__D019525 Price Lists %28%PT%29%
% 210.47/210.67 |- mesh__dateRevised mesh__D019525 2005-06-30
% 210.47/210.67 |- mesh__dateCreated mesh__D019525 1996-06-21
% 210.47/210.67 |- skos__broader mesh__D019525smesh__D019494
% 210.47/210.67 |- skos__scopeNote mesh__D019525
% 210.47/210.67 Works consisting of lists giving the prices of items for sale, including drugs, equipment, books, etc. Price lists are less detailed than catalogs and not as long.%A%
% 210.47/210.67 |- mesh__recordOriginator mesh__D019525 TGC
% 210.47/210.67 |- mesh__historyNote mesh__D019525 1997
% 210.47/210.67 |- mesh__recordMaintainer mesh__D019525 jls
% 210.47/210.67 |- mesh__dateEstablished mesh__D019525 1997-01-01
% 210.47/210.67 |- mesh__dateCreated mesh__D011542 1999-01-01
% 210.47/210.67 |- mesh__dateRevised mesh__D011542 2005-06-30
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D011542 2006
% 210.47/210.67 |- skos__hiddenLabel mesh__D011542 Pseudarthroses
% 210.47/210.67 |- mesh__recordOriginator mesh__D011542 NLM
% 210.47/210.67 |- mesh__recordMaintainer mesh__D011542 ssb
% 210.47/210.67 |- skos__scopeNote mesh__D011542
% 210.47/210.67 A pathologic entity characterized by deossification of a weight-bearing long bone, followed by bending and pathologic fracture, with inability to form normal BONY CALLUS leading to existence of the %22%false joint%22% that gives the condition its name. %28%Dorland, 27th ed%29%%A%
% 210.47/210.67 |- skos__prefLabel mesh__D011542 Pseudarthrosis
% 210.47/210.67 |- mesh__recordAuthorizer mesh__D011542 sjn
% 210.47/210.67 |- skos__altLabel mesh__D011542 Pseudoarthrosis
% 210.47/210.67 |- skos__broader mesh__D011542smesh__D005599
% 210.47/210.67 |- skos__annotation mesh__D011542
% 210.47/210.67 a type of ununited fract; do not index under FRACTURES, UNUNITED unless particularly discussed%A%
% 210.47/210.67 |- rdf__type mesh__D011542sskos__Concept
% 210.47/210.67 |- skos__hiddenLabel mesh__D011542 Pseudoarthroses
% 210.47/210.67 |- mesh__activeMeSHYear mesh__D005505 2006
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D005505 sjn
% 210.47/210.68 |- skos__annotation mesh__D005505 D25-26 qualif
% 210.47/210.68 |- mesh__recordOriginator mesh__D005505 NLM
% 210.47/210.68 |- mesh__recordMaintainer mesh__D005505 ssb
% 210.47/210.68 |- mesh__dateCreated mesh__D005505 1974-11-19
% 210.47/210.68 |- mesh__historyNote mesh__D005505 75
% 210.47/210.68 |- skos__hiddenLabel mesh__D005505 Agents, Food Coloring
% 210.47/210.68 |- skos__altLabel mesh__D005505 Food Colorants
% 210.47/210.68 |- skos__altLabel mesh__D005505 Coloring Agents, Food
% 210.47/210.68 |- skos__scopeNote mesh__D005505
% 210.47/210.68 Natural or synthetic dyes used as coloring agents in processed foods.%A%
% 210.47/210.68 |- rdf__type mesh__D005505sskos__Concept
% 210.47/210.68 |- skos__historyNote mesh__D005505 Food Additives %28%1966-1974%29%
% 210.47/210.68 |- skos__broader mesh__D005505smesh__D004396
% 210.47/210.68 |- skos__hiddenLabel mesh__D005505 Colorants, Food
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D005505 75
% 210.47/210.68 |- skos__broader mesh__D005505smesh__D005503
% 210.47/210.68 |- skos__prefLabel mesh__D005505 Food Coloring Agents
% 210.47/210.68 |- mesh__dateRevised mesh__D005505 2005-06-30
% 210.47/210.68 |- mesh__dateEstablished mesh__D005505 1975-09-01
% 210.47/210.68 |- rdf__type mesh__D015933sskos__Concept
% 210.47/210.68 |- skos__historyNote mesh__D015933 Complement 3 %28%1975-1989%29%
% 210.47/210.68 |- mesh__dateRevised mesh__D015933 2005-06-30
% 210.47/210.68 |- mesh__historyNote mesh__D015933 2006 %28%1990%29%
% 210.47/210.68 |- skos__historyNote mesh__D015933 Complement %28%1973-1976%29%
% 210.47/210.68 |- skos__hiddenLabel mesh__D015933 Complement, C3d
% 210.47/210.68 |- skos__hiddenLabel mesh__D015933 C3d, Complement
% 210.47/210.68 |- mesh__dateEstablished mesh__D015933 1990-01-01
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D015933 2006; see COMPLEMENT 3D 1990-2005
% 210.47/210.68 |- skos__altLabel mesh__D015933 Complement C3d Fragment
% 210.47/210.68 |- mesh__recordMaintainer mesh__D015933 lkt
% 210.47/210.68 |- skos__hiddenLabel mesh__D015933 Component 3d, Complement
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D015933 sjn
% 210.47/210.68 |- skos__altLabel mesh__D015933 Complement 3d
% 210.47/210.68 |- mesh__dateCreated mesh__D015933 1989-05-25
% 210.47/210.68 |- skos__hiddenLabel mesh__D015933 C3d Fragment, Complement
% 210.47/210.68 |- skos__prefLabel mesh__D015933 Complement C3d
% 210.47/210.68 |- skos__altLabel mesh__D015933 Complement Component 3d
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D015933 2006
% 210.47/210.68 |- skos__hiddenLabel mesh__D015933 Fragment, Complement C3d
% 210.47/210.68 |- skos__related mesh__D015933smesh__D017464
% 210.47/210.68 |- mesh__recordOriginator mesh__D015933 AGS
% 210.47/210.68 |- skos__scopeNote mesh__D015933
% 210.47/210.68 A 302-amino-acid fragment in the alpha chain %28%672-1663%29% of C3b. It is generated when C3b is inactivated %28%iC3b%29% and its alpha chain is cleaved by COMPLEMENT FACTOR I into C3c, and C3dg %28%955-1303%29% in the presence COMPLEMENT FACTOR H. Serum proteases further degrade C3dg into C3d %28%1002-1303%29% and C3g %28%955-1001%29%.%A%
% 210.47/210.68 |- skos__altLabel mesh__D015933 C3d Complement
% 210.47/210.68 |- skos__broader mesh__D015933smesh__D003179
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 1998
% 210.47/210.68 |- mesh__dateCreated mesh__D001913 1999-01-01
% 210.47/210.68 |- skos__scopeNote mesh__D001913
% 210.47/210.68 A persistent progressive non-elevated red scaly or crusted plaque which is due to an intradermal carcinoma and is potentially malignant. Atypical squamous cells proliferate through the whole thickness of the epidermis. The lesions may occur anywhere on the skin surface or on mucosal surfaces. The cause most frequently found is trivalent arsenic compounds. Freezing, cauterization or diathermy coagulation is often effective. %28%From Rook et al., Textbook of Dermatology, 4th ed, pp2428-9%29%%A%
% 210.47/210.68 |- mesh__recordMaintainer mesh__D001913 KEV
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 2002
% 210.47/210.68 |- mesh__historyNote mesh__D001913
% 210.47/210.68 91%28%75%29%; was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80%A%
% 210.47/210.68 |- rdf__type mesh__D001913sskos__Concept
% 210.47/210.68 |- skos__prefLabel mesh__D001913 Bowen%27%s Disease
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 2001
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 2004
% 210.47/210.68 |- skos__broader mesh__D001913smesh__D002294
% 210.47/210.68 |- skos__annotation mesh__D001913
% 210.47/210.68 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29%%A%
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D001913
% 210.47/210.68 91; was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80%A%
% 210.47/210.68 |- skos__hiddenLabel mesh__D001913 Bowens Disease
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 2000
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 1997
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D001913 PLS
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 2006
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 2003
% 210.47/210.68 |- skos__hiddenLabel mesh__D001913 Disease, Bowen%27%s
% 210.47/210.68 |- mesh__dateEstablished mesh__D001913 1991-01-01
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 1999
% 210.47/210.68 |- mesh__onlineNote mesh__D001913
% 210.47/210.68 search CARCINOMA, SQUAMOUS CELL 1969-74
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 1996
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001913 2005
% 210.47/210.68 |- skos__altLabel mesh__D001913 Bowen Disease
% 210.47/210.68 |- skos__hiddenLabel mesh__D001913 Disease, Bowen
% 210.47/210.68 |- mesh__recordOriginator mesh__D001913 NLM
% 210.47/210.68 |- mesh__dateRevised mesh__D001913 1995-06-08
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001115 2005
% 210.47/210.68 |- skos__historyNote mesh__D001115 Nicotinic Acids %28%1969-1972%29%
% 210.47/210.68 |- skos__broader mesh__D001115smesh__D009539
% 210.47/210.68 |- skos__scopeNote mesh__D001115
% 210.47/210.68 An alkaloid obtained from the betel nut %28%Areca catechu%29%, fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.%A%
% 210.47/210.68 |- skos__prefLabel mesh__D001115 Arecoline
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D001115
% 210.47/210.68 73; was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95%A%
% 210.47/210.68 |- mesh__historyNote mesh__D001115
% 210.47/210.68 73%28%72%29%; was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95%A%
% 210.47/210.68 |- skos__historyNote mesh__D001115 Parasympatholytics %28%1966-1968%29%
% 210.47/210.68 |- skos__altLabel mesh__D001115 Arecolin
% 210.47/210.68 |- mesh__recordMaintainer mesh__D001115 jls
% 210.47/210.68 |- skos__altLabel mesh__D001115 Arecaline
% 210.47/210.68 |- mesh__dateEstablished mesh__D001115 1973-01-01
% 210.47/210.68 |- mesh__recordOriginator mesh__D001115 NLM
% 210.47/210.68 |- skos__altLabel mesh__D001115 Methylarecaidin
% 210.47/210.68 |- mesh__dateRevised mesh__D001115 2004-07-19
% 210.47/210.68 |- mesh__onlineNote mesh__D001115
% 210.47/210.68 search NICOTINIC ACID 1969-71 %26% PARASYMPATHOMIMETICS 1966-68%A%
% 210.47/210.68 |- skos__altLabel mesh__D001115 Arecholin
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D001115 sjn
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001115 2006
% 210.47/210.68 |- rdf__type mesh__D001115sskos__Concept
% 210.47/210.68 |- skos__altLabel mesh__D001115 Arecholine
% 210.47/210.68 |- skos__broader mesh__D001115smesh__D000470
% 210.47/210.68 |- mesh__dateCreated mesh__D001115 1999-01-01
% 210.47/210.68 |- mesh__dateRevised mesh__D020878 2002-07-03
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D020878 2003
% 210.47/210.68 |- skos__broader mesh__D020878smesh__D013514
% 210.47/210.68 |- skos__hiddenLabel mesh__D020878 Device Removals
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D020878 2004
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D020878 2005
% 210.47/210.68 |- mesh__historyNote mesh__D020878 2000
% 210.47/210.68 |- mesh__dateCreated mesh__D020878 1999-11-03
% 210.47/210.68 |- rdf__type mesh__D020878sskos__Concept
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D020878 2006
% 210.47/210.68 |- skos__hiddenLabel mesh__D020878 Removals, Device
% 210.47/210.68 |- skos__hiddenLabel mesh__D020878 Removal, Device
% 210.47/210.68 |- skos__scopeNote mesh__D020878
% 210.47/210.68 Removal of an implanted therapeutic or prosthetic device.%A%
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D020878 2000
% 210.47/210.68 |- mesh__dateEstablished mesh__D020878 2000-01-01
% 210.47/210.68 |- skos__prefLabel mesh__D020878 Device Removal
% 210.47/210.68 |- mesh__dateCreated mesh__D011543 1999-01-01
% 210.47/210.68 |- skos__scopeNote mesh__D011543 An aspect of cholinesterases.
% 210.47/210.68 |- skos__prefLabel mesh__D011543 Pseudocholinesterase
% 210.47/210.68 |- skos__altLabel mesh__D011543 Benzoylcholinesterase
% 210.47/210.68 |- skos__annotation mesh__D011543
% 210.47/210.68 /antag = CHOLINESTERASE INHIBITORS %28%IM%29% + PSEUDOCHOLINESTERASE %28%NIM with no qualif%29%%A%
% 210.47/210.68 |- mesh__recordOriginator mesh__D011543 NLM
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D011543 2005
% 210.47/210.68 |- mesh__historyNote mesh__D011543
% 210.47/210.68 91%28%75%29%; was see under CHOLINESTERASES 1975-90; was see under CHOLINESTERASE 1963-74%A%
% 210.47/210.68 |- mesh__recordMaintainer mesh__D011543 ssb
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D011543 sjn
% 210.47/210.68 |- mesh__dateEstablished mesh__D011543 1991-01-01
% 210.47/210.68 |- skos__broader mesh__D011543smesh__D002802
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D011543 2006
% 210.47/210.68 |- rdf__type mesh__D011543sskos__Concept
% 210.47/210.68 |- mesh__dateRevised mesh__D011543 2003-07-09
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D011543 2004
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D011543
% 210.47/210.68 91; was see under CHOLINESTERASES 1975-90; was see under CHOLINESTERASE 1963-74%A%
% 210.47/210.68 |- mesh__onlineNote mesh__D011543 search CHOLINESTERASES 1966-74
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 1995
% 210.47/210.68 |- skos__hiddenLabel mesh__D005506 Food Adulterations
% 210.47/210.68 |- rdf__type mesh__D005506sskos__Concept
% 210.47/210.68 |- skos__hiddenLabel mesh__D005506 Contamination, Food
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 2001
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 1994
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 2004
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 1997
% 210.47/210.68 |- skos__scopeNote mesh__D005506
% 210.47/210.68 The presence in food of harmful, unpalatable, or otherwise objectionable foreign substances, e.g. chemicals, microorganisms or diluents, before, during, or after processing or storage.%A%
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 2000
% 210.47/210.68 |- mesh__recordMaintainer mesh__D005506 TAP
% 210.47/210.68 |- skos__hiddenLabel mesh__D005506 Food Contaminations
% 210.47/210.68 |- mesh__dateCreated mesh__D005506 1999-01-01
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 2003
% 210.47/210.68 |- skos__prefLabel mesh__D005506 Food Contamination
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 1996
% 210.47/210.68 |- mesh__dateRevised mesh__D005506 1992-05-15
% 210.47/210.68 |- skos__broader mesh__D005506smesh__D004787
% 210.47/210.68 |- mesh__recordOriginator mesh__D005506 NLM
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 1993
% 210.47/210.68 |- skos__hiddenLabel mesh__D005506 Adulteration, Food
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 2006
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 1999
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D005506 PLS
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 2002
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 2005
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005506 1998
% 210.47/210.68 |- skos__hiddenLabel mesh__D005506 Adulterations, Food
% 210.47/210.68 |- skos__hiddenLabel mesh__D005506 Contaminations, Food
% 210.47/210.68 |- skos__annotation mesh__D005506
% 210.47/210.68 coord IM with specific food item probably NIM; contamination by dirt, dust, chemicals %26% toxic substances, organisms; contamination by microbes: consider FOOD MICROBIOLOGY %28%IM%29% + specific microbe %28%IM%29% + specific food item %28%IM or NIM%29%; contamination by parasites: consider FOOD PARASITOLOGY %28%IM%29% + specific parasite %28%IM%29% + specific food item %28%IM or NIM%29%%A%
% 210.47/210.68 |- mesh__historyNote mesh__D015934 2006 %28%1990%29%
% 210.47/210.68 |- mesh__recordMaintainer mesh__D015934 ssb
% 210.47/210.68 |- mesh__dateEstablished mesh__D015934 1990-01-01
% 210.47/210.68 |- skos__altLabel mesh__D015934 Complement Component 4a
% 210.47/210.68 |- skos__altLabel mesh__D015934 C4a Complement
% 210.47/210.68 |- skos__hiddenLabel mesh__D015934 Complement, C4a
% 210.47/210.68 |- mesh__dateCreated mesh__D015934 1989-05-25
% 210.47/210.68 |- mesh__dateRevised mesh__D015934 2005-06-30
% 210.47/210.68 |- skos__broader mesh__D015934smesh__D000706
% 210.47/210.68 |- skos__hiddenLabel mesh__D015934 Component 4a, Complement
% 210.47/210.68 |- skos__hiddenLabel mesh__D015934 C4a, Complement
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D015934 2006
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D015934 sjn
% 210.47/210.68 |- skos__historyNote mesh__D015934 Complement 4 %28%1978-1989%29%
% 210.47/210.68 |- skos__prefLabel mesh__D015934 Complement C4a
% 210.47/210.68 |- skos__scopeNote mesh__D015934
% 210.47/210.68 The smaller fragment formed when complement C4 is cleaved by COMPLEMENT C1S. It is an anaphylatoxin that causes symptoms of immediate hypersensitivity %28%HYPERSENSITIVITY, IMMEDIATE%29% but its activity is weaker than that of COMPLEMENT C3A or COMPLEMENT C5A.%A%
% 210.47/210.68 |- skos__altLabel mesh__D015934 Complement 4a
% 210.47/210.68 |- skos__broader mesh__D015934smesh__D003181
% 210.47/210.68 |- skos__historyNote mesh__D015934 Anaphylatoxins %28%1980-1982%29%
% 210.47/210.68 |- rdf__type mesh__D015934sskos__Concept
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D015934 2006; see COMPLEMENT 4A 1990-2005
% 210.47/210.68 |- mesh__recordOriginator mesh__D015934 AGS
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D001914 PLS
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 2004
% 210.47/210.68 |- skos__broader mesh__D001914smesh__D013177
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 1997
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 2006
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 2003
% 210.47/210.68 |- mesh__recordOriginator mesh__D001914 NLM
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 1999
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 2005
% 210.47/210.68 |- skos__hiddenLabel mesh__D001914 Boxings
% 210.47/210.68 |- skos__annotation mesh__D001914
% 210.47/210.68 /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 2002
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 1998
% 210.47/210.68 |- skos__prefLabel mesh__D001914 Boxing
% 210.47/210.68 |- mesh__dateRevised mesh__D001914 1996-06-10
% 210.47/210.68 |- mesh__recordMaintainer mesh__D001914 TAP
% 210.47/210.68 |- mesh__dateCreated mesh__D001914 1999-01-01
% 210.47/210.68 |- skos__scopeNote mesh__D001914
% 210.47/210.68 A two-person sport in which the fists are skillfully used to attack and defend.%A%
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 2001
% 210.47/210.68 |- rdf__type mesh__D001914sskos__Concept
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001914 2000
% 210.47/210.68 |- mesh__dateRevised mesh__D001116 2001-07-25
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001116 2003
% 210.47/210.68 |- mesh__dateCreated mesh__D001116 1977-05-04
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D001116 sjn
% 210.47/210.68 |- mesh__recordOriginator mesh__D001116 AEP
% 210.47/210.68 |- skos__historyNote mesh__D001116 RNA Viruses %28%1966-1977%29%
% 210.47/210.68 |- skos__prefLabel mesh__D001116 Arenaviridae
% 210.47/210.68 |- mesh__dateEstablished mesh__D001116 1978-01-01
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001116 2002
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001116 2004
% 210.47/210.68 |- mesh__onlineNote mesh__D001116
% 210.47/210.68 use ARENAVIRIDAE to search ARENAVIRUSES 1978-80
% 210.47/210.68 |- mesh__historyNote mesh__D001116 81; was ARENAVIRUSES 1978-80
% 210.47/210.68 |- mesh__recordMaintainer mesh__D001116 ags
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001116 2005
% 210.47/210.68 |- skos__scopeNote mesh__D001116
% 210.47/210.68 A family of RNA viruses naturally infecting rodents and consisting of one genus %28%ARENAVIRUS%29% with two groups: Old World Arenaviruses %28%ARENAVIRUSES, OLD WORLD%29% and New World Arenaviruses %28%ARENAVIRUSES, NEW WORLD%29%. Infection in rodents is persistent and silent. Vertical transmission is through milk-, saliva-, or urine-borne routes. Horizontal transmission to humans, monkeys, and other animals is important.%A%
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D001116 81; was ARENAVIRUSES 1978-80
% 210.47/210.68 |- skos__broader mesh__D001116smesh__D012328
% 210.47/210.68 |- skos__annotation mesh__D001116 infection = ARENAVIRIDAE INFECTIONS
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001116 2006
% 210.47/210.68 |- rdf__type mesh__D001116sskos__Concept
% 210.47/210.68 |- skos__hiddenLabel mesh__D020879 Muscle Disease Manifestation
% 210.47/210.68 |- skos__hiddenLabel mesh__D020879 Manifestation, Muscle Disease
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D020879 2004
% 210.47/210.68 |- mesh__historyNote mesh__D020879 2000
% 210.47/210.68 |- skos__altLabel mesh__D020879 Neuromuscular Signs and Symptoms
% 210.47/210.68 |- skos__hiddenLabel mesh__D020879 Manifestation, Neuromuscular
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D020879 2006
% 210.47/210.68 |- rdf__type mesh__D020879sskos__Concept
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D020879 2000
% 210.47/210.68 |- skos__annotation mesh__D020879 not used for indexing
% 210.47/210.68 |- skos__broader mesh__D020879smesh__D009461
% 210.47/210.68 |- mesh__recordMaintainer mesh__D020879 sjn
% 210.47/210.68 |- mesh__dateRevised mesh__D020879 2003-07-22
% 210.47/210.68 |- mesh__recordOriginator mesh__D020879 KEV
% 210.47/210.68 |- skos__hiddenLabel mesh__D020879 Disease Manifestation, Muscle
% 210.47/210.68 |- mesh__dateCreated mesh__D020879 1999-11-03
% 210.47/210.68 |- skos__hiddenLabel mesh__D020879 Manifestations, Neuromuscular
% 210.47/210.68 |- skos__prefLabel mesh__D020879 Neuromuscular Manifestations
% 210.47/210.68 |- mesh__dateEstablished mesh__D020879 2000-01-01
% 210.47/210.68 |- skos__altLabel mesh__D020879 Manifestations, Muscle Disease
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D020879 sjn
% 210.47/210.68 |- skos__scopeNote mesh__D020879
% 210.47/210.68 Signs and symptoms associated with diseases of the muscle, neuromuscular junction, or peripheral nerves.%A%
% 210.47/210.68 |- skos__altLabel mesh__D020879 Signs and Symptoms, Neuromuscular
% 210.47/210.68 |- skos__hiddenLabel mesh__D020879 Disease Manifestations, Muscle
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D020879 2005
% 210.47/210.68 |- skos__hiddenLabel mesh__D020879 Neuromuscular Manifestation
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D019527 2006
% 210.47/210.68 |- skos__altLabel mesh__D019527 Prospectuses %28%PT%29%
% 210.47/210.68 |- skos__prefLabel mesh__D019527 Prospectuses %5B%Publication Type%5D%
% 210.47/210.68 |- mesh__dateRevised mesh__D019527 2005-06-30
% 210.47/210.68 |- rdf__type mesh__D019527sskos__Concept
% 210.47/210.68 |- mesh__recordMaintainer mesh__D019527 jls
% 210.47/210.68 |- mesh__recordOriginator mesh__D019527 TGC
% 210.47/210.68 |- mesh__historyNote mesh__D019527 1997
% 210.47/210.68 |- skos__broader mesh__D019527smesh__D019502
% 210.47/210.68 |- skos__scopeNote mesh__D019527
% 210.47/210.68 Works consisting of advertisements separately printed and distributed by a publisher to describe and solicit orders for a recent or forthcoming publication. In the case of books, they may include sample pages. %28%From: ALA Glossary of Library and Information Science, 1983%29%%A%
% 210.47/210.68 |- skos__altLabel mesh__D019527 Prospectuses
% 210.47/210.68 |- mesh__dateEstablished mesh__D019527 1997-01-01
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D019527 sjn
% 210.47/210.68 |- mesh__dateCreated mesh__D019527 1996-06-21
% 210.47/210.68 |- skos__annotation mesh__D019527
% 210.47/210.68 publication type only; for prospectuses as a subject, index under main heading ADVERTISING; not used for indexing; CATALOG: do not use for current materials%A%
% 210.47/210.68 |- skos__hiddenLabel mesh__D011544 Gene, Processed
% 210.47/210.68 |- mesh__recordMaintainer mesh__D011544 nns
% 210.47/210.68 |- mesh__historyNote mesh__D011544 88
% 210.47/210.68 |- skos__hiddenLabel mesh__D011544 beta-Tubulin Pseudogenes
% 210.47/210.68 |- mesh__dateEstablished mesh__D011544 1988-01-01
% 210.47/210.68 |- mesh__recordOriginator mesh__D011544 SCD
% 210.47/210.68 |- skos__historyNote mesh__D011544 Genes, Structural %28%1975-1987%29%
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D011544 2006
% 210.47/210.68 |- mesh__dateRevised mesh__D011544 2005-06-30
% 210.47/210.68 |- rdf__type mesh__D011544sskos__Concept
% 210.47/210.68 |- skos__hiddenLabel mesh__D011544 Pseudogene
% 210.47/210.68 |- skos__prefLabel mesh__D011544 Pseudogenes
% 210.47/210.68 |- mesh__dateCreated mesh__D011544 1987-05-09
% 210.47/210.68 |- skos__hiddenLabel mesh__D011544 Pseudogenes, beta-Tubulin
% 210.47/210.68 |- skos__hiddenLabel mesh__D011544 Pseudogene, beta-Tubulin
% 210.47/210.68 |- skos__hiddenLabel mesh__D011544 Processed Gene
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D011544 sjn
% 210.47/210.68 |- skos__hiddenLabel mesh__D011544 Processed Genes
% 210.47/210.68 |- skos__hiddenLabel mesh__D011544 beta Tubulin Pseudogene
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D011544 88
% 210.47/210.68 |- skos__broader mesh__D011544smesh__D005796
% 210.47/210.68 |- skos__historyNote mesh__D011544 Genes %28%1975-1987%29%
% 210.47/210.68 |- skos__scopeNote mesh__D011544
% 210.47/210.68 Genes bearing close resemblance to known genes at different loci, but rendered non-functional by additions or deletions in structure that prevent normal transcription or translation. When lacking introns and containing a poly-A segment near the downstream end %28%as a result of reverse copying from processed nuclear RNA into double-stranded DNA%29%, they are called processed genes.%A%
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 2004
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 1997
% 210.47/210.68 |- skos__hiddenLabel mesh__D005507 Radioactive Food Contaminations
% 210.47/210.68 |- mesh__dateCreated mesh__D005507 1999-01-01
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 2003
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 1996
% 210.47/210.68 |- skos__prefLabel mesh__D005507 Food Contamination, Radioactive
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 2001
% 210.47/210.68 |- skos__hiddenLabel mesh__D005507 Radioactive Food Contamination
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 1993
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 2006
% 210.47/210.68 |- skos__hiddenLabel mesh__D005507 Food Contaminations, Radioactive
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 1999
% 210.47/210.68 |- skos__broader mesh__D005507smesh__D005506
% 210.47/210.68 |- skos__hiddenLabel mesh__D005507 Contaminations, Radioactive Food
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 2000
% 210.47/210.68 |- mesh__recordMaintainer mesh__D005507 TAP
% 210.47/210.68 |- skos__broader mesh__D005507smesh__D011870
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 2005
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 1998
% 210.47/210.68 |- mesh__dateRevised mesh__D005507 1992-05-15
% 210.47/210.68 |- mesh__recordOriginator mesh__D005507 NLM
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 1995
% 210.47/210.68 |- skos__annotation mesh__D005507
% 210.47/210.68 do not confuse with FOOD IRRADIATION: food preservation by irradiation%A%
% 210.47/210.68 |- skos__hiddenLabel mesh__D005507 Contamination, Radioactive Food
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D005507 PLS
% 210.47/210.68 |- rdf__type mesh__D005507sskos__Concept
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 2002
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D005507 1994
% 210.47/210.68 |- skos__altLabel mesh__D015935 Complement 4b
% 210.47/210.68 |- skos__hiddenLabel mesh__D015935 C4b, Complement
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D015935 sjn
% 210.47/210.68 |- mesh__recordMaintainer mesh__D015935 lkt
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D015935 2006; see COMPLEMENT 4B 1990-2005
% 210.47/210.68 |- skos__broader mesh__D015935smesh__D003181
% 210.47/210.68 |- skos__hiddenLabel mesh__D015935 Component 4b, Complement
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D015935 2006
% 210.47/210.68 |- skos__altLabel mesh__D015935 C4b Complement
% 210.47/210.68 |- skos__hiddenLabel mesh__D015935 Complement, C4b
% 210.47/210.68 |- skos__scopeNote mesh__D015935
% 210.47/210.68 The large fragment formed when COMPLEMENT C4 is cleaved by COMPLEMENT C1S. The membrane-bound C4b binds COMPLEMENT C2A, a SERINE PROTEASE, to form C4b2a %28%CLASSICAL PATHWAY C3 CONVERTASE%29% and subsequent C4b2a3b %28%CLASSICAL PATHWAY C5 CONVERTASE%29%.%A%
% 210.47/210.68 |- mesh__historyNote mesh__D015935 2006 %28%1990%29%
% 210.47/210.68 |- skos__prefLabel mesh__D015935 Complement C4b
% 210.47/210.68 |- mesh__dateRevised mesh__D015935 2005-06-30
% 210.47/210.68 |- skos__altLabel mesh__D015935 Complement Component 4b
% 210.47/210.68 |- rdf__type mesh__D015935sskos__Concept
% 210.47/210.68 |- mesh__dateEstablished mesh__D015935 1990-01-01
% 210.47/210.68 |- skos__historyNote mesh__D015935 Complement 4 %28%1975-1989%29%
% 210.47/210.68 |- mesh__dateCreated mesh__D015935 1989-05-25
% 210.47/210.68 |- mesh__recordOriginator mesh__D015935 AGS
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001915 2006
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001915 2003
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D001915 SJN
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001915 2005
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001915 1999
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001915 2000
% 210.47/210.68 |- skos__prefLabel mesh__D001915 Braces
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001915 1998
% 210.47/210.68 |- mesh__recordMaintainer mesh__D001915 PXP
% 210.47/210.68 |- skos__broader mesh__D001915smesh__D009989
% 210.47/210.68 |- mesh__recordOriginator mesh__D001915 NLM
% 210.47/210.68 |- mesh__dateCreated mesh__D001915 1999-01-01
% 210.47/210.68 |- skos__hiddenLabel mesh__D001915 Brace
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001915 2002
% 210.47/210.68 |- rdf__type mesh__D001915sskos__Concept
% 210.47/210.68 |- skos__scopeNote mesh__D001915
% 210.47/210.68 Orthopedic appliances used to support, align, or hold parts of the body in correct position. %28%Dorland, 28th ed%29%%A%
% 210.47/210.68 |- mesh__dateRevised mesh__D001915 1997-06-20
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001915 2004
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001915 2001
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 1997
% 210.47/210.68 |- skos__hiddenLabel mesh__D001117 Arenavirus Infection
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 2000
% 210.47/210.68 |- skos__historyNote mesh__D001117 Arenaviridae %28%1978-1980%29%
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 2004
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 1998
% 210.47/210.68 |- skos__hiddenLabel mesh__D001117 Infection, Arenaviridae
% 210.47/210.68 |- mesh__dateEstablished mesh__D001117 1981-01-01
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 2001
% 210.47/210.68 |- mesh__recordOriginator mesh__D001117 RC
% 210.47/210.68 |- mesh__onlineNote mesh__D001117
% 210.47/210.68 use ARENAVIRIDAE INFECTIONS to search ARENAVIRUS INFECTIONS 1981-93%A%
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 2005
% 210.47/210.68 |- skos__prefLabel mesh__D001117 Arenaviridae Infections
% 210.47/210.68 |- mesh__dateCreated mesh__D001117 1980-05-13
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 1999
% 210.47/210.68 |- mesh__historyNote mesh__D001117 94; was ARENAVIRUS INFECTIONS 1981-93
% 210.47/210.68 |- mesh__dateRevised mesh__D001117 1993-06-04
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D001117 PLS
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 2002
% 210.47/210.68 |- skos__altLabel mesh__D001117 Arenavirus Infections
% 210.47/210.68 |- skos__hiddenLabel mesh__D001117 Infection, Arenavirus
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 1994
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 2006
% 210.47/210.68 |- rdf__type mesh__D001117sskos__Concept
% 210.47/210.68 |- mesh__publicMeSHNote mesh__D001117
% 210.47/210.68 94; was ARENAVIRUS INFECTIONS 1981-93
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 1995
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 1996
% 210.47/210.68 |- skos__broader mesh__D001117smesh__D012327
% 210.47/210.68 |- skos__historyNote mesh__D001117 Virus Diseases %28%1966-1980%29%
% 210.47/210.68 |- skos__hiddenLabel mesh__D001117 Arenaviridae Infection
% 210.47/210.68 |- skos__altLabel mesh__D001117 Infections, Arenaviridae
% 210.47/210.68 |- skos__scopeNote mesh__D001117
% 210.47/210.68 Virus diseases caused by the ARENAVIRIDAE.
% 210.47/210.68 |- mesh__recordMaintainer mesh__D001117 AGS
% 210.47/210.68 |- skos__annotation mesh__D001117 GEN or unspecified; prefer specifics
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D001117 2003
% 210.47/210.68 |- mesh__recordOriginator mesh__D006600 NLM
% 210.47/210.68 |- rdf__type mesh__D006600sskos__Concept
% 210.47/210.68 |- mesh__recordMaintainer mesh__D006600 ssb
% 210.47/210.68 |- skos__prefLabel mesh__D006600 Hexosephosphates
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D006600 sjn
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D006600 2005
% 210.47/210.68 |- mesh__dateCreated mesh__D006600 1999-01-01
% 210.47/210.68 |- mesh__dateRevised mesh__D006600 2004-07-07
% 210.47/210.68 |- mesh__activeMeSHYear mesh__D006600 2006
% 210.47/210.68 |- skos__broader mesh__D006600smesh__D013403
% 210.47/210.68 |- mesh__recordAuthorizer mesh__D019528 sjn
% 210.47/210.68 |- skos__broader mesh__D019528smesh__D019514
% 210.47/210.68 |- mesh__dateCreated mesh__D019528 1996-06-21
% 210.47/210.68 |- skos__prefLabel mesh__D019528 Lecture Notes %5B%Publication Type%5D%
% 210.47/210.68 |- skos__annotation mesh__D019528
% 210.47/210.68 publication type only; for notes %28%usually instructive%29% taken at a lecture or class%A%
% 210.47/210.69 |- mesh__recordMaintainer mesh__D019528 jls
% 210.47/210.69 |- skos__altLabel mesh__D019528 Lecture Notes %28%PT%29%
% 210.47/210.69 |- mesh__dateRevised mesh__D019528 2005-06-30
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D019528 2006
% 210.47/210.69 |- skos__scopeNote mesh__D019528
% 210.47/210.69 Works consisting of notes taken at the delivery or reading of a speech before an audience or class, usually given to instruct. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%
% 210.47/210.69 |- mesh__recordOriginator mesh__D019528 TGC
% 210.47/210.69 |- mesh__historyNote mesh__D019528 1997
% 210.47/210.69 |- skos__altLabel mesh__D019528 Lecture Notes
% 210.47/210.69 |- rdf__type mesh__D019528sskos__Concept
% 210.47/210.69 |- mesh__dateEstablished mesh__D019528 1997-01-01
% 210.47/210.69 |- rdf__type mesh__D011545sskos__Concept
% 210.47/210.69 |- skos__historyNote mesh__D011545 Hermaphroditism %28%1966-1972%29%
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D011545 sjn
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D011545
% 210.47/210.69 73; was see under HERMAPHRODITISM 1963-72
% 210.47/210.69 |- skos__broader mesh__D011545smesh__D006546
% 210.47/210.69 |- skos__hiddenLabel mesh__D011545 Pseudohermaphroditism, Male
% 210.47/210.69 |- mesh__historyNote mesh__D011545
% 210.47/210.69 73; was see under HERMAPHRODITISM 1963-72
% 210.47/210.69 |- skos__prefLabel mesh__D011545 Pseudohermaphroditism
% 210.47/210.69 |- mesh__dateCreated mesh__D011545 1999-01-01
% 210.47/210.69 |- mesh__onlineNote mesh__D011545 search HERMAPHRODITISM 1966-72
% 210.47/210.69 |- mesh__recordMaintainer mesh__D011545 lkt
% 210.47/210.69 |- mesh__dateRevised mesh__D011545 2005-06-30
% 210.47/210.69 |- skos__scopeNote mesh__D011545
% 210.47/210.69 A condition of sexual ambiguity in which the individual %28%pseudohermaphrodite%29% possesses gonadal tissue of one SEX but exhibits external PHENOTYPE of the opposite sex. Female pseudohermaphroditism is an individual with XX karyotype, normal development of OVARIES and internal reproductive tract, but with ambiguous or virilized external GENITALIA. Male pseudohermaphroditism is characterized by the presence of a Y CHROMOSOME and TESTES, but the genital tract and external genitalia are ambiguous or completely female.%A%
% 210.47/210.69 |- mesh__recordOriginator mesh__D011545 NLM
% 210.47/210.69 |- skos__annotation mesh__D011545 use check tag for genetic sex
% 210.47/210.69 |- mesh__dateEstablished mesh__D011545 1973-01-01
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D011545 2006
% 210.47/210.69 |- skos__hiddenLabel mesh__D011545 Pseudohermaphroditism, Female
% 210.47/210.69 |- skos__hiddenLabel mesh__D005508 Deprivations, Food
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 1992
% 210.47/210.69 |- mesh__recordOriginator mesh__D005508 NLM
% 210.47/210.69 |- skos__broader mesh__D005508smesh__D009042
% 210.47/210.69 |- skos__scopeNote mesh__D005508
% 210.47/210.69 The withholding of food in a structured experimental situation.%A%
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 2005
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 1998
% 210.47/210.69 |- skos__annotation mesh__D005508
% 210.47/210.69 human %26% animal; /physiol permitted for physiol %26% metab eff%A%
% 210.47/210.69 |- mesh__dateEstablished mesh__D005508 1969-01-01
% 210.47/210.69 |- mesh__dateRevised mesh__D005508 1991-06-20
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D005508 69
% 210.47/210.69 |- mesh__historyNote mesh__D005508 69
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 1993
% 210.47/210.69 |- skos__prefLabel mesh__D005508 Food Deprivation
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 2006
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 1999
% 210.47/210.69 |- skos__historyNote mesh__D005508 Motivation %28%1966-1968%29%
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 2000
% 210.47/210.69 |- skos__hiddenLabel mesh__D005508 Food Deprivations
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 1994
% 210.47/210.69 |- mesh__dateCreated mesh__D005508 1999-01-01
% 210.47/210.69 |- skos__related mesh__D005508smesh__D013217
% 210.47/210.69 |- skos__historyNote mesh__D005508 Hunger %28%1966-1968%29%
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 2001
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 1995
% 210.47/210.69 |- skos__hiddenLabel mesh__D005508 Deprivation, Food
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 2003
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 1996
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D005508 PLS
% 210.47/210.69 |- rdf__type mesh__D005508sskos__Concept
% 210.47/210.69 |- mesh__recordMaintainer mesh__D005508 TGC
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 2002
% 210.47/210.69 |- skos__related mesh__D005508smesh__D006815
% 210.47/210.69 |- skos__related mesh__D005508smesh__D005215
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 2004
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005508 1997
% 210.47/210.69 |- rdf__type mesh__D002210sskos__Concept
% 210.47/210.69 |- skos__prefLabel mesh__D002210 Caprylates
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D002210 2005
% 210.47/210.69 |- skos__altLabel mesh__D002210 Octanoates
% 210.47/210.69 |- mesh__recordOriginator mesh__D002210 NLM
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D002210 2004
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D002210 sjn
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D002210 2006
% 210.47/210.69 |- mesh__recordMaintainer mesh__D002210 ssb
% 210.47/210.69 |- mesh__dateRevised mesh__D002210 2003-07-09
% 210.47/210.69 |- skos__broader mesh__D002210smesh__D000144
% 210.47/210.69 |- skos__broader mesh__D002210smesh__D005227
% 210.47/210.69 |- mesh__dateCreated mesh__D002210 1999-01-01
% 210.47/210.69 |- skos__historyNote mesh__D015936 Complement 5 %28%1975-1989%29%
% 210.47/210.69 |- skos__broader mesh__D015936smesh__D000706
% 210.47/210.69 |- skos__historyNote mesh__D015936 Anaphylatoxins %28%1977-1989%29%
% 210.47/210.69 |- mesh__recordOriginator mesh__D015936 AGS
% 210.47/210.69 |- skos__prefLabel mesh__D015936 Complement C5a
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015936 2006
% 210.47/210.69 |- mesh__recordMaintainer mesh__D015936 ssb
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D015936 sjn
% 210.47/210.69 |- skos__altLabel mesh__D015936 Complement Component 5a
% 210.47/210.69 |- skos__hiddenLabel mesh__D015936 Complement, C5a
% 210.47/210.69 |- mesh__historyNote mesh__D015936 2006 %28%1990%29%
% 210.47/210.69 |- skos__scopeNote mesh__D015936
% 210.47/210.69 The minor fragment formed when C5 convertase cleaves C5 into C5a and COMPLEMENT C5B. C5a is a 74-amino-acid glycopeptide with a carboxy-terminal ARGININE that is crucial for its spasmogenic activity. Of all the complement-derived anaphylatoxins, C5a is the most potent in mediating immediate hypersensitivity %28%HYPERSENSITIVITY, IMMEDIATE%29%, smooth MUSCLE CONTRACTION; HISTAMINE RELEASE; and migration of LEUKOCYTES to site of INFLAMMATION.%A%
% 210.47/210.69 |- skos__hiddenLabel mesh__D015936 5a, Complement Component
% 210.47/210.69 |- skos__hiddenLabel mesh__D015936 C5a, Complement
% 210.47/210.69 |- skos__broader mesh__D015936smesh__D003182
% 210.47/210.69 |- skos__altLabel mesh__D015936 C5a Complement
% 210.47/210.69 |- rdf__type mesh__D015936sskos__Concept
% 210.47/210.69 |- mesh__dateEstablished mesh__D015936 1990-01-01
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D015936 2006; see COMPLEMENT 5A 1990-2005
% 210.47/210.69 |- skos__hiddenLabel mesh__D015936 Component 5a, Complement
% 210.47/210.69 |- mesh__dateCreated mesh__D015936 1989-07-14
% 210.47/210.69 |- skos__historyNote mesh__D015936 Complement %28%1972-1975%29%
% 210.47/210.69 |- mesh__dateRevised mesh__D015936 2005-06-30
% 210.47/210.69 |- skos__altLabel mesh__D015936 Complement 5a
% 210.47/210.69 |- skos__historyNote mesh__D015138 RNA %28%1966-1988%29%
% 210.47/210.69 |- rdf__type mesh__D015138sskos__Concept
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 2001
% 210.47/210.69 |- skos__altLabel mesh__D015138 Chromosomal RNA
% 210.47/210.69 |- mesh__dateCreated mesh__D015138 1988-03-18
% 210.47/210.69 |- skos__scopeNote mesh__D015138
% 210.47/210.69 RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm.%A%
% 210.47/210.69 |- skos__historyNote mesh__D015138 Chromosomes %28%1966-1988%29%
% 210.47/210.69 |- mesh__dateRevised mesh__D015138 1995-06-08
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 2000
% 210.47/210.69 |- mesh__historyNote mesh__D015138 89
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 2004
% 210.47/210.69 |- mesh__recordMaintainer mesh__D015138 AGS
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 1997
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 2006
% 210.47/210.69 |- mesh__dateEstablished mesh__D015138 1989-01-01
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 1999
% 210.47/210.69 |- skos__annotation mesh__D015138 IM; /drug eff /ultrastruct permitted
% 210.47/210.69 |- skos__broader mesh__D015138smesh__D012313
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 2003
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D015138 PLS
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 1996
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 2005
% 210.47/210.69 |- skos__prefLabel mesh__D015138 RNA, Nuclear
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 1998
% 210.47/210.69 |- mesh__recordOriginator mesh__D015138 SCD
% 210.47/210.69 |- skos__historyNote mesh__D015138 Cell Nucleus %28%1966-1988%29%
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015138 2002
% 210.47/210.69 |- skos__altLabel mesh__D015138 Nuclear RNA
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D015138 89
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 2006
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 1997
% 210.47/210.69 |- skos__hiddenLabel mesh__D001916 Artery, Brachial
% 210.47/210.69 |- skos__hiddenLabel mesh__D001916 Arteries, Brachial
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 1999
% 210.47/210.69 |- skos__prefLabel mesh__D001916 Brachial Artery
% 210.47/210.69 |- mesh__recordMaintainer mesh__D001916 TAP
% 210.47/210.69 |- mesh__dateCreated mesh__D001916 1999-01-01
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 2000
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 1994
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D001916 PLS
% 210.47/210.69 |- mesh__dateRevised mesh__D001916 1992-03-25
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 2001
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 1993
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 1995
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 2003
% 210.47/210.69 |- rdf__type mesh__D001916sskos__Concept
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 2002
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 2005
% 210.47/210.69 |- skos__broader mesh__D001916smesh__D001158
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 1996
% 210.47/210.69 |- skos__scopeNote mesh__D001916
% 210.47/210.69 The continuation of the axillary artery; it branches into the radial and ulnar arteries.%A%
% 210.47/210.69 |- skos__hiddenLabel mesh__D001916 Brachial Arteries
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 2004
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001916 1998
% 210.47/210.69 |- mesh__recordOriginator mesh__D001916 NLM
% 210.47/210.69 |- mesh__dateCreated mesh__D001118 1999-01-01
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 2005
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1993
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1999
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1991
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1994
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 2006
% 210.47/210.69 |- rdf__type mesh__D001118sskos__Concept
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1989
% 210.47/210.69 |- mesh__recordMaintainer mesh__D001118 PLS
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1995
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1996
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 2000
% 210.47/210.69 |- mesh__dateRevised mesh__D001118 1991-11-02
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 2003
% 210.47/210.69 |- mesh__recordOriginator mesh__D001118 NLM
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1997
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 2001
% 210.47/210.69 |- skos__broader mesh__D001118smesh__D013020
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 2004
% 210.47/210.69 |- skos__prefLabel mesh__D001118 Argentina
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1992
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1998
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D001118 PLS
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 2002
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001118 1990
% 210.47/210.69 |- rdf__type mesh__D006601sskos__Concept
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D006601 2005
% 210.47/210.69 |- mesh__dateCreated mesh__D006601 1999-01-01
% 210.47/210.69 |- mesh__dateRevised mesh__D006601 2004-07-07
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D006601 2006
% 210.47/210.69 |- mesh__recordOriginator mesh__D006601 NLM
% 210.47/210.69 |- mesh__recordMaintainer mesh__D006601 ssb
% 210.47/210.69 |- skos__annotation mesh__D006601
% 210.47/210.69 monosaccharides; GEN only; prefer specifics
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D006601 sjn
% 210.47/210.69 |- skos__prefLabel mesh__D006601 Hexoses
% 210.47/210.69 |- skos__broader mesh__D006601smesh__D009005
% 210.47/210.69 |- mesh__recordOriginator mesh__D019529 JLS
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D019529 sjn
% 210.47/210.69 |- skos__scopeNote mesh__D019529
% 210.47/210.69 The sexual functions, activities, attitudes, and orientations of an individual. Sexuality, male or female, becomes evident at PUBERTY under the influence of gonadal steroids %28%TESTOSTERONE or ESTRADIOL%29%, and social effects.%A%
% 210.47/210.69 |- skos__related mesh__D019529smesh__D011606
% 210.47/210.69 |- skos__broader mesh__D019529smesh__D012725
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D019529 2005
% 210.47/210.69 |- skos__annotation mesh__D019529 human only
% 210.47/210.69 |- skos__historyNote mesh__D019529 Sex Behavior %28%1974-1996%29%
% 210.47/210.69 |- mesh__recordMaintainer mesh__D019529 lkt
% 210.47/210.69 |- mesh__dateCreated mesh__D019529 1996-06-13
% 210.47/210.69 |- mesh__historyNote mesh__D019529 1997; use SEX BEHAVIOR 1978-1996
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D019529 1997; see SEX BEHAVIOR 1978-1996
% 210.47/210.69 |- rdf__type mesh__D019529sskos__Concept
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D019529 2006
% 210.47/210.69 |- mesh__dateRevised mesh__D019529 2004-07-07
% 210.47/210.69 |- mesh__dateEstablished mesh__D019529 1997-01-01
% 210.47/210.69 |- skos__prefLabel mesh__D019529 Sexuality
% 210.47/210.69 |- skos__prefLabel mesh__D011546 Pseudohypoaldosteronism
% 210.47/210.69 |- skos__broader mesh__D011546smesh__D015499
% 210.47/210.69 |- skos__historyNote mesh__D011546 Hyperaldosteronism %28%1975-1980%29%
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D011546 sjn
% 210.47/210.69 |- skos__scopeNote mesh__D011546
% 210.47/210.69 A heterogeneous group of disorders with common symptoms of apparent HYPOALDOSTERONISM despite the elevated levels of ALDOSTERONE and RENIN. Other clinical symptoms include HYPERKALEMIA with %28%Type I%29% or without %28%Type II%29% sodium wasting. Pseudohypoaldosteronism can be the result of defective MINERALOCORTICOID RECEPTORS or defects in the epithelial SODIUM CHANNEL. It can also be acquired after KIDNEY TRANSPLANTATION.%A%
% 210.47/210.69 |- skos__hiddenLabel mesh__D011546 Pseudohypoaldosteronisms, Type II
% 210.47/210.69 |- skos__hiddenLabel mesh__D011546 Type II Pseudohypoaldosteronisms
% 210.47/210.69 |- mesh__dateRevised mesh__D011546 2004-07-07
% 210.47/210.69 |- skos__historyNote mesh__D011546
% 210.47/210.69 Renal Tubular Transport, Inborn Errors %28%1971-1987%29%
% 210.47/210.69 |- mesh__historyNote mesh__D011546
% 210.47/210.69 91%28%88%29%; was see under RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90%A%
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D011546 2005
% 210.47/210.69 |- skos__historyNote mesh__D011546 Aldosterone %28%1971-1987%29%
% 210.47/210.69 |- skos__hiddenLabel mesh__D011546 Type II Pseudohypoaldosteronism
% 210.47/210.69 |- mesh__dateCreated mesh__D011546 1987-03-13
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D011546 2006
% 210.47/210.69 |- skos__hiddenLabel mesh__D011546 Pseudohypoaldosteronisms
% 210.47/210.69 |- mesh__recordOriginator mesh__D011546 SD
% 210.47/210.69 |- rdf__type mesh__D011546sskos__Concept
% 210.47/210.69 |- mesh__dateEstablished mesh__D011546 1991-01-01
% 210.47/210.69 |- mesh__recordMaintainer mesh__D011546 lkt
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D011546
% 210.47/210.69 91; was see under RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90%A%
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Food Vending Machine
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005509 2005
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005509 1998
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Automatic Food Dispenser
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005509 2002
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005509 2006
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005509 1999
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Automatic Food Dispensers
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Food Dispenser, Automatic
% 210.47/210.69 |- mesh__dateEstablished mesh__D005509 1991-01-01
% 210.47/210.69 |- mesh__dateRevised mesh__D005509 1997-06-20
% 210.47/210.69 |- skos__prefLabel mesh__D005509 Food Dispensers, Automatic
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Dispenser, Automatic Food
% 210.47/210.69 |- mesh__historyNote mesh__D005509
% 210.47/210.69 91%28%Aug 77%29%; was see under FOOD SERVICES 1977-90
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Dispensers, Automatic Food
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Vending Machine, Food
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Machine, Food Vending
% 210.47/210.69 |- mesh__dateCreated mesh__D005509 1977-05-05
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005509 2003
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Food Vending Machines
% 210.47/210.69 |- skos__scopeNote mesh__D005509 Mechanical food dispensing machines.
% 210.47/210.69 |- rdf__type mesh__D005509sskos__Concept
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005509 2000
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D005509 SJN
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005509 2004
% 210.47/210.69 |- skos__broader mesh__D005509smesh__D005511
% 210.47/210.69 |- mesh__recordOriginator mesh__D005509 EC
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D005509
% 210.47/210.69 91; was see under FOOD SERVICES 1977-90
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D005509 2001
% 210.47/210.69 |- skos__hiddenLabel mesh__D005509 Machines, Food Vending
% 210.47/210.69 |- mesh__recordMaintainer mesh__D005509 JLS
% 210.47/210.69 |- mesh__onlineNote mesh__D016231
% 210.47/210.69 use FLUOROIMMUNOASSAY to search POLARIZATION FLUOROIMMUNOASSAY 1989-91%A%
% 210.47/210.69 |- skos__hiddenLabel mesh__D016231 Polarization Immunoassay, Fluorescence
% 210.47/210.69 |- skos__historyNote mesh__D016231
% 210.47/210.69 Fluorescent Antibody Technique %28%1978-1988%29%
% 210.47/210.69 |- mesh__recordOriginator mesh__D016231 AGS
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D016231 2006
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D016231
% 210.47/210.69 91; POLARIZATION FLUOROIMMUNOASSAY was see FLUOROIMMUNOASSAY 1989-91%A%
% 210.47/210.69 |- skos__hiddenLabel mesh__D016231 Immunoassays, Fluorescence Polarization
% 210.47/210.69 |- skos__hiddenLabel mesh__D016231 Fluorescence Polarization Immunoassays
% 210.47/210.69 |- skos__hiddenLabel mesh__D016231 Polarization Fluoroimmunoassays
% 210.47/210.69 |- skos__altLabel mesh__D016231 Polarization Fluoroimmunoassay
% 210.47/210.69 |- mesh__dateRevised mesh__D016231 2004-07-07
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D016231 sjn
% 210.47/210.69 |- skos__annotation mesh__D016231
% 210.47/210.69 NIM; application of fluorescence polarization to hapten-antibody reaction: do not confuse with FLUORESCENCE POLARIZATION, determ of polarization of fluorescent light; DF: FPIA%A%
% 210.47/210.69 |- skos__hiddenLabel mesh__D016231 Polarization Immunoassays, Fluorescence
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D016231 2005
% 210.47/210.69 |- rdf__type mesh__D016231sskos__Concept
% 210.47/210.69 |- skos__broader mesh__D016231smesh__D015200
% 210.47/210.69 |- skos__scopeNote mesh__D016231
% 210.47/210.69 Fluoroimmunoassay where detection of the hapten-antibody reaction is based on measurement of the increased polarization of fluorescence-labeled hapten when it is combined with antibody. The assay is very useful for the measurement of small haptenic antigens such as drugs at low concentrations.%A%
% 210.47/210.69 |- mesh__dateCreated mesh__D016231 1990-05-07
% 210.47/210.69 |- skos__hiddenLabel mesh__D016231 Fluoroimmunoassays, Polarization
% 210.47/210.69 |- skos__hiddenLabel mesh__D016231 Fluoroimmunoassay, Polarization
% 210.47/210.69 |- skos__historyNote mesh__D016231 Fluoroimmunoassay %28%1989-1990%29%
% 210.47/210.69 |- skos__altLabel mesh__D016231 Immunoassay, Fluorescence Polarization
% 210.47/210.69 |- mesh__historyNote mesh__D016231
% 210.47/210.69 91; POLARIZATION FLUOROIMMUNOASSAY was see FLUOROIMMUNOASSAY 1989-91%A%
% 210.47/210.69 |- skos__historyNote mesh__D016231
% 210.47/210.69 Fluorescence Polarization %28%1978-1990%29%
% 210.47/210.69 |- mesh__dateEstablished mesh__D016231 1991-01-01
% 210.47/210.69 |- skos__prefLabel mesh__D016231 Fluorescence Polarization Immunoassay
% 210.47/210.69 |- skos__broader mesh__D016231smesh__D005454
% 210.47/210.69 |- mesh__recordMaintainer mesh__D016231 ssb
% 210.47/210.69 |- mesh__dateRevised mesh__D002211 2005-06-30
% 210.47/210.69 |- skos__altLabel mesh__D002211 Centrum Brand of Capsaicin
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Capsaicin Elan Brand
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Capsaicin Vinas Brand
% 210.47/210.69 |- skos__historyNote mesh__D002211 Amides %28%1966-1974%29%
% 210.47/210.69 |- skos__altLabel mesh__D002211 Carter Horner Brand of Capsaicin
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Farmaya, Capsicum
% 210.47/210.69 |- skos__broader mesh__D002211smesh__D012991
% 210.47/210.69 |- skos__altLabel mesh__D002211 Link Brand of Capsaicin
% 210.47/210.69 |- skos__altLabel mesh__D002211 Zacin
% 210.47/210.69 |- skos__altLabel mesh__D002211 Thompson Brand of Capsaicin
% 210.47/210.69 |- mesh__historyNote mesh__D002211 84%28%75%29%
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Capsaicin Flemming Brand
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Capsaicin Thompson Brand
% 210.47/210.69 |- mesh__dateEstablished mesh__D002211 1984-01-01
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D002211 2006
% 210.47/210.69 |- skos__prefLabel mesh__D002211 Capsaicin
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Antiphlogistine Rub A535 Capsaicin
% 210.47/210.69 |- skos__altLabel mesh__D002211 Medicis Brand of Capsaicin
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Capsaicin Centrum Brand
% 210.47/210.69 |- skos__historyNote mesh__D002211
% 210.47/210.69 Fatty Acids, Unsaturated %28%1973-1974%29%
% 210.47/210.69 |- skos__altLabel mesh__D002211 Flemming Brand of Capsaicin
% 210.47/210.69 |- skos__historyNote mesh__D002211 Capsicum %28%1966-1974%29%
% 210.47/210.69 |- mesh__dateCreated mesh__D002211 1974-11-27
% 210.47/210.69 |- skos__altLabel mesh__D002211 Capsaicine
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Capsaicin Link Brand
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Capsaicin Alacan Brand
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Capsaicin Medicis Brand
% 210.47/210.69 |- skos__scopeNote mesh__D002211
% 210.47/210.69 Cytotoxic alkaloid from various species of Capsicum %28%pepper, paprika%29%, of the Solanaceae.%A%
% 210.47/210.69 |- skos__altLabel mesh__D002211 Smaller Brand of Capsaicin
% 210.47/210.69 |- skos__altLabel mesh__D002211 Vinas Brand of Capsaicin
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D002211
% 210.47/210.69 84; see FATTY ACIDS, UNSATURATED 1975-83
% 210.47/210.69 |- skos__altLabel mesh__D002211 Elan Brand of Capsaicin
% 210.47/210.69 |- skos__altLabel mesh__D002211 Alacan Brand of Capsaicin
% 210.47/210.69 |- mesh__recordMaintainer mesh__D002211 lkw
% 210.47/210.69 |- skos__broader mesh__D002211smesh__D005229
% 210.47/210.69 |- skos__altLabel mesh__D002211 8-Methyl-N-Vanillyl-6-Nonenamide
% 210.47/210.69 |- skos__historyNote mesh__D002211 Catechols %28%1966-1974%29%
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 8 Methyl N Vanillyl 6 Nonenamide
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Capsaicin Smaller Brand
% 210.47/210.69 |- skos__historyNote mesh__D002211 Alkaloids %28%1966-1974%29%
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D002211 sjn
% 210.47/210.69 |- mesh__recordOriginator mesh__D002211 NLM
% 210.47/210.69 |- rdf__type mesh__D002211sskos__Concept
% 210.47/210.69 |- skos__hiddenLabel mesh__D002211 Antiphlogistine Rub A 535 Capsaicin
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 des-Arginine C5 a
% 210.47/210.69 |- skos__altLabel mesh__D015937 C5 a, des-Arg
% 210.47/210.69 |- skos__altLabel mesh__D015937 Complement 5a, des-Arginine
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 C5a, des Arg
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 Complement C5a, des Arginine
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015937 2006
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 C5a des Arginine
% 210.47/210.69 |- mesh__dateEstablished mesh__D015937 1990-01-01
% 210.47/210.69 |- skos__broader mesh__D015937smesh__D015936
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D015937
% 210.47/210.69 2006; see COMPLEMENT 5A, DES-ARGININE 1990-2005
% 210.47/210.69 |- rdf__type mesh__D015937sskos__Concept
% 210.47/210.69 |- skos__altLabel mesh__D015937 C5a des-Arginine
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 des-Arginine Complement 5a
% 210.47/210.69 |- mesh__recordMaintainer mesh__D015937 ssb
% 210.47/210.69 |- skos__historyNote mesh__D015937 Complement 5 %28%1979-1989%29%
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 C5a, des-Arginine Complement
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 C5a, des Arginine
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 de-Arginine Complement 5a
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 des-Arginine, C5a
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 C5 a, des Arg
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 des-Arg C5 a
% 210.47/210.69 |- skos__altLabel mesh__D015937 C5a, des-Arg
% 210.47/210.69 |- skos__altLabel mesh__D015937 Complement 5a, de-Arginine
% 210.47/210.69 |- skos__prefLabel mesh__D015937 Complement C5a, des-Arginine
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D015937 sjn
% 210.47/210.69 |- skos__altLabel mesh__D015937 C5a des-Arg
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 des-Arginine Complement C5a
% 210.47/210.69 |- skos__altLabel mesh__D015937 C5a, des-Arginine
% 210.47/210.69 |- mesh__dateRevised mesh__D015937 2005-06-30
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 des-Arg C5a
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 C5 a, des Arginine
% 210.47/210.69 |- mesh__historyNote mesh__D015937 2006 %28%1990%29%
% 210.47/210.69 |- mesh__dateCreated mesh__D015937 1989-07-14
% 210.47/210.69 |- skos__altLabel mesh__D015937 C5 a, des-Arginine
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 Complement 5a, de Arginine
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 des-Arg, C5a
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 Complement 5a, des Arginine
% 210.47/210.69 |- skos__hiddenLabel mesh__D015937 des-Arginine C5a
% 210.47/210.69 |- mesh__recordOriginator mesh__D015937 AGS
% 210.47/210.69 |- skos__scopeNote mesh__D015937
% 210.47/210.69 A derivative of complement C5a, generated when the carboxy-terminal ARGININE is removed by CARBOXYPEPTIDASE B present in normal human serum. C5a des-Arg shows complete loss of spasmogenic activity though it retains some chemotactic ability %28%CHEMOATTRACTANTS%29%.%A%
% 210.47/210.69 |- skos__historyNote mesh__D015139
% 210.47/210.69 Nucleic Acid Hybridization %28%1980-1988%29%
% 210.47/210.69 |- skos__altLabel mesh__D015139 Southern Blotting
% 210.47/210.69 |- skos__altLabel mesh__D015139 Southern Blot
% 210.47/210.69 |- skos__annotation mesh__D015139
% 210.47/210.69 %22%Southern%22% %28%developed by E.M. Southern%29% is capitalized in titles %26% translations; DF: SOUTHERN BLOT%A%
% 210.47/210.69 |- skos__historyNote mesh__D015139
% 210.47/210.69 Electrophoresis, Agar Gel %28%1979-1988%29%
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015139 2004
% 210.47/210.69 |- skos__prefLabel mesh__D015139 Blotting, Southern
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015139 2006
% 210.47/210.69 |- mesh__dateEstablished mesh__D015139 1989-01-01
% 210.47/210.69 |- mesh__dateCreated mesh__D015139 1988-03-18
% 210.47/210.69 |- skos__historyNote mesh__D015139 DNA or specific %28%1975-1988%29%
% 210.47/210.69 |- skos__scopeNote mesh__D015139
% 210.47/210.69 A method %28%first developed by E.M. Southern%29% for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.%A%
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015139 2003
% 210.47/210.69 |- mesh__dateRevised mesh__D015139 2002-07-02
% 210.47/210.69 |- mesh__historyNote mesh__D015139 89
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D015139 2005
% 210.47/210.69 |- mesh__recordOriginator mesh__D015139 SCD
% 210.47/210.69 |- skos__broader mesh__D015139smesh__D015336
% 210.47/210.69 |- mesh__recordMaintainer mesh__D015139 lkt
% 210.47/210.69 |- mesh__publicMeSHNote mesh__D015139 89
% 210.47/210.69 |- rdf__type mesh__D015139sskos__Concept
% 210.47/210.69 |- skos__historyNote mesh__D015139
% 210.47/210.69 Electrophoresis, Polyacrylamide Gel %28%1980-1988%29%
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D015139 sjn
% 210.47/210.69 |- skos__broader mesh__D015139smesh__D009710
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001917 2002
% 210.47/210.69 |- mesh__dateCreated mesh__D001917 1999-01-01
% 210.47/210.69 |- mesh__recordAuthorizer mesh__D001917 sjn
% 210.47/210.69 |- mesh__recordOriginator mesh__D001917 NLM
% 210.47/210.69 |- mesh__dateRevised mesh__D001917 2001-07-25
% 210.47/210.69 |- skos__hiddenLabel mesh__D001917 Plexus, Brachial
% 210.47/210.69 |- skos__related mesh__D001917smesh__D020516
% 210.47/210.69 |- skos__prefLabel mesh__D001917 Brachial Plexus
% 210.47/210.69 |- mesh__activeMeSHYear mesh__D001917 2003
% 210.47/210.70 |- skos__scopeNote mesh__D001917
% 210.47/210.70 The large network of nerve fibers which distributes the innervation of the upper extremity. The brachial plexus extends from the neck into the axilla. In humans, the nerves of the plexus usually originate from the lower cervical and the first thoracic spinal cord segments %28%C5-C8 and T1%29%, but variations are not uncommon.%A%
% 210.47/210.70 |- rdf__type mesh__D001917sskos__Concept
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D001917 2005
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D001917 2004
% 210.47/210.70 |- skos__broader mesh__D001917smesh__D013127
% 210.47/210.70 |- mesh__recordMaintainer mesh__D001917 ags
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D001917 2006
% 210.47/210.70 |- skos__related mesh__D001917smesh__D013901
% 210.47/210.70 |- skos__annotation mesh__D001917
% 210.47/210.70 dis = BRACHIAL PLEXUS NEUROPATHIES; inflammation = BRACHIAL PLEXUS NEURITIS%A%
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D001119 2006
% 210.47/210.70 |- skos__scopeNote mesh__D001119
% 210.47/210.70 A ureahydrolase that catalyzes the hydrolysis of arginine or canavanine to yield L-ORNITHINE and urea. Deficiency of this enzyme causes HYPERARGININEMIA. EC 3.5.3.1.%A%
% 210.47/210.70 |- rdf__type mesh__D001119sskos__Concept
% 210.47/210.70 |- mesh__recordMaintainer mesh__D001119 ssb
% 210.47/210.70 |- skos__hiddenLabel mesh__D001119 Proliferation Inhibitor, Hepatic
% 210.47/210.70 |- skos__annotation mesh__D001119 /defic: consider also HYPERARGININEMIA
% 210.47/210.70 |- mesh__dateRevised mesh__D001119 2003-07-09
% 210.47/210.70 |- skos__broader mesh__D001119smesh__D014512
% 210.47/210.70 |- skos__hiddenLabel mesh__D001119 Immunoregulatory Protein, Liver
% 210.47/210.70 |- skos__hiddenLabel mesh__D001119 Protein, Liver-Derived Inhibitory
% 210.47/210.70 |- skos__hiddenLabel mesh__D001119
% 210.47/210.70 Liver Derived Lymphocyte Proliferation Inhibiting Protein
% 210.47/210.70 |- skos__hiddenLabel mesh__D001119 Inhibitory Protein, Liver-Derived
% 210.47/210.70 |- skos__altLabel mesh__D001119 Hepatic Proliferation Inhibitor
% 210.47/210.70 |- skos__altLabel mesh__D001119 Liver-Derived Inhibitory Protein
% 210.47/210.70 |- skos__prefLabel mesh__D001119 Arginase
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D001119 2004
% 210.47/210.70 |- mesh__dateCreated mesh__D001119 1999-01-01
% 210.47/210.70 |- skos__hiddenLabel mesh__D001119 Liver Derived Inhibitory Protein
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D001119 2005
% 210.47/210.70 |- mesh__recordOriginator mesh__D001119 NLM
% 210.47/210.70 |- skos__related mesh__D001119smesh__D020162
% 210.47/210.70 |- skos__hiddenLabel mesh__D001119 Inhibitor, Hepatic Proliferation
% 210.47/210.70 |- skos__hiddenLabel mesh__D001119 Protein, Liver Immunoregulatory
% 210.47/210.70 |- skos__altLabel mesh__D001119 Liver Immunoregulatory Protein
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D001119 sjn
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D006602 2006
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D006602 sjn
% 210.47/210.70 |- mesh__dateRevised mesh__D006602 2003-07-09
% 210.47/210.70 |- mesh__historyNote mesh__D006602 72
% 210.47/210.70 |- skos__broader mesh__D006602smesh__D016695
% 210.47/210.70 |- mesh__dateEstablished mesh__D006602 1972-01-01
% 210.47/210.70 |- skos__historyNote mesh__D006602 Transferases %28%1966-1971%29%
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D006602 72
% 210.47/210.70 |- rdf__type mesh__D006602sskos__Concept
% 210.47/210.70 |- skos__scopeNote mesh__D006602
% 210.47/210.70 Enzymes that catalyze the transfer of hexose groups. EC 2.4.1.-.%A%
% 210.47/210.70 |- skos__prefLabel mesh__D006602 Hexosyltransferases
% 210.47/210.70 |- mesh__recordOriginator mesh__D006602 NLM
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D006602 2005
% 210.47/210.70 |- mesh__recordMaintainer mesh__D006602 ssb
% 210.47/210.70 |- mesh__dateCreated mesh__D006602 1999-01-01
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D006602 2004
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D011547 2004
% 210.47/210.70 |- rdf__type mesh__D011547sskos__Concept
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D011547 2005
% 210.47/210.70 |- skos__annotation mesh__D011547
% 210.47/210.70 a metab bone dis; do not confuse with PSEUDOPSEUDOHYPOPARATHYROIDISM%A%
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D011547 2003
% 210.47/210.70 |- skos__scopeNote mesh__D011547
% 210.47/210.70 A hereditary condition clinically resembling HYPOPARATHYROIDISM, but caused by failure of response to rather than deficiency of parathyroid hormones. It is characterized by hypocalcemia and hyperphosphatemia, and is commonly associated with short stature, obesity, short metacarpals, and ectopic calcification. %28%Dorland, 27th ed%29%%A%
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D011547 2002
% 210.47/210.70 |- skos__broader mesh__D011547smesh__D001851
% 210.47/210.70 |- skos__hiddenLabel mesh__D011547 Pseudohypoparathyroidisms
% 210.47/210.70 |- skos__broader mesh__D011547smesh__D008664
% 210.47/210.70 |- skos__broader mesh__D011547smesh__D002128
% 210.47/210.70 |- mesh__recordOriginator mesh__D011547 NLM
% 210.47/210.70 |- skos__prefLabel mesh__D011547 Pseudohypoparathyroidism
% 210.47/210.70 |- mesh__dateCreated mesh__D011547 1999-01-01
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D011547 sjn
% 210.47/210.70 |- mesh__recordMaintainer mesh__D011547 nns
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D011547 65
% 210.47/210.70 |- mesh__historyNote mesh__D011547 65%28%63%29%
% 210.47/210.70 |- mesh__dateEstablished mesh__D011547 1965-01-01
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D011547 2006
% 210.47/210.70 |- mesh__dateRevised mesh__D011547 2001-07-25
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D030701 2004
% 210.47/210.70 |- skos__broader mesh__D030701smesh__D019684
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D030701 2002
% 210.47/210.70 |- skos__prefLabel mesh__D030701 Nyssaceae
% 210.47/210.70 |- mesh__dateEstablished mesh__D030701 2002-01-01
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D030701 2005
% 210.47/210.70 |- mesh__historyNote mesh__D030701 2002
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D030701 2002
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D030701 2006
% 210.47/210.70 |- rdf__type mesh__D030701sskos__Concept
% 210.47/210.70 |- skos__annotation mesh__D030701
% 210.47/210.70 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D030701 2003
% 210.47/210.70 |- skos__scopeNote mesh__D030701
% 210.47/210.70 A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida. Some botanical classifications do not recognize this family and place the members in CORNACEAE.%A%
% 210.47/210.70 |- mesh__dateCreated mesh__D030701 2001-07-25
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016232 2005
% 210.47/210.70 |- skos__scopeNote mesh__D016232
% 210.47/210.70 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides.%A%
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016232 2004
% 210.47/210.70 |- skos__altLabel mesh__D016232 Endothelium-Derived Vasoconstrictor Factors
% 210.47/210.70 |- mesh__recordMaintainer mesh__D016232 jmp
% 210.47/210.70 |- mesh__historyNote mesh__D016232 91
% 210.47/210.70 |- rdf__type mesh__D016232sskos__Concept
% 210.47/210.70 |- skos__historyNote mesh__D016232 Peptides %28%1966-1990%29%
% 210.47/210.70 |- skos__altLabel mesh__D016232 Endothelin
% 210.47/210.70 |- mesh__recordOriginator mesh__D016232 RLS
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D016232 91
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D016232 sjn
% 210.47/210.70 |- mesh__dateCreated mesh__D016232 1990-06-28
% 210.47/210.70 |- skos__annotation mesh__D016232
% 210.47/210.70 GEN or unspecified; prefer specifics; /drug eff permitted%A%
% 210.47/210.70 |- skos__hiddenLabel mesh__D016232
% 210.47/210.70 Vasoconstrictor Factors, Endothelium-Derived
% 210.47/210.70 |- mesh__dateEstablished mesh__D016232 1991-01-01
% 210.47/210.70 |- skos__related mesh__D016232smesh__D017466
% 210.47/210.70 |- skos__prefLabel mesh__D016232 Endothelins
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016232 2006
% 210.47/210.70 |- mesh__dateRevised mesh__D016232 2003-07-09
% 210.47/210.70 |- skos__broader mesh__D016232smesh__D036341
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Peppers, Chili
% 210.47/210.70 |- mesh__historyNote mesh__D002212
% 210.47/210.70 91%28%86%29%63; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85%A%
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Pepper, Chili
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Bell Peppers
% 210.47/210.70 |- skos__altLabel mesh__D002212 Green Pepper
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Chili Peppers
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Pepper, Jalapeno
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Peppers, Bell
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D002212 2003
% 210.47/210.70 |- skos__prefLabel mesh__D002212 Capsicum
% 210.47/210.70 |- mesh__dateRevised mesh__D002212 2002-07-02
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Pepper, Bell
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Peppers, Red
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Cayenne Peppers
% 210.47/210.70 |- skos__altLabel mesh__D002212 Chili Pepper
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D002212 2004
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Pepper, Red
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Green Peppers
% 210.47/210.70 |- skos__broader mesh__D002212smesh__D019657
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Peppers, Jalapeno
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Peppers, Chilli
% 210.47/210.70 |- skos__scopeNote mesh__D002212
% 210.47/210.70 A plant genus of the family SOLANACEAE. The hot peppers yield CAPSAICIN, which activates vanilloid receptors. Several varieties have sweet or pungent edible fruits that are used as vegetables when fresh and spices when the pods are dried.%A%
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D002212
% 210.47/210.70 91,63-85; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85%A%
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Chilli Peppers
% 210.47/210.70 |- mesh__dateEstablished mesh__D002212 1991-01-01
% 210.47/210.70 |- rdf__type mesh__D002212sskos__Concept
% 210.47/210.70 |- mesh__recordMaintainer mesh__D002212 ssb
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Peppers, Cayenne
% 210.47/210.70 |- mesh__dateCreated mesh__D002212 1999-01-01
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Pepper, Chilli
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Peppers, Green
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Pepper, Cayenne
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Jalapeno Peppers
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D002212 2005
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D002212 sjn
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Red Peppers
% 210.47/210.70 |- mesh__recordOriginator mesh__D002212 NLM
% 210.47/210.70 |- skos__broader mesh__D002212smesh__D014675
% 210.47/210.70 |- skos__altLabel mesh__D002212 Red Pepper
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D002212 2006
% 210.47/210.70 |- skos__hiddenLabel mesh__D002212 Pepper, Green
% 210.47/210.70 |- skos__annotation mesh__D002212
% 210.47/210.70 Tabasco goes here; BLACK PEPPER is available as a spice; black pepper as a plant use PIPER NIGRUM; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.47/210.70 |- skos__hiddenLabel mesh__D015938 Complement Complex, Terminal
% 210.47/210.70 |- rdf__type mesh__D015938sskos__Concept
% 210.47/210.70 |- skos__altLabel mesh__D015938 C 5b-9
% 210.47/210.70 |- mesh__historyNote mesh__D015938 90
% 210.47/210.70 |- mesh__dateCreated mesh__D015938 1989-05-25
% 210.47/210.70 |- skos__altLabel mesh__D015938 Cytolytic Terminal Complement Complex
% 210.47/210.70 |- skos__historyNote mesh__D015938 Complement %28%1973-1989%29%
% 210.47/210.70 |- skos__hiddenLabel mesh__D015938 Complex, Terminal Complement
% 210.47/210.70 |- skos__annotation mesh__D015938 DF: COMPLEMENT MAC
% 210.47/210.70 |- skos__hiddenLabel mesh__D015938 C5b 8 poly C9
% 210.47/210.70 |- mesh__dateEstablished mesh__D015938 1990-01-01
% 210.47/210.70 |- skos__altLabel mesh__D015938 Membrane Attack Complex
% 210.47/210.70 |- skos__altLabel mesh__D015938 Terminal Complement Complex
% 210.47/210.70 |- skos__prefLabel mesh__D015938 Complement Membrane Attack Complex
% 210.47/210.70 |- mesh__dateRevised mesh__D015938 2005-06-30
% 210.47/210.70 |- skos__scopeNote mesh__D015938
% 210.47/210.70 A product of COMPLEMENT ACTIVATION cascade, regardless of the pathways, that forms transmembrane channels causing disruption of the target CELL MEMBRANE and cell lysis. It is formed by the sequential assembly of terminal complement components %28%COMPLEMENT C5B; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; and COMPLEMENT C9%29% into the target membrane. The resultant C5b-8-poly-C9 is the %22%membrane attack complex%22% or MAC.%A%
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D015938 90
% 210.47/210.70 |- skos__altLabel mesh__D015938 C5b-8-poly-C9
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D015938 2006
% 210.47/210.70 |- skos__altLabel mesh__D015938 C5b-9
% 210.47/210.70 |- mesh__recordMaintainer mesh__D015938 lkt
% 210.47/210.70 |- mesh__recordOriginator mesh__D015938 AGS
% 210.47/210.70 |- skos__hiddenLabel mesh__D015938 Complement Complex C5b 9
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D015938 sjn
% 210.47/210.70 |- skos__broader mesh__D015938smesh__D003165
% 210.47/210.70 |- skos__altLabel mesh__D015938 Complement Complex C5b-9
% 210.47/210.70 |- skos__altLabel mesh__D001918 Radiotherapy, Surface
% 210.47/210.70 |- mesh__dateRevised mesh__D001918 2005-06-30
% 210.47/210.70 |- skos__altLabel mesh__D001918 Brachytherapy, Radioisotope
% 210.47/210.70 |- skos__annotation mesh__D001918 a type of radiother
% 210.47/210.70 |- rdf__type mesh__D001918sskos__Concept
% 210.47/210.70 |- skos__historyNote mesh__D001918
% 210.47/210.70 specific radioisotope/administration %26% dosage/therapeutic use %28%1966-1979%29%
% 210.47/210.70 |- skos__altLabel mesh__D001918 Curietherapy
% 210.47/210.70 |- skos__scopeNote mesh__D001918
% 210.47/210.70 A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.%A%
% 210.47/210.70 |- skos__altLabel mesh__D001918 Intracavity Radiotherapy
% 210.47/210.70 |- mesh__recordOriginator mesh__D001918 SMH
% 210.47/210.70 |- skos__altLabel mesh__D001918 Implant Radiotherapy
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D001918 2006
% 210.47/210.70 |- skos__prefLabel mesh__D001918 Brachytherapy
% 210.47/210.70 |- skos__historyNote mesh__D001918 Neoplasms/radiotherapy %28%1966-1979%29%
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D001918 sjn
% 210.47/210.70 |- skos__historyNote mesh__D001918
% 210.47/210.70 specific neoplasm/radiotherapy %28%1966-1979%29%
% 210.47/210.70 |- skos__historyNote mesh__D001918
% 210.47/210.70 Radioisotopes/administration %26% dosage/therapeutic use %28%1966-1979%29%
% 210.47/210.70 |- skos__altLabel mesh__D001918 Radioisotope Plaque Therapy
% 210.47/210.70 |- skos__altLabel mesh__D001918 Radioisotope Brachytherapy
% 210.47/210.70 |- mesh__historyNote mesh__D001918 80
% 210.47/210.70 |- mesh__dateEstablished mesh__D001918 1980-01-01
% 210.47/210.70 |- skos__broader mesh__D001918smesh__D011878
% 210.47/210.70 |- skos__hiddenLabel mesh__D001918 Therapy, Radioisotope Plaque
% 210.47/210.70 |- mesh__recordMaintainer mesh__D001918 lkt
% 210.47/210.70 |- skos__altLabel mesh__D001918 Radiotherapy, Implant
% 210.47/210.70 |- skos__altLabel mesh__D001918 Interstitial Radiotherapy
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D001918 80
% 210.47/210.70 |- skos__historyNote mesh__D001918 Radiotherapy %28%1966-1979%29%
% 210.47/210.70 |- mesh__dateCreated mesh__D001918 1979-03-07
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D012640 2006
% 210.47/210.70 |- skos__historyNote mesh__D012640 Convulsions %28%1966-1978%29%
% 210.47/210.70 |- skos__broader mesh__D012640smesh__D004827
% 210.47/210.70 |- skos__altLabel mesh__D012640 Seizures, Convulsive
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Clonic
% 210.47/210.70 |- mesh__dateEstablished mesh__D012640 1979-01-01
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Motor Seizure
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Gustatory Seizure
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Vestibular Seizure
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Convulsion
% 210.47/210.70 |- skos__related mesh__D012640smesh__D003292
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Tonic-Clonic
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Vertiginous Seizure
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Visual
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Tonic
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Sensory Seizures
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Generalized Seizure
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Somatosensory
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D012640 sjn
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Vestibular Seizures
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Visual Seizures
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Clonic Seizure
% 210.47/210.70 |- skos__related mesh__D012640smesh__D000927
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Non-Epileptic Convulsions
% 210.47/210.70 |- rdf__type mesh__D012640sskos__Concept
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Sensory
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Sensory Seizure
% 210.47/210.70 |- skos__historyNote mesh__D012640 Epilepsy %28%1966-1978%29%
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Visual Seizure
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Motor Seizures
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Olfactory
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Tonic Seizure
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Jacksonian
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Generalized Seizures
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Clonic Seizures
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Vestibular
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D012640
% 210.47/210.70 1979; for CONVULSIVE SEIZURES %26% SEIZURES, CONVULSIVE see CONVULSIONS 1998-1999; for JACKSONIAN SEIZURE see EPILEPSY, PARTIAL 1992-1999; for CONVULSIONS see CONVULSIONS 1963-2004; for CONVULSION, NON-EPILEPTIC see CONVULSIONS 2000-2004%A%
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Auditory Seizures
% 210.47/210.70 |- skos__annotation mesh__D012640
% 210.47/210.70 note other specific seizure terms in MeSH; audiogenic or acoustic seizures = REFLEX EPILEPSY, AUDIOGENIC%A%
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Convulsion, Non Epileptic
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Tonic Seizures
% 210.47/210.70 |- skos__related mesh__D012640smesh__D004461
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Convulsive
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Tonic-Clonic Seizure
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizures, Tonic Clonic
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Auditory Seizure
% 210.47/210.70 |- mesh__historyNote mesh__D012640
% 210.47/210.70 1979; for CONVULSIVE SEIZURES %26% SEIZURES, CONVULSIVE use CONVULSIONS 1998-1999; for JACKSONIAN SEIZURE use EPILEPSY, PARTIAL 1992-1999%A%
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Focal Seizure
% 210.47/210.70 |- skos__related mesh__D012640smesh__D004827
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure
% 210.47/210.70 |- mesh__recordMaintainer mesh__D012640 lkt
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Somatosensory Seizures
% 210.47/210.70 |- mesh__recordOriginator mesh__D012640 RC
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Gustatory
% 210.47/210.70 |- skos__broader mesh__D012640smesh__D009461
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Somatosensory Seizure
% 210.47/210.70 |- skos__altLabel mesh__D012640 Seizures, Motor
% 210.47/210.70 |- skos__altLabel mesh__D012640 Seizures, Vestibular
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Tonic-Clonic Seizures
% 210.47/210.70 |- skos__historyNote mesh__D012640
% 210.47/210.70 specific epilepsy heading %28%1966-1978%29%
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Non-Epileptic Convulsion
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Vertiginous
% 210.47/210.70 |- mesh__dateRevised mesh__D012640 2004-07-07
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Olfactory Seizures
% 210.47/210.70 |- mesh__dateCreated mesh__D012640 1978-05-17
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Convulsions, Non-Epileptic
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Olfactory Seizure
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D012640 2005
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Vertiginous Seizures
% 210.47/210.70 |- skos__scopeNote mesh__D012640
% 210.47/210.70 Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or %22%seizure disorder.%22%%A%
% 210.47/210.70 |- skos__prefLabel mesh__D012640 Seizures
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Auditory
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Motor
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Convulsive Seizure
% 210.47/210.70 |- skos__related mesh__D012640smesh__D007696
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Focal Seizures
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Gustatory Seizures
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Generalized
% 210.47/210.70 |- skos__hiddenLabel mesh__D012640 Seizure, Focal
% 210.47/210.70 |- mesh__recordOriginator mesh__D006603 NLM
% 210.47/210.70 |- skos__hiddenLabel mesh__D006603 Acids, Hexouronic
% 210.47/210.70 |- mesh__recordMaintainer mesh__D006603 ssb
% 210.47/210.70 |- skos__altLabel mesh__D006603 Hexouronic Acids
% 210.47/210.70 |- mesh__historyNote mesh__D006603
% 210.47/210.70 91%28%75%29%; was see under URONIC ACIDS 1975-90
% 210.47/210.70 |- skos__scopeNote mesh__D006603
% 210.47/210.70 Term used to designate tetrahydroxy aldehydic acids obtained by oxidation of hexose sugars, i.e. glucuronic acid, galacturonic acid, etc. Historically, the name hexuronic acid was originally given to ascorbic acid.%A%
% 210.47/210.70 |- mesh__dateCreated mesh__D006603 1974-11-19
% 210.47/210.70 |- skos__historyNote mesh__D006603 Uronic Acids %28%1971-1974%29%
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D006603 sjn
% 210.47/210.70 |- skos__broader mesh__D006603smesh__D014574
% 210.47/210.70 |- skos__prefLabel mesh__D006603 Hexuronic Acids
% 210.47/210.70 |- mesh__dateEstablished mesh__D006603 1991-01-01
% 210.47/210.70 |- rdf__type mesh__D006603sskos__Concept
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D006603 2005
% 210.47/210.70 |- skos__hiddenLabel mesh__D006603 Acids, Hexuronic
% 210.47/210.70 |- mesh__dateRevised mesh__D006603 2004-07-07
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D006603 2006
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D006603
% 210.47/210.70 91; was see under URONIC ACIDS 1975-90
% 210.47/210.70 |- mesh__recordOriginator mesh__D044722 ags
% 210.47/210.70 |- mesh__dateRevised mesh__D044722 2005-06-30
% 210.47/210.70 |- mesh__historyNote mesh__D044722 2004
% 210.47/210.70 |- rdf__type mesh__D044722sskos__Concept
% 210.47/210.70 |- skos__historyNote mesh__D044722 Algae, Red %28%1973-2003%29%
% 210.47/210.70 |- skos__prefLabel mesh__D044722 Laurencia
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D044722 2006
% 210.47/210.70 |- skos__scopeNote mesh__D044722
% 210.47/210.70 A genus of RED ALGAE in the family Rhodomelaceae. Some species are a rich source of chlorine-and bromine-containing metabolites which show significant antibacterial activity.%A%
% 210.47/210.70 |- mesh__dateCreated mesh__D044722 2003-07-09
% 210.47/210.70 |- mesh__recordMaintainer mesh__D044722 SYSTEM
% 210.47/210.70 |- mesh__dateEstablished mesh__D044722 2004-01-01
% 210.47/210.70 |- skos__broader mesh__D044722smesh__D000461
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D044722 2004
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D044722 sjn
% 210.47/210.70 |- mesh__dateEstablished mesh__D011548 1975-01-01
% 210.47/210.70 |- skos__broader mesh__D011548smesh__D020563
% 210.47/210.70 |- skos__historyNote mesh__D011548 Bacteria %28%1966-1974%29%
% 210.47/210.70 |- mesh__dateCreated mesh__D011548 1999-01-01
% 210.47/210.70 |- skos__prefLabel mesh__D011548 Pseudomonadaceae
% 210.47/210.70 |- mesh__dateRevised mesh__D011548 2005-06-30
% 210.47/210.70 |- mesh__recordOriginator mesh__D011548 NLM
% 210.47/210.70 |- mesh__recordMaintainer mesh__D011548 SYSTEM
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D011548 2006
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D011548 sjn
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D011548 75
% 210.47/210.70 |- skos__broader mesh__D011548smesh__D016946
% 210.47/210.70 |- rdf__type mesh__D011548sskos__Concept
% 210.47/210.70 |- skos__scopeNote mesh__D011548
% 210.47/210.70 A family of gram-negative bacteria usually found in soil or water and including many plant pathogens and a few animal pathogens.%A%
% 210.47/210.70 |- mesh__historyNote mesh__D011548 75
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D030702 sjn
% 210.47/210.70 |- mesh__dateRevised mesh__D030702 2002-07-03
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D030702 2005
% 210.47/210.70 |- mesh__dateCreated mesh__D030702 2001-07-25
% 210.47/210.70 |- mesh__dateEstablished mesh__D030702 2002-01-01
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D030702 2002
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D030702 2006
% 210.47/210.70 |- skos__broader mesh__D030702smesh__D019684
% 210.47/210.70 |- skos__scopeNote mesh__D030702
% 210.47/210.70 The sour gum plant family of the order Nymphaeales, subclass Magnoliidae, class Magnoliopsida. All have horizontal or hanging branches and broad alternate leaves, and they are dioecious %28%male and female flowers on different plants%29%.%A%
% 210.47/210.70 |- rdf__type mesh__D030702sskos__Concept
% 210.47/210.70 |- skos__prefLabel mesh__D030702 Nymphaeaceae
% 210.47/210.70 |- mesh__recordOriginator mesh__D030702 ssb
% 210.47/210.70 |- mesh__historyNote mesh__D030702 2002
% 210.47/210.70 |- skos__annotation mesh__D030702
% 210.47/210.70 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D030702 2003
% 210.47/210.70 |- mesh__recordMaintainer mesh__D030702 ssb
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D030702 2004
% 210.47/210.70 |- skos__hiddenLabel mesh__D016233 Active Immunotherapies
% 210.47/210.70 |- skos__altLabel mesh__D016233 Active Immunotherapy
% 210.47/210.70 |- skos__prefLabel mesh__D016233 Immunotherapy, Active
% 210.47/210.70 |- skos__broader mesh__D016233smesh__D007114
% 210.47/210.70 |- mesh__onlineNote mesh__D016233
% 210.47/210.70 use IMMUNIZATION, PASSIVE to search IMMUNE RNA MANIPULATION 1983-96; use IMMUNOTHERAPY to search VACCINE THERAPY 1990%A%
% 210.47/210.70 |- skos__hiddenLabel mesh__D016233 Vaccine Therapies
% 210.47/210.70 |- skos__hiddenLabel mesh__D016233 RNA Manipulation, Immune
% 210.47/210.70 |- skos__hiddenLabel mesh__D016233 Immune RNA Manipulations
% 210.47/210.70 |- skos__hiddenLabel mesh__D016233 Manipulation, Immune RNA
% 210.47/210.70 |- skos__altLabel mesh__D016233 Therapy, Vaccine
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 2002
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 1999
% 210.47/210.70 |- mesh__dateRevised mesh__D016233 1996-06-10
% 210.47/210.70 |- skos__scopeNote mesh__D016233
% 210.47/210.70 Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system.%A%
% 210.47/210.70 |- mesh__dateEstablished mesh__D016233 1991-01-01
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 2006
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D016233 PLS
% 210.47/210.70 |- skos__historyNote mesh__D016233 Immunotherapy %28%1967-1990%29%
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 1998
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 1997
% 210.47/210.70 |- mesh__recordOriginator mesh__D016233 AGS
% 210.47/210.70 |- skos__hiddenLabel mesh__D016233 Manipulations, Immune RNA
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 2005
% 210.47/210.70 |- skos__hiddenLabel mesh__D016233 Immunotherapies, Active
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 2004
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 2001
% 210.47/210.70 |- rdf__type mesh__D016233sskos__Concept
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 2003
% 210.47/210.70 |- skos__annotation mesh__D016233
% 210.47/210.70 IM; do not use /util except by MeSH definition
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D016233
% 210.47/210.70 91; IMMUNE RNA MANIPULATION was see IMMUNIZATION, PASSIVE 1983-96; VACCINE THERAPY was see IMMUNOTHERAPY 1990, was heading 1963-82%A%
% 210.47/210.70 |- mesh__dateCreated mesh__D016233 1990-05-07
% 210.47/210.70 |- skos__hiddenLabel mesh__D016233 Therapies, Vaccine
% 210.47/210.70 |- mesh__historyNote mesh__D016233
% 210.47/210.70 91; IMMUNE RNA MANIPULATION was see IMMUNIZATION, PASSIVE 1983-96; VACCINE THERAPY was see IMMUNOTHERAPY 1990, was heading 1963-82%A%
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D016233 2000
% 210.47/210.70 |- skos__hiddenLabel mesh__D016233 RNA Manipulations, Immune
% 210.47/210.70 |- mesh__recordMaintainer mesh__D016233 AGS
% 210.47/210.70 |- skos__annotation mesh__D002213 CAPSID PROTEINS is also available
% 210.47/210.70 |- mesh__recordMaintainer mesh__D002213 jmp
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D002213 2003
% 210.47/210.70 |- mesh__recordAuthorizer mesh__D002213 sjn
% 210.47/210.70 |- mesh__recordOriginator mesh__D002213 NLM
% 210.47/210.70 |- mesh__dateEstablished mesh__D002213 1984-01-01
% 210.47/210.70 |- mesh__dateRevised mesh__D002213 2002-07-03
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D002213 2006
% 210.47/210.70 |- skos__hiddenLabel mesh__D002213 Capsids
% 210.47/210.70 |- skos__prefLabel mesh__D002213 Capsid
% 210.47/210.70 |- mesh__historyNote mesh__D002213
% 210.47/210.70 84%28%75%29%; was see under VIRAL PROTEINS 1975-83
% 210.47/210.70 |- mesh__publicMeSHNote mesh__D002213
% 210.47/210.70 84; was see under VIRAL PROTEINS 1975-83
% 210.47/210.70 |- skos__historyNote mesh__D002213 Viral Proteins %28%1968-1974%29%
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D002213 2005
% 210.47/210.70 |- skos__scopeNote mesh__D002213
% 210.47/210.70 The outer protein protective shell of a virus, which protects the viral nucleic acid.%A%
% 210.47/210.70 |- mesh__dateCreated mesh__D002213 1974-11-11
% 210.47/210.70 |- rdf__type mesh__D002213sskos__Concept
% 210.47/210.70 |- skos__broader mesh__D002213smesh__D019251
% 210.47/210.70 |- mesh__activeMeSHYear mesh__D002213 2004
% 210.47/210.70 |- mesh__recordOriginator mesh__D015939 RLS
% 210.47/210.71 |- skos__historyNote mesh__D015939 Leucomycins %28%1981-1989%29%
% 210.47/210.71 |- skos__scopeNote mesh__D015939
% 210.47/210.71 A macrolide antibiotic produced by Streptomyces kitasatoensis. The drug has antimicrobial activity against a wide spectrum of pathogens.%A%
% 210.47/210.71 |- mesh__historyNote mesh__D015939
% 210.47/210.71 90; was KITASAMYCINS see under ANTIBIOTICS 1976-80; was see LEUCOMYCINS 1981-89%A%
% 210.47/210.71 |- mesh__activeMeSHYear mesh__D015939 2005
% 210.47/210.71 |- skos__broader mesh__D015939smesh__D007933
% 210.47/210.71 |- rdf__type mesh__D015939sskos__Concept
% 210.47/210.71 |- mesh__recordAuthorizer mesh__D015939 sjn
% 210.47/210.71 |- mesh__dateEstablished mesh__D015939 1990-01-01
% 210.47/210.71 |- mesh__publicMeSHNote mesh__D015939
% 210.47/210.71 90; was KITASAMYCINS see under ANTIBIOTICS 1976-80; was see LEUCOMYCINS 1981-89%A%
% 210.47/210.71 |- mesh__onlineNote mesh__D015939
% 210.47/210.71 use KITASAMYCINS to search KITASAMICIN 1976-80; use LEUCOMYCINS 1981-89%A%
% 210.47/210.71 |- mesh__dateCreated mesh__D015939 1989-05-25
% 210.47/210.71 |- skos__historyNote mesh__D015939 Antibiotics %28%1970-1975%29%
% 210.47/210.71 |- skos__annotation mesh__D015939
% 210.47/210.71 do not use /biosyn unless by living matter; do not confuse X ref LEUCOMYCIN see KITASAMYCIN with LEUCOMYCINS%A%
% 210.47/210.71 |- mesh__recordMaintainer mesh__D015939 ssb
% 210.47/210.71 |- skos__altLabel mesh__D015939 Leucomycin
% 210.47/210.71 |- mesh__activeMeSHYear mesh__D015939 2006
% 210.47/210.71 |- skos__prefLabel mesh__D015939 Kitasamycin
% 210.47/210.71 |- skos__historyNote mesh__D015939 Kitasamycins %28%1976-1980%29%
% 210.47/210.71 |- mesh__dateRevised mesh__D015939 2004-07-07
% 210.47/210.71 |- skos__hiddenLabel mesh__D026661 Safety Monitoring Board
% 210.47/210.71 |- skos__scopeNote mesh__D026661
% 210.47/210.71 Committees established to review interim data and efficacy outcomes in CLINICAL TRIALS. The findings of these committees are used in deciding whether a trial should be continued as designed, changed, or terminated. Government regulations regarding federally-funded research involving human subjects %28%the %22%Common Rule%22%%29% require %28%45 CFR 46.111%29% that research ethics committees reviewing large-scale clinical trials monitor the data collected using a mechanism such as a data monitoring committee. FDA regulations %28%21 CFR 50.24%29% require that such committees be established to monitor studies conducted in emergency settings.%A%
% 210.47/210.71 |- skos__related mesh__D026661smesh__D012107
% 210.47/210.71 |- skos__historyNote mesh__D026661
% 210.47/210.71 Professional Staff Committees %28%1991-2001%29%
% 210.47/210.71 |- mesh__publicMeSHNote mesh__D026661 2002
% 210.47/210.71 |- skos__hiddenLabel mesh__D026661 Committee, Data Monitoring
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D026661 2006
% 210.56/210.71 |- mesh__dateEstablished mesh__D026661 2002-01-01
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D026661 2005
% 210.56/210.71 |- skos__hiddenLabel mesh__D026661 Monitoring Committee, Data
% 210.56/210.71 |- mesh__recordOriginator mesh__D026661 hjn
% 210.56/210.71 |- mesh__dateRevised mesh__D026661 2004-07-13
% 210.56/210.71 |- skos__broader mesh__D026661smesh__D011367
% 210.56/210.71 |- skos__altLabel mesh__D026661 Safety Monitoring Boards
% 210.56/210.71 |- mesh__dateCreated mesh__D026661 2001-07-25
% 210.56/210.71 |- mesh__recordMaintainer mesh__D026661 sjn
% 210.56/210.71 |- skos__hiddenLabel mesh__D026661 Monitoring Committees, Data
% 210.56/210.71 |- skos__hiddenLabel mesh__D026661 Monitoring Boards, Safety
% 210.56/210.71 |- skos__hiddenLabel mesh__D026661 Monitoring Board, Safety
% 210.56/210.71 |- skos__hiddenLabel mesh__D026661 Data Monitoring Committee
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D026661 sjn
% 210.56/210.71 |- skos__altLabel mesh__D026661 Data and Safety Monitoring Boards
% 210.56/210.71 |- skos__altLabel mesh__D026661 Data Monitoring Committees
% 210.56/210.71 |- skos__historyNote mesh__D026661 Clinical Trials %28%1991-2001%29%
% 210.56/210.71 |- skos__hiddenLabel mesh__D026661 Boards, Safety Monitoring
% 210.56/210.71 |- skos__hiddenLabel mesh__D026661 Board, Safety Monitoring
% 210.56/210.71 |- rdf__type mesh__D026661sskos__Concept
% 210.56/210.71 |- skos__related mesh__D026661smesh__D002986
% 210.56/210.71 |- mesh__historyNote mesh__D026661 2002
% 210.56/210.71 |- skos__prefLabel mesh__D026661 Clinical Trials Data Monitoring Committees
% 210.56/210.71 |- skos__related mesh__D026661smesh__D028744
% 210.56/210.71 |- skos__hiddenLabel mesh__D026661 Committees, Data Monitoring
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D001919 2005
% 210.56/210.71 |- skos__prefLabel mesh__D001919 Bradycardia
% 210.56/210.71 |- skos__hiddenLabel mesh__D001919 Bradyarrhythmias
% 210.56/210.71 |- skos__scopeNote mesh__D001919
% 210.56/210.71 Excessive slowness in the action of the heart, usually with a heart rate below 60 beats per minute.%A%
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D001919 2004
% 210.56/210.71 |- skos__broader mesh__D001919smesh__D001145
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D001919 2001
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D001919 2006
% 210.56/210.71 |- skos__hiddenLabel mesh__D001919 Bradycardias
% 210.56/210.71 |- mesh__dateCreated mesh__D001919 1999-01-01
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D001919 2002
% 210.56/210.71 |- mesh__dateRevised mesh__D001919 1999-11-08
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D001919 sjn
% 210.56/210.71 |- mesh__recordMaintainer mesh__D001919 adp
% 210.56/210.71 |- skos__annotation mesh__D001919 TN 99: BRADYCARDIA vs HEART RATE
% 210.56/210.71 |- mesh__recordOriginator mesh__D001919 NLM
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D001919 2003
% 210.56/210.71 |- rdf__type mesh__D001919sskos__Concept
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D001919 2000
% 210.56/210.71 |- skos__scopeNote mesh__D012641
% 210.56/210.71 Differential and non-random reproduction of different genotypes, operating to alter the gene frequencies within a population.%A%
% 210.56/210.71 |- mesh__dateRevised mesh__D012641 2002-07-03
% 210.56/210.71 |- mesh__onlineNote mesh__D012641
% 210.56/210.71 use EVOLUTION %26% SELECTION %28%GENETICS%29% to search NATURAL SELECTION 1978%A%
% 210.56/210.71 |- mesh__recordOriginator mesh__D012641 NLM
% 210.56/210.71 |- skos__historyNote mesh__D012641 Genetics %28%1966-1967%29%
% 210.56/210.71 |- skos__broader mesh__D012641smesh__D039361
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D012641 2004
% 210.56/210.71 |- mesh__dateEstablished mesh__D012641 1968-01-01
% 210.56/210.71 |- skos__prefLabel mesh__D012641 Selection %28%Genetics%29%
% 210.56/210.71 |- rdf__type mesh__D012641sskos__Concept
% 210.56/210.71 |- skos__hiddenLabel mesh__D012641 Selections %28%Genetics%29%
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D012641 2003
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D012641
% 210.56/210.71 68; NATURAL SELECTION was indexed under EVOLUTION 1978
% 210.56/210.71 |- mesh__dateCreated mesh__D012641 1999-01-01
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D012641 sjn
% 210.56/210.71 |- skos__hiddenLabel mesh__D012641 Selections, Natural
% 210.56/210.71 |- mesh__historyNote mesh__D012641
% 210.56/210.71 68; NATURAL SELECTION was indexed under EVOLUTION 1978
% 210.56/210.71 |- skos__annotation mesh__D012641 DF: SELECTION
% 210.56/210.71 |- skos__hiddenLabel mesh__D012641 Natural Selections
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D012641 2006
% 210.56/210.71 |- skos__hiddenLabel mesh__D012641 Selection, Natural
% 210.56/210.71 |- mesh__recordMaintainer mesh__D012641 KEV
% 210.56/210.71 |- skos__historyNote mesh__D012641 Genetics, Population %28%1966-1967%29%
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D012641 2005
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006604 2006
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D006604 sjn
% 210.56/210.71 |- skos__prefLabel mesh__D006604 Hexylresorcinol
% 210.56/210.71 |- mesh__dateRevised mesh__D006604 2000-06-22
% 210.56/210.71 |- rdf__type mesh__D006604sskos__Concept
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006604 2002
% 210.56/210.71 |- skos__scopeNote mesh__D006604
% 210.56/210.71 A substituted dihydroxybenzene that is used topically as an antiseptic for the treatment of minor skin infections.%A%
% 210.56/210.71 |- mesh__dateCreated mesh__D006604 1999-01-01
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006604 2003
% 210.56/210.71 |- mesh__recordMaintainer mesh__D006604 CCR
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006604 2005
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006604 2004
% 210.56/210.71 |- mesh__recordOriginator mesh__D006604 NLM
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006604 2001
% 210.56/210.71 |- skos__broader mesh__D006604smesh__D012118
% 210.56/210.71 |- mesh__dateEstablished mesh__D050760 2006-01-01
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D050760 2006
% 210.56/210.71 |- skos__altLabel mesh__D050760 p27Kip1 Protein
% 210.56/210.71 |- skos__altLabel mesh__D050760 CDK Inhibitor p27
% 210.56/210.71 |- mesh__dateCreated mesh__D050760 2005-06-30
% 210.56/210.71 |- skos__altLabel mesh__D050760 p27 CDK Inhibitor
% 210.56/210.71 |- rdf__type mesh__D050760sskos__Concept
% 210.56/210.71 |- skos__altLabel mesh__D050760 Cyclin-Dependent Kinase Inhibitor 1B
% 210.56/210.71 |- skos__hiddenLabel mesh__D050760 CDK Inhibitor, p27
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D050760 ags
% 210.56/210.71 |- mesh__dateRevised mesh__D050760 2005-07-12
% 210.56/210.71 |- skos__scopeNote mesh__D050760
% 210.56/210.71 A cyclin-dependent kinase inhibitor that coordinates the activation of CYCLIN and CYCLIN-DEPENDENT KINASES during the CELL CYCLE. It interacts with active CYCLIN D complexed to CYCLIN-DEPENDENT KINASE 4 in proliferating cells, while in arrested cells it binds and inhibits CYCLIN E complexed to CYCLIN-DEPENDENT KINASE 2.%A%
% 210.56/210.71 |- skos__hiddenLabel mesh__D050760 Kip1 Protein, p27
% 210.56/210.71 |- mesh__recordMaintainer mesh__D050760 ags
% 210.56/210.71 |- skos__altLabel mesh__D050760 CDKN1B Protein
% 210.56/210.71 |- skos__altLabel mesh__D050760 CDKN4 Protein
% 210.56/210.71 |- mesh__historyNote mesh__D050760 2006%28%1992%29%
% 210.56/210.71 |- skos__hiddenLabel mesh__D050760 p27, CDK Inhibitor
% 210.56/210.71 |- skos__hiddenLabel mesh__D050760 Cyclin Dependent Kinase Inhibitor 1B
% 210.56/210.71 |- skos__altLabel mesh__D050760 p27 Kip1 Protein
% 210.56/210.71 |- skos__prefLabel mesh__D050760 Cyclin-Dependent Kinase Inhibitor p27
% 210.56/210.71 |- skos__hiddenLabel mesh__D050760 Cyclin Dependent Kinase Inhibitor p27
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D050760 2006A
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D050760
% 210.56/210.71 2006; CYCLIN-DEPENDENT KINASE INHIBITOR P27 was indexed under CELL CYCLE PROTEINS %26% TUMOR SUPPRESSOR PROTEINS 1992-2005%A%
% 210.56/210.71 |- mesh__recordOriginator mesh__D050760 DRC
% 210.56/210.71 |- skos__broader mesh__D050760smesh__D050756
% 210.56/210.71 |- skos__related mesh__D044723smesh__D002351
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D044723 sjn
% 210.56/210.71 |- rdf__type mesh__D044723sskos__Concept
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D044723 2006
% 210.56/210.71 |- skos__prefLabel mesh__D044723 Chondrus
% 210.56/210.71 |- skos__scopeNote mesh__D044723
% 210.56/210.71 A genus of RED ALGAE, in the family Gigartinaceae. The species Chondrus crispus is a source of CARRAGEENAN.%A%
% 210.56/210.71 |- mesh__dateCreated mesh__D044723 2003-07-09
% 210.56/210.71 |- mesh__recordOriginator mesh__D044723 ags
% 210.56/210.71 |- mesh__recordMaintainer mesh__D044723 SYSTEM
% 210.56/210.71 |- mesh__dateRevised mesh__D044723 2005-06-30
% 210.56/210.71 |- skos__altLabel mesh__D044723 Carrageen
% 210.56/210.71 |- mesh__historyNote mesh__D044723 2004
% 210.56/210.71 |- skos__broader mesh__D044723smesh__D000461
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D044723 2004
% 210.56/210.71 |- skos__historyNote mesh__D044723 Algae, Red %28%1973-2003%29%
% 210.56/210.71 |- mesh__dateEstablished mesh__D044723 2004-01-01
% 210.56/210.71 |- skos__altLabel mesh__D044723 Moss, Irish
% 210.56/210.71 |- mesh__dateRevised mesh__D011549 2005-06-30
% 210.56/210.71 |- mesh__recordOriginator mesh__D011549 NLM
% 210.56/210.71 |- skos__broader mesh__D011549smesh__D011548
% 210.56/210.71 |- skos__prefLabel mesh__D011549 Pseudomonas
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D011549 sjn
% 210.56/210.71 |- skos__altLabel mesh__D011549 Flavimonas
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D011549 2006
% 210.56/210.71 |- rdf__type mesh__D011549sskos__Concept
% 210.56/210.71 |- mesh__recordMaintainer mesh__D011549 SYSTEM
% 210.56/210.71 |- skos__altLabel mesh__D011549 Chrysemonas
% 210.56/210.71 |- skos__scopeNote mesh__D011549
% 210.56/210.71 A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants.%A%
% 210.56/210.71 |- skos__annotation mesh__D011549 infection = PSEUDOMONAS INFECTIONS
% 210.56/210.71 |- mesh__dateCreated mesh__D011549 1999-01-01
% 210.56/210.71 |- skos__scopeNote mesh__D016234
% 210.56/210.71 A system of metabolic interactions by products produced in the distal nephron of the KIDNEY. These products include KALLIKREIN; KININS; KININASE I; KININASE II; and ENKEPHALINASE. This system participates in the control of renal functions. It interacts with the RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM to regulate BLOOD PRESSURE, generation of PROSTAGLANDINS, release of VASOPRESSINS, and WATER-ELECTROLYTE BALANCE.%A%
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D016234 91
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D016234 sjn
% 210.56/210.71 |- skos__hiddenLabel mesh__D016234 Kallikrein-Kinin Systems
% 210.56/210.71 |- mesh__dateEstablished mesh__D016234 1991-01-01
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016234 2006
% 210.56/210.71 |- skos__broader mesh__D016234smesh__D008660
% 210.56/210.71 |- mesh__dateRevised mesh__D016234 2004-07-09
% 210.56/210.71 |- skos__historyNote mesh__D016234 Kinins %28%1966-1990%29%
% 210.56/210.71 |- skos__broader mesh__D016234smesh__D006439
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016234 2005
% 210.56/210.71 |- skos__prefLabel mesh__D016234 Kallikrein-Kinin System
% 210.56/210.71 |- skos__hiddenLabel mesh__D016234 Systems, Kallikrein-Kinin
% 210.56/210.71 |- skos__related mesh__D016234smesh__D012084
% 210.56/210.71 |- skos__hiddenLabel mesh__D016234 Kallikrein Kinin System
% 210.56/210.71 |- rdf__type mesh__D016234sskos__Concept
% 210.56/210.71 |- mesh__historyNote mesh__D016234 91
% 210.56/210.71 |- mesh__dateCreated mesh__D016234 1990-05-07
% 210.56/210.71 |- skos__annotation mesh__D016234 DF: KK SYSTEM
% 210.56/210.71 |- mesh__recordMaintainer mesh__D016234 jmp
% 210.56/210.71 |- skos__broader mesh__D016234smesh__D014882
% 210.56/210.71 |- mesh__recordOriginator mesh__D016234 RLS
% 210.56/210.71 |- skos__historyNote mesh__D016234 Kallikrein %28%1966-1990%29%
% 210.56/210.71 |- skos__broader mesh__D002214smesh__D004304
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D002214 2005
% 210.56/210.71 |- skos__scopeNote mesh__D002214
% 210.56/210.71 Hard or soft soluble containers used for the oral administration of medicine.%A%
% 210.56/210.71 |- rdf__type mesh__D002214sskos__Concept
% 210.56/210.71 |- mesh__recordMaintainer mesh__D002214 ssb
% 210.56/210.71 |- mesh__dateCreated mesh__D002214 1999-01-01
% 210.56/210.71 |- skos__prefLabel mesh__D002214 Capsules
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D002214 2004
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D002214 sjn
% 210.56/210.71 |- mesh__recordOriginator mesh__D002214 NLM
% 210.56/210.71 |- skos__annotation mesh__D002214
% 210.56/210.71 IM for general only; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the drug in capsule form, not the capsule; note X ref MICROCAPSULES: do not confuse with MICROENCAPSULATION see DRUG COMPOUNDING%A%
% 210.56/210.71 |- mesh__dateRevised mesh__D002214 2003-07-09
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D002214 2006
% 210.56/210.71 |- mesh__recordOriginator mesh__D012642 RLS
% 210.56/210.71 |- mesh__recordMaintainer mesh__D012642 sjn
% 210.56/210.71 |- rdf__type mesh__D012642sskos__Concept
% 210.56/210.71 |- skos__altLabel mesh__D012642 Selegiline, %28%R%29%-Isomer
% 210.56/210.71 |- skos__hiddenLabel mesh__D012642 E250
% 210.56/210.71 |- skos__broader mesh__D012642smesh__D010627
% 210.56/210.71 |- mesh__onlineNote mesh__D012642
% 210.56/210.71 use SELEGILINE to search DEPRENYL 1979-83
% 210.56/210.71 |- skos__altLabel mesh__D012642 L-Deprenyl
% 210.56/210.71 |- skos__hiddenLabel mesh__D012642 Hydrochloride, Selegiline
% 210.56/210.71 |- skos__altLabel mesh__D012642 Humex
% 210.56/210.71 |- skos__hiddenLabel mesh__D012642 L Deprenyl
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D012642 2006
% 210.56/210.71 |- skos__altLabel mesh__D012642 Deprenalin
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D012642
% 210.56/210.71 91; was see under PHENETHYLAMINES 1984-90; was DEPRENYL see under PHENETHYLAMINES 1979-83%A%
% 210.56/210.71 |- mesh__historyNote mesh__D012642
% 210.56/210.71 91%28%84%29%; was see under PHENETHYLAMINES 1984-90; was DEPRENYL see under PHENETHYLAMINES 1979-83%A%
% 210.56/210.71 |- mesh__dateEstablished mesh__D012642 1991-01-01
% 210.56/210.71 |- skos__altLabel mesh__D012642 Selegyline
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D012642 sjn
% 210.56/210.71 |- skos__prefLabel mesh__D012642 Selegiline
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D012642 2005
% 210.56/210.71 |- skos__historyNote mesh__D012642 Phenethylamines %28%1966-1978%29%
% 210.56/210.71 |- skos__scopeNote mesh__D012642
% 210.56/210.71 A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson%27%s disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. %28%From AMA Drug Evaluations Annual, 1994, p385%29% The compound without isomeric designation is Deprenyl.%A%
% 210.56/210.71 |- skos__historyNote mesh__D012642
% 210.56/210.71 Monoamine Oxidase Inhibitors %28%1966-1978%29%
% 210.56/210.71 |- mesh__dateCreated mesh__D012642 1977-12-09
% 210.56/210.71 |- skos__altLabel mesh__D012642 Jumex
% 210.56/210.71 |- skos__altLabel mesh__D012642 Selegiline Hydrochloride
% 210.56/210.71 |- skos__altLabel mesh__D012642 Deprenil
% 210.56/210.71 |- mesh__dateRevised mesh__D012642 2003-07-25
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D012642 2004
% 210.56/210.71 |- skos__hiddenLabel mesh__D012642 E 250
% 210.56/210.71 |- mesh__dateRevised mesh__D006605 2003-07-09
% 210.56/210.71 |- skos__hiddenLabel mesh__D006605 Hibernations
% 210.56/210.71 |- skos__broader mesh__D006605smesh__D001833
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006605 2006
% 210.56/210.71 |- mesh__recordOriginator mesh__D006605 NLM
% 210.56/210.71 |- skos__prefLabel mesh__D006605 Hibernation
% 210.56/210.71 |- skos__annotation mesh__D006605
% 210.56/210.71 animal only; a natural physiol process; summer dormancy corresponding to this winter dormancy = ESTIVATION%A%
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006605 2005
% 210.56/210.71 |- skos__scopeNote mesh__D006605
% 210.56/210.71 The dormant state in which some animal species pass the winter. It is characterized by narcosis and by sharp reduction in body temperature and metabolic activity and by a depression of vital signs. It is a natural physiological process in many warm-blooded animals.%A%
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D006605 sjn
% 210.56/210.71 |- rdf__type mesh__D006605sskos__Concept
% 210.56/210.71 |- skos__broader mesh__D006605smesh__D000222
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006605 2004
% 210.56/210.71 |- mesh__dateCreated mesh__D006605 1999-01-01
% 210.56/210.71 |- mesh__recordMaintainer mesh__D006605 lkt
% 210.56/210.71 |- skos__altLabel mesh__D050761 CDKN1C Protein
% 210.56/210.71 |- skos__hiddenLabel mesh__D050761 KIP2 Protein, p57
% 210.56/210.71 |- skos__altLabel mesh__D050761 Cyclin Kinase Inhibitor Protein 2
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D050761 2006
% 210.56/210.71 |- skos__altLabel mesh__D050761 p57KIP2 Protein
% 210.56/210.71 |- skos__scopeNote mesh__D050761
% 210.56/210.71 A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.%A%
% 210.56/210.71 |- rdf__type mesh__D050761sskos__Concept
% 210.56/210.71 |- skos__prefLabel mesh__D050761 Cyclin-Dependent Kinase Inhibitor p57
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D050761
% 210.56/210.71 2006; CYCLIN-DEPENDENT KINASE INHIBITOR P57 was indexed under NUCLEAR PROTEINS 1995-2005%A%
% 210.56/210.71 |- skos__broader mesh__D050761smesh__D050756
% 210.56/210.71 |- mesh__dateCreated mesh__D050761 2005-06-30
% 210.56/210.71 |- mesh__recordOriginator mesh__D050761 DRC
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D050761 sjn
% 210.56/210.71 |- mesh__recordMaintainer mesh__D050761 DRC
% 210.56/210.71 |- mesh__historyNote mesh__D050761 2006%28%1995%29%
% 210.56/210.71 |- mesh__dateEstablished mesh__D050761 2006-01-01
% 210.56/210.71 |- skos__hiddenLabel mesh__D050761 Cyclin Dependent Kinase Inhibitor 1C
% 210.56/210.71 |- skos__hiddenLabel mesh__D050761 Cyclin Dependent Kinase Inhibitor p57
% 210.56/210.71 |- skos__altLabel mesh__D050761 Cyclin-Dependent Kinase Inhibitor 1C
% 210.56/210.71 |- skos__altLabel mesh__D050761 p57 KIP2 Protein
% 210.56/210.71 |- mesh__dateCreated mesh__D044724 2003-07-09
% 210.56/210.71 |- mesh__dateEstablished mesh__D044724 2004-01-01
% 210.56/210.71 |- skos__historyNote mesh__D044724 Algae, Red %28%1976-2003%29%
% 210.56/210.71 |- skos__broader mesh__D044724smesh__D000461
% 210.56/210.71 |- skos__scopeNote mesh__D044724
% 210.56/210.71 A genus of RED ALGAE in the family Gracilariaceae. It is a highly commercial SEAWEED and a source of AGAR.%A%
% 210.56/210.71 |- skos__prefLabel mesh__D044724 Gracilaria
% 210.56/210.71 |- mesh__recordMaintainer mesh__D044724 SYSTEM
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D044724 2004
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D044724 sjn
% 210.56/210.71 |- rdf__type mesh__D044724sskos__Concept
% 210.56/210.71 |- mesh__recordOriginator mesh__D044724 ags
% 210.56/210.71 |- mesh__dateRevised mesh__D044724 2005-06-30
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D044724 2006
% 210.56/210.71 |- mesh__historyNote mesh__D044724 2004
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 1993
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 2005
% 210.56/210.71 |- mesh__dateCreated mesh__D016235 1990-06-06
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 1996
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 1999
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 2000
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 2003
% 210.56/210.71 |- skos__annotation mesh__D016235
% 210.56/210.71 add UNITED STATES %28%NIM%29%; DF: ASHA CATALOG: use NAF entry%A%
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 2006
% 210.56/210.71 |- skos__hiddenLabel mesh__D016235
% 210.56/210.71 Association, American Speech-Language-Hearing
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 2001
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 1997
% 210.56/210.71 |- skos__historyNote mesh__D016235
% 210.56/210.71 Speech-Language Pathology %28%1980-1990%29%
% 210.56/210.71 |- skos__hiddenLabel mesh__D016235
% 210.56/210.71 American Speech Language Hearing Association
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 2004
% 210.56/210.71 |- skos__historyNote mesh__D016235 Audiology %28%1978-1990%29%
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 2002
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D016235 91
% 210.56/210.71 |- skos__historyNote mesh__D016235 Speech Therapy %28%1966-1979%29%
% 210.56/210.71 |- rdf__type mesh__D016235sskos__Concept
% 210.56/210.71 |- mesh__historyNote mesh__D016235 91
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 1994
% 210.56/210.71 |- skos__hiddenLabel mesh__D016235
% 210.56/210.71 Speech-Language-Hearing Association, American
% 210.56/210.71 |- skos__historyNote mesh__D016235 Hearing %28%1966-1974%29%
% 210.56/210.71 |- mesh__recordOriginator mesh__D016235 TGC
% 210.56/210.71 |- mesh__dateEstablished mesh__D016235 1991-01-01
% 210.56/210.71 |- skos__broader mesh__D016235smesh__D012952
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D016235 PLS
% 210.56/210.71 |- mesh__dateRevised mesh__D016235 1992-03-25
% 210.56/210.71 |- skos__scopeNote mesh__D016235
% 210.56/210.71 A professional society concerned with the diagnosis, prevention, treatment, and remediation of speech, language, and hearing disorders.%A%
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 1995
% 210.56/210.71 |- skos__historyNote mesh__D016235 Societies %28%1966-1990%29%
% 210.56/210.71 |- skos__prefLabel mesh__D016235
% 210.56/210.71 American Speech-Language-Hearing Association
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D016235 1998
% 210.56/210.71 |- mesh__recordMaintainer mesh__D016235 TAP
% 210.56/210.71 |- skos__broader mesh__D002215smesh__D007211
% 210.56/210.71 |- skos__historyNote mesh__D002215 Pesticides %28%1966-1971%29%
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D002215 2006
% 210.56/210.71 |- mesh__recordMaintainer mesh__D002215 nns
% 210.56/210.71 |- skos__hiddenLabel mesh__D002215
% 210.56/210.71 N Trichloromethylthio 4 cyclohexane 1,2 dicarboximide
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D002215 2002
% 210.56/210.71 |- mesh__dateEstablished mesh__D002215 1974-01-01
% 210.56/210.71 |- mesh__dateRevised mesh__D002215 2001-07-25
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D002215 2005
% 210.56/210.71 |- skos__historyNote mesh__D002215 Indoles %28%1966-1971%29%
% 210.56/210.71 |- rdf__type mesh__D002215sskos__Concept
% 210.56/210.71 |- skos__scopeNote mesh__D002215 One of the phthalimide fungicides.
% 210.56/210.71 |- mesh__dateCreated mesh__D002215 1999-01-01
% 210.56/210.71 |- mesh__recordOriginator mesh__D002215 NLM
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D002215 sjn
% 210.56/210.71 |- skos__historyNote mesh__D002215 Antifungal Agents %28%1966-1971%29%
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D002215 2004
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D002215 74
% 210.56/210.71 |- skos__prefLabel mesh__D002215 Captan
% 210.56/210.71 |- mesh__historyNote mesh__D002215 74%28%72%29%
% 210.56/210.71 |- skos__altLabel mesh__D002215
% 210.56/210.71 N-Trichloromethylthio-4-cyclohexane-1,2-dicarboximide
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D002215 2003
% 210.56/210.71 |- skos__prefLabel mesh__D012643 Selenium
% 210.56/210.71 |- mesh__recordOriginator mesh__D012643 NLM
% 210.56/210.71 |- mesh__dateCreated mesh__D012643 1999-01-01
% 210.56/210.71 |- skos__annotation mesh__D012643
% 210.56/210.71 Se-80; Se-74, 76-78, 82 = SELENIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Se-70-73, 75, 79, 81, 83-85 = SELENIUM RADIOISOTOPES %28%IM%29%%A%
% 210.56/210.71 |- skos__broader mesh__D012643smesh__D008903
% 210.56/210.71 |- skos__scopeNote mesh__D012643
% 210.56/210.71 An element with the atomic symbol Se, atomic number 34, and atomic weight 78.96. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE.%A%
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D012643 sjn
% 210.56/210.71 |- mesh__dateRevised mesh__D012643 2005-06-30
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D012643 2006
% 210.56/210.71 |- skos__related mesh__D012643smesh__D012644
% 210.56/210.71 |- skos__broader mesh__D012643smesh__D018011
% 210.56/210.71 |- mesh__recordMaintainer mesh__D012643 ssb
% 210.56/210.71 |- rdf__type mesh__D012643sskos__Concept
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006606 2006
% 210.56/210.71 |- skos__broader mesh__D006606smesh__D012817
% 210.56/210.71 |- skos__hiddenLabel mesh__D006606 Hiccups
% 210.56/210.71 |- mesh__dateRevised mesh__D006606 1999-11-03
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006606 2005
% 210.56/210.71 |- skos__prefLabel mesh__D006606 Hiccup
% 210.56/210.71 |- rdf__type mesh__D006606sskos__Concept
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006606 2002
% 210.56/210.71 |- mesh__recordMaintainer mesh__D006606 KEV
% 210.56/210.71 |- mesh__recordOriginator mesh__D006606 NLM
% 210.56/210.71 |- skos__scopeNote mesh__D006606
% 210.56/210.71 A spasm of the diaphragm that causes a sudden inhalation followed by rapid closure of the glottis which produces a sound.%A%
% 210.56/210.71 |- skos__hiddenLabel mesh__D006606 Hiccoughs
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006606 2004
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D006606 sjn
% 210.56/210.71 |- mesh__dateCreated mesh__D006606 1999-01-01
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006606 2001
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006606 2003
% 210.56/210.71 |- skos__altLabel mesh__D006606 Hiccough
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D006606 2000
% 210.56/210.71 |- skos__altLabel mesh__D050762 Cyclin-Dependent Kinase Inhibitor 2B
% 210.56/210.71 |- skos__hiddenLabel mesh__D050762 Cyclin Dependent Kinase Inhibitor p15
% 210.56/210.71 |- skos__altLabel mesh__D050762 INK4B Protein
% 210.56/210.71 |- skos__altLabel mesh__D050762 CDKN2B Protein
% 210.56/210.71 |- mesh__historyNote mesh__D050762 2006%28%1994%29%
% 210.56/210.71 |- mesh__publicMeSHNote mesh__D050762
% 210.56/210.71 2006; CYCLIN-DEPENDENT KINASE INHIBITOR P15 was indexed under TUMOR SUPPRESSOR PROTEINS %26% CELL CYCLE PROTEINS 2004-2005, under PROTEIN P16 2002-2004, %26% under CARRIER PROTEINS 1994-2001%A%
% 210.56/210.71 |- skos__prefLabel mesh__D050762 Cyclin-Dependent Kinase Inhibitor p15
% 210.56/210.71 |- skos__broader mesh__D050762smesh__D050756
% 210.56/210.71 |- skos__hiddenLabel mesh__D050762 CDK4 Inhibitor, p15
% 210.56/210.71 |- skos__altLabel mesh__D050762 p15 CDK4 Inhibitor
% 210.56/210.71 |- mesh__recordOriginator mesh__D050762 DRC
% 210.56/210.71 |- skos__hiddenLabel mesh__D050762 Cyclin Dependent Kinase Inhibitor 2B
% 210.56/210.71 |- skos__altLabel mesh__D050762 INK4b Cyclin-Dependent Kinase Inhibitor
% 210.56/210.71 |- skos__hiddenLabel mesh__D050762 INK4b Cyclin Dependent Kinase Inhibitor
% 210.56/210.71 |- mesh__dateCreated mesh__D050762 2005-06-30
% 210.56/210.71 |- skos__scopeNote mesh__D050762
% 210.56/210.71 An INK4 cyclin-dependent kinase inhibitor containing four ANKYRIN-LIKE REPEATS. INK4B is often inactivated by deletions, mutations, or hypermethylation in HEMATOLOGIC NEOPLASMS.%A%
% 210.56/210.71 |- mesh__recordAuthorizer mesh__D050762 sjn
% 210.56/210.71 |- mesh__dateEstablished mesh__D050762 2006-01-01
% 210.56/210.71 |- mesh__activeMeSHYear mesh__D050762 2006
% 210.56/210.72 |- mesh__recordMaintainer mesh__D050762 DRC
% 210.56/210.72 |- skos__altLabel mesh__D050762 p15INK4B Protein
% 210.56/210.72 |- rdf__type mesh__D050762sskos__Concept
% 210.56/210.72 |- mesh__recordOriginator mesh__D044725 ags
% 210.56/210.72 |- mesh__recordMaintainer mesh__D044725 SYSTEM
% 210.56/210.72 |- mesh__dateRevised mesh__D044725 2005-06-30
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D044725 2004
% 210.56/210.72 |- mesh__historyNote mesh__D044725 2004
% 210.56/210.72 |- skos__prefLabel mesh__D044725 Plocamium
% 210.56/210.72 |- mesh__dateEstablished mesh__D044725 2004-01-01
% 210.56/210.72 |- skos__scopeNote mesh__D044725
% 210.56/210.72 A genus of RED ALGAE, in the family Plocamiaceae, found in temperate marine environments worldwide. Polyhalogenated monoterpenes of potential medicinal use have been isolated from its species.%A%
% 210.56/210.72 |- rdf__type mesh__D044725sskos__Concept
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D044725 2006
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D044725 sjn
% 210.56/210.72 |- mesh__dateCreated mesh__D044725 2003-07-09
% 210.56/210.72 |- skos__historyNote mesh__D044725 Algae, Red %28%1977-2003%29%
% 210.56/210.72 |- skos__broader mesh__D044725smesh__D000461
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D049410 2006
% 210.56/210.72 |- skos__altLabel mesh__D049410 Renilla Luciferases
% 210.56/210.72 |- skos__broader mesh__D049410smesh__D008156
% 210.56/210.72 |- mesh__dateCreated mesh__D049410 2004-07-07
% 210.56/210.72 |- mesh__historyNote mesh__D049410 2005
% 210.56/210.72 |- rdf__type mesh__D049410sskos__Concept
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D049410 sjn
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D049410 2005
% 210.56/210.72 |- mesh__recordMaintainer mesh__D049410 ssb
% 210.56/210.72 |- mesh__dateEstablished mesh__D049410 2005-01-01
% 210.56/210.72 |- skos__altLabel mesh__D049410 Luciferases, Sea Pansy
% 210.56/210.72 |- skos__scopeNote mesh__D049410
% 210.56/210.72 Luciferases from RENILLA that oxidizes certain LUMINESCENT AGENTS to cause emission of PHOTONS.%A%
% 210.56/210.72 |- skos__historyNote mesh__D049410 Luciferases %28%1966-2004%29%
% 210.56/210.72 |- skos__hiddenLabel mesh__D049410 Sea Pansy Luciferases
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D049410 2005
% 210.56/210.72 |- mesh__recordOriginator mesh__D049410 ssb
% 210.56/210.72 |- skos__prefLabel mesh__D049410 Luciferases, Renilla
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D016236 2006
% 210.56/210.72 |- mesh__recordOriginator mesh__D016236 AGS
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 v-fms Gene
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 c fms Proto Oncogenes
% 210.56/210.72 |- mesh__dateRevised mesh__D016236 2005-07-22
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 c-fms Proto-Oncogene
% 210.56/210.72 |- skos__altLabel mesh__D016236 fms Genes
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 c-fms Gene
% 210.56/210.72 |- mesh__recordMaintainer mesh__D016236 ags
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 v fms Oncogenes
% 210.56/210.72 |- skos__altLabel mesh__D016236 v-fms Oncogenes
% 210.56/210.72 |- mesh__historyNote mesh__D016236 91
% 210.56/210.72 |- rdf__type mesh__D016236sskos__Concept
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 c fms Genes
% 210.56/210.72 |- mesh__dateEstablished mesh__D016236 1991-01-01
% 210.56/210.72 |- skos__prefLabel mesh__D016236 Genes, fms
% 210.56/210.72 |- skos__related mesh__D016236smesh__D016186
% 210.56/210.72 |- skos__related mesh__D016236smesh__D016281
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 Oncogenes, v-fms
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 Gene, c-fms
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 v-fms Oncogene
% 210.56/210.72 |- skos__scopeNote mesh__D016236
% 210.56/210.72 Family of genes originally isolated from the Susan McDonough strain of feline sarcoma virus %28%SARCOMA VIRUSES, FELINE%29%. The proto-oncogene fms %28%c-fms%29% codes for the MCSF receptor %28%RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR%29%. The oncogene fms %28%v-fms%29% codes for ONCOGENE PROTEIN GP140%28%V-FMS%29% which is a mutated form of the MCSF. The human c-fms gene is located between 5q33.2 and 5q33.3.%A%
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 fms Gene
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 Oncogene, v-fms
% 210.56/210.72 |- skos__historyNote mesh__D016236 Oncogenes %28%1983-1990%29%
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D016236 91
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 v fms Genes
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 Proto-Oncogenes, c-fms
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D016236 ags
% 210.56/210.72 |- mesh__dateCreated mesh__D016236 1990-06-28
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 Gene, fms
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 Genes, v-fms
% 210.56/210.72 |- skos__broader mesh__D016236smesh__D011519
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D016236 2006A
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 Proto-Oncogene, c-fms
% 210.56/210.72 |- skos__historyNote mesh__D016236 Proto-Oncogenes %28%1986-1990%29%
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 Gene, v-fms
% 210.56/210.72 |- skos__hiddenLabel mesh__D016236 Genes, c-fms
% 210.56/210.72 |- skos__altLabel mesh__D016236 c-fms Proto-Oncogenes
% 210.56/210.72 |- skos__scopeNote mesh__D002216
% 210.56/210.72 A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.%A%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002216 2005
% 210.56/210.72 |- skos__hiddenLabel mesh__D002216 SQ14225
% 210.56/210.72 |- rdf__type mesh__D002216sskos__Concept
% 210.56/210.72 |- skos__hiddenLabel mesh__D002216 SQ 14534
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D002216 ags
% 210.56/210.72 |- skos__broader mesh__D002216smesh__D011392
% 210.56/210.72 |- skos__hiddenLabel mesh__D002216 SQ14,225
% 210.56/210.72 |- mesh__onlineNote mesh__D002216
% 210.56/210.72 use CAPTOPRIL to search SQ 14225 1980-93
% 210.56/210.72 |- skos__hiddenLabel mesh__D002216 SQ14534
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002216 2000B
% 210.56/210.72 |- skos__prefLabel mesh__D002216 Captopril
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002216 2002
% 210.56/210.72 |- skos__altLabel mesh__D002216 SQ-14225
% 210.56/210.72 |- mesh__dateEstablished mesh__D002216 1986-01-01
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002216 2004
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002216 2000A
% 210.56/210.72 |- skos__hiddenLabel mesh__D002216 SQ 14,225
% 210.56/210.72 |- skos__historyNote mesh__D002216
% 210.56/210.72 Peptide Peptidohydrolases %28%1966-1967%29% /antagonists %26% inhibitors %28%1968-1972%29%
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D002216
% 210.56/210.72 86; was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93%A%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002216 2003
% 210.56/210.72 |- skos__historyNote mesh__D002216
% 210.56/210.72 Kininase II/antagonists %26% inhibitors %28%1973-1979%29%
% 210.56/210.72 |- mesh__recordMaintainer mesh__D002216 ags
% 210.56/210.72 |- mesh__dateRevised mesh__D002216 2000-01-19
% 210.56/210.72 |- skos__altLabel mesh__D002216
% 210.56/210.72 %28%S%29%-1-%28%3-Mercapto-2-methyl-1-oxopropyl%29%-L-proline
% 210.56/210.72 |- skos__altLabel mesh__D002216 SQ-14534
% 210.56/210.72 |- skos__hiddenLabel mesh__D002216 SQ14,534
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002216 2001
% 210.56/210.72 |- mesh__historyNote mesh__D002216
% 210.56/210.72 86%28%80%29%; was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93%A%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002216 2006
% 210.56/210.72 |- skos__hiddenLabel mesh__D002216 SQ 14,534
% 210.56/210.72 |- skos__historyNote mesh__D002216
% 210.56/210.72 Proline %28%1966-1974%29% /antagonists %26% inhibitors %28%1975-1979%29%
% 210.56/210.72 |- mesh__dateCreated mesh__D002216 1979-05-23
% 210.56/210.72 |- skos__hiddenLabel mesh__D002216 SQ 14225
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002216 2000
% 210.56/210.72 |- mesh__recordOriginator mesh__D002216 RLS
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 2004
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 1994
% 210.56/210.72 |- skos__hiddenLabel mesh__D012644 Radioisotopes, Selenium
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 1998
% 210.56/210.72 |- mesh__recordMaintainer mesh__D012644 TPW
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 1995
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 2000
% 210.56/210.72 |- mesh__historyNote mesh__D012644 88
% 210.56/210.72 |- skos__scopeNote mesh__D012644
% 210.56/210.72 Unstable isotopes of selenium that decay or disintegrate emitting radiation. Se atoms with atomic weights 70-73, 75, 79, 81, and 83-85 are radioactive selenium isotopes.%A%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 1999
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D012644 PLS
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 2005
% 210.56/210.72 |- skos__historyNote mesh__D012644 Radioisotopes %28%1966-1987%29%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 2001
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 1996
% 210.56/210.72 |- skos__prefLabel mesh__D012644 Selenium Radioisotopes
% 210.56/210.72 |- skos__broader mesh__D012644smesh__D011868
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D012644 88
% 210.56/210.72 |- skos__annotation mesh__D012644
% 210.56/210.72 Se-70-73, 75, 79, 81, 83-85; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 2006
% 210.56/210.72 |- mesh__recordOriginator mesh__D012644 RLS
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 1997
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 2003
% 210.56/210.72 |- mesh__dateEstablished mesh__D012644 1988-01-01
% 210.56/210.72 |- skos__historyNote mesh__D012644 Selenium %28%1966-1987%29%
% 210.56/210.72 |- mesh__dateCreated mesh__D012644 1987-04-08
% 210.56/210.72 |- rdf__type mesh__D012644sskos__Concept
% 210.56/210.72 |- mesh__dateRevised mesh__D012644 1993-06-03
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012644 2002
% 210.56/210.72 |- skos__scopeNote mesh__D006607
% 210.56/210.72 A benign neoplasm derived from epithelial cells of sweat glands. %28%Stedman, 25th ed%29%%A%
% 210.56/210.72 |- skos__hiddenLabel mesh__D006607 Sweat Gland Adenomas
% 210.56/210.72 |- mesh__recordMaintainer mesh__D006607 KEV
% 210.56/210.72 |- skos__broader mesh__D006607smesh__D018294
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 1997
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 2001
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 2004
% 210.56/210.72 |- skos__hiddenLabel mesh__D006607 Sweat Gland Adenoma
% 210.56/210.72 |- skos__altLabel mesh__D006607 Hidradenoma
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 1996
% 210.56/210.72 |- skos__hiddenLabel mesh__D006607 Adenomas, Sweat Gland
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 2000
% 210.56/210.72 |- mesh__dateCreated mesh__D006607 1999-01-01
% 210.56/210.72 |- skos__hiddenLabel mesh__D006607 Hidradenomas
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 2003
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D006607 94; was HIDRADENOMA 1963-93
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D006607 PLS
% 210.56/210.72 |- skos__hiddenLabel mesh__D006607 Syringadenomas
% 210.56/210.72 |- mesh__historyNote mesh__D006607 94; was HIDRADENOMA 1963-93
% 210.56/210.72 |- skos__altLabel mesh__D006607 Syringadenoma
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 1999
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 2006
% 210.56/210.72 |- skos__annotation mesh__D006607
% 210.56/210.72 /blood supply /chem /secret /ultrastruct permitted; coord IM with SWEAT GLAND NEOPLASMS %28%IM%29%%A%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 1998
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 2002
% 210.56/210.72 |- skos__broader mesh__D006607smesh__D000236
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006607 2005
% 210.56/210.72 |- mesh__recordOriginator mesh__D006607 NLM
% 210.56/210.72 |- mesh__dateRevised mesh__D006607 1995-06-08
% 210.56/210.72 |- rdf__type mesh__D006607sskos__Concept
% 210.56/210.72 |- mesh__onlineNote mesh__D006607
% 210.56/210.72 use ADENOMA, SWEAT GLAND to search HIDRADENOMA 1966-93
% 210.56/210.72 |- skos__prefLabel mesh__D006607 Adenoma, Sweat Gland
% 210.56/210.72 |- mesh__dateEstablished mesh__D050763 2006-01-01
% 210.56/210.72 |- mesh__recordMaintainer mesh__D050763 DRC
% 210.56/210.72 |- mesh__dateCreated mesh__D050763 2005-06-30
% 210.56/210.72 |- skos__altLabel mesh__D050763 p18INK4c Protein
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D050763 sjn
% 210.56/210.72 |- skos__hiddenLabel mesh__D050763 p18, CDK6-Associated Protein
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D050763 2006
% 210.56/210.72 |- skos__altLabel mesh__D050763 CDKN2C Protein
% 210.56/210.72 |- skos__hiddenLabel mesh__D050763 Cyclin Dependent Kinase Inhibitor 2C
% 210.56/210.72 |- skos__altLabel mesh__D050763 p18 CDK6 Inhibitor
% 210.56/210.72 |- mesh__historyNote mesh__D050763 2006%28%1994%29%
% 210.56/210.72 |- skos__hiddenLabel mesh__D050763 CDK6 Inhibitor, p18
% 210.56/210.72 |- rdf__type mesh__D050763sskos__Concept
% 210.56/210.72 |- skos__altLabel mesh__D050763 INK4C Protein
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D050763
% 210.56/210.72 2006; CYCLIN-DEPENDENT KINASE INHIBITOR P 18 was indexed under TUMOR SUPPRESSOR PROTEINS %26% CELL CYCLE PROTEINS 2002-2005, %26% under CARRIER PROTEINS 1994-2001%A%
% 210.56/210.72 |- skos__hiddenLabel mesh__D050763 Cyclin Dependent Kinase Inhibitor p18
% 210.56/210.72 |- skos__altLabel mesh__D050763 Cyclin-Dependent Kinase Inhibitor 2C
% 210.56/210.72 |- skos__prefLabel mesh__D050763 Cyclin-Dependent Kinase Inhibitor p18
% 210.56/210.72 |- skos__hiddenLabel mesh__D050763 CDK6 Associated Protein p18
% 210.56/210.72 |- skos__scopeNote mesh__D050763
% 210.56/210.72 An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN-LIKE REPEATS. Aberrant expression of this protein has been associated with deregulated EPITHELIAL CELL growth, organ enlargement, and a variety of NEOPLASMS.%A%
% 210.56/210.72 |- mesh__recordOriginator mesh__D050763 DRC
% 210.56/210.72 |- skos__altLabel mesh__D050763 CDK6-Associated Protein p18
% 210.56/210.72 |- skos__broader mesh__D050763smesh__D050756
% 210.56/210.72 |- skos__broader mesh__D044726smesh__D009868
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D044726 2004
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D044726 sjn
% 210.56/210.72 |- skos__prefLabel mesh__D044726 Lagenidium
% 210.56/210.72 |- skos__annotation mesh__D044726
% 210.56/210.72 infection: coord IM with INFECTION %28%IM%29%
% 210.56/210.72 |- skos__historyNote mesh__D044726 Oomycetes %28%1983-2003%29%
% 210.56/210.72 |- mesh__recordOriginator mesh__D044726 ags
% 210.56/210.72 |- mesh__dateRevised mesh__D044726 2005-06-30
% 210.56/210.72 |- mesh__recordMaintainer mesh__D044726 SYSTEM
% 210.56/210.72 |- mesh__historyNote mesh__D044726 2004
% 210.56/210.72 |- rdf__type mesh__D044726sskos__Concept
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D044726 2006
% 210.56/210.72 |- skos__scopeNote mesh__D044726
% 210.56/210.72 A genus of ALGAE in the family Lagenidiaceae. One species %28%L. giganteum%29% parasitizes the larval stage of MOSQUITOES and is used in its biological control %28%PEST CONTROL, BIOLOGICAL%29%; it also causes disease in freshwater FISHES.%A%
% 210.56/210.72 |- mesh__dateCreated mesh__D044726 2003-07-09
% 210.56/210.72 |- mesh__dateEstablished mesh__D044726 2004-01-01
% 210.56/210.72 |- skos__historyNote mesh__D044726 Fungi %28%1972-1982%29%
% 210.56/210.72 |- skos__broader mesh__D005971Q000819smesh__D005971
% 210.56/210.72 |- mesh__preferredCombination mesh__D005971Q000819smesh__D018690
% 210.56/210.72 |- rdf__type mesh__D005971Q000819smesh__CompoundConcept
% 210.56/210.72 |- rdf__type mesh__D049411sskos__Concept
% 210.56/210.72 |- skos__prefLabel mesh__D049411 Utrophin
% 210.56/210.72 |- skos__broader mesh__D049411smesh__D003598
% 210.56/210.72 |- skos__historyNote mesh__D049411 Membrane Proteins %28%1991-2004%29%
% 210.56/210.72 |- skos__hiddenLabel mesh__D049411 Dystrophin Related Protein
% 210.56/210.72 |- mesh__recordOriginator mesh__D049411 jmp
% 210.56/210.72 |- skos__historyNote mesh__D049411 Cytoskeletal Proteins %28%1991-2004%29%
% 210.56/210.72 |- skos__broader mesh__D049411smesh__D008565
% 210.56/210.72 |- mesh__dateRevised mesh__D049411 2004-08-03
% 210.56/210.72 |- skos__related mesh__D049411smesh__D049028
% 210.56/210.72 |- skos__scopeNote mesh__D049411
% 210.56/210.72 An autosomally-encoded 376-kDa cytoskeletal protein that is similar in structure and function to DYSTROPHIN. It is a ubiquitously-expressed protein that plays a role in anchoring the CYTOSKELETON to the PLASMA MEMBRANE.%A%
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D049411
% 210.56/210.72 2005; UTROPHIN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE PROTEINS 1991-2004%A%
% 210.56/210.72 |- skos__altLabel mesh__D049411 Dystrophin-Related Protein
% 210.56/210.72 |- mesh__dateEstablished mesh__D049411 2005-01-01
% 210.56/210.72 |- mesh__recordMaintainer mesh__D049411 jls
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D049411 2005
% 210.56/210.72 |- skos__hiddenLabel mesh__D049411 Dystrophin Related Protein 1
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D049411 jls
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D049411 2006
% 210.56/210.72 |- mesh__dateCreated mesh__D049411 2004-07-07
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D049411 2005A
% 210.56/210.72 |- skos__altLabel mesh__D049411 UTRN Protein
% 210.56/210.72 |- skos__altLabel mesh__D049411 Dystrophin-Related Protein 1
% 210.56/210.72 |- mesh__historyNote mesh__D049411 2005%28%1991%29%
% 210.56/210.72 |- skos__altLabel mesh__D002217 Carbacholine
% 210.56/210.72 |- skos__altLabel mesh__D002217 Bioniche Brand of Carbachol
% 210.56/210.72 |- mesh__recordOriginator mesh__D002217 NLM
% 210.56/210.72 |- rdf__type mesh__D002217sskos__Concept
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol NutraMax Brand
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D002217 sjn
% 210.56/210.72 |- skos__altLabel mesh__D002217 Optopics Brand of Carbachol
% 210.56/210.72 |- skos__prefLabel mesh__D002217 Carbachol
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol Alcon Brand
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol Optopics Brand
% 210.56/210.72 |- skos__altLabel mesh__D002217 Miostat
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol Mann Brand
% 210.56/210.72 |- skos__altLabel mesh__D002217 Carbocholine
% 210.56/210.72 |- skos__altLabel mesh__D002217 Allphar Brand of Carbachol
% 210.56/210.72 |- skos__altLabel mesh__D002217 Carbamoylcholine
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol Allphar Brand
% 210.56/210.72 |- skos__broader mesh__D002217smesh__D002794
% 210.56/210.72 |- mesh__recordMaintainer mesh__D002217 ssb
% 210.56/210.72 |- skos__altLabel mesh__D002217 Bipharma Brand of Carbachol
% 210.56/210.72 |- skos__altLabel mesh__D002217 NutraMax Brand of Carbachol
% 210.56/210.72 |- skos__altLabel mesh__D002217 Novartis Brand of Carbachol
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol Novartis Brand
% 210.56/210.72 |- mesh__dateRevised mesh__D002217 2005-06-30
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol, Isopto
% 210.56/210.72 |- skos__altLabel mesh__D002217 Alcon Brand of Carbachol
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol Merck Brand
% 210.56/210.72 |- skos__altLabel mesh__D002217 Mann Brand of Carbachol
% 210.56/210.72 |- skos__altLabel mesh__D002217 Merck Brand of Carbachol
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol Chauvin Brand
% 210.56/210.72 |- mesh__dateCreated mesh__D002217 1999-01-01
% 210.56/210.72 |- skos__scopeNote mesh__D002217
% 210.56/210.72 A slowly hydrolyzed cholinergic agonist that acts at both muscarinic and nicotinic receptors.%A%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D002217 2006
% 210.56/210.72 |- skos__altLabel mesh__D002217 Chauvin Brand of Carbachol
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol Bipharma Brand
% 210.56/210.72 |- skos__hiddenLabel mesh__D002217 Carbachol Bioniche Brand
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D007700 2005
% 210.56/210.72 |- skos__broader mesh__D007700smesh__D002620
% 210.56/210.72 |- mesh__recordOriginator mesh__D007700 NLM
% 210.56/210.72 |- skos__broader mesh__D007700smesh__D019563
% 210.56/210.72 |- skos__hiddenLabel mesh__D007700 Kinetic
% 210.56/210.72 |- mesh__dateRevised mesh__D007700 2003-07-09
% 210.56/210.72 |- skos__prefLabel mesh__D007700 Kinetics
% 210.56/210.72 |- rdf__type mesh__D007700sskos__Concept
% 210.56/210.72 |- skos__annotation mesh__D007700
% 210.56/210.72 almost never IM; do not confuse with KINESICS %28%%22%use of posture or gesture for communication%22%%29% or KINESIS %28%a form of movement%29%; pharmacokinetics of chemicals and drugs is PHARMACOKINETICS or better, specific drug term /pharmacokin%A%
% 210.56/210.72 |- skos__broader mesh__D007700smesh__D001696
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D007700 sjn
% 210.56/210.72 |- mesh__dateEstablished mesh__D007700 1966-01-01
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D007700 2004
% 210.56/210.72 |- mesh__dateCreated mesh__D007700 1999-01-01
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D007700 2006
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D007700 66
% 210.56/210.72 |- mesh__historyNote mesh__D007700 66%28%64%29%
% 210.56/210.72 |- mesh__recordMaintainer mesh__D007700 nns
% 210.56/210.72 |- skos__scopeNote mesh__D007700
% 210.56/210.72 The study of rate dynamics in chemical or physical systems.%A%
% 210.56/210.72 |- skos__broader mesh__D000486Q000379smesh__D000486
% 210.56/210.72 |- mesh__preferredCombination mesh__D000486Q000379smesh__D007158
% 210.56/210.72 |- rdf__type mesh__D000486Q000379smesh__CompoundConcept
% 210.56/210.72 |- mesh__recordMaintainer mesh__D012645 ssb
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D012645 sjn
% 210.56/210.72 |- skos__hiddenLabel mesh__D012645 Se 75, Selenomethionine
% 210.56/210.72 |- skos__altLabel mesh__D012645 Radioselenomethionine
% 210.56/210.72 |- mesh__dateRevised mesh__D012645 2005-06-30
% 210.56/210.72 |- mesh__dateCreated mesh__D012645 1974-11-19
% 210.56/210.72 |- skos__historyNote mesh__D012645 Selenium %28%1969-1974%29%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D012645 2006
% 210.56/210.72 |- skos__broader mesh__D012645smesh__D016566
% 210.56/210.72 |- skos__annotation mesh__D012645
% 210.56/210.72 for radiolabeled x-refs, coord IM with SELENIUM RADIOISOTOPES %28%NIM%29%%A%
% 210.56/210.72 |- skos__prefLabel mesh__D012645 Selenomethionine
% 210.56/210.72 |- mesh__recordOriginator mesh__D012645 NLM
% 210.56/210.72 |- skos__broader mesh__D012645smesh__D008715
% 210.56/210.72 |- rdf__type mesh__D012645sskos__Concept
% 210.56/210.72 |- mesh__dateEstablished mesh__D012645 1991-01-01
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D012645 91; was see under SELENIUM 1975-90
% 210.56/210.72 |- skos__scopeNote mesh__D012645
% 210.56/210.72 Diagnostic aid in pancreas function determination.
% 210.56/210.72 |- skos__historyNote mesh__D012645 Methionine %28%1971-1974%29%
% 210.56/210.72 |- mesh__historyNote mesh__D012645
% 210.56/210.72 91%28%75%29%; was see under SELENIUM 1975-90
% 210.56/210.72 |- mesh__onlineNote mesh__D006608 search SOCIAL DOMINANCE 1968-74
% 210.56/210.72 |- mesh__dateEstablished mesh__D006608 1991-01-01
% 210.56/210.72 |- skos__hiddenLabel mesh__D006608 Social Hierarchy
% 210.56/210.72 |- mesh__recordOriginator mesh__D006608 NLM
% 210.56/210.72 |- mesh__dateCreated mesh__D006608 1999-01-01
% 210.56/210.72 |- mesh__dateRevised mesh__D006608 1997-06-20
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D006608
% 210.56/210.72 91; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968%A%
% 210.56/210.72 |- skos__hiddenLabel mesh__D006608 Hierarchies, Social
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006608 2003
% 210.56/210.72 |- skos__broader mesh__D006608smesh__D012961
% 210.56/210.72 |- skos__prefLabel mesh__D006608 Hierarchy, Social
% 210.56/210.72 |- skos__scopeNote mesh__D006608
% 210.56/210.72 Social rank-order established by certain behavioral patterns.%A%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006608 1999
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006608 2001
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006608 2006
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006608 2000
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006608 1998
% 210.56/210.72 |- mesh__historyNote mesh__D006608
% 210.56/210.72 91%28%75%29%; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968%A%
% 210.56/210.72 |- mesh__recordMaintainer mesh__D006608 JLS
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006608 2005
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D006608 SJN
% 210.56/210.72 |- rdf__type mesh__D006608sskos__Concept
% 210.56/210.72 |- skos__hiddenLabel mesh__D006608 Social Hierarchies
% 210.56/210.72 |- skos__annotation mesh__D006608 human %26% animal; no qualif
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006608 2002
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D006608 2004
% 210.56/210.72 |- skos__hiddenLabel mesh__D017330 Hydrochloride, Remoxipride
% 210.56/210.72 |- skos__hiddenLabel mesh__D017330 FLA731
% 210.56/210.72 |- skos__prefLabel mesh__D017330 Remoxipride
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D017330 2002
% 210.56/210.72 |- mesh__onlineNote mesh__D017330
% 210.56/210.72 use REMOXIPRIDE %28%NM%29% to search REMOXIPRIDE 1984-92
% 210.56/210.72 |- mesh__recordOriginator mesh__D017330 TPW
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D017330 2005
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D017330
% 210.56/210.72 93; REMOXIPRIDE was indexed under BENZAMIDES 1984-92
% 210.56/210.72 |- skos__hiddenLabel mesh__D017330 Monohydrochloride, Remoxipride
% 210.56/210.72 |- mesh__dateCreated mesh__D017330 1992-05-20
% 210.56/210.72 |- skos__historyNote mesh__D017330 Benzamides %28%1984-1992%29%
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D017330 2006
% 210.56/210.72 |- mesh__dateRevised mesh__D017330 2000-06-22
% 210.56/210.72 |- mesh__recordMaintainer mesh__D017330 CCR
% 210.56/210.72 |- skos__scopeNote mesh__D017330
% 210.56/210.72 An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.%A%
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D017330 sjn
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D017330 2003
% 210.56/210.72 |- mesh__dateEstablished mesh__D017330 1993-01-01
% 210.56/210.72 |- rdf__type mesh__D017330sskos__Concept
% 210.56/210.72 |- skos__altLabel mesh__D017330
% 210.56/210.72 %28%S%29%-3-Bromo-N-%28%%28%1-ethyl-2-pyrrolidinyl%29%methyl%29%-2,6-dimethoxybenzamide
% 210.56/210.72 |- mesh__historyNote mesh__D017330
% 210.56/210.72 93; was REMOXIPRIDE %28%NM%29% 1984-92
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D017330 2001
% 210.56/210.72 |- skos__broader mesh__D017330smesh__D001549
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D017330 2004
% 210.56/210.72 |- skos__hiddenLabel mesh__D017330
% 210.56/210.72 Monohydrochloride Monohydrate, Remoxipride
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D031001 2006
% 210.56/210.72 |- skos__scopeNote mesh__D031001
% 210.56/210.72 A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are opposite and usually toothed or lobed. The fruit, a samara %28%a winged nutlet%29%, splits into two %28%rarely three%29% winged, one-seeded parts. This family is widely distributed in the Northern Hemisphere.%A%
% 210.56/210.72 |- mesh__historyNote mesh__D031001 2003
% 210.56/210.72 |- skos__prefLabel mesh__D031001 Aceraceae
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D031001 2003
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D031001 2003
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D031001 2004
% 210.56/210.72 |- skos__annotation mesh__D031001
% 210.56/210.72 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.72 |- mesh__dateEstablished mesh__D031001 2003-01-01
% 210.56/210.72 |- rdf__type mesh__D031001sskos__Concept
% 210.56/210.72 |- skos__broader mesh__D031001smesh__D019684
% 210.56/210.72 |- mesh__dateCreated mesh__D031001 2002-07-02
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D031001 2005
% 210.56/210.72 |- skos__altLabel mesh__D050764 Cyclin-Dependent Kinase Inhibitor 2D
% 210.56/210.72 |- mesh__publicMeSHNote mesh__D050764
% 210.56/210.72 2006; CYCLIN-DEPENDENT KINASE INHIBITOR P19 was indexed under CARRIER PROTEINS 1995-2001, under PROTEIN P16 2002-2004, %26% under CELL CYCLE PROTEINS 2005%A%
% 210.56/210.72 |- mesh__recordMaintainer mesh__D050764 DRC
% 210.56/210.72 |- mesh__dateEstablished mesh__D050764 2006-01-01
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D050764 2006
% 210.56/210.72 |- mesh__dateCreated mesh__D050764 2005-06-30
% 210.56/210.72 |- rdf__type mesh__D050764sskos__Concept
% 210.56/210.72 |- skos__scopeNote mesh__D050764
% 210.56/210.72 An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.%A%
% 210.56/210.72 |- mesh__recordAuthorizer mesh__D050764 sjn
% 210.56/210.72 |- skos__prefLabel mesh__D050764 Cyclin-Dependent Kinase Inhibitor p19
% 210.56/210.72 |- skos__altLabel mesh__D050764 INK4D Protein
% 210.56/210.72 |- mesh__historyNote mesh__D050764 2006%28%1995%29%
% 210.56/210.72 |- skos__hiddenLabel mesh__D050764 Cyclin Dependent Kinase Inhibitor 2D
% 210.56/210.72 |- skos__altLabel mesh__D050764 p19INK4D Protein
% 210.56/210.72 |- mesh__recordOriginator mesh__D050764 DRC
% 210.56/210.72 |- skos__altLabel mesh__D050764 CDKN2D Protein
% 210.56/210.72 |- skos__broader mesh__D050764smesh__D050756
% 210.56/210.72 |- skos__hiddenLabel mesh__D050764 Cyclin Dependent Kinase Inhibitor p19
% 210.56/210.72 |- mesh__activeMeSHYear mesh__D003310 2001
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D003310 2006
% 210.56/210.73 |- skos__scopeNote mesh__D003310
% 210.56/210.73 A congenital anomaly characterized by the presence in the atrium of a perforated muscular membrane which separates the atrium into upper and lower chambers.%A%
% 210.56/210.73 |- mesh__dateEstablished mesh__D003310 1987-01-01
% 210.56/210.73 |- skos__hiddenLabel mesh__D003310 Triatrial Hearts
% 210.56/210.73 |- skos__hiddenLabel mesh__D003310 Heart, Triatrial
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D003310 2002
% 210.56/210.73 |- mesh__recordMaintainer mesh__D003310 kle
% 210.56/210.73 |- rdf__type mesh__D003310sskos__Concept
% 210.56/210.73 |- skos__prefLabel mesh__D003310 Cor Triatriatum
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D003310 sjn
% 210.56/210.73 |- skos__historyNote mesh__D003310 Heart Atrium %28%1966-1986%29%
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D003310 87
% 210.56/210.73 |- mesh__historyNote mesh__D003310 87
% 210.56/210.73 |- mesh__dateRevised mesh__D003310 1999-11-03
% 210.56/210.73 |- skos__hiddenLabel mesh__D003310 Hearts, Triatrial
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D003310 2003
% 210.56/210.73 |- mesh__recordOriginator mesh__D003310 VDK
% 210.56/210.73 |- skos__historyNote mesh__D003310
% 210.56/210.73 Heart Defects, Congenital %28%1966-1986%29%
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D003310 2005
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D003310 2000
% 210.56/210.73 |- skos__broader mesh__D003310smesh__D006330
% 210.56/210.73 |- mesh__dateCreated mesh__D003310 1986-06-23
% 210.56/210.73 |- skos__altLabel mesh__D003310 Triatrial Heart
% 210.56/210.73 |- skos__annotation mesh__D003310
% 210.56/210.73 a heart with 3 atrial chambers; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D003310 2004
% 210.56/210.73 |- mesh__dateEstablished mesh__D016238 1991-01-01
% 210.56/210.73 |- skos__annotation mesh__D016238
% 210.56/210.73 do not use /util except by MeSH definition
% 210.56/210.73 |- mesh__recordMaintainer mesh__D016238 lkt
% 210.56/210.73 |- skos__hiddenLabel mesh__D016238 Cytaphereses
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D016238 91
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D016238 sjn
% 210.56/210.73 |- skos__broader mesh__D016238smesh__D002469
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D016238 2006
% 210.56/210.73 |- skos__broader mesh__D016238smesh__D001691
% 210.56/210.73 |- skos__prefLabel mesh__D016238 Cytapheresis
% 210.56/210.73 |- mesh__recordOriginator mesh__D016238 AGS
% 210.56/210.73 |- skos__related mesh__D016238smesh__D019264
% 210.56/210.73 |- skos__historyNote mesh__D016238
% 210.56/210.73 Blood Component Removal %28%1986-1990%29%
% 210.56/210.73 |- skos__scopeNote mesh__D016238
% 210.56/210.73 Separation of one or more kinds of cells from whole blood with the return of other blood cell constituents to the patient or donor. This is accomplished with an instrument that uses centrifugation to separate the cells into different layers based on the differences in cell density %28%displacement%29% or drag coefficients in a current %28%elutriation%29%. The procedure is commonly used in adoptive transfer to isolate NK cells, lymphocytes, or monocytes.%A%
% 210.56/210.73 |- rdf__type mesh__D016238sskos__Concept
% 210.56/210.73 |- mesh__historyNote mesh__D016238 91
% 210.56/210.73 |- mesh__dateRevised mesh__D016238 2005-06-30
% 210.56/210.73 |- skos__historyNote mesh__D016238 Cell Separation %28%1978-1990%29%
% 210.56/210.73 |- mesh__dateCreated mesh__D016238 1990-06-06
% 210.56/210.73 |- skos__broader mesh__D016238smesh__D001781
% 210.56/210.73 |- skos__related mesh__D016238smesh__D016219
% 210.56/210.73 |- skos__broader mesh__D002218smesh__D011810
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D002218 2003
% 210.56/210.73 |- skos__scopeNote mesh__D002218
% 210.56/210.73 An antibacterial agent that has been used in veterinary practice for treating swine dysentery and enteritis and for promoting growth. However, its use has been prohibited in the UK following reports of carcinogenicity and mutagenicity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p125%29%%A%
% 210.56/210.73 |- skos__prefLabel mesh__D002218 Carbadox
% 210.56/210.73 |- skos__historyNote mesh__D002218 Carbamates %28%1969-1974%29%
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D002218 2004
% 210.56/210.73 |- mesh__recordMaintainer mesh__D002218 CCR
% 210.56/210.73 |- mesh__dateCreated mesh__D002218 1974-11-19
% 210.56/210.73 |- mesh__recordOriginator mesh__D002218 NLM
% 210.56/210.73 |- mesh__historyNote mesh__D002218
% 210.56/210.73 91%28%75%29%; was see under QUINOXALINES 1975-90
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D002218 sjn
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D002218 2001
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D002218 2005
% 210.56/210.73 |- skos__broader mesh__D002218smesh__D002219
% 210.56/210.73 |- mesh__dateEstablished mesh__D002218 1991-01-01
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D002218 2002
% 210.56/210.73 |- skos__historyNote mesh__D002218 Quinoxalines %28%1973-1974%29%
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D002218 2006
% 210.56/210.73 |- mesh__dateRevised mesh__D002218 2000-06-22
% 210.56/210.73 |- rdf__type mesh__D002218sskos__Concept
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D002218
% 210.56/210.73 91; was see under QUINOXALINES 1975-90
% 210.56/210.73 |- mesh__historyNote mesh__D007701
% 210.56/210.73 2006%28%1975%29%; for KINETIN use KINETINS %28%NM%29% 1974-2005; use PLANT GROWTH REGULATORS 1975-1990%A%
% 210.56/210.73 |- skos__altLabel mesh__D007701 6-Furfuryladenine
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D007701
% 210.56/210.73 2006; see KINETINS 1991-2005, see PLANT GROWTH REGULATORS 1975-1990%A%
% 210.56/210.73 |- mesh__dateCreated mesh__D007701 1999-01-01
% 210.56/210.73 |- rdf__type mesh__D007701sskos__Concept
% 210.56/210.73 |- skos__broader mesh__D007701smesh__D003583
% 210.56/210.73 |- skos__hiddenLabel mesh__D007701 6 Furfuryladenine
% 210.56/210.73 |- skos__altLabel mesh__D007701 6-Furfurylaminopurine
% 210.56/210.73 |- mesh__dateEstablished mesh__D007701 1991-01-01
% 210.56/210.73 |- mesh__recordOriginator mesh__D007701 NLM
% 210.56/210.73 |- skos__hiddenLabel mesh__D007701 6 Furfurylaminopurine
% 210.56/210.73 |- skos__scopeNote mesh__D007701
% 210.56/210.73 A furanyl adenine found in PLANTS and FUNGI. It has plant growth regulation effects.%A%
% 210.56/210.73 |- skos__annotation mesh__D007701 do not confuse with KINECTIN
% 210.56/210.73 |- mesh__recordMaintainer mesh__D007701 ssb
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D007701 2006
% 210.56/210.73 |- skos__prefLabel mesh__D007701 Kinetin
% 210.56/210.73 |- mesh__dateRevised mesh__D007701 2005-06-30
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D007701 sjn
% 210.56/210.73 |- skos__broader mesh__D012646smesh__D012648
% 210.56/210.73 |- mesh__dateCreated mesh__D012646 1976-04-16
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012646 2006
% 210.56/210.73 |- mesh__dateEstablished mesh__D012646 1977-01-01
% 210.56/210.73 |- skos__hiddenLabel mesh__D012646 Administrations, Self
% 210.56/210.73 |- mesh__recordOriginator mesh__D012646 SMH
% 210.56/210.73 |- rdf__type mesh__D012646sskos__Concept
% 210.56/210.73 |- skos__prefLabel mesh__D012646 Self Administration
% 210.56/210.73 |- mesh__dateRevised mesh__D012646 2004-07-13
% 210.56/210.73 |- skos__historyNote mesh__D012646 Self Medication %28%1966-1976%29%
% 210.56/210.73 |- skos__broader mesh__D012646smesh__D004358
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D012646 sjn
% 210.56/210.73 |- skos__hiddenLabel mesh__D012646 Self Administrations
% 210.56/210.73 |- skos__altLabel mesh__D012646 Administration, Self
% 210.56/210.73 |- skos__annotation mesh__D012646
% 210.56/210.73 NIM; differentiate from SELF MEDICATION %26% SELF CARE %28%see note there%29%%A%
% 210.56/210.73 |- mesh__recordMaintainer mesh__D012646 sjn
% 210.56/210.73 |- skos__historyNote mesh__D012646
% 210.56/210.73 specific heading/administration %26% dosage %28%1966-1976%29%
% 210.56/210.73 |- skos__scopeNote mesh__D012646
% 210.56/210.73 Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal.%A%
% 210.56/210.73 |- mesh__historyNote mesh__D012646 77
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D012646 77
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012646 2005
% 210.56/210.73 |- skos__historyNote mesh__D045022
% 210.56/210.73 L-Lactate Dehydrogenase %28%1974-2003%29%
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D045022 2004
% 210.56/210.73 |- skos__prefLabel mesh__D045022 Lactate Dehydrogenases
% 210.56/210.73 |- mesh__historyNote mesh__D045022 2004
% 210.56/210.73 |- mesh__dateCreated mesh__D045022 2003-07-09
% 210.56/210.73 |- skos__annotation mesh__D045022
% 210.56/210.73 L-LACTATE DEHYDROGENASE and L-LACTATE DEHYDROGENASE %28%CYTOCHROME%29% are also available%A%
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D045022 2006
% 210.56/210.73 |- rdf__type mesh__D045022sskos__Concept
% 210.56/210.73 |- skos__broader mesh__D045022smesh__D000429
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D045022 2004
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D045022 2005
% 210.56/210.73 |- mesh__dateEstablished mesh__D045022 2004-01-01
% 210.56/210.73 |- skos__scopeNote mesh__D045022
% 210.56/210.73 Alcohol oxidoreductases with substrate specificity for LACTIC ACID.%A%
% 210.56/210.73 |- skos__hiddenLabel mesh__D045022 Dehydrogenases, Lactate
% 210.56/210.73 |- skos__historyNote mesh__D006609
% 210.56/210.73 Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 210.56/210.73 |- skos__broader mesh__D006609smesh__D002868
% 210.56/210.73 |- mesh__historyNote mesh__D006609 85
% 210.56/210.73 |- mesh__dateEstablished mesh__D006609 1985-01-01
% 210.56/210.73 |- skos__historyNote mesh__D006609 Nucleoproteins %28%1966-1981%29%
% 210.56/210.73 |- skos__altLabel mesh__D006609 HMG Proteins
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D006609 2006
% 210.56/210.73 |- skos__annotation mesh__D006609
% 210.56/210.73 GEN or unspecified; HMG-BOX DOMAINS is also available
% 210.56/210.73 |- mesh__recordMaintainer mesh__D006609 SYSTEM
% 210.56/210.73 |- mesh__recordOriginator mesh__D006609 RLS
% 210.56/210.73 |- mesh__dateRevised mesh__D006609 2005-06-30
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D006609 sjn
% 210.56/210.73 |- rdf__type mesh__D006609sskos__Concept
% 210.56/210.73 |- mesh__dateCreated mesh__D006609 1984-05-30
% 210.56/210.73 |- skos__scopeNote mesh__D006609
% 210.56/210.73 A family of low-molecular weight, non-histone proteins found in chromatin.%A%
% 210.56/210.73 |- skos__altLabel mesh__D006609 High Mobility Group Chromosomal Proteins
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D006609 85
% 210.56/210.73 |- skos__prefLabel mesh__D006609 High Mobility Group Proteins
% 210.56/210.73 |- skos__altLabel mesh__D031002 Maple
% 210.56/210.73 |- skos__altLabel mesh__D031002 Elder, Box
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031002 2006
% 210.56/210.73 |- skos__prefLabel mesh__D031002 Acer
% 210.56/210.73 |- mesh__historyNote mesh__D031002 2003
% 210.56/210.73 |- skos__scopeNote mesh__D031002
% 210.56/210.73 A plant genus of the family ACERACEAE, best known for trees with palmately lobed leaves.%A%
% 210.56/210.73 |- skos__annotation mesh__D031002
% 210.56/210.73 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.73 |- mesh__dateRevised mesh__D031002 2003-07-25
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D031002 sjn
% 210.56/210.73 |- skos__altLabel mesh__D031002 Sugar Maple
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D031002 2003
% 210.56/210.73 |- rdf__type mesh__D031002sskos__Concept
% 210.56/210.73 |- skos__altLabel mesh__D031002 Box Elder
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031002 2004
% 210.56/210.73 |- mesh__dateEstablished mesh__D031002 2003-01-01
% 210.56/210.73 |- skos__broader mesh__D031002smesh__D031001
% 210.56/210.73 |- mesh__dateCreated mesh__D031002 2002-07-02
% 210.56/210.73 |- mesh__recordMaintainer mesh__D031002 sjn
% 210.56/210.73 |- mesh__recordOriginator mesh__D031002 ssb
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031002 2005
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin Protein
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 3B Protein
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 7 Protein
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 3A Protein
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxins
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 17 Protein
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D050765 2006
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 6 Protein
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 11 Protein
% 210.56/210.73 |- skos__scopeNote mesh__D050765
% 210.56/210.73 A subfamily of Q-SNARE PROTEINS which occupy the same position as syntaxin 1A in the SNARE complex and which also are most similar to syntaxin 1A in their AMINO ACID SEQUENCE. This subfamily is also known as the syntaxins, although a few so called syntaxins are Qc-SNARES.%A%
% 210.56/210.73 |- skos__broader mesh__D050765smesh__D050682
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin Proteins
% 210.56/210.73 |- mesh__recordOriginator mesh__D050765 nns
% 210.56/210.73 |- mesh__recordMaintainer mesh__D050765 ags
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 18 Protein
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D050765
% 210.56/210.73 2006; SYNTAXIN %28%now QA-SNARE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1995-2005 and PROTEINS 1994%A%
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D050765 2006A
% 210.56/210.73 |- rdf__type mesh__D050765sskos__Concept
% 210.56/210.73 |- mesh__historyNote mesh__D050765 2006 %28%1994%29%
% 210.56/210.73 |- mesh__dateCreated mesh__D050765 2005-06-30
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 4 Protein
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D050765 ags
% 210.56/210.73 |- skos__hiddenLabel mesh__D050765 Qa SNAREs
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 13 Protein
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 3D Protein
% 210.56/210.73 |- skos__prefLabel mesh__D050765 Qa-SNARE Proteins
% 210.56/210.73 |- skos__hiddenLabel mesh__D050765 11 Protein, Syntaxin
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 5 Protein
% 210.56/210.73 |- skos__hiddenLabel mesh__D050765 Protein, Syntaxin
% 210.56/210.73 |- skos__hiddenLabel mesh__D050765 Protein, Syntaxin 11
% 210.56/210.73 |- skos__hiddenLabel mesh__D050765 Qa SNARE Proteins
% 210.56/210.73 |- mesh__dateEstablished mesh__D050765 2006-01-01
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 8 Protein
% 210.56/210.73 |- skos__altLabel mesh__D050765 Qa-SNAREs
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 10 Protein
% 210.56/210.73 |- mesh__dateRevised mesh__D050765 2005-07-27
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 1A Homologs
% 210.56/210.73 |- skos__hiddenLabel mesh__D050765 Proteins, Syntaxin
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 3 Protein
% 210.56/210.73 |- skos__altLabel mesh__D050765 Syntaxin 3C Protein
% 210.56/210.73 |- mesh__dateEstablished mesh__D003311 1991-01-01
% 210.56/210.73 |- skos__altLabel mesh__D003311 Cord Factor
% 210.56/210.73 |- mesh__recordMaintainer mesh__D003311 ssb
% 210.56/210.73 |- skos__hiddenLabel mesh__D003311 Factors, Cord
% 210.56/210.73 |- skos__broader mesh__D003311smesh__D001427
% 210.56/210.73 |- rdf__type mesh__D003311sskos__Concept
% 210.56/210.73 |- mesh__dateCreated mesh__D003311 1974-11-11
% 210.56/210.73 |- skos__historyNote mesh__D003311 Trehalose %28%1973-1974%29%
% 210.56/210.73 |- skos__hiddenLabel mesh__D003311 Trehalose 6,6%27% Dimycolate
% 210.56/210.73 |- skos__altLabel mesh__D003311 Trehalose Dimycolates
% 210.56/210.73 |- mesh__historyNote mesh__D003311
% 210.56/210.73 91%28%80%29%; was see under GLYCOLIPIDS 1980-90; was CORD FACTOR see under GLYCOLIPIDS 1975-79%A%
% 210.56/210.73 |- skos__scopeNote mesh__D003311
% 210.56/210.73 Toxic glycolipids composed of trehalose dimycolate derivatives. They are produced by MYCOBACTERIUM TUBERCULOSIS and other species of MYCOBACTERIUM. They induce cellular dysfunction in animals.%A%
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D003311 2006
% 210.56/210.73 |- skos__hiddenLabel mesh__D003311 Factor, Cord
% 210.56/210.73 |- skos__broader mesh__D003311smesh__D006017
% 210.56/210.73 |- skos__hiddenLabel mesh__D003311 Dimycolates, Trehalose
% 210.56/210.73 |- mesh__dateRevised mesh__D003311 2005-06-30
% 210.56/210.73 |- skos__historyNote mesh__D003311 Glycolipids %28%1971-1974%29%
% 210.56/210.73 |- mesh__recordOriginator mesh__D003311 NLM
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D003311
% 210.56/210.73 91; was see under GLYCOLIPIDS 1980-90; was CORD FACTOR see under GLYCOLIPIDS 1975-79%A%
% 210.56/210.73 |- skos__prefLabel mesh__D003311 Cord Factors
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D003311 sjn
% 210.56/210.73 |- skos__historyNote mesh__D003311 Mycobacterium Tuberculosis %28%1974%29%
% 210.56/210.73 |- mesh__onlineNote mesh__D003311
% 210.56/210.73 use CORD FACTORS to search CORD FACTOR 1975-79
% 210.56/210.73 |- rdf__type mesh__D016239sskos__Concept
% 210.56/210.73 |- skos__historyNote mesh__D016239 MEDLARS %28%1978-1990%29%
% 210.56/210.73 |- skos__historyNote mesh__D016239
% 210.56/210.73 National Library of Medicine %28%U.S.%29% %28%1966-1977%29%
% 210.56/210.73 |- skos__related mesh__D016239smesh__D046650
% 210.56/210.73 |- mesh__dateCreated mesh__D016239 1990-06-06
% 210.56/210.73 |- mesh__recordMaintainer mesh__D016239 ags
% 210.56/210.73 |- mesh__historyNote mesh__D016239
% 210.56/210.73 1991; use MEDLARS 1978-1990; for INDEX MEDICUS use MEDLINE 1979-2004%A%
% 210.56/210.73 |- skos__annotation mesh__D016239 CATALOG: use NAF entry
% 210.56/210.73 |- skos__scopeNote mesh__D016239
% 210.56/210.73 The premier bibliographic database of the NATIONAL LIBRARY OF MEDICINE. MEDLINE%C2%%AE% %28%MEDLARS Online%29% is the primary subset of PUBMED and can be searched on NLM%27%s Web site in PubMed or the NLM Gateway. MEDLINE references are indexed with MEDICAL SUBJECT HEADINGS %28%MeSH%29%.%A%
% 210.56/210.73 |- mesh__dateEstablished mesh__D016239 1991-01-01
% 210.56/210.73 |- mesh__recordOriginator mesh__D016239 TGC
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D016239
% 210.56/210.73 1991; see MEDLARS-MEDLINE INFORMATION SYSTEM 1978-1990; for INDEX MEDICUS see MEDLINE 1979-2004%A%
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D016239 sjn
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D016239 2006
% 210.56/210.73 |- mesh__dateRevised mesh__D016239 2004-07-07
% 210.56/210.73 |- skos__broader mesh__D016239smesh__D008523
% 210.56/210.73 |- skos__prefLabel mesh__D016239 MEDLINE
% 210.56/210.73 |- skos__historyNote mesh__D016239 Information Systems %28%1966-1977%29%
% 210.56/210.73 |- skos__related mesh__D016239smesh__D039781
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D016239 2005
% 210.56/210.73 |- skos__broader mesh__D016239smesh__D039781
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D002219 2005
% 210.56/210.73 |- mesh__recordMaintainer mesh__D002219 ssb
% 210.56/210.73 |- mesh__dateCreated mesh__D002219 1999-01-01
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D002219 2006
% 210.56/210.73 |- skos__broader mesh__D002219smesh__D000144
% 210.56/210.73 |- rdf__type mesh__D002219sskos__Concept
% 210.56/210.73 |- mesh__onlineNote mesh__D002219
% 210.56/210.73 use CARBAMATES to search TYBAMATE 1966-84 %28%as Prov 1966-72%29%%A%
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D002219 TYBAMATE was heading 1973-84
% 210.56/210.73 |- skos__scopeNote mesh__D002219
% 210.56/210.73 Salts or esters of carbamic acid, H2NC%28%=O%29%OH, or of N-substituted carbamic acids: R2NC%28%=O%29%OR%27%, %28%R%27% = hydrocarbyl or a cation%29%. The esters are often called URETHANE or urethan, a usage that is strictly correct only for the ethyl esters. %28%From IUPAC %5B%Internet%5D%. International Union Of Pure And Applied Chemistry; c1995 %5B%updated 2004 Jan 9; cited 2004 May 3%5D%. Available from http://www.chem.qmul.ac.uk/iupac/class/oneN.html%23%35/%29%.%A%
% 210.56/210.73 |- mesh__dateRevised mesh__D002219 2004-07-07
% 210.56/210.73 |- skos__prefLabel mesh__D002219 Carbamates
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D002219 sjn
% 210.56/210.73 |- mesh__recordOriginator mesh__D002219 NLM
% 210.56/210.73 |- mesh__historyNote mesh__D002219
% 210.56/210.73 TYBAMATE was heading 1965-84 %28%Prov 1965-72%29%
% 210.56/210.73 |- skos__prefLabel mesh__D007702 Kinetocardiography
% 210.56/210.73 |- skos__hiddenLabel mesh__D007702 Accelographies
% 210.56/210.73 |- skos__scopeNote mesh__D007702
% 210.56/210.73 The graphic recording of chest wall movement due to cardiac impulses.%A%
% 210.56/210.73 |- mesh__dateCreated mesh__D007702 1999-01-01
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D007702 sjn
% 210.56/210.73 |- rdf__type mesh__D007702sskos__Concept
% 210.56/210.73 |- skos__hiddenLabel mesh__D007702 Vibrocardiographies
% 210.56/210.73 |- mesh__dateEstablished mesh__D007702 1967-01-01
% 210.56/210.73 |- mesh__dateRevised mesh__D007702 1999-11-03
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D007702 67
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D007702 2003
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D007702 2000
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D007702 2005
% 210.56/210.73 |- mesh__recordMaintainer mesh__D007702 KEV
% 210.56/210.73 |- skos__broader mesh__D007702smesh__D006334
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D007702 2004
% 210.56/210.73 |- skos__annotation mesh__D007702 DF: KINETOCARDIOGR
% 210.56/210.73 |- skos__hiddenLabel mesh__D007702 Apex Cardiographies
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D007702 2001
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D007702 2006
% 210.56/210.73 |- skos__hiddenLabel mesh__D007702 Kinetocardiographies
% 210.56/210.73 |- mesh__recordOriginator mesh__D007702 NLM
% 210.56/210.73 |- skos__hiddenLabel mesh__D007702 Cardiographies, Apex
% 210.56/210.73 |- skos__altLabel mesh__D007702 Cardiography, Apex
% 210.56/210.73 |- mesh__historyNote mesh__D007702 67%28%64%29%
% 210.56/210.73 |- skos__altLabel mesh__D007702 Vibrocardiography
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D007702 2002
% 210.56/210.73 |- skos__broader mesh__D005740Q000506smesh__D005740
% 210.56/210.73 |- mesh__preferredCombination mesh__D005740Q000506smesh__D005739
% 210.56/210.73 |- rdf__type mesh__D005740Q000506smesh__CompoundConcept
% 210.56/210.73 |- skos__broader mesh__D012647smesh__D012649
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 2003
% 210.56/210.73 |- mesh__dateEstablished mesh__D012647 1979-01-01
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 2000
% 210.56/210.73 |- skos__hiddenLabel mesh__D012647 Self Assessments %28%Psychology%29%
% 210.56/210.73 |- rdf__type mesh__D012647sskos__Concept
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 2004
% 210.56/210.73 |- skos__historyNote mesh__D012647 Self Concept %28%1969-1974%29%
% 210.56/210.73 |- skos__annotation mesh__D012647 no qualif; DF: SELF ASSESS
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D012647 PLS
% 210.56/210.73 |- skos__altLabel mesh__D012647 Assessment, Self
% 210.56/210.73 |- mesh__recordOriginator mesh__D012647 NLM
% 210.56/210.73 |- mesh__dateRevised mesh__D012647 1994-02-08
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 2001
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 1998
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 1995
% 210.56/210.73 |- skos__hiddenLabel mesh__D012647 Assessment, Self %28%Psychology%29%
% 210.56/210.73 |- skos__hiddenLabel mesh__D012647 Assessments, Self %28%Psychology%29%
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 1999
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D012647
% 210.56/210.73 79; was SELF ASSESSMENT see under SELF CONCEPT 1969-78
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 2005
% 210.56/210.73 |- skos__altLabel mesh__D012647 Self Assessment
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 2002
% 210.56/210.73 |- mesh__recordMaintainer mesh__D012647 TGC
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 1996
% 210.56/210.73 |- skos__hiddenLabel mesh__D012647 Assessments, Self
% 210.56/210.73 |- skos__prefLabel mesh__D012647 Self Assessment %28%Psychology%29%
% 210.56/210.73 |- skos__hiddenLabel mesh__D012647 Self Assessments
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 2006
% 210.56/210.73 |- skos__scopeNote mesh__D012647
% 210.56/210.73 Appraisal of one%27%s own personal qualities or traits.
% 210.56/210.73 |- mesh__onlineNote mesh__D012647
% 210.56/210.73 use SELF ASSESSMENT %28%PSYCHOLOGY%29% to search SELF ASSESSMENT 1975-78; use SELF CONCEPT 1969-74%A%
% 210.56/210.73 |- mesh__historyNote mesh__D012647
% 210.56/210.73 79; was SELF ASSESSMENT see under SELF CONCEPT 1969-78
% 210.56/210.73 |- mesh__dateCreated mesh__D012647 1999-01-01
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D012647 1997
% 210.56/210.73 |- skos__broader mesh__D031801smesh__D029608
% 210.56/210.73 |- skos__annotation mesh__D031801
% 210.56/210.73 other snakeroots are available such as ASARUM; SANICULA; ARISTOLOCHIA; AGERATINA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031801 2005
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D031801 2003
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031801 2006
% 210.56/210.73 |- mesh__historyNote mesh__D031801 2003
% 210.56/210.73 |- skos__altLabel mesh__D031801 Snakeroot, Seneca
% 210.56/210.73 |- rdf__type mesh__D031801sskos__Concept
% 210.56/210.73 |- skos__scopeNote mesh__D031801
% 210.56/210.73 A plant genus of the family POLYGALACEAE that contains onjisaponins, xanthones, pyrones, and benzophenones. The name is similar to other snakeroots such as ASARUM; SANICULA; ARISTOLOCHIA; AGERATINA; and others.%A%
% 210.56/210.73 |- mesh__dateEstablished mesh__D031801 2003-01-01
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031801 2003
% 210.56/210.73 |- skos__prefLabel mesh__D031801 Polygala
% 210.56/210.73 |- mesh__dateCreated mesh__D031801 2002-07-03
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031801 2004
% 210.56/210.73 |- skos__historyNote mesh__D017332
% 210.56/210.73 Hydroxyzine/analogs %26% derivatives %28%1987-1992%29%
% 210.56/210.73 |- skos__scopeNote mesh__D017332
% 210.56/210.73 A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.%A%
% 210.56/210.73 |- skos__altLabel mesh__D017332 Krewel Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 Azupharma Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- mesh__dateRevised mesh__D017332 2005-06-30
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 Sanofi Synthelabo Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332 Rodleben Brand of Cetirizine
% 210.56/210.73 |- skos__prefLabel mesh__D017332 Cetirizine
% 210.56/210.73 |- skos__altLabel mesh__D017332 UCB Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 UCB Pharma Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 AWD.pharma Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- mesh__recordMaintainer mesh__D017332 lkw
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 ct-Arzneimittel Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 Merck dura Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 Dermapharm Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D017332 2006
% 210.56/210.73 |- skos__altLabel mesh__D017332 Aliud Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- rdf__type mesh__D017332sskos__Concept
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 Menarini Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 W%C3%%B6%rwag Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 Pfizer Consumer Healthcare Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__broader mesh__D017332smesh__D006919
% 210.56/210.73 |- skos__hiddenLabel mesh__D017332 P 071
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 United Drug Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332 Zirtek
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 Alpharma Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332 TAD Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- mesh__dateCreated mesh__D017332 1992-05-07
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 %28%2-%28%4-%28%%28%4-Chlorophenyl%29%phenylmethyl%29%-1-piperazinyl%29%ethoxy%29%acetic Acid
% 210.56/210.73 |- skos__altLabel mesh__D017332 Reactine
% 210.56/210.73 |- mesh__historyNote mesh__D017332 93; was CETIRIZINE %28%NM%29% 1987-92
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D017332
% 210.56/210.73 93; CETIRIZINE was indexed under HYDROXYZINE/analogs %26% derivatives 1987-92%A%
% 210.56/210.73 |- skos__hiddenLabel mesh__D017332 Dihydrochloride, Cetirizine
% 210.56/210.73 |- mesh__dateEstablished mesh__D017332 1993-01-01
% 210.56/210.73 |- skos__altLabel mesh__D017332 Wolff Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- mesh__onlineNote mesh__D017332
% 210.56/210.73 use CETIRIZINE %28%NM%29% to search CETIRIZINE 1987-92
% 210.56/210.73 |- skos__hiddenLabel mesh__D017332 P071
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 Glaxo Wellcome Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332
% 210.56/210.73 Lichtenstein Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332 Pfizer Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- mesh__recordOriginator mesh__D017332 TPW
% 210.56/210.73 |- mesh__recordAuthorizer mesh__D017332 sjn
% 210.56/210.73 |- skos__altLabel mesh__D017332 Basics Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332 Lacer Brand of Cetirizine Dihydrochloride
% 210.56/210.73 |- skos__altLabel mesh__D017332 Voltric
% 210.56/210.73 |- mesh__dateCreated mesh__D031003 2002-07-02
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031003 2003
% 210.56/210.73 |- skos__annotation mesh__D031003
% 210.56/210.73 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.73 |- mesh__publicMeSHNote mesh__D031003 2003
% 210.56/210.73 |- rdf__type mesh__D031003sskos__Concept
% 210.56/210.73 |- skos__prefLabel mesh__D031003 Adoxaceae
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031003 2004
% 210.56/210.73 |- mesh__historyNote mesh__D031003 2003
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031003 2005
% 210.56/210.73 |- mesh__dateEstablished mesh__D031003 2003-01-01
% 210.56/210.73 |- skos__altLabel mesh__D031003 Muskroot
% 210.56/210.73 |- skos__broader mesh__D031003smesh__D019684
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D031003 2006
% 210.56/210.73 |- skos__scopeNote mesh__D031003
% 210.56/210.73 A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE.%A%
% 210.56/210.73 |- skos__scopeNote mesh__D050766
% 210.56/210.73 A subfamily of Q-SNARE PROTEINS which occupy the same position in the SNARE complex as the N-terminal SNARE domain of SNAP-25 and which also are most similar to the N-terminal region of SNAP-25 in their AMINO ACID SEQUENCE.%A%
% 210.56/210.73 |- mesh__dateEstablished mesh__D050766 2006-01-01
% 210.56/210.73 |- mesh__recordMaintainer mesh__D050766 ags
% 210.56/210.73 |- skos__hiddenLabel mesh__D050766 Qb SNAREs
% 210.56/210.73 |- mesh__activeMeSHYear mesh__D050766 2006
% 210.56/210.73 |- skos__altLabel mesh__D050766 Qb-SNAREs
% 210.56/210.73 |- mesh__dateCreated mesh__D050766 2005-06-30
% 210.56/210.73 |- skos__prefLabel mesh__D050766 Qb-SNARE Proteins
% 210.56/210.73 |- rdf__type mesh__D050766sskos__Concept
% 210.56/210.74 |- mesh__dateRevised mesh__D050766 2005-07-27
% 210.56/210.74 |- skos__broader mesh__D050766smesh__D050682
% 210.56/210.74 |- mesh__historyNote mesh__D050766 2006
% 210.56/210.74 |- mesh__recordOriginator mesh__D050766 nns
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D050766 2006A
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D050766 ags
% 210.56/210.74 |- skos__hiddenLabel mesh__D050766 Qb SNARE Proteins
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D050766 2006
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 2002
% 210.56/210.74 |- mesh__recordOriginator mesh__D003312 NLM
% 210.56/210.74 |- mesh__dateEstablished mesh__D003312 1970-01-01
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D003312 PLS
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 2003
% 210.56/210.74 |- mesh__dateRevised mesh__D003312 1995-05-18
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 2005
% 210.56/210.74 |- mesh__dateCreated mesh__D003312 1999-01-01
% 210.56/210.74 |- skos__broader mesh__D003312smesh__D009038
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 2004
% 210.56/210.74 |- skos__prefLabel mesh__D003312 Coriolis Force
% 210.56/210.74 |- skos__hiddenLabel mesh__D003312 Acceleration, Coriolis
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 1996
% 210.56/210.74 |- mesh__onlineNote mesh__D003312
% 210.56/210.74 use CORIOLIS FORCE to search CORIOLIS EFFECT 1966-69 %28%as Prov%29%%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 2006
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 2000
% 210.56/210.74 |- skos__scopeNote mesh__D003312
% 210.56/210.74 The apparent deflection %28%Coriolis acceleration%29% of a body in motion with respect to the earth, as seen by an observer on the earth, attributed to a fictitious force %28%Coriolis force%29% but actually caused by the rotation of the earth. In a medical context it refers to the physiological effects %28%nausea, vertigo, dizziness, etc.%29% felt by a person moving radially in a rotating system, as a rotating space station. %28%From Random House Unabridged Dictionary, 2d ed %26% McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 1998
% 210.56/210.74 |- skos__hiddenLabel mesh__D003312 Stimulation, Coriolis
% 210.56/210.74 |- mesh__recordMaintainer mesh__D003312 TGC
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 1997
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 2001
% 210.56/210.74 |- skos__annotation mesh__D003312
% 210.56/210.74 a principle of motion; named for Gaspard Coriolis %28%d. 1843%29%, a French civil engineer; no qualif%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003312 1999
% 210.56/210.74 |- skos__hiddenLabel mesh__D003312 Effect, Coriolis
% 210.56/210.74 |- skos__hiddenLabel mesh__D003312 Force, Coriolis
% 210.56/210.74 |- rdf__type mesh__D003312sskos__Concept
% 210.56/210.74 |- mesh__historyNote mesh__D003312
% 210.56/210.74 70; was CORIOLIS EFFECT 1964-69 %28%Prov%29%
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D003312 70
% 210.56/210.74 |- skos__scopeNote mesh__D007703
% 210.56/210.74 A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, -Xaa-*-Xbb-Xcc, when neither Xaa nor Xbb is Pro. It is a Cl%28%-%29%-dependent, zinc glycoprotein that is generally membrane-bound and active at neutral pH. It may also have endopeptidase activity on some substrates. %28%From Enzyme Nomenclature, 1992%29% EC 3.4.15.1.%A%
% 210.56/210.74 |- mesh__recordOriginator mesh__D007703 NLM
% 210.56/210.74 |- skos__broader mesh__D007703smesh__D015703
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D007703 2006
% 210.56/210.74 |- skos__altLabel mesh__D007703 Carboxycathepsin
% 210.56/210.74 |- mesh__recordMaintainer mesh__D007703 ssb
% 210.56/210.74 |- skos__hiddenLabel mesh__D007703 Angiotensin I Converting Enzyme
% 210.56/210.74 |- mesh__historyNote mesh__D007703
% 210.56/210.74 94; was KININASE II 1973-93 %28%Prov 1973%29%; TONIN was see KININASE II 1984-93%A%
% 210.56/210.74 |- skos__altLabel mesh__D007703 Dipeptidyl Peptidase A
% 210.56/210.74 |- skos__altLabel mesh__D007703 CD143 Antigens
% 210.56/210.74 |- mesh__dateRevised mesh__D007703 2005-06-30
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D007703
% 210.56/210.74 94; was KININASE II 1974-93; TONIN was see KININASE II 1984-93%A%
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D007703 sjn
% 210.56/210.74 |- skos__altLabel mesh__D007703 Antigens, CD143
% 210.56/210.74 |- skos__annotation mesh__D007703
% 210.56/210.74 /antag = ANGIOTENSIN-CONVERTING ENZYME INHIBITORS
% 210.56/210.74 |- skos__hiddenLabel mesh__D007703 Peptidyl Dipeptidase A
% 210.56/210.74 |- skos__broader mesh__D007703smesh__D020689
% 210.56/210.74 |- skos__historyNote mesh__D007703
% 210.56/210.74 Peptide Peptidohydrolases %28%1966-1972%29%
% 210.56/210.74 |- skos__altLabel mesh__D007703 Kininase A
% 210.56/210.74 |- mesh__onlineNote mesh__D007703
% 210.56/210.74 use PEPTIDYL-DIPEPTIDASE A to search KININASE II 1973-93 %28%as Prov 1973%29% %26% TONIN 1984-93%A%
% 210.56/210.74 |- mesh__dateCreated mesh__D007703 1999-01-01
% 210.56/210.74 |- rdf__type mesh__D007703sskos__Concept
% 210.56/210.74 |- mesh__dateEstablished mesh__D007703 1974-01-01
% 210.56/210.74 |- skos__altLabel mesh__D007703 Angiotensin I-Converting Enzyme
% 210.56/210.74 |- skos__altLabel mesh__D007703 Angiotensin Converting Enzyme
% 210.56/210.74 |- skos__altLabel mesh__D007703 Kininase II
% 210.56/210.74 |- skos__prefLabel mesh__D007703 Peptidyl-Dipeptidase A
% 210.56/210.74 |- skos__broader mesh__D002343Q000293smesh__D002343
% 210.56/210.74 |- mesh__preferredCombination mesh__D002343Q000293smesh__D020212
% 210.56/210.74 |- rdf__type mesh__D002343Q000293smesh__CompoundConcept
% 210.56/210.74 |- mesh__historyNote mesh__D045822
% 210.56/210.74 2004; use INTESTINAL OBSTRUCTION 1975-2003
% 210.56/210.74 |- skos__prefLabel mesh__D045822 Intestinal Volvulus
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D045822 2005
% 210.56/210.74 |- skos__altLabel mesh__D045822 Volvulus
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D045822
% 210.56/210.74 2004; see INTESTINAL OBSTRUCTION 1975-2003
% 210.56/210.74 |- skos__historyNote mesh__D045822 Intestinal Obstruction %28%1965-2003%29%
% 210.56/210.74 |- rdf__type mesh__D045822sskos__Concept
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D045822 2006
% 210.56/210.74 |- mesh__dateEstablished mesh__D045822 2004-01-01
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D045822 2004
% 210.56/210.74 |- skos__altLabel mesh__D045822 Volvulus, Intestine
% 210.56/210.74 |- skos__broader mesh__D045822smesh__D007415
% 210.56/210.74 |- skos__scopeNote mesh__D045822
% 210.56/210.74 A twisting in the intestine %28%INTESTINES%29% that can cause INTESTINAL OBSTRUCTION.%A%
% 210.56/210.74 |- mesh__dateCreated mesh__D045822 2003-07-09
% 210.56/210.74 |- skos__broader mesh__D045822smesh__D014102
% 210.56/210.74 |- skos__hiddenLabel mesh__D045822 Volvulus, Intestinal
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 1998
% 210.56/210.74 |- skos__historyNote mesh__D012648 Health Education %28%1966-1980%29%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 2006
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 2000
% 210.56/210.74 |- mesh__dateCreated mesh__D012648 1980-05-19
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 1996
% 210.56/210.74 |- mesh__dateEstablished mesh__D012648 1981-01-01
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 2004
% 210.56/210.74 |- skos__hiddenLabel mesh__D012648 Care, Self
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D012648 PLS
% 210.56/210.74 |- skos__annotation mesh__D012648
% 210.56/210.74 = care prescribed by MD or generated by person himself %26% includes care for self, family or friends; differentiate from SELF MEDICATION %28%medication not prescribed by MD%29% and SELF ADMINISTRATION %28%admin of medication prescribed by MD or self admin of substances by exper animals%29%%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 2005
% 210.56/210.74 |- rdf__type mesh__D012648sskos__Concept
% 210.56/210.74 |- mesh__historyNote mesh__D012648
% 210.56/210.74 81; was see ACTIVITIES OF DAILY LIVING 1979-80
% 210.56/210.74 |- skos__altLabel mesh__D012648 Self-Care
% 210.56/210.74 |- skos__historyNote mesh__D012648 Patient Participation %28%1978%29%
% 210.56/210.74 |- skos__historyNote mesh__D012648 Consumer Participation %28%1974-1978%29%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 2003
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 2002
% 210.56/210.74 |- skos__historyNote mesh__D012648 Patient Education %28%1966-1980%29%
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D012648
% 210.56/210.74 81; was see ACTIVITIES OF DAILY LIVING 1979-80
% 210.56/210.74 |- skos__hiddenLabel mesh__D012648 Self Management
% 210.56/210.74 |- mesh__onlineNote mesh__D012648
% 210.56/210.74 search ACTIVITIES OF DAILY LIVING 1979-80
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 1999
% 210.56/210.74 |- mesh__recordMaintainer mesh__D012648 KEV
% 210.56/210.74 |- skos__broader mesh__D012648smesh__D013812
% 210.56/210.74 |- skos__broader mesh__D012648smesh__D012046
% 210.56/210.74 |- mesh__recordOriginator mesh__D012648 SMH
% 210.56/210.74 |- skos__prefLabel mesh__D012648 Self Care
% 210.56/210.74 |- skos__scopeNote mesh__D012648
% 210.56/210.74 Performance of activities or tasks traditionally performed by professional health care providers. The concept includes care of oneself or one%27%s family and friends.%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 1997
% 210.56/210.74 |- skos__historyNote mesh__D012648
% 210.56/210.74 Activities of Daily Living %28%1978-1980%29%
% 210.56/210.74 |- mesh__dateRevised mesh__D012648 1995-05-23
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012648 2001
% 210.56/210.74 |- skos__prefLabel mesh__D031802 Securidaca
% 210.56/210.74 |- mesh__dateCreated mesh__D031802 2002-07-03
% 210.56/210.74 |- skos__scopeNote mesh__D031802
% 210.56/210.74 A plant genus of the family POLYGALACEAE that contains securiosides and indole alkaloids.%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D031802 2003
% 210.56/210.74 |- skos__broader mesh__D031802smesh__D029608
% 210.56/210.74 |- rdf__type mesh__D031802sskos__Concept
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D031802 2004
% 210.56/210.74 |- skos__annotation mesh__D031802
% 210.56/210.74 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D031802 2005
% 210.56/210.74 |- mesh__historyNote mesh__D031802 2003
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D031802 2003
% 210.56/210.74 |- mesh__dateEstablished mesh__D031802 2003-01-01
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D031802 2006
% 210.56/210.74 |- rdf__type mesh__D050767sskos__Concept
% 210.56/210.74 |- skos__scopeNote mesh__D050767
% 210.56/210.74 A subfamily of Q-SNARE PROTEINS which occupy the same position in the SNARE complex as the C-terminal SNARE domain of SNAP-25 and which also are most similar to the C-terminal region of SNAP-25 in their AMINO ACID SEQUENCE.%A%
% 210.56/210.74 |- skos__broader mesh__D050767smesh__D050682
% 210.56/210.74 |- mesh__dateRevised mesh__D050767 2005-07-27
% 210.56/210.74 |- mesh__historyNote mesh__D050767 2006
% 210.56/210.74 |- mesh__dateEstablished mesh__D050767 2006-01-01
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D050767 2006A
% 210.56/210.74 |- skos__prefLabel mesh__D050767 Qc-SNARE Proteins
% 210.56/210.74 |- skos__hiddenLabel mesh__D050767 Qc SNARE Proteins
% 210.56/210.74 |- mesh__recordOriginator mesh__D050767 nns
% 210.56/210.74 |- skos__hiddenLabel mesh__D050767 Qc SNAREs
% 210.56/210.74 |- skos__altLabel mesh__D050767 Qc-SNAREs
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D050767 ags
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D050767 2006
% 210.56/210.74 |- mesh__dateCreated mesh__D050767 2005-06-30
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D050767 2006
% 210.56/210.74 |- mesh__recordMaintainer mesh__D050767 ags
% 210.56/210.74 |- mesh__dateRevised mesh__D003313 2002-07-03
% 210.56/210.74 |- skos__broader mesh__D003313smesh__D002523
% 210.56/210.74 |- skos__hiddenLabel mesh__D003313 Corn, Indian
% 210.56/210.74 |- rdf__type mesh__D003313sskos__Concept
% 210.56/210.74 |- skos__broader mesh__D003313smesh__D000821
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D003313
% 210.56/210.74 2003; see CORN 1966-2002, see GRAIN 1963-1965
% 210.56/210.74 |- mesh__recordMaintainer mesh__D003313 ssb
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003313 2004
% 210.56/210.74 |- mesh__recordOriginator mesh__D003313 NLM
% 210.56/210.74 |- skos__altLabel mesh__D003313 Maize
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D003313 sjn
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003313 2003
% 210.56/210.74 |- skos__prefLabel mesh__D003313 Zea mays
% 210.56/210.74 |- skos__altLabel mesh__D003313 Indian Corn
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003313 2006
% 210.56/210.74 |- mesh__dateCreated mesh__D003313 1999-01-01
% 210.56/210.74 |- skos__broader mesh__D003313smesh__D006109
% 210.56/210.74 |- skos__annotation mesh__D003313
% 210.56/210.74 restrict to American corn, Zea mays: for ancient %26% non-American use of the word %22%corn%22% index under CEREALS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.74 |- mesh__historyNote mesh__D003313 2003%28%1963%29%
% 210.56/210.74 |- skos__scopeNote mesh__D003313
% 210.56/210.74 A plant species of the family POACEAE. It is a tall grass grown for its seed, corn, used as food and animal fodder.%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003313 2005
% 210.56/210.74 |- mesh__dateEstablished mesh__D003313 1966-01-01
% 210.56/210.74 |- rdf__type mesh__D027761sskos__Concept
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D027761 2002; see Liliaceae 1998-2001
% 210.56/210.74 |- skos__broader mesh__D027761smesh__D019668
% 210.56/210.74 |- mesh__dateCreated mesh__D027761 2001-07-25
% 210.56/210.74 |- mesh__historyNote mesh__D027761 2002; use Liliaceae 1998-2001
% 210.56/210.74 |- skos__prefLabel mesh__D027761 Asparagus Plant
% 210.56/210.74 |- skos__historyNote mesh__D027761 Liliaceae %28%1998-2001%29%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D027761 2004
% 210.56/210.74 |- mesh__dateRevised mesh__D027761 2002-07-02
% 210.56/210.74 |- skos__scopeNote mesh__D027761
% 210.56/210.74 A plant genus in the family LILIACEAE %28%sometimes placed in Asparagaceae%29% that contains ECDYSTEROIDS and is an ingredient of Siotone. The shoots are used as a vegetable and the roots are used in FOLK MEDICINE.%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D027761 2006
% 210.56/210.74 |- mesh__recordMaintainer mesh__D027761 ssb
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D027761 2003
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D027761 2005
% 210.56/210.74 |- skos__annotation mesh__D027761
% 210.56/210.74 coord with specific PLANT COMPONENTS and FOOD term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.74 |- mesh__recordOriginator mesh__D027761 ssb
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D027761 sjn
% 210.56/210.74 |- mesh__dateEstablished mesh__D027761 2002-01-01
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 Reductase, Steroid delta-4-5-alpha
% 210.56/210.74 |- skos__prefLabel mesh__D013741 Testosterone 5-alpha-Reductase
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D013741 2006
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 5Alpha Reductase, Steroid
% 210.56/210.74 |- skos__altLabel mesh__D013741 4-Ene-5-alpha-Reductase
% 210.56/210.74 |- skos__historyNote mesh__D013741 Oxidoreductases %28%1972-1974%29%
% 210.56/210.74 |- skos__altLabel mesh__D013741 4-Ene-3-Oxosteroid-5alpha-Reductase
% 210.56/210.74 |- skos__altLabel mesh__D013741 Steroid delta-4-5-alpha Reductase
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 NADH 5 alpha Reductase
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 delta-4-5-alpha Reductase, Steroid
% 210.56/210.74 |- mesh__recordMaintainer mesh__D013741 jmp
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 Reductase, Steroid 5Alpha
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D013741
% 210.56/210.74 86; was see under OXIDOREDUCTASES 1975-85
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 4 Ene 5 alpha Reductase
% 210.56/210.74 |- skos__historyNote mesh__D013741 Testosterone %28%1972-1974%29%
% 210.56/210.74 |- skos__altLabel mesh__D013741 NADH-5-alpha-Reductase
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 delta 4 Reductase
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741
% 210.56/210.74 3 Keto 5 alpha Steroid delta 4 Dehydrogenase
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D013741 sjn
% 210.56/210.74 |- mesh__historyNote mesh__D013741
% 210.56/210.74 86%28%75%29%; was see under OXIDOREDUCTASES 1975-85
% 210.56/210.74 |- mesh__dateCreated mesh__D013741 1974-11-19
% 210.56/210.74 |- skos__altLabel mesh__D013741 5-alpha-Reductase, Testosterone
% 210.56/210.74 |- skos__altLabel mesh__D013741
% 210.56/210.74 3-Keto-5-alpha-Steroid delta-4-Dehydrogenase
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 5 alpha Reductase, Testosterone
% 210.56/210.74 |- skos__altLabel mesh__D013741
% 210.56/210.74 delta%28%4%29%-3-Ketosteroid-5alpha-Reductase
% 210.56/210.74 |- mesh__dateRevised mesh__D013741 2005-06-30
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 4 Ene 3 Oxosteroid 5alpha Reductase
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 Steroid delta 4 5 alpha Reductase
% 210.56/210.74 |- skos__altLabel mesh__D013741 Testosterone delta-4-5-alpha-Reductase
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 delta-4-5-alpha-Reductase, Testosterone
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741
% 210.56/210.74 delta-4-Dehydrogenase, 3-Keto-5-alpha-Steroid
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 4-Reductase, delta
% 210.56/210.74 |- rdf__type mesh__D013741sskos__Concept
% 210.56/210.74 |- skos__altLabel mesh__D013741 Steroid 5Alpha Reductase
% 210.56/210.74 |- skos__altLabel mesh__D013741 SRD5A2
% 210.56/210.74 |- mesh__dateEstablished mesh__D013741 1986-01-01
% 210.56/210.74 |- skos__broader mesh__D013741smesh__D044925
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 Testosterone delta 4 5 alpha Reductase
% 210.56/210.74 |- skos__hiddenLabel mesh__D013741 Testosterone 5 alpha Reductase
% 210.56/210.74 |- skos__altLabel mesh__D013741
% 210.56/210.74 NADPH delta%28%4%29%-3-Ketosteroid 5 alpha-Oxidoreductase
% 210.56/210.74 |- mesh__recordOriginator mesh__D013741 NLM
% 210.56/210.74 |- skos__altLabel mesh__D013741 delta 4-Reductase
% 210.56/210.74 |- skos__scopeNote mesh__D007704
% 210.56/210.74 Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; %28%HMWK%29%; is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; %28%LMWK%29%; is split by tissue kallikrein to produce KALLIDIN.%A%
% 210.56/210.74 |- mesh__recordMaintainer mesh__D007704 ssb
% 210.56/210.74 |- mesh__historyNote mesh__D007704 74%28%72%29%
% 210.56/210.74 |- skos__hiddenLabel mesh__D007704 T Kininogen
% 210.56/210.74 |- skos__annotation mesh__D007704
% 210.56/210.74 cysteine proteinase inhib; /drug eff /physiol permitted
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D007704 2006
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D007704 sjn
% 210.56/210.74 |- skos__altLabel mesh__D007704 Prokinins
% 210.56/210.74 |- mesh__dateRevised mesh__D007704 2005-06-30
% 210.56/210.74 |- skos__broader mesh__D007704smesh__D011498
% 210.56/210.74 |- skos__prefLabel mesh__D007704 Kininogens
% 210.56/210.74 |- mesh__dateCreated mesh__D007704 1999-01-01
% 210.56/210.74 |- skos__broader mesh__D007704smesh__D007705
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D007704 74
% 210.56/210.74 |- rdf__type mesh__D007704sskos__Concept
% 210.56/210.74 |- mesh__dateEstablished mesh__D007704 1974-01-01
% 210.56/210.74 |- skos__altLabel mesh__D007704 Cystatins, Kininogen
% 210.56/210.74 |- skos__historyNote mesh__D007704 Proteins %28%1966-1971%29%
% 210.56/210.74 |- skos__altLabel mesh__D007704 Prekinins
% 210.56/210.74 |- skos__hiddenLabel mesh__D007704 Kininogen Cystatins
% 210.56/210.74 |- mesh__recordOriginator mesh__D007704 NLM
% 210.56/210.74 |- skos__historyNote mesh__D007704 Kinins %28%1966-1971%29%
% 210.56/210.74 |- skos__broader mesh__D007704smesh__D001779
% 210.56/210.74 |- skos__altLabel mesh__D051860 FMRP Protein
% 210.56/210.74 |- mesh__dateCreated mesh__D051860 2005-06-30
% 210.56/210.74 |- skos__scopeNote mesh__D051860
% 210.56/210.74 A RNA-binding protein that is found predominately in the CYTOPLASM. It helps regulate GENETIC TRANSLATION in NEURONS and is absent or under-expressed in FRAGILE X SYNDROME.%A%
% 210.56/210.74 |- mesh__historyNote mesh__D051860 2006%28%1991%29%
% 210.56/210.74 |- skos__prefLabel mesh__D051860 Fragile X Mental Retardation Protein
% 210.56/210.74 |- mesh__dateRevised mesh__D051860 2005-08-02
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D051860 2006
% 210.56/210.74 |- rdf__type mesh__D051860sskos__Concept
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D051860
% 210.56/210.74 2006; FRAGILE X MENTAL RETARDATION PROTEIN was indexed under NERVE TISSUE PROTEINS %26% RNA-BINDING PROTEINS 1991-2005%A%
% 210.56/210.74 |- mesh__recordOriginator mesh__D051860 DRC
% 210.56/210.74 |- skos__hiddenLabel mesh__D051860 Fragile X Mental Retardation 1 Protein
% 210.56/210.74 |- mesh__recordMaintainer mesh__D051860 ags
% 210.56/210.74 |- skos__broader mesh__D051860smesh__D016601
% 210.56/210.74 |- skos__altLabel mesh__D051860 Fragile X Mental Retardation-1 Protein
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D051860 2006A
% 210.56/210.74 |- mesh__dateEstablished mesh__D051860 2006-01-01
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D051860 ags
% 210.56/210.74 |- skos__broader mesh__D051860smesh__D009419
% 210.56/210.74 |- skos__annotation mesh__D045823
% 210.56/210.74 coord IM with specific precoord intestinal dis %28%IM%29%; PARALYTIC ILEUS see INTESTINAL PSEUDO-OBSTRUCTION is also available%A%
% 210.56/210.74 |- skos__prefLabel mesh__D045823 Ileus
% 210.56/210.74 |- mesh__dateCreated mesh__D045823 2003-07-09
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D045823 2004
% 210.56/210.74 |- mesh__dateEstablished mesh__D045823 2004-01-01
% 210.56/210.74 |- rdf__type mesh__D045823sskos__Concept
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D045823 2006
% 210.56/210.74 |- skos__historyNote mesh__D045823 Intestinal Obstruction %28%1968-2003%29%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D045823 2005
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D045823
% 210.56/210.74 2004; see INTESTINAL OBSTRUCTION 1975-2003
% 210.56/210.74 |- skos__broader mesh__D045823smesh__D007415
% 210.56/210.74 |- skos__scopeNote mesh__D045823
% 210.56/210.74 A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.%A%
% 210.56/210.74 |- mesh__historyNote mesh__D045823
% 210.56/210.74 2004; use INTESTINAL OBSTRUCTION 1975-2003
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012649 2004
% 210.56/210.74 |- mesh__recordMaintainer mesh__D012649 tjk
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Concepts, Self
% 210.56/210.74 |- mesh__dateCreated mesh__D012649 1999-01-01
% 210.56/210.74 |- mesh__onlineNote mesh__D012649
% 210.56/210.74 use SELF CONCEPT to search SELF PERCEPTION 1969-78
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012649 2005
% 210.56/210.74 |- rdf__type mesh__D012649sskos__Concept
% 210.56/210.74 |- skos__scopeNote mesh__D012649 A person%27%s view of himself.
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Self Esteems
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012649 2003
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Self-Perceptions
% 210.56/210.74 |- skos__related mesh__D012649smesh__D026684
% 210.56/210.74 |- skos__prefLabel mesh__D012649 Self Concept
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D012649 sjn
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Concept, Self
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Perceptions, Self
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Perception, Self
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D012649 69
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Esteems, Self
% 210.56/210.74 |- skos__related mesh__D012649smesh__D001828
% 210.56/210.74 |- skos__altLabel mesh__D012649 Self Perception
% 210.56/210.74 |- mesh__historyNote mesh__D012649
% 210.56/210.74 69; SELF PERCEPTION was see under SELF CONCEPT 1969-78
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Self Concepts
% 210.56/210.74 |- mesh__dateRevised mesh__D012649 2001-07-25
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Esteem, Self
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012649 2002
% 210.56/210.74 |- skos__hiddenLabel mesh__D012649 Self Perceptions
% 210.56/210.74 |- skos__annotation mesh__D012649
% 210.56/210.74 do not confuse with SELF PSYCHOLOGY: see MeSH definition; no qualif%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D012649 2006
% 210.56/210.74 |- mesh__recordOriginator mesh__D012649 NLM
% 210.56/210.74 |- mesh__dateEstablished mesh__D012649 1969-01-01
% 210.56/210.74 |- skos__broader mesh__D012649smesh__D010553
% 210.56/210.74 |- mesh__historyNote mesh__D031803 2003
% 210.56/210.74 |- mesh__dateEstablished mesh__D031803 2003-01-01
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D031803 2003
% 210.56/210.74 |- rdf__type mesh__D031803sskos__Concept
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D031803 2004
% 210.56/210.74 |- skos__scopeNote mesh__D031803
% 210.56/210.74 A plant genus of the family POLYGONACEAE.
% 210.56/210.74 |- skos__broader mesh__D031803smesh__D019664
% 210.56/210.74 |- skos__annotation mesh__D031803
% 210.56/210.74 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D031803 2005
% 210.56/210.74 |- skos__altLabel mesh__D031803 Buckwheat, Red
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D031803 2003
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D031803 2006
% 210.56/210.74 |- skos__prefLabel mesh__D031803 Eriogonum
% 210.56/210.74 |- skos__altLabel mesh__D031803 Buckwheat, Wild
% 210.56/210.74 |- mesh__dateCreated mesh__D031803 2002-07-02
% 210.56/210.74 |- mesh__dateEstablished mesh__D017334 1993-01-01
% 210.56/210.74 |- skos__altLabel mesh__D017334 Teichomycin
% 210.56/210.74 |- rdf__type mesh__D017334sskos__Concept
% 210.56/210.74 |- skos__altLabel mesh__D017334 Hoechst Brand of Teicoplanin
% 210.56/210.74 |- skos__altLabel mesh__D017334 Aventis Pharma Brand of Teicoplanin
% 210.56/210.74 |- mesh__dateRevised mesh__D017334 2005-06-30
% 210.56/210.74 |- skos__prefLabel mesh__D017334 Teicoplanin
% 210.56/210.74 |- skos__scopeNote mesh__D017334
% 210.56/210.74 Glycopeptide antibiotic complex from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety.%A%
% 210.56/210.74 |- skos__altLabel mesh__D017334 Aventis Brand of Teicoplanin
% 210.56/210.74 |- mesh__recordOriginator mesh__D017334 AGS
% 210.56/210.74 |- mesh__recordMaintainer mesh__D017334 CCR
% 210.56/210.74 |- skos__broader mesh__D017334smesh__D006020
% 210.56/210.74 |- mesh__onlineNote mesh__D017334
% 210.56/210.74 use TEICOPLANIN %28%NM%29% to search TEICHOMYCINS 1980-92
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D017334
% 210.56/210.74 93; TEICOMYCINS was indexed under GLYCOPEPTIDES 1978-92
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D017334 2006
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D017334 sjn
% 210.56/210.74 |- mesh__historyNote mesh__D017334
% 210.56/210.74 93; was TEICHOMYCINS %28%NM%29% 1978-92
% 210.56/210.74 |- skos__historyNote mesh__D017334 Glycopeptides %28%1978-1992%29%
% 210.56/210.74 |- mesh__dateCreated mesh__D017334 1992-05-22
% 210.56/210.74 |- skos__historyNote mesh__D050768 Protoporphyrins %28%1975-1982%29%
% 210.56/210.74 |- skos__altLabel mesh__D050768 Protox
% 210.56/210.74 |- skos__altLabel mesh__D050768 Protoporphyrinogenase
% 210.56/210.74 |- skos__broader mesh__D050768smesh__D008565
% 210.56/210.74 |- mesh__recordMaintainer mesh__D050768 AKE
% 210.56/210.74 |- skos__historyNote mesh__D050768 Porphyrins %28%1975-1976%29%
% 210.56/210.74 |- skos__historyNote mesh__D050768 Oxidoreductases %28%1993-2003%29%
% 210.56/210.74 |- skos__scopeNote mesh__D050768
% 210.56/210.74 A membrane-bound flavoenzyme that catalyzes the oxygen-dependent aromatization of PROTOPORPHYRINOGEN IX %28%Protogen%29% to protoporphyrin IX %28%Proto IX%29%. It is the last enzyme of the common branch of the HEME and CHLOROPHYLL pathways in plants, and is the molecular target of diphenyl ether-type herbicides. VARIEGATE PORPHYRIA is an autosomal dominant disorder associated with deficiency of protoporphyrinogen oxidase.%A%
% 210.56/210.74 |- skos__altLabel mesh__D050768 Protoporphyrinogen IX Oxidase
% 210.56/210.74 |- mesh__dateEstablished mesh__D050768 2006-01-01
% 210.56/210.74 |- skos__broader mesh__D050768smesh__D044925
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D050768
% 210.56/210.74 2006; PROTOPORPHYRINOGEN OXIDASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1993-2003, under PORPHYRINS 1975-1976, and under PROTOPORPHYRINS 1975-1982%A%
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D050768 sjn
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D050768 2006
% 210.56/210.74 |- skos__prefLabel mesh__D050768 Protoporphyrinogen Oxidase
% 210.56/210.74 |- skos__hiddenLabel mesh__D050768 Oxidase, Protoporphyrinogen
% 210.56/210.74 |- skos__hiddenLabel mesh__D050768 Dehydrogenase, Protoporphyrinogen
% 210.56/210.74 |- rdf__type mesh__D050768sskos__Concept
% 210.56/210.74 |- skos__hiddenLabel mesh__D050768 Oxidase, Protoporphyrinogen IX
% 210.56/210.74 |- mesh__historyNote mesh__D050768 2006%28%1975%29%
% 210.56/210.74 |- skos__historyNote mesh__D050768
% 210.56/210.74 Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.56/210.74 |- mesh__recordOriginator mesh__D050768 AKE
% 210.56/210.74 |- skos__altLabel mesh__D050768 Protoporphyrinogen Dehydrogenase
% 210.56/210.74 |- mesh__dateCreated mesh__D050768 2005-06-30
% 210.56/210.74 |- mesh__dateEstablished mesh__D003314 1991-01-01
% 210.56/210.74 |- skos__broader mesh__D003314smesh__D010938
% 210.56/210.74 |- skos__historyNote mesh__D003314 Oils %28%1966-1986%29%
% 210.56/210.74 |- skos__hiddenLabel mesh__D003314 Lipomuls
% 210.56/210.74 |- skos__hiddenLabel mesh__D003314 Oil, Maize
% 210.56/210.74 |- skos__hiddenLabel mesh__D003314 Oils, Maize
% 210.56/210.74 |- skos__broader mesh__D003314smesh__D005224
% 210.56/210.74 |- mesh__recordMaintainer mesh__D003314 ssb
% 210.56/210.74 |- skos__scopeNote mesh__D003314 Oil from ZEA MAYS or corn plant.
% 210.56/210.74 |- mesh__activeMeSHYear mesh__D003314 2006
% 210.56/210.74 |- mesh__recordOriginator mesh__D003314 RLS
% 210.56/210.74 |- mesh__dateRevised mesh__D003314 2005-06-30
% 210.56/210.74 |- mesh__dateCreated mesh__D003314 1986-06-03
% 210.56/210.74 |- skos__prefLabel mesh__D003314 Corn Oil
% 210.56/210.74 |- skos__hiddenLabel mesh__D003314 Corn Oils
% 210.56/210.74 |- mesh__publicMeSHNote mesh__D003314
% 210.56/210.74 91; was see under PLANT OILS 1987-90
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D003314 sjn
% 210.56/210.74 |- skos__altLabel mesh__D003314 Maize Oil
% 210.56/210.74 |- skos__hiddenLabel mesh__D003314 Maize Oils
% 210.56/210.74 |- skos__broader mesh__D003314smesh__D004042
% 210.56/210.74 |- mesh__historyNote mesh__D003314
% 210.56/210.74 91%28%87%29%; was see under PLANT OILS 1987-90
% 210.56/210.74 |- skos__hiddenLabel mesh__D003314 Oil, Corn
% 210.56/210.74 |- skos__hiddenLabel mesh__D003314 Oils, Corn
% 210.56/210.74 |- rdf__type mesh__D003314sskos__Concept
% 210.56/210.74 |- skos__prefLabel mesh__D027762 Lilium
% 210.56/210.74 |- mesh__dateRevised mesh__D027762 2003-07-09
% 210.56/210.74 |- mesh__recordAuthorizer mesh__D027762 sjn
% 210.56/210.75 |- skos__historyNote mesh__D027762 Liliaceae %28%1998-2001%29%
% 210.56/210.75 |- skos__scopeNote mesh__D027762
% 210.56/210.75 A plant genus in the family LILIACEAE generally growing in temperate areas. The word lily is also used in the common names of many plants of other genera that resemble true lilies. True lilies are erect perennial plants with leafy stems, scaly bulbs, usually narrow leaves, and solitary or clustered flowers.%A%
% 210.56/210.75 |- skos__annotation mesh__D027762
% 210.56/210.75 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D027762 2004
% 210.56/210.75 |- mesh__dateCreated mesh__D027762 2001-07-25
% 210.56/210.75 |- mesh__historyNote mesh__D027762 2002; use Liliaceae 1998-2001
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D027762 2006
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D027762 2005
% 210.56/210.75 |- skos__altLabel mesh__D027762 Lily
% 210.56/210.75 |- mesh__recordOriginator mesh__D027762 ssb
% 210.56/210.75 |- mesh__dateEstablished mesh__D027762 2002-01-01
% 210.56/210.75 |- mesh__recordMaintainer mesh__D027762 ssb
% 210.56/210.75 |- rdf__type mesh__D027762sskos__Concept
% 210.56/210.75 |- skos__broader mesh__D027762smesh__D019668
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D027762 2002; see Liliaceae 1998-2001
% 210.56/210.75 |- mesh__recordMaintainer mesh__D013742 ags
% 210.56/210.75 |- skos__prefLabel mesh__D013742 Tetanus
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D013742 2006
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D013742 sjn
% 210.56/210.75 |- mesh__dateRevised mesh__D013742 2003-07-09
% 210.56/210.75 |- skos__related mesh__D013742smesh__D014313
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D013742 2005
% 210.56/210.75 |- skos__annotation mesh__D013742
% 210.56/210.75 caused by Clostridium tetani; do not confuse with TETANY; do not use for tonic spasm of muscle %28% = SPASM%29% or for tetanic contraction %28% = MUSCLE CONTRACTION%29%%A%
% 210.56/210.75 |- skos__scopeNote mesh__D013742
% 210.56/210.75 A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form.%A%
% 210.56/210.75 |- rdf__type mesh__D013742sskos__Concept
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D013742 2004
% 210.56/210.75 |- skos__broader mesh__D013742smesh__D003015
% 210.56/210.75 |- mesh__dateCreated mesh__D013742 1999-01-01
% 210.56/210.75 |- mesh__recordOriginator mesh__D013742 NLM
% 210.56/210.75 |- mesh__historyNote mesh__D007705 66%28%64%29%
% 210.56/210.75 |- mesh__recordOriginator mesh__D007705 NLM
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D007705 66
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D007705 2006
% 210.56/210.75 |- skos__broader mesh__D007705smesh__D012898
% 210.56/210.75 |- skos__prefLabel mesh__D007705 Kinins
% 210.56/210.75 |- skos__broader mesh__D007705smesh__D036341
% 210.56/210.75 |- mesh__dateEstablished mesh__D007705 1966-01-01
% 210.56/210.75 |- mesh__recordMaintainer mesh__D007705 ssb
% 210.56/210.75 |- mesh__dateCreated mesh__D007705 1999-01-01
% 210.56/210.75 |- skos__scopeNote mesh__D007705
% 210.56/210.75 A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. %28%From Goodman and Gilman%27%s The Pharmacologic Basis of Therapeutics, 8th ed, p588%29%%A%
% 210.56/210.75 |- rdf__type mesh__D007705sskos__Concept
% 210.56/210.75 |- skos__annotation mesh__D007705 a group of polypeptide autacoids
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D007705 sjn
% 210.56/210.75 |- mesh__dateRevised mesh__D007705 2005-06-30
% 210.56/210.75 |- mesh__dateEstablished mesh__D051861 2006-01-01
% 210.56/210.75 |- skos__altLabel mesh__D051861 KAI1 Protein
% 210.56/210.75 |- skos__broader mesh__D051861smesh__D015703
% 210.56/210.75 |- skos__hiddenLabel mesh__D051861 Antigen, CD82
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D051861 2006
% 210.56/210.75 |- rdf__type mesh__D051861sskos__Concept
% 210.56/210.75 |- mesh__recordOriginator mesh__D051861 DRC
% 210.56/210.75 |- mesh__recordMaintainer mesh__D051861 DRC
% 210.56/210.75 |- mesh__dateCreated mesh__D051861 2005-06-30
% 210.56/210.75 |- skos__prefLabel mesh__D051861 Kangai-1 Protein
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D051861
% 210.56/210.75 2006; KANGAI-1 PROTEIN was indexed under MEMBRANE GLYCOPROTEINS %26% PROTO-ONCOGENE PROTEINS 1993-2005, %26% under ANTIGENS, CD 2005, %26% under SURFACE ANTIGENS 1993-2004%A%
% 210.56/210.75 |- mesh__historyNote mesh__D051861 2006%28%1993%29%
% 210.56/210.75 |- skos__hiddenLabel mesh__D051861 Kangai 1 Protein
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D051861 sjn
% 210.56/210.75 |- skos__altLabel mesh__D051861 CD82 Antigen
% 210.56/210.75 |- skos__hiddenLabel mesh__D051861 CD82 Antigens
% 210.56/210.75 |- skos__broader mesh__D051861smesh__D008562
% 210.56/210.75 |- skos__broader mesh__D051861smesh__D025521
% 210.56/210.75 |- skos__scopeNote mesh__D051861
% 210.56/210.75 A widely expressed transmembrane glycoprotein that functions as a METASTASIS suppressor protein. It is under-expressed in a variety of human NEOPLASMS.%A%
% 210.56/210.75 |- skos__altLabel mesh__D051861 Antigens, CD82
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Lawsonia Infection
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D045824 2004
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Infection, Desulfovibrionaceae
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Desulfovibrio Infection
% 210.56/210.75 |- skos__prefLabel mesh__D045824 Desulfovibrionaceae Infections
% 210.56/210.75 |- rdf__type mesh__D045824sskos__Concept
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D045824 2006
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Infections, Bilophila
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Infection, Bilophila
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D045824 2005
% 210.56/210.75 |- skos__scopeNote mesh__D045824
% 210.56/210.75 Infections with bacteria of the family Desulfovibrionaceae.%A%
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Infection, Lawsonia
% 210.56/210.75 |- mesh__dateEstablished mesh__D045824 2004-01-01
% 210.56/210.75 |- skos__broader mesh__D045824smesh__D016905
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Infections, Lawsonia
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Infections, Desulfovibrionaceae
% 210.56/210.75 |- mesh__historyNote mesh__D045824 2004
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Infection, Desulfovibrio
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Desulfovibrionaceae Infection
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D045824 2004
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Bilophila Infection
% 210.56/210.75 |- skos__hiddenLabel mesh__D045824 Infections, Desulfovibrio
% 210.56/210.75 |- mesh__dateCreated mesh__D045824 2003-07-09
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D031804 2006
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D031804 2005
% 210.56/210.75 |- skos__scopeNote mesh__D031804
% 210.56/210.75 A plant genus of the family POLYGONACEAE that contains patientosides and other naphthalene glycosides.%A%
% 210.56/210.75 |- skos__altLabel mesh__D031804 Canaigre
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D031804 2004
% 210.56/210.75 |- skos__altLabel mesh__D031804 Yellow Dock
% 210.56/210.75 |- mesh__dateCreated mesh__D031804 2002-07-03
% 210.56/210.75 |- rdf__type mesh__D031804sskos__Concept
% 210.56/210.75 |- mesh__dateEstablished mesh__D031804 2003-01-01
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D031804 2003
% 210.56/210.75 |- skos__prefLabel mesh__D031804 Rumex
% 210.56/210.75 |- skos__broader mesh__D031804smesh__D019664
% 210.56/210.75 |- skos__altLabel mesh__D031804 Sorrel
% 210.56/210.75 |- mesh__historyNote mesh__D031804 2003
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D031804 2003
% 210.56/210.75 |- skos__altLabel mesh__D031804 Dock, Yellow
% 210.56/210.75 |- skos__annotation mesh__D031804
% 210.56/210.75 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D017335 sjn
% 210.56/210.75 |- mesh__historyNote mesh__D017335 93; was MDL 17043 %28%NM%29% 1982-92
% 210.56/210.75 |- skos__hiddenLabel mesh__D017335 MDL 19,438
% 210.56/210.75 |- skos__prefLabel mesh__D017335 Enoximone
% 210.56/210.75 |- skos__hiddenLabel mesh__D017335 19438, MDL
% 210.56/210.75 |- mesh__dateEstablished mesh__D017335 1993-01-01
% 210.56/210.75 |- skos__altLabel mesh__D017335 MDL-17043
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D017335
% 210.56/210.75 93; MDL 17043 was indexed under IMIDAZOLES 1982-92
% 210.56/210.75 |- skos__altLabel mesh__D017335 Fenoximone
% 210.56/210.75 |- skos__hiddenLabel mesh__D017335 MDL 17043
% 210.56/210.75 |- skos__hiddenLabel mesh__D017335 MDL17,043
% 210.56/210.75 |- mesh__recordOriginator mesh__D017335 TPW
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D017335 2006
% 210.56/210.75 |- skos__altLabel mesh__D017335 MDL-19,438
% 210.56/210.75 |- skos__historyNote mesh__D017335 Imidazoles %28%1982-1992%29%
% 210.56/210.75 |- mesh__dateRevised mesh__D017335 2005-06-30
% 210.56/210.75 |- skos__scopeNote mesh__D017335
% 210.56/210.75 1,3-Dihydro-4-methyl-5-%28%4-%28%methylthio%29%benzoyl%29%-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.%A%
% 210.56/210.75 |- mesh__onlineNote mesh__D017335
% 210.56/210.75 use ENOXIMONE %28%NM%29% to search MDL 17043 1982-92
% 210.56/210.75 |- mesh__recordMaintainer mesh__D017335 ssb
% 210.56/210.75 |- mesh__dateCreated mesh__D017335 1992-05-08
% 210.56/210.75 |- skos__hiddenLabel mesh__D017335 MDL17043
% 210.56/210.75 |- skos__hiddenLabel mesh__D017335 MDL 17,043
% 210.56/210.75 |- skos__hiddenLabel mesh__D017335 MDL19,438
% 210.56/210.75 |- skos__broader mesh__D017335smesh__D007093
% 210.56/210.75 |- rdf__type mesh__D017335sskos__Concept
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D050769 sjn
% 210.56/210.75 |- skos__hiddenLabel mesh__D050769 A Dehydrogenase, Isovaleryl-Coenzyme
% 210.56/210.75 |- mesh__dateEstablished mesh__D050769 2006-01-01
% 210.56/210.75 |- skos__altLabel mesh__D050769 Isovaleryl CoA Dehydrogenase
% 210.56/210.75 |- mesh__recordMaintainer mesh__D050769 AKE
% 210.56/210.75 |- skos__historyNote mesh__D050769
% 210.56/210.75 Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D050769
% 210.56/210.75 2006; ISOVALERYL-COA DEHYDROGENASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1983-2003, under ACYL COENZYME A 1980-1982, COENZYME A 1973-1980, and under VALERATES 1973-1982%A%
% 210.56/210.75 |- mesh__dateCreated mesh__D050769 2005-06-30
% 210.56/210.75 |- skos__scopeNote mesh__D050769
% 210.56/210.75 A mitochondrial flavoprotein, this enzyme catalyzes the oxidation of 3-methylbutanoyl-CoA to 3-methylbut-2-enoyl-CoA using FAD as a cofactor. Defects in the enzyme, is associated with isovaleric acidemia %28%IVA%29%.%A%
% 210.56/210.75 |- skos__hiddenLabel mesh__D050769 Dehydrogenase, Isovaleryl-CoA
% 210.56/210.75 |- mesh__recordOriginator mesh__D050769 AKE
% 210.56/210.75 |- skos__hiddenLabel mesh__D050769 Dehydrogenase, Isovaleryl CoA
% 210.56/210.75 |- skos__altLabel mesh__D050769 Isovaleryl-Coenzyme A Dehydrogenase
% 210.56/210.75 |- skos__hiddenLabel mesh__D050769 Dehydrogenase, Isovaleryl-Coenzyme A
% 210.56/210.75 |- skos__historyNote mesh__D050769 Oxidoreductases %28%1983-2003%29%
% 210.56/210.75 |- skos__prefLabel mesh__D050769 Isovaleryl-CoA Dehydrogenase
% 210.56/210.75 |- skos__hiddenLabel mesh__D050769 CoA Dehydrogenase, Isovaleryl
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D050769 2006
% 210.56/210.75 |- skos__historyNote mesh__D050769 Valerates %28%1973-1982%29%
% 210.56/210.75 |- skos__historyNote mesh__D050769 Acyl Coenzyme A %28%1980-1982%29%
% 210.56/210.75 |- rdf__type mesh__D050769sskos__Concept
% 210.56/210.75 |- skos__historyNote mesh__D050769 Coenzyme A %28%1973-1980%29%
% 210.56/210.75 |- skos__hiddenLabel mesh__D050769 Isovaleryl Coenzyme A Dehydrogenase
% 210.56/210.75 |- mesh__historyNote mesh__D050769 2006%28%1973%29%
% 210.56/210.75 |- skos__broader mesh__D050769smesh__D044925
% 210.56/210.75 |- mesh__considerAlso mesh__D003315 consider also terms at KERAT-
% 210.56/210.75 |- skos__broader mesh__D003315smesh__D000869
% 210.56/210.75 |- skos__hiddenLabel mesh__D003315 Corneas
% 210.56/210.75 |- skos__annotation mesh__D003315
% 210.56/210.75 inflammation = KERATITIS; neoplasms = CORNEAL DISEASES %28%IM%29% + EYE NEOPLASMS %28%IM%29% + histological type of neoplasm %28%IM%29%; /anat: consider CORNEAL TOPOGRAPHY; KERATOPLASTY, PENETRATING is also available%A%
% 210.56/210.75 |- mesh__historyNote mesh__D003315
% 210.56/210.75 /transplantation was CORNEAL TRANSPLANTATION 1963-65; was CORNEA/transplantation 1966-89%A%
% 210.56/210.75 |- mesh__dateCreated mesh__D003315 1999-01-01
% 210.56/210.75 |- skos__prefLabel mesh__D003315 Cornea
% 210.56/210.75 |- skos__related mesh__D003315smesh__D018903
% 210.56/210.75 |- mesh__recordMaintainer mesh__D003315 lkt
% 210.56/210.75 |- mesh__recordOriginator mesh__D003315 NLM
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D003315
% 210.56/210.75 /transplantation was CORNEAL TRANSPLANTATION 1963-65; was CORNEA/transplantation 1966-89%A%
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D003315 sjn
% 210.56/210.75 |- mesh__dateRevised mesh__D003315 2005-06-30
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003315 2006
% 210.56/210.75 |- rdf__type mesh__D003315sskos__Concept
% 210.56/210.75 |- skos__related mesh__D003315smesh__D007646
% 210.56/210.75 |- skos__scopeNote mesh__D003315
% 210.56/210.75 The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%
% 210.56/210.75 |- skos__related mesh__D003315smesh__D004728
% 210.56/210.75 |- mesh__dateCreated mesh__D008000 1999-01-01
% 210.56/210.75 |- skos__scopeNote mesh__D008000
% 210.56/210.75 Collection and analysis of data pertaining to operations of a particular library, library system, or group of independent libraries, with recommendations for improvement and/or ordered plans for further development.%A%
% 210.56/210.75 |- mesh__recordOriginator mesh__D008000 NLM
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008000 2006
% 210.56/210.75 |- skos__hiddenLabel mesh__D008000 Surveys, Library
% 210.56/210.75 |- skos__hiddenLabel mesh__D008000 Library Survey
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008000 2005
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008000 2002
% 210.56/210.75 |- mesh__dateRevised mesh__D008000 1999-11-03
% 210.56/210.75 |- skos__prefLabel mesh__D008000 Library Surveys
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008000 2004
% 210.56/210.75 |- mesh__recordMaintainer mesh__D008000 kle
% 210.56/210.75 |- skos__hiddenLabel mesh__D008000 Survey, Library
% 210.56/210.75 |- skos__broader mesh__D008000smesh__D007998
% 210.56/210.75 |- rdf__type mesh__D008000sskos__Concept
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D008000 sjn
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008000 2001
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008000 2003
% 210.56/210.75 |- skos__annotation mesh__D008000 IM
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008000 2000
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D013743 sjn
% 210.56/210.75 |- skos__annotation mesh__D013743
% 210.56/210.75 for therapy: for prevention index under TETANUS TOXOID
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D013743 2006
% 210.56/210.75 |- rdf__type mesh__D013743sskos__Concept
% 210.56/210.75 |- skos__scopeNote mesh__D013743
% 210.56/210.75 An antitoxin used for the treatment of TETANUS.
% 210.56/210.75 |- skos__broader mesh__D013743smesh__D000992
% 210.56/210.75 |- mesh__dateRevised mesh__D013743 2005-06-30
% 210.56/210.75 |- mesh__dateCreated mesh__D013743 1999-01-01
% 210.56/210.75 |- mesh__recordOriginator mesh__D013743 NLM
% 210.56/210.75 |- skos__related mesh__D013743smesh__D013745
% 210.56/210.75 |- skos__prefLabel mesh__D013743 Tetanus Antitoxin
% 210.56/210.75 |- skos__hiddenLabel mesh__D013743 Antitoxin, Tetanus
% 210.56/210.75 |- mesh__recordMaintainer mesh__D013743 ssb
% 210.56/210.75 |- skos__altLabel mesh__D007706 Kinky Hair Syndrome
% 210.56/210.75 |- skos__related mesh__D007706smesh__D002570
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Congenital Hypocupremias
% 210.56/210.75 |- skos__related mesh__D007706smesh__D013482
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Disease, Steely Hair
% 210.56/210.75 |- skos__broader mesh__D007706smesh__D008664
% 210.56/210.75 |- mesh__dateCreated mesh__D007706 1976-05-05
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D007706 2005
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Diseases, Steely Hair
% 210.56/210.75 |- skos__prefLabel mesh__D007706 Menkes Kinky Hair Syndrome
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D007706 sjn
% 210.56/210.75 |- skos__historyNote mesh__D007706 Brain Diseases %28%1966-1976%29%
% 210.56/210.75 |- mesh__dateEstablished mesh__D007706 1991-01-01
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Hypocupremias, Congenital
% 210.56/210.75 |- skos__altLabel mesh__D007706 Kinky Hair Disease
% 210.56/210.75 |- skos__altLabel mesh__D007706 Hypocupremia, Congenital
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D007706
% 210.56/210.75 2000; see KINKY HAIR SYNDROME 1991-1999; see BRAIN DISEASES, METABOLIC 1977-1990%A%
% 210.56/210.75 |- skos__altLabel mesh__D007706 Menkes%27% Disease
% 210.56/210.75 |- skos__altLabel mesh__D007706 Steely Hair Syndrome
% 210.56/210.75 |- skos__altLabel mesh__D007706 Congenital Hypocupremia
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D007706 2006
% 210.56/210.75 |- skos__scopeNote mesh__D007706
% 210.56/210.75 An inherited disorder of copper metabolism transmitted as an X-linked trait and characterized by the infantile onset of HYPOTHERMIA, feeding difficulties, hypotonia, SEIZURES, bony deformities, pili torti %28%twisted hair%29%, and severely impaired intellectual development. Defective copper transport across plasma and endoplasmic reticulum membranes results in copper being unavailable for the synthesis of several copper containing enzymes, including PROTEIN-LYSINE 6-OXIDASE; CERULOPLASMIN; and SUPEROXIDE DISMUTASE. Pathologic changes include defects in arterial elastin, neuronal loss, and gliosis. %28%From Menkes, Textbook of Child Neurology, 5th ed, p125%29%%A%
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Hair Diseases, Steely
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Steely Hair Syndromes
% 210.56/210.75 |- mesh__historyNote mesh__D007706 2000%28%1977%29%
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Diseases, Menkes%27%
% 210.56/210.75 |- mesh__dateRevised mesh__D007706 2002-07-03
% 210.56/210.75 |- rdf__type mesh__D007706sskos__Concept
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D007706 2003
% 210.56/210.75 |- skos__broader mesh__D007706smesh__D020271
% 210.56/210.75 |- skos__altLabel mesh__D007706 Menkes Disease
% 210.56/210.75 |- skos__altLabel mesh__D007706 Steely Hair Disease
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Hair Diseases, Kinky
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Kinky Hair Diseases
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Syndrome, Steely Hair
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Syndromes, Steely Hair
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D007706 2004
% 210.56/210.75 |- mesh__recordOriginator mesh__D007706 MM
% 210.56/210.75 |- skos__broader mesh__D007706smesh__D006201
% 210.56/210.75 |- skos__related mesh__D007706smesh__D008249
% 210.56/210.75 |- skos__broader mesh__D007706smesh__D020739
% 210.56/210.75 |- skos__altLabel mesh__D007706 Menkes Syndrome
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Diseases, Kinky Hair
% 210.56/210.75 |- skos__broader mesh__D007706smesh__D038901
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Menkes%27% Diseases
% 210.56/210.75 |- skos__hiddenLabel mesh__D007706 Steely Hair Diseases
% 210.56/210.75 |- mesh__recordMaintainer mesh__D007706 lkt
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D045825 2005
% 210.56/210.75 |- mesh__historyNote mesh__D045825 2004
% 210.56/210.75 |- skos__prefLabel mesh__D045825 Fusobacteriaceae Infections
% 210.56/210.75 |- skos__hiddenLabel mesh__D045825 Fusobacteriaceae Infection
% 210.56/210.75 |- skos__hiddenLabel mesh__D045825 Infection, Fusobacteriaceae
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D045825 2004
% 210.56/210.75 |- mesh__dateCreated mesh__D045825 2003-07-09
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D045825 2004
% 210.56/210.75 |- skos__scopeNote mesh__D045825
% 210.56/210.75 Infections with bacteria of the family Fusobacteriaceae, in the order Fusobacterales, phylum FUSOBACTERIA.%A%
% 210.56/210.75 |- mesh__dateEstablished mesh__D045825 2004-01-01
% 210.56/210.75 |- rdf__type mesh__D045825sskos__Concept
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D045825 2006
% 210.56/210.75 |- skos__hiddenLabel mesh__D045825 Infections, Fusobacteriaceae
% 210.56/210.75 |- skos__broader mesh__D045825smesh__D016905
% 210.56/210.75 |- mesh__historyNote mesh__D031805 2003
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D031805 2004
% 210.56/210.75 |- rdf__type mesh__D031805sskos__Concept
% 210.56/210.75 |- skos__scopeNote mesh__D031805
% 210.56/210.75 A plant family of the order Liliales, subclass Liliidae, class Liliopsida %28%monocotyledons%29%. Most species are perennials, native primarily to tropical America. They have creeping rootstocks, fibrous roots, and leaves in clusters at the base of the plant or borne on branched stems. The fruit is a capsule containing many seeds, or a one-seeded winged structure.%A%
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D031805 2003
% 210.56/210.75 |- skos__broader mesh__D031805smesh__D019684
% 210.56/210.75 |- mesh__dateCreated mesh__D031805 2002-07-03
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D031805 2003
% 210.56/210.75 |- mesh__dateEstablished mesh__D031805 2003-01-01
% 210.56/210.75 |- skos__prefLabel mesh__D031805 Pontederiaceae
% 210.56/210.75 |- skos__annotation mesh__D031805
% 210.56/210.75 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D031805 2006
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D031805 2005
% 210.56/210.75 |- skos__broader mesh__D013435Q000097smesh__D013435
% 210.56/210.75 |- mesh__preferredCombination mesh__D013435Q000097smesh__D013436
% 210.56/210.75 |- rdf__type mesh__D013435Q000097smesh__CompoundConcept
% 210.56/210.75 |- mesh__recordOriginator mesh__D017336 TPW
% 210.56/210.75 |- skos__hiddenLabel mesh__D017336 Sch29851
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D017336 sjn
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D017336 2005
% 210.56/210.75 |- skos__hiddenLabel mesh__D017336 Sch 29851
% 210.56/210.75 |- skos__historyNote mesh__D017336
% 210.56/210.75 Cyproheptadine/analogs %26% derivatives %28%1987-1992%29%
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D017336
% 210.56/210.75 93; LORATADINE was indexed under CYPROHEPTADINE/analogs %26% derivatives 1976-92 %26% PIPERIDINES 1984-86%A%
% 210.56/210.75 |- skos__historyNote mesh__D017336 Piperidines %28%1984-1986%29%
% 210.56/210.75 |- mesh__onlineNote mesh__D017336
% 210.56/210.75 use LORATADINE %28%NM%29% to search LORATADINE 1984-92
% 210.56/210.75 |- mesh__dateCreated mesh__D017336 1992-05-22
% 210.56/210.75 |- skos__broader mesh__D017336smesh__D003533
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D017336 2006
% 210.56/210.75 |- skos__prefLabel mesh__D017336 Loratadine
% 210.56/210.75 |- skos__scopeNote mesh__D017336
% 210.56/210.75 A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines %28%HISTAMINE H1 ANTAGONISTS%29% it lacks central nervous system depressing effects such as drowsiness.%A%
% 210.56/210.75 |- mesh__dateRevised mesh__D017336 2003-07-09
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D017336 2004
% 210.56/210.75 |- mesh__dateEstablished mesh__D017336 1993-01-01
% 210.56/210.75 |- mesh__recordMaintainer mesh__D017336 ssb
% 210.56/210.75 |- skos__altLabel mesh__D017336 Wyeth Brand of Loratadine
% 210.56/210.75 |- skos__hiddenLabel mesh__D017336 Loratadine Wyeth Brand
% 210.56/210.75 |- skos__altLabel mesh__D017336
% 210.56/210.75 4-%28%8-Chloro-5,6-dihydro-11H-benzo%28%5,6%29%cyclohepta%28%1,2-b%29%pyridin-11-ylidene%29%-1-piperidinecarboxylic Acid Ethyl Ester
% 210.56/210.75 |- mesh__historyNote mesh__D017336 93; was LORATADINE %28%NM%29% 1984-92
% 210.56/210.75 |- rdf__type mesh__D017336sskos__Concept
% 210.56/210.75 |- mesh__dateEstablished mesh__D003316 1976-01-01
% 210.56/210.75 |- mesh__recordMaintainer mesh__D003316 PLS
% 210.56/210.75 |- skos__hiddenLabel mesh__D003316 Diseases, Corneal
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 1993
% 210.56/210.75 |- skos__annotation mesh__D003316 inflamm dis = KERATITIS %26% specific
% 210.56/210.75 |- skos__hiddenLabel mesh__D003316 Corneal Disease
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 2006
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 1999
% 210.56/210.75 |- skos__prefLabel mesh__D003316 Corneal Diseases
% 210.56/210.75 |- skos__historyNote mesh__D003316 Cornea %28%1966-1975%29%
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 2002
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 1992
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 2005
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 1998
% 210.56/210.75 |- rdf__type mesh__D003316sskos__Concept
% 210.56/210.75 |- skos__historyNote mesh__D003316 specific corneal disease heading
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D003316 NLM
% 210.56/210.75 |- mesh__recordOriginator mesh__D003316 SMH
% 210.56/210.75 |- skos__scopeNote mesh__D003316 Diseases of the cornea.
% 210.56/210.75 |- skos__broader mesh__D003316smesh__D005128
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 1995
% 210.56/210.75 |- skos__hiddenLabel mesh__D003316 Disease, Corneal
% 210.56/210.75 |- mesh__historyNote mesh__D003316 76; was NON MESH before 1976
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 1991
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D003316 76
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 2001
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 1994
% 210.56/210.75 |- mesh__dateCreated mesh__D003316 1975-07-25
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 2004
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 1997
% 210.56/210.75 |- mesh__dateRevised mesh__D003316 1990-05-29
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 2000
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 2003
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D003316 1996
% 210.56/210.75 |- skos__altLabel mesh__D008001 Technical Services Library
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D008001 sjn
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008001 2001
% 210.56/210.75 |- mesh__dateEstablished mesh__D008001 1976-01-01
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008001 2005
% 210.56/210.75 |- skos__hiddenLabel mesh__D008001 Services Technical, Library
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008001 2000
% 210.56/210.75 |- skos__hiddenLabel mesh__D008001 Technical Services Libraries
% 210.56/210.75 |- skos__hiddenLabel mesh__D008001 Library Technical Service
% 210.56/210.75 |- skos__hiddenLabel mesh__D008001 Libraries, Technical Services
% 210.56/210.75 |- skos__altLabel mesh__D008001 Library Services Technical
% 210.56/210.75 |- skos__hiddenLabel mesh__D008001 Library, Technical Services
% 210.56/210.75 |- skos__prefLabel mesh__D008001 Library Technical Services
% 210.56/210.75 |- mesh__historyNote mesh__D008001
% 210.56/210.75 76; was LIBRARY TECHNICAL PROCESSES %28%NON MESH%29% before 1976%A%
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008001 2004
% 210.56/210.75 |- mesh__dateCreated mesh__D008001 1975-07-25
% 210.56/210.75 |- skos__historyNote mesh__D008001
% 210.56/210.75 specific library or library science heading%28%1966-1975%29%
% 210.56/210.75 |- skos__broader mesh__D008001smesh__D007998
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D008001 76
% 210.56/210.75 |- skos__broader mesh__D008001smesh__D007255
% 210.56/210.75 |- rdf__type mesh__D008001sskos__Concept
% 210.56/210.75 |- skos__altLabel mesh__D008001 Services, Library Technical
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008001 2002
% 210.56/210.75 |- skos__hiddenLabel mesh__D008001 Library Services, Technical
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008001 2003
% 210.56/210.75 |- mesh__dateRevised mesh__D008001 1999-11-03
% 210.56/210.75 |- skos__annotation mesh__D008001 IM; DF: LIBRARY TECHNICAL SERV
% 210.56/210.75 |- skos__scopeNote mesh__D008001
% 210.56/210.75 Acquisition, organization, and preparation of library materials for use, including selection, weeding, cataloging, classification, and preservation.%A%
% 210.56/210.75 |- skos__altLabel mesh__D008001 Technical Library Services
% 210.56/210.75 |- skos__altLabel mesh__D008001 Services, Technical Library
% 210.56/210.75 |- skos__hiddenLabel mesh__D008001 Library Service, Technical
% 210.56/210.75 |- mesh__recordMaintainer mesh__D008001 kle
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D008001 2006
% 210.56/210.75 |- skos__hiddenLabel mesh__D008001 Technical Library Service
% 210.56/210.75 |- mesh__recordOriginator mesh__D008001 SMH
% 210.56/210.75 |- skos__annotation mesh__D013744
% 210.56/210.75 /antag permitted but consider also TETANUS ANTITOXIN
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D013744 2006
% 210.56/210.75 |- mesh__recordMaintainer mesh__D013744 ssb
% 210.56/210.75 |- skos__altLabel mesh__D013744 Tetanus Toxins
% 210.56/210.75 |- rdf__type mesh__D013744sskos__Concept
% 210.56/210.75 |- skos__hiddenLabel mesh__D013744 Toxin, Tetanus
% 210.56/210.75 |- mesh__recordAuthorizer mesh__D013744 sjn
% 210.56/210.75 |- mesh__dateCreated mesh__D013744 1999-01-01
% 210.56/210.75 |- skos__broader mesh__D013744smesh__D001426
% 210.56/210.75 |- mesh__dateEstablished mesh__D013744 1965-01-01
% 210.56/210.75 |- skos__hiddenLabel mesh__D013744 Toxins, Tetanus
% 210.56/210.75 |- skos__prefLabel mesh__D013744 Tetanus Toxin
% 210.56/210.75 |- skos__related mesh__D013744smesh__D013743
% 210.56/210.75 |- mesh__historyNote mesh__D013744 65
% 210.56/210.75 |- mesh__publicMeSHNote mesh__D013744 65
% 210.56/210.75 |- skos__hiddenLabel mesh__D013744 Toxin, Clostridium tetani
% 210.56/210.75 |- skos__hiddenLabel mesh__D013744 Neurotoxin, Clostridial
% 210.56/210.75 |- mesh__dateRevised mesh__D013744 2005-06-30
% 210.56/210.75 |- skos__altLabel mesh__D013744 Clostridium tetani Toxin
% 210.56/210.75 |- skos__broader mesh__D013744smesh__D001427
% 210.56/210.75 |- skos__scopeNote mesh__D013744
% 210.56/210.75 Protein synthesized by CLOSTRIDIUM TETANI as a single chain of %7E%150 kDa with 35%25% sequence identity to BOTULINUM TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. Tetanolysin is the hemolytic and tetanospasmin is the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal CONVULSIONS.%A%
% 210.56/210.75 |- mesh__recordOriginator mesh__D013744 NLM
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D007707 1998
% 210.56/210.75 |- skos__prefLabel mesh__D007707 Kyrgyzstan
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D007707 2000
% 210.56/210.75 |- mesh__activeMeSHYear mesh__D007707 2006
% 210.56/210.75 |- skos__altLabel mesh__D007707 Kirghizia
% 210.56/210.76 |- skos__annotation mesh__D007707 use this spelling in translations
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007707 1995
% 210.56/210.76 |- skos__broader mesh__D007707smesh__D014586
% 210.56/210.76 |- skos__altLabel mesh__D007707 Kirgizstan
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007707 2005
% 210.56/210.76 |- rdf__type mesh__D007707sskos__Concept
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007707 1997
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D007707 PLS
% 210.56/210.76 |- skos__altLabel mesh__D007707 Kirghiz SSR
% 210.56/210.76 |- skos__altLabel mesh__D007707 Kirghiz S.S.R.
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007707 2002
% 210.56/210.76 |- mesh__recordMaintainer mesh__D007707 PLS
% 210.56/210.76 |- skos__altLabel mesh__D007707 Kyrgyz Republic
% 210.56/210.76 |- mesh__dateCreated mesh__D007707 1999-01-01
% 210.56/210.76 |- skos__broader mesh__D007707smesh__D001209
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007707 1996
% 210.56/210.76 |- mesh__onlineNote mesh__D007707
% 210.56/210.76 use KYRGYZSTAN to search KIRGHIZ S.S.R. 1982-92 %26% KIRGHIZIA 1966-81%A%
% 210.56/210.76 |- mesh__dateRevised mesh__D007707 1994-05-31
% 210.56/210.76 |- mesh__recordOriginator mesh__D007707 NLM
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007707 2004
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007707 1999
% 210.56/210.76 |- skos__broader mesh__D007707smesh__D017517
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007707 2001
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007707 2003
% 210.56/210.76 |- mesh__historyNote mesh__D007707
% 210.56/210.76 93; was KIRGHIZ S.S.R. 1982-92; was KIRGHIZIA 1963-81
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D051863 ags
% 210.56/210.76 |- mesh__historyNote mesh__D051863 2006%28%1995%29%
% 210.56/210.76 |- skos__scopeNote mesh__D051863
% 210.56/210.76 A cellular transcriptional coactivator that was originally identified by its requirement for the stable assembly IMMEDIATE-EARLY PROTEINS of the HERPES SIMPLEX VIRUS. It is a nuclear protein that is a transcriptional coactivator for a number of transcription factors including VP16 PROTEIN; GA-BINDING PROTEIN; EARLY GROWTH RESPONSE PROTEIN 2; and E2F4 TRANSCRIPTION FACTOR. It also interacts with and stabilizes HERPES SIMPLEX VIRUS PROTEIN VMW65 and helps regulate GENETIC TRANSCRIPTION of IMMEDIATE-EARLY GENES in HERPES SIMPLEX VIRUS.%A%
% 210.56/210.76 |- skos__altLabel mesh__D051863 Cell Proliferation Factor HCF
% 210.56/210.76 |- mesh__dateRevised mesh__D051863 2005-07-18
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D051863 2006A
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D051863
% 210.56/210.76 2006; HOST CELL FACTOR C1 was indexed under TRANSCRIPTION FACTORS 1995-2005%A%
% 210.56/210.76 |- mesh__recordOriginator mesh__D051863 DRC
% 210.56/210.76 |- skos__prefLabel mesh__D051863 Host Cell Factor C1
% 210.56/210.76 |- mesh__dateEstablished mesh__D051863 2006-01-01
% 210.56/210.76 |- skos__altLabel mesh__D051863 C1 Host Cell Factor
% 210.56/210.76 |- skos__broader mesh__D051863smesh__D014157
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D051863 2006
% 210.56/210.76 |- mesh__dateCreated mesh__D051863 2005-06-30
% 210.56/210.76 |- mesh__recordMaintainer mesh__D051863 ags
% 210.56/210.76 |- rdf__type mesh__D051863sskos__Concept
% 210.56/210.76 |- skos__broader mesh__D045826smesh__D016905
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D045826 2004
% 210.56/210.76 |- skos__hiddenLabel mesh__D045826 Flavobacteriaceae Infection
% 210.56/210.76 |- mesh__historyNote mesh__D045826 2004
% 210.56/210.76 |- mesh__dateCreated mesh__D045826 2003-07-09
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D045826 2004
% 210.56/210.76 |- rdf__type mesh__D045826sskos__Concept
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D045826 2006
% 210.56/210.76 |- skos__prefLabel mesh__D045826 Flavobacteriaceae Infections
% 210.56/210.76 |- skos__hiddenLabel mesh__D045826 Infections, Flavobacteriaceae
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D045826 2005
% 210.56/210.76 |- skos__hiddenLabel mesh__D045826 Infection, Flavobacteriaceae
% 210.56/210.76 |- mesh__dateEstablished mesh__D045826 2004-01-01
% 210.56/210.76 |- skos__scopeNote mesh__D045826
% 210.56/210.76 Infections with bacteria of the family FLAVOBACTERIACEAE.%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D031806 2003
% 210.56/210.76 |- mesh__dateCreated mesh__D031806 2002-07-03
% 210.56/210.76 |- skos__annotation mesh__D031806
% 210.56/210.76 X ref WATER HYACINTH: HYACINTH see HYACINTHUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.76 |- skos__prefLabel mesh__D031806 Eichhornia
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D031806 2003
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D031806 2006
% 210.56/210.76 |- skos__altLabel mesh__D031806 Water Hyacinth
% 210.56/210.76 |- mesh__historyNote mesh__D031806 2003
% 210.56/210.76 |- skos__scopeNote mesh__D031806
% 210.56/210.76 A plant genus of the family PONTEDERIACEAE that is used as a biological filter for treating wastewater.%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D031806 2005
% 210.56/210.76 |- skos__broader mesh__D031806smesh__D031805
% 210.56/210.76 |- skos__altLabel mesh__D031806 Hyacinth, Water
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D031806 2004
% 210.56/210.76 |- rdf__type mesh__D031806sskos__Concept
% 210.56/210.76 |- mesh__dateEstablished mesh__D031806 2003-01-01
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017337 2002
% 210.56/210.76 |- mesh__onlineNote mesh__D017337
% 210.56/210.76 use SERMORELIN %28%NM%29% to search SOMATOTROPIN RELEASING HORMONE%28%1-29%29%AMIDE 1984-92%A%
% 210.56/210.76 |- skos__altLabel mesh__D017337 GRF%28%1-29%29%NH2
% 210.56/210.76 |- skos__altLabel mesh__D017337 hGHRH%28%1-29%29%NH2
% 210.56/210.76 |- skos__historyNote mesh__D017337
% 210.56/210.76 Somatotropin-Releasing Hormone/analogs %26% derivatives %28%1984-1992%29%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017337 2005
% 210.56/210.76 |- mesh__dateRevised mesh__D017337 2001-07-25
% 210.56/210.76 |- skos__scopeNote mesh__D017337
% 210.56/210.76 Human growth hormone-releasing factor %28%1-29%29%amide. The biologically active fragment of SOMATOTROPIN-RELEASING HORMONE. It is used to stimulate growth in children with a growth hormone deficiency or insufficiency.%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017337 2006
% 210.56/210.76 |- mesh__recordOriginator mesh__D017337 TPW
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017337 2003
% 210.56/210.76 |- mesh__historyNote mesh__D017337
% 210.56/210.76 93; was SOMATOTROPIN RELEASING HORMONE%28%1-29%29%AMIDE %28%NM%29% 1984-92%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017337 2004
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D017337 sjn
% 210.56/210.76 |- skos__historyNote mesh__D017337 Peptide Fragments %28%1984-1992%29%
% 210.56/210.76 |- mesh__dateCreated mesh__D017337 1992-05-22
% 210.56/210.76 |- rdf__type mesh__D017337sskos__Concept
% 210.56/210.76 |- skos__altLabel mesh__D017337
% 210.56/210.76 Somatotropin-Releasing-Hormone%28%1-29%29%Amide
% 210.56/210.76 |- skos__altLabel mesh__D017337 GHRH%28%1-29%29%NH2
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D017337
% 210.56/210.76 93; SOMATOTROPIN RELEASING HORMONE%28%1-29%29%AMIDE was indexed under SOMATOTROPIN-RELEASING HORMONE/analogs %26% derivatives %26% PEPTIDE FRAGMENTS 1984-92%A%
% 210.56/210.76 |- skos__prefLabel mesh__D017337 Sermorelin
% 210.56/210.76 |- skos__altLabel mesh__D017337
% 210.56/210.76 Growth Hormone-Releasing Factor%28%1-29%29%Amide
% 210.56/210.76 |- skos__broader mesh__D017337smesh__D013007
% 210.56/210.76 |- mesh__dateEstablished mesh__D017337 1993-01-01
% 210.56/210.76 |- mesh__recordMaintainer mesh__D017337 ssb
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Corneal Stromal Dystrophy
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003317 2002
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Corneal Granular Dystrophies
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Corneal Granular Dystrophy
% 210.56/210.76 |- mesh__dateCreated mesh__D003317 1999-01-01
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003317 2003
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D003317
% 210.56/210.76 90; was CORNEAL DYSTROPHIES 1963-89
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Dystrophy, Corneal Stromal
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Groenouws Dystrophies
% 210.56/210.76 |- mesh__onlineNote mesh__D003317
% 210.56/210.76 use CORNEAL DYSTROPHIES, HEREDITARY to search CORNEAL DYSTROPHIES 1966-89%A%
% 210.56/210.76 |- mesh__historyNote mesh__D003317 90; was CORNEAL DYSTROPHIES 1963-89
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003317 2004
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Dystrophy, Corneal Macular
% 210.56/210.76 |- skos__scopeNote mesh__D003317
% 210.56/210.76 Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect.%A%
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Groenouw Dystrophies
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Dystrophy, Hereditary Corneal
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Dystrophies, Corneal Granular
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Corneal Macular Dystrophies
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Dystrophies, Groenouw%27%s
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D003317 sjn
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Corneal Macular Dystrophy
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Macular Dystrophies, Corneal
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Dystrophies, Hereditary Corneal
% 210.56/210.76 |- mesh__recordMaintainer mesh__D003317 nns
% 210.56/210.76 |- skos__prefLabel mesh__D003317 Corneal Dystrophies, Hereditary
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Dystrophies, Corneal Stromal
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003317 2005
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Corneal Stromal Dystrophies
% 210.56/210.76 |- skos__broader mesh__D003317smesh__D015785
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Dystrophies, Corneal Macular
% 210.56/210.76 |- skos__broader mesh__D003317smesh__D003316
% 210.56/210.76 |- rdf__type mesh__D003317sskos__Concept
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Dystrophy, Corneal Granular
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Granular Dystrophies, Corneal
% 210.56/210.76 |- mesh__dateRevised mesh__D003317 2001-07-25
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003317 2006
% 210.56/210.76 |- mesh__recordOriginator mesh__D003317 NLM
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Corneal Dystrophy, Hereditary
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Hereditary Corneal Dystrophy
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Hereditary Corneal Dystrophies
% 210.56/210.76 |- skos__hiddenLabel mesh__D003317 Stromal Dystrophy, Corneal
% 210.56/210.76 |- skos__broader mesh__D008800smesh__D009656
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 1997
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 2003
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 1999
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 2005
% 210.56/210.76 |- mesh__dateRevised mesh__D008800 1993-04-21
% 210.56/210.76 |- mesh__recordMaintainer mesh__D008800 PLS
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 1996
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 1995
% 210.56/210.76 |- mesh__recordOriginator mesh__D008800 NLM
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 1998
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D008800 PLS
% 210.56/210.76 |- rdf__type mesh__D008800sskos__Concept
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 2002
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 1994
% 210.56/210.76 |- mesh__dateCreated mesh__D008800 1999-01-01
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 2001
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 2004
% 210.56/210.76 |- skos__annotation mesh__D008800
% 210.56/210.76 part of No. Amer., not So. Amer. nor Cent. Amer.; Indians of Mexico are indexed under MEXICO + INDIANS, NORTH AMERICAN: do not confuse with INDIANS, CENTRAL AMERICAN%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 2000
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008800 2006
% 210.56/210.76 |- skos__prefLabel mesh__D008800 Mexico
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D008002 SJN
% 210.56/210.76 |- mesh__dateRevised mesh__D008002 1998-06-10
% 210.56/210.76 |- skos__prefLabel mesh__D008002 Libya
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008002 2000
% 210.56/210.76 |- mesh__recordMaintainer mesh__D008002 JLS
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008002 2003
% 210.56/210.76 |- mesh__dateCreated mesh__D008002 1999-01-01
% 210.56/210.76 |- skos__broader mesh__D008002smesh__D008877
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008002 2004
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008002 2001
% 210.56/210.76 |- rdf__type mesh__D008002sskos__Concept
% 210.56/210.76 |- mesh__recordOriginator mesh__D008002 NLM
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008002 2002
% 210.56/210.76 |- skos__scopeNote mesh__D008002
% 210.56/210.76 A country in northern Africa. Its capital is Tripoli. The general geographical area has been known since ancient times to the Phoenicians, Greeks, and Romans. Although the name is ancient and appeared in Egyptian hieroglyphics as early as 2000 B.C., the meaning is not known. %28%From Webster%27%s New Geographical Dictionary, 1988, p668%29%%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008002 2005
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008002 1999
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008002 2006
% 210.56/210.76 |- skos__broader mesh__D008002smesh__D000352
% 210.56/210.76 |- mesh__dateCreated mesh__D013745 1999-01-01
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D013745 2006
% 210.56/210.76 |- mesh__recordMaintainer mesh__D013745 ssb
% 210.56/210.76 |- rdf__type mesh__D013745sskos__Concept
% 210.56/210.76 |- skos__hiddenLabel mesh__D013745 Toxoid, Tetanus
% 210.56/210.76 |- mesh__dateRevised mesh__D013745 2005-06-30
% 210.56/210.76 |- skos__prefLabel mesh__D013745 Tetanus Toxoid
% 210.56/210.76 |- mesh__recordOriginator mesh__D013745 NLM
% 210.56/210.76 |- skos__broader mesh__D013745smesh__D014121
% 210.56/210.76 |- skos__hiddenLabel mesh__D013745 Vaccine, Tetanus
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D013745 sjn
% 210.56/210.76 |- skos__related mesh__D013745smesh__D013743
% 210.56/210.76 |- skos__annotation mesh__D013745 note specific indentions
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007708 2005
% 210.56/210.76 |- skos__prefLabel mesh__D007708 Kirsten murine sarcoma virus
% 210.56/210.76 |- rdf__type mesh__D007708sskos__Concept
% 210.56/210.76 |- skos__broader mesh__D007708smesh__D009053
% 210.56/210.76 |- skos__historyNote mesh__D007708 Mouse Tumor Viruses %28%1966-1974%29%
% 210.56/210.76 |- skos__historyNote mesh__D007708 Mouse Sarcoma Viruses %28%1975-1979%29%
% 210.56/210.76 |- skos__altLabel mesh__D007708 Kirsten Sarcoma Virus
% 210.56/210.76 |- skos__hiddenLabel mesh__D007708 Virus, Kirsten Sarcoma
% 210.56/210.76 |- mesh__dateCreated mesh__D007708 1979-04-18
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D007708 sjn
% 210.56/210.76 |- skos__scopeNote mesh__D007708
% 210.56/210.76 A replication-defective murine sarcoma virus %28%SARCOMA VIRUSES, MURINE%29% capable of transforming mouse lymphoid cells and producing erythroid leukemia after superinfection with murine leukemia viruses %28%LEUKEMIA VIRUS, MURINE%29%. It has also been found to transform cultured human fibroblasts, rat liver epithelial cells, and rat adrenocortical cells.%A%
% 210.56/210.76 |- skos__hiddenLabel mesh__D007708 Sarcoma Virus, Kirsten
% 210.56/210.76 |- mesh__dateRevised mesh__D007708 2004-07-13
% 210.56/210.76 |- mesh__dateEstablished mesh__D007708 1991-01-01
% 210.56/210.76 |- mesh__historyNote mesh__D007708 2002 %28%1980%29%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D007708 2006
% 210.56/210.76 |- mesh__recordOriginator mesh__D007708 AEP
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D007708
% 210.56/210.76 2002; see KIRSTEN SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1980-1990%A%
% 210.56/210.76 |- skos__annotation mesh__D007708
% 210.56/210.76 infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + SARCOMA, EXPERIMENTAL %28%IM%29%%A%
% 210.56/210.76 |- mesh__recordMaintainer mesh__D007708 sjn
% 210.56/210.76 |- skos__broader mesh__D032101smesh__D027821
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D032101 2005
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D032101 2003
% 210.56/210.76 |- mesh__historyNote mesh__D032101 2003
% 210.56/210.76 |- skos__scopeNote mesh__D032101
% 210.56/210.76 A plant genus of the family RUTACEAE. Members contain murrayanine, koenine, isomahanine, kwangsine, siamenol, murrayafoline A, murrayaquinone A and other cytotoxic carbazolequinones.%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D032101 2006
% 210.56/210.76 |- mesh__dateEstablished mesh__D032101 2003-01-01
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D032101 2003
% 210.56/210.76 |- skos__prefLabel mesh__D032101 Murraya
% 210.56/210.76 |- rdf__type mesh__D032101sskos__Concept
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D032101 2004
% 210.56/210.76 |- skos__annotation mesh__D032101
% 210.56/210.76 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.76 |- mesh__dateCreated mesh__D032101 2002-07-03
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Reading Disabilities, Developmental
% 210.56/210.76 |- skos__altLabel mesh__D004410 Reading Disorder
% 210.56/210.76 |- skos__prefLabel mesh__D004410 Dyslexia
% 210.56/210.76 |- mesh__recordOriginator mesh__D004410 NLM
% 210.56/210.76 |- mesh__dateRevised mesh__D004410 2001-07-25
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D004410
% 210.56/210.76 1966; see READING 1963-1965; for ALEXIA see DYSLEXIA, ACQUIRED 1977-1999%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D004410 2005
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D004410 2004
% 210.56/210.76 |- mesh__historyNote mesh__D004410
% 210.56/210.76 1966%28%1963%29%; for ALEXIA use DYSLEXIA, ACQUIRED 1977-1999
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Developmental Reading Disorders
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Disability, Developmental Reading
% 210.56/210.76 |- skos__related mesh__D004410smesh__D007859
% 210.56/210.76 |- skos__scopeNote mesh__D004410
% 210.56/210.76 A cognitive disorder characterized by an impaired ability to comprehend written and printed words or phrases despite intact vision. This condition may be developmental or acquired. Developmental dyslexia is marked by reading achievement that falls substantially below that expected given the individual%27%s chronological age, measured intelligence, and age-appropriate education. The disturbance in reading significantly interferes with academic achievement or with activities of daily living that require reading skills. %28%From DSM-IV%29%%A%
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Disorder, Reading
% 210.56/210.76 |- rdf__type mesh__D004410sskos__Concept
% 210.56/210.76 |- skos__altLabel mesh__D004410 Word Blindness
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D004410 sjn
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Alexias
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Developmental Dyslexia
% 210.56/210.76 |- skos__broader mesh__D004410smesh__D007806
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Blindnesses, Word
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D004410 2003
% 210.56/210.76 |- skos__altLabel mesh__D004410 Dyslexia, Developmental
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Dyslexias
% 210.56/210.76 |- mesh__dateCreated mesh__D004410 1999-01-01
% 210.56/210.76 |- skos__altLabel mesh__D004410 Developmental Reading Disorder
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D004410 2002
% 210.56/210.76 |- skos__annotation mesh__D004410
% 210.56/210.76 dyslexia caused by a brain lesion is DYSLEXIA, ACQUIRED; note x-ref: ALEXIA, PURE is also available%A%
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Developmental Reading Disabilities
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Blindness, Word
% 210.56/210.76 |- skos__altLabel mesh__D004410 Reading Disability, Developmental
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Developmental Dyslexias
% 210.56/210.76 |- mesh__dateEstablished mesh__D004410 1966-01-01
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Disorder, Developmental Reading
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Reading Disorders
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Word Blindnesses
% 210.56/210.76 |- mesh__recordMaintainer mesh__D004410 nns
% 210.56/210.76 |- skos__broader mesh__D004410smesh__D007859
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Disorders, Reading
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Reading Disorders, Developmental
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Dyslexias, Developmental
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D004410 2006
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Disorders, Developmental Reading
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Developmental Reading Disability
% 210.56/210.76 |- skos__hiddenLabel mesh__D004410 Disabilities, Developmental Reading
% 210.56/210.76 |- skos__hiddenLabel mesh__D045827 Infection, Flexibacteraceae
% 210.56/210.76 |- skos__prefLabel mesh__D045827 Flexibacteraceae Infections
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D045827 2004
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D045827 2005
% 210.56/210.76 |- mesh__dateCreated mesh__D045827 2003-07-09
% 210.56/210.76 |- mesh__dateEstablished mesh__D045827 2004-01-01
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D045827 2004
% 210.56/210.76 |- skos__broader mesh__D045827smesh__D016905
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D045827 2006
% 210.56/210.76 |- rdf__type mesh__D045827sskos__Concept
% 210.56/210.76 |- skos__hiddenLabel mesh__D045827 Flexibacteraceae Infection
% 210.56/210.76 |- mesh__historyNote mesh__D045827 2004
% 210.56/210.76 |- skos__scopeNote mesh__D045827
% 210.56/210.76 Infections with bacteria of the family FLEXIBACTERACEAE.%A%
% 210.56/210.76 |- skos__hiddenLabel mesh__D045827 Infections, Flexibacteraceae
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017338 2003
% 210.56/210.76 |- mesh__dateCreated mesh__D017338 1992-05-22
% 210.56/210.76 |- skos__prefLabel mesh__D017338 Cladribine
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017338 2004
% 210.56/210.76 |- mesh__dateEstablished mesh__D017338 1993-01-01
% 210.56/210.76 |- skos__broader mesh__D017338smesh__D015762
% 210.56/210.76 |- skos__altLabel mesh__D017338 2-Chloro-2%27%-deoxyadenosine
% 210.56/210.76 |- rdf__type mesh__D017338sskos__Concept
% 210.56/210.76 |- skos__altLabel mesh__D017338 2-Chlorodeoxyadenosine
% 210.56/210.76 |- mesh__recordMaintainer mesh__D017338 ssb
% 210.56/210.76 |- skos__historyNote mesh__D017338 Deoxyadenosines %28%1986-1992%29%
% 210.56/210.76 |- mesh__onlineNote mesh__D017338
% 210.56/210.76 use CLADRIBINE to search 2-CHLORODEOXYADENOSINE 1993-94; use CLADRIBINE %28%NM%29% to search 2-CHLORO-2%27%-DEOXYADENOSINE 1986-92%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017338 2002
% 210.56/210.76 |- skos__broader mesh__D017338smesh__D003839
% 210.56/210.76 |- mesh__recordOriginator mesh__D017338 TPW
% 210.56/210.76 |- skos__altLabel mesh__D017338 2%27%-Deoxy-2-chloroadenosine
% 210.56/210.76 |- mesh__dateRevised mesh__D017338 2001-07-25
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D017338
% 210.56/210.76 95; was 2-CHLORODEOXYADENOSINE 1993-94; 2-CHLORO-2%27%-DEOXYADENOSINE was indexed under 2-CHLOROADENOSINE/analogs %26% derivatives %26% DEOXYADENOSINES 1986-92%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017338 2005
% 210.56/210.76 |- skos__scopeNote mesh__D017338
% 210.56/210.76 An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.%A%
% 210.56/210.76 |- skos__historyNote mesh__D017338
% 210.56/210.76 2-Chloroadenosine/analogs %26% derivatives %28%1986-1992%29%
% 210.56/210.76 |- mesh__historyNote mesh__D017338
% 210.56/210.76 95; was 2-CHLORODEOXYADENOSINE 1993-94; was 2-CHLORO-2%27%-DEOXYADENOSINE %28%NM%29% 1986-92%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D017338 2006
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D017338 sjn
% 210.56/210.76 |- skos__hiddenLabel mesh__D003318 Opacities, Corneal
% 210.56/210.76 |- skos__hiddenLabel mesh__D003318 Corneal Opacities
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 2006
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 1999
% 210.56/210.76 |- skos__hiddenLabel mesh__D003318 Leukomas
% 210.56/210.76 |- skos__scopeNote mesh__D003318
% 210.56/210.76 Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 2000
% 210.56/210.76 |- mesh__dateRevised mesh__D003318 1994-03-14
% 210.56/210.76 |- rdf__type mesh__D003318sskos__Concept
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 2003
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 2001
% 210.56/210.76 |- mesh__dateCreated mesh__D003318 1999-01-01
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 1996
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 1995
% 210.56/210.76 |- mesh__recordOriginator mesh__D003318 NLM
% 210.56/210.76 |- mesh__historyNote mesh__D003318
% 210.56/210.76 ARCUS SENILIS was see under EYE DISEASES 1964-89
% 210.56/210.76 |- skos__hiddenLabel mesh__D003318 Opacity, Corneal
% 210.56/210.76 |- skos__prefLabel mesh__D003318 Corneal Opacity
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 2002
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 2004
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 1997
% 210.56/210.76 |- skos__broader mesh__D003318smesh__D003316
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 2005
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D003318 1998
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D003318 PLS
% 210.56/210.76 |- mesh__recordMaintainer mesh__D003318 PLS
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D003318
% 210.56/210.76 ARCUS SENILIS was see under EYE DISEASES 1964-89
% 210.56/210.76 |- skos__altLabel mesh__D003318 Leukoma
% 210.56/210.76 |- skos__hiddenLabel mesh__D014040 Token Economies
% 210.56/210.76 |- mesh__dateCreated mesh__D014040 1974-12-12
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 2005
% 210.56/210.76 |- skos__altLabel mesh__D014040 Token Reinforcement
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 1992
% 210.56/210.76 |- skos__hiddenLabel mesh__D014040 Token Reinforcements
% 210.56/210.76 |- skos__annotation mesh__D014040 no qualif
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 1998
% 210.56/210.76 |- mesh__dateEstablished mesh__D014040 1979-01-01
% 210.56/210.76 |- mesh__historyNote mesh__D014040
% 210.56/210.76 79%28%75%29%; was see under REWARD 1975-78
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 2006
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 1993
% 210.56/210.76 |- skos__historyNote mesh__D014040 Reward %28%1966-1974%29%
% 210.56/210.76 |- mesh__recordMaintainer mesh__D014040 PLS
% 210.56/210.76 |- skos__hiddenLabel mesh__D014040 Economies, Token
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 2002
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 1999
% 210.56/210.76 |- skos__altLabel mesh__D014040 Economy, Token
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 2003
% 210.56/210.76 |- skos__broader mesh__D014040smesh__D012201
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 1996
% 210.56/210.76 |- skos__scopeNote mesh__D014040
% 210.56/210.76 A practice whereby tokens representing money, toys, candy, etc., are given as secondary reinforcers contingent upon certain desired behaviors or performances.%A%
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 2004
% 210.56/210.76 |- rdf__type mesh__D014040sskos__Concept
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 2000
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D014040 79; was see under REWARD 1975-78
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 1997
% 210.56/210.76 |- mesh__recordOriginator mesh__D014040 NLM
% 210.56/210.76 |- skos__hiddenLabel mesh__D014040 Reinforcement, Token
% 210.56/210.76 |- skos__hiddenLabel mesh__D014040 Reinforcements, Token
% 210.56/210.76 |- mesh__dateRevised mesh__D014040 1991-06-11
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 1994
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 2001
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D014040 PLS
% 210.56/210.76 |- skos__prefLabel mesh__D014040 Token Economy
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D014040 1995
% 210.56/210.76 |- skos__hiddenLabel mesh__D008801 KO 1173
% 210.56/210.76 |- skos__altLabel mesh__D008801
% 210.56/210.76 Boehringer Ingelheim Brand of Mexiletine Hydrochloride
% 210.56/210.76 |- skos__altLabel mesh__D008801 KO1173
% 210.56/210.76 |- mesh__dateEstablished mesh__D008801 1987-01-01
% 210.56/210.76 |- mesh__dateRevised mesh__D008801 2005-06-30
% 210.56/210.76 |- mesh__recordMaintainer mesh__D008801 CCR
% 210.56/210.76 |- skos__historyNote mesh__D008801 Phenyl Ethers %28%1974%29%
% 210.56/210.76 |- rdf__type mesh__D008801sskos__Concept
% 210.56/210.76 |- skos__altLabel mesh__D008801 Mexityl
% 210.56/210.76 |- skos__broader mesh__D008801smesh__D011437
% 210.56/210.76 |- skos__hiddenLabel mesh__D008801 KOE1173
% 210.56/210.76 |- mesh__dateCreated mesh__D008801 1974-11-19
% 210.56/210.76 |- skos__historyNote mesh__D008801 Propylamines %28%1972-1974%29%
% 210.56/210.76 |- skos__prefLabel mesh__D008801 Mexiletine
% 210.56/210.76 |- skos__hiddenLabel mesh__D008801 Novo Mexiletine
% 210.56/210.76 |- mesh__recordOriginator mesh__D008801 NLM
% 210.56/210.76 |- skos__hiddenLabel mesh__D008801 KOE 1173
% 210.56/210.76 |- skos__altLabel mesh__D008801 Mexitil PL
% 210.56/210.76 |- skos__altLabel mesh__D008801 KOE-1173
% 210.56/210.76 |- skos__altLabel mesh__D008801 Novopharm Brand of Mexiletine Hydrochloride
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D008801
% 210.56/210.76 87; was see under PROPYLAMINES 1975-86
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008801 2006
% 210.56/210.76 |- mesh__recordAuthorizer mesh__D008801 sjn
% 210.56/210.76 |- mesh__historyNote mesh__D008801
% 210.56/210.76 87%28%75%29%; was see under PROPYLAMINES 1975-86
% 210.56/210.76 |- skos__scopeNote mesh__D008801
% 210.56/210.76 Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.%A%
% 210.56/210.76 |- mesh__recordMaintainer mesh__D008003 ags
% 210.56/210.76 |- mesh__publicMeSHNote mesh__D008003 PHTHIRAPTERA was heading 1975-79
% 210.56/210.76 |- mesh__dateCreated mesh__D008003 1999-01-01
% 210.56/210.76 |- mesh__activeMeSHYear mesh__D008003 2004
% 210.56/210.77 |- skos__annotation mesh__D008003
% 210.56/210.77 do not use /drug eff for insecticides: TN 111
% 210.56/210.77 |- rdf__type mesh__D008003sskos__Concept
% 210.56/210.77 |- mesh__historyNote mesh__D008003 PHTHIRAPTERA was heading 1975-79
% 210.56/210.77 |- mesh__onlineNote mesh__D008003
% 210.56/210.77 use LICE to search PHTHIRAPTERA 1975-79
% 210.56/210.77 |- skos__scopeNote mesh__D008003
% 210.56/210.77 A general name for small, wingless, parasitic insects, previously of the order Phthiraptera. Though exact taxonomy is still controversial, they can be grouped in the orders ANOPLURA %28%sucking lice%29%, MALLOPHAGA %28%biting lice%29%, and Rhynchophthirina %28%elephant-lice%29%.%A%
% 210.56/210.77 |- mesh__dateRevised mesh__D008003 2003-07-09
% 210.56/210.77 |- skos__related mesh__D008003smesh__D010373
% 210.56/210.77 |- skos__altLabel mesh__D008003 Louse
% 210.56/210.77 |- skos__prefLabel mesh__D008003 Lice
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008003 2005
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D008003 sjn
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008003 2006
% 210.56/210.77 |- skos__altLabel mesh__D008003 Phthiraptera
% 210.56/210.77 |- mesh__recordOriginator mesh__D008003 NLM
% 210.56/210.77 |- skos__broader mesh__D008003smesh__D007313
% 210.56/210.77 |- skos__altLabel mesh__D000020 Abortifacient Agents, Non-Steroidal
% 210.56/210.77 |- rdf__type mesh__D000020sskos__Concept
% 210.56/210.77 |- skos__prefLabel mesh__D000020 Abortifacient Agents, Nonsteroidal
% 210.56/210.77 |- skos__hiddenLabel mesh__D000020 Abortifacient Agents, Non Steroidal
% 210.56/210.77 |- skos__historyNote mesh__D000020 specific chemical %28%1971-1974%29%
% 210.56/210.77 |- skos__historyNote mesh__D000020 Abortion, Induced %28%1970-1974%29%
% 210.56/210.77 |- skos__broader mesh__D000020smesh__D000019
% 210.56/210.77 |- skos__hiddenLabel mesh__D000020 Non-Steroidal Abortifacient Agents
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D000020 sjn
% 210.56/210.77 |- skos__annotation mesh__D000020
% 210.56/210.77 do not use /ther use for use of the abortifacients as abortifacients%A%
% 210.56/210.77 |- skos__hiddenLabel mesh__D000020 Agents, Nonsteroidal Abortifacient
% 210.56/210.77 |- skos__hiddenLabel mesh__D000020 Agents, Non-Steroidal Abortifacient
% 210.56/210.77 |- mesh__dateRevised mesh__D000020 2005-06-30
% 210.56/210.77 |- mesh__recordMaintainer mesh__D000020 ssb
% 210.56/210.77 |- mesh__recordOriginator mesh__D000020 NLM
% 210.56/210.77 |- skos__scopeNote mesh__D000020
% 210.56/210.77 Non-steroidal chemical compounds with abortifacient activity.%A%
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D000020 2006
% 210.56/210.77 |- mesh__dateEstablished mesh__D000020 1991-01-01
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D000020
% 210.56/210.77 91; was see under ABORTIFACIENT AGENTS 1975-90
% 210.56/210.77 |- skos__hiddenLabel mesh__D000020 Nonsteroidal Abortifacient Agents
% 210.56/210.77 |- mesh__dateCreated mesh__D000020 1974-11-11
% 210.56/210.77 |- mesh__historyNote mesh__D000020
% 210.56/210.77 91%28%75%29%; was see under ABORTIFACIENT AGENTS 1975-90
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D013746 SPASMOPHILIA was heading 1963-76
% 210.56/210.77 |- mesh__historyNote mesh__D013746 SPASMOPHILIA was heading 1963-76
% 210.56/210.77 |- skos__scopeNote mesh__D013746
% 210.56/210.77 A disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This condition is associated with unstable depolarization of axonal membranes, primarily in the peripheral nervous system. Tetany usually results from HYPOCALCEMIA or reduced serum levels of MAGNESIUM that may be associated with HYPERVENTILATION; HYPOPARATHYROIDISM; RICKETS; UREMIA; or other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, p1490%29%%A%
% 210.56/210.77 |- skos__hiddenLabel mesh__D013746 Neonatal Tetanies
% 210.56/210.77 |- skos__broader mesh__D013746smesh__D006996
% 210.56/210.77 |- skos__hiddenLabel mesh__D013746 Tetanies
% 210.56/210.77 |- skos__hiddenLabel mesh__D013746 Spasmophilias
% 210.56/210.77 |- skos__broader mesh__D013746smesh__D020879
% 210.56/210.77 |- mesh__dateRevised mesh__D013746 2005-06-30
% 210.56/210.77 |- skos__annotation mesh__D013746
% 210.56/210.77 do not confuse with TETANUS, a Clostridium tetani infection; tetanic spasm of muscle = SPASM; tetanic contraction = MUSCLE CONTRACTION; coordinate with cause if given%A%
% 210.56/210.77 |- mesh__recordOriginator mesh__D013746 NLM
% 210.56/210.77 |- skos__hiddenLabel mesh__D013746 Tetanillas
% 210.56/210.77 |- mesh__recordMaintainer mesh__D013746 lkt
% 210.56/210.77 |- skos__prefLabel mesh__D013746 Tetany
% 210.56/210.77 |- skos__hiddenLabel mesh__D013746 Tetanies, Neonatal
% 210.56/210.77 |- mesh__onlineNote mesh__D013746
% 210.56/210.77 use TETANY to search SPASMOPHILIA 1966-76
% 210.56/210.77 |- skos__hiddenLabel mesh__D013746 Neonatal Tetany
% 210.56/210.77 |- mesh__dateCreated mesh__D013746 1999-01-01
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D013746 sjn
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D013746 2006
% 210.56/210.77 |- rdf__type mesh__D013746sskos__Concept
% 210.56/210.77 |- skos__annotation mesh__D007709
% 210.56/210.77 KLEBSIELLA AEROGENES and KLEBSIELLA MOBILIS see ENTEROBACTER AEROGENES are also available%A%
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D007709 2006A
% 210.56/210.77 |- mesh__dateRevised mesh__D007709 2005-07-18
% 210.56/210.77 |- skos__scopeNote mesh__D007709
% 210.56/210.77 A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.%A%
% 210.56/210.77 |- skos__prefLabel mesh__D007709 Klebsiella
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D007709 ags
% 210.56/210.77 |- mesh__recordMaintainer mesh__D007709 ags
% 210.56/210.77 |- mesh__recordOriginator mesh__D007709 NLM
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D007709 2006
% 210.56/210.77 |- skos__broader mesh__D007709smesh__D004755
% 210.56/210.77 |- rdf__type mesh__D007709sskos__Concept
% 210.56/210.77 |- mesh__dateCreated mesh__D007709 1999-01-01
% 210.56/210.77 |- skos__prefLabel mesh__D018431 Newspaper Article %5B%Publication Type%5D%
% 210.56/210.77 |- mesh__dateRevised mesh__D018431 2005-06-30
% 210.56/210.77 |- skos__annotation mesh__D018431
% 210.56/210.77 publication type only; for items indexed from newspapers or newsletters: do not confuse with the Publication Type NEWS used for news items indexed from journals%A%
% 210.56/210.77 |- mesh__dateEstablished mesh__D018431 1996-01-01
% 210.56/210.77 |- skos__altLabel mesh__D018431 Newspaper Article %28%PT%29%
% 210.56/210.77 |- mesh__historyNote mesh__D018431 1995
% 210.56/210.77 |- skos__broader mesh__D018431smesh__D052180
% 210.56/210.77 |- mesh__recordMaintainer mesh__D018431 jls
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D018431 sjn
% 210.56/210.77 |- skos__altLabel mesh__D018431 Newspaper Article
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D018431 2006
% 210.56/210.77 |- skos__scopeNote mesh__D018431
% 210.56/210.77 Work consisting of a news item appearing in a general-interest newspaper or other general news periodical, containing information of current and timely interest in the field of medicine or science. This publication type should not be confused with NEWS %5B%PUBLICATION TYPE%5D%, reserved for news reports published in various medical or other scientific journals, such as %22%Nature%22%.%A%
% 210.56/210.77 |- rdf__type mesh__D018431sskos__Concept
% 210.56/210.77 |- mesh__recordOriginator mesh__D018431 TGC
% 210.56/210.77 |- mesh__dateCreated mesh__D018431 1995-06-23
% 210.56/210.77 |- mesh__dateCreated mesh__D032102 2002-07-03
% 210.56/210.77 |- skos__scopeNote mesh__D032102
% 210.56/210.77 A plant genus of the family RUTACEAE. Members contain BERBERINE, indolopyridoquinazoline and other ALKALOIDS and limonoids.%A%
% 210.56/210.77 |- skos__broader mesh__D032102smesh__D027821
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D032102 2005
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D032102 2003
% 210.56/210.77 |- mesh__historyNote mesh__D032102 2003
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D032102 2006
% 210.56/210.77 |- mesh__dateEstablished mesh__D032102 2003-01-01
% 210.56/210.77 |- skos__altLabel mesh__D032102 Corktree
% 210.56/210.77 |- rdf__type mesh__D032102sskos__Concept
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D032102 2003
% 210.56/210.77 |- skos__prefLabel mesh__D032102 Phellodendron
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D032102 2004
% 210.56/210.77 |- skos__annotation mesh__D032102
% 210.56/210.77 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D004411 1977; see ALEXIA 1963-1976
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Spelling Dyslexia, Acquired
% 210.56/210.77 |- skos__broader mesh__D004411smesh__D004410
% 210.56/210.77 |- skos__altLabel mesh__D004411 Word Blindness, Acquired
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Blindnesses, Acquired Word
% 210.56/210.77 |- mesh__recordMaintainer mesh__D004411 KEV
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Disability, Acquired Reading
% 210.56/210.77 |- rdf__type mesh__D004411sskos__Concept
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Dyslexia, Acquired Spelling
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Global Dyslexia, Acquired
% 210.56/210.77 |- skos__scopeNote mesh__D004411
% 210.56/210.77 A receptive visual aphasia characterized by the loss of a previously possessed ability to comprehend the meaning or significance of handwritten words, despite intact vision. This condition may be associated with posterior cerebral artery infarction %28%INFARCTION, POSTERIOR CEREBRAL ARTERY%29% and other BRAIN DISEASES.%A%
% 210.56/210.77 |- skos__broader mesh__D004411smesh__D019965
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D004411 2002
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Acquired Reading Disability
% 210.56/210.77 |- mesh__dateRevised mesh__D004411 1999-11-04
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Disabilities, Acquired Reading
% 210.56/210.77 |- skos__altLabel mesh__D004411 Reading Disability, Acquired
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Reading Disabilities, Acquired
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Acquired Word Blindness
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Dyslexia, Acquired Global
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Acquired Word Blindnesses
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D004411 sjn
% 210.56/210.77 |- mesh__historyNote mesh__D004411 1977%28%1963%29%
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Blindness, Acquired Word
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Acquired Alexia
% 210.56/210.77 |- mesh__recordOriginator mesh__D004411 NLM
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D004411 2003
% 210.56/210.77 |- mesh__dateCreated mesh__D004411 1999-01-01
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Word Blindnesses, Acquired
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Acquired Reading Disabilities
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D004411 2000
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D004411 2005
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D004411 2004
% 210.56/210.77 |- skos__hiddenLabel mesh__D004411 Acquired Dyslexia
% 210.56/210.77 |- skos__prefLabel mesh__D004411 Dyslexia, Acquired
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D004411 2001
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D004411 2006
% 210.56/210.77 |- skos__hiddenLabel mesh__D045828 Infection, Moraxella
% 210.56/210.77 |- skos__hiddenLabel mesh__D045828 Psychobacter Infection
% 210.56/210.77 |- skos__hiddenLabel mesh__D045828 Moraxella Infection
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D045828 2004
% 210.56/210.77 |- skos__hiddenLabel mesh__D045828 Infections, Moraxellaceae
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D045828 2005
% 210.56/210.77 |- mesh__dateCreated mesh__D045828 2003-07-09
% 210.56/210.77 |- skos__hiddenLabel mesh__D045828 Infection, Moraxellaceae
% 210.56/210.77 |- skos__hiddenLabel mesh__D045828 Infections, Psychobacter
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D045828 2004
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D045828 2006
% 210.56/210.77 |- rdf__type mesh__D045828sskos__Concept
% 210.56/210.77 |- skos__prefLabel mesh__D045828 Moraxellaceae Infections
% 210.56/210.77 |- skos__scopeNote mesh__D045828
% 210.56/210.77 Infections with bacteria of the family MORAXELLACEAE.
% 210.56/210.77 |- skos__hiddenLabel mesh__D045828 Infections, Moraxella
% 210.56/210.77 |- mesh__dateEstablished mesh__D045828 2004-01-01
% 210.56/210.77 |- skos__broader mesh__D045828smesh__D016905
% 210.56/210.77 |- skos__hiddenLabel mesh__D045828 Infection, Psychobacter
% 210.56/210.77 |- skos__hiddenLabel mesh__D045828 Moraxellaceae Infection
% 210.56/210.77 |- mesh__historyNote mesh__D045828 2004
% 210.56/210.77 |- mesh__recordOriginator mesh__D028061 jmp
% 210.56/210.77 |- mesh__recordMaintainer mesh__D028061 SYSTEM
% 210.56/210.77 |- rdf__type mesh__D028061sskos__Concept
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D028061 2006
% 210.56/210.77 |- skos__broader mesh__D028061smesh__D027321
% 210.56/210.77 |- skos__altLabel mesh__D028061 Inorganic Phosphate Transporter
% 210.56/210.77 |- mesh__dateRevised mesh__D028061 2005-06-30
% 210.56/210.77 |- skos__prefLabel mesh__D028061 Phosphate Transport Proteins
% 210.56/210.77 |- mesh__dateCreated mesh__D028061 2001-07-25
% 210.56/210.77 |- skos__hiddenLabel mesh__D028061 Transporters, Inorganic Phosphate
% 210.56/210.77 |- skos__scopeNote mesh__D028061
% 210.56/210.77 Membrane proteins that are involved in the active transport of phosphate.%A%
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D028061 sjn
% 210.56/210.77 |- skos__hiddenLabel mesh__D028061 Carriers, Phosphate
% 210.56/210.77 |- skos__historyNote mesh__D028061 Carrier Proteins %28%1991-2001%29%
% 210.56/210.77 |- skos__altLabel mesh__D028061 Inorganic Phosphate Transporters
% 210.56/210.77 |- skos__hiddenLabel mesh__D028061 Phosphate Transporters, Inorganic
% 210.56/210.77 |- skos__hiddenLabel mesh__D028061 Transporters, Phosphate
% 210.56/210.77 |- skos__hiddenLabel mesh__D028061 Transporter, Phosphate
% 210.56/210.77 |- skos__altLabel mesh__D028061 Phosphate Transporter
% 210.56/210.77 |- skos__broader mesh__D028061smesh__D028044
% 210.56/210.77 |- skos__annotation mesh__D028061
% 210.56/210.77 do not confuse with PHOSPHATE-BINDING PROTEINS
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D028061
% 210.56/210.77 2002; PHOSPHATE TRANSPORT PROTEINS %26% PHOSPHATE TRANSPORTER were indexed under CARRIER PROTEINS 1991-2001; INORGANIC PHOSPHATE TRANSPORTER was indexed under CARRIER PROTEINS 1999-2001%A%
% 210.56/210.77 |- mesh__historyNote mesh__D028061
% 210.56/210.77 2002; for PHOSPHATE TRANSPORT PROTEINS %26% PHOSPHATE TRANSPORTER use PHOSPHATE BINDING PROTEINS %28%NM%29% 1991-2001; for INORGANIC PHOSPHATE TRANSPORTER use PHOSPHATE BINDING PROTEINS %28%NM%29% 1999-2001%A%
% 210.56/210.77 |- skos__altLabel mesh__D028061 Phosphate Transporters
% 210.56/210.77 |- mesh__dateEstablished mesh__D028061 2002-01-01
% 210.56/210.77 |- rdf__type mesh__D003319sskos__Concept
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D003319 PLS
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D003319 91; was see under CORNEA 1983-90
% 210.56/210.77 |- skos__hiddenLabel mesh__D003319 Stroma, Corneal
% 210.56/210.77 |- skos__broader mesh__D003319smesh__D003315
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 1991
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 1995
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 2003
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 1996
% 210.56/210.77 |- skos__historyNote mesh__D003319 Cornea %28%1966-1982%29%
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 2000
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 2004
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 1997
% 210.56/210.77 |- skos__prefLabel mesh__D003319 Corneal Stroma
% 210.56/210.77 |- mesh__recordOriginator mesh__D003319 RC
% 210.56/210.77 |- skos__hiddenLabel mesh__D003319 Stromas, Corneal
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 2001
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 1992
% 210.56/210.77 |- mesh__historyNote mesh__D003319
% 210.56/210.77 91%28%83%29%; was see under CORNEA 1983-90
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 2005
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 1998
% 210.56/210.77 |- mesh__dateEstablished mesh__D003319 1991-01-01
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 2002
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 1993
% 210.56/210.77 |- skos__scopeNote mesh__D003319
% 210.56/210.77 The lamellated connective tissue constituting the thickest layer of the cornea between the Bowman and Descemet membranes.%A%
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 2006
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 1999
% 210.56/210.77 |- mesh__recordMaintainer mesh__D003319 NLM
% 210.56/210.77 |- mesh__dateRevised mesh__D003319 1990-04-13
% 210.56/210.77 |- skos__hiddenLabel mesh__D003319 Corneal Stromas
% 210.56/210.77 |- mesh__dateCreated mesh__D003319 1982-04-28
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D003319 1994
% 210.56/210.77 |- skos__broader mesh__D014041smesh__D007564
% 210.56/210.77 |- mesh__historyNote mesh__D014041 BONIN ISLANDS was see JAPAN 1975-83
% 210.56/210.77 |- mesh__onlineNote mesh__D014041
% 210.56/210.77 use JAPAN to search BONIN ISLANDS 1975-83
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 2002
% 210.56/210.77 |- mesh__recordOriginator mesh__D014041 NLM
% 210.56/210.77 |- mesh__dateCreated mesh__D014041 1999-01-01
% 210.56/210.77 |- mesh__dateRevised mesh__D014041 1991-06-11
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 1995
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 1993
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 1994
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 2006
% 210.56/210.77 |- skos__prefLabel mesh__D014041 Tokyo
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 1992
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 2004
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 2001
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 1999
% 210.56/210.77 |- skos__broader mesh__D014041smesh__D002947
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 1997
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 2000
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 2005
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 2003
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 1998
% 210.56/210.77 |- rdf__type mesh__D014041sskos__Concept
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D014041 1996
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D014041 PLS
% 210.56/210.77 |- mesh__recordMaintainer mesh__D014041 TGC
% 210.56/210.77 |- skos__hiddenLabel mesh__D008802 Bay f 1353
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D008802 84
% 210.56/210.77 |- skos__altLabel mesh__D008802
% 210.56/210.77 curasan Brand of Mezlocillin Sodium %28%Sterile%29%
% 210.56/210.77 |- skos__altLabel mesh__D008802
% 210.56/210.77 Bayer Brand of Mezlocillin Sodium %28%Sterile%29%
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D008802 sjn
% 210.56/210.77 |- skos__prefLabel mesh__D008802 Mezlocillin
% 210.56/210.77 |- mesh__dateCreated mesh__D008802 1983-04-04
% 210.56/210.77 |- rdf__type mesh__D008802sskos__Concept
% 210.56/210.77 |- mesh__recordOriginator mesh__D008802 SH
% 210.56/210.77 |- skos__scopeNote mesh__D008802
% 210.56/210.77 Semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections.%A%
% 210.56/210.77 |- skos__altLabel mesh__D008802 Meslocillin
% 210.56/210.77 |- mesh__dateRevised mesh__D008802 2005-06-30
% 210.56/210.77 |- skos__broader mesh__D008802smesh__D000667
% 210.56/210.77 |- skos__hiddenLabel mesh__D008802 Bayf 1353
% 210.56/210.77 |- mesh__historyNote mesh__D008802 84
% 210.56/210.77 |- mesh__dateEstablished mesh__D008802 1984-01-01
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008802 2006
% 210.56/210.77 |- skos__altLabel mesh__D008802 Baypen
% 210.56/210.77 |- mesh__recordMaintainer mesh__D008802 CCR
% 210.56/210.77 |- skos__historyNote mesh__D008802 Penicillins %28%1966-1983%29%
% 210.56/210.77 |- skos__altLabel mesh__D008802 Mezlocilline
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008004 2005
% 210.56/210.77 |- rdf__type mesh__D008004sskos__Concept
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D008004 sjn
% 210.56/210.77 |- skos__hiddenLabel mesh__D008004 Permit
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008004 2002
% 210.56/210.77 |- skos__related mesh__D008004smesh__D002568
% 210.56/210.77 |- skos__hiddenLabel mesh__D008004 Licensures
% 210.56/210.77 |- mesh__recordOriginator mesh__D008004 NLM
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008004 2006
% 210.56/210.77 |- skos__scopeNote mesh__D008004
% 210.56/210.77 The legal authority or formal permission from authorities to carry on certain activities which by law or regulation require such permission. It may be applied to licensure of institutions as well as individuals.%A%
% 210.56/210.77 |- skos__altLabel mesh__D008004 Institutional Personnel Licensure
% 210.56/210.77 |- skos__hiddenLabel mesh__D008004 Institutional Personnel Licensures
% 210.56/210.77 |- skos__hiddenLabel mesh__D008004 Personnel Licensure, Institutional
% 210.56/210.77 |- skos__prefLabel mesh__D008004 Licensure
% 210.56/210.77 |- skos__broader mesh__D008004smesh__D003406
% 210.56/210.77 |- skos__annotation mesh__D008004
% 210.56/210.77 by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog%A%
% 210.56/210.77 |- skos__hiddenLabel mesh__D008004 License
% 210.56/210.77 |- skos__altLabel mesh__D008004 Licenses
% 210.56/210.77 |- skos__hiddenLabel mesh__D008004 Licensures, Institutional Personnel
% 210.56/210.77 |- mesh__dateRevised mesh__D008004 1999-11-03
% 210.56/210.77 |- skos__hiddenLabel mesh__D008004 Personnel Licensures, Institutional
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008004 2003
% 210.56/210.77 |- skos__hiddenLabel mesh__D008004 Licensure, Institutional Personnel
% 210.56/210.77 |- mesh__recordMaintainer mesh__D008004 kle
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008004 2000
% 210.56/210.77 |- mesh__dateCreated mesh__D008004 1999-01-01
% 210.56/210.77 |- skos__related mesh__D008004smesh__D000068
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008004 2004
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D008004 2001
% 210.56/210.77 |- skos__hiddenLabel mesh__D000021 Abortifacients, Steroid
% 210.56/210.77 |- mesh__historyNote mesh__D000021
% 210.56/210.77 91%28%75%29%; was see under ABORTIFACIENT AGENTS 1975-90
% 210.56/210.77 |- skos__historyNote mesh__D000021 Abortion, Induced %28%1970-1974%29%
% 210.56/210.77 |- skos__annotation mesh__D000021
% 210.56/210.77 do not use /ther use for use of the abortifacients as abortifacients%A%
% 210.56/210.77 |- skos__hiddenLabel mesh__D000021 Steroidal Abortifacient Agents
% 210.56/210.77 |- skos__prefLabel mesh__D000021 Abortifacient Agents, Steroidal
% 210.56/210.77 |- skos__altLabel mesh__D000021 Steroid Abortifacients
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D000021 2006
% 210.56/210.77 |- skos__broader mesh__D000021smesh__D000019
% 210.56/210.77 |- skos__historyNote mesh__D000021 specific chemical %28%1970-1974%29%
% 210.56/210.77 |- mesh__dateEstablished mesh__D000021 1991-01-01
% 210.56/210.77 |- skos__hiddenLabel mesh__D000021 Agents, Steroidal Abortifacient
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D000021
% 210.56/210.77 91; was see under ABORTIFACIENT AGENTS 1975-90
% 210.56/210.77 |- mesh__dateCreated mesh__D000021 1974-11-11
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D000021 sjn
% 210.56/210.77 |- skos__scopeNote mesh__D000021
% 210.56/210.77 Steroidal compounds with abortifacient activity.
% 210.56/210.77 |- mesh__dateRevised mesh__D000021 2005-06-30
% 210.56/210.77 |- mesh__recordMaintainer mesh__D000021 ssb
% 210.56/210.77 |- mesh__recordOriginator mesh__D000021 NLM
% 210.56/210.77 |- rdf__type mesh__D000021sskos__Concept
% 210.56/210.77 |- skos__broader mesh__D052160smesh__D006574
% 210.56/210.77 |- skos__scopeNote mesh__D052160
% 210.56/210.77 Compounds with a benzene ring fused to a thiazole ring.%A%
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D052160 2006
% 210.56/210.77 |- mesh__recordMaintainer mesh__D052160 ssb
% 210.56/210.77 |- skos__prefLabel mesh__D052160 Benzothiazoles
% 210.56/210.77 |- mesh__recordOriginator mesh__D052160 ssb
% 210.56/210.77 |- skos__broader mesh__D052160smesh__D013844
% 210.56/210.77 |- mesh__dateEstablished mesh__D052160 2006-01-01
% 210.56/210.77 |- rdf__type mesh__D052160sskos__Concept
% 210.56/210.77 |- mesh__dateCreated mesh__D052160 2005-06-30
% 210.56/210.77 |- mesh__historyNote mesh__D052160 2006
% 210.56/210.77 |- skos__historyNote mesh__D052160 Thiazoles %28%1965-2005%29%
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D052160 sjn
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D052160 2006
% 210.56/210.77 |- mesh__recordMaintainer mesh__D013747 CCR
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D013747 sjn
% 210.56/210.77 |- skos__scopeNote mesh__D013747
% 210.56/210.77 A drug formerly used as an antipsychotic but now used primarily in the treatment of various movement disorders including tardive dyskinesia. Tetrabenazine blocks uptake into adrenergic storage vesicles and has been used as a high affinity label for the vesicle transport system.%A%
% 210.56/210.77 |- skos__altLabel mesh__D013747
% 210.56/210.77 Cambridge Laboratories Brand of Tetrabenazine
% 210.56/210.77 |- mesh__dateCreated mesh__D013747 1999-01-01
% 210.56/210.77 |- skos__altLabel mesh__D013747 Roche Brand of Tetrabenazine
% 210.56/210.77 |- skos__annotation mesh__D013747
% 210.56/210.77 do not confuse with TETRACYCLINES, the group
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D013747 2006
% 210.56/210.77 |- skos__altLabel mesh__D013747 Shire Brand of Tetrabenazine
% 210.56/210.77 |- rdf__type mesh__D013747sskos__Concept
% 210.56/210.77 |- skos__prefLabel mesh__D013747 Tetrabenazine
% 210.56/210.77 |- skos__broader mesh__D013747smesh__D011807
% 210.56/210.77 |- mesh__dateRevised mesh__D013747 2005-06-30
% 210.56/210.77 |- mesh__recordOriginator mesh__D013747 NLM
% 210.56/210.77 |- skos__scopeNote mesh__D032901
% 210.56/210.77 A fungal genus in the family Trichocomaceae, order EUROTIALES, characterized by loose hyphal fruiting bodies containing spherical asci. Anamorphs include PENICILLIUM and PAECILOMYCES.%A%
% 210.56/210.77 |- mesh__dateRevised mesh__D032901 2005-06-30
% 210.56/210.77 |- mesh__recordAuthorizer mesh__D032901 sjn
% 210.56/210.77 |- mesh__dateCreated mesh__D032901 2002-07-03
% 210.56/210.77 |- mesh__dateEstablished mesh__D032901 2003-01-01
% 210.56/210.77 |- skos__broader mesh__D032901smesh__D032641
% 210.56/210.77 |- mesh__publicMeSHNote mesh__D032901 2003
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D032901 2006
% 210.56/210.77 |- skos__prefLabel mesh__D032901 Talaromyces
% 210.56/210.77 |- mesh__recordMaintainer mesh__D032901 SYSTEM
% 210.56/210.77 |- mesh__historyNote mesh__D032901 2003
% 210.56/210.77 |- rdf__type mesh__D032901sskos__Concept
% 210.56/210.77 |- mesh__recordOriginator mesh__D032901 ags
% 210.56/210.77 |- skos__historyNote mesh__D032901 Ascomycota %28%1965-2002%29%
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D018432 2005
% 210.56/210.77 |- mesh__historyNote mesh__D018432 95
% 210.56/210.77 |- skos__annotation mesh__D018432
% 210.56/210.77 DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, VIRAL; and DRUG RESISTANCE, MULTIPLE, FUNGAL are also available%A%
% 210.56/210.77 |- skos__related mesh__D018432smesh__D019450
% 210.56/210.77 |- skos__hiddenLabel mesh__D018432 Resistance, Multiple Drug
% 210.56/210.77 |- skos__related mesh__D018432smesh__D018435
% 210.56/210.77 |- skos__related mesh__D018432smesh__D018088
% 210.56/210.77 |- skos__broader mesh__D018432smesh__D008827
% 210.56/210.77 |- mesh__activeMeSHYear mesh__D018432 2006
% 210.75/210.89 |- skos__scopeNote mesh__D018432
% 210.75/210.89 Simultaneous resistance to several structurally and functionally distinct drugs.%A%
% 210.75/210.89 |- mesh__recordOriginator mesh__D018432 AGS
% 210.75/210.89 |- skos__hiddenLabel mesh__D018432 Multiple Drug Resistance
% 210.75/210.89 |- mesh__dateRevised mesh__D018432 2003-07-09
% 210.75/210.89 |- mesh__dateEstablished mesh__D018432 1995-01-01
% 210.75/210.89 |- skos__historyNote mesh__D018432
% 210.75/210.89 Drug Resistance, Microbial %28%1966-1994%29%
% 210.75/210.89 |- skos__historyNote mesh__D018432 Drug Resistance %28%1981-1994%29%
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D018432 95
% 210.75/210.89 |- skos__altLabel mesh__D018432 Multidrug Resistance
% 210.75/210.89 |- rdf__type mesh__D018432sskos__Concept
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D018432 sjn
% 210.75/210.89 |- mesh__dateCreated mesh__D018432 1994-01-25
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D018432 2004
% 210.75/210.89 |- skos__related mesh__D018432smesh__D027425
% 210.75/210.89 |- mesh__recordMaintainer mesh__D018432 ssb
% 210.75/210.89 |- skos__altLabel mesh__D018432 Multi-Drug Resistance
% 210.75/210.89 |- skos__prefLabel mesh__D018432 Drug Resistance, Multiple
% 210.75/210.89 |- skos__broader mesh__D018432smesh__D004351
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D032103 2006
% 210.75/210.89 |- rdf__type mesh__D032103sskos__Concept
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D032103 2003
% 210.75/210.89 |- mesh__dateCreated mesh__D032103 2002-07-03
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D032103 2004
% 210.75/210.89 |- skos__scopeNote mesh__D032103
% 210.75/210.89 A plant genus of the family RUTACEAE that is the natural source of PILOCARPINE.%A%
% 210.75/210.89 |- skos__annotation mesh__D032103
% 210.75/210.89 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.75/210.89 |- skos__broader mesh__D032103smesh__D027821
% 210.75/210.89 |- mesh__dateEstablished mesh__D032103 2003-01-01
% 210.75/210.89 |- mesh__historyNote mesh__D032103 2003
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D032103 2005
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D032103 2003
% 210.75/210.89 |- skos__prefLabel mesh__D032103 Pilocarpus
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D004412 sjn
% 210.75/210.89 |- mesh__recordOriginator mesh__D004412 NLM
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004412 2000
% 210.75/210.89 |- skos__altLabel mesh__D004412 Menstruation, Painful
% 210.75/210.89 |- skos__hiddenLabel mesh__D004412 Menstrual Pain
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004412 2003
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004412 2001
% 210.75/210.89 |- mesh__dateCreated mesh__D004412 1999-01-01
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004412 2005
% 210.75/210.89 |- skos__hiddenLabel mesh__D004412 Menstrual Pains
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004412 2004
% 210.75/210.89 |- skos__altLabel mesh__D004412 Pain, Menstrual
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004412 2006
% 210.75/210.89 |- mesh__dateRevised mesh__D004412 1999-11-04
% 210.75/210.89 |- skos__hiddenLabel mesh__D004412 Painful Menstruation
% 210.75/210.89 |- skos__broader mesh__D004412smesh__D008599
% 210.75/210.89 |- skos__hiddenLabel mesh__D004412 Pains, Menstrual
% 210.75/210.89 |- skos__hiddenLabel mesh__D004412 Painful Menstruations
% 210.75/210.89 |- skos__scopeNote mesh__D004412 Painful menstruation.
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004412 2002
% 210.75/210.89 |- skos__prefLabel mesh__D004412 Dysmenorrhea
% 210.75/210.89 |- skos__hiddenLabel mesh__D004412 Menstruations, Painful
% 210.75/210.89 |- mesh__recordMaintainer mesh__D004412 KEV
% 210.75/210.89 |- skos__hiddenLabel mesh__D004412 Dysmenorrheas
% 210.75/210.89 |- rdf__type mesh__D004412sskos__Concept
% 210.75/210.89 |- skos__broader mesh__D004412smesh__D017699
% 210.75/210.89 |- mesh__recordMaintainer mesh__D014840 KEV
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D014840 2004
% 210.75/210.89 |- mesh__dateRevised mesh__D014840 1999-11-03
% 210.75/210.89 |- mesh__historyNote mesh__D014840 88
% 210.75/210.89 |- rdf__type mesh__D014840sskos__Concept
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D014840 2005
% 210.75/210.89 |- skos__broader mesh__D014840smesh__D014839
% 210.75/210.89 |- skos__scopeNote mesh__D014840
% 210.75/210.89 Vomiting caused by expectation of discomfort or unpleasantness.%A%
% 210.75/210.89 |- mesh__dateEstablished mesh__D014840 1988-01-01
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D014840 2006
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D014840 2000
% 210.75/210.89 |- skos__annotation mesh__D014840
% 210.75/210.89 do not use /chem ind in cancer chemother: prefer /etiol, /psychol, etc.%A%
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D014840 2001
% 210.75/210.89 |- skos__prefLabel mesh__D014840 Vomiting, Anticipatory
% 210.75/210.89 |- mesh__dateCreated mesh__D014840 1987-05-01
% 210.75/210.89 |- skos__historyNote mesh__D014840 Vomiting %28%1966-1987%29%
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D014840 88
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D014840 2002
% 210.75/210.89 |- skos__altLabel mesh__D014840 Anticipatory Vomiting
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D014840 2003
% 210.75/210.89 |- mesh__recordOriginator mesh__D014840 EC
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D014840 sjn
% 210.75/210.89 |- skos__broader mesh__D014042smesh__D013453
% 210.75/210.89 |- mesh__dateRevised mesh__D014042 2005-06-30
% 210.75/210.89 |- mesh__historyNote mesh__D014042 73%28%64%29%
% 210.75/210.89 |- mesh__dateEstablished mesh__D014042 1973-01-01
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D014042 2006
% 210.75/210.89 |- mesh__recordOriginator mesh__D014042 NLM
% 210.75/210.89 |- skos__scopeNote mesh__D014042
% 210.75/210.89 A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.%A%
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D014042 sjn
% 210.75/210.89 |- skos__prefLabel mesh__D014042 Tolazamide
% 210.75/210.89 |- skos__altLabel mesh__D014042 Pharmacia Brand of Tolazamide
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D014042 73
% 210.75/210.89 |- rdf__type mesh__D014042sskos__Concept
% 210.75/210.89 |- mesh__recordMaintainer mesh__D014042 CCR
% 210.75/210.89 |- mesh__dateCreated mesh__D014042 1999-01-01
% 210.75/210.89 |- skos__altLabel mesh__D008803 Mianserin Monohydrochloride
% 210.75/210.89 |- rdf__type mesh__D008803sskos__Concept
% 210.75/210.89 |- mesh__recordOriginator mesh__D008803 NLM
% 210.75/210.89 |- skos__prefLabel mesh__D008803 Mianserin
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008803 2003
% 210.75/210.89 |- skos__historyNote mesh__D008803 Dibenzazepines %28%1972-1974%29%
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008803 2005
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D008803 sjn
% 210.75/210.89 |- mesh__dateRevised mesh__D008803 2000-06-21
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008803 2004
% 210.75/210.89 |- skos__hiddenLabel mesh__D008803 Hydrochloride, Mianserin
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008803 2001
% 210.75/210.89 |- skos__scopeNote mesh__D008803
% 210.75/210.89 A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.%A%
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008803 2006
% 210.75/210.89 |- skos__broader mesh__D008803smesh__D003984
% 210.75/210.89 |- mesh__recordMaintainer mesh__D008803 TWD
% 210.75/210.89 |- skos__historyNote mesh__D008803 Pyrazines %28%1972-1974%29%
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D008803
% 210.75/210.89 87; was see under DIBENZAZEPINES 1975-86
% 210.75/210.89 |- skos__hiddenLabel mesh__D008803 Monohydrochloride, Mianserin
% 210.75/210.89 |- mesh__historyNote mesh__D008803
% 210.75/210.89 87%28%75%29%; was see under DIBENZAZEPINES 1975-86
% 210.75/210.89 |- mesh__dateCreated mesh__D008803 1974-11-19
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008803 2002
% 210.75/210.89 |- mesh__dateEstablished mesh__D008803 1987-01-01
% 210.75/210.89 |- mesh__recordMaintainer mesh__D000820 ags
% 210.75/210.89 |- mesh__historyNote mesh__D000820
% 210.75/210.89 66; was see under VETERINARY MEDICINE %26% ZOONOSES 1963-65
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D000820 sjn
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D000820 2005
% 210.75/210.89 |- rdf__type mesh__D000820sskos__Concept
% 210.75/210.89 |- skos__altLabel mesh__D000820 Diseases, Animal
% 210.75/210.89 |- mesh__dateEstablished mesh__D000820 1966-01-01
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D000820
% 210.75/210.89 66; was see under VETERINARY MEDICINE %26% ZOONOSES 1963-65
% 210.75/210.89 |- mesh__runningHead mesh__D000820 C22 - DISEASES-ANIMAL
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D000820 2006
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D000820 2004
% 210.75/210.89 |- skos__prefLabel mesh__D000820 Animal Diseases
% 210.75/210.89 |- skos__annotation mesh__D000820
% 210.75/210.89 avoid: too general; IM general only for unspecified animal %26% unspecified disease; NIM with specific animal %28%IM%29% for which no precoord animal/diseases term exists; do not use at all when a specific dis /vet is used; do not forget also to check tag ANIMALS; policy: Manual 23.33+; animal neopl: Manual 24.6+; TN 136; TN 193%A%
% 210.75/210.89 |- mesh__dateCreated mesh__D000820 1999-01-01
% 210.75/210.89 |- mesh__dateRevised mesh__D000820 2003-07-30
% 210.75/210.89 |- mesh__recordOriginator mesh__D000820 NLM
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008005 2006
% 210.75/210.89 |- mesh__recordMaintainer mesh__D008005 kle
% 210.75/210.89 |- skos__scopeNote mesh__D008005
% 210.75/210.89 The granting of a license to practice dentistry.
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008005 2000
% 210.75/210.89 |- skos__broader mesh__D008005smesh__D008004
% 210.75/210.89 |- skos__prefLabel mesh__D008005 Licensure, Dental
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008005 2001
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D008005 sjn
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008005 2002
% 210.75/210.89 |- mesh__recordOriginator mesh__D008005 NLM
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008005 2003
% 210.75/210.89 |- skos__hiddenLabel mesh__D008005 Licensures, Dental
% 210.75/210.89 |- mesh__dateCreated mesh__D008005 1999-01-01
% 210.75/210.89 |- skos__hiddenLabel mesh__D008005 Dental Licensures
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008005 2004
% 210.75/210.89 |- skos__annotation mesh__D008005
% 210.75/210.89 by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog; DF: LICENSURE DENT%A%
% 210.75/210.89 |- skos__altLabel mesh__D008005 Dental Licensure
% 210.75/210.89 |- mesh__dateRevised mesh__D008005 1999-11-03
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D008005 2005
% 210.75/210.89 |- rdf__type mesh__D008005sskos__Concept
% 210.75/210.89 |- mesh__recordMaintainer mesh__D000022 lkt
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D000022 sjn
% 210.75/210.89 |- skos__scopeNote mesh__D000022
% 210.75/210.89 Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.%A%
% 210.75/210.89 |- rdf__type mesh__D000022sskos__Concept
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D000022
% 210.75/210.89 99; see ABORTION 1966-98; for ABORTION, SPONTANEOUS see ABORTION 1992-98%A%
% 210.75/210.89 |- skos__hiddenLabel mesh__D000022 Abortions, Spontaneous
% 210.75/210.89 |- mesh__dateRevised mesh__D000022 2005-06-30
% 210.75/210.89 |- mesh__historyNote mesh__D000022 99%28%63%29%
% 210.75/210.89 |- skos__related mesh__D000022smesh__D037881
% 210.75/210.89 |- skos__hiddenLabel mesh__D000022 Spontaneous Abortions
% 210.75/210.89 |- mesh__recordOriginator mesh__D000022 NLM
% 210.75/210.89 |- skos__prefLabel mesh__D000022 Abortion, Spontaneous
% 210.75/210.89 |- skos__hiddenLabel mesh__D000022 Tubal Abortion
% 210.75/210.89 |- skos__altLabel mesh__D000022 Spontaneous Abortion
% 210.75/210.89 |- skos__altLabel mesh__D000022 Miscarriage
% 210.75/210.89 |- mesh__dateCreated mesh__D000022 1999-01-01
% 210.75/210.89 |- skos__hiddenLabel mesh__D000022 Abortions, Tubal
% 210.75/210.89 |- skos__related mesh__D000022smesh__D000019
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D000022 2006
% 210.75/210.89 |- skos__hiddenLabel mesh__D000022 Tubal Abortions
% 210.75/210.89 |- skos__annotation mesh__D000022
% 210.75/210.89 /chem ind permitted but do not confuse with ABORTION, INDUCED; check the tags HUMANS %26% FEMALE %26% PREGNANCY%A%
% 210.75/210.89 |- skos__hiddenLabel mesh__D000022 Miscarriages
% 210.75/210.89 |- skos__broader mesh__D000022smesh__D011248
% 210.75/210.89 |- mesh__dateCreated mesh__D052161 2005-06-30
% 210.75/210.89 |- mesh__historyNote mesh__D052161 2006
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D052161 2006
% 210.75/210.89 |- skos__hiddenLabel mesh__D052161 papillomavirus 18, Human
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D052161 sjn
% 210.75/210.89 |- skos__scopeNote mesh__D052161
% 210.75/210.89 A type of HUMAN PAPILLOMAVIRUS especially associated with malignant tumors of the genital and RESPIRATORY MUCOSA.%A%
% 210.75/210.89 |- skos__altLabel mesh__D052161 HPV-18
% 210.75/210.89 |- skos__broader mesh__D052161smesh__D018145
% 210.75/210.89 |- mesh__recordOriginator mesh__D052161 ags
% 210.75/210.89 |- skos__altLabel mesh__D052161 Human papillomavirus type 18
% 210.75/210.89 |- rdf__type mesh__D052161sskos__Concept
% 210.75/210.89 |- mesh__recordMaintainer mesh__D052161 ags
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D052161 2006
% 210.75/210.89 |- skos__historyNote mesh__D052161 Papillomavirus %28%1985-1993%29%
% 210.75/210.89 |- skos__hiddenLabel mesh__D052161 HPV 18
% 210.75/210.89 |- mesh__dateEstablished mesh__D052161 2006-01-01
% 210.75/210.89 |- skos__prefLabel mesh__D052161 Human papillomavirus 18
% 210.75/210.89 |- skos__historyNote mesh__D052161 Papillomavirus, Human %28%1994-2005%29%
% 210.75/210.89 |- mesh__recordMaintainer mesh__D013748 jmp
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D013748 2005
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D013748 2002
% 210.75/210.89 |- mesh__recordOriginator mesh__D013748 NLM
% 210.75/210.89 |- mesh__dateCreated mesh__D013748 1999-01-01
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D013748 2006
% 210.75/210.89 |- rdf__type mesh__D013748sskos__Concept
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D013748 sjn
% 210.75/210.89 |- skos__scopeNote mesh__D013748
% 210.75/210.89 A potent local anesthetic of the ester type used for surface and spinal anesthesia.%A%
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D013748 2003
% 210.75/210.89 |- skos__altLabel mesh__D013748 Amethocaine
% 210.75/210.89 |- skos__altLabel mesh__D013748 Tetrakain
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D013748 2004
% 210.75/210.89 |- skos__prefLabel mesh__D013748 Tetracaine
% 210.75/210.89 |- mesh__dateRevised mesh__D013748 2001-07-25
% 210.75/210.89 |- skos__broader mesh__D013748smesh__D010129
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D032902 2003
% 210.75/210.89 |- mesh__recordOriginator mesh__D032902 ags
% 210.75/210.89 |- mesh__dateEstablished mesh__D032902 2003-01-01
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D032902 2006
% 210.75/210.89 |- mesh__dateRevised mesh__D032902 2005-06-30
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D032902 sjn
% 210.75/210.89 |- mesh__dateCreated mesh__D032902 2002-07-03
% 210.75/210.89 |- skos__broader mesh__D032902smesh__D020072
% 210.75/210.89 |- skos__historyNote mesh__D032902 Basidiomycota %28%1971-2002%29%
% 210.75/210.89 |- mesh__recordMaintainer mesh__D032902 ags
% 210.75/210.89 |- skos__prefLabel mesh__D032902 Ganoderma
% 210.75/210.89 |- skos__scopeNote mesh__D032902
% 210.75/210.89 A genus of fungi in the family Ganodermataceae, order POLYPORALES, containing a dimitic hyphal system. It causes a white rot, and is a wood decomposer. Ganoderma lucidum %28%REISHI%29% is used in traditional Chinese medicine %28%MEDICINE, CHINESE TRADITIONAL%29%.%A%
% 210.75/210.89 |- rdf__type mesh__D032902sskos__Concept
% 210.75/210.89 |- mesh__historyNote mesh__D032902 2003
% 210.75/210.89 |- skos__historyNote mesh__D032902 Aphyllophorales %28%1979-2002%29%
% 210.75/210.89 |- mesh__dateEstablished mesh__D018433 1995-01-01
% 210.75/210.89 |- mesh__recordMaintainer mesh__D018433 sjn
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D018433 95
% 210.75/210.89 |- skos__hiddenLabel mesh__D018433 Twin Study
% 210.75/210.89 |- mesh__dateCreated mesh__D018433 1994-05-27
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D018433 sjn
% 210.75/210.89 |- mesh__dateRevised mesh__D018433 2004-07-13
% 210.75/210.89 |- skos__annotation mesh__D018433
% 210.75/210.89 an epidemiol technique for study of twins: do not confuse with articles on TWINS as persons or on specific or general DISEASES IN TWINS; IM GEN only; coord NIM with specific subject %28%IM%29% + TWINS %28%IM%29% or with specific dis %28%IM%29% + DISEASES IN TWINS %28%IM%29%; do not confuse with Publication Type TWIN STUDY%A%
% 210.75/210.89 |- mesh__historyNote mesh__D018433 95
% 210.75/210.89 |- skos__historyNote mesh__D018433 Diseases in Twins %28%1966-1994%29%
% 210.75/210.89 |- skos__historyNote mesh__D018433 Twins %28%1966-1994%29%
% 210.75/210.89 |- skos__scopeNote mesh__D018433
% 210.75/210.89 Methods of detecting genetic etiology in human traits. The basic premise of twin studies is that monozygotic twins, being formed by the division of a single fertilized ovum, carry identical genes, while dizygotic twins, being formed by the fertilization of two ova by two different spermatozoa, are genetically no more similar than two siblings born after separate pregnancies. %28%Last, J.M., A Dictionary of Epidemiology, 2d ed%29%%A%
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D018433 2006
% 210.75/210.89 |- skos__broader mesh__D018433smesh__D016020
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D018433 2005
% 210.75/210.89 |- mesh__recordOriginator mesh__D018433 TGC
% 210.75/210.89 |- skos__hiddenLabel mesh__D018433 Studies, Twin
% 210.75/210.89 |- rdf__type mesh__D018433sskos__Concept
% 210.75/210.89 |- skos__prefLabel mesh__D018433 Twin Studies
% 210.75/210.89 |- mesh__recordOriginator mesh__D010450 NLM
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D010450 2005
% 210.75/210.89 |- skos__prefLabel mesh__D010450 Endopeptidases
% 210.75/210.89 |- mesh__recordMaintainer mesh__D010450 jmp
% 210.75/210.89 |- mesh__dateCreated mesh__D010450 1999-01-01
% 210.75/210.89 |- skos__scopeNote mesh__D010450
% 210.75/210.89 A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.%A%
% 210.75/210.89 |- mesh__historyNote mesh__D010450 2000%28%1963%29%
% 210.75/210.89 |- rdf__type mesh__D010450sskos__Concept
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D010450
% 210.75/210.89 2000; see PEPTIDE PEPTIDOHYDROLASES 1963-1999; for ENDOPEPTIDASES see PEPTIDE PEPTIDOHYDROLASES 1980-1999%A%
% 210.75/210.89 |- skos__broader mesh__D010450smesh__D010447
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D010450 sjn
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D010450 2006
% 210.75/210.89 |- mesh__dateRevised mesh__D010450 2004-07-07
% 210.75/210.89 |- skos__altLabel mesh__D010450 Peptide Peptidohydrolases
% 210.75/210.89 |- mesh__historyNote mesh__D032104 2003
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D032104 2003
% 210.75/210.89 |- skos__scopeNote mesh__D032104
% 210.75/210.89 A plant genus of the family RUTACEAE. Members contain ponfolin, a coumarin %28%COUMARINS%29%.%A%
% 210.75/210.89 |- skos__altLabel mesh__D032104 Orange, Trifoliate
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D032104 2004
% 210.75/210.89 |- skos__annotation mesh__D032104
% 210.75/210.89 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.75/210.89 |- skos__prefLabel mesh__D032104 Poncirus
% 210.75/210.89 |- skos__broader mesh__D032104smesh__D027821
% 210.75/210.89 |- mesh__dateCreated mesh__D032104 2002-07-03
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D032104 2005
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D032104 2003
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D032104 2006
% 210.75/210.89 |- rdf__type mesh__D032104sskos__Concept
% 210.75/210.89 |- mesh__dateEstablished mesh__D032104 2003-01-01
% 210.75/210.89 |- mesh__dateRevised mesh__D004413 1993-05-27
% 210.75/210.89 |- skos__altLabel mesh__D004413 Dysostosis
% 210.75/210.89 |- skos__historyNote mesh__D004413
% 210.75/210.89 Bone Diseases, Developmental %28%1970-1984%29%
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 2003
% 210.75/210.89 |- mesh__dateEstablished mesh__D004413 1985-01-01
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 2005
% 210.75/210.89 |- skos__annotation mesh__D004413 defective bone formation
% 210.75/210.89 |- mesh__recordOriginator mesh__D004413 RC
% 210.75/210.89 |- mesh__recordAuthorizer mesh__D004413 PLS
% 210.75/210.89 |- mesh__publicMeSHNote mesh__D004413 85
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 2004
% 210.75/210.89 |- skos__scopeNote mesh__D004413
% 210.75/210.89 Defective bone formation involving individual bones, singly or in combination.%A%
% 210.75/210.89 |- skos__prefLabel mesh__D004413 Dysostoses
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 2006
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 2000
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 1996
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 2001
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 1998
% 210.75/210.89 |- mesh__historyNote mesh__D004413 85
% 210.75/210.89 |- skos__broader mesh__D004413smesh__D001848
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 1997
% 210.75/210.89 |- rdf__type mesh__D004413sskos__Concept
% 210.75/210.89 |- mesh__activeMeSHYear mesh__D004413 1994
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D004413 1999
% 210.75/210.90 |- mesh__recordMaintainer mesh__D004413 PLS
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D004413 1995
% 210.75/210.90 |- mesh__dateCreated mesh__D004413 1984-04-05
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D004413 2002
% 210.75/210.90 |- skos__historyNote mesh__D004413 Bone Diseases %28%1966-1969%29%
% 210.75/210.90 |- skos__historyNote mesh__D028861 Nuclear Proteins %28%1991-2001%29%
% 210.75/210.90 |- mesh__recordAuthorizer mesh__D028861 sjn
% 210.75/210.90 |- skos__scopeNote mesh__D028861
% 210.75/210.90 Proteins that form the structure of the NUCLEAR PORE. They are involved in active, facilitated and passive transport of molecules in and out of the CELL NUCLEUS.%A%
% 210.75/210.90 |- mesh__recordMaintainer mesh__D028861 SYSTEM
% 210.75/210.90 |- mesh__dateCreated mesh__D028861 2001-07-25
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D028861 2006
% 210.75/210.90 |- mesh__historyNote mesh__D028861 2002
% 210.75/210.90 |- skos__broader mesh__D028861smesh__D029543
% 210.75/210.90 |- skos__prefLabel mesh__D028861 Nuclear Pore Complex Proteins
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D028861 2002
% 210.75/210.90 |- mesh__recordOriginator mesh__D028861 jmp
% 210.75/210.90 |- mesh__dateRevised mesh__D028861 2005-06-30
% 210.75/210.90 |- rdf__type mesh__D028861sskos__Concept
% 210.75/210.90 |- mesh__dateEstablished mesh__D028861 2002-01-01
% 210.75/210.90 |- skos__altLabel mesh__D028861 Nucleoporins
% 210.75/210.90 |- skos__altLabel mesh__D028861 Nucleoporin
% 210.75/210.90 |- skos__broader mesh__D020080smesh__D040481
% 210.75/210.90 |- skos__hiddenLabel mesh__D020080 Repeat Sequences, Tandem
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D020080
% 210.75/210.90 99; for TANDEM REPEAT see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%
% 210.75/210.90 |- skos__altLabel mesh__D020080 Tandem Repeats
% 210.75/210.90 |- mesh__dateRevised mesh__D020080 2005-06-30
% 210.75/210.90 |- skos__hiddenLabel mesh__D020080 Sequences, Tandem Repeat
% 210.75/210.90 |- mesh__recordAuthorizer mesh__D020080 sjn
% 210.75/210.90 |- skos__broader mesh__D020080smesh__D012091
% 210.75/210.90 |- skos__hiddenLabel mesh__D020080 Repeats, Tandem
% 210.75/210.90 |- skos__hiddenLabel mesh__D020080 Repeat, Tandem
% 210.75/210.90 |- rdf__type mesh__D020080sskos__Concept
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D020080 2006
% 210.75/210.90 |- skos__altLabel mesh__D020080 Tandem Repeat
% 210.75/210.90 |- mesh__recordMaintainer mesh__D020080 nns
% 210.75/210.90 |- skos__prefLabel mesh__D020080 Tandem Repeat Sequences
% 210.75/210.90 |- skos__historyNote mesh__D020080
% 210.75/210.90 Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.75/210.90 |- skos__hiddenLabel mesh__D020080 Tandem Repeat Sequence
% 210.75/210.90 |- mesh__dateCreated mesh__D020080 1998-06-11
% 210.75/210.90 |- skos__hiddenLabel mesh__D020080 Repeat Sequence, Tandem
% 210.75/210.90 |- mesh__recordOriginator mesh__D020080 NNS
% 210.75/210.90 |- mesh__dateEstablished mesh__D020080 1999-01-01
% 210.75/210.90 |- skos__scopeNote mesh__D020080
% 210.75/210.90 Copies of DNA sequences which lie adjacent to each other in the same orientation %28%direct tandem repeats%29% or in the opposite direction to each other %28%inverted tandem repeats%29%.%A%
% 210.75/210.90 |- skos__hiddenLabel mesh__D020080 Sequence, Tandem Repeat
% 210.75/210.90 |- mesh__historyNote mesh__D020080
% 210.75/210.90 99; for TANDEM REPEAT use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%
% 210.75/210.90 |- skos__hiddenLabel mesh__D014841 Factor VIIIR Ag
% 210.75/210.90 |- skos__hiddenLabel mesh__D014841 F VIII vWf
% 210.75/210.90 |- skos__altLabel mesh__D014841 vWF Ag
% 210.75/210.90 |- mesh__recordMaintainer mesh__D014841 ssb
% 210.75/210.90 |- skos__hiddenLabel mesh__D014841 Ag, vWF
% 210.75/210.90 |- skos__historyNote mesh__D014841
% 210.75/210.90 Blood Coagulation Factors %28%1966-1974%29%
% 210.75/210.90 |- skos__related mesh__D014841smesh__D020302
% 210.75/210.90 |- skos__scopeNote mesh__D014841
% 210.75/210.90 A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in von Willebrand%27%s disease is due to the deficiency of this factor.%A%
% 210.75/210.90 |- mesh__dateRevised mesh__D014841 2005-06-30
% 210.75/210.90 |- skos__hiddenLabel mesh__D014841 Factor VIII Related Antigen
% 210.75/210.90 |- skos__hiddenLabel mesh__D014841 Protein, von Willebrand
% 210.75/210.90 |- skos__altLabel mesh__D014841 Ristocetin-Willebrand Factor
% 210.75/210.90 |- skos__annotation mesh__D014841 DF: VWF
% 210.75/210.90 |- mesh__dateCreated mesh__D014841 1975-07-25
% 210.75/210.90 |- mesh__recordAuthorizer mesh__D014841 sjn
% 210.75/210.90 |- rdf__type mesh__D014841sskos__Concept
% 210.75/210.90 |- skos__hiddenLabel mesh__D014841 Cofactor, Ristocetin
% 210.75/210.90 |- skos__altLabel mesh__D014841 Ristocetin Cofactor
% 210.75/210.90 |- skos__hiddenLabel mesh__D014841 Factor VIIIR RCo
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D014841
% 210.75/210.90 86; was see under BLOOD COAGULATION FACTORS 1976-85
% 210.75/210.90 |- mesh__dateEstablished mesh__D014841 1986-01-01
% 210.75/210.90 |- mesh__onlineNote mesh__D014841
% 210.75/210.90 use FACTOR VIII %26% ANTIGENS to search FACTOR VIII RELATED ANTIGEN 1977-89%A%
% 210.75/210.90 |- skos__prefLabel mesh__D014841 von Willebrand Factor
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D014841 2006
% 210.75/210.90 |- skos__hiddenLabel mesh__D014841 Ristocetin Willebrand Factor
% 210.75/210.90 |- mesh__historyNote mesh__D014841
% 210.75/210.90 86%28%76%29%; was see under BLOOD COAGULATION FACTORS 1976-85; FACTOR VIII RELATED ANTIGEN, previously in the Supplementary Chemical File, was mapped to both FACTOR VIII %26% ANTIGENS 1977-89%A%
% 210.75/210.90 |- skos__altLabel mesh__D014841 von Willebrand Protein
% 210.75/210.90 |- mesh__recordOriginator mesh__D014841 RLS
% 210.75/210.90 |- skos__hiddenLabel mesh__D014841 Antigen, Factor VIII-Related
% 210.75/210.90 |- skos__related mesh__D014841smesh__D003029
% 210.75/210.90 |- skos__broader mesh__D014841smesh__D001779
% 210.75/210.90 |- skos__historyNote mesh__D014841
% 210.75/210.90 von Willebrand%27%s Disease %28%1966-1975%29%
% 210.75/210.90 |- skos__historyNote mesh__D014841 Blood Platelets %28%1966-1974%29%
% 210.75/210.90 |- skos__scopeNote mesh__D014043
% 210.75/210.90 A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.%A%
% 210.75/210.90 |- rdf__type mesh__D014043sskos__Concept
% 210.75/210.90 |- skos__prefLabel mesh__D014043 Tolazoline
% 210.75/210.90 |- skos__altLabel mesh__D014043
% 210.75/210.90 Ciba Vision Brand of Tolazoline Hydrochloride
% 210.75/210.90 |- mesh__dateRevised mesh__D014043 2005-06-30
% 210.75/210.90 |- skos__altLabel mesh__D014043 Benzalolin
% 210.75/210.90 |- skos__altLabel mesh__D014043 Novartis Brand of Tolazoline Hydrochloride
% 210.75/210.90 |- skos__altLabel mesh__D014043 Tolazoline Monohydrochloride
% 210.75/210.90 |- mesh__dateCreated mesh__D014043 1999-01-01
% 210.75/210.90 |- mesh__recordOriginator mesh__D014043 NLM
% 210.75/210.90 |- mesh__recordAuthorizer mesh__D014043 sjn
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D014043 2006
% 210.75/210.90 |- mesh__recordMaintainer mesh__D014043 ssb
% 210.75/210.90 |- skos__broader mesh__D014043smesh__D048288
% 210.75/210.90 |- mesh__historyNote mesh__D000821 68%28%66%29%
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000821 2003
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D000821 68
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000821 2006
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000821 1998
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000821 2001
% 210.75/210.90 |- mesh__dateRevised mesh__D000821 1997-06-20
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000821 2004
% 210.75/210.90 |- mesh__dateEstablished mesh__D000821 1968-01-01
% 210.75/210.90 |- mesh__dateCreated mesh__D000821 1999-01-01
% 210.75/210.90 |- mesh__recordOriginator mesh__D000821 NLM
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000821 1999
% 210.75/210.90 |- skos__broader mesh__D000821smesh__D018556
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000821 2002
% 210.75/210.90 |- skos__hiddenLabel mesh__D000821 Animal Feeds
% 210.75/210.90 |- skos__hiddenLabel mesh__D000821 Feeds, Animal
% 210.75/210.90 |- skos__hiddenLabel mesh__D000821 Feed, Animal
% 210.75/210.90 |- skos__prefLabel mesh__D000821 Animal Feed
% 210.75/210.90 |- skos__annotation mesh__D000821
% 210.75/210.90 TN 50: differentiate from ANIMAL NUTRITION %26% DIET
% 210.75/210.90 |- mesh__recordAuthorizer mesh__D000821 SJN
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000821 2005
% 210.75/210.90 |- mesh__recordMaintainer mesh__D000821 JLS
% 210.75/210.90 |- rdf__type mesh__D000821sskos__Concept
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000821 2000
% 210.75/210.90 |- mesh__dateEstablished mesh__D008006 1991-01-01
% 210.75/210.90 |- rdf__type mesh__D008006sskos__Concept
% 210.75/210.90 |- skos__altLabel mesh__D008006 Hospital Licensure
% 210.75/210.90 |- mesh__recordOriginator mesh__D008006 EC
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D008006 2002
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D008006 2006
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D008006 2001
% 210.75/210.90 |- skos__hiddenLabel mesh__D008006 Hospital Licensures
% 210.75/210.90 |- skos__prefLabel mesh__D008006 Licensure, Hospital
% 210.75/210.90 |- mesh__dateRevised mesh__D008006 1999-11-03
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D008006 2005
% 210.75/210.90 |- mesh__historyNote mesh__D008006
% 210.75/210.90 91%28%Aug 77%29%; was see under LICENSURE 1977-90
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D008006 2000
% 210.75/210.90 |- mesh__dateCreated mesh__D008006 1977-05-11
% 210.75/210.90 |- skos__scopeNote mesh__D008006
% 210.75/210.90 The granting of a license to a hospital.
% 210.75/210.90 |- skos__hiddenLabel mesh__D008006 Licensures, Hospital
% 210.75/210.90 |- mesh__recordAuthorizer mesh__D008006 sjn
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D008006 2004
% 210.75/210.90 |- skos__broader mesh__D008006smesh__D008004
% 210.75/210.90 |- skos__annotation mesh__D008006
% 210.75/210.90 by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; specify geog%A%
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D008006 2003
% 210.75/210.90 |- mesh__recordMaintainer mesh__D008006 kle
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D008006
% 210.75/210.90 91; was see under LICENSURE Aug 1977-90
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Refused Abortion Seeker
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Applicant, Abortion
% 210.75/210.90 |- skos__altLabel mesh__D000023 Abortion Seekers
% 210.75/210.90 |- skos__prefLabel mesh__D000023 Abortion Applicants
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Abortion Seeker, Repeated
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Seeker, Abortion
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Applicants, Abortion
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D000023 76; was see under ABORTION 1975
% 210.75/210.90 |- mesh__recordAuthorizer mesh__D000023 sjn
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Abortion Seeker, Refused
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Seeker, Refused Abortion
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Abortion Applicant
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Seekers, Refused Abortion
% 210.75/210.90 |- mesh__recordMaintainer mesh__D000023 sjn
% 210.75/210.90 |- skos__historyNote mesh__D000023 Abortion, Induced %28%1970-1974%29%
% 210.75/210.90 |- mesh__dateEstablished mesh__D000023 1976-01-01
% 210.75/210.90 |- skos__scopeNote mesh__D000023
% 210.75/210.90 Individuals requesting induced abortions.
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Repeated Abortion Seeker
% 210.75/210.90 |- mesh__recordOriginator mesh__D000023 NLM
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000023 2006
% 210.75/210.90 |- mesh__dateCreated mesh__D000023 1974-11-19
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Abortion Seeker
% 210.75/210.90 |- skos__broader mesh__D000023smesh__D009272
% 210.75/210.90 |- skos__historyNote mesh__D000023 Abortion, Therapeutic %28%1966-1974%29%
% 210.75/210.90 |- skos__annotation mesh__D000023
% 210.75/210.90 don%27%t forget also check tags HUMANS %26% FEMALE %26% PREGNANCY%A%
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Seekers, Repeated Abortion
% 210.75/210.90 |- mesh__dateRevised mesh__D000023 2004-07-13
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D000023 2005
% 210.75/210.90 |- mesh__historyNote mesh__D000023
% 210.75/210.90 76%28%75%29%; was see under ABORTION 1975
% 210.75/210.90 |- rdf__type mesh__D000023sskos__Concept
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Seekers, Abortion
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Refused Abortion Seekers
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Seeker, Repeated Abortion
% 210.75/210.90 |- skos__hiddenLabel mesh__D000023 Repeated Abortion Seekers
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D052162 2006
% 210.75/210.90 |- skos__annotation mesh__D052162
% 210.75/210.90 infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS %28%IM%29% + UTERINE CERVICAL NEOPLASMS %28%IM%29%, RESPIRATORY TRACT NEOPLASMS %28%IM%29% or other neoplasm term %28%IM%29% if pertinent%A%
% 210.75/210.90 |- skos__historyNote mesh__D052162 Papillomavirus %28%1983-1993%29%
% 210.75/210.90 |- mesh__historyNote mesh__D052162 2006
% 210.75/210.90 |- mesh__dateEstablished mesh__D052162 2006-01-01
% 210.75/210.90 |- mesh__recordMaintainer mesh__D052162 ags
% 210.75/210.90 |- mesh__dateCreated mesh__D052162 2005-06-30
% 210.75/210.90 |- skos__hiddenLabel mesh__D052162 papillomavirus 16, Human
% 210.75/210.90 |- skos__prefLabel mesh__D052162 Human papillomavirus 16
% 210.75/210.90 |- mesh__recordAuthorizer mesh__D052162 sjn
% 210.75/210.90 |- rdf__type mesh__D052162sskos__Concept
% 210.75/210.90 |- skos__broader mesh__D052162smesh__D018145
% 210.75/210.90 |- skos__hiddenLabel mesh__D052162 HPV 16
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D052162 2006
% 210.75/210.90 |- mesh__recordOriginator mesh__D052162 ags
% 210.75/210.90 |- skos__historyNote mesh__D052162 Papillomavirus, Human %28%1994-2005%29%
% 210.75/210.90 |- skos__altLabel mesh__D052162 HPV-16
% 210.75/210.90 |- skos__scopeNote mesh__D052162
% 210.75/210.90 A type of HUMAN PAPILLOMAVIRUS especially associated with malignant tumors of the CERVIX and the RESPIRATORY MUCOSA.%A%
% 210.75/210.90 |- skos__historyNote mesh__D013749 Dioxins %28%1972-1974%29%
% 210.75/210.90 |- mesh__dateEstablished mesh__D013749 1991-01-01
% 210.75/210.90 |- mesh__dateCreated mesh__D013749 1974-11-19
% 210.75/210.90 |- mesh__dateRevised mesh__D013749 1999-11-03
% 210.75/210.90 |- mesh__historyNote mesh__D013749
% 210.75/210.90 91%28%75%29%; was see under DIOXINS 1975-90
% 210.75/210.90 |- skos__altLabel mesh__D013749 TCDD
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D013749 91; was see under DIOXINS 1975-90
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D013749 2001
% 210.75/210.90 |- skos__historyNote mesh__D013749 Chlorobenzenes %28%1974%29%
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D013749 2006
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D013749 2000
% 210.75/210.90 |- mesh__recordOriginator mesh__D013749 NLM
% 210.75/210.90 |- rdf__type mesh__D013749sskos__Concept
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D013749 2004
% 210.75/210.90 |- skos__altLabel mesh__D013749 2,3,7,8-Tetrachlorodibenzo-p-dioxin
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D013749 2005
% 210.75/210.90 |- skos__broader mesh__D013749smesh__D004147
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D013749 2003
% 210.75/210.90 |- mesh__recordAuthorizer mesh__D013749 sjn
% 210.75/210.90 |- skos__prefLabel mesh__D013749 Tetrachlorodibenzodioxin
% 210.75/210.90 |- mesh__recordMaintainer mesh__D013749 adp
% 210.75/210.90 |- skos__scopeNote mesh__D013749
% 210.75/210.90 A chemical by-product that results from burning or incinerating chlorinated industrial chemicals and other hydrocarbons. This compound is considered an environmental toxin, and may pose reproductive, as well as, other health risks for animals and humans.%A%
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D013749 2002
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D032903
% 210.75/210.90 2003; see RELIGIOUS PHILOSOPHIES 2002
% 210.75/210.90 |- skos__prefLabel mesh__D032903 Confucianism
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D032903 2003
% 210.75/210.90 |- rdf__type mesh__D032903sskos__Concept
% 210.75/210.90 |- skos__scopeNote mesh__D032903
% 210.75/210.90 A school of thought and set of moral, ethical, and political teachings usually considered to be founded by Confucius in 6th-5th century B.C. China. %28%from Cambridge Dictionary of Philosophy, 1995%29%%A%
% 210.75/210.90 |- mesh__dateEstablished mesh__D032903 2003-01-01
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D032903 2004
% 210.75/210.90 |- mesh__historyNote mesh__D032903 2003; use RELIGIOUS PHILOSOPHIES 2002
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D032903 2005
% 210.75/210.90 |- mesh__dateCreated mesh__D032903 2002-07-03
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D032903 2006
% 210.75/210.90 |- skos__broader mesh__D032903smesh__D012072
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 1999
% 210.75/210.90 |- skos__historyNote mesh__D018434 Attitude to Health %28%1976-1994%29%
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 2000
% 210.75/210.90 |- skos__annotation mesh__D018434 a health status indicator
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 1998
% 210.75/210.90 |- mesh__historyNote mesh__D018434 95
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 1997
% 210.75/210.90 |- skos__scopeNote mesh__D018434
% 210.75/210.90 A quality-of-life scale developed in the United States in 1972 as a measure of health status or dysfunction generated by a disease. It is a behaviorally based questionnaire for patients and addresses activities such as sleep and rest, mobility, recreation, home management, emotional behavior, social interaction, and the like. It measures the patient%27%s perceived health status and is sensitive enough to detect changes or differences in health status occurring over time or between groups. %28%From Medical Care, vol.xix, no.8, August 1981, p.787-805%29%%A%
% 210.75/210.90 |- mesh__dateEstablished mesh__D018434 1995-01-01
% 210.75/210.90 |- skos__hiddenLabel mesh__D018434 Profiles, Sickness Impact
% 210.75/210.90 |- mesh__publicMeSHNote mesh__D018434 95
% 210.75/210.90 |- skos__hiddenLabel mesh__D018434 Profile, Sickness Impact
% 210.75/210.90 |- skos__historyNote mesh__D018434 Quality of Life %28%1976-1994%29%
% 210.75/210.90 |- skos__hiddenLabel mesh__D018434 Impact Profiles, Sickness
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 1996
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 2006
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 2002
% 210.75/210.90 |- skos__prefLabel mesh__D018434 Sickness Impact Profile
% 210.75/210.90 |- skos__hiddenLabel mesh__D018434 Sickness Impact Profiles
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 2005
% 210.75/210.90 |- skos__hiddenLabel mesh__D018434 Impact Profile, Sickness
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 2004
% 210.75/210.90 |- mesh__dateCreated mesh__D018434 1994-02-28
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 1995
% 210.75/210.90 |- rdf__type mesh__D018434sskos__Concept
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 2003
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D018434 2001
% 210.75/210.90 |- skos__historyNote mesh__D018434
% 210.75/210.90 Health Status Indicators %28%1976-1994%29%
% 210.75/210.90 |- skos__broader mesh__D018434smesh__D006305
% 210.75/210.90 |- skos__historyNote mesh__D018434
% 210.75/210.90 Activities of Daily Living %28%1975-1994%29%
% 210.75/210.90 |- skos__hiddenLabel mesh__D010451 Peptide Histidine Isoleucine
% 210.75/210.90 |- skos__historyNote mesh__D010451
% 210.75/210.90 Gastrointestinal Hormones %28%1966-1986%29%
% 210.75/210.90 |- skos__hiddenLabel mesh__D010451 Peptide, PHI
% 210.75/210.90 |- mesh__recordMaintainer mesh__D010451 ssb
% 210.75/210.90 |- skos__altLabel mesh__D010451 Neuropeptide PHI 27
% 210.75/210.90 |- skos__hiddenLabel mesh__D010451 Peptide, Pro-Vasoactive Intestinal
% 210.75/210.90 |- skos__hiddenLabel mesh__D010451 Histidine Methionine, Peptide
% 210.75/210.90 |- skos__hiddenLabel mesh__D010451 Heptacosapeptide, Porcine Intestinal
% 210.75/210.90 |- skos__hiddenLabel mesh__D010451 Peptide PHI 27
% 210.75/210.90 |- skos__altLabel mesh__D010451 Peptide PHI-27
% 210.75/210.90 |- mesh__dateEstablished mesh__D010451 1987-01-01
% 210.75/210.90 |- skos__altLabel mesh__D010451 Peptide PHM
% 210.75/210.90 |- mesh__dateRevised mesh__D010451 2005-06-30
% 210.75/210.90 |- mesh__dateCreated mesh__D010451 1986-04-14
% 210.75/210.90 |- skos__hiddenLabel mesh__D010451 PHM, Peptide
% 210.75/210.90 |- skos__altLabel mesh__D010451 PHM Neuropeptide
% 210.75/210.90 |- skos__altLabel mesh__D010451 Pro-Vasoactive Intestinal Peptide
% 210.75/210.90 |- skos__hiddenLabel mesh__D010451 Intestinal Heptacosapeptide, Porcine
% 210.75/210.90 |- skos__historyNote mesh__D010451 Peptides %28%1966-1986%29%
% 210.75/210.90 |- mesh__activeMeSHYear mesh__D010451 2006
% 210.76/210.90 |- skos__prefLabel mesh__D010451 Peptide PHI
% 210.76/210.90 |- skos__altLabel mesh__D010451 PHM-27
% 210.76/210.90 |- skos__altLabel mesh__D010451 Peptide Histidine Methionine
% 210.76/210.90 |- skos__altLabel mesh__D010451 Peptide-Histidine-Isoleucinamide
% 210.76/210.90 |- skos__hiddenLabel mesh__D010451 Methionine, Peptide Histidine
% 210.76/210.90 |- skos__annotation mesh__D010451
% 210.76/210.90 a neurotransmitter; X ref explains PHI; /biosyn /physiol permitted%A%
% 210.76/210.90 |- skos__hiddenLabel mesh__D010451 Pro Vasoactive Intestinal Peptide
% 210.76/210.90 |- skos__scopeNote mesh__D010451
% 210.76/210.90 A 27-amino acid peptide with histidine at the N-terminal and isoleucine amide at the C-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory, and central nervous systems.%A%
% 210.76/210.90 |- skos__altLabel mesh__D010451 Peptide HI
% 210.76/210.90 |- skos__altLabel mesh__D010451 Peptide Histidine-Isoleucine
% 210.76/210.90 |- skos__hiddenLabel mesh__D010451 PHI, Human
% 210.76/210.90 |- mesh__recordAuthorizer mesh__D010451 sjn
% 210.76/210.90 |- skos__hiddenLabel mesh__D010451 Peptide Histidine Isoleucinamide
% 210.76/210.90 |- mesh__historyNote mesh__D010451 87
% 210.76/210.90 |- mesh__recordOriginator mesh__D010451 RLS
% 210.76/210.90 |- skos__broader mesh__D010451smesh__D009479
% 210.76/210.90 |- skos__broader mesh__D010451smesh__D036361
% 210.76/210.90 |- skos__hiddenLabel mesh__D010451 Neuropeptide, PHM
% 210.76/210.90 |- skos__hiddenLabel mesh__D010451 Histidine-Isoleucine, Peptide
% 210.76/210.90 |- skos__hiddenLabel mesh__D010451 Intestinal Peptide, Pro-Vasoactive
% 210.76/210.90 |- mesh__publicMeSHNote mesh__D010451 87
% 210.76/210.90 |- rdf__type mesh__D010451sskos__Concept
% 210.76/210.90 |- skos__altLabel mesh__D010451 PHI Peptide
% 210.76/210.90 |- skos__scopeNote mesh__D032105
% 210.76/210.90 A plant genus of the family RUTACEAE. Members contain quinoline alkaloids.%A%
% 210.76/210.90 |- mesh__dateCreated mesh__D032105 2002-07-03
% 210.76/210.90 |- skos__altLabel mesh__D032105 Rue
% 210.76/210.90 |- mesh__activeMeSHYear mesh__D032105 2006
% 210.76/210.90 |- rdf__type mesh__D032105sskos__Concept
% 210.76/210.90 |- mesh__activeMeSHYear mesh__D032105 2004
% 210.76/210.90 |- skos__annotation mesh__D032105
% 210.76/210.90 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.76/210.90 |- mesh__activeMeSHYear mesh__D032105 2005
% 210.76/210.90 |- mesh__activeMeSHYear mesh__D032105 2003
% 210.76/210.90 |- mesh__historyNote mesh__D032105 2003
% 210.76/210.90 |- skos__broader mesh__D032105smesh__D027821
% 210.76/210.90 |- mesh__dateEstablished mesh__D032105 2003-01-01
% 210.76/210.90 |- skos__prefLabel mesh__D032105 Ruta
% 210.76/210.90 |- mesh__publicMeSHNote mesh__D032105 2003
% 210.76/210.90 |- skos__prefLabel mesh__D004414 Dyspareunia
% 210.76/210.90 |- skos__broader mesh__D004414smesh__D020018
% 210.76/210.90 |- skos__scopeNote mesh__D004414
% 210.76/210.90 Recurrent genital pain occurring during, before, or after SEXUAL INTERCOURSE in either the male or the female.%A%
% 210.76/210.90 |- skos__broader mesh__D004414smesh__D012735
% 210.76/210.90 |- mesh__historyNote mesh__D004414 67%28%63%29%
% 210.76/210.90 |- mesh__dateCreated mesh__D004414 1999-01-01
% 210.76/210.90 |- mesh__recordMaintainer mesh__D004414 lkt
% 210.76/210.90 |- mesh__activeMeSHYear mesh__D004414 2006
% 210.76/210.90 |- mesh__recordAuthorizer mesh__D004414 sjn
% 210.76/210.90 |- mesh__recordOriginator mesh__D004414 NLM
% 210.76/210.90 |- skos__broader mesh__D004414smesh__D014623
% 210.76/210.90 |- mesh__dateEstablished mesh__D004414 1967-01-01
% 210.76/210.90 |- mesh__publicMeSHNote mesh__D004414 67
% 210.76/210.90 |- rdf__type mesh__D004414sskos__Concept
% 210.76/210.90 |- mesh__dateRevised mesh__D004414 2005-06-30
% 210.76/210.90 |- mesh__dateEstablished mesh__D020081 1999-01-01
% 210.76/210.90 |- skos__related mesh__D020081smesh__D020231
% 210.76/210.90 |- mesh__dateCreated mesh__D020081 1998-06-10
% 210.76/210.90 |- rdf__type mesh__D020081sskos__Concept
% 210.76/210.90 |- mesh__activeMeSHYear mesh__D020081 2006
% 210.76/210.90 |- mesh__historyNote mesh__D020081 99
% 210.76/210.90 |- mesh__dateRevised mesh__D020081 2005-06-30
% 210.76/210.90 |- skos__prefLabel mesh__D020081 Phyllachorales
% 210.76/210.90 |- mesh__recordAuthorizer mesh__D020081 sjn
% 210.76/210.90 |- skos__scopeNote mesh__D020081
% 210.76/210.90 An order of fungi in the phylum ASCOMYCOTA characterized by stromatic perithecial forms in most species. Notable genera are Magnaporthe and Glomerella, the latter having the anamorph %28%mitosporic form%29% COLLETOTRICHUM.%A%
% 210.76/210.90 |- mesh__recordMaintainer mesh__D020081 SYSTEM
% 210.76/210.90 |- skos__broader mesh__D020081smesh__D001203
% 210.76/210.90 |- mesh__publicMeSHNote mesh__D020081 99
% 210.76/210.90 |- mesh__recordOriginator mesh__D020081 AGS
% 210.76/210.90 |- mesh__dateCreated mesh__D014842 1999-01-01
% 210.76/210.90 |- skos__hiddenLabel mesh__D014842 Vascular Hemophilias
% 210.76/210.90 |- mesh__historyNote mesh__D014842 99%28%63%29%
% 210.76/210.90 |- mesh__activeMeSHYear mesh__D014842 2003
% 210.76/210.90 |- skos__hiddenLabel mesh__D014842 Disease, von Willebrand%27%s
% 210.76/210.90 |- skos__prefLabel mesh__D014842 von Willebrand Disease
% 210.76/210.90 |- mesh__dateEstablished mesh__D014842 1968-01-01
% 210.76/210.90 |- rdf__type mesh__D014842sskos__Concept
% 210.76/210.90 |- skos__scopeNote mesh__D014842
% 210.76/210.90 Group of hemorrhagic disorders in which the von Willebrand factor %28%Factor VIII-related antigen%29% is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.%A%
% 210.76/210.90 |- skos__hiddenLabel mesh__D014842 Disease, von Willebrand
% 210.76/210.90 |- skos__hiddenLabel mesh__D014842 Vascular Hemophilia
% 210.76/210.90 |- skos__annotation mesh__D014842
% 210.76/210.90 do not coord with INFANT, NEWBORN, DISEASES
% 210.76/210.90 |- mesh__recordMaintainer mesh__D014842 nns
% 210.76/210.90 |- skos__broader mesh__D014842smesh__D025861
% 210.76/210.90 |- mesh__activeMeSHYear mesh__D014842 2006
% 210.76/210.90 |- skos__broader mesh__D014842smesh__D006474
% 210.76/210.90 |- skos__hiddenLabel mesh__D014842 von Willebrands Disease
% 210.76/210.90 |- mesh__recordAuthorizer mesh__D014842 sjn
% 210.76/210.90 |- skos__altLabel mesh__D014842 von Willebrand%27%s Disease
% 210.76/210.90 |- mesh__recordOriginator mesh__D014842 NLM
% 210.76/210.90 |- skos__altLabel mesh__D014842 Angiohemophilia
% 210.76/210.90 |- skos__altLabel mesh__D014842 Hemophilia, Vascular
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D014842 2005
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D014842 2002
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D014842
% 210.76/210.91 99; see von Willebrand%27%s Disease 1968-98, see HEMORRHAGIC DIATHESIS 1967, see THROMBOCYTOPATHY 1963-66%A%
% 210.76/210.91 |- skos__broader mesh__D014842smesh__D020147
% 210.76/210.91 |- mesh__dateRevised mesh__D014842 2001-07-25
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D014842 2004
% 210.76/210.91 |- skos__hiddenLabel mesh__D014842 Hemophilias, Vascular
% 210.76/210.91 |- skos__hiddenLabel mesh__D014842 Angiohemophilias
% 210.76/210.91 |- skos__broader mesh__D014842smesh__D001791
% 210.76/210.91 |- rdf__type mesh__D014044sskos__Concept
% 210.76/210.91 |- skos__altLabel mesh__D014044 Hoechst Brand of Tolbutamide
% 210.76/210.91 |- skos__altLabel mesh__D014044 Apotex Brand of Tolbutamide
% 210.76/210.91 |- skos__hiddenLabel mesh__D014044 Berlin Chemie Brand of Tolbutamide
% 210.76/210.91 |- skos__altLabel mesh__D014044 Valdecasas Brand of Tolbutamide
% 210.76/210.91 |- skos__altLabel mesh__D014044 Rastinon
% 210.76/210.91 |- skos__altLabel mesh__D014044 Pharmacia Brand of Tolbutamide
% 210.76/210.91 |- mesh__recordMaintainer mesh__D014044 CCR
% 210.76/210.91 |- skos__prefLabel mesh__D014044 Tolbutamide
% 210.76/210.91 |- skos__broader mesh__D014044smesh__D013453
% 210.76/210.91 |- mesh__dateCreated mesh__D014044 1999-01-01
% 210.76/210.91 |- skos__altLabel mesh__D014044 R.A.N. Brand of Tolbutamide
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D014044 2006
% 210.76/210.91 |- skos__altLabel mesh__D014044 Berlin-Chemie Brand of Tolbutamide
% 210.76/210.91 |- mesh__dateRevised mesh__D014044 2005-06-30
% 210.76/210.91 |- skos__scopeNote mesh__D014044
% 210.76/210.91 A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p290%29%%A%
% 210.76/210.91 |- skos__altLabel mesh__D014044 Aventis Brand of Tolbutamide
% 210.76/210.91 |- skos__altLabel mesh__D014044 Yamanouchi Brand of Tolbutamide
% 210.76/210.91 |- skos__hiddenLabel mesh__D014044 Apo Tolbutamide
% 210.76/210.91 |- mesh__recordOriginator mesh__D014044 NLM
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D014044 sjn
% 210.76/210.91 |- skos__broader mesh__D008805smesh__D008815
% 210.76/210.91 |- skos__hiddenLabel mesh__D008805 Inbred A Mice
% 210.76/210.91 |- skos__annotation mesh__D008805
% 210.76/210.91 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.76/210.91 |- mesh__dateCreated mesh__D008805 1999-01-01
% 210.76/210.91 |- mesh__dateRevised mesh__D008805 2005-06-30
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D008805 2006
% 210.76/210.91 |- skos__altLabel mesh__D008805 Mouse, Inbred A
% 210.76/210.91 |- mesh__recordOriginator mesh__D008805 NLM
% 210.76/210.91 |- mesh__dateEstablished mesh__D008805 1974-01-01
% 210.76/210.91 |- skos__hiddenLabel mesh__D008805 Inbred A Mouse
% 210.76/210.91 |- skos__historyNote mesh__D008805 Mice %28%1966-1971%29%
% 210.76/210.91 |- rdf__type mesh__D008805sskos__Concept
% 210.76/210.91 |- mesh__recordMaintainer mesh__D008805 ags
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D008805 sjn
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D008805 74
% 210.76/210.91 |- skos__prefLabel mesh__D008805 Mice, Inbred A
% 210.76/210.91 |- mesh__historyNote mesh__D008805 74%28%72%29%
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1995
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D000822 PLS
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1996
% 210.76/210.91 |- mesh__dateEstablished mesh__D000822 1976-01-01
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1993
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 2000
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1999
% 210.76/210.91 |- mesh__recordMaintainer mesh__D000822 TGC
% 210.76/210.91 |- skos__hiddenLabel mesh__D000822 Husbandry, Animal
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1997
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D000822 76
% 210.76/210.91 |- skos__related mesh__D000822smesh__D014730
% 210.76/210.91 |- skos__hiddenLabel mesh__D000822 Animal Husbandries
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 2001
% 210.76/210.91 |- skos__historyNote mesh__D000822 Agriculture %28%1966-1975%29%
% 210.76/210.91 |- mesh__dateCreated mesh__D000822 1975-07-23
% 210.76/210.91 |- skos__annotation mesh__D000822
% 210.76/210.91 includes animal %22%breeding, feeding %26% care ... housing %26% nutrition%22%; do not confuse with VETERINARY MEDICINE; SPEC: SPEC qualif%A%
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1990
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 2002
% 210.76/210.91 |- mesh__recordOriginator mesh__D000822 FPG
% 210.76/210.91 |- skos__prefLabel mesh__D000822 Animal Husbandry
% 210.76/210.91 |- skos__hiddenLabel mesh__D000822 Husbandries, Animal
% 210.76/210.91 |- mesh__historyNote mesh__D000822 76
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1991
% 210.76/210.91 |- skos__broader mesh__D000822smesh__D000383
% 210.76/210.91 |- mesh__dateRevised mesh__D000822 1989-06-13
% 210.76/210.91 |- rdf__type mesh__D000822sskos__Concept
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 2005
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1994
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 2003
% 210.76/210.91 |- skos__scopeNote mesh__D000822
% 210.76/210.91 The science of breeding, feeding and care of domestic animals; includes housing and nutrition.%A%
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 2006
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1992
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 1998
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000822 2004
% 210.76/210.91 |- mesh__recordOriginator mesh__D008007 NLM
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D008007 2006
% 210.76/210.91 |- mesh__recordMaintainer mesh__D008007 kle
% 210.76/210.91 |- skos__prefLabel mesh__D008007 Licensure, Medical
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D008007 2005
% 210.76/210.91 |- mesh__dateCreated mesh__D008007 1999-01-01
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D008007 2002
% 210.76/210.91 |- skos__scopeNote mesh__D008007
% 210.76/210.91 The granting of a license to practice medicine.
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D008007 2004
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D008007 2001
% 210.76/210.91 |- skos__broader mesh__D008007smesh__D008004
% 210.76/210.91 |- mesh__dateRevised mesh__D008007 1999-11-03
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D008007 2003
% 210.76/210.91 |- skos__annotation mesh__D008007
% 210.76/210.91 by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog; DF: LICENSURE MED%A%
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D008007 2000
% 210.76/210.91 |- rdf__type mesh__D008007sskos__Concept
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D008007 sjn
% 210.76/210.91 |- skos__altLabel mesh__D008007 Medical Licensure
% 210.76/210.91 |- skos__hiddenLabel mesh__D000024 Abortions, Criminal
% 210.76/210.91 |- skos__hiddenLabel mesh__D000024 Criminal Abortion
% 210.76/210.91 |- mesh__dateCreated mesh__D000024 1999-01-01
% 210.76/210.91 |- skos__hiddenLabel mesh__D000024 Criminal Abortions
% 210.76/210.91 |- mesh__dateRevised mesh__D000024 2004-07-13
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000024 2006
% 210.76/210.91 |- skos__broader mesh__D000024smesh__D003415
% 210.76/210.91 |- skos__altLabel mesh__D000024 Illegal Abortion
% 210.76/210.91 |- skos__annotation mesh__D000024
% 210.76/210.91 don%27%t forget also check tags HUMANS %26% FEMALE %26% PREGNANCY; for abortifacients in crim abort see note on ABORTION, INDUCED%A%
% 210.76/210.91 |- skos__prefLabel mesh__D000024 Abortion, Criminal
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D000024 2005
% 210.76/210.91 |- skos__hiddenLabel mesh__D000024 Illegal Abortions
% 210.76/210.91 |- rdf__type mesh__D000024sskos__Concept
% 210.76/210.91 |- mesh__recordMaintainer mesh__D000024 sjn
% 210.76/210.91 |- skos__altLabel mesh__D000024 Abortion, Illegal
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D000024 sjn
% 210.76/210.91 |- skos__scopeNote mesh__D000024 Illegal termination of pregnancy.
% 210.76/210.91 |- mesh__recordOriginator mesh__D000024 NLM
% 210.76/210.91 |- skos__hiddenLabel mesh__D000024 Abortions, Illegal
% 210.76/210.91 |- skos__annotation mesh__D052163
% 210.76/210.91 infection: coordinate IM with probably GENITAL WARTS %28%IM%29% or PAPILLOMAVIRUS INFECTIONS %28%IM%29%; coordinate with LARYNGEAL NEOPLASMS if pertinent%A%
% 210.76/210.91 |- mesh__recordMaintainer mesh__D052163 ags
% 210.76/210.91 |- skos__altLabel mesh__D052163 Human papillomavirus type 6
% 210.76/210.91 |- rdf__type mesh__D052163sskos__Concept
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D052163 2006
% 210.76/210.91 |- skos__historyNote mesh__D052163 Papillomavirus, Human %28%1994-2005%29%
% 210.76/210.91 |- skos__altLabel mesh__D052163 HPV-6
% 210.76/210.91 |- skos__hiddenLabel mesh__D052163 papillomavirus 6, Human
% 210.76/210.91 |- skos__hiddenLabel mesh__D052163 HPV 6
% 210.76/210.91 |- mesh__dateCreated mesh__D052163 2005-06-30
% 210.76/210.91 |- mesh__dateEstablished mesh__D052163 2006-01-01
% 210.76/210.91 |- mesh__historyNote mesh__D052163 2006
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D052163 sjn
% 210.76/210.91 |- skos__broader mesh__D052163smesh__D018145
% 210.76/210.91 |- skos__scopeNote mesh__D052163
% 210.76/210.91 A type of HUMAN PAPILLOMAVIRUS usually associated with GENITAL WARTS; and LARYNGEAL NEOPLASMS.%A%
% 210.76/210.91 |- skos__prefLabel mesh__D052163 Human papillomavirus 6
% 210.76/210.91 |- skos__historyNote mesh__D052163 Papillomavirus %28%1982-1993%29%
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D052163 2006
% 210.76/210.91 |- mesh__recordOriginator mesh__D052163 ags
% 210.76/210.91 |- skos__annotation mesh__D032904
% 210.76/210.91 note X refs: do not confuse with CASSIA SENNA or CASSIA ANGUSTIFOLIA see SENNA PLANT; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.76/210.91 |- mesh__dateCreated mesh__D032904 2002-07-03
% 210.76/210.91 |- skos__broader mesh__D032904smesh__D027424
% 210.76/210.91 |- skos__altLabel mesh__D032904 Cassia Tree
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D032904 2003
% 210.76/210.91 |- rdf__type mesh__D032904sskos__Concept
% 210.76/210.91 |- skos__scopeNote mesh__D032904
% 210.76/210.91 A plant species of the genus CINNAMOMUM that contains CINNAMATES and has been used in traditional Chinese medicine %28%DRUGS, CHINESE HERBAL%29%.%A%
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D032904 2004
% 210.76/210.91 |- mesh__historyNote mesh__D032904 2003
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D032904 2003
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D032904 2005
% 210.76/210.91 |- skos__altLabel mesh__D032904 Cassia, Chinese
% 210.76/210.91 |- skos__altLabel mesh__D032904 Cinnamomum cassia
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D032904 2006
% 210.76/210.91 |- mesh__dateEstablished mesh__D032904 2003-01-01
% 210.76/210.91 |- skos__prefLabel mesh__D032904 Cinnamomum aromaticum
% 210.76/210.91 |- skos__historyNote mesh__D018435 Membrane Proteins %28%1980-1988%29%
% 210.76/210.91 |- skos__historyNote mesh__D018435 Glycoproteins %28%1980-1987%29%
% 210.76/210.91 |- mesh__dateRevised mesh__D018435 2005-06-30
% 210.76/210.91 |- rdf__type mesh__D018435sskos__Concept
% 210.76/210.91 |- mesh__historyNote mesh__D018435 99; use P-GLYCOPROTEIN 1995-98
% 210.76/210.91 |- skos__related mesh__D018435smesh__D018432
% 210.76/210.91 |- skos__hiddenLabel mesh__D018435 P Glycoproteins
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D018435
% 210.76/210.91 99; see P-GLYCOPROTEIN 1995-98; P-GLYCOPROTEIN was indexed under CARRIER PROTEINS %26% MEMBRANE GLYCOPROTEINS 1980-94, GLYCOPROTEINS 1980-87, and MEMBRANE PROTEINS 1980-82%A%
% 210.76/210.91 |- mesh__dateCreated mesh__D018435 1994-01-25
% 210.76/210.91 |- mesh__dateEstablished mesh__D018435 1995-01-01
% 210.76/210.91 |- skos__altLabel mesh__D018435 ATP-Binding Cassette, Sub-Family B Proteins
% 210.76/210.91 |- skos__related mesh__D018435smesh__D027425
% 210.76/210.91 |- skos__related mesh__D018435smesh__D020112
% 210.76/210.91 |- skos__related mesh__D018435smesh__D019450
% 210.76/210.91 |- skos__historyNote mesh__D018435 Membrane Glycoproteins %28%1989-1994%29%
% 210.76/210.91 |- skos__broader mesh__D018435smesh__D029365
% 210.76/210.91 |- skos__annotation mesh__D018435
% 210.76/210.91 P-GLYCOPROTEIN is also available; P stands for %22%permeability%22%%A%
% 210.76/210.91 |- mesh__recordOriginator mesh__D018435 AGS
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D018435 sjn
% 210.76/210.91 |- skos__scopeNote mesh__D018435
% 210.76/210.91 A subfamily of transmembrane proteins from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS that are closely related in sequence to P-GLYCOPROTEIN. When overexpressed, they function as ATP-dependent efflux pumps able to extrude lipophilic drugs, especially ANTINEOPLASTIC AGENTS, from cells causing multidrug resistance %28%DRUG RESISTANCE, MULTIPLE%29%. Although P-Glycoproteins share functional similarities to MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS they are two distinct subclasses of ATP-BINDING CASSETTE TRANSPORTERS, and have little sequence homology.%A%
% 210.76/210.91 |- mesh__recordMaintainer mesh__D018435 jmp
% 210.76/210.91 |- skos__prefLabel mesh__D018435 P-Glycoproteins
% 210.76/210.91 |- skos__hiddenLabel mesh__D018435
% 210.76/210.91 ATP Binding Cassette, Sub Family B Proteins
% 210.76/210.91 |- skos__altLabel mesh__D018435 Multidrug Resistance Proteins
% 210.76/210.91 |- skos__broader mesh__D018435smesh__D018528
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D018435 2006
% 210.76/210.91 |- skos__prefLabel mesh__D010452 Peptide Biosynthesis
% 210.76/210.91 |- mesh__recordMaintainer mesh__D010452 nns
% 210.76/210.91 |- mesh__historyNote mesh__D010452 2005 %28%1998%29%
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D010452 2006
% 210.76/210.91 |- mesh__dateRevised mesh__D010452 2004-07-07
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D010452 sjn
% 210.76/210.91 |- skos__annotation mesh__D010452
% 210.76/210.91 general or unspecified; prefer specific peptide/biosyn; PROTEIN BIOSYNTHESIS and PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT are also available%A%
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D010452 2005
% 210.76/210.91 |- mesh__dateCreated mesh__D010452 1999-01-01
% 210.76/210.91 |- mesh__recordOriginator mesh__D010452 NLM
% 210.76/210.91 |- mesh__dateEstablished mesh__D010452 1998-01-01
% 210.76/210.91 |- skos__hiddenLabel mesh__D010452 Biosynthesis, Peptide
% 210.76/210.91 |- skos__historyNote mesh__D010452 Peptides/biosynthesis %28%1966-1997%29%
% 210.76/210.91 |- skos__related mesh__D010452smesh__D014176
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D010452
% 210.76/210.91 2005; see PEPTIDE SYNTHESIS 1998-2004
% 210.76/210.91 |- skos__scopeNote mesh__D010452
% 210.76/210.91 The production of PEPTIDES or PROTEINS by the constituents of a living organism. The biosynthesis of proteins on RIBOSOMES following an RNA template is termed translation %28%TRANSLATION, GENETIC%29%. There are other, non-ribosomal peptide biosynthesis %28%PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%29% mechanisms carried out by PEPTIDE SYNTHASES and PEPTIDYLTRANSFERASES. Further modifications of peptide chains yield functional peptide and protein molecules.%A%
% 210.76/210.91 |- skos__broader mesh__D010452smesh__D008660
% 210.76/210.91 |- rdf__type mesh__D010452sskos__Concept
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D032106 2004
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D032106 2005
% 210.76/210.91 |- skos__scopeNote mesh__D032106
% 210.76/210.91 A plant genus of the family RUTACEAE. Most plants that are called Fagara are actually Zanthoxylum. Some members of Zanthoxylum are reclassified from ELEUTHEROCOCCUS, Melicope, and EVODIA. The twigs are used as dental brushing sticks %28%TOOTHBRUSHING%29%.%A%
% 210.76/210.91 |- mesh__dateEstablished mesh__D032106 2003-01-01
% 210.76/210.91 |- mesh__dateCreated mesh__D032106 2002-07-03
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D032106 2003
% 210.76/210.91 |- skos__altLabel mesh__D032106 Fagara rhetza
% 210.76/210.91 |- skos__altLabel mesh__D032106 Fagara boninensis
% 210.76/210.91 |- skos__altLabel mesh__D032106 Xanthoxylum
% 210.76/210.91 |- skos__altLabel mesh__D032106 Fagara xanthoxyloides
% 210.76/210.91 |- mesh__historyNote mesh__D032106 2003
% 210.76/210.91 |- skos__altLabel mesh__D032106 Fagara zanthoxyloides
% 210.76/210.91 |- skos__broader mesh__D032106smesh__D027821
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D032106 2003
% 210.76/210.91 |- skos__prefLabel mesh__D032106 Zanthoxylum
% 210.76/210.91 |- skos__annotation mesh__D032106
% 210.76/210.91 note FAGARA X refs: FAGARA see RUTACEAE and FAGARA HORRIDA see GLEDITSIA are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D032106 2006
% 210.76/210.91 |- rdf__type mesh__D032106sskos__Concept
% 210.76/210.91 |- skos__hiddenLabel mesh__D004415 Indigestions
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D004415 2001
% 210.76/210.91 |- skos__broader mesh__D004415smesh__D012817
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D004415 2000
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D004415 2004
% 210.76/210.91 |- mesh__dateCreated mesh__D004415 1999-01-01
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D004415 sjn
% 210.76/210.91 |- mesh__recordOriginator mesh__D004415 NLM
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D004415 2003
% 210.76/210.91 |- skos__altLabel mesh__D004415 Indigestion
% 210.76/210.91 |- mesh__recordMaintainer mesh__D004415 KEV
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D004415 2002
% 210.76/210.91 |- skos__hiddenLabel mesh__D004415 Dyspepsias
% 210.76/210.91 |- skos__prefLabel mesh__D004415 Dyspepsia
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D004415 2006
% 210.76/210.91 |- rdf__type mesh__D004415sskos__Concept
% 210.76/210.91 |- skos__scopeNote mesh__D004415
% 210.76/210.91 Impaired digestion, especially after eating.
% 210.76/210.91 |- mesh__dateRevised mesh__D004415 1999-11-04
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D004415 2005
% 210.76/210.91 |- skos__broader mesh__D009100smesh__D002239
% 210.76/210.91 |- skos__hiddenLabel mesh__D009100 Multiple Carboxylase Deficiencies
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D009100 2006
% 210.76/210.91 |- skos__hiddenLabel mesh__D009100 Carboxylase Deficiencies, Multiple
% 210.76/210.91 |- mesh__dateRevised mesh__D009100 2001-07-25
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D009100 87
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D009100 2005
% 210.76/210.91 |- skos__historyNote mesh__D009100
% 210.76/210.91 specific enzyme/deficiency %28%1975-1986%29%
% 210.76/210.91 |- skos__altLabel mesh__D009100 Combined Carboxylase Deficiency
% 210.76/210.91 |- skos__historyNote mesh__D009100 specific enzyme %28%1966-1974%29%
% 210.76/210.91 |- mesh__dateEstablished mesh__D009100 1987-01-01
% 210.76/210.91 |- mesh__recordMaintainer mesh__D009100 nns
% 210.76/210.91 |- skos__hiddenLabel mesh__D009100 Deficiencies, Multiple Carboxylase
% 210.76/210.91 |- rdf__type mesh__D009100sskos__Concept
% 210.76/210.91 |- skos__hiddenLabel mesh__D009100 Deficiencies, Combined Carboxylase
% 210.76/210.91 |- skos__scopeNote mesh__D009100
% 210.76/210.91 A deficiency in the activities of biotin-dependent enzymes %28%propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and PYRUVATE CARBOXYLASE%29% due to one of two defects in BIOTIN metabolism. The neonatal form is due to HOLOCARBOXYLASE SYNTHETASE DEFICIENCY. The late-onset form is due to BIOTINIDASE DEFICIENCY.%A%
% 210.76/210.91 |- mesh__dateCreated mesh__D009100 1986-04-18
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D009100 2002
% 210.76/210.91 |- mesh__recordOriginator mesh__D009100 VDK
% 210.76/210.91 |- skos__related mesh__D009100smesh__D001710
% 210.76/210.91 |- mesh__recordAuthorizer mesh__D009100 sjn
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D009100 2004
% 210.76/210.91 |- skos__hiddenLabel mesh__D009100 Combined Carboxylase Deficiencies
% 210.76/210.91 |- skos__altLabel mesh__D009100 Carboxylase Deficiency, Combined
% 210.76/210.91 |- skos__hiddenLabel mesh__D009100 Carboxylase Deficiencies, Combined
% 210.76/210.91 |- skos__altLabel mesh__D009100 Deficiency, Multiple Carboxylase
% 210.76/210.91 |- mesh__historyNote mesh__D009100 87
% 210.76/210.91 |- skos__prefLabel mesh__D009100 Multiple Carboxylase Deficiency
% 210.76/210.91 |- skos__altLabel mesh__D009100 Carboxylase Deficiency, Multiple
% 210.76/210.91 |- mesh__activeMeSHYear mesh__D009100 2003
% 210.76/210.91 |- skos__broader mesh__D009100smesh__D000592
% 210.76/210.91 |- skos__altLabel mesh__D009100 Deficiency, Combined Carboxylase
% 210.76/210.91 |- skos__broader mesh__D020880smesh__D009414
% 210.76/210.91 |- skos__scopeNote mesh__D020880
% 210.76/210.91 A family of peptides originally found as factors that stimulate the phosphorylation of the erbB-2 receptor %28%RECEPTORS, ERBB-2%29%. Multiple variant forms of NEUREGULINS occur due to alternative splicing of their mRNAs. The NEUREGULINS include products from the three known genes %28%NGR1; NGR2 and NGR3%29%.%A%
% 210.76/210.91 |- skos__annotation mesh__D020880 GEN: prefer specifics
% 210.76/210.91 |- mesh__publicMeSHNote mesh__D020880
% 210.76/210.91 2000; NEURONAL DIFFERENTIATION FACTOR, CHOLINERGIC %28%now NEUREGULINS%29% was indexed under GLYCOPROTEINS 1986-1999%A%
% 210.76/210.91 |- mesh__recordOriginator mesh__D020880 jmp
% 210.77/210.91 |- skos__prefLabel mesh__D020880 Neuregulins
% 210.77/210.91 |- skos__broader mesh__D020880smesh__D036341
% 210.77/210.91 |- mesh__dateEstablished mesh__D020880 2000-01-01
% 210.77/210.91 |- mesh__historyNote mesh__D020880
% 210.77/210.91 2000; use NEUREGULINS %28%NM%29% 1986-1999
% 210.77/210.91 |- mesh__dateRevised mesh__D020880 2005-06-30
% 210.77/210.91 |- mesh__recordAuthorizer mesh__D020880 sjn
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D020880 2006
% 210.77/210.91 |- skos__historyNote mesh__D020880 Glycoproteins %28%1986-1999%29%
% 210.77/210.91 |- mesh__dateCreated mesh__D020880 1999-11-04
% 210.77/210.91 |- rdf__type mesh__D020880sskos__Concept
% 210.77/210.91 |- skos__related mesh__D020880smesh__D018719
% 210.77/210.91 |- mesh__recordMaintainer mesh__D020880 ssb
% 210.77/210.91 |- skos__broader mesh__D020880smesh__D006133
% 210.77/210.91 |- skos__altLabel mesh__D020880 NRG Proteins
% 210.77/210.91 |- mesh__dateRevised mesh__D020082 2005-06-30
% 210.77/210.91 |- mesh__recordAuthorizer mesh__D020082 sjn
% 210.77/210.91 |- skos__broader mesh__D020082smesh__D001203
% 210.77/210.91 |- mesh__recordOriginator mesh__D020082 AGS
% 210.77/210.91 |- skos__prefLabel mesh__D020082 Magnaporthe
% 210.77/210.91 |- mesh__dateEstablished mesh__D020082 1999-01-01
% 210.77/210.91 |- mesh__publicMeSHNote mesh__D020082 99
% 210.77/210.91 |- skos__scopeNote mesh__D020082
% 210.77/210.91 A genus of FUNGI, in the family Magnaporthaceae of uncertain position %28%incertae sedis%29%. It is best known for its species, M. grisea, which is one of the most popular experimental organisms of all fungal plant pathogens.%A%
% 210.77/210.91 |- mesh__recordMaintainer mesh__D020082 ags
% 210.77/210.91 |- mesh__dateCreated mesh__D020082 1998-06-10
% 210.77/210.91 |- mesh__historyNote mesh__D020082 99
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D020082 2006
% 210.77/210.91 |- skos__historyNote mesh__D020082 Ascomycota %28%1990-1998%29%
% 210.77/210.91 |- rdf__type mesh__D020082sskos__Concept
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D014843 2000
% 210.77/210.91 |- rdf__type mesh__D014843sskos__Concept
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D014843 2003
% 210.77/210.91 |- mesh__dateEstablished mesh__D014843 1991-01-01
% 210.77/210.91 |- mesh__recordAuthorizer mesh__D014843 SJN
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D014843 1999
% 210.77/210.91 |- skos__broader mesh__D014843smesh__D010262
% 210.77/210.91 |- mesh__recordOriginator mesh__D014843 NLM
% 210.77/210.91 |- skos__scopeNote mesh__D014843
% 210.77/210.91 A paraphilia characterized by repetitive looking at unsuspecting people, usually strangers, who are either naked, in the act of disrobing, or engaging in sexual activity, as the method for achieving sexual excitement.%A%
% 210.77/210.91 |- skos__prefLabel mesh__D014843 Voyeurism
% 210.77/210.91 |- mesh__historyNote mesh__D014843
% 210.77/210.91 91%28%75%29%; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A%
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D014843 2006
% 210.77/210.91 |- skos__hiddenLabel mesh__D014843 Voyeurisms
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D014843 2002
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D014843 2005
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D014843 2001
% 210.77/210.91 |- mesh__dateCreated mesh__D014843 1999-01-01
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D014843 2004
% 210.77/210.91 |- mesh__recordMaintainer mesh__D014843 JLS
% 210.77/210.91 |- mesh__onlineNote mesh__D014843 search PARAPHILIAS 1968-74
% 210.77/210.91 |- mesh__dateRevised mesh__D014843 1998-06-11
% 210.77/210.91 |- mesh__publicMeSHNote mesh__D014843
% 210.77/210.91 91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A%
% 210.77/210.91 |- skos__hiddenLabel mesh__D008806 AKR Mouse, Inbred
% 210.77/210.91 |- skos__hiddenLabel mesh__D008806 AKR Mouse
% 210.77/210.91 |- skos__hiddenLabel mesh__D008806 AKR Mice, Inbred
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D008806 2006
% 210.77/210.91 |- skos__prefLabel mesh__D008806 Mice, Inbred AKR
% 210.77/210.91 |- mesh__historyNote mesh__D008806 74%28%72%29%
% 210.77/210.91 |- skos__hiddenLabel mesh__D008806 Inbred AKR Mouse
% 210.77/210.91 |- skos__broader mesh__D008806smesh__D008815
% 210.77/210.91 |- skos__hiddenLabel mesh__D008806 Inbred AKR Mice
% 210.77/210.91 |- rdf__type mesh__D008806sskos__Concept
% 210.77/210.91 |- mesh__recordMaintainer mesh__D008806 ags
% 210.77/210.91 |- skos__annotation mesh__D008806
% 210.77/210.91 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.77/210.91 |- mesh__dateRevised mesh__D008806 2005-06-30
% 210.77/210.91 |- skos__hiddenLabel mesh__D008806 AKR Mice
% 210.77/210.91 |- skos__altLabel mesh__D008806 Mice, AKR
% 210.77/210.91 |- mesh__recordOriginator mesh__D008806 NLM
% 210.77/210.91 |- mesh__dateEstablished mesh__D008806 1974-01-01
% 210.77/210.91 |- skos__historyNote mesh__D008806 Mice %28%1966-1971%29%
% 210.77/210.91 |- mesh__recordAuthorizer mesh__D008806 sjn
% 210.77/210.91 |- skos__altLabel mesh__D008806 Mouse, AKR
% 210.77/210.91 |- skos__altLabel mesh__D008806 Mouse, Inbred AKR
% 210.77/210.91 |- mesh__publicMeSHNote mesh__D008806 74
% 210.77/210.91 |- mesh__dateCreated mesh__D008806 1999-01-01
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D000823 1994
% 210.77/210.91 |- rdf__type mesh__D000823sskos__Concept
% 210.77/210.91 |- mesh__recordAuthorizer mesh__D000823 PLS
% 210.77/210.91 |- mesh__dateRevised mesh__D000823 1992-05-26
% 210.77/210.91 |- mesh__historyNote mesh__D000823 78
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D000823 2006
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D000823 2003
% 210.77/210.91 |- skos__hiddenLabel mesh__D000823 Systems, Animal Identification
% 210.77/210.91 |- skos__hiddenLabel mesh__D000823 Animal Identification System
% 210.77/210.91 |- mesh__activeMeSHYear mesh__D000823 1997
% 210.77/210.91 |- mesh__publicMeSHNote mesh__D000823 78
% 210.77/210.92 |- mesh__dateEstablished mesh__D000823 1978-01-01
% 210.77/210.92 |- skos__scopeNote mesh__D000823
% 210.77/210.92 Procedures for recognizing individual animals and certain identifiable characteristics pertaining to them; includes computerized methods, ear tags, etc.%A%
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 2002
% 210.77/210.92 |- mesh__dateCreated mesh__D000823 1977-05-12
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 2005
% 210.77/210.92 |- skos__prefLabel mesh__D000823 Animal Identification Systems
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 1999
% 210.77/210.92 |- mesh__recordMaintainer mesh__D000823 TAP
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 1996
% 210.77/210.92 |- skos__hiddenLabel mesh__D000823 Identification System, Animal
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 2001
% 210.77/210.92 |- skos__broader mesh__D000823smesh__D008919
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 1993
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 2000
% 210.77/210.92 |- skos__hiddenLabel mesh__D000823 Identification Systems, Animal
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 1998
% 210.77/210.92 |- mesh__recordOriginator mesh__D000823 EC
% 210.77/210.92 |- skos__annotation mesh__D000823
% 210.77/210.92 does not include classif or taxonomy: for individual animals only%A%
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 1995
% 210.77/210.92 |- skos__hiddenLabel mesh__D000823 System, Animal Identification
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000823 2004
% 210.77/210.92 |- skos__altLabel mesh__D008008 Nursing Licensures
% 210.77/210.92 |- skos__annotation mesh__D008008
% 210.77/210.92 by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog; DF: LICENSURE NURS%A%
% 210.77/210.92 |- skos__prefLabel mesh__D008008 Licensure, Nursing
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008008 2004
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008008 2000
% 210.77/210.92 |- skos__broader mesh__D008008smesh__D008004
% 210.77/210.92 |- mesh__dateEstablished mesh__D008008 1966-01-01
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D008008 sjn
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D008008 66
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008008 2003
% 210.77/210.92 |- skos__scopeNote mesh__D008008
% 210.77/210.92 The granting of a license to practice the profession of nursing.%A%
% 210.77/210.92 |- mesh__recordOriginator mesh__D008008 NLM
% 210.77/210.92 |- rdf__type mesh__D008008sskos__Concept
% 210.77/210.92 |- mesh__recordMaintainer mesh__D008008 kle
% 210.77/210.92 |- skos__altLabel mesh__D008008 Nursing Licensure
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008008 2006
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008008 2002
% 210.77/210.92 |- mesh__dateRevised mesh__D008008 1999-11-03
% 210.77/210.92 |- skos__altLabel mesh__D008008 Licensures, Nursing
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008008 2005
% 210.77/210.92 |- mesh__dateCreated mesh__D008008 1999-01-01
% 210.77/210.92 |- mesh__historyNote mesh__D008008 66
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008008 2001
% 210.77/210.92 |- mesh__dateCreated mesh__D000025 1974-11-19
% 210.77/210.92 |- mesh__recordOriginator mesh__D000025 NLM
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000025 2005
% 210.77/210.92 |- skos__altLabel mesh__D000025 Eugenic Abortion
% 210.77/210.92 |- skos__hiddenLabel mesh__D000025 Selective Abortions
% 210.77/210.92 |- skos__hiddenLabel mesh__D000025 Abortions, Eugenic
% 210.77/210.92 |- mesh__dateRevised mesh__D000025 2004-07-13
% 210.77/210.92 |- rdf__type mesh__D000025sskos__Concept
% 210.77/210.92 |- mesh__dateEstablished mesh__D000025 1991-01-01
% 210.77/210.92 |- skos__hiddenLabel mesh__D000025 Abortions, Selective
% 210.77/210.92 |- skos__altLabel mesh__D000025 Selective Abortion
% 210.77/210.92 |- skos__broader mesh__D000025smesh__D000028
% 210.77/210.92 |- mesh__recordMaintainer mesh__D000025 sjn
% 210.77/210.92 |- skos__prefLabel mesh__D000025 Abortion, Eugenic
% 210.77/210.92 |- mesh__historyNote mesh__D000025
% 210.77/210.92 91%28%75%29%; was see under ABORTION, INDUCED 1975-90
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D000025
% 210.77/210.92 91; was see under ABORTION, INDUCED 1975-90
% 210.77/210.92 |- skos__annotation mesh__D000025
% 210.77/210.92 do not use /util except by MeSH definition; don%27%t forget also check tags HUMANS or ANIMALS %26% FEMALE %26% PREGNANCY%A%
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D000025 sjn
% 210.77/210.92 |- skos__scopeNote mesh__D000025
% 210.77/210.92 Abortion performed because of possible fetal defects.
% 210.77/210.92 |- skos__hiddenLabel mesh__D000025 Eugenic Abortions
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000025 2006
% 210.77/210.92 |- rdf__type mesh__D018436sskos__Concept
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D018436 2003
% 210.77/210.92 |- mesh__recordMaintainer mesh__D018436 TGC
% 210.77/210.92 |- skos__prefLabel mesh__D018436 Ancient Lands
% 210.77/210.92 |- mesh__historyNote mesh__D018436 98; use explode 1995-97
% 210.77/210.92 |- skos__scopeNote mesh__D018436
% 210.77/210.92 Geographical sites known to be extant in a remote period in the history of civilization, familiar as the names of ancient countries and empires.%A%
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D018436 1999
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D018436 2001
% 210.77/210.92 |- skos__broader mesh__D018436smesh__D017516
% 210.77/210.92 |- skos__annotation mesh__D018436
% 210.77/210.92 %22%ancient%22% refers to a far-past date or period; GEN or unspecified ancient countries or empires; prefer specifics; use historical tags%A%
% 210.77/210.92 |- mesh__recordOriginator mesh__D018436 TGC
% 210.77/210.92 |- mesh__dateRevised mesh__D018436 1997-06-20
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D018436 1998
% 210.77/210.92 |- skos__historyNote mesh__D018436
% 210.77/210.92 specific geographic location %28%1966-1997%29%
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D018436 2000
% 210.77/210.92 |- mesh__dateEstablished mesh__D018436 1998-01-01
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D018436 SJN
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D018436 2006
% 210.77/210.92 |- mesh__dateCreated mesh__D018436 1994-04-19
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D018436 2004
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D018436 2005
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D018436 2002
% 210.77/210.92 |- mesh__recordOriginator mesh__D010453 NLM
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D010453 2005
% 210.77/210.92 |- mesh__historyNote mesh__D010453 98%28%73%29%
% 210.77/210.92 |- mesh__recordMaintainer mesh__D010453 nns
% 210.77/210.92 |- mesh__dateCreated mesh__D010453 1999-01-01
% 210.77/210.92 |- skos__prefLabel mesh__D010453 Peptide Synthases
% 210.77/210.92 |- skos__scopeNote mesh__D010453
% 210.77/210.92 Ligases that catalyze the joining of adjacent AMINO ACIDS by the formation of carbon-nitrogen bonds between their carboxylic acid groups and amine groups.%A%
% 210.77/210.92 |- skos__altLabel mesh__D010453 Acid-Amino-Acid Ligases
% 210.77/210.92 |- mesh__dateEstablished mesh__D010453 1973-01-01
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D010453 2006
% 210.77/210.92 |- skos__hiddenLabel mesh__D010453 Synthases, Peptide
% 210.77/210.92 |- skos__altLabel mesh__D010453 Peptide Synthetases
% 210.77/210.92 |- skos__hiddenLabel mesh__D010453 Ligases, Acid-Amino-Acid
% 210.77/210.92 |- skos__broader mesh__D010453smesh__D019731
% 210.77/210.92 |- skos__hiddenLabel mesh__D010453 Acid Amino Acid Ligases
% 210.77/210.92 |- skos__historyNote mesh__D010453 Ligases %28%1966-1972%29%
% 210.77/210.92 |- skos__hiddenLabel mesh__D010453 Synthetases, Peptide
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D010453 sjn
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D010453
% 210.77/210.92 98%28%73%29%; see PEPTIDE SYNTHETASES 1973-97
% 210.77/210.92 |- mesh__dateRevised mesh__D010453 2004-07-07
% 210.77/210.92 |- rdf__type mesh__D010453sskos__Concept
% 210.77/210.92 |- mesh__historyNote mesh__D032107 2003
% 210.77/210.92 |- skos__prefLabel mesh__D032107 Populus
% 210.77/210.92 |- skos__altLabel mesh__D032107 Poplar, Black
% 210.77/210.92 |- skos__scopeNote mesh__D032107
% 210.77/210.92 A plant genus of the family SALICACEAE. Balm of Gilead is a common name used for P. candicans, or P. gileadensis, or P. jackii, and sometimes also used for ABIES BALSAMEA or for COMMIPHORA.%A%
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D032107 2003
% 210.77/210.92 |- mesh__dateEstablished mesh__D032107 2003-01-01
% 210.77/210.92 |- skos__altLabel mesh__D032107 Cottonwood
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D032107 2006
% 210.77/210.92 |- rdf__type mesh__D032107sskos__Concept
% 210.77/210.92 |- mesh__dateCreated mesh__D032107 2002-07-03
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D032107 2004
% 210.77/210.92 |- skos__annotation mesh__D032107
% 210.77/210.92 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.77/210.92 |- skos__altLabel mesh__D032107 Poplar, True
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D032107 2005
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D032107 2003
% 210.77/210.92 |- skos__broader mesh__D032107smesh__D029629
% 210.77/210.92 |- skos__altLabel mesh__D032107 Poplar, Balsam
% 210.77/210.92 |- skos__altLabel mesh__D004416 B-K Mole Syndrome
% 210.77/210.92 |- mesh__dateEstablished mesh__D004416 1987-01-01
% 210.77/210.92 |- mesh__recordOriginator mesh__D004416 VDK
% 210.77/210.92 |- skos__broader mesh__D004416smesh__D009506
% 210.77/210.92 |- skos__altLabel mesh__D004416 Nevus, Dysplastic
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D004416 2004
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D004416 87
% 210.77/210.92 |- skos__historyNote mesh__D004416 Nevus %28%1966-1986%29%
% 210.77/210.92 |- skos__hiddenLabel mesh__D004416 B K Mole Syndrome
% 210.77/210.92 |- skos__prefLabel mesh__D004416 Dysplastic Nevus Syndrome
% 210.77/210.92 |- skos__scopeNote mesh__D004416
% 210.77/210.92 Clinically atypical nevi %28%usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders%29% with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. %28%Stedman, 25th ed%29%%A%
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D004416 2003
% 210.77/210.92 |- mesh__historyNote mesh__D004416 87
% 210.77/210.92 |- skos__altLabel mesh__D004416 Nevus Syndrome, Dysplastic
% 210.77/210.92 |- skos__historyNote mesh__D004416 Melanoma %28%1966-1986%29%
% 210.77/210.92 |- skos__hiddenLabel mesh__D004416 Familial Atypical Multiple Mole Melanoma
% 210.77/210.92 |- mesh__recordMaintainer mesh__D004416 nns
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D004416 2006
% 210.77/210.92 |- mesh__dateCreated mesh__D004416 1986-04-18
% 210.77/210.92 |- rdf__type mesh__D004416sskos__Concept
% 210.77/210.92 |- skos__broader mesh__D004416smesh__D009386
% 210.77/210.92 |- skos__hiddenLabel mesh__D004416 Syndrome, Dysplastic Nevus
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D004416 sjn
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D004416 2005
% 210.77/210.92 |- skos__hiddenLabel mesh__D004416 Nevi, Dysplastic
% 210.77/210.92 |- mesh__dateRevised mesh__D004416 2001-07-25
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D004416 2002
% 210.77/210.92 |- skos__hiddenLabel mesh__D004416 Syndrome, B-K Mole
% 210.77/210.92 |- skos__hiddenLabel mesh__D004416 Dysplastic Nevus
% 210.77/210.92 |- skos__annotation mesh__D004416
% 210.77/210.92 do not use /blood supply /chem /second /secret /ultrastruct%A%
% 210.77/210.92 |- skos__historyNote mesh__D004416 Nevus, Pigmented %28%1966-1986%29%
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D009101 sjn
% 210.77/210.92 |- skos__annotation mesh__D009101
% 210.77/210.92 myeloma unspecified is probably MULTIPLE MYELOMA; solitary myeloma = PLASMACYTOMA%A%
% 210.77/210.92 |- mesh__recordMaintainer mesh__D009101 jmp
% 210.77/210.92 |- skos__hiddenLabel mesh__D009101 Myeloma, Plasma Cell
% 210.77/210.92 |- skos__hiddenLabel mesh__D009101 Myelomas, Plasma-Cell
% 210.77/210.92 |- rdf__type mesh__D009101sskos__Concept
% 210.77/210.92 |- skos__broader mesh__D009101smesh__D010265
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D009101 2004
% 210.77/210.92 |- skos__related mesh__D009101smesh__D009194
% 210.77/210.92 |- skos__hiddenLabel mesh__D009101 Plasma-Cell Myeloma
% 210.77/210.92 |- skos__broader mesh__D009101smesh__D010954
% 210.77/210.92 |- skos__hiddenLabel mesh__D009101 Myelomas, Multiple
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D009101 2001
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D009101 2003
% 210.77/210.92 |- skos__broader mesh__D009101smesh__D020141
% 210.77/210.92 |- mesh__dateCreated mesh__D009101 1999-01-01
% 210.77/210.92 |- skos__altLabel mesh__D009101 Myeloma, Plasma-Cell
% 210.77/210.92 |- skos__hiddenLabel mesh__D009101 Myeloma, Multiple
% 210.77/210.92 |- skos__scopeNote mesh__D009101
% 210.77/210.92 A malignant tumor of plasma cells usually arising in the bone marrow; characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria, and anemia.%A%
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D009101 2006
% 210.77/210.92 |- skos__hiddenLabel mesh__D009101 Plasma-Cell Myelomas
% 210.77/210.92 |- mesh__recordOriginator mesh__D009101 NLM
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D009101 2005
% 210.77/210.92 |- skos__hiddenLabel mesh__D009101 Multiple Myelomas
% 210.77/210.92 |- skos__prefLabel mesh__D009101 Multiple Myeloma
% 210.77/210.92 |- mesh__dateRevised mesh__D009101 2000-06-22
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D009101 2002
% 210.77/210.92 |- skos__hiddenLabel mesh__D020881 Bis Pen Enkephalin
% 210.77/210.92 |- skos__hiddenLabel mesh__D020881 D Pen2, L Pen5 Enkephalin
% 210.77/210.92 |- mesh__dateEstablished mesh__D020881 2000-01-01
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D020881
% 210.77/210.92 2000; ENKEPHALIN, PEN%28%2,5%29%- %28%now ENKEPHALIN, D-PENICILLAMINE %28%2,5%29%-%29% was indexed under ENKEPHALINS 1983-1999%A%
% 210.77/210.92 |- skos__altLabel mesh__D020881 Bis-Pen-Enkephalin
% 210.77/210.92 |- skos__scopeNote mesh__D020881
% 210.77/210.92 A disulfide opioid pentapeptide that selectively binds to the DELTA OPIOID RECEPTOR. It possesses antinociceptive activity.%A%
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D020881 2006
% 210.77/210.92 |- skos__hiddenLabel mesh__D020881 D Pen2, D Pen5 Enkephalin
% 210.77/210.92 |- mesh__historyNote mesh__D020881
% 210.77/210.92 2000; use ENKEPHALIN, D-PENICILLAMINE %28%2,5%29%- %28%NM%29% 1983-1999%A%
% 210.77/210.92 |- skos__historyNote mesh__D020881 Enkephalins %28%1983-1999%29%
% 210.77/210.92 |- skos__altLabel mesh__D020881 DPLPE
% 210.77/210.92 |- rdf__type mesh__D020881sskos__Concept
% 210.77/210.92 |- mesh__recordOriginator mesh__D020881 adp
% 210.77/210.92 |- skos__hiddenLabel mesh__D020881 L-Pen5-Enkephalin D-Pen2
% 210.77/210.92 |- skos__altLabel mesh__D020881 DPDPE%28%SH%29%2
% 210.77/210.92 |- skos__altLabel mesh__D020881 Enkephalin, Penicillamine %28%2,5%29%-
% 210.77/210.92 |- skos__altLabel mesh__D020881 D-Penicillamine %28%2,5%29%-Enkephalin
% 210.77/210.92 |- mesh__dateCreated mesh__D020881 1999-11-08
% 210.77/210.92 |- mesh__dateRevised mesh__D020881 2005-06-30
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D020881 sjn
% 210.77/210.92 |- skos__altLabel mesh__D020881 Enkephalin, Pen%28%2,5%29%-
% 210.77/210.92 |- skos__hiddenLabel mesh__D020881 D-Pen5-Enkephalin D-Pen2
% 210.77/210.92 |- skos__hiddenLabel mesh__D020881 Bis Penicillamine Enkephalin
% 210.77/210.92 |- skos__prefLabel mesh__D020881 Enkephalin, D-Penicillamine %28%2,5%29%-
% 210.77/210.92 |- skos__altLabel mesh__D020881 DPDPE
% 210.77/210.92 |- skos__broader mesh__D020881smesh__D004745
% 210.77/210.92 |- mesh__recordMaintainer mesh__D020881 ssb
% 210.77/210.92 |- skos__altLabel mesh__D020881 D-Pen2, D-Pen5-Enkephalin
% 210.77/210.92 |- skos__altLabel mesh__D020083 SAPHO Syndrome
% 210.77/210.92 |- mesh__historyNote mesh__D020083 99
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D020083 99
% 210.77/210.92 |- skos__hiddenLabel mesh__D020083 Syndrome, SAPHO
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D020083 2002
% 210.77/210.92 |- skos__hiddenLabel mesh__D020083 Hyperostosis Syndromes, Acquired
% 210.77/210.92 |- skos__hiddenLabel mesh__D020083 Syndrome, Acquired Hyperostosis
% 210.77/210.92 |- skos__hiddenLabel mesh__D020083 Syndromes, SAPHO
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D020083 2003
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D020083 2005
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D020083 1999
% 210.77/210.92 |- mesh__dateEstablished mesh__D020083 1999-01-01
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D020083 2004
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D020083 2006
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D020083 2000
% 210.77/210.92 |- skos__hiddenLabel mesh__D020083 Acquired Hyperostosis Syndromes
% 210.77/210.92 |- skos__broader mesh__D020083smesh__D010009
% 210.77/210.92 |- skos__hiddenLabel mesh__D020083 Syndromes, Acquired Hyperostosis
% 210.77/210.92 |- rdf__type mesh__D020083sskos__Concept
% 210.77/210.92 |- skos__scopeNote mesh__D020083
% 210.77/210.92 Syndrome consisting of synovitis, acne, palmoplantar pustulosis, hyperostosis, and osteitis %28%SAPHO%29%. The most common site of the disease is the upper anterior chest wall, characterized by predominantly osteosclerotic lesions, hyperostosis, and arthritis of the adjacent joints. The association of sterile inflammatory bone lesions and neutrophilic skin eruptions is indicative of this syndrome.%A%
% 210.77/210.92 |- skos__prefLabel mesh__D020083 Acquired Hyperostosis Syndrome
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D020083 2001
% 210.77/210.92 |- mesh__dateCreated mesh__D020083 1998-06-10
% 210.77/210.92 |- skos__hiddenLabel mesh__D020083 SAPHO Syndromes
% 210.77/210.92 |- skos__hiddenLabel mesh__D020083 Hyperostosis Syndrome, Acquired
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D014844 2006
% 210.77/210.92 |- skos__prefLabel mesh__D014844 Vulva
% 210.77/210.92 |- skos__annotation mesh__D014844 inflammation = VULVITIS
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D014844 2005
% 210.77/210.92 |- mesh__dateRevised mesh__D014844 2004-07-07
% 210.77/210.92 |- mesh__dateCreated mesh__D014844 1999-01-01
% 210.77/210.92 |- skos__broader mesh__D014844smesh__D005836
% 210.77/210.92 |- mesh__recordMaintainer mesh__D014844 lkt
% 210.77/210.92 |- rdf__type mesh__D014844sskos__Concept
% 210.77/210.92 |- skos__scopeNote mesh__D014844
% 210.77/210.92 The external genitalia of the female. It includes the CLITORIS, the labia, the vestibule, and its glands.%A%
% 210.77/210.92 |- skos__hiddenLabel mesh__D014844 Vulvas
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D014844 sjn
% 210.77/210.92 |- mesh__recordOriginator mesh__D014844 NLM
% 210.77/210.92 |- skos__altLabel mesh__D014046 Tolmetin Sodium, Dihydrate
% 210.77/210.92 |- mesh__dateRevised mesh__D014046 2005-06-30
% 210.77/210.92 |- mesh__recordMaintainer mesh__D014046 ssb
% 210.77/210.92 |- skos__scopeNote mesh__D014046
% 210.77/210.92 A non-steroidal anti-inflammatory agent %28%ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL%29% similar in mode of action to INDOMETHACIN.%A%
% 210.77/210.92 |- skos__hiddenLabel mesh__D014046 McN2559
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D014046 2006
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D014046 90; was see under PYRROLES 1976-89
% 210.77/210.92 |- skos__historyNote mesh__D014046 Pyrroles %28%1973-1975%29%
% 210.77/210.92 |- skos__hiddenLabel mesh__D014046 McN 2559
% 210.77/210.92 |- skos__hiddenLabel mesh__D014046 Dihydrate Tolmetin Sodium
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D014046 sjn
% 210.77/210.92 |- mesh__historyNote mesh__D014046
% 210.77/210.92 90%28%76%29%; was see under PYRROLES 1976-89
% 210.77/210.92 |- skos__historyNote mesh__D014046 Benzoates %28%1973-1975%29%
% 210.77/210.92 |- mesh__dateEstablished mesh__D014046 1990-01-01
% 210.77/210.92 |- mesh__dateCreated mesh__D014046 1975-07-25
% 210.77/210.92 |- skos__broader mesh__D014046smesh__D011758
% 210.77/210.92 |- skos__hiddenLabel mesh__D014046 Anhydrous Tolmetin Sodium
% 210.77/210.92 |- rdf__type mesh__D014046sskos__Concept
% 210.77/210.92 |- mesh__recordOriginator mesh__D014046 SH
% 210.77/210.92 |- skos__prefLabel mesh__D014046 Tolmetin
% 210.77/210.92 |- skos__altLabel mesh__D008807 Inbred BALB C Mice
% 210.77/210.92 |- mesh__historyNote mesh__D008807 74%28%72%29%
% 210.77/210.92 |- skos__altLabel mesh__D008807 BALB C Mouse, Inbred
% 210.77/210.92 |- skos__hiddenLabel mesh__D008807 BALB C Mouse
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D008807 sjn
% 210.77/210.92 |- skos__altLabel mesh__D008807 Mouse, BALB C
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008807 2006
% 210.77/210.92 |- mesh__dateCreated mesh__D008807 1999-01-01
% 210.77/210.92 |- mesh__recordMaintainer mesh__D008807 ags
% 210.77/210.92 |- skos__altLabel mesh__D008807 Inbred BALB C Mouse
% 210.77/210.92 |- skos__altLabel mesh__D008807 Mouse, Inbred BALB C
% 210.77/210.92 |- rdf__type mesh__D008807sskos__Concept
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D008807 74
% 210.77/210.92 |- skos__broader mesh__D008807smesh__D008815
% 210.77/210.92 |- skos__altLabel mesh__D008807 Mice, BALB C
% 210.77/210.92 |- mesh__dateEstablished mesh__D008807 1974-01-01
% 210.77/210.92 |- mesh__dateRevised mesh__D008807 2005-06-30
% 210.77/210.92 |- skos__prefLabel mesh__D008807 Mice, Inbred BALB C
% 210.77/210.92 |- skos__hiddenLabel mesh__D008807 BALB C Mice
% 210.77/210.92 |- mesh__recordOriginator mesh__D008807 NLM
% 210.77/210.92 |- skos__historyNote mesh__D008807 Mice %28%1966-1971%29%
% 210.77/210.92 |- skos__altLabel mesh__D008807 BALB C Mice, Inbred
% 210.77/210.92 |- skos__annotation mesh__D008807
% 210.77/210.92 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.77/210.92 |- skos__hiddenLabel mesh__D000824 Nutritions, Animal
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1997
% 210.77/210.92 |- skos__broader mesh__D000824smesh__D009747
% 210.77/210.92 |- mesh__recordOriginator mesh__D000824 NLM
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1991
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 2005
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D000824 PLS
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1999
% 210.77/210.92 |- skos__hiddenLabel mesh__D000824 Animal Nutritions
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1996
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D000824 68
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1990
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1993
% 210.77/210.92 |- mesh__dateRevised mesh__D000824 1989-06-13
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1998
% 210.77/210.92 |- mesh__dateEstablished mesh__D000824 1968-01-01
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 2002
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1995
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1992
% 210.77/210.92 |- skos__prefLabel mesh__D000824 Animal Nutrition
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 2004
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 2001
% 210.77/210.92 |- mesh__dateCreated mesh__D000824 1999-01-01
% 210.77/210.92 |- skos__historyNote mesh__D000824 Nutrition %28%1966-1967%29%
% 210.77/210.92 |- mesh__recordMaintainer mesh__D000824 TGC
% 210.77/210.92 |- rdf__type mesh__D000824sskos__Concept
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 1994
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 2000
% 210.77/210.92 |- skos__hiddenLabel mesh__D000824 Nutrition, Animal
% 210.77/210.92 |- mesh__historyNote mesh__D000824 68
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 2006
% 210.77/210.92 |- skos__annotation mesh__D000824
% 210.77/210.92 no qualif; TN 50: differentiate from ANIMAL FEED %26% DIET
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000824 2003
% 210.77/210.92 |- skos__broader mesh__D008009smesh__D008004
% 210.77/210.92 |- skos__hiddenLabel mesh__D008009 Licensures, Pharmacy
% 210.77/210.92 |- mesh__dateRevised mesh__D008009 1999-11-03
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008009 2003
% 210.77/210.92 |- mesh__dateEstablished mesh__D008009 1968-01-01
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008009 2001
% 210.77/210.92 |- skos__prefLabel mesh__D008009 Licensure, Pharmacy
% 210.77/210.92 |- skos__scopeNote mesh__D008009
% 210.77/210.92 The granting of a license to practice pharmacy.
% 210.77/210.92 |- rdf__type mesh__D008009sskos__Concept
% 210.77/210.92 |- skos__altLabel mesh__D008009 Pharmacy Licensure
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008009 2000
% 210.77/210.92 |- mesh__historyNote mesh__D008009 68
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008009 2006
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D008009 sjn
% 210.77/210.92 |- mesh__publicMeSHNote mesh__D008009 68
% 210.77/210.92 |- mesh__recordOriginator mesh__D008009 NLM
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008009 2005
% 210.77/210.92 |- mesh__recordMaintainer mesh__D008009 kle
% 210.77/210.92 |- mesh__dateCreated mesh__D008009 1999-01-01
% 210.77/210.92 |- skos__hiddenLabel mesh__D008009 Pharmacy Licensures
% 210.77/210.92 |- skos__annotation mesh__D008009
% 210.77/210.92 by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog; DF: LICENSURE PHARM%A%
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008009 2004
% 210.77/210.92 |- skos__historyNote mesh__D008009 Pharmacy %28%1966-1967%29%
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D008009 2002
% 210.77/210.92 |- mesh__dateRevised mesh__D000026 2005-06-30
% 210.77/210.92 |- skos__hiddenLabel mesh__D000026 Miscarriages, Recurrent
% 210.77/210.92 |- mesh__activeMeSHYear mesh__D000026 2006
% 210.77/210.92 |- skos__prefLabel mesh__D000026 Abortion, Habitual
% 210.77/210.92 |- skos__scopeNote mesh__D000026
% 210.77/210.92 Three or more consecutive spontaneous abortions.
% 210.77/210.92 |- rdf__type mesh__D000026sskos__Concept
% 210.77/210.92 |- skos__hiddenLabel mesh__D000026 Habitual Abortions
% 210.77/210.92 |- skos__hiddenLabel mesh__D000026 Recurrent Miscarriages
% 210.77/210.92 |- skos__hiddenLabel mesh__D000026 Habitual Abortion
% 210.77/210.92 |- skos__related mesh__D000026smesh__D020964
% 210.77/210.92 |- skos__related mesh__D000026smesh__D005313
% 210.77/210.92 |- skos__broader mesh__D000026smesh__D000022
% 210.77/210.92 |- skos__altLabel mesh__D000026 Abortion, Recurrent
% 210.77/210.92 |- skos__hiddenLabel mesh__D000026 Recurrent Miscarriage
% 210.77/210.92 |- skos__hiddenLabel mesh__D000026 Abortions, Recurrent
% 210.77/210.92 |- skos__hiddenLabel mesh__D000026 Recurrent Abortions
% 210.77/210.92 |- mesh__recordMaintainer mesh__D000026 lkt
% 210.77/210.92 |- skos__hiddenLabel mesh__D000026 Abortions, Habitual
% 210.77/210.92 |- mesh__dateCreated mesh__D000026 1999-01-01
% 210.77/210.92 |- mesh__recordAuthorizer mesh__D000026 sjn
% 210.77/210.92 |- skos__altLabel mesh__D000026 Miscarriage, Recurrent
% 210.77/210.92 |- skos__hiddenLabel mesh__D000026 Recurrent Abortion
% 210.77/210.92 |- mesh__recordOriginator mesh__D000026 NLM
% 210.77/210.92 |- mesh__dateEstablished mesh__D046128 2005-01-01
% 210.77/210.92 |- mesh__recordOriginator mesh__D046128 lkt
% 210.77/210.92 |- skos__scopeNote mesh__D046128
% 210.77/210.92 Prenatal interventions to correct fetal anomalies or treat FETAL DISEASES in utero. Fetal therapies include several major areas, such as open surgery; FETOSCOPY; pharmacological therapy; INTRAUTERINE TRANSFUSION; STEM CELL TRANSPLANTATION; and GENE THERAPY.%A%
% 210.77/210.93 |- mesh__historyNote mesh__D046128
% 210.77/210.93 2005; use FETAL DISEASES 1993-2004, use FETUS 1986-1992
% 210.77/210.93 |- skos__hiddenLabel mesh__D046128 Therapies, Fetal
% 210.77/210.93 |- skos__historyNote mesh__D046128 Fetal Diseases %28%1982-2004%29%
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D046128 sjn
% 210.77/210.93 |- mesh__dateCreated mesh__D046128 2004-07-07
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D046128 2005
% 210.77/210.93 |- skos__altLabel mesh__D046128 Fetal Therapy
% 210.77/210.93 |- skos__annotation mesh__D046128 General only; prefer specifics
% 210.77/210.93 |- skos__prefLabel mesh__D046128 Fetal Therapies
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D046128 2006
% 210.77/210.93 |- mesh__recordMaintainer mesh__D046128 lkt
% 210.77/210.93 |- rdf__type mesh__D046128sskos__Concept
% 210.77/210.93 |- skos__altLabel mesh__D046128 Therapy, Fetal
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D046128
% 210.77/210.93 2005; see FETAL DISEASES 1993-2004, see FETUS 1986-1992
% 210.77/210.93 |- skos__broader mesh__D046128smesh__D013812
% 210.77/210.93 |- mesh__dateRevised mesh__D018437 2001-08-13
% 210.77/210.93 |- skos__historyNote mesh__D018437 Spinal Cord Injuries %28%1970-1994%29%
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D018437 2003
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D018437 sjn
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D018437 2006
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Brown Sequard%27%s Syndrome
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Syndrome, Hemispinal Cord
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Brown Sequard%27%s Disease
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D018437 2002
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Brown-Sequards Syndrome
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Paralysis, Brown-Sequard%27%s
% 210.77/210.93 |- rdf__type mesh__D018437sskos__Concept
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Brown Sequard Syndrome
% 210.77/210.93 |- skos__scopeNote mesh__D018437
% 210.77/210.93 A syndrome associated with injury to the lateral half of the spinal cord. The condition is characterized by the following clinical features %28%which are found below the level of the lesion%29%: contralateral hemisensory anesthesia to pain and temperature, ipsilateral loss of propioception, and ipsilateral motor paralysis. Tactile sensation is generally spared. %28%From Adams et al., Principles of Neurology, 6th ed, p162%29%.%A%
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Brown-Sequards Paralysis
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D018437 2005
% 210.77/210.93 |- skos__altLabel mesh__D018437 Brown-Sequard%27%s Disease
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Brown-Sequards Disease
% 210.77/210.93 |- mesh__recordOriginator mesh__D018437 TGC
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Hemicord Syndromes
% 210.77/210.93 |- mesh__historyNote mesh__D018437 1995
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Brown Sequard%27%s Paralysis
% 210.77/210.93 |- skos__annotation mesh__D018437
% 210.77/210.93 do not confuse with flaccid paralysis of the bladder, also called Brown S%C3%%A9%quard paralysis; in titles %26% translations use diacrit: Brown-Sequard%A%
% 210.77/210.93 |- skos__historyNote mesh__D018437 Spinal Cord Diseases %28%1975-1991%29%
% 210.77/210.93 |- mesh__dateCreated mesh__D018437 1994-07-06
% 210.77/210.93 |- skos__altLabel mesh__D018437 Hemispinal Cord Syndrome
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D018437 1995
% 210.77/210.93 |- skos__altLabel mesh__D018437 Brown-Sequard%27%s Syndrome
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Syndrome, Brown-Sequard%27%s
% 210.77/210.93 |- skos__historyNote mesh__D018437 Paralysis %28%1968-1994%29%
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Hemispinal Cord Syndromes
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Syndromes, Hemiparaplegic
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Brown Sequard Disease
% 210.77/210.93 |- skos__historyNote mesh__D018437 Hemiplegia %28%1970-1994%29%
% 210.77/210.93 |- skos__altLabel mesh__D018437 Hemicord Syndrome
% 210.77/210.93 |- mesh__recordMaintainer mesh__D018437 jls
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Brown-Sequard Paralysis
% 210.77/210.93 |- skos__altLabel mesh__D018437 Brown-Sequard Disease
% 210.77/210.93 |- skos__altLabel mesh__D018437 Hemiparaplegic Syndrome
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D018437 2004
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Syndrome, Hemicord
% 210.77/210.93 |- skos__prefLabel mesh__D018437 Brown-Sequard Syndrome
% 210.77/210.93 |- skos__broader mesh__D018437smesh__D010264
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Syndrome, Hemiparaplegic
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Syndromes, Hemispinal Cord
% 210.77/210.93 |- mesh__dateEstablished mesh__D018437 1995-01-01
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Hemiparaplegic Syndromes
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Syndromes, Hemicord
% 210.77/210.93 |- skos__hiddenLabel mesh__D018437 Syndrome, Brown-Sequard
% 210.77/210.93 |- mesh__dateCreated mesh__D010454 1999-01-01
% 210.77/210.93 |- mesh__historyNote mesh__D010454 73
% 210.77/210.93 |- skos__hiddenLabel mesh__D010454 Release Factor, Termination
% 210.77/210.93 |- skos__prefLabel mesh__D010454 Peptide Termination Factors
% 210.77/210.93 |- mesh__dateEstablished mesh__D010454 1973-01-01
% 210.77/210.93 |- skos__hiddenLabel mesh__D010454 Termination Factors, Peptide
% 210.77/210.93 |- skos__historyNote mesh__D010454 Bacterial Proteins %28%1966-1972%29%
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D010454 2006
% 210.77/210.93 |- mesh__dateRevised mesh__D010454 2005-06-30
% 210.77/210.93 |- skos__historyNote mesh__D010454 Peptides %28%1966-1972%29%
% 210.77/210.93 |- skos__hiddenLabel mesh__D010454 Factor, Termination Release
% 210.77/210.93 |- skos__broader mesh__D010454smesh__D012269
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D010454 sjn
% 210.77/210.93 |- mesh__recordMaintainer mesh__D010454 SYSTEM
% 210.77/210.93 |- skos__historyNote mesh__D010454 Proteins %28%1966-1972%29%
% 210.77/210.93 |- rdf__type mesh__D010454sskos__Concept
% 210.77/210.93 |- skos__scopeNote mesh__D010454
% 210.77/210.93 Proteins that are involved in the peptide chain termination reaction %28%PEPTIDE CHAIN TERMINATION, TRANSLATIONAL%29% on RIBOSOMES. They include codon-specific class-I release factors, which recognize stop signals %28%TERMINATOR CODON%29% in the MESSENGER RNA; and codon-nonspecific class-II release factors.%A%
% 210.77/210.93 |- skos__hiddenLabel mesh__D010454 Factors, Peptide Termination
% 210.77/210.93 |- mesh__recordOriginator mesh__D010454 NLM
% 210.77/210.93 |- skos__related mesh__D010454smesh__D010443
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D010454 73
% 210.77/210.93 |- skos__broader mesh__D032108smesh__D029629
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D032108 2003
% 210.77/210.93 |- mesh__historyNote mesh__D032108 2003
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D032108 2006
% 210.77/210.93 |- skos__prefLabel mesh__D032108 Salix
% 210.77/210.93 |- rdf__type mesh__D032108sskos__Concept
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D032108 2004
% 210.77/210.93 |- skos__annotation mesh__D032108
% 210.77/210.93 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D032108 2005
% 210.77/210.93 |- mesh__dateEstablished mesh__D032108 2003-01-01
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D032108 2003
% 210.77/210.93 |- skos__scopeNote mesh__D032108
% 210.77/210.93 A plant genus of the family SALICACEAE. Members contain salicin, which yields SALICYLIC ACID.%A%
% 210.77/210.93 |- skos__altLabel mesh__D032108 Willow
% 210.77/210.93 |- mesh__dateCreated mesh__D032108 2002-07-03
% 210.77/210.93 |- mesh__recordOriginator mesh__D004417 NLM
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D004417 sjn
% 210.77/210.93 |- mesh__dateRevised mesh__D004417 1999-11-03
% 210.77/210.93 |- skos__prefLabel mesh__D004417 Dyspnea
% 210.77/210.93 |- rdf__type mesh__D004417sskos__Concept
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D004417 2006
% 210.77/210.93 |- skos__broader mesh__D004417smesh__D012818
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D004417 2002
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D004417 2005
% 210.77/210.93 |- skos__annotation mesh__D004417
% 210.77/210.93 do not confuse with APNEA or other resp disord; use only when text uses DYSPNEA%A%
% 210.77/210.93 |- skos__broader mesh__D004417smesh__D012120
% 210.77/210.93 |- skos__hiddenLabel mesh__D004417 Dyspneas
% 210.77/210.93 |- skos__scopeNote mesh__D004417 Difficult or labored breathing.
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D004417 2001
% 210.77/210.93 |- skos__hiddenLabel mesh__D004417 Breath Shortness
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D004417 2004
% 210.77/210.93 |- skos__hiddenLabel mesh__D004417 Breath Shortnesses
% 210.77/210.93 |- mesh__dateCreated mesh__D004417 1999-01-01
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D004417 2000
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D004417 2003
% 210.77/210.93 |- mesh__recordMaintainer mesh__D004417 KEV
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Nerve II, Cranial
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009900 2002
% 210.77/210.93 |- skos__annotation mesh__D009900
% 210.77/210.93 2d cranial nerve; neopl = OPTIC NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; atrophy = OPTIC ATROPHY; neuritis = OPTIC NEURITIS; optic nerve head = OPTIC DISK%A%
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 IIs, Cranial Nerve
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009900 2004
% 210.77/210.93 |- mesh__recordOriginator mesh__D009900 NLM
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Nerve IIs, Cranial
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009900 2001
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009900 2006
% 210.77/210.93 |- skos__broader mesh__D009900smesh__D003391
% 210.77/210.93 |- skos__scopeNote mesh__D009900
% 210.77/210.93 The 2nd cranial nerve. The optic nerve conveys visual information from the retina to the brain. The nerve carries the axons of the retinal ganglion cells which sort at the optic chiasm and continue via the optic tracts to the brain. The largest projection is to the lateral geniculate nuclei; other important targets include the superior colliculi and the suprachiasmatic nuclei. Though known as the second cranial nerve, it is considered part of the central nervous system.%A%
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Nerve, Optic
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009900 2003
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Nerves, Second Cranial
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Nerve, Second Cranial
% 210.77/210.93 |- mesh__recordMaintainer mesh__D009900 KEV
% 210.77/210.93 |- mesh__dateCreated mesh__D009900 1999-01-01
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009900 2000
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009900 2005
% 210.77/210.93 |- mesh__dateRevised mesh__D009900 1999-11-03
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Cranial Nerves, Second
% 210.77/210.93 |- skos__altLabel mesh__D009900 Cranial Nerve II
% 210.77/210.93 |- rdf__type mesh__D009900sskos__Concept
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Cranial Nerve, Second
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Optic Nerves
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Cranial Nerve IIs
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Second Cranial Nerves
% 210.77/210.93 |- skos__altLabel mesh__D009900 Second Cranial Nerve
% 210.77/210.93 |- skos__prefLabel mesh__D009900 Optic Nerve
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D009900 sjn
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 Nerves, Optic
% 210.77/210.93 |- skos__hiddenLabel mesh__D009900 II, Cranial Nerve
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009102 2004
% 210.77/210.93 |- mesh__dateCreated mesh__D009102 1982-04-26
% 210.77/210.93 |- skos__hiddenLabel mesh__D009102 Failure, Multiple Organ
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009102 2002
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D009102 sjn
% 210.77/210.93 |- skos__altLabel mesh__D009102 Multiple Organ Dysfunction Syndrome
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009102 2003
% 210.77/210.93 |- skos__altLabel mesh__D009102 MODS
% 210.77/210.93 |- skos__prefLabel mesh__D009102 Multiple Organ Failure
% 210.77/210.93 |- mesh__recordOriginator mesh__D009102 CAB
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009102 2006
% 210.77/210.93 |- skos__altLabel mesh__D009102 Organ Failure, Multiple
% 210.77/210.93 |- mesh__historyNote mesh__D009102 83
% 210.77/210.93 |- skos__scopeNote mesh__D009102
% 210.77/210.93 A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.%A%
% 210.77/210.93 |- skos__hiddenLabel mesh__D009102 Multiple Organ Failures
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D009102 2005
% 210.77/210.93 |- mesh__recordMaintainer mesh__D009102 ags
% 210.77/210.93 |- mesh__dateRevised mesh__D009102 2001-07-25
% 210.77/210.93 |- mesh__dateEstablished mesh__D009102 1983-01-01
% 210.77/210.93 |- skos__altLabel mesh__D009102 Organ Dysfunction Syndrome, Multiple
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D009102 83
% 210.77/210.93 |- skos__broader mesh__D009102smesh__D010335
% 210.77/210.93 |- rdf__type mesh__D009102sskos__Concept
% 210.77/210.93 |- rdf__type mesh__D020084sskos__Concept
% 210.77/210.93 |- skos__altLabel mesh__D020084 Long Interspersed DNA Sequence Elements
% 210.77/210.93 |- mesh__dateEstablished mesh__D020084 1999-01-01
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Repeat Sequence, LINE
% 210.77/210.93 |- skos__historyNote mesh__D020084
% 210.77/210.93 Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.77/210.93 |- mesh__dateCreated mesh__D020084 1998-06-10
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Sequence, LINE Repeat
% 210.77/210.93 |- mesh__recordMaintainer mesh__D020084 nns
% 210.77/210.93 |- mesh__recordOriginator mesh__D020084 NNS
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 L1 Element
% 210.77/210.93 |- skos__altLabel mesh__D020084 L1 Elements
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Elements, L1
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Elements, Jockey
% 210.77/210.93 |- mesh__dateRevised mesh__D020084 2005-06-30
% 210.77/210.93 |- skos__prefLabel mesh__D020084 Long Interspersed Nucleotide Elements
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Elements, LINE-1
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D020084 sjn
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 LINE-1 Element
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Repeat Sequences, LINE
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Jockey Element
% 210.77/210.93 |- skos__scopeNote mesh__D020084
% 210.77/210.93 Highly repeated sequences, 6K-8K base pairs in length, which contain RNA polymerase II promoters. They also have an open reading frame that is related to the reverse transcriptase of retroviruses but they do not contain LTRs %28%long terminal repeats%29%. Copies of the LINE 1 %28%L1%29% family form about 15%25% of the human genome. The jockey elements of Drosophila are LINEs.%A%
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Element, L1
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Element, Jockey
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 LINE Repeat Sequence
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D020084 99
% 210.77/210.93 |- skos__broader mesh__D020084smesh__D018626
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Sequences, LINE Repeat
% 210.77/210.93 |- mesh__historyNote mesh__D020084 99
% 210.77/210.93 |- skos__altLabel mesh__D020084 LINE Repeat Sequences
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 LINE 1 Elements
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D020084 2006
% 210.77/210.93 |- skos__hiddenLabel mesh__D020084 Element, LINE-1
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D014845 2006
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D014845 sjn
% 210.77/210.93 |- mesh__dateRevised mesh__D014845 2005-06-30
% 210.77/210.93 |- skos__historyNote mesh__D014845 Vulva %28%1966-1975%29%
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D014845 76
% 210.77/210.93 |- skos__historyNote mesh__D014845 specific vulvar disease
% 210.77/210.93 |- skos__broader mesh__D014845smesh__D005831
% 210.77/210.93 |- mesh__historyNote mesh__D014845 76; was NON MESH before 1976
% 210.77/210.93 |- skos__scopeNote mesh__D014845 Pathological processes of the VULVA.
% 210.77/210.93 |- mesh__recordOriginator mesh__D014845 SMH
% 210.77/210.93 |- rdf__type mesh__D014845sskos__Concept
% 210.77/210.93 |- skos__annotation mesh__D014845 inflammatory disease = VULVITIS
% 210.77/210.93 |- skos__hiddenLabel mesh__D014845 Disease, Vulvar
% 210.77/210.93 |- skos__hiddenLabel mesh__D014845 Diseases, Vulvar
% 210.77/210.93 |- mesh__dateCreated mesh__D014845 1975-07-25
% 210.77/210.93 |- mesh__recordMaintainer mesh__D014845 lkt
% 210.77/210.93 |- mesh__dateEstablished mesh__D014845 1976-01-01
% 210.77/210.93 |- skos__prefLabel mesh__D014845 Vulvar Diseases
% 210.77/210.93 |- skos__hiddenLabel mesh__D014845 Vulvar Disease
% 210.77/210.93 |- skos__scopeNote mesh__D014047 A synthetic antifungal agent.
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D014047 73
% 210.77/210.93 |- skos__altLabel mesh__D014047 Stiefel Brand of Tolnaftate
% 210.77/210.93 |- mesh__historyNote mesh__D014047 73%28%72%29%
% 210.77/210.93 |- skos__historyNote mesh__D014047 Thiocarbamates %28%1966-1971%29%
% 210.77/210.93 |- skos__altLabel mesh__D014047 Tinaderm
% 210.77/210.93 |- skos__altLabel mesh__D014047 Insight Brand of Tolnaftate
% 210.77/210.93 |- skos__altLabel mesh__D014047 Schering-Plough Brand 1 of Tolnaftate
% 210.77/210.93 |- skos__altLabel mesh__D014047 Carter Wallace Brand of Tolnaftate
% 210.77/210.93 |- skos__altLabel mesh__D014047 Pedinol Brand 2 of Tolnaftate
% 210.77/210.93 |- skos__hiddenLabel mesh__D014047 NP27
% 210.77/210.93 |- skos__altLabel mesh__D014047 Schering Brand of Tolnaftate
% 210.77/210.93 |- skos__altLabel mesh__D014047 Sporiline
% 210.77/210.93 |- mesh__recordMaintainer mesh__D014047 CCR
% 210.77/210.93 |- skos__prefLabel mesh__D014047 Tolnaftate
% 210.77/210.93 |- rdf__type mesh__D014047sskos__Concept
% 210.77/210.93 |- skos__altLabel mesh__D014047 Zenith Brand of Tolnaftate
% 210.77/210.93 |- skos__altLabel mesh__D014047 Wernigerode Brand of Tolnaftate
% 210.77/210.93 |- mesh__dateCreated mesh__D014047 1999-01-01
% 210.77/210.93 |- skos__broader mesh__D014047smesh__D009281
% 210.77/210.93 |- skos__hiddenLabel mesh__D014047 Purder N, Tolnaftat
% 210.77/210.93 |- mesh__dateEstablished mesh__D014047 1973-01-01
% 210.77/210.93 |- skos__historyNote mesh__D014047 Antifungal Agents %28%1966-1971%29%
% 210.77/210.93 |- skos__altLabel mesh__D014047 Schering-Plough Brand 2 of Tolnaftate
% 210.77/210.93 |- skos__altLabel mesh__D014047 Essex Brand of Tolnaftate
% 210.77/210.93 |- skos__altLabel mesh__D014047 Chinosol Brand of Tolnaftate
% 210.77/210.93 |- skos__altLabel mesh__D014047 Bioglan Brand of Tolnaftate
% 210.77/210.93 |- mesh__dateRevised mesh__D014047 2005-06-30
% 210.77/210.93 |- skos__altLabel mesh__D014047 Pedinol Brand 1 of Tolnaftate
% 210.77/210.93 |- skos__hiddenLabel mesh__D014047 Ony Clear
% 210.77/210.93 |- skos__altLabel mesh__D014047 Thompson Brand of Tolnaftate
% 210.77/210.93 |- skos__altLabel mesh__D014047 Isdin Brand of Tolnaftate
% 210.77/210.93 |- mesh__recordOriginator mesh__D014047 NLM
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D014047 sjn
% 210.77/210.93 |- skos__broader mesh__D014047smesh__D013859
% 210.77/210.93 |- skos__hiddenLabel mesh__D014047 NP 27
% 210.77/210.93 |- skos__altLabel mesh__D014047 Douglas Brand of Tolnaftate
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D014047 2006
% 210.77/210.93 |- mesh__dateEstablished mesh__D008808 1974-01-01
% 210.77/210.93 |- skos__prefLabel mesh__D008808 Mice, Inbred CBA
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D008808 2006
% 210.77/210.93 |- mesh__dateCreated mesh__D008808 1999-01-01
% 210.77/210.93 |- skos__historyNote mesh__D008808 Mice %28%1966-1971%29%
% 210.77/210.93 |- skos__annotation mesh__D008808
% 210.77/210.93 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.77/210.93 |- mesh__recordOriginator mesh__D008808 NLM
% 210.77/210.93 |- skos__hiddenLabel mesh__D008808 Inbred CBA Mice
% 210.77/210.93 |- skos__hiddenLabel mesh__D008808 Inbred CBA Mouse
% 210.77/210.93 |- skos__altLabel mesh__D008808 Mice, CBA
% 210.77/210.93 |- mesh__recordMaintainer mesh__D008808 ags
% 210.77/210.93 |- skos__altLabel mesh__D008808 Mouse, CBA
% 210.77/210.93 |- rdf__type mesh__D008808sskos__Concept
% 210.77/210.93 |- mesh__historyNote mesh__D008808 74%28%72%29%
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D008808 sjn
% 210.77/210.93 |- skos__hiddenLabel mesh__D008808 CBA Mice, Inbred
% 210.77/210.93 |- skos__hiddenLabel mesh__D008808 CBA Mouse, Inbred
% 210.77/210.93 |- skos__altLabel mesh__D008808 Mouse, Inbred CBA
% 210.77/210.93 |- skos__broader mesh__D008808smesh__D008815
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D008808 74
% 210.77/210.93 |- skos__hiddenLabel mesh__D008808 CBA Mouse
% 210.77/210.93 |- skos__hiddenLabel mesh__D008808 CBA Mice
% 210.77/210.93 |- mesh__dateRevised mesh__D008808 2005-06-30
% 210.77/210.93 |- skos__hiddenLabel mesh__D000825 Animal Structure
% 210.77/210.93 |- mesh__dateRevised mesh__D000825 2003-07-09
% 210.77/210.93 |- skos__hiddenLabel mesh__D000825 Animal Organ
% 210.77/210.93 |- mesh__historyNote mesh__D000825
% 210.77/210.93 1998 %28%1967%29%; for ANIMAL ORGANS use ANIMALS 1986-2003
% 210.77/210.93 |- mesh__dateEstablished mesh__D000825 1998-01-01
% 210.77/210.93 |- mesh__dateCreated mesh__D000825 1999-01-01
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D000825 2004
% 210.77/210.93 |- rdf__type mesh__D000825sskos__Concept
% 210.77/210.93 |- skos__hiddenLabel mesh__D000825 Structure, Animal
% 210.77/210.93 |- skos__prefLabel mesh__D000825 Animal Structures
% 210.77/210.93 |- mesh__recordOriginator mesh__D000825 NLM
% 210.77/210.93 |- skos__scopeNote mesh__D000825
% 210.77/210.93 Organs and other anatomical structures of non-human vertebrate and invertebrate animals.%A%
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D000825 2006
% 210.77/210.93 |- skos__historyNote mesh__D000825
% 210.77/210.93 Animals/anatomy %26% histology %28%1966-1997%29%
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D000825 sjn
% 210.77/210.93 |- mesh__recordMaintainer mesh__D000825 ags
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D000825 2005
% 210.77/210.93 |- skos__annotation mesh__D000825 avoid: too general; prefer specifics
% 210.77/210.93 |- mesh__runningHead mesh__D000825 A13 - ANATOMY-ANIMAL STRUCTURES
% 210.77/210.93 |- skos__hiddenLabel mesh__D000825 Structures, Animal
% 210.77/210.93 |- skos__hiddenLabel mesh__D000825 Organ, Animal
% 210.77/210.93 |- skos__historyNote mesh__D000825
% 210.77/210.93 specific animal/anatomy %26% histology %28%1966-1997%29%
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D000825
% 210.77/210.93 1998; for ANIMAL ORGANS see ANIMAL 1986-2003
% 210.77/210.93 |- skos__hiddenLabel mesh__D000825 Organs, Animal
% 210.77/210.93 |- rdf__type mesh__D033201sskos__Concept
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D033201
% 210.77/210.93 2003; see CRUSTACEA 1990-2002; for EUPHAUSIA %26% NYCTIPHANES see CRUSTACEA 1986-2002%A%
% 210.77/210.93 |- skos__annotation mesh__D033201
% 210.77/210.93 as animal %26% food; IM; as food, coord IM with SHELLFISH %28%IM%29%%A%
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D033201 2004
% 210.77/210.93 |- mesh__historyNote mesh__D033201
% 210.77/210.93 2003; use CRUSTACEA 1990-2002; for EUPHAUSIA %26% NYCTIPHANES use CRUSTACEA 1986-2002%A%
% 210.77/210.93 |- skos__historyNote mesh__D033201 Plankton %28%1986-1989%29%
% 210.77/210.93 |- skos__altLabel mesh__D033201 Krill
% 210.77/210.93 |- skos__scopeNote mesh__D033201
% 210.77/210.93 An order of pelagic, shrimplike CRUSTACEA. Many consume ZOOPLANKTON and a few are predacious. Many antarctic species, such as Euphuasia superba, constitute the chief food of other animals.%A%
% 210.77/210.93 |- mesh__dateCreated mesh__D033201 2002-07-03
% 210.77/210.93 |- skos__broader mesh__D033201smesh__D003445
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D033201 2005
% 210.77/210.93 |- mesh__dateRevised mesh__D033201 2003-07-09
% 210.77/210.93 |- skos__historyNote mesh__D033201 Zooplankton %28%1983-1985%29%
% 210.77/210.93 |- mesh__dateEstablished mesh__D033201 2003-01-01
% 210.77/210.93 |- skos__historyNote mesh__D033201 Crustacea %28%1970-2002%29%
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D033201 2006
% 210.77/210.93 |- skos__prefLabel mesh__D033201 Euphausiacea
% 210.77/210.93 |- skos__scopeNote mesh__D000027
% 210.77/210.93 Premature loss of PREGNANCY in which not all the products of CONCEPTION have been expelled.%A%
% 210.77/210.93 |- skos__hiddenLabel mesh__D000027 Incomplete Abortion
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D000027 2006
% 210.77/210.93 |- mesh__historyNote mesh__D000027 75
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D000027 sjn
% 210.77/210.93 |- skos__historyNote mesh__D000027 Abortion, Spontaneous %28%1966-1974%29%
% 210.77/210.93 |- rdf__type mesh__D000027sskos__Concept
% 210.77/210.93 |- skos__hiddenLabel mesh__D000027 Abortions, Incomplete
% 210.77/210.93 |- mesh__recordMaintainer mesh__D000027 lkt
% 210.77/210.93 |- skos__annotation mesh__D000027
% 210.77/210.93 restrict to spontaneous, not induced abortions; check the tags FEMALE %26% PREGNANCY%A%
% 210.77/210.93 |- mesh__recordOriginator mesh__D000027 NLM
% 210.77/210.93 |- mesh__dateRevised mesh__D000027 2005-06-30
% 210.77/210.93 |- skos__broader mesh__D000027smesh__D000022
% 210.77/210.93 |- mesh__dateEstablished mesh__D000027 1975-09-01
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D000027 75
% 210.77/210.93 |- mesh__dateCreated mesh__D000027 1974-11-11
% 210.77/210.93 |- skos__hiddenLabel mesh__D000027 Incomplete Abortions
% 210.77/210.93 |- skos__prefLabel mesh__D000027 Abortion, Incomplete
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Habits, Food
% 210.77/210.93 |- skos__annotation mesh__D005510 IM
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Habit, Dietary
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Dietary Modifications
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Modification, Diet
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Habits, Diet
% 210.77/210.93 |- mesh__onlineNote mesh__D005510
% 210.77/210.93 use FOOD HABITS to search DIETARY HABITS 1969-78
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Habits, Dietary
% 210.77/210.93 |- skos__altLabel mesh__D005510 Diet Habits
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D005510 2006
% 210.77/210.93 |- mesh__dateRevised mesh__D005510 2002-07-03
% 210.77/210.93 |- mesh__recordAuthorizer mesh__D005510 sjn
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D005510 2003
% 210.77/210.93 |- mesh__dateCreated mesh__D005510 1999-01-01
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Modification, Dietary
% 210.77/210.93 |- mesh__dateEstablished mesh__D005510 1969-01-01
% 210.77/210.93 |- rdf__type mesh__D005510sskos__Concept
% 210.77/210.93 |- mesh__publicMeSHNote mesh__D005510 69
% 210.77/210.93 |- mesh__activeMeSHYear mesh__D005510 2004
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Diet Habit
% 210.77/210.93 |- mesh__historyNote mesh__D005510
% 210.77/210.93 69; DIETARY HABITS was see under FOOD HABITS 1969-78
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Modifications, Diet
% 210.77/210.93 |- skos__scopeNote mesh__D005510 Acquired or learned food preferences.
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Modifications, Dietary
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Diet Modifications
% 210.77/210.93 |- skos__historyNote mesh__D005510 Food %28%1966-1968%29%
% 210.77/210.93 |- skos__broader mesh__D005510smesh__D005247
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Dietary Habit
% 210.77/210.93 |- skos__prefLabel mesh__D005510 Food Habits
% 210.77/210.93 |- skos__broader mesh__D005510smesh__D006184
% 210.77/210.93 |- skos__altLabel mesh__D005510 Diet Modification
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Food Habit
% 210.77/210.93 |- skos__historyNote mesh__D005510 Nutrition Surveys %28%1966-1968%29%
% 210.77/210.93 |- skos__hiddenLabel mesh__D005510 Habit, Diet
% 210.77/210.93 |- skos__historyNote mesh__D005510 Diet %28%1966-1968%29%
% 210.77/210.93 |- mesh__recordOriginator mesh__D005510 NLM
% 210.77/210.93 |- skos__historyNote mesh__D005510 Ethnology %28%1966-1968%29%
% 210.77/210.94 |- mesh__recordMaintainer mesh__D005510 kle
% 210.77/210.94 |- skos__hiddenLabel mesh__D005510 Habit, Food
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D005510 2005
% 210.77/210.94 |- skos__broader mesh__D046129smesh__D014765
% 210.77/210.94 |- mesh__recordOriginator mesh__D046129 ags
% 210.77/210.94 |- skos__hiddenLabel mesh__D046129 Vaccines, Ebola Virus
% 210.77/210.94 |- mesh__dateCreated mesh__D046129 2004-07-07
% 210.77/210.94 |- mesh__dateEstablished mesh__D046129 2005-01-01
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D046129 2006
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D046129 sjn
% 210.77/210.94 |- skos__prefLabel mesh__D046129 Ebola Vaccines
% 210.77/210.94 |- mesh__historyNote mesh__D046129 2005
% 210.77/210.94 |- skos__hiddenLabel mesh__D046129 Vaccines, Ebola
% 210.77/210.94 |- rdf__type mesh__D046129sskos__Concept
% 210.77/210.94 |- skos__scopeNote mesh__D046129
% 210.77/210.94 Vaccines or candidate vaccines used to prevent EBOLA HEMORRHAGIC FEVER.%A%
% 210.77/210.94 |- mesh__recordMaintainer mesh__D046129 ssb
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D046129 2005
% 210.77/210.94 |- skos__altLabel mesh__D046129 Ebola Virus Vaccines
% 210.77/210.94 |- mesh__dateRevised mesh__D046129 2005-06-30
% 210.77/210.94 |- skos__historyNote mesh__D046129 Viral Vaccines %28%1980-2004%29%
% 210.77/210.94 |- skos__historyNote mesh__D018438 Toes/blood supply %28%1976-1994%29%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 1998
% 210.77/210.94 |- mesh__dateCreated mesh__D018438 1994-01-25
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 2001
% 210.77/210.94 |- skos__scopeNote mesh__D018438
% 210.77/210.94 Atherothrombotic microembolism of the lower extremities due to recurrent cholesterol embolic %27%showers%27% with painful cyanotic discoloration of the toes and embolism to other sites that completely resolve between attacks. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 1999
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 2002
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 1996
% 210.77/210.94 |- skos__annotation mesh__D018438
% 210.77/210.94 caused by recur cholesterol embolism of the toes; do not confuse with black toe disease %28% = AINHUM%29%%A%
% 210.77/210.94 |- skos__broader mesh__D018438smesh__D017700
% 210.77/210.94 |- mesh__historyNote mesh__D018438 95
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 1997
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 2005
% 210.77/210.94 |- mesh__dateEstablished mesh__D018438 1995-01-01
% 210.77/210.94 |- skos__prefLabel mesh__D018438 Blue Toe Syndrome
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D018438 95
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 2006
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 2003
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 2004
% 210.77/210.94 |- skos__historyNote mesh__D018438 Embolism %28%1976-1994%29%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 1995
% 210.77/210.94 |- skos__hiddenLabel mesh__D018438 Syndrome, Blue Toe
% 210.77/210.94 |- rdf__type mesh__D018438sskos__Concept
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D018438 2000
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D010455 2005
% 210.77/210.94 |- mesh__recordOriginator mesh__D010455 NLM
% 210.77/210.94 |- skos__annotation mesh__D010455
% 210.77/210.94 general; prefer specifics; fewer than 13 amino acids = oligopeptides; %22%primary structure%22% = PROTEIN STRUCTURE, PRIMARY see AMINO ACID SEQUENCE; peptide structure other than primary: coordinate IM with PROTEIN CONFORMATION or its specifics%A%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D010455 2006
% 210.77/210.94 |- mesh__recordMaintainer mesh__D010455 nns
% 210.77/210.94 |- skos__related mesh__D010455smesh__D000595
% 210.77/210.94 |- skos__scopeNote mesh__D010455
% 210.77/210.94 Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.%A%
% 210.77/210.94 |- skos__prefLabel mesh__D010455 Peptides
% 210.77/210.94 |- rdf__type mesh__D010455sskos__Concept
% 210.77/210.94 |- mesh__dateRevised mesh__D010455 2004-07-07
% 210.77/210.94 |- mesh__dateCreated mesh__D010455 1999-01-01
% 210.77/210.94 |- skos__broader mesh__D010455smesh__D000602
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D010455 sjn
% 210.77/210.94 |- rdf__type mesh__D004418sskos__Concept
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D004418 2006
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D004418 2000
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D004418 2005
% 210.77/210.94 |- skos__hiddenLabel mesh__D004418 Paroxysmal Dyspneas
% 210.77/210.94 |- skos__broader mesh__D004418smesh__D004417
% 210.77/210.94 |- skos__hiddenLabel mesh__D004418 Nocturnal Dyspneas, Paroxysmal
% 210.77/210.94 |- skos__altLabel mesh__D004418 Asthma, Cardiac
% 210.77/210.94 |- mesh__recordOriginator mesh__D004418 NLM
% 210.77/210.94 |- skos__scopeNote mesh__D004418
% 210.77/210.94 A disorder characterized by episodes of respiratory distress, usually occurring after several hours of sleep in a reclining position. It is most commonly caused by pulmonary edema resulting from congestive heart failure. The episodes may be accompanied by coughing, a feeling of suffocation, a cold sweat, and tachycardia.%A%
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D004418 sjn
% 210.77/210.94 |- skos__hiddenLabel mesh__D004418 Cardiac Asthma
% 210.77/210.94 |- skos__altLabel mesh__D004418 Dyspnea, Paroxysmal Nocturnal
% 210.77/210.94 |- skos__broader mesh__D004418smesh__D006333
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D004418 2002
% 210.77/210.94 |- mesh__dateRevised mesh__D004418 1999-11-04
% 210.77/210.94 |- skos__hiddenLabel mesh__D004418 Nocturnal Dyspnea, Paroxysmal
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D004418 2004
% 210.77/210.94 |- mesh__dateCreated mesh__D004418 1999-01-01
% 210.77/210.94 |- skos__hiddenLabel mesh__D004418 Dyspneas, Paroxysmal
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D004418 2003
% 210.77/210.94 |- mesh__recordMaintainer mesh__D004418 KEV
% 210.77/210.94 |- skos__hiddenLabel mesh__D004418 Paroxysmal Dyspnea
% 210.77/210.94 |- skos__hiddenLabel mesh__D004418 Dyspneas, Paroxysmal Nocturnal
% 210.77/210.94 |- skos__prefLabel mesh__D004418 Dyspnea, Paroxysmal
% 210.77/210.94 |- skos__hiddenLabel mesh__D004418 Paroxysmal Nocturnal Dyspnea
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D004418 2001
% 210.77/210.94 |- skos__hiddenLabel mesh__D004418 Paroxysmal Nocturnal Dyspneas
% 210.77/210.94 |- skos__broader mesh__D015140smesh__D002537
% 210.77/210.94 |- skos__historyNote mesh__D015140
% 210.77/210.94 Cerebrovascular Disorders %28%1966-1988%29%
% 210.77/210.94 |- skos__altLabel mesh__D015140 Binswanger Encephalopathy
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Vascular Dementias, Subcortical
% 210.77/210.94 |- skos__historyNote mesh__D015140
% 210.77/210.94 Cerebral Arteriosclerosis %28%1966-1988%29%
% 210.77/210.94 |- mesh__historyNote mesh__D015140 1989
% 210.77/210.94 |- skos__altLabel mesh__D015140
% 210.77/210.94 Subcortical Encephalopathy, Chronic Progressive
% 210.77/210.94 |- skos__altLabel mesh__D015140
% 210.77/210.94 Arteriosclerotic Encephalopathy, Subcortical
% 210.77/210.94 |- skos__prefLabel mesh__D015140 Dementia, Vascular
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Binswanger%27%s Encephalopathy
% 210.77/210.94 |- mesh__dateRevised mesh__D015140 2004-07-19
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Subcortical Leukoencephalopathies
% 210.77/210.94 |- skos__altLabel mesh__D015140
% 210.77/210.94 Encephalopathy, Subcortical Arteriosclerotic
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140
% 210.77/210.94 Arteriosclerotic Encephalopathies, Subcortical
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Subcortical Vascular Dementias
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Dementias, Arteriosclerotic
% 210.77/210.94 |- skos__altLabel mesh__D015140 Encephalopathy, Binswanger
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Vascular Dementia, Subcortical
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Disease, Binswanger
% 210.77/210.94 |- skos__altLabel mesh__D015140 Encephalopathy, Binswanger%27%s
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140
% 210.77/210.94 Subcortical Arteriosclerotic Encephalopathies
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D015140 2006
% 210.77/210.94 |- skos__altLabel mesh__D015140
% 210.77/210.94 Encephalopathy, Subcortical, Chronic Progressive
% 210.77/210.94 |- skos__altLabel mesh__D015140
% 210.77/210.94 Encephalopathy, Chronic Progressive Subcortical
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Vascular Dementias
% 210.77/210.94 |- mesh__dateCreated mesh__D015140 1988-03-18
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D015140 sjn
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Arteriosclerotic Dementias
% 210.77/210.94 |- mesh__recordMaintainer mesh__D015140 jls
% 210.77/210.94 |- mesh__recordOriginator mesh__D015140 EC
% 210.77/210.94 |- skos__altLabel mesh__D015140 Leukoencephalopathy, Subcortical
% 210.77/210.94 |- skos__altLabel mesh__D015140
% 210.77/210.94 Chronic Progressive Subcortical Encephalopathy
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Dementias, Vascular
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140
% 210.77/210.94 Encephalopathies, Subcortical Arteriosclerotic
% 210.77/210.94 |- skos__broader mesh__D015140smesh__D003704
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D015140 2005
% 210.77/210.94 |- skos__scopeNote mesh__D015140
% 210.77/210.94 An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION %28%single or multiple%29%, and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. %28%From Gerontol Geriatr 1998 Feb;31%28%1%29%:36-44%29%%A%
% 210.77/210.94 |- rdf__type mesh__D015140sskos__Concept
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Dementia, Arteriosclerotic
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D015140 1989
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Dementias, Subcortical Vascular
% 210.77/210.94 |- skos__altLabel mesh__D015140 Acute Onset Vascular Dementia
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Leukoencephalopathies, Subcortical
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Encephalopathy, Binswangers
% 210.77/210.94 |- skos__historyNote mesh__D015140 Dementia %28%1981-1988%29%
% 210.77/210.94 |- skos__hiddenLabel mesh__D015140 Dementia, Subcortical Vascular
% 210.77/210.94 |- skos__altLabel mesh__D015140 Subcortical Leukoencephalopathy
% 210.77/210.94 |- mesh__dateEstablished mesh__D015140 1989-01-01
% 210.77/210.94 |- skos__altLabel mesh__D015140 Vascular Dementia
% 210.77/210.94 |- skos__broader mesh__D015140smesh__D002561
% 210.77/210.94 |- skos__altLabel mesh__D015140 Subcortical Arteriosclerotic Encephalopathy
% 210.77/210.94 |- skos__scopeNote mesh__D009901
% 210.77/210.94 Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.%A%
% 210.77/210.94 |- skos__prefLabel mesh__D009901 Optic Nerve Diseases
% 210.77/210.94 |- skos__altLabel mesh__D009901 Second Cranial Nerve Diseases
% 210.77/210.94 |- mesh__dateCreated mesh__D009901 1975-07-25
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009901 2004
% 210.77/210.94 |- skos__broader mesh__D009901smesh__D003389
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Lesion, Neural-Optical
% 210.77/210.94 |- mesh__recordMaintainer mesh__D009901 KEV
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Neuropathy, Optic
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009901 2000
% 210.77/210.94 |- skos__altLabel mesh__D009901 Optic Neuropathy
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Neural-Optical Lesions
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Optic Nerve Disease
% 210.77/210.94 |- skos__historyNote mesh__D009901 Optic Nerve %28%1966-1975%29%
% 210.77/210.94 |- skos__broader mesh__D009901smesh__D005128
% 210.77/210.94 |- skos__altLabel mesh__D009901 Cranial Nerve II Diseases
% 210.77/210.94 |- mesh__dateRevised mesh__D009901 1999-11-04
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009901 2001
% 210.77/210.94 |- rdf__type mesh__D009901sskos__Concept
% 210.77/210.94 |- skos__altLabel mesh__D009901 Neural-Optical Lesion
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Optic Disk Disorder
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009901 2005
% 210.77/210.94 |- skos__altLabel mesh__D009901 Cranial Nerve II Disorder
% 210.77/210.94 |- mesh__recordOriginator mesh__D009901 SMH
% 210.77/210.94 |- skos__annotation mesh__D009901
% 210.77/210.94 SMON: see note on OPTIC NEURITIS; inflamm dis = OPTIC NEURITIS%A%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009901 2002
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Foster Kennedy Syndrome
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Syndrome, Foster-Kennedy
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009901 2006
% 210.77/210.94 |- mesh__historyNote mesh__D009901 76; was NON MESH before 1976
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D009901 sjn
% 210.77/210.94 |- mesh__dateEstablished mesh__D009901 1976-01-01
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Disk Disorders, Optic
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Neural Optical Lesion
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Disk Disorder, Optic
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Optic Neuropathies
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009901 2003
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D009901 76
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Neuropathies, Optic
% 210.77/210.94 |- skos__hiddenLabel mesh__D009901 Lesions, Neural-Optical
% 210.77/210.94 |- mesh__dateRevised mesh__D009103 2004-07-29
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009103 2004
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009103 2005A
% 210.77/210.94 |- skos__prefLabel mesh__D009103 Multiple Sclerosis
% 210.77/210.94 |- skos__altLabel mesh__D009103 Sclerosis, Disseminated
% 210.77/210.94 |- skos__hiddenLabel mesh__D009103 Disseminated Sclerosis
% 210.77/210.94 |- skos__hiddenLabel mesh__D009103 Sclerosis, Multiple
% 210.77/210.94 |- skos__broader mesh__D009103smesh__D020278
% 210.77/210.94 |- mesh__recordMaintainer mesh__D009103 jls
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009103 2005
% 210.77/210.94 |- mesh__recordOriginator mesh__D009103 NLM
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009103 2006
% 210.77/210.94 |- skos__scopeNote mesh__D009103
% 210.77/210.94 An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery %28%see MULTIPLE SCLEROSIS, RELAPSING-REMITTING%29%, but acute fulminating and chronic progressive forms %28%see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE%29% also occur. %28%Adams et al., Principles of Neurology, 6th ed, p903%29%%A%
% 210.77/210.94 |- skos__related mesh__D009103smesh__D009188
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D009103 jls
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D009103 2003
% 210.77/210.94 |- rdf__type mesh__D009103sskos__Concept
% 210.77/210.94 |- skos__altLabel mesh__D009103 MS %28%Multiple Sclerosis%29%
% 210.77/210.94 |- mesh__dateCreated mesh__D009103 1999-01-01
% 210.77/210.94 |- skos__annotation mesh__D001120 /biosyn /defic /physiol permitted
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D001120 2003
% 210.77/210.94 |- skos__broader mesh__D001120smesh__D024361
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D001120 2005
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D001120 2004
% 210.77/210.94 |- skos__prefLabel mesh__D001120 Arginine
% 210.77/210.94 |- skos__broader mesh__D001120smesh__D000599
% 210.77/210.94 |- skos__hiddenLabel mesh__D001120 Monohydrate DL-Arginine Acetate
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D001120 2006
% 210.77/210.94 |- skos__altLabel mesh__D001120 L-Arginine
% 210.77/210.94 |- skos__broader mesh__D001120smesh__D000601
% 210.77/210.94 |- rdf__type mesh__D001120sskos__Concept
% 210.77/210.94 |- mesh__recordOriginator mesh__D001120 NLM
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D001120 sjn
% 210.77/210.94 |- skos__hiddenLabel mesh__D001120 DL Arginine Acetate, Monohydrate
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D001120 2002
% 210.77/210.94 |- mesh__dateCreated mesh__D001120 1999-01-01
% 210.77/210.94 |- skos__hiddenLabel mesh__D001120 L-Isomer Arginine
% 210.77/210.94 |- mesh__recordMaintainer mesh__D001120 nns
% 210.77/210.94 |- skos__scopeNote mesh__D001120
% 210.77/210.94 An essential amino acid that is physiologically active in the L-form.%A%
% 210.77/210.94 |- skos__hiddenLabel mesh__D001120 Arginine, L Isomer
% 210.77/210.94 |- skos__altLabel mesh__D001120 Arginine, L-Isomer
% 210.77/210.94 |- mesh__dateRevised mesh__D001120 2001-07-25
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D020883 2006
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D020883 2001
% 210.77/210.94 |- skos__scopeNote mesh__D020883
% 210.77/210.94 An incision in the uterus, performed through either the abdomen or the vagina.%A%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D020883 2004
% 210.77/210.94 |- mesh__historyNote mesh__D020883 2000
% 210.77/210.94 |- mesh__dateRevised mesh__D020883 1999-12-28
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D020883 ags
% 210.77/210.94 |- mesh__dateCreated mesh__D020883 1999-11-03
% 210.77/210.94 |- skos__prefLabel mesh__D020883 Hysterotomy
% 210.77/210.94 |- mesh__recordOriginator mesh__D020883 nns
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D020883 2002
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D020883 2000A
% 210.77/210.94 |- mesh__recordMaintainer mesh__D020883 ags
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D020883 2000
% 210.77/210.94 |- skos__hiddenLabel mesh__D020883 Hysterotomies
% 210.77/210.94 |- skos__broader mesh__D020883smesh__D013513
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D020883 2005
% 210.77/210.94 |- skos__historyNote mesh__D020883 Uterus/surgery %28%1966-1999%29%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D020883 2000
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D020883 2003
% 210.77/210.94 |- mesh__dateEstablished mesh__D020883 2000-01-01
% 210.77/210.94 |- rdf__type mesh__D020883sskos__Concept
% 210.77/210.94 |- skos__prefLabel mesh__D020085 Neocallimasticales
% 210.77/210.94 |- mesh__historyNote mesh__D020085 99
% 210.77/210.94 |- skos__scopeNote mesh__D020085
% 210.77/210.94 An order of fungi in the phylum CHYTRIDIOMYCOTA comprising anaerobic chytrids that inhabit the RUMEN; and CECUM of herbivorous animals. Genera %28%all in the lone family Neocallimasticaceae%29% include NEOCALLIMASTIX, Orpinomyces, PIROMYCES, and Caecomyces.%A%
% 210.77/210.94 |- mesh__dateEstablished mesh__D020085 1999-01-01
% 210.77/210.94 |- mesh__recordOriginator mesh__D020085 AGS
% 210.77/210.94 |- mesh__recordMaintainer mesh__D020085 SYSTEM
% 210.77/210.94 |- mesh__dateCreated mesh__D020085 1998-06-10
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D020085 99
% 210.77/210.94 |- skos__broader mesh__D020085smesh__D008411
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D020085 2006
% 210.77/210.94 |- skos__altLabel mesh__D020085 Sphaeromonas
% 210.77/210.94 |- rdf__type mesh__D020085sskos__Concept
% 210.77/210.94 |- mesh__dateRevised mesh__D020085 2005-06-30
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D020085 sjn
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D014846 2006
% 210.77/210.94 |- skos__scopeNote mesh__D014846 Tumors or cancer of the VULVA.
% 210.77/210.94 |- skos__altLabel mesh__D014846 Vulva Cancer
% 210.77/210.94 |- skos__broader mesh__D014846smesh__D014845
% 210.77/210.94 |- skos__broader mesh__D014846smesh__D005833
% 210.77/210.94 |- skos__altLabel mesh__D014846 Cancer of the Vulva
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Neoplasm, Vulvar
% 210.77/210.94 |- mesh__recordMaintainer mesh__D014846 lkt
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Vulvar Cancers
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Cancer, Vulvar
% 210.77/210.94 |- mesh__recordOriginator mesh__D014846 NLM
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D014846 sjn
% 210.77/210.94 |- rdf__type mesh__D014846sskos__Concept
% 210.77/210.94 |- mesh__dateRevised mesh__D014846 2005-06-30
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Vulva Neoplasm
% 210.77/210.94 |- skos__prefLabel mesh__D014846 Vulvar Neoplasms
% 210.77/210.94 |- skos__annotation mesh__D014846
% 210.77/210.94 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Cancer, Vulva
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Vulva Cancers
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Cancers, Vulva
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Cancers, Vulvar
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Vulvar Neoplasm
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Neoplasm, Vulva
% 210.77/210.94 |- skos__hiddenLabel mesh__D014846 Neoplasms, Vulva
% 210.77/210.94 |- skos__altLabel mesh__D014846 Neoplasms, Vulvar
% 210.77/210.94 |- mesh__dateCreated mesh__D014846 1999-01-01
% 210.77/210.94 |- skos__altLabel mesh__D014846 Vulvar Cancer
% 210.77/210.94 |- skos__altLabel mesh__D014846 Vulva Neoplasms
% 210.77/210.94 |- skos__hiddenLabel mesh__D014048 CI52040
% 210.77/210.94 |- mesh__recordOriginator mesh__D014048 NLM
% 210.77/210.94 |- skos__annotation mesh__D014048 D25-26 qualif
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D014048 sjn
% 210.77/210.94 |- rdf__type mesh__D014048sskos__Concept
% 210.77/210.94 |- skos__hiddenLabel mesh__D014048 CI 52040
% 210.77/210.94 |- skos__hiddenLabel mesh__D014048 Blue, Toluidine
% 210.77/210.94 |- skos__hiddenLabel mesh__D014048 Blue O, Toluidine
% 210.77/210.94 |- mesh__dateCreated mesh__D014048 1999-01-01
% 210.77/210.94 |- skos__altLabel mesh__D014048 Toluidine Blue
% 210.77/210.94 |- skos__hiddenLabel mesh__D014048 O, Toluidine Blue
% 210.77/210.94 |- skos__hiddenLabel mesh__D014048 Chloride, Tolonium
% 210.77/210.94 |- skos__altLabel mesh__D014048 Toluidine Blue O
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D014048
% 210.77/210.94 74; was see under HEMOSTATICS 1963-73
% 210.77/210.94 |- mesh__onlineNote mesh__D014048
% 210.77/210.94 use TOLONIUM CHLORIDE to search TOLUIDINE BLUE O 1972-73 %28%as Prov 1972-73%29%; search HEMOSTATICS 1966-71%A%
% 210.77/210.94 |- skos__broader mesh__D014048smesh__D010640
% 210.77/210.94 |- skos__scopeNote mesh__D014048
% 210.77/210.94 A phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk. Tolonium chloride has also been used as a diagnostic aid for oral and gastric neoplasms and in the identification of the parathyroid gland in thyroid surgery.%A%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D014048 2006
% 210.77/210.94 |- skos__prefLabel mesh__D014048 Tolonium Chloride
% 210.77/210.94 |- mesh__dateRevised mesh__D014048 2005-06-30
% 210.77/210.94 |- mesh__historyNote mesh__D014048
% 210.77/210.94 74; was see under HEMOSTATICS 1963-73, was TOLUIDINE BLUE O 1972-73 %28%Prov%29%%A%
% 210.77/210.94 |- mesh__recordMaintainer mesh__D014048 ssb
% 210.77/210.94 |- mesh__recordMaintainer mesh__D008809 ags
% 210.77/210.94 |- skos__hiddenLabel mesh__D008809 C3H Mice
% 210.77/210.94 |- skos__broader mesh__D008809smesh__D008815
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D008809 74
% 210.77/210.94 |- mesh__dateEstablished mesh__D008809 1974-01-01
% 210.77/210.94 |- skos__annotation mesh__D008809
% 210.77/210.94 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.77/210.94 |- skos__historyNote mesh__D008809 Mice %28%1966-1971%29%
% 210.77/210.94 |- skos__altLabel mesh__D008809 Mouse, Inbred C3H
% 210.77/210.94 |- mesh__dateRevised mesh__D008809 2005-06-30
% 210.77/210.94 |- skos__altLabel mesh__D008809 Mouse, C3H
% 210.77/210.94 |- skos__hiddenLabel mesh__D008809 Inbred C3H Mice
% 210.77/210.94 |- skos__hiddenLabel mesh__D008809 C3H Mouse
% 210.77/210.94 |- skos__hiddenLabel mesh__D008809 C3H Mice, Inbred
% 210.77/210.94 |- skos__prefLabel mesh__D008809 Mice, Inbred C3H
% 210.77/210.94 |- skos__altLabel mesh__D008809 Mice, C3H
% 210.77/210.94 |- mesh__recordOriginator mesh__D008809 NLM
% 210.77/210.94 |- skos__hiddenLabel mesh__D008809 Inbred C3H Mouse
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D008809 2006
% 210.77/210.94 |- mesh__dateCreated mesh__D008809 1999-01-01
% 210.77/210.94 |- mesh__historyNote mesh__D008809 74%28%72%29%
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D008809 sjn
% 210.77/210.94 |- rdf__type mesh__D008809sskos__Concept
% 210.77/210.94 |- skos__hiddenLabel mesh__D008809 C3H Mouse, Inbred
% 210.77/210.94 |- skos__annotation mesh__D000826 SPEC qualif
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D000826 85
% 210.77/210.94 |- skos__hiddenLabel mesh__D000826 Alternative, Animal Testing
% 210.77/210.94 |- mesh__dateRevised mesh__D000826 2005-08-02
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D000826 2004
% 210.77/210.94 |- skos__altLabel mesh__D000826 Alternatives to Animal Testing
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D000826 ags
% 210.77/210.94 |- rdf__type mesh__D000826sskos__Concept
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D000826 2006A
% 210.77/210.94 |- skos__prefLabel mesh__D000826 Animal Testing Alternatives
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D000826 2006
% 210.77/210.94 |- skos__hiddenLabel mesh__D000826 Animal Testing Alternative
% 210.77/210.94 |- mesh__dateEstablished mesh__D000826 1985-01-01
% 210.77/210.94 |- mesh__dateCreated mesh__D000826 1984-06-11
% 210.77/210.94 |- mesh__historyNote mesh__D000826 85
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D000826 2003
% 210.77/210.94 |- skos__hiddenLabel mesh__D000826 Testing Alternative, Animal
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D000826 2005
% 210.77/210.94 |- skos__hiddenLabel mesh__D000826 Testing Alternatives, Animal
% 210.77/210.94 |- skos__broader mesh__D000826smesh__D023401
% 210.77/210.94 |- mesh__recordMaintainer mesh__D000826 ags
% 210.77/210.94 |- mesh__recordOriginator mesh__D000826 CAB
% 210.77/210.94 |- skos__scopeNote mesh__D000826
% 210.77/210.94 Procedures, such as TISSUE CULTURE TECHNIQUES; mathematical models; etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories.%A%
% 210.77/210.94 |- skos__hiddenLabel mesh__D000826 Alternatives, Animal Testing
% 210.77/210.94 |- mesh__recordMaintainer mesh__D019531 jls
% 210.77/210.94 |- rdf__type mesh__D019531sskos__Concept
% 210.77/210.94 |- mesh__dateCreated mesh__D019531 1996-06-21
% 210.77/210.94 |- mesh__recordOriginator mesh__D019531 TGC
% 210.77/210.94 |- skos__altLabel mesh__D019531 Lectures %28%PT%29%
% 210.77/210.94 |- mesh__dateRevised mesh__D019531 2005-06-30
% 210.77/210.94 |- skos__prefLabel mesh__D019531 Lectures %5B%Publication Type%5D%
% 210.77/210.94 |- skos__broader mesh__D019531smesh__D019484
% 210.77/210.94 |- skos__altLabel mesh__D019531 Lectures
% 210.77/210.94 |- mesh__historyNote mesh__D019531 1997
% 210.77/210.94 |- skos__scopeNote mesh__D019531
% 210.77/210.94 Works consisting of speeches read or delivered before an audience or class, especially for instruction or to set forth some subject. They are differentiated from ADDRESSES %5B%PUBLICATION TYPE%5D% which are less didactic and more informational, entertaining, inspirational, or polemic. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%
% 210.77/210.94 |- mesh__dateEstablished mesh__D019531 1997-01-01
% 210.77/210.94 |- mesh__recordAuthorizer mesh__D019531 sjn
% 210.77/210.94 |- skos__annotation mesh__D019531
% 210.77/210.94 publication type only; usually for instruction; do not confuse with the publication type ADDRESSES; CATALOG: publication type LECTURE NOTES is also available%A%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D019531 2006
% 210.77/210.94 |- skos__historyNote mesh__D033202 Crustacea %28%1968-2002%29%
% 210.77/210.94 |- skos__altLabel mesh__D033202 Fairy Shrimp
% 210.77/210.94 |- skos__prefLabel mesh__D033202 Anostraca
% 210.77/210.94 |- skos__annotation mesh__D033202
% 210.77/210.94 note X ref FAIRY SHRIMP: several other shrimp terms are available; check text and MeSH; as animal %26% food; as food, coord IM with SHELLFISH %28%IM%29%; unspecified shrimp as food is probably PENAEIDAE%A%
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D033202 2004
% 210.77/210.94 |- mesh__historyNote mesh__D033202 2003
% 210.77/210.94 |- mesh__publicMeSHNote mesh__D033202 2003
% 210.77/210.94 |- skos__broader mesh__D033202smesh__D003445
% 210.77/210.94 |- mesh__dateCreated mesh__D033202 2002-07-02
% 210.77/210.94 |- skos__altLabel mesh__D033202 Shrimp, Fairy
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D033202 2005
% 210.77/210.94 |- mesh__dateRevised mesh__D033202 2003-07-09
% 210.77/210.94 |- mesh__dateEstablished mesh__D033202 2003-01-01
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D033202 2006
% 210.77/210.94 |- rdf__type mesh__D033202sskos__Concept
% 210.77/210.94 |- skos__scopeNote mesh__D033202
% 210.77/210.94 An order of CRUSTACEA comprised of shrimp-like organisms containing body trunks with at least 20 segments. The are commonly used as aquarium food.%A%
% 210.77/210.94 |- skos__hiddenLabel mesh__D000028 Abortions, Previous
% 210.77/210.94 |- mesh__dateCreated mesh__D000028 1999-01-01
% 210.77/210.94 |- skos__hiddenLabel mesh__D000028 Abortions, Drug-Induced
% 210.77/210.94 |- skos__annotation mesh__D000028
% 210.77/210.94 do not use /util except by MeSH definition; for use of an abortifacient here or in ABORTION, CRIMINAL, coord IM with abortifacient agent %28%IM with no qualif, not /adv eff unless text specifically discusses adverse eff%29%; don%27%t forget also check tags FEMALE %26% PREGNANCY%A%
% 210.77/210.94 |- skos__hiddenLabel mesh__D000028 Anti-Abortion Group
% 210.77/210.94 |- skos__hiddenLabel mesh__D000028 Embryotomies
% 210.77/210.94 |- mesh__activeMeSHYear mesh__D000028 2005
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Soap-Solution Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Histories, Abortion
% 210.77/210.95 |- mesh__dateEstablished mesh__D000028 1971-01-01
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Rivanol Abortion
% 210.77/210.95 |- skos__altLabel mesh__D000028 Abortion %28%Induced%29%
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Postconception Fertility Control
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D000028 2004
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortion Rates
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortions %28%Induced%29%
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Anti Abortion Groups
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortion, Drug Induced
% 210.77/210.95 |- mesh__dateRevised mesh__D000028 2002-07-02
% 210.77/210.95 |- mesh__recordOriginator mesh__D000028 NLM
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Failures, Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Induced Abortions
% 210.77/210.95 |- skos__related mesh__D000028smesh__D037881
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortion, Previous
% 210.77/210.95 |- skos__altLabel mesh__D000028 Induced Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Rate, Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortion, Soap Solution
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Previous Abortions
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortions, Rivanol
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Drug-Induced Abortion
% 210.77/210.95 |- skos__altLabel mesh__D000028 Abortion History
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Technic, Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Saline-Solution Abortions
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortion Technic
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D000028 2003
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortion Failures
% 210.77/210.95 |- rdf__type mesh__D000028sskos__Concept
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Techniques, Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Group, Anti-Abortion
% 210.77/210.95 |- skos__scopeNote mesh__D000028
% 210.77/210.95 Intentional removal of a fetus from the uterus by any of a number of techniques. %28%POPLINE, 1978%29%%A%
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortions, Induced
% 210.77/210.95 |- mesh__onlineNote mesh__D000028
% 210.77/210.95 use ABORTION, INDUCED to search EMBRYOTOMY 1966-85; search ABORTION, CRIMINAL %26% ABORTION, LEGAL %26% ABORTION, THERAPEUTIC 1966-70%A%
% 210.77/210.95 |- mesh__historyNote mesh__D000028
% 210.77/210.95 71; was see under ABORTION, CRIMINAL %26% ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85%A%
% 210.77/210.95 |- skos__historyNote mesh__D000028 Abortion, Therapeutic %28%1966-1970%29%
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortions, Saline-Solution
% 210.77/210.95 |- skos__historyNote mesh__D000028 Abortion, Legal %28%1966-1970%29%
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortion Histories
% 210.77/210.95 |- skos__altLabel mesh__D000028 Abortion Technics
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortion, Saline Solution
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Saline-Solution Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortion Technique
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Technics, Abortion
% 210.77/210.95 |- skos__historyNote mesh__D000028 Abortion, Criminal %28%1966-1970%29%
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Failure, Abortion
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D000028 sjn
% 210.77/210.95 |- mesh__recordMaintainer mesh__D000028 hjn
% 210.77/210.95 |- skos__prefLabel mesh__D000028 Abortion, Induced
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Technique, Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Groups, Anti-Abortion
% 210.77/210.95 |- skos__broader mesh__D000028smesh__D013513
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Abortions, Soap-Solution
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Drug-Induced Abortions
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D000028 2006
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Rivanol Abortions
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D000028
% 210.77/210.95 71; was see under ABORTION, CRIMINAL %26% ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85%A%
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 History, Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Rates, Abortion
% 210.77/210.95 |- skos__hiddenLabel mesh__D000028 Soap-Solution Abortions
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D005511 2004
% 210.77/210.95 |- skos__related mesh__D005511smesh__D015416
% 210.77/210.95 |- skos__hiddenLabel mesh__D005511 Handling, Food
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D005511 2002
% 210.77/210.95 |- mesh__recordMaintainer mesh__D005511 JLS
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D005511 2006
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D005511 1998
% 210.77/210.95 |- mesh__dateRevised mesh__D005511 1997-06-20
% 210.77/210.95 |- skos__broader mesh__D005511smesh__D019649
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D005511 1999
% 210.77/210.95 |- skos__prefLabel mesh__D005511 Food Handling
% 210.77/210.95 |- skos__scopeNote mesh__D005511
% 210.77/210.95 Any aspect of the operations in the preparation, transport, storage, packaging, wrapping, exposure for sale, service, or delivery of food.%A%
% 210.77/210.95 |- mesh__recordOriginator mesh__D005511 NLM
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D005511 2000
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D005511 SJN
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D005511 2001
% 210.77/210.95 |- skos__hiddenLabel mesh__D005511 Processing, Food
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D005511 2003
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D005511 2005
% 210.77/210.95 |- rdf__type mesh__D005511sskos__Concept
% 210.77/210.95 |- mesh__dateCreated mesh__D005511 1999-01-01
% 210.77/210.95 |- skos__annotation mesh__D005511
% 210.77/210.95 includes prep, processing, handling, transport, serving, delivering, etc.%A%
% 210.77/210.95 |- skos__altLabel mesh__D046928 Peptidoglycan TGase
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D046928
% 210.77/210.95 2005; PEPTIDOGLYCAN GLYCOSYLTRANSFERASE was indexed under HEXOSYLTRANSFERASES 1981-2004%A%
% 210.77/210.95 |- mesh__dateCreated mesh__D046928 2004-07-07
% 210.77/210.95 |- skos__prefLabel mesh__D046928 Peptidoglycan Glycosyltransferase
% 210.77/210.95 |- skos__hiddenLabel mesh__D046928 Transglycosylase, Peptidoglycan
% 210.77/210.95 |- skos__hiddenLabel mesh__D046928 Glycosyltransferase, Peptidoglycan
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D046928 2005
% 210.77/210.95 |- skos__altLabel mesh__D046928 Peptidoglycan Transglycosylase
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D046928 2006
% 210.77/210.95 |- rdf__type mesh__D046928sskos__Concept
% 210.77/210.95 |- skos__scopeNote mesh__D046928
% 210.77/210.95 A hexosyltransferase involved in the transfer of disaccharide molecules to the peptidoglycan structure of the CELL WALL SKELETON. It plays an important role in the genesis of the bacterial CELL WALL.%A%
% 210.77/210.95 |- mesh__recordMaintainer mesh__D046928 jmp
% 210.77/210.95 |- mesh__recordOriginator mesh__D046928 jmp
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D046928 sjn
% 210.77/210.95 |- mesh__dateEstablished mesh__D046928 2005-01-01
% 210.77/210.95 |- skos__historyNote mesh__D046928 Hexosyltransferases %28%1981-2004%29%
% 210.77/210.95 |- skos__broader mesh__D046928smesh__D006602
% 210.77/210.95 |- mesh__historyNote mesh__D046928
% 210.77/210.95 2005; use PEPTIDOGLYCAN GLYCOSYLTRANSFERASE %28%NM%29% 1981-2004%A%
% 210.77/210.95 |- skos__broader mesh__D014867Q000382smesh__D014867
% 210.77/210.95 |- mesh__preferredCombination mesh__D014867Q000382smesh__D014871
% 210.77/210.95 |- rdf__type mesh__D014867Q000382smesh__CompoundConcept
% 210.77/210.95 |- skos__broader mesh__D010456smesh__D010455
% 210.77/210.95 |- skos__historyNote mesh__D010456 Peptides %28%1966-1970%29%
% 210.77/210.95 |- rdf__type mesh__D010456sskos__Concept
% 210.77/210.95 |- mesh__recordMaintainer mesh__D010456 ssb
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D010456 sjn
% 210.77/210.95 |- mesh__dateRevised mesh__D010456 2004-07-07
% 210.77/210.95 |- mesh__recordOriginator mesh__D010456 NLM
% 210.77/210.95 |- mesh__dateCreated mesh__D010456 1999-01-01
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D010456 73
% 210.77/210.95 |- skos__prefLabel mesh__D010456 Peptides, Cyclic
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D010456 2005
% 210.77/210.95 |- mesh__historyNote mesh__D010456 73%28%71%29%
% 210.77/210.95 |- mesh__dateEstablished mesh__D010456 1973-01-01
% 210.77/210.95 |- skos__broader mesh__D010456smesh__D047028
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D010456 2006
% 210.77/210.95 |- skos__hiddenLabel mesh__D010456 Cyclic Peptides
% 210.77/210.95 |- skos__hiddenLabel mesh__D029161 Oleaviruses
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D029161 2003
% 210.77/210.95 |- mesh__dateEstablished mesh__D029161 2002-01-01
% 210.77/210.95 |- skos__historyNote mesh__D029161 Bromoviridae %28%1997-2001%29%
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D029161 2002
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D029161 2006
% 210.77/210.95 |- skos__broader mesh__D029161smesh__D019177
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D029161 2002
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D029161 2005
% 210.77/210.95 |- skos__prefLabel mesh__D029161 Oleavirus
% 210.77/210.95 |- skos__annotation mesh__D029161 coord IM with speciic plant /virol
% 210.77/210.95 |- mesh__historyNote mesh__D029161 2002
% 210.77/210.95 |- skos__scopeNote mesh__D029161
% 210.77/210.95 A genus in the family BROMOVIRIDAE containing one species: Olive latent virus 2.%A%
% 210.77/210.95 |- rdf__type mesh__D029161sskos__Concept
% 210.77/210.95 |- mesh__dateCreated mesh__D029161 2001-07-25
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D029161 2004
% 210.77/210.95 |- mesh__dateCreated mesh__D004419 1999-01-01
% 210.77/210.95 |- mesh__recordMaintainer mesh__D004419 jmp
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D004419 2003
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D004419 2002
% 210.77/210.95 |- skos__scopeNote mesh__D004419
% 210.77/210.95 Dysprosium. An element of the rare earth family that has the atomic symbol Dy, atomic number 66, and atomic weight 162.50. Dysprosium is a silvery metal used primarily in the form of various salts.%A%
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D004419 2004
% 210.77/210.95 |- mesh__dateRevised mesh__D004419 2001-07-25
% 210.77/210.95 |- skos__prefLabel mesh__D004419 Dysprosium
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D004419 sjn
% 210.77/210.95 |- skos__broader mesh__D004419smesh__D028581
% 210.77/210.95 |- skos__annotation mesh__D004419
% 210.77/210.95 a rare earth metal; Dy-164; Dy-156, 158, 160-163 = DYSPROSIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Dy-149-155, 157, 159, 165-167 = DYSPROSIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 210.77/210.95 |- mesh__recordOriginator mesh__D004419 NLM
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D004419 2005
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D004419 2006
% 210.77/210.95 |- rdf__type mesh__D004419sskos__Concept
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D015141 2005
% 210.77/210.95 |- mesh__recordMaintainer mesh__D015141 PXP
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D015141 1998
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D015141 2006
% 210.77/210.95 |- mesh__recordOriginator mesh__D015141 EC
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D015141 1999
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D015141 2002
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D015141 SJN
% 210.77/210.95 |- skos__broader mesh__D015141smesh__D002947
% 210.77/210.95 |- skos__broader mesh__D015141smesh__D002140
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D015141 2003
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D015141 2004
% 210.77/210.95 |- mesh__dateRevised mesh__D015141 1997-06-20
% 210.77/210.95 |- mesh__historyNote mesh__D015141 89
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D015141 2000
% 210.77/210.95 |- rdf__type mesh__D015141sskos__Concept
% 210.77/210.95 |- skos__prefLabel mesh__D015141 Los Angeles
% 210.77/210.95 |- mesh__dateEstablished mesh__D015141 1989-01-01
% 210.77/210.95 |- mesh__dateCreated mesh__D015141 1988-03-18
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D015141 2001
% 210.77/210.95 |- skos__broader mesh__D009902smesh__D009901
% 210.77/210.95 |- rdf__type mesh__D009902sskos__Concept
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Anterior Optic Neuritides
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009902 2000
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Neuritis, Optic
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Posterior Optic Neuritides
% 210.77/210.95 |- skos__annotation mesh__D009902
% 210.77/210.95 SMON %28%Subacute Myelo-Optico-Neuropathy%29% is indexed here + MYELITIS + SYNDROME%A%
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Neuritis, Posterior Optic
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Optic Neuritides, Anterior
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Optic Neuritides, Posterior
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Neuritides, Optic
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D009902 sjn
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Retrobulbar Neuritides
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009902 2004
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009902 2002
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Neuritis, Anterior Optic
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009902 2006
% 210.77/210.95 |- skos__related mesh__D009902smesh__D009443
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Neuritides, Posterior Optic
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Optic Neuritis, Anterior
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Neuropapillitides
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Neuritides, Anterior Optic
% 210.77/210.95 |- skos__altLabel mesh__D009902 Posterior Optic Neuritis
% 210.77/210.95 |- mesh__recordOriginator mesh__D009902 NLM
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009902 2003
% 210.77/210.95 |- mesh__recordMaintainer mesh__D009902 KEV
% 210.77/210.95 |- skos__prefLabel mesh__D009902 Optic Neuritis
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009902 2001
% 210.77/210.95 |- mesh__dateCreated mesh__D009902 1999-01-01
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Optic Neuritis, Posterior
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009902 2005
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Neuritides, Retrobulbar
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Neuritis, Retrobulbar
% 210.77/210.95 |- skos__altLabel mesh__D009902 Anterior Optic Neuritis
% 210.77/210.95 |- mesh__dateRevised mesh__D009902 1999-11-03
% 210.77/210.95 |- skos__scopeNote mesh__D009902
% 210.77/210.95 Inflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect %28%Marcus-Gunn pupil%29%, and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe %28%neuropapillitis or anterior optic neuritis%29% or the portion behind the globe %28%retrobulbar neuritis or posterior optic neuritis%29%.%A%
% 210.77/210.95 |- skos__hiddenLabel mesh__D009902 Optic Neuritides
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 2004
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 1995
% 210.77/210.95 |- mesh__recordOriginator mesh__D009104 EC
% 210.77/210.95 |- mesh__dateEstablished mesh__D009104 1988-01-01
% 210.77/210.95 |- skos__hiddenLabel mesh__D009104 Injury, Multiple
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D009104 PLS
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 1993
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D009104 88
% 210.77/210.95 |- skos__hiddenLabel mesh__D009104 Multiple Wound
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 2003
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 1999
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 1994
% 210.77/210.95 |- mesh__recordMaintainer mesh__D009104 TGC
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 1992
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 2002
% 210.77/210.95 |- skos__broader mesh__D009104smesh__D014947
% 210.77/210.95 |- skos__altLabel mesh__D009104 Multiple Injuries
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 1998
% 210.77/210.95 |- skos__prefLabel mesh__D009104 Multiple Trauma
% 210.77/210.95 |- rdf__type mesh__D009104sskos__Concept
% 210.77/210.95 |- mesh__dateRevised mesh__D009104 1991-06-18
% 210.77/210.95 |- skos__annotation mesh__D009104
% 210.77/210.95 coord IM with specific inj term or organ/inj IM or NIM if pertinent%A%
% 210.77/210.95 |- skos__altLabel mesh__D009104 Injuries, Multiple
% 210.77/210.95 |- skos__hiddenLabel mesh__D009104 Wound, Multiple
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 2006
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 2001
% 210.77/210.95 |- skos__scopeNote mesh__D009104
% 210.77/210.95 Physical insults or injuries occurring simultaneously in several parts of the body.%A%
% 210.77/210.95 |- skos__historyNote mesh__D009104 Wounds and Injuries %28%1966-1987%29%
% 210.77/210.95 |- skos__hiddenLabel mesh__D009104 Traumas, Multiple
% 210.77/210.95 |- skos__altLabel mesh__D009104 Wounds, Multiple
% 210.77/210.95 |- skos__hiddenLabel mesh__D009104 Multiple Traumas
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 1997
% 210.77/210.95 |- skos__hiddenLabel mesh__D009104 Multiple Wounds
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 2005
% 210.77/210.95 |- skos__hiddenLabel mesh__D009104 Multiple Injury
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 2000
% 210.77/210.95 |- skos__altLabel mesh__D009104 Trauma, Multiple
% 210.77/210.95 |- mesh__historyNote mesh__D009104 88
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D009104 1996
% 210.77/210.95 |- mesh__dateCreated mesh__D009104 1987-04-30
% 210.77/210.95 |- skos__altLabel mesh__D001121 Kininase I
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D001121 sjn
% 210.77/210.95 |- rdf__type mesh__D001121sskos__Concept
% 210.77/210.95 |- skos__prefLabel mesh__D001121 Lysine Carboxypeptidase
% 210.77/210.95 |- skos__broader mesh__D001121smesh__D045727
% 210.77/210.95 |- skos__hiddenLabel mesh__D001121 Carboxypeptidase, Lysine
% 210.77/210.95 |- skos__historyNote mesh__D001121 Arginine %28%1972-1974%29%
% 210.77/210.95 |- skos__hiddenLabel mesh__D001121 Inactivator, Anaphylatoxin
% 210.77/210.95 |- skos__broader mesh__D001121smesh__D002268
% 210.77/210.95 |- mesh__dateRevised mesh__D001121 2003-07-09
% 210.77/210.95 |- skos__scopeNote mesh__D001121
% 210.77/210.95 A metallocarboxypeptidase that removes C-terminal basic amino acid from peptides and proteins, with preference shown for lysine over arginine. It is a plasma zinc enzyme that inactivates bradykinin and anaphylatoxins.%A%
% 210.77/210.95 |- mesh__dateEstablished mesh__D001121 1991-01-01
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D001121
% 210.77/210.95 1997; see ARGININE CARBOXYPEPTIDASE 1991-1996, see CARBOXYPEPTIDASES 1975-1990; for KININASE I see CARBOXYPEPTIDASES 1975-1981%A%
% 210.77/210.95 |- skos__altLabel mesh__D001121 Carboxypeptidase N
% 210.77/210.95 |- skos__historyNote mesh__D001121 Peptides %28%1972-1974%29%
% 210.77/210.95 |- skos__altLabel mesh__D001121 Anaphylatoxin Inactivator
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D001121 2005
% 210.77/210.95 |- mesh__historyNote mesh__D001121 1997 %28%1975%29%
% 210.77/210.95 |- skos__historyNote mesh__D001121 Carboxypeptidases %28%1972-1974%29%
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D001121 2004
% 210.77/210.95 |- mesh__recordMaintainer mesh__D001121 jmp
% 210.77/210.95 |- skos__altLabel mesh__D001121 Bradykininase
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D001121 2006
% 210.77/210.95 |- mesh__dateCreated mesh__D001121 1974-11-19
% 210.77/210.95 |- mesh__recordOriginator mesh__D001121 NLM
% 210.77/210.95 |- skos__hiddenLabel mesh__D020884 Vaginotomies
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D020884 2000
% 210.77/210.95 |- skos__altLabel mesh__D020884 Vaginotomy
% 210.77/210.95 |- skos__scopeNote mesh__D020884 An incision in the vagina.
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D020884 2001
% 210.77/210.95 |- skos__hiddenLabel mesh__D020884 Colpotomies
% 210.77/210.95 |- skos__historyNote mesh__D020884 Vagina/surgery %28%1978-1999%29%
% 210.77/210.95 |- skos__broader mesh__D020884smesh__D013509
% 210.77/210.95 |- mesh__dateCreated mesh__D020884 1999-11-03
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D020884 2002
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D020884 2005
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D020884 2000
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D020884 2003
% 210.77/210.95 |- mesh__dateEstablished mesh__D020884 2000-01-01
% 210.77/210.95 |- rdf__type mesh__D020884sskos__Concept
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D020884 2006
% 210.77/210.95 |- skos__prefLabel mesh__D020884 Colpotomy
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D020884 2004
% 210.77/210.95 |- mesh__historyNote mesh__D020884 2000
% 210.77/210.95 |- skos__broader mesh__D020884smesh__D013513
% 210.77/210.95 |- mesh__dateRevised mesh__D020086 2005-06-30
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D020086 99
% 210.77/210.95 |- skos__scopeNote mesh__D020086
% 210.77/210.95 Highly repeated sequences, 100-300 bases long, which contain RNA polymerase III promoters. The primate Alu %28%ALU ELEMENTS%29% and the rodent B1 SINEs are derived from 7SL RNA, the RNA component of the signal recognition particle. Most other SINEs are derived from tRNAs including the MIRs %28%mammalian-wide interspersed repeats%29%.%A%
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D020086 sjn
% 210.77/210.95 |- skos__broader mesh__D020086smesh__D018626
% 210.77/210.95 |- skos__prefLabel mesh__D020086 Short Interspersed Nucleotide Elements
% 210.77/210.95 |- mesh__dateCreated mesh__D020086 1998-06-11
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D020086 2006
% 210.77/210.95 |- rdf__type mesh__D020086sskos__Concept
% 210.77/210.95 |- mesh__historyNote mesh__D020086 99
% 210.77/210.95 |- skos__altLabel mesh__D020086 SINEs
% 210.77/210.95 |- mesh__dateEstablished mesh__D020086 1999-01-01
% 210.77/210.95 |- skos__altLabel mesh__D020086 Short Interspersed DNA Sequence Elements
% 210.77/210.95 |- mesh__recordMaintainer mesh__D020086 nns
% 210.77/210.95 |- mesh__recordOriginator mesh__D020086 NNS
% 210.77/210.95 |- skos__historyNote mesh__D020086
% 210.77/210.95 Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.77/210.95 |- skos__hiddenLabel mesh__D014847 Vulvitides
% 210.77/210.95 |- rdf__type mesh__D014847sskos__Concept
% 210.77/210.95 |- skos__broader mesh__D014847smesh__D014845
% 210.77/210.95 |- skos__prefLabel mesh__D014847 Vulvitis
% 210.77/210.95 |- mesh__recordMaintainer mesh__D014847 lkt
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D014847 sjn
% 210.77/210.95 |- mesh__dateRevised mesh__D014847 2005-06-30
% 210.77/210.95 |- mesh__recordOriginator mesh__D014847 NLM
% 210.77/210.95 |- mesh__dateCreated mesh__D014847 1999-01-01
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D014847 2006
% 210.77/210.95 |- skos__scopeNote mesh__D014847
% 210.77/210.95 Inflammation of the VULVA. It is characterized by PRURITUS and painful urination.%A%
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D014049 2006
% 210.77/210.95 |- skos__historyNote mesh__D014049 Piperidines %28%1966-1978%29%
% 210.77/210.95 |- mesh__historyNote mesh__D014049
% 210.77/210.95 91%28%79%29%; was see under PROPIOPHENONES 1979-90
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D014049
% 210.77/210.95 91; was see under PROPIOPHENONES 1979-90
% 210.77/210.95 |- mesh__dateRevised mesh__D014049 2005-06-30
% 210.77/210.95 |- mesh__dateCreated mesh__D014049 1978-03-20
% 210.77/210.95 |- skos__altLabel mesh__D014049
% 210.77/210.95 Strathmann Brand of Tolperisone Hydrochloride
% 210.77/210.95 |- skos__hiddenLabel mesh__D014049 Hydrochloride, Tolperisone
% 210.77/210.95 |- skos__historyNote mesh__D014049 Propiophenones %28%1966-1978%29%
% 210.77/210.95 |- skos__altLabel mesh__D014049 Midocalm
% 210.77/210.95 |- rdf__type mesh__D014049sskos__Concept
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D014049 sjn
% 210.77/210.95 |- mesh__recordOriginator mesh__D014049 SH
% 210.77/210.95 |- mesh__recordMaintainer mesh__D014049 CCR
% 210.77/210.95 |- mesh__dateEstablished mesh__D014049 1991-01-01
% 210.77/210.95 |- skos__broader mesh__D014049smesh__D011427
% 210.77/210.95 |- skos__scopeNote mesh__D014049
% 210.77/210.95 A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1211%29%%A%
% 210.77/210.95 |- skos__prefLabel mesh__D014049 Tolperisone
% 210.77/210.95 |- skos__broader mesh__D014049smesh__D011725
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D000827 2005
% 210.77/210.95 |- mesh__historyNote mesh__D000827 1986
% 210.77/210.95 |- skos__broader mesh__D000827smesh__D012926
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D000827 2004
% 210.77/210.95 |- skos__related mesh__D000827smesh__D023401
% 210.77/210.95 |- rdf__type mesh__D000827sskos__Concept
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D000827 2006
% 210.77/210.95 |- mesh__dateRevised mesh__D000827 2003-07-24
% 210.77/210.95 |- mesh__dateCreated mesh__D000827 1985-02-25
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D000827 sjn
% 210.77/210.95 |- mesh__recordOriginator mesh__D000827 EC
% 210.77/210.95 |- skos__scopeNote mesh__D000827
% 210.77/210.95 The protection of animals in laboratories or other specific environments by promoting their health through better nutrition, housing, and care.%A%
% 210.77/210.95 |- skos__hiddenLabel mesh__D000827 Welfare, Animal
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D000827 1986
% 210.77/210.95 |- mesh__dateEstablished mesh__D000827 1986-01-01
% 210.77/210.95 |- skos__prefLabel mesh__D000827 Animal Welfare
% 210.77/210.95 |- mesh__recordMaintainer mesh__D000827 sjn
% 210.77/210.95 |- skos__hiddenLabel mesh__D000827 Cruelty, Animal
% 210.77/210.95 |- skos__related mesh__D000827smesh__D037901
% 210.77/210.95 |- skos__scopeNote mesh__D019532
% 210.77/210.95 Works consisting of representations, normally to scale and on a flat medium, of a selection of material or abstract features on the surface of the earth. They may be used also in delineating the heavens and celestial bodies. %28%From Anglo-American Cataloguing Rules, 2d ed, p619%29%%A%
% 210.77/210.95 |- skos__broader mesh__D019532smesh__D019489
% 210.77/210.95 |- skos__annotation mesh__D019532
% 210.77/210.95 publication type only; Use for geographic atlases. Do not also use the publication type ATLASES; maps as a subject are indexed under the main heading MAPS%A%
% 210.77/210.95 |- skos__altLabel mesh__D019532 Maps %28%PT%29%
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D019532 sjn
% 210.77/210.95 |- mesh__recordMaintainer mesh__D019532 jls
% 210.77/210.95 |- skos__broader mesh__D019532smesh__D020495
% 210.77/210.95 |- mesh__dateCreated mesh__D019532 1996-06-21
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D019532 2006
% 210.77/210.95 |- mesh__recordOriginator mesh__D019532 TGC
% 210.77/210.95 |- mesh__dateRevised mesh__D019532 2005-06-30
% 210.77/210.95 |- mesh__dateEstablished mesh__D019532 1997-01-01
% 210.77/210.95 |- rdf__type mesh__D019532sskos__Concept
% 210.77/210.95 |- skos__prefLabel mesh__D019532 Maps %5B%Publication Type%5D%
% 210.77/210.95 |- mesh__historyNote mesh__D019532 1997
% 210.77/210.95 |- skos__hiddenLabel mesh__D000029 Legal Abortion
% 210.77/210.95 |- mesh__historyNote mesh__D000029 64
% 210.77/210.95 |- mesh__dateRevised mesh__D000029 2004-07-13
% 210.77/210.95 |- skos__broader mesh__D000029smesh__D000028
% 210.77/210.95 |- skos__annotation mesh__D000029
% 210.77/210.95 /adv eff permitted; do not use /util %28%except by MeSH definition%29% /vet; don%27%t forget also HUMANS %26% FEMALE %26% PREGNANCY%A%
% 210.77/210.95 |- skos__hiddenLabel mesh__D000029 Abortions, Legal
% 210.77/210.95 |- skos__hiddenLabel mesh__D000029 Legal Abortions
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D000029 2005
% 210.77/210.95 |- skos__prefLabel mesh__D000029 Abortion, Legal
% 210.77/210.95 |- mesh__publicMeSHNote mesh__D000029 64
% 210.77/210.95 |- mesh__recordMaintainer mesh__D000029 sjn
% 210.77/210.95 |- mesh__activeMeSHYear mesh__D000029 2006
% 210.77/210.95 |- rdf__type mesh__D000029sskos__Concept
% 210.77/210.95 |- mesh__dateCreated mesh__D000029 1999-01-01
% 210.77/210.95 |- mesh__dateEstablished mesh__D000029 1964-01-01
% 210.77/210.95 |- mesh__recordAuthorizer mesh__D000029 sjn
% 210.77/210.95 |- skos__scopeNote mesh__D000029
% 210.77/210.95 Termination of pregnancy under conditions allowed under local laws. %28%POPLINE Thesaurus, 1991%29%%A%
% 210.77/210.96 |- mesh__recordOriginator mesh__D000029 NLM
% 210.77/210.96 |- skos__scopeNote mesh__D005512
% 210.77/210.96 Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food.%A%
% 210.77/210.96 |- skos__altLabel mesh__D005512 Food Allergy
% 210.77/210.96 |- skos__hiddenLabel mesh__D005512 Food Hypersensitivities
% 210.77/210.96 |- mesh__recordMaintainer mesh__D005512 tpw
% 210.77/210.96 |- skos__related mesh__D005512smesh__D005517
% 210.77/210.96 |- mesh__historyNote mesh__D005512 66; was FOOD ALLERGY 1963-65
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005512 2002
% 210.77/210.96 |- mesh__dateRevised mesh__D005512 2001-07-25
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D005512 sjn
% 210.77/210.96 |- skos__prefLabel mesh__D005512 Food Hypersensitivity
% 210.77/210.96 |- skos__annotation mesh__D005512
% 210.77/210.96 GEN: Prefer specific precoord; coord IM with specific food /adv eff %28%IM%29%: Manual 31.12%A%
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005512 2003
% 210.77/210.96 |- mesh__recordOriginator mesh__D005512 NLM
% 210.77/210.96 |- skos__broader mesh__D005512smesh__D006969
% 210.77/210.96 |- rdf__type mesh__D005512sskos__Concept
% 210.77/210.96 |- skos__hiddenLabel mesh__D005512 Hypersensitivities, Food
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005512 2005
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D005512 66; was FOOD ALLERGY 1963-65
% 210.77/210.96 |- skos__hiddenLabel mesh__D005512 Allergies, Food
% 210.77/210.96 |- mesh__dateCreated mesh__D005512 1999-01-01
% 210.77/210.96 |- mesh__dateEstablished mesh__D005512 1966-01-01
% 210.77/210.96 |- skos__altLabel mesh__D005512 Allergy, Food
% 210.77/210.96 |- skos__hiddenLabel mesh__D005512 Food Allergies
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005512 2004
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005512 2006
% 210.77/210.96 |- skos__altLabel mesh__D005512 Hypersensitivity, Food
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929 Ala Ala Carboxypeptidase, Serine Type
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929
% 210.77/210.96 D-Ala-D-Ala Carboxypeptidases, Serine-Type
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D046929 2005
% 210.77/210.96 |- skos__altLabel mesh__D046929 Serine-Type D-Ala-D-Ala Carboxypeptidases
% 210.77/210.96 |- skos__prefLabel mesh__D046929 Serine-Type D-Ala-D-Ala Carboxypeptidase
% 210.77/210.96 |- skos__altLabel mesh__D046929 D-D Carboxypeptidase
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929 Carboxypeptidase, Serine-Type Ala-Ala
% 210.77/210.96 |- skos__scopeNote mesh__D046929
% 210.77/210.96 A carboxypeptidase that is specific for proteins that contain two ALANINE residues on their C-terminal. Enzymes in this class play an important role in bacterial CELL WALL biosynthesis.%A%
% 210.77/210.96 |- rdf__type mesh__D046929sskos__Concept
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929 D D Carboxypeptidase
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D046929 2006
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929
% 210.77/210.96 Transpeptidase, D-Alanyl-D-Alanine-Cleaving
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929
% 210.77/210.96 Serine Type D Ala D Ala Carboxypeptidases
% 210.77/210.96 |- mesh__recordMaintainer mesh__D046929 jmp
% 210.77/210.96 |- mesh__historyNote mesh__D046929
% 210.77/210.96 2005%28%1993%29%; for D-ALANYL-D-ALANINE-CLEAVING TRANSPEPTIDASE use MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1984-2004; for D-D CARBOXYPEPTIDASE use MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1974-2004%A%
% 210.77/210.96 |- skos__broader mesh__D046929smesh__D002268
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929
% 210.77/210.96 D Alanyl D Alanine Cleaving Transpeptidase
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929 Serine-Type Ala-Ala Carboxypeptidase
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929
% 210.77/210.96 Carboxypeptidase, Serine-Type D-Ala-D-Ala
% 210.77/210.96 |- skos__altLabel mesh__D046929 Ala-Ala Carboxypeptidase, Serine-Type
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929
% 210.77/210.96 D-Ala-D-Ala Carboxypeptidase, Serine-Type
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929 Serine Type D Ala D Ala Carboxypeptidase
% 210.77/210.96 |- skos__altLabel mesh__D046929 DD-Peptidase
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929
% 210.77/210.96 Carboxypeptidases, Serine-Type D-Ala-D-Ala
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929 D Alanyl D Alanine Carboxypeptidase
% 210.77/210.96 |- mesh__recordOriginator mesh__D046929 jmp
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929 DD Peptidase
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D046929
% 210.77/210.96 2005; SERINE-TYPE D-ALA-D-ALA CARBOXYPEPTIDASE was indexed under CARBOXYPEPTIDASES 1993-2003; for D-ALANYL-D-ALANINE-CLEAVING TRANSPEPTIDASE see MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1984-2004; for D-D CARBOXYPEPTIDASE see MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1974-2004%A%
% 210.77/210.96 |- skos__altLabel mesh__D046929 D-Alanyl-D-Alanine-Carboxypeptidase
% 210.77/210.96 |- skos__altLabel mesh__D046929 D-Alanyl-D-Alanine-Cleaving Transpeptidase
% 210.77/210.96 |- mesh__dateCreated mesh__D046929 2004-07-07
% 210.77/210.96 |- skos__historyNote mesh__D046929 Carboxypeptidases %28%1993-2004%29%
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D046929 sjn
% 210.77/210.96 |- mesh__dateEstablished mesh__D046929 2005-01-01
% 210.77/210.96 |- skos__hiddenLabel mesh__D046929 Carboxypeptidase, D-D
% 210.77/210.96 |- rdf__type mesh__D010457sskos__Concept
% 210.77/210.96 |- skos__broader mesh__D010457smesh__D006020
% 210.77/210.96 |- skos__historyNote mesh__D010457 Mucopolysaccharides %28%1966-1970%29%
% 210.77/210.96 |- mesh__dateCreated mesh__D010457 1999-01-01
% 210.77/210.96 |- skos__broader mesh__D010457smesh__D011135
% 210.77/210.96 |- mesh__dateRevised mesh__D010457 2005-06-30
% 210.77/210.96 |- skos__altLabel mesh__D010457 Murein
% 210.77/210.96 |- skos__prefLabel mesh__D010457 Peptidoglycan
% 210.77/210.96 |- mesh__recordMaintainer mesh__D010457 ssb
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D010457 sjn
% 210.77/210.96 |- skos__broader mesh__D010457smesh__D009088
% 210.77/210.96 |- mesh__recordOriginator mesh__D010457 NLM
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D010457 2006
% 210.77/210.96 |- skos__annotation mesh__D010457
% 210.77/210.96 coord IM with specific bacterium %28%IM%29% %26% do not coord with POLYSACCHARIDES, BACTERIAL%A%
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D010457 73
% 210.77/210.96 |- mesh__historyNote mesh__D010457 73%28%71%29%
% 210.77/210.96 |- skos__historyNote mesh__D010457
% 210.77/210.96 Polysaccharides, Bacterial %28%1966-1970%29%
% 210.77/210.96 |- mesh__dateEstablished mesh__D010457 1973-01-01
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015142 2002
% 210.77/210.96 |- mesh__recordMaintainer mesh__D015142 PXP
% 210.77/210.96 |- skos__prefLabel mesh__D015142 Baltimore
% 210.77/210.96 |- mesh__historyNote mesh__D015142 89
% 210.77/210.96 |- mesh__recordOriginator mesh__D015142 EC
% 210.77/210.96 |- skos__annotation mesh__D015142 DF: BALT
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D015142 SJN
% 210.77/210.96 |- skos__broader mesh__D015142smesh__D002947
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015142 2006
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015142 1999
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015142 2004
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015142 2001
% 210.77/210.96 |- mesh__dateRevised mesh__D015142 1997-06-20
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015142 2000
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015142 2005
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015142 1998
% 210.77/210.96 |- mesh__dateEstablished mesh__D015142 1989-01-01
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015142 2003
% 210.77/210.96 |- rdf__type mesh__D015142sskos__Concept
% 210.77/210.96 |- skos__broader mesh__D015142smesh__D008396
% 210.77/210.96 |- mesh__dateCreated mesh__D015142 1988-03-18
% 210.77/210.96 |- rdf__type mesh__D009903sskos__Concept
% 210.77/210.96 |- skos__broader mesh__D009903smesh__D007088
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 2000
% 210.77/210.96 |- mesh__recordOriginator mesh__D009903 NLM
% 210.77/210.96 |- skos__scopeNote mesh__D009903
% 210.77/210.96 An illusion of vision usually affecting spatial relations.%A%
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 2001
% 210.77/210.96 |- mesh__dateEstablished mesh__D009903 1991-01-01
% 210.77/210.96 |- mesh__onlineNote mesh__D009903 search ILLUSIONS 1966-74
% 210.77/210.96 |- mesh__recordMaintainer mesh__D009903 TAP
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 2003
% 210.77/210.96 |- skos__hiddenLabel mesh__D009903 Illusions, Optical
% 210.77/210.96 |- mesh__dateCreated mesh__D009903 1999-01-01
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 1996
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D009903
% 210.77/210.96 91; was see under ILLUSIONS 1975-90
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 2005
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 1998
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 2004
% 210.77/210.96 |- mesh__historyNote mesh__D009903
% 210.77/210.96 91%28%75%29%; was see under ILLUSIONS 1975-90
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 2002
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 1997
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 2006
% 210.77/210.96 |- skos__hiddenLabel mesh__D009903 Optical Illusion
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 1994
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 1999
% 210.77/210.96 |- skos__hiddenLabel mesh__D009903 Illusion, Optical
% 210.77/210.96 |- skos__prefLabel mesh__D009903 Optical Illusions
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 1993
% 210.77/210.96 |- mesh__dateRevised mesh__D009903 1992-05-15
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D009903 PLS
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009903 1995
% 210.77/210.96 |- mesh__recordOriginator mesh__D001920 NLM
% 210.77/210.96 |- skos__broader mesh__D001920smesh__D009842
% 210.77/210.96 |- skos__hiddenLabel mesh__D001920 Arg Pro Pro Gly Phe Ser Pro Phe Arg
% 210.77/210.96 |- skos__broader mesh__D001920smesh__D007705
% 210.77/210.96 |- skos__scopeNote mesh__D001920
% 210.77/210.96 A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter.%A%
% 210.77/210.96 |- mesh__dateRevised mesh__D001920 2005-06-30
% 210.77/210.96 |- rdf__type mesh__D001920sskos__Concept
% 210.77/210.96 |- skos__related mesh__D001920smesh__D018002
% 210.77/210.96 |- skos__altLabel mesh__D001920 Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
% 210.77/210.96 |- skos__prefLabel mesh__D001920 Bradykinin
% 210.77/210.96 |- mesh__dateCreated mesh__D001920 1999-01-01
% 210.77/210.96 |- skos__broader mesh__D001920smesh__D009479
% 210.77/210.96 |- mesh__recordMaintainer mesh__D001920 ssb
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D001920 2006
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D001920 sjn
% 210.77/210.96 |- mesh__dateEstablished mesh__D009105 1979-01-01
% 210.77/210.96 |- mesh__recordOriginator mesh__D009105 NLM
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Disorder, Multiple Personality
% 210.77/210.96 |- skos__altLabel mesh__D009105 Dissociative Identity Disorder
% 210.77/210.96 |- mesh__recordMaintainer mesh__D009105 JLS
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Multiple Personality
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Personalities, Multiple
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Personality Disorder, Multiple
% 210.77/210.96 |- mesh__historyNote mesh__D009105 98%28%68%29%
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009105 2003
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Disorder, Multiple Identity
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Disorder, Dissociative Identity
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Identity Disorder, Multiple
% 210.77/210.96 |- skos__prefLabel mesh__D009105 Multiple Personality Disorder
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009105 1998
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009105 2000
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Personality Disorders, Multiple
% 210.77/210.96 |- mesh__dateCreated mesh__D009105 1999-01-01
% 210.77/210.96 |- rdf__type mesh__D009105sskos__Concept
% 210.77/210.96 |- skos__altLabel mesh__D009105 Multiple Personalities
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009105 2004
% 210.77/210.96 |- skos__broader mesh__D009105smesh__D004213
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009105 2001
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Multiple Personality Disorders
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D009105
% 210.77/210.96 98; see MULTIPLE-PERSONALITY DISORDER 1979-97; for MULTIPLE PERSONALITIES see DUAL PERSONALITY 1968-78; DUAL PERSONALITY was heading 1968-78%A%
% 210.77/210.96 |- skos__altLabel mesh__D009105 Multiple Identity Disorder
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009105 1999
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009105 2005
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Personality, Dual
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Multiple Identity Disorders
% 210.77/210.96 |- mesh__dateRevised mesh__D009105 1997-06-20
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009105 2002
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Personalities, Dual
% 210.77/210.96 |- skos__scopeNote mesh__D009105
% 210.77/210.96 A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden.%A%
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D009105 2006
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D009105 SJN
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Identity Disorder, Dissociative
% 210.77/210.96 |- skos__hiddenLabel mesh__D009105 Personality, Multiple
% 210.77/210.96 |- mesh__dateCreated mesh__D001122 1977-12-08
% 210.77/210.96 |- mesh__recordMaintainer mesh__D001122 ssb
% 210.77/210.96 |- mesh__dateEstablished mesh__D001122 1991-01-01
% 210.77/210.96 |- mesh__dateRevised mesh__D001122 2003-07-09
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D001122
% 210.77/210.96 91; was see under PHOSPHOTRANSFERASES, ATP 1979-90
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D001122 sjn
% 210.77/210.96 |- skos__hiddenLabel mesh__D001122 Kinase, Arginine
% 210.77/210.96 |- skos__historyNote mesh__D001122 Phosphotransferases %28%1966-1973%29%
% 210.77/210.96 |- skos__historyNote mesh__D001122
% 210.77/210.96 Phosphotransferases, ATP %28%1974-1978%29%
% 210.77/210.96 |- skos__prefLabel mesh__D001122 Arginine Kinase
% 210.77/210.96 |- mesh__historyNote mesh__D001122
% 210.77/210.96 91%28%79%29%; was see under PHOSPHOTRANSFERASES, ATP 1979-90
% 210.77/210.96 |- skos__broader mesh__D001122smesh__D017852
% 210.77/210.96 |- skos__scopeNote mesh__D001122
% 210.77/210.96 An enzyme that catalyzes the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. EC 2.7.3.3.%A%
% 210.77/210.96 |- mesh__recordOriginator mesh__D001122 RLS
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D001122 2005
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D001122 2004
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D001122 2006
% 210.77/210.96 |- rdf__type mesh__D001122sskos__Concept
% 210.77/210.96 |- skos__historyNote mesh__D001122 Arginine %28%1966-1978%29%
% 210.77/210.96 |- mesh__historyNote mesh__D020885
% 210.77/210.96 2000; for U7 SNRNP, U7 SMALL NUCLEAR RIBONUCLEARPROTEINS and SMALL NUCLEAR RIBONUCLEARPROTEINS, U7 use RIBONUCLEOPROTEINS, SMALL NUCLEAR %28%1993-1999%29%%A%
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D020885 2006
% 210.77/210.96 |- mesh__dateCreated mesh__D020885 1999-11-05
% 210.77/210.96 |- skos__scopeNote mesh__D020885
% 210.77/210.96 This ribonucleoprotein particle, composed of U7 snRNA, Sm core protein, and U7 snRNP-specific proteins, is involved in the 3%27%end processing of histone premessenger RNAs.%A%
% 210.77/210.96 |- skos__broader mesh__D020885smesh__D017411
% 210.77/210.96 |- skos__altLabel mesh__D020885 Small Nuclear Ribonucleoproteins, U7
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D020885
% 210.77/210.96 2000; for U7 SNRNP, U7 SMALL NUCLEAR RIBONUCLEARPROTEINS and SMALL NUCLEAR RIBONUCLEARPROTEINS, U7 see RIBONUCLEOPROTEINS, SMALL NUCLEAR %28%1993-1999%29%%A%
% 210.77/210.96 |- skos__historyNote mesh__D020885 Ribonucleoproteins %28%1986-1999%29%
% 210.77/210.96 |- mesh__recordOriginator mesh__D020885 nns
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D020885 sjn
% 210.77/210.96 |- skos__hiddenLabel mesh__D020885 snRNP, U7
% 210.77/210.96 |- mesh__dateRevised mesh__D020885 2005-06-30
% 210.77/210.96 |- skos__historyNote mesh__D020885
% 210.77/210.96 Ribonucleoproteins, Small Nuclear %28%1993-1999%29%
% 210.77/210.96 |- skos__prefLabel mesh__D020885 Ribonucleoprotein, U7 Small Nuclear
% 210.77/210.96 |- mesh__recordMaintainer mesh__D020885 SYSTEM
% 210.77/210.96 |- skos__altLabel mesh__D020885 U7 snRNP
% 210.77/210.96 |- rdf__type mesh__D020885sskos__Concept
% 210.77/210.96 |- skos__altLabel mesh__D020885 U7 Small Nuclear Ribonucleoproteins
% 210.77/210.96 |- mesh__dateEstablished mesh__D020885 2000-01-01
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Repetitive Sequences, Alu
% 210.77/210.96 |- mesh__dateCreated mesh__D020087 1998-06-10
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D020087
% 210.77/210.96 99; see REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98; for ALU REPETITIVE SEQUENCE, ALU FAMILY, and ALU-LIKE REPETITIVE SEQUENCE see REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98%A%
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Repetitive Sequence, Alu
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D020087 2006
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Families, Alu
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Alu Element
% 210.77/210.96 |- rdf__type mesh__D020087sskos__Concept
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Elements, Alu
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Alu Families
% 210.77/210.96 |- skos__prefLabel mesh__D020087 Alu Elements
% 210.77/210.96 |- mesh__historyNote mesh__D020087
% 210.77/210.96 99; use REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98; for ALU REPETITIVE SEQUENCE, ALU FAMILY, and ALU-LIKE REPETITIVE SEQUENCE use REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98%A%
% 210.77/210.96 |- skos__broader mesh__D020087smesh__D020086
% 210.77/210.96 |- mesh__dateRevised mesh__D020087 2005-06-30
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D020087 sjn
% 210.77/210.96 |- mesh__recordOriginator mesh__D020087 NNS
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Alu Repetitive Sequence
% 210.77/210.96 |- skos__scopeNote mesh__D020087
% 210.77/210.96 The Alu sequence family %28%named for the restriction endonuclease cleavage enzyme Alu I%29% is the most highly repeated interspersed repeat element in humans %28%over a million copies%29%. It is derived from the 7SL RNA component of the SIGNAL RECOGNITION PARTICLE and contains an RNA polymerase III promoter. Transposition of this element into coding and regulatory regions of genes is responsible for many heritable diseases.%A%
% 210.77/210.96 |- skos__altLabel mesh__D020087 Alu Family
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Element, Alu
% 210.77/210.96 |- mesh__dateEstablished mesh__D020087 1999-01-01
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Family, Alu
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Sequence, Alu Repetitive
% 210.77/210.96 |- skos__hiddenLabel mesh__D020087 Sequences, Alu Repetitive
% 210.77/210.96 |- skos__related mesh__D020087smesh__D016254
% 210.77/210.96 |- skos__altLabel mesh__D020087 Alu Repetitive Sequences
% 210.77/210.96 |- mesh__recordMaintainer mesh__D020087 nns
% 210.77/210.96 |- skos__historyNote mesh__D020087
% 210.77/210.96 Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.77/210.96 |- skos__prefLabel mesh__D014848 Vulvovaginitis
% 210.77/210.96 |- mesh__dateRevised mesh__D014848 2005-06-30
% 210.77/210.96 |- mesh__recordOriginator mesh__D014848 NLM
% 210.77/210.96 |- mesh__dateCreated mesh__D014848 1999-01-01
% 210.77/210.96 |- skos__hiddenLabel mesh__D014848 Vulvovaginitides
% 210.77/210.96 |- skos__broader mesh__D014848smesh__D014847
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D014848 2006
% 210.77/210.96 |- skos__broader mesh__D014848smesh__D014627
% 210.77/210.96 |- skos__scopeNote mesh__D014848
% 210.77/210.96 Inflammation of the VULVA and the VAGINA, characterized by discharge, burning, and PRURITUS.%A%
% 210.77/210.96 |- mesh__recordMaintainer mesh__D014848 lkt
% 210.77/210.96 |- rdf__type mesh__D014848sskos__Concept
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D014848 sjn
% 210.77/210.96 |- mesh__dateEstablished mesh__D019533 1997-01-01
% 210.77/210.96 |- skos__prefLabel mesh__D019533 Streptococcus oralis
% 210.77/210.96 |- mesh__recordOriginator mesh__D019533 PXP
% 210.77/210.96 |- mesh__recordMaintainer mesh__D019533 SYSTEM
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D019533 2006
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D019533 97
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D019533 sjn
% 210.77/210.96 |- mesh__historyNote mesh__D019533 97
% 210.77/210.96 |- rdf__type mesh__D019533sskos__Concept
% 210.77/210.96 |- skos__annotation mesh__D019533
% 210.77/210.96 infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; DF: STREP ORALIS%A%
% 210.77/210.96 |- skos__scopeNote mesh__D019533
% 210.77/210.96 A species of gram-positive, coccoid bacteria that is numerous in the mouth and throat. It is a common cause of endocarditis and is also implicated in dental plaque formation.%A%
% 210.77/210.96 |- mesh__dateCreated mesh__D019533 1996-06-10
% 210.77/210.96 |- skos__broader mesh__D019533smesh__D034363
% 210.77/210.96 |- skos__historyNote mesh__D019533 Streptococcus %28%1983-1996%29%
% 210.77/210.96 |- mesh__dateRevised mesh__D019533 2005-06-30
% 210.77/210.96 |- skos__scopeNote mesh__D000828
% 210.77/210.96 Animals grouped according to ecological, morphological or genetic populations.%A%
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D000828 2004
% 210.77/210.96 |- rdf__type mesh__D000828sskos__Concept
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D000828 2006
% 210.77/210.96 |- skos__hiddenLabel mesh__D000828 Animal Population Group
% 210.77/210.96 |- mesh__recordMaintainer mesh__D000828 ags
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D000828 2004; see ANIMALS 1963-2003
% 210.77/210.96 |- mesh__recordOriginator mesh__D000828 NLM
% 210.77/210.96 |- skos__annotation mesh__D000828
% 210.77/210.96 GEN; prefer specifics; /surg: consider also SURGERY, VETERINARY%A%
% 210.77/210.96 |- skos__hiddenLabel mesh__D000828 Population Group, Animal
% 210.77/210.96 |- skos__prefLabel mesh__D000828 Animal Population Groups
% 210.77/210.96 |- mesh__dateRevised mesh__D000828 2003-07-09
% 210.77/210.96 |- mesh__dateCreated mesh__D000828 1999-01-01
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D000828 sjn
% 210.77/210.96 |- skos__broader mesh__D000828smesh__D000818
% 210.77/210.96 |- mesh__historyNote mesh__D000828 2004 %28%1963%29%
% 210.77/210.96 |- skos__hiddenLabel mesh__D000828 Population Groups, Animal
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D000828 2005
% 210.77/210.96 |- rdf__type mesh__D011550sskos__Concept
% 210.77/210.96 |- skos__prefLabel mesh__D011550 Pseudomonas aeruginosa
% 210.77/210.96 |- skos__altLabel mesh__D011550 Pseudomonas pyocyanea
% 210.77/210.96 |- mesh__dateRevised mesh__D011550 2005-06-30
% 210.77/210.96 |- skos__scopeNote mesh__D011550
% 210.77/210.96 A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens %28%wound, burn, and urinary tract infections%29%. It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.%A%
% 210.77/210.96 |- mesh__recordMaintainer mesh__D011550 SYSTEM
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D011550 2006
% 210.77/210.96 |- skos__broader mesh__D011550smesh__D011549
% 210.77/210.96 |- mesh__recordOriginator mesh__D011550 NLM
% 210.77/210.96 |- mesh__dateCreated mesh__D011550 1999-01-01
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D011550 sjn
% 210.77/210.96 |- skos__annotation mesh__D011550
% 210.77/210.96 infection = PSEUDOMONAS INFECTIONS %26% do not bother to coord with Ps. aerug. unless pertinent%A%
% 210.77/210.96 |- mesh__recordOriginator mesh__D005513 NLM
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005513 2000
% 210.77/210.96 |- skos__hiddenLabel mesh__D005513 Food Inspections
% 210.77/210.96 |- skos__hiddenLabel mesh__D005513 Inspections, Food
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005513 2003
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005513 2001
% 210.77/210.96 |- rdf__type mesh__D005513sskos__Concept
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005513 2005
% 210.77/210.96 |- mesh__dateCreated mesh__D005513 1999-01-01
% 210.77/210.96 |- skos__hiddenLabel mesh__D005513 Inspection, Food
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005513 2004
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005513 2006
% 210.77/210.96 |- skos__annotation mesh__D005513
% 210.77/210.96 IM; coord with milieu %28%IM%29% or specific food %28%IM%29% if pertinent%A%
% 210.77/210.96 |- skos__prefLabel mesh__D005513 Food Inspection
% 210.77/210.96 |- skos__broader mesh__D005513smesh__D012499
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D005513 2002
% 210.77/210.96 |- skos__scopeNote mesh__D005513
% 210.77/210.96 Examination of foods to assure wholesome and clean products free from unsafe microbes or chemical contamination, natural or added deleterious substances, and decomposition during production, processing, packaging, etc.%A%
% 210.77/210.96 |- skos__broader mesh__D005513smesh__D005524
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D005513 sjn
% 210.77/210.96 |- mesh__recordMaintainer mesh__D005513 kle
% 210.77/210.96 |- mesh__dateRevised mesh__D005513 1999-11-03
% 210.77/210.96 |- skos__prefLabel mesh__D029961 Zebrafish Proteins
% 210.77/210.96 |- mesh__recordOriginator mesh__D029961 jmp
% 210.77/210.96 |- skos__scopeNote mesh__D029961
% 210.77/210.96 Proteins obtained from the ZEBRAFISH. Many of the proteins in this species have been the subject of studies involving basic embryological development %28%EMBRYOLOGY%29%.%A%
% 210.77/210.96 |- mesh__dateEstablished mesh__D029961 2002-01-01
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D029961 2006
% 210.77/210.96 |- mesh__dateCreated mesh__D029961 2001-07-25
% 210.77/210.96 |- rdf__type mesh__D029961sskos__Concept
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D029961 2002
% 210.77/210.96 |- skos__altLabel mesh__D029961 Danio rerio Proteins
% 210.77/210.96 |- skos__related mesh__D029961smesh__D015027
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D029961 sjn
% 210.77/210.96 |- mesh__dateRevised mesh__D029961 2005-06-30
% 210.77/210.96 |- skos__altLabel mesh__D029961 Brachydanio rerio Proteins
% 210.77/210.96 |- skos__altLabel mesh__D029961 Zebra Fish Proteins
% 210.77/210.96 |- mesh__historyNote mesh__D029961 2002
% 210.77/210.96 |- skos__annotation mesh__D029961
% 210.77/210.96 coord IM with specific protein %28%IM%29%
% 210.77/210.96 |- skos__broader mesh__D029961smesh__D029941
% 210.77/210.96 |- mesh__recordMaintainer mesh__D029961 SYSTEM
% 210.77/210.96 |- skos__altLabel mesh__D029961 Zebra Danio Proteins
% 210.77/210.96 |- mesh__recordMaintainer mesh__D010458 nns
% 210.77/210.96 |- skos__related mesh__D010458smesh__D010441
% 210.77/210.96 |- skos__scopeNote mesh__D010458
% 210.77/210.96 Acyltransferases that use AMINO ACYL TRNA as the amino acid donor in formation of a peptide bond. There are ribosomal and non-ribosomal peptidyltransferases.%A%
% 210.77/210.96 |- skos__hiddenLabel mesh__D010458 Transferases, Peptidyl
% 210.77/210.96 |- mesh__recordOriginator mesh__D010458 NLM
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D010458 2005
% 210.77/210.96 |- skos__hiddenLabel mesh__D010458 Translocases, Peptidyl
% 210.77/210.96 |- skos__broader mesh__D010458smesh__D019881
% 210.77/210.96 |- rdf__type mesh__D010458sskos__Concept
% 210.77/210.96 |- mesh__dateEstablished mesh__D010458 1991-01-01
% 210.77/210.96 |- skos__prefLabel mesh__D010458 Peptidyl Transferases
% 210.77/210.96 |- skos__historyNote mesh__D010458
% 210.77/210.96 Peptide Elongation Factors %28%1973-1974%29%
% 210.77/210.96 |- skos__related mesh__D010458smesh__D012269
% 210.77/210.96 |- skos__altLabel mesh__D010458 Peptidyltransferase
% 210.77/210.96 |- skos__altLabel mesh__D010458 Peptidyl Translocases
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D010458
% 210.77/210.96 2005; see PEPTIDYLTRANSFERASE 1998-2004, see PEPTIDYL TRANSFERASES 1991-1997, see ACYLTRANSFERASES 1975-1990%A%
% 210.77/210.96 |- mesh__dateCreated mesh__D010458 1974-11-19
% 210.77/210.96 |- skos__historyNote mesh__D010458 Acyltransferases %28%1972-1974%29%
% 210.77/210.96 |- mesh__dateRevised mesh__D010458 2004-07-07
% 210.77/210.96 |- skos__historyNote mesh__D010458 Peptides %28%1972-1974%29%
% 210.77/210.96 |- skos__altLabel mesh__D010458 Peptidyltransferases
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D010458 2006
% 210.77/210.96 |- mesh__recordAuthorizer mesh__D010458 sjn
% 210.77/210.96 |- skos__altLabel mesh__D010458 Transpeptidases
% 210.77/210.96 |- mesh__historyNote mesh__D010458 2005%28%1975%29%
% 210.77/210.96 |- skos__broader mesh__D015941smesh__D017186
% 210.77/210.96 |- skos__altLabel mesh__D015941 Hemolytic Titration Assay
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015941 2006A
% 210.77/210.96 |- skos__hiddenLabel mesh__D015941 CH50 Assays
% 210.77/210.96 |- skos__hiddenLabel mesh__D015941 Titer, Serum Complement
% 210.77/210.96 |- skos__hiddenLabel mesh__D015941 Titration Assay, Hemolytic
% 210.77/210.96 |- mesh__publicMeSHNote mesh__D015941 90
% 210.77/210.96 |- mesh__activeMeSHYear mesh__D015941 2006
% 210.77/210.96 |- skos__broader mesh__D015941smesh__D003601
% 210.77/210.96 |- skos__hiddenLabel mesh__D015941 Assay, CH50
% 210.77/210.96 |- skos__prefLabel mesh__D015941 Complement Hemolytic Activity Assay
% 210.77/210.96 |- skos__hiddenLabel mesh__D015941 Hemolytic Complement, Total
% 210.77/210.96 |- mesh__recordOriginator mesh__D015941 AGS
% 210.77/210.96 |- skos__historyNote mesh__D015941 Complement/analysis %28%1969-1989%29%
% 210.77/210.96 |- mesh__recordMaintainer mesh__D015941 ags
% 210.77/210.96 |- skos__altLabel mesh__D015941 CH%28%50%29%
% 210.77/210.96 |- mesh__dateEstablished mesh__D015941 1990-01-01
% 210.77/210.96 |- skos__hiddenLabel mesh__D015941 Hemolytic Titration Assays
% 210.77/210.97 |- rdf__type mesh__D015941sskos__Concept
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Assays, CH50
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Hemolytic Complements, Total
% 210.77/210.97 |- mesh__dateCreated mesh__D015941 1989-05-25
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Complement H50s
% 210.77/210.97 |- skos__broader mesh__D015941smesh__D012698
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Complements, Total Hemolytic
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Titers, Serum Complement
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D015941 ags
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Titration Assays, Hemolytic
% 210.77/210.97 |- skos__scopeNote mesh__D015941
% 210.77/210.97 A screening assay for circulating COMPLEMENT PROTEINS. Diluted SERUM samples are added to antibody-coated ERYTHROCYTES and the percentage of cell lysis is measured. The values are expressed by the so called CH50, in HEMOLYTIC COMPLEMENT units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay.%A%
% 210.77/210.97 |- mesh__historyNote mesh__D015941 90
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Total Hemolytic Complements
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Whole Complement Titers
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Titers, Whole Complement
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Titer, Whole Complement
% 210.77/210.97 |- skos__altLabel mesh__D015941 CH50 Assay
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Complement, Total Hemolytic
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Serum Complement Titers
% 210.77/210.97 |- mesh__dateRevised mesh__D015941 2005-07-12
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Assay, Hemolytic Titration
% 210.77/210.97 |- skos__hiddenLabel mesh__D015941 Assays, Hemolytic Titration
% 210.77/210.97 |- skos__broader mesh__D015143smesh__D010414
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015143 2006
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015143 2002
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015143 1999
% 210.77/210.97 |- mesh__dateCreated mesh__D015143 1988-03-18
% 210.77/210.97 |- mesh__recordMaintainer mesh__D015143 PXP
% 210.77/210.97 |- mesh__historyNote mesh__D015143 89
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015143 2005
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015143 2004
% 210.77/210.97 |- mesh__recordOriginator mesh__D015143 EC
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015143 1998
% 210.77/210.97 |- mesh__dateEstablished mesh__D015143 1989-01-01
% 210.77/210.97 |- skos__prefLabel mesh__D015143 Philadelphia
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015143 2003
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D015143 SJN
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015143 2001
% 210.77/210.97 |- skos__broader mesh__D015143smesh__D002947
% 210.77/210.97 |- rdf__type mesh__D015143sskos__Concept
% 210.77/210.97 |- skos__annotation mesh__D015143 DF: PHILA
% 210.77/210.97 |- mesh__dateRevised mesh__D015143 1997-06-20
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015143 2000
% 210.77/210.97 |- mesh__recordOriginator mesh__D009904 NLM
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1995
% 210.77/210.97 |- skos__hiddenLabel mesh__D009904 Optical Rotations
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 2001
% 210.77/210.97 |- skos__prefLabel mesh__D009904 Optical Rotation
% 210.77/210.97 |- skos__hiddenLabel mesh__D009904 Rotations, Optical
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1996
% 210.77/210.97 |- mesh__historyNote mesh__D009904 74%28%71%29%
% 210.77/210.97 |- mesh__dateCreated mesh__D009904 1999-01-01
% 210.77/210.97 |- mesh__dateRevised mesh__D009904 1989-06-14
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1990
% 210.77/210.97 |- skos__hiddenLabel mesh__D009904 Rotation, Optical
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 2003
% 210.77/210.97 |- mesh__recordMaintainer mesh__D009904 TGC
% 210.77/210.97 |- skos__broader mesh__D009904smesh__D009906
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1998
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1997
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 2002
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D009904 74
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 2005
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1992
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 2004
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D009904 PLS
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1999
% 210.77/210.97 |- skos__historyNote mesh__D009904 Chemistry, Physical %28%1966-1970%29%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1991
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1994
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 2006
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 1993
% 210.77/210.97 |- mesh__dateEstablished mesh__D009904 1974-01-01
% 210.77/210.97 |- rdf__type mesh__D009904sskos__Concept
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009904 2000
% 210.77/210.97 |- skos__annotation mesh__D009904 NIM; no qualif
% 210.77/210.97 |- skos__prefLabel mesh__D001921 Brain
% 210.77/210.97 |- skos__annotation mesh__D001921
% 210.77/210.97 GEN; /blood supply: consider also CEREBROVASCULAR CIRCULATION; CEREBRAL ARTERIES; CEREBRAL VEINS; CRANIAL SINUSES; /cytol: do not routinely convert to NEURONS; /drug eff: consider terms in D14 %26% D15; /surg: consider also CEREBRAL DECORTICATION %26% PSYCHOSURGERY; inflammation = ENCEPHALITIS %26% its specifics; infarct = CEREBRAL INFARCTION; malacia = ENCEPHALOMALACIA; brain-isolated, enc%C3%%A9%phale isol%C3%%A9%, cerveau isol%C3%%A9%: index DECEREBRATE STATE%A%
% 210.77/210.97 |- skos__related mesh__D001921smesh__D011612
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D001921 sjn
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D001921 2002
% 210.77/210.97 |- skos__hiddenLabel mesh__D001921 Brains
% 210.77/210.97 |- mesh__recordOriginator mesh__D001921 NLM
% 210.77/210.97 |- skos__altLabel mesh__D001921 Encephalon
% 210.77/210.97 |- rdf__type mesh__D001921sskos__Concept
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D001921
% 210.77/210.97 /enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65%A%
% 210.77/210.97 |- mesh__dateRevised mesh__D001921 2001-08-13
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D001921 2005
% 210.77/210.97 |- mesh__dateCreated mesh__D001921 1999-01-01
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D001921 2003
% 210.77/210.97 |- skos__scopeNote mesh__D001921
% 210.77/210.97 The part of the central nervous system contained within the cranium, comprising the prosencephalon, mesencephalon, and rhombencephalon. It is derived from the anterior part of the embryonic neural tube.%A%
% 210.77/210.97 |- mesh__historyNote mesh__D001921
% 210.77/210.97 /enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D001921 2006
% 210.77/210.97 |- mesh__recordMaintainer mesh__D001921 jls
% 210.77/210.97 |- skos__related mesh__D001921smesh__D002541
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D001921 2004
% 210.77/210.97 |- mesh__onlineNote mesh__D001921 pre-explosion = BRAIN %28%PX%29%
% 210.77/210.97 |- mesh__considerAlso mesh__D001921
% 210.77/210.97 consider also terms at CEREBR- and ENCEPHAL-
% 210.77/210.97 |- skos__broader mesh__D001921smesh__D002490
% 210.77/210.97 |- skos__hiddenLabel mesh__D001921 Encephalons
% 210.77/210.97 |- skos__broader mesh__D011095Q000031smesh__D011095
% 210.77/210.97 |- mesh__preferredCombination mesh__D011095Q000031smesh__D020959
% 210.77/210.97 |- rdf__type mesh__D011095Q000031smesh__CompoundConcept
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 2003
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 1997
% 210.77/210.97 |- mesh__dateRevised mesh__D009106 1996-06-10
% 210.77/210.97 |- mesh__recordOriginator mesh__D009106 NLM
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 1998
% 210.77/210.97 |- rdf__type mesh__D009106sskos__Concept
% 210.77/210.97 |- mesh__dateCreated mesh__D009106 1999-01-01
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 2004
% 210.77/210.97 |- skos__hiddenLabel mesh__D009106 Mummy
% 210.77/210.97 |- skos__broader mesh__D009106smesh__D010163
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 1999
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 2005
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D009106 PLS
% 210.77/210.97 |- skos__annotation mesh__D009106
% 210.77/210.97 do not routinely check tags HISTORICAL ARTICLE + ANCIENT: check only when the hist %26% ancient med aspects are particularly discussed; /pathol: do not bother to coord with PALEOPATHOLOGY%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 2006
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 2000
% 210.77/210.97 |- skos__scopeNote mesh__D009106
% 210.77/210.97 Bodies preserved either by the ancient Egyptian technique or due to chance under favorable climatic conditions.%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 2001
% 210.77/210.97 |- mesh__recordMaintainer mesh__D009106 TGC
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D009106 2002
% 210.77/210.97 |- skos__prefLabel mesh__D009106 Mummies
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D001123 91; was see under LYASES 1975-90
% 210.77/210.97 |- mesh__recordMaintainer mesh__D001123 ssb
% 210.77/210.97 |- mesh__dateCreated mesh__D001123 1974-11-19
% 210.77/210.97 |- mesh__dateRevised mesh__D001123 2003-07-09
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D001123 2005
% 210.77/210.97 |- rdf__type mesh__D001123sskos__Concept
% 210.77/210.97 |- skos__hiddenLabel mesh__D001123 Lyase, Argininosuccinate
% 210.77/210.97 |- skos__historyNote mesh__D001123 Succinates %28%1973-1974%29%
% 210.77/210.97 |- skos__historyNote mesh__D001123 Arginine %28%1973-1974%29%
% 210.77/210.97 |- skos__scopeNote mesh__D001123
% 210.77/210.97 An enzyme of the urea cycle which splits argininosuccinate to fumarate plus arginine. Its absence leads to the metabolic disease argininosuccinic acidemia in man. EC 4.3.2.1.%A%
% 210.77/210.97 |- mesh__dateEstablished mesh__D001123 1991-01-01
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D001123 2004
% 210.77/210.97 |- skos__prefLabel mesh__D001123 Argininosuccinate Lyase
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D001123 sjn
% 210.77/210.97 |- mesh__recordOriginator mesh__D001123 NLM
% 210.77/210.97 |- skos__broader mesh__D001123smesh__D019760
% 210.77/210.97 |- skos__annotation mesh__D001123
% 210.77/210.97 /defic: consider also ARGININOSUCCINIC ACID /urine %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A%
% 210.77/210.97 |- skos__altLabel mesh__D001123 Argininosuccinase
% 210.77/210.97 |- skos__historyNote mesh__D001123 Lyases %28%1973-1974%29%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D001123 2006
% 210.77/210.97 |- mesh__historyNote mesh__D001123
% 210.77/210.97 91%28%75%29%; was see under LYASES 1975-90
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sensation Disorder, Somatic
% 210.77/210.97 |- skos__altLabel mesh__D020886 Somatic Sensation Disorders
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Thermal Sensation Disorder
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Diminished, Pinprick Sensation
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Somatic Sensation Disorder
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Diminisheds, Pinprick Sensation
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Somatosensory Disorder
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sensation Diminished, Pinprick
% 210.77/210.97 |- skos__prefLabel mesh__D020886 Somatosensory Disorders
% 210.77/210.97 |- skos__annotation mesh__D020886 GEN: prefer specifics
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Pinprick Sensation Diminisheds
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sensation Diminisheds, Pain
% 210.77/210.97 |- skos__broader mesh__D020886smesh__D012678
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Diminished, Pain Sensation
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D020886 2000
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sense Disorders, Position
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D020886 2005
% 210.77/210.97 |- skos__altLabel mesh__D020886 Light Touch Sensation Impairment
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D020886 2000
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sensation Diminisheds, Pinprick
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Pain Sensation Diminisheds
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sensation Diminished, Pain
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Position Sense Disorder
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sensation Disorders, Somatic
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D020886 2001
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D020886 2006
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D020886 2003
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Diminisheds, Pain Sensation
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sensation Disorder, Thermal
% 210.77/210.97 |- skos__historyNote mesh__D020886 Sensation Disorders %28%1966-1999%29%
% 210.77/210.97 |- rdf__type mesh__D020886sskos__Concept
% 210.77/210.97 |- mesh__dateCreated mesh__D020886 1999-11-03
% 210.77/210.97 |- skos__scopeNote mesh__D020886
% 210.77/210.97 Disorders of sensory information received from superficial and deep regions of the body. The somatosensory system conveys neural impulses which pertain to proprioception, tactile sensation, thermal sensation, pressure sensation, and pain. PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL CORD DISEASES; and BRAIN DISEASES may be associated with impaired or abnormal somatic sensation.%A%
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sense Disorder, Position
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Sensation Disorders, Thermal
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D020886 2002
% 210.77/210.97 |- mesh__dateEstablished mesh__D020886 2000-01-01
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D020886 2004
% 210.77/210.97 |- mesh__historyNote mesh__D020886 2000
% 210.77/210.97 |- skos__hiddenLabel mesh__D020886 Proprioceptive Disorder
% 210.77/210.97 |- mesh__recordOriginator mesh__D020088 AGS
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D020088 2006
% 210.77/210.97 |- skos__historyNote mesh__D020088 Chytridiomycota %28%1989-1995%29%
% 210.77/210.97 |- rdf__type mesh__D020088sskos__Concept
% 210.77/210.97 |- skos__scopeNote mesh__D020088
% 210.77/210.97 A genus of fungi in the family Neocallimasticaceae, order NEOCALLIMASTICALES. They contain polyflagellate zoospores and grow on a range of simple and complex carbohydrates in the rumen of sheep and cattle.%A%
% 210.77/210.97 |- mesh__dateEstablished mesh__D020088 1999-01-01
% 210.77/210.97 |- skos__historyNote mesh__D020088 Fungi %28%1975-1998%29%
% 210.77/210.97 |- mesh__dateCreated mesh__D020088 1998-06-10
% 210.77/210.97 |- mesh__recordMaintainer mesh__D020088 SYSTEM
% 210.77/210.97 |- skos__prefLabel mesh__D020088 Neocallimastix
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D020088 99
% 210.77/210.97 |- mesh__historyNote mesh__D020088 99
% 210.77/210.97 |- skos__broader mesh__D020088smesh__D020085
% 210.77/210.97 |- mesh__dateRevised mesh__D020088 2005-06-30
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D020088 sjn
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Klein Syndrome
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Syndrome, Klein%27%s
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D014849 2005
% 210.77/210.97 |- skos__altLabel mesh__D014849 Waardenburg-Klein Syndrome
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D014849 2002
% 210.77/210.97 |- mesh__dateCreated mesh__D014849 1999-01-01
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Waardenburg Klein Syndrome
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Syndrome, Waardenburg%27%s
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D014849 2006
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D014849 sjn
% 210.77/210.97 |- mesh__recordOriginator mesh__D014849 NLM
% 210.77/210.97 |- skos__scopeNote mesh__D014849
% 210.77/210.97 Rare, autosomal dominant disease with variable penetrance and several known clinical types. Characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. The underlying cause may be defective development of the neural crest %28%neurocristopathy%29%. Waardenburg%27%s syndrome may be closely related to piebaldism. Klein-Waardenburg Syndrome refers to a disorder that also includes upper limb abnormalities.%A%
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Syndrome, Klein-Waardenburg
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D014849 2003
% 210.77/210.97 |- skos__annotation mesh__D014849
% 210.77/210.97 a syndrome of multiple abnorm; check syndrome book for other Waardenburg skull deform syndromes; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D014849 2000
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Kleins Syndrome
% 210.77/210.97 |- mesh__historyNote mesh__D014849
% 210.77/210.97 91%28%66%29%; was see under ABNORMALITIES, MULTIPLE 1975-90
% 210.77/210.97 |- skos__altLabel mesh__D014849 Klein-Waardenburg Syndrome
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Syndrome, Waardenburg-Klein
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D014849 2004
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D014849
% 210.77/210.97 91; was see under ABNORMALITIES, MULTIPLE 1975-90
% 210.77/210.97 |- mesh__dateEstablished mesh__D014849 1991-01-01
% 210.77/210.97 |- skos__prefLabel mesh__D014849 Waardenburg%27%s Syndrome
% 210.77/210.97 |- rdf__type mesh__D014849sskos__Concept
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D014849 2001
% 210.77/210.97 |- skos__broader mesh__D014849smesh__D000015
% 210.77/210.97 |- mesh__dateRevised mesh__D014849 1999-11-03
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Waardenburgs Syndrome
% 210.77/210.97 |- mesh__recordMaintainer mesh__D014849 kle
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Klein Waardenburg Syndrome
% 210.77/210.97 |- skos__hiddenLabel mesh__D014849 Waardenburg Syndrome
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Syndromes, Subacromial Impingement
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Syndrome, Shoulder Impingement
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Impingement Syndromes, Shoulder
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Impingement Syndrome, Shoulder
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 2002
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 1999
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Impingement Syndrome, Subacromial
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Subacromial Impingement Syndromes
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 1998
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Syndrome, Subacromial Impingement
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 1997
% 210.77/210.97 |- mesh__dateCreated mesh__D019534 1996-06-10
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Syndromes, Shoulder Impingement
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Shoulder Impingement Syndromes
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 2006
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 2001
% 210.77/210.97 |- skos__broader mesh__D019534smesh__D007592
% 210.77/210.97 |- skos__altLabel mesh__D019534 Subacromial Impingement Syndrome
% 210.77/210.97 |- skos__historyNote mesh__D019534 Joint Diseases %28%1982-1996%29%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 2005
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 2004
% 210.77/210.97 |- rdf__type mesh__D019534sskos__Concept
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 2000
% 210.77/210.97 |- mesh__historyNote mesh__D019534 97
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D019534 97
% 210.77/210.97 |- mesh__dateEstablished mesh__D019534 1997-01-01
% 210.77/210.97 |- skos__scopeNote mesh__D019534
% 210.77/210.97 Compression of the rotator cuff tendons and subacromial bursa between the humeral head and structures that make up the coracoacromial arch and the humeral tuberosities. This condition is associated with subacromial bursitis and rotator cuff %28%largely supraspinatus%29% and bicipital tendon inflammation, with or without degenerative changes in the tendon. Pain that is most severe when the arm is abducted in an arc between 40 and 120 degrees, sometimes associated with tears in the rotator cuff, is the chief symptom. %28%From Jablonski%27%s Dictionary of Syndromes and Eponymic Diseases, 2d ed%29%%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D019534 2003
% 210.77/210.97 |- skos__prefLabel mesh__D019534 Shoulder Impingement Syndrome
% 210.77/210.97 |- skos__hiddenLabel mesh__D019534 Impingement Syndromes, Subacromial
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D000829 sjn
% 210.77/210.97 |- skos__hiddenLabel mesh__D000829 Animals, Farm
% 210.77/210.97 |- skos__broader mesh__D000829smesh__D000828
% 210.77/210.97 |- skos__hiddenLabel mesh__D000829 Animal, Farm
% 210.77/210.97 |- skos__hiddenLabel mesh__D000829 Domestic Animal
% 210.77/210.97 |- mesh__dateCreated mesh__D000829 1999-01-01
% 210.77/210.97 |- skos__annotation mesh__D000829
% 210.77/210.97 GEN or unspecified; prefer specific domestic animals like CATTLE; SHEEP; HORSES; DOGS; CATS; etc.; IM; qualif permitted; PETS: TN 146; domestication goes here; do not forget also to check tag ANIMALS%A%
% 210.77/210.97 |- skos__hiddenLabel mesh__D000829 Farm Animal
% 210.77/210.97 |- skos__hiddenLabel mesh__D000829 Pet
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D000829 2005
% 210.77/210.97 |- skos__altLabel mesh__D000829 Livestock
% 210.77/210.97 |- skos__hiddenLabel mesh__D000829 Domestic Animals
% 210.77/210.97 |- skos__hiddenLabel mesh__D000829 Livestocks
% 210.77/210.97 |- mesh__dateRevised mesh__D000829 2003-07-30
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D000829 2004
% 210.77/210.97 |- skos__hiddenLabel mesh__D000829 Animal, Domestic
% 210.77/210.97 |- rdf__type mesh__D000829sskos__Concept
% 210.77/210.97 |- mesh__recordOriginator mesh__D000829 NLM
% 210.77/210.97 |- skos__scopeNote mesh__D000829
% 210.77/210.97 Animals which have become adapted through breeding in captivity to a life intimately associated with man. They include animals domesticated by man to live and breed in a tame condition on farms or ranches %28%e.g., horses, cattle, sheep%29% and those raised or kept for pleasure and companionship %28%e.g., dogs, cats, horses%29%.%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D000829 2006
% 210.77/210.97 |- skos__prefLabel mesh__D000829 Animals, Domestic
% 210.77/210.97 |- mesh__recordMaintainer mesh__D000829 ags
% 210.77/210.97 |- mesh__recordOriginator mesh__D011551 NLM
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D011551 sjn
% 210.77/210.97 |- skos__prefLabel mesh__D011551 Pseudomonas fluorescens
% 210.77/210.97 |- mesh__recordMaintainer mesh__D011551 SYSTEM
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D011551 2006
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D011551 74
% 210.77/210.97 |- skos__historyNote mesh__D011551 Pseudomonas %28%1966-1971%29%
% 210.77/210.97 |- mesh__dateCreated mesh__D011551 1999-01-01
% 210.77/210.97 |- mesh__dateRevised mesh__D011551 2005-06-30
% 210.77/210.97 |- mesh__dateEstablished mesh__D011551 1974-01-01
% 210.77/210.97 |- skos__scopeNote mesh__D011551
% 210.77/210.97 A species of nonpathogenic fluorescent bacteria found in feces, sewage, soil, and water, and which liquefy gelatin.%A%
% 210.77/210.97 |- skos__broader mesh__D011551smesh__D011549
% 210.77/210.97 |- rdf__type mesh__D011551sskos__Concept
% 210.77/210.97 |- mesh__historyNote mesh__D011551 74%28%72%29%
% 210.77/210.97 |- skos__hiddenLabel mesh__D005514 Irradiations, Food
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D005514 2003
% 210.77/210.97 |- skos__hiddenLabel mesh__D005514 Irradiated Food
% 210.77/210.97 |- rdf__type mesh__D005514sskos__Concept
% 210.77/210.97 |- skos__hiddenLabel mesh__D005514 Irradiation, Food
% 210.77/210.97 |- skos__hiddenLabel mesh__D005514 Irradiated Foods
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D005514 2005
% 210.77/210.97 |- mesh__dateCreated mesh__D005514 1999-01-01
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D005514 2004
% 210.77/210.97 |- mesh__recordOriginator mesh__D005514 NLM
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D005514 2006
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D005514 2000
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D005514 SJN
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D005514 1998
% 210.77/210.97 |- skos__broader mesh__D005514smesh__D005519
% 210.77/210.97 |- skos__annotation mesh__D005514
% 210.77/210.97 food preservation by irradiation: do not confuse with FOOD CONTAMINATION, RADIOACTIVE; DF: FOOD IRRAD%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D005514 2001
% 210.77/210.97 |- skos__hiddenLabel mesh__D005514 Foods, Irradiated
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D005514 1999
% 210.77/210.97 |- skos__prefLabel mesh__D005514 Food Irradiation
% 210.77/210.97 |- mesh__recordMaintainer mesh__D005514 JLS
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D005514 2002
% 210.77/210.97 |- skos__hiddenLabel mesh__D005514 Food Irradiations
% 210.77/210.97 |- mesh__dateRevised mesh__D005514 1997-06-20
% 210.77/210.97 |- skos__scopeNote mesh__D029962
% 210.77/210.97 A plant family of the order Fagales subclass Hamamelidae, class Magnoliopsida.%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D029962 2002
% 210.77/210.97 |- mesh__historyNote mesh__D029962 2002
% 210.77/210.97 |- mesh__dateEstablished mesh__D029962 2002-01-01
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D029962 2004
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D029962 2006
% 210.77/210.97 |- rdf__type mesh__D029962sskos__Concept
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D029962 2003
% 210.77/210.97 |- skos__prefLabel mesh__D029962 Fagaceae
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D029962 2002
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D029962 2005
% 210.77/210.97 |- skos__broader mesh__D029962smesh__D019684
% 210.77/210.97 |- mesh__dateCreated mesh__D029962 2001-07-25
% 210.77/210.97 |- skos__annotation mesh__D029962
% 210.77/210.97 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.77/210.97 |- skos__historyNote mesh__D010459 Lactobacillaceae %28%1975%29%
% 210.77/210.97 |- rdf__type mesh__D010459sskos__Concept
% 210.77/210.97 |- mesh__dateCreated mesh__D010459 1975-07-21
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D010459 sjn
% 210.77/210.97 |- skos__historyNote mesh__D010459 Micrococcaceae %28%1975%29%
% 210.77/210.97 |- skos__prefLabel mesh__D010459 Peptococcaceae
% 210.77/210.97 |- skos__annotation mesh__D010459 in man, animals, soil
% 210.77/210.97 |- skos__scopeNote mesh__D010459
% 210.77/210.97 A family of bacteria found in the mouth and intestinal and respiratory tracts of man and other animals as well as in the human female urogenital tract. Its organisms are also found in soil and on cereal grains.%A%
% 210.77/210.97 |- mesh__historyNote mesh__D010459 76
% 210.77/210.97 |- skos__historyNote mesh__D010459 Bacteria %28%1966-1977%29%
% 210.77/210.97 |- mesh__recordMaintainer mesh__D010459 SYSTEM
% 210.77/210.97 |- mesh__dateEstablished mesh__D010459 1976-01-01
% 210.77/210.97 |- mesh__recordOriginator mesh__D010459 JW
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D010459 2006
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D010459 76
% 210.77/210.97 |- skos__broader mesh__D010459smesh__D006095
% 210.77/210.97 |- mesh__dateRevised mesh__D010459 2005-06-30
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D021181 2004
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D021181 2005
% 210.77/210.97 |- skos__altLabel mesh__D021181 Allergy, Egg
% 210.77/210.97 |- skos__altLabel mesh__D021181 Egg Allergy
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D021181 2002
% 210.77/210.97 |- skos__scopeNote mesh__D021181
% 210.77/210.97 Allergic reaction to eggs that is triggered by the immune system.%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D021181 2006
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D021181 2002
% 210.77/210.97 |- mesh__dateEstablished mesh__D021181 2002-01-01
% 210.77/210.97 |- skos__historyNote mesh__D021181 Food Hypersensitivity %28%1965-2001%29%
% 210.77/210.97 |- skos__hiddenLabel mesh__D021181 Egg Allergies
% 210.77/210.97 |- skos__annotation mesh__D021181
% 210.77/210.97 coord IM with specific egg component /adv eff %28%IM%29% if pertinent%A%
% 210.77/210.97 |- skos__broader mesh__D021181smesh__D005512
% 210.77/210.97 |- skos__altLabel mesh__D021181 Hypersensitivity, Egg
% 210.77/210.97 |- mesh__dateCreated mesh__D021181 2001-07-25
% 210.77/210.97 |- rdf__type mesh__D021181sskos__Concept
% 210.77/210.97 |- mesh__historyNote mesh__D021181 2002
% 210.77/210.97 |- skos__hiddenLabel mesh__D021181 Hypersensitivities, Egg
% 210.77/210.97 |- skos__historyNote mesh__D021181 Eggs %28%1965-2001%29%
% 210.77/210.97 |- skos__prefLabel mesh__D021181 Egg Hypersensitivity
% 210.77/210.97 |- skos__hiddenLabel mesh__D021181 Egg Hypersensitivities
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D021181 2003
% 210.77/210.97 |- skos__hiddenLabel mesh__D021181 Allergies, Egg
% 210.77/210.97 |- skos__related mesh__D015942smesh__D003029
% 210.77/210.97 |- mesh__historyNote mesh__D015942 90
% 210.77/210.97 |- skos__hiddenLabel mesh__D015942 Activated Factor VII
% 210.77/210.97 |- skos__historyNote mesh__D015942 Factor VII %28%1975-1989%29%
% 210.77/210.97 |- rdf__type mesh__D015942sskos__Concept
% 210.77/210.97 |- skos__scopeNote mesh__D015942
% 210.77/210.97 Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation.%A%
% 210.77/210.97 |- mesh__dateEstablished mesh__D015942 1990-01-01
% 210.77/210.97 |- skos__broader mesh__D015942smesh__D012697
% 210.77/210.97 |- skos__altLabel mesh__D015942 Blood Coagulation Factor VII, Activated
% 210.77/210.97 |- skos__altLabel mesh__D015942 Factor VII, Activated
% 210.77/210.97 |- mesh__recordAuthorizer mesh__D015942 sjn
% 210.77/210.97 |- skos__annotation mesh__D015942
% 210.77/210.97 a blood coag factor; a serine proteinase; /defic = FACTOR VII DEFICIENCY%A%
% 210.77/210.97 |- mesh__activeMeSHYear mesh__D015942 2006
% 210.77/210.97 |- mesh__publicMeSHNote mesh__D015942 90
% 210.77/210.97 |- skos__altLabel mesh__D015942 Coagulation Factor VIIa
% 210.77/210.97 |- skos__broader mesh__D015942smesh__D005167
% 210.77/210.97 |- skos__prefLabel mesh__D015942 Factor VIIa
% 210.77/210.97 |- mesh__recordOriginator mesh__D015942 AGS
% 210.77/210.98 |- mesh__recordMaintainer mesh__D015942 ssb
% 210.77/210.98 |- mesh__dateCreated mesh__D015942 1989-05-25
% 210.77/210.98 |- mesh__dateRevised mesh__D015942 2005-06-30
% 210.77/210.98 |- skos__hiddenLabel mesh__D015942 VIIa, Coagulation Factor
% 210.77/210.98 |- skos__hiddenLabel mesh__D015942 Factor VIIa, Coagulation
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015144 2001
% 210.77/210.98 |- mesh__dateEstablished mesh__D015144 1989-01-01
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015144 2003
% 210.77/210.98 |- mesh__dateRevised mesh__D015144 1997-06-20
% 210.77/210.98 |- skos__prefLabel mesh__D015144 Southeastern United States
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015144 2000
% 210.77/210.98 |- rdf__type mesh__D015144sskos__Concept
% 210.77/210.98 |- skos__altLabel mesh__D015144 Southeast US
% 210.77/210.98 |- mesh__dateCreated mesh__D015144 1988-03-18
% 210.77/210.98 |- mesh__recordOriginator mesh__D015144 EC
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015144 2002
% 210.77/210.98 |- mesh__recordMaintainer mesh__D015144 PXP
% 210.77/210.98 |- skos__broader mesh__D015144smesh__D014481
% 210.77/210.98 |- skos__annotation mesh__D015144
% 210.77/210.98 includes Ala, Ark, Fla, Ga, La, Miss, N Carolina, S Carolina, W Virginia, Virginia; specify as needed but use SOUTHEASTERN UNITED STATES when text uses the term; DF: note short X ref CATALOG: use for 4 or more states%A%
% 210.77/210.98 |- mesh__historyNote mesh__D015144 89
% 210.77/210.98 |- skos__altLabel mesh__D015144 Southeast U.S.
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015144 2006
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015144 1999
% 210.77/210.98 |- skos__scopeNote mesh__D015144
% 210.77/210.98 The geographic area of the southeastern region of the United States in general or when the specific state or states are not included. The states usually included in this region are Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, West Virginia, and Virginia.%A%
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015144 2005
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D015144 SJN
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015144 2004
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015144 1998
% 210.77/210.98 |- skos__annotation mesh__D009905 a type of spectrum anal; NIM
% 210.77/210.98 |- skos__prefLabel mesh__D009905 Optical Rotatory Dispersion
% 210.77/210.98 |- mesh__dateCreated mesh__D009905 1999-01-01
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D009905 70
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009905 2003
% 210.77/210.98 |- mesh__recordOriginator mesh__D009905 NLM
% 210.77/210.98 |- mesh__dateEstablished mesh__D009905 1970-01-01
% 210.77/210.98 |- mesh__dateRevised mesh__D009905 2002-07-03
% 210.77/210.98 |- skos__broader mesh__D009905smesh__D013057
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009905 2005
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009905 2004
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009905 2006
% 210.77/210.98 |- skos__historyNote mesh__D009905 Spectrum Analysis %28%1966-1967%29%
% 210.77/210.98 |- rdf__type mesh__D009905sskos__Concept
% 210.77/210.98 |- skos__hiddenLabel mesh__D009905 Rotatory Dispersion, Optical
% 210.77/210.98 |- mesh__historyNote mesh__D009905 70%28%68%29%
% 210.77/210.98 |- skos__scopeNote mesh__D009905
% 210.77/210.98 The method of measuring the dispersion of an optically active molecule to determine the relative magnitude of right- or left-handed components and sometimes structural features of the molecule.%A%
% 210.77/210.98 |- mesh__recordMaintainer mesh__D009905 lkt
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D009905 sjn
% 210.77/210.98 |- skos__hiddenLabel mesh__D009905 Dispersion, Optical Rotatory
% 210.77/210.98 |- skos__prefLabel mesh__D001922 Brain Abscess
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Abscess, Child Brain
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Child Brain Abscess
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001922 2005
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D001922 ags
% 210.77/210.98 |- mesh__dateCreated mesh__D001922 1999-01-01
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Brain Abscesses, Multiple
% 210.77/210.98 |- skos__broader mesh__D001922smesh__D001423
% 210.77/210.98 |- skos__broader mesh__D001922smesh__D000038
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Multiple Brain Abscess
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001922 2006
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Sterile Brain Abscesses
% 210.77/210.98 |- skos__annotation mesh__D001922
% 210.77/210.98 coord IM with specific infection %28%IM%29% + specific CNS infect term %28%IM%29% + site/dis term %28%IM%29% if pertinent%A%
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Pyogenic Brain Abscess
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Abscesses, Cerebral
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001922 2004
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Brain Abscesses
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Multiple Brain Abscesses
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Abscesses, Multiple Brain
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Sterile Brain Abscess
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001922 2006A
% 210.77/210.98 |- skos__scopeNote mesh__D001922
% 210.77/210.98 A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear %28%see EAR, MIDDLE%29%; HEART %28%see also ENDOCARDITIS, BACTERIAL%29%, and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. %28%Adams et al., Principles of Neurology, 6th ed, pp712-6%29%%A%
% 210.77/210.98 |- skos__broader mesh__D001922smesh__D002494
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Brain Abscesses, Sterile
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Brain Abscesses, Pyogenic
% 210.77/210.98 |- mesh__recordOriginator mesh__D001922 NLM
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Abscess, Pyogenic Brain
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Pyogenic Brain Abscesses
% 210.77/210.98 |- mesh__dateRevised mesh__D001922 2005-07-15
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Abscess, Brain
% 210.77/210.98 |- skos__related mesh__D001922smesh__D013354
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Cerebral Abscesses
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Abscess, Cerebral
% 210.77/210.98 |- skos__broader mesh__D001922smesh__D001927
% 210.77/210.98 |- rdf__type mesh__D001922sskos__Concept
% 210.77/210.98 |- skos__hiddenLabel mesh__D001922 Abscess, Multiple Brain
% 210.77/210.98 |- mesh__recordMaintainer mesh__D001922 ags
% 210.77/210.98 |- skos__broader mesh__D001922smesh__D020806
% 210.77/210.98 |- skos__broader mesh__D009107smesh__D010309
% 210.77/210.98 |- skos__hiddenLabel mesh__D009107 Parotitides, Epidemic
% 210.77/210.98 |- mesh__dateRevised mesh__D009107 2001-08-03
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009107 2005
% 210.77/210.98 |- mesh__dateCreated mesh__D009107 1999-01-01
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009107 2004
% 210.77/210.98 |- skos__annotation mesh__D009107
% 210.77/210.98 caused by the MUMPS VIRUS, a rubulavirus
% 210.77/210.98 |- skos__hiddenLabel mesh__D009107 Epidemic Parotitides
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009107 2003
% 210.77/210.98 |- rdf__type mesh__D009107sskos__Concept
% 210.77/210.98 |- skos__hiddenLabel mesh__D009107 Epidemic Parotitis
% 210.77/210.98 |- skos__prefLabel mesh__D009107 Mumps
% 210.77/210.98 |- mesh__recordOriginator mesh__D009107 NLM
% 210.77/210.98 |- skos__broader mesh__D009107smesh__D019351
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009107 2002
% 210.77/210.98 |- skos__scopeNote mesh__D009107
% 210.77/210.98 An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. %28%From Dorland, 28th ed%29%%A%
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009107 2006
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D009107 sjn
% 210.77/210.98 |- mesh__recordMaintainer mesh__D009107 sjn
% 210.77/210.98 |- skos__altLabel mesh__D009107 Parotitis, Epidemic
% 210.77/210.98 |- skos__prefLabel mesh__D001124 Argininosuccinate Synthase
% 210.77/210.98 |- skos__hiddenLabel mesh__D001124 Synthetase, Argininosuccinate
% 210.77/210.98 |- skos__historyNote mesh__D001124 Succinates %28%1973-1974%29%
% 210.77/210.98 |- mesh__recordMaintainer mesh__D001124 ssb
% 210.77/210.98 |- mesh__dateCreated mesh__D001124 1974-11-19
% 210.77/210.98 |- mesh__dateEstablished mesh__D001124 1991-01-01
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001124 2004
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D001124
% 210.77/210.98 98; see ARGININOSUCCINATE SYNTHETASE 1991-97; see LIGASES 1975-90%A%
% 210.77/210.98 |- skos__historyNote mesh__D001124 Arginine %28%1973-1974%29%
% 210.77/210.98 |- skos__scopeNote mesh__D001124
% 210.77/210.98 An enzyme of the urea cycle that catalyzes the formation of argininosuccinic acid from citrulline and aspartic acid in the presence of ATP. Absence or deficiency of this enzyme causes the metabolic disease CITRULLINEMIA in humans. EC 6.3.4.5.%A%
% 210.77/210.98 |- skos__broader mesh__D001124smesh__D019731
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001124 2006
% 210.77/210.98 |- skos__annotation mesh__D001124 /defic: consider also CITRULLINEMIA
% 210.77/210.98 |- mesh__historyNote mesh__D001124 98%28%75%29%
% 210.77/210.98 |- mesh__recordOriginator mesh__D001124 NLM
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D001124 sjn
% 210.77/210.98 |- rdf__type mesh__D001124sskos__Concept
% 210.77/210.98 |- skos__historyNote mesh__D001124 Ligases %28%1973-1974%29%
% 210.77/210.98 |- skos__hiddenLabel mesh__D001124 Synthase, Argininosuccinate
% 210.77/210.98 |- skos__altLabel mesh__D001124 Argininosuccinate Synthetase
% 210.77/210.98 |- skos__related mesh__D001124smesh__D020159
% 210.77/210.98 |- mesh__dateRevised mesh__D001124 2003-07-09
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001124 2005
% 210.77/210.98 |- skos__historyNote mesh__D020887 Oxides %28%1974-1979%29%
% 210.77/210.98 |- mesh__recordOriginator mesh__D020887 adp
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020887 2000
% 210.77/210.98 |- skos__historyNote mesh__D020887 Selenium %28%1974-1993%29%
% 210.77/210.98 |- rdf__type mesh__D020887sskos__Concept
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020887 2004
% 210.77/210.98 |- mesh__recordMaintainer mesh__D020887 ags
% 210.77/210.98 |- skos__broader mesh__D020887smesh__D018036
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D020887
% 210.77/210.98 2000; SELENIOUS ACID was indexed under SELENIUM COMPOUNDS 1994-1999, SELENIUM 1974-1993, %26% OXIDES 1974-1979%A%
% 210.77/210.98 |- mesh__dateCreated mesh__D020887 1999-11-08
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020887 2006
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D020887 ags
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020887 2003
% 210.77/210.98 |- skos__scopeNote mesh__D020887
% 210.77/210.98 A selenium compound used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.%A%
% 210.77/210.98 |- mesh__dateEstablished mesh__D020887 2000-01-01
% 210.77/210.98 |- mesh__dateRevised mesh__D020887 2000-01-19
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020887 2000B
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020887 2005
% 210.77/210.98 |- mesh__historyNote mesh__D020887
% 210.77/210.98 2000; use SELENIOUS ACID %28%NM%29% 1974-1999
% 210.77/210.98 |- skos__prefLabel mesh__D020887 Selenious Acid
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020887 2002
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020887 2000A
% 210.77/210.98 |- skos__hiddenLabel mesh__D020887 Acid, Selenious
% 210.77/210.98 |- skos__historyNote mesh__D020887 Selenium Compounds %28%1994-1999%29%
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020887 2001
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D020089 sjn
% 210.77/210.98 |- skos__altLabel mesh__D020089 Piromonas
% 210.77/210.98 |- mesh__recordMaintainer mesh__D020089 SYSTEM
% 210.77/210.98 |- mesh__recordOriginator mesh__D020089 AGS
% 210.77/210.98 |- mesh__historyNote mesh__D020089
% 210.77/210.98 1999; for PIROMONAS use NEOCALLIMASTICALES 1999-2004
% 210.77/210.98 |- skos__broader mesh__D020089smesh__D020085
% 210.77/210.98 |- mesh__dateEstablished mesh__D020089 1999-01-01
% 210.77/210.98 |- mesh__dateCreated mesh__D020089 1998-06-10
% 210.77/210.98 |- skos__scopeNote mesh__D020089
% 210.77/210.98 A genus of fungi in the family Neocallimasticaceae, order NEOCALLIMASTICALES, containing uniflagellate zoospores.%A%
% 210.77/210.98 |- skos__historyNote mesh__D020089 Fungi %28%1992-1998%29%
% 210.77/210.98 |- skos__prefLabel mesh__D020089 Piromyces
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D020089
% 210.77/210.98 1999; for PIROMONAS see NEOCALLIMASTICALES 1999-2004
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D020089 2006
% 210.77/210.98 |- skos__historyNote mesh__D020089 Chytridiomycota %28%1991-1996%29%
% 210.77/210.98 |- rdf__type mesh__D020089sskos__Concept
% 210.77/210.98 |- mesh__dateRevised mesh__D020089 2005-06-30
% 210.77/210.98 |- mesh__recordOriginator mesh__D019535 PXP
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D019535 97
% 210.77/210.98 |- mesh__dateEstablished mesh__D019535 1997-01-01
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D019535 sjn
% 210.77/210.98 |- skos__annotation mesh__D019535
% 210.77/210.98 infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%
% 210.77/210.98 |- skos__prefLabel mesh__D019535 Mycoplasma hominis
% 210.77/210.98 |- mesh__dateCreated mesh__D019535 1996-06-13
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D019535 2006
% 210.77/210.98 |- skos__scopeNote mesh__D019535
% 210.77/210.98 A common inhabitant of the vagina and cervix and a potential human pathogen, causing infections of the male and female reproductive tracts. It has also been associated with respiratory disease and pharyngitis. %28%From Dorland, 28th ed%29%%A%
% 210.77/210.98 |- mesh__recordMaintainer mesh__D019535 SYSTEM
% 210.77/210.98 |- skos__historyNote mesh__D019535 Mycoplasma %28%1966-1996%29%
% 210.77/210.98 |- mesh__dateRevised mesh__D019535 2005-06-30
% 210.77/210.98 |- rdf__type mesh__D019535sskos__Concept
% 210.77/210.98 |- mesh__historyNote mesh__D019535 97
% 210.77/210.98 |- skos__broader mesh__D019535smesh__D009174
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 2006
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 2002
% 210.77/210.98 |- skos__altLabel mesh__D011552 Infections, Pseudomonas
% 210.77/210.98 |- mesh__dateCreated mesh__D011552 1999-01-01
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 2005
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 1999
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 2001
% 210.77/210.98 |- mesh__recordMaintainer mesh__D011552 PLS
% 210.77/210.98 |- mesh__recordOriginator mesh__D011552 NLM
% 210.77/210.98 |- rdf__type mesh__D011552sskos__Concept
% 210.77/210.98 |- skos__hiddenLabel mesh__D011552 Infection, Pseudomonas
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 2004
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 1998
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 2000
% 210.77/210.98 |- mesh__dateRevised mesh__D011552 1995-05-31
% 210.77/210.98 |- skos__prefLabel mesh__D011552 Pseudomonas Infections
% 210.77/210.98 |- skos__scopeNote mesh__D011552
% 210.77/210.98 Infections with bacteria of the genus PSEUDOMONAS.
% 210.77/210.98 |- skos__broader mesh__D011552smesh__D016905
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D011552 PLS
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 2003
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 1997
% 210.77/210.98 |- skos__hiddenLabel mesh__D011552 Pseudomonas Infection
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D011552 1996
% 210.77/210.98 |- skos__annotation mesh__D011552
% 210.77/210.98 gram-neg bact infect; see note under PSEUDOMONAS AERUGINOSA%A%
% 210.77/210.98 |- rdf__type mesh__D005515sskos__Concept
% 210.77/210.98 |- mesh__dateCreated mesh__D005515 1999-01-01
% 210.77/210.98 |- skos__broader mesh__D005515smesh__D018857
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D005515 2003
% 210.77/210.98 |- mesh__recordOriginator mesh__D005515 NLM
% 210.77/210.98 |- mesh__dateEstablished mesh__D005515 1974-01-01
% 210.77/210.98 |- skos__altLabel mesh__D005515 Product Labeling, Food
% 210.77/210.98 |- skos__hiddenLabel mesh__D005515 Labeling, Food Product
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D005515 2000
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D005515 SJN
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D005515 2005
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D005515 2004
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D005515 1998
% 210.77/210.98 |- mesh__historyNote mesh__D005515 74
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D005515 74
% 210.77/210.98 |- skos__altLabel mesh__D005515 Food Labelling
% 210.77/210.98 |- skos__prefLabel mesh__D005515 Food Labeling
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D005515 2001
% 210.77/210.98 |- skos__scopeNote mesh__D005515
% 210.77/210.98 Use of written, printed, or graphic materials upon or accompanying a food or its container or wrapper. The concept includes ingredients, nutritional value, directions, warnings, and other relevant information.%A%
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D005515 2006
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D005515 1999
% 210.77/210.98 |- mesh__recordMaintainer mesh__D005515 JLS
% 210.77/210.98 |- skos__hiddenLabel mesh__D005515 Labeling, Nutrition
% 210.77/210.98 |- skos__altLabel mesh__D005515 Labeling, Food
% 210.77/210.98 |- mesh__dateRevised mesh__D005515 1997-06-20
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D005515 2002
% 210.77/210.98 |- skos__hiddenLabel mesh__D005515 Food Product Labeling
% 210.77/210.98 |- skos__hiddenLabel mesh__D005515 Labelling, Food
% 210.77/210.98 |- rdf__type mesh__D029963sskos__Concept
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D029963 2003
% 210.77/210.98 |- mesh__dateEstablished mesh__D029963 2002-01-01
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D029963 2002
% 210.77/210.98 |- skos__annotation mesh__D029963
% 210.77/210.98 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D029963 2005
% 210.77/210.98 |- skos__broader mesh__D029963smesh__D029962
% 210.77/210.98 |- mesh__dateCreated mesh__D029963 2001-07-25
% 210.77/210.98 |- mesh__dateRevised mesh__D029963 2002-07-03
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D029963 sjn
% 210.77/210.98 |- mesh__historyNote mesh__D029963 2002
% 210.77/210.98 |- skos__scopeNote mesh__D029963
% 210.77/210.98 A plant genus of the family FAGACEAE that is a source of TANNINS. Do not confuse with Holly %28%ILEX%29%.%A%
% 210.77/210.98 |- skos__prefLabel mesh__D029963 Quercus
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D029963 2004
% 210.77/210.98 |- mesh__recordOriginator mesh__D029963 ssb
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D029963 2006
% 210.77/210.98 |- mesh__recordMaintainer mesh__D029963 ssb
% 210.77/210.98 |- skos__scopeNote mesh__D021182
% 210.77/210.98 Allergic reaction to wheat that is triggered by the immune system.%A%
% 210.77/210.98 |- skos__broader mesh__D021182smesh__D005512
% 210.77/210.98 |- mesh__dateEstablished mesh__D021182 2002-01-01
% 210.77/210.98 |- skos__historyNote mesh__D021182 Food Allergy %28%1967-2001%29%
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D021182 2002
% 210.77/210.98 |- skos__historyNote mesh__D021182 Wheat %28%1967-2001%29%
% 210.77/210.98 |- rdf__type mesh__D021182sskos__Concept
% 210.77/210.98 |- skos__altLabel mesh__D021182 Wheat Allergy
% 210.77/210.98 |- skos__annotation mesh__D021182 differentiate from CELIAC DISEASE
% 210.77/210.98 |- skos__hiddenLabel mesh__D021182 Wheat Hypersensitivities
% 210.77/210.98 |- skos__hiddenLabel mesh__D021182 Hypersensitivities, Wheat
% 210.77/210.98 |- skos__prefLabel mesh__D021182 Wheat Hypersensitivity
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D021182 2003
% 210.77/210.98 |- skos__hiddenLabel mesh__D021182 Allergies, Wheat
% 210.77/210.98 |- mesh__historyNote mesh__D021182 2002
% 210.77/210.98 |- mesh__dateCreated mesh__D021182 2001-07-25
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D021182 2005
% 210.77/210.98 |- skos__altLabel mesh__D021182 Allergy, Wheat
% 210.77/210.98 |- skos__hiddenLabel mesh__D021182 Wheat Allergies
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D021182 2004
% 210.77/210.98 |- skos__altLabel mesh__D021182 Hypersensitivity, Wheat
% 210.77/210.98 |- skos__related mesh__D021182smesh__D002446
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D021182 2006
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D021182 2002
% 210.77/210.98 |- mesh__dateEstablished mesh__D015943 1990-01-01
% 210.77/210.98 |- rdf__type mesh__D015943sskos__Concept
% 210.77/210.98 |- skos__hiddenLabel mesh__D015943 Va, Coagulation Factor
% 210.77/210.98 |- skos__related mesh__D015943smesh__D003029
% 210.77/210.98 |- skos__broader mesh__D015943smesh__D005165
% 210.77/210.98 |- skos__altLabel mesh__D015943 Blood Coagulation Factor V, Activated
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D015943 sjn
% 210.77/210.98 |- skos__altLabel mesh__D015943 Coagulation Factor Va
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D015943 90
% 210.77/210.98 |- skos__hiddenLabel mesh__D015943 Factor Va, Coagulation
% 210.77/210.98 |- skos__altLabel mesh__D015943 Factor V, Activated
% 210.77/210.98 |- skos__historyNote mesh__D015943 Factor V %28%1974-1989%29%
% 210.77/210.98 |- mesh__dateCreated mesh__D015943 1989-05-25
% 210.77/210.98 |- mesh__recordMaintainer mesh__D015943 ssb
% 210.77/210.98 |- mesh__recordOriginator mesh__D015943 AGS
% 210.77/210.98 |- skos__annotation mesh__D015943
% 210.77/210.98 a blood coag factor; /defic = FACTOR V DEFICIENCY
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015943 2006
% 210.77/210.98 |- skos__scopeNote mesh__D015943
% 210.77/210.98 Activated form of factor V. It is an essential cofactor for the activation of prothrombin catalyzed by factor Xa.%A%
% 210.77/210.98 |- mesh__historyNote mesh__D015943 90
% 210.77/210.98 |- mesh__dateRevised mesh__D015943 2005-06-30
% 210.77/210.98 |- skos__prefLabel mesh__D015943 Factor Va
% 210.77/210.98 |- skos__hiddenLabel mesh__D015943 Activated Factor V
% 210.77/210.98 |- skos__altLabel mesh__D015145 Therapy, Tocolytic
% 210.77/210.98 |- skos__hiddenLabel mesh__D015145 Treatments, Tocolytic
% 210.77/210.98 |- skos__historyNote mesh__D015145 Labor, Premature %28%1973-1988%29%
% 210.77/210.98 |- skos__historyNote mesh__D015145 Uterine Contraction %28%1975-1988%29%
% 210.77/210.98 |- rdf__type mesh__D015145sskos__Concept
% 210.77/210.98 |- mesh__recordOriginator mesh__D015145 SCD
% 210.77/210.98 |- mesh__recordMaintainer mesh__D015145 lkt
% 210.77/210.98 |- skos__scopeNote mesh__D015145
% 210.77/210.98 Any drug treatment modality designed to inhibit UTERINE CONTRACTION. It is used in pregnant women to arrest PREMATURE LABOR.%A%
% 210.77/210.98 |- skos__annotation mesh__D015145
% 210.77/210.98 check tags FEMALE %26% PREGNANCY; %22%tokolysis%22%: translate as %22%tocolysis%22%; TOCOLYTIC AGENTS is available%A%
% 210.77/210.98 |- skos__historyNote mesh__D015145 Uterus %28%1966-1974%29%
% 210.77/210.98 |- skos__hiddenLabel mesh__D015145 Tocolyses
% 210.77/210.98 |- mesh__dateRevised mesh__D015145 2005-06-30
% 210.77/210.98 |- skos__historyNote mesh__D015145 Muscle Contraction %28%1966-1974%29%
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D015145 2006
% 210.77/210.98 |- skos__hiddenLabel mesh__D015145 Treatment, Tocolytic
% 210.77/210.98 |- skos__altLabel mesh__D015145 Tocolytic Therapy
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D015145 sjn
% 210.77/210.98 |- skos__prefLabel mesh__D015145 Tocolysis
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D015145 89
% 210.77/210.98 |- skos__hiddenLabel mesh__D015145 Therapies, Tocolytic
% 210.77/210.98 |- mesh__dateEstablished mesh__D015145 1989-01-01
% 210.77/210.98 |- skos__hiddenLabel mesh__D015145 Tocolytic Treatments
% 210.77/210.98 |- mesh__dateCreated mesh__D015145 1988-03-21
% 210.77/210.98 |- skos__broader mesh__D015145smesh__D012099
% 210.77/210.98 |- mesh__historyNote mesh__D015145 89
% 210.77/210.98 |- skos__altLabel mesh__D015145 Tocolytic Treatment
% 210.77/210.98 |- skos__hiddenLabel mesh__D015145 Tocolytic Therapies
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 2005
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 2004
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 1999
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 2002
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 1994
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 2006
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 1993
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D009906 PLS
% 210.77/210.98 |- skos__hiddenLabel mesh__D009906 Optic
% 210.77/210.98 |- rdf__type mesh__D009906sskos__Concept
% 210.77/210.98 |- mesh__dateRevised mesh__D009906 1992-05-15
% 210.77/210.98 |- skos__prefLabel mesh__D009906 Optics
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 1995
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 2000
% 210.77/210.98 |- skos__broader mesh__D009906smesh__D010825
% 210.77/210.98 |- mesh__recordOriginator mesh__D009906 NLM
% 210.77/210.98 |- skos__related mesh__D009906smesh__D007909
% 210.77/210.98 |- skos__related mesh__D009906smesh__D014785
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 1996
% 210.77/210.98 |- mesh__dateCreated mesh__D009906 1999-01-01
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 2001
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 2003
% 210.77/210.98 |- mesh__recordMaintainer mesh__D009906 TAP
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 1998
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D009906 1997
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 2003
% 210.77/210.98 |- mesh__historyNote mesh__D001923 65
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 1998
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 2006
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 1995
% 210.77/210.98 |- skos__hiddenLabel mesh__D001923 Chemistries, Brain
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 1993
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 1996
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 2004
% 210.77/210.98 |- mesh__recordMaintainer mesh__D001923 TAP
% 210.77/210.98 |- skos__annotation mesh__D001923
% 210.77/210.98 TN 29: differentiate from BRAIN /metab; consider also /chem with specific parts of the brain but probably as NIM with BRAIN CHEMISTRY %28%IM%29% if site is merely locational %26% illustrative%A%
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 1999
% 210.77/210.98 |- skos__prefLabel mesh__D001923 Brain Chemistry
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 2000
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 1997
% 210.77/210.98 |- mesh__dateRevised mesh__D001923 1992-05-26
% 210.77/210.98 |- mesh__dateEstablished mesh__D001923 1965-01-01
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 2001
% 210.77/210.98 |- skos__broader mesh__D001923smesh__D001669
% 210.77/210.98 |- skos__altLabel mesh__D001923 Chemistry, Brain
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 2002
% 210.77/210.98 |- rdf__type mesh__D001923sskos__Concept
% 210.77/210.98 |- mesh__publicMeSHNote mesh__D001923 65
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D001923 PLS
% 210.77/210.98 |- mesh__recordOriginator mesh__D001923 NLM
% 210.77/210.98 |- skos__hiddenLabel mesh__D001923 Brain Chemistries
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 2005
% 210.77/210.98 |- mesh__activeMeSHYear mesh__D001923 1994
% 210.77/210.98 |- mesh__dateCreated mesh__D001923 1999-01-01
% 210.77/210.98 |- skos__historyNote mesh__D009108 Mumps Virus %28%1966-1968%29%
% 210.77/210.98 |- mesh__recordAuthorizer mesh__D009108 sjn
% 210.77/210.98 |- mesh__dateRevised mesh__D009108 2005-06-30
% 210.77/210.98 |- skos__scopeNote mesh__D009108
% 210.77/210.98 A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.%A%
% 210.77/210.99 |- rdf__type mesh__D009108sskos__Concept
% 210.77/210.99 |- mesh__historyNote mesh__D009108 72%28%69%29%
% 210.77/210.99 |- mesh__recordMaintainer mesh__D009108 ssb
% 210.77/210.99 |- mesh__dateEstablished mesh__D009108 1972-01-01
% 210.77/210.99 |- skos__hiddenLabel mesh__D009108 Vaccine, Mumps
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009108 2006
% 210.77/210.99 |- skos__historyNote mesh__D009108 Viral Vaccines %28%1966-1968%29%
% 210.77/210.99 |- skos__prefLabel mesh__D009108 Mumps Vaccine
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D009108 72
% 210.77/210.99 |- skos__broader mesh__D009108smesh__D014765
% 210.77/210.99 |- mesh__recordOriginator mesh__D009108 NLM
% 210.77/210.99 |- mesh__dateCreated mesh__D009108 1999-01-01
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001125 2004
% 210.77/210.99 |- skos__hiddenLabel mesh__D001125 Acid, Argininosuccinic
% 210.77/210.99 |- skos__scopeNote mesh__D001125
% 210.77/210.99 This amino acid is formed during the urea cycle from citrulline, aspartate and ATP. This reaction is catalyzed by argininosuccinic acid synthetase.%A%
% 210.77/210.99 |- mesh__dateEstablished mesh__D001125 1991-01-01
% 210.77/210.99 |- mesh__dateRevised mesh__D001125 2001-07-25
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D001125 sjn
% 210.77/210.99 |- mesh__dateCreated mesh__D001125 1975-07-21
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001125 2003
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001125 2006
% 210.77/210.99 |- skos__altLabel mesh__D001125
% 210.77/210.99 N-%28%4-Amino-4-carboxybutyl%29%amidino-L-aspartic Acid
% 210.77/210.99 |- rdf__type mesh__D001125sskos__Concept
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001125 2005
% 210.77/210.99 |- skos__historyNote mesh__D001125 Succinates %28%1971-1975%29%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001125 2002
% 210.77/210.99 |- mesh__historyNote mesh__D001125
% 210.77/210.99 91%28%76%29%; was see under ARGININE 1976-90
% 210.77/210.99 |- skos__historyNote mesh__D001125
% 210.77/210.99 Arginine %28%1971-1974%29% /analogs %26% derivatives %28%1975%29%
% 210.77/210.99 |- mesh__recordOriginator mesh__D001125 RLS
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D001125 91; was see under ARGININE 1976-90
% 210.77/210.99 |- skos__broader mesh__D001125smesh__D019822
% 210.77/210.99 |- skos__broader mesh__D001125smesh__D001120
% 210.77/210.99 |- skos__prefLabel mesh__D001125 Argininosuccinic Acid
% 210.77/210.99 |- mesh__recordMaintainer mesh__D001125 nns
% 210.77/210.99 |- rdf__type mesh__D020888sskos__Concept
% 210.77/210.99 |- mesh__historyNote mesh__D020888 2000; use VIGABATRIN 1977-1999
% 210.77/210.99 |- mesh__recordMaintainer mesh__D020888 ssb
% 210.77/210.99 |- skos__historyNote mesh__D020888
% 210.77/210.99 GABA/analogs %26% derivatives %28%1979-1980%29%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020888 2006
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D020888 sjn
% 210.77/210.99 |- mesh__recordOriginator mesh__D020888 adp
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D020888
% 210.77/210.99 2000; VIGABATRIN was indexed under GABA/analogs %26% derivatives 1994-1999, AMINOCAPROIC ACIDS 1981-1994, %26% GABA/analogs 1979-1980%A%
% 210.77/210.99 |- skos__altLabel mesh__D020888 gamma-Vinyl-GABA
% 210.77/210.99 |- mesh__dateRevised mesh__D020888 2005-06-30
% 210.77/210.99 |- mesh__dateEstablished mesh__D020888 2000-01-01
% 210.77/210.99 |- skos__hiddenLabel mesh__D020888 gamma Vinyl GABA
% 210.77/210.99 |- skos__broader mesh__D020888smesh__D005680
% 210.77/210.99 |- mesh__dateCreated mesh__D020888 1999-11-04
% 210.77/210.99 |- skos__hiddenLabel mesh__D020888 gamma Vinyl gamma Aminobutyric Acid
% 210.77/210.99 |- skos__hiddenLabel mesh__D020888 Acid, gamma-Vinyl-gamma-Aminobutyric
% 210.77/210.99 |- skos__scopeNote mesh__D020888
% 210.77/210.99 An analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID. %28%From Martindale The Extra Pharmacopoeia, 31st ed%29%%A%
% 210.77/210.99 |- skos__prefLabel mesh__D020888 Vigabatrin
% 210.77/210.99 |- skos__altLabel mesh__D020888 gamma-Vinyl-gamma-Aminobutyric Acid
% 210.77/210.99 |- skos__historyNote mesh__D020888
% 210.77/210.99 GABA/analogs %26% derivatives %28%1994-1999%29%
% 210.77/210.99 |- skos__historyNote mesh__D020888 Aminocaproic Acids %28%1981-1994%29%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 2005
% 210.77/210.99 |- mesh__dateCreated mesh__D011553 1986-04-18
% 210.77/210.99 |- mesh__recordMaintainer mesh__D011553 KEV
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 1999
% 210.77/210.99 |- mesh__historyNote mesh__D011553 87
% 210.77/210.99 |- skos__annotation mesh__D011553
% 210.77/210.99 neoplastic; accumulation of mucoid matter in peritoneal cavity: see MeSH definition; coord IM with PERITONEAL NEOPLASMS %28%IM%29%%A%
% 210.77/210.99 |- skos__prefLabel mesh__D011553 Pseudomyxoma Peritonei
% 210.77/210.99 |- skos__scopeNote mesh__D011553
% 210.77/210.99 A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma %28%CYSTADENOCARCINOMA, MUCINOUS%29%, which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 2004
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 1998
% 210.77/210.99 |- rdf__type mesh__D011553sskos__Concept
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 2002
% 210.77/210.99 |- skos__altLabel mesh__D011553 Ascites, Gelatinous
% 210.77/210.99 |- mesh__dateEstablished mesh__D011553 1987-01-01
% 210.77/210.99 |- skos__broader mesh__D011553smesh__D018297
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 2003
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 1997
% 210.77/210.99 |- mesh__dateRevised mesh__D011553 1995-06-08
% 210.77/210.99 |- skos__altLabel mesh__D011553 Gelatinous Ascites
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 2001
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D011553 87
% 210.77/210.99 |- skos__historyNote mesh__D011553 Ascitic Fluid %28%1968-1986%29%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 1996
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 2000
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D011553 PLS
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011553 2006
% 210.77/210.99 |- mesh__recordOriginator mesh__D011553 VDK
% 210.77/210.99 |- skos__historyNote mesh__D011553 Peritoneal Neoplasms %28%1966-1986%29%
% 210.77/210.99 |- mesh__dateEstablished mesh__D005516 1966-01-01
% 210.77/210.99 |- skos__broader mesh__D005516smesh__D005524
% 210.77/210.99 |- mesh__dateRevised mesh__D005516 2001-07-25
% 210.77/210.99 |- skos__scopeNote mesh__D005516
% 210.77/210.99 The presence of bacteria, viruses, and fungi in food and food products. This term is not restricted to pathogenic organisms: the presence of various non-pathogenic bacteria and fungi in cheeses and wines, for example, is included in this concept.%A%
% 210.77/210.99 |- skos__broader mesh__D005516smesh__D005506
% 210.77/210.99 |- rdf__type mesh__D005516sskos__Concept
% 210.77/210.99 |- skos__broader mesh__D005516smesh__D004783
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005516 2004
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D005516 sjn
% 210.77/210.99 |- mesh__historyNote mesh__D005516 66
% 210.77/210.99 |- mesh__dateCreated mesh__D005516 1999-01-01
% 210.77/210.99 |- mesh__recordMaintainer mesh__D005516 jls
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005516 2003
% 210.77/210.99 |- mesh__recordOriginator mesh__D005516 NLM
% 210.77/210.99 |- skos__annotation mesh__D005516
% 210.77/210.99 coord with specific food /microbiol or /virol and specific microbe; FOOD PARASITOLOGY is also available; DF: FOOD MICROBIOL%A%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005516 2002
% 210.77/210.99 |- skos__altLabel mesh__D005516 Microbiology, Food
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005516 2006
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D005516 66
% 210.77/210.99 |- skos__prefLabel mesh__D005516 Food Microbiology
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005516 2005
% 210.77/210.99 |- mesh__dateCreated mesh__D029964 2001-07-25
% 210.77/210.99 |- skos__prefLabel mesh__D029964 Fagus
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D029964 2004
% 210.77/210.99 |- skos__scopeNote mesh__D029964 A plant genus of the family FAGACEAE.
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D029964 2002
% 210.77/210.99 |- mesh__historyNote mesh__D029964 2002
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D029964 2006
% 210.77/210.99 |- mesh__dateEstablished mesh__D029964 2002-01-01
% 210.77/210.99 |- rdf__type mesh__D029964sskos__Concept
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D029964 2002
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D029964 2003
% 210.77/210.99 |- skos__annotation mesh__D029964
% 210.77/210.99 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D029964 2005
% 210.77/210.99 |- skos__broader mesh__D029964smesh__D029962
% 210.77/210.99 |- skos__altLabel mesh__D021183 Allergy, Peanut
% 210.77/210.99 |- rdf__type mesh__D021183sskos__Concept
% 210.77/210.99 |- mesh__historyNote mesh__D021183 2002
% 210.77/210.99 |- mesh__dateCreated mesh__D021183 2001-07-25
% 210.77/210.99 |- skos__altLabel mesh__D021183 Peanut Allergy
% 210.77/210.99 |- skos__altLabel mesh__D021183 Hypersensitivity, Peanut
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D021183 2003
% 210.77/210.99 |- skos__hiddenLabel mesh__D021183 Allergies, Peanut
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D021183 2005
% 210.77/210.99 |- skos__hiddenLabel mesh__D021183 Hypersensitivity, Groundnut
% 210.77/210.99 |- skos__annotation mesh__D021183 NUT HYPERSENSITIVITY is also available
% 210.77/210.99 |- skos__hiddenLabel mesh__D021183 Peanut Allergies
% 210.77/210.99 |- skos__historyNote mesh__D021183 Food Hypersensitivity %28%1966-2001%29%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D021183 2004
% 210.77/210.99 |- skos__altLabel mesh__D021183 Groundnut Hypersensitivity
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D021183 2006
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D021183 2002
% 210.77/210.99 |- skos__prefLabel mesh__D021183 Peanut Hypersensitivity
% 210.77/210.99 |- skos__broader mesh__D021183smesh__D005512
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D021183 2002
% 210.77/210.99 |- skos__historyNote mesh__D021183 Arachis hypogaea %28%1966-2001%29%
% 210.77/210.99 |- skos__scopeNote mesh__D021183
% 210.77/210.99 Allergic reaction to peanuts that is triggered by the immune system.%A%
% 210.77/210.99 |- mesh__dateEstablished mesh__D021183 2002-01-01
% 210.77/210.99 |- skos__hiddenLabel mesh__D015944 Activated Factor VIII
% 210.77/210.99 |- skos__altLabel mesh__D015944 Blood Coagulation Factor VIII, Activated
% 210.77/210.99 |- mesh__historyNote mesh__D015944 90
% 210.77/210.99 |- mesh__dateRevised mesh__D015944 2005-06-30
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D015944 90
% 210.77/210.99 |- skos__hiddenLabel mesh__D015944 Thrombin-Activated Factor VIII
% 210.77/210.99 |- skos__related mesh__D015944smesh__D003029
% 210.77/210.99 |- skos__prefLabel mesh__D015944 Factor VIIIa
% 210.77/210.99 |- skos__annotation mesh__D015944
% 210.77/210.99 a blood coag factor; /defic = HEMOPHILIA
% 210.77/210.99 |- skos__scopeNote mesh__D015944
% 210.77/210.99 Activated form of factor VIII. The B-domain of factor VIII is proteolytically cleaved by thrombin to form factor VIIIa. Factor VIIIa exists as a non-covalent dimer in a metal-linked %28%probably calcium%29% complex and functions as a cofactor in the enzymatic activation of factor X by factor IXa. Factor VIIIa is similar in structure and generation to factor Va.%A%
% 210.77/210.99 |- mesh__dateCreated mesh__D015944 1989-05-25
% 210.77/210.99 |- skos__altLabel mesh__D015944 Factor VIII, Thrombin-Activated
% 210.77/210.99 |- skos__altLabel mesh__D015944 Factor VIII, Activated
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015944 2006
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D015944 sjn
% 210.77/210.99 |- skos__hiddenLabel mesh__D015944 Factor VIIIa, Coagulation
% 210.77/210.99 |- skos__altLabel mesh__D015944 Coagulation Factor VIIIa
% 210.77/210.99 |- skos__broader mesh__D015944smesh__D005169
% 210.77/210.99 |- mesh__dateEstablished mesh__D015944 1990-01-01
% 210.77/210.99 |- rdf__type mesh__D015944sskos__Concept
% 210.77/210.99 |- skos__hiddenLabel mesh__D015944 Factor VIII, Thrombin Activated
% 210.77/210.99 |- mesh__recordMaintainer mesh__D015944 ssb
% 210.77/210.99 |- skos__hiddenLabel mesh__D015944 VIIIa, Coagulation Factor
% 210.77/210.99 |- mesh__recordOriginator mesh__D015944 AGS
% 210.77/210.99 |- skos__historyNote mesh__D015944 Factor VIII %28%1981-1989%29%
% 210.77/210.99 |- rdf__type mesh__D015146sskos__Concept
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D015146 SJN
% 210.77/210.99 |- skos__prefLabel mesh__D015146 Midwestern United States
% 210.77/210.99 |- skos__altLabel mesh__D015146 Middle West U.S.
% 210.77/210.99 |- mesh__historyNote mesh__D015146 89
% 210.77/210.99 |- skos__annotation mesh__D015146
% 210.77/210.99 includes Ill, Ind, Iowa, Kans, Ky, Mich, Minn, Missouri, Nebr, Ohio, Okla, N Dakota, S Dakota, Wisc; specify as needed but use MIDWESTERN UNITED STATES when text uses the term; DF: note short X ref CATALOG: use for 4 or more states%A%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015146 2005
% 210.77/210.99 |- skos__scopeNote mesh__D015146
% 210.77/210.99 The geographic area of the midwestern region of the United States in general or when the specific state or states are not indicated. The states usually included in this region are Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, Ohio, Oklahoma, North Dakota, South Dakota and Wisconsin.%A%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015146 1998
% 210.77/210.99 |- skos__broader mesh__D015146smesh__D014481
% 210.77/210.99 |- mesh__dateRevised mesh__D015146 1997-06-20
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015146 2000
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015146 2003
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015146 2006
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015146 2001
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015146 1999
% 210.77/210.99 |- skos__altLabel mesh__D015146 Midwest U.S.
% 210.77/210.99 |- skos__altLabel mesh__D015146 Midwest US
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015146 2004
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D015146 2002
% 210.77/210.99 |- mesh__dateEstablished mesh__D015146 1989-01-01
% 210.77/210.99 |- mesh__recordMaintainer mesh__D015146 PXP
% 210.77/210.99 |- mesh__dateCreated mesh__D015146 1988-03-21
% 210.77/210.99 |- mesh__recordOriginator mesh__D015146 EC
% 210.77/210.99 |- skos__hiddenLabel mesh__D009907 Optometries
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 1994
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 2006
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 1993
% 210.77/210.99 |- rdf__type mesh__D009907sskos__Concept
% 210.77/210.99 |- skos__annotation mesh__D009907 SPEC: SPEC qualif
% 210.77/210.99 |- skos__broader mesh__D009907smesh__D006281
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 1995
% 210.77/210.99 |- skos__prefLabel mesh__D009907 Optometry
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 2002
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D009907 PLS
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 1996
% 210.77/210.99 |- mesh__dateCreated mesh__D009907 1999-01-01
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 1991
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 2003
% 210.77/210.99 |- skos__scopeNote mesh__D009907
% 210.77/210.99 The professional practice of primary eye and vision care that includes the measurement of visual refractive power and the correction of visual defects with lenses or glasses.%A%
% 210.77/210.99 |- mesh__recordMaintainer mesh__D009907 AGS
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 1998
% 210.77/210.99 |- mesh__dateRevised mesh__D009907 1990-05-29
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 1997
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 2000
% 210.77/210.99 |- mesh__recordOriginator mesh__D009907 NLM
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 2005
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 1992
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 2004
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 1999
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009907 2001
% 210.77/210.99 |- rdf__type mesh__D001924sskos__Concept
% 210.77/210.99 |- skos__broader mesh__D001924smesh__D014949
% 210.77/210.99 |- skos__broader mesh__D001924smesh__D016489
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D001924 sjn
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001924 2004
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Cerebral Concussions
% 210.77/210.99 |- skos__broader mesh__D001924smesh__D001930
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Mild Concussions
% 210.77/210.99 |- mesh__recordOriginator mesh__D001924 NLM
% 210.77/210.99 |- skos__prefLabel mesh__D001924 Brain Concussion
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001924 2006
% 210.77/210.99 |- skos__scopeNote mesh__D001924
% 210.77/210.99 A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness %28%often defined as greater than 6 hours in duration%29% may be referred to as post-traumatic coma %28%COMA, POST-HEAD INJURY%29%. %28%From Rowland, Merritt%27%s Textbook of Neurology, 9th ed, p418%29%%A%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001924 2003
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Intermediate Concussions
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Intermediate Concussion
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001924 2002
% 210.77/210.99 |- mesh__dateEstablished mesh__D001924 1965-01-01
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001924 2005
% 210.77/210.99 |- mesh__historyNote mesh__D001924 65%28%63%29%
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Severe Concussions
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001924 2001
% 210.77/210.99 |- skos__altLabel mesh__D001924 Cerebral Concussion
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Brain Concussions
% 210.77/210.99 |- mesh__dateCreated mesh__D001924 1999-01-01
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001924 2000
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Concussion, Brain
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D001924 65
% 210.77/210.99 |- mesh__recordMaintainer mesh__D001924 KEV
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Severe Concussion
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Concussion, Cerebral
% 210.77/210.99 |- skos__altLabel mesh__D001924 Commotio Cerebri
% 210.77/210.99 |- skos__hiddenLabel mesh__D001924 Mild Concussion
% 210.77/210.99 |- mesh__dateRevised mesh__D001924 1999-11-03
% 210.77/210.99 |- skos__hiddenLabel mesh__D009109 Mumps viruses
% 210.77/210.99 |- mesh__recordMaintainer mesh__D009109 ags
% 210.77/210.99 |- skos__scopeNote mesh__D009109
% 210.77/210.99 The type species of RUBULAVIRUS that causes an acute infectious disease in humans, affecting mainly children. Transmission occurs by droplet infection.%A%
% 210.77/210.99 |- mesh__recordOriginator mesh__D009109 NLM
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009109 2006
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009109 2002
% 210.77/210.99 |- skos__altLabel mesh__D009109 Myxovirus parotitidis
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009109 2005
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D009109 sjn
% 210.77/210.99 |- skos__annotation mesh__D009109 infection = MUMPS
% 210.77/210.99 |- mesh__dateCreated mesh__D009109 1999-01-01
% 210.77/210.99 |- skos__altLabel mesh__D009109 Epidemic Parotitis Virus
% 210.77/210.99 |- mesh__dateRevised mesh__D009109 2001-07-25
% 210.77/210.99 |- skos__prefLabel mesh__D009109 Mumps virus
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009109 2004
% 210.77/210.99 |- skos__broader mesh__D009109smesh__D019213
% 210.77/210.99 |- rdf__type mesh__D009109sskos__Concept
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D009109 2003
% 210.77/210.99 |- skos__hiddenLabel mesh__D009109 Epidemic Parotitis Viruses
% 210.77/210.99 |- mesh__dateEstablished mesh__D001126 1991-01-01
% 210.77/210.99 |- mesh__recordOriginator mesh__D001126 NLM
% 210.77/210.99 |- skos__altLabel mesh__D001126 Arginyl-tRNA Synthetase
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D001126 sjn
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001126 2004
% 210.77/210.99 |- skos__hiddenLabel mesh__D001126 Arginyl tRNA Synthetase
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D001126
% 210.77/210.99 98; see ARGINYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%
% 210.77/210.99 |- skos__hiddenLabel mesh__D001126 Arginine tRNA Ligase
% 210.77/210.99 |- skos__altLabel mesh__D001126 Arg-tRNA Ligase
% 210.77/210.99 |- mesh__historyNote mesh__D001126 98%28%75%29%
% 210.77/210.99 |- skos__historyNote mesh__D001126
% 210.77/210.99 Amino Acyl T RNA Synthetases %28%1973-1974%29%
% 210.77/210.99 |- skos__prefLabel mesh__D001126 Arginine-tRNA Ligase
% 210.77/210.99 |- skos__altLabel mesh__D001126 Arginyl T RNA Synthetase
% 210.77/210.99 |- skos__hiddenLabel mesh__D001126 Ligase, Arg-tRNA
% 210.77/210.99 |- rdf__type mesh__D001126sskos__Concept
% 210.77/210.99 |- mesh__dateCreated mesh__D001126 1974-11-19
% 210.77/210.99 |- skos__hiddenLabel mesh__D001126 Arg tRNA Ligase
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001126 2006
% 210.77/210.99 |- mesh__recordMaintainer mesh__D001126 ssb
% 210.77/210.99 |- skos__hiddenLabel mesh__D001126 Ligase, Arginine-tRNA
% 210.77/210.99 |- mesh__dateRevised mesh__D001126 2003-07-09
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D001126 2005
% 210.77/210.99 |- skos__historyNote mesh__D001126 Arginine %28%1973-1974%29%
% 210.77/210.99 |- skos__broader mesh__D001126smesh__D000604
% 210.77/210.99 |- skos__scopeNote mesh__D001126
% 210.77/210.99 An enzyme that activates arginine with its specific transfer RNA. EC 6.1.1.19.%A%
% 210.77/210.99 |- skos__hiddenLabel mesh__D001126 Synthetase, Arginyl-tRNA
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2002
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2004
% 210.77/210.99 |- skos__broader mesh__D020889smesh__D011760
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2005
% 210.77/210.99 |- skos__hiddenLabel mesh__D020889 ZK62711
% 210.77/210.99 |- skos__historyNote mesh__D020889 Cyclopentanes %28%1979-1982%29%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2006
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2000A
% 210.77/210.99 |- mesh__recordOriginator mesh__D020889 adp
% 210.77/210.99 |- skos__hiddenLabel mesh__D020889 ZK 62711
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2000
% 210.77/210.99 |- skos__scopeNote mesh__D020889
% 210.77/210.99 A phosphodiesterase inhibitor with antidepressant properties.%A%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2000B
% 210.77/210.99 |- skos__prefLabel mesh__D020889 Rolipram
% 210.77/210.99 |- skos__historyNote mesh__D020889 Pyrrolidinones %28%1983-1999%29%
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D020889
% 210.77/210.99 2000; ROLIPRAM was indexed under PYRROLIDINONES 1983-1999 %26% CYCLOPENTANES 1979-1982%A%
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2001
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2000C
% 210.77/210.99 |- mesh__dateEstablished mesh__D020889 2000-01-01
% 210.77/210.99 |- mesh__dateCreated mesh__D020889 1999-11-03
% 210.77/210.99 |- mesh__recordMaintainer mesh__D020889 ags
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D020889 ags
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D020889 2003
% 210.77/210.99 |- mesh__dateRevised mesh__D020889 2000-01-19
% 210.77/210.99 |- mesh__historyNote mesh__D020889
% 210.77/210.99 2000; use ROLIPRAM %28%NM%29% 1979-1999
% 210.77/210.99 |- rdf__type mesh__D020889sskos__Concept
% 210.77/210.99 |- skos__prefLabel mesh__D047228 Angiotensin II Type 1 Receptor Blockers
% 210.77/210.99 |- skos__altLabel mesh__D047228 Angiotensin II Type 1 Receptor Antagonists
% 210.77/210.99 |- mesh__dateEstablished mesh__D047228 2005-01-01
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D047228 2005
% 210.77/210.99 |- skos__broader mesh__D047228smesh__D045504
% 210.77/210.99 |- skos__altLabel mesh__D047228 Sartans
% 210.77/210.99 |- skos__historyNote mesh__D047228 Angiotensin II %28%1975-2004%29%
% 210.77/210.99 |- skos__altLabel mesh__D047228 Type 1 Angiotensin Receptor Blockers
% 210.77/210.99 |- rdf__type mesh__D047228sskos__Concept
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D047228 sjn
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D047228 2006
% 210.77/210.99 |- mesh__dateCreated mesh__D047228 2004-07-07
% 210.77/210.99 |- skos__historyNote mesh__D047228
% 210.77/210.99 Angiotensin Receptors/antagonists %26% inhibitors %28%1984-2004%29%
% 210.77/210.99 |- skos__scopeNote mesh__D047228
% 210.77/210.99 Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS.%A%
% 210.77/210.99 |- skos__related mesh__D047228smesh__D000806
% 210.77/210.99 |- mesh__historyNote mesh__D047228 2005
% 210.77/210.99 |- skos__altLabel mesh__D047228 Type 1 Angiotensin Receptor Antagonists
% 210.77/210.99 |- mesh__recordOriginator mesh__D047228 ssb
% 210.77/210.99 |- mesh__recordMaintainer mesh__D047228 ssb
% 210.77/210.99 |- mesh__dateRevised mesh__D047228 2005-06-30
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011554 2006
% 210.77/210.99 |- mesh__publicMeSHNote mesh__D011554 72
% 210.77/210.99 |- mesh__recordMaintainer mesh__D011554 nns
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011554 2005
% 210.77/210.99 |- rdf__type mesh__D011554sskos__Concept
% 210.77/210.99 |- skos__hiddenLabel mesh__D011554 Lamellipodias
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011554 2002
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011554 2004
% 210.77/210.99 |- mesh__historyNote mesh__D011554 72%28%70%29%
% 210.77/210.99 |- mesh__recordOriginator mesh__D011554 NLM
% 210.77/210.99 |- skos__hiddenLabel mesh__D011554 Cell Surface Microspike
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011554 2001
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D011554 2003
% 210.77/210.99 |- skos__broader mesh__D011554smesh__D022081
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D011554 sjn
% 210.77/210.99 |- skos__hiddenLabel mesh__D011554 Microspike, Cell Surface
% 210.77/210.99 |- skos__hiddenLabel mesh__D011554 Surface Microspike, Cell
% 210.77/210.99 |- skos__prefLabel mesh__D011554 Pseudopodia
% 210.77/210.99 |- skos__scopeNote mesh__D011554
% 210.77/210.99 A dynamic actin-rich extension of the surface of an animal cell used for locomotion or prehension of food.%A%
% 210.77/210.99 |- skos__historyNote mesh__D011554 Organoids %28%1966-1969%29%
% 210.77/210.99 |- mesh__dateRevised mesh__D011554 2000-06-21
% 210.77/210.99 |- skos__hiddenLabel mesh__D011554 Surface Microspikes, Cell
% 210.77/210.99 |- skos__hiddenLabel mesh__D011554 Cell Surface Microspikes
% 210.77/210.99 |- mesh__dateEstablished mesh__D011554 1972-01-01
% 210.77/210.99 |- skos__altLabel mesh__D011554 Pseudopodium
% 210.77/210.99 |- mesh__dateCreated mesh__D011554 1999-01-01
% 210.77/210.99 |- rdf__type mesh__D005517sskos__Concept
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005517 2004
% 210.77/210.99 |- skos__prefLabel mesh__D005517 Food Poisoning
% 210.77/210.99 |- mesh__dateCreated mesh__D005517 1999-01-01
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005517 2003
% 210.77/210.99 |- mesh__dateRevised mesh__D005517 2001-07-25
% 210.77/210.99 |- skos__broader mesh__D005517smesh__D011041
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005517 2006
% 210.77/210.99 |- mesh__recordAuthorizer mesh__D005517 sjn
% 210.77/210.99 |- skos__altLabel mesh__D005517 Poisoning, Food
% 210.77/210.99 |- skos__hiddenLabel mesh__D005517 Food Poisonings
% 210.77/210.99 |- mesh__recordOriginator mesh__D005517 NLM
% 210.77/210.99 |- mesh__recordMaintainer mesh__D005517 tpw
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005517 2005
% 210.77/210.99 |- skos__hiddenLabel mesh__D005517 Poisonings, Food
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D005517 2002
% 210.77/210.99 |- skos__related mesh__D005517smesh__D005512
% 210.77/210.99 |- skos__annotation mesh__D005517
% 210.77/210.99 GEN only; prefer /pois with specific food items in Cat J2: Manual 31.11; MUSHROOM POISONING; PLANT POISONING; SALMONELLA FOOD POISONING %26% STAPHYLOCOCCAL FOOD POISONING are also available%A%
% 210.77/210.99 |- mesh__dateRevised mesh__D029965 2005-06-30
% 210.77/210.99 |- skos__annotation mesh__D029965
% 210.77/210.99 GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.77/210.99 |- mesh__historyNote mesh__D029965 2002
% 210.77/210.99 |- mesh__recordOriginator mesh__D029965 ssb
% 210.77/210.99 |- mesh__recordMaintainer mesh__D029965 ssb
% 210.77/210.99 |- mesh__dateEstablished mesh__D029965 2002-01-01
% 210.77/210.99 |- skos__broader mesh__D029965smesh__D019684
% 210.77/210.99 |- skos__prefLabel mesh__D029965 Gentianaceae
% 210.77/210.99 |- mesh__dateCreated mesh__D029965 2001-07-25
% 210.77/210.99 |- mesh__activeMeSHYear mesh__D029965 2006
% 210.77/211.00 |- rdf__type mesh__D029965sskos__Concept
% 210.77/211.00 |- skos__scopeNote mesh__D029965
% 210.77/211.00 A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.%A%
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D029965 2002
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D029965 sjn
% 210.77/211.00 |- skos__hiddenLabel mesh__D021982 Adhesions, Cell-Matrix
% 210.77/211.00 |- skos__prefLabel mesh__D021982 Cell-Matrix Junctions
% 210.77/211.00 |- skos__related mesh__D021982smesh__D002448
% 210.77/211.00 |- skos__hiddenLabel mesh__D021982 Cell-Matrix Junction
% 210.77/211.00 |- skos__altLabel mesh__D021982 Cell-Matrix Adhesions
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D021982 2001
% 210.77/211.00 |- skos__hiddenLabel mesh__D021982 Cell Matrix Adhesions
% 210.77/211.00 |- skos__hiddenLabel mesh__D021982 Junctions, Cell-Matrix
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021982 2005
% 210.77/211.00 |- mesh__dateCreated mesh__D021982 2000-06-21
% 210.77/211.00 |- mesh__historyNote mesh__D021982 2001
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021982 2001
% 210.77/211.00 |- rdf__type mesh__D021982sskos__Concept
% 210.77/211.00 |- skos__scopeNote mesh__D021982
% 210.77/211.00 Specialized areas at the CELL MEMBRANE where a cell attaches to the EXTRACELLULAR MATRIX or other substratum.%A%
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021982 2003
% 210.77/211.00 |- mesh__dateEstablished mesh__D021982 2001-01-01
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021982 2006
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021982 2002
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021982 2004
% 210.77/211.00 |- skos__broader mesh__D021982smesh__D021961
% 210.77/211.00 |- skos__hiddenLabel mesh__D021982 Junction, Cell-Matrix
% 210.77/211.00 |- skos__hiddenLabel mesh__D021982 Cell Matrix Junctions
% 210.77/211.00 |- skos__historyNote mesh__D021982 Cell Adhesion %28%1991-2000%29%
% 210.77/211.00 |- skos__historyNote mesh__D021982 Extracellular Matrix %28%1991-2000%29%
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Tree Nut Allergies
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Allergy, Tree Nut
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Hypersensitivity, Tree Nut
% 210.77/211.00 |- skos__altLabel mesh__D021184 Tree Nut Allergy
% 210.77/211.00 |- skos__annotation mesh__D021184
% 210.77/211.00 PEANUT HYPERSENSITIVITY is also available
% 210.77/211.00 |- skos__altLabel mesh__D021184 Nut Allergy
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021184 2003
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Hypersensitivities, Tree Nut
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021184 2005
% 210.77/211.00 |- skos__prefLabel mesh__D021184 Nut Hypersensitivity
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Nut Hypersensitivity, Tree
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Nut Hypersensitivities
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021184 2004
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Nut Hypersensitivities, Tree
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Hypersensitivities, Nut
% 210.77/211.00 |- mesh__historyNote mesh__D021184 2002
% 210.77/211.00 |- mesh__dateCreated mesh__D021184 2001-07-25
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021184 2006
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D021184 2002
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Allergies, Nut
% 210.77/211.00 |- skos__broader mesh__D021184smesh__D005512
% 210.77/211.00 |- skos__historyNote mesh__D021184 Nuts %28%1968-2001%29%
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Nut Allergies
% 210.77/211.00 |- skos__altLabel mesh__D021184 Tree Nut Hypersensitivity
% 210.77/211.00 |- skos__scopeNote mesh__D021184
% 210.77/211.00 Allergic reaction to tree nuts that is triggered by the immune system.%A%
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Tree Nut Hypersensitivities
% 210.77/211.00 |- skos__altLabel mesh__D021184 Allergy, Nut
% 210.77/211.00 |- mesh__dateEstablished mesh__D021184 2002-01-01
% 210.77/211.00 |- skos__altLabel mesh__D021184 Hypersensitivity, Nut
% 210.77/211.00 |- rdf__type mesh__D021184sskos__Concept
% 210.77/211.00 |- skos__hiddenLabel mesh__D021184 Allergies, Tree Nut
% 210.77/211.00 |- skos__historyNote mesh__D021184 Food Hypersensitivity %28%1968-2001%29%
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021184 2002
% 210.77/211.00 |- skos__hiddenLabel mesh__D015945 Factor XIa, Coagulation
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D015945 90
% 210.77/211.00 |- skos__historyNote mesh__D015945 Factor XI %28%1972-1989%29%
% 210.77/211.00 |- skos__altLabel mesh__D015945 Contact Activation Product
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015945 2006
% 210.77/211.00 |- mesh__recordMaintainer mesh__D015945 ssb
% 210.77/211.00 |- mesh__recordOriginator mesh__D015945 AGS
% 210.77/211.00 |- mesh__historyNote mesh__D015945 90
% 210.77/211.00 |- skos__annotation mesh__D015945 /defic = FACTOR XI DEFICIENCY
% 210.77/211.00 |- skos__prefLabel mesh__D015945 Factor XIa
% 210.77/211.00 |- rdf__type mesh__D015945sskos__Concept
% 210.77/211.00 |- skos__scopeNote mesh__D015945
% 210.77/211.00 Activated form of factor XI. In the intrinsic pathway, Factor XI is activated to XIa by factor XIIa in the presence of cofactor HMWK; %28%HIGH MOLECULAR WEIGHT KININOGEN%29%. Factor XIa then activates factor IX to factor IXa in the presence of calcium.%A%
% 210.77/211.00 |- mesh__dateRevised mesh__D015945 2005-06-30
% 210.77/211.00 |- skos__altLabel mesh__D015945 Activated Factor XI
% 210.77/211.00 |- mesh__dateEstablished mesh__D015945 1990-01-01
% 210.77/211.00 |- skos__broader mesh__D015945smesh__D012697
% 210.77/211.00 |- skos__broader mesh__D015945smesh__D005172
% 210.77/211.00 |- skos__related mesh__D015945smesh__D003029
% 210.77/211.00 |- skos__historyNote mesh__D015945 Serine Proteinases %28%1988-1989%29%
% 210.77/211.00 |- skos__altLabel mesh__D015945 Blood Coagulation Factor XI, Activated
% 210.77/211.00 |- skos__hiddenLabel mesh__D015945 XIa, Coagulation Factor
% 210.77/211.00 |- skos__altLabel mesh__D015945 Coagulation Factor XIa
% 210.77/211.00 |- skos__altLabel mesh__D015945 Factor XI, Activated
% 210.77/211.00 |- mesh__dateCreated mesh__D015945 1989-09-06
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D015945 sjn
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D001925 2000
% 210.77/211.00 |- skos__scopeNote mesh__D001925
% 210.77/211.00 A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders %28%see BRAIN DISEASES, METABOLIC%29%; and other conditions.%A%
% 210.77/211.00 |- mesh__recordMaintainer mesh__D001925 ags
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D001925 2006
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D001925 2003
% 210.77/211.00 |- skos__altLabel mesh__D001925 Encephalopathy, Chronic
% 210.77/211.00 |- mesh__dateRevised mesh__D001925 2005-07-21
% 210.77/211.00 |- skos__altLabel mesh__D001925 Chronic Encephalopathy
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D001925 2005
% 210.77/211.00 |- skos__annotation mesh__D001925
% 210.77/211.00 coord with specific condition causing damage if pertinent%A%
% 210.77/211.00 |- mesh__recordOriginator mesh__D001925 NLM
% 210.77/211.00 |- mesh__dateCreated mesh__D001925 1999-01-01
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D001925 2006A
% 210.77/211.00 |- skos__hiddenLabel mesh__D001925 Chronic Brain Damage
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D001925 2002
% 210.77/211.00 |- rdf__type mesh__D001925sskos__Concept
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D001925 ags
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D001925 2001
% 210.77/211.00 |- skos__broader mesh__D001925smesh__D001927
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D001925 2004
% 210.77/211.00 |- skos__prefLabel mesh__D001925 Brain Damage, Chronic
% 210.77/211.00 |- skos__prefLabel mesh__D034301 Deinococcus
% 210.77/211.00 |- skos__broader mesh__D034301smesh__D006095
% 210.77/211.00 |- mesh__dateCreated mesh__D034301 2002-07-03
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D034301 sjn
% 210.77/211.00 |- mesh__recordMaintainer mesh__D034301 SYSTEM
% 210.77/211.00 |- rdf__type mesh__D034301sskos__Concept
% 210.77/211.00 |- mesh__historyNote mesh__D034301 2003
% 210.77/211.00 |- mesh__recordOriginator mesh__D034301 ags
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D034301 2003
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D034301 2006
% 210.77/211.00 |- mesh__dateRevised mesh__D034301 2005-06-30
% 210.77/211.00 |- mesh__dateEstablished mesh__D034301 2003-01-01
% 210.77/211.00 |- skos__scopeNote mesh__D034301
% 210.77/211.00 A genus of gram-positive aerobic cocci found in the soil, that is highly resistant to radiation, especially ionizing radiation %28%RADIATION, IONIZING%29%. Deinococcus radiodurans is the type species.%A%
% 210.77/211.00 |- skos__historyNote mesh__D034301 Gram-Positive Cocci %28%1983-2002%29%
% 210.77/211.00 |- skos__historyNote mesh__D034301 Micrococcus %28%1983-1999%29%
% 210.77/211.00 |- skos__historyNote mesh__D001127 Vasopressins %28%1966-1974%29%
% 210.77/211.00 |- mesh__historyNote mesh__D001127
% 210.77/211.00 1979; for PITRESSIN use VASOPRESSINS %28%1981-2001%29%
% 210.77/211.00 |- skos__prefLabel mesh__D001127 Argipressin
% 210.77/211.00 |- skos__hiddenLabel mesh__D001127 Tannate, Argipressin
% 210.77/211.00 |- mesh__dateEstablished mesh__D001127 1979-01-01
% 210.77/211.00 |- mesh__recordOriginator mesh__D001127 NLM
% 210.77/211.00 |- rdf__type mesh__D001127sskos__Concept
% 210.77/211.00 |- skos__altLabel mesh__D001127 Arginine Vasopressin
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D001127 sjn
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D001127 2006
% 210.77/211.00 |- skos__scopeNote mesh__D001127
% 210.77/211.00 Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2, cyclic 1-6 disulfide. The usual mammalian antidiuretic hormone, it is a cyclic nonapeptide with arginine in position 8 of the chain. Argipressin is used to treat DIABETES INSIPIDUS and as a hemostatic because of its vasoconstrictor action.%A%
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D001127
% 210.77/211.00 1979; for PITRESSIN see VASOPRESSINS %28%1981-2001%29%
% 210.77/211.00 |- skos__altLabel mesh__D001127 Vasopressin, Arginine
% 210.77/211.00 |- mesh__recordMaintainer mesh__D001127 ssb
% 210.77/211.00 |- mesh__dateRevised mesh__D001127 2005-06-30
% 210.77/211.00 |- skos__historyNote mesh__D001127 Arginine %28%1966-1974%29%
% 210.77/211.00 |- skos__broader mesh__D001127smesh__D014667
% 210.77/211.00 |- mesh__dateCreated mesh__D001127 1974-11-11
% 210.77/211.00 |- rdf__type mesh__D006610sskos__Concept
% 210.77/211.00 |- skos__related mesh__D006610smesh__D003665
% 210.77/211.00 |- mesh__recordOriginator mesh__D006610 RC
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D006610 2001
% 210.77/211.00 |- skos__annotation mesh__D006610
% 210.77/211.00 in divers; do not confuse with INERT GAS NARCOSIS
% 210.77/211.00 |- skos__broader mesh__D006610smesh__D002493
% 210.77/211.00 |- skos__historyNote mesh__D006610 Syndrome %28%1972-1985%29%
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D006610
% 210.77/211.00 2000; see HIGH PRESSURE NERVOUS SYNDROME 1991-1999; see CENTRAL NERVOUS SYSTEM DISEASES 1986-1990%A%
% 210.77/211.00 |- skos__altLabel mesh__D006610 High Pressure Nervous Syndrome
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D006610 2004
% 210.77/211.00 |- mesh__recordMaintainer mesh__D006610 KEV
% 210.77/211.00 |- skos__altLabel mesh__D006610 High Pressure Neural Syndrome
% 210.77/211.00 |- skos__altLabel mesh__D006610 HPNS
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D006610 2000
% 210.77/211.00 |- mesh__dateEstablished mesh__D006610 1991-01-01
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D006610 2006
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D006610 sjn
% 210.77/211.00 |- skos__historyNote mesh__D006610 Diving %28%1966-1985%29%
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D006610 2003
% 210.77/211.00 |- skos__altLabel mesh__D006610
% 210.77/211.00 High Pressure Neurological Syndrome, Experimental
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D006610 2005
% 210.77/211.00 |- skos__hiddenLabel mesh__D006610 HPNSs
% 210.77/211.00 |- mesh__dateRevised mesh__D006610 1999-11-05
% 210.77/211.00 |- skos__scopeNote mesh__D006610
% 210.77/211.00 A syndrome related to increased atmospheric pressure and characterized by tremors, nausea, dizziness, decreased motor and mental performance, and SEIZURES. This condition may occur in those who dive deeply %28%c. 1000 ft%29% usually while breathing a mixture of oxygen and helium. The condition is associated with a neuroexcitatory effect of helium.%A%
% 210.77/211.00 |- skos__historyNote mesh__D006610 Atmospheric Pressure %28%1966-1985%29%
% 210.77/211.00 |- skos__historyNote mesh__D006610 Pressure %28%1966-1985%29%
% 210.77/211.00 |- skos__historyNote mesh__D006610
% 210.77/211.00 Central Nervous System Diseases %28%1966-1985%29%
% 210.77/211.00 |- mesh__historyNote mesh__D006610 2000%28%1986%29%
% 210.77/211.00 |- skos__broader mesh__D006610smesh__D009784
% 210.77/211.00 |- skos__related mesh__D006610smesh__D001469
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D006610 2002
% 210.77/211.00 |- mesh__dateCreated mesh__D006610 1985-05-09
% 210.77/211.00 |- skos__related mesh__D006610smesh__D004242
% 210.77/211.00 |- skos__prefLabel mesh__D006610 High Pressure Neurological Syndrome
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D047229 sjn
% 210.77/211.00 |- skos__historyNote mesh__D047229 Porifera %28%1990-2004%29%
% 210.77/211.00 |- mesh__recordOriginator mesh__D047229 ags
% 210.77/211.00 |- mesh__historyNote mesh__D047229 2005
% 210.77/211.00 |- skos__scopeNote mesh__D047229
% 210.77/211.00 A genus of SPONGES in the family Plakinidae, with the skeleton formed by small diactine %28%and some triactine%29% needle-like terminations.%A%
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D047229 2005
% 210.77/211.00 |- mesh__dateCreated mesh__D047229 2004-07-07
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D047229 2005
% 210.77/211.00 |- skos__prefLabel mesh__D047229 Plakortis
% 210.77/211.00 |- skos__broader mesh__D047229smesh__D011161
% 210.77/211.00 |- mesh__dateEstablished mesh__D047229 2005-01-01
% 210.77/211.00 |- mesh__recordMaintainer mesh__D047229 ags
% 210.77/211.00 |- rdf__type mesh__D047229sskos__Concept
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D047229 2006
% 210.77/211.00 |- mesh__dateEstablished mesh__D019538 1997-01-01
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D019538 sjn
% 210.77/211.00 |- skos__annotation mesh__D019538
% 210.77/211.00 do not confuse with HEALTH SURVEYS: health care surveys are on health services provided, health surveys are on health statist; specify geog if pertinent%A%
% 210.77/211.00 |- skos__broader mesh__D019538smesh__D003625
% 210.77/211.00 |- skos__scopeNote mesh__D019538
% 210.77/211.00 Statistical measures of utilization and other aspects of the provision of health care services including hospitalization and ambulatory care.%A%
% 210.77/211.00 |- mesh__dateRevised mesh__D019538 1999-11-03
% 210.77/211.00 |- skos__hiddenLabel mesh__D019538 Survey, Health Care
% 210.77/211.00 |- skos__hiddenLabel mesh__D019538 Survey, Healthcare
% 210.77/211.00 |- skos__broader mesh__D019538smesh__D006302
% 210.77/211.00 |- skos__hiddenLabel mesh__D019538 Healthcare Survey
% 210.77/211.00 |- skos__hiddenLabel mesh__D019538 Care Surveys, Health
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D019538 2005
% 210.77/211.00 |- skos__hiddenLabel mesh__D019538 Care Survey, Health
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D019538 2000
% 210.77/211.00 |- mesh__dateCreated mesh__D019538 1996-06-13
% 210.77/211.00 |- skos__prefLabel mesh__D019538 Health Care Surveys
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D019538 2006
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D019538 2003
% 210.77/211.00 |- skos__hiddenLabel mesh__D019538 Surveys, Health Care
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D019538 2001
% 210.77/211.00 |- skos__hiddenLabel mesh__D019538 Health Care Survey
% 210.77/211.00 |- skos__hiddenLabel mesh__D019538 Surveys, Healthcare
% 210.77/211.00 |- skos__altLabel mesh__D019538 Healthcare Surveys
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D019538 2004
% 210.77/211.00 |- mesh__recordMaintainer mesh__D019538 kle
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D019538 2002
% 210.77/211.00 |- mesh__recordOriginator mesh__D019538 JLS
% 210.77/211.00 |- rdf__type mesh__D019538sskos__Concept
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D019538 97
% 210.77/211.00 |- mesh__historyNote mesh__D019538 97
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D011555 2006
% 210.77/211.00 |- skos__annotation mesh__D011555 do NOT check tag PREGNANCY
% 210.77/211.00 |- skos__broader mesh__D011555smesh__D011247
% 210.77/211.00 |- rdf__type mesh__D011555sskos__Concept
% 210.77/211.00 |- skos__hiddenLabel mesh__D011555 Pseudopregnancies
% 210.77/211.00 |- mesh__dateCreated mesh__D011555 1999-01-01
% 210.77/211.00 |- skos__scopeNote mesh__D011555
% 210.77/211.00 An acyclic state that resembles PREGNANCY in that there is no ovarian cycle, ESTROUS CYCLE, or MENSTRUAL CYCLE. Unlike pregnancy, there is no EMBRYO IMPLANTATION. Pseudopregnancy can be experimentally induced to form DECIDUOMA in the UTERUS.%A%
% 210.77/211.00 |- skos__prefLabel mesh__D011555 Pseudopregnancy
% 210.77/211.00 |- mesh__dateRevised mesh__D011555 2004-07-07
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D011555 2005
% 210.77/211.00 |- mesh__recordOriginator mesh__D011555 NLM
% 210.77/211.00 |- skos__altLabel mesh__D011555 Pseudocyesis
% 210.77/211.00 |- mesh__recordMaintainer mesh__D011555 lkt
% 210.77/211.00 |- mesh__historyNote mesh__D011555
% 210.77/211.00 was in Cat G only 1968-78, was in Cat F only 1963-67
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D011555 sjn
% 210.77/211.00 |- mesh__recordOriginator mesh__D005518 NLM
% 210.77/211.00 |- skos__hiddenLabel mesh__D005518 Selections, Food
% 210.77/211.00 |- skos__hiddenLabel mesh__D005518 Preferences, Food
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D005518 2006
% 210.77/211.00 |- mesh__historyNote mesh__D005518 69
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D005518 2005
% 210.77/211.00 |- skos__historyNote mesh__D005518 Food %28%1966-1968%29%
% 210.77/211.00 |- skos__hiddenLabel mesh__D005518 Preference, Food
% 210.77/211.00 |- skos__historyNote mesh__D005518 Diet %28%1966-1968%29%
% 210.77/211.00 |- skos__hiddenLabel mesh__D005518 Selection, Food
% 210.77/211.00 |- skos__hiddenLabel mesh__D005518 Food Selections
% 210.77/211.00 |- skos__historyNote mesh__D005518 Behavior, Animal %28%1966-1968%29%
% 210.77/211.00 |- skos__prefLabel mesh__D005518 Food Preferences
% 210.77/211.00 |- rdf__type mesh__D005518sskos__Concept
% 210.77/211.00 |- skos__hiddenLabel mesh__D005518 Food Preference
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D005518 2004
% 210.77/211.00 |- skos__scopeNote mesh__D005518
% 210.77/211.00 The selection of one food over another.
% 210.77/211.00 |- skos__historyNote mesh__D005518 Behavior %28%1966-1968%29%
% 210.77/211.00 |- mesh__dateCreated mesh__D005518 1999-01-01
% 210.77/211.00 |- mesh__recordMaintainer mesh__D005518 TAP
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D005518 2003
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D005518 sjn
% 210.77/211.00 |- skos__broader mesh__D005518smesh__D005247
% 210.77/211.00 |- skos__annotation mesh__D005518 human %26% animal
% 210.77/211.00 |- mesh__dateRevised mesh__D005518 2002-07-03
% 210.77/211.00 |- mesh__dateEstablished mesh__D005518 1969-01-01
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D005518 69
% 210.77/211.00 |- rdf__type mesh__D016240sskos__Concept
% 210.77/211.00 |- mesh__historyNote mesh__D016240 91
% 210.77/211.00 |- mesh__dateEstablished mesh__D016240 1991-01-01
% 210.77/211.00 |- mesh__dateCreated mesh__D016240 1990-06-06
% 210.77/211.00 |- skos__broader mesh__D016240smesh__D012984
% 210.77/211.00 |- skos__prefLabel mesh__D016240 Grateful Med
% 210.77/211.00 |- mesh__recordMaintainer mesh__D016240 jls
% 210.77/211.00 |- skos__historyNote mesh__D016240 MEDLARS %28%1986-1990%29%
% 210.77/211.00 |- mesh__recordOriginator mesh__D016240 TGC
% 210.77/211.00 |- skos__scopeNote mesh__D016240
% 210.77/211.00 A microcomputer-based software package providing a user-friendly interface to the MEDLARS system of the National Library of Medicine.%A%
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D016240 sjn
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D016240 2005
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D016240 91
% 210.77/211.00 |- skos__broader mesh__D016240smesh__D016247
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D016240 2006
% 210.77/211.00 |- mesh__dateRevised mesh__D016240 2004-07-07
% 210.77/211.00 |- skos__annotation mesh__D016240 IM CATALOG: use NAF entry
% 210.77/211.00 |- mesh__dateEstablished mesh__D029966 2002-01-01
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D029966 sjn
% 210.77/211.00 |- skos__prefLabel mesh__D029966 Centaurium
% 210.77/211.00 |- skos__scopeNote mesh__D029966
% 210.77/211.00 A plant genus of the family GENTIANACEAE. Triterpene lactones and other compounds have been isolated from species of this genus. The common name of century plant has also been used for the AGAVE genus.%A%
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D029966 2003
% 210.77/211.00 |- mesh__historyNote mesh__D029966 2002
% 210.77/211.00 |- mesh__dateCreated mesh__D029966 2001-08-03
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D029966 2005
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D029966 2004
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D029966 2006
% 210.77/211.00 |- rdf__type mesh__D029966sskos__Concept
% 210.77/211.00 |- mesh__recordMaintainer mesh__D029966 jls
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D029966 2002
% 210.77/211.00 |- skos__broader mesh__D029966smesh__D029965
% 210.77/211.00 |- skos__annotation mesh__D029966
% 210.77/211.00 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D029966 2002
% 210.77/211.00 |- mesh__recordOriginator mesh__D029966 ssb
% 210.77/211.00 |- skos__prefLabel mesh__D002220 Carbamazepine
% 210.77/211.00 |- mesh__dateEstablished mesh__D002220 1972-01-01
% 210.77/211.00 |- mesh__dateCreated mesh__D002220 1999-01-01
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D002220 2001
% 210.77/211.00 |- rdf__type mesh__D002220sskos__Concept
% 210.77/211.00 |- skos__hiddenLabel mesh__D002220 Hydrochloride, Carbamazepine
% 210.77/211.00 |- skos__historyNote mesh__D002220 Anticonvulsants %28%1966-1967%29%
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D002220 2003
% 210.77/211.00 |- mesh__recordOriginator mesh__D002220 NLM
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D002220 sjn
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D002220 2005
% 210.77/211.00 |- mesh__recordMaintainer mesh__D002220 jmp
% 210.77/211.00 |- mesh__dateRevised mesh__D002220 2000-06-21
% 210.77/211.00 |- skos__scopeNote mesh__D002220
% 210.77/211.00 An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.%A%
% 210.77/211.00 |- skos__historyNote mesh__D002220 Azepines %28%1966-1967%29%
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D002220 2004
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D002220 2002
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D002220 72
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D002220 2006
% 210.77/211.00 |- skos__hiddenLabel mesh__D002220 Phosphate, Carbamazepine
% 210.77/211.00 |- skos__hiddenLabel mesh__D002220 Dihydrate, Carbamazepine
% 210.77/211.00 |- skos__broader mesh__D002220smesh__D003984
% 210.77/211.00 |- skos__hiddenLabel mesh__D002220 Acetate, Carbamazepine
% 210.77/211.00 |- mesh__historyNote mesh__D002220 72%28%68%29%
% 210.77/211.00 |- skos__prefLabel mesh__D021983 Cyclophilins
% 210.77/211.00 |- skos__altLabel mesh__D021983 Cyclosporin-Binding Proteins
% 210.77/211.00 |- skos__scopeNote mesh__D021983
% 210.77/211.00 A family of peptidyl-prolyl cis-trans isomerases that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1.-%A%
% 210.77/211.00 |- mesh__recordOriginator mesh__D021983 jmp
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021983 2005
% 210.77/211.00 |- skos__broader mesh__D021983smesh__D020104
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D021983
% 210.77/211.00 2001; see PEPTIDYLPROLYL ISOMERASE 1998-2000, was indexed under CARRIER PROTEINS %26% AMINO ACID ISOMERASES 1984-1997%A%
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D021983 sjn
% 210.77/211.00 |- rdf__type mesh__D021983sskos__Concept
% 210.77/211.00 |- mesh__historyNote mesh__D021983
% 210.77/211.00 2001; use PEPTIDYLPROLYL ISOMERASE 1998-2000 %26% PEPTIDYLPROLYL ISOMERASE %28%NM%29% 1984-1997%A%
% 210.77/211.00 |- mesh__dateEstablished mesh__D021983 2001-01-01
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021983 2006
% 210.77/211.00 |- skos__hiddenLabel mesh__D021983 Cyclosporin Binding Proteins
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D021983 2004
% 210.77/211.00 |- skos__historyNote mesh__D021983 Amino Acid Isomerases %28%1984-1997%29%
% 210.77/211.00 |- skos__hiddenLabel mesh__D021983 Cyclosporin Binding Protein
% 210.77/211.00 |- mesh__dateCreated mesh__D021983 2000-07-05
% 210.77/211.00 |- mesh__recordMaintainer mesh__D021983 jmp
% 210.77/211.00 |- skos__altLabel mesh__D021983 Cyclophilin
% 210.77/211.00 |- skos__hiddenLabel mesh__D021983 Protein, Cyclosporin-Binding
% 210.77/211.00 |- skos__historyNote mesh__D021983
% 210.77/211.00 Peptidylprolyl Isomerase %28%1998-2000%29%
% 210.77/211.00 |- mesh__dateRevised mesh__D021983 2003-07-09
% 210.77/211.00 |- skos__hiddenLabel mesh__D021983 Proteins, Cyclosporin-Binding
% 210.77/211.00 |- skos__altLabel mesh__D021983 Cyclosporin-Binding Protein
% 210.77/211.00 |- skos__hiddenLabel mesh__D015946 Dibromides, Ethylene
% 210.77/211.00 |- skos__historyNote mesh__D015946 Ethylene Dibromides %28%1977-1989%29%
% 210.77/211.00 |- skos__hiddenLabel mesh__D015946 sym Dibromoethane
% 210.77/211.00 |- mesh__historyNote mesh__D015946
% 210.77/211.00 90; was ETHYLENE DIBROMIDES see under HYDROCARBONS, BROMINATED 1977-89; was ETHYLENE DIBROMIDE see under HYDROCARBONS, BROMINATED 1975-76; ETHYLENE DIBROMIDES was see under HYDROCARBONS, BROMINATED 1977-90%A%
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015946 2005
% 210.77/211.00 |- skos__hiddenLabel mesh__D015946 Dibromide, Ethylene
% 210.77/211.00 |- mesh__recordAuthorizer mesh__D015946 sjn
% 210.77/211.00 |- skos__altLabel mesh__D015946 Dowfume W85
% 210.77/211.00 |- rdf__type mesh__D015946sskos__Concept
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015946 2002
% 210.77/211.00 |- mesh__onlineNote mesh__D015946
% 210.77/211.00 use ETHYLENE DIBROMIDE to search ETHYLENE DIBROMIDES 1975-90%A%
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015946 2004
% 210.77/211.00 |- mesh__recordOriginator mesh__D015946 RLS
% 210.77/211.00 |- skos__altLabel mesh__D015946 1,2-Dibromoethane
% 210.77/211.00 |- skos__hiddenLabel mesh__D015946 Bromide, Ethylene
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015946 2001
% 210.77/211.00 |- mesh__dateEstablished mesh__D015946 1990-01-01
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015946 2003
% 210.77/211.00 |- skos__broader mesh__D015946smesh__D006842
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D015946
% 210.77/211.00 90; was ETHYLENE DIBROMIDES see under HYDROCARBONS, BROMINATED 1977-89; was ETHYLENE DIBROMIDE see under HYDROCARBONS, BROMINATED 1975-76; ETHYLENE DIBROMIDES was see under HYDROCARBONS, BROMINATED 1977-90%A%
% 210.77/211.00 |- skos__historyNote mesh__D015946 Hydrocarbons, Brominated %28%1974%29%
% 210.77/211.00 |- skos__altLabel mesh__D015946 sym-Dibromoethane
% 210.77/211.00 |- skos__prefLabel mesh__D015946 Ethylene Dibromide
% 210.77/211.00 |- skos__scopeNote mesh__D015946
% 210.77/211.00 An effective soil fumigant, insecticide, and nematocide. In humans, it causes severe burning of skin and irritation of the eyes and respiratory tract. Prolonged inhalation may cause liver necrosis. It is also used in gasoline. Members of this group have caused liver and lung cancers in rodents. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, 1,2-dibromoethane may reasonably be anticipated to be a carcinogen.%A%
% 210.77/211.00 |- skos__hiddenLabel mesh__D015946 1,2 Dibromoethane
% 210.77/211.00 |- mesh__recordMaintainer mesh__D015946 CCR
% 210.77/211.00 |- mesh__dateCreated mesh__D015946 1989-05-25
% 210.77/211.00 |- mesh__dateRevised mesh__D015946 2000-06-22
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015946 2006
% 210.77/211.00 |- mesh__dateRevised mesh__D015148 1997-06-20
% 210.77/211.00 |- skos__historyNote mesh__D015148 Fetal Monitoring %28%1978-1988%29%
% 210.77/211.00 |- skos__hiddenLabel mesh__D015148 Cardiotocograms
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015148 2000
% 210.77/211.00 |- skos__broader mesh__D015148smesh__D005323
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015148 2004
% 210.77/211.00 |- mesh__publicMeSHNote mesh__D015148 89
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015148 2001
% 210.77/211.00 |- mesh__dateCreated mesh__D015148 1988-03-21
% 210.77/211.00 |- mesh__dateEstablished mesh__D015148 1989-01-01
% 210.77/211.00 |- skos__hiddenLabel mesh__D015148 Antepartum CTG
% 210.77/211.00 |- skos__altLabel mesh__D015148 CTG, Antepartum
% 210.77/211.00 |- skos__prefLabel mesh__D015148 Cardiotocography
% 210.77/211.00 |- mesh__activeMeSHYear mesh__D015148 2002
% 210.77/211.00 |- mesh__recordMaintainer mesh__D015148 PXP
% 210.77/211.00 |- rdf__type mesh__D015148sskos__Concept
% 210.77/211.00 |- mesh__recordOriginator mesh__D015148 SCD
% 210.77/211.01 |- skos__historyNote mesh__D015148 Fetal Heart %28%1969-1988%29%
% 210.77/211.01 |- skos__historyNote mesh__D015148 Labor, Premature %28%1977-1988%29%
% 210.77/211.01 |- skos__annotation mesh__D015148
% 210.77/211.01 monitors fetal heart rate; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CARDIOTOCOGR%A%
% 210.77/211.01 |- skos__historyNote mesh__D015148 Uterine Contraction %28%1974-1988%29%
% 210.77/211.01 |- mesh__recordAuthorizer mesh__D015148 SJN
% 210.77/211.01 |- skos__broader mesh__D015148smesh__D006334
% 210.77/211.01 |- mesh__activeMeSHYear mesh__D015148 2005
% 210.77/211.01 |- mesh__activeMeSHYear mesh__D015148 1998
% 210.77/211.01 |- skos__scopeNote mesh__D015148
% 210.77/211.01 Monitoring of fetal heart frequency before birth in order to assess impending prematurity in relation to the pattern or intensity of antepartum UTERINE CONTRACTION.%A%
% 210.77/211.01 |- mesh__historyNote mesh__D015148 89
% 210.77/211.01 |- mesh__activeMeSHYear mesh__D015148 2006
% 210.77/211.01 |- mesh__activeMeSHYear mesh__D015148 2003
% 210.77/211.01 |- mesh__activeMeSHYear mesh__D015148 1999
% 210.77/211.01 |- skos__related mesh__D009909smesh__D003753
% 210.77/211.01 |- mesh__recordMaintainer mesh__D009909 PXP
% 210.77/211.01 |- mesh__activeMeSHYear mesh__D009909 2006
% 210.77/211.01 |- skos__hiddenLabel mesh__D009909 Health, Oral
% 210.77/211.01 |- skos__related mesh__D009909smesh__D009065
% 210.77/211.01 |- mesh__activeMeSHYear mesh__D009909 1998
% 210.77/211.01 |- rdf__type mesh__D009909sskos__Concept
% 210.77/211.01 |- mesh__activeMeSHYear mesh__D009909 2005
% 210.86/211.01 |- skos__prefLabel mesh__D009909 Oral Health
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D009909 2002
% 210.86/211.01 |- mesh__historyNote mesh__D009909
% 210.86/211.01 65; DENTAL HYGIENE was heading 1963-64
% 210.86/211.01 |- mesh__recordOriginator mesh__D009909 NLM
% 210.86/211.01 |- skos__related mesh__D009909smesh__D003945
% 210.86/211.01 |- skos__related mesh__D009909smesh__D003740
% 210.86/211.01 |- mesh__dateRevised mesh__D009909 1997-06-20
% 210.86/211.01 |- mesh__dateEstablished mesh__D009909 1965-01-01
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D009909 2004
% 210.86/211.01 |- mesh__dateCreated mesh__D009909 1999-01-01
% 210.86/211.01 |- mesh__publicMeSHNote mesh__D009909
% 210.86/211.01 65; DENTAL HYGIENE was heading 1963-64
% 210.86/211.01 |- skos__broader mesh__D009909smesh__D006262
% 210.86/211.01 |- skos__annotation mesh__D009909
% 210.86/211.01 differentiate from ORAL HYGIENE; oral health is the state of health of the mouth%A%
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D009909 2001
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D009909 2003
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D009909 1999
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D009909 SJN
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D009909 2000
% 210.86/211.01 |- skos__related mesh__D009909smesh__D009059
% 210.86/211.01 |- skos__scopeNote mesh__D009909
% 210.86/211.01 The optimal state of the mouth and normal functioning of the organs of the mouth without evidence of disease.%A%
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001926 2002
% 210.86/211.01 |- skos__hiddenLabel mesh__D001926 Death, Brain
% 210.86/211.01 |- skos__broader mesh__D001926smesh__D003643
% 210.86/211.01 |- mesh__dateEstablished mesh__D001926 1972-01-01
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001926 2001
% 210.86/211.01 |- mesh__historyNote mesh__D001926 1972%28%1969%29%
% 210.86/211.01 |- mesh__dateCreated mesh__D001926 1999-01-01
% 210.86/211.01 |- skos__historyNote mesh__D001926 Death %28%1966-1968%29%
% 210.86/211.01 |- mesh__recordMaintainer mesh__D001926 jls
% 210.86/211.01 |- skos__altLabel mesh__D001926 Brain Dead
% 210.86/211.01 |- rdf__type mesh__D001926sskos__Concept
% 210.86/211.01 |- skos__hiddenLabel mesh__D001926 Brain Deads
% 210.86/211.01 |- mesh__dateRevised mesh__D001926 2000-06-22
% 210.86/211.01 |- mesh__publicMeSHNote mesh__D001926 1972
% 210.86/211.01 |- skos__hiddenLabel mesh__D001926 Coma, Irreversible
% 210.86/211.01 |- skos__broader mesh__D001926smesh__D003128
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001926 2004
% 210.86/211.01 |- skos__altLabel mesh__D001926 Coma Depasse
% 210.86/211.01 |- skos__broader mesh__D001926smesh__D001927
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001926 2006
% 210.86/211.01 |- skos__scopeNote mesh__D001926
% 210.86/211.01 A state of prolonged irreversible cessation of all brain activity, including lower brain stem function with the complete absence of voluntary movements, responses to stimuli, brain stem reflexes, and spontaneous respirations. Reversible conditions which mimic this clinical state %28%e.g., sedative overdose, hypothermia, etc.%29% are excluded prior to making the determination of brain death. %28%From Adams et al., Principles of Neurology, 6th ed, pp348-9%29%%A%
% 210.86/211.01 |- skos__prefLabel mesh__D001926 Brain Death
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D001926 sjn
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001926 2003
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001926 2005
% 210.86/211.01 |- mesh__recordOriginator mesh__D001926 NLM
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 1998
% 210.86/211.01 |- mesh__recordMaintainer mesh__D001128 TPW
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 2005
% 210.86/211.01 |- skos__scopeNote mesh__D001128
% 210.86/211.01 Argon. A noble gas with the atomic symbol Ar, atomic number 18, and atomic weight 39.948. It is used in fluorescent tubes and wherever an inert atmosphere is desired and nitrogen cannot be used.%A%
% 210.86/211.01 |- rdf__type mesh__D001128sskos__Concept
% 210.86/211.01 |- mesh__dateCreated mesh__D001128 1999-01-01
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 1999
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 2006
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 1994
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 2000
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 1995
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 1996
% 210.86/211.01 |- mesh__recordOriginator mesh__D001128 NLM
% 210.86/211.01 |- skos__prefLabel mesh__D001128 Argon
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 2001
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 2003
% 210.86/211.01 |- mesh__dateRevised mesh__D001128 1993-06-04
% 210.86/211.01 |- skos__broader mesh__D001128smesh__D005741
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 1997
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 2002
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001128 2004
% 210.86/211.01 |- skos__annotation mesh__D001128
% 210.86/211.01 a rare gas; Ar-40; Ar-36, 38 = ARGON %28%IM%29% + ISOTOPES %28%NIM%29%; Ar-35, 37, 39, 41, 42 = ARGON %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D001128 PLS
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 2004
% 210.86/211.01 |- skos__hiddenLabel mesh__D006611 Ventilations, High-Frequency Jet
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 2002
% 210.86/211.01 |- skos__hiddenLabel mesh__D006611 Ventilation, High-Frequency Jet
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 2006
% 210.86/211.01 |- skos__broader mesh__D006611smesh__D006612
% 210.86/211.01 |- skos__scopeNote mesh__D006611
% 210.86/211.01 Respiratory support system used primarily with rates of about 100 to 200/min with volumes of from about one to three times predicted anatomic dead space. Used to treat respiratory failure and maintain ventilation under severe circumstances.%A%
% 210.86/211.01 |- mesh__dateEstablished mesh__D006611 1988-01-01
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 1997
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 2003
% 210.86/211.01 |- skos__hiddenLabel mesh__D006611 Jet Ventilation, High-Frequency
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 2001
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 1999
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 2005
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 1993
% 210.86/211.01 |- skos__annotation mesh__D006611
% 210.86/211.01 a type of artif resp; do not use /util except by MeSH definition; DF: HFJV%A%
% 210.86/211.01 |- skos__historyNote mesh__D006611
% 210.86/211.01 Respiration, Artificial %28%1966-1987%29%
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 1996
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 1995
% 210.86/211.01 |- mesh__recordOriginator mesh__D006611 EC
% 210.86/211.01 |- skos__hiddenLabel mesh__D006611 Jet Ventilations, High-Frequency
% 210.86/211.01 |- mesh__recordMaintainer mesh__D006611 TGC
% 210.86/211.01 |- mesh__historyNote mesh__D006611 88
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 2000
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 1998
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 1992
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D006611 PLS
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006611 1994
% 210.86/211.01 |- mesh__publicMeSHNote mesh__D006611 88
% 210.86/211.01 |- rdf__type mesh__D006611sskos__Concept
% 210.86/211.01 |- mesh__dateCreated mesh__D006611 1987-04-30
% 210.86/211.01 |- skos__prefLabel mesh__D006611 High-Frequency Jet Ventilation
% 210.86/211.01 |- skos__altLabel mesh__D006611 High Frequency Jet Ventilation
% 210.86/211.01 |- skos__hiddenLabel mesh__D006611 High-Frequency Jet Ventilations
% 210.86/211.01 |- mesh__dateRevised mesh__D006611 1991-06-27
% 210.86/211.01 |- skos__altLabel mesh__D006611 Ventilation, High Frequency Jet
% 210.86/211.01 |- skos__annotation mesh__D019539
% 210.86/211.01 publication type only; for pharmacopoeias as a subject, index under main heading PHARMACOPOEIAS%A%
% 210.86/211.01 |- skos__broader mesh__D019539smesh__D052180
% 210.86/211.01 |- mesh__dateEstablished mesh__D019539 1997-01-01
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D019539 sjn
% 210.86/211.01 |- mesh__dateCreated mesh__D019539 1996-06-21
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D019539 2006
% 210.86/211.01 |- skos__prefLabel mesh__D019539 Pharmacopoeias %5B%Publication Type%5D%
% 210.86/211.01 |- skos__altLabel mesh__D019539 Pharmacopoeias %28%PT%29%
% 210.86/211.01 |- mesh__dateRevised mesh__D019539 2005-06-30
% 210.86/211.01 |- mesh__recordMaintainer mesh__D019539 jls
% 210.86/211.01 |- rdf__type mesh__D019539sskos__Concept
% 210.86/211.01 |- skos__scopeNote mesh__D019539
% 210.86/211.01 Authoritative works containing lists of drugs and preparations, their description, formulation, analytic composition, main chemical properties, standards for strength, purity, and dosage, chemical tests for determining identity, etc. They have the status of a standard.%A%
% 210.86/211.01 |- mesh__recordOriginator mesh__D019539 TGC
% 210.86/211.01 |- mesh__historyNote mesh__D019539 1997
% 210.86/211.01 |- mesh__recordOriginator mesh__D011556 NLM
% 210.86/211.01 |- skos__annotation mesh__D011556
% 210.86/211.01 do not confuse with PSEUDOHYPOPARATHYROIDISM of which it is an incomplete form%A%
% 210.86/211.01 |- skos__scopeNote mesh__D011556
% 210.86/211.01 A genetically related form of PSEUDOHYPOPARATHYROIDISM characterized by the same features except for the abnormal response to parathyroid hormone.%A%
% 210.86/211.01 |- skos__prefLabel mesh__D011556 Pseudopseudohypoparathyroidism
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D011556 2004
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D011556 sjn
% 210.86/211.01 |- skos__hiddenLabel mesh__D011556 Pseudopseudo Hypoparathyroidism
% 210.86/211.01 |- skos__hiddenLabel mesh__D011556 Pseudo-Pseudohypoparathyroidisms
% 210.86/211.01 |- mesh__dateCreated mesh__D011556 1999-01-01
% 210.86/211.01 |- mesh__dateEstablished mesh__D011556 1965-01-01
% 210.86/211.01 |- skos__altLabel mesh__D011556 Pseudo-Pseudohypoparathyroidism
% 210.86/211.01 |- skos__hiddenLabel mesh__D011556 Pseudopseudo-Hypoparathyroidisms
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D011556 2002
% 210.86/211.01 |- skos__hiddenLabel mesh__D011556 Pseudo Pseudohypoparathyroidism
% 210.86/211.01 |- mesh__recordMaintainer mesh__D011556 nns
% 210.86/211.01 |- skos__altLabel mesh__D011556 Pseudopseudo-Hypoparathyroidism
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D011556 2005
% 210.86/211.01 |- mesh__publicMeSHNote mesh__D011556 65
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D011556 2006
% 210.86/211.01 |- skos__broader mesh__D011556smesh__D011547
% 210.86/211.01 |- mesh__dateRevised mesh__D011556 2001-07-25
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D011556 2003
% 210.86/211.01 |- skos__hiddenLabel mesh__D011556 Pseudopseudohypoparathyroidisms
% 210.86/211.01 |- mesh__historyNote mesh__D011556 65%28%63%29%
% 210.86/211.01 |- rdf__type mesh__D011556sskos__Concept
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D005519 SJN
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D005519 2005
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D005519 1998
% 210.86/211.01 |- skos__hiddenLabel mesh__D005519 Canned Foods
% 210.86/211.01 |- skos__broader mesh__D005519smesh__D005524
% 210.86/211.01 |- mesh__recordOriginator mesh__D005519 NLM
% 210.86/211.01 |- skos__hiddenLabel mesh__D005519 Dried Foods
% 210.86/211.01 |- skos__related mesh__D005519smesh__D015416
% 210.86/211.01 |- skos__prefLabel mesh__D005519 Food Preservation
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D005519 2002
% 210.86/211.01 |- rdf__type mesh__D005519sskos__Concept
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D005519 2004
% 210.86/211.01 |- skos__hiddenLabel mesh__D005519 Foods, Dried
% 210.86/211.01 |- skos__hiddenLabel mesh__D005519 Foods, Canned
% 210.86/211.01 |- mesh__dateCreated mesh__D005519 1999-01-01
% 210.86/211.01 |- skos__hiddenLabel mesh__D005519 Preserved Foods
% 210.86/211.01 |- skos__altLabel mesh__D005519 Preservation, Food
% 210.86/211.01 |- mesh__dateRevised mesh__D005519 1997-06-20
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D005519 2003
% 210.86/211.01 |- skos__hiddenLabel mesh__D005519 Preserved Food
% 210.86/211.01 |- mesh__recordMaintainer mesh__D005519 JLS
% 210.86/211.01 |- skos__hiddenLabel mesh__D005519 Canned Food
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D005519 2001
% 210.86/211.01 |- skos__hiddenLabel mesh__D005519 Dried Food
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D005519 2006
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D005519 1999
% 210.86/211.01 |- skos__hiddenLabel mesh__D005519 Foods, Preserved
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D005519 2000
% 210.86/211.01 |- mesh__recordMaintainer mesh__D016241 PXP
% 210.86/211.01 |- mesh__recordOriginator mesh__D016241 TGC
% 210.86/211.01 |- skos__broader mesh__D016241smesh__D009272
% 210.86/211.01 |- mesh__dateEstablished mesh__D016241 1991-01-01
% 210.86/211.01 |- skos__scopeNote mesh__D016241
% 210.86/211.01 Child with one or more parents afflicted by a physical or mental disorder.%A%
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D016241 sjn
% 210.86/211.01 |- skos__hiddenLabel mesh__D016241 Parents Offspring, Impaired
% 210.86/211.01 |- skos__annotation mesh__D016241
% 210.86/211.01 coord IM with parental dis %28%IM with no qualif%29%; restrict to impaired parents: for child with impaired siblings; index CHILD %28%IM%29% + disease of sibling %28%IM%29% + SIBLINGS %28%IM%29%; interpret %22%child%22% as %22%offspring%22% %26% check appropriate age check tags%A%
% 210.86/211.01 |- skos__hiddenLabel mesh__D016241 Parents Offsprings, Impaired
% 210.86/211.01 |- skos__hiddenLabel mesh__D016241 Children, Impaired Parents%27%
% 210.86/211.01 |- mesh__publicMeSHNote mesh__D016241 91
% 210.86/211.01 |- mesh__dateRevised mesh__D016241 2002-07-03
% 210.86/211.01 |- skos__hiddenLabel mesh__D016241 Impaired Parents Offsprings
% 210.86/211.01 |- skos__altLabel mesh__D016241 Impaired Parents%27% Children
% 210.86/211.01 |- skos__altLabel mesh__D016241 Offspring of Impaired Parents
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D016241 2005
% 210.86/211.01 |- skos__prefLabel mesh__D016241 Child of Impaired Parents
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D016241 2006
% 210.86/211.01 |- skos__altLabel mesh__D016241 Children of Impaired Parents
% 210.86/211.01 |- skos__hiddenLabel mesh__D016241 Impaired Parents Offspring
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D016241 2003
% 210.86/211.01 |- rdf__type mesh__D016241sskos__Concept
% 210.86/211.01 |- mesh__dateCreated mesh__D016241 1990-06-06
% 210.86/211.01 |- mesh__historyNote mesh__D016241 91
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D016241 2004
% 210.86/211.01 |- mesh__dateCreated mesh__D029967 2001-07-25
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D029967 2004
% 210.86/211.01 |- skos__scopeNote mesh__D029967
% 210.86/211.01 A plant genus of the family GENTIANACEAE. It is a source of swertiapuniside and iridoid glycosides.%A%
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D029967 2006
% 210.86/211.01 |- rdf__type mesh__D029967sskos__Concept
% 210.86/211.01 |- mesh__publicMeSHNote mesh__D029967 2002
% 210.86/211.01 |- skos__broader mesh__D029967smesh__D029965
% 210.86/211.01 |- skos__annotation mesh__D029967
% 210.86/211.01 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D029967 2002
% 210.86/211.01 |- skos__prefLabel mesh__D029967 Swertia
% 210.86/211.01 |- mesh__historyNote mesh__D029967 2002
% 210.86/211.01 |- mesh__dateEstablished mesh__D029967 2002-01-01
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D029967 2003
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D029967 2005
% 210.86/211.01 |- skos__broader mesh__D002221smesh__D009943
% 210.86/211.01 |- skos__hiddenLabel mesh__D002221 Phosphate, Carbamyl
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 2003
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 1997
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 1994
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 2005
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 1999
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 2000
% 210.86/211.01 |- skos__scopeNote mesh__D002221 Phosphate salt of carbamic acid.
% 210.86/211.01 |- skos__broader mesh__D002221smesh__D002219
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 1993
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 2004
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 2001
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 1995
% 210.86/211.01 |- skos__historyNote mesh__D002221 Carbamates %28%1973-1974%29%
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 2006
% 210.86/211.01 |- skos__hiddenLabel mesh__D002221 Phosphate, Dilithium Carbamyl
% 210.86/211.01 |- mesh__dateCreated mesh__D002221 1974-11-19
% 210.86/211.01 |- skos__prefLabel mesh__D002221 Carbamyl Phosphate
% 210.86/211.01 |- skos__altLabel mesh__D002221 Carbamoyl Phosphate
% 210.86/211.01 |- mesh__recordOriginator mesh__D002221 NLM
% 210.86/211.01 |- mesh__dateEstablished mesh__D002221 1991-01-01
% 210.86/211.01 |- mesh__recordMaintainer mesh__D002221 TGC
% 210.86/211.01 |- mesh__historyNote mesh__D002221
% 210.86/211.01 91%28%75%29%; was see under CARBAMATES 1975-90
% 210.86/211.01 |- skos__historyNote mesh__D002221
% 210.86/211.01 Organophosphorus Compounds %28%1973-1974%29%
% 210.86/211.01 |- skos__hiddenLabel mesh__D002221 Phosphate, Carbamoyl
% 210.86/211.01 |- skos__hiddenLabel mesh__D002221 Carbamyl Phosphate, Dilithium
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 2002
% 210.86/211.01 |- mesh__dateRevised mesh__D002221 1992-05-11
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 1996
% 210.86/211.01 |- rdf__type mesh__D002221sskos__Concept
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D002221 PLS
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D002221 1998
% 210.86/211.01 |- mesh__publicMeSHNote mesh__D002221
% 210.86/211.01 91; was see under CARBAMATES 1975-90
% 210.86/211.01 |- skos__historyNote mesh__D021984
% 210.86/211.01 Peptidylprolyl Isomerase %28%1998-2000%29%
% 210.86/211.01 |- mesh__historyNote mesh__D021984
% 210.86/211.01 2001; use PEPTIDYLPROLYL ISOMERASE 1998-2000 %26% PEPTIDYLPROLYL ISOMERASE %28%NM%29% 1984-1997%A%
% 210.86/211.01 |- mesh__dateEstablished mesh__D021984 2001-01-01
% 210.86/211.01 |- mesh__dateRevised mesh__D021984 2004-07-07
% 210.86/211.01 |- skos__prefLabel mesh__D021984 Cyclophilin A
% 210.86/211.01 |- skos__hiddenLabel mesh__D021984 A, Cyclophilin
% 210.86/211.01 |- skos__scopeNote mesh__D021984
% 210.86/211.01 A 17-KDa cytoplasmic PEPTIDYLPROLYL ISOMERASE involved in immunoregulation. It is a member of the cyclophilin family of proteins that binds to CYCLOSPORINE.%A%
% 210.86/211.01 |- mesh__recordMaintainer mesh__D021984 jmp
% 210.86/211.01 |- skos__altLabel mesh__D021984 Peptidyl-Prolyl cis-trans Isomerase A
% 210.86/211.01 |- mesh__recordOriginator mesh__D021984 jmp
% 210.86/211.01 |- skos__broader mesh__D021984smesh__D021983
% 210.86/211.01 |- skos__historyNote mesh__D021984 Carrier Proteins %28%1984-1997%29%
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D021984 sjn
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D021984 2005
% 210.86/211.01 |- mesh__publicMeSHNote mesh__D021984
% 210.86/211.01 2001; see PEPTIDYLPROLYL ISOMERASE 1998-2000, was indexed under CARRIER PROTEINS %26% AMINO ACID ISOMERASES 1984-1997%A%
% 210.86/211.01 |- rdf__type mesh__D021984sskos__Concept
% 210.86/211.01 |- skos__historyNote mesh__D021984 Amino Acid Isomerases %28%1984-1997%29%
% 210.86/211.01 |- mesh__dateCreated mesh__D021984 2000-07-05
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D021984 2006
% 210.86/211.01 |- skos__broader mesh__D003391Q000293smesh__D003391
% 210.86/211.01 |- mesh__preferredCombination mesh__D003391Q000293smesh__D020209
% 210.86/211.01 |- rdf__type mesh__D003391Q000293smesh__CompoundConcept
% 210.86/211.01 |- skos__broader mesh__D011976Q000819smesh__D011976
% 210.86/211.01 |- mesh__preferredCombination mesh__D011976Q000819smesh__D018721
% 210.86/211.01 |- rdf__type mesh__D011976Q000819smesh__CompoundConcept
% 210.86/211.01 |- mesh__dateCreated mesh__D015149 1988-03-21
% 210.86/211.01 |- mesh__dateEstablished mesh__D015149 1989-01-01
% 210.86/211.01 |- mesh__historyNote mesh__D015149 89
% 210.86/211.01 |- skos__broader mesh__D015149smesh__D012102
% 210.86/211.01 |- skos__scopeNote mesh__D015149
% 210.86/211.01 Drugs that prevent preterm labor and immature birth by suppressing uterine contractions. Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete.%A%
% 210.86/211.01 |- rdf__type mesh__D015149sskos__Concept
% 210.86/211.01 |- skos__hiddenLabel mesh__D015149 Agents, Tocolytic
% 210.86/211.01 |- mesh__recordMaintainer mesh__D015149 ssb
% 210.86/211.01 |- mesh__recordOriginator mesh__D015149 SCD
% 210.86/211.01 |- skos__historyNote mesh__D015149 Muscle Contraction %28%1966-1974%29%
% 210.86/211.01 |- skos__historyNote mesh__D015149 Uterus %28%1966-1974%29%
% 210.86/211.01 |- mesh__dateRevised mesh__D015149 2005-06-30
% 210.86/211.01 |- skos__altLabel mesh__D015149 Tocolytics
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D015149 2006
% 210.86/211.01 |- skos__prefLabel mesh__D015149 Tocolytic Agents
% 210.86/211.01 |- skos__annotation mesh__D015149
% 210.86/211.01 suppress uterine contractions to prevent preterm labor %26% premature birth%A%
% 210.86/211.01 |- skos__historyNote mesh__D015149 Labor, Premature %28%1973-1988%29%
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D015149 sjn
% 210.86/211.01 |- skos__historyNote mesh__D015149 Uterine Contraction %28%1975-1988%29%
% 210.86/211.01 |- mesh__publicMeSHNote mesh__D015149 89
% 210.86/211.01 |- skos__altLabel mesh__D001927 Encephalon Diseases
% 210.86/211.01 |- mesh__dateCreated mesh__D001927 1999-01-01
% 210.86/211.01 |- mesh__recordOriginator mesh__D001927 NLM
% 210.86/211.01 |- skos__altLabel mesh__D001927
% 210.86/211.01 Central Nervous System Disorders, Intracranial
% 210.86/211.01 |- skos__hiddenLabel mesh__D001927 Brain Disease
% 210.86/211.01 |- skos__hiddenLabel mesh__D001927 Brain Disorder
% 210.86/211.01 |- rdf__type mesh__D001927sskos__Concept
% 210.86/211.01 |- skos__scopeNote mesh__D001927
% 210.86/211.01 Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes %28%but is not limited to%29% the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.%A%
% 210.86/211.01 |- skos__altLabel mesh__D001927 Brain Disorders
% 210.86/211.01 |- skos__altLabel mesh__D001927 Brain Pathology
% 210.86/211.01 |- skos__prefLabel mesh__D001927 Brain Diseases
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001927 2004
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001927 2006
% 210.86/211.01 |- skos__hiddenLabel mesh__D001927 CNS Disorder, Intracranial
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001927 2003
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001927 2005
% 210.86/211.01 |- skos__broader mesh__D001927smesh__D002493
% 210.86/211.01 |- mesh__dateRevised mesh__D001927 2002-07-02
% 210.86/211.01 |- skos__altLabel mesh__D001927 Intracranial CNS Disorders
% 210.86/211.01 |- skos__altLabel mesh__D001927 CNS Disorders, Intracranial
% 210.86/211.01 |- skos__altLabel mesh__D001927
% 210.86/211.01 Intracranial Central Nervous System Disorders
% 210.86/211.01 |- skos__hiddenLabel mesh__D001927 Encephalon Disease
% 210.86/211.01 |- skos__altLabel mesh__D001927
% 210.86/211.01 Central Nervous System Intracranial Disorders
% 210.86/211.01 |- skos__hiddenLabel mesh__D001927 Intracranial CNS Disorder
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D001927 sjn
% 210.86/211.01 |- mesh__recordMaintainer mesh__D001927 hjn
% 210.86/211.01 |- mesh__dateRevised mesh__D001129 1997-06-20
% 210.86/211.01 |- mesh__dateCreated mesh__D001129 1999-01-01
% 210.86/211.01 |- skos__prefLabel mesh__D001129 Argyria
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001129 2002
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001129 1999
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001129 2006
% 210.86/211.01 |- skos__scopeNote mesh__D001129
% 210.86/211.01 A permanent ashen-gray discoloration of the skin, conjunctiva, and internal organs resulting from long-continued use of silver salts. %28%Dorland, 27th ed%29%%A%
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001129 2003
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001129 2000
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001129 2004
% 210.86/211.01 |- skos__broader mesh__D001129smesh__D011041
% 210.86/211.01 |- skos__hiddenLabel mesh__D001129 Argyrias
% 210.86/211.01 |- skos__annotation mesh__D001129
% 210.86/211.01 caused by prolonged use of silver salts
% 210.86/211.01 |- mesh__recordOriginator mesh__D001129 NLM
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001129 2001
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001129 1998
% 210.86/211.01 |- skos__broader mesh__D001129smesh__D010859
% 210.86/211.01 |- mesh__recordMaintainer mesh__D001129 TPW
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D001129 2005
% 210.86/211.01 |- rdf__type mesh__D001129sskos__Concept
% 210.86/211.01 |- mesh__recordAuthorizer mesh__D001129 SJN
% 210.86/211.01 |- skos__historyNote mesh__D006612
% 210.86/211.01 Respiration, Artificial %28%1966-1987%29%
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006612 2004
% 210.86/211.01 |- skos__altLabel mesh__D006612 High Frequency Oscillation
% 210.86/211.01 |- skos__altLabel mesh__D006612 Ventilation, High-Frequency
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006612 2002
% 210.86/211.01 |- mesh__activeMeSHYear mesh__D006612 2006
% 210.86/211.02 |- mesh__dateRevised mesh__D006612 2001-07-25
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 Oscillations, High Frequency
% 210.86/211.02 |- skos__altLabel mesh__D006612 High Frequency Ventilation
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 Ventilations, High Frequency
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 High Frequency Oscillations
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 Ventilations, High-Frequency
% 210.86/211.02 |- skos__broader mesh__D006612smesh__D012121
% 210.86/211.02 |- skos__scopeNote mesh__D006612
% 210.86/211.02 Ventilatory support system using frequencies from 60-900 cycles/min or more. Three types of systems have been distinguished on the basis of rates, volumes, and the system used. They are high frequency positive-pressure ventilation %28%HFPPV%29%; HIGH-FREQUENCY JET VENTILATION; %28%HFJV%29%; and high-frequency oscillation %28%HFO%29%.%A%
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 Oscillation, High-Frequency
% 210.86/211.02 |- mesh__dateEstablished mesh__D006612 1988-01-01
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 High Frequency Ventilations
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 High-Frequency Ventilations
% 210.86/211.02 |- skos__prefLabel mesh__D006612 High-Frequency Ventilation
% 210.86/211.02 |- skos__altLabel mesh__D006612 Ventilation, High Frequency
% 210.86/211.02 |- mesh__recordOriginator mesh__D006612 EC
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 High-Frequency Oscillations
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D006612 88
% 210.86/211.02 |- rdf__type mesh__D006612sskos__Concept
% 210.86/211.02 |- skos__altLabel mesh__D006612
% 210.86/211.02 High Frequency Positive Pressure Ventilation
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 Oscillations, High-Frequency
% 210.86/211.02 |- mesh__dateCreated mesh__D006612 1987-04-30
% 210.86/211.02 |- skos__hiddenLabel mesh__D006612 Oscillation, High Frequency
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006612 2003
% 210.86/211.02 |- mesh__recordMaintainer mesh__D006612 mdb
% 210.86/211.02 |- mesh__historyNote mesh__D006612 88
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D006612 sjn
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006612 2005
% 210.86/211.02 |- skos__annotation mesh__D006612
% 210.86/211.02 a type of artif resp; do not use /util except by MeSH definition; DF: HFV%A%
% 210.86/211.02 |- skos__altLabel mesh__D011557 Aujeszky%27%s Disease
% 210.86/211.02 |- mesh__recordMaintainer mesh__D011557 ags
% 210.86/211.02 |- skos__altLabel mesh__D011557 Aujeszky Disease
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011557 2005
% 210.86/211.02 |- mesh__dateRevised mesh__D011557 2001-07-25
% 210.86/211.02 |- skos__prefLabel mesh__D011557 Pseudorabies
% 210.86/211.02 |- mesh__recordOriginator mesh__D011557 NLM
% 210.86/211.02 |- skos__broader mesh__D011557smesh__D000820
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011557 2006
% 210.86/211.02 |- skos__broader mesh__D011557smesh__D020805
% 210.86/211.02 |- skos__scopeNote mesh__D011557
% 210.86/211.02 A highly contagious herpesvirus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.%A%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011557 2003
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D011557 sjn
% 210.86/211.02 |- rdf__type mesh__D011557sskos__Concept
% 210.86/211.02 |- skos__broader mesh__D011557smesh__D006566
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011557 2004
% 210.86/211.02 |- skos__hiddenLabel mesh__D011557 Aujeszkys Disease
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011557 2002
% 210.86/211.02 |- mesh__dateCreated mesh__D011557 1999-01-01
% 210.86/211.02 |- mesh__recordMaintainer mesh__D016242 TAP
% 210.86/211.02 |- skos__scopeNote mesh__D016242
% 210.86/211.02 The use of automatic machines or processing devices in libraries. The automation may be applied to library administrative activities, office procedures, and delivery of library services to users.%A%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 2001
% 210.86/211.02 |- mesh__dateRevised mesh__D016242 1992-03-25
% 210.86/211.02 |- mesh__dateCreated mesh__D016242 1990-05-07
% 210.86/211.02 |- skos__hiddenLabel mesh__D016242 Automation, Library
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 1998
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 2005
% 210.86/211.02 |- skos__prefLabel mesh__D016242 Library Automation
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D016242 PLS
% 210.86/211.02 |- mesh__recordOriginator mesh__D016242 TGC
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 1993
% 210.86/211.02 |- skos__historyNote mesh__D016242 Automation %28%1966-1990%29%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 1999
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 2006
% 210.86/211.02 |- skos__historyNote mesh__D016242 Libraries %28%1966-1990%29%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 2002
% 210.86/211.02 |- skos__historyNote mesh__D016242
% 210.86/211.02 Automatic Data Processing %28%1966-1990%29%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 1996
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D016242 91
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 2003
% 210.86/211.02 |- skos__broader mesh__D016242smesh__D007998
% 210.86/211.02 |- rdf__type mesh__D016242sskos__Concept
% 210.86/211.02 |- mesh__historyNote mesh__D016242 91
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 1997
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 2004
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 2000
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 1994
% 210.86/211.02 |- mesh__dateEstablished mesh__D016242 1991-01-01
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016242 1995
% 210.86/211.02 |- skos__broader mesh__D000388Q000382smesh__D000388
% 210.86/211.02 |- mesh__preferredCombination mesh__D000388Q000382smesh__D000391
% 210.86/211.02 |- rdf__type mesh__D000388Q000382smesh__CompoundConcept
% 210.86/211.02 |- skos__altLabel mesh__D002222 Carbamoylphosphate Synthetase I
% 210.86/211.02 |- skos__broader mesh__D002222smesh__D019731
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D002222 ags
% 210.86/211.02 |- skos__related mesh__D002222smesh__D020165
% 210.86/211.02 |- skos__altLabel mesh__D002222 CP Synthase I
% 210.86/211.02 |- skos__altLabel mesh__D002222 Carbamoyl-Phosphate Synthetase I
% 210.86/211.02 |- skos__historyNote mesh__D002222 Ammonia %28%1974%29%
% 210.86/211.02 |- skos__scopeNote mesh__D002222
% 210.86/211.02 An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. This enzyme is specific for arginine biosynthesis or the urea cycle. Absence or lack of this enzyme may cause CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE. EC 6.3.4.16.%A%
% 210.86/211.02 |- skos__annotation mesh__D002222
% 210.86/211.02 /defic: consider CARBAMOYL-PHOSPHATE SYNTHETASE I DEFICIENCY DISEASE; DF: AMMONIA CP SYNTHASE or CP SYNTHASE I%A%
% 210.86/211.02 |- skos__hiddenLabel mesh__D002222 Synthase I, CP
% 210.86/211.02 |- skos__hiddenLabel mesh__D002222 Synthetase I, Carbamoyl-Phosphate
% 210.86/211.02 |- mesh__historyNote mesh__D002222 98%28%75%29%
% 210.86/211.02 |- rdf__type mesh__D002222sskos__Concept
% 210.86/211.02 |- mesh__dateEstablished mesh__D002222 1989-01-01
% 210.86/211.02 |- skos__hiddenLabel mesh__D002222 I, Carbamoyl-Phosphate Synthetase
% 210.86/211.02 |- skos__historyNote mesh__D002222 Phosphotransferases, ATP %28%1974%29%
% 210.86/211.02 |- mesh__dateCreated mesh__D002222 1974-11-19
% 210.86/211.02 |- skos__hiddenLabel mesh__D002222 Synthetase I, Carbamoylphosphate
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D002222
% 210.86/211.02 98; see CARBAMYL PHOSPHATE SYNTHASE %28%AMMONIA%29% 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80%A%
% 210.86/211.02 |- skos__altLabel mesh__D002222
% 210.86/211.02 Carbamoyl-Phosphate Synthetase %28%Ammonia%29%
% 210.86/211.02 |- skos__altLabel mesh__D002222 Carbamyl Phosphate Synthase %28%Ammonia%29%
% 210.86/211.02 |- skos__altLabel mesh__D002222 Carbamyl-Phosphate Synthase %28%Ammonia%29%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D002222 2006A
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D002222 2005
% 210.86/211.02 |- skos__historyNote mesh__D002222 Carbamates %28%1974%29%
% 210.86/211.02 |- skos__prefLabel mesh__D002222
% 210.86/211.02 Carbamoyl-Phosphate Synthase %28%Ammonia%29%
% 210.86/211.02 |- skos__altLabel mesh__D002222 Carbamoyl Phosphate Synthetase I
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D002222 2004
% 210.86/211.02 |- mesh__dateRevised mesh__D002222 2005-07-11
% 210.86/211.02 |- mesh__recordMaintainer mesh__D002222 ags
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D002222 2006
% 210.86/211.02 |- mesh__recordOriginator mesh__D002222 NLM
% 210.86/211.02 |- mesh__dateCreated mesh__D029968 2001-07-25
% 210.86/211.02 |- skos__related mesh__D029968smesh__D004926
% 210.86/211.02 |- rdf__type mesh__D029968sskos__Concept
% 210.86/211.02 |- skos__altLabel mesh__D029968 E coli Proteins
% 210.86/211.02 |- skos__scopeNote mesh__D029968
% 210.86/211.02 Proteins obtained from ESCHERICHIA COLI.
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D029968 2006
% 210.86/211.02 |- skos__prefLabel mesh__D029968 Escherichia coli Proteins
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D029968 sjn
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D029968 2002
% 210.86/211.02 |- skos__broader mesh__D029968smesh__D001426
% 210.86/211.02 |- mesh__recordMaintainer mesh__D029968 SYSTEM
% 210.86/211.02 |- mesh__dateEstablished mesh__D029968 2002-01-01
% 210.86/211.02 |- mesh__dateRevised mesh__D029968 2005-06-30
% 210.86/211.02 |- mesh__recordOriginator mesh__D029968 jmp
% 210.86/211.02 |- mesh__historyNote mesh__D029968 2002
% 210.86/211.02 |- skos__historyNote mesh__D029968 Bacterial Proteins %28%1994-2001%29%
% 210.86/211.02 |- rdf__type mesh__D015948sskos__Concept
% 210.86/211.02 |- mesh__recordMaintainer mesh__D015948 lkt
% 210.86/211.02 |- mesh__dateEstablished mesh__D015948 1990-01-01
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D015948 2004
% 210.86/211.02 |- skos__hiddenLabel mesh__D015948 Penetrating Keratoplasty
% 210.86/211.02 |- skos__scopeNote mesh__D015948
% 210.86/211.02 Partial or total replacement of all layers of a central portion of the cornea.%A%
% 210.86/211.02 |- mesh__dateRevised mesh__D015948 2002-07-03
% 210.86/211.02 |- mesh__dateCreated mesh__D015948 1989-05-25
% 210.86/211.02 |- mesh__historyNote mesh__D015948 90
% 210.86/211.02 |- skos__hiddenLabel mesh__D015948 Penetrating Keratoplasties
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D015948 90
% 210.86/211.02 |- skos__historyNote mesh__D015948 Cornea/transplantation %28%1966-1989%29%
% 210.86/211.02 |- mesh__recordOriginator mesh__D015948 EGC
% 210.86/211.02 |- skos__broader mesh__D015948smesh__D016039
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D015948 2005
% 210.86/211.02 |- skos__hiddenLabel mesh__D015948 Keratoplasties, Penetrating
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D015948 2006
% 210.86/211.02 |- skos__prefLabel mesh__D015948 Keratoplasty, Penetrating
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D015948 sjn
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D015948 2003
% 210.86/211.02 |- skos__annotation mesh__D015948
% 210.86/211.02 do not use /util except by MeSH definition
% 210.86/211.02 |- skos__altLabel mesh__D040341 Genetic Phenomenon
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D040341 2003
% 210.86/211.02 |- mesh__dateEstablished mesh__D040341 2003-01-01
% 210.86/211.02 |- skos__hiddenLabel mesh__D040341 Phenomena, Genetic
% 210.86/211.02 |- mesh__dateCreated mesh__D040341 2002-07-03
% 210.86/211.02 |- mesh__recordOriginator mesh__D040341 nns
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D040341 sjn
% 210.86/211.02 |- skos__related mesh__D040341smesh__D039361
% 210.86/211.02 |- skos__hiddenLabel mesh__D040341 Phenomenon, Genetic
% 210.86/211.02 |- skos__prefLabel mesh__D040341 Genetic Phenomena
% 210.86/211.02 |- mesh__recordMaintainer mesh__D040341 nns
% 210.86/211.02 |- mesh__historyNote mesh__D040341 2003
% 210.86/211.02 |- mesh__dateRevised mesh__D040341 2003-07-09
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D040341 2005
% 210.86/211.02 |- skos__scopeNote mesh__D040341
% 210.86/211.02 Temporal, spatial, qualitative, and quantitative concepts related to GENETIC PROCESSES and GENETIC STRUCTURES.%A%
% 210.86/211.02 |- rdf__type mesh__D040341sskos__Concept
% 210.86/211.02 |- skos__related mesh__D040341smesh__D040342
% 210.86/211.02 |- skos__annotation mesh__D040341 GEN only: avoid: prefer specifics
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D040341 2006
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D040341 2004
% 210.86/211.02 |- mesh__runningHead mesh__D040341 G13 - GENETIC PHENOMENA
% 210.86/211.02 |- skos__related mesh__D040341smesh__D005823
% 210.86/211.02 |- mesh__dateCreated mesh__D001928 1999-01-01
% 210.86/211.02 |- skos__altLabel mesh__D001928 Encephalopathies, Metabolic
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Brain Metabolic Disorder
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Disorders, Brain
% 210.86/211.02 |- mesh__dateEstablished mesh__D001928 1977-01-01
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Metabolic Brain Disease
% 210.86/211.02 |- skos__annotation mesh__D001928
% 210.86/211.02 GEN; avoid: prefer specifics; DF: BRAIN DIS METAB
% 210.86/211.02 |- mesh__historyNote mesh__D001928 1977; was NON MESH before 1977
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Brain Syndromes
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D001928 2003
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D001928 2002
% 210.86/211.02 |- skos__broader mesh__D001928smesh__D001927
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Encephalopathies
% 210.86/211.02 |- skos__historyNote mesh__D001928 Brain Diseases %28%1966-1976%29%
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Brain Metabolic Disorders
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Metabolic Brain Disorders
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Brain Diseases
% 210.86/211.02 |- skos__prefLabel mesh__D001928 Brain Diseases, Metabolic
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Disorders, CNS, Acquired
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Metabolic Disorder, CNS
% 210.86/211.02 |- skos__altLabel mesh__D001928 Encephalopathy, Metabolic, Acquired
% 210.86/211.02 |- skos__scopeNote mesh__D001928
% 210.86/211.02 Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary %28%i.e., disorders intrinsic to the brain%29% and secondary %28%i.e., extracranial%29% metabolic conditions that adversely affect cerebral function.%A%
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Disorders, CNS
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Metabolic Brain Disorder
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Encephalopathy, Metabolic
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Metabolic Disorder, Brain
% 210.86/211.02 |- skos__altLabel mesh__D001928 CNS Metabolic Disorders, Acquired
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Encephalopathy, Acquired Metabolic
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Brain Syndrome, Acquired
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Brain Disorder, Metabolic
% 210.86/211.02 |- mesh__recordMaintainer mesh__D001928 nns
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Encephalopathies, Acquired Metabolic
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Brain Syndrome
% 210.86/211.02 |- rdf__type mesh__D001928sskos__Concept
% 210.86/211.02 |- skos__altLabel mesh__D001928 CNS Metabolic Disorders
% 210.86/211.02 |- skos__altLabel mesh__D001928 Brain Syndrome, Metabolic, Acquired
% 210.86/211.02 |- skos__altLabel mesh__D001928 Brain Disorders, Metabolic, Acquired
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Brain Disease, Metabolic
% 210.86/211.02 |- skos__broader mesh__D001928smesh__D008659
% 210.86/211.02 |- skos__altLabel mesh__D001928
% 210.86/211.02 Metabolic Diseases, Acquired, Nervous System
% 210.86/211.02 |- skos__altLabel mesh__D001928 Brain Disorders, Metabolic
% 210.86/211.02 |- mesh__dateRevised mesh__D001928 2001-07-25
% 210.86/211.02 |- skos__altLabel mesh__D001928 Nervous System Acquired Metabolic Diseases
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Metabolic Encephalopathy
% 210.86/211.02 |- skos__altLabel mesh__D001928 Acquired Metabolic Encephalopathies
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D001928 2006
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Disorders, Central Nervous System
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Acquired Metabolic Encephalopathy
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Brain Syndromes, Acquired
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 CNS Metabolic Disorder
% 210.86/211.02 |- mesh__recordOriginator mesh__D001928 NLM
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D001928 1977
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D001928 2005
% 210.86/211.02 |- skos__altLabel mesh__D001928 Brain Syndrome, Metabolic
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Metabolic Encephalopathy, Acquired
% 210.86/211.02 |- skos__hiddenLabel mesh__D001928 Metabolic Encephalopathies, Acquired
% 210.86/211.02 |- skos__altLabel mesh__D001928 Acquired Metabolic Diseases, Brain
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D001928 sjn
% 210.86/211.02 |- skos__altLabel mesh__D001928 Metabolic Brain Diseases, Acquired
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D001928 2004
% 210.86/211.02 |- skos__broader mesh__D002645Q000196smesh__D002645
% 210.86/211.02 |- mesh__preferredCombination mesh__D002645Q000196smesh__D002642
% 210.86/211.02 |- rdf__type mesh__D002645Q000196smesh__CompoundConcept
% 210.86/211.02 |- skos__hiddenLabel mesh__D012650 Disclosure, Self
% 210.86/211.02 |- rdf__type mesh__D012650sskos__Concept
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1991
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 2003
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1996
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 2004
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1992
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1997
% 210.86/211.02 |- skos__scopeNote mesh__D012650
% 210.86/211.02 A willingness to reveal information about oneself to others.%A%
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D012650
% 210.86/211.02 79; was see under SELF CONCEPT 1969-78
% 210.86/211.02 |- mesh__dateRevised mesh__D012650 1989-05-16
% 210.86/211.02 |- skos__hiddenLabel mesh__D012650 Disclosures, Self
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 2005
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D012650 PLS
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1993
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1998
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 2006
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 2000
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1994
% 210.86/211.02 |- skos__hiddenLabel mesh__D012650 Self Disclosures
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1999
% 210.86/211.02 |- mesh__recordMaintainer mesh__D012650 TGC
% 210.86/211.02 |- mesh__recordOriginator mesh__D012650 NLM
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 2001
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1995
% 210.86/211.02 |- skos__broader mesh__D012650smesh__D012649
% 210.86/211.02 |- skos__historyNote mesh__D012650 Self Concept %28%1969-1974%29%
% 210.86/211.02 |- skos__annotation mesh__D012650
% 210.86/211.02 %22%a willingness to reveal information about oneself to others%22%; no qualif%A%
% 210.86/211.02 |- mesh__dateCreated mesh__D012650 1999-01-01
% 210.86/211.02 |- mesh__historyNote mesh__D012650
% 210.86/211.02 79%28%75%29%; was see under SELF CONCEPT 1969-78
% 210.86/211.02 |- skos__prefLabel mesh__D012650 Self Disclosure
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 2002
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D012650 1990
% 210.86/211.02 |- mesh__onlineNote mesh__D012650 search SELF CONCEPT 1969-74
% 210.86/211.02 |- mesh__dateEstablished mesh__D012650 1979-01-01
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 1997
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 1994
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 1999
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D006613 65
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 1993
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 1995
% 210.86/211.02 |- skos__hiddenLabel mesh__D006613 Activity, Higher Nervous
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 2002
% 210.86/211.02 |- mesh__historyNote mesh__D006613 65%28%64%29%
% 210.86/211.02 |- skos__annotation mesh__D006613
% 210.86/211.02 this expression is found intact as %22%vysshaia nervnaia deiatel%27%nost%22% in Russian neurophysiol lit%A%
% 210.86/211.02 |- mesh__recordMaintainer mesh__D006613 TAP
% 210.86/211.02 |- rdf__type mesh__D006613sskos__Concept
% 210.86/211.02 |- skos__hiddenLabel mesh__D006613 Nervous Activity, Higher
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 2003
% 210.86/211.02 |- mesh__dateEstablished mesh__D006613 1965-01-01
% 210.86/211.02 |- skos__hiddenLabel mesh__D006613 Nervous Activities, Higher
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 2000
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 2005
% 210.86/211.02 |- skos__hiddenLabel mesh__D006613 Higher Nervous Activities
% 210.86/211.02 |- mesh__dateCreated mesh__D006613 1999-01-01
% 210.86/211.02 |- skos__hiddenLabel mesh__D006613 Activities, Higher Nervous
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 2004
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 1996
% 210.86/211.02 |- mesh__dateRevised mesh__D006613 1992-05-15
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D006613 PLS
% 210.86/211.02 |- mesh__recordOriginator mesh__D006613 NLM
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 2001
% 210.86/211.02 |- skos__prefLabel mesh__D006613 Higher Nervous Activity
% 210.86/211.02 |- skos__broader mesh__D006613smesh__D009424
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 2006
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D006613 1998
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011558 2005
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011558 2002
% 210.86/211.02 |- skos__hiddenLabel mesh__D011558 Herpesvirus 1, Swine
% 210.86/211.02 |- skos__historyNote mesh__D011558 Herpesviridae %28%1966-1974%29%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011558 2006
% 210.86/211.02 |- skos__altLabel mesh__D011558 Herpesvirus 1 %28%alpha%29%, Suid
% 210.86/211.02 |- skos__prefLabel mesh__D011558 Herpesvirus 1, Suid
% 210.86/211.02 |- mesh__dateEstablished mesh__D011558 1980-01-01
% 210.86/211.02 |- skos__altLabel mesh__D011558 Pseudorabies virus
% 210.86/211.02 |- skos__altLabel mesh__D011558 Aujeszky Disease Virus
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011558 2003
% 210.86/211.02 |- skos__annotation mesh__D011558 infection = PSEUDORABIES
% 210.86/211.02 |- rdf__type mesh__D011558sskos__Concept
% 210.86/211.02 |- skos__hiddenLabel mesh__D011558 Pseudorabies viruses
% 210.86/211.02 |- mesh__dateRevised mesh__D011558 2001-07-25
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D011558 2004
% 210.86/211.02 |- mesh__onlineNote mesh__D011558
% 210.86/211.02 use HERPESVIRUS 1, SUID to search HERPESVIRUS SUIS 1975-93 %26% PSEUDORABIES VIRUS 1966-93%A%
% 210.86/211.02 |- skos__altLabel mesh__D011558 Swine Herpesvirus 1
% 210.86/211.02 |- skos__altLabel mesh__D011558 Herpesvirus Suis
% 210.86/211.02 |- skos__hiddenLabel mesh__D011558 Aujeszkys Disease Virus
% 210.86/211.02 |- skos__altLabel mesh__D011558 Suid herpesvirus 1
% 210.86/211.02 |- mesh__recordOriginator mesh__D011558 NLM
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D011558
% 210.86/211.02 94; was PSEUDORABIES VIRUS 1963-93 %28%see under HERPESVIRUSES 1975-79, see under HERPESVIRUS 1963-74%29%; HERPESVIRUS SUIS was see PSEUDORABIES VIRUS 1975-93%A%
% 210.86/211.02 |- mesh__dateCreated mesh__D011558 1999-01-01
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D011558 sjn
% 210.86/211.02 |- skos__scopeNote mesh__D011558
% 210.86/211.02 A species of VARICELLOVIRUS producing a respiratory infection %28%PSEUDORABIES%29% in swine, its natural host. It also produces an usually fatal ENCEPHALOMYELITIS in cattle, sheep, dogs, cats, foxes, and mink.%A%
% 210.86/211.02 |- skos__broader mesh__D011558smesh__D018140
% 210.86/211.02 |- mesh__historyNote mesh__D011558
% 210.86/211.02 94; was PSEUDORABIES VIRUS 1963-93 %28%see under HERPESVIRUSES 1975-79, see under HERPESVIRUS 1963-74%29%; HERPESVIRUS SUIS was see PSEUDORABIES VIRUS 1975-93%A%
% 210.86/211.02 |- mesh__recordMaintainer mesh__D011558 ags
% 210.86/211.02 |- skos__altLabel mesh__D011558 Aujeszky%27%s Disease Virus
% 210.86/211.02 |- mesh__recordOriginator mesh__D016243 TGC
% 210.86/211.02 |- mesh__dateRevised mesh__D016243 1992-03-25
% 210.86/211.02 |- skos__broader mesh__D016243smesh__D007998
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 2002
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 1995
% 210.86/211.02 |- skos__scopeNote mesh__D016243
% 210.86/211.02 Development of a library collection, including the determination and coordination of selection policy, assessment of needs of users and potential users, collection use studies, collection evaluation, identification of collection needs, selection of materials, planning for resource sharing, collection maintenance and weeding, and budgeting.%A%
% 210.86/211.02 |- skos__hiddenLabel mesh__D016243
% 210.86/211.02 Developments, Collection %28%Libraries%29%
% 210.86/211.02 |- skos__altLabel mesh__D016243 Collection Development %28%Libraries%29%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 1994
% 210.86/211.02 |- mesh__recordMaintainer mesh__D016243 TAP
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 1993
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D016243 PLS
% 210.86/211.02 |- skos__historyNote mesh__D016243 Book Selection %28%1966-1990%29%
% 210.86/211.02 |- mesh__dateEstablished mesh__D016243 1991-01-01
% 210.86/211.02 |- skos__hiddenLabel mesh__D016243 Development, Library Collection
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 1999
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 2006
% 210.86/211.02 |- skos__hiddenLabel mesh__D016243 Collection Development, Library
% 210.86/211.02 |- skos__prefLabel mesh__D016243 Library Collection Development
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 2001
% 210.86/211.02 |- skos__hiddenLabel mesh__D016243
% 210.86/211.02 Development, Collection %28%Libraries%29%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 1998
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 2005
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 1997
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 2004
% 210.86/211.02 |- skos__hiddenLabel mesh__D016243
% 210.86/211.02 Collection Developments %28%Libraries%29%
% 210.86/211.02 |- mesh__historyNote mesh__D016243 91
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 2000
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D016243 91
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 1996
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D016243 2003
% 210.86/211.02 |- skos__annotation mesh__D016243 DF: COLLECTION DEVELOPMENT
% 210.86/211.02 |- rdf__type mesh__D016243sskos__Concept
% 210.86/211.02 |- mesh__dateCreated mesh__D016243 1990-05-07
% 210.86/211.02 |- skos__historyNote mesh__D002223 Carbamates %28%1974%29%
% 210.86/211.02 |- skos__annotation mesh__D002223 DF: GLUTAMINE CP SYNTHASE
% 210.86/211.02 |- skos__hiddenLabel mesh__D002223 Synthetase II, Carbamoylphosphate
% 210.86/211.02 |- mesh__recordAuthorizer mesh__D002223 sjn
% 210.86/211.02 |- mesh__recordOriginator mesh__D002223 NLM
% 210.86/211.02 |- skos__prefLabel mesh__D002223
% 210.86/211.02 Carbamoyl-Phosphate Synthase %28%Glutamine-Hydrolyzing%29%
% 210.86/211.02 |- rdf__type mesh__D002223sskos__Concept
% 210.86/211.02 |- skos__altLabel mesh__D002223
% 210.86/211.02 Carbamoyl-Phosphate Synthase %28%Glutamine%29%
% 210.86/211.02 |- mesh__recordMaintainer mesh__D002223 ssb
% 210.86/211.02 |- mesh__dateEstablished mesh__D002223 1989-01-01
% 210.86/211.02 |- skos__historyNote mesh__D002223 Phosphotransferases, ATP %28%1974%29%
% 210.86/211.02 |- skos__historyNote mesh__D002223 Glutamine %28%1974%29%
% 210.86/211.02 |- skos__altLabel mesh__D002223 Carbamoylphosphate Synthetase II
% 210.86/211.02 |- mesh__publicMeSHNote mesh__D002223
% 210.86/211.02 98; see CARBAMYL PHOSPHATE SYNTHASE %28%GLUTAMINE%29% 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80%A%
% 210.86/211.02 |- skos__altLabel mesh__D002223
% 210.86/211.02 Carbamyl-Phosphate Synthase %28%Glutamine%29%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D002223 2005
% 210.86/211.02 |- mesh__historyNote mesh__D002223 98%28%75%29%
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D002223 2004
% 210.86/211.02 |- mesh__activeMeSHYear mesh__D002223 2006
% 210.86/211.02 |- skos__broader mesh__D002223smesh__D019733
% 210.86/211.02 |- mesh__dateCreated mesh__D002223 1974-11-19
% 210.86/211.02 |- skos__altLabel mesh__D002223
% 210.86/211.02 Carbamyl Phosphate Synthase %28%Glutamine%29%
% 210.86/211.02 |- skos__scopeNote mesh__D002223
% 210.86/211.02 An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. This enzyme is important in the de novo biosynthesis of pyrimidines. EC 6.3.5.5.%A%
% 210.86/211.02 |- mesh__dateRevised mesh__D002223 2003-07-09
% 210.86/211.03 |- skos__prefLabel mesh__D029969 Angelica
% 210.86/211.03 |- mesh__historyNote mesh__D029969 2002
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D029969 2006
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D029969 2002
% 210.86/211.03 |- mesh__dateCreated mesh__D029969 2001-07-25
% 210.86/211.03 |- skos__scopeNote mesh__D029969 A plant genus of the family Apiaceae.
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D029969 2002
% 210.86/211.03 |- mesh__dateEstablished mesh__D029969 2002-01-01
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D029969 2003
% 210.86/211.03 |- skos__broader mesh__D029969smesh__D019661
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D029969 2005
% 210.86/211.03 |- rdf__type mesh__D029969sskos__Concept
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D029969 2004
% 210.86/211.03 |- skos__annotation mesh__D029969
% 210.86/211.03 GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.86/211.03 |- skos__annotation mesh__D015949 /defic = CHRISTMAS DISEASE
% 210.86/211.03 |- mesh__recordMaintainer mesh__D015949 ssb
% 210.86/211.03 |- skos__altLabel mesh__D015949 Blood Coagulation Factor IX, Activated
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D015949 sjn
% 210.86/211.03 |- mesh__recordOriginator mesh__D015949 AGS
% 210.86/211.03 |- skos__broader mesh__D015949smesh__D005164
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D015949 90
% 210.86/211.03 |- skos__altLabel mesh__D015949 Coagulation Factor IXa
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D015949 2006
% 210.86/211.03 |- skos__altLabel mesh__D015949 Factor IX, Activated
% 210.86/211.03 |- mesh__historyNote mesh__D015949 90
% 210.86/211.03 |- skos__scopeNote mesh__D015949
% 210.86/211.03 Activated form of factor IX. This activation can take place via the intrinsic pathway by the action of factor XIa and calcium, or via the extrinsic pathway by the action of factor VIIa, thromboplastin, and calcium. Factor IXa serves to activate factor X to Xa by cleaving the arginyl-leucine peptide bond in factor X.%A%
% 210.86/211.03 |- rdf__type mesh__D015949sskos__Concept
% 210.86/211.03 |- mesh__dateRevised mesh__D015949 2005-06-30
% 210.86/211.03 |- skos__hiddenLabel mesh__D015949 Activated Factor IX
% 210.86/211.03 |- skos__hiddenLabel mesh__D015949 Factor IXa, Coagulation
% 210.86/211.03 |- skos__broader mesh__D015949smesh__D012697
% 210.86/211.03 |- skos__related mesh__D015949smesh__D003029
% 210.86/211.03 |- mesh__dateEstablished mesh__D015949 1990-01-01
% 210.86/211.03 |- skos__hiddenLabel mesh__D015949 IXa, Coagulation Factor
% 210.86/211.03 |- skos__historyNote mesh__D015949 Factor IX %28%1975-1989%29%
% 210.86/211.03 |- mesh__dateCreated mesh__D015949 1989-07-14
% 210.86/211.03 |- skos__historyNote mesh__D015949 Serine Proteinases %28%1988-1989%29%
% 210.86/211.03 |- skos__prefLabel mesh__D015949 Factor IXa
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D040342 2006
% 210.86/211.03 |- mesh__dateRevised mesh__D040342 2003-07-09
% 210.86/211.03 |- skos__hiddenLabel mesh__D040342 Structures, Genetic
% 210.86/211.03 |- mesh__dateCreated mesh__D040342 2002-07-03
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D040342 2005
% 210.86/211.03 |- mesh__recordMaintainer mesh__D040342 nns
% 210.86/211.03 |- skos__hiddenLabel mesh__D040342 Genetic Structure
% 210.86/211.03 |- skos__related mesh__D040342smesh__D005823
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D040342 2003
% 210.86/211.03 |- mesh__historyNote mesh__D040342 2003
% 210.86/211.03 |- skos__annotation mesh__D040342 GEN only; avoid: prefer specifics
% 210.86/211.03 |- skos__related mesh__D040342smesh__D039361
% 210.86/211.03 |- mesh__dateEstablished mesh__D040342 2003-01-01
% 210.86/211.03 |- mesh__recordOriginator mesh__D040342 nns
% 210.86/211.03 |- skos__prefLabel mesh__D040342 Genetic Structures
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D040342 sjn
% 210.86/211.03 |- skos__scopeNote mesh__D040342
% 210.86/211.03 The biological objects that contain genetic information and that are involved in transmitting genetically encoded traits from one organism to another.%A%
% 210.86/211.03 |- mesh__runningHead mesh__D040342 G14 - GENETIC STRUCTURES
% 210.86/211.03 |- skos__related mesh__D040342smesh__D040341
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D040342 2004
% 210.86/211.03 |- skos__hiddenLabel mesh__D040342 Structure, Genetic
% 210.86/211.03 |- rdf__type mesh__D040342sskos__Concept
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D001929 2003
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D001929 2001
% 210.86/211.03 |- rdf__type mesh__D001929sskos__Concept
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Brain Edema, Vasogenic
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D001929 2005
% 210.86/211.03 |- mesh__dateRevised mesh__D001929 1999-11-04
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Edema, Cerebral
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Edema, Brain
% 210.86/211.03 |- skos__altLabel mesh__D001929 Intracranial Edema
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D001929 2004
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Edema, Vasogenic Cerebral
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D001929 2006
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Brain Swellings
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Edema, Cytotoxic Brain
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Edema, Intracranial
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D001929 2002
% 210.86/211.03 |- mesh__dateCreated mesh__D001929 1999-01-01
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D001929 sjn
% 210.86/211.03 |- skos__broader mesh__D001929smesh__D001927
% 210.86/211.03 |- skos__related mesh__D001929smesh__D019586
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Edema, Cytotoxic Cerebral
% 210.86/211.03 |- skos__altLabel mesh__D001929 Cerebral Edema, Cytotoxic
% 210.86/211.03 |- mesh__recordOriginator mesh__D001929 NLM
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Brain Edema, Cytotoxic
% 210.86/211.03 |- skos__prefLabel mesh__D001929 Brain Edema
% 210.86/211.03 |- skos__scopeNote mesh__D001929
% 210.86/211.03 Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema %28%swelling due to increased intracellular fluid%29% is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries %28%see HYPOXIA, BRAIN%29%. An increase in extracellular fluid may be caused by increased brain capillary permeability %28%vasogenic edema%29%, an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow %28%e.g., obstructive HYDROCEPHALUS%29%. %28%From Childs Nerv Syst 1992 Sep; 8%28%6%29%:301-6%29%%A%
% 210.86/211.03 |- mesh__historyNote mesh__D001929 1965%28%1964%29%
% 210.86/211.03 |- mesh__recordMaintainer mesh__D001929 KEV
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Edema, Vasogenic Brain
% 210.86/211.03 |- skos__altLabel mesh__D001929 Cerebral Edema, Vasogenic
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D001929 2000
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D001929 1965
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Cerebral Edemas, Vasogenic
% 210.86/211.03 |- mesh__dateEstablished mesh__D001929 1965-01-01
% 210.86/211.03 |- skos__hiddenLabel mesh__D001929 Swelling, Brain
% 210.86/211.03 |- skos__altLabel mesh__D001929 Brain Swelling
% 210.86/211.03 |- skos__hiddenLabel mesh__D012651 Medication, Self
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 2005
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 1998
% 210.86/211.03 |- mesh__recordMaintainer mesh__D012651 KEV
% 210.86/211.03 |- mesh__recordOriginator mesh__D012651 NLM
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 2000
% 210.86/211.03 |- mesh__dateRevised mesh__D012651 1995-05-23
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 2004
% 210.86/211.03 |- rdf__type mesh__D012651sskos__Concept
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 1997
% 210.86/211.03 |- skos__hiddenLabel mesh__D012651 Medications, Self
% 210.86/211.03 |- mesh__dateEstablished mesh__D012651 1968-01-01
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D012651 PLS
% 210.86/211.03 |- mesh__historyNote mesh__D012651 68%28%65%29%
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 2003
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 1996
% 210.86/211.03 |- skos__prefLabel mesh__D012651 Self Medication
% 210.86/211.03 |- skos__scopeNote mesh__D012651
% 210.86/211.03 The self administration of medication not prescribed by a physician or in a manner not directed by a physician.%A%
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 2002
% 210.86/211.03 |- mesh__dateCreated mesh__D012651 1999-01-01
% 210.86/211.03 |- skos__broader mesh__D012651smesh__D004358
% 210.86/211.03 |- skos__broader mesh__D012651smesh__D012648
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 2006
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 1999
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012651 2001
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D012651 68
% 210.86/211.03 |- skos__hiddenLabel mesh__D012651 Self Medications
% 210.86/211.03 |- skos__annotation mesh__D012651
% 210.86/211.03 differentiate from SELF ADMINISTRATION %26% SELF CARE %28%see note there%29%%A%
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D006614 1968
% 210.86/211.03 |- rdf__type mesh__D006614sskos__Concept
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D006614 ags
% 210.86/211.03 |- mesh__historyNote mesh__D006614 1968
% 210.86/211.03 |- skos__annotation mesh__D006614
% 210.86/211.03 non-primate vertebrates only; for primates use LEG
% 210.86/211.03 |- mesh__recordOriginator mesh__D006614 NLM
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006614 2003
% 210.86/211.03 |- skos__scopeNote mesh__D006614
% 210.86/211.03 Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. %28%From Storer et al., General Zoology, 6th ed, p73%29%%A%
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006614 2006A
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006614 2005
% 210.86/211.03 |- mesh__dateCreated mesh__D006614 1999-01-01
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006614 2004
% 210.86/211.03 |- mesh__recordMaintainer mesh__D006614 ags
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006614 2006
% 210.86/211.03 |- skos__hiddenLabel mesh__D006614 Hindlimbs
% 210.86/211.03 |- skos__prefLabel mesh__D006614 Hindlimb
% 210.86/211.03 |- mesh__dateRevised mesh__D006614 2005-07-13
% 210.86/211.03 |- skos__historyNote mesh__D006614 Extremities %28%1966-1967%29%
% 210.86/211.03 |- skos__broader mesh__D006614smesh__D000825
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006614 2002
% 210.86/211.03 |- mesh__dateEstablished mesh__D006614 1968-01-01
% 210.86/211.03 |- skos__historyNote mesh__D006614 Leg %28%1966-1967%29%
% 210.86/211.03 |- skos__hiddenLabel mesh__D050770 Dehydrogenase, Glutaryl-Coenzyme A
% 210.86/211.03 |- skos__hiddenLabel mesh__D050770 Dehydrogenase, Glutaryl CoA
% 210.86/211.03 |- skos__altLabel mesh__D050770 Glutaryl CoA Dehydrogenase
% 210.86/211.03 |- mesh__dateEstablished mesh__D050770 2006-01-01
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D050770
% 210.86/211.03 2006; GLUTARYL-COA DEHYDROGENASE was indexed under ACYL COENZYME A 1973-1979; under GLUTARATES 1973-1982; and under COENZYME A 1973-1979; under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005%A%
% 210.86/211.03 |- skos__hiddenLabel mesh__D050770 Dehydrogenase, Glutaryl-CoA
% 210.86/211.03 |- mesh__dateCreated mesh__D050770 2005-06-30
% 210.86/211.03 |- skos__hiddenLabel mesh__D050770 Glutaryl Coenzyme A Dehydrogenase
% 210.86/211.03 |- skos__historyNote mesh__D050770 Glutarates %28%1973-1980%29%
% 210.86/211.03 |- skos__historyNote mesh__D050770 Coenzymes %28%1973-1979%29%
% 210.86/211.03 |- skos__historyNote mesh__D050770 Oxidoreductases %28%1983-2003%29%
% 210.86/211.03 |- skos__scopeNote mesh__D050770
% 210.86/211.03 A flavoprotein enzyme that is responsible for the catabolism of LYSINE; HYDROXYLYSINE; and TRYPTOPHAN. It catalyzes the oxidation of GLUTARYL-CoA to crotonoyl-CoA using FAD as a cofactor. Glutaric aciduria type I is an inborn error of metabolism due to the deficiency of glutaryl-CoA dehydrogenase.%A%
% 210.86/211.03 |- mesh__recordOriginator mesh__D050770 AKE
% 210.86/211.03 |- skos__hiddenLabel mesh__D050770 CoA Dehydrogenase, Glutaryl
% 210.86/211.03 |- skos__broader mesh__D050770smesh__D044925
% 210.86/211.03 |- skos__historyNote mesh__D050770
% 210.86/211.03 Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.86/211.03 |- skos__prefLabel mesh__D050770 Glutaryl-CoA Dehydrogenase
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D050770 2006
% 210.86/211.03 |- skos__historyNote mesh__D050770 Acyl Coenzyme A %28%1973-1979%29%
% 210.86/211.03 |- mesh__recordMaintainer mesh__D050770 AKE
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D050770 sjn
% 210.86/211.03 |- rdf__type mesh__D050770sskos__Concept
% 210.86/211.03 |- mesh__historyNote mesh__D050770 2006%28%1973%29%
% 210.86/211.03 |- skos__altLabel mesh__D050770 Glutaryl-Coenzyme A Dehydrogenase
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D011559 ags
% 210.86/211.03 |- mesh__recordOriginator mesh__D011559 NLM
% 210.86/211.03 |- mesh__dateCreated mesh__D011559 1999-01-01
% 210.86/211.03 |- skos__hiddenLabel mesh__D011559 Hypertension, Benign Intracranial
% 210.86/211.03 |- skos__altLabel mesh__D011559 Idiopathic Intracranial Hypertension
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D011559 2000A
% 210.86/211.03 |- mesh__dateRevised mesh__D011559 1999-12-08
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D011559 2001
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D011559 1973
% 210.86/211.03 |- mesh__dateEstablished mesh__D011559 1973-01-01
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D011559 2006
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D011559 2000
% 210.86/211.03 |- mesh__historyNote mesh__D011559 1973%28%1964%29%
% 210.86/211.03 |- skos__altLabel mesh__D011559 Benign Intracranial Hypertension
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D011559 2004
% 210.86/211.03 |- skos__altLabel mesh__D011559 Intracranial Hypertension, Benign
% 210.86/211.03 |- rdf__type mesh__D011559sskos__Concept
% 210.86/211.03 |- skos__hiddenLabel mesh__D011559 Hypertension, Idiopathic Intracranial
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D011559 2005
% 210.86/211.03 |- skos__hiddenLabel mesh__D011559 Intracranial Hypertension, Idiopathic
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D011559 2003
% 210.86/211.03 |- skos__broader mesh__D011559smesh__D019586
% 210.86/211.03 |- skos__scopeNote mesh__D011559
% 210.86/211.03 A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury %28%see OPTIC NERVE DISEASES%29% and visual loss %28%see BLINDNESS%29%.%A%
% 210.86/211.03 |- skos__prefLabel mesh__D011559 Pseudotumor Cerebri
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D011559 2002
% 210.86/211.03 |- skos__annotation mesh__D011559 note category: non-neopl
% 210.86/211.03 |- mesh__recordMaintainer mesh__D011559 ags
% 210.86/211.03 |- skos__hiddenLabel mesh__D022281 Vaccines, Shigella
% 210.86/211.03 |- mesh__recordMaintainer mesh__D022281 ssb
% 210.86/211.03 |- mesh__recordOriginator mesh__D022281 ags
% 210.86/211.03 |- mesh__dateCreated mesh__D022281 2000-06-22
% 210.86/211.03 |- skos__broader mesh__D022281smesh__D001428
% 210.86/211.03 |- skos__scopeNote mesh__D022281
% 210.86/211.03 Vaccines or candidate vaccines used to prevent bacillary dysentery %28%DYSENTERY, BACILLARY%29% caused by species of SHIGELLA.%A%
% 210.86/211.03 |- skos__historyNote mesh__D022281 Bacterial Vaccines %28%1967-2000%29%
% 210.86/211.03 |- mesh__historyNote mesh__D022281 2001
% 210.86/211.03 |- skos__related mesh__D022281smesh__D012762
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D022281 2006
% 210.86/211.03 |- rdf__type mesh__D022281sskos__Concept
% 210.86/211.03 |- mesh__dateEstablished mesh__D022281 2001-01-01
% 210.86/211.03 |- mesh__dateRevised mesh__D022281 2005-06-30
% 210.86/211.03 |- skos__annotation mesh__D022281
% 210.86/211.03 coord IM with specific Shigella species /immunol %28%IM%29%
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D022281 2001
% 210.86/211.03 |- skos__prefLabel mesh__D022281 Shigella Vaccines
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D022281 sjn
% 210.86/211.03 |- skos__annotation mesh__D016244 /biosyn /physiol permitted
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D016244 sjn
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D016244 91
% 210.86/211.03 |- mesh__dateEstablished mesh__D016244 1991-01-01
% 210.86/211.03 |- skos__scopeNote mesh__D016244
% 210.86/211.03 Guanosine 5%27%-%28%trihydrogen diphosphate%29%, monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes.%A%
% 210.86/211.03 |- skos__broader mesh__D016244smesh__D013873
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D016244 2006
% 210.86/211.03 |- skos__altLabel mesh__D016244 GTPgammaS
% 210.86/211.03 |- skos__historyNote mesh__D016244 Thionucleotides %28%1977-1990%29%
% 210.86/211.03 |- skos__broader mesh__D016244smesh__D006160
% 210.86/211.03 |- mesh__dateRevised mesh__D016244 2005-06-30
% 210.86/211.03 |- skos__historyNote mesh__D016244 Guanosine Triphosphate %28%1972-1990%29%
% 210.86/211.03 |- skos__altLabel mesh__D016244 Guanosine 5%27%-%28%gamma-S%29%Triphosphate
% 210.86/211.03 |- mesh__historyNote mesh__D016244 91
% 210.86/211.03 |- mesh__recordMaintainer mesh__D016244 ssb
% 210.86/211.03 |- rdf__type mesh__D016244sskos__Concept
% 210.86/211.03 |- skos__hiddenLabel mesh__D016244 gamma Thio GTP
% 210.86/211.03 |- mesh__dateCreated mesh__D016244 1990-05-07
% 210.86/211.03 |- skos__altLabel mesh__D016244 gamma-Thio-GTP
% 210.86/211.03 |- skos__altLabel mesh__D016244
% 210.86/211.03 Guanosine 5%27%-%28%3-O-Thio%29%Triphosphate
% 210.86/211.03 |- skos__prefLabel mesh__D016244
% 210.86/211.03 Guanosine 5%27%-O-%28%3-Thiotriphosphate%29%
% 210.86/211.03 |- mesh__recordOriginator mesh__D016244 RLS
% 210.86/211.03 |- skos__altLabel mesh__D016244 GTP gamma S
% 210.86/211.03 |- skos__hiddenLabel mesh__D016244 gamma S, GTP
% 210.86/211.03 |- mesh__recordMaintainer mesh__D002224 TGC
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 2002
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 1994
% 210.86/211.03 |- skos__altLabel mesh__D002224 Diphenylurea Compounds
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 2005
% 210.86/211.03 |- skos__broader mesh__D002224smesh__D000813
% 210.86/211.03 |- mesh__dateRevised mesh__D002224 1992-05-11
% 210.86/211.03 |- mesh__dateEstablished mesh__D002224 1974-01-01
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 1997
% 210.86/211.03 |- skos__prefLabel mesh__D002224 Carbanilides
% 210.86/211.03 |- skos__hiddenLabel mesh__D002224 Compounds, Diphenylurea
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D002224 PLS
% 210.86/211.03 |- rdf__type mesh__D002224sskos__Concept
% 210.86/211.03 |- mesh__recordOriginator mesh__D002224 NLM
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 2001
% 210.86/211.03 |- mesh__dateCreated mesh__D002224 1999-01-01
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 1993
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 2004
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 1996
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D002224 74
% 210.86/211.03 |- mesh__historyNote mesh__D002224 74%28%72%29%
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 2000
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 1999
% 210.86/211.03 |- skos__historyNote mesh__D002224 Urea %28%1970-1971%29%
% 210.86/211.03 |- skos__broader mesh__D002224smesh__D010671
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 2003
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 1995
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 2006
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002224 1998
% 210.86/211.03 |- skos__broader mesh__D006653Q000379smesh__D006653
% 210.86/211.03 |- mesh__preferredCombination mesh__D006653Q000379smesh__D006652
% 210.86/211.03 |- rdf__type mesh__D006653Q000379smesh__CompoundConcept
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D040343 2005
% 210.86/211.03 |- skos__historyNote mesh__D040343 Health Surveys %28%1985-2002%29%
% 210.86/211.03 |- skos__scopeNote mesh__D040343
% 210.86/211.03 Telephone surveys are conducted to monitor prevalence of the major behavioral risks among adults associated with premature MORBIDITY and MORTALITY. The data collected is in regard to actual behaviors, rather than on attitudes or knowledge. The Centers for Disease Control and Prevention %28%CDC%29% established the Behavioral Risk Factor Surveillance System %28%BRFSS%29% in 1984.%A%
% 210.86/211.03 |- skos__annotation mesh__D040343 CATALOG: Use NAF entry
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D040343 2003
% 210.86/211.03 |- skos__prefLabel mesh__D040343 Behavioral Risk Factor Surveillance System
% 210.86/211.03 |- skos__altLabel mesh__D040343 Behavior Risk Factor Surveillance System
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D040343 2004
% 210.86/211.03 |- mesh__historyNote mesh__D040343 2003
% 210.86/211.03 |- rdf__type mesh__D040343sskos__Concept
% 210.86/211.03 |- skos__broader mesh__D040343smesh__D006306
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D040343 2003
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D040343 2006
% 210.86/211.03 |- mesh__dateCreated mesh__D040343 2002-07-02
% 210.86/211.03 |- mesh__dateEstablished mesh__D040343 2003-01-01
% 210.86/211.03 |- skos__altLabel mesh__D040343 BRFSS
% 210.86/211.03 |- skos__scopeNote mesh__D012652
% 210.86/211.03 The act of injuring one%27%s own body to the extent of cutting off or permanently destroying a limb or other essential part of a body.%A%
% 210.86/211.03 |- skos__prefLabel mesh__D012652 Self Mutilation
% 210.86/211.03 |- rdf__type mesh__D012652sskos__Concept
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012652 2004
% 210.86/211.03 |- mesh__dateRevised mesh__D012652 2002-07-03
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012652 2003
% 210.86/211.03 |- mesh__recordOriginator mesh__D012652 NLM
% 210.86/211.03 |- mesh__recordMaintainer mesh__D012652 JLS
% 210.86/211.03 |- skos__broader mesh__D012652smesh__D016728
% 210.86/211.03 |- mesh__dateCreated mesh__D012652 1999-01-01
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D012652 sjn
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012652 2006
% 210.86/211.03 |- skos__hiddenLabel mesh__D012652 Mutilation, Self
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012652 2005
% 210.86/211.03 |- skos__broader mesh__D012652smesh__D014947
% 210.86/211.03 |- skos__annotation mesh__D012652
% 210.86/211.03 SELF-INJURIOUS BEHAVIOR is also available
% 210.86/211.03 |- rdf__type mesh__D006615sskos__Concept
% 210.86/211.03 |- skos__hiddenLabel mesh__D006615 Coxas
% 210.86/211.03 |- mesh__considerAlso mesh__D006615 consider also terms at COX-
% 210.86/211.03 |- mesh__recordOriginator mesh__D006615 NLM
% 210.86/211.03 |- mesh__dateRevised mesh__D006615 2002-07-03
% 210.86/211.03 |- mesh__dateCreated mesh__D006615 1999-01-01
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006615 2003
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D006615 sjn
% 210.86/211.03 |- skos__prefLabel mesh__D006615 Hip
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006615 2005
% 210.86/211.03 |- skos__altLabel mesh__D006615 Coxa
% 210.86/211.03 |- skos__annotation mesh__D006615
% 210.86/211.03 do not confuse with HIP JOINT or PELVIC BONES %28%os coxae%29%; aseptic or avascular necrosis = FEMUR HEAD NECROSIS; differentiate from HIP JOINT%A%
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006615 2004
% 210.86/211.03 |- mesh__recordMaintainer mesh__D006615 lkt
% 210.86/211.03 |- skos__hiddenLabel mesh__D006615 Hips
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D006615 2006
% 210.86/211.03 |- skos__scopeNote mesh__D006615
% 210.86/211.03 The projecting part on each side of the body, formed by the side of the pelvis and the top portion of the femur.%A%
% 210.86/211.03 |- skos__broader mesh__D006615smesh__D035002
% 210.86/211.03 |- skos__broader mesh__D003585Q000379smesh__D003585
% 210.86/211.03 |- mesh__preferredCombination mesh__D003585Q000379smesh__D003584
% 210.86/211.03 |- rdf__type mesh__D003585Q000379smesh__CompoundConcept
% 210.86/211.03 |- skos__annotation mesh__D022282
% 210.86/211.03 IM general only; coord NIM with specific vaccine %28%IM%29%
% 210.86/211.03 |- skos__prefLabel mesh__D022282 Vaccines, Acellular
% 210.86/211.03 |- skos__broader mesh__D022282smesh__D022223
% 210.86/211.03 |- mesh__recordMaintainer mesh__D022282 ssb
% 210.86/211.03 |- mesh__dateRevised mesh__D022282 2005-06-30
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D022282 2006
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D022282 sjn
% 210.86/211.03 |- mesh__recordOriginator mesh__D022282 ags
% 210.86/211.03 |- skos__hiddenLabel mesh__D022282 Acellular Vaccines
% 210.86/211.03 |- rdf__type mesh__D022282sskos__Concept
% 210.86/211.03 |- skos__scopeNote mesh__D022282
% 210.86/211.03 Vaccines that are produced by using only the antigenic part of the disease causing organism. They often require a %22%booster%22% every few years to maintain their effectiveness.%A%
% 210.86/211.03 |- mesh__dateEstablished mesh__D022282 2001-01-01
% 210.86/211.03 |- mesh__dateCreated mesh__D022282 2000-06-21
% 210.86/211.03 |- mesh__historyNote mesh__D022282 2001
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D022282 2001
% 210.86/211.03 |- mesh__dateEstablished mesh__D016245 1991-01-01
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D016245 2005
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D016245 2004
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D016245 2001
% 210.86/211.03 |- skos__annotation mesh__D016245
% 210.86/211.03 IM; coord with area of specialism of the librarian %28%IM%29%
% 210.86/211.03 |- mesh__historyNote mesh__D016245 91
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D016245 2003
% 210.86/211.03 |- mesh__dateRevised mesh__D016245 1999-11-03
% 210.86/211.03 |- rdf__type mesh__D016245sskos__Concept
% 210.86/211.03 |- mesh__dateCreated mesh__D016245 1990-05-07
% 210.86/211.03 |- skos__scopeNote mesh__D016245
% 210.86/211.03 Specialists in the management of a library or the services rendered by a library, bringing professional skills to administration, organization of material and personnel, interpretation of bibliothecal rules, the development and maintenance of the library%27%s collection, and the provision of information services.%A%
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D016245 sjn
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D016245 2000
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D016245 91
% 210.86/211.03 |- mesh__recordMaintainer mesh__D016245 kle
% 210.86/211.03 |- mesh__recordOriginator mesh__D016245 TGC
% 210.86/211.03 |- skos__hiddenLabel mesh__D016245 Librarian
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D016245 2002
% 210.86/211.03 |- skos__historyNote mesh__D016245 Libraries %28%1966-1990%29%
% 210.86/211.03 |- skos__broader mesh__D016245smesh__D009274
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D016245 2006
% 210.86/211.03 |- skos__prefLabel mesh__D016245 Librarians
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002225 2005
% 210.86/211.03 |- skos__altLabel mesh__D002225 Carboquinone
% 210.86/211.03 |- skos__historyNote mesh__D002225 Azirines %28%1971-1974%29%
% 210.86/211.03 |- skos__historyNote mesh__D002225 Carbamates %28%1972-1974%29%
% 210.86/211.03 |- skos__broader mesh__D002225smesh__D016227
% 210.86/211.03 |- rdf__type mesh__D002225sskos__Concept
% 210.86/211.03 |- mesh__dateEstablished mesh__D002225 1991-01-01
% 210.86/211.03 |- skos__broader mesh__D002225smesh__D001388
% 210.86/211.03 |- mesh__recordMaintainer mesh__D002225 sjn
% 210.86/211.03 |- skos__historyNote mesh__D002225 Quinones %28%1972-1974%29%
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D002225 91; was see under AZIRINES 1975-90
% 210.86/211.03 |- mesh__dateRevised mesh__D002225 2004-07-13
% 210.86/211.03 |- mesh__recordAuthorizer mesh__D002225 sjn
% 210.86/211.03 |- skos__altLabel mesh__D002225 Carboquone
% 210.86/211.03 |- mesh__recordOriginator mesh__D002225 NLM
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D002225 2006
% 210.86/211.03 |- mesh__historyNote mesh__D002225
% 210.86/211.03 91%28%75%29%; was see under AZIRINES 1975-90
% 210.86/211.03 |- skos__prefLabel mesh__D002225 Carbazilquinone
% 210.86/211.03 |- skos__scopeNote mesh__D002225
% 210.86/211.03 An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.%A%
% 210.86/211.03 |- mesh__dateCreated mesh__D002225 1974-11-19
% 210.86/211.03 |- mesh__dateCreated mesh__D012653 1999-01-01
% 210.86/211.03 |- skos__broader mesh__D012653smesh__D001519
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012653 2006
% 210.86/211.03 |- mesh__publicMeSHNote mesh__D012653 65
% 210.86/211.03 |- skos__hiddenLabel mesh__D012653 Stimulations, Self
% 210.86/211.03 |- skos__annotation mesh__D012653 human %26% animal
% 210.86/211.03 |- skos__hiddenLabel mesh__D012653 Stimulation, Self
% 210.86/211.03 |- skos__scopeNote mesh__D012653
% 210.86/211.03 Stimulation of the brain, which is self-administered. The stimulation may result in negative or positive reinforcement.%A%
% 210.86/211.03 |- mesh__activeMeSHYear mesh__D012653 2005
% 210.86/211.03 |- mesh__recordMaintainer mesh__D012653 JLS
% 210.86/211.03 |- skos__broader mesh__D012653smesh__D011603
% 210.86/211.03 |- skos__hiddenLabel mesh__D012653 Self Stimulations
% 210.86/211.03 |- mesh__dateRevised mesh__D012653 2002-07-03
% 210.86/211.03 |- rdf__type mesh__D012653sskos__Concept
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012653 2004
% 210.86/211.04 |- mesh__recordOriginator mesh__D012653 NLM
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012653 2003
% 210.86/211.04 |- mesh__dateEstablished mesh__D012653 1965-01-01
% 210.86/211.04 |- mesh__historyNote mesh__D012653 65%28%64%29%
% 210.86/211.04 |- skos__prefLabel mesh__D012653 Self Stimulation
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D012653 sjn
% 210.86/211.04 |- skos__scopeNote mesh__D006616
% 210.86/211.04 Permanent fixation of the hip in primary positions, with limited passive or active motion at the hip joint. Locomotion is difficult and pain is sometimes present when the hip is in motion. It may be caused by trauma, infection, or poliomyelitis. %28%From Current Medical Information %26% Technology, 5th ed%29%%A%
% 210.86/211.04 |- mesh__dateCreated mesh__D006616 1999-01-01
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 1996
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 2003
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 2000
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 1998
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 2005
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 1997
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 2004
% 210.86/211.04 |- mesh__recordOriginator mesh__D006616 NLM
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D006616 PLS
% 210.86/211.04 |- skos__broader mesh__D006616smesh__D003286
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 2001
% 210.86/211.04 |- skos__hiddenLabel mesh__D006616 Hip Contractures
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 1999
% 210.86/211.04 |- skos__hiddenLabel mesh__D006616 Contractures, Hip
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 2006
% 210.86/211.04 |- skos__prefLabel mesh__D006616 Hip Contracture
% 210.86/211.04 |- mesh__dateRevised mesh__D006616 1994-05-24
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 1995
% 210.86/211.04 |- rdf__type mesh__D006616sskos__Concept
% 210.86/211.04 |- skos__hiddenLabel mesh__D006616 Contracture, Hip
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006616 2002
% 210.86/211.04 |- mesh__recordMaintainer mesh__D006616 TGC
% 210.86/211.04 |- skos__prefLabel mesh__D022283 Herpesvirus Vaccines
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D022283 2001
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D022283 2006
% 210.86/211.04 |- skos__scopeNote mesh__D022283
% 210.86/211.04 Vaccines or candidate vaccines used to prevent infection by any virus from the family HERPESVIRIDAE.%A%
% 210.86/211.04 |- skos__hiddenLabel mesh__D022283 Vaccines, Herpesvirus
% 210.86/211.04 |- skos__broader mesh__D022283smesh__D014765
% 210.86/211.04 |- skos__historyNote mesh__D022283 Viral Vaccines %28%1965-2000%29%
% 210.86/211.04 |- rdf__type mesh__D022283sskos__Concept
% 210.86/211.04 |- mesh__dateEstablished mesh__D022283 2001-01-01
% 210.86/211.04 |- mesh__dateCreated mesh__D022283 2000-06-22
% 210.86/211.04 |- mesh__recordMaintainer mesh__D022283 ssb
% 210.86/211.04 |- mesh__dateRevised mesh__D022283 2005-06-30
% 210.86/211.04 |- skos__annotation mesh__D022283
% 210.86/211.04 coord IM with specific herpesvirus /immunol %28%IM%29% but note specifics%A%
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D022283 sjn
% 210.86/211.04 |- mesh__recordOriginator mesh__D022283 ags
% 210.86/211.04 |- mesh__historyNote mesh__D022283 2001
% 210.86/211.04 |- skos__hiddenLabel mesh__D016246 Tumor Derived Activated Cells
% 210.86/211.04 |- mesh__historyNote mesh__D016246 91
% 210.86/211.04 |- skos__hiddenLabel mesh__D016246 Tumor Infiltrating Lymphocytes
% 210.86/211.04 |- rdf__type mesh__D016246sskos__Concept
% 210.86/211.04 |- skos__hiddenLabel mesh__D016246 Tumor-Infiltrating Lymphocyte
% 210.86/211.04 |- skos__hiddenLabel mesh__D016246 Tumor-Derived Activated Cell
% 210.86/211.04 |- skos__annotation mesh__D016246
% 210.86/211.04 A 11 qualif; subpopulations: coord IM with LYMPHOCYTE SUBSETS %28%IM%29%; DF: TIL%A%
% 210.86/211.04 |- mesh__recordMaintainer mesh__D016246 jmp
% 210.86/211.04 |- mesh__dateCreated mesh__D016246 1990-06-06
% 210.86/211.04 |- skos__historyNote mesh__D016246
% 210.86/211.04 T-Lymphocytes, Cytotoxic %28%1984-1990%29%
% 210.86/211.04 |- skos__broader mesh__D016246smesh__D008214
% 210.86/211.04 |- mesh__recordOriginator mesh__D016246 AGS
% 210.86/211.04 |- skos__historyNote mesh__D016246 Lymphocytes %28%1976-1990%29%
% 210.86/211.04 |- skos__historyNote mesh__D016246 T-Lymphocytes %28%1977-1990%29%
% 210.86/211.04 |- skos__hiddenLabel mesh__D016246 Activated Cells, Tumor-Derived
% 210.86/211.04 |- skos__scopeNote mesh__D016246
% 210.86/211.04 Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer.%A%
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D016246 sjn
% 210.86/211.04 |- skos__related mesh__D016246smesh__D016219
% 210.86/211.04 |- skos__hiddenLabel mesh__D016246 Lymphocytes, Tumor Infiltrating
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D016246 91
% 210.86/211.04 |- skos__hiddenLabel mesh__D016246 Lymphocyte, Tumor-Infiltrating
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D016246 2006
% 210.86/211.04 |- mesh__dateEstablished mesh__D016246 1991-01-01
% 210.86/211.04 |- mesh__dateRevised mesh__D016246 2003-07-09
% 210.86/211.04 |- skos__altLabel mesh__D016246 Tumor-Infiltrating Lymphocytes
% 210.86/211.04 |- skos__hiddenLabel mesh__D016246 Activated Cell, Tumor-Derived
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D016246 2005
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D016246 2004
% 210.86/211.04 |- skos__prefLabel mesh__D016246 Lymphocytes, Tumor-Infiltrating
% 210.86/211.04 |- skos__broader mesh__D019789Q000031smesh__D019789
% 210.86/211.04 |- mesh__preferredCombination mesh__D019789Q000031smesh__D013757
% 210.86/211.04 |- rdf__type mesh__D019789Q000031smesh__CompoundConcept
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D048328 2005; see KANGAROOS 2001-2004
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Rat Kangaroos, Long-Nosed
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Kangaroo, Rat
% 210.86/211.04 |- skos__historyNote mesh__D048328 Marsupialia %28%1967-1996%29%
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D048328 2005B
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Potoroos
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D048328 jls
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Rat Kangaroo, Long-Nosed
% 210.86/211.04 |- mesh__dateEstablished mesh__D048328 2005-01-01
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Potoroo, Long-Nosed
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Long-Nosed Potoroos
% 210.86/211.04 |- mesh__dateRevised mesh__D048328 2004-07-30
% 210.86/211.04 |- skos__scopeNote mesh__D048328
% 210.86/211.04 A family of rat kangaroos found in and around Australia. Genera include Potorous and Bettongia.%A%
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Long Nosed Potoroo
% 210.86/211.04 |- skos__annotation mesh__D048328
% 210.86/211.04 do not confuse rat kangaroo with KANGAROO RATS see DIPODOMYS%A%
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Potoroos, Long-Nosed
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Long Nosed Rat Kangaroo
% 210.86/211.04 |- skos__broader mesh__D048328smesh__D008394
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Rat Kangaroos
% 210.86/211.04 |- mesh__dateCreated mesh__D048328 2004-07-07
% 210.86/211.04 |- rdf__type mesh__D048328sskos__Concept
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Kangaroos, Rat
% 210.86/211.04 |- skos__altLabel mesh__D048328 Rat Kangaroo
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D048328 2006
% 210.86/211.04 |- skos__prefLabel mesh__D048328 Potoroidae
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D048328 2005A
% 210.86/211.04 |- skos__altLabel mesh__D048328 Potorous tridactylus
% 210.86/211.04 |- mesh__recordMaintainer mesh__D048328 jls
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D048328 2005
% 210.86/211.04 |- mesh__historyNote mesh__D048328 2005; use MACROPODIDAE 2001-2004
% 210.86/211.04 |- skos__hiddenLabel mesh__D048328 Long-Nosed Rat Kangaroos
% 210.86/211.04 |- mesh__recordOriginator mesh__D048328 ags
% 210.86/211.04 |- skos__altLabel mesh__D048328 Long-Nosed Rat Kangaroo
% 210.86/211.04 |- skos__historyNote mesh__D048328 Macropodidae %28%1997-2004%29%
% 210.86/211.04 |- skos__hiddenLabel mesh__D012654 Unit, Self-Care
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 1995
% 210.86/211.04 |- mesh__recordOriginator mesh__D012654 EC
% 210.86/211.04 |- skos__scopeNote mesh__D012654
% 210.86/211.04 Rooms in health care facilities for patients who require a minimal level of care.%A%
% 210.86/211.04 |- skos__hiddenLabel mesh__D012654 Units, Self-Care
% 210.86/211.04 |- mesh__dateCreated mesh__D012654 1977-05-19
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 1999
% 210.86/211.04 |- mesh__recordMaintainer mesh__D012654 TGC
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 1994
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 2002
% 210.86/211.04 |- mesh__historyNote mesh__D012654
% 210.86/211.04 91%28%Aug 77%29%; was see under HOSPITAL UNITS 1977-90
% 210.86/211.04 |- mesh__dateEstablished mesh__D012654 1991-01-01
% 210.86/211.04 |- skos__hiddenLabel mesh__D012654 Units, Minimal Care
% 210.86/211.04 |- skos__hiddenLabel mesh__D012654 Self-Care Unit
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 1998
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 1993
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D012654
% 210.86/211.04 91; was see under HOSPITAL UNITS Aug 1977-90
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 2006
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 2001
% 210.86/211.04 |- skos__broader mesh__D012654smesh__D006757
% 210.86/211.04 |- rdf__type mesh__D012654sskos__Concept
% 210.86/211.04 |- skos__hiddenLabel mesh__D012654 Self Care Units
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 1997
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 2005
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 2000
% 210.86/211.04 |- skos__prefLabel mesh__D012654 Self-Care Units
% 210.86/211.04 |- mesh__dateRevised mesh__D012654 1992-05-18
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 1996
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 2004
% 210.86/211.04 |- skos__hiddenLabel mesh__D012654 Unit, Minimal Care
% 210.86/211.04 |- skos__hiddenLabel mesh__D012654 Minimal Care Unit
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012654 2003
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D012654 PLS
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D006617 sjn
% 210.86/211.04 |- rdf__type mesh__D006617sskos__Concept
% 210.86/211.04 |- mesh__dateRevised mesh__D006617 2001-07-25
% 210.86/211.04 |- skos__broader mesh__D006617smesh__D004204
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006617 2004
% 210.86/211.04 |- mesh__recordMaintainer mesh__D006617 lkt
% 210.86/211.04 |- mesh__dateCreated mesh__D006617 1999-01-01
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006617 2003
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006617 2002
% 210.86/211.04 |- mesh__recordOriginator mesh__D006617 NLM
% 210.86/211.04 |- skos__broader mesh__D006617smesh__D025981
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006617 2006
% 210.86/211.04 |- skos__scopeNote mesh__D006617
% 210.86/211.04 Displacement of the femur bone from its normal position at the HIP JOINT.%A%
% 210.86/211.04 |- skos__prefLabel mesh__D006617 Hip Dislocation
% 210.86/211.04 |- skos__related mesh__D006617smesh__D006618
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006617 2005
% 210.86/211.04 |- mesh__recordMaintainer mesh__D016247 jls
% 210.86/211.04 |- rdf__type mesh__D016247sskos__Concept
% 210.86/211.04 |- skos__altLabel mesh__D016247 Information Retrieval
% 210.86/211.04 |- skos__altLabel mesh__D016247 Information Storage
% 210.86/211.04 |- mesh__recordOriginator mesh__D016247 TGC
% 210.86/211.04 |- skos__hiddenLabel mesh__D016247 Storage, Data
% 210.86/211.04 |- mesh__dateEstablished mesh__D016247 1991-01-01
% 210.86/211.04 |- mesh__dateCreated mesh__D016247 1990-05-07
% 210.86/211.04 |- skos__annotation mesh__D016247 DF: INFORMATION STORAGE
% 210.86/211.04 |- skos__hiddenLabel mesh__D016247 Retrieval, Data
% 210.86/211.04 |- mesh__onlineNote mesh__D016247
% 210.86/211.04 use INFORMATION SYSTEMS to search INFORMATION STORAGE AND RETRIEVAL 1982-90%A%
% 210.86/211.04 |- skos__historyNote mesh__D016247 Information Systems %28%1966-1990%29%
% 210.86/211.04 |- skos__broader mesh__D016247smesh__D008491
% 210.86/211.04 |- skos__scopeNote mesh__D016247
% 210.86/211.04 A branch of computer or library science relating to the storage, locating, searching, and selecting, upon demand, relevant data on a given subject.%A%
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D016247 2005
% 210.86/211.04 |- mesh__dateRevised mesh__D016247 2004-07-07
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D016247 2006
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D016247
% 210.86/211.04 91; was see INFORMATION SYSTEMS 1982-90
% 210.86/211.04 |- skos__prefLabel mesh__D016247 Information Storage and Retrieval
% 210.86/211.04 |- mesh__historyNote mesh__D016247
% 210.86/211.04 91; was see INFORMATION SYSTEMS 1982-90
% 210.86/211.04 |- skos__broader mesh__D016247smesh__D007254
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D016247 sjn
% 210.86/211.04 |- skos__prefLabel mesh__D035401 Conyza
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D035401 2005
% 210.86/211.04 |- mesh__dateEstablished mesh__D035401 2003-01-01
% 210.86/211.04 |- mesh__dateCreated mesh__D035401 2002-07-02
% 210.86/211.04 |- mesh__historyNote mesh__D035401 2003
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D035401 2004
% 210.86/211.04 |- skos__scopeNote mesh__D035401
% 210.86/211.04 A plant genus of the family ASTERACEAE. Members contain alkenynes, daucosterol, friedelinol, conyzasaponins and other TRITERPENES.%A%
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D035401 2003
% 210.86/211.04 |- rdf__type mesh__D035401sskos__Concept
% 210.86/211.04 |- skos__altLabel mesh__D035401 Horseweed
% 210.86/211.04 |- skos__annotation mesh__D035401
% 210.86/211.04 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D035401 2003
% 210.86/211.04 |- skos__broader mesh__D035401smesh__D019659
% 210.86/211.04 |- skos__altLabel mesh__D035401 Asthmaweed
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D035401 2006
% 210.86/211.04 |- skos__scopeNote mesh__D002227
% 210.86/211.04 Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.%A%
% 210.86/211.04 |- skos__broader mesh__D002227smesh__D006575
% 210.86/211.04 |- skos__prefLabel mesh__D002227 Carbazoles
% 210.86/211.04 |- mesh__dateEstablished mesh__D002227 1969-01-01
% 210.86/211.04 |- mesh__dateRevised mesh__D002227 2004-07-07
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D002227 2006
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D002227 69; was see under AZOLES 1963-68
% 210.86/211.04 |- skos__historyNote mesh__D002227 Azoles %28%1966-1968%29%
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D002227 2005
% 210.86/211.04 |- mesh__historyNote mesh__D002227 69; was see under AZOLES 1963-68
% 210.86/211.04 |- mesh__onlineNote mesh__D002227 search AZOLES 1966-68
% 210.86/211.04 |- rdf__type mesh__D002227sskos__Concept
% 210.86/211.04 |- mesh__recordMaintainer mesh__D002227 ssb
% 210.86/211.04 |- mesh__dateCreated mesh__D002227 1999-01-01
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D002227 sjn
% 210.86/211.04 |- mesh__recordOriginator mesh__D002227 NLM
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 2003
% 210.86/211.04 |- mesh__recordOriginator mesh__D007710 NLM
% 210.86/211.04 |- skos__hiddenLabel mesh__D007710 Klebsiella Infection
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 2005
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 2000
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 1994
% 210.86/211.04 |- mesh__dateRevised mesh__D007710 1993-06-02
% 210.86/211.04 |- mesh__historyNote mesh__D007710 68
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D007710 68
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D007710 PLS
% 210.86/211.04 |- skos__altLabel mesh__D007710 Infections, Klebsiella
% 210.86/211.04 |- rdf__type mesh__D007710sskos__Concept
% 210.86/211.04 |- mesh__recordMaintainer mesh__D007710 TAP
% 210.86/211.04 |- skos__prefLabel mesh__D007710 Klebsiella Infections
% 210.86/211.04 |- mesh__dateEstablished mesh__D007710 1968-01-01
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 2002
% 210.86/211.04 |- skos__historyNote mesh__D007710 Klebsiella %28%1966-1967%29%
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 1997
% 210.86/211.04 |- skos__broader mesh__D007710smesh__D004756
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 2004
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 1999
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 2001
% 210.86/211.04 |- mesh__dateCreated mesh__D007710 1999-01-01
% 210.86/211.04 |- skos__annotation mesh__D007710
% 210.86/211.04 gram-neg bact infect; coord IM with various species %28%IM%29%
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 1996
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 2006
% 210.86/211.04 |- skos__scopeNote mesh__D007710
% 210.86/211.04 Infections with bacteria of the genus KLEBSIELLA.
% 210.86/211.04 |- skos__hiddenLabel mesh__D007710 Infection, Klebsiella
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 1995
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D007710 1998
% 210.86/211.04 |- mesh__recordOriginator mesh__D048329 ags
% 210.86/211.04 |- skos__annotation mesh__D048329
% 210.86/211.04 possums unspecified go here; OPOSSUMS is also available
% 210.86/211.04 |- mesh__recordMaintainer mesh__D048329 ags
% 210.86/211.04 |- skos__hiddenLabel mesh__D048329 Phalangers
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D048329 sjn
% 210.86/211.04 |- mesh__dateCreated mesh__D048329 2004-07-07
% 210.86/211.04 |- rdf__type mesh__D048329sskos__Concept
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D048329 2006
% 210.86/211.04 |- mesh__dateEstablished mesh__D048329 2005-01-01
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D048329 2005
% 210.86/211.04 |- mesh__historyNote mesh__D048329 2005
% 210.86/211.04 |- skos__broader mesh__D048329smesh__D008394
% 210.86/211.04 |- skos__scopeNote mesh__D048329
% 210.86/211.04 A family of possums and cuscuses found in Australia, Tasmania, New Guinea and other islands.%A%
% 210.86/211.04 |- skos__historyNote mesh__D048329 Marsupialia %28%1967-2004%29%
% 210.86/211.04 |- skos__prefLabel mesh__D048329 Phalangeridae
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D048329 2005
% 210.86/211.04 |- mesh__recordMaintainer mesh__D012655 TGC
% 210.86/211.04 |- skos__prefLabel mesh__D012655 Self-Evaluation Programs
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 1994
% 210.86/211.04 |- mesh__dateEstablished mesh__D012655 1991-01-01
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D012655 PLS
% 210.86/211.04 |- skos__hiddenLabel mesh__D012655 Self-Evaluation Program
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 2006
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 1993
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 1998
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D012655
% 210.86/211.04 91; was see under EDUCATIONAL MEASUREMENT 1979-90
% 210.86/211.04 |- skos__hiddenLabel mesh__D012655 Self Evaluation Programs
% 210.86/211.04 |- mesh__historyNote mesh__D012655
% 210.86/211.04 91%28%79%29%; was see under EDUCATIONAL MEASUREMENT 1979-90
% 210.86/211.04 |- skos__hiddenLabel mesh__D012655 Programs, Self-Evaluation
% 210.86/211.04 |- rdf__type mesh__D012655sskos__Concept
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 1997
% 210.86/211.04 |- mesh__recordOriginator mesh__D012655 EC
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 2005
% 210.86/211.04 |- skos__broader mesh__D012655smesh__D004521
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 2002
% 210.86/211.04 |- mesh__dateRevised mesh__D012655 1992-05-18
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 1996
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 2004
% 210.86/211.04 |- mesh__dateCreated mesh__D012655 1978-05-10
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 2001
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 2003
% 210.86/211.04 |- skos__hiddenLabel mesh__D012655 Program, Self-Evaluation
% 210.86/211.04 |- skos__historyNote mesh__D012655
% 210.86/211.04 Educational Measurement %28%1974-1978%29%
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 2000
% 210.86/211.04 |- skos__scopeNote mesh__D012655
% 210.86/211.04 Educational programs structured in such a manner that the participating professionals, physicians, or students develop an increased awareness of their performance, usually on the basis of self-evaluation questionnaires.%A%
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 1995
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D012655 1999
% 210.86/211.04 |- skos__broader mesh__D005502Q000506smesh__D005502
% 210.86/211.04 |- mesh__preferredCombination mesh__D005502Q000506smesh__D005517
% 210.86/211.04 |- rdf__type mesh__D005502Q000506smesh__CompoundConcept
% 210.86/211.04 |- skos__scopeNote mesh__D006618
% 210.86/211.04 Congenital dislocation of the hip generally includes subluxation of the femoral head, acetabular dysplasia, and complete dislocation of the femoral head from the true acetabulum. This condition occurs in approximately 1 in 1000 live births and is more common in females than in males.%A%
% 210.86/211.04 |- skos__hiddenLabel mesh__D006618 Dislocations, Congenital Hip
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006618 2004
% 210.86/211.04 |- skos__annotation mesh__D006618
% 210.86/211.04 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; /vet permitted but congen hip disloc in dogs = HIP DYSPLASIA, CANINE: see note there%A%
% 210.86/211.04 |- skos__altLabel mesh__D006618 Dysplasia, Congenital Hip
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D006618 sjn
% 210.86/211.04 |- mesh__dateCreated mesh__D006618 1999-01-01
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006618 2001
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006618 2003
% 210.86/211.04 |- skos__broader mesh__D006618smesh__D009139
% 210.86/211.04 |- skos__altLabel mesh__D006618 Congenital Hip Dysplasia
% 210.86/211.04 |- skos__hiddenLabel mesh__D006618 Congenital Hip Dysplasias
% 210.86/211.04 |- skos__hiddenLabel mesh__D006618 Hip Dysplasias, Congenital
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006618 2000
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006618 2006
% 210.86/211.04 |- skos__altLabel mesh__D006618 Congenital Hip Dislocation
% 210.86/211.04 |- skos__hiddenLabel mesh__D006618 Congenital Hip Dislocations
% 210.86/211.04 |- skos__altLabel mesh__D006618 Hip Dysplasia, Congenital
% 210.86/211.04 |- mesh__dateRevised mesh__D006618 1999-11-03
% 210.86/211.04 |- skos__hiddenLabel mesh__D006618 Hip Dislocations, Congenital
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006618 2005
% 210.86/211.04 |- mesh__recordMaintainer mesh__D006618 kle
% 210.86/211.04 |- skos__hiddenLabel mesh__D006618 Dysplasias, Congenital Hip
% 210.86/211.04 |- skos__prefLabel mesh__D006618 Hip Dislocation, Congenital
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D006618 2002
% 210.86/211.04 |- skos__broader mesh__D006618smesh__D007592
% 210.86/211.04 |- rdf__type mesh__D006618sskos__Concept
% 210.86/211.04 |- mesh__recordOriginator mesh__D006618 NLM
% 210.86/211.04 |- skos__altLabel mesh__D006618 Dislocation, Congenital Hip
% 210.86/211.04 |- skos__broader mesh__D011506Q000096smesh__D011506
% 210.86/211.04 |- mesh__preferredCombination mesh__D011506Q000096smesh__D014176
% 210.86/211.04 |- rdf__type mesh__D011506Q000096smesh__CompoundConcept
% 210.86/211.04 |- skos__broader mesh__D003320smesh__D007634
% 210.86/211.04 |- mesh__dateCreated mesh__D003320 1999-01-01
% 210.86/211.04 |- skos__broader mesh__D003320smesh__D015817
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 1999
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 1996
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D003320 65
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 2000
% 210.86/211.04 |- skos__hiddenLabel mesh__D003320 Ulcerative Keratitides
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 1995
% 210.86/211.04 |- mesh__dateRevised mesh__D003320 1993-06-02
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 1998
% 210.86/211.04 |- mesh__recordOriginator mesh__D003320 NLM
% 210.86/211.04 |- rdf__type mesh__D003320sskos__Concept
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 1994
% 210.86/211.04 |- skos__prefLabel mesh__D003320 Corneal Ulcer
% 210.86/211.04 |- skos__hiddenLabel mesh__D003320 Ulcerative Keratitis
% 210.86/211.04 |- mesh__historyNote mesh__D003320 65%28%64%29%
% 210.86/211.04 |- skos__altLabel mesh__D003320 Keratitis, Ulcerative
% 210.86/211.04 |- mesh__dateEstablished mesh__D003320 1965-01-01
% 210.86/211.04 |- skos__scopeNote mesh__D003320
% 210.86/211.04 Loss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection.%A%
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 2004
% 210.86/211.04 |- skos__annotation mesh__D003320 a form of keratitis
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 2002
% 210.86/211.04 |- skos__hiddenLabel mesh__D003320 Ulcer, Corneal
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 2006
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 2003
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D003320 PLS
% 210.86/211.04 |- skos__hiddenLabel mesh__D003320 Keratitides, Ulcerative
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 2001
% 210.86/211.04 |- mesh__recordMaintainer mesh__D003320 TAP
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 2005
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D003320 1997
% 210.86/211.04 |- mesh__dateCreated mesh__D016248 1990-05-07
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Memory Systems, Computer
% 210.86/211.04 |- skos__historyNote mesh__D016248 Computers %28%1966-1990%29%
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Devices, Mass Storage
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 System, Computer Memory
% 210.86/211.04 |- mesh__recordAuthorizer mesh__D016248 sjn
% 210.86/211.04 |- skos__altLabel mesh__D016248 Computer Memory Systems
% 210.86/211.04 |- mesh__recordMaintainer mesh__D016248 jls
% 210.86/211.04 |- mesh__publicMeSHNote mesh__D016248 91
% 210.86/211.04 |- skos__scopeNote mesh__D016248
% 210.86/211.04 Devices capable of receiving data, retaining data for an indefinite or finite period of time, and supplying data upon demand.%A%
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Device, Computer Storage
% 210.86/211.04 |- skos__annotation mesh__D016248
% 210.86/211.04 do not use /util except by MeSH definition
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Mass Storage Device
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Devices, Computer Storage
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D016248 2005
% 210.86/211.04 |- mesh__recordOriginator mesh__D016248 TGC
% 210.86/211.04 |- mesh__dateRevised mesh__D016248 2004-07-07
% 210.86/211.04 |- mesh__activeMeSHYear mesh__D016248 2006
% 210.86/211.04 |- skos__altLabel mesh__D016248 Mass Storage Devices
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Memory System, Computer
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Device, Mass Storage
% 210.86/211.04 |- mesh__historyNote mesh__D016248 91
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Systems, Computer Memory
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Computer Storage Device
% 210.86/211.04 |- skos__prefLabel mesh__D016248 Computer Storage Devices
% 210.86/211.04 |- skos__hiddenLabel mesh__D016248 Computer Memory System
% 210.86/211.04 |- rdf__type mesh__D016248sskos__Concept
% 210.86/211.04 |- skos__broader mesh__D016248smesh__D016287
% 210.86/211.04 |- mesh__dateEstablished mesh__D016248 1991-01-01
% 210.86/211.04 |- mesh__recordMaintainer mesh__D002228 ssb
% 210.86/211.04 |- skos__altLabel mesh__D002228 Sanfer Brand of Carbenicillin Disodium Salt
% 210.86/211.04 |- skos__scopeNote mesh__D002228
% 210.86/211.04 Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.%A%
% 210.86/211.04 |- mesh__recordOriginator mesh__D002228 NLM
% 210.86/211.04 |- skos__historyNote mesh__D002228 Penicillins %28%1966-1970%29%
% 210.86/211.04 |- mesh__dateRevised mesh__D002228 2004-07-07
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D002228 sjn
% 210.86/211.05 |- skos__altLabel mesh__D002228 Carboxybenzyl Penicillin
% 210.86/211.05 |- skos__altLabel mesh__D002228 CSL Brand of Carbenicillin Disodium Salt
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D002228 2006
% 210.86/211.05 |- mesh__dateEstablished mesh__D002228 1973-01-01
% 210.86/211.05 |- mesh__historyNote mesh__D002228 73%28%71%29%
% 210.86/211.05 |- skos__broader mesh__D002228smesh__D010400
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D002228 73
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D002228 2005
% 210.86/211.05 |- rdf__type mesh__D002228sskos__Concept
% 210.86/211.05 |- skos__prefLabel mesh__D002228 Carbenicillin
% 210.86/211.05 |- skos__hiddenLabel mesh__D002228 Penicillin, Carboxybenzyl
% 210.86/211.05 |- mesh__dateCreated mesh__D002228 1999-01-01
% 210.86/211.05 |- skos__hiddenLabel mesh__D002228 Disodium, Carbenicillin
% 210.86/211.05 |- mesh__historyNote mesh__D007711 1974%28%1972%29%
% 210.86/211.05 |- rdf__type mesh__D007711sskos__Concept
% 210.86/211.05 |- skos__prefLabel mesh__D007711 Klebsiella pneumoniae
% 210.86/211.05 |- skos__historyNote mesh__D007711 Klebsiella %28%1966-1971%29%
% 210.86/211.05 |- mesh__dateCreated mesh__D007711 1999-01-01
% 210.86/211.05 |- mesh__recordOriginator mesh__D007711 NLM
% 210.86/211.05 |- mesh__dateEstablished mesh__D007711 1974-01-01
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D007711 2006
% 210.86/211.05 |- skos__broader mesh__D007711smesh__D007709
% 210.86/211.05 |- skos__scopeNote mesh__D007711
% 210.86/211.05 Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.%A%
% 210.86/211.05 |- skos__annotation mesh__D007711
% 210.86/211.05 infection: coord IM with KLEBSIELLA INFECTIONS %28%IM%29%
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D007711
% 210.86/211.05 1974; for KLEBSIELLA RHINOSCLEROMATIS see KLEBSIELLA RHINOSCLEROMATIS 1972-2003%A%
% 210.86/211.05 |- mesh__dateRevised mesh__D007711 2005-06-30
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D007711 sjn
% 210.86/211.05 |- mesh__recordMaintainer mesh__D007711 SYSTEM
% 210.86/211.05 |- skos__related mesh__D007711smesh__D021902
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Devices, Self-Help
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012656 1999
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012656 2001
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Self-Help Device
% 210.86/211.05 |- mesh__dateRevised mesh__D012656 1998-06-11
% 210.86/211.05 |- mesh__recordOriginator mesh__D012656 NLM
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012656 2006
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Assistive Device
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D012656 SJN
% 210.86/211.05 |- mesh__recordMaintainer mesh__D012656 NNS
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012656 2003
% 210.86/211.05 |- rdf__type mesh__D012656sskos__Concept
% 210.86/211.05 |- skos__prefLabel mesh__D012656 Self-Help Devices
% 210.86/211.05 |- mesh__dateCreated mesh__D012656 1999-01-01
% 210.86/211.05 |- skos__altLabel mesh__D012656 Assistive Technology
% 210.86/211.05 |- skos__altLabel mesh__D012656 Assistive Devices
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012656 2002
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Devices, Assistive
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012656 2004
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Device, Assistive
% 210.86/211.05 |- skos__scopeNote mesh__D012656
% 210.86/211.05 Devices, not affixed to the body, designed to help persons having musculoskeletal or neuromuscular disabilities to perform activities involving movement.%A%
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Assistive Technologies
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Technologies, Assistive
% 210.86/211.05 |- skos__broader mesh__D012656smesh__D004864
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012656 2000
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Device, Self-Help
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Self Help Devices
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012656 2005
% 210.86/211.05 |- skos__hiddenLabel mesh__D012656 Technology, Assistive
% 210.86/211.05 |- skos__historyNote mesh__D006619
% 210.86/211.05 Hip Dislocation, Congenital/veterinary %28%1966-1975%29%
% 210.86/211.05 |- skos__scopeNote mesh__D006619
% 210.86/211.05 A hereditary disease of the hip joints in dogs. Signs of the disease may be evident any time after 4 weeks of age.%A%
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D006619 2006
% 210.86/211.05 |- skos__prefLabel mesh__D006619 Hip Dysplasia, Canine
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D006619
% 210.86/211.05 91; was see under HIP DISLOCATION, CONGENITAL 1976-90
% 210.86/211.05 |- mesh__dateCreated mesh__D006619 1975-07-25
% 210.86/211.05 |- skos__altLabel mesh__D006619 Canine Hip Dysplasia
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D006619 2005
% 210.86/211.05 |- skos__broader mesh__D006619smesh__D004283
% 210.86/211.05 |- rdf__type mesh__D006619sskos__Concept
% 210.86/211.05 |- mesh__historyNote mesh__D006619
% 210.86/211.05 91%28%76%29%; was see under HIP DISLOCATION, CONGENITAL 1976-90%A%
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D006619 sjn
% 210.86/211.05 |- skos__annotation mesh__D006619
% 210.86/211.05 congen hip disloc in dogs; don%27%t forget check tags ANIMALS %26% DOGS %28%NIM%29%%A%
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D006619 2004
% 210.86/211.05 |- mesh__recordOriginator mesh__D006619 FPG
% 210.86/211.05 |- mesh__dateEstablished mesh__D006619 1991-01-01
% 210.86/211.05 |- skos__hiddenLabel mesh__D006619 Dysplasia, Canine Hip
% 210.86/211.05 |- mesh__recordMaintainer mesh__D006619 ags
% 210.86/211.05 |- mesh__dateRevised mesh__D006619 2003-07-30
% 210.86/211.05 |- skos__prefLabel mesh__D017341 Etanidazole
% 210.86/211.05 |- skos__hiddenLabel mesh__D017341 NSC301467
% 210.86/211.05 |- mesh__dateCreated mesh__D017341 1992-05-08
% 210.86/211.05 |- skos__scopeNote mesh__D017341
% 210.86/211.05 A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.%A%
% 210.86/211.05 |- mesh__onlineNote mesh__D017341
% 210.86/211.05 use ETANIDAZOLE %28%NM%29% to search ETANIDAZOLE 1981-92
% 210.86/211.05 |- mesh__historyNote mesh__D017341
% 210.86/211.05 93; was ETANIDAZOLE %28%NM%29% 1981-92
% 210.86/211.05 |- skos__hiddenLabel mesh__D017341 SR2508
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D017341 2006
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D017341
% 210.86/211.05 93; ETANIDAZOLE was indexed under NITROIMIDAZOLES 1981-92%A%
% 210.86/211.05 |- skos__broader mesh__D017341smesh__D009593
% 210.86/211.05 |- mesh__dateRevised mesh__D017341 2005-06-30
% 210.86/211.05 |- skos__hiddenLabel mesh__D017341 SR 2508
% 210.86/211.05 |- mesh__recordOriginator mesh__D017341 TPW
% 210.86/211.05 |- rdf__type mesh__D017341sskos__Concept
% 210.86/211.05 |- skos__hiddenLabel mesh__D017341 NSC 301467
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D017341 sjn
% 210.86/211.05 |- mesh__recordMaintainer mesh__D017341 ssb
% 210.86/211.05 |- skos__historyNote mesh__D017341 Nitroimidazoles %28%1981-1992%29%
% 210.86/211.05 |- mesh__dateEstablished mesh__D017341 1993-01-01
% 210.86/211.05 |- skos__broader mesh__D011506Q000097smesh__D011506
% 210.86/211.05 |- mesh__preferredCombination mesh__D011506Q000097smesh__D001798
% 210.86/211.05 |- rdf__type mesh__D011506Q000097smesh__CompoundConcept
% 210.86/211.05 |- mesh__dateEstablished mesh__D003321 1991-01-01
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003321 1999
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D003321
% 210.86/211.05 91; was see under MEDICAL HISTORY TAKING 1975-90
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003321 2000
% 210.86/211.05 |- skos__scopeNote mesh__D003321
% 210.86/211.05 Self-administered health questionnaire developed to obtain details of the medical history as an adjunct to the medical interview. It consists of 195 questions divided into eighteen sections; the first twelve deal with somatic complaints and the last six with mood and feeling patterns. The Index is used also as a personality inventory or in epidemiologic studies.%A%
% 210.86/211.05 |- rdf__type mesh__D003321sskos__Concept
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003321 2001
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D003321 SJN
% 210.86/211.05 |- mesh__historyNote mesh__D003321
% 210.86/211.05 91%28%75%29%; was see under MEDICAL HISTORY TAKING 1975-90
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003321 2003
% 210.86/211.05 |- skos__broader mesh__D003321smesh__D008487
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003321 2005
% 210.86/211.05 |- mesh__dateRevised mesh__D003321 1997-06-20
% 210.86/211.05 |- mesh__recordOriginator mesh__D003321 NLM
% 210.86/211.05 |- skos__annotation mesh__D003321 no qualif; DF: CORNELL MED INDEX
% 210.86/211.05 |- mesh__dateCreated mesh__D003321 1975-02-04
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003321 2004
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003321 2002
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003321 2006
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003321 1998
% 210.86/211.05 |- mesh__recordMaintainer mesh__D003321 PXP
% 210.86/211.05 |- skos__prefLabel mesh__D003321 Cornell Medical Index
% 210.86/211.05 |- skos__scopeNote mesh__D016249
% 210.86/211.05 A computer disk read by a laser beam, containing data prerecorded by a vendor. The buyer cannot enter or modify data in any way but the advantages lie in the speed of accessibility, relative immunity to damage, and relatively low cost of purchase.%A%
% 210.86/211.05 |- mesh__dateRevised mesh__D016249 2004-07-07
% 210.86/211.05 |- skos__hiddenLabel mesh__D016249 Disks, WORM
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D016249 2006
% 210.86/211.05 |- skos__hiddenLabel mesh__D016249 Devices, Optical Storage
% 210.86/211.05 |- mesh__historyNote mesh__D016249 91
% 210.86/211.05 |- mesh__recordMaintainer mesh__D016249 jls
% 210.86/211.05 |- skos__hiddenLabel mesh__D016249 Optical Storage Device
% 210.86/211.05 |- rdf__type mesh__D016249sskos__Concept
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D016249 sjn
% 210.86/211.05 |- mesh__dateCreated mesh__D016249 1990-05-07
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D016249 91
% 210.86/211.05 |- skos__broader mesh__D016249smesh__D016248
% 210.86/211.05 |- skos__hiddenLabel mesh__D016249 WORM Disk
% 210.86/211.05 |- mesh__recordOriginator mesh__D016249 TGC
% 210.86/211.05 |- skos__hiddenLabel mesh__D016249 Storage Device, Optical
% 210.86/211.05 |- mesh__dateEstablished mesh__D016249 1991-01-01
% 210.86/211.05 |- skos__hiddenLabel mesh__D016249 Device, Optical Storage
% 210.86/211.05 |- skos__broader mesh__D016249smesh__D001296
% 210.86/211.05 |- skos__annotation mesh__D016249
% 210.86/211.05 do not use /util except by MeSH definition
% 210.86/211.05 |- skos__hiddenLabel mesh__D016249 Disk, WORM
% 210.86/211.05 |- skos__prefLabel mesh__D016249 Optical Storage Devices
% 210.86/211.05 |- skos__hiddenLabel mesh__D016249 Storage Devices, Optical
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D016249 2005
% 210.86/211.05 |- skos__historyNote mesh__D002229 Triterpenes %28%1974%29%
% 210.86/211.05 |- skos__hiddenLabel mesh__D002229 Acid 3-O-hemisuccinate, Glycyrrhetinic
% 210.86/211.05 |- skos__historyNote mesh__D002229 Glycyrrhiza %28%1966-1974%29%
% 210.86/211.05 |- skos__broader mesh__D002229smesh__D006034
% 210.86/211.05 |- skos__altLabel mesh__D002229 Glycyrrhetinic Acid 3-O-hemisuccinate
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D002229 2005
% 210.86/211.05 |- skos__altLabel mesh__D002229 Rowa Brand of Carbenoxolone Disodium Salt
% 210.86/211.05 |- skos__hiddenLabel mesh__D002229
% 210.86/211.05 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid
% 210.86/211.05 |- skos__hiddenLabel mesh__D002229
% 210.86/211.05 18alpha Glycyrrhetinic Acid 3beta O Hemisuccinate
% 210.86/211.05 |- mesh__dateCreated mesh__D002229 1974-11-11
% 210.86/211.05 |- skos__prefLabel mesh__D002229 Carbenoxolone
% 210.86/211.05 |- mesh__dateEstablished mesh__D002229 1991-01-01
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D002229 2006
% 210.86/211.05 |- skos__altLabel mesh__D002229
% 210.86/211.05 18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate
% 210.86/211.05 |- skos__altLabel mesh__D002229 Carbeneoxolone
% 210.86/211.05 |- skos__hiddenLabel mesh__D002229
% 210.86/211.05 Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic
% 210.86/211.05 |- skos__historyNote mesh__D002229 Succinates %28%1974%29%
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D002229 sjn
% 210.86/211.05 |- mesh__recordOriginator mesh__D002229 NLM
% 210.86/211.05 |- rdf__type mesh__D002229sskos__Concept
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D002229
% 210.86/211.05 1991; see GLYCYRRHETINIC ACID 1979-1990, see TRITERPENES 1975-1978; for 18ALPHA-CARBENOXOLONE was indexed under CARBENOXOLONE %28%NM%29% 1995-2002%A%
% 210.86/211.05 |- mesh__recordMaintainer mesh__D002229 mdb
% 210.86/211.05 |- skos__altLabel mesh__D002229 Carbenoxalone
% 210.86/211.05 |- skos__annotation mesh__D002229 /biosyn permitted if by plant
% 210.86/211.05 |- mesh__historyNote mesh__D002229
% 210.86/211.05 1991%28%1975%29%; for 18ALPHA-CARBENOXOLONE use CARBENOXOLONE %28%NM%29% 1995-2002%A%
% 210.86/211.05 |- skos__altLabel mesh__D002229 Carbenoxolone Disodium Salt
% 210.86/211.05 |- mesh__dateRevised mesh__D002229 2004-07-07
% 210.86/211.05 |- skos__hiddenLabel mesh__D002229 3-O-hemisuccinate, Glycyrrhetinic Acid
% 210.86/211.05 |- skos__altLabel mesh__D002229 Byk Brand of Carbenoxolone Disodium Salt
% 210.86/211.05 |- skos__hiddenLabel mesh__D002229 18alpha Carbenoxolone
% 210.86/211.05 |- skos__scopeNote mesh__D002229
% 210.86/211.05 An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity.%A%
% 210.86/211.05 |- skos__hiddenLabel mesh__D002229 Glycyrrhetinic Acid 3 O hemisuccinate
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 2000
% 210.86/211.05 |- skos__prefLabel mesh__D012657 Self-Help Groups
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Self Help Groups
% 210.86/211.05 |- mesh__onlineNote mesh__D012657
% 210.86/211.05 use SELF-HELP GROUPS to search SOCIAL CLUBS %28%now SOCIAL CLUBS, THERAPEUTIC see SELF-HELP GROUPS%29% 1973-78 %28%as Prov 1973-74%29%%A%
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 2003
% 210.86/211.05 |- rdf__type mesh__D012657sskos__Concept
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 1997
% 210.86/211.05 |- mesh__dateEstablished mesh__D012657 1979-01-01
% 210.86/211.05 |- skos__scopeNote mesh__D012657
% 210.86/211.05 Organizations which provide an environment encouraging social interactions through group activities or individual relationships especially for the purpose of rehabilitating or supporting patients, individuals with common health problems, or the elderly. They include therapeutic social clubs.%A%
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Support Group
% 210.86/211.05 |- mesh__dateCreated mesh__D012657 1999-01-01
% 210.86/211.05 |- skos__altLabel mesh__D012657 Social Clubs, Therapeutic
% 210.86/211.05 |- skos__altLabel mesh__D012657 Support Groups
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Self-Help Group
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 2001
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Groups, Self-Help
% 210.86/211.05 |- mesh__dateRevised mesh__D012657 1994-05-23
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Group, Support
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 2004
% 210.86/211.05 |- mesh__recordOriginator mesh__D012657 NLM
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D012657 PLS
% 210.86/211.05 |- mesh__recordMaintainer mesh__D012657 JLS
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Club, Therapeutic Social
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Group, Self-Help
% 210.86/211.05 |- skos__altLabel mesh__D012657 Therapeutic Social Clubs
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Therapeutic Social Club
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D012657
% 210.86/211.05 79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78
% 210.86/211.05 |- skos__historyNote mesh__D012657 Organizations %28%1968-1972%29%
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Social Club, Therapeutic
% 210.86/211.05 |- skos__broader mesh__D012657smesh__D009938
% 210.86/211.05 |- skos__hiddenLabel mesh__D012657 Groups, Support
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 1998
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 1995
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 2002
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 2005
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 1999
% 210.86/211.05 |- mesh__historyNote mesh__D012657
% 210.86/211.05 79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78, was SOCIAL CLUBS 1973-74 %28%Prov%29%%A%
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 1996
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012657 2006
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D050776 2006A
% 210.86/211.05 |- skos__hiddenLabel mesh__D050776 Complement, C5b
% 210.86/211.05 |- mesh__dateCreated mesh__D050776 2005-06-30
% 210.86/211.05 |- skos__broader mesh__D050776smesh__D003182
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D050776 2006
% 210.86/211.05 |- rdf__type mesh__D050776sskos__Concept
% 210.86/211.05 |- skos__altLabel mesh__D050776 C5b Complement
% 210.86/211.05 |- mesh__historyNote mesh__D050776 2006 %28%1982%29%
% 210.86/211.05 |- skos__scopeNote mesh__D050776
% 210.86/211.05 The larger fragment generated from the cleavage of C5 by C5 CONVERTASE that yields COMPLEMENT C5A and C5b %28%beta chain + alpha%27% chain, the residual alpha chain, bound by disulfide bond%29%. C5b remains bound to the membrane and initiates the spontaneous assembly of the late complement components to form C5b-8-poly-C9, the MEMBRANE ATTACK COMPLEX.%A%
% 210.86/211.05 |- skos__hiddenLabel mesh__D050776 C5b, Complement
% 210.86/211.05 |- skos__altLabel mesh__D050776 Complement 5b
% 210.86/211.05 |- mesh__recordMaintainer mesh__D050776 ags
% 210.86/211.05 |- skos__prefLabel mesh__D050776 Complement C5b
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D050776 ags
% 210.86/211.05 |- skos__hiddenLabel mesh__D050776 Component 5b, Complement
% 210.86/211.05 |- mesh__dateEstablished mesh__D050776 2006-01-01
% 210.86/211.05 |- mesh__dateRevised mesh__D050776 2005-07-11
% 210.86/211.05 |- mesh__recordOriginator mesh__D050776 lkt
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D050776
% 210.86/211.05 2006; COMPLEMENT C5B was indexed under COMPLEMENT 5 1982-2005%A%
% 210.86/211.05 |- skos__altLabel mesh__D050776 Complement Component 5b
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 X-Linked Retinoschises
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 Retinoschises, Juvenile
% 210.86/211.05 |- skos__broader mesh__D041441smesh__D012162
% 210.86/211.05 |- rdf__type mesh__D041441sskos__Concept
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 Retinoschises, Degenerative
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 Juvenile Retinoschises
% 210.86/211.05 |- mesh__historyNote mesh__D041441 2003
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D041441 2005
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 Degenerative Retinoschisis
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D041441 2003
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 X Linked Retinoschisis
% 210.86/211.05 |- skos__historyNote mesh__D041441 Retinal Diseases %28%1970-2002%29%
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 Retinoschises, X-Linked
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D041441 2006
% 210.86/211.05 |- skos__historyNote mesh__D041441 Retinal Degeneration %28%1969-2002%29%
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D041441 2004
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 Juvenile Retinoschisis
% 210.86/211.05 |- skos__prefLabel mesh__D041441 Retinoschisis
% 210.86/211.05 |- skos__altLabel mesh__D041441
% 210.86/211.05 Retinoschisis, Juvenile, X Chromosome-Linked
% 210.86/211.05 |- skos__related mesh__D041441smesh__D012163
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 Degenerative Retinoschises
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D041441 2003
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 Retinoschisis, X Linked
% 210.86/211.05 |- mesh__dateEstablished mesh__D041441 2003-01-01
% 210.86/211.05 |- mesh__dateCreated mesh__D041441 2002-07-18
% 210.86/211.05 |- skos__scopeNote mesh__D041441
% 210.86/211.05 A vitreoretinal dystrophy characterized by splitting of the neuroretinal layers. It occurs in two forms: degenerative retinoschisis and X chromosome-linked juvenile retinoschisis.%A%
% 210.86/211.05 |- skos__hiddenLabel mesh__D041441 Retinoschises
% 210.86/211.05 |- skos__altLabel mesh__D041441 X-Linked Retinoschisis
% 210.86/211.05 |- skos__altLabel mesh__D041441 Retinoschisis, X-Linked
% 210.86/211.05 |- skos__altLabel mesh__D041441 Retinoschisis, Juvenile
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D013750 2005
% 210.86/211.05 |- skos__altLabel mesh__D013750 Tetrachlorethylene
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D013750 2002
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D013750 2006
% 210.86/211.05 |- mesh__dateCreated mesh__D013750 1999-01-01
% 210.86/211.05 |- mesh__recordOriginator mesh__D013750 NLM
% 210.86/211.05 |- skos__altLabel mesh__D013750 Tetrachloroethene
% 210.86/211.05 |- skos__scopeNote mesh__D013750
% 210.86/211.05 A chlorinated hydrocarbon used as an industrial solvent and cooling liquid in electrical transformers. It is a potential carcinogen.%A%
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D013750 sjn
% 210.86/211.05 |- skos__altLabel mesh__D013750 Perchlorethylene
% 210.86/211.05 |- rdf__type mesh__D013750sskos__Concept
% 210.86/211.05 |- skos__broader mesh__D013750smesh__D006843
% 210.86/211.05 |- skos__altLabel mesh__D013750 Perchloroethylene
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D013750 2003
% 210.86/211.05 |- mesh__dateRevised mesh__D013750 2001-07-25
% 210.86/211.05 |- mesh__recordMaintainer mesh__D013750 ssb
% 210.86/211.05 |- skos__prefLabel mesh__D013750 Tetrachloroethylene
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D013750 2004
% 210.86/211.05 |- mesh__recordOriginator mesh__D007713 NLM
% 210.86/211.05 |- skos__prefLabel mesh__D007713 Klinefelter Syndrome
% 210.86/211.05 |- skos__hiddenLabel mesh__D007713 Klinefelters Syndrome
% 210.86/211.05 |- skos__hiddenLabel mesh__D007713 Klinefelter Syndromes
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D007713 2006
% 210.86/211.05 |- skos__altLabel mesh__D007713 Klinefelter%27%s Syndrome
% 210.86/211.05 |- mesh__dateRevised mesh__D007713 2005-06-30
% 210.86/211.05 |- mesh__recordMaintainer mesh__D007713 lkt
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D007713 sjn
% 210.86/211.05 |- skos__annotation mesh__D007713
% 210.86/211.05 index here karyotypes XXXY, XXXXY, XXYY, XXXYY, XX/XXY, XX/YY, XY/XXY, XXY/XXXY, XXY/XXYY, XY/XXY/XXXY if called KLINEFELTER SYNDROME by author but if not so named by author, index under SEX CHROMOSOME DISORDERS%A%
% 210.86/211.05 |- skos__broader mesh__D007713smesh__D025064
% 210.86/211.05 |- skos__broader mesh__D007713smesh__D012734
% 210.86/211.05 |- skos__hiddenLabel mesh__D007713 Syndrome, Klinefelter%27%s
% 210.86/211.05 |- skos__hiddenLabel mesh__D007713 Syndromes, Klinefelter
% 210.86/211.05 |- skos__hiddenLabel mesh__D007713 Syndrome, Klinefelter
% 210.86/211.05 |- mesh__dateCreated mesh__D007713 1999-01-01
% 210.86/211.05 |- rdf__type mesh__D007713sskos__Concept
% 210.86/211.05 |- skos__broader mesh__D007713smesh__D007006
% 210.86/211.05 |- skos__scopeNote mesh__D007713
% 210.86/211.05 A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility %28%INFERTILITY, MALE%29%. Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns %28% 46,XY/47,XXY; 47,XXY/48,XXXY, etc.%29%.%A%
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D012658 sjn
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012658 2002
% 210.86/211.05 |- skos__prefLabel mesh__D012658 Sella Turcica
% 210.86/211.05 |- skos__scopeNote mesh__D012658
% 210.86/211.05 A bony prominence situated on the upper surface of the body of the sphenoid bone. It houses the PITUITARY GLAND.%A%
% 210.86/211.05 |- skos__hiddenLabel mesh__D012658 Sella Turcicas
% 210.86/211.05 |- skos__hiddenLabel mesh__D012658 Turcicas, Sella
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012658 2000
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012658 2005
% 210.86/211.05 |- skos__broader mesh__D012658smesh__D013100
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012658 2006
% 210.86/211.05 |- skos__hiddenLabel mesh__D012658 Turcica, Sella
% 210.86/211.05 |- mesh__recordMaintainer mesh__D012658 KEV
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012658 2001
% 210.86/211.05 |- rdf__type mesh__D012658sskos__Concept
% 210.86/211.05 |- skos__related mesh__D012658smesh__D004652
% 210.86/211.05 |- mesh__recordOriginator mesh__D012658 NLM
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012658 2003
% 210.86/211.05 |- mesh__dateCreated mesh__D012658 1999-01-01
% 210.86/211.05 |- mesh__dateRevised mesh__D012658 1999-11-03
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D012658 2004
% 210.86/211.05 |- mesh__dateCreated mesh__D017343 1992-05-20
% 210.86/211.05 |- skos__annotation mesh__D017343
% 210.86/211.05 coordinate IM with specific plant term /genet %28%IM%29%
% 210.86/211.05 |- rdf__type mesh__D017343sskos__Concept
% 210.86/211.05 |- skos__broader mesh__D017343smesh__D005796
% 210.86/211.05 |- skos__historyNote mesh__D017343 Genes %28%1966-1992%29%
% 210.86/211.05 |- skos__hiddenLabel mesh__D017343 Gene, Plant
% 210.86/211.05 |- mesh__dateEstablished mesh__D017343 1993-01-01
% 210.86/211.05 |- skos__historyNote mesh__D017343 specific plant %28%1966-1992%29%
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D017343 sjn
% 210.86/211.05 |- skos__hiddenLabel mesh__D017343 Plant Gene
% 210.86/211.05 |- skos__altLabel mesh__D017343 Plant Genes
% 210.86/211.05 |- mesh__recordMaintainer mesh__D017343 nns
% 210.86/211.05 |- skos__scopeNote mesh__D017343
% 210.86/211.05 The functional hereditary units of PLANTS.
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D017343 2006
% 210.86/211.05 |- skos__prefLabel mesh__D017343 Genes, Plant
% 210.86/211.05 |- skos__related mesh__D017343smesh__D018745
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D017343 93
% 210.86/211.05 |- mesh__historyNote mesh__D017343 93
% 210.86/211.05 |- skos__broader mesh__D017343smesh__D018745
% 210.86/211.05 |- mesh__recordOriginator mesh__D017343 PXP
% 210.86/211.05 |- mesh__dateRevised mesh__D017343 2005-06-30
% 210.86/211.05 |- skos__broader mesh__D050777smesh__D010750
% 210.86/211.05 |- skos__altLabel mesh__D050777 Oncoprotein 18
% 210.86/211.05 |- skos__scopeNote mesh__D050777
% 210.86/211.05 A ubiquitous phosphoprotein that serves as an intracellular substrate for a variety of SIGNAL TRANSDUCTION PATHWAYS. PHOSPHORYLATION of stathmin occurs during CELL CYCLE progression, and stathmin functions as a microtubule-destabilizing protein that promotes MICROTUBULE depolymerization during INTERPHASE and late MITOSIS. Stathmin is expressed at very high levels in a variety of human CANCERS.%A%
% 210.86/211.05 |- skos__prefLabel mesh__D050777 Stathmin
% 210.86/211.05 |- mesh__recordAuthorizer mesh__D050777 sjn
% 210.86/211.05 |- skos__altLabel mesh__D050777 Metablastin
% 210.86/211.05 |- skos__altLabel mesh__D050777 Lap18 Protein
% 210.86/211.05 |- mesh__historyNote mesh__D050777 2006%28%1987%29%
% 210.86/211.05 |- skos__hiddenLabel mesh__D050777 p19, Phosphoprotein
% 210.86/211.05 |- skos__broader mesh__D050777smesh__D008869
% 210.86/211.05 |- mesh__publicMeSHNote mesh__D050777
% 210.86/211.05 2006; STATHMIN was indexed under MICROTUBULE PROTEINS %26% PHOSPHOPROTEINS 1987-2005%A%
% 210.86/211.05 |- skos__hiddenLabel mesh__D050777 p18, Leukemia-Associated Phosphoprotein
% 210.86/211.05 |- skos__altLabel mesh__D050777 Op18b Protein
% 210.86/211.05 |- skos__altLabel mesh__D050777 Op18 Phosphoprotein
% 210.86/211.05 |- mesh__dateEstablished mesh__D050777 2006-01-01
% 210.86/211.05 |- skos__altLabel mesh__D050777 Phosphoprotein p19
% 210.86/211.05 |- mesh__recordMaintainer mesh__D050777 DRC
% 210.86/211.05 |- skos__altLabel mesh__D050777 Leukemia-Associated Phosphoprotein p18
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D050777 2006
% 210.86/211.05 |- skos__altLabel mesh__D050777 Phosphoprotein p18
% 210.86/211.05 |- skos__hiddenLabel mesh__D050777 Phosphoprotein, Op18
% 210.86/211.05 |- skos__altLabel mesh__D050777 Prosolin
% 210.86/211.05 |- skos__hiddenLabel mesh__D050777 Alpha Stathmin
% 210.86/211.05 |- skos__broader mesh__D050777smesh__D011518
% 210.86/211.05 |- rdf__type mesh__D050777sskos__Concept
% 210.86/211.05 |- mesh__recordOriginator mesh__D050777 DRC
% 210.86/211.05 |- skos__hiddenLabel mesh__D050777 Leukemia Associated Phosphoprotein p18
% 210.86/211.05 |- skos__hiddenLabel mesh__D050777 Beta Stathmin
% 210.86/211.05 |- skos__altLabel mesh__D050777 Op18a Protein
% 210.86/211.05 |- skos__hiddenLabel mesh__D050777 p18, Phosphoprotein
% 210.86/211.05 |- mesh__dateCreated mesh__D050777 2005-06-30
% 210.86/211.05 |- mesh__dateEstablished mesh__D003323 1987-01-01
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003323 2004
% 210.86/211.05 |- skos__related mesh__D003323smesh__D006322
% 210.86/211.05 |- skos__hiddenLabel mesh__D003323 Coronary Aneurysms
% 210.86/211.05 |- mesh__dateRevised mesh__D003323 1997-06-20
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003323 2006
% 210.86/211.05 |- skos__hiddenLabel mesh__D003323 Aneurysms, Coronary
% 210.86/211.05 |- skos__scopeNote mesh__D003323
% 210.86/211.05 Aneurysm of a coronary vessel. A coronary artery aneurysm is rarely congenital; it is usually due to atherosclerosis, inflammatory processes, or a coronary fistula. %28%From Stedman, 26th ed%29%%A%
% 210.86/211.05 |- mesh__activeMeSHYear mesh__D003323 1998
% 210.86/211.06 |- mesh__recordMaintainer mesh__D003323 TGC
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003323 2002
% 210.86/211.06 |- skos__prefLabel mesh__D003323 Coronary Aneurysm
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003323 1999
% 210.86/211.06 |- skos__altLabel mesh__D003323 Aneurysm, Coronary
% 210.86/211.06 |- skos__broader mesh__D003323smesh__D000783
% 210.86/211.06 |- mesh__recordOriginator mesh__D003323 VDK
% 210.86/211.06 |- mesh__dateCreated mesh__D003323 1986-03-27
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D003323 87
% 210.86/211.06 |- rdf__type mesh__D003323sskos__Concept
% 210.86/211.06 |- skos__broader mesh__D003323smesh__D003327
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003323 2000
% 210.86/211.06 |- mesh__historyNote mesh__D003323 87
% 210.86/211.06 |- skos__historyNote mesh__D003323 Coronary Disease %28%1966-1986%29%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003323 2003
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003323 2001
% 210.86/211.06 |- skos__historyNote mesh__D003323 Aneurysm %28%1966-1986%29%
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D003323 SJN
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003323 2005
% 210.86/211.06 |- mesh__dateCreated mesh__D013751 1999-01-01
% 210.86/211.06 |- mesh__dateRevised mesh__D013751 2004-07-07
% 210.86/211.06 |- skos__historyNote mesh__D013751 Organophosphorus Compounds %28%1971%29%
% 210.86/211.06 |- mesh__onlineNote mesh__D013751
% 210.86/211.06 use TETRACHLORVINPHOS to search GARDONA 1972-78 %28%as Prov 1972-73%29%%A%
% 210.86/211.06 |- skos__prefLabel mesh__D013751 Tetrachlorvinphos
% 210.86/211.06 |- rdf__type mesh__D013751sskos__Concept
% 210.86/211.06 |- skos__scopeNote mesh__D013751
% 210.86/211.06 An organophosphate cholinesterase inhibitor that is used as an insecticide. It has low mammalian toxicity. %28%From Merck Index, 11th ed%29%%A%
% 210.86/211.06 |- mesh__recordOriginator mesh__D013751 NLM
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D013751 79; was GARDONA 1974-78
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D013751 sjn
% 210.86/211.06 |- mesh__historyNote mesh__D013751
% 210.86/211.06 79; was GARDONA 1972-78 %28%Prov 1972-73%29%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D013751 2005
% 210.86/211.06 |- mesh__dateEstablished mesh__D013751 1974-01-01
% 210.86/211.06 |- skos__broader mesh__D013751smesh__D009943
% 210.86/211.06 |- skos__altLabel mesh__D013751 Stirofos
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D013751 2006
% 210.86/211.06 |- skos__annotation mesh__D013751 TN 111 for eff on insects
% 210.86/211.06 |- mesh__recordMaintainer mesh__D013751 ssb
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007714 2004
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007714 2001
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007714 2006
% 210.86/211.06 |- skos__prefLabel mesh__D007714 Klippel-Feil Syndrome
% 210.86/211.06 |- skos__hiddenLabel mesh__D007714 Syndrome, Klippel-Feil
% 210.86/211.06 |- skos__hiddenLabel mesh__D007714 Klippel Feil Syndrome
% 210.86/211.06 |- mesh__recordOriginator mesh__D007714 NLM
% 210.86/211.06 |- skos__annotation mesh__D007714
% 210.86/211.06 short neck as result of vertebral abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 210.86/211.06 |- mesh__recordMaintainer mesh__D007714 kle
% 210.86/211.06 |- skos__hiddenLabel mesh__D007714 Dystrophia Brevicollis Congenitas
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007714 2002
% 210.86/211.06 |- skos__broader mesh__D007714smesh__D004413
% 210.86/211.06 |- skos__broader mesh__D007714smesh__D009139
% 210.86/211.06 |- mesh__dateCreated mesh__D007714 1999-01-01
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D007714 sjn
% 210.86/211.06 |- rdf__type mesh__D007714sskos__Concept
% 210.86/211.06 |- skos__altLabel mesh__D007714 Dystrophia Brevicollis Congenita
% 210.86/211.06 |- mesh__dateRevised mesh__D007714 1999-11-03
% 210.86/211.06 |- skos__scopeNote mesh__D007714
% 210.86/211.06 A condition characterized by shortness of the neck resulting from reduction in the number of vertebrae or the fusion of multiple hemivertebrae into one osseous mass. The hairline is low and the motion of the neck is limited. %28%Dorland, 27th ed%29%%A%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007714 2003
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007714 2000
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007714 2005
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 1998
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 1995
% 210.86/211.06 |- skos__historyNote mesh__D012659 Semantics %28%1966-1967%29%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 1999
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 2005
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 2002
% 210.86/211.06 |- skos__scopeNote mesh__D012659
% 210.86/211.06 Analysis of word concepts by the association of polar adjectives, e.g., good-bad, with the concept, father. The adjectives are usually scaled in 7 steps. The subject%27%s placement of the concept on the adjectival scale indicates the connotative meaning of the concept.%A%
% 210.86/211.06 |- mesh__dateRevised mesh__D012659 1992-05-18
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 1993
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 1996
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 2006
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D012659 68
% 210.86/211.06 |- skos__prefLabel mesh__D012659 Semantic Differential
% 210.86/211.06 |- rdf__type mesh__D012659sskos__Concept
% 210.86/211.06 |- skos__historyNote mesh__D012659 Psychological Tests %28%1966-1967%29%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 2003
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 1997
% 210.86/211.06 |- mesh__dateEstablished mesh__D012659 1968-01-01
% 210.86/211.06 |- mesh__dateCreated mesh__D012659 1999-01-01
% 210.86/211.06 |- skos__altLabel mesh__D012659 Differential, Semantic
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 2000
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 2004
% 210.86/211.06 |- skos__hiddenLabel mesh__D012659 Semantic Differentials
% 210.86/211.06 |- mesh__historyNote mesh__D012659 68
% 210.86/211.06 |- skos__broader mesh__D012659smesh__D011578
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 2001
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D012659 1994
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D012659 PLS
% 210.86/211.06 |- mesh__recordMaintainer mesh__D012659 TAP
% 210.86/211.06 |- skos__annotation mesh__D012659
% 210.86/211.06 a type of psychol test: do not confuse with SEMANTICS; DF: SEMANTIC DIFFER%A%
% 210.86/211.06 |- mesh__recordOriginator mesh__D012659 NLM
% 210.86/211.06 |- skos__broader mesh__D012659smesh__D010556
% 210.86/211.06 |- skos__hiddenLabel mesh__D012659 Differentials, Semantic
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Assays, End Point
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023381 2002
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Point Assays, End
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Determinations, End Point
% 210.86/211.06 |- skos__prefLabel mesh__D023381 Endpoint Determination
% 210.86/211.06 |- skos__broader mesh__D023381smesh__D001681
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023381 2001
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Determination, Endpoint
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023381 2004
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Endpoint Assays
% 210.86/211.06 |- mesh__historyNote mesh__D023381 2001
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Determinations, Endpoint
% 210.86/211.06 |- rdf__type mesh__D023381sskos__Concept
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 End Point Determinations
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D023381 2001
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Assay, End Point
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023381 2006
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023381 2003
% 210.86/211.06 |- skos__scopeNote mesh__D023381
% 210.86/211.06 Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.%A%
% 210.86/211.06 |- skos__historyNote mesh__D023381 Biological Assay %28%1980-2000%29%
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Point Determinations, End
% 210.86/211.06 |- skos__altLabel mesh__D023381 End Point Determination
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Endpoint Determinations
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Assays, Endpoint
% 210.86/211.06 |- skos__altLabel mesh__D023381 End Point Assay
% 210.86/211.06 |- mesh__dateCreated mesh__D023381 2000-06-21
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023381 2005
% 210.86/211.06 |- mesh__dateEstablished mesh__D023381 2001-01-01
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Assay, Endpoint
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 End Point Assays
% 210.86/211.06 |- skos__hiddenLabel mesh__D023381 Point Assay, End
% 210.86/211.06 |- skos__historyNote mesh__D017344 specific insect %28%1966-1992%29%
% 210.86/211.06 |- mesh__dateEstablished mesh__D017344 1993-01-01
% 210.86/211.06 |- mesh__historyNote mesh__D017344 93
% 210.86/211.06 |- skos__annotation mesh__D017344
% 210.86/211.06 coordinate IM with specific insect /genet %28%IM%29%
% 210.86/211.06 |- mesh__recordOriginator mesh__D017344 PXP
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D017344 93
% 210.86/211.06 |- rdf__type mesh__D017344sskos__Concept
% 210.86/211.06 |- skos__hiddenLabel mesh__D017344 Gene, Insect
% 210.86/211.06 |- mesh__dateRevised mesh__D017344 2005-06-30
% 210.86/211.06 |- mesh__dateCreated mesh__D017344 1992-05-20
% 210.86/211.06 |- skos__related mesh__D017344smesh__D049750
% 210.86/211.06 |- skos__scopeNote mesh__D017344
% 210.86/211.06 The functional hereditary units of INSECTS.
% 210.86/211.06 |- skos__historyNote mesh__D017344 Genes %28%1966-1992%29%
% 210.86/211.06 |- skos__altLabel mesh__D017344 Insect Genes
% 210.86/211.06 |- mesh__recordMaintainer mesh__D017344 nns
% 210.86/211.06 |- skos__prefLabel mesh__D017344 Genes, Insect
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D017344 sjn
% 210.86/211.06 |- skos__broader mesh__D017344smesh__D049750
% 210.86/211.06 |- skos__broader mesh__D017344smesh__D005796
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D017344 2006
% 210.86/211.06 |- skos__hiddenLabel mesh__D017344 Insect Gene
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATC3 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T-Cells, Cytoplasmic 3 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 TonEBP Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFAT3 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 Osmotic Response Element Binding Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Nuclear Factors of Activated T Cells
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFAT-2 Protein
% 210.86/211.06 |- skos__prefLabel mesh__D050778 NFATC Transcription Factors
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 NFAT 2 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Factor, NFATC2 Transcription
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFAT5 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Factor, NFATC3 Transcription
% 210.86/211.06 |- skos__altLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T-Cells, Cytoplasmic 2 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778
% 210.86/211.06 Tonicity Responsive Enhancer Binding Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T-Cells, Cytoplasmic 4 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T Cells, Cytoplasmic 4 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFAT Proteins
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATC4 Transcription Factor
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T Cells, Cytoplasmic 3 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T Cells, Cytoplasmic
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATC2 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 NFAT 1 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Transcription Factor, NFATC4
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T Cells, Cytoplasmic 1 Protein
% 210.86/211.06 |- mesh__recordMaintainer mesh__D050778 ags
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATz Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATL1 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NF-AT3 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATC Proteins
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Transcription Factor NF AT
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D050778 2006
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFAT-1 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NF-AT Proteins
% 210.86/211.06 |- skos__altLabel mesh__D050778 Transcription Factor NF-AT
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 NF AT4 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATx Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T-Cells, Cytoplasmic
% 210.86/211.06 |- mesh__dateCreated mesh__D050778 2005-06-30
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATC4 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Transcription Factor, NFATC3
% 210.86/211.06 |- mesh__recordOriginator mesh__D050778 DRC
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATC3 Transcription Factor
% 210.86/211.06 |- skos__altLabel mesh__D050778 NF-ATc1 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778
% 210.86/211.06 Tonicity-Responsive Enhancer-Binding Protein
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D050778 ags
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFAT4 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NF-AT4 Protein
% 210.86/211.06 |- mesh__historyNote mesh__D050778 2006%28%1993%29%
% 210.86/211.06 |- skos__altLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T-Cells, Cytoplasmic 1 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T Cells 5 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATC1 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 OREBP Protein
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D050778
% 210.86/211.06 2006; NFATC TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEIN, NUCLEAR PROTEINS, %26% TRANSCRIPTION FACTORS 1993-2005%A%
% 210.86/211.06 |- rdf__type mesh__D050778sskos__Concept
% 210.86/211.06 |- skos__scopeNote mesh__D050778
% 210.86/211.06 A family of transcription factors characterized by the presence of highly conserved calcineurin- and DNA-binding domains. NFAT proteins are activated in the CYTOPLASM by the calcium-dependent phosphatase CALCINEURIN. They transduce calcium signals to the nucleus where they can interact with TRANSCRIPTION FACTOR AP-1 or NF-KAPPA B and initiate GENETIC TRANSCRIPTION of GENES involved in CELL DIFFERENTIATION and development. NFAT proteins stimulate T-CELL activation through the induction of IMMEDIATE-EARLY GENES such as INTERLEUKIN-2.%A%
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Transcription Factor, NFATC2
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFAT2 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 Nuclear Factors of Activated T-Cells
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 NF-AT, Transcription Factor
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 NF AT3 Protein
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFAT1 Protein
% 210.86/211.06 |- mesh__dateEstablished mesh__D050778 2006-01-01
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATC1 Transcription Factor
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Transcription Factors, NFATC
% 210.86/211.06 |- mesh__dateRevised mesh__D050778 2005-07-21
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T Cells, Cytoplasmic 2 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 NF ATc1 Protein
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D050778 2006A
% 210.86/211.06 |- skos__broader mesh__D050778smesh__D014157
% 210.86/211.06 |- skos__altLabel mesh__D050778
% 210.86/211.06 Nuclear Factor of Activated T-Cells 5 Protein
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Transcription Factor, NFATC1
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 Factor, NFATC1 Transcription
% 210.86/211.06 |- skos__hiddenLabel mesh__D050778 NF AT Proteins
% 210.86/211.06 |- skos__altLabel mesh__D050778 NFATC2 Transcription Factor
% 210.86/211.06 |- skos__hiddenLabel mesh__D003324 Coronary Artery Diseases
% 210.86/211.06 |- skos__altLabel mesh__D003324 Coronary Artery Disease
% 210.86/211.06 |- skos__hiddenLabel mesh__D003324 Atheroscleroses, Coronary
% 210.86/211.06 |- skos__altLabel mesh__D003324 Arteriosclerosis, Coronary
% 210.86/211.06 |- skos__hiddenLabel mesh__D003324 Disease, Coronary Artery
% 210.86/211.06 |- skos__altLabel mesh__D003324 Atherosclerosis, Coronary
% 210.86/211.06 |- skos__hiddenLabel mesh__D003324 Coronary Atheroscleroses
% 210.86/211.06 |- mesh__dateEstablished mesh__D003324 1987-01-01
% 210.86/211.06 |- skos__prefLabel mesh__D003324 Coronary Arteriosclerosis
% 210.86/211.06 |- skos__hiddenLabel mesh__D003324 Arterioscleroses, Coronary
% 210.86/211.06 |- skos__hiddenLabel mesh__D003324 Artery Disease, Coronary
% 210.86/211.06 |- mesh__historyNote mesh__D003324
% 210.86/211.06 1987; use CORONARY DISEASE 1974-1987; for CORONARY ARTERY DISEASE use CORONARY DISEASE 1986-2001%A%
% 210.86/211.06 |- skos__hiddenLabel mesh__D003324 Artery Diseases, Coronary
% 210.86/211.06 |- skos__altLabel mesh__D003324 Coronary Atherosclerosis
% 210.86/211.06 |- mesh__recordMaintainer mesh__D003324 nns
% 210.86/211.06 |- mesh__dateRevised mesh__D003324 2004-07-07
% 210.86/211.06 |- skos__related mesh__D003324smesh__D017225
% 210.86/211.06 |- mesh__dateCreated mesh__D003324 1986-03-27
% 210.86/211.06 |- rdf__type mesh__D003324sskos__Concept
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D003324
% 210.86/211.06 1987; see CORONARY DISEASE 1974-1987; for CORONARY ARTERY DISEASE see CORONARY DISEASE 1986-2001%A%
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D003324 sjn
% 210.86/211.06 |- skos__scopeNote mesh__D003324
% 210.86/211.06 Thickening and loss of elasticity of the coronary arteries, leading to progressive insufficiency of the arteries %28%CORONARY DISEASE%29%.%A%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003324 2005
% 210.86/211.06 |- mesh__recordOriginator mesh__D003324 VDK
% 210.86/211.06 |- skos__hiddenLabel mesh__D003324 Diseases, Coronary Artery
% 210.86/211.06 |- skos__broader mesh__D003324smesh__D001161
% 210.86/211.06 |- skos__broader mesh__D003324smesh__D003327
% 210.86/211.06 |- skos__hiddenLabel mesh__D003324 Coronary Arterioscleroses
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003324 2006
% 210.86/211.06 |- skos__historyNote mesh__D003324 Coronary Disease %28%1966-1986%29%
% 210.86/211.06 |- skos__hiddenLabel mesh__D013752 4 Epitetracycline
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D013752 sjn
% 210.86/211.06 |- skos__broader mesh__D013752smesh__D013754
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D013752 2006
% 210.86/211.06 |- skos__scopeNote mesh__D013752
% 210.86/211.06 A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.%A%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D013752 2005
% 210.86/211.06 |- mesh__dateRevised mesh__D013752 2004-07-07
% 210.86/211.06 |- rdf__type mesh__D013752sskos__Concept
% 210.86/211.06 |- mesh__recordOriginator mesh__D013752 NLM
% 210.86/211.06 |- skos__altLabel mesh__D013752 Tetracycline Monohydrochloride
% 210.86/211.06 |- mesh__dateCreated mesh__D013752 1999-01-01
% 210.86/211.06 |- skos__prefLabel mesh__D013752 Tetracycline
% 210.86/211.06 |- mesh__recordMaintainer mesh__D013752 ssb
% 210.86/211.06 |- mesh__recordMaintainer mesh__D007715 TGC
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 2005
% 210.86/211.06 |- skos__altLabel mesh__D007715 Klippel-Trenaunay Disease
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 2004
% 210.86/211.06 |- mesh__recordOriginator mesh__D007715 NLM
% 210.86/211.06 |- skos__hiddenLabel mesh__D007715 Syndrome, Klippel-Trenaunay-Weber
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D007715 PLS
% 210.86/211.06 |- skos__hiddenLabel mesh__D007715 Disease, Klippel-Trenaunay
% 210.86/211.06 |- skos__annotation mesh__D007715 a form of angiomatosis
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 2006
% 210.86/211.06 |- skos__prefLabel mesh__D007715 Klippel-Trenaunay-Weber Syndrome
% 210.86/211.06 |- skos__hiddenLabel mesh__D007715 Klippel Trenaunay Disease
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 1995
% 210.86/211.06 |- skos__broader mesh__D007715smesh__D000798
% 210.86/211.06 |- mesh__onlineNote mesh__D007715
% 210.86/211.06 use KLIPPEL-TRENAUNAY-WEBER SYNDROME to search KLIPPEL-TRENAUNAY DISEASE 1975-93; search ANGIOMATOSIS 1966-74%A%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 2002
% 210.86/211.06 |- mesh__dateCreated mesh__D007715 1999-01-01
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 1996
% 210.86/211.06 |- mesh__dateRevised mesh__D007715 1994-05-24
% 210.86/211.06 |- rdf__type mesh__D007715sskos__Concept
% 210.86/211.06 |- mesh__dateEstablished mesh__D007715 1991-01-01
% 210.86/211.06 |- mesh__historyNote mesh__D007715
% 210.86/211.06 94; was KLIPPEL-TRENAUNAY DISEASE 1975-93 %28%see under ANGIOMATOSIS 1975-90%29%%A%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 1998
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 2000
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 1997
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 2003
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D007715
% 210.86/211.06 94; was KLIPPEL-TRENAUNAY DISEASE 1975-93 %28%see under ANGIOMATOSIS 1975-90%29%%A%
% 210.86/211.06 |- skos__hiddenLabel mesh__D007715 Klippel Trenaunay Weber Syndrome
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 1999
% 210.86/211.06 |- skos__scopeNote mesh__D007715
% 210.86/211.06 A rare condition usually affecting one extremity, characterized by hypertrophy of the bone and related soft tissues, large cutaneous hemangiomas, persistent nevus flammeus, and skin varices. %28%Dorland, 27th ed%29%%A%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D007715 2001
% 210.86/211.06 |- skos__historyNote mesh__D023382 Toxicity Tests %28%1995-2000%29%
% 210.86/211.06 |- mesh__historyNote mesh__D023382 2001
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023382 2004
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023382 2002
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023382 2006
% 210.86/211.06 |- skos__hiddenLabel mesh__D023382 Test, Acute Toxicity
% 210.86/211.06 |- skos__prefLabel mesh__D023382 Acute Toxicity Tests
% 210.86/211.06 |- skos__hiddenLabel mesh__D023382 Tests, Acute Toxicity
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023382 2003
% 210.86/211.06 |- rdf__type mesh__D023382sskos__Concept
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023382 2001
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D023382 2005
% 210.86/211.06 |- skos__altLabel mesh__D023382 Toxicity Tests, Acute
% 210.86/211.06 |- mesh__dateCreated mesh__D023382 2000-06-21
% 210.86/211.06 |- mesh__dateEstablished mesh__D023382 2001-01-01
% 210.86/211.06 |- skos__scopeNote mesh__D023382
% 210.86/211.06 Experiments designed to determine the potential toxic effects of one-time, short-term exposure to a chemical or chemicals.%A%
% 210.86/211.06 |- skos__broader mesh__D023382smesh__D018675
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D023382 2001
% 210.86/211.06 |- skos__hiddenLabel mesh__D023382 Toxicity Test, Acute
% 210.86/211.06 |- skos__hiddenLabel mesh__D023382 Acute Toxicity Test
% 210.86/211.06 |- skos__historyNote mesh__D023382
% 210.86/211.06 specific substance/toxicity %28%1966-1994%29%
% 210.86/211.06 |- skos__hiddenLabel mesh__D050779
% 210.86/211.06 NF90 Double Stranded RNA Binding Proteins
% 210.86/211.06 |- mesh__historyNote mesh__D050779 2006%28%1993%29%
% 210.86/211.06 |- rdf__type mesh__D050779sskos__Concept
% 210.86/211.06 |- skos__altLabel mesh__D050779 Interleukin Enhancer Binding Factor 3
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D050779
% 210.86/211.06 2006; NUCLEAR FACTOR 90 PROTEINS were indexed under DNA-BINDING PROTEINS, NUCLEAR PROTEINS, %26% TRANSCRIPTION FACTORS 1993-2005%A%
% 210.86/211.06 |- skos__altLabel mesh__D050779 NF90 Protein
% 210.86/211.06 |- mesh__recordOriginator mesh__D050779 DRC
% 210.86/211.06 |- skos__altLabel mesh__D050779 M Phase Phosphoprotein 4
% 210.86/211.06 |- skos__altLabel mesh__D050779 ILF3 Protein
% 210.86/211.06 |- skos__scopeNote mesh__D050779
% 210.86/211.06 A family of double-stranded RNA-binding proteins that are related to NFATC TRANSCRIPTION FACTORS. In addition to binding to RNA, nuclear factor 90 proteins form heterodimeric complexes that regulate GENETIC TRANSCRIPTION and may play a role in T-CELL activation.%A%
% 210.86/211.06 |- mesh__dateCreated mesh__D050779 2005-06-30
% 210.86/211.06 |- skos__prefLabel mesh__D050779 Nuclear Factor 90 Proteins
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D050779 sjn
% 210.86/211.06 |- skos__broader mesh__D050779smesh__D014157
% 210.86/211.06 |- mesh__dateEstablished mesh__D050779 2006-01-01
% 210.86/211.06 |- skos__broader mesh__D050779smesh__D016601
% 210.86/211.06 |- mesh__recordMaintainer mesh__D050779 DRC
% 210.86/211.06 |- skos__altLabel mesh__D050779 Nuclear Factor 90
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D050779 2006
% 210.86/211.06 |- skos__altLabel mesh__D050779 NF90 Double-Stranded RNA-Binding Proteins
% 210.86/211.06 |- skos__hiddenLabel mesh__D003325 Units, Coronary Care
% 210.86/211.06 |- mesh__publicMeSHNote mesh__D003325 72
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 2003
% 210.86/211.06 |- skos__hiddenLabel mesh__D003325 Care Units, Coronary
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 1997
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 2006
% 210.86/211.06 |- mesh__dateCreated mesh__D003325 1999-01-01
% 210.86/211.06 |- skos__historyNote mesh__D003325 Coronary Disease %28%1966-1969%29%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 1993
% 210.86/211.06 |- skos__prefLabel mesh__D003325 Coronary Care Units
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 2002
% 210.86/211.06 |- mesh__dateEstablished mesh__D003325 1972-01-01
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 1996
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 2005
% 210.86/211.06 |- skos__hiddenLabel mesh__D003325 Unit, Coronary Care
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 1999
% 210.86/211.06 |- skos__historyNote mesh__D003325 Intensive Care Units %28%1966-1969%29%
% 210.86/211.06 |- skos__scopeNote mesh__D003325
% 210.86/211.06 The hospital unit in which patients with acute cardiac disorders receive intensive care.%A%
% 210.86/211.06 |- skos__broader mesh__D003325smesh__D007362
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 1995
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D003325 PLS
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 1998
% 210.86/211.06 |- rdf__type mesh__D003325sskos__Concept
% 210.86/211.06 |- mesh__historyNote mesh__D003325 72%28%70%29%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 2001
% 210.86/211.06 |- skos__hiddenLabel mesh__D003325 Coronary Care Unit
% 210.86/211.06 |- mesh__dateRevised mesh__D003325 1992-05-14
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 1994
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 2004
% 210.86/211.06 |- mesh__recordOriginator mesh__D003325 NLM
% 210.86/211.06 |- mesh__recordMaintainer mesh__D003325 TGC
% 210.86/211.06 |- skos__hiddenLabel mesh__D003325 Care Unit, Coronary
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D003325 2000
% 210.86/211.06 |- skos__scopeNote mesh__D008010
% 210.86/211.06 An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a %22%saw-tooth%22% pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.%A%
% 210.86/211.06 |- mesh__dateCreated mesh__D008010 1999-01-01
% 210.86/211.06 |- skos__altLabel mesh__D008010 Lichen Ruber Planus
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 2006
% 210.86/211.06 |- mesh__dateRevised mesh__D008010 1994-04-11
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 1999
% 210.86/211.06 |- skos__prefLabel mesh__D008010 Lichen Planus
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 2002
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 1995
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 1998
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 2005
% 210.86/211.06 |- mesh__recordAuthorizer mesh__D008010 PLS
% 210.86/211.06 |- mesh__recordMaintainer mesh__D008010 TGC
% 210.86/211.06 |- skos__altLabel mesh__D008010 Lichen Rubra Planus
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 2001
% 210.86/211.06 |- skos__annotation mesh__D008010
% 210.86/211.06 a skin dis; sometimes called simply %22%lichen%22%: check text %26% its bibliog; lichen planus atrophicus: index here %26% do not confuse with LICHEN SCLEROSUS ET ATROPHICUS%A%
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 1997
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 2004
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 2000
% 210.86/211.06 |- mesh__recordOriginator mesh__D008010 NLM
% 210.86/211.06 |- rdf__type mesh__D008010sskos__Concept
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 1996
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D008010 2003
% 210.86/211.06 |- skos__broader mesh__D008010smesh__D017512
% 210.86/211.06 |- mesh__activeMeSHYear mesh__D013753 2006
% 210.86/211.06 |- skos__broader mesh__D013753smesh__D024881
% 210.86/211.06 |- skos__historyNote mesh__D013753 Tetracycline %28%1966-1987%29%
% 210.86/211.07 |- mesh__dateRevised mesh__D013753 2003-07-09
% 210.86/211.07 |- mesh__recordMaintainer mesh__D013753 ssb
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013753 2005
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D013753 sjn
% 210.86/211.07 |- mesh__recordOriginator mesh__D013753 SCD
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D013753 88
% 210.86/211.07 |- rdf__type mesh__D013753sskos__Concept
% 210.86/211.07 |- skos__scopeNote mesh__D013753
% 210.86/211.07 Nonsusceptibility of bacteria to the action of TETRACYCLINE which inhibits aminoacyl-tRNA binding to the 30S ribosomal subunit during protein synthesis.%A%
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013753 2004
% 210.86/211.07 |- skos__historyNote mesh__D013753
% 210.86/211.07 Drug Resistance, Microbial %28%1966-1987%29%
% 210.86/211.07 |- mesh__dateEstablished mesh__D013753 1988-01-01
% 210.86/211.07 |- mesh__dateCreated mesh__D013753 1987-05-08
% 210.86/211.07 |- mesh__historyNote mesh__D013753 88
% 210.86/211.07 |- skos__prefLabel mesh__D013753 Tetracycline Resistance
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D007716 91; see ENDOMYCETALES 1986-90
% 210.86/211.07 |- skos__prefLabel mesh__D007716 Kluyveromyces
% 210.86/211.07 |- mesh__dateRevised mesh__D007716 2005-06-30
% 210.86/211.07 |- skos__historyNote mesh__D007716 Ascomycetes %28%1966-1985%29%
% 210.86/211.07 |- rdf__type mesh__D007716sskos__Concept
% 210.86/211.07 |- mesh__dateEstablished mesh__D007716 1991-01-01
% 210.86/211.07 |- skos__broader mesh__D007716smesh__D004718
% 210.86/211.07 |- mesh__recordOriginator mesh__D007716 RC
% 210.86/211.07 |- skos__broader mesh__D007716smesh__D015003
% 210.86/211.07 |- skos__scopeNote mesh__D007716
% 210.86/211.07 An ascomycetous yeast of the fungal family Saccharomycetaceae, order SACCHAROMYCETALES.%A%
% 210.86/211.07 |- mesh__historyNote mesh__D007716 91%28%86%29%
% 210.86/211.07 |- mesh__dateCreated mesh__D007716 1985-02-07
% 210.86/211.07 |- mesh__recordMaintainer mesh__D007716 SYSTEM
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007716 2006
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D007716 sjn
% 210.86/211.07 |- skos__historyNote mesh__D007716 Endomycetales %28%1975-1985%29%
% 210.86/211.07 |- skos__scopeNote mesh__D017346
% 210.86/211.07 A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors.%A%
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Kinase, Serine
% 210.86/211.07 |- mesh__dateRevised mesh__D017346 2003-07-09
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D017346 2006
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Kinase, Threonine
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Serine Threonine Kinases
% 210.86/211.07 |- mesh__dateCreated mesh__D017346 1992-05-22
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Kinases, Serine-Threonine Protein
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Kinase, Serine-Threonine
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Protein Threonine Kinase
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Protein Kinases, Serine-Threonine
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D017346
% 210.86/211.07 93; SERINE KINASE was indexed under PROTEIN KINASES 1985-92; PROTEIN-THREONINE KINASE was indexed under PROTEIN KINASES 1983-92%A%
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Protein Serine Threonine Kinases
% 210.86/211.07 |- mesh__recordMaintainer mesh__D017346 ssb
% 210.86/211.07 |- skos__altLabel mesh__D017346 Protein-Serine-Threonine Kinase
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Protein Serine Threonine Kinase
% 210.86/211.07 |- mesh__dateEstablished mesh__D017346 1993-01-01
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D017346 sjn
% 210.86/211.07 |- mesh__onlineNote mesh__D017346
% 210.86/211.07 use PROTEIN-SERINE-THREONINE KINASES %28%NM%29% to search SERINE KINASE 1985-92 %26% PROTEIN-THREONINE KINASE 1983-92%A%
% 210.86/211.07 |- skos__altLabel mesh__D017346 Protein-Serine Kinase
% 210.86/211.07 |- skos__prefLabel mesh__D017346 Protein-Serine-Threonine Kinases
% 210.86/211.07 |- skos__altLabel mesh__D017346 Serine-Threonine Kinases
% 210.86/211.07 |- skos__altLabel mesh__D017346 Serine Kinase
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Kinase, Protein-Serine-Threonine
% 210.86/211.07 |- skos__historyNote mesh__D017346 Protein Kinases %28%1983-1992%29%
% 210.86/211.07 |- mesh__recordOriginator mesh__D017346 TPW
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Protein Serine Kinase
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Kinase, Protein-Threonine
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Kinases, Protein-Serine-Threonine
% 210.86/211.07 |- skos__altLabel mesh__D017346 Serine-Threonine Protein Kinases
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Serine Threonine Kinase
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Kinase, Protein-Serine
% 210.86/211.07 |- skos__broader mesh__D017346smesh__D011494
% 210.86/211.07 |- skos__altLabel mesh__D017346 Protein-Threonine Kinase
% 210.86/211.07 |- skos__altLabel mesh__D017346 Serine-Threonine Kinase
% 210.86/211.07 |- rdf__type mesh__D017346sskos__Concept
% 210.86/211.07 |- mesh__historyNote mesh__D017346
% 210.86/211.07 93; was SERINE KINASE %28%NM%29% 1985-92 %26% PROTEIN-THREONINE KINASE %28%NM%29% 1983-92%A%
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D017346 2004
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Kinases, Serine-Threonine
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D017346 2005
% 210.86/211.07 |- skos__hiddenLabel mesh__D017346 Serine Threonine Protein Kinases
% 210.86/211.07 |- skos__altLabel mesh__D017346 Threonine Kinase
% 210.86/211.07 |- mesh__dateCreated mesh__D003326 1999-01-01
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D003326 72
% 210.86/211.07 |- skos__historyNote mesh__D003326 Coronary Vessels %28%1966-1971%29%
% 210.86/211.07 |- skos__prefLabel mesh__D003326 Coronary Circulation
% 210.86/211.07 |- mesh__historyNote mesh__D003326 72
% 210.86/211.07 |- mesh__dateEstablished mesh__D003326 1972-01-01
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D003326 2006
% 210.86/211.07 |- skos__annotation mesh__D003326 DF: CORONARY CIRC
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D003326 2005
% 210.86/211.07 |- mesh__recordMaintainer mesh__D003326 nns
% 210.86/211.07 |- rdf__type mesh__D003326sskos__Concept
% 210.86/211.07 |- skos__altLabel mesh__D003326 Circulation, Coronary
% 210.86/211.07 |- mesh__dateRevised mesh__D003326 2003-07-09
% 210.86/211.07 |- mesh__recordOriginator mesh__D003326 NLM
% 210.86/211.07 |- skos__scopeNote mesh__D003326
% 210.86/211.07 The circulation of blood through the CORONARY VESSELS of the HEART.%A%
% 210.86/211.07 |- skos__broader mesh__D003326smesh__D001775
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D003326 sjn
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D003326 2004
% 210.86/211.07 |- skos__scopeNote mesh__D008011
% 210.86/211.07 Any of a group of plants formed by a mutual combination of an alga and a fungus.%A%
% 210.86/211.07 |- skos__prefLabel mesh__D008011 Lichens
% 210.86/211.07 |- mesh__recordOriginator mesh__D008011 NLM
% 210.86/211.07 |- skos__hiddenLabel mesh__D008011 Lichen
% 210.86/211.07 |- mesh__recordMaintainer mesh__D008011 SYSTEM
% 210.86/211.07 |- skos__broader mesh__D008011smesh__D005658
% 210.86/211.07 |- skos__broader mesh__D008011smesh__D000456
% 210.86/211.07 |- rdf__type mesh__D008011sskos__Concept
% 210.86/211.07 |- skos__annotation mesh__D008011 plant, not skin disease
% 210.86/211.07 |- mesh__dateRevised mesh__D008011 2005-06-30
% 210.86/211.07 |- mesh__dateCreated mesh__D008011 1999-01-01
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D008011 sjn
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D008011 2006
% 210.86/211.07 |- skos__hiddenLabel mesh__D049428 Barrier, Blood-Nerve
% 210.86/211.07 |- skos__historyNote mesh__D049428 Endothelium, Vascular %28%1970-2004%29%
% 210.86/211.07 |- mesh__historyNote mesh__D049428 2005
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D049428 2005
% 210.86/211.07 |- mesh__recordMaintainer mesh__D049428 ags
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D049428 2005
% 210.86/211.07 |- skos__hiddenLabel mesh__D049428 Barriers, Blood-Nerve
% 210.86/211.07 |- mesh__dateCreated mesh__D049428 2004-07-07
% 210.86/211.07 |- skos__hiddenLabel mesh__D049428 Blood-Nerve Barriers
% 210.86/211.07 |- mesh__recordOriginator mesh__D049428 ags
% 210.86/211.07 |- skos__related mesh__D049428smesh__D002199
% 210.86/211.07 |- skos__broader mesh__D049428smesh__D002319
% 210.86/211.07 |- skos__prefLabel mesh__D049428 Blood-Nerve Barrier
% 210.86/211.07 |- skos__hiddenLabel mesh__D049428 Blood Nerve Barrier
% 210.86/211.07 |- rdf__type mesh__D049428sskos__Concept
% 210.86/211.07 |- skos__broader mesh__D049428smesh__D010525
% 210.86/211.07 |- mesh__dateEstablished mesh__D049428 2005-01-01
% 210.86/211.07 |- skos__scopeNote mesh__D049428
% 210.86/211.07 The barrier between the perineurium of PERIPHERAL NERVES and the endothelium %28%ENDOTHELIUM, VASCULAR%29% of endoneurial CAPILLARIES. The perineurium acts as a diffusion barrier, but ion permeability at the blood-nerve barrier is still higher than at the BLOOD-BRAIN BARRIER.%A%
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D049428 2006
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D049428 sjn
% 210.86/211.07 |- mesh__recordMaintainer mesh__D013754 ssb
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D013754 sjn
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013754 2006
% 210.86/211.07 |- mesh__dateCreated mesh__D013754 1975-07-23
% 210.86/211.07 |- skos__prefLabel mesh__D013754 Tetracyclines
% 210.86/211.07 |- rdf__type mesh__D013754sskos__Concept
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013754 2005
% 210.86/211.07 |- mesh__historyNote mesh__D013754 76; was NON MESH before 1976
% 210.86/211.07 |- mesh__dateRevised mesh__D013754 2004-07-07
% 210.86/211.07 |- mesh__dateEstablished mesh__D013754 1976-01-01
% 210.86/211.07 |- mesh__recordOriginator mesh__D013754 SH
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D013754 76
% 210.86/211.07 |- skos__broader mesh__D013754smesh__D009279
% 210.86/211.07 |- skos__scopeNote mesh__D013754
% 210.86/211.07 Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. %28%Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1117%29%%A%
% 210.86/211.07 |- skos__annotation mesh__D013754 TETRACYCLINE is also available
% 210.86/211.07 |- skos__prefLabel mesh__D007717 Knee
% 210.86/211.07 |- mesh__recordMaintainer mesh__D007717 TPW
% 210.86/211.07 |- skos__annotation mesh__D007717
% 210.86/211.07 primates only; /inj = KNEE INJURIES but PATELLA /inj is also available; TN 238: differentiation from KNEE JOINT %26% indexing instructions%A%
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D007717 sjn
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007717 2003
% 210.86/211.07 |- mesh__dateRevised mesh__D007717 2002-07-03
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007717 2005
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007717 2004
% 210.86/211.07 |- mesh__recordOriginator mesh__D007717 NLM
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007717 2006
% 210.86/211.07 |- skos__broader mesh__D007717smesh__D035002
% 210.86/211.07 |- skos__hiddenLabel mesh__D007717 Knees
% 210.86/211.07 |- mesh__dateCreated mesh__D007717 1999-01-01
% 210.86/211.07 |- rdf__type mesh__D007717sskos__Concept
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D017347 93
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D017347 2006
% 210.86/211.07 |- skos__broader mesh__D017347smesh__D002002
% 210.86/211.07 |- mesh__dateRevised mesh__D017347 2005-06-30
% 210.86/211.07 |- mesh__dateCreated mesh__D017347 1992-05-07
% 210.86/211.07 |- skos__scopeNote mesh__D017347
% 210.86/211.07 A species of the genus BRUCELLA whose natural hosts are sheep and goats. Other mammals, including humans, may be infected. In general, these organisms tend to be more virulent for laboratory animals than BRUCELLA ABORTUS and may cause fatal infections.%A%
% 210.86/211.07 |- mesh__historyNote mesh__D017347 93
% 210.86/211.07 |- rdf__type mesh__D017347sskos__Concept
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D017347 sjn
% 210.86/211.07 |- mesh__recordOriginator mesh__D017347 PXP
% 210.86/211.07 |- mesh__dateEstablished mesh__D017347 1993-01-01
% 210.86/211.07 |- skos__prefLabel mesh__D017347 Brucella melitensis
% 210.86/211.07 |- skos__historyNote mesh__D017347 Brucella %28%1966-1992%29%
% 210.86/211.07 |- skos__annotation mesh__D017347
% 210.86/211.07 note specific biovars are X refs to other species; infection: coord IM with BRUCELLOSIS %28%IM%29%%A%
% 210.86/211.07 |- mesh__recordMaintainer mesh__D017347 SYSTEM
% 210.86/211.07 |- skos__annotation mesh__D036501
% 210.86/211.07 do not confuse X ref SPACER INHALERS with INHALATION SPACERS%A%
% 210.86/211.07 |- skos__hiddenLabel mesh__D036501 Inhaler, Metered Dose
% 210.86/211.07 |- skos__historyNote mesh__D036501
% 210.86/211.07 Nebulizers and Vaporizers %28%1986-2002%29%
% 210.86/211.07 |- skos__altLabel mesh__D036501 Spacer-Inhalers
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D036501 2006
% 210.86/211.07 |- skos__hiddenLabel mesh__D036501 Spacer Inhaler
% 210.86/211.07 |- skos__altLabel mesh__D036501 Spinhaler
% 210.86/211.07 |- mesh__dateEstablished mesh__D036501 2003-01-01
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D036501 2005
% 210.86/211.07 |- skos__broader mesh__D036501smesh__D009330
% 210.86/211.07 |- skos__altLabel mesh__D036501 Inhalers, Metered Dose
% 210.86/211.07 |- skos__historyNote mesh__D036501 Aerosols %28%1976-2002%29%
% 210.86/211.07 |- skos__scopeNote mesh__D036501
% 210.86/211.07 A medical device used to ensure the proper amount of medication is delivered for inhalation. Usually, it is a small aerosol canister placed in a plastic holder. When the canister is pressed, a calibrated amount of drug is released.%A%
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D036501 2003
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D036501 2004
% 210.86/211.07 |- rdf__type mesh__D036501sskos__Concept
% 210.86/211.07 |- skos__hiddenLabel mesh__D036501 Spacer-Inhaler
% 210.86/211.07 |- skos__historyNote mesh__D036501 Respiratory Therapy %28%1980-2002%29%
% 210.86/211.07 |- skos__altLabel mesh__D036501 MDI %28%Inhalers%29%
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D036501 2003
% 210.86/211.07 |- mesh__historyNote mesh__D036501 2003
% 210.86/211.07 |- mesh__dateCreated mesh__D036501 2002-07-03
% 210.86/211.07 |- skos__prefLabel mesh__D036501 Metered Dose Inhalers
% 210.86/211.07 |- skos__hiddenLabel mesh__D036501 Spinhalers
% 210.86/211.07 |- skos__hiddenLabel mesh__D036501 Metered Dose Inhaler
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D003327 sjn
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Diseases, Coronary Heart
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Heart Disease, Coronary
% 210.86/211.07 |- mesh__dateRevised mesh__D003327 2001-07-25
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Coronary Heart Diseases
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D003327 2006
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Disease, Coronary Heart
% 210.86/211.07 |- skos__annotation mesh__D003327
% 210.86/211.07 GEN or unspecified; prefer specific; /surg: coord with specific surgical procedure if pertinent%A%
% 210.86/211.07 |- skos__broader mesh__D003327smesh__D017202
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D003327 2005
% 210.86/211.07 |- skos__prefLabel mesh__D003327 Coronary Disease
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Diseases, Coronary
% 210.86/211.07 |- rdf__type mesh__D003327sskos__Concept
% 210.86/211.07 |- skos__scopeNote mesh__D003327
% 210.86/211.07 An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA %28%insufficient blood supply to the heart muscle%29% caused by a decreased capacity of the coronary vessels.%A%
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Coronary Diseases
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Occlusions, Coronary
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D003327 2002
% 210.86/211.07 |- skos__related mesh__D003327smesh__D009204
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D003327 2004
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Coronary Occlusions
% 210.86/211.07 |- mesh__recordMaintainer mesh__D003327 nns
% 210.86/211.07 |- mesh__dateCreated mesh__D003327 1999-01-01
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D003327 2003
% 210.86/211.07 |- mesh__recordOriginator mesh__D003327 NLM
% 210.86/211.07 |- skos__related mesh__D003327smesh__D015906
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Heart Diseases, Coronary
% 210.86/211.07 |- skos__related mesh__D003327smesh__D001026
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Disease, Coronary
% 210.86/211.07 |- skos__hiddenLabel mesh__D003327 Occlusion, Coronary
% 210.86/211.07 |- skos__altLabel mesh__D003327 Coronary Heart Disease
% 210.86/211.07 |- skos__annotation mesh__D008810
% 210.86/211.07 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.86/211.07 |- skos__altLabel mesh__D008810 Mouse, Inbred C57BL
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D008810 2006
% 210.86/211.07 |- mesh__dateRevised mesh__D008810 2005-06-30
% 210.86/211.07 |- mesh__historyNote mesh__D008810 74%28%72%29%
% 210.86/211.07 |- skos__prefLabel mesh__D008810 Mice, Inbred C57BL
% 210.86/211.07 |- skos__hiddenLabel mesh__D008810 C57BL Mouse, Inbred
% 210.86/211.07 |- skos__altLabel mesh__D008810 Mice, C57BL
% 210.86/211.07 |- skos__hiddenLabel mesh__D008810 C57BL Mouse
% 210.86/211.07 |- mesh__recordOriginator mesh__D008810 NLM
% 210.86/211.07 |- mesh__recordMaintainer mesh__D008810 ags
% 210.86/211.07 |- mesh__dateCreated mesh__D008810 1999-01-01
% 210.86/211.07 |- rdf__type mesh__D008810sskos__Concept
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D008810 sjn
% 210.86/211.07 |- skos__historyNote mesh__D008810 Mice %28%1966-1971%29%
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D008810 74
% 210.86/211.07 |- skos__hiddenLabel mesh__D008810 Inbred C57BL Mouse
% 210.86/211.07 |- skos__related mesh__D008810smesh__D018827
% 210.86/211.07 |- skos__hiddenLabel mesh__D008810 Inbred C57BL Mice
% 210.86/211.07 |- skos__altLabel mesh__D008810 Mouse, C57BL
% 210.86/211.07 |- skos__hiddenLabel mesh__D008810 C57BL Mice
% 210.86/211.07 |- skos__broader mesh__D008810smesh__D008815
% 210.86/211.07 |- mesh__dateEstablished mesh__D008810 1974-01-01
% 210.86/211.07 |- skos__hiddenLabel mesh__D008810 C57BL Mice, Inbred
% 210.86/211.07 |- mesh__recordMaintainer mesh__D008012 ssb
% 210.86/211.07 |- skos__hiddenLabel mesh__D008012 Carbonate, Lidocaine
% 210.86/211.07 |- mesh__dateRevised mesh__D008012 2005-06-30
% 210.86/211.07 |- skos__altLabel mesh__D008012 2-2EtN-2MePhAcN
% 210.86/211.07 |- rdf__type mesh__D008012sskos__Concept
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D008012 sjn
% 210.86/211.07 |- skos__prefLabel mesh__D008012 Lidocaine
% 210.86/211.07 |- skos__hiddenLabel mesh__D008012 Hydrochloride, Lidocaine
% 210.86/211.07 |- skos__altLabel mesh__D008012 Lidocaine Carbonate
% 210.86/211.07 |- skos__hiddenLabel mesh__D008012 Monohydrochloride, Lidocaine
% 210.86/211.07 |- mesh__dateCreated mesh__D008012 1999-01-01
% 210.86/211.07 |- skos__hiddenLabel mesh__D008012 Monohydrate Lidocaine Monohydrochloride
% 210.86/211.07 |- skos__altLabel mesh__D008012
% 210.86/211.07 2-%28%Diethylamino%29%-N-%28%2,6-Dimethylphenyl%29%Acetamide
% 210.86/211.07 |- skos__scopeNote mesh__D008012
% 210.86/211.07 A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine.%A%
% 210.86/211.07 |- mesh__recordOriginator mesh__D008012 NLM
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D008012 2006
% 210.86/211.07 |- skos__broader mesh__D008012smesh__D000083
% 210.86/211.07 |- skos__hiddenLabel mesh__D008012 Hydrocarbonate, Lidocaine
% 210.86/211.07 |- skos__hiddenLabel mesh__D008012 2 2EtN 2MePhAcN
% 210.86/211.07 |- skos__altLabel mesh__D008012 Lignocaine
% 210.86/211.07 |- skos__altLabel mesh__D008012 Lidocaine Monohydrochloride
% 210.86/211.07 |- skos__hiddenLabel mesh__D008012 Monoacetate, Lidocaine
% 210.86/211.07 |- skos__prefLabel mesh__D049429 Forensic Pathology
% 210.86/211.07 |- skos__annotation mesh__D049429
% 210.86/211.07 specialty; may also be used for forensic aspects in pathology%A%
% 210.86/211.07 |- mesh__dateEstablished mesh__D049429 2005-01-01
% 210.86/211.07 |- skos__historyNote mesh__D049429 Forensic Medicine %28%1966-2004%29%
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D049429 sjn
% 210.86/211.07 |- rdf__type mesh__D049429sskos__Concept
% 210.86/211.07 |- skos__broader mesh__D049429smesh__D010336
% 210.86/211.07 |- mesh__historyNote mesh__D049429 2005
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D049429 2006
% 210.86/211.07 |- skos__broader mesh__D049429smesh__D005554
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D049429 2005
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D049429 2005
% 210.86/211.07 |- mesh__dateCreated mesh__D049429 2004-07-07
% 210.86/211.07 |- skos__scopeNote mesh__D049429
% 210.86/211.07 The application of pathology to questions of law.
% 210.86/211.07 |- mesh__recordMaintainer mesh__D049429 ags
% 210.86/211.07 |- mesh__recordOriginator mesh__D049429 ags
% 210.86/211.07 |- skos__altLabel mesh__D049429 Pathology, Forensic
% 210.86/211.07 |- skos__historyNote mesh__D013755 Fatty Acids %28%1966-1974%29%
% 210.86/211.07 |- skos__prefLabel mesh__D013755 Tetradecanoylphorbol Acetate
% 210.86/211.07 |- skos__historyNote mesh__D013755 Diterpenes %28%1974%29%
% 210.86/211.07 |- mesh__dateRevised mesh__D013755 2000-06-21
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013755 2004
% 210.86/211.07 |- skos__hiddenLabel mesh__D013755 Acetate, Tetradecanoylphorbol
% 210.86/211.07 |- skos__historyNote mesh__D013755 Croton Oil %28%1966-1974%29%
% 210.86/211.07 |- mesh__recordOriginator mesh__D013755 NLM
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013755 2003
% 210.86/211.07 |- skos__hiddenLabel mesh__D013755
% 210.86/211.07 Tetradecanoylphorbol Acetate, 4a alpha Isomer
% 210.86/211.07 |- skos__hiddenLabel mesh__D013755 12 O Tetradecanoyl Phorbol 13 Acetate
% 210.86/211.07 |- skos__altLabel mesh__D013755 Phorbol Myristate Acetate
% 210.86/211.07 |- skos__hiddenLabel mesh__D013755 Myristate Acetate, Phorbol
% 210.86/211.07 |- mesh__dateEstablished mesh__D013755 1987-01-01
% 210.86/211.07 |- mesh__recordMaintainer mesh__D013755 jmp
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D013755 sjn
% 210.86/211.07 |- skos__hiddenLabel mesh__D013755 Acetate, Phorbol Myristate
% 210.86/211.07 |- skos__scopeNote mesh__D013755
% 210.86/211.07 A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA.%A%
% 210.86/211.07 |- skos__historyNote mesh__D013755 Alcohols %28%1966-1974%29%
% 210.86/211.07 |- mesh__historyNote mesh__D013755
% 210.86/211.07 87%28%75%29%; was see under PHORBOLS 1975-86
% 210.86/211.07 |- skos__annotation mesh__D013755 D25-26 qualif
% 210.86/211.07 |- skos__hiddenLabel mesh__D013755 Phorbol 13-Acetate, 12-O-Tetradecanoyl
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013755 2002
% 210.86/211.07 |- skos__altLabel mesh__D013755 12-Myristoyl-13-acetylphorbol
% 210.86/211.07 |- skos__hiddenLabel mesh__D013755 12 Myristoyl 13 acetylphorbol
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D013755 87; was see under PHORBOLS 1975-86
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013755 2006
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013755 2001
% 210.86/211.07 |- skos__altLabel mesh__D013755 12-O-Tetradecanoyl Phorbol 13-Acetate
% 210.86/211.07 |- skos__broader mesh__D013755smesh__D010703
% 210.86/211.07 |- mesh__dateCreated mesh__D013755 1974-11-14
% 210.86/211.07 |- skos__historyNote mesh__D013755 Terpenes %28%1966-1973%29%
% 210.86/211.07 |- skos__hiddenLabel mesh__D013755 13-Acetate, 12-O-Tetradecanoyl Phorbol
% 210.86/211.07 |- rdf__type mesh__D013755sskos__Concept
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D013755 2005
% 210.86/211.07 |- mesh__recordOriginator mesh__D007718 NLM
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 2005
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 1994
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 1997
% 210.86/211.07 |- skos__scopeNote mesh__D007718
% 210.86/211.07 Injuries to the knee or the knee joint.
% 210.86/211.07 |- rdf__type mesh__D007718sskos__Concept
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 2001
% 210.86/211.07 |- mesh__dateRevised mesh__D007718 1990-11-10
% 210.86/211.07 |- mesh__dateCreated mesh__D007718 1999-01-01
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 1996
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 2000
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 2004
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 1993
% 210.86/211.07 |- skos__hiddenLabel mesh__D007718 Knee Injury
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 1999
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 2003
% 210.86/211.07 |- skos__annotation mesh__D007718 consider also PATELLA /inj
% 210.86/211.07 |- skos__broader mesh__D007718smesh__D007869
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 1992
% 210.86/211.07 |- mesh__recordMaintainer mesh__D007718 PXP
% 210.86/211.07 |- skos__hiddenLabel mesh__D007718 Injury, Knee
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 1998
% 210.86/211.07 |- skos__altLabel mesh__D007718 Injuries, Knee
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D007718 PLS
% 210.86/211.07 |- skos__prefLabel mesh__D007718 Knee Injuries
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 2002
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 2006
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D007718 1995
% 210.86/211.07 |- mesh__recordMaintainer mesh__D018440 ags
% 210.86/211.07 |- mesh__dateRevised mesh__D018440 2005-07-07
% 210.86/211.07 |- mesh__recordOriginator mesh__D018440 AGS
% 210.86/211.07 |- skos__hiddenLabel mesh__D018440 beta Lactam Resistance
% 210.86/211.07 |- mesh__dateCreated mesh__D018440 1994-01-25
% 210.86/211.07 |- skos__annotation mesh__D018440 GEN or unspecified; prefer specifics
% 210.86/211.07 |- skos__prefLabel mesh__D018440 beta-Lactam Resistance
% 210.86/211.07 |- mesh__publicMeSHNote mesh__D018440 1995
% 210.86/211.07 |- skos__broader mesh__D018440smesh__D024881
% 210.86/211.07 |- skos__historyNote mesh__D018440
% 210.86/211.07 Drug Resistance, Microbial %28%1974-1994%29%
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D018440 ags
% 210.86/211.07 |- mesh__dateEstablished mesh__D018440 1995-01-01
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D018440 2006A
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D018440 2006
% 210.86/211.07 |- rdf__type mesh__D018440sskos__Concept
% 210.86/211.07 |- mesh__historyNote mesh__D018440 1995
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D018440 2005
% 210.86/211.07 |- skos__hiddenLabel mesh__D018440 beta-Lactam Resistances
% 210.86/211.07 |- skos__scopeNote mesh__D018440
% 210.86/211.07 Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.%A%
% 210.86/211.07 |- skos__historyNote mesh__D018440 Lactams/pharmacology %28%1974-1994%29%
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D018440 2004
% 210.86/211.07 |- skos__scopeNote mesh__D004420
% 210.86/211.07 Slow or difficult OBSTETRIC LABOR or CHILDBIRTH.
% 210.86/211.07 |- mesh__dateCreated mesh__D004420 1999-01-01
% 210.86/211.07 |- mesh__recordMaintainer mesh__D004420 lkt
% 210.86/211.07 |- rdf__type mesh__D004420sskos__Concept
% 210.86/211.07 |- skos__broader mesh__D004420smesh__D007744
% 210.86/211.07 |- mesh__recordAuthorizer mesh__D004420 sjn
% 210.86/211.07 |- mesh__recordOriginator mesh__D004420 NLM
% 210.86/211.07 |- mesh__dateRevised mesh__D004420 2005-06-30
% 210.86/211.07 |- skos__hiddenLabel mesh__D004420 Dystocias
% 210.86/211.07 |- mesh__activeMeSHYear mesh__D004420 2006
% 210.86/211.07 |- skos__prefLabel mesh__D004420 Dystocia
% 210.86/211.07 |- skos__altLabel mesh__D051076 Proto-Oncogene Protein c-syn
% 210.86/211.07 |- skos__altLabel mesh__D051076 p72%28%fyn%29% Protein
% 210.86/211.07 |- skos__broader mesh__D051076smesh__D019061
% 210.86/211.07 |- skos__hiddenLabel mesh__D051076 p59 c fyn Protein
% 210.86/211.07 |- skos__broader mesh__D051076smesh__D047908
% 210.86/211.07 |- skos__altLabel mesh__D051076 fyn Proto-Oncogene Proteins
% 210.86/211.07 |- skos__altLabel mesh__D051076 Fyn Tyrosine Kinase
% 210.86/211.07 |- skos__scopeNote mesh__D051076
% 210.86/211.07 Src-family kinases that associate with T-CELL ANTIGEN RECEPTOR and phosphorylate a wide variety of intracellular signaling molecules.%A%
% 210.86/211.07 |- skos__altLabel mesh__D051076 c-fyn Protein
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 c fyn Proto Oncogene Proteins
% 210.86/211.08 |- skos__altLabel mesh__D051076 p72 c-fyn Protein
% 210.86/211.08 |- mesh__historyNote mesh__D051076 2006%28%1989%29%
% 210.86/211.08 |- skos__prefLabel mesh__D051076 Proto-Oncogene Proteins c-fyn
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 p60 c fyn Protein
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 Proto Oncogene Protein c syn
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 c-fyn, Proto-Oncogene Protein
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 c-fyn Protein, p60
% 210.86/211.08 |- mesh__recordMaintainer mesh__D051076 DRC
% 210.86/211.08 |- skos__altLabel mesh__D051076 p59 c-fyn Protein
% 210.86/211.08 |- rdf__type mesh__D051076sskos__Concept
% 210.86/211.08 |- mesh__dateEstablished mesh__D051076 2006-01-01
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 c-fyn Protein, p59
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 p72 c fyn Protein
% 210.86/211.08 |- skos__altLabel mesh__D051076 Protein-Tyrosine Kinase p59%28%fyn%29%
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 Proto-Oncogene Proteins, fyn
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 Proteins c-fyn, Proto-Oncogene
% 210.86/211.08 |- mesh__recordOriginator mesh__D051076 DRC
% 210.86/211.08 |- skos__broader mesh__D051076smesh__D011518
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 Proto Oncogene Protein c fyn
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D051076 sjn
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 c-fyn, Proto-Oncogene Proteins
% 210.86/211.08 |- skos__altLabel mesh__D051076 c-fyn Proto-Oncogene Proteins
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 fyn Proto Oncogene Proteins
% 210.86/211.08 |- skos__altLabel mesh__D051076 p59%28%fyn%29% Protein
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D051076 2006
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 c-syn, Proto-Oncogene Protein
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D051076
% 210.86/211.08 2006; PROTO-ONCOGENE PROTEIN C-FYN was indexed under SRC-FAMILY KINASES %26% PROTO-ONCOGENE PROTEINS 1989-2005%A%
% 210.86/211.08 |- skos__altLabel mesh__D051076 Proto-Oncogene Protein c-fyn
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 Proto Oncogene Proteins c fyn
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 Proto-Oncogene Proteins, c-fyn
% 210.86/211.08 |- skos__altLabel mesh__D051076 p60%28%fyn%29% Protein
% 210.86/211.08 |- mesh__dateCreated mesh__D051076 2005-06-30
% 210.86/211.08 |- skos__hiddenLabel mesh__D051076 Tyrosine Kinase, Fyn
% 210.86/211.08 |- skos__altLabel mesh__D051076 p60 c-fyn Protein
% 210.86/211.08 |- skos__scopeNote mesh__D017348
% 210.86/211.08 A type of TRANSMISSION ELECTRON MICROSCOPY in which the object is examined directly by an extremely narrow electron beam scanning the specimen point-by-point and using the reactions of the electrons that are transmitted through the specimen to create the image. It should not be confused with SCANNING ELECTRON MICROSCOPY.%A%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D017348 2006
% 210.86/211.08 |- skos__broader mesh__D017348smesh__D046529
% 210.86/211.08 |- mesh__dateEstablished mesh__D017348 1993-01-01
% 210.86/211.08 |- skos__altLabel mesh__D017348 STEM
% 210.86/211.08 |- mesh__historyNote mesh__D017348 93
% 210.86/211.08 |- mesh__recordOriginator mesh__D017348 TGC
% 210.86/211.08 |- skos__prefLabel mesh__D017348
% 210.86/211.08 Microscopy, Electron, Scanning Transmission
% 210.86/211.08 |- mesh__recordMaintainer mesh__D017348 ags
% 210.86/211.08 |- skos__altLabel mesh__D017348 Scanning Transmission Electron Microscopy
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D017348 93
% 210.86/211.08 |- rdf__type mesh__D017348sskos__Concept
% 210.86/211.08 |- skos__altLabel mesh__D017348 Electron Microscopy, Scanning Transmission
% 210.86/211.08 |- mesh__dateRevised mesh__D017348 2005-06-30
% 210.86/211.08 |- skos__historyNote mesh__D017348
% 210.86/211.08 Microscopy, Electron, Scanning %28%1969-1992%29%
% 210.86/211.08 |- mesh__dateCreated mesh__D017348 1992-05-18
% 210.86/211.08 |- skos__annotation mesh__D017348
% 210.86/211.08 do not confuse with MICROSCOPY, ELECTRON, SCANNING nor with MICROSCOPY, ELECTRON, TRANSMISSION; since the techniques have different applications, do not interpret: if in doubt, use words of author%A%
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D017348 sjn
% 210.86/211.08 |- skos__hiddenLabel mesh__D036502 Infusion, Intralesional
% 210.86/211.08 |- skos__hiddenLabel mesh__D036502 Intralesional Infusions
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D036502 2006
% 210.86/211.08 |- skos__prefLabel mesh__D036502 Infusions, Intralesional
% 210.86/211.08 |- skos__annotation mesh__D036502
% 210.86/211.08 do not confuse with INJECTIONS, INTRALESIONAL
% 210.86/211.08 |- mesh__dateEstablished mesh__D036502 2003-01-01
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D036502 2005
% 210.86/211.08 |- rdf__type mesh__D036502sskos__Concept
% 210.86/211.08 |- skos__hiddenLabel mesh__D036502 Intralesional Infusion
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D036502 2004
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D036502 2003
% 210.86/211.08 |- skos__scopeNote mesh__D036502
% 210.86/211.08 The administration of medication or fluid directly into localized lesions, by means of gravity flow or INFUSION PUMPS.%A%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D036502 2003
% 210.86/211.08 |- mesh__dateCreated mesh__D036502 2002-07-03
% 210.86/211.08 |- mesh__historyNote mesh__D036502 2003
% 210.86/211.08 |- skos__broader mesh__D036502smesh__D007263
% 210.86/211.08 |- mesh__onlineNote mesh__D003328
% 210.86/211.08 use CORONARY THROMBOSIS to search THROMBOSIS, CORONARY 1987-91; use CORONARY DISEASE 1974-86%A%
% 210.86/211.08 |- skos__altLabel mesh__D003328 Thrombosis, Coronary
% 210.86/211.08 |- skos__prefLabel mesh__D003328 Coronary Thrombosis
% 210.86/211.08 |- skos__broader mesh__D003328smesh__D003327
% 210.86/211.08 |- skos__historyNote mesh__D003328 Coronary Disease %28%1966-1986%29%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003328 2001
% 210.86/211.08 |- mesh__dateEstablished mesh__D003328 1991-01-01
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003328 2004
% 210.86/211.08 |- mesh__historyNote mesh__D003328
% 210.86/211.08 91%28%87%29%; was see under CORONARY DISEASE 1987-90; was THROMBOSIS, CORONARY see CORONARY DISEASE 1974-86%A%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003328 2000
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003328 2003
% 210.86/211.08 |- mesh__recordMaintainer mesh__D003328 MSR
% 210.86/211.08 |- skos__hiddenLabel mesh__D003328 Coronary Thromboses
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D003328 SJN
% 210.86/211.08 |- skos__broader mesh__D003328smesh__D013927
% 210.86/211.08 |- skos__annotation mesh__D003328
% 210.86/211.08 do not confuse %22%mural thrombus%22% with %22%coronary thrombosis%22%: index under HEART DISEASES + THROMBOSIS%A%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003328 2006
% 210.86/211.08 |- skos__hiddenLabel mesh__D003328 Thromboses, Coronary
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003328 1999
% 210.86/211.08 |- skos__scopeNote mesh__D003328
% 210.86/211.08 Presence of a thrombus in a coronary artery, often causing a myocardial infarction.%A%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003328 2002
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003328 2005
% 210.86/211.08 |- mesh__dateRevised mesh__D003328 1998-06-10
% 210.86/211.08 |- mesh__dateCreated mesh__D003328 1986-03-27
% 210.86/211.08 |- mesh__recordOriginator mesh__D003328 VDK
% 210.86/211.08 |- rdf__type mesh__D003328sskos__Concept
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D003328
% 210.86/211.08 91; was see under CORONARY DISEASE 1987-90; was THROMBOSIS, CORONARY see CORONARY DISEASE 1974-86%A%
% 210.86/211.08 |- skos__broader mesh__D014050smesh__D001555
% 210.86/211.08 |- mesh__dateRevised mesh__D014050 2001-07-25
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D014050 2005
% 210.86/211.08 |- mesh__recordMaintainer mesh__D014050 ssb
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D014050 2002
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D014050 2006
% 210.86/211.08 |- skos__scopeNote mesh__D014050 A widely used industrial solvent.
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D014050 2003
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D014050 sjn
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D014050 2004
% 210.86/211.08 |- mesh__recordOriginator mesh__D014050 NLM
% 210.86/211.08 |- rdf__type mesh__D014050sskos__Concept
% 210.86/211.08 |- skos__prefLabel mesh__D014050 Toluene
% 210.86/211.08 |- mesh__dateCreated mesh__D014050 1999-01-01
% 210.86/211.08 |- skos__hiddenLabel mesh__D008811 DBA Mouse, Inbred
% 210.86/211.08 |- skos__hiddenLabel mesh__D008811 Inbred DBA Mice
% 210.86/211.08 |- skos__altLabel mesh__D008811 Mouse, Inbred DBA
% 210.86/211.08 |- skos__hiddenLabel mesh__D008811 DBA Mice
% 210.86/211.08 |- skos__broader mesh__D008811smesh__D008815
% 210.86/211.08 |- skos__hiddenLabel mesh__D008811 DBA Mouse
% 210.86/211.08 |- mesh__recordMaintainer mesh__D008811 ags
% 210.86/211.08 |- mesh__dateEstablished mesh__D008811 1974-01-01
% 210.86/211.08 |- mesh__dateRevised mesh__D008811 2005-06-30
% 210.86/211.08 |- mesh__dateCreated mesh__D008811 1999-01-01
% 210.86/211.08 |- skos__annotation mesh__D008811
% 210.86/211.08 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.86/211.08 |- rdf__type mesh__D008811sskos__Concept
% 210.86/211.08 |- mesh__historyNote mesh__D008811 74%28%72%29%
% 210.86/211.08 |- skos__altLabel mesh__D008811 Mouse, DBA
% 210.86/211.08 |- mesh__recordOriginator mesh__D008811 NLM
% 210.86/211.08 |- skos__hiddenLabel mesh__D008811 DBA Mice, Inbred
% 210.86/211.08 |- skos__hiddenLabel mesh__D008811 Inbred DBA Mouse
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D008811 sjn
% 210.86/211.08 |- skos__altLabel mesh__D008811 Mice, DBA
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D008811 2006
% 210.86/211.08 |- skos__prefLabel mesh__D008811 Mice, Inbred DBA
% 210.86/211.08 |- skos__historyNote mesh__D008811 Mice %28%1966-1971%29%
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D008811 74
% 210.86/211.08 |- skos__historyNote mesh__D008013 Acetic Acids %28%1966-1972%29%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D008013 2002
% 210.86/211.08 |- rdf__type mesh__D008013sskos__Concept
% 210.86/211.08 |- skos__historyNote mesh__D008013 Amides %28%1966-1972%29%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D008013 2003
% 210.86/211.08 |- skos__prefLabel mesh__D008013 Lidoflazine
% 210.86/211.08 |- mesh__recordMaintainer mesh__D008013 TWD
% 210.86/211.08 |- mesh__dateEstablished mesh__D008013 1991-01-01
% 210.86/211.08 |- skos__historyNote mesh__D008013 Piperazines %28%1966-1972%29%
% 210.86/211.08 |- mesh__dateCreated mesh__D008013 1999-01-01
% 210.86/211.08 |- skos__scopeNote mesh__D008013
% 210.86/211.08 Coronary vasodilator with some antiarrhythmic action.
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D008013 2006
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D008013
% 210.86/211.08 91; was see under PIPERAZINES 1973-90
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D008013 sjn
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D008013 2001
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D008013 2005
% 210.86/211.08 |- mesh__dateRevised mesh__D008013 2000-06-22
% 210.86/211.08 |- mesh__recordOriginator mesh__D008013 NLM
% 210.86/211.08 |- skos__historyNote mesh__D008013 Xylenes %28%1966-1972%29%
% 210.86/211.08 |- mesh__historyNote mesh__D008013
% 210.86/211.08 91%28%73%29%; was see under PIPERAZINES 1973-90
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D008013 2004
% 210.86/211.08 |- skos__broader mesh__D008013smesh__D010879
% 210.86/211.08 |- skos__prefLabel mesh__D000030 Abortion, Missed
% 210.86/211.08 |- rdf__type mesh__D000030sskos__Concept
% 210.86/211.08 |- skos__hiddenLabel mesh__D000030 Missed Abortion
% 210.86/211.08 |- mesh__recordMaintainer mesh__D000030 lkt
% 210.86/211.08 |- skos__hiddenLabel mesh__D000030 Missed Abortions
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D000030 sjn
% 210.86/211.08 |- skos__hiddenLabel mesh__D000030 Abortions, Missed
% 210.86/211.08 |- mesh__dateRevised mesh__D000030 2005-06-30
% 210.86/211.08 |- mesh__recordOriginator mesh__D000030 NLM
% 210.86/211.08 |- skos__broader mesh__D000030smesh__D000022
% 210.86/211.08 |- skos__scopeNote mesh__D000030
% 210.86/211.08 The retention in the UTERUS of a dead FETUS two months or more after its DEATH.%A%
% 210.86/211.08 |- skos__annotation mesh__D000030 check the tags FEMALE %26% PREGNANCY
% 210.86/211.08 |- mesh__dateCreated mesh__D000030 1999-01-01
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D000030 2006
% 210.86/211.08 |- skos__historyNote mesh__D046930 Thyme %28%1998-2004%29%
% 210.86/211.08 |- mesh__dateEstablished mesh__D046930 2005-01-01
% 210.86/211.08 |- skos__scopeNote mesh__D046930
% 210.86/211.08 A plant genus of the family LAMIACEAE best known for the thyme spice added to foods.%A%
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D046930 sjn
% 210.86/211.08 |- mesh__dateCreated mesh__D046930 2004-07-07
% 210.86/211.08 |- rdf__type mesh__D046930sskos__Concept
% 210.86/211.08 |- mesh__recordOriginator mesh__D046930 ssb
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D046930 2006
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D046930
% 210.86/211.08 2005; for THYME, see THYME 2002-2004, see LAMIACEAE 1998-2001, see HERBS 1983-1997, see THYME 1963-1982%A%
% 210.86/211.08 |- skos__broader mesh__D046930smesh__D019686
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D046930 2005
% 210.86/211.08 |- skos__prefLabel mesh__D046930 Thymus Plant
% 210.86/211.08 |- mesh__historyNote mesh__D046930 2005
% 210.86/211.08 |- mesh__recordMaintainer mesh__D046930 ssb
% 210.86/211.08 |- skos__annotation mesh__D046930
% 210.86/211.08 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.86/211.08 |- skos__scopeNote mesh__D013756
% 210.86/211.08 A highly toxic compound used as a gasoline additive. It causes acute toxic psychosis or chronic poisoning if inhaled or absorbed through the skin.%A%
% 210.86/211.08 |- skos__historyNote mesh__D013756
% 210.86/211.08 Organometallic Compounds %28%1969-1975%29%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D013756 2001
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D013756 2003
% 210.86/211.08 |- mesh__dateRevised mesh__D013756 2000-06-22
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D013756
% 210.86/211.08 91; was see under ORGANOMETALLIC COMPOUNDS 1976-90
% 210.86/211.08 |- mesh__dateEstablished mesh__D013756 1991-01-01
% 210.86/211.08 |- skos__hiddenLabel mesh__D013756 Lead, Tetraethyl
% 210.86/211.08 |- mesh__dateCreated mesh__D013756 1975-07-25
% 210.86/211.08 |- mesh__recordMaintainer mesh__D013756 CCR
% 210.86/211.08 |- skos__altLabel mesh__D013756 Tetraethyllead
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D013756 2006
% 210.86/211.08 |- mesh__historyNote mesh__D013756
% 210.86/211.08 91%28%76%29%; was see under ORGANOMETALLIC COMPOUNDS 1976-90
% 210.86/211.08 |- rdf__type mesh__D013756sskos__Concept
% 210.86/211.08 |- skos__broader mesh__D013756smesh__D009942
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D013756 sjn
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D013756 2005
% 210.86/211.08 |- skos__prefLabel mesh__D013756 Tetraethyl Lead
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D013756 2002
% 210.86/211.08 |- skos__historyNote mesh__D013756 Lead %28%1969-1975%29%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D013756 2004
% 210.86/211.08 |- mesh__recordOriginator mesh__D013756 RLS
% 210.86/211.08 |- mesh__dateEstablished mesh__D007719 1965-01-01
% 210.86/211.08 |- mesh__dateCreated mesh__D007719 1999-01-01
% 210.86/211.08 |- skos__prefLabel mesh__D007719 Knee Joint
% 210.86/211.08 |- mesh__dateRevised mesh__D007719 1992-05-14
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 1996
% 210.86/211.08 |- mesh__historyNote mesh__D007719 65
% 210.86/211.08 |- skos__annotation mesh__D007719
% 210.86/211.08 primates only; TN 238: differentiation from KNEE %26% indexing instructions%A%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 2004
% 210.86/211.08 |- mesh__recordOriginator mesh__D007719 NLM
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 1993
% 210.86/211.08 |- skos__hiddenLabel mesh__D007719 Knee Joints
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 1999
% 210.86/211.08 |- skos__broader mesh__D007719smesh__D007596
% 210.86/211.08 |- skos__hiddenLabel mesh__D007719 Joint, Knee
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 2003
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 2001
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D007719 65
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 2000
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 1998
% 210.86/211.08 |- skos__hiddenLabel mesh__D007719 Joints, Knee
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 2006
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 1995
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 2005
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 1997
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 1994
% 210.86/211.08 |- mesh__recordMaintainer mesh__D007719 TAP
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D007719 PLS
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D007719 2002
% 210.86/211.08 |- rdf__type mesh__D007719sskos__Concept
% 210.86/211.08 |- skos__related mesh__D018441smesh__D016459
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 1995
% 210.86/211.08 |- mesh__dateEstablished mesh__D018441 1995-01-01
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 2002
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 1998
% 210.86/211.08 |- skos__historyNote mesh__D018441 Bacteria %28%1981-1994%29%
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D018441 95
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 1999
% 210.86/211.08 |- skos__related mesh__D018441smesh__D001422
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 2000
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 2005
% 210.86/211.08 |- mesh__historyNote mesh__D018441 95
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 1996
% 210.86/211.08 |- skos__scopeNote mesh__D018441
% 210.86/211.08 Films of bacteria or other microbial organisms, usually embedded in extracellular polymers such as implanted medical devices, which adhere to surfaces submerged in, or subjected to, aquatic environments %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%. Biofilms consist of multilayers of microbial cells glued together to form microbial communities which are highly resistant to both phagocytes and antibiotics.%A%
% 210.86/211.08 |- skos__annotation mesh__D018441
% 210.86/211.08 films of multilayers of bacteria or other micro-organism on polymers, usually implanted med devices; bacteria-named biofilms: coord IM with specific bacterium %28%IM%29% with no qualif, as Pseudomonas biofilm = PSEUDOMONAS %28%IM%29% + BIOFILMS %28%IM%29%; biofilm formation, production, generation, deposition: coord BIOFILMS /growth %28%IM%29% + specific micro-organism /physiol %28%IM%29%; occurrence of biofilms on prostheses or other devices: coord IM with specific device %28%IM%29%; infection of prostheses by biofilms: coord BIOFILMS %28%IM%29% with specific prosthesis %28%IM%29% + PROSTHESIS-RELATED INFECTIONS %28%IM%29% + specific infection %28%IM%29%%A%
% 210.86/211.08 |- skos__prefLabel mesh__D018441 Biofilms
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 2006
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 1997
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 2001
% 210.86/211.08 |- skos__altLabel mesh__D018441 Biofilm
% 210.86/211.08 |- rdf__type mesh__D018441sskos__Concept
% 210.86/211.08 |- mesh__dateCreated mesh__D018441 1994-04-16
% 210.86/211.08 |- skos__broader mesh__D018441smesh__D001419
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 2003
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D018441 2004
% 210.86/211.08 |- mesh__historyNote mesh__D004421 1982
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D004421
% 210.86/211.08 1982; see MUSCLE DYSTONIA 1979-1981
% 210.86/211.08 |- rdf__type mesh__D004421sskos__Concept
% 210.86/211.08 |- skos__related mesh__D004421smesh__D004422
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D004421 2000
% 210.86/211.08 |- skos__hiddenLabel mesh__D004421 Dystonia, Muscle
% 210.86/211.08 |- mesh__dateRevised mesh__D004421 1999-12-02
% 210.86/211.08 |- skos__annotation mesh__D004421
% 210.86/211.08 do not confuse with MUSCLE HYPERTONIA or MUSCLE HYPOTONIA; DYSTONIC DISORDERS is available%A%
% 210.86/211.08 |- skos__hiddenLabel mesh__D004421 Paroxysmal Dystonia
% 210.86/211.08 |- skos__prefLabel mesh__D004421 Dystonia
% 210.86/211.08 |- skos__historyNote mesh__D004421 Movement Disorders %28%1966-1978%29%
% 210.86/211.08 |- skos__hiddenLabel mesh__D004421 Diurnal Dystonia
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D004421 ags
% 210.86/211.08 |- mesh__dateEstablished mesh__D004421 1979-01-01
% 210.86/211.08 |- skos__altLabel mesh__D004421 Muscle Dystonia
% 210.86/211.08 |- skos__historyNote mesh__D004421 Muscle Tonus %28%1970-1978%29%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D004421 2004
% 210.86/211.08 |- skos__hiddenLabel mesh__D004421 Limb Dystonia
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D004421 2002
% 210.86/211.08 |- skos__related mesh__D004421smesh__D020821
% 210.86/211.08 |- mesh__dateCreated mesh__D004421 1978-05-17
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D004421 2006
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D004421 2003
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D004421 2001
% 210.86/211.08 |- mesh__recordMaintainer mesh__D004421 ags
% 210.86/211.08 |- skos__broader mesh__D004421smesh__D020820
% 210.86/211.08 |- skos__scopeNote mesh__D004421
% 210.86/211.08 A persistent attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. %28%Adams et al., Principles of Neurology, 6th ed, p77%29%%A%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D004421 2005
% 210.86/211.08 |- mesh__recordOriginator mesh__D004421 RC
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D004421 2000A
% 210.86/211.08 |- mesh__dateCreated mesh__D051077 2005-06-30
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D051077 2006
% 210.86/211.08 |- mesh__historyNote mesh__D051077 2006
% 210.86/211.08 |- skos__historyNote mesh__D051077 Cebidae %28%1992-2005%29%
% 210.86/211.08 |- rdf__type mesh__D051077sskos__Concept
% 210.86/211.08 |- skos__broader mesh__D051077smesh__D051078
% 210.86/211.08 |- mesh__recordOriginator mesh__D051077 ags
% 210.86/211.08 |- skos__annotation mesh__D051077
% 210.86/211.08 diseases: coordinate IM with MONKEY DISEASES %28%IM%29%
% 210.86/211.08 |- mesh__dateEstablished mesh__D051077 2006-01-01
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D051077 sjn
% 210.86/211.08 |- skos__scopeNote mesh__D051077
% 210.86/211.08 A family of new world monkeys in the infraorder PLATYRRHINI, comprising the HOWLER MONKEYS, spider monkeys, and wooley monkeys.%A%
% 210.86/211.08 |- skos__prefLabel mesh__D051077 Atelidae
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D051077 2006
% 210.86/211.08 |- mesh__recordMaintainer mesh__D051077 ags
% 210.86/211.08 |- mesh__dateRevised mesh__D017349 2003-07-09
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D017349 2004
% 210.86/211.08 |- skos__broader mesh__D017349smesh__D016695
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D017349 sjn
% 210.86/211.08 |- mesh__historyNote mesh__D017349 93
% 210.86/211.08 |- skos__hiddenLabel mesh__D017349 N Acetylhexosaminyltransferases
% 210.86/211.08 |- mesh__dateCreated mesh__D017349 1992-05-22
% 210.86/211.08 |- rdf__type mesh__D017349sskos__Concept
% 210.86/211.08 |- skos__historyNote mesh__D017349 Hexosyltransferases %28%1972-1992%29%
% 210.86/211.08 |- skos__hiddenLabel mesh__D017349 Transferases, N-Acetylhexosamine
% 210.86/211.08 |- skos__altLabel mesh__D017349 N-Acetylhexosamine Transferases
% 210.86/211.08 |- skos__hiddenLabel mesh__D017349 N Acetylhexosamine Transferases
% 210.86/211.08 |- mesh__dateEstablished mesh__D017349 1993-01-01
% 210.86/211.08 |- skos__scopeNote mesh__D017349
% 210.86/211.08 Enzymes that catalyze the transfer of N-acetylhexosaminyl groups to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.%A%
% 210.86/211.08 |- mesh__recordMaintainer mesh__D017349 ssb
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D017349 93
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D017349 2005
% 210.86/211.08 |- skos__prefLabel mesh__D017349 N-Acetylhexosaminyltransferases
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D017349 2006
% 210.86/211.08 |- mesh__recordOriginator mesh__D017349 TPW
% 210.86/211.08 |- skos__prefLabel mesh__D036503 Inhalation Spacers
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D036503 2005
% 210.86/211.08 |- rdf__type mesh__D036503sskos__Concept
% 210.86/211.08 |- skos__annotation mesh__D036503
% 210.86/211.08 do not confuse with spacer inhalers see METERED DOSE INHALERS%A%
% 210.86/211.08 |- skos__hiddenLabel mesh__D036503 Spacers, Tube
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D036503 2004
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D036503 2003
% 210.86/211.08 |- mesh__dateCreated mesh__D036503 2002-07-03
% 210.86/211.08 |- mesh__historyNote mesh__D036503 2003
% 210.86/211.08 |- skos__hiddenLabel mesh__D036503 Spacer, Inhalation
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D036503 2003
% 210.86/211.08 |- skos__hiddenLabel mesh__D036503 Spacers, Inhalation
% 210.86/211.08 |- skos__hiddenLabel mesh__D036503 Spacer, Tube
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D036503 sjn
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D036503 2003A
% 210.86/211.08 |- mesh__recordOriginator mesh__D036503 lkt
% 210.86/211.08 |- skos__broader mesh__D036503smesh__D036501
% 210.86/211.08 |- skos__historyNote mesh__D036503
% 210.86/211.08 Nebulizers and Vaporizers %28%1986-2002%29%
% 210.86/211.08 |- mesh__dateEstablished mesh__D036503 2003-01-01
% 210.86/211.08 |- mesh__dateRevised mesh__D036503 2002-10-28
% 210.86/211.08 |- skos__scopeNote mesh__D036503
% 210.86/211.08 A variety of devices used in conjunction with METERED DOSE INHALERS. Their purpose is to hold the released medication for inhalation and make it easy for the patients to inhale the metered dose of medication into their lungs.%A%
% 210.86/211.08 |- skos__hiddenLabel mesh__D036503 Tube Spacer
% 210.86/211.08 |- skos__historyNote mesh__D036503 Aerosols %28%1979-2002%29%
% 210.86/211.08 |- skos__hiddenLabel mesh__D036503 Inhalation Spacer
% 210.86/211.08 |- skos__historyNote mesh__D036503 Respiratory Therapy %28%1979-2002%29%
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D036503 2006
% 210.86/211.08 |- mesh__recordMaintainer mesh__D036503 sjn
% 210.86/211.08 |- mesh__publicMeSHNote mesh__D003329 82
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 2002
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 2004
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 1994
% 210.86/211.08 |- mesh__recordOriginator mesh__D003329 VDK
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 1997
% 210.86/211.08 |- skos__hiddenLabel mesh__D003329 Artery Vasospasm, Coronary
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 2003
% 210.86/211.08 |- mesh__dateRevised mesh__D003329 1992-05-13
% 210.86/211.08 |- mesh__historyNote mesh__D003329 82
% 210.86/211.08 |- skos__hiddenLabel mesh__D003329 Coronary Vasospasms
% 210.86/211.08 |- mesh__recordAuthorizer mesh__D003329 PLS
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 1996
% 210.86/211.08 |- skos__broader mesh__D003329smesh__D003327
% 210.86/211.08 |- skos__hiddenLabel mesh__D003329 Vasospasm, Coronary Artery
% 210.86/211.08 |- skos__altLabel mesh__D003329 Coronary Artery Vasospasm
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 2001
% 210.86/211.08 |- mesh__dateEstablished mesh__D003329 1982-01-01
% 210.86/211.08 |- skos__hiddenLabel mesh__D003329 Vasospasms, Coronary Artery
% 210.86/211.08 |- skos__hiddenLabel mesh__D003329 Artery Vasospasms, Coronary
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 1993
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 2006
% 210.86/211.08 |- skos__hiddenLabel mesh__D003329 Vasospasm, Coronary
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 2000
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 1999
% 210.86/211.08 |- skos__hiddenLabel mesh__D003329 Vasospasms, Coronary
% 210.86/211.08 |- skos__hiddenLabel mesh__D003329 Coronary Artery Vasospasms
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 2005
% 210.86/211.08 |- skos__prefLabel mesh__D003329 Coronary Vasospasm
% 210.86/211.08 |- rdf__type mesh__D003329sskos__Concept
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 1998
% 210.86/211.08 |- mesh__recordMaintainer mesh__D003329 PLS
% 210.86/211.08 |- mesh__dateCreated mesh__D003329 1981-05-19
% 210.86/211.08 |- skos__scopeNote mesh__D003329
% 210.86/211.08 Spasm of the large- or medium-sized coronary arteries.
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D003329 1995
% 210.86/211.08 |- skos__broader mesh__D014051smesh__D014050
% 210.86/211.08 |- mesh__recordOriginator mesh__D014051 NLM
% 210.86/211.08 |- mesh__activeMeSHYear mesh__D014051 2003
% 210.86/211.09 |- skos__hiddenLabel mesh__D014051 Diisocyanate, Toluene
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014051 2001
% 210.86/211.09 |- skos__hiddenLabel mesh__D014051 Diisocyanate, Tolylene
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014051 2004
% 210.86/211.09 |- mesh__dateEstablished mesh__D014051 1991-01-01
% 210.86/211.09 |- rdf__type mesh__D014051sskos__Concept
% 210.86/211.09 |- skos__historyNote mesh__D014051 Toluene %28%1973-1974%29%
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D014051
% 210.86/211.09 94; was TOLUENE DIISOCYANATE 1975-93 %28%see under CYANATES 1975-90%29%%A%
% 210.86/211.09 |- skos__hiddenLabel mesh__D014051 2,4 Toluenediisocyanate
% 210.86/211.09 |- mesh__onlineNote mesh__D014051
% 210.86/211.09 use TOLUENE 2,4-DIISOCYANATE to search TOLUENE DIISOCYANATE 1975-93%A%
% 210.86/211.09 |- skos__hiddenLabel mesh__D014051 2,4-Diisocyanate, Toluene
% 210.86/211.09 |- mesh__recordMaintainer mesh__D014051 CCR
% 210.86/211.09 |- skos__historyNote mesh__D014051 Cyanates %28%1970-1974%29%
% 210.86/211.09 |- skos__scopeNote mesh__D014051
% 210.86/211.09 Skin irritant and allergen used in the manufacture of polyurethane foams and other elastomers.%A%
% 210.86/211.09 |- skos__altLabel mesh__D014051 Toluene Diisocyanate
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014051 2002
% 210.86/211.09 |- mesh__dateRevised mesh__D014051 2000-06-22
% 210.86/211.09 |- mesh__historyNote mesh__D014051
% 210.86/211.09 94; was TOLUENE DIISOCYANATE 1975-93 %28%see under CYANATES 1975-90%29%%A%
% 210.86/211.09 |- mesh__dateCreated mesh__D014051 1974-11-19
% 210.86/211.09 |- skos__broader mesh__D014051smesh__D017953
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014051 2005
% 210.86/211.09 |- skos__hiddenLabel mesh__D014051 Toluene 2,4 Diisocyanate
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014051 2006
% 210.86/211.09 |- skos__altLabel mesh__D014051 2,4-Toluenediisocyanate
% 210.86/211.09 |- skos__prefLabel mesh__D014051 Toluene 2,4-Diisocyanate
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D014051 sjn
% 210.86/211.09 |- mesh__recordMaintainer mesh__D008812 ags
% 210.86/211.09 |- skos__hiddenLabel mesh__D008812 Mouse, Hairless
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D008812 sjn
% 210.86/211.09 |- skos__altLabel mesh__D008812 Mice, HRS
% 210.86/211.09 |- skos__prefLabel mesh__D008812 Mice, Inbred HRS
% 210.86/211.09 |- skos__altLabel mesh__D008812 Mouse, Inbred HRS
% 210.86/211.09 |- skos__altLabel mesh__D008812 Mouse, HRS
% 210.86/211.09 |- mesh__dateCreated mesh__D008812 1981-05-14
% 210.86/211.09 |- skos__hiddenLabel mesh__D008812 Inbred HRS Mice
% 210.86/211.09 |- skos__altLabel mesh__D008812 Hairless Mice
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008812 2006
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D008812
% 210.86/211.09 82; HAIRLESS MICE was see MICE, NUDE 1975-81
% 210.86/211.09 |- skos__scopeNote mesh__D008812
% 210.86/211.09 Homozygous, permanently near-hairless mice which lose their hair at about 10 days of age.%A%
% 210.86/211.09 |- skos__broader mesh__D008812smesh__D008815
% 210.86/211.09 |- skos__annotation mesh__D008812
% 210.86/211.09 NIM when exper animal: no qualif; when IM, qualif permitted; do not confuse X ref MICE, HAIRLESS with MICE, NUDE; do not forget also to check tag MICE%A%
% 210.86/211.09 |- mesh__dateRevised mesh__D008812 2005-06-30
% 210.86/211.09 |- mesh__historyNote mesh__D008812
% 210.86/211.09 82; HAIRLESS MICE was see MICE, NUDE 1975-81
% 210.86/211.09 |- skos__hiddenLabel mesh__D008812 HRS Mice
% 210.86/211.09 |- skos__hiddenLabel mesh__D008812 HRS Mouse, Inbred
% 210.86/211.09 |- skos__hiddenLabel mesh__D008812 HRS Mice, Inbred
% 210.86/211.09 |- skos__hiddenLabel mesh__D008812 Inbred HRS Mouse
% 210.86/211.09 |- mesh__dateEstablished mesh__D008812 1982-01-01
% 210.86/211.09 |- skos__hiddenLabel mesh__D008812 HRS Mouse
% 210.86/211.09 |- mesh__recordOriginator mesh__D008812 EC
% 210.86/211.09 |- rdf__type mesh__D008812sskos__Concept
% 210.86/211.09 |- skos__altLabel mesh__D008812 Mice, Hairless
% 210.86/211.09 |- skos__altLabel mesh__D008812 Hairless Mouse
% 210.86/211.09 |- mesh__onlineNote mesh__D008812
% 210.86/211.09 use MICE, NUDE to search HAIRLESS MICE 1975-81
% 210.86/211.09 |- skos__hiddenLabel mesh__D008014 Detections, Lie
% 210.86/211.09 |- rdf__type mesh__D008014sskos__Concept
% 210.86/211.09 |- mesh__recordOriginator mesh__D008014 NLM
% 210.86/211.09 |- mesh__dateRevised mesh__D008014 2003-07-09
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008014 2005
% 210.86/211.09 |- skos__broader mesh__D008014smesh__D003417
% 210.86/211.09 |- skos__broader mesh__D008014smesh__D005554
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008014 2006
% 210.86/211.09 |- skos__scopeNote mesh__D008014
% 210.86/211.09 Ascertaining of deception through detection of emotional disturbance as manifested by changes in physiologic processes usually using a polygraph.%A%
% 210.86/211.09 |- skos__broader mesh__D008014smesh__D011603
% 210.86/211.09 |- skos__hiddenLabel mesh__D008014 Detection, Lie
% 210.86/211.09 |- skos__prefLabel mesh__D008014 Lie Detection
% 210.86/211.09 |- skos__hiddenLabel mesh__D008014 Lie Detections
% 210.86/211.09 |- mesh__recordMaintainer mesh__D008014 lkt
% 210.86/211.09 |- mesh__dateCreated mesh__D008014 1999-01-01
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D008014 sjn
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008014 2004
% 210.86/211.09 |- rdf__type mesh__D000031sskos__Concept
% 210.86/211.09 |- skos__prefLabel mesh__D000031 Abortion, Septic
% 210.86/211.09 |- skos__altLabel mesh__D000031 Septic Abortion
% 210.86/211.09 |- skos__broader mesh__D000031smesh__D000022
% 210.86/211.09 |- skos__scopeNote mesh__D000031
% 210.86/211.09 Any type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characterized by FEVER, uterine tenderness, and foul discharge.%A%
% 210.86/211.09 |- mesh__dateCreated mesh__D000031 1999-01-01
% 210.86/211.09 |- skos__broader mesh__D000031smesh__D011251
% 210.86/211.09 |- skos__annotation mesh__D000031
% 210.86/211.09 /vet permitted only if discussed as %22%septic%22% abortion: do not use automatically for animal abortion in brucellosis, vibriosis, trichomoniasis, etc; check the tags FEMALE %26% PREGNANCY%A%
% 210.86/211.09 |- mesh__recordMaintainer mesh__D000031 lkt
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D000031 sjn
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D000031 2006
% 210.86/211.09 |- mesh__recordOriginator mesh__D000031 NLM
% 210.86/211.09 |- mesh__dateRevised mesh__D000031 2005-06-30
% 210.86/211.09 |- skos__hiddenLabel mesh__D000031 Abortions, Septic
% 210.86/211.09 |- skos__hiddenLabel mesh__D000031 Septic Abortions
% 210.86/211.09 |- mesh__historyNote mesh__D046931 2005
% 210.86/211.09 |- skos__scopeNote mesh__D046931
% 210.86/211.09 A form-genus of CYANOBACTERIA in the order Chroococcales. Many species are planktonic and possess gas vacuoles.%A%
% 210.86/211.09 |- mesh__dateCreated mesh__D046931 2004-07-07
% 210.86/211.09 |- skos__historyNote mesh__D046931 Cyanobacteria %28%1969-2004%29%
% 210.86/211.09 |- mesh__recordOriginator mesh__D046931 ags
% 210.86/211.09 |- rdf__type mesh__D046931sskos__Concept
% 210.86/211.09 |- skos__broader mesh__D046931smesh__D000458
% 210.86/211.09 |- mesh__dateEstablished mesh__D046931 2005-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D046931 2006
% 210.86/211.09 |- skos__prefLabel mesh__D046931 Microcystis
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D046931 sjn
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D046931 2005
% 210.86/211.09 |- mesh__dateRevised mesh__D046931 2005-06-30
% 210.86/211.09 |- mesh__recordMaintainer mesh__D046931 SYSTEM
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D013757 sjn
% 210.86/211.09 |- skos__broader mesh__D013757smesh__D000644
% 210.86/211.09 |- skos__hiddenLabel mesh__D013757 Compounds, Tetraethylammonium
% 210.86/211.09 |- skos__annotation mesh__D013757 DF: TETRAETHYLAMMONIUM CPDS
% 210.86/211.09 |- skos__prefLabel mesh__D013757 Tetraethylammonium Compounds
% 210.86/211.09 |- mesh__dateCreated mesh__D013757 1999-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D013757 2006
% 210.86/211.09 |- mesh__recordMaintainer mesh__D013757 ssb
% 210.86/211.09 |- rdf__type mesh__D013757sskos__Concept
% 210.86/211.09 |- mesh__dateRevised mesh__D013757 2005-06-30
% 210.86/211.09 |- skos__altLabel mesh__D013757 Tetrylammonium
% 210.86/211.09 |- mesh__recordOriginator mesh__D013757 NLM
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D018442 1998
% 210.86/211.09 |- skos__broader mesh__D018442smesh__D016393
% 210.86/211.09 |- skos__scopeNote mesh__D018442
% 210.86/211.09 Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire MALT tissue as a result of an immunologically mediated disorder.%A%
% 210.86/211.09 |- skos__historyNote mesh__D018442 Lymphoma, B-Cell %28%1990-1994%29%
% 210.86/211.09 |- skos__hiddenLabel mesh__D018442
% 210.86/211.09 Lymphoma, Mucosa Associated Lymphoid Tissue
% 210.86/211.09 |- skos__altLabel mesh__D018442 MALT Lymphoma
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D018442 1999
% 210.86/211.09 |- skos__historyNote mesh__D018442 Lymphoma %28%1989-1994%29%
% 210.86/211.09 |- skos__hiddenLabel mesh__D018442 Lymphomas, MALT
% 210.86/211.09 |- skos__historyNote mesh__D018442 Lymphoid Tissue %28%1989-1994%29%
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D018442 2005
% 210.86/211.09 |- mesh__historyNote mesh__D018442 95
% 210.86/211.09 |- skos__altLabel mesh__D018442
% 210.86/211.09 Lymphoma of Mucosa-Associated Lymphoid Tissue
% 210.86/211.09 |- mesh__dateEstablished mesh__D018442 1995-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D018442 2002
% 210.86/211.09 |- mesh__dateCreated mesh__D018442 1994-06-03
% 210.86/211.09 |- mesh__recordOriginator mesh__D018442 AGS
% 210.86/211.09 |- skos__historyNote mesh__D018442
% 210.86/211.09 Lymphoma, Non-Hodgkin%27%s %28%1991-1994%29%
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D018442 2006
% 210.86/211.09 |- skos__prefLabel mesh__D018442
% 210.86/211.09 Lymphoma, Mucosa-Associated Lymphoid Tissue
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D018442 95
% 210.86/211.09 |- rdf__type mesh__D018442sskos__Concept
% 210.86/211.09 |- mesh__recordMaintainer mesh__D018442 PXP
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D018442 2003
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D018442 SJN
% 210.86/211.09 |- mesh__dateRevised mesh__D018442 1997-06-20
% 210.86/211.09 |- skos__broader mesh__D018442smesh__D016397
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D018442 2000
% 210.86/211.09 |- skos__hiddenLabel mesh__D018442
% 210.86/211.09 Lymphoma of Mucosa Associated Lymphoid Tissue
% 210.86/211.09 |- skos__hiddenLabel mesh__D018442
% 210.86/211.09 Mucosa Associated Lymphoid Tissue Lymphoma
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D018442 2004
% 210.86/211.09 |- skos__altLabel mesh__D018442 Mucosa-Associated Lymphoid Tissue Lymphoma
% 210.86/211.09 |- skos__hiddenLabel mesh__D018442 Lymphoma, MALT
% 210.86/211.09 |- skos__hiddenLabel mesh__D018442 MALT Lymphomas
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D018442 2001
% 210.86/211.09 |- skos__annotation mesh__D018442
% 210.86/211.09 a low-grade B-cell lymphoma; DF: LYMPHOMA MALT
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D051876 2006
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D051876 sjn
% 210.86/211.09 |- rdf__type mesh__D051876sskos__Concept
% 210.86/211.09 |- skos__prefLabel mesh__D051876 Sex-Determining Region Y Protein
% 210.86/211.09 |- skos__broader mesh__D051876smesh__D004268
% 210.86/211.09 |- mesh__recordMaintainer mesh__D051876 DRC
% 210.86/211.09 |- mesh__dateEstablished mesh__D051876 2006-01-01
% 210.86/211.09 |- skos__related mesh__D051876smesh__D024282
% 210.86/211.09 |- mesh__historyNote mesh__D051876 2006%28%1990%29%
% 210.86/211.09 |- mesh__recordOriginator mesh__D051876 DRC
% 210.86/211.09 |- skos__hiddenLabel mesh__D051876 Sex Determining Region Y Protein
% 210.86/211.09 |- skos__altLabel mesh__D051876 Testis-Determining Factor
% 210.86/211.09 |- skos__scopeNote mesh__D051876
% 210.86/211.09 A high mobility group protein encoded by the Y CHROMOSOME. It functions as a transcription factor and is essential for development of the TESTES.%A%
% 210.86/211.09 |- skos__hiddenLabel mesh__D051876 SRY Sex Determining Region Protein
% 210.86/211.09 |- mesh__dateCreated mesh__D051876 2005-06-30
% 210.86/211.09 |- skos__altLabel mesh__D051876 SRY Sex-Determining Region Protein
% 210.86/211.09 |- skos__broader mesh__D051876smesh__D014157
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D051876
% 210.86/211.09 2006; SEX-DETERMINING REGION Y PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%
% 210.86/211.09 |- skos__broader mesh__D051876smesh__D006609
% 210.86/211.09 |- skos__hiddenLabel mesh__D004422 Dystonias, Idiopathic Torsion
% 210.86/211.09 |- rdf__type mesh__D004422sskos__Concept
% 210.86/211.09 |- mesh__recordOriginator mesh__D004422 NLM
% 210.86/211.09 |- skos__altLabel mesh__D004422 Idiopathic Torsion Dystonia
% 210.86/211.09 |- skos__scopeNote mesh__D004422
% 210.86/211.09 A condition characterized by focal DYSTONIA that progresses to involuntary spasmodic contractions of the muscles of the legs, trunk, arms, and face. The hands are often spared, however, sustained axial and limb contractions may lead to a state where the body is grossly contorted. Onset is usually in the first or second decade. Familial patterns of inheritance, primarily autosomal dominant with incomplete penetrance, have been identified. %28%Adams et al., Principles of Neurology, 6th ed, p1078%29%%A%
% 210.86/211.09 |- skos__hiddenLabel mesh__D004422 Torsion Dystonia, Idiopathic
% 210.86/211.09 |- skos__altLabel mesh__D004422 Progressive Torsion Spasm
% 210.86/211.09 |- skos__hiddenLabel mesh__D004422 Torsion Disease, Childhood
% 210.86/211.09 |- skos__altLabel mesh__D004422 Dystonia Deformans Musculorum
% 210.86/211.09 |- mesh__dateRevised mesh__D004422 2004-07-19
% 210.86/211.09 |- skos__altLabel mesh__D004422 Childhood Torsion Disease
% 210.86/211.09 |- skos__altLabel mesh__D004422 Oppenheim-Ziehen Disease
% 210.86/211.09 |- skos__hiddenLabel mesh__D004422 Idiopathic Torsion Dystonias
% 210.86/211.09 |- skos__hiddenLabel mesh__D004422 Torsion Spasm, Progressive
% 210.86/211.09 |- skos__altLabel mesh__D004422 Torsion Disease of Childhood
% 210.86/211.09 |- skos__broader mesh__D004422smesh__D020271
% 210.86/211.09 |- mesh__dateCreated mesh__D004422 1999-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D004422 2005
% 210.86/211.09 |- skos__hiddenLabel mesh__D004422 Dystonias, Torsion
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D004422 2006
% 210.86/211.09 |- mesh__recordMaintainer mesh__D004422 jls
% 210.86/211.09 |- skos__hiddenLabel mesh__D004422 Spasm, Progressive Torsion
% 210.86/211.09 |- skos__hiddenLabel mesh__D004422 Oppenheim Ziehen Disease
% 210.86/211.09 |- skos__hiddenLabel mesh__D004422 Dystonia, Idiopathic Torsion
% 210.86/211.09 |- skos__related mesh__D004422smesh__D004421
% 210.86/211.09 |- skos__altLabel mesh__D004422 Dystonia Deformans Progressiva
% 210.86/211.09 |- skos__prefLabel mesh__D004422 Dystonia Musculorum Deformans
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D004422 sjn
% 210.86/211.09 |- skos__broader mesh__D004422smesh__D020821
% 210.86/211.09 |- skos__broader mesh__D004422smesh__D001480
% 210.86/211.09 |- skos__altLabel mesh__D004422 Torsion Dystonia
% 210.86/211.09 |- mesh__recordMaintainer mesh__D051078 ags
% 210.86/211.09 |- mesh__historyNote mesh__D051078
% 210.86/211.09 2006; for MONKEYS, NEW WORLD use CEBIDAE 1981-2005
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D051078
% 210.86/211.09 2006; for MONKEYS, NEW WORLD see CEBIDAE 1981-2005
% 210.86/211.09 |- skos__broader mesh__D051078smesh__D000882
% 210.86/211.09 |- skos__scopeNote mesh__D051078
% 210.86/211.09 An infraorder of new world monkeys, comprised of the families ATELIDAE; CALLITRICHIDAE; and CEBIDAE. They are found exclusively in the Americas.%A%
% 210.86/211.09 |- skos__hiddenLabel mesh__D051078 New World Monkeys
% 210.86/211.09 |- skos__hiddenLabel mesh__D051078 New World Monkey
% 210.86/211.09 |- mesh__dateEstablished mesh__D051078 2006-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D051078 2006
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D051078 sjn
% 210.86/211.09 |- skos__hiddenLabel mesh__D051078 Monkey, New World
% 210.86/211.09 |- skos__hiddenLabel mesh__D051078 World Monkey, New
% 210.86/211.09 |- mesh__dateCreated mesh__D051078 2005-06-30
% 210.86/211.09 |- rdf__type mesh__D051078sskos__Concept
% 210.86/211.09 |- skos__hiddenLabel mesh__D051078 World Monkeys, New
% 210.86/211.09 |- skos__altLabel mesh__D051078 Monkeys, New World
% 210.86/211.09 |- mesh__recordOriginator mesh__D051078 ags
% 210.86/211.09 |- skos__prefLabel mesh__D051078 Platyrrhini
% 210.86/211.09 |- skos__annotation mesh__D051078
% 210.86/211.09 diseases: coordinate IM with MONKEY DISEASES %28%IM%29%
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D042541 sjn
% 210.86/211.09 |- skos__hiddenLabel mesh__D042541 Space, Subcellular
% 210.86/211.09 |- skos__hiddenLabel mesh__D042541 Space, Intracellular
% 210.86/211.09 |- mesh__dateCreated mesh__D042541 2003-07-09
% 210.86/211.09 |- skos__broader mesh__D042541smesh__D022082
% 210.86/211.09 |- mesh__dateEstablished mesh__D042541 2004-01-01
% 210.86/211.09 |- skos__related mesh__D042541smesh__D007424
% 210.86/211.09 |- skos__prefLabel mesh__D042541 Intracellular Space
% 210.86/211.09 |- mesh__historyNote mesh__D042541 2004
% 210.86/211.09 |- mesh__recordMaintainer mesh__D042541 nns
% 210.86/211.09 |- skos__related mesh__D042541smesh__D005110
% 210.86/211.09 |- skos__scopeNote mesh__D042541 The area within CELLS.
% 210.86/211.09 |- mesh__recordOriginator mesh__D042541 nns
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D042541 2004
% 210.86/211.09 |- skos__hiddenLabel mesh__D042541 Subcellular Spaces
% 210.86/211.09 |- rdf__type mesh__D042541sskos__Concept
% 210.86/211.09 |- skos__hiddenLabel mesh__D042541 Intracellular Spaces
% 210.86/211.09 |- skos__hiddenLabel mesh__D042541 Spaces, Subcellular
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D042541 2005
% 210.86/211.09 |- mesh__dateRevised mesh__D042541 2004-07-07
% 210.86/211.09 |- skos__hiddenLabel mesh__D042541 Spaces, Intracellular
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D042541 2006
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D014850 PLS
% 210.86/211.09 |- mesh__dateEstablished mesh__D014850 1991-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 1993
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 2004
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 1998
% 210.86/211.09 |- mesh__dateRevised mesh__D014850 1990-04-13
% 210.86/211.09 |- rdf__type mesh__D014850sskos__Concept
% 210.86/211.09 |- skos__hiddenLabel mesh__D014850 Lists, Waiting
% 210.86/211.09 |- skos__hiddenLabel mesh__D014850 List, Waiting
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 2000
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 1994
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 2005
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 1999
% 210.86/211.09 |- mesh__onlineNote mesh__D014850
% 210.86/211.09 search APPOINTMENTS AND SCHEDULES 1968-74
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 2001
% 210.86/211.09 |- skos__annotation mesh__D014850 no qualif
% 210.86/211.09 |- mesh__dateCreated mesh__D014850 1999-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 1995
% 210.86/211.09 |- skos__prefLabel mesh__D014850 Waiting Lists
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 2006
% 210.86/211.09 |- skos__hiddenLabel mesh__D014850 Waiting List
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 1991
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 2002
% 210.86/211.09 |- skos__scopeNote mesh__D014850
% 210.86/211.09 Prospective patient listings for appointments.
% 210.86/211.09 |- mesh__recordMaintainer mesh__D014850 NLM
% 210.86/211.09 |- mesh__historyNote mesh__D014850
% 210.86/211.09 91%28%75%29%; was see under APPOINTMENTS AND SCHEDULES 1975-90
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D014850
% 210.86/211.09 91; was see under APPOINTMENTS AND SCHEDULES 1975-90
% 210.86/211.09 |- skos__broader mesh__D014850smesh__D001071
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 1996
% 210.86/211.09 |- mesh__recordOriginator mesh__D014850 NLM
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 1992
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 2003
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014850 1997
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 2004
% 210.86/211.09 |- rdf__type mesh__D014052sskos__Concept
% 210.86/211.09 |- mesh__historyNote mesh__D014052 73%28%72%29%
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 2000
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 1997
% 210.86/211.09 |- skos__prefLabel mesh__D014052 Toluidines
% 210.86/211.09 |- skos__broader mesh__D014052smesh__D014050
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D014052 73
% 210.86/211.09 |- skos__historyNote mesh__D014052 Toluene %28%1966-1971%29%
% 210.86/211.09 |- mesh__recordOriginator mesh__D014052 NLM
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 1994
% 210.86/211.09 |- mesh__dateCreated mesh__D014052 1999-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 2001
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D014052 PLS
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 1995
% 210.86/211.09 |- mesh__dateEstablished mesh__D014052 1973-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 2005
% 210.86/211.09 |- mesh__recordMaintainer mesh__D014052 TGC
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 1998
% 210.86/211.09 |- skos__broader mesh__D014052smesh__D000814
% 210.86/211.09 |- mesh__dateRevised mesh__D014052 1992-05-20
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 2006
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 2002
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 1993
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 1999
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 2003
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D014052 1996
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 ICR Mouse, Inbred
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 ICRC Mice, Inbred
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 ICR Mouse
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 Inbred ICRC Mouse
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 Inbred ICRC Mice
% 210.86/211.09 |- mesh__recordOriginator mesh__D008813 NLM
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 ICR Mice, Inbred
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008813 2006
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D008813 sjn
% 210.86/211.09 |- skos__altLabel mesh__D008813 Mouse, Inbred ICR
% 210.86/211.09 |- skos__historyNote mesh__D008813 Mice %28%1966-1971%29%
% 210.86/211.09 |- skos__prefLabel mesh__D008813 Mice, Inbred ICR
% 210.86/211.09 |- skos__altLabel mesh__D008813 Mice, Inbred ICRC
% 210.86/211.09 |- mesh__publicMeSHNote mesh__D008813 74
% 210.86/211.09 |- mesh__dateEstablished mesh__D008813 1974-01-01
% 210.86/211.09 |- skos__annotation mesh__D008813
% 210.86/211.09 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.86/211.09 |- mesh__dateCreated mesh__D008813 1999-01-01
% 210.86/211.09 |- rdf__type mesh__D008813sskos__Concept
% 210.86/211.09 |- skos__broader mesh__D008813smesh__D008815
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 Inbred ICR Mice
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 ICR Mice
% 210.86/211.09 |- skos__altLabel mesh__D008813 Mice, ICR
% 210.86/211.09 |- mesh__recordMaintainer mesh__D008813 ags
% 210.86/211.09 |- mesh__dateRevised mesh__D008813 2005-06-30
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 Inbred ICR Mouse
% 210.86/211.09 |- skos__hiddenLabel mesh__D008813 ICRC Mouse, Inbred
% 210.86/211.09 |- mesh__historyNote mesh__D008813 74%28%72%29%
% 210.86/211.09 |- skos__altLabel mesh__D008813 Mouse, ICR
% 210.86/211.09 |- skos__related mesh__D000830smesh__D000826
% 210.86/211.09 |- mesh__recordMaintainer mesh__D000830 lkt
% 210.86/211.09 |- rdf__type mesh__D000830sskos__Concept
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D000830 sjn
% 210.86/211.09 |- skos__broader mesh__D000830smesh__D000828
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D000830 2006
% 210.86/211.09 |- skos__related mesh__D000830smesh__D004195
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D000830 2005
% 210.86/211.09 |- skos__altLabel mesh__D000830 Laboratory Animals
% 210.86/211.09 |- mesh__dateRevised mesh__D000830 2004-07-07
% 210.86/211.09 |- skos__prefLabel mesh__D000830 Animals, Laboratory
% 210.86/211.09 |- skos__annotation mesh__D000830
% 210.86/211.09 GEN or unspecified; prefer specifics; IM; qualif permitted; do not forget also to check tag ANIMALS%A%
% 210.86/211.09 |- mesh__dateCreated mesh__D000830 1999-01-01
% 210.86/211.09 |- mesh__recordOriginator mesh__D000830 NLM
% 210.86/211.09 |- skos__related mesh__D000830smesh__D007756
% 210.86/211.09 |- rdf__type mesh__D008015sskos__Concept
% 210.86/211.09 |- mesh__dateRevised mesh__D008015 1991-11-26
% 210.86/211.09 |- mesh__recordMaintainer mesh__D008015 PLS
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 1994
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 2001
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 1999
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 2006
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 1995
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 2002
% 210.86/211.09 |- mesh__recordOriginator mesh__D008015 NLM
% 210.86/211.09 |- mesh__recordAuthorizer mesh__D008015 PLS
% 210.86/211.09 |- skos__altLabel mesh__D008015 Leichtenstein
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 1996
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 2003
% 210.86/211.09 |- mesh__dateCreated mesh__D008015 1999-01-01
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 1992
% 210.86/211.09 |- mesh__activeMeSHYear mesh__D008015 1997
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008015 2004
% 210.86/211.10 |- skos__broader mesh__D008015smesh__D005060
% 210.86/211.10 |- skos__prefLabel mesh__D008015 Liechtenstein
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008015 1998
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008015 2005
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008015 2000
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008015 1993
% 210.86/211.10 |- mesh__dateCreated mesh__D000032 1999-01-01
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000032 2005
% 210.86/211.10 |- mesh__recordOriginator mesh__D000032 NLM
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000032 2004
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000032 2006
% 210.86/211.10 |- skos__scopeNote mesh__D000032
% 210.86/211.10 Abortion induced to save the life or health of a pregnant woman. %28%From Dorland, 28th ed%29%%A%
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000032 1998
% 210.86/211.10 |- skos__hiddenLabel mesh__D000032 Therapeutic Abortions
% 210.86/211.10 |- mesh__dateRevised mesh__D000032 1997-06-20
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000032 2002
% 210.86/211.10 |- skos__annotation mesh__D000032
% 210.86/211.10 do not use /util except by MeSH definition; don%27%t forget also check tags FEMALE %26% PREGNANCY%A%
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000032 1999
% 210.86/211.10 |- skos__broader mesh__D000032smesh__D000028
% 210.86/211.10 |- skos__altLabel mesh__D000032 Therapeutic Abortion
% 210.86/211.10 |- skos__prefLabel mesh__D000032 Abortion, Therapeutic
% 210.86/211.10 |- rdf__type mesh__D000032sskos__Concept
% 210.86/211.10 |- skos__hiddenLabel mesh__D000032 Abortions, Therapeutic
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D000032 SJN
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000032 2000
% 210.86/211.10 |- mesh__recordMaintainer mesh__D000032 PXP
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000032 2003
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000032 2001
% 210.86/211.10 |- mesh__dateRevised mesh__D046932 2005-06-30
% 210.86/211.10 |- skos__scopeNote mesh__D046932
% 210.86/211.10 A form-genus of filamentous CYANOBACTERIA in the order Nostocales. Its members can be planktonic or benthic and the trichomes are composed of disc-shaped vegetative cells.%A%
% 210.86/211.10 |- mesh__recordMaintainer mesh__D046932 SYSTEM
% 210.86/211.10 |- skos__historyNote mesh__D046932 Cyanobacteria %28%1977-2004%29%
% 210.86/211.10 |- rdf__type mesh__D046932sskos__Concept
% 210.86/211.10 |- skos__broader mesh__D046932smesh__D000458
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D046932 2006
% 210.86/211.10 |- mesh__historyNote mesh__D046932 2005
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D046932 2005
% 210.86/211.10 |- mesh__dateEstablished mesh__D046932 2005-01-01
% 210.86/211.10 |- mesh__recordOriginator mesh__D046932 ags
% 210.86/211.10 |- mesh__dateCreated mesh__D046932 2004-07-07
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D046932 sjn
% 210.86/211.10 |- skos__prefLabel mesh__D046932 Nodularia
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013758 2000
% 210.86/211.10 |- skos__altLabel mesh__D013758 Cholecystokinin-Tetrapeptide
% 210.86/211.10 |- mesh__dateCreated mesh__D013758 1978-03-16
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013758 2004
% 210.86/211.10 |- skos__altLabel mesh__D013758 Cholecystokinin %28%30-33%29%
% 210.86/211.10 |- skos__historyNote mesh__D013758 Oligopeptides %28%1973-1978%29%
% 210.86/211.10 |- skos__altLabel mesh__D013758 CCK %28%30-33%29%
% 210.86/211.10 |- skos__prefLabel mesh__D013758 Tetragastrin
% 210.86/211.10 |- mesh__recordMaintainer mesh__D013758 TGC
% 210.86/211.10 |- skos__historyNote mesh__D013758 Peptides %28%1966-1972%29%
% 210.86/211.10 |- skos__related mesh__D013758smesh__D005765
% 210.86/211.10 |- mesh__historyNote mesh__D013758
% 210.86/211.10 91%28%79%29%; was see under GASTRINS 1979-90
% 210.86/211.10 |- skos__broader mesh__D013758smesh__D005755
% 210.86/211.10 |- skos__scopeNote mesh__D013758
% 210.86/211.10 L-Tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide. The C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin.%A%
% 210.86/211.10 |- mesh__recordOriginator mesh__D013758 RLS
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013758 2003
% 210.86/211.10 |- mesh__dateEstablished mesh__D013758 1991-01-01
% 210.86/211.10 |- skos__hiddenLabel mesh__D013758 Tetrapeptide, Gastrin
% 210.86/211.10 |- skos__altLabel mesh__D013758 Gastrin Tetrapeptide
% 210.86/211.10 |- skos__hiddenLabel mesh__D013758 AOC Tetrapeptide
% 210.86/211.10 |- skos__hiddenLabel mesh__D013758 Cholecystokinin Tetrapeptide
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013758 2002
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D013758 91; was see under GASTRINS 1979-90
% 210.86/211.10 |- skos__altLabel mesh__D013758 Cholecystokinin 4
% 210.86/211.10 |- skos__altLabel mesh__D013758 AOC-Tetrapeptide
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013758 2006
% 210.86/211.10 |- skos__broader mesh__D013758smesh__D009842
% 210.86/211.10 |- skos__altLabel mesh__D013758 CKK-4
% 210.86/211.10 |- skos__altLabel mesh__D013758 AOC-Tetragastrin
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013758 1999
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D013758 SJN
% 210.86/211.10 |- skos__historyNote mesh__D013758 Gastrins %28%1966-1978%29%
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013758 2005
% 210.86/211.10 |- skos__hiddenLabel mesh__D013758 4, Cholecystokinin
% 210.86/211.10 |- mesh__dateRevised mesh__D013758 1997-06-20
% 210.86/211.10 |- skos__hiddenLabel mesh__D013758 AOC Tetragastrin
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013758 1998
% 210.86/211.10 |- skos__annotation mesh__D013758
% 210.86/211.10 %22%smallest peptide fragment of gastrin%22%
% 210.86/211.10 |- rdf__type mesh__D013758sskos__Concept
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013758 2001
% 210.86/211.10 |- skos__altLabel mesh__D013758 CCK-4
% 210.86/211.10 |- mesh__dateCreated mesh__D010460 1999-01-01
% 210.86/211.10 |- rdf__type mesh__D010460sskos__Concept
% 210.86/211.10 |- mesh__recordMaintainer mesh__D010460 SYSTEM
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D010460 2006
% 210.86/211.10 |- skos__prefLabel mesh__D010460 Peptococcus
% 210.86/211.10 |- skos__scopeNote mesh__D010460
% 210.86/211.10 A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of the mouth, upper respiratory tract, and large intestine in humans. Its organisms cause infections of soft tissues and bacteremias.%A%
% 210.86/211.10 |- mesh__dateRevised mesh__D010460 2005-06-30
% 210.86/211.10 |- skos__annotation mesh__D010460
% 210.86/211.10 infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 210.86/211.10 |- skos__broader mesh__D010460smesh__D010459
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D010460 sjn
% 210.86/211.10 |- mesh__recordOriginator mesh__D010460 NLM
% 210.86/211.10 |- mesh__dateCreated mesh__D051877 2005-06-30
% 210.86/211.10 |- skos__prefLabel mesh__D051877 RNA Polymerase Sigma 54
% 210.86/211.10 |- mesh__recordMaintainer mesh__D051877 ags
% 210.86/211.10 |- mesh__dateRevised mesh__D051877 2005-08-03
% 210.86/211.10 |- skos__broader mesh__D051877smesh__D012321
% 210.86/211.10 |- skos__broader mesh__D051877smesh__D001426
% 210.86/211.10 |- mesh__historyNote mesh__D051877 2006%28%1991%29%
% 210.86/211.10 |- skos__hiddenLabel mesh__D051877 54, Sigma Factor
% 210.86/211.10 |- skos__altLabel mesh__D051877 Sigma54 Protein
% 210.86/211.10 |- mesh__recordOriginator mesh__D051877 DRC
% 210.86/211.10 |- skos__altLabel mesh__D051877 Transcription Factor Sigma-54
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D051877 2006A
% 210.86/211.10 |- skos__altLabel mesh__D051877 RNA Polymerase SigmaN
% 210.86/211.10 |- mesh__dateEstablished mesh__D051877 2006-01-01
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D051877 2006
% 210.86/211.10 |- skos__hiddenLabel mesh__D051877 SigmaN, RNA Polymerase
% 210.86/211.10 |- skos__scopeNote mesh__D051877
% 210.86/211.10 A DNA-directed RNA polymerase found in BACTERIA. It is a holoenzyme that consists of multiple subunits including sigma factor 54.%A%
% 210.86/211.10 |- skos__hiddenLabel mesh__D051877 Factor 54, Sigma
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D051877
% 210.86/211.10 2006; RNA POLYMERASE SIGMA 54 was indexed under DNA-BINDING PROTEINS %26% DNA-DIRECTED RNA POLYMERASES 1991-2005, %26% under SIGMA FACTOR 2005, %26% under BACTERIAL PROTEINS %26% TRANSCRIPTION FACTORS 1991-2004%A%
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D051877 ags
% 210.86/211.10 |- skos__hiddenLabel mesh__D051877 Transcription Factor Sigma 54
% 210.86/211.10 |- rdf__type mesh__D051877sskos__Concept
% 210.86/211.10 |- skos__prefLabel mesh__D004423 Ear
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D004423
% 210.86/211.10 EAR, EXTERNAL, DEFORMITY was heading 1966-70
% 210.86/211.10 |- mesh__recordMaintainer mesh__D004423 lkt
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D004423 sjn
% 210.86/211.10 |- mesh__considerAlso mesh__D004423 consider also terms at OTI- and OTO-
% 210.86/211.10 |- mesh__recordOriginator mesh__D004423 NLM
% 210.86/211.10 |- mesh__dateCreated mesh__D004423 1999-01-01
% 210.86/211.10 |- skos__scopeNote mesh__D004423
% 210.86/211.10 The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE.%A%
% 210.86/211.10 |- skos__altLabel mesh__D004423 Vestibulocochlear Apparatus
% 210.86/211.10 |- skos__broader mesh__D004423smesh__D012679
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004423 2006
% 210.86/211.10 |- skos__hiddenLabel mesh__D004423 Ears
% 210.86/211.10 |- mesh__onlineNote mesh__D004423
% 210.86/211.10 use EAR /AB %26% EAR, EXTERNAL /AB %26% EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70; in searching non-acquired ear abnormalities consider EAR DEFORMITIES, ACQUIRED 1966-74%A%
% 210.86/211.10 |- mesh__dateRevised mesh__D004423 2005-06-30
% 210.86/211.10 |- mesh__historyNote mesh__D004423
% 210.86/211.10 EAR, EXTERNAL, DEFORMITY was heading 1966-70
% 210.86/211.10 |- skos__annotation mesh__D004423
% 210.86/211.10 general only or unspecified; prefer EAR, EXTERNAL or EAR, MIDDLE or EAR, INNER; /abnorm permitted but note EAR DEFORMITIES, ACQUIRED; /surg: consider also OTOLOGIC SURGICAL PROCEDURES; ear acupuncture or otopuncture or auriculoacupuncture %28%acupunct ther with ear as pressure point%29%: index under ACUPUNCTURE THERAPY %28%IM%29% + EAR, EXTERNAL %28%IM%29%%A%
% 210.86/211.10 |- rdf__type mesh__D004423sskos__Concept
% 210.86/211.10 |- skos__broader mesh__D004423smesh__D006257
% 210.86/211.10 |- skos__hiddenLabel mesh__D004423 System, Vestibulocochlear
% 210.86/211.10 |- skos__hiddenLabel mesh__D004423 Apparatus, Vestibulocochlear
% 210.86/211.10 |- skos__altLabel mesh__D004423 Vestibulocochlear System
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D051079 2006
% 210.86/211.10 |- mesh__recordOriginator mesh__D051079 ags
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D051079 2006
% 210.86/211.10 |- skos__scopeNote mesh__D051079
% 210.86/211.10 An infraorder of PRIMATES comprised of the families CERCOPITHECIDAE %28%old world monkeys%29%; HYLOBATIDAE %28%siamangs and GIBBONS%29%; and HOMINIDAE %28%great apes and HUMANS%29%. With the exception of humans, they all live exclusively in Africa and Asia.%A%
% 210.86/211.10 |- rdf__type mesh__D051079sskos__Concept
% 210.86/211.10 |- mesh__dateEstablished mesh__D051079 2006-01-01
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D051079 sjn
% 210.86/211.10 |- skos__prefLabel mesh__D051079 Catarrhini
% 210.86/211.10 |- mesh__dateCreated mesh__D051079 2005-06-30
% 210.86/211.10 |- mesh__recordMaintainer mesh__D051079 ags
% 210.86/211.10 |- skos__broader mesh__D051079smesh__D000882
% 210.86/211.10 |- mesh__historyNote mesh__D051079 2006
% 210.86/211.10 |- skos__historyNote mesh__D051079 Cercopithecidae %28%1980-2005%29%
% 210.86/211.10 |- rdf__type mesh__D020090sskos__Concept
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D020090 99
% 210.86/211.10 |- skos__scopeNote mesh__D020090
% 210.86/211.10 The orderly segregation of CHROMOSOMES during MEIOSIS or MITOSIS.%A%
% 210.86/211.10 |- skos__hiddenLabel mesh__D020090 Segregations, Chromosome
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D020090 2006
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D020090 sjn
% 210.86/211.10 |- skos__hiddenLabel mesh__D020090 Segregation, Chromosome
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D020090 2005
% 210.86/211.10 |- mesh__historyNote mesh__D020090 99
% 210.86/211.10 |- mesh__dateEstablished mesh__D020090 1999-01-01
% 210.86/211.10 |- skos__prefLabel mesh__D020090 Chromosome Segregation
% 210.86/211.10 |- skos__broader mesh__D020090smesh__D048750
% 210.86/211.10 |- mesh__recordMaintainer mesh__D020090 lkt
% 210.86/211.10 |- mesh__recordOriginator mesh__D020090 NDW
% 210.86/211.10 |- skos__hiddenLabel mesh__D020090 Chromosome Segregations
% 210.86/211.10 |- mesh__dateRevised mesh__D020090 2004-07-07
% 210.86/211.10 |- mesh__dateCreated mesh__D020090 1998-06-10
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D014851 2002
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D014851 69
% 210.86/211.10 |- mesh__dateCreated mesh__D014851 1999-01-01
% 210.86/211.10 |- skos__scopeNote mesh__D014851
% 210.86/211.10 A state in which there is an enhanced potential for sensitivity and an efficient responsiveness to external stimuli.%A%
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D014851 2006
% 210.86/211.10 |- skos__prefLabel mesh__D014851 Wakefulness
% 210.86/211.10 |- mesh__historyNote mesh__D014851 69%28%67%29%
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D014851 sjn
% 210.86/211.10 |- mesh__recordOriginator mesh__D014851 NLM
% 210.86/211.10 |- skos__hiddenLabel mesh__D014851 Wakefulnesses
% 210.86/211.10 |- skos__related mesh__D014851smesh__D007319
% 210.86/211.10 |- mesh__dateRevised mesh__D014851 1999-11-03
% 210.86/211.10 |- skos__broader mesh__D014851smesh__D001143
% 210.86/211.10 |- skos__historyNote mesh__D014851 Consciousness %28%1966%29%
% 210.86/211.10 |- mesh__dateEstablished mesh__D014851 1969-01-01
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D014851 2003
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D014851 2000
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D014851 2004
% 210.86/211.10 |- mesh__recordMaintainer mesh__D014851 KEV
% 210.86/211.10 |- skos__historyNote mesh__D014851 Cerebral Cortex/physiology %28%1966%29%
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D014851 2001
% 210.86/211.10 |- rdf__type mesh__D014851sskos__Concept
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D014851 2005
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D014053 2005
% 210.86/211.10 |- skos__prefLabel mesh__D014053 Tomatine
% 210.86/211.10 |- rdf__type mesh__D014053sskos__Concept
% 210.86/211.10 |- skos__broader mesh__D014053smesh__D006027
% 210.86/211.10 |- mesh__dateEstablished mesh__D014053 1991-01-01
% 210.86/211.10 |- mesh__dateRevised mesh__D014053 2004-07-07
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D014053 sjn
% 210.86/211.10 |- mesh__recordOriginator mesh__D014053 NLM
% 210.86/211.10 |- mesh__dateCreated mesh__D014053 1999-01-01
% 210.86/211.10 |- skos__scopeNote mesh__D014053
% 210.86/211.10 An alkaloid that occurs in the extract of leaves of wild tomato plants. It has been found to inhibit the growth of various fungi and bacteria. It is used as a precipitating agent for steroids. %28%From The Merck Index, 11th ed%29%%A%
% 210.86/211.10 |- mesh__recordMaintainer mesh__D014053 ssb
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D014053
% 210.86/211.10 91; was see under ALKALOIDS 1964-90
% 210.86/211.10 |- mesh__historyNote mesh__D014053
% 210.86/211.10 91%28%64%29%; was see under ALKALOIDS 1964-90
% 210.86/211.10 |- skos__broader mesh__D014053smesh__D012991
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D014053 2006
% 210.86/211.10 |- skos__hiddenLabel mesh__D008814 Inbred NZB Mouse
% 210.86/211.10 |- skos__prefLabel mesh__D008814 Mice, Inbred NZB
% 210.86/211.10 |- skos__broader mesh__D008814smesh__D008815
% 210.86/211.10 |- skos__hiddenLabel mesh__D008814 NZB Mice
% 210.86/211.10 |- skos__hiddenLabel mesh__D008814 NZB Mice, Inbred
% 210.86/211.10 |- skos__annotation mesh__D008814
% 210.86/211.10 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.86/211.10 |- skos__hiddenLabel mesh__D008814 NZB Mouse
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008814 2006
% 210.86/211.10 |- mesh__dateRevised mesh__D008814 2005-06-30
% 210.86/211.10 |- mesh__dateCreated mesh__D008814 1999-01-01
% 210.86/211.10 |- skos__altLabel mesh__D008814 Mouse, Inbred NZB
% 210.86/211.10 |- mesh__recordOriginator mesh__D008814 NLM
% 210.86/211.10 |- skos__historyNote mesh__D008814 Mice %28%1966-1971%29%
% 210.86/211.10 |- mesh__recordMaintainer mesh__D008814 ags
% 210.86/211.10 |- rdf__type mesh__D008814sskos__Concept
% 210.86/211.10 |- skos__hiddenLabel mesh__D008814 NZB Mouse, Inbred
% 210.86/211.10 |- skos__altLabel mesh__D008814 Mice, NZB
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D008814 sjn
% 210.86/211.10 |- mesh__dateEstablished mesh__D008814 1974-01-01
% 210.86/211.10 |- skos__hiddenLabel mesh__D008814 Inbred NZB Mice
% 210.86/211.10 |- skos__altLabel mesh__D008814 Mouse, NZB
% 210.86/211.10 |- mesh__historyNote mesh__D008814 74%28%72%29%
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D008814 74
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000831 2005
% 210.86/211.10 |- rdf__type mesh__D000831sskos__Concept
% 210.86/211.10 |- skos__hiddenLabel mesh__D000831 Newborn Animal
% 210.86/211.10 |- mesh__recordOriginator mesh__D000831 NLM
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000831 2006
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000831 2004
% 210.86/211.10 |- skos__hiddenLabel mesh__D000831 Animal, Newborn
% 210.86/211.10 |- skos__annotation mesh__D000831
% 210.86/211.10 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag ANIMALS%A%
% 210.86/211.10 |- mesh__dateCreated mesh__D000831 1999-01-01
% 210.86/211.10 |- mesh__dateRevised mesh__D000831 2003-07-30
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D000831 sjn
% 210.86/211.10 |- skos__broader mesh__D000831smesh__D000828
% 210.86/211.10 |- skos__hiddenLabel mesh__D000831 Newborn Animals
% 210.86/211.10 |- skos__prefLabel mesh__D000831 Animals, Newborn
% 210.86/211.10 |- mesh__recordMaintainer mesh__D000831 ags
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D008016 77
% 210.86/211.10 |- mesh__recordOriginator mesh__D008016 EC
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Event, Stressful
% 210.86/211.10 |- skos__scopeNote mesh__D008016
% 210.86/211.10 Those occurrences, including social, psychological, and environmental, which require an adjustment or effect a change in an individual%27%s pattern of living.%A%
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Event History Analyses
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D008016 SJN
% 210.86/211.10 |- skos__broader mesh__D008016smesh__D008019
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008016 2003
% 210.86/211.10 |- mesh__recordMaintainer mesh__D008016 TGC
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Stressful Event
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Event, Life Change
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008016 2000
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Events, Stressful
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Analyses, Event History
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Experience, Life
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008016 2004
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008016 2001
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008016 2005
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008016 1998
% 210.86/211.10 |- mesh__dateCreated mesh__D008016 1976-04-16
% 210.86/211.10 |- rdf__type mesh__D008016sskos__Concept
% 210.86/211.10 |- skos__annotation mesh__D008016
% 210.86/211.10 human only: do not confuse with life cycles %26% life stages of animals %26% lower organisms; no qualif; FAMILY LIFE CYCLES see FAMILY is also available for %22%transitional stages through which the family evolves...e.g., marriage, childbearing %26% death%22%%A%
% 210.86/211.10 |- skos__historyNote mesh__D008016 Stress, Psychological %28%1969-1976%29%
% 210.86/211.10 |- skos__prefLabel mesh__D008016 Life Change Events
% 210.86/211.10 |- skos__historyNote mesh__D008016 Life Style %28%1972-1976%29%
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Events, Life Change
% 210.86/211.10 |- skos__altLabel mesh__D008016 Event History Analysis
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008016 2002
% 210.86/211.10 |- mesh__dateEstablished mesh__D008016 1977-01-01
% 210.86/211.10 |- mesh__historyNote mesh__D008016 77
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Life Experience
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008016 1999
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D008016 2006
% 210.86/211.10 |- mesh__dateRevised mesh__D008016 1997-06-20
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Experiences, Life
% 210.86/211.10 |- skos__hiddenLabel mesh__D008016 Life Change Event
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000033 2006
% 210.86/211.10 |- mesh__recordMaintainer mesh__D000033 ags
% 210.86/211.10 |- mesh__dateRevised mesh__D000033 2005-07-12
% 210.86/211.10 |- mesh__recordOriginator mesh__D000033 NLM
% 210.86/211.10 |- rdf__type mesh__D000033sskos__Concept
% 210.86/211.10 |- skos__hiddenLabel mesh__D000033 Threatened Abortions
% 210.86/211.10 |- skos__hiddenLabel mesh__D000033 Abortions, Threatened
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D000033 2006A
% 210.86/211.10 |- skos__broader mesh__D000033smesh__D000022
% 210.86/211.10 |- skos__hiddenLabel mesh__D000033 Threatened Abortion
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D000033 ags
% 210.86/211.10 |- skos__scopeNote mesh__D000033
% 210.86/211.10 UTERINE BLEEDING from a GESTATION of less than 20 weeks without any CERVICAL DILATATION. It is characterized by vaginal bleeding, lower back discomfort, or midline pelvic cramping and a risk factor for MISCARRIAGE.%A%
% 210.86/211.10 |- mesh__dateCreated mesh__D000033 1999-01-01
% 210.86/211.10 |- skos__annotation mesh__D000033 check the tags FEMALE %26% PREGNANCY
% 210.86/211.10 |- skos__prefLabel mesh__D000033 Abortion, Threatened
% 210.86/211.10 |- skos__broader mesh__D013759smesh__D002186
% 210.86/211.10 |- skos__altLabel mesh__D013759 THC
% 210.86/211.10 |- rdf__type mesh__D013759sskos__Concept
% 210.86/211.10 |- skos__scopeNote mesh__D013759
% 210.86/211.10 A psychoactive compound extracted from the resin of Cannabis sativa %28%marihuana, hashish%29%. The isomer delta-9-tetrahydrocannabinol %28%THC%29% is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC.%A%
% 210.86/211.10 |- skos__altLabel mesh__D013759 delta%28%9%29%-THC
% 210.86/211.10 |- skos__altLabel mesh__D013759 delta%28%1%29%-Tetrahydrocannabinol
% 210.86/211.10 |- mesh__publicMeSHNote mesh__D013759 77; was see under CANNABIS 1975-76
% 210.86/211.10 |- skos__prefLabel mesh__D013759 Tetrahydrocannabinol
% 210.86/211.10 |- mesh__dateRevised mesh__D013759 2005-06-30
% 210.86/211.10 |- skos__altLabel mesh__D013759 Dronabinol
% 210.86/211.10 |- skos__altLabel mesh__D013759 9-ene-Tetrahydrocannabinol
% 210.86/211.10 |- mesh__recordOriginator mesh__D013759 NLM
% 210.86/211.10 |- skos__altLabel mesh__D013759 delta%28%1%29%-THC
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D013759 sjn
% 210.86/211.10 |- skos__hiddenLabel mesh__D013759 9 ene Tetrahydrocannabinol
% 210.86/211.10 |- skos__hiddenLabel mesh__D013759 Tetrahydrocannabinol, Trans Isomer
% 210.86/211.10 |- skos__altLabel mesh__D013759 delta%28%9%29%-Tetrahydrocannabinol
% 210.86/211.10 |- mesh__historyNote mesh__D013759
% 210.86/211.10 77%28%71%29%; was see under CANNABIS 1975-76
% 210.86/211.10 |- mesh__recordMaintainer mesh__D013759 exl
% 210.86/211.10 |- mesh__dateCreated mesh__D013759 1999-01-01
% 210.86/211.10 |- skos__altLabel mesh__D013759 Solvay Brand of Tetrahydrocannabinol
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D013759 2006
% 210.86/211.10 |- mesh__dateEstablished mesh__D013759 1977-01-01
% 210.86/211.10 |- skos__historyNote mesh__D013759 Cannabis %28%1966-1970%29%
% 210.86/211.10 |- skos__altLabel mesh__D010461 Peptone
% 210.86/211.10 |- skos__scopeNote mesh__D010461
% 210.86/211.10 Derived proteins or mixtures of cleavage products produced by the partial hydrolysis of a native protein either by an acid or by an enzyme. Peptones are readily soluble in water, and are not precipitable by heat, by alkalis, or by saturation with ammonium sulfate. %28%Dorland, 28th ed%29%%A%
% 210.86/211.10 |- skos__prefLabel mesh__D010461 Peptones
% 210.86/211.10 |- mesh__recordAuthorizer mesh__D010461 sjn
% 210.86/211.10 |- mesh__recordMaintainer mesh__D010461 SYSTEM
% 210.86/211.10 |- rdf__type mesh__D010461sskos__Concept
% 210.86/211.10 |- skos__annotation mesh__D010461 proteins
% 210.86/211.10 |- mesh__recordOriginator mesh__D010461 NLM
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D010461 2006
% 210.86/211.10 |- skos__broader mesh__D010461smesh__D011506
% 210.86/211.10 |- mesh__dateRevised mesh__D010461 2005-06-30
% 210.86/211.10 |- mesh__dateCreated mesh__D010461 1999-01-01
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004424 2004
% 210.86/211.10 |- skos__hiddenLabel mesh__D004424 External Auditory Canals
% 210.86/211.10 |- skos__prefLabel mesh__D004424 Ear Canal
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004424 2006
% 210.86/211.10 |- mesh__recordMaintainer mesh__D004424 PLS
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004424 1996
% 210.86/211.10 |- skos__hiddenLabel mesh__D004424 Canal, Ear
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004424 2002
% 210.86/211.10 |- skos__hiddenLabel mesh__D004424 External Auditory Canal
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004424 1998
% 210.86/211.10 |- rdf__type mesh__D004424sskos__Concept
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004424 1997
% 210.86/211.10 |- skos__altLabel mesh__D004424 Auditory Canal, External
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004424 1992
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004424 1990
% 210.86/211.10 |- skos__hiddenLabel mesh__D004424 Canal, External Auditory
% 210.86/211.10 |- skos__related mesh__D004424smesh__D002571
% 210.86/211.10 |- mesh__activeMeSHYear mesh__D004424 1994
% 210.86/211.11 |- skos__hiddenLabel mesh__D004424 Canals, Ear
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D004424 1999
% 210.86/211.11 |- mesh__recordAuthorizer mesh__D004424 PLS
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D004424 1993
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D004424 1995
% 210.86/211.11 |- mesh__recordOriginator mesh__D004424 NLM
% 210.86/211.11 |- skos__hiddenLabel mesh__D004424 Auditory Canals, External
% 210.86/211.11 |- skos__broader mesh__D004424smesh__D004431
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D004424 2000
% 210.86/211.11 |- mesh__dateRevised mesh__D004424 1989-10-06
% 210.86/211.11 |- skos__hiddenLabel mesh__D004424 Canals, External Auditory
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D004424 1991
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D004424 2003
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D004424 2001
% 210.86/211.11 |- mesh__dateCreated mesh__D004424 1999-01-01
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D004424 2005
% 210.86/211.11 |- skos__hiddenLabel mesh__D004424 Ear Canals
% 210.86/211.11 |- mesh__publicMeSHNote mesh__D020091 99
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D020091 2006
% 210.86/211.11 |- mesh__recordMaintainer mesh__D020091 SYSTEM
% 210.86/211.11 |- mesh__dateCreated mesh__D020091 1998-06-10
% 210.86/211.11 |- skos__broader mesh__D020091smesh__D015052
% 210.86/211.11 |- skos__prefLabel mesh__D020091 Entomophthorales
% 210.86/211.11 |- mesh__recordOriginator mesh__D020091 AGS
% 210.86/211.11 |- skos__annotation mesh__D020091
% 210.86/211.11 infection: coord IM with ZYGOMYCOSIS %28%IM%29%
% 210.86/211.11 |- mesh__dateRevised mesh__D020091 2005-06-30
% 210.86/211.11 |- skos__historyNote mesh__D020091 Zygomycota %28%1976-1998%29%
% 210.86/211.11 |- skos__scopeNote mesh__D020091
% 210.86/211.11 An order of fungi comprising mostly insect pathogens, though some infect mammals including humans. Strict host specificity make these fungi a focus of many biological control studies.%A%
% 210.86/211.11 |- mesh__recordAuthorizer mesh__D020091 sjn
% 210.86/211.11 |- mesh__historyNote mesh__D020091 99
% 210.86/211.11 |- mesh__dateEstablished mesh__D020091 1999-01-01
% 210.86/211.11 |- rdf__type mesh__D020091sskos__Concept
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 2001
% 210.86/211.11 |- skos__broader mesh__D014852smesh__D006113
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 2002
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 1996
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 2003
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 1997
% 210.86/211.11 |- mesh__recordOriginator mesh__D014852 NLM
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 2004
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 1998
% 210.86/211.11 |- mesh__recordMaintainer mesh__D014852 KEV
% 210.86/211.11 |- mesh__recordAuthorizer mesh__D014852 PLS
% 210.86/211.11 |- rdf__type mesh__D014852sskos__Concept
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 2005
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 1999
% 210.86/211.11 |- skos__prefLabel mesh__D014852 Wales
% 210.86/211.11 |- mesh__dateCreated mesh__D014852 1999-01-01
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 2006
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014852 2000
% 210.86/211.11 |- mesh__dateRevised mesh__D014852 1995-05-23
% 210.86/211.11 |- mesh__recordAuthorizer mesh__D014054 SJN
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014054 2003
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014054 2001
% 210.86/211.11 |- rdf__type mesh__D014054sskos__Concept
% 210.86/211.11 |- skos__broader mesh__D014054smesh__D003952
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014054 2000
% 210.86/211.11 |- mesh__dateRevised mesh__D014054 1997-06-20
% 210.86/211.11 |- mesh__recordMaintainer mesh__D014054 PXP
% 210.86/211.11 |- skos__related mesh__D014054smesh__D019412
% 210.86/211.11 |- skos__prefLabel mesh__D014054 Tomography
% 210.86/211.11 |- mesh__dateCreated mesh__D014054 1999-01-01
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014054 2006
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014054 2002
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014054 1999
% 210.86/211.11 |- skos__scopeNote mesh__D014054
% 210.86/211.11 Imaging methods that result in sharp images of objects located on a chosen plane and blurred images located above or below the plane.%A%
% 210.86/211.11 |- mesh__recordOriginator mesh__D014054 NLM
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014054 2005
% 210.86/211.11 |- skos__hiddenLabel mesh__D014054 Tomographies
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014054 2004
% 210.86/211.11 |- skos__annotation mesh__D014054
% 210.86/211.11 do not use /util except by MeSH definition; used for non-x-ray %26% non-radionuclide tomographies; echotomography seen in foreign lit is probably ULTRASONOGRAPHY %26% if so use %22%ultrasonics%22% or %22%ultrasonic diagnosis%22% or %22%ultrasonography%22% in translations %26% not %22%echotomography%22%; DF: TOMOGR%A%
% 210.86/211.11 |- mesh__activeMeSHYear mesh__D014054 1998
% 210.86/211.11 |- mesh__historyNote mesh__D008815 72
% 210.86/211.11 |- skos__hiddenLabel mesh__D008815 Strain, Inbred Mouse
% 210.86/211.11 |- mesh__dateCreated mesh__D008815 1999-01-01
% 210.86/211.11 |- skos__altLabel mesh__D008815 Mouse, Inbred Strain
% 210.86/211.11 |- skos__broader mesh__D008815smesh__D051379
% 210.96/211.11 |- skos__hiddenLabel mesh__D008815 Strains, Inbred Mouse
% 210.96/211.11 |- skos__scopeNote mesh__D008815
% 210.96/211.11 Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation.%A%
% 210.96/211.11 |- mesh__dateRevised mesh__D008815 2005-06-30
% 210.96/211.11 |- skos__hiddenLabel mesh__D008815 Inbred Mouse Strain
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D008815 72
% 210.96/211.11 |- mesh__recordOriginator mesh__D008815 NLM
% 210.96/211.11 |- skos__broader mesh__D008815smesh__D017849
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D008815 2006
% 210.96/211.11 |- skos__historyNote mesh__D008815 Mice %28%1966-1971%29%
% 210.96/211.11 |- skos__altLabel mesh__D008815 Inbred Strain of Mice
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D008815 sjn
% 210.96/211.11 |- rdf__type mesh__D008815sskos__Concept
% 210.96/211.11 |- skos__prefLabel mesh__D008815 Mice, Inbred Strains
% 210.96/211.11 |- skos__altLabel mesh__D008815 Inbred Strain of Mouse
% 210.96/211.11 |- mesh__recordMaintainer mesh__D008815 ags
% 210.96/211.11 |- skos__hiddenLabel mesh__D008815 Mouse Inbred Strain
% 210.96/211.11 |- skos__altLabel mesh__D008815 Inbred Strains of Mice
% 210.96/211.11 |- skos__hiddenLabel mesh__D008815 Mouse Inbred Strains
% 210.96/211.11 |- skos__annotation mesh__D008815
% 210.96/211.11 GEN or unspecified; prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE; Manual 22.36%A%
% 210.96/211.11 |- skos__hiddenLabel mesh__D008815 Mouse Strains, Inbred
% 210.96/211.11 |- mesh__dateEstablished mesh__D008815 1972-01-01
% 210.96/211.11 |- skos__altLabel mesh__D008815 Inbred Mouse Strains
% 210.96/211.11 |- skos__hiddenLabel mesh__D008815 Mouse Strain, Inbred
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D000832 2006
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D000832 2004
% 210.96/211.11 |- mesh__dateEstablished mesh__D000832 1968-01-01
% 210.96/211.11 |- mesh__dateCreated mesh__D000832 1999-01-01
% 210.96/211.11 |- mesh__historyNote mesh__D000832 68
% 210.96/211.11 |- mesh__dateRevised mesh__D000832 2003-07-30
% 210.96/211.11 |- skos__annotation mesh__D000832
% 210.96/211.11 IM; qualif permitted; coord IM with specific poisonous animal %28%IM%29%; do not forget also to check tag ANIMALS%A%
% 210.96/211.11 |- skos__broader mesh__D000832smesh__D000828
% 210.96/211.11 |- mesh__recordOriginator mesh__D000832 NLM
% 210.96/211.11 |- skos__prefLabel mesh__D000832 Animals, Poisonous
% 210.96/211.11 |- mesh__recordMaintainer mesh__D000832 ags
% 210.96/211.11 |- skos__hiddenLabel mesh__D000832 Poisonous Animal
% 210.96/211.11 |- skos__altLabel mesh__D000832 Poisonous Animals
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D000832 sjn
% 210.96/211.11 |- skos__historyNote mesh__D000832 Animals %28%1966-1967%29%
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D000832 2005
% 210.96/211.11 |- rdf__type mesh__D000832sskos__Concept
% 210.96/211.11 |- skos__hiddenLabel mesh__D000832 Animal, Poisonous
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D000832 68
% 210.96/211.11 |- mesh__historyNote mesh__D008017
% 210.96/211.11 was in Cat H %26% N 1979-81; was in Cat N only 1968-78; was in Cat G only 1967; was in Cat G %26% I 1963-66%A%
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D008017 2003
% 210.96/211.11 |- skos__hiddenLabel mesh__D008017 Expectancies, Life
% 210.96/211.11 |- mesh__dateCreated mesh__D008017 1999-01-01
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D008017 2004
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D008017 2005
% 210.96/211.11 |- mesh__dateRevised mesh__D008017 1999-11-03
% 210.96/211.11 |- rdf__type mesh__D008017sskos__Concept
% 210.96/211.11 |- skos__related mesh__D008017smesh__D008136
% 210.96/211.11 |- mesh__recordMaintainer mesh__D008017 kle
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D008017 2006
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D008017 2000
% 210.96/211.11 |- skos__hiddenLabel mesh__D008017 Expectancy, Life
% 210.96/211.11 |- skos__broader mesh__D008017smesh__D014798
% 210.96/211.11 |- skos__prefLabel mesh__D008017 Life Expectancy
% 210.96/211.11 |- skos__annotation mesh__D008017
% 210.96/211.11 IM for human, NIM for animal; consider also LONGEVITY
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D008017 2001
% 210.96/211.11 |- skos__scopeNote mesh__D008017
% 210.96/211.11 A figure representing the number of years, based on known statistics, to which any person of a given age may reasonably expect to live.%A%
% 210.96/211.11 |- skos__hiddenLabel mesh__D008017 Life Expectancies
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D008017 sjn
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D008017 2002
% 210.96/211.11 |- mesh__recordOriginator mesh__D008017 NLM
% 210.96/211.11 |- mesh__dateCreated mesh__D000034 1999-01-01
% 210.96/211.11 |- skos__prefLabel mesh__D000034 Abortion, Veterinary
% 210.96/211.11 |- skos__annotation mesh__D000034
% 210.96/211.11 coordinate IM with specific type of abortion /vet %28%IM%29%; check the tags ANIMALS %26% FEMALE %26% PREGNANCY%A%
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D000034 2006
% 210.96/211.11 |- skos__altLabel mesh__D000034 Veterinary Abortion
% 210.96/211.11 |- mesh__recordMaintainer mesh__D000034 lkt
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D000034 sjn
% 210.96/211.11 |- skos__scopeNote mesh__D000034
% 210.96/211.11 Premature expulsion of the FETUS in animals.
% 210.96/211.11 |- rdf__type mesh__D000034sskos__Concept
% 210.96/211.11 |- mesh__dateRevised mesh__D000034 2005-06-30
% 210.96/211.11 |- skos__broader mesh__D000034smesh__D000022
% 210.96/211.11 |- mesh__recordOriginator mesh__D000034 NLM
% 210.96/211.11 |- skos__broader mesh__D000034smesh__D000820
% 210.96/211.11 |- skos__hiddenLabel mesh__D000034 Abortions, Veterinary
% 210.96/211.11 |- skos__hiddenLabel mesh__D000034 Veterinary Abortions
% 210.96/211.11 |- mesh__dateEstablished mesh__D046934 2005-01-01
% 210.96/211.11 |- mesh__historyNote mesh__D046934 2005
% 210.96/211.11 |- skos__scopeNote mesh__D046934
% 210.96/211.11 DITERPENES with three LACTONES and a unique tert-butyl group, which are found in GINKGO plants along with BILOBALIDES.%A%
% 210.96/211.11 |- mesh__dateCreated mesh__D046934 2004-07-07
% 210.96/211.11 |- skos__broader mesh__D046934smesh__D004224
% 210.96/211.11 |- skos__prefLabel mesh__D046934 Ginkgolides
% 210.96/211.11 |- mesh__recordOriginator mesh__D046934 ssb
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D046934 sjn
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D046934 2005
% 210.96/211.11 |- rdf__type mesh__D046934sskos__Concept
% 210.96/211.11 |- mesh__recordMaintainer mesh__D046934 ssb
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D046934 2006
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D046934 2005
% 210.96/211.11 |- mesh__dateCreated mesh__D024482 2001-07-25
% 210.96/211.11 |- skos__altLabel mesh__D024482 Vitamin K2
% 210.96/211.11 |- rdf__type mesh__D024482sskos__Concept
% 210.96/211.11 |- skos__scopeNote mesh__D024482
% 210.96/211.11 A group of substances similar to VITAMIN K 1 which contains a ring of 2-methyl-1,4-naphthoquinione and an isoprenoid side chain of varying number of isoprene units. In vitamin K 2, each isoprene unit contains a double bond. They are produced by bacteria including the normal intestinal flora.%A%
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D024482 sjn
% 210.96/211.11 |- skos__prefLabel mesh__D024482 Vitamin K 2
% 210.96/211.11 |- skos__altLabel mesh__D024482 Menaquinones
% 210.96/211.11 |- skos__historyNote mesh__D024482 Vitamin K %28%1965-2001%29%
% 210.96/211.11 |- mesh__historyNote mesh__D024482 2002; use VITAMIN K 1965-2001
% 210.96/211.11 |- skos__broader mesh__D024482smesh__D009285
% 210.96/211.11 |- skos__altLabel mesh__D024482 Vitamin K Quinone
% 210.96/211.11 |- skos__annotation mesh__D024482
% 210.96/211.11 deficiency: coordinate VITAMIN K 2 %28%IM%29% with VITAMIN K DEFICIENCY %28%IM%29%%A%
% 210.96/211.11 |- mesh__recordMaintainer mesh__D024482 ssb
% 210.96/211.11 |- mesh__dateRevised mesh__D024482 2005-06-30
% 210.96/211.11 |- mesh__dateEstablished mesh__D024482 2002-01-01
% 210.96/211.11 |- skos__altLabel mesh__D024482 Menaquinone
% 210.96/211.11 |- mesh__recordOriginator mesh__D024482 lkt
% 210.96/211.11 |- skos__broader mesh__D024482smesh__D014812
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D024482 2002; see VITAMIN K 1965-2001
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D024482 2006
% 210.96/211.11 |- skos__scopeNote mesh__D018445
% 210.96/211.11 The transmission of infectious disease or pathogens from one generation to another. It includes transmission in utero or intrapartum by exposure to blood and secretions, and postpartum exposure via breastfeeding.%A%
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 2006
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 2001
% 210.96/211.11 |- skos__hiddenLabel mesh__D018445 Transmission, Maternal Fetal
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D018445 PLS
% 210.96/211.11 |- skos__hiddenLabel mesh__D018445 Transmission, Vertical Disease
% 210.96/211.11 |- mesh__recordMaintainer mesh__D018445 TGC
% 210.96/211.11 |- skos__altLabel mesh__D018445 Vertical Disease Transmission
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 2005
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 2004
% 210.96/211.11 |- rdf__type mesh__D018445sskos__Concept
% 210.96/211.11 |- skos__altLabel mesh__D018445 Fetomaternal Transmission
% 210.96/211.11 |- skos__altLabel mesh__D018445 Vertical Transmission
% 210.96/211.11 |- skos__altLabel mesh__D018445 Transmission, Fetomaternal
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 2000
% 210.96/211.11 |- mesh__dateEstablished mesh__D018445 1995-01-01
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 2003
% 210.96/211.11 |- skos__prefLabel mesh__D018445 Disease Transmission, Vertical
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D018445 95
% 210.96/211.11 |- skos__annotation mesh__D018445
% 210.96/211.11 vertical refers to transm from one generation to another; coord IM with specific dis /transm %28%IM%29%; DISEASE TRANSMISSION, HORIZONTAL %28%transm in same generation%29% is also available; DF: DIS TRANSM VERTICAL%A%
% 210.96/211.11 |- skos__hiddenLabel mesh__D018445 Maternal Fetal Transmission
% 210.96/211.11 |- skos__historyNote mesh__D018445
% 210.96/211.11 specific diseases/transmission %28%1975-1994%29%
% 210.96/211.11 |- mesh__dateCreated mesh__D018445 1994-01-25
% 210.96/211.11 |- mesh__recordOriginator mesh__D018445 AGS
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 2002
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 1999
% 210.96/211.11 |- skos__altLabel mesh__D018445 Transmission, Maternal-Fetal
% 210.96/211.11 |- skos__broader mesh__D018445smesh__D018562
% 210.96/211.11 |- skos__altLabel mesh__D018445 Vertical Transmission of Disease
% 210.96/211.11 |- mesh__historyNote mesh__D018445 95
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 1998
% 210.96/211.11 |- skos__altLabel mesh__D018445 Transmission, Vertical
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D018445 1997
% 210.96/211.11 |- mesh__dateRevised mesh__D018445 1996-06-10
% 210.96/211.11 |- mesh__dateRevised mesh__D010462 2005-06-30
% 210.96/211.11 |- mesh__recordMaintainer mesh__D010462 SYSTEM
% 210.96/211.11 |- skos__broader mesh__D010462smesh__D006095
% 210.96/211.11 |- rdf__type mesh__D010462sskos__Concept
% 210.96/211.11 |- skos__scopeNote mesh__D010462
% 210.96/211.11 A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of humans. Its organisms are opportunistic pathogens causing bacteremias and soft tissue infections.%A%
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D010462 sjn
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D010462 2006
% 210.96/211.11 |- mesh__recordOriginator mesh__D010462 NLM
% 210.96/211.11 |- skos__prefLabel mesh__D010462 Peptostreptococcus
% 210.96/211.11 |- mesh__historyNote mesh__D010462
% 210.96/211.11 GAFFKYA ANAEROBIA was see MICROCOCCUS 1979-91
% 210.96/211.11 |- mesh__dateCreated mesh__D010462 1999-01-01
% 210.96/211.11 |- mesh__onlineNote mesh__D010462
% 210.96/211.11 use MICROCOCCUS to search GAFFKYA ANAEROBIA 1979-91
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D010462
% 210.96/211.11 GAFFKYA ANAEROBIA was see MICROCOCCUS 1979-91
% 210.96/211.11 |- skos__annotation mesh__D010462
% 210.96/211.11 opportunistic; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 210.96/211.11 |- rdf__type mesh__D051879sskos__Concept
% 210.96/211.11 |- mesh__historyNote mesh__D051879 2006%28%1990%29%
% 210.96/211.11 |- skos__prefLabel mesh__D051879 Twist Transcription Factor
% 210.96/211.11 |- skos__hiddenLabel mesh__D051879 Transcription Factor, Twist
% 210.96/211.11 |- mesh__dateCreated mesh__D051879 2005-06-30
% 210.96/211.11 |- mesh__recordOriginator mesh__D051879 DRC
% 210.96/211.11 |- skos__scopeNote mesh__D051879
% 210.96/211.11 A basic helix-loop-helix transcription factor that was originally identified in DROSOPHILA as essential for proper gastrulation and MESODERM formation. It plays an important role in EMBRYONIC DEVELOPMENT and CELL DIFFERENTIATION of MUSCLE CELLS, and is found in a wide variety of organisms.%A%
% 210.96/211.11 |- mesh__dateEstablished mesh__D051879 2006-01-01
% 210.96/211.11 |- skos__altLabel mesh__D051879 Twist Protein
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D051879
% 210.96/211.11 2006; TWIST TRANSCRIPTION FACTOR was indexed under NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D051879 2006
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D051879 sjn
% 210.96/211.11 |- mesh__recordMaintainer mesh__D051879 DRC
% 210.96/211.11 |- skos__broader mesh__D051879smesh__D051792
% 210.96/211.11 |- mesh__recordMaintainer mesh__D004425 ags
% 210.96/211.11 |- mesh__dateRevised mesh__D004425 2005-06-30
% 210.96/211.11 |- skos__hiddenLabel mesh__D004425 Cartilages, Ear
% 210.96/211.11 |- mesh__dateEstablished mesh__D004425 1991-01-01
% 210.96/211.11 |- rdf__type mesh__D004425sskos__Concept
% 210.96/211.11 |- skos__historyNote mesh__D004425 Ear, External %28%1966-1978%29%
% 210.96/211.11 |- skos__prefLabel mesh__D004425 Ear Cartilages
% 210.96/211.11 |- skos__broader mesh__D004425smesh__D004431
% 210.96/211.11 |- skos__hiddenLabel mesh__D004425 Cartilage, Ear
% 210.96/211.11 |- mesh__dateCreated mesh__D004425 1978-05-19
% 210.96/211.11 |- skos__historyNote mesh__D004425 Cartilage %28%1966-1978%29%
% 210.96/211.11 |- skos__annotation mesh__D004425
% 210.96/211.11 /abnorm permitted for congen deform but acquired deform = EAR DEFORMITIES, ACQUIRED %28%IM%29% + EAR CARTILAGES %28%NIM%29%%A%
% 210.96/211.11 |- skos__scopeNote mesh__D004425
% 210.96/211.11 Cartilages of the auricle %28%pinna%29% and the external acoustic meatus.%A%
% 210.96/211.11 |- skos__hiddenLabel mesh__D004425 Ear Cartilage
% 210.96/211.11 |- mesh__historyNote mesh__D004425
% 210.96/211.11 91%28%79%29%; was see under EAR, EXTERNAL 1979-90
% 210.96/211.11 |- mesh__recordOriginator mesh__D004425 RC
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D004425 sjn
% 210.96/211.11 |- skos__broader mesh__D004425smesh__D051472
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D004425 2006
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D004425
% 210.96/211.11 91; was see under EAR, EXTERNAL 1979-90
% 210.96/211.11 |- skos__broader mesh__D009887Q000295smesh__D009887
% 210.96/211.11 |- mesh__preferredCombination mesh__D009887Q000295smesh__D019721
% 210.96/211.11 |- rdf__type mesh__D009887Q000295smesh__CompoundConcept
% 210.96/211.11 |- rdf__type mesh__D009110sskos__Concept
% 210.96/211.11 |- skos__hiddenLabel mesh__D009110 Syndrome, Hospital Addiction
% 210.96/211.11 |- skos__annotation mesh__D009110
% 210.96/211.11 dis symptoms fabricated by a person seeking hospitalization repeatedly; MUNCHAUSEN SYNDROME BY PROXY is available%A%
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D009110 2002
% 210.96/211.11 |- skos__hiddenLabel mesh__D009110 Syndromes, Hospital-Addiction
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D009110 2003
% 210.96/211.11 |- skos__hiddenLabel mesh__D009110 Syndrome, Munchausen
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D009110 1998
% 210.96/211.11 |- skos__hiddenLabel mesh__D009110 Hospital Addiction Syndrome
% 210.96/211.11 |- mesh__recordOriginator mesh__D009110 NLM
% 210.96/211.11 |- skos__hiddenLabel mesh__D009110 Hospital-Addiction Syndromes
% 210.96/211.11 |- mesh__recordMaintainer mesh__D009110 JLS
% 210.96/211.11 |- mesh__dateCreated mesh__D009110 1999-01-01
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D009110 2005
% 210.96/211.11 |- skos__altLabel mesh__D009110 Hospital-Addiction Syndrome
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D009110 2004
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D009110 1999
% 210.96/211.11 |- skos__scopeNote mesh__D009110
% 210.96/211.11 A factitious disorder characterized by habitual presentation for hospital treatment of an apparent acute illness, the patient giving a plausible and dramatic history, all of which is false.%A%
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D009110 2000
% 210.96/211.11 |- mesh__historyNote mesh__D009110 68%28%64%29%
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D009110 2006
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D009110 2001
% 210.96/211.11 |- mesh__dateRevised mesh__D009110 1997-06-20
% 210.96/211.11 |- mesh__dateEstablished mesh__D009110 1968-01-01
% 210.96/211.11 |- skos__altLabel mesh__D009110 Syndrome, Hospital-Addiction
% 210.96/211.11 |- skos__hiddenLabel mesh__D009110 Syndrome, Munchhausen
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D009110 SJN
% 210.96/211.11 |- skos__broader mesh__D009110smesh__D005162
% 210.96/211.11 |- skos__prefLabel mesh__D009110 Munchausen Syndrome
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D009110 68
% 210.96/211.11 |- skos__altLabel mesh__D009110 Munchhausen Syndrome
% 210.96/211.11 |- skos__hiddenLabel mesh__D020890 Differentiation Factor, neu
% 210.96/211.11 |- mesh__historyNote mesh__D020890
% 210.96/211.11 2000; use NEUREGULIN-1 %28%NM%29% 1993-1999; for GLIAL GROWTH FACTOR use GLIA MATURATION FACTOR %28%NM%29% 1980-1999%A%
% 210.96/211.11 |- skos__altLabel mesh__D020890 NRG1 Protein
% 210.96/211.11 |- mesh__recordOriginator mesh__D020890 jmp
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D020890 2006
% 210.96/211.11 |- skos__historyNote mesh__D020890 Nerve Tissue Proteins %28%1980-1999%29%
% 210.96/211.11 |- mesh__dateRevised mesh__D020890 2005-06-30
% 210.96/211.11 |- rdf__type mesh__D020890sskos__Concept
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D020890 sjn
% 210.96/211.11 |- skos__altLabel mesh__D020890 NDF Protein
% 210.96/211.11 |- skos__historyNote mesh__D020890 Glycoproteins %28%1986-1999%29%
% 210.96/211.11 |- skos__scopeNote mesh__D020890
% 210.96/211.11 A peptide factor originally identified by its ability to stimulate the phosphorylation the erbB-2 receptor %28%RECEPTOR, ERBB-2%29%. It is a ligand for the erbB-3 receptor %28%RECEPTOR, ERBB-3%29% and the erbB-4 receptor. Variant forms of NEUREGULIN-1 occur through alternative splicing of its mRNA.%A%
% 210.96/211.11 |- skos__broader mesh__D020890smesh__D020880
% 210.96/211.11 |- skos__prefLabel mesh__D020890 Neuregulin-1
% 210.96/211.11 |- skos__hiddenLabel mesh__D020890 Neuregulin 1
% 210.96/211.11 |- mesh__dateEstablished mesh__D020890 2000-01-01
% 210.96/211.11 |- skos__annotation mesh__D020890
% 210.96/211.11 do not confuse X ref GLIAL GROWTH FACTOR with GLIA MATURATION FACTOR%A%
% 210.96/211.11 |- skos__altLabel mesh__D020890 GGF Protein
% 210.96/211.11 |- mesh__dateCreated mesh__D020890 1999-11-04
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D020890
% 210.96/211.11 2000; NEUREGULIN-1 was indexed under GLYCOPROTEINS 1993-1999; GLIAL GROWTH FACTOR was indexed under NERVE TISSUE PROTEINS 1980-1999%A%
% 210.96/211.11 |- mesh__recordMaintainer mesh__D020890 ssb
% 210.96/211.11 |- skos__broader mesh__D020168Q000031smesh__D020168
% 210.96/211.11 |- mesh__preferredCombination mesh__D020168Q000031smesh__D018435
% 210.96/211.11 |- rdf__type mesh__D020168Q000031smesh__CompoundConcept
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D020092 2006
% 210.96/211.11 |- skos__scopeNote mesh__D020092
% 210.96/211.11 A genus of fungi in the family Ancylistaceae, order ENTOMOPHTHORALES, characterized by the presence of small nuclei with a prominent central nucleolus in interphase. They are commonly found in the soil but also infect termites, aphids, and sometimes, though rarely, mammals including humans. %28%Alexopoulos et al, Introductory Mycology, 4th ed, pp159-60%29%%A%
% 210.96/211.11 |- mesh__recordOriginator mesh__D020092 AGS
% 210.96/211.11 |- skos__annotation mesh__D020092
% 210.96/211.11 infection: coord IM with ZYGOMYCOSIS %28%IM%29%
% 210.96/211.11 |- skos__historyNote mesh__D020092 Zygomycota %28%1976-1998%29%
% 210.96/211.11 |- skos__broader mesh__D020092smesh__D020091
% 210.96/211.11 |- mesh__dateEstablished mesh__D020092 1999-01-01
% 210.96/211.11 |- mesh__dateCreated mesh__D020092 1998-06-10
% 210.96/211.11 |- mesh__recordMaintainer mesh__D020092 SYSTEM
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D020092 99
% 210.96/211.11 |- mesh__dateRevised mesh__D020092 2005-06-30
% 210.96/211.11 |- skos__prefLabel mesh__D020092 Conidiobolus
% 210.96/211.11 |- mesh__historyNote mesh__D020092 99
% 210.96/211.11 |- rdf__type mesh__D020092sskos__Concept
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D020092 sjn
% 210.96/211.11 |- skos__hiddenLabel mesh__D014853 Walker
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 1993
% 210.96/211.11 |- mesh__dateEstablished mesh__D014853 1991-01-01
% 210.96/211.11 |- mesh__dateRevised mesh__D014853 1992-05-18
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 2006
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 1998
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 2001
% 210.96/211.11 |- mesh__recordMaintainer mesh__D014853 TAP
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 2005
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 1997
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 2000
% 210.96/211.11 |- mesh__historyNote mesh__D014853
% 210.96/211.11 91%28%75%29%; was see under ORTHOPEDIC EQUIPMENT 1975-90
% 210.96/211.11 |- mesh__dateCreated mesh__D014853 1974-12-12
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 2004
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 1996
% 210.96/211.11 |- mesh__activeMeSHYear mesh__D014853 1995
% 210.96/211.11 |- mesh__recordAuthorizer mesh__D014853 PLS
% 210.96/211.11 |- mesh__publicMeSHNote mesh__D014853
% 210.96/211.11 91; was see under ORTHOPEDIC EQUIPMENT 1975-90
% 210.96/211.11 |- skos__broader mesh__D014853smesh__D009983
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014853 2003
% 210.96/211.12 |- skos__scopeNote mesh__D014853
% 210.96/211.12 Walking aids generally having two handgrips and four legs.%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014853 1994
% 210.96/211.12 |- mesh__recordOriginator mesh__D014853 NLM
% 210.96/211.12 |- rdf__type mesh__D014853sskos__Concept
% 210.96/211.12 |- skos__prefLabel mesh__D014853 Walkers
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014853 1999
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014853 2002
% 210.96/211.12 |- skos__broader mesh__D014055smesh__D011877
% 210.96/211.12 |- skos__altLabel mesh__D014055 CAT Scan, Radionuclide
% 210.96/211.12 |- mesh__recordOriginator mesh__D014055 SMH
% 210.96/211.12 |- mesh__dateEstablished mesh__D014055 1980-01-01
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Radionuclide Computed Tomography
% 210.96/211.12 |- skos__altLabel mesh__D014055 Tomography, Computerized Emission
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Radionuclide CAT Scan
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Emission Tomography, Computerized
% 210.96/211.12 |- skos__historyNote mesh__D014055
% 210.96/211.12 Tomography, X-Ray Computed %28%1977-1979%29%
% 210.96/211.12 |- skos__altLabel mesh__D014055 Tomography, Radionuclide-Computed
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Tomography, Emission Computed
% 210.96/211.12 |- skos__altLabel mesh__D014055 Radionuclide Tomography, Computed
% 210.96/211.12 |- mesh__dateCreated mesh__D014055 1979-05-29
% 210.96/211.12 |- mesh__historyNote mesh__D014055
% 210.96/211.12 90; was TOMOGRAPHY, EMISSION COMPUTED 1980-89
% 210.96/211.12 |- skos__altLabel mesh__D014055 Emission-Computed Tomography
% 210.96/211.12 |- skos__altLabel mesh__D014055 Computerized Emission Tomography
% 210.96/211.12 |- skos__annotation mesh__D014055
% 210.96/211.12 uses radionuclides %26% computer: do not confuse with TOMOGRAPHY, X-RAY COMPUTED using x-rays %26% computer; %22%computed tomography%22% unspecified is probably TOMOGRAPHY, X-RAY COMPUTED;%A%
% 210.96/211.12 |- skos__altLabel mesh__D014055 Computed Tomographic Scintigraphy
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Scan, Radionuclide CAT
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Computed Radionuclide Tomography
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Tomographic Scintigraphy, Computed
% 210.96/211.12 |- skos__historyNote mesh__D014055 Tomography %28%1966-1979%29%
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Radionuclide CAT Scans
% 210.96/211.12 |- skos__broader mesh__D014055smesh__D007089
% 210.96/211.12 |- skos__broader mesh__D014055smesh__D007090
% 210.96/211.12 |- skos__broader mesh__D014055smesh__D014054
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014055 2005
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Emission Computed Tomography
% 210.96/211.12 |- mesh__onlineNote mesh__D014055
% 210.96/211.12 use TOMOGRAPHY, EMISSION-COMPUTED to search TOMOGRAPHY, EMISSION COMPUTED 1980-89%A%
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Scans, Radionuclide CAT
% 210.96/211.12 |- skos__scopeNote mesh__D014055
% 210.96/211.12 Tomography using emissions from radionuclides and a computer algorithm to reconstruct the image.%A%
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Tomography, Computed Radionuclide
% 210.96/211.12 |- mesh__recordMaintainer mesh__D014055 ssb
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D014055
% 210.96/211.12 90; was TOMOGRAPHY, EMISSION COMPUTED 1980-89
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 CAT Scans, Radionuclide
% 210.96/211.12 |- skos__altLabel mesh__D014055 Scintigraphy, Computed Tomographic
% 210.96/211.12 |- skos__prefLabel mesh__D014055 Tomography, Emission-Computed
% 210.96/211.12 |- mesh__dateRevised mesh__D014055 2004-07-07
% 210.96/211.12 |- rdf__type mesh__D014055sskos__Concept
% 210.96/211.12 |- skos__hiddenLabel mesh__D014055 Tomography, Radionuclide Computed
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014055 2006
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D014055 sjn
% 210.96/211.12 |- skos__related mesh__D014055smesh__D015902
% 210.96/211.12 |- mesh__dateCreated mesh__D008816 1978-03-20
% 210.96/211.12 |- skos__prefLabel mesh__D008816 Mice, Jimpy
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D008816 2006
% 210.96/211.12 |- mesh__historyNote mesh__D008816
% 210.96/211.12 91%28%79%29%; was see under MICE, NEUROLOGIC MUTANTS 1979-90
% 210.96/211.12 |- mesh__dateEstablished mesh__D008816 1991-01-01
% 210.96/211.12 |- rdf__type mesh__D008816sskos__Concept
% 210.96/211.12 |- mesh__recordOriginator mesh__D008816 EC
% 210.96/211.12 |- mesh__recordMaintainer mesh__D008816 ags
% 210.96/211.12 |- skos__hiddenLabel mesh__D008816 Jimpy Mice
% 210.96/211.12 |- mesh__dateRevised mesh__D008816 2005-06-30
% 210.96/211.12 |- skos__scopeNote mesh__D008816
% 210.96/211.12 Myelin-deficient mutants which are from the inbred Tabby-Jimpy strain.%A%
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D008816
% 210.96/211.12 91; was see under MICE, NEUROLOGIC MUTANTS 1979-90
% 210.96/211.12 |- skos__historyNote mesh__D008816 Mice, Inbred Strains %28%1972-1978%29%
% 210.96/211.12 |- skos__annotation mesh__D008816
% 210.96/211.12 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.96/211.12 |- skos__broader mesh__D008816smesh__D008817
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D008816 sjn
% 210.96/211.12 |- mesh__historyNote mesh__D000833
% 210.96/211.12 87%28%79%29%; was see under ANIMALS 1979-86
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D000833 sjn
% 210.96/211.12 |- mesh__dateRevised mesh__D000833 2003-07-30
% 210.96/211.12 |- mesh__dateEstablished mesh__D000833 1987-01-01
% 210.96/211.12 |- skos__broader mesh__D000833smesh__D000828
% 210.96/211.12 |- skos__prefLabel mesh__D000833 Animals, Suckling
% 210.96/211.12 |- skos__hiddenLabel mesh__D000833 Animal, Suckling
% 210.96/211.12 |- mesh__recordMaintainer mesh__D000833 ags
% 210.96/211.12 |- skos__scopeNote mesh__D000833
% 210.96/211.12 Young, unweaned mammals. Refers to nursing animals whether nourished by their biological mother, foster mother, or bottle fed.%A%
% 210.96/211.12 |- mesh__dateCreated mesh__D000833 1978-05-04
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000833 2005
% 210.96/211.12 |- rdf__type mesh__D000833sskos__Concept
% 210.96/211.12 |- skos__hiddenLabel mesh__D000833 Suckling Animals
% 210.96/211.12 |- skos__hiddenLabel mesh__D000833 Suckling Animal
% 210.96/211.12 |- mesh__recordOriginator mesh__D000833 EC
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000833 2006
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000833 2004
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D000833 87; was see under ANIMALS 1979-86
% 210.96/211.12 |- skos__annotation mesh__D000833
% 210.96/211.12 suckled by mother or by bottle; coord with specific suckling; NIM when exper animal: no qualif; when IM, qualif permitted; suckling of animals %28%the act, as in the eff of suckling on animal physiol%29% goes under LACTATION; do not forget also to check tag ANIMALS%A%
% 210.96/211.12 |- mesh__dateCreated mesh__D008018 1999-01-01
% 210.96/211.12 |- skos__hiddenLabel mesh__D008018 Cycle, Life
% 210.96/211.12 |- mesh__dateEstablished mesh__D008018 1998-01-01
% 210.96/211.12 |- skos__historyNote mesh__D008018
% 210.96/211.12 specific organism/growth %26% development %28%1967-1997%29%
% 210.96/211.12 |- skos__hiddenLabel mesh__D008018 Stage, Life Cycle
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D008018 sjn
% 210.96/211.12 |- skos__annotation mesh__D008018
% 210.96/211.12 GEN or unspecified; prefer specifics; coord IM with name of organism with /growth %28%IM%29%%A%
% 210.96/211.12 |- mesh__recordOriginator mesh__D008018 NLM
% 210.96/211.12 |- skos__hiddenLabel mesh__D008018 Stages, Life Cycle
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D008018 98
% 210.96/211.12 |- skos__prefLabel mesh__D008018 Life Cycle Stages
% 210.96/211.12 |- skos__hiddenLabel mesh__D008018 Life Cycle Stage
% 210.96/211.12 |- rdf__type mesh__D008018sskos__Concept
% 210.96/211.12 |- skos__scopeNote mesh__D008018
% 210.96/211.12 The continuous sequence of changes undergone by metamorphosing insects and other animals during the post-embryonic development process.%A%
% 210.96/211.12 |- mesh__historyNote mesh__D008018 98; use explode 1975-97
% 210.96/211.12 |- skos__broader mesh__D008018smesh__D008675
% 210.96/211.12 |- mesh__dateRevised mesh__D008018 2004-07-07
% 210.96/211.12 |- skos__altLabel mesh__D008018 Life Cycle
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D008018 2006
% 210.96/211.12 |- skos__historyNote mesh__D008018
% 210.96/211.12 Metamorphosis, Biological %28%1967-1997%29%
% 210.96/211.12 |- skos__hiddenLabel mesh__D008018 Life Cycles
% 210.96/211.12 |- skos__hiddenLabel mesh__D008018 Cycles, Life
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D008018 2005
% 210.96/211.12 |- mesh__recordMaintainer mesh__D008018 lkt
% 210.96/211.12 |- skos__scopeNote mesh__D000035
% 210.96/211.12 A process in psychotherapy in which the patient is %22%desensitized%22% to emotionally painful, often forgotten %28%repressed%29% memories by recalling and reacting to them in the %22%safety%22% of the treatment setting.%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000035 2001
% 210.96/211.12 |- skos__hiddenLabel mesh__D000035 Abreactions
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000035 2006
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D000035 SJN
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D000035 68
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000035 2000
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000035 2005
% 210.96/211.12 |- mesh__recordMaintainer mesh__D000035 PXP
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000035 1999
% 210.96/211.12 |- skos__prefLabel mesh__D000035 Abreaction
% 210.96/211.12 |- rdf__type mesh__D000035sskos__Concept
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000035 1998
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000035 2002
% 210.96/211.12 |- mesh__historyNote mesh__D000035 68
% 210.96/211.12 |- skos__broader mesh__D000035smesh__D013811
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000035 2004
% 210.96/211.12 |- mesh__dateRevised mesh__D000035 1997-06-20
% 210.96/211.12 |- mesh__dateEstablished mesh__D000035 1968-01-01
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D000035 2003
% 210.96/211.12 |- mesh__recordOriginator mesh__D000035 NLM
% 210.96/211.12 |- mesh__dateCreated mesh__D000035 1999-01-01
% 210.96/211.12 |- skos__annotation mesh__D000035 no qualif
% 210.96/211.12 |- mesh__recordOriginator mesh__D046935 ssb
% 210.96/211.12 |- mesh__dateEstablished mesh__D046935 2005-01-01
% 210.96/211.12 |- mesh__historyNote mesh__D046935 2005
% 210.96/211.12 |- skos__scopeNote mesh__D046935
% 210.96/211.12 A degraded form of GINKGOLIDES that have three LACTONES and a unique tert-butyl group which are found in GINKGO plants.%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D046935 2005
% 210.96/211.12 |- rdf__type mesh__D046935sskos__Concept
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D046935 2006
% 210.96/211.12 |- skos__broader mesh__D046935smesh__D046934
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D046935 sjn
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D046935 2005
% 210.96/211.12 |- mesh__recordMaintainer mesh__D046935 ssb
% 210.96/211.12 |- skos__prefLabel mesh__D046935 Bilobalides
% 210.96/211.12 |- mesh__dateCreated mesh__D046935 2004-07-07
% 210.96/211.12 |- skos__broader mesh__D024483smesh__D014812
% 210.96/211.12 |- skos__historyNote mesh__D024483 Vitamin K %28%1965-2001%29%
% 210.96/211.12 |- skos__altLabel mesh__D024483 Vitamin K3
% 210.96/211.12 |- mesh__dateCreated mesh__D024483 2001-07-25
% 210.96/211.12 |- skos__prefLabel mesh__D024483 Vitamin K 3
% 210.96/211.12 |- mesh__dateEstablished mesh__D024483 2002-01-01
% 210.96/211.12 |- skos__annotation mesh__D024483
% 210.96/211.12 deficiency: coordinate VITAMIN K 3 %28%IM%29% with VITAMIN K DEFICIENCY %28%IM%29%%A%
% 210.96/211.12 |- skos__altLabel mesh__D024483 Menadione
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D024483 sjn
% 210.96/211.12 |- mesh__recordOriginator mesh__D024483 lkt
% 210.96/211.12 |- skos__altLabel mesh__D024483 Menadione sodium bisulfite
% 210.96/211.12 |- skos__scopeNote mesh__D024483
% 210.96/211.12 A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.%A%
% 210.96/211.12 |- mesh__historyNote mesh__D024483 2002; use VITAMIN K 1965-2001
% 210.96/211.12 |- skos__broader mesh__D024483smesh__D009285
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D024483 2002; see VITAMIN K 1965-2001
% 210.96/211.12 |- mesh__dateRevised mesh__D024483 2005-06-30
% 210.96/211.12 |- mesh__recordMaintainer mesh__D024483 ssb
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D024483 2006
% 210.96/211.12 |- skos__altLabel mesh__D024483 2-Methyl-1,4-naphthalenedione
% 210.96/211.12 |- skos__altLabel mesh__D024483 2-Methylnaphthoquinone
% 210.96/211.12 |- skos__altLabel mesh__D024483 2-Methyl-1,4-naphthoquinone
% 210.96/211.12 |- rdf__type mesh__D024483sskos__Concept
% 210.96/211.12 |- skos__scopeNote mesh__D018446
% 210.96/211.12 The transmission of infectious disease or pathogens from one individual to another in the same generation.%A%
% 210.96/211.12 |- skos__altLabel mesh__D018446 Horizontal Disease Transmission
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 2005
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 2004
% 210.96/211.12 |- rdf__type mesh__D018446sskos__Concept
% 210.96/211.12 |- skos__hiddenLabel mesh__D018446 Transmissions, Horizontal
% 210.96/211.12 |- skos__hiddenLabel mesh__D018446 Disease Transmissions, Horizontal
% 210.96/211.12 |- mesh__dateRevised mesh__D018446 1996-06-10
% 210.96/211.12 |- skos__annotation mesh__D018446
% 210.96/211.12 horizontal refers to transm in same generation; coord IM with specific dis /transm %28%IM%29%; DISEASE TRANSMISSION, VERTICAL %28%transm from one generation to another%29% is also available; DF: DIS TRANSM HORIZONTAL%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 2003
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 2001
% 210.96/211.12 |- skos__hiddenLabel mesh__D018446 Transmissions, Horizontal Disease
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D018446 PLS
% 210.96/211.12 |- mesh__dateCreated mesh__D018446 1994-01-25
% 210.96/211.12 |- skos__prefLabel mesh__D018446 Disease Transmission, Horizontal
% 210.96/211.12 |- skos__altLabel mesh__D018446 Transmission, Horizontal
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 2000
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 1999
% 210.96/211.12 |- mesh__dateEstablished mesh__D018446 1995-01-01
% 210.96/211.12 |- skos__hiddenLabel mesh__D018446 Horizontal Transmissions
% 210.96/211.12 |- skos__altLabel mesh__D018446 Horizontal Transmission of Disease
% 210.96/211.12 |- mesh__historyNote mesh__D018446 95
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D018446 95
% 210.96/211.12 |- skos__hiddenLabel mesh__D018446 Horizontal Disease Transmissions
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 1998
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 1997
% 210.96/211.12 |- skos__historyNote mesh__D018446
% 210.96/211.12 specific diseases/transmission %28%1975-1994%29%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 2006
% 210.96/211.12 |- mesh__recordOriginator mesh__D018446 AGS
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D018446 2002
% 210.96/211.12 |- skos__hiddenLabel mesh__D018446 Transmission, Horizontal Disease
% 210.96/211.12 |- skos__broader mesh__D018446smesh__D018562
% 210.96/211.12 |- skos__altLabel mesh__D018446 Horizontal Transmission
% 210.96/211.12 |- mesh__recordMaintainer mesh__D018446 TGC
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D010463 2006
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D010463 2002
% 210.96/211.12 |- skos__hiddenLabel mesh__D010463 Desoxone1
% 210.96/211.12 |- mesh__dateRevised mesh__D010463 2000-06-21
% 210.96/211.12 |- mesh__dateCreated mesh__D010463 1974-11-19
% 210.96/211.12 |- skos__broader mesh__D010463smesh__D000088
% 210.96/211.12 |- skos__altLabel mesh__D010463 Acetyl Hydroperoxide
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D010463 2005
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D010463
% 210.96/211.12 91; was see under ACETIC ACIDS 1975-90
% 210.96/211.12 |- skos__historyNote mesh__D010463 Peroxides %28%1969-1974%29%
% 210.96/211.12 |- skos__hiddenLabel mesh__D010463 Peracetate, Zinc
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D010463 2001
% 210.96/211.12 |- skos__historyNote mesh__D010463 Acetic Acids %28%1969-1974%29%
% 210.96/211.12 |- skos__scopeNote mesh__D010463
% 210.96/211.12 A liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant.%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D010463 2004
% 210.96/211.12 |- skos__hiddenLabel mesh__D010463 Acid, Peracetic
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D010463 2003
% 210.96/211.12 |- rdf__type mesh__D010463sskos__Concept
% 210.96/211.12 |- skos__altLabel mesh__D010463 Peroxyethanoic Acid
% 210.96/211.12 |- skos__prefLabel mesh__D010463 Peracetic Acid
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D010463 sjn
% 210.96/211.12 |- skos__hiddenLabel mesh__D010463 Acid, Peroxyethanoic
% 210.96/211.12 |- mesh__recordMaintainer mesh__D010463 CCR
% 210.96/211.12 |- skos__altLabel mesh__D010463 Sodium Peracetate
% 210.96/211.12 |- skos__hiddenLabel mesh__D010463 Peracetate, Sodium
% 210.96/211.12 |- mesh__dateEstablished mesh__D010463 1991-01-01
% 210.96/211.12 |- mesh__historyNote mesh__D010463
% 210.96/211.12 91%28%75%29%; was see under ACETIC ACIDS 1975-90
% 210.96/211.12 |- skos__hiddenLabel mesh__D010463 Desoxone 1
% 210.96/211.12 |- skos__altLabel mesh__D010463 Peroxyacetic Acid
% 210.96/211.12 |- mesh__recordOriginator mesh__D010463 NLM
% 210.96/211.12 |- skos__hiddenLabel mesh__D010463 Acid, Peroxyacetic
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 1998
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 1997
% 210.96/211.12 |- mesh__dateEstablished mesh__D004426 1971-01-01
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 2006
% 210.96/211.12 |- skos__broader mesh__D004426smesh__D004427
% 210.96/211.12 |- rdf__type mesh__D004426sskos__Concept
% 210.96/211.12 |- mesh__historyNote mesh__D004426
% 210.96/211.12 71; was EAR, EXTERNAL, DEFORMITY 1963-70
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 1992
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 1999
% 210.96/211.12 |- mesh__recordMaintainer mesh__D004426 TAP
% 210.96/211.12 |- mesh__dateRevised mesh__D004426 1990-06-04
% 210.96/211.12 |- skos__hiddenLabel mesh__D004426 Deformity, Acquired Ear
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 1994
% 210.96/211.12 |- skos__scopeNote mesh__D004426
% 210.96/211.12 Distortion or disfigurement of the ear caused by disease or injury after birth.%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 1993
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 2002
% 210.96/211.12 |- skos__hiddenLabel mesh__D004426 Ear Deformity, Acquired
% 210.96/211.12 |- skos__hiddenLabel mesh__D004426 Acquired Ear Deformity
% 210.96/211.12 |- mesh__dateCreated mesh__D004426 1999-01-01
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 1995
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D004426 PLS
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 2003
% 210.96/211.12 |- mesh__recordOriginator mesh__D004426 NLM
% 210.96/211.12 |- skos__annotation mesh__D004426
% 210.96/211.12 acquired through inj or dis; do not use /congen : = EAR, EXTERNAL /abnorm %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 2000
% 210.96/211.12 |- skos__hiddenLabel mesh__D004426 Deformities, Acquired Ear
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 1996
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 2005
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 2004
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D004426
% 210.96/211.12 71; was EAR, EXTERNAL, DEFORMITY 1963-70
% 210.96/211.12 |- mesh__onlineNote mesh__D004426
% 210.96/211.12 use EAR /AB %26% EAR, EXTERNAL /AB %26% EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 2001
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D004426 1991
% 210.96/211.12 |- skos__prefLabel mesh__D004426 Ear Deformities, Acquired
% 210.96/211.12 |- skos__hiddenLabel mesh__D004426 Acquired Ear Deformities
% 210.96/211.12 |- mesh__dateRevised mesh__D009111 1999-11-03
% 210.96/211.12 |- rdf__type mesh__D009111sskos__Concept
% 210.96/211.12 |- skos__scopeNote mesh__D009111
% 210.96/211.12 Smallest political subdivisions within a country at which general governmental functions are carried-out.%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D009111 2004
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D009111 2001
% 210.96/211.12 |- skos__altLabel mesh__D009111 Government, Local
% 210.96/211.12 |- skos__annotation mesh__D009111 specify geog
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D009111 2000
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D009111
% 210.96/211.12 99; was MUNICIPAL GOVERNMENT 1966-98
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D009111 2003
% 210.96/211.12 |- mesh__historyNote mesh__D009111 99; was MUNICIPAL GOVERNMENT 1966-98
% 210.96/211.12 |- skos__hiddenLabel mesh__D009111 Government, City
% 210.96/211.12 |- mesh__recordOriginator mesh__D009111 NLM
% 210.96/211.12 |- mesh__dateCreated mesh__D009111 1999-01-01
% 210.96/211.12 |- skos__prefLabel mesh__D009111 Local Government
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D009111 2006
% 210.96/211.12 |- skos__broader mesh__D009111smesh__D006076
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D009111 2002
% 210.96/211.12 |- skos__hiddenLabel mesh__D009111 Government, County
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D009111 sjn
% 210.96/211.12 |- skos__hiddenLabel mesh__D009111 Government, Municipal
% 210.96/211.12 |- skos__hiddenLabel mesh__D009111 Government, Metropolitan
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D009111 2005
% 210.96/211.12 |- mesh__recordMaintainer mesh__D009111 kle
% 210.96/211.12 |- rdf__type mesh__D020891sskos__Concept
% 210.96/211.12 |- skos__scopeNote mesh__D020891
% 210.96/211.12 A substituted benzamide that has antipsychotic properties. It is a dopamine D2 receptor %28%see RECEPTORS, DOPAMINE D2%29% antagonist.%A%
% 210.96/211.12 |- skos__hiddenLabel mesh__D020891 FLA870
% 210.96/211.12 |- skos__historyNote mesh__D020891 Benzamides %28%1985-1986%29%
% 210.96/211.12 |- skos__hiddenLabel mesh__D020891 FLB472
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D020891 2004
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D020891 2005
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D020891 2002
% 210.96/211.12 |- mesh__recordMaintainer mesh__D020891 ssb
% 210.96/211.12 |- mesh__dateRevised mesh__D020891 2001-07-25
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D020891 2003
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D020891
% 210.96/211.12 2000; RACLOPRIDE was indexed under SALICYLAMIDES 1987-1999 %26% BENZAMIDES 1985-1986%A%
% 210.96/211.12 |- skos__prefLabel mesh__D020891 Raclopride
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D020891 sjn
% 210.96/211.12 |- mesh__dateEstablished mesh__D020891 2000-01-01
% 210.96/211.12 |- skos__historyNote mesh__D020891 Salicylamides %28%1987-1999%29%
% 210.96/211.12 |- mesh__recordOriginator mesh__D020891 adp
% 210.96/211.12 |- skos__hiddenLabel mesh__D020891 FLB 472
% 210.96/211.12 |- mesh__dateCreated mesh__D020891 1999-11-03
% 210.96/211.12 |- skos__hiddenLabel mesh__D020891 FLA 870
% 210.96/211.12 |- skos__broader mesh__D020891smesh__D001549
% 210.96/211.12 |- skos__hiddenLabel mesh__D020891 C11, Raclopride
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D020891 2006
% 210.96/211.12 |- mesh__historyNote mesh__D020891 2000; use RACLOPRIDE 1985-1999
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D020093 sjn
% 210.96/211.12 |- mesh__recordMaintainer mesh__D020093 SYSTEM
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D020093 99
% 210.96/211.12 |- skos__scopeNote mesh__D020093
% 210.96/211.12 A genus of zygomycetous fungi of the family Cunninghamellaceae, order MUCORALES. Some species cause systemic infections in humans.%A%
% 210.96/211.12 |- mesh__recordOriginator mesh__D020093 AGS
% 210.96/211.12 |- skos__prefLabel mesh__D020093 Cunninghamella
% 210.96/211.12 |- skos__broader mesh__D020093smesh__D009090
% 210.96/211.12 |- mesh__dateEstablished mesh__D020093 1999-01-01
% 210.96/211.12 |- rdf__type mesh__D020093sskos__Concept
% 210.96/211.12 |- mesh__dateCreated mesh__D020093 1998-06-10
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D020093 2006
% 210.96/211.12 |- mesh__historyNote mesh__D020093 99
% 210.96/211.12 |- skos__annotation mesh__D020093
% 210.96/211.12 infection: coord IM with MUCORMYCOSIS %28%IM%29%
% 210.96/211.12 |- mesh__dateRevised mesh__D020093 2005-06-30
% 210.96/211.12 |- skos__altLabel mesh__D014854 Wallenberg%27%s Syndrome
% 210.96/211.12 |- skos__hiddenLabel mesh__D014854 Vieseaux Wallenberg Syndrome
% 210.96/211.12 |- skos__hiddenLabel mesh__D014854 Lateral Medullary Syndromes
% 210.96/211.12 |- skos__scopeNote mesh__D014854
% 210.96/211.12 Infarction of the dorsolateral aspect of the medulla due to occlusion of the vertebral artery and/or the posterior inferior cerebellar artery. Clinical manifestations vary with the size of infarction, but may include loss of pain and temperature sensation in the ipsilateral face and contralateral body below the chin; ipsilateral HORNER SYNDROME; ipsilateral ATAXIA; DYSARTHRIA; VERTIGO; nausea, hiccup; dysphagia; and VOCAL CORD PARALYSIS. %28%From Adams et al., Principles of Neurology, 6th ed, p801%29%%A%
% 210.96/211.12 |- skos__altLabel mesh__D014854 Vieseaux-Wallenberg Syndrome
% 210.96/211.12 |- skos__hiddenLabel mesh__D014854 Medullary Syndrome, Dorsolateral
% 210.96/211.12 |- skos__hiddenLabel mesh__D014854 Wallenbergs Syndrome
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014854 2006
% 210.96/211.12 |- skos__hiddenLabel mesh__D014854 Syndromes, Lateral Medullary
% 210.96/211.12 |- mesh__historyNote mesh__D014854 f f
% 210.96/211.12 |- mesh__recordMaintainer mesh__D014854 ssb
% 210.96/211.12 |- skos__hiddenLabel mesh__D014854 Syndrome, Vieseaux-Wallenberg
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D014854
% 210.96/211.12 2000 %28%1991%29%; see WALLENBERG%27%S SYNDROME 1991-1999, see CEREBRAL EMBOLISM AND THROMBOSIS 1964-1990%A%
% 210.96/211.12 |- skos__altLabel mesh__D014854 Lateral Bulbar Syndrome
% 210.96/211.12 |- skos__altLabel mesh__D014854 Dorsolateral Medullary Syndrome
% 210.96/211.12 |- skos__prefLabel mesh__D014854 Lateral Medullary Syndrome
% 210.96/211.12 |- mesh__dateCreated mesh__D014854 1999-01-01
% 210.96/211.12 |- skos__hiddenLabel mesh__D014854 Syndrome, Wallenberg
% 210.96/211.12 |- skos__altLabel mesh__D014854
% 210.96/211.12 Posterior Inferior Cerebellar Artery Syndrome
% 210.96/211.12 |- mesh__recordOriginator mesh__D014854 NLM
% 210.96/211.12 |- skos__altLabel mesh__D014854 Wallenberg Syndrome
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D014854 sjn
% 210.96/211.12 |- skos__broader mesh__D014854smesh__D020526
% 210.96/211.12 |- mesh__dateRevised mesh__D014854 2005-06-30
% 210.96/211.12 |- rdf__type mesh__D014854sskos__Concept
% 210.96/211.12 |- mesh__dateEstablished mesh__D014854 1991-01-01
% 210.96/211.12 |- skos__broader mesh__D047230smesh__D011161
% 210.96/211.12 |- skos__scopeNote mesh__D047230
% 210.96/211.12 A genus of large, brightly colored SPONGES in the family Agelasidae, possessing a skeleton of spongin fibers with a core of large spicules %28%megascleres%29%.%A%
% 210.96/211.12 |- mesh__publicMeSHNote mesh__D047230 2005
% 210.96/211.12 |- skos__historyNote mesh__D047230 Porifera %28%1989-2004%29%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D047230 2006
% 210.96/211.12 |- mesh__recordAuthorizer mesh__D047230 sjn
% 210.96/211.12 |- mesh__historyNote mesh__D047230 2005
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D047230 2005
% 210.96/211.12 |- mesh__recordMaintainer mesh__D047230 ags
% 210.96/211.12 |- mesh__dateEstablished mesh__D047230 2005-01-01
% 210.96/211.12 |- mesh__recordOriginator mesh__D047230 ags
% 210.96/211.12 |- rdf__type mesh__D047230sskos__Concept
% 210.96/211.12 |- mesh__dateCreated mesh__D047230 2004-07-07
% 210.96/211.12 |- skos__prefLabel mesh__D047230 Agelas
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014056 2000
% 210.96/211.12 |- mesh__dateRevised mesh__D014056 1997-06-20
% 210.96/211.12 |- mesh__dateEstablished mesh__D014056 1973-01-01
% 210.96/211.12 |- mesh__recordMaintainer mesh__D014056 PXP
% 210.96/211.12 |- skos__altLabel mesh__D014056 Tomography, Transmission
% 210.96/211.12 |- skos__annotation mesh__D014056
% 210.96/211.12 do not use /util except by MeSH definition; DF: TOMOGR X RAY%A%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014056 2006
% 210.96/211.12 |- skos__broader mesh__D014056smesh__D011859
% 210.96/211.12 |- skos__altLabel mesh__D014056 Radiographic Tomography
% 210.96/211.12 |- skos__historyNote mesh__D014056 Tomography %28%1966-1972%29%
% 210.96/211.12 |- mesh__activeMeSHYear mesh__D014056 1999
% 210.96/211.12 |- mesh__onlineNote mesh__D014056
% 210.96/211.12 use TOMOGRAPHY, X-RAY to search TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY X-RAY, PLANIGRAPHY, X-RAY %26% STRATIGRAPHY, X-RAY 1980-96; RADIOGRAPHY, BODY-SECTION 1973-96; LAMINAGRAPHY, RADIOGRAPHIC 1975-79; PLANIGRAPHY, RADIOGRAPHIC %26% STRATIGRAPHY, RADIOGRAPHIC 1973-79%A%
% 210.96/211.12 |- skos__altLabel mesh__D014056 Tomography, Radiographic
% 210.96/211.12 |- skos__altLabel mesh__D014056 X-Ray Tomography
% 210.96/211.13 |- skos__altLabel mesh__D014056 Transmission Tomography
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014056 2005
% 210.96/211.13 |- skos__altLabel mesh__D014056 Tomography, Xray
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014056 2004
% 210.96/211.13 |- mesh__historyNote mesh__D014056
% 210.96/211.13 80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY, X-RAY was see TOMOGRAPHY, X-RAY 1980-96, was LAMINAGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1975-79; PLANIGRAPHY, X-RAY %26% STRATIGRAPHY, X-RAY were see TOMOGRAPHY, X-RAY 1980-96, were PLANIGRAPHY, RADIOGRAPHIC %26% STRATIGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1973-79; RADIOGRAPHY, BODY-SECTION was see TOMOGRAPHY, X-RAY 1973-96%A%
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014056 2002
% 210.96/211.13 |- skos__broader mesh__D014056smesh__D014054
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014056 1998
% 210.96/211.13 |- skos__altLabel mesh__D014056 X Ray Tomography
% 210.96/211.13 |- mesh__recordOriginator mesh__D014056 NLM
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014056 2003
% 210.96/211.13 |- skos__scopeNote mesh__D014056 Tomography using x-ray transmission.
% 210.96/211.13 |- rdf__type mesh__D014056sskos__Concept
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D014056 SJN
% 210.96/211.13 |- skos__altLabel mesh__D014056 Xray Tomography
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D014056
% 210.96/211.13 80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY, X-RAY was see TOMOGRAPHY, X-RAY 1980-96, was LAMINAGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1975-96; PLANIGRAPHY, X-RAY %26% STRATIGRAPHY, X-RAY were see TOMOGRAPHY, X-RAY 1980-96, were PLANIGRAPHY, RADIOGRAPHIC %26% STRATIGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1973-79; RADIOGRAPHY, BODY-SECTION was see TOMOGRAPHY, X-RAY 1973-96%A%
% 210.96/211.13 |- skos__prefLabel mesh__D014056 Tomography, X-Ray
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014056 2001
% 210.96/211.13 |- skos__altLabel mesh__D014056 Tomography, X Ray
% 210.96/211.13 |- mesh__dateCreated mesh__D014056 1999-01-01
% 210.96/211.13 |- skos__altLabel mesh__D014056 Zonography
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Mouse Strains, Mutant
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Mutant Strain Mouse
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D008817 sjn
% 210.96/211.13 |- skos__annotation mesh__D008817
% 210.96/211.13 GEN or unspecified; prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 210.96/211.13 |- mesh__recordMaintainer mesh__D008817 ags
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Mice Mutant Strain
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Mutant Mouse Strains
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Strain, Mutant Mouse
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Strains Mice, Mutant
% 210.96/211.13 |- skos__altLabel mesh__D008817 Mutant Strains of Mice
% 210.96/211.13 |- skos__prefLabel mesh__D008817 Mice, Mutant Strains
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Mouse Mutant Strain
% 210.96/211.13 |- mesh__historyNote mesh__D008817 79
% 210.96/211.13 |- skos__altLabel mesh__D008817 Mutant Mouse Strain
% 210.96/211.13 |- mesh__dateEstablished mesh__D008817 1979-01-01
% 210.96/211.13 |- mesh__recordOriginator mesh__D008817 EC
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Mouse Strain, Mutant
% 210.96/211.13 |- skos__altLabel mesh__D008817 Mutant Strain of Mouse
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Mutant Strains Mice
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Strain Mouse, Mutant
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D008817 2006
% 210.96/211.13 |- skos__broader mesh__D008817smesh__D051379
% 210.96/211.13 |- mesh__dateCreated mesh__D008817 1978-04-26
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Mouse Mutant Strains
% 210.96/211.13 |- rdf__type mesh__D008817sskos__Concept
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Mice Mutant Strains
% 210.96/211.13 |- mesh__dateRevised mesh__D008817 2005-06-30
% 210.96/211.13 |- skos__scopeNote mesh__D008817
% 210.96/211.13 Mice bearing mutant genes which are phenotypically expressed in the animals.%A%
% 210.96/211.13 |- skos__altLabel mesh__D008817 Mouse, Mutant Strain
% 210.96/211.13 |- skos__hiddenLabel mesh__D008817 Strains, Mutant Mouse
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D008817 79
% 210.96/211.13 |- skos__scopeNote mesh__D008019
% 210.96/211.13 Typical way of life or manner of living characteristic of an individual or group. %28%From APA, Thesaurus of Psychological Index Terms, 8th ed%29%%A%
% 210.96/211.13 |- skos__hiddenLabel mesh__D008019 Styles, Life
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D008019 jls
% 210.96/211.13 |- skos__hiddenLabel mesh__D008019 Induced Illness, Self
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D008019 2001
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D008019 72
% 210.96/211.13 |- mesh__historyNote mesh__D008019 72%28%70%29%
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D008019 2003
% 210.96/211.13 |- skos__hiddenLabel mesh__D008019 Style, Life
% 210.96/211.13 |- skos__hiddenLabel mesh__D008019 Illnesses, Self Induced
% 210.96/211.13 |- skos__hiddenLabel mesh__D008019 Illness, Self Induced
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D008019 2000
% 210.96/211.13 |- skos__hiddenLabel mesh__D008019 Induced Illnesses, Self
% 210.96/211.13 |- mesh__recordMaintainer mesh__D008019 jls
% 210.96/211.13 |- skos__broader mesh__D008019smesh__D011593
% 210.96/211.13 |- skos__related mesh__D008019smesh__D011788
% 210.96/211.13 |- rdf__type mesh__D008019sskos__Concept
% 210.96/211.13 |- skos__hiddenLabel mesh__D008019 Self Induced Illnesses
% 210.96/211.13 |- skos__altLabel mesh__D008019 Lifestyle
% 210.96/211.13 |- skos__prefLabel mesh__D008019 Life Style
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D008019 2006
% 210.96/211.13 |- mesh__dateRevised mesh__D008019 2004-07-28
% 210.96/211.13 |- mesh__recordOriginator mesh__D008019 NLM
% 210.96/211.13 |- mesh__dateEstablished mesh__D008019 1972-01-01
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D008019 2005A
% 210.96/211.13 |- skos__hiddenLabel mesh__D008019 Lifestyles
% 210.96/211.13 |- skos__related mesh__D008019smesh__D015438
% 210.96/211.13 |- skos__hiddenLabel mesh__D008019 Life Styles
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D008019 2005
% 210.96/211.13 |- mesh__dateCreated mesh__D008019 1999-01-01
% 210.96/211.13 |- skos__historyNote mesh__D008019
% 210.96/211.13 Personality Development %28%1968-1969%29%
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D008019 2002
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D008019 2004
% 210.96/211.13 |- rdf__type mesh__D000036sskos__Concept
% 210.96/211.13 |- skos__broader mesh__D000036smesh__D037121
% 210.96/211.13 |- mesh__dateEstablished mesh__D000036 1991-01-01
% 210.96/211.13 |- skos__historyNote mesh__D000036 Plant Proteins %28%1971-1975%29%
% 210.96/211.13 |- mesh__recordOriginator mesh__D000036 NLM
% 210.96/211.13 |- mesh__dateCreated mesh__D000036 1974-11-19
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D000036
% 210.96/211.13 91; was see under PLANT PROTEINS 1975-90
% 210.96/211.13 |- mesh__dateRevised mesh__D000036 2005-07-29
% 210.96/211.13 |- mesh__recordMaintainer mesh__D000036 jls
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D000036 2006
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D000036 jls
% 210.96/211.13 |- skos__prefLabel mesh__D000036 Abrin
% 210.96/211.13 |- skos__scopeNote mesh__D000036
% 210.96/211.13 A toxic lectin from the seeds of jequirity, Abrus precatorius L. Very active poison. Five different proteins have so far been isolated: Abrus agglutinin, the component responsible for: hemagglutinating activity, %26% abrins a-d, the toxic principals each consisting of two peptide chains are held together by disulfide bonds.%A%
% 210.96/211.13 |- skos__historyNote mesh__D000036 Disulfides %28%1973-1974%29%
% 210.96/211.13 |- mesh__historyNote mesh__D000036
% 210.96/211.13 91%28%75%29%; was see under PLANT PROTEINS 1975-90
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D000036 2006A
% 210.96/211.13 |- skos__altLabel mesh__D046936 Black Chokecherry Tree
% 210.96/211.13 |- mesh__dateRevised mesh__D046936 2005-06-30
% 210.96/211.13 |- skos__annotation mesh__D046936
% 210.96/211.13 X ref BLACK CHOKECHERRY TREE: CHOKECHERRY TREE see PRUNUS is also available; coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.96/211.13 |- skos__prefLabel mesh__D046936 Photinia
% 210.96/211.13 |- mesh__historyNote mesh__D046936 2005
% 210.96/211.13 |- skos__altLabel mesh__D046936 Black Chokeberry Tree
% 210.96/211.13 |- skos__broader mesh__D046936smesh__D027824
% 210.96/211.13 |- mesh__dateEstablished mesh__D046936 2005-01-01
% 210.96/211.13 |- rdf__type mesh__D046936sskos__Concept
% 210.96/211.13 |- skos__altLabel mesh__D046936 Aronia melanocarpa
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D046936 2006
% 210.96/211.13 |- mesh__recordMaintainer mesh__D046936 ssb
% 210.96/211.13 |- mesh__dateCreated mesh__D046936 2004-07-07
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D046936 2005
% 210.96/211.13 |- mesh__recordOriginator mesh__D046936 ssb
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D046936 sjn
% 210.96/211.13 |- skos__scopeNote mesh__D046936
% 210.96/211.13 A plant genus of the family ROSACEAE. The common names of chokeberry or chokecherry are also used for some species of PRUNUS.%A%
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D018447 95
% 210.96/211.13 |- skos__hiddenLabel mesh__D018447 Futile Treatments
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D018447 sjn
% 210.96/211.13 |- skos__historyNote mesh__D018447 Ethics, Medical %28%1990-1994%29%
% 210.96/211.13 |- mesh__historyNote mesh__D018447 95
% 210.96/211.13 |- skos__hiddenLabel mesh__D018447 Treatments, Futile
% 210.96/211.13 |- mesh__dateRevised mesh__D018447 2003-07-09
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D018447 2006
% 210.96/211.13 |- skos__annotation mesh__D018447 DF: MED FUTILITY
% 210.96/211.13 |- skos__related mesh__D018447smesh__D016414
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D018447 2004
% 210.96/211.13 |- skos__hiddenLabel mesh__D018447 Treatment, Futile
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D018447 2005
% 210.96/211.13 |- rdf__type mesh__D018447sskos__Concept
% 210.96/211.13 |- mesh__recordMaintainer mesh__D018447 jls
% 210.96/211.13 |- skos__historyNote mesh__D018447 Decision Making %28%1985-1994%29%
% 210.96/211.13 |- mesh__dateEstablished mesh__D018447 1995-01-01
% 210.96/211.13 |- skos__historyNote mesh__D018447 Resuscitation %28%1989%29%
% 210.96/211.13 |- skos__scopeNote mesh__D018447
% 210.96/211.13 The absence of a useful purpose or useful result in a diagnostic procedure or therapeutic intervention. The situation of a patient whose condition will not be improved by treatment or instances in which treatment preserves permanent unconsciousness or cannot end dependence on intensive medical care. %28%From Ann Intern Med 1990 Jun 15;112%28%12%29%:949%29%%A%
% 210.96/211.13 |- skos__prefLabel mesh__D018447 Medical Futility
% 210.96/211.13 |- skos__altLabel mesh__D018447 Futility, Medical
% 210.96/211.13 |- mesh__recordOriginator mesh__D018447 JLS
% 210.96/211.13 |- mesh__dateCreated mesh__D018447 1994-06-01
% 210.96/211.13 |- skos__broader mesh__D018447smesh__D011379
% 210.96/211.13 |- skos__hiddenLabel mesh__D018447 Futility, Treatment
% 210.96/211.13 |- mesh__historyNote mesh__D010464
% 210.96/211.13 91%28%76%29%; was see under PHENOTHIAZINE TRANQUILIZERS 1976-90%A%
% 210.96/211.13 |- skos__historyNote mesh__D010464
% 210.96/211.13 Phenothiazine Tranquilizers %28%1973-1975%29%
% 210.96/211.13 |- skos__prefLabel mesh__D010464 Perazine
% 210.96/211.13 |- skos__historyNote mesh__D010464 Piperazines %28%1972-1975%29%
% 210.96/211.13 |- mesh__recordMaintainer mesh__D010464 ssb
% 210.96/211.13 |- mesh__recordOriginator mesh__D010464 SH
% 210.96/211.13 |- skos__altLabel mesh__D010464 Pernazine
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D010464
% 210.96/211.13 91; was see under PHENOTHIAZINE TRANQUILIZERS 1976-90
% 210.96/211.13 |- rdf__type mesh__D010464sskos__Concept
% 210.96/211.13 |- mesh__dateCreated mesh__D010464 1975-07-25
% 210.96/211.13 |- skos__hiddenLabel mesh__D010464 Maleate, Perazine
% 210.96/211.13 |- mesh__dateRevised mesh__D010464 2005-06-30
% 210.96/211.13 |- mesh__dateEstablished mesh__D010464 1991-01-01
% 210.96/211.13 |- skos__broader mesh__D010464smesh__D010640
% 210.96/211.13 |- skos__scopeNote mesh__D010464
% 210.96/211.13 A phenothiazine antipsychotic with actions and uses similar to those of CHLORPROMAZINE. Extrapyramidal symptoms may be more common than other side effects.%A%
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D010464 2006
% 210.96/211.13 |- skos__hiddenLabel mesh__D010464 Dihydrochloride, Perazine
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D010464 sjn
% 210.96/211.13 |- skos__hiddenLabel mesh__D037601 Mannan Binding Lectin
% 210.96/211.13 |- mesh__dateCreated mesh__D037601 2002-07-03
% 210.96/211.13 |- skos__prefLabel mesh__D037601 Mannose-Binding Lectin
% 210.96/211.13 |- skos__hiddenLabel mesh__D037601 Mannan Binding Protein
% 210.96/211.13 |- skos__altLabel mesh__D037601 Mannose-Binding Protein
% 210.96/211.13 |- skos__historyNote mesh__D037601 Carrier Proteins %28%1990-2002%29%
% 210.96/211.13 |- skos__altLabel mesh__D037601 Mannan-Binding Protein
% 210.96/211.13 |- mesh__dateRevised mesh__D037601 2005-06-30
% 210.96/211.13 |- skos__altLabel mesh__D037601 Mannan-Binding Lectin
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D037601 2006
% 210.96/211.13 |- skos__scopeNote mesh__D037601
% 210.96/211.13 A specific mannose-binding member of the collectin family of lectins. It binds to carbohydrate groups on invading pathogens and plays a key role in the MANNOSE-BINDING LECTIN COMPLEMENT PATHWAY.%A%
% 210.96/211.13 |- skos__broader mesh__D037601smesh__D037222
% 210.96/211.13 |- skos__hiddenLabel mesh__D037601 Lectin, Mannan-Binding
% 210.96/211.13 |- mesh__recordOriginator mesh__D037601 jmp
% 210.96/211.13 |- skos__hiddenLabel mesh__D037601 Mannose Binding Lectin
% 210.96/211.13 |- mesh__historyNote mesh__D037601
% 210.96/211.13 2003; for MANNOSE-BINDING LECTIN, MANNAN-BINDING PROTEIN %26% MANNAN-BINDING LECTIN use COLLECTINS 1990-2002%A%
% 210.96/211.13 |- skos__hiddenLabel mesh__D037601 Mannose Binding Protein
% 210.96/211.13 |- skos__annotation mesh__D037601
% 210.96/211.13 MANNOSE-BINDING LECTINS is also available; see SCR for species specific terms; analogs %26% homologs are not MANNOSE-BINDING LECTINS%A%
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D037601 sjn
% 210.96/211.13 |- rdf__type mesh__D037601sskos__Concept
% 210.96/211.13 |- mesh__recordMaintainer mesh__D037601 ssb
% 210.96/211.13 |- skos__broader mesh__D037601smesh__D037241
% 210.96/211.13 |- skos__hiddenLabel mesh__D037601 Lectin, Mannose-Binding
% 210.96/211.13 |- mesh__dateEstablished mesh__D037601 2003-01-01
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D037601
% 210.96/211.13 2003; MANNOSE-BINDING LECTIN, MANNAN-BINDING PROTEIN %26% MANNAN-BINDING LECTIN were indexed under CARRIER PROTEINS 1990-2002%A%
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D004427 2003
% 210.96/211.13 |- mesh__recordOriginator mesh__D004427 NLM
% 210.96/211.13 |- mesh__dateEstablished mesh__D004427 1966-01-01
% 210.96/211.13 |- skos__prefLabel mesh__D004427 Ear Diseases
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D004427 2002
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D004427 2006
% 210.96/211.13 |- mesh__dateRevised mesh__D004427 1997-06-20
% 210.96/211.13 |- rdf__type mesh__D004427sskos__Concept
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D004427 66
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D004427 2005
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D004427 1999
% 210.96/211.13 |- skos__hiddenLabel mesh__D004427 Ear Disease
% 210.96/211.13 |- skos__annotation mesh__D004427
% 210.96/211.13 GEN only; NIM with coord for diseases of specific parts; /diag: consider also DIAGNOSTIC TECHNIQUES, OTOLOGICAL; inflamm dis = OTITIS and its specifics%A%
% 210.96/211.13 |- skos__broader mesh__D004427smesh__D010038
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D004427 2001
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D004427 1998
% 210.96/211.13 |- skos__hiddenLabel mesh__D004427 Disease, Ear
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D004427 2000
% 210.96/211.13 |- skos__scopeNote mesh__D004427
% 210.96/211.13 Diseases of the ear, general or unspecified.
% 210.96/211.13 |- mesh__recordMaintainer mesh__D004427 TGC
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D004427 2004
% 210.96/211.13 |- mesh__historyNote mesh__D004427 66
% 210.96/211.13 |- skos__hiddenLabel mesh__D004427 Diseases, Ear
% 210.96/211.13 |- mesh__dateCreated mesh__D004427 1999-01-01
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D004427 SJN
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 1997
% 210.96/211.13 |- skos__scopeNote mesh__D009910
% 210.96/211.13 The practice of personal hygiene of the mouth. It includes the maintenance of oral cleanliness, tissue tone, and general preservation of oral health.%A%
% 210.96/211.13 |- skos__broader mesh__D009910smesh__D011313
% 210.96/211.13 |- mesh__historyNote mesh__D009910
% 210.96/211.13 73; DENTAL HYGIENE was heading 1963-64, was see DENTAL PROPHYLAXIS 1991%A%
% 210.96/211.13 |- mesh__recordOriginator mesh__D009910 NLM
% 210.96/211.13 |- rdf__type mesh__D009910sskos__Concept
% 210.96/211.13 |- mesh__onlineNote mesh__D009910
% 210.96/211.13 use DENTAL PROPHYLAXIS to search DENTAL HYGIENE 1991
% 210.96/211.13 |- skos__related mesh__D009910smesh__D003742
% 210.96/211.13 |- skos__altLabel mesh__D009910 Hygiene, Dental
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 1994
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 2000
% 210.96/211.13 |- mesh__dateCreated mesh__D009910 1999-01-01
% 210.96/211.13 |- skos__prefLabel mesh__D009910 Oral Hygiene
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 2001
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 1995
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D009910 PLS
% 210.96/211.13 |- mesh__dateRevised mesh__D009910 1992-12-28
% 210.96/211.13 |- skos__hiddenLabel mesh__D009910 Hygiene, Oral
% 210.96/211.13 |- skos__altLabel mesh__D009910 Dental Hygiene
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 2005
% 210.96/211.13 |- skos__broader mesh__D009910smesh__D006920
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D009910
% 210.96/211.13 73; DENTAL HYGIENE was heading 1963-64, was see DENTAL PROPHYLAXIS 1991%A%
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 2002
% 210.96/211.13 |- mesh__dateEstablished mesh__D009910 1973-01-01
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 1998
% 210.96/211.13 |- mesh__recordMaintainer mesh__D009910 PLS
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 2003
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 2006
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 1996
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 1999
% 210.96/211.13 |- skos__historyNote mesh__D009910 Oral Health %28%1966-1972%29%
% 210.96/211.13 |- skos__related mesh__D009910smesh__D014099
% 210.96/211.13 |- skos__annotation mesh__D009910
% 210.96/211.13 differentiate from ORAL HEALTH; oral hyg is care toward maintaining good oral health performed by the person himself or a caregiver in the case of invalid or disabled persons; differentiate also from DENTAL CARE, care by professionals; for oral hyg using dental floss, water picks, etc. use DENTAL DEVICES, HOME CARE or TOOTHBRUSHING%A%
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009910 2004
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D009112
% 210.96/211.13 91; was see under SUGAR ACIDS 1975-90; was MURAMIC ACID 1973-74 %28%Prov%29%%A%
% 210.96/211.13 |- mesh__recordMaintainer mesh__D009112 ssb
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D009112 sjn
% 210.96/211.13 |- rdf__type mesh__D009112sskos__Concept
% 210.96/211.13 |- mesh__dateEstablished mesh__D009112 1991-01-01
% 210.96/211.13 |- mesh__onlineNote mesh__D009112
% 210.96/211.13 use MURAMIC ACIDS to search MURAMIC ACID 1973-74 %28%as Prov%29%%A%
% 210.96/211.13 |- skos__broader mesh__D009112smesh__D000606
% 210.96/211.13 |- mesh__dateCreated mesh__D009112 1999-01-01
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009112 2006
% 210.96/211.13 |- skos__historyNote mesh__D009112 Hexosamines %28%1966-1972%29%
% 210.96/211.13 |- skos__broader mesh__D009112smesh__D013400
% 210.96/211.13 |- skos__historyNote mesh__D009112 Glucosamine %28%1966-1972%29%
% 210.96/211.13 |- skos__hiddenLabel mesh__D009112 Acids, Muramic
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D009112 2005
% 210.96/211.13 |- mesh__dateRevised mesh__D009112 2004-07-07
% 210.96/211.13 |- mesh__recordOriginator mesh__D009112 NLM
% 210.96/211.13 |- skos__scopeNote mesh__D009112
% 210.96/211.13 Compounds consisting of glucosamine and lactate joined by an ether linkage. They occur naturally as N-acetyl derivatives in peptidoglycan, the characteristic polysaccharide composing bacterial cell walls. %28%From Dorland, 28th ed%29%%A%
% 210.96/211.13 |- mesh__historyNote mesh__D009112
% 210.96/211.13 91%28%75%29%; was see under SUGAR ACIDS 1975-90; was MURAMIC ACID 1973-74 %28%Prov%29%%A%
% 210.96/211.13 |- skos__historyNote mesh__D009112 Amino Sugars %28%1966-1970%29%
% 210.96/211.13 |- skos__historyNote mesh__D009112 Disaccharides %28%1971-1972%29%
% 210.96/211.13 |- skos__prefLabel mesh__D009112 Muramic Acids
% 210.96/211.13 |- skos__hiddenLabel mesh__D009112 Acid, Muramic
% 210.96/211.13 |- mesh__recordMaintainer mesh__D020094 SYSTEM
% 210.96/211.13 |- mesh__dateCreated mesh__D020094 1998-06-10
% 210.96/211.13 |- skos__historyNote mesh__D020094 Fungi %28%1965-1981%29%
% 210.96/211.13 |- skos__annotation mesh__D020094
% 210.96/211.13 infection: coord IM with MUCORMYCOSIS %28%IM%29%
% 210.96/211.13 |- skos__broader mesh__D020094smesh__D009090
% 210.96/211.13 |- rdf__type mesh__D020094sskos__Concept
% 210.96/211.13 |- mesh__historyNote mesh__D020094 99
% 210.96/211.13 |- mesh__dateRevised mesh__D020094 2005-06-30
% 210.96/211.13 |- skos__prefLabel mesh__D020094 Mortierella
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D020094 2006
% 210.96/211.13 |- skos__scopeNote mesh__D020094
% 210.96/211.13 A genus of zygomycetous fungi of the family Mortierellaceae, order MUCORALES. Its species are abundant in soil and can cause rare infections in humans and animals. Mortierella alpinais is used for production of arachidonic acid.%A%
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D020094 sjn
% 210.96/211.13 |- mesh__recordOriginator mesh__D020094 AGS
% 210.96/211.13 |- skos__historyNote mesh__D020094 Mucorales %28%1973-1998%29%
% 210.96/211.13 |- mesh__dateEstablished mesh__D020094 1999-01-01
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D020094 99
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014855 2006
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014855 2002
% 210.96/211.13 |- mesh__onlineNote mesh__D014855 search NERVE DEGENERATION 1967-74
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D014855
% 210.96/211.13 91; was see under NERVE DEGENERATION 1975-90
% 210.96/211.13 |- skos__hiddenLabel mesh__D014855 Degeneration, Wallerian
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014855 2005
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014855 2001
% 210.96/211.13 |- mesh__dateCreated mesh__D014855 1999-01-01
% 210.96/211.13 |- skos__prefLabel mesh__D014855 Wallerian Degeneration
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014855 2004
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014855 2000
% 210.96/211.13 |- mesh__historyNote mesh__D014855
% 210.96/211.13 91%28%75%29%; was see under NERVE DEGENERATION 1975-90
% 210.96/211.13 |- mesh__dateRevised mesh__D014855 1999-11-03
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014855 2003
% 210.96/211.13 |- rdf__type mesh__D014855sskos__Concept
% 210.96/211.13 |- skos__broader mesh__D014855smesh__D009410
% 210.96/211.13 |- mesh__dateEstablished mesh__D014855 1991-01-01
% 210.96/211.13 |- mesh__recordMaintainer mesh__D014855 KEV
% 210.96/211.13 |- mesh__recordOriginator mesh__D014855 NLM
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D014855 sjn
% 210.96/211.13 |- skos__scopeNote mesh__D014855
% 210.96/211.13 Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.%A%
% 210.96/211.13 |- mesh__dateEstablished mesh__D047231 2005-01-01
% 210.96/211.13 |- mesh__recordOriginator mesh__D047231 ags
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D047231 2005
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D047231 2006
% 210.96/211.13 |- skos__scopeNote mesh__D047231
% 210.96/211.13 A genus of massive or globular SPONGES in the family Geodiidae, with large spicules at or near the surface.%A%
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D047231 2005
% 210.96/211.13 |- skos__historyNote mesh__D047231 Porifera %28%1974-2004%29%
% 210.96/211.13 |- mesh__recordMaintainer mesh__D047231 ags
% 210.96/211.13 |- rdf__type mesh__D047231sskos__Concept
% 210.96/211.13 |- mesh__dateCreated mesh__D047231 2004-07-07
% 210.96/211.13 |- skos__prefLabel mesh__D047231 Geodia
% 210.96/211.13 |- skos__broader mesh__D047231smesh__D011161
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D047231 sjn
% 210.96/211.13 |- mesh__historyNote mesh__D047231 2005
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Scans, X-Ray CAT
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Computed X-Ray Tomographies
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Tomographies, Xray Computed
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Scan, X-Ray CAT
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Computed Tomographies, Transmission
% 210.96/211.13 |- skos__altLabel mesh__D014057 CAT Scan, X Ray
% 210.96/211.13 |- skos__altLabel mesh__D014057 Electron Beam Tomography
% 210.96/211.13 |- mesh__onlineNote mesh__D014057
% 210.96/211.13 use TOMOGRAPHY, X-RAY COMPUTED to search TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79%A%
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 X Ray, CT
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Electron Beam Tomographies
% 210.96/211.13 |- skos__altLabel mesh__D014057 CAT Scan, X-Ray
% 210.96/211.13 |- skos__altLabel mesh__D014057 Computerized Tomography, X-Ray
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Xray Computed Tomography
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014057 2000
% 210.96/211.13 |- skos__scopeNote mesh__D014057
% 210.96/211.13 Tomography using x-ray transmission and a computer algorithm to reconstruct the image.%A%
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Tomographies, X-Ray Computed
% 210.96/211.13 |- mesh__recordAuthorizer mesh__D014057 SJN
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 X-Ray Tomographies, Computed
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 X-Ray Computed Tomography
% 210.96/211.13 |- skos__altLabel mesh__D014057 CT X Ray
% 210.96/211.13 |- skos__broader mesh__D014057smesh__D014056
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Tomographies, X-Ray Computerized
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Tomographies, Transmission Computed
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Xray Computed Tomographies
% 210.96/211.13 |- skos__historyNote mesh__D014057 Tomography, X-Ray %28%1973-1976%29%
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Computed Tomographies, X-Ray
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Tomographies, Computed X-Ray
% 210.96/211.13 |- mesh__dateRevised mesh__D014057 1998-06-11
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 X Rays, CT
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Computed Tomographies, Xray
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 X-Ray CAT Scan
% 210.96/211.13 |- mesh__recordMaintainer mesh__D014057 NDW
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014057 2004
% 210.96/211.13 |- skos__altLabel mesh__D014057 Tomography, Xray Computed
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Computed Tomography, Transmission
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Computed X-Ray Tomography
% 210.96/211.13 |- mesh__dateCreated mesh__D014057 1976-04-13
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Tomographies, Electron Beam
% 210.96/211.13 |- skos__broader mesh__D014057smesh__D007090
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 X-Ray CAT Scans
% 210.96/211.13 |- skos__altLabel mesh__D014057 Tomodensitometry
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014057 2003
% 210.96/211.13 |- rdf__type mesh__D014057sskos__Concept
% 210.96/211.13 |- skos__broader mesh__D014057smesh__D011856
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014057 2006
% 210.96/211.13 |- skos__altLabel mesh__D014057 X-Ray Tomography, Computed
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014057 2002
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Tomography, X-Ray Computerized
% 210.96/211.13 |- skos__altLabel mesh__D014057 X Ray Tomography, Computed
% 210.96/211.13 |- skos__altLabel mesh__D014057 Computerized Tomography, X Ray
% 210.96/211.13 |- mesh__publicMeSHNote mesh__D014057
% 210.96/211.13 80; was TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Tomography, Electron Beam
% 210.96/211.13 |- mesh__dateEstablished mesh__D014057 1977-01-01
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 X-Ray Computerized Tomographies
% 210.96/211.13 |- mesh__historyNote mesh__D014057
% 210.96/211.13 80; was TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Beam Tomography, Electron
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014057 2005
% 210.96/211.13 |- skos__annotation mesh__D014057
% 210.96/211.13 uses x-rays %26% computer: do not confuse with TOMOGRAPHY, EMISSION-COMPUTED using radionuclides %26% computer; %22%computed tomography%22% unspecified probably goes here; /instrum: consider also TOMOGRAPHY SCANNERS, X-RAY COMPUTED; DF: CT XRAY%A%
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Computed Tomography, X-Ray
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 CAT Scans, X-Ray
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Cine CT
% 210.96/211.13 |- mesh__activeMeSHYear mesh__D014057 2001
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Computed Tomography, Xray
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 X-Ray Computed Tomographies
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 CT X Rays
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Tomodensitometries
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Beam Tomographies, Electron
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 X-Ray Computerized Tomography
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Transmission Computed Tomography
% 210.96/211.13 |- mesh__recordOriginator mesh__D014057 SMH
% 210.96/211.13 |- skos__hiddenLabel mesh__D014057 Computerized Tomographies, X-Ray
% 210.96/211.14 |- skos__prefLabel mesh__D014057 Tomography, X-Ray Computed
% 210.96/211.14 |- skos__altLabel mesh__D014057 Tomography, X Ray Computed
% 210.96/211.14 |- skos__hiddenLabel mesh__D014057 Transmission Computed Tomographies
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D014057 1999
% 210.96/211.14 |- skos__hiddenLabel mesh__D014057 Tomography, Computed X-Ray
% 210.96/211.14 |- mesh__recordMaintainer mesh__D008818 ags
% 210.96/211.14 |- skos__altLabel mesh__D008818 Lurcher Mouse
% 210.96/211.14 |- skos__altLabel mesh__D008818 Mouse, Neurologic Mutant
% 210.96/211.14 |- skos__altLabel mesh__D008818 Nervous Mouse
% 210.96/211.14 |- mesh__dateRevised mesh__D008818 2005-06-30
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mice, Weaver
% 210.96/211.14 |- skos__altLabel mesh__D008818 Neurologic Mutant Mice
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mouse, Reeler
% 210.96/211.14 |- mesh__dateCreated mesh__D008818 1978-05-17
% 210.96/211.14 |- skos__broader mesh__D008818smesh__D008817
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D008818 sjn
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mouse, Nervous
% 210.96/211.14 |- mesh__dateEstablished mesh__D008818 1979-01-01
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mouse, Weaver
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mice, Neurologic Mutant
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mouse, Staggerer
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mice, Nervous
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mice, Staggerer
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D008818 2006
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mice, Reeler
% 210.96/211.14 |- mesh__historyNote mesh__D008818 79
% 210.96/211.14 |- skos__altLabel mesh__D008818 Weaver Mice
% 210.96/211.14 |- skos__annotation mesh__D008818
% 210.96/211.14 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE; MICE, JIMPY %26% MICE, QUAKING, both neurol mutants, are available; DF: MICE NEUROL MUTANTS%A%
% 210.96/211.14 |- rdf__type mesh__D008818sskos__Concept
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mutant Mice, Neurologic
% 210.96/211.14 |- skos__altLabel mesh__D008818 Neurological Mutant Mouse
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mutant Mouse, Neurologic
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D008818 79
% 210.96/211.14 |- skos__altLabel mesh__D008818 Reeler Mouse
% 210.96/211.14 |- mesh__recordOriginator mesh__D008818 EC
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Neurologic Mutant Mouse
% 210.96/211.14 |- skos__altLabel mesh__D008818 Mice, Neurological Mutants
% 210.96/211.14 |- skos__scopeNote mesh__D008818
% 210.96/211.14 Mice which carry mutant genes for neurologic defects or abnormalities.%A%
% 210.96/211.14 |- skos__altLabel mesh__D008818 Mouse, Neurological Mutant
% 210.96/211.14 |- skos__historyNote mesh__D008818 Mice, Inbred Strains %28%1972-1978%29%
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mouse, Lurcher
% 210.96/211.14 |- skos__hiddenLabel mesh__D008818 Mice, Lurcher
% 210.96/211.14 |- skos__altLabel mesh__D008818 Staggerer Mouse
% 210.96/211.14 |- skos__prefLabel mesh__D008818 Mice, Neurologic Mutants
% 210.96/211.14 |- skos__scopeNote mesh__D000835
% 210.96/211.14 Animals considered to be wild or feral or not adapted for domestic use. It does not include wild animals in zoos for which ANIMALS, ZOO is available.%A%
% 210.96/211.14 |- skos__broader mesh__D000835smesh__D000828
% 210.96/211.14 |- skos__annotation mesh__D000835
% 210.96/211.14 GEN or unspecified; do not index as coord with animals ordinarily considered wild, as LIONS; BEARS; etc.; coord IM with animal not usually wild %28%IM%29% as wild dogs; IM; qualif permitted; do not forget also to check tag ANIMALS%A%
% 210.96/211.14 |- skos__historyNote mesh__D000835 Animals %28%1966-1977%29%
% 210.96/211.14 |- mesh__dateEstablished mesh__D000835 1987-01-01
% 210.96/211.14 |- skos__hiddenLabel mesh__D000835 Animal, Nondomestic
% 210.96/211.14 |- mesh__recordOriginator mesh__D000835 EC
% 210.96/211.14 |- skos__prefLabel mesh__D000835 Animals, Wild
% 210.96/211.14 |- skos__hiddenLabel mesh__D000835 Wild Animal
% 210.96/211.14 |- skos__hiddenLabel mesh__D000835 Animal, Wild
% 210.96/211.14 |- mesh__dateRevised mesh__D000835 2003-07-30
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D000835 2004
% 210.96/211.14 |- rdf__type mesh__D000835sskos__Concept
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D000835 2006
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D000835 sjn
% 210.96/211.14 |- mesh__recordMaintainer mesh__D000835 ags
% 210.96/211.14 |- skos__hiddenLabel mesh__D000835 Wild Animals
% 210.96/211.14 |- skos__hiddenLabel mesh__D000835 Nondomestic Animals
% 210.96/211.14 |- mesh__dateCreated mesh__D000835 1977-05-12
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D000835 2005
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D000835 87; was see under ANIMALS 1978-86
% 210.96/211.14 |- mesh__historyNote mesh__D000835
% 210.96/211.14 87%28%78%29%; was see under ANIMALS 1978-86
% 210.96/211.14 |- skos__hiddenLabel mesh__D000835 Nondomestic Animal
% 210.96/211.14 |- skos__altLabel mesh__D019540 AUC
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 2005
% 210.96/211.14 |- mesh__dateCreated mesh__D019540 1996-06-13
% 210.96/211.14 |- rdf__type mesh__D019540sskos__Concept
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 2001
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 2004
% 210.96/211.14 |- mesh__dateEstablished mesh__D019540 1997-01-01
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 2000
% 210.96/211.14 |- skos__hiddenLabel mesh__D019540 Under Curves, Area
% 210.96/211.14 |- skos__broader mesh__D019540smesh__D010599
% 210.96/211.14 |- skos__hiddenLabel mesh__D019540 Under Curve, Area
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 2003
% 210.96/211.14 |- skos__prefLabel mesh__D019540 Area Under Curve
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D019540 97
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 1999
% 210.96/211.14 |- skos__broader mesh__D019540smesh__D013223
% 210.96/211.14 |- skos__hiddenLabel mesh__D019540 Area Under Curves
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 1998
% 210.96/211.14 |- skos__scopeNote mesh__D019540
% 210.96/211.14 A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. %28%From Winslade, Dictionary of Clinical Research, 1992%29%%A%
% 210.96/211.14 |- skos__hiddenLabel mesh__D019540 Curve, Area Under
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 1997
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 2006
% 210.96/211.14 |- skos__hiddenLabel mesh__D019540 Curves, Area Under
% 210.96/211.14 |- skos__annotation mesh__D019540
% 210.96/211.14 a measure of drug bioavailability after a single dose; DF: note short X ref%A%
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D019540 2002
% 210.96/211.14 |- mesh__historyNote mesh__D019540 97
% 210.96/211.14 |- mesh__recordMaintainer mesh__D000037 lkt
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D000037 sjn
% 210.96/211.14 |- skos__hiddenLabel mesh__D000037 Abruption, Placental
% 210.96/211.14 |- mesh__recordOriginator mesh__D000037 NLM
% 210.96/211.14 |- mesh__dateRevised mesh__D000037 2005-06-30
% 210.96/211.14 |- skos__prefLabel mesh__D000037 Abruptio Placentae
% 210.96/211.14 |- mesh__dateCreated mesh__D000037 1999-01-01
% 210.96/211.14 |- skos__altLabel mesh__D000037 Placental Abruption
% 210.96/211.14 |- skos__scopeNote mesh__D000037
% 210.96/211.14 Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH.%A%
% 210.96/211.14 |- skos__hiddenLabel mesh__D000037 Placental Abruptions
% 210.96/211.14 |- skos__hiddenLabel mesh__D000037 Abruptions, Placental
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D000037 2006
% 210.96/211.14 |- skos__broader mesh__D000037smesh__D007744
% 210.96/211.14 |- rdf__type mesh__D000037sskos__Concept
% 210.96/211.14 |- skos__broader mesh__D000037smesh__D010922
% 210.96/211.14 |- skos__scopeNote mesh__D005520
% 210.96/211.14 Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods.%A%
% 210.96/211.14 |- skos__annotation mesh__D005520 D25-26 qualif
% 210.96/211.14 |- mesh__recordMaintainer mesh__D005520 ssb
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D005520 75
% 210.96/211.14 |- skos__related mesh__D005520smesh__D000975
% 210.96/211.14 |- mesh__recordOriginator mesh__D005520 NLM
% 210.96/211.14 |- mesh__dateRevised mesh__D005520 2003-07-09
% 210.96/211.14 |- rdf__type mesh__D005520sskos__Concept
% 210.96/211.14 |- skos__prefLabel mesh__D005520 Food Preservatives
% 210.96/211.14 |- skos__historyNote mesh__D005520 Food Additives %28%1966-1974%29%
% 210.96/211.14 |- mesh__dateCreated mesh__D005520 1974-11-19
% 210.96/211.14 |- mesh__historyNote mesh__D005520 75
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D005520 2004
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D005520 sjn
% 210.96/211.14 |- skos__broader mesh__D005520smesh__D005503
% 210.96/211.14 |- skos__hiddenLabel mesh__D005520 Preservatives, Food
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D005520 2006
% 210.96/211.14 |- mesh__dateEstablished mesh__D005520 1975-09-01
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D005520 2005
% 210.96/211.14 |- skos__scopeNote mesh__D052176
% 210.96/211.14 Compounds based on a seven-membered ring fused to a five-membered ring. Heat can rearrange them to NAPHTHALENES which have two fused six-membered rings. They are similar to guaiazulenes which are SESQUITERPENES with a six-membered ring fused to a five-membered ring.%A%
% 210.96/211.14 |- skos__broader mesh__D052176smesh__D011084
% 210.96/211.14 |- mesh__dateEstablished mesh__D052176 2006-01-01
% 210.96/211.14 |- rdf__type mesh__D052176sskos__Concept
% 210.96/211.14 |- mesh__dateCreated mesh__D052176 2005-06-30
% 210.96/211.14 |- mesh__historyNote mesh__D052176 2006
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D052176 sjn
% 210.96/211.14 |- skos__broader mesh__D052176smesh__D003508
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D052176 2006
% 210.96/211.14 |- skos__altLabel mesh__D052176 Cyclopentacycloheptenes
% 210.96/211.14 |- mesh__recordMaintainer mesh__D052176 ssb
% 210.96/211.14 |- skos__historyNote mesh__D052176 Cycloheptanes %28%1968-2005%29%
% 210.96/211.14 |- mesh__recordOriginator mesh__D052176 ssb
% 210.96/211.14 |- skos__prefLabel mesh__D052176 Azulenes
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D052176 2006
% 210.96/211.14 |- mesh__recordOriginator mesh__D046937 ags
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D046937 sjn
% 210.96/211.14 |- mesh__recordMaintainer mesh__D046937 ags
% 210.96/211.14 |- mesh__dateRevised mesh__D046937 2005-06-30
% 210.96/211.14 |- skos__broader mesh__D046937smesh__D000458
% 210.96/211.14 |- rdf__type mesh__D046937sskos__Concept
% 210.96/211.14 |- skos__prefLabel mesh__D046937 Nostoc
% 210.96/211.14 |- mesh__historyNote mesh__D046937 2005
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D046937 2006
% 210.96/211.14 |- skos__historyNote mesh__D046937 Cyanobacteria %28%1971-2004%29%
% 210.96/211.14 |- mesh__dateCreated mesh__D046937 2004-07-07
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D046937 2005
% 210.96/211.14 |- mesh__dateEstablished mesh__D046937 2005-01-01
% 210.96/211.14 |- skos__scopeNote mesh__D046937
% 210.96/211.14 A form-genus of CYANOBACTERIA in the order Nostocales. Trichomes composed of spherical or ovoid vegetative cells along with heterocysts and akinetes. The species form symbiotic associations with a wide range of eukaryotes.%A%
% 210.96/211.14 |- skos__hiddenLabel mesh__D018448 Model, Immunological
% 210.96/211.14 |- skos__prefLabel mesh__D018448 Models, Immunological
% 210.96/211.14 |- mesh__historyNote mesh__D018448 95
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 2000
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 1997
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 1998
% 210.96/211.14 |- skos__altLabel mesh__D018448 Immunological Models
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 2006
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D018448 95
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 1996
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 2004
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 2005
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 2002
% 210.96/211.14 |- rdf__type mesh__D018448sskos__Concept
% 210.96/211.14 |- skos__altLabel mesh__D018448 Model, Immunologic
% 210.96/211.14 |- skos__annotation mesh__D018448
% 210.96/211.14 no qualif; TN 128: definition of MODELS, BIOLOGICAL; DF: MODELS IMMUNOL%A%
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 1995
% 210.96/211.14 |- skos__hiddenLabel mesh__D018448 Immunological Model
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 2003
% 210.96/211.14 |- skos__altLabel mesh__D018448 Immunologic Model
% 210.96/211.14 |- skos__historyNote mesh__D018448 Models, Biological %28%1967-1994%29%
% 210.96/211.14 |- skos__broader mesh__D018448smesh__D008954
% 210.96/211.14 |- skos__hiddenLabel mesh__D018448 Models, Immunologic
% 210.96/211.14 |- skos__hiddenLabel mesh__D018448 Immunologic Models
% 210.96/211.14 |- mesh__dateCreated mesh__D018448 1994-01-25
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 2001
% 210.96/211.14 |- skos__scopeNote mesh__D018448
% 210.96/211.14 Theoretical representations that simulate the behavior or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment.%A%
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D018448 1999
% 210.96/211.14 |- mesh__dateEstablished mesh__D018448 1995-01-01
% 210.96/211.14 |- mesh__recordOriginator mesh__D010465 NLM
% 210.96/211.14 |- skos__scopeNote mesh__D010465
% 210.96/211.14 The process by which the nature and meaning of sensory stimuli are recognized and interpreted.%A%
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D010465 2005
% 210.96/211.14 |- mesh__recordMaintainer mesh__D010465 lkt
% 210.96/211.14 |- skos__annotation mesh__D010465 general; prefer specifics
% 210.96/211.14 |- rdf__type mesh__D010465sskos__Concept
% 210.96/211.14 |- skos__prefLabel mesh__D010465 Perception
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D010465 sjn
% 210.96/211.14 |- skos__broader mesh__D010465smesh__D008606
% 210.96/211.14 |- skos__hiddenLabel mesh__D010465 Perceptions
% 210.96/211.14 |- skos__related mesh__D010465smesh__D012677
% 210.96/211.14 |- mesh__dateRevised mesh__D010465 2004-07-07
% 210.96/211.14 |- mesh__dateCreated mesh__D010465 1999-01-01
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D010465 2006
% 210.96/211.14 |- mesh__dateEstablished mesh__D037602 2003-01-01
% 210.96/211.14 |- mesh__dateCreated mesh__D037602 2002-07-03
% 210.96/211.14 |- mesh__historyNote mesh__D037602 2003
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D037602 2003
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D037602 2006
% 210.96/211.14 |- skos__annotation mesh__D037602
% 210.96/211.14 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.96/211.14 |- skos__prefLabel mesh__D037602 Isodon
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D037602 2005
% 210.96/211.14 |- rdf__type mesh__D037602sskos__Concept
% 210.96/211.14 |- skos__broader mesh__D037602smesh__D019686
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D037602 2004
% 210.96/211.14 |- skos__scopeNote mesh__D037602
% 210.96/211.14 A plant genus of the family LAMIACEAE. Members contain ent-kaurene type DITERPENES.%A%
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D037602 2003
% 210.96/211.14 |- mesh__historyNote mesh__D004428 66
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D004428 2006
% 210.96/211.14 |- rdf__type mesh__D004428sskos__Concept
% 210.96/211.14 |- skos__altLabel mesh__D004428 Cancer of Ear
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Neoplasm, Auricular
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Cancer, Ear
% 210.96/211.14 |- skos__altLabel mesh__D004428 Neoplasms, Auricular
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D004428 66
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D004428 sjn
% 210.96/211.14 |- mesh__recordOriginator mesh__D004428 NLM
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D004428 2005
% 210.96/211.14 |- mesh__dateEstablished mesh__D004428 1966-01-01
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D004428 2002
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Cancer, Auricular
% 210.96/211.14 |- skos__altLabel mesh__D004428 Cancer of the Ear
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Cancers, Ear
% 210.96/211.14 |- skos__altLabel mesh__D004428 Neoplasms, Ear
% 210.96/211.14 |- skos__broader mesh__D004428smesh__D004427
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Neoplasm, Ear
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D004428 2004
% 210.96/211.14 |- skos__prefLabel mesh__D004428 Ear Neoplasms
% 210.96/211.14 |- mesh__dateRevised mesh__D004428 1999-11-04
% 210.96/211.14 |- mesh__dateCreated mesh__D004428 1999-01-01
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Ear Cancers
% 210.96/211.14 |- skos__scopeNote mesh__D004428
% 210.96/211.14 Tumors or cancer of the internal, external, or middle ear.%A%
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Ear Neoplasm
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Cancers, Auricular
% 210.96/211.14 |- skos__altLabel mesh__D004428 Auricular Neoplasms
% 210.96/211.14 |- skos__altLabel mesh__D004428 Ear Cancer
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D004428 2001
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D004428 2003
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Auricular Neoplasm
% 210.96/211.14 |- mesh__recordMaintainer mesh__D004428 KEV
% 210.96/211.14 |- skos__broader mesh__D004428smesh__D010039
% 210.96/211.14 |- skos__annotation mesh__D004428
% 210.96/211.14 coord IM with specific ear term %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 210.96/211.14 |- skos__hiddenLabel mesh__D004428 Auricular Cancers
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D004428 2000
% 210.96/211.14 |- mesh__dateRevised mesh__D015150 2001-07-25
% 210.96/211.14 |- skos__hiddenLabel mesh__D015150 Doppler Echocardiography, 2 D
% 210.96/211.14 |- skos__altLabel mesh__D015150 Continuous Doppler Echocardiography
% 210.96/211.14 |- skos__altLabel mesh__D015150 Doppler Echocardiography
% 210.96/211.14 |- mesh__dateCreated mesh__D015150 1988-03-21
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D015150 2005
% 210.96/211.14 |- skos__scopeNote mesh__D015150
% 210.96/211.14 Measurement of intracardiac blood flow using an M-mode and/or two-dimensional %28%2-D%29% echocardiogram while simultaneously recording the spectrum of the audible Doppler signal %28%e.g., velocity, direction, amplitude, intensity, timing%29% reflected from the moving column of red blood cells.%A%
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D015150 sjn
% 210.96/211.14 |- skos__broader mesh__D015150smesh__D004452
% 210.96/211.14 |- rdf__type mesh__D015150sskos__Concept
% 210.96/211.14 |- skos__altLabel mesh__D015150 Two-Dimensional Doppler Echocardiography
% 210.96/211.14 |- skos__altLabel mesh__D015150 Doppler Echocardiography, Two-Dimensional
% 210.96/211.14 |- mesh__recordOriginator mesh__D015150 SCD
% 210.96/211.14 |- skos__altLabel mesh__D015150 Doppler Echocardiography, Continuous
% 210.96/211.14 |- skos__hiddenLabel mesh__D015150 2 D Doppler Echocardiography
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D015150
% 210.96/211.14 89; was DOPPLER ECHOCARDIOGRAPHY see ECHOCARDIOGRAPHY 1985-88%A%
% 210.96/211.14 |- skos__altLabel mesh__D015150 Echocardiography, 2D Doppler
% 210.96/211.14 |- skos__altLabel mesh__D015150 Doppler Echocardiography, 2D
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D015150 2004
% 210.96/211.14 |- mesh__recordMaintainer mesh__D015150 nns
% 210.96/211.14 |- skos__hiddenLabel mesh__D015150 Echocardiography, 2 D Doppler
% 210.96/211.14 |- skos__annotation mesh__D015150
% 210.96/211.14 GEN or unspecified; prefer specifics; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOCARDIOGR DOPPLER%A%
% 210.96/211.14 |- skos__historyNote mesh__D015150 Ultrasonic Diagnosis %28%1985-1988%29%
% 210.96/211.14 |- mesh__historyNote mesh__D015150
% 210.96/211.14 89; was DOPPLER ECHOCARDIOGRAPHY see ECHOCARDIOGRAPHY 1985-88%A%
% 210.96/211.14 |- skos__altLabel mesh__D015150 Doppler Echocardiography, 2-D
% 210.96/211.14 |- skos__hiddenLabel mesh__D015150 Two Dimensional Doppler Echocardiography
% 210.96/211.14 |- skos__altLabel mesh__D015150 Echocardiography, 2-D Doppler
% 210.96/211.14 |- skos__altLabel mesh__D015150 Echocardiography, Two-Dimensional Doppler
% 210.96/211.14 |- skos__hiddenLabel mesh__D015150
% 210.96/211.14 Doppler Echocardiography, Two Dimensional
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D015150 2003
% 210.96/211.14 |- skos__historyNote mesh__D015150 Echocardiography %28%1966-1988%29%
% 210.96/211.14 |- skos__historyNote mesh__D015150 Ultrasonics %28%1966-1988%29%
% 210.96/211.14 |- skos__altLabel mesh__D015150 2-D Doppler Echocardiography
% 210.96/211.14 |- skos__broader mesh__D015150smesh__D018608
% 210.96/211.14 |- skos__prefLabel mesh__D015150 Echocardiography, Doppler
% 210.96/211.14 |- mesh__dateEstablished mesh__D015150 1989-01-01
% 210.96/211.14 |- skos__hiddenLabel mesh__D015150
% 210.96/211.14 Echocardiography, Two Dimensional Doppler
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D015150 2002
% 210.96/211.14 |- mesh__onlineNote mesh__D015150
% 210.96/211.14 use ECHOCARDIOGRAPHY to search DOPPLER ECHOCARDIOGRAPHY 1985-88%A%
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D015150 2006
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 1999
% 210.96/211.14 |- skos__hiddenLabel mesh__D009911 Hygiene Indexe, Oral
% 210.96/211.14 |- skos__broader mesh__D009911smesh__D003753
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 2003
% 210.96/211.14 |- skos__hiddenLabel mesh__D009911 Oral Hygiene Indices
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 1993
% 210.96/211.14 |- skos__prefLabel mesh__D009911 Oral Hygiene Index
% 210.96/211.14 |- mesh__dateCreated mesh__D009911 1999-01-01
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 1996
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 1995
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 2005
% 210.96/211.14 |- skos__annotation mesh__D009911 no qualif
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 1998
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 2002
% 210.96/211.14 |- mesh__dateRevised mesh__D009911 1992-05-22
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 1994
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D009911
% 210.96/211.14 91; was see under DENTAL HEALTH SURVEYS 1975-90
% 210.96/211.14 |- rdf__type mesh__D009911sskos__Concept
% 210.96/211.14 |- skos__hiddenLabel mesh__D009911 Indexes, Oral Hygiene
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D009911 PLS
% 210.96/211.14 |- skos__scopeNote mesh__D009911
% 210.96/211.14 A combination of the debris index and the dental calculus index to determine the status of oral hygiene.%A%
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 2001
% 210.96/211.14 |- mesh__recordOriginator mesh__D009911 NLM
% 210.96/211.14 |- mesh__recordMaintainer mesh__D009911 PLS
% 210.96/211.14 |- skos__hiddenLabel mesh__D009911 Index, Oral Hygiene
% 210.96/211.14 |- skos__hiddenLabel mesh__D009911 Oral Hygiene Indexe
% 210.96/211.14 |- mesh__onlineNote mesh__D009911
% 210.96/211.14 use DENTAL HEALTH SURVEYS to search ORAL HYGIENE INDEX 1973-74%A%
% 210.96/211.14 |- skos__hiddenLabel mesh__D009911 Indices, Oral Hygiene
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 2000
% 210.96/211.14 |- skos__hiddenLabel mesh__D009911 Hygiene Indexes, Oral
% 210.96/211.14 |- skos__altLabel mesh__D009911 Oral Hygiene Indexes
% 210.96/211.14 |- skos__hiddenLabel mesh__D009911 Indexe, Oral Hygiene
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 2004
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 1997
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009911 2006
% 210.96/211.14 |- mesh__dateEstablished mesh__D009911 1991-01-01
% 210.96/211.14 |- mesh__historyNote mesh__D009911
% 210.96/211.14 91%28%75%29%; was see under DENTAL HEALTH SURVEYS 1975-90
% 210.96/211.14 |- mesh__dateCreated mesh__D009113 1999-01-01
% 210.96/211.14 |- skos__hiddenLabel mesh__D009113 Glycanhydrolase, N-Acetylmuramide
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009113 2006
% 210.96/211.14 |- mesh__recordOriginator mesh__D009113 NLM
% 210.96/211.14 |- skos__altLabel mesh__D009113 Lysozyme
% 210.96/211.14 |- skos__altLabel mesh__D009113 N-Acetylmuramide Glycanhydrolase
% 210.96/211.14 |- mesh__dateRevised mesh__D009113 2003-07-09
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009113 2005
% 210.96/211.14 |- skos__broader mesh__D009113smesh__D006026
% 210.96/211.14 |- mesh__recordMaintainer mesh__D009113 ssb
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D009113 sjn
% 210.96/211.14 |- skos__hiddenLabel mesh__D009113 N Acetylmuramide Glycanhydrolase
% 210.96/211.14 |- skos__annotation mesh__D009113 an anti-infective glycoside hydrolase
% 210.96/211.14 |- skos__scopeNote mesh__D009113
% 210.96/211.14 A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17.%A%
% 210.96/211.14 |- rdf__type mesh__D009113sskos__Concept
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D009113 2004
% 210.96/211.14 |- skos__prefLabel mesh__D009113 Muramidase
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D001130 2006
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D001130 2003
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D001130 2001
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D001130 1999
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D001130 2005
% 210.96/211.14 |- rdf__type mesh__D001130sskos__Concept
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D001130 1998
% 210.96/211.14 |- mesh__recordMaintainer mesh__D001130 PXP
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D001130 2000
% 210.96/211.14 |- skos__prefLabel mesh__D001130 Arizona
% 210.96/211.14 |- mesh__recordOriginator mesh__D001130 NLM
% 210.96/211.14 |- skos__broader mesh__D001130smesh__D015206
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D001130 SJN
% 210.96/211.14 |- mesh__dateRevised mesh__D001130 1997-06-20
% 210.96/211.14 |- mesh__dateCreated mesh__D001130 1999-01-01
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D001130 2004
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D001130 2002
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 Proto Oncogene Protein c erbB 3
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 HER 3 Proto Oncogene Protein
% 210.96/211.14 |- mesh__activeMeSHYear mesh__D020893 2006
% 210.96/211.14 |- skos__historyNote mesh__D020893
% 210.96/211.14 Proto-Oncogene Proteins %28%1993-1999%29%
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 Receptor, erbB 3
% 210.96/211.14 |- skos__broader mesh__D020893smesh__D014408
% 210.96/211.14 |- skos__historyNote mesh__D020893
% 210.96/211.14 Receptor, Epidermal Growth Factor %28%1990-1999%29%
% 210.96/211.14 |- mesh__publicMeSHNote mesh__D020893
% 210.96/211.14 2000; PROTO-ONCOGENE PROTEIN ERBB-3 %28%now RECEPTOR, ERBB-3%29% was indexed under EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1993-1999 %26% PROTO-ONCOGENE PROTEINS 1990-1999%A%
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 erbB-3, Proto-Oncogene Protein
% 210.96/211.14 |- skos__scopeNote mesh__D020893
% 210.96/211.14 A cell surface protein-tyrosine kinase receptor that is specific for NEUREGULINS. It has extensive homology to and can heterodimerize with the EGF Receptor %28%RECEPTOR, EPIDERMAL GROWTH FACTOR%29% and the erbB-2 receptor %28%RECEPTOR, ERBB-2%29%. Overexpression of the erbB-3 receptor is associated with tumorigenesis.%A%
% 210.96/211.14 |- skos__broader mesh__D020893smesh__D020794
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 erbB-3 Receptor
% 210.96/211.14 |- skos__altLabel mesh__D020893 HER-3 Proto-Oncogene Protein
% 210.96/211.14 |- mesh__dateCreated mesh__D020893 1999-11-03
% 210.96/211.14 |- mesh__recordMaintainer mesh__D020893 jmp
% 210.96/211.14 |- skos__altLabel mesh__D020893 Proto-Oncogene Protein c-erbB-3
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 Proto Oncogene Proteins erbB 3
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 Proto-Oncogene Protein, HER-3
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 c-erbB-3, Proto-Oncogene Protein
% 210.96/211.14 |- skos__altLabel mesh__D020893 c-erbB-3 Protein
% 210.96/211.14 |- skos__broader mesh__D020893smesh__D011518
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 erbB-3, Proto-Oncogene Proteins
% 210.96/211.14 |- skos__altLabel mesh__D020893 Proto-Oncogene Proteins erbB-3
% 210.96/211.14 |- mesh__recordOriginator mesh__D020893 jmp
% 210.96/211.14 |- skos__altLabel mesh__D020893 erbB-3 Protein
% 210.96/211.14 |- mesh__recordAuthorizer mesh__D020893 sjn
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 erbB 3 Protein
% 210.96/211.14 |- skos__hiddenLabel mesh__D020893 c erbB 3 Protein
% 210.96/211.14 |- skos__prefLabel mesh__D020893 Receptor, erbB-3
% 210.96/211.14 |- rdf__type mesh__D020893sskos__Concept
% 210.96/211.14 |- mesh__dateRevised mesh__D020893 2005-06-30
% 210.96/211.15 |- mesh__historyNote mesh__D020893
% 210.96/211.15 2000; use RECEPTOR, ERBB-3 %28%NM%29% 1990-1999
% 210.96/211.15 |- skos__hiddenLabel mesh__D020893 Proto Oncogene Protein erbB 3
% 210.96/211.15 |- mesh__dateEstablished mesh__D020893 2000-01-01
% 210.96/211.15 |- skos__broader mesh__D020893smesh__D017978
% 210.96/211.15 |- skos__altLabel mesh__D020893 Proto-Oncogene Protein erbB-3
% 210.96/211.15 |- skos__scopeNote mesh__D020095
% 210.96/211.15 A genus of zygomycetous fungi, family Mucoraceae, order MUCORALES, which sometimes causes infection in humans.%A%
% 210.96/211.15 |- mesh__dateEstablished mesh__D020095 1999-01-01
% 210.96/211.15 |- skos__broader mesh__D020095smesh__D009090
% 210.96/211.15 |- rdf__type mesh__D020095sskos__Concept
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D020095 2006
% 210.96/211.15 |- mesh__dateCreated mesh__D020095 1998-06-10
% 210.96/211.15 |- skos__annotation mesh__D020095
% 210.96/211.15 infection: coord IM with MUCORMYCOSIS %28%IM%29%
% 210.96/211.15 |- mesh__historyNote mesh__D020095 99
% 210.96/211.15 |- mesh__dateRevised mesh__D020095 2005-06-30
% 210.96/211.15 |- skos__prefLabel mesh__D020095 Absidia
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D020095 sjn
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D020095 99
% 210.96/211.15 |- skos__historyNote mesh__D020095 Mucorales %28%1975-1998%29%
% 210.96/211.15 |- mesh__recordMaintainer mesh__D020095 SYSTEM
% 210.96/211.15 |- skos__historyNote mesh__D020095 Fungi %28%1966-1977%29%
% 210.96/211.15 |- mesh__recordOriginator mesh__D020095 AGS
% 210.96/211.15 |- mesh__recordMaintainer mesh__D014856 jls
% 210.96/211.15 |- skos__altLabel mesh__D014856 Walrus
% 210.96/211.15 |- mesh__dateRevised mesh__D014856 2004-08-03
% 210.96/211.15 |- rdf__type mesh__D014856sskos__Concept
% 210.96/211.15 |- mesh__recordOriginator mesh__D014856 NLM
% 210.96/211.15 |- skos__prefLabel mesh__D014856 Walruses
% 210.96/211.15 |- skos__broader mesh__D014856smesh__D010872
% 210.96/211.15 |- mesh__dateEstablished mesh__D014856 1991-01-01
% 210.96/211.15 |- mesh__historyNote mesh__D014856 2005 %28%1975%29%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014856 2005A
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014856 2006
% 210.96/211.15 |- skos__altLabel mesh__D014856 Odobenidae
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D014856
% 210.96/211.15 2005; see WALRUS 1991-2004, see PINNIPEDIA 1975-1990
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D014856 jls
% 210.96/211.15 |- skos__scopeNote mesh__D014856
% 210.96/211.15 The family Odobenidae, suborder PINNIPEDIA, order CARNIVORA. It is represented by a single species of large, nearly hairless mammal found on Arctic shorelines, whose upper canines are modified into tusks.%A%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014856 2005
% 210.96/211.15 |- mesh__dateCreated mesh__D014856 1999-01-01
% 210.96/211.15 |- skos__historyNote mesh__D047232 Porifera %28%1987-2004%29%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D047232 2005
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D047232 2005
% 210.96/211.15 |- skos__scopeNote mesh__D047232
% 210.96/211.15 A genus of shallow-cupped SPONGES with a broad base in the family Theonellidae. They are characterized by ectosomal spicules dominated by phyllotriaenes.%A%
% 210.96/211.15 |- mesh__dateEstablished mesh__D047232 2005-01-01
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D047232 sjn
% 210.96/211.15 |- mesh__historyNote mesh__D047232 2005
% 210.96/211.15 |- skos__prefLabel mesh__D047232 Theonella
% 210.96/211.15 |- mesh__dateCreated mesh__D047232 2004-07-07
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D047232 2006
% 210.96/211.15 |- mesh__recordMaintainer mesh__D047232 ags
% 210.96/211.15 |- skos__broader mesh__D047232smesh__D011161
% 210.96/211.15 |- mesh__recordOriginator mesh__D047232 ags
% 210.96/211.15 |- rdf__type mesh__D047232sskos__Concept
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 2004
% 210.96/211.15 |- mesh__dateCreated mesh__D014058 1974-11-11
% 210.96/211.15 |- mesh__recordOriginator mesh__D014058 NLM
% 210.96/211.15 |- skos__prefLabel mesh__D014058 Tonga
% 210.96/211.15 |- skos__scopeNote mesh__D014058
% 210.96/211.15 An archipelago in Polynesia in the southwest Pacific Ocean, comprising about 150 islands. It is a kingdom whose capital is Nukualofa. It was discovered by the Dutch in 1616, visited by Tasman in 1643, and by Captain Cook in 1773 and 1777. The modern kingdom was established during the reign of King George Tupou I, 1845-93. It became a British protectorate in 1900 and gained independence in 1970. The name Tonga may be of local origin, meaning either island or holy. Its other name, Friendly Islands, was given by Captain Cook from the welcome given him by the natives. %28%From Webster%27%s New Geographical Dictionary, 1988, p1219 %26% Room, Brewer%27%s Dictionary of Names, 1992, p549%29%%A%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 1997
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 2000
% 210.96/211.15 |- skos__annotation mesh__D014058 an island group in Polynesia
% 210.96/211.15 |- skos__broader mesh__D014058smesh__D011114
% 210.96/211.15 |- rdf__type mesh__D014058sskos__Concept
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 2001
% 210.96/211.15 |- mesh__dateEstablished mesh__D014058 1975-01-01
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D014058 PLS
% 210.96/211.15 |- mesh__recordMaintainer mesh__D014058 KEV
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 2002
% 210.96/211.15 |- mesh__dateRevised mesh__D014058 1995-05-23
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 2005
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 1998
% 210.96/211.15 |- mesh__historyNote mesh__D014058 75
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 2006
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 2003
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 1999
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D014058 1996
% 210.96/211.15 |- mesh__dateEstablished mesh__D008819 1975-09-01
% 210.96/211.15 |- skos__hiddenLabel mesh__D008819 Nude Mouse
% 210.96/211.15 |- skos__altLabel mesh__D008819 Mouse, Nude
% 210.96/211.15 |- mesh__recordMaintainer mesh__D008819 ags
% 210.96/211.15 |- mesh__dateCreated mesh__D008819 1974-11-11
% 210.96/211.15 |- skos__altLabel mesh__D008819 Athymic Mice
% 210.96/211.15 |- skos__historyNote mesh__D008819 Mice %28%1966-1974%29%
% 210.96/211.15 |- skos__altLabel mesh__D008819 Mice, Athymic
% 210.96/211.15 |- mesh__dateRevised mesh__D008819 2005-06-30
% 210.96/211.15 |- mesh__recordOriginator mesh__D008819 NLM
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D008819 sjn
% 210.96/211.15 |- mesh__historyNote mesh__D008819 75
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D008819 75
% 210.96/211.15 |- skos__scopeNote mesh__D008819
% 210.96/211.15 Mutant mice homozygous for the recessive gene %22%nude%22% which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.%A%
% 210.96/211.15 |- skos__hiddenLabel mesh__D008819 Athymic Mouse
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D008819 2006
% 210.96/211.15 |- skos__broader mesh__D008819smesh__D008817
% 210.96/211.15 |- skos__altLabel mesh__D008819 Mouse, Athymic
% 210.96/211.15 |- skos__prefLabel mesh__D008819 Mice, Nude
% 210.96/211.15 |- rdf__type mesh__D008819sskos__Concept
% 210.96/211.15 |- skos__altLabel mesh__D008819 Nude Mice
% 210.96/211.15 |- skos__annotation mesh__D008819
% 210.96/211.15 NIM when exper animal: no qualif; when IM, qualif permitted; do not confuse with MICE, HAIRLESS see MICE, INBRED HRS; do not forget also to check tag MICE%A%
% 210.96/211.15 |- mesh__recordMaintainer mesh__D000836 meshuser
% 210.96/211.15 |- skos__hiddenLabel mesh__D000836 Animal, Zoo
% 210.96/211.15 |- skos__hiddenLabel mesh__D000836 Zoo Animals
% 210.96/211.15 |- mesh__dateRevised mesh__D000836 2003-07-30
% 210.96/211.15 |- mesh__dateCreated mesh__D000836 1999-01-01
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000836 2004
% 210.96/211.15 |- skos__historyNote mesh__D000836 Animals %28%1966-1967%29%
% 210.96/211.15 |- rdf__type mesh__D000836sskos__Concept
% 210.96/211.15 |- mesh__historyNote mesh__D000836 68
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000836 2006
% 210.96/211.15 |- skos__prefLabel mesh__D000836 Animals, Zoo
% 210.96/211.15 |- mesh__recordOriginator mesh__D000836 NLM
% 210.96/211.15 |- skos__hiddenLabel mesh__D000836 Zoo Animal
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000836 2005
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D000836 meshuser
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D000836 68
% 210.96/211.15 |- skos__broader mesh__D000836smesh__D000828
% 210.96/211.15 |- skos__annotation mesh__D000836
% 210.96/211.15 IM; qualif permitted; coord IM with specific zoo animal %28%IM%29%; do not forget also to check tag ANIMALS%A%
% 210.96/211.15 |- mesh__dateEstablished mesh__D000836 1968-01-01
% 210.96/211.15 |- mesh__dateRevised mesh__D000038 2005-08-01
% 210.96/211.15 |- skos__broader mesh__D000038smesh__D013492
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000038 2002
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000038 2004
% 210.96/211.15 |- mesh__dateCreated mesh__D000038 1999-01-01
% 210.96/211.15 |- skos__related mesh__D000038smesh__D004653
% 210.96/211.15 |- skos__hiddenLabel mesh__D000038 Abscesses
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000038 2003
% 210.96/211.15 |- mesh__recordOriginator mesh__D000038 NLM
% 210.96/211.15 |- mesh__recordMaintainer mesh__D000038 ags
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000038 2001
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D000038 ags
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000038 2006
% 210.96/211.15 |- skos__annotation mesh__D000038
% 210.96/211.15 IM; coord IM with site %28%organ/dis term%29% %28%IM%29% + precoord organism/infect term %28%IM%29%; if unspecified bacterial abscess do not coord with BACTERIAL INFECTIONS %28%since most abscesses are bact%29% but coord with specific bact infect term if given %28%as ABSCESS + STAPHYLOCOCCAL INFECTIONS%29%%A%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000038 2000
% 210.96/211.15 |- rdf__type mesh__D000038sskos__Concept
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000038 2005
% 210.96/211.15 |- skos__prefLabel mesh__D000038 Abscess
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D000038 2006A
% 210.96/211.15 |- skos__scopeNote mesh__D000038
% 210.96/211.15 Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.%A%
% 210.96/211.15 |- skos__hiddenLabel mesh__D005521 Food Services, Hospital
% 210.96/211.15 |- skos__broader mesh__D005521smesh__D006748
% 210.96/211.15 |- skos__broader mesh__D005521smesh__D005522
% 210.96/211.15 |- rdf__type mesh__D005521sskos__Concept
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D005521 2001
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D005521 sjn
% 210.96/211.15 |- skos__altLabel mesh__D005521 Service, Hospital Food
% 210.96/211.15 |- skos__annotation mesh__D005521 DF: FOOD SERV HOSP
% 210.96/211.15 |- skos__scopeNote mesh__D005521
% 210.96/211.15 Hospital department that manages and supervises the dietary program in accordance with the patients%27% requirements.%A%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D005521 2004
% 210.96/211.15 |- mesh__historyNote mesh__D005521 78; was HOSPITAL FOOD SERVICE 1963-77
% 210.96/211.15 |- skos__hiddenLabel mesh__D005521 Services, Hospital Food
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D005521 2000
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D005521 2006
% 210.96/211.15 |- mesh__onlineNote mesh__D005521
% 210.96/211.15 use FOOD SERVICE, HOSPITAL to search HOSPITAL FOOD SERVICE 1966-77%A%
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D005521
% 210.96/211.15 78; was HOSPITAL FOOD SERVICE 1963-77
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D005521 2003
% 210.96/211.15 |- skos__broader mesh__D005521smesh__D004045
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D005521 2005
% 210.96/211.15 |- skos__altLabel mesh__D005521 Hospital Food Service
% 210.96/211.15 |- skos__hiddenLabel mesh__D005521 Hospital Food Services
% 210.96/211.15 |- mesh__recordMaintainer mesh__D005521 kle
% 210.96/211.15 |- skos__prefLabel mesh__D005521 Food Service, Hospital
% 210.96/211.15 |- mesh__recordOriginator mesh__D005521 NLM
% 210.96/211.15 |- mesh__dateRevised mesh__D005521 1999-11-03
% 210.96/211.15 |- mesh__dateCreated mesh__D005521 1999-01-01
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D005521 2002
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D052177 2006
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Renal Disease, Cystic
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Cystic Kidneys
% 210.96/211.15 |- skos__historyNote mesh__D052177
% 210.96/211.15 Polycystic Kidney Diseases %28%1976-2005%29%
% 210.96/211.15 |- skos__prefLabel mesh__D052177 Kidney Diseases, Cystic
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Kidney Disease, Cystic
% 210.96/211.15 |- rdf__type mesh__D052177sskos__Concept
% 210.96/211.15 |- mesh__recordMaintainer mesh__D052177 lkt
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Diseases, Cystic Kidney
% 210.96/211.15 |- mesh__recordOriginator mesh__D052177 lkt
% 210.96/211.15 |- mesh__dateEstablished mesh__D052177 2006-01-01
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D052177 sjn
% 210.96/211.15 |- skos__historyNote mesh__D052177 Kidney, Cystic %28%1975-2005%29%
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Kidneys, Cystic
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Cystic Renal Disease
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Cystic Kidney
% 210.96/211.15 |- mesh__historyNote mesh__D052177 2006
% 210.96/211.15 |- skos__broader mesh__D052177smesh__D016146
% 210.96/211.15 |- skos__scopeNote mesh__D052177
% 210.96/211.15 A heterogeneous group of hereditary and acquired disorders in which the KIDNEY contains one or more CYSTS unilaterally or bilaterally %28%KIDNEY, CYSTIC%29%.%A%
% 210.96/211.15 |- skos__broader mesh__D052177smesh__D007674
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Disease, Cystic Renal
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D052177 2006
% 210.96/211.15 |- skos__altLabel mesh__D052177 Cystic Kidney Diseases
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Diseases, Cystic Renal
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Disease, Cystic Kidney
% 210.96/211.15 |- mesh__dateCreated mesh__D052177 2005-06-30
% 210.96/211.15 |- skos__altLabel mesh__D052177 Cystic Renal Diseases
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Renal Diseases, Cystic
% 210.96/211.15 |- skos__annotation mesh__D052177 note specifics
% 210.96/211.15 |- skos__hiddenLabel mesh__D052177 Cystic Kidney Disease
% 210.96/211.15 |- rdf__type mesh__D046938sskos__Concept
% 210.96/211.15 |- skos__scopeNote mesh__D046938
% 210.96/211.15 A form-genus of CYANOBACTERIA in the order Oscillatoriales. They are non-heterocystous but may carry out NITROGEN FIXATION under microaerobic conditions. Some smaller members have undergone transfer to the form-genus Leptolyngbya.%A%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D046938 2006
% 210.96/211.15 |- mesh__recordMaintainer mesh__D046938 SYSTEM
% 210.96/211.15 |- mesh__dateCreated mesh__D046938 2004-07-07
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D046938 2005
% 210.96/211.15 |- mesh__recordOriginator mesh__D046938 ags
% 210.96/211.15 |- skos__prefLabel mesh__D046938 Plectonema
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D046938 sjn
% 210.96/211.15 |- mesh__dateRevised mesh__D046938 2005-06-30
% 210.96/211.15 |- skos__historyNote mesh__D046938 Cyanobacteria %28%1970-2004%29%
% 210.96/211.15 |- skos__broader mesh__D046938smesh__D000458
% 210.96/211.15 |- mesh__historyNote mesh__D046938 2005
% 210.96/211.15 |- mesh__dateEstablished mesh__D046938 2005-01-01
% 210.96/211.15 |- mesh__dateCreated mesh__D018449 1994-05-23
% 210.96/211.15 |- skos__hiddenLabel mesh__D018449 Vaccines, SIV
% 210.96/211.15 |- mesh__historyNote mesh__D018449 95
% 210.96/211.15 |- skos__hiddenLabel mesh__D018449 AIDS Vaccines, Simian
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D018449 2006
% 210.96/211.15 |- mesh__recordMaintainer mesh__D018449 sjn
% 210.96/211.15 |- skos__hiddenLabel mesh__D018449 Vaccines, SAIDS
% 210.96/211.15 |- skos__annotation mesh__D018449
% 210.96/211.15 coord IM with specific SAIDS virus %28%IM or NIM%29% if pertinent%A%
% 210.96/211.15 |- skos__hiddenLabel mesh__D018449 Vaccines, Simian AIDS
% 210.96/211.15 |- rdf__type mesh__D018449sskos__Concept
% 210.96/211.15 |- skos__hiddenLabel mesh__D018449 Vaccine, SIV
% 210.96/211.15 |- skos__historyNote mesh__D018449
% 210.96/211.15 Simian Acquired Immunodeficiency Syndrome/prevention %26% control %28%1990-1994%29%
% 210.96/211.15 |- mesh__recordOriginator mesh__D018449 AGS
% 210.96/211.15 |- mesh__dateEstablished mesh__D018449 1995-01-01
% 210.96/211.15 |- skos__broader mesh__D018449smesh__D014765
% 210.96/211.15 |- skos__altLabel mesh__D018449 SIV Vaccines
% 210.96/211.15 |- skos__prefLabel mesh__D018449 SAIDS Vaccines
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D018449 95
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D018449 sjn
% 210.96/211.15 |- skos__scopeNote mesh__D018449
% 210.96/211.15 Vaccines or candidate vaccines designed to prevent SAIDS; %28%SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME%29%; and containing inactivated SIMIAN IMMUNODEFICIENCY VIRUS or type D retroviruses or some of their component antigens.%A%
% 210.96/211.15 |- mesh__dateRevised mesh__D018449 2005-07-01
% 210.96/211.15 |- skos__altLabel mesh__D018449 Simian AIDS Vaccines
% 210.96/211.15 |- skos__historyNote mesh__D018449
% 210.96/211.15 Viral Vaccines/immunology %28%1991-1994%29%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 1999
% 210.96/211.15 |- skos__altLabel mesh__D010466 Perceptual Completion Phenomena
% 210.96/211.15 |- skos__broader mesh__D010466smesh__D014796
% 210.96/211.15 |- skos__historyNote mesh__D010466 Visual Perception %28%1966-1968%29%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 2003A
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 2003
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 1996
% 210.96/211.15 |- skos__prefLabel mesh__D010466 Perceptual Closure
% 210.96/211.15 |- skos__hiddenLabel mesh__D010466 Perceptual Closures
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 1993
% 210.96/211.15 |- skos__historyNote mesh__D010466 Form Perception %28%1966-1968%29%
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D010466 sjn
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 2002
% 210.96/211.15 |- skos__hiddenLabel mesh__D010466 Closure, Perceptual
% 210.96/211.15 |- skos__hiddenLabel mesh__D010466 Completion Phenomena, Perceptual
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 2004
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 1997
% 210.96/211.15 |- rdf__type mesh__D010466sskos__Concept
% 210.96/211.15 |- mesh__dateRevised mesh__D010466 2002-10-24
% 210.96/211.15 |- mesh__recordOriginator mesh__D010466 NLM
% 210.96/211.15 |- mesh__historyNote mesh__D010466
% 210.96/211.15 69; GESTALT LAW OF CLOSURE was see under PERCEPTUAL CLOSURE 1969-78%A%
% 210.96/211.15 |- mesh__onlineNote mesh__D010466
% 210.96/211.15 use PERCEPTUAL CLOSURE to search GESTALT LAW OF CLOSURE 1969-78%A%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 2000
% 210.96/211.15 |- mesh__dateCreated mesh__D010466 1999-01-01
% 210.96/211.15 |- skos__scopeNote mesh__D010466
% 210.96/211.15 The tendency to perceive an incomplete pattern or object as complete or whole. This includes the Gestalt Law of Closure.%A%
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D010466 69
% 210.96/211.15 |- mesh__dateEstablished mesh__D010466 1969-01-01
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 1994
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 2005
% 210.96/211.15 |- mesh__recordMaintainer mesh__D010466 sjn
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 1998
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 2001
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 1995
% 210.96/211.15 |- skos__hiddenLabel mesh__D010466 Phenomena, Perceptual Completion
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D010466 2006
% 210.96/211.15 |- skos__hiddenLabel mesh__D010466 Closures, Perceptual
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1998
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 2001
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1995
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D004429 PLS
% 210.96/211.15 |- skos__hiddenLabel mesh__D004429 Ossicles, Ear
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 2004
% 210.96/211.15 |- skos__hiddenLabel mesh__D004429 Auditory Ossicle
% 210.96/211.15 |- mesh__dateCreated mesh__D004429 1999-01-01
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1991
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 2000
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1994
% 210.96/211.15 |- skos__altLabel mesh__D004429 Auditory Ossicles
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 2003
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1997
% 210.96/211.15 |- skos__broader mesh__D004429smesh__D004432
% 210.96/211.15 |- skos__related mesh__D004429smesh__D013201
% 210.96/211.15 |- skos__hiddenLabel mesh__D004429 Ear Ossicle
% 210.96/211.15 |- mesh__dateRevised mesh__D004429 1989-10-06
% 210.96/211.15 |- skos__prefLabel mesh__D004429 Ear Ossicles
% 210.96/211.15 |- skos__hiddenLabel mesh__D004429 Ossicle, Auditory
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1996
% 210.96/211.15 |- skos__hiddenLabel mesh__D004429 Ossicles, Auditory
% 210.96/211.15 |- mesh__recordOriginator mesh__D004429 NLM
% 210.96/211.15 |- mesh__recordMaintainer mesh__D004429 PLS
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 2006
% 210.96/211.15 |- rdf__type mesh__D004429sskos__Concept
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1990
% 210.96/211.15 |- skos__hiddenLabel mesh__D004429 Ossicle, Ear
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 2002
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1993
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 2005
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1999
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D004429 1992
% 210.96/211.15 |- skos__annotation mesh__D015151
% 210.96/211.15 GEN or unspecified: prefer specifics; DF: IMMUNOBLOT
% 210.96/211.15 |- skos__hiddenLabel mesh__D015151 Reverse Immunoblottings
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D015151 2005
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D015151 2002
% 210.96/211.15 |- skos__historyNote mesh__D015151
% 210.96/211.15 Electrophoresis, Polyacrylamide Gel %28%1982-1988%29%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D015151 2006
% 210.96/211.15 |- skos__broader mesh__D015151smesh__D007118
% 210.96/211.15 |- mesh__dateCreated mesh__D015151 1988-03-22
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D015151 sjn
% 210.96/211.15 |- skos__hiddenLabel mesh__D015151 Immunoblottings, Reverse
% 210.96/211.15 |- mesh__historyNote mesh__D015151 89
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D015151 2003
% 210.96/211.15 |- skos__historyNote mesh__D015151
% 210.96/211.15 Immunoenzyme Techniques %28%1983-1988%29%
% 210.96/211.15 |- skos__altLabel mesh__D015151 Reverse Immunoblotting
% 210.96/211.15 |- skos__historyNote mesh__D015151 Isoelectric Focusing %28%1984-1988%29%
% 210.96/211.15 |- skos__hiddenLabel mesh__D015151 Immunoblottings, Dot
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D015151 2004
% 210.96/211.15 |- rdf__type mesh__D015151sskos__Concept
% 210.96/211.15 |- skos__hiddenLabel mesh__D015151 Electroimmunoblottings
% 210.96/211.15 |- skos__hiddenLabel mesh__D015151 Immunoelectroblottings
% 210.96/211.15 |- skos__altLabel mesh__D015151 Electroimmunoblotting
% 210.96/211.15 |- skos__hiddenLabel mesh__D015151 Dot Immunoblottings
% 210.96/211.15 |- skos__altLabel mesh__D015151 Immunoblotting, Dot
% 210.96/211.15 |- mesh__dateRevised mesh__D015151 2001-07-25
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D015151 89
% 210.96/211.15 |- skos__scopeNote mesh__D015151
% 210.96/211.15 Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies.%A%
% 210.96/211.15 |- mesh__recordMaintainer mesh__D015151 nns
% 210.96/211.15 |- skos__hiddenLabel mesh__D015151 Immunoblottings
% 210.96/211.15 |- mesh__dateEstablished mesh__D015151 1989-01-01
% 210.96/211.15 |- skos__prefLabel mesh__D015151 Immunoblotting
% 210.96/211.15 |- skos__historyNote mesh__D015151 Immunoelectrophoresis %28%1984-1988%29%
% 210.96/211.15 |- skos__historyNote mesh__D015151 Immunochemistry %28%1983-1988%29%
% 210.96/211.15 |- mesh__recordOriginator mesh__D015151 SCD
% 210.96/211.15 |- skos__related mesh__D015151smesh__D007120
% 210.96/211.15 |- skos__broader mesh__D009912smesh__D009059
% 210.96/211.15 |- rdf__type mesh__D009912sskos__Concept
% 210.96/211.15 |- skos__hiddenLabel mesh__D009912 Manifestations, Oral
% 210.96/211.15 |- mesh__recordMaintainer mesh__D009912 ags
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D009912 sjn
% 210.96/211.15 |- skos__hiddenLabel mesh__D009912 Oral Manifestation
% 210.96/211.15 |- mesh__historyNote mesh__D009912 65
% 210.96/211.15 |- mesh__dateRevised mesh__D009912 2004-07-07
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009912 2006
% 210.96/211.15 |- mesh__recordOriginator mesh__D009912 NLM
% 210.96/211.15 |- mesh__dateEstablished mesh__D009912 1965-01-01
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D009912 65
% 210.96/211.15 |- skos__prefLabel mesh__D009912 Oral Manifestations
% 210.96/211.15 |- skos__broader mesh__D009912smesh__D012816
% 210.96/211.15 |- skos__hiddenLabel mesh__D009912 Manifestation, Oral
% 210.96/211.15 |- skos__annotation mesh__D009912
% 210.96/211.15 not used for indexing since 1989; prior to 1989 used for oral manifest of non-oral diseases%A%
% 210.96/211.15 |- mesh__dateCreated mesh__D009912 1999-01-01
% 210.96/211.15 |- skos__scopeNote mesh__D009912
% 210.96/211.15 Disorders of the mouth attendant upon non-oral disease or injury.%A%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009912 2005
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 1998
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D009114 PLS
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 2001
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 2005
% 210.96/211.15 |- mesh__recordMaintainer mesh__D009114 JRT
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 2000
% 210.96/211.15 |- skos__altLabel mesh__D009114 Acid Ammonium Purpurate
% 210.96/211.15 |- skos__prefLabel mesh__D009114 Murexide
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 1997
% 210.96/211.15 |- skos__scopeNote mesh__D009114
% 210.96/211.15 5,5%27%-Nitrilodibarbituric acid ammonium derivative. Used as an indicator for complexometric titrations.%A%
% 210.96/211.15 |- skos__hiddenLabel mesh__D009114 Ammonium Purpurate, Acid
% 210.96/211.15 |- mesh__recordOriginator mesh__D009114 NLM
% 210.96/211.15 |- rdf__type mesh__D009114sskos__Concept
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 2004
% 210.96/211.15 |- skos__hiddenLabel mesh__D009114 Purpurate, Ammonium
% 210.96/211.15 |- skos__altLabel mesh__D009114 Ammonium Purpurate
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 1996
% 210.96/211.15 |- mesh__historyNote mesh__D009114
% 210.96/211.15 91%28%75%29%; was see under BARBITURATES 1975-90
% 210.96/211.15 |- mesh__dateRevised mesh__D009114 1995-06-08
% 210.96/211.15 |- skos__annotation mesh__D009114 an indicator; D25-26 qualif
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 2002
% 210.96/211.15 |- skos__broader mesh__D009114smesh__D001463
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 2003
% 210.96/211.15 |- mesh__publicMeSHNote mesh__D009114
% 210.96/211.15 91; was see under BARBITURATES 1975-90
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 1999
% 210.96/211.15 |- mesh__dateEstablished mesh__D009114 1991-01-01
% 210.96/211.15 |- skos__hiddenLabel mesh__D009114 Purpurate, Acid Ammonium
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D009114 2006
% 210.96/211.15 |- mesh__dateCreated mesh__D009114 1974-11-19
% 210.96/211.15 |- skos__historyNote mesh__D009114 Barbiturates %28%1969-1974%29%
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D001131 2002
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D001131 2006
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D001131 1999
% 210.96/211.15 |- skos__broader mesh__D001131smesh__D015144
% 210.96/211.15 |- rdf__type mesh__D001131sskos__Concept
% 210.96/211.15 |- mesh__recordMaintainer mesh__D001131 PXP
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D001131 2000
% 210.96/211.15 |- mesh__dateCreated mesh__D001131 1999-01-01
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D001131 2001
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D001131 2003
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D001131 2005
% 210.96/211.15 |- mesh__dateRevised mesh__D001131 1997-06-20
% 210.96/211.15 |- mesh__recordAuthorizer mesh__D001131 SJN
% 210.96/211.15 |- mesh__recordOriginator mesh__D001131 NLM
% 210.96/211.15 |- mesh__activeMeSHYear mesh__D001131 2004
% 210.96/211.16 |- skos__prefLabel mesh__D001131 Arkansas
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D001131 1998
% 210.96/211.16 |- skos__broader mesh__D020894smesh__D005109
% 210.96/211.16 |- skos__scopeNote mesh__D020894
% 210.96/211.16 Components of the extracellular matrix consisting primarily of fibrillin. They are essential for the integrity of elastic fibers.%A%
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020894 2001
% 210.96/211.16 |- skos__prefLabel mesh__D020894 Microfibrils
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020894 2002
% 210.96/211.16 |- mesh__dateCreated mesh__D020894 1999-11-03
% 210.96/211.16 |- rdf__type mesh__D020894sskos__Concept
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020894 2005
% 210.96/211.16 |- mesh__dateRevised mesh__D020894 2000-06-22
% 210.96/211.16 |- mesh__dateEstablished mesh__D020894 2000-01-01
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D020894 2000
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020894 2003
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020894 2006
% 210.96/211.16 |- skos__hiddenLabel mesh__D020894 Microfibril
% 210.96/211.16 |- mesh__historyNote mesh__D020894 2000
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020894 2004
% 210.96/211.16 |- skos__historyNote mesh__D020096 Mucormycosis %28%1975-1998%29%
% 210.96/211.16 |- skos__hiddenLabel mesh__D020096 Phycomycoses
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020096 2004
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D020096 sjn
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D020096 99; see MUCORMYCOSIS 1989-98
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020096 2003
% 210.96/211.16 |- mesh__dateRevised mesh__D020096 2000-06-22
% 210.96/211.16 |- skos__hiddenLabel mesh__D020096 Zygomycoses
% 210.96/211.16 |- rdf__type mesh__D020096sskos__Concept
% 210.96/211.16 |- mesh__dateCreated mesh__D020096 1998-06-11
% 210.96/211.16 |- mesh__historyNote mesh__D020096 99; use MUCORMYCOSIS 1989-98
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020096 2006
% 210.96/211.16 |- skos__prefLabel mesh__D020096 Zygomycosis
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020096 2002
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020096 2005
% 210.96/211.16 |- skos__historyNote mesh__D020096 Mycoses %28%1976-1991%29%
% 210.96/211.16 |- skos__scopeNote mesh__D020096
% 210.96/211.16 Infection in humans and animals caused by fungi in the class Zygomycetes. It includes MUCORMYCOSIS and entomophthoramycosis. The latter is a tropical infection of subcutaneous tissue or paranasal sinuses caused by fungi in the order Entomophthorales. Phycomycosis, closely related to zygomycosis, describes infection with members of Phycomycetes, an obsolete classification.%A%
% 210.96/211.16 |- mesh__dateEstablished mesh__D020096 1999-01-01
% 210.96/211.16 |- mesh__recordOriginator mesh__D020096 AGS
% 210.96/211.16 |- skos__hiddenLabel mesh__D020096 Entomophthoramycoses
% 210.96/211.16 |- mesh__recordMaintainer mesh__D020096 ags
% 210.96/211.16 |- skos__annotation mesh__D020096
% 210.96/211.16 fungus dis caused by various Zygomycetes; for dis caused by Mucorales, MUCORMYCOSIS is available%A%
% 210.96/211.16 |- skos__broader mesh__D020096smesh__D009181
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D020096 2001
% 210.96/211.16 |- skos__scopeNote mesh__D014857
% 210.96/211.16 Hostile conflict between organized groups of people.
% 210.96/211.16 |- skos__related mesh__D014857smesh__D014754
% 210.96/211.16 |- skos__hiddenLabel mesh__D014857 Wars
% 210.96/211.16 |- mesh__recordMaintainer mesh__D014857 jls
% 210.96/211.16 |- skos__broader mesh__D014857smesh__D012940
% 210.96/211.16 |- skos__annotation mesh__D014857
% 210.96/211.16 war wounds: index under WOUNDS AND INJURIES or specific inj %28%IM%29% + WAR %28%IM or NIM%29%; note specific wars indented under HISTORY; other wars: index WAR + geographical term%A%
% 210.96/211.16 |- mesh__recordOriginator mesh__D014857 NLM
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D014857 2006
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D014857 sjn
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D014857 2005
% 210.96/211.16 |- mesh__dateRevised mesh__D014857 2004-07-07
% 210.96/211.16 |- mesh__dateCreated mesh__D014857 1999-01-01
% 210.96/211.16 |- skos__prefLabel mesh__D014857 War
% 210.96/211.16 |- skos__related mesh__D014857smesh__D003130
% 210.96/211.16 |- rdf__type mesh__D014857sskos__Concept
% 210.96/211.16 |- mesh__dateCreated mesh__D047233 2004-07-07
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D047233 2006
% 210.96/211.16 |- mesh__recordMaintainer mesh__D047233 ags
% 210.96/211.16 |- skos__broader mesh__D047233smesh__D011161
% 210.96/211.16 |- rdf__type mesh__D047233sskos__Concept
% 210.96/211.16 |- mesh__dateEstablished mesh__D047233 2005-01-01
% 210.96/211.16 |- skos__scopeNote mesh__D047233
% 210.96/211.16 A genus of velvety smooth SPONGES in the family Suberitidae, characterized by the ectosomal and choanosomal skeletons dominated by tylostyles %28%pin-like spicules with a pinched bulbous end%29%.%A%
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D047233 sjn
% 210.96/211.16 |- mesh__historyNote mesh__D047233 2005
% 210.96/211.16 |- mesh__recordOriginator mesh__D047233 ags
% 210.96/211.16 |- skos__prefLabel mesh__D047233 Suberites
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D047233 2005
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D047233 2005
% 210.96/211.16 |- skos__historyNote mesh__D047233 Porifera %28%1971-2004%29%
% 210.96/211.16 |- skos__related mesh__D014059smesh__D005927
% 210.96/211.16 |- skos__hiddenLabel mesh__D014059 Microglossias
% 210.96/211.16 |- mesh__dateRevised mesh__D014059 2003-07-09
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D014059 2005
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D014059 sjn
% 210.96/211.16 |- mesh__recordMaintainer mesh__D014059 lkt
% 210.96/211.16 |- mesh__recordOriginator mesh__D014059 NLM
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D014059 2006
% 210.96/211.16 |- mesh__considerAlso mesh__D014059
% 210.96/211.16 consider also terms at GLOSS- and LINGUAL
% 210.96/211.16 |- mesh__historyNote mesh__D014059
% 210.96/211.16 /abnormalities was TONGUE ABNORMALITIES 1965
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D014059 2004
% 210.96/211.16 |- skos__prefLabel mesh__D014059 Tongue
% 210.96/211.16 |- skos__hiddenLabel mesh__D014059 Tongues
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D014059
% 210.96/211.16 /abnormalities was TONGUE ABNORMALITIES 1965
% 210.96/211.16 |- skos__annotation mesh__D014059
% 210.96/211.16 /surg: consider GLOSSECTOMY; /transpl permitted for tongue grafts as in palate surg; inflammation = GLOSSITIS; tongue thrust: index under TONGUE HABITS; painful or sore tongue = GLOSSALGIA; scrotal tongue = TONGUE, FISSURED%A%
% 210.96/211.16 |- mesh__dateCreated mesh__D014059 1999-01-01
% 210.96/211.16 |- skos__broader mesh__D014059smesh__D009055
% 210.96/211.16 |- rdf__type mesh__D014059sskos__Concept
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000837 2006
% 210.96/211.16 |- mesh__recordMaintainer mesh__D000837 ssb
% 210.96/211.16 |- rdf__type mesh__D000837sskos__Concept
% 210.96/211.16 |- mesh__recordOriginator mesh__D000837 NLM
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000837 2005
% 210.96/211.16 |- skos__broader mesh__D000837smesh__D007475
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D000837 sjn
% 210.96/211.16 |- skos__prefLabel mesh__D000837 Anion Exchange Resins
% 210.96/211.16 |- skos__scopeNote mesh__D000837
% 210.96/211.16 High-molecular-weight insoluble polymers that contain functional cationic groups capable of undergoing exchange reactions with anions.%A%
% 210.96/211.16 |- mesh__historyNote mesh__D000837
% 210.96/211.16 91%28%75%29%; was see under ION EXCHANGE RESINS 1975-90
% 210.96/211.16 |- mesh__dateRevised mesh__D000837 2003-07-09
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D000837
% 210.96/211.16 91; was see under ION EXCHANGE RESINS 1975-90
% 210.96/211.16 |- mesh__dateEstablished mesh__D000837 1991-01-01
% 210.96/211.16 |- skos__hiddenLabel mesh__D000837 Resins, Anion Exchange
% 210.96/211.16 |- mesh__onlineNote mesh__D000837 search ION EXCHANGE RESINS 1966-74
% 210.96/211.16 |- mesh__dateCreated mesh__D000837 1999-01-01
% 210.96/211.16 |- skos__altLabel mesh__D000837 Anion Exchangers %28%Resins%29%
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000837 2004
% 210.96/211.16 |- skos__hiddenLabel mesh__D000837 Exchange Resins, Anion
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D019542 sjn
% 210.96/211.16 |- skos__broader mesh__D019542smesh__D019502
% 210.96/211.16 |- skos__scopeNote mesh__D019542
% 210.96/211.16 Works consisting of lists of the events, pieces, performers, speakers, etc., of an entertainment, ceremony, or the like. %28%From: Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloging, 2d ed%29%%A%
% 210.96/211.16 |- mesh__recordMaintainer mesh__D019542 jls
% 210.96/211.16 |- mesh__dateCreated mesh__D019542 1996-06-21
% 210.96/211.16 |- skos__prefLabel mesh__D019542 Programs %5B%Publication Type%5D%
% 210.96/211.16 |- mesh__recordOriginator mesh__D019542 TGC
% 210.96/211.16 |- skos__altLabel mesh__D019542 Programs %28%PT%29%
% 210.96/211.16 |- skos__annotation mesh__D019542 publication type only
% 210.96/211.16 |- skos__altLabel mesh__D019542 Programs
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D019542 2006
% 210.96/211.16 |- mesh__dateRevised mesh__D019542 2005-06-30
% 210.96/211.16 |- mesh__historyNote mesh__D019542 1997
% 210.96/211.16 |- rdf__type mesh__D019542sskos__Concept
% 210.96/211.16 |- mesh__dateEstablished mesh__D019542 1997-01-01
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D000039
% 210.96/211.16 89; was ABSCESS, PERITONSILLAR 1963-88
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 1995
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 1996
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 2002
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D000039 PLS
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 2004
% 210.96/211.16 |- skos__hiddenLabel mesh__D000039 Peritonsillar Abscesses
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 1997
% 210.96/211.16 |- skos__scopeNote mesh__D000039
% 210.96/211.16 An abscess in the peritonsillar tissue extending into the tonsil capsule, resulting from suppuration of the tonsil. %28%Dorland, 27th ed%29%%A%
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 2005
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 1998
% 210.96/211.16 |- skos__broader mesh__D000039smesh__D014069
% 210.96/211.16 |- skos__prefLabel mesh__D000039 Peritonsillar Abscess
% 210.96/211.16 |- mesh__recordMaintainer mesh__D000039 PLS
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 2006
% 210.96/211.16 |- mesh__historyNote mesh__D000039
% 210.96/211.16 89; was ABSCESS, PERITONSILLAR 1963-88
% 210.96/211.16 |- skos__altLabel mesh__D000039 Abscess, Peritonsillar
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 1999
% 210.96/211.16 |- mesh__onlineNote mesh__D000039
% 210.96/211.16 use PERITONSILLAR ABSCESS to search ABSCESS, PERITONSILLAR 1966-88%A%
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 2000
% 210.96/211.16 |- skos__broader mesh__D000039smesh__D010608
% 210.96/211.16 |- rdf__type mesh__D000039sskos__Concept
% 210.96/211.16 |- mesh__recordOriginator mesh__D000039 NLM
% 210.96/211.16 |- skos__hiddenLabel mesh__D000039 Abscesses, Peritonsillar
% 210.96/211.16 |- skos__broader mesh__D000039smesh__D000038
% 210.96/211.16 |- mesh__dateCreated mesh__D000039 1999-01-01
% 210.96/211.16 |- skos__annotation mesh__D000039 for coord read note on ABSCESS
% 210.96/211.16 |- mesh__dateRevised mesh__D000039 1994-05-27
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 2001
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D000039 2003
% 210.96/211.16 |- mesh__dateRevised mesh__D005522 1999-11-03
% 210.96/211.16 |- skos__broader mesh__D005522smesh__D019649
% 210.96/211.16 |- skos__annotation mesh__D005522
% 210.96/211.16 includes food distribution programs, food stamp plans, school lunches, child feeding programs; do not confuse with DIETARY SERVICES where nutrition is emphasized; DF: FOOD SER%A%
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D005522 2004
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D005522 2002
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D005522 2006
% 210.96/211.16 |- mesh__recordOriginator mesh__D005522 JW
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D005522 2003
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D005522 sjn
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D005522 2001
% 210.96/211.16 |- skos__altLabel mesh__D005522 Services, Food
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D005522 2005
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D005522 76
% 210.96/211.16 |- skos__prefLabel mesh__D005522 Food Services
% 210.96/211.16 |- skos__hiddenLabel mesh__D005522 Food Service
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D005522 2000
% 210.96/211.16 |- mesh__historyNote mesh__D005522
% 210.96/211.16 76; was FOOD SERVICE %28%NON MESH%29% before 1976
% 210.96/211.16 |- skos__hiddenLabel mesh__D005522 Service, Food
% 210.96/211.16 |- mesh__dateEstablished mesh__D005522 1976-01-01
% 210.96/211.16 |- skos__altLabel mesh__D005522 Meals on Wheels
% 210.96/211.16 |- mesh__recordMaintainer mesh__D005522 kle
% 210.96/211.16 |- mesh__dateCreated mesh__D005522 1975-07-25
% 210.96/211.16 |- rdf__type mesh__D005522sskos__Concept
% 210.96/211.16 |- skos__scopeNote mesh__D005522
% 210.96/211.16 Functions, equipment, and facilities concerned with the preparation and distribution of ready-to-eat food.%A%
% 210.96/211.16 |- rdf__type mesh__D052178sskos__Concept
% 210.96/211.16 |- mesh__recordOriginator mesh__D052178 lkt
% 210.96/211.16 |- skos__scopeNote mesh__D052178
% 210.96/211.16 A condition in which the HEAD of the FETUS is larger than the mother%27%s PELVIS through which the fetal head must pass during a vaginal delivery.%A%
% 210.96/211.16 |- skos__hiddenLabel mesh__D052178 Disproportion, Cephalopelvic
% 210.96/211.16 |- skos__prefLabel mesh__D052178 Cephalopelvic Disproportion
% 210.96/211.16 |- mesh__recordMaintainer mesh__D052178 lkt
% 210.96/211.16 |- mesh__dateEstablished mesh__D052178 2006-01-01
% 210.96/211.16 |- skos__broader mesh__D052178smesh__D007744
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D052178 sjn
% 210.96/211.16 |- mesh__historyNote mesh__D052178
% 210.96/211.16 2006; use LABOR COOMPLICATIONS 1992-2005
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D052178 2006
% 210.96/211.16 |- mesh__dateCreated mesh__D052178 2005-06-30
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D052178
% 210.96/211.16 2006; see LABOR COOMPLICATIONS 1992-2005
% 210.96/211.16 |- skos__historyNote mesh__D046939 Cyanobacteria %28%1971-2004%29%
% 210.96/211.16 |- mesh__dateCreated mesh__D046939 2004-07-07
% 210.96/211.16 |- mesh__historyNote mesh__D046939 2005
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D046939 2005
% 210.96/211.16 |- mesh__dateEstablished mesh__D046939 2005-01-01
% 210.96/211.16 |- skos__prefLabel mesh__D046939 Synechocystis
% 210.96/211.16 |- mesh__recordOriginator mesh__D046939 ags
% 210.96/211.16 |- skos__scopeNote mesh__D046939
% 210.96/211.16 A form-genus of unicellular CYANOBACTERIA in the order Chroococcales. None of the strains fix NITROGEN, there are no gas vacuoles, and sheath layers are never produced.%A%
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D046939 sjn
% 210.96/211.16 |- rdf__type mesh__D046939sskos__Concept
% 210.96/211.16 |- mesh__dateRevised mesh__D046939 2005-06-30
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D046939 2006
% 210.96/211.16 |- mesh__recordMaintainer mesh__D046939 SYSTEM
% 210.96/211.16 |- skos__broader mesh__D046939smesh__D000458
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D029970 2002
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D029970 2002
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D029970 2005
% 210.96/211.16 |- skos__prefLabel mesh__D029970 Angelica archangelica
% 210.96/211.16 |- mesh__dateEstablished mesh__D029970 2002-01-01
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D029970 2003
% 210.96/211.16 |- rdf__type mesh__D029970sskos__Concept
% 210.96/211.16 |- mesh__dateCreated mesh__D029970 2001-07-25
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D029970 2006
% 210.96/211.16 |- mesh__historyNote mesh__D029970 2002
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D029970 2004
% 210.96/211.16 |- skos__scopeNote mesh__D029970
% 210.96/211.16 A plant species of the family Apiaceae that contains COUMARINS.%A%
% 210.96/211.16 |- skos__annotation mesh__D029970
% 210.96/211.16 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.96/211.16 |- skos__broader mesh__D029970smesh__D029969
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D010467 2001
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D010467 70
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D010467 2004
% 210.96/211.16 |- mesh__dateRevised mesh__D010467 1997-06-20
% 210.96/211.16 |- rdf__type mesh__D010467sskos__Concept
% 210.96/211.16 |- mesh__historyNote mesh__D010467 70%28%65%29%
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D010467 SJN
% 210.96/211.16 |- skos__annotation mesh__D010467 no qualif
% 210.96/211.16 |- skos__broader mesh__D010467smesh__D003674
% 210.96/211.16 |- skos__scopeNote mesh__D010467
% 210.96/211.16 Selective perceiving such that the individual protects himself from becoming aware of something unpleasant or threatening, e.g., obscene words are not heard correctly, or violent acts are not seen accurately.%A%
% 210.96/211.16 |- mesh__dateCreated mesh__D010467 1999-01-01
% 210.96/211.16 |- mesh__recordMaintainer mesh__D010467 JLS
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D010467 2002
% 210.96/211.16 |- skos__hiddenLabel mesh__D010467 Defense, Perceptual
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D010467 2005
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D010467 1998
% 210.96/211.16 |- mesh__recordOriginator mesh__D010467 NLM
% 210.96/211.16 |- skos__prefLabel mesh__D010467 Perceptual Defense
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D010467 2006
% 210.96/211.16 |- mesh__dateEstablished mesh__D010467 1970-01-01
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D010467 2000
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D010467 1999
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D010467 2003
% 210.96/211.16 |- skos__hiddenLabel mesh__D010467 Defenses, Perceptual
% 210.96/211.16 |- skos__historyNote mesh__D015152 RNA or specific %28%1979-1988%29%
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D015152 2003
% 210.96/211.16 |- mesh__dateRevised mesh__D015152 2002-07-02
% 210.96/211.16 |- skos__broader mesh__D015152smesh__D009710
% 210.96/211.16 |- mesh__historyNote mesh__D015152
% 210.96/211.16 91%28%89%29%; was see under MOLECULAR PROBE TECHNIQUES 1989-90
% 210.96/211.16 |- rdf__type mesh__D015152sskos__Concept
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D015152 2004
% 210.96/211.16 |- skos__hiddenLabel mesh__D015152 Blots, Northern
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D015152
% 210.96/211.16 91; was see under MOLECULAR PROBE TECHNIQUES 1989-90
% 210.96/211.16 |- skos__hiddenLabel mesh__D015152 Northern Blots
% 210.96/211.16 |- skos__hiddenLabel mesh__D015152 Northern Blottings
% 210.96/211.16 |- skos__altLabel mesh__D015152 Northern Blotting
% 210.96/211.16 |- mesh__recordMaintainer mesh__D015152 lkt
% 210.96/211.16 |- skos__annotation mesh__D015152
% 210.96/211.16 %22%northern%22% is not capitalized in titles or translations; DF: NORTHERN BLOT%A%
% 210.96/211.16 |- mesh__recordOriginator mesh__D015152 SCD
% 210.96/211.16 |- mesh__dateEstablished mesh__D015152 1991-01-01
% 210.96/211.16 |- skos__prefLabel mesh__D015152 Blotting, Northern
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D015152 2005
% 210.96/211.16 |- skos__broader mesh__D015152smesh__D015336
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D015152 sjn
% 210.96/211.16 |- skos__historyNote mesh__D015152
% 210.96/211.16 Nucleic Acid Hybridization %28%1979-1988%29%
% 210.96/211.16 |- skos__hiddenLabel mesh__D015152 Blottings, Northern
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D015152 2006
% 210.96/211.16 |- skos__scopeNote mesh__D015152
% 210.96/211.16 Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.%A%
% 210.96/211.16 |- mesh__dateCreated mesh__D015152 1988-03-22
% 210.96/211.16 |- skos__historyNote mesh__D015152
% 210.96/211.16 Electrophoresis, Polyacrylamide Gel %28%1984-1988%29%
% 210.96/211.16 |- skos__altLabel mesh__D015152 Northern Blot
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 2000
% 210.96/211.16 |- mesh__dateCreated mesh__D009913 1999-01-01
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 1997
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Stages, Oral Sadistic
% 210.96/211.16 |- skos__prefLabel mesh__D009913 Oral Stage
% 210.96/211.16 |- mesh__historyNote mesh__D009913
% 210.96/211.16 91%28%75%29%; was see under PSYCHOSEXUAL DEVELOPMENT 1975-90
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 2001
% 210.96/211.16 |- mesh__dateRevised mesh__D009913 1991-06-11
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 2005
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Stages, Oral
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 1992
% 210.96/211.16 |- skos__broader mesh__D009913smesh__D011606
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Oral Sadistic Stages
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 1994
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Stage, Oral
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 2002
% 210.96/211.16 |- mesh__recordMaintainer mesh__D009913 TGC
% 210.96/211.16 |- skos__scopeNote mesh__D009913
% 210.96/211.16 The earliest of the stages of infantile psychosexual development, lasting from birth to 12 months or longer.%A%
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D009913
% 210.96/211.16 91; was see under PSYCHOSEXUAL DEVELOPMENT 1975-90
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Stage, Oral Sadistic
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 2006
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 1993
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 2003
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 1998
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 1995
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Erotic Stage, Oral
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Oral Erotic Stages
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Erotic Stages, Oral
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Oral Stages
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Stage, Oral Erotic
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D009913 PLS
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Sadistic Stages, Oral
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 2004
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 1999
% 210.96/211.16 |- mesh__recordOriginator mesh__D009913 NLM
% 210.96/211.16 |- mesh__onlineNote mesh__D009913
% 210.96/211.16 search PSYCHOSEXUAL DEVELOPMENT 1968-74
% 210.96/211.16 |- skos__annotation mesh__D009913 no qualif
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D009913 1996
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Sadistic Stage, Oral
% 210.96/211.16 |- rdf__type mesh__D009913sskos__Concept
% 210.96/211.16 |- mesh__dateEstablished mesh__D009913 1991-01-01
% 210.96/211.16 |- skos__hiddenLabel mesh__D009913 Stages, Oral Erotic
% 210.96/211.16 |- skos__altLabel mesh__D001930 Encephalopathy, Traumatic
% 210.96/211.16 |- skos__altLabel mesh__D001930 Injuries, Brain
% 210.96/211.16 |- skos__altLabel mesh__D001930 Traumatic Brain Injury
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Contusions, Brain
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Injuries, Traumatic Brain
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D001930
% 210.96/211.16 1981; see BRAIN INJURIES 1981-1999, see BRAIN INJURIES, ACUTE 1973-1980, see BRAIN INJURY, ACUTE 1963-1972; for BRAIN CONTUSION see BRAIN CONCUSSION 1998-1999%A%
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Injuries, Diffuse Brain
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Encephalopathies, Post-Traumatic
% 210.96/211.16 |- skos__altLabel mesh__D001930 Acute Brain Injuries
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Contusions, Cortical
% 210.96/211.16 |- rdf__type mesh__D001930sskos__Concept
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Brain Injury
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Encephalopathy, Post Traumatic
% 210.96/211.16 |- skos__altLabel mesh__D001930 Injury, Brain, Traumatic
% 210.96/211.16 |- mesh__historyNote mesh__D001930
% 210.96/211.16 1981%28%1963%29%; for BRAIN CONTUSION use BRAIN CONCUSSION 1998-1999%A%
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Brain Injury, Focal
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 TBIs %28%Traumatic Brain Injury%29%
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Injury, Brain
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Post Concussive Encephalopathy
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Contusion, Brain
% 210.96/211.16 |- skos__broader mesh__D001930smesh__D001927
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Brain Laceration
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Encephalopathy, Post Concussive
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Traumatic Encephalopathies
% 210.96/211.16 |- mesh__dateCreated mesh__D001930 1999-01-01
% 210.96/211.16 |- mesh__activeMeSHYear mesh__D001930 2006
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Post Traumatic Encephalopathy
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Laceration, Brain
% 210.96/211.16 |- skos__scopeNote mesh__D001930
% 210.96/211.16 Acute and chronic %28%see also BRAIN INJURIES, CHRONIC%29% injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.%A%
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Brain Injury, Acute
% 210.96/211.16 |- skos__prefLabel mesh__D001930 Brain Injuries
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Diffuse Brain Injury
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Contusion, Cortical
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Injuries, Focal Brain
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Brain Injury, Diffuse
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Injury, Focal Brain
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Injury, Diffuse Brain
% 210.96/211.16 |- skos__altLabel mesh__D001930 Post-Traumatic Encephalopathy
% 210.96/211.16 |- mesh__dateRevised mesh__D001930 2005-06-30
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Acute Brain Injury
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Brain Trauma
% 210.96/211.16 |- skos__altLabel mesh__D001930 Focal Brain Injuries
% 210.96/211.16 |- skos__altLabel mesh__D001930 Trauma, Brain
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Post-Traumatic Encephalopathies
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Traumas, Brain
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Lacerations, Brain
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Cortical Contusions
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Post-Concussive Encephalopathies
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Encephalopathies, Post-Concussive
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Focal Brain Injury
% 210.96/211.16 |- skos__altLabel mesh__D001930 Brain Injuries, Acute
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Encephalopathies, Traumatic
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Injury, Traumatic Brain
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Brain Contusions
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Traumatic Brain Injuries
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Brain Traumas
% 210.96/211.16 |- skos__annotation mesh__D001930
% 210.96/211.16 general or unspecified; consider also /inj with specific parts of the brain; X ref BRAIN CONTUSION: do not coordinate with CONTUSIONS; do not confuse with CRANIOCEREBRAL TRAUMA%A%
% 210.96/211.16 |- mesh__recordOriginator mesh__D001930 NLM
% 210.96/211.16 |- skos__altLabel mesh__D001930 Traumatic Encephalopathy
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D001930 sjn
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Diffuse Brain Injuries
% 210.96/211.16 |- mesh__recordMaintainer mesh__D001930 lkt
% 210.96/211.16 |- skos__altLabel mesh__D001930 Post-Concussive Encephalopathy
% 210.96/211.16 |- skos__altLabel mesh__D001930 TBI %28%Traumatic Brain Injury%29%
% 210.96/211.16 |- skos__broader mesh__D001930smesh__D006259
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Injury, Acute Brain
% 210.96/211.16 |- mesh__dateEstablished mesh__D001930 1973-01-01
% 210.96/211.16 |- skos__hiddenLabel mesh__D001930 Brain Injury, Traumatic
% 210.96/211.16 |- mesh__recordMaintainer mesh__D009115 ags
% 210.96/211.16 |- skos__broader mesh__D009115smesh__D012377
% 210.96/211.16 |- mesh__publicMeSHNote mesh__D009115 82
% 210.96/211.16 |- skos__historyNote mesh__D009115 Mice %28%1966-1981%29%
% 210.96/211.16 |- mesh__recordAuthorizer mesh__D009115 sjn
% 210.96/211.16 |- mesh__historyNote mesh__D009115 82
% 210.96/211.16 |- skos__historyNote mesh__D009115 Rats %28%1966-1981%29%
% 210.96/211.16 |- mesh__dateRevised mesh__D009115 2005-06-30
% 210.96/211.16 |- skos__prefLabel mesh__D009115 Muridae
% 210.96/211.16 |- mesh__dateEstablished mesh__D009115 1982-01-01
% 210.96/211.17 |- rdf__type mesh__D009115sskos__Concept
% 210.96/211.17 |- skos__hiddenLabel mesh__D009115 Murid
% 210.96/211.17 |- mesh__dateCreated mesh__D009115 1981-05-14
% 210.96/211.17 |- skos__historyNote mesh__D009115 Rodentia %28%1966-1981%29%
% 210.96/211.17 |- skos__annotation mesh__D009115 do not check tags MICE or RATS
% 210.96/211.17 |- mesh__recordOriginator mesh__D009115 EC
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009115 2006
% 210.96/211.17 |- skos__altLabel mesh__D009115 Murids
% 210.96/211.17 |- skos__scopeNote mesh__D009115
% 210.96/211.17 A family of the order Rodentia containing 250 genera including the two genera Mus %28%MICE%29% and Rattus %28%RATS%29%, from which the laboratory inbred strains are developed. The fifteen subfamilies are SIGMODONTINAE %28%New World mice and rats%29%, CRICETINAE, Spalacinae, Myospalacinae, Lophiomyinae, ARVICOLINAE, Platacanthomyinae, Nesomyinae, Otomyinae, Rhizomyinae, GERBILLINAE, Dendromurinae, Cricetomyinae, MURINAE %28%Old World mice and rats%29%, and Hydromyinae.%A%
% 210.96/211.17 |- rdf__type mesh__D001132sskos__Concept
% 210.96/211.17 |- mesh__recordOriginator mesh__D001132 NLM
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D001132 sjn
% 210.96/211.17 |- mesh__dateRevised mesh__D001132 2002-07-02
% 210.96/211.17 |- mesh__dateCreated mesh__D001132 1999-01-01
% 210.96/211.17 |- skos__broader mesh__D001132smesh__D034941
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001132 2003
% 210.96/211.17 |- mesh__recordMaintainer mesh__D001132 ags
% 210.96/211.17 |- skos__prefLabel mesh__D001132 Arm
% 210.96/211.17 |- skos__scopeNote mesh__D001132
% 210.96/211.17 The superior part of the upper extremity between the SHOULDER and the ELBOW.%A%
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001132 2005
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001132 2004
% 210.96/211.17 |- skos__annotation mesh__D001132
% 210.96/211.17 primates only; for whole arm or upper arm; FOREARM is also available; Manual 21.58: extremities of humans %26% animals; NIM when merely locational as in skin dis %28%IM%29%%A%
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001132 2006
% 210.96/211.17 |- skos__related mesh__D001132smesh__D005552
% 210.96/211.17 |- skos__hiddenLabel mesh__D001132 Arms
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D020895 2000
% 210.96/211.17 |- skos__hiddenLabel mesh__D020895 Enterocyte
% 210.96/211.17 |- mesh__recordMaintainer mesh__D020895 lkt
% 210.96/211.17 |- rdf__type mesh__D020895sskos__Concept
% 210.96/211.17 |- skos__scopeNote mesh__D020895
% 210.96/211.17 Absorptive cells in the lining of the INTESTINAL MUCOSA. They are differentiated EPITHELIAL CELLS with apical MICROVILLI facing the intestinal lumen. Enterocytes are more abundant in the SMALL INTESTINE than in the LARGE INTESTINE. Their microvilli greatly increase the luminal surface area of the cell by 14- to 40 fold.%A%
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D020895 sjn
% 210.96/211.17 |- skos__broader mesh__D020895smesh__D007413
% 210.96/211.17 |- mesh__dateRevised mesh__D020895 2005-06-30
% 210.96/211.17 |- mesh__dateEstablished mesh__D020895 2000-01-01
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D020895 2006
% 210.96/211.17 |- mesh__recordOriginator mesh__D020895 ndw
% 210.96/211.17 |- mesh__historyNote mesh__D020895 2000
% 210.96/211.17 |- skos__prefLabel mesh__D020895 Enterocytes
% 210.96/211.17 |- mesh__dateCreated mesh__D020895 1999-11-03
% 210.96/211.17 |- skos__broader mesh__D020895smesh__D004847
% 210.96/211.17 |- skos__historyNote mesh__D020895 Intestinal Mucosa %28%1968-1999%29%
% 210.96/211.17 |- skos__altLabel mesh__D020097 BNP-32
% 210.96/211.17 |- skos__altLabel mesh__D020097 Brain Natriuretic Peptide-32
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Natriuretic Peptide-32, Brain
% 210.96/211.17 |- mesh__dateRevised mesh__D020097 2005-06-30
% 210.96/211.17 |- rdf__type mesh__D020097sskos__Concept
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Peptide-32, Brain Natriuretic
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Peptide, Brain Natriuretic
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D020097 2006
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Ventricular Natriuretic Peptide, B type
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Natriuretic Peptide, Type-B
% 210.96/211.17 |- skos__prefLabel mesh__D020097 Natriuretic Peptide, Brain
% 210.96/211.17 |- mesh__recordMaintainer mesh__D020097 ssb
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D020097 sjn
% 210.96/211.17 |- skos__altLabel mesh__D020097 Natriuretic Peptide Type-B
% 210.96/211.17 |- mesh__historyNote mesh__D020097
% 210.96/211.17 1999, use BRAIN NATRIURETIC PEPTIDE %28%NM%29% 1988-1998; use NATRIURETIC PEPTIDE, BRAIN %28%NM%29% for NATRIURETIC PEPTIDE TYPE-B 1994-2003; use NATRIURETIC PEPTIDE, BRAIN %28%NM%29% for NESIRITIDE 2003; for VENTRICULAR NATRIURETIC PEPTIDE, B-TYPE use NATRIURETIC PEPTIDE, BRAIN %28%NM%29% 1994-2003.%A%
% 210.96/211.17 |- skos__altLabel mesh__D020097 Nesiritide
% 210.96/211.17 |- skos__altLabel mesh__D020097 Natriuretic Factor-32
% 210.96/211.17 |- skos__historyNote mesh__D020097 Nerve Tissue Proteins %28%1988-1998%29%
% 210.96/211.17 |- skos__broader mesh__D020097smesh__D009419
% 210.96/211.17 |- skos__scopeNote mesh__D020097
% 210.96/211.17 A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.%A%
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Natriuretic Peptide, B-Type
% 210.96/211.17 |- skos__altLabel mesh__D020097 BNP Gene Product
% 210.96/211.17 |- skos__altLabel mesh__D020097 Type-B Natriuretic Peptide
% 210.96/211.17 |- skos__broader mesh__D020097smesh__D001685
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Type B Natriuretic Peptide
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Brain Natriuretic Peptide 32
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 BNP 32
% 210.96/211.17 |- skos__altLabel mesh__D020097 Brain Natriuretic Peptide
% 210.96/211.17 |- mesh__recordOriginator mesh__D020097 TPW
% 210.96/211.17 |- mesh__dateEstablished mesh__D020097 1999-01-01
% 210.96/211.17 |- skos__broader mesh__D020097smesh__D045265
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D020097
% 210.96/211.17 1999; BRAIN NATRIURETIC PEPTIDE was indexed under NERVE TISSUE PROTEINS 1988-1998; NATRIURETIC PEPTIDE TYPE-B was indexed under ATRIAL NATRIURETIC FACTOR 1994-2003; NESIRITIDE was indexed under NATRIURETIC HORMONE 2003; VENTRICULAR NATRIURETIC PEPTIDE, B-TYPE was indexed under ATRIAL NATRIURETIC FACTOR 1994-2003.%A%
% 210.96/211.17 |- skos__altLabel mesh__D020097 B-Type Natriuretic Peptide
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Natriuretic Factor 32
% 210.96/211.17 |- mesh__dateCreated mesh__D020097 1998-06-10
% 210.96/211.17 |- skos__hiddenLabel mesh__D020097 Natriuretic Peptide Type B
% 210.96/211.17 |- skos__related mesh__D014858smesh__D045809
% 210.96/211.17 |- skos__prefLabel mesh__D014858 War Crimes
% 210.96/211.17 |- skos__hiddenLabel mesh__D014858 Crimes, War
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D014858 2005
% 210.96/211.17 |- mesh__dateCreated mesh__D014858 1999-01-01
% 210.96/211.17 |- skos__broader mesh__D014858smesh__D003415
% 210.96/211.17 |- mesh__dateRevised mesh__D014858 2003-07-09
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D014858 2006
% 210.96/211.17 |- mesh__recordMaintainer mesh__D014858 jls
% 210.96/211.17 |- skos__broader mesh__D014858smesh__D014857
% 210.96/211.17 |- skos__hiddenLabel mesh__D014858 Crime, War
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D014858 2004
% 210.96/211.17 |- skos__scopeNote mesh__D014858
% 210.96/211.17 Criminal acts committed during, or in connection with, war, e.g., maltreatment of prisoners, willful killing of civilians, etc.%A%
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D014858 sjn
% 210.96/211.17 |- mesh__recordOriginator mesh__D014858 NLM
% 210.96/211.17 |- skos__hiddenLabel mesh__D014858 War Crime
% 210.96/211.17 |- rdf__type mesh__D014858sskos__Concept
% 210.96/211.17 |- mesh__historyNote mesh__D000838 74
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D000838 1999
% 210.96/211.17 |- mesh__dateEstablished mesh__D000838 1974-01-01
% 210.96/211.17 |- mesh__recordOriginator mesh__D000838 NLM
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D000838 74
% 210.96/211.17 |- mesh__recordMaintainer mesh__D000838 ADP
% 210.96/211.17 |- mesh__dateRevised mesh__D000838 1998-06-10
% 210.96/211.17 |- skos__broader mesh__D000838smesh__D007477
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D000838 SJN
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D000838 2002
% 210.96/211.17 |- mesh__dateCreated mesh__D000838 1999-01-01
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D000838 2004
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D000838 2001
% 210.96/211.17 |- skos__scopeNote mesh__D000838
% 210.96/211.17 Negatively charged atoms, radicals or groups of atoms which travel to the anode or positive pole during electrolysis.%A%
% 210.96/211.17 |- skos__prefLabel mesh__D000838 Anions
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D000838 2006
% 210.96/211.17 |- rdf__type mesh__D000838sskos__Concept
% 210.96/211.17 |- skos__annotation mesh__D000838 GEN or unspecified; prefer specifics
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D000838 2003
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D000838 2005
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D000838 2000
% 210.96/211.17 |- skos__annotation mesh__D011560 /biosyn permitted for micro-organisms
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 2002
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 1997
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 2006
% 210.96/211.17 |- skos__prefLabel mesh__D011560 Pseudouridine
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 1998
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 1993
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D011560 PLS
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 1994
% 210.96/211.17 |- mesh__dateRevised mesh__D011560 1992-05-20
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 1999
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D011560 91; was see under URIDINE 1972-90
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 2003
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 1995
% 210.96/211.17 |- mesh__recordMaintainer mesh__D011560 TGC
% 210.96/211.17 |- skos__historyNote mesh__D011560 Uridine %28%1966-1971%29%
% 210.96/211.17 |- mesh__recordOriginator mesh__D011560 NLM
% 210.96/211.17 |- rdf__type mesh__D011560sskos__Concept
% 210.96/211.17 |- mesh__dateEstablished mesh__D011560 1991-01-01
% 210.96/211.17 |- mesh__dateCreated mesh__D011560 1999-01-01
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 2000
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 2004
% 210.96/211.17 |- skos__broader mesh__D011560smesh__D014529
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 2001
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 1996
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D011560 2005
% 210.96/211.17 |- mesh__historyNote mesh__D011560
% 210.96/211.17 91%28%72%29%; was see under URIDINE 1972-90
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D005523 2005
% 210.96/211.17 |- skos__broader mesh__D005523smesh__D019649
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D005523 2004
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D005523 2002
% 210.96/211.17 |- skos__annotation mesh__D005523 specify geog if pertinent
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D005523 2006
% 210.96/211.17 |- mesh__recordMaintainer mesh__D005523 kle
% 210.96/211.17 |- mesh__dateCreated mesh__D005523 1999-01-01
% 210.96/211.17 |- mesh__recordOriginator mesh__D005523 NLM
% 210.96/211.17 |- skos__hiddenLabel mesh__D005523 Supplies, Food
% 210.96/211.17 |- skos__prefLabel mesh__D005523 Food Supply
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D005523 2000
% 210.96/211.17 |- mesh__dateRevised mesh__D005523 1999-11-03
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D005523 sjn
% 210.96/211.17 |- skos__hiddenLabel mesh__D005523 Food Supplies
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D005523 2001
% 210.96/211.17 |- skos__hiddenLabel mesh__D005523 Supply, Food
% 210.96/211.17 |- rdf__type mesh__D005523sskos__Concept
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D005523 2003
% 210.96/211.17 |- mesh__historyNote mesh__D052179 2006
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D052179 2006
% 210.96/211.17 |- mesh__dateEstablished mesh__D052179 2006-01-01
% 210.96/211.17 |- rdf__type mesh__D052179sskos__Concept
% 210.96/211.17 |- mesh__dateCreated mesh__D052179 2005-06-30
% 210.96/211.17 |- skos__prefLabel mesh__D052179 Antigens, Plant
% 210.96/211.17 |- skos__annotation mesh__D052179
% 210.96/211.17 if allergen is LATEX consider LATEX HYPERSENSITIVITY
% 210.96/211.17 |- skos__scopeNote mesh__D052179
% 210.96/211.17 Substances from PLANTS that have antigenic activity.
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D052179 2006
% 210.96/211.17 |- skos__hiddenLabel mesh__D052179 Plant Allergens
% 210.96/211.17 |- skos__broader mesh__D052179smesh__D000941
% 210.96/211.17 |- mesh__recordMaintainer mesh__D052179 ssb
% 210.96/211.17 |- skos__altLabel mesh__D052179 Plant Antigens
% 210.96/211.17 |- mesh__recordOriginator mesh__D052179 ssb
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D052179 sjn
% 210.96/211.17 |- skos__annotation mesh__D029971
% 210.96/211.17 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.96/211.17 |- rdf__type mesh__D029971sskos__Concept
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D029971 2004
% 210.96/211.17 |- skos__scopeNote mesh__D029971
% 210.96/211.17 A plant species of the family APIACEAE that is the source of dong quai.%A%
% 210.96/211.17 |- mesh__dateEstablished mesh__D029971 2002-01-01
% 210.96/211.17 |- skos__prefLabel mesh__D029971 Angelica sinensis
% 210.96/211.17 |- skos__broader mesh__D029971smesh__D029969
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D029971 2002
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D029971 2002
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D029971 2005
% 210.96/211.17 |- mesh__dateCreated mesh__D029971 2001-07-25
% 210.96/211.17 |- mesh__historyNote mesh__D029971 2002
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D029971 2003
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D029971 2006
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 Receptor, M5 Muscarinic
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 Muscarinic Receptor, M5
% 210.96/211.17 |- mesh__dateCreated mesh__D043642 2003-07-09
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 M5 Receptors, Muscarinic
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 Muscarinic M5 Receptor
% 210.96/211.17 |- skos__altLabel mesh__D043642 Muscarinic Receptor M5
% 210.96/211.17 |- mesh__historyNote mesh__D043642
% 210.96/211.17 2004; use RECEPTOR, MUSCARINIC M5 %28%NM%29% 1996-2003
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 Receptor M5, Muscarinic
% 210.96/211.17 |- mesh__recordOriginator mesh__D043642 jmp
% 210.96/211.17 |- mesh__recordMaintainer mesh__D043642 jmp
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 Receptors M5, Muscarinic
% 210.96/211.17 |- mesh__dateEstablished mesh__D043642 2004-01-01
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D043642 sjn
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D043642 2005
% 210.96/211.17 |- skos__broader mesh__D043642smesh__D011976
% 210.96/211.17 |- skos__scopeNote mesh__D043642
% 210.96/211.17 A specific subtype of muscarinic receptor found in a variety of locations including the SALIVARY GLANDS and the SUBSTANTIA NIGRA and VENTRAL TEGMENTAL AREA of the BRAIN.%A%
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 M5, Muscarinic Receptors
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D043642
% 210.96/211.17 2004; M5 MUSCARINIC RECEPTOR was indexed under RECEPTORS, MUSCARINIC 1996-2003%A%
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D043642 2006
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D043642 2004
% 210.96/211.17 |- skos__altLabel mesh__D043642 M5 Muscarinic Receptor
% 210.96/211.17 |- rdf__type mesh__D043642sskos__Concept
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 M5, Muscarinic Receptor
% 210.96/211.17 |- skos__historyNote mesh__D043642 Receptors, Muscarinic %28%1996-2003%29%
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 M5 Receptor, Muscarinic
% 210.96/211.17 |- skos__altLabel mesh__D043642 Receptors, Muscarinic M5
% 210.96/211.17 |- skos__prefLabel mesh__D043642 Receptor, Muscarinic M5
% 210.96/211.17 |- skos__hiddenLabel mesh__D043642 Muscarinic M5 Receptors
% 210.96/211.17 |- skos__altLabel mesh__D043642 Muscarinic Receptors M5
% 210.96/211.17 |- mesh__dateCreated mesh__D010468 1999-01-01
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Neglects, Hemisensory
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Discrimination Disorders, Somatosensory
% 210.96/211.17 |- mesh__dateEstablished mesh__D010468 1969-01-01
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Discrimination Disorder, Somatosensory
% 210.96/211.17 |- skos__historyNote mesh__D010468 Illusions %28%1966-1968%29%
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D010468 2005
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D010468 2000
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Neglect, Hemispatial
% 210.96/211.17 |- mesh__dateRevised mesh__D010468 1999-11-03
% 210.96/211.17 |- skos__scopeNote mesh__D010468
% 210.96/211.17 Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.%A%
% 210.96/211.17 |- skos__prefLabel mesh__D010468 Perceptual Disorders
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Perceptual Disorder
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Hemispatial Neglects
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D010468 2006
% 210.96/211.17 |- skos__historyNote mesh__D010468 Perception %28%1966-1968%29%
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D010468 2001
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Neglect, Sensory
% 210.96/211.17 |- mesh__recordMaintainer mesh__D010468 KEV
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D010468 2003
% 210.96/211.17 |- skos__broader mesh__D010468smesh__D019954
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Hemisensory Neglects
% 210.96/211.17 |- mesh__historyNote mesh__D010468 1969
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D010468 2004
% 210.96/211.17 |- rdf__type mesh__D010468sskos__Concept
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D010468 1969
% 210.96/211.17 |- skos__historyNote mesh__D010468 Hallucinations %28%1966-1968%29%
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Somatosensory Discrimination Disorders
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Sensory Neglects
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D010468 sjn
% 210.96/211.17 |- skos__hiddenLabel mesh__D010468 Neglect, Hemisensory
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D010468 2002
% 210.96/211.17 |- skos__historyNote mesh__D010468 Phantom Limb %28%1966-1968%29%
% 210.96/211.17 |- skos__historyNote mesh__D010468 Agnosia %28%1966-1968%29%
% 210.96/211.17 |- mesh__recordOriginator mesh__D010468 NLM
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D015951 sjn
% 210.96/211.17 |- rdf__type mesh__D015951sskos__Concept
% 210.96/211.17 |- skos__hiddenLabel mesh__D015951 Factor Xa, Coagulation
% 210.96/211.17 |- mesh__dateEstablished mesh__D015951 1990-01-01
% 210.96/211.17 |- mesh__dateCreated mesh__D015951 1989-05-25
% 210.96/211.17 |- skos__altLabel mesh__D015951 Factor X, Activated
% 210.96/211.17 |- skos__historyNote mesh__D015951 Serine Proteinases %28%1988-1989%29%
% 210.96/211.17 |- skos__hiddenLabel mesh__D015951 Xa, Coagulation Factor
% 210.96/211.17 |- skos__altLabel mesh__D015951 Activated Factor X
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D015951 90
% 210.96/211.17 |- skos__related mesh__D015951smesh__D003029
% 210.96/211.17 |- mesh__historyNote mesh__D015951 90
% 210.96/211.17 |- mesh__dateRevised mesh__D015951 2005-06-30
% 210.96/211.17 |- skos__prefLabel mesh__D015951 Factor Xa
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D015951 2006
% 210.96/211.17 |- skos__altLabel mesh__D015951 Coagulation Factor Xa
% 210.96/211.17 |- skos__altLabel mesh__D015951 Blood Coagulation Factor X, Activated
% 210.96/211.17 |- skos__broader mesh__D015951smesh__D012697
% 210.96/211.17 |- skos__altLabel mesh__D015951 Thrombokinase
% 210.96/211.17 |- skos__historyNote mesh__D015951 Factor X %28%1970-1989%29%
% 210.96/211.17 |- mesh__recordMaintainer mesh__D015951 ssb
% 210.96/211.17 |- skos__annotation mesh__D015951 /defic = FACTOR X DEFICIENCY
% 210.96/211.17 |- skos__scopeNote mesh__D015951
% 210.96/211.17 Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors.%A%
% 210.96/211.17 |- skos__altLabel mesh__D015951 Autoprothrombin C
% 210.96/211.17 |- skos__broader mesh__D015951smesh__D005170
% 210.96/211.17 |- mesh__recordOriginator mesh__D015951 AGS
% 210.96/211.17 |- mesh__historyNote mesh__D015153 89
% 210.96/211.17 |- skos__broader mesh__D015153smesh__D015151
% 210.96/211.17 |- skos__prefLabel mesh__D015153 Blotting, Western
% 210.96/211.17 |- skos__altLabel mesh__D015153 Immunoblot, Western
% 210.96/211.17 |- skos__altLabel mesh__D015153 Western Blotting
% 210.96/211.17 |- skos__annotation mesh__D015153
% 210.96/211.17 %22%western%22% is not capitalized in titles or translations; DF: WESTERN BLOT%A%
% 210.96/211.17 |- skos__historyNote mesh__D015153 Immunologic Techniques %28%1981-1988%29%
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D015153 89
% 210.96/211.17 |- skos__hiddenLabel mesh__D015153 Western Blottings
% 210.96/211.17 |- mesh__recordMaintainer mesh__D015153 nns
% 210.96/211.17 |- skos__altLabel mesh__D015153 Western Immunoblotting
% 210.96/211.17 |- skos__altLabel mesh__D015153 Western Blot
% 210.96/211.17 |- mesh__dateEstablished mesh__D015153 1989-01-01
% 210.96/211.17 |- mesh__dateRevised mesh__D015153 2001-07-25
% 210.96/211.17 |- mesh__recordOriginator mesh__D015153 SCD
% 210.96/211.17 |- skos__hiddenLabel mesh__D015153 Immunoblottings, Western
% 210.96/211.17 |- skos__hiddenLabel mesh__D015153 Western Blots
% 210.96/211.17 |- skos__altLabel mesh__D015153 Immunoblotting, Western
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D015153 2005
% 210.96/211.17 |- skos__broader mesh__D015153smesh__D015336
% 210.96/211.17 |- skos__hiddenLabel mesh__D015153 Blottings, Western
% 210.96/211.17 |- skos__historyNote mesh__D015153
% 210.96/211.17 Electrophoresis, Polyacrylamide Gel %28%1982-1988%29%
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D015153 2006
% 210.96/211.17 |- skos__hiddenLabel mesh__D015153 Western Immunoblots
% 210.96/211.17 |- mesh__dateCreated mesh__D015153 1988-03-22
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D015153 2002
% 210.96/211.17 |- skos__hiddenLabel mesh__D015153 Blots, Western
% 210.96/211.17 |- skos__hiddenLabel mesh__D015153 Immunoblots, Western
% 210.96/211.17 |- skos__historyNote mesh__D015153
% 210.96/211.17 Immunoenzyme Techniques %28%1981-1988%29%
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D015153 2003
% 210.96/211.17 |- skos__scopeNote mesh__D015153
% 210.96/211.17 Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.%A%
% 210.96/211.17 |- skos__historyNote mesh__D015153
% 210.96/211.17 Enzyme-Linked Immunosorbent Assay %28%1983-1988%29%
% 210.96/211.17 |- skos__hiddenLabel mesh__D015153 Western Immunoblottings
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D015153 sjn
% 210.96/211.17 |- skos__altLabel mesh__D015153 Western Immunoblot
% 210.96/211.17 |- rdf__type mesh__D015153sskos__Concept
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D015153 2004
% 210.96/211.17 |- mesh__historyNote mesh__D009914
% 210.96/211.17 91%28%68%29%; was see under MOUTH DISEASES 1968-90
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 2004
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 2002
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 1997
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 2006
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D009914
% 210.96/211.17 91; was see under MOUTH DISEASES 1968-90
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 1999
% 210.96/211.17 |- skos__hiddenLabel mesh__D009914 Fibroses, Oral Submucous
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 2003
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 2001
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D009914 PLS
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 1996
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 1993
% 210.96/211.17 |- mesh__recordOriginator mesh__D009914 NLM
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 1995
% 210.96/211.17 |- mesh__dateCreated mesh__D009914 1999-01-01
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 1991
% 210.96/211.17 |- mesh__dateEstablished mesh__D009914 1991-01-01
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 2005
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 1998
% 210.96/211.17 |- skos__hiddenLabel mesh__D009914 Submucous Fibrosis, Oral
% 210.96/211.17 |- skos__broader mesh__D009914smesh__D009059
% 210.96/211.17 |- skos__hiddenLabel mesh__D009914 Submucous Fibroses, Oral
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 1992
% 210.96/211.17 |- mesh__recordMaintainer mesh__D009914 NLM
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 2000
% 210.96/211.17 |- rdf__type mesh__D009914sskos__Concept
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D009914 1994
% 210.96/211.17 |- mesh__dateRevised mesh__D009914 1990-04-13
% 210.96/211.17 |- skos__hiddenLabel mesh__D009914 Oral Submucous Fibroses
% 210.96/211.17 |- skos__historyNote mesh__D009914 Mouth Diseases %28%1966-1967%29%
% 210.96/211.17 |- skos__hiddenLabel mesh__D009914 Fibrosis, Oral Submucous
% 210.96/211.17 |- skos__prefLabel mesh__D009914 Oral Submucous Fibrosis
% 210.96/211.17 |- mesh__dateEstablished mesh__D001931 1968-01-01
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 2000
% 210.96/211.17 |- rdf__type mesh__D001931sskos__Concept
% 210.96/211.17 |- skos__hiddenLabel mesh__D001931 Brain Mappings
% 210.96/211.17 |- mesh__recordOriginator mesh__D001931 NLM
% 210.96/211.17 |- mesh__historyNote mesh__D001931 68%28%64%29%
% 210.96/211.17 |- mesh__publicMeSHNote mesh__D001931 68
% 210.96/211.17 |- skos__broader mesh__D001931smesh__D008919
% 210.96/211.17 |- skos__hiddenLabel mesh__D001931 Brain Mappings, Topographic
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 2006
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 1995
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 2002
% 210.96/211.17 |- mesh__recordMaintainer mesh__D001931 TAP
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 2004
% 210.96/211.17 |- mesh__dateRevised mesh__D001931 1992-05-18
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 1993
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 1999
% 210.96/211.17 |- mesh__recordAuthorizer mesh__D001931 PLS
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 2005
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 1994
% 210.96/211.17 |- skos__hiddenLabel mesh__D001931 Brain Mapping, Topographic
% 210.96/211.17 |- mesh__dateCreated mesh__D001931 1999-01-01
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 1997
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 2003
% 210.96/211.17 |- skos__hiddenLabel mesh__D001931 Mappings, Topographic Brain
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 1998
% 210.96/211.17 |- skos__hiddenLabel mesh__D001931 Mapping, Topographic Brain
% 210.96/211.17 |- skos__hiddenLabel mesh__D001931 Mappings, Brain
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 1996
% 210.96/211.17 |- skos__hiddenLabel mesh__D001931 Topographic Brain Mappings
% 210.96/211.17 |- mesh__activeMeSHYear mesh__D001931 2001
% 210.96/211.17 |- skos__prefLabel mesh__D001931 Brain Mapping
% 210.96/211.17 |- skos__annotation mesh__D001931
% 210.96/211.17 coord IM with specific part of brain /physiol %28%IM%29%
% 210.96/211.17 |- skos__hiddenLabel mesh__D001931 Mapping, Brain
% 210.96/211.17 |- skos__broader mesh__D009116smesh__D000644
% 210.96/211.17 |- skos__broader mesh__D009116smesh__D000470
% 210.96/211.17 |- mesh__dateCreated mesh__D009116 1976-05-19
% 210.96/211.17 |- skos__historyNote mesh__D009116 Ammonium Compounds %28%1970-1976%29%
% 210.96/211.18 |- mesh__recordOriginator mesh__D009116 SH
% 210.96/211.18 |- skos__historyNote mesh__D009116 Mycotoxins %28%1975-1976%29%
% 210.96/211.18 |- skos__historyNote mesh__D009116 Parasympathomimetics %28%1966-1976%29%
% 210.96/211.18 |- skos__historyNote mesh__D009116 Furans %28%1972-1976%29%
% 210.96/211.18 |- skos__historyNote mesh__D009116 Alkaloids %28%1968-1976%29%
% 210.96/211.18 |- skos__prefLabel mesh__D009116 Muscarine
% 210.96/211.18 |- mesh__historyNote mesh__D009116
% 210.96/211.18 77; was see under PARASYMPATHOMIMETICS 1963-68
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D009116 sjn
% 210.96/211.18 |- rdf__type mesh__D009116sskos__Concept
% 210.96/211.18 |- mesh__dateRevised mesh__D009116 2005-06-30
% 210.96/211.18 |- skos__broader mesh__D009116smesh__D050337
% 210.96/211.18 |- skos__scopeNote mesh__D009116
% 210.96/211.18 A toxic alkaloid found in Amanita muscaria %28%fly fungus%29% and other fungi of the Inocybe species. It is the first parasympathomimetic substance ever studied and causes profound parasympathetic activation that may end in convulsions and death. The specific antidote is atropine.%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009116 2006
% 210.96/211.18 |- mesh__dateEstablished mesh__D009116 1977-01-01
% 210.96/211.18 |- mesh__onlineNote mesh__D009116 search PARASYMPATHOMIMETICS 1966-68
% 210.96/211.18 |- skos__annotation mesh__D009116
% 210.96/211.18 /biosyn if permitted by plant; do not confuse with the dye muscarine%A%
% 210.96/211.18 |- mesh__recordMaintainer mesh__D009116 ssb
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D001133 98
% 210.96/211.18 |- mesh__dateEstablished mesh__D001133 1998-01-01
% 210.96/211.18 |- skos__hiddenLabel mesh__D001133 Upper Extremity Bones
% 210.96/211.18 |- skos__annotation mesh__D001133
% 210.96/211.18 avoid: too general; prefer specifics; permitted with all vertebrates; Manual 21.58%A%
% 210.96/211.18 |- mesh__recordMaintainer mesh__D001133 ags
% 210.96/211.18 |- mesh__historyNote mesh__D001133 98; use explode 1975-97
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D001133 2006
% 210.96/211.18 |- skos__broader mesh__D001133smesh__D001842
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D001133 sjn
% 210.96/211.18 |- skos__hiddenLabel mesh__D001133 Upper Extremity Bone
% 210.96/211.18 |- mesh__recordOriginator mesh__D001133 NLM
% 210.96/211.18 |- rdf__type mesh__D001133sskos__Concept
% 210.96/211.18 |- mesh__dateRevised mesh__D001133 2005-06-30
% 210.96/211.18 |- skos__prefLabel mesh__D001133 Bones of Upper Extremity
% 210.96/211.18 |- skos__scopeNote mesh__D001133
% 210.96/211.18 The bones of the upper and lower ARM. They include the CLAVICLE and SCAPULA.%A%
% 210.96/211.18 |- mesh__dateCreated mesh__D001133 1999-01-01
% 210.96/211.18 |- skos__historyNote mesh__D001133 specific bones of arm %28%1966-1997%29%
% 210.96/211.18 |- skos__historyNote mesh__D001133 Forearm %28%1969-1997%29%
% 210.96/211.18 |- skos__historyNote mesh__D001133 Arm %28%1966-1997%29%
% 210.96/211.18 |- mesh__dateCreated mesh__D020896 1999-11-03
% 210.96/211.18 |- rdf__type mesh__D020896sskos__Concept
% 210.96/211.18 |- skos__scopeNote mesh__D020896
% 210.96/211.18 An abnormally low volume of blood circulating through the body. It may result in hypovolemic shock %28%see SHOCK%29%.%A%
% 210.96/211.18 |- skos__prefLabel mesh__D020896 Hypovolemia
% 210.96/211.18 |- skos__historyNote mesh__D020896 Blood Volume %28%1966-1999%29%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D020896 2005
% 210.96/211.18 |- skos__hiddenLabel mesh__D020896 Hypovolemias
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D020896 2003
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D020896 2006
% 210.96/211.18 |- mesh__dateEstablished mesh__D020896 2000-01-01
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D020896 2000
% 210.96/211.18 |- mesh__historyNote mesh__D020896 2000
% 210.96/211.18 |- skos__related mesh__D020896smesh__D001810
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D020896 2004
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D020896 2000
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D020896 2001
% 210.96/211.18 |- skos__hiddenLabel mesh__D020896 Hypovolemics
% 210.96/211.18 |- skos__broader mesh__D020896smesh__D010335
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D020896 2002
% 210.96/211.18 |- skos__related mesh__D020896smesh__D012769
% 210.96/211.18 |- mesh__dateEstablished mesh__D020098 1999-01-01
% 210.96/211.18 |- skos__prefLabel mesh__D020098 Natriuretic Peptide, C-Type
% 210.96/211.18 |- skos__broader mesh__D020098smesh__D036361
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D020098
% 210.96/211.18 99; C-TYPE NATRIURETIC PEPTIDE was indexed under PROTEINS 1995-98 %26% NERVE TISSUE PROTEINS 1990-94%A%
% 210.96/211.18 |- skos__altLabel mesh__D020098 C-Type Natriuretic Peptide
% 210.96/211.18 |- skos__broader mesh__D020098smesh__D001685
% 210.96/211.18 |- mesh__dateCreated mesh__D020098 1998-06-10
% 210.96/211.18 |- mesh__recordMaintainer mesh__D020098 ags
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D020098 2006A
% 210.96/211.18 |- mesh__historyNote mesh__D020098
% 210.96/211.18 99; use C-TYPE NATRIURETIC PEPTIDE %28%NM%29% 1990-98
% 210.96/211.18 |- skos__broader mesh__D020098smesh__D045265
% 210.96/211.18 |- skos__scopeNote mesh__D020098
% 210.96/211.18 A PEPTIDE of 22 amino acids, derived mainly from cells of VASCULAR ENDOTHELIUM. It is also found in the BRAIN, major endocrine glands, and other tissues. It shares structural homology with ATRIAL NATRIURETIC FACTOR. It has vasorelaxant activity thus is important in the regulation of vascular tone and blood flow. Several high molecular weight forms containing the 22 amino acids have been identified.%A%
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D020098 ags
% 210.96/211.18 |- mesh__dateRevised mesh__D020098 2005-07-08
% 210.96/211.18 |- skos__altLabel mesh__D020098 CNP-22
% 210.96/211.18 |- skos__hiddenLabel mesh__D020098 Natriuretic Peptide, C Type
% 210.96/211.18 |- skos__historyNote mesh__D020098 Nerve Tissue Proteins %28%1990-1994%29%
% 210.96/211.18 |- rdf__type mesh__D020098sskos__Concept
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D020098 2006
% 210.96/211.18 |- skos__hiddenLabel mesh__D020098 Peptide, C-Type Natriuretic
% 210.96/211.18 |- skos__historyNote mesh__D020098 Proteins %28%1995-1998%29%
% 210.96/211.18 |- skos__hiddenLabel mesh__D020098 C Type Natriuretic Peptide
% 210.96/211.18 |- mesh__recordOriginator mesh__D020098 TPW
% 210.96/211.18 |- skos__hiddenLabel mesh__D014859 Sodium, Warfarin
% 210.96/211.18 |- skos__altLabel mesh__D014859 Boots Brand of Warfarin Sodium
% 210.96/211.18 |- skos__altLabel mesh__D014859 Bailly Brand of Warfarin Sodium
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D014859 sjn
% 210.96/211.18 |- mesh__recordOriginator mesh__D014859 NLM
% 210.96/211.18 |- skos__prefLabel mesh__D014859 Warfarin
% 210.96/211.18 |- mesh__dateRevised mesh__D014859 2005-06-30
% 210.96/211.18 |- mesh__dateCreated mesh__D014859 1999-01-01
% 210.96/211.18 |- skos__altLabel mesh__D014859 Genpharm Brand of Warfarin Sodium
% 210.96/211.18 |- skos__altLabel mesh__D014859 Goldshield Brand of Warfarin Sodium
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D014859 2006
% 210.96/211.18 |- mesh__recordMaintainer mesh__D014859 lkw
% 210.96/211.18 |- skos__altLabel mesh__D014859 Apotex Brand of Warfarin Sodium
% 210.96/211.18 |- skos__broader mesh__D014859smesh__D015110
% 210.96/211.18 |- skos__altLabel mesh__D014859 Antigen Brand of Warfarin Sodium
% 210.96/211.18 |- skos__altLabel mesh__D014859 Marevan
% 210.96/211.18 |- skos__altLabel mesh__D014859 Aldo Brand of Warfarin Sodium
% 210.96/211.18 |- skos__altLabel mesh__D014859
% 210.96/211.18 Bristol-Myers Squibb Brand of Warfarin Sodium
% 210.96/211.18 |- skos__altLabel mesh__D014859 Estedi Brand of Warfarin Sodium
% 210.96/211.18 |- skos__altLabel mesh__D014859
% 210.96/211.18 4-Hydroxy-3-%28%3-oxo-1-phenylbutyl%29%-2H-1-benzopyran-2-one
% 210.96/211.18 |- rdf__type mesh__D014859sskos__Concept
% 210.96/211.18 |- skos__hiddenLabel mesh__D014859 Potassium, Warfarin
% 210.96/211.18 |- skos__annotation mesh__D014859 an anticoagulant %26% rodenticide
% 210.96/211.18 |- skos__scopeNote mesh__D014859
% 210.96/211.18 An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.%A%
% 210.96/211.18 |- skos__related mesh__D025581smesh__D016515
% 210.96/211.18 |- skos__scopeNote mesh__D025581
% 210.96/211.18 A membrane protein homologous to the ERM %28%Ezrin-Radixin-Moesin%29% family of cytoskeleton-associated proteins which regulate physical properties of membranes. Alterations in neurofibromin 2 are the cause of NEUROFIBROMATOSIS 2.%A%
% 210.96/211.18 |- skos__historyNote mesh__D025581 Neoplasm Proteins %28%1993-2001%29%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D025581 2004
% 210.96/211.18 |- rdf__type mesh__D025581sskos__Concept
% 210.96/211.18 |- skos__altLabel mesh__D025581 Moesin-Ezrin-Radixin-Like Protein
% 210.96/211.18 |- skos__prefLabel mesh__D025581 Neurofibromin 2
% 210.96/211.18 |- skos__altLabel mesh__D025581 NF2 Gene Product
% 210.96/211.18 |- skos__altLabel mesh__D025581 Neurofibromatosis Type 2 Protein
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D025581 2006
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D025581 2003
% 210.96/211.18 |- skos__hiddenLabel mesh__D025581 Protein, Schwannomin
% 210.96/211.18 |- skos__historyNote mesh__D025581 Membrane Proteins %28%1993-2001%29%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D025581 2005
% 210.96/211.18 |- skos__related mesh__D025581smesh__D016518
% 210.96/211.18 |- skos__altLabel mesh__D025581 Schwannomin Protein
% 210.96/211.18 |- skos__hiddenLabel mesh__D025581 Moesin Ezrin Radixin Like Protein
% 210.96/211.18 |- skos__broader mesh__D025581smesh__D008565
% 210.96/211.18 |- skos__altLabel mesh__D025581 Neurofibromatosis 2 Gene Product
% 210.96/211.18 |- skos__hiddenLabel mesh__D025581 Gene Product, NF2
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D025581 2002
% 210.96/211.18 |- mesh__historyNote mesh__D025581
% 210.96/211.18 2002; for SCHWANNOMIN PROTEIN use NEUROFIBROMIN 2 %28%NM%29% 1993-2001%A%
% 210.96/211.18 |- skos__altLabel mesh__D025581 Merlin
% 210.96/211.18 |- skos__broader mesh__D025581smesh__D025521
% 210.96/211.18 |- skos__altLabel mesh__D025581 Schwannomin
% 210.96/211.18 |- mesh__dateCreated mesh__D025581 2001-07-25
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D025581
% 210.96/211.18 2002; SCHWANNOMIN PROTEIN was indexed under MEMBRANE PROTEINS 1993-2001%A%
% 210.96/211.18 |- mesh__dateEstablished mesh__D025581 2002-01-01
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 1997
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Materials Failure Analyses
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 2000
% 210.96/211.18 |- skos__altLabel mesh__D019544 Analysis, Equipment Failure
% 210.96/211.18 |- skos__altLabel mesh__D019544 Analysis, Materials Failure
% 210.96/211.18 |- mesh__dateCreated mesh__D019544 1996-06-13
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 2003
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 2001
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Equipment Failure Analyses
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Failure Analyses, Equipment
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Analyses, Equipment Failure
% 210.96/211.18 |- mesh__historyNote mesh__D019544 97
% 210.96/211.18 |- mesh__dateEstablished mesh__D019544 1997-01-01
% 210.96/211.18 |- rdf__type mesh__D019544sskos__Concept
% 210.96/211.18 |- skos__broader mesh__D019544smesh__D008919
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Failure Analyses, Prosthesis
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Prosthesis Failure Analyses
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 2004
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 1998
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Analyses, Materials Failure
% 210.96/211.18 |- skos__historyNote mesh__D019544 Equipment and Supplies %28%1993-1996%29%
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Analyses, Prosthesis Failure
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Failure Analysis, Equipment
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 1999
% 210.96/211.18 |- skos__annotation mesh__D019544
% 210.96/211.18 NIM; coord with specific equip %28%IM%29% or specific techn /instrum %28%IM%29%%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 2002
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D019544 97
% 210.96/211.18 |- skos__scopeNote mesh__D019544
% 210.96/211.18 Determination of reliability and maintainability of equipment.%A%
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Failure Analyses, Materials
% 210.96/211.18 |- skos__prefLabel mesh__D019544 Equipment Failure Analysis
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 2005
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Failure Analysis, Prosthesis
% 210.96/211.18 |- skos__hiddenLabel mesh__D019544 Failure Analysis, Materials
% 210.96/211.18 |- skos__altLabel mesh__D019544 Analysis, Prosthesis Failure
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D019544 2006
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 1997
% 210.96/211.18 |- mesh__dateRevised mesh__D000839 1993-08-06
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 1999
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 2001
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 1994
% 210.96/211.18 |- skos__prefLabel mesh__D000839 Aniseikonia
% 210.96/211.18 |- mesh__dateCreated mesh__D000839 1999-01-01
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D000839 66
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D000839 PLS
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 1995
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 2003
% 210.96/211.18 |- skos__annotation mesh__D000839
% 210.96/211.18 refractive error in which each eye sees a different size %26% shape of an object%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 2002
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 2005
% 210.96/211.18 |- mesh__historyNote mesh__D000839 66%28%64%29%
% 210.96/211.18 |- mesh__recordOriginator mesh__D000839 NLM
% 210.96/211.18 |- skos__broader mesh__D000839smesh__D012030
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 2004
% 210.96/211.18 |- mesh__dateEstablished mesh__D000839 1966-01-01
% 210.96/211.18 |- rdf__type mesh__D000839sskos__Concept
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 1996
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 2006
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 1998
% 210.96/211.18 |- skos__scopeNote mesh__D000839
% 210.96/211.18 A condition in which the ocular image of an object as seen by one eye differs in size and shape from that seen by the other.%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D000839 2000
% 210.96/211.18 |- mesh__recordMaintainer mesh__D000839 PLS
% 210.96/211.18 |- skos__broader mesh__D011561smesh__D020141
% 210.96/211.18 |- mesh__dateRevised mesh__D011561 2001-08-13
% 210.96/211.18 |- skos__broader mesh__D011561smesh__D003240
% 210.96/211.18 |- skos__annotation mesh__D011561
% 210.96/211.18 skin %26% other abnorm; in titles %26% translations use diacrit: Gr%C3%%B6%nblad%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D011561 2002
% 210.96/211.18 |- skos__broader mesh__D011561smesh__D012868
% 210.96/211.18 |- mesh__recordMaintainer mesh__D011561 nns
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D011561 2003
% 210.96/211.18 |- rdf__type mesh__D011561sskos__Concept
% 210.96/211.18 |- mesh__dateCreated mesh__D011561 1999-01-01
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D011561 2004
% 210.96/211.18 |- skos__prefLabel mesh__D011561 Pseudoxanthoma Elasticum
% 210.96/211.18 |- skos__broader mesh__D011561smesh__D012873
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D011561 2005
% 210.96/211.18 |- skos__hiddenLabel mesh__D011561 Gronblad Strandberg Syndrome
% 210.96/211.18 |- mesh__recordOriginator mesh__D011561 NLM
% 210.96/211.18 |- skos__scopeNote mesh__D011561
% 210.96/211.18 A rare, progressive inherited disorder resulting from extensive basophilic degeneration of elastic tissue, usually presenting after puberty and involving the skin, eye, and cardiovascular system. Characteristic manifestations are small, circumscribed yellowish patches at sites of considerable movement of the skin, ANGIOID STREAKS in the retina, and a tendency towards hemorrhage and arterial insufficiency.%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D011561 2006
% 210.96/211.18 |- skos__hiddenLabel mesh__D011561 Syndrome, Gronblad-Strandberg
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D011561 sjn
% 210.96/211.18 |- mesh__dateEstablished mesh__D005524 1976-01-01
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D005524 76
% 210.96/211.18 |- skos__scopeNote mesh__D005524
% 210.96/211.18 The application of knowledge to the food industry.
% 210.96/211.18 |- mesh__dateCreated mesh__D005524 1975-07-25
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D005524 2002
% 210.96/211.18 |- mesh__recordMaintainer mesh__D005524 kle
% 210.96/211.18 |- skos__altLabel mesh__D005524 Technology, Food
% 210.96/211.18 |- mesh__historyNote mesh__D005524 76; was NON MESH before 1976
% 210.96/211.18 |- rdf__type mesh__D005524sskos__Concept
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D005524 2003
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D005524 2000
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D005524 2005
% 210.96/211.18 |- mesh__dateRevised mesh__D005524 1999-11-03
% 210.96/211.18 |- skos__broader mesh__D005524smesh__D019649
% 210.96/211.18 |- skos__prefLabel mesh__D005524 Food Technology
% 210.96/211.18 |- mesh__recordOriginator mesh__D005524 JW
% 210.96/211.18 |- skos__annotation mesh__D005524
% 210.96/211.18 IM; usually in ref to the food industry %26% food manufacture or prep on a large scale; covers aroma, flavor, color, texture, temperature, preparability, cookability, packaging, etc.; SPEC: SPEC qualif; DF: FOOD TECHNOL%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D005524 2004
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D005524 sjn
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D005524 2001
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D005524 2006
% 210.96/211.18 |- mesh__dateEstablished mesh__D029972 2002-01-01
% 210.96/211.18 |- mesh__dateCreated mesh__D029972 2001-07-25
% 210.96/211.18 |- mesh__historyNote mesh__D029972 2002
% 210.96/211.18 |- skos__prefLabel mesh__D029972 Bupleurum
% 210.96/211.18 |- skos__scopeNote mesh__D029972
% 210.96/211.18 A plant genus of the family APIACEAE that is the source of bupleurum root and of bupleurotoxin and is an ingredient of sho-saiko-to.%A%
% 210.96/211.18 |- mesh__recordOriginator mesh__D029972 ssb
% 210.96/211.18 |- mesh__dateRevised mesh__D029972 2002-07-02
% 210.96/211.18 |- skos__broader mesh__D029972smesh__D019661
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D029972 2002
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D029972 2005
% 210.96/211.18 |- skos__annotation mesh__D029972
% 210.96/211.18 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D029972 2003
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D029972 2006
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D029972 sjn
% 210.96/211.18 |- mesh__recordMaintainer mesh__D029972 ssb
% 210.96/211.18 |- rdf__type mesh__D029972sskos__Concept
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D029972 2004
% 210.96/211.18 |- skos__hiddenLabel mesh__D043643 Receptor M1, Muscarinic
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D043643 2005
% 210.96/211.18 |- skos__altLabel mesh__D043643 Muscarinic Receptor M1
% 210.96/211.18 |- skos__prefLabel mesh__D043643 Receptor, Muscarinic M1
% 210.96/211.18 |- skos__scopeNote mesh__D043643
% 210.96/211.18 A specific subtype of muscarinic receptor that has a high affinity for the drug PIRENZEPINE. It is found in the peripheral GANGLIA where it signals a variety of physiological functions such as GASTRIC ACID secretion and BRONCHOCONSTRICTION. This subtype of muscarinic receptor is also found in neuronal tissues including the CEREBRAL CORTEX and HIPPOCAMPUS where it mediates the process of MEMORY and LEARNING.%A%
% 210.96/211.18 |- skos__hiddenLabel mesh__D043643 Receptors M1, Muscarinic
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D043643 2006
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D043643 2004
% 210.96/211.18 |- rdf__type mesh__D043643sskos__Concept
% 210.96/211.18 |- skos__hiddenLabel mesh__D043643 M1, Muscarinic Receptor
% 210.96/211.18 |- mesh__historyNote mesh__D043643
% 210.96/211.18 2004; use RECEPTOR, MUSCARINIC M1%28%NM%29% 1996-2003
% 210.96/211.18 |- skos__altLabel mesh__D043643 Muscarinic Receptors M1
% 210.96/211.18 |- mesh__dateEstablished mesh__D043643 2004-01-01
% 210.96/211.18 |- skos__hiddenLabel mesh__D043643 M1 Receptors, Muscarinic
% 210.96/211.18 |- skos__historyNote mesh__D043643 Receptors, Muscarinic %28%1996-2003%29%
% 210.96/211.18 |- skos__altLabel mesh__D043643 Receptors, Muscarinic M1
% 210.96/211.18 |- mesh__dateCreated mesh__D043643 2003-07-09
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D043643
% 210.96/211.18 2004; MUSCARINIC RECEPTOR M1 was indexed under RECEPTORS, MUSCARINIC 1996-2003%A%
% 210.96/211.18 |- skos__hiddenLabel mesh__D043643 M1 Receptor, Muscarinic
% 210.96/211.18 |- skos__hiddenLabel mesh__D043643 Muscarinic M1 Receptor
% 210.96/211.18 |- skos__hiddenLabel mesh__D043643 Muscarinic M1 Receptors
% 210.96/211.18 |- skos__broader mesh__D043643smesh__D011976
% 210.96/211.18 |- skos__hiddenLabel mesh__D043643 M1, Muscarinic Receptors
% 210.96/211.18 |- skos__scopeNote mesh__D010469
% 210.96/211.18 Lack of correspondence between the way a stimulus is commonly perceived and the way an individual perceives it under given conditions.%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 1998
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 2002
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 1995
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D010469 PLS
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 2006
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 1999
% 210.96/211.18 |- mesh__recordOriginator mesh__D010469 NLM
% 210.96/211.18 |- mesh__dateRevised mesh__D010469 1992-05-15
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 2003
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 1996
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 2000
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 1993
% 210.96/211.18 |- skos__hiddenLabel mesh__D010469 Distortions, Perceptual
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 2004
% 210.96/211.18 |- skos__broader mesh__D010469smesh__D010465
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 1997
% 210.96/211.18 |- rdf__type mesh__D010469sskos__Concept
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 2001
% 210.96/211.18 |- skos__historyNote mesh__D010469 Perception %28%1966%29%
% 210.96/211.18 |- skos__prefLabel mesh__D010469 Perceptual Distortion
% 210.96/211.18 |- skos__related mesh__D010469smesh__D010468
% 210.96/211.18 |- skos__hiddenLabel mesh__D010469 Distortion, Perceptual
% 210.96/211.18 |- mesh__dateCreated mesh__D010469 1999-01-01
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 1994
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D010469 69
% 210.96/211.18 |- mesh__dateEstablished mesh__D010469 1969-01-01
% 210.96/211.18 |- mesh__historyNote mesh__D010469 69%28%67%29%
% 210.96/211.18 |- skos__hiddenLabel mesh__D010469 Perceptual Distortions
% 210.96/211.18 |- mesh__recordMaintainer mesh__D010469 TAP
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D010469 2005
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D015154 2005
% 210.96/211.18 |- skos__prefLabel mesh__D015154 Esophageal Motility Disorders
% 210.96/211.18 |- skos__hiddenLabel mesh__D015154 Disorder, Esophageal Motility
% 210.96/211.18 |- skos__historyNote mesh__D015154
% 210.96/211.18 Gastrointestinal Motility %28%1966-1988%29%
% 210.96/211.18 |- mesh__dateEstablished mesh__D015154 1989-01-01
% 210.96/211.18 |- mesh__dateRevised mesh__D015154 2004-07-07
% 210.96/211.18 |- skos__historyNote mesh__D015154 Peristalsis %28%1975-1988%29%
% 210.96/211.18 |- mesh__dateCreated mesh__D015154 1988-03-22
% 210.96/211.18 |- mesh__recordMaintainer mesh__D015154 lkt
% 210.96/211.18 |- skos__altLabel mesh__D015154 Esophageal Dysmotility
% 210.96/211.18 |- skos__historyNote mesh__D015154 Esophageal Diseases %28%1966-1988%29%
% 210.96/211.18 |- rdf__type mesh__D015154sskos__Concept
% 210.96/211.18 |- skos__scopeNote mesh__D015154
% 210.96/211.18 Disorders affecting the motor function of the UPPER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGEAL SPHINCTER; the ESOPHAGUS body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus %28%GASTROESOPHAGEAL REFLUX%29%. Other disorders include hypermotility %28%spastic disorders%29% and markedly increased amplitude in contraction %28%nutcracker esophagus%29%.%A%
% 210.96/211.18 |- skos__broader mesh__D015154smesh__D003680
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D015154 sjn
% 210.96/211.18 |- skos__hiddenLabel mesh__D015154 Motility Disorder, Esophageal
% 210.96/211.18 |- skos__hiddenLabel mesh__D015154 Dysmotilities, Esophageal
% 210.96/211.18 |- mesh__publicMeSHNote mesh__D015154 1989
% 210.96/211.18 |- skos__hiddenLabel mesh__D015154 Esophagus, Nutcracker
% 210.96/211.18 |- skos__hiddenLabel mesh__D015154 Dysmotility, Esophageal
% 210.96/211.18 |- mesh__recordOriginator mesh__D015154 EC
% 210.96/211.18 |- skos__hiddenLabel mesh__D015154 Motility Disorders, Esophageal
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D015154 2006
% 210.96/211.18 |- mesh__historyNote mesh__D015154 1989
% 210.96/211.18 |- skos__hiddenLabel mesh__D015154 Esophageal Motility Disorder
% 210.96/211.18 |- skos__hiddenLabel mesh__D015154 Esophageal Dysmotilities
% 210.96/211.18 |- skos__hiddenLabel mesh__D015154 Disorders, Esophageal Motility
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 2002
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 2004
% 210.96/211.18 |- mesh__recordMaintainer mesh__D009915 TGC
% 210.96/211.18 |- mesh__recordAuthorizer mesh__D009915 PLS
% 210.96/211.18 |- mesh__recordOriginator mesh__D009915 NLM
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1996
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1999
% 210.96/211.18 |- mesh__dateCreated mesh__D009915 1999-01-01
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 2001
% 210.96/211.18 |- skos__broader mesh__D009915smesh__D005147
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 2003
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1991
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 2006
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1998
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1993
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 2000
% 210.96/211.18 |- rdf__type mesh__D009915sskos__Concept
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1990
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 2005
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1995
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1992
% 210.96/211.18 |- skos__prefLabel mesh__D009915 Orbit
% 210.96/211.18 |- skos__annotation mesh__D009915
% 210.96/211.18 bony cavity %26% its contents as a unit; not a synonym for EYE%A%
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1994
% 210.96/211.18 |- skos__hiddenLabel mesh__D009915 Orbits
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D009915 1997
% 210.96/211.18 |- mesh__dateRevised mesh__D009915 1989-05-26
% 210.96/211.18 |- skos__annotation mesh__D001932
% 210.96/211.18 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific site in brain %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Recurrent Brain Tumor
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Brain Cancers
% 210.96/211.18 |- mesh__recordMaintainer mesh__D001932 nns
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Cancers, Brain
% 210.96/211.18 |- skos__altLabel mesh__D001932 Cancer of the Brain
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Primary Brain Tumors
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Brain Neoplasms, Primary
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Brain Neoplasm, Malignant
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Cancer, Brain
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Benign Brain Neoplasms
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Neoplasm, Brain
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Tumors, Brain
% 210.96/211.18 |- mesh__activeMeSHYear mesh__D001932 2005
% 210.96/211.18 |- skos__altLabel mesh__D001932 Primary Malignant Brain Tumors
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Primary Brain Tumor
% 210.96/211.18 |- mesh__dateRevised mesh__D001932 2001-07-25
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Brain Malignant Neoplasm
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Brain Tumors, Recurrent
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Recurrent Brain Tumors
% 210.96/211.18 |- skos__altLabel mesh__D001932 Neoplasms, Brain, Benign
% 210.96/211.18 |- skos__altLabel mesh__D001932 Primary Malignant Brain Neoplasms
% 210.96/211.18 |- skos__altLabel mesh__D001932 Primary Brain Neoplasms
% 210.96/211.18 |- skos__hiddenLabel mesh__D001932 Brain Neoplasm, Benign
% 210.96/211.18 |- skos__altLabel mesh__D001932 Brain Neoplasms, Benign
% 210.96/211.18 |- skos__altLabel mesh__D001932 Neoplasms, Brain, Malignant
% 210.96/211.19 |- skos__prefLabel mesh__D001932 Brain Neoplasms
% 210.96/211.19 |- mesh__dateCreated mesh__D001932 1999-01-01
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Brain Tumors, Primary
% 210.96/211.19 |- skos__altLabel mesh__D001932 Brain Neoplasms, Malignant, Primary
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Brain Tumor
% 210.96/211.19 |- skos__broader mesh__D001932smesh__D001927
% 210.96/211.19 |- skos__altLabel mesh__D001932 Brain Tumors
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Brain Benign Neoplasm
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Brain Benign Neoplasms
% 210.96/211.19 |- skos__altLabel mesh__D001932 Brain Neoplasms, Primary Malignant
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Malignant Neoplasm, Brain
% 210.96/211.19 |- skos__altLabel mesh__D001932 Intracranial Neoplasms
% 210.96/211.19 |- skos__altLabel mesh__D001932 Cancer of Brain
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Malignant Brain Neoplasm
% 210.96/211.19 |- skos__altLabel mesh__D001932 Brain Neoplasm, Primary
% 210.96/211.19 |- mesh__recordOriginator mesh__D001932 NLM
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D001932 sjn
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Benign Brain Neoplasm
% 210.96/211.19 |- skos__broader mesh__D001932smesh__D016543
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001932 2004
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Malignant Brain Neoplasms
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Benign Neoplasm, Brain
% 210.96/211.19 |- rdf__type mesh__D001932sskos__Concept
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Primary Brain Neoplasm
% 210.96/211.19 |- skos__altLabel mesh__D001932 Malignant Neoplasms, Brain
% 210.96/211.19 |- skos__altLabel mesh__D001932 Neoplasms, Brain, Primary
% 210.96/211.19 |- skos__scopeNote mesh__D001932
% 210.96/211.19 Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary %28%originating from brain tissue%29% and secondary %28%i.e., metastatic%29% forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.%A%
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Tumor, Brain
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Brain Neoplasm
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Intracranial Neoplasm
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001932 2003
% 210.96/211.19 |- skos__altLabel mesh__D001932 Brain Neoplasms, Malignant
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Brain Malignant Neoplasms
% 210.96/211.19 |- skos__altLabel mesh__D001932 Neoplasms, Brain
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001932 2002
% 210.96/211.19 |- skos__hiddenLabel mesh__D001932 Neoplasm, Intracranial
% 210.96/211.19 |- skos__altLabel mesh__D001932 Malignant Primary Brain Neoplasms
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001932 2006
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009117 2004
% 210.96/211.19 |- skos__broader mesh__D009117smesh__D004175
% 210.96/211.19 |- skos__scopeNote mesh__D009117
% 210.96/211.19 A family of the order DIPTERA with over 700 species. Important species that may be mechanical vectors of disease include Musca domesticus %28%HOUSEFLIES%29%, Musca autumnalis %28%face fly%29%, Stomoxys calcitrans %28%stable fly%29%, Haematobia irritans %28%horn fly%29% and Fannia spp.%A%
% 210.96/211.19 |- skos__altLabel mesh__D009117 Face Fly
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009117 2005
% 210.96/211.19 |- skos__prefLabel mesh__D009117 Muscidae
% 210.96/211.19 |- mesh__dateCreated mesh__D009117 1987-05-02
% 210.96/211.19 |- mesh__recordOriginator mesh__D009117 EC
% 210.96/211.19 |- mesh__historyNote mesh__D009117 88
% 210.96/211.19 |- skos__historyNote mesh__D009117 Houseflies %28%1966-1987%29%
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009117 2006
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D009117 88
% 210.96/211.19 |- skos__annotation mesh__D009117
% 210.96/211.19 do not use /drug eff for insecticides: TN 111; note MUSCA DOMESTICA see HOUSEFLIES%A%
% 210.96/211.19 |- mesh__dateRevised mesh__D009117 2003-07-09
% 210.96/211.19 |- skos__historyNote mesh__D009117 Diptera %28%1966-1987%29%
% 210.96/211.19 |- mesh__recordMaintainer mesh__D009117 ags
% 210.96/211.19 |- skos__altLabel mesh__D009117 Stomoxys calcitrans
% 210.96/211.19 |- skos__altLabel mesh__D009117 Haematobia irritans
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D009117 sjn
% 210.96/211.19 |- mesh__dateEstablished mesh__D009117 1988-01-01
% 210.96/211.19 |- rdf__type mesh__D009117sskos__Concept
% 210.96/211.19 |- skos__scopeNote mesh__D001134
% 210.96/211.19 General or unspecified injuries involving the arm.
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001134 2005
% 210.96/211.19 |- mesh__dateRevised mesh__D001134 2001-07-25
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001134 2004
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001134 2006
% 210.96/211.19 |- mesh__recordMaintainer mesh__D001134 mdb
% 210.96/211.19 |- skos__hiddenLabel mesh__D001134 Arm Injury
% 210.96/211.19 |- skos__annotation mesh__D001134
% 210.96/211.19 GEN or unspecified; consider also /inj with specific bones of arm; also available are FOREARM INJURIES; HAND INJURIES; FINGER INJURIES; WRIST INJURIES %26% many specific organ/fract precoords%A%
% 210.96/211.19 |- rdf__type mesh__D001134sskos__Concept
% 210.96/211.19 |- skos__altLabel mesh__D001134 Injuries, Arm
% 210.96/211.19 |- mesh__dateCreated mesh__D001134 1999-01-01
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D001134 sjn
% 210.96/211.19 |- skos__broader mesh__D001134smesh__D014947
% 210.96/211.19 |- mesh__recordOriginator mesh__D001134 NLM
% 210.96/211.19 |- skos__hiddenLabel mesh__D001134 Injury, Arm
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001134 2002
% 210.96/211.19 |- skos__prefLabel mesh__D001134 Arm Injuries
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001134 2003
% 210.96/211.19 |- skos__related mesh__D020897smesh__D004627
% 210.96/211.19 |- skos__prefLabel mesh__D020897 Organizers, Embryonic
% 210.96/211.19 |- skos__altLabel mesh__D020897 Hensen%27%s Node
% 210.96/211.19 |- skos__scopeNote mesh__D020897
% 210.96/211.19 The regions within an embryo that control development and differentiation. In AMPHIBIA, the organizer forms at the dorsal-most lip of the blastopore during gastrulation and is named after its discoverer, Hans Spemann.%A%
% 210.96/211.19 |- mesh__dateCreated mesh__D020897 1999-11-03
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Spemanns Organizer
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Embryonic Organizer
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020897 2004
% 210.96/211.19 |- rdf__type mesh__D020897sskos__Concept
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Organizers, Embryo
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Embryo Organizer
% 210.96/211.19 |- mesh__dateEstablished mesh__D020897 2000-01-01
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Node, Hensen%27%s
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020897 2006
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020897 2003
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Organizer, Embryonic
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Organizer, Embryo
% 210.96/211.19 |- skos__altLabel mesh__D020897 Spemann%27%s Organizer
% 210.96/211.19 |- mesh__historyNote mesh__D020897 2000
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020897 2002
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Hensens Node
% 210.96/211.19 |- skos__historyNote mesh__D020897 Embryonic Induction %28%1990-1999%29%
% 210.96/211.19 |- skos__altLabel mesh__D020897 Embryo Organizers
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020897 2005
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Organizer, Spemann%27%s
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Organizer, Spemann
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D020897 2000
% 210.96/211.19 |- skos__broader mesh__D020897smesh__D004622
% 210.96/211.19 |- skos__hiddenLabel mesh__D020897 Node, Hensen
% 210.96/211.19 |- skos__altLabel mesh__D020897 Embryonic Organizers
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020897 2001
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020897 2000
% 210.96/211.19 |- skos__historyNote mesh__D020099
% 210.96/211.19 Biocompatible Materials %28%1967-1998%29%
% 210.96/211.19 |- mesh__historyNote mesh__D020099 99
% 210.96/211.19 |- mesh__dateEstablished mesh__D020099 1999-01-01
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020099 2004
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020099 2002
% 210.96/211.19 |- skos__hiddenLabel mesh__D020099 Materials, Surface-Coated
% 210.96/211.19 |- skos__hiddenLabel mesh__D020099 Surface Coated Materials
% 210.96/211.19 |- skos__hiddenLabel mesh__D020099 Biocompatible Coated Materials
% 210.96/211.19 |- skos__prefLabel mesh__D020099 Coated Materials, Biocompatible
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020099 2003
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020099 1999
% 210.96/211.19 |- mesh__dateCreated mesh__D020099 1998-06-10
% 210.96/211.19 |- rdf__type mesh__D020099sskos__Concept
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D020099 99
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020099 2006
% 210.96/211.19 |- skos__altLabel mesh__D020099 Surface-Coated Materials
% 210.96/211.19 |- skos__broader mesh__D020099smesh__D001672
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020099 2001
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020099 2005
% 210.96/211.19 |- skos__annotation mesh__D020099 coord with specific coating material
% 210.96/211.19 |- skos__hiddenLabel mesh__D020099 Materials, Biocompatible Coated
% 210.96/211.19 |- skos__scopeNote mesh__D020099
% 210.96/211.19 Biocompatible materials usually used in dental and bone implants that enhance biologic fixation, thereby increasing the bond strength between the coated material and bone, and minimize possible biological effects that may result from the implant itself.%A%
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D020099 2000
% 210.96/211.19 |- skos__broader mesh__D006321Q000254smesh__D006321
% 210.96/211.19 |- rdf__type mesh__D006321Q000254smesh__CompoundConcept
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019545 2003
% 210.96/211.19 |- mesh__historyNote mesh__D019545 97
% 210.96/211.19 |- skos__prefLabel mesh__D019545 Intuition
% 210.96/211.19 |- rdf__type mesh__D019545sskos__Concept
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019545 2004
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019545 1998
% 210.96/211.19 |- skos__historyNote mesh__D019545 Consciousness %28%1966-1996%29%
% 210.96/211.19 |- mesh__dateRevised mesh__D019545 1997-06-20
% 210.96/211.19 |- mesh__dateCreated mesh__D019545 1996-06-10
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019545 2000
% 210.96/211.19 |- skos__scopeNote mesh__D019545
% 210.96/211.19 Knowing or understanding without conscious use of reasoning. %28%Thesaurus of ERIC Descriptors, 1994%29%%A%
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D019545 SJN
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019545 2001
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019545 1999
% 210.96/211.19 |- skos__broader mesh__D019545smesh__D003071
% 210.96/211.19 |- mesh__dateEstablished mesh__D019545 1997-01-01
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019545 2005
% 210.96/211.19 |- skos__annotation mesh__D019545 knowing without conscious reasoning
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019545 2006
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019545 2002
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D019545 97
% 210.96/211.19 |- mesh__recordMaintainer mesh__D019545 JLS
% 210.96/211.19 |- mesh__recordOriginator mesh__D019545 JLS
% 210.96/211.19 |- skos__broader mesh__D011562smesh__D026121
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D011562 2006
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D011562 66
% 210.96/211.19 |- skos__altLabel mesh__D011562 Psilocibin
% 210.96/211.19 |- mesh__recordOriginator mesh__D011562 NLM
% 210.96/211.19 |- mesh__historyNote mesh__D011562 66%28%63%29%
% 210.96/211.19 |- mesh__dateCreated mesh__D011562 1999-01-01
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D011562 2005
% 210.96/211.19 |- mesh__dateRevised mesh__D011562 2004-07-07
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D011562 sjn
% 210.96/211.19 |- skos__prefLabel mesh__D011562 Psilocybine
% 210.96/211.19 |- rdf__type mesh__D011562sskos__Concept
% 210.96/211.19 |- mesh__recordMaintainer mesh__D011562 ssb
% 210.96/211.19 |- mesh__dateEstablished mesh__D011562 1966-01-01
% 210.96/211.19 |- skos__broader mesh__D011562smesh__D014363
% 210.96/211.19 |- skos__scopeNote mesh__D011562
% 210.96/211.19 The major of two hallucinogenic components of Teonanacatl, the sacred mushroom of Mexico, the other component being psilocin. %28%From Merck Index, 11th ed%29%%A%
% 210.96/211.19 |- mesh__recordOriginator mesh__D005525 NLM
% 210.96/211.19 |- skos__annotation mesh__D005525
% 210.96/211.19 SPEC: SPEC qualifs; DF: FOOD PROCESSING INDUST
% 210.96/211.19 |- skos__altLabel mesh__D005525 Industry, Food-Processing
% 210.96/211.19 |- skos__broader mesh__D005525smesh__D005511
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005525 2000
% 210.96/211.19 |- mesh__recordMaintainer mesh__D005525 JLS
% 210.96/211.19 |- skos__hiddenLabel mesh__D005525 Food-Processing Industries
% 210.96/211.19 |- rdf__type mesh__D005525sskos__Concept
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005525 2003
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005525 2001
% 210.96/211.19 |- skos__hiddenLabel mesh__D005525 Industries, Food-Processing
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005525 2005
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005525 1998
% 210.96/211.19 |- skos__hiddenLabel mesh__D005525 Food Processing Industry
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005525 2004
% 210.96/211.19 |- skos__hiddenLabel mesh__D005525 Industry, Food Processing
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005525 2006
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005525 1999
% 210.96/211.19 |- mesh__dateRevised mesh__D005525 1997-06-20
% 210.96/211.19 |- mesh__dateCreated mesh__D005525 1999-01-01
% 210.96/211.19 |- skos__prefLabel mesh__D005525 Food-Processing Industry
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005525 2002
% 210.96/211.19 |- skos__scopeNote mesh__D005525
% 210.96/211.19 The productive enterprises concerned with food processing.%A%
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D005525 SJN
% 210.96/211.19 |- mesh__dateCreated mesh__D015155 1988-03-22
% 210.96/211.19 |- skos__historyNote mesh__D015155 Esophageal Diseases %28%1966-1988%29%
% 210.96/211.19 |- rdf__type mesh__D015155sskos__Concept
% 210.96/211.19 |- skos__annotation mesh__D015155
% 210.96/211.19 %22%diffuse%22% need not be used by author: note X ref
% 210.96/211.19 |- skos__historyNote mesh__D015155 Spasm %28%1966-1988%29%
% 210.96/211.19 |- skos__hiddenLabel mesh__D015155 Esophageal Spasms
% 210.96/211.19 |- skos__scopeNote mesh__D015155
% 210.96/211.19 A hypermotility disorder of the ESOPHAGUS that is characterized by spastic non-peristaltic responses to SWALLOWING; CHEST PAIN; and DYSPHAGIA.%A%
% 210.96/211.19 |- skos__hiddenLabel mesh__D015155 Diffuse Esophageal Spasms
% 210.96/211.19 |- mesh__recordMaintainer mesh__D015155 lkt
% 210.96/211.19 |- skos__prefLabel mesh__D015155 Esophageal Spasm, Diffuse
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D015155 sjn
% 210.96/211.19 |- skos__broader mesh__D015155smesh__D015154
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D015155 2006
% 210.96/211.19 |- skos__altLabel mesh__D015155 Spasm, Esophageal
% 210.96/211.19 |- skos__hiddenLabel mesh__D015155 Diffuse Esophageal Spasm
% 210.96/211.19 |- skos__hiddenLabel mesh__D015155 Spasms, Esophageal
% 210.96/211.19 |- mesh__historyNote mesh__D015155 89
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D015155 2005
% 210.96/211.19 |- skos__hiddenLabel mesh__D015155 Spasm, Diffuse Esophageal
% 210.96/211.19 |- skos__hiddenLabel mesh__D015155 Esophageal Spasms, Diffuse
% 210.96/211.19 |- skos__altLabel mesh__D015155 Esophageal Spasm
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D015155 89
% 210.96/211.19 |- skos__hiddenLabel mesh__D015155 Spasms, Diffuse Esophageal
% 210.96/211.19 |- mesh__dateEstablished mesh__D015155 1989-01-01
% 210.96/211.19 |- mesh__recordOriginator mesh__D015155 EC
% 210.96/211.19 |- mesh__dateRevised mesh__D015155 2004-07-07
% 210.96/211.19 |- mesh__dateRevised mesh__D009916 1990-05-29
% 210.96/211.19 |- skos__hiddenLabel mesh__D009916 Disease, Orbital
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 2002
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 2005
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 2004
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 1992
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 1999
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D009916 81
% 210.96/211.19 |- skos__historyNote mesh__D009916 Orbit %28%1966-1980%29%
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 1994
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 2006
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 1991
% 210.96/211.19 |- skos__annotation mesh__D009916
% 210.96/211.19 dis of bony cavity %26% its contents except eyeball %28% = EYE DISEASES or specifics%29%%A%
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 1993
% 210.96/211.19 |- skos__scopeNote mesh__D009916
% 210.96/211.19 Diseases of the bony orbit and contents except the eyeball.%A%
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 2000
% 210.96/211.19 |- skos__hiddenLabel mesh__D009916 Orbital Disease
% 210.96/211.19 |- rdf__type mesh__D009916sskos__Concept
% 210.96/211.19 |- skos__hiddenLabel mesh__D009916 Diseases, Orbital
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 1995
% 210.96/211.19 |- skos__prefLabel mesh__D009916 Orbital Diseases
% 210.96/211.19 |- mesh__dateCreated mesh__D009916 1980-04-09
% 210.96/211.19 |- mesh__recordOriginator mesh__D009916 RC
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 2001
% 210.96/211.19 |- mesh__historyNote mesh__D009916 81
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 1996
% 210.96/211.19 |- mesh__recordMaintainer mesh__D009916 PLS
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D009916 NLM
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 2003
% 210.96/211.19 |- mesh__dateEstablished mesh__D009916 1981-01-01
% 210.96/211.19 |- skos__broader mesh__D009916smesh__D005128
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 1998
% 210.96/211.19 |- skos__historyNote mesh__D009916 Eye Diseases %28%1966-1980%29%
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009916 1997
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001933 2005
% 210.96/211.19 |- mesh__dateCreated mesh__D001933 1999-01-01
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D001933 ags
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001933 2003
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001933 2006
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001933 2000
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001933 2004
% 210.96/211.19 |- skos__broader mesh__D001933smesh__D001921
% 210.96/211.19 |- skos__hiddenLabel mesh__D001933 Brain Stems
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001933 2001
% 210.96/211.19 |- skos__scopeNote mesh__D001933
% 210.96/211.19 The part of the brain that connects the cerebral hemispheres with the spinal cord. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA.%A%
% 210.96/211.19 |- mesh__dateRevised mesh__D001933 2005-07-20
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001933 2002
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001933 2006A
% 210.96/211.19 |- mesh__recordMaintainer mesh__D001933 ags
% 210.96/211.19 |- skos__altLabel mesh__D001933 Brainstem
% 210.96/211.19 |- mesh__recordOriginator mesh__D001933 NLM
% 210.96/211.19 |- skos__hiddenLabel mesh__D001933 Brainstems
% 210.96/211.19 |- rdf__type mesh__D001933sskos__Concept
% 210.96/211.19 |- skos__prefLabel mesh__D001933 Brain Stem
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D009118 86; was see under OXAZOLES 1979-85
% 210.96/211.19 |- mesh__dateRevised mesh__D009118 2005-06-30
% 210.96/211.19 |- skos__altLabel mesh__D009118 Agarin
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D009118 2006
% 210.96/211.19 |- skos__altLabel mesh__D009118 Pantherine
% 210.96/211.19 |- skos__scopeNote mesh__D009118
% 210.96/211.19 Neurotoxic isoxazole isolated from Amanita muscaria and A. phalloides and also obtained by decarboxylation of IBOTENIC ACID. It is a potent agonist at GABA-A receptors and is used mainly as an experimental tool in animal and tissue studies.%A%
% 210.96/211.19 |- skos__historyNote mesh__D009118 Oxazoles %28%1966-1978%29%
% 210.96/211.19 |- skos__prefLabel mesh__D009118 Muscimol
% 210.96/211.19 |- mesh__historyNote mesh__D009118
% 210.96/211.19 86%28%79%29%; was see under OXAZOLES 1979-85
% 210.96/211.19 |- mesh__recordOriginator mesh__D009118 SH
% 210.96/211.19 |- mesh__recordMaintainer mesh__D009118 ssb
% 210.96/211.19 |- skos__broader mesh__D009118smesh__D010080
% 210.96/211.19 |- skos__related mesh__D009118smesh__D011963
% 210.96/211.19 |- skos__historyNote mesh__D009118 Mycotoxins %28%1967-1978%29%
% 210.96/211.19 |- rdf__type mesh__D009118sskos__Concept
% 210.96/211.19 |- mesh__dateEstablished mesh__D009118 1986-01-01
% 210.96/211.19 |- skos__broader mesh__D009118smesh__D009183
% 210.96/211.19 |- mesh__dateCreated mesh__D009118 1978-05-03
% 210.96/211.19 |- skos__historyNote mesh__D009118 Toxins %28%1966%29%
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D009118 sjn
% 210.96/211.19 |- mesh__dateEstablished mesh__D001135 1991-01-01
% 210.96/211.19 |- skos__annotation mesh__D001135 IM; qualif permitted
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D001135 sjn
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001135 2004
% 210.96/211.19 |- mesh__recordOriginator mesh__D001135 NLM
% 210.96/211.19 |- mesh__recordMaintainer mesh__D001135 ags
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D001135 91; was see under EDENTATA 1975-90
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001135 2006
% 210.96/211.19 |- skos__prefLabel mesh__D001135 Armadillos
% 210.96/211.19 |- mesh__historyNote mesh__D001135
% 210.96/211.19 91%28%75%29%; was see under EDENTATA 1975-90
% 210.96/211.19 |- skos__broader mesh__D001135smesh__D004490
% 210.96/211.19 |- mesh__dateRevised mesh__D001135 2003-07-09
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D001135 2005
% 210.96/211.19 |- mesh__dateCreated mesh__D001135 1974-11-19
% 210.96/211.19 |- rdf__type mesh__D001135sskos__Concept
% 210.96/211.19 |- skos__scopeNote mesh__D001135
% 210.96/211.19 Burrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates. They are widely distributed in the warmer parts of the Americas.%A%
% 210.96/211.19 |- skos__hiddenLabel mesh__D001135 Armadillo
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 2006
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 2001
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 2005
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 2004
% 210.96/211.19 |- skos__related mesh__D019546smesh__D008388
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 2000
% 210.96/211.19 |- mesh__historyNote mesh__D019546 97
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D019546 97
% 210.96/211.19 |- skos__altLabel mesh__D019546 Couple Therapy
% 210.96/211.19 |- rdf__type mesh__D019546sskos__Concept
% 210.96/211.19 |- mesh__dateEstablished mesh__D019546 1997-01-01
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 2003
% 210.96/211.19 |- skos__hiddenLabel mesh__D019546 Couples Therapies
% 210.96/211.19 |- skos__hiddenLabel mesh__D019546 Therapy, Couples
% 210.96/211.19 |- skos__hiddenLabel mesh__D019546 Therapy, Couple
% 210.96/211.19 |- skos__scopeNote mesh__D019546
% 210.96/211.19 Psychotherapy used specifically for unmarried couples, of mixed or same sex. %28%From APA, Thesaurus of Psychological Index Terms, 1994%29%%A%
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 2002
% 210.96/211.19 |- skos__hiddenLabel mesh__D019546 Couple Therapies
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 1999
% 210.96/211.19 |- skos__historyNote mesh__D019546 Psychotherapy %28%1990-1996%29%
% 210.96/211.19 |- skos__broader mesh__D019546smesh__D011615
% 210.96/211.19 |- skos__hiddenLabel mesh__D019546 Therapies, Couple
% 210.96/211.19 |- skos__hiddenLabel mesh__D019546 Therapies, Couples
% 210.96/211.19 |- skos__annotation mesh__D019546
% 210.96/211.19 a psychother technique for unmarried couples: for married couples index under MARITAL THERAPY; DF: COUPLES THER%A%
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 1998
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D019546 1997
% 210.96/211.19 |- mesh__dateCreated mesh__D019546 1996-06-13
% 210.96/211.19 |- skos__prefLabel mesh__D019546 Couples Therapy
% 210.96/211.19 |- skos__scopeNote mesh__D011563
% 210.96/211.19 An order of BIRDS comprised of several families and more than 300 species. It includes COCKATOOS; PARROTS; PARAKEETS; macaws; and BUDGERIGARS.%A%
% 210.96/211.19 |- mesh__dateCreated mesh__D011563 1999-01-01
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D011563 2005
% 210.96/211.19 |- mesh__dateRevised mesh__D011563 2004-07-07
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D011563 2005; see PSITTACINES 1968-2004
% 210.96/211.19 |- rdf__type mesh__D011563sskos__Concept
% 210.96/211.19 |- mesh__dateEstablished mesh__D011563 1968-01-01
% 210.96/211.19 |- mesh__recordOriginator mesh__D011563 NLM
% 210.96/211.19 |- skos__altLabel mesh__D011563 Psittacines
% 210.96/211.19 |- mesh__historyNote mesh__D011563 2005 %28%1968%29%
% 210.96/211.19 |- skos__prefLabel mesh__D011563 Psittaciformes
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D011563 sjn
% 210.96/211.19 |- mesh__recordMaintainer mesh__D011563 ags
% 210.96/211.19 |- skos__historyNote mesh__D011563 Birds %28%1966-1967%29%
% 210.96/211.19 |- skos__broader mesh__D011563smesh__D001717
% 210.96/211.19 |- skos__annotation mesh__D011563
% 210.96/211.19 General or unspecified; prefer specifics
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D011563 2006
% 210.96/211.19 |- mesh__historyNote mesh__D005526
% 210.96/211.19 80; was FOOD, ARTIFICIAL 1979; was FOOD, ARTIFICIAL see under FOOD 1973-78 %28%Prov 1973-74%29%; was FOODS, ARTIFICIAL 1972 %28%Prov%29%%A%
% 210.96/211.19 |- skos__altLabel mesh__D005526 Diet, Synthetic
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Diets, Formula
% 210.96/211.19 |- skos__historyNote mesh__D005526 Food %28%1966-1971%29%
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Elemental Diets
% 210.96/211.19 |- skos__historyNote mesh__D005526 specific food %28%1966-1971%29%
% 210.96/211.19 |- mesh__recordAuthorizer mesh__D005526 sjn
% 210.96/211.19 |- rdf__type mesh__D005526sskos__Concept
% 210.96/211.19 |- mesh__publicMeSHNote mesh__D005526
% 210.96/211.19 80; was FOOD, ARTIFICIAL 1979; was FOOD, ARTIFICIAL see under FOOD 1975-78%A%
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Formulations, Dietary
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Dietary Formulation
% 210.96/211.19 |- mesh__recordMaintainer mesh__D005526 ssb
% 210.96/211.19 |- mesh__dateRevised mesh__D005526 2003-07-09
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Formulated Foods
% 210.96/211.19 |- mesh__dateEstablished mesh__D005526 1979-01-01
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Diets, Synthetic
% 210.96/211.19 |- mesh__onlineNote mesh__D005526
% 210.96/211.19 use FOOD, FORMULATED to search FOOD, ARTIFICIAL %26% FOODS, ARTIFICIAL 1972-79 %28%as Prov 1972-74%29%%A%
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005526 2005
% 210.96/211.19 |- mesh__dateCreated mesh__D005526 1999-01-01
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005526 2004
% 210.96/211.19 |- skos__annotation mesh__D005526
% 210.96/211.19 includes imitation eggs, meat, dairy prod, space diets, weight reduction formulas, tube-feeding diets; does not include infant formulas and baby foods %28% = INFANT FORMULA or INFANT FOOD%29%; do not confuse with FOOD, FORTIFIED which emphasizes addition of essential nutrients%A%
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Elemental Diet
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Diets, Elemental
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Diets, Chemically Defined
% 210.96/211.19 |- skos__altLabel mesh__D005526 Chemically Defined Diet
% 210.96/211.19 |- mesh__activeMeSHYear mesh__D005526 2006
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Chemically Defined Diets
% 210.96/211.19 |- skos__prefLabel mesh__D005526 Food, Formulated
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Formulation, Dietary
% 210.96/211.19 |- skos__hiddenLabel mesh__D005526 Formulated Food
% 210.96/211.19 |- skos__scopeNote mesh__D005526
% 210.96/211.19 Food and dietary formulations including elemental %28%chemically defined formula%29% diets, synthetic and semisynthetic diets, space diets, weight-reduction formulas, tube-feeding diets, complete liquid diets, and supplemental liquid and solid diets.%A%
% 210.96/211.20 |- mesh__recordOriginator mesh__D005526 NLM
% 210.96/211.20 |- skos__hiddenLabel mesh__D005526 Foods, Formulated
% 210.96/211.20 |- skos__broader mesh__D005526smesh__D019648
% 210.96/211.20 |- skos__prefLabel mesh__D029974 Carum
% 210.96/211.20 |- skos__scopeNote mesh__D029974
% 210.96/211.20 A plant genus of the family Apiaceae. The seeds are used as flavoring.%A%
% 210.96/211.20 |- skos__altLabel mesh__D029974 Caraway
% 210.96/211.20 |- mesh__dateCreated mesh__D029974 2001-07-25
% 210.96/211.20 |- skos__broader mesh__D029974smesh__D019661
% 210.96/211.20 |- skos__altLabel mesh__D029974 Ajowan
% 210.96/211.20 |- mesh__historyNote mesh__D029974 2002
% 210.96/211.20 |- skos__annotation mesh__D029974
% 210.96/211.20 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D029974 2004
% 210.96/211.20 |- mesh__dateEstablished mesh__D029974 2002-01-01
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D029974 2006
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D029974 2003
% 210.96/211.20 |- rdf__type mesh__D029974sskos__Concept
% 210.96/211.20 |- mesh__dateRevised mesh__D029974 2002-07-02
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D029974 2005
% 210.96/211.20 |- mesh__publicMeSHNote mesh__D029974 2002
% 210.96/211.20 |- rdf__type mesh__D048330sskos__Concept
% 210.96/211.20 |- mesh__historyNote mesh__D048330 2005
% 210.96/211.20 |- skos__prefLabel mesh__D048330 Trichosurus
% 210.96/211.20 |- skos__hiddenLabel mesh__D048330 Brush-Tailed Possums
% 210.96/211.20 |- mesh__publicMeSHNote mesh__D048330 2005
% 210.96/211.20 |- mesh__recordMaintainer mesh__D048330 ags
% 210.96/211.20 |- skos__broader mesh__D048330smesh__D048329
% 210.96/211.20 |- skos__hiddenLabel mesh__D048330 Brush-Tailed Possum
% 210.96/211.20 |- skos__historyNote mesh__D048330 Marsupialia %28%1965-2004%29%
% 210.96/211.20 |- mesh__recordOriginator mesh__D048330 ags
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D048330 2006
% 210.96/211.20 |- skos__altLabel mesh__D048330 Possums, Brush-Tailed
% 210.96/211.20 |- skos__scopeNote mesh__D048330
% 210.96/211.20 A genus of brush-tailed possums found chiefly in Australia and New Zealand. Secretions from their ANAL GLAND function both in defense and demarcating territory.%A%
% 210.96/211.20 |- skos__hiddenLabel mesh__D048330 Possum, Brush-Tailed
% 210.96/211.20 |- skos__hiddenLabel mesh__D048330 Possums, Brush Tailed
% 210.96/211.20 |- mesh__dateEstablished mesh__D048330 2005-01-01
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D048330 2005
% 210.96/211.20 |- mesh__dateCreated mesh__D048330 2004-07-07
% 210.96/211.20 |- mesh__recordAuthorizer mesh__D048330 sjn
% 210.96/211.20 |- mesh__recordMaintainer mesh__D009917 ssb
% 210.96/211.20 |- skos__broader mesh__D009917smesh__D012887
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D009917 2006
% 210.96/211.20 |- skos__historyNote mesh__D009917 Fractures %28%1966-1982%29%
% 210.96/211.20 |- mesh__dateCreated mesh__D009917 1982-04-27
% 210.96/211.20 |- rdf__type mesh__D009917sskos__Concept
% 210.96/211.20 |- skos__broader mesh__D009917smesh__D008446
% 210.96/211.20 |- skos__hiddenLabel mesh__D009917 Orbital Fracture
% 210.96/211.20 |- mesh__dateRevised mesh__D009917 2005-06-30
% 210.96/211.20 |- skos__scopeNote mesh__D009917
% 210.96/211.20 Fractures of the bones in the orbit, which include parts of the frontal, ethmoidal, lacrimal, and sphenoid bones and the maxilla and zygoma.%A%
% 210.96/211.20 |- skos__hiddenLabel mesh__D009917 Blow-Out Fracture
% 210.96/211.20 |- mesh__recordOriginator mesh__D009917 RC
% 210.96/211.20 |- mesh__recordAuthorizer mesh__D009917 sjn
% 210.96/211.20 |- mesh__dateEstablished mesh__D009917 1991-01-01
% 210.96/211.20 |- mesh__publicMeSHNote mesh__D009917
% 210.96/211.20 91; was see under SKULL FRACTURES 1983-90
% 210.96/211.20 |- skos__hiddenLabel mesh__D009917 Blow Out Fractures
% 210.96/211.20 |- skos__hiddenLabel mesh__D009917 Fracture, Orbital
% 210.96/211.20 |- mesh__historyNote mesh__D009917
% 210.96/211.20 91%28%83%29%; was see under SKULL FRACTURES 1983-90
% 210.96/211.20 |- skos__hiddenLabel mesh__D009917 Fractures, Blow Out
% 210.96/211.20 |- skos__hiddenLabel mesh__D009917 Fracture, Blow-Out
% 210.96/211.20 |- skos__prefLabel mesh__D009917 Orbital Fractures
% 210.96/211.20 |- skos__annotation mesh__D009917
% 210.96/211.20 ZYGOMATIC FRACTURES %26% MAXILLARY FRACTURES are also available%A%
% 210.96/211.20 |- skos__historyNote mesh__D009917 Orbit %28%1966-1982%29%
% 210.96/211.20 |- skos__altLabel mesh__D009917 Fractures, Blow-Out
% 210.96/211.20 |- skos__historyNote mesh__D009917 Skull Fractures %28%1966-1982%29%
% 210.96/211.20 |- skos__hiddenLabel mesh__D009917 Fractures, Orbital
% 210.96/211.20 |- skos__hiddenLabel mesh__D001934 Branchial Cleft
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D001934 2003
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D001934 1992
% 210.96/211.20 |- skos__altLabel mesh__D001934 Visceral Arches
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D001934 2001
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D001934 2006
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D001934 1995
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D001934 1998
% 210.96/211.20 |- skos__hiddenLabel mesh__D001934 Arch, Pharyngeal
% 210.96/211.20 |- skos__annotation mesh__D001934
% 210.96/211.20 includes branchial arch %26% branchial cleft; branchial arch syndrome: index under BRANCHIAL REGION %28%IM%29% + SYNDROME %28%NIM%29%%A%
% 210.96/211.20 |- skos__hiddenLabel mesh__D001934 Arches, Pharyngeal
% 210.96/211.20 |- skos__prefLabel mesh__D001934 Branchial Region
% 210.96/211.20 |- skos__hiddenLabel mesh__D001934 Region, Branchial
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D001934 2000
% 210.96/211.20 |- skos__hiddenLabel mesh__D001934 Arches, Branchial
% 210.96/211.20 |- skos__hiddenLabel mesh__D001934 Pharyngeal Archs
% 210.96/211.20 |- mesh__activeMeSHYear mesh__D001934 2005
% 210.96/211.20 |- skos__hiddenLabel mesh__D001934 Clefts, Branchial
% 210.96/211.20 |- skos__altLabel mesh__D001934 Branchial Arches
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001934 1994
% 211.05/211.20 |- skos__scopeNote mesh__D001934
% 211.05/211.20 Region containing paired arched columns that bear gills in lower aquatic vertebrates and appear in the embryos of higher vertebrates in comparable form. In higher vertebrates the arches are subsequently modified into structures of the neck and ear.%A%
% 211.05/211.20 |- skos__hiddenLabel mesh__D001934 Arch, Visceral
% 211.05/211.20 |- skos__hiddenLabel mesh__D001934 Branchial Regions
% 211.05/211.20 |- mesh__dateRevised mesh__D001934 2005-07-30
% 211.05/211.20 |- skos__hiddenLabel mesh__D001934 Archs, Pharyngeal
% 211.05/211.20 |- skos__hiddenLabel mesh__D001934 Arch, Branchial
% 211.05/211.20 |- mesh__dateCreated mesh__D001934 1999-01-01
% 211.05/211.20 |- mesh__recordAuthorizer mesh__D001934 jls
% 211.05/211.20 |- mesh__recordOriginator mesh__D001934 NLM
% 211.05/211.20 |- skos__altLabel mesh__D001934 Visceral Arch
% 211.05/211.20 |- skos__hiddenLabel mesh__D001934 Arches, Visceral
% 211.05/211.20 |- skos__broader mesh__D001934smesh__D004622
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001934 1997
% 211.05/211.20 |- skos__hiddenLabel mesh__D001934 Cleft, Branchial
% 211.05/211.20 |- skos__altLabel mesh__D001934 Pharyngeal Arches
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001934 2006A
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001934 2004
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001934 1993
% 211.05/211.20 |- skos__hiddenLabel mesh__D001934 Regions, Branchial
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001934 1996
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001934 2002
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001934 1991
% 211.05/211.20 |- rdf__type mesh__D001934sskos__Concept
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001934 1999
% 211.05/211.20 |- mesh__recordMaintainer mesh__D001934 jls
% 211.05/211.20 |- skos__altLabel mesh__D001934 Pharyngeal Arch
% 211.05/211.20 |- mesh__recordOriginator mesh__D009119 NLM
% 211.05/211.20 |- skos__hiddenLabel mesh__D009119 Contractions, Muscle
% 211.05/211.20 |- skos__annotation mesh__D009119
% 211.05/211.20 do not use for HEART or MYOCARDIUM %28% = MYOCARDIAL CONTRACTION%29% or UTERUS %28% = UTERINE CONTRACTION%29%%A%
% 211.05/211.20 |- skos__hiddenLabel mesh__D009119 Contraction, Muscular
% 211.05/211.20 |- skos__altLabel mesh__D009119 Muscular Contraction
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D009119 2006
% 211.05/211.20 |- mesh__recordAuthorizer mesh__D009119 sjn
% 211.05/211.20 |- skos__prefLabel mesh__D009119 Muscle Contraction
% 211.05/211.20 |- skos__altLabel mesh__D009119 Muscular Tension
% 211.05/211.20 |- skos__broader mesh__D009119smesh__D043702
% 211.05/211.20 |- skos__hiddenLabel mesh__D009119 Tension, Muscular
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D009119 2005
% 211.05/211.20 |- mesh__dateCreated mesh__D009119 1999-01-01
% 211.05/211.20 |- skos__hiddenLabel mesh__D009119 Contractions, Muscular
% 211.05/211.20 |- skos__scopeNote mesh__D009119
% 211.05/211.20 A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.%A%
% 211.05/211.20 |- skos__related mesh__D009119smesh__D018763
% 211.05/211.20 |- skos__hiddenLabel mesh__D009119 Tension, Muscle
% 211.05/211.20 |- mesh__dateRevised mesh__D009119 2003-07-09
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D009119 2004
% 211.05/211.20 |- mesh__historyNote mesh__D009119 65%28%64%29%
% 211.05/211.20 |- mesh__recordMaintainer mesh__D009119 nns
% 211.05/211.20 |- mesh__dateEstablished mesh__D009119 1965-01-01
% 211.05/211.20 |- skos__hiddenLabel mesh__D009119 Contraction, Muscle
% 211.05/211.20 |- skos__hiddenLabel mesh__D009119 Muscular Contractions
% 211.05/211.20 |- mesh__publicMeSHNote mesh__D009119 65
% 211.05/211.20 |- skos__hiddenLabel mesh__D009119 Muscle Contractions
% 211.05/211.20 |- rdf__type mesh__D009119sskos__Concept
% 211.05/211.20 |- skos__related mesh__D009119smesh__D009126
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 1997
% 211.05/211.20 |- skos__annotation mesh__D001136
% 211.05/211.20 includes present and historical contexts
% 211.05/211.20 |- skos__broader mesh__D001136smesh__D017517
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 2003
% 211.05/211.20 |- skos__broader mesh__D001136smesh__D018436
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 2001
% 211.05/211.20 |- skos__broader mesh__D001136smesh__D014586
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 2006
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 1996
% 211.05/211.20 |- skos__scopeNote mesh__D001136
% 211.05/211.20 An ancient country in western Asia, by the twentieth century divided among the former USSR, Turkey, and Iran. It was attacked at various times from before the 7th century B.C. to 69 B.C. by Assyrians, Medes, Persians, the Greeks under Alexander, and the Romans. It changed hands frequently in wars between Neo-Persian and Roman Empires from the 3d to 7th centuries and later under Arabs, Seljuks, Byzantines, and Mongols. In the 19th century Armenian nationalism arose but suffered during Russo-Turkish hostilities. It became part of the Soviet Republic in 1921, with part remaining under Turkey. %28%Webster%27%s New Geographical Dictionary, 1988%29%%A%
% 211.05/211.20 |- mesh__recordOriginator mesh__D001136 NLM
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 1999
% 211.05/211.20 |- mesh__dateRevised mesh__D001136 1994-04-19
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 2000
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 2005
% 211.05/211.20 |- skos__altLabel mesh__D001136 Armenian SSR
% 211.05/211.20 |- rdf__type mesh__D001136sskos__Concept
% 211.05/211.20 |- mesh__onlineNote mesh__D001136
% 211.05/211.20 use ARMENIA to search ARMENIAN S.S.R 1982-92 %26% ARMENIAN SSR 1975-81%A%
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 1995
% 211.05/211.20 |- skos__altLabel mesh__D001136 Armenian S.S.R.
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 1998
% 211.05/211.20 |- skos__prefLabel mesh__D001136 Armenia
% 211.05/211.20 |- mesh__historyNote mesh__D001136
% 211.05/211.20 ARMENIAN S.S.R. was heading 1982-92; was ARMENIAN SSR 1975-81%A%
% 211.05/211.20 |- skos__broader mesh__D001136smesh__D014154
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 2002
% 211.05/211.20 |- mesh__dateCreated mesh__D001136 1999-01-01
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001136 2004
% 211.05/211.20 |- mesh__recordMaintainer mesh__D001136 PLS
% 211.05/211.20 |- mesh__recordAuthorizer mesh__D001136 PLS
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Cervical Pain, Anterior
% 211.05/211.20 |- skos__scopeNote mesh__D019547
% 211.05/211.20 Discomfort or more intense forms of pain that are localized to the cervical region. This term generally refers to pain in the posterior or lateral regions of the neck.%A%
% 211.05/211.20 |- mesh__recordMaintainer mesh__D019547 ags
% 211.05/211.20 |- mesh__recordAuthorizer mesh__D019547 ags
% 211.05/211.20 |- skos__prefLabel mesh__D019547 Neck Pain
% 211.05/211.20 |- mesh__dateEstablished mesh__D019547 1997-01-01
% 211.05/211.20 |- mesh__recordOriginator mesh__D019547 PXP
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pain, Anterior Neck
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Posterior Neck Pains
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Cervical Pains
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pain, Neck
% 211.05/211.20 |- skos__altLabel mesh__D019547 Cervicalgia
% 211.05/211.20 |- mesh__publicMeSHNote mesh__D019547 1997
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D019547 2003
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Ache, Neck
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Posterior Cervical Pains
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pain, Posterior Neck
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Cervical Pains, Posterior
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D019547 2002
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D019547 2000A
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pains, Anterior Neck
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D019547 2004
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pains, Posterior Cervical
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pain, Anterior Cervical
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D019547 2005
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Cervicodynias
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Cervicalgias
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Neck Aches
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Cervical Pain, Posterior
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pains, Anterior Cervical
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Anterior Neck Pains
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Aches, Neck
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Anterior Cervical Pains
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D019547 2006
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pain, Cervical
% 211.05/211.20 |- mesh__dateRevised mesh__D019547 1999-12-13
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pains, Posterior Neck
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Neck Pains, Anterior
% 211.05/211.20 |- rdf__type mesh__D019547sskos__Concept
% 211.05/211.20 |- skos__altLabel mesh__D019547 Neck Ache
% 211.05/211.20 |- skos__altLabel mesh__D019547 Cervical Pain
% 211.05/211.20 |- skos__historyNote mesh__D019547 Pain %28%1966-1996%29%
% 211.05/211.20 |- skos__altLabel mesh__D019547 Anterior Neck Pain
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Neck Pain, Posterior
% 211.05/211.20 |- mesh__historyNote mesh__D019547 1997
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pain, Posterior Cervical
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Cervical Pains, Anterior
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D019547 2000
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pains, Cervical
% 211.05/211.20 |- skos__altLabel mesh__D019547 Cervicodynia
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Neckaches
% 211.05/211.20 |- skos__altLabel mesh__D019547 Neckache
% 211.05/211.20 |- skos__broader mesh__D019547smesh__D010146
% 211.05/211.20 |- skos__historyNote mesh__D019547 Neck %28%1966-1996%29%
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Pains, Neck
% 211.05/211.20 |- mesh__dateCreated mesh__D019547 1996-06-10
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Neck Pain, Anterior
% 211.05/211.20 |- skos__altLabel mesh__D019547 Posterior Neck Pain
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Neck Pains, Posterior
% 211.05/211.20 |- skos__hiddenLabel mesh__D019547 Neck Pains
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D019547 2001
% 211.05/211.20 |- mesh__dateCreated mesh__D011564 1978-03-13
% 211.05/211.20 |- rdf__type mesh__D011564sskos__Concept
% 211.05/211.20 |- skos__broader mesh__D011564smesh__D006575
% 211.05/211.20 |- skos__scopeNote mesh__D011564
% 211.05/211.20 Linear furanocoumarins which are found in many PLANTS, especially UMBELLIFERAE and RUTACEAE, as well as PSORALEA from which they were originally discovered. They can intercalate DNA and, in an UV-initiated reaction of the furan portion, alkylate PYRIMIDINES, resulting in PHOTOSENSITIVITY DISORDERS.%A%
% 211.05/211.20 |- skos__related mesh__D011564smesh__D003374
% 211.05/211.20 |- skos__historyNote mesh__D011564 Furans %28%1966-1978%29%
% 211.05/211.20 |- mesh__recordMaintainer mesh__D011564 ssb
% 211.05/211.20 |- mesh__publicMeSHNote mesh__D011564
% 211.05/211.20 79; FICUSIN %26% TRIOXSALEN were see under COUMARINS 1975-78%A%
% 211.05/211.20 |- skos__prefLabel mesh__D011564 Psoralens
% 211.05/211.20 |- mesh__recordOriginator mesh__D011564 SH
% 211.05/211.20 |- mesh__dateEstablished mesh__D011564 1979-01-01
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D011564 2006
% 211.05/211.20 |- skos__historyNote mesh__D011564 Coumarins %28%1966-1978%29%
% 211.05/211.20 |- mesh__historyNote mesh__D011564 79
% 211.05/211.20 |- skos__altLabel mesh__D011564 Furanocoumarins
% 211.05/211.20 |- mesh__dateRevised mesh__D011564 2005-06-30
% 211.05/211.20 |- skos__broader mesh__D011564smesh__D005663
% 211.05/211.20 |- skos__broader mesh__D011564smesh__D003374
% 211.05/211.20 |- skos__annotation mesh__D011564
% 211.05/211.20 dermatol agents; do not confuse with the specific drug PSORALEN see FICUSIN; do not index here for psoralens in PUVA THERAPY unless particularly discussed%A%
% 211.05/211.20 |- mesh__recordAuthorizer mesh__D011564 sjn
% 211.05/211.20 |- mesh__onlineNote mesh__D005527
% 211.05/211.20 use FOOD, FORTIFIED to search FOODS, FORTIFIED 1970-72 %28%as Prov%29%%A%
% 211.05/211.20 |- mesh__recordOriginator mesh__D005527 NLM
% 211.05/211.20 |- skos__hiddenLabel mesh__D005527 Fortified Food
% 211.05/211.20 |- skos__altLabel mesh__D005527 Enriched Food
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D005527 1998
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D005527 2003
% 211.05/211.20 |- mesh__historyNote mesh__D005527
% 211.05/211.20 73; was FOODS, FORTIFIED 1970-72 %28%Prov%29%
% 211.05/211.20 |- skos__annotation mesh__D005527
% 211.05/211.20 coord IM with added nutrient if relevant %28%IM%29%; do not confuse with FOOD, FORMULATED or DIETARY SUPPLEMENTS: read MeSH definitions%A%
% 211.05/211.20 |- skos__hiddenLabel mesh__D005527 Enriched Foods
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D005527 2000
% 211.05/211.20 |- mesh__recordMaintainer mesh__D005527 JLS
% 211.05/211.20 |- mesh__dateEstablished mesh__D005527 1973-01-01
% 211.05/211.20 |- skos__prefLabel mesh__D005527 Food, Fortified
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D005527 2005
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D005527 1999
% 211.05/211.20 |- mesh__dateCreated mesh__D005527 1999-01-01
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D005527 2004
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D005527 2001
% 211.05/211.20 |- skos__hiddenLabel mesh__D005527 Fortified Foods
% 211.05/211.20 |- skos__hiddenLabel mesh__D005527 Foods, Enriched
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D005527 2006
% 211.05/211.20 |- skos__hiddenLabel mesh__D005527 Food, Enriched
% 211.05/211.20 |- skos__scopeNote mesh__D005527
% 211.05/211.20 Any food that has been supplemented with essential nutrients either in quantities that are greater than those present normally, or which are not present in the fortified food. The supplementation of cereals with iron and vitamins is an example of fortified food. Fortified food includes also enriched food to which various nutrients have been added to compensate for those essential nutrients removed by refinement or processing. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%
% 211.05/211.20 |- skos__historyNote mesh__D005527 Food %28%1966-1969%29%
% 211.05/211.20 |- skos__broader mesh__D005527smesh__D019648
% 211.05/211.20 |- mesh__dateRevised mesh__D005527 1997-06-20
% 211.05/211.20 |- mesh__publicMeSHNote mesh__D005527 73
% 211.05/211.20 |- skos__hiddenLabel mesh__D005527 Foods, Fortified
% 211.05/211.20 |- mesh__recordAuthorizer mesh__D005527 SJN
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D005527 2002
% 211.05/211.20 |- rdf__type mesh__D005527sskos__Concept
% 211.05/211.20 |- skos__broader mesh__D009918smesh__D012888
% 211.05/211.20 |- skos__related mesh__D009918smesh__D005134
% 211.05/211.20 |- mesh__recordOriginator mesh__D009918 NLM
% 211.05/211.20 |- skos__broader mesh__D009918smesh__D009916
% 211.05/211.20 |- skos__hiddenLabel mesh__D009918 Neoplasm, Orbital
% 211.05/211.20 |- skos__hiddenLabel mesh__D009918 Neoplasms, Orbital
% 211.05/211.20 |- mesh__dateCreated mesh__D009918 1999-01-01
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D009918 2001
% 211.05/211.20 |- skos__scopeNote mesh__D009918
% 211.05/211.20 Neoplasms of the bony orbit and contents except the eyeball.%A%
% 211.05/211.20 |- skos__prefLabel mesh__D009918 Orbital Neoplasms
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D009918 2003
% 211.05/211.20 |- mesh__dateRevised mesh__D009918 2000-06-22
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D009918 2005
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D009918 2004
% 211.05/211.20 |- skos__hiddenLabel mesh__D009918 Orbital Neoplasm
% 211.05/211.20 |- mesh__recordMaintainer mesh__D009918 KEV
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D009918 2002
% 211.05/211.20 |- skos__broader mesh__D009918smesh__D005134
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D009918 2006
% 211.05/211.20 |- rdf__type mesh__D009918sskos__Concept
% 211.05/211.20 |- mesh__recordAuthorizer mesh__D009918 sjn
% 211.05/211.20 |- skos__annotation mesh__D009918
% 211.05/211.20 neopl of bony cavity %26% its contents except eyeball %28% = EYE NEOPLASMS or specifics%29%; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%
% 211.05/211.20 |- skos__prefLabel mesh__D001935 Branchioma
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 2001
% 211.05/211.20 |- skos__altLabel mesh__D001935 Branchial Cleft Cyst
% 211.05/211.20 |- mesh__dateRevised mesh__D001935 1995-06-08
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 2002
% 211.05/211.20 |- rdf__type mesh__D001935sskos__Concept
% 211.05/211.20 |- skos__hiddenLabel mesh__D001935 Cleft Cysts, Branchial
% 211.05/211.20 |- skos__broader mesh__D001935smesh__D003560
% 211.05/211.20 |- skos__hiddenLabel mesh__D001935 Cyst, Branchial
% 211.05/211.20 |- mesh__recordAuthorizer mesh__D001935 PLS
% 211.05/211.20 |- mesh__recordOriginator mesh__D001935 NLM
% 211.05/211.20 |- skos__hiddenLabel mesh__D001935 Cleft Cyst, Branchial
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 2005
% 211.05/211.20 |- mesh__dateCreated mesh__D001935 1999-01-01
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 2003
% 211.05/211.20 |- skos__annotation mesh__D001935
% 211.05/211.20 neoplastic; includes branchial inclusion cyst, branchial chondroma, branchial fistula; /blood supply /chem /secret /ultrastruct permitted; coord IM with HEAD AND NECK NEOPLASMS %28%IM%29%%A%
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 1998
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 2006
% 211.05/211.20 |- skos__hiddenLabel mesh__D001935 Branchiomas
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 1996
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 2004
% 211.05/211.20 |- skos__hiddenLabel mesh__D001935 Branchial Cleft Cysts
% 211.05/211.20 |- skos__scopeNote mesh__D001935
% 211.05/211.20 A tumor derived from branchial epithelium or branchial rests. %28%Dorland, 27th ed%29%%A%
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 1999
% 211.05/211.20 |- skos__hiddenLabel mesh__D001935 Cysts, Branchial
% 211.05/211.20 |- skos__hiddenLabel mesh__D001935 Branchial Cysts
% 211.05/211.20 |- skos__hiddenLabel mesh__D001935 Cyst, Branchial Cleft
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 2000
% 211.05/211.20 |- mesh__activeMeSHYear mesh__D001935 1997
% 211.05/211.20 |- skos__hiddenLabel mesh__D001935 Cysts, Branchial Cleft
% 211.05/211.20 |- mesh__recordMaintainer mesh__D001935 KEV
% 211.05/211.20 |- skos__altLabel mesh__D001935 Branchial Cyst
% 211.05/211.20 |- skos__historyNote mesh__D006620 Femoral Fractures %28%1966-1977%29%
% 211.05/211.20 |- skos__hiddenLabel mesh__D006620 Fractures, Intertrochanteric
% 211.05/211.20 |- mesh__dateEstablished mesh__D006620 1978-01-01
% 211.05/211.20 |- mesh__dateRevised mesh__D006620 2005-07-14
% 211.05/211.20 |- rdf__type mesh__D006620sskos__Concept
% 211.07/211.20 |- mesh__recordMaintainer mesh__D006620 ags
% 211.07/211.20 |- skos__broader mesh__D006620smesh__D005264
% 211.07/211.20 |- skos__hiddenLabel mesh__D006620 Fractures, Subtrochanteric
% 211.07/211.20 |- mesh__recordOriginator mesh__D006620 AEP
% 211.07/211.20 |- mesh__publicMeSHNote mesh__D006620 78
% 211.07/211.20 |- mesh__activeMeSHYear mesh__D006620 2006
% 211.07/211.20 |- mesh__dateCreated mesh__D006620 1977-05-04
% 211.07/211.20 |- skos__hiddenLabel mesh__D006620 Fractures, Trochanteric
% 211.07/211.20 |- skos__scopeNote mesh__D006620
% 211.07/211.20 Fractures of the FEMUR HEAD; the FEMUR NECK; %28%FEMORAL NECK FRACTURES%29%; the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region %28%FEMORAL FRACTURES%29%.%A%
% 211.07/211.20 |- mesh__recordAuthorizer mesh__D006620 ags
% 211.07/211.20 |- mesh__historyNote mesh__D006620 78
% 211.07/211.20 |- skos__hiddenLabel mesh__D006620 Fractures, Hip
% 211.07/211.20 |- skos__broader mesh__D006620smesh__D050723
% 211.07/211.20 |- skos__prefLabel mesh__D006620 Hip Fractures
% 211.07/211.20 |- skos__annotation mesh__D006620
% 211.07/211.20 GEN or unspecified; note X refs: fract below subtrochant = FEMORAL FRACTURES; FEMORAL NECK FRACTURES is available; femur head fract = FEMUR HEAD /inj %28%IM%29% + HIP FRACTURES %28%IM%29%; acetabular fract = ACETABULUM /inj %28%IM%29% + FRACTURES, BONE %28%IM%29%%A%
% 211.07/211.20 |- mesh__activeMeSHYear mesh__D006620 2006B
% 211.07/211.20 |- skos__historyNote mesh__D006620 Fractures %28%1966-1977%29%
% 211.07/211.20 |- skos__broader mesh__D006620smesh__D025981
% 211.07/211.20 |- mesh__activeMeSHYear mesh__D006620 2006A
% 211.07/211.20 |- mesh__activeMeSHYear mesh__D019548 1999
% 211.07/211.20 |- mesh__activeMeSHYear mesh__D019548 2002
% 211.07/211.20 |- mesh__activeMeSHYear mesh__D019548 1998
% 211.07/211.20 |- skos__hiddenLabel mesh__D019548 Victims, Crime
% 211.07/211.20 |- mesh__activeMeSHYear mesh__D019548 2006
% 211.07/211.20 |- mesh__dateCreated mesh__D019548 1996-06-13
% 211.07/211.20 |- skos__annotation mesh__D019548
% 211.07/211.20 coord IM with specific crime if pertinent %28%IM%29%
% 211.07/211.20 |- skos__broader mesh__D019548smesh__D009272
% 211.07/211.20 |- skos__scopeNote mesh__D019548
% 211.07/211.20 Individuals subjected to and adversely affected by criminal activity. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A%
% 211.07/211.20 |- skos__historyNote mesh__D019548 Crime %28%1986-1996%29%
% 211.07/211.20 |- mesh__activeMeSHYear mesh__D019548 2004
% 211.07/211.20 |- mesh__activeMeSHYear mesh__D019548 2005
% 211.07/211.20 |- skos__hiddenLabel mesh__D019548 Crime Victim
% 211.07/211.21 |- skos__prefLabel mesh__D019548 Crime Victims
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D019548 2001
% 211.07/211.21 |- mesh__recordOriginator mesh__D019548 JLS
% 211.07/211.21 |- mesh__historyNote mesh__D019548 97
% 211.07/211.21 |- mesh__dateEstablished mesh__D019548 1997-01-01
% 211.07/211.21 |- rdf__type mesh__D019548sskos__Concept
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D019548 2003
% 211.07/211.21 |- skos__hiddenLabel mesh__D019548 Victim, Crime
% 211.07/211.21 |- mesh__dateRevised mesh__D019548 1997-06-20
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D019548 97
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D019548 2000
% 211.07/211.21 |- skos__related mesh__D019548smesh__D014754
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D019548 SJN
% 211.07/211.21 |- mesh__recordMaintainer mesh__D019548 JLS
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011565 2004
% 211.07/211.21 |- mesh__dateRevised mesh__D011565 1997-06-20
% 211.07/211.21 |- skos__altLabel mesh__D011565 Palmoplantaris Pustulosis
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011565 2003
% 211.07/211.21 |- skos__hiddenLabel mesh__D011565 Psoriases
% 211.07/211.21 |- skos__altLabel mesh__D011565 Pustulosis Palmaris et Plantaris
% 211.07/211.21 |- skos__prefLabel mesh__D011565 Psoriasis
% 211.07/211.21 |- skos__scopeNote mesh__D011565
% 211.07/211.21 A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.%A%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011565 2002
% 211.07/211.21 |- mesh__dateCreated mesh__D011565 1999-01-01
% 211.07/211.21 |- mesh__recordOriginator mesh__D011565 NLM
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011565 2006
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011565 2001
% 211.07/211.21 |- skos__annotation mesh__D011565
% 211.07/211.21 a papulosquamous skin dis; ARTHRITIS, PSORIATIC is also available%A%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011565 1999
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011565 2005
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011565 2000
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D011565 SJN
% 211.07/211.21 |- skos__altLabel mesh__D011565 Pustular Psoriasis of Palms and Soles
% 211.07/211.21 |- rdf__type mesh__D011565sskos__Concept
% 211.07/211.21 |- mesh__recordMaintainer mesh__D011565 TGC
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011565 1998
% 211.07/211.21 |- skos__broader mesh__D011565smesh__D017444
% 211.07/211.21 |- skos__historyNote mesh__D038702 Glycoproteins %28%2001-2002%29%
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D038702 sjn
% 211.07/211.21 |- skos__altLabel mesh__D038702 Follistatin-Related Protein 1
% 211.07/211.21 |- skos__altLabel mesh__D038702 FSTL3 Gene Product
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D038702 2003
% 211.07/211.21 |- mesh__dateCreated mesh__D038702 2002-07-03
% 211.07/211.21 |- skos__hiddenLabel mesh__D038702 Follistatin Related Protein 1
% 211.07/211.21 |- skos__hiddenLabel mesh__D038702 Follistatin Like Secreted Glycoprotein
% 211.07/211.21 |- rdf__type mesh__D038702sskos__Concept
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D038702 2006
% 211.07/211.21 |- skos__scopeNote mesh__D038702
% 211.07/211.21 Broadly distributed glycoproteins that are homologous to the activin-binding protein, FOLLISTATIN. These follistatin-related proteins are encoded by a number of genes.%A%
% 211.07/211.21 |- mesh__historyNote mesh__D038702 2003
% 211.07/211.21 |- mesh__dateEstablished mesh__D038702 2003-01-01
% 211.07/211.21 |- skos__hiddenLabel mesh__D038702 Follistatin Like Protein 3
% 211.07/211.21 |- mesh__dateRevised mesh__D038702 2005-06-30
% 211.07/211.21 |- skos__broader mesh__D038702smesh__D002352
% 211.07/211.21 |- skos__hiddenLabel mesh__D038702 Follistatin Related Proteins
% 211.07/211.21 |- skos__altLabel mesh__D038702 FLRG Protein
% 211.07/211.21 |- skos__prefLabel mesh__D038702 Follistatin-Related Proteins
% 211.07/211.21 |- skos__historyNote mesh__D038702 Activins %28%1994-2002%29%
% 211.07/211.21 |- skos__altLabel mesh__D038702 Follistatin Secreted Related Protein
% 211.07/211.21 |- skos__hiddenLabel mesh__D038702 Follistatin Like Protein 1
% 211.07/211.21 |- mesh__recordOriginator mesh__D038702 lkt
% 211.07/211.21 |- skos__altLabel mesh__D038702 FSTL1 Gene Product
% 211.07/211.21 |- skos__altLabel mesh__D038702 Follistatin-Like Secreted Glycoprotein
% 211.07/211.21 |- skos__annotation mesh__D038702 note species-specific terms in SCR
% 211.07/211.21 |- mesh__recordMaintainer mesh__D038702 SYSTEM
% 211.07/211.21 |- skos__annotation mesh__D005528
% 211.07/211.21 vertebrates only: for invertebrates use EXTREMITIES: dis of foot = FOOT DISEASES; skin dis on foot = FOOT DERMATOSES: see note there; neopl of foot: use neopl coords %28%IM%29% + FOOT DISEASES %28%IM%29%; foot prints %28%like finger prints%29% = PLANTAR PRINTS see DERMATOGLYPHICS%A%
% 211.07/211.21 |- rdf__type mesh__D005528sskos__Concept
% 211.07/211.21 |- mesh__recordMaintainer mesh__D005528 ags
% 211.07/211.21 |- mesh__dateRevised mesh__D005528 2002-07-03
% 211.07/211.21 |- skos__prefLabel mesh__D005528 Foot
% 211.07/211.21 |- skos__scopeNote mesh__D005528
% 211.07/211.21 The distal extremity of the leg in vertebrates, consisting of the tarsus %28%ANKLE%29%, METATARSUS, phalanges, and the soft tissues surrounding these bones.%A%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D005528 2004
% 211.07/211.21 |- mesh__recordOriginator mesh__D005528 NLM
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D005528 2003
% 211.07/211.21 |- skos__altLabel mesh__D005528 Feet
% 211.07/211.21 |- mesh__dateCreated mesh__D005528 1999-01-01
% 211.07/211.21 |- skos__related mesh__D005528smesh__D005529
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D005528 sjn
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D005528 2006
% 211.07/211.21 |- skos__broader mesh__D005528smesh__D035002
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D005528 2005
% 211.07/211.21 |- skos__broader mesh__D001854Q000637smesh__D001854
% 211.07/211.21 |- mesh__preferredCombination mesh__D001854Q000637smesh__D016026
% 211.07/211.21 |- rdf__type mesh__D001854Q000637smesh__CompoundConcept
% 211.07/211.21 |- skos__scopeNote mesh__D016250
% 211.07/211.21 Computer disks storing data with a maximum reduction of space and bandwidth. The compact size reduces cost of transmission and storage.%A%
% 211.07/211.21 |- mesh__dateRevised mesh__D016250 2004-07-07
% 211.07/211.21 |- skos__hiddenLabel mesh__D016250 Compact Disc
% 211.07/211.21 |- skos__hiddenLabel mesh__D016250 Disks, Compact
% 211.07/211.21 |- skos__hiddenLabel mesh__D016250 Discs, Compact
% 211.07/211.21 |- skos__hiddenLabel mesh__D016250 Disc, Compact
% 211.07/211.21 |- mesh__dateCreated mesh__D016250 1990-05-07
% 211.07/211.21 |- skos__hiddenLabel mesh__D016250 Disk, Compact
% 211.07/211.21 |- skos__hiddenLabel mesh__D016250 Compact Disk
% 211.07/211.21 |- mesh__dateEstablished mesh__D016250 1991-01-01
% 211.07/211.21 |- skos__broader mesh__D016250smesh__D014742
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D016250 2006
% 211.07/211.21 |- mesh__recordOriginator mesh__D016250 TGC
% 211.07/211.21 |- skos__annotation mesh__D016250
% 211.07/211.21 do not use /util except by MeSH definition
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D016250 sjn
% 211.07/211.21 |- skos__altLabel mesh__D016250 Compact Discs
% 211.07/211.21 |- mesh__recordMaintainer mesh__D016250 jls
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D016250 91
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D016250 2005
% 211.07/211.21 |- skos__prefLabel mesh__D016250 Compact Disks
% 211.07/211.21 |- skos__broader mesh__D016250smesh__D016249
% 211.07/211.21 |- rdf__type mesh__D016250sskos__Concept
% 211.07/211.21 |- mesh__historyNote mesh__D016250 91
% 211.07/211.21 |- skos__prefLabel mesh__D002230 Carbidopa
% 211.07/211.21 |- mesh__recordMaintainer mesh__D002230 jmp
% 211.07/211.21 |- skos__historyNote mesh__D002230 Methyldopa %28%1972-1974%29%
% 211.07/211.21 |- skos__hiddenLabel mesh__D002230 MK485
% 211.07/211.21 |- mesh__onlineNote mesh__D002230
% 211.07/211.21 use CARBIDOPA to search METHYLDOPAHYDRAZINE 1973-79 %28%as Prov 1973-74%29%%A%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D002230 2004
% 211.07/211.21 |- skos__altLabel mesh__D002230 Lodosyn
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D002230 sjn
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D002230 2006
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D002230
% 211.07/211.21 80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79
% 211.07/211.21 |- skos__broader mesh__D002230smesh__D008750
% 211.07/211.21 |- skos__hiddenLabel mesh__D002230 MK486
% 211.07/211.21 |- skos__altLabel mesh__D002230 Methyldopahydrazine
% 211.07/211.21 |- skos__hiddenLabel mesh__D002230 MK 485
% 211.07/211.21 |- mesh__recordOriginator mesh__D002230 NLM
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D002230 2003
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D002230 2005
% 211.07/211.21 |- skos__hiddenLabel mesh__D002230 MK 486
% 211.07/211.21 |- skos__broader mesh__D002230smesh__D006834
% 211.07/211.21 |- skos__historyNote mesh__D002230 Hydrazines %28%1972-1974%29%
% 211.07/211.21 |- mesh__dateEstablished mesh__D002230 1980-01-01
% 211.07/211.21 |- mesh__historyNote mesh__D002230
% 211.07/211.21 80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79; was METHYLDOPAHYDRAZINE 1973-74 %28%Prov%29%%A%
% 211.07/211.21 |- mesh__dateRevised mesh__D002230 2001-07-25
% 211.07/211.21 |- rdf__type mesh__D002230sskos__Concept
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D002230 2002
% 211.07/211.21 |- skos__scopeNote mesh__D002230
% 211.07/211.21 An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.%A%
% 211.07/211.21 |- mesh__dateCreated mesh__D002230 1999-01-01
% 211.07/211.21 |- skos__historyNote mesh__D002230 Dopa %28%1972-1974%29%
% 211.07/211.21 |- skos__historyNote mesh__D015956 Serine Proteinases %28%1988-1989%29%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D015956 2006
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D015956 sjn
% 211.07/211.21 |- skos__historyNote mesh__D015956 Peptide Fragments %28%1979-1987%29%
% 211.07/211.21 |- skos__altLabel mesh__D015956 Activated Factor XII
% 211.07/211.21 |- rdf__type mesh__D015956sskos__Concept
% 211.07/211.21 |- skos__altLabel mesh__D015956 Factor XII, Activated
% 211.07/211.21 |- mesh__dateEstablished mesh__D015956 1990-01-01
% 211.07/211.21 |- skos__historyNote mesh__D015956 Factor XII %28%1966-1989%29%
% 211.07/211.21 |- skos__hiddenLabel mesh__D015956 Fragments, Hageman-Factor
% 211.07/211.21 |- skos__annotation mesh__D015956 /defic = FACTOR XII DEFICIENCY
% 211.07/211.21 |- mesh__recordOriginator mesh__D015956 AGS
% 211.07/211.21 |- mesh__recordMaintainer mesh__D015956 ssb
% 211.07/211.21 |- skos__scopeNote mesh__D015956
% 211.07/211.21 Activated form of factor XII. In the initial event in the intrinsic pathway of blood coagulation, kallikrein %28%with cofactor HIGH MOLECULAR WEIGHT KININOGEN%29% cleaves factor XII to XIIa. Factor XIIa is then further cleaved by kallikrein, plasmin, and trypsin to yield smaller factor XII fragments %28%Hageman-Factor fragments%29%. These fragments increase the activity of prekallikrein to kallikrein but decrease the procoagulant activity of factor XII.%A%
% 211.07/211.21 |- skos__broader mesh__D015956smesh__D005174
% 211.07/211.21 |- skos__hiddenLabel mesh__D015956 XIIa, Coagulation Factor
% 211.07/211.21 |- skos__altLabel mesh__D015956 Coagulation Factor XIIa
% 211.07/211.21 |- skos__prefLabel mesh__D015956 Factor XIIa
% 211.07/211.21 |- skos__broader mesh__D015956smesh__D012697
% 211.07/211.21 |- mesh__historyNote mesh__D015956 90
% 211.07/211.21 |- skos__altLabel mesh__D015956 Prekallikrein Activator
% 211.07/211.21 |- mesh__dateRevised mesh__D015956 2005-06-30
% 211.07/211.21 |- skos__hiddenLabel mesh__D015956 Hageman Factor Fragments
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D015956 90
% 211.07/211.21 |- skos__hiddenLabel mesh__D015956 Activator, Prekallikrein
% 211.07/211.21 |- skos__related mesh__D015956smesh__D003029
% 211.07/211.21 |- skos__altLabel mesh__D015956 Blood Coagulation Factor XII, Activated
% 211.07/211.21 |- skos__hiddenLabel mesh__D015956 Factor XIIa, Coagulation
% 211.07/211.21 |- mesh__dateCreated mesh__D015956 1989-05-25
% 211.07/211.21 |- mesh__dateEstablished mesh__D009919 1986-01-01
% 211.07/211.21 |- skos__hiddenLabel mesh__D009919 Male Castrations
% 211.07/211.21 |- skos__hiddenLabel mesh__D009919 Orchidectomies
% 211.07/211.21 |- skos__hiddenLabel mesh__D009919 Male Castration
% 211.07/211.21 |- skos__broader mesh__D009919smesh__D013521
% 211.07/211.21 |- skos__hiddenLabel mesh__D009919 Castrations, Male
% 211.07/211.21 |- skos__historyNote mesh__D009919 Castration %28%1966-1985%29%
% 211.07/211.21 |- mesh__recordMaintainer mesh__D009919 sjn
% 211.07/211.21 |- skos__prefLabel mesh__D009919 Orchiectomy
% 211.07/211.21 |- skos__altLabel mesh__D009919 Orchidectomy
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D009919 2004
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D009919 2005
% 211.07/211.21 |- skos__scopeNote mesh__D009919
% 211.07/211.21 The surgical removal of one or both testicles.
% 211.07/211.21 |- skos__annotation mesh__D009919
% 211.07/211.21 do not use /util except by MeSH definition; check tags MALE %26% ANIMALS or HUMAN%A%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D009919 2006
% 211.07/211.21 |- mesh__recordOriginator mesh__D009919 SH
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D009919 86
% 211.07/211.21 |- mesh__dateRevised mesh__D009919 2003-07-30
% 211.07/211.21 |- mesh__historyNote mesh__D009919 86
% 211.07/211.21 |- rdf__type mesh__D009919sskos__Concept
% 211.07/211.21 |- mesh__dateCreated mesh__D009919 1985-06-06
% 211.07/211.21 |- skos__broader mesh__D009919smesh__D002369
% 211.07/211.21 |- skos__hiddenLabel mesh__D009919 Orchiectomies
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D009919 sjn
% 211.07/211.21 |- skos__historyNote mesh__D001936 Neisseria %28%1975-1987%29%
% 211.07/211.21 |- mesh__dateCreated mesh__D001936 1987-05-07
% 211.07/211.21 |- skos__broader mesh__D001936smesh__D009016
% 211.07/211.21 |- skos__historyNote mesh__D001936 Moraxella %28%1983-1987%29%
% 211.07/211.21 |- skos__historyNote mesh__D001936 Neisseriaceae %28%1975-1987%29%
% 211.07/211.21 |- mesh__dateRevised mesh__D001936 2005-07-19
% 211.07/211.21 |- mesh__historyNote mesh__D001936
% 211.07/211.21 92; was BRANHAMELLA CATARRHALIS 1988-91; MORAXELLA %28%BRANHAMELLA%29% CATARRHALIS was see BRANHAMELLA CATARRHALIS 1988-91%A%
% 211.07/211.21 |- mesh__onlineNote mesh__D001936
% 211.07/211.21 use MORAXELLA %28%BRANHAMELLA%29% CATARRHALIS to search BRANHAMELLA CATARRHALIS 1988-91%A%
% 211.07/211.21 |- skos__altLabel mesh__D001936 Branhamella catarrhalis
% 211.07/211.21 |- skos__altLabel mesh__D001936 Moraxella catarrhalis
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D001936 ags
% 211.07/211.21 |- rdf__type mesh__D001936sskos__Concept
% 211.07/211.21 |- mesh__recordOriginator mesh__D001936 SCD
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D001936
% 211.07/211.21 92; was BRANHAMELLA CATARRHALIS 1988-91; MORAXELLA %28%BRANHAMELLA%29% CATARRHALIS was see BRANHAMELLA CATARRHALIS 1988-91%A%
% 211.07/211.21 |- skos__scopeNote mesh__D001936
% 211.07/211.21 Gram-negative aerobic cocci of low virulence that colonize the nasopharynx and occasionally cause MENINGITIS; BACTEREMIA; EMPYEMA; PERICARDITIS; and PNEUMONIA.%A%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001936 2006
% 211.07/211.21 |- skos__annotation mesh__D001936
% 211.07/211.21 infection: coord IM with MORAXELLACEAE INFECTIONS %28%IM%29%
% 211.07/211.21 |- mesh__recordMaintainer mesh__D001936 ags
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001936 2006A
% 211.07/211.21 |- mesh__dateEstablished mesh__D001936 1988-01-01
% 211.07/211.21 |- skos__prefLabel mesh__D001936 Moraxella %28%Branhamella%29% catarrhalis
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001138 2006
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001138 2002
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001138 2005
% 211.07/211.21 |- mesh__recordMaintainer mesh__D001138 CCR
% 211.07/211.21 |- mesh__dateCreated mesh__D001138 1978-05-17
% 211.07/211.21 |- skos__altLabel mesh__D001138 Ethyl-p-Nitrophenyl Ethylphosphonate
% 211.07/211.21 |- skos__broader mesh__D001138smesh__D009943
% 211.07/211.21 |- skos__historyNote mesh__D001138
% 211.07/211.21 Cholinesterase Inhibitors %28%1966-1978%29%
% 211.07/211.21 |- skos__altLabel mesh__D001138 Armine
% 211.07/211.21 |- mesh__historyNote mesh__D001138
% 211.07/211.21 91%28%79%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90
% 211.07/211.21 |- skos__scopeNote mesh__D001138
% 211.07/211.21 A reversible organophosphorus cholinesterase inhibitor. It also affects the presynaptic membrane and inhibits membrane postsynaptic cholinergic receptors. The compound had former use as a miotic.%A%
% 211.07/211.21 |- mesh__recordOriginator mesh__D001138 RLS
% 211.07/211.21 |- skos__prefLabel mesh__D001138 Armin
% 211.07/211.21 |- mesh__dateEstablished mesh__D001138 1991-01-01
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001138 2001
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D001138
% 211.07/211.21 91; was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D001138 sjn
% 211.07/211.21 |- skos__historyNote mesh__D001138
% 211.07/211.21 Organophosphorus Compounds %28%1971-1978%29%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001138 2004
% 211.07/211.21 |- mesh__dateRevised mesh__D001138 2000-06-21
% 211.07/211.21 |- skos__historyNote mesh__D001138 Nitrobenzenes %28%1966-1978%29%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001138 2003
% 211.07/211.21 |- rdf__type mesh__D001138sskos__Concept
% 211.07/211.21 |- mesh__dateRevised mesh__D006621 2002-07-03
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D006621 2004
% 211.07/211.21 |- mesh__historyNote mesh__D006621 65
% 211.07/211.21 |- mesh__recordOriginator mesh__D006621 NLM
% 211.07/211.21 |- skos__hiddenLabel mesh__D006621 Joint, Hip
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D006621 2006
% 211.07/211.21 |- skos__broader mesh__D006621smesh__D007596
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D006621 2003
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D006621 2005
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D006621 sjn
% 211.07/211.21 |- mesh__dateCreated mesh__D006621 1999-01-01
% 211.07/211.21 |- skos__prefLabel mesh__D006621 Hip Joint
% 211.07/211.21 |- mesh__recordMaintainer mesh__D006621 ssb
% 211.07/211.21 |- skos__hiddenLabel mesh__D006621 Joints, Hip
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D006621 65
% 211.07/211.21 |- rdf__type mesh__D006621sskos__Concept
% 211.07/211.21 |- mesh__dateEstablished mesh__D006621 1965-01-01
% 211.07/211.21 |- skos__hiddenLabel mesh__D006621 Hip Joints
% 211.07/211.21 |- skos__annotation mesh__D006621
% 211.07/211.21 /inj is probably HIP DISLOCATION or HIP FRACTURES, otherwise coord IM with HIP INJURIES %28%IM%29%; differentiate from HIP%A%
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Attendant, Psychiatric Ward
% 211.07/211.21 |- mesh__dateEstablished mesh__D011566 1971-01-01
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Psychiatric Aide
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Orderlies, Psychiatric Hospital
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011566 2000
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D011566 SJN
% 211.07/211.21 |- mesh__historyNote mesh__D011566 71
% 211.07/211.21 |- skos__historyNote mesh__D011566 Health Manpower %28%1968-1970%29%
% 211.07/211.21 |- skos__prefLabel mesh__D011566 Psychiatric Aides
% 211.07/211.21 |- skos__annotation mesh__D011566
% 211.07/211.21 coord IM with HOSPITALS, PSYCHIATRIC or PSYCHIATRIC DEPARTMENT, HOSPITAL %28%IM or NIM%29% if pertinent%A%
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D011566 71
% 211.07/211.21 |- mesh__dateRevised mesh__D011566 1997-06-20
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Ward Attendant, Psychiatric
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Hospital Orderlies, Psychiatric
% 211.07/211.21 |- mesh__dateCreated mesh__D011566 1999-01-01
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Orderly, Psychiatric Hospital
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011566 2006
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Psychiatric Hospital Orderly
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Psychiatric Ward Attendant
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011566 1999
% 211.07/211.21 |- skos__broader mesh__D011566smesh__D009728
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Aides, Psychiatric
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011566 2005
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Attendants, Psychiatric Ward
% 211.07/211.21 |- rdf__type mesh__D011566sskos__Concept
% 211.07/211.21 |- skos__scopeNote mesh__D011566
% 211.07/211.21 Persons who assist in the routine care of psychiatric persons, usually under the supervision of the nursing department.%A%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011566 2002
% 211.07/211.21 |- mesh__recordMaintainer mesh__D011566 TGC
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011566 1998
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Aide, Psychiatric
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011566 2004
% 211.07/211.21 |- skos__historyNote mesh__D011566 Psychiatry %28%1968-1970%29%
% 211.07/211.21 |- mesh__recordOriginator mesh__D011566 NLM
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Ward Attendants, Psychiatric
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011566 2001
% 211.07/211.21 |- skos__hiddenLabel mesh__D011566 Hospital Orderly, Psychiatric
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D011566 2003
% 211.07/211.21 |- rdf__type mesh__D005529sskos__Concept
% 211.07/211.21 |- skos__hiddenLabel mesh__D005529 Feet Bone
% 211.07/211.21 |- skos__hiddenLabel mesh__D005529 Foot Bone
% 211.07/211.21 |- mesh__recordMaintainer mesh__D005529 ags
% 211.07/211.21 |- skos__scopeNote mesh__D005529
% 211.07/211.21 The TARSAL BONES; METATARSAL BONES; and PHALANGES OF TOES. The tarsal bones consists of seven bones: CALCANEUS; TALUS; cuboid; navicular; internal; middle; and external cuneiform bones. The five metatarsal bones are numbered one through five, running medial to lateral. There are 14 phalanges in each foot, the great toe has two while the other toes have three each.%A%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D005529 2006A
% 211.07/211.21 |- mesh__recordOriginator mesh__D005529 EC
% 211.07/211.21 |- skos__hiddenLabel mesh__D005529 Feet Bones
% 211.07/211.21 |- skos__broader mesh__D005529smesh__D050281
% 211.07/211.21 |- skos__prefLabel mesh__D005529 Foot Bones
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D005529 ags
% 211.07/211.21 |- skos__historyNote mesh__D005529 specific bones of foot %28%1966-1997%29%
% 211.07/211.21 |- skos__hiddenLabel mesh__D005529 Bone, Foot
% 211.07/211.21 |- skos__hiddenLabel mesh__D005529 Bones, Foot
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D005529 2006
% 211.07/211.21 |- mesh__dateRevised mesh__D005529 2005-08-02
% 211.07/211.21 |- mesh__dateCreated mesh__D005529 1987-04-02
% 211.07/211.21 |- skos__historyNote mesh__D005529 Foot %28%1966-1997%29%
% 211.07/211.21 |- skos__altLabel mesh__D005529 Bones of Foot
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D005529 2006B
% 211.07/211.21 |- mesh__dateEstablished mesh__D005529 1998-01-01
% 211.07/211.21 |- skos__related mesh__D005529smesh__D005528
% 211.07/211.21 |- skos__annotation mesh__D005529
% 211.07/211.21 general or unspecified; prefer specifics; permitted with all vertebrates; Manual 21.58%A%
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D005529 98
% 211.07/211.21 |- mesh__historyNote mesh__D005529 98; use explode 1988-97
% 211.07/211.21 |- skos__altLabel mesh__D005529 Bones of Feet
% 211.07/211.21 |- mesh__dateEstablished mesh__D016251 1991-01-01
% 211.07/211.21 |- mesh__recordOriginator mesh__D016251 TGC
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D016251 sjn
% 211.07/211.21 |- skos__altLabel mesh__D016251 Compact Disk Read-Only Memory
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D016251 91
% 211.07/211.21 |- skos__hiddenLabel mesh__D016251 Compact Disk Read Only Memory
% 211.07/211.21 |- skos__broader mesh__D016251smesh__D016250
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D016251 2005
% 211.07/211.21 |- skos__prefLabel mesh__D016251 CD-ROM
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D016251 2006
% 211.07/211.21 |- skos__annotation mesh__D016251
% 211.07/211.21 a type of compact disk; X ref explains acronym; do not use /util except by MeSH definition%A%
% 211.07/211.21 |- mesh__dateRevised mesh__D016251 2004-07-07
% 211.07/211.21 |- skos__scopeNote mesh__D016251
% 211.07/211.21 An optical disk storage system for computers on which data can be read or from which data can be retrieved but not entered or modified. A CD-ROM unit is almost identical to the compact disk playback device for home use.%A%
% 211.07/211.21 |- mesh__recordMaintainer mesh__D016251 jls
% 211.07/211.21 |- rdf__type mesh__D016251sskos__Concept
% 211.07/211.21 |- mesh__dateCreated mesh__D016251 1990-06-11
% 211.07/211.21 |- mesh__historyNote mesh__D016251 91
% 211.07/211.21 |- skos__altLabel mesh__D016251 CDROM
% 211.07/211.21 |- skos__broader mesh__D006632Q000557smesh__D006632
% 211.07/211.21 |- mesh__preferredCombination mesh__D006632Q000557smesh__D006636
% 211.07/211.21 |- rdf__type mesh__D006632Q000557smesh__CompoundConcept
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D002231 2006
% 211.07/211.21 |- skos__altLabel mesh__D002231 Sanofi Synthelabo Brand of Carbimazole
% 211.07/211.21 |- skos__prefLabel mesh__D002231 Carbimazole
% 211.07/211.21 |- mesh__historyNote mesh__D002231 73%28%68%29%
% 211.07/211.21 |- mesh__recordMaintainer mesh__D002231 lkw
% 211.07/211.21 |- skos__scopeNote mesh__D002231
% 211.07/211.21 An imidazole antithyroid agent. Carbimazole is metabolized to METHIMAZOLE, which is responsible for the antithyroid activity.%A%
% 211.07/211.21 |- skos__historyNote mesh__D002231 Thyroid Antagonists %28%1966-1967%29%
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D002231 73
% 211.07/211.21 |- mesh__dateEstablished mesh__D002231 1973-01-01
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D002231 sjn
% 211.07/211.21 |- skos__broader mesh__D002231smesh__D007093
% 211.07/211.21 |- rdf__type mesh__D002231sskos__Concept
% 211.07/211.21 |- mesh__recordOriginator mesh__D002231 NLM
% 211.07/211.21 |- skos__altLabel mesh__D002231 Neo-Mercazole
% 211.07/211.21 |- skos__altLabel mesh__D002231 Roche Brand of Carbimazole
% 211.07/211.21 |- skos__altLabel mesh__D002231 Tarbis Brand of Carbimazole
% 211.07/211.21 |- skos__altLabel mesh__D002231 Herbrand Brand of Carbimazole
% 211.07/211.21 |- mesh__dateCreated mesh__D002231 1999-01-01
% 211.07/211.21 |- skos__historyNote mesh__D002231 Imidazoles %28%1966-1967%29%
% 211.07/211.21 |- skos__altLabel mesh__D002231 Henning Berlin Brand of Carbimazole
% 211.07/211.21 |- mesh__dateRevised mesh__D002231 2005-06-30
% 211.07/211.21 |- skos__historyNote mesh__D001937 Plants %28%1966-1977%29%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001937 2006A
% 211.07/211.21 |- mesh__recordAuthorizer mesh__D001937 ags
% 211.07/211.21 |- skos__hiddenLabel mesh__D001937 Cabbages
% 211.07/211.21 |- rdf__type mesh__D001937sskos__Concept
% 211.07/211.21 |- mesh__publicMeSHNote mesh__D001937 78
% 211.07/211.21 |- skos__broader mesh__D001937smesh__D019607
% 211.07/211.21 |- mesh__dateEstablished mesh__D001937 1978-01-01
% 211.07/211.21 |- skos__historyNote mesh__D001937 Plants, Edible %28%1966-1977%29%
% 211.07/211.21 |- skos__annotation mesh__D001937
% 211.07/211.21 GEN or unspecified; prefer specifics; note common names as X refs; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001937 2006
% 211.07/211.21 |- mesh__dateCreated mesh__D001937 1977-04-27
% 211.07/211.21 |- mesh__historyNote mesh__D001937 78
% 211.07/211.21 |- mesh__dateRevised mesh__D001937 2005-07-20
% 211.07/211.21 |- mesh__recordMaintainer mesh__D001937 ags
% 211.07/211.21 |- skos__scopeNote mesh__D001937
% 211.07/211.21 A plant genus of the family Cruciferae. It contains many species and cultivars used as food including cabbage, cauliflower, broccoli, Brussel sprouts, kale, collard greens, MUSTARD PLANT; %28%B. alba, B. junica, and B. nigra%29%, turnips %28%BRASSICA NAPUS%29% and rapeseed %28%BRASSICA RAPA%29%.%A%
% 211.07/211.21 |- skos__hiddenLabel mesh__D001937 Collard Greens
% 211.07/211.21 |- skos__broader mesh__D001937smesh__D014675
% 211.07/211.21 |- mesh__activeMeSHYear mesh__D001937 2005
% 211.07/211.22 |- mesh__recordOriginator mesh__D001937 VDK
% 211.07/211.22 |- skos__prefLabel mesh__D001937 Brassica
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Syndrome, Arnold-Chiari
% 211.07/211.22 |- skos__altLabel mesh__D001139 Type IV Arnold-Chiari Malformation
% 211.07/211.22 |- skos__scopeNote mesh__D001139
% 211.07/211.22 A group of congenital malformations involving the brainstem, cerebellum, upper spinal cord, and surrounding bony structures. Type II is the most common, and features compression of the medulla and cerebellar tonsils into the upper cervical spinal canal and an associated MENINGOMYELOCELE. Type I features similar, but less severe malformations and is without an associated meningomyelocele. Type III has the features of type II with an additional herniation of the entire cerebellum through the bony defect involving the foramen magnum, forming an ENCEPHALOCELE. Type IV is a form a cerebellar hypoplasia. Clinical manifestations of types I-III include TORTICOLLIS; opisthotonus; HEADACHE; VERTIGO; VOCAL CORD PARALYSIS; APNEA; NYSTAGMUS, CONGENITAL; swallowing difficulties; and ATAXIA. %28%From Menkes, Textbook of Child Neurology, 5th ed, p261; Davis, Textbook of Neuropathology, 2nd ed, pp236-46%29%%A%
% 211.07/211.22 |- mesh__recordMaintainer mesh__D001139 ags
% 211.07/211.22 |- skos__annotation mesh__D001139
% 211.07/211.22 do not confuse with CHIARI%27%S SYNDROME see HEPATIC VEIN THROMBOSIS%A%
% 211.07/211.22 |- mesh__dateRevised mesh__D001139 2005-07-21
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Type IV Arnold Chiari Malformation
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D001139 ags
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001139 2004
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Type II Arnold Chiari Malformation
% 211.07/211.22 |- skos__broader mesh__D001139smesh__D009436
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Type III Arnold Chiari Malformation
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation, Type I
% 211.07/211.22 |- mesh__historyNote mesh__D001139 2000%28%1963%29%
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Deformity, Arnold-Chiari
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001139 2000
% 211.07/211.22 |- skos__altLabel mesh__D001139 Arnold-Chiari Syndrome
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation
% 211.07/211.22 |- skos__altLabel mesh__D001139 Malformation, Arnold-Chiari
% 211.07/211.22 |- skos__altLabel mesh__D001139 Arnold-Chiari Deformity
% 211.07/211.22 |- mesh__dateCreated mesh__D001139 1999-01-01
% 211.07/211.22 |- rdf__type mesh__D001139sskos__Concept
% 211.07/211.22 |- skos__altLabel mesh__D001139 Type II Arnold-Chiari Malformation
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D001139
% 211.07/211.22 2000; see ARNOLD-CHIARI DEFORMITY 1963-1999; for ARNOLD-CHIARI MALFORMATION see ARNOLD-CHIARI DEFORMITY 1963-1999%A%
% 211.07/211.22 |- skos__altLabel mesh__D001139 Type I Arnold-Chiari Malformation
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001139 2001
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Arnold Chiari Syndrome
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation, Type II
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001139 2005
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation, Type IV
% 211.07/211.22 |- mesh__recordOriginator mesh__D001139 NLM
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Arnold Chiari Deformity
% 211.07/211.22 |- skos__altLabel mesh__D001139 Type III Arnold-Chiari Malformation
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001139 2006
% 211.07/211.22 |- skos__prefLabel mesh__D001139 Arnold-Chiari Malformation
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Type I Arnold Chiari Malformation
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation, Type III
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001139 2002
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001139 2006A
% 211.07/211.22 |- skos__hiddenLabel mesh__D001139 Malformation, Arnold Chiari
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001139 2003
% 211.07/211.22 |- skos__hiddenLabel mesh__D006622 Prosthesis, Femoral Head
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006622 2005
% 211.07/211.22 |- mesh__historyNote mesh__D006622 80
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D006622 SJN
% 211.07/211.22 |- skos__historyNote mesh__D006622 Hip Joint %28%1966-1979%29%
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006622 1998
% 211.07/211.22 |- skos__broader mesh__D006622smesh__D007595
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006622 2002
% 211.07/211.22 |- skos__historyNote mesh__D006622 Arthroplasty %28%1966-1979%29%
% 211.07/211.22 |- rdf__type mesh__D006622sskos__Concept
% 211.07/211.22 |- mesh__recordOriginator mesh__D006622 SMH
% 211.07/211.22 |- skos__prefLabel mesh__D006622 Hip Prosthesis
% 211.07/211.22 |- mesh__dateRevised mesh__D006622 1997-06-20
% 211.07/211.22 |- skos__historyNote mesh__D006622 Hip %28%1966-1979%29%
% 211.07/211.22 |- skos__hiddenLabel mesh__D006622 Hip Prostheses
% 211.07/211.22 |- mesh__dateEstablished mesh__D006622 1980-01-01
% 211.07/211.22 |- skos__historyNote mesh__D006622 Prosthesis %28%1966-1970%29%
% 211.07/211.22 |- skos__hiddenLabel mesh__D006622 Prostheses, Hip
% 211.07/211.22 |- skos__hiddenLabel mesh__D006622 Prostheses, Femoral Head
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006622 2001
% 211.07/211.22 |- skos__related mesh__D006622smesh__D019644
% 211.07/211.22 |- mesh__dateCreated mesh__D006622 1978-12-19
% 211.07/211.22 |- skos__historyNote mesh__D006622 Joint Prosthesis %28%1971-1979%29%
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006622 2004
% 211.07/211.22 |- skos__hiddenLabel mesh__D006622 Prosthesis, Hip
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006622 2000
% 211.07/211.22 |- skos__scopeNote mesh__D006622 Replacement for a hip joint.
% 211.07/211.22 |- skos__hiddenLabel mesh__D006622 Femoral Head Prostheses
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006622 2006
% 211.07/211.22 |- mesh__recordMaintainer mesh__D006622 PXP
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006622 2003
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006622 1999
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D006622 80
% 211.07/211.22 |- mesh__dateCreated mesh__D011567 1999-01-01
% 211.07/211.22 |- skos__annotation mesh__D011567
% 211.07/211.22 orderlies %26% ward attendants go under PSYCHIATRIC AIDES; DF: PSYCHIATR DEP%A%
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 2000
% 211.07/211.22 |- mesh__historyNote mesh__D011567
% 211.07/211.22 78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D011567 PLS
% 211.07/211.22 |- mesh__recordOriginator mesh__D011567 NLM
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 1994
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 2005
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 2001
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 1998
% 211.07/211.22 |- mesh__dateEstablished mesh__D011567 1966-01-01
% 211.07/211.22 |- skos__hiddenLabel mesh__D011567 Department, Hospital Psychiatric
% 211.07/211.22 |- skos__altLabel mesh__D011567 Psychiatric Departments, Hospital
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 1995
% 211.07/211.22 |- skos__hiddenLabel mesh__D011567 Hospital Psychiatric Departments
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 2006
% 211.07/211.22 |- mesh__recordMaintainer mesh__D011567 TGC
% 211.07/211.22 |- skos__altLabel mesh__D011567 Hospital Psychiatric Department
% 211.07/211.22 |- skos__hiddenLabel mesh__D011567 Departments, Hospital Psychiatric
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 1999
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 2003
% 211.07/211.22 |- rdf__type mesh__D011567sskos__Concept
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 1996
% 211.07/211.22 |- skos__broader mesh__D011567smesh__D006748
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 2002
% 211.07/211.22 |- mesh__dateRevised mesh__D011567 1993-06-02
% 211.07/211.22 |- mesh__onlineNote mesh__D011567
% 211.07/211.22 use PSYCHIATRIC DEPARTMENT, HOSPITAL to search HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77%A%
% 211.07/211.22 |- skos__scopeNote mesh__D011567
% 211.07/211.22 Hospital department responsible for the organization and administration of psychiatric services.%A%
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 2004
% 211.07/211.22 |- skos__prefLabel mesh__D011567 Psychiatric Department, Hospital
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D011567
% 211.07/211.22 78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011567 1997
% 211.07/211.22 |- skos__broader mesh__D017674Q000151smesh__D017674
% 211.07/211.22 |- mesh__preferredCombination mesh__D017674Q000151smesh__D007015
% 211.07/211.22 |- rdf__type mesh__D017674Q000151smesh__CompoundConcept
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D030721 2003
% 211.07/211.22 |- mesh__dateCreated mesh__D030721 2001-07-25
% 211.07/211.22 |- skos__altLabel mesh__D030721 Waterlily
% 211.07/211.22 |- skos__scopeNote mesh__D030721
% 211.07/211.22 A plant genus of the family NYMPHAEACEAE. The common name of lotus is also used for LOTUS and NELUMBO.%A%
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D030721 2002
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D030721 2006
% 211.07/211.22 |- mesh__historyNote mesh__D030721 2002
% 211.07/211.22 |- rdf__type mesh__D030721sskos__Concept
% 211.07/211.22 |- skos__altLabel mesh__D030721 Water Lily
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D030721 2005
% 211.07/211.22 |- skos__broader mesh__D030721smesh__D030702
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D030721 sjn
% 211.07/211.22 |- mesh__dateEstablished mesh__D030721 2002-01-01
% 211.07/211.22 |- skos__altLabel mesh__D030721 Lily, Water
% 211.07/211.22 |- mesh__dateRevised mesh__D030721 2002-07-03
% 211.07/211.22 |- mesh__recordMaintainer mesh__D030721 ssb
% 211.07/211.22 |- skos__annotation mesh__D030721
% 211.07/211.22 X ref NYMPHAEA LOTUS: LOTUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D030721 2004
% 211.07/211.22 |- skos__prefLabel mesh__D030721 Nymphaea
% 211.07/211.22 |- mesh__recordOriginator mesh__D030721 ssb
% 211.07/211.22 |- skos__hiddenLabel mesh__D016252 Tunnelling Microscopies, Scanning
% 211.07/211.22 |- mesh__recordOriginator mesh__D016252 PXP
% 211.07/211.22 |- skos__hiddenLabel mesh__D016252 Scanning Tunneling Microscopies
% 211.07/211.22 |- mesh__dateCreated mesh__D016252 1990-05-07
% 211.07/211.22 |- skos__hiddenLabel mesh__D016252 Tunneling Microscopy, Scanning
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D016252 sjn
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D016252 2005
% 211.07/211.22 |- skos__hiddenLabel mesh__D016252 Microscopy, Scanning Tunnelling
% 211.07/211.22 |- skos__hiddenLabel mesh__D016252 Tunnelling Microscopy, Scanning
% 211.07/211.22 |- skos__hiddenLabel mesh__D016252 Microscopies, Scanning Tunnelling
% 211.07/211.22 |- skos__altLabel mesh__D016252 Scanning Tunnelling Microscopy
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D016252 2006
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D016252 91
% 211.07/211.22 |- skos__altLabel mesh__D016252 Scanning Tunneling Microscopy
% 211.07/211.22 |- skos__related mesh__D016252smesh__D018625
% 211.07/211.22 |- mesh__dateRevised mesh__D016252 2004-07-07
% 211.07/211.22 |- skos__broader mesh__D016252smesh__D020527
% 211.07/211.22 |- skos__historyNote mesh__D016252
% 211.07/211.22 Microscopy, Electron, Scanning %28%1987-1990%29%
% 211.07/211.22 |- rdf__type mesh__D016252sskos__Concept
% 211.07/211.22 |- skos__hiddenLabel mesh__D016252 Microscopies, Scanning Tunneling
% 211.07/211.22 |- mesh__historyNote mesh__D016252 91
% 211.07/211.22 |- mesh__dateEstablished mesh__D016252 1991-01-01
% 211.07/211.22 |- skos__prefLabel mesh__D016252 Microscopy, Scanning Tunneling
% 211.07/211.22 |- skos__hiddenLabel mesh__D016252 Scanning Tunnelling Microscopies
% 211.07/211.22 |- skos__scopeNote mesh__D016252
% 211.07/211.22 A type of scanning probe microscopy in which a very sharp conducting needle is swept just a few angstroms above the surface of a sample. The tiny tunneling current that flows between the sample and the needle tip is measured, and from this are produced three-dimensional topographs. Due to the poor electron conductivity of most biological samples, thin metal coatings are deposited on the sample.%A%
% 211.07/211.22 |- mesh__recordMaintainer mesh__D016252 nns
% 211.07/211.22 |- skos__hiddenLabel mesh__D016252 Tunneling Microscopies, Scanning
% 211.07/211.22 |- mesh__dateEstablished mesh__D002232 1991-01-01
% 211.07/211.22 |- mesh__recordOriginator mesh__D002232 SH
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D002232 2006
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D002232 NLM
% 211.07/211.22 |- skos__historyNote mesh__D002232 Quinolines %28%1972-1975%29%
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D002232
% 211.07/211.22 91; was see under QUINOLINES 1976-90
% 211.07/211.22 |- skos__historyNote mesh__D002232 Alkenes %28%1972-1975%29%
% 211.07/211.22 |- rdf__type mesh__D002232sskos__Concept
% 211.07/211.22 |- skos__annotation mesh__D002232 D25-26 qualif
% 211.07/211.22 |- mesh__dateRevised mesh__D002232 2005-07-06
% 211.07/211.22 |- skos__prefLabel mesh__D002232 Carbocyanines
% 211.07/211.22 |- skos__scopeNote mesh__D002232
% 211.07/211.22 Compounds that contain three methine groups. They are frequently used as cationic dyes used for differential staining of biological materials.%A%
% 211.07/211.22 |- skos__broader mesh__D002232smesh__D000480
% 211.07/211.22 |- mesh__historyNote mesh__D002232
% 211.07/211.22 91%28%76%29%; was see under QUINOLINES 1976-90
% 211.07/211.22 |- mesh__recordMaintainer mesh__D002232 NLM
% 211.07/211.22 |- mesh__dateCreated mesh__D002232 1975-07-18
% 211.07/211.22 |- rdf__type mesh__D001938sskos__Concept
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D001938 PLS
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 2004
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1991
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 2006
% 211.07/211.22 |- skos__broader mesh__D001938smesh__D013020
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 2003
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1990
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1997
% 211.07/211.22 |- mesh__recordMaintainer mesh__D001938 PLS
% 211.07/211.22 |- skos__prefLabel mesh__D001938 Brazil
% 211.07/211.22 |- mesh__recordOriginator mesh__D001938 NLM
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 2005
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1999
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1996
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 2002
% 211.07/211.22 |- mesh__dateRevised mesh__D001938 1991-11-02
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1998
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1993
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 2001
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1995
% 211.07/211.22 |- mesh__dateCreated mesh__D001938 1999-01-01
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1992
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1989
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 1994
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001938 2000
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1991
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 2003
% 211.07/211.22 |- rdf__type mesh__D012660sskos__Concept
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1996
% 211.07/211.22 |- skos__broader mesh__D012660smesh__D008037
% 211.07/211.22 |- skos__annotation mesh__D012660
% 211.07/211.22 hist or psychol study of changes in language %26% meaning; do not confuse with LINGUISTICS %28%overall study of LANGUAGE %26% SPEECH%29% or NOMENCLATURE %28%names of things %26% etymology%29%; no qualif%A%
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D012660 PLS
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1992
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 2004
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1997
% 211.07/211.22 |- mesh__dateRevised mesh__D012660 1989-05-16
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 2005
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 2000
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1998
% 211.07/211.22 |- skos__hiddenLabel mesh__D012660 Semantic
% 211.07/211.22 |- mesh__recordMaintainer mesh__D012660 TGC
% 211.07/211.22 |- skos__prefLabel mesh__D012660 Semantics
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1993
% 211.07/211.22 |- mesh__recordOriginator mesh__D012660 NLM
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 2001
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1994
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 2006
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1999
% 211.07/211.22 |- skos__scopeNote mesh__D012660
% 211.07/211.22 The relationships between symbols and their meanings.
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1990
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 2002
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D012660 1995
% 211.07/211.22 |- mesh__dateCreated mesh__D012660 1999-01-01
% 211.07/211.22 |- skos__broader mesh__D006623smesh__D020752
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Hippel Lindau Disease
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Cerebelloretinal Angiomatoses, Familial
% 211.07/211.22 |- skos__altLabel mesh__D006623 Familial Cerebello-Retinal Angiomatosis
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Angiomatoses, Familial Cerebelloretinal
% 211.07/211.22 |- skos__prefLabel mesh__D006623 Hippel-Lindau Disease
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D006623 sjn
% 211.07/211.22 |- skos__scopeNote mesh__D006623
% 211.07/211.22 An autosomal dominant disorder associated with various neoplasms including central nervous system %28%most often cerebellar%29% and retinal HEMANGIOBLASTOMA, endolymphatic sac tumors, renal cell carcinoma %28%see CARCINOMA, RENAL CELL%29%, renal and pancreatic cysts, HEMANGIOMA of the spinal cord, and PHEOCHROMOCYTOMA. The most common presenting manifestations are neurologic deficits associated with intracranial hemangioblastomas which may HEMORRHAGE, causing ataxia, INTRACRANIAL HYPERTENSION, and other signs of neurologic dysfunction. %28%From Neurochirurgie 1998 Nov;44%28%4%29%:258-66%29%%A%
% 211.07/211.22 |- mesh__historyNote mesh__D006623
% 211.07/211.22 91%28%75%29%; was see under ANGIOMATOSIS 1975-90
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Lindau%27%s Diseases
% 211.07/211.22 |- mesh__recordOriginator mesh__D006623 NLM
% 211.07/211.22 |- skos__altLabel mesh__D006623 Lindau%27%s Disease
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006623 2005
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Lindaus Disease
% 211.07/211.22 |- mesh__dateRevised mesh__D006623 2003-07-09
% 211.07/211.22 |- mesh__onlineNote mesh__D006623 search ANGIOMATOSIS 1966-74
% 211.07/211.22 |- skos__altLabel mesh__D006623 Lindau Disease
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Familial Cerebello Retinal Angiomatosis
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Diseases, Lindau%27%s
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006623 2006
% 211.07/211.22 |- skos__altLabel mesh__D006623 von Hippel-Lindau Syndrome
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Angiomatosis, Familial Cerebelloretinal
% 211.07/211.22 |- mesh__dateEstablished mesh__D006623 1991-01-01
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Familial Cerebelloretinal Angiomatosis
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Cerebello-Retinal Angiomatoses, Familial
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Familial Cerebelloretinal Angiomatoses
% 211.07/211.22 |- skos__altLabel mesh__D006623 Cerebelloretinal Angiomatosis, Familial
% 211.07/211.22 |- mesh__dateCreated mesh__D006623 1999-01-01
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Angiomatosis, Familial Cerebello-Retinal
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Cerebello-Retinal Angiomatosis, Familial
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Syndrome, von Hippel-Lindau
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D006623
% 211.07/211.22 91; was see under ANGIOMATOSIS 1975-90
% 211.07/211.22 |- skos__altLabel mesh__D006623 von Hippel-Lindau Disease
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D006623 2004
% 211.07/211.22 |- rdf__type mesh__D006623sskos__Concept
% 211.07/211.22 |- skos__broader mesh__D006623smesh__D000798
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 von Hippel Lindau Syndrome
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Familial Cerebello-Retinal Angiomatoses
% 211.07/211.22 |- mesh__recordMaintainer mesh__D006623 lkt
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 Angiomatoses, Familial Cerebello-Retinal
% 211.07/211.22 |- skos__hiddenLabel mesh__D006623 von Hippel Lindau Disease
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D044742 2004
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D044742 2006
% 211.07/211.22 |- rdf__type mesh__D044742sskos__Concept
% 211.07/211.22 |- mesh__recordOriginator mesh__D044742 ags
% 211.07/211.22 |- mesh__dateRevised mesh__D044742 2005-06-30
% 211.07/211.22 |- mesh__historyNote mesh__D044742 2004
% 211.07/211.22 |- skos__historyNote mesh__D044742 Oomycetes %28%1978-2003%29%
% 211.07/211.22 |- mesh__dateEstablished mesh__D044742 2004-01-01
% 211.07/211.22 |- mesh__recordMaintainer mesh__D044742 SYSTEM
% 211.07/211.22 |- skos__broader mesh__D044742smesh__D009868
% 211.07/211.22 |- skos__historyNote mesh__D044742 Fungi %28%1968-1977%29%
% 211.07/211.22 |- mesh__dateCreated mesh__D044742 2003-07-09
% 211.07/211.22 |- skos__prefLabel mesh__D044742 Peronospora
% 211.07/211.22 |- skos__scopeNote mesh__D044742
% 211.07/211.22 A genus of ALGAE in the family Peronosporaceae. Most species are obligatory parasites and many are plant pathogens.%A%
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D044742 sjn
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011568 2005
% 211.07/211.22 |- skos__broader mesh__D011568smesh__D009732
% 211.07/211.22 |- mesh__recordMaintainer mesh__D011568 jls
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011568 2006
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011568 2003
% 211.07/211.22 |- mesh__recordOriginator mesh__D011568 NLM
% 211.07/211.22 |- rdf__type mesh__D011568sskos__Concept
% 211.07/211.22 |- skos__prefLabel mesh__D011568 Psychiatric Nursing
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011568 2001
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011568 2004
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D011568 sjn
% 211.07/211.22 |- mesh__dateRevised mesh__D011568 2000-06-22
% 211.07/211.22 |- mesh__dateCreated mesh__D011568 1999-01-01
% 211.07/211.22 |- skos__scopeNote mesh__D011568
% 211.07/211.22 A specialty concerned with the application of psychiatric principles in caring for the mentally ill. It also includes the nursing care provided the mentally ill patient.%A%
% 211.07/211.22 |- skos__broader mesh__D011568smesh__D013041
% 211.07/211.22 |- skos__altLabel mesh__D011568 Nursing, Psychiatric
% 211.07/211.22 |- skos__annotation mesh__D011568 SPEC: SPEC qualif
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D011568 2002
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D016253 2006
% 211.07/211.22 |- mesh__recordMaintainer mesh__D016253 nns
% 211.07/211.22 |- skos__hiddenLabel mesh__D016253 Microscopies, Immuno-Electron
% 211.07/211.22 |- skos__hiddenLabel mesh__D016253 Immuno-Electron Microscopy
% 211.07/211.22 |- mesh__dateRevised mesh__D016253 2004-07-07
% 211.07/211.22 |- skos__annotation mesh__D016253 NIM
% 211.07/211.22 |- skos__altLabel mesh__D016253 Microscopy, Immuno-Electron
% 211.07/211.22 |- skos__hiddenLabel mesh__D016253 Immuno-Electron Microscopies
% 211.07/211.22 |- rdf__type mesh__D016253sskos__Concept
% 211.07/211.22 |- skos__prefLabel mesh__D016253 Microscopy, Immunoelectron
% 211.07/211.22 |- mesh__historyNote mesh__D016253 91
% 211.07/211.22 |- skos__hiddenLabel mesh__D016253 Microscopy, Immuno Electron
% 211.07/211.22 |- skos__altLabel mesh__D016253 Immunoelectron Microscopy
% 211.07/211.22 |- skos__historyNote mesh__D016253 Microscopy, Electron %28%1973-1990%29%
% 211.07/211.22 |- skos__hiddenLabel mesh__D016253 Microscopies, Immunoelectron
% 211.07/211.22 |- mesh__dateEstablished mesh__D016253 1991-01-01
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D016253 sjn
% 211.07/211.22 |- skos__scopeNote mesh__D016253
% 211.07/211.22 Microscopy in which the samples are first stained immunocytochemically and then examined using an electron microscope. Immunoelectron microscopy is used extensively in diagnostic virology as part of very sensitive immunoassays.%A%
% 211.07/211.22 |- skos__broader mesh__D016253smesh__D008854
% 211.07/211.22 |- mesh__dateCreated mesh__D016253 1990-05-07
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D016253 91
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D016253 2005
% 211.07/211.22 |- skos__hiddenLabel mesh__D016253 Immunoelectron Microscopies
% 211.07/211.22 |- mesh__recordOriginator mesh__D016253 PXP
% 211.07/211.22 |- skos__altLabel mesh__D002233 3-%28%Carboxymethylthio%29%alanine
% 211.07/211.22 |- skos__prefLabel mesh__D002233 Carbocysteine
% 211.07/211.22 |- mesh__recordOriginator mesh__D002233 NLM
% 211.07/211.22 |- mesh__recordMaintainer mesh__D002233 ssb
% 211.07/211.22 |- rdf__type mesh__D002233sskos__Concept
% 211.07/211.22 |- skos__altLabel mesh__D002233 S-Carboxymethylcysteine
% 211.07/211.22 |- skos__scopeNote mesh__D002233
% 211.07/211.22 A compound formed when iodoacetic acid reacts with sulfhydryl groups in proteins. It has been used as an anti-infective nasal spray with mucolytic and expectorant action.%A%
% 211.07/211.22 |- mesh__dateRevised mesh__D002233 2005-06-30
% 211.07/211.22 |- mesh__historyNote mesh__D002233
% 211.07/211.22 91%28%80%29%; was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79%A%
% 211.07/211.22 |- skos__altLabel mesh__D002233 Mucodyne
% 211.07/211.22 |- mesh__dateCreated mesh__D002233 1974-11-19
% 211.07/211.22 |- skos__hiddenLabel mesh__D002233 L-Isomer Carbocysteine
% 211.07/211.22 |- skos__broader mesh__D002233smesh__D003545
% 211.07/211.22 |- skos__broader mesh__D002233smesh__D000600
% 211.07/211.22 |- mesh__onlineNote mesh__D002233
% 211.07/211.22 use CARBOCYSTEINE to search CARBOXYMETHYLCYSTEINE 1975-79%A%
% 211.07/211.22 |- skos__historyNote mesh__D002233 Amino Acids, Sulfur %28%1974%29%
% 211.07/211.22 |- skos__altLabel mesh__D002233 S-%28%Carboxymethyl%29%-L-cysteine
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D002233
% 211.07/211.22 91; was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79%A%
% 211.07/211.22 |- mesh__dateEstablished mesh__D002233 1991-01-01
% 211.07/211.22 |- skos__historyNote mesh__D002233 Amino Acids, Dicarboxylic %28%1974%29%
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D002233 2006
% 211.07/211.22 |- skos__altLabel mesh__D002233 Mucodine
% 211.07/211.22 |- skos__hiddenLabel mesh__D002233 Carbocysteine, L Isomer
% 211.07/211.22 |- skos__hiddenLabel mesh__D002233 S Carboxymethylcysteine
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D002233 sjn
% 211.07/211.22 |- mesh__dateEstablished mesh__D026681 2002-01-01
% 211.07/211.22 |- skos__scopeNote mesh__D026681
% 211.07/211.22 A nutritional condition produced by a deficiency of VITAMIN B 6 in the diet, characterized by dermatitis, glossitis, cheilosis, and stomatitis. Marked deficiency causes irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures. In infants and children typical manifestations are diarrhea, anemia, and seizures. Deficiency can be caused by certain medications, such as isoniazid.%A%
% 211.07/211.22 |- skos__altLabel mesh__D026681 Deficiency, Pyridoxine
% 211.07/211.22 |- rdf__type mesh__D026681sskos__Concept
% 211.07/211.22 |- mesh__publicMeSHNote mesh__D026681
% 211.07/211.22 2000; for PYRIDOXINE DEFICIENCY see PYRIDOXINE DEFICIENCY 1963-2001%A%
% 211.07/211.22 |- skos__altLabel mesh__D026681 Deficiency, Vitamin B6
% 211.07/211.22 |- mesh__recordAuthorizer mesh__D026681 sjn
% 211.07/211.22 |- skos__hiddenLabel mesh__D026681 Deficiencies, Vitamin B6
% 211.07/211.22 |- mesh__recordOriginator mesh__D026681 ssb
% 211.07/211.22 |- skos__hiddenLabel mesh__D026681 B6 Deficiencies, Vitamin
% 211.07/211.22 |- skos__hiddenLabel mesh__D026681 Vitamin B6 Deficiencies
% 211.07/211.22 |- skos__prefLabel mesh__D026681 Vitamin B 6 Deficiency
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D026681 2005
% 211.07/211.22 |- mesh__recordMaintainer mesh__D026681 lkt
% 211.07/211.22 |- skos__hiddenLabel mesh__D026681 B6 Deficiency, Vitamin
% 211.07/211.22 |- skos__historyNote mesh__D026681 Pyridoxine Deficiency %28%1963-2001%29%
% 211.07/211.22 |- skos__altLabel mesh__D026681 Vitamin B6 Deficiency
% 211.07/211.22 |- skos__altLabel mesh__D026681 Deficiency, Vitamin B 6
% 211.07/211.22 |- mesh__dateCreated mesh__D026681 2001-07-25
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D026681 2006
% 211.07/211.22 |- mesh__historyNote mesh__D026681 2000
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D026681 2004
% 211.07/211.22 |- skos__broader mesh__D026681smesh__D014804
% 211.07/211.22 |- mesh__dateRevised mesh__D026681 2003-07-09
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001939 2006
% 211.07/211.22 |- mesh__activeMeSHYear mesh__D001939 2003
% 211.07/211.22 |- skos__hiddenLabel mesh__D001939 Breads
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D001939 2005
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D001939 2000
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D001939 SJN
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D001939 1999
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D001939 1998
% 211.07/211.23 |- mesh__recordOriginator mesh__D001939 NLM
% 211.07/211.23 |- skos__broader mesh__D001939smesh__D005502
% 211.07/211.23 |- mesh__dateCreated mesh__D001939 1999-01-01
% 211.07/211.23 |- skos__scopeNote mesh__D001939
% 211.07/211.23 Baked food product made of flour or meal that is moistened, kneaded, and sometimes fermented. A major food since prehistoric times, it has been made in various forms using a variety of ingredients and methods.%A%
% 211.07/211.23 |- mesh__recordMaintainer mesh__D001939 JLS
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D001939 2002
% 211.07/211.23 |- rdf__type mesh__D001939sskos__Concept
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D001939 2004
% 211.07/211.23 |- mesh__dateRevised mesh__D001939 1997-06-20
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D001939 2001
% 211.07/211.23 |- skos__prefLabel mesh__D001939 Bread
% 211.07/211.23 |- skos__related mesh__D012661smesh__D013094
% 211.07/211.23 |- mesh__recordOriginator mesh__D012661 NLM
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012661 2001
% 211.07/211.23 |- skos__scopeNote mesh__D012661
% 211.07/211.23 The thick, yellowish-white, viscid fluid secretion of male reproductive organs discharged upon ejaculation. In addition to reproductive organ secretions, it contains SPERMATOZOA and their nutrient plasma.%A%
% 211.07/211.23 |- skos__related mesh__D012661smesh__D013074
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012661 2005
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012661 2002
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012661 2006
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D012661 sjn
% 211.07/211.23 |- skos__hiddenLabel mesh__D012661 Plasma, Seminal
% 211.07/211.23 |- mesh__recordMaintainer mesh__D012661 KEV
% 211.07/211.23 |- mesh__dateCreated mesh__D012661 1999-01-01
% 211.07/211.23 |- skos__prefLabel mesh__D012661 Semen
% 211.07/211.23 |- skos__broader mesh__D012661smesh__D012634
% 211.07/211.23 |- rdf__type mesh__D012661sskos__Concept
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012661 2003
% 211.07/211.23 |- skos__annotation mesh__D012661
% 211.07/211.23 semen donors: coord SEMEN %28%IM%29% + TISSUE DONORS %28%IM%29%; consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS %28%husband%29% %28%IM%29% or INSEMINATION, ARTIFICIAL, HETEROLOGOUS %28%non-husband%29% %28%IM%29% if pertinent; hemospermia: index under SEMEN %28%IM%29% + BLOOD %28%IM%29%%A%
% 211.07/211.23 |- mesh__dateRevised mesh__D012661 1999-11-03
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012661 2000
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012661 2004
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006624 2000
% 211.07/211.23 |- skos__broader mesh__D006624smesh__D008032
% 211.07/211.23 |- skos__prefLabel mesh__D006624 Hippocampus
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006624 2001
% 211.07/211.23 |- mesh__recordOriginator mesh__D006624 NLM
% 211.07/211.23 |- rdf__type mesh__D006624sskos__Concept
% 211.07/211.23 |- skos__hiddenLabel mesh__D006624 Hippocampal Formations
% 211.07/211.23 |- skos__hiddenLabel mesh__D006624 Formations, Hippocampal
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006624 2003
% 211.07/211.23 |- mesh__recordMaintainer mesh__D006624 ags
% 211.07/211.23 |- skos__hiddenLabel mesh__D006624 Horn, Ammon%27%s
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D006624 sjn
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006624 2005
% 211.07/211.23 |- skos__hiddenLabel mesh__D006624 Ammons Horn
% 211.07/211.23 |- mesh__dateCreated mesh__D006624 1999-01-01
% 211.07/211.23 |- skos__altLabel mesh__D006624 Cornu Ammonis
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006624 2004
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006624 2002
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006624 2006
% 211.07/211.23 |- mesh__dateRevised mesh__D006624 1999-11-03
% 211.07/211.23 |- skos__altLabel mesh__D006624 Ammon Horn
% 211.07/211.23 |- skos__hiddenLabel mesh__D006624 Formation, Hippocampal
% 211.07/211.23 |- skos__related mesh__D006624smesh__D019580
% 211.07/211.23 |- skos__scopeNote mesh__D006624
% 211.07/211.23 A curved elevation of gray matter extending the entire length of the floor of the temporal horn of the lateral ventricle %28%Dorland, 28th ed%29%. The hippocampus, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.%A%
% 211.07/211.23 |- skos__hiddenLabel mesh__D006624 Subiculums
% 211.07/211.23 |- skos__altLabel mesh__D006624 Ammon%27%s Horn
% 211.07/211.23 |- skos__related mesh__D006624smesh__D018728
% 211.07/211.23 |- skos__hiddenLabel mesh__D006624 Horn, Ammon
% 211.07/211.23 |- skos__scopeNote mesh__D044743
% 211.07/211.23 A genus of ALGAE in the family Saprolegniaceae. They are pathogens of FISHES and INSECTS.%A%
% 211.07/211.23 |- skos__historyNote mesh__D044743 Fungi %28%1967-2003%29%
% 211.07/211.23 |- mesh__recordMaintainer mesh__D044743 SYSTEM
% 211.07/211.23 |- skos__broader mesh__D044743smesh__D009868
% 211.07/211.23 |- mesh__dateCreated mesh__D044743 2003-07-09
% 211.07/211.23 |- mesh__recordOriginator mesh__D044743 ags
% 211.07/211.23 |- mesh__dateRevised mesh__D044743 2005-06-30
% 211.07/211.23 |- mesh__historyNote mesh__D044743 2004
% 211.07/211.23 |- mesh__dateEstablished mesh__D044743 2004-01-01
% 211.07/211.23 |- skos__annotation mesh__D044743
% 211.07/211.23 infection: coord IM with INFECTION %28%IM%29%
% 211.07/211.23 |- skos__historyNote mesh__D044743 Oomycetes %28%1975-2003%29%
% 211.07/211.23 |- skos__prefLabel mesh__D044743 Achlya
% 211.07/211.23 |- rdf__type mesh__D044743sskos__Concept
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D044743 2004
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D044743 2006
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D044743 sjn
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 2003
% 211.07/211.23 |- skos__broader mesh__D011569smesh__D004191
% 211.07/211.23 |- rdf__type mesh__D011569sskos__Concept
% 211.07/211.23 |- mesh__onlineNote mesh__D011569
% 211.07/211.23 use PSYCHIATRIC STATUS RATING SCALES to search KATZ ADJUSTMENT SCALES 1975-96, LORR%27%S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE 1975-91, WITTENBORN SCALES 1979-91, WITTENBORN SCALE 1969-78, %26% FACTOR CONSTRUCT RATING SCALES 1973-78%A%
% 211.07/211.23 |- skos__hiddenLabel mesh__D011569 Adjustment Scales, Katz
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 2004
% 211.07/211.23 |- skos__scopeNote mesh__D011569
% 211.07/211.23 Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.%A%
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 1997
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 2002
% 211.07/211.23 |- mesh__dateCreated mesh__D011569 1999-01-01
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D011569
% 211.07/211.23 69; KATZ ADJUSTMENT SCALES was heading 1975-96 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%; WITTENBORN SCALES was heading 1991, was see under PSYCHIATRIC STATUS RATING SCALES 1979-90, was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78; LORR%27%S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE was heading 1991, see under PSYCHIATRIC STATUS RATING SCALES 1975-90%A%
% 211.07/211.23 |- skos__hiddenLabel mesh__D011569 Scales, Katz Adjustment
% 211.07/211.23 |- mesh__dateRevised mesh__D011569 1996-06-10
% 211.07/211.23 |- mesh__historyNote mesh__D011569
% 211.07/211.23 69; KATZ ADJUSTMENT SCALES was heading 1975-96 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%; WITTENBORN SCALES was heading 1979-91 %28%see under PSYCHIATRIC STATUS RATING SCALES 1979-90%29%, was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78; LORR%27%S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE was heading 1975-91 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%; FACTOR CONSTRUCT RATING SCALES was see under PSYCHIATRIC STATUS RATING SCALES 1973-78%A%
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 2000
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 2005
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D011569 PLS
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 1998
% 211.07/211.23 |- mesh__recordMaintainer mesh__D011569 PXP
% 211.07/211.23 |- skos__historyNote mesh__D011569 Psychological Tests %28%1966-1968%29%
% 211.07/211.23 |- mesh__dateEstablished mesh__D011569 1969-01-01
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 2006
% 211.07/211.23 |- mesh__recordOriginator mesh__D011569 NLM
% 211.07/211.23 |- skos__annotation mesh__D011569 DF: PSR SCALES
% 211.07/211.23 |- skos__hiddenLabel mesh__D011569 Scales, Wittenborn
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 2001
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D011569 1999
% 211.07/211.23 |- skos__prefLabel mesh__D011569 Psychiatric Status Rating Scales
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D016254 2003
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Mutageneses, Insertional
% 211.07/211.23 |- mesh__historyNote mesh__D016254 91
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Activations, Insertional
% 211.07/211.23 |- mesh__dateRevised mesh__D016254 2002-07-02
% 211.07/211.23 |- skos__scopeNote mesh__D016254
% 211.07/211.23 Mutagenesis where the mutation is caused by the introduction of foreign DNA sequences into a gene. This may occur spontaneously in vivo or be experimentally induced in vivo or in vitro. Proviral DNA can be inserted into or adjacent to a cellular proto-oncogene. Insertion of the provirus can cause mutations by interrupting coding sequences or regulatory elements, or cause unregulated expression of the proto-oncogene resulting in tumor formation.%A%
% 211.07/211.23 |- rdf__type mesh__D016254sskos__Concept
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Mutagenesis, Linker-Insertion
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D016254 2004
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Mutageneses, Viral Insertional
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Cassette Mutagenesis
% 211.07/211.23 |- mesh__recordOriginator mesh__D016254 AGS
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Viral Insertional Mutageneses
% 211.07/211.23 |- skos__broader mesh__D016254smesh__D015202
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Insertional Mutagenesis, Viral
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Mutageneses, Cassette
% 211.07/211.23 |- mesh__dateEstablished mesh__D016254 1991-01-01
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Cassette Mutageneses
% 211.07/211.23 |- skos__altLabel mesh__D016254 Insertional Mutagenesis
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D016254 2005
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Insertional Mutageneses, Viral
% 211.07/211.23 |- mesh__recordMaintainer mesh__D016254 NDW
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Mutageneses, Linker-Insertion
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Linker Insertion Mutagenesis
% 211.07/211.23 |- skos__broader mesh__D016254smesh__D016296
% 211.07/211.23 |- skos__prefLabel mesh__D016254 Mutagenesis, Insertional
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Activation, Insertional
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D016254 2006
% 211.07/211.23 |- skos__historyNote mesh__D016254 Mutation %28%1982-1990%29%
% 211.07/211.23 |- skos__historyNote mesh__D016254 DNA Insertion Elements %28%1983-1990%29%
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Mutagenesis, Viral Insertional
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D016254 sjn
% 211.07/211.23 |- skos__annotation mesh__D016254 selected qualif from Cat G %26% Cat E
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Linker-Insertion Mutageneses
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Insertional Mutageneses
% 211.07/211.23 |- mesh__dateCreated mesh__D016254 1990-05-29
% 211.07/211.23 |- skos__hiddenLabel mesh__D016254 Insertional Activations
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D016254 91
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 2000
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 1993
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 1995
% 211.07/211.23 |- skos__historyNote mesh__D002234 Imines %28%1966-1972%29%
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 2003
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 2001
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 2005
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D002234 73
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 2004
% 211.07/211.23 |- mesh__dateEstablished mesh__D002234 1973-01-01
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 2006
% 211.07/211.23 |- mesh__recordOriginator mesh__D002234 NLM
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 2002
% 211.07/211.23 |- mesh__dateRevised mesh__D002234 1992-05-11
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D002234 PLS
% 211.07/211.23 |- skos__prefLabel mesh__D002234 Carbodiimides
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 1996
% 211.07/211.23 |- mesh__dateCreated mesh__D002234 1999-01-01
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 1998
% 211.07/211.23 |- mesh__historyNote mesh__D002234 73
% 211.07/211.23 |- mesh__recordMaintainer mesh__D002234 TGC
% 211.07/211.23 |- rdf__type mesh__D002234sskos__Concept
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 1997
% 211.07/211.23 |- skos__broader mesh__D002234smesh__D007097
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 1994
% 211.07/211.23 |- skos__annotation mesh__D002234
% 211.07/211.23 do not confuse CARBODIIMIDES %28%a group term%29% with %22%carbodiimide%22% %28%a specific chemical%29%%A%
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002234 1999
% 211.07/211.23 |- skos__broader mesh__D019271Q000031smesh__D019271
% 211.07/211.23 |- mesh__preferredCombination mesh__D019271Q000031smesh__D007042
% 211.07/211.23 |- rdf__type mesh__D019271Q000031smesh__CompoundConcept
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012662 2006
% 211.07/211.23 |- mesh__recordMaintainer mesh__D012662 NLM
% 211.07/211.23 |- mesh__dateEstablished mesh__D012662 1978-01-01
% 211.07/211.23 |- skos__related mesh__D012662smesh__D013074
% 211.07/211.23 |- skos__annotation mesh__D012662
% 211.07/211.23 cryopreservation of semen: coord IM with CRYOPRESERVATION %28%IM%29%%A%
% 211.07/211.23 |- skos__related mesh__D012662smesh__D020858
% 211.07/211.23 |- mesh__dateCreated mesh__D012662 1977-04-22
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D012662 NLM
% 211.07/211.23 |- rdf__type mesh__D012662sskos__Concept
% 211.07/211.23 |- mesh__historyNote mesh__D012662 78
% 211.07/211.23 |- skos__scopeNote mesh__D012662
% 211.07/211.23 The process by which semen is kept viable outside of the organism from which it was derived %28%i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism%29%.%A%
% 211.07/211.23 |- skos__historyNote mesh__D012662 Freezing %28%1966-1977%29%
% 211.07/211.23 |- skos__hiddenLabel mesh__D012662 Semen, Frozen
% 211.07/211.23 |- mesh__dateRevised mesh__D012662 2004-07-20
% 211.07/211.23 |- skos__broader mesh__D012662smesh__D014021
% 211.07/211.23 |- skos__hiddenLabel mesh__D012662 Preservation, Semen
% 211.07/211.23 |- skos__prefLabel mesh__D012662 Semen Preservation
% 211.07/211.23 |- skos__hiddenLabel mesh__D012662 Preservation, Sperm
% 211.07/211.23 |- mesh__recordOriginator mesh__D012662 EC
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D012662 78
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012662 2005
% 211.07/211.23 |- skos__historyNote mesh__D012662 Semen %28%1966-1977%29%
% 211.07/211.23 |- mesh__recordMaintainer mesh__D006625 jrf
% 211.07/211.23 |- rdf__type mesh__D006625sskos__Concept
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006625 2003
% 211.07/211.23 |- mesh__dateRevised mesh__D006625 2002-07-03
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006625 2005
% 211.07/211.23 |- skos__prefLabel mesh__D006625 Hippocratic Oath
% 211.07/211.23 |- skos__scopeNote mesh__D006625
% 211.07/211.23 An oath, attributed to Hippocrates, that serves as an ethical guide for the medical profession.%A%
% 211.07/211.23 |- mesh__dateCreated mesh__D006625 1999-01-01
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006625 2004
% 211.07/211.23 |- mesh__recordOriginator mesh__D006625 NLM
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006625 2006
% 211.07/211.23 |- skos__broader mesh__D006625smesh__D004992
% 211.07/211.23 |- skos__annotation mesh__D006625
% 211.07/211.23 capitalize Hippocratic in titles %26% translations
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D006625 sjn
% 211.07/211.23 |- skos__broader mesh__D006625smesh__D032781
% 211.07/211.23 |- skos__hiddenLabel mesh__D006625 Oath, Hippocratic
% 211.07/211.23 |- mesh__historyNote mesh__D039001 2003
% 211.07/211.23 |- mesh__recordOriginator mesh__D039001 MDJ
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D039001 2006A
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D039001 2005
% 211.07/211.23 |- skos__altLabel mesh__D039001 alpha Integrins
% 211.07/211.23 |- skos__hiddenLabel mesh__D039001 alpha Chains, Integrin
% 211.07/211.23 |- skos__altLabel mesh__D039001 Integrin alpha Subunits
% 211.07/211.23 |- mesh__dateCreated mesh__D039001 2002-07-02
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D039001 2006
% 211.07/211.23 |- skos__scopeNote mesh__D039001
% 211.07/211.23 The alpha subunits of integrin heterodimers %28%INTEGRINS%29%, which mediate ligand specificity. There are approximately 18 different alpha chains, exhibiting great sequence diversity; several chains are also spliced into alternative isoforms. They possess a long extracellular portion %28%1200 amino acids%29% containing a MIDAS %28%metal ion-dependent adhesion site%29% motif, and seven 60-amino acid tandem repeats, the last 4 of which form EF HAND MOTIFS. The intracellular portion is short %28%%3E%50 AA%29% with the exception of INTEGRIN ALPHA4.%A%
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D039001 ags
% 211.07/211.23 |- skos__prefLabel mesh__D039001 Integrin alpha Chains
% 211.07/211.23 |- skos__broader mesh__D039001smesh__D016023
% 211.07/211.23 |- mesh__dateRevised mesh__D039001 2005-07-13
% 211.07/211.23 |- skos__historyNote mesh__D039001 Integrins %28%1966-2002%29%
% 211.07/211.23 |- skos__hiddenLabel mesh__D039001 Integrins, alpha
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D039001 2004
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D039001 2003
% 211.07/211.23 |- rdf__type mesh__D039001sskos__Concept
% 211.07/211.23 |- mesh__dateEstablished mesh__D039001 2003-01-01
% 211.07/211.23 |- mesh__recordMaintainer mesh__D039001 ags
% 211.07/211.23 |- skos__hiddenLabel mesh__D050781 Stimulations, Transcranial Magnetic
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D050781 2006
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D050781 sjn
% 211.07/211.23 |- skos__historyNote mesh__D050781 Magnetics %28%1988-2005%29%
% 211.07/211.23 |- skos__hiddenLabel mesh__D050781 Stimulation, Transcranial Magnetic
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D050781 2006
% 211.07/211.23 |- mesh__recordOriginator mesh__D050781 ssb
% 211.07/211.23 |- mesh__dateEstablished mesh__D050781 2006-01-01
% 211.07/211.23 |- skos__hiddenLabel mesh__D050781 Transcranial Magnetic Stimulations
% 211.07/211.23 |- rdf__type mesh__D050781sskos__Concept
% 211.07/211.23 |- skos__related mesh__D050781smesh__D015225
% 211.07/211.23 |- skos__prefLabel mesh__D050781 Transcranial Magnetic Stimulation
% 211.07/211.23 |- skos__broader mesh__D050781smesh__D003943
% 211.07/211.23 |- skos__hiddenLabel mesh__D050781 Magnetic Stimulations, Transcranial
% 211.07/211.23 |- mesh__dateCreated mesh__D050781 2005-06-30
% 211.07/211.23 |- skos__hiddenLabel mesh__D050781 Magnetic Stimulation, Transcranial
% 211.07/211.23 |- mesh__historyNote mesh__D050781 2006
% 211.07/211.23 |- mesh__recordMaintainer mesh__D050781 ssb
% 211.07/211.23 |- skos__scopeNote mesh__D050781
% 211.07/211.23 A technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the CEREBRAL CORTEX. It is coupled with ELECTROMYOGRAPHY response detection to assess cortical excitability by the threshold required to induce MOTOR EVOKED POTENTIALS. This method is also used for BRAIN MAPPING, to study NEUROPHYSIOLOGY, and as a substitute for ELECTROCONVULSIVE THERAPY for treating DEPRESSION. Induction of SEIZURES limits its clinical usage.%A%
% 211.07/211.23 |- skos__annotation mesh__D044744
% 211.07/211.23 infection: coord IM with INFECTION %28%IM%29%
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D044744 sjn
% 211.07/211.23 |- skos__historyNote mesh__D044744 Fungi %28%1966-1977%29%
% 211.07/211.23 |- rdf__type mesh__D044744sskos__Concept
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D044744 2004
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D044744 2006
% 211.07/211.23 |- mesh__dateEstablished mesh__D044744 2004-01-01
% 211.07/211.23 |- mesh__recordOriginator mesh__D044744 ags
% 211.07/211.23 |- skos__scopeNote mesh__D044744
% 211.07/211.23 A genus of ALGAE in the family Saprolegniaceae. It causes root rot in plants and is also a pathogen of FISHES.%A%
% 211.07/211.23 |- mesh__dateRevised mesh__D044744 2005-06-30
% 211.07/211.23 |- skos__broader mesh__D044744smesh__D009868
% 211.07/211.23 |- mesh__historyNote mesh__D044744 2004
% 211.07/211.23 |- skos__historyNote mesh__D044744 Oomycetes %28%1978-2003%29%
% 211.07/211.23 |- skos__prefLabel mesh__D044744 Aphanomyces
% 211.07/211.23 |- mesh__dateCreated mesh__D044744 2003-07-09
% 211.07/211.23 |- mesh__recordMaintainer mesh__D044744 SYSTEM
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D016255 2006
% 211.07/211.23 |- mesh__recordMaintainer mesh__D016255 ssb
% 211.07/211.23 |- skos__altLabel mesh__D016255
% 211.07/211.23 Anisoylated Plasminogen-Streptokinase Activator Complex
% 211.07/211.23 |- skos__altLabel mesh__D016255 Reusch Brand of Anistreplase
% 211.07/211.23 |- skos__altLabel mesh__D016255 Madaus Brand of Anistreplase
% 211.07/211.23 |- skos__historyNote mesh__D016255 Fibrinolytic Agents %28%1966-1990%29%
% 211.07/211.23 |- mesh__recordOriginator mesh__D016255 RLS
% 211.07/211.23 |- skos__historyNote mesh__D016255 Streptokinase %28%1966-1990%29%
% 211.07/211.23 |- skos__altLabel mesh__D016255 APSAC
% 211.07/211.23 |- skos__prefLabel mesh__D016255 Anistreplase
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D016255 sjn
% 211.07/211.23 |- mesh__historyNote mesh__D016255 91
% 211.07/211.23 |- skos__altLabel mesh__D016255 Monmouth Brand Anistreplase
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D016255 91
% 211.07/211.23 |- rdf__type mesh__D016255sskos__Concept
% 211.07/211.23 |- skos__hiddenLabel mesh__D016255 Anistreplase Reusch Brand
% 211.07/211.23 |- mesh__dateCreated mesh__D016255 1990-05-07
% 211.07/211.23 |- skos__broader mesh__D016255smesh__D010960
% 211.07/211.23 |- skos__hiddenLabel mesh__D016255 Anistreplase Roberts Brand
% 211.07/211.23 |- skos__altLabel mesh__D016255 Roberts Brand of Anistreplase
% 211.07/211.23 |- skos__altLabel mesh__D016255 SmithKline Beecham Brand of Anistreplase
% 211.07/211.23 |- skos__hiddenLabel mesh__D016255 Brand Anistreplase, Monmouth
% 211.07/211.23 |- skos__hiddenLabel mesh__D016255 BRL26921
% 211.07/211.23 |- skos__broader mesh__D016255smesh__D013300
% 211.07/211.23 |- skos__hiddenLabel mesh__D016255 Anistreplase Madaus Brand
% 211.07/211.23 |- skos__hiddenLabel mesh__D016255 BRL 26921
% 211.07/211.23 |- skos__historyNote mesh__D016255 Plasminogen %28%1966-1990%29%
% 211.07/211.23 |- skos__hiddenLabel mesh__D016255 Anistreplase, Monmouth Brand
% 211.07/211.23 |- skos__scopeNote mesh__D016255
% 211.07/211.23 An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; %28%TISSUE PLASMINOGEN ACTIVATOR%29%; 16 minutes for URINARY PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents.%A%
% 211.07/211.23 |- mesh__dateEstablished mesh__D016255 1991-01-01
% 211.07/211.23 |- mesh__dateRevised mesh__D016255 2005-06-30
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002235 2005
% 211.07/211.23 |- skos__hiddenLabel mesh__D002235 70143, Bayer
% 211.07/211.23 |- mesh__dateRevised mesh__D002235 2004-07-07
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D002235 2006
% 211.07/211.23 |- skos__historyNote mesh__D002235 Carbamates %28%1966-1971%29%
% 211.07/211.23 |- skos__hiddenLabel mesh__D002235 NIA 10242
% 211.07/211.23 |- mesh__dateEstablished mesh__D002235 1991-01-01
% 211.07/211.23 |- skos__annotation mesh__D002235 TN 111 for eff on insects
% 211.07/211.23 |- mesh__dateCreated mesh__D002235 1999-01-01
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D002235 sjn
% 211.07/211.23 |- mesh__historyNote mesh__D002235
% 211.07/211.23 91%28%72%29%; was see under INSECTICIDES, CARBAMATE 1972-90
% 211.07/211.23 |- skos__broader mesh__D002235smesh__D048448
% 211.07/211.23 |- rdf__type mesh__D002235sskos__Concept
% 211.07/211.23 |- mesh__recordOriginator mesh__D002235 NLM
% 211.07/211.23 |- mesh__recordMaintainer mesh__D002235 ssb
% 211.07/211.23 |- skos__historyNote mesh__D002235 Insecticides %28%1966-1971%29%
% 211.07/211.23 |- skos__hiddenLabel mesh__D002235 NIA10242
% 211.07/211.23 |- skos__prefLabel mesh__D002235 Carbofuran
% 211.07/211.23 |- skos__scopeNote mesh__D002235
% 211.07/211.23 A cholinesterase inhibitor that is used as a systemic insecticide, an acaricide, and nematocide. %28%From Merck Index, 11th ed%29%%A%
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D002235
% 211.07/211.23 91; was see under INSECTICIDES, CARBAMATE 1972-90
% 211.07/211.23 |- mesh__dateCreated mesh__D026683 2001-07-25
% 211.07/211.23 |- mesh__historyNote mesh__D026683 2002
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Committees, Advisory
% 211.07/211.23 |- skos__scopeNote mesh__D026683
% 211.07/211.23 Groups set up to advise governmental bodies, societies, or other institutions on policy. %28%Bioethics Thesaurus%29%%A%
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Commissions, Governmental
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Review Committee
% 211.07/211.23 |- rdf__type mesh__D026683sskos__Concept
% 211.07/211.23 |- skos__broader mesh__D026683smesh__D011050
% 211.07/211.23 |- skos__historyNote mesh__D026683 Public Policy %28%1981-2001%29%
% 211.07/211.23 |- skos__prefLabel mesh__D026683 Advisory Committees
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Governmental Commission
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Committee, Review
% 211.07/211.23 |- skos__annotation mesh__D026683
% 211.07/211.23 coord IM with specific activity or agency %28%IM%29% + geog if pertinent%A%
% 211.07/211.23 |- skos__altLabel mesh__D026683 Task Forces
% 211.07/211.23 |- skos__related mesh__D026683smesh__D017041
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D026683 2002
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D026683 2004
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Commission, Governmental
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Committee, Advisory
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D026683 2006
% 211.07/211.23 |- mesh__dateEstablished mesh__D026683 2002-01-01
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Advisory Committee
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D026683 2002
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D026683 2003
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Task Force
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D026683 2005
% 211.07/211.23 |- skos__hiddenLabel mesh__D026683 Committees, Review
% 211.07/211.23 |- mesh__dateEstablished mesh__D012663 1966-01-01
% 211.07/211.23 |- mesh__historyNote mesh__D012663 66
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 2002
% 211.07/211.23 |- mesh__publicMeSHNote mesh__D012663 66
% 211.07/211.23 |- mesh__dateCreated mesh__D012663 1999-01-01
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 1994
% 211.07/211.23 |- skos__broader mesh__D012663smesh__D009930
% 211.07/211.23 |- mesh__dateRevised mesh__D012663 1992-05-20
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 2006
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 1999
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 2001
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 1993
% 211.07/211.23 |- mesh__recordMaintainer mesh__D012663 TAP
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 2005
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 1998
% 211.07/211.23 |- mesh__recordOriginator mesh__D012663 NLM
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 2000
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 2004
% 211.07/211.23 |- skos__prefLabel mesh__D012663 Semicarbazides
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 1997
% 211.07/211.23 |- rdf__type mesh__D012663sskos__Concept
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D012663 PLS
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 2003
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 1996
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D012663 1995
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006626 2000
% 211.07/211.23 |- mesh__dateCreated mesh__D006626 1999-01-01
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006626 2003
% 211.07/211.23 |- skos__broader mesh__D006626smesh__D001549
% 211.07/211.23 |- mesh__recordOriginator mesh__D006626 NLM
% 211.07/211.23 |- mesh__dateRevised mesh__D006626 1998-06-10
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006626 2001
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006626 2005
% 211.07/211.23 |- mesh__recordAuthorizer mesh__D006626 SJN
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006626 2004
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006626 1999
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006626 2006
% 211.07/211.23 |- skos__scopeNote mesh__D006626 Salts and esters of hippuric acid.
% 211.07/211.23 |- mesh__activeMeSHYear mesh__D006626 2002
% 211.07/211.23 |- mesh__recordMaintainer mesh__D006626 ADP
% 211.07/211.23 |- skos__broader mesh__D006626smesh__D007651
% 211.07/211.23 |- skos__prefLabel mesh__D006626 Hippurates
% 211.07/211.23 |- rdf__type mesh__D006626sskos__Concept
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D039002 2005
% 211.07/211.24 |- mesh__dateEstablished mesh__D039002 2003-01-01
% 211.07/211.24 |- skos__scopeNote mesh__D039002
% 211.07/211.24 Genomes of temperate BACTERIOPHAGES integrated into the DNA of their bacterial host cell. The prophages can be duplicated for many cell generations until some stimulus induces its activation and virulence.%A%
% 211.07/211.24 |- mesh__historyNote mesh__D039002 2003
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D039002 2006
% 211.07/211.24 |- skos__related mesh__D039002smesh__D008242
% 211.07/211.24 |- skos__annotation mesh__D039002
% 211.07/211.24 coord IM with specific bacteriophage %28%IM%29%
% 211.07/211.24 |- skos__altLabel mesh__D039002 Prophage
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D039002 2003
% 211.07/211.24 |- mesh__dateCreated mesh__D039002 2002-07-03
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D039002 2003
% 211.07/211.24 |- skos__historyNote mesh__D039002 Bacteriophages %28%1965-2002%29%
% 211.07/211.24 |- skos__prefLabel mesh__D039002 Prophages
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D039002 2004
% 211.07/211.24 |- rdf__type mesh__D039002sskos__Concept
% 211.07/211.24 |- skos__broader mesh__D039002smesh__D001435
% 211.07/211.24 |- skos__related mesh__D039002smesh__D011533
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782 pH Monitoring, Esophageal
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782 Recordings, Esophageal pH
% 211.07/211.24 |- mesh__recordMaintainer mesh__D050782 ags
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782 pH Recordings, Esophageal
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D050782 2006
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782 Monitorings, Esophageal pH
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D050782 sjn
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782
% 211.07/211.24 Ambulatory 24 hour Esophageal pH Monitoring
% 211.07/211.24 |- rdf__type mesh__D050782sskos__Concept
% 211.07/211.24 |- skos__altLabel mesh__D050782 Monitoring, Esophageal pH
% 211.07/211.24 |- skos__prefLabel mesh__D050782 Esophageal pH Monitoring
% 211.07/211.24 |- skos__historyNote mesh__D050782
% 211.07/211.24 Hydrogen-Ion Concentration %28%1975-2005%29%
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782 pH Recording, Esophageal
% 211.07/211.24 |- skos__broader mesh__D050782smesh__D018670
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782 Recording, Esophageal pH
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782 Esophageal pH Monitorings
% 211.07/211.24 |- mesh__dateEstablished mesh__D050782 2006-01-01
% 211.07/211.24 |- skos__broader mesh__D050782smesh__D019963
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782 pH Monitorings, Esophageal
% 211.07/211.24 |- skos__altLabel mesh__D050782 Esophageal pH Recording
% 211.07/211.24 |- skos__hiddenLabel mesh__D050782 Esophageal pH Recordings
% 211.07/211.24 |- skos__altLabel mesh__D050782 Ambulatory 24-hour Esophageal pH Monitoring
% 211.07/211.24 |- skos__scopeNote mesh__D050782
% 211.07/211.24 Analysis of the HYDROGEN ION CONCENTRATION in the lumen of the ESOPHAGUS. It is used to record the pattern, frequency, and duration of GASTROESOPHAGEAL REFLUX.%A%
% 211.07/211.24 |- mesh__dateCreated mesh__D050782 2005-06-30
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D050782 2006
% 211.07/211.24 |- mesh__historyNote mesh__D050782 2006
% 211.07/211.24 |- skos__broader mesh__D050782smesh__D008991
% 211.07/211.24 |- skos__broader mesh__D050782smesh__D003938
% 211.07/211.24 |- skos__historyNote mesh__D050782 Esophagus %28%1975-2005%29%
% 211.07/211.24 |- mesh__recordOriginator mesh__D050782 ags
% 211.07/211.24 |- skos__altLabel mesh__D016256 SSEA 1 Determinant
% 211.07/211.24 |- skos__historyNote mesh__D016256 Antigenic Determinants %28%1970-1990%29%
% 211.07/211.24 |- skos__altLabel mesh__D016256 Stage-Specific Embryonic Antigen-1
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 Sialyl SSEA 1
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 Embryonic Antigen-1, Stage-Specific
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 Fucosyl SSEA 1
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 SSEA-1, Sialyl
% 211.07/211.24 |- skos__altLabel mesh__D016256 SSEA-1
% 211.07/211.24 |- skos__annotation mesh__D016256
% 211.07/211.24 do not coord FUCOSYL SSEA-1 or SIALYL SSEA-1 with FUCOSE or SIALIC ACID unless particularly discussed; DF: SSEA1%A%
% 211.07/211.24 |- mesh__onlineNote mesh__D016256
% 211.07/211.24 use ANTIGENS, CD15 to search STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; use ANTIGENS, CD15 %28%NM%29% to search CD15 ANTIGEN %26% LEWIS X HAPTEN 1987-94; use ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC to search LEU-M1 ANTIGENS 1989-94%A%
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 3 Fucosyl N acetyl lactosamine
% 211.07/211.24 |- skos__historyNote mesh__D016256 Glycolipids %28%1966-1990%29%
% 211.07/211.24 |- skos__altLabel mesh__D016256 Hapten X
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 Determinant, SSEA 1
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D016256
% 211.07/211.24 95; was STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; LEU-M1 ANTIGENS was see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; CD 15 ANTIGEN was indexed under ANTIGENS, CD %26% ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1992-94 %26% ANTIGENS, DIFFERENTIATION 1987-91; LEWIS X HAPTEN was indexed under GANGLIOSIDES 1987-94%A%
% 211.07/211.24 |- mesh__recordOriginator mesh__D016256 RLS
% 211.07/211.24 |- mesh__dateRevised mesh__D016256 2005-06-30
% 211.07/211.24 |- skos__altLabel mesh__D016256 Le%28%X%29% Antigen
% 211.07/211.24 |- skos__altLabel mesh__D016256 Hapten Y
% 211.07/211.24 |- skos__altLabel mesh__D016256 CD15 Antigens
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D016256 2006
% 211.07/211.24 |- skos__altLabel mesh__D016256 CD15 Antigen
% 211.07/211.24 |- skos__altLabel mesh__D016256 SSEA 1
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D016256 sjn
% 211.07/211.24 |- skos__altLabel mesh__D016256 Lewis X Antigen
% 211.07/211.24 |- skos__broader mesh__D016256smesh__D020384
% 211.07/211.24 |- mesh__historyNote mesh__D016256
% 211.07/211.24 95; was STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; LEU-M1 ANTIGENS was see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; CD15 ANTIGENS was CD15 ANTIGEN %28%NM%29% 1987-94; LEWIS X HAPTEN was NM 1987-94%A%
% 211.07/211.24 |- skos__historyNote mesh__D016256
% 211.07/211.24 Tumor Markers, Biological %28%1988-1990%29%
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 3 Fucosyllactosamine Determinant
% 211.07/211.24 |- mesh__dateCreated mesh__D016256 1990-06-08
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 Stage Specific Embryonic Antigen 1
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 1 Determinant, SSEA
% 211.07/211.24 |- skos__historyNote mesh__D016256 Antigens, Neoplasm %28%1973-1990%29%
% 211.07/211.24 |- skos__broader mesh__D016256smesh__D015703
% 211.07/211.24 |- skos__altLabel mesh__D016256 Leu-M1 Antigens
% 211.07/211.24 |- skos__broader mesh__D016256smesh__D015295
% 211.07/211.24 |- rdf__type mesh__D016256sskos__Concept
% 211.07/211.24 |- skos__altLabel mesh__D016256 Lewis X Hapten
% 211.07/211.24 |- skos__prefLabel mesh__D016256 Antigens, CD15
% 211.07/211.24 |- mesh__recordMaintainer mesh__D016256 ssb
% 211.07/211.24 |- skos__scopeNote mesh__D016256
% 211.07/211.24 Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors.%A%
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 SSEA-1, Fucosyl
% 211.07/211.24 |- skos__broader mesh__D016256smesh__D015214
% 211.07/211.24 |- mesh__dateEstablished mesh__D016256 1991-01-01
% 211.07/211.24 |- skos__hiddenLabel mesh__D016256 Leu M1 Antigens
% 211.07/211.24 |- skos__altLabel mesh__D016256 SSEA-1 Determinant
% 211.07/211.24 |- mesh__recordMaintainer mesh__D002236 nns
% 211.07/211.24 |- skos__annotation mesh__D002236
% 211.07/211.24 IM general only; coord NIM with specific carbohydrate %28%IM%29%; do not confuse CARBOHYDRATE LINKAGE see CARBOHYDRATE CONFORMATION with CARBOHYDRATE SEQUENCE: conform = spatial or 3-dimensional struct, sequ = order in which components are arranged%A%
% 211.07/211.24 |- skos__hiddenLabel mesh__D002236 Conformations, Carbohydrate
% 211.07/211.24 |- mesh__dateCreated mesh__D002236 1979-05-24
% 211.07/211.24 |- skos__hiddenLabel mesh__D002236 Conformation, Carbohydrate
% 211.07/211.24 |- skos__hiddenLabel mesh__D002236 Carbohydrate Linkages
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D002236 2006
% 211.07/211.24 |- mesh__dateRevised mesh__D002236 2004-07-07
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D002236 80
% 211.07/211.24 |- skos__prefLabel mesh__D002236 Carbohydrate Conformation
% 211.07/211.24 |- skos__broader mesh__D002236smesh__D008968
% 211.07/211.24 |- mesh__dateEstablished mesh__D002236 1980-01-01
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D002236 2005
% 211.07/211.24 |- skos__hiddenLabel mesh__D002236 Linkage, Carbohydrate
% 211.07/211.24 |- mesh__recordOriginator mesh__D002236 VDK
% 211.07/211.24 |- skos__scopeNote mesh__D002236
% 211.07/211.24 The characteristic 3-dimensional shape of a carbohydrate.%A%
% 211.07/211.24 |- skos__historyNote mesh__D002236 Molecular Conformation %28%1973-1979%29%
% 211.07/211.24 |- skos__hiddenLabel mesh__D002236 Linkages, Carbohydrate
% 211.07/211.24 |- rdf__type mesh__D002236sskos__Concept
% 211.07/211.24 |- mesh__historyNote mesh__D002236 80
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D002236 sjn
% 211.07/211.24 |- skos__hiddenLabel mesh__D002236 Carbohydrate Conformations
% 211.07/211.24 |- mesh__historyNote mesh__D026684
% 211.07/211.24 2002; for SELF DETERMINATION use FREEDOM 1990-2001
% 211.07/211.24 |- skos__scopeNote mesh__D026684
% 211.07/211.24 Self-directing freedom and especially moral independence. An ethical principle holds that the autonomy of persons ought to be respected. %28%Bioethics Thesaurus%29%%A%
% 211.07/211.24 |- skos__broader mesh__D026684smesh__D011579
% 211.07/211.24 |- skos__broader mesh__D026684smesh__D005610
% 211.07/211.24 |- skos__prefLabel mesh__D026684 Personal Autonomy
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D026684
% 211.07/211.24 2002; for SELF DETERMINATION see FREEDOM 1990-2001
% 211.07/211.24 |- skos__altLabel mesh__D026684 Autonomy, Personal
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D026684 2004
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D026684 sjn
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D026684 2006
% 211.07/211.24 |- mesh__dateCreated mesh__D026684 2001-07-25
% 211.07/211.24 |- skos__related mesh__D026684smesh__D012649
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D026684 2003
% 211.07/211.24 |- mesh__recordMaintainer mesh__D026684 jrf
% 211.07/211.24 |- skos__related mesh__D026684smesh__D026706
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D026684 2005
% 211.07/211.24 |- mesh__dateEstablished mesh__D026684 2002-01-01
% 211.07/211.24 |- mesh__recordOriginator mesh__D026684 jrf
% 211.07/211.24 |- skos__historyNote mesh__D026684 Freedom %28%1974-2001%29%
% 211.07/211.24 |- skos__related mesh__D026684smesh__D017009
% 211.07/211.24 |- rdf__type mesh__D026684sskos__Concept
% 211.07/211.24 |- skos__broader mesh__D026684smesh__D028662
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D026684 2002
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 1994
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 2006
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D012664 PLS
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 1999
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D012664 74
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 1993
% 211.07/211.24 |- skos__historyNote mesh__D012664 Semicarbazides %28%1966-1971%29%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 2005
% 211.07/211.24 |- skos__historyNote mesh__D012664 Hemostatics %28%1966-1971%29%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 1998
% 211.07/211.24 |- skos__prefLabel mesh__D012664 Semicarbazones
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 2002
% 211.07/211.24 |- mesh__dateRevised mesh__D012664 1992-05-20
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 2004
% 211.07/211.24 |- skos__broader mesh__D012664smesh__D012663
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 1997
% 211.07/211.24 |- rdf__type mesh__D012664sskos__Concept
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 2001
% 211.07/211.24 |- skos__historyNote mesh__D012664 Nitrofurazone %28%1966-1971%29%
% 211.07/211.24 |- mesh__recordMaintainer mesh__D012664 TAP
% 211.07/211.24 |- mesh__historyNote mesh__D012664 74%28%72%29%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 2003
% 211.07/211.24 |- mesh__dateEstablished mesh__D012664 1974-01-01
% 211.07/211.24 |- skos__historyNote mesh__D012664 Thiosemicarbazones %28%1966-1971%29%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 1996
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 1995
% 211.07/211.24 |- mesh__recordOriginator mesh__D012664 NLM
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012664 2000
% 211.07/211.24 |- mesh__dateCreated mesh__D012664 1999-01-01
% 211.07/211.24 |- mesh__onlineNote mesh__D006627 search MEGACOLON 1966-82
% 211.07/211.24 |- mesh__recordMaintainer mesh__D006627 lkt
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D006627 2006
% 211.07/211.24 |- mesh__historyNote mesh__D006627
% 211.07/211.24 83; was HIRSCHSPRUNG%27%S DISEASE see MEGACOLON 1963-82
% 211.07/211.24 |- skos__altLabel mesh__D006627 Total Colonic Aganglionosis
% 211.07/211.24 |- skos__altLabel mesh__D006627 Hirschsprung%27%s Disease
% 211.07/211.24 |- skos__broader mesh__D006627smesh__D008531
% 211.07/211.24 |- skos__altLabel mesh__D006627 Rectosigmoid Aganglionosis
% 211.07/211.24 |- mesh__dateRevised mesh__D006627 2003-07-09
% 211.07/211.24 |- skos__altLabel mesh__D006627 Colonic Aganglionosis
% 211.07/211.24 |- skos__scopeNote mesh__D006627
% 211.07/211.24 Congenital MEGACOLON resulting from the absence of ganglion cells %28%aganglionosis%29% in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.%A%
% 211.07/211.24 |- skos__annotation mesh__D006627 acquired megacolon = MEGACOLON
% 211.07/211.24 |- skos__hiddenLabel mesh__D006627 Hirschsprungs Disease
% 211.07/211.24 |- skos__altLabel mesh__D006627 Megacolon, Congenital
% 211.07/211.24 |- skos__prefLabel mesh__D006627 Hirschsprung Disease
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D006627
% 211.07/211.24 83; was HIRSCHSPRUNG%27%S DISEASE see MEGACOLON 1963-82
% 211.07/211.24 |- skos__broader mesh__D006627smesh__D004065
% 211.07/211.24 |- mesh__dateCreated mesh__D006627 1982-04-27
% 211.07/211.24 |- mesh__recordOriginator mesh__D006627 RC
% 211.07/211.24 |- skos__historyNote mesh__D006627 Megacolon %28%1966-1982%29%
% 211.07/211.24 |- rdf__type mesh__D006627sskos__Concept
% 211.07/211.24 |- mesh__dateEstablished mesh__D006627 1983-01-01
% 211.07/211.24 |- skos__hiddenLabel mesh__D006627 Disease, Hirschsprung
% 211.07/211.24 |- skos__hiddenLabel mesh__D006627 Disease, Hirschsprung%27%s
% 211.07/211.24 |- skos__hiddenLabel mesh__D006627 Rectosigmoid Colon Aganglionosis
% 211.07/211.24 |- skos__hiddenLabel mesh__D006627 Aganglionosis, Rectosigmoid
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D006627 sjn
% 211.07/211.24 |- skos__altLabel mesh__D006627 Congenital Megacolon
% 211.07/211.24 |- skos__altLabel mesh__D006627 Aganglionosis, Total Colonic
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D006627 2005
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D006627 2004
% 211.07/211.24 |- skos__broader mesh__D011618Q000139smesh__D011618
% 211.07/211.24 |- mesh__preferredCombination mesh__D011618Q000139smesh__D011605
% 211.07/211.24 |- rdf__type mesh__D011618Q000139smesh__CompoundConcept
% 211.07/211.24 |- skos__hiddenLabel mesh__D050783 Transcription Factors, ets
% 211.07/211.24 |- skos__broader mesh__D050783smesh__D004268
% 211.07/211.24 |- skos__altLabel mesh__D050783 Proto-Oncogene Protein ets
% 211.07/211.24 |- skos__altLabel mesh__D050783 c-ets Protein
% 211.07/211.24 |- mesh__recordOriginator mesh__D050783 jmp
% 211.07/211.24 |- skos__broader mesh__D050783smesh__D014157
% 211.07/211.24 |- skos__prefLabel mesh__D050783 Proto-Oncogene Proteins c-ets
% 211.07/211.24 |- skos__hiddenLabel mesh__D050783 Proto Oncogene Proteins c ets
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D050783
% 211.07/211.24 2006; PROTO-ONCOGENE PROTEINS C-ETS was indexed under PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1986-2005%A%
% 211.07/211.24 |- skos__hiddenLabel mesh__D050783 c-ets, Proto-Oncogene Proteins
% 211.07/211.24 |- mesh__dateCreated mesh__D050783 2005-06-30
% 211.07/211.24 |- mesh__recordMaintainer mesh__D050783 jmp
% 211.07/211.24 |- skos__hiddenLabel mesh__D050783 Proto Oncogene Protein ets
% 211.07/211.24 |- skos__altLabel mesh__D050783 c-ets Proto-Oncogene Proteins
% 211.07/211.24 |- skos__altLabel mesh__D050783 ets Transcription Factors
% 211.07/211.24 |- skos__hiddenLabel mesh__D050783 c ets Proto Oncogene Proteins
% 211.07/211.24 |- skos__historyNote mesh__D050783 Transcription Factors %28%1986-2005%29%
% 211.07/211.24 |- skos__broader mesh__D050783smesh__D011518
% 211.07/211.24 |- mesh__historyNote mesh__D050783 2006%28%1986%29%
% 211.07/211.24 |- skos__historyNote mesh__D050783
% 211.07/211.24 Proto-Oncogene Proteins %28%1986-2005%29%
% 211.07/211.24 |- skos__hiddenLabel mesh__D050783 Proto-Oncogene Proteins, ets
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D050783 sjn
% 211.07/211.24 |- skos__scopeNote mesh__D050783
% 211.07/211.24 A family of transcription factors that share a unique DNA-binding domain. The name derives from viral oncogene-derived protein ONCOGENE PROTEIN V-ETS of the AVIAN ERYTHROBLASTOSIS VIRUS.%A%
% 211.07/211.24 |- skos__altLabel mesh__D050783 ets Proto-Oncogene Proteins
% 211.07/211.24 |- skos__hiddenLabel mesh__D050783 c ets Protein
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D050783 2006
% 211.07/211.24 |- mesh__dateEstablished mesh__D050783 2006-01-01
% 211.07/211.24 |- skos__hiddenLabel mesh__D050783 Proto-Oncogene Proteins, c-ets
% 211.07/211.24 |- skos__hiddenLabel mesh__D050783 ets Proto Oncogene Proteins
% 211.07/211.24 |- rdf__type mesh__D050783sskos__Concept
% 211.07/211.24 |- skos__annotation mesh__D016257 D25-26 qualif
% 211.07/211.24 |- skos__prefLabel mesh__D016257 Fura-2
% 211.07/211.24 |- skos__historyNote mesh__D016257 Chelating Agents %28%1966-1990%29%
% 211.07/211.24 |- skos__broader mesh__D016257smesh__D010080
% 211.07/211.24 |- skos__historyNote mesh__D016257 Benzofurans %28%1966-1990%29%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D016257 2006
% 211.07/211.24 |- mesh__dateEstablished mesh__D016257 1991-01-01
% 211.07/211.24 |- mesh__dateRevised mesh__D016257 2005-06-30
% 211.07/211.24 |- skos__broader mesh__D016257smesh__D001572
% 211.07/211.24 |- mesh__recordMaintainer mesh__D016257 ssb
% 211.07/211.24 |- mesh__recordOriginator mesh__D016257 RLS
% 211.07/211.24 |- skos__historyNote mesh__D016257 Oxazoles %28%1966-1990%29%
% 211.07/211.24 |- skos__historyNote mesh__D016257 Fluorescent Dyes %28%1966-1990%29%
% 211.07/211.24 |- skos__scopeNote mesh__D016257
% 211.07/211.24 A fluorescent calcium chelating agent which is used to study intracellular calcium in many tissues. The fluorescent and chelating properties of Fura-2 aid in the quantitation of endothelial cell injury, in monitoring ATP-dependent calcium uptake by membrane vesicles, and in the determination of the relationship between cytoplasmic free calcium and oxidase activation in rat neutrophils.%A%
% 211.07/211.24 |- skos__hiddenLabel mesh__D016257 Fura 2
% 211.07/211.24 |- mesh__historyNote mesh__D016257 91
% 211.07/211.24 |- rdf__type mesh__D016257sskos__Concept
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D016257 sjn
% 211.07/211.24 |- mesh__dateCreated mesh__D016257 1990-05-07
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D016257 91
% 211.07/211.24 |- skos__hiddenLabel mesh__D002237 Oxidoreductases, Carbohydrate
% 211.07/211.24 |- skos__scopeNote mesh__D002237
% 211.07/211.24 Reversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2.; and 1.1.99.%A%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D002237 2004
% 211.07/211.24 |- skos__altLabel mesh__D002237 Carbohydrate Oxidoreductases
% 211.07/211.24 |- skos__broader mesh__D002237smesh__D000429
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D002237
% 211.07/211.24 78; FRUCTURONATE REDUCTASE, PHOSPHOGLYCERATE DEHYDROGENASE, TAGATURONATE REDUCTASE %26% URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE were see under ALCOHOL OXIDOREDUCTASES 1975-77%A%
% 211.07/211.24 |- mesh__historyNote mesh__D002237 78
% 211.07/211.24 |- mesh__recordOriginator mesh__D002237 RLS
% 211.07/211.24 |- mesh__dateRevised mesh__D002237 2003-07-09
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D002237 2006
% 211.07/211.24 |- skos__hiddenLabel mesh__D002237 Dehydrogenases, Carbohydrate
% 211.07/211.24 |- skos__prefLabel mesh__D002237 Carbohydrate Dehydrogenases
% 211.07/211.24 |- mesh__recordMaintainer mesh__D002237 ssb
% 211.07/211.24 |- rdf__type mesh__D002237sskos__Concept
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D002237 2005
% 211.07/211.24 |- skos__historyNote mesh__D002237
% 211.07/211.24 Alcohol Oxidoreductases %28%1966-1977%29%
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D002237 sjn
% 211.07/211.24 |- mesh__dateEstablished mesh__D002237 1978-01-01
% 211.07/211.24 |- mesh__dateCreated mesh__D002237 1977-04-15
% 211.07/211.24 |- skos__broader mesh__D007720smesh__D007595
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D007720 2001
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D007720 1998
% 211.07/211.24 |- skos__annotation mesh__D007720
% 211.07/211.24 do not use /util except by MeSH definition
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D007720 SJN
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D007720 2005
% 211.07/211.24 |- skos__hiddenLabel mesh__D007720 Knee Prostheses
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D007720 2002
% 211.07/211.24 |- skos__scopeNote mesh__D007720 Replacement for a knee joint.
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D007720 1999
% 211.07/211.24 |- mesh__recordOriginator mesh__D007720 SMH
% 211.07/211.24 |- skos__historyNote mesh__D007720 Knee Joint %28%1966-1979%29%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D007720 2003
% 211.07/211.24 |- skos__historyNote mesh__D007720 Knee %28%1966-1979%29%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D007720 2006
% 211.07/211.24 |- skos__hiddenLabel mesh__D007720 Prostheses, Knee
% 211.07/211.24 |- skos__historyNote mesh__D007720 Prosthesis %28%1966-1970%29%
% 211.07/211.24 |- mesh__historyNote mesh__D007720 80
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D007720 2004
% 211.07/211.24 |- skos__related mesh__D007720smesh__D019645
% 211.07/211.24 |- skos__historyNote mesh__D007720 Arthroplasty %28%1966-1979%29%
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D007720 80
% 211.07/211.24 |- skos__historyNote mesh__D007720 Joint Prosthesis %28%1971-1979%29%
% 211.07/211.24 |- skos__prefLabel mesh__D007720 Knee Prosthesis
% 211.07/211.24 |- mesh__dateCreated mesh__D007720 1978-12-19
% 211.07/211.24 |- mesh__dateRevised mesh__D007720 1997-06-20
% 211.07/211.24 |- skos__hiddenLabel mesh__D007720 Prosthesis, Knee
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D007720 2000
% 211.07/211.24 |- mesh__dateEstablished mesh__D007720 1980-01-01
% 211.07/211.24 |- mesh__recordMaintainer mesh__D007720 PXP
% 211.07/211.24 |- rdf__type mesh__D007720sskos__Concept
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1991
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1999
% 211.07/211.24 |- skos__scopeNote mesh__D012665
% 211.07/211.24 Three long canals %28%anterior, posterior, and lateral%29% of the labyrinth. They are set at right angles to each other and are situated superior and posterior to the vestibule.%A%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1994
% 211.07/211.24 |- mesh__dateRevised mesh__D012665 1989-05-16
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1990
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1998
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 2006
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1993
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 2002
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1997
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 2005
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1992
% 211.07/211.24 |- rdf__type mesh__D012665sskos__Concept
% 211.07/211.24 |- skos__hiddenLabel mesh__D012665 Canal, Semicircular
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 2001
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1996
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 2004
% 211.07/211.24 |- mesh__recordOriginator mesh__D012665 NLM
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 2000
% 211.07/211.24 |- mesh__recordMaintainer mesh__D012665 PXP
% 211.07/211.24 |- skos__hiddenLabel mesh__D012665 Semicircular Canal
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 2003
% 211.07/211.24 |- mesh__dateCreated mesh__D012665 1999-01-01
% 211.07/211.24 |- skos__broader mesh__D012665smesh__D007758
% 211.07/211.24 |- skos__hiddenLabel mesh__D012665 Canals, Semicircular
% 211.07/211.24 |- skos__prefLabel mesh__D012665 Semicircular Canals
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D012665 1995
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D012665 PLS
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D006628 sjn
% 211.07/211.24 |- mesh__recordMaintainer mesh__D006628 lkt
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D006628
% 211.07/211.24 66; was see under HYPERTRICHOSIS 1963-65
% 211.07/211.24 |- rdf__type mesh__D006628sskos__Concept
% 211.07/211.24 |- mesh__historyNote mesh__D006628
% 211.07/211.24 66%28%64%29%; was see under HYPERTRICHOSIS 1963-65
% 211.07/211.24 |- skos__prefLabel mesh__D006628 Hirsutism
% 211.07/211.24 |- skos__broader mesh__D006628smesh__D014770
% 211.07/211.24 |- skos__broader mesh__D006628smesh__D006201
% 211.07/211.24 |- mesh__dateCreated mesh__D006628 1999-01-01
% 211.07/211.24 |- skos__related mesh__D006628smesh__D006983
% 211.07/211.24 |- skos__scopeNote mesh__D006628
% 211.07/211.24 A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.%A%
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D006628 2005
% 211.07/211.24 |- mesh__recordOriginator mesh__D006628 NLM
% 211.07/211.24 |- mesh__dateRevised mesh__D006628 2004-07-07
% 211.07/211.24 |- mesh__dateEstablished mesh__D006628 1966-01-01
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D006628 2006
% 211.07/211.24 |- skos__broader mesh__D017350smesh__D017349
% 211.07/211.24 |- skos__hiddenLabel mesh__D017350 Transferases, N-Acetylgalactosamine
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D017350 2006
% 211.07/211.24 |- mesh__dateCreated mesh__D017350 1992-05-22
% 211.07/211.24 |- skos__hiddenLabel mesh__D017350 N Acetylgalactosaminyltransferases
% 211.07/211.24 |- skos__prefLabel mesh__D017350 N-Acetylgalactosaminyltransferases
% 211.07/211.24 |- skos__altLabel mesh__D017350 N-Acetylgalactosamine Transferases
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D017350 sjn
% 211.07/211.24 |- mesh__dateEstablished mesh__D017350 1993-01-01
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D017350 2005
% 211.07/211.24 |- mesh__historyNote mesh__D017350 93
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D017350 2004
% 211.07/211.24 |- rdf__type mesh__D017350sskos__Concept
% 211.07/211.24 |- skos__hiddenLabel mesh__D017350 N Acetylgalactosamine Transferases
% 211.07/211.24 |- mesh__dateRevised mesh__D017350 2003-07-09
% 211.07/211.24 |- skos__historyNote mesh__D017350 Galactosyltransferases %28%1976-1992%29%
% 211.07/211.24 |- skos__scopeNote mesh__D017350
% 211.07/211.24 Enzymes that catalyze the transfer of N-acetylgalactosamine from a nucleoside diphosphate N-acetylgalactosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A%
% 211.07/211.24 |- mesh__recordMaintainer mesh__D017350 ssb
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D017350 93
% 211.07/211.24 |- mesh__recordOriginator mesh__D017350 TPW
% 211.07/211.24 |- mesh__historyNote mesh__D031021 2003
% 211.07/211.24 |- skos__broader mesh__D031021smesh__D027926
% 211.07/211.24 |- mesh__recordAuthorizer mesh__D031021 sjn
% 211.07/211.24 |- rdf__type mesh__D031021sskos__Concept
% 211.07/211.24 |- skos__scopeNote mesh__D031021
% 211.07/211.24 A plant genus of the family ANACARDIACEAE. This is the source of the familiar cashew nuts, which are heat treated to remove the irritant toxin. Cashew nut shell liquid %28%frequently abbreviated as CNSL%29% is a major source of alkenyl phenolic compounds, especially ANACARDIC ACIDS, cardol, and cardanol.%A%
% 211.07/211.24 |- skos__annotation mesh__D031021
% 211.07/211.24 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.24 |- mesh__dateRevised mesh__D031021 2004-07-07
% 211.07/211.24 |- mesh__recordMaintainer mesh__D031021 ssb
% 211.07/211.24 |- mesh__recordOriginator mesh__D031021 ssb
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D031021 2006
% 211.07/211.24 |- mesh__dateEstablished mesh__D031021 2003-01-01
% 211.07/211.24 |- mesh__publicMeSHNote mesh__D031021 2003
% 211.07/211.24 |- skos__prefLabel mesh__D031021 Anacardium
% 211.07/211.24 |- mesh__dateCreated mesh__D031021 2002-07-02
% 211.07/211.24 |- mesh__activeMeSHYear mesh__D031021 2005
% 211.07/211.24 |- skos__hiddenLabel mesh__D050784 c ets 1 Protein
% 211.07/211.24 |- mesh__dateEstablished mesh__D050784 2006-01-01
% 211.07/211.24 |- skos__altLabel mesh__D050784 Ets-1 Transcription Factor
% 211.07/211.24 |- skos__altLabel mesh__D050784 Proto-Oncogene Protein ets-1
% 211.07/211.24 |- mesh__recordMaintainer mesh__D050784 jmp
% 211.07/211.24 |- skos__hiddenLabel mesh__D050784 c ets1 Transcription Factor
% 211.07/211.24 |- skos__hiddenLabel mesh__D050784 Proto Oncogene Protein c ets 1
% 211.07/211.24 |- skos__historyNote mesh__D050784 Transcription Factors %28%1986-2005%29%
% 211.07/211.24 |- mesh__recordOriginator mesh__D050784 jmp
% 211.07/211.24 |- skos__altLabel mesh__D050784 c-ets-1 Protein
% 211.07/211.24 |- skos__hiddenLabel mesh__D050784 Ets 1 Transcription Factor
% 211.07/211.24 |- skos__prefLabel mesh__D050784 Proto-Oncogene Protein c-ets-1
% 211.07/211.24 |- mesh__dateCreated mesh__D050784 2005-06-30
% 211.07/211.24 |- skos__hiddenLabel mesh__D050784 Proto Oncogene Proteins c ets 1
% 211.07/211.24 |- mesh__historyNote mesh__D050784 2006%28%1986%29%
% 211.07/211.25 |- skos__hiddenLabel mesh__D050784 Transcription Factor, c-ets1
% 211.07/211.25 |- skos__broader mesh__D050784smesh__D050783
% 211.07/211.25 |- skos__hiddenLabel mesh__D050784 Proto Oncogene Protein ets 1
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D050784 2006
% 211.07/211.25 |- skos__hiddenLabel mesh__D050784 Transcription Factor, Ets-1
% 211.07/211.25 |- rdf__type mesh__D050784sskos__Concept
% 211.07/211.25 |- skos__altLabel mesh__D050784 Proto-Oncogene Proteins c-ets-1
% 211.07/211.25 |- skos__altLabel mesh__D050784 c-ets1 Transcription Factor
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D050784
% 211.07/211.25 2006; PROTO-ONCOGENE PROTEINS C-ETS-1 was indexed under PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1986-2005%A%
% 211.07/211.25 |- skos__historyNote mesh__D050784
% 211.07/211.25 Proto-Oncogene Proteins %28%1986-2005%29%
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D050784 sjn
% 211.07/211.25 |- skos__hiddenLabel mesh__D050784 c-ets-1, Proto-Oncogene Proteins
% 211.07/211.25 |- skos__hiddenLabel mesh__D050784 ets-1, Proto-Oncogene Protein
% 211.07/211.25 |- skos__hiddenLabel mesh__D050784 c-ets-1, Proto-Oncogene Protein
% 211.07/211.25 |- skos__annotation mesh__D050784 see SCR for organism-specific terms
% 211.07/211.25 |- skos__scopeNote mesh__D050784
% 211.07/211.25 An ets proto-oncogene expressed primarily in adult LYMPHOID TISSUE; BRAIN; and VASCULAR ENDOTHELIAL CELLS.%A%
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D003330 2005
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D003330 2000
% 211.07/211.25 |- mesh__dateCreated mesh__D003330 1999-01-01
% 211.07/211.25 |- skos__broader mesh__D003330smesh__D006330
% 211.07/211.25 |- skos__hiddenLabel mesh__D003330 Coronary Vessel Anomaly
% 211.07/211.25 |- mesh__recordOriginator mesh__D003330 NLM
% 211.07/211.25 |- skos__hiddenLabel mesh__D003330 Anomalies, Coronary Vessel
% 211.07/211.25 |- skos__scopeNote mesh__D003330
% 211.07/211.25 Defects of coronary arteries or veins including anomalous origin, arteriovenous fistula or aneurysm, myocardial bridging, or other abnormalities of structure or development.%A%
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D003330 sjn
% 211.07/211.25 |- mesh__recordMaintainer mesh__D003330 kle
% 211.07/211.25 |- rdf__type mesh__D003330sskos__Concept
% 211.07/211.25 |- mesh__dateRevised mesh__D003330 1999-11-03
% 211.07/211.25 |- skos__prefLabel mesh__D003330 Coronary Vessel Anomalies
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D003330 2002
% 211.07/211.25 |- skos__annotation mesh__D003330
% 211.07/211.25 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 211.07/211.25 |- skos__hiddenLabel mesh__D003330 Anomaly, Coronary Vessel
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D003330 2004
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D003330 2001
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D003330 2006
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D003330 2003
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Genes, v-mos
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 mos Gene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 v mos Oncogenes
% 211.07/211.25 |- skos__historyNote mesh__D016258 Oncogenes %28%1983-1985%29%
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 c-mos Gene
% 211.07/211.25 |- skos__altLabel mesh__D016258 mos Genes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 mos Oncogene
% 211.07/211.25 |- mesh__dateRevised mesh__D016258 2005-06-30
% 211.07/211.25 |- mesh__recordMaintainer mesh__D016258 nns
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Oncogenes, v-mos
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Proto-Oncogenes, mos
% 211.07/211.25 |- skos__scopeNote mesh__D016258
% 211.07/211.25 Retrovirus-associated DNA sequences %28%mos%29% originally isolated from the Moloney murine sarcoma virus %28%Mo-MSV%29%. The proto-oncogene mos %28%c-mos%29% codes for a protein which is a member of the serine kinase family. There is no evidence as yet that human c-mos can become transformed or has a role in human cancer. However, in mice, activation can occur when the retrovirus-like intracisternal A-particle inserts itself near the c-mos sequence. The human c-mos gene is located at 8q22 on the long arm of chromosome 8.%A%
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 c mos Proto Oncogenes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 c mos Genes
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D016258 sjn
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 mos Proto-Oncogene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 mos Proto Oncogenes
% 211.07/211.25 |- skos__historyNote mesh__D016258 Proto-Oncogenes %28%1986-1990%29%
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 v-mos Oncogene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Proto-Oncogenes, c-mos
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Oncogene, v-mos
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 c-mos Proto-Oncogene
% 211.07/211.25 |- mesh__dateCreated mesh__D016258 1990-05-07
% 211.07/211.25 |- skos__annotation mesh__D016258 mos stands for %22%MOloney Sarcoma%22%
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D016258 2006
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 v-mos Gene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 v mos Genes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Oncogenes, mos
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Gene, c-mos
% 211.07/211.25 |- skos__broader mesh__D016258smesh__D011519
% 211.07/211.25 |- mesh__historyNote mesh__D016258 91
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Proto-Oncogene, c-mos
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Gene, mos
% 211.07/211.25 |- skos__prefLabel mesh__D016258 Genes, mos
% 211.07/211.25 |- mesh__dateEstablished mesh__D016258 1991-01-01
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Gene, v-mos
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D016258 91
% 211.07/211.25 |- skos__related mesh__D016258smesh__D007426
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Proto-Oncogene, mos
% 211.07/211.25 |- rdf__type mesh__D016258sskos__Concept
% 211.07/211.25 |- mesh__recordOriginator mesh__D016258 AGS
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Oncogene, mos
% 211.07/211.25 |- skos__historyNote mesh__D016258 Genes, Viral %28%1982%29%
% 211.07/211.25 |- skos__hiddenLabel mesh__D016258 Genes, c-mos
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D002238 2004
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D002238 sjn
% 211.07/211.25 |- mesh__recordOriginator mesh__D002238 NLM
% 211.07/211.25 |- skos__hiddenLabel mesh__D002238 Epimerases, Carbohydrate
% 211.07/211.25 |- skos__altLabel mesh__D002238 Carbohydrate Isomerases
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D002238 73
% 211.07/211.25 |- mesh__historyNote mesh__D002238 73
% 211.07/211.25 |- mesh__dateRevised mesh__D002238 2003-07-09
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D002238 2006
% 211.07/211.25 |- skos__historyNote mesh__D002238 Isomerases %28%1966-1972%29%
% 211.07/211.25 |- skos__hiddenLabel mesh__D002238 Isomerases, Carbohydrate
% 211.07/211.25 |- skos__prefLabel mesh__D002238 Carbohydrate Epimerases
% 211.07/211.25 |- rdf__type mesh__D002238sskos__Concept
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D002238 2005
% 211.07/211.25 |- mesh__dateCreated mesh__D002238 1999-01-01
% 211.07/211.25 |- skos__scopeNote mesh__D002238
% 211.07/211.25 Enzymes that catalyze the epimerization of chiral centers within carbohydrates or their derivatives. EC 5.1.3.%A%
% 211.07/211.25 |- mesh__dateEstablished mesh__D002238 1973-01-01
% 211.07/211.25 |- skos__broader mesh__D002238smesh__D019998
% 211.07/211.25 |- mesh__recordMaintainer mesh__D002238 ssb
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D007721
% 211.07/211.25 79; was KNOWLEDGE OF RESULTS 1965-78
% 211.07/211.25 |- mesh__onlineNote mesh__D007721
% 211.07/211.25 use KNOWLEDGE OF RESULTS %28%PSYCHOLOGY%29% to search KNOWLEDGE OF RESULTS 1966-78%A%
% 211.07/211.25 |- mesh__dateEstablished mesh__D007721 1965-01-01
% 211.07/211.25 |- skos__hiddenLabel mesh__D007721 Results Knowledge %28%Psychology%29%
% 211.07/211.25 |- skos__annotation mesh__D007721 no qualif; DF: KNOWLEDGE OF RESULTS
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007721 2001
% 211.07/211.25 |- skos__broader mesh__D007721smesh__D012054
% 211.07/211.25 |- skos__related mesh__D007721smesh__D005246
% 211.07/211.25 |- rdf__type mesh__D007721sskos__Concept
% 211.07/211.25 |- mesh__recordOriginator mesh__D007721 NLM
% 211.07/211.25 |- skos__scopeNote mesh__D007721
% 211.07/211.25 A principle that learning is facilitated when the learner receives immediate evaluation of learning performance. The concept also hypothesizes that learning is facilitated when the learner is promptly informed whether a response is correct, and, if incorrect, of the direction of error.%A%
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007721 2000
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007721 2004
% 211.07/211.25 |- mesh__dateCreated mesh__D007721 1999-01-01
% 211.07/211.25 |- skos__prefLabel mesh__D007721 Knowledge of Results %28%Psychology%29%
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007721 2006
% 211.07/211.25 |- mesh__historyNote mesh__D007721 79; was KNOWLEDGE OF RESULTS 1965-78
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007721 2003
% 211.07/211.25 |- mesh__recordMaintainer mesh__D007721 jls
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D007721 sjn
% 211.07/211.25 |- mesh__dateRevised mesh__D007721 1999-11-03
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007721 2005
% 211.07/211.25 |- skos__altLabel mesh__D007721 Knowledge of Results
% 211.07/211.25 |- skos__hiddenLabel mesh__D007721 Results Knowledges %28%Psychology%29%
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007721 2002
% 211.07/211.25 |- skos__broader mesh__D012601Q000031smesh__D012601
% 211.07/211.25 |- mesh__preferredCombination mesh__D012601Q000031smesh__D012602
% 211.07/211.25 |- rdf__type mesh__D012601Q000031smesh__CompoundConcept
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D026686 2005
% 211.07/211.25 |- skos__prefLabel mesh__D026686 Beneficence
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D026686 2004
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D026686 2002
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D026686 2006
% 211.07/211.25 |- skos__historyNote mesh__D026686 Altruism %28%1974-2001%29%
% 211.07/211.25 |- skos__related mesh__D026686smesh__D026706
% 211.07/211.25 |- skos__altLabel mesh__D026686 Benevolence
% 211.07/211.25 |- skos__related mesh__D026686smesh__D000533
% 211.07/211.25 |- rdf__type mesh__D026686sskos__Concept
% 211.07/211.25 |- mesh__dateCreated mesh__D026686 2001-07-25
% 211.07/211.25 |- skos__broader mesh__D026686smesh__D028662
% 211.07/211.25 |- mesh__historyNote mesh__D026686 2002; use ALTRUISM 1978-2001
% 211.07/211.25 |- mesh__dateEstablished mesh__D026686 2002-01-01
% 211.07/211.25 |- skos__scopeNote mesh__D026686
% 211.07/211.25 The state or quality of being kind, charitable, or beneficial. %28%from American Heritage Dictionary of the English Language, 4th ed%29%. The ethical principle of BENEFICENCE requires producing net benefit over harm. %28%Bioethics Thesaurus%29%%A%
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D026686 2002; see ALTRUISM 1978-2001
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D026686 2003
% 211.07/211.25 |- skos__broader mesh__D012666smesh__D004581
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 1997
% 211.07/211.25 |- mesh__recordOriginator mesh__D012666 NLM
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 2005
% 211.07/211.25 |- rdf__type mesh__D012666sskos__Concept
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 2000
% 211.07/211.25 |- mesh__dateRevised mesh__D012666 1992-05-18
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 1996
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D012666 73
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 2004
% 211.07/211.25 |- skos__prefLabel mesh__D012666 Semiconductors
% 211.07/211.25 |- skos__annotation mesh__D012666 NIM
% 211.07/211.25 |- skos__hiddenLabel mesh__D012666 Semiconductor
% 211.07/211.25 |- mesh__historyNote mesh__D012666
% 211.07/211.25 73%28%67%29%; was in Cat H %26% J 1967-82
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 2003
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D012666 PLS
% 211.07/211.25 |- mesh__dateCreated mesh__D012666 1999-01-01
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 1995
% 211.07/211.25 |- skos__historyNote mesh__D012666 Electronics %28%1966%29%
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 1999
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 1994
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 2002
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 1998
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 2006
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 1993
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D012666 2001
% 211.07/211.25 |- skos__historyNote mesh__D012666 Electricity %28%1966%29%
% 211.07/211.25 |- mesh__dateEstablished mesh__D012666 1973-01-01
% 211.07/211.25 |- mesh__recordMaintainer mesh__D012666 TAP
% 211.07/211.25 |- mesh__dateCreated mesh__D045042 2003-07-09
% 211.07/211.25 |- skos__prefLabel mesh__D045042 Pedunculopontine Tegmental Nucleus
% 211.07/211.25 |- mesh__dateEstablished mesh__D045042 2004-01-01
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D045042 2004
% 211.07/211.25 |- skos__historyNote mesh__D045042 Mesencephalon %28%1980-2003%29%
% 211.07/211.25 |- skos__broader mesh__D045042smesh__D013681
% 211.07/211.25 |- skos__historyNote mesh__D045042 Tegmentum Mesencephali %28%1980-2003%29%
% 211.07/211.25 |- skos__scopeNote mesh__D045042
% 211.07/211.25 Dense collection of cells in the caudal pontomesencephalic tegmentum known to play a role in the functional organization of the BASAL GANGLIA and in the modulation of the thalamocortical neuronal system.%A%
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D045042 2005
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D045042 2004
% 211.07/211.25 |- skos__hiddenLabel mesh__D045042 Tegmental Nucleus, Pedunculopontine
% 211.07/211.25 |- mesh__historyNote mesh__D045042 2004
% 211.07/211.25 |- skos__hiddenLabel mesh__D045042 Nucleus, Pedunculopontine Tegmental
% 211.07/211.25 |- rdf__type mesh__D045042sskos__Concept
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D045042 2006
% 211.07/211.25 |- skos__altLabel mesh__D045042 Nucleus tegmentalis pedunculopontinus
% 211.07/211.25 |- skos__scopeNote mesh__D006629
% 211.07/211.25 Single-chain polypeptides of about 65 amino acids %28%7 kDa%29% from LEECHES that have a neutral hydrophobic N terminus, an acidic hydrophilic C terminus, and a compact, hydrophobic core region. Recombinant hirudins lack tyr-63 sulfation so are referred to as %27%desulfato-hirudins%27%. They form a stable non-covalent complex with ALPHA-THROMBIN, thereby abolishing its ability to cleave FIBRINOGEN.%A%
% 211.07/211.25 |- skos__broader mesh__D006629smesh__D000991
% 211.07/211.25 |- mesh__historyNote mesh__D006629 2005%28%1963%29%
% 211.07/211.25 |- mesh__dateRevised mesh__D006629 2004-08-06
% 211.07/211.25 |- mesh__recordOriginator mesh__D006629 NLM
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D006629 2006
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D006629 2005
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D006629 2005B
% 211.07/211.25 |- mesh__recordMaintainer mesh__D006629 jls
% 211.07/211.25 |- rdf__type mesh__D006629sskos__Concept
% 211.07/211.25 |- mesh__dateCreated mesh__D006629 1999-01-01
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D006629 2005A
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D006629 jls
% 211.07/211.25 |- skos__prefLabel mesh__D006629 Hirudins
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D006629 2005; see HIRUDIN 1963-2004
% 211.07/211.25 |- mesh__recordMaintainer mesh__D017351 ssb
% 211.07/211.25 |- skos__hiddenLabel mesh__D017351 Transferases, N-Acetylglucosamine
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D017351 93
% 211.07/211.25 |- mesh__recordOriginator mesh__D017351 TPW
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D017351 2005
% 211.07/211.25 |- mesh__historyNote mesh__D017351 93
% 211.07/211.25 |- skos__historyNote mesh__D017351 Glucosyltransferases %28%1966-1992%29%
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D017351 2004
% 211.07/211.25 |- rdf__type mesh__D017351sskos__Concept
% 211.07/211.25 |- skos__altLabel mesh__D017351 N-Acetylglucosamine Transferases
% 211.07/211.25 |- skos__prefLabel mesh__D017351 N-Acetylglucosaminyltransferases
% 211.07/211.25 |- mesh__dateCreated mesh__D017351 1992-05-22
% 211.07/211.25 |- mesh__dateRevised mesh__D017351 2003-07-09
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D017351 sjn
% 211.07/211.25 |- mesh__dateEstablished mesh__D017351 1993-01-01
% 211.07/211.25 |- skos__scopeNote mesh__D017351
% 211.07/211.25 Enzymes that catalyze the transfer of N-acetylglucosamine from a nucleoside diphosphate N-acetylglucosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A%
% 211.07/211.25 |- skos__broader mesh__D017351smesh__D017349
% 211.07/211.25 |- skos__hiddenLabel mesh__D017351 N Acetylglucosamine Transferases
% 211.07/211.25 |- skos__hiddenLabel mesh__D017351 N Acetylglucosaminyltransferases
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D017351 2006
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D031022 2004
% 211.07/211.25 |- rdf__type mesh__D031022sskos__Concept
% 211.07/211.25 |- mesh__dateEstablished mesh__D031022 2003-01-01
% 211.07/211.25 |- skos__scopeNote mesh__D031022
% 211.07/211.25 A plant genus of the family ANACARDIACEAE best known for the edible fruit.%A%
% 211.07/211.25 |- skos__annotation mesh__D031022
% 211.07/211.25 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D031022 2003
% 211.07/211.25 |- mesh__historyNote mesh__D031022 2003
% 211.07/211.25 |- skos__broader mesh__D031022smesh__D027926
% 211.07/211.25 |- mesh__dateCreated mesh__D031022 2002-07-03
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D031022 2006
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D031022 2003
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D031022 2005
% 211.07/211.25 |- skos__prefLabel mesh__D031022 Mangifera
% 211.07/211.25 |- mesh__historyNote mesh__D050785
% 211.07/211.25 2006; use HYPOTHERMIA, INDUCED 1984-2005
% 211.07/211.25 |- skos__historyNote mesh__D050785 Anesthesia %28%1968-2005%29%
% 211.07/211.25 |- mesh__recordOriginator mesh__D050785 lkt
% 211.07/211.25 |- mesh__recordMaintainer mesh__D050785 lkt
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D050785
% 211.07/211.25 2006; see HYPOTHERMIA, INDUCED 1984-2005
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D050785 sjn
% 211.07/211.25 |- skos__broader mesh__D050785smesh__D000758
% 211.07/211.25 |- skos__prefLabel mesh__D050785 Cryoanesthesia
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D050785 2006
% 211.07/211.25 |- mesh__dateEstablished mesh__D050785 2006-01-01
% 211.07/211.25 |- skos__scopeNote mesh__D050785
% 211.07/211.25 ANESTHESIA achieved by lowering either BODY TEMPERATURE %28%core cooling%29% or SKIN TEMPERATURE %28%external cooling%29%.%A%
% 211.07/211.25 |- skos__altLabel mesh__D050785 Refrigeration Anesthesia
% 211.07/211.25 |- rdf__type mesh__D050785sskos__Concept
% 211.07/211.25 |- mesh__dateCreated mesh__D050785 2005-06-30
% 211.07/211.25 |- skos__altLabel mesh__D050785 Anesthesia, Refrigeration
% 211.07/211.25 |- rdf__type mesh__D003331sskos__Concept
% 211.07/211.25 |- skos__hiddenLabel mesh__D003331 Sinus Node Arteries
% 211.07/211.25 |- skos__scopeNote mesh__D003331 The veins and arteries of the HEART.
% 211.07/211.25 |- skos__hiddenLabel mesh__D003331 Arteries, Coronary
% 211.07/211.25 |- skos__hiddenLabel mesh__D003331 Arteries, Sinus Node
% 211.07/211.25 |- skos__prefLabel mesh__D003331 Coronary Vessels
% 211.07/211.25 |- skos__hiddenLabel mesh__D003331 Artery, Coronary
% 211.07/211.25 |- skos__hiddenLabel mesh__D003331 Vessels, Coronary
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D003331 2006
% 211.07/211.25 |- skos__hiddenLabel mesh__D003331 Artery, Sinus Node
% 211.07/211.25 |- mesh__recordOriginator mesh__D003331 NLM
% 211.07/211.25 |- skos__hiddenLabel mesh__D003331 Coronary Vessel
% 211.07/211.25 |- mesh__dateRevised mesh__D003331 2005-06-30
% 211.07/211.25 |- skos__broader mesh__D003331smesh__D014680
% 211.07/211.25 |- mesh__recordMaintainer mesh__D003331 ags
% 211.07/211.25 |- skos__annotation mesh__D003331
% 211.07/211.25 consider also CORONARY CIRCULATION; /surg: consider also CORONARY ARTERY BYPASS%A%
% 211.07/211.25 |- skos__hiddenLabel mesh__D003331 Vessel, Coronary
% 211.07/211.25 |- mesh__dateCreated mesh__D003331 1999-01-01
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D003331 sjn
% 211.07/211.25 |- skos__related mesh__D003331smesh__D001026
% 211.07/211.25 |- skos__hiddenLabel mesh__D003331 Coronary Artery
% 211.07/211.25 |- skos__broader mesh__D003331smesh__D001158
% 211.07/211.25 |- skos__prefLabel mesh__D016259 Genes, myc
% 211.07/211.25 |- skos__historyNote mesh__D016259 Oncogenes %28%1983-1990%29%
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Gene, N-myc
% 211.07/211.25 |- mesh__dateRevised mesh__D016259 2005-06-30
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 c myc Proto Oncogenes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Proto-Oncogenes, N-myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Oncogene, myc
% 211.07/211.25 |- mesh__dateEstablished mesh__D016259 1991-01-01
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Genes, c-myc
% 211.07/211.25 |- mesh__recordOriginator mesh__D016259 AGS
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Oncogene, v-myc
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D016259 sjn
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 v-myc Oncogene
% 211.07/211.25 |- skos__related mesh__D016259smesh__D016271
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D016259 2006
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 L myc Proto Oncogenes
% 211.07/211.25 |- mesh__recordMaintainer mesh__D016259 nns
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 L-myc Gene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 v myc Oncogenes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Proto-Oncogene, N-myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Proto-Oncogenes, c-myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 c-myc Proto-Oncogene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Proto-Oncogene, c-myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 N-myc Proto-Oncogene
% 211.07/211.25 |- mesh__dateCreated mesh__D016259 1990-06-28
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 myc Oncogenes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 N myc Proto Oncogenes
% 211.07/211.25 |- mesh__historyNote mesh__D016259
% 211.07/211.25 91; was MYC GENES see ONCOGENES 1985-90
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 N-myc Gene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Gene, myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Genes, N-myc
% 211.07/211.25 |- skos__historyNote mesh__D016259 Genes, Viral %28%1982%29%
% 211.07/211.25 |- mesh__onlineNote mesh__D016259
% 211.07/211.25 use ONCOGENES to search MYC GENES 1985-90
% 211.07/211.25 |- skos__broader mesh__D016259smesh__D011519
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 v-myc Gene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 v myc Genes
% 211.07/211.25 |- rdf__type mesh__D016259sskos__Concept
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Gene, L-myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Genes, L-myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 c myc Genes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Genes, v-myc
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D016259
% 211.07/211.25 91; was MYC GENES see ONCOGENES 1985-90
% 211.07/211.25 |- skos__altLabel mesh__D016259 myc Genes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Gene, v-myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 N myc Genes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Oncogenes, myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 L-myc Proto-Oncogene
% 211.07/211.25 |- skos__annotation mesh__D016259
% 211.07/211.25 myc stands for %22%MYeloCytomatosis%22%
% 211.07/211.25 |- skos__related mesh__D016259smesh__D016274
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Proto-Oncogene, L-myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Gene, c-myc
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Oncogenes, v-myc
% 211.07/211.25 |- skos__scopeNote mesh__D016259
% 211.07/211.25 Family of retrovirus-associated DNA sequences %28%myc%29% originally isolated from an avian myelocytomatosis virus. The proto-oncogene myc %28%c-myc%29% codes for a nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Truncation of the first exon, which appears to regulate c-myc expression, is crucial for tumorigenicity. The human c-myc gene is located at 8q24 on the long arm of chromosome 8.%A%
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 c-myc Gene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 L myc Genes
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 myc Gene
% 211.07/211.25 |- skos__hiddenLabel mesh__D016259 Proto-Oncogenes, L-myc
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D002239 2006
% 211.07/211.25 |- skos__prefLabel mesh__D002239 Carbohydrate Metabolism, Inborn Errors
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D002239 2002
% 211.07/211.25 |- rdf__type mesh__D002239sskos__Concept
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D002239 65
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D002239 2005
% 211.07/211.25 |- mesh__dateCreated mesh__D002239 1999-01-01
% 211.07/211.25 |- mesh__recordMaintainer mesh__D002239 nns
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D002239 sjn
% 211.07/211.25 |- mesh__historyNote mesh__D002239 65
% 211.07/211.25 |- mesh__dateRevised mesh__D002239 2001-07-25
% 211.07/211.25 |- mesh__recordOriginator mesh__D002239 NLM
% 211.07/211.25 |- skos__annotation mesh__D002239
% 211.07/211.25 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific carbohydrate /metab %28%IM%29%; FRUCTOSE METABOLISM, INBORN ERRORS %26% PYRUVATE METABOLISM, INBORN ERRORS are also available; DF: CARB METAB INBORN ERR%A%
% 211.07/211.25 |- skos__broader mesh__D002239smesh__D008661
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D002239 2004
% 211.07/211.25 |- skos__altLabel mesh__D002239 Carbohydrate Metabolism, Inborn Error
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D002239 2003
% 211.07/211.25 |- mesh__dateEstablished mesh__D002239 1965-01-01
% 211.07/211.25 |- rdf__type mesh__D007722sskos__Concept
% 211.07/211.25 |- skos__annotation mesh__D007722
% 211.07/211.25 examples include FAMILY PLANNING; knowledge of physicians see CLINICAL COMPETENCE; do not use for knowledge or attitude or practice in psychol literature %28% = possibly KNOWLEDGE OF RESULTS or ATTITUDE or PRACTICE %28%PSYCHOLOGY%29% %29%; DF: KAP%A%
% 211.07/211.25 |- mesh__dateCreated mesh__D007722 1974-11-11
% 211.07/211.25 |- skos__scopeNote mesh__D007722
% 211.07/211.25 Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers %28%HEALTH PERSONNEL%29%.%A%
% 211.07/211.25 |- skos__prefLabel mesh__D007722 Health Knowledge, Attitudes, Practice
% 211.07/211.25 |- skos__broader mesh__D007722smesh__D001294
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D007722
% 211.07/211.25 %60%2004; see KNOWLEDGE ATTITUDES PRACTICE 1975-2003
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007722 2004
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007722 2006
% 211.07/211.25 |- skos__altLabel mesh__D007722 Knowledge, Attitudes, Practice
% 211.07/211.25 |- mesh__historyNote mesh__D007722 2004 %28%1975%29%
% 211.07/211.25 |- mesh__recordOriginator mesh__D007722 NLM
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D007722 2005
% 211.07/211.25 |- mesh__dateEstablished mesh__D007722 1990-01-01
% 211.07/211.25 |- mesh__recordMaintainer mesh__D007722 lkt
% 211.07/211.25 |- mesh__recordAuthorizer mesh__D007722 sjn
% 211.07/211.25 |- mesh__dateRevised mesh__D007722 2003-07-09
% 211.07/211.25 |- skos__altLabel mesh__D051080 Malonyl-CoA-ACP-Transacylase
% 211.07/211.25 |- skos__altLabel mesh__D051080
% 211.07/211.25 Malonyl Coenzyme A-Acyl Carrier Protein Transacylase
% 211.07/211.25 |- skos__altLabel mesh__D051080 Malonyl CoA Transferase
% 211.07/211.25 |- skos__altLabel mesh__D051080
% 211.07/211.25 %28%Acyl-Carrier-Protein%29% S-Malonyltransferase
% 211.07/211.25 |- skos__altLabel mesh__D051080 Malonyl Coenzyme A Transferase
% 211.07/211.25 |- mesh__historyNote mesh__D051080
% 211.07/211.25 2006%28%1980%29%; use ACYLTRANSFERASES %26% CARRIER PROTEINS 1973-1979%A%
% 211.07/211.25 |- skos__hiddenLabel mesh__D051080
% 211.07/211.25 Malonyl Coenzyme A Acyl Carrier Protein Transacylase
% 211.07/211.25 |- skos__hiddenLabel mesh__D051080
% 211.07/211.25 S-Malonyltransferase, Acyl-Carrier Protein
% 211.07/211.25 |- mesh__recordMaintainer mesh__D051080 ags
% 211.07/211.25 |- skos__broader mesh__D051080smesh__D000217
% 211.07/211.25 |- skos__prefLabel mesh__D051080 Acyl-Carrier Protein S-Malonyltransferase
% 211.07/211.25 |- rdf__type mesh__D051080sskos__Concept
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D051080 2006A
% 211.07/211.25 |- skos__scopeNote mesh__D051080
% 211.07/211.25 This enzyme catalyzes the transacylation of malonate from MALONYL CoA to activated holo-ACP, to generate malonyl-%28%acyl-carrier protein%29%, which is an elongation substrate in FATTY ACIDS biosynthesis. It is an essential enzyme in the biosynthesis of FATTY ACIDS in all BACTERIA.%A%
% 211.07/211.25 |- skos__hiddenLabel mesh__D051080
% 211.07/211.25 Acyl Carrier Protein S Malonyltransferase
% 211.07/211.25 |- skos__hiddenLabel mesh__D051080 Malonyl CoA ACP Transacylase
% 211.07/211.25 |- mesh__publicMeSHNote mesh__D051080
% 211.07/211.25 2006; %28%ACYL-CARRIER PROTEIN%29% MALONYLTRANSFERASE was indexed under ACYLTRANSFERASES 1973-2005, %26% under CARRIER PROTEINS 1973-1979%A%
% 211.07/211.25 |- mesh__dateCreated mesh__D051080 2005-06-30
% 211.07/211.25 |- skos__hiddenLabel mesh__D051080 Transacylase, Malonyl
% 211.07/211.25 |- mesh__dateEstablished mesh__D051080 2006-01-01
% 211.07/211.25 |- mesh__activeMeSHYear mesh__D051080 2006
% 211.07/211.25 |- mesh__recordOriginator mesh__D051080 AKE
% 211.07/211.25 |- skos__hiddenLabel mesh__D051080 Transferase, Malonyl CoA
% 211.07/211.25 |- skos__altLabel mesh__D051080
% 211.07/211.25 %28%Acyl-Carrier-Protein%29% Malonyltransferase
% 211.07/211.26 |- skos__hiddenLabel mesh__D051080 CoA Transferase, Malonyl
% 211.07/211.26 |- skos__altLabel mesh__D051080 Malonyl Transacylase
% 211.07/211.26 |- mesh__dateRevised mesh__D051080 2005-07-13
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D051080 ags
% 211.07/211.26 |- skos__broader mesh__D012667smesh__D002348
% 211.07/211.26 |- skos__hiddenLabel mesh__D012667 Lunate Bones
% 211.07/211.26 |- skos__prefLabel mesh__D012667 Lunate Bone
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D012667 ags
% 211.07/211.26 |- skos__altLabel mesh__D012667 Semilunar Bone
% 211.07/211.26 |- mesh__recordOriginator mesh__D012667 NLM
% 211.07/211.26 |- mesh__dateCreated mesh__D012667 1999-01-01
% 211.07/211.26 |- mesh__recordMaintainer mesh__D012667 ags
% 211.07/211.26 |- skos__hiddenLabel mesh__D012667 Semilunar Bones
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D012667 2006; see SEMILUNAR BONE 1963-2005
% 211.07/211.26 |- skos__scopeNote mesh__D012667
% 211.07/211.26 A moon-shaped carpal bone which is located between the SCAPHOID BONE and TRIQUETRUM BONE.%A%
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012667 2006A
% 211.07/211.26 |- mesh__historyNote mesh__D012667 2006 %28%1963%29%
% 211.07/211.26 |- skos__altLabel mesh__D012667 Os Lunatum
% 211.07/211.26 |- skos__hiddenLabel mesh__D012667 Bones, Lunate
% 211.07/211.26 |- mesh__dateRevised mesh__D012667 2005-08-02
% 211.07/211.26 |- skos__hiddenLabel mesh__D012667 Bone, Semilunar
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012667 2006
% 211.07/211.26 |- skos__hiddenLabel mesh__D012667 Bone, Lunate
% 211.07/211.26 |- rdf__type mesh__D012667sskos__Concept
% 211.07/211.26 |- skos__hiddenLabel mesh__D012667 Bones, Semilunar
% 211.07/211.26 |- mesh__dateEstablished mesh__D031821 2003-01-01
% 211.07/211.26 |- skos__scopeNote mesh__D031821
% 211.07/211.26 A plant family of the order Najadales, subclass Alismatidae, class Liliopsida %28%monocotyledons%29%.%A%
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D031821 2003
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031821 2006
% 211.07/211.26 |- skos__broader mesh__D031821smesh__D035961
% 211.07/211.26 |- mesh__historyNote mesh__D031821 2003
% 211.07/211.26 |- skos__prefLabel mesh__D031821 Potamogetonaceae
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031821 2005
% 211.07/211.26 |- rdf__type mesh__D031821sskos__Concept
% 211.07/211.26 |- mesh__dateCreated mesh__D031821 2002-07-03
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031821 2004
% 211.07/211.26 |- skos__annotation mesh__D031821
% 211.07/211.26 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031821 2003
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D017352 SJN
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Imagings, Echo-Planar
% 211.07/211.26 |- skos__altLabel mesh__D017352 Echoplanar Imaging
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 MR Tomography, Echo Planar
% 211.07/211.26 |- mesh__historyNote mesh__D017352 93
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017352 2006
% 211.07/211.26 |- skos__broader mesh__D017352smesh__D008279
% 211.07/211.26 |- skos__historyNote mesh__D017352
% 211.07/211.26 Nuclear Magnetic Resonance %28%1984-1987%29%
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Echoplanar Imagings
% 211.07/211.26 |- skos__altLabel mesh__D017352 MR Tomography, Echo-Planar
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017352 1999
% 211.07/211.26 |- skos__scopeNote mesh__D017352
% 211.07/211.26 A type of MAGNETIC RESONANCE IMAGING that uses only one nuclear spin excitation per image and therefore can obtain images in a fraction of a second rather than the minutes required in traditional MRI techniques. It is used in a variety of medical and scientific applications.%A%
% 211.07/211.26 |- skos__altLabel mesh__D017352 Echo-Planar Magnetic Resonance Imaging
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017352 2005
% 211.07/211.26 |- mesh__recordOriginator mesh__D017352 PXP
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017352 2001
% 211.07/211.26 |- skos__altLabel mesh__D017352 Magnetic Resonance Imaging, Echoplanar
% 211.07/211.26 |- mesh__dateEstablished mesh__D017352 1993-01-01
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Tomography, Echo-Planar MR
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Imaging, Echoplanar
% 211.07/211.26 |- skos__historyNote mesh__D017352
% 211.07/211.26 Magnetic Resonance Imaging %28%1988-1992%29%
% 211.07/211.26 |- skos__altLabel mesh__D017352 Magnetic Resonance Imaging, Echo-Planar
% 211.07/211.26 |- rdf__type mesh__D017352sskos__Concept
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Echo Planar Magnetic Resonance Imaging
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Tomographies, Echo-Planar MR
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Imagings, Echoplanar
% 211.07/211.26 |- mesh__dateCreated mesh__D017352 1992-05-08
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017352 1998
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Tomography, Echoplanar MR
% 211.07/211.26 |- skos__altLabel mesh__D017352 MR Tomography, Echoplanar
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017352 2000
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Echoplanar MR Tomographies
% 211.07/211.26 |- skos__altLabel mesh__D017352 Echoplanar MR Tomography
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D017352 93
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Echo-Planar Imagings
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Tomographies, Echoplanar MR
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017352 2004
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Echo Planar MR Tomography
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Magnetic Resonance Imaging, Echo Planar
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Echo-Planar MR Tomographies
% 211.07/211.26 |- mesh__recordMaintainer mesh__D017352 PXP
% 211.07/211.26 |- skos__altLabel mesh__D017352 Echoplanar Magnetic Resonance Imaging
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 MR Tomographies, Echo-Planar
% 211.07/211.26 |- mesh__dateRevised mesh__D017352 1997-06-20
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 MR Tomographies, Echoplanar
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Imaging, Echo-Planar
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017352 2003
% 211.07/211.26 |- skos__prefLabel mesh__D017352 Echo-Planar Imaging
% 211.07/211.26 |- skos__annotation mesh__D017352
% 211.07/211.26 a type of magnetic resonance imaging; for coord see note on MAGNETIC RESONANCE IMAGING%A%
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017352 2002
% 211.07/211.26 |- skos__hiddenLabel mesh__D017352 Echo Planar Imaging
% 211.07/211.26 |- rdf__type mesh__D031023sskos__Concept
% 211.07/211.26 |- skos__prefLabel mesh__D031023 Semecarpus
% 211.07/211.26 |- skos__annotation mesh__D031023
% 211.07/211.26 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.26 |- mesh__dateEstablished mesh__D031023 2003-01-01
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031023 2005
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031023 2006
% 211.07/211.26 |- skos__scopeNote mesh__D031023
% 211.07/211.26 A plant genus of the family ANACARDIACEAE that is the source of anacarcin forte. The nut milk extract is cytotoxic.%A%
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D031023 2003
% 211.07/211.26 |- mesh__historyNote mesh__D031023 2003
% 211.07/211.26 |- skos__broader mesh__D031023smesh__D027926
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031023 2003
% 211.07/211.26 |- mesh__dateCreated mesh__D031023 2002-07-03
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031023 2004
% 211.07/211.26 |- skos__broader mesh__D050786smesh__D007036
% 211.07/211.26 |- mesh__dateCreated mesh__D050786 2005-06-30
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D050786
% 211.07/211.26 2006; see HYPOTHERMIA, INDUCED 1984-2005
% 211.07/211.26 |- skos__hiddenLabel mesh__D050786 Cold Gastric Lavages
% 211.07/211.26 |- skos__hiddenLabel mesh__D050786 Gastric Lavage, Cold
% 211.07/211.26 |- skos__scopeNote mesh__D050786
% 211.07/211.26 A method of lowering core BODY TEMPERATURE by filling the STOMACH with chilled fluids.%A%
% 211.07/211.26 |- skos__prefLabel mesh__D050786 Gastric Hypothermia
% 211.07/211.26 |- mesh__historyNote mesh__D050786
% 211.07/211.26 2006; use HYPOTHERMIA, INDUCED 1984-2005
% 211.07/211.26 |- mesh__recordMaintainer mesh__D050786 lkt
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D050786 2006
% 211.07/211.26 |- skos__hiddenLabel mesh__D050786 Gastric Lavages, Cold
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D050786 sjn
% 211.07/211.26 |- rdf__type mesh__D050786sskos__Concept
% 211.07/211.26 |- skos__altLabel mesh__D050786 Cold Gastric Lavage
% 211.07/211.26 |- skos__hiddenLabel mesh__D050786 Lavages, Cold Gastric
% 211.07/211.26 |- skos__hiddenLabel mesh__D050786 Lavage, Cold Gastric
% 211.07/211.26 |- skos__hiddenLabel mesh__D050786 Hypothermia, Gastric
% 211.07/211.26 |- mesh__dateEstablished mesh__D050786 2006-01-01
% 211.07/211.26 |- mesh__recordOriginator mesh__D050786 lkt
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003332 2004
% 211.07/211.26 |- mesh__historyNote mesh__D003332 81; was CORONAVIRUSES 1974-80
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003332 2002
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003332 2006
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003332 2003
% 211.07/211.26 |- skos__broader mesh__D003332smesh__D028381
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003332 2005
% 211.07/211.26 |- mesh__dateRevised mesh__D003332 2001-07-25
% 211.07/211.26 |- mesh__recordMaintainer mesh__D003332 ags
% 211.07/211.26 |- mesh__dateCreated mesh__D003332 1999-01-01
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D003332 81; was CORONAVIRUSES 1974-80
% 211.07/211.26 |- mesh__dateEstablished mesh__D003332 1974-01-01
% 211.07/211.26 |- skos__annotation mesh__D003332 infection = CORONAVIRIDAE INFECTIONS
% 211.07/211.26 |- mesh__onlineNote mesh__D003332
% 211.07/211.26 use CORONAVIRIDAE to search CORONAVIRUSES 1974-80
% 211.07/211.26 |- mesh__recordOriginator mesh__D003332 NLM
% 211.07/211.26 |- rdf__type mesh__D003332sskos__Concept
% 211.07/211.26 |- skos__scopeNote mesh__D003332
% 211.07/211.26 Spherical RNA viruses, in the order NIDOVIRALES, infecting a wide range of animals including humans. Transmission is by fecal-oral and respiratory routes. Mechanical transmission is also common. There are two genera: CORONAVIRUS and TOROVIRUS.%A%
% 211.07/211.26 |- skos__prefLabel mesh__D003332 Coronaviridae
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D003332 sjn
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D013760
% 211.07/211.26 91; was see under HYDROCORTISONE 1973-90
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D013760 2005
% 211.07/211.26 |- mesh__dateCreated mesh__D013760 1999-01-01
% 211.07/211.26 |- mesh__recordOriginator mesh__D013760 NLM
% 211.07/211.26 |- mesh__dateRevised mesh__D013760 2003-07-09
% 211.07/211.26 |- skos__annotation mesh__D013760
% 211.07/211.26 do not confuse with TETRAHYDROCORTISONE
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D013760 2006
% 211.07/211.26 |- skos__broader mesh__D013760smesh__D011278
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D013760 sjn
% 211.07/211.26 |- skos__broader mesh__D013760smesh__D015065
% 211.07/211.26 |- skos__prefLabel mesh__D013760 Tetrahydrocortisol
% 211.07/211.26 |- mesh__dateEstablished mesh__D013760 1991-01-01
% 211.07/211.26 |- rdf__type mesh__D013760sskos__Concept
% 211.07/211.26 |- mesh__historyNote mesh__D013760
% 211.07/211.26 91%28%73%29%; was see under HYDROCORTISONE 1973-90
% 211.07/211.26 |- mesh__recordMaintainer mesh__D013760 ssb
% 211.07/211.26 |- skos__historyNote mesh__D013760 Hydrocortisone %28%1966-1972%29%
% 211.07/211.26 |- skos__broader mesh__D013760smesh__D015062
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D013760 2004
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 1993
% 211.07/211.26 |- skos__broader mesh__D007723smesh__D005202
% 211.07/211.26 |- mesh__recordMaintainer mesh__D007723 PLS
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 1996
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 1995
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 2003
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 1998
% 211.07/211.26 |- skos__prefLabel mesh__D007723 Korea
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 2005
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 1992
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 1994
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D007723 PLS
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 2002
% 211.07/211.26 |- rdf__type mesh__D007723sskos__Concept
% 211.07/211.26 |- skos__altLabel mesh__D007723 Korea, Democratic People%27%s Republic of
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 2001
% 211.07/211.26 |- skos__altLabel mesh__D007723 South Korea
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 1997
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 2004
% 211.07/211.26 |- mesh__recordOriginator mesh__D007723 NLM
% 211.07/211.26 |- mesh__dateCreated mesh__D007723 1999-01-01
% 211.07/211.26 |- mesh__dateRevised mesh__D007723 1991-11-25
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 2000
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 1999
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D007723 2006
% 211.07/211.26 |- skos__related mesh__D026688smesh__D028701
% 211.07/211.26 |- skos__related mesh__D026688smesh__D005065
% 211.07/211.26 |- skos__hiddenLabel mesh__D026688 Issue, Bioethical
% 211.07/211.26 |- mesh__historyNote mesh__D026688 2002; use BIOETHICS 1978-2001
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D026688 2002; see BIOETHICS 1978-2001
% 211.07/211.26 |- skos__broader mesh__D026688smesh__D004989
% 211.07/211.26 |- skos__historyNote mesh__D026688 Bioethics %28%1974-2001%29%
% 211.07/211.26 |- mesh__dateCreated mesh__D026688 2001-07-25
% 211.07/211.26 |- mesh__recordMaintainer mesh__D026688 jls
% 211.07/211.26 |- skos__related mesh__D026688smesh__D006805
% 211.07/211.26 |- mesh__dateEstablished mesh__D026688 2002-01-01
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D026688 2005
% 211.07/211.26 |- mesh__recordOriginator mesh__D026688 jrf
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D026688 2004
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D026688 sjn
% 211.07/211.26 |- skos__hiddenLabel mesh__D026688 Issues, Bioethical
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D026688 2006
% 211.07/211.26 |- skos__related mesh__D026688smesh__D032761
% 211.07/211.26 |- skos__annotation mesh__D026688
% 211.07/211.26 used for discussions of several specific issues that fall within the domain of BIOETHICS but not for discussions of the field or discipline as such; BIOETHICS is available for the specialty and BIOETHICISTS see ETHICISTS is available for the person%A%
% 211.07/211.26 |- skos__hiddenLabel mesh__D026688 Bioethical Issue
% 211.07/211.26 |- skos__prefLabel mesh__D026688 Bioethical Issues
% 211.07/211.26 |- skos__scopeNote mesh__D026688
% 211.07/211.26 Clusters of topics that fall within the domain of BIOETHICS, the field of study concerned with value questions that arise in biomedicine and health care delivery.%A%
% 211.07/211.26 |- mesh__dateRevised mesh__D026688 2003-07-09
% 211.07/211.26 |- rdf__type mesh__D026688sskos__Concept
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081 Acetylase, Glucosamine-6-Phosphate
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081
% 211.07/211.26 Acetyltransferase, Glucosamine-6-Phosphate
% 211.07/211.26 |- skos__broader mesh__D051081smesh__D000123
% 211.07/211.26 |- mesh__historyNote mesh__D051081
% 211.07/211.26 2006%28%1980%29%; use ACETYLTRANSFERASES 1977-1979
% 211.07/211.26 |- mesh__recordMaintainer mesh__D051081 AKE
% 211.07/211.26 |- mesh__dateEstablished mesh__D051081 2006-01-01
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081 Glucosamine 6 Phosphate Acetylase
% 211.07/211.26 |- skos__altLabel mesh__D051081 Glucosamine-Phosphate Acetyltransferase
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081
% 211.07/211.26 Glucosamine 6 Phosphate N Acetyltransferase
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D051081 sjn
% 211.07/211.26 |- skos__scopeNote mesh__D051081
% 211.07/211.26 An enzyme that catalyses the reaction of D-glucosamine 6-phosphate with ACETYL-COA to form N-acetylglucosamine 6-phosphate.%A%
% 211.07/211.26 |- skos__altLabel mesh__D051081 Glucosamine-6-Phosphate Acetyltransferase
% 211.07/211.26 |- mesh__dateCreated mesh__D051081 2005-06-30
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081
% 211.07/211.26 N-Acetyltransferase, Glucosamine-Phosphate
% 211.07/211.26 |- rdf__type mesh__D051081sskos__Concept
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081
% 211.07/211.26 6-Phosphate N-Acetyltransferase, Glucosamine
% 211.07/211.26 |- skos__prefLabel mesh__D051081
% 211.07/211.26 Glucosamine 6-Phosphate N-Acetyltransferase
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081 Acetyltransferase, Glucosamine-Phosphate
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081
% 211.07/211.26 N-Acetyltransferase, Glucosamine 6-Phosphate
% 211.07/211.26 |- skos__altLabel mesh__D051081 GlcNP-AcT
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081
% 211.07/211.26 Glucosamine Phosphate N Acetyltransferase
% 211.07/211.26 |- mesh__recordOriginator mesh__D051081 AKE
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D051081
% 211.07/211.26 2006; GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1977-2005%A%
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081
% 211.07/211.26 Glucosamine 6 Phosphate Acetyltransferase
% 211.07/211.26 |- skos__altLabel mesh__D051081 Glucosamine-Phosphate N-Acetyltransferase
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D051081 2006
% 211.07/211.26 |- skos__altLabel mesh__D051081 Glucosamine-6-Phosphate Acetylase
% 211.07/211.26 |- skos__hiddenLabel mesh__D051081 Glucosamine Phosphate Acetyltransferase
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 2003
% 211.07/211.26 |- mesh__recordOriginator mesh__D012668 NLM
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Gasser Ganglion
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 2002
% 211.07/211.26 |- mesh__dateEstablished mesh__D012668 1990-01-01
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 1997
% 211.07/211.26 |- rdf__type mesh__D012668sskos__Concept
% 211.07/211.26 |- skos__broader mesh__D012668smesh__D017950
% 211.07/211.26 |- skos__altLabel mesh__D012668 Gasserian Ganglion
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 2006
% 211.07/211.26 |- mesh__dateCreated mesh__D012668 1999-01-01
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Trigeminal Ganglias
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Trigeminal Ganglions
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 1996
% 211.07/211.26 |- skos__broader mesh__D012668smesh__D014276
% 211.07/211.26 |- mesh__historyNote mesh__D012668
% 211.07/211.26 90%28%75%29%; was SEMILUNAR GANGLION see under TRIGEMINAL NERVE 1963-89%A%
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 2001
% 211.07/211.26 |- skos__prefLabel mesh__D012668 Trigeminal Ganglion
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Gassers Ganglion
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 2005
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Ganglia, Trigeminal
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D012668 PLS
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 1999
% 211.07/211.26 |- skos__altLabel mesh__D012668 Trigeminal Ganglia
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 2000
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D012668
% 211.07/211.26 90; was SEMILUNAR GANGLION see under TRIGEMINAL NERVE 1963-89%A%
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Ganglion, Gasserian
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Ganglion, Trigeminal
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Ganglion, Gasser%27%s
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 1995
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 1998
% 211.07/211.26 |- mesh__dateRevised mesh__D012668 1994-04-11
% 211.07/211.26 |- skos__annotation mesh__D012668
% 211.07/211.26 neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D012668 2004
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Ganglion, Semilunar
% 211.07/211.26 |- skos__altLabel mesh__D012668 Semilunar Ganglion
% 211.07/211.26 |- mesh__recordMaintainer mesh__D012668 TGC
% 211.07/211.26 |- skos__scopeNote mesh__D012668
% 211.07/211.26 The semilunar-shaped ganglion containing the cells of origin of most of the sensory fibers of the trigeminal nerve. It is situated within the dural cleft on the cerebral surface of the petrous portion of the temporal bone and gives off the ophthalmic, maxillary, and part of the mandibular nerves.%A%
% 211.07/211.26 |- skos__altLabel mesh__D012668 Gasser%27%s Ganglion
% 211.07/211.26 |- skos__hiddenLabel mesh__D012668 Semilunar Ganglions
% 211.07/211.26 |- mesh__onlineNote mesh__D012668
% 211.07/211.26 use TRIGEMINAL NERVE to search SEMILUNAR GANGLION 1966-74; use TRIGEMINAL GANGLION 1975-89%A%
% 211.07/211.26 |- skos__altLabel mesh__D031822 Portulaca oleracae
% 211.07/211.26 |- mesh__dateCreated mesh__D031822 2002-07-03
% 211.07/211.26 |- mesh__dateEstablished mesh__D031822 2003-01-01
% 211.07/211.26 |- rdf__type mesh__D031822sskos__Concept
% 211.07/211.26 |- skos__scopeNote mesh__D031822
% 211.07/211.26 A plant genus of the family PORTULACACEAE.
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031822 2004
% 211.07/211.26 |- skos__altLabel mesh__D031822 Purslane
% 211.07/211.26 |- skos__annotation mesh__D031822
% 211.07/211.26 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.26 |- skos__prefLabel mesh__D031822 Portulaca
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031822 2003
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D031822 2003
% 211.07/211.26 |- mesh__historyNote mesh__D031822 2003
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031822 2006
% 211.07/211.26 |- skos__broader mesh__D031822smesh__D029622
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D031822 2005
% 211.07/211.26 |- mesh__onlineNote mesh__D017353
% 211.07/211.26 use CHROMOSOME DELETION to search GENE DELETION 1984-92
% 211.07/211.26 |- rdf__type mesh__D017353sskos__Concept
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017353 2004
% 211.07/211.26 |- skos__hiddenLabel mesh__D017353 Deletion, Gene
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D017353 sjn
% 211.07/211.26 |- mesh__dateRevised mesh__D017353 2002-07-03
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D017353
% 211.07/211.26 93; was see CHROMOSOME DELETION 1984-92
% 211.07/211.26 |- skos__historyNote mesh__D017353 Mutation %28%1972-1975%29%
% 211.07/211.26 |- skos__historyNote mesh__D017353 Chromosome Deletion %28%1976-1992%29%
% 211.07/211.26 |- mesh__dateEstablished mesh__D017353 1993-01-01
% 211.07/211.26 |- skos__scopeNote mesh__D017353
% 211.07/211.26 A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.%A%
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017353 2005
% 211.07/211.26 |- skos__prefLabel mesh__D017353 Gene Deletion
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017353 2006
% 211.07/211.26 |- skos__broader mesh__D017353smesh__D017384
% 211.07/211.26 |- mesh__recordOriginator mesh__D017353 PXP
% 211.07/211.26 |- skos__hiddenLabel mesh__D017353 Gene Deletions
% 211.07/211.26 |- mesh__historyNote mesh__D017353
% 211.07/211.26 93; was see CHROMOSOME DELETION 1984-92
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D017353 2003
% 211.07/211.26 |- mesh__dateCreated mesh__D017353 1992-05-20
% 211.07/211.26 |- mesh__recordMaintainer mesh__D017353 PXP
% 211.07/211.26 |- skos__hiddenLabel mesh__D017353 Deletions, Gene
% 211.07/211.26 |- mesh__dateEstablished mesh__D050787 2006-01-01
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D050787
% 211.07/211.26 2006; PROTO-ONCOGENE PROTEINS ETS-2 was indexed under PROTO-ONCOGENE PROTEINS %26% TRANS-ACTIVATORS 1990-2005%A%
% 211.07/211.26 |- skos__hiddenLabel mesh__D050787 c-ets-2, Proto-Oncogene Protein
% 211.07/211.26 |- rdf__type mesh__D050787sskos__Concept
% 211.07/211.26 |- skos__prefLabel mesh__D050787 Proto-Oncogene Protein c-ets-2
% 211.07/211.26 |- skos__altLabel mesh__D050787 c-ets-2 Protein
% 211.07/211.26 |- skos__hiddenLabel mesh__D050787 Proto Oncogene Protein c ets 2
% 211.07/211.26 |- mesh__recordOriginator mesh__D050787 jmp
% 211.07/211.26 |- skos__hiddenLabel mesh__D050787 c ets 2 Protein
% 211.07/211.26 |- mesh__historyNote mesh__D050787 2006%28%1990%29%
% 211.07/211.26 |- skos__hiddenLabel mesh__D050787 c-ets-2, Proto-Oncogene Proteins
% 211.07/211.26 |- skos__hiddenLabel mesh__D050787 Proto Oncogene Proteins ets 2
% 211.07/211.26 |- mesh__dateCreated mesh__D050787 2005-06-30
% 211.07/211.26 |- skos__hiddenLabel mesh__D050787 ets-2, Proto-Oncogene Proteins
% 211.07/211.26 |- skos__altLabel mesh__D050787 Proto-Oncogene Protein ets-2
% 211.07/211.26 |- mesh__recordMaintainer mesh__D050787 jmp
% 211.07/211.26 |- skos__broader mesh__D050787smesh__D050783
% 211.07/211.26 |- skos__altLabel mesh__D050787 Proto-Oncogene Proteins ets-2
% 211.07/211.26 |- skos__hiddenLabel mesh__D050787 Proto Oncogene Proteins c ets 2
% 211.07/211.26 |- skos__scopeNote mesh__D050787
% 211.07/211.26 A ubiquitously expressed ets proto-oncogene protein that may play a role in regulation of CELL PROLIFERATION and CELL DIFFERENTIATION.%A%
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D050787 sjn
% 211.07/211.26 |- skos__annotation mesh__D050787 see SCR for organism-specific terms
% 211.07/211.26 |- skos__altLabel mesh__D050787 Proto-Oncogene Proteins c-ets-2
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D050787 2006
% 211.07/211.26 |- mesh__onlineNote mesh__D003333
% 211.07/211.26 use CORONAVIRIDAE INFECTIONS to search CORONAVIRUS INFECTIONS 1977-93%A%
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003333 2005
% 211.07/211.26 |- skos__hiddenLabel mesh__D003333 Infection, Coronaviridae
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003333 2004
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003333 2002
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003333 2006
% 211.07/211.26 |- skos__prefLabel mesh__D003333 Coronaviridae Infections
% 211.07/211.26 |- skos__broader mesh__D003333smesh__D030341
% 211.07/211.26 |- skos__scopeNote mesh__D003333
% 211.07/211.26 Virus diseases caused by CORONAVIRIDAE.
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D003333 sjn
% 211.07/211.26 |- mesh__recordMaintainer mesh__D003333 ags
% 211.07/211.26 |- skos__hiddenLabel mesh__D003333 Coronaviridae Infection
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D003333
% 211.07/211.26 94; was CORONAVIRUS INFECTIONS 1977-93
% 211.07/211.26 |- mesh__dateCreated mesh__D003333 1976-04-27
% 211.07/211.26 |- skos__altLabel mesh__D003333 Infections, Coronaviridae
% 211.07/211.26 |- mesh__dateRevised mesh__D003333 2001-07-25
% 211.07/211.26 |- skos__historyNote mesh__D003333 Virus Diseases %28%1968-1976%29%
% 211.07/211.26 |- skos__annotation mesh__D003333
% 211.07/211.26 caused by members of the Coronaviridae family: do not confuse with CORONAVIRUS INFECTIONS caused by members of the Coronavirus genus; GEN or unspecified; prefer specifics%A%
% 211.07/211.26 |- rdf__type mesh__D003333sskos__Concept
% 211.07/211.26 |- mesh__recordOriginator mesh__D003333 FPG
% 211.07/211.26 |- mesh__historyNote mesh__D003333
% 211.07/211.26 94; was CORONAVIRUS INFECTIONS 1977-93
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D003333 2003
% 211.07/211.26 |- mesh__dateEstablished mesh__D003333 1977-01-01
% 211.07/211.26 |- skos__altLabel mesh__D027781 Shallot
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D027781 2005
% 211.07/211.26 |- skos__prefLabel mesh__D027781 Shallots
% 211.07/211.26 |- skos__annotation mesh__D027781
% 211.07/211.26 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D027781 2006
% 211.07/211.26 |- skos__historyNote mesh__D027781 Allium %28%1998-2001%29%
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D027781 2002; see Allium 1998-2001
% 211.07/211.26 |- skos__broader mesh__D027781smesh__D000490
% 211.07/211.26 |- mesh__dateCreated mesh__D027781 2001-07-25
% 211.07/211.26 |- rdf__type mesh__D027781sskos__Concept
% 211.07/211.26 |- mesh__dateEstablished mesh__D027781 2002-01-01
% 211.07/211.26 |- mesh__recordAuthorizer mesh__D027781 sjn
% 211.07/211.26 |- mesh__historyNote mesh__D027781 2002; use Allium 1998-2001
% 211.07/211.26 |- mesh__recordMaintainer mesh__D027781 ssb
% 211.07/211.26 |- mesh__recordOriginator mesh__D027781 ssb
% 211.07/211.26 |- mesh__dateRevised mesh__D027781 2004-07-07
% 211.07/211.26 |- skos__scopeNote mesh__D027781
% 211.07/211.26 Mildly aromatic herb in the Allium genus related to ONIONS and garlic used in SPICES.%A%
% 211.07/211.26 |- skos__broader mesh__D027781smesh__D014675
% 211.07/211.26 |- skos__annotation mesh__D013761 do not confuse with TETRAHYDROCORTISOL
% 211.07/211.26 |- mesh__dateRevised mesh__D013761 2003-07-09
% 211.07/211.26 |- mesh__activeMeSHYear mesh__D013761 2006
% 211.07/211.26 |- skos__prefLabel mesh__D013761 Tetrahydrocortisone
% 211.07/211.26 |- mesh__publicMeSHNote mesh__D013761
% 211.07/211.26 91; was see under CORTISONE 1973-90
% 211.07/211.26 |- mesh__dateEstablished mesh__D013761 1991-01-01
% 211.07/211.27 |- rdf__type mesh__D013761sskos__Concept
% 211.07/211.27 |- skos__broader mesh__D013761smesh__D011277
% 211.07/211.27 |- mesh__recordOriginator mesh__D013761 NLM
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D013761 sjn
% 211.07/211.27 |- skos__broader mesh__D013761smesh__D015065
% 211.07/211.27 |- mesh__historyNote mesh__D013761
% 211.07/211.27 91%28%73%29%; was see under CORTISONE 1973-90
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D013761 2004
% 211.07/211.27 |- mesh__recordMaintainer mesh__D013761 ssb
% 211.07/211.27 |- skos__historyNote mesh__D013761 Cortisone %28%1966-1972%29%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D013761 2005
% 211.07/211.27 |- mesh__dateCreated mesh__D013761 1999-01-01
% 211.07/211.27 |- mesh__recordOriginator mesh__D007724 NLM
% 211.07/211.27 |- skos__altLabel mesh__D007724 Kraurosis Vulvae
% 211.07/211.27 |- mesh__recordMaintainer mesh__D007724 lkt
% 211.07/211.27 |- skos__hiddenLabel mesh__D007724 Lichen Sclerosus, Vulvar
% 211.07/211.27 |- rdf__type mesh__D007724sskos__Concept
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D007724
% 211.07/211.27 2006; see KRAUROSIS VULVAE 1963-2005
% 211.07/211.27 |- skos__hiddenLabel mesh__D007724 Vulvae, Kraurosis
% 211.07/211.27 |- mesh__dateRevised mesh__D007724 2005-06-30
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D007724 sjn
% 211.07/211.27 |- skos__scopeNote mesh__D007724
% 211.07/211.27 Atrophy and shriveling of the SKIN of the VULVA that is characterized by the whitish LICHEN SCLEROSUS appearance, inflammation, and PRURITUS.%A%
% 211.07/211.27 |- skos__hiddenLabel mesh__D007724 Vulva Lichen Sclerosus
% 211.07/211.27 |- skos__hiddenLabel mesh__D007724 Sclerosus, Vulvar Lichen
% 211.07/211.27 |- skos__altLabel mesh__D007724 Lichen Sclerosus of Vulva
% 211.07/211.27 |- mesh__dateCreated mesh__D007724 1999-01-01
% 211.07/211.27 |- skos__broader mesh__D007724smesh__D014845
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D007724 2006
% 211.07/211.27 |- skos__prefLabel mesh__D007724 Vulvar Lichen Sclerosus
% 211.07/211.27 |- mesh__historyNote mesh__D007724 2006 %28%1963%29%
% 211.07/211.27 |- mesh__recordMaintainer mesh__D051880 ags
% 211.07/211.27 |- mesh__dateCreated mesh__D051880 2005-06-30
% 211.07/211.27 |- skos__scopeNote mesh__D051880
% 211.07/211.27 A family of conserved cell surface receptors that contain EPIDERMAL GROWTH FACTOR repeats in their extracellular domain and ANKYRIN repeats in their cytoplasmic domains. The cytoplasmic domain of notch receptors is released upon ligand binding and translocates to the CELL NUCLEUS where it acts as transcription factor.%A%
% 211.07/211.27 |- skos__altLabel mesh__D051880 Notch Receptors
% 211.07/211.27 |- skos__altLabel mesh__D051880 Notch Proteins
% 211.07/211.27 |- mesh__dateRevised mesh__D051880 2005-07-19
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D051880
% 211.07/211.27 2006; RECEPTORS, NOTCH was indexed under MEMBRANE PROTEINS 1990-2005, %26% under INSECT HORMONES 1990-1995%A%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D051880 2006A
% 211.07/211.27 |- mesh__historyNote mesh__D051880 2006%28%1990%29%
% 211.07/211.27 |- skos__prefLabel mesh__D051880 Receptors, Notch
% 211.07/211.27 |- mesh__dateEstablished mesh__D051880 2006-01-01
% 211.07/211.27 |- mesh__recordOriginator mesh__D051880 DRC
% 211.07/211.27 |- skos__broader mesh__D051880smesh__D014157
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D051880 2006
% 211.07/211.27 |- rdf__type mesh__D051880sskos__Concept
% 211.07/211.27 |- skos__broader mesh__D051880smesh__D011956
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D051880 ags
% 211.07/211.27 |- skos__prefLabel mesh__D026689 Ethical Analysis
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D026689 2003
% 211.07/211.27 |- mesh__dateEstablished mesh__D026689 2002-01-01
% 211.07/211.27 |- skos__scopeNote mesh__D026689
% 211.07/211.27 The use of systematic methods of ethical examination, such as CASUISTRY or ETHICAL THEORY, in reasoning about moral problems.%A%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D026689 2005
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D026689 2004
% 211.07/211.27 |- skos__hiddenLabel mesh__D026689 Analyses, Ethical
% 211.07/211.27 |- skos__broader mesh__D026689smesh__D004989
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D026689 2006
% 211.07/211.27 |- skos__historyNote mesh__D026689 Ethics %28%1979-2001%29%
% 211.07/211.27 |- mesh__dateCreated mesh__D026689 2001-07-25
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D026689 2002; see ETHICS 1979-2001
% 211.07/211.27 |- mesh__historyNote mesh__D026689 2002; use ETHICS 1978-2001
% 211.07/211.27 |- mesh__recordMaintainer mesh__D026689 hjn
% 211.07/211.27 |- mesh__recordOriginator mesh__D026689 hjn
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D026689 sjn
% 211.07/211.27 |- rdf__type mesh__D026689sskos__Concept
% 211.07/211.27 |- mesh__dateRevised mesh__D026689 2002-07-02
% 211.07/211.27 |- skos__hiddenLabel mesh__D026689 Ethical Analyses
% 211.07/211.27 |- skos__altLabel mesh__D026689 Analysis, Ethical
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D051082
% 211.07/211.27 2006; HOMOSERINE O-SUCCINYLTRANSFERASE was indexed under ACYLTRANSFERASES 1971-2005%A%
% 211.07/211.27 |- skos__hiddenLabel mesh__D051082 Transsuccinylase, Homoserine
% 211.07/211.27 |- mesh__historyNote mesh__D051082
% 211.07/211.27 2006%28%1980%29%; use ACYLTRANSFERASES 1971-1979
% 211.07/211.27 |- rdf__type mesh__D051082sskos__Concept
% 211.07/211.27 |- skos__hiddenLabel mesh__D051082 Succinyltransferase, Homoserine
% 211.07/211.27 |- mesh__dateEstablished mesh__D051082 2006-01-01
% 211.07/211.27 |- skos__prefLabel mesh__D051082 Homoserine O-Succinyltransferase
% 211.07/211.27 |- skos__hiddenLabel mesh__D051082 O-Succinyltransferase, Homoserine
% 211.07/211.27 |- skos__altLabel mesh__D051082 Homoserine Succinyltransferase
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D051082 sjn
% 211.07/211.27 |- skos__hiddenLabel mesh__D051082 Homoserine O Succinyltransferase
% 211.07/211.27 |- mesh__dateCreated mesh__D051082 2005-06-30
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D051082 2006
% 211.07/211.27 |- skos__altLabel mesh__D051082 Homoserine Transsuccinylase
% 211.07/211.27 |- skos__broader mesh__D051082smesh__D000217
% 211.07/211.27 |- skos__scopeNote mesh__D051082
% 211.07/211.27 The first enzyme in the METHIONINE biosynthetic pathway, this enzyme catalyzes the succinylation reaction of L-homoserine to O-succinyl-L-homoserine and COENZYME A using succinyl-CoA.%A%
% 211.07/211.27 |- mesh__recordOriginator mesh__D051082 AKE
% 211.07/211.27 |- mesh__recordMaintainer mesh__D051082 AKE
% 211.07/211.27 |- skos__scopeNote mesh__D012669
% 211.07/211.27 A saclike, glandular diverticulum on each ductus deferens in male vertebrates. It is united with the excretory duct and serves for temporary storage of semen. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 211.07/211.27 |- mesh__dateRevised mesh__D012669 1995-05-23
% 211.07/211.27 |- skos__broader mesh__D012669smesh__D005837
% 211.07/211.27 |- skos__hiddenLabel mesh__D012669 Vesicle, Seminal
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 1998
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 2002
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 1999
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 2005
% 211.07/211.27 |- skos__hiddenLabel mesh__D012669 Vesicles, Seminal
% 211.07/211.27 |- skos__hiddenLabel mesh__D012669 Seminal Vesicle
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 1996
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 2006
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 2000
% 211.07/211.27 |- mesh__recordMaintainer mesh__D012669 KEV
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 1997
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 2003
% 211.07/211.27 |- rdf__type mesh__D012669sskos__Concept
% 211.07/211.27 |- mesh__dateCreated mesh__D012669 1999-01-01
% 211.07/211.27 |- skos__prefLabel mesh__D012669 Seminal Vesicles
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 2001
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D012669 2004
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D012669 PLS
% 211.07/211.27 |- mesh__recordOriginator mesh__D012669 NLM
% 211.07/211.27 |- skos__broader mesh__D031823smesh__D029623
% 211.07/211.27 |- rdf__type mesh__D031823sskos__Concept
% 211.07/211.27 |- skos__altLabel mesh__D031823 Pimpernel
% 211.07/211.27 |- mesh__dateCreated mesh__D031823 2002-07-02
% 211.07/211.27 |- mesh__dateRevised mesh__D031823 2004-07-19
% 211.07/211.27 |- skos__scopeNote mesh__D031823
% 211.07/211.27 A plant genus of the family PRIMULACEAE that contains anagallosides, which are molluscacidal triterpenoid saponins.%A%
% 211.07/211.27 |- mesh__recordOriginator mesh__D031823 ssb
% 211.07/211.27 |- skos__annotation mesh__D031823
% 211.07/211.27 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.27 |- mesh__dateEstablished mesh__D031823 2003-01-01
% 211.07/211.27 |- skos__prefLabel mesh__D031823 Anagallis
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D031823 2003
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D031823 2006
% 211.07/211.27 |- mesh__recordMaintainer mesh__D031823 jls
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D031823 2005
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D031823 sjn
% 211.07/211.27 |- mesh__historyNote mesh__D031823 2003
% 211.07/211.27 |- skos__broader mesh__D017354smesh__D009154
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D017354 2005
% 211.07/211.27 |- skos__historyNote mesh__D017354 Mutation %28%1966-1992%29%
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D017354 93
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D017354 2006
% 211.07/211.27 |- mesh__dateCreated mesh__D017354 1992-05-22
% 211.07/211.27 |- mesh__recordMaintainer mesh__D017354 NDW
% 211.07/211.27 |- skos__annotation mesh__D017354
% 211.07/211.27 see MUTATION for correct use of /drug eff %26% /rad eff
% 211.07/211.27 |- mesh__dateRevised mesh__D017354 2002-07-03
% 211.07/211.27 |- mesh__dateEstablished mesh__D017354 1993-01-01
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D017354 2003
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D017354 sjn
% 211.07/211.27 |- mesh__historyNote mesh__D017354 93
% 211.07/211.27 |- skos__hiddenLabel mesh__D017354 Mutations, Point
% 211.07/211.27 |- mesh__recordOriginator mesh__D017354 PXP
% 211.07/211.27 |- skos__hiddenLabel mesh__D017354 Point Mutations
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D017354 2004
% 211.07/211.27 |- rdf__type mesh__D017354sskos__Concept
% 211.07/211.27 |- skos__scopeNote mesh__D017354
% 211.07/211.27 A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.%A%
% 211.07/211.27 |- skos__prefLabel mesh__D017354 Point Mutation
% 211.07/211.27 |- skos__related mesh__D017354smesh__D020125
% 211.07/211.27 |- skos__altLabel mesh__D017354 Mutation, Point
% 211.07/211.27 |- rdf__type mesh__D050788sskos__Concept
% 211.07/211.27 |- skos__hiddenLabel mesh__D050788 Dehydrogenase, Alanine
% 211.07/211.27 |- mesh__historyNote mesh__D050788
% 211.07/211.27 2006%28%1980%29% use AMINO ACID OXIDOREDUCTASES %26% ALANINE 1972-1979%A%
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D050788 sjn
% 211.07/211.27 |- mesh__dateEstablished mesh__D050788 2006-01-01
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D050788
% 211.07/211.27 2006; ALANINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1972-2005, %26% under ALANINE 1972-1980%A%
% 211.07/211.27 |- skos__prefLabel mesh__D050788 Alanine Dehydrogenase
% 211.07/211.27 |- mesh__dateCreated mesh__D050788 2005-06-30
% 211.07/211.27 |- skos__hiddenLabel mesh__D050788 L Alanine Dehydrogenase
% 211.07/211.27 |- mesh__recordOriginator mesh__D050788 AKE
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D050788 2006
% 211.07/211.27 |- skos__broader mesh__D050788smesh__D000594
% 211.07/211.27 |- skos__scopeNote mesh__D050788
% 211.07/211.27 An NAD-dependent enzyme that catalyzes the reversible DEAMINATION of L-ALANINE to PYRUVATE and AMMONIA. The enzyme is needed for growth when ALANINE is the sole CARBON or NITROGEN source. It may also play a role in CELL WALL synthesis because L-ALANINE is an important constituent of the PEPTIDOGLYCAN layer.%A%
% 211.07/211.27 |- skos__hiddenLabel mesh__D050788 Dehydrogenase, L-Alanine
% 211.07/211.27 |- mesh__recordMaintainer mesh__D050788 AKE
% 211.07/211.27 |- skos__altLabel mesh__D050788 L-Alanine Dehydrogenase
% 211.07/211.27 |- mesh__dateRevised mesh__D003334 1992-05-14
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 1996
% 211.07/211.27 |- skos__prefLabel mesh__D003334 Coroners and Medical Examiners
% 211.07/211.27 |- skos__annotation mesh__D003334 IM; DF: CORONERS
% 211.07/211.27 |- skos__broader mesh__D003334smesh__D006282
% 211.07/211.27 |- mesh__recordMaintainer mesh__D003334 TAP
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 1998
% 211.07/211.27 |- skos__scopeNote mesh__D003334
% 211.07/211.27 Physicians appointed to investigate all cases of sudden or violent death.%A%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 1997
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 1994
% 211.07/211.27 |- skos__hiddenLabel mesh__D003334 Coroner
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 1999
% 211.07/211.27 |- skos__altLabel mesh__D003334 Medical Examiner
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 2002
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 1993
% 211.07/211.27 |- mesh__recordOriginator mesh__D003334 NLM
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 1995
% 211.07/211.27 |- skos__altLabel mesh__D003334 Medical Examiners and Coroners
% 211.07/211.27 |- skos__altLabel mesh__D003334 Medical Examiners
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D003334 PLS
% 211.07/211.27 |- rdf__type mesh__D003334sskos__Concept
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 2003
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 2000
% 211.07/211.27 |- skos__altLabel mesh__D003334 Examiners, Medical
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 2005
% 211.07/211.27 |- mesh__dateCreated mesh__D003334 1999-01-01
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 2004
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 2001
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003334 2006
% 211.07/211.27 |- mesh__historyNote mesh__D027782 2002; use Allium 1998-2001
% 211.07/211.27 |- skos__historyNote mesh__D027782 Allium %28%1998-2001%29%
% 211.07/211.27 |- mesh__recordMaintainer mesh__D027782 ssb
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D027782 2002; see Allium 1998-2001
% 211.07/211.27 |- skos__hiddenLabel mesh__D027782 Chive, Chinese
% 211.07/211.27 |- skos__altLabel mesh__D027782 Chives
% 211.07/211.27 |- skos__hiddenLabel mesh__D027782 Chinese Chives
% 211.07/211.27 |- skos__altLabel mesh__D027782 Allium schoenoprasum
% 211.07/211.27 |- rdf__type mesh__D027782sskos__Concept
% 211.07/211.27 |- skos__scopeNote mesh__D027782
% 211.07/211.27 A plant in the genus ALLIUM, similar to ONIONS.
% 211.07/211.27 |- skos__altLabel mesh__D027782 Allium tuberosum
% 211.07/211.27 |- mesh__dateEstablished mesh__D027782 2002-01-01
% 211.07/211.27 |- skos__broader mesh__D027782smesh__D000490
% 211.07/211.27 |- mesh__dateCreated mesh__D027782 2001-07-25
% 211.07/211.27 |- skos__annotation mesh__D027782
% 211.07/211.27 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.27 |- mesh__recordOriginator mesh__D027782 ssb
% 211.07/211.27 |- skos__hiddenLabel mesh__D027782 Chives, Chinese
% 211.07/211.27 |- mesh__dateRevised mesh__D027782 2004-07-07
% 211.07/211.27 |- skos__broader mesh__D027782smesh__D014675
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D027782 2005
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D027782 sjn
% 211.07/211.27 |- skos__prefLabel mesh__D027782 Chive
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D027782 2006
% 211.07/211.27 |- skos__hiddenLabel mesh__D013762 Dehydrogenase, Dihydrofolate
% 211.07/211.27 |- skos__altLabel mesh__D013762 Dihydrofolate Reductase
% 211.07/211.27 |- skos__hiddenLabel mesh__D013762 Dehydrogenase, Tetrahydrofolate
% 211.07/211.27 |- skos__scopeNote mesh__D013762
% 211.07/211.27 An enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and NADPH to yield 5,6,7,8-tetrahydrofolate and NADPH+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. Methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. %28%Dorland, 27th ed%29% EC 1.5.1.3.%A%
% 211.07/211.27 |- skos__prefLabel mesh__D013762 Tetrahydrofolate Dehydrogenase
% 211.07/211.27 |- mesh__dateEstablished mesh__D013762 1966-01-01
% 211.07/211.27 |- skos__hiddenLabel mesh__D013762 Reductase, Folic Acid
% 211.07/211.27 |- mesh__onlineNote mesh__D013762
% 211.07/211.27 use TETRAHYDROFOLATE DEHYDROGENASE to search DIHYDROFOLATE DEHYDROGENASE 1966-88%A%
% 211.07/211.27 |- mesh__recordMaintainer mesh__D013762 jmp
% 211.07/211.27 |- skos__altLabel mesh__D013762 Folic Acid Reductase
% 211.07/211.27 |- skos__hiddenLabel mesh__D013762 Acid Reductase, Folic
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D013762
% 211.07/211.27 66; DIHYDROFOLATE DEHYDROGENASE was heading 1966-88
% 211.07/211.27 |- mesh__historyNote mesh__D013762
% 211.07/211.27 66; DIHYDROFOLATE DEHYDROGENASE was heading 1966-88
% 211.07/211.27 |- mesh__dateRevised mesh__D013762 2005-06-30
% 211.07/211.27 |- mesh__dateCreated mesh__D013762 1999-01-01
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D013762 2006
% 211.07/211.27 |- skos__hiddenLabel mesh__D013762 Reductase, Dihydrofolate
% 211.07/211.27 |- skos__broader mesh__D013762smesh__D000587
% 211.07/211.27 |- mesh__recordOriginator mesh__D013762 NLM
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D013762 sjn
% 211.07/211.27 |- rdf__type mesh__D013762sskos__Concept
% 211.07/211.27 |- skos__altLabel mesh__D013762 Dihydrofolate Dehydrogenase
% 211.07/211.27 |- skos__historyNote mesh__D007725 Ovarian Neoplasms %28%1966-1974%29%
% 211.07/211.27 |- skos__hiddenLabel mesh__D007725 Tumor, Krukenberg
% 211.07/211.27 |- skos__hiddenLabel mesh__D007725 Tumor, Krukenberg%27%s
% 211.07/211.27 |- mesh__dateRevised mesh__D007725 2003-07-09
% 211.07/211.27 |- skos__prefLabel mesh__D007725 Krukenberg Tumor
% 211.07/211.27 |- mesh__dateCreated mesh__D007725 1974-11-19
% 211.07/211.27 |- skos__scopeNote mesh__D007725
% 211.07/211.27 Mucocellular carcinoma of the ovary, usually metastatic from the gastrointestinal tract, characterized by areas of mucoid degeneration and the presence of signet-ring-like cells. It accounts for 30%25%-40%25% of metastatic cancers to the ovaries and possibly 1%25%-2%25% of all malignant ovarian tumors. The lesions may not be discovered until the primary disease is advanced, and most patients die of their disease within a year. In some cases, a primary tumor is not found. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1685%29%%A%
% 211.07/211.27 |- skos__annotation mesh__D007725
% 211.07/211.27 /blood supply /chem /second /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS %28%IM%29%%A%
% 211.07/211.27 |- rdf__type mesh__D007725sskos__Concept
% 211.07/211.27 |- mesh__recordOriginator mesh__D007725 NLM
% 211.07/211.27 |- skos__altLabel mesh__D007725 Krukenberg%27%s Tumor
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D007725 2005
% 211.07/211.27 |- mesh__historyNote mesh__D007725 94; was KRUKENBERG%27%S TUMOR 1975-93
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D007725 2004
% 211.07/211.27 |- skos__broader mesh__D007725smesh__D018279
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D007725 2006
% 211.07/211.27 |- mesh__recordMaintainer mesh__D007725 mdb
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D007725
% 211.07/211.27 94; was KRUKENBERG%27%S TUMOR 1975-93
% 211.07/211.27 |- skos__hiddenLabel mesh__D007725 Krukenbergs Tumor
% 211.07/211.27 |- mesh__onlineNote mesh__D007725
% 211.07/211.27 use KRUKENBERG TUMOR to search KRUKENBERG%27%S TUMOR 1975-93%A%
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D007725 sjn
% 211.07/211.27 |- mesh__dateEstablished mesh__D007725 1975-09-01
% 211.07/211.27 |- mesh__historyNote mesh__D051881 2006%28%1991%29%
% 211.07/211.27 |- mesh__dateCreated mesh__D051881 2005-06-30
% 211.07/211.27 |- skos__altLabel mesh__D051881 Notch1 Protein
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D051881 sjn
% 211.07/211.27 |- mesh__recordMaintainer mesh__D051881 DRC
% 211.07/211.27 |- skos__altLabel mesh__D051881 Notch1 Receptor
% 211.07/211.27 |- mesh__recordOriginator mesh__D051881 DRC
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D051881 2006
% 211.07/211.27 |- rdf__type mesh__D051881sskos__Concept
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D051881
% 211.07/211.27 2006; RECEPTOR, NOTCH1 was indexed under TRANSCRIPTION FACTORS 1991-2005, under RECEPTORS, CELL SURFACE 2004-2005, %26% under MEMBRANE PROTEINS 1991-2003%A%
% 211.07/211.27 |- mesh__dateEstablished mesh__D051881 2006-01-01
% 211.07/211.27 |- skos__scopeNote mesh__D051881
% 211.07/211.27 A notch receptor that interacts with a variety of ligands and regulates SIGNAL TRANSDUCTION PATHWAYS for multiple cellular processes. It is widely expressed during EMBRYOGENESIS and is essential for EMBRYONIC DEVELOPMENT.%A%
% 211.07/211.27 |- skos__broader mesh__D051881smesh__D051880
% 211.07/211.27 |- skos__prefLabel mesh__D051881 Receptor, Notch1
% 211.07/211.27 |- skos__scopeNote mesh__D031824
% 211.07/211.27 A plant genus of the family PRIMULACEAE that contains triterpenoid saponins.%A%
% 211.07/211.27 |- rdf__type mesh__D031824sskos__Concept
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D031824 2004
% 211.07/211.27 |- mesh__historyNote mesh__D031824 2003
% 211.07/211.27 |- skos__annotation mesh__D031824
% 211.07/211.27 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D031824 2005
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D031824 2003
% 211.07/211.27 |- skos__prefLabel mesh__D031824 Cyclamen
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D031824 2006
% 211.07/211.27 |- mesh__dateEstablished mesh__D031824 2003-01-01
% 211.07/211.27 |- skos__broader mesh__D031824smesh__D029623
% 211.07/211.27 |- mesh__dateCreated mesh__D031824 2002-07-03
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D031824 2003
% 211.07/211.27 |- skos__historyNote mesh__D017355 Gram-Negative Bacteria %28%1984-1992%29%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D017355 2006
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D017355 93
% 211.07/211.27 |- mesh__historyNote mesh__D017355 93
% 211.07/211.27 |- mesh__recordOriginator mesh__D017355 PXP
% 211.07/211.27 |- mesh__dateRevised mesh__D017355 2005-06-30
% 211.07/211.27 |- skos__broader mesh__D017355smesh__D042301
% 211.07/211.27 |- rdf__type mesh__D017355sskos__Concept
% 211.07/211.27 |- skos__scopeNote mesh__D017355
% 211.07/211.27 A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that is not known to be pathogenic for man, animals, or plants. Its organisms are spoilers for beers and ciders and in sweet English ciders they are the causative agents of a secondary fermentation known as %22%cider sickness.%22% The species Z. mobilis is used for experiments in molecular genetic studies.%A%
% 211.07/211.27 |- skos__prefLabel mesh__D017355 Zymomonas
% 211.07/211.27 |- mesh__recordMaintainer mesh__D017355 SYSTEM
% 211.07/211.27 |- mesh__dateCreated mesh__D017355 1992-05-22
% 211.07/211.27 |- mesh__dateEstablished mesh__D017355 1993-01-01
% 211.07/211.27 |- skos__annotation mesh__D017355
% 211.07/211.27 non-pathogenic but spoils fermented beverages
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D017355 sjn
% 211.07/211.27 |- skos__broader mesh__D017355smesh__D006092
% 211.07/211.27 |- skos__historyNote mesh__D017355
% 211.07/211.27 Gram-Negative Anaerobic Bacteria %28%1987-1992%29%
% 211.07/211.27 |- skos__historyNote mesh__D017355 Bacteria %28%1967-1983%29%
% 211.07/211.27 |- skos__hiddenLabel mesh__D050789 Dehydrogenase, Glycine
% 211.07/211.27 |- skos__prefLabel mesh__D050789 Glycine Dehydrogenase
% 211.07/211.27 |- mesh__recordMaintainer mesh__D050789 AKE
% 211.07/211.27 |- rdf__type mesh__D050789sskos__Concept
% 211.07/211.27 |- skos__broader mesh__D050789smesh__D000594
% 211.07/211.27 |- mesh__dateCreated mesh__D050789 2005-06-30
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D050789 sjn
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D050789
% 211.07/211.27 2006; GLYCINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1977-2005%A%
% 211.07/211.27 |- skos__scopeNote mesh__D050789
% 211.07/211.27 An oxidoreductase that catalyzes the oxidative DEAMINATION of GLYCINE to GLYOXYLATE and AMMONIA in the presence of NAD. In BACTERIA lacking transaminating pathways the enzyme can act in the reverse direction to synthesize glycine from glyoxylate and ammonia and NADH.%A%
% 211.07/211.27 |- mesh__recordOriginator mesh__D050789 AKE
% 211.07/211.27 |- mesh__historyNote mesh__D050789 2006%28%1977%29%
% 211.07/211.27 |- mesh__dateEstablished mesh__D050789 2006-01-01
% 211.07/211.27 |- skos__historyNote mesh__D050789
% 211.07/211.27 Amino Acid Oxidoreductases %28%1977-2005%29%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D050789 2006
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 1995
% 211.07/211.27 |- skos__annotation mesh__D003335
% 211.07/211.27 hormone-secreting bodies in head of insects
% 211.07/211.27 |- skos__prefLabel mesh__D003335 Corpora Allata
% 211.07/211.27 |- rdf__type mesh__D003335sskos__Concept
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 2000
% 211.07/211.27 |- skos__altLabel mesh__D003335 Corpus Allatum
% 211.07/211.27 |- mesh__recordOriginator mesh__D003335 FPG
% 211.07/211.27 |- skos__broader mesh__D003335smesh__D009490
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 2003
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 2001
% 211.07/211.27 |- mesh__dateEstablished mesh__D003335 1977-01-01
% 211.07/211.27 |- mesh__dateRevised mesh__D003335 1992-05-14
% 211.07/211.27 |- mesh__recordMaintainer mesh__D003335 TAP
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 2005
% 211.07/211.27 |- skos__broader mesh__D003335smesh__D000825
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 2004
% 211.07/211.27 |- mesh__dateCreated mesh__D003335 1976-04-16
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D003335 77
% 211.07/211.27 |- skos__historyNote mesh__D003335 Neurosecretion %28%1966-1967%29%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 2006
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 1996
% 211.07/211.27 |- skos__scopeNote mesh__D003335
% 211.07/211.27 Paired or fused ganglion-like bodies in the head of insects. The bodies secrete hormones important in the regulation of metamorphosis and the development of some adult tissues.%A%
% 211.07/211.27 |- skos__historyNote mesh__D003335
% 211.07/211.27 Metamorphosis, Biological %28%1966-1976%29%
% 211.07/211.27 |- skos__hiddenLabel mesh__D003335 Allatum, Corpus
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 1998
% 211.07/211.27 |- skos__historyNote mesh__D003335 Juvenile Hormones %28%1972-1976%29%
% 211.07/211.27 |- skos__hiddenLabel mesh__D003335 Allata, Corpora
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 2002
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 1997
% 211.07/211.27 |- mesh__historyNote mesh__D003335 77
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 1994
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 1999
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D003335 PLS
% 211.07/211.27 |- skos__historyNote mesh__D003335 Neurosecretory Systems %28%1970-1976%29%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D003335 1993
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D008020 2001
% 211.07/211.27 |- mesh__dateRevised mesh__D008020 1997-06-20
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D008020 1999
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D008020 2005
% 211.07/211.27 |- skos__broader mesh__D008020smesh__D005791
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D008020 2004
% 211.07/211.27 |- skos__scopeNote mesh__D008020
% 211.07/211.27 Care provided patients requiring extraordinary therapeutic measures in order to sustain and prolong life.%A%
% 211.07/211.27 |- skos__annotation mesh__D008020
% 211.07/211.27 extraordinary measures in patient care: do not confuse with LIFE SUPPORT SYSTEMS which is non-med%A%
% 211.07/211.27 |- skos__hiddenLabel mesh__D008020 Extraordinary Treatments
% 211.07/211.27 |- mesh__historyNote mesh__D008020 78
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D008020 SJN
% 211.07/211.27 |- mesh__recordOriginator mesh__D008020 EC
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D008020 2006
% 211.07/211.27 |- mesh__recordMaintainer mesh__D008020 PXP
% 211.07/211.27 |- skos__hiddenLabel mesh__D008020 Care, Life Support
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D008020 2002
% 211.07/211.27 |- mesh__publicMeSHNote mesh__D008020 78
% 211.07/211.27 |- skos__hiddenLabel mesh__D008020 Treatments, Extraordinary
% 211.07/211.27 |- skos__prefLabel mesh__D008020 Life Support Care
% 211.07/211.27 |- mesh__dateEstablished mesh__D008020 1978-01-01
% 211.07/211.27 |- skos__historyNote mesh__D008020 Ethics, Medical %28%1966-1977%29%
% 211.07/211.27 |- skos__hiddenLabel mesh__D008020 Treatment, Extraordinary
% 211.07/211.27 |- skos__altLabel mesh__D008020 Prolongation of Life
% 211.07/211.27 |- skos__related mesh__D008020smesh__D016414
% 211.07/211.27 |- skos__hiddenLabel mesh__D008020 Life Prolongation
% 211.07/211.27 |- mesh__dateCreated mesh__D008020 1977-04-22
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D008020 2000
% 211.07/211.27 |- skos__historyNote mesh__D008020 Longevity %28%1966-1977%29%
% 211.07/211.27 |- skos__historyNote mesh__D008020 Life Expectancy %28%1966-1977%29%
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D008020 1998
% 211.07/211.27 |- mesh__activeMeSHYear mesh__D008020 2003
% 211.07/211.27 |- rdf__type mesh__D008020sskos__Concept
% 211.07/211.27 |- mesh__recordOriginator mesh__D013763 NLM
% 211.07/211.27 |- skos__historyNote mesh__D013763 Coenzymes %28%1966-1971%29%
% 211.07/211.27 |- skos__annotation mesh__D013763
% 211.07/211.27 deficiency: coordinate TETRAHYDROFOLATES /defic %28%IM%29% with FOLIC ACID DEFICIENCY %28%IM%29%%A%
% 211.07/211.27 |- mesh__recordAuthorizer mesh__D013763 sjn
% 211.07/211.27 |- skos__scopeNote mesh__D013763
% 211.07/211.27 Compounds based on 5,6,7,8-tetrahydrofolate.
% 211.07/211.27 |- mesh__dateCreated mesh__D013763 1999-01-01
% 211.07/211.27 |- skos__broader mesh__D013763smesh__D003067
% 211.07/211.28 |- mesh__recordMaintainer mesh__D013763 ssb
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013763 2006
% 211.07/211.28 |- mesh__dateEstablished mesh__D013763 1974-01-01
% 211.07/211.28 |- skos__broader mesh__D013763smesh__D005492
% 211.07/211.28 |- mesh__dateRevised mesh__D013763 2005-06-30
% 211.07/211.28 |- rdf__type mesh__D013763sskos__Concept
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D013763 74
% 211.07/211.28 |- skos__prefLabel mesh__D013763 Tetrahydrofolates
% 211.07/211.28 |- skos__historyNote mesh__D013763 Folic Acid %28%1966-1971%29%
% 211.07/211.28 |- mesh__historyNote mesh__D013763 74%28%72%29%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007726 2000
% 211.07/211.28 |- mesh__dateCreated mesh__D007726 1999-01-01
% 211.07/211.28 |- skos__broader mesh__D007726smesh__D005741
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007726 2001
% 211.07/211.28 |- rdf__type mesh__D007726sskos__Concept
% 211.07/211.28 |- mesh__recordOriginator mesh__D007726 NLM
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007726 1998
% 211.07/211.28 |- mesh__dateRevised mesh__D007726 1997-06-20
% 211.07/211.28 |- mesh__recordMaintainer mesh__D007726 ADP
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007726 2003
% 211.07/211.28 |- skos__related mesh__D007726smesh__D007727
% 211.07/211.28 |- skos__annotation mesh__D007726
% 211.07/211.28 a rare gas; Kr-84; Kr-78, 80, 82, 83, 86 = KRYPTON %28%IM%29% + ISOTOPES %28%NIM%29%; Kr-74-77, 79, 81, 85, 87-94 = KRYPTON RADIOISOTOPES %28%IM%29%%A%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007726 2002
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007726 1999
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007726 2005
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007726 2004
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D007726 SJN
% 211.07/211.28 |- skos__prefLabel mesh__D007726 Krypton
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007726 2006
% 211.07/211.28 |- skos__scopeNote mesh__D007726
% 211.07/211.28 A noble gas that is found in the atmosphere. It has the atomic symbol Kr, atomic number 36, atomic weight 83.80, and has been used in electric bulbs.%A%
% 211.07/211.28 |- skos__altLabel mesh__D031825 Primrose
% 211.07/211.28 |- skos__annotation mesh__D031825
% 211.07/211.28 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D031825 2005
% 211.07/211.28 |- skos__scopeNote mesh__D031825
% 211.07/211.28 A plant genus of the family PRIMULACEAE. It can cause CONTACT DERMATITIS. SAPONINS have been identified in the root.%A%
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D031825 2003
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D031825 2006
% 211.07/211.28 |- skos__broader mesh__D031825smesh__D029623
% 211.07/211.28 |- mesh__historyNote mesh__D031825 2003
% 211.07/211.28 |- skos__prefLabel mesh__D031825 Primula
% 211.07/211.28 |- mesh__dateEstablished mesh__D031825 2003-01-01
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D031825 2003
% 211.07/211.28 |- rdf__type mesh__D031825sskos__Concept
% 211.07/211.28 |- mesh__dateCreated mesh__D031825 2002-07-03
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D031825 2004
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 2002
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 1993
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 1994
% 211.07/211.28 |- skos__scopeNote mesh__D017356
% 211.07/211.28 Devices for accelerating protons or electrons in closed orbits where the accelerating voltage and magnetic field strength varies %28%the accelerating voltage is held constant for electrons%29% in order to keep the orbit radius constant.%A%
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D017356
% 211.07/211.28 93; was see PARTICLE ACCELERATORS 1978-92
% 211.07/211.28 |- mesh__onlineNote mesh__D017356
% 211.07/211.28 use PARTICLE ACCELERATORS to search SYNCHROTRONS 1978-92
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 1999
% 211.07/211.28 |- mesh__dateCreated mesh__D017356 1992-05-22
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 2006
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 1998
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 2001
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 1997
% 211.07/211.28 |- skos__annotation mesh__D017356
% 211.07/211.28 particle accelerators; do not confuse with SYNCHROCYCLOTRONS see CYCLOTRONS%A%
% 211.07/211.28 |- mesh__historyNote mesh__D017356
% 211.07/211.28 93; was see PARTICLE ACCELERATORS 1978-92
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 2005
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 2004
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 1996
% 211.07/211.28 |- skos__hiddenLabel mesh__D017356 Synchrotron
% 211.07/211.28 |- mesh__dateEstablished mesh__D017356 1993-01-01
% 211.07/211.28 |- skos__historyNote mesh__D017356 Particle Accelerators %28%1978-1992%29%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 2000
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 2003
% 211.07/211.28 |- skos__prefLabel mesh__D017356 Synchrotrons
% 211.07/211.28 |- skos__broader mesh__D017356smesh__D010315
% 211.07/211.28 |- rdf__type mesh__D017356sskos__Concept
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017356 1995
% 211.07/211.28 |- skos__broader mesh__D001141Q000037smesh__D001141
% 211.07/211.28 |- mesh__preferredCombination mesh__D001141Q000037smesh__D047072
% 211.07/211.28 |- rdf__type mesh__D001141Q000037smesh__CompoundConcept
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Quadrigeminal Plates
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D003336 sjn
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003336 2005
% 211.07/211.28 |- mesh__dateCreated mesh__D003336 1999-01-01
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003336 2004
% 211.07/211.28 |- skos__scopeNote mesh__D003336
% 211.07/211.28 A composite substructure of the mesencephalic tectum comprised of the SUPERIOR COLLICULUS and INFERIOR COLLICULUS.%A%
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Mesencephalus, Tectum
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003336 2006
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Plates, Quadrigeminal
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Quadrigemina, Lamina
% 211.07/211.28 |- skos__prefLabel mesh__D003336 Corpora Quadrigemina
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Tectum Mesencephalus
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Lobes, Human Optic
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Human Optic Lobes
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Optic Lobes, Human
% 211.07/211.28 |- mesh__recordMaintainer mesh__D003336 ags
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Quadrigemina, Corpora
% 211.07/211.28 |- skos__altLabel mesh__D003336 Lamina Quadrigemina
% 211.07/211.28 |- skos__broader mesh__D003336smesh__D008636
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Plate, Quadrigeminal
% 211.07/211.28 |- skos__altLabel mesh__D003336 Quadrigeminal Plate
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Human Optic Lobe
% 211.07/211.28 |- rdf__type mesh__D003336sskos__Concept
% 211.07/211.28 |- skos__hiddenLabel mesh__D003336 Lobe, Human Optic
% 211.07/211.28 |- mesh__recordOriginator mesh__D003336 NLM
% 211.07/211.28 |- skos__altLabel mesh__D003336 Optic Lobe, Human
% 211.07/211.28 |- mesh__dateRevised mesh__D003336 2003-07-09
% 211.07/211.28 |- skos__broader mesh__D008021smesh__D004780
% 211.07/211.28 |- skos__related mesh__D008021smesh__D007185
% 211.07/211.28 |- skos__hiddenLabel mesh__D008021 Support Systems, Life
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008021 2006
% 211.07/211.28 |- mesh__dateCreated mesh__D008021 1999-01-01
% 211.07/211.28 |- skos__hiddenLabel mesh__D008021 Systems, Life Support
% 211.07/211.28 |- skos__hiddenLabel mesh__D008021 System, Life Support
% 211.07/211.28 |- skos__prefLabel mesh__D008021 Life Support Systems
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008021 2001
% 211.07/211.28 |- mesh__dateRevised mesh__D008021 1997-06-20
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D008021 SJN
% 211.07/211.28 |- mesh__recordOriginator mesh__D008021 NLM
% 211.07/211.28 |- mesh__recordMaintainer mesh__D008021 PXP
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008021 1998
% 211.07/211.28 |- mesh__historyNote mesh__D008021
% 211.07/211.28 91%28%66%29%; was see under SEALED CABIN ECOLOGY 1966-90
% 211.07/211.28 |- rdf__type mesh__D008021sskos__Concept
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008021 2002
% 211.07/211.28 |- skos__hiddenLabel mesh__D008021 Support System, Life
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008021 2003
% 211.07/211.28 |- skos__hiddenLabel mesh__D008021 Life Support System
% 211.07/211.28 |- skos__scopeNote mesh__D008021
% 211.07/211.28 Systems that provide all or most of the items necessary for maintaining life and health. Provisions are made for the supplying of oxygen, food, water, temperature and pressure control, disposition of carbon dioxide and body waste. The milieu may be a spacecraft, a submarine, or the surface of the moon. In medical care, usually under hospital conditions, LIFE SUPPORT CARE is available. %28%From Webster%27%s New Collegiate Dictionary%29%%A%
% 211.07/211.28 |- mesh__dateEstablished mesh__D008021 1991-01-01
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008021 1999
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008021 2005
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D008021
% 211.07/211.28 91; was see under SEALED CABIN ECOLOGY 1966-90
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008021 2004
% 211.07/211.28 |- skos__annotation mesh__D008021
% 211.07/211.28 do not confuse with LIFE SUPPORT CARE: read MeSH definition%A%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008021 2000
% 211.07/211.28 |- rdf__type mesh__D013764sskos__Concept
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 2000
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 1997
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 2004
% 211.07/211.28 |- mesh__dateRevised mesh__D013764 1993-06-03
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 2003
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 1996
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 1995
% 211.07/211.28 |- mesh__dateEstablished mesh__D013764 1991-01-01
% 211.07/211.28 |- skos__historyNote mesh__D013764 Naphthalenes %28%1966-1977%29%
% 211.07/211.28 |- skos__scopeNote mesh__D013764
% 211.07/211.28 Partially saturated 1,2,3,4-tetrahydronaphthalene compounds.%A%
% 211.07/211.28 |- skos__altLabel mesh__D013764 Tetralins
% 211.07/211.28 |- mesh__dateCreated mesh__D013764 1977-05-17
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 1994
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 2002
% 211.07/211.28 |- mesh__historyNote mesh__D013764
% 211.07/211.28 91%28%78%29%; was see under NAPHTHALENES 1978-90
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 1999
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D013764 PLS
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 2006
% 211.07/211.28 |- skos__broader mesh__D013764smesh__D009281
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D013764
% 211.07/211.28 91; was see under NAPHTHALENES 1978-90
% 211.07/211.28 |- mesh__recordMaintainer mesh__D013764 PLS
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 2001
% 211.07/211.28 |- skos__prefLabel mesh__D013764 Tetrahydronaphthalenes
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 1998
% 211.07/211.28 |- mesh__recordOriginator mesh__D013764 RLS
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013764 2005
% 211.07/211.28 |- skos__historyNote mesh__D007727 Radioisotopes %28%1966-1987%29%
% 211.07/211.28 |- mesh__recordMaintainer mesh__D007727 TPW
% 211.07/211.28 |- rdf__type mesh__D007727sskos__Concept
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 1996
% 211.07/211.28 |- skos__annotation mesh__D007727
% 211.07/211.28 Kr-74-77, 79, 81, 85, 87-94; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%
% 211.07/211.28 |- mesh__historyNote mesh__D007727 88
% 211.07/211.28 |- skos__broader mesh__D007727smesh__D011868
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 2000
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 1998
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 1997
% 211.07/211.28 |- skos__hiddenLabel mesh__D007727 Radioisotopes, Krypton
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 2003
% 211.07/211.28 |- mesh__dateRevised mesh__D007727 1993-06-02
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 2001
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 1999
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 2005
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 2004
% 211.07/211.28 |- skos__scopeNote mesh__D007727
% 211.07/211.28 Unstable isotopes of krypton that decay or disintegrate emitting radiation. Kr atoms with atomic weights 74-77, 79, 81, 85, and 87-94 are radioactive krypton isotopes.%A%
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D007727 PLS
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 1994
% 211.07/211.28 |- mesh__dateEstablished mesh__D007727 1988-01-01
% 211.07/211.28 |- skos__prefLabel mesh__D007727 Krypton Radioisotopes
% 211.07/211.28 |- skos__historyNote mesh__D007727 Krypton %28%1966-1987%29%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 2006
% 211.07/211.28 |- mesh__dateCreated mesh__D007727 1987-04-08
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D007727 88
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 1995
% 211.07/211.28 |- mesh__recordOriginator mesh__D007727 RLS
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007727 2002
% 211.07/211.28 |- skos__prefLabel mesh__D051883 Receptor, Notch2
% 211.07/211.28 |- mesh__dateEstablished mesh__D051883 2006-01-01
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D051883
% 211.07/211.28 2006; RECEPTOR, NOTCH2 was indexed under RECEPTORS, CELL SURFACE 1995-2005%A%
% 211.07/211.28 |- rdf__type mesh__D051883sskos__Concept
% 211.07/211.28 |- mesh__recordOriginator mesh__D051883 DRC
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D051883 2006
% 211.07/211.28 |- skos__broader mesh__D051883smesh__D051880
% 211.07/211.28 |- skos__altLabel mesh__D051883 Notch2 Receptor
% 211.07/211.28 |- skos__scopeNote mesh__D051883
% 211.07/211.28 A notch receptor that plays an important role in CELL DIFFERENTIATION in a variety of cell types. It is the preferentially expressed notch receptor in mature B-LYMPHOCYTES.%A%
% 211.07/211.28 |- mesh__dateCreated mesh__D051883 2005-06-30
% 211.07/211.28 |- mesh__recordMaintainer mesh__D051883 DRC
% 211.07/211.28 |- skos__altLabel mesh__D051883 Notch2 Protein
% 211.07/211.28 |- mesh__historyNote mesh__D051883 2006%28%1995%29%
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D051883 sjn
% 211.07/211.28 |- mesh__dateCreated mesh__D031826 2002-07-03
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D031826 2003
% 211.07/211.28 |- rdf__type mesh__D031826sskos__Concept
% 211.07/211.28 |- skos__prefLabel mesh__D031826 Punicaceae
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D031826 2004
% 211.07/211.28 |- skos__scopeNote mesh__D031826
% 211.07/211.28 A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida that is a small family with a single genus.%A%
% 211.07/211.28 |- skos__annotation mesh__D031826
% 211.07/211.28 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.28 |- skos__broader mesh__D031826smesh__D019684
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D031826 2005
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D031826 2003
% 211.07/211.28 |- mesh__historyNote mesh__D031826 2003
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D031826 2006
% 211.07/211.28 |- mesh__dateEstablished mesh__D031826 2003-01-01
% 211.07/211.28 |- skos__broader mesh__D017357smesh__D010315
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 1999
% 211.07/211.28 |- mesh__onlineNote mesh__D017357
% 211.07/211.28 use PARTICLE ACCELERATORS to search CYCLOTRONS %26% SYNCHROCYCLOTRONS 1978-92%A%
% 211.07/211.28 |- skos__historyNote mesh__D017357 Neutrons %28%1966-1977%29%
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D017357
% 211.07/211.28 93; was see PARTICLE ACCELERATORS 1978-92; SYNCHROCYCLOTRONS was see PARTICLE ACCELERATORS 1978-92%A%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 2006
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 1998
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 2002
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 1997
% 211.07/211.28 |- mesh__dateCreated mesh__D017357 1992-05-07
% 211.07/211.28 |- skos__hiddenLabel mesh__D017357 Cyclotron
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 2005
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 2004
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 1996
% 211.07/211.28 |- skos__historyNote mesh__D017357 Particle Accelerators %28%1978-1992%29%
% 211.07/211.28 |- skos__historyNote mesh__D017357 Fast Neutrons %28%1971-1977%29%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 2003
% 211.07/211.28 |- skos__annotation mesh__D017357
% 211.07/211.28 particle accelerators; do not confuse X ref SYNCHROCYCLOTRONS with SYNCHROTRONS%A%
% 211.07/211.28 |- rdf__type mesh__D017357sskos__Concept
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 2001
% 211.07/211.28 |- skos__hiddenLabel mesh__D017357 Synchrocyclotron
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 1995
% 211.07/211.28 |- mesh__dateEstablished mesh__D017357 1993-01-01
% 211.07/211.28 |- skos__historyNote mesh__D017357 Nuclear Medicine %28%1967-1977%29%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 1993
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 1994
% 211.07/211.28 |- skos__prefLabel mesh__D017357 Cyclotrons
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D017357 2000
% 211.07/211.28 |- skos__scopeNote mesh__D017357
% 211.07/211.28 Devices for accelerating charged particles in a spiral path by a constant-frequency alternating electric field. This electric field is synchronized with the movement of the particles in a constant magnetic field.%A%
% 211.07/211.28 |- mesh__historyNote mesh__D017357
% 211.07/211.28 93; was see PARTICLE ACCELERATORS 1978-92; SYNCHROCYCLOTRONS was see PARTICLE ACCELERATORS 1978-92%A%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 1995
% 211.07/211.28 |- mesh__dateCreated mesh__D003337 1999-01-01
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 2003
% 211.07/211.28 |- skos__hiddenLabel mesh__D003337 Callosum, Corpus
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 1996
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 2000
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 2005
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 2004
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 1998
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 1997
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 2001
% 211.07/211.28 |- mesh__dateRevised mesh__D003337 1992-05-14
% 211.07/211.28 |- skos__scopeNote mesh__D003337
% 211.07/211.28 Broad plate of dense myelinated fibers that reciprocally interconnect regions of the cortex in all lobes with corresponding regions of the opposite hemisphere. The corpus callosum is located deep in the longitudinal fissure.%A%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 2006
% 211.07/211.28 |- mesh__recordMaintainer mesh__D003337 TAP
% 211.07/211.28 |- skos__hiddenLabel mesh__D003337 Corpus Callosums
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 1999
% 211.07/211.28 |- skos__broader mesh__D003337smesh__D013687
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 1994
% 211.07/211.28 |- mesh__recordOriginator mesh__D003337 NLM
% 211.07/211.28 |- rdf__type mesh__D003337sskos__Concept
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 1993
% 211.07/211.28 |- skos__hiddenLabel mesh__D003337 Callosums, Corpus
% 211.07/211.28 |- skos__prefLabel mesh__D003337 Corpus Callosum
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D003337 2002
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D003337 PLS
% 211.07/211.28 |- mesh__recordOriginator mesh__D008820 NLM
% 211.07/211.28 |- mesh__historyNote mesh__D008820 75
% 211.07/211.28 |- skos__altLabel mesh__D008820 Hyperglycemic Mice
% 211.07/211.28 |- mesh__dateEstablished mesh__D008820 1975-09-01
% 211.07/211.28 |- skos__hiddenLabel mesh__D008820 Obese Mouse
% 211.07/211.28 |- skos__prefLabel mesh__D008820 Mice, Obese
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D008820 sjn
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D008820 75
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008820 2006
% 211.07/211.28 |- skos__altLabel mesh__D008820 Obese Mice
% 211.07/211.28 |- mesh__recordMaintainer mesh__D008820 ags
% 211.07/211.28 |- skos__broader mesh__D008820smesh__D008817
% 211.07/211.28 |- mesh__dateCreated mesh__D008820 1974-11-11
% 211.07/211.28 |- skos__scopeNote mesh__D008820
% 211.07/211.28 Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid.%A%
% 211.07/211.28 |- skos__altLabel mesh__D008820 Mouse, Obese
% 211.07/211.28 |- skos__hiddenLabel mesh__D008820 Hyperglycemic Mouse
% 211.07/211.28 |- skos__annotation mesh__D008820
% 211.07/211.28 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE; for X ref HYPERGLYCEMIC MICE do not add HYPERGLYCEMIA or OBESITY unless particularly discussed as diseases%A%
% 211.07/211.28 |- skos__hiddenLabel mesh__D008820 Mice, Hyperglycemic
% 211.07/211.28 |- skos__historyNote mesh__D008820 Mice %28%1966-1974%29%
% 211.07/211.28 |- rdf__type mesh__D008820sskos__Concept
% 211.07/211.28 |- mesh__dateRevised mesh__D008820 2005-06-30
% 211.07/211.28 |- skos__annotation mesh__D008022
% 211.07/211.28 IM; coord with site %28%IM%29%; joint ligaments = LIGAMENTS, ARTICULAR%A%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008022 2003
% 211.07/211.28 |- skos__prefLabel mesh__D008022 Ligaments
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D008022 sjn
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008022 2006
% 211.07/211.28 |- skos__scopeNote mesh__D008022
% 211.07/211.28 Shiny, flexible bands of fibrous tissue connecting together articular extremities of bones. They are pliant, tough, and inextensile.%A%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008022 2002
% 211.07/211.28 |- mesh__dateCreated mesh__D008022 1999-01-01
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008022 2005
% 211.07/211.28 |- mesh__dateRevised mesh__D008022 1999-11-03
% 211.07/211.28 |- skos__broader mesh__D008022smesh__D009141
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008022 2004
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008022 2001
% 211.07/211.28 |- rdf__type mesh__D008022sskos__Concept
% 211.07/211.28 |- mesh__recordMaintainer mesh__D008022 KEV
% 211.07/211.28 |- mesh__recordOriginator mesh__D008022 NLM
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D008022 2000
% 211.07/211.28 |- skos__hiddenLabel mesh__D008022 Ligament
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013765 2005
% 211.07/211.28 |- mesh__dateRevised mesh__D013765 2003-07-09
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D013765
% 211.07/211.28 91; was see under PAPAVERINE 1978-90
% 211.07/211.28 |- skos__broader mesh__D013765smesh__D010208
% 211.07/211.28 |- skos__scopeNote mesh__D013765
% 211.07/211.28 A leukomaine %28%animal alkaloid%29% formed in brain and liver from dopamine and L-dopa; it may be implicated in psychiatric problems.%A%
% 211.07/211.28 |- skos__historyNote mesh__D013765 Quinolines %28%1966-1973%29%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013765 2004
% 211.07/211.28 |- mesh__dateEstablished mesh__D013765 1991-01-01
% 211.07/211.28 |- skos__historyNote mesh__D013765 Papaverine %28%1966-1977%29%
% 211.07/211.28 |- skos__altLabel mesh__D013765 Tetrahydroxypapaveroline
% 211.07/211.28 |- skos__annotation mesh__D013765 /biosyn /physiol permitted
% 211.07/211.28 |- mesh__recordMaintainer mesh__D013765 ssb
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D013765 sjn
% 211.07/211.28 |- mesh__historyNote mesh__D013765
% 211.07/211.28 91%28%78%29%; was see under PAPAVERINE 1978-90
% 211.07/211.28 |- skos__historyNote mesh__D013765 Alcohols %28%1966-1973%29%
% 211.07/211.28 |- skos__altLabel mesh__D013765 Norlaudanosoline
% 211.07/211.28 |- skos__prefLabel mesh__D013765 Tetrahydropapaveroline
% 211.07/211.28 |- skos__historyNote mesh__D013765 Benzene Derivatives %28%1968-1973%29%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D013765 2006
% 211.07/211.28 |- rdf__type mesh__D013765sskos__Concept
% 211.07/211.28 |- mesh__dateCreated mesh__D013765 1977-03-01
% 211.07/211.28 |- mesh__recordOriginator mesh__D013765 SH
% 211.07/211.28 |- skos__annotation mesh__D007728
% 211.07/211.28 also called reticuloendothelial cells of liver
% 211.07/211.28 |- skos__historyNote mesh__D007728 Macrophages %28%1966-1972%29%
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007728 2005
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007728 2004
% 211.07/211.28 |- skos__broader mesh__D007728smesh__D008264
% 211.07/211.28 |- skos__prefLabel mesh__D007728 Kupffer Cells
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D007728 2006
% 211.07/211.28 |- skos__hiddenLabel mesh__D007728 Cells, Kupffer
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D007728 sjn
% 211.07/211.28 |- mesh__recordMaintainer mesh__D007728 nns
% 211.07/211.28 |- mesh__historyNote mesh__D007728 73
% 211.07/211.28 |- mesh__dateEstablished mesh__D007728 1973-01-01
% 211.07/211.28 |- mesh__dateCreated mesh__D007728 1999-01-01
% 211.07/211.28 |- rdf__type mesh__D007728sskos__Concept
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D007728 73
% 211.07/211.28 |- skos__scopeNote mesh__D007728
% 211.07/211.28 Specialized phagocytic cells of the RETICULOENDOTHELIAL SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood, and dispose of worn out red blood cells.%A%
% 211.07/211.28 |- mesh__dateRevised mesh__D007728 2003-07-09
% 211.07/211.28 |- mesh__recordOriginator mesh__D007728 NLM
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D018450 2002
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D018450 2004
% 211.07/211.28 |- mesh__recordOriginator mesh__D018450 AGS
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D018450 2001
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D018450 2003
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D018450 2000
% 211.07/211.28 |- skos__hiddenLabel mesh__D018450 Progression, Disease
% 211.07/211.28 |- skos__hiddenLabel mesh__D018450 Progressions, Disease
% 211.07/211.28 |- mesh__dateRevised mesh__D018450 1999-11-03
% 211.07/211.28 |- mesh__recordMaintainer mesh__D018450 KEV
% 211.07/211.28 |- skos__broader mesh__D018450smesh__D020969
% 211.07/211.28 |- skos__prefLabel mesh__D018450 Disease Progression
% 211.07/211.28 |- skos__hiddenLabel mesh__D018450 Disease Progressions
% 211.07/211.28 |- mesh__historyNote mesh__D018450 95
% 211.07/211.28 |- skos__scopeNote mesh__D018450
% 211.07/211.28 The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.%A%
% 211.07/211.28 |- mesh__dateEstablished mesh__D018450 1995-01-01
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D018450 2006
% 211.07/211.28 |- skos__annotation mesh__D018450
% 211.07/211.28 almost never IM; coord NIM with specific disease %28%IM%29%; since most dis %22%progress%22% unless arrested spontaneously, by med intervention or death, do not index here at all unless particularly discussed as a stage in determ of progn or ther; no qualif; DF: DIS PROGRESSION%A%
% 211.07/211.28 |- mesh__recordAuthorizer mesh__D018450 sjn
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D018450 95
% 211.07/211.28 |- rdf__type mesh__D018450sskos__Concept
% 211.07/211.28 |- mesh__dateCreated mesh__D018450 1994-04-19
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D018450 2005
% 211.07/211.28 |- mesh__publicMeSHNote mesh__D032121 2003
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D032121 2006
% 211.07/211.28 |- skos__prefLabel mesh__D032121 Salvadoraceae
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D032121 2005
% 211.07/211.28 |- rdf__type mesh__D032121sskos__Concept
% 211.07/211.28 |- skos__scopeNote mesh__D032121
% 211.07/211.28 A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida, a small family growing in the tropics. Members contain piperidine alkaloids and GLUCOSINOLATES.%A%
% 211.07/211.28 |- mesh__dateEstablished mesh__D032121 2003-01-01
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D032121 2004
% 211.07/211.28 |- skos__annotation mesh__D032121
% 211.07/211.28 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.28 |- mesh__dateCreated mesh__D032121 2002-07-03
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D032121 2003
% 211.07/211.28 |- skos__broader mesh__D032121smesh__D019684
% 211.07/211.28 |- mesh__historyNote mesh__D032121 2003
% 211.07/211.28 |- skos__hiddenLabel mesh__D004430 Earplug
% 211.07/211.28 |- mesh__activeMeSHYear mesh__D004430 2003
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Protective Device, Ear
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D004430 2005
% 211.07/211.29 |- mesh__recordMaintainer mesh__D004430 lkt
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Earmuff
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Ear Protective Device
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D004430 sjn
% 211.07/211.29 |- mesh__recordOriginator mesh__D004430 NLM
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Device, Ear Protective
% 211.07/211.29 |- skos__scopeNote mesh__D004430
% 211.07/211.29 Personal devices for protection of the ears from loud or high intensity noise, water, or cold. These include earmuffs and earplugs.%A%
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Device, Hearing Protective
% 211.07/211.29 |- rdf__type mesh__D004430sskos__Concept
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Devices, Ear Protective
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Hearing Protective Device
% 211.07/211.29 |- mesh__dateEstablished mesh__D004430 1991-01-01
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Protective Devices, Hearing
% 211.07/211.29 |- skos__broader mesh__D004430smesh__D011481
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Devices, Hearing Protective
% 211.07/211.29 |- mesh__historyNote mesh__D004430 91%28%75%29%
% 211.07/211.29 |- mesh__dateRevised mesh__D004430 2002-07-03
% 211.07/211.29 |- skos__broader mesh__D004430smesh__D011482
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D004430 91; see PROTECTIVE DEVICES 1975-90
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Protective Device, Hearing
% 211.07/211.29 |- skos__prefLabel mesh__D004430 Ear Protective Devices
% 211.07/211.29 |- mesh__dateCreated mesh__D004430 1974-12-12
% 211.07/211.29 |- skos__hiddenLabel mesh__D004430 Protective Devices, Ear
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D004430 2004
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D004430 2006
% 211.07/211.29 |- mesh__historyNote mesh__D031827 2003
% 211.07/211.29 |- mesh__dateEstablished mesh__D031827 2003-01-01
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D031827 2003
% 211.07/211.29 |- rdf__type mesh__D031827sskos__Concept
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D031827 2004
% 211.07/211.29 |- skos__annotation mesh__D031827
% 211.07/211.29 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D031827 2005
% 211.07/211.29 |- mesh__dateCreated mesh__D031827 2002-07-03
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D031827 2003
% 211.07/211.29 |- skos__scopeNote mesh__D031827
% 211.07/211.29 A plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida.%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D031827 2006
% 211.07/211.29 |- skos__prefLabel mesh__D031827 Pyrolaceae
% 211.07/211.29 |- skos__broader mesh__D031827smesh__D019684
% 211.07/211.29 |- skos__historyNote mesh__D017358 Peptides %28%1974-1975%29%
% 211.07/211.29 |- mesh__onlineNote mesh__D017358
% 211.07/211.29 use CELL WALL SKELETON %28%NM%29% to search CELL WALL SKELETON 1982-92%A%
% 211.07/211.29 |- rdf__type mesh__D017358sskos__Concept
% 211.07/211.29 |- skos__historyNote mesh__D017358 Mycolic Acids %28%1976-1992%29%
% 211.07/211.29 |- mesh__recordMaintainer mesh__D017358 lkt
% 211.07/211.29 |- mesh__recordOriginator mesh__D017358 TPW
% 211.07/211.29 |- skos__annotation mesh__D017358
% 211.07/211.29 restrict to bacteria; a mucoprotein of the bact cell wall: do not confuse with CYTOSKELETON, a network within the cytoplasm; coord IM with specific bacterium /ultrastruct, /chem or other pertinent qualif%A%
% 211.07/211.29 |- skos__historyNote mesh__D017358 Polysaccharides %28%1974-1975%29%
% 211.07/211.29 |- mesh__dateCreated mesh__D017358 1992-05-13
% 211.07/211.29 |- mesh__historyNote mesh__D017358
% 211.07/211.29 93; was CELL WALL SKELETON %28%NM%29% 1974-92
% 211.07/211.29 |- mesh__dateRevised mesh__D017358 2005-06-30
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D017358
% 211.07/211.29 93; CELL WALL SKELETON was indexed under MYCOLIC ACIDS %26% MUCOPROTEINS 1976-92 %26% POLYSACCHARIDES %26% PEPTIDES 1974-75%A%
% 211.07/211.29 |- skos__historyNote mesh__D017358 Mucoproteins %28%1976-1992%29%
% 211.07/211.29 |- skos__broader mesh__D017358smesh__D009088
% 211.07/211.29 |- skos__broader mesh__D017358smesh__D001426
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D017358 2006
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D017358 sjn
% 211.07/211.29 |- skos__prefLabel mesh__D017358 Cell Wall Skeleton
% 211.07/211.29 |- mesh__dateEstablished mesh__D017358 1993-01-01
% 211.07/211.29 |- skos__broader mesh__D017358smesh__D002473
% 211.07/211.29 |- skos__scopeNote mesh__D017358
% 211.07/211.29 A mucoprotein found in the cell wall of various types of bacteria. It has adjuvant and antitumor activities and has been used to augment the production of lymphokine-activated killer %28%LAK%29% cells.%A%
% 211.07/211.29 |- rdf__type mesh__D003338sskos__Concept
% 211.07/211.29 |- mesh__recordMaintainer mesh__D003338 lkt
% 211.07/211.29 |- mesh__recordOriginator mesh__D003338 NLM
% 211.07/211.29 |- mesh__dateRevised mesh__D003338 2002-07-03
% 211.07/211.29 |- skos__related mesh__D003338smesh__D008186
% 211.07/211.29 |- skos__broader mesh__D003338smesh__D010053
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D003338 sjn
% 211.07/211.29 |- skos__altLabel mesh__D003338 Corpora Lutea
% 211.07/211.29 |- skos__hiddenLabel mesh__D003338 Lutea, Corpora
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D003338 2004
% 211.07/211.29 |- mesh__dateCreated mesh__D003338 1999-01-01
% 211.07/211.29 |- skos__annotation mesh__D003338 /cytol: consider also LUTEAL CELLS
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D003338 2003
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D003338 2006
% 211.07/211.29 |- skos__prefLabel mesh__D003338 Corpus Luteum
% 211.07/211.29 |- skos__scopeNote mesh__D003338
% 211.07/211.29 The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE.%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D003338 2005
% 211.07/211.29 |- mesh__dateCreated mesh__D014060 1999-01-01
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 1994
% 211.07/211.29 |- skos__annotation mesh__D014060 inflamm dis = GLOSSITIS
% 211.07/211.29 |- skos__broader mesh__D014060smesh__D009059
% 211.07/211.29 |- mesh__recordMaintainer mesh__D014060 PLS
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 1993
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 2005
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 1999
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 1991
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 1992
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 2004
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 1998
% 211.07/211.29 |- rdf__type mesh__D014060sskos__Concept
% 211.07/211.29 |- mesh__recordOriginator mesh__D014060 NLM
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D014060 NLM
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 2002
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 2003
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 1997
% 211.07/211.29 |- mesh__dateEstablished mesh__D014060 1965-01-01
% 211.07/211.29 |- skos__hiddenLabel mesh__D014060 Tongue Disease
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 2001
% 211.07/211.29 |- mesh__dateRevised mesh__D014060 1990-05-29
% 211.07/211.29 |- skos__prefLabel mesh__D014060 Tongue Diseases
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 1996
% 211.07/211.29 |- mesh__historyNote mesh__D014060 65
% 211.07/211.29 |- skos__hiddenLabel mesh__D014060 Disease, Tongue
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 2000
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 1995
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D014060 65
% 211.07/211.29 |- skos__hiddenLabel mesh__D014060 Diseases, Tongue
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014060 2006
% 211.07/211.29 |- skos__hiddenLabel mesh__D008821 Quaking Mice
% 211.07/211.29 |- skos__prefLabel mesh__D008821 Mice, Quaking
% 211.07/211.29 |- mesh__dateRevised mesh__D008821 2005-06-30
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D008821 78
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008821 2006
% 211.07/211.29 |- skos__historyNote mesh__D008821 Mice %28%1966-1977%29%
% 211.07/211.29 |- mesh__dateCreated mesh__D008821 1977-05-12
% 211.07/211.29 |- mesh__recordMaintainer mesh__D008821 ags
% 211.07/211.29 |- skos__annotation mesh__D008821
% 211.07/211.29 NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%
% 211.07/211.29 |- mesh__recordOriginator mesh__D008821 EC
% 211.07/211.29 |- mesh__historyNote mesh__D008821 78
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D008821 sjn
% 211.07/211.29 |- mesh__dateEstablished mesh__D008821 1978-01-01
% 211.07/211.29 |- skos__historyNote mesh__D008821 Mutation %28%1966-1977%29%
% 211.07/211.29 |- rdf__type mesh__D008821sskos__Concept
% 211.07/211.29 |- skos__broader mesh__D008821smesh__D008817
% 211.07/211.29 |- skos__scopeNote mesh__D008821
% 211.07/211.29 Mice homozygous for the mutant autosomal recessive gene, quaking %28%qk%29%, associated with disorder in myelin formation and manifested by axial tremors.%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 2001
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1998
% 211.07/211.29 |- skos__annotation mesh__D008023
% 211.07/211.29 IM; coord with specific joint %28%IM%29%
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D008023 65
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 2006
% 211.07/211.29 |- mesh__recordOriginator mesh__D008023 NLM
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 2000
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1994
% 211.07/211.29 |- mesh__dateCreated mesh__D008023 1999-01-01
% 211.07/211.29 |- skos__broader mesh__D008023smesh__D007596
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 2005
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1989
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1997
% 211.07/211.29 |- mesh__recordMaintainer mesh__D008023 GJB
% 211.07/211.29 |- skos__hiddenLabel mesh__D008023 Ligament, Articular
% 211.07/211.29 |- mesh__dateRevised mesh__D008023 1978-11-24
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1991
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1993
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 2002
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1996
% 211.07/211.29 |- mesh__dateEstablished mesh__D008023 1965-01-01
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 2004
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D008023 NLM
% 211.07/211.29 |- skos__prefLabel mesh__D008023 Ligaments, Articular
% 211.07/211.29 |- rdf__type mesh__D008023sskos__Concept
% 211.07/211.29 |- skos__hiddenLabel mesh__D008023 Articular Ligaments
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1992
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1999
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 2003
% 211.07/211.29 |- skos__hiddenLabel mesh__D008023 Articular Ligament
% 211.07/211.29 |- mesh__historyNote mesh__D008023 65
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1990
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D008023 1995
% 211.07/211.29 |- skos__broader mesh__D008023smesh__D008022
% 211.07/211.29 |- rdf__type mesh__D000040sskos__Concept
% 211.07/211.29 |- mesh__dateEstablished mesh__D000040 1991-01-01
% 211.07/211.29 |- skos__altLabel mesh__D000040 Abscissins
% 211.07/211.29 |- skos__broader mesh__D000040smesh__D012717
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D000040
% 211.07/211.29 93; see ABSCISSINS 1991-92, see CYCLOHEXANECARBOXYLIC ACID 1975-90%A%
% 211.07/211.29 |- skos__altLabel mesh__D000040 Abscissic Acid
% 211.07/211.29 |- skos__broader mesh__D000040smesh__D003509
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D000040 sjn
% 211.07/211.29 |- mesh__historyNote mesh__D000040 93%28%75%29%
% 211.07/211.29 |- mesh__dateCreated mesh__D000040 1974-11-19
% 211.07/211.29 |- mesh__dateRevised mesh__D000040 2005-06-30
% 211.07/211.29 |- mesh__recordOriginator mesh__D000040 NLM
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D000040 2006
% 211.07/211.29 |- skos__historyNote mesh__D000040 Cyclohexanecarboxylic Acids %28%1974%29%
% 211.07/211.29 |- skos__scopeNote mesh__D000040
% 211.07/211.29 Abscission-accelerating plant growth substance isolated from young cotton fruit, leaves of sycamore, birch, and other plants, and from potatoes, lemons, avocados, and other fruits.%A%
% 211.07/211.29 |- mesh__recordMaintainer mesh__D000040 ssb
% 211.07/211.29 |- skos__prefLabel mesh__D000040 Abscisic Acid
% 211.07/211.29 |- mesh__historyNote mesh__D046940 2005
% 211.07/211.29 |- mesh__dateCreated mesh__D046940 2004-07-07
% 211.07/211.29 |- mesh__recordOriginator mesh__D046940 ags
% 211.07/211.29 |- skos__scopeNote mesh__D046940
% 211.07/211.29 A form-genus of spherical to rod-shaped CYANOBACTERIA in the order Chroococcales. They contain THYLAKOIDS and are found in a wide range of habitats.%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D046940 2006
% 211.07/211.29 |- mesh__dateRevised mesh__D046940 2005-06-30
% 211.07/211.29 |- skos__historyNote mesh__D046940 Cyanobacteria %28%1971-2004%29%
% 211.07/211.29 |- skos__broader mesh__D046940smesh__D000458
% 211.07/211.29 |- rdf__type mesh__D046940sskos__Concept
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D046940 sjn
% 211.07/211.29 |- skos__prefLabel mesh__D046940 Synechococcus
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D046940 2005
% 211.07/211.29 |- mesh__dateEstablished mesh__D046940 2005-01-01
% 211.07/211.29 |- mesh__recordMaintainer mesh__D046940 SYSTEM
% 211.07/211.29 |- mesh__dateEstablished mesh__D013766 1991-01-01
% 211.07/211.29 |- skos__altLabel mesh__D013766
% 211.07/211.29 Methyltetrahydrofolate Homocysteine Methyltransferase
% 211.07/211.29 |- mesh__historyNote mesh__D013766 98%28%75%29%
% 211.07/211.29 |- skos__historyNote mesh__D013766 Methyltransferases %28%1973-1974%29%
% 211.07/211.29 |- skos__hiddenLabel mesh__D013766
% 211.07/211.29 Homocysteine Methyltransferase, Methyltetrahydrofolate
% 211.07/211.29 |- skos__related mesh__D013766smesh__D006712
% 211.07/211.29 |- skos__hiddenLabel mesh__D013766
% 211.07/211.29 Methyltransferase, Methyltetrahydrofolate Homocysteine
% 211.07/211.29 |- mesh__dateRevised mesh__D013766 2005-06-30
% 211.07/211.29 |- skos__altLabel mesh__D013766 Methionine Synthase
% 211.07/211.29 |- skos__historyNote mesh__D013766 Methionine %28%1973-1974%29%
% 211.07/211.29 |- skos__hiddenLabel mesh__D013766 Synthetase, Methionine
% 211.07/211.29 |- skos__broader mesh__D013766smesh__D008780
% 211.07/211.29 |- mesh__recordMaintainer mesh__D013766 ags
% 211.07/211.29 |- mesh__recordOriginator mesh__D013766 NLM
% 211.07/211.29 |- skos__annotation mesh__D013766
% 211.07/211.29 /defic: consider also HOMOCYSTINURIA; DF: note short X ref%A%
% 211.07/211.29 |- skos__hiddenLabel mesh__D013766 Synthase, Methionine
% 211.07/211.29 |- skos__altLabel mesh__D013766
% 211.07/211.29 Tetrahydropteroylglutamate Methyltransferase
% 211.07/211.29 |- skos__historyNote mesh__D013766 Tetrahydrofolates %28%1973-1974%29%
% 211.07/211.29 |- skos__altLabel mesh__D013766 Methionine Synthetase
% 211.07/211.29 |- skos__prefLabel mesh__D013766
% 211.07/211.29 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D013766 sjn
% 211.07/211.29 |- mesh__dateCreated mesh__D013766 1974-11-19
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D013766
% 211.07/211.29 98; see TETRAHYDROPTEROYLGLUTAMATE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D013766 2006
% 211.07/211.29 |- rdf__type mesh__D013766sskos__Concept
% 211.07/211.29 |- skos__hiddenLabel mesh__D013766
% 211.07/211.29 Methyltransferase, Tetrahydropteroylglutamate
% 211.07/211.29 |- skos__hiddenLabel mesh__D013766
% 211.07/211.29 S-Methyltransferase, 5-Methyltetrahydrofolate-Homocysteine
% 211.07/211.29 |- skos__scopeNote mesh__D013766
% 211.07/211.29 An enzyme that catalyzes the formation of methionine by transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine. It requires a cobamide coenzyme. The enzyme can act on mono- or triglutamate derivatives. EC 2.1.1.13.%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D007729 2001
% 211.07/211.29 |- mesh__recordOriginator mesh__D007729 NLM
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D007729 jls
% 211.07/211.29 |- mesh__dateRevised mesh__D007729 2004-07-28
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D007729 2006
% 211.07/211.29 |- skos__broader mesh__D007729smesh__D017096
% 211.07/211.29 |- skos__altLabel mesh__D007729 Kuru Encephalopathy
% 211.07/211.29 |- mesh__dateCreated mesh__D007729 1999-01-01
% 211.07/211.29 |- rdf__type mesh__D007729sskos__Concept
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D007729 2005A
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D007729 2002
% 211.07/211.29 |- skos__scopeNote mesh__D007729
% 211.07/211.29 A prion disease found exclusively among the Fore linguistic group natives of the highlands of NEW GUINEA. The illness is primarily restricted to adult females and children of both sexes. It is marked by the subacute onset of tremor and ataxia followed by motor weakness and incontinence. Death occurs within 3-6 months of disease onset. The condition is associated with ritual cannibalism, and has become rare since this practice has been discontinued. Pathologic features include a noninflammatory loss of neurons that is most prominent in the cerebellum, glial proliferation, and amyloid plaques. %28%From Adams et al., Principles of Neurology, 6th ed, p773%29%%A%
% 211.07/211.29 |- skos__altLabel mesh__D007729 Encephalopathy, Kuru
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D007729 2003
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D007729 2000
% 211.07/211.29 |- skos__prefLabel mesh__D007729 Kuru
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D007729 2005
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D007729 2004
% 211.07/211.29 |- skos__annotation mesh__D007729
% 211.07/211.29 do not confuse with KORO, a depersonalization disord
% 211.07/211.29 |- mesh__recordMaintainer mesh__D007729 jls
% 211.07/211.29 |- skos__annotation mesh__D018451 check tag MALE
% 211.07/211.29 |- skos__historyNote mesh__D018451 Homosexuality %28%1966-1994%29%
% 211.07/211.29 |- mesh__recordMaintainer mesh__D018451 lkt
% 211.07/211.29 |- skos__broader mesh__D018451smesh__D006716
% 211.07/211.29 |- mesh__historyNote mesh__D018451 95
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D018451 sjn
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D018451 95
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D018451 2006
% 211.07/211.29 |- skos__scopeNote mesh__D018451
% 211.07/211.29 Sexual attraction or relationship between males.
% 211.07/211.29 |- mesh__dateRevised mesh__D018451 2004-07-07
% 211.07/211.29 |- skos__prefLabel mesh__D018451 Homosexuality, Male
% 211.07/211.29 |- rdf__type mesh__D018451sskos__Concept
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D018451 2005
% 211.07/211.29 |- skos__hiddenLabel mesh__D018451 Male Homosexuality
% 211.07/211.29 |- mesh__recordOriginator mesh__D018451 TGC
% 211.07/211.29 |- skos__hiddenLabel mesh__D018451 Gay
% 211.07/211.29 |- mesh__dateCreated mesh__D018451 1994-04-16
% 211.07/211.29 |- mesh__dateEstablished mesh__D018451 1995-01-01
% 211.07/211.29 |- rdf__type mesh__D032122sskos__Concept
% 211.07/211.29 |- mesh__dateCreated mesh__D032122 2002-07-03
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D032122 2004
% 211.07/211.29 |- skos__broader mesh__D032122smesh__D029630
% 211.07/211.29 |- skos__prefLabel mesh__D032122 Pyrularia
% 211.07/211.29 |- skos__annotation mesh__D032122
% 211.07/211.29 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D032122 2003
% 211.07/211.29 |- mesh__historyNote mesh__D032122 2003
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D032122 2003
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D032122 2006
% 211.07/211.29 |- mesh__dateEstablished mesh__D032122 2003-01-01
% 211.07/211.29 |- skos__scopeNote mesh__D032122
% 211.07/211.29 A plant genus of the family SANTALACEAE. Members contain thionin toxin, which shouldn%27%t be confused with thionine.%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D032122 2005
% 211.07/211.29 |- skos__broader mesh__D004431smesh__D004423
% 211.07/211.29 |- skos__hiddenLabel mesh__D004431 Outer Ears
% 211.07/211.29 |- rdf__type mesh__D004431sskos__Concept
% 211.07/211.29 |- mesh__onlineNote mesh__D004431
% 211.07/211.29 use EAR /AB %26% EAR, EXTERNAL /AB %26% EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70; in searching non-acquired ear abnormalities consider EAR DEFORMITIES, ACQUIRED 1966-74%A%
% 211.07/211.29 |- skos__hiddenLabel mesh__D004431 Ears, Outer
% 211.07/211.29 |- mesh__recordMaintainer mesh__D004431 lkt
% 211.07/211.29 |- skos__hiddenLabel mesh__D004431 External Ears
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D004431
% 211.07/211.29 EAR, EXTERNAL, DEFORMITY was heading 1966-70
% 211.07/211.29 |- skos__prefLabel mesh__D004431 Ear, External
% 211.07/211.29 |- mesh__recordOriginator mesh__D004431 NLM
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D004431 sjn
% 211.07/211.29 |- skos__scopeNote mesh__D004431
% 211.07/211.29 The outer part of the hearing system of the body. It includes the external EAR CANAL, cartilages of the auricle %28%EAR CARTILAGES%29%, and the TYMPANIC MEMBRANE.%A%
% 211.07/211.29 |- skos__altLabel mesh__D004431 External Ear
% 211.07/211.29 |- skos__hiddenLabel mesh__D004431 Ears, External
% 211.07/211.29 |- skos__annotation mesh__D004431
% 211.07/211.29 /abnorm permitted for congenital deformities but acquired deformities = EAR DEFORMITIES, ACQUIRED; inflammation = OTITIS EXTERNA; ear acupuncture or auriculoacupuncture or otoacupuncture %28%acupuncture therapy with ear as pressure point%29% goes here %28%IM%29% + ACUPUNCTURE THERAPY %28%IM%29%%A%
% 211.07/211.29 |- mesh__historyNote mesh__D004431
% 211.07/211.29 EAR, EXTERNAL, DEFORMITY was heading 1966-70
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D004431 2006
% 211.07/211.29 |- mesh__dateRevised mesh__D004431 2005-06-30
% 211.07/211.29 |- skos__altLabel mesh__D004431 Outer Ear
% 211.07/211.29 |- skos__hiddenLabel mesh__D004431 Ear, Outer
% 211.07/211.29 |- mesh__dateCreated mesh__D004431 1999-01-01
% 211.07/211.29 |- mesh__dateCreated mesh__D045848 2003-07-09
% 211.07/211.29 |- skos__annotation mesh__D045848
% 211.07/211.29 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 211.07/211.29 |- rdf__type mesh__D045848sskos__Concept
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D045848 2006
% 211.07/211.29 |- mesh__dateRevised mesh__D045848 2005-06-30
% 211.07/211.29 |- mesh__recordMaintainer mesh__D045848 SYSTEM
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D045848 sjn
% 211.07/211.29 |- mesh__recordOriginator mesh__D045848 ags
% 211.07/211.29 |- mesh__dateEstablished mesh__D045848 2004-01-01
% 211.07/211.29 |- skos__scopeNote mesh__D045848
% 211.07/211.29 A genus of gram-negative, anaerobic bacteria in the family Fibrobacteraceae, isolated from the human GASTROINTESTINAL TRACT.%A%
% 211.07/211.29 |- skos__broader mesh__D045848smesh__D016965
% 211.07/211.29 |- mesh__historyNote mesh__D045848 2004
% 211.07/211.29 |- skos__prefLabel mesh__D045848 Fibrobacter
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D045848 2004
% 211.07/211.29 |- skos__altLabel mesh__D031828 Shinleaf
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D031828 2005
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D031828 2004
% 211.07/211.29 |- mesh__dateCreated mesh__D031828 2002-07-03
% 211.07/211.29 |- rdf__type mesh__D031828sskos__Concept
% 211.07/211.29 |- skos__prefLabel mesh__D031828 Pyrola
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D031828 2003
% 211.07/211.29 |- mesh__dateEstablished mesh__D031828 2003-01-01
% 211.07/211.29 |- skos__scopeNote mesh__D031828
% 211.07/211.29 A plant genus of the family PYROLACEAE. The common name of wintergreen is more often used for GAULTHERIA.%A%
% 211.07/211.29 |- skos__broader mesh__D031828smesh__D031827
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D031828 2003
% 211.07/211.29 |- skos__annotation mesh__D031828
% 211.07/211.29 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D031828 2006
% 211.07/211.29 |- mesh__historyNote mesh__D031828 2003
% 211.07/211.29 |- skos__broader mesh__D017359smesh__D046110
% 211.07/211.29 |- mesh__dateEstablished mesh__D017359 1993-01-01
% 211.07/211.29 |- mesh__recordOriginator mesh__D017359 TGC
% 211.07/211.29 |- skos__hiddenLabel mesh__D017359 Syndrome, HELLP
% 211.07/211.29 |- skos__scopeNote mesh__D017359
% 211.07/211.29 A syndrome of HEMOLYSIS, elevated liver ENZYMES, and low blood platelets count %28%THROMBOCYTOPENIA%29%. HELLP syndrome is observed in pregnant women with PRE-ECLAMPSIA or ECLAMPSIA who also exhibit LIVER damage and abnormalities in BLOOD COAGULATION.%A%
% 211.07/211.29 |- skos__historyNote mesh__D017359 Eclampsia %28%1985-1992%29%
% 211.07/211.29 |- mesh__recordMaintainer mesh__D017359 lkt
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D017359 93
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D017359 2006
% 211.07/211.29 |- skos__historyNote mesh__D017359 Pre-Eclampsia %28%1982-1992%29%
% 211.07/211.29 |- mesh__dateCreated mesh__D017359 1992-05-18
% 211.07/211.29 |- mesh__dateRevised mesh__D017359 2005-06-30
% 211.07/211.29 |- skos__annotation mesh__D017359
% 211.07/211.29 Hemolysis-Elevated Liver enzymes-Low Platelet count syndrome; DF: HELLP%A%
% 211.07/211.29 |- skos__historyNote mesh__D017359 Hemolysis %28%1982-1992%29%
% 211.07/211.29 |- skos__prefLabel mesh__D017359 HELLP Syndrome
% 211.07/211.29 |- mesh__historyNote mesh__D017359 93
% 211.07/211.29 |- skos__historyNote mesh__D017359 Liver/enzymology %28%1982-1992%29%
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D017359 sjn
% 211.07/211.29 |- skos__historyNote mesh__D017359 Thrombocytopenia %28%1982-1992%29%
% 211.07/211.29 |- rdf__type mesh__D017359sskos__Concept
% 211.07/211.29 |- skos__broader mesh__D028081smesh__D027981
% 211.07/211.29 |- mesh__dateEstablished mesh__D028081 2002-01-01
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D028081 sjn
% 211.07/211.29 |- skos__hiddenLabel mesh__D028081 H+ Pi Symporter
% 211.07/211.29 |- skos__altLabel mesh__D028081 Proton-Phosphate Cotransporters
% 211.07/211.29 |- skos__historyNote mesh__D028081 Carrier Proteins %28%1991-2001%29%
% 211.07/211.29 |- mesh__dateRevised mesh__D028081 2005-06-30
% 211.07/211.29 |- mesh__recordMaintainer mesh__D028081 SYSTEM
% 211.07/211.29 |- skos__scopeNote mesh__D028081
% 211.07/211.29 Proteins that cotransport hydrogen ions and phosphate ions across cellular membranes.%A%
% 211.07/211.29 |- skos__altLabel mesh__D028081 H+-Pi Symporter
% 211.07/211.29 |- skos__broader mesh__D028081smesh__D028061
% 211.07/211.29 |- skos__altLabel mesh__D028081 Proton-Phosphate Symporter
% 211.07/211.29 |- skos__prefLabel mesh__D028081 Proton-Phosphate Symporters
% 211.07/211.29 |- mesh__publicMeSHNote mesh__D028081
% 211.07/211.29 2002; H+-PI SYMPORTER was indexed under CARRIER PROTEINS 1991-2001; PROTON-PHOSPHATE SYMPORTER was indexed under CARRIER PROTEINS 1991-2001%A%
% 211.07/211.29 |- skos__hiddenLabel mesh__D028081 Proton Phosphate Symporters
% 211.07/211.29 |- rdf__type mesh__D028081sskos__Concept
% 211.07/211.29 |- skos__hiddenLabel mesh__D028081 Symporter, Proton-Phosphate
% 211.07/211.29 |- mesh__recordOriginator mesh__D028081 jmp
% 211.07/211.29 |- skos__hiddenLabel mesh__D028081 Cotransporters, Proton-Phosphate
% 211.07/211.29 |- mesh__dateCreated mesh__D028081 2001-07-25
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D028081 2006
% 211.07/211.29 |- skos__hiddenLabel mesh__D028081 Symporter, H+-Pi
% 211.07/211.29 |- skos__hiddenLabel mesh__D028081 Proton Phosphate Symporter
% 211.07/211.29 |- mesh__historyNote mesh__D028081
% 211.07/211.29 2002; for H+-PI SYMPORTER use PHOSPHATE-BINDING PROTEINS 1991-2001; for PROTON-PHOSPHATE SYMPORTER use PHOSPHATE-BINDING PROTEINS 1991-2001%A%
% 211.07/211.29 |- skos__hiddenLabel mesh__D028081 Symporters, Proton-Phosphate
% 211.07/211.29 |- skos__hiddenLabel mesh__D028081 Proton Phosphate Cotransporters
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D003339 2004
% 211.07/211.29 |- skos__hiddenLabel mesh__D003339 Luteum Hormones, Corpus
% 211.07/211.29 |- mesh__dateCreated mesh__D003339 1999-01-01
% 211.07/211.29 |- mesh__recordMaintainer mesh__D003339 lkt
% 211.07/211.29 |- mesh__recordOriginator mesh__D003339 NLM
% 211.07/211.29 |- skos__annotation mesh__D003339 /biosyn /physiol permitted
% 211.07/211.29 |- skos__broader mesh__D003339smesh__D042341
% 211.07/211.29 |- mesh__recordAuthorizer mesh__D003339 sjn
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D003339 2006
% 211.07/211.29 |- skos__hiddenLabel mesh__D003339 Hormones, Corpus Luteum
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D003339 2005
% 211.07/211.29 |- rdf__type mesh__D003339sskos__Concept
% 211.07/211.29 |- skos__prefLabel mesh__D003339 Corpus Luteum Hormones
% 211.07/211.29 |- mesh__dateRevised mesh__D003339 2003-07-09
% 211.07/211.29 |- skos__prefLabel mesh__D014061 Tongue Habits
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014061 2003
% 211.07/211.29 |- mesh__dateEstablished mesh__D014061 1965-01-01
% 211.07/211.29 |- mesh__activeMeSHYear mesh__D014061 2004
% 211.07/211.29 |- mesh__recordMaintainer mesh__D014061 JLS
% 211.07/211.29 |- skos__broader mesh__D014061smesh__D006184
% 211.07/211.29 |- skos__scopeNote mesh__D014061
% 211.07/211.29 Acquired responses regularly manifested by tongue movement or positioning.%A%
% 211.07/211.29 |- mesh__historyNote mesh__D014061 65
% 211.07/211.29 |- rdf__type mesh__D014061sskos__Concept
% 211.07/211.29 |- mesh__dateCreated mesh__D014061 1999-01-01
% 211.25/211.40 |- skos__hiddenLabel mesh__D014061 Habits, Tongue
% 211.25/211.40 |- mesh__dateRevised mesh__D014061 2002-07-03
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014061 2005
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D014061 sjn
% 211.25/211.40 |- mesh__recordOriginator mesh__D014061 NLM
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D014061 65
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014061 2006
% 211.25/211.40 |- skos__altLabel mesh__D008822 Transgenic Mice
% 211.25/211.40 |- skos__scopeNote mesh__D008822
% 211.25/211.40 Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO.%A%
% 211.25/211.40 |- skos__altLabel mesh__D008822 Mouse, Transgenic
% 211.25/211.40 |- skos__hiddenLabel mesh__D008822 Transgenic Founder Mice
% 211.25/211.40 |- mesh__dateCreated mesh__D008822 1987-05-08
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D008822 88
% 211.25/211.40 |- skos__broader mesh__D008822smesh__D030801
% 211.25/211.40 |- skos__broader mesh__D008822smesh__D051379
% 211.25/211.40 |- skos__hiddenLabel mesh__D008822 Transgenic Mouse
% 211.25/211.40 |- mesh__historyNote mesh__D008822 88
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008822 2006
% 211.25/211.40 |- skos__prefLabel mesh__D008822 Mice, Transgenic
% 211.25/211.40 |- mesh__dateRevised mesh__D008822 2005-06-30
% 211.25/211.40 |- skos__annotation mesh__D008822
% 211.25/211.40 NIM with no qualifiers when experimental animal; check the tag MICE; for transgenic founder mice, coordinate with FOUNDER EFFECT%A%
% 211.25/211.40 |- skos__altLabel mesh__D008822 Mouse, Founder, Transgenic
% 211.25/211.40 |- mesh__recordOriginator mesh__D008822 SCD
% 211.25/211.40 |- mesh__dateEstablished mesh__D008822 1988-01-01
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D008822 sjn
% 211.25/211.40 |- mesh__recordMaintainer mesh__D008822 ags
% 211.25/211.40 |- rdf__type mesh__D008822sskos__Concept
% 211.25/211.40 |- skos__hiddenLabel mesh__D008822 Mice, Transgenic Founder
% 211.25/211.40 |- skos__annotation mesh__D008024
% 211.25/211.40 IM for general only; usually NIM with specific cpd IM; no qualif%A%
% 211.25/211.40 |- mesh__recordMaintainer mesh__D008024 ssb
% 211.25/211.40 |- mesh__dateEstablished mesh__D008024 1974-01-01
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008024 2004
% 211.25/211.40 |- rdf__type mesh__D008024sskos__Concept
% 211.25/211.40 |- skos__related mesh__D008024smesh__D011956
% 211.25/211.40 |- skos__related mesh__D008024smesh__D011869
% 211.25/211.40 |- mesh__historyNote mesh__D008024 74%28%73%29%
% 211.25/211.40 |- skos__historyNote mesh__D008024 Metals %28%1966-1972%29%
% 211.25/211.40 |- mesh__recordOriginator mesh__D008024 NLM
% 211.25/211.40 |- skos__scopeNote mesh__D008024
% 211.25/211.40 A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. %28%From Dorland, 27th ed%29%%A%
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D008024 74
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008024 2006
% 211.25/211.40 |- skos__historyNote mesh__D008024
% 211.25/211.40 Organometallic Compounds %28%1968-1972%29%
% 211.25/211.40 |- mesh__dateCreated mesh__D008024 1999-01-01
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D008024 sjn
% 211.25/211.40 |- skos__prefLabel mesh__D008024 Ligands
% 211.25/211.40 |- skos__broader mesh__D008024smesh__D019995
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008024 2005
% 211.25/211.40 |- mesh__dateRevised mesh__D008024 2003-07-09
% 211.25/211.40 |- skos__annotation mesh__D000041 IM; no qualif
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D000041 PLS
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 2004
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 2002
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 2006
% 211.25/211.40 |- mesh__recordMaintainer mesh__D000041 JLS
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 2003
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 2001
% 211.25/211.40 |- mesh__dateCreated mesh__D000041 1999-01-01
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 2005
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 1997
% 211.25/211.40 |- skos__broader mesh__D000041smesh__D011590
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 1999
% 211.25/211.40 |- skos__scopeNote mesh__D000041
% 211.25/211.40 Chronic absence from work or other duty.
% 211.25/211.40 |- mesh__recordOriginator mesh__D000041 NLM
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 1996
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 2000
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 1995
% 211.25/211.40 |- mesh__historyNote mesh__D000041
% 211.25/211.40 was in Cat F %26% J 1967-82, was in Cat F %26% I 1963-66
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000041 1998
% 211.25/211.40 |- rdf__type mesh__D000041sskos__Concept
% 211.25/211.40 |- skos__prefLabel mesh__D000041 Absenteeism
% 211.25/211.40 |- mesh__dateRevised mesh__D000041 1994-05-27
% 211.25/211.40 |- skos__altLabel mesh__D052180 Publication Formats %5B%Pub Type%5D%
% 211.25/211.40 |- mesh__recordOriginator mesh__D052180 jls
% 211.25/211.40 |- mesh__dateCreated mesh__D052180 2005-06-30
% 211.25/211.40 |- rdf__type mesh__D052180sskos__Concept
% 211.25/211.40 |- mesh__dateEstablished mesh__D052180 2006-01-01
% 211.25/211.40 |- mesh__runningHead mesh__D052180 V2 - PUBLICATION FORMATS
% 211.25/211.40 |- skos__scopeNote mesh__D052180 Specific genre of publication.
% 211.25/211.40 |- skos__annotation mesh__D052180 not used for indexing or cataloging
% 211.25/211.40 |- mesh__recordMaintainer mesh__D052180 jls
% 211.25/211.40 |- mesh__historyNote mesh__D052180 2006
% 211.25/211.40 |- skos__altLabel mesh__D052180 Publication Formats %5B%PT%5D%
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D052180 sjn
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D052180 2006
% 211.25/211.40 |- skos__prefLabel mesh__D052180
% 211.25/211.40 Publication Formats %5B%Publication Type%5D%
% 211.25/211.40 |- mesh__historyNote mesh__D013767
% 211.25/211.40 91%28%75%29%; was see under URIDINE 1975-90
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D013767 sjn
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D013767 2002
% 211.25/211.40 |- skos__historyNote mesh__D013767 Uridine %28%1971-1974%29%
% 211.25/211.40 |- rdf__type mesh__D013767sskos__Concept
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D013767 2006
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D013767 2005
% 211.25/211.40 |- skos__broader mesh__D013767smesh__D014529
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D013767 2004
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D013767 2003
% 211.25/211.40 |- skos__scopeNote mesh__D013767
% 211.25/211.40 An inhibitor of nucleotide metabolism.
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D013767 91; was see under URIDINE 1975-90
% 211.25/211.40 |- skos__prefLabel mesh__D013767 Tetrahydrouridine
% 211.25/211.40 |- mesh__dateEstablished mesh__D013767 1991-01-01
% 211.25/211.40 |- mesh__recordOriginator mesh__D013767 NLM
% 211.25/211.40 |- mesh__dateCreated mesh__D013767 1974-11-19
% 211.25/211.40 |- mesh__recordMaintainer mesh__D013767 ssb
% 211.25/211.40 |- mesh__dateRevised mesh__D013767 2001-07-25
% 211.25/211.40 |- mesh__historyNote mesh__D032921 2003; use DECISION MAKING 1997-2002
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D032921 2003
% 211.25/211.40 |- mesh__recordMaintainer mesh__D032921 hjn
% 211.25/211.40 |- mesh__dateEstablished mesh__D032921 2003-01-01
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D032921 2006
% 211.25/211.40 |- skos__prefLabel mesh__D032921 Consensus
% 211.25/211.40 |- mesh__recordOriginator mesh__D032921 jrf
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D032921
% 211.25/211.40 2003; see DECISION MAKING 1997-2002
% 211.25/211.40 |- skos__broader mesh__D032921smesh__D006126
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D032921 2005
% 211.25/211.40 |- skos__related mesh__D032921smesh__D003245
% 211.25/211.40 |- skos__scopeNote mesh__D032921
% 211.25/211.40 General agreement or collective opinion; the judgment arrived at by most of those concerned.%A%
% 211.25/211.40 |- skos__hiddenLabel mesh__D032921 Development, Consensus
% 211.25/211.40 |- rdf__type mesh__D032921sskos__Concept
% 211.25/211.40 |- skos__related mesh__D032921smesh__D034462
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D032921 sjn
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D032921 2004
% 211.25/211.40 |- mesh__dateCreated mesh__D032921 2002-07-03
% 211.25/211.40 |- skos__broader mesh__D032921smesh__D003657
% 211.25/211.40 |- skos__annotation mesh__D018452 check tag FEMALE
% 211.25/211.40 |- mesh__dateEstablished mesh__D018452 1995-01-01
% 211.25/211.40 |- skos__hiddenLabel mesh__D018452 Female Homosexuality
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D018452 2006
% 211.25/211.40 |- mesh__dateRevised mesh__D018452 2004-07-07
% 211.25/211.40 |- mesh__onlineNote mesh__D018452
% 211.25/211.40 use HOMOSEXUALITY to search HOMOSEXUALITY, FEMALE 1976-80 %26% LESBIANISM 1968-94%A%
% 211.25/211.40 |- skos__prefLabel mesh__D018452 Homosexuality, Female
% 211.25/211.40 |- rdf__type mesh__D018452sskos__Concept
% 211.25/211.40 |- skos__scopeNote mesh__D018452
% 211.25/211.40 Sexual attraction or relationship between females.
% 211.25/211.40 |- mesh__recordMaintainer mesh__D018452 lkt
% 211.25/211.40 |- skos__historyNote mesh__D018452 Homosexuality %28%1966-1994%29%
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D018452
% 211.25/211.40 95; was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY 1981-94, was see HOMOSEXUALITY, FEMALE 1976-80, %26% was see under HOMOSEXUALITY 1968-75%A%
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D018452 2005
% 211.25/211.40 |- skos__broader mesh__D018452smesh__D006716
% 211.25/211.40 |- mesh__historyNote mesh__D018452
% 211.25/211.40 95; was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY 1981-94, was see HOMOSEXUALITY, FEMALE 1976-80, %26% was see under HOMOSEXUALITY 1968-75%A%
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D018452 sjn
% 211.25/211.40 |- skos__hiddenLabel mesh__D018452 Lesbian
% 211.25/211.40 |- mesh__dateCreated mesh__D018452 1994-04-16
% 211.25/211.40 |- skos__altLabel mesh__D018452 Lesbianism
% 211.25/211.40 |- mesh__recordOriginator mesh__D018452 TGC
% 211.25/211.40 |- skos__scopeNote mesh__D032123
% 211.25/211.40 A plant genus of the family SANTALACEAE which is the source of sandalwood oil.%A%
% 211.25/211.40 |- skos__annotation mesh__D032123
% 211.25/211.40 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D032123 2003
% 211.25/211.40 |- mesh__dateCreated mesh__D032123 2002-07-03
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D032123 2003
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D032123 2006
% 211.25/211.40 |- mesh__historyNote mesh__D032123 2003
% 211.25/211.40 |- skos__prefLabel mesh__D032123 Santalum
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D032123 2005
% 211.25/211.40 |- rdf__type mesh__D032123sskos__Concept
% 211.25/211.40 |- skos__altLabel mesh__D032123 Sandalwood
% 211.25/211.40 |- mesh__dateEstablished mesh__D032123 2003-01-01
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D032123 2004
% 211.25/211.40 |- skos__broader mesh__D032123smesh__D029630
% 211.25/211.40 |- skos__hiddenLabel mesh__D004432 Tympanums
% 211.25/211.40 |- skos__related mesh__D004432smesh__D000158
% 211.25/211.40 |- skos__hiddenLabel mesh__D004432 Ears, Middle
% 211.25/211.40 |- skos__altLabel mesh__D004432 Middle Ear
% 211.25/211.40 |- mesh__dateRevised mesh__D004432 2005-06-30
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D004432 2006
% 211.25/211.40 |- skos__altLabel mesh__D004432 Tympanum
% 211.25/211.40 |- mesh__dateCreated mesh__D004432 1999-01-01
% 211.25/211.40 |- mesh__recordMaintainer mesh__D004432 lkt
% 211.25/211.40 |- skos__hiddenLabel mesh__D004432 Cavities, Tympanic
% 211.25/211.40 |- skos__hiddenLabel mesh__D004432 Middle Ears
% 211.25/211.40 |- skos__broader mesh__D004432smesh__D004423
% 211.25/211.40 |- skos__prefLabel mesh__D004432 Ear, Middle
% 211.25/211.40 |- rdf__type mesh__D004432sskos__Concept
% 211.25/211.40 |- skos__hiddenLabel mesh__D004432 Cavity, Tympanic
% 211.25/211.40 |- mesh__recordOriginator mesh__D004432 NLM
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D004432 sjn
% 211.25/211.40 |- skos__annotation mesh__D004432
% 211.25/211.40 /surg: consider TYMPANOPLASTY; inflammation = OTITIS MEDIA; inj caused by pressure = EAR, MIDDLE /inj %28%IM%29% + BAROTRAUMA %28%IM%29%; middle ear effusions = OTITIS MEDIA%A%
% 211.25/211.40 |- skos__related mesh__D004432smesh__D014433
% 211.25/211.40 |- skos__hiddenLabel mesh__D004432 Tympanic Cavities
% 211.25/211.40 |- mesh__dateEstablished mesh__D028082 2002-01-01
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D028082 2002
% 211.25/211.40 |- skos__annotation mesh__D028082
% 211.25/211.40 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.40 |- skos__scopeNote mesh__D028082
% 211.25/211.40 The Borage plant family is in the class Magnoliopsida, subclass Asteridae, order Lamiales. It is characterized by hairy foliage, usually alternate and simple; flowers are funnel-shaped or tubular. Some of the species contain PYRROLIZIDINE ALKALOIDS.%A%
% 211.25/211.40 |- mesh__historyNote mesh__D028082 2002
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D028082 2005
% 211.25/211.40 |- mesh__dateRevised mesh__D028082 2003-07-09
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D028082 2004
% 211.25/211.40 |- rdf__type mesh__D028082sskos__Concept
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D028082 2006
% 211.25/211.40 |- skos__broader mesh__D028082smesh__D019684
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D028082 sjn
% 211.25/211.40 |- mesh__recordOriginator mesh__D028082 ssb
% 211.25/211.40 |- mesh__recordMaintainer mesh__D028082 ssb
% 211.25/211.40 |- skos__prefLabel mesh__D028082 Boraginaceae
% 211.25/211.40 |- mesh__dateCreated mesh__D028082 2001-07-25
% 211.25/211.40 |- rdf__type mesh__D014860sskos__Concept
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014860 2003
% 211.25/211.40 |- skos__broader mesh__D014860smesh__D017193
% 211.25/211.40 |- skos__scopeNote mesh__D014860
% 211.25/211.40 Benign epidermal proliferations or tumors; some are viral in origin.%A%
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014860 2006
% 211.25/211.40 |- mesh__dateRevised mesh__D014860 2001-07-25
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014860 2005
% 211.25/211.40 |- skos__broader mesh__D014860smesh__D030361
% 211.25/211.40 |- mesh__dateCreated mesh__D014860 1999-01-01
% 211.25/211.40 |- skos__broader mesh__D014860smesh__D014412
% 211.25/211.40 |- skos__hiddenLabel mesh__D014860 Wart
% 211.25/211.40 |- skos__altLabel mesh__D014860 Verruca
% 211.25/211.40 |- mesh__recordOriginator mesh__D014860 NLM
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D014860 sjn
% 211.25/211.40 |- skos__annotation mesh__D014860
% 211.25/211.40 a non-neoplastic tumor virus infect; coord IM with precoord organ/dis term %28%IM%29%%A%
% 211.25/211.40 |- mesh__recordMaintainer mesh__D014860 ags
% 211.25/211.40 |- skos__hiddenLabel mesh__D014860 Verrucas
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014860 2004
% 211.25/211.40 |- skos__prefLabel mesh__D014860 Warts
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014860 2002
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014062 2000
% 211.25/211.40 |- skos__altLabel mesh__D014062 Cancer of the Tongue
% 211.25/211.40 |- mesh__recordOriginator mesh__D014062 NLM
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D014062 sjn
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014062 2004
% 211.25/211.40 |- skos__broader mesh__D014062smesh__D014060
% 211.25/211.40 |- rdf__type mesh__D014062sskos__Concept
% 211.25/211.40 |- skos__hiddenLabel mesh__D014062 Cancers, Tongue
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014062 2001
% 211.25/211.40 |- skos__annotation mesh__D014062
% 211.25/211.40 coord IM with histol type of neopl %28%IM%29%
% 211.25/211.40 |- skos__hiddenLabel mesh__D014062 Cancer, Tongue
% 211.25/211.40 |- skos__broader mesh__D014062smesh__D009062
% 211.25/211.40 |- mesh__dateCreated mesh__D014062 1999-01-01
% 211.25/211.40 |- skos__prefLabel mesh__D014062 Tongue Neoplasms
% 211.25/211.40 |- skos__hiddenLabel mesh__D014062 Tongue Neoplasm
% 211.25/211.40 |- skos__hiddenLabel mesh__D014062 Neoplasm, Tongue
% 211.25/211.40 |- skos__scopeNote mesh__D014062 Tumors or cancer of the TONGUE.
% 211.25/211.40 |- skos__altLabel mesh__D014062 Tongue Cancer
% 211.25/211.40 |- mesh__dateRevised mesh__D014062 1999-11-03
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014062 2005
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014062 2002
% 211.25/211.40 |- skos__altLabel mesh__D014062 Neoplasms, Tongue
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014062 2006
% 211.25/211.40 |- skos__hiddenLabel mesh__D014062 Tongue Cancers
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D014062 2003
% 211.25/211.40 |- mesh__recordMaintainer mesh__D014062 nns
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 2002
% 211.25/211.40 |- mesh__recordOriginator mesh__D008823 NLM
% 211.25/211.40 |- mesh__recordMaintainer mesh__D008823 NLM
% 211.25/211.40 |- mesh__dateCreated mesh__D008823 1974-11-11
% 211.25/211.40 |- mesh__dateRevised mesh__D008823 1990-04-13
% 211.25/211.40 |- skos__annotation mesh__D008823 no qualif
% 211.25/211.40 |- skos__scopeNote mesh__D008823
% 211.25/211.40 Electrically charged colloidal particles or ions consisting of oriented molecules; aggregates of a number of molecules held loosely together by secondary bonds.%A%
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 1997
% 211.25/211.40 |- skos__prefLabel mesh__D008823 Micelles
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 2004
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 1991
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 2001
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 1999
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 2006
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 1993
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 1996
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 1995
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 2003
% 211.25/211.40 |- skos__broader mesh__D008823smesh__D003102
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 2000
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 1998
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 2005
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 1992
% 211.25/211.40 |- skos__hiddenLabel mesh__D008823 Micelle
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008823 1994
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D008823 91; was see under COLLOIDS 1975-90
% 211.25/211.40 |- rdf__type mesh__D008823sskos__Concept
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D008823 PLS
% 211.25/211.40 |- mesh__historyNote mesh__D008823
% 211.25/211.40 91%28%75%29%; was see under COLLOIDS 1975-90
% 211.25/211.40 |- skos__historyNote mesh__D008823 Colloids %28%1968-1974%29%
% 211.25/211.40 |- mesh__dateEstablished mesh__D008823 1991-01-01
% 211.25/211.40 |- skos__scopeNote mesh__D000840
% 211.25/211.40 A group of compounds that are structurally related to methoxybenzene and contain the general formula R-C7H70.%A%
% 211.25/211.40 |- skos__broader mesh__D000840smesh__D010636
% 211.25/211.40 |- skos__altLabel mesh__D000840 Methylphenyl Ethers
% 211.25/211.40 |- skos__broader mesh__D000840smesh__D010647
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 2002
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D000840 73
% 211.25/211.40 |- skos__broader mesh__D000840smesh__D008738
% 211.25/211.40 |- rdf__type mesh__D000840sskos__Concept
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 2006
% 211.25/211.40 |- mesh__onlineNote mesh__D000840
% 211.25/211.40 use ANISOLES to search ANISOLE 1971-72 %28%as Prov%29%
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 2004
% 211.25/211.40 |- mesh__dateRevised mesh__D000840 1995-05-18
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 2005
% 211.25/211.40 |- skos__prefLabel mesh__D000840 Anisoles
% 211.25/211.40 |- mesh__historyNote mesh__D000840 73; was ANISOLE 1971-72 %28%Prov%29%
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 2001
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 2003
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D000840 PLS
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 1999
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 1997
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 2000
% 211.25/211.40 |- skos__historyNote mesh__D000840 Phenols %28%1966-1970%29%
% 211.25/211.40 |- mesh__recordOriginator mesh__D000840 NLM
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 1998
% 211.25/211.40 |- skos__historyNote mesh__D000840 Ethers %28%1966-1970%29%
% 211.25/211.40 |- mesh__recordMaintainer mesh__D000840 KEV
% 211.25/211.40 |- skos__hiddenLabel mesh__D000840 Ethers, Methylphenyl
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000840 1996
% 211.25/211.40 |- mesh__dateCreated mesh__D000840 1999-01-01
% 211.25/211.40 |- mesh__dateEstablished mesh__D000840 1973-01-01
% 211.25/211.40 |- mesh__publicMeSHNote mesh__D008025
% 211.25/211.40 CARBOXYLASES was see under CARBOXY-LYASES %26% LIGASES 1964-74, was heading 1963; CARBAMYL PHOSPHATE SYNTHASE %28%AMMONIA%29% %26% CARBAMYL PHOSPHATE SYNTHASE %28%GLUTAMINE%29% were see under PHOSPHOTRANSFERASES, ATP 1975-80%A%
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D008025 sjn
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008025 2004
% 211.25/211.40 |- rdf__type mesh__D008025sskos__Concept
% 211.25/211.40 |- skos__altLabel mesh__D008025 Synthetases
% 211.25/211.40 |- skos__scopeNote mesh__D008025
% 211.25/211.40 A class of enzymes that catalyze the formation of a bond between two substrate molecules, coupled with the hydrolysis of a pyrophosphate bond in ATP or a similar energy donor. %28%Dorland, 28th ed%29% EC 6.%A%
% 211.25/211.40 |- mesh__recordMaintainer mesh__D008025 ssb
% 211.25/211.40 |- skos__prefLabel mesh__D008025 Ligases
% 211.25/211.40 |- mesh__onlineNote mesh__D008025
% 211.25/211.40 use LIGASES %26% CARBOXY-LYASES to search CARBOXYLASES 1966-74%A%
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008025 2006
% 211.25/211.40 |- mesh__historyNote mesh__D008025
% 211.25/211.40 CARBOXYLASES was see under CARBOXY-LYASES %26% LIGASES 1964-74, was heading 1963%A%
% 211.25/211.40 |- skos__broader mesh__D008025smesh__D004798
% 211.25/211.40 |- mesh__dateCreated mesh__D008025 1999-01-01
% 211.25/211.40 |- skos__altLabel mesh__D008025 Synthetase
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D008025 2005
% 211.25/211.40 |- mesh__dateRevised mesh__D008025 2003-07-09
% 211.25/211.40 |- mesh__recordOriginator mesh__D008025 NLM
% 211.25/211.40 |- mesh__recordOriginator mesh__D000042 NLM
% 211.25/211.40 |- mesh__dateRevised mesh__D000042 2005-06-30
% 211.25/211.40 |- skos__scopeNote mesh__D000042
% 211.25/211.40 The physical or physiological processes by which substances or energy are absorbed.%A%
% 211.25/211.40 |- mesh__dateCreated mesh__D000042 1999-01-01
% 211.25/211.40 |- skos__broader mesh__D000042smesh__D008660
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D000042 2006
% 211.25/211.40 |- skos__hiddenLabel mesh__D000042 Absorptions
% 211.25/211.40 |- skos__prefLabel mesh__D000042 Absorption
% 211.25/211.40 |- skos__related mesh__D000042smesh__D012869
% 211.25/211.40 |- skos__broader mesh__D000042smesh__D002627
% 211.25/211.40 |- skos__related mesh__D000042smesh__D007408
% 211.25/211.40 |- rdf__type mesh__D000042sskos__Concept
% 211.25/211.40 |- skos__annotation mesh__D000042
% 211.25/211.40 almost never IM; coordinate NIM with substance /pharmacokin %28%IM%29% or /metab %28%IM%29% or organ /metab %28%IM%29%%A%
% 211.25/211.40 |- mesh__recordMaintainer mesh__D000042 lkt
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D000042 sjn
% 211.25/211.40 |- rdf__type mesh__D052181sskos__Concept
% 211.25/211.40 |- skos__altLabel mesh__D052181 Publication Components %5B%PT%5D%
% 211.25/211.40 |- skos__prefLabel mesh__D052181
% 211.25/211.40 Publication Components %5B%Publication Type%5D%
% 211.25/211.40 |- mesh__runningHead mesh__D052181 V1 - PUBLICATION COMPONENTS
% 211.25/211.40 |- mesh__dateCreated mesh__D052181 2005-06-30
% 211.25/211.40 |- skos__altLabel mesh__D052181 Publication Components %5B%Pub Type%5D%
% 211.25/211.40 |- mesh__dateEstablished mesh__D052181 2006-01-01
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D052181 2006
% 211.25/211.40 |- skos__annotation mesh__D052181 not used for indexing or cataloging
% 211.25/211.40 |- mesh__recordMaintainer mesh__D052181 jls
% 211.25/211.40 |- mesh__historyNote mesh__D052181 2006
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D052181 sjn
% 211.25/211.40 |- skos__scopeNote mesh__D052181 Specific parts of publications.
% 211.25/211.40 |- mesh__recordOriginator mesh__D052181 jls
% 211.25/211.40 |- mesh__recordMaintainer mesh__D013768 ags
% 211.25/211.40 |- mesh__recordOriginator mesh__D013768 NLM
% 211.25/211.40 |- rdf__type mesh__D013768sskos__Concept
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D013768 2006
% 211.25/211.40 |- mesh__recordAuthorizer mesh__D013768 sjn
% 211.25/211.40 |- mesh__dateRevised mesh__D013768 2003-07-09
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D013768 2005
% 211.25/211.40 |- mesh__dateCreated mesh__D013768 1999-01-01
% 211.25/211.40 |- mesh__activeMeSHYear mesh__D013768 2004
% 211.25/211.40 |- skos__prefLabel mesh__D013768 Tetrahymena
% 211.25/211.40 |- skos__annotation mesh__D013768
% 211.25/211.40 a genus of ciliate protozoa: do not confuse with suborder TETRAHYMENINA; a much used research tool%A%
% 211.25/211.40 |- skos__scopeNote mesh__D013768
% 211.25/211.40 A genus of ciliate protozoa commonly used in genetic, cytological, and other research.%A%
% 211.25/211.40 |- skos__broader mesh__D013768smesh__D016806
% 211.25/211.40 |- skos__hiddenLabel mesh__D018453 Child, Homeless
% 211.25/211.40 |- mesh__historyNote mesh__D018453 95
% 211.25/211.40 |- skos__prefLabel mesh__D018453 Homeless Youth
% 211.25/211.41 |- skos__altLabel mesh__D018453 Street Child
% 211.25/211.41 |- mesh__dateRevised mesh__D018453 2002-07-03
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018453 2006
% 211.25/211.41 |- skos__hiddenLabel mesh__D018453 Children, Homeless
% 211.25/211.41 |- skos__broader mesh__D018453smesh__D006703
% 211.25/211.41 |- mesh__dateCreated mesh__D018453 1994-04-16
% 211.25/211.41 |- rdf__type mesh__D018453sskos__Concept
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018453 2003
% 211.25/211.41 |- mesh__recordOriginator mesh__D018453 TGC
% 211.25/211.41 |- skos__altLabel mesh__D018453 Homeless Children
% 211.25/211.41 |- skos__hiddenLabel mesh__D018453 Child, Street
% 211.25/211.41 |- skos__hiddenLabel mesh__D018453 Children, Street
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018453 2004
% 211.25/211.41 |- skos__hiddenLabel mesh__D018453 Youths, Homeless
% 211.25/211.41 |- skos__hiddenLabel mesh__D018453 Youth, Street
% 211.25/211.41 |- skos__hiddenLabel mesh__D018453 Youth, Homeless
% 211.25/211.41 |- skos__historyNote mesh__D018453 Homeless Persons %28%1987-1994%29%
% 211.25/211.41 |- skos__scopeNote mesh__D018453
% 211.25/211.41 Runaway and homeless children and adolescents living on the streets of cities and having no fixed place of residence.%A%
% 211.25/211.41 |- skos__hiddenLabel mesh__D018453 Runaway
% 211.25/211.41 |- mesh__dateEstablished mesh__D018453 1995-01-01
% 211.25/211.41 |- skos__altLabel mesh__D018453 Homeless Child
% 211.25/211.41 |- skos__hiddenLabel mesh__D018453 Youths, Street
% 211.25/211.41 |- skos__hiddenLabel mesh__D018453 Homeless Youths
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D018453 sjn
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D018453 95
% 211.25/211.41 |- mesh__recordMaintainer mesh__D018453 PXP
% 211.25/211.41 |- skos__annotation mesh__D018453
% 211.25/211.41 check the tag CHILD or specific age group; specify geog if pertinent%A%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018453 2005
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 2001
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 1994
% 211.25/211.41 |- mesh__dateCreated mesh__D010470 1999-01-01
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 2006
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 1999
% 211.25/211.41 |- skos__altLabel mesh__D010470 Masking, Perceptual
% 211.25/211.41 |- skos__historyNote mesh__D010470 Visual Perception %28%1966-1971%29%
% 211.25/211.41 |- skos__hiddenLabel mesh__D010470 Perceptual Maskings
% 211.25/211.41 |- skos__broader mesh__D010470smesh__D001307
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D010470 72
% 211.25/211.41 |- skos__prefLabel mesh__D010470 Perceptual Masking
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 2002
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 1995
% 211.25/211.41 |- skos__historyNote mesh__D010470 Auditory Threshold %28%1968-1971%29%
% 211.25/211.41 |- mesh__recordOriginator mesh__D010470 NLM
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D010470 PLS
% 211.25/211.41 |- skos__hiddenLabel mesh__D010470 Maskings, Perceptual
% 211.25/211.41 |- mesh__recordMaintainer mesh__D010470 TAP
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 2003
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 1996
% 211.25/211.41 |- mesh__historyNote mesh__D010470 72
% 211.25/211.41 |- mesh__dateRevised mesh__D010470 1992-05-15
% 211.25/211.41 |- rdf__type mesh__D010470sskos__Concept
% 211.25/211.41 |- skos__broader mesh__D010470smesh__D014796
% 211.25/211.41 |- skos__scopeNote mesh__D010470
% 211.25/211.41 The interference of one perceptual stimulus with another causing a decrease or lessening in perceptual effectiveness.%A%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 2004
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 1997
% 211.25/211.41 |- skos__historyNote mesh__D010470 Auditory Perception %28%1967-1971%29%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 2005
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 1998
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 2000
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010470 1993
% 211.25/211.41 |- mesh__dateEstablished mesh__D010470 1972-01-01
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D032124 2004
% 211.25/211.41 |- mesh__dateEstablished mesh__D032124 2003-01-01
% 211.25/211.41 |- skos__annotation mesh__D032124
% 211.25/211.41 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.41 |- skos__broader mesh__D032124smesh__D029631
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D032124 2003
% 211.25/211.41 |- skos__scopeNote mesh__D032124
% 211.25/211.41 A plant genus of the family SAPINDACEAE. Members contain hypoglycins and ackee oil.%A%
% 211.25/211.41 |- skos__prefLabel mesh__D032124 Blighia
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D032124 2003
% 211.25/211.41 |- rdf__type mesh__D032124sskos__Concept
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D032124 2006
% 211.25/211.41 |- mesh__historyNote mesh__D032124 2003
% 211.25/211.41 |- skos__altLabel mesh__D032124 Akee
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D032124 2005
% 211.25/211.41 |- mesh__dateCreated mesh__D032124 2002-07-02
% 211.25/211.41 |- skos__altLabel mesh__D032124 Ackee
% 211.25/211.41 |- skos__prefLabel mesh__D004433 Earache
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D004433 sjn
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D004433 2004
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D004433 2002
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D004433 2006
% 211.25/211.41 |- mesh__historyNote mesh__D004433 83
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D004433 83
% 211.25/211.41 |- skos__historyNote mesh__D004433 Pain %28%1966-1982%29%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D004433 2003
% 211.25/211.41 |- mesh__dateCreated mesh__D004433 1982-04-26
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D004433 2001
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D004433 2005
% 211.25/211.41 |- skos__altLabel mesh__D004433 Otalgia
% 211.25/211.41 |- mesh__recordOriginator mesh__D004433 RC
% 211.25/211.41 |- mesh__dateEstablished mesh__D004433 1983-01-01
% 211.25/211.41 |- skos__historyNote mesh__D004433 Ear %28%1966-1982%29%
% 211.25/211.41 |- skos__hiddenLabel mesh__D004433 Earaches
% 211.25/211.41 |- mesh__recordMaintainer mesh__D004433 KEV
% 211.25/211.41 |- skos__broader mesh__D004433smesh__D004427
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D004433 2000
% 211.25/211.41 |- rdf__type mesh__D004433sskos__Concept
% 211.25/211.41 |- skos__broader mesh__D004433smesh__D010146
% 211.25/211.41 |- mesh__dateRevised mesh__D004433 1999-11-03
% 211.25/211.41 |- skos__scopeNote mesh__D004433 Pain in the ear.
% 211.25/211.41 |- skos__hiddenLabel mesh__D004433 Otalgias
% 211.25/211.41 |- skos__historyNote mesh__D004433 Ear Diseases %28%1966-1982%29%
% 211.25/211.41 |- mesh__recordMaintainer mesh__D028083 ssb
% 211.25/211.41 |- rdf__type mesh__D028083sskos__Concept
% 211.25/211.41 |- mesh__dateCreated mesh__D028083 2001-07-25
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D028083 2006
% 211.25/211.41 |- skos__annotation mesh__D028083
% 211.25/211.41 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.41 |- mesh__historyNote mesh__D028083 2002
% 211.25/211.41 |- skos__prefLabel mesh__D028083 Scrophulariaceae
% 211.25/211.41 |- mesh__recordOriginator mesh__D028083 ssb
% 211.25/211.41 |- skos__broader mesh__D028083smesh__D019684
% 211.25/211.41 |- skos__scopeNote mesh__D028083
% 211.25/211.41 The figwort plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida. The family is characterized by bisexual flowers with tubular corollas %28%fused petals%29% that are bilaterally symmetrical %28%two-lips%29% and have four stamens in most, two of which are usually shorter.%A%
% 211.25/211.41 |- mesh__dateEstablished mesh__D028083 2002-01-01
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D028083 2002
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D028083 sjn
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D028083 2005
% 211.25/211.41 |- mesh__dateRevised mesh__D028083 2003-07-09
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D028083 2004
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014861 1999
% 211.25/211.41 |- rdf__type mesh__D014861sskos__Concept
% 211.25/211.41 |- skos__broader mesh__D014861smesh__D019601
% 211.25/211.41 |- mesh__dateCreated mesh__D014861 1999-01-01
% 211.25/211.41 |- mesh__recordMaintainer mesh__D014861 PXP
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014861 2006
% 211.25/211.41 |- mesh__recordOriginator mesh__D014861 NLM
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D014861 SJN
% 211.25/211.41 |- skos__broader mesh__D014861smesh__D015205
% 211.25/211.41 |- mesh__dateRevised mesh__D014861 1997-06-20
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014861 2000
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014861 2003
% 211.25/211.41 |- skos__annotation mesh__D014861
% 211.25/211.41 the state; for Washington, D. C. use DISTRICT OF COLUMBIA%A%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014861 2001
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014861 2004
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014861 1998
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014861 2002
% 211.25/211.41 |- skos__prefLabel mesh__D014861 Washington
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014861 2005
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 1994
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 2002
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 2005
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 1995
% 211.25/211.41 |- skos__hiddenLabel mesh__D014063 Fissured Tongue
% 211.25/211.41 |- skos__altLabel mesh__D014063 Tongue, Furrowed
% 211.25/211.41 |- skos__broader mesh__D014063smesh__D014060
% 211.25/211.41 |- skos__hiddenLabel mesh__D014063 Tongues, Fissured
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 2006
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 2000
% 211.25/211.41 |- mesh__recordMaintainer mesh__D014063 TGC
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 1998
% 211.25/211.41 |- mesh__recordOriginator mesh__D014063 NLM
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 2003
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 1999
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 2001
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D014063 PLS
% 211.25/211.41 |- skos__hiddenLabel mesh__D014063 Fissured Tongues
% 211.25/211.41 |- skos__hiddenLabel mesh__D014063 Furrowed Tongue
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 2004
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 1996
% 211.25/211.41 |- skos__hiddenLabel mesh__D014063 Furrowed Tongues
% 211.25/211.41 |- mesh__dateRevised mesh__D014063 1992-12-28
% 211.25/211.41 |- rdf__type mesh__D014063sskos__Concept
% 211.25/211.41 |- skos__hiddenLabel mesh__D014063 Tongues, Furrowed
% 211.25/211.41 |- skos__related mesh__D014063smesh__D008556
% 211.25/211.41 |- skos__prefLabel mesh__D014063 Tongue, Fissured
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D014063 1997
% 211.25/211.41 |- mesh__dateCreated mesh__D014063 1999-01-01
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008824 2003
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008824 1998
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008824 2005
% 211.25/211.41 |- skos__prefLabel mesh__D008824 Michigan
% 211.25/211.41 |- mesh__dateCreated mesh__D008824 1999-01-01
% 211.25/211.41 |- mesh__recordMaintainer mesh__D008824 PXP
% 211.25/211.41 |- rdf__type mesh__D008824sskos__Concept
% 211.25/211.41 |- mesh__dateRevised mesh__D008824 1997-06-20
% 211.25/211.41 |- mesh__recordOriginator mesh__D008824 NLM
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008824 2002
% 211.25/211.41 |- skos__broader mesh__D008824smesh__D006114
% 211.25/211.41 |- skos__broader mesh__D008824smesh__D015146
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008824 2001
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008824 2004
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D008824 SJN
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008824 2000
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008824 1999
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008824 2006
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D000841 2004
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D000841
% 211.25/211.41 91; was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95%A%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D000841 2005
% 211.25/211.41 |- mesh__dateCreated mesh__D000841 1974-11-19
% 211.25/211.41 |- mesh__recordOriginator mesh__D000841 NLM
% 211.25/211.41 |- skos__historyNote mesh__D000841 Pyrrolidines %28%1968-1974%29%
% 211.25/211.41 |- mesh__dateEstablished mesh__D000841 1991-01-01
% 211.25/211.41 |- mesh__dateRevised mesh__D000841 2003-07-30
% 211.25/211.41 |- skos__historyNote mesh__D000841 Antibiotics %28%1968-1974%29%
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D000841 NLM
% 211.25/211.41 |- skos__historyNote mesh__D000841 Benzyl Compounds %28%1972-1974%29%
% 211.25/211.41 |- mesh__historyNote mesh__D000841
% 211.25/211.41 91%28%75%29%; was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95%A%
% 211.25/211.41 |- skos__broader mesh__D000841smesh__D011759
% 211.25/211.41 |- mesh__recordMaintainer mesh__D000841 SYSTEM
% 211.25/211.41 |- skos__scopeNote mesh__D000841
% 211.25/211.41 An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.%A%
% 211.25/211.41 |- rdf__type mesh__D000841sskos__Concept
% 211.25/211.41 |- skos__prefLabel mesh__D000841 Anisomycin
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D000841 2006
% 211.25/211.41 |- skos__broader mesh__D008026smesh__D013514
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008026 2004
% 211.25/211.41 |- mesh__dateEstablished mesh__D008026 1977-01-01
% 211.25/211.41 |- rdf__type mesh__D008026sskos__Concept
% 211.25/211.41 |- skos__hiddenLabel mesh__D008026 Ligatures
% 211.25/211.41 |- mesh__recordOriginator mesh__D008026 NLM
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008026 2002
% 211.25/211.41 |- mesh__historyNote mesh__D008026 77%28%71%29%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008026 2005
% 211.25/211.41 |- mesh__dateCreated mesh__D008026 1999-01-01
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008026 2006
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D008026 77
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D008026 sjn
% 211.25/211.41 |- mesh__recordMaintainer mesh__D008026 ndw
% 211.25/211.41 |- skos__hiddenLabel mesh__D008026 Ligations
% 211.25/211.41 |- skos__historyNote mesh__D008026
% 211.25/211.41 specific heading/surgery %28%1966-1970%29%
% 211.25/211.41 |- skos__annotation mesh__D008026
% 211.25/211.41 never IM; do not use /util except by MeSH definition
% 211.25/211.41 |- mesh__dateRevised mesh__D008026 1999-11-03
% 211.25/211.41 |- skos__historyNote mesh__D008026
% 211.25/211.41 Surgical Procedures, Operative %28%1966-1970%29%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008026 2000
% 211.25/211.41 |- skos__prefLabel mesh__D008026 Ligation
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008026 2003
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D008026 2001
% 211.25/211.41 |- skos__scopeNote mesh__D008026
% 211.25/211.41 Application of a ligature to tie a vessel or strangulate a part.%A%
% 211.25/211.41 |- skos__altLabel mesh__D000043 Indexes
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D000043 2004
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D000043 2006
% 211.25/211.41 |- mesh__dateRevised mesh__D000043 2005-07-07
% 211.25/211.41 |- mesh__recordOriginator mesh__D000043 NLM
% 211.25/211.41 |- skos__prefLabel mesh__D000043 Abstracting and Indexing
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D000043
% 211.25/211.41 66; INDEXES see REFERENCE BOOKS 1996-98
% 211.25/211.41 |- skos__annotation mesh__D000043
% 211.25/211.41 IM; med abstracting %26% indexing: do not coord with MEDICINE; do not confuse with ABSTRACTS %5B%PUBLICATION TYPE%5D% or with MEETING ABSTRACTS %5B%PUBLICATION TYPE%5D%%A%
% 211.25/211.41 |- rdf__type mesh__D000043sskos__Concept
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D000043 2006A
% 211.25/211.41 |- skos__broader mesh__D000043smesh__D004282
% 211.25/211.41 |- skos__scopeNote mesh__D000043
% 211.25/211.41 Shortening or summarizing of documents; assigning of descriptors for referencing documents.%A%
% 211.25/211.41 |- mesh__historyNote mesh__D000043
% 211.25/211.41 66; INDEXES see REFERENCE BOOKS 1996-98; INDEX see REFERENCE BOOKS 1984-98%A%
% 211.25/211.41 |- skos__altLabel mesh__D000043 Indexing and Abstracting
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D000043 2003
% 211.25/211.41 |- skos__hiddenLabel mesh__D000043 Indices
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D000043 2005
% 211.25/211.41 |- mesh__dateCreated mesh__D000043 1999-01-01
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D000043 ags
% 211.25/211.41 |- mesh__recordMaintainer mesh__D000043 ags
% 211.25/211.41 |- skos__prefLabel mesh__D052182
% 211.25/211.41 Study Characteristics %5B%Publication Type%5D%
% 211.25/211.41 |- mesh__dateEstablished mesh__D052182 2006-01-01
% 211.25/211.41 |- mesh__historyNote mesh__D052182 2006
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D052182 sjn
% 211.25/211.41 |- mesh__dateCreated mesh__D052182 2005-06-30
% 211.25/211.41 |- mesh__recordOriginator mesh__D052182 jls
% 211.25/211.41 |- rdf__type mesh__D052182sskos__Concept
% 211.25/211.41 |- mesh__recordMaintainer mesh__D052182 jls
% 211.25/211.41 |- mesh__runningHead mesh__D052182 V3 - STUDY CHARACTERISTICS
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D052182 2006
% 211.25/211.41 |- skos__annotation mesh__D052182 not used for indexing or cataloging
% 211.25/211.41 |- skos__prefLabel mesh__D013769 Tetrahymena pyriformis
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D013769 2006
% 211.25/211.41 |- rdf__type mesh__D013769sskos__Concept
% 211.25/211.41 |- mesh__dateEstablished mesh__D013769 1972-01-01
% 211.25/211.41 |- skos__scopeNote mesh__D013769
% 211.25/211.41 A species of ciliate protozoa used extensively in genetic research.%A%
% 211.25/211.41 |- mesh__dateRevised mesh__D013769 2003-07-09
% 211.25/211.41 |- skos__historyNote mesh__D013769 Tetrahymena %28%1966-1971%29%
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D013769 72
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D013769 2004
% 211.25/211.41 |- skos__annotation mesh__D013769 a protozoon used in genetic research
% 211.25/211.41 |- mesh__recordOriginator mesh__D013769 NLM
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D013769 sjn
% 211.25/211.41 |- mesh__historyNote mesh__D013769 72
% 211.25/211.41 |- mesh__dateCreated mesh__D013769 1999-01-01
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D013769 2005
% 211.25/211.41 |- mesh__recordMaintainer mesh__D013769 ags
% 211.25/211.41 |- skos__broader mesh__D013769smesh__D013768
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D018454 95
% 211.25/211.41 |- skos__historyNote mesh__D018454 Marriage %28%1966-1994%29%
% 211.25/211.41 |- skos__hiddenLabel mesh__D018454 Partners, Domestic
% 211.25/211.41 |- mesh__recordMaintainer mesh__D018454 JLS
% 211.25/211.41 |- skos__hiddenLabel mesh__D018454 Husband
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018454 2003
% 211.25/211.41 |- mesh__dateCreated mesh__D018454 1994-04-16
% 211.25/211.41 |- rdf__type mesh__D018454sskos__Concept
% 211.25/211.41 |- skos__hiddenLabel mesh__D018454 Partner, Domestic
% 211.25/211.41 |- skos__scopeNote mesh__D018454
% 211.25/211.41 Married persons, i.e., husbands and wives, or partners. Domestic partners, or spousal equivalents, are two adults who have chosen to share their lives in an intimate and committed relationship, reside together, and share a mutual obligation of support for the basic necessities of life.%A%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018454 2000
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D018454 SJN
% 211.25/211.41 |- skos__annotation mesh__D018454
% 211.25/211.41 husbands, wives, or partners as persons: differentiate from MARRIAGE, the sociol or anthropol concept%A%
% 211.25/211.41 |- skos__hiddenLabel mesh__D018454 Notification, Spousal
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018454 2004
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018454 2001
% 211.25/211.41 |- skos__altLabel mesh__D018454 Married Persons
% 211.25/211.41 |- skos__broader mesh__D018454smesh__D009679
% 211.25/211.41 |- skos__prefLabel mesh__D018454 Spouses
% 211.25/211.41 |- skos__altLabel mesh__D018454 Spouse
% 211.25/211.41 |- skos__hiddenLabel mesh__D018454 Persons, Married
% 211.25/211.41 |- skos__hiddenLabel mesh__D018454 Married Person
% 211.25/211.41 |- skos__hiddenLabel mesh__D018454 Domestic Partner
% 211.25/211.41 |- mesh__recordOriginator mesh__D018454 TGC
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018454 1999
% 211.25/211.41 |- skos__hiddenLabel mesh__D018454 Person, Married
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018454 2005
% 211.25/211.41 |- mesh__dateRevised mesh__D018454 1998-06-11
% 211.25/211.41 |- skos__broader mesh__D018454smesh__D009272
% 211.25/211.41 |- mesh__historyNote mesh__D018454 95
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018454 2002
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D018454 2006
% 211.25/211.41 |- skos__altLabel mesh__D018454 Wife
% 211.25/211.41 |- mesh__dateEstablished mesh__D018454 1995-01-01
% 211.25/211.41 |- skos__historyNote mesh__D010471 Fishes %28%1966-1986%29%
% 211.25/211.41 |- skos__scopeNote mesh__D010471
% 211.25/211.41 A common name for fish of the family Percidae, belonging to the suborder Percoidei, order PERCIFORMES.%A%
% 211.25/211.41 |- mesh__historyNote mesh__D010471
% 211.25/211.41 91%28%87%29%; was see under PERCIFORMES 1987-90
% 211.25/211.41 |- mesh__dateRevised mesh__D010471 2004-07-30
% 211.25/211.41 |- rdf__type mesh__D010471sskos__Concept
% 211.25/211.41 |- skos__prefLabel mesh__D010471 Perches
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D010471 jls
% 211.25/211.41 |- mesh__dateEstablished mesh__D010471 1991-01-01
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010471 2004
% 211.25/211.41 |- skos__broader mesh__D010471smesh__D010473
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010471 2005
% 211.25/211.41 |- mesh__recordOriginator mesh__D010471 EC
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010471 2006
% 211.25/211.41 |- mesh__recordMaintainer mesh__D010471 jls
% 211.25/211.41 |- skos__altLabel mesh__D010471 Percidae
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D010471
% 211.25/211.41 91; was see under PERCIFORMES 1987-90
% 211.25/211.41 |- mesh__dateCreated mesh__D010471 1986-04-15
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D010471 2005A
% 211.25/211.41 |- skos__annotation mesh__D032125
% 211.25/211.41 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.41 |- mesh__historyNote mesh__D032125 2003
% 211.25/211.41 |- mesh__dateRevised mesh__D032125 2004-07-13
% 211.25/211.41 |- mesh__dateEstablished mesh__D032125 2003-01-01
% 211.25/211.41 |- mesh__recordOriginator mesh__D032125 ssb
% 211.25/211.41 |- skos__prefLabel mesh__D032125 Litchi
% 211.25/211.41 |- skos__altLabel mesh__D032125 Leechee
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D032125 2005
% 211.25/211.41 |- mesh__recordMaintainer mesh__D032125 sjn
% 211.25/211.41 |- skos__altLabel mesh__D032125 Lychee
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D032125 2003
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D032125 2006
% 211.25/211.41 |- rdf__type mesh__D032125sskos__Concept
% 211.25/211.41 |- skos__broader mesh__D032125smesh__D029631
% 211.25/211.41 |- mesh__dateCreated mesh__D032125 2002-07-03
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D032125 sjn
% 211.25/211.41 |- skos__scopeNote mesh__D032125
% 211.25/211.41 A plant genus of the family SAPINDACEAE that bears sweet fruits. Unusual fatty acids such as cyclopropanoic fatty acids have been identified in the seeds.%A%
% 211.25/211.41 |- skos__altLabel mesh__D004434 Accelerated Ambulation
% 211.25/211.41 |- skos__altLabel mesh__D004434 Ambulation, Early
% 211.25/211.41 |- skos__hiddenLabel mesh__D004434 Mobilization, Early
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D004434 2006
% 211.25/211.41 |- skos__historyNote mesh__D004434
% 211.25/211.41 specific heading/rehabilitation %28%1966-1975%29%
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D004434 76
% 211.25/211.41 |- skos__hiddenLabel mesh__D004434 Ambulation, Accelerated
% 211.25/211.41 |- mesh__recordMaintainer mesh__D004434 lkt
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D004434 sjn
% 211.25/211.41 |- skos__broader mesh__D004434smesh__D012046
% 211.25/211.41 |- rdf__type mesh__D004434sskos__Concept
% 211.25/211.41 |- mesh__historyNote mesh__D004434 76
% 211.25/211.41 |- skos__annotation mesh__D004434
% 211.25/211.41 for patient recovery not child development
% 211.25/211.41 |- mesh__recordOriginator mesh__D004434 SMH
% 211.25/211.41 |- mesh__dateCreated mesh__D004434 1975-07-23
% 211.25/211.41 |- mesh__dateRevised mesh__D004434 2005-06-30
% 211.25/211.41 |- skos__scopeNote mesh__D004434
% 211.25/211.41 Procedure to accelerate the ability of a patient to walk or move about by reducing the time to AMBULATION. It is characterized by a shorter period of hospitalization or recumbency than is normally practiced.%A%
% 211.25/211.41 |- skos__prefLabel mesh__D004434 Early Ambulation
% 211.25/211.41 |- mesh__dateEstablished mesh__D004434 1976-01-01
% 211.25/211.41 |- mesh__recordMaintainer mesh__D028084 ssb
% 211.25/211.41 |- mesh__historyNote mesh__D028084 2002; use Theales 1999-2001
% 211.25/211.41 |- mesh__dateCreated mesh__D028084 2001-07-25
% 211.25/211.41 |- skos__prefLabel mesh__D028084 Clusiaceae
% 211.25/211.41 |- mesh__dateEstablished mesh__D028084 2002-01-01
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D028084 sjn
% 211.25/211.41 |- rdf__type mesh__D028084sskos__Concept
% 211.25/211.41 |- skos__altLabel mesh__D028084 Plum, Waika
% 211.25/211.41 |- skos__scopeNote mesh__D028084
% 211.25/211.41 The mangosteen plant family %28%sometimes classified as Guttiferae; also known as Hypericaceae%29% of the order THEALES, subclass Dilleniidae, class Magnoliopsida. It includes trees and shrubs with resinous, sticky sap, usually with broad-ended, oblong, leathery leaves with a strong, central vein, flowers with many stamens.%A%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D028084 2006
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D028084 2005
% 211.25/211.41 |- mesh__recordOriginator mesh__D028084 ssb
% 211.25/211.41 |- skos__broader mesh__D028084smesh__D020448
% 211.25/211.41 |- skos__annotation mesh__D028084
% 211.25/211.41 prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.41 |- mesh__activeMeSHYear mesh__D028084 2004
% 211.25/211.41 |- skos__historyNote mesh__D028084 Theales %28%1999-2001%29%
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D028084 2002; see Theales 1989-2001
% 211.25/211.41 |- mesh__dateRevised mesh__D028084 2003-07-09
% 211.25/211.41 |- skos__altLabel mesh__D014862 Vespid Venoms
% 211.25/211.41 |- skos__hiddenLabel mesh__D014862 Venom, Vespid
% 211.25/211.41 |- mesh__dateCreated mesh__D014862 1977-04-27
% 211.25/211.41 |- mesh__publicMeSHNote mesh__D014862
% 211.25/211.41 91; was see under BEE VENOMS 1978-90
% 211.25/211.41 |- skos__prefLabel mesh__D014862 Wasp Venoms
% 211.25/211.41 |- mesh__historyNote mesh__D014862
% 211.25/211.41 91%28%78%29%; was see under BEE VENOMS 1978-90
% 211.25/211.41 |- mesh__dateRevised mesh__D014862 2005-06-30
% 211.25/211.41 |- mesh__recordOriginator mesh__D014862 SH
% 211.25/211.41 |- skos__hiddenLabel mesh__D014862 Venoms, Vespid
% 211.25/211.41 |- skos__historyNote mesh__D014862
% 211.25/211.41 Insect Bites and Stings %28%1966-1974%29%
% 211.25/211.41 |- skos__altLabel mesh__D014862 Vespid Venom
% 211.25/211.41 |- mesh__recordAuthorizer mesh__D014862 sjn
% 211.25/211.41 |- skos__annotation mesh__D014862
% 211.25/211.41 /antag permitted but consider also ANTIVENINS; /enzymol permitted%A%
% 211.25/211.41 |- mesh__recordMaintainer mesh__D014862 ssb
% 211.25/211.41 |- skos__historyNote mesh__D014862 Insects %28%1966-1975%29%
% 211.25/211.42 |- mesh__dateEstablished mesh__D014862 1991-01-01
% 211.25/211.42 |- skos__altLabel mesh__D014862 Vespa Venoms
% 211.25/211.42 |- skos__hiddenLabel mesh__D014862 Venoms, Vespa
% 211.25/211.42 |- skos__altLabel mesh__D014862 Wasp Venom
% 211.25/211.42 |- skos__historyNote mesh__D014862 Wasps %28%1975-1977%29%
% 211.25/211.42 |- rdf__type mesh__D014862sskos__Concept
% 211.25/211.42 |- skos__hiddenLabel mesh__D014862 Venoms, Wasp
% 211.25/211.42 |- skos__historyNote mesh__D014862 Venoms %28%1966-1977%29%
% 211.25/211.42 |- skos__broader mesh__D014862smesh__D001180
% 211.25/211.42 |- skos__historyNote mesh__D014862 Bees %28%1966-1974%29%
% 211.25/211.42 |- skos__hiddenLabel mesh__D014862 Venom, Wasp
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014862 2006
% 211.25/211.42 |- skos__scopeNote mesh__D014862
% 211.25/211.42 Venoms produced by the wasp %28%Vespid%29% family of stinging insects, including hornets; the venoms contain enzymes, biogenic amines, histamine releasing factors, kinins, toxic polypeptides, etc., and are similar to bee venoms.%A%
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 2005
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 1995
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 2006
% 211.25/211.42 |- mesh__recordMaintainer mesh__D014064 TGC
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 1998
% 211.25/211.42 |- mesh__onlineNote mesh__D014064 search TONGUE DISEASES 1966-74
% 211.25/211.42 |- mesh__historyNote mesh__D014064
% 211.25/211.42 91%28%75%29%; was see under TONGUE DISEASES 1975-90
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 2002
% 211.25/211.42 |- skos__related mesh__D014064smesh__D017733
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 2003
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 1999
% 211.25/211.42 |- skos__scopeNote mesh__D014064
% 211.25/211.42 A benign condition of the tongue characterized by hypertrophy of the filiform papillae that give the dorsum of the tongue a furry appearance. The color of the elongated papillae varies from yellowish white to brown or black, depending upon staining by substances such as tobacco, food, or drugs. %28%Dorland, 27th ed%29%%A%
% 211.25/211.42 |- skos__hiddenLabel mesh__D014064 Tongues, Hairy
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 2004
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 1996
% 211.25/211.42 |- skos__annotation mesh__D014064
% 211.25/211.42 hairy refers to appearance of hypertrophied papillae on tongue%A%
% 211.25/211.42 |- skos__broader mesh__D014064smesh__D014060
% 211.25/211.42 |- rdf__type mesh__D014064sskos__Concept
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 2000
% 211.25/211.42 |- mesh__dateEstablished mesh__D014064 1991-01-01
% 211.25/211.42 |- skos__hiddenLabel mesh__D014064 Hairy Tongues
% 211.25/211.42 |- mesh__recordOriginator mesh__D014064 NLM
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 1997
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D014064
% 211.25/211.42 91; was see under TONGUE DISEASES 1975-90
% 211.25/211.42 |- skos__prefLabel mesh__D014064 Tongue, Hairy
% 211.25/211.42 |- skos__hiddenLabel mesh__D014064 Hairy Tongue
% 211.25/211.42 |- mesh__dateCreated mesh__D014064 1999-01-01
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 2001
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014064 1994
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D014064 PLS
% 211.25/211.42 |- mesh__dateRevised mesh__D014064 1993-06-03
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D008825
% 211.25/211.42 84; was see under IMIDAZOLES 1975-83
% 211.25/211.42 |- rdf__type mesh__D008825sskos__Concept
% 211.25/211.42 |- mesh__recordMaintainer mesh__D008825 ssb
% 211.25/211.42 |- mesh__dateCreated mesh__D008825 1974-11-19
% 211.25/211.42 |- skos__historyNote mesh__D008825 Ethers %28%1971-1974%29%
% 211.25/211.42 |- mesh__dateRevised mesh__D008825 2005-06-30
% 211.25/211.42 |- skos__altLabel mesh__D008825 Miconasil Nitrate
% 211.25/211.42 |- skos__hiddenLabel mesh__D008825 R 14,889
% 211.25/211.42 |- mesh__dateEstablished mesh__D008825 1984-01-01
% 211.25/211.42 |- skos__historyNote mesh__D008825 Benzyl Compounds %28%1972-1974%29%
% 211.25/211.42 |- skos__scopeNote mesh__D008825
% 211.25/211.42 An imidazole antifungal agent that is used topically and by intravenous infusion.%A%
% 211.25/211.42 |- mesh__recordOriginator mesh__D008825 NLM
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008825 2006
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D008825 sjn
% 211.25/211.42 |- mesh__historyNote mesh__D008825
% 211.25/211.42 84%28%75%29%; was see under IMIDAZOLES 1975-83
% 211.25/211.42 |- skos__prefLabel mesh__D008825 Miconazole
% 211.25/211.42 |- skos__hiddenLabel mesh__D008825 R14,889
% 211.25/211.42 |- skos__broader mesh__D008825smesh__D007093
% 211.25/211.42 |- skos__historyNote mesh__D008825 Imidazoles %28%1971-1974%29%
% 211.25/211.42 |- skos__altLabel mesh__D000842 Regio tarsalis
% 211.25/211.42 |- skos__related mesh__D000842smesh__D013639
% 211.25/211.42 |- skos__altLabel mesh__D000842 Tarsus
% 211.25/211.42 |- skos__related mesh__D000842smesh__D000843
% 211.25/211.42 |- mesh__dateCreated mesh__D000842 1999-01-01
% 211.25/211.42 |- mesh__recordOriginator mesh__D000842 NLM
% 211.25/211.42 |- skos__scopeNote mesh__D000842
% 211.25/211.42 The region of the lower limb between the FOOT and the LEG.%A%
% 211.25/211.42 |- mesh__recordMaintainer mesh__D000842 ags
% 211.25/211.42 |- skos__hiddenLabel mesh__D000842 Ankles
% 211.25/211.42 |- mesh__dateRevised mesh__D000842 2002-07-02
% 211.25/211.42 |- mesh__historyNote mesh__D000842
% 211.25/211.42 1963; use ANKLE INJURIES to search ANKLE/injuries 1966-91%A%
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D000842
% 211.25/211.42 1963; see ANKLE INJURIES to search ANKLE/injuries 1966-91; for TARSUS see TARSUS 1988-2001%A%
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D000842 sjn
% 211.25/211.42 |- rdf__type mesh__D000842sskos__Concept
% 211.25/211.42 |- skos__prefLabel mesh__D000842 Ankle
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000842 2006
% 211.25/211.42 |- skos__annotation mesh__D000842
% 211.25/211.42 primates only; use TARSUS, ANIMAL for non-primate vertebrates; differentiate from ANKLE JOINT; ANKLE BONES see TARSAL BONES is also available; do not confuse X ref TARSUS with tarsus or tarsal referring to the eyelid%A%
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000842 2004
% 211.25/211.42 |- skos__broader mesh__D000842smesh__D005528
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000842 2005
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000842 2003
% 211.25/211.42 |- skos__scopeNote mesh__D008027
% 211.25/211.42 That portion of the electromagnetic spectrum to which the human eye is sensitive. Light is about 400 to 800 nanometers in wavelength, i.e., between the ultraviolet and infrared spectra.%A%
% 211.25/211.42 |- skos__related mesh__D008027smesh__D008029
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008027 2005
% 211.25/211.42 |- skos__annotation mesh__D008027
% 211.25/211.42 differentiate from LIGHTING %28%the environment%29%; light scattering = SCATTERING, RADIATION %28%IM%29% + LIGHT %28%NIM%29%; LIGHT + PERIODICITY is not necessarily CIRCADIAN RHYTHM; luminance goes here or under LIGHTING but not under LUMINESCENCE, PHYSICAL; black light: index under INFRARED RAYS or ULTRAVIOLET RAYS depending on text but unspecified, index under ULTRAVIOLET RAYS%A%
% 211.25/211.42 |- skos__related mesh__D008027smesh__D010783
% 211.25/211.42 |- skos__related mesh__D008027smesh__D018462
% 211.25/211.42 |- skos__hiddenLabel mesh__D008027 Radiations, Visible
% 211.25/211.42 |- mesh__dateRevised mesh__D008027 2004-07-13
% 211.25/211.42 |- mesh__dateCreated mesh__D008027 1999-01-01
% 211.25/211.42 |- skos__hiddenLabel mesh__D008027 Photoradiations
% 211.25/211.42 |- skos__related mesh__D008027smesh__D013472
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008027 2006
% 211.25/211.42 |- skos__hiddenLabel mesh__D008027 Visible Light
% 211.25/211.42 |- skos__altLabel mesh__D008027 Photoradiation
% 211.25/211.42 |- mesh__recordMaintainer mesh__D008027 sjn
% 211.25/211.42 |- mesh__recordOriginator mesh__D008027 NLM
% 211.25/211.42 |- skos__broader mesh__D008027smesh__D011840
% 211.25/211.42 |- skos__broader mesh__D008027smesh__D009906
% 211.25/211.42 |- skos__related mesh__D008027smesh__D018524
% 211.25/211.42 |- skos__related mesh__D008027smesh__D010778
% 211.25/211.42 |- skos__altLabel mesh__D008027 Radiation, Visible
% 211.25/211.42 |- skos__prefLabel mesh__D008027 Light
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D008027 sjn
% 211.25/211.42 |- skos__related mesh__D008027smesh__D010777
% 211.25/211.42 |- skos__related mesh__D008027smesh__D010789
% 211.25/211.42 |- mesh__considerAlso mesh__D008027
% 211.25/211.42 consider also terms at PHOTIC and PHOTO-
% 211.25/211.42 |- rdf__type mesh__D008027sskos__Concept
% 211.25/211.42 |- skos__related mesh__D008027smesh__D014467
% 211.25/211.42 |- skos__hiddenLabel mesh__D008027 Visible Radiations
% 211.25/211.42 |- skos__related mesh__D008027smesh__D010775
% 211.25/211.42 |- skos__related mesh__D008027smesh__D010788
% 211.25/211.42 |- skos__related mesh__D008027smesh__D008163
% 211.25/211.42 |- skos__altLabel mesh__D008027 Visible Radiation
% 211.25/211.42 |- skos__related mesh__D008027smesh__D010787
% 211.25/211.42 |- skos__prefLabel mesh__D000044 Dental Abutments
% 211.25/211.42 |- skos__altLabel mesh__D000044 Abutments, Dental
% 211.25/211.42 |- skos__annotation mesh__D000044
% 211.25/211.42 tooth or root used as anchor for denture or implant, etc.; DF: DENT ABUTMENTS%A%
% 211.25/211.42 |- rdf__type mesh__D000044sskos__Concept
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D000044 SJN
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000044 2000
% 211.25/211.42 |- mesh__recordMaintainer mesh__D000044 PXP
% 211.25/211.42 |- skos__altLabel mesh__D000044 Dental Abutment
% 211.25/211.42 |- skos__altLabel mesh__D000044 Abutment, Dental
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000044 2003
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000044 2001
% 211.25/211.42 |- mesh__dateCreated mesh__D000044 1999-01-01
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000044 2005
% 211.25/211.42 |- mesh__onlineNote mesh__D000044
% 211.25/211.42 use DENTAL ABUTMENTS to search ABUTMENTS, DENTAL 1970-90
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000044 2004
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D000044 91; was ABUTMENTS, DENTAL 1970-90
% 211.25/211.42 |- mesh__recordOriginator mesh__D000044 NLM
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000044 2006
% 211.25/211.42 |- mesh__dateEstablished mesh__D000044 1970-01-01
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000044 1998
% 211.25/211.42 |- skos__scopeNote mesh__D000044
% 211.25/211.42 Natural teeth or teeth roots used as anchorage for a fixed or removable denture or other prosthesis %28%such as an implant%29% serving the same purpose.%A%
% 211.25/211.42 |- mesh__historyNote mesh__D000044 91; was ABUTMENTS, DENTAL 1970-90
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000044 2002
% 211.25/211.42 |- mesh__dateRevised mesh__D000044 1997-06-20
% 211.25/211.42 |- skos__historyNote mesh__D000044 Denture, Partial %28%1966-1969%29%
% 211.25/211.42 |- skos__historyNote mesh__D000044
% 211.25/211.42 Dental Cavity Preparation %28%1966-1969%29%
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000044 1999
% 211.25/211.42 |- skos__broader mesh__D000044smesh__D017266
% 211.25/211.42 |- skos__broader mesh__D018455smesh__D001796
% 211.25/211.42 |- mesh__dateEstablished mesh__D018455 1995-01-01
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D018455 2002
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D018455 1999
% 211.25/211.42 |- mesh__recordMaintainer mesh__D018455 NNS
% 211.25/211.42 |- skos__broader mesh__D018455smesh__D019851
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D018455 2005
% 211.25/211.42 |- skos__prefLabel mesh__D018455 Protein S Deficiency
% 211.25/211.42 |- skos__annotation mesh__D018455
% 211.25/211.42 a blood protein disord causing thromboses; DF: PROTEIN S DEFIC%A%
% 211.25/211.42 |- mesh__historyNote mesh__D018455 95
% 211.25/211.42 |- skos__historyNote mesh__D018455
% 211.25/211.42 Glycoproteins/deficiency %28%1984-1992%29%
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D018455 95
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D018455 2006
% 211.25/211.42 |- skos__hiddenLabel mesh__D018455 Protein S Deficiencies
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D018455 2000
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D018455 SJN
% 211.25/211.42 |- skos__broader mesh__D018455smesh__D001778
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D018455 2003
% 211.25/211.42 |- mesh__dateCreated mesh__D018455 1994-04-16
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D018455 2001
% 211.25/211.42 |- rdf__type mesh__D018455sskos__Concept
% 211.25/211.42 |- skos__historyNote mesh__D018455 Protein S/deficiency %28%1993-1994%29%
% 211.25/211.42 |- mesh__dateRevised mesh__D018455 1998-06-10
% 211.25/211.42 |- skos__scopeNote mesh__D018455
% 211.25/211.42 An autosomal dominant disorder showing decreased levels of plasma protein S antigen or activity, associated with venous thrombosis and pulmonary embolism. PROTEIN S is a vitamin K-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated PROTEIN C %28%also a vitamin K-dependent protein%29%, and the clinical manifestations of its deficiency are virtually identical to those of protein C deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis. %28%From Harrison%27%s Principles of Internal Medicine, 12th ed, p1511; Wintrobe%27%s Clinical Hematology, 9th ed, p1523%29%%A%
% 211.25/211.42 |- skos__hiddenLabel mesh__D018455 Deficiencies, Protein S
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D018455 2004
% 211.25/211.42 |- skos__altLabel mesh__D018455 Deficiency, Protein S
% 211.25/211.42 |- mesh__recordOriginator mesh__D018455 TGC
% 211.25/211.42 |- rdf__type mesh__D010472sskos__Concept
% 211.25/211.42 |- mesh__onlineNote mesh__D010472
% 211.25/211.42 use PERCHLORIC ACID to search PERCHLORIC ACIDS 1966-93
% 211.25/211.42 |- skos__broader mesh__D010472smesh__D017606
% 211.25/211.42 |- mesh__dateRevised mesh__D010472 1997-06-20
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D010472 2004
% 211.25/211.42 |- skos__hiddenLabel mesh__D010472 Acid, Perchloric
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D010472 2005
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D010472 1998
% 211.25/211.42 |- mesh__recordMaintainer mesh__D010472 KEV
% 211.25/211.42 |- skos__broader mesh__D010472smesh__D000148
% 211.25/211.42 |- mesh__dateCreated mesh__D010472 1999-01-01
% 211.25/211.42 |- skos__prefLabel mesh__D010472 Perchloric Acid
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D010472 2006
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D010472 2000
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D010472 1999
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D010472
% 211.25/211.42 94; was PERCHLORIC ACIDS 1963-93; PERCHLORIC ACID was indexed under PERCHLORIC ACIDS 1981-93%A%
% 211.25/211.42 |- skos__hiddenLabel mesh__D010472 Acids, Perchloric
% 211.25/211.42 |- mesh__historyNote mesh__D010472
% 211.25/211.42 94; was PERCHLORIC ACIDS 1963-93; PERCHLORIC ACID was NM 1981-93%A%
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D010472 2001
% 211.25/211.42 |- skos__annotation mesh__D010472
% 211.25/211.42 used in anal chem to separate potassium from sodium
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D010472 2002
% 211.25/211.42 |- skos__scopeNote mesh__D010472
% 211.25/211.42 An oxidizing agent that is used in analytical chemistry for separation of potassium from sodium. %28%From Merck Index, 11th ed%29%%A%
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D010472 2003
% 211.25/211.42 |- mesh__recordOriginator mesh__D010472 NLM
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D010472 SJN
% 211.25/211.42 |- mesh__dateCreated mesh__D032126 2002-07-02
% 211.25/211.42 |- skos__altLabel mesh__D032126 Barbasco
% 211.25/211.42 |- skos__altLabel mesh__D032126 Guarana
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D032126 2005
% 211.25/211.42 |- mesh__historyNote mesh__D032126 2003
% 211.25/211.42 |- skos__prefLabel mesh__D032126 Paullinia
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D032126 2003
% 211.25/211.42 |- rdf__type mesh__D032126sskos__Concept
% 211.25/211.42 |- mesh__dateEstablished mesh__D032126 2003-01-01
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D032126 2006
% 211.25/211.42 |- skos__broader mesh__D032126smesh__D029631
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D032126 2003
% 211.25/211.42 |- skos__scopeNote mesh__D032126
% 211.25/211.42 A plant genus of the family SAPINDACEAE. The seed of P. cupana is the source of guarana powder which contains 4%25% CAFFEINE.%A%
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D032126 2004
% 211.25/211.42 |- skos__annotation mesh__D032126
% 211.25/211.42 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D004435 73
% 211.25/211.42 |- skos__altLabel mesh__D004435 Food Intake
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 1996
% 211.25/211.42 |- skos__prefLabel mesh__D004435 Eating
% 211.25/211.42 |- mesh__recordMaintainer mesh__D004435 TAP
% 211.25/211.42 |- mesh__dateEstablished mesh__D004435 1973-01-01
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 1998
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 1997
% 211.25/211.42 |- rdf__type mesh__D004435sskos__Concept
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 2002
% 211.25/211.42 |- skos__hiddenLabel mesh__D004435 Intakes, Food
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 1994
% 211.25/211.42 |- mesh__historyNote mesh__D004435 73%28%66%29%
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 1999
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 1993
% 211.25/211.42 |- skos__broader mesh__D004435smesh__D004068
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 1995
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D004435 PLS
% 211.25/211.42 |- skos__annotation mesh__D004435
% 211.25/211.42 the act of eating: do not confuse with FOOD %28%the substance eaten%29% or EATING BEHAVIOR see FEEDING BEHAVIOR %28%the manner of eating%29%: TN 63%A%
% 211.25/211.42 |- mesh__recordOriginator mesh__D004435 NLM
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 2003
% 211.25/211.42 |- skos__hiddenLabel mesh__D004435 Intake, Food
% 211.25/211.42 |- mesh__dateCreated mesh__D004435 1999-01-01
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 2000
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 2005
% 211.25/211.42 |- skos__hiddenLabel mesh__D004435 Eatings
% 211.25/211.42 |- skos__hiddenLabel mesh__D004435 Food Intakes
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 2004
% 211.25/211.42 |- mesh__dateRevised mesh__D004435 1992-05-15
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 2001
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D004435 2006
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Cramps, Limb
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Cramps, Muscular
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Muscle Cramps
% 211.25/211.42 |- skos__altLabel mesh__D009120 Cramp
% 211.25/211.42 |- mesh__recordOriginator mesh__D009120 NLM
% 211.25/211.42 |- mesh__dateRevised mesh__D009120 2003-07-25
% 211.25/211.42 |- rdf__type mesh__D009120sskos__Concept
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Cramp, Muscular
% 211.25/211.42 |- mesh__recordMaintainer mesh__D009120 sjn
% 211.25/211.42 |- mesh__dateCreated mesh__D009120 1999-01-01
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D009120 2005
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D009120 sjn
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D009120 2004
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Cramp, Muscle
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D009120 2006
% 211.25/211.42 |- skos__scopeNote mesh__D009120
% 211.25/211.42 A sustained and usually painful contraction of muscle fibers. This may occur as an isolated phenomenon or as a manifestation of an underlying disease process %28%e.g., UREMIA; HYPOTHYROIDISM; MOTOR NEURON DISEASE; etc.%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p1398%29%%A%
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Cramp, Limb
% 211.25/211.42 |- skos__related mesh__D009120smesh__D013035
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Muscular Cramps
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Limb Cramps
% 211.25/211.42 |- skos__prefLabel mesh__D009120 Muscle Cramp
% 211.25/211.42 |- skos__broader mesh__D009120smesh__D009135
% 211.25/211.42 |- skos__broader mesh__D009120smesh__D020879
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Cramps
% 211.25/211.42 |- skos__hiddenLabel mesh__D009120 Cramps, Muscle
% 211.25/211.42 |- skos__altLabel mesh__D009120 Muscular Cramp
% 211.25/211.42 |- mesh__dateCreated mesh__D014863 1974-12-12
% 211.25/211.42 |- skos__prefLabel mesh__D014863 Wasps
% 211.25/211.42 |- skos__annotation mesh__D014863
% 211.25/211.42 /microbiol /parasitol /virol permitted; wasp stings: coord IM with INSECT BITES AND STINGS %28%IM%29%%A%
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D014863
% 211.25/211.42 91; was see under HYMENOPTERA 1975-90
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014863 2004
% 211.25/211.42 |- mesh__dateRevised mesh__D014863 2003-07-09
% 211.25/211.42 |- mesh__recordMaintainer mesh__D014863 ags
% 211.25/211.42 |- mesh__dateEstablished mesh__D014863 1991-01-01
% 211.25/211.42 |- rdf__type mesh__D014863sskos__Concept
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014863 2005
% 211.25/211.42 |- skos__scopeNote mesh__D014863
% 211.25/211.42 Any of numerous winged hymenopterous insects of social as well as solitary habits and having formidable stings.%A%
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014863 2006
% 211.25/211.42 |- mesh__historyNote mesh__D014863
% 211.25/211.42 91%28%75%29%; was see under HYMENOPTERA 1975-90
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D014863 sjn
% 211.25/211.42 |- mesh__recordOriginator mesh__D014863 NLM
% 211.25/211.42 |- skos__broader mesh__D014863smesh__D006927
% 211.25/211.42 |- skos__prefLabel mesh__D014065 Tonometry, Ocular
% 211.25/211.42 |- mesh__recordOriginator mesh__D014065 NLM
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D014065 sjn
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D014065 2004; see TONOMETRY 1966-2003
% 211.25/211.42 |- mesh__dateCreated mesh__D014065 1999-01-01
% 211.25/211.42 |- mesh__dateRevised mesh__D014065 2003-07-09
% 211.25/211.42 |- mesh__recordMaintainer mesh__D014065 lkt
% 211.25/211.42 |- mesh__historyNote mesh__D014065 2004; use TONOMETRY 1966-2003
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014065 2006
% 211.25/211.42 |- skos__broader mesh__D014065smesh__D003941
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014065 2005
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D014065 2004
% 211.25/211.42 |- skos__scopeNote mesh__D014065
% 211.25/211.42 Measurement of ocular tension %28%INTRAOCULAR PRESSURE%29% with a tonometer. %28%Cline, et al., Dictionary of Visual Science, 4th ed%29%%A%
% 211.25/211.42 |- skos__annotation mesh__D014065
% 211.25/211.42 TONOMETRY see MANOMETRY is available for non-ocular tension or pressure%A%
% 211.25/211.42 |- rdf__type mesh__D014065sskos__Concept
% 211.25/211.42 |- skos__altLabel mesh__D014065 Ocular Tonometry
% 211.25/211.42 |- skos__historyNote mesh__D008826 Antibiotics %28%1966-1969%29%
% 211.25/211.42 |- mesh__dateEstablished mesh__D008826 1970-01-01
% 211.25/211.42 |- mesh__historyNote mesh__D008826 70
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Test, Microbial Sensitivity
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008826 2001
% 211.25/211.42 |- skos__scopeNote mesh__D008826
% 211.25/211.42 Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms %28%i.e., bacteria, fungi, viruses%29%.%A%
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Sensitivity Test, Microbial
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008826 2005
% 211.25/211.42 |- skos__altLabel mesh__D008826 Viral Drug Sensitivity Tests
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D008826 sjn
% 211.25/211.42 |- skos__historyNote mesh__D008826
% 211.25/211.42 Drug Resistance, Microbial %28%1966-1969%29%
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Inhibitory Concentrations, Minimum
% 211.25/211.42 |- skos__annotation mesh__D008826
% 211.25/211.42 IM when general; NIM when with specific drug %28%IM%29% %26% specific micro-organisms %28%IM%29%; note X ref MINIMUM INHIBITORY CONCENTRATION but bactericidal eff of an antimicrobial drug using patient%27%s blood %28%= SERUM BACTERICIDAL TEST + specific drug%29%; PARASITIC SENSITIVITY TESTS is also available%A%
% 211.25/211.42 |- mesh__recordMaintainer mesh__D008826 NDW
% 211.25/211.42 |- skos__related mesh__D008826smesh__D021261
% 211.25/211.42 |- skos__altLabel mesh__D008826 Bacterial Sensitivity Test
% 211.25/211.42 |- rdf__type mesh__D008826sskos__Concept
% 211.25/211.42 |- skos__altLabel mesh__D008826 Sensitivity Test, Bacterial
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008826 2002
% 211.25/211.42 |- skos__related mesh__D008826smesh__D020128
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Inhibitory Concentration, Minimum
% 211.25/211.42 |- skos__altLabel mesh__D008826 Sensitivity Tests, Bacterial
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008826 2006
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008826 2003
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Concentrations, Minimum Inhibitory
% 211.25/211.42 |- skos__broader mesh__D008826smesh__D008828
% 211.25/211.42 |- skos__altLabel mesh__D008826 Drug Sensitivity Assay, Microbial
% 211.25/211.42 |- mesh__dateCreated mesh__D008826 1999-01-01
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D008826 70
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Microbial Sensitivity Test
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Sensitivity Tests, Microbial
% 211.25/211.42 |- skos__altLabel mesh__D008826 Fungal Drug Sensitivity Tests
% 211.25/211.42 |- skos__related mesh__D008826smesh__D004352
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Minimum Inhibitory Concentrations
% 211.25/211.42 |- mesh__recordOriginator mesh__D008826 NLM
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008826 2004
% 211.25/211.42 |- skos__prefLabel mesh__D008826 Microbial Sensitivity Tests
% 211.25/211.42 |- skos__broader mesh__D008826smesh__D004353
% 211.25/211.42 |- skos__altLabel mesh__D008826 Test, Bacterial Sensitivity
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Concentration, Minimum Inhibitory
% 211.25/211.42 |- skos__altLabel mesh__D008826 Tests, Bacterial Sensitivity
% 211.25/211.42 |- skos__hiddenLabel mesh__D008826 Tests, Microbial Sensitivity
% 211.25/211.42 |- mesh__dateRevised mesh__D008826 2000-06-22
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D000843 sjn
% 211.25/211.42 |- mesh__onlineNote mesh__D000843
% 211.25/211.42 use ANKLE INJURIES to search ANKLE JOINT/injuries 1966-91%A%
% 211.25/211.42 |- mesh__recordMaintainer mesh__D000843 ags
% 211.25/211.42 |- skos__scopeNote mesh__D000843
% 211.25/211.42 The joint that is formed by the inferior articular and malleolar articular surfaces of the TIBIA; the malleolar articular surface of the FIBULA; and the medial malleolar, lateral malleolar, and superior surfaces of the TALUS.%A%
% 211.25/211.42 |- skos__related mesh__D000843smesh__D000842
% 211.25/211.42 |- mesh__publicMeSHNote mesh__D000843
% 211.25/211.42 65; /injuries was ANKLE JOINT/injuries 1965-91
% 211.25/211.42 |- skos__hiddenLabel mesh__D000843 Joint, Ankle
% 211.25/211.42 |- skos__hiddenLabel mesh__D000843 Ankle Joints
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000843 2005
% 211.25/211.42 |- mesh__dateRevised mesh__D000843 2002-07-02
% 211.25/211.42 |- mesh__historyNote mesh__D000843
% 211.25/211.42 65; /injuries was ANKLE JOINT/injuries 1965-91
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000843 2003
% 211.25/211.42 |- mesh__dateEstablished mesh__D000843 1965-01-01
% 211.25/211.42 |- rdf__type mesh__D000843sskos__Concept
% 211.25/211.42 |- skos__hiddenLabel mesh__D000843 Joints, Ankle
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000843 2006
% 211.25/211.42 |- skos__prefLabel mesh__D000843 Ankle Joint
% 211.25/211.42 |- mesh__recordOriginator mesh__D000843 NLM
% 211.25/211.42 |- skos__altLabel mesh__D000843 Articulatio talocruralis
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D000843 2004
% 211.25/211.42 |- mesh__dateCreated mesh__D000843 1999-01-01
% 211.25/211.42 |- skos__annotation mesh__D000843
% 211.25/211.42 primates only; differentiation from ANKLE
% 211.25/211.42 |- skos__broader mesh__D000843smesh__D033023
% 211.25/211.42 |- skos__hiddenLabel mesh__D008028 Coagulation, Light
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008028 2003
% 211.25/211.42 |- skos__prefLabel mesh__D008028 Light Coagulation
% 211.25/211.42 |- skos__hiddenLabel mesh__D008028 Light Coagulations
% 211.25/211.42 |- skos__altLabel mesh__D008028 Photocoagulation
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008028 1998
% 211.25/211.42 |- skos__scopeNote mesh__D008028
% 211.25/211.42 The coagulation of tissue by an intense beam of light, including laser %28%LASER COAGULATION%29%. In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, hemorrhages, and malignant and benign neoplasms. %28%Dictionary of Visual Science, 3d ed%29%%A%
% 211.25/211.42 |- skos__hiddenLabel mesh__D008028 Coagulations, Light
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008028 2000
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008028 2004
% 211.25/211.42 |- skos__broader mesh__D008028smesh__D013508
% 211.25/211.42 |- rdf__type mesh__D008028sskos__Concept
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008028 2001
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008028 1999
% 211.25/211.42 |- skos__hiddenLabel mesh__D008028 Photocoagulations
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008028 2005
% 211.25/211.42 |- mesh__dateRevised mesh__D008028 1997-06-20
% 211.25/211.42 |- mesh__dateCreated mesh__D008028 1999-01-01
% 211.25/211.42 |- mesh__recordOriginator mesh__D008028 NLM
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008028 2002
% 211.25/211.42 |- mesh__activeMeSHYear mesh__D008028 2006
% 211.25/211.42 |- mesh__recordAuthorizer mesh__D008028 SJN
% 211.25/211.42 |- mesh__recordMaintainer mesh__D008028 PXP
% 211.25/211.42 |- skos__annotation mesh__D008028
% 211.25/211.42 non-ionizing; used predominantly in eye surg; do not confuse with LASER COAGULATION also used in ophthalmol surg; do not use /util except by MeSH definition; coord IM with Cat A or C term with /surg; DF: LIGHT COAG%A%
% 211.25/211.43 |- mesh__historyNote mesh__D000045
% 211.25/211.43 91%28%86%29%63; was see under TREES 1986-90; was heading 1963-85%A%
% 211.25/211.43 |- mesh__dateRevised mesh__D000045 2002-07-02
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000045 2003
% 211.25/211.43 |- skos__annotation mesh__D000045
% 211.25/211.43 acacia pharmaceut agents are probably GUM ARABIC; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.43 |- mesh__dateCreated mesh__D000045 1999-01-01
% 211.25/211.43 |- skos__altLabel mesh__D000045 Wattle Tree
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000045 2005
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000045 2004
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000045 2006
% 211.25/211.43 |- skos__altLabel mesh__D000045 Locust Tree
% 211.25/211.43 |- mesh__dateEstablished mesh__D000045 1991-01-01
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D000045 sjn
% 211.25/211.43 |- skos__scopeNote mesh__D000045
% 211.25/211.43 A plant genus of the family FABACEAE. The gums and tanning agents obtained from Acacia are called GUM ARABIC. The common name of catechu is more often used for Areca catechu %28%ARECA%29%.%A%
% 211.25/211.43 |- mesh__recordMaintainer mesh__D000045 ssb
% 211.25/211.43 |- skos__broader mesh__D000045smesh__D007887
% 211.25/211.43 |- mesh__recordOriginator mesh__D000045 NLM
% 211.25/211.43 |- skos__prefLabel mesh__D000045 Acacia
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D000045
% 211.25/211.43 91,63-85; was see under TREES 1986-90; was heading 1963-85%A%
% 211.25/211.43 |- rdf__type mesh__D000045sskos__Concept
% 211.25/211.43 |- skos__broader mesh__D018456smesh__D013040
% 211.25/211.43 |- skos__prefLabel mesh__D018456 Reproductive Medicine
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D018456 2005
% 211.25/211.43 |- skos__altLabel mesh__D018456 Medicine, Reproductive
% 211.25/211.43 |- mesh__recordOriginator mesh__D018456 TGC
% 211.25/211.43 |- mesh__historyNote mesh__D018456 95
% 211.25/211.43 |- skos__hiddenLabel mesh__D018456 Health, Reproductive
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D018456 2006
% 211.25/211.43 |- mesh__recordMaintainer mesh__D018456 NLM
% 211.25/211.43 |- skos__scopeNote mesh__D018456
% 211.25/211.43 A medical-surgical specialty concerned with the morphology, physiology, biochemistry, and pathology of reproduction in man and other animals, and on the biological, medical, and veterinary problems of fertility and lactation. It includes ovulation induction, diagnosis of infertility and recurrent pregnancy loss, and assisted reproductive technologies such as embryo transfer, in vitro fertilization, and intrafallopian transfer of zygotes. %28%From Infertility and Reproductive Medicine Clinics of North America, Foreword 1990; Journal of Reproduction and Fertility, Notice to Contributors, Jan 1979%29%%A%
% 211.25/211.43 |- mesh__dateEstablished mesh__D018456 1995-01-01
% 211.25/211.43 |- skos__related mesh__D018456smesh__D012099
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D018456 2002
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D018456 2003
% 211.25/211.43 |- rdf__type mesh__D018456sskos__Concept
% 211.25/211.43 |- mesh__dateRevised mesh__D018456 2001-08-14
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D018456 95
% 211.25/211.43 |- skos__annotation mesh__D018456
% 211.25/211.43 SPEC: SPEC qualif; DF: REPRODUCTIVE MED
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D018456 2004
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D018456 NLM
% 211.25/211.43 |- mesh__dateCreated mesh__D018456 1994-03-17
% 211.25/211.43 |- skos__hiddenLabel mesh__D010473 Mackerel
% 211.25/211.43 |- skos__historyNote mesh__D010473 Fishes %28%1966-1986%29%
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D010473 87
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010473 2004
% 211.25/211.43 |- skos__broader mesh__D010473smesh__D005399
% 211.25/211.43 |- mesh__dateEstablished mesh__D010473 1987-01-01
% 211.25/211.43 |- rdf__type mesh__D010473sskos__Concept
% 211.25/211.43 |- mesh__recordOriginator mesh__D010473 EC
% 211.25/211.43 |- skos__hiddenLabel mesh__D010473 Bluegills
% 211.25/211.43 |- mesh__dateRevised mesh__D010473 2003-07-09
% 211.25/211.43 |- skos__altLabel mesh__D010473 Centrarchidae
% 211.25/211.43 |- skos__annotation mesh__D010473
% 211.25/211.43 GEN; prefer specifics; do not confuse X ref DOLPHIN FISH with DOLPHINS which are mammals%A%
% 211.25/211.43 |- mesh__dateCreated mesh__D010473 1986-04-15
% 211.25/211.43 |- mesh__historyNote mesh__D010473 87
% 211.25/211.43 |- skos__altLabel mesh__D010473 Mahi-Mahi
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D010473 sjn
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010473 2006
% 211.25/211.43 |- skos__altLabel mesh__D010473 Mackerels
% 211.25/211.43 |- skos__prefLabel mesh__D010473 Perciformes
% 211.25/211.43 |- skos__scopeNote mesh__D010473
% 211.25/211.43 The most diversified of all fish orders and the largest vertebrate order. It includes many of the commonly known fish such as porgies, croakers, sunfishes, dolphin fish, mackerels, TUNA, etc.%A%
% 211.25/211.43 |- skos__hiddenLabel mesh__D010473 Fish, Sparid
% 211.25/211.43 |- mesh__recordMaintainer mesh__D010473 ags
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010473 2005
% 211.25/211.43 |- skos__hiddenLabel mesh__D010473 Croaker
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D032127 2003
% 211.25/211.43 |- skos__altLabel mesh__D032127 Soapberry
% 211.25/211.43 |- rdf__type mesh__D032127sskos__Concept
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D032127 2006
% 211.25/211.43 |- skos__broader mesh__D032127smesh__D029631
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D032127 2003
% 211.25/211.43 |- mesh__dateCreated mesh__D032127 2002-07-03
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D032127 2004
% 211.25/211.43 |- skos__annotation mesh__D032127
% 211.25/211.43 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.43 |- mesh__dateEstablished mesh__D032127 2003-01-01
% 211.25/211.43 |- skos__prefLabel mesh__D032127 Sapindus
% 211.25/211.43 |- mesh__historyNote mesh__D032127 2003
% 211.25/211.43 |- skos__scopeNote mesh__D032127
% 211.25/211.43 A plant genus of the family SAPINDACEAE that contain SAPONINS.%A%
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D032127 2005
% 211.25/211.43 |- mesh__dateCreated mesh__D009121 1999-01-01
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009121 2005
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009121 2004
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009121 1999
% 211.25/211.43 |- mesh__dateRevised mesh__D009121 1997-06-20
% 211.25/211.43 |- skos__broader mesh__D009121smesh__D003714
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009121 2006
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D009121 SJN
% 211.25/211.43 |- skos__prefLabel mesh__D009121 Muscle Denervation
% 211.25/211.43 |- skos__scopeNote mesh__D009121
% 211.25/211.43 The resection or removal of the innervation of a muscle or muscle tissue.%A%
% 211.25/211.43 |- skos__hiddenLabel mesh__D009121 Muscle Denervations
% 211.25/211.43 |- skos__hiddenLabel mesh__D009121 Denervation, Muscle
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009121 2002
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D009121 65
% 211.25/211.43 |- mesh__recordOriginator mesh__D009121 NLM
% 211.25/211.43 |- mesh__recordMaintainer mesh__D009121 PXP
% 211.25/211.43 |- skos__hiddenLabel mesh__D009121 Denervations, Muscle
% 211.25/211.43 |- mesh__dateEstablished mesh__D009121 1965-01-01
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009121 2000
% 211.25/211.43 |- rdf__type mesh__D009121sskos__Concept
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009121 2003
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009121 1998
% 211.25/211.43 |- skos__annotation mesh__D009121
% 211.25/211.43 coord with specific muscle /innerv; NIM when a study technique; do not use /util except by MeSH definition%A%
% 211.25/211.43 |- mesh__historyNote mesh__D009121 65
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009121 2001
% 211.25/211.43 |- skos__altLabel mesh__D028884 Importin
% 211.25/211.43 |- mesh__dateEstablished mesh__D028884 2002-01-01
% 211.25/211.43 |- mesh__dateCreated mesh__D028884 2001-07-25
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D028884
% 211.25/211.43 2002; IMPORTIN %28%now KARYOPHERINS%29% was indexed under NUCLEAR PROTEINS 1995-2001; TRANSPORTIN %28%now KARYOPHERINS%29% was indexed under NUCLEAR PROTEINS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1995-2001%A%
% 211.25/211.43 |- skos__related mesh__D028884smesh__D021581
% 211.25/211.43 |- skos__historyNote mesh__D028884 Nuclear Proteins %28%1995-2001%29%
% 211.25/211.43 |- mesh__historyNote mesh__D028884
% 211.25/211.43 2002; use KARYOPHERINS %28%NM%29% 1995-2001
% 211.25/211.43 |- skos__prefLabel mesh__D028884 Karyopherins
% 211.25/211.43 |- mesh__recordOriginator mesh__D028884 jmp
% 211.25/211.43 |- skos__altLabel mesh__D028884 Transportin
% 211.25/211.43 |- mesh__recordMaintainer mesh__D028884 nns
% 211.25/211.43 |- mesh__dateRevised mesh__D028884 2005-06-30
% 211.25/211.43 |- skos__broader mesh__D028884smesh__D029543
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D028884 2006
% 211.25/211.43 |- skos__broader mesh__D028884smesh__D009687
% 211.25/211.43 |- skos__scopeNote mesh__D028884
% 211.25/211.43 A family of proteins involved in NUCLEOCYTOPLASMIC TRANSPORT. Karyopherins are heteromeric molecules composed two major types of components, ALPHA KARYOPHERINS and BETA KARYOPHERINS, that function together to transport molecules through the NUCLEAR PORE COMPLEX. Several other proteins such as RAN GTP BINDING PROTEIN and CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN bind to karyopherins and participate in the transport process.%A%
% 211.25/211.43 |- skos__historyNote mesh__D028884
% 211.25/211.43 Receptors, Cytoplasmic and Nuclear %28%1995-2001%29%
% 211.25/211.43 |- skos__altLabel mesh__D028884 Transportins
% 211.25/211.43 |- rdf__type mesh__D028884sskos__Concept
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D028884 sjn
% 211.25/211.43 |- mesh__dateCreated mesh__D014066 1999-01-01
% 211.25/211.43 |- mesh__dateRevised mesh__D014066 2003-07-09
% 211.25/211.43 |- skos__broader mesh__D014066smesh__D009960
% 211.25/211.43 |- skos__annotation mesh__D014066
% 211.25/211.43 /surg: probably TONSILLECTOMY; inflammation = TONSILLITIS %28%note -LL-%29%; lingual tonsils = TONSIL %28%IM%29% + TONGUE %28%NIM%29%; pharyngeal tonsil = ADENOIDS; enlarged tonsils = TONSIL /pathol %28%IM%29% + HYPERPLASIA %28%NIM%29%%A%
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D014066 2006
% 211.25/211.43 |- skos__hiddenLabel mesh__D014066 Palatine Tonsils
% 211.25/211.43 |- mesh__recordOriginator mesh__D014066 NLM
% 211.25/211.43 |- skos__related mesh__D014066smesh__D014068
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D014066 sjn
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D014066 2005
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D014066 2004
% 211.25/211.43 |- skos__altLabel mesh__D014066 Palatine Tonsil
% 211.25/211.43 |- skos__hiddenLabel mesh__D014066 Tonsils
% 211.25/211.43 |- mesh__recordMaintainer mesh__D014066 lkt
% 211.25/211.43 |- skos__scopeNote mesh__D014066
% 211.25/211.43 A round-to-oval mass of lymphoid tissue embedded in the lateral wall of the PHARYNX situated on each side of the fauces, between the anterior and posterior pillars of the soft palate %28%PALATE, SOFT%29%.%A%
% 211.25/211.43 |- skos__prefLabel mesh__D014066 Tonsil
% 211.25/211.43 |- rdf__type mesh__D014066sskos__Concept
% 211.25/211.43 |- skos__broader mesh__D014066smesh__D008221
% 211.25/211.43 |- skos__hiddenLabel mesh__D014066 Tonsils, Palatine
% 211.25/211.43 |- skos__altLabel mesh__D014066 Tonsil, Palatine
% 211.25/211.43 |- skos__hiddenLabel mesh__D008827 Phenomena, Microbiological
% 211.25/211.43 |- rdf__type mesh__D008827sskos__Concept
% 211.25/211.43 |- mesh__dateEstablished mesh__D008827 1998-01-01
% 211.25/211.43 |- skos__prefLabel mesh__D008827 Microbiologic Phenomena
% 211.25/211.43 |- skos__annotation mesh__D008827
% 211.25/211.43 not used for indexing; DF: MICROBIOL PHENOMENA CATALOG: do not use%A%
% 211.25/211.43 |- skos__related mesh__D008827smesh__D018407
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008827 2001
% 211.25/211.43 |- skos__altLabel mesh__D008827 Phenomena, Microbiologic
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008827 1998
% 211.25/211.43 |- mesh__historyNote mesh__D008827 98; use explode
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008827 2003
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D008827 98
% 211.25/211.43 |- mesh__recordMaintainer mesh__D008827 TGC
% 211.25/211.43 |- mesh__dateCreated mesh__D008827 1999-01-01
% 211.25/211.43 |- skos__scopeNote mesh__D008827
% 211.25/211.43 Physiological processes and activities of microorganisms, including archaea, bacteria, rickettsia, viruses, protozoa, and fungi.%A%
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008827 2002
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008827 1999
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008827 2005
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008827 2004
% 211.25/211.43 |- skos__altLabel mesh__D008827 Microbiological Phenomena
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008827 2006
% 211.25/211.43 |- mesh__recordOriginator mesh__D008827 NLM
% 211.25/211.43 |- skos__related mesh__D008827smesh__D018406
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D008827 SJN
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008827 2000
% 211.25/211.43 |- skos__broader mesh__D008827smesh__D001686
% 211.25/211.43 |- mesh__dateRevised mesh__D008827 1997-06-26
% 211.25/211.43 |- skos__scopeNote mesh__D000844 Fixation and immobility of a joint.
% 211.25/211.43 |- skos__broader mesh__D000844smesh__D007592
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D000844 sjn
% 211.25/211.43 |- skos__prefLabel mesh__D000844 Ankylosis
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000844 2005
% 211.25/211.43 |- rdf__type mesh__D000844sskos__Concept
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000844 2003
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000844 2006
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000844 2000
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000844 2004
% 211.25/211.43 |- skos__hiddenLabel mesh__D000844 Ankyloses
% 211.25/211.43 |- mesh__dateCreated mesh__D000844 1999-01-01
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000844 2001
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000844 2002
% 211.25/211.43 |- mesh__recordOriginator mesh__D000844 NLM
% 211.25/211.43 |- mesh__dateRevised mesh__D000844 1999-11-03
% 211.25/211.43 |- mesh__recordMaintainer mesh__D000844 KEV
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D008029 SJN
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008029 2003
% 211.25/211.43 |- mesh__recordMaintainer mesh__D008029 JLS
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008029 2004
% 211.25/211.43 |- rdf__type mesh__D008029sskos__Concept
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008029 1999
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008029 2005
% 211.25/211.43 |- mesh__dateCreated mesh__D008029 1999-01-01
% 211.25/211.43 |- skos__prefLabel mesh__D008029 Lighting
% 211.25/211.43 |- skos__annotation mesh__D008029
% 211.25/211.43 the environment: differentiate from LIGHT, a principle of physics; /adv eff permitted but do not confuse with LIGHT /adv eff%A%
% 211.25/211.43 |- mesh__dateRevised mesh__D008029 1998-06-10
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008029 2006
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008029 2000
% 211.25/211.43 |- skos__broader mesh__D008029smesh__D004780
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008029 2001
% 211.25/211.43 |- skos__scopeNote mesh__D008029
% 211.25/211.43 The illumination of an environment and the arrangement of lights to achieve an effect or optimal visibility. Its application is in domestic or in public settings and in medical and non-medical environments.%A%
% 211.25/211.43 |- mesh__recordOriginator mesh__D008029 NLM
% 211.25/211.43 |- skos__altLabel mesh__D008029 Illumination
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D008029 2002
% 211.25/211.43 |- skos__broader mesh__D000046smesh__D006268
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D000046 sjn
% 211.25/211.43 |- mesh__dateRevised mesh__D000046 1999-11-03
% 211.25/211.43 |- mesh__onlineNote mesh__D000046 search HOSPITALS, UNIVERSITY 1979
% 211.25/211.43 |- mesh__recordMaintainer mesh__D000046 kle
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D000046
% 211.25/211.43 80; was see HOSPITALS, UNIVERSITY 1979
% 211.25/211.43 |- skos__altLabel mesh__D000046 Center, Academic Medical
% 211.25/211.43 |- skos__altLabel mesh__D000046 Centers, University Medical
% 211.25/211.43 |- rdf__type mesh__D000046sskos__Concept
% 211.25/211.43 |- skos__altLabel mesh__D000046 Medical Centers, University
% 211.25/211.43 |- mesh__recordOriginator mesh__D000046 EC
% 211.25/211.43 |- mesh__dateEstablished mesh__D000046 1980-01-01
% 211.25/211.43 |- skos__annotation mesh__D000046 specify geog; DF: ACAD MED CENTERS
% 211.25/211.43 |- skos__altLabel mesh__D000046 Medical Centers, Academic
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000046 2001
% 211.25/211.43 |- skos__altLabel mesh__D000046 University Medical Centers
% 211.25/211.43 |- skos__altLabel mesh__D000046 Medical Center, University
% 211.25/211.43 |- skos__altLabel mesh__D000046 Academic Medical Center
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000046 2004
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000046 2000
% 211.25/211.43 |- mesh__dateCreated mesh__D000046 1979-06-01
% 211.25/211.43 |- skos__altLabel mesh__D000046 Medical Center, Academic
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000046 2003
% 211.25/211.43 |- skos__scopeNote mesh__D000046
% 211.25/211.43 Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.%A%
% 211.25/211.43 |- skos__altLabel mesh__D000046 University Medical Center
% 211.25/211.43 |- skos__altLabel mesh__D000046 Centers, Academic Medical
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000046 2006
% 211.25/211.43 |- skos__historyNote mesh__D000046 Hospitals, University %28%1975-1979%29%
% 211.25/211.43 |- skos__prefLabel mesh__D000046 Academic Medical Centers
% 211.25/211.43 |- skos__historyNote mesh__D000046 Hospitals, Teaching %28%1968-1974%29%
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000046 2002
% 211.25/211.43 |- mesh__historyNote mesh__D000046
% 211.25/211.43 80; was see HOSPITALS, UNIVERSITY 1979
% 211.25/211.43 |- skos__altLabel mesh__D000046 Center, University Medical
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D000046 2005
% 211.25/211.43 |- skos__broader mesh__D046148smesh__D009927
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D046148 2006
% 211.25/211.43 |- mesh__recordMaintainer mesh__D046148 ags
% 211.25/211.43 |- skos__altLabel mesh__D046148 Donor Screening
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D046148 2005
% 211.25/211.43 |- mesh__dateCreated mesh__D046148 2004-07-07
% 211.25/211.43 |- rdf__type mesh__D046148sskos__Concept
% 211.25/211.43 |- mesh__historyNote mesh__D046148 2005
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D046148 2006A
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D046148 2005
% 211.25/211.43 |- skos__hiddenLabel mesh__D046148 Selection, Donor
% 211.25/211.43 |- skos__hiddenLabel mesh__D046148 Donor Screenings
% 211.25/211.43 |- mesh__dateEstablished mesh__D046148 2005-01-01
% 211.25/211.43 |- skos__prefLabel mesh__D046148 Donor Selection
% 211.25/211.43 |- mesh__dateRevised mesh__D046148 2005-07-22
% 211.25/211.43 |- skos__broader mesh__D046148smesh__D020858
% 211.25/211.43 |- skos__scopeNote mesh__D046148
% 211.25/211.43 The procedure established to evaluate the health status and risk factors of the potential DONORS of biological materials. Donors are selected based on the principles that their health will not be compromised in the process, and the donated materials, such as TISSUES or organs, are safe for reuse in the recipients.%A%
% 211.25/211.43 |- mesh__recordOriginator mesh__D046148 lkt
% 211.25/211.43 |- skos__hiddenLabel mesh__D046148 Donor Exclusions
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D046148 ags
% 211.25/211.43 |- skos__historyNote mesh__D046148 Tissue Donors %28%1966-2004%29%
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D018457 95
% 211.25/211.43 |- mesh__recordMaintainer mesh__D018457 lkt
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D018457 sjn
% 211.25/211.43 |- skos__hiddenLabel mesh__D018457 Retained Placentas
% 211.25/211.43 |- skos__altLabel mesh__D018457 Retained Placenta
% 211.25/211.43 |- skos__prefLabel mesh__D018457 Placenta, Retained
% 211.25/211.43 |- skos__hiddenLabel mesh__D018457 Placentas, Retained
% 211.25/211.43 |- skos__historyNote mesh__D018457 Placenta Diseases %28%1970-1994%29%
% 211.25/211.43 |- mesh__historyNote mesh__D018457 95
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D018457 2006
% 211.25/211.43 |- skos__historyNote mesh__D018457 Placenta %28%1966-1994%29%
% 211.25/211.43 |- mesh__dateRevised mesh__D018457 2005-06-30
% 211.25/211.43 |- skos__broader mesh__D018457smesh__D010922
% 211.25/211.43 |- skos__scopeNote mesh__D018457
% 211.25/211.43 A placenta that fails to be expelled after BIRTH of the FETUS. A PLACENTA is retained when the UTERUS fails to contract after the delivery of its content, or when the placenta is abnormally attached to the MYOMETRIUM.%A%
% 211.25/211.43 |- rdf__type mesh__D018457sskos__Concept
% 211.25/211.43 |- mesh__recordOriginator mesh__D018457 TGC
% 211.25/211.43 |- skos__annotation mesh__D018457 check the tags FEMALE %26% PREGNANCY
% 211.25/211.43 |- mesh__dateCreated mesh__D018457 1994-04-16
% 211.25/211.43 |- mesh__dateEstablished mesh__D018457 1995-01-01
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010474 2001
% 211.25/211.43 |- mesh__dateCreated mesh__D010474 1999-01-01
% 211.25/211.43 |- rdf__type mesh__D010474sskos__Concept
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010474 2003
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010474 2000
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D010474 SJN
% 211.25/211.43 |- skos__prefLabel mesh__D010474 Percussion
% 211.25/211.43 |- skos__scopeNote mesh__D010474
% 211.25/211.43 Act of striking a part with short, sharp blows as an aid in diagnosing the condition beneath the sound obtained.%A%
% 211.25/211.43 |- skos__annotation mesh__D010474
% 211.25/211.43 diag from sound obtained by short sharp blows
% 211.25/211.43 |- mesh__dateRevised mesh__D010474 1997-06-20
% 211.25/211.43 |- mesh__recordMaintainer mesh__D010474 PXP
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010474 2006
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010474 1999
% 211.25/211.43 |- mesh__recordOriginator mesh__D010474 NLM
% 211.25/211.43 |- skos__broader mesh__D010474smesh__D010808
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010474 2005
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010474 1998
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010474 2002
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D010474 2004
% 211.25/211.43 |- skos__hiddenLabel mesh__D010474 Percussions
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D032128 2003
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D032128 2004
% 211.25/211.43 |- skos__prefLabel mesh__D032128 Madhuca
% 211.25/211.43 |- skos__annotation mesh__D032128
% 211.25/211.43 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.43 |- skos__broader mesh__D032128smesh__D029632
% 211.25/211.43 |- mesh__dateCreated mesh__D032128 2002-07-03
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D032128 2005
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D032128 2006
% 211.25/211.43 |- mesh__publicMeSHNote mesh__D032128 2003
% 211.25/211.43 |- rdf__type mesh__D032128sskos__Concept
% 211.25/211.43 |- mesh__dateEstablished mesh__D032128 2003-01-01
% 211.25/211.43 |- skos__scopeNote mesh__D032128
% 211.25/211.43 A plant genus of the family SAPOTACEAE that is the source of mahua oil. Members contain oleanene triterpenoid saponins.%A%
% 211.25/211.43 |- mesh__historyNote mesh__D032128 2003
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D004437 2000
% 211.25/211.43 |- skos__prefLabel mesh__D004437 Ebstein%27%s Anomaly
% 211.25/211.43 |- skos__scopeNote mesh__D004437
% 211.25/211.43 Congenital downward displacement of the tricuspid valve with the septal and posterior leaflets being attached to the wall of the right ventricle.%A%
% 211.25/211.43 |- mesh__dateCreated mesh__D004437 1999-01-01
% 211.25/211.43 |- skos__hiddenLabel mesh__D004437 Ebsteins Anomaly
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D004437 2001
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D004437 2003
% 211.25/211.43 |- skos__annotation mesh__D004437
% 211.25/211.43 a congen heart defect; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D004437 2005
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D004437 2004
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D004437 2002
% 211.25/211.43 |- skos__hiddenLabel mesh__D004437 Anomaly, Ebstein%27%s
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D004437 2006
% 211.25/211.43 |- rdf__type mesh__D004437sskos__Concept
% 211.25/211.43 |- skos__broader mesh__D004437smesh__D006330
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D004437 sjn
% 211.25/211.43 |- mesh__recordOriginator mesh__D004437 NLM
% 211.25/211.43 |- mesh__dateRevised mesh__D004437 1999-11-03
% 211.25/211.43 |- mesh__recordMaintainer mesh__D004437 kle
% 211.25/211.43 |- skos__hiddenLabel mesh__D004437 Ebstein Anomaly
% 211.25/211.43 |- mesh__recordOriginator mesh__D009920 NLM
% 211.25/211.43 |- skos__broader mesh__D009920smesh__D013733
% 211.25/211.43 |- rdf__type mesh__D009920sskos__Concept
% 211.25/211.43 |- mesh__dateCreated mesh__D009920 1999-01-01
% 211.25/211.43 |- mesh__dateRevised mesh__D009920 2005-06-30
% 211.25/211.43 |- mesh__recordMaintainer mesh__D009920 lkt
% 211.25/211.43 |- skos__prefLabel mesh__D009920 Orchitis
% 211.25/211.43 |- mesh__recordAuthorizer mesh__D009920 sjn
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009920 2006
% 211.25/211.43 |- skos__scopeNote mesh__D009920
% 211.25/211.43 Inflammation of a TESTIS. It has many features of EPIDIDYMITIS, such as swollen SCROTUM; PAIN; PYURIA; and FEVER. It is usually related to infections in the URINARY TRACT, which likely spread to the EPIDIDYMIS and then the TESTIS through either the VAS DEFERENS or the lymphatics of the SPERMATIC CORD.%A%
% 211.25/211.43 |- skos__hiddenLabel mesh__D009920 Orchitides
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Hypertonias, Neonatal
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Hypertonias, Infantile
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Muscular Hypertonicities
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Neonatal Hypertonias
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009122 2002
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009122 2003
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Increased, Muscle Tone
% 211.25/211.43 |- mesh__historyNote mesh__D009122 1979
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Hypertonias, Muscle
% 211.25/211.43 |- skos__historyNote mesh__D009122 Muscle Tonus %28%1970-1978%29%
% 211.25/211.43 |- skos__broader mesh__D009122smesh__D020879
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Tone Increased, Muscle
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Detrusor Muscle Hypertonia
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Hypertonias, Sphincter
% 211.25/211.43 |- mesh__dateRevised mesh__D009122 1999-12-06
% 211.25/211.43 |- skos__annotation mesh__D009122
% 211.25/211.43 coord IM with specific muscle/physiopathol %28%IM%29% if available%A%
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Neonatal Hypertonia
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Hypertonias, Transient
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Transient Hypertonias
% 211.25/211.43 |- mesh__recordOriginator mesh__D009122 RC
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Hypertonicity, Muscular
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Infantile Hypertonias
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Muscle Hypertonias, Detrusor
% 211.25/211.43 |- skos__altLabel mesh__D009122 Muscle Tone Increased
% 211.25/211.43 |- skos__historyNote mesh__D009122 Muscle Spasticity %28%1977-1978%29%
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009122 2001
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009122 2000A
% 211.25/211.43 |- mesh__recordMaintainer mesh__D009122 ags
% 211.25/211.43 |- skos__altLabel mesh__D009122 Muscular Hypertonicity
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Hypermyotonias
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Muscle Hypertonias
% 211.25/211.43 |- skos__prefLabel mesh__D009122 Muscle Hypertonia
% 211.25/211.43 |- skos__hiddenLabel mesh__D009122 Transient Hypertonia
% 211.25/211.43 |- mesh__activeMeSHYear mesh__D009122 2006
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D009122 2000
% 211.25/211.44 |- skos__hiddenLabel mesh__D009122 Hypertonia, Muscle
% 211.25/211.44 |- mesh__dateEstablished mesh__D009122 1979-01-01
% 211.25/211.44 |- skos__scopeNote mesh__D009122
% 211.25/211.44 Abnormal increase in skeletal or smooth muscle tone. Skeletal muscle hypertonicity may be associated with PYRAMIDAL TRACT lesions or BASAL GANGLIA DISEASES.%A%
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D009122 1979
% 211.25/211.44 |- skos__hiddenLabel mesh__D009122 Sphincter Hypertonias
% 211.25/211.44 |- mesh__dateCreated mesh__D009122 1978-05-17
% 211.25/211.44 |- skos__altLabel mesh__D009122 Hypermyotonia
% 211.25/211.44 |- skos__hiddenLabel mesh__D009122 Sphincter Hypertonia
% 211.25/211.44 |- skos__hiddenLabel mesh__D009122 Detrusor Muscle Hypertonias
% 211.25/211.44 |- skos__hiddenLabel mesh__D009122 Muscle Hypertonia, Detrusor
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D009122 2005
% 211.25/211.44 |- skos__hiddenLabel mesh__D009122 Infantile Hypertonia
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D009122 2004
% 211.25/211.44 |- rdf__type mesh__D009122sskos__Concept
% 211.25/211.44 |- skos__hiddenLabel mesh__D009122 Hypertonias, Detrusor Muscle
% 211.25/211.44 |- skos__hiddenLabel mesh__D009122 Hypertonicities, Muscular
% 211.25/211.44 |- skos__historyNote mesh__D009122 Spasm %28%1966-1976%29%
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D009122 ags
% 211.25/211.44 |- skos__broader mesh__D014865smesh__D012498
% 211.25/211.44 |- rdf__type mesh__D014865sskos__Concept
% 211.25/211.44 |- skos__hiddenLabel mesh__D014865 Disposal, Fluid Waste
% 211.25/211.44 |- mesh__recordMaintainer mesh__D014865 JLS
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 2004
% 211.25/211.44 |- skos__broader mesh__D014865smesh__D012722
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 1999
% 211.25/211.44 |- mesh__dateCreated mesh__D014865 1999-01-01
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 2000
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 2005
% 211.25/211.44 |- skos__prefLabel mesh__D014865 Waste Disposal, Fluid
% 211.25/211.44 |- skos__hiddenLabel mesh__D014865 Fluid Waste Disposal
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D014865 91; was see under SEWAGE 1975-90
% 211.25/211.44 |- skos__scopeNote mesh__D014865
% 211.25/211.44 The discarding or destroying of liquid waste products or their transformation into something useful or innocuous.%A%
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 2001
% 211.25/211.44 |- skos__broader mesh__D014865smesh__D012037
% 211.25/211.44 |- skos__hiddenLabel mesh__D014865 Fluid Waste Disposals
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 1995
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 1996
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 2006
% 211.25/211.44 |- mesh__onlineNote mesh__D014865 search SEWAGE 1969-74
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 2002
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 1997
% 211.25/211.44 |- mesh__historyNote mesh__D014865
% 211.25/211.44 91%28%75%29%; was see under SEWAGE 1975-90
% 211.25/211.44 |- mesh__recordOriginator mesh__D014865 NLM
% 211.25/211.44 |- skos__hiddenLabel mesh__D014865 Waste Disposals, Fluid
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 2003
% 211.25/211.44 |- skos__hiddenLabel mesh__D014865 Disposals, Fluid Waste
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014865 1998
% 211.25/211.44 |- mesh__dateRevised mesh__D014865 1994-07-01
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D014865 PLS
% 211.25/211.44 |- mesh__dateEstablished mesh__D014865 1991-01-01
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014067 2001
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Cancer, Tonsillar
% 211.25/211.44 |- skos__broader mesh__D014067smesh__D009959
% 211.25/211.44 |- skos__altLabel mesh__D014067 Tonsillar Cancer
% 211.25/211.44 |- skos__altLabel mesh__D014067 Neoplasms, Tonsillar
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014067 2003
% 211.25/211.44 |- skos__annotation mesh__D014067
% 211.25/211.44 coord IM with histol type of neopl %28%IM%29%
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Tonsillar Neoplasm
% 211.25/211.44 |- skos__altLabel mesh__D014067 Cancer of the Tonsil
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014067 2000
% 211.25/211.44 |- rdf__type mesh__D014067sskos__Concept
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Tonsillar Cancers
% 211.25/211.44 |- skos__altLabel mesh__D014067 Tonsil Neoplasms
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Tonsil Cancers
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Cancers, Tonsil
% 211.25/211.44 |- skos__scopeNote mesh__D014067 Tumors or cancer of the TONSIL.
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Cancers, Tonsillar
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014067 2002
% 211.25/211.44 |- mesh__dateCreated mesh__D014067 1999-01-01
% 211.25/211.44 |- skos__altLabel mesh__D014067 Tonsil Cancer
% 211.25/211.44 |- mesh__recordOriginator mesh__D014067 NLM
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Tonsil Neoplasm
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D014067 sjn
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Cancer, Tonsil
% 211.25/211.44 |- skos__altLabel mesh__D014067 Neoplasms, Tonsil
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014067 2006
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Neoplasm, Tonsil
% 211.25/211.44 |- skos__prefLabel mesh__D014067 Tonsillar Neoplasms
% 211.25/211.44 |- skos__hiddenLabel mesh__D014067 Neoplasm, Tonsillar
% 211.25/211.44 |- mesh__recordMaintainer mesh__D014067 nns
% 211.25/211.44 |- mesh__dateRevised mesh__D014067 1999-11-03
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014067 2005
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D014067 2004
% 211.25/211.44 |- mesh__historyNote mesh__D008828
% 211.25/211.44 91; was MICROBIOLOGICAL TECHNICS 1978-90
% 211.25/211.44 |- skos__altLabel mesh__D008828 Technics, Microbiological
% 211.25/211.44 |- skos__annotation mesh__D008828
% 211.25/211.44 GEN or unspecified; bacteriologic techniques = BACTERIOLOGICAL TECHNIQUES; virologic techniques = VIROLOGY /methods; mycologic techniques = MYCOLOGY /methods; parasitologic techniques = PARASITOLOGY /methods; do not use /util except by MeSH definition: DF: MICROBIOL TECHNIQUES%A%
% 211.25/211.44 |- skos__altLabel mesh__D008828 Techniques, Microbiologic
% 211.25/211.44 |- mesh__recordMaintainer mesh__D008828 kle
% 211.25/211.44 |- skos__hiddenLabel mesh__D008828 Technic, Microbiological
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D008828 sjn
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D008828 2003
% 211.25/211.44 |- skos__altLabel mesh__D008828 Technic, Microbiologic
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D008828 2001
% 211.25/211.44 |- skos__broader mesh__D008828smesh__D019411
% 211.25/211.44 |- skos__altLabel mesh__D008828 Technique, Microbiologic
% 211.25/211.44 |- skos__altLabel mesh__D008828 Microbiologic Technic
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D008828 2005
% 211.25/211.44 |- skos__historyNote mesh__D008828 Microbiology %28%1966-1977%29%
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D008828 2004
% 211.25/211.44 |- mesh__onlineNote mesh__D008828
% 211.25/211.44 use MICROBIOLOGICAL TECHNIQUES to search MICROBIOLOGICAL TECHNICS 1978-90%A%
% 211.25/211.44 |- skos__hiddenLabel mesh__D008828 Microbiological Technique
% 211.25/211.44 |- skos__hiddenLabel mesh__D008828 Technics, Microbiologic
% 211.25/211.44 |- skos__historyNote mesh__D008828 Mycology %28%1966-1977%29%
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D008828 2006
% 211.25/211.44 |- mesh__recordOriginator mesh__D008828 SMH
% 211.25/211.44 |- skos__historyNote mesh__D008828 Parasitology %28%1966-1977%29%
% 211.25/211.44 |- skos__hiddenLabel mesh__D008828 Microbiological Technic
% 211.25/211.44 |- skos__hiddenLabel mesh__D008828 Microbiologic Techniques
% 211.25/211.44 |- skos__altLabel mesh__D008828 Microbiological Technics
% 211.25/211.44 |- skos__scopeNote mesh__D008828 Techniques used in microbiology.
% 211.25/211.44 |- skos__altLabel mesh__D008828 Microbiologic Technics
% 211.25/211.44 |- skos__altLabel mesh__D008828 Microbiologic Technique
% 211.25/211.44 |- rdf__type mesh__D008828sskos__Concept
% 211.25/211.44 |- skos__prefLabel mesh__D008828 Microbiological Techniques
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D008828 2002
% 211.25/211.44 |- mesh__dateRevised mesh__D008828 2000-06-22
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D008828
% 211.25/211.44 91; was MICROBIOLOGICAL TECHNICS 1978-90
% 211.25/211.44 |- skos__hiddenLabel mesh__D008828 Techniques, Microbiological
% 211.25/211.44 |- skos__hiddenLabel mesh__D008828 Technique, Microbiological
% 211.25/211.44 |- mesh__dateCreated mesh__D008828 1977-03-01
% 211.25/211.44 |- mesh__dateEstablished mesh__D008828 1978-01-01
% 211.25/211.44 |- rdf__type mesh__D000845sskos__Concept
% 211.25/211.44 |- skos__altLabel mesh__D000845 Segmented Worms
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000845 2006
% 211.25/211.44 |- skos__annotation mesh__D000845
% 211.25/211.44 a phylum of segmented worms; GEN or unspecified; prefer specifics; /microbiol /parasitol /virol permitted%A%
% 211.25/211.44 |- skos__prefLabel mesh__D000845 Annelida
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000845 2004
% 211.25/211.44 |- mesh__dateCreated mesh__D000845 1999-01-01
% 211.25/211.44 |- mesh__recordOriginator mesh__D000845 NLM
% 211.25/211.44 |- mesh__dateRevised mesh__D000845 2003-07-09
% 211.25/211.44 |- skos__broader mesh__D000845smesh__D007448
% 211.25/211.44 |- skos__altLabel mesh__D000845 Worms, Segmented
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D000845 sjn
% 211.25/211.44 |- skos__scopeNote mesh__D000845
% 211.25/211.44 A phylum of metazoan invertebrates comprising the segmented worms, and including marine annelids %28%POLYCHAETA%29%, freshwater annelids, earthworms %28%OLIGOCHAETA%29%, and LEECHES. Only the leeches are of medical interest. %28%Dorland, 27th ed%29%%A%
% 211.25/211.44 |- mesh__recordMaintainer mesh__D000845 ags
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000845 2005
% 211.25/211.44 |- skos__prefLabel mesh__D019550 Environmental Medicine
% 211.25/211.44 |- skos__broader mesh__D019550smesh__D011634
% 211.25/211.44 |- mesh__dateRevised mesh__D019550 2004-07-13
% 211.25/211.44 |- mesh__recordOriginator mesh__D019550 JLS
% 211.25/211.44 |- skos__historyNote mesh__D019550 Environmental Health %28%1990-1996%29%
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D019550 97
% 211.25/211.44 |- mesh__dateEstablished mesh__D019550 1997-01-01
% 211.25/211.44 |- mesh__historyNote mesh__D019550 97
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D019550 2006
% 211.25/211.44 |- skos__altLabel mesh__D019550 Medicine, Environmental
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D019550 sjn
% 211.25/211.44 |- rdf__type mesh__D019550sskos__Concept
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D019550 2005
% 211.25/211.44 |- mesh__dateCreated mesh__D019550 1996-06-24
% 211.25/211.44 |- skos__scopeNote mesh__D019550
% 211.25/211.44 Medical specialty concerned with environmental factors that may impinge upon human disease, and development of methods for the detection, prevention, and control of environmentally related disease.%A%
% 211.25/211.44 |- mesh__recordMaintainer mesh__D019550 sjn
% 211.25/211.44 |- skos__annotation mesh__D019550
% 211.25/211.44 SPEC dealing with envir factors in human dis; SPEC qualif; DF: ENVIR MED%A%
% 211.25/211.44 |- skos__broader mesh__D019550smesh__D011315
% 211.25/211.44 |- skos__annotation mesh__D033221 specify geog if pertinent
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D033221 2003; see CHRISTIANITY 1978-2002
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D033221 2003
% 211.25/211.44 |- skos__prefLabel mesh__D033221 Jehovah%27%s Witnesses
% 211.25/211.44 |- mesh__dateCreated mesh__D033221 2002-07-03
% 211.25/211.44 |- skos__hiddenLabel mesh__D033221 Witnesses, Jehovah%27%s
% 211.25/211.44 |- skos__hiddenLabel mesh__D033221 Jehovah Witnesses
% 211.25/211.44 |- skos__hiddenLabel mesh__D033221 Jehovahs Witnesses
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D033221 2006
% 211.25/211.44 |- mesh__historyNote mesh__D033221 2003; use CHRISTIANITY 1978-2002
% 211.25/211.44 |- skos__historyNote mesh__D033221 Christianity %28%1974-2002%29%
% 211.25/211.44 |- skos__scopeNote mesh__D033221
% 211.25/211.44 Members of a religious denomination founded in the United States during the late 19th century in which active evangelism is practiced, the imminent approach of the millennium is preached, and war and organized government authority in matters of conscience are strongly opposed %28%from American Heritage Dictionary of the English Language, 4th ed%29%. Jehovah%27%s Witnesses generally refuse blood transfusions and other blood-based treatments based on religious belief.%A%
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D033221 2005
% 211.25/211.44 |- skos__broader mesh__D033221smesh__D002835
% 211.25/211.44 |- skos__altLabel mesh__D033221 Watchtower Bible and Tract Society
% 211.25/211.44 |- skos__broader mesh__D033221smesh__D009272
% 211.25/211.44 |- rdf__type mesh__D033221sskos__Concept
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D033221 2004
% 211.25/211.44 |- mesh__dateEstablished mesh__D033221 2003-01-01
% 211.25/211.44 |- rdf__type mesh__D000047sskos__Concept
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000047 2002
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D000047 70
% 211.25/211.44 |- skos__altLabel mesh__D000047 Academy and Institute
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000047 2004
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D000047 sjn
% 211.25/211.44 |- mesh__dateRevised mesh__D000047 1999-11-03
% 211.25/211.44 |- mesh__historyNote mesh__D000047 70%28%65%29%
% 211.25/211.44 |- mesh__recordMaintainer mesh__D000047 kle
% 211.25/211.44 |- mesh__dateEstablished mesh__D000047 1970-01-01
% 211.25/211.44 |- skos__scopeNote mesh__D000047
% 211.25/211.44 Organizations representing specialized fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., National Academy of Sciences, Brookings Institution, etc.%A%
% 211.25/211.44 |- skos__hiddenLabel mesh__D000047 Institute, Research
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000047 2003
% 211.25/211.44 |- mesh__dateCreated mesh__D000047 1999-01-01
% 211.25/211.44 |- mesh__recordOriginator mesh__D000047 NLM
% 211.25/211.44 |- skos__annotation mesh__D000047
% 211.25/211.44 not for educ acad %26% institutes %28% = SCHOOLS or its indentions%29%; Acad of Med: do not index also under MEDICINE; NY Acad of Med: when geog coord needed use NEW YORK CITY; DF: ACADEMIES%A%
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000047 2001
% 211.25/211.44 |- skos__altLabel mesh__D000047 Institutes and Academies
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000047 2006
% 211.25/211.44 |- skos__prefLabel mesh__D000047 Academies and Institutes
% 211.25/211.44 |- skos__hiddenLabel mesh__D000047 Institute and Academy
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000047 2000
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D000047 2005
% 211.25/211.44 |- skos__broader mesh__D000047smesh__D009938
% 211.25/211.44 |- skos__hiddenLabel mesh__D000047 Institutes, Research
% 211.25/211.44 |- skos__hiddenLabel mesh__D000047 Academy
% 211.25/211.44 |- skos__hiddenLabel mesh__D000047 Research Institute
% 211.25/211.44 |- rdf__type mesh__D005530sskos__Concept
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 2005
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 1998
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 2002
% 211.25/211.44 |- skos__hiddenLabel mesh__D005530 Deformity, Cavus
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 2003
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 2006
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 1999
% 211.25/211.44 |- skos__hiddenLabel mesh__D005530 Deformity, Metatarsal
% 211.25/211.44 |- skos__hiddenLabel mesh__D005530 Deformities, Foot
% 211.25/211.44 |- skos__hiddenLabel mesh__D005530 Deformities, Cavus
% 211.25/211.44 |- skos__hiddenLabel mesh__D005530 Cavus Deformities
% 211.25/211.44 |- skos__altLabel mesh__D005530 Talipes Cavus
% 211.25/211.44 |- skos__scopeNote mesh__D005530
% 211.25/211.44 Alterations or deviations from normal shape or size which result in a disfigurement of the foot.%A%
% 211.25/211.44 |- mesh__recordMaintainer mesh__D005530 TGC
% 211.25/211.44 |- skos__hiddenLabel mesh__D005530 Metatarsal Deformities
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 2004
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 1997
% 211.25/211.44 |- skos__broader mesh__D005530smesh__D009140
% 211.25/211.44 |- mesh__historyNote mesh__D005530 88
% 211.25/211.44 |- mesh__dateCreated mesh__D005530 1987-04-02
% 211.25/211.44 |- skos__annotation mesh__D005530 GEN or unspecified; prefer specifics
% 211.25/211.44 |- mesh__dateRevised mesh__D005530 1996-06-10
% 211.25/211.44 |- skos__prefLabel mesh__D005530 Foot Deformities
% 211.25/211.44 |- mesh__dateEstablished mesh__D005530 1988-01-01
% 211.25/211.44 |- mesh__recordOriginator mesh__D005530 EC
% 211.25/211.44 |- skos__historyNote mesh__D005530 Foot/abnormalities %28%1966-1987%29%
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 2000
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D005530 88
% 211.25/211.44 |- skos__hiddenLabel mesh__D005530 Foot Deformity
% 211.25/211.44 |- skos__hiddenLabel mesh__D005530 Deformities, Metatarsal
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D005530 PLS
% 211.25/211.44 |- skos__hiddenLabel mesh__D005530 Deformity, Foot
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D005530 2001
% 211.25/211.44 |- skos__hiddenLabel mesh__D046149 Culture Technique, Blastocyst
% 211.25/211.44 |- mesh__recordMaintainer mesh__D046149 ags
% 211.25/211.44 |- skos__annotation mesh__D046149
% 211.25/211.44 restrict to whole mammalian embryos; for cultures of embryonic tissue or cells, use TISSUE CULTURE TECHNIQUES or CELL CULTURE%A%
% 211.25/211.44 |- skos__broader mesh__D046149smesh__D046508
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D046149 2006
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D046149 2006A
% 211.25/211.44 |- rdf__type mesh__D046149sskos__Concept
% 211.25/211.44 |- skos__scopeNote mesh__D046149
% 211.25/211.44 The technique of maintaining or growing mammalian EMBRYOS in vitro. This method offers an opportunity to observe EMBRYONIC DEVELOPMENT; METABOLISM; and susceptibility to TERATOGENS%A%
% 211.25/211.44 |- skos__historyNote mesh__D046149 Culture Techniques %28%1965-2004%29%
% 211.25/211.44 |- skos__hiddenLabel mesh__D046149 Embryo Culture Technique
% 211.25/211.44 |- skos__prefLabel mesh__D046149 Embryo Culture Techniques
% 211.25/211.44 |- skos__historyNote mesh__D046149 Embryo %28%1966-2004%29%
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D046149 2005
% 211.25/211.44 |- mesh__historyNote mesh__D046149 2005
% 211.25/211.44 |- skos__hiddenLabel mesh__D046149 Blastocyst Culture Technique
% 211.25/211.44 |- mesh__dateCreated mesh__D046149 2004-07-07
% 211.25/211.44 |- mesh__dateRevised mesh__D046149 2005-08-02
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D046149 2005
% 211.25/211.44 |- mesh__dateEstablished mesh__D046149 2005-01-01
% 211.25/211.44 |- skos__hiddenLabel mesh__D046149 Culture Techniques, Blastocyst
% 211.25/211.44 |- skos__hiddenLabel mesh__D046149 Culture Technique, Embryo
% 211.25/211.44 |- mesh__recordOriginator mesh__D046149 lkt
% 211.25/211.44 |- skos__hiddenLabel mesh__D046149 Culture Techniques, Embryo
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D046149 ags
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D046149 2006B
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Minimally Conscious
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Vegetative
% 211.25/211.44 |- skos__related mesh__D018458smesh__D000405
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Vegetative States, Persistent
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness, Prolonged Post-Traumatic
% 211.25/211.44 |- skos__altLabel mesh__D018458 Posttraumatic Unawareness State
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Posttraumatic Unawareness
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D018458 2003
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Vegetative State, Post-Traumatic
% 211.25/211.44 |- skos__altLabel mesh__D018458 PVS %28%Persistent Vegetative State%29%
% 211.25/211.44 |- skos__altLabel mesh__D018458 Vegetative State, Persistent
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D018458
% 211.25/211.44 1995; VEGETATIVE STATE was see COMA 1980-1994
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Persistent Vegetative
% 211.25/211.44 |- skos__broader mesh__D018458smesh__D001925
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Prolonged Post Traumatic Unawareness
% 211.25/211.44 |- skos__related mesh__D018458smesh__D003128
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Prolonged Post-Traumatic Unawarenesses
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Post-Comatose Unawareness
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness State, Post-Traumatic
% 211.25/211.44 |- skos__historyNote mesh__D018458 Coma %28%1972-1994%29%
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Persistent Unawareness
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Permanent Vegetative States
% 211.25/211.44 |- skos__broader mesh__D018458smesh__D014474
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness State, Posttraumatic
% 211.25/211.44 |- mesh__dateEstablished mesh__D018458 1995-01-01
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Postcomatose Unawareness
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Post-Traumatic Unawareness, Prolonged
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D018458 2002
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Transient Vegetative
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Transient Vegetative States
% 211.25/211.44 |- mesh__recordOriginator mesh__D018458 TGC
% 211.25/211.44 |- rdf__type mesh__D018458sskos__Concept
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D018458 2004
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Post-Traumatic Unawareness
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Vegetative States, Post-Traumatic
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Vegetative
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness States, Posttraumatic
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D018458 2005
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Post Traumatic Unawareness State
% 211.25/211.44 |- mesh__dateCreated mesh__D018458 1994-04-16
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Vegetative States
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 PVSs %28%Persistent Vegetative State%29%
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Posttraumatic Unawareness
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Post Comatose Unawareness State
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Post-Traumatic Unawareness States
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Post Traumatic Vegetative State
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Permanent Vegetative
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Post-Traumatic Vegetative
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Persistent Vegetative
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness State, Postcomatose
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawarenesses, Prolonged Post-Traumatic
% 211.25/211.44 |- skos__prefLabel mesh__D018458 Persistent Vegetative State
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D018458 2006
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness States, Postcomatose
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Persistent Unawareness
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Post-Comatose Unawareness
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Post-Traumatic Unawarenesses, Prolonged
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Vegetative State, Transient
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Vegetative States, Permanent
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Permanent Vegetative
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness State, Persistent
% 211.25/211.44 |- skos__altLabel mesh__D018458 Postcomatose Unawareness State
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D018458 sjn
% 211.25/211.44 |- mesh__recordMaintainer mesh__D018458 lkt
% 211.25/211.44 |- mesh__historyNote mesh__D018458
% 211.25/211.44 1995; VEGETATIVE STATE was see COMA 1980-1994
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness State, Post-Comatose
% 211.25/211.44 |- skos__altLabel mesh__D018458 Persistent Unawareness State
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Minimally Conscious
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Minimally Conscious States
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Post-Traumatic Unawareness
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Post-Comatose Unawareness States
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Post-Traumatic Vegetative States
% 211.25/211.44 |- mesh__dateRevised mesh__D018458 2001-07-25
% 211.25/211.44 |- skos__altLabel mesh__D018458 Post-Traumatic Unawareness State
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Vegetative States, Transient
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Posttraumatic Unawareness States
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness States, Post-Traumatic
% 211.25/211.44 |- skos__annotation mesh__D018458 see also AKINETIC MUTISM
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Postcomatose Unawareness States
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Post-Traumatic Vegetative
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 State, Postcomatose Unawareness
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Vegetative State, Permanent
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness States, Persistent
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 States, Transient Vegetative
% 211.25/211.44 |- skos__scopeNote mesh__D018458
% 211.25/211.44 Vegetative state refers to the neurocognitive status of individuals with severe brain damage, in whom physiologic functions %28%sleep-wake cycles, autonomic control, and breathing%29% persist, but awareness %28%including all cognitive function and emotion%29% is abolished.%A%
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Unawareness States, Post-Comatose
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Persistent Vegetative States
% 211.25/211.44 |- skos__hiddenLabel mesh__D018458 Persistent Unawareness States
% 211.25/211.44 |- skos__altLabel mesh__D032129 Achras zapotilla
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D032129 sjn
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D032129 2006
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D032129 2003
% 211.25/211.44 |- rdf__type mesh__D032129sskos__Concept
% 211.25/211.44 |- mesh__recordMaintainer mesh__D032129 sjn
% 211.25/211.44 |- skos__altLabel mesh__D032129 Zapote
% 211.25/211.44 |- skos__altLabel mesh__D032129 Sapodilla
% 211.25/211.44 |- skos__annotation mesh__D032129
% 211.25/211.44 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D032129 2005
% 211.25/211.44 |- mesh__historyNote mesh__D032129 2003
% 211.25/211.44 |- mesh__dateRevised mesh__D032129 2004-07-13
% 211.25/211.44 |- skos__prefLabel mesh__D032129 Manilkara
% 211.25/211.44 |- skos__broader mesh__D032129smesh__D029632
% 211.25/211.44 |- skos__altLabel mesh__D032129 Sapote
% 211.25/211.44 |- skos__altLabel mesh__D032129 Lucuma mammosa
% 211.25/211.44 |- mesh__dateCreated mesh__D032129 2002-07-02
% 211.25/211.44 |- skos__altLabel mesh__D032129 Sapota zapotilla
% 211.25/211.44 |- mesh__recordOriginator mesh__D032129 ssb
% 211.25/211.44 |- skos__scopeNote mesh__D032129
% 211.25/211.44 A plant genus of the family SAPOTACEAE that bears sweet fruit.%A%
% 211.25/211.44 |- mesh__dateEstablished mesh__D032129 2003-01-01
% 211.25/211.44 |- mesh__dateCreated mesh__D004438 1999-01-01
% 211.25/211.44 |- mesh__historyNote mesh__D004438 64
% 211.25/211.44 |- mesh__dateEstablished mesh__D004438 1964-01-01
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D004438 sjn
% 211.25/211.44 |- mesh__recordOriginator mesh__D004438 NLM
% 211.25/211.44 |- mesh__dateRevised mesh__D004438 1999-11-03
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D004438 2003
% 211.25/211.44 |- skos__broader mesh__D004438smesh__D012877
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D004438 2000
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D004438 2005
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D004438 2004
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D004438 2001
% 211.25/211.44 |- skos__related mesh__D004438smesh__D011693
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D004438 2006
% 211.25/211.44 |- skos__broader mesh__D004438smesh__D006470
% 211.25/211.44 |- skos__hiddenLabel mesh__D004438 Ecchymoses
% 211.25/211.44 |- skos__scopeNote mesh__D004438
% 211.25/211.44 Extravasation of blood into the skin, resulting in a nonelevated, rounded or irregular, blue or purplish patch, larger than a petechia.%A%
% 211.25/211.44 |- rdf__type mesh__D004438sskos__Concept
% 211.25/211.44 |- skos__prefLabel mesh__D004438 Ecchymosis
% 211.25/211.44 |- mesh__recordMaintainer mesh__D004438 KEV
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D004438 64
% 211.25/211.44 |- skos__annotation mesh__D004438
% 211.25/211.44 differentiate from CONTUSIONS: use term in the text
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D004438 2002
% 211.25/211.44 |- skos__broader mesh__D015160smesh__D017085
% 211.25/211.44 |- skos__historyNote mesh__D015160 Fetal Diseases %28%1966-1988%29%
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D015160 sjn
% 211.25/211.44 |- mesh__historyNote mesh__D015160 89
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D015160 2006
% 211.25/211.44 |- skos__altLabel mesh__D015160 Non-Immune Hydrops Fetalis
% 211.25/211.44 |- skos__historyNote mesh__D015160 Edema %28%1966-1988%29%
% 211.25/211.44 |- skos__scopeNote mesh__D015160
% 211.25/211.44 Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS.%A%
% 211.25/211.44 |- mesh__recordOriginator mesh__D015160 EC
% 211.25/211.44 |- skos__altLabel mesh__D015160 Edema, Fetal
% 211.25/211.44 |- rdf__type mesh__D015160sskos__Concept
% 211.25/211.44 |- skos__broader mesh__D015160smesh__D004899
% 211.25/211.44 |- skos__altLabel mesh__D015160 Hydrops Fetalis, Immune
% 211.25/211.44 |- mesh__dateCreated mesh__D015160 1988-03-28
% 211.25/211.44 |- skos__prefLabel mesh__D015160 Hydrops Fetalis
% 211.25/211.44 |- skos__broader mesh__D015160smesh__D004487
% 211.25/211.44 |- skos__altLabel mesh__D015160 Fetal Hydrops
% 211.25/211.44 |- mesh__publicMeSHNote mesh__D015160 89
% 211.25/211.44 |- skos__hiddenLabel mesh__D015160 Hydrops, Fetal
% 211.25/211.44 |- mesh__recordMaintainer mesh__D015160 lkt
% 211.25/211.44 |- mesh__dateEstablished mesh__D015160 1989-01-01
% 211.25/211.44 |- mesh__dateRevised mesh__D015160 2005-06-30
% 211.25/211.44 |- skos__altLabel mesh__D015160 Fetal Edema
% 211.25/211.44 |- skos__scopeNote mesh__D009921
% 211.25/211.44 A beta-adrenergic agonist used in the treatment of asthma and bronchospasms.%A%
% 211.25/211.44 |- mesh__recordAuthorizer mesh__D009921 sjn
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D009921 2005
% 211.25/211.44 |- skos__broader mesh__D009921smesh__D002395
% 211.25/211.44 |- mesh__historyNote mesh__D009921 72%28%65%29%
% 211.25/211.44 |- skos__altLabel mesh__D009921 Metaproterenol
% 211.25/211.44 |- mesh__dateEstablished mesh__D009921 1972-01-01
% 211.25/211.44 |- skos__broader mesh__D009921smesh__D004983
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D009921 2003
% 211.25/211.44 |- mesh__recordOriginator mesh__D009921 NLM
% 211.25/211.44 |- mesh__activeMeSHYear mesh__D009921 2006
% 211.25/211.44 |- mesh__recordMaintainer mesh__D009921 ssb
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D009921 72
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009921 2004
% 211.25/211.45 |- mesh__dateRevised mesh__D009921 2001-07-25
% 211.25/211.45 |- skos__hiddenLabel mesh__D009921 Polistirex, Metaproterenol
% 211.25/211.45 |- skos__prefLabel mesh__D009921 Orciprenaline
% 211.25/211.45 |- rdf__type mesh__D009921sskos__Concept
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009921 2002
% 211.25/211.45 |- mesh__dateCreated mesh__D009921 1999-01-01
% 211.25/211.45 |- skos__altLabel mesh__D009123 Muscle Flaccidity
% 211.25/211.45 |- mesh__recordMaintainer mesh__D009123 nns
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Tone Atonic, Muscle
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Hypotonia, Muscular
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Flaccidity, Muscular
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Muscle Tone Atonics
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Muscle Tone, Decreased
% 211.25/211.45 |- skos__altLabel mesh__D009123 Decreased Muscle Tone
% 211.25/211.45 |- skos__altLabel mesh__D009123 Muscular Flaccidity
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009123 2006
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Muscle, Floppy
% 211.25/211.45 |- skos__altLabel mesh__D009123 Hypomyotonia
% 211.25/211.45 |- mesh__historyNote mesh__D009123 1977
% 211.25/211.45 |- skos__altLabel mesh__D009123 Muscle Tone Poor
% 211.25/211.45 |- skos__altLabel mesh__D009123 Muscular Hypotonia
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Muscles, Floppy
% 211.25/211.45 |- mesh__dateEstablished mesh__D009123 1977-01-01
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Hypotonias, Neonatal
% 211.25/211.45 |- skos__historyNote mesh__D009123 Muscular Diseases %28%1966-1976%29%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009123 2003
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Tone Poor, Muscle
% 211.25/211.45 |- rdf__type mesh__D009123sskos__Concept
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D009123 sjn
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Hypotonia, Muscle
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009123 2002
% 211.25/211.45 |- mesh__dateRevised mesh__D009123 2001-07-25
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Muscular Flaccidities
% 211.25/211.45 |- skos__altLabel mesh__D009123 Hypotonia
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009123 2004
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Neonatal Hypotonias
% 211.25/211.45 |- skos__prefLabel mesh__D009123 Muscle Hypotonia
% 211.25/211.45 |- mesh__recordOriginator mesh__D009123 MM
% 211.25/211.45 |- skos__altLabel mesh__D009123 Hypotony, Muscle
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Muscle Hypotony
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Hypotonia, Unilateral
% 211.25/211.45 |- skos__scopeNote mesh__D009123
% 211.25/211.45 A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.%A%
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Floppy Muscle
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Muscle Tone, Flaccid
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D009123 1977
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Flaccidity, Muscle
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Hypotonias, Unilateral
% 211.25/211.45 |- mesh__dateCreated mesh__D009123 1976-05-19
% 211.25/211.45 |- skos__hiddenLabel mesh__D009123 Hypotonia, Neonatal
% 211.25/211.45 |- skos__broader mesh__D009123smesh__D020879
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009123 2005
% 211.25/211.45 |- skos__annotation mesh__D001140
% 211.25/211.45 indust chem, a widespread environ pollutant; TN 111: eff on insects; AROCLOR 1254 also available%A%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D001140 2006
% 211.25/211.45 |- mesh__recordMaintainer mesh__D001140 jls
% 211.25/211.45 |- skos__scopeNote mesh__D001140
% 211.25/211.45 Industrial chemicals which have become widespread environmental pollutants. Each aroclor is a mixture of chlorinated biphenyls %28%1200 series%29% or chlorinated terphenyls %28%5400 series%29% or a combination of both %28%4400 series%29%.%A%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D001140 2005
% 211.25/211.45 |- mesh__dateRevised mesh__D001140 2004-07-07
% 211.25/211.45 |- mesh__recordOriginator mesh__D001140 NLM
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D001140 sjn
% 211.25/211.45 |- rdf__type mesh__D001140sskos__Concept
% 211.25/211.45 |- skos__broader mesh__D001140smesh__D011080
% 211.25/211.45 |- mesh__onlineNote mesh__D001140
% 211.25/211.45 search POLYCHLOROBIPHENYL COMPOUNDS 1973-74
% 211.25/211.45 |- skos__broader mesh__D001140smesh__D011078
% 211.25/211.45 |- skos__prefLabel mesh__D001140 Aroclors
% 211.25/211.45 |- mesh__dateEstablished mesh__D001140 1991-01-01
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D001140
% 211.25/211.45 91; was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90
% 211.25/211.45 |- mesh__historyNote mesh__D001140
% 211.25/211.45 91%28%75%29%; was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90%A%
% 211.25/211.45 |- mesh__dateCreated mesh__D001140 1999-01-01
% 211.25/211.45 |- skos__prefLabel mesh__D014866 Waste Products
% 211.25/211.45 |- mesh__dateCreated mesh__D014866 1999-01-01
% 211.25/211.45 |- skos__hiddenLabel mesh__D014866 Product, Waste
% 211.25/211.45 |- mesh__dateEstablished mesh__D014866 1976-01-01
% 211.25/211.45 |- skos__hiddenLabel mesh__D014866 Products, Waste
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D014866 sjn
% 211.25/211.45 |- mesh__recordOriginator mesh__D014866 NLM
% 211.25/211.45 |- skos__annotation mesh__D014866
% 211.25/211.45 MEDICAL WASTE %26% DENTAL WASTE are also available
% 211.25/211.45 |- mesh__dateRevised mesh__D014866 2005-06-30
% 211.25/211.45 |- rdf__type mesh__D014866sskos__Concept
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D014866 76
% 211.25/211.45 |- skos__scopeNote mesh__D014866
% 211.25/211.45 Debris resulting from a process that is of no further use to the system producing it. The concept includes materials discharged from or stored in a system in inert form as a by-product of vital activities. %28%From Webster%27%s New Collegiate Dictionary, 1981%29%%A%
% 211.25/211.45 |- mesh__historyNote mesh__D014866 76; was NON MESH before 1976
% 211.25/211.45 |- skos__hiddenLabel mesh__D014866 Waste Product
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014866 2006
% 211.25/211.45 |- skos__broader mesh__D014866smesh__D045424
% 211.25/211.45 |- mesh__recordMaintainer mesh__D014866 ssb
% 211.25/211.45 |- skos__broader mesh__D014866smesh__D004787
% 211.25/211.45 |- rdf__type mesh__D014068sskos__Concept
% 211.25/211.45 |- skos__broader mesh__D014068smesh__D013517
% 211.25/211.45 |- skos__scopeNote mesh__D014068
% 211.25/211.45 Surgical removal of a tonsil or tonsils. %28%Dorland, 28th ed%29%%A%
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D014068 SJN
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014068 2001
% 211.25/211.45 |- skos__hiddenLabel mesh__D014068 Tonsillectomies
% 211.25/211.45 |- mesh__dateCreated mesh__D014068 1999-01-01
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014068 2000
% 211.25/211.45 |- mesh__dateRevised mesh__D014068 1997-06-20
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014068 2006
% 211.25/211.45 |- mesh__recordMaintainer mesh__D014068 PXP
% 211.25/211.45 |- skos__prefLabel mesh__D014068 Tonsillectomy
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014068 2005
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014068 1999
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014068 2004
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014068 2002
% 211.25/211.45 |- mesh__recordOriginator mesh__D014068 NLM
% 211.25/211.45 |- skos__annotation mesh__D014068
% 211.25/211.45 do not use /util except by MeSH definition; post-tonsillectomy hemorrh = HEMORRHAGE + POSTOPERATIVE COMPLICATIONS, not HEMORRHAGE, ORAL%A%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014068 1998
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D014068 2003
% 211.25/211.45 |- mesh__dateRevised mesh__D008829 2001-07-25
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D008829 2005
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D008829 2004
% 211.25/211.45 |- skos__related mesh__D008829smesh__D014780
% 211.25/211.45 |- skos__related mesh__D008829smesh__D001105
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D008829 2002
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D008829 2006
% 211.25/211.45 |- skos__related mesh__D008829smesh__D005658
% 211.25/211.45 |- skos__annotation mesh__D008829
% 211.25/211.45 SPEC only; prefer /microbiol with specific organ, higher animal %26% disease: Manual 19.7+, 19.8.46; note precoord microbiology terms %28%AIR MICROBIOLOGY; FOOD MICROBIOLOGY; etc%29%; presence of microbes in the blood: coord with the disease /microbiol, not /blood ; DF: MICROBIOL%A%
% 211.25/211.45 |- rdf__type mesh__D008829sskos__Concept
% 211.25/211.45 |- mesh__recordOriginator mesh__D008829 NLM
% 211.25/211.45 |- skos__broader mesh__D008829smesh__D001695
% 211.25/211.45 |- skos__prefLabel mesh__D008829 Microbiology
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D008829 sjn
% 211.25/211.45 |- skos__related mesh__D008829smesh__D001419
% 211.25/211.45 |- skos__related mesh__D008829smesh__D011527
% 211.25/211.45 |- skos__scopeNote mesh__D008829
% 211.25/211.45 The study of microorganisms such as fungi, bacteria, algae, archaea, and viruses.%A%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D008829 2003
% 211.25/211.45 |- mesh__recordMaintainer mesh__D008829 jls
% 211.25/211.45 |- mesh__dateCreated mesh__D008829 1999-01-01
% 211.25/211.45 |- skos__broader mesh__D000846smesh__D006664
% 211.25/211.45 |- skos__hiddenLabel mesh__D000846 Special Event
% 211.25/211.45 |- mesh__historyNote mesh__D000846
% 211.25/211.45 91%28%Aug 77%29%; was see under PUBLIC RELATIONS 1977-90
% 211.25/211.45 |- skos__prefLabel mesh__D000846 Anniversaries and Special Events
% 211.25/211.45 |- skos__broader mesh__D000846smesh__D011641
% 211.25/211.45 |- mesh__recordOriginator mesh__D000846 EC
% 211.25/211.45 |- skos__hiddenLabel mesh__D000846 Anniversary
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D000846
% 211.25/211.45 91; was see under PUBLIC RELATIONS 1977-90
% 211.25/211.45 |- mesh__recordMaintainer mesh__D000846 jls
% 211.25/211.45 |- skos__scopeNote mesh__D000846
% 211.25/211.45 Occasions to commemorate an event or occasions designated for a specific purpose.%A%
% 211.25/211.45 |- skos__hiddenLabel mesh__D000846 Events, Special
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D000846 2005
% 211.25/211.45 |- rdf__type mesh__D000846sskos__Concept
% 211.25/211.45 |- skos__annotation mesh__D000846
% 211.25/211.45 NIM; no qualif; note X ref below: do not index here for anniversaries, centennials, etc. in historical articles; do not coord here for ANNIVERSARY REACTION; DF: ANNIVERSARIES%A%
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D000846 sjn
% 211.25/211.45 |- mesh__dateRevised mesh__D000846 2004-07-07
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D000846 2006
% 211.25/211.45 |- skos__hiddenLabel mesh__D000846 Event, Special
% 211.25/211.45 |- mesh__dateEstablished mesh__D000846 1991-01-01
% 211.25/211.45 |- mesh__dateCreated mesh__D000846 1977-05-05
% 211.25/211.45 |- mesh__recordMaintainer mesh__D019551 ssb
% 211.25/211.45 |- mesh__recordOriginator mesh__D019551 JLS
% 211.25/211.45 |- skos__broader mesh__D019551smesh__D004202
% 211.25/211.45 |- skos__historyNote mesh__D019551 Disinfectants %28%1967-1996%29%
% 211.25/211.45 |- mesh__historyNote mesh__D019551 97
% 211.25/211.45 |- mesh__dateCreated mesh__D019551 1996-06-10
% 211.25/211.45 |- mesh__dateRevised mesh__D019551 2003-07-09
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D019551 2006
% 211.25/211.45 |- rdf__type mesh__D019551sskos__Concept
% 211.25/211.45 |- skos__altLabel mesh__D019551 Disinfectants, Dental
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D019551 2005
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D019551 97
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D019551 2004
% 211.25/211.45 |- skos__annotation mesh__D019551 DF: DENT DISINFECTANTS
% 211.25/211.45 |- mesh__dateEstablished mesh__D019551 1997-01-01
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D019551 sjn
% 211.25/211.45 |- skos__prefLabel mesh__D019551 Dental Disinfectants
% 211.25/211.45 |- skos__scopeNote mesh__D019551
% 211.25/211.45 Chemicals especially for use on instruments to destroy pathogenic organisms. %28%Boucher, Clinical Dental Terminology, 4th ed%29%%A%
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Action, Court
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Actions, Court
% 211.25/211.45 |- skos__altLabel mesh__D033222 Court Action
% 211.25/211.45 |- mesh__dateEstablished mesh__D033222 2003-01-01
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Judicial Roles
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D033222 2006
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Court Actions
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Action, Judicial
% 211.25/211.45 |- mesh__recordOriginator mesh__D033222 jrf
% 211.25/211.45 |- skos__prefLabel mesh__D033222 Judicial Role
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Actions, Judicial
% 211.25/211.45 |- mesh__recordMaintainer mesh__D033222 sjn
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Judicial Actions
% 211.25/211.45 |- mesh__historyNote mesh__D033222 2003; use JURISPRUDENCE 1978-2002
% 211.25/211.45 |- mesh__dateRevised mesh__D033222 2003-07-25
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D033222 sjn
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D033222 2005
% 211.25/211.45 |- skos__altLabel mesh__D033222 Judicial Action
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Consent, Judicial
% 211.25/211.45 |- rdf__type mesh__D033222sskos__Concept
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D033222 2004
% 211.25/211.45 |- skos__historyNote mesh__D033222 Jurisprudence %28%1975-2002%29%
% 211.25/211.45 |- skos__annotation mesh__D033222
% 211.25/211.45 use only for discussions of the role of judges or courts in decision making, not routinely for individual court cases%A%
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Bypass, Judicial
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D033222 2003; see JURISPRUDENCE 1978-2002
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Role, Judicial
% 211.25/211.45 |- skos__scopeNote mesh__D033222
% 211.25/211.45 The kind of action or activity proper to the judiciary, particularly its responsibility for decision making.%A%
% 211.25/211.45 |- skos__broader mesh__D033222smesh__D007603
% 211.25/211.45 |- skos__hiddenLabel mesh__D033222 Roles, Judicial
% 211.25/211.45 |- mesh__dateCreated mesh__D033222 2002-07-02
% 211.25/211.45 |- skos__historyNote mesh__D000048 Amoeba %28%1966-1987%29%
% 211.25/211.45 |- mesh__dateEstablished mesh__D000048 1988-01-01
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D000048 sjn
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D000048 88
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D000048 2004
% 211.25/211.45 |- skos__broader mesh__D000048smesh__D016842
% 211.25/211.45 |- mesh__dateCreated mesh__D000048 1987-04-30
% 211.25/211.45 |- mesh__recordMaintainer mesh__D000048 ags
% 211.25/211.45 |- mesh__recordOriginator mesh__D000048 EC
% 211.25/211.45 |- skos__prefLabel mesh__D000048 Acanthamoeba
% 211.25/211.45 |- skos__scopeNote mesh__D000048
% 211.25/211.45 A genus of free-living soil amoebae that produces no flagellate stage. Its organisms are pathogens for several infections in humans and have been found in the eye, bone, brain, and respiratory tract.%A%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D000048 2006
% 211.25/211.45 |- mesh__historyNote mesh__D000048 88
% 211.25/211.45 |- mesh__dateRevised mesh__D000048 2003-07-09
% 211.25/211.45 |- skos__annotation mesh__D000048
% 211.25/211.45 infection: coord IM with AMEBIASIS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D000048 2005
% 211.25/211.45 |- rdf__type mesh__D000048sskos__Concept
% 211.25/211.45 |- skos__historyNote mesh__D005531 Foot Diseases %28%1966-1970%29%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 2001
% 211.25/211.45 |- skos__broader mesh__D005531smesh__D005530
% 211.25/211.45 |- skos__prefLabel mesh__D005531 Foot Deformities, Acquired
% 211.25/211.45 |- skos__scopeNote mesh__D005531
% 211.25/211.45 Distortion or disfigurement of the foot, or a part of the foot, acquired through disease or injury after birth.%A%
% 211.25/211.45 |- mesh__recordMaintainer mesh__D005531 TGC
% 211.25/211.45 |- skos__hiddenLabel mesh__D005531 Deformity, Acquired Foot
% 211.25/211.45 |- rdf__type mesh__D005531sskos__Concept
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 2000
% 211.25/211.45 |- skos__hiddenLabel mesh__D005531 Acquired Foot Deformity
% 211.25/211.45 |- skos__annotation mesh__D005531 deformity of bone, joint, muscle, etc.
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 2004
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 1997
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D005531 71
% 211.25/211.45 |- skos__hiddenLabel mesh__D005531 Deformities, Acquired Foot
% 211.25/211.45 |- mesh__dateEstablished mesh__D005531 1971-01-01
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 2006
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 1999
% 211.25/211.45 |- mesh__dateRevised mesh__D005531 1992-05-20
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 2003
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 1996
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 1993
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 1995
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 2005
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 1998
% 211.25/211.45 |- mesh__historyNote mesh__D005531 71
% 211.25/211.45 |- mesh__recordOriginator mesh__D005531 NLM
% 211.25/211.45 |- skos__hiddenLabel mesh__D005531 Acquired Foot Deformities
% 211.25/211.45 |- skos__hiddenLabel mesh__D005531 Foot Deformity, Acquired
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 1994
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D005531 2002
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D005531 PLS
% 211.25/211.45 |- mesh__dateCreated mesh__D005531 1999-01-01
% 211.25/211.45 |- mesh__dateEstablished mesh__D046948 2005-01-01
% 211.25/211.45 |- rdf__type mesh__D046948sskos__Concept
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Tryptamine Alkaloids, Secologanin
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Alkaloids, Secologanin Tryptamine
% 211.25/211.45 |- skos__prefLabel mesh__D046948 Secologanin Tryptamine Alkaloids
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Indole Alkaloids, Monoterpenoid
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D046948 2006
% 211.25/211.45 |- skos__altLabel mesh__D046948 Monoterpenoid Indole Alkaloids
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Alkaloids, Rauwolfia
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Alkaloids, Monoterpenoid Indole
% 211.25/211.45 |- skos__broader mesh__D046948smesh__D026121
% 211.25/211.45 |- mesh__dateCreated mesh__D046948 2004-07-07
% 211.25/211.45 |- mesh__recordMaintainer mesh__D046948 ssb
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Indole Alkaloids, Terpenoid
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Alkaloids, Rauvolfia
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D046948 sjn
% 211.25/211.45 |- mesh__recordOriginator mesh__D046948 ssb
% 211.25/211.45 |- skos__historyNote mesh__D046948 Rauwolfia Alkaloids %28%1975-2004%29%
% 211.25/211.45 |- skos__altLabel mesh__D046948 Secologanin Indole Alkaloids
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D046948 2005
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D046948
% 211.25/211.45 2005; for YOHIMBANS see YOHIMBANS 1969-2004; for RAUWOLFIA ALKALOIDS see RAUWOLFIA ALKALOIDS 1975-2004%A%
% 211.25/211.45 |- skos__altLabel mesh__D046948 Rauvolfia Alkaloids
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Alkaloids, Terpenoid Indole
% 211.25/211.45 |- skos__scopeNote mesh__D046948
% 211.25/211.45 Compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds. These are especially found in plants of the APOCYNACEAE; LOGANIACEAE; and RUBIACEAE families.%A%
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Indole Alkaloids, Secologanin
% 211.25/211.45 |- mesh__historyNote mesh__D046948
% 211.25/211.45 2005; for YOHIMBANS use YOHIMBANS 1969-2004; for RAUWOLFIA ALKALOIDS use RAUWOLFIA ALKALOIDS 1975-2004%A%
% 211.25/211.45 |- skos__hiddenLabel mesh__D046948 Alkaloids, Secologanin Indole
% 211.25/211.45 |- skos__altLabel mesh__D046948 Terpenoid Indole Alkaloids
% 211.25/211.45 |- rdf__type mesh__D018459sskos__Concept
% 211.25/211.45 |- mesh__dateRevised mesh__D018459 2005-07-01
% 211.25/211.45 |- mesh__dateCreated mesh__D018459 1994-04-16
% 211.25/211.45 |- skos__historyNote mesh__D018459 Skin Diseases %28%1966-1992%29%
% 211.25/211.45 |- mesh__dateEstablished mesh__D018459 1995-01-01
% 211.25/211.45 |- skos__historyNote mesh__D018459 Lichenoid Eruptions %28%1993-1994%29%
% 211.25/211.45 |- mesh__recordMaintainer mesh__D018459 sjn
% 211.25/211.45 |- mesh__recordOriginator mesh__D018459 TGC
% 211.25/211.45 |- skos__broader mesh__D018459smesh__D017512
% 211.25/211.45 |- skos__altLabel mesh__D018459 Lichen Sclerosus
% 211.25/211.45 |- skos__annotation mesh__D018459
% 211.25/211.45 a skin dis; do not confuse with lichen planus atrophicus %28%index under LICHEN PLANUS%29%; DF: note short X ref%A%
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D018459 95
% 211.25/211.45 |- skos__prefLabel mesh__D018459 Lichen Sclerosus et Atrophicus
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D018459 sjn
% 211.25/211.45 |- mesh__historyNote mesh__D018459 95
% 211.25/211.45 |- skos__scopeNote mesh__D018459
% 211.25/211.45 A chronic, atrophic skin disease characterized by white, angular, flat, well-defined, indurated papules with an erythematous halo and follicular, black, keratotic plugs. It is the most common cause of VULVAR LICHEN SCLEROSUS in females and balanitis xerotica obliterans in males. It is called also white spot disease and Csillag%27%s disease. %28%Dorland, 27th ed%29%%A%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D018459 2006
% 211.25/211.45 |- mesh__recordMaintainer mesh__D010476 ssb
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D010476 sjn
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D010476 2006
% 211.25/211.45 |- skos__annotation mesh__D010476
% 211.25/211.45 IM; coord with specific substance if pertinent %28%IM%29%; D25-26 qualif%A%
% 211.25/211.45 |- skos__broader mesh__D010476smesh__D003358
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D010476 2005
% 211.25/211.45 |- mesh__dateCreated mesh__D010476 1999-01-01
% 211.25/211.45 |- rdf__type mesh__D010476sskos__Concept
% 211.25/211.45 |- skos__prefLabel mesh__D010476 Perfume
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D010476 2004
% 211.25/211.45 |- skos__scopeNote mesh__D010476
% 211.25/211.45 A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell, especially a fluid containing fragrant natural oils extracted from flowers, woods, etc., or similar synthetic oils. %28%Random House Unabridged Dictionary, 2d ed%29%%A%
% 211.25/211.45 |- mesh__recordOriginator mesh__D010476 NLM
% 211.25/211.45 |- mesh__dateRevised mesh__D010476 2003-07-09
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D029181 2002
% 211.25/211.45 |- rdf__type mesh__D029181sskos__Concept
% 211.25/211.45 |- skos__scopeNote mesh__D029181
% 211.25/211.45 Sensitivity or attachment to religious values, or to things of the spirit as opposed to material or worldly interests. %28%from Merriam-Webster%27%s Collegiate Dictionary, 10th ed, and Oxford English Dictionary, 2nd ed%29%%A%
% 211.25/211.45 |- mesh__dateEstablished mesh__D029181 2002-01-01
% 211.25/211.45 |- mesh__dateCreated mesh__D029181 2001-07-25
% 211.25/211.45 |- mesh__historyNote mesh__D029181 2002
% 211.25/211.45 |- skos__broader mesh__D029181smesh__D012069
% 211.25/211.45 |- skos__related mesh__D029181smesh__D026443
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D029181 2003
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D029181 2002
% 211.25/211.45 |- skos__hiddenLabel mesh__D029181 Spiritualities
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D029181 2005
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D029181 2004
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D029181 2006
% 211.25/211.45 |- skos__prefLabel mesh__D029181 Spirituality
% 211.25/211.45 |- mesh__dateEstablished mesh__D004439 1991-01-01
% 211.25/211.45 |- mesh__dateRevised mesh__D004439 2002-07-03
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D004439 2004
% 211.25/211.45 |- skos__hiddenLabel mesh__D004439 Gland, Eccrine
% 211.25/211.45 |- mesh__historyNote mesh__D004439
% 211.25/211.45 91%28%75%29%; was see under SWEAT GLANDS 1975-90
% 211.25/211.45 |- mesh__dateCreated mesh__D004439 1999-01-01
% 211.25/211.45 |- mesh__recordOriginator mesh__D004439 NLM
% 211.25/211.45 |- skos__annotation mesh__D004439
% 211.25/211.45 /secret: see also SWEAT or SWEATING: TN 181
% 211.25/211.45 |- skos__scopeNote mesh__D004439
% 211.25/211.45 Simple sweat glands that secrete sweat directly onto the SKIN.%A%
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D004439 sjn
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D004439 2003
% 211.25/211.45 |- mesh__recordMaintainer mesh__D004439 NNS
% 211.25/211.45 |- skos__hiddenLabel mesh__D004439 Glands, Eccrine
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D004439
% 211.25/211.45 91; was see under SWEAT GLANDS 1975-90
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D004439 2006
% 211.25/211.45 |- mesh__onlineNote mesh__D004439 search SWEAT GLANDS 1971-74
% 211.25/211.45 |- rdf__type mesh__D004439sskos__Concept
% 211.25/211.45 |- skos__hiddenLabel mesh__D004439 Eccrine Gland
% 211.25/211.45 |- skos__prefLabel mesh__D004439 Eccrine Glands
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D004439 2005
% 211.25/211.45 |- skos__broader mesh__D004439smesh__D013545
% 211.25/211.45 |- mesh__publicMeSHNote mesh__D015161 1989
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Dementias, Multiinfarct
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D015161 sjn
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Multiinfarct Dementias
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Multiinfarct Dementia
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Multi-Infarct Dementias
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Multi Infarct Dementia
% 211.25/211.45 |- rdf__type mesh__D015161sskos__Concept
% 211.25/211.45 |- mesh__dateCreated mesh__D015161 1988-04-06
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Dementias, Multi-Infarct
% 211.25/211.45 |- skos__prefLabel mesh__D015161 Dementia, Multi-Infarct
% 211.25/211.45 |- mesh__historyNote mesh__D015161 1989
% 211.25/211.45 |- skos__altLabel mesh__D015161 Dementia, Multiinfarct
% 211.25/211.45 |- mesh__dateEstablished mesh__D015161 1989-01-01
% 211.25/211.45 |- mesh__recordOriginator mesh__D015161 EC
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Dementias, Lacunar
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Dementia, Lacunar
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Dementia, Multi Infarct
% 211.25/211.45 |- skos__hiddenLabel mesh__D015161 Lacunar Dementias
% 211.25/211.45 |- mesh__recordMaintainer mesh__D015161 ssb
% 211.25/211.45 |- skos__broader mesh__D015161smesh__D015140
% 211.25/211.45 |- skos__altLabel mesh__D015161 Multi-Infarct Dementia
% 211.25/211.45 |- skos__historyNote mesh__D015161 Dementia %28%1981-1988%29%
% 211.25/211.45 |- mesh__dateRevised mesh__D015161 2005-06-30
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D015161 2006
% 211.25/211.45 |- skos__broader mesh__D015161smesh__D002544
% 211.25/211.45 |- skos__scopeNote mesh__D015161
% 211.25/211.45 Loss of higher cortical functions with retained awareness due to multiple cortical or subcortical CEREBRAL INFARCTION. Memory, judgment, attention span, and impulse control are often impaired, and may be accompanied by PSEUDOBULBAR PALSY; HEMIPARESIS; reflex abnormalities, and other signs of localized neurologic dysfunction. %28%From Adams et al., Principles of Neurology, 6th ed, p1060%29%%A%
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009922 2005
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009922 2002
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009922 1998
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009922 2006
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009922 2003
% 211.25/211.45 |- mesh__recordAuthorizer mesh__D009922 SJN
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009922 1999
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009922 2004
% 211.25/211.45 |- skos__broader mesh__D009922smesh__D015205
% 211.25/211.45 |- mesh__recordMaintainer mesh__D009922 PXP
% 211.25/211.45 |- skos__broader mesh__D009922smesh__D019601
% 211.25/211.45 |- skos__prefLabel mesh__D009922 Oregon
% 211.25/211.45 |- rdf__type mesh__D009922sskos__Concept
% 211.25/211.45 |- mesh__recordOriginator mesh__D009922 NLM
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009922 2000
% 211.25/211.45 |- mesh__dateCreated mesh__D009922 1999-01-01
% 211.25/211.45 |- mesh__dateRevised mesh__D009922 1997-06-20
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009922 2001
% 211.25/211.45 |- skos__hiddenLabel mesh__D009124 Proteins, Muscle
% 211.25/211.45 |- mesh__activeMeSHYear mesh__D009124 2006
% 211.25/211.45 |- mesh__recordOriginator mesh__D009124 NLM
% 211.25/211.45 |- skos__altLabel mesh__D009124 Muscle Protein
% 211.25/211.45 |- skos__hiddenLabel mesh__D009124 Protein, Muscle
% 211.25/211.46 |- skos__scopeNote mesh__D009124
% 211.25/211.46 The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN.%A%
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D009124 sjn
% 211.25/211.46 |- rdf__type mesh__D009124sskos__Concept
% 211.25/211.46 |- skos__broader mesh__D009124smesh__D003285
% 211.25/211.46 |- skos__annotation mesh__D009124
% 211.25/211.46 /biosyn /drug eff /physiol permitted; for contractile proteins in muscle, index only under MUSCLE PROTEINS or specifics %26% not also under CONTRACTILE PROTEINS%A%
% 211.25/211.46 |- mesh__dateRevised mesh__D009124 2005-06-30
% 211.25/211.46 |- mesh__recordMaintainer mesh__D009124 SYSTEM
% 211.25/211.46 |- skos__prefLabel mesh__D009124 Muscle Proteins
% 211.25/211.46 |- mesh__dateCreated mesh__D009124 1999-01-01
% 211.25/211.46 |- skos__altLabel mesh__D001141 Estrogen Synthase
% 211.25/211.46 |- mesh__recordMaintainer mesh__D001141 ssb
% 211.25/211.46 |- rdf__type mesh__D001141sskos__Concept
% 211.25/211.46 |- skos__prefLabel mesh__D001141 Aromatase
% 211.25/211.46 |- mesh__historyNote mesh__D001141
% 211.25/211.46 86%28%75%29%; was see under OXIDOREDUCTASES 1975-85
% 211.25/211.46 |- skos__altLabel mesh__D001141 CYP19
% 211.25/211.46 |- mesh__dateCreated mesh__D001141 1974-11-19
% 211.25/211.46 |- skos__altLabel mesh__D001141 Estrogen Synthetase
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D001141
% 211.25/211.46 86; was see under OXIDOREDUCTASES 1975-85
% 211.25/211.46 |- skos__altLabel mesh__D001141 Cytochrome P-450 CYP19
% 211.25/211.46 |- skos__altLabel mesh__D001141 Androstenedione Aromatase
% 211.25/211.46 |- skos__historyNote mesh__D001141 Estrogens %28%1972-1974%29%
% 211.25/211.46 |- skos__historyNote mesh__D001141 Androstanes %28%1972-1974%29%
% 211.25/211.46 |- skos__altLabel mesh__D001141 CYP19 Protein
% 211.25/211.46 |- skos__broader mesh__D001141smesh__D013250
% 211.25/211.46 |- skos__hiddenLabel mesh__D001141 Cytochrome P 450 CYP19
% 211.25/211.46 |- mesh__dateEstablished mesh__D001141 1986-01-01
% 211.25/211.46 |- skos__altLabel mesh__D001141 P450AROM
% 211.25/211.46 |- skos__hiddenLabel mesh__D001141 Aromatase, Androstenedione
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D001141 2006
% 211.25/211.46 |- mesh__recordOriginator mesh__D001141 NLM
% 211.25/211.46 |- skos__altLabel mesh__D001141 Cytochrome P450 19
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D001141 sjn
% 211.25/211.46 |- skos__altLabel mesh__D001141 Cytochrome P-450%28%AROM%29%
% 211.25/211.46 |- skos__historyNote mesh__D001141 Oxidoreductases %28%1972-1974%29%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D001141 2005
% 211.25/211.46 |- mesh__dateRevised mesh__D001141 2004-07-07
% 211.25/211.46 |- skos__scopeNote mesh__D001141
% 211.25/211.46 An enzyme that catalyzes the desaturation %28%aromatization%29% of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system.%A%
% 211.25/211.46 |- skos__altLabel mesh__D001141 CYP 19
% 211.25/211.46 |- skos__hiddenLabel mesh__D001141 Protein, CYP19
% 211.25/211.46 |- skos__hiddenLabel mesh__D014867 Hydrogen Oxides
% 211.25/211.46 |- mesh__dateRevised mesh__D014867 1995-06-09
% 211.25/211.46 |- skos__hiddenLabel mesh__D014867 Oxides, Hydrogen
% 211.25/211.46 |- skos__prefLabel mesh__D014867 Water
% 211.25/211.46 |- skos__scopeNote mesh__D014867
% 211.25/211.46 Water. A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 2003
% 211.25/211.46 |- skos__annotation mesh__D014867
% 211.25/211.46 note category: D1 as H2O, G3 as environmental; in body or tissue = BODY WATER; /admin: consider also FLUID THERAPY or INFUSIONS, PARENTERAL or REHYDRATION SOLUTIONS; /adv eff: consider also WATER INTOXICATION; /metab must refer to metab of exogenous water: for water content of organs %26% tissue use BODY WATER /metab or BODY WATER /chem; /stand: consider also WATER SUPPLY; /ther use: try HYDROTHERAPY %26% related terms; /microbiol = WATER MICROBIOLOGY %28%IM%29% + specific microbe %28%IM%29%, /parasitol permitted: coord IM with specific parasite %28%IM%29%, /virol = WATER MICROBIOLOGY %28%IM%29% + specific virus %28%IM%29%; atmospheric water = HUMIDITY; heavy water = DEUTERIUM OXIDE; water intake = DRINKING; hardness or softness of water: probably WATER /chem %26% not also HARDNESS but consider also WATER SOFTENING; water consumption = WATER or WATER SUPPLY if on a wide scale: on a personal level = DRINKING%A%
% 211.25/211.46 |- rdf__type mesh__D014867sskos__Concept
% 211.25/211.46 |- skos__broader mesh__D014867smesh__D004777
% 211.25/211.46 |- skos__related mesh__D014867smesh__D012623
% 211.25/211.46 |- skos__hiddenLabel mesh__D014867 Oxide, Hydrogen
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D014867 PLS
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 1999
% 211.25/211.46 |- skos__related mesh__D014867smesh__D008900
% 211.25/211.46 |- mesh__recordMaintainer mesh__D014867 PLS
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 1998
% 211.25/211.46 |- mesh__recordOriginator mesh__D014867 NLM
% 211.25/211.46 |- skos__altLabel mesh__D014867 Hydrogen Oxide
% 211.25/211.46 |- skos__related mesh__D014867smesh__D005618
% 211.25/211.46 |- skos__broader mesh__D014867smesh__D010087
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 1997
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 2006
% 211.25/211.46 |- skos__related mesh__D014867smesh__D001834
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 2002
% 211.25/211.46 |- skos__hiddenLabel mesh__D014867 Waters
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 1996
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 2005
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 2001
% 211.25/211.46 |- mesh__dateCreated mesh__D014867 1999-01-01
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 2004
% 211.25/211.46 |- skos__broader mesh__D014867smesh__D006878
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014867 2000
% 211.25/211.46 |- mesh__dateCreated mesh__D014069 1999-01-01
% 211.25/211.46 |- rdf__type mesh__D014069sskos__Concept
% 211.25/211.46 |- skos__scopeNote mesh__D014069
% 211.25/211.46 Inflammation of the tonsils, especially the palatine tonsils. It is often caused by a bacterium. Tonsillitis may be acute, chronic, or recurrent.%A%
% 211.25/211.46 |- mesh__recordMaintainer mesh__D014069 TGC
% 211.25/211.46 |- skos__broader mesh__D014069smesh__D010608
% 211.25/211.46 |- skos__hiddenLabel mesh__D014069 Tonsillitides
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 1994
% 211.25/211.46 |- mesh__recordOriginator mesh__D014069 NLM
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 2005
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 1995
% 211.25/211.46 |- skos__annotation mesh__D014069
% 211.25/211.46 coord IM with infection %28%IM%29% if specified; lingual tonsillitis: coord IM with TONGUE %28%NIM%29%%A%
% 211.25/211.46 |- skos__broader mesh__D014069smesh__D012141
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 2000
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 1993
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 2006
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 1998
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 2003
% 211.25/211.46 |- mesh__dateRevised mesh__D014069 1992-05-22
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 2001
% 211.25/211.46 |- skos__prefLabel mesh__D014069 Tonsillitis
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 2004
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 1999
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D014069 PLS
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 1996
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 2002
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014069 1997
% 211.25/211.46 |- skos__prefLabel mesh__D000847 Annual Reports
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D000847 2006
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D000847 sjn
% 211.25/211.46 |- skos__broader mesh__D000847smesh__D009934
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D000847 2003
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D000847
% 211.25/211.46 91; was see under ORGANIZATION AND ADMINISTRATION 1977-90%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D000847 2005
% 211.25/211.46 |- skos__annotation mesh__D000847
% 211.25/211.46 NIM; no qualif; coord with specific organiz or society %28%IM%29% + geog; do not confuse with Publication Type ANNUAL REPORTS%A%
% 211.25/211.46 |- mesh__dateEstablished mesh__D000847 1991-01-01
% 211.25/211.46 |- skos__hiddenLabel mesh__D000847 Reports, Annual
% 211.25/211.46 |- skos__scopeNote mesh__D000847
% 211.25/211.46 Annual statements reviewing the status of the administrative and operational functions and accomplishments of an institution or organization.%A%
% 211.25/211.46 |- mesh__dateCreated mesh__D000847 1977-05-05
% 211.25/211.46 |- mesh__historyNote mesh__D000847
% 211.25/211.46 91%28%Aug 77%29%; was see under ORGANIZATION AND ADMINISTRATION 1977-90%A%
% 211.25/211.46 |- skos__hiddenLabel mesh__D000847 Report, Annual
% 211.25/211.46 |- mesh__dateRevised mesh__D000847 2002-07-24
% 211.25/211.46 |- mesh__recordMaintainer mesh__D000847 sjn
% 211.25/211.46 |- mesh__recordOriginator mesh__D000847 EC
% 211.25/211.46 |- skos__hiddenLabel mesh__D000847 Annual Report
% 211.25/211.46 |- rdf__type mesh__D000847sskos__Concept
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D000847 2004
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D019552 97
% 211.25/211.46 |- rdf__type mesh__D019552sskos__Concept
% 211.25/211.46 |- skos__hiddenLabel mesh__D019552 Infection Controls, Dental
% 211.25/211.46 |- skos__altLabel mesh__D019552 Dental Infection Control
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 2005
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 1999
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 2001
% 211.25/211.46 |- skos__annotation mesh__D019552
% 211.25/211.46 prev of infect in dent health facilities, not prev of tooth infect in mouth; DF: INFECT CONTROL DENT%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 2004
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 2000
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 1998
% 211.25/211.46 |- skos__scopeNote mesh__D019552
% 211.25/211.46 Efforts to prevent and control the spread of infections within dental health facilities or those involving provision of dental care.%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 2003
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 1997
% 211.25/211.46 |- skos__broader mesh__D019552smesh__D017053
% 211.25/211.46 |- skos__prefLabel mesh__D019552 Infection Control, Dental
% 211.25/211.46 |- skos__hiddenLabel mesh__D019552 Dental Infection Controls
% 211.25/211.46 |- skos__broader mesh__D019552smesh__D003813
% 211.25/211.46 |- skos__hiddenLabel mesh__D019552 Control, Dental Infection
% 211.25/211.46 |- skos__historyNote mesh__D019552 Infection Control %28%1990-1996%29%
% 211.25/211.46 |- mesh__dateCreated mesh__D019552 1996-06-13
% 211.25/211.46 |- mesh__dateEstablished mesh__D019552 1997-01-01
% 211.25/211.46 |- mesh__historyNote mesh__D019552 97
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 2006
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019552 2002
% 211.25/211.46 |- skos__hiddenLabel mesh__D019552 Controls, Dental Infection
% 211.25/211.46 |- mesh__dateEstablished mesh__D000049 1974-01-01
% 211.25/211.46 |- mesh__recordMaintainer mesh__D000049 ags
% 211.25/211.46 |- skos__broader mesh__D000049smesh__D006376
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D000049 2006
% 211.25/211.46 |- mesh__dateRevised mesh__D000049 2003-07-09
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D000049 2005
% 211.25/211.46 |- mesh__historyNote mesh__D000049 74; was see under HELMINTHS 1963-73
% 211.25/211.46 |- rdf__type mesh__D000049sskos__Concept
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D000049 sjn
% 211.25/211.46 |- mesh__onlineNote mesh__D000049 search HELMINTHS 1966-73
% 211.25/211.46 |- skos__annotation mesh__D000049
% 211.25/211.46 infection: coord IM with HELMINTHIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 211.25/211.46 |- skos__altLabel mesh__D000049 Thorny-Headed Worms
% 211.25/211.46 |- mesh__recordOriginator mesh__D000049 NLM
% 211.25/211.46 |- skos__scopeNote mesh__D000049
% 211.25/211.46 A phylum of parasitic worms, closely related to tapeworms and containing two genera: Moniliformis, which sometimes infects man, and Macracanthorhynchus, which infects swine.%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D000049 2004
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D000049
% 211.25/211.46 74; was see under HELMINTHS 1963-73
% 211.25/211.46 |- mesh__dateCreated mesh__D000049 1999-01-01
% 211.25/211.46 |- skos__prefLabel mesh__D000049 Acanthocephala
% 211.25/211.46 |- skos__prefLabel mesh__D005532 Foot Deformities, Congenital
% 211.25/211.46 |- rdf__type mesh__D005532sskos__Concept
% 211.25/211.46 |- mesh__dateEstablished mesh__D005532 1988-01-01
% 211.25/211.46 |- skos__annotation mesh__D005532
% 211.25/211.46 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D005532 2004
% 211.25/211.46 |- skos__altLabel mesh__D005532 Deformity, Congenital Foot
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D005532 sjn
% 211.25/211.46 |- skos__altLabel mesh__D005532 Foot Deformity, Congenital
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D005532 2006
% 211.25/211.46 |- mesh__recordOriginator mesh__D005532 EC
% 211.25/211.46 |- skos__altLabel mesh__D005532 Congenital Foot Deformity
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D005532 2003
% 211.25/211.46 |- skos__altLabel mesh__D005532 Deformities, Congenital Foot
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D005532 2005
% 211.25/211.46 |- skos__altLabel mesh__D005532 Congenital Foot Deformities
% 211.25/211.46 |- skos__broader mesh__D005532smesh__D017880
% 211.25/211.46 |- mesh__dateRevised mesh__D005532 2002-07-03
% 211.25/211.46 |- skos__scopeNote mesh__D005532
% 211.25/211.46 Alterations or deviations from normal shape or size which result in a disfigurement of the foot occurring at or before birth.%A%
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D005532 88
% 211.25/211.46 |- mesh__recordMaintainer mesh__D005532 kle
% 211.25/211.46 |- mesh__dateCreated mesh__D005532 1987-04-02
% 211.25/211.46 |- mesh__historyNote mesh__D005532 88
% 211.25/211.46 |- skos__broader mesh__D005532smesh__D005530
% 211.25/211.46 |- skos__broader mesh__D005532smesh__D038061
% 211.25/211.46 |- mesh__historyNote mesh__D046949 2005
% 211.25/211.46 |- skos__prefLabel mesh__D046949 Thermotoga neapolitana
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D046949 2006
% 211.25/211.46 |- mesh__dateCreated mesh__D046949 2004-07-07
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D046949 2005
% 211.25/211.46 |- mesh__dateEstablished mesh__D046949 2005-01-01
% 211.25/211.46 |- skos__historyNote mesh__D046949
% 211.25/211.46 Gram-Negative Anaerobic Straight, Curved, and Helical Rods %28%1998-2004%29%
% 211.25/211.46 |- skos__broader mesh__D046949smesh__D016965
% 211.25/211.46 |- mesh__recordOriginator mesh__D046949 ags
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D046949 sjn
% 211.25/211.46 |- skos__historyNote mesh__D046949
% 211.25/211.46 Gram-Negative Anaerobic Bacteria %28%1993-1998%29%
% 211.25/211.46 |- mesh__dateRevised mesh__D046949 2005-06-30
% 211.25/211.46 |- mesh__recordMaintainer mesh__D046949 SYSTEM
% 211.25/211.46 |- skos__scopeNote mesh__D046949
% 211.25/211.46 A species of extremophilic bacteria in the family Thermotogaceae. Generally anaerobic but in the presence of OXYGEN, it can produce hydrogen gas as a byproduct of metabolism.%A%
% 211.25/211.46 |- rdf__type mesh__D046949sskos__Concept
% 211.25/211.46 |- mesh__recordOriginator mesh__D010477 NLM
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 1993
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 1998
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 2006
% 211.25/211.46 |- skos__prefLabel mesh__D010477 Perfusion
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 1997
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 2005
% 211.25/211.46 |- mesh__recordMaintainer mesh__D010477 TAP
% 211.25/211.46 |- skos__annotation mesh__D010477
% 211.25/211.46 note category; a technique: not for perfusion of blood through a vessel %28% = a circulation concept%29%; REPERFUSION is available for restoration of blood supply to tissue %26% MYOCARDIAL REPERFUSION for heart%A%
% 211.25/211.46 |- mesh__dateCreated mesh__D010477 1999-01-01
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 2002
% 211.25/211.46 |- rdf__type mesh__D010477sskos__Concept
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 1996
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 2004
% 211.25/211.46 |- skos__broader mesh__D010477smesh__D008919
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 2001
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 2003
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D010477 PLS
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 2000
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 1995
% 211.25/211.46 |- skos__hiddenLabel mesh__D010477 Perfusions
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 1999
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D010477 1994
% 211.25/211.46 |- mesh__dateRevised mesh__D010477 1992-05-15
% 211.25/211.46 |- skos__altLabel mesh__D015162 Micronucleus Assays
% 211.25/211.46 |- mesh__dateRevised mesh__D015162 2004-07-07
% 211.25/211.46 |- mesh__recordMaintainer mesh__D015162 nns
% 211.25/211.46 |- skos__historyNote mesh__D015162 Cell Nucleus %28%1971-1988%29%
% 211.25/211.46 |- skos__annotation mesh__D015162 NIM
% 211.25/211.46 |- skos__hiddenLabel mesh__D015162 Micronucleus Assay
% 211.25/211.46 |- rdf__type mesh__D015162sskos__Concept
% 211.25/211.46 |- skos__hiddenLabel mesh__D015162 Assays, Micronucleus
% 211.25/211.46 |- skos__hiddenLabel mesh__D015162 Micronucleus Test
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D015162 89
% 211.25/211.46 |- skos__prefLabel mesh__D015162 Micronucleus Tests
% 211.25/211.46 |- mesh__dateEstablished mesh__D015162 1989-01-01
% 211.25/211.46 |- mesh__dateCreated mesh__D015162 1988-04-06
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D015162 sjn
% 211.25/211.46 |- mesh__recordOriginator mesh__D015162 SCD
% 211.25/211.46 |- skos__hiddenLabel mesh__D015162 Tests, Micronucleus
% 211.25/211.46 |- mesh__historyNote mesh__D015162 89
% 211.25/211.46 |- skos__historyNote mesh__D015162 Mutagenicity Tests %28%1981-1988%29%
% 211.25/211.46 |- skos__historyNote mesh__D015162 Genetic Techniques %28%1972-1980%29%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D015162 2005
% 211.25/211.46 |- skos__related mesh__D015162smesh__D048629
% 211.25/211.46 |- skos__broader mesh__D015162smesh__D009152
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D015162 2006
% 211.25/211.46 |- skos__scopeNote mesh__D015162
% 211.25/211.46 Induction and quantitative measurement of chromosomal damage leading to the formation of micronuclei %28%MICRONUCLEI, CHROMOSOME-DEFECTIVE%29% in cells which have been exposed to genotoxic agents or IONIZING RADIATION.%A%
% 211.25/211.46 |- skos__hiddenLabel mesh__D015162 Assay, Micronucleus
% 211.25/211.46 |- skos__hiddenLabel mesh__D015162 Test, Micronucleus
% 211.25/211.46 |- mesh__dateCreated mesh__D009923 1974-12-12
% 211.25/211.46 |- skos__altLabel mesh__D009923 Sheep Contagious Pustular Dermatitis Virus
% 211.25/211.46 |- skos__altLabel mesh__D009923 Contagious Ecthyma Virus of Sheep
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 ecthyma viruses, Contagious
% 211.25/211.46 |- mesh__recordOriginator mesh__D009923 NLM
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 viruses, Contagious ecthyma
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 Viruses, Ecthyma contagiosum
% 211.25/211.46 |- skos__prefLabel mesh__D009923 Orf virus
% 211.25/211.46 |- skos__broader mesh__D009923smesh__D018157
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D009923
% 211.25/211.46 91; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D009923 2004
% 211.25/211.46 |- mesh__dateRevised mesh__D009923 2001-07-25
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 virus, Contagious ecthyma
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D009923 2006
% 211.25/211.46 |- skos__annotation mesh__D009923
% 211.25/211.46 infection = ECTHYMA, CONTAGIOUS but see note there
% 211.25/211.46 |- mesh__dateEstablished mesh__D009923 1991-01-01
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 Virus, Ecthyma contagiosum
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D009923 2003
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 virus, Orf
% 211.25/211.46 |- skos__altLabel mesh__D009923 Sheep Contagious Ecthyma Virus
% 211.25/211.46 |- mesh__historyNote mesh__D009923
% 211.25/211.46 91%28%75%29%; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D009923 2005
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D009923 sjn
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 ecthyma virus, Contagious
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 Orf viruses
% 211.25/211.46 |- skos__altLabel mesh__D009923 Ecthyma contagiosum Virus
% 211.25/211.46 |- skos__altLabel mesh__D009923
% 211.25/211.46 Contagious Pustular Dermatitis Virus of Sheep
% 211.25/211.46 |- rdf__type mesh__D009923sskos__Concept
% 211.25/211.46 |- skos__altLabel mesh__D009923 Contagious ecthyma virus
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 viruses, Orf
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D009923 2002
% 211.25/211.46 |- skos__altLabel mesh__D009923 Contagious pustular dermatitis virus
% 211.25/211.46 |- mesh__recordMaintainer mesh__D009923 ags
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 Contagious ecthyma viruses
% 211.25/211.46 |- skos__hiddenLabel mesh__D009923 Ecthyma contagiosum Viruses
% 211.25/211.46 |- skos__scopeNote mesh__D009923
% 211.25/211.46 The type species of PARAPOXVIRUS which causes a skin infection in natural hosts, usually young sheep. Humans may contract local skin lesions by contact. The virus apparently persists in soil.%A%
% 211.25/211.46 |- mesh__considerAlso mesh__D001940
% 211.25/211.46 consider also terms at MAMMA- and MAST-
% 211.25/211.46 |- skos__hiddenLabel mesh__D001940 Breasts
% 211.25/211.46 |- mesh__recordMaintainer mesh__D001940 lkt
% 211.25/211.46 |- skos__related mesh__D001940smesh__D008321
% 211.25/211.46 |- rdf__type mesh__D001940sskos__Concept
% 211.25/211.46 |- skos__scopeNote mesh__D001940
% 211.25/211.46 In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.%A%
% 211.25/211.46 |- skos__related mesh__D001940smesh__D016462
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D001940 2006
% 211.25/211.46 |- skos__related mesh__D001940smesh__D008327
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D001940 sjn
% 211.25/211.46 |- mesh__dateRevised mesh__D001940 2003-07-09
% 211.25/211.46 |- skos__broader mesh__D001940smesh__D001829
% 211.25/211.46 |- skos__prefLabel mesh__D001940 Breast
% 211.25/211.46 |- skos__annotation mesh__D001940
% 211.25/211.46 human only; animal is MAMMARY GLANDS, ANIMAL; /surg: consider also MASTECTOMY %26% MAMMAPLASTY; inflammation = MASTITIS; tuberc of breast = MASTITIS %28%IM%29% + TUBERCULOSIS %28%IM%29%, not TUBERCULOSIS, ENDOCRINE; self-examination = BREAST SELF-EXAMINATION%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D001940 2004
% 211.25/211.46 |- mesh__recordOriginator mesh__D001940 NLM
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D001940 2005
% 211.25/211.46 |- skos__related mesh__D001940smesh__D008408
% 211.25/211.46 |- skos__related mesh__D001940smesh__D007774
% 211.25/211.46 |- mesh__dateCreated mesh__D001940 1999-01-01
% 211.25/211.46 |- mesh__recordMaintainer mesh__D009125 ssb
% 211.25/211.46 |- skos__prefLabel mesh__D009125 Muscle Relaxants, Central
% 211.25/211.46 |- mesh__dateRevised mesh__D009125 2005-06-30
% 211.25/211.46 |- rdf__type mesh__D009125sskos__Concept
% 211.25/211.46 |- skos__altLabel mesh__D009125 Centrally Acting Muscle Relaxants
% 211.25/211.46 |- skos__scopeNote mesh__D009125
% 211.25/211.46 A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p358%29%%A%
% 211.25/211.46 |- skos__annotation mesh__D009125
% 211.25/211.46 GEN or unspecified; prefer specifics; refers to skeletal muscle relaxants only: smooth muscle relaxants = PARASYMPATHOLYTICS%A%
% 211.25/211.46 |- mesh__dateCreated mesh__D009125 1999-01-01
% 211.25/211.46 |- skos__broader mesh__D009125smesh__D002491
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D009125 2006
% 211.25/211.46 |- mesh__onlineNote mesh__D009125
% 211.25/211.46 search MUSCLE RELAXANTS under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 %26% MUSCLES 1966-69%A%
% 211.25/211.46 |- mesh__historyNote mesh__D009125
% 211.25/211.46 70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69%A%
% 211.25/211.46 |- skos__hiddenLabel mesh__D009125 Relaxants, Central Muscle
% 211.25/211.46 |- mesh__recordOriginator mesh__D009125 NLM
% 211.25/211.46 |- skos__hiddenLabel mesh__D009125 Central Muscle Relaxants
% 211.25/211.46 |- skos__historyNote mesh__D009125 Muscles %28%1966-1969%29%
% 211.25/211.46 |- mesh__dateEstablished mesh__D009125 1970-01-01
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D009125
% 211.25/211.46 70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69%A%
% 211.25/211.46 |- skos__broader mesh__D009125smesh__D045505
% 211.25/211.46 |- skos__broader mesh__D009125smesh__D009465
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D009125 sjn
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D001142 sjn
% 211.25/211.46 |- skos__altLabel mesh__D001142 5-HTPase
% 211.25/211.46 |- mesh__recordMaintainer mesh__D001142 ssb
% 211.25/211.46 |- mesh__dateCreated mesh__D001142 1979-02-21
% 211.25/211.46 |- skos__hiddenLabel mesh__D001142 Aromatic L Amino Acid Decarboxylases
% 211.25/211.46 |- skos__altLabel mesh__D001142 Hydroxytryptophan Decarboxylase
% 211.25/211.46 |- mesh__recordOriginator mesh__D001142 RLS
% 211.25/211.46 |- skos__altLabel mesh__D001142 Amino Acid Decarboxylases, Aromatic
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D001142 2004
% 211.25/211.46 |- skos__altLabel mesh__D001142 Aromatic Amino Acid Decarboxylases
% 211.25/211.46 |- skos__altLabel mesh__D001142 5-Hydroxytryptophan Decarboxylase
% 211.25/211.46 |- skos__hiddenLabel mesh__D001142 Decarboxylase, Tryptophan
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D001142 2006
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D001142
% 211.25/211.46 98; see AROMATIC AMINO ACID DECARBOXYLASES 1980-97
% 211.25/211.46 |- mesh__historyNote mesh__D001142 98%28%80%29%
% 211.25/211.46 |- skos__hiddenLabel mesh__D001142 Decarboxylase, 5-Hydroxytryptophan
% 211.25/211.46 |- skos__altLabel mesh__D001142 Tryptophan Decarboxylase
% 211.25/211.46 |- skos__hiddenLabel mesh__D001142 Decarboxylases, Aromatic-L-Amino-Acid
% 211.25/211.46 |- skos__historyNote mesh__D001142 Dopa Decarboxylase %28%1966-1979%29%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D001142 2005
% 211.25/211.46 |- skos__hiddenLabel mesh__D001142 5 Hydroxytryptophan Decarboxylase
% 211.25/211.46 |- skos__scopeNote mesh__D001142
% 211.25/211.46 An enzyme group with broad specificity. The enzymes decarboxylate a range of aromatic amino acids including dihydroxyphenylalanine %28%DOPA DECARBOXYLASE%29%, tryptophan, and hydroxytryptophan. EC 4.1.1.28.%A%
% 211.25/211.46 |- rdf__type mesh__D001142sskos__Concept
% 211.25/211.46 |- skos__broader mesh__D001142smesh__D002262
% 211.25/211.46 |- skos__annotation mesh__D001142 DF: AAAD
% 211.25/211.46 |- skos__prefLabel mesh__D001142 Aromatic-L-Amino-Acid Decarboxylases
% 211.25/211.46 |- skos__hiddenLabel mesh__D001142 Decarboxylase, Hydroxytryptophan
% 211.25/211.46 |- skos__hiddenLabel mesh__D001142 5 HTPase
% 211.25/211.46 |- mesh__dateEstablished mesh__D001142 1980-01-01
% 211.25/211.46 |- mesh__dateRevised mesh__D001142 2003-07-09
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 1993
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 2002
% 211.25/211.46 |- skos__historyNote mesh__D014868 Motivation %28%1966-1968%29%
% 211.25/211.46 |- skos__annotation mesh__D014868
% 211.25/211.46 human %26% animal; /physiol permitted for physiol %26% metab eff%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 1997
% 211.25/211.46 |- skos__hiddenLabel mesh__D014868 Water Deprivations
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 1992
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 2006
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 2001
% 211.25/211.46 |- mesh__dateEstablished mesh__D014868 1969-01-01
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 1996
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 2005
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 2000
% 211.25/211.46 |- mesh__recordMaintainer mesh__D014868 TGC
% 211.25/211.46 |- skos__broader mesh__D014868smesh__D009042
% 211.25/211.46 |- mesh__dateRevised mesh__D014868 1991-06-20
% 211.25/211.46 |- mesh__dateCreated mesh__D014868 1999-01-01
% 211.25/211.46 |- skos__scopeNote mesh__D014868
% 211.25/211.46 The withholding of water in a structured experimental situation.%A%
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 2004
% 211.25/211.46 |- mesh__recordAuthorizer mesh__D014868 PLS
% 211.25/211.46 |- skos__prefLabel mesh__D014868 Water Deprivation
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 2003
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 1995
% 211.25/211.46 |- rdf__type mesh__D014868sskos__Concept
% 211.25/211.46 |- skos__related mesh__D014868smesh__D013894
% 211.25/211.46 |- skos__hiddenLabel mesh__D014868 Deprivations, Water
% 211.25/211.46 |- mesh__recordOriginator mesh__D014868 NLM
% 211.25/211.46 |- skos__hiddenLabel mesh__D014868 Deprivation, Water
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 1999
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 1994
% 211.25/211.46 |- skos__historyNote mesh__D014868 Thirst %28%1966-1968%29%
% 211.25/211.46 |- mesh__historyNote mesh__D014868 69
% 211.25/211.46 |- mesh__publicMeSHNote mesh__D014868 69
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D014868 1998
% 211.25/211.46 |- skos__hiddenLabel mesh__D019553 Endodontically-Treated Teeth
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019553 2004
% 211.25/211.46 |- mesh__dateEstablished mesh__D019553 1997-01-01
% 211.25/211.46 |- skos__hiddenLabel mesh__D019553 Pulpless Tooth
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019553 1998
% 211.25/211.46 |- mesh__activeMeSHYear mesh__D019553 2002
% 211.25/211.47 |- skos__altLabel mesh__D019553 Teeth, Pulpless
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D019553 97
% 211.25/211.47 |- mesh__recordMaintainer mesh__D019553 JLS
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019553 2003
% 211.25/211.47 |- skos__hiddenLabel mesh__D019553 Tooth, Endodontically Treated
% 211.25/211.47 |- mesh__dateRevised mesh__D019553 1997-06-20
% 211.25/211.47 |- skos__scopeNote mesh__D019553
% 211.25/211.47 A tooth from which the dental pulp has been removed or is necrotic. %28%Boucher, Clinical Dental Terminology, 4th ed%29%%A%
% 211.25/211.47 |- skos__hiddenLabel mesh__D019553 Teeth, Endodontically Treated
% 211.25/211.47 |- skos__hiddenLabel mesh__D019553 Devitalized Tooth
% 211.25/211.47 |- skos__altLabel mesh__D019553 Tooth, Pulpless
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019553 2001
% 211.25/211.47 |- skos__altLabel mesh__D019553 Tooth, Devitalized
% 211.25/211.47 |- skos__hiddenLabel mesh__D019553 Nonvital Teeth
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019553 2000
% 211.25/211.47 |- mesh__recordOriginator mesh__D019553 JLS
% 211.25/211.47 |- skos__broader mesh__D019553smesh__D003788
% 211.25/211.47 |- skos__hiddenLabel mesh__D019553 Nonvital Tooth
% 211.25/211.47 |- mesh__historyNote mesh__D019553 97
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019553 2006
% 211.25/211.47 |- skos__hiddenLabel mesh__D019553 Devitalized Teeth
% 211.25/211.47 |- skos__altLabel mesh__D019553 Tooth, Endodontically-Treated
% 211.25/211.47 |- rdf__type mesh__D019553sskos__Concept
% 211.25/211.47 |- skos__hiddenLabel mesh__D019553 Pulpless Teeth
% 211.25/211.47 |- skos__hiddenLabel mesh__D019553 Endodontically-Treated Tooth
% 211.25/211.47 |- skos__altLabel mesh__D019553 Teeth, Nonvital
% 211.25/211.47 |- mesh__dateCreated mesh__D019553 1996-06-10
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019553 2005
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019553 1999
% 211.25/211.47 |- skos__annotation mesh__D019553 a devitalized tooth: note X ref
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D019553 SJN
% 211.25/211.47 |- skos__prefLabel mesh__D019553 Tooth, Nonvital
% 211.25/211.47 |- skos__altLabel mesh__D019553 Teeth, Devitalized
% 211.25/211.47 |- mesh__historyNote mesh__D000848 65
% 211.25/211.47 |- mesh__dateRevised mesh__D000848 1999-11-03
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000848 2005
% 211.25/211.47 |- mesh__recordOriginator mesh__D000848 NLM
% 211.25/211.47 |- skos__prefLabel mesh__D000848 Anodontia
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D000848 sjn
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000848 2002
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000848 2001
% 211.25/211.47 |- mesh__dateEstablished mesh__D000848 1965-01-01
% 211.25/211.47 |- mesh__recordMaintainer mesh__D000848 kle
% 211.25/211.47 |- rdf__type mesh__D000848sskos__Concept
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000848 2004
% 211.25/211.47 |- skos__broader mesh__D000848smesh__D014071
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000848 2000
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000848 2006
% 211.25/211.47 |- skos__scopeNote mesh__D000848
% 211.25/211.47 Congenital absence of the teeth; it may involve all %28%total anodontia%29% or only some of the teeth %28%partial anodontia, hypodontia%29%, and both the deciduous and the permanent dentition, or only teeth of the permanent dentition. %28%Dorland, 27th ed%29%%A%
% 211.25/211.47 |- mesh__dateCreated mesh__D000848 1999-01-01
% 211.25/211.47 |- skos__annotation mesh__D000848
% 211.25/211.47 congen absence of teeth; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; congen absence of one or more teeth: do not confuse with JAW, EDENTULOUS %28%total lack of teeth in either jaw through disease or extraction%29%, JAW, EDENTULOUS, PARTIALLY %28%partial lack in either jaw%29% or MOUTH, EDENTULOUS %28%total lack of teeth in both jaws through disease or extraction%29%%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000848 2003
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D000848 65
% 211.25/211.47 |- skos__hiddenLabel mesh__D011570 Psychiatrist
% 211.25/211.47 |- skos__broader mesh__D011570smesh__D001525
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011570 2006
% 211.25/211.47 |- skos__broader mesh__D011570smesh__D008511
% 211.25/211.47 |- skos__prefLabel mesh__D011570 Psychiatry
% 211.25/211.47 |- mesh__dateRevised mesh__D011570 1999-11-03
% 211.25/211.47 |- mesh__recordOriginator mesh__D011570 NLM
% 211.25/211.47 |- skos__annotation mesh__D011570
% 211.25/211.47 SPEC only: SPEC qualif; do not confuse with MENTAL DISORDERS%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011570 2000
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011570 2003
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D011570 sjn
% 211.25/211.47 |- mesh__recordMaintainer mesh__D011570 kle
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011570 2001
% 211.25/211.47 |- rdf__type mesh__D011570sskos__Concept
% 211.25/211.47 |- mesh__dateCreated mesh__D011570 1999-01-01
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011570 2004
% 211.25/211.47 |- skos__broader mesh__D011570smesh__D013040
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011570 2002
% 211.25/211.47 |- skos__scopeNote mesh__D011570
% 211.25/211.47 The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders.%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011570 2005
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005533 2003
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005533 2005
% 211.25/211.47 |- mesh__dateCreated mesh__D005533 1999-01-01
% 211.25/211.47 |- mesh__dateRevised mesh__D005533 1999-11-03
% 211.25/211.47 |- mesh__recordOriginator mesh__D005533 NLM
% 211.25/211.47 |- skos__annotation mesh__D005533
% 211.25/211.47 GEN %26% coord for specific diseases of the foot; not as coord for neoplasms of the foot %28%use neopl coords %28%IM%29% with FOOT DISEASES %28%IM%29%%29%; consider synonym for dermatitis of foot %26% do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH%A%
% 211.25/211.47 |- skos__hiddenLabel mesh__D005533 Dermatoses, Foot
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005533 2002
% 211.25/211.47 |- skos__altLabel mesh__D005533 Foot Dermatosis
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D005533 66
% 211.25/211.47 |- skos__hiddenLabel mesh__D005533 Dermatosis, Foot
% 211.25/211.47 |- skos__prefLabel mesh__D005533 Foot Dermatoses
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D005533 sjn
% 211.25/211.47 |- skos__broader mesh__D005533smesh__D005534
% 211.25/211.47 |- rdf__type mesh__D005533sskos__Concept
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005533 2001
% 211.25/211.47 |- mesh__dateEstablished mesh__D005533 1966-01-01
% 211.25/211.47 |- skos__scopeNote mesh__D005533
% 211.25/211.47 Skin diseases of the foot, general or unspecified.
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005533 2004
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005533 2000
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005533 2006
% 211.25/211.47 |- mesh__historyNote mesh__D005533 66
% 211.25/211.47 |- mesh__recordMaintainer mesh__D005533 KEV
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D029981 2003
% 211.25/211.47 |- mesh__dateEstablished mesh__D029981 2002-01-01
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D029981 2006
% 211.25/211.47 |- rdf__type mesh__D029981sskos__Concept
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D029981 2004
% 211.25/211.47 |- skos__altLabel mesh__D029981 Hemlock, Spotted Water
% 211.25/211.47 |- skos__annotation mesh__D029981
% 211.25/211.47 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.47 |- mesh__recordOriginator mesh__D029981 ssb
% 211.25/211.47 |- skos__historyNote mesh__D029981 Hemlock %28%1995-2001%29%
% 211.25/211.47 |- skos__broader mesh__D029981smesh__D018652
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D029981 sjn
% 211.25/211.47 |- mesh__recordMaintainer mesh__D029981 ssb
% 211.25/211.47 |- skos__altLabel mesh__D029981 Water Hemlock
% 211.25/211.47 |- mesh__dateRevised mesh__D029981 2002-07-03
% 211.25/211.47 |- mesh__historyNote mesh__D029981
% 211.25/211.47 2002; for CICUTA MAJOR %26% CICUTA VIROSA use HEMLOCK 1995-2001%A%
% 211.25/211.47 |- mesh__dateCreated mesh__D029981 2001-07-25
% 211.25/211.47 |- skos__altLabel mesh__D029981 Hemlock, Water
% 211.25/211.47 |- skos__scopeNote mesh__D029981
% 211.25/211.47 A plant genus of the family APIACEAE. It is a source of cicutoxin.%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D029981 2005
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D029981
% 211.25/211.47 2002; for CICUTA MAJOR %26% CICUTA VIROSA see HEMLOCK 1995-2001%A%
% 211.25/211.47 |- skos__prefLabel mesh__D029981 Cicuta
% 211.25/211.47 |- skos__scopeNote mesh__D010478
% 211.25/211.47 Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part.%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D010478 2006
% 211.25/211.47 |- mesh__dateRevised mesh__D010478 2005-06-30
% 211.25/211.47 |- skos__prefLabel mesh__D010478 Chemotherapy, Cancer, Regional Perfusion
% 211.25/211.47 |- skos__altLabel mesh__D010478 Cancer Chemotherapy, Regional Perfusion
% 211.25/211.47 |- rdf__type mesh__D010478sskos__Concept
% 211.25/211.47 |- mesh__recordOriginator mesh__D010478 NLM
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D010478
% 211.25/211.47 2006; see PERFUSION, REGIONAL 1978-2005, see ISOLATION PERFUSION 1964-1977%A%
% 211.25/211.47 |- mesh__recordMaintainer mesh__D010478 nns
% 211.25/211.47 |- skos__altLabel mesh__D010478 Perfusion Cancer Chemotherapy, Regional
% 211.25/211.47 |- skos__altLabel mesh__D010478 Regional Perfusion Cancer Chemotherapy
% 211.25/211.47 |- mesh__historyNote mesh__D010478 2006 %28%1963%29%
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D010478 sjn
% 211.25/211.47 |- mesh__dateEstablished mesh__D010478 1964-01-01
% 211.25/211.47 |- skos__broader mesh__D010478smesh__D005112
% 211.25/211.47 |- skos__annotation mesh__D010478
% 211.25/211.47 restricted to a special technique in cancer therapy; do not confuse with INFUSIONS, INTRA-ARTERIAL which is also used in cancer therapy; Manual 24.4.2.5+%A%
% 211.25/211.47 |- skos__altLabel mesh__D010478 Isolation Perfusion Cancer Chemotherapy
% 211.25/211.47 |- mesh__dateCreated mesh__D010478 1999-01-01
% 211.25/211.47 |- skos__broader mesh__D010478smesh__D004333
% 211.25/211.47 |- skos__altLabel mesh__D010478
% 211.25/211.47 Regional Perfusion Antineoplastic Chemotherapy
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D015163 2004
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D015163 2000A
% 211.25/211.47 |- rdf__type mesh__D015163sskos__Concept
% 211.25/211.47 |- skos__hiddenLabel mesh__D015163 Superinvasions, Microbial
% 211.25/211.47 |- skos__altLabel mesh__D015163 Superinvasion, Microbial
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D015163 2001
% 211.25/211.47 |- mesh__dateEstablished mesh__D015163 1989-01-01
% 211.25/211.47 |- mesh__recordOriginator mesh__D015163 SCD
% 211.25/211.47 |- skos__prefLabel mesh__D015163 Superinfection
% 211.25/211.47 |- skos__historyNote mesh__D015163 Cell Line %28%1969-1988%29%
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D015163 1989
% 211.25/211.47 |- skos__historyNote mesh__D015163 Tissue Culture %28%1967-1980%29%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D015163 2005
% 211.25/211.47 |- skos__hiddenLabel mesh__D015163 Microbial Superinvasions
% 211.25/211.47 |- skos__related mesh__D015163smesh__D014762
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D015163 2002
% 211.25/211.47 |- skos__historyNote mesh__D015163 Cells, Cultured %28%1974-1988%29%
% 211.25/211.47 |- mesh__dateRevised mesh__D015163 1999-12-16
% 211.25/211.47 |- skos__historyNote mesh__D015163
% 211.25/211.47 Drug Resistance, Microbial %28%1966-1988%29%
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D015163 ags
% 211.25/211.47 |- mesh__historyNote mesh__D015163 1989
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D015163 2006
% 211.25/211.47 |- skos__altLabel mesh__D015163 Microbial Superinvasion
% 211.25/211.47 |- skos__hiddenLabel mesh__D015163 Superinfections
% 211.25/211.47 |- mesh__dateCreated mesh__D015163 1988-04-06
% 211.25/211.47 |- mesh__recordMaintainer mesh__D015163 ags
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D015163 1999
% 211.25/211.47 |- skos__broader mesh__D015163smesh__D009894
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D015163 2003
% 211.25/211.47 |- skos__annotation mesh__D015163
% 211.25/211.47 opportunistic infect; IM; coord with specific infect %28%IM%29%%A%
% 211.25/211.47 |- skos__scopeNote mesh__D015163
% 211.25/211.47 A frequent complication of drug therapy for microbial infection. It may result from opportunistic colonization following immunosuppression by the primary pathogen and can be influenced by the time interval between infections, microbial physiology, or host resistance. Experimental challenge and in vitro models are sometimes used in virulence and infectivity studies.%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D015163 2000
% 211.25/211.47 |- skos__prefLabel mesh__D009924 Organ Culture Techniques
% 211.25/211.47 |- mesh__dateRevised mesh__D009924 2004-07-07
% 211.25/211.47 |- skos__related mesh__D009924smesh__D023822
% 211.25/211.47 |- skos__hiddenLabel mesh__D009924 Organ Culture Technique
% 211.25/211.47 |- skos__hiddenLabel mesh__D009924 Culture Technique, Organ
% 211.25/211.47 |- skos__hiddenLabel mesh__D009924 Culture Techniques, Organ
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D009924 2006
% 211.25/211.47 |- mesh__historyNote mesh__D009924 2005 %28%1972%29%
% 211.25/211.47 |- skos__altLabel mesh__D009924 Organ Culture
% 211.25/211.47 |- mesh__recordOriginator mesh__D009924 NLM
% 211.25/211.47 |- skos__broader mesh__D009924smesh__D046508
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D009924 2005
% 211.25/211.47 |- skos__annotation mesh__D009924 NIM
% 211.25/211.47 |- rdf__type mesh__D009924sskos__Concept
% 211.25/211.47 |- skos__scopeNote mesh__D009924
% 211.25/211.47 A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. %28%Freshney, Culture of Animal Cells, 3d ed, p1%29%%A%
% 211.25/211.47 |- mesh__dateCreated mesh__D009924 1999-01-01
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D009924 2005; see ORGAN CULTURE 1972-2004
% 211.25/211.47 |- skos__hiddenLabel mesh__D009924 Organ Cultures
% 211.25/211.47 |- skos__historyNote mesh__D009924 Tissue Culture %28%1966-1968%29%
% 211.25/211.47 |- mesh__dateEstablished mesh__D009924 1972-01-01
% 211.25/211.47 |- skos__related mesh__D009924smesh__D002478
% 211.25/211.47 |- mesh__recordMaintainer mesh__D009924 lkt
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D009924 sjn
% 211.25/211.47 |- mesh__recordOriginator mesh__D001941 NLM
% 211.25/211.47 |- skos__hiddenLabel mesh__D001941 Endocrine Breast Disease
% 211.25/211.47 |- skos__hiddenLabel mesh__D001941 Breast Disease, Endocrine
% 211.25/211.47 |- skos__hiddenLabel mesh__D001941 Breast Disease
% 211.25/211.47 |- rdf__type mesh__D001941sskos__Concept
% 211.25/211.47 |- skos__broader mesh__D001941smesh__D012871
% 211.25/211.47 |- mesh__recordMaintainer mesh__D001941 lkt
% 211.25/211.47 |- skos__scopeNote mesh__D001941 Pathological processes of the BREAST.
% 211.25/211.47 |- skos__hiddenLabel mesh__D001941 Diseases, Breast
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D001941 2006
% 211.25/211.47 |- skos__annotation mesh__D001941
% 211.25/211.47 inflamm dis = MASTITIS; tuberc of breast = MASTITIS %28%IM%29% + TUBERCULOSIS %28%IM%29%, not TUBERCULOSIS, ENDOCRINE%A%
% 211.25/211.47 |- mesh__dateRevised mesh__D001941 2004-07-07
% 211.25/211.47 |- skos__hiddenLabel mesh__D001941 Diseases, Endocrine Breast
% 211.25/211.47 |- skos__hiddenLabel mesh__D001941 Breast Diseases, Endocrine
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D001941 2005
% 211.25/211.47 |- skos__hiddenLabel mesh__D001941 Disease, Endocrine Breast
% 211.25/211.47 |- skos__prefLabel mesh__D001941 Breast Diseases
% 211.25/211.47 |- mesh__dateCreated mesh__D001941 1999-01-01
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D001941 sjn
% 211.25/211.47 |- skos__hiddenLabel mesh__D001941 Disease, Breast
% 211.25/211.47 |- skos__prefLabel mesh__D009126 Muscle Relaxation
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D009126 2004
% 211.25/211.47 |- rdf__type mesh__D009126sskos__Concept
% 211.25/211.47 |- mesh__historyNote mesh__D009126
% 211.25/211.47 91%28%77%29%; was see under MUSCLE CONTRACTION 1977-90
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D009126 sjn
% 211.25/211.47 |- mesh__dateEstablished mesh__D009126 1991-01-01
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D009126 2006
% 211.25/211.47 |- skos__scopeNote mesh__D009126
% 211.25/211.47 That phase of a muscle twitch during which a muscle returns to a resting position.%A%
% 211.25/211.47 |- mesh__dateCreated mesh__D009126 1976-04-27
% 211.25/211.47 |- mesh__dateRevised mesh__D009126 2003-07-09
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D009126 2005
% 211.25/211.47 |- skos__annotation mesh__D009126
% 211.25/211.47 do not use as coord for relaxation of cardiac muscle %28% = MYOCARDIAL CONTRACTION%29%%A%
% 211.25/211.47 |- skos__hiddenLabel mesh__D009126 Muscle Relaxations
% 211.25/211.47 |- skos__hiddenLabel mesh__D009126 Relaxation, Muscle
% 211.25/211.47 |- skos__broader mesh__D009126smesh__D009119
% 211.25/211.47 |- skos__historyNote mesh__D009126 Muscle Contraction %28%1966-1976%29%
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D009126
% 211.25/211.47 91; was see under MUSCLE CONTRACTION 1977-90
% 211.25/211.47 |- mesh__recordOriginator mesh__D009126 MM
% 211.25/211.47 |- mesh__recordMaintainer mesh__D009126 nns
% 211.25/211.47 |- skos__hiddenLabel mesh__D009126 Relaxations, Muscle
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D001143 2001
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D001143 2003
% 211.25/211.47 |- mesh__dateRevised mesh__D001143 1999-11-03
% 211.25/211.47 |- mesh__recordMaintainer mesh__D001143 ags
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D001143 2005
% 211.25/211.47 |- skos__scopeNote mesh__D001143
% 211.25/211.47 Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system.%A%
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D001143 66
% 211.25/211.47 |- mesh__recordOriginator mesh__D001143 NLM
% 211.25/211.47 |- skos__hiddenLabel mesh__D001143 Cortical Vigilance
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D001143 sjn
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D001143 2004
% 211.25/211.47 |- mesh__dateEstablished mesh__D001143 1966-01-01
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D001143 2002
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D001143 2006
% 211.25/211.47 |- skos__prefLabel mesh__D001143 Arousal
% 211.25/211.47 |- skos__broader mesh__D001143smesh__D009424
% 211.25/211.47 |- skos__hiddenLabel mesh__D001143 Arousals
% 211.25/211.47 |- rdf__type mesh__D001143sskos__Concept
% 211.25/211.47 |- mesh__historyNote mesh__D001143 66%28%64%29%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D001143 2000
% 211.25/211.47 |- skos__annotation mesh__D001143 human %26% animal
% 211.25/211.47 |- mesh__dateCreated mesh__D001143 1999-01-01
% 211.25/211.47 |- skos__broader mesh__D001143smesh__D011603
% 211.25/211.47 |- mesh__recordOriginator mesh__D014869 NLM
% 211.25/211.47 |- mesh__historyNote mesh__D014869 65
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D014869 65
% 211.25/211.47 |- mesh__recordMaintainer mesh__D014869 adp
% 211.25/211.47 |- skos__broader mesh__D014869smesh__D014883
% 211.25/211.47 |- skos__scopeNote mesh__D014869
% 211.25/211.47 A condition resulting from the excessive retention of water with sodium depletion.%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D014869 2005
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D014869 2002
% 211.25/211.47 |- mesh__dateCreated mesh__D014869 1999-01-01
% 211.25/211.47 |- skos__broader mesh__D014869smesh__D011041
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D014869 2004
% 211.25/211.47 |- skos__related mesh__D014869smesh__D014883
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D014869 2001
% 211.25/211.47 |- mesh__dateRevised mesh__D014869 1999-11-03
% 211.25/211.47 |- rdf__type mesh__D014869sskos__Concept
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D014869 2003
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D014869 2000
% 211.25/211.47 |- skos__prefLabel mesh__D014869 Water Intoxication
% 211.25/211.47 |- mesh__dateEstablished mesh__D014869 1965-01-01
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D014869 2006
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D014869 sjn
% 211.25/211.47 |- skos__historyNote mesh__D019554 Surface Properties %28%1986-1996%29%
% 211.25/211.47 |- skos__altLabel mesh__D019554 Wear, Restoration Occlusal
% 211.25/211.47 |- skos__altLabel mesh__D019554 Occlusal Wear, Restoration
% 211.25/211.47 |- skos__altLabel mesh__D019554 Wear, Dental Restoration
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 2004
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 2002
% 211.25/211.47 |- skos__hiddenLabel mesh__D019554 Wear, Denture
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 1997
% 211.25/211.47 |- skos__prefLabel mesh__D019554 Dental Restoration Wear
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 2005
% 211.25/211.47 |- skos__altLabel mesh__D019554 Restoration Occlusal Wear
% 211.25/211.47 |- mesh__dateCreated mesh__D019554 1996-06-13
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 2000
% 211.25/211.47 |- mesh__dateEstablished mesh__D019554 1997-01-01
% 211.25/211.47 |- skos__altLabel mesh__D019554 Restoration Wear, Dental
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 2006
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D019554 97
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 1998
% 211.25/211.47 |- skos__broader mesh__D019554smesh__D003793
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 2001
% 211.25/211.47 |- mesh__historyNote mesh__D019554 97
% 211.25/211.47 |- skos__annotation mesh__D019554
% 211.25/211.47 surface wear of restorations %26% dentures; DF: DENT RESTORATION WEAR%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 2003
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D019554 1999
% 211.25/211.47 |- rdf__type mesh__D019554sskos__Concept
% 211.25/211.47 |- skos__scopeNote mesh__D019554
% 211.25/211.47 Occlusal wear of the surfaces of restorations and surface wear of dentures.%A%
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D000849 sjn
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Dysphasia, Anomic
% 211.25/211.47 |- mesh__recordOriginator mesh__D000849 RC
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000849 2001
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Amnesic Aphasia
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Anomias, Color
% 211.25/211.47 |- mesh__historyNote mesh__D000849
% 211.25/211.47 1991%28%1980%29%; use APHASIA 1975-1979
% 211.25/211.47 |- skos__prefLabel mesh__D000849 Anomia
% 211.25/211.47 |- mesh__dateEstablished mesh__D000849 1991-01-01
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000849 2005
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Dysphasia, Nominal
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000849 2002
% 211.25/211.47 |- skos__altLabel mesh__D000849 Aphasia, Anomic
% 211.25/211.47 |- mesh__dateCreated mesh__D000849 1978-12-14
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Dysphasias, Nominal
% 211.25/211.47 |- skos__historyNote mesh__D000849 Aphasia %28%1966-1979%29%
% 211.25/211.47 |- skos__altLabel mesh__D000849 Aphasia, Amnesic
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Dysphasias, Anomic
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000849 2006
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000849 2003
% 211.25/211.47 |- skos__altLabel mesh__D000849 Nominal Dysphasia
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D000849
% 211.25/211.47 1991; see under APHASIA 1980-1990, see APHASIA 1975-1979
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Color Anomias
% 211.25/211.47 |- rdf__type mesh__D000849sskos__Concept
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Dysnomias
% 211.25/211.47 |- skos__scopeNote mesh__D000849
% 211.25/211.47 A language dysfunction characterized by the inability to name people and objects that are correctly perceived. The individual is able to describe the object in question, but cannot provide the name. This condition is associated with lesions of the dominant hemisphere involving the language areas, in particular the TEMPORAL LOBE. %28%From Adams et al., Principles of Neurology, 6th ed, p484%29%%A%
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Nominal Dysphasias
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Anomic Dysphasias
% 211.25/211.47 |- mesh__dateRevised mesh__D000849 1999-11-08
% 211.25/211.47 |- skos__altLabel mesh__D000849 Dysnomia
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000849 2004
% 211.25/211.47 |- mesh__recordMaintainer mesh__D000849 KEV
% 211.25/211.47 |- skos__altLabel mesh__D000849 Aphasia, Nominal
% 211.25/211.47 |- skos__altLabel mesh__D000849 Anomic Dysphasia
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Nominal Aphasia
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Anomic Aphasia
% 211.25/211.47 |- skos__hiddenLabel mesh__D000849 Anomia, Color
% 211.25/211.47 |- skos__broader mesh__D000849smesh__D007806
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D000849 2000
% 211.25/211.47 |- skos__annotation mesh__D000849
% 211.25/211.47 inability to name objects: do not confuse with ANOMIE %28%%22%state of social disorganization %26% demoralization in society...%22%, often called %22%anomia%22%%29%%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 2006
% 211.25/211.47 |- mesh__publicMeSHNote mesh__D011571 72
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1998
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 2002
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1993
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1994
% 211.25/211.47 |- mesh__dateRevised mesh__D011571 1989-05-16
% 211.25/211.47 |- mesh__recordMaintainer mesh__D011571 TGC
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1999
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D011571 PLS
% 211.25/211.47 |- skos__hiddenLabel mesh__D011571 Psychoacoustic
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1990
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1995
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 2003
% 211.25/211.47 |- skos__broader mesh__D011571smesh__D000162
% 211.25/211.47 |- rdf__type mesh__D011571sskos__Concept
% 211.25/211.47 |- mesh__dateCreated mesh__D011571 1999-01-01
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1991
% 211.25/211.47 |- mesh__historyNote mesh__D011571 72%28%68%29%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 2004
% 211.25/211.47 |- mesh__recordOriginator mesh__D011571 NLM
% 211.25/211.47 |- skos__scopeNote mesh__D011571
% 211.25/211.47 The science pertaining to the interrelationship of psychologic phenomena and the individual%27%s response to the physical properties of sound.%A%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1996
% 211.25/211.47 |- skos__historyNote mesh__D011571 Auditory Perception %28%1967%29%
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 2005
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 2000
% 211.25/211.47 |- skos__prefLabel mesh__D011571 Psychoacoustics
% 211.25/211.47 |- skos__broader mesh__D011571smesh__D011601
% 211.25/211.47 |- skos__historyNote mesh__D011571 Acoustics %28%1966-1967%29%
% 211.25/211.47 |- mesh__dateEstablished mesh__D011571 1972-01-01
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 2001
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1992
% 211.25/211.47 |- skos__annotation mesh__D011571 IM; no qualif
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D011571 1997
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005534 2000
% 211.25/211.47 |- skos__prefLabel mesh__D005534 Foot Diseases
% 211.25/211.47 |- skos__hiddenLabel mesh__D005534 Foot Disease
% 211.25/211.47 |- mesh__dateCreated mesh__D005534 1999-01-01
% 211.25/211.47 |- skos__scopeNote mesh__D005534
% 211.25/211.47 Anatomical and functional disorders affecting the foot.%A%
% 211.25/211.47 |- rdf__type mesh__D005534sskos__Concept
% 211.25/211.47 |- skos__annotation mesh__D005534
% 211.25/211.47 skin dis on foot = FOOT DERMATOSES; neopl of foot: use neopl coords %28%IM%29% + FOOT DISEASES %28%IM%29%%A%
% 211.25/211.47 |- skos__broader mesh__D005534smesh__D012871
% 211.25/211.47 |- mesh__dateRevised mesh__D005534 1999-11-03
% 211.25/211.47 |- mesh__recordOriginator mesh__D005534 NLM
% 211.25/211.47 |- skos__broader mesh__D005534smesh__D009140
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005534 2004
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005534 2002
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005534 2006
% 211.25/211.47 |- skos__hiddenLabel mesh__D005534 Disease, Foot
% 211.25/211.47 |- mesh__recordAuthorizer mesh__D005534 sjn
% 211.25/211.47 |- mesh__recordMaintainer mesh__D005534 KEV
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005534 2003
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005534 2001
% 211.25/211.47 |- mesh__activeMeSHYear mesh__D005534 2005
% 211.25/211.47 |- skos__hiddenLabel mesh__D005534 Diseases, Foot
% 211.25/211.47 |- rdf__type mesh__D029982sskos__Concept
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D029982 2004
% 211.25/211.48 |- mesh__recordOriginator mesh__D029982 ssb
% 211.25/211.48 |- skos__prefLabel mesh__D029982 Conium
% 211.25/211.48 |- skos__broader mesh__D029982smesh__D018652
% 211.25/211.48 |- skos__altLabel mesh__D029982 Poison Hemlock
% 211.25/211.48 |- skos__scopeNote mesh__D029982
% 211.25/211.48 A plant genus of the family APIACEAE that is a source of coniine.%A%
% 211.25/211.48 |- skos__altLabel mesh__D029982 Hemlock, Poison
% 211.25/211.48 |- skos__historyNote mesh__D029982 Hemlock %28%1995-2001%29%
% 211.25/211.48 |- skos__annotation mesh__D029982
% 211.25/211.48 note X ref POISON HEMLOCK: use only for this plant and not for poisoning by other HEMLOCK plants; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D029982
% 211.25/211.48 2002; for CONIUM MACULATUM see HEMLOCK 1995-2001
% 211.25/211.48 |- mesh__historyNote mesh__D029982
% 211.25/211.48 2002; for CONIUM MACULATUM use HEMLOCK 1995-2001
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D029982 2005
% 211.25/211.48 |- mesh__dateRevised mesh__D029982 2002-07-03
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D029982 sjn
% 211.25/211.48 |- mesh__recordMaintainer mesh__D029982 ssb
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D029982 2003
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D029982 2006
% 211.25/211.48 |- mesh__dateCreated mesh__D029982 2001-07-25
% 211.25/211.48 |- mesh__dateEstablished mesh__D029982 2002-01-01
% 211.25/211.48 |- skos__altLabel mesh__D010479 Draxis Brand of Pergolide Mesylate
% 211.25/211.48 |- skos__hiddenLabel mesh__D010479 Mesylate, Pergolide
% 211.25/211.48 |- skos__hiddenLabel mesh__D010479 LY127809
% 211.25/211.48 |- rdf__type mesh__D010479sskos__Concept
% 211.25/211.48 |- skos__altLabel mesh__D010479 Athena Brand of Pergolide Mesylate
% 211.25/211.48 |- skos__historyNote mesh__D010479 Ergolines %28%1969-1986%29%
% 211.25/211.48 |- mesh__recordMaintainer mesh__D010479 lkw
% 211.25/211.48 |- skos__altLabel mesh__D010479 Celance
% 211.25/211.48 |- skos__altLabel mesh__D010479 Elanco Brand of Pergolide Mesylate
% 211.25/211.48 |- mesh__dateRevised mesh__D010479 2005-06-30
% 211.25/211.48 |- mesh__dateEstablished mesh__D010479 1987-01-01
% 211.25/211.48 |- skos__broader mesh__D010479smesh__D004873
% 211.25/211.48 |- skos__historyNote mesh__D010479 Ergot Alkaloids %28%1966-1986%29%
% 211.25/211.48 |- mesh__recordOriginator mesh__D010479 RLS
% 211.25/211.48 |- skos__hiddenLabel mesh__D010479 LY127,809
% 211.25/211.48 |- skos__altLabel mesh__D010479 Parkotil
% 211.25/211.48 |- skos__altLabel mesh__D010479 Lilly Brand of Pergolide Mesylate
% 211.25/211.48 |- skos__altLabel mesh__D010479 LY-127,809
% 211.25/211.48 |- skos__prefLabel mesh__D010479 Pergolide
% 211.25/211.48 |- skos__altLabel mesh__D010479 Lilly Brand of Pergolide
% 211.25/211.48 |- mesh__dateCreated mesh__D010479 1986-06-12
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D010479 2006
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D010479 sjn
% 211.25/211.48 |- mesh__historyNote mesh__D010479 87
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D010479 87
% 211.25/211.48 |- skos__scopeNote mesh__D010479
% 211.25/211.48 A long-acting dopamine agonist which is effective in the treatment of Parkinson%27%s disease and hyperprolactinemia. It has also been observed to have antihypertensive effects.%A%
% 211.25/211.48 |- mesh__recordOriginator mesh__D015164 SCD
% 211.25/211.48 |- skos__hiddenLabel mesh__D015164 Inactivated Vaccines
% 211.25/211.48 |- skos__broader mesh__D015164smesh__D014612
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D015164 sjn
% 211.25/211.48 |- skos__annotation mesh__D015164
% 211.25/211.48 coord NIM with specific vaccine %28%IM%29%
% 211.25/211.48 |- mesh__historyNote mesh__D015164 89
% 211.25/211.48 |- skos__altLabel mesh__D015164 Killed Vaccines
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D015164 2006
% 211.25/211.48 |- mesh__recordMaintainer mesh__D015164 ssb
% 211.25/211.48 |- skos__historyNote mesh__D015164 Vaccines, Attenuated %28%1973-1988%29%
% 211.25/211.48 |- skos__scopeNote mesh__D015164
% 211.25/211.48 Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment %28%e.g., formalin, beta-propiolactone, gamma radiation%29% without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.%A%
% 211.25/211.48 |- skos__altLabel mesh__D015164 Vaccines, Killed
% 211.25/211.48 |- rdf__type mesh__D015164sskos__Concept
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D015164 89
% 211.25/211.48 |- mesh__dateRevised mesh__D015164 2005-06-30
% 211.25/211.48 |- mesh__dateEstablished mesh__D015164 1989-01-01
% 211.25/211.48 |- mesh__dateCreated mesh__D015164 1988-04-06
% 211.25/211.48 |- skos__prefLabel mesh__D015164 Vaccines, Inactivated
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009925 2005
% 211.25/211.48 |- rdf__type mesh__D009925sskos__Concept
% 211.25/211.48 |- skos__hiddenLabel mesh__D009925 Spiral Organs
% 211.25/211.48 |- mesh__dateCreated mesh__D009925 1999-01-01
% 211.25/211.48 |- skos__hiddenLabel mesh__D009925 Organs, Spiral
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D009925 jls
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009925 2005A
% 211.25/211.48 |- mesh__dateEstablished mesh__D009925 1968-01-01
% 211.25/211.48 |- mesh__recordMaintainer mesh__D009925 jls
% 211.25/211.48 |- skos__altLabel mesh__D009925 Spiral Organ
% 211.25/211.48 |- skos__prefLabel mesh__D009925 Organ of Corti
% 211.25/211.48 |- skos__broader mesh__D009925smesh__D003051
% 211.25/211.48 |- skos__hiddenLabel mesh__D009925 Organ, Spiral
% 211.25/211.48 |- skos__scopeNote mesh__D009925
% 211.25/211.48 The organ that contains the special sensory receptors for hearing. It is composed of a series of epithelial structures placed upon the inner part of the basilar membrane.%A%
% 211.25/211.48 |- mesh__historyNote mesh__D009925 68%28%65%29%
% 211.25/211.48 |- skos__hiddenLabel mesh__D009925 Papilla, Basilar
% 211.25/211.48 |- mesh__recordOriginator mesh__D009925 NLM
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009925 2004
% 211.25/211.48 |- skos__hiddenLabel mesh__D009925 Cortis Organ
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D009925 68
% 211.25/211.48 |- skos__hiddenLabel mesh__D009925 Corti Organ
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009925 2006
% 211.25/211.48 |- skos__altLabel mesh__D009925 Corti%27%s Organ
% 211.25/211.48 |- mesh__dateRevised mesh__D009925 2004-07-29
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009925 2003
% 211.25/211.48 |- skos__hiddenLabel mesh__D009925 Organ, Corti%27%s
% 211.25/211.48 |- mesh__recordMaintainer mesh__D001942 sjn
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001942 2006
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001942 2004
% 211.25/211.48 |- skos__broader mesh__D001942smesh__D007227
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001942 2005
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D001942 sjn
% 211.25/211.48 |- mesh__dateCreated mesh__D001942 1999-01-01
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001942 2003
% 211.25/211.48 |- mesh__recordOriginator mesh__D001942 NLM
% 211.25/211.48 |- skos__altLabel mesh__D001942 Breastfeeding
% 211.25/211.48 |- skos__annotation mesh__D001942
% 211.25/211.48 human only; /adv eff: refers to eff on infant or mother
% 211.25/211.48 |- skos__altLabel mesh__D001942 Breastfeeding, Exclusive
% 211.25/211.48 |- skos__hiddenLabel mesh__D001942 Feeding, Breast
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001942 2005A
% 211.25/211.48 |- skos__related mesh__D001942smesh__D001903
% 211.25/211.48 |- skos__prefLabel mesh__D001942 Breast Feeding
% 211.25/211.48 |- rdf__type mesh__D001942sskos__Concept
% 211.25/211.48 |- skos__hiddenLabel mesh__D001942 Exclusive Breast Feeding
% 211.25/211.48 |- mesh__dateRevised mesh__D001942 2005-05-18
% 211.25/211.48 |- skos__hiddenLabel mesh__D001942 Exclusive Breastfeeding
% 211.25/211.48 |- skos__scopeNote mesh__D001942
% 211.25/211.48 The nursing of an infant at the mother%27%s breast.
% 211.25/211.48 |- skos__broader mesh__D009127smesh__D009122
% 211.25/211.48 |- mesh__dateCreated mesh__D009127 1999-01-01
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Rigidity, Cogwheel
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Rigidities, Cogwheel
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009127 2004
% 211.25/211.48 |- mesh__dateEstablished mesh__D009127 1973-01-01
% 211.25/211.48 |- rdf__type mesh__D009127sskos__Concept
% 211.25/211.48 |- skos__broader mesh__D009127smesh__D009135
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009127 2002
% 211.25/211.48 |- skos__scopeNote mesh__D009127
% 211.25/211.48 Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. %28%From Adams et al., Principles of Neurology, 6th ed, p73%29%%A%
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Rigidity, Nuchal
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009127 2005
% 211.25/211.48 |- skos__historyNote mesh__D009127 Muscular Diseases %28%1966-1971%29%
% 211.25/211.48 |- skos__prefLabel mesh__D009127 Muscle Rigidity
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Gegenhaltens
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Cogwheel Rigidities
% 211.25/211.48 |- mesh__recordOriginator mesh__D009127 NLM
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009127 2006
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Rigidity, Muscle
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D009127 1973
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D009127 ags
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Rigidity, Catatonic
% 211.25/211.48 |- mesh__recordMaintainer mesh__D009127 ags
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Rigidity, Extensor
% 211.25/211.48 |- mesh__historyNote mesh__D009127 1973%28%1972%29%
% 211.25/211.48 |- mesh__dateRevised mesh__D009127 1999-12-06
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Rigidity, Extrapyramidal
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009127 2000A
% 211.25/211.48 |- skos__altLabel mesh__D009127 Rigidity, Muscular
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009127 2000
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009127 2003
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009127 2001
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009127 2000B
% 211.25/211.48 |- skos__hiddenLabel mesh__D009127 Muscular Rigidity
% 211.25/211.48 |- skos__annotation mesh__D019555
% 211.25/211.48 no qualif; IM; coord with med %26% nurs spec %28%IM%29% if pertinent; DF: PHYSICIAN NURSE RELAT%A%
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Nurse-Physician Relation
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 1997
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Relationships, Physician Nurse
% 211.25/211.48 |- skos__broader mesh__D019555smesh__D007400
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 2005
% 211.25/211.48 |- skos__altLabel mesh__D019555 Physician Nurse Relationship
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 2002
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Physician Nurse Relations
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Nurse Relationship, Physician
% 211.25/211.48 |- skos__prefLabel mesh__D019555 Physician-Nurse Relations
% 211.25/211.48 |- skos__historyNote mesh__D019555 Nurses %28%1966-1996%29%
% 211.25/211.48 |- skos__historyNote mesh__D019555
% 211.25/211.48 Interprofessional Relations %28%1966-1996%29%
% 211.25/211.48 |- mesh__dateCreated mesh__D019555 1996-06-10
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 2006
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 1998
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Nurse Physician Relations
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Relations, Nurse-Physician
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Nurse Relationships, Physician
% 211.25/211.48 |- mesh__historyNote mesh__D019555 97
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Relationship, Physician Nurse
% 211.25/211.48 |- skos__altLabel mesh__D019555 Nurse-Physician Relations
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 2003
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 1999
% 211.25/211.48 |- rdf__type mesh__D019555sskos__Concept
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 2000
% 211.25/211.48 |- mesh__dateEstablished mesh__D019555 1997-01-01
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Relation, Nurse-Physician
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Relations, Physician-Nurse
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Physician-Nurse Relation
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D019555 97
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 2004
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019555 2001
% 211.25/211.48 |- skos__scopeNote mesh__D019555
% 211.25/211.48 The reciprocal interaction of physicians and nurses.
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Relation, Physician-Nurse
% 211.25/211.48 |- skos__historyNote mesh__D019555 Physicians %28%1966-1996%29%
% 211.25/211.48 |- skos__hiddenLabel mesh__D019555 Physician Nurse Relationships
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011572 2003
% 211.25/211.48 |- rdf__type mesh__D011572sskos__Concept
% 211.25/211.48 |- mesh__dateCreated mesh__D011572 1999-01-01
% 211.25/211.48 |- mesh__recordOriginator mesh__D011572 NLM
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011572 2000
% 211.25/211.48 |- mesh__recordMaintainer mesh__D011572 adp
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011572 2004
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D011572 sjn
% 211.25/211.48 |- skos__broader mesh__D011572smesh__D011570
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011572 2001
% 211.25/211.48 |- skos__hiddenLabel mesh__D011572 Psychoanalyses
% 211.25/211.48 |- skos__scopeNote mesh__D011572
% 211.25/211.48 The separation or resolution of the psyche into its constituent elements. The term has two separate meanings: 1. a procedure devised by Sigmund Freud, for investigating mental processes by means of free association, dream interpretation and interpretation of resistance and transference manifestations; and 2. a theory of psychology developed by Freud from his clinical experience with hysterical patients. %28%From Campbell, Psychiatric Dictionary, 1996%29%.%A%
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011572 2005
% 211.25/211.48 |- skos__annotation mesh__D011572
% 211.25/211.48 SPEC only: SPEC qualif; as ther = PSYCHOANALYTIC THERAPY
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011572 2002
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011572 2006
% 211.25/211.48 |- mesh__dateRevised mesh__D011572 1999-11-08
% 211.25/211.48 |- skos__prefLabel mesh__D011572 Psychoanalysis
% 211.25/211.48 |- skos__hiddenLabel mesh__D005535 Rot, Foot
% 211.25/211.48 |- mesh__historyNote mesh__D005535 70
% 211.25/211.48 |- skos__related mesh__D005535smesh__D020376
% 211.25/211.48 |- skos__historyNote mesh__D005535 Foot Diseases %28%1966-1969%29%
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D005535 sjn
% 211.25/211.48 |- mesh__dateRevised mesh__D005535 2003-07-30
% 211.25/211.48 |- skos__broader mesh__D005535smesh__D000820
% 211.25/211.48 |- skos__historyNote mesh__D005535 Sheep Diseases %28%1966-1969%29%
% 211.25/211.48 |- skos__annotation mesh__D005535
% 211.25/211.48 coord IM with appropriate infection term %28%IM%29% + precoord animal/dis term %28%IM%29% + animal %28%NIM%29% or animal %28%IM%29% in absence of precoord + check tag ANIMALS%A%
% 211.25/211.48 |- mesh__dateEstablished mesh__D005535 1970-01-01
% 211.25/211.48 |- skos__historyNote mesh__D005535 Swine Diseases %28%1966-1969%29%
% 211.25/211.48 |- rdf__type mesh__D005535sskos__Concept
% 211.25/211.48 |- skos__hiddenLabel mesh__D005535 Rots, Foot
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D005535 2005
% 211.25/211.48 |- skos__historyNote mesh__D005535 Cattle Diseases %28%1966-1969%29%
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D005535 2004
% 211.25/211.48 |- skos__hiddenLabel mesh__D005535 Foot Rots
% 211.25/211.48 |- skos__scopeNote mesh__D005535
% 211.25/211.48 A disease of the horny parts and of the adjacent soft structures of the feet of cattle, swine, and sheep. It is usually caused by Corynebacterium pyogenes or Bacteroides nodosus %28%see DICHELOBACTER NODOSUS%29%. It is also known as interdigital necrobacillosis. %28%From Black%27%s Veterinary Dictionary, 18th ed%29%%A%
% 211.25/211.48 |- skos__related mesh__D005535smesh__D005675
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D005535 2006
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D005535 70
% 211.25/211.48 |- skos__prefLabel mesh__D005535 Foot Rot
% 211.25/211.48 |- mesh__dateCreated mesh__D005535 1999-01-01
% 211.25/211.48 |- mesh__recordMaintainer mesh__D005535 sjn
% 211.25/211.48 |- mesh__recordOriginator mesh__D005535 NLM
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009926 2006
% 211.25/211.48 |- rdf__type mesh__D009926sskos__Concept
% 211.25/211.48 |- mesh__dateCreated mesh__D009926 1999-01-01
% 211.25/211.48 |- skos__hiddenLabel mesh__D009926 Organ Preservations
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D009926
% 211.25/211.48 84; was see under TISSUE PRESERVATION 1970-83
% 211.25/211.48 |- skos__related mesh__D009926smesh__D020858
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009926 2005
% 211.25/211.48 |- mesh__recordMaintainer mesh__D009926 NLM
% 211.25/211.48 |- skos__hiddenLabel mesh__D009926 Preservation, Organ
% 211.25/211.48 |- mesh__recordOriginator mesh__D009926 NLM
% 211.25/211.48 |- skos__prefLabel mesh__D009926 Organ Preservation
% 211.25/211.48 |- skos__annotation mesh__D009926
% 211.25/211.48 cryopreservation of organ: coord IM with organ %28%no qualif%29% + CRYOPRESERVATION%A%
% 211.25/211.48 |- skos__scopeNote mesh__D009926
% 211.25/211.48 The process by which organs are kept viable outside of the organism from which they were removed %28%i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism%29%.%A%
% 211.25/211.48 |- mesh__historyNote mesh__D009926
% 211.25/211.48 84%28%75%29%; was see under TISSUE PRESERVATION 1969-83
% 211.25/211.48 |- mesh__dateRevised mesh__D009926 2004-07-20
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D009926 NLM
% 211.25/211.48 |- mesh__dateEstablished mesh__D009926 1984-01-01
% 211.25/211.48 |- skos__broader mesh__D009926smesh__D014021
% 211.25/211.48 |- skos__hiddenLabel mesh__D009926 Preservations, Organ
% 211.25/211.48 |- mesh__onlineNote mesh__D009926 search TISSUE PRESERVATION 1969-74
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Mammary Carcinomas, Human
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001943 2005
% 211.25/211.48 |- skos__broader mesh__D001943smesh__D009371
% 211.25/211.48 |- skos__altLabel mesh__D001943 Cancer of Breast
% 211.25/211.48 |- mesh__dateCreated mesh__D001943 1999-01-01
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Breast Tumor
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Human Mammary Neoplasms
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Human Mammary Neoplasm
% 211.25/211.48 |- skos__altLabel mesh__D001943 Tumors, Breast
% 211.25/211.48 |- skos__altLabel mesh__D001943 Human Mammary Carcinoma
% 211.25/211.48 |- mesh__recordMaintainer mesh__D001943 sjn
% 211.25/211.48 |- mesh__dateRevised mesh__D001943 2004-07-13
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Neoplasms, Human Mammary
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Neoplasm, Breast
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Human Mammary Carcinomas
% 211.25/211.48 |- skos__altLabel mesh__D001943 Cancer of the Breast
% 211.25/211.48 |- skos__altLabel mesh__D001943 Breast Tumors
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Cancer, Breast
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D001943 sjn
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Tumor, Breast
% 211.25/211.48 |- skos__prefLabel mesh__D001943 Breast Neoplasms
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Breast Neoplasm
% 211.25/211.48 |- rdf__type mesh__D001943sskos__Concept
% 211.25/211.48 |- mesh__recordOriginator mesh__D001943 NLM
% 211.25/211.48 |- skos__annotation mesh__D001943
% 211.25/211.48 human only; BREAST NEOPLASMS, MALE is also available; for animal use MAMMARY NEOPLASMS, ANIMAL or MAMMARY NEOPLASMS, EXPERIMENTAL: Manual 24.5+, 24.6+; coordinate IM with histological type of neoplasm %28%IM%29%%A%
% 211.25/211.48 |- skos__broader mesh__D001943smesh__D001941
% 211.25/211.48 |- skos__scopeNote mesh__D001943 Tumors or cancer of the human BREAST.
% 211.25/211.48 |- skos__altLabel mesh__D001943 Mammary Neoplasm, Human
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Carcinomas, Human Mammary
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Neoplasm, Human Mammary
% 211.25/211.48 |- skos__altLabel mesh__D001943 Neoplasms, Breast
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001943 2006
% 211.25/211.48 |- skos__hiddenLabel mesh__D001943 Carcinoma, Human Mammary
% 211.25/211.48 |- skos__broader mesh__D011976Q000037smesh__D011976
% 211.25/211.48 |- mesh__preferredCombination mesh__D011976Q000037smesh__D018727
% 211.25/211.48 |- rdf__type mesh__D011976Q000037smesh__CompoundConcept
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009128 2000
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009128 2001
% 211.25/211.48 |- mesh__recordOriginator mesh__D009128 MM
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009128 2006
% 211.25/211.48 |- skos__broader mesh__D009128smesh__D009122
% 211.25/211.48 |- mesh__dateEstablished mesh__D009128 1977-01-01
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D009128 1977
% 211.25/211.48 |- skos__broader mesh__D009128smesh__D009135
% 211.25/211.48 |- skos__hiddenLabel mesh__D009128 Spasticity, Muscle
% 211.25/211.48 |- skos__hiddenLabel mesh__D009128 Clasp Knife Spasticity
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D009128 ags
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009128 2002
% 211.25/211.48 |- mesh__recordMaintainer mesh__D009128 ags
% 211.25/211.48 |- skos__related mesh__D009128smesh__D013035
% 211.25/211.48 |- skos__scopeNote mesh__D009128
% 211.25/211.48 A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance %28%a %22%free interval%22%%29% followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. %28%From Adams et al., Principles of Neurology, 6th ed, p54%29%%A%
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009128 2000A
% 211.25/211.48 |- skos__prefLabel mesh__D009128 Muscle Spasticity
% 211.25/211.48 |- mesh__dateCreated mesh__D009128 1976-05-19
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009128 2003
% 211.25/211.48 |- skos__annotation mesh__D009128
% 211.25/211.48 skeletal muscle only; note category: not physiological; spastic paralysis: coord NIM with PARALYSIS %28%IM%29%; spasticity in cerebral palsy: coord NIM with CEREBRAL PALSY only if musc spasticity is especially discussed%A%
% 211.25/211.48 |- skos__hiddenLabel mesh__D009128 Spasticity, Clasp-Knife
% 211.25/211.48 |- skos__historyNote mesh__D009128 Spasm %28%1966-1976%29%
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009128 2004
% 211.25/211.48 |- rdf__type mesh__D009128sskos__Concept
% 211.25/211.48 |- mesh__dateRevised mesh__D009128 1999-12-06
% 211.25/211.48 |- mesh__historyNote mesh__D009128 1977
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D009128 2005
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001145 2002
% 211.25/211.48 |- skos__broader mesh__D001145smesh__D010335
% 211.25/211.48 |- skos__related mesh__D001145smesh__D000889
% 211.25/211.48 |- skos__broader mesh__D001145smesh__D006331
% 211.25/211.48 |- rdf__type mesh__D001145sskos__Concept
% 211.25/211.48 |- skos__hiddenLabel mesh__D001145 Arrhythmias
% 211.25/211.48 |- skos__altLabel mesh__D001145 Arrythmia
% 211.25/211.48 |- mesh__dateCreated mesh__D001145 1999-01-01
% 211.25/211.48 |- skos__scopeNote mesh__D001145
% 211.25/211.48 Any variation from the normal rhythm or rate of the heart beat.%A%
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001145 2000
% 211.25/211.48 |- skos__related mesh__D001145smesh__D004554
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001145 2003
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001145 2001
% 211.25/211.48 |- mesh__dateRevised mesh__D001145 1999-11-03
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001145 2005
% 211.25/211.48 |- mesh__recordMaintainer mesh__D001145 KEV
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001145 2004
% 211.25/211.48 |- skos__prefLabel mesh__D001145 Arrhythmia
% 211.25/211.48 |- skos__annotation mesh__D001145
% 211.25/211.48 GEN: prefer specifics; /drug ther: consider also ANTI-ARRHYTHMIA AGENTS%A%
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D001145 2006
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D001145 sjn
% 211.25/211.48 |- mesh__recordOriginator mesh__D001145 NLM
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 Cell, COS
% 211.25/211.48 |- mesh__dateEstablished mesh__D019556 1997-01-01
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 COS-7 Cell
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 Cell, COS-1
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019556 2006
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 COS 7 Cells
% 211.25/211.48 |- skos__prefLabel mesh__D019556 COS Cells
% 211.25/211.48 |- mesh__historyNote mesh__D019556 97
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 Cell, COS-7
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 COS Cell
% 211.25/211.48 |- mesh__publicMeSHNote mesh__D019556 97
% 211.25/211.48 |- rdf__type mesh__D019556sskos__Concept
% 211.25/211.48 |- skos__scopeNote mesh__D019556
% 211.25/211.48 CELL LINES derived from the CV-1 cell line by transformation with a replication origin defective mutant of SV40 VIRUS, which codes for wild type large T antigen %28%ANTIGENS, POLYOMAVIRUS TRANSFORMING%29%. They are used for transfection and cloning. %28%The CV-1 cell line was derived from the kidney of an adult male African green monkey %28%CERCOPITHECUS AETHIOPS%29%.%29%%A%
% 211.25/211.48 |- mesh__recordMaintainer mesh__D019556 nns
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D019556 sjn
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019556 2004
% 211.25/211.48 |- mesh__dateRevised mesh__D019556 2003-07-30
% 211.25/211.48 |- skos__annotation mesh__D019556
% 211.25/211.48 almost always NIM with no subheadings; check ANIMALS %26% add CERCOPITHECUS AETHIOPS %28%NIM%29%%A%
% 211.25/211.48 |- mesh__recordOriginator mesh__D019556 AGS
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 Cells, COS
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 COS 1 Cells
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 COS-1 Cell
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 Cells, COS-1
% 211.25/211.48 |- skos__broader mesh__D019556smesh__D002461
% 211.25/211.48 |- mesh__dateCreated mesh__D019556 1996-06-10
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D019556 2005
% 211.25/211.48 |- skos__historyNote mesh__D019556 Cell Line %28%1983-1996%29%
% 211.25/211.48 |- skos__broader mesh__D019556smesh__D005347
% 211.25/211.48 |- skos__hiddenLabel mesh__D019556 Cells, COS-7
% 211.25/211.48 |- skos__altLabel mesh__D011573 Interpretation, Psychoanalytic
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 2004
% 211.25/211.48 |- skos__hiddenLabel mesh__D011573 Psychoanalytic Interpretations
% 211.25/211.48 |- skos__hiddenLabel mesh__D011573 Interpretations, Psychoanalytic
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 1996
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 2005
% 211.25/211.48 |- mesh__recordMaintainer mesh__D011573 TAP
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 2006
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 1997
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 2000
% 211.25/211.48 |- mesh__recordOriginator mesh__D011573 NLM
% 211.25/211.48 |- skos__broader mesh__D011573smesh__D004191
% 211.25/211.48 |- skos__altLabel mesh__D011573 Psychoanalytical Interpretation
% 211.25/211.48 |- skos__hiddenLabel mesh__D011573 Psychoanalytical Interpretations
% 211.25/211.48 |- skos__scopeNote mesh__D011573
% 211.25/211.48 Utilization of Freudian theories to explain various psychologic aspects of art, literature, biographical material, etc.%A%
% 211.25/211.48 |- skos__prefLabel mesh__D011573 Psychoanalytic Interpretation
% 211.25/211.48 |- skos__annotation mesh__D011573
% 211.25/211.48 IM; no qualif; differentiate from PSYCHOANALYTIC THEORY in that the theory is on a more universal level%A%
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 1998
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 1993
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 2001
% 211.25/211.48 |- mesh__dateRevised mesh__D011573 1992-05-18
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 1994
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 1999
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 2002
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 1995
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D011573 2003
% 211.25/211.48 |- rdf__type mesh__D011573sskos__Concept
% 211.25/211.48 |- skos__hiddenLabel mesh__D011573 Interpretations, Psychoanalytical
% 211.25/211.48 |- skos__hiddenLabel mesh__D011573 Interpretation, Psychoanalytical
% 211.25/211.48 |- mesh__dateCreated mesh__D011573 1999-01-01
% 211.25/211.48 |- mesh__recordAuthorizer mesh__D011573 PLS
% 211.25/211.48 |- mesh__dateRevised mesh__D005536 2003-07-30
% 211.25/211.48 |- skos__prefLabel mesh__D005536 Foot-and-Mouth Disease
% 211.25/211.48 |- skos__annotation mesh__D005536
% 211.25/211.48 caused by a picornavirus: do not confuse with HAND, FOOT AND MOUTH DISEASE, a Coxsackie virus infect; check tag ANIMALS; DF: FOOT MOUTH DIS%A%
% 211.25/211.48 |- mesh__recordOriginator mesh__D005536 NLM
% 211.25/211.48 |- mesh__recordMaintainer mesh__D005536 ags
% 211.25/211.48 |- rdf__type mesh__D005536sskos__Concept
% 211.25/211.48 |- mesh__activeMeSHYear mesh__D005536 2005
% 211.25/211.48 |- skos__altLabel mesh__D005536 Foot and Mouth Disease
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D005536 2004
% 211.25/211.49 |- mesh__recordAuthorizer mesh__D005536 sjn
% 211.25/211.49 |- skos__broader mesh__D005536smesh__D000820
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D005536 2006
% 211.25/211.49 |- skos__hiddenLabel mesh__D005536 Diseases, Foot-and-Mouth
% 211.25/211.49 |- mesh__dateCreated mesh__D005536 1999-01-01
% 211.25/211.49 |- skos__hiddenLabel mesh__D005536 Disease, Foot-and-Mouth
% 211.25/211.49 |- skos__broader mesh__D005536smesh__D010850
% 211.25/211.49 |- skos__hiddenLabel mesh__D005536 Foot-and-Mouth Diseases
% 211.25/211.49 |- skos__altLabel mesh__D015964 Regulation of Gene Expression, Bacterial
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015964 2003
% 211.25/211.49 |- mesh__historyNote mesh__D015964 90
% 211.25/211.49 |- skos__historyNote mesh__D015964
% 211.25/211.49 Gene Expression Regulation %28%1981-1989%29%
% 211.25/211.49 |- mesh__recordMaintainer mesh__D015964 NDW
% 211.25/211.49 |- skos__scopeNote mesh__D015964
% 211.25/211.49 Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria.%A%
% 211.25/211.49 |- skos__prefLabel mesh__D015964 Gene Expression Regulation, Bacterial
% 211.25/211.49 |- rdf__type mesh__D015964sskos__Concept
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015964 2004
% 211.25/211.49 |- mesh__dateCreated mesh__D015964 1989-05-25
% 211.25/211.49 |- skos__broader mesh__D015964smesh__D005786
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015964 2005
% 211.25/211.49 |- skos__altLabel mesh__D015964 Regulation, Gene Expression, Bacterial
% 211.25/211.49 |- mesh__dateEstablished mesh__D015964 1990-01-01
% 211.25/211.49 |- mesh__recordOriginator mesh__D015964 PXP
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015964 2006
% 211.25/211.49 |- mesh__dateRevised mesh__D015964 2002-07-02
% 211.25/211.49 |- mesh__publicMeSHNote mesh__D015964 90
% 211.25/211.49 |- skos__annotation mesh__D015964
% 211.25/211.49 coord IM with specific bacterium /genet %28%IM%29%; DF: GENE EXPRESSION REG BACT%A%
% 211.25/211.49 |- mesh__recordAuthorizer mesh__D015964 sjn
% 211.25/211.49 |- skos__historyNote mesh__D015964 specific bacteria %28%1973-1989%29%
% 211.25/211.49 |- skos__historyNote mesh__D015964 Genes, Regulator %28%1973-1980%29%
% 211.25/211.49 |- skos__altLabel mesh__D015964 Bacterial Gene Expression Regulation
% 211.25/211.49 |- skos__hiddenLabel mesh__D015166 Radioimmunological Monitoring
% 211.25/211.49 |- mesh__historyNote mesh__D015166 89
% 211.25/211.49 |- skos__historyNote mesh__D015166
% 211.25/211.49 Monitoring, Physiologic %28%1976-1988%29%
% 211.25/211.49 |- skos__altLabel mesh__D015166 Immunosurveillance
% 211.25/211.49 |- mesh__recordAuthorizer mesh__D015166 SJN
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015166 2006
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015166 2001
% 211.25/211.49 |- skos__historyNote mesh__D015166 Immunotherapy %28%1974-1988%29%
% 211.25/211.49 |- skos__altLabel mesh__D015166 Monitoring, Immunological
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015166 1999
% 211.25/211.49 |- skos__altLabel mesh__D015166 Monitoring, Immune
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015166 2005
% 211.25/211.49 |- skos__altLabel mesh__D015166 Monitoring, Radioimmunological
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015166 2004
% 211.25/211.49 |- skos__broader mesh__D015166smesh__D007158
% 211.25/211.49 |- skos__broader mesh__D015166smesh__D007159
% 211.25/211.49 |- skos__annotation mesh__D015166
% 211.25/211.49 determ of immune status of patient in diag %26% ther: do not confuse X ref IMMUNOSURVEILLANCE with IMMUNOLOGIC SURVEILLANCE, a function of T-lymphocytes; IM GEN only; avoid indexing routinely every word %22%monitoring%22% as %22%monitoring%22%: read MeSH definition; DF: MONITORING IMMUNOL%A%
% 211.25/211.49 |- mesh__publicMeSHNote mesh__D015166 89
% 211.25/211.49 |- skos__altLabel mesh__D015166 Immunologic Monitoring
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015166 1998
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015166 2000
% 211.25/211.49 |- mesh__dateEstablished mesh__D015166 1989-01-01
% 211.25/211.49 |- mesh__dateRevised mesh__D015166 1997-06-20
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015166 2003
% 211.25/211.49 |- mesh__dateCreated mesh__D015166 1988-04-08
% 211.25/211.49 |- skos__hiddenLabel mesh__D015166 Immunological Monitoring
% 211.25/211.49 |- rdf__type mesh__D015166sskos__Concept
% 211.25/211.49 |- skos__scopeNote mesh__D015166
% 211.25/211.49 Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers %28%often by RADIOIMMUNOASSAY%29%, studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc.%A%
% 211.25/211.49 |- skos__altLabel mesh__D015166 Monitoring, Radioimmunologic
% 211.25/211.49 |- skos__altLabel mesh__D015166 Immune Monitoring
% 211.25/211.49 |- mesh__recordOriginator mesh__D015166 SCD
% 211.25/211.49 |- mesh__recordMaintainer mesh__D015166 PXP
% 211.25/211.49 |- skos__prefLabel mesh__D015166 Monitoring, Immunologic
% 211.25/211.49 |- skos__historyNote mesh__D015166 Immunosuppression %28%1977-1988%29%
% 211.25/211.49 |- mesh__activeMeSHYear mesh__D015166 2002
% 211.25/211.49 |- skos__broader mesh__D015166smesh__D008991
% 211.25/211.49 |- skos__hiddenLabel mesh__D009927 Organ Procurements
% 211.25/211.49 |- skos__prefLabel mesh__D009927 Tissue and Organ Procurement
% 211.25/211.49 |- mesh__publicMeSHNote mesh__D009927
% 211.25/211.49 2005; see ORGAN PROCUREMENT 1987-2004
% 211.25/211.49 |- skos__hiddenLabel mesh__D009927 Organ Procurement System
% 211.25/211.49 |- skos__altLabel mesh__D009927 Required Request
% 211.25/211.49 |- skos__related mesh__D009927smesh__D014019
% 211.25/211.49 |- mesh__historyNote mesh__D009927 2005 %28%1987%29%
% 211.25/211.49 |- skos__related mesh__D009927smesh__D014015
% 211.25/211.49 |- skos__hiddenLabel mesh__D009927 Required Requests
% 211.25/211.49 |- skos__hiddenLabel mesh__D009927 Cards, Donor
% 211.25/211.49 |- mesh__recordAuthorizer mesh__D009927 sjn
% 211.25/211.49 |- skos__historyNote mesh__D009927 Tissue Donors %28%1966-1986%29%
% 211.25/211.49 |- mesh__dateRevised mesh__D009927 2004-07-13
% 211.25/211.49 |- skos__hiddenLabel mesh__D009927 Tissue Donations
% 211.25/211.49 |- skos__broader mesh__D009927smesh__D006296
% 211.25/211.49 |- skos__hiddenLabel mesh__D009927 Tissue Procurements
% 211.25/211.49 |- skos__hiddenLabel mesh__D009927 Donor Card
% 211.25/211.49 |- mesh__dateEstablished mesh__D009927 1987-01-01
% 211.25/211.49 |- mesh__recordMaintainer mesh__D009927 sjn
% 211.25/211.49 |- mesh__recordOriginator mesh__D009927 EC
% 211.34/211.49 |- skos__hiddenLabel mesh__D009927 Organ Donations
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D009927 2006
% 211.34/211.49 |- rdf__type mesh__D009927sskos__Concept
% 211.34/211.49 |- skos__scopeNote mesh__D009927
% 211.34/211.49 The administrative procedures involved with acquiring TISSUES or organs for TRANSPLANTATION through various programs, systems, or organizations. These procedures include obtaining consent from TISSUE DONORS and arranging for transportation of donated tissues and organs, after TISSUE HARVESTING, to HOSPITALS for processing and transplantation.%A%
% 211.34/211.49 |- skos__related mesh__D009927smesh__D020858
% 211.34/211.49 |- mesh__dateCreated mesh__D009927 1986-05-30
% 211.34/211.49 |- skos__hiddenLabel mesh__D009927 Card, Donor
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D009927 2005
% 211.34/211.49 |- mesh__recordOriginator mesh__D001944 NLM
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D001944 1999
% 211.34/211.49 |- skos__prefLabel mesh__D001944 Breath Tests
% 211.34/211.49 |- skos__hiddenLabel mesh__D001944 Tests, Breath
% 211.34/211.49 |- skos__hiddenLabel mesh__D001944 Tests, Breathalyzer
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D001944 2000
% 211.34/211.49 |- skos__hiddenLabel mesh__D001944 Test, Breathalyzer
% 211.34/211.49 |- rdf__type mesh__D001944sskos__Concept
% 211.34/211.49 |- skos__broader mesh__D001944smesh__D019937
% 211.34/211.49 |- skos__hiddenLabel mesh__D001944 Breath Test
% 211.34/211.49 |- mesh__historyNote mesh__D001944 74
% 211.34/211.49 |- mesh__dateRevised mesh__D001944 1997-06-20
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D001944 2005
% 211.34/211.49 |- mesh__dateCreated mesh__D001944 1999-01-01
% 211.34/211.49 |- skos__annotation mesh__D001944 NIM
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D001944 2001
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D001944 2003
% 211.34/211.49 |- skos__scopeNote mesh__D001944 Any tests done on exhaled air.
% 211.34/211.49 |- mesh__dateEstablished mesh__D001944 1974-01-01
% 211.34/211.49 |- skos__hiddenLabel mesh__D001944 Test, Breath
% 211.34/211.49 |- mesh__recordMaintainer mesh__D001944 PXP
% 211.34/211.49 |- mesh__publicMeSHNote mesh__D001944 74
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D001944 2006
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D001944 2002
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D001944 1998
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D001944 2004
% 211.34/211.49 |- mesh__recordAuthorizer mesh__D001944 SJN
% 211.34/211.49 |- skos__hiddenLabel mesh__D001944 Breathalyzer Test
% 211.34/211.49 |- mesh__historyNote mesh__D009129 72%28%70%29%
% 211.34/211.49 |- skos__scopeNote mesh__D009129
% 211.34/211.49 The state of activity or tension of a muscle beyond that related to its physical properties, that is, its active resistance to stretch. In skeletal muscle, tonus is dependent upon efferent innervation. %28%Stedman, 25th ed%29%%A%
% 211.34/211.49 |- mesh__recordAuthorizer mesh__D009129 sjn
% 211.34/211.49 |- skos__related mesh__D009129smesh__D004421
% 211.34/211.49 |- mesh__recordMaintainer mesh__D009129 nns
% 211.34/211.49 |- skos__historyNote mesh__D009129 Muscle Contraction %28%1966-1969%29%
% 211.34/211.49 |- mesh__dateCreated mesh__D009129 1999-01-01
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D009129 2004
% 211.34/211.49 |- rdf__type mesh__D009129sskos__Concept
% 211.34/211.49 |- skos__related mesh__D009129smesh__D009123
% 211.34/211.49 |- skos__prefLabel mesh__D009129 Muscle Tonus
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D009129 2005
% 211.34/211.49 |- skos__broader mesh__D009129smesh__D043703
% 211.34/211.49 |- mesh__publicMeSHNote mesh__D009129 72
% 211.34/211.49 |- skos__related mesh__D009129smesh__D009122
% 211.34/211.49 |- mesh__activeMeSHYear mesh__D009129 2006
% 211.35/211.49 |- mesh__dateRevised mesh__D009129 2003-07-09
% 211.35/211.49 |- skos__hiddenLabel mesh__D009129 Tonus, Muscle
% 211.35/211.49 |- mesh__recordOriginator mesh__D009129 NLM
% 211.35/211.49 |- mesh__dateEstablished mesh__D009129 1972-01-01
% 211.35/211.49 |- mesh__dateCreated mesh__D001146 1999-01-01
% 211.35/211.49 |- mesh__recordOriginator mesh__D001146 NLM
% 211.35/211.49 |- mesh__recordAuthorizer mesh__D001146 sjn
% 211.35/211.49 |- skos__scopeNote mesh__D001146
% 211.35/211.49 Irregularity of the heart rate related to functioning of the sinoatrial node.%A%
% 211.35/211.49 |- skos__hiddenLabel mesh__D001146 Sinus Arrhythmias
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001146 2002
% 211.35/211.49 |- skos__prefLabel mesh__D001146 Arrhythmia, Sinus
% 211.35/211.49 |- skos__altLabel mesh__D001146 Sinus Arrhythmia
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001146 2003
% 211.35/211.49 |- skos__annotation mesh__D001146
% 211.35/211.49 sinus refers to sinoatrial node; sinus parasystole: coord IM with PARASYSTOLE %28%IM%29%%A%
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001146 2005
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001146 2004
% 211.35/211.49 |- skos__hiddenLabel mesh__D001146 Arrhythmias, Sinus
% 211.35/211.49 |- skos__broader mesh__D001146smesh__D001145
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001146 2006
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001146 2000
% 211.35/211.49 |- mesh__recordMaintainer mesh__D001146 TPW
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001146 2001
% 211.35/211.49 |- mesh__dateRevised mesh__D001146 1999-11-03
% 211.35/211.49 |- rdf__type mesh__D001146sskos__Concept
% 211.35/211.49 |- skos__hiddenLabel mesh__D020300 Posterior Fossa Hemorrhages
% 211.35/211.49 |- skos__prefLabel mesh__D020300 Intracranial Hemorrhages
% 211.35/211.49 |- skos__broader mesh__D020300smesh__D006470
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D020300 2000
% 211.35/211.49 |- mesh__dateCreated mesh__D020300 1999-11-03
% 211.35/211.49 |- rdf__type mesh__D020300sskos__Concept
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D020300 2005
% 211.35/211.49 |- mesh__publicMeSHNote mesh__D020300 2000
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D020300 2001
% 211.35/211.49 |- skos__hiddenLabel mesh__D020300 Hemorrhage, Posterior Fossa
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D020300 2003
% 211.35/211.49 |- skos__historyNote mesh__D020300 Cerebral Hemorrhage %28%1966-1999%29%
% 211.35/211.49 |- skos__hiddenLabel mesh__D020300 Hemorrhage, Brain
% 211.35/211.49 |- skos__scopeNote mesh__D020300
% 211.35/211.49 Bleeding within the intracranial cavity, including hemorrhages in the brain and within the cranial epidural, subdural, and subarachnoid spaces.%A%
% 211.35/211.49 |- mesh__historyNote mesh__D020300 2000
% 211.35/211.49 |- skos__broader mesh__D020300smesh__D002561
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D020300 2006
% 211.35/211.49 |- skos__hiddenLabel mesh__D020300 Hemorrhages, Brain
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D020300 2002
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D020300 2004
% 211.35/211.49 |- skos__hiddenLabel mesh__D020300 Hemorrhages, Posterior Fossa
% 211.35/211.49 |- skos__hiddenLabel mesh__D020300 Intracranial Hemorrhage
% 211.35/211.49 |- skos__hiddenLabel mesh__D020300 Hemorrhages, Intracranial
% 211.35/211.49 |- mesh__dateEstablished mesh__D020300 2000-01-01
% 211.35/211.49 |- skos__altLabel mesh__D020300 Hemorrhage, Intracranial
% 211.35/211.49 |- skos__hiddenLabel mesh__D020300 Brain Hemorrhages
% 211.35/211.49 |- skos__hiddenLabel mesh__D047248 Compounds, Thia Crown
% 211.35/211.49 |- skos__hiddenLabel mesh__D047248 Crown Compounds, Aza-Thia
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D047248 2006
% 211.35/211.49 |- mesh__recordMaintainer mesh__D047248 ssb
% 211.35/211.49 |- mesh__recordOriginator mesh__D047248 ssb
% 211.35/211.49 |- skos__hiddenLabel mesh__D047248 Compounds, Aza-Thia Crown
% 211.35/211.49 |- skos__historyNote mesh__D047248 Crown Ethers %28%1992-2004%29%
% 211.35/211.49 |- mesh__dateCreated mesh__D047248 2004-07-07
% 211.35/211.49 |- mesh__historyNote mesh__D047248 2005; use CROWN ETHERS 1993-2004
% 211.35/211.49 |- skos__hiddenLabel mesh__D047248 Aza Thia Crown Compounds
% 211.35/211.49 |- skos__hiddenLabel mesh__D047248 Compounds, Aza Crown
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D047248 2005
% 211.35/211.49 |- skos__hiddenLabel mesh__D047248 Crown Compounds, Aza
% 211.35/211.49 |- skos__hiddenLabel mesh__D047248 Compounds, Crown
% 211.35/211.49 |- skos__hiddenLabel mesh__D047248 Crown Compounds, Thia
% 211.35/211.49 |- mesh__publicMeSHNote mesh__D047248 2005; see CROWN ETHERS 1993-2004
% 211.35/211.49 |- rdf__type mesh__D047248sskos__Concept
% 211.35/211.49 |- mesh__dateEstablished mesh__D047248 2005-01-01
% 211.35/211.49 |- skos__scopeNote mesh__D047248
% 211.35/211.49 Macrocyclic compounds analogous to CROWN ETHERS but which lack any OXYGEN atoms.%A%
% 211.35/211.49 |- skos__prefLabel mesh__D047248 Crown Compounds
% 211.35/211.49 |- mesh__recordAuthorizer mesh__D047248 sjn
% 211.35/211.49 |- skos__broader mesh__D047248smesh__D047028
% 211.35/211.49 |- rdf__type mesh__D019557sskos__Concept
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 2003
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 1999
% 211.35/211.49 |- skos__altLabel mesh__D019557 Periocular Dermatitis
% 211.35/211.49 |- skos__broader mesh__D019557smesh__D005148
% 211.35/211.49 |- mesh__dateEstablished mesh__D019557 1997-01-01
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 2004
% 211.35/211.49 |- skos__altLabel mesh__D019557 Perioral Dermatitis
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 2000
% 211.35/211.49 |- skos__annotation mesh__D019557
% 211.35/211.49 note X ref DERMATITIS, PERIOCULAR: can extend to this area%A%
% 211.35/211.49 |- skos__historyNote mesh__D019557 Facial Dermatoses %28%1968-1996%29%
% 211.35/211.49 |- mesh__publicMeSHNote mesh__D019557 97
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 2001
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 1997
% 211.35/211.49 |- skos__hiddenLabel mesh__D019557 Periocular Dermatitides
% 211.35/211.49 |- skos__scopeNote mesh__D019557
% 211.35/211.49 A papular eruption of unknown etiology that progresses to residual papular erythema and scaling usually confined to the area of the mouth, and almost exclusively occurring in young women. It may also be localized or extend to involve the eyelids and adjacent glabella area of the forehead %28%periocular dermatitis%29%. %28%Dorland, 28th ed%29%%A%
% 211.35/211.49 |- skos__hiddenLabel mesh__D019557 Perioral Dermatitides
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 2005
% 211.35/211.49 |- skos__historyNote mesh__D019557 Dermatitis %28%1969-1996%29%
% 211.35/211.49 |- mesh__dateCreated mesh__D019557 1996-06-13
% 211.35/211.49 |- skos__broader mesh__D019557smesh__D003872
% 211.35/211.49 |- skos__hiddenLabel mesh__D019557 Dermatitides, Perioral
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 2006
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 1998
% 211.35/211.49 |- skos__prefLabel mesh__D019557 Dermatitis, Perioral
% 211.35/211.49 |- skos__hiddenLabel mesh__D019557 Dermatitides, Periocular
% 211.35/211.49 |- mesh__historyNote mesh__D019557 97
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D019557 2002
% 211.35/211.49 |- skos__annotation mesh__D011574
% 211.35/211.49 IM; no qualif; /hist = PSYCHOANALYSIS /hist; differentiate from PSYCHOANALYTIC INTERPRETATION in that the theory is on a more universal, less subjective level%A%
% 211.35/211.49 |- skos__altLabel mesh__D011574 Theory, Psychoanalytic
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 2004
% 211.35/211.49 |- skos__scopeNote mesh__D011574
% 211.35/211.49 Conceptual system developed by Freud and his followers in which unconscious motivations are considered to shape normal and abnormal personality development and behavior.%A%
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 1998
% 211.35/211.49 |- rdf__type mesh__D011574sskos__Concept
% 211.35/211.49 |- skos__hiddenLabel mesh__D011574 Characters, Oral
% 211.35/211.49 |- mesh__dateEstablished mesh__D011574 1966-01-01
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 2003
% 211.35/211.49 |- skos__hiddenLabel mesh__D011574 Psychoanalytic Theories
% 211.35/211.49 |- skos__altLabel mesh__D011574 Psychoanalytical Theory
% 211.35/211.49 |- skos__broader mesh__D011574smesh__D011582
% 211.35/211.49 |- skos__hiddenLabel mesh__D011574 Character, Oral
% 211.35/211.49 |- mesh__publicMeSHNote mesh__D011574
% 211.35/211.49 66; ORAL CHARACTER was heading 1975-96 %28%see under PSYCHOANALYTIC THEORY 1975-90%29%%A%
% 211.35/211.49 |- skos__hiddenLabel mesh__D011574 Theories, Psychoanalytic
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 1997
% 211.35/211.49 |- skos__hiddenLabel mesh__D011574 Oral Characters
% 211.35/211.49 |- mesh__dateRevised mesh__D011574 1996-06-10
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 2002
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 2006
% 211.35/211.49 |- skos__hiddenLabel mesh__D011574 Theories, Psychoanalytical
% 211.35/211.49 |- skos__hiddenLabel mesh__D011574 Theory, Psychoanalytical
% 211.35/211.49 |- mesh__recordMaintainer mesh__D011574 PXP
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 2001
% 211.35/211.49 |- mesh__recordOriginator mesh__D011574 NLM
% 211.35/211.49 |- mesh__dateCreated mesh__D011574 1999-01-01
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 2005
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 2000
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D011574 1999
% 211.35/211.49 |- mesh__historyNote mesh__D011574
% 211.35/211.49 66; ORAL CHARACTER was heading 1975-96 %28%see under PSYCHOANALYTIC THEORY 1975-90%29%%A%
% 211.35/211.49 |- skos__prefLabel mesh__D011574 Psychoanalytic Theory
% 211.35/211.49 |- skos__hiddenLabel mesh__D011574 Psychoanalytical Theories
% 211.35/211.49 |- mesh__recordAuthorizer mesh__D011574 PLS
% 211.35/211.49 |- skos__prefLabel mesh__D005537 Aphthovirus
% 211.35/211.49 |- rdf__type mesh__D005537sskos__Concept
% 211.35/211.49 |- mesh__dateRevised mesh__D005537 2001-07-25
% 211.35/211.49 |- skos__broader mesh__D005537smesh__D010849
% 211.35/211.49 |- mesh__recordMaintainer mesh__D005537 ags
% 211.35/211.49 |- skos__hiddenLabel mesh__D005537 rhinovirus 1, Equine
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D005537 2003
% 211.35/211.49 |- mesh__recordAuthorizer mesh__D005537 sjn
% 211.35/211.49 |- skos__annotation mesh__D005537
% 211.35/211.49 infection: coord IM with PICORNAVIRIDAE INFECTIONS %28%IM%29%
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D005537 2005
% 211.35/211.49 |- mesh__dateCreated mesh__D005537 1999-01-01
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D005537 2004
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D005537 2006
% 211.35/211.49 |- skos__scopeNote mesh__D005537
% 211.35/211.49 A genus of the family PICORNAVIRIDAE infecting mainly cloven-hoofed animals. They cause vesicular lesions and upper respiratory tract infections. FOOT AND MOUTH DISEASE VIRUS is the type species.%A%
% 211.35/211.49 |- skos__hiddenLabel mesh__D005537 Aphthoviruses
% 211.35/211.49 |- mesh__historyNote mesh__D005537 1994 %28%1963%29%
% 211.35/211.49 |- skos__altLabel mesh__D005537 Equine rhinovirus 1
% 211.35/211.49 |- mesh__publicMeSHNote mesh__D005537
% 211.35/211.49 1994; see FOOT-AND-MOUTH DISEASE VIRUS 1963-1993
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D005537 2002
% 211.35/211.49 |- mesh__recordOriginator mesh__D005537 NLM
% 211.35/211.49 |- skos__scopeNote mesh__D015167
% 211.35/211.49 Bilateral dissection of the abdominal branches of the vagus nerve. It is used frequently in the surgical management of duodenal and gastric ulcers, as well as in physiologic studies of gastrointestinal secretion and motility.%A%
% 211.35/211.49 |- skos__annotation mesh__D015167
% 211.35/211.49 do not use /util except by MeSH definition
% 211.35/211.49 |- mesh__recordMaintainer mesh__D015167 PXP
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D015167 2006
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D015167 2002
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D015167 1999
% 211.35/211.49 |- mesh__historyNote mesh__D015167 89
% 211.35/211.49 |- skos__hiddenLabel mesh__D015167 Truncal Vagotomies
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D015167 2005
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D015167 2004
% 211.35/211.49 |- skos__historyNote mesh__D015167 Vagotomy %28%1966-1988%29%
% 211.35/211.49 |- mesh__publicMeSHNote mesh__D015167 89
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D015167 1998
% 211.35/211.49 |- mesh__recordAuthorizer mesh__D015167 SJN
% 211.35/211.49 |- mesh__dateEstablished mesh__D015167 1989-01-01
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D015167 2003
% 211.35/211.49 |- skos__broader mesh__D015167smesh__D014628
% 211.35/211.49 |- skos__hiddenLabel mesh__D015167 Vagotomies, Truncal
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D015167 2001
% 211.35/211.49 |- rdf__type mesh__D015167sskos__Concept
% 211.35/211.49 |- mesh__recordOriginator mesh__D015167 SCD
% 211.35/211.49 |- skos__altLabel mesh__D015167 Truncal Vagotomy
% 211.35/211.49 |- skos__prefLabel mesh__D015167 Vagotomy, Truncal
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D015167 2000
% 211.35/211.49 |- mesh__dateRevised mesh__D015167 1997-06-20
% 211.35/211.49 |- mesh__dateCreated mesh__D015167 1988-04-08
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 1995
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 2001
% 211.35/211.49 |- mesh__recordOriginator mesh__D009928 NLM
% 211.35/211.49 |- skos__scopeNote mesh__D009928
% 211.35/211.49 Restriction of a characteristic or response to a particular organ of the body; it usually refers to that property of the immune response which differentiates one organ from another on the basis of antigen recognition, but the concept is not limited to immunology.%A%
% 211.35/211.49 |- skos__broader mesh__D009928smesh__D000918
% 211.35/211.49 |- skos__hiddenLabel mesh__D009928 Specificity, Organ
% 211.35/211.49 |- mesh__recordMaintainer mesh__D009928 TAP
% 211.35/211.49 |- skos__hiddenLabel mesh__D009928 Organ Specificities
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 1996
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 2003
% 211.35/211.49 |- mesh__dateCreated mesh__D009928 1999-01-01
% 211.35/211.49 |- mesh__dateEstablished mesh__D009928 1967-01-01
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 1998
% 211.35/211.49 |- skos__hiddenLabel mesh__D009928 Specificities, Organ
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 1997
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 2002
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 2005
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 2004
% 211.35/211.49 |- skos__prefLabel mesh__D009928 Organ Specificity
% 211.35/211.49 |- skos__annotation mesh__D009928
% 211.35/211.49 IM GEN only; coord NIM with specific organ %28%IM%29%; %22%tissue specificity%22% goes here if reasonable %28%i.e., liver tissue specificity = LIVER + ORGAN SPECIFICITY but connective tissue specificity is not CONNECTIVE TISSUE + ORGAN SPECIFICITY%29%%A%
% 211.35/211.49 |- mesh__dateRevised mesh__D009928 1992-05-15
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 1999
% 211.35/211.49 |- rdf__type mesh__D009928sskos__Concept
% 211.35/211.49 |- mesh__recordAuthorizer mesh__D009928 PLS
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 2006
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 1994
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 2000
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D009928 1993
% 211.35/211.49 |- mesh__historyNote mesh__D009928 67%28%64%29%
% 211.35/211.49 |- mesh__publicMeSHNote mesh__D009928 67
% 211.35/211.49 |- skos__hiddenLabel mesh__D001945 Muscle Training, Respiratory
% 211.35/211.49 |- mesh__recordAuthorizer mesh__D001945 sjn
% 211.35/211.49 |- skos__related mesh__D001945smesh__D015013
% 211.35/211.49 |- skos__hiddenLabel mesh__D001945 Gong, Qi
% 211.35/211.49 |- skos__hiddenLabel mesh__D001945 Training, Respiratory Muscle
% 211.35/211.49 |- mesh__recordOriginator mesh__D001945 NLM
% 211.35/211.49 |- skos__scopeNote mesh__D001945
% 211.35/211.49 Therapeutic exercises aimed to deepen inspiration or expiration or even to alter the rate and rhythm of respiration.%A%
% 211.35/211.49 |- rdf__type mesh__D001945sskos__Concept
% 211.35/211.49 |- skos__altLabel mesh__D001945 Respiratory Muscle Training
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001945 2005
% 211.35/211.49 |- mesh__dateCreated mesh__D001945 1999-01-01
% 211.35/211.49 |- skos__hiddenLabel mesh__D001945 Exercise, Breathing
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001945 2003
% 211.35/211.49 |- skos__hiddenLabel mesh__D001945 Kung, Ch%27%i
% 211.35/211.49 |- skos__broader mesh__D001945smesh__D026441
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001945 2006
% 211.35/211.49 |- skos__prefLabel mesh__D001945 Breathing Exercises
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D001945 2004
% 211.35/211.49 |- skos__altLabel mesh__D001945 Qi Gong
% 211.35/211.49 |- mesh__dateRevised mesh__D001945 2002-07-02
% 211.35/211.49 |- skos__broader mesh__D001945smesh__D026241
% 211.35/211.49 |- mesh__recordMaintainer mesh__D001945 mdb
% 211.35/211.49 |- skos__scopeNote mesh__D034321
% 211.35/211.49 A condition with abnormally elevated level of AMYLASES in the serum. Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes.%A%
% 211.35/211.49 |- skos__broader mesh__D034321smesh__D008659
% 211.35/211.49 |- mesh__dateCreated mesh__D034321 2002-07-03
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D034321 2003
% 211.35/211.49 |- mesh__historyNote mesh__D034321 2003
% 211.35/211.49 |- mesh__activeMeSHYear mesh__D034321 2004
% 211.35/211.50 |- mesh__dateEstablished mesh__D034321 2003-01-01
% 211.35/211.50 |- rdf__type mesh__D034321sskos__Concept
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D034321 2005
% 211.35/211.50 |- skos__historyNote mesh__D034321 Amylases %28%1967-2002%29%
% 211.35/211.50 |- skos__prefLabel mesh__D034321 Hyperamylasemia
% 211.35/211.50 |- skos__historyNote mesh__D034321 Metabolic Diseases %28%1970-2002%29%
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D034321 2003
% 211.35/211.50 |- skos__related mesh__D034321smesh__D000681
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D034321 2006
% 211.35/211.50 |- skos__broader mesh__D006521Q000139smesh__D006521
% 211.35/211.50 |- mesh__preferredCombination mesh__D006521Q000139smesh__D019702
% 211.35/211.50 |- rdf__type mesh__D006521Q000139smesh__CompoundConcept
% 211.35/211.50 |- skos__hiddenLabel mesh__D001147 Acid, Arsanilic
% 211.35/211.50 |- skos__altLabel mesh__D001147 p-Aminophenylarsonic Acid
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D001147 2002
% 211.35/211.50 |- mesh__historyNote mesh__D001147
% 211.35/211.50 91%28%79%29%; was see under ARSENICALS 1979-90
% 211.35/211.50 |- mesh__dateCreated mesh__D001147 1978-05-17
% 211.35/211.50 |- skos__hiddenLabel mesh__D001147 p Aminophenylarsonic Acid
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D001147 2005
% 211.35/211.50 |- skos__altLabel mesh__D001147 4-Aminobenzenearsonic Acid
% 211.35/211.50 |- skos__historyNote mesh__D001147 Arsenicals %28%1966-1978%29%
% 211.35/211.50 |- rdf__type mesh__D001147sskos__Concept
% 211.35/211.50 |- skos__altLabel mesh__D001147 Sodium Arsanilate
% 211.35/211.50 |- skos__hiddenLabel mesh__D001147 4 Aminobenzenearsonic Acid
% 211.35/211.50 |- mesh__recordMaintainer mesh__D001147 CCR
% 211.35/211.50 |- mesh__recordOriginator mesh__D001147 RLS
% 211.35/211.50 |- skos__broader mesh__D001147smesh__D001152
% 211.35/211.50 |- skos__prefLabel mesh__D001147 Arsanilic Acid
% 211.35/211.50 |- skos__hiddenLabel mesh__D001147 Acid, p-Aminophenylarsonic
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D001147 2001
% 211.35/211.50 |- mesh__recordAuthorizer mesh__D001147 sjn
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D001147 2004
% 211.35/211.50 |- mesh__dateEstablished mesh__D001147 1991-01-01
% 211.35/211.50 |- skos__scopeNote mesh__D001147
% 211.35/211.50 An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals.%A%
% 211.35/211.50 |- mesh__dateRevised mesh__D001147 2000-06-21
% 211.35/211.50 |- skos__hiddenLabel mesh__D001147 Arsenilate, Sodium
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D001147 2003
% 211.35/211.50 |- skos__hiddenLabel mesh__D001147 Arsanilate, Sodium
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D001147 2006
% 211.35/211.50 |- skos__hiddenLabel mesh__D001147 Acid, 4-Aminobenzenearsonic
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D001147
% 211.35/211.50 91; was see under ARSENICALS 1979-90
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Hispanic American
% 211.35/211.50 |- skos__historyNote mesh__D006630 Mexico %28%1966-1977%29%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D006630 2004
% 211.35/211.50 |- skos__historyNote mesh__D006630 Ethnic Groups %28%1968-1977%29%
% 211.35/211.50 |- mesh__dateEstablished mesh__D006630 1978-01-01
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D006630 78
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D006630 2004B
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Cuban American
% 211.35/211.50 |- skos__annotation mesh__D006630
% 211.35/211.50 does not include Brazilian Americans %28% = UNITED STATES + BRAZIL /ethnol%29% nor Portuguese Americans %28% = UNITED STATES + PORTUGAL /ethnol%29%; specify geog; despite X refs specify NIM PUERTO RICO/ethnol or other Hispanic country with /ethnol when pertinent; MEXICAN AMERICANS is available%A%
% 211.35/211.50 |- mesh__dateCreated mesh__D006630 1977-03-01
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Hispanic
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Puerto Rican
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 American, Hispanic
% 211.35/211.50 |- mesh__recordAuthorizer mesh__D006630 jls
% 211.35/211.50 |- skos__scopeNote mesh__D006630
% 211.35/211.50 Persons living in the United States of Mexican %28%MEXICAN AMERICANS%29%, Puerto Rican, Cuban, Central or South American, or other Spanish culture or origin. The concept does not include Brazilian Americans or Portuguese Americans.%A%
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Americans, Spanish
% 211.35/211.50 |- skos__historyNote mesh__D006630 Puerto Rico %28%1966-1977%29%
% 211.35/211.50 |- skos__historyNote mesh__D006630 United States %28%1966-1977%29%
% 211.35/211.50 |- rdf__type mesh__D006630sskos__Concept
% 211.35/211.50 |- skos__prefLabel mesh__D006630 Hispanic Americans
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Latina
% 211.35/211.50 |- mesh__recordMaintainer mesh__D006630 jls
% 211.35/211.50 |- skos__historyNote mesh__D006630 specific state %28%1966-1977%29%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D006630 2005
% 211.35/211.50 |- skos__broader mesh__D006630smesh__D005006
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Spanish American
% 211.35/211.50 |- mesh__historyNote mesh__D006630 78
% 211.35/211.50 |- mesh__recordOriginator mesh__D006630 SMH
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Americans, Cuban
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Americans, Hispanic
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D006630 2006
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D006630 2004A
% 211.35/211.50 |- skos__altLabel mesh__D006630 Spanish Americans
% 211.35/211.50 |- mesh__dateRevised mesh__D006630 2003-10-30
% 211.35/211.50 |- skos__hiddenLabel mesh__D006630 Latino
% 211.35/211.50 |- rdf__type mesh__D020301sskos__Concept
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Vascular Spasm, Intracranial
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D020301 2005
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D020301 2003
% 211.35/211.50 |- skos__broader mesh__D020301smesh__D002561
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Vasospasms, Intracranial
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Spasms, Cerebral Artery
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Artery Spasm, Cerebral
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Spasms, Cerebrovascular
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D020301 2006
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D020301 2000
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Vascular Spasms, Intracranial
% 211.35/211.50 |- skos__altLabel mesh__D020301 Intracranial Vascular Spasm
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D020301 2004
% 211.35/211.50 |- mesh__dateCreated mesh__D020301 1999-11-03
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Intracranial Vasospasms
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Spasms, Intracranial Vascular
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D020301
% 211.35/211.50 2000; for CEREBRAL VASOSPASM see CEREBRAL ISCHEMIA, TRANSIENT 1966-1999%A%
% 211.35/211.50 |- skos__altLabel mesh__D020301 Cerebrovascular Spasm
% 211.35/211.50 |- skos__altLabel mesh__D020301 Intracranial Vasospasm
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Vasospasms, Cerebral
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D020301 2001
% 211.35/211.50 |- skos__historyNote mesh__D020301
% 211.35/211.50 Ischemic Attack, Transient %28%1966-1999%29%
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Vasospasm, Cerebral
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Spasm, Cerebrovascular
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Artery Spasms, Cerebral
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Cerebrovascular Spasms
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Cerebral Artery Spasms
% 211.35/211.50 |- skos__prefLabel mesh__D020301 Vasospasm, Intracranial
% 211.35/211.50 |- mesh__dateEstablished mesh__D020301 2000-01-01
% 211.35/211.50 |- skos__scopeNote mesh__D020301
% 211.35/211.50 Narrowing of the lumen of one or more intracranial arteries due to contraction of arterial smooth muscle or to morphologic changes of the blood vessel wall. Large blood vessels near the base of the brain are primarily affected and reduced blood flow may result in hypoxic-ischemic brain injury %28%HYPOXIA-ISCHEMIA, BRAIN%29%. Vasospasm may be associated with SUBARACHNOID HEMORRHAGE; CRANIOCEREBRAL TRAUMA; and other disorders. %28%From Neurosurg Clin N Am, 1998 Jul;9%28%3%29%:615-27%29%%A%
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Intracranial Vascular Spasms
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Spasm, Cerebral Artery
% 211.35/211.50 |- mesh__historyNote mesh__D020301
% 211.35/211.50 2000; for CEREBRAL VASOSPASM use CEREBRAL ISCHEMIA, TRANSIENT 1966-1999%A%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D020301 2002
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Cerebral Vasospasms
% 211.35/211.50 |- skos__hiddenLabel mesh__D020301 Spasm, Intracranial Vascular
% 211.35/211.50 |- skos__altLabel mesh__D020301 Cerebral Artery Spasm
% 211.35/211.50 |- mesh__dateEstablished mesh__D019558 1997-01-01
% 211.35/211.50 |- skos__broader mesh__D019558smesh__D009971
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 2006
% 211.35/211.50 |- skos__prefLabel mesh__D019558 Occlusal Adjustment
% 211.35/211.50 |- skos__historyNote mesh__D019558
% 211.35/211.50 Dental Occlusion, Balanced %28%1993-1996%29%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 2001
% 211.35/211.50 |- mesh__historyNote mesh__D019558
% 211.35/211.50 97; OCCLUSAL EQUILIBRATION was see DENTAL OCCLUSION, BALANCED 1975-96; was see under DENTAL OCCLUSION, BALANCED 1969-74%A%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 2004
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 2005
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 1999
% 211.35/211.50 |- skos__scopeNote mesh__D019558
% 211.35/211.50 Selective grinding of occlusal surfaces of the teeth in an effort to eliminate premature contacts and occlusal interferences; to establish optimal masticatory effectiveness, stable occlusal relationships, direction of main occlusal forces, and efficient multidirectional patterns, to improve functional relations and to induce physiologic stimulation of the masticatory system; to eliminate occlusal trauma; to eliminate abnormal muscle tension; to aid in the stabilization of orthodontic results; to treat periodontal and temporomandibular joint problems; and in restorative procedures. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%
% 211.35/211.50 |- rdf__type mesh__D019558sskos__Concept
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 2000
% 211.35/211.50 |- skos__annotation mesh__D019558
% 211.35/211.50 grinding of occlusal surfaces of teeth to achieve optimal occlusion%A%
% 211.35/211.50 |- mesh__onlineNote mesh__D019558
% 211.35/211.50 use DENTAL OCCLUSION, BALANCED to search OCCLUSAL ADJUSTMENT 1969-96%A%
% 211.35/211.50 |- skos__hiddenLabel mesh__D019558 Equilibrations, Occlusal
% 211.35/211.50 |- skos__hiddenLabel mesh__D019558 Adjustments, Occlusal
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 2003
% 211.35/211.50 |- skos__altLabel mesh__D019558 Occlusal Equilibration
% 211.35/211.50 |- mesh__recordAuthorizer mesh__D019558 jls
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 1997
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 1998
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D019558
% 211.35/211.50 97; OCCLUSAL EQUILIBRATION was see DENTAL OCCLUSION, BALANCED 1975-96; was see under DENTAL OCCLUSION, BALANCED 1969-74%A%
% 211.35/211.50 |- skos__hiddenLabel mesh__D019558 Adjustment, Occlusal
% 211.35/211.50 |- mesh__dateRevised mesh__D019558 2004-07-29
% 211.35/211.50 |- skos__hiddenLabel mesh__D019558 Occlusal Adjustments
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 2002
% 211.35/211.50 |- mesh__recordMaintainer mesh__D019558 jls
% 211.35/211.50 |- mesh__dateCreated mesh__D019558 1996-06-13
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 2005B
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D019558 2005A
% 211.35/211.50 |- mesh__recordOriginator mesh__D019558 JLS
% 211.35/211.50 |- skos__hiddenLabel mesh__D011575 Therapies, Psychoanalytical
% 211.35/211.50 |- skos__altLabel mesh__D011575 Therapy, Balint Psychoanalytic
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 2003
% 211.35/211.50 |- skos__scopeNote mesh__D011575
% 211.35/211.50 A form of psychiatric treatment, based on Freudian principles, which seeks to eliminate or diminish the undesirable effects of unconscious conflicts by making the patient aware of their existence, origin, and inappropriate expression in current emotions and behavior.%A%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 2000
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 1997
% 211.35/211.50 |- mesh__recordMaintainer mesh__D011575 PLS
% 211.35/211.50 |- mesh__recordAuthorizer mesh__D011575 PLS
% 211.35/211.50 |- mesh__dateRevised mesh__D011575 1995-05-31
% 211.35/211.50 |- skos__hiddenLabel mesh__D011575 Psychoanalytical Therapies
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 1996
% 211.35/211.50 |- skos__altLabel mesh__D011575 Therapy, Psychoanalytic
% 211.35/211.50 |- skos__hiddenLabel mesh__D011575 Psychoanalytic Therapies
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 2006
% 211.35/211.50 |- skos__prefLabel mesh__D011575 Psychoanalytic Therapy
% 211.35/211.50 |- skos__broader mesh__D011575smesh__D011613
% 211.35/211.50 |- skos__annotation mesh__D011575
% 211.35/211.50 a psychother technique; DF: PSYCHOANAL THER
% 211.35/211.50 |- mesh__dateCreated mesh__D011575 1999-01-01
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 2005
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 2002
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 1999
% 211.35/211.50 |- skos__hiddenLabel mesh__D011575 Therapy, Psychoanalytical
% 211.35/211.50 |- skos__altLabel mesh__D011575 Psychoanalytical Therapy
% 211.35/211.50 |- skos__altLabel mesh__D011575 Psychoanalytic Therapy, Balint
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 2004
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 2001
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D011575 1998
% 211.35/211.50 |- rdf__type mesh__D011575sskos__Concept
% 211.35/211.50 |- mesh__recordOriginator mesh__D011575 NLM
% 211.35/211.50 |- skos__hiddenLabel mesh__D011575 Therapies, Psychoanalytic
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 2005
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 2004
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 1999
% 211.35/211.50 |- skos__historyNote mesh__D005538 Sports %28%1966-1975%29%
% 211.35/211.50 |- skos__broader mesh__D005538smesh__D013177
% 211.35/211.50 |- mesh__recordAuthorizer mesh__D005538 PLS
% 211.35/211.50 |- skos__scopeNote mesh__D005538
% 211.35/211.50 A competitive team sport played on a rectangular field. This is the American or Canadian version of the game and also includes the form known as rugby. It does not include non-North American football %28%= SOCCER%29%.%A%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 2002
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 2006
% 211.35/211.50 |- mesh__dateRevised mesh__D005538 1996-06-10
% 211.35/211.50 |- mesh__recordMaintainer mesh__D005538 TPW
% 211.35/211.50 |- skos__hiddenLabel mesh__D005538 Rugbies
% 211.35/211.50 |- skos__annotation mesh__D005538
% 211.35/211.50 /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15+; note X ref RUGBY; does not include non-North American %22%football%22% %28% = SOCCER%29%%A%
% 211.35/211.50 |- skos__prefLabel mesh__D005538 Football
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 2000
% 211.35/211.50 |- mesh__dateEstablished mesh__D005538 1976-01-01
% 211.35/211.50 |- mesh__dateCreated mesh__D005538 1975-07-25
% 211.35/211.50 |- mesh__recordOriginator mesh__D005538 JW
% 211.35/211.50 |- rdf__type mesh__D005538sskos__Concept
% 211.35/211.50 |- mesh__historyNote mesh__D005538 76
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 2001
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D005538 76
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 1998
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 2003
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D005538 1997
% 211.35/211.50 |- skos__prefLabel mesh__D016260 Monocytes, Activated Killer
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D016260 2004
% 211.35/211.50 |- mesh__dateCreated mesh__D016260 1990-06-06
% 211.35/211.50 |- skos__historyNote mesh__D016260 Monocytes %28%1988-1990%29%
% 211.35/211.50 |- mesh__dateRevised mesh__D016260 2003-07-09
% 211.35/211.50 |- mesh__historyNote mesh__D016260 91
% 211.35/211.50 |- skos__hiddenLabel mesh__D016260 Activated Killer Monocyte
% 211.35/211.50 |- skos__altLabel mesh__D016260 Killer Monocytes, Activated
% 211.35/211.50 |- mesh__dateEstablished mesh__D016260 1991-01-01
% 211.35/211.50 |- skos__altLabel mesh__D016260 Activated Killer Monocytes
% 211.35/211.50 |- skos__hiddenLabel mesh__D016260 Killer Monocyte, Activated
% 211.35/211.50 |- skos__related mesh__D016260smesh__D016219
% 211.35/211.50 |- skos__scopeNote mesh__D016260
% 211.35/211.50 Monocytes made cytotoxic by ex vivo incubation with cytokines, especially interferon-gamma. AKM cells are used for adoptive immunotherapy in cancer patients.%A%
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D016260 91
% 211.35/211.50 |- skos__annotation mesh__D016260 A 11 qualif; DF: AKM
% 211.35/211.50 |- skos__hiddenLabel mesh__D016260 Monocyte, Activated Killer
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D016260 2006
% 211.35/211.50 |- skos__broader mesh__D016260smesh__D009000
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D016260 2005
% 211.35/211.50 |- rdf__type mesh__D016260sskos__Concept
% 211.35/211.50 |- skos__annotation mesh__D002240
% 211.35/211.50 IM for general only; coord NIM with specific carbohydrate %28%IM%29%; do not confuse with CARBOHYDRATE LINKAGE see CARBOHYDRATE CONFORMATION: sequ = order in which components are arranged, conform = spatial or 3-dimensional struct; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: CARB SEQ%A%
% 211.35/211.50 |- skos__broader mesh__D002240smesh__D008969
% 211.35/211.50 |- mesh__dateRevised mesh__D002240 2005-07-27
% 211.35/211.50 |- mesh__recordAuthorizer mesh__D002240 ags
% 211.35/211.50 |- mesh__dateCreated mesh__D002240 1979-05-24
% 211.35/211.50 |- skos__hiddenLabel mesh__D002240 Sequences, Carbohydrate
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D002240 2006A
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D002240 2004
% 211.35/211.50 |- mesh__recordMaintainer mesh__D002240 ags
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D002240 2006
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D002240 2003
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D002240 2005
% 211.35/211.50 |- skos__prefLabel mesh__D002240 Carbohydrate Sequence
% 211.35/211.50 |- mesh__dateEstablished mesh__D002240 1980-01-01
% 211.35/211.50 |- skos__broader mesh__D002240smesh__D015394
% 211.35/211.50 |- mesh__recordOriginator mesh__D002240 VDK
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D002240 80
% 211.35/211.50 |- skos__hiddenLabel mesh__D002240 Sequence, Carbohydrate
% 211.35/211.50 |- skos__hiddenLabel mesh__D002240 Carbohydrate Sequences
% 211.35/211.50 |- mesh__historyNote mesh__D002240 80
% 211.35/211.50 |- rdf__type mesh__D002240sskos__Concept
% 211.35/211.50 |- skos__scopeNote mesh__D002240
% 211.35/211.50 The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS.%A%
% 211.35/211.50 |- mesh__dateEstablished mesh__D015966 1990-01-01
% 211.35/211.50 |- mesh__historyNote mesh__D015966 90
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015966 2004
% 211.35/211.50 |- skos__historyNote mesh__D015966 specific fungi %28%1972-1989%29%
% 211.35/211.50 |- mesh__recordMaintainer mesh__D015966 NDW
% 211.35/211.50 |- mesh__recordOriginator mesh__D015966 PXP
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D015966 90
% 211.35/211.50 |- skos__scopeNote mesh__D015966
% 211.35/211.50 Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in fungi.%A%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015966 2005
% 211.35/211.50 |- skos__historyNote mesh__D015966 Genes, Regulator %28%1972-1980%29%
% 211.35/211.50 |- skos__historyNote mesh__D015966
% 211.35/211.50 Gene Expression Regulation %28%1981-1989%29%
% 211.35/211.50 |- skos__broader mesh__D015966smesh__D005786
% 211.35/211.50 |- skos__altLabel mesh__D015966 Fungal Gene Expression Regulation
% 211.35/211.50 |- mesh__dateRevised mesh__D015966 2002-07-03
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015966 2006
% 211.35/211.50 |- mesh__dateCreated mesh__D015966 1989-05-25
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015966 2003
% 211.35/211.50 |- rdf__type mesh__D015966sskos__Concept
% 211.35/211.50 |- skos__annotation mesh__D015966
% 211.35/211.50 coord IM with specific fungus /genet %28%IM%29%; DF: GENE EXPRESSION REG FUNGAL%A%
% 211.35/211.50 |- skos__altLabel mesh__D015966 Regulation, Gene Expression, Fungal
% 211.35/211.50 |- skos__prefLabel mesh__D015966 Gene Expression Regulation, Fungal
% 211.35/211.50 |- mesh__recordAuthorizer mesh__D015966 sjn
% 211.35/211.50 |- skos__altLabel mesh__D015966 Regulation of Gene Expression, Fungal
% 211.35/211.50 |- skos__prefLabel mesh__D015168 Lightning Injuries
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 1998
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 1997
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 2003
% 211.35/211.50 |- skos__hiddenLabel mesh__D015168 Lightning Injury
% 211.35/211.50 |- mesh__dateCreated mesh__D015168 1988-04-08
% 211.35/211.50 |- rdf__type mesh__D015168sskos__Concept
% 211.35/211.50 |- mesh__recordAuthorizer mesh__D015168 PLS
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 1996
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 2000
% 211.35/211.50 |- skos__historyNote mesh__D015168 Electric Injuries %28%1966-1988%29%
% 211.35/211.50 |- mesh__dateRevised mesh__D015168 1992-03-25
% 211.35/211.50 |- mesh__recordMaintainer mesh__D015168 TGC
% 211.35/211.50 |- mesh__recordOriginator mesh__D015168 SCD
% 211.35/211.50 |- skos__scopeNote mesh__D015168
% 211.35/211.50 Accidental injuries caused by brief high-voltage electrical discharges during thunderstorms. Cardiopulmonary arrest, coma and other neurologic symptoms, myocardial necrosis, and dermal burns are common. Prompt treatment of the acute sequelae, including cardiopulmonary resuscitation, is indicated for survival.%A%
% 211.35/211.50 |- skos__hiddenLabel mesh__D015168 Lightning Strokes
% 211.35/211.50 |- skos__hiddenLabel mesh__D015168 Strokes, Lightning
% 211.35/211.50 |- skos__historyNote mesh__D015168 Burns, Electric %28%1966-1988%29%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 1995
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 2002
% 211.35/211.50 |- mesh__historyNote mesh__D015168
% 211.35/211.50 91%28%89%29%; was see under ELECTRIC INJURIES 1989-90
% 211.35/211.50 |- skos__annotation mesh__D015168 DF: LIGHTNING INJ
% 211.35/211.50 |- skos__altLabel mesh__D015168 Injuries, Lightning
% 211.35/211.50 |- skos__historyNote mesh__D015168 Lightning %28%1966-1988%29%
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 1994
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 1993
% 211.35/211.50 |- skos__hiddenLabel mesh__D015168 Stroke, Lightning
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 2006
% 211.35/211.50 |- skos__hiddenLabel mesh__D015168 Injury, Lightning
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D015168
% 211.35/211.50 91; was see under ELECTRIC INJURIES 1989-90
% 211.35/211.50 |- skos__broader mesh__D015168smesh__D004556
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 1999
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 2005
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 2004
% 211.35/211.50 |- mesh__dateEstablished mesh__D015168 1991-01-01
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D015168 2001
% 211.35/211.50 |- mesh__recordMaintainer mesh__D009929 lkt
% 211.35/211.50 |- mesh__dateCreated mesh__D009929 1999-01-01
% 211.35/211.50 |- mesh__recordOriginator mesh__D009929 NLM
% 211.35/211.50 |- mesh__historyNote mesh__D009929 2005 %28%1966%29%
% 211.35/211.50 |- skos__scopeNote mesh__D009929
% 211.35/211.50 The measurement of an organ in volume, mass, or heaviness.%A%
% 211.35/211.50 |- skos__hiddenLabel mesh__D009929 Size, Organ
% 211.35/211.50 |- skos__broader mesh__D009929smesh__D001837
% 211.35/211.50 |- rdf__type mesh__D009929sskos__Concept
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D009929 2006
% 211.35/211.50 |- skos__prefLabel mesh__D009929 Organ Size
% 211.35/211.50 |- skos__annotation mesh__D009929
% 211.35/211.50 almost never IM; coordinate NIM with organ /anat %28%IM%29% or /growth %28%IM%29% or /pathol %28%IM%29% or disease /pathol %28%IM%29%%A%
% 211.35/211.50 |- mesh__dateRevised mesh__D009929 2005-06-30
% 211.35/211.50 |- skos__hiddenLabel mesh__D009929 Weight, Organ
% 211.35/211.50 |- skos__broader mesh__D009929smesh__D006128
% 211.35/211.50 |- mesh__dateEstablished mesh__D009929 1966-01-01
% 211.35/211.50 |- mesh__recordAuthorizer mesh__D009929 sjn
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D009929 2005; see ORGAN WEIGHT 1966-2004
% 211.35/211.50 |- skos__broader mesh__D001946smesh__D007744
% 211.35/211.50 |- mesh__onlineNote mesh__D001946 search LABOR PRESENTATION 1966-74
% 211.35/211.50 |- mesh__dateRevised mesh__D001946 2005-06-30
% 211.35/211.50 |- mesh__dateCreated mesh__D001946 1999-01-01
% 211.35/211.50 |- skos__hiddenLabel mesh__D001946 Presentation, Breech Fetal
% 211.35/211.50 |- skos__hiddenLabel mesh__D001946 Breech Presentation, Frank
% 211.35/211.50 |- mesh__publicMeSHNote mesh__D001946
% 211.35/211.50 85; was see under LABOR PRESENTATION 1963-84
% 211.35/211.50 |- skos__annotation mesh__D001946 check the tags FEMALE %26% PREGNANCY
% 211.35/211.50 |- skos__altLabel mesh__D001946 Presentation, Breech
% 211.35/211.50 |- mesh__activeMeSHYear mesh__D001946 2006
% 211.35/211.50 |- skos__altLabel mesh__D001946 Fetal Presentation, Breech
% 211.35/211.50 |- skos__hiddenLabel mesh__D001946 Presentation, Breech Labor
% 211.35/211.50 |- skos__hiddenLabel mesh__D001946 Breech Labor Presentation
% 211.36/211.50 |- mesh__dateEstablished mesh__D001946 1985-01-01
% 211.36/211.50 |- skos__hiddenLabel mesh__D001946 Breech Fetal Presentation
% 211.36/211.50 |- mesh__recordAuthorizer mesh__D001946 sjn
% 211.36/211.50 |- mesh__historyNote mesh__D001946
% 211.36/211.50 85%28%75%29%; was see under LABOR PRESENTATION 1963-84
% 211.36/211.50 |- mesh__recordOriginator mesh__D001946 NLM
% 211.36/211.50 |- skos__altLabel mesh__D001946 Labor Presentation, Breech
% 211.36/211.50 |- skos__hiddenLabel mesh__D001946 Breech, Complete
% 211.36/211.50 |- skos__scopeNote mesh__D001946
% 211.36/211.50 A malpresentation of the FETUS at near term or during OBSTETRIC LABOR with the fetal cephalic pole in the fundus of the UTERUS. There are three types of breech: the complete breech with flexed hips and knees; the incomplete breech with one or both hips partially or fully extended; the frank breech with flexed hips and extended knees.%A%
% 211.36/211.50 |- skos__hiddenLabel mesh__D001946 Presentation, Frank Breech
% 211.36/211.50 |- mesh__recordMaintainer mesh__D001946 lkt
% 211.36/211.50 |- skos__historyNote mesh__D001946 Labor Presentation %28%1966-1974%29%
% 211.36/211.50 |- skos__prefLabel mesh__D001946 Breech Presentation
% 211.36/211.50 |- skos__hiddenLabel mesh__D001946 Breech, Incomplete
% 211.36/211.50 |- skos__broader mesh__D001946smesh__D007746
% 211.36/211.50 |- rdf__type mesh__D001946sskos__Concept
% 211.36/211.50 |- rdf__type mesh__D001148sskos__Concept
% 211.36/211.50 |- mesh__activeMeSHYear mesh__D001148 2006
% 211.36/211.50 |- mesh__dateCreated mesh__D001148 1974-11-19
% 211.36/211.50 |- skos__prefLabel mesh__D001148 Arsenamide
% 211.36/211.50 |- mesh__recordMaintainer mesh__D001148 CCR
% 211.36/211.50 |- mesh__activeMeSHYear mesh__D001148 2005
% 211.36/211.50 |- skos__broader mesh__D001148smesh__D001152
% 211.36/211.50 |- skos__scopeNote mesh__D001148
% 211.36/211.50 Proposed chemotherapeutic agent against filaria and trichomonas.%A%
% 211.36/211.50 |- skos__historyNote mesh__D001148 Benzamides %28%1973-1974%29%
% 211.36/211.50 |- skos__historyNote mesh__D001148 Arsenicals %28%1969-1974%29%
% 211.36/211.50 |- mesh__recordOriginator mesh__D001148 NLM
% 211.36/211.50 |- mesh__activeMeSHYear mesh__D001148 2001
% 211.36/211.50 |- mesh__recordAuthorizer mesh__D001148 sjn
% 211.36/211.50 |- mesh__dateEstablished mesh__D001148 1991-01-01
% 211.36/211.50 |- mesh__dateRevised mesh__D001148 2000-06-21
% 211.36/211.50 |- mesh__publicMeSHNote mesh__D001148
% 211.36/211.50 91; was see under ARSENICALS 1975-90
% 211.36/211.50 |- mesh__activeMeSHYear mesh__D001148 2004
% 211.36/211.50 |- mesh__historyNote mesh__D001148
% 211.36/211.50 91%28%75%29%; was see under ARSENICALS 1975-90
% 211.36/211.50 |- skos__altLabel mesh__D001148 Thiacetarsamide
% 211.36/211.50 |- skos__altLabel mesh__D001148 Thioarsenite
% 211.36/211.50 |- skos__historyNote mesh__D001148 Sulfides %28%1973-1974%29%
% 211.36/211.50 |- mesh__activeMeSHYear mesh__D001148 2003
% 211.36/211.50 |- mesh__activeMeSHYear mesh__D001148 2002
% 211.36/211.50 |- skos__hiddenLabel mesh__D006631 Copper-Containing Amine Oxidase
% 211.36/211.50 |- skos__hiddenLabel mesh__D006631 Oxidase, Semicarbazide-Sensitive Amine
% 211.36/211.50 |- mesh__recordOriginator mesh__D006631 NLM
% 211.36/211.50 |- skos__hiddenLabel mesh__D006631 Oxidase, Xylylene Diamine
% 211.36/211.50 |- skos__altLabel mesh__D006631 Xylylene Diamine Oxidase
% 211.36/211.50 |- skos__hiddenLabel mesh__D006631 Amine Oxidase, Copper Containing
% 211.36/211.50 |- mesh__onlineNote mesh__D006631
% 211.36/211.50 use AMINE OXIDASE %28%COPPER-CONTAINING%29% to search HISTAMINASE 1966-91; use AMINE OXIDASE %28%NM%29% to search COPPER AMINE OXIDASE 1978-91%A%
% 211.36/211.51 |- skos__hiddenLabel mesh__D006631 Semicarbazide Sensitive Amine Oxidase
% 211.36/211.51 |- mesh__dateRevised mesh__D006631 2005-06-30
% 211.36/211.51 |- skos__prefLabel mesh__D006631 Amine Oxidase %28%Copper-Containing%29%
% 211.36/211.51 |- skos__hiddenLabel mesh__D006631 Oxidase, Diamine
% 211.36/211.51 |- skos__altLabel mesh__D006631 Copper Amine Oxidase
% 211.36/211.51 |- skos__hiddenLabel mesh__D006631 Amine Oxidase, Semicarbazide-Sensitive
% 211.36/211.51 |- skos__altLabel mesh__D006631 Amine Oxidase, Copper-Containing
% 211.36/211.51 |- skos__hiddenLabel mesh__D006631 Amine Oxidase, Copper
% 211.36/211.51 |- mesh__dateCreated mesh__D006631 1999-01-01
% 211.36/211.51 |- rdf__type mesh__D006631sskos__Concept
% 211.36/211.51 |- mesh__historyNote mesh__D006631
% 211.36/211.51 92; was HISTAMINASE 1963-91; COPPER AMINE OXIDASE was SY to AMINE OXIDASE %28%NM%29% 1978-91%A%
% 211.36/211.51 |- skos__hiddenLabel mesh__D006631 Oxidase, Copper-Containing Amine
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D006631 sjn
% 211.36/211.51 |- mesh__recordMaintainer mesh__D006631 jmp
% 211.36/211.51 |- skos__hiddenLabel mesh__D006631 Oxidase, Diaminobenzidine
% 211.36/211.51 |- skos__altLabel mesh__D006631 Diamine Oxidase
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D006631 2006
% 211.36/211.51 |- skos__altLabel mesh__D006631 Semicarbazide-Sensitive Amine Oxidase
% 211.36/211.51 |- skos__scopeNote mesh__D006631
% 211.36/211.51 A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. EC 1.4.3.6.%A%
% 211.36/211.51 |- skos__hiddenLabel mesh__D006631 Oxidase, Copper Amine
% 211.36/211.51 |- skos__broader mesh__D006631smesh__D050891
% 211.36/211.51 |- skos__hiddenLabel mesh__D006631 Diamine Oxidase, Xylylene
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D006631
% 211.36/211.51 92; was HISTAMINASE 1963-91; COPPER AMINE OXIDASE was indexed under AMINE OXIDOREDUCTASES 1978-91%A%
% 211.36/211.51 |- skos__altLabel mesh__D006631 Histaminase
% 211.36/211.51 |- skos__historyNote mesh__D020302 Cytoplasmic Granules %28%1981-1998%29%
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D020302 2004
% 211.36/211.51 |- mesh__recordOriginator mesh__D020302 AGS
% 211.36/211.51 |- mesh__recordMaintainer mesh__D020302 nns
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D020302 sjn
% 211.36/211.51 |- skos__prefLabel mesh__D020302 Weibel-Palade Bodies
% 211.36/211.51 |- mesh__dateEstablished mesh__D020302 1999-01-01
% 211.36/211.51 |- skos__broader mesh__D020302smesh__D003594
% 211.36/211.51 |- mesh__dateRevised mesh__D020302 2003-07-09
% 211.36/211.51 |- skos__historyNote mesh__D020302 Organelles %28%1981-1998%29%
% 211.36/211.51 |- skos__related mesh__D020302smesh__D014841
% 211.36/211.51 |- skos__scopeNote mesh__D020302
% 211.36/211.51 Rod-shaped storage granules for VON WILLEBRAND FACTOR specific to endothelial cells.%A%
% 211.36/211.51 |- rdf__type mesh__D020302sskos__Concept
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D020302 2005
% 211.36/211.51 |- skos__hiddenLabel mesh__D020302 Bodies, Weibel-Palade
% 211.36/211.51 |- mesh__dateCreated mesh__D020302 1998-06-11
% 211.36/211.51 |- skos__hiddenLabel mesh__D020302 Weibel Palade Bodies
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D020302 99
% 211.36/211.51 |- mesh__historyNote mesh__D020302 99
% 211.36/211.51 |- skos__historyNote mesh__D020302 Inclusion Bodies %28%1987-1998%29%
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D020302 2006
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D019559 97
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D019559 2004
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D019559 2005
% 211.36/211.51 |- skos__broader mesh__D019559smesh__D014652
% 211.36/211.51 |- rdf__type mesh__D019559sskos__Concept
% 211.36/211.51 |- skos__prefLabel mesh__D019559 Capillary Leak Syndrome
% 211.36/211.51 |- skos__hiddenLabel mesh__D019559 Capillary Leak Syndromes
% 211.36/211.51 |- mesh__dateEstablished mesh__D019559 1997-01-01
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D019559 sjn
% 211.36/211.51 |- skos__historyNote mesh__D019559 Capillary Permeability %28%1972-1996%29%
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D019559 2003
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D019559 2001
% 211.36/211.51 |- skos__scopeNote mesh__D019559
% 211.36/211.51 A rare and sometimes fatal disease characterized by recurring attacks of leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, or poisoning. It can lead to generalized edema and MULTIPLE ORGAN FAILURE. %28%Zikria, et al. %28%eds.%29%, Reperfusion Injuries and Clinical Capillary Leak Syndrome, pp. 470-72, 1994%29%%A%
% 211.36/211.51 |- mesh__dateRevised mesh__D019559 1999-11-03
% 211.36/211.51 |- mesh__recordMaintainer mesh__D019559 KEV
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D019559 2000
% 211.36/211.51 |- mesh__recordOriginator mesh__D019559 AGS
% 211.36/211.51 |- mesh__dateCreated mesh__D019559 1996-06-10
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D019559 2006
% 211.36/211.51 |- skos__related mesh__D019559smesh__D009102
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D019559 2002
% 211.36/211.51 |- mesh__historyNote mesh__D019559 97
% 211.36/211.51 |- skos__altLabel mesh__D019559 Systemic Capillary Leak Syndrome
% 211.36/211.51 |- mesh__dateEstablished mesh__D011576 1973-01-01
% 211.36/211.51 |- mesh__historyNote mesh__D011576
% 211.36/211.51 85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72%A%
% 211.36/211.51 |- mesh__recordMaintainer mesh__D011576 ags
% 211.36/211.51 |- skos__scopeNote mesh__D011576
% 211.36/211.51 Small, hairy, moth-like flies which are of considerable public health importance as vectors of certain pathogenic organisms. Important disease-related genera are PHLEBOTOMUS, Lutzomyia, and Sergentomyia.%A%
% 211.36/211.51 |- mesh__dateCreated mesh__D011576 1999-01-01
% 211.36/211.51 |- skos__broader mesh__D011576smesh__D004175
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D011576 2006
% 211.36/211.51 |- skos__historyNote mesh__D011576 Phlebotomus %28%1966-1972%29%
% 211.36/211.51 |- mesh__onlineNote mesh__D011576
% 211.36/211.51 use PSYCHODIDAE to search SANDFLIES 1973-84; use PHLEBOTOMUS 1966-72%A%
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D011576 2005
% 211.36/211.51 |- mesh__recordOriginator mesh__D011576 NLM
% 211.36/211.51 |- skos__annotation mesh__D011576
% 211.36/211.51 do not use /drug eff for insecticides: TN 111
% 211.36/211.51 |- rdf__type mesh__D011576sskos__Concept
% 211.36/211.51 |- skos__altLabel mesh__D011576 Phlebotominae
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D011576
% 211.36/211.51 85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72%A%
% 211.36/211.51 |- mesh__dateRevised mesh__D011576 2003-07-09
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D011576 2004
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D011576 sjn
% 211.36/211.51 |- skos__altLabel mesh__D011576 Psychodinae
% 211.36/211.51 |- skos__prefLabel mesh__D011576 Psychodidae
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1993
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 2006
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1990
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1995
% 211.36/211.51 |- skos__hiddenLabel mesh__D005539 Foramen Magnums
% 211.36/211.51 |- skos__hiddenLabel mesh__D005539 Magnum, Foramen
% 211.36/211.51 |- skos__hiddenLabel mesh__D005539 Magnums, Foramen
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D005539 PLS
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 2002
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1996
% 211.36/211.51 |- mesh__dateRevised mesh__D005539 1989-03-14
% 211.36/211.51 |- rdf__type mesh__D005539sskos__Concept
% 211.36/211.51 |- mesh__recordOriginator mesh__D005539 NLM
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1991
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 2003
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1998
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1997
% 211.36/211.51 |- skos__prefLabel mesh__D005539 Foramen Magnum
% 211.36/211.51 |- skos__broader mesh__D005539smesh__D009777
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 2000
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 2005
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1992
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1999
% 211.36/211.51 |- mesh__dateCreated mesh__D005539 1999-01-01
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 2004
% 211.36/211.51 |- mesh__recordMaintainer mesh__D005539 TGC
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 2001
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D005539 1994
% 211.36/211.51 |- skos__scopeNote mesh__D002241
% 211.36/211.51 The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn%28%H2O%29%n.%A%
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D002241 2006
% 211.36/211.51 |- mesh__historyNote mesh__D002241
% 211.36/211.51 /metabolism was CARBOHYDRATE METABOLISM 1963-65
% 211.36/211.51 |- mesh__onlineNote mesh__D002241
% 211.36/211.51 pre-explosion = CARBOHYDRATES %28%PX%29%
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D002241 sjn
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D002241
% 211.36/211.51 /metabolism was CARBOHYDRATE METABOLISM 1963-65
% 211.36/211.51 |- mesh__recordMaintainer mesh__D002241 lkt
% 211.36/211.51 |- mesh__recordOriginator mesh__D002241 NLM
% 211.36/211.51 |- rdf__type mesh__D002241sskos__Concept
% 211.36/211.51 |- skos__annotation mesh__D002241
% 211.36/211.51 general only; prefer specifics; glucides go here but could also be GLYCOSIDES; carbohydrates in the diet = DIETARY CARBOHYDRATES%A%
% 211.36/211.51 |- mesh__runningHead mesh__D002241 D9 - CARBOHYDRATES
% 211.36/211.51 |- mesh__dateCreated mesh__D002241 1999-01-01
% 211.36/211.51 |- skos__related mesh__D002241smesh__D004040
% 211.36/211.51 |- mesh__dateRevised mesh__D002241 2005-06-30
% 211.36/211.51 |- skos__prefLabel mesh__D002241 Carbohydrates
% 211.36/211.51 |- skos__altLabel mesh__D015967 Viral Gene Expression Regulation
% 211.36/211.51 |- rdf__type mesh__D015967sskos__Concept
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D015967 2004
% 211.36/211.51 |- mesh__dateEstablished mesh__D015967 1990-01-01
% 211.36/211.51 |- skos__broader mesh__D015967smesh__D005786
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D015967 2003
% 211.36/211.51 |- mesh__recordOriginator mesh__D015967 PXP
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D015967 sjn
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D015967 90
% 211.36/211.51 |- skos__altLabel mesh__D015967 Regulation of Gene Expression, Viral
% 211.36/211.51 |- skos__historyNote mesh__D015967 Genes, Regulator %28%1973-1980%29%
% 211.36/211.51 |- skos__prefLabel mesh__D015967 Gene Expression Regulation, Viral
% 211.36/211.51 |- skos__altLabel mesh__D015967 Regulation, Gene Expression, Viral
% 211.36/211.51 |- mesh__recordMaintainer mesh__D015967 NDW
% 211.36/211.51 |- mesh__dateCreated mesh__D015967 1989-05-25
% 211.36/211.51 |- skos__historyNote mesh__D015967 specific viruses %28%1973-1989%29%
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D015967 2006
% 211.36/211.51 |- skos__historyNote mesh__D015967
% 211.36/211.51 Gene Expression Regulation %28%1981-1989%29%
% 211.36/211.51 |- skos__scopeNote mesh__D015967
% 211.36/211.51 Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses.%A%
% 211.36/211.51 |- skos__annotation mesh__D015967
% 211.36/211.51 coord IM with specific virus /genet %28%IM%29%; DF: GENE EXPRESSION REG VIRAL%A%
% 211.36/211.51 |- mesh__dateRevised mesh__D015967 2002-07-03
% 211.36/211.51 |- mesh__historyNote mesh__D015967 90
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D015967 2005
% 211.36/211.51 |- skos__related mesh__D015169smesh__D050296
% 211.36/211.51 |- mesh__historyNote mesh__D015169 89
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Count, Pour Plate
% 211.36/211.51 |- skos__altLabel mesh__D015169 Colony Forming Units Assays, Microbial
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Count, Fungal
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Streak Plate Counts
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Counts, Pour Plate
% 211.36/211.51 |- skos__altLabel mesh__D015169 Count, Bacterial
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Counts, Microbial Colony
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Count, Spore
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Count, Microbial Colony
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D015169 89
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Dilution Counts, Agar
% 211.36/211.51 |- rdf__type mesh__D015169sskos__Concept
% 211.36/211.51 |- mesh__dateEstablished mesh__D015169 1989-01-01
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D015169 2006
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Counts, Spore
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Pour Plate Counts
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Agar Dilution Counts
% 211.36/211.51 |- mesh__dateRevised mesh__D015169 2005-06-30
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Count, Agar Dilution
% 211.36/211.51 |- skos__broader mesh__D015169smesh__D008828
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Microbial Colony Count
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Counts, Fungal
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D015169 sjn
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Spore Counts
% 211.36/211.51 |- skos__prefLabel mesh__D015169 Colony Count, Microbial
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Colony Counts, Microbial
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Counts, Spread Plate
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Spread Plate Counts
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Microbial Colony Counts
% 211.36/211.51 |- skos__scopeNote mesh__D015169
% 211.36/211.51 Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. Each colony %28%i.e., microbial colony-forming unit%29% represents the progeny of a single cell in the original inoculum. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients%27% microbial load; and in antimicrobial drug testing.%A%
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Count, Streak Plate
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Fungal Counts
% 211.36/211.51 |- skos__annotation mesh__D015169
% 211.36/211.51 coordinate NIM with organism /growth or /isol %28%IM%29% as appropriate%A%
% 211.36/211.51 |- skos__altLabel mesh__D015169 Bacterial Counts
% 211.36/211.51 |- skos__altLabel mesh__D015169 Counts, Bacterial
% 211.36/211.51 |- mesh__recordOriginator mesh__D015169 SCD
% 211.36/211.51 |- skos__historyNote mesh__D015169
% 211.36/211.51 Microbiological Techniques %28%1978-1988%29%
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Counts, Agar Dilution
% 211.36/211.51 |- skos__altLabel mesh__D015169 Colony-Forming Units Assay, Microbial
% 211.36/211.51 |- mesh__dateCreated mesh__D015169 1988-04-08
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Dilution Count, Agar
% 211.36/211.51 |- skos__historyNote mesh__D015169
% 211.36/211.51 Bacteriological Techniques %28%1967-1988%29%
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Counts, Streak Plate
% 211.36/211.51 |- mesh__recordMaintainer mesh__D015169 ags
% 211.36/211.51 |- skos__altLabel mesh__D015169 Colony Forming Units Assay, Microbial
% 211.36/211.51 |- skos__hiddenLabel mesh__D015169 Count, Spread Plate
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001947 2003
% 211.36/211.51 |- skos__broader mesh__D001947smesh__D039361
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001947 2006
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001947 2004
% 211.36/211.51 |- skos__prefLabel mesh__D001947 Breeding
% 211.36/211.51 |- skos__broader mesh__D001947smesh__D012099
% 211.36/211.51 |- skos__hiddenLabel mesh__D001947 Breedings
% 211.36/211.51 |- mesh__dateRevised mesh__D001947 2002-07-02
% 211.36/211.51 |- skos__annotation mesh__D001947 animals %26% plants only
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D001947 sjn
% 211.36/211.51 |- rdf__type mesh__D001947sskos__Concept
% 211.36/211.51 |- mesh__recordOriginator mesh__D001947 NLM
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001947 2005
% 211.36/211.51 |- mesh__dateCreated mesh__D001947 1999-01-01
% 211.36/211.51 |- skos__scopeNote mesh__D001947
% 211.36/211.51 The production of offspring by selective mating or HYBRIDIZATION, GENETIC in animals or plants.%A%
% 211.36/211.51 |- mesh__recordMaintainer mesh__D001947 lkt
% 211.36/211.51 |- skos__broader mesh__D005333Q000293smesh__D005333
% 211.36/211.51 |- mesh__preferredCombination mesh__D005333Q000293smesh__D049188
% 211.36/211.51 |- rdf__type mesh__D005333Q000293smesh__CompoundConcept
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 2005
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 1998
% 211.36/211.51 |- skos__broader mesh__D001149smesh__D001152
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D001149 91; was see under ARSENIC 1975-90
% 211.36/211.51 |- mesh__dateCreated mesh__D001149 1999-01-01
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 2002
% 211.36/211.51 |- mesh__dateEstablished mesh__D001149 1991-01-01
% 211.36/211.51 |- mesh__recordMaintainer mesh__D001149 JRT
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D001149 PLS
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 2004
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 1997
% 211.36/211.51 |- skos__prefLabel mesh__D001149 Arsenates
% 211.36/211.51 |- skos__annotation mesh__D001149 do not confuse with ARSENITES
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 2001
% 211.36/211.51 |- skos__scopeNote mesh__D001149
% 211.36/211.51 Inorganic or organic salts and esters of arsenic acid.
% 211.36/211.51 |- mesh__recordOriginator mesh__D001149 NLM
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 2003
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 1996
% 211.36/211.51 |- skos__broader mesh__D001149smesh__D000838
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 2000
% 211.36/211.51 |- mesh__onlineNote mesh__D001149 search ARSENATES 1968-74
% 211.36/211.51 |- rdf__type mesh__D001149sskos__Concept
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 2006
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D001149 1999
% 211.36/211.51 |- mesh__historyNote mesh__D001149
% 211.36/211.51 91%28%75%29%; was see under ARSENIC 1975-90
% 211.36/211.51 |- mesh__dateRevised mesh__D001149 1995-06-08
% 211.36/211.51 |- skos__broader mesh__D006632smesh__D007093
% 211.36/211.51 |- skos__related mesh__D006632smesh__D011968
% 211.36/211.51 |- skos__prefLabel mesh__D006632 Histamine
% 211.36/211.51 |- skos__related mesh__D006632smesh__D006969
% 211.36/211.51 |- skos__hiddenLabel mesh__D006632 Dichloride, Histamine
% 211.36/211.51 |- skos__broader mesh__D006632smesh__D012898
% 211.36/211.51 |- skos__hiddenLabel mesh__D006632 Dihydrochloride, Histamine
% 211.36/211.51 |- mesh__onlineNote mesh__D006632
% 211.36/211.51 search HISTAMINE /antagonists %26% inhibitors under HISTAMINE H1 RECEPTOR BLOCKADERS 1966-76%A%
% 211.36/211.51 |- mesh__dateCreated mesh__D006632 1999-01-01
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D006632
% 211.36/211.51 /antagonists %26% inhibitors was ANTIHISTAMINICS 1963-76
% 211.36/211.51 |- skos__broader mesh__D006632smesh__D005021
% 211.36/211.51 |- skos__broader mesh__D006632smesh__D015306
% 211.36/211.51 |- mesh__dateRevised mesh__D006632 2005-06-30
% 211.36/211.51 |- rdf__type mesh__D006632sskos__Concept
% 211.36/211.51 |- mesh__historyNote mesh__D006632
% 211.36/211.51 /antagonists %26% inhibitors was ANTIHISTAMINICS 1963-76
% 211.36/211.51 |- skos__altLabel mesh__D006632 Histamine Dichloride
% 211.36/211.51 |- mesh__recordOriginator mesh__D006632 NLM
% 211.36/211.51 |- skos__annotation mesh__D006632
% 211.36/211.51 /secret or histamine liberation = HISTAMINE RELEASE
% 211.36/211.51 |- skos__scopeNote mesh__D006632
% 211.36/211.51 An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.%A%
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D006632 sjn
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D006632 2006
% 211.36/211.51 |- mesh__recordMaintainer mesh__D006632 ssb
% 211.36/211.51 |- mesh__historyNote mesh__D020303 99
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Rats, Dahl Hypertensive
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Rats, Dahl
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Dahl Salt Resistant Rats
% 211.36/211.51 |- mesh__recordOriginator mesh__D020303 NDW
% 211.36/211.51 |- skos__altLabel mesh__D020303 Dahl Rats
% 211.36/211.51 |- skos__prefLabel mesh__D020303 Rats, Inbred Dahl
% 211.36/211.51 |- skos__annotation mesh__D020303 NIM when exper animal; check tag RATS
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Hypertensive Rats, Dahl
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Dahl Rats, Inbred
% 211.36/211.51 |- mesh__dateRevised mesh__D020303 2005-06-30
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Dahl Salt Sensitive Rats
% 211.36/211.51 |- skos__altLabel mesh__D020303 Dahl Hypertensive Rats
% 211.36/211.51 |- rdf__type mesh__D020303sskos__Concept
% 211.36/211.51 |- skos__historyNote mesh__D020303 Rats, Inbred Strains %28%1982-1998%29%
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Inbred Dahl Rats
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D020303 sjn
% 211.36/211.51 |- mesh__dateEstablished mesh__D020303 1999-01-01
% 211.36/211.51 |- mesh__dateCreated mesh__D020303 1998-06-11
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D020303 99
% 211.36/211.51 |- skos__scopeNote mesh__D020303
% 211.36/211.51 Inbred rats derived from Sprague-Dawley rats and used for the study of salt-dependent hypertension. Salt-sensitive and salt-resistant strains have been selectively bred to show the opposite genetically determined blood pressure responses to excess sodium chloride ingestion.%A%
% 211.36/211.51 |- skos__historyNote mesh__D020303 Rats %28%1980-1981%29%
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Rats, Dahl Salt-Sensitive
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D020303 2006
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Salt-Resistant Rats, Dahl
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Salt-Sensitive Rats, Dahl
% 211.36/211.51 |- skos__hiddenLabel mesh__D020303 Rats, Dahl Salt-Resistant
% 211.36/211.51 |- mesh__recordMaintainer mesh__D020303 ags
% 211.36/211.51 |- skos__broader mesh__D020303smesh__D011919
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D011577 2002
% 211.36/211.51 |- mesh__dateCreated mesh__D011577 1999-01-01
% 211.36/211.51 |- skos__scopeNote mesh__D011577
% 211.36/211.51 Primarily a technique of group psychotherapy which involves a structure, directed, and dramatized acting out of the patient%27%s personal and emotional problems.%A%
% 211.36/211.51 |- skos__hiddenLabel mesh__D011577 Psychodramas
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D011577 2006
% 211.36/211.51 |- mesh__recordOriginator mesh__D011577 NLM
% 211.36/211.51 |- skos__annotation mesh__D011577 a group psychother technique
% 211.36/211.51 |- skos__broader mesh__D011577smesh__D026421
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D011577 sjn
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D011577 2005
% 211.36/211.51 |- mesh__dateRevised mesh__D011577 2001-07-25
% 211.36/211.51 |- skos__broader mesh__D011577smesh__D011615
% 211.36/211.51 |- rdf__type mesh__D011577sskos__Concept
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D011577 2004
% 211.36/211.51 |- skos__related mesh__D011577smesh__D000184
% 211.36/211.51 |- mesh__recordMaintainer mesh__D011577 ssb
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D011577 2003
% 211.36/211.51 |- skos__prefLabel mesh__D011577 Psychodrama
% 211.36/211.51 |- skos__broader mesh__D001182Q000295smesh__D001182
% 211.36/211.51 |- mesh__preferredCombination mesh__D001182Q000295smesh__D020679
% 211.36/211.51 |- rdf__type mesh__D001182Q000295smesh__CompoundConcept
% 211.36/211.51 |- mesh__historyNote mesh__D016262 1991
% 211.36/211.51 |- skos__hiddenLabel mesh__D016262 Post-Poliomyelitis Muscular Atrophies
% 211.36/211.51 |- skos__altLabel mesh__D016262 Post-Poliomyelitis Syndrome
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D016262 2006
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D016262 sjn
% 211.36/211.51 |- skos__broader mesh__D016262smesh__D020966
% 211.36/211.51 |- mesh__recordOriginator mesh__D016262 PXP
% 211.36/211.51 |- skos__altLabel mesh__D016262 Muscular Atrophy, Postpoliomyelitis
% 211.36/211.51 |- skos__altLabel mesh__D016262 Post-Poliomyelitis Muscular Atrophy
% 211.36/211.51 |- skos__hiddenLabel mesh__D016262 Postpoliomyelitis Muscular Atrophies
% 211.36/211.51 |- skos__hiddenLabel mesh__D016262 Muscular Atrophies, Post-Poliomyelitis
% 211.36/211.51 |- skos__broader mesh__D016262smesh__D011051
% 211.36/211.51 |- rdf__type mesh__D016262sskos__Concept
% 211.36/211.51 |- skos__hiddenLabel mesh__D016262 Post-Polio Syndromes
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D016262 2005
% 211.36/211.51 |- skos__altLabel mesh__D016262 Post-Polio Syndrome
% 211.36/211.51 |- mesh__dateRevised mesh__D016262 2000-06-22
% 211.36/211.51 |- skos__historyNote mesh__D016262
% 211.36/211.51 Poliomyelitis/complications %28%1983-1990%29%
% 211.36/211.51 |- skos__altLabel mesh__D016262 Postpoliomyelitis Muscular Atrophy
% 211.36/211.51 |- skos__hiddenLabel mesh__D016262 Muscular Atrophies, Postpoliomyelitis
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D016262 2004
% 211.36/211.51 |- skos__hiddenLabel mesh__D016262 Post Poliomyelitis Syndrome
% 211.36/211.51 |- skos__prefLabel mesh__D016262 Postpoliomyelitis Syndrome
% 211.36/211.51 |- skos__annotation mesh__D016262 DF: POSTPOLIO SYNDROME or PPMA
% 211.36/211.51 |- skos__hiddenLabel mesh__D016262 Post Poliomyelitis Muscular Atrophy
% 211.36/211.51 |- skos__related mesh__D016262smesh__D011051
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D016262 2002
% 211.36/211.51 |- skos__hiddenLabel mesh__D016262 Muscular Atrophy, Post-Poliomyelitis
% 211.36/211.51 |- mesh__recordMaintainer mesh__D016262 sjn
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D016262 2003
% 211.36/211.51 |- mesh__dateCreated mesh__D016262 1999-11-08
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D016262 1991
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D016262 2001
% 211.36/211.51 |- skos__scopeNote mesh__D016262
% 211.36/211.51 A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. %28%From Ann NY Acad Sci 1995 May 25;753:68-80%29%%A%
% 211.36/211.51 |- mesh__dateEstablished mesh__D016262 1991-01-01
% 211.36/211.51 |- skos__broader mesh__D016262smesh__D019636
% 211.36/211.51 |- skos__broader mesh__D014867Q000600smesh__D014867
% 211.36/211.51 |- mesh__preferredCombination mesh__D014867Q000600smesh__D014881
% 211.36/211.51 |- rdf__type mesh__D014867Q000600smesh__CompoundConcept
% 211.36/211.51 |- mesh__recordAuthorizer mesh__D026690 sjn
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D026690 2003
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D026690 2006
% 211.36/211.51 |- mesh__recordOriginator mesh__D026690 tjk
% 211.36/211.51 |- mesh__dateEstablished mesh__D026690 2002-01-01
% 211.36/211.51 |- mesh__activeMeSHYear mesh__D026690 2004
% 211.36/211.51 |- skos__related mesh__D026690smesh__D026822
% 211.36/211.51 |- mesh__recordMaintainer mesh__D026690 jrf
% 211.36/211.51 |- skos__annotation mesh__D026690
% 211.36/211.51 ETHICS, MEDICAL is available for ethics in relation to the physician. Do not use routinely; reserve for discussions of clinical ethics as a topic in its own right%A%
% 211.36/211.51 |- rdf__type mesh__D026690sskos__Concept
% 211.36/211.51 |- skos__broader mesh__D026690smesh__D001675
% 211.36/211.51 |- mesh__publicMeSHNote mesh__D026690
% 211.36/211.51 2002; see ETHICS, MEDICAL 1993-2001
% 211.36/211.51 |- mesh__dateCreated mesh__D026690 2001-07-25
% 211.36/211.51 |- mesh__historyNote mesh__D026690 2002; use ETHICS, MEDICAL 1993-2001
% 211.36/211.51 |- skos__scopeNote mesh__D026690
% 211.36/211.51 The identification, analysis, and resolution of moral problems that arise in the care of patients. %28%Bioethics Thesaurus%29%%A%
% 211.36/211.51 |- skos__related mesh__D026690smesh__D028741
% 211.36/211.51 |- skos__prefLabel mesh__D026690 Ethics, Clinical
% 211.36/211.51 |- skos__historyNote mesh__D026690 Ethics, Medical %28%1992-2001%29%
% 211.36/211.51 |- skos__altLabel mesh__D026690 Clinical Ethics
% 211.36/211.51 |- skos__broader mesh__D026690smesh__D004995
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D026690 2005
% 211.36/211.52 |- skos__related mesh__D026690smesh__D033061
% 211.36/211.52 |- mesh__dateRevised mesh__D026690 2002-07-03
% 211.36/211.52 |- skos__hiddenLabel mesh__D040361 People Programs, Healthy
% 211.36/211.52 |- skos__scopeNote mesh__D040361
% 211.36/211.52 Healthy People Programs are a set of health objectives to be used by governments, communities, professional organizations, and others to help develop programs to improve health. It builds on initiatives pursued over the past two decades beginning with the 1979 Surgeon General%27%s Report, Healthy People, Healthy People 2000: National Health Promotion and Disease Prevention Objectives, and Healthy People 2010. These established national health objectives and served as the basis for the development of state and community plans. These are administered by the Office of Disease Prevention and Health Promotion %28%ODPHP%29%. Similar programs are conducted by other national governments.%A%
% 211.36/211.52 |- skos__prefLabel mesh__D040361 Healthy People Programs
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D040361 jls
% 211.36/211.52 |- mesh__dateRevised mesh__D040361 2004-07-27
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D040361 2005
% 211.36/211.52 |- skos__historyNote mesh__D040361 Health Promotion %28%1990-2002%29%
% 211.36/211.52 |- mesh__dateCreated mesh__D040361 2002-07-03
% 211.36/211.52 |- skos__hiddenLabel mesh__D040361 Program, Healthy People
% 211.36/211.52 |- mesh__dateEstablished mesh__D040361 2003-01-01
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D040361 2005B
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D040361 2006
% 211.36/211.52 |- mesh__recordOriginator mesh__D040361 jls
% 211.36/211.52 |- mesh__recordMaintainer mesh__D040361 jls
% 211.36/211.52 |- skos__annotation mesh__D040361 specify geog if pertinent
% 211.36/211.52 |- skos__hiddenLabel mesh__D040361 People Program, Healthy
% 211.36/211.52 |- rdf__type mesh__D040361sskos__Concept
% 211.36/211.52 |- skos__hiddenLabel mesh__D040361 Programs, Healthy People
% 211.36/211.52 |- mesh__historyNote mesh__D040361 2003
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D040361 2004
% 211.36/211.52 |- skos__hiddenLabel mesh__D040361 Healthy People Program
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D040361 2003
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D040361 2005A
% 211.36/211.52 |- skos__broader mesh__D040361smesh__D006293
% 211.36/211.52 |- skos__broader mesh__D001948smesh__D010051
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D001948 sjn
% 211.36/211.52 |- rdf__type mesh__D001948sskos__Concept
% 211.36/211.52 |- skos__prefLabel mesh__D001948 Brenner Tumor
% 211.36/211.52 |- skos__hiddenLabel mesh__D001948 Brenner Tumor, Proliferative
% 211.36/211.52 |- mesh__recordOriginator mesh__D001948 NLM
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D001948 2006
% 211.36/211.52 |- skos__scopeNote mesh__D001948
% 211.36/211.52 A smooth, solid or cystic fibroepithelial %28%FIBROEPITHELIAL NEOPLASMS%29% tumor, usually found in the OVARIES but can also be found in the adnexal region and the KIDNEYS. It consists of a fibrous stroma with nests of epithelial cells that sometimes resemble the transitional cells lining the urinary bladder. Brenner tumors generally are benign and asymptomatic. Malignant Brenner tumors have been reported.%A%
% 211.36/211.52 |- skos__hiddenLabel mesh__D001948 Brenner Tumor, Benign
% 211.36/211.52 |- skos__hiddenLabel mesh__D001948 Brenner Tumor, Malignant
% 211.36/211.52 |- mesh__recordMaintainer mesh__D001948 lkt
% 211.36/211.52 |- skos__annotation mesh__D001948
% 211.36/211.52 coordinate IM with OVARIAN NEOPLASMS %28%IM%29%
% 211.36/211.52 |- mesh__dateRevised mesh__D001948 2005-06-30
% 211.36/211.52 |- mesh__dateCreated mesh__D001948 1999-01-01
% 211.36/211.52 |- skos__broader mesh__D001948smesh__D018225
% 211.36/211.52 |- mesh__dateCreated mesh__D012670 1974-11-11
% 211.36/211.52 |- mesh__recordMaintainer mesh__D012670 lkt
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D012670 2004
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D012670 91; was see under TESTIS 1975-90
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D012670 2003
% 211.36/211.52 |- skos__hiddenLabel mesh__D012670 Epitheliums, Seminiferous
% 211.36/211.52 |- skos__scopeNote mesh__D012670
% 211.36/211.52 The epithelium lining the seminiferous tubules composed of primary male germ cells %28%SPERMATOGONIA%29% and supporting SERTOLI CELLS. As SPERMATOGENESIS proceeds, the developing germ cells migrate toward the lumen. The adluminal compartment, the inner two thirds of the tubules, contains SPERMATOCYTES and the more advanced germ cells.%A%
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D012670 2006
% 211.36/211.52 |- mesh__historyNote mesh__D012670
% 211.36/211.52 91%28%75%29%; was see under TESTIS 1975-90
% 211.36/211.52 |- mesh__recordOriginator mesh__D012670 NLM
% 211.36/211.52 |- mesh__dateRevised mesh__D012670 2002-07-03
% 211.36/211.52 |- skos__prefLabel mesh__D012670 Seminiferous Epithelium
% 211.36/211.52 |- skos__broader mesh__D012670smesh__D012671
% 211.36/211.52 |- skos__hiddenLabel mesh__D012670 Epithelium, Seminiferous
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D012670 2005
% 211.36/211.52 |- skos__hiddenLabel mesh__D012670 Seminiferous Epitheliums
% 211.36/211.52 |- mesh__dateEstablished mesh__D012670 1991-01-01
% 211.36/211.52 |- skos__broader mesh__D012670smesh__D004848
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D012670 sjn
% 211.36/211.52 |- rdf__type mesh__D012670sskos__Concept
% 211.36/211.52 |- skos__historyNote mesh__D006633
% 211.36/211.52 Histamine H1 Receptor Blockaders %28%1966-1976%29%
% 211.36/211.52 |- skos__annotation mesh__D006633
% 211.36/211.52 GEN or unspecified; prefer specifics; do not confuse with HISTAMINE AGONISTS; DF: HISTAMINE ANTAG%A%
% 211.36/211.52 |- mesh__recordMaintainer mesh__D006633 ssb
% 211.36/211.52 |- skos__hiddenLabel mesh__D006633 Antagonists, Histamine
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D006633
% 211.36/211.52 77; was see ANTIHISTAMINICS 1963-76
% 211.36/211.52 |- rdf__type mesh__D006633sskos__Concept
% 211.36/211.52 |- skos__prefLabel mesh__D006633 Histamine Antagonists
% 211.36/211.52 |- mesh__dateEstablished mesh__D006633 1977-01-01
% 211.36/211.52 |- mesh__dateCreated mesh__D006633 1976-05-05
% 211.36/211.52 |- mesh__onlineNote mesh__D006633
% 211.36/211.52 search HISTAMINE H1 RECEPTOR BLOCKADERS 1966-76
% 211.36/211.52 |- skos__scopeNote mesh__D006633
% 211.36/211.52 Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.%A%
% 211.36/211.52 |- mesh__recordOriginator mesh__D006633 SH
% 211.36/211.52 |- mesh__dateRevised mesh__D006633 2005-06-30
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D006633 2006
% 211.36/211.52 |- mesh__historyNote mesh__D006633 77; was see ANTIHISTAMINICS 1963-76
% 211.36/211.52 |- skos__broader mesh__D006633smesh__D018494
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D006633 sjn
% 211.36/211.52 |- mesh__dateRevised mesh__D020304 2004-12-02
% 211.36/211.52 |- skos__altLabel mesh__D020304 Bird of Prey
% 211.36/211.52 |- mesh__dateEstablished mesh__D020304 1999-01-01
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D020304 ags
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D020304 2005
% 211.36/211.52 |- skos__broader mesh__D020304smesh__D001717
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D020304 99
% 211.36/211.52 |- skos__altLabel mesh__D020304 Birds of Prey
% 211.36/211.52 |- mesh__recordOriginator mesh__D020304 NDW
% 211.36/211.52 |- mesh__historyNote mesh__D020304 99
% 211.36/211.52 |- skos__scopeNote mesh__D020304
% 211.36/211.52 BIRDS that hunt and kill other animals, especially higher vertebrates, for food. They include the FALCONIFORMES order, or diurnal birds of prey, comprised of EAGLES, falcons, HAWKS, and others, as well as the STRIGIFORMES order, or nocturnal birds of prey, which includes OWLS.%A%
% 211.36/211.52 |- mesh__recordMaintainer mesh__D020304 ags
% 211.36/211.52 |- skos__hiddenLabel mesh__D020304 Prey Birds
% 211.36/211.52 |- skos__hiddenLabel mesh__D020304 Raptor
% 211.36/211.52 |- skos__prefLabel mesh__D020304 Raptors
% 211.36/211.52 |- mesh__dateCreated mesh__D020304 1998-06-11
% 211.36/211.52 |- skos__historyNote mesh__D020304 Birds %28%1984-1998%29%
% 211.36/211.52 |- skos__hiddenLabel mesh__D020304 Prey Bird
% 211.36/211.52 |- rdf__type mesh__D020304sskos__Concept
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D020304 2005A
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D020304 2006
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1999
% 211.36/211.52 |- skos__hiddenLabel mesh__D011578 Psycholinguistic
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1994
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 2005
% 211.36/211.52 |- rdf__type mesh__D011578sskos__Concept
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1991
% 211.36/211.52 |- mesh__recordMaintainer mesh__D011578 TGC
% 211.36/211.52 |- mesh__historyNote mesh__D011578 67
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 2002
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1998
% 211.36/211.52 |- mesh__dateEstablished mesh__D011578 1967-01-01
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1993
% 211.36/211.52 |- skos__broader mesh__D011578smesh__D011579
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 2004
% 211.36/211.52 |- skos__broader mesh__D011578smesh__D001525
% 211.36/211.52 |- skos__broader mesh__D011578smesh__D008037
% 211.36/211.52 |- mesh__dateRevised mesh__D011578 1989-05-16
% 211.36/211.52 |- mesh__recordOriginator mesh__D011578 NLM
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1990
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 2001
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1997
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1992
% 211.36/211.52 |- skos__scopeNote mesh__D011578
% 211.36/211.52 A discipline concerned with relations between messages and the characteristics of individuals who select and interpret them; it deals directly with the processes of encoding %28%phonetics%29% and decoding %28%psychoacoustics%29% as they relate states of messages to states of communicators.%A%
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 2003
% 211.36/211.52 |- skos__annotation mesh__D011578
% 211.36/211.52 SPEC: IM, SPEC qualif; coord with specific linguistic %26% psychol concepts %28%IM%29%; NIM coord, no qualif%A%
% 211.36/211.52 |- skos__prefLabel mesh__D011578 Psycholinguistics
% 211.36/211.52 |- skos__historyNote mesh__D011578 Language %28%1966%29%
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 2000
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1996
% 211.36/211.52 |- skos__related mesh__D011578smesh__D007804
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D011578 PLS
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D011578 67
% 211.36/211.52 |- mesh__dateCreated mesh__D011578 1999-01-01
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 1995
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011578 2006
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 AIDS Nephropathies
% 211.36/211.52 |- skos__altLabel mesh__D016263 Nephropathies, HIV-Related
% 211.36/211.52 |- skos__altLabel mesh__D016263 Nephropathy, HIV-Associated
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 Nephropathy, AIDS Associated
% 211.36/211.52 |- skos__scopeNote mesh__D016263
% 211.36/211.52 Renal syndrome in human immunodeficiency virus-infected patients characterized by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.%A%
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263
% 211.36/211.52 Human Immunodeficiency Virus Associated Nephropathy
% 211.36/211.52 |- skos__historyNote mesh__D016263
% 211.36/211.52 Acquired Immunodeficiency Syndrome %28%1984-1990%29%
% 211.36/211.52 |- skos__broader mesh__D016263smesh__D015658
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 Nephropathies, AIDS Associated
% 211.36/211.52 |- skos__broader mesh__D016263smesh__D007674
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 Nephropathies, HIV Associated
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 HIV Related Nephropathies
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D016263 sjn
% 211.36/211.52 |- mesh__recordOriginator mesh__D016263 AGS
% 211.36/211.52 |- mesh__dateCreated mesh__D016263 1990-05-25
% 211.36/211.52 |- skos__altLabel mesh__D016263 Nephropathies, AIDS-Associated
% 211.36/211.52 |- skos__historyNote mesh__D016263
% 211.36/211.52 specific kidney diseases %28%1984-1990%29%
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 AIDS Associated Nephropathies
% 211.36/211.52 |- mesh__dateEstablished mesh__D016263 1991-01-01
% 211.36/211.52 |- skos__altLabel mesh__D016263 HIV-Related Nephropathy
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 HIV Associated Nephropathies
% 211.36/211.52 |- skos__historyNote mesh__D016263 Kidney Diseases %28%1984-1990%29%
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 Nephropathy, AIDS
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 AIDS Associated Nephropathy
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 HIV Related Nephropathy
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D016263 2006
% 211.36/211.52 |- skos__altLabel mesh__D016263 HIV-Related Nephropathies
% 211.36/211.52 |- skos__altLabel mesh__D016263 HIV-Associated Nephropathy
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 Nephropathy, HIV Associated
% 211.36/211.52 |- skos__altLabel mesh__D016263 Nephropathy, HIV-Related
% 211.36/211.52 |- skos__altLabel mesh__D016263
% 211.36/211.52 Human Immunodeficiency Virus-Associated Nephropathy
% 211.36/211.52 |- skos__altLabel mesh__D016263 Nephropathy, AIDS-Associated
% 211.36/211.52 |- skos__altLabel mesh__D016263 AIDS-Associated Nephropathies
% 211.36/211.52 |- mesh__historyNote mesh__D016263 91
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 Nephropathy, HIV Related
% 211.36/211.52 |- skos__altLabel mesh__D016263 Nephropathies, HIV-Associated
% 211.36/211.52 |- skos__annotation mesh__D016263
% 211.36/211.52 coord IM with specific kidney dis %28%IM%29%; specify HIV-1 or HIV-2 %28%IM or NIM%29% if pertinent; DF: HIVAN%A%
% 211.36/211.52 |- skos__altLabel mesh__D016263 HIV-Associated Nephropathies
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D016263 2005
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D016263 91
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 HIV Associated Nephropathy
% 211.36/211.52 |- skos__altLabel mesh__D016263 AIDS Nephropathy
% 211.36/211.52 |- mesh__dateRevised mesh__D016263 2004-07-13
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 Nephropathies, AIDS
% 211.36/211.52 |- mesh__recordMaintainer mesh__D016263 sjn
% 211.36/211.52 |- rdf__type mesh__D016263sskos__Concept
% 211.36/211.52 |- skos__hiddenLabel mesh__D016263 Nephropathies, HIV Related
% 211.36/211.52 |- skos__prefLabel mesh__D016263 AIDS-Associated Nephropathy
% 211.36/211.52 |- rdf__type mesh__D002243sskos__Concept
% 211.36/211.52 |- mesh__recordOriginator mesh__D002243 NLM
% 211.36/211.52 |- skos__scopeNote mesh__D002243
% 211.36/211.52 A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles.%A%
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D002243 2004
% 211.36/211.52 |- skos__broader mesh__D002243smesh__D006575
% 211.36/211.52 |- mesh__recordMaintainer mesh__D002243 ssb
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D002243 2006
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D002243 86; was see under INDOLES 1975-85
% 211.36/211.52 |- mesh__dateEstablished mesh__D002243 1986-01-01
% 211.36/211.52 |- skos__prefLabel mesh__D002243 Carbolines
% 211.36/211.52 |- skos__broader mesh__D002243smesh__D011725
% 211.36/211.52 |- skos__hiddenLabel mesh__D002243 Beta Carbolines
% 211.36/211.52 |- skos__historyNote mesh__D002243 Pyridines %28%1969-1974%29%
% 211.36/211.52 |- skos__altLabel mesh__D002243 Pyrido%5B%4,3-b%5D%Indole
% 211.36/211.52 |- skos__hiddenLabel mesh__D002243 Pyrido%5B%4,3 b%5D%Indole
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D002243 2005
% 211.36/211.52 |- mesh__dateCreated mesh__D002243 1974-11-19
% 211.36/211.52 |- mesh__dateRevised mesh__D002243 2003-07-09
% 211.36/211.52 |- mesh__historyNote mesh__D002243
% 211.36/211.52 86%28%75%29%; was see under INDOLES 1975-85
% 211.36/211.52 |- skos__historyNote mesh__D002243 Indoles %28%1969-1974%29%
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D002243 sjn
% 211.36/211.52 |- skos__broader mesh__D002243smesh__D007211
% 211.36/211.52 |- mesh__dateCreated mesh__D015969 1989-07-03
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 1993
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D015969 90
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 2006
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 1998
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 2001
% 211.36/211.52 |- skos__altLabel mesh__D015969 Institute of Medicine
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 1997
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 2000
% 211.36/211.52 |- skos__prefLabel mesh__D015969 Institute of Medicine %28%U.S.%29%
% 211.36/211.52 |- mesh__historyNote mesh__D015969 90
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 2005
% 211.36/211.52 |- skos__broader mesh__D015969smesh__D009307
% 211.36/211.52 |- rdf__type mesh__D015969sskos__Concept
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 2004
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 1996
% 211.36/211.52 |- mesh__recordOriginator mesh__D015969 EGC
% 211.36/211.52 |- mesh__recordMaintainer mesh__D015969 TAP
% 211.36/211.52 |- skos__hiddenLabel mesh__D015969 Medicine Institute %28%U.S.%29%
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D015969 PLS
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 2003
% 211.36/211.52 |- skos__annotation mesh__D015969
% 211.36/211.52 add UNITED STATES %28%NIM%29%; research support by this agency is checked as NON-US GOVT SUP; DF: IOM CATALOG: use NAF entry%A%
% 211.36/211.52 |- mesh__dateRevised mesh__D015969 1992-05-14
% 211.36/211.52 |- mesh__dateEstablished mesh__D015969 1990-01-01
% 211.36/211.52 |- skos__scopeNote mesh__D015969
% 211.36/211.52 Identifies, for study and analysis, important issues and problems that relate to health and medicine. The Institute initiates and conducts studies of national policy and planning for health care and health-related education and research; it also responds to requests from the federal government and other agencies for studies and advice.%A%
% 211.36/211.52 |- skos__hiddenLabel mesh__D015969 Medicine Institutes %28%U.S.%29%
% 211.36/211.52 |- skos__historyNote mesh__D015969 Organizations %28%1986-1989%29%
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 1995
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 1999
% 211.36/211.52 |- skos__historyNote mesh__D015969
% 211.36/211.52 Academies and Institutes %28%1970-1989%29%
% 211.36/211.52 |- skos__historyNote mesh__D015969
% 211.36/211.52 National Academy of Sciences %28%1986-1989%29%
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 2002
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D015969 1994
% 211.36/211.52 |- skos__prefLabel mesh__D040362 Geographic Information Systems
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D040362 2005
% 211.36/211.52 |- skos__broader mesh__D040362smesh__D016208
% 211.36/211.52 |- skos__broader mesh__D040362smesh__D007256
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D040362 2006
% 211.36/211.52 |- mesh__recordOriginator mesh__D040362 jls
% 211.36/211.52 |- rdf__type mesh__D040362sskos__Concept
% 211.36/211.52 |- skos__hiddenLabel mesh__D040362 Geographic Information System
% 211.36/211.52 |- mesh__dateCreated mesh__D040362 2002-07-03
% 211.36/211.52 |- mesh__dateEstablished mesh__D040362 2003-01-01
% 211.36/211.52 |- skos__hiddenLabel mesh__D040362 Information Systems, Geographic
% 211.36/211.52 |- skos__scopeNote mesh__D040362
% 211.36/211.52 Computer systems capable of assembling, storing, manipulating, and displaying geographically referenced information, i.e. data identified according to their locations.%A%
% 211.36/211.52 |- mesh__recordMaintainer mesh__D040362 jls
% 211.36/211.52 |- mesh__historyNote mesh__D040362 2003
% 211.36/211.52 |- mesh__dateRevised mesh__D040362 2004-07-07
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D040362 2003
% 211.36/211.52 |- skos__hiddenLabel mesh__D040362 Information System, Geographic
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D040362 sjn
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D001949 2006
% 211.36/211.52 |- skos__broader mesh__D001949smesh__D000644
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D001949 sjn
% 211.36/211.52 |- mesh__recordOriginator mesh__D001949 NLM
% 211.36/211.52 |- mesh__dateCreated mesh__D001949 1999-01-01
% 211.36/211.52 |- skos__annotation mesh__D001949 ammonium cpds; DF: BRETYLIUM CPDS
% 211.36/211.52 |- skos__broader mesh__D001949smesh__D050339
% 211.36/211.52 |- skos__hiddenLabel mesh__D001949 Compounds, Bretylium
% 211.36/211.52 |- mesh__recordMaintainer mesh__D001949 ssb
% 211.36/211.52 |- rdf__type mesh__D001949sskos__Concept
% 211.36/211.52 |- skos__prefLabel mesh__D001949 Bretylium Compounds
% 211.36/211.52 |- mesh__dateRevised mesh__D001949 2005-06-30
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D012671 2004
% 211.36/211.52 |- mesh__dateEstablished mesh__D012671 1991-01-01
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D012671 91; was see under TESTIS 1975-90
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D012671 2005
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D012671 sjn
% 211.36/211.52 |- skos__hiddenLabel mesh__D012671 Seminiferous Tubule
% 211.36/211.52 |- skos__scopeNote mesh__D012671
% 211.36/211.52 The convoluted tubules in the TESTIS where sperm are produced %28%SPERMATOGENESIS%29% and conveyed to the RETE TESTIS. Spermatogenic tubules are composed of developing germ cells and the supporting SERTOLI CELLS.%A%
% 211.36/211.52 |- skos__broader mesh__D012671smesh__D013737
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D012671 2006
% 211.36/211.52 |- mesh__historyNote mesh__D012671
% 211.36/211.52 91%28%75%29%; was see under TESTIS 1975-90
% 211.36/211.52 |- mesh__recordMaintainer mesh__D012671 lkt
% 211.36/211.52 |- mesh__dateCreated mesh__D012671 1974-11-11
% 211.36/211.52 |- skos__hiddenLabel mesh__D012671 Tubules, Seminiferous
% 211.36/211.52 |- mesh__dateRevised mesh__D012671 2002-07-03
% 211.36/211.52 |- mesh__recordOriginator mesh__D012671 NLM
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D012671 2003
% 211.36/211.52 |- skos__prefLabel mesh__D012671 Seminiferous Tubules
% 211.36/211.52 |- rdf__type mesh__D012671sskos__Concept
% 211.36/211.52 |- skos__hiddenLabel mesh__D012671 Tubule, Seminiferous
% 211.36/211.52 |- mesh__dateRevised mesh__D006634 2005-06-30
% 211.36/211.52 |- skos__hiddenLabel mesh__D006634 Blockers, Histamine H1
% 211.36/211.52 |- skos__hiddenLabel mesh__D006634 Classical Antihistaminics
% 211.36/211.52 |- skos__altLabel mesh__D006634 Blockaders, Histamine H1 Receptor
% 211.36/211.52 |- mesh__historyNote mesh__D006634
% 211.36/211.52 95; was HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94; was ANTIHISTAMINICS 1963-76; ANTIHISTAMINICS, CLASSICAL was ANTIHISTAMINICS see HISTAMINE H1 RECEPTOR BLOCKADERS 1977-90%A%
% 211.36/211.52 |- skos__hiddenLabel mesh__D006634 Classical Antihistamines
% 211.36/211.52 |- skos__altLabel mesh__D006634 Antihistamines, Classical
% 211.36/211.52 |- skos__altLabel mesh__D006634 Histamine H1 Receptor Blockaders
% 211.36/211.52 |- skos__altLabel mesh__D006634 Antagonists, Histamine H1 Receptor
% 211.36/211.52 |- mesh__recordOriginator mesh__D006634 SH
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D006634 2006
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D006634 sjn
% 211.36/211.52 |- skos__hiddenLabel mesh__D006634 Blockaders, H1 Receptor
% 211.36/211.52 |- skos__related mesh__D006634smesh__D001993
% 211.36/211.52 |- skos__hiddenLabel mesh__D006634 H1 Blockers, Histamine
% 211.36/211.52 |- skos__altLabel mesh__D006634 Histamine H1 Receptor Antagonists
% 211.36/211.52 |- skos__broader mesh__D006634smesh__D006633
% 211.36/211.52 |- skos__hiddenLabel mesh__D006634 H1 Antihistaminics
% 211.36/211.52 |- mesh__recordMaintainer mesh__D006634 ssb
% 211.36/211.52 |- mesh__dateEstablished mesh__D006634 1977-01-01
% 211.36/211.52 |- skos__altLabel mesh__D006634 Antagonists, Histamine H1
% 211.36/211.52 |- skos__related mesh__D006634smesh__D018926
% 211.36/211.52 |- skos__related mesh__D006634smesh__D006969
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D006634
% 211.36/211.52 95; was HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94; was ANTIHISTAMINICS 1963-76; ANTIHISTAMINICS, CLASSICAL was ANTIHISTAMINICS see HISTAMINE H1 RECEPTOR BLOCKADERS 1977-90%A%
% 211.36/211.52 |- rdf__type mesh__D006634sskos__Concept
% 211.36/211.52 |- skos__altLabel mesh__D006634 Antihistaminics, H1
% 211.36/211.52 |- skos__scopeNote mesh__D006634
% 211.36/211.52 Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.%A%
% 211.36/211.52 |- skos__prefLabel mesh__D006634 Histamine H1 Antagonists
% 211.36/211.52 |- skos__annotation mesh__D006634
% 211.36/211.52 the %22%classical antihistaminics%22%: note X refs; GEN or unspecified; prefer specifics; DF: HISTAMINE H1 ANTAG%A%
% 211.36/211.52 |- mesh__onlineNote mesh__D006634
% 211.36/211.52 use HISTAMINE H1 ANTAGONISTS to search HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94 and ANTIHISTAMINICS 1966-76%A%
% 211.36/211.52 |- skos__hiddenLabel mesh__D006634 H1 Antagonists, Histamine
% 211.36/211.52 |- skos__altLabel mesh__D006634 Receptor Blockaders, H1
% 211.36/211.52 |- skos__altLabel mesh__D006634 Histamine H1 Blockers
% 211.36/211.52 |- skos__altLabel mesh__D006634 H1 Receptor Blockaders
% 211.36/211.52 |- skos__altLabel mesh__D006634 Antihistaminics, Classical
% 211.36/211.52 |- mesh__dateCreated mesh__D006634 1976-05-05
% 211.36/211.52 |- skos__hiddenLabel mesh__D020305 Owls, Great Horned
% 211.36/211.52 |- mesh__historyNote mesh__D020305 2005 %28%1999%29%
% 211.36/211.52 |- mesh__recordOriginator mesh__D020305 NDW
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D020305 2005; see OWLS 1999-2004
% 211.36/211.52 |- mesh__recordMaintainer mesh__D020305 ags
% 211.36/211.52 |- mesh__dateEstablished mesh__D020305 1999-01-01
% 211.36/211.52 |- skos__hiddenLabel mesh__D020305 Owl
% 211.36/211.52 |- skos__historyNote mesh__D020305 Birds %28%1966-1998%29%
% 211.36/211.52 |- rdf__type mesh__D020305sskos__Concept
% 211.36/211.52 |- skos__altLabel mesh__D020305 Barn Owl
% 211.36/211.52 |- mesh__dateRevised mesh__D020305 2004-11-18
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D020305 2006
% 211.36/211.52 |- skos__hiddenLabel mesh__D020305 Great Horned Owl
% 211.36/211.52 |- skos__broader mesh__D020305smesh__D020304
% 211.36/211.52 |- skos__hiddenLabel mesh__D020305 Owl, Great Horned
% 211.36/211.52 |- mesh__dateCreated mesh__D020305 1998-06-10
% 211.36/211.52 |- skos__altLabel mesh__D020305 Owls
% 211.36/211.52 |- skos__scopeNote mesh__D020305
% 211.36/211.52 An order of BIRDS with the common name owls characterized by strongly hooked beaks, sharp talons, large heads, forward facing eyes, and facial disks. While considered nocturnal RAPTORS, some owls do hunt by day.%A%
% 211.36/211.52 |- skos__prefLabel mesh__D020305 Strigiformes
% 211.36/211.52 |- skos__broader mesh__D020305smesh__D001717
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D020305 2005A
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D020305 ags
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D020305 2005
% 211.36/211.52 |- skos__altLabel mesh__D050790 L-Glutamate Synthetase
% 211.36/211.52 |- mesh__recordMaintainer mesh__D050790 AKE
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D050790
% 211.36/211.52 2006; GLUTAMATE SYNTHASE %28%NADH%29% was indexed under AMINO ACID OXIDOREDUCTASES 1998-2005%A%
% 211.36/211.52 |- mesh__dateEstablished mesh__D050790 2006-01-01
% 211.36/211.52 |- skos__scopeNote mesh__D050790
% 211.36/211.52 A FLAVOPROTEIN enzyme for AMMONIA assimilation in BACTERIA, microorganisms and PLANTS. It catalyzes the oxidation of 2 molecules of L-GLUTAMATE to generate L-GLUTAMINE and 2-oxoglutarate in the presence of NAD+.%A%
% 211.36/211.52 |- skos__altLabel mesh__D050790 NADH-Glutamate Synthase
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D050790 sjn
% 211.36/211.52 |- rdf__type mesh__D050790sskos__Concept
% 211.36/211.52 |- skos__hiddenLabel mesh__D050790 Synthase, NADH-Dependent Glutamate
% 211.36/211.52 |- skos__hiddenLabel mesh__D050790 L Glutamate Synthetase
% 211.36/211.52 |- skos__historyNote mesh__D050790
% 211.36/211.52 Amino Acid Oxidoreductases %28%1998-2005%29%
% 211.36/211.52 |- skos__hiddenLabel mesh__D050790 NADH GOGAT
% 211.36/211.52 |- skos__hiddenLabel mesh__D050790 NADH Dependent Glutamate Synthase
% 211.36/211.52 |- skos__hiddenLabel mesh__D050790 NADH Glutamate Synthase
% 211.36/211.52 |- mesh__dateCreated mesh__D050790 2005-06-30
% 211.36/211.52 |- skos__hiddenLabel mesh__D050790 Synthetase, L-Glutamate
% 211.36/211.52 |- mesh__recordOriginator mesh__D050790 AKE
% 211.36/211.52 |- mesh__historyNote mesh__D050790 2006%28%1998%29%
% 211.36/211.52 |- skos__broader mesh__D050790smesh__D005420
% 211.36/211.52 |- skos__altLabel mesh__D050790 NADH-GOGAT
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D050790 2006
% 211.36/211.52 |- skos__broader mesh__D050790smesh__D000594
% 211.36/211.52 |- skos__hiddenLabel mesh__D050790 Glutamate Synthase, NADH-Dependent
% 211.36/211.52 |- skos__altLabel mesh__D050790 NADH-Dependent Glutamate Synthase
% 211.36/211.52 |- skos__prefLabel mesh__D050790 Glutamate Synthase %28%NADH%29%
% 211.36/211.52 |- mesh__recordMaintainer mesh__D011579 TGC
% 211.36/211.52 |- skos__altLabel mesh__D011579 Psychologic Processes and Principles
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011579 1999
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011579 2003
% 211.36/211.52 |- rdf__type mesh__D011579sskos__Concept
% 211.36/211.52 |- mesh__dateEstablished mesh__D011579 1998-01-01
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011579 2002
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011579 2004
% 211.36/211.52 |- skos__prefLabel mesh__D011579 Psychological Phenomena and Processes
% 211.36/211.52 |- mesh__dateCreated mesh__D011579 1999-01-01
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011579 2000
% 211.36/211.52 |- mesh__recordAuthorizer mesh__D011579 SJN
% 211.36/211.52 |- mesh__onlineNote mesh__D011579
% 211.36/211.52 pre-explosion = PSYCHOLOGICAL PHENOMENA PROCESSES %28%PX%29%
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011579 2005
% 211.36/211.52 |- mesh__historyNote mesh__D011579 98; use pre-explosion
% 211.36/211.52 |- mesh__dateRevised mesh__D011579 1997-06-26
% 211.36/211.52 |- mesh__publicMeSHNote mesh__D011579 98
% 211.36/211.52 |- mesh__recordOriginator mesh__D011579 NLM
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011579 2001
% 211.36/211.52 |- skos__annotation mesh__D011579
% 211.36/211.52 not used for indexing; DF: PSYCHOL PHENOMENA CATALOG: do not use%A%
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011579 1998
% 211.36/211.52 |- skos__scopeNote mesh__D011579
% 211.36/211.52 Mechanisms and underlying psychological principles of mental processes and their applications.%A%
% 211.36/211.52 |- mesh__activeMeSHYear mesh__D011579 2006
% 211.36/211.52 |- mesh__runningHead mesh__D011579
% 211.36/211.52 F2 - PSYCHOLOGICAL PHENOMENA AND PROCESSES
% 211.36/211.53 |- skos__scopeNote mesh__D016264
% 211.36/211.53 Long-chain polymer of glucose containing 17-20%25% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4+ T-lymphocytes. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications.%A%
% 211.36/211.53 |- mesh__dateEstablished mesh__D016264 1991-01-01
% 211.36/211.53 |- rdf__type mesh__D016264sskos__Concept
% 211.36/211.53 |- skos__historyNote mesh__D016264 Dextrans %28%1966-1990%29%
% 211.36/211.53 |- mesh__dateRevised mesh__D016264 2004-07-07
% 211.36/211.53 |- skos__hiddenLabel mesh__D016264 Sulfate, Dextran
% 211.36/211.53 |- skos__hiddenLabel mesh__D016264 Dextran Sulfate, Sodium
% 211.36/211.53 |- mesh__historyNote mesh__D016264 91
% 211.36/211.53 |- skos__altLabel mesh__D016264 Sodium Dextran Sulfate
% 211.36/211.53 |- skos__hiddenLabel mesh__D016264 Sulfate, Sodium Dextran
% 211.36/211.53 |- skos__hiddenLabel mesh__D016264 Sulfate Sodium, Dextran
% 211.36/211.53 |- skos__broader mesh__D016264smesh__D003911
% 211.36/211.53 |- skos__prefLabel mesh__D016264 Dextran Sulfate
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D016264 sjn
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016264 2005
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D016264 91
% 211.36/211.53 |- mesh__dateCreated mesh__D016264 1990-05-25
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016264 2006
% 211.36/211.53 |- mesh__recordMaintainer mesh__D016264 jmp
% 211.36/211.53 |- mesh__recordOriginator mesh__D016264 AGS
% 211.36/211.53 |- rdf__type mesh__D002244sskos__Concept
% 211.36/211.53 |- mesh__recordMaintainer mesh__D002244 mdb
% 211.36/211.53 |- skos__prefLabel mesh__D002244 Carbon
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D002244 sjn
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002244 2003
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002244 2005
% 211.36/211.53 |- skos__hiddenLabel mesh__D002244 Black, Carbon
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002244 2004
% 211.36/211.53 |- mesh__dateRevised mesh__D002244 2001-07-25
% 211.36/211.53 |- mesh__recordOriginator mesh__D002244 NLM
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002244 2002
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002244 2006
% 211.36/211.53 |- skos__related mesh__D002244smesh__D002250
% 211.36/211.53 |- skos__hiddenLabel mesh__D002244 Carbon, Vitreous
% 211.36/211.53 |- skos__annotation mesh__D002244 C-12
% 211.36/211.53 |- skos__scopeNote mesh__D002244
% 211.36/211.53 A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight 12.011. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE.%A%
% 211.36/211.53 |- skos__broader mesh__D002244smesh__D004602
% 211.36/211.53 |- mesh__dateCreated mesh__D002244 1999-01-01
% 211.36/211.53 |- skos__related mesh__D002244smesh__D002247
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D040363
% 211.36/211.53 2003; see SOCIETIES, SCIENTIFIC 1980-2002
% 211.36/211.53 |- skos__annotation mesh__D040363 DF: AM PUBLIC HEALTH ASSOC
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D040363 2005
% 211.36/211.53 |- rdf__type mesh__D040363sskos__Concept
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D040363 2003
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D040363 2006
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D040363 2004
% 211.36/211.53 |- skos__scopeNote mesh__D040363
% 211.36/211.53 Professional organization concerned with issues affecting personal and environmental health, including federal and state funding for health programs, programs related to chronic and infectious diseases, and professional education in public health.%A%
% 211.36/211.53 |- skos__broader mesh__D040363smesh__D012952
% 211.36/211.53 |- mesh__dateEstablished mesh__D040363 2003-01-01
% 211.36/211.53 |- mesh__historyNote mesh__D040363
% 211.36/211.53 2003; use SOCIETIES, SCIENTIFIC 1980-2002
% 211.36/211.53 |- skos__prefLabel mesh__D040363 American Public Health Association
% 211.36/211.53 |- mesh__dateCreated mesh__D040363 2002-07-02
% 211.36/211.53 |- mesh__dateRevised mesh__D012672 2001-07-25
% 211.36/211.53 |- mesh__recordOriginator mesh__D012672 NLM
% 211.36/211.53 |- skos__prefLabel mesh__D012672 Semliki forest virus
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012672 2006
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012672 2002
% 211.36/211.53 |- mesh__recordMaintainer mesh__D012672 ags
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D012672 sjn
% 211.36/211.53 |- mesh__dateCreated mesh__D012672 1999-01-01
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D012672 66
% 211.36/211.53 |- mesh__historyNote mesh__D012672 66%28%64%29%
% 211.36/211.53 |- skos__broader mesh__D012672smesh__D000524
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012672 2003
% 211.36/211.53 |- rdf__type mesh__D012672sskos__Concept
% 211.36/211.53 |- skos__annotation mesh__D012672
% 211.36/211.53 infection: coord IM with ALPHAVIRUS INFECTIONS %28%IM%29%
% 211.36/211.53 |- mesh__dateEstablished mesh__D012672 1966-01-01
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012672 2004
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012672 2005
% 211.36/211.53 |- skos__scopeNote mesh__D012672
% 211.36/211.53 A species of ALPHAVIRUS isolated in central, eastern, and southern Africa.%A%
% 211.36/211.53 |- skos__related mesh__D006635smesh__D000897
% 211.36/211.53 |- skos__altLabel mesh__D006635 H2 Receptor Blockaders
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006635 2006
% 211.36/211.53 |- skos__broader mesh__D006635smesh__D006633
% 211.36/211.53 |- skos__hiddenLabel mesh__D006635 Blockaders, H2 Receptor
% 211.36/211.53 |- mesh__dateRevised mesh__D006635 2005-06-30
% 211.36/211.53 |- skos__scopeNote mesh__D006635
% 211.36/211.53 Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.%A%
% 211.36/211.53 |- mesh__onlineNote mesh__D006635
% 211.36/211.53 use HISTAMINE H2 ANTAGONISTS to search HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94%A%
% 211.36/211.53 |- skos__altLabel mesh__D006635 Antagonists, Histamine H2
% 211.36/211.53 |- skos__altLabel mesh__D006635 Histamine H2 Receptor Blockaders
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D006635 sjn
% 211.36/211.53 |- skos__hiddenLabel mesh__D006635 H2 Blockers, Histamine
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D006635
% 211.36/211.53 95; was HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94
% 211.36/211.53 |- skos__hiddenLabel mesh__D006635 Blockers, Histamine H2
% 211.36/211.53 |- skos__hiddenLabel mesh__D006635 H2 Antihistaminics
% 211.36/211.53 |- skos__altLabel mesh__D006635 Antihistaminics, H2
% 211.36/211.53 |- rdf__type mesh__D006635sskos__Concept
% 211.36/211.53 |- mesh__recordMaintainer mesh__D006635 ssb
% 211.36/211.53 |- skos__altLabel mesh__D006635 Receptor Blockaders, H2
% 211.36/211.53 |- skos__altLabel mesh__D006635 Histamine H2 Blockers
% 211.36/211.53 |- mesh__dateEstablished mesh__D006635 1977-01-01
% 211.36/211.53 |- skos__prefLabel mesh__D006635 Histamine H2 Antagonists
% 211.36/211.53 |- mesh__dateCreated mesh__D006635 1976-05-05
% 211.36/211.53 |- skos__hiddenLabel mesh__D006635 H2 Antagonists, Histamine
% 211.36/211.53 |- skos__altLabel mesh__D006635 Histamine H2 Receptor Antagonists
% 211.36/211.53 |- skos__altLabel mesh__D006635 Blockaders, Histamine H2 Receptor
% 211.36/211.53 |- skos__annotation mesh__D006635
% 211.36/211.53 GEN or unspecified; prefer specifics; DF: HISTAMINE H2 ANTAG%A%
% 211.36/211.53 |- skos__altLabel mesh__D006635 Receptor Antagonists, Histamine H2
% 211.36/211.53 |- mesh__historyNote mesh__D006635
% 211.36/211.53 95; was HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94
% 211.36/211.53 |- mesh__recordOriginator mesh__D006635 SH
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020306 2000
% 211.36/211.53 |- mesh__dateEstablished mesh__D020306 2000-01-01
% 211.36/211.53 |- rdf__type mesh__D020306sskos__Concept
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020306 2004
% 211.36/211.53 |- skos__broader mesh__D020306smesh__D020806
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D020306 2000
% 211.36/211.53 |- skos__altLabel mesh__D020306 Central Nervous System Tuberculosis
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020306 2006
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020306 2003
% 211.36/211.53 |- mesh__dateCreated mesh__D020306 1999-11-03
% 211.36/211.53 |- skos__historyNote mesh__D020306 Tuberculoma %28%1966-1999%29%
% 211.36/211.53 |- mesh__historyNote mesh__D020306 2000
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020306 2005
% 211.36/211.53 |- skos__scopeNote mesh__D020306
% 211.36/211.53 Tuberculosis of the brain, spinal cord, or meninges %28%TUBERCULOSIS, MENINGEAL%29%, most often caused by MYCOBACTERIUM TUBERCULOSIS and rarely by MYCOBACTERIUM BOVIS. The infection may be limited to the nervous system or coexist in other organs %28%e.g., TUBERCULOSIS, PULMONARY%29%. The organism tends to seed the meninges causing a diffuse meningitis and leads to the formation of TUBERCULOMA, which may occur within the brain, spinal cord, or perimeningeal spaces. Tuberculous involvement of the vertebral column %28%TUBERCULOSIS, SPINAL%29% may result in nerve root or spinal cord compression. %28%From Adams et al., Principles of Neurology, 6th ed, pp717-20%29%%A%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020306 2002
% 211.36/211.53 |- skos__annotation mesh__D020306 DF: TUBERCULOSIS CNS
% 211.36/211.53 |- skos__prefLabel mesh__D020306 Tuberculosis, Central Nervous System
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020306 2001
% 211.36/211.53 |- skos__historyNote mesh__D020306
% 211.36/211.53 Tuberculosis, Meningeal %28%1966-1999%29%
% 211.36/211.53 |- skos__broader mesh__D020306smesh__D014376
% 211.36/211.53 |- mesh__recordMaintainer mesh__D050791 ags
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D050791 ags
% 211.36/211.53 |- rdf__type mesh__D050791sskos__Concept
% 211.36/211.53 |- skos__altLabel mesh__D050791
% 211.36/211.53 STAT %28%Signal Transducers and Activators of Transcription%29% Proteins
% 211.36/211.53 |- mesh__dateEstablished mesh__D050791 2006-01-01
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D050791 2006A
% 211.36/211.53 |- mesh__dateRevised mesh__D050791 2005-08-01
% 211.36/211.53 |- skos__scopeNote mesh__D050791
% 211.36/211.53 A family of transcription factors containing SH2 DOMAINS that are involved in CYTOKINE-mediated SIGNAL TRANSDUCTION. STAT transcription factors are recruited to the cytoplasmic region of CELL SURFACE RECEPTORS and are activated via PHOSPHORYLATION. Once activated they dimerize and translocate into the CELL NUCLEUS where they influence GENE expression. They play a role in regulating CELL GROWTH PROCESSES and CELL DIFFERENTIATION. STAT transcription factors are inhibited by SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS and PROTEIN INHIBITORS OF ACTIVATED STAT.%A%
% 211.36/211.53 |- mesh__historyNote mesh__D050791 2006
% 211.36/211.53 |- mesh__dateCreated mesh__D050791 2005-06-30
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D050791 2006
% 211.36/211.53 |- skos__hiddenLabel mesh__D050791 Transcription Factors, STAT
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D050791 2006B
% 211.36/211.53 |- skos__annotation mesh__D050791 general; prefer specifics
% 211.36/211.53 |- skos__prefLabel mesh__D050791 STAT Transcription Factors
% 211.36/211.53 |- skos__broader mesh__D050791smesh__D048868
% 211.36/211.53 |- skos__broader mesh__D050791smesh__D014157
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D050791 2006
% 211.36/211.53 |- mesh__recordOriginator mesh__D050791 DRC
% 211.36/211.53 |- mesh__dateCreated mesh__D016265 1990-05-25
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D016265 1991
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016265 2002
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D016265 sjn
% 211.36/211.53 |- skos__prefLabel mesh__D016265 Conflict of Interest
% 211.36/211.53 |- skos__broader mesh__D016265smesh__D004989
% 211.36/211.53 |- mesh__recordMaintainer mesh__D016265 jrf
% 211.36/211.53 |- skos__related mesh__D016265smesh__D028743
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016265 2005
% 211.36/211.53 |- skos__historyNote mesh__D016265
% 211.36/211.53 Conflict %28%Psychology%29% %28%1966-1990%29%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016265 2006
% 211.36/211.53 |- skos__hiddenLabel mesh__D016265 Interest Conflict
% 211.36/211.53 |- skos__scopeNote mesh__D016265
% 211.36/211.53 A situation in which an individual might benefit personally from official or professional actions. It includes a conflict between a person%27%s private interests and official responsibilities in a position of trust. The term is not restricted to government officials. The concept refers both to actual conflict of interest and the appearance or perception of conflict.%A%
% 211.36/211.53 |- skos__historyNote mesh__D016265 Ethics %28%1966-1990%29%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016265 2003
% 211.36/211.53 |- rdf__type mesh__D016265sskos__Concept
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016265 2004
% 211.36/211.53 |- mesh__recordOriginator mesh__D016265 TGC
% 211.36/211.53 |- mesh__dateRevised mesh__D016265 2001-07-25
% 211.36/211.53 |- mesh__dateEstablished mesh__D016265 1991-01-01
% 211.36/211.53 |- mesh__historyNote mesh__D016265 1991
% 211.36/211.53 |- skos__hiddenLabel mesh__D016265 Interest Conflicts
% 211.36/211.53 |- mesh__dateRevised mesh__D002245 1996-06-13
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 2003
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 2000
% 211.36/211.53 |- skos__scopeNote mesh__D002245
% 211.36/211.53 A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.%A%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 2005
% 211.36/211.53 |- skos__annotation mesh__D002245
% 211.36/211.53 in respiration, /physiol permitted; /metab permitted for cell %26% tissue resp %26% non-lung tissue but do not use /metab for gas exchange in lung %28% = PULMONARY GAS EXCHANGE%29% or blood CO2 transport %28% = /blood but consider also HYPERCAPNIA %26% HYPOCAPNIA%29%%A%
% 211.36/211.53 |- skos__prefLabel mesh__D002245 Carbon Dioxide
% 211.36/211.53 |- skos__hiddenLabel mesh__D002245 Dioxide, Carbon
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 2004
% 211.36/211.53 |- skos__broader mesh__D002245smesh__D005740
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 2001
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 2006
% 211.36/211.53 |- skos__related mesh__D002245smesh__D019296
% 211.36/211.53 |- skos__related mesh__D002245smesh__D006935
% 211.36/211.53 |- skos__broader mesh__D002245smesh__D010087
% 211.36/211.53 |- skos__related mesh__D002245smesh__D016857
% 211.36/211.53 |- mesh__recordMaintainer mesh__D002245 TGC
% 211.36/211.53 |- skos__altLabel mesh__D002245 Carbonic Anhydride
% 211.36/211.53 |- mesh__dateCreated mesh__D002245 1999-01-01
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 2002
% 211.36/211.53 |- mesh__recordOriginator mesh__D002245 NLM
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 1998
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D002245 PLS
% 211.36/211.53 |- skos__hiddenLabel mesh__D002245 Anhydride, Carbonic
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 1997
% 211.36/211.53 |- rdf__type mesh__D002245sskos__Concept
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002245 1999
% 211.36/211.53 |- skos__broader mesh__D002245smesh__D017554
% 211.36/211.53 |- skos__historyNote mesh__D012673 Nitrosourea Compounds %28%1973-1974%29%
% 211.36/211.53 |- skos__hiddenLabel mesh__D012673 NSC 95441
% 211.36/211.53 |- skos__altLabel mesh__D012673 MeCCNU
% 211.36/211.53 |- skos__scopeNote mesh__D012673
% 211.36/211.53 4-Methyl derivative of LOMUSTINE; %28%CCNU%29%. An antineoplastic agent which functions as an alkylating agent.%A%
% 211.36/211.53 |- skos__historyNote mesh__D012673 Nitroso Compounds %28%1966-1972%29%
% 211.36/211.53 |- skos__broader mesh__D012673smesh__D008130
% 211.36/211.53 |- skos__hiddenLabel mesh__D012673 NSC95441
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012673 2003
% 211.36/211.53 |- rdf__type mesh__D012673sskos__Concept
% 211.36/211.53 |- skos__altLabel mesh__D012673 Me-CCNU
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D012673
% 211.36/211.53 91; was see under NITROSOUREA COMPOUNDS 1975-90
% 211.36/211.53 |- mesh__dateCreated mesh__D012673 1974-11-19
% 211.36/211.53 |- mesh__dateRevised mesh__D012673 2001-07-25
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012673 2004
% 211.36/211.53 |- mesh__recordOriginator mesh__D012673 NLM
% 211.36/211.53 |- skos__historyNote mesh__D012673 Cyclohexanes %28%1966-1974%29%
% 211.36/211.53 |- skos__hiddenLabel mesh__D012673 Methyl CCNU
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012673 2005
% 211.36/211.53 |- mesh__dateEstablished mesh__D012673 1991-01-01
% 211.36/211.53 |- skos__hiddenLabel mesh__D012673 Me CCNU
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012673 2002
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D012673 sjn
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012673 2006
% 211.36/211.53 |- mesh__recordMaintainer mesh__D012673 mdb
% 211.36/211.53 |- skos__prefLabel mesh__D012673 Semustine
% 211.36/211.53 |- mesh__historyNote mesh__D012673
% 211.36/211.53 91%28%75%29%; was see under NITROSOUREA COMPOUNDS 1975-90
% 211.36/211.53 |- skos__altLabel mesh__D012673 Methyl-CCNU
% 211.36/211.53 |- skos__historyNote mesh__D012673 Urea %28%1966-1972%29%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 2006
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 2002
% 211.36/211.53 |- mesh__dateCreated mesh__D006636 1999-01-01
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 1996
% 211.36/211.53 |- skos__altLabel mesh__D006636 Histamine Liberation
% 211.36/211.53 |- mesh__dateRevised mesh__D006636 1995-01-06
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 1998
% 211.36/211.53 |- skos__hiddenLabel mesh__D006636 Histamine Liberations
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 1997
% 211.36/211.53 |- mesh__historyNote mesh__D006636 96; was HISTAMINE LIBERATION 1963-95
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 1999
% 211.36/211.53 |- skos__prefLabel mesh__D006636 Histamine Release
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 2000
% 211.36/211.53 |- skos__broader mesh__D006636smesh__D007109
% 211.36/211.53 |- rdf__type mesh__D006636sskos__Concept
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 2001
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D006636 PLS
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D006636
% 211.36/211.53 96; was HISTAMINE LIBERATION 1963-95
% 211.36/211.53 |- mesh__recordOriginator mesh__D006636 NLM
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 2003
% 211.36/211.53 |- mesh__recordMaintainer mesh__D006636 AGS
% 211.36/211.53 |- skos__related mesh__D006636smesh__D003189
% 211.36/211.53 |- skos__scopeNote mesh__D006636
% 211.36/211.53 The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil%27%s Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects.%A%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 2005
% 211.36/211.53 |- skos__hiddenLabel mesh__D006636 Histamine Releases
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006636 2004
% 211.36/211.53 |- rdf__type mesh__D020307sskos__Concept
% 211.36/211.53 |- skos__scopeNote mesh__D020307
% 211.36/211.53 Large members of the FALCONIFORMES order of birds, family Accipitridae, most especially the genera Aquila, Haliaeetus, Harpia, and Circaetus. They are characterized by their powerful talons, which carry long, curved, pointed claws and by their opposable hindtoe.%A%
% 211.36/211.53 |- mesh__dateRevised mesh__D020307 2004-07-07
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020307 2006
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020307 2005
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D020307 1999
% 211.36/211.53 |- skos__broader mesh__D020307smesh__D046093
% 211.36/211.53 |- mesh__dateCreated mesh__D020307 1998-06-10
% 211.36/211.53 |- skos__historyNote mesh__D020307 Birds %28%1970-1998%29%
% 211.36/211.53 |- mesh__recordOriginator mesh__D020307 NDW
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D020307 sjn
% 211.36/211.53 |- mesh__dateEstablished mesh__D020307 1999-01-01
% 211.36/211.53 |- skos__hiddenLabel mesh__D020307 Eagle
% 211.36/211.53 |- mesh__recordMaintainer mesh__D020307 ags
% 211.36/211.53 |- mesh__historyNote mesh__D020307 1999
% 211.36/211.53 |- skos__prefLabel mesh__D020307 Eagles
% 211.36/211.53 |- skos__altLabel mesh__D050792 Deep Hypothermic Circulatory Arrest
% 211.36/211.53 |- mesh__recordOriginator mesh__D050792 lkt
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D050792 sjn
% 211.36/211.53 |- skos__broader mesh__D050792smesh__D006324
% 211.36/211.53 |- mesh__dateEstablished mesh__D050792 2006-01-01
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D050792 2006
% 211.36/211.53 |- skos__historyNote mesh__D050792 Hypothermia, Induced %28%1966-2005%29%
% 211.36/211.53 |- skos__prefLabel mesh__D050792
% 211.36/211.53 Circulatory Arrest, Deep Hypothermia Induced
% 211.36/211.53 |- skos__scopeNote mesh__D050792
% 211.36/211.53 A technique to arrest the flow of blood by lowering BODY TEMPERATURE to about 20 degrees Centigrade, usually achieved by infusing chilled perfusate. The technique provides a bloodless surgical field for complex surgeries.%A%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D050792 2006
% 211.36/211.53 |- mesh__historyNote mesh__D050792 2006
% 211.36/211.53 |- mesh__dateCreated mesh__D050792 2005-06-30
% 211.36/211.53 |- mesh__recordMaintainer mesh__D050792 lkt
% 211.36/211.53 |- rdf__type mesh__D050792sskos__Concept
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016266 2005
% 211.36/211.53 |- mesh__recordOriginator mesh__D016266 TGC
% 211.36/211.53 |- mesh__dateRevised mesh__D016266 2001-07-25
% 211.36/211.53 |- skos__broader mesh__D016266smesh__D005524
% 211.36/211.53 |- skos__annotation mesh__D016266
% 211.36/211.53 coord with specific food /parasitol and specific parasite; DF: FOOD PARASITOL%A%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016266 2006
% 211.36/211.53 |- mesh__dateCreated mesh__D016266 1990-05-25
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D016266 91
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016266 2002
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D016266 sjn
% 211.36/211.53 |- skos__scopeNote mesh__D016266
% 211.36/211.53 The presence of parasites in food and food products. For the presence of bacteria, viruses, and fungi in food, FOOD MICROBIOLOGY is available.%A%
% 211.36/211.53 |- skos__historyNote mesh__D016266 Food Contamination %28%1966-1990%29%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016266 2003
% 211.36/211.53 |- skos__historyNote mesh__D016266 specific parasite %28%1966-1990%29%
% 211.36/211.53 |- rdf__type mesh__D016266sskos__Concept
% 211.36/211.53 |- skos__broader mesh__D016266smesh__D010274
% 211.36/211.53 |- skos__broader mesh__D016266smesh__D005506
% 211.36/211.53 |- skos__altLabel mesh__D016266 Parasitology, Food
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D016266 2004
% 211.36/211.53 |- mesh__historyNote mesh__D016266 91
% 211.36/211.53 |- mesh__dateEstablished mesh__D016266 1991-01-01
% 211.36/211.53 |- skos__prefLabel mesh__D016266 Food Parasitology
% 211.36/211.53 |- mesh__recordMaintainer mesh__D016266 jls
% 211.36/211.53 |- skos__broader mesh__D002246smesh__D004220
% 211.36/211.53 |- skos__scopeNote mesh__D002246
% 211.36/211.53 Carbon disulfide %28%CS2%29%. A colorless, flammable, poisonous liquid, CS2. It is used as a solvent, and is a counterirritant and has local anesthetic properties but is not used as such. It is highly toxic with pronounced CNS, hematologic, and dermatologic effects.%A%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 2002
% 211.36/211.53 |- mesh__recordOriginator mesh__D002246 NLM
% 211.36/211.53 |- skos__prefLabel mesh__D002246 Carbon Disulfide
% 211.36/211.53 |- mesh__recordMaintainer mesh__D002246 TPW
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D002246 PLS
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 1996
% 211.36/211.53 |- mesh__dateCreated mesh__D002246 1999-01-01
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 1998
% 211.36/211.53 |- skos__annotation mesh__D002246
% 211.36/211.53 a poisonous liquid; a solvent %26% counterirritant
% 211.36/211.53 |- mesh__dateRevised mesh__D002246 1993-06-29
% 211.36/211.53 |- rdf__type mesh__D002246sskos__Concept
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 1997
% 211.36/211.53 |- skos__hiddenLabel mesh__D002246 Disulfide, Carbon
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 1994
% 211.36/211.53 |- skos__broader mesh__D002246smesh__D017554
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 1999
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 2000
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 1995
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 2003
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 2001
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 2005
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 2004
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D002246 2006
% 211.36/211.53 |- rdf__type mesh__D048348sskos__Concept
% 211.36/211.53 |- skos__prefLabel mesh__D048348 Reverse Transcription
% 211.36/211.53 |- mesh__recordMaintainer mesh__D048348 nns
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D048348 sjn
% 211.36/211.53 |- skos__scopeNote mesh__D048348
% 211.36/211.53 The biosynthesis of DNA carried out on a template of RNA.%A%
% 211.36/211.53 |- skos__related mesh__D048348smesh__D020133
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D048348
% 211.36/211.53 2005; see TRANSCRIPTION, GENETIC 1988-2004
% 211.36/211.53 |- mesh__recordOriginator mesh__D048348 nns
% 211.36/211.53 |- skos__broader mesh__D048348smesh__D014158
% 211.36/211.53 |- skos__historyNote mesh__D048348 Transcription, Genetic %28%1971-2004%29%
% 211.36/211.53 |- mesh__dateEstablished mesh__D048348 2005-01-01
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D048348 2005
% 211.36/211.53 |- mesh__dateCreated mesh__D048348 2004-07-07
% 211.36/211.53 |- skos__related mesh__D048348smesh__D012194
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D048348 2006
% 211.36/211.53 |- mesh__historyNote mesh__D048348
% 211.36/211.53 2005; use TRANSCRIPTION, GENETIC 1988-2004
% 211.36/211.53 |- skos__altLabel mesh__D048348 Transcription, Reverse
% 211.36/211.53 |- rdf__type mesh__D012674sskos__Concept
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012674 2003
% 211.36/211.53 |- skos__annotation mesh__D012674 poisonous to livestock
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012674 2004
% 211.36/211.53 |- skos__scopeNote mesh__D012674
% 211.36/211.53 A species of toxic plants of the Compositae. The poisonous compounds are alkaloids which cause cattle diseases, neoplasms, and liver damage and are used to produce cancers in experimental animals.%A%
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012674 2005
% 211.36/211.53 |- skos__prefLabel mesh__D012674 Senecio
% 211.36/211.53 |- mesh__recordMaintainer mesh__D012674 ssb
% 211.36/211.53 |- skos__related mesh__D012674smesh__D011763
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012674 2006
% 211.36/211.53 |- mesh__dateRevised mesh__D012674 2001-07-25
% 211.36/211.53 |- mesh__recordOriginator mesh__D012674 NLM
% 211.36/211.53 |- mesh__dateCreated mesh__D012674 1999-01-01
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D012674 2002
% 211.36/211.53 |- skos__broader mesh__D012674smesh__D019659
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D012674 sjn
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006637 2005
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006637 2004
% 211.36/211.53 |- mesh__dateCreated mesh__D006637 1974-11-19
% 211.36/211.53 |- skos__altLabel mesh__D006637 Histamine Methyltransferase
% 211.36/211.53 |- skos__broader mesh__D006637smesh__D008780
% 211.36/211.53 |- skos__hiddenLabel mesh__D006637 N-Methyltransferase, Histamine
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D006637 2006
% 211.36/211.53 |- skos__hiddenLabel mesh__D006637 Methyltransferase, Histamine
% 211.36/211.53 |- skos__historyNote mesh__D006637 Histamine %28%1973-1974%29%
% 211.36/211.53 |- mesh__dateEstablished mesh__D006637 1991-01-01
% 211.36/211.53 |- mesh__dateRevised mesh__D006637 2003-07-09
% 211.36/211.53 |- skos__scopeNote mesh__D006637
% 211.36/211.53 An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to histamine, forming N-methylhistamine, the major metabolite of histamine in man. EC 2.1.1.8.%A%
% 211.36/211.53 |- skos__hiddenLabel mesh__D006637 Histamine N Methyltransferase
% 211.36/211.53 |- rdf__type mesh__D006637sskos__Concept
% 211.36/211.53 |- mesh__recordMaintainer mesh__D006637 ssb
% 211.36/211.53 |- mesh__recordOriginator mesh__D006637 NLM
% 211.36/211.53 |- mesh__historyNote mesh__D006637 98%28%75%29%
% 211.36/211.53 |- skos__historyNote mesh__D006637 Methyltransferases %28%1973-1974%29%
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D006637 sjn
% 211.36/211.53 |- skos__prefLabel mesh__D006637 Histamine N-Methyltransferase
% 211.36/211.53 |- mesh__publicMeSHNote mesh__D006637
% 211.36/211.53 98; see HISTAMINE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90%A%
% 211.36/211.53 |- rdf__type mesh__D020308sskos__Concept
% 211.36/211.53 |- mesh__recordOriginator mesh__D020308 NDW
% 211.36/211.53 |- skos__altLabel mesh__D020308 Turdidae
% 211.36/211.53 |- skos__annotation mesh__D020308
% 211.36/211.53 prefer specifics; X ref EREMOPHILA ALPESTRIS: EREMOPHILA PLANT and EREMOPHILUS MUTISII see CATFISHES are also available%A%
% 211.36/211.53 |- skos__hiddenLabel mesh__D020308 Horned Larks
% 211.36/211.53 |- mesh__recordAuthorizer mesh__D020308 sjn
% 211.36/211.53 |- skos__altLabel mesh__D020308 Horned Lark
% 211.36/211.53 |- skos__hiddenLabel mesh__D020308 Robin
% 211.36/211.53 |- mesh__activeMeSHYear mesh__D020308 2006
% 211.36/211.53 |- skos__altLabel mesh__D020308 Oscines
% 211.36/211.53 |- mesh__dateEstablished mesh__D020308 1999-01-01
% 211.36/211.53 |- skos__historyNote mesh__D020308 Birds %28%1966-1998%29%
% 211.36/211.53 |- skos__broader mesh__D020308smesh__D046109
% 211.36/211.53 |- mesh__recordMaintainer mesh__D020308 ags
% 211.36/211.53 |- mesh__historyNote mesh__D020308 1999
% 211.36/211.53 |- skos__prefLabel mesh__D020308 Songbirds
% 211.36/211.53 |- mesh__dateCreated mesh__D020308 1998-06-11
% 211.36/211.53 |- mesh__dateRevised mesh__D020308 2004-07-07
% 211.36/211.53 |- skos__hiddenLabel mesh__D020308 Songbird
% 211.36/211.53 |- skos__hiddenLabel mesh__D020308 Larks, Horned
% 211.36/211.53 |- skos__hiddenLabel mesh__D020308 Flycatcher
% 211.36/211.53 |- skos__hiddenLabel mesh__D020308 Oscine
% 211.36/211.53 |- skos__hiddenLabel mesh__D020308 Wren
% 211.36/211.53 |- skos__altLabel mesh__D020308 Troglodytidae
% 211.36/211.54 |- skos__hiddenLabel mesh__D020308 Lark, Horned
% 211.36/211.54 |- skos__hiddenLabel mesh__D020308 Warbler
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D020308 2005
% 211.36/211.54 |- skos__scopeNote mesh__D020308
% 211.36/211.54 PASSERIFORMES of the suborder, Oscines, in which the flexor tendons of the toes are separate, and the lower syrinx has 4 to 9 pairs of tensor muscles inserted at both ends of the tracheal half rings. They include many commonly recognized birds such as CROWS; FINCHES; robins; SPARROWS; and SWALLOWS.%A%
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D020308 1999
% 211.36/211.54 |- skos__altLabel mesh__D020308 Troglodytinae
% 211.36/211.54 |- skos__historyNote mesh__D050793 Tooth Movement %28%1974-2005%29%
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D050793 2006; see TOOTH MOVEMENT 1998-2005
% 211.36/211.54 |- rdf__type mesh__D050793sskos__Concept
% 211.36/211.54 |- skos__hiddenLabel mesh__D050793 Extrusion, Tooth
% 211.36/211.54 |- skos__hiddenLabel mesh__D050793 Forced Eruptions
% 211.36/211.54 |- mesh__dateCreated mesh__D050793 2005-06-30
% 211.36/211.54 |- mesh__recordMaintainer mesh__D050793 ssb
% 211.36/211.54 |- skos__hiddenLabel mesh__D050793 Tooth Extrusions
% 211.36/211.54 |- skos__hiddenLabel mesh__D050793 Extrusion, Orthodontic
% 211.36/211.54 |- skos__hiddenLabel mesh__D050793 Orthodontic Extrusions
% 211.36/211.54 |- skos__broader mesh__D050793smesh__D009971
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D050793 sjn
% 211.36/211.54 |- skos__scopeNote mesh__D050793
% 211.36/211.54 Orthodontic movement in the coronal direction achieved by outward tension on the PERIODONTAL LIGAMENT. It does not include the operative procedure that CROWN LENGTHENING involves.%A%
% 211.36/211.54 |- mesh__historyNote mesh__D050793 2006; use TOOTH MOVEMENT 1998-2005
% 211.36/211.54 |- skos__altLabel mesh__D050793 Tooth Extrusion
% 211.36/211.54 |- skos__related mesh__D050793smesh__D016556
% 211.36/211.54 |- skos__hiddenLabel mesh__D050793 Eruption, Forced
% 211.36/211.54 |- skos__altLabel mesh__D050793 Forced Eruption
% 211.36/211.54 |- mesh__recordOriginator mesh__D050793 ssb
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D050793 2006
% 211.36/211.54 |- mesh__dateEstablished mesh__D050793 2006-01-01
% 211.36/211.54 |- skos__prefLabel mesh__D050793 Orthodontic Extrusion
% 211.36/211.54 |- skos__hiddenLabel mesh__D016267 External Fixation Devices
% 211.36/211.54 |- skos__hiddenLabel mesh__D016267 External Fixation Device
% 211.36/211.54 |- mesh__recordMaintainer mesh__D016267 PXP
% 211.36/211.54 |- skos__hiddenLabel mesh__D016267 Device, External Fixation
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016267 2002
% 211.36/211.54 |- mesh__dateEstablished mesh__D016267 1991-01-01
% 211.36/211.54 |- mesh__recordOriginator mesh__D016267 PXP
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D016267 SJN
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016267 1999
% 211.36/211.54 |- mesh__dateCreated mesh__D016267 1990-05-25
% 211.36/211.54 |- skos__hiddenLabel mesh__D016267 External Fixator
% 211.36/211.54 |- skos__altLabel mesh__D016267 Fixation Devices, External
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016267 1998
% 211.36/211.54 |- skos__annotation mesh__D016267 for fracture fixation
% 211.36/211.54 |- skos__hiddenLabel mesh__D016267 Devices, External Fixation
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016267 2006
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016267 2001
% 211.36/211.54 |- skos__broader mesh__D016267smesh__D009984
% 211.36/211.54 |- skos__prefLabel mesh__D016267 External Fixators
% 211.36/211.54 |- skos__related mesh__D016267smesh__D019857
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016267 2005
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016267 2004
% 211.36/211.54 |- rdf__type mesh__D016267sskos__Concept
% 211.36/211.54 |- skos__hiddenLabel mesh__D016267 Fixation Device, External
% 211.36/211.54 |- mesh__dateRevised mesh__D016267 1997-06-20
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D016267 91
% 211.36/211.54 |- skos__hiddenLabel mesh__D016267 Fixator, External
% 211.36/211.54 |- skos__historyNote mesh__D016267
% 211.36/211.54 Orthopedic Fixation Devices %28%1979-1990%29%
% 211.36/211.54 |- skos__historyNote mesh__D016267 Fracture Fixation %28%1979-1990%29%
% 211.36/211.54 |- skos__scopeNote mesh__D016267
% 211.36/211.54 External devices which hold wires or pins that are placed through one or both cortices of bone in order to hold the position of a fracture in proper alignment. These devices allow easy access to wounds, adjustment during the course of healing, and more functional use of the limbs involved.%A%
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016267 2000
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016267 2003
% 211.36/211.54 |- skos__hiddenLabel mesh__D016267 Fixators, External
% 211.36/211.54 |- mesh__historyNote mesh__D016267 91
% 211.36/211.54 |- rdf__type mesh__D035421sskos__Concept
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D035421 2004
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D035421 2005
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D035421 2003
% 211.36/211.54 |- skos__scopeNote mesh__D035421
% 211.36/211.54 The region of the face on either side, around the PAROTID GLAND.%A%
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D035421 2006
% 211.36/211.54 |- mesh__historyNote mesh__D035421 2003
% 211.36/211.54 |- skos__hiddenLabel mesh__D035421 Region, Parotid
% 211.36/211.54 |- mesh__dateCreated mesh__D035421 2002-07-03
% 211.36/211.54 |- skos__prefLabel mesh__D035421 Parotid Region
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D035421 2003
% 211.36/211.54 |- skos__broader mesh__D035421smesh__D005145
% 211.36/211.54 |- mesh__dateEstablished mesh__D035421 2003-01-01
% 211.36/211.54 |- mesh__dateCreated mesh__D002247 1999-01-01
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D002247 sjn
% 211.36/211.54 |- rdf__type mesh__D002247sskos__Concept
% 211.36/211.54 |- mesh__recordOriginator mesh__D002247 NLM
% 211.36/211.54 |- mesh__recordMaintainer mesh__D002247 nns
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002247 2002
% 211.36/211.54 |- skos__hiddenLabel mesh__D002247 Isotopes, Carbon
% 211.36/211.54 |- mesh__dateRevised mesh__D002247 2000-06-22
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002247 2003
% 211.36/211.54 |- skos__annotation mesh__D002247 C-13; NIM
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002247 2005
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002247 2004
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002247 2006
% 211.36/211.54 |- skos__scopeNote mesh__D002247
% 211.36/211.54 Stable carbon atoms that have the same atomic number as the element carbon, but differ in atomic weight. C-13 is a stable carbon isotope.%A%
% 211.36/211.54 |- skos__prefLabel mesh__D002247 Carbon Isotopes
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002247 2001
% 211.36/211.54 |- skos__broader mesh__D002247smesh__D007554
% 211.36/211.54 |- mesh__dateRevised mesh__D007730 1992-05-20
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 1995
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 2002
% 211.36/211.54 |- rdf__type mesh__D007730sskos__Concept
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 1998
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 2005
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 1993
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 1996
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 2003
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 1999
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 2006
% 211.36/211.54 |- skos__prefLabel mesh__D007730 Kuwait
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 1997
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 2004
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D007730 PLS
% 211.36/211.54 |- skos__broader mesh__D007730smesh__D008877
% 211.36/211.54 |- mesh__dateCreated mesh__D007730 1999-01-01
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 2000
% 211.36/211.54 |- mesh__recordOriginator mesh__D007730 NLM
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 1994
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007730 2001
% 211.36/211.54 |- mesh__recordMaintainer mesh__D007730 PLS
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 2005
% 211.36/211.54 |- mesh__recordOriginator mesh__D012675 NLM
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 2000
% 211.36/211.54 |- skos__prefLabel mesh__D012675 Senegal
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 1998
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 2004
% 211.36/211.54 |- rdf__type mesh__D012675sskos__Concept
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 1997
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D012675 PLS
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 2003
% 211.36/211.54 |- mesh__recordMaintainer mesh__D012675 TGC
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 1996
% 211.36/211.54 |- skos__scopeNote mesh__D012675
% 211.36/211.54 A republic in western Africa, southwest of MAURITANIA and east of MALI. Its capital is Dakar. The first settlements were by the Portuguese in the 15th century and the French in the 17th century, with the coastal region becoming the object of much rivalry and conflict between the two until French possession was recognized in 1814. Senegal became independent in 1960. The nation was named for the Senegal River, its main river, which possibly derived its name from a local African word meaning navigable. %28%From Webster%27%s New Geographical Dictionary, 1988, p1097 %26% Room, Brewer%27%s Dictionary of Names, 1992, p493%29%%A%
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 2002
% 211.36/211.54 |- mesh__dateCreated mesh__D012675 1999-01-01
% 211.36/211.54 |- skos__broader mesh__D012675smesh__D000354
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 2006
% 211.36/211.54 |- skos__annotation mesh__D012675 a republic in western Africa
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 2001
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012675 1999
% 211.36/211.54 |- mesh__dateRevised mesh__D012675 1995-02-21
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D006638 2006
% 211.36/211.54 |- skos__hiddenLabel mesh__D006638 Deaminase, Histidine
% 211.36/211.54 |- skos__altLabel mesh__D006638 Histidinase
% 211.36/211.54 |- mesh__dateEstablished mesh__D006638 1991-01-01
% 211.36/211.54 |- skos__hiddenLabel mesh__D006638 Histidine Ammonia Lyase
% 211.36/211.54 |- mesh__dateRevised mesh__D006638 2003-07-09
% 211.36/211.54 |- skos__prefLabel mesh__D006638 Histidine Ammonia-Lyase
% 211.36/211.54 |- rdf__type mesh__D006638sskos__Concept
% 211.36/211.54 |- skos__scopeNote mesh__D006638
% 211.36/211.54 An enzyme that catalyzes the first step of histidine catabolism, forming UROCANIC ACID and AMMONIA from HISTIDINE. Deficiency of this enzyme is associated with elevated levels of serum histidine. EC 4.3.1.3.%A%
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D006638
% 211.36/211.54 98; see HISTIDASE 1991-97, see AMMONIA-LYASES 1973-90
% 211.36/211.54 |- skos__altLabel mesh__D006638 Histidine Deaminase
% 211.36/211.54 |- skos__altLabel mesh__D006638 Histidase
% 211.36/211.54 |- skos__hiddenLabel mesh__D006638 alpha-Deaminase, Histidine
% 211.36/211.54 |- skos__altLabel mesh__D006638 Histidine alpha-Deaminase
% 211.36/211.54 |- skos__hiddenLabel mesh__D006638 Histidine alpha Deaminase
% 211.36/211.54 |- mesh__dateCreated mesh__D006638 1999-01-01
% 211.36/211.54 |- skos__broader mesh__D006638smesh__D000642
% 211.36/211.54 |- mesh__recordMaintainer mesh__D006638 ssb
% 211.36/211.54 |- mesh__recordOriginator mesh__D006638 NLM
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D006638 2005
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D006638 2004
% 211.36/211.54 |- skos__hiddenLabel mesh__D006638 Ammonia-Lyase, Histidine
% 211.36/211.54 |- skos__annotation mesh__D006638 /defic: consider also HISTIDINEMIA
% 211.36/211.54 |- mesh__historyNote mesh__D006638 98%28%73%29%
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D006638 sjn
% 211.36/211.54 |- skos__altLabel mesh__D017360 Cress, Mouse-ear
% 211.36/211.54 |- skos__historyNote mesh__D017360 Plants %28%1966-1992%29%
% 211.36/211.54 |- skos__scopeNote mesh__D017360
% 211.36/211.54 A plant genus of the family BRASSICACEAE that contains ARABIDOPSIS PROTEINS and MADS DOMAIN PROTEINS. The species A. thaliana is used for experiments in classical plant genetics as well as molecular genetic studies in plant physiology, biochemistry, and development.%A%
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D017360 sjn
% 211.36/211.54 |- mesh__recordMaintainer mesh__D017360 JLS
% 211.36/211.54 |- mesh__dateCreated mesh__D017360 1992-05-07
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D017360 2006
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D017360 2005
% 211.36/211.54 |- mesh__dateEstablished mesh__D017360 1993-01-01
% 211.36/211.54 |- mesh__historyNote mesh__D017360 93
% 211.36/211.54 |- skos__broader mesh__D017360smesh__D019607
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D017360 2004
% 211.36/211.54 |- rdf__type mesh__D017360sskos__Concept
% 211.36/211.54 |- skos__prefLabel mesh__D017360 Arabidopsis
% 211.36/211.54 |- mesh__recordOriginator mesh__D017360 PXP
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D017360 2003
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D017360 93
% 211.36/211.54 |- skos__annotation mesh__D017360
% 211.36/211.54 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.36/211.54 |- mesh__dateRevised mesh__D017360 2002-07-02
% 211.36/211.54 |- skos__broader mesh__D050794smesh__D050833
% 211.36/211.54 |- mesh__recordMaintainer mesh__D050794 DRC
% 211.36/211.54 |- skos__hiddenLabel mesh__D050794 Gamma Activated Factor, 91 kDa
% 211.36/211.54 |- skos__altLabel mesh__D050794 STAT91 Transcription Factor
% 211.36/211.54 |- mesh__dateEstablished mesh__D050794 2006-01-01
% 211.36/211.54 |- skos__altLabel mesh__D050794 Transcription Factor STAT91
% 211.36/211.54 |- skos__altLabel mesh__D050794 STAT-91 Protein
% 211.36/211.54 |- skos__hiddenLabel mesh__D050794 Transcription Factor, STAT-91
% 211.36/211.54 |- skos__hiddenLabel mesh__D050794 Transcription Factor, STAT91
% 211.36/211.54 |- skos__scopeNote mesh__D050794
% 211.36/211.54 A signal transducer and activator of transcription that mediates cellular responses to INTERFERONS. Stat1 interacts with P53 TUMOR SUPPRESSOR PROTEIN and regulates expression of GENES involved in growth control and APOPTOSIS.%A%
% 211.36/211.54 |- mesh__dateCreated mesh__D050794 2005-06-30
% 211.36/211.54 |- skos__altLabel mesh__D050794 STAT1 Protein
% 211.36/211.54 |- skos__broader mesh__D050794smesh__D050791
% 211.36/211.54 |- skos__altLabel mesh__D050794 STAT-91 Transcription Factor
% 211.36/211.54 |- skos__hiddenLabel mesh__D050794 STAT 91 Protein
% 211.36/211.54 |- skos__altLabel mesh__D050794
% 211.36/211.54 Signal Transducer and Activator of Transcription 1
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D050794 2006
% 211.36/211.54 |- mesh__historyNote mesh__D050794 2006%28%1993%29%
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D050794
% 211.36/211.54 2006; STAT1 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1992-2005%A%
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D050794 sjn
% 211.36/211.54 |- skos__prefLabel mesh__D050794 STAT1 Transcription Factor
% 211.36/211.54 |- skos__altLabel mesh__D050794 Gamma-Activated Factor, 91 kDa
% 211.36/211.54 |- skos__hiddenLabel mesh__D050794 STAT 91 Transcription Factor
% 211.36/211.54 |- mesh__recordOriginator mesh__D050794 DRC
% 211.36/211.54 |- rdf__type mesh__D050794sskos__Concept
% 211.36/211.54 |- skos__hiddenLabel mesh__D050794 Transcription Factor, STAT1
% 211.36/211.54 |- skos__hiddenLabel mesh__D003340 Luteum Maintenance, Corpus
% 211.36/211.54 |- skos__historyNote mesh__D003340 Corpus Luteum %28%1966-1974%29%
% 211.36/211.54 |- skos__altLabel mesh__D003340 Luteal Maintenance
% 211.36/211.54 |- mesh__historyNote mesh__D003340
% 211.36/211.54 76%28%75%29%; was see under CORPUS LUTEUM 1975
% 211.36/211.54 |- mesh__dateRevised mesh__D003340 2004-07-07
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D003340 2005
% 211.36/211.54 |- mesh__recordOriginator mesh__D003340 NLM
% 211.36/211.54 |- skos__hiddenLabel mesh__D003340 Luteal Function Maintenance
% 211.36/211.54 |- skos__broader mesh__D003340smesh__D034461
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D003340 sjn
% 211.36/211.54 |- skos__altLabel mesh__D003340 Maintenance of Luteal Function
% 211.36/211.54 |- skos__hiddenLabel mesh__D003340 Luteum Maintenances, Corpus
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D003340 2006
% 211.36/211.54 |- skos__scopeNote mesh__D003340
% 211.36/211.54 Process of maintaining the functions of CORPORA LUTEA, specifically PROGESTERONE production which is regulated primarily by pituitary LUTEINIZING HORMONE in cycling females, and by PLACENTAL HORMONES in pregnant females. The ability to maintain luteal functions is important in PREGNANCY MAINTENANCE.%A%
% 211.36/211.54 |- mesh__dateEstablished mesh__D003340 1976-01-01
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D003340
% 211.36/211.54 76; was see under CORPUS LUTEUM 1975
% 211.36/211.54 |- mesh__dateCreated mesh__D003340 1974-11-11
% 211.36/211.54 |- mesh__recordMaintainer mesh__D003340 lkt
% 211.36/211.54 |- skos__prefLabel mesh__D003340 Corpus Luteum Maintenance
% 211.36/211.54 |- rdf__type mesh__D003340sskos__Concept
% 211.36/211.54 |- skos__broader mesh__D003340smesh__D011255
% 211.36/211.54 |- skos__hiddenLabel mesh__D016268 Internal Fixation Device
% 211.36/211.54 |- mesh__recordOriginator mesh__D016268 PXP
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016268 2000
% 211.36/211.54 |- skos__scopeNote mesh__D016268
% 211.36/211.54 Internal devices used in osteosynthesis to hold the position of the fracture in proper alignment. By applying the principles of biomedical engineering, the surgeon uses metal plates, nails, rods, etc., for the correction of skeletal defects.%A%
% 211.36/211.54 |- skos__broader mesh__D016268smesh__D019736
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016268 1999
% 211.36/211.54 |- skos__hiddenLabel mesh__D016268 Internal Fixator
% 211.36/211.54 |- skos__historyNote mesh__D016268
% 211.36/211.54 Fracture Fixation, Internal %28%1986-1990%29%
% 211.36/211.54 |- skos__hiddenLabel mesh__D016268 Devices, Internal Fixation
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016268 1998
% 211.36/211.54 |- mesh__recordMaintainer mesh__D016268 PXP
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016268 2006
% 211.36/211.54 |- skos__broader mesh__D016268smesh__D009984
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016268 2002
% 211.36/211.54 |- mesh__dateCreated mesh__D016268 1990-05-29
% 211.36/211.54 |- skos__hiddenLabel mesh__D016268 Fixators, Internal
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D016268 SJN
% 211.36/211.54 |- skos__altLabel mesh__D016268 Fixation Devices, Internal
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016268 2005
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016268 2004
% 211.36/211.54 |- skos__prefLabel mesh__D016268 Internal Fixators
% 211.36/211.54 |- skos__hiddenLabel mesh__D016268 Fixation Device, Internal
% 211.36/211.54 |- skos__hiddenLabel mesh__D016268 Device, Internal Fixation
% 211.36/211.54 |- rdf__type mesh__D016268sskos__Concept
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016268 2003
% 211.36/211.54 |- skos__annotation mesh__D016268 for fracture fixation
% 211.36/211.54 |- skos__historyNote mesh__D016268
% 211.36/211.54 Orthopedic Fixation Devices %28%1986-1990%29%
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D016268 2001
% 211.36/211.54 |- mesh__historyNote mesh__D016268 91
% 211.36/211.54 |- skos__hiddenLabel mesh__D016268 Internal Fixation Devices
% 211.36/211.54 |- skos__hiddenLabel mesh__D016268 Fixator, Internal
% 211.36/211.54 |- mesh__dateEstablished mesh__D016268 1991-01-01
% 211.36/211.54 |- mesh__dateRevised mesh__D016268 1997-06-20
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D016268 91
% 211.36/211.54 |- skos__prefLabel mesh__D035422 Pleural Cavity
% 211.36/211.54 |- mesh__dateCreated mesh__D035422 2002-07-03
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D035422 2003
% 211.36/211.54 |- mesh__dateEstablished mesh__D035422 2003-01-01
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D035422 2006
% 211.36/211.54 |- skos__historyNote mesh__D035422 Pleura %28%1965-2002%29%
% 211.36/211.54 |- skos__scopeNote mesh__D035422
% 211.36/211.54 Paired but separate cavity within the THORACIC CAVITY. It consists of the space between the parietal and visceral PLEURA and normally contains a capillary layer of serous fluid that lubricates the pleural surfaces.%A%
% 211.36/211.54 |- skos__hiddenLabel mesh__D035422 Pleural Cavities
% 211.36/211.54 |- skos__hiddenLabel mesh__D035422 Cavity, Pleural
% 211.36/211.54 |- mesh__historyNote mesh__D035422 2003
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D035422 2003
% 211.36/211.54 |- skos__hiddenLabel mesh__D035422 Cavities, Pleural
% 211.36/211.54 |- rdf__type mesh__D035422sskos__Concept
% 211.36/211.54 |- skos__broader mesh__D035422smesh__D035423
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D035422 2004
% 211.36/211.54 |- skos__annotation mesh__D035422 PLEURA is also available
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D035422 2005
% 211.36/211.54 |- mesh__recordMaintainer mesh__D002248 ADP
% 211.36/211.54 |- skos__broader mesh__D002248smesh__D010087
% 211.36/211.54 |- rdf__type mesh__D002248sskos__Concept
% 211.36/211.54 |- skos__hiddenLabel mesh__D002248 Monoxide, Carbon
% 211.36/211.54 |- mesh__recordOriginator mesh__D002248 NLM
% 211.36/211.54 |- skos__scopeNote mesh__D002248
% 211.36/211.54 Carbon monoxide %28%CO%29%. A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. %28%From Merck Index, 11th ed%29%%A%
% 211.36/211.54 |- skos__broader mesh__D002248smesh__D017554
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D002248 SJN
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002248 1999
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002248 2002
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002248 2003
% 211.36/211.54 |- skos__broader mesh__D002248smesh__D005740
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002248 2000
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002248 2005
% 211.36/211.54 |- mesh__dateRevised mesh__D002248 1998-06-10
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002248 2004
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002248 2001
% 211.36/211.54 |- skos__annotation mesh__D002248
% 211.36/211.54 a poisonous gas; /tox permitted but consider also CARBON MONOXIDE POISONING%A%
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D002248 2006
% 211.36/211.54 |- mesh__dateCreated mesh__D002248 1999-01-01
% 211.36/211.54 |- skos__prefLabel mesh__D002248 Carbon Monoxide
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007731 2003
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007731 1999
% 211.36/211.54 |- mesh__dateEstablished mesh__D007731 1991-01-01
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007731 2006
% 211.36/211.54 |- skos__prefLabel mesh__D007731 Kveim Test
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D007731
% 211.36/211.54 91; was see under SKIN TESTS 1975-90
% 211.36/211.54 |- mesh__dateRevised mesh__D007731 1997-06-20
% 211.36/211.54 |- skos__scopeNote mesh__D007731
% 211.36/211.54 Intradermal injection of a heated %28%pasteurized%29% saline suspension of sarcoid tissue obtained from a sarcoid spleen or lymph node. In patients with active sarcoidosis a dusky red nodule develops slowly over the next few weeks at the injection site. Histologic examination, an essential part of the complete test, reveals sarcoid tissue.%A%
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007731 2000
% 211.36/211.54 |- mesh__recordOriginator mesh__D007731 NLM
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007731 2004
% 211.36/211.54 |- mesh__recordMaintainer mesh__D007731 PXP
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007731 2001
% 211.36/211.54 |- mesh__dateCreated mesh__D007731 1974-12-12
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D007731 SJN
% 211.36/211.54 |- mesh__historyNote mesh__D007731
% 211.36/211.54 91%28%75%29%; was see under SKIN TESTS 1975-90
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007731 2002
% 211.36/211.54 |- skos__hiddenLabel mesh__D007731 Test, Kveim
% 211.36/211.54 |- skos__broader mesh__D007731smesh__D007428
% 211.36/211.54 |- rdf__type mesh__D007731sskos__Concept
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007731 1998
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D007731 2005
% 211.36/211.54 |- skos__annotation mesh__D007731 for diag of sarcoidosis
% 211.36/211.54 |- mesh__dateEstablished mesh__D045850 2004-01-01
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D045850 2006
% 211.36/211.54 |- mesh__dateRevised mesh__D045850 2005-06-30
% 211.36/211.54 |- skos__prefLabel mesh__D045850 Acidaminococcus
% 211.36/211.54 |- mesh__dateCreated mesh__D045850 2003-07-09
% 211.36/211.54 |- rdf__type mesh__D045850sskos__Concept
% 211.36/211.54 |- skos__scopeNote mesh__D045850
% 211.36/211.54 A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, isolated from the INTESTINES of PIGS and humans.%A%
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D045850 2004
% 211.36/211.54 |- mesh__recordOriginator mesh__D045850 ags
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D045850 sjn
% 211.36/211.54 |- mesh__historyNote mesh__D045850 2004
% 211.36/211.54 |- mesh__recordMaintainer mesh__D045850 SYSTEM
% 211.36/211.54 |- skos__broader mesh__D045850smesh__D045854
% 211.36/211.54 |- skos__annotation mesh__D045850
% 211.36/211.54 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D012676 2002; see SENNA 1963-2001
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012676 2006A
% 211.36/211.54 |- rdf__type mesh__D012676sskos__Concept
% 211.36/211.54 |- skos__broader mesh__D012676smesh__D010936
% 211.36/211.54 |- skos__annotation mesh__D012676 SENNA PLANT is also available
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D012676 ags
% 211.36/211.54 |- mesh__dateRevised mesh__D012676 2005-07-29
% 211.36/211.54 |- mesh__recordMaintainer mesh__D012676 ags
% 211.36/211.54 |- mesh__dateCreated mesh__D012676 1999-01-01
% 211.36/211.54 |- mesh__historyNote mesh__D012676 2002%28%1963%29%
% 211.36/211.54 |- skos__scopeNote mesh__D012676
% 211.36/211.54 Preparations of Cassia senna and C. angustifolia %28%see SENNA PLANT%29%. They contain sennosides, which are anthraquinone type CATHARTICS and are used in many different preparations as laxatives.%A%
% 211.36/211.54 |- skos__prefLabel mesh__D012676 Senna Extract
% 211.36/211.54 |- skos__hiddenLabel mesh__D012676 Extract, Senna
% 211.36/211.54 |- mesh__recordOriginator mesh__D012676 NLM
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D012676 2006
% 211.36/211.54 |- skos__hiddenLabel mesh__D006639 Histidine, L isomer
% 211.36/211.54 |- mesh__recordOriginator mesh__D006639 NLM
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D006639 2003
% 211.36/211.54 |- skos__broader mesh__D006639smesh__D000598
% 211.36/211.54 |- skos__prefLabel mesh__D006639 Histidine
% 211.36/211.54 |- mesh__dateCreated mesh__D006639 1999-01-01
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D006639 sjn
% 211.36/211.54 |- skos__altLabel mesh__D006639 Histidine, L-isomer
% 211.36/211.54 |- skos__annotation mesh__D006639 /biosyn /defic /physiol permitted
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D006639 2005
% 211.36/211.54 |- mesh__recordMaintainer mesh__D006639 jmp
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D006639 2004
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D006639 2002
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D006639 2006
% 211.36/211.54 |- skos__hiddenLabel mesh__D006639 L-isomer Histidine
% 211.36/211.54 |- skos__broader mesh__D006639smesh__D000601
% 211.36/211.54 |- skos__altLabel mesh__D006639 L-Histidine
% 211.36/211.54 |- mesh__dateRevised mesh__D006639 2001-07-25
% 211.36/211.54 |- skos__scopeNote mesh__D006639
% 211.36/211.54 An essential amino acid that is required for the production of HISTAMINE.%A%
% 211.36/211.54 |- rdf__type mesh__D006639sskos__Concept
% 211.36/211.54 |- skos__altLabel mesh__D017361 Viral Nonstructural Protein
% 211.36/211.54 |- mesh__activeMeSHYear mesh__D017361 2006
% 211.36/211.54 |- skos__annotation mesh__D017361
% 211.36/211.54 coordinate IM with specific protein %28%IM%29% + specific virus %28%IM%29%%A%
% 211.36/211.54 |- skos__historyNote mesh__D017361 Viral Proteins %28%1980-1988%29%
% 211.36/211.54 |- mesh__publicMeSHNote mesh__D017361
% 211.36/211.54 93; NS PROTEINS was indexed under VIRAL CORE PROTEINS %26% CAPSID 1988-92, %26% VIRAL PROTEINS 1980-88%A%
% 211.36/211.54 |- skos__historyNote mesh__D017361 Capsid %28%1988-1992%29%
% 211.36/211.54 |- skos__broader mesh__D017361smesh__D014764
% 211.36/211.54 |- skos__hiddenLabel mesh__D017361 Proteins, Viral Nonstructural
% 211.36/211.54 |- skos__hiddenLabel mesh__D017361 Proteins, Viral Non-Structural
% 211.36/211.54 |- mesh__dateRevised mesh__D017361 2005-06-30
% 211.36/211.54 |- skos__hiddenLabel mesh__D017361 Proteins, Viral NS
% 211.36/211.54 |- skos__hiddenLabel mesh__D017361 Viral Non Structural Proteins
% 211.36/211.54 |- mesh__recordOriginator mesh__D017361 TPW
% 211.36/211.54 |- skos__historyNote mesh__D017361 Viral Core Proteins %28%1988-1992%29%
% 211.36/211.54 |- skos__altLabel mesh__D017361 Viral NS Proteins
% 211.36/211.54 |- mesh__recordMaintainer mesh__D017361 nns
% 211.36/211.54 |- mesh__dateCreated mesh__D017361 1992-05-22
% 211.36/211.54 |- skos__prefLabel mesh__D017361 Viral Nonstructural Proteins
% 211.36/211.54 |- mesh__recordAuthorizer mesh__D017361 sjn
% 211.36/211.54 |- skos__altLabel mesh__D017361 Nonstructural Proteins, Viral
% 211.36/211.54 |- rdf__type mesh__D017361sskos__Concept
% 211.36/211.54 |- skos__hiddenLabel mesh__D017361 Nonstructural Protein, Viral
% 211.36/211.54 |- mesh__historyNote mesh__D017361
% 211.36/211.54 93; was NS PROTEINS %28%NM%29% 1980-92
% 211.36/211.54 |- skos__hiddenLabel mesh__D017361 Protein, Viral Nonstructural
% 211.36/211.55 |- mesh__dateEstablished mesh__D017361 1993-01-01
% 211.36/211.55 |- skos__altLabel mesh__D017361 NS Proteins, Viral
% 211.36/211.55 |- skos__scopeNote mesh__D017361
% 211.36/211.55 Proteins encoded by a VIRAL GENOME that are produced in the organisms they infect, but not packaged into the VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY.%A%
% 211.36/211.55 |- mesh__onlineNote mesh__D017361
% 211.36/211.55 use VIRAL NONSTRUCTURAL PROTEINS %28%NM%29% to search NS PROTEINS 1980-92%A%
% 211.36/211.55 |- skos__hiddenLabel mesh__D017361 Non-Structural Proteins, Viral
% 211.36/211.55 |- skos__altLabel mesh__D017361 Viral Non-Structural Proteins
% 211.36/211.55 |- skos__altLabel mesh__D050795 STAT2 Protein
% 211.36/211.55 |- skos__prefLabel mesh__D050795 STAT2 Transcription Factor
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D050795 sjn
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D050795
% 211.36/211.55 2006; STAT2 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1995-2005%A%
% 211.36/211.55 |- mesh__recordMaintainer mesh__D050795 DRC
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D050795 2006
% 211.36/211.55 |- mesh__historyNote mesh__D050795 2006%28%1995%29%
% 211.36/211.55 |- mesh__dateEstablished mesh__D050795 2006-01-01
% 211.36/211.55 |- skos__altLabel mesh__D050795 Transcription Factor STAT2
% 211.36/211.55 |- rdf__type mesh__D050795sskos__Concept
% 211.36/211.55 |- mesh__recordOriginator mesh__D050795 DRC
% 211.36/211.55 |- skos__scopeNote mesh__D050795
% 211.36/211.55 A signal transducer and activator of transcription that mediates cellular responses to TYPE I INTERFERONS. Stat2 protein is associated constitutively with INTERFERON REGULATORY FACTOR-9. After PHOSPHORYLATION Stat2 forms the IFN-STIMULATED GENE FACTOR 3 COMPLEX to regulate expression of target GENES.%A%
% 211.36/211.55 |- skos__hiddenLabel mesh__D050795 Transcription Factor, STAT2
% 211.36/211.55 |- skos__altLabel mesh__D050795
% 211.36/211.55 Signal Transducer and Activator of Transcription 2
% 211.36/211.55 |- mesh__dateCreated mesh__D050795 2005-06-30
% 211.36/211.55 |- skos__hiddenLabel mesh__D050795 Factor STAT2, Transcription
% 211.36/211.55 |- skos__broader mesh__D050795smesh__D050833
% 211.36/211.55 |- skos__broader mesh__D050795smesh__D050791
% 211.36/211.55 |- skos__scopeNote mesh__D003341
% 211.36/211.55 Degradation of CORPUS LUTEUM. In the absence of pregnancy and diminishing trophic hormones, the corpus luteum undergoes luteolysis which is characterized by the involution and cessation of its endocrine function.%A%
% 211.36/211.55 |- skos__hiddenLabel mesh__D003341 Regression, Corpus Luteum
% 211.36/211.55 |- skos__prefLabel mesh__D003341 Luteolysis
% 211.36/211.55 |- mesh__dateRevised mesh__D003341 2004-07-07
% 211.36/211.55 |- skos__broader mesh__D003341smesh__D010060
% 211.36/211.55 |- mesh__recordMaintainer mesh__D003341 lkt
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003341 2006
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D003341
% 211.36/211.55 2003; see CORPUS LUTEUM REGRESSION 1976-2002; see CORPUS LUTEUM 1975%A%
% 211.36/211.55 |- mesh__recordOriginator mesh__D003341 NLM
% 211.36/211.55 |- mesh__dateCreated mesh__D003341 1974-11-11
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D003341 sjn
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003341 2005
% 211.36/211.55 |- mesh__historyNote mesh__D003341
% 211.36/211.55 2003 %28%1976%29%; use CORPUS LUTEUM 1975
% 211.36/211.55 |- skos__altLabel mesh__D003341 Corpus Luteum Regression
% 211.36/211.55 |- skos__altLabel mesh__D003341 Luteal Regression
% 211.36/211.55 |- skos__hiddenLabel mesh__D003341 Regression, Luteal
% 211.36/211.55 |- mesh__dateEstablished mesh__D003341 1976-01-01
% 211.36/211.55 |- skos__historyNote mesh__D003341 Corpus Luteum %28%1966-1974%29%
% 211.36/211.55 |- rdf__type mesh__D003341sskos__Concept
% 211.36/211.55 |- skos__hiddenLabel mesh__D016269 Allergies, Milk
% 211.36/211.55 |- skos__annotation mesh__D016269
% 211.36/211.55 coord IM with specific milk product /adv eff %28%IM%29% if pertinent; do not confuse with LACTOSE INTOLERANCE, a lactase defic%A%
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D016269 2004
% 211.36/211.55 |- skos__hiddenLabel mesh__D016269 Milk Allergies
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D016269 2005
% 211.36/211.55 |- skos__broader mesh__D016269smesh__D005512
% 211.36/211.55 |- mesh__recordMaintainer mesh__D016269 tpw
% 211.36/211.55 |- skos__historyNote mesh__D016269 Food Hypersensitivity %28%1966-1990%29%
% 211.36/211.55 |- rdf__type mesh__D016269sskos__Concept
% 211.36/211.55 |- skos__altLabel mesh__D016269 Allergy, Milk
% 211.36/211.55 |- skos__altLabel mesh__D016269 Hypersensitivity, Milk
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D016269 2003
% 211.36/211.55 |- mesh__recordOriginator mesh__D016269 TGC
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D016269 91
% 211.36/211.55 |- mesh__historyNote mesh__D016269 91
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D016269 sjn
% 211.36/211.55 |- skos__altLabel mesh__D016269 Milk Allergy
% 211.36/211.55 |- skos__related mesh__D016269smesh__D007787
% 211.36/211.55 |- skos__historyNote mesh__D016269 Milk/adverse effects %28%1966-1990%29%
% 211.36/211.55 |- skos__scopeNote mesh__D016269
% 211.36/211.55 Allergic reaction to milk %28%usually cow%27%s milk%29% or milk products. MILK HYPERSENSITIVITY should be differentiated from LACTOSE INTOLERANCE, an intolerance to milk as a result of congenital deficiency of lactase.%A%
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D016269 2002
% 211.36/211.55 |- mesh__dateEstablished mesh__D016269 1991-01-01
% 211.36/211.55 |- mesh__dateRevised mesh__D016269 2001-07-25
% 211.36/211.55 |- skos__hiddenLabel mesh__D016269 Hypersensitivities, Milk
% 211.36/211.55 |- skos__prefLabel mesh__D016269 Milk Hypersensitivity
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D016269 2006
% 211.36/211.55 |- skos__hiddenLabel mesh__D016269 Milk Hypersensitivities
% 211.36/211.55 |- mesh__dateCreated mesh__D016269 1990-05-29
% 211.36/211.55 |- rdf__type mesh__D035423sskos__Concept
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D035423 2003
% 211.36/211.55 |- mesh__dateRevised mesh__D035423 2002-09-24
% 211.36/211.55 |- skos__prefLabel mesh__D035423 Thoracic Cavity
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D035423 2003
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D035423 2006
% 211.36/211.55 |- mesh__historyNote mesh__D035423 2003
% 211.36/211.55 |- skos__annotation mesh__D035423 prefer specifics
% 211.36/211.55 |- skos__scopeNote mesh__D035423
% 211.36/211.55 The region of the thorax that includes the PLEURAL CAVITY and MEDIASTINUM.%A%
% 211.36/211.55 |- mesh__dateEstablished mesh__D035423 2003-01-01
% 211.36/211.55 |- skos__hiddenLabel mesh__D035423 Cavity, Thoracic
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D035423 2005
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D035423 2003A
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D035423 sjn
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D035423 2004
% 211.36/211.55 |- skos__broader mesh__D035423smesh__D013909
% 211.36/211.55 |- mesh__dateCreated mesh__D035423 2002-07-03
% 211.36/211.55 |- skos__altLabel mesh__D035423 Cavitas thoracis
% 211.36/211.55 |- mesh__recordOriginator mesh__D035423 ags
% 211.36/211.55 |- mesh__recordMaintainer mesh__D035423 sjn
% 211.36/211.55 |- skos__hiddenLabel mesh__D002249 Monoxide Poisonings, Carbon
% 211.36/211.55 |- skos__hiddenLabel mesh__D002249 Monoxide Poisoning, Carbon
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 2002
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 1997
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 2006
% 211.36/211.55 |- mesh__recordMaintainer mesh__D002249 TGC
% 211.36/211.55 |- skos__prefLabel mesh__D002249 Carbon Monoxide Poisoning
% 211.36/211.55 |- mesh__onlineNote mesh__D002249
% 211.36/211.55 use CARBON MONOXIDE POISONING to search ILLUMINATING GAS POISONING 1969-78%A%
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D002249 PLS
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 1996
% 211.36/211.55 |- skos__hiddenLabel mesh__D002249 Poisonings, Carbon Monoxide
% 211.36/211.55 |- skos__hiddenLabel mesh__D002249 Gas Poisonings, Illuminating
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 2005
% 211.36/211.55 |- mesh__dateCreated mesh__D002249 1999-01-01
% 211.36/211.55 |- rdf__type mesh__D002249sskos__Concept
% 211.36/211.55 |- skos__hiddenLabel mesh__D002249 Carbon Monoxide Poisonings
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 1993
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 2001
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 1999
% 211.36/211.55 |- mesh__recordOriginator mesh__D002249 NLM
% 211.36/211.55 |- skos__hiddenLabel mesh__D002249 Poisonings, Illuminating Gas
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 2000
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 1998
% 211.36/211.55 |- skos__broader mesh__D002249smesh__D005739
% 211.36/211.55 |- mesh__dateRevised mesh__D002249 1992-05-07
% 211.36/211.55 |- skos__altLabel mesh__D002249 Poisoning, Carbon Monoxide
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 2004
% 211.36/211.55 |- skos__hiddenLabel mesh__D002249 Illuminating Gas Poisonings
% 211.36/211.55 |- skos__hiddenLabel mesh__D002249 Gas Poisoning, Illuminating
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 1995
% 211.36/211.55 |- skos__altLabel mesh__D002249 Illuminating Gas Poisoning
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 2003
% 211.36/211.55 |- mesh__historyNote mesh__D002249
% 211.36/211.55 ILLUMINATING GAS POISONING was see under CARBON MONOXIDE POISONING 1969-78%A%
% 211.36/211.55 |- skos__scopeNote mesh__D002249
% 211.36/211.55 Toxic asphyxiation due to the displacement of oxygen from oxyhemoglobin by carbon monoxide.%A%
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D002249 1994
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007732 2004
% 211.36/211.55 |- skos__annotation mesh__D007732 severe form of protein malnutrition
% 211.36/211.55 |- mesh__dateRevised mesh__D007732 2003-07-09
% 211.36/211.55 |- mesh__dateCreated mesh__D007732 1999-01-01
% 211.36/211.55 |- mesh__recordOriginator mesh__D007732 NLM
% 211.36/211.55 |- skos__hiddenLabel mesh__D007732 Kwashiorkors
% 211.36/211.55 |- rdf__type mesh__D007732sskos__Concept
% 211.36/211.55 |- skos__prefLabel mesh__D007732 Kwashiorkor
% 211.36/211.55 |- mesh__recordMaintainer mesh__D007732 lkt
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007732 2005
% 211.36/211.55 |- skos__scopeNote mesh__D007732
% 211.36/211.55 A syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in Gold Coast, Africa, meaning %22%displaced child%22%. Although first reported from Africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus. %28%From Dorland, 27th ed%29%%A%
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007732 2006
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D007732 sjn
% 211.36/211.55 |- skos__broader mesh__D007732smesh__D011502
% 211.36/211.55 |- skos__annotation mesh__D045851
% 211.36/211.55 infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 211.36/211.55 |- mesh__dateCreated mesh__D045851 2003-07-09
% 211.36/211.55 |- rdf__type mesh__D045851sskos__Concept
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D045851 2004
% 211.36/211.55 |- mesh__dateEstablished mesh__D045851 2004-01-01
% 211.36/211.55 |- skos__prefLabel mesh__D045851 Megasphaera
% 211.36/211.55 |- skos__broader mesh__D045851smesh__D016964
% 211.36/211.55 |- mesh__dateRevised mesh__D045851 2005-06-30
% 211.36/211.55 |- mesh__recordMaintainer mesh__D045851 SYSTEM
% 211.36/211.55 |- mesh__recordOriginator mesh__D045851 ags
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D045851 sjn
% 211.36/211.55 |- mesh__historyNote mesh__D045851 2004
% 211.36/211.55 |- skos__scopeNote mesh__D045851
% 211.36/211.55 A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, found in the RUMEN of SHEEP and CATTLE, and also in humans.%A%
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D045851 2006
% 211.36/211.55 |- skos__historyNote mesh__D045851 Veillonellaceae %28%1975-2003%29%
% 211.36/211.55 |- skos__related mesh__D012677smesh__D010465
% 211.36/211.55 |- mesh__recordOriginator mesh__D012677 NLM
% 211.36/211.55 |- skos__annotation mesh__D012677
% 211.36/211.55 SENSATION DISORDERS is available but burning, tingling or prickling sensations go under PARESTHESIA%A%
% 211.36/211.55 |- skos__broader mesh__D012677smesh__D011603
% 211.36/211.55 |- mesh__dateCreated mesh__D012677 1999-01-01
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D012677 sjn
% 211.36/211.55 |- mesh__dateRevised mesh__D012677 2005-06-30
% 211.36/211.55 |- skos__broader mesh__D012677smesh__D009424
% 211.36/211.55 |- skos__altLabel mesh__D012677 Organoleptic
% 211.36/211.55 |- skos__hiddenLabel mesh__D012677 Sensations
% 211.36/211.55 |- mesh__recordMaintainer mesh__D012677 ssb
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D012677 2006
% 211.36/211.55 |- skos__scopeNote mesh__D012677
% 211.36/211.55 Transduction of physical or chemical changes in the external or internal environment into nerve impulses by specialized receptors, transmission of these impulses by afferent neurons to the effectors, either directly or through the CNS.%A%
% 211.36/211.55 |- rdf__type mesh__D012677sskos__Concept
% 211.36/211.55 |- skos__prefLabel mesh__D012677 Sensation
% 211.36/211.55 |- rdf__type mesh__D017362sskos__Concept
% 211.36/211.55 |- skos__hiddenLabel mesh__D017362
% 211.36/211.55 DNA Binding Protein, Cyclic AMP Responsive
% 211.36/211.55 |- mesh__recordMaintainer mesh__D017362 DRC
% 211.36/211.55 |- mesh__historyNote mesh__D017362
% 211.36/211.55 93; was CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN %28%NM%29% 1989-92%A%
% 211.36/211.55 |- skos__scopeNote mesh__D017362
% 211.36/211.55 A protein that has been shown to function as a calcium-regulated transcription factor as well as a substrate for depolarization-activated CALCIUM-CALMODULIN DEPENDENT PROTEIN KINASES. This protein functions to integrate both calcium and cAMP signals.%A%
% 211.36/211.55 |- skos__prefLabel mesh__D017362
% 211.36/211.55 Cyclic AMP Response Element-Binding Protein
% 211.36/211.55 |- skos__altLabel mesh__D017362 Cyclic AMP-Responsive DNA-Binding Protein
% 211.36/211.55 |- skos__hiddenLabel mesh__D017362 cAMP Response Element Binding Protein
% 211.36/211.55 |- mesh__recordOriginator mesh__D017362 PXP
% 211.36/211.55 |- skos__hiddenLabel mesh__D017362
% 211.36/211.55 Cyclic AMP Responsive DNA Binding Protein
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D017362
% 211.36/211.55 93; CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN was indexed under DNA-BINDING PROTEINS 1989-92%A%
% 211.36/211.55 |- mesh__dateCreated mesh__D017362 1992-05-14
% 211.36/211.55 |- skos__altLabel mesh__D017362 cAMP Response Element-Binding Protein
% 211.36/211.55 |- mesh__dateRevised mesh__D017362 2005-06-30
% 211.36/211.55 |- skos__broader mesh__D017362smesh__D050976
% 211.36/211.55 |- mesh__onlineNote mesh__D017362
% 211.36/211.55 use DNA-BINDING PROTEIN, CYCLIC AMP-RESPONSIVE %28%NM%29% to search CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN 1989-92%A%
% 211.36/211.55 |- skos__historyNote mesh__D017362 DNA-Binding Proteins %28%1989-1992%29%
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D017362 2006
% 211.36/211.55 |- skos__altLabel mesh__D017362 CREB Protein
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D017362 sjn
% 211.36/211.55 |- mesh__dateEstablished mesh__D017362 1993-01-01
% 211.36/211.55 |- skos__altLabel mesh__D017362 DNA-Binding Protein, Cyclic AMP-Responsive
% 211.36/211.55 |- skos__broader mesh__D050796smesh__D050791
% 211.36/211.55 |- skos__altLabel mesh__D050796
% 211.36/211.55 Signal Transducer and Activator of Transcription 3
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D050796 2006
% 211.36/211.55 |- skos__altLabel mesh__D050796 LIF-Response Factor
% 211.36/211.55 |- skos__altLabel mesh__D050796 APRF Transcription Factor
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 Transcription Factor, APRF
% 211.36/211.55 |- skos__prefLabel mesh__D050796 STAT3 Transcription Factor
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 Transcription Factor, STAT3a
% 211.36/211.55 |- rdf__type mesh__D050796sskos__Concept
% 211.36/211.55 |- mesh__recordOriginator mesh__D050796 DRC
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D050796 sjn
% 211.36/211.55 |- skos__scopeNote mesh__D050796
% 211.36/211.55 A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-6 family members. STAT3 is constitutively activated in a variety of TUMORS and is a major downstream transducer for the CYTOKINE RECEPTOR GP130.%A%
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 IL6 Response Factor
% 211.36/211.55 |- skos__altLabel mesh__D050796 Stat3beta Transcription Factor
% 211.36/211.55 |- mesh__recordMaintainer mesh__D050796 DRC
% 211.36/211.55 |- mesh__dateEstablished mesh__D050796 2006-01-01
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D050796
% 211.36/211.55 2006; STAT3 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSACTIVATORS 1994-2005%A%
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 Acute Phase Response Factor
% 211.36/211.55 |- skos__altLabel mesh__D050796 Stat3alpha Transcription Factor
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 Transcription Factor, STAT3b
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 Transcription Factor, Stat3beta
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 Transcription Factor, STAT3
% 211.36/211.55 |- skos__altLabel mesh__D050796 IL6-Response Factor
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 Transcription Factor, Stat3alpha
% 211.36/211.55 |- mesh__historyNote mesh__D050796 2006
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 LIF Response Factor
% 211.36/211.55 |- skos__altLabel mesh__D050796 Acute-Phase Response Factor
% 211.36/211.55 |- mesh__dateCreated mesh__D050796 2005-06-30
% 211.36/211.55 |- skos__altLabel mesh__D050796 STAT3 Protein
% 211.36/211.55 |- skos__hiddenLabel mesh__D050796 Response Factor, Acute-Phase
% 211.36/211.55 |- skos__hiddenLabel mesh__D003342 Lentiformis, Nucleus
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003342 2002
% 211.36/211.55 |- mesh__recordMaintainer mesh__D003342 ags
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003342 2004
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003342 2001
% 211.36/211.55 |- skos__hiddenLabel mesh__D003342 Nucleus, Lentiform
% 211.36/211.55 |- skos__broader mesh__D003342smesh__D001479
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003342 2006
% 211.36/211.55 |- skos__scopeNote mesh__D003342
% 211.36/211.55 Striped gray and white matter consisting of the NEOSTRIATUM and paleostriatum %28%GLOBUS PALLIDUS%29%. It is located in front of and lateral to the thalamus in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus %28%the latter consisting of the GLOBUS PALLIDUS and PUTAMEN%29%. The white matter is the internal capsule.%A%
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003342 2003
% 211.36/211.55 |- skos__altLabel mesh__D003342 Nucleus Lentiformis
% 211.36/211.55 |- mesh__historyNote mesh__D003342
% 211.36/211.55 74%28%72%29%; LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A%
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003342 2005
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003342 2000
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D003342
% 211.36/211.55 74; LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A%
% 211.36/211.55 |- mesh__dateEstablished mesh__D003342 1974-01-01
% 211.36/211.55 |- mesh__dateCreated mesh__D003342 1999-01-01
% 211.36/211.55 |- mesh__recordOriginator mesh__D003342 NLM
% 211.36/211.55 |- rdf__type mesh__D003342sskos__Concept
% 211.36/211.55 |- skos__annotation mesh__D003342
% 211.36/211.55 do not confuse with STRIATE CORTEX see VISUAL CORTEX or VENTRAL STRIATUM see BASAL GANGLIA%A%
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D003342 sjn
% 211.36/211.55 |- skos__historyNote mesh__D003342 Basal Ganglia %28%1966-1971%29%
% 211.36/211.55 |- skos__hiddenLabel mesh__D003342 Striatum, Corpus
% 211.36/211.55 |- mesh__onlineNote mesh__D003342
% 211.36/211.55 use CORPUS STRIATUM to search LENTICULAR NUCLEUS 1974-78; use BASAL GANGLIA 1966-73%A%
% 211.36/211.55 |- skos__altLabel mesh__D003342 Lentiform Nucleus
% 211.36/211.55 |- skos__hiddenLabel mesh__D003342 Nucleus, Lenticular
% 211.36/211.55 |- mesh__dateRevised mesh__D003342 1999-11-03
% 211.36/211.55 |- skos__prefLabel mesh__D003342 Corpus Striatum
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 2006
% 211.36/211.55 |- mesh__recordMaintainer mesh__D013770 JRT
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 1998
% 211.36/211.55 |- mesh__recordOriginator mesh__D013770 NLM
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 2005
% 211.36/211.55 |- skos__prefLabel mesh__D013770 Tetraisopropylpyrophosphamide
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D013770 PLS
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 2002
% 211.36/211.55 |- rdf__type mesh__D013770sskos__Concept
% 211.36/211.55 |- skos__scopeNote mesh__D013770
% 211.36/211.55 N,N%27%,N%27%%27%,N%27%%27%%27%-Tetraisopropylpyrophosphamide. A specific inhibitor of pseudocholinesterases. It is commonly used experimentally to determine whether pseudo- or acetylcholinesterases are involved in an enzymatic process.%A%
% 211.36/211.55 |- skos__historyNote mesh__D013770 Amides %28%1972-1974%29%
% 211.36/211.55 |- skos__hiddenLabel mesh__D013770 Iso OMPA
% 211.36/211.55 |- mesh__dateRevised mesh__D013770 1995-06-08
% 211.36/211.55 |- mesh__dateCreated mesh__D013770 1974-11-19
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 1997
% 211.36/211.55 |- skos__altLabel mesh__D013770 Iso-OMPA
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 2004
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 2001
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 1996
% 211.36/211.55 |- mesh__dateEstablished mesh__D013770 1991-01-01
% 211.36/211.55 |- skos__annotation mesh__D013770 a cholinesterase inhib
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 2003
% 211.36/211.55 |- skos__broader mesh__D013770smesh__D009943
% 211.36/211.55 |- skos__historyNote mesh__D013770
% 211.36/211.55 Organophosphorus Compounds %28%1972-1974%29%
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D013770
% 211.36/211.55 91; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 2000
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D013770 1999
% 211.36/211.55 |- mesh__historyNote mesh__D013770
% 211.36/211.55 91%28%75%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90
% 211.36/211.55 |- skos__hiddenLabel mesh__D007733 Forest Disease, Kyasanur
% 211.36/211.55 |- skos__broader mesh__D007733smesh__D006482
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 1999
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 2006
% 211.36/211.55 |- mesh__dateRevised mesh__D007733 1993-06-04
% 211.36/211.55 |- mesh__historyNote mesh__D007733
% 211.36/211.55 78%28%75%29%; was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76%A%
% 211.36/211.55 |- skos__broader mesh__D007733smesh__D017282
% 211.36/211.55 |- skos__prefLabel mesh__D007733 Kyasanur Forest Disease
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 1996
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 1995
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 2003
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D007733 PLS
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 1998
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 2005
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D007733
% 211.36/211.55 78; was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76%A%
% 211.36/211.55 |- mesh__recordMaintainer mesh__D007733 AGS
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 1994
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 2002
% 211.36/211.55 |- skos__historyNote mesh__D007733 Arbovirus Infections %28%1966-1977%29%
% 211.36/211.55 |- skos__scopeNote mesh__D007733
% 211.36/211.55 Tick-borne flavivirus infection occurring in the Kyasanur Forest in India.%A%
% 211.36/211.55 |- skos__hiddenLabel mesh__D007733 Disease, Kyasanur Forest
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 2001
% 211.36/211.55 |- mesh__dateEstablished mesh__D007733 1978-01-01
% 211.36/211.55 |- mesh__dateCreated mesh__D007733 1974-11-11
% 211.36/211.55 |- rdf__type mesh__D007733sskos__Concept
% 211.36/211.55 |- skos__historyNote mesh__D007733
% 211.36/211.55 Hemorrhagic Fevers, Viral %28%1966-1974%29%
% 211.36/211.55 |- mesh__recordOriginator mesh__D007733 NLM
% 211.36/211.55 |- skos__broader mesh__D007733smesh__D018177
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 2000
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 1997
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D007733 2004
% 211.36/211.55 |- skos__annotation mesh__D007733
% 211.36/211.55 note spelling: not Kyanasur; the forest is in India; a hemorrhagic fever caused by a flavivirus%A%
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D045852 2006
% 211.36/211.55 |- rdf__type mesh__D045852sskos__Concept
% 211.36/211.55 |- mesh__dateCreated mesh__D045852 2003-07-09
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D045852 2004
% 211.36/211.55 |- mesh__dateEstablished mesh__D045852 2004-01-01
% 211.36/211.55 |- mesh__dateRevised mesh__D045852 2005-06-30
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D045852 sjn
% 211.36/211.55 |- mesh__recordOriginator mesh__D045852 ags
% 211.36/211.55 |- skos__scopeNote mesh__D045852
% 211.36/211.55 A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, isolated from spoiled BEER and pitching yeast.%A%
% 211.36/211.55 |- mesh__recordMaintainer mesh__D045852 SYSTEM
% 211.36/211.55 |- mesh__historyNote mesh__D045852 2004
% 211.36/211.55 |- skos__broader mesh__D045852smesh__D045854
% 211.36/211.55 |- skos__prefLabel mesh__D045852 Pectinatus
% 211.36/211.55 |- skos__scopeNote mesh__D012678
% 211.36/211.55 Disorders of the special senses %28%i.e., VISION; HEARING; TASTE; and SMELL%29% or somatosensory system %28%i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM%29%.%A%
% 211.36/211.55 |- mesh__dateRevised mesh__D012678 2003-07-09
% 211.36/211.55 |- skos__hiddenLabel mesh__D012678 Senses Disorder, Special
% 211.36/211.55 |- skos__broader mesh__D012678smesh__D009461
% 211.36/211.55 |- skos__hiddenLabel mesh__D012678 Sensory Disorder
% 211.36/211.55 |- skos__hiddenLabel mesh__D012678 Special Senses Disorder
% 211.36/211.55 |- mesh__recordMaintainer mesh__D012678 lkt
% 211.36/211.55 |- skos__hiddenLabel mesh__D012678 Sensation Disorder
% 211.36/211.55 |- skos__hiddenLabel mesh__D012678 Senses Disorders, Special
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D012678 2006
% 211.36/211.55 |- skos__annotation mesh__D012678 GEN or unspecified: prefer specifics
% 211.36/211.55 |- skos__historyNote mesh__D012678 Sensation %28%1969-1992%29%
% 211.36/211.55 |- mesh__recordOriginator mesh__D012678 NLM
% 211.36/211.55 |- skos__prefLabel mesh__D012678 Sensation Disorders
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D012678 2005
% 211.36/211.55 |- rdf__type mesh__D012678sskos__Concept
% 211.36/211.55 |- mesh__historyNote mesh__D012678
% 211.36/211.55 1993; was SENSATION DISORDERS %28%NON MESH%29% 1967-92
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D012678 2004
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D012678 1993
% 211.36/211.55 |- skos__historyNote mesh__D012678
% 211.36/211.55 Nervous System Diseases %28%1980-1992%29%
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D012678 sjn
% 211.36/211.55 |- mesh__dateCreated mesh__D012678 1999-01-01
% 211.36/211.55 |- mesh__dateEstablished mesh__D012678 1993-01-01
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D050797 2006
% 211.36/211.55 |- mesh__dateEstablished mesh__D050797 2006-01-01
% 211.36/211.55 |- skos__scopeNote mesh__D050797
% 211.36/211.55 A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-12 in T-LYMPHOCYTES. Stat4 is an important signaling molecule for differentiation in TH1 CELLS.%A%
% 211.36/211.55 |- skos__altLabel mesh__D050797
% 211.36/211.55 Signal Transducer and Activator of Transcription 4
% 211.36/211.55 |- mesh__historyNote mesh__D050797 2006%28%1994%29%
% 211.36/211.55 |- rdf__type mesh__D050797sskos__Concept
% 211.36/211.55 |- mesh__dateCreated mesh__D050797 2005-06-30
% 211.36/211.55 |- skos__broader mesh__D050797smesh__D050791
% 211.36/211.55 |- skos__hiddenLabel mesh__D050797 Transcription Factor, STAT4A
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D050797
% 211.36/211.55 2006; STAT4 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1994-2005%A%
% 211.36/211.55 |- skos__altLabel mesh__D050797 Transcription Factor STAT4
% 211.36/211.55 |- skos__hiddenLabel mesh__D050797 Transcription Factor, STAT4b
% 211.36/211.55 |- skos__altLabel mesh__D050797 STAT4beta Protein
% 211.36/211.55 |- mesh__recordMaintainer mesh__D050797 DRC
% 211.36/211.55 |- skos__hiddenLabel mesh__D050797 Transcription Factor, STAT4
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D050797 sjn
% 211.36/211.55 |- skos__altLabel mesh__D050797 STAT4 Protein
% 211.36/211.55 |- mesh__recordOriginator mesh__D050797 DRC
% 211.36/211.55 |- skos__prefLabel mesh__D050797 STAT4 Transcription Factor
% 211.36/211.55 |- skos__altLabel mesh__D050797 STAT4alpha Protein
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 2003
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 2005
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1990
% 211.36/211.55 |- mesh__recordOriginator mesh__D003343 NLM
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1997
% 211.36/211.55 |- skos__historyNote mesh__D003343 Chemistry, Physical %28%1966-1969%29%
% 211.36/211.55 |- skos__prefLabel mesh__D003343 Corrosion
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1999
% 211.36/211.55 |- mesh__historyNote mesh__D003343 73%28%70%29%
% 211.36/211.55 |- mesh__dateCreated mesh__D003343 1999-01-01
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1993
% 211.36/211.55 |- rdf__type mesh__D003343sskos__Concept
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1996
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1995
% 211.36/211.55 |- skos__hiddenLabel mesh__D003343 Corrosions
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1998
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 2002
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1992
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1994
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 2001
% 211.36/211.55 |- mesh__publicMeSHNote mesh__D003343 73
% 211.36/211.55 |- mesh__recordAuthorizer mesh__D003343 PLS
% 211.36/211.55 |- skos__broader mesh__D003343smesh__D002627
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 2004
% 211.36/211.55 |- skos__annotation mesh__D003343 almost never IM; no qualif
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 2000
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 2006
% 211.36/211.55 |- mesh__activeMeSHYear mesh__D003343 1991
% 211.36/211.55 |- mesh__dateEstablished mesh__D003343 1973-01-01
% 211.36/211.55 |- mesh__dateRevised mesh__D003343 1989-06-14
% 211.36/211.55 |- mesh__recordMaintainer mesh__D003343 TGC
% 211.36/211.55 |- mesh__dateCreated mesh__D013771 1999-01-01
% 211.36/211.55 |- rdf__type mesh__D013771sskos__Concept
% 211.36/211.55 |- skos__scopeNote mesh__D013771
% 211.36/211.55 A combination of congenital cardiac defects consisting of pulmonary stenosis, interventricular septal defects, dextroposition of the aorta so that it overrides the interventricular septum and receives venous as well as arterial blood, and right ventricular hypertrophy.%A%
% 211.36/211.56 |- skos__altLabel mesh__D013771 Fallot%27%s Tetralogy
% 211.36/211.56 |- skos__hiddenLabel mesh__D013771 Tetralogy, Fallot
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013771 2000
% 211.36/211.56 |- skos__hiddenLabel mesh__D013771 Tetralogy, Fallots
% 211.36/211.56 |- mesh__dateRevised mesh__D013771 1999-11-03
% 211.36/211.56 |- mesh__recordOriginator mesh__D013771 NLM
% 211.36/211.56 |- mesh__recordMaintainer mesh__D013771 kle
% 211.36/211.56 |- skos__hiddenLabel mesh__D013771 Fallots Tetralogy
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013771 2004
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D013771 sjn
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013771 2002
% 211.36/211.56 |- skos__hiddenLabel mesh__D013771 Fallot Tetralogy
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013771 2003
% 211.36/211.56 |- skos__prefLabel mesh__D013771 Tetralogy of Fallot
% 211.36/211.56 |- skos__annotation mesh__D013771
% 211.36/211.56 multiple heart defects; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; do not confuse with TRILOGY OF FALLOT%A%
% 211.36/211.56 |- skos__broader mesh__D013771smesh__D006330
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013771 2006
% 211.36/211.56 |- skos__altLabel mesh__D013771 Tetralogy, Fallot%27%s
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013771 2001
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013771 2005
% 211.36/211.56 |- mesh__recordOriginator mesh__D007734 NLM
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007734 2000
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007734 2005
% 211.36/211.56 |- skos__prefLabel mesh__D007734 Kymography
% 211.36/211.56 |- skos__broader mesh__D007734smesh__D019937
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D007734 sjn
% 211.36/211.56 |- skos__scopeNote mesh__D007734
% 211.36/211.56 The recording of wavelike motions or undulations. It is usually used on arteries to detect variations in blood pressure.%A%
% 211.36/211.56 |- mesh__dateRevised mesh__D007734 1999-11-03
% 211.36/211.56 |- rdf__type mesh__D007734sskos__Concept
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007734 2002
% 211.36/211.56 |- skos__annotation mesh__D007734 DF: KYMOGR
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007734 2004
% 211.36/211.56 |- mesh__dateCreated mesh__D007734 1999-01-01
% 211.36/211.56 |- mesh__recordMaintainer mesh__D007734 KEV
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007734 2001
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007734 2006
% 211.36/211.56 |- skos__hiddenLabel mesh__D007734 Kymographies
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007734 2003
% 211.36/211.56 |- skos__broader mesh__D045853smesh__D015656
% 211.36/211.56 |- skos__hiddenLabel mesh__D045853 Exhalations
% 211.36/211.56 |- mesh__historyNote mesh__D045853 2004
% 211.36/211.56 |- skos__hiddenLabel mesh__D045853 Expirations, Respiratory
% 211.36/211.56 |- skos__altLabel mesh__D045853 Exhaling
% 211.36/211.56 |- skos__altLabel mesh__D045853 Expiration, Respiratory
% 211.36/211.56 |- skos__prefLabel mesh__D045853 Exhalation
% 211.36/211.56 |- mesh__dateEstablished mesh__D045853 2004-01-01
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D045853 2006
% 211.36/211.56 |- rdf__type mesh__D045853sskos__Concept
% 211.36/211.56 |- skos__scopeNote mesh__D045853 The act of BREATHING out.
% 211.36/211.56 |- mesh__dateCreated mesh__D045853 2003-07-09
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D045853 2004
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D045853 2005
% 211.36/211.56 |- skos__hiddenLabel mesh__D045853 Respiratory Expirations
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D045853 2004
% 211.36/211.56 |- skos__hiddenLabel mesh__D045853 Respiratory Expiration
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D012679 sjn
% 211.36/211.56 |- skos__historyNote mesh__D012679 Sensation %28%1966-1971%29%
% 211.36/211.56 |- skos__annotation mesh__D012679 GEN: prefer specifics
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D012679 2006
% 211.36/211.56 |- mesh__runningHead mesh__D012679 A9 - ANATOMY-SENSE ORGANS
% 211.36/211.56 |- skos__hiddenLabel mesh__D012679 Sense Organ
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D012679 2005
% 211.36/211.56 |- rdf__type mesh__D012679sskos__Concept
% 211.36/211.56 |- skos__prefLabel mesh__D012679 Sense Organs
% 211.36/211.56 |- skos__hiddenLabel mesh__D012679 Organs, Sense
% 211.36/211.56 |- skos__related mesh__D012679smesh__D011984
% 211.36/211.56 |- mesh__recordOriginator mesh__D012679 NLM
% 211.36/211.56 |- mesh__dateRevised mesh__D012679 2004-07-07
% 211.36/211.56 |- mesh__dateCreated mesh__D012679 1999-01-01
% 211.36/211.56 |- mesh__historyNote mesh__D012679 72
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D012679 72
% 211.36/211.56 |- mesh__dateEstablished mesh__D012679 1972-01-01
% 211.36/211.56 |- skos__historyNote mesh__D012679 Receptors, Sensory %28%1966-1971%29%
% 211.36/211.56 |- mesh__recordMaintainer mesh__D012679 ags
% 211.36/211.56 |- skos__hiddenLabel mesh__D012679 Organ, Sense
% 211.36/211.56 |- skos__altLabel mesh__D017364 Collagen-Degrading Enzyme
% 211.36/211.56 |- skos__hiddenLabel mesh__D017364 Collagen Degrading Enzyme
% 211.36/211.56 |- mesh__recordOriginator mesh__D017364 TPW
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D017364 ags
% 211.36/211.56 |- skos__broader mesh__D017364smesh__D008666
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017364 2005
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D017364
% 211.36/211.56 93; COLLAGENASE was see CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1966-92%A%
% 211.36/211.56 |- mesh__dateRevised mesh__D017364 2005-07-11
% 211.36/211.56 |- mesh__onlineNote mesh__D017364
% 211.36/211.56 use CLOSTRIDIUM HISTOLYTICUM COLLAGENASE to search COLLAGENASE 1966-92%A%
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017364 2006
% 211.36/211.56 |- mesh__historyNote mesh__D017364
% 211.36/211.56 93; COLLAGENASE was see CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1966-92%A%
% 211.36/211.56 |- skos__annotation mesh__D017364
% 211.36/211.56 72-KDA TYPE IV COLLAGENASE see GELATINASE A and 92-KDA TYPE IV COLLAGENASE see GELATINASE B are available%A%
% 211.36/211.56 |- skos__altLabel mesh__D017364 Collagen Peptidase
% 211.36/211.56 |- skos__altLabel mesh__D017364 Collagenase
% 211.36/211.56 |- skos__hiddenLabel mesh__D017364 Peptidase, Collagen
% 211.36/211.56 |- skos__historyNote mesh__D017364
% 211.36/211.56 Clostridium histolyticum Collagenase %28%1975-1992%29%
% 211.36/211.56 |- mesh__dateEstablished mesh__D017364 1993-01-01
% 211.36/211.56 |- skos__scopeNote mesh__D017364
% 211.36/211.56 Enzymes that catalyze the degradation of collagen by acting on the peptide bonds. EC 3.4.24.-.%A%
% 211.36/211.56 |- mesh__recordMaintainer mesh__D017364 ags
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017364 2004
% 211.36/211.56 |- mesh__dateCreated mesh__D017364 1992-05-13
% 211.36/211.56 |- rdf__type mesh__D017364sskos__Concept
% 211.36/211.56 |- skos__prefLabel mesh__D017364 Collagenases
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017364 2006A
% 211.36/211.56 |- rdf__type mesh__D050798sskos__Concept
% 211.36/211.56 |- mesh__dateEstablished mesh__D050798 2006-01-01
% 211.36/211.56 |- skos__annotation mesh__D050798
% 211.36/211.56 SUNCT = shortlasting, unilateral, neuralgiform, conjunctival, tearing.%A%
% 211.36/211.56 |- mesh__recordOriginator mesh__D050798 lkt
% 211.36/211.56 |- skos__historyNote mesh__D050798 Neuralgia %28%1991-2005%29%
% 211.36/211.56 |- skos__historyNote mesh__D050798 Tears %28%1991-2005%29%
% 211.36/211.56 |- mesh__historyNote mesh__D050798 2006
% 211.36/211.56 |- skos__broader mesh__D050798smesh__D051303
% 211.36/211.56 |- mesh__dateCreated mesh__D050798 2005-06-30
% 211.36/211.56 |- skos__prefLabel mesh__D050798 SUNCT Syndrome
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D050798 2006
% 211.36/211.56 |- skos__hiddenLabel mesh__D050798 Syndrome, SUNCT
% 211.36/211.56 |- skos__historyNote mesh__D050798 Headache %28%1991-2005%29%
% 211.36/211.56 |- mesh__recordMaintainer mesh__D050798 lkt
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D050798 2006
% 211.36/211.56 |- skos__hiddenLabel mesh__D050798 Syndromes, SUNCT
% 211.36/211.56 |- skos__scopeNote mesh__D050798
% 211.36/211.56 A primary headache disorder that is characterized by frequent short-lasting, unilateral, neuralgiform pain attacks in the ocular area, with CONJUNCTIVA fluid-filling and tearing. SUNCT syndrome is usually resistant to treatment.%A%
% 211.36/211.56 |- skos__hiddenLabel mesh__D050798 SUNCT Syndromes
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D050798 sjn
% 211.36/211.56 |- skos__hiddenLabel mesh__D003344 Synchronization, Cortical
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003344 1999
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003344 2000
% 211.36/211.56 |- mesh__dateCreated mesh__D003344 1999-01-01
% 211.36/211.56 |- skos__hiddenLabel mesh__D003344 Desynchronizations, Cortical
% 211.36/211.56 |- rdf__type mesh__D003344sskos__Concept
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D003344 SJN
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003344 1998
% 211.36/211.56 |- skos__prefLabel mesh__D003344 Cortical Synchronization
% 211.36/211.56 |- skos__hiddenLabel mesh__D003344 Desynchronization, Cortical
% 211.36/211.56 |- skos__hiddenLabel mesh__D003344 Synchronizations, Cortical
% 211.36/211.56 |- mesh__recordOriginator mesh__D003344 NLM
% 211.36/211.56 |- skos__historyNote mesh__D003344 Electroencephalography %28%1966-1971%29%
% 211.36/211.56 |- skos__annotation mesh__D003344 /drug eff /rad eff permitted
% 211.36/211.56 |- skos__broader mesh__D003344smesh__D004569
% 211.36/211.56 |- mesh__dateRevised mesh__D003344 1997-06-20
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D003344
% 211.36/211.56 91; was see under ELECTROENCEPHALOGRAPHY 1975-90; CORTICAL DESYNCHRONIZATION was see under ELECTROENCEPHALOGRAPHY 1975-83%A%
% 211.36/211.56 |- mesh__dateEstablished mesh__D003344 1991-01-01
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003344 2004
% 211.36/211.56 |- skos__hiddenLabel mesh__D003344 Cortical Desynchronizations
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003344 2002
% 211.36/211.56 |- mesh__onlineNote mesh__D003344
% 211.36/211.56 use CORTICAL SYNCHRONIZATION to search CORTICAL DESYNCHRONIZATION 1972-83 %28%as Prov 1972-74%29%%A%
% 211.36/211.56 |- mesh__historyNote mesh__D003344
% 211.36/211.56 91%28%72%29%; was see under ELECTROENCEPHALOGRAPHY 1972-90 %28%Prov 1972-74%29%; CORTICAL DESYNCHRONIZATION was see under ELECTROENCEPHALOGRAPHY 1972-83 %28%Prov 1972-74%29%%A%
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003344 2006
% 211.36/211.56 |- mesh__recordMaintainer mesh__D003344 PXP
% 211.36/211.56 |- skos__hiddenLabel mesh__D003344 Cortical Synchronizations
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003344 2003
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003344 2001
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003344 2005
% 211.36/211.56 |- mesh__dateEstablished mesh__D013772 1991-01-01
% 211.36/211.56 |- mesh__historyNote mesh__D013772
% 211.36/211.56 91%28%75%29%; was see under PHENYLENEDIAMINES 1975-90
% 211.36/211.56 |- rdf__type mesh__D013772sskos__Concept
% 211.36/211.56 |- skos__hiddenLabel mesh__D013772 Wursters Blue
% 211.36/211.56 |- skos__altLabel mesh__D013772 Wurster%27%s Blue
% 211.36/211.56 |- skos__historyNote mesh__D013772 Dimethylamines %28%1974%29%
% 211.36/211.56 |- skos__hiddenLabel mesh__D013772 Blue, Wurster%27%s
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013772 2003
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013772 2001
% 211.36/211.56 |- skos__scopeNote mesh__D013772
% 211.36/211.56 Used in the form of the hydrochloride as a reagent in analytical chemistry.%A%
% 211.36/211.56 |- skos__altLabel mesh__D013772 Wurster%27%s Reagent
% 211.36/211.56 |- skos__broader mesh__D013772smesh__D010655
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013772 2004
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D013772
% 211.36/211.56 91; was see under PHENYLENEDIAMINES 1975-90
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013772 2002
% 211.36/211.56 |- skos__hiddenLabel mesh__D013772 Reagent, Wurster%27%s
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013772 2005
% 211.36/211.56 |- skos__prefLabel mesh__D013772 Tetramethylphenylenediamine
% 211.36/211.56 |- skos__hiddenLabel mesh__D013772 Blue, Wurster
% 211.36/211.56 |- mesh__recordMaintainer mesh__D013772 CCR
% 211.36/211.56 |- skos__historyNote mesh__D013772 Phenylenediamines %28%1974%29%
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013772 2006
% 211.36/211.56 |- mesh__recordOriginator mesh__D013772 NLM
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D013772 sjn
% 211.36/211.56 |- skos__hiddenLabel mesh__D013772 Wurster Reagent
% 211.36/211.56 |- skos__annotation mesh__D013772 D25-26 qualif
% 211.36/211.56 |- skos__altLabel mesh__D013772 Wurster Blue
% 211.36/211.56 |- mesh__dateRevised mesh__D013772 2000-06-22
% 211.36/211.56 |- skos__hiddenLabel mesh__D013772 Wursters Reagent
% 211.36/211.56 |- mesh__dateCreated mesh__D013772 1974-11-19
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007735 2002
% 211.36/211.56 |- rdf__type mesh__D007735sskos__Concept
% 211.36/211.56 |- skos__historyNote mesh__D007735 Amines %28%1972-1974%29%
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007735 2001
% 211.36/211.56 |- skos__historyNote mesh__D007735 Propiophenones %28%1972-1974%29%
% 211.36/211.56 |- mesh__historyNote mesh__D007735
% 211.36/211.56 91%28%75%29%; was see under PROPIOPHENONES 1975-90
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007735 2004
% 211.36/211.56 |- mesh__recordOriginator mesh__D007735 NLM
% 211.36/211.56 |- mesh__recordMaintainer mesh__D007735 CCR
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007735 2006
% 211.36/211.56 |- mesh__dateCreated mesh__D007735 1974-11-19
% 211.36/211.56 |- mesh__dateRevised mesh__D007735 2000-06-22
% 211.36/211.56 |- skos__prefLabel mesh__D007735 Kynuramine
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007735 2003
% 211.36/211.56 |- skos__hiddenLabel mesh__D007735 2,3 Diaminopropiophenone
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007735 2005
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D007735
% 211.36/211.56 91; was see under PROPIOPHENONES 1975-90
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D007735 sjn
% 211.36/211.56 |- mesh__dateEstablished mesh__D007735 1991-01-01
% 211.36/211.56 |- skos__broader mesh__D007735smesh__D011427
% 211.36/211.56 |- skos__altLabel mesh__D007735 Diaminopropiophenone
% 211.36/211.56 |- skos__altLabel mesh__D007735 2,3-Diaminopropiophenone
% 211.36/211.56 |- skos__scopeNote mesh__D045854
% 211.36/211.56 A family of gram-negative bacteria, in the order Clostridiales.%A%
% 211.36/211.56 |- mesh__dateRevised mesh__D045854 2005-06-30
% 211.36/211.56 |- mesh__recordOriginator mesh__D045854 ags
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D045854 sjn
% 211.36/211.56 |- mesh__recordMaintainer mesh__D045854 SYSTEM
% 211.36/211.56 |- rdf__type mesh__D045854sskos__Concept
% 211.36/211.56 |- mesh__historyNote mesh__D045854 2004
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D045854 2006
% 211.36/211.56 |- mesh__dateCreated mesh__D045854 2003-07-09
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D045854 2004
% 211.36/211.56 |- mesh__dateEstablished mesh__D045854 2004-01-01
% 211.36/211.56 |- skos__prefLabel mesh__D045854 Acidaminococcaceae
% 211.36/211.56 |- skos__broader mesh__D045854smesh__D016965
% 211.36/211.56 |- mesh__dateRevised mesh__D017365 2001-07-25
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017365 2002
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017365 2006
% 211.36/211.56 |- mesh__historyNote mesh__D017365
% 211.36/211.56 93; was see CONDIMENTS 1984-92; was see under CONDIMENTS 1963-82%A%
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017365 2003
% 211.36/211.56 |- mesh__recordOriginator mesh__D017365 TPW
% 211.36/211.56 |- skos__annotation mesh__D017365
% 211.36/211.56 coord with specific plant + specific plant component %28%if pertinent%29%; for use in therapy coord with PHYTOTHERAPY %28%IM%29% + disease /*drug ther %28%IM%29%%A%
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D017365
% 211.36/211.56 93; was see CONDIMENTS 1984-92; was see under CONDIMENTS 1963-82%A%
% 211.36/211.56 |- mesh__dateCreated mesh__D017365 1992-05-22
% 211.36/211.56 |- skos__scopeNote mesh__D017365
% 211.36/211.56 The dried seeds, bark, root, stems, buds, leaves, or fruit of aromatic plants used to season food.%A%
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017365 2004
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D017365 sjn
% 211.36/211.56 |- rdf__type mesh__D017365sskos__Concept
% 211.36/211.56 |- mesh__dateEstablished mesh__D017365 1993-01-01
% 211.36/211.56 |- skos__prefLabel mesh__D017365 Spices
% 211.36/211.56 |- skos__historyNote mesh__D017365 Condiments %28%1966-1992%29%
% 211.36/211.56 |- skos__hiddenLabel mesh__D017365 Spice
% 211.36/211.56 |- mesh__recordMaintainer mesh__D017365 ssb
% 211.36/211.56 |- skos__broader mesh__D017365smesh__D003212
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017365 2005
% 211.36/211.56 |- skos__altLabel mesh__D050799 STAT5 Protein
% 211.36/211.56 |- skos__broader mesh__D050799smesh__D050791
% 211.36/211.56 |- skos__altLabel mesh__D050799
% 211.36/211.56 Signal Transducer and Activator of Transcription 5A
% 211.36/211.56 |- skos__altLabel mesh__D050799 STAT5a Protein
% 211.36/211.56 |- mesh__recordMaintainer mesh__D050799 DRC
% 211.36/211.56 |- skos__hiddenLabel mesh__D050799 Mammary Gland Specific Nuclear Factor
% 211.36/211.56 |- mesh__recordOriginator mesh__D050799 DRC
% 211.36/211.56 |- skos__altLabel mesh__D050799
% 211.36/211.56 Signal Transducer and Activator of Transcription 5
% 211.36/211.56 |- mesh__historyNote mesh__D050799 2006%28%1992%29%
% 211.36/211.56 |- skos__altLabel mesh__D050799
% 211.36/211.56 Signal Transducer and Activator of Transcription 5B
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D050799 sjn
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D050799 2006
% 211.36/211.56 |- skos__prefLabel mesh__D050799 STAT5 Transcription Factor
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D050799
% 211.36/211.56 2006; STAT5 PROTEIN was indexed under DNA-BINDING PROTEINS; MILK PROTEINS; %26% TRANS-ACTIVATORS 1992-2005%A%
% 211.36/211.56 |- mesh__dateEstablished mesh__D050799 2006-01-01
% 211.36/211.56 |- skos__hiddenLabel mesh__D050799 Transcription Factor, STAT5b
% 211.36/211.56 |- skos__altLabel mesh__D050799 STAT5b Protein
% 211.36/211.56 |- skos__hiddenLabel mesh__D050799 Factor, STAT5 Transcription
% 211.36/211.56 |- skos__altLabel mesh__D050799 STAT5beta Protein
% 211.36/211.56 |- skos__altLabel mesh__D050799 Mammary Gland Factor
% 211.36/211.56 |- rdf__type mesh__D050799sskos__Concept
% 211.36/211.56 |- skos__hiddenLabel mesh__D050799 Transcription Factor, STAT5a
% 211.36/211.56 |- skos__altLabel mesh__D050799 STAT5alpha Protein
% 211.36/211.56 |- skos__altLabel mesh__D050799 Mammary Gland-Specific Nuclear Factor
% 211.36/211.56 |- skos__hiddenLabel mesh__D050799 Transcription Factor, STAT5
% 211.36/211.56 |- skos__scopeNote mesh__D050799
% 211.36/211.56 A signal transducer and activator of transcription that mediates cellular responses to a variety of CYTOKINES. Stat5 activation is associated with transcription of CELL CYCLE regulators such as CYCLIN KINASE INHIBITOR P21 and anti-apoptotic genes such as BCL-2 GENES. Stat5 is constitutively activated in many patients with acute MYELOID LEUKEMIA.%A%
% 211.36/211.56 |- mesh__dateCreated mesh__D050799 2005-06-30
% 211.36/211.56 |- rdf__type mesh__D003345sskos__Concept
% 211.36/211.56 |- skos__broader mesh__D003345smesh__D015062
% 211.36/211.56 |- mesh__dateRevised mesh__D003345 2003-07-09
% 211.36/211.56 |- skos__annotation mesh__D003345 /biosyn /physiol permitted
% 211.36/211.56 |- skos__prefLabel mesh__D003345 Corticosterone
% 211.36/211.56 |- skos__broader mesh__D003345smesh__D011282
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003345 2005
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003345 2004
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D003345 2006
% 211.36/211.56 |- mesh__dateCreated mesh__D003345 1999-01-01
% 211.36/211.56 |- skos__scopeNote mesh__D003345
% 211.36/211.56 An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. %28%From Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1437%29%%A%
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D003345 sjn
% 211.36/211.56 |- mesh__recordOriginator mesh__D003345 NLM
% 211.36/211.56 |- mesh__recordMaintainer mesh__D003345 ssb
% 211.36/211.56 |- rdf__type mesh__D008030sskos__Concept
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1994
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1993
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1999
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 2005
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 2004
% 211.36/211.56 |- skos__annotation mesh__D008030
% 211.36/211.56 no qualif; /adv eff = probably LIGHTNING INJURIES
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1995
% 211.36/211.56 |- mesh__recordOriginator mesh__D008030 NLM
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1991
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 2002
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 2006
% 211.36/211.56 |- mesh__dateCreated mesh__D008030 1999-01-01
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D008030 PLS
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 2000
% 211.36/211.56 |- mesh__dateRevised mesh__D008030 1989-04-28
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1996
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1990
% 211.36/211.56 |- mesh__recordMaintainer mesh__D008030 TGC
% 211.36/211.56 |- skos__prefLabel mesh__D008030 Lightning
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 2001
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1992
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1998
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 1997
% 211.36/211.56 |- skos__hiddenLabel mesh__D008030 Lightnings
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D008030 2003
% 211.36/211.56 |- skos__broader mesh__D008030smesh__D014887
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D013773 sjn
% 211.36/211.56 |- mesh__historyNote mesh__D013773 74
% 211.36/211.56 |- skos__broader mesh__D013773smesh__D007093
% 211.36/211.56 |- skos__prefLabel mesh__D013773 Tetramisole
% 211.36/211.56 |- mesh__recordMaintainer mesh__D013773 ssb
% 211.36/211.56 |- mesh__dateCreated mesh__D013773 1999-01-01
% 211.36/211.56 |- skos__broader mesh__D013773smesh__D013844
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D013773 2006
% 211.36/211.56 |- mesh__dateRevised mesh__D013773 2005-06-30
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D013773 74
% 211.36/211.56 |- mesh__dateEstablished mesh__D013773 1974-01-01
% 211.36/211.56 |- rdf__type mesh__D013773sskos__Concept
% 211.36/211.56 |- mesh__recordOriginator mesh__D013773 NLM
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D007736 sjn
% 211.36/211.56 |- skos__broader mesh__D007736smesh__D006912
% 211.36/211.56 |- mesh__dateRevised mesh__D007736 2000-06-21
% 211.36/211.56 |- skos__scopeNote mesh__D007736
% 211.36/211.56 A broad-spectrum excitatory amino acid antagonist used as a research tool.%A%
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007736 2004
% 211.36/211.56 |- mesh__dateCreated mesh__D007736 1999-01-01
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007736 2002
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007736 2006
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007736 2003
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007736 2001
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D007736 2005
% 211.36/211.56 |- mesh__recordOriginator mesh__D007736 NLM
% 211.36/211.56 |- skos__broader mesh__D007736smesh__D014977
% 211.36/211.56 |- skos__hiddenLabel mesh__D007736 Acid, Kynurenic
% 211.36/211.56 |- mesh__recordMaintainer mesh__D007736 TWD
% 211.36/211.56 |- rdf__type mesh__D007736sskos__Concept
% 211.36/211.56 |- skos__prefLabel mesh__D007736 Kynurenic Acid
% 211.36/211.56 |- skos__annotation mesh__D045855 do not confuse with ACETOBACTER
% 211.36/211.56 |- skos__broader mesh__D045855smesh__D016988
% 211.36/211.56 |- mesh__dateEstablished mesh__D045855 2004-01-01
% 211.36/211.56 |- skos__scopeNote mesh__D045855
% 211.36/211.56 A genus of gram-negative bacteria in the family Eubacteriaceae. Species are homoacetogenic, having the ability to use CARBON DIOXIDE as an electron sink, and to reduce it producing acetate as a typical fermentation product.%A%
% 211.36/211.56 |- rdf__type mesh__D045855sskos__Concept
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D045855 2006
% 211.36/211.56 |- mesh__dateRevised mesh__D045855 2005-06-30
% 211.36/211.56 |- skos__historyNote mesh__D045855 Gram Positive Rods %28%1981-2003%29%
% 211.36/211.56 |- mesh__dateCreated mesh__D045855 2003-07-09
% 211.36/211.56 |- mesh__recordOriginator mesh__D045855 ags
% 211.36/211.56 |- mesh__recordAuthorizer mesh__D045855 sjn
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D045855 2004
% 211.36/211.56 |- skos__prefLabel mesh__D045855 Acetobacterium
% 211.36/211.56 |- mesh__recordMaintainer mesh__D045855 SYSTEM
% 211.36/211.56 |- mesh__historyNote mesh__D045855 2004
% 211.36/211.56 |- skos__altLabel mesh__D017366 5-HT1 Agonist
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 HT Agonist
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonist, 5-HT1
% 211.36/211.56 |- skos__altLabel mesh__D017366 5-HT3 Agonist
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 HT1 Agonist
% 211.36/211.56 |- mesh__dateEstablished mesh__D017366 1993-01-01
% 211.36/211.56 |- mesh__dateRevised mesh__D017366 2005-07-01
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 Hydroxytrytamine Agonist
% 211.36/211.56 |- mesh__publicMeSHNote mesh__D017366 93
% 211.36/211.56 |- mesh__recordOriginator mesh__D017366 TPW
% 211.36/211.56 |- skos__scopeNote mesh__D017366
% 211.36/211.56 Agents that have an affinity for serotonin receptors and are able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. These compounds are used as antidepressants, anxiolytics, and in the treatment of MIGRAINE DISORDERS.%A%
% 211.36/211.56 |- skos__broader mesh__D017366smesh__D018490
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonists, Serotonin Receptor
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonists, 5-HT1
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonist, 5-HT2
% 211.36/211.56 |- skos__altLabel mesh__D017366 Serotonin Receptor Agonists
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonists, Serotonin
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonist, 5-HT3
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonists, 5-HT
% 211.36/211.56 |- skos__altLabel mesh__D017366 Serotonin Agonist
% 211.36/211.56 |- skos__altLabel mesh__D017366 Receptor Agonists, Serotonin
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Receptor Agonist, Serotonin
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 HT Agonists
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonists, 5-HT2
% 211.36/211.56 |- skos__altLabel mesh__D017366 5-Hydroxytryptamine Agonists
% 211.36/211.56 |- skos__altLabel mesh__D017366 5-HT Agonist
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonist, Serotonin
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonists, 5-Hydroxytryptamine
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 HT1 Agonists
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 HT2 Agonists
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 Hydroxytryptamine Agonists
% 211.36/211.56 |- skos__historyNote mesh__D017366 Serotonin/physiology %28%1966-1992%29%
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonist, 5-Hydroxytrytamine
% 211.36/211.56 |- skos__altLabel mesh__D017366 Serotonergic Agonists
% 211.36/211.56 |- skos__altLabel mesh__D017366 5-Hydroxytrytamine Agonist
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonist, 5-HT
% 211.36/211.56 |- skos__prefLabel mesh__D017366 Serotonin Agonists
% 211.36/211.56 |- skos__altLabel mesh__D017366 Serotonin Receptor Agonist
% 211.36/211.56 |- skos__altLabel mesh__D017366 Serotonergic Agonist
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 HT3 Agonist
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonist, Serotonergic
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 HT2 Agonist
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonist, Serotonin Receptor
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 5 HT3 Agonists
% 211.36/211.56 |- mesh__activeMeSHYear mesh__D017366 2006
% 211.36/211.56 |- skos__annotation mesh__D017366
% 211.36/211.56 GEN or unspecified; prefer specifics; do not confuse with SEROTONIN ANTAGONISTS; DF: SEROTONIN AGON or SEROTONIN AG%A%
% 211.36/211.56 |- mesh__historyNote mesh__D017366 93
% 211.36/211.56 |- skos__hiddenLabel mesh__D017366 Agonists, Serotonergic
% 211.36/211.56 |- mesh__dateCreated mesh__D017366 1992-05-22
% 211.36/211.56 |- rdf__type mesh__D017366sskos__Concept
% 211.36/211.57 |- skos__hiddenLabel mesh__D017366 Agonists, 5-HT3
% 211.36/211.57 |- skos__altLabel mesh__D017366 5-HT2 Agonist
% 211.36/211.57 |- skos__altLabel mesh__D017366 5-HT Agonists
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D017366 sjn
% 211.36/211.57 |- mesh__recordMaintainer mesh__D017366 sjn
% 211.36/211.57 |- skos__annotation mesh__D003346 DF: CRH
% 211.36/211.57 |- mesh__recordMaintainer mesh__D003346 ssb
% 211.36/211.57 |- skos__hiddenLabel mesh__D003346 Corticotropin Releasing Hormone
% 211.36/211.57 |- skos__hiddenLabel mesh__D003346 Factor, Corticotropin-Releasing
% 211.36/211.57 |- skos__broader mesh__D003346smesh__D010906
% 211.36/211.57 |- skos__prefLabel mesh__D003346 Corticotropin-Releasing Hormone
% 211.36/211.57 |- skos__altLabel mesh__D003346 ACTH-Releasing Factor
% 211.36/211.57 |- skos__altLabel mesh__D003346 Corticoliberin
% 211.36/211.57 |- skos__broader mesh__D003346smesh__D009479
% 211.36/211.57 |- skos__broader mesh__D003346smesh__D036361
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D003346
% 211.36/211.57 90; was CORTICOTROPIN RELEASING HORMONE 1974-89; was CORTICOTROPIN RELEASING FACTOR 1968-73%A%
% 211.36/211.57 |- skos__scopeNote mesh__D003346
% 211.36/211.57 A neuropeptide of about 41 amino acids released by the HYPOTHALAMUS that stimulates the release of CORTICOTROPIN by the ANTERIOR PITUITARY GLAND.%A%
% 211.36/211.57 |- skos__historyNote mesh__D003346
% 211.36/211.57 Adrenocorticotropic Hormone %28%1966-1967%29%
% 211.36/211.57 |- mesh__dateEstablished mesh__D003346 1968-01-01
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D003346 2006
% 211.36/211.57 |- mesh__dateCreated mesh__D003346 1999-01-01
% 211.36/211.57 |- skos__hiddenLabel mesh__D003346 Corticotropin Releasing Hormone 41
% 211.36/211.57 |- skos__altLabel mesh__D003346 CRF-41
% 211.36/211.57 |- skos__altLabel mesh__D003346 Corticotropin-Releasing Hormone-41
% 211.36/211.57 |- skos__hiddenLabel mesh__D003346 Corticotropin Releasing Factor
% 211.36/211.57 |- skos__hiddenLabel mesh__D003346 Corticotropin Releasing Factor 41
% 211.36/211.57 |- skos__altLabel mesh__D003346 Corticotropin-Releasing Factor
% 211.36/211.57 |- skos__hiddenLabel mesh__D003346 Hormone, Corticotropin-Releasing
% 211.36/211.57 |- mesh__dateRevised mesh__D003346 2005-06-30
% 211.36/211.57 |- skos__hiddenLabel mesh__D003346 Factor, ACTH-Releasing
% 211.36/211.57 |- mesh__historyNote mesh__D003346
% 211.36/211.57 90; was CORTICOTROPIN RELEASING HORMONE 1974-89; was CORTICOTROPIN RELEASING FACTOR 1968-73%A%
% 211.36/211.57 |- skos__altLabel mesh__D003346 Corticotropin-Releasing Factor-41
% 211.36/211.57 |- skos__hiddenLabel mesh__D003346 ACTH Releasing Factor
% 211.36/211.57 |- skos__related mesh__D003346smesh__D018019
% 211.36/211.57 |- rdf__type mesh__D003346sskos__Concept
% 211.36/211.57 |- mesh__recordOriginator mesh__D003346 NLM
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D003346 sjn
% 211.36/211.57 |- skos__historyNote mesh__D003346
% 211.36/211.57 Hypothalamo-Hypophyseal System/physiology %28%1966-1967%29%
% 211.36/211.57 |- mesh__onlineNote mesh__D003346
% 211.36/211.57 use CORTICOTROPIN-RELEASING HORMONE to search CORTICOTROPIN RELEASING HORMONE 1974-89 %26% CORTICOTROPIN RELEASING FACTOR 1968-73%A%
% 211.36/211.57 |- mesh__dateRevised mesh__D008031 2004-07-07
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D008031 2006
% 211.36/211.57 |- mesh__dateCreated mesh__D008031 1999-01-01
% 211.36/211.57 |- mesh__recordMaintainer mesh__D008031 jmp
% 211.36/211.57 |- skos__scopeNote mesh__D008031
% 211.36/211.57 The most abundant natural aromatic organic polymer found in all vascular plants. Lignin together with cellulose and hemicellulose are the major cell wall components of the fibers of all wood and grass species. Lignin is composed of coniferyl, p-coumaryl, and sinapyl alcohols in varying ratios in different plant species. %28%From Merck Index, 11th ed%29%%A%
% 211.36/211.57 |- skos__prefLabel mesh__D008031 Lignin
% 211.36/211.57 |- skos__annotation mesh__D008031
% 211.36/211.57 do not confuse with LIGNANS; D25-26 qualif
% 211.36/211.57 |- mesh__recordOriginator mesh__D008031 NLM
% 211.36/211.57 |- skos__broader mesh__D008031smesh__D001704
% 211.36/211.57 |- skos__broader mesh__D008031smesh__D002482
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D008031 sjn
% 211.36/211.57 |- rdf__type mesh__D008031sskos__Concept
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D008031 2005
% 211.36/211.57 |- rdf__type mesh__D049448sskos__Concept
% 211.36/211.57 |- mesh__dateCreated mesh__D049448 2004-07-07
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D049448 2005
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D049448 sjn
% 211.36/211.57 |- skos__historyNote mesh__D049448
% 211.36/211.57 Magnetic Resonance Imaging %28%1995-2004%29%
% 211.36/211.57 |- skos__prefLabel mesh__D049448
% 211.36/211.57 Cholangiopancreatography, Magnetic Resonance
% 211.36/211.57 |- mesh__recordMaintainer mesh__D049448 ags
% 211.36/211.57 |- mesh__historyNote mesh__D049448 2005
% 211.36/211.57 |- skos__altLabel mesh__D049448 Magnetic Resonance Cholangiopancreatography
% 211.36/211.57 |- mesh__dateEstablished mesh__D049448 2005-01-01
% 211.36/211.57 |- skos__hiddenLabel mesh__D049448
% 211.36/211.57 Magnetic Resonance Cholangiopancreatographies
% 211.36/211.57 |- skos__scopeNote mesh__D049448
% 211.36/211.57 Non-invasive diagnostic technique for visualizing the PANCREATIC DUCTS and BILE DUCTS. It has excellent sensitivity for duct dilatation, biliary stricture, and intraductal abnormalities.%A%
% 211.36/211.57 |- skos__hiddenLabel mesh__D049448
% 211.36/211.57 Cholangiopancreatographies, Magnetic Resonance
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D049448 2005
% 211.36/211.57 |- mesh__recordOriginator mesh__D049448 ags
% 211.36/211.57 |- skos__broader mesh__D049448smesh__D008279
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D049448 2006
% 211.36/211.57 |- skos__broader mesh__D049448smesh__D002758
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013774 2005
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013774 2002
% 211.36/211.57 |- mesh__historyNote mesh__D013774
% 211.36/211.57 91%28%75%29%; was see under METHANE 1975-90
% 211.36/211.57 |- mesh__dateCreated mesh__D013774 1974-11-11
% 211.36/211.57 |- mesh__recordMaintainer mesh__D013774 CCR
% 211.36/211.57 |- skos__broader mesh__D013774smesh__D009595
% 211.36/211.57 |- skos__historyNote mesh__D013774 Nitro Compounds %28%1972-1974%29%
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013774 2006
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D013774 91; was see under METHANE 1975-90
% 211.36/211.57 |- skos__scopeNote mesh__D013774
% 211.36/211.57 Corrosive oxidant, explosive; additive to diesel and rocket fuels; causes skin and lung irritation; proposed war gas. A useful reagent for studying the modification of specific amino acids, particularly tyrosine residues in proteins. Has also been used for studying carbanion formation and for detecting the presence of double bonds in organic compounds.%A%
% 211.36/211.57 |- mesh__recordOriginator mesh__D013774 NLM
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D013774 sjn
% 211.36/211.57 |- skos__annotation mesh__D013774 D25-26 qualif
% 211.36/211.57 |- skos__prefLabel mesh__D013774 Tetranitromethane
% 211.36/211.57 |- rdf__type mesh__D013774sskos__Concept
% 211.36/211.57 |- skos__broader mesh__D013774smesh__D008697
% 211.36/211.57 |- mesh__dateRevised mesh__D013774 2000-06-22
% 211.36/211.57 |- skos__historyNote mesh__D013774 Methane %28%1972-1974%29%
% 211.36/211.57 |- mesh__dateEstablished mesh__D013774 1991-01-01
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013774 2003
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013774 2004
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013774 2001
% 211.36/211.57 |- skos__historyNote mesh__D046150 Dwarfism %28%1976-2004%29%
% 211.36/211.57 |- mesh__dateRevised mesh__D046150 2005-06-30
% 211.36/211.57 |- mesh__dateEstablished mesh__D046150 2005-01-01
% 211.36/211.57 |- skos__hiddenLabel mesh__D046150 Dwarfism, Laron
% 211.36/211.57 |- mesh__recordOriginator mesh__D046150 lkt
% 211.36/211.57 |- mesh__recordMaintainer mesh__D046150 lkt
% 211.36/211.57 |- rdf__type mesh__D046150sskos__Concept
% 211.36/211.57 |- skos__prefLabel mesh__D046150 Laron Syndrome
% 211.36/211.57 |- skos__altLabel mesh__D046150 Laron Type Dwarfism I
% 211.36/211.57 |- skos__altLabel mesh__D046150 Laron Dwarfism
% 211.36/211.57 |- skos__scopeNote mesh__D046150
% 211.36/211.57 An autosomal recessive disorder characterized by short stature, defective GROWTH HORMONE RECEPTOR, and failure to generate INSULIN-LIKE GROWTH FACTOR I by GROWTH HORMONE. Laron syndrome is not a form of primary pituitary dwarfism %28%GROWTH HORMONE DEFICIENCY DWARFISM%29% but the result of mutation of the human GHR gene on chromosome 5.%A%
% 211.36/211.57 |- skos__historyNote mesh__D046150
% 211.36/211.57 Receptors, Somatotropin %28%1991-2004%29%
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D046150 2005
% 211.36/211.57 |- skos__altLabel mesh__D046150 Severe GH Insensitivity
% 211.36/211.57 |- mesh__historyNote mesh__D046150 2005
% 211.36/211.57 |- skos__altLabel mesh__D046150 Growth Hormone Insensitivity Syndrome
% 211.36/211.57 |- skos__altLabel mesh__D046150 Growth Hormone Receptor Defect
% 211.36/211.57 |- skos__hiddenLabel mesh__D046150 Syndrome, Laron
% 211.36/211.57 |- skos__altLabel mesh__D046150 Primary GH Resistance
% 211.36/211.57 |- skos__broader mesh__D046150smesh__D004392
% 211.36/211.57 |- skos__hiddenLabel mesh__D046150 GH Resistance, Primary
% 211.36/211.57 |- skos__altLabel mesh__D046150 Primary Growth Hormone Resistance
% 211.36/211.57 |- skos__historyNote mesh__D046150
% 211.36/211.57 Receptors, Cell Surface %28%1976-2004%29%
% 211.36/211.57 |- mesh__dateCreated mesh__D046150 2004-07-07
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D046150 sjn
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D046150 2006
% 211.36/211.57 |- skos__historyNote mesh__D046150 Growth Hormone %28%1976-2004%29%
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 1997
% 211.36/211.57 |- mesh__dateCreated mesh__D007737 1999-01-01
% 211.36/211.57 |- mesh__recordMaintainer mesh__D007737 TAP
% 211.36/211.57 |- mesh__dateRevised mesh__D007737 1992-05-18
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 2002
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 1996
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 1999
% 211.36/211.57 |- skos__annotation mesh__D007737 an amino acid
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 2004
% 211.36/211.57 |- skos__broader mesh__D007737smesh__D000596
% 211.36/211.57 |- skos__prefLabel mesh__D007737 Kynurenine
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 2001
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 1998
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 1993
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 2003
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 2006
% 211.36/211.57 |- mesh__recordOriginator mesh__D007737 NLM
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 2000
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 1995
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 2005
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007737 1994
% 211.36/211.57 |- rdf__type mesh__D007737sskos__Concept
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D007737 PLS
% 211.36/211.57 |- mesh__dateCreated mesh__D032130 2002-07-03
% 211.36/211.57 |- skos__prefLabel mesh__D032130 Mimusops
% 211.36/211.57 |- rdf__type mesh__D032130sskos__Concept
% 211.36/211.57 |- skos__broader mesh__D032130smesh__D029632
% 211.36/211.57 |- mesh__dateEstablished mesh__D032130 2003-01-01
% 211.36/211.57 |- skos__annotation mesh__D032130
% 211.36/211.57 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.36/211.57 |- mesh__historyNote mesh__D032130 2003
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D032130 2003
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D032130 2004
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D032130 2005
% 211.36/211.57 |- skos__scopeNote mesh__D032130
% 211.36/211.57 A plant genus of the family SAPOTACEAE. Members contain triterpenoid saponins. Latex from bark incisions is processed into gutta balata.%A%
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D032130 2003
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D032130 2006
% 211.36/211.57 |- skos__historyNote mesh__D045856
% 211.36/211.57 Gram-Negative Anaerobic Bacteria %28%1975-2003%29%
% 211.36/211.57 |- mesh__historyNote mesh__D045856 2004
% 211.36/211.57 |- skos__prefLabel mesh__D045856 Butyrivibrio
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D045856 2006
% 211.36/211.57 |- rdf__type mesh__D045856sskos__Concept
% 211.36/211.57 |- mesh__dateCreated mesh__D045856 2003-07-09
% 211.36/211.57 |- skos__broader mesh__D045856smesh__D016965
% 211.36/211.57 |- skos__broader mesh__D045856smesh__D016988
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D045856 2004
% 211.36/211.57 |- mesh__dateEstablished mesh__D045856 2004-01-01
% 211.36/211.57 |- mesh__recordMaintainer mesh__D045856 SYSTEM
% 211.36/211.57 |- mesh__dateRevised mesh__D045856 2005-06-30
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D045856 sjn
% 211.36/211.57 |- skos__scopeNote mesh__D045856
% 211.36/211.57 A species of anaerobic bacteria, in the family Lachnospiraceae, found in RUMINANTS. It is considered both gram-positive and gram-negative.%A%
% 211.36/211.57 |- mesh__recordOriginator mesh__D045856 ags
% 211.36/211.57 |- skos__annotation mesh__D045856
% 211.36/211.57 infection: coord IM with BACTERIAL INFECTIONS %28%IM%29%
% 211.36/211.57 |- skos__broader mesh__D017367smesh__D014179
% 211.36/211.57 |- skos__related mesh__D017367smesh__D018687
% 211.36/211.57 |- skos__altLabel mesh__D017367 Inhibitors, Serotonin Reuptake
% 211.36/211.57 |- mesh__dateRevised mesh__D017367 2005-06-30
% 211.36/211.57 |- skos__altLabel mesh__D017367 5-Hydroxytryptamine Uptake Inhibitors
% 211.36/211.57 |- skos__altLabel mesh__D017367 Uptake Inhibitors, 5-Hydroxytryptamine
% 211.36/211.57 |- rdf__type mesh__D017367sskos__Concept
% 211.36/211.57 |- skos__altLabel mesh__D017367 Reuptake Inhibitors, Serotonin
% 211.36/211.57 |- mesh__dateCreated mesh__D017367 1992-05-22
% 211.36/211.57 |- skos__hiddenLabel mesh__D017367 5 Hydroxytryptamine Uptake Inhibitors
% 211.36/211.57 |- mesh__dateEstablished mesh__D017367 1993-01-01
% 211.36/211.57 |- skos__related mesh__D017367smesh__D018759
% 211.36/211.57 |- skos__altLabel mesh__D017367 Inhibitors, 5-Hydroxytryptamine Uptake
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D017367 sjn
% 211.36/211.57 |- skos__hiddenLabel mesh__D017367 Inhibitors, 5 Hydroxytryptamine Uptake
% 211.36/211.57 |- skos__altLabel mesh__D017367 Uptake Inhibitors, 5-HT
% 211.36/211.57 |- skos__hiddenLabel mesh__D017367 Inhibitors, 5 HT Uptake
% 211.36/211.57 |- mesh__recordMaintainer mesh__D017367 ssb
% 211.36/211.57 |- skos__altLabel mesh__D017367 Inhibitors, Serotonin Uptake
% 211.36/211.57 |- skos__altLabel mesh__D017367 Inhibitors, 5-HT Uptake
% 211.36/211.57 |- skos__annotation mesh__D017367
% 211.36/211.57 GEN or unspecified; prefer specifics; do not confuse with SEROTONIN ANTAGONISTS; DF: SEROTONIN UPTAKE INHIB%A%
% 211.36/211.57 |- skos__historyNote mesh__D017367 Serotonin Antagonists %28%1978-1992%29%
% 211.36/211.57 |- skos__altLabel mesh__D017367 5-HT Uptake Inhibitors
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D017367 2006
% 211.36/211.57 |- skos__hiddenLabel mesh__D017367 Uptake Inhibitors, 5 Hydroxytryptamine
% 211.36/211.57 |- skos__altLabel mesh__D017367 Uptake Inhibitors, Serotonin
% 211.36/211.57 |- skos__broader mesh__D017367smesh__D018490
% 211.36/211.57 |- skos__hiddenLabel mesh__D017367 5 HT Uptake Inhibitors
% 211.36/211.57 |- mesh__recordOriginator mesh__D017367 TPW
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D017367 93
% 211.36/211.57 |- skos__scopeNote mesh__D017367
% 211.36/211.57 Compounds that specifically inhibit the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. These agents have been used in treatment of depression, panic disorder, obsessive-compulsive behavior, and alcoholism, as analgesics, and to treat obesity and bulimia. Many of the ADRENERGIC UPTAKE INHIBITORS also inhibit serotonin uptake; they are not included here.%A%
% 211.36/211.57 |- skos__hiddenLabel mesh__D017367 Uptake Inhibitors, 5 HT
% 211.36/211.57 |- skos__prefLabel mesh__D017367 Serotonin Uptake Inhibitors
% 211.36/211.57 |- mesh__historyNote mesh__D017367 93
% 211.36/211.57 |- skos__altLabel mesh__D017367 Serotonin Reuptake Inhibitors
% 211.36/211.57 |- rdf__type mesh__D008830sskos__Concept
% 211.36/211.57 |- skos__broader mesh__D008830smesh__D003594
% 211.36/211.57 |- mesh__recordOriginator mesh__D008830 NLM
% 211.36/211.57 |- mesh__dateEstablished mesh__D008830 1984-01-01
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D008830 ags
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D008830 2006A
% 211.36/211.57 |- skos__historyNote mesh__D008830 Organoids %28%1966-1972%29%
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D008830 2005
% 211.36/211.57 |- mesh__dateCreated mesh__D008830 1999-01-01
% 211.36/211.57 |- mesh__recordMaintainer mesh__D008830 ags
% 211.36/211.57 |- skos__scopeNote mesh__D008830
% 211.36/211.57 Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes.%A%
% 211.36/211.57 |- skos__prefLabel mesh__D008830 Microbodies
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D008830 2006
% 211.36/211.57 |- skos__hiddenLabel mesh__D008830 Glycosome
% 211.36/211.57 |- mesh__historyNote mesh__D008830
% 211.36/211.57 84%28%73%29%; was see under ORGANOIDS 1975-83
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D008830 2004
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D008830
% 211.36/211.57 84; was see under ORGANOIDS 1975-83
% 211.36/211.57 |- mesh__dateRevised mesh__D008830 2005-07-22
% 211.36/211.57 |- skos__hiddenLabel mesh__D008830 Microbody
% 211.36/211.57 |- mesh__dateRevised mesh__D022501 2005-06-30
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D022501 2001
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D022501 sjn
% 211.36/211.57 |- mesh__dateEstablished mesh__D022501 2001-01-01
% 211.36/211.57 |- skos__prefLabel mesh__D022501 Marek Disease Vaccines
% 211.36/211.57 |- skos__scopeNote mesh__D022501
% 211.36/211.57 Vaccines or candidate vaccines used to prevent MAREK DISEASE, an avian disease caused by a herpesvirus.%A%
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D022501 2006
% 211.36/211.57 |- skos__altLabel mesh__D022501 Marek%27%s Disease Vaccines
% 211.36/211.57 |- rdf__type mesh__D022501sskos__Concept
% 211.36/211.57 |- skos__historyNote mesh__D022501 Viral Vaccines %28%1970-2000%29%
% 211.36/211.57 |- mesh__historyNote mesh__D022501 2001
% 211.36/211.57 |- mesh__dateCreated mesh__D022501 2000-06-22
% 211.36/211.57 |- skos__broader mesh__D022501smesh__D022283
% 211.36/211.57 |- skos__hiddenLabel mesh__D022501 Vaccines, Marek%27%s Disease
% 211.36/211.57 |- skos__hiddenLabel mesh__D022501 Disease Vaccines, Marek
% 211.36/211.57 |- skos__hiddenLabel mesh__D022501 Vaccines, Marek Disease
% 211.36/211.57 |- mesh__recordMaintainer mesh__D022501 ssb
% 211.36/211.57 |- skos__hiddenLabel mesh__D022501 Mareks Disease Vaccines
% 211.36/211.57 |- mesh__recordOriginator mesh__D022501 ags
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D008032 2006A
% 211.36/211.57 |- skos__prefLabel mesh__D008032 Limbic System
% 211.36/211.57 |- skos__hiddenLabel mesh__D008032 Limbic Systems
% 211.36/211.57 |- rdf__type mesh__D008032sskos__Concept
% 211.36/211.57 |- skos__broader mesh__D008032smesh__D001921
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D008032 2005
% 211.36/211.57 |- skos__scopeNote mesh__D008032
% 211.36/211.57 A set of forebrain structures common to all mammals that is defined functionally and anatomically. It is implicated in the higher integration of visceral, olfactory, and somatic information as well as homeostatic responses including fundamental survival behaviors %28%feeding, mating, emotion%29%. For most authors, it includes the AMYGDALA; EPITHALAMUS; GYRUS CINGULI; hippocampal formation %28%see HIPPOCAMPUS%29%; HYPOTHALAMUS; PARAHIPPOCAMPAL GYRUS; SEPTAL NUCLEI; anterior nuclear group of thalamus, and portions of the basal ganglia. %28%Parent, Carpenter%27%s Human Neuroanatomy, 9th ed, p744; NeuroNames, http://rprcsgi.rprc.washington.edu/neuronames/index.html %28%September 2, 1998%29%%29%.%A%
% 211.36/211.57 |- mesh__dateCreated mesh__D008032 1999-01-01
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D008032 2006
% 211.36/211.57 |- mesh__recordOriginator mesh__D008032 NLM
% 211.36/211.57 |- mesh__dateRevised mesh__D008032 2005-07-07
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D008032 ags
% 211.36/211.57 |- mesh__recordMaintainer mesh__D008032 ags
% 211.36/211.57 |- skos__hiddenLabel mesh__D008032 Systems, Limbic
% 211.36/211.57 |- skos__hiddenLabel mesh__D008032 System, Limbic
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D049449 2006
% 211.36/211.57 |- skos__altLabel mesh__D049449 Luminescence, Physical
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D049449 sjn
% 211.36/211.57 |- mesh__dateCreated mesh__D049449 2004-07-07
% 211.36/211.57 |- mesh__recordMaintainer mesh__D049449 ssb
% 211.36/211.57 |- mesh__recordOriginator mesh__D049449 ssb
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D049449
% 211.36/211.57 2006; see LUMINESCENCE, PHYSICAL 2005-2006; for CHEMILUMENCENCE see CHEMILUMINESCENCE, PHYSICAL 2005-2006%A%
% 211.36/211.57 |- mesh__dateEstablished mesh__D049449 2005-01-01
% 211.36/211.57 |- skos__hiddenLabel mesh__D049449 Physical Luminescence
% 211.36/211.57 |- mesh__dateRevised mesh__D049449 2005-06-30
% 211.36/211.57 |- skos__historyNote mesh__D049449
% 211.36/211.57 Luminescent Measurements %28%1964-2004%29%
% 211.36/211.57 |- skos__broader mesh__D049449smesh__D008027
% 211.36/211.57 |- rdf__type mesh__D049449sskos__Concept
% 211.36/211.57 |- skos__altLabel mesh__D049449 Chemiluminescence, Physical
% 211.36/211.57 |- skos__scopeNote mesh__D049449
% 211.36/211.57 Emission of LIGHT when ELECTRONS return to the electronic ground state from an excited state and lose the energy as PHOTONS. It is sometimes called cool light in contrast to INCANDESCENCE. LUMINESCENT MEASUREMENTS take advantage of this type of light emitted from LUMINESCENT AGENTS.%A%
% 211.36/211.57 |- skos__prefLabel mesh__D049449 Luminescence
% 211.36/211.57 |- mesh__historyNote mesh__D049449 2006
% 211.36/211.57 |- skos__hiddenLabel mesh__D049449 Physical Chemiluminescence
% 211.36/211.57 |- skos__hiddenLabel mesh__D013775 Ammonium Salt Tetraphenylborate
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013775 2001
% 211.36/211.57 |- skos__historyNote mesh__D013775 Boron Compounds %28%1973-1974%29%
% 211.36/211.57 |- skos__scopeNote mesh__D013775
% 211.36/211.57 An anionic compound that is used as a reagent for determination of potassium, ammonium, rubidium, and cesium ions. It also uncouples oxidative phosphorylation and forms complexes with biological materials, and is used in biological assays.%A%
% 211.36/211.57 |- skos__altLabel mesh__D013775 Sodium Tetraphenylborate
% 211.36/211.57 |- skos__historyNote mesh__D013775 Benzene Derivatives %28%1973-1974%29%
% 211.36/211.57 |- rdf__type mesh__D013775sskos__Concept
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013775 2002
% 211.36/211.57 |- mesh__recordMaintainer mesh__D013775 CCR
% 211.36/211.57 |- mesh__dateEstablished mesh__D013775 1991-01-01
% 211.36/211.57 |- skos__hiddenLabel mesh__D013775 Tetraphenylborate, Sodium
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013775 2003
% 211.36/211.57 |- skos__hiddenLabel mesh__D013775 Potassium Salt Tetraphenylborate
% 211.36/211.57 |- skos__broader mesh__D013775smesh__D001894
% 211.36/211.57 |- skos__prefLabel mesh__D013775 Tetraphenylborate
% 211.36/211.57 |- mesh__dateRevised mesh__D013775 2000-06-21
% 211.36/211.57 |- mesh__recordOriginator mesh__D013775 NLM
% 211.36/211.57 |- mesh__dateCreated mesh__D013775 1974-11-19
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013775 2004
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D013775 sjn
% 211.36/211.57 |- skos__hiddenLabel mesh__D013775 Sodium Salt, Tetraphenylborate
% 211.36/211.57 |- skos__annotation mesh__D013775 D25-26 qualif
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D013775
% 211.36/211.57 91; was see under BORON COMPOUNDS 1975-90
% 211.36/211.57 |- skos__hiddenLabel mesh__D013775 Sodium, Tetraphenylboron
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013775 2005
% 211.36/211.57 |- skos__altLabel mesh__D013775 Kalignost
% 211.36/211.57 |- skos__altLabel mesh__D013775 Tetraphenylborate Sodium Salt
% 211.36/211.57 |- skos__altLabel mesh__D013775 Tetraphenylboron
% 211.36/211.57 |- mesh__historyNote mesh__D013775
% 211.36/211.57 91%28%75%29%; was see under BORON COMPOUNDS 1975-90
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D013775 2006
% 211.36/211.57 |- skos__hiddenLabel mesh__D046151 Lingual Thyroids
% 211.36/211.57 |- skos__hiddenLabel mesh__D046151 Thyroid, Lingual
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D046151 2006
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D046151 sjn
% 211.36/211.57 |- mesh__dateEstablished mesh__D046151 2005-01-01
% 211.36/211.57 |- mesh__historyNote mesh__D046151 2005
% 211.36/211.57 |- skos__historyNote mesh__D046151 Thyroid Gland %28%1965-2004%29%
% 211.36/211.57 |- skos__scopeNote mesh__D046151
% 211.36/211.57 A condition characterized by the presence of rudimentary THYROID tissue at the base of the TONGUE. It is due to failed embryonic development and migration of thyroid tissue to its normal location. The lingual thyroid usually cannot maintain adequate hormone production thereby resulting in HYPOTHYROIDISM.%A%
% 211.36/211.57 |- mesh__dateRevised mesh__D046151 2005-06-30
% 211.36/211.57 |- rdf__type mesh__D046151sskos__Concept
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D046151 2005
% 211.36/211.57 |- skos__broader mesh__D046151smesh__D050033
% 211.36/211.57 |- mesh__dateCreated mesh__D046151 2004-07-07
% 211.36/211.57 |- mesh__recordMaintainer mesh__D046151 lkt
% 211.36/211.57 |- skos__prefLabel mesh__D046151 Lingual Thyroid
% 211.36/211.57 |- skos__historyNote mesh__D046151 Tongue %28%1965-2004%29%
% 211.36/211.57 |- skos__hiddenLabel mesh__D046151 Thyroids, Lingual
% 211.36/211.57 |- mesh__recordOriginator mesh__D046151 lkt
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 1997
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 2003
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 2002
% 211.36/211.57 |- skos__prefLabel mesh__D007738 Kyphosis
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 1999
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 2005
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 2004
% 211.36/211.57 |- mesh__recordMaintainer mesh__D007738 TGC
% 211.36/211.57 |- skos__annotation mesh__D007738 a type of spinal curvature
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 2006
% 211.36/211.57 |- skos__hiddenLabel mesh__D007738 Kyphoses
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 2000
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 1995
% 211.36/211.57 |- skos__scopeNote mesh__D007738
% 211.36/211.57 Abnormally increased convexity in the curvature of the thoracic spine as viewed from the side. %28%Dorland, 27th ed%29%%A%
% 211.36/211.57 |- mesh__dateCreated mesh__D007738 1999-01-01
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 2001
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 1996
% 211.36/211.57 |- rdf__type mesh__D007738sskos__Concept
% 211.36/211.57 |- mesh__recordOriginator mesh__D007738 NLM
% 211.36/211.57 |- mesh__dateRevised mesh__D007738 1994-04-11
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D007738 PLS
% 211.36/211.57 |- skos__broader mesh__D007738smesh__D013121
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D007738 1998
% 211.36/211.57 |- skos__prefLabel mesh__D018460 Fractures, Comminuted
% 211.36/211.57 |- skos__broader mesh__D018460smesh__D050723
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D018460 2006
% 211.36/211.57 |- mesh__dateRevised mesh__D018460 2005-06-30
% 211.36/211.57 |- skos__hiddenLabel mesh__D018460 Fracture, Comminuted
% 211.36/211.57 |- rdf__type mesh__D018460sskos__Concept
% 211.36/211.57 |- mesh__recordOriginator mesh__D018460 TGC
% 211.36/211.57 |- skos__hiddenLabel mesh__D018460 Comminuted Fractures
% 211.36/211.57 |- skos__scopeNote mesh__D018460
% 211.36/211.57 A fracture in which the bone is splintered or crushed. %28%Dorland, 27th ed%29%%A%
% 211.36/211.57 |- mesh__recordMaintainer mesh__D018460 ssb
% 211.36/211.57 |- mesh__historyNote mesh__D018460 95
% 211.36/211.57 |- mesh__dateCreated mesh__D018460 1994-04-16
% 211.36/211.57 |- skos__historyNote mesh__D018460 specific fracture %28%1966-1994%29%
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D018460 95
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D018460 sjn
% 211.36/211.57 |- skos__historyNote mesh__D018460 Fractures %28%1966-1994%29%
% 211.36/211.57 |- skos__annotation mesh__D018460
% 211.36/211.57 fract where bone is splintered or crushed; IM; coord with specific organ/inj or precoord organ/fract term %28%IM%29%%A%
% 211.36/211.57 |- skos__hiddenLabel mesh__D018460 Comminuted Fracture
% 211.36/211.57 |- mesh__dateEstablished mesh__D018460 1995-01-01
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D032131 2003
% 211.36/211.57 |- mesh__dateCreated mesh__D032131 2002-07-03
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D032131 2004
% 211.36/211.57 |- mesh__dateEstablished mesh__D032131 2003-01-01
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D032131 2005
% 211.36/211.57 |- skos__scopeNote mesh__D032131
% 211.36/211.57 A plant genus of the family SAPOTACEAE. Latex from bark incisions is processed into GUTTA-PERCHA.%A%
% 211.36/211.57 |- mesh__historyNote mesh__D032131 2003
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D032131 2006
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D032131 2003
% 211.36/211.57 |- skos__prefLabel mesh__D032131 Palaquium
% 211.36/211.57 |- rdf__type mesh__D032131sskos__Concept
% 211.36/211.57 |- skos__broader mesh__D032131smesh__D029632
% 211.36/211.57 |- skos__annotation mesh__D032131
% 211.36/211.57 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.36/211.57 |- skos__broader mesh__D004440smesh__D026461
% 211.36/211.57 |- mesh__recordAuthorizer mesh__D004440 sjn
% 211.36/211.57 |- mesh__recordOriginator mesh__D004440 NLM
% 211.36/211.57 |- mesh__publicMeSHNote mesh__D004440 1967
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D004440 2005
% 211.36/211.57 |- skos__annotation mesh__D004440 do not confuse with ECDYSTERONE
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D004440 2003
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D004440 2006
% 211.36/211.57 |- skos__scopeNote mesh__D004440
% 211.36/211.57 A steroid hormone that regulates the processes of MOLTING or ecdysis in insects.%A%
% 211.36/211.57 |- mesh__dateEstablished mesh__D004440 1967-01-01
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D004440 2004
% 211.36/211.57 |- mesh__dateRevised mesh__D004440 2001-07-25
% 211.36/211.57 |- mesh__historyNote mesh__D004440 1967%28%1964%29%
% 211.36/211.57 |- skos__prefLabel mesh__D004440 Ecdysone
% 211.36/211.57 |- rdf__type mesh__D004440sskos__Concept
% 211.36/211.57 |- mesh__activeMeSHYear mesh__D004440 2002
% 211.36/211.57 |- mesh__recordMaintainer mesh__D004440 lkt
% 211.36/211.57 |- skos__altLabel mesh__D004440 Molting Hormone
% 211.36/211.57 |- mesh__dateCreated mesh__D004440 1999-01-01
% 211.36/211.58 |- skos__broader mesh__D051096smesh__D011518
% 211.36/211.58 |- mesh__recordOriginator mesh__D051096 DRC
% 211.36/211.58 |- mesh__historyNote mesh__D051096 2006%28%1999%29%
% 211.36/211.58 |- rdf__type mesh__D051096sskos__Concept
% 211.36/211.58 |- skos__altLabel mesh__D051096 Receptor Tyrosine Kinase RET
% 211.36/211.58 |- skos__hiddenLabel mesh__D051096 Proto Oncogene Proteins c ret
% 211.36/211.58 |- skos__altLabel mesh__D051096 Proto-Oncogene Protein Ret
% 211.36/211.58 |- skos__hiddenLabel mesh__D051096 c-ret, Proto-Oncogene Proteins
% 211.36/211.58 |- mesh__dateEstablished mesh__D051096 2006-01-01
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D051096
% 211.36/211.58 2006; PROTO-ONCOGENE PROTEIN C-RET was indexed under PROTO-ONCOGENE PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2005%A%
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D051096 2006A
% 211.36/211.58 |- skos__scopeNote mesh__D051096
% 211.36/211.58 Receptor protein-tyrosine kinases involved in the signaling of GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR ligands. They contain an extracellular cadherin domain and form a receptor complexes with GDNF RECEPTORS. Mutations in ret protein are responsible for HIRSCHSPRUNG DISEASE and MULTIPLE ENDOCRINE NEOPLASIA TYPE 2.%A%
% 211.36/211.58 |- skos__hiddenLabel mesh__D051096 Proto Oncogene Protein Ret
% 211.36/211.58 |- skos__prefLabel mesh__D051096 Proto-Oncogene Proteins c-ret
% 211.36/211.58 |- skos__hiddenLabel mesh__D051096 ret Proto Oncogene Proteins
% 211.36/211.58 |- skos__hiddenLabel mesh__D051096 Proto Oncogene Protein c ret
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D051096 2006
% 211.36/211.58 |- mesh__dateRevised mesh__D051096 2005-07-15
% 211.36/211.58 |- mesh__recordMaintainer mesh__D051096 ags
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D051096 ags
% 211.36/211.58 |- skos__hiddenLabel mesh__D051096 Proto-Oncogene Proteins, ret
% 211.36/211.58 |- mesh__dateCreated mesh__D051096 2005-06-30
% 211.36/211.58 |- skos__altLabel mesh__D051096 ret Proto-Oncogene Proteins
% 211.36/211.58 |- skos__broader mesh__D051096smesh__D020794
% 211.36/211.58 |- skos__altLabel mesh__D051096 Proto-Oncogene Protein c-ret
% 211.36/211.58 |- skos__hiddenLabel mesh__D051096 c-ret, Proto-Oncogene Protein
% 211.36/211.58 |- skos__altLabel mesh__D051096 c-ret Protein
% 211.36/211.58 |- skos__hiddenLabel mesh__D051096 Ret, Proto-Oncogene Protein
% 211.36/211.58 |- mesh__dateRevised mesh__D045857 2005-06-30
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D045857 2004
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D045857 sjn
% 211.36/211.58 |- mesh__recordOriginator mesh__D045857 ags
% 211.36/211.58 |- skos__broader mesh__D045857smesh__D006095
% 211.36/211.58 |- mesh__recordMaintainer mesh__D045857 SYSTEM
% 211.36/211.58 |- mesh__historyNote mesh__D045857 2004
% 211.36/211.58 |- skos__annotation mesh__D045857
% 211.36/211.58 infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%
% 211.36/211.58 |- skos__historyNote mesh__D045857 Gram-Positive Cocci %28%1977-2003%29%
% 211.36/211.58 |- mesh__dateEstablished mesh__D045857 2004-01-01
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D045857 2006
% 211.36/211.58 |- rdf__type mesh__D045857sskos__Concept
% 211.36/211.58 |- skos__scopeNote mesh__D045857
% 211.36/211.58 A genus of gram-positive bacteria in the family Lachnospiraceae that inhabits the RUMEN; LARGE INTESTINE; and CECUM of MAMMALS.%A%
% 211.36/211.58 |- mesh__dateCreated mesh__D045857 2003-07-09
% 211.36/211.58 |- skos__prefLabel mesh__D045857 Ruminococcus
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D017368 2005
% 211.36/211.58 |- skos__prefLabel mesh__D017368 Protein Isoprenylation
% 211.36/211.58 |- mesh__dateEstablished mesh__D017368 1993-01-01
% 211.36/211.58 |- skos__annotation mesh__D017368 a post-translational protein change
% 211.36/211.58 |- mesh__historyNote mesh__D017368 93
% 211.36/211.58 |- skos__altLabel mesh__D017368 Post-Translational Isoprenylation
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D017368 93
% 211.36/211.58 |- rdf__type mesh__D017368sskos__Concept
% 211.36/211.58 |- skos__scopeNote mesh__D017368
% 211.36/211.58 A post-translational modification of proteins by the attachment of an isoprenoid to the C-terminal cysteine residue. The isoprenoids used, farnesyl diphosphate or geranylgeranyl diphosphate, are derived from the same biochemical pathway that produces cholesterol.%A%
% 211.36/211.58 |- skos__broader mesh__D017368smesh__D011499
% 211.36/211.58 |- skos__hiddenLabel mesh__D017368 Prenylation, Protein
% 211.36/211.58 |- mesh__dateCreated mesh__D017368 1992-06-03
% 211.36/211.58 |- mesh__recordOriginator mesh__D017368 TPW
% 211.36/211.58 |- skos__hiddenLabel mesh__D017368 Post Translational Isoprenylation
% 211.36/211.58 |- skos__hiddenLabel mesh__D017368 Geranylgeranylation, Protein
% 211.36/211.58 |- skos__hiddenLabel mesh__D017368 Isoprenylation, Protein
% 211.36/211.58 |- skos__altLabel mesh__D017368 Protein Prenylation
% 211.36/211.58 |- mesh__recordMaintainer mesh__D017368 nns
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D017368 sjn
% 211.36/211.58 |- skos__historyNote mesh__D017368
% 211.36/211.58 Protein Processing, Post-Translational %28%1987-1992%29%
% 211.36/211.58 |- skos__hiddenLabel mesh__D017368 Farnesylation, Protein
% 211.36/211.58 |- skos__hiddenLabel mesh__D017368 Polyisoprenylation, Protein
% 211.36/211.58 |- skos__hiddenLabel mesh__D017368 Isoprenylation, Post-Translational
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D017368 2006
% 211.36/211.58 |- mesh__dateRevised mesh__D017368 2004-07-07
% 211.36/211.58 |- skos__annotation mesh__D003348 /biosyn/physiol permitted
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D003348 2005
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D003348 2004
% 211.36/211.58 |- mesh__recordOriginator mesh__D003348 NLM
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D003348 sjn
% 211.36/211.58 |- skos__broader mesh__D003348smesh__D015065
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D003348
% 211.36/211.58 /adverse effects /poisoning /toxicity were CORTISONE TOXICOLOGY 1963-65; /therapeutic use was CORTISONE, THERAPEUTIC 1965%A%
% 211.36/211.58 |- mesh__historyNote mesh__D003348
% 211.36/211.58 /adv eff-pois-tox was CORTISONE TOXICOLOGY 1963-65; /ther use was CORTISONE, THERAPEUTIC 1965%A%
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D003348 2006
% 211.36/211.58 |- skos__prefLabel mesh__D003348 Cortisone
% 211.36/211.58 |- mesh__recordMaintainer mesh__D003348 ssb
% 211.36/211.58 |- skos__scopeNote mesh__D003348
% 211.36/211.58 A naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite HYDROCORTISONE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p726%29%%A%
% 211.36/211.58 |- rdf__type mesh__D003348sskos__Concept
% 211.36/211.58 |- skos__broader mesh__D003348smesh__D011283
% 211.36/211.58 |- mesh__dateRevised mesh__D003348 2003-07-09
% 211.36/211.58 |- mesh__dateCreated mesh__D003348 1999-01-01
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D014070
% 211.36/211.58 65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965%A%
% 211.36/211.58 |- mesh__dateCreated mesh__D014070 1999-01-01
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D014070 2006
% 211.36/211.58 |- skos__related mesh__D014070smesh__D009805
% 211.36/211.58 |- mesh__dateRevised mesh__D014070 2003-07-09
% 211.36/211.58 |- skos__related mesh__D014070smesh__D003817
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D014070 2005
% 211.36/211.58 |- skos__prefLabel mesh__D014070 Tooth
% 211.36/211.58 |- mesh__recordOriginator mesh__D014070 NLM
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D014070 sjn
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D014070 2004
% 211.36/211.58 |- skos__related mesh__D014070smesh__D008409
% 211.36/211.58 |- rdf__type mesh__D014070sskos__Concept
% 211.36/211.58 |- mesh__recordMaintainer mesh__D014070 lkt
% 211.36/211.58 |- mesh__historyNote mesh__D014070
% 211.36/211.58 65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965%A%
% 211.36/211.58 |- mesh__dateEstablished mesh__D014070 1965-01-01
% 211.36/211.58 |- skos__broader mesh__D014070smesh__D003817
% 211.36/211.58 |- skos__altLabel mesh__D014070 Teeth
% 211.36/211.58 |- skos__related mesh__D014070smesh__D008310
% 211.36/211.58 |- mesh__considerAlso mesh__D014070
% 211.36/211.58 consider also terms at DENT- and ODONTO-
% 211.36/211.58 |- skos__annotation mesh__D014070
% 211.36/211.58 /embryol: consider also TOOTH GERM %26% ODONTOGENESIS; /ph permitted but consider DENTAL PHYSIOLOGY for function of dentition as a whole; tooth size %26% dimension = TOOTH /anat %28%IM%29% + ODONTOMETRY %28%NIM%29%; permanent tooth = TOOTH, deciduous tooth = TOOTH, DECIDUOUS; tooth pain = TOOTHACHE; tooth avulsion or luxation = TOOTH AVULSION; tooth socket: index under ALVEOLAR PROCESS; tooth sensitivity = DENTIN SENSITIVITY%A%
% 211.36/211.58 |- skos__related mesh__D014070smesh__D010161
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008831 2002
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008831 2005
% 211.36/211.58 |- mesh__dateCreated mesh__D008831 1999-01-01
% 211.36/211.58 |- skos__hiddenLabel mesh__D008831 Microcephalies
% 211.36/211.58 |- skos__broader mesh__D008831smesh__D019465
% 211.36/211.58 |- skos__scopeNote mesh__D008831
% 211.36/211.58 Abnormal smallness of the head, usually associated with mental retardation. %28%Dorland, 27th ed%29%%A%
% 211.36/211.58 |- mesh__recordOriginator mesh__D008831 NLM
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008831 2003
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008831 2006
% 211.36/211.58 |- skos__annotation mesh__D008831
% 211.36/211.58 abnormally small head; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 211.36/211.58 |- mesh__dateRevised mesh__D008831 1999-11-03
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D008831 sjn
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008831 2004
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008831 2000
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008831 2001
% 211.36/211.58 |- rdf__type mesh__D008831sskos__Concept
% 211.36/211.58 |- mesh__recordMaintainer mesh__D008831 kle
% 211.36/211.58 |- skos__prefLabel mesh__D008831 Microcephaly
% 211.36/211.58 |- mesh__dateCreated mesh__D022502 2000-06-22
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D022502 2001
% 211.36/211.58 |- skos__historyNote mesh__D022502 Cytoskeleton %28%1978-2000%29%
% 211.36/211.58 |- mesh__dateEstablished mesh__D022502 2001-01-01
% 211.36/211.58 |- skos__hiddenLabel mesh__D022502 Fibers, Stress
% 211.36/211.58 |- skos__broader mesh__D022502smesh__D008841
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D022502 2005
% 211.36/211.58 |- mesh__historyNote mesh__D022502 2001
% 211.36/211.58 |- skos__historyNote mesh__D022502 Actins %28%1978-2000%29%
% 211.36/211.58 |- skos__hiddenLabel mesh__D022502 Stress Fiber
% 211.36/211.58 |- skos__prefLabel mesh__D022502 Stress Fibers
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D022502 2006
% 211.36/211.58 |- rdf__type mesh__D022502sskos__Concept
% 211.36/211.58 |- skos__hiddenLabel mesh__D022502 Stress Fibre
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D022502 2004
% 211.36/211.58 |- skos__hiddenLabel mesh__D022502 Fiber, Stress
% 211.36/211.58 |- skos__scopeNote mesh__D022502
% 211.36/211.58 Bundles of actin filaments %28%MICROFILAMENTS%29% and myosin-II that span across the cell attaching to the cell membrane at FOCAL ADHESIONS and to the network of INTERMEDIATE FILAMENTS that surrounds the nucleus.%A%
% 211.36/211.58 |- mesh__dateRevised mesh__D022502 2003-07-09
% 211.36/211.58 |- skos__hiddenLabel mesh__D022502 Fibre, Stress
% 211.36/211.58 |- skos__altLabel mesh__D022502 Stress Fibres
% 211.36/211.58 |- skos__hiddenLabel mesh__D022502 Fibres, Stress
% 211.36/211.58 |- mesh__recordMaintainer mesh__D008033 PXP
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008033 2002
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008033 2003
% 211.36/211.58 |- rdf__type mesh__D008033sskos__Concept
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D008033 sjn
% 211.36/211.58 |- skos__broader mesh__D008033smesh__D001431
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008033 2004
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008033 2005
% 211.36/211.58 |- mesh__dateCreated mesh__D008033 1977-04-27
% 211.36/211.58 |- skos__broader mesh__D008033smesh__D019963
% 211.36/211.58 |- mesh__dateRevised mesh__D008033 2000-06-22
% 211.36/211.58 |- skos__prefLabel mesh__D008033 Limulus Test
% 211.36/211.58 |- skos__historyNote mesh__D008033 Endotoxins %28%1966-1977%29%
% 211.36/211.58 |- skos__hiddenLabel mesh__D008033 Limulus Tests
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008033 2006
% 211.36/211.58 |- skos__annotation mesh__D008033
% 211.36/211.58 for detection of bact endotoxins using horseshoe crab blood%A%
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D008033 2001
% 211.36/211.58 |- skos__scopeNote mesh__D008033
% 211.36/211.58 Sensitive method for detection of bacterial endotoxins and endotoxin-like substances that depends on the in vitro gelation of Limulus amebocyte lysate %28%LAL%29%, prepared from the circulating blood %28%amebocytes%29% of the horseshoe crab, by the endotoxin or related compound. Used for detection of endotoxin in body fluids and parenteral pharmaceuticals.%A%
% 211.36/211.58 |- skos__broader mesh__D008033smesh__D001681
% 211.36/211.58 |- mesh__recordOriginator mesh__D008033 SMH
% 211.36/211.58 |- skos__hiddenLabel mesh__D008033 Test, Limulus
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D008033 78
% 211.36/211.58 |- skos__hiddenLabel mesh__D008033 Tests, Limulus
% 211.36/211.58 |- mesh__dateEstablished mesh__D008033 1978-01-01
% 211.36/211.58 |- mesh__historyNote mesh__D008033 78
% 211.36/211.58 |- mesh__dateRevised mesh__D000050 2003-07-09
% 211.36/211.58 |- skos__prefLabel mesh__D000050 Acanthocytes
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D000050 sjn
% 211.36/211.58 |- skos__scopeNote mesh__D000050
% 211.36/211.58 Erythrocytes with protoplasmic projections giving the cell a thorny appearance.%A%
% 211.36/211.58 |- skos__annotation mesh__D000050 A 11 qualif
% 211.36/211.58 |- mesh__recordMaintainer mesh__D000050 nns
% 211.36/211.58 |- mesh__dateCreated mesh__D000050 1974-11-11
% 211.36/211.58 |- mesh__recordOriginator mesh__D000050 NLM
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D000050 2004
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D000050
% 211.36/211.58 91; was see under ERYTHROCYTES, ABNORMAL 1975-90
% 211.36/211.58 |- mesh__historyNote mesh__D000050
% 211.36/211.58 91%28%75%29%; was see under ERYTHROCYTES, ABNORMAL 1975-90
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D000050 2006
% 211.36/211.58 |- skos__broader mesh__D000050smesh__D004913
% 211.36/211.58 |- skos__hiddenLabel mesh__D000050 Acanthocyte
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D000050 2005
% 211.36/211.58 |- rdf__type mesh__D000050sskos__Concept
% 211.36/211.58 |- mesh__dateEstablished mesh__D000050 1991-01-01
% 211.36/211.58 |- skos__prefLabel mesh__D046950 Thermoanaerobacterium
% 211.36/211.58 |- mesh__recordOriginator mesh__D046950 ags
% 211.36/211.58 |- skos__annotation mesh__D046950 do not confuse with THERMOANAEROBACTER
% 211.36/211.58 |- skos__historyNote mesh__D046950 Bacteria, Anaerobic %28%1985-2004%29%
% 211.36/211.58 |- mesh__recordMaintainer mesh__D046950 ags
% 211.36/211.58 |- skos__broader mesh__D046950smesh__D016988
% 211.36/211.58 |- skos__scopeNote mesh__D046950
% 211.36/211.58 A genus of gram-negative, anaerobic bacteria in the family Thermoanaerobacteriaceae. They are thermophilic and saccharolytic.%A%
% 211.36/211.58 |- mesh__dateRevised mesh__D046950 2005-08-02
% 211.36/211.58 |- mesh__dateCreated mesh__D046950 2004-07-07
% 211.36/211.58 |- mesh__dateEstablished mesh__D046950 2005-01-01
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D046950 2006A
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D046950 ags
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D046950 2006
% 211.36/211.58 |- rdf__type mesh__D046950sskos__Concept
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D046950 2005
% 211.36/211.58 |- mesh__historyNote mesh__D046950 2005
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D013776 2006
% 211.36/211.58 |- rdf__type mesh__D013776sskos__Concept
% 211.36/211.58 |- skos__hiddenLabel mesh__D013776 Tetrathionate, Sodium
% 211.36/211.58 |- mesh__dateEstablished mesh__D013776 1991-01-01
% 211.36/211.58 |- skos__prefLabel mesh__D013776 Tetrathionic Acid
% 211.36/211.58 |- mesh__dateRevised mesh__D013776 2002-07-02
% 211.36/211.58 |- skos__scopeNote mesh__D013776
% 211.36/211.58 A sulfuric acid dimer, formed by disulfide linkage. This compound has been used to prolong coagulation time and as an antidote in cyanide poisoning.%A%
% 211.36/211.58 |- mesh__recordOriginator mesh__D013776 NLM
% 211.36/211.58 |- mesh__historyNote mesh__D013776
% 211.36/211.58 91%28%75%29%; was see under THIOSULFATES 1975-90
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D013776 2003
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D013776 sjn
% 211.36/211.58 |- mesh__dateCreated mesh__D013776 1974-11-19
% 211.36/211.58 |- mesh__recordMaintainer mesh__D013776 ags
% 211.36/211.58 |- skos__hiddenLabel mesh__D013776 Tetrathionate, Potassium
% 211.36/211.58 |- skos__annotation mesh__D013776 D25-26 qualif
% 211.36/211.58 |- skos__historyNote mesh__D013776 Thiosulfates %28%1970-1974%29%
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D013776 2004
% 211.36/211.58 |- skos__broader mesh__D013776smesh__D013464
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D013776 2005
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D013776
% 211.36/211.58 91; was see under THIOSULFATES 1975-90
% 211.36/211.58 |- skos__hiddenLabel mesh__D046152 Stromal Tumor, Gastrointestinal
% 211.36/211.58 |- skos__hiddenLabel mesh__D046152 Neoplasm, Gastrointestinal Stromal
% 211.36/211.58 |- skos__hiddenLabel mesh__D046152 Gastrointestinal Stromal Neoplasm
% 211.36/211.58 |- skos__hiddenLabel mesh__D046152 Neoplasms, Gastrointestinal Stromal
% 211.36/211.58 |- skos__scopeNote mesh__D046152
% 211.36/211.58 All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells %28%MESODERM%29% except those of smooth muscle cells %28%LEIOMYOMA%29% or SCHWANN CELLS %28%SCHWANNOMA%29%.%A%
% 211.36/211.58 |- skos__hiddenLabel mesh__D046152 Gastrointestinal Stromal Tumor
% 211.36/211.58 |- rdf__type mesh__D046152sskos__Concept
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D046152 2005
% 211.36/211.58 |- skos__historyNote mesh__D046152
% 211.36/211.58 Digestive System Neoplasms %28%1988-2004%29%
% 211.36/211.58 |- mesh__dateCreated mesh__D046152 2004-07-07
% 211.36/211.58 |- mesh__dateEstablished mesh__D046152 2005-01-01
% 211.36/211.58 |- mesh__historyNote mesh__D046152 2005
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D046152 sjn
% 211.36/211.58 |- skos__hiddenLabel mesh__D046152 Stromal Neoplasms, Gastrointestinal
% 211.36/211.58 |- mesh__recordOriginator mesh__D046152 lkt
% 211.36/211.58 |- mesh__dateRevised mesh__D046152 2005-06-30
% 211.36/211.58 |- skos__altLabel mesh__D046152 Gastrointestinal Stromal Neoplasms
% 211.36/211.58 |- skos__hiddenLabel mesh__D046152 Stromal Neoplasm, Gastrointestinal
% 211.36/211.58 |- skos__broader mesh__D046152smesh__D005770
% 211.36/211.58 |- skos__historyNote mesh__D046152
% 211.36/211.58 Gastrointestinal Neoplasms %28%1987-2004%29%
% 211.36/211.58 |- skos__hiddenLabel mesh__D046152 Stromal Tumors, Gastrointestinal
% 211.36/211.58 |- skos__prefLabel mesh__D046152 Gastrointestinal Stromal Tumors
% 211.36/211.58 |- mesh__recordMaintainer mesh__D046152 lkt
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D046152 2006
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D007739 2005
% 211.36/211.58 |- mesh__recordOriginator mesh__D007739 NLM
% 211.36/211.58 |- skos__hiddenLabel mesh__D007739 Cell, L %28%Cell Line%29%
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D007739 2004
% 211.36/211.58 |- skos__broader mesh__D007739smesh__D005347
% 211.36/211.58 |- skos__annotation mesh__D007739
% 211.36/211.58 almost always NIM with no subheadings; check ANIMALS %26% MICE; do not routinely add FIBROBLASTS%A%
% 211.36/211.58 |- skos__hiddenLabel mesh__D007739 L Cell %28%Cell Line%29%
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D007739 2006
% 211.36/211.58 |- mesh__dateRevised mesh__D007739 2003-07-30
% 211.36/211.58 |- mesh__dateEstablished mesh__D007739 1966-01-01
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D007739 sjn
% 211.36/211.58 |- mesh__dateCreated mesh__D007739 1999-01-01
% 211.36/211.58 |- rdf__type mesh__D007739sskos__Concept
% 211.36/211.58 |- skos__scopeNote mesh__D007739
% 211.36/211.58 A cultured line of C3H mouse FIBROBLASTS that do not adhere to one another and do not express CADHERINS.%A%
% 211.36/211.58 |- skos__hiddenLabel mesh__D007739 Cells, L %28%Cell Line%29%
% 211.36/211.58 |- mesh__historyNote mesh__D007739 98%28%64%29%
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D007739 98; see L CELLS 1966-97
% 211.36/211.58 |- mesh__recordMaintainer mesh__D007739 nns
% 211.36/211.58 |- skos__prefLabel mesh__D007739 L Cells %28%Cell Line%29%
% 211.36/211.58 |- skos__broader mesh__D007739smesh__D002460
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D018461 95
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D018461 sjn
% 211.36/211.58 |- skos__hiddenLabel mesh__D018461 Soft Tissue Infection
% 211.36/211.58 |- mesh__recordMaintainer mesh__D018461 sjn
% 211.36/211.58 |- skos__altLabel mesh__D018461 Infections, Soft Tissue
% 211.36/211.58 |- mesh__historyNote mesh__D018461 95
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D018461 2006
% 211.36/211.58 |- mesh__dateRevised mesh__D018461 2004-07-13
% 211.36/211.58 |- skos__broader mesh__D018461smesh__D007239
% 211.36/211.58 |- skos__hiddenLabel mesh__D018461 Infection, Soft Tissue
% 211.36/211.58 |- rdf__type mesh__D018461sskos__Concept
% 211.36/211.58 |- skos__annotation mesh__D018461
% 211.36/211.58 GEN or unspecified soft tissue; coord IM with organism/infect precoord %28%IM%29%; DF: SOFT TISSUE INFECT%A%
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D018461 2005
% 211.36/211.58 |- mesh__recordOriginator mesh__D018461 TGC
% 211.36/211.58 |- skos__related mesh__D018461smesh__D012874
% 211.36/211.58 |- skos__scopeNote mesh__D018461
% 211.36/211.58 Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the fecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites. %28%From Cecil Textbook of Medicine, 19th ed, p1688%29%%A%
% 211.36/211.58 |- skos__prefLabel mesh__D018461 Soft Tissue Infections
% 211.36/211.58 |- mesh__dateEstablished mesh__D018461 1995-01-01
% 211.36/211.58 |- mesh__dateCreated mesh__D018461 1994-04-16
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D032132 2005
% 211.36/211.58 |- mesh__dateCreated mesh__D032132 2002-07-03
% 211.36/211.58 |- skos__scopeNote mesh__D032132
% 211.36/211.58 A plant genus of the family SAPOTACEAE. Members contain triterpenes. Some species in this genus are called mamey which is also a common name for MAMMEA.%A%
% 211.36/211.58 |- rdf__type mesh__D032132sskos__Concept
% 211.36/211.58 |- skos__prefLabel mesh__D032132 Pouteria
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D032132 2004
% 211.36/211.58 |- mesh__historyNote mesh__D032132 2003
% 211.36/211.58 |- skos__annotation mesh__D032132
% 211.36/211.58 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D032132 2003
% 211.36/211.58 |- skos__broader mesh__D032132smesh__D029632
% 211.36/211.58 |- skos__altLabel mesh__D032132 Sapote, Yellow
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D032132 2006
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D032132 2003
% 211.36/211.58 |- mesh__dateEstablished mesh__D032132 2003-01-01
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D004441 2005
% 211.36/211.58 |- skos__annotation mesh__D004441 do not confuse with ECDYSONE
% 211.36/211.58 |- skos__altLabel mesh__D004441 Beta-Ecdysone
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D004441 2002
% 211.36/211.58 |- mesh__recordMaintainer mesh__D004441 lkt
% 211.36/211.58 |- skos__historyNote mesh__D004441 Ecdysone %28%1966-1974%29%
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D004441 2003
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D004441 2006
% 211.36/211.58 |- skos__prefLabel mesh__D004441 Ecdysterone
% 211.36/211.58 |- skos__broader mesh__D004441smesh__D026461
% 211.36/211.58 |- skos__historyNote mesh__D004441 Insects %28%1966%29%
% 211.36/211.58 |- skos__altLabel mesh__D004441 20-Hydroxyecdysone
% 211.36/211.58 |- mesh__historyNote mesh__D004441 1977 %28%1969%29%
% 211.36/211.58 |- skos__scopeNote mesh__D004441
% 211.36/211.58 A steroid hormone that regulates the processes of MOLTING or ecdysis in insects. Ecdysterone is the 20-hydroxylated ECDYSONE.%A%
% 211.36/211.58 |- skos__altLabel mesh__D004441 Crustecdysone
% 211.36/211.58 |- mesh__recordOriginator mesh__D004441 NLM
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D004441 sjn
% 211.36/211.58 |- mesh__dateEstablished mesh__D004441 1977-01-01
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D004441 2004
% 211.36/211.58 |- skos__hiddenLabel mesh__D004441 Beta Ecdysone
% 211.36/211.58 |- rdf__type mesh__D004441sskos__Concept
% 211.36/211.58 |- skos__historyNote mesh__D004441 Cholestanes %28%1968-1972%29%
% 211.36/211.58 |- mesh__dateCreated mesh__D004441 1999-01-01
% 211.36/211.58 |- skos__hiddenLabel mesh__D004441 20 Hydroxyecdysone
% 211.36/211.58 |- skos__historyNote mesh__D004441 Hormones %28%1966%29%
% 211.36/211.58 |- mesh__dateRevised mesh__D004441 2001-07-25
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D004441
% 211.36/211.58 1977; see CHOLESTENES 1975-1977, see INVERTEBRATE HORMONES 1972-1974, see CHOLESTANES 1969-1971%A%
% 211.36/211.58 |- skos__historyNote mesh__D004441 Invertebrate Hormones %28%1967-1974%29%
% 211.36/211.58 |- skos__altLabel mesh__D051097
% 211.36/211.58 Glial Derived Neurotrophic Factor Receptor 4
% 211.36/211.58 |- skos__altLabel mesh__D051097
% 211.36/211.58 Glial Derived Neurotrophic Factor Receptor 1
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D051097 sjn
% 211.36/211.58 |- rdf__type mesh__D051097sskos__Concept
% 211.36/211.58 |- skos__altLabel mesh__D051097 GDNF Family Receptor Alpha 4
% 211.36/211.58 |- skos__altLabel mesh__D051097 GDNF Family Receptor Alpha 1
% 211.36/211.58 |- mesh__dateCreated mesh__D051097 2005-06-30
% 211.36/211.58 |- skos__altLabel mesh__D051097 GDNF Family Receptor 3
% 211.36/211.58 |- mesh__recordMaintainer mesh__D051097 DRC
% 211.36/211.58 |- skos__altLabel mesh__D051097 GDNF Family Receptor Alpha 2
% 211.36/211.58 |- skos__broader mesh__D051097smesh__D017475
% 211.36/211.58 |- skos__altLabel mesh__D051097 GDNF Family Receptor 1
% 211.36/211.58 |- skos__altLabel mesh__D051097 GDNF Family Receptor Alpha 3
% 211.36/211.58 |- skos__prefLabel mesh__D051097
% 211.36/211.58 Glial Cell Line-Derived Neurotrophic Factor Receptors
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D051097 2006
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D051097
% 211.36/211.58 2006; GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR RECEPTORS was indexed under PROTO-ONCOGENE PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2005%A%
% 211.36/211.58 |- skos__altLabel mesh__D051097 GDNF Family Receptor 2
% 211.36/211.58 |- skos__altLabel mesh__D051097 GDNF Family Receptor 4
% 211.36/211.58 |- mesh__recordOriginator mesh__D051097 DRC
% 211.36/211.58 |- mesh__historyNote mesh__D051097 2006%28%1999%29%
% 211.36/211.58 |- skos__altLabel mesh__D051097
% 211.36/211.58 Glial Derived Neurotrophic Factor Receptor 2
% 211.36/211.58 |- skos__hiddenLabel mesh__D051097
% 211.36/211.58 Glial Cell Line Derived Neurotrophic Factor Receptors
% 211.36/211.58 |- skos__altLabel mesh__D051097 GDNF Receptors
% 211.36/211.58 |- skos__scopeNote mesh__D051097
% 211.36/211.58 A family of GLYCOSYLPHOSPHATIDYLINOSITOL-anchored cell surface receptors that are specific for GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS. They form a multi-component receptor complex with PROTO-ONCOGENE PROTEIN C-RET and regulate a variety of intracellular SIGNAL TRANSDUCTION PATHWAYS in conjunction with c-ret protein.%A%
% 211.36/211.58 |- skos__altLabel mesh__D051097
% 211.36/211.58 Glial Derived Neurotrophic Factor Receptor 3
% 211.36/211.58 |- mesh__dateEstablished mesh__D051097 2006-01-01
% 211.36/211.58 |- mesh__dateEstablished mesh__D045858 2004-01-01
% 211.36/211.58 |- skos__broader mesh__D045858smesh__D016999
% 211.36/211.58 |- mesh__recordMaintainer mesh__D045858 SYSTEM
% 211.36/211.58 |- mesh__dateRevised mesh__D045858 2005-06-30
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D045858 sjn
% 211.36/211.58 |- mesh__recordOriginator mesh__D045858 ags
% 211.36/211.58 |- skos__prefLabel mesh__D045858 Desulfitobacterium
% 211.36/211.58 |- rdf__type mesh__D045858sskos__Concept
% 211.36/211.58 |- mesh__historyNote mesh__D045858 2004
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D045858 2006
% 211.36/211.58 |- mesh__dateCreated mesh__D045858 2003-07-09
% 211.36/211.58 |- skos__scopeNote mesh__D045858
% 211.36/211.58 A genus of anaerobic, gram-positive bacteria in the family Peptococcaceae, that reductively dechlorinates CHLOROPHENOLS.%A%
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D045858 2004
% 211.36/211.58 |- mesh__dateCreated mesh__D003349 1974-11-27
% 211.36/211.58 |- skos__hiddenLabel mesh__D003349 20 beta Hydroxysteroid Dehydrogenase
% 211.36/211.58 |- skos__broader mesh__D003349smesh__D015089
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D003349 2006
% 211.36/211.58 |- skos__altLabel mesh__D003349 20-beta-Hydroxysteroid Dehydrogenase
% 211.36/211.58 |- rdf__type mesh__D003349sskos__Concept
% 211.36/211.58 |- mesh__historyNote mesh__D003349
% 211.36/211.58 91%28%75%29%; was see under 20-HYDROXYSTEROID DEHYDROGENASES 1975-90%A%
% 211.36/211.58 |- mesh__dateEstablished mesh__D003349 1991-01-01
% 211.36/211.58 |- skos__prefLabel mesh__D003349 Cortisone Reductase
% 211.36/211.58 |- skos__hiddenLabel mesh__D003349 Dehydrogenase, 20-beta-Hydroxysteroid
% 211.36/211.58 |- mesh__recordOriginator mesh__D003349 NLM
% 211.36/211.58 |- mesh__recordAuthorizer mesh__D003349 sjn
% 211.36/211.58 |- skos__hiddenLabel mesh__D003349 Reductase, Cortisone
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D003349
% 211.36/211.58 91; was see under 20-HYDROXYSTEROID DEHYDROGENASES 1975-90%A%
% 211.36/211.58 |- mesh__recordMaintainer mesh__D003349 ssb
% 211.36/211.58 |- skos__historyNote mesh__D003349
% 211.36/211.58 Hydroxysteroid Dehydrogenases %28%1972-1974%29%
% 211.36/211.58 |- skos__scopeNote mesh__D003349
% 211.36/211.58 An enzyme that catalyzes the interconversion of a ketone and hydroxy group at C-20 of cortisone and other 17,20,21-trihydroxy steroids. EC 1.1.1.53.%A%
% 211.36/211.58 |- mesh__dateRevised mesh__D003349 2003-07-09
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D003349 2005
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D003349 2004
% 211.36/211.58 |- skos__historyNote mesh__D003349 Cortisone %28%1972-1974%29%
% 211.36/211.58 |- skos__broader mesh__D014071smesh__D014076
% 211.36/211.58 |- skos__hiddenLabel mesh__D014071 Odontomes
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D014071 2004
% 211.36/211.58 |- skos__prefLabel mesh__D014071 Tooth Abnormalities
% 211.36/211.58 |- skos__altLabel mesh__D014071 Abnormalities, Teeth
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D014071 2000
% 211.36/211.58 |- mesh__dateRevised mesh__D014071 1999-11-03
% 211.36/211.58 |- rdf__type mesh__D014071sskos__Concept
% 211.36/211.58 |- mesh__publicMeSHNote mesh__D014071 65
% 211.36/211.58 |- mesh__activeMeSHYear mesh__D014071 2003
% 211.36/211.59 |- skos__hiddenLabel mesh__D014071 Abnormality, Tooth
% 211.36/211.59 |- skos__scopeNote mesh__D014071
% 211.36/211.59 Congenital absence of or defects in structures of the teeth.%A%
% 211.36/211.59 |- mesh__historyNote mesh__D014071 65
% 211.36/211.59 |- skos__annotation mesh__D014071
% 211.36/211.59 do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; duplication of teeth = TOOTH, SUPERNUMERARY; abnorm in congen syphilis = HUTCHINSON%27%S TEETH see SYPHILIS, CONGENITAL; X ref ODONTOME %28%a form of developmental dental anomaly%29%: do not confuse with ODONTOMA%A%
% 211.36/211.59 |- skos__altLabel mesh__D014071 Abnormalities, Tooth
% 211.36/211.59 |- skos__broader mesh__D014071smesh__D018640
% 211.36/211.59 |- skos__hiddenLabel mesh__D014071 Teeth Abnormality
% 211.36/211.59 |- skos__hiddenLabel mesh__D014071 Tooth Abnormality
% 211.36/211.59 |- mesh__dateCreated mesh__D014071 1999-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014071 2006
% 211.36/211.59 |- mesh__recordOriginator mesh__D014071 NLM
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014071 2002
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D014071 sjn
% 211.36/211.59 |- mesh__dateEstablished mesh__D014071 1965-01-01
% 211.36/211.59 |- mesh__recordMaintainer mesh__D014071 kle
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014071 2005
% 211.36/211.59 |- skos__hiddenLabel mesh__D014071 Abnormality, Teeth
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014071 2001
% 211.36/211.59 |- skos__altLabel mesh__D014071 Teeth Abnormalities
% 211.36/211.59 |- mesh__recordMaintainer mesh__D008832 nns
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008832 2004
% 211.36/211.59 |- skos__prefLabel mesh__D008832 Microchemistry
% 211.36/211.59 |- skos__related mesh__D008832smesh__D008904
% 211.36/211.59 |- rdf__type mesh__D008832sskos__Concept
% 211.36/211.59 |- skos__scopeNote mesh__D008832
% 211.36/211.59 The development and use of techniques and equipment to study or perform chemical reactions, with small quantities of materials, frequently less than a milligram or a milliliter.%A%
% 211.36/211.59 |- skos__related mesh__D008832smesh__D036103
% 211.36/211.59 |- skos__broader mesh__D008832smesh__D002621
% 211.36/211.59 |- mesh__dateRevised mesh__D008832 2002-07-03
% 211.36/211.59 |- mesh__recordOriginator mesh__D008832 NLM
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008832 2005
% 211.36/211.59 |- mesh__dateCreated mesh__D008832 1999-01-01
% 211.36/211.59 |- skos__broader mesh__D008832smesh__D002623
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D008832 sjn
% 211.36/211.59 |- skos__related mesh__D008832smesh__D015374
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008832 2003
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008832 2006
% 211.36/211.59 |- skos__hiddenLabel mesh__D008034 Monohydrochloride, Lincomycin
% 211.36/211.59 |- skos__scopeNote mesh__D008034
% 211.36/211.59 An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.%A%
% 211.36/211.59 |- mesh__recordMaintainer mesh__D008034 ssb
% 211.36/211.59 |- skos__altLabel mesh__D008034 Lincolnensin
% 211.36/211.59 |- skos__broader mesh__D008034smesh__D006027
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D008034 66
% 211.36/211.59 |- skos__altLabel mesh__D008034 Epilincomycin
% 211.36/211.59 |- skos__hiddenLabel mesh__D008034 Hemihydrate Lincomycin Monohydrochloride
% 211.36/211.59 |- rdf__type mesh__D008034sskos__Concept
% 211.36/211.59 |- mesh__historyNote mesh__D008034 66%28%64%29%
% 211.36/211.59 |- mesh__recordOriginator mesh__D008034 NLM
% 211.36/211.59 |- skos__broader mesh__D008034smesh__D011759
% 211.36/211.59 |- skos__prefLabel mesh__D008034 Lincomycin
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D008034 sjn
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008034 2006
% 211.36/211.59 |- skos__hiddenLabel mesh__D008034 Hydrochloride, Lincomycin
% 211.36/211.59 |- mesh__dateRevised mesh__D008034 2004-07-07
% 211.36/211.59 |- mesh__dateCreated mesh__D008034 1999-01-01
% 211.36/211.59 |- mesh__dateEstablished mesh__D008034 1966-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008034 2005
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D000051
% 211.36/211.59 91; was see under SKIN DISEASES 1969-90
% 211.36/211.59 |- skos__scopeNote mesh__D000051
% 211.36/211.59 Separation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer. It is seen in diseases such as pemphigus vulgaris %28%see PEMPHIGUS%29% and KERATOSIS FOLLICULARIS.%A%
% 211.36/211.59 |- skos__historyNote mesh__D000051 Skin/pathology %28%1966-1968%29%
% 211.36/211.59 |- skos__historyNote mesh__D000051
% 211.36/211.59 specific skin disease/pathology %28%1966-1968%29%
% 211.36/211.59 |- skos__hiddenLabel mesh__D000051 Acantholyses
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000051 2002
% 211.36/211.59 |- skos__annotation mesh__D000051
% 211.36/211.59 ACANTHOLYSIS BULLOSA see EPIDERMOLYSIS BULLOSA is also available%A%
% 211.36/211.59 |- skos__broader mesh__D000051smesh__D012872
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000051 2004
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000051 2001
% 211.36/211.59 |- mesh__dateRevised mesh__D000051 1999-11-03
% 211.36/211.59 |- mesh__historyNote mesh__D000051
% 211.36/211.59 91%28%69%29%; was see under SKIN DISEASES 1969-90
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D000051 sjn
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000051 2006
% 211.36/211.59 |- mesh__recordMaintainer mesh__D000051 KEV
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000051 2003
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000051 2005
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000051 2000
% 211.36/211.59 |- skos__prefLabel mesh__D000051 Acantholysis
% 211.36/211.59 |- mesh__recordOriginator mesh__D000051 NLM
% 211.36/211.59 |- skos__broader mesh__D000051smesh__D010335
% 211.36/211.59 |- mesh__dateCreated mesh__D000051 1999-01-01
% 211.36/211.59 |- rdf__type mesh__D000051sskos__Concept
% 211.36/211.59 |- mesh__dateEstablished mesh__D000051 1991-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 2002
% 211.36/211.59 |- mesh__historyNote mesh__D013777
% 211.36/211.59 91%28%73%29%; was see under AZOLES 1973-90
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D013777 PLS
% 211.36/211.59 |- mesh__recordMaintainer mesh__D013777 TAP
% 211.36/211.59 |- skos__broader mesh__D013777smesh__D001393
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 1999
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 1994
% 211.36/211.59 |- mesh__onlineNote mesh__D013777 search AZOLES 1966-72
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 2001
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 1998
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 1993
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 2006
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 2000
% 211.36/211.59 |- rdf__type mesh__D013777sskos__Concept
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 1997
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 2005
% 211.36/211.59 |- mesh__dateCreated mesh__D013777 1999-01-01
% 211.36/211.59 |- skos__prefLabel mesh__D013777 Tetrazoles
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 1996
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 2004
% 211.36/211.59 |- mesh__dateEstablished mesh__D013777 1991-01-01
% 211.36/211.59 |- mesh__dateRevised mesh__D013777 1992-05-20
% 211.36/211.59 |- skos__historyNote mesh__D013777 Azoles %28%1966-1972%29%
% 211.36/211.59 |- mesh__recordOriginator mesh__D013777 NLM
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 2003
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D013777 91; was see under AZOLES 1973-90
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013777 1995
% 211.36/211.59 |- skos__broader mesh__D018462smesh__D001695
% 211.36/211.59 |- mesh__historyNote mesh__D018462 95
% 211.36/211.59 |- mesh__dateEstablished mesh__D018462 1995-01-01
% 211.36/211.59 |- skos__annotation mesh__D018462
% 211.36/211.59 SPEC or GEN only; photobiol eff on or eff of light on = LIGHT %28%IM%29% + specific target %28%IM%29%; photobiol eff of ultraviolet light = ULTRAVIOLET RAYS %28%IM%29% + specific target %28%IM%29%; DF: PHOTOBIOL%A%
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D018462 2006
% 211.36/211.59 |- skos__related mesh__D018462smesh__D010777
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D018462 95
% 211.36/211.59 |- skos__historyNote mesh__D018462 Light %28%1966-1994%29%
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D018462 sjn
% 211.36/211.59 |- skos__prefLabel mesh__D018462 Photobiology
% 211.36/211.59 |- mesh__dateRevised mesh__D018462 2001-07-25
% 211.36/211.59 |- rdf__type mesh__D018462sskos__Concept
% 211.36/211.59 |- skos__related mesh__D018462smesh__D010788
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D018462 2005
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D018462 2002
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D018462 2004
% 211.36/211.59 |- skos__scopeNote mesh__D018462
% 211.36/211.59 The branch of biology dealing with the effect of light on organisms.%A%
% 211.36/211.59 |- mesh__dateCreated mesh__D018462 1994-06-07
% 211.36/211.59 |- skos__related mesh__D018462smesh__D008027
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D018462 2003
% 211.36/211.59 |- mesh__recordMaintainer mesh__D018462 jls
% 211.36/211.59 |- mesh__recordOriginator mesh__D018462 TGC
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D032133 2004
% 211.36/211.59 |- mesh__dateEstablished mesh__D032133 2003-01-01
% 211.36/211.59 |- skos__scopeNote mesh__D032133
% 211.36/211.59 A plant genus of the family SAPOTACEAE. Members contain miraculin %28%also spelled mieraculin%29%, a sweet protein.%A%
% 211.36/211.59 |- skos__altLabel mesh__D032133 Fruit, Miracle
% 211.36/211.59 |- skos__annotation mesh__D032133
% 211.36/211.59 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D032133 2003
% 211.36/211.59 |- skos__prefLabel mesh__D032133 Synsepalum
% 211.36/211.59 |- mesh__dateCreated mesh__D032133 2002-07-03
% 211.36/211.59 |- skos__broader mesh__D032133smesh__D029632
% 211.36/211.59 |- mesh__historyNote mesh__D032133 2003
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D032133 2006
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D032133 2003
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D032133 2005
% 211.36/211.59 |- rdf__type mesh__D032133sskos__Concept
% 211.36/211.59 |- skos__altLabel mesh__D032133 Miracle Fruit
% 211.36/211.59 |- skos__broader mesh__D051896smesh__D051785
% 211.36/211.59 |- skos__hiddenLabel mesh__D051896 Smad Proteins, Receptor Regulated
% 211.36/211.59 |- skos__hiddenLabel mesh__D051896 Receptor Regulated Smad Proteins
% 211.36/211.59 |- skos__altLabel mesh__D051896 R-Smad Proteins
% 211.36/211.59 |- mesh__dateEstablished mesh__D051896 2006-01-01
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D051896 2006
% 211.36/211.59 |- skos__broader mesh__D051896smesh__D010750
% 211.36/211.59 |- mesh__historyNote mesh__D051896 2006
% 211.36/211.59 |- mesh__recordMaintainer mesh__D051896 DRC
% 211.36/211.59 |- mesh__dateCreated mesh__D051896 2005-06-30
% 211.36/211.59 |- skos__prefLabel mesh__D051896 Smad Proteins, Receptor-Regulated
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D051896 2006
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D051896 sjn
% 211.36/211.59 |- rdf__type mesh__D051896sskos__Concept
% 211.36/211.59 |- skos__altLabel mesh__D051896 Receptor-Regulated Smad Proteins
% 211.36/211.59 |- mesh__recordOriginator mesh__D051896 DRC
% 211.36/211.59 |- skos__scopeNote mesh__D051896
% 211.36/211.59 A family of smad proteins that undergo PHOSPHORYLATION by CELL SURFACE RECEPTORS in response to TRANSFORMING GROWTH FACTOR BETA; ACTIVIN; or BONE MORPHOGENETIC PROTEIN signaling.%A%
% 211.36/211.59 |- mesh__dateRevised mesh__D004442 2003-07-09
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D004442
% 211.36/211.59 91; was see under MONOTREMATA 1975-90
% 211.36/211.59 |- skos__prefLabel mesh__D004442 Echidna
% 211.36/211.59 |- mesh__dateEstablished mesh__D004442 1991-01-01
% 211.36/211.59 |- skos__hiddenLabel mesh__D004442 Anteaters, Spiny
% 211.36/211.59 |- skos__hiddenLabel mesh__D004442 Ant-Eater, Spiny
% 211.36/211.59 |- mesh__historyNote mesh__D004442
% 211.36/211.59 91%28%75%29%; was see under MONOTREMATA 1975-90
% 211.36/211.59 |- skos__broader mesh__D004442smesh__D009007
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D004442 2004
% 211.36/211.59 |- skos__hiddenLabel mesh__D004442 Anteater, Spiny
% 211.36/211.59 |- skos__hiddenLabel mesh__D004442 Spiny Ant-Eaters
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D004442 2006
% 211.36/211.59 |- mesh__recordMaintainer mesh__D004442 ags
% 211.36/211.59 |- skos__hiddenLabel mesh__D004442 Ant-Eaters, Spiny
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D004442 2005
% 211.36/211.59 |- skos__altLabel mesh__D004442 Spiny Anteater
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D004442 sjn
% 211.36/211.59 |- mesh__recordOriginator mesh__D004442 NLM
% 211.36/211.59 |- mesh__dateCreated mesh__D004442 1974-11-19
% 211.36/211.59 |- skos__annotation mesh__D004442
% 211.36/211.59 do not confuse X ref SPINY ANTEATER with X ref ANTEATERS see XENARTHRA; IM; qualif permitted%A%
% 211.36/211.59 |- rdf__type mesh__D004442sskos__Concept
% 211.36/211.59 |- skos__hiddenLabel mesh__D004442 Spiny Anteaters
% 211.36/211.59 |- skos__hiddenLabel mesh__D004442 Spiny Ant Eater
% 211.36/211.59 |- skos__scopeNote mesh__D004442
% 211.36/211.59 An oviparous burrowing mammal of the order Monotremata native to Australia, Tasmania, and New Guinea. It has hair mingled with spines on the upper part of the body and is adapted for feeding on ants.%A%
% 211.36/211.59 |- skos__altLabel mesh__D004442 Spiny Ant-Eater
% 211.36/211.59 |- mesh__dateEstablished mesh__D051098 2006-01-01
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D051098 sjn
% 211.36/211.59 |- skos__broader mesh__D051098smesh__D009414
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D051098 2006
% 211.36/211.59 |- mesh__dateCreated mesh__D051098 2005-06-30
% 211.36/211.59 |- skos__annotation mesh__D051098
% 211.36/211.59 GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR is also available%A%
% 211.36/211.59 |- mesh__recordOriginator mesh__D051098 DRC
% 211.36/211.59 |- skos__prefLabel mesh__D051098
% 211.36/211.59 Glial Cell Line-Derived Neurotrophic Factors
% 211.36/211.59 |- mesh__recordMaintainer mesh__D051098 DRC
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D051098 2006
% 211.36/211.59 |- skos__hiddenLabel mesh__D051098
% 211.36/211.59 Glial Cell Line Derived Neurotrophic Factors
% 211.36/211.59 |- skos__altLabel mesh__D051098 GDNF Family Ligands
% 211.36/211.59 |- mesh__historyNote mesh__D051098 2006
% 211.36/211.59 |- skos__scopeNote mesh__D051098
% 211.36/211.59 A family of closely related nerve growth factors that promote NEURON survival. They bind to GDNF RECEPTORS and stimulate SIGNAL TRANSDUCTION through PROTO-ONCOGENE PROTEIN C-RET.%A%
% 211.36/211.59 |- rdf__type mesh__D051098sskos__Concept
% 211.36/211.59 |- skos__altLabel mesh__D051098 GDNF Protein Family
% 211.36/211.59 |- skos__broader mesh__D045859smesh__D016999
% 211.36/211.59 |- skos__scopeNote mesh__D045859
% 211.36/211.59 A genus of anaerobic bacteria in the family PEPTOCOCCACEAE, widely distributed in SOIL and the RUMEN of animals. Stains gram-negative but cell well is gram-positive type.%A%
% 211.36/211.59 |- mesh__recordMaintainer mesh__D045859 SYSTEM
% 211.36/211.59 |- skos__broader mesh__D045859smesh__D016937
% 211.36/211.59 |- skos__prefLabel mesh__D045859 Desulfotomaculum
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D045859 2004
% 211.36/211.59 |- mesh__dateRevised mesh__D045859 2005-06-30
% 211.36/211.59 |- mesh__dateCreated mesh__D045859 2003-07-09
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D045859 sjn
% 211.36/211.59 |- mesh__recordOriginator mesh__D045859 ags
% 211.36/211.59 |- mesh__dateEstablished mesh__D045859 2004-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D045859 2006
% 211.36/211.59 |- rdf__type mesh__D045859sskos__Concept
% 211.36/211.59 |- mesh__historyNote mesh__D045859 2004
% 211.36/211.59 |- mesh__dateEstablished mesh__D042561 2004-01-01
% 211.36/211.59 |- skos__annotation mesh__D042561 see SCR for organism-specific terms
% 211.36/211.59 |- mesh__historyNote mesh__D042561
% 211.36/211.59 2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR B %28%NM%29% 1996-2003%A%
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D042561 2006
% 211.36/211.59 |- rdf__type mesh__D042561sskos__Concept
% 211.36/211.59 |- mesh__recordOriginator mesh__D042561 jmp
% 211.36/211.59 |- skos__hiddenLabel mesh__D042561 VEGF Related Factor, VEGF B
% 211.36/211.59 |- skos__altLabel mesh__D042561 Vascular Endothelial Growth Factor-B
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D042561 sjn
% 211.36/211.59 |- skos__altLabel mesh__D042561 VEGF-Related Factor, VEGF-B
% 211.36/211.59 |- mesh__recordMaintainer mesh__D042561 ssb
% 211.36/211.59 |- skos__broader mesh__D042561smesh__D042442
% 211.36/211.59 |- skos__hiddenLabel mesh__D042561 VEGF-B VEGF-Related Factor
% 211.36/211.59 |- mesh__dateCreated mesh__D042561 2003-07-09
% 211.36/211.59 |- skos__prefLabel mesh__D042561 Vascular Endothelial Growth Factor B
% 211.36/211.59 |- skos__historyNote mesh__D042561
% 211.36/211.59 Endothelial Growth Factors %28%1996-2003%29%
% 211.36/211.59 |- mesh__dateRevised mesh__D042561 2005-06-30
% 211.36/211.59 |- skos__hiddenLabel mesh__D042561 VEGF Related Protein, VEGF B
% 211.36/211.59 |- skos__scopeNote mesh__D042561
% 211.36/211.59 A vascular endothelial growth factor expressed in a variety of tissues. It binds with high specificity to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 and NEUROPILIN-1.%A%
% 211.36/211.59 |- skos__hiddenLabel mesh__D042561 VEGF-B VEGF-Related Protein
% 211.36/211.59 |- skos__altLabel mesh__D042561 VEGF-B
% 211.36/211.59 |- skos__altLabel mesh__D042561 VEGF-Related Protein, VEGF-B
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D042561
% 211.36/211.59 2004; VASCULAR ENDOTHELIAL GROWTH FACTOR B was indexed under ENDOTHELIAL GROWTH FACTORS 1996-2003%A%
% 211.36/211.59 |- rdf__type mesh__D014870sskos__Concept
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014870 2003
% 211.36/211.59 |- skos__historyNote mesh__D014870 Respiration %28%1966-1971%29%
% 211.36/211.59 |- skos__scopeNote mesh__D014870
% 211.36/211.59 Loss of water by diffusion through the skin and by evaporation from the respiratory tract.%A%
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014870 2001
% 211.36/211.59 |- skos__broader mesh__D014870smesh__D014882
% 211.36/211.59 |- mesh__dateRevised mesh__D014870 2000-06-22
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014870 2006
% 211.36/211.59 |- mesh__historyNote mesh__D014870 74%28%72%29%
% 211.36/211.59 |- skos__prefLabel mesh__D014870 Water Loss, Insensible
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014870 2005
% 211.36/211.59 |- mesh__recordMaintainer mesh__D014870 TGC
% 211.36/211.59 |- mesh__dateEstablished mesh__D014870 1974-01-01
% 211.36/211.59 |- skos__historyNote mesh__D014870 Sweating %28%1966-1971%29%
% 211.36/211.59 |- skos__hiddenLabel mesh__D014870 Insensible Water Loss
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D014870 74
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D014870 sjn
% 211.36/211.59 |- mesh__recordOriginator mesh__D014870 NLM
% 211.36/211.59 |- mesh__dateCreated mesh__D014870 1999-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014870 2002
% 211.36/211.59 |- skos__hiddenLabel mesh__D014870 Insensible Water Losses
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014870 2004
% 211.36/211.59 |- mesh__recordOriginator mesh__D014072 NLM
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 2003
% 211.36/211.59 |- mesh__dateEstablished mesh__D014072 1965-01-01
% 211.36/211.59 |- skos__prefLabel mesh__D014072 Tooth Abrasion
% 211.36/211.59 |- skos__altLabel mesh__D014072 Abrasion, Dental
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 2001
% 211.36/211.59 |- skos__annotation mesh__D014072
% 211.36/211.59 loss of substance caused by friction: differentiate from TOOTH ATTRITION %28%wearing away by tooth-to-tooth contact like mastication%29% %26% TOOTH EROSION %28%loss of substance by chemical action without bact action%29%%A%
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 2000
% 211.36/211.59 |- mesh__historyNote mesh__D014072 65
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D014072 65
% 211.36/211.59 |- mesh__dateCreated mesh__D014072 1999-01-01
% 211.36/211.59 |- skos__hiddenLabel mesh__D014072 Abrasion, Tooth
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 2006
% 211.36/211.59 |- mesh__recordMaintainer mesh__D014072 TGC
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D014072 PLS
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 1999
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 2005
% 211.36/211.59 |- skos__scopeNote mesh__D014072
% 211.36/211.59 The pathologic wearing away of the tooth substance by brushing, bruxism, clenching, and other mechanical causes. It is differentiated from TOOTH ATTRITION in that this type of wearing away is the result of tooth-to-tooth contact, as in mastication, occurring only on the occlusal, incisal, and proximal surfaces. It differs also from TOOTH EROSION, the progressive loss of the hard substance of a tooth by chemical processes not involving bacterial action. %28%From Jablonski, Dictionary of Dentistry, 1992, p2%29%%A%
% 211.36/211.59 |- skos__broader mesh__D014072smesh__D014076
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 2004
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 1998
% 211.36/211.59 |- rdf__type mesh__D014072sskos__Concept
% 211.36/211.59 |- skos__altLabel mesh__D014072 Dental Abrasion
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 2002
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D014072 1997
% 211.36/211.59 |- mesh__dateRevised mesh__D014072 1996-06-10
% 211.36/211.59 |- skos__hiddenLabel mesh__D008833 Microcirculations
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D008833 sjn
% 211.36/211.59 |- skos__annotation mesh__D008833
% 211.36/211.59 IM GEN only; NIM as coord with specific organ /blood supply; not for lymphatic microcirc %28% = LYMPHATIC SYSTEM /physiol%29%; Manual 21.5; DF: MICROCIRC%A%
% 211.36/211.59 |- mesh__dateEstablished mesh__D008833 1972-01-01
% 211.36/211.59 |- rdf__type mesh__D008833sskos__Concept
% 211.36/211.59 |- skos__prefLabel mesh__D008833 Microcirculation
% 211.36/211.59 |- mesh__recordMaintainer mesh__D008833 nns
% 211.36/211.59 |- skos__historyNote mesh__D008833 Capillaries %28%1966-1969%29%
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D008833 72
% 211.36/211.59 |- mesh__historyNote mesh__D008833 72%28%70%29%
% 211.36/211.59 |- skos__scopeNote mesh__D008833
% 211.36/211.59 The circulation of the BLOOD through the microvascular network lying between the ARTERIOLES and VENULES. This network includes CAPILLARIES, metarterioles, and ARTERIOVENOUS ANASTOMOSES; and the flow of blood through this network.%A%
% 211.36/211.59 |- mesh__dateCreated mesh__D008833 1999-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008833 2005
% 211.36/211.59 |- skos__historyNote mesh__D008833 Blood Circulation %28%1966-1969%29%
% 211.36/211.59 |- skos__broader mesh__D008833smesh__D001775
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008833 2006
% 211.36/211.59 |- mesh__dateRevised mesh__D008833 2003-07-09
% 211.36/211.59 |- skos__broader mesh__D008833smesh__D001808
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008833 2004
% 211.36/211.59 |- mesh__recordOriginator mesh__D008833 NLM
% 211.36/211.59 |- skos__historyNote mesh__D000850 Social Problems %28%1968-1970%29%
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000850 2004
% 211.36/211.59 |- skos__historyNote mesh__D000850
% 211.36/211.59 Social Behavior Disorders %28%1969-1970%29%
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000850 2005
% 211.36/211.59 |- skos__hiddenLabel mesh__D000850 Disorganizations, Social
% 211.36/211.59 |- mesh__dateRevised mesh__D000850 2002-07-02
% 211.36/211.59 |- mesh__historyNote mesh__D000850 71
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000850 2003
% 211.36/211.59 |- skos__annotation mesh__D000850
% 211.36/211.59 no qualif; %22%state of social disorganization %26% demoralization in society...%22%; sometimes called %22%anomia%22% but do not confuse with ANOMIA %28%%22%inability to name objects%22%%29%%A%
% 211.36/211.59 |- mesh__recordOriginator mesh__D000850 NLM
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D000850 71
% 211.36/211.59 |- mesh__dateEstablished mesh__D000850 1971-01-01
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D000850 sjn
% 211.36/211.59 |- skos__hiddenLabel mesh__D000850 Anomies
% 211.36/211.59 |- skos__broader mesh__D000850smesh__D012924
% 211.36/211.59 |- skos__related mesh__D000850smesh__D012920
% 211.36/211.59 |- skos__related mesh__D000850smesh__D010554
% 211.36/211.59 |- skos__hiddenLabel mesh__D000850 Social Disorganizations
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000850 2006
% 211.36/211.59 |- mesh__dateCreated mesh__D000850 1999-01-01
% 211.36/211.59 |- skos__scopeNote mesh__D000850
% 211.36/211.59 A state of social disorganization and demoralization in society which is largely the result of disharmony between cultural goals and the means for attaining them. This may be reflected in the behavior of the individual in many ways - non-conformity, social withdrawal, deviant behavior, etc.%A%
% 211.36/211.59 |- skos__prefLabel mesh__D000850 Anomie
% 211.36/211.59 |- skos__broader mesh__D000850smesh__D012919
% 211.36/211.59 |- skos__hiddenLabel mesh__D000850 Disorganization, Social
% 211.36/211.59 |- rdf__type mesh__D000850sskos__Concept
% 211.36/211.59 |- mesh__recordMaintainer mesh__D000850 JLS
% 211.36/211.59 |- skos__hiddenLabel mesh__D008035 Frenums, Lingual
% 211.36/211.59 |- mesh__dateEstablished mesh__D008035 1965-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008035 2004
% 211.36/211.59 |- rdf__type mesh__D008035sskos__Concept
% 211.36/211.59 |- skos__hiddenLabel mesh__D008035 Lingual Frenums
% 211.36/211.59 |- mesh__historyNote mesh__D008035 65
% 211.36/211.59 |- mesh__publicMeSHNote mesh__D008035 65
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008035 2006
% 211.36/211.59 |- mesh__recordMaintainer mesh__D008035 lkt
% 211.36/211.59 |- skos__prefLabel mesh__D008035 Lingual Frenum
% 211.36/211.59 |- skos__broader mesh__D008035smesh__D014059
% 211.36/211.59 |- mesh__recordOriginator mesh__D008035 NLM
% 211.36/211.59 |- skos__altLabel mesh__D008035 Frenum, Lingual
% 211.36/211.59 |- mesh__dateCreated mesh__D008035 1999-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D008035 2005
% 211.36/211.59 |- mesh__dateRevised mesh__D008035 2003-07-09
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D008035 sjn
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 2006
% 211.36/211.59 |- mesh__recordOriginator mesh__D000052 NLM
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 2003
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 2005
% 211.36/211.59 |- skos__scopeNote mesh__D000052
% 211.36/211.59 A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.%A%
% 211.36/211.59 |- mesh__dateRevised mesh__D000052 1993-06-02
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 1997
% 211.36/211.59 |- mesh__dateCreated mesh__D000052 1999-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 1999
% 211.36/211.59 |- rdf__type mesh__D000052sskos__Concept
% 211.36/211.59 |- mesh__recordMaintainer mesh__D000052 TAP
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 1996
% 211.36/211.59 |- skos__prefLabel mesh__D000052 Acanthosis Nigricans
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 1995
% 211.36/211.59 |- skos__broader mesh__D000052smesh__D008548
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 1998
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 2002
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D000052 PLS
% 211.36/211.59 |- skos__annotation mesh__D000052 a type of melanosis
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 1994
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 2001
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 2004
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D000052 2000
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 1998
% 211.36/211.59 |- mesh__recordMaintainer mesh__D013778 JRT
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 2006
% 211.36/211.59 |- skos__broader mesh__D013778smesh__D013777
% 211.36/211.59 |- rdf__type mesh__D013778sskos__Concept
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 2002
% 211.36/211.59 |- mesh__recordAuthorizer mesh__D013778 PLS
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 1997
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 2005
% 211.36/211.59 |- mesh__dateCreated mesh__D013778 1999-01-01
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 2001
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 1996
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 2004
% 211.36/211.59 |- skos__prefLabel mesh__D013778 Tetrazolium Salts
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 2000
% 211.36/211.59 |- skos__hiddenLabel mesh__D013778 Salts, Tetrazolium
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 2003
% 211.36/211.59 |- skos__scopeNote mesh__D013778
% 211.36/211.59 Quaternary salts derived from tetrazoles. They are used in tests to distinguish between reducing sugars and simple aldehydes, for detection of dehydrogenase in tissues, cells, and bacteria, for determination of corticosteroids, and in color photography. %28%From Mall%27%s Dictionary of Chemistry, 5th ed, p455%29%%A%
% 211.36/211.59 |- skos__annotation mesh__D013778
% 211.36/211.59 indicators %26% reagents; D25-26 qualif
% 211.36/211.59 |- mesh__dateRevised mesh__D013778 1995-06-16
% 211.36/211.59 |- mesh__activeMeSHYear mesh__D013778 1999
% 211.36/211.59 |- mesh__recordOriginator mesh__D013778 NLM
% 211.36/211.60 |- skos__prefLabel mesh__D018463 Filtering Surgery
% 211.36/211.60 |- rdf__type mesh__D018463sskos__Concept
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D018463 2005
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D018463 2001
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D018463 2004
% 211.36/211.60 |- mesh__recordMaintainer mesh__D018463 PXP
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D018463 2000
% 211.36/211.60 |- mesh__recordOriginator mesh__D018463 TGC
% 211.36/211.60 |- skos__altLabel mesh__D018463 Surgery, Filtering
% 211.36/211.60 |- mesh__dateRevised mesh__D018463 1997-06-20
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D018463 SJN
% 211.36/211.60 |- skos__historyNote mesh__D018463 Glaucoma/surgery %28%1966-1994%29%
% 211.36/211.60 |- skos__scopeNote mesh__D018463
% 211.36/211.60 A surgical procedure used in treatment of glaucoma in which an opening is created through which aqueous fluid may pass from the anterior chamber into a sac created beneath the conjunctiva, thus lowering the pressure within the eye. %28%Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989%29%%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D018463 2003
% 211.36/211.60 |- mesh__dateEstablished mesh__D018463 1995-01-01
% 211.36/211.60 |- mesh__dateCreated mesh__D018463 1994-04-16
% 211.36/211.60 |- skos__altLabel mesh__D018463 Filtration Surgery
% 211.36/211.60 |- skos__altLabel mesh__D018463 Surgery, Filtration
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D018463 1999
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D018463 95
% 211.36/211.60 |- mesh__historyNote mesh__D018463 95
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D018463 2006
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D018463 1998
% 211.36/211.60 |- skos__broader mesh__D018463smesh__D013508
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D018463 2002
% 211.36/211.60 |- skos__related mesh__D018463smesh__D018465
% 211.36/211.60 |- skos__annotation mesh__D018463
% 211.36/211.60 in glaucoma surg; do not use /util except by MeSH definition; DF: FILTERING SURG%A%
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D010480
% 211.36/211.60 84; was see under PIPERIDINES 1975-83
% 211.36/211.60 |- mesh__dateCreated mesh__D010480 1999-01-01
% 211.36/211.60 |- skos__annotation mesh__D010480 a vasodilator calcium channel blocker
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 2000
% 211.36/211.60 |- mesh__dateEstablished mesh__D010480 1984-01-01
% 211.36/211.60 |- mesh__recordOriginator mesh__D010480 NLM
% 211.36/211.60 |- skos__altLabel mesh__D010480 Perhexilene
% 211.36/211.60 |- skos__historyNote mesh__D010480 Piperidines %28%1966-1974%29%
% 211.36/211.60 |- skos__broader mesh__D010480smesh__D010880
% 211.36/211.60 |- rdf__type mesh__D010480sskos__Concept
% 211.36/211.60 |- mesh__historyNote mesh__D010480
% 211.36/211.60 84%28%73%29%; was see under PIPERIDINES 1975-83, was Prov 1973-74%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 2004
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 1997
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 2002
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 2003
% 211.36/211.60 |- skos__prefLabel mesh__D010480 Perhexiline
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 1996
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D010480 PLS
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 2006
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 1999
% 211.36/211.60 |- skos__scopeNote mesh__D010480
% 211.36/211.60 2-%28%2,2-Dicyclohexylethyl%29%piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 2001
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 2005
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010480 1998
% 211.36/211.60 |- mesh__dateRevised mesh__D010480 1995-06-08
% 211.36/211.60 |- mesh__recordMaintainer mesh__D010480 JRT
% 211.36/211.60 |- skos__scopeNote mesh__D032134
% 211.36/211.60 A plant family of the order Piperales, subclass Magnoliidae class Magnoliopsida. Members contain sauristolactam, and aristololactam BII.%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D032134 2006
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D032134 2003
% 211.36/211.60 |- mesh__dateEstablished mesh__D032134 2003-01-01
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D032134 2005
% 211.36/211.60 |- skos__broader mesh__D032134smesh__D019684
% 211.36/211.60 |- rdf__type mesh__D032134sskos__Concept
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D032134 2004
% 211.36/211.60 |- mesh__dateCreated mesh__D032134 2002-07-03
% 211.36/211.60 |- skos__annotation mesh__D032134
% 211.36/211.60 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D032134 2003
% 211.36/211.60 |- skos__prefLabel mesh__D032134 Saururaceae
% 211.36/211.60 |- mesh__historyNote mesh__D032134 2003
% 211.36/211.60 |- skos__altLabel mesh__D051897 I-Smad Proteins
% 211.36/211.60 |- skos__broader mesh__D051897smesh__D051785
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D051897 2006
% 211.36/211.60 |- mesh__dateEstablished mesh__D051897 2006-01-01
% 211.36/211.60 |- skos__scopeNote mesh__D051897
% 211.36/211.60 A sub-family of smad proteins that inhibit cell signaling by RECEPTOR-REGULATED SMAD PROTEINS. They form autoinhibitory feedback loops in the TGF-BETA signaling pathway and mediate signaling cross-talk with other signaling pathways%A%
% 211.36/211.60 |- skos__prefLabel mesh__D051897 Smad Proteins, Inhibitory
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D051897 2006
% 211.36/211.60 |- rdf__type mesh__D051897sskos__Concept
% 211.36/211.60 |- mesh__recordOriginator mesh__D051897 DRC
% 211.36/211.60 |- mesh__historyNote mesh__D051897 2006
% 211.36/211.60 |- mesh__recordMaintainer mesh__D051897 DRC
% 211.36/211.60 |- skos__altLabel mesh__D051897 Inhibitory Smad Proteins
% 211.36/211.60 |- mesh__dateCreated mesh__D051897 2005-06-30
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D051897 sjn
% 211.36/211.60 |- mesh__recordMaintainer mesh__D004443 jls
% 211.36/211.60 |- skos__altLabel mesh__D004443 Hydatidosis
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D004443 2002
% 211.36/211.60 |- skos__hiddenLabel mesh__D004443 Hydatid Cysts
% 211.36/211.60 |- mesh__dateRevised mesh__D004443 1999-11-09
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D004443 2004
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D004443 2001
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D004443 2006
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D004443 2003
% 211.36/211.60 |- mesh__dateCreated mesh__D004443 1999-01-01
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D004443 2005
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D004443 2000
% 211.36/211.60 |- skos__prefLabel mesh__D004443 Echinococcosis
% 211.36/211.60 |- skos__scopeNote mesh__D004443
% 211.36/211.60 An infection caused by the infestation of the larval form of tapeworms of the genus Echinococcus. The liver, lungs, and kidney are the most common areas of infestation.%A%
% 211.36/211.60 |- skos__hiddenLabel mesh__D004443 Echinococcoses
% 211.36/211.60 |- skos__hiddenLabel mesh__D004443 Cyst, Hydatid
% 211.36/211.60 |- skos__hiddenLabel mesh__D004443 Hydatidoses
% 211.36/211.60 |- rdf__type mesh__D004443sskos__Concept
% 211.36/211.60 |- skos__altLabel mesh__D004443 Hydatid Cyst
% 211.36/211.60 |- skos__altLabel mesh__D004443 Cysts, Hydatid
% 211.36/211.60 |- skos__annotation mesh__D004443
% 211.36/211.60 of liver = ECHINOCOCCOSIS, HEPATIC, of lung = ECHINOCOCCOSIS, PULMONARY; Taenia echinococcus infect = Echinococcus granulosus infect = ECHINOCOCCOSIS%A%
% 211.36/211.60 |- skos__broader mesh__D004443smesh__D002590
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D004443 sjn
% 211.36/211.60 |- mesh__recordOriginator mesh__D004443 NLM
% 211.36/211.60 |- skos__historyNote mesh__D051099 Primates %28%1968-2005%29%
% 211.36/211.60 |- skos__prefLabel mesh__D051099 Tarsii
% 211.36/211.60 |- mesh__dateEstablished mesh__D051099 2006-01-01
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D051099 sjn
% 211.36/211.60 |- skos__altLabel mesh__D051099 Tarsiiformes
% 211.36/211.60 |- mesh__recordMaintainer mesh__D051099 ags
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D051099 2006
% 211.36/211.60 |- skos__scopeNote mesh__D051099
% 211.36/211.60 An infraorder %28%or suborder%29% of small PRIMATES comprised of a single family and genus.%A%
% 211.36/211.60 |- mesh__dateCreated mesh__D051099 2005-06-30
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D051099 2006
% 211.36/211.60 |- skos__annotation mesh__D051099
% 211.36/211.60 diseases: coordinate IM with PRIMATE DISEASES %28%IM%29%
% 211.36/211.60 |- skos__broader mesh__D051099smesh__D000882
% 211.36/211.60 |- mesh__historyNote mesh__D051099 2006
% 211.36/211.60 |- rdf__type mesh__D051099sskos__Concept
% 211.36/211.60 |- mesh__recordOriginator mesh__D051099 ags
% 211.36/211.60 |- mesh__recordMaintainer mesh__D014871 jls
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D014871 sjn
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014871 2005
% 211.36/211.60 |- mesh__recordOriginator mesh__D014871 NLM
% 211.36/211.60 |- skos__annotation mesh__D014871
% 211.36/211.60 IM; coord with specific bact, virus or fungus %28%IM%29%; DF: WATER MICROBIOL%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014871 2002
% 211.36/211.60 |- skos__prefLabel mesh__D014871 Water Microbiology
% 211.36/211.60 |- mesh__dateCreated mesh__D014871 1999-01-01
% 211.36/211.60 |- skos__broader mesh__D014871smesh__D004783
% 211.36/211.60 |- skos__altLabel mesh__D014871 Microbiology, Water
% 211.36/211.60 |- mesh__dateRevised mesh__D014871 2001-07-25
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014871 2004
% 211.36/211.60 |- rdf__type mesh__D014871sskos__Concept
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014871 2003
% 211.36/211.60 |- skos__scopeNote mesh__D014871
% 211.36/211.60 The presence of bacteria, viruses, and fungi in water. This term is not restricted to pathogenic organisms.%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014871 2006
% 211.36/211.60 |- mesh__dateCreated mesh__D014073 1999-01-01
% 211.36/211.60 |- skos__historyNote mesh__D014073 Root Canal Therapy %28%1966-1970%29%
% 211.36/211.60 |- skos__prefLabel mesh__D014073 Tooth Bleaching
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014073 2000
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014073 2005
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D014073 sjn
% 211.36/211.60 |- mesh__recordOriginator mesh__D014073 NLM
% 211.36/211.60 |- mesh__dateEstablished mesh__D014073 1972-01-01
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014073 2006
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D014073 72
% 211.36/211.60 |- skos__hiddenLabel mesh__D014073 Bleaching, Tooth
% 211.36/211.60 |- skos__scopeNote mesh__D014073
% 211.36/211.60 The use of a chemical oxidizing agent %28%sometimes in combination with heat%29% to lighten tooth discolorations. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p34%29%%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014073 2001
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014073 2003
% 211.36/211.60 |- mesh__recordMaintainer mesh__D014073 ags
% 211.36/211.60 |- skos__historyNote mesh__D014073
% 211.36/211.60 Tooth Discoloration/therapy %28%1966-1970%29%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014073 2004
% 211.36/211.60 |- mesh__historyNote mesh__D014073 72%28%71%29%
% 211.36/211.60 |- skos__broader mesh__D014073smesh__D004955
% 211.36/211.60 |- rdf__type mesh__D014073sskos__Concept
% 211.36/211.60 |- skos__annotation mesh__D014073 to lighten tooth discoloration
% 211.36/211.60 |- mesh__dateRevised mesh__D014073 1999-11-03
% 211.36/211.60 |- skos__hiddenLabel mesh__D014073 Tooth Bleachings
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D014073 2002
% 211.36/211.60 |- skos__historyNote mesh__D014073 Mottled Enamel/therapy %28%1966-1970%29%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 1999
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 1993
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D008834 PLS
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 2003
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 1996
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 1995
% 211.36/211.60 |- skos__prefLabel mesh__D008834 Microclimate
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 2005
% 211.36/211.60 |- skos__hiddenLabel mesh__D008834 Microclimates
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 1998
% 211.36/211.60 |- mesh__dateCreated mesh__D008834 1974-12-12
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 1992
% 211.36/211.60 |- mesh__recordOriginator mesh__D008834 NLM
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D008834 91; was see under CLIMATE 1975-90
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 2002
% 211.36/211.60 |- skos__broader mesh__D008834smesh__D002980
% 211.36/211.60 |- skos__annotation mesh__D008834
% 211.36/211.60 no qualif; refers to climate in a limited geog or environ area, as in a forest or factory%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 1994
% 211.36/211.60 |- mesh__dateRevised mesh__D008834 1990-04-13
% 211.36/211.60 |- rdf__type mesh__D008834sskos__Concept
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 1991
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 2001
% 211.36/211.60 |- skos__scopeNote mesh__D008834 The climate of a very small area.
% 211.36/211.60 |- mesh__recordMaintainer mesh__D008834 NLM
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 2000
% 211.36/211.60 |- mesh__dateEstablished mesh__D008834 1991-01-01
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 2004
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 1997
% 211.36/211.60 |- mesh__historyNote mesh__D008834
% 211.36/211.60 91%28%75%29%; was see under CLIMATE 1975-90
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008834 2006
% 211.36/211.60 |- skos__annotation mesh__D000851 no qualif; DF: ANONYMS
% 211.36/211.60 |- mesh__dateRevised mesh__D000851 1995-03-13
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D000851 PLS
% 211.36/211.60 |- mesh__recordMaintainer mesh__D000851 TGC
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 2004
% 211.36/211.60 |- mesh__recordOriginator mesh__D000851 NLM
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 2005
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 2003
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 1999
% 211.36/211.60 |- skos__broader mesh__D000851smesh__D009275
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 2002
% 211.36/211.60 |- skos__hiddenLabel mesh__D000851 Pseudonym
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 1997
% 211.36/211.60 |- skos__scopeNote mesh__D000851
% 211.36/211.60 Designations for persons whose names are not known or who wish to remain anonymous %28%anonyms%29% and for persons who wish to conceal or obscure their identity by assuming a fictitious name %28%pseudonyms%29%.%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 1998
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 1996
% 211.36/211.60 |- skos__altLabel mesh__D000851 Pseudonyms and Anonyms
% 211.36/211.60 |- mesh__dateCreated mesh__D000851 1999-01-01
% 211.36/211.60 |- rdf__type mesh__D000851sskos__Concept
% 211.36/211.60 |- skos__hiddenLabel mesh__D000851 Anonym
% 211.36/211.60 |- skos__prefLabel mesh__D000851 Anonyms and Pseudonyms
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 2001
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 2006
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000851 2000
% 211.36/211.60 |- skos__historyNote mesh__D008036 Mandibular Nerve %28%1966-1970%29%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008036 2000
% 211.36/211.60 |- mesh__recordOriginator mesh__D008036 NLM
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008036 2006
% 211.36/211.60 |- mesh__dateEstablished mesh__D008036 1991-01-01
% 211.36/211.60 |- skos__prefLabel mesh__D008036 Lingual Nerve
% 211.36/211.60 |- mesh__dateCreated mesh__D008036 1999-01-01
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008036 2005
% 211.36/211.60 |- mesh__recordMaintainer mesh__D008036 MSR
% 211.36/211.60 |- skos__hiddenLabel mesh__D008036 Nerves, Lingual
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008036 2002
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D008036 SJN
% 211.36/211.60 |- skos__scopeNote mesh__D008036
% 211.36/211.60 A sensory branch of the MANDIBULAR NERVE, which is part of the trigeminal %28%5th cranial%29% nerve. The lingual nerve carries general afferent fibers from the anterior two-thirds of the tongue, the floor of the mouth, and the mandibular gingivae.%A%
% 211.36/211.60 |- skos__hiddenLabel mesh__D008036 Nerve, Lingual
% 211.36/211.60 |- skos__broader mesh__D008036smesh__D008340
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008036 2004
% 211.36/211.60 |- mesh__dateRevised mesh__D008036 1998-06-10
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D008036
% 211.36/211.60 91; was see under MANDIBULAR NERVE 1971-90
% 211.36/211.60 |- rdf__type mesh__D008036sskos__Concept
% 211.36/211.60 |- skos__annotation mesh__D008036
% 211.36/211.60 a branch of the trigeminal %28%5th cranial%29% nerve; dis: coord IM with CRANIAL NERVE DISEASES %28%IM%29%; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 211.36/211.60 |- mesh__historyNote mesh__D008036
% 211.36/211.60 91%28%71%29%; was see under MANDIBULAR NERVE 1971-90
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008036 2001
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008036 1999
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D008036 2003
% 211.36/211.60 |- skos__hiddenLabel mesh__D008036 Lingual Nerves
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D000053 sjn
% 211.36/211.60 |- skos__annotation mesh__D000053
% 211.36/211.60 acaricides: index under INSECTICIDES even though Acari are not insects%A%
% 211.36/211.60 |- skos__scopeNote mesh__D000053
% 211.36/211.60 A large, subclass of arachnids comprising the MITES and TICKS, including parasites of plants, animals, and humans, as well as several important disease vectors.%A%
% 211.36/211.60 |- mesh__dateCreated mesh__D000053 1999-01-01
% 211.36/211.60 |- mesh__dateRevised mesh__D000053 2003-07-09
% 211.36/211.60 |- rdf__type mesh__D000053sskos__Concept
% 211.36/211.60 |- mesh__recordOriginator mesh__D000053 NLM
% 211.36/211.60 |- mesh__historyNote mesh__D000053 75
% 211.36/211.60 |- skos__broader mesh__D000053smesh__D001097
% 211.36/211.60 |- mesh__dateEstablished mesh__D000053 1975-01-01
% 211.36/211.60 |- skos__historyNote mesh__D000053 Arachnida %28%1966-1974%29%
% 211.36/211.60 |- skos__prefLabel mesh__D000053 Acari
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D000053 75
% 211.36/211.60 |- mesh__recordMaintainer mesh__D000053 ags
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000053 2004
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000053 2006
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D000053 2005
% 211.36/211.60 |- skos__altLabel mesh__D013779 Tarichatoxin
% 211.36/211.60 |- skos__broader mesh__D013779smesh__D008387
% 211.36/211.60 |- skos__altLabel mesh__D013779 Tetradotoxin
% 211.36/211.60 |- skos__altLabel mesh__D013779 Fugu Toxin
% 211.36/211.60 |- mesh__dateRevised mesh__D013779 2005-06-30
% 211.36/211.60 |- mesh__dateEstablished mesh__D013779 1968-01-01
% 211.36/211.60 |- mesh__recordOriginator mesh__D013779 NLM
% 211.36/211.60 |- skos__broader mesh__D013779smesh__D011799
% 211.36/211.60 |- mesh__recordMaintainer mesh__D013779 ssb
% 211.36/211.60 |- skos__hiddenLabel mesh__D013779 Toxin, Fugu
% 211.36/211.60 |- mesh__recordAuthorizer mesh__D013779 sjn
% 211.36/211.60 |- skos__prefLabel mesh__D013779 Tetrodotoxin
% 211.36/211.60 |- mesh__historyNote mesh__D013779 68%28%64%29%
% 211.36/211.60 |- skos__scopeNote mesh__D013779
% 211.36/211.60 An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction.%A%
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D013779 2006
% 211.36/211.60 |- skos__annotation mesh__D013779
% 211.36/211.60 /antag permitted but consider also ANTITOXINS
% 211.36/211.60 |- rdf__type mesh__D013779sskos__Concept
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D013779 68
% 211.36/211.60 |- mesh__dateCreated mesh__D013779 1999-01-01
% 211.36/211.60 |- skos__historyNote mesh__D010481 Anus %28%1966-1967%29%
% 211.36/211.60 |- mesh__recordMaintainer mesh__D010481 TGC
% 211.36/211.60 |- mesh__dateRevised mesh__D010481 1991-01-08
% 211.36/211.60 |- skos__broader mesh__D010481smesh__D000825
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010481 2003
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010481 2000
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010481 1996
% 211.36/211.60 |- mesh__publicMeSHNote mesh__D010481 68
% 211.36/211.60 |- mesh__dateEstablished mesh__D010481 1968-01-01
% 211.36/211.60 |- skos__prefLabel mesh__D010481 Perianal Glands
% 211.36/211.60 |- skos__hiddenLabel mesh__D010481 Glands, Perianal
% 211.36/211.60 |- skos__altLabel mesh__D010481 Circumanal Glands
% 211.36/211.60 |- mesh__activeMeSHYear mesh__D010481 2001
% 211.36/211.60 |- rdf__type mesh__D010481sskos__Concept
% 211.36/211.60 |- skos__hiddenLabel mesh__D010481 Gland, Circumanal
% 211.46/211.60 |- skos__hiddenLabel mesh__D010481 Circumanal Gland
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 1992
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 2004
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 1997
% 211.46/211.60 |- skos__annotation mesh__D010481 animal only
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 2002
% 211.46/211.60 |- skos__hiddenLabel mesh__D010481 Perianal Gland
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 2005
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 1998
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 1993
% 211.46/211.60 |- skos__hiddenLabel mesh__D010481 Gland, Perianal
% 211.46/211.60 |- mesh__recordOriginator mesh__D010481 NLM
% 211.46/211.60 |- mesh__recordAuthorizer mesh__D010481 PLS
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 1994
% 211.46/211.60 |- mesh__dateCreated mesh__D010481 1999-01-01
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 2006
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 1999
% 211.46/211.60 |- skos__hiddenLabel mesh__D010481 Glands, Circumanal
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D010481 1995
% 211.46/211.60 |- mesh__historyNote mesh__D010481 68
% 211.46/211.60 |- mesh__historyNote mesh__D032135 2003
% 211.46/211.60 |- skos__broader mesh__D032135smesh__D029633
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D032135 2006
% 211.46/211.60 |- mesh__publicMeSHNote mesh__D032135 2003
% 211.46/211.60 |- mesh__dateEstablished mesh__D032135 2003-01-01
% 211.46/211.60 |- rdf__type mesh__D032135sskos__Concept
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D032135 2005
% 211.46/211.60 |- skos__prefLabel mesh__D032135 Kadsura
% 211.46/211.60 |- skos__scopeNote mesh__D032135
% 211.46/211.60 A plant genus of the family SCHISANDRACEAE that is used in folk medicine much like SCHISANDRA. Members contain kadsurenone and kadsurin.%A%
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D032135 2004
% 211.46/211.60 |- mesh__dateCreated mesh__D032135 2002-07-03
% 211.46/211.60 |- skos__annotation mesh__D032135
% 211.46/211.60 coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D032135 2003
% 211.46/211.60 |- skos__scopeNote mesh__D051898
% 211.46/211.60 A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and plays an essential role in EMBRYONIC DEVELOPMENT.%A%
% 211.46/211.60 |- mesh__historyNote mesh__D051898 2006
% 211.46/211.60 |- mesh__dateEstablished mesh__D051898 2006-01-01
% 211.46/211.60 |- mesh__publicMeSHNote mesh__D051898 2006
% 211.46/211.60 |- mesh__recordOriginator mesh__D051898 DRC
% 211.46/211.60 |- mesh__dateCreated mesh__D051898 2005-06-30
% 211.46/211.60 |- skos__prefLabel mesh__D051898 Smad1 Protein
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D051898 2006
% 211.46/211.60 |- mesh__recordMaintainer mesh__D051898 ags
% 211.46/211.60 |- rdf__type mesh__D051898sskos__Concept
% 211.46/211.60 |- skos__broader mesh__D051898smesh__D051896
% 211.46/211.60 |- mesh__recordAuthorizer mesh__D051898 ags
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D051898 2006A
% 211.46/211.60 |- mesh__dateRevised mesh__D051898 2005-07-08
% 211.46/211.60 |- mesh__dateCreated mesh__D004444 1999-01-01
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hepatic Hydatid Cyst
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D004444 2005
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Echinococcis, Hepatic Alveolar
% 211.46/211.60 |- mesh__recordMaintainer mesh__D004444 lkt
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Echinococcoses, Hepatic Alveolar
% 211.46/211.60 |- skos__prefLabel mesh__D004444 Echinococcosis, Hepatic
% 211.46/211.60 |- skos__broader mesh__D004444smesh__D008109
% 211.46/211.60 |- rdf__type mesh__D004444sskos__Concept
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Alveolar Echinococcosis, Hepatic
% 211.46/211.60 |- mesh__recordAuthorizer mesh__D004444 sjn
% 211.46/211.60 |- skos__altLabel mesh__D004444 Hydatid Cyst, Hepatic
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Echinococcoses, Hepatic
% 211.46/211.60 |- mesh__recordOriginator mesh__D004444 NLM
% 211.46/211.60 |- skos__scopeNote mesh__D004444
% 211.46/211.60 Liver disease caused by infections with parasitic tapeworms of the genus ECHINOCOCCUS, such as Echinococcus granulosus or Echinococcus multilocularis. Ingested Echinococcus ova burrow into the intestinal mucosa. The larval migration to the liver via the PORTAL VEIN leads to watery vesicles %28%HYDATID CYST%29%.%A%
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Alveolar Echinococcoses, Hepatic
% 211.46/211.60 |- skos__altLabel mesh__D004444 Alveolar Echinococcis, Hepatic
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hepatic Alveolar Echinococcis
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Cysts, Hepatic Hydatid
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hepatic Echinococcoses
% 211.46/211.60 |- skos__altLabel mesh__D004444 Hydatidosis, Hepatic
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hepatic Hydatidosis
% 211.46/211.60 |- mesh__dateRevised mesh__D004444 2004-07-07
% 211.46/211.60 |- skos__altLabel mesh__D004444 Echinococcosis, Hepatic Alveolar
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hydatidoses, Hepatic
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D004444 2006
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hydatid Cysts, Hepatic
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hepatic Echinococcosis
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hepatic Hydatidoses
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Cyst, Hepatic Hydatid
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hepatic Alveolar Echinococcoses
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hepatic Hydatid Cysts
% 211.46/211.60 |- skos__hiddenLabel mesh__D004444 Hepatic Alveolar Echinococcosis
% 211.46/211.60 |- skos__broader mesh__D004444smesh__D004443
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D014872 2000
% 211.46/211.60 |- mesh__recordMaintainer mesh__D014872 TGC
% 211.46/211.60 |- skos__historyNote mesh__D014872 Oceanography %28%1966-1971%29%
% 211.46/211.60 |- mesh__dateCreated mesh__D014872 1999-01-01
% 211.46/211.60 |- skos__prefLabel mesh__D014872 Water Movements
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D014872 1997
% 211.46/211.60 |- mesh__publicMeSHNote mesh__D014872 74
% 211.46/211.60 |- skos__historyNote mesh__D014872 Water %28%1966-1971%29%
% 211.46/211.60 |- skos__annotation mesh__D014872
% 211.46/211.60 no qualif; for waves, currents, tides; floods = NATURAL DISASTERS%A%
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D014872 2004
% 211.46/211.60 |- mesh__dateRevised mesh__D014872 1989-05-16
% 211.46/211.60 |- rdf__type mesh__D014872sskos__Concept
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D014872 2002
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D014872 1993
% 211.46/211.60 |- mesh__recordOriginator mesh__D014872 NLM
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D014872 1991
% 211.46/211.60 |- mesh__activeMeSHYear mesh__D014872 1996
% 211.46/211.60 |- skos__broader mesh__D014872smesh__D014867
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 2003
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 1999
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 1992
% 211.46/211.61 |- skos__hiddenLabel mesh__D014872 Movements, Water
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 2006
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 1995
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 1998
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 2001
% 211.46/211.61 |- skos__hiddenLabel mesh__D014872 Water Movement
% 211.46/211.61 |- skos__hiddenLabel mesh__D014872 Movement, Water
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 2005
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 1990
% 211.46/211.61 |- mesh__dateEstablished mesh__D014872 1974-01-01
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D014872 PLS
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014872 1994
% 211.46/211.61 |- mesh__historyNote mesh__D014872 74%28%72%29%
% 211.46/211.61 |- skos__altLabel mesh__D014074 Calcification, Tooth
% 211.46/211.61 |- skos__altLabel mesh__D014074 Teeth Calcification
% 211.46/211.61 |- skos__hiddenLabel mesh__D014074 Calcifications, Teeth
% 211.46/211.61 |- mesh__recordMaintainer mesh__D014074 TGC
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 2005
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 2002
% 211.46/211.61 |- skos__scopeNote mesh__D014074
% 211.46/211.61 The process whereby calcium salts are deposited in the dental enamel. The process is normal in the development of bones and teeth. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p43%29%%A%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 2006
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 1998
% 211.46/211.61 |- skos__annotation mesh__D014074
% 211.46/211.61 the physiol process; hypocalcification is probably indexed under AMELOGENESIS IMPERFECTA or DENTAL ENAMEL HYPOPLASIA%A%
% 211.46/211.61 |- skos__hiddenLabel mesh__D014074 Teeth Calcifications
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 2003
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 1999
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 2000
% 211.46/211.61 |- skos__broader mesh__D014074smesh__D009063
% 211.46/211.61 |- skos__hiddenLabel mesh__D014074 Calcifications, Tooth
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 2004
% 211.46/211.61 |- mesh__recordOriginator mesh__D014074 NLM
% 211.46/211.61 |- mesh__dateRevised mesh__D014074 1996-06-10
% 211.46/211.61 |- mesh__publicMeSHNote mesh__D014074 65
% 211.46/211.61 |- skos__hiddenLabel mesh__D014074 Calcification, Teeth
% 211.46/211.61 |- skos__prefLabel mesh__D014074 Tooth Calcification
% 211.46/211.61 |- skos__hiddenLabel mesh__D014074 Tooth Calcifications
% 211.46/211.61 |- mesh__historyNote mesh__D014074 65
% 211.46/211.61 |- rdf__type mesh__D014074sskos__Concept
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 2001
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D014074 PLS
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014074 1997
% 211.46/211.61 |- mesh__dateCreated mesh__D014074 1999-01-01
% 211.46/211.61 |- mesh__dateEstablished mesh__D014074 1965-01-01
% 211.46/211.61 |- skos__broader mesh__D014074smesh__D002113
% 211.46/211.61 |- skos__prefLabel mesh__D008835 Micrococcaceae
% 211.46/211.61 |- skos__broader mesh__D008835smesh__D000192
% 211.46/211.61 |- mesh__dateCreated mesh__D008835 1999-01-01
% 211.46/211.61 |- mesh__historyNote mesh__D008835 75
% 211.46/211.61 |- mesh__dateRevised mesh__D008835 2005-06-30
% 211.46/211.61 |- rdf__type mesh__D008835sskos__Concept
% 211.46/211.61 |- skos__historyNote mesh__D008835 Bacteria %28%1966-1974%29%
% 211.46/211.61 |- mesh__publicMeSHNote mesh__D008835 75
% 211.46/211.61 |- mesh__recordOriginator mesh__D008835 NLM
% 211.46/211.61 |- skos__scopeNote mesh__D008835
% 211.46/211.61 A family of bacteria ranging from free living and saprophytic to parasitic and pathogenic forms.%A%
% 211.46/211.61 |- mesh__recordMaintainer mesh__D008835 SYSTEM
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D008835 sjn
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008835 2006
% 211.46/211.61 |- skos__broader mesh__D008835smesh__D006095
% 211.46/211.61 |- mesh__dateEstablished mesh__D008835 1975-01-01
% 211.46/211.61 |- mesh__dateRevised mesh__D000852 2003-07-09
% 211.46/211.61 |- skos__prefLabel mesh__D000852 Anopheles
% 211.46/211.61 |- skos__annotation mesh__D000852
% 211.46/211.61 mosquito; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%
% 211.46/211.61 |- mesh__recordMaintainer mesh__D000852 ags
% 211.46/211.61 |- mesh__recordOriginator mesh__D000852 NLM
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D000852 sjn
% 211.46/211.61 |- mesh__dateCreated mesh__D000852 1999-01-01
% 211.46/211.61 |- rdf__type mesh__D000852sskos__Concept
% 211.46/211.61 |- skos__scopeNote mesh__D000852
% 211.46/211.61 A genus of mosquitoes %28%CULICIDAE%29% that are known vectors of MALARIA.%A%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000852 2006
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000852 2004
% 211.46/211.61 |- skos__broader mesh__D000852smesh__D009033
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000852 2005
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 2001
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 2005
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D008037 PLS
% 211.46/211.61 |- mesh__dateRevised mesh__D008037 1995-05-18
% 211.46/211.61 |- mesh__dateCreated mesh__D008037 1999-01-01
% 211.46/211.61 |- mesh__recordOriginator mesh__D008037 NLM
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 2000
% 211.46/211.61 |- mesh__dateEstablished mesh__D008037 1967-01-01
% 211.46/211.61 |- mesh__recordMaintainer mesh__D008037 TGC
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 1997
% 211.46/211.61 |- mesh__historyNote mesh__D008037 67%28%65%29%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 1996
% 211.46/211.61 |- skos__hiddenLabel mesh__D008037 Linguistic
% 211.46/211.61 |- skos__broader mesh__D008037smesh__D007802
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 2004
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 2002
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 1999
% 211.46/211.61 |- rdf__type mesh__D008037sskos__Concept
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 2003
% 211.46/211.61 |- skos__annotation mesh__D008037
% 211.46/211.61 = science of LANGUAGE %26% SPEECH; do not confuse with LANGUAGE %28%what is spoken%29%, SEMANTICS %28%hist or psychol study of language %26% meaning changes%29%, NOMENCLATURE %28%names of things %26% etymology, the origin or words%29%, PHONETICS %28%how words are sounded%29%, LITERATURE %28%literary works%29%, PHILOLOGY %28%study of literature or language as used in literature%29% or VOCABULARY %28%a person%27%s stock of words%29%; grammar, syntax, accent go here; SPEC: SPEC qualif%A%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 1998
% 211.46/211.61 |- skos__scopeNote mesh__D008037
% 211.46/211.61 The science of language, including phonetics, phonology, morphology, syntax, semantics, pragmatics, and historical linguistics. %28%Random House Unabridged Dictionary, 2d ed%29%%A%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008037 2006
% 211.46/211.61 |- skos__prefLabel mesh__D008037 Linguistics
% 211.46/211.61 |- mesh__publicMeSHNote mesh__D008037 67
% 211.46/211.61 |- mesh__recordMaintainer mesh__D000054 TAP
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 1997
% 211.46/211.61 |- skos__hiddenLabel mesh__D000054 Accelerations
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 1994
% 211.46/211.61 |- rdf__type mesh__D000054sskos__Concept
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 1999
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 2000
% 211.46/211.61 |- skos__annotation mesh__D000054 IM
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 1993
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 1995
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 2001
% 211.46/211.61 |- mesh__dateRevised mesh__D000054 1992-03-25
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 2003
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 2005
% 211.46/211.61 |- mesh__recordOriginator mesh__D000054 NLM
% 211.46/211.61 |- skos__prefLabel mesh__D000054 Acceleration
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 2004
% 211.46/211.61 |- mesh__dateCreated mesh__D000054 1999-01-01
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 2002
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 2006
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D000054 PLS
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 1996
% 211.46/211.61 |- skos__broader mesh__D000054smesh__D009038
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000054 1998
% 211.46/211.61 |- skos__broader mesh__D004798Q000097smesh__D004798
% 211.46/211.61 |- rdf__type mesh__D004798Q000097smesh__CompoundConcept
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D018465 2004
% 211.46/211.61 |- skos__altLabel mesh__D018465 Molteno Shunts
% 211.46/211.61 |- skos__historyNote mesh__D018465 Implants, Artificial %28%1980-1994%29%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D018465 2002
% 211.46/211.61 |- mesh__dateEstablished mesh__D018465 1995-01-01
% 211.46/211.61 |- mesh__publicMeSHNote mesh__D018465 95
% 211.46/211.61 |- skos__altLabel mesh__D018465 Implants, Molteno
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D018465 2005
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D018465 1999
% 211.46/211.61 |- skos__historyNote mesh__D018465 Glaucoma/surgery %28%1980-1994%29%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D018465 2000
% 211.46/211.61 |- mesh__historyNote mesh__D018465 95
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D018465 SJN
% 211.46/211.61 |- mesh__recordMaintainer mesh__D018465 NDW
% 211.46/211.61 |- skos__hiddenLabel mesh__D018465 Shunts, Molteno
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D018465 2006
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D018465 2001
% 211.46/211.61 |- mesh__dateRevised mesh__D018465 1998-06-10
% 211.46/211.61 |- skos__prefLabel mesh__D018465 Molteno Implants
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D018465 2003
% 211.46/211.61 |- mesh__dateCreated mesh__D018465 1994-04-16
% 211.46/211.61 |- skos__broader mesh__D018465smesh__D020327
% 211.46/211.61 |- rdf__type mesh__D018465sskos__Concept
% 211.46/211.61 |- mesh__recordOriginator mesh__D018465 TGC
% 211.46/211.61 |- skos__scopeNote mesh__D018465
% 211.46/211.61 Devices implanted to control intraocular pressure by allowing aqueous fluid to drain from the anterior chamber. %28%Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989%29%%A%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 2002
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Periapical Abscesses
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Abscess, Apical Alveolar
% 211.46/211.61 |- skos__altLabel mesh__D010482 Alveolar Abscess, Apical
% 211.46/211.61 |- mesh__recordOriginator mesh__D010482 NLM
% 211.46/211.61 |- rdf__type mesh__D010482sskos__Concept
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 1999
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Apical Alveolar Abscess
% 211.46/211.61 |- skos__annotation mesh__D010482
% 211.46/211.61 do not confuse with PERIODONTAL ABSCESS: note X refs below; for coord read note on ABSCESS%A%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 2006
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 2001
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Abscesses, Periapical
% 211.46/211.61 |- skos__prefLabel mesh__D010482 Periapical Abscess
% 211.46/211.61 |- mesh__dateEstablished mesh__D010482 1965-01-01
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Apical Dentoalveolar Abscess
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Dentoalveolar Abscesses, Apical
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D010482 PLS
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Apical Alveolar Abscesses
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 1998
% 211.46/211.61 |- skos__altLabel mesh__D010482 Dentoalveolar Abscess, Apical
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 2005
% 211.46/211.61 |- skos__altLabel mesh__D010482 Abscess, Periapical
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 2000
% 211.46/211.61 |- mesh__publicMeSHNote mesh__D010482 65
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Periodontitis, Suppurative Periapical
% 211.46/211.61 |- skos__altLabel mesh__D010482 Periapical Periodontitis, Suppurative
% 211.46/211.61 |- skos__broader mesh__D010482smesh__D000038
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Periodontitides, Suppurative Periapical
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Abscesses, Apical Dentoalveolar
% 211.46/211.61 |- skos__scopeNote mesh__D010482
% 211.46/211.61 Acute or chronic inflammation of tissues surrounding the apical portion of a tooth, associated with the collection of pus, resulting from infection following pulp infection through a carious lesion or as a result of an injury causing pulp necrosis. %28%Dorland, 27th ed%29%%A%
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Abscesses, Apical Alveolar
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 1997
% 211.46/211.61 |- mesh__historyNote mesh__D010482 65
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 2004
% 211.46/211.61 |- skos__broader mesh__D010482smesh__D010485
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Abscess, Apical Dentoalveolar
% 211.46/211.61 |- mesh__dateRevised mesh__D010482 1994-05-27
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Suppurative Periapical Periodontitides
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Apical Dentoalveolar Abscesses
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Suppurative Periapical Periodontitis
% 211.46/211.61 |- mesh__dateCreated mesh__D010482 1999-01-01
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 1996
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 2003
% 211.46/211.61 |- skos__altLabel mesh__D010482 Periodontitis, Apical, Suppurative
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Alveolar Abscesses, Apical
% 211.46/211.61 |- skos__hiddenLabel mesh__D010482 Periapical Periodontitides, Suppurative
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D010482 1995
% 211.46/211.61 |- mesh__recordMaintainer mesh__D010482 PLS
% 211.46/211.61 |- skos__altLabel mesh__D051899 MADR2 Protein
% 211.46/211.61 |- skos__hiddenLabel mesh__D051899 MAD Related 2 Protein
% 211.46/211.61 |- mesh__dateEstablished mesh__D051899 2006-01-01
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D051899 2006
% 211.46/211.61 |- mesh__recordMaintainer mesh__D051899 ags
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D051899 ags
% 211.46/211.61 |- rdf__type mesh__D051899sskos__Concept
% 211.46/211.61 |- mesh__dateCreated mesh__D051899 2005-06-30
% 211.46/211.61 |- mesh__dateRevised mesh__D051899 2005-08-03
% 211.46/211.61 |- skos__prefLabel mesh__D051899 Smad2 Protein
% 211.46/211.61 |- skos__scopeNote mesh__D051899
% 211.46/211.61 A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. It regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.%A%
% 211.46/211.61 |- mesh__historyNote mesh__D051899 2006%28%1996%29%
% 211.46/211.61 |- skos__broader mesh__D051899smesh__D051896
% 211.46/211.61 |- mesh__publicMeSHNote mesh__D051899
% 211.46/211.61 2006; SMAD2 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1996-2005%A%
% 211.46/211.61 |- skos__altLabel mesh__D051899 MAD-Related 2 Protein
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D051899 2006A
% 211.46/211.61 |- mesh__recordOriginator mesh__D051899 DRC
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D004445 2000
% 211.46/211.61 |- skos__altLabel mesh__D004445 Pulmonary Echinococcosis
% 211.46/211.61 |- skos__broader mesh__D004445smesh__D008174
% 211.46/211.61 |- rdf__type mesh__D004445sskos__Concept
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D004445 1999
% 211.46/211.61 |- skos__altLabel mesh__D004445 Pulmonary Hydatid Cyst
% 211.46/211.61 |- skos__altLabel mesh__D004445 Cyst, Pulmonary Hydatid
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D004445 SJN
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D004445 1998
% 211.46/211.61 |- skos__prefLabel mesh__D004445 Echinococcosis, Pulmonary
% 211.46/211.61 |- skos__altLabel mesh__D004445 Cysts, Pulmonary Hydatid
% 211.46/211.61 |- skos__altLabel mesh__D004445 Hydatid Cyst, Pulmonary
% 211.46/211.61 |- mesh__recordMaintainer mesh__D004445 TPW
% 211.46/211.61 |- skos__altLabel mesh__D004445 Pulmonary Echinococcoses
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D004445 2004
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D004445 2002
% 211.46/211.61 |- mesh__recordOriginator mesh__D004445 NLM
% 211.46/211.61 |- skos__altLabel mesh__D004445 Pulmonary Hydatidosis
% 211.46/211.61 |- mesh__dateRevised mesh__D004445 1997-06-20
% 211.46/211.61 |- skos__altLabel mesh__D004445 Hydatidoses, Pulmonary
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D004445 2006
% 211.46/211.61 |- skos__altLabel mesh__D004445 Pulmonary Hydatid Cysts
% 211.46/211.61 |- skos__altLabel mesh__D004445 Hydatid Cysts, Pulmonary
% 211.46/211.61 |- skos__altLabel mesh__D004445 Echinococcoses, Pulmonary
% 211.46/211.61 |- skos__broader mesh__D004445smesh__D004443
% 211.46/211.61 |- skos__scopeNote mesh__D004445
% 211.46/211.61 Helminth infection of the lung caused by Echinococcus granulosus or Echinococcus multilocularis.%A%
% 211.46/211.61 |- skos__annotation mesh__D004445
% 211.46/211.61 tapeworm infect of the lung; DF: ECHINOCOCCOSIS PULM
% 211.46/211.61 |- skos__altLabel mesh__D004445 Hydatidosis, Pulmonary
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D004445 2003
% 211.46/211.61 |- skos__altLabel mesh__D004445 Pulmonary Hydatidoses
% 211.46/211.61 |- mesh__dateCreated mesh__D004445 1999-01-01
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D004445 2001
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D004445 2005
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D009130 2004
% 211.46/211.61 |- mesh__recordOriginator mesh__D009130 NLM
% 211.46/211.61 |- skos__hiddenLabel mesh__D009130 Muscles, Involuntary
% 211.46/211.61 |- skos__scopeNote mesh__D009130
% 211.46/211.61 Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. %28%From Stedman, 25th ed%29%%A%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D009130 2002
% 211.46/211.61 |- skos__hiddenLabel mesh__D009130 Muscles, Smooth
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D009130 2003
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D009130 sjn
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D009130 2006
% 211.46/211.61 |- skos__hiddenLabel mesh__D009130 Smooth Muscle
% 211.46/211.61 |- skos__altLabel mesh__D009130 Muscle, Involuntary
% 211.46/211.61 |- skos__hiddenLabel mesh__D009130 Involuntary Muscles
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D009130 2005
% 211.46/211.61 |- mesh__dateRevised mesh__D009130 2001-07-25
% 211.46/211.61 |- skos__hiddenLabel mesh__D009130 Smooth Muscles
% 211.46/211.61 |- skos__broader mesh__D009130smesh__D009132
% 211.46/211.61 |- mesh__dateCreated mesh__D009130 1999-01-01
% 211.46/211.61 |- skos__prefLabel mesh__D009130 Muscle, Smooth
% 211.46/211.61 |- skos__annotation mesh__D009130
% 211.46/211.61 coord IM with specific organ %28%NIM %26% then only if pertinent%29%; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%
% 211.46/211.61 |- mesh__recordMaintainer mesh__D009130 nns
% 211.46/211.61 |- skos__hiddenLabel mesh__D009130 Involuntary Muscle
% 211.46/211.61 |- rdf__type mesh__D009130sskos__Concept
% 211.46/211.61 |- skos__hiddenLabel mesh__D014873 Pollutants, Water
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014873 2004
% 211.46/211.61 |- rdf__type mesh__D014873sskos__Concept
% 211.46/211.61 |- mesh__publicMeSHNote mesh__D014873 75
% 211.46/211.61 |- mesh__dateRevised mesh__D014873 2003-07-09
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014873 2005
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D014873 sjn
% 211.46/211.61 |- skos__broader mesh__D014873smesh__D004785
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014873 2006
% 211.46/211.61 |- mesh__recordMaintainer mesh__D014873 ssb
% 211.46/211.61 |- mesh__dateCreated mesh__D014873 1999-01-01
% 211.46/211.61 |- skos__historyNote mesh__D014873 Water Pollution %28%1966-1974%29%
% 211.46/211.61 |- mesh__historyNote mesh__D014873 75
% 211.46/211.61 |- mesh__recordOriginator mesh__D014873 NLM
% 211.46/211.61 |- skos__scopeNote mesh__D014873
% 211.46/211.61 Substances which pollute the water or bodies of water. Use for water pollutants in general or for which there is no specific heading.%A%
% 211.46/211.61 |- mesh__dateEstablished mesh__D014873 1975-09-01
% 211.46/211.61 |- skos__prefLabel mesh__D014873 Water Pollutants
% 211.46/211.61 |- skos__annotation mesh__D014873
% 211.46/211.61 specify pollutant if pertinent %28%IM or NIM%29%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 2003
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 1999
% 211.46/211.61 |- mesh__dateEstablished mesh__D014075 1965-01-01
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 2001
% 211.46/211.61 |- skos__related mesh__D014075smesh__D019243
% 211.46/211.61 |- skos__hiddenLabel mesh__D014075 Discolorations, Tooth
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 2004
% 211.46/211.61 |- mesh__recordMaintainer mesh__D014075 ags
% 211.46/211.61 |- mesh__historyNote mesh__D014075 65
% 211.46/211.61 |- rdf__type mesh__D014075sskos__Concept
% 211.46/211.61 |- mesh__dateRevised mesh__D014075 2005-07-14
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 1997
% 211.46/211.61 |- mesh__dateCreated mesh__D014075 1999-01-01
% 211.46/211.61 |- skos__prefLabel mesh__D014075 Tooth Discoloration
% 211.46/211.61 |- skos__scopeNote mesh__D014075
% 211.46/211.61 Any change in the hue, color, or translucency of a tooth due to any cause. Restorative filling materials, drugs %28%both topical and systemic%29%, pulpal necrosis, or hemorrhage may be responsible. %28%Jablonski, Dictionary of Dentistry, 1992, p253%29%%A%
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 2002
% 211.46/211.61 |- skos__annotation mesh__D014075
% 211.46/211.61 external staining or staining within pulp; from any cause; coord IM with cause if pertinent %28%IM or NIM%29%; do not confuse with FLUOROSIS, DENTAL %28%occurring during tooth calcification%29%%A%
% 211.46/211.61 |- skos__related mesh__D014075smesh__D014073
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 2005
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 2006A
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D014075 ags
% 211.46/211.61 |- skos__broader mesh__D014075smesh__D014076
% 211.46/211.61 |- skos__hiddenLabel mesh__D014075 Tooth Discolorations
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 2006
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 2000
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D014075 1998
% 211.46/211.61 |- skos__hiddenLabel mesh__D014075 Discoloration, Tooth
% 211.46/211.61 |- mesh__recordOriginator mesh__D014075 NLM
% 211.46/211.61 |- mesh__publicMeSHNote mesh__D014075 65
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D008836 sjn
% 211.46/211.61 |- skos__broader mesh__D008836smesh__D004722
% 211.46/211.61 |- skos__prefLabel mesh__D008836 Micrococcal Nuclease
% 211.46/211.61 |- skos__altLabel mesh__D008836 Thermostable Nuclease
% 211.46/211.61 |- mesh__dateEstablished mesh__D008836 1973-01-01
% 211.46/211.61 |- skos__scopeNote mesh__D008836
% 211.46/211.61 An enzyme that catalyzes the endonucleolytic cleavage to 3%27%-phosphomononucleotide and 3%27%-phospholigonucleotide end-products. It can cause hydrolysis of double- or single-stranded DNA or RNA. %28%From Enzyme Nomenclature, 1992%29% EC 3.1.31.1.%A%
% 211.46/211.61 |- skos__altLabel mesh__D008836 Thermonuclease
% 211.46/211.61 |- mesh__historyNote mesh__D008836 73%28%65%29%
% 211.46/211.61 |- skos__altLabel mesh__D008836 TNase
% 211.46/211.61 |- skos__broader mesh__D008836smesh__D004706
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008836 2004
% 211.46/211.61 |- skos__hiddenLabel mesh__D008836 Nuclease, Micrococcal
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008836 2006
% 211.46/211.61 |- skos__annotation mesh__D008836 DF: STAPH NUCLEASE
% 211.46/211.61 |- mesh__recordMaintainer mesh__D008836 ssb
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008836 2005
% 211.46/211.61 |- skos__hiddenLabel mesh__D008836 Nuclease, Thermostable
% 211.46/211.61 |- mesh__publicMeSHNote mesh__D008836 73
% 211.46/211.61 |- mesh__dateRevised mesh__D008836 2003-07-09
% 211.46/211.61 |- mesh__dateCreated mesh__D008836 1999-01-01
% 211.46/211.61 |- skos__hiddenLabel mesh__D008836 Nuclease, Staphylococcal
% 211.46/211.61 |- skos__altLabel mesh__D008836 Staphylococcal Nuclease
% 211.46/211.61 |- mesh__recordOriginator mesh__D008836 NLM
% 211.46/211.61 |- rdf__type mesh__D008836sskos__Concept
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000853 2002
% 211.46/211.61 |- skos__scopeNote mesh__D000853
% 211.46/211.61 Congenital absence of the eye or eyes.
% 211.46/211.61 |- mesh__dateCreated mesh__D000853 1999-01-01
% 211.46/211.61 |- rdf__type mesh__D000853sskos__Concept
% 211.46/211.61 |- skos__prefLabel mesh__D000853 Anophthalmos
% 211.46/211.61 |- skos__hiddenLabel mesh__D000853 Anophthalmias
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000853 2006
% 211.46/211.61 |- mesh__dateRevised mesh__D000853 1999-11-03
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000853 2001
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000853 2004
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000853 2005
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000853 2000
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000853 2003
% 211.46/211.61 |- mesh__recordOriginator mesh__D000853 NLM
% 211.46/211.61 |- skos__broader mesh__D000853smesh__D005124
% 211.46/211.61 |- skos__altLabel mesh__D000853 Anophthalmia
% 211.46/211.61 |- skos__annotation mesh__D000853
% 211.46/211.61 absence of one or both eyes; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%
% 211.46/211.61 |- mesh__recordMaintainer mesh__D000853 kle
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D000853 sjn
% 211.46/211.61 |- skos__broader mesh__D008038smesh__D004304
% 211.46/211.61 |- mesh__dateRevised mesh__D008038 2003-07-09
% 211.46/211.61 |- skos__annotation mesh__D008038
% 211.46/211.61 IM for general only, qualif permitted; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the drug in liniment form, not the liniment%A%
% 211.46/211.61 |- skos__prefLabel mesh__D008038 Liniments
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008038 2004
% 211.46/211.61 |- skos__scopeNote mesh__D008038
% 211.46/211.61 Heat-generating liquids that are thinner than ointments and are applied to the skin with friction. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%
% 211.46/211.61 |- mesh__recordOriginator mesh__D008038 NLM
% 211.46/211.61 |- rdf__type mesh__D008038sskos__Concept
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008038 2005
% 211.46/211.61 |- mesh__dateCreated mesh__D008038 1999-01-01
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D008038 2006
% 211.46/211.61 |- mesh__recordMaintainer mesh__D008038 ssb
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D008038 sjn
% 211.46/211.61 |- skos__hiddenLabel mesh__D000055 Accessory Nerves, Spinal
% 211.46/211.61 |- skos__hiddenLabel mesh__D000055 Nerves, Accessory
% 211.46/211.61 |- skos__hiddenLabel mesh__D000055 Nerves, Spinal Accessory
% 211.46/211.61 |- skos__hiddenLabel mesh__D000055 Nerves, Eleventh Cranial
% 211.46/211.61 |- skos__hiddenLabel mesh__D000055 Nerve, Spinal Accessory
% 211.46/211.61 |- skos__altLabel mesh__D000055 Spinal Accessory Nerve
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000055 2003
% 211.46/211.61 |- mesh__recordMaintainer mesh__D000055 ags
% 211.46/211.61 |- skos__hiddenLabel mesh__D000055 Cranial Nerve, Eleventh
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000055 2005
% 211.46/211.61 |- skos__broader mesh__D000055smesh__D003391
% 211.46/211.61 |- skos__altLabel mesh__D000055 Eleventh Cranial Nerve
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000055 2004
% 211.46/211.61 |- mesh__dateCreated mesh__D000055 1999-01-01
% 211.46/211.61 |- mesh__recordAuthorizer mesh__D000055 sjn
% 211.46/211.61 |- mesh__activeMeSHYear mesh__D000055 2006
% 211.46/211.61 |- skos__scopeNote mesh__D000055
% 211.46/211.61 The 11th cranial nerve. The accessory nerve originates from neurons in the medulla and in the cervical spinal cord. It has a cranial root, which joins the vagus %28%10th cranial%29% nerve and sends motor fibers to the muscles of the larynx, and a spinal root, which sends motor fibers to the trapezius and the sternocleidomastoid muscles. Damage to the nerve produces weakness in head rotation and shoulder elevation.%A%
% 211.46/211.62 |- skos__hiddenLabel mesh__D000055 Cranial Nerves, Eleventh
% 211.46/211.62 |- skos__prefLabel mesh__D000055 Accessory Nerve
% 211.46/211.62 |- skos__annotation mesh__D000055
% 211.46/211.62 neopl = ACCESSORY NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%
% 211.46/211.62 |- skos__hiddenLabel mesh__D000055 Nerve, Accessory
% 211.46/211.62 |- skos__hiddenLabel mesh__D000055 Eleventh Cranial Nerves
% 211.46/211.62 |- skos__hiddenLabel mesh__D000055 Spinal Accessory Nerves
% 211.46/211.62 |- skos__altLabel mesh__D000055 Cranial Nerve XI
% 211.46/211.62 |- skos__hiddenLabel mesh__D000055 Accessory Nerves
% 211.46/211.62 |- mesh__dateRevised mesh__D000055 2001-07-25
% 211.46/211.62 |- skos__hiddenLabel mesh__D000055 Nerve, Eleventh Cranial
% 211.46/211.62 |- skos__hiddenLabel mesh__D000055 Accessory Nerve, Spinal
% 211.46/211.62 |- mesh__recordOriginator mesh__D000055 NLM
% 211.46/211.62 |- rdf__type mesh__D000055sskos__Concept
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D000055 2002
% 211.46/211.62 |- skos__historyNote mesh__D018466 Gravitation %28%1966-1994%29%
% 211.46/211.62 |- skos__hiddenLabel mesh__D018466 Sensing, Gravity
% 211.46/211.62 |- skos__altLabel mesh__D018466 Gravity Sensing
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 2005
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 1999
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 2002
% 211.46/211.62 |- mesh__historyNote mesh__D018466 95
% 211.46/211.62 |- skos__prefLabel mesh__D018466 Gravity Perception
% 211.46/211.62 |- skos__annotation mesh__D018466 human, animal or plant
% 211.46/211.62 |- skos__altLabel mesh__D018466 Gravisensing
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 2006
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 1996
% 211.46/211.62 |- skos__hiddenLabel mesh__D018466 Gravisensings
% 211.46/211.62 |- mesh__dateEstablished mesh__D018466 1995-01-01
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D018466 95
% 211.46/211.62 |- skos__broader mesh__D018466smesh__D018521
% 211.46/211.62 |- skos__broader mesh__D018466smesh__D012677
% 211.46/211.62 |- skos__broader mesh__D018466smesh__D010465
% 211.46/211.62 |- skos__hiddenLabel mesh__D018466 Perception, Gravity
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 2003
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 1997
% 211.46/211.62 |- rdf__type mesh__D018466sskos__Concept
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 2000
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 2004
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 2001
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 1995
% 211.46/211.62 |- skos__scopeNote mesh__D018466
% 211.46/211.62 Process whereby a bodily structure or organism %28%animal or plant%29% receives or detects a gravity stimulus. The sensing may be direct or indirect and may or may not initiate a reaction to the stimulus.%A%
% 211.46/211.62 |- mesh__dateCreated mesh__D018466 1994-06-07
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018466 1998
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010483 2006
% 211.46/211.62 |- skos__broader mesh__D010483smesh__D009059
% 211.46/211.62 |- skos__hiddenLabel mesh__D010483 Diseases, Periapical
% 211.46/211.62 |- skos__historyNote mesh__D010483 Periodontal Diseases %28%1966-1979%29%
% 211.46/211.62 |- mesh__recordOriginator mesh__D010483 SMH
% 211.46/211.62 |- skos__prefLabel mesh__D010483 Periapical Diseases
% 211.46/211.62 |- skos__hiddenLabel mesh__D010483 Periapical Disease
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D010483 sjn
% 211.46/211.62 |- skos__historyNote mesh__D010483 Periapical Tissue %28%1972-1979%29%
% 211.46/211.62 |- mesh__dateRevised mesh__D010483 2003-07-09
% 211.46/211.62 |- skos__annotation mesh__D010483 inflamm dis = PERIAPICAL PERIODONTITIS
% 211.46/211.62 |- skos__scopeNote mesh__D010483
% 211.46/211.62 Diseases of the PERIAPICAL TISSUE surrounding the root of the tooth, which is distinguished from DENTAL PULP DISEASES inside the root.%A%
% 211.46/211.62 |- mesh__dateCreated mesh__D010483 1979-04-25
% 211.46/211.62 |- skos__related mesh__D010483smesh__D003788
% 211.46/211.62 |- rdf__type mesh__D010483sskos__Concept
% 211.46/211.62 |- mesh__historyNote mesh__D010483 80
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D010483 80
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010483 2004
% 211.46/211.62 |- mesh__recordMaintainer mesh__D010483 ssb
% 211.46/211.62 |- skos__hiddenLabel mesh__D010483 Disease, Periapical
% 211.46/211.62 |- mesh__dateEstablished mesh__D010483 1980-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010483 2005
% 211.46/211.62 |- rdf__type mesh__D004446sskos__Concept
% 211.46/211.62 |- mesh__dateRevised mesh__D004446 2004-07-07
% 211.46/211.62 |- skos__annotation mesh__D004446
% 211.46/211.62 infection = ECHINOCOCCOSIS or its specifics; coordinate with specific helminth terms %28%for example, ANTIGENS, HELMINTH%29% if pertinent%A%
% 211.46/211.62 |- skos__scopeNote mesh__D004446
% 211.46/211.62 A genus of very small TAPEWORMS, in the family Taeniidae. The adult form is found in various CARNIVORA but not humans. The larval form is seen in humans under certain epidemiologic circumstances.%A%
% 211.46/211.62 |- skos__broader mesh__D004446smesh__D002589
% 211.46/211.62 |- mesh__dateCreated mesh__D004446 1999-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D004446 2005
% 211.46/211.62 |- skos__prefLabel mesh__D004446 Echinococcus
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D004446 2006
% 211.46/211.62 |- mesh__recordMaintainer mesh__D004446 ags
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D004446 sjn
% 211.46/211.62 |- mesh__recordOriginator mesh__D004446 NLM
% 211.46/211.62 |- skos__historyNote mesh__D009131 Muscle, Smooth %28%1966-1979%29%
% 211.46/211.62 |- skos__broader mesh__D009131smesh__D001808
% 211.46/211.62 |- skos__altLabel mesh__D009131 Vascular Smooth Muscle
% 211.46/211.62 |- skos__annotation mesh__D009131
% 211.46/211.62 coord IM with specific vein or artery %28%NIM %26% then only if pertinent%29%; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009131 2005
% 211.46/211.62 |- mesh__dateEstablished mesh__D009131 1980-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009131 2004
% 211.46/211.62 |- skos__hiddenLabel mesh__D009131 Muscle, Vascular Smooth
% 211.46/211.62 |- skos__hiddenLabel mesh__D009131 Smooth Muscles, Vascular
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009131 2002
% 211.46/211.62 |- mesh__historyNote mesh__D009131 80
% 211.46/211.62 |- skos__scopeNote mesh__D009131
% 211.46/211.62 The nonstriated, involuntary muscle tissue of blood vessels.%A%
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009131 2006
% 211.46/211.62 |- mesh__dateCreated mesh__D009131 1979-04-25
% 211.46/211.62 |- skos__hiddenLabel mesh__D009131 Vascular Smooth Muscles
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D009131 80
% 211.46/211.62 |- mesh__dateRevised mesh__D009131 2001-07-25
% 211.46/211.62 |- mesh__recordOriginator mesh__D009131 VDK
% 211.46/211.62 |- skos__hiddenLabel mesh__D009131 Muscles, Vascular Smooth
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D009131 sjn
% 211.46/211.62 |- rdf__type mesh__D009131sskos__Concept
% 211.46/211.62 |- skos__hiddenLabel mesh__D009131 Smooth Muscle, Vascular
% 211.46/211.62 |- mesh__recordMaintainer mesh__D009131 nns
% 211.46/211.62 |- skos__broader mesh__D009131smesh__D009130
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009131 2003
% 211.46/211.62 |- skos__prefLabel mesh__D009131 Muscle, Smooth, Vascular
% 211.46/211.62 |- skos__annotation mesh__D014874
% 211.46/211.62 restrict to in situ water in rivers, reservoirs, streams, lakes, sea %26% the like; specify pollutant if pertinent %28%IM or NIM%29%%A%
% 211.46/211.62 |- mesh__dateEstablished mesh__D014874 1991-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014874 2004
% 211.46/211.62 |- skos__hiddenLabel mesh__D014874 Pollutants, Chemical Water
% 211.46/211.62 |- rdf__type mesh__D014874sskos__Concept
% 211.46/211.62 |- mesh__historyNote mesh__D014874
% 211.46/211.62 91%28%75%29%; was see under WATER POLLUTANTS 1975-90
% 211.46/211.62 |- mesh__dateRevised mesh__D014874 2003-07-09
% 211.46/211.62 |- skos__broader mesh__D014874smesh__D014873
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014874 2005
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D014874
% 211.46/211.62 91; was see under WATER POLLUTANTS 1975-90
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014874 2006
% 211.46/211.62 |- skos__prefLabel mesh__D014874 Water Pollutants, Chemical
% 211.46/211.62 |- mesh__dateCreated mesh__D014874 1999-01-01
% 211.46/211.62 |- skos__scopeNote mesh__D014874
% 211.46/211.62 Chemical compounds which pollute the water of rivers, streams, lakes, the sea, reservoirs, or other bodies of water.%A%
% 211.46/211.62 |- skos__altLabel mesh__D014874 Chemical Water Pollutants
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D014874 sjn
% 211.46/211.62 |- mesh__recordMaintainer mesh__D014874 ssb
% 211.46/211.62 |- mesh__recordOriginator mesh__D014874 NLM
% 211.46/211.62 |- mesh__dateEstablished mesh__D047250 2005-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D047250 2006
% 211.46/211.62 |- skos__altLabel mesh__D047250 Calix%28%n%29%Arenes
% 211.46/211.62 |- skos__broader mesh__D047250smesh__D047028
% 211.46/211.62 |- rdf__type mesh__D047250sskos__Concept
% 211.46/211.62 |- mesh__dateCreated mesh__D047250 2004-07-08
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D047250 sjn
% 211.46/211.62 |- skos__scopeNote mesh__D047250
% 211.46/211.62 Phenolic metacyclophanes derived from condensation of PHENOLS and ALDEHYDES. The name derives from the vase-like molecular structures. A bracketed %5B%n%5D% indicates the number of aromatic rings.%A%
% 211.46/211.62 |- mesh__recordMaintainer mesh__D047250 ssb
% 211.46/211.62 |- skos__altLabel mesh__D047250 Calixarene
% 211.46/211.62 |- skos__prefLabel mesh__D047250 Calixarenes
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D047250 2005
% 211.46/211.62 |- mesh__historyNote mesh__D047250 2005
% 211.46/211.62 |- mesh__recordOriginator mesh__D047250 ssb
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D047250 2005
% 211.46/211.62 |- skos__broader mesh__D014076smesh__D009057
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014076 2004
% 211.46/211.62 |- mesh__historyNote mesh__D014076 65
% 211.46/211.62 |- rdf__type mesh__D014076sskos__Concept
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014076 2000
% 211.46/211.62 |- skos__hiddenLabel mesh__D014076 Diseases, Tooth
% 211.46/211.62 |- skos__hiddenLabel mesh__D014076 Disease, Tooth
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D014076 65
% 211.46/211.62 |- mesh__recordMaintainer mesh__D014076 kle
% 211.46/211.62 |- mesh__recordOriginator mesh__D014076 NLM
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D014076 sjn
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014076 2001
% 211.46/211.62 |- skos__prefLabel mesh__D014076 Tooth Diseases
% 211.46/211.62 |- mesh__dateCreated mesh__D014076 1999-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014076 2005
% 211.46/211.62 |- mesh__dateRevised mesh__D014076 1999-11-03
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014076 2006
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014076 2002
% 211.46/211.62 |- skos__annotation mesh__D014076 GEN: prefer specifics
% 211.46/211.62 |- skos__hiddenLabel mesh__D014076 Tooth Disease
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014076 2003
% 211.46/211.62 |- skos__related mesh__D014076smesh__D009065
% 211.46/211.62 |- skos__broader mesh__D008837smesh__D008835
% 211.46/211.62 |- skos__scopeNote mesh__D008837
% 211.46/211.62 A genus of gram-positive, spherical bacteria found in soils and fresh water, and frequently on the skin of man and other animals.%A%
% 211.46/211.62 |- mesh__recordMaintainer mesh__D008837 SYSTEM
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D008837 2006
% 211.46/211.62 |- mesh__historyNote mesh__D008837
% 211.46/211.62 GAFFKYA TETRAGENA was see MICROCOCCUS 1979-91; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75%A%
% 211.46/211.62 |- skos__prefLabel mesh__D008837 Micrococcus
% 211.46/211.62 |- mesh__dateCreated mesh__D008837 1999-01-01
% 211.46/211.62 |- mesh__recordOriginator mesh__D008837 NLM
% 211.46/211.62 |- mesh__dateRevised mesh__D008837 2005-06-30
% 211.46/211.62 |- skos__annotation mesh__D008837
% 211.46/211.62 found in soil %26% fresh water %26% on mammalian skin
% 211.46/211.62 |- rdf__type mesh__D008837sskos__Concept
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D008837
% 211.46/211.62 GAFFKYA TETRAGENA was see MICROCOCCUS 1979-91; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75%A%
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D008837 sjn
% 211.46/211.62 |- mesh__onlineNote mesh__D008837
% 211.46/211.62 use MICROCOCCUS to search GAFFKYA TETRAGENA 1979-91 %26% GAFFKYA 1966-78%A%
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D000854 jls
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D000854 2006A
% 211.46/211.62 |- skos__annotation mesh__D000854
% 211.46/211.62 do not use /drug eff for insecticides: TN 111
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D000854 2006
% 211.46/211.62 |- skos__prefLabel mesh__D000854 Anoplura
% 211.46/211.62 |- skos__altLabel mesh__D000854 Sucking Lice
% 211.46/211.62 |- skos__broader mesh__D000854smesh__D008003
% 211.46/211.62 |- mesh__dateEstablished mesh__D000854 1972-01-01
% 211.46/211.62 |- skos__scopeNote mesh__D000854
% 211.46/211.62 An order of insects comprising the sucking lice, which are blood-sucking ectoparasites of mammals. Recognized families include: Echinphthiriidae, Haematopinidae, and Pediculidae. The latter contains the medically important genera affecting humans: PEDICULUS and PHTHIRUS.%A%
% 211.46/211.62 |- mesh__dateRevised mesh__D000854 2005-07-29
% 211.46/211.62 |- mesh__historyNote mesh__D000854 72
% 211.46/211.62 |- skos__historyNote mesh__D000854 Lice %28%1966-1971%29%
% 211.46/211.62 |- skos__altLabel mesh__D000854 Sucking Louse
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D000854 72
% 211.46/211.62 |- mesh__dateCreated mesh__D000854 1999-01-01
% 211.46/211.62 |- mesh__recordOriginator mesh__D000854 NLM
% 211.46/211.62 |- mesh__recordMaintainer mesh__D000854 jls
% 211.46/211.62 |- rdf__type mesh__D000854sskos__Concept
% 211.46/211.62 |- mesh__historyNote mesh__D008039
% 211.46/211.62 91%28%75%29%; was see under CARCINOMA, SCIRRHOUS 1975-90
% 211.46/211.62 |- mesh__onlineNote mesh__D008039 search CARCINOMA, SCIRRHOUS 1966-74
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D008039 2003
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D008039 sjn
% 211.46/211.62 |- mesh__dateEstablished mesh__D008039 1991-01-01
% 211.46/211.62 |- mesh__recordMaintainer mesh__D008039 KEV
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D008039 2004
% 211.46/211.62 |- skos__annotation mesh__D008039
% 211.46/211.62 neoplastic; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with STOMACH NEOPLASMS %28%IM%29%%A%
% 211.46/211.62 |- rdf__type mesh__D008039sskos__Concept
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D008039 2005
% 211.46/211.62 |- mesh__dateRevised mesh__D008039 1999-11-03
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D008039 2000
% 211.46/211.62 |- mesh__dateCreated mesh__D008039 1999-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D008039 2001
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D008039 2006
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D008039 2002
% 211.46/211.62 |- mesh__recordOriginator mesh__D008039 NLM
% 211.46/211.62 |- skos__scopeNote mesh__D008039
% 211.46/211.62 A condition where the stomach wall becomes thickened, rubbery and loses its ability to distend. The stomach assumes a %22%leather bottle%22% shape. It is most often seen in adenocarcinoma of the stomach. The term is often used synonymously with diffuse adenocarcinoma of the stomach.%A%
% 211.46/211.62 |- skos__prefLabel mesh__D008039 Linitis Plastica
% 211.46/211.62 |- skos__broader mesh__D008039smesh__D002293
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D008039
% 211.46/211.62 91; was see under CARCINOMA, SCIRRHOUS 1975-90
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D000056 2005
% 211.46/211.62 |- skos__hiddenLabel mesh__D000056 Accident Preventions
% 211.46/211.62 |- skos__broader mesh__D000056smesh__D000059
% 211.46/211.62 |- mesh__dateCreated mesh__D000056 1999-01-01
% 211.46/211.62 |- skos__hiddenLabel mesh__D000056 Preventions, Accident
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D000056 2006
% 211.46/211.62 |- mesh__recordOriginator mesh__D000056 NLM
% 211.46/211.62 |- skos__altLabel mesh__D000056 Prevention, Accident
% 211.46/211.62 |- mesh__dateRevised mesh__D000056 2004-07-07
% 211.46/211.62 |- skos__prefLabel mesh__D000056 Accident Prevention
% 211.46/211.62 |- skos__scopeNote mesh__D000056
% 211.46/211.62 Efforts and designs to reduce the incidence of unexpected undesirable events in various environments and situations.%A%
% 211.46/211.62 |- rdf__type mesh__D000056sskos__Concept
% 211.46/211.62 |- mesh__recordMaintainer mesh__D000056 lkt
% 211.46/211.62 |- skos__related mesh__D000056smesh__D011482
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D000056 sjn
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 2000
% 211.46/211.62 |- skos__broader mesh__D018467smesh__D012131
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467
% 211.46/211.62 Positive Pressure Respiration, Non Therapeutic
% 211.46/211.62 |- mesh__dateRevised mesh__D018467 1996-06-10
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467 Occult PEEP
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467
% 211.46/211.62 Non Therapeutic Positive Pressure Respiration
% 211.46/211.62 |- mesh__dateCreated mesh__D018467 1994-04-16
% 211.46/211.62 |- rdf__type mesh__D018467sskos__Concept
% 211.46/211.62 |- skos__altLabel mesh__D018467
% 211.46/211.62 Positive-Pressure Respiration, Non-Therapeutic
% 211.46/211.62 |- skos__altLabel mesh__D018467 Auto-PEEP
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467
% 211.46/211.62 Positive Pressure Respiration, Nontherapeutic
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467
% 211.46/211.62 Respiration, Non Therapeutic Positive Pressure
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 1999
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 2004
% 211.46/211.62 |- skos__altLabel mesh__D018467 PEEP, Intrinsic
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467 Intrinsic Positive-Pressure Respiration
% 211.46/211.62 |- skos__scopeNote mesh__D018467
% 211.46/211.62 Non-therapeutic positive end-expiratory pressure occurring frequently in patients with severe airway obstruction. It can appear with or without the administration of external positive end-expiratory pressure %28%POSITIVE-PRESSURE RESPIRATION%29%. It presents an important load on the inspiratory muscles which are operating at a mechanical disadvantage due to hyperinflation. Auto-PEEP may cause profound hypotension that should be treated by intravascular volume expansion, increasing the time for expiration, and/or changing from assist mode to intermittent mandatory ventilation mode. %28%From Harrison%27%s Principles of Internal Medicine, 12th ed, p1127%29%%A%
% 211.46/211.62 |- skos__altLabel mesh__D018467 AutoPEEP
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 2002
% 211.46/211.62 |- skos__altLabel mesh__D018467 PEEP, Occult
% 211.46/211.62 |- skos__altLabel mesh__D018467
% 211.46/211.62 Respiration, Non-Therapeutic Positive-Pressure
% 211.46/211.62 |- skos__annotation mesh__D018467
% 211.46/211.62 note category: a type of resp insuff; do not confuse with POSITIVE END-EXPIRATORY PRESSURE or PEEP see POSITIVE-PRESSURE RESPIRATION, a form of artif resp %28%Cat E%29%; DF: note short X ref%A%
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467 Intrinsic PEEP
% 211.46/211.62 |- mesh__recordMaintainer mesh__D018467 TGC
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 1998
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467 Positive Pressure Respiration, Intrinsic
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 2003
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467 Respiration, Occult Positive-Pressure
% 211.46/211.62 |- skos__altLabel mesh__D018467
% 211.46/211.62 Non-Therapeutic Positive-Pressure Respiration
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467 Respiration, Intrinsic Positive-Pressure
% 211.46/211.62 |- skos__altLabel mesh__D018467
% 211.46/211.62 Positive-Pressure Respiration, Nontherapeutic
% 211.46/211.62 |- skos__altLabel mesh__D018467 Positive-Pressure Respiration, Occult
% 211.46/211.62 |- skos__historyNote mesh__D018467
% 211.46/211.62 Positive-Pressure Respiration %28%1982-1994%29%
% 211.46/211.62 |- skos__prefLabel mesh__D018467 Positive-Pressure Respiration, Intrinsic
% 211.46/211.62 |- skos__altLabel mesh__D018467
% 211.46/211.62 Respiration, Nontherapeutic Positive-Pressure
% 211.46/211.62 |- skos__altLabel mesh__D018467
% 211.46/211.62 Nontherapeutic Positive-Pressure Respiration
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467
% 211.46/211.62 Nontherapeutic Positive Pressure Respiration
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 2006
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 2001
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D018467 95
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467 Occult Positive-Pressure Respiration
% 211.46/211.62 |- mesh__dateEstablished mesh__D018467 1995-01-01
% 211.46/211.62 |- mesh__historyNote mesh__D018467 95
% 211.46/211.62 |- mesh__recordOriginator mesh__D018467 TGC
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D018467 PLS
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467 Auto PEEP
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467 Positive Pressure Respiration, Occult
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 1997
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D018467 2005
% 211.46/211.62 |- skos__hiddenLabel mesh__D018467
% 211.46/211.62 Respiration, Nontherapeutic Positive Pressure
% 211.46/211.62 |- skos__prefLabel mesh__D010484 Periapical Granuloma
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010484 2001
% 211.46/211.62 |- skos__altLabel mesh__D010484 Dental Granuloma
% 211.46/211.62 |- mesh__onlineNote mesh__D010484
% 211.46/211.62 use PERIAPICAL GRANULOMA to search GRANULOMA, PERIAPICAL 1966-79%A%
% 211.46/211.62 |- skos__hiddenLabel mesh__D010484 Granulomas, Periapical
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010484 2002
% 211.46/211.62 |- skos__altLabel mesh__D010484 Granuloma, Periapical
% 211.46/211.62 |- skos__altLabel mesh__D010484 Granuloma, Dental
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010484 2003
% 211.46/211.62 |- mesh__dateRevised mesh__D010484 1999-11-03
% 211.46/211.62 |- mesh__recordOriginator mesh__D010484 NLM
% 211.46/211.62 |- skos__scopeNote mesh__D010484
% 211.46/211.62 Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment.%A%
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D010484
% 211.46/211.62 80; was GRANULOMA, PERIAPICAL 1965-79
% 211.46/211.62 |- rdf__type mesh__D010484sskos__Concept
% 211.46/211.62 |- skos__altLabel mesh__D010484 Granulomas, Dental
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010484 2004
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D010484 sjn
% 211.46/211.62 |- skos__broader mesh__D010484smesh__D010485
% 211.46/211.62 |- mesh__dateEstablished mesh__D010484 1965-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010484 2005
% 211.46/211.62 |- mesh__recordMaintainer mesh__D010484 KEV
% 211.46/211.62 |- mesh__historyNote mesh__D010484 80; was GRANULOMA, PERIAPICAL 1965-79
% 211.46/211.62 |- mesh__dateCreated mesh__D010484 1999-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010484 2006
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D010484 2000
% 211.46/211.62 |- skos__hiddenLabel mesh__D010484 Periapical Granulomas
% 211.46/211.62 |- mesh__dateRevised mesh__D037621 2005-06-30
% 211.46/211.62 |- mesh__recordOriginator mesh__D037621 ssb
% 211.46/211.62 |- skos__broader mesh__D037621smesh__D012717
% 211.46/211.62 |- rdf__type mesh__D037621sskos__Concept
% 211.46/211.62 |- skos__historyNote mesh__D037621 Sesquiterpenes %28%1982-2002%29%
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D037621 sjn
% 211.46/211.62 |- mesh__historyNote mesh__D037621 2003
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D037621 2003
% 211.46/211.62 |- skos__prefLabel mesh__D037621 Artemisinins
% 211.46/211.62 |- skos__scopeNote mesh__D037621
% 211.46/211.62 A group of SESQUITERPENES and their analogs that contain a peroxide group %28%PEROXIDES%29% within an oxepin ring %28%OXEPINS%29%.%A%
% 211.46/211.62 |- mesh__dateCreated mesh__D037621 2002-07-02
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D037621 2006
% 211.46/211.62 |- mesh__dateEstablished mesh__D037621 2003-01-01
% 211.46/211.62 |- skos__broader mesh__D037621smesh__D010545
% 211.46/211.62 |- mesh__recordMaintainer mesh__D037621 ssb
% 211.46/211.62 |- mesh__dateRevised mesh__D004447 2003-07-09
% 211.46/211.62 |- skos__annotation mesh__D004447
% 211.46/211.62 includes SEA URCHINS; STARFISH; sea lilies, SEA CUCUMBERS %26% brittle stars; /microbiol /parasitol /virol permitted%A%
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D004447 sjn
% 211.46/211.62 |- mesh__recordOriginator mesh__D004447 NLM
% 211.46/211.62 |- mesh__dateCreated mesh__D004447 1999-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D004447 2005
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D004447 2004
% 211.46/211.62 |- skos__broader mesh__D004447smesh__D007448
% 211.46/211.62 |- skos__scopeNote mesh__D004447
% 211.46/211.62 A phylum of the most familiar marine invertebrates. Its class Stelleroidea contains two subclasses, the Asteroidea %28%the STARFISH or sea stars%29% and the Ophiuroidea %28%the brittle stars, also called basket stars and serpent stars%29%. There are 1500 described species of STARFISH found throughout the world. The second class, Echinoidea, contains about 950 species of SEA URCHINS, heart urchins, and sand dollars. A third class, Holothuroidea, comprises about 900 echinoderms known as SEA CUCUMBERS. Echinoderms are used extensively in biological research. %28%From Barnes, Invertebrate Zoology, 5th ed, pp773-826%29%%A%
% 211.46/211.62 |- skos__prefLabel mesh__D004447 Echinodermata
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D004447 2006
% 211.46/211.62 |- mesh__recordMaintainer mesh__D004447 ags
% 211.46/211.62 |- rdf__type mesh__D004447sskos__Concept
% 211.46/211.62 |- mesh__recordOriginator mesh__D009930 NLM
% 211.46/211.62 |- mesh__dateRevised mesh__D009930 2000-06-22
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009930 2001
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D009930 98
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009930 2006
% 211.46/211.62 |- mesh__runningHead mesh__D009930 D2 - ORGANIC CHEMICALS
% 211.46/211.62 |- mesh__dateCreated mesh__D009930 1999-01-01
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D009930 sjn
% 211.46/211.62 |- skos__hiddenLabel mesh__D009930 Chemicals, Organic
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009930 2005
% 211.46/211.62 |- mesh__dateEstablished mesh__D009930 1998-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009930 2004
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009930 2002
% 211.46/211.62 |- skos__scopeNote mesh__D009930
% 211.46/211.62 A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form.%A%
% 211.46/211.62 |- rdf__type mesh__D009930sskos__Concept
% 211.46/211.62 |- skos__annotation mesh__D009930
% 211.46/211.62 GEN or unspecified; prefer specific groups or specific chemicals%A%
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009930 2003
% 211.46/211.62 |- mesh__recordMaintainer mesh__D009930 jls
% 211.46/211.62 |- skos__prefLabel mesh__D009930 Organic Chemicals
% 211.46/211.62 |- mesh__historyNote mesh__D009930 98; use explode 1967-97
% 211.46/211.62 |- mesh__dateCreated mesh__D009132 1999-01-01
% 211.46/211.62 |- mesh__recordMaintainer mesh__D009132 ags
% 211.46/211.62 |- skos__annotation mesh__D009132
% 211.46/211.62 Manual 21.8; as tissue: Manual 21.9, 21.52; unspecified as smooth or striated; MUSCLES, SKELETAL and MUSCLE, SMOOTH and their indentions are available; /innerv: consider also NEUROMUSCULAR JUNCTION %26% MUSCLE DENERVATION; /surg: consider also SURGICAL FLAPS but see note there; /embryol: coord with MUSCLE DEVELOPMENT if pertinent; inflammation = MYOSITIS%A%
% 211.46/211.62 |- skos__scopeNote mesh__D009132
% 211.46/211.62 Contractile tissue that produces movement in animals.
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009132 2006
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D009132
% 211.46/211.62 /transplantation was MUSCLE TRANSPLANTATION 1963-65
% 211.46/211.62 |- mesh__dateRevised mesh__D009132 2004-07-07
% 211.46/211.62 |- skos__broader mesh__D009132smesh__D014024
% 211.46/211.62 |- mesh__considerAlso mesh__D009132 consider also terms at MYO-
% 211.46/211.62 |- skos__prefLabel mesh__D009132 Muscles
% 211.46/211.62 |- skos__broader mesh__D009132smesh__D009141
% 211.46/211.62 |- rdf__type mesh__D009132sskos__Concept
% 211.46/211.62 |- skos__related mesh__D009132smesh__D009213
% 211.46/211.62 |- mesh__historyNote mesh__D009132
% 211.46/211.62 /transplantation was MUSCLE TRANSPLANTATION 1963-65
% 211.46/211.62 |- skos__hiddenLabel mesh__D009132 Muscle
% 211.46/211.62 |- mesh__recordOriginator mesh__D009132 NLM
% 211.46/211.62 |- skos__related mesh__D009132smesh__D012508
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D009132 2005
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D009132 sjn
% 211.46/211.62 |- skos__related mesh__D009132smesh__D012519
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014875 2006
% 211.46/211.62 |- skos__broader mesh__D014875smesh__D011848
% 211.46/211.62 |- skos__annotation mesh__D014875
% 211.46/211.62 specify radiopollutant if pertinent %28%IM or NIM%29%
% 211.46/211.62 |- mesh__dateCreated mesh__D014875 1999-01-01
% 211.46/211.62 |- mesh__recordAuthorizer mesh__D014875 sjn
% 211.46/211.62 |- mesh__recordMaintainer mesh__D014875 ssb
% 211.46/211.62 |- skos__hiddenLabel mesh__D014875 Radioactive Water Pollutants
% 211.46/211.62 |- skos__hiddenLabel mesh__D014875 Pollutants, Radioactive Water
% 211.46/211.62 |- mesh__recordOriginator mesh__D014875 NLM
% 211.46/211.62 |- skos__prefLabel mesh__D014875 Water Pollutants, Radioactive
% 211.46/211.62 |- skos__scopeNote mesh__D014875
% 211.46/211.62 Pollutants, present in water or bodies of water, which exhibit radioactivity.%A%
% 211.46/211.62 |- mesh__publicMeSHNote mesh__D014875
% 211.46/211.62 91; was see under WATER POLLUTANTS 1975-90
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014875 2004
% 211.46/211.62 |- rdf__type mesh__D014875sskos__Concept
% 211.46/211.62 |- mesh__historyNote mesh__D014875
% 211.46/211.62 91%28%75%29%; was see under WATER POLLUTANTS 1975-90
% 211.46/211.62 |- mesh__dateRevised mesh__D014875 2003-07-09
% 211.46/211.62 |- skos__broader mesh__D014875smesh__D014873
% 211.46/211.62 |- mesh__dateEstablished mesh__D014875 1991-01-01
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014875 2005
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014077 2005
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014077 1999
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014077 2004
% 211.46/211.62 |- skos__broader mesh__D014077smesh__D014076
% 211.46/211.62 |- mesh__activeMeSHYear mesh__D014077 2000
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014077 2003
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D014077 65
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014077 1998
% 211.46/211.63 |- skos__prefLabel mesh__D014077 Tooth Erosion
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014077 1997
% 211.46/211.63 |- rdf__type mesh__D014077sskos__Concept
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D014077 PLS
% 211.46/211.63 |- mesh__recordMaintainer mesh__D014077 TGC
% 211.46/211.63 |- mesh__historyNote mesh__D014077 65
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014077 2002
% 211.46/211.63 |- skos__scopeNote mesh__D014077
% 211.46/211.63 Progressive loss of the hard substance of a tooth by chemical processes that do not involve bacterial action. %28%Jablonski, Dictionary of Dentistry, 1992, p296%29%%A%
% 211.46/211.63 |- mesh__recordOriginator mesh__D014077 NLM
% 211.46/211.63 |- mesh__dateCreated mesh__D014077 1999-01-01
% 211.46/211.63 |- skos__hiddenLabel mesh__D014077 Erosions, Tooth
% 211.46/211.63 |- skos__hiddenLabel mesh__D014077 Erosion, Tooth
% 211.46/211.63 |- skos__annotation mesh__D014077
% 211.46/211.63 loss of substance caused by chem action without bact action: differentiate from TOOTH ABRASION %28%loss of substance caused by friction%29% %26% TOOTH ATTRITION %28%wearing away through tooth-to-tooth contact%29%%A%
% 211.46/211.63 |- skos__hiddenLabel mesh__D014077 Tooth Erosions
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014077 2006
% 211.46/211.63 |- mesh__dateRevised mesh__D014077 1996-06-10
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014077 2001
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D008838
% 211.46/211.63 89; was see under COMPUTERS 1980-88
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D008838 sjn
% 211.46/211.63 |- skos__prefLabel mesh__D008838 Microcomputers
% 211.46/211.63 |- skos__scopeNote mesh__D008838
% 211.46/211.63 Small computers using LSI %28%large-scale integration%29% microprocessor chips as the CPU %28%central processing unit%29% and semiconductor memories for compact, inexpensive storage of program instructions and data. They are smaller and less expensive than minicomputers and are usually built into a dedicated system where they are optimized for a particular application. %22%Microprocessor%22% may refer to just the CPU or the entire microcomputer.%A%
% 211.46/211.63 |- skos__hiddenLabel mesh__D008838 Microcomputer
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008838 2006
% 211.46/211.63 |- skos__broader mesh__D008838smesh__D003201
% 211.46/211.63 |- mesh__dateEstablished mesh__D008838 1989-01-01
% 211.46/211.63 |- mesh__dateRevised mesh__D008838 2004-07-07
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008838 2005
% 211.46/211.63 |- skos__hiddenLabel mesh__D008838 Microprocessor
% 211.46/211.63 |- skos__annotation mesh__D008838 do not confuse with MINICOMPUTERS
% 211.46/211.63 |- rdf__type mesh__D008838sskos__Concept
% 211.46/211.63 |- mesh__recordOriginator mesh__D008838 SMH
% 211.46/211.63 |- mesh__dateCreated mesh__D008838 1979-05-31
% 211.46/211.63 |- skos__hiddenLabel mesh__D008838 Personal Computer
% 211.46/211.63 |- mesh__recordMaintainer mesh__D008838 jls
% 211.46/211.63 |- skos__hiddenLabel mesh__D008838 Personal Computers
% 211.46/211.63 |- mesh__historyNote mesh__D008838
% 211.46/211.63 89%28%80%29%; was see under COMPUTERS 1980-88
% 211.46/211.63 |- skos__historyNote mesh__D008838 Computers %28%1966-1979%29%
% 211.46/211.63 |- skos__hiddenLabel mesh__D008838 Computer, Personal
% 211.46/211.63 |- skos__prefLabel mesh__D000855 Anorexia
% 211.46/211.63 |- mesh__dateEstablished mesh__D000855 1991-01-01
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D000855
% 211.46/211.63 91; was see under EATING DISORDERS 1975-90
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D000855 2006
% 211.46/211.63 |- skos__scopeNote mesh__D000855
% 211.46/211.63 The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.%A%
% 211.46/211.63 |- mesh__dateRevised mesh__D000855 2005-06-30
% 211.46/211.63 |- mesh__recordOriginator mesh__D000855 NLM
% 211.46/211.63 |- skos__annotation mesh__D000855 ANOREXIA NERVOSA is also available
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D000855 sjn
% 211.46/211.63 |- mesh__historyNote mesh__D000855
% 211.46/211.63 91%28%75%29%; was see under EATING DISORDERS 1975-90
% 211.46/211.63 |- skos__broader mesh__D000855smesh__D012817
% 211.46/211.63 |- skos__related mesh__D000855smesh__D000856
% 211.46/211.63 |- skos__hiddenLabel mesh__D000855 Anorexias
% 211.46/211.63 |- mesh__recordMaintainer mesh__D000855 lkt
% 211.46/211.63 |- mesh__dateCreated mesh__D000855 1974-11-11
% 211.46/211.63 |- rdf__type mesh__D000855sskos__Concept
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 3D Echocardiographies
% 211.46/211.63 |- skos__broader mesh__D019560smesh__D004452
% 211.46/211.63 |- skos__annotation mesh__D019560
% 211.46/211.63 ECHOCARDIOGRAPHY, FOUR-DIMENSIONAL is also available; DF: ECHOCARDIOGR 3D%A%
% 211.46/211.63 |- rdf__type mesh__D019560sskos__Concept
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 Three Dimensional Echocardiography
% 211.46/211.63 |- mesh__recordMaintainer mesh__D019560 PXP
% 211.46/211.63 |- skos__scopeNote mesh__D019560
% 211.46/211.63 Echocardiography amplified by the addition of depth to the conventional two-dimensional ECHOCARDIOGRAPHY visualizing only the length and width of the heart. Three-dimensional ultrasound imaging was first described in 1961 but its application to echocardiography did not take place until 1974. %28%Mayo Clin Proc 1993;68:221-40%29%%A%
% 211.46/211.63 |- skos__altLabel mesh__D019560 Echocardiography, 3D
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D019560 97
% 211.46/211.63 |- mesh__recordOriginator mesh__D019560 TGC
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D019560 2003
% 211.46/211.63 |- skos__altLabel mesh__D019560 Echocardiography, 3-D
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 Three-Dimensional Echocardiographies
% 211.46/211.63 |- mesh__historyNote mesh__D019560 97
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 Echocardiographies, Three-Dimensional
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 Echocardiographies, 3D
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D019560 sjn
% 211.46/211.63 |- skos__altLabel mesh__D019560 3D Echocardiography
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D019560 2004
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 Echocardiography, 3 D
% 211.46/211.63 |- skos__prefLabel mesh__D019560 Echocardiography, Three-Dimensional
% 211.46/211.63 |- mesh__dateRevised mesh__D019560 2000-06-21
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D019560 2001
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 Echocardiographies, 3-D
% 211.46/211.63 |- skos__historyNote mesh__D019560 Echocardiography %28%1974-1996%29%
% 211.46/211.63 |- skos__broader mesh__D019560smesh__D021621
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D019560 2005
% 211.46/211.63 |- mesh__dateCreated mesh__D019560 1996-06-10
% 211.46/211.63 |- skos__altLabel mesh__D019560 Three-Dimensional Echocardiography
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 Echocardiography, Three Dimensional
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 3-D Echocardiographies
% 211.46/211.63 |- skos__hiddenLabel mesh__D019560 3 D Echocardiography
% 211.46/211.63 |- skos__altLabel mesh__D019560 3-D Echocardiography
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D019560 2002
% 211.46/211.63 |- mesh__dateEstablished mesh__D019560 1997-01-01
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D019560 2006
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D000057 sjn
% 211.46/211.63 |- skos__hiddenLabel mesh__D000057 Pronenesses, Accident
% 211.46/211.63 |- skos__annotation mesh__D000057 no qualif
% 211.46/211.63 |- mesh__dateCreated mesh__D000057 1974-11-11
% 211.46/211.63 |- rdf__type mesh__D000057sskos__Concept
% 211.46/211.63 |- skos__historyNote mesh__D000057 Accidents %28%1966-1974%29%
% 211.46/211.63 |- mesh__recordOriginator mesh__D000057 NLM
% 211.46/211.63 |- skos__prefLabel mesh__D000057 Accident Proneness
% 211.46/211.63 |- skos__broader mesh__D000057smesh__D001519
% 211.46/211.63 |- mesh__historyNote mesh__D000057 75
% 211.46/211.63 |- skos__hiddenLabel mesh__D000057 Proneness, Accident
% 211.46/211.63 |- mesh__recordMaintainer mesh__D000057 TGC
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D000057 75
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D000057 2003
% 211.46/211.63 |- skos__scopeNote mesh__D000057
% 211.46/211.63 Tendency toward involvement in accidents. Implies certain personality characteristics which predispose to accidents.%A%
% 211.46/211.63 |- mesh__dateRevised mesh__D000057 2002-07-02
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D000057 2005
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D000057 2004
% 211.46/211.63 |- mesh__dateEstablished mesh__D000057 1975-09-01
% 211.46/211.63 |- skos__hiddenLabel mesh__D000057 Accident Pronenesses
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D000057 2006
% 211.46/211.63 |- skos__annotation mesh__D005540
% 211.46/211.63 GEN or unspecified; prefer specifics; do not confuse with FORCED EXPIRATORY VOLUME, a specific test of pulm ventilation; usually NIM%A%
% 211.46/211.63 |- rdf__type mesh__D005540sskos__Concept
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D005540 2005
% 211.46/211.63 |- mesh__recordMaintainer mesh__D005540 nns
% 211.46/211.63 |- skos__altLabel mesh__D005540 Flow Rates, Forced Expiratory
% 211.46/211.63 |- mesh__recordOriginator mesh__D005540 NLM
% 211.46/211.63 |- skos__altLabel mesh__D005540 Expiratory Forced Flow Rates
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D005540 2006
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D005540 75
% 211.46/211.63 |- skos__scopeNote mesh__D005540
% 211.46/211.63 The rate of airflow measured during a FORCED VITAL CAPACITY determination.%A%
% 211.46/211.63 |- mesh__historyNote mesh__D005540 75
% 211.46/211.63 |- skos__altLabel mesh__D005540 Flow Rates, Expiratory Forced
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D005540 2004
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D005540 sjn
% 211.46/211.63 |- mesh__dateCreated mesh__D005540 1974-11-19
% 211.46/211.63 |- mesh__dateEstablished mesh__D005540 1975-09-01
% 211.46/211.63 |- skos__historyNote mesh__D005540 Spirometry %28%1966-1974%29%
% 211.46/211.63 |- mesh__dateRevised mesh__D005540 2003-07-09
% 211.46/211.63 |- skos__prefLabel mesh__D005540 Forced Expiratory Flow Rates
% 211.46/211.63 |- skos__broader mesh__D005540smesh__D012123
% 211.46/211.63 |- skos__historyNote mesh__D005540 Respiratory Airflow %28%1971-1974%29%
% 211.46/211.63 |- mesh__dateEstablished mesh__D052196 2006-01-01
% 211.46/211.63 |- skos__historyNote mesh__D052196 Lactobacillus %28%1967-2005%29%
% 211.46/211.63 |- rdf__type mesh__D052196sskos__Concept
% 211.46/211.63 |- mesh__historyNote mesh__D052196 2006
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D052196 sjn
% 211.46/211.63 |- mesh__recordMaintainer mesh__D052196 ags
% 211.46/211.63 |- mesh__dateCreated mesh__D052196 2005-06-30
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D052196 2006
% 211.46/211.63 |- mesh__recordOriginator mesh__D052196 ags
% 211.46/211.63 |- skos__broader mesh__D052196smesh__D007778
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D052196 2006
% 211.46/211.63 |- skos__scopeNote mesh__D052196
% 211.46/211.63 A species of gram-positive, rod-shaped LACTIC ACID bacteria that is frequently used as starter culture in SILAGE fermentation, sourdough, and lactic-acid-fermented types of beer and wine.%A%
% 211.46/211.63 |- skos__prefLabel mesh__D052196 Lactobacillus brevis
% 211.46/211.63 |- skos__scopeNote mesh__D010485
% 211.46/211.63 Inflammation of the PERIAPICAL TISSUE. It includes general, unspecified, or acute nonsuppurative inflammation. Chronic nonsuppurative inflammation is PERIAPICAL GRANULOMA. Suppurative inflammation is PERIAPICAL ABSCESS.%A%
% 211.46/211.63 |- skos__prefLabel mesh__D010485 Periapical Periodontitis
% 211.46/211.63 |- mesh__recordMaintainer mesh__D010485 ssb
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D010485 sjn
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Periodontitis, Periapical
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D010485 2006
% 211.46/211.63 |- skos__altLabel mesh__D010485 Periodontitis, Apical
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D010485 2005
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Nonsuppurative Periodontitis, Acute
% 211.46/211.63 |- skos__historyNote mesh__D010485 Periodontal Diseases %28%1966-1979%29%
% 211.46/211.63 |- skos__annotation mesh__D010485 GEN or unspecified
% 211.46/211.63 |- skos__related mesh__D010485smesh__D011671
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Periodontitides, Apical
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Nonsuppurative Periodontitides, Acute
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D010485 2004
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Periapical Periodontitides
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Acute Nonsuppurative Periodontitis
% 211.46/211.63 |- mesh__historyNote mesh__D010485 80
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Apical Periodontitides
% 211.46/211.63 |- mesh__dateCreated mesh__D010485 1979-04-25
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D010485 80
% 211.46/211.63 |- skos__broader mesh__D010485smesh__D010483
% 211.46/211.63 |- rdf__type mesh__D010485sskos__Concept
% 211.46/211.63 |- mesh__dateEstablished mesh__D010485 1980-01-01
% 211.46/211.63 |- mesh__dateRevised mesh__D010485 2003-07-09
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Acute Nonsuppurative Periodontitides
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Apical Periodontitis
% 211.46/211.63 |- mesh__recordOriginator mesh__D010485 SMH
% 211.46/211.63 |- skos__historyNote mesh__D010485 Periodontitis %28%1966-1979%29%
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Periodontitides, Periapical
% 211.46/211.63 |- skos__hiddenLabel mesh__D010485 Periodontitides, Acute Nonsuppurative
% 211.46/211.63 |- mesh__dateRevised mesh__D004448 2004-07-07
% 211.46/211.63 |- skos__hiddenLabel mesh__D004448 NSC526417
% 211.46/211.63 |- mesh__recordOriginator mesh__D004448 SH
% 211.46/211.63 |- skos__hiddenLabel mesh__D004448 NSC 526417
% 211.46/211.63 |- skos__historyNote mesh__D004448 Quinoxalines %28%1972-1975%29%
% 211.46/211.63 |- skos__prefLabel mesh__D004448 Echinomycin
% 211.46/211.63 |- skos__historyNote mesh__D004448 Antibiotics %28%1968-1975%29%
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D004448 2005
% 211.46/211.63 |- skos__broader mesh__D004448smesh__D011810
% 211.46/211.63 |- mesh__dateEstablished mesh__D004448 1991-01-01
% 211.46/211.63 |- skos__historyNote mesh__D004448 Peptides, Cyclic %28%1975%29%
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D004448 2006
% 211.46/211.63 |- mesh__historyNote mesh__D004448
% 211.46/211.63 91%28%76%29%; was see under QUINOXALINES 1976-90
% 211.46/211.63 |- mesh__dateCreated mesh__D004448 1975-07-18
% 211.46/211.63 |- rdf__type mesh__D004448sskos__Concept
% 211.46/211.63 |- skos__altLabel mesh__D004448 Quinomycin A
% 211.46/211.63 |- mesh__recordMaintainer mesh__D004448 ssb
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D004448
% 211.46/211.63 91; was see under QUINOXALINES 1976-90
% 211.46/211.63 |- skos__scopeNote mesh__D004448
% 211.46/211.63 A cytotoxic polypeptide quinoxaline antibiotic isolated from Streptomyces echinatus that binds to DNA and inhibits RNA synthesis.%A%
% 211.46/211.63 |- skos__broader mesh__D004448smesh__D010456
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D004448 sjn
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D015170 89
% 211.46/211.63 |- skos__historyNote mesh__D015170 Pressure %28%1966-1988%29%
% 211.46/211.63 |- skos__altLabel mesh__D015170 Pressure, Cerebrospinal Fluid
% 211.46/211.63 |- mesh__dateCreated mesh__D015170 1988-04-12
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 2004
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 1996
% 211.46/211.63 |- rdf__type mesh__D015170sskos__Concept
% 211.46/211.63 |- skos__altLabel mesh__D015170 Cerebrospinal Fluid Pressures
% 211.46/211.63 |- skos__prefLabel mesh__D015170 Cerebrospinal Fluid Pressure
% 211.46/211.63 |- skos__historyNote mesh__D015170 Cerebrospinal Fluid %28%1966-1988%29%
% 211.46/211.63 |- skos__altLabel mesh__D015170 Pressures, Cerebrospinal Fluid
% 211.46/211.63 |- skos__hiddenLabel mesh__D015170 Fluid Pressure, Cerebrospinal
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 2005
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 1997
% 211.46/211.63 |- skos__hiddenLabel mesh__D015170 Pressure, Spinal Fluid
% 211.46/211.63 |- skos__hiddenLabel mesh__D015170 Fluid Pressures, Spinal
% 211.46/211.63 |- skos__related mesh__D015170smesh__D007427
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 2006
% 211.46/211.63 |- skos__hiddenLabel mesh__D015170 Pressures, Spinal Fluid
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 2000
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 1998
% 211.46/211.63 |- skos__hiddenLabel mesh__D015170 Fluid Pressures, Cerebrospinal
% 211.46/211.63 |- skos__historyNote mesh__D015170 Intracranial Pressure %28%1966-1988%29%
% 211.46/211.63 |- mesh__historyNote mesh__D015170 89
% 211.46/211.63 |- mesh__dateRevised mesh__D015170 1993-06-02
% 211.46/211.63 |- mesh__dateEstablished mesh__D015170 1989-01-01
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 1994
% 211.46/211.63 |- skos__hiddenLabel mesh__D015170 Spinal Fluid Pressures
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 2001
% 211.46/211.63 |- skos__hiddenLabel mesh__D015170 Fluid Pressure, Spinal
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 1999
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D015170 PLS
% 211.46/211.63 |- skos__annotation mesh__D015170 DF: CSF PRESSURE
% 211.46/211.63 |- skos__broader mesh__D015170smesh__D009424
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 2003
% 211.46/211.63 |- mesh__recordMaintainer mesh__D015170 TAP
% 211.46/211.63 |- mesh__recordOriginator mesh__D015170 SCD
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 1995
% 211.46/211.63 |- skos__scopeNote mesh__D015170
% 211.46/211.63 Manometric pressure of the cerebrospinal fluid as measured by lumbar, cerebroventricular, or cisternal puncture. Within the cranial cavity it is called INTRACRANIAL PRESSURE.%A%
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D015170 2002
% 211.46/211.63 |- skos__altLabel mesh__D009133 Atrophy, Muscle
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Atrophy, Neurogenic Muscular
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Muscular Atrophy, Neurotrophic
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Muscular Atrophies, Neurogenic
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Muscular Atrophies, Neurotrophic
% 211.46/211.63 |- rdf__type mesh__D009133sskos__Concept
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Atrophies, Neurogenic Muscular
% 211.46/211.63 |- mesh__dateRevised mesh__D009133 1999-11-04
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Muscular Atrophies
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Atrophy, Muscular
% 211.46/211.63 |- mesh__recordOriginator mesh__D009133 NLM
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D009133 2000
% 211.46/211.63 |- skos__broader mesh__D009133smesh__D020879
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D009133 sjn
% 211.46/211.63 |- skos__prefLabel mesh__D009133 Muscular Atrophy
% 211.46/211.63 |- skos__annotation mesh__D009133
% 211.46/211.63 MUSCULAR ATROPHY, SPINAL is also available
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D009133 2003
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Atrophies, Muscular
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D009133 2001
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Neurotrophic Muscular Atrophies
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D009133 2004
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D009133 2005
% 211.46/211.63 |- mesh__dateCreated mesh__D009133 1999-01-01
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Muscle Atrophy
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Atrophies, Muscle
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D009133 2006
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Muscular Atrophy, Neurogenic
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Neurogenic Muscular Atrophies
% 211.46/211.63 |- skos__broader mesh__D009133smesh__D001284
% 211.46/211.63 |- skos__altLabel mesh__D009133 Neurotrophic Muscular Atrophy
% 211.46/211.63 |- skos__scopeNote mesh__D009133
% 211.46/211.63 Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.%A%
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D009133 2002
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Muscle Atrophies
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Atrophies, Neurotrophic Muscular
% 211.46/211.63 |- skos__related mesh__D009133smesh__D020966
% 211.46/211.63 |- mesh__recordMaintainer mesh__D009133 KEV
% 211.46/211.63 |- skos__hiddenLabel mesh__D009133 Atrophy, Neurotrophic Muscular
% 211.46/211.63 |- skos__prefLabel mesh__D001150 Arsenazo III
% 211.46/211.63 |- mesh__recordOriginator mesh__D001150 SH
% 211.46/211.63 |- skos__annotation mesh__D001150 D25-26 qualif
% 211.46/211.63 |- skos__historyNote mesh__D001150 Dyes %28%1966-1979%29%
% 211.46/211.63 |- skos__scopeNote mesh__D001150
% 211.46/211.63 Metallochrome indicator that changes color when complexed to the calcium ion under physiological conditions. It is used to measure local calcium ion concentrations in vivo.%A%
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D001150 NLM
% 211.46/211.63 |- skos__broader mesh__D001150smesh__D001391
% 211.46/211.63 |- skos__historyNote mesh__D001150
% 211.46/211.63 Indicators and Reagents %28%1966-1979%29%
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D001150 2006
% 211.46/211.63 |- skos__hiddenLabel mesh__D001150 III, Arsenazo
% 211.46/211.63 |- mesh__historyNote mesh__D001150
% 211.46/211.63 91%28%80%29%; was see under AZO COMPOUNDS 1980-90
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D001150
% 211.46/211.63 91; was see under AZO COMPOUNDS 1980-90
% 211.46/211.63 |- skos__historyNote mesh__D001150 Azo Compounds %28%1966-1979%29%
% 211.46/211.63 |- mesh__dateCreated mesh__D001150 1979-05-30
% 211.46/211.63 |- skos__broader mesh__D001150smesh__D001152
% 211.46/211.63 |- mesh__recordMaintainer mesh__D001150 NLM
% 211.46/211.63 |- rdf__type mesh__D001150sskos__Concept
% 211.46/211.63 |- skos__historyNote mesh__D001150 Arsenicals %28%1966-1979%29%
% 211.46/211.63 |- mesh__dateRevised mesh__D001150 2005-07-06
% 211.46/211.63 |- mesh__dateEstablished mesh__D001150 1991-01-01
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014876 2005
% 211.46/211.63 |- mesh__dateCreated mesh__D014876 1999-01-01
% 211.46/211.63 |- skos__hiddenLabel mesh__D014876 Pollutions, Thermal Water
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D014876 sjn
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D014876
% 211.46/211.63 WATER POLLUTION, THERMAL was heading 1973-96; THERMAL WATER POLLUTION was see WATER POLLUTION, THERMAL 1973-96%A%
% 211.46/211.63 |- mesh__historyNote mesh__D014876
% 211.46/211.63 WATER POLLUTION, THERMAL was heading 1971-96 %28%Prov 1971-72%29%; THERMAL WATER POLLUTION was see WATER POLLUTION, THERMAL 1973-96%A%
% 211.46/211.63 |- mesh__recordOriginator mesh__D014876 NLM
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014876 2006
% 211.46/211.63 |- skos__hiddenLabel mesh__D014876 Pollution, Water
% 211.46/211.63 |- skos__hiddenLabel mesh__D014876 Pollutions, Water
% 211.46/211.63 |- mesh__dateRevised mesh__D014876 1999-11-03
% 211.46/211.63 |- mesh__recordMaintainer mesh__D014876 kle
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014876 2000
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014876 2003
% 211.46/211.63 |- skos__hiddenLabel mesh__D014876 Pollution, Thermal Water
% 211.46/211.63 |- rdf__type mesh__D014876sskos__Concept
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014876 2001
% 211.46/211.63 |- skos__broader mesh__D014876smesh__D004787
% 211.46/211.63 |- skos__hiddenLabel mesh__D014876 Water Pollutions
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014876 2004
% 211.46/211.63 |- skos__hiddenLabel mesh__D014876 Thermal Water Pollutions
% 211.46/211.63 |- skos__prefLabel mesh__D014876 Water Pollution
% 211.46/211.63 |- skos__annotation mesh__D014876
% 211.46/211.63 IM; coord with source of pollution %28%IM%29%; note X ref THERMAL WATER POLLUTION: coord with HEAT %28%IM%29% only if heat is particularly discussed; specify geog if pertinent%A%
% 211.46/211.63 |- skos__hiddenLabel mesh__D014876 Water Pollutions, Thermal
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014876 2002
% 211.46/211.63 |- skos__altLabel mesh__D014876 Water Pollution, Thermal
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014078 1998
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014078 2003
% 211.46/211.63 |- mesh__dateEstablished mesh__D014078 1965-01-01
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D014078 SJN
% 211.46/211.63 |- skos__broader mesh__D014078smesh__D009063
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014078 2001
% 211.46/211.63 |- skos__prefLabel mesh__D014078 Tooth Eruption
% 211.46/211.63 |- skos__hiddenLabel mesh__D014078 Eruptions, Tooth
% 211.46/211.63 |- rdf__type mesh__D014078sskos__Concept
% 211.46/211.63 |- mesh__recordMaintainer mesh__D014078 TGC
% 211.46/211.63 |- skos__hiddenLabel mesh__D014078 Eruption, Tooth
% 211.46/211.63 |- mesh__historyNote mesh__D014078 65
% 211.46/211.63 |- skos__hiddenLabel mesh__D014078 Tooth Eruptions
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014078 2000
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D014078 65
% 211.46/211.63 |- mesh__dateRevised mesh__D014078 1997-06-20
% 211.46/211.63 |- mesh__dateCreated mesh__D014078 1999-01-01
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014078 2006
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014078 2002
% 211.46/211.63 |- mesh__recordOriginator mesh__D014078 NLM
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014078 2005
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014078 1999
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D014078 2004
% 211.46/211.63 |- skos__scopeNote mesh__D008839
% 211.46/211.63 Electrodes with an extremely small tip, used in a voltage clamp or other apparatus to stimulate or record bioelectric potentials of single cells intracellularly or extracellularly. %28%Dorland, 28th ed%29%%A%
% 211.46/211.63 |- skos__historyNote mesh__D008839 Electrodes %28%1968-1970%29%
% 211.46/211.63 |- mesh__dateCreated mesh__D008839 1999-01-01
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008839 2002
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008839 2005
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008839 2004
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008839 1999
% 211.46/211.63 |- mesh__recordOriginator mesh__D008839 NLM
% 211.46/211.63 |- mesh__publicMeSHNote mesh__D008839 73
% 211.46/211.63 |- mesh__recordMaintainer mesh__D008839 PXP
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008839 2006
% 211.46/211.63 |- skos__altLabel mesh__D008839 Electrodes, Miniaturized
% 211.46/211.63 |- skos__hiddenLabel mesh__D008839 Miniaturized Electrode
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008839 2000
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D008839 SJN
% 211.46/211.63 |- rdf__type mesh__D008839sskos__Concept
% 211.46/211.63 |- mesh__historyNote mesh__D008839 73%28%71%29%
% 211.46/211.63 |- skos__annotation mesh__D008839 NIM
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008839 2001
% 211.46/211.63 |- skos__prefLabel mesh__D008839 Microelectrodes
% 211.46/211.63 |- skos__hiddenLabel mesh__D008839 Miniaturized Electrodes
% 211.46/211.63 |- skos__broader mesh__D008839smesh__D004566
% 211.46/211.63 |- skos__hiddenLabel mesh__D008839 Microelectrode
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008839 2003
% 211.46/211.63 |- skos__hiddenLabel mesh__D008839 Electrode, Miniaturized
% 211.46/211.63 |- mesh__dateEstablished mesh__D008839 1973-01-01
% 211.46/211.63 |- mesh__activeMeSHYear mesh__D008839 1998
% 211.46/211.63 |- mesh__dateRevised mesh__D008839 1997-06-20
% 211.46/211.63 |- skos__hiddenLabel mesh__D000856 Nervosas, Anorexia
% 211.46/211.63 |- skos__related mesh__D000856smesh__D000855
% 211.46/211.63 |- skos__broader mesh__D000856smesh__D001068
% 211.46/211.63 |- mesh__dateCreated mesh__D000856 1999-01-01
% 211.46/211.63 |- skos__annotation mesh__D000856 ANOREXIA is also available
% 211.46/211.63 |- skos__hiddenLabel mesh__D000856 Anorexia Nervosas
% 211.46/211.63 |- skos__scopeNote mesh__D000856
% 211.46/211.63 An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A%
% 211.46/211.63 |- skos__hiddenLabel mesh__D000856 Nervosa, Anorexia
% 211.46/211.63 |- mesh__dateRevised mesh__D000856 2005-06-30
% 211.46/211.63 |- mesh__recordOriginator mesh__D000856 NLM
% 211.46/211.63 |- mesh__recordAuthorizer mesh__D000856 sjn
% 211.46/211.63 |- rdf__type mesh__D000856sskos__Concept
% 211.46/211.64 |- skos__prefLabel mesh__D000856 Anorexia Nervosa
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000856 2006
% 211.46/211.64 |- mesh__recordMaintainer mesh__D000856 lkt
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 Four Dimensional Echocardiography
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019561 2002
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 Echocardiographies, 4D
% 211.46/211.64 |- mesh__dateEstablished mesh__D019561 1997-01-01
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019561 2003
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 Echocardiography, Four Dimensional
% 211.46/211.64 |- mesh__historyNote mesh__D019561 97
% 211.46/211.64 |- skos__altLabel mesh__D019561 4D Echocardiography
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 Echocardiographies, Four-Dimensional
% 211.46/211.64 |- skos__prefLabel mesh__D019561 Echocardiography, Four-Dimensional
% 211.46/211.64 |- skos__annotation mesh__D019561
% 211.46/211.64 ECHOCARDIOGRAPHY, THREE-DIMENSIONAL is also available; DF: ECHOCARDIOGR 4D%A%
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 4 D Echocardiography
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 Echocardiography, 4 D
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019561 2004
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 Echocardiographies, 4-D
% 211.46/211.64 |- skos__altLabel mesh__D019561 Echocardiography, 4-D
% 211.46/211.64 |- skos__broader mesh__D019561smesh__D019560
% 211.46/211.64 |- mesh__recordMaintainer mesh__D019561 PXP
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D019561 97
% 211.46/211.64 |- mesh__dateRevised mesh__D019561 2000-06-21
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 Four-Dimensional Echocardiographies
% 211.46/211.64 |- mesh__recordOriginator mesh__D019561 TGC
% 211.46/211.64 |- skos__altLabel mesh__D019561 Four-Dimensional Echocardiography
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019561 2005
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 4-D Echocardiographies
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D019561 sjn
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019561 2006
% 211.46/211.64 |- skos__hiddenLabel mesh__D019561 4D Echocardiographies
% 211.46/211.64 |- skos__altLabel mesh__D019561 Echocardiography, 4D
% 211.46/211.64 |- skos__scopeNote mesh__D019561
% 211.46/211.64 Dynamic three-dimensional echocardiography using the added dimension of time to impart the cinematic perception of motion. %28%Mayo Clin Proc 1993;68:221-40%29%%A%
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019561 2001
% 211.46/211.64 |- rdf__type mesh__D019561sskos__Concept
% 211.46/211.64 |- mesh__dateCreated mesh__D019561 1996-06-10
% 211.46/211.64 |- skos__altLabel mesh__D019561 4-D Echocardiography
% 211.46/211.64 |- skos__historyNote mesh__D019561 Echocardiography %28%1993-1996%29%
% 211.46/211.64 |- skos__prefLabel mesh__D000058 Accidental Falls
% 211.46/211.64 |- mesh__historyNote mesh__D000058
% 211.46/211.64 91%28%87%29%; was see under ACCIDENTS 1987-90
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000058 2006
% 211.46/211.64 |- mesh__dateRevised mesh__D000058 2003-07-09
% 211.46/211.64 |- mesh__recordOriginator mesh__D000058 SH
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000058 2005
% 211.46/211.64 |- skos__hiddenLabel mesh__D000058 Fall, Accidental
% 211.46/211.64 |- skos__hiddenLabel mesh__D000058 Accidental Fall
% 211.46/211.64 |- skos__scopeNote mesh__D000058
% 211.46/211.64 Falls due to slipping or tripping which result in injury.%A%
% 211.46/211.64 |- skos__altLabel mesh__D000058 Falls, Accidental
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D000058 sjn
% 211.46/211.64 |- rdf__type mesh__D000058sskos__Concept
% 211.46/211.64 |- mesh__dateEstablished mesh__D000058 1991-01-01
% 211.46/211.64 |- skos__broader mesh__D000058smesh__D000059
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D000058
% 211.46/211.64 91; was see under ACCIDENTS 1987-90
% 211.46/211.64 |- mesh__recordMaintainer mesh__D000058 lkt
% 211.46/211.64 |- mesh__dateCreated mesh__D000058 1986-06-24
% 211.46/211.64 |- skos__annotation mesh__D000058
% 211.46/211.64 coord IM with specific inj %28%IM%29% if pertinent
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000058 2004
% 211.46/211.64 |- skos__historyNote mesh__D000058 Accidents %28%1966-1986%29%
% 211.46/211.64 |- skos__hiddenLabel mesh__D005541 Vital Capacities, Timed
% 211.46/211.64 |- skos__prefLabel mesh__D005541 Forced Expiratory Volume
% 211.46/211.64 |- skos__hiddenLabel mesh__D005541 Timed Vital Capacities
% 211.46/211.64 |- skos__altLabel mesh__D005541 Vital Capacity, Timed
% 211.46/211.64 |- mesh__historyNote mesh__D005541 75
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D005541 2004
% 211.46/211.64 |- skos__hiddenLabel mesh__D005541 Expiratory Volume, Forced
% 211.46/211.64 |- skos__scopeNote mesh__D005541
% 211.46/211.64 Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.%A%
% 211.46/211.64 |- skos__hiddenLabel mesh__D005541 Forced Expiratory Volumes
% 211.46/211.64 |- skos__altLabel mesh__D005541 Timed Vital Capacity
% 211.46/211.64 |- mesh__dateRevised mesh__D005541 2003-07-09
% 211.46/211.64 |- skos__broader mesh__D005541smesh__D012123
% 211.46/211.64 |- mesh__recordMaintainer mesh__D005541 nns
% 211.46/211.64 |- mesh__dateEstablished mesh__D005541 1975-09-01
% 211.46/211.64 |- skos__hiddenLabel mesh__D005541 Capacity, Timed Vital
% 211.46/211.64 |- skos__hiddenLabel mesh__D005541 Volume, Forced Expiratory
% 211.46/211.64 |- skos__annotation mesh__D005541
% 211.46/211.64 usually NIM; do not confuse with FORCED EXPIRATORY FLOW RATES; DF: FEV%A%
% 211.46/211.64 |- skos__altLabel mesh__D005541 FEVt
% 211.46/211.64 |- skos__altLabel mesh__D005541 Forced Vital Capacity, Timed
% 211.46/211.64 |- mesh__recordOriginator mesh__D005541 NLM
% 211.46/211.64 |- rdf__type mesh__D005541sskos__Concept
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D005541 2005
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D005541 75
% 211.46/211.64 |- skos__hiddenLabel mesh__D005541 Expiratory Volumes, Forced
% 211.46/211.64 |- mesh__dateCreated mesh__D005541 1974-11-19
% 211.46/211.64 |- skos__historyNote mesh__D005541 Vital Capacity %28%1969-1974%29%
% 211.46/211.64 |- skos__historyNote mesh__D005541 Spirometry %28%1966-1974%29%
% 211.46/211.64 |- skos__hiddenLabel mesh__D005541 Volumes, Forced Expiratory
% 211.46/211.64 |- skos__hiddenLabel mesh__D005541 Capacities, Timed Vital
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D005541 2006
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D005541 sjn
% 211.46/211.64 |- rdf__type mesh__D052197sskos__Concept
% 211.46/211.64 |- mesh__recordMaintainer mesh__D052197 ags
% 211.46/211.64 |- mesh__dateEstablished mesh__D052197 2006-01-01
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D052197 2006
% 211.46/211.64 |- skos__prefLabel mesh__D052197 Lactobacillus fermentum
% 211.46/211.64 |- skos__broader mesh__D052197smesh__D007778
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D052197 2006
% 211.46/211.64 |- skos__altLabel mesh__D052197 Lactobacillus cellobiosus
% 211.46/211.64 |- mesh__historyNote mesh__D052197 2006
% 211.46/211.64 |- skos__scopeNote mesh__D052197
% 211.46/211.64 A species of gram-positive, rod-shaped bacteria associated with DENTAL CARIES.%A%
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D052197 sjn
% 211.46/211.64 |- mesh__dateCreated mesh__D052197 2005-06-30
% 211.46/211.64 |- mesh__recordOriginator mesh__D052197 ags
% 211.46/211.64 |- skos__historyNote mesh__D052197 Lactobacillus %28%1975-2005%29%
% 211.46/211.64 |- mesh__dateRevised mesh__D018469 2005-06-30
% 211.46/211.64 |- skos__scopeNote mesh__D018469
% 211.46/211.64 A species of gram-negative bacteria that is the causative agent of human EHRLICHIOSIS. This organism was first discovered at Fort Chaffee, Arkansas, when blood samples from suspected human ehrlichiosis patients were studied.%A%
% 211.46/211.64 |- mesh__recordOriginator mesh__D018469 PXP
% 211.46/211.64 |- rdf__type mesh__D018469sskos__Concept
% 211.46/211.64 |- skos__historyNote mesh__D018469 Ehrlichia %28%1991-1994%29%
% 211.46/211.64 |- mesh__dateEstablished mesh__D018469 1995-01-01
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D018469 95
% 211.46/211.64 |- mesh__recordMaintainer mesh__D018469 SYSTEM
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D018469 sjn
% 211.46/211.64 |- skos__prefLabel mesh__D018469 Ehrlichia chaffeensis
% 211.46/211.64 |- skos__broader mesh__D018469smesh__D004536
% 211.46/211.64 |- skos__annotation mesh__D018469
% 211.46/211.64 chaffeensis refers to Fort Chaffee, Arkansas, where first discovered; infection: coord IM with EHRLICHIOSIS %28%IM%29%%A%
% 211.46/211.64 |- mesh__dateCreated mesh__D018469 1994-06-03
% 211.46/211.64 |- mesh__historyNote mesh__D018469 95
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D018469 2006
% 211.46/211.64 |- skos__hiddenLabel mesh__D010486 Periodontiums, Apical
% 211.46/211.64 |- mesh__recordOriginator mesh__D010486 NLM
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D010486 73
% 211.46/211.64 |- mesh__historyNote mesh__D010486 73%28%72%29%
% 211.46/211.64 |- skos__historyNote mesh__D010486 Periodontium %28%1966-1971%29%
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D010486 2005
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D010486 sjn
% 211.46/211.64 |- mesh__dateEstablished mesh__D010486 1973-01-01
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D010486 2004
% 211.46/211.64 |- skos__hiddenLabel mesh__D010486 Apical Periodontium
% 211.46/211.64 |- mesh__dateCreated mesh__D010486 1999-01-01
% 211.46/211.64 |- rdf__type mesh__D010486sskos__Concept
% 211.46/211.64 |- skos__hiddenLabel mesh__D010486 Apical Periodontiums
% 211.46/211.64 |- skos__hiddenLabel mesh__D010486 Tissue, Periapical
% 211.46/211.64 |- skos__altLabel mesh__D010486 Periodontium, Apical
% 211.46/211.64 |- mesh__dateRevised mesh__D010486 2003-07-09
% 211.46/211.64 |- mesh__recordMaintainer mesh__D010486 lkt
% 211.46/211.64 |- skos__scopeNote mesh__D010486
% 211.46/211.64 Tissue surrounding the apex of a tooth, including the apical portion of the periodontal membrane and alveolar bone.%A%
% 211.46/211.64 |- skos__hiddenLabel mesh__D010486 Tissues, Periapical
% 211.46/211.64 |- skos__broader mesh__D010486smesh__D010519
% 211.46/211.64 |- skos__prefLabel mesh__D010486 Periapical Tissue
% 211.46/211.64 |- skos__annotation mesh__D010486
% 211.46/211.64 diseases = PERIAPICAL DISEASES; inflammation = PERIAPICAL PERIODONTITIS%A%
% 211.46/211.64 |- skos__hiddenLabel mesh__D010486 Periapical Tissues
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D010486 2006
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D004449 2005
% 211.46/211.64 |- skos__altLabel mesh__D004449 Fascioletta ilocanum
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D004449 2004
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D004449 2006
% 211.46/211.64 |- skos__altLabel mesh__D004449 Euparyphium ilocanum
% 211.46/211.64 |- rdf__type mesh__D004449sskos__Concept
% 211.46/211.64 |- mesh__recordMaintainer mesh__D004449 ags
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D004449 sjn
% 211.46/211.64 |- skos__broader mesh__D004449smesh__D004450
% 211.46/211.64 |- mesh__recordOriginator mesh__D004449 NLM
% 211.46/211.64 |- skos__annotation mesh__D004449
% 211.46/211.64 infection = ECHINOSTOMIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%
% 211.46/211.64 |- skos__prefLabel mesh__D004449 Echinostoma
% 211.46/211.64 |- mesh__dateCreated mesh__D004449 1999-01-01
% 211.46/211.64 |- mesh__dateRevised mesh__D004449 2003-07-09
% 211.46/211.64 |- skos__scopeNote mesh__D004449
% 211.46/211.64 A genus of intestinal flukes of the family Echinostomatidae which consists of many species. They occur in man and other vertebrates. The intermediate hosts are frequently mollusks.%A%
% 211.46/211.64 |- skos__broader mesh__D015171smesh__D003714
% 211.46/211.64 |- skos__historyNote mesh__D015171 Sympathectomy %28%1966-1988%29%
% 211.46/211.64 |- skos__hiddenLabel mesh__D015171 Ganglionectomies
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D015171 2006
% 211.46/211.64 |- skos__historyNote mesh__D015171
% 211.46/211.64 Ganglia, Autonomic or specific %28%1966-1988%29%
% 211.46/211.64 |- mesh__recordMaintainer mesh__D015171 PXP
% 211.46/211.64 |- mesh__historyNote mesh__D015171 89
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D015171 2005
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D015171 1999
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D015171 SJN
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D015171 2002
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D015171 2004
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D015171 1998
% 211.46/211.64 |- rdf__type mesh__D015171sskos__Concept
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D015171 2001
% 211.46/211.64 |- skos__scopeNote mesh__D015171
% 211.46/211.64 Removal of an autonomic or sensory ganglion by any means.%A%
% 211.46/211.64 |- skos__annotation mesh__D015171
% 211.46/211.64 do not use /util except by MeSH definition; coord IM with specific ganglion %28%NIM%29%; coord IM with disease /surg %28%IM%29%%A%
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D015171 2003
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D015171 89
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D015171 2000
% 211.46/211.64 |- mesh__dateEstablished mesh__D015171 1989-01-01
% 211.46/211.64 |- mesh__dateRevised mesh__D015171 1997-06-20
% 211.46/211.64 |- mesh__recordOriginator mesh__D015171 SCD
% 211.46/211.64 |- skos__broader mesh__D015171smesh__D013562
% 211.46/211.64 |- skos__prefLabel mesh__D015171 Ganglionectomy
% 211.46/211.64 |- skos__historyNote mesh__D015171
% 211.46/211.64 Sympathectomy, Chemical %28%1984-1988%29%
% 211.46/211.64 |- mesh__dateCreated mesh__D015171 1988-04-13
% 211.46/211.64 |- skos__annotation mesh__D009134
% 211.46/211.64 MUSCULAR ATROPHY, SPINAL, INFANTILE see SPINAL MUSCULAR ATROPHIES OF CHILDHOOD is also available%A%
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D009134 1988
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Atrophy, Myelopathic Muscular
% 211.46/211.64 |- skos__altLabel mesh__D009134 Progressive Myelopathic Muscular Atrophy
% 211.46/211.64 |- skos__scopeNote mesh__D009134
% 211.46/211.64 A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. %28%Adams et al., Principles of Neurology, 6th ed, p1089%29%%A%
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 X Linked Bulbo Spinal Atrophy
% 211.46/211.64 |- mesh__dateEstablished mesh__D009134 1988-01-01
% 211.46/211.64 |- mesh__recordMaintainer mesh__D009134 ags
% 211.46/211.64 |- skos__altLabel mesh__D009134 Adult Spinal Muscular Atrophy
% 211.46/211.64 |- skos__altLabel mesh__D009134 Spinal Muscular Atrophy, Distal
% 211.46/211.64 |- skos__altLabel mesh__D009134
% 211.46/211.64 Proximal Myelopathic Muscular Atrophy, Progressive
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D009134 sjn
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D009134 2006
% 211.46/211.64 |- skos__altLabel mesh__D009134 Bulbo-Spinal Atrophy, X-Linked
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Bulbo Spinal Atrophy, X Linked
% 211.46/211.64 |- skos__altLabel mesh__D009134 Myelopathic Muscular Atrophy, Progressive
% 211.46/211.64 |- skos__broader mesh__D009134smesh__D013118
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 X-Linked Bulbo-Spinal Atrophies
% 211.46/211.64 |- skos__broader mesh__D009134smesh__D016472
% 211.46/211.64 |- skos__prefLabel mesh__D009134 Muscular Atrophy, Spinal
% 211.46/211.64 |- mesh__recordOriginator mesh__D009134 SD
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D009134 2005
% 211.46/211.64 |- skos__altLabel mesh__D009134
% 211.46/211.64 Spinal Muscular Atrophy, Scapuloperoneal Form
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Atrophy, Spinal Muscular
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D009134 2004
% 211.46/211.64 |- rdf__type mesh__D009134sskos__Concept
% 211.46/211.64 |- mesh__dateCreated mesh__D009134 1987-03-10
% 211.46/211.64 |- mesh__historyNote mesh__D009134 1988
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Bulbo-Spinal Atrophies, X-Linked
% 211.46/211.64 |- skos__altLabel mesh__D009134 Spinal Muscular Atrophy
% 211.46/211.64 |- skos__altLabel mesh__D009134 X-Linked Bulbo-Spinal Atrophy
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Syndrome, Kennedy
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Atrophy, X-Linked Bulbo-Spinal
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D009134 2002
% 211.46/211.64 |- skos__altLabel mesh__D009134 Kennedy Syndrome
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D009134 2003
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Bulbospinal Neuronopathies
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Neuronopathies, Bulbospinal
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Muscular Atrophy, Myelopathic
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Atrophies, X-Linked Bulbo-Spinal
% 211.46/211.64 |- skos__hiddenLabel mesh__D009134 Neuronopathy, Bulbospinal
% 211.46/211.64 |- skos__altLabel mesh__D009134 Spinal Muscular Atrophy, Oculopharyngeal
% 211.46/211.64 |- skos__broader mesh__D009134smesh__D009468
% 211.46/211.64 |- mesh__dateRevised mesh__D009134 2001-07-25
% 211.46/211.64 |- skos__historyNote mesh__D009134 Spinal Cord Diseases %28%1966-1987%29%
% 211.46/211.64 |- skos__historyNote mesh__D009134 Muscular Atrophy %28%1966-1987%29%
% 211.46/211.64 |- skos__prefLabel mesh__D001151 Arsenic
% 211.46/211.64 |- mesh__dateRevised mesh__D001151 2005-06-30
% 211.46/211.64 |- rdf__type mesh__D001151sskos__Concept
% 211.46/211.64 |- skos__annotation mesh__D001151
% 211.46/211.64 As-75; As-69-81, except As-75 = ARSENIC %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%
% 211.46/211.64 |- skos__scopeNote mesh__D001151
% 211.46/211.64 A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, arsenic and certain arsenic compounds have been listed as known carcinogens. %28%From Merck Index, 11th ed%29%%A%
% 211.46/211.64 |- mesh__dateCreated mesh__D001151 1999-01-01
% 211.46/211.64 |- mesh__recordOriginator mesh__D001151 NLM
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D001151 sjn
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D001151 2006
% 211.46/211.64 |- skos__broader mesh__D001151smesh__D004602
% 211.46/211.64 |- mesh__recordMaintainer mesh__D001151 ssb
% 211.46/211.64 |- skos__broader mesh__D004865Q000458smesh__D004865
% 211.46/211.64 |- mesh__preferredCombination mesh__D004865Q000458smesh__D008421
% 211.46/211.64 |- rdf__type mesh__D004865Q000458smesh__CompoundConcept
% 211.46/211.64 |- skos__hiddenLabel mesh__D014877 Pollution, Chemical Water
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D014877 73
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014877 2006
% 211.46/211.64 |- skos__hiddenLabel mesh__D014877 Chemical Water Pollutions
% 211.46/211.64 |- skos__broader mesh__D014877smesh__D014876
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014877 2002
% 211.46/211.64 |- skos__altLabel mesh__D014877 Chemical Water Pollution
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D014877 sjn
% 211.46/211.64 |- skos__historyNote mesh__D014877 Water Pollution %28%1966-1970%29%
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014877 2003
% 211.46/211.64 |- mesh__recordOriginator mesh__D014877 NLM
% 211.46/211.64 |- skos__hiddenLabel mesh__D014877 Pollutions, Chemical Water
% 211.46/211.64 |- rdf__type mesh__D014877sskos__Concept
% 211.46/211.64 |- skos__related mesh__D014877smesh__D005068
% 211.46/211.64 |- mesh__dateEstablished mesh__D014877 1973-01-01
% 211.46/211.64 |- mesh__historyNote mesh__D014877 73%28%71%29%
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014877 2004
% 211.46/211.64 |- skos__historyNote mesh__D014877 specific chemical %28%1966-1970%29%
% 211.46/211.64 |- skos__prefLabel mesh__D014877 Water Pollution, Chemical
% 211.46/211.64 |- mesh__dateRevised mesh__D014877 1999-11-03
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014877 2000
% 211.46/211.64 |- mesh__recordMaintainer mesh__D014877 kle
% 211.46/211.64 |- skos__hiddenLabel mesh__D014877 Water Pollutions, Chemical
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014877 2005
% 211.46/211.64 |- mesh__dateCreated mesh__D014877 1999-01-01
% 211.46/211.64 |- skos__annotation mesh__D014877
% 211.46/211.64 IM; coord with specific source of pollution %28%IM%29%; specify geog if pertinent%A%
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014877 2001
% 211.46/211.64 |- mesh__dateRevised mesh__D014079 1990-05-29
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 2002
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 1995
% 211.46/211.64 |- mesh__dateCreated mesh__D014079 1999-01-01
% 211.46/211.64 |- skos__hiddenLabel mesh__D014079 Eruptions, Ectopic Tooth
% 211.46/211.64 |- mesh__recordOriginator mesh__D014079 NLM
% 211.46/211.64 |- skos__hiddenLabel mesh__D014079 Ectopic Tooth Eruption
% 211.46/211.64 |- skos__hiddenLabel mesh__D014079 Eruption, Ectopic Tooth
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 2006
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 1994
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 1993
% 211.46/211.64 |- skos__prefLabel mesh__D014079 Tooth Eruption, Ectopic
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 2005
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 2004
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D014079 66
% 211.46/211.64 |- mesh__dateEstablished mesh__D014079 1966-01-01
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 1999
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 1992
% 211.46/211.64 |- mesh__historyNote mesh__D014079 66%28%65%29%
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 2001
% 211.46/211.64 |- skos__hiddenLabel mesh__D014079 Ectopic Tooth Eruptions
% 211.46/211.64 |- skos__broader mesh__D014079smesh__D014076
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 2003
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 1998
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 1997
% 211.46/211.64 |- skos__annotation mesh__D014079 note category
% 211.46/211.64 |- skos__hiddenLabel mesh__D014079 Tooth Eruptions, Ectopic
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 2000
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 1996
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D014079 NLM
% 211.46/211.64 |- rdf__type mesh__D014079sskos__Concept
% 211.46/211.64 |- mesh__recordMaintainer mesh__D014079 PLS
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D014079 1991
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D000857 2000; see ANOSMIA 1963-1999
% 211.46/211.64 |- mesh__dateEstablished mesh__D000857 1966-01-01
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D000857 sjn
% 211.46/211.64 |- mesh__recordMaintainer mesh__D000857 KEV
% 211.46/211.64 |- mesh__historyNote mesh__D000857 2000%28%1963%29%
% 211.46/211.64 |- skos__broader mesh__D000857smesh__D012678
% 211.46/211.64 |- skos__hiddenLabel mesh__D000857 Cacosmias
% 211.46/211.64 |- skos__hiddenLabel mesh__D000857 Dysosmias
% 211.46/211.64 |- rdf__type mesh__D000857sskos__Concept
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000857 2000
% 211.46/211.64 |- skos__altLabel mesh__D000857 Smell Disorders
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000857 2005
% 211.46/211.64 |- skos__prefLabel mesh__D000857 Olfaction Disorders
% 211.46/211.64 |- skos__related mesh__D000857smesh__D020431
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000857 2003
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000857 2006
% 211.46/211.64 |- mesh__dateRevised mesh__D000857 1999-11-03
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000857 2001
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000857 2004
% 211.46/211.64 |- skos__scopeNote mesh__D000857
% 211.46/211.64 Loss of or impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions.%A%
% 211.46/211.64 |- skos__altLabel mesh__D000857 Dysosmia
% 211.46/211.64 |- skos__hiddenLabel mesh__D000857 Smell Disorder
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000857 2002
% 211.46/211.64 |- skos__hiddenLabel mesh__D000857 Olfaction Disorder
% 211.46/211.64 |- skos__hiddenLabel mesh__D000857 Paraosmias
% 211.46/211.64 |- mesh__dateCreated mesh__D000857 1999-01-01
% 211.46/211.64 |- mesh__recordOriginator mesh__D000857 NLM
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019562 2001
% 211.46/211.64 |- rdf__type mesh__D019562sskos__Concept
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019562 2005
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019562 2004
% 211.46/211.64 |- skos__broader mesh__D019562smesh__D008828
% 211.46/211.64 |- mesh__dateRevised mesh__D019562 2000-06-22
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019562 2003
% 211.46/211.64 |- skos__altLabel mesh__D019562 Viral Burden
% 211.46/211.64 |- skos__hiddenLabel mesh__D019562 Load, Viral
% 211.46/211.64 |- mesh__dateCreated mesh__D019562 1996-06-10
% 211.46/211.64 |- skos__prefLabel mesh__D019562 Viral Load
% 211.46/211.64 |- skos__hiddenLabel mesh__D019562 Burden, Viral
% 211.46/211.64 |- skos__scopeNote mesh__D019562
% 211.46/211.64 The quantity of measurable virus in the blood. Change in viral load, measured in plasma, is used as a surrogate marker in HIV disease progression.%A%
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019562 2002
% 211.46/211.64 |- mesh__publicMeSHNote mesh__D019562 97
% 211.46/211.64 |- mesh__historyNote mesh__D019562 97
% 211.46/211.64 |- mesh__dateEstablished mesh__D019562 1997-01-01
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D019562 2006
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000059 2003
% 211.46/211.64 |- mesh__dateCreated mesh__D000059 1999-01-01
% 211.46/211.64 |- skos__hiddenLabel mesh__D000059 Accident
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000059 2002
% 211.46/211.64 |- skos__broader mesh__D000059smesh__D011634
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000059 2006
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D000059 sjn
% 211.46/211.64 |- rdf__type mesh__D000059sskos__Concept
% 211.46/211.64 |- skos__annotation mesh__D000059 GEN or unspecified; prefer specifics
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000059 2005
% 211.46/211.64 |- mesh__dateRevised mesh__D000059 1999-11-03
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000059 2001
% 211.46/211.64 |- mesh__recordMaintainer mesh__D000059 kle
% 211.46/211.64 |- mesh__recordOriginator mesh__D000059 NLM
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000059 2000
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D000059 2004
% 211.46/211.64 |- skos__prefLabel mesh__D000059 Accidents
% 211.46/211.64 |- mesh__recordMaintainer mesh__D005542 TAP
% 211.46/211.64 |- mesh__recordAuthorizer mesh__D005542 sjn
% 211.46/211.64 |- skos__prefLabel mesh__D005542 Forearm
% 211.46/211.64 |- skos__hiddenLabel mesh__D005542 Forearms
% 211.46/211.64 |- skos__annotation mesh__D005542
% 211.46/211.64 primates only: use FORELIMB for non-primate vertebrates %26% EXTREMITIES for invertebrates: TN 117; for bones use RADIUS or ULNA; NIM when merely locational as in skin dis %28%IM%29%%A%
% 211.46/211.64 |- mesh__dateRevised mesh__D005542 2002-07-03
% 211.46/211.64 |- skos__broader mesh__D005542smesh__D034941
% 211.46/211.64 |- rdf__type mesh__D005542sskos__Concept
% 211.46/211.64 |- mesh__activeMeSHYear mesh__D005542 2005
% 211.46/211.65 |- mesh__dateCreated mesh__D005542 1999-01-01
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D005542 2003
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D005542 2006
% 211.46/211.65 |- mesh__recordOriginator mesh__D005542 NLM
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D005542 2004
% 211.46/211.65 |- rdf__type mesh__D052198sskos__Concept
% 211.46/211.65 |- skos__broader mesh__D052198smesh__D007778
% 211.46/211.65 |- skos__prefLabel mesh__D052198 Lactobacillus helveticus
% 211.46/211.65 |- mesh__recordOriginator mesh__D052198 ags
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D052198 2006
% 211.46/211.65 |- skos__historyNote mesh__D052198 Lactobacillus %28%1970-2005%29%
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D052198 2006
% 211.46/211.65 |- skos__scopeNote mesh__D052198
% 211.46/211.65 A species of gram-positive bacteria isolated from MILK and cheese-starter cultures.%A%
% 211.46/211.65 |- mesh__dateEstablished mesh__D052198 2006-01-01
% 211.46/211.65 |- mesh__historyNote mesh__D052198 2006
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D052198 sjn
% 211.46/211.65 |- mesh__recordMaintainer mesh__D052198 ags
% 211.46/211.65 |- mesh__dateCreated mesh__D052198 2005-06-30
% 211.46/211.65 |- skos__prefLabel mesh__D010487 Periaqueductal Gray
% 211.46/211.65 |- mesh__dateRevised mesh__D010487 2002-07-03
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010487 2006
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D010487 sjn
% 211.46/211.65 |- skos__hiddenLabel mesh__D010487 Gray, Periaqueductal
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010487 2005
% 211.46/211.65 |- mesh__recordOriginator mesh__D010487 RC
% 211.46/211.65 |- mesh__dateEstablished mesh__D010487 1983-01-01
% 211.46/211.65 |- skos__broader mesh__D010487smesh__D013681
% 211.46/211.65 |- skos__altLabel mesh__D010487 Mesencephalic Central Gray
% 211.46/211.65 |- rdf__type mesh__D010487sskos__Concept
% 211.46/211.65 |- skos__hiddenLabel mesh__D010487 Gray, Midbrain Central
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010487 2004
% 211.46/211.65 |- mesh__recordMaintainer mesh__D010487 mdb
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D010487 83
% 211.46/211.65 |- skos__altLabel mesh__D010487 Midbrain Central Gray
% 211.46/211.65 |- skos__historyNote mesh__D010487 Mesencephalon %28%1966-1982%29%
% 211.46/211.65 |- skos__hiddenLabel mesh__D010487 Central Gray, Mesencephalic
% 211.46/211.65 |- mesh__historyNote mesh__D010487 83
% 211.46/211.65 |- skos__hiddenLabel mesh__D010487 Central Gray, Midbrain
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010487 2003
% 211.46/211.65 |- skos__hiddenLabel mesh__D010487 Gray, Mesencephalic Central
% 211.46/211.65 |- skos__historyNote mesh__D010487 Brain %28%1966-1982%29%
% 211.46/211.65 |- skos__scopeNote mesh__D010487
% 211.46/211.65 Central gray matter surrounding the cerebral aqueduct in the mesencephalon. Physiologically it is probably involved in rage reactions, the lordosis reflex, feeding responses, bladder tonus, and pain.%A%
% 211.46/211.65 |- skos__historyNote mesh__D010487 Cerebral Aqueduct %28%1971-1982%29%
% 211.46/211.65 |- mesh__dateCreated mesh__D010487 1982-04-26
% 211.46/211.65 |- skos__altLabel mesh__D001950 American Regent Brand of Bretylium Tosilate
% 211.46/211.65 |- skos__altLabel mesh__D001950 Bretylium Tosilate
% 211.46/211.65 |- mesh__dateEstablished mesh__D001950 1991-01-01
% 211.46/211.65 |- skos__broader mesh__D001950smesh__D001949
% 211.46/211.65 |- skos__scopeNote mesh__D001950
% 211.46/211.65 An agent that blocks the release of adrenergic transmitters and may have other actions. It was formerly used as an antihypertensive agent, but is now proposed as an anti-arrhythmic.%A%
% 211.46/211.65 |- skos__historyNote mesh__D001950 Bretylium Compounds %28%1969-1975%29%
% 211.46/211.65 |- skos__altLabel mesh__D001950 GlaxoSmithKline Brand of Bretylium Tosilate
% 211.46/211.65 |- skos__hiddenLabel mesh__D001950 Injection, Bretylium Tosylate
% 211.46/211.65 |- skos__hiddenLabel mesh__D001950 Tosilate, Bretylium
% 211.46/211.65 |- skos__historyNote mesh__D001950 Aryl Sulfonates %28%1974-1975%29%
% 211.46/211.65 |- mesh__dateRevised mesh__D001950 2005-06-30
% 211.46/211.65 |- skos__prefLabel mesh__D001950 Bretylium Tosylate
% 211.46/211.65 |- skos__altLabel mesh__D001950 Sabex Brand of Bretylium Tosilate
% 211.46/211.65 |- skos__altLabel mesh__D001950 Abbott Brand of Bretylium Tosilate
% 211.46/211.65 |- mesh__dateCreated mesh__D001950 1975-07-23
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D001950
% 211.46/211.65 91; was see under BRETYLIUM COMPOUNDS 1976-90
% 211.46/211.65 |- mesh__recordMaintainer mesh__D001950 ssb
% 211.46/211.65 |- skos__hiddenLabel mesh__D001950 Tosylate, Bretylium
% 211.46/211.65 |- skos__altLabel mesh__D001950 Du Pont Brand of Bretylium Tosilate
% 211.46/211.65 |- mesh__recordOriginator mesh__D001950 RLS
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D001950 2006
% 211.46/211.65 |- rdf__type mesh__D001950sskos__Concept
% 211.46/211.65 |- mesh__historyNote mesh__D001950
% 211.46/211.65 91%28%76%29%; was see under BRETYLIUM COMPOUNDS 1976-90
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D001950 sjn
% 211.46/211.65 |- skos__hiddenLabel mesh__D001950 Tosylate Injection, Bretylium
% 211.46/211.65 |- skos__hiddenLabel mesh__D009135 Myopathy
% 211.46/211.65 |- skos__altLabel mesh__D009135 Myopathic Conditions
% 211.46/211.65 |- mesh__dateRevised mesh__D009135 1999-11-08
% 211.46/211.65 |- skos__broader mesh__D009135smesh__D009140
% 211.46/211.65 |- rdf__type mesh__D009135sskos__Concept
% 211.46/211.65 |- skos__hiddenLabel mesh__D009135 Muscle Disorder
% 211.46/211.65 |- skos__altLabel mesh__D009135 Myopathies
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009135 2004
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009135 2001
% 211.46/211.65 |- skos__hiddenLabel mesh__D009135 Myopathic Condition
% 211.46/211.65 |- skos__hiddenLabel mesh__D009135 Muscular Disease
% 211.46/211.65 |- skos__scopeNote mesh__D009135
% 211.46/211.65 Acquired, familial, and congenital disorders of skeletal muscle %28%MUSCLE, SKELETAL%29% and smooth muscle %28%MUSCLE, SMOOTH%29%.%A%
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009135 2000
% 211.46/211.65 |- skos__broader mesh__D009135smesh__D009468
% 211.46/211.65 |- mesh__recordMaintainer mesh__D009135 adp
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009135 2003
% 211.46/211.65 |- skos__prefLabel mesh__D009135 Muscular Diseases
% 211.46/211.65 |- skos__annotation mesh__D009135
% 211.46/211.65 GEN; prefer specifics; inflamm dis = MYOSITIS. /congen: consider also Myopathies, Structural, Congenital %26% its indentions%A%
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009135 2006
% 211.46/211.65 |- mesh__recordOriginator mesh__D009135 NLM
% 211.46/211.65 |- mesh__dateCreated mesh__D009135 1999-01-01
% 211.46/211.65 |- skos__altLabel mesh__D009135 Muscle Disorders
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009135 2002
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D009135 sjn
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009135 2005
% 211.46/211.65 |- skos__hiddenLabel mesh__D001152 Compounds, Arsenic
% 211.46/211.65 |- skos__prefLabel mesh__D001152 Arsenicals
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D001152 2002
% 211.46/211.65 |- skos__scopeNote mesh__D001152
% 211.46/211.65 Inorganic or organic compounds that contain arsenic.
% 211.46/211.65 |- mesh__historyNote mesh__D001152 ARSENIC COMPOUNDS was heading 1994-95
% 211.46/211.65 |- mesh__dateCreated mesh__D001152 1999-01-01
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D001152 2004
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D001152 2001
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D001152
% 211.46/211.65 ARSENIC COMPOUNDS was heading 1994-95
% 211.46/211.65 |- skos__annotation mesh__D001152 inorganic or organic arsenic cpds
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D001152 2006
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D001152 2003
% 211.46/211.65 |- skos__broader mesh__D001152smesh__D009942
% 211.46/211.65 |- skos__altLabel mesh__D001152 Arsenic Compounds
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D001152 2005
% 211.46/211.65 |- mesh__dateRevised mesh__D001152 1999-11-03
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D001152 2000
% 211.46/211.65 |- skos__broader mesh__D001152smesh__D007287
% 211.46/211.65 |- mesh__recordOriginator mesh__D001152 NLM
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D001152 sjn
% 211.46/211.65 |- rdf__type mesh__D001152sskos__Concept
% 211.46/211.65 |- mesh__recordMaintainer mesh__D001152 tpw
% 211.46/211.65 |- skos__broader mesh__D014878smesh__D011870
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D014878 2001
% 211.46/211.65 |- skos__hiddenLabel mesh__D014878 Water Pollutions, Radioactive
% 211.46/211.65 |- skos__broader mesh__D014878smesh__D014876
% 211.46/211.65 |- skos__hiddenLabel mesh__D014878 Pollutions, Radioactive Water
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D014878 2006
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D014878 2000
% 211.46/211.65 |- skos__hiddenLabel mesh__D014878 Radioactive Water Pollution
% 211.46/211.65 |- mesh__dateRevised mesh__D014878 1999-11-03
% 211.46/211.65 |- mesh__historyNote mesh__D014878 66
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D014878 2005
% 211.46/211.65 |- mesh__dateEstablished mesh__D014878 1966-01-01
% 211.46/211.65 |- skos__annotation mesh__D014878
% 211.46/211.65 IM; coord with specific source of pollution %28%IM%29%; specify geog if pertinent%A%
% 211.46/211.65 |- skos__hiddenLabel mesh__D014878 Pollution, Radioactive Water
% 211.46/211.65 |- mesh__recordMaintainer mesh__D014878 kle
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D014878 2004
% 211.46/211.65 |- skos__prefLabel mesh__D014878 Water Pollution, Radioactive
% 211.46/211.65 |- rdf__type mesh__D014878sskos__Concept
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D014878 sjn
% 211.46/211.65 |- mesh__dateCreated mesh__D014878 1999-01-01
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D014878 2003
% 211.46/211.65 |- mesh__recordOriginator mesh__D014878 NLM
% 211.46/211.65 |- skos__hiddenLabel mesh__D014878 Radioactive Water Pollutions
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D014878 2002
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D014878 66
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 1999
% 211.46/211.65 |- skos__historyNote mesh__D019563 Physics %28%1966-1996%29%
% 211.46/211.65 |- skos__related mesh__D019563smesh__D001696
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 2002
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D019563 97
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 2004
% 211.46/211.65 |- mesh__dateEstablished mesh__D019563 1997-01-01
% 211.46/211.65 |- skos__prefLabel mesh__D019563 Mechanics
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 1998
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 2001
% 211.46/211.65 |- skos__scopeNote mesh__D019563
% 211.46/211.65 The branch of physics which deals with the motions of material bodies, including kinematics, dynamics, and statics. When the laws of mechanics are applied to living structures, as to the locomotor system, it is referred to as BIOMECHANICS. %28%From Dorland, 28th ed%29%%A%
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 2003
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 1997
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 2000
% 211.46/211.65 |- mesh__dateCreated mesh__D019563 1996-06-20
% 211.46/211.65 |- skos__annotation mesh__D019563
% 211.46/211.65 for materials, machines %26% other inanimate objects; for structures in living bodies index under BIOMECHANICS; GEN; prefer specifics; IM for principle of physics, NIM as coord for object described %28%IM%29%%A%
% 211.46/211.65 |- mesh__historyNote mesh__D019563 97
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 2006
% 211.46/211.65 |- rdf__type mesh__D019563sskos__Concept
% 211.46/211.65 |- skos__broader mesh__D019563smesh__D010825
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D019563 2005
% 211.46/211.65 |- mesh__dateCreated mesh__D000858 1974-11-11
% 211.46/211.65 |- skos__scopeNote mesh__D000858
% 211.46/211.65 Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries %28%OVARIAN FOLLICLE%29%. Depending on the etiology, OVULATION may be induced with appropriate therapy.%A%
% 211.46/211.65 |- rdf__type mesh__D000858sskos__Concept
% 211.46/211.65 |- mesh__recordOriginator mesh__D000858 NLM
% 211.46/211.65 |- mesh__dateRevised mesh__D000858 2004-07-07
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D000858 2005
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D000858 sjn
% 211.46/211.65 |- skos__broader mesh__D000858smesh__D010049
% 211.46/211.65 |- skos__historyNote mesh__D000858 Ovulation %28%1966-1974%29%
% 211.46/211.65 |- skos__broader mesh__D000858smesh__D010060
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D000858 2006
% 211.46/211.65 |- mesh__recordMaintainer mesh__D000858 lkt
% 211.46/211.65 |- skos__prefLabel mesh__D000858 Anovulation
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D000858 75
% 211.46/211.65 |- skos__hiddenLabel mesh__D000858 Anovulations
% 211.46/211.65 |- mesh__historyNote mesh__D000858 75
% 211.46/211.65 |- mesh__dateEstablished mesh__D000858 1975-09-01
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Technics, Theoretical
% 211.46/211.65 |- skos__altLabel mesh__D011580 Techniques, Psychological
% 211.46/211.65 |- mesh__recordMaintainer mesh__D011580 TGC
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D011580 2000
% 211.46/211.65 |- skos__altLabel mesh__D011580 Theoretical Technics
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D011580 1999
% 211.46/211.65 |- mesh__dateCreated mesh__D011580 1999-01-01
% 211.46/211.65 |- skos__broader mesh__D011580smesh__D004191
% 211.46/211.65 |- mesh__historyNote mesh__D011580 98; use explode 1970-97
% 211.46/211.65 |- skos__scopeNote mesh__D011580
% 211.46/211.65 Methods used in the diagnosis and treatment of behavioral, personality, and mental disorders.%A%
% 211.46/211.65 |- skos__prefLabel mesh__D011580 Psychological Techniques
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Technics, Psychologic
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Psychologic Technique
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Psychologic Technic
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D011580 2001
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Technic, Psychologic
% 211.46/211.65 |- skos__altLabel mesh__D011580 Technics, Psychological
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D011580 2005
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Technique, Psychologic
% 211.46/211.65 |- mesh__recordOriginator mesh__D011580 NLM
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Techniques, Theoretical
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Theoretical Technic
% 211.46/211.65 |- skos__annotation mesh__D011580
% 211.46/211.65 GEN or unspecified; prefer specifics; DF: PSYCHOL TECHNIQUES%A%
% 211.46/211.65 |- skos__altLabel mesh__D011580 Technic, Psychological
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D011580 SJN
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Theoretical Technique
% 211.46/211.65 |- skos__altLabel mesh__D011580 Psychological Technic
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D011580 2006
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Technique, Theoretical
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D011580 98
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Technic, Theoretical
% 211.46/211.65 |- skos__altLabel mesh__D011580 Psychologic Techniques
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D011580 2002
% 211.46/211.65 |- mesh__dateEstablished mesh__D011580 1998-01-01
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D011580 2003
% 211.46/211.65 |- skos__hiddenLabel mesh__D011580 Techniques, Psychologic
% 211.46/211.65 |- skos__altLabel mesh__D011580 Psychological Technics
% 211.46/211.65 |- rdf__type mesh__D011580sskos__Concept
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D011580 1998
% 211.46/211.65 |- skos__altLabel mesh__D011580 Theoretical Techniques
% 211.46/211.65 |- mesh__dateRevised mesh__D011580 1997-06-20
% 211.46/211.65 |- skos__altLabel mesh__D011580 Technique, Psychological
% 211.46/211.65 |- skos__altLabel mesh__D011580 Psychological Technique
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D011580 2004
% 211.46/211.65 |- skos__altLabel mesh__D011580 Psychologic Technics
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D005543 2003
% 211.46/211.65 |- skos__prefLabel mesh__D005543 Forearm Injuries
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D005543 2005
% 211.46/211.65 |- mesh__recordOriginator mesh__D005543 NLM
% 211.46/211.65 |- skos__annotation mesh__D005543
% 211.46/211.65 GEN %26% unspecified for soft tissue %26% bones; consider also /inj with specific bones %26% also specific fracture terms; available also are HAND INJURIES; FINGER INJURIES %26% WRIST INJURIES%A%
% 211.46/211.65 |- skos__scopeNote mesh__D005543
% 211.46/211.65 Injuries to the part of the upper limb of the body between the wrist and elbow.%A%
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D005543 2002
% 211.46/211.65 |- skos__broader mesh__D005543smesh__D001134
% 211.46/211.65 |- skos__altLabel mesh__D005543 Injuries, Forearm
% 211.46/211.65 |- mesh__dateRevised mesh__D005543 2001-07-25
% 211.46/211.65 |- mesh__dateCreated mesh__D005543 1999-01-01
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D005543 sjn
% 211.46/211.65 |- skos__hiddenLabel mesh__D005543 Injury, Forearm
% 211.46/211.65 |- skos__hiddenLabel mesh__D005543 Forearm Injury
% 211.46/211.65 |- rdf__type mesh__D005543sskos__Concept
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D005543 2004
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D005543 2006
% 211.46/211.65 |- mesh__recordMaintainer mesh__D005543 mdb
% 211.46/211.65 |- skos__scopeNote mesh__D052199
% 211.46/211.65 A species of gram-negative bacteria isolated from MILK, cheese, and compressed yeast.%A%
% 211.46/211.65 |- mesh__dateCreated mesh__D052199 2005-06-30
% 211.46/211.65 |- mesh__recordOriginator mesh__D052199 ags
% 211.46/211.65 |- skos__broader mesh__D052199smesh__D007778
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D052199 2006
% 211.46/211.65 |- skos__prefLabel mesh__D052199 Lactobacillus leichmannii
% 211.46/211.65 |- skos__historyNote mesh__D052199 Lactobacillus %28%1965-2005%29%
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D052199 2006
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D052199 sjn
% 211.46/211.65 |- mesh__historyNote mesh__D052199 2006
% 211.46/211.65 |- mesh__dateEstablished mesh__D052199 2006-01-01
% 211.46/211.65 |- rdf__type mesh__D052199sskos__Concept
% 211.46/211.65 |- mesh__recordMaintainer mesh__D052199 ags
% 211.46/211.65 |- mesh__dateCreated mesh__D010488 1999-01-01
% 211.46/211.65 |- skos__hiddenLabel mesh__D010488 Arteritis, Necrotizing
% 211.46/211.65 |- mesh__onlineNote mesh__D010488
% 211.46/211.65 use POLYARTERITIS NODOSA to search PERIARTERITIS NODOSA 1966-94;%A%
% 211.46/211.65 |- rdf__type mesh__D010488sskos__Concept
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010488 2004
% 211.46/211.65 |- skos__hiddenLabel mesh__D010488 Polyarteritis, Essential
% 211.46/211.65 |- skos__hiddenLabel mesh__D010488 Polyarteritides, Essential
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010488 2003
% 211.46/211.65 |- skos__annotation mesh__D010488 a form of necrotizing vasculitis
% 211.46/211.65 |- mesh__recordOriginator mesh__D010488 NLM
% 211.46/211.65 |- mesh__historyNote mesh__D010488
% 211.46/211.65 95; was PERIARTERITIS NODOSA 1963-94; POLYARTERITIS NODOSA was see PERIARTERITIS NODOSA 1968-94%A%
% 211.46/211.65 |- skos__hiddenLabel mesh__D010488 Essential Polyarteritides
% 211.46/211.65 |- skos__broader mesh__D010488smesh__D001167
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D010488 sjn
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010488 2002
% 211.46/211.65 |- mesh__recordMaintainer mesh__D010488 KEV
% 211.46/211.65 |- skos__related mesh__D010488smesh__D020293
% 211.46/211.65 |- skos__hiddenLabel mesh__D010488 Arteritides, Necrotizing
% 211.46/211.65 |- skos__scopeNote mesh__D010488
% 211.46/211.65 A form of necrotizing vasculitis involving small- and medium-sized arteries. The signs and symptoms result from infarction and scarring of the affected organ system.%A%
% 211.46/211.65 |- skos__broader mesh__D010488smesh__D017445
% 211.46/211.65 |- skos__hiddenLabel mesh__D010488 Necrotizing Arteritides
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010488 2006
% 211.46/211.65 |- skos__prefLabel mesh__D010488 Polyarteritis Nodosa
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010488 2001
% 211.46/211.65 |- skos__altLabel mesh__D010488 Periarteritis Nodosa
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D010488
% 211.46/211.65 95; was PERIARTERITIS NODOSA 1963-94; POLYARTERITIS NODOSA was see PERIARTERITIS NODOSA 1968-94%A%
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010488 2005
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D010488 2000
% 211.46/211.65 |- mesh__dateRevised mesh__D010488 1999-11-08
% 211.46/211.65 |- skos__historyNote mesh__D015971 Genes, Regulator %28%1972-1980%29%
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D015971 90
% 211.46/211.65 |- skos__historyNote mesh__D015971 Enzymes %28%1972-1989%29%
% 211.46/211.65 |- mesh__dateRevised mesh__D015971 2002-07-03
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015971 2003
% 211.46/211.65 |- skos__altLabel mesh__D015971 Regulation of Gene Expression, Enzymologic
% 211.46/211.65 |- mesh__historyNote mesh__D015971 90
% 211.46/211.65 |- skos__altLabel mesh__D015971 Enzymologic Gene Expression Regulation
% 211.46/211.65 |- skos__altLabel mesh__D015971 Regulation, Gene Expression, Enzymologic
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015971 2006
% 211.46/211.65 |- skos__prefLabel mesh__D015971 Gene Expression Regulation, Enzymologic
% 211.46/211.65 |- mesh__dateCreated mesh__D015971 1989-05-25
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015971 2005
% 211.46/211.65 |- mesh__recordMaintainer mesh__D015971 NDW
% 211.46/211.65 |- mesh__recordOriginator mesh__D015971 PXP
% 211.46/211.65 |- skos__annotation mesh__D015971
% 211.46/211.65 coord IM with specific enzyme /genet %28%IM%29%; DF: GENE EXPRESSION REG ENZYMOL%A%
% 211.46/211.65 |- skos__broader mesh__D015971smesh__D005786
% 211.46/211.65 |- skos__historyNote mesh__D015971
% 211.46/211.65 Gene Expression Regulation %28%1981-1989%29%
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D015971 sjn
% 211.46/211.65 |- skos__scopeNote mesh__D015971
% 211.46/211.65 Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis.%A%
% 211.46/211.65 |- rdf__type mesh__D015971sskos__Concept
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015971 2004
% 211.46/211.65 |- mesh__dateEstablished mesh__D015971 1990-01-01
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Neoplasms, Primary Supratentorial
% 211.46/211.65 |- skos__altLabel mesh__D015173 Supratentorial Neoplasms, Malignant
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Supratentorial Tumor
% 211.46/211.65 |- skos__scopeNote mesh__D015173
% 211.46/211.65 Primary and metastatic %28%secondary%29% tumors of the brain located above the tentorium cerebelli, a fold of dura mater separating the CEREBELLUM and BRAIN STEM from the cerebral hemispheres and DIENCEPHALON %28%i.e., THALAMUS and HYPOTHALAMUS and related structures%29%. In adults, primary neoplasms tend to arise in the supratentorial compartment, whereas in children they occur more frequently in the infratentorial space. Clinical manifestations vary with the location of the lesion, but SEIZURES; APHASIA; HEMIANOPSIA; hemiparesis; and sensory deficits are relatively common features. Metastatic supratentorial neoplasms are frequently multiple at the time of presentation.%A%
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015173 2004
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Supratentorial Neoplasm, Benign
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Benign Supratentorial Neoplasm
% 211.46/211.65 |- skos__altLabel mesh__D015173 Neoplasms, Supratentorial
% 211.46/211.65 |- skos__prefLabel mesh__D015173 Supratentorial Neoplasms
% 211.46/211.65 |- rdf__type mesh__D015173sskos__Concept
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Primary Supratentorial Neoplasm
% 211.46/211.65 |- mesh__historyNote mesh__D015173 1989
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Neoplasm, Malignant Supratentorial
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Supratentorial Neoplasm, Primary
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015173 2005
% 211.46/211.65 |- skos__altLabel mesh__D015173 Malignant Supratentorial Neoplasms
% 211.46/211.65 |- skos__historyNote mesh__D015173 Brain Neoplasms %28%1966-1988%29%
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Neoplasms, Malignant Supratentorial
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Tumor, Supratentorial
% 211.46/211.65 |- mesh__dateCreated mesh__D015173 1988-04-13
% 211.46/211.65 |- mesh__dateRevised mesh__D015173 1999-12-08
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Neoplasms, Benign Supratentorial
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D015173 ags
% 211.46/211.65 |- skos__altLabel mesh__D015173 Supratentorial Neoplasms, Benign
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015173 2000
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015173 2006
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D015173 1989
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015173 2000A
% 211.46/211.65 |- skos__broader mesh__D015173smesh__D001932
% 211.46/211.65 |- skos__annotation mesh__D015173
% 211.46/211.65 GEN: prefer specifics; coord IM with histol type of neopl %28%IM%29%%A%
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Supratentorial Cancer
% 211.46/211.65 |- mesh__recordOriginator mesh__D015173 EJB
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Tumors, Supratentorial
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Supratentorial Neoplasm
% 211.46/211.65 |- skos__altLabel mesh__D015173 Supratentorial Neoplasms, Primary
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015173 2001
% 211.46/211.65 |- mesh__dateEstablished mesh__D015173 1989-01-01
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Supratentorial Cancers
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Malignant Supratentorial Neoplasm
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Cancers, Supratentorial
% 211.46/211.65 |- mesh__recordMaintainer mesh__D015173 ags
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Neoplasm, Benign Supratentorial
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Neoplasm, Primary Supratentorial
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015173 2002
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Supratentorial Neoplasm, Malignant
% 211.46/211.65 |- skos__hiddenLabel mesh__D015173 Neoplasm, Supratentorial
% 211.46/211.65 |- skos__altLabel mesh__D015173 Supratentorial Tumors
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D015173 2003
% 211.46/211.65 |- mesh__onlineNote mesh__D009934
% 211.46/211.65 use ORGANIZATION AND ADMINISTRATION to search ADMINISTRATIVE MANAGEMENT 1966-67%A%
% 211.46/211.65 |- skos__altLabel mesh__D009934 Administrative Technics
% 211.46/211.65 |- mesh__recordOriginator mesh__D009934 NLM
% 211.46/211.65 |- mesh__publicMeSHNote mesh__D009934
% 211.46/211.65 68; was ADMINISTRATIVE MANAGEMENT 1963-67
% 211.46/211.65 |- skos__prefLabel mesh__D009934 Organization and Administration
% 211.46/211.65 |- skos__altLabel mesh__D009934 Administration and Organization
% 211.46/211.65 |- skos__broader mesh__D009934smesh__D006298
% 211.46/211.65 |- skos__altLabel mesh__D009934 Administrative Techniques
% 211.46/211.65 |- mesh__dateCreated mesh__D009934 1999-01-01
% 211.46/211.65 |- mesh__dateRevised mesh__D009934 2002-07-02
% 211.46/211.65 |- skos__hiddenLabel mesh__D009934 Administrative Technic
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009934 2005
% 211.46/211.65 |- skos__hiddenLabel mesh__D009934 Technic, Administrative
% 211.46/211.65 |- mesh__historyNote mesh__D009934
% 211.46/211.65 68; was ADMINISTRATIVE MANAGEMENT 1963-67
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009934 2006
% 211.46/211.65 |- mesh__recordMaintainer mesh__D009934 jrf
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009934 2003
% 211.46/211.65 |- skos__scopeNote mesh__D009934
% 211.46/211.65 The planning and managing of programs, services, and resources.%A%
% 211.46/211.65 |- skos__hiddenLabel mesh__D009934 Administrative Technique
% 211.46/211.65 |- skos__hiddenLabel mesh__D009934 Administrative Coordination
% 211.46/211.65 |- mesh__recordAuthorizer mesh__D009934 sjn
% 211.46/211.65 |- mesh__dateEstablished mesh__D009934 1968-01-01
% 211.46/211.65 |- skos__hiddenLabel mesh__D009934 Technique, Administrative
% 211.46/211.65 |- skos__annotation mesh__D009934
% 211.46/211.65 GEN only: prefer /organ: Manual 19.7+, 19.8.49; almost never IM; DF: ORGAN ADMIN but do not confuse with ORGAN for ORGANIZATIONS%A%
% 211.46/211.65 |- mesh__activeMeSHYear mesh__D009934 2004
% 211.46/211.65 |- skos__altLabel mesh__D009934 Technics, Administrative
% 211.46/211.65 |- rdf__type mesh__D009934sskos__Concept
% 211.46/211.65 |- mesh__dateCreated mesh__D001951 1999-01-01
% 211.46/211.65 |- skos__annotation mesh__D001951
% 211.46/211.65 in soil, water, dairy prod %26% decaying matter
% 211.46/211.65 |- skos__prefLabel mesh__D001951 Brevibacterium
% 211.46/211.65 |- skos__broader mesh__D001951smesh__D039903
% 211.46/211.65 |- mesh__recordMaintainer mesh__D001951 SYSTEM
% 211.46/211.65 |- mesh__dateRevised mesh__D001951 2005-06-30
% 211.46/211.66 |- skos__broader mesh__D001951smesh__D000192
% 211.46/211.66 |- skos__scopeNote mesh__D001951
% 211.46/211.66 A gram-positive organism found in dairy products, fresh and salt water, marine organisms, insects, and decaying organic matter.%A%
% 211.46/211.66 |- rdf__type mesh__D001951sskos__Concept
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D001951 sjn
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001951 2006
% 211.46/211.66 |- mesh__recordOriginator mesh__D001951 NLM
% 211.46/211.66 |- skos__annotation mesh__D009136
% 211.46/211.66 GEN: prefer specifics; do not confuse with MYOTONIC DYSTROPHY%A%
% 211.46/211.66 |- skos__hiddenLabel mesh__D009136 Myodystrophicas
% 211.46/211.66 |- mesh__recordMaintainer mesh__D009136 lkt
% 211.46/211.66 |- skos__prefLabel mesh__D009136 Muscular Dystrophies
% 211.46/211.66 |- skos__hiddenLabel mesh__D009136 Dystrophies, Muscular
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D009136
% 211.46/211.66 2000; see MUSCULAR DYSTROPHY 1966-1999
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D009136 sjn
% 211.46/211.66 |- skos__related mesh__D009136smesh__D018101
% 211.46/211.66 |- skos__altLabel mesh__D009136 Myodystrophy
% 211.46/211.66 |- mesh__dateCreated mesh__D009136 1999-11-08
% 211.46/211.66 |- skos__altLabel mesh__D009136 Muscular Dystrophy
% 211.46/211.66 |- skos__scopeNote mesh__D009136
% 211.46/211.66 A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.%A%
% 211.46/211.66 |- skos__broader mesh__D009136smesh__D030342
% 211.46/211.66 |- skos__hiddenLabel mesh__D009136 Dystrophy, Muscular
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009136 2006
% 211.46/211.66 |- mesh__historyNote mesh__D009136 2000%28%1966%29%
% 211.46/211.66 |- mesh__dateRevised mesh__D009136 2004-07-07
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009136 2005
% 211.46/211.66 |- skos__altLabel mesh__D009136 Myodystrophica
% 211.46/211.66 |- mesh__recordOriginator mesh__D009136 NLM
% 211.46/211.66 |- skos__broader mesh__D009136smesh__D020966
% 211.46/211.66 |- rdf__type mesh__D009136sskos__Concept
% 211.46/211.66 |- skos__hiddenLabel mesh__D009136 Myodystrophies
% 211.46/211.66 |- mesh__dateCreated mesh__D001153 1999-01-01
% 211.46/211.66 |- mesh__dateEstablished mesh__D001153 1968-01-01
% 211.46/211.66 |- skos__altLabel mesh__D001153 Arsenobenzol
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001153 2004
% 211.46/211.66 |- skos__prefLabel mesh__D001153 Arsphenamine
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001153 2006
% 211.46/211.66 |- mesh__recordOriginator mesh__D001153 NLM
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001153 2003
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D001153 sjn
% 211.46/211.66 |- mesh__onlineNote mesh__D001153
% 211.46/211.66 use ARSPHENAMINE to search ARSPHENAMINES 1966-67
% 211.46/211.66 |- mesh__dateRevised mesh__D001153 2000-06-21
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001153 2005
% 211.46/211.66 |- mesh__historyNote mesh__D001153 68; was ARSPHENAMINES 1963-67
% 211.46/211.66 |- rdf__type mesh__D001153sskos__Concept
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D001153 68; was ARSPHENAMINES 1963-67
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001153 2002
% 211.46/211.66 |- skos__hiddenLabel mesh__D001153 Arsenobenzol, Sodium
% 211.46/211.66 |- mesh__recordMaintainer mesh__D001153 CCR
% 211.46/211.66 |- skos__broader mesh__D001153smesh__D001152
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001153 2001
% 211.46/211.66 |- skos__scopeNote mesh__D019564
% 211.46/211.66 Diagnostic, therapeutic, and investigative procedures prescribed and performed by health professionals, the results of which do not justify the benefits or hazards and costs to the patient.%A%
% 211.46/211.66 |- mesh__dateCreated mesh__D019564 1996-06-10
% 211.46/211.66 |- skos__broader mesh__D019564smesh__D006300
% 211.46/211.66 |- mesh__recordOriginator mesh__D019564 TGC
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D019564 SJN
% 211.46/211.66 |- skos__annotation mesh__D019564
% 211.46/211.66 IM; coord with specific procedure %28%IM%29% with probably /util%A%
% 211.46/211.66 |- mesh__historyNote mesh__D019564 97
% 211.46/211.66 |- mesh__dateEstablished mesh__D019564 1997-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019564 2006
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019564 2002
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D019564 97
% 211.46/211.66 |- rdf__type mesh__D019564sskos__Concept
% 211.46/211.66 |- skos__hiddenLabel mesh__D019564 Procedures, Unnecessary
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019564 2005
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019564 1999
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019564 2001
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019564 2004
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019564 2000
% 211.46/211.66 |- mesh__dateRevised mesh__D019564 1998-06-11
% 211.46/211.66 |- mesh__recordMaintainer mesh__D019564 TPW
% 211.46/211.66 |- skos__hiddenLabel mesh__D019564 Unnecessary Procedure
% 211.46/211.66 |- skos__hiddenLabel mesh__D019564 Procedure, Unnecessary
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019564 2003
% 211.46/211.66 |- skos__altLabel mesh__D019564 Surgery, Unnecessary
% 211.46/211.66 |- skos__prefLabel mesh__D019564 Unnecessary Procedures
% 211.46/211.66 |- skos__prefLabel mesh__D000859 Anoxemia
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D000859 2000
% 211.46/211.66 |- mesh__dateRevised mesh__D000859 1999-11-03
% 211.46/211.66 |- skos__scopeNote mesh__D000859
% 211.46/211.66 Clinical manifestation of respiratory distress consisting of relatively complete absence of oxygen in arterial blood.%A%
% 211.46/211.66 |- mesh__recordMaintainer mesh__D000859 KEV
% 211.46/211.66 |- skos__hiddenLabel mesh__D000859 Anoxemias
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D000859 2004
% 211.46/211.66 |- rdf__type mesh__D000859sskos__Concept
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D000859 2006
% 211.46/211.66 |- mesh__recordOriginator mesh__D000859 NLM
% 211.46/211.66 |- mesh__dateCreated mesh__D000859 1999-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D000859 2003
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D000859 sjn
% 211.46/211.66 |- skos__annotation mesh__D000859 differentiate from ANOXIA
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D000859 2002
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D000859 2005
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D000859 2001
% 211.46/211.66 |- skos__broader mesh__D000859smesh__D000860
% 211.46/211.66 |- skos__hiddenLabel mesh__D000859 Hypoxemias
% 211.46/211.66 |- skos__scopeNote mesh__D011581
% 211.46/211.66 Standardized tests designed to measure abilities, as in intelligence, aptitude, and achievement tests, or to evaluate personality traits.%A%
% 211.46/211.66 |- mesh__recordMaintainer mesh__D011581 JLS
% 211.46/211.66 |- skos__altLabel mesh__D011581 Test, Psychological
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 2000
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 1999
% 211.46/211.66 |- rdf__type mesh__D011581sskos__Concept
% 211.46/211.66 |- skos__annotation mesh__D011581 DF: PSYCHOL TESTS
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 1995
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 1998
% 211.46/211.66 |- skos__altLabel mesh__D011581 Psychologic Tests
% 211.46/211.66 |- skos__hiddenLabel mesh__D011581 Tests, Psychologic
% 211.46/211.66 |- mesh__dateRevised mesh__D011581 1993-06-04
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 2004
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 1994
% 211.46/211.66 |- skos__hiddenLabel mesh__D011581 Psychologic Test
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 2002
% 211.46/211.66 |- skos__altLabel mesh__D011581 Psychological Test
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 2003
% 211.46/211.66 |- skos__hiddenLabel mesh__D011581 Test, Psychologic
% 211.46/211.66 |- skos__broader mesh__D011581smesh__D004191
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 2006
% 211.46/211.66 |- mesh__recordOriginator mesh__D011581 NLM
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 1997
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D011581 PLS
% 211.46/211.66 |- mesh__dateCreated mesh__D011581 1999-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 2001
% 211.46/211.66 |- skos__prefLabel mesh__D011581 Psychological Tests
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 2005
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011581 1996
% 211.46/211.66 |- skos__altLabel mesh__D011581 Tests, Psychological
% 211.46/211.66 |- skos__altLabel mesh__D005544 Projections and Predictions
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 1998
% 211.46/211.66 |- skos__hiddenLabel mesh__D005544 Population Forecasts
% 211.46/211.66 |- mesh__dateEstablished mesh__D005544 1971-01-01
% 211.46/211.66 |- skos__hiddenLabel mesh__D005544 Population Projections
% 211.46/211.66 |- mesh__dateCreated mesh__D005544 1999-01-01
% 211.46/211.66 |- skos__hiddenLabel mesh__D005544 Predictions and Projections
% 211.46/211.66 |- skos__prefLabel mesh__D005544 Forecasting
% 211.46/211.66 |- skos__altLabel mesh__D005544 Population Projection
% 211.46/211.66 |- skos__broader mesh__D005544smesh__D012942
% 211.46/211.66 |- mesh__dateRevised mesh__D005544 1996-06-10
% 211.46/211.66 |- mesh__recordOriginator mesh__D005544 NLM
% 211.46/211.66 |- skos__hiddenLabel mesh__D005544 Projection, Population
% 211.46/211.66 |- mesh__onlineNote mesh__D005544
% 211.46/211.66 use FORECASTING to search FUTUROLOGY 1971-79
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 2002
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D005544 80; was FUTUROLOGY 1971-79
% 211.46/211.66 |- mesh__recordMaintainer mesh__D005544 TGC
% 211.46/211.66 |- rdf__type mesh__D005544sskos__Concept
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D005544 PLS
% 211.46/211.66 |- mesh__historyNote mesh__D005544 80; was FUTUROLOGY 1971-79
% 211.46/211.66 |- skos__scopeNote mesh__D005544
% 211.46/211.66 The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology.%A%
% 211.46/211.66 |- skos__hiddenLabel mesh__D005544 Forecasts, Population
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 2004
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 2001
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 1997
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 2006
% 211.46/211.66 |- skos__annotation mesh__D005544
% 211.46/211.66 IM general only; consider also as IM coord with specific subject /trends %28%IM%29% if future is particularly significant: Manual 19.8.76, 35.2.9%A%
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 1999
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 2003
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 2000
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005544 2005
% 211.46/211.66 |- skos__prefLabel mesh__D010489 Periarthritis
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 2003
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D010489 PLS
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 2000
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 1995
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 1999
% 211.46/211.66 |- skos__annotation mesh__D010489
% 211.46/211.66 %22%inflamm of tissues around a joint%22%
% 211.46/211.66 |- skos__scopeNote mesh__D010489
% 211.46/211.66 Inflammation of the tissues around a joint. %28%Dorland, 27th ed%29%%A%
% 211.46/211.66 |- skos__broader mesh__D010489smesh__D001168
% 211.46/211.66 |- mesh__dateRevised mesh__D010489 1994-05-24
% 211.46/211.66 |- mesh__recordOriginator mesh__D010489 NLM
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 1998
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 2006
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 1997
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 2005
% 211.46/211.66 |- skos__broader mesh__D010489smesh__D002062
% 211.46/211.66 |- mesh__recordMaintainer mesh__D010489 TGC
% 211.46/211.66 |- mesh__dateCreated mesh__D010489 1999-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 2002
% 211.46/211.66 |- rdf__type mesh__D010489sskos__Concept
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 1996
% 211.46/211.66 |- skos__hiddenLabel mesh__D010489 Periarthritides
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 2004
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D010489 2001
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015972 2005
% 211.46/211.66 |- skos__annotation mesh__D015972
% 211.46/211.66 coord IM with specific organ/neopl term with /genet %28%IM%29% + specific histol type of neopl /genet %28%IM%29%; DF: GENE EXPRESSION REG NEOPL%A%
% 211.46/211.66 |- skos__broader mesh__D015972smesh__D005786
% 211.46/211.66 |- skos__historyNote mesh__D015972 specific neoplasm %28%1972-1989%29%
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D015972 sjn
% 211.46/211.66 |- mesh__recordOriginator mesh__D015972 PXP
% 211.46/211.66 |- skos__altLabel mesh__D015972 Regulation, Gene Expression, Neoplastic
% 211.46/211.66 |- skos__altLabel mesh__D015972 Regulation of Gene Expression, Neoplastic
% 211.46/211.66 |- mesh__historyNote mesh__D015972 90
% 211.46/211.66 |- mesh__dateRevised mesh__D015972 2002-07-03
% 211.46/211.66 |- skos__prefLabel mesh__D015972 Gene Expression Regulation, Neoplastic
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015972 2004
% 211.46/211.66 |- rdf__type mesh__D015972sskos__Concept
% 211.46/211.66 |- skos__scopeNote mesh__D015972
% 211.46/211.66 Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.%A%
% 211.46/211.66 |- skos__historyNote mesh__D015972 Genes %28%1972-1989%29%
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015972 2003
% 211.46/211.66 |- mesh__dateEstablished mesh__D015972 1990-01-01
% 211.46/211.66 |- skos__historyNote mesh__D015972
% 211.46/211.66 Gene Expression Regulation %28%1981-1989%29%
% 211.46/211.66 |- skos__altLabel mesh__D015972 Neoplastic Gene Expression Regulation
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015972 2006
% 211.46/211.66 |- mesh__recordMaintainer mesh__D015972 NDW
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D015972 90
% 211.46/211.66 |- mesh__dateCreated mesh__D015972 1989-05-25
% 211.46/211.66 |- mesh__dateEstablished mesh__D015174 1989-01-01
% 211.46/211.66 |- skos__hiddenLabel mesh__D015174 Epidural Neoplasm
% 211.46/211.66 |- skos__annotation mesh__D015174
% 211.46/211.66 coord IM with histol type of neopl %28%IM%29%; coord IM with specific vertebrae %28%NIM%29% to locate site on spinal cord%A%
% 211.46/211.66 |- skos__altLabel mesh__D015174 Epidural Tumors
% 211.46/211.66 |- mesh__dateRevised mesh__D015174 1999-12-08
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015174 2000
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015174 2005
% 211.46/211.66 |- skos__historyNote mesh__D015174 Spinal Neoplasms %28%1966-1988%29%
% 211.46/211.66 |- skos__historyNote mesh__D015174 Spinal Cord Diseases %28%1966-1988%29%
% 211.46/211.66 |- skos__hiddenLabel mesh__D015174 Epidural Neoplasms, Malignant
% 211.46/211.66 |- skos__prefLabel mesh__D015174 Epidural Neoplasms
% 211.46/211.66 |- mesh__dateCreated mesh__D015174 1988-04-13
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D015174 ags
% 211.46/211.66 |- mesh__historyNote mesh__D015174 1989
% 211.46/211.66 |- skos__historyNote mesh__D015174
% 211.46/211.66 Spinal Cord Compression %28%1966-1988%29%
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015174 2006
% 211.46/211.66 |- skos__hiddenLabel mesh__D015174 Epidural Tumor
% 211.46/211.66 |- skos__altLabel mesh__D015174 Malignant Epidural Neoplasm
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015174 2001
% 211.46/211.66 |- mesh__recordMaintainer mesh__D015174 ags
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015174 2003
% 211.46/211.66 |- mesh__recordOriginator mesh__D015174 EJB
% 211.46/211.66 |- skos__broader mesh__D015174smesh__D013120
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015174 2004
% 211.46/211.66 |- rdf__type mesh__D015174sskos__Concept
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015174 2000A
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D015174 1989
% 211.46/211.66 |- skos__altLabel mesh__D015174 Neoplasms, Epidural
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D015174 2002
% 211.46/211.66 |- skos__hiddenLabel mesh__D015174 Malignant Epidural Neoplasms
% 211.46/211.66 |- skos__historyNote mesh__D015174 Spinal Cord Neoplasms %28%1966-1988%29%
% 211.46/211.66 |- skos__scopeNote mesh__D015174
% 211.46/211.66 Neoplasms located in the space between the vertebral PERIOSTEUM and DURA MATER surrounding the SPINAL CORD. Tumors in this location are most often metastatic in origin and may cause neurologic deficits by mass effect on the spinal cord or nerve roots or by interfering with blood supply to the spinal cord.%A%
% 211.46/211.66 |- skos__hiddenLabel mesh__D009935 Affiliations, Organizational
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 2003
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 1999
% 211.46/211.66 |- skos__scopeNote mesh__D009935
% 211.46/211.66 Formal relationships established between otherwise independent organizations. These include affiliation agreements, interlocking boards, common controls, hospital medical school affiliations, etc.%A%
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 2005
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 1996
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 1995
% 211.46/211.66 |- mesh__historyNote mesh__D009935 68
% 211.46/211.66 |- rdf__type mesh__D009935sskos__Concept
% 211.46/211.66 |- mesh__dateCreated mesh__D009935 1999-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 2002
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 1998
% 211.46/211.66 |- mesh__dateEstablished mesh__D009935 1968-01-01
% 211.46/211.66 |- mesh__recordMaintainer mesh__D009935 TGC
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 2001
% 211.46/211.66 |- skos__historyNote mesh__D009935 specific organization %28%1966-1967%29%
% 211.46/211.66 |- skos__annotation mesh__D009935
% 211.46/211.66 med or non-med affiliation; DF: ORGAN AFFILIATION
% 211.46/211.66 |- skos__prefLabel mesh__D009935 Organizational Affiliation
% 211.46/211.66 |- mesh__dateRevised mesh__D009935 1994-05-05
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D009935 PLS
% 211.46/211.66 |- skos__broader mesh__D009935smesh__D009934
% 211.46/211.66 |- mesh__recordOriginator mesh__D009935 NLM
% 211.46/211.66 |- skos__altLabel mesh__D009935 Affiliation, Organizational
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 2000
% 211.46/211.66 |- skos__hiddenLabel mesh__D009935 Organizational Affiliations
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 2004
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D009935 68
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 2006
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009935 1997
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 2001
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 2006
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 2000
% 211.46/211.66 |- skos__hiddenLabel mesh__D001952 Compounds, Bridged
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 2004
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 2005
% 211.46/211.66 |- mesh__recordOriginator mesh__D001952 NLM
% 211.46/211.66 |- skos__broader mesh__D001952smesh__D006844
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 1999
% 211.46/211.66 |- mesh__dateCreated mesh__D001952 1999-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 2003
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 1997
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 1998
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 2002
% 211.46/211.66 |- skos__annotation mesh__D001952 DF: BRIDGED CPDS
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001952 1996
% 211.46/211.66 |- skos__broader mesh__D001952smesh__D011083
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D001952 PLS
% 211.46/211.66 |- mesh__recordMaintainer mesh__D001952 JRT
% 211.46/211.66 |- skos__prefLabel mesh__D001952 Bridged Compounds
% 211.46/211.66 |- mesh__dateRevised mesh__D001952 1995-06-08
% 211.46/211.66 |- skos__scopeNote mesh__D001952
% 211.46/211.66 Cyclic hydrocarbons that contain multiple rings and share one or more atoms.%A%
% 211.46/211.66 |- rdf__type mesh__D001952sskos__Concept
% 211.46/211.66 |- skos__annotation mesh__D009137
% 211.46/211.66 exper or vet but do not use /vet; don%27%t forget to check tag ANIMALS%A%
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009137 2006
% 211.46/211.66 |- skos__hiddenLabel mesh__D009137 Animal Muscular Dystrophy
% 211.46/211.66 |- skos__broader mesh__D009137smesh__D000820
% 211.46/211.66 |- mesh__dateCreated mesh__D009137 1999-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009137 2005
% 211.46/211.66 |- skos__hiddenLabel mesh__D009137 Dystrophy, Animal Muscular
% 211.46/211.66 |- skos__prefLabel mesh__D009137 Muscular Dystrophy, Animal
% 211.46/211.66 |- mesh__recordMaintainer mesh__D009137 ags
% 211.46/211.66 |- mesh__dateEstablished mesh__D009137 1970-01-01
% 211.46/211.66 |- mesh__historyNote mesh__D009137 70
% 211.46/211.66 |- mesh__recordOriginator mesh__D009137 NLM
% 211.46/211.66 |- mesh__dateRevised mesh__D009137 2003-07-30
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D009137 sjn
% 211.46/211.66 |- skos__hiddenLabel mesh__D009137 Dystrophies, Animal Muscular
% 211.46/211.66 |- skos__hiddenLabel mesh__D009137 Animal Muscular Dystrophies
% 211.46/211.66 |- rdf__type mesh__D009137sskos__Concept
% 211.46/211.66 |- skos__hiddenLabel mesh__D009137 Muscular Dystrophies, Animal
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D009137 2004
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D009137 70
% 211.46/211.66 |- skos__historyNote mesh__D009137 Muscular Dystrophy %28%1966-1969%29%
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 2006
% 211.46/211.66 |- skos__broader mesh__D001154smesh__D006809
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 2003
% 211.46/211.66 |- skos__related mesh__D001154smesh__D000716
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 2001
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 1997
% 211.46/211.66 |- skos__hiddenLabel mesh__D001154 Arts
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 2005
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 1999
% 211.46/211.66 |- rdf__type mesh__D001154sskos__Concept
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 2000
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 1998
% 211.46/211.66 |- mesh__recordMaintainer mesh__D001154 TGC
% 211.46/211.66 |- skos__annotation mesh__D001154
% 211.46/211.66 works of art, the field of fine arts, artistic production; art as therapy = ART THERAPY%A%
% 211.46/211.66 |- mesh__recordOriginator mesh__D001154 NLM
% 211.46/211.66 |- mesh__dateRevised mesh__D001154 1996-06-10
% 211.46/211.66 |- skos__related mesh__D001154smesh__D008488
% 211.46/211.66 |- skos__prefLabel mesh__D001154 Art
% 211.46/211.66 |- skos__related mesh__D001154smesh__D008512
% 211.46/211.66 |- mesh__dateCreated mesh__D001154 1999-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 2004
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D001154 2002
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D001154 PLS
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019565 2000
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019565 2006
% 211.46/211.66 |- skos__annotation mesh__D019565 GEN: prefer specifics
% 211.46/211.66 |- mesh__historyNote mesh__D019565 97
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019565 2005
% 211.46/211.66 |- skos__broader mesh__D019565smesh__D008670
% 211.46/211.66 |- skos__scopeNote mesh__D019565
% 211.46/211.66 Metals with low specific gravity, typically smaller than 5, characterized by a single valence %28%1, 2, or 3%29%, a simple spectrum, strong electromotive force %28%positive%29%, and colorless compounds. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019565 1999
% 211.46/211.66 |- mesh__recordMaintainer mesh__D019565 TGC
% 211.46/211.66 |- rdf__type mesh__D019565sskos__Concept
% 211.46/211.66 |- mesh__recordOriginator mesh__D019565 PXP
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019565 1998
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D019565 SJN
% 211.46/211.66 |- mesh__dateEstablished mesh__D019565 1997-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019565 2004
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019565 2002
% 211.46/211.66 |- skos__historyNote mesh__D019565 Metals or specifics %28%1966-1996%29%
% 211.46/211.66 |- skos__broader mesh__D019565smesh__D004602
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019565 2003
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D019565 97
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D019565 2001
% 211.46/211.66 |- mesh__onlineNote mesh__D019565
% 211.46/211.66 pre-explosion = METALS, LIGHT %28%PX%29%
% 211.46/211.66 |- mesh__dateRevised mesh__D019565 1997-06-20
% 211.46/211.66 |- skos__prefLabel mesh__D019565 Metals, Light
% 211.46/211.66 |- skos__altLabel mesh__D019565 Light Metals
% 211.46/211.66 |- mesh__dateCreated mesh__D019565 1996-06-20
% 211.46/211.66 |- skos__scopeNote mesh__D011582
% 211.46/211.66 Principles applied to the analysis and explanation of psychological or behavioral phenomena.%A%
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 1999
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 2000
% 211.46/211.66 |- skos__broader mesh__D011582smesh__D011579
% 211.46/211.66 |- rdf__type mesh__D011582sskos__Concept
% 211.46/211.66 |- mesh__recordOriginator mesh__D011582 NLM
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 2003
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 2001
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D011582 69
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 1995
% 211.46/211.66 |- skos__altLabel mesh__D011582 Theories, Psychological
% 211.46/211.66 |- mesh__dateRevised mesh__D011582 1993-06-04
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 2004
% 211.46/211.66 |- skos__hiddenLabel mesh__D011582 Theory, Psychologic
% 211.46/211.66 |- mesh__dateCreated mesh__D011582 1999-01-01
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 2002
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 2005
% 211.46/211.66 |- skos__historyNote mesh__D011582 Psychology %28%1966-1968%29%
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 1996
% 211.46/211.66 |- mesh__recordMaintainer mesh__D011582 JLS
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 2006
% 211.46/211.66 |- skos__annotation mesh__D011582 no qualif; DF: PSYCHOL THEORY
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 1997
% 211.46/211.66 |- skos__hiddenLabel mesh__D011582 Theories, Psychologic
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D011582 PLS
% 211.46/211.66 |- skos__altLabel mesh__D011582 Psychologic Theory
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 1998
% 211.46/211.66 |- skos__hiddenLabel mesh__D011582 Psychologic Theories
% 211.46/211.66 |- mesh__historyNote mesh__D011582 69
% 211.46/211.66 |- skos__altLabel mesh__D011582 Psychological Theories
% 211.46/211.66 |- mesh__dateEstablished mesh__D011582 1969-01-01
% 211.46/211.66 |- skos__prefLabel mesh__D011582 Psychological Theory
% 211.46/211.66 |- skos__altLabel mesh__D011582 Theory, Psychological
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D011582 1994
% 211.46/211.66 |- skos__annotation mesh__D005545
% 211.46/211.66 do not confuse with FORELIMB for non-primate vertebrates
% 211.46/211.66 |- skos__scopeNote mesh__D005545
% 211.46/211.66 The forepart of the foot including the metatarsals and the TOES.%A%
% 211.46/211.66 |- mesh__recordAuthorizer mesh__D005545 sjn
% 211.46/211.66 |- skos__prefLabel mesh__D005545 Forefoot, Human
% 211.46/211.66 |- rdf__type mesh__D005545sskos__Concept
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005545 2004
% 211.46/211.66 |- mesh__recordMaintainer mesh__D005545 TGC
% 211.46/211.66 |- mesh__dateRevised mesh__D005545 2002-07-03
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005545 2006
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005545 2003
% 211.46/211.66 |- mesh__activeMeSHYear mesh__D005545 2005
% 211.46/211.66 |- mesh__historyNote mesh__D005545 88
% 211.46/211.66 |- mesh__publicMeSHNote mesh__D005545 88
% 211.46/211.66 |- skos__broader mesh__D005545smesh__D005528
% 211.46/211.67 |- mesh__dateEstablished mesh__D005545 1988-01-01
% 211.46/211.67 |- skos__altLabel mesh__D005545 Human Forefoot
% 211.46/211.67 |- mesh__dateCreated mesh__D005545 1987-04-02
% 211.46/211.67 |- mesh__recordOriginator mesh__D005545 EC
% 211.46/211.67 |- skos__altLabel mesh__D015973 Regulation of Gene Expression, Leukemic
% 211.46/211.67 |- mesh__recordMaintainer mesh__D015973 NDW
% 211.46/211.67 |- skos__annotation mesh__D015973
% 211.46/211.67 coord IM with specific type of LEUKEMIA /genet %28%IM%29%; DF: GENE EXPRESSION REG LEUKEMIC%A%
% 211.46/211.67 |- skos__altLabel mesh__D015973 Leukemic Gene Expression Regulation
% 211.46/211.67 |- skos__scopeNote mesh__D015973
% 211.46/211.67 Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukemia.%A%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015973 2004
% 211.46/211.67 |- skos__broader mesh__D015973smesh__D015972
% 211.46/211.67 |- skos__prefLabel mesh__D015973 Gene Expression Regulation, Leukemic
% 211.46/211.67 |- rdf__type mesh__D015973sskos__Concept
% 211.46/211.67 |- skos__historyNote mesh__D015973 Genes %28%1973-1980%29%
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D015973 sjn
% 211.46/211.67 |- skos__historyNote mesh__D015973 specific leukemia %28%1973-1989%29%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015973 2003
% 211.46/211.67 |- mesh__historyNote mesh__D015973 90
% 211.46/211.67 |- mesh__dateEstablished mesh__D015973 1990-01-01
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015973 2006
% 211.46/211.67 |- mesh__dateRevised mesh__D015973 2002-07-03
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D015973 90
% 211.46/211.67 |- skos__altLabel mesh__D015973 Regulation, Gene Expression, Leukemic
% 211.46/211.67 |- mesh__dateCreated mesh__D015973 1989-05-25
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015973 2005
% 211.46/211.67 |- skos__historyNote mesh__D015973
% 211.46/211.67 Gene Expression Regulation %28%1981-1989%29%
% 211.46/211.67 |- mesh__recordOriginator mesh__D015973 PXP
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Pituitary Adenomas, Prolactin-Secreting
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Pituitary Adenoma, Prolactin-Producing
% 211.46/211.67 |- mesh__dateRevised mesh__D015175 2005-06-30
% 211.46/211.67 |- mesh__dateCreated mesh__D015175 1988-04-13
% 211.46/211.67 |- skos__broader mesh__D015175smesh__D000236
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Macroprolactinomas
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Prolactin Secreting Pituitary Adenoma
% 211.46/211.67 |- skos__altLabel mesh__D015175 Adenoma, Prolactin-Secreting, Pituitary
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015175 2006
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Pituitary Adenoma, PRL-Secreting
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Pituitary Adenomas, Prolactin-Producing
% 211.46/211.67 |- skos__annotation mesh__D015175
% 211.46/211.67 coordinate IM with PITUITARY NEOPLASMS %28%IM%29%
% 211.46/211.67 |- skos__altLabel mesh__D015175 Prolactin-Producing Pituitary Adenoma
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Adenoma, Lactotroph
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Pituitary Adenoma, Prolactin Secreting
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Pituitary Adenomas, PRL-Secreting
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Prolactinomas
% 211.46/211.67 |- skos__altLabel mesh__D015175 Lactotroph Adenoma
% 211.46/211.67 |- mesh__dateEstablished mesh__D015175 1989-01-01
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 PRL-Secreting Pituitary Adenomas
% 211.46/211.67 |- skos__altLabel mesh__D015175 Pituitary Adenoma, Prolactin-Secreting
% 211.46/211.67 |- skos__historyNote mesh__D015175 Adenoma %28%1966-1988%29%
% 211.46/211.67 |- mesh__historyNote mesh__D015175 1989
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Prolactin-Secreting Pituitary Adenomas
% 211.46/211.67 |- skos__historyNote mesh__D015175 Prolactin %28%1966-1988%29%
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D015175 sjn
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 PRL Secreting Pituitary Adenoma
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Microprolactinomas
% 211.46/211.67 |- skos__broader mesh__D015175smesh__D010911
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Prolactin Producing Pituitary Adenoma
% 211.46/211.67 |- skos__historyNote mesh__D015175 Pituitary Neoplasms %28%1966-1988%29%
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Lactotroph Adenomas
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D015175 1989
% 211.46/211.67 |- mesh__recordOriginator mesh__D015175 EJB
% 211.46/211.67 |- skos__prefLabel mesh__D015175 Prolactinoma
% 211.46/211.67 |- mesh__recordMaintainer mesh__D015175 lkt
% 211.46/211.67 |- skos__altLabel mesh__D015175 PRL-Secreting Pituitary Adenoma
% 211.46/211.67 |- skos__related mesh__D015175smesh__D006966
% 211.46/211.67 |- rdf__type mesh__D015175sskos__Concept
% 211.46/211.67 |- skos__scopeNote mesh__D015175
% 211.46/211.67 A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.%A%
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Prolactin-Producing Pituitary Adenomas
% 211.46/211.67 |- skos__altLabel mesh__D015175 Prolactin-Secreting Pituitary Adenoma
% 211.46/211.67 |- skos__hiddenLabel mesh__D015175 Adenomas, Lactotroph
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D009936
% 211.46/211.67 89; was see under ORGANIZATION AND ADMINISTRATION 1982-88%A%
% 211.46/211.67 |- rdf__type mesh__D009936sskos__Concept
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 1998
% 211.46/211.67 |- skos__hiddenLabel mesh__D009936 Innovations, Organizational
% 211.46/211.67 |- skos__altLabel mesh__D009936 Organizational Change
% 211.46/211.67 |- skos__prefLabel mesh__D009936 Organizational Innovation
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 1994
% 211.46/211.67 |- skos__hiddenLabel mesh__D009936 Organizational Innovations
% 211.46/211.67 |- mesh__dateEstablished mesh__D009936 1989-01-01
% 211.46/211.67 |- skos__broader mesh__D009936smesh__D009934
% 211.46/211.67 |- mesh__dateCreated mesh__D009936 1981-05-19
% 211.46/211.67 |- skos__hiddenLabel mesh__D009936 Changes, Organizational
% 211.46/211.67 |- mesh__historyNote mesh__D009936
% 211.46/211.67 89%28%82%29%; was see under ORGANIZATION AND ADMINISTRATION 1982-88%A%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 2002
% 211.46/211.67 |- skos__scopeNote mesh__D009936
% 211.46/211.67 Introduction of changes which are new to the organization and are created by management.%A%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 2004
% 211.46/211.67 |- mesh__dateRevised mesh__D009936 1992-05-15
% 211.46/211.67 |- skos__annotation mesh__D009936
% 211.46/211.67 NIM; coord with specific organiz %28%IM%29%; DF: ORGAN INNOVATION%A%
% 211.46/211.67 |- skos__altLabel mesh__D009936 Innovation, Organizational
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 2001
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 2006
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 1997
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D009936 PLS
% 211.46/211.67 |- skos__hiddenLabel mesh__D009936 Organizational Changes
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 2003
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 1999
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 2000
% 211.46/211.67 |- mesh__recordOriginator mesh__D009936 EC
% 211.46/211.67 |- mesh__recordMaintainer mesh__D009936 TAP
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 2005
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 1993
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 1996
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009936 1995
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009138 2001
% 211.46/211.67 |- mesh__dateCreated mesh__D009138 1999-01-01
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009138 2005
% 211.46/211.67 |- skos__scopeNote mesh__D009138
% 211.46/211.67 A major nerve of the upper extremity. The fibers of the musculocutaneous nerve originate in the lower cervical spinal cord %28%usually C5 to C7%29%, travel via the lateral cord of the brachial plexus, and supply sensory and motor innervation to the upper arm, elbow, and forearm.%A%
% 211.46/211.67 |- skos__hiddenLabel mesh__D009138 Nerve, Musculocutaneous
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009138 2000
% 211.46/211.67 |- skos__hiddenLabel mesh__D009138 Nerves, Musculocutaneous
% 211.46/211.67 |- skos__hiddenLabel mesh__D009138 Musculocutaneous Nerves
% 211.46/211.67 |- rdf__type mesh__D009138sskos__Concept
% 211.46/211.67 |- skos__broader mesh__D009138smesh__D001917
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009138 2004
% 211.46/211.67 |- mesh__recordOriginator mesh__D009138 NLM
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009138 2002
% 211.46/211.67 |- skos__prefLabel mesh__D009138 Musculocutaneous Nerve
% 211.46/211.67 |- mesh__dateRevised mesh__D009138 1999-11-03
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009138 2003
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D009138 sjn
% 211.46/211.67 |- mesh__recordMaintainer mesh__D009138 kle
% 211.46/211.67 |- skos__annotation mesh__D009138
% 211.46/211.67 dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES %28%IM%29%; neopl: coord IM with PERIPHERAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl%A%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009138 2006
% 211.46/211.67 |- mesh__dateEstablished mesh__D001155 1974-01-01
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D001155 74
% 211.46/211.67 |- skos__broader mesh__D001155smesh__D011613
% 211.46/211.67 |- skos__hiddenLabel mesh__D001155 Therapies, Art
% 211.46/211.67 |- mesh__dateRevised mesh__D001155 2001-07-25
% 211.46/211.67 |- rdf__type mesh__D001155sskos__Concept
% 211.46/211.67 |- mesh__historyNote mesh__D001155 74
% 211.46/211.67 |- skos__prefLabel mesh__D001155 Art Therapy
% 211.46/211.67 |- mesh__dateCreated mesh__D001155 1999-01-01
% 211.46/211.67 |- skos__hiddenLabel mesh__D001155 Art Therapies
% 211.46/211.67 |- skos__annotation mesh__D001155 a psychother technique; DF: ART THER
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001155 2003
% 211.46/211.67 |- mesh__recordMaintainer mesh__D001155 ssb
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001155 2005
% 211.46/211.67 |- skos__broader mesh__D001155smesh__D026421
% 211.46/211.67 |- skos__broader mesh__D001155smesh__D012046
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D001155 sjn
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001155 2004
% 211.46/211.67 |- skos__altLabel mesh__D001155 Therapy, Art
% 211.46/211.67 |- mesh__recordOriginator mesh__D001155 NLM
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001155 2002
% 211.46/211.67 |- skos__scopeNote mesh__D001155
% 211.46/211.67 The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders.%A%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001155 2006
% 211.46/211.67 |- skos__hiddenLabel mesh__D011583 Warfare, Psychologic
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 2004
% 211.46/211.67 |- mesh__dateCreated mesh__D011583 1999-01-01
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 2000
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 2005
% 211.46/211.67 |- skos__annotation mesh__D011583 no qualif; DF: PSYCHOL WARFARE
% 211.46/211.67 |- skos__altLabel mesh__D011583 Warfare, Psychological
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 1996
% 211.46/211.67 |- mesh__recordOriginator mesh__D011583 NLM
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 2001
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 2006
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 1997
% 211.46/211.67 |- mesh__dateRevised mesh__D011583 1993-06-04
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 2002
% 211.46/211.67 |- skos__altLabel mesh__D011583 Psychologic Warfare
% 211.46/211.67 |- skos__prefLabel mesh__D011583 Psychological Warfare
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 1998
% 211.46/211.67 |- skos__related mesh__D011583smesh__D010565
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 1994
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 1999
% 211.46/211.67 |- skos__scopeNote mesh__D011583
% 211.46/211.67 The manipulation of psychological influences, primarily concerned with morale, to strengthen the ability of one%27%s own country and weaken the enemy.%A%
% 211.46/211.67 |- skos__related mesh__D011583smesh__D011406
% 211.46/211.67 |- mesh__recordMaintainer mesh__D011583 JLS
% 211.46/211.67 |- skos__broader mesh__D011583smesh__D014857
% 211.46/211.67 |- rdf__type mesh__D011583sskos__Concept
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 2003
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011583 1995
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D011583 PLS
% 211.46/211.67 |- skos__prefLabel mesh__D005546 Forehead
% 211.46/211.67 |- mesh__dateCreated mesh__D005546 1976-04-16
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 2004
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 2002
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D005546 PLS
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 1997
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 2006
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 1999
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 2003
% 211.46/211.67 |- mesh__recordMaintainer mesh__D005546 TAP
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 1993
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 2001
% 211.46/211.67 |- skos__annotation mesh__D005546 NIM as locational, no qualif
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 2005
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 1996
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 1995
% 211.46/211.67 |- skos__historyNote mesh__D005546 Face %28%1966-1976%29%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 1998
% 211.46/211.67 |- skos__scopeNote mesh__D005546 The part of the face above the eyes.
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 2000
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D005546 1994
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D005546 77
% 211.46/211.67 |- skos__broader mesh__D005546smesh__D005145
% 211.46/211.67 |- mesh__recordOriginator mesh__D005546 MM
% 211.46/211.67 |- mesh__historyNote mesh__D005546 77
% 211.46/211.67 |- mesh__dateEstablished mesh__D005546 1977-01-01
% 211.46/211.67 |- skos__hiddenLabel mesh__D005546 Foreheads
% 211.46/211.67 |- rdf__type mesh__D005546sskos__Concept
% 211.46/211.67 |- mesh__dateRevised mesh__D005546 1992-05-15
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 2000
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 2003
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 1996
% 211.46/211.67 |- mesh__historyNote mesh__D015974 90
% 211.46/211.67 |- mesh__recordOriginator mesh__D015974 EGC
% 211.46/211.67 |- skos__prefLabel mesh__D015974 Wrongful Life
% 211.46/211.67 |- mesh__dateRevised mesh__D015974 2002-10-31
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 2001
% 211.46/211.67 |- mesh__dateCreated mesh__D015974 1989-07-05
% 211.46/211.67 |- rdf__type mesh__D015974sskos__Concept
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 2004
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 1997
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 2003A
% 211.46/211.67 |- skos__historyNote mesh__D015974 Jurisprudence %28%1978-1989%29%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 2002
% 211.46/211.67 |- mesh__dateEstablished mesh__D015974 1990-01-01
% 211.46/211.67 |- skos__hiddenLabel mesh__D015974 Lives, Wrongful
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 2005
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 1998
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 1993
% 211.46/211.67 |- skos__altLabel mesh__D015974 Wrongful Lives
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D015974 90
% 211.46/211.67 |- skos__scopeNote mesh__D015974
% 211.46/211.67 In civil law a cause of action which alleges that a defendant has wrongfully caused a child to be born.%A%
% 211.46/211.67 |- skos__broader mesh__D015974smesh__D007603
% 211.46/211.67 |- mesh__recordMaintainer mesh__D015974 jls
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 1994
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 2006
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 1999
% 211.46/211.67 |- skos__hiddenLabel mesh__D015974 Life, Wrongful
% 211.46/211.67 |- skos__hiddenLabel mesh__D015974 Birth, Wrongful
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D015974 1995
% 211.46/211.67 |- skos__hiddenLabel mesh__D015974 Births, Wrongful
% 211.46/211.67 |- skos__hiddenLabel mesh__D015974 Wrongful Births
% 211.46/211.67 |- skos__historyNote mesh__D015974 Malpractice %28%1973-1989%29%
% 211.46/211.67 |- skos__annotation mesh__D015974
% 211.46/211.67 legal action alleging %22%that a defendant has wrongfully caused a child to be born%22%%A%
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D015974 jls
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 1993
% 211.46/211.67 |- skos__hiddenLabel mesh__D009937 Organizational Objective
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 2005
% 211.46/211.67 |- mesh__historyNote mesh__D009937
% 211.46/211.67 91%28%82%29%; was see under ORGANIZATION AND ADMINISTRATION 1982-90%A%
% 211.46/211.67 |- skos__prefLabel mesh__D009937 Organizational Objectives
% 211.46/211.67 |- skos__scopeNote mesh__D009937
% 211.46/211.67 The purposes, missions, and goals of an individual organization or its units, established through administrative processes. It includes an organization%27%s long-range plans and administrative philosophy.%A%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 1995
% 211.46/211.67 |- skos__altLabel mesh__D009937 Goals, Organizational
% 211.46/211.67 |- skos__hiddenLabel mesh__D009937 Objective, Organizational
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 1994
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D009937
% 211.46/211.67 91; was see under ORGANIZATION AND ADMINISTRATION 1982-90%A%
% 211.46/211.67 |- skos__hiddenLabel mesh__D009937 Goal, Organizational
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 2002
% 211.46/211.67 |- mesh__dateCreated mesh__D009937 1981-05-19
% 211.46/211.67 |- skos__hiddenLabel mesh__D009937 Organizational Goal
% 211.46/211.67 |- skos__broader mesh__D009937smesh__D009934
% 211.46/211.67 |- skos__annotation mesh__D009937
% 211.46/211.67 NIM; coord with specific organiz %28%IM%29%; DF: ORGAN OBJECTIVES%A%
% 211.46/211.67 |- mesh__dateRevised mesh__D009937 1992-05-15
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 2001
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 1997
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D009937 PLS
% 211.46/211.67 |- mesh__dateEstablished mesh__D009937 1991-01-01
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 2004
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 2000
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 1996
% 211.46/211.67 |- skos__altLabel mesh__D009937 Organizational Goals
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 1999
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 2003
% 211.46/211.67 |- mesh__recordMaintainer mesh__D009937 TAP
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 2006
% 211.46/211.67 |- mesh__recordOriginator mesh__D009937 EC
% 211.46/211.67 |- rdf__type mesh__D009937sskos__Concept
% 211.46/211.67 |- skos__altLabel mesh__D009937 Objectives, Organizational
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009937 1998
% 211.46/211.67 |- mesh__recordMaintainer mesh__D001954 ssb
% 211.46/211.67 |- skos__altLabel mesh__D001954 Brinase
% 211.46/211.67 |- rdf__type mesh__D001954sskos__Concept
% 211.46/211.67 |- mesh__historyNote mesh__D001954
% 211.46/211.67 91%28%75%29%; was see under PEPTIDE HYDROLASES 1975-90
% 211.46/211.67 |- skos__broader mesh__D001954smesh__D010450
% 211.46/211.67 |- skos__historyNote mesh__D001954 Peptide Hydrolases %28%1972-1974%29%
% 211.46/211.67 |- skos__scopeNote mesh__D001954
% 211.46/211.67 A fibrinolytic and thrombolytic enzyme from Aspergillus oryzae. EC 3.4.99.-.%A%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001954 2006
% 211.46/211.67 |- mesh__dateRevised mesh__D001954 2003-07-09
% 211.46/211.67 |- skos__prefLabel mesh__D001954 Brinolase
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001954 2004
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D001954
% 211.46/211.67 91; was see under PEPTIDE HYDROLASES 1975-90
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001954 2005
% 211.46/211.67 |- skos__historyNote mesh__D001954 Aspergillus/enzymology %28%1972-1974%29%
% 211.46/211.67 |- mesh__dateCreated mesh__D001954 1974-11-19
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D001954 sjn
% 211.46/211.67 |- mesh__recordOriginator mesh__D001954 NLM
% 211.46/211.67 |- mesh__dateEstablished mesh__D001954 1991-01-01
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D009139 98
% 211.46/211.67 |- mesh__historyNote mesh__D009139 98; use explode 1971-97
% 211.46/211.67 |- skos__broader mesh__D009139smesh__D000013
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D009139 sjn
% 211.46/211.67 |- mesh__recordMaintainer mesh__D009139 kle
% 211.46/211.67 |- skos__hiddenLabel mesh__D009139 Musculoskeletal Abnormality
% 211.46/211.67 |- mesh__dateRevised mesh__D009139 1999-11-03
% 211.46/211.67 |- skos__historyNote mesh__D009139
% 211.46/211.67 Musculoskeletal System/abnormalities %28%1966-1997%29%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009139 2000
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009139 2003
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009139 2001
% 211.46/211.67 |- skos__annotation mesh__D009139
% 211.46/211.67 for congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ /abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: MUSCULOSKELETAL ABNORM%A%
% 211.46/211.67 |- rdf__type mesh__D009139sskos__Concept
% 211.46/211.67 |- skos__prefLabel mesh__D009139 Musculoskeletal Abnormalities
% 211.46/211.67 |- skos__scopeNote mesh__D009139
% 211.46/211.67 Congenital structural abnormalities and deformities of the musculoskeletal system.%A%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009139 2004
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009139 2002
% 211.46/211.67 |- skos__hiddenLabel mesh__D009139 Abnormality, Musculoskeletal
% 211.46/211.67 |- mesh__dateCreated mesh__D009139 1999-01-01
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009139 2005
% 211.46/211.67 |- skos__altLabel mesh__D009139 Abnormalities, Musculoskeletal
% 211.46/211.67 |- mesh__dateEstablished mesh__D009139 1998-01-01
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D009139 2006
% 211.46/211.67 |- skos__broader mesh__D009139smesh__D009140
% 211.46/211.67 |- mesh__recordOriginator mesh__D009139 NLM
% 211.46/211.67 |- skos__annotation mesh__D001156
% 211.46/211.67 note X ref BRINE SHRIMP: several other shrimp terms are available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE%A%
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D001156 sjn
% 211.46/211.67 |- rdf__type mesh__D001156sskos__Concept
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D001156 79
% 211.46/211.67 |- skos__historyNote mesh__D001156 Crustacea %28%1966-1978%29%
% 211.46/211.67 |- mesh__dateRevised mesh__D001156 2003-07-09
% 211.46/211.67 |- skos__altLabel mesh__D001156 Shrimp, Brine
% 211.46/211.67 |- skos__scopeNote mesh__D001156
% 211.46/211.67 A genus of CRUSTACEA of the order ANOSTRACA, found in briny pools and lakes and often cultured for fish food. It has 168 chromosomes and differs from most crustaceans in that its blood contains hemoglobin.%A%
% 211.46/211.67 |- skos__prefLabel mesh__D001156 Artemia
% 211.46/211.67 |- skos__historyNote mesh__D001156 Shrimp %28%1972-1978%29%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001156 2005
% 211.46/211.67 |- mesh__recordMaintainer mesh__D001156 ags
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001156 2004
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D001156 2006
% 211.46/211.67 |- mesh__recordOriginator mesh__D001156 AEP
% 211.46/211.67 |- skos__altLabel mesh__D001156 Brine Shrimp
% 211.46/211.67 |- mesh__dateCreated mesh__D001156 1978-03-20
% 211.46/211.67 |- mesh__historyNote mesh__D001156 79
% 211.46/211.67 |- mesh__dateEstablished mesh__D001156 1979-01-01
% 211.46/211.67 |- skos__broader mesh__D001156smesh__D033202
% 211.46/211.67 |- mesh__recordOriginator mesh__D020310 NDW
% 211.46/211.67 |- rdf__type mesh__D020310sskos__Concept
% 211.46/211.67 |- skos__scopeNote mesh__D020310
% 211.46/211.67 An order of flightless birds comprising the ostriches, which naturally inhabit open, low rainfall areas of Africa.%A%
% 211.46/211.67 |- skos__historyNote mesh__D020310 Birds %28%1968-1998%29%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D020310 2006
% 211.46/211.67 |- mesh__dateCreated mesh__D020310 1998-06-10
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D020310 2005; see OSTRICHES 1999-2004
% 211.46/211.67 |- mesh__recordMaintainer mesh__D020310 ags
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D020310 2005
% 211.46/211.67 |- mesh__dateRevised mesh__D020310 2004-07-07
% 211.46/211.67 |- mesh__historyNote mesh__D020310 2005 %28%1999%29%
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D020310 sjn
% 211.46/211.67 |- skos__broader mesh__D020310smesh__D046108
% 211.46/211.67 |- mesh__dateEstablished mesh__D020310 1999-01-01
% 211.46/211.67 |- skos__altLabel mesh__D020310 Ostriches
% 211.46/211.67 |- skos__prefLabel mesh__D020310 Struthioniformes
% 211.46/211.67 |- skos__annotation mesh__D020310
% 211.46/211.67 OSTRICH, AMERICAN see RHEIFORMES is available
% 211.46/211.67 |- skos__broader mesh__D006321Q000276smesh__D006321
% 211.46/211.67 |- mesh__preferredCombination mesh__D006321Q000276smesh__D009206Q000276
% 211.46/211.67 |- rdf__type mesh__D006321Q000276smesh__CompoundConcept
% 211.46/211.67 |- skos__related mesh__D019567smesh__D013124
% 211.46/211.67 |- mesh__publicMeSHNote mesh__D019567 98
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D019567 2003
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D019567 1999
% 211.46/211.67 |- skos__prefLabel mesh__D019567 Back Injuries
% 211.46/211.67 |- rdf__type mesh__D019567sskos__Concept
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D019567 2000
% 211.46/211.67 |- skos__altLabel mesh__D019567 Injuries, Back
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D019567 2004
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D019567 2001
% 211.46/211.67 |- skos__hiddenLabel mesh__D019567 Back Injury
% 211.46/211.67 |- mesh__dateEstablished mesh__D019567 1998-01-01
% 211.46/211.67 |- skos__hiddenLabel mesh__D019567 Injury, Back
% 211.46/211.67 |- skos__annotation mesh__D019567
% 211.46/211.67 GEN or unspecified; coord IM with specific inj %28%IM%29% or specific region %28%NIM%29%; do not confuse with SPINAL INJURIES which refers to vertebrae only: see note there; DF: BACK INJ%A%
% 211.46/211.67 |- mesh__historyNote mesh__D019567 98
% 211.46/211.67 |- mesh__dateCreated mesh__D019567 1997-06-20
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D019567 2005
% 211.46/211.67 |- skos__broader mesh__D019567smesh__D014947
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D019567 2002
% 211.46/211.67 |- skos__scopeNote mesh__D019567
% 211.46/211.67 General or unspecified injuries to the posterior part of the trunk. It includes injuries to the muscles of the back.%A%
% 211.46/211.67 |- skos__historyNote mesh__D019567 Back/injuries %28%1966-1997%29%
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D019567 2006
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D019567 1998
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011584 2006
% 211.46/211.67 |- skos__prefLabel mesh__D011584 Psychology
% 211.46/211.67 |- skos__hiddenLabel mesh__D011584 Psychological Factor
% 211.46/211.67 |- skos__broader mesh__D011584smesh__D001525
% 211.46/211.67 |- skos__scopeNote mesh__D011584
% 211.46/211.67 The science dealing with the study of mental processes and behavior in man and animals.%A%
% 211.46/211.67 |- skos__hiddenLabel mesh__D011584 Psychologist
% 211.46/211.67 |- skos__hiddenLabel mesh__D011584 Factor, Psychological
% 211.46/211.67 |- mesh__dateRevised mesh__D011584 1999-11-03
% 211.46/211.67 |- skos__altLabel mesh__D011584 Psychological Side Effects
% 211.46/211.67 |- rdf__type mesh__D011584sskos__Concept
% 211.46/211.67 |- skos__hiddenLabel mesh__D011584 Factor, Psychosocial
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011584 2003
% 211.46/211.67 |- skos__hiddenLabel mesh__D011584 Psychological Side Effect
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011584 2000
% 211.46/211.67 |- skos__annotation mesh__D011584
% 211.46/211.67 SPEC: IM, SPEC qualif; prefer /psychol: Manual 19.7+, 19.8.59; NIM for %22%psychological aspects of%22% terms not in Cat C, E1-6 %26% F3: no qualif; as NIM: Manual 27.10 DF: PSYCHOL%A%
% 211.46/211.67 |- skos__hiddenLabel mesh__D011584 Psychosocial Factor
% 211.46/211.67 |- skos__hiddenLabel mesh__D011584 Side Effect, Psychological
% 211.46/211.67 |- mesh__activeMeSHYear mesh__D011584 2004
% 211.46/211.67 |- mesh__recordAuthorizer mesh__D011584 sjn
% 211.46/211.67 |- skos__hiddenLabel mesh__D011584 Factors, Psychosocial
% 211.46/211.68 |- mesh__recordOriginator mesh__D011584 NLM
% 211.46/211.68 |- mesh__dateCreated mesh__D011584 1999-01-01
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011584 2001
% 211.46/211.68 |- mesh__recordMaintainer mesh__D011584 kle
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011584 2005
% 211.46/211.68 |- skos__altLabel mesh__D011584 Factors, Psychological
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011584 2002
% 211.46/211.68 |- skos__hiddenLabel mesh__D005547 Foreign Body
% 211.46/211.68 |- skos__prefLabel mesh__D005547 Foreign Bodies
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005547 2006
% 211.46/211.68 |- mesh__dateCreated mesh__D005547 1999-01-01
% 211.46/211.68 |- mesh__recordOriginator mesh__D005547 NLM
% 211.46/211.68 |- skos__hiddenLabel mesh__D005547 Bodies, Foreign
% 211.46/211.68 |- skos__scopeNote mesh__D005547
% 211.46/211.68 Objects that inadvertently enter the body or body cavities from the environment.%A%
% 211.46/211.68 |- mesh__dateRevised mesh__D005547 2004-07-07
% 211.46/211.68 |- skos__annotation mesh__D005547
% 211.46/211.68 coord IM with organ %28%IM%29%, not organ/dis: Manual 21.39; EYE FOREIGN BODIES is available; FOREIGN-BODY MIGRATION %26% FOREIGN-BODY REACTION are also available%A%
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D005547 sjn
% 211.46/211.68 |- mesh__recordMaintainer mesh__D005547 lkt
% 211.46/211.68 |- skos__hiddenLabel mesh__D005547 Body, Foreign
% 211.46/211.68 |- skos__broader mesh__D005547smesh__D014947
% 211.46/211.68 |- rdf__type mesh__D005547sskos__Concept
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005547 2005
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D024701 sjn
% 211.46/211.68 |- skos__annotation mesh__D024701
% 211.46/211.68 do not confuse with MYOSIN V1 and MYOSIN V3 see VENTRICULAR MYOSINS%A%
% 211.46/211.68 |- mesh__historyNote mesh__D024701
% 211.46/211.68 2002; for MYOSIN-V P190 use CHICKEN BRAIN MYOSIN-V P190 %28%NM%29% 1993-2001%A%
% 211.46/211.68 |- skos__hiddenLabel mesh__D024701 Myosin V p190
% 211.46/211.68 |- skos__scopeNote mesh__D024701
% 211.46/211.68 A subclass of myosin involved in organelle transport and membrane targeting. It is abundantly found in nervous tissue and neurosecretory cells. The heavy chains of myosin V contain unusually long neck domains that are believed to aid in translocating molecules over large distances.%A%
% 211.46/211.68 |- rdf__type mesh__D024701sskos__Concept
% 211.46/211.68 |- skos__broader mesh__D024701smesh__D009218
% 211.46/211.68 |- mesh__dateRevised mesh__D024701 2005-06-30
% 211.46/211.68 |- mesh__dateEstablished mesh__D024701 2002-01-01
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D024701 2006
% 211.46/211.68 |- mesh__recordOriginator mesh__D024701 jmp
% 211.46/211.68 |- mesh__dateCreated mesh__D024701 2001-07-25
% 211.46/211.68 |- mesh__recordMaintainer mesh__D024701 DRC
% 211.46/211.68 |- skos__historyNote mesh__D024701 Nerve Tissue Proteins %28%1993-2001%29%
% 211.46/211.68 |- skos__historyNote mesh__D024701
% 211.46/211.68 Calmodulin-Binding Proteins %28%1993-2001%29%
% 211.46/211.68 |- skos__altLabel mesh__D024701 Myosin V
% 211.46/211.68 |- skos__prefLabel mesh__D024701 Myosin Type V
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D024701 2002
% 211.46/211.68 |- skos__broader mesh__D015975smesh__D003245
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 2004
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 1997
% 211.46/211.68 |- rdf__type mesh__D015975sskos__Concept
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 2000A
% 211.46/211.68 |- skos__historyNote mesh__D015975
% 211.46/211.68 Consensus Development Conferences %28%1988-1989%29%
% 211.46/211.68 |- mesh__dateEstablished mesh__D015975 1990-01-01
% 211.46/211.68 |- skos__prefLabel mesh__D015975 Consensus Development Conferences, NIH
% 211.46/211.68 |- mesh__dateCreated mesh__D015975 1989-05-26
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 2000
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 2005
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 1998
% 211.46/211.68 |- mesh__historyNote mesh__D015975
% 211.46/211.68 90; was see CONSENSUS DEVELOPMENT CONFERENCES 1988-89; was NIH CONSENSUS DEVELOPMENT see NATIONAL INSTITUTES OF HEALTH %28%U.S.%29% 1982-87; for both the publication type %26% the main heading 1988-90; main heading only 1991 forward%A%
% 211.46/211.68 |- skos__annotation mesh__D015975
% 211.46/211.68 no qualif; do not confuse with Publication Type CONSENSUS DEVELOPMENT CONFERENCE, NIH; IM for NIH conf as a means of scientific communication; for any article in any publication of the NIH Office of Medical Applications of Research %28%OMAR%29%; Manual section 12 %26% TN L; include name of NIH conf as part of title when it appears in author position, in footnote or at end of article; add UNITED STATES %28%NIM%29%; DF: CONSENS DEV CONF NIH%A%
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 2001
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 2006
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 1999
% 211.46/211.68 |- skos__historyNote mesh__D015975
% 211.46/211.68 National Institutes of Health %28%U.S.%29% %28%1982-1987%29%
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 2002
% 211.46/211.68 |- mesh__onlineNote mesh__D015975
% 211.46/211.68 use CONSENSUS DEVELOPMENT CONFERENCES, NIH to search for conferences reported in OMAR publications 1977-90; use CONSENSUS DEVELOPMENT CONFERENCES to search NIH CONSENSUS DEVELOPMENT reported in non-OMAR publications 1988-89; use NATIONAL INSTITUTES OF HEALTH %28%U.S.%29% for conferences reported in non-OMAR publications 1982-87; use CONSENSUS DEVELOPMENT CONFERENCES, NIH %28%PUBLICATION TYPE%29% to search for OMAR %26% non-OMAR publications 1991 forward%A%
% 211.46/211.68 |- mesh__recordOriginator mesh__D015975 PLS
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D015975
% 211.46/211.68 90; was see CONSENSUS DEVELOPMENT CONFERENCES 1988-89; was NIH CONSENSUS DEVELOPMENT see NATIONAL INSTITUTES OF HEALTH %28%U.S%29% 1982-87%A%
% 211.46/211.68 |- skos__scopeNote mesh__D015975
% 211.46/211.68 Articles on conferences sponsored by NIH presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for NIH consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the NIH Office of Medical Applications of Research %28%OMAR%29%.%A%
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D015975 ags
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 2003
% 211.46/211.68 |- mesh__recordMaintainer mesh__D015975 ags
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D015975 1996
% 211.46/211.68 |- skos__altLabel mesh__D015975 NIH Consensus Development Conferences
% 211.46/211.68 |- mesh__dateRevised mesh__D015975 1999-12-16
% 211.46/211.68 |- mesh__dateEstablished mesh__D009938 1968-01-01
% 211.46/211.68 |- skos__broader mesh__D009938smesh__D004472
% 211.46/211.68 |- mesh__recordOriginator mesh__D009938 NLM
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009938 2004
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D009938 68
% 211.46/211.68 |- skos__annotation mesh__D009938
% 211.46/211.68 has a limited use since there are other more specific terms available; read notes under SOCIETIES; SOCIETIES, MEDICAL %26% SOCIETIES, SCIENTIFIC for likely exclusions: ORGANIZATIONS tends to be for groups with a common goal based on interest, SOCIETIES tends to be for groups with common educ or professional status: TN 174; policy: Manual 35.9; specify geog: Manual 36.15; DF: ORGAN but do not confuse with ORGAN ADMIN for ORGANIZATION AND ADMINISTRATION%A%
% 211.46/211.68 |- skos__hiddenLabel mesh__D009938 Organization
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009938 2003
% 211.46/211.68 |- mesh__recordMaintainer mesh__D009938 mdb
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009938 2006
% 211.46/211.68 |- mesh__dateCreated mesh__D009938 1999-01-01
% 211.46/211.68 |- rdf__type mesh__D009938sskos__Concept
% 211.46/211.68 |- mesh__dateRevised mesh__D009938 2001-07-25
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D009938 sjn
% 211.46/211.68 |- skos__scopeNote mesh__D009938
% 211.46/211.68 Administration and functional structures for the purpose of collectively systematizing activities for a particular goal.%A%
% 211.46/211.68 |- skos__hiddenLabel mesh__D009938 Organization, Nongovernmental
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009938 2005
% 211.46/211.68 |- skos__related mesh__D009938smesh__D012952
% 211.46/211.68 |- skos__altLabel mesh__D009938 Organizations, Nongovernmental
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009938 2002
% 211.46/211.68 |- mesh__historyNote mesh__D009938 68
% 211.46/211.68 |- skos__prefLabel mesh__D009938 Organizations
% 211.46/211.68 |- skos__historyNote mesh__D009938 specific organization %28%1966-1967%29%
% 211.46/211.68 |- skos__hiddenLabel mesh__D009938 Nongovernmental Organization
% 211.46/211.68 |- rdf__type mesh__D001955sskos__Concept
% 211.46/211.68 |- mesh__recordOriginator mesh__D001955 NLM
% 211.46/211.68 |- skos__annotation mesh__D001955
% 211.46/211.68 a province of Canada on the Pacific coast
% 211.46/211.68 |- mesh__recordMaintainer mesh__D001955 TGC
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 2006
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 2002
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 2004
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D001955 PLS
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 2005
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 1999
% 211.46/211.68 |- mesh__dateCreated mesh__D001955 1999-01-01
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 2003
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 1997
% 211.46/211.68 |- skos__prefLabel mesh__D001955 British Columbia
% 211.46/211.68 |- skos__scopeNote mesh__D001955
% 211.46/211.68 A province of Canada on the Pacific coast. Its capital is Victoria. The name given in 1858 derives from the Columbia River which was named by the American captain Robert Gray for his ship Columbia which in turn was named for Columbus. %28%From Webster%27%s New Geographical Dictionary, 1988, p178 %26% Room, Brewer%27%s Dictionary of Names, 1992, p81-2%29%%A%
% 211.46/211.68 |- mesh__dateRevised mesh__D001955 1995-02-17
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 1998
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 2001
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 1996
% 211.46/211.68 |- skos__broader mesh__D001955smesh__D002170
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001955 2000
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Occlusive Diseases, Arterial
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001157 2003
% 211.46/211.68 |- mesh__dateRevised mesh__D001157 1998-06-10
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001157 2001
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Arterial Obstructive Disease
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001157 2005
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Diseases, Arterial Obstructive
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001157 2004
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Obstructive Disease, Arterial
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Obstructive Diseases, Arterial
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001157 2006
% 211.46/211.68 |- skos__prefLabel mesh__D001157 Arterial Occlusive Diseases
% 211.46/211.68 |- skos__broader mesh__D001157smesh__D014652
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Disease, Arterial Occlusive
% 211.46/211.68 |- mesh__recordOriginator mesh__D001157 NLM
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D001157 SJN
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001157 2002
% 211.46/211.68 |- skos__historyNote mesh__D001157 Vascular Diseases %28%1966-1972%29%
% 211.46/211.68 |- mesh__historyNote mesh__D001157 73
% 211.46/211.68 |- skos__annotation mesh__D001157
% 211.46/211.68 IM for general or specific artery occlusion %28%as POPLITEAL ARTERY %28%IM%29% + ARTERIAL OCCLUSIVE DISEASES %28%IM%29%%29%%A%
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001157 1999
% 211.46/211.68 |- skos__scopeNote mesh__D001157
% 211.46/211.68 Diseases in which arterial vessels are partially or completely obstructed or in which the blood flow through the vessels is impeded.%A%
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Diseases, Arterial Occlusive
% 211.46/211.68 |- rdf__type mesh__D001157sskos__Concept
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Disease, Arterial Obstructive
% 211.46/211.68 |- mesh__dateEstablished mesh__D001157 1973-01-01
% 211.46/211.68 |- mesh__dateCreated mesh__D001157 1999-01-01
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D001157 73
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Occlusive Disease, Arterial
% 211.46/211.68 |- mesh__recordMaintainer mesh__D001157 NDW
% 211.46/211.68 |- skos__hiddenLabel mesh__D001157 Arterial Occlusive Disease
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001157 2000
% 211.46/211.68 |- skos__altLabel mesh__D001157 Arterial Obstructive Diseases
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D006640 sjn
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D006640
% 211.46/211.68 91; was see under CARBOXY-LYASES 1975-90
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D006640 2004
% 211.46/211.68 |- skos__altLabel mesh__D006640 Histidine Carboxy-Lyase
% 211.46/211.68 |- mesh__historyNote mesh__D006640
% 211.46/211.68 91%28%75%29%; was see under CARBOXY-LYASES 1975-90
% 211.46/211.68 |- mesh__dateEstablished mesh__D006640 1991-01-01
% 211.46/211.68 |- skos__historyNote mesh__D006640 Carboxy-Lyases %28%1973-1974%29%
% 211.46/211.68 |- rdf__type mesh__D006640sskos__Concept
% 211.46/211.68 |- skos__historyNote mesh__D006640 Histidine %28%1973-1974%29%
% 211.46/211.68 |- skos__hiddenLabel mesh__D006640 Histidine Carboxy Lyase
% 211.46/211.68 |- skos__hiddenLabel mesh__D006640 Carboxy-Lyase, Histidine
% 211.46/211.68 |- mesh__recordMaintainer mesh__D006640 ssb
% 211.46/211.68 |- skos__scopeNote mesh__D006640
% 211.46/211.68 An enzyme that catalyzes the decarboxylation of histidine to histamine and carbon dioxide. It requires pyridoxal phosphate in animal tissues, but not in microorganisms. EC 4.1.1.22.%A%
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D006640 2005
% 211.46/211.68 |- mesh__dateCreated mesh__D006640 1974-11-19
% 211.46/211.68 |- skos__broader mesh__D006640smesh__D002262
% 211.46/211.68 |- skos__hiddenLabel mesh__D006640 Decarboxylase, Histidine
% 211.46/211.68 |- mesh__recordOriginator mesh__D006640 NLM
% 211.46/211.68 |- mesh__dateRevised mesh__D006640 2003-07-09
% 211.46/211.68 |- skos__prefLabel mesh__D006640 Histidine Decarboxylase
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D006640 2006
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D020311 2006
% 211.46/211.68 |- skos__hiddenLabel mesh__D020311 American Ostrich
% 211.46/211.68 |- skos__hiddenLabel mesh__D020311 American Ostrichs
% 211.46/211.68 |- skos__altLabel mesh__D020311 Rheas
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D020311 2005
% 211.46/211.68 |- skos__hiddenLabel mesh__D020311 Ostrichs, American
% 211.46/211.68 |- mesh__dateRevised mesh__D020311 2004-07-13
% 211.46/211.68 |- skos__altLabel mesh__D020311 Rhea americana
% 211.46/211.68 |- skos__prefLabel mesh__D020311 Rheiformes
% 211.46/211.68 |- skos__altLabel mesh__D020311 Ostriches, American
% 211.46/211.68 |- skos__hiddenLabel mesh__D020311 American Ostriches
% 211.46/211.68 |- mesh__recordMaintainer mesh__D020311 sjn
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D020311 2005; see RHEAS 1999-2004
% 211.46/211.68 |- skos__annotation mesh__D020311
% 211.46/211.68 note X ref OSTRICH, AMERICAN: OSTRICHES see STRUTHIONIFORMES is available%A%
% 211.46/211.68 |- skos__historyNote mesh__D020311 Birds %28%1971-1998%29%
% 211.46/211.68 |- skos__scopeNote mesh__D020311
% 211.46/211.68 An order of large, long-necked, long-legged, flightless birds, found in South America. Known as rheas, they are sometimes called American ostriches, though they are in a separate order from true OSTRICHES.%A%
% 211.46/211.68 |- mesh__historyNote mesh__D020311 2005 %28%1999%29%
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D020311 sjn
% 211.46/211.68 |- mesh__recordOriginator mesh__D020311 NDW
% 211.46/211.68 |- rdf__type mesh__D020311sskos__Concept
% 211.46/211.68 |- skos__broader mesh__D020311smesh__D046108
% 211.46/211.68 |- mesh__dateEstablished mesh__D020311 1999-01-01
% 211.46/211.68 |- mesh__dateCreated mesh__D020311 1998-06-11
% 211.46/211.68 |- skos__hiddenLabel mesh__D019568 Lungs, Hyperlucent
% 211.46/211.68 |- skos__prefLabel mesh__D019568 Lung, Hyperlucent
% 211.46/211.68 |- mesh__dateCreated mesh__D019568 1997-06-20
% 211.46/211.68 |- skos__historyNote mesh__D019568 Lung Diseases %28%1966-1997%29%
% 211.46/211.68 |- mesh__dateRevised mesh__D019568 2001-07-25
% 211.46/211.68 |- mesh__recordMaintainer mesh__D019568 lkt
% 211.46/211.68 |- skos__hiddenLabel mesh__D019568 Hyperlucent Thorax
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D019568 2002
% 211.46/211.68 |- mesh__historyNote mesh__D019568 98
% 211.46/211.68 |- skos__broader mesh__D019568smesh__D011656
% 211.46/211.68 |- skos__altLabel mesh__D019568 MacLeod Syndrome
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D019568 2005
% 211.46/211.68 |- skos__historyNote mesh__D019568 Pulmonary Emphysema %28%1966-1997%29%
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D019568 98
% 211.46/211.68 |- skos__annotation mesh__D019568
% 211.46/211.68 a type of pulm emphysema manifesting as hyperlucency on x-ray%A%
% 211.46/211.68 |- skos__hiddenLabel mesh__D019568 Syndrome, Swyer-James
% 211.46/211.68 |- skos__hiddenLabel mesh__D019568 Syndrome, MacLeod
% 211.46/211.68 |- skos__altLabel mesh__D019568 Thorax, Hyperlucent
% 211.46/211.68 |- mesh__recordOriginator mesh__D019568 TGC
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D019568 2006
% 211.46/211.68 |- skos__scopeNote mesh__D019568
% 211.46/211.68 Hyperlucency of one lung with decreased size and vascularity of the lung. It is often associated with BRONCHIOLITIS OBLITERANS and with adenovirus infection in childhood.%A%
% 211.46/211.68 |- mesh__dateEstablished mesh__D019568 1998-01-01
% 211.46/211.68 |- skos__hiddenLabel mesh__D019568 Swyer James Syndrome
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D019568 2003
% 211.46/211.68 |- rdf__type mesh__D019568sskos__Concept
% 211.46/211.68 |- skos__hiddenLabel mesh__D019568 Hyperlucent Lung
% 211.46/211.68 |- skos__hiddenLabel mesh__D019568 Hyperlucent Lungs
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D019568 sjn
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D019568 2004
% 211.46/211.68 |- mesh__dateRevised mesh__D011585 1991-06-28
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 2001
% 211.46/211.68 |- skos__scopeNote mesh__D011585
% 211.46/211.68 The science which utilizes psychologic principles to derive more effective means in dealing with practical problems.%A%
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 1993
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 1998
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 2002
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 1994
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 1999
% 211.46/211.68 |- mesh__recordMaintainer mesh__D011585 TGC
% 211.46/211.68 |- rdf__type mesh__D011585sskos__Concept
% 211.46/211.68 |- skos__hiddenLabel mesh__D011585 Psychologies, Applied
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 2003
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 1995
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 2004
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D011585 PLS
% 211.46/211.68 |- skos__altLabel mesh__D011585 Applied Psychology
% 211.46/211.68 |- mesh__dateCreated mesh__D011585 1999-01-01
% 211.46/211.68 |- skos__hiddenLabel mesh__D011585 Applied Psychologies
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 2005
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 1996
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 2006
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 2000
% 211.46/211.68 |- skos__prefLabel mesh__D011585 Psychology, Applied
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 1992
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D011585 1997
% 211.46/211.68 |- skos__annotation mesh__D011585 SPEC: SPEC qualif; DF: PSYCHOL APPLIED
% 211.46/211.68 |- mesh__recordOriginator mesh__D011585 NLM
% 211.46/211.68 |- skos__broader mesh__D011585smesh__D011579
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 1997
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D005548 PLS
% 211.46/211.68 |- mesh__historyNote mesh__D005548
% 211.46/211.68 91%28%75%29%; was FOREIGN BODY MIGRATION see under FOREIGN BODIES 1975-90%A%
% 211.46/211.68 |- mesh__recordMaintainer mesh__D005548 TGC
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 2002
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 2005
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 2004
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 1999
% 211.46/211.68 |- mesh__recordOriginator mesh__D005548 NLM
% 211.46/211.68 |- mesh__onlineNote mesh__D005548
% 211.46/211.68 use FOREIGN-BODY MIGRATION to search FOREIGN BODY MIGRATION 1975-90%A%
% 211.46/211.68 |- skos__hiddenLabel mesh__D005548 Foreign-Body Migrations
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 2006
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 1994
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 1993
% 211.46/211.68 |- skos__annotation mesh__D005548 note category
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 2000
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 1995
% 211.46/211.68 |- skos__hiddenLabel mesh__D005548 Migration, Foreign-Body
% 211.46/211.68 |- skos__hiddenLabel mesh__D005548 Foreign Body Migration
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 2001
% 211.46/211.68 |- mesh__dateEstablished mesh__D005548 1991-01-01
% 211.46/211.68 |- skos__scopeNote mesh__D005548
% 211.46/211.68 Migration of a foreign body from its original location to some other location in the body.%A%
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 1996
% 211.46/211.68 |- rdf__type mesh__D005548sskos__Concept
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D005548
% 211.46/211.68 91; was FOREIGN BODY MIGRATION see under FOREIGN BODIES 1975-90%A%
% 211.46/211.68 |- skos__hiddenLabel mesh__D005548 Migrations, Foreign-Body
% 211.46/211.68 |- skos__broader mesh__D005548smesh__D005547
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 2003
% 211.46/211.68 |- skos__prefLabel mesh__D005548 Foreign-Body Migration
% 211.46/211.68 |- mesh__dateCreated mesh__D005548 1974-11-11
% 211.46/211.68 |- mesh__dateRevised mesh__D005548 1992-05-15
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D005548 1998
% 211.46/211.68 |- skos__annotation mesh__D016270
% 211.46/211.68 add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: AHCPR CATALOG: use NAF entry%A%
% 211.46/211.68 |- mesh__historyNote mesh__D016270 91
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D016270 2006
% 211.46/211.68 |- mesh__recordMaintainer mesh__D016270 jls
% 211.46/211.68 |- mesh__dateCreated mesh__D016270 1990-05-29
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D016270 2001
% 211.46/211.68 |- mesh__recordOriginator mesh__D016270 TGC
% 211.46/211.68 |- rdf__type mesh__D016270sskos__Concept
% 211.46/211.68 |- skos__altLabel mesh__D016270
% 211.46/211.68 United States Agency for Health Care Policy and Research
% 211.46/211.68 |- skos__prefLabel mesh__D016270
% 211.46/211.68 United States Agency for Healthcare Research and Quality
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D016270 2005A
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D016270 2003
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D016270 2002
% 211.46/211.68 |- mesh__dateEstablished mesh__D016270 1991-01-01
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D016270 91
% 211.46/211.68 |- skos__scopeNote mesh__D016270
% 211.46/211.68 An agency of the PUBLIC HEALTH SERVICE established in 1990 to %22%provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery...%22% It supersedes the National Center for Health Services Research. The United States Agency for Health Care Policy and Research was renamed Agency for Healthcare Research and Quality %28%AHRQ%29% under the Healthcare Research and Quality Act of 1999.%A%
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D016270 jls
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D016270 2004
% 211.46/211.68 |- skos__altLabel mesh__D016270 Agency for Health Care Policy and Research
% 211.46/211.68 |- skos__broader mesh__D016270smesh__D014492
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D016270 2005
% 211.46/211.68 |- mesh__dateRevised mesh__D016270 2004-08-03
% 211.46/211.68 |- mesh__recordMaintainer mesh__D002250 TPW
% 211.46/211.68 |- skos__hiddenLabel mesh__D002250 Radioisotopes, Carbon
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D002250 74
% 211.46/211.68 |- skos__scopeNote mesh__D002250
% 211.46/211.68 Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes.%A%
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 1995
% 211.46/211.68 |- mesh__historyNote mesh__D002250 74
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 2001
% 211.46/211.68 |- mesh__recordOriginator mesh__D002250 NLM
% 211.46/211.68 |- rdf__type mesh__D002250sskos__Concept
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 1998
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 2002
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 1996
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 1999
% 211.46/211.68 |- mesh__onlineNote mesh__D002250 search CARBON ISOTOPES 1966-73
% 211.46/211.68 |- skos__annotation mesh__D002250
% 211.46/211.68 C-10,11,14-16; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 1997
% 211.46/211.68 |- skos__prefLabel mesh__D002250 Carbon Radioisotopes
% 211.46/211.68 |- skos__broader mesh__D002250smesh__D002247
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 2005
% 211.46/211.68 |- mesh__dateEstablished mesh__D002250 1974-01-01
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 2003
% 211.46/211.68 |- skos__broader mesh__D002250smesh__D011868
% 211.46/211.68 |- mesh__dateCreated mesh__D002250 1999-01-01
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 2006
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 2000
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 1994
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D002250 2004
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D002250 PLS
% 211.46/211.68 |- mesh__dateRevised mesh__D002250 1993-06-04
% 211.46/211.68 |- mesh__recordMaintainer mesh__D009939 TGC
% 211.46/211.68 |- mesh__dateEstablished mesh__D009939 1982-01-01
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 2002
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 1997
% 211.46/211.68 |- skos__hiddenLabel mesh__D009939 Non-Profit Organization
% 211.46/211.68 |- skos__scopeNote mesh__D009939
% 211.46/211.68 Organizations which are not operated for a profit and may be supported by endowments or private contributions.%A%
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 2004
% 211.46/211.68 |- skos__hiddenLabel mesh__D009939 Organization, Non-Profit
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 2001
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 1999
% 211.46/211.68 |- skos__annotation mesh__D009939 DF: ORGAN NONPROFIT
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 2006
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D009939 PLS
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 2003
% 211.46/211.68 |- mesh__recordOriginator mesh__D009939 EC
% 211.46/211.68 |- skos__prefLabel mesh__D009939 Organizations, Nonprofit
% 211.46/211.68 |- rdf__type mesh__D009939sskos__Concept
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 2000
% 211.46/211.68 |- skos__hiddenLabel mesh__D009939 Organization, Nonprofit
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 1998
% 211.46/211.68 |- mesh__historyNote mesh__D009939 82
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D009939 2005
% 211.46/211.68 |- mesh__dateCreated mesh__D009939 1981-03-04
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D009939 82
% 211.46/211.68 |- skos__hiddenLabel mesh__D009939 Non Profit Organizations
% 211.46/211.68 |- skos__broader mesh__D009939smesh__D009938
% 211.46/211.68 |- skos__hiddenLabel mesh__D009939 Nonprofit Organization
% 211.46/211.68 |- skos__altLabel mesh__D009939 Organizations, Non-Profit
% 211.46/211.68 |- mesh__dateRevised mesh__D009939 1996-06-10
% 211.46/211.68 |- skos__altLabel mesh__D009939 Nonprofit Organizations
% 211.46/211.68 |- skos__altLabel mesh__D009939 Non-Profit Organizations
% 211.46/211.68 |- skos__hiddenLabel mesh__D009939 Organizations, Non Profit
% 211.46/211.68 |- skos__annotation mesh__D001956
% 211.46/211.68 an adnexal ligament; inflammation = PARAMETRITIS
% 211.46/211.68 |- rdf__type mesh__D001956sskos__Concept
% 211.46/211.68 |- mesh__dateRevised mesh__D001956 1990-02-12
% 211.46/211.68 |- mesh__onlineNote mesh__D001956 search ADNEXA UTERI 1966-74
% 211.46/211.68 |- mesh__dateEstablished mesh__D001956 1991-01-01
% 211.46/211.68 |- skos__broader mesh__D001956smesh__D008022
% 211.46/211.68 |- skos__broader mesh__D001956smesh__D000290
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 2005
% 211.46/211.68 |- mesh__dateCreated mesh__D001956 1999-01-01
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 2001
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 2003
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 1994
% 211.46/211.68 |- mesh__publicMeSHNote mesh__D001956
% 211.46/211.68 91; was see under ADNEXA UTERI 1975-90
% 211.46/211.68 |- skos__hiddenLabel mesh__D001956 Ligament, Broad
% 211.46/211.68 |- mesh__historyNote mesh__D001956
% 211.46/211.68 91%28%75%29%; was see under ADNEXA UTERI 1975-90
% 211.46/211.68 |- mesh__recordMaintainer mesh__D001956 PXP
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 2006
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 1992
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 2002
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 1998
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 2004
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 1995
% 211.46/211.68 |- skos__hiddenLabel mesh__D001956 Ligaments, Broad
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 1991
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 1996
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 1993
% 211.46/211.68 |- mesh__recordAuthorizer mesh__D001956 PLS
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 1999
% 211.46/211.68 |- mesh__recordOriginator mesh__D001956 NLM
% 211.46/211.68 |- mesh__activeMeSHYear mesh__D001956 1997
% 211.46/211.68 |- skos__scopeNote mesh__D001956
% 211.46/211.68 A broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis.%A%
% 211.46/211.68 |- skos__hiddenLabel mesh__D001956 Broad Ligaments
% 211.46/211.68 |- skos__prefLabel mesh__D001956 Broad Ligament
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001956 2000
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 2005
% 211.46/211.69 |- skos__scopeNote mesh__D001158
% 211.46/211.69 The vessels carrying blood away from the heart.
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 2004
% 211.46/211.69 |- skos__annotation mesh__D001158
% 211.46/211.69 IM GEN only; NIM as coord to indicate specific artery, as %22%pancreatic artery%22% = PANCREAS /blood supply %28%IM%29% + ARTERIES %28%NIM%29%; /surg: consider also ENDARTERECTOMY; inflammation = ARTERITIS; arterial blood: index only if significant %26% coord BLOOD %28%NIM%29% + ARTERIES or specific artery %28%NIM%29%; arterial pressure = BLOOD PRESSURE %28%IM%29% only: specify specific artery only if pertinent%A%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 1996
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 2006
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 2000
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 1998
% 211.46/211.69 |- skos__prefLabel mesh__D001158 Arteries
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 1997
% 211.46/211.69 |- skos__related mesh__D001158smesh__D000792
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 2001
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 1994
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 1999
% 211.46/211.69 |- mesh__dateRevised mesh__D001158 1992-03-25
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 1993
% 211.46/211.69 |- rdf__type mesh__D001158sskos__Concept
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 1995
% 211.46/211.69 |- mesh__dateCreated mesh__D001158 1999-01-01
% 211.46/211.69 |- skos__broader mesh__D001158smesh__D001808
% 211.46/211.69 |- skos__hiddenLabel mesh__D001158 Artery
% 211.46/211.69 |- mesh__recordOriginator mesh__D001158 NLM
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 2002
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D001158 PLS
% 211.46/211.69 |- skos__related mesh__D001158smesh__D004691
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001158 2003
% 211.46/211.69 |- mesh__recordMaintainer mesh__D001158 TAP
% 211.46/211.69 |- skos__broader mesh__D006641smesh__D007093
% 211.46/211.69 |- mesh__recordOriginator mesh__D006641 NLM
% 211.46/211.69 |- skos__historyNote mesh__D006641 Imidazoles %28%1972-1974%29%
% 211.46/211.69 |- skos__altLabel mesh__D006641 Histidol
% 211.46/211.69 |- mesh__dateEstablished mesh__D006641 1991-01-01
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D006641 sjn
% 211.46/211.69 |- skos__scopeNote mesh__D006641
% 211.46/211.69 The penultimate step in the pathway of histidine biosynthesis. Oxidation of the alcohol group on the side chain gives the acid group forming histidine. Histidinol has also been used as an inhibitor of protein synthesis.%A%
% 211.46/211.69 |- skos__broader mesh__D006641smesh__D011412
% 211.46/211.69 |- rdf__type mesh__D006641sskos__Concept
% 211.46/211.69 |- mesh__historyNote mesh__D006641
% 211.46/211.69 91%28%75%29%; was see under IMIDAZOLES 1975-90
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D006641
% 211.46/211.69 91; was see under IMIDAZOLES 1975-90
% 211.46/211.69 |- skos__prefLabel mesh__D006641 Histidinol
% 211.46/211.69 |- skos__historyNote mesh__D006641 Amino Alcohols %28%1972-1974%29%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D006641 2006
% 211.46/211.69 |- mesh__recordMaintainer mesh__D006641 ssb
% 211.46/211.69 |- mesh__dateCreated mesh__D006641 1974-11-19
% 211.46/211.69 |- mesh__dateRevised mesh__D006641 2005-06-30
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D020312 2006
% 211.46/211.69 |- skos__altLabel mesh__D020312 Emus
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D020312 sjn
% 211.46/211.69 |- mesh__recordOriginator mesh__D020312 NDW
% 211.46/211.69 |- skos__broader mesh__D020312smesh__D046108
% 211.46/211.69 |- skos__altLabel mesh__D020312 Dromaius novaehollandiae
% 211.46/211.69 |- mesh__dateEstablished mesh__D020312 1999-01-01
% 211.46/211.69 |- skos__scopeNote mesh__D020312
% 211.46/211.69 A family of flightless, running BIRDS, in the order Casuariiformes. The emu is the only surviving member of the family. They naturally inhabit forests, open plains, and grasslands in Australia.%A%
% 211.46/211.69 |- skos__prefLabel mesh__D020312 Dromaiidae
% 211.46/211.69 |- rdf__type mesh__D020312sskos__Concept
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D020312 2005
% 211.46/211.69 |- mesh__dateRevised mesh__D020312 2004-07-07
% 211.46/211.69 |- mesh__historyNote mesh__D020312 2005 %28%1999%29%
% 211.46/211.69 |- skos__historyNote mesh__D020312 Birds %28%1973-1998%29%
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D020312 2005; see EMUS 1999
% 211.46/211.69 |- mesh__recordMaintainer mesh__D020312 ags
% 211.46/211.69 |- mesh__dateCreated mesh__D020312 1998-06-10
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D019569 2001
% 211.46/211.69 |- mesh__historyNote mesh__D019569 1998
% 211.46/211.69 |- skos__hiddenLabel mesh__D019569 Spasms, Unilateral Facial
% 211.46/211.69 |- skos__hiddenLabel mesh__D019569 Unilateral Facial Spasms
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D019569 2005
% 211.46/211.69 |- skos__hiddenLabel mesh__D019569 Spasm, Unilateral Facial
% 211.46/211.69 |- skos__historyNote mesh__D019569 Facial Nerve Diseases %28%1981-1997%29%
% 211.46/211.69 |- skos__historyNote mesh__D019569 Facial Muscles %28%1966-1997%29%
% 211.46/211.69 |- skos__hiddenLabel mesh__D019569 Unilateral Facial Spasm
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D019569 ags
% 211.46/211.69 |- mesh__dateCreated mesh__D019569 1997-06-20
% 211.46/211.69 |- skos__broader mesh__D019569smesh__D009059
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D019569 2006
% 211.46/211.69 |- skos__altLabel mesh__D019569 Spasm, Hemifacial
% 211.46/211.69 |- skos__broader mesh__D019569smesh__D013035
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D019569 1998
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D019569 2002
% 211.46/211.69 |- mesh__recordMaintainer mesh__D019569 ags
% 211.46/211.69 |- skos__hiddenLabel mesh__D019569 Hemifacial Spasms
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D019569 2003
% 211.46/211.69 |- rdf__type mesh__D019569sskos__Concept
% 211.46/211.69 |- skos__historyNote mesh__D019569 Spasm %28%1966-1997%29%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D019569 2000A
% 211.46/211.69 |- skos__hiddenLabel mesh__D019569 Myokymia, Hemifacial
% 211.46/211.69 |- skos__altLabel mesh__D019569 Facial Spasm, Unilateral
% 211.46/211.69 |- mesh__recordOriginator mesh__D019569 TGC
% 211.46/211.69 |- skos__hiddenLabel mesh__D019569 Facial Spasms, Unilateral
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D019569 2004
% 211.46/211.69 |- skos__prefLabel mesh__D019569 Hemifacial Spasm
% 211.46/211.69 |- mesh__dateEstablished mesh__D019569 1998-01-01
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D019569 2000
% 211.46/211.69 |- skos__hiddenLabel mesh__D019569 Spasms, Hemifacial
% 211.46/211.69 |- mesh__dateRevised mesh__D019569 1999-12-13
% 211.46/211.69 |- skos__scopeNote mesh__D019569
% 211.46/211.69 Recurrent clonic contraction of facial muscles, restricted to one side. It may occur as a manifestation of compressive lesions involving the seventh cranial nerve %28%FACIAL NERVE DISEASES%29%, during recovery from BELL PALSY, or in association with other disorders. %28%From Adams et al., Principles of Neurology, 6th ed, p1378%29%%A%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 2006
% 211.46/211.69 |- skos__scopeNote mesh__D011586
% 211.46/211.69 The branch of psychology concerned with psychological methods of recognizing and treating behavior disorders.%A%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 1996
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 1995
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 2001
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 2005
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 1994
% 211.46/211.69 |- mesh__recordOriginator mesh__D011586 NLM
% 211.46/211.69 |- skos__annotation mesh__D011586 SPEC: SPEC qualif; DF: PSYCHOL CLIN
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 2000
% 211.46/211.69 |- mesh__dateCreated mesh__D011586 1999-01-01
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 1999
% 211.46/211.69 |- rdf__type mesh__D011586sskos__Concept
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 2004
% 211.46/211.69 |- skos__altLabel mesh__D011586 Clinical Psychology
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D011586 PLS
% 211.46/211.69 |- mesh__dateRevised mesh__D011586 1993-06-04
% 211.46/211.69 |- skos__prefLabel mesh__D011586 Psychology, Clinical
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 1998
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 2003
% 211.46/211.69 |- mesh__recordMaintainer mesh__D011586 JLS
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 1997
% 211.46/211.69 |- skos__broader mesh__D011586smesh__D011584
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011586 2002
% 211.46/211.69 |- skos__broader mesh__D005549smesh__D007249
% 211.46/211.69 |- mesh__recordMaintainer mesh__D005549 KEV
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D005549
% 211.46/211.69 91; was FOREIGN BODY REACTION 1974-90
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D005549 2006
% 211.46/211.69 |- skos__hiddenLabel mesh__D005549 Foreign Body Reaction
% 211.46/211.69 |- skos__historyNote mesh__D005549 Foreign Bodies %28%1966-1971%29%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D005549 2002
% 211.46/211.69 |- skos__hiddenLabel mesh__D005549 Reaction, Foreign-Body
% 211.46/211.69 |- skos__annotation mesh__D005549
% 211.46/211.69 note category: in presence of a dis, use /etiol, not /compl%A%
% 211.46/211.69 |- mesh__recordOriginator mesh__D005549 NLM
% 211.46/211.69 |- mesh__dateEstablished mesh__D005549 1974-01-01
% 211.46/211.69 |- skos__scopeNote mesh__D005549
% 211.46/211.69 Chronic inflammation and granuloma formation around irritating foreign bodies.%A%
% 211.46/211.69 |- rdf__type mesh__D005549sskos__Concept
% 211.46/211.69 |- skos__prefLabel mesh__D005549 Foreign-Body Reaction
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D005549 2000
% 211.46/211.69 |- skos__broader mesh__D005549smesh__D005547
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D005549 2003
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D005549 sjn
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D005549 2001
% 211.46/211.69 |- mesh__historyNote mesh__D005549
% 211.46/211.69 91%28%72%29%; was FOREIGN BODY REACTION 1972-90 %28%Prov 1972-73%29%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D005549 2005
% 211.46/211.69 |- mesh__dateRevised mesh__D005549 1999-11-03
% 211.46/211.69 |- mesh__dateCreated mesh__D005549 1999-01-01
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D005549 2004
% 211.46/211.69 |- mesh__onlineNote mesh__D005549
% 211.46/211.69 use FOREIGN-BODY REACTION to search FOREIGN BODY REACTION 1972-90 %28%as Prov 1972-73%29%%A%
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 myc Proto Oncogene Proteins
% 211.46/211.69 |- skos__historyNote mesh__D016271 Phosphoproteins %28%1985%29%
% 211.46/211.69 |- skos__broader mesh__D016271smesh__D009687
% 211.46/211.69 |- mesh__dateCreated mesh__D016271 1990-06-19
% 211.46/211.69 |- skos__altLabel mesh__D016271 c-myc Proteins
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 L myc Proteins
% 211.46/211.69 |- skos__altLabel mesh__D016271 Proto-Oncogene Products c-myc
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 p62 c myc
% 211.46/211.69 |- skos__altLabel mesh__D016271 Proto-Oncogene Proteins myc
% 211.46/211.69 |- skos__broader mesh__D016271smesh__D011518
% 211.46/211.69 |- skos__prefLabel mesh__D016271 Proto-Oncogene Proteins c-myc
% 211.46/211.69 |- skos__scopeNote mesh__D016271
% 211.46/211.69 Cellular DNA-binding proteins encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated %28%constitutive%29% expression of c-myc proteins can cause tumorigenesis.%A%
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 Proto Oncogene Proteins myc
% 211.46/211.69 |- mesh__recordOriginator mesh__D016271 AGS
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D016271 2006
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 myc Proto Oncogene Product p62
% 211.46/211.69 |- skos__altLabel mesh__D016271 myc Proto-Oncogene Product p62
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 Proto-Oncogene Proteins, myc
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 myc, Proto-Oncogene Proteins
% 211.46/211.69 |- skos__historyNote mesh__D016271
% 211.46/211.69 Proto-Oncogene Proteins %28%1986-1990%29%
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 c myc Proteins
% 211.46/211.69 |- skos__altLabel mesh__D016271 p62%28%c-myc%29%
% 211.46/211.69 |- rdf__type mesh__D016271sskos__Concept
% 211.46/211.69 |- mesh__dateRevised mesh__D016271 2005-06-30
% 211.46/211.69 |- skos__annotation mesh__D016271
% 211.46/211.69 /drug eff /ultrastruct permitted; DF: note short X refs
% 211.46/211.69 |- skos__historyNote mesh__D016271 Neoplasm Proteins %28%1983-1984%29%
% 211.46/211.69 |- skos__altLabel mesh__D016271 myc Proto-Oncogene Proteins
% 211.46/211.69 |- mesh__recordMaintainer mesh__D016271 DRC
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 Proto Oncogene Products c myc
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 Proteins myc, Proto-Oncogene
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D016271 sjn
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 Proto Oncogene Proteins c myc
% 211.46/211.69 |- skos__broader mesh__D016271smesh__D004268
% 211.46/211.69 |- mesh__historyNote mesh__D016271 91
% 211.46/211.69 |- skos__hiddenLabel mesh__D016271 N myc Proteins
% 211.46/211.69 |- skos__altLabel mesh__D016271 p62 c-myc
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D016271 91
% 211.46/211.69 |- mesh__dateEstablished mesh__D016271 1991-01-01
% 211.46/211.69 |- rdf__type mesh__D002251sskos__Concept
% 211.46/211.69 |- skos__scopeNote mesh__D002251
% 211.46/211.69 A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. %28%Merck Index, 11th ed%29%%A%
% 211.46/211.69 |- skos__altLabel mesh__D002251 Tetrachloromethane
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D002251 sjn
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D002251 2001
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D002251 2005
% 211.46/211.69 |- mesh__recordOriginator mesh__D002251 NLM
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D002251 2002
% 211.46/211.69 |- mesh__dateRevised mesh__D002251 2000-06-22
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D002251 2003
% 211.46/211.69 |- skos__hiddenLabel mesh__D002251 Tetrachloride, Carbon
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D002251 2006
% 211.46/211.69 |- skos__prefLabel mesh__D002251 Carbon Tetrachloride
% 211.46/211.69 |- skos__broader mesh__D002251smesh__D006843
% 211.46/211.69 |- mesh__dateCreated mesh__D002251 1999-01-01
% 211.46/211.69 |- skos__annotation mesh__D002251
% 211.46/211.69 /tox permitted but consider also CARBON TETRACHLORIDE POISONING; DF: CCL4%A%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D002251 2004
% 211.46/211.69 |- mesh__recordMaintainer mesh__D002251 CCR
% 211.46/211.69 |- mesh__historyNote mesh__D015977 2003%28%1990%29%
% 211.46/211.69 |- skos__hiddenLabel mesh__D015977 Peptide Initiation Factor EIF 1
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D015977 2006
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D015977 sjn
% 211.46/211.69 |- mesh__recordOriginator mesh__D015977 AGS
% 211.46/211.69 |- skos__historyNote mesh__D015977
% 211.46/211.69 Peptide Initiation Factors %28%1978-1989%29%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D015977 2003
% 211.46/211.69 |- skos__altLabel mesh__D015977 Peptide Initiation Factor EIF-1
% 211.46/211.69 |- skos__broader mesh__D015977smesh__D039642
% 211.46/211.69 |- rdf__type mesh__D015977sskos__Concept
% 211.46/211.69 |- skos__altLabel mesh__D015977 Eukaryotic Peptide Initiation Factor-1
% 211.46/211.69 |- skos__altLabel mesh__D015977 EIF-1
% 211.46/211.69 |- skos__scopeNote mesh__D015977
% 211.46/211.69 A eukaryotic initiation factor that binds to 40S ribosomal subunits. Although initially considered a %22%non-essential%22% factor for eukaryotic transcription initiation, eukaryotic initiation factor-1 is now thought to play an important role in localizing RIBOSOMES at the initiation codon of MRNA.%A%
% 211.46/211.69 |- mesh__recordMaintainer mesh__D015977 jmp
% 211.46/211.69 |- skos__hiddenLabel mesh__D015977 Eukaryotic Peptide Initiation Factor 1
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D015977 2004
% 211.46/211.69 |- mesh__dateEstablished mesh__D015977 1990-01-01
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D015977 2003; see EIF-1 1990-2002
% 211.46/211.69 |- mesh__dateRevised mesh__D015977 2002-07-03
% 211.46/211.69 |- mesh__dateCreated mesh__D015977 1989-10-18
% 211.46/211.69 |- skos__prefLabel mesh__D015977 Eukaryotic Initiation Factor-1
% 211.46/211.69 |- skos__hiddenLabel mesh__D015977 Eukaryotic Initiation Factor 1
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D015977 2005
% 211.46/211.69 |- mesh__dateEstablished mesh__D015179 1989-01-01
% 211.46/211.69 |- skos__historyNote mesh__D015179 Colonic Neoplasms %28%1966-1988%29%
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Neoplasm, Colorectal
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Tumors, Colorectal
% 211.46/211.69 |- rdf__type mesh__D015179sskos__Concept
% 211.46/211.69 |- skos__broader mesh__D015179smesh__D012002
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Carcinomas, Colorectal
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Colorectal Neoplasm
% 211.46/211.69 |- mesh__dateRevised mesh__D015179 2005-06-30
% 211.46/211.69 |- skos__related mesh__D015179smesh__D016163
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Cancers, Colorectal
% 211.46/211.69 |- skos__broader mesh__D015179smesh__D003108
% 211.46/211.69 |- skos__historyNote mesh__D015179 Rectal Neoplasms %28%1966-1988%29%
% 211.46/211.69 |- skos__broader mesh__D015179smesh__D007414
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Colorectal Carcinomas
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D015179 sjn
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Colorectal Cancers
% 211.46/211.69 |- skos__altLabel mesh__D015179 Neoplasms, Colorectal
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D015179 2006
% 211.46/211.69 |- mesh__recordOriginator mesh__D015179 EJB
% 211.46/211.69 |- skos__altLabel mesh__D015179 Colorectal Tumors
% 211.46/211.69 |- skos__scopeNote mesh__D015179
% 211.46/211.69 Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.%A%
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Colorectal Tumor
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Carcinoma, Colorectal
% 211.46/211.69 |- mesh__historyNote mesh__D015179 89
% 211.46/211.69 |- mesh__dateCreated mesh__D015179 1988-04-14
% 211.46/211.69 |- skos__prefLabel mesh__D015179 Colorectal Neoplasms
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Cancer, Colorectal
% 211.46/211.69 |- mesh__recordMaintainer mesh__D015179 ags
% 211.46/211.69 |- skos__annotation mesh__D015179
% 211.46/211.69 a clinical entity: not a synonym for COLONIC NEOPLASMS + RECTAL NEOPLASMS; coord IM with histol type of neopl %28%IM%29%; GENES, DCC %28%for %22%Deleted in Colorectal Cancer%22%%29% %26% GENES, MCC %28%for %22%Mutated in Colorectal Cancer%22%%29% are available: see MeSH scope notes and annotations there%A%
% 211.46/211.69 |- skos__related mesh__D015179smesh__D017431
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D015179 89
% 211.46/211.69 |- skos__hiddenLabel mesh__D015179 Tumor, Colorectal
% 211.46/211.69 |- mesh__dateCreated mesh__D001957 1999-01-01
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001957 2003
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001957 2006
% 211.46/211.69 |- skos__scopeNote mesh__D001957
% 211.46/211.69 Published pieces of paper or other material, usually printed on one side and intended to be read unfolded and usually intended to be posted, publicly distributed, or sold. %28%From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed%29%%A%
% 211.46/211.69 |- mesh__recordMaintainer mesh__D001957 sjn
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001957 2004
% 211.46/211.69 |- mesh__dateRevised mesh__D001957 2002-07-24
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D001957 sjn
% 211.46/211.69 |- skos__prefLabel mesh__D001957 Broadsides
% 211.46/211.69 |- skos__broader mesh__D001957smesh__D011642
% 211.46/211.69 |- skos__annotation mesh__D001957
% 211.46/211.69 IM; coord with subject %28%IM%29%; do not confuse with Publication Type BROADSIDES%A%
% 211.46/211.69 |- mesh__recordOriginator mesh__D001957 NLM
% 211.46/211.69 |- rdf__type mesh__D001957sskos__Concept
% 211.46/211.69 |- skos__hiddenLabel mesh__D001957 Broadside
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001957 2005
% 211.46/211.69 |- mesh__dateRevised mesh__D001159 1999-11-08
% 211.46/211.69 |- skos__hiddenLabel mesh__D001159 Arterio Arterial Fistula
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001159 2000
% 211.46/211.69 |- mesh__dateEstablished mesh__D001159 1987-01-01
% 211.46/211.69 |- skos__scopeNote mesh__D001159
% 211.46/211.69 Abnormal communication between two arteries that may result from injury or occur as a congenital abnormality.%A%
% 211.46/211.69 |- skos__annotation mesh__D001159
% 211.46/211.69 coord IM with specific arteries %28%IM%29% or precoord artery/dis term %28%IM%29%; if congenital use /abnorm on the arteries and /congen on the artery/dis term and fistula%A%
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D001159 87
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001159 2005
% 211.46/211.69 |- mesh__dateCreated mesh__D001159 1986-04-18
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001159 2004
% 211.46/211.69 |- skos__hiddenLabel mesh__D001159 Fistula, Arterio-Arterial
% 211.46/211.69 |- skos__prefLabel mesh__D001159 Arterio-Arterial Fistula
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001159 2001
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001159 2006
% 211.46/211.69 |- rdf__type mesh__D001159sskos__Concept
% 211.46/211.69 |- mesh__historyNote mesh__D001159 87
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D001159 sjn
% 211.46/211.69 |- skos__broader mesh__D001159smesh__D016157
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001159 2002
% 211.46/211.69 |- skos__hiddenLabel mesh__D001159 Fistulas, Arterio-Arterial
% 211.46/211.69 |- skos__historyNote mesh__D001159 specific arteries %28%1966-1986%29%
% 211.46/211.69 |- skos__hiddenLabel mesh__D001159 Arterio-Arterial Fistulas
% 211.46/211.69 |- mesh__recordOriginator mesh__D001159 VDK
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D001159 2003
% 211.46/211.69 |- skos__broader mesh__D001159smesh__D018376
% 211.46/211.69 |- mesh__recordMaintainer mesh__D001159 KEV
% 211.46/211.69 |- mesh__dateEstablished mesh__D006642 1991-01-01
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D006642
% 211.46/211.69 94; was HISTIDINOLPHOSPHATASE 1975-93 %28%see under PHOSPHOMONOESTERASES 1975-90%29%%A%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D006642 2005
% 211.46/211.69 |- mesh__dateCreated mesh__D006642 1974-11-19
% 211.46/211.69 |- mesh__recordMaintainer mesh__D006642 ssb
% 211.46/211.69 |- skos__scopeNote mesh__D006642
% 211.46/211.69 An enzyme that catalyzes the hydrolysis of histidinol-phosphate to histidinol. One of the regulatory enzymes in histidine biosynthesis. EC 3.1.3.15.%A%
% 211.46/211.69 |- mesh__historyNote mesh__D006642
% 211.46/211.69 94; was HISTIDINOLPHOSPHATASE 1975-93 %28%see under PHOSPHOMONOESTERASES 1975-90%29%%A%
% 211.46/211.69 |- skos__historyNote mesh__D006642 Imidazoles %28%1972-1974%29%
% 211.46/211.69 |- skos__historyNote mesh__D006642 Amino Alcohols %28%1972-1974%29%
% 211.46/211.69 |- skos__altLabel mesh__D006642 Histidinolphosphatase
% 211.46/211.69 |- mesh__dateRevised mesh__D006642 2003-07-09
% 211.46/211.69 |- skos__altLabel mesh__D006642 Histidinol Phosphate Phosphatase
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D006642 2006
% 211.46/211.69 |- mesh__recordOriginator mesh__D006642 NLM
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D006642 2004
% 211.46/211.69 |- skos__prefLabel mesh__D006642 Histidinol-Phosphatase
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D006642 sjn
% 211.46/211.69 |- mesh__onlineNote mesh__D006642
% 211.46/211.69 use HISTIDINOL-PHOSPHATASE to search HISTIDINOLPHOSPHATASE 1975-93%A%
% 211.46/211.69 |- skos__historyNote mesh__D006642 Phosphatases %28%1973-1974%29%
% 211.46/211.69 |- skos__broader mesh__D006642smesh__D010744
% 211.46/211.69 |- rdf__type mesh__D006642sskos__Concept
% 211.46/211.69 |- mesh__recordOriginator mesh__D020313 ADP
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D020313 ags
% 211.46/211.69 |- mesh__publicMeSHNote mesh__D020313
% 211.46/211.69 2004; see USES OF CHEMICALS AND DRUGS 1999-2003 and SPECIALTY CHEMICALS AND PRODUCTS 1975-2003%A%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D020313 2006A
% 211.46/211.69 |- skos__altLabel mesh__D020313 Specialty Chemicals and Products
% 211.46/211.69 |- mesh__historyNote mesh__D020313 2004%28%1999%29%
% 211.46/211.69 |- rdf__type mesh__D020313sskos__Concept
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D020313 2005
% 211.46/211.69 |- mesh__dateEstablished mesh__D020313 1999-01-01
% 211.46/211.69 |- skos__broader mesh__D020313smesh__D020164
% 211.46/211.69 |- mesh__dateCreated mesh__D020313 1998-06-11
% 211.46/211.69 |- skos__scopeNote mesh__D020313
% 211.46/211.69 Uses of chemicals in a research, industrial, or household setting. This does not include PHARMACOLOGIC ACTIONS.%A%
% 211.46/211.69 |- skos__prefLabel mesh__D020313 Specialty Uses of Chemicals
% 211.46/211.69 |- mesh__recordMaintainer mesh__D020313 ags
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D020313 2006
% 211.46/211.69 |- mesh__dateRevised mesh__D020313 2005-07-22
% 211.46/211.69 |- skos__annotation mesh__D020313
% 211.46/211.69 not used for indexing CATALOG: do not use
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D020313 2004
% 211.46/211.69 |- skos__hiddenLabel mesh__D011587 Comparative Psychologies
% 211.46/211.69 |- skos__broader mesh__D011587smesh__D011584
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 2001
% 211.46/211.69 |- skos__altLabel mesh__D011587 Comparative Psychology
% 211.46/211.69 |- mesh__recordOriginator mesh__D011587 NLM
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 2006
% 211.46/211.69 |- mesh__recordMaintainer mesh__D011587 TGC
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 2000
% 211.46/211.69 |- skos__annotation mesh__D011587
% 211.46/211.69 SPEC: IM, SPEC qualif; NIM coord, no qualif; do not check COMPARATIVE STUDY for as a field it is not a substitute for a comparison of two or more psychol concepts %28% = COMPARATIVE STUDY tag%29%: Manual 18.13.4; DF: PSYCHOL COMPARATIVE%A%
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 1995
% 211.46/211.69 |- mesh__dateCreated mesh__D011587 1999-01-01
% 211.46/211.69 |- skos__scopeNote mesh__D011587
% 211.46/211.69 The branch of psychology concerned with similarities or differences in the behavior of different animal species or of different races or peoples.%A%
% 211.46/211.69 |- rdf__type mesh__D011587sskos__Concept
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 2005
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 1999
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 1994
% 211.46/211.69 |- mesh__recordAuthorizer mesh__D011587 PLS
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 2004
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 1993
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 1998
% 211.46/211.69 |- skos__prefLabel mesh__D011587 Psychology, Comparative
% 211.46/211.69 |- mesh__activeMeSHYear mesh__D011587 2003
% 211.55/211.69 |- mesh__dateRevised mesh__D011587 1991-06-28
% 211.55/211.69 |- mesh__activeMeSHYear mesh__D011587 1992
% 211.55/211.69 |- mesh__activeMeSHYear mesh__D011587 1997
% 211.55/211.69 |- skos__hiddenLabel mesh__D011587 Psychologies, Comparative
% 211.55/211.69 |- mesh__activeMeSHYear mesh__D011587 2002
% 211.55/211.69 |- mesh__activeMeSHYear mesh__D011587 1996
% 211.55/211.69 |- mesh__historyNote mesh__D030741 2002
% 211.55/211.69 |- mesh__dateCreated mesh__D030741 2001-07-25
% 211.55/211.69 |- mesh__activeMeSHYear mesh__D030741 2005
% 211.55/211.69 |- mesh__activeMeSHYear mesh__D030741 2004
% 211.55/211.69 |- mesh__publicMeSHNote mesh__D030741 2002
% 211.55/211.69 |- skos__scopeNote mesh__D030741
% 211.55/211.69 A membrane-bound carbonic anhydrase found in lung capillaries and kidney.%A%
% 211.55/211.69 |- skos__hiddenLabel mesh__D030741 Anhydrase 4, Carbonic
% 211.55/211.69 |- mesh__activeMeSHYear mesh__D030741 2006
% 211.55/211.69 |- rdf__type mesh__D030741sskos__Concept
% 211.55/211.69 |- mesh__dateEstablished mesh__D030741 2002-01-01
% 211.55/211.69 |- skos__altLabel mesh__D030741 Carbonic Anhydrase Isozyme IV
% 211.55/211.69 |- skos__altLabel mesh__D030741 Carbonic Anhydrase 4
% 211.55/211.69 |- mesh__dateRevised mesh__D030741 2003-07-09
% 211.55/211.69 |- skos__historyNote mesh__D030741 Carbonic Anhydrases %28%1990-2001%29%
% 211.55/211.69 |- skos__prefLabel mesh__D030741 Carbonic Anhydrase IV
% 211.55/211.69 |- skos__broader mesh__D030741smesh__D002256
% 211.55/211.69 |- skos__annotation mesh__D030741
% 211.55/211.69 /antag: coord with CARBONIC ANHYDRASE INHIBITORS
% 211.55/211.69 |- mesh__recordAuthorizer mesh__D016272 sjn
% 211.55/211.69 |- mesh__recordMaintainer mesh__D016272 kle
% 211.55/211.69 |- skos__scopeNote mesh__D016272
% 211.55/211.69 The promotion and maintenance of physical and mental health in the work environment.%A%
% 211.55/211.69 |- mesh__recordOriginator mesh__D016272 PXP
% 211.55/211.69 |- skos__historyNote mesh__D016272 Occupational Medicine %28%1966-1990%29%
% 211.55/211.69 |- mesh__publicMeSHNote mesh__D016272 91
% 211.55/211.69 |- mesh__activeMeSHYear mesh__D016272 2006
% 211.55/211.69 |- skos__altLabel mesh__D016272 Occupational Safety
% 211.55/211.69 |- skos__altLabel mesh__D016272 Industrial Health
% 211.55/211.69 |- mesh__dateRevised mesh__D016272 1999-11-03
% 211.55/211.69 |- mesh__dateCreated mesh__D016272 1990-05-29
% 211.55/211.70 |- skos__broader mesh__D016272smesh__D006262
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D016272 2005
% 211.55/211.70 |- rdf__type mesh__D016272sskos__Concept
% 211.55/211.70 |- skos__hiddenLabel mesh__D016272 Health, Employee
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D016272 2002
% 211.55/211.70 |- skos__historyNote mesh__D016272
% 211.55/211.70 Occupational Health Services %28%1968-1990%29%
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D016272 2004
% 211.55/211.70 |- skos__prefLabel mesh__D016272 Occupational Health
% 211.55/211.70 |- skos__annotation mesh__D016272
% 211.55/211.70 %22%promotion %26% maintenance of physical %26% mental health in the work environment%22%: do not confuse with OCCUPATIONAL MEDICINE %28%the specialty%29% or OCCUPATIONAL HEALTH SERVICES; note X ref OCCUPATIONAL SAFETY which is GEN only: do not use as coord for safety in an industrial milieu %28% = SAFETY + specific indust or occup heading%29%; DF: OCCUP HEALTH%A%
% 211.55/211.70 |- skos__altLabel mesh__D016272 Health, Industrial
% 211.55/211.70 |- mesh__historyNote mesh__D016272 91
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D016272 2001
% 211.55/211.70 |- skos__historyNote mesh__D016272
% 211.55/211.70 Occupational Health Nursing %28%1966-1990%29%
% 211.55/211.70 |- mesh__dateEstablished mesh__D016272 1991-01-01
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D016272 2003
% 211.55/211.70 |- skos__hiddenLabel mesh__D016272 Health, Occupational
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D016272 2000
% 211.55/211.70 |- skos__altLabel mesh__D016272 Hygiene, Industrial
% 211.55/211.70 |- skos__altLabel mesh__D002252 CCl4 Poisoning
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D002252 2002
% 211.55/211.70 |- skos__hiddenLabel mesh__D002252 CCl4 Poisonings
% 211.55/211.70 |- skos__hiddenLabel mesh__D002252 Carbon Tetrachloride Poisonings
% 211.55/211.70 |- rdf__type mesh__D002252sskos__Concept
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D002252 2001
% 211.55/211.70 |- skos__prefLabel mesh__D002252 Carbon Tetrachloride Poisoning
% 211.55/211.70 |- skos__altLabel mesh__D002252 Poisoning, Carbon Tetrachloride
% 211.55/211.70 |- skos__hiddenLabel mesh__D002252 Poisonings, Carbon Tetrachloride
% 211.55/211.70 |- mesh__dateCreated mesh__D002252 1999-01-01
% 211.55/211.70 |- mesh__recordAuthorizer mesh__D002252 sjn
% 211.55/211.70 |- skos__broader mesh__D002252smesh__D011041
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D002252 2000
% 211.55/211.70 |- mesh__recordOriginator mesh__D002252 NLM
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D002252 2004
% 211.55/211.70 |- mesh__dateRevised mesh__D002252 1999-11-03
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D002252 2006
% 211.55/211.70 |- skos__annotation mesh__D002252 DF: CCL4 POIS
% 211.55/211.70 |- mesh__recordMaintainer mesh__D002252 ags
% 211.55/211.70 |- mesh__activeMeSHYear mesh__D00225